PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Fiala, M; Kooij, G; Wagner, K; Hammock, B; Pellegrini, M				Fiala, Milan; Kooij, Gijs; Wagner, Karen; Hammock, Bruce; Pellegrini, Matteo			Modulation of innate immunity of patients with Alzheimer's disease by omega-3 fatty acids	FASEB JOURNAL			English	Review							SOLUBLE EPOXIDE HYDROLASE; AMYLOID-BETA PHAGOCYTOSIS; M2 MACROPHAGE POLARIZATION; RESOLVING LIPID MEDIATORS; BLOOD-BRAIN-BARRIER; DOCOSAHEXAENOIC ACID; FATTY-ACIDS; VITAMIN-D; ACUTE-INFLAMMATION; COGNITIVE DECLINE	The innate immune system of patients with Alzheimer's disease and mild cognitive impairment (MCI) is deregulated with highly increased or decreased transcription of inflammatory genes and consistently depressed phagocytosis of amyloid-beta(1-42) (A beta) by monocytes and macrophages. Current immune therapies target single mechanisms in the adaptive immune system but not innate immunity. Here, we summarize recent advances in therapy by omega-3, omega-6, and epoxy fatty acids; specialized proresolving mediators; and vitamin D-3 that have proven immune effects and emerging cognitive effects in patients with MCI. The hypothesis of this approach is that macrophages of normal participants, but not those of patients with Alzheimer's disease and MCI, possess effective phagocytosis for A beta and protect homeostasis of the brain and, furthermore, that defective MCI macrophages recover phagocytic function via omega-3. Recent studies of fish-derived omega-3 supplementation in patients with MCI have shown polarization of Apo epsilon 3/epsilon 3 patients' macrophages to an intermediate M1-M2 phenotype that is optimal for A beta phagocytosis and the stabilization of cognitive decline. Therefore, accumulating preclinical and preliminary clinical evidence indicates that omega-3 supplementation should be tested in a randomized controlled clinical trial and that the analysis should involve the apolipoprotein E genotype and intervening conditions during trial.	[Fiala, Milan; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Kooij, Gijs] Vrije Univ, Med Ctr, Multiple Sclerosis Ctr Amsterdam, Dept Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Kooij, Gijs] Brigham & Womens Hosp, Perioperat & Pain Med, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol,Harvard Inst Med, 75 Francis St, Boston, MA 02115 USA; [Kooij, Gijs] Harvard Med Sch, Boston, MA USA; [Wagner, Karen; Hammock, Bruce] Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA	University of California System; University of California Los Angeles; Vrije Universiteit Amsterdam; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; University of California System; University of California Davis	Fiala, M (corresponding author), UCLA Sch Med, 100 UCLA Med Plaza,Suite 220, Los Angeles, CA 90095 USA.	mfiala@ucla.edu	Kooij, Gijs/AAA-4268-2020	Kooij, Gijs/0000-0002-9488-2918; Pellegrini, Matteo/0000-0001-9355-9564	Alzheimer's Association; Smartfish AS; Dutch MS Research Foundation [14-878 MS]; U.S. National Institutes of Health, National Institute of Environmental Health Sciences [R01-ES002710];  [5T32L086350-08]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES002710] Funding Source: NIH RePORTER	Alzheimer's Association(Alzheimer's Association); Smartfish AS; Dutch MS Research Foundation; U.S. National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); ; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Studies of innate immunity in AD and MCI were supported by a grant from the Alzheimer's Association and a donation from Smartfish AS. Smartfish AS supplied the drink to patients who requested it, but was not involved in the design, analysis, interpretation of the data, or the decision to submit the manuscript for publication. M.F. received paid travel to meetings and honoraria from Smartfish AS. G.K. received support from the Dutch MS Research Foundation (14-878 MS). B.H. and K.W. were supported by U.S. National Institutes of Health, National Institute of Environmental Health Sciences Grant R01-ES002710, and K.W. by Grant 5T32L086350-08. The authors thank J. Gornbein (Department of Biomathematics, University of California Los Angeles) for calculating the sample size of the omega-3 study.	Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Akiyama H, 2000, ALZ DIS ASSOC DIS, V14, pS47, DOI 10.1097/00002093-200000001-00008; Annweiler C, 2015, J INTERN MED, V277, P45, DOI 10.1111/joim.12279; Annweiler C, 2013, J ALZHEIMERS DIS, V33, P659, DOI 10.3233/JAD-2012-121432; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Atkins HL, 2013, NEUROTHERAPEUTICS, V10, P68, DOI 10.1007/s13311-012-0162-5; Avagyan H, 2009, J NEUROIMMUNOL, V210, P67, DOI 10.1016/j.jneuroim.2009.02.015; Barnard ND, 2014, NEUROBIOL AGING, V35, pS74, DOI 10.1016/j.neurobiolaging.2014.03.033; Baruch K, 2016, NAT MED, V22, P135, DOI 10.1038/nm.4022; Baruch K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8967; Bazan NG, 2013, PROSTAG LEUKOTR ESS, V88, P127, DOI 10.1016/j.plefa.2012.08.008; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; Bennett ML, 2016, P NATL ACAD SCI USA, V113, pE1738, DOI 10.1073/pnas.1525528113; Biber K, 2016, NAT REV DRUG DISCOV, V15, P110, DOI 10.1038/nrd.2015.14; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Borgeson E, 2015, CELL METAB, V22, P125, DOI 10.1016/j.cmet.2015.05.003; Bohrmann B, 2012, J ALZHEIMERS DIS, V28, P49, DOI 10.3233/JAD-2011-110977; Bordoni A, 2006, GENES NUTR, V1, P95, DOI 10.1007/BF02829951; Bradshaw EM, 2013, NAT NEUROSCI, V16, P848, DOI 10.1038/nn.3435; Bredesen DE, 2016, AGING-US, V8, P1250, DOI 10.18632/aging.100981; Burckhardt M, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009002.pub3; Busche MA, 2015, NAT NEUROSCI, V18, P1725, DOI 10.1038/nn.4163; Chang HY, 2015, LIFE SCI, V120, P39, DOI 10.1016/j.lfs.2014.10.014; Chew EY, 2015, JAMA-J AM MED ASSOC, V314, P791, DOI 10.1001/jama.2015.9677; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Colton CA, 2014, J NEUROPATH EXP NEUR, V73, P752, DOI 10.1097/NEN.0000000000000094; Cramer PE, 2012, SCIENCE, V335, P1503, DOI 10.1126/science.1217697; Dalli J, 2015, FASEB J, V29, P2120, DOI 10.1096/fj.14-268441; Dalli J, 2014, P NATL ACAD SCI USA, V111, pE4753, DOI 10.1073/pnas.1415006111; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Dalli J, 2013, CHEM BIOL, V20, P188, DOI 10.1016/j.chembiol.2012.11.010; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Doody RS, 2014, NEW ENGL J MED, V370, P311, DOI 10.1056/NEJMoa1312889; Duara R, 2011, AM J GERIAT PSYCHIAT, V19, P951, DOI 10.1097/JGP.0b013e3182107c69; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Elajami TK, 2016, FASEB J, V30, P2792, DOI 10.1096/fj.201500155R; Elali A, 2016, BRAIN BEHAV IMMUN, V55, P138, DOI 10.1016/j.bbi.2015.07.021; Famenini S, 2017, FASEB J, V31, P148, DOI 10.1096/fj.201600677RR; Fiala M, 1998, MOL MED, V4, P480, DOI 10.1007/BF03401753; Fiala M, 2002, EUR J CLIN INVEST, V32, P360, DOI 10.1046/j.1365-2362.2002.00994.x; Fiala M, 2007, J ALZHEIMERS DIS, V11, P457; Fiala M, 2007, P NATL ACAD SCI USA, V104, P12849, DOI 10.1073/pnas.0701267104; Fiala M, 2015, J ALZHEIMERS DIS, V48, P293, DOI 10.3233/JAD-150367; Fiala M, 2015, FASEB J, V29, P2681, DOI 10.1096/fj.14-264218; Fiala M, 2011, J ALZHEIMERS DIS, V25, P135, DOI 10.3233/JAD-2011-101950; Fiala M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-76; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Goel A, 2008, BIOCHEM PHARMACOL, V75, P787, DOI 10.1016/j.bcp.2007.08.016; Goel A, 2010, NUTR CANCER, V62, P919, DOI 10.1080/01635581.2010.509835; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Goozee KG, 2016, BRIT J NUTR, V115, P449, DOI 10.1017/S0007114515004687; GOTTLICHER M, 1992, P NATL ACAD SCI USA, V89, P4653, DOI 10.1073/pnas.89.10.4653; Greene ER, 2011, PROSTAG OTH LIPID M, V96, P27, DOI 10.1016/j.prostaglandins.2011.08.004; Griciuc A, 2013, NEURON, V78, P631, DOI 10.1016/j.neuron.2013.04.014; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Hagemeyer N, 2016, EMBO J, V35, P1730, DOI 10.15252/embj.201693801; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Hasturk H, 2007, J IMMUNOL, V179, P7021, DOI 10.4049/jimmunol.179.10.7021; Hawkes CA, 2009, P NATL ACAD SCI USA, V106, P1261, DOI 10.1073/pnas.0805453106; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Heras-Sandoval D, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0525-7; Hjorth E, 2013, J ALZHEIMERS DIS, V35, P697, DOI 10.3233/JAD-130131; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Iliff JJ, 2010, PROSTAG OTH LIPID M, V91, P68, DOI 10.1016/j.prostaglandins.2009.06.004; Iliff JJ, 2009, AM J PHYSIOL-HEART C, V296, pH1352, DOI 10.1152/ajpheart.00950.2008; Inceoglu B, 2015, P NATL ACAD SCI USA, V112, P9082, DOI 10.1073/pnas.1510137112; Inceoglu B, 2011, P NATL ACAD SCI USA, V108, P5093, DOI 10.1073/pnas.1101073108; Jackowski SA, 2015, J NUTR SCI, V4, DOI 10.1017/jns.2015.21; Jay T, 2015, J EXP MED, V212, P1758, DOI 10.1084/jem.21211insight5; Jerneren F, 2015, AM J CLIN NUTR, V102, P215, DOI 10.3945/ajcn.114.103283; Jha AK, 2015, IMMUNITY, V42, P419, DOI 10.1016/j.immuni.2015.02.005; Jicha GA, 2010, CLIN INTERV AGING, V5, P45; Jump DB, 2008, CURR OPIN LIPIDOL, V19, P242, DOI 10.1097/MOL.0b013e3282ffaf6a; Kizuka Y, 2015, EMBO MOL MED, V7, P175, DOI 10.15252/emmm.201404438; Kodani SD, 2015, DRUG METAB DISPOS, V43, P788, DOI 10.1124/dmd.115.063339; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Kulzow N, 2016, J ALZHEIMERS DIS, V51, P713, DOI 10.3233/JAD-150886; Lam L, 2016, FASEB J, V30, P3461, DOI 10.1096/fj.201600259RR; Lam Larry, 2015, Am J Neurodegener Dis, V4, P28; Landreth GE, 2013, SCIENCE, V340, DOI 10.1126/science.1234114; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Lohcharoenkal W, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/180549; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Ma M, 2013, PHARMACOL BIOCHEM BE, V110, P98, DOI 10.1016/j.pbb.2013.06.005; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martinez Fernando O, 2014, F1000Prime Rep, V6, P13, DOI 10.12703/P6-13; Martinez-Nunez RT, 2011, J BIOL CHEM, V286, P1786, DOI 10.1074/jbc.M110.169367; Masoodi M, 2015, BBA-MOL CELL BIOL L, V1851, P503, DOI 10.1016/j.bbalip.2014.09.023; Masoumi A, 2009, J ALZHEIMERS DIS, V17, P703, DOI 10.3233/JAD-2009-1080; McGeer PL, 2015, EXPERT OPIN THER TAR, V19, P497, DOI 10.1517/14728222.2014.988707; McGeer PL, 1996, NEUROLOGY, V47, P425, DOI 10.1212/WNL.47.2.425; MCGEER PL, 1993, GLIA, V7, P84, DOI 10.1002/glia.440070114; Medeiros R, 2013, AM J PATHOL, V182, P1780, DOI 10.1016/j.ajpath.2013.01.051; Meyer-Luehmann M, 2015, TRENDS NEUROSCI, V38, P659, DOI 10.1016/j.tins.2015.08.011; Mildner A, 2007, NAT NEUROSCI, V10, P1544, DOI 10.1038/nn2015; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Mizwicki MT, 2013, J ALZHEIMERS DIS, V34, P155, DOI 10.3233/JAD-121735; Mizwicki MT, 2012, J ALZHEIMERS DIS, V29, P51, DOI 10.3233/JAD-2012-110560; Mizwicki MT, 2009, J BIOL CHEM, V284, P36292, DOI 10.1074/jbc.M109.042069; Morisseau C, 2010, J LIPID RES, V51, P3481, DOI 10.1194/jlr.M006007; Morris MC, 2016, JAMA-J AM MED ASSOC, V315, P489, DOI 10.1001/jama.2015.19451; Nelson JW, 2014, PROSTAG OTH LIPID M, V113, P30, DOI 10.1016/j.prostaglandins.2014.09.003; Norling LV, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85922; O'Hare E, 2016, NEUROPHARMACOLOGY, V100, P124, DOI 10.1016/j.neuropharm.2015.04.020; Oulhaj A, 2016, J ALZHEIMERS DIS, V50, P547, DOI 10.3233/JAD-150777; Paresce DM, 1997, J BIOL CHEM, V272, P29390, DOI 10.1074/jbc.272.46.29390; Pasinetti Giulio Maria, 2015, Biochim Biophys Acta, V1852, P1202, DOI 10.1016/j.bbadis.2014.10.006; Persidsky Y, 1999, AM J PATHOL, V155, P1599, DOI 10.1016/S0002-9440(10)65476-4; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Polidori M, 2014, DIET NUTR DEMENTIA C; Prokop S, 2015, J EXP MED, V212, P1811, DOI 10.1084/jem.20150479; Quinn JF, 2010, JAMA-J AM MED ASSOC, V304, P1903, DOI 10.1001/jama.2010.1510; Rajasagi NK, 2013, INVEST OPHTH VIS SCI, V54, P6269, DOI 10.1167/iovs.13-12152; Ramon S, 2016, AM J PATHOL, V186, P962, DOI 10.1016/j.ajpath.2015.12.012; Ren Q, 2016, P NATL ACAD SCI USA, V113, pE1944, DOI 10.1073/pnas.1601532113; Roberts RO, 2014, NEUROLOGY, V82, P317, DOI 10.1212/WNL.0000000000000055; Rogers J, 2001, NEUROCHEM INT, V39, P333, DOI 10.1016/S0197-0186(01)00040-7; Salloway S, 2014, NEW ENGL J MED, V370, P322, DOI 10.1056/NEJMoa1304839; Saresella M, 2014, J ALZHEIMERS DIS, V38, P403, DOI 10.3233/JAD-131160; Sarkar S, 2016, CRIT REV CL LAB SCI, V53, P132, DOI 10.3109/10408363.2015.1094443; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schmelzer KR, 2006, P NATL ACAD SCI USA, V103, P13646, DOI 10.1073/pnas.0605908103; Schmelzer KR, 2005, P NATL ACAD SCI USA, V102, P9772, DOI 10.1073/pnas.0503279102; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; Seok J, 2013, P NATL ACAD SCI USA, V110, P3507, DOI 10.1073/pnas.1222878110; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Serhan CN, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016311; Serhan CN, 2015, BBA-MOL CELL BIOL L, V1851, P397, DOI 10.1016/j.bbalip.2014.08.006; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2010, AM J PATHOL, V177, P1576, DOI 10.2353/ajpath.2010.100322; SERHAN CN, 1991, J BIOENERG BIOMEMBR, V23, P105; Sevigny J, 2016, NATURE, V537, P50, DOI 10.1038/nature19323; Shinto L, 2014, J ALZHEIMERS DIS, V38, P111, DOI 10.3233/JAD-130722; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Sperling R, 2012, LANCET NEUROL, V11, P241, DOI 10.1016/S1474-4422(12)70015-7; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Sudhahar V, 2010, CURR MED CHEM, V17, P1181, DOI 10.2174/092986710790827843; Takeuchi O, 2010, CELL, V140, P805, DOI 10.1016/j.cell.2010.01.022; Terrando N, 2013, FASEB J, V27, P3564, DOI 10.1096/fj.13-230276; Theendakara V, 2013, P NATL ACAD SCI USA, V110, P18303, DOI 10.1073/pnas.1314145110; Turner RS, 2015, NEUROLOGY, V85, P1383, DOI 10.1212/WNL.0000000000002035; Vasconcelos DP, 2015, BIOMATERIALS, V37, P116, DOI 10.1016/j.biomaterials.2014.10.035; Wagner K, 2014, PROSTAG OTH LIPID M, V113, P2, DOI 10.1016/j.prostaglandins.2014.09.001; Wagner K, 2011, PROSTAG OTH LIPID M, V96, P76, DOI 10.1016/j.prostaglandins.2011.08.001; Wagner K, 2011, J AGR FOOD CHEM, V59, P2816, DOI 10.1021/jf102559q; Wang XZ, 2015, ALZHEIMERS DEMENT, V11, P40, DOI 10.1016/j.jalz.2013.12.024; WISNIEWSKI HM, 1991, ACTA NEUROPATHOL, V81, P588, DOI 10.1007/BF00310142; Wu J, 2011, BIOCHEM BIOPH RES CO, V408, P382, DOI 10.1016/j.bbrc.2011.04.013; Wu Y, 2010, J MOL NEUROSCI, V42, P226, DOI 10.1007/s12031-010-9355-8; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Yakeu G, 2010, ATHEROSCLEROSIS, V212, P668, DOI 10.1016/j.atherosclerosis.2010.07.002; Zaghi J, 2009, ACTA NEUROPATHOL, V117, P111, DOI 10.1007/s00401-008-0481-0; Zeilhofer HU, 2007, BIOCHEM PHARMACOL, V73, P165, DOI 10.1016/j.bcp.2006.07.037; Zhao YH, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0015816, 10.1371/journal.pone.0016470]; Zhu MQ, 2016, MOL NEUROBIOL, V53, P2733, DOI 10.1007/s12035-015-9544-0	160	29	29	0	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3229	3239		10.1096/fj.201700065R	http://dx.doi.org/10.1096/fj.201700065R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28420693	Green Published			2022-12-28	WOS:000405932400004
J	Li, MS; Ren, HL; Sheth, KN; Shi, FD; Liu, Q				Li, Minshu; Ren, Honglei; Sheth, Kevin N.; Shi, Fu-Dong; Liu, Qiang			A TSPO ligand attenuates brain injury after intracerebral hemorrhage	FASEB JOURNAL			English	Article						immune modulation; etifoxine; hemorrhagic stroke; inflammation	NATURAL-KILLER-CELLS; MULTIPLE-SCLEROSIS; NERVOUS-SYSTEM; TRANSLOCATOR PROTEIN; RAT MODEL; T-CELLS; 18 KDA; MICROGLIA; INFLAMMATION; ETIFOXINE	Intracerebral hemorrhage (ICH) is a devastating disease without effective treatment. After ICH, the immediate infiltration of leukocytes and activation of microglia are accompanied by a rapid up-regulation of the 18-kDa translocator protein (TSPO). TSPO ligands have shown anti-inflammatory and neuroprotective properties in models of CNS injury. In this study, we determined the impact of a TSPO ligand, etifoxine, on brain injury and inflammation in 2 mouse models of ICH. TSPO was up-regulated in Iba1(+) cells from brains of patients with ICH and in CD11b(+)CD45(int) cells from mice subjected to collagenase-induced ICH. Etifoxine significantly reduced neurodeficits and perihematomal brain edema after ICH induction by injection of either autologous blood or collagenase. In collagenase-induced ICH mice, the protection of etifoxine was associated with reduced leukocyte infiltration into the brain and microglial production of IL-6 and TNF-alpha. Etifoxine improved blood-brain barrier integrity and diminished cell death. Notably, the protective effect of etifoxine was abolished in mice depleted of microglia by using a colony-stimulating factor 1 receptor inhibitor. These results indicate that the TSPO ligand etifoxine attenuates brain injury and inflammation after ICH. TSPO may be a viable therapeutic target that requires further investigations in ICH.	[Li, Minshu; Ren, Honglei; Shi, Fu-Dong; Liu, Qiang] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin 30050, Peoples R China; [Li, Minshu; Liu, Qiang] St Josephs Hosp, Dept Neurol, Barrow Neurol Inst, Phoenix, AZ USA; [Sheth, Kevin N.; Shi, Fu-Dong] Yale Univ, Sch Med, Dept Neurol, New Haven, CT 06510 USA	Tianjin Medical University; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Yale University	Liu, Q (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Tianjin 30050, Peoples R China.	qliu.asu@gmail.com	Liu, Qiang/HHZ-3181-2022		American Heart Association [16SDG27250236]; U.S. National Institutes of Health, Institute of Neurological Disorders and Stroke [R01NS092713]; National Multiple Sclerosis Society [RG-1507-05318]; National Basic Research Program of China [2013CB966900]; National Science Foundation of China [81230028, 81301044, 81471535]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS092713] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health, Institute of Neurological Disorders and Stroke; National Multiple Sclerosis Society(National Multiple Sclerosis Society); National Basic Research Program of China(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported, in part, by American Heart Association Grant 16SDG27250236 (to Q.L.); U.S. National Institutes of Health, Institute of Neurological Disorders and Stroke Grant R01NS092713 (to F.-D.S.); National Multiple Sclerosis Society Research Grant RG-1507-05318 (to F.-D.S.); National Basic Research Program of China Grant 2013CB966900 (to F.-D.S.); and National Science Foundation of China Grants 81230028 (to F.-D.S.), 81301044 (to M.L.), and 81471535 (to M.L.). The authors declare no conflicts of interest.	Aouad M, 2014, PAIN, V155, P403, DOI 10.1016/j.pain.2013.11.003; Bonsack F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0619-2; Cannon JR, 2006, ACTA NEUROCHIR SUPPL, V96, P222; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Chen S, 2014, PROG NEUROBIOL, V115, P64, DOI 10.1016/j.pneurobio.2013.09.002; Cosenza-Nashat M, 2009, NEUROPATH APPL NEURO, V35, P306, DOI 10.1111/j.1365-2990.2008.01006.x; Daugherty DJ, 2013, EMBO MOL MED, V5, P891, DOI 10.1002/emmm.201202124; Dionisio L, 2011, NEUROPHARMACOLOGY, V60, P513, DOI 10.1016/j.neuropharm.2010.11.007; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Gan Y, 2014, P NATL ACAD SCI USA, V111, P2704, DOI 10.1073/pnas.1315943111; Gerhard A, 2005, NEUROIMAGE, V24, P591, DOI 10.1016/j.neuroimage.2004.09.034; Grossetete M, 2008, J CEREBR BLOOD F MET, V28, P752, DOI 10.1038/sj.jcbfm.9600572; Han RR, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0559-x; Hua Y, 2002, STROKE, V33, P2478, DOI 10.1161/01.STR.0000032302.91894.0F; Iniaghe LO, 2015, NEUROBIOL DIS, V82, P349, DOI 10.1016/j.nbd.2015.07.001; Jiang C, 2016, NEUROBIOL AGING, V42, P13, DOI 10.1016/j.neurobiolaging.2016.02.029; Jin WN, 2016, J CEREBR BLOOD F MET, V36, P1464, DOI 10.1177/0271678X15611137; Keep RF, 2012, LANCET NEUROL, V11, P720, DOI 10.1016/S1474-4422(12)70104-7; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kuramatsu JB, 2013, J NEURAL TRANSM, V120, pS35, DOI 10.1007/s00702-013-1040-y; Lee M, 2011, GLIA, V59, P152, DOI 10.1002/glia.21087; Lei BL, 2016, NEUROENDOCRINOLOGY, V103, P665, DOI 10.1159/000442204; Li MS, 2017, J CEREBR BLOOD F MET, V37, P2383, DOI 10.1177/0271678X16666551; Li YJ, 2015, NEUROSCI BULL, V31, P755, DOI 10.1007/s12264-015-1532-2; Liu Q, 2016, NAT NEUROSCI, V19, P243, DOI 10.1038/nn.4211; Lu AG, 2006, J CEREBR BLOOD F MET, V26, P230, DOI 10.1038/sj.jcbfm.9600183; Melcangi RC, 2014, PROG NEUROBIOL, V113, P56, DOI 10.1016/j.pneurobio.2013.07.006; Mendu SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042959; Qureshi AI, 2009, LANCET, V373, P1632, DOI 10.1016/S0140-6736(09)60371-8; Ravikumar B, 2016, NEUROPHARMACOLOGY, V108, P229, DOI 10.1016/j.neuropharm.2016.03.053; Rupprecht R, 2010, NAT REV DRUG DISCOV, V9, P971, DOI 10.1038/nrd3295; Schlichter R, 2000, NEUROPHARMACOLOGY, V39, P1523, DOI 10.1016/S0028-3908(99)00253-1; Schumacher M, 2014, PROG NEUROBIOL, V113, P6, DOI 10.1016/j.pneurobio.2013.09.004; Selim M, 2015, TRANSL STROKE RES, V6, P104, DOI 10.1007/s12975-015-0389-7; Sheth KN, 2014, JAMA NEUROL, V71, P1083, DOI 10.1001/jamaneurol.2014.1653; Simon-O'Brien E, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0687-3; Stoll G, 2004, BRAIN PATHOL, V14, P51, DOI 10.1111/j.1750-3639.2004.tb00497.x; Sun N, 2016, STROKE, V47, P1899, DOI 10.1161/STROKEAHA.115.012236; Takano A, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-30; Urday S, 2015, NAT REV NEUROL, V11, P111, DOI 10.1038/nrneurol.2014.264; van Asch CJJ, 2010, LANCET NEUROL, V9, P167, DOI 10.1016/S1474-4422(09)70340-0; Wan S, 2016, TRANSL STROKE RES, V7, P478, DOI 10.1007/s12975-016-0472-8; Wang J, 2005, NEUROCRIT CARE, V3, P77, DOI 10.1385/NCC:3:1:077; Wang J, 2003, ANN NEUROL, V54, P655, DOI 10.1002/ana.10750; Wang JA, 2010, PROG NEUROBIOL, V92, P463, DOI 10.1016/j.pneurobio.2010.08.001; Wang X, 2015, STROKE, V46, P2762, DOI 10.1161/STROKEAHA.115.009357; Xiong XY, 2014, TRANSL STROKE RES, V5, P429, DOI 10.1007/s12975-013-0317-7; Yan T, 2014, CNS NEUROSCI THER, V20, P935, DOI 10.1111/cns.12307; Zhao F, 2011, STROKE, V42, P3587, DOI 10.1161/STROKEAHA.111.623926; Zhao XR, 2007, ANN NEUROL, V61, P352, DOI 10.1002/ana.21097; Zhou K, 2017, J CEREBR BLOOD F MET, V37, P967, DOI 10.1177/0271678X16648712; Zhou Y, 2014, PROG NEUROBIOL, V115, P25, DOI 10.1016/j.pneurobio.2013.11.003	52	41	41	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3278	3287		10.1096/fj.201601377RR	http://dx.doi.org/10.1096/fj.201601377RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28416580	Green Published, hybrid			2022-12-28	WOS:000405932400008
J	Baker, JG; Gardiner, SM; Woolard, J; Fromont, C; Jadhav, GP; Mistry, SN; Thompson, KSJ; Kellam, B; Hill, SJ; Fischer, PM				Baker, Jillian G.; Gardiner, Sheila M.; Woolard, Jeanette; Fromont, Christophe; Jadhav, Gopal P.; Mistry, Shailesh N.; Thompson, Kevin S. J.; Kellam, Barrie; Hill, Stephen J.; Fischer, Peter M.			Novel selective beta(1)-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease	FASEB JOURNAL			English	Article						beta-blocker; selectivity; heart disease; asthma	BETA-BLOCKERS; BRONCHODILATOR REVERSIBILITY; FATAL BRONCHOSPASM; HEART-FAILURE; ASTHMA; BISOPROLOL; COPD; METAANALYSIS; BINDING; PHARMACOKINETICS	beta-Blockers reduce mortality and improve symptoms in people with heart disease; however, current clinically available beta-blockers have poor selectivity for the cardiac I31-adrenoceptor (AR) over the lung I32-AR. Unwanted beta 2 blockade risks causing life-threatening bronchospasm and reduced efficacy of beta 2-agonist emergency rescue therapy. Thus, current life-prolonging beta-blockers are contraindicated in patients with both heart disease and asthma. Here, we describe NDD-713 and-825, novel highly beta(1)-selective neutral antagonists with good pharmaceutical properties that can potentially overcome this limitation. Radioligand binding studies and functional assays that use human receptors expressed in Chinese hamster ovary cells demonstrate that NDD-713 and-825 have nanomolar beta(1)-AR affinity >500-fold beta(1)-AR vs. beta(2)-AR selectivity and no agonism. Studies in conscious rats demonstrate that these antagonists are orally bioavailable and cause pronounced beta(1)-mediated reduction of heart rate while showing no effect on I32-mediated hindquarters vasodilatation. These compounds also have good disposition properties and show no adverse toxicologic effects. They potentially offer a truly cardioselective beta-blocker therapy for the large number of patients with heart and respiratory or peripheral vascular comorbidities. Baker, J. G., Gardiner, S. M., Woolard, J., Fromont, C., Jadhav, G. P., Mistry, S. N., Thompson, K. S. J., Kellam, B., Hill, S. J., Fischer, P. M. Novel selective I31-adrenoceptor antagonists for concomitant cardiovascular and respiratory disease.	[Baker, Jillian G.; Gardiner, Sheila M.; Woolard, Jeanette; Thompson, Kevin S. J.; Hill, Stephen J.] Univ Nottingham, Sch Life Sci, Cell Signalling Res Grp, Nottingham, England; [Fromont, Christophe; Jadhav, Gopal P.; Mistry, Shailesh N.; Kellam, Barrie; Fischer, Peter M.] Univ Nottingham, Sch Pharm, Nottingham, England; [Fromont, Christophe; Jadhav, Gopal P.; Mistry, Shailesh N.; Kellam, Barrie; Fischer, Peter M.] Univ Nottingham, Ctr Biomol Sci, Nottingham, England	University of Nottingham; University of Nottingham; University of Nottingham	Baker, JG (corresponding author), Univ Nottingham, Queens Med Ctr, Sch Life Sci, Nottingham NG7 2UH, England.; Fischer, PM (corresponding author), Univ Nottingham, Ctr Biomol Sci, Nottingham NG7 2RD, England.	jillian.baker@nottingham.ac.uk; peter.fischer@nottingham.ac.uk	Mistry, Shailesh/O-2697-2014; Jadhav, Gopal P/R-7901-2018; Kellam, Barrie/AAE-2960-2019; Hill, Stephen/N-6753-2013; Hill, Stephen J/M-6243-2018	Mistry, Shailesh/0000-0002-2252-1689; Jadhav, Gopal P/0000-0002-2883-5574; Hill, Stephen/0000-0002-4424-239X; Hill, Stephen J/0000-0002-4424-239X; baker, jillian/0000-0003-2371-8202; Woolard, Jeanette/0000-0001-5406-6847; Kellam, Barrie/0000-0003-0030-9908	Wellcome Trust [086039/Z/08/Z]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was supported by a Wellcome Trust Seeding Drug Discovery award (Grant 086039/Z/08/Z). The authors thank Richard Proudman, Marleen Groenen, June McCulloch, Philip Kemp, Julie March, and Thomas Clayton (all from the University of Nottingham) for technical assistance, Etienne Daras (University of Nottingham) for chemistry assistance, and Fiona Marshall (Heptares Therapeutics, London, United Kingdom), John Camm (St. George's London, London, United Kingdom), Robert Wilcox (University of Nottingham), John Harris (CJH Consultants, Brockenhurst, United Kingdom), John Dixon (Wellcome Trust, London, United Kingdom), and Nicola Shepherd (Wellcome Trust) for advice.	[Anonymous], 1990, Lancet, V336, P1; ARUNLAKSHANA O, 1959, BRIT J PHARM CHEMOTH, V14, P48, DOI 10.1111/j.1476-5381.1959.tb00928.x; Baker JG, 2008, BRIT J PHARMACOL, V153, P1011, DOI 10.1038/sj.bjp.0707644; Baker J.G., 2012, WO patent, Patent No. [WO 2012104659, 2012104659]; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Baker JG, 2003, MOL PHARMACOL, V64, P1357, DOI 10.1124/mol.64.6.1357; Baker JG, 2005, J PHARMACOL EXP THER, V313, P1163, DOI 10.1124/jpet.104.082875; Baker JG, 2017, THORAX, V72, P271, DOI 10.1136/thoraxjnl-2016-208412; Baker JG, 2015, MOL PHARMACOL, V87, P103, DOI 10.1124/mol.114.095364; Baker JG, 2011, FASEB J, V25, P4486, DOI 10.1096/fj.11-192435; Baker JG, 2010, BRIT J PHARMACOL, V160, P1048, DOI 10.1111/j.1476-5381.2010.00754.x; Bell DSH, 2004, AM J CARDIOL, V93, p49B, DOI 10.1016/j.amjcard.2004.01.026; Berthold R., 1982, Eur. Pat. Appl. Publ. EP52072, Patent No. 52072; Bevan CD, 2000, ANAL CHEM, V72, P1781, DOI 10.1021/ac9912247; BLACK JW, 1973, BRIT MED BULL, V29, P163, DOI 10.1093/oxfordjournals.bmb.a070988; Boudestein LCM, 2009, EUR J HEART FAIL, V11, P1182, DOI 10.1093/eurjhf/hfp148; British Thoracic Society, BRIT GUID MAN ASTHM; BUHRING KU, 1986, J CARDIOVASC PHARM, V8, pS21; Calverley PMA, 2003, THORAX, V58, P659, DOI 10.1136/thorax.58.8.659; Cruickshank JM, 2007, INT J CARDIOL, V120, P10, DOI 10.1016/j.ijcard.2007.01.069; DECALMER PBS, 1978, BRIT HEART J, V40, P184; DOOLEY DJ, 1986, EUR J PHARMACOL, V130, P137, DOI 10.1016/0014-2999(86)90193-7; Eichhorn E, 2001, NEW ENGL J MED, V344, P1659; Feary JR, 2010, THORAX, V65, P956, DOI 10.1136/thx.2009.128082; Finlayson K, 2001, EUR J PHARMACOL, V412, P203, DOI 10.1016/S0014-2999(01)00731-2; Foresi A, 2010, RESPIRATION, V80, P177, DOI 10.1159/000318583; FRALEY DS, 1980, SOUTHERN MED J, V73, P238, DOI 10.1097/00007611-198002000-00030; Global Initiative for Chronic Obstructive Lung Disease, GLOB STRAT DIAGN MAN; Hanania NA, 2011, CHEST, V140, P1055, DOI 10.1378/chest.10-2974; Hawkins NM, 2011, J AM COLL CARDIOL, V57, P2127, DOI 10.1016/j.jacc.2011.02.020; HJALMARSON A, 1981, LANCET, V2, P823; Hjalmarson A, 1999, LANCET, V353, P2001; Jovanovic D, 2006, J CLIN PHARMACOL, V46, P1217, DOI 10.1177/0091270006291626; LAURSEN SO, 1982, ACTA MED SCAND, V211, P505; Lechat P, 1999, LANCET, V353, P9; LEOPOLD G, 1986, J CLIN PHARMACOL, V26, P616, DOI 10.1002/j.1552-4604.1986.tb02959.x; LEOPOLD G, 1986, BRIT J CLIN PHARMACO, V22, P293, DOI 10.1111/j.1365-2125.1986.tb02890.x; LEWIS RV, 1993, DRUG SAFETY, V9, P272, DOI 10.2165/00002018-199309040-00005; Lombardo F, 2001, J MED CHEM, V44, P2490, DOI 10.1021/jm0100990; Loth DW, 2014, BRIT J CLIN PHARMACO, V77, P190, DOI 10.1111/bcp.12181; Malerba M, 2015, DRUG DISCOV TODAY, V20, P129, DOI 10.1016/j.drudis.2014.09.005; McAlister FA, 2009, ANN INTERN MED, V150, P784, DOI 10.7326/0003-4819-150-11-200906020-00006; Miki A, 2003, INT J CLIN PHARM TH, V41, P358; Mistry SN, 2013, J MED CHEM, V56, P3852, DOI 10.1021/jm400348g; Morales DR, 2017, BMC MED, V15, DOI 10.1186/s12916-017-0781-0; Morales DR, 2016, BRIT J CLIN PHARMACO, V82, P814, DOI 10.1111/bcp.13006; Morales DR, 2014, CHEST, V145, P779, DOI 10.1378/chest.13-1235; ODEH M, 1991, J FAM PRACTICE, V32, P97; PEDERSEN TR, 1981, NEW ENGL J MED, V304, P801; RAINE JM, 1981, BRIT MED J, V282, P548, DOI 10.1136/bmj.282.6263.548; SANO M, 1993, LIFE SCI, V52, P1063, DOI 10.1016/0024-3205(93)90199-D; SCHLIEP HJ, 1984, J CARDIOVASC PHARM, V6, P1156; Schnabel P, 2000, J CARDIOVASC PHARM, V36, P466, DOI 10.1097/00005344-200010000-00008; SCHUTZ W, 1983, EUR HEART J, V4, P367; SCHWARTZ S, 1980, CHEST, V78, P100, DOI 10.1378/chest.78.1.100; Scottish Intercollegiate Guidelines Network, GUID 147 MAN CHRON H; Smith C, 1999, CARDIOVASC DRUG THER, V13, P123, DOI 10.1023/A:1007784109255; THEODORSSONNORHEIM E, 1987, COMPUT BIOL MED, V17, P85, DOI 10.1016/0010-4825(87)90003-5; UK Department of Health, OUTC STRAT CHRON OBS; Valko K, 2003, J PHARM SCI-US, V92, P2236, DOI 10.1002/jps.10494; WILCOX RG, 1980, LANCET, V2, P765; WILLIAMS IP, 1980, THORAX, V35, P160, DOI 10.1136/thx.35.2.160; Yamada Y, 1995, J PHARMACOKINET BIOP, V23, P463, DOI 10.1007/BF02353469	63	7	7	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3150	3166		10.1096/fj.201601305R	http://dx.doi.org/10.1096/fj.201601305R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28400472	hybrid, Green Published			2022-12-28	WOS:000405931000038
J	Hesse, J; Leberling, S; Boden, E; Friebe, D; Schmidt, T; Ding, ZP; Dieterich, P; Deussen, A; Roderigo, C; Rose, CR; Floss, DM; Scheller, J; Schrader, J				Hesse, Julia; Leberling, Stella; Boden, Elisabeth; Friebe, Daniela; Schmidt, Timo; Ding, Zhaoping; Dieterich, Peter; Deussen, Andreas; Roderigo, Claudia; Rose, Christine R.; Floss, Doreen M.; Scheller, Juergen; Schrader, Juergen			CD73-derived adenosine and tenascin-C control cytokine production by epicardium-derived cells formed after myocardial infarction	FASEB JOURNAL			English	Article						A(2B) receptor; IL-6; inflammasome; mesenchymal cells; P2X(7) receptor	EXTRACELLULAR-MATRIX; PROGENITOR CELLS; RECEPTORS; INJURY; HEART; ATP; INFLAMMATION; ACTIVATION; FIBROBLASTS; METABOLISM	Epicardium-derived cells (EPDCs) play a fundamental role in embryonic cardiac development and are reactivated in the adult heart in response to myocardial infarction (MI). In this study, EPDCs from post-MI rat hearts highly expressed the ectoenzyme CD73 and secreted the profibrotic matricellular protein tenascin-C (TNC). CD73 on EPDCs extensively generated adenosine from both extracellular ATP and NAD. This in turn stimulated the release of additional nucleotides from a Brefeldin A-sensitive intracellular pool via adenosine-A2BR signaling, forming a positive-feedback loop. A2BR activation, in addition, strongly promoted the release of major regulatory cytokines, such as IL-6, IL-11, and VEGF. TNC was found to stimulate EPDC migration and, together with ATPP2X7R signaling, to activate inflammasomes in EPDCs via TLR4. Our results demonstrate that EPDCs are an important source of various proinflammatory factors in the post-MI heart controlled by purinergic and TNC signaling. Hesse, J., Leberling, S., Boden, E., Friebe, D., Schmidt, T., Ding, Z., Dieterich, P., Deussen, A., Roderigo, C., Rose, C. R., Floss, D. M., Scheller, J., Schrader, J. CD73-derived adenosine and tenascin-C control cytokine production by epicardium-derived cells formed after myocardial infarction.	[Hesse, Julia; Leberling, Stella; Boden, Elisabeth; Friebe, Daniela; Schmidt, Timo; Ding, Zhaoping; Schrader, Juergen] Heinrich Heine Univ Dusseldorf, Dept Mol Cardiol, Univ Str 1, D-40225 Dusseldorf, Germany; [Dieterich, Peter; Deussen, Andreas] Heinrich Heine Univ Dusseldorf, Inst Neurobiol, Dusseldorf, Germany; [Floss, Doreen M.; Scheller, Juergen] Heinrich Heine Univ Dusseldorf, Inst Biochem & Mol Biol 2, Dusseldorf, Germany; [Roderigo, Claudia; Rose, Christine R.] Tech Univ Dresden, Med Fac Carl Gustav Carus, Inst Physiol, Dresden, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Technische Universitat Dresden; Carl Gustav Carus University Hospital	Schrader, J (corresponding author), Heinrich Heine Univ Dusseldorf, Dept Mol Cardiol, Univ Str 1, D-40225 Dusseldorf, Germany.	schrader@uni-duesseldorf.de	Dieterich, Peter/G-8495-2016; Scheller, Jürgen/K-5290-2015	Dieterich, Peter/0000-0002-3564-0193; 	German Research Foundation [SFB 1116]	German Research Foundation(German Research Foundation (DFG))	The authors thank Bodo Steckel (Heinrich Heine University Dusseldorf, Dusseldorf) for his technical support with the HPLC measurements. This study was supported by the German Research Foundation (SFB 1116; to D.F. and J.S.). The authors declare no conflicts of interest.	Aherne CM, 2011, BBA-BIOMEMBRANES, V1808, P1329, DOI 10.1016/j.bbamem.2010.05.016; Akopova I, 2012, PURINERG SIGNAL, V8, P59, DOI 10.1007/s11302-011-9259-2; Antonioli L, 2013, TRENDS MOL MED, V19, P355, DOI 10.1016/j.molmed.2013.03.005; Bollini S, 2014, STEM CELLS DEV, V23, P1719, DOI 10.1089/scd.2014.0019; Boros D, 2016, PERFUSION-UK, V31, P103, DOI 10.1177/0267659115586579; Braitsch CM, 2013, J DEV BIOL, V1, P92, DOI 10.3390/jdb1020092; Burnstock G, 2015, PURINERG SIGNAL, V11, P1, DOI 10.1007/s11302-014-9436-1; Carmona R, 2010, J CELL MOL MED, V14, P2066, DOI 10.1111/j.1582-4934.2010.01088.x; Di Virgilio F, 2013, PHARMACOL REV, V65, P872, DOI 10.1124/pr.112.006171; Ding ZP, 2016, STEM CELL TRANSL MED, V5, P639, DOI 10.5966/sctm.2015-0159; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Eckle T, 2008, J CLIN INVEST, V118, P3301, DOI 10.1172/JCI34203; Eckle T, 2007, CIRCULATION, V115, P1581, DOI 10.1161/CIRCULATIONAHA.106.669697; Erb Laurie, 2012, Wiley Interdiscip Rev Membr Transp Signal, V1, P789; Fang M, 2016, J MOL CELL CARDIOL, V91, P23, DOI 10.1016/j.yjmcc.2015.12.019; Feng W, 2010, BRIT J PHARMACOL, V159, P1598, DOI 10.1111/j.1476-5381.2009.00558.x; FEOKTISTOV I, 1994, MOL PHARMACOL, V45, P1160; Feranchak AP, 2010, J BIOL CHEM, V285, P8138, DOI 10.1074/jbc.M109.065482; Fischer M, 1997, NAT BIOTECHNOL, V15, P142, DOI 10.1038/nbt0297-142; Fontes JA, 2015, CYTOKINE, V74, P62, DOI 10.1016/j.cyto.2014.12.024; Goding JW, 2003, BBA-MOL BASIS DIS, V1638, P1, DOI 10.1016/S0925-4439(03)00058-9; Gorini S, 2013, AM J BLOOD RES, V3, P14; Haanes KA, 2014, PURINERG SIGNAL, V10, P431, DOI 10.1007/s11302-014-9406-7; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; Hirota H, 1999, CELL, V97, P189, DOI 10.1016/S0092-8674(00)80729-1; Huang MY, 2015, HEART FAIL REV, V20, P25, DOI 10.1007/s10741-014-9431-1; Idzko M, 2014, NATURE, V509, P310, DOI 10.1038/nature13085; Imanaka-Yoshida K, 2001, LAB INVEST, V81, P1015, DOI 10.1038/labinvest.3780313; Imanaka-Yoshida K, 2012, CIRC J, V76, P2513, DOI 10.1253/circj.CJ-12-1033; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Kleveland O, 2016, EUR HEART J, V37, P2406, DOI 10.1093/eurheartj/ehw171; Krebs C, 2005, J IMMUNOL, V174, P3298, DOI 10.4049/jimmunol.174.6.3298; KROLL K, 1992, CIRC RES, V71, P590, DOI 10.1161/01.RES.71.3.590; Liu Y, 2014, BASIC RES CARDIOL, V109, DOI 10.1007/s00395-014-0415-z; Lohman AW, 2012, CARDIOVASC RES, V95, P269, DOI 10.1093/cvr/cvs187; Machino-Ohtsuka T, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.001052; Mercer SE, 2013, DEV BIOL, V382, P457, DOI 10.1016/j.ydbio.2013.08.002; Mezzaroma E, 2011, P NATL ACAD SCI USA, V108, P19725, DOI 10.1073/pnas.1108586108; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Mirabet M, 1999, J CELL SCI, V112, P491; Mitrophanov AY, 2008, BIOESSAYS, V30, P542, DOI 10.1002/bies.20769; Nishioka T, 2010, AM J PHYSIOL-HEART C, V298, pH1072, DOI 10.1152/ajpheart.00255.2009; Obana M, 2010, CIRCULATION, V121, P684, DOI 10.1161/CIRCULATIONAHA.109.893677; Pangrsic T, 2007, J BIOL CHEM, V282, P28749, DOI 10.1074/jbc.M700290200; Pomerening JR, 2009, FEBS LETT, V583, P3388, DOI 10.1016/j.febslet.2009.10.001; Ruiz-Villalba A, 2015, J AM COLL CARDIOL, V65, P2057, DOI 10.1016/j.jacc.2015.03.520; Sadej R, 2012, ACTA BIOCHIM POL, V59, P647; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Skilling J, 2006, BAYESIAN ANAL, V1, P833, DOI 10.1214/06-BA127; Smart N, 2013, VASC PHARMACOL, V58, P164, DOI 10.1016/j.vph.2012.08.001; Smart N, 2011, NATURE, V474, P640, DOI 10.1038/nature10188; SMOLENSKI RT, 1990, J CHROMATOGR-BIOMED, V527, P414, DOI 10.1016/S0378-4347(00)82125-8; Tamaoki M, 2005, AM J PATHOL, V167, P71, DOI 10.1016/S0002-9440(10)62954-9; van Wijk B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044692; VonDerLinden W, 2014, BAYESIAN PROBABILITY THEORY: APPLICATIONS IN THE PHYSICAL SCIENCES, P1; Willems IEMG, 1996, J PATHOL, V179, P321; Yegutkin GG, 2014, CRIT REV BIOCHEM MOL, V49, P473, DOI 10.3109/10409238.2014.953627; Zhou B, 2011, J CLIN INVEST, V121, P1894, DOI 10.1172/JCI45529; Zuo PY, 2008, J BIOL CHEM, V283, P26805, DOI 10.1074/jbc.M801516200	61	24	26	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3040	3053		10.1096/fj.201601307R	http://dx.doi.org/10.1096/fj.201601307R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28363952				2022-12-28	WOS:000405931000028
J	Poppelaars, F; van Werkhoven, MB; Kotimaa, J; Veldhuis, ZJ; Ausema, A; Broeren, SGM; Damman, J; Hempel, JC; Leuvenink, HGD; Daha, MR; van Son, WJ; van Kooten, C; van Os, RP; Hillebrands, JL; Seelen, MA				Poppelaars, Felix; van Werkhoven, Maaike B.; Kotimaa, Juha; Veldhuis, Zwanida J.; Ausema, Albertina; Broeren, Stefan G. M.; Damman, Jeffrey; Hempel, Julia C.; Leuvenink, Henri G. D.; Daha, Mohamed R.; van Son, Willem J.; van Kooten, Cees; van Os, Ronald P.; Hillebrands, Jan-Luuk; Seelen, Marc A.			Critical role for complement receptor C5aR2 in the pathogenesis of renal ischemia-reperfusion injury	FASEB JOURNAL			English	Article						innate immunity; PMNs; kidney	ACUTE KIDNEY INJURY; DONOR BRAIN-DEATH; ISCHEMIA/REPERFUSION INJURY; CHEMOATTRACTANT RECEPTOR; 2 PARTS; C5L2; ACTIVATION; CELLS; ANAPHYLATOXIN; PATHWAY	The complement system, and specifically C5a, is involved in renal ischemia-reperfusion (IR) injury. The 2 receptors for complement anaphylatoxin C5a (C5aR1 and C5aR2) are expressed on leukocytes as well as on renal epithelium. Extensive evidence shows that C5aR1 inhibition protects kidneys from IR injury; however, the role of C5aR2 in IR injury is less clear as initial studies proposed the hypothesis that C5aR2 functions as a decoy receptor. By Using wild-type, C5aR1(-/-), and C5aR2(-/-) mice in a model of renal IR injury, we found that a deficiency of either of these receptors protected mice from renal IR injury. Surprisingly, C5aR2(-/-) mice were most protected and had lower creatinine levels and reduced acute tubular necrosis. Next, an in vivo migration study demonstrated that leukocyte chemotaxis was unaffected in C5aR2(-/-) mice, whereas neutrophil activation was reduced by C5aR2 deficiency. To further investigate the contribution of renal cell-expressed C5aR2 vs. leukocyte-expressed C5aR2 to renal IR injury, bone marrow chimeras were created. Our data show that both renal cell-expressed C5aR2 and leukocyte-expressed C5aR2 mediate IR-induced renal dysfunction. These studies reveal the importance of C5aR2 in renal IR injury. They further show that C5aR2 is a functional receptor, rather than a decoy receptor, and may provide a new target for intervention.-Poppelaars, F., van Werkhoven, M. B., Kotimaa, J., Veldhuis, Z. J., Ausema, A., Broeren, S. G. M., Damman, J., Hempel, J. C., Leuvenink, H. G. D., Daha, M. R., van Son, W. J., van Kooten, C., van Os, R. P., Hillebrands, J.-L., Seelen, M. A. Critical role for complement receptor C5aR2 in the pathogenesis of renal ischemia-reperfusion injury. FASEB J. 31, 3193-3204 (2017). www.fasebj.org	[Poppelaars, Felix; van Werkhoven, Maaike B.; Broeren, Stefan G. M.; Hempel, Julia C.; Daha, Mohamed R.; van Son, Willem J.; Seelen, Marc A.] Univ Groningen, Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, Groningen, Netherlands; [Veldhuis, Zwanida J.; Leuvenink, Henri G. D.] Univ Groningen, Univ Med Ctr Groningen, Dept Surg, Groningen, Netherlands; [Ausema, Albertina; van Os, Ronald P.] Univ Groningen, Univ Med Ctr Groningen, European Res Inst Biol Ageing, Lab Ageing Biol & Stem Cells, Groningen, Netherlands; [Hillebrands, Jan-Luuk] Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Med Biol, Div Pathol, Groningen, Netherlands; [Kotimaa, Juha; Daha, Mohamed R.; van Kooten, Cees] Leiden Univ, Med Ctr, Dept Nephrol, Leiden, Netherlands; [Damman, Jeffrey] Univ Amsterdam, Acad Med Ctr, Dept Pathol, Amsterdam, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam	Seelen, MA (corresponding author), Univ Med Ctr Groningen, Dept Internal Med, Div Nephrol, AA53,Postbus 196, NL-9700 AD Groningen, Netherlands.	m.seelen@umcg.nl	van Kooten, Cees/E-5694-2018; Kotimaa, Juha/N-2443-2015; Poppelaars, Felix/Y-2120-2019	van Kooten, Cees/0000-0002-6257-0899; Poppelaars, Felix/0000-0002-5173-8078; Hillebrands, Jan-Luuk/0000-0003-3135-3274; Leuvenink, Henri/0000-0001-5036-2999	Dutch Kidney Foundation [IP1167]; Graduate School of Medical Sciences of the University of Groningen; Jan Kornelis de Cock Foundation of the University Medical Centre Groningen	Dutch Kidney Foundation; Graduate School of Medical Sciences of the University of Groningen; Jan Kornelis de Cock Foundation of the University Medical Centre Groningen	This work was supported by the Dutch Kidney Foundation (Project IP1167), Graduate School of Medical Sciences of the University of Groningen, and the Jan Kornelis de Cock Foundation of the University Medical Centre Groningen. The authors thank Andre Zandvoort, Anita Meter-Arkema, Annemieke Smit-van Oosten, Bianca Meijeringh, Mariana Gaya da Costa, Petra Ottens, Pieter Klok, Tina Jager (all from the University of Groningen), and Michel Weij (Beatrix Children's Hospital, Groningen, The Netherlands) for excellent technical assistance. The authors declare no conflicts of interest.	Arumugam TV, 2003, KIDNEY INT, V63, P134, DOI 10.1046/j.1523-1755.2003.00737.x; Asgari E, 2014, CURR OPIN ORGAN TRAN, V19, P342, DOI 10.1097/MOT.0000000000000094; Bamberg CE, 2010, J BIOL CHEM, V285, P7633, DOI 10.1074/jbc.M109.092106; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Brooks C, 2009, J CLIN INVEST, V119, P1275, DOI 10.1172/JCI37829; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Chen NJ, 2007, NATURE, V446, P203, DOI 10.1038/nature05559; Damman J, 2008, TRANSPLANTATION, V85, P923, DOI 10.1097/TP.0b013e3181683cf5; Damman J, 2011, NEPHROL DIAL TRANSPL, V26, P2345, DOI 10.1093/ndt/gfq717; Damman J, 2011, AM J TRANSPLANT, V11, P660, DOI 10.1111/j.1600-6143.2011.03475.x; Davies MJ, 2011, J CLIN BIOCHEM NUTR, V48, P8, DOI 10.3164/jcbn.11-006FR; de Vries B, 2004, AM J PATHOL, V165, P1677, DOI 10.1016/S0002-9440(10)63424-4; de Vries B, 2003, J IMMUNOL, V170, P3883, DOI 10.4049/jimmunol.170.7.3883; De Vries B, 2003, TRANSPLANTATION, V75, P375, DOI 10.1097/01.TP.0000044455.05584.2A; Eltzschig HK, 2011, NAT MED, V17, P1391, DOI 10.1038/nm.2507; Farrar CA, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00341; Furuichi K, 2006, CRIT CARE MED, V34, P2447, DOI 10.1097/01.CCM.0000233878.36340.10; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Hao J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066305; Haq M, 1998, J AM SOC NEPHROL, V9, P614; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Kielar ML, 2005, J AM SOC NEPHROL, V16, P3315, DOI 10.1681/asn.2003090757; Kotimaa JP, 2015, J IMMUNOL METHODS, V419, P25, DOI 10.1016/j.jim.2015.02.010; Lau D, 2005, P NATL ACAD SCI USA, V102, P431, DOI 10.1073/pnas.0405193102; Le Dorze M, 2009, CURR OPIN CRIT CARE, V15, P503, DOI 10.1097/MCC.0b013e328332f6cf; Lee H, 2008, IMMUNOL CELL BIOL, V86, P153, DOI 10.1038/sj.icb.7100166; Lewis AG, 2008, CLIN EXP IMMUNOL, V153, P117, DOI 10.1111/j.1365-2249.2008.03678.x; Li QJ, 2010, J AM SOC NEPHROL, V21, P1344, DOI 10.1681/ASN.2009090977; Li R, 2013, FASEB J, V27, P855, DOI 10.1096/fj.12-220509; MARDER SR, 1985, J IMMUNOL, V134, P3325; MCCOY R, 1995, J EXP MED, V182, P207, DOI 10.1084/jem.182.1.207; Mercier FE, 2016, STEM CELL REP, V6, P985, DOI 10.1016/j.stemcr.2016.04.010; Monk PN, 2007, BRIT J PHARMACOL, V152, P429, DOI 10.1038/sj.bjp.0707332; Nataf S, 1999, J IMMUNOL, V162, P4018; Ohno M, 2000, MOL IMMUNOL, V37, P407, DOI 10.1016/S0161-5890(00)00067-5; Okinaga S, 2003, BIOCHEMISTRY-US, V42, P9406, DOI 10.1021/bi034489v; Patel NSA, 2005, J PHARMACOL EXP THER, V312, P1170, DOI 10.1124/jpet.104.078659; Peng Q, 2012, J AM SOC NEPHROL, V23, P1474, DOI 10.1681/ASN.2011111072; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rusai K, 2008, TRANSPL INT, V21, P572, DOI 10.1111/j.1432-2277.2008.00651.x; Scola AM, 2009, MOL IMMUNOL, V46, P1149, DOI 10.1016/j.molimm.2008.11.001; Singbartl K, 2001, FASEB J, V15, P2337, DOI 10.1096/fj.01-0199com; SNYDERMAN R, 1984, ANNU REV IMMUNOL, V2, P257, DOI 10.1146/annurev.immunol.2.1.257; Thurman JM, 2005, KIDNEY INT, V67, P524, DOI 10.1111/j.1523-1755.2005.67109.x; Thurman JM, 2003, J IMMUNOL, V170, P1517, DOI 10.4049/jimmunol.170.3.1517; van der Veen BS, 2009, ANTIOXID REDOX SIGN, V11, P2899, DOI [10.1089/ars.2009.2538, 10.1089/ARS.2009.2538]; van Werkhoven MB, 2013, AM J TRANSPLANT, V13, P875, DOI 10.1111/ajt.12130; van Werkhoven MB, 2013, MOL IMMUNOL, V53, P237, DOI 10.1016/j.molimm.2012.08.013; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Wysoczynski M, 2007, LEUKEMIA, V21, P973, DOI 10.1038/sj.leu.2404629; Xu YQ, 2006, AM J PHYSIOL-HEART C, V290, pH692, DOI 10.1152/ajpheart.00634.2005; Yago T, 2015, J EXP MED, V212, P1267, DOI 10.1084/jem.20142358; Yamada K, 2004, J IMMUNOL, V172, P3869, DOI 10.4049/jimmunol.172.6.3869; Zheng XF, 2008, AM J PATHOL, V173, P973, DOI 10.2353/ajpath.2008.080103; Zhou WD, 2000, J CLIN INVEST, V105, P1363, DOI 10.1172/JCI8621; Zwirner J, 1999, MOL IMMUNOL, V36, P877, DOI 10.1016/S0161-5890(99)00109-1	58	26	27	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3193	3204		10.1096/fj.201601218R	http://dx.doi.org/10.1096/fj.201601218R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28396344				2022-12-28	WOS:000405931000041
J	Gonzalez, AE; Munoz, VC; Cavieres, VA; Bustamante, HA; Cornejo, VH; Januario, YC; Gonzalez, I; Hetz, C; daSilva, LL; Rojas-Fernandez, A; Hay, RT; Mardones, GA; Burgos, PV				Gonzalez, Alexis E.; Munoz, Vanessa C.; Cavieres, Viviana A.; Bustamante, Hianara A.; Cornejo, Victor-Hugo; Januario, Yunan C.; Gonzalez, Ibeth; Hetz, Claudio; daSilva, Luis L.; Rojas-Fernandez, Alejandro; Hay, Ronald T.; Mardones, Gonzalo A.; Burgos, Patricia V.			Autophagosomes cooperate in the degradation of intracellular C-terminal fragments of the amyloid precursor protein via the MVB/lysosomal pathway	FASEB JOURNAL			English	Article						Alzheimer disease; APP; C99; multivesicular bodies; amphisome; proteostasis	TRANS-GOLGI NETWORK; ALZHEIMERS-DISEASE; A-BETA; MULTIVESICULAR BODIES; ENDOCYTIC PATHWAY; NEURODEGENERATIVE DISEASE; ENDOPLASMIC-RETICULUM; COGNITIVE DEFICITS; EARLY ENDOSOMES; DOWN-SYNDROME	Brain regions affected by Alzheimer disease (AD) displaywell-recognized early neuropathologic features in the endolysosomal and autophagy systems of neurons, including enlargement of endosomal compartments, progressive accumulation of autophagic vacuoles, and lysosomal dysfunction. Although the primary causes of these disturbances are still under investigation, a growing body of evidence suggests that the amyloid precursor protein (APP) intracellular C-terminal fragment beta (C99), generated by cleavage of APP by beta-site APP cleaving enzyme 1 (BACE-1), is the primary cause of the endosome enlargement inADand the earliest initiator of synaptic plasticity and long-termmemory impairment. The aim of the present study was to evaluate the possible relationship between the endolysosomal degradation pathway and autophagy on the proteolytic processing and turnover of C99. We found that pharmacologic treatments that either inhibit autophagosome formation or block the fusion of autophagosomes to endolysosomal compartments caused an increase in C99 levels. We also found that inhibition of autophagosome formation by depletion of Atg5 led to higher levels of C99 and to its massive accumulation in the lumen of enlarged perinuclear, lysosomal-associated membrane protein 1 (LAMP1)-positive organelles. In contrast, activation of autophagosome formation, either by starvation or by inhibition of the mammalian target of rapamycin, enhanced lysosomal clearance of C99. Altogether, our results indicate that autophagosomes are key organelles to help avoid C99 accumulation preventing its deleterious effects.	[Gonzalez, Alexis E.; Munoz, Vanessa C.; Cavieres, Viviana A.; Bustamante, Hianara A.; Gonzalez, Ibeth; Mardones, Gonzalo A.; Burgos, Patricia V.] Univ Austral Chile, Sch Med, Dept Physiol, Valdivia, Chile; [Rojas-Fernandez, Alejandro; Mardones, Gonzalo A.; Burgos, Patricia V.] Univ Austral Chile, Ctr Interdisciplinary Studies Nervous Syst CISNe, Valdivia, Chile; [Cornejo, Victor-Hugo; Hetz, Claudio] Univ Chile, Biomed Neurosci Inst, Fac Med, Santiago, Chile; [Cornejo, Victor-Hugo; Hetz, Claudio] Ctr Gerosci Brain Hlth & Metab, Santiago, Chile; [Januario, Yunan C.; daSilva, Luis L.] Univ Sao Paulo, Ribeirao Preto Med Sch, Dept Cell & Mol Biol, Ribeirao Preto, Brazil; [Hetz, Claudio] Buck Inst Res Aging, Novato, CA USA; [Hetz, Claudio] Harvard Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA USA; [Rojas-Fernandez, Alejandro; Hay, Ronald T.] Univ Dundee, Coll Life Sci, Ctr Gene Regulat & Express, Dundee, Scotland	Universidad Austral de Chile; Universidad Austral de Chile; Universidad de Chile; Universidade de Sao Paulo; Buck Institute for Research on Aging; Harvard University; Harvard T.H. Chan School of Public Health; University of Dundee	Burgos, PV (corresponding author), Univ Austral Chile, Sch Med, Dept Physiol, Lab Cell & Mol Biol, Valdivia 5110566, Chile.	patricia.burgos@uach.cl	Cornejo, Victor Hugo/ABD-8410-2021; Fernandez, Alejandro Rojas/K-3291-2014; LP daSilva, Luis/A-9949-2010; daSilva, Luis LP/AAD-5657-2019; Hay, Ronald/S-3233-2019; Hetz, Claudio/ABD-7514-2021	Fernandez, Alejandro Rojas/0000-0002-6004-5425; LP daSilva, Luis/0000-0003-3558-0087; daSilva, Luis LP/0000-0003-3558-0087; Hay, Ronald/0000-0001-7113-9024; 	National Fund for Scientific and Technological Development (FONDECYT) [1130929, 1130710, 1140549]; International Cooperation Program (PCI) of the National Commission for Scientific and Technological Research (CONICYT; Grant ECOS/CONICYT) [C14B03]; International Cooperation Program (PCI) of the National Commission for Scientific and Technological Research (CONICYT; Grant Fondo Newton-Picarte CONICYT) [DPI20140068]; International Cooperation Program (PCI) of the National Commission for Scientific and Technological Research (CONICYT; Grant Fondo CONICYT Chile-Brazil) [441921/2016-7]; Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (FONDAP) [15150012]; Millennium Institute [P09-015-F]; Office of Naval Research-Global (ONR-G) [N62909-16-1-2003]; Sao Paulo Research Foundation (FAPESP) [2014/25812-0]; Direccion de Investigacion y Desarrollo-Universidad Austral de Chile (DID-UACh) [D-2013-07, D-2015-02]; Programa de Mejoramiento de la Calidad y la Equidad de la Educacion (MECESUP) [AUS 1203]; CONICYT [201110746, 21151194, 21130315]; Coordination for the Improvement of Higher Education Personnel (CAPES) fellowship from the Brazilian Ministry of Education; Medical Research Council (MRC) Next Generation Optical Microscopy award [MR/K015869/1]; Medical Research Council [MR/K015869/1] Funding Source: researchfish; MRC [MR/K015869/1] Funding Source: UKRI	National Fund for Scientific and Technological Development (FONDECYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); International Cooperation Program (PCI) of the National Commission for Scientific and Technological Research (CONICYT; Grant ECOS/CONICYT); International Cooperation Program (PCI) of the National Commission for Scientific and Technological Research (CONICYT; Grant Fondo Newton-Picarte CONICYT); International Cooperation Program (PCI) of the National Commission for Scientific and Technological Research (CONICYT; Grant Fondo CONICYT Chile-Brazil); Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (FONDAP)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDAP); Millennium Institute(Takeda Pharmaceutical Company Ltd); Office of Naval Research-Global (ONR-G)(Office of Naval Research); Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Direccion de Investigacion y Desarrollo-Universidad Austral de Chile (DID-UACh); Programa de Mejoramiento de la Calidad y la Equidad de la Educacion (MECESUP); CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); Coordination for the Improvement of Higher Education Personnel (CAPES) fellowship from the Brazilian Ministry of Education(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Medical Research Council (MRC) Next Generation Optical Microscopy award(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was funded by the National Fund for Scientific and Technological Development (FONDECYT; Grants 1130929 to P.V.B., 1130710 to G.A.M., and 1140549 to C.H.); International Cooperation Program (PCI) of the National Commission for Scientific and Technological Research (CONICYT; Grants ECOS/CONICYT C14B03 to P.V.B., Fondo Newton-Picarte CONICYT DPI20140068 to P.V.B., and Fondo CONICYT Chile-Brazil 441921/2016-7 to C.H.); Fondo de Financiamiento de Centros de Investigacion en Areas Prioritarias (FONDAP; Program 15150012 to C.H.); Millennium Institute (Grant P09-015-F to C.H.); Office of Naval Research-Global (ONR-G; N62909-16-1-2003 to C.H.); Sao Paulo Research Foundation (FAPESP; 2014/25812-0 to L.L.D.); Direccion de Investigacion y Desarrollo-Universidad Austral de Chile (DID-UACh; Grant D-2013-07 to A.E.G. and D-2015-02 to H.A.B.); and Programa de Mejoramiento de la Calidad y la Equidad de la Educacion (MECESUP; AUS 1203). A.E.G., V.A.C., and H.A.B. were supported by CONICYT fellowships 201110746, 21151194, and 21130315, respectively. Y.C.J. was supported by a Coordination for the Improvement of Higher Education Personnel (CAPES) fellowship from the Brazilian Ministry of Education. The use of the OMX microscope was funded by a Medical Research Council (MRC) Next Generation Optical Microscopy award (MR/K015869/1).	Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; Bago R., MOL CANC THER; Bellettato CM, 2010, J INHERIT METAB DIS, V33, P347, DOI 10.1007/s10545-010-9075-9; Berg TO, 1998, J BIOL CHEM, V273, P21883, DOI 10.1074/jbc.273.34.21883; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Boland B, 2008, J NEUROSCI, V28, P6926, DOI 10.1523/JNEUROSCI.0800-08.2008; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Burgos PV, 2010, DEV CELL, V18, P425, DOI 10.1016/j.devcel.2010.01.015; Bustamante HA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083096; Cataldo AM, 1996, J NEUROSCI, V16, P186; Cavieres VA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136313; Choy RWY, 2012, P NATL ACAD SCI USA, V109, pE2077, DOI 10.1073/pnas.1208635109; De Strooper B, 2010, ANNU REV CELL DEV BI, V26, P235, DOI 10.1146/annurev-cellbio-100109-104117; Edgar JR, 2015, J CELL SCI, V128, P2520, DOI 10.1242/jcs.170233; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Filimonenko M, 2007, J CELL BIOL, V179, P485, DOI 10.1083/jcb.200702115; Ganley IG, 2011, MOL CELL, V42, P731, DOI 10.1016/j.molcel.2011.04.024; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hattersley N, 2011, MOL BIOL CELL, V22, P78, DOI 10.1091/mbc.E10-06-0504; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Henne WM, 2011, DEV CELL, V21, P77, DOI 10.1016/j.devcel.2011.05.015; Hetz C, 2009, GENE DEV, V23, P2294, DOI 10.1101/gad.1830709; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; IHARA Y, 1986, J BIOCHEM-TOKYO, V99, P1807, DOI 10.1093/oxfordjournals.jbchem.a135662; Jaber N, 2012, P NATL ACAD SCI USA, V109, P2003, DOI 10.1073/pnas.1112848109; Jiang Yanfang, 2010, Mediators Inflamm, V2010, P143026, DOI 10.1155/2010/143026; Jiang Y, 2016, NEUROBIOL AGING, V39, P90, DOI 10.1016/j.neurobiolaging.2015.11.013; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim S, 2016, MOL PSYCHIATR, V21, P707, DOI 10.1038/mp.2015.97; KOO EH, 1994, J BIOL CHEM, V269, P17386; Lamb CA, 2013, BIOESSAYS, V35, P34, DOI 10.1002/bies.201200130; Lanz TA, 2003, J PHARMACOL EXP THER, V305, P864, DOI 10.1124/jpet.102.048280; Lauritzen I, 2016, ACTA NEUROPATHOL, V132, P257, DOI 10.1007/s00401-016-1577-6; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lee JA, 2007, CURR BIOL, V17, P1561, DOI 10.1016/j.cub.2007.07.029; Lee JY, 2008, J BIOL CHEM, V283, P11501, DOI 10.1074/jbc.M800642200; Li J, 2008, CELL DEATH DIFFER, V15, P1460, DOI 10.1038/cdd.2008.81; LYTTON J, 1991, J BIOL CHEM, V266, P17067; MANDERS EMM, 1992, J CELL SCI, V103, P857; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Mizushima N, 2007, GENE DEV, V21, P2861, DOI 10.1101/gad.1599207; Morel E, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3250; Murrow L, 2015, NAT CELL BIOL, V17, P300, DOI 10.1038/ncb3112; Nixon RA, 2005, J NEUROPATH EXP NEUR, V64, P113, DOI 10.1093/jnen/64.2.113; Nixon RA, 2007, J CELL SCI, V120, P4081, DOI 10.1242/jcs.019265; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Ohm TG, 2003, PHARMACOPSYCHIATRY, V36, pS120; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Peng JY, 2014, SCI CHINA LIFE SCI, V57, P59, DOI 10.1007/s11427-013-4588-8; Perez RG, 1999, J BIOL CHEM, V274, P18851, DOI 10.1074/jbc.274.27.18851; Prabhu Y, 2012, MOL BIOL CELL, V23, P2339, DOI 10.1091/mbc.E11-11-0944; Razi M, 2009, J CELL BIOL, V185, P305, DOI 10.1083/jcb.200810098; Repnik U, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008755; Rusten TE, 2007, CURR BIOL, V17, P1817, DOI 10.1016/j.cub.2007.09.032; Rusten TE, 2010, NAT CELL BIOL, V12, P207, DOI 10.1038/ncb0310-207; Rusten TE, 2009, J CELL SCI, V122, P2179, DOI 10.1242/jcs.050021; Schermelleh L, 2008, SCIENCE, V320, P1332, DOI 10.1126/science.1156947; Schwake M, 2013, TRAFFIC, V14, P739, DOI 10.1111/tra.12056; Sharples RA, 2008, FASEB J, V22, P1469, DOI 10.1096/fj.07-9357com; SIMAN R, 1993, J BIOL CHEM, V268, P16602; Spilman P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009979; Tenorio MJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154719; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Tian Y, 2011, FASEB J, V25, P1934, DOI 10.1096/fj.10-175158; Toh W. H., TRAFFIC; Vassar R, 2009, J NEUROSCI, V29, P12787, DOI 10.1523/JNEUROSCI.3657-09.2009; Walczak M, 2013, AUTOPHAGY, V9, P424, DOI 10.4161/auto.22931; Wolfe DM, 2013, EUR J NEUROSCI, V37, P1949, DOI 10.1111/ejn.12169; Wong YC, 2015, J CELL SCI, V128, P1259, DOI 10.1242/jcs.161216; Xiao QL, 2015, J NEUROSCI, V35, P12137, DOI 10.1523/JNEUROSCI.0705-15.2015; Xu HX, 1997, P NATL ACAD SCI USA, V94, P3748, DOI 10.1073/pnas.94.8.3748; Xu W, 2016, J CLIN INVEST, V126, P1815, DOI 10.1172/JCI82409; Yi J, 1999, CELL RES, V9, P243, DOI 10.1038/sj.cr.7290023; Yuyama K, 2006, FEBS LETT, V580, P6972, DOI 10.1016/j.febslet.2006.11.072	75	29	29	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2446	2459		10.1096/fj.201600713R	http://dx.doi.org/10.1096/fj.201600713R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28254759	Green Submitted			2022-12-28	WOS:000401553400020
J	Zayed, MA; Wei, XC; Park, KM; Belaygorod, L; Naim, UM; Harvey, J; Yin, L; Blumer, K; Semenkovich, CF				Zayed, Mohamed A.; Wei, Xiachao; Park, Kyoung-mi; Belaygorod, Larisa; Naim, Uzma; Harvey, Joseph; Yin, Li; Blumer, Kendall; Semenkovich, Clay F.			N-Acetylcysteine accelerates amputation stump healing in the setting of diabetes	FASEB JOURNAL			English	Article						NAC; peripheral arterial disease; G alpha q; arterial perfusion	ENDOTHELIAL-CELL APOPTOSIS; NITRIC-OXIDE SYNTHASE; KAPPA-B ACTIVATION; PROTEIN PALMITOYLATION; LOWER-EXTREMITY; INSULIN-RESISTANCE; ACYL TRANSFERASES; MICE; ANGIOGENESIS; EXPRESSION	Over 60% of lower extremity amputations are performed in patients with diabetes and peripheral arterial disease, and at least 25% require subsequent reamputation due to poor surgical site healing. The mechanisms underlying poor amputation stump healing in the setting of diabetes are not understood. N-acetylcysteine (NAC) is known to promote endothelial cell function and angiogenesis and may have therapeutic benefits in the setting of diabetes. We tested the hypothesis that NAC alters the vascular milieu to improve healing of amputation stumps in diabetes using a novel in vivo murine hindlimb ischemia-amputation model. Amputation stump tissue perfusion and healing were evaluated in C57BL/6J adult mice with streptozotocin-induced diabetes. Compared with controls, mice treated with daily NAC demonstrated improved postamputation stump healing, perfusion, adductor muscle neovascularization, and decreased muscle fiber damage. Additionally, NAC stimulated HUVEC migration and proliferation in a phospholipase C beta-dependent fashion and decreased G alpha q palmitoylation. Similarly, NAC treatment also decreased Gaq palmitoylation in ischemic and nonischemic hindlimbs in vivo. In summary, we demonstrate that NAC accelerates healing of amputation stumps in the setting of diabetes and ischemia. The underlying mechanism appears to involve a previously unrecognized effect of NAC on Gaq palmitoylation and phospholipase C beta-mediated signaling in endothelial cells.	[Zayed, Mohamed A.; Park, Kyoung-mi; Belaygorod, Larisa; Naim, Uzma] Washington Univ, Sch Med, Dept Surg, Sect Vasc Surg, St Louis, MO 63110 USA; [Wei, Xiachao; Yin, Li; Semenkovich, Clay F.] Washington Univ, Sch Med, Dept Med, Div Endocrinol Metab & Lipid Res, St Louis, MO 63110 USA; [Harvey, Joseph; Blumer, Kendall; Semenkovich, Clay F.] Washington Univ, Sch Med, Dept Cell Biol & Physiol, St Louis, MO 63110 USA; [Zayed, Mohamed A.] St Louis Vet Affairs Hlth Care Syst, Dept Surg, St Louis, MO USA	Washington University (WUSTL); Washington University (WUSTL); Washington University (WUSTL)	Zayed, MA (corresponding author), Washington Univ, Sch Med, Vasc & Endovasc Surg, Campus Box 8109 Surg,660 South Euclid Ave, St Louis, MO 63110 USA.	zayedm@wustl.edu		Park, Kyoung-Mi/0000-0001-7548-8432	Vascular Cures Foundation; Society for Vascular Surgery Foundation; Washington University Diabetes Research Center [P30 DK020579]; U. S. Department of Veterans Affairs [VA-STL-151-16-01]; U. S. National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases [DK076729, DK101392, DK056341]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL132060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007120, P30DK020579, P30DK056341, R01DK101392, R01DK076729] Funding Source: NIH RePORTER	Vascular Cures Foundation; Society for Vascular Surgery Foundation; Washington University Diabetes Research Center; U. S. Department of Veterans Affairs(US Department of Veterans Affairs); U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Vascular Cures Foundation Wylie Scholar Award (to M.A.Z.), Society for Vascular Surgery Foundation Research Seed Grant (to M.A.Z.), Washington University Diabetes Research Center grant (P30 DK020579), the U. S. Department of Veterans Affairs (VA-STL-151-16-01), and U. S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grants DK076729, DK101392, and DK056341. The authors thank Dr. Sangeeta Adak, Dr. Larry Spears, and Malik Darwech (all from Washington University) for their scientific and technical input; the Washington University Diabetes Models Phenotyping Core for assistance with murine morphometric studies; and Dr. Luis Sanchez and Dr. Timothy Eberlein (all from Washington University) for institutional support.	Aicart-Ramos C, 2011, BBA-BIOMEMBRANES, V1808, P2981, DOI 10.1016/j.bbamem.2011.07.009; Al Suleimani YM, 2016, PHYSIOL RES, V65, P53, DOI 10.33549/physiolres.932962; AMMON HPT, 1992, ARZNEIMITTEL-FORSCH, V42-1, P642; Atkins KB, 2000, J APPL TOXICOL, V21, pS125; Burgoyne JR, 2012, FASEB J, V26, P832, DOI 10.1096/fj.11-189415; Chen JM, 2011, J CLIN INVEST, V121, P593, DOI 10.1172/JCI41062; Dillingham TR, 2005, ARCH PHYS MED REHAB, V86, P480, DOI 10.1016/j.apmr.2004.06.072; Ebrahimian TG, 2006, AM J PATHOL, V169, P719, DOI 10.2353/ajpath.2006.060042; EBSKOV B, 1980, PROSTHET ORTHOT INT, V4, P77; Fernandez-Hernando C, 2006, J CELL BIOL, V174, P369, DOI 10.1083/jcb.200601051; Forrester MT, 2011, J LIPID RES, V52, P393, DOI 10.1194/jlr.D011106; GarciaCardena G, 1996, P NATL ACAD SCI USA, V93, P6448, DOI 10.1073/pnas.93.13.6448; Gregg EW, 2014, NEW ENGL J MED, V370, P1514, DOI 10.1056/NEJMoa1310799; Ho E, 1999, FASEB J, V13, P1845, DOI 10.1096/fasebj.13.13.1845; Hubbard KB, 2006, CELL SIGNAL, V18, P135, DOI 10.1016/j.cellsig.2005.08.004; Ismael MA, 2008, EUR J PHARMACOL, V589, P66, DOI 10.1016/j.ejphar.2008.05.006; Kanade Rajani, 2007, Int Wound J, V4, P344; Kaneto H, 1999, DIABETES, V48, P2398, DOI 10.2337/diabetes.48.12.2398; Kim H, 2000, FREE RADICAL BIO MED, V29, P674, DOI 10.1016/S0891-5849(00)00368-3; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Lasram MM, 2015, CLIN BIOCHEM, V48, P1200, DOI 10.1016/j.clinbiochem.2015.04.017; Linder ME, 2007, NAT REV MOL CELL BIO, V8, P74, DOI 10.1038/nrm2084; Mangram AJ, 1999, AM J INFECT CONTROL, V27, P97, DOI 10.1016/S0196-6553(99)70088-X; Marin EP, 2012, CIRC RES, V110, P1336, DOI 10.1161/CIRCRESAHA.112.269514; MEYER M, 1993, EMBO J, V12, P2005, DOI 10.1002/j.1460-2075.1993.tb05850.x; Pieper GM, 1998, J CARDIOVASC PHARM, V32, P101, DOI 10.1097/00005344-199807000-00016; Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908; PRESCOTT LF, 1977, LANCET, V2, P432; Resh MD, 2006, METHODS, V40, P191, DOI 10.1016/j.ymeth.2006.04.013; Resh Marilyn D, 2006, Sci STKE, V2006, pre14, DOI 10.1126/stke.3592006re14; Salaun C, 2010, J CELL BIOL, V191, P1229, DOI 10.1083/jcb.201008160; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Sen CK, 2009, WOUND REPAIR REGEN, V17, P763, DOI 10.1111/j.1524-475X.2009.00543.x; SHEFFNER AL, 1964, AM REV RESPIR DIS, V90, P721; Shih RH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-104; Sivaraj KK, 2015, CARDIOVASC RES, V108, P171, DOI 10.1093/cvr/cvv216; SMRCKA AV, 1991, SCIENCE, V251, P804, DOI 10.1126/science.1846707; Victor VM, 2003, FREE RADICAL RES, V37, P919, DOI 10.1080/1071576031000148727; Wan J, 2007, NAT PROTOC, V2, P1573, DOI 10.1038/nprot.2007.225; Wang AY, 2007, MOL THER, V15, P255, DOI 10.1038/sj.mt.6300032; Wang SP, 2015, J CLIN INVEST, V125, P3077, DOI 10.1172/JCI81067; Wang TT, 2013, FREE RADICAL BIO MED, V63, P291, DOI 10.1016/j.freeradbiomed.2013.05.043; Wanivenhaus F, 2016, ORTHOPEDICS, V39, pE149, DOI 10.3928/01477447-20151222-14; WEDEGAERTNER PB, 1993, J BIOL CHEM, V268, P25001; WEDEGAERTNER PB, 1994, CELL, V77, P1063, DOI 10.1016/0092-8674(94)90445-6; Wei XC, 2014, ARTERIOSCL THROM VAS, V34, P346, DOI 10.1161/ATVBAHA.113.302848; Xia ZY, 2006, EUR J PHARMACOL, V550, P134, DOI 10.1016/j.ejphar.2006.08.044; Zayed M, 2014, ANN VASC SURG, V28, P1157, DOI 10.1016/j.avsg.2013.11.008; Zayed MA, 2007, CIRC RES, V101, P1185, DOI 10.1161/CIRCRESAHA.107.157586	49	13	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2686	2695		10.1096/fj.201601348R	http://dx.doi.org/10.1096/fj.201601348R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28280002	Green Published			2022-12-28	WOS:000401553400038
J	Mohammed, SG; Arjona, FJ; Latta, F; Bindels, RJM; Roepman, R; Hoenderop, JGJ				Mohammed, Sami G.; Arjona, Francisco J.; Latta, Femke; Bindels, Rene J. M.; Roepman, Ronald; Hoenderop, Joost G. J.			Fluid shear stress increases transepithelial transport of Ca2+ in ciliated distal convoluted and connecting tubule cells	FASEB JOURNAL			English	Article						renal tubules; mechanosensation; primary cilia; Ca2+ reabsorption	CORTICAL COLLECTING DUCT; PRIMARY CILIUM; EPITHELIAL CA2+; ENDOTHELIN-1 PRODUCTION; CALCIUM REABSORPTION; PROSTAGLANDIN E-2; FLOW REGULATION; CHANNEL FAMILY; KIDNEY-DISEASE; POLYCYSTIN-1	In kidney, transcellular transport of Ca2+ is mediated by transient receptor potential vanilloid 5 and Na+-Ca2+ exchanger 1 proteins in distal convoluted and connecting tubules (DCTs and CNTs, respectively). It is not yet understood howDCT/CNT cells can adapt to differences in tubular flow rate and, consequently, Ca2+ load. This study aims to elucidate the molecular mechanisms by which DCT/CNT cells sense fluid dynamics to control transepithelial Ca2+ reabsorption and whether their primary cilia play an active role in this process. Mouse primary DCT/CNT cultures were subjected to a physiologic fluid shear stress (FSS) of 0.12 dyn/cm(2). Transient receptor potential vanilloid 5 and Na+-Ca2+ exchanger 1 mRNA levels were significantly increased upon FSS exposure compared with static controls. Functional studies with Ca-45(2+) demonstrated a significant stimulation of transepithelial Ca2+ transport under FSS comparedwith static conditions. Primary cilia removal decreased Ca2+ transport in both static and FSS conditions, a finding that correlated with decreased expression of genes involved in transepithelial Ca2+ transport; however, FSS-induced stimulation of Ca2+ transport was still observed. These results indicate that nephron DCT and CNT segments translate FSS into a physiologic response that implicates an increased Ca-2+ reabsorption. Moreover, primary cilia influence transepithelial Ca2+ transport in DCTs/CNTs, yet this process is not distinctly coupled to FSS sensing by these organelles.-Mohammed, S. G., Arjona, F. J., Latta, F., Bindels, R. J. M., Roepman, R., Hoenderop, J. G. J. Fluid shear stress increases transepithelial transport of Ca2+ in ciliated distal convoluted and connecting tubule cells.	[Mohammed, Sami G.; Arjona, Francisco J.; Latta, Femke; Bindels, Rene J. M.; Hoenderop, Joost G. J.] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, POB 9101, NL-6500 HB Nijmegen, Netherlands; [Roepman, Ronald] Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Human Genet, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen	Hoenderop, JGJ (corresponding author), Radboud Univ Nijmegen, Med Ctr, Radboud Inst Mol Life Sci, Dept Physiol, POB 9101, NL-6500 HB Nijmegen, Netherlands.	joost.hoenderop@radboudumc.nl	Mohammed, Sami Gemal/F-3894-2016; Bindels, René JM/B-9824-2013; Arjona, Francisco J/P-6059-2015; Roepman, Ronald/B-1339-2014; Hoenderop, Joost G.J./H-8047-2014	Mohammed, Sami Gemal/0000-0002-0903-8131; Bindels, René JM/0000-0003-1167-1339; Arjona, Francisco J/0000-0002-2479-0735; Roepman, Ronald/0000-0002-5178-8163; Hoenderop, Joost G.J./0000-0002-1816-8544	Radboud Institute for Molecular Life Sciences; Netherlands Organization for Scientific Research [NWO] [Vici-865.12.005, Vici-016.130.668]	Radboud Institute for Molecular Life Sciences; Netherlands Organization for Scientific Research [NWO](Netherlands Organization for Scientific Research (NWO))	This work was supported by grants from the Radboud Institute for Molecular Life Sciences (to J.G.J.H. and R.R.) and The Netherlands Organization for Scientific Research [NWO Vici-865.12.005 (to R. R.) and NWO Vici-016.130.668 (to J.G.J.H.)]. The authors thank the COPAS sorting team: Caro Bos, Marla Lavrijsen, and Daisy Ermers. The authors also thank Dr. Jeppe Praetorius for the TRPV5-GFP mouse strain and Rico Bongaarts from Union Biometrica for technical assistance with the COPAS; the Radboud animal facility for breeding and maintaining animals; the Microscope Imaging Centre in Nijmegen for providing the FV1000 confocal laser scanning microscope; and Louis Wolf for ImageJ software assistance. The authors declare no conflicts of interest.	Berrout J, 2012, J BIOL CHEM, V287, P8782, DOI 10.1074/jbc.M111.308411; Boehlke C, 2010, NAT CELL BIOL, V12, P1115, DOI 10.1038/ncb2117; Bonny O, 2013, AM J PHYSIOL-RENAL, V304, pF585, DOI 10.1152/ajprenal.00493.2012; Boros S, 2009, PFLUG ARCH EUR J PHY, V458, P99, DOI 10.1007/s00424-008-0602-6; Chang Q, 2005, SCIENCE, V310, P490, DOI 10.1126/science.1114245; de Groot T, 2009, J AM SOC NEPHROL, V20, P1693, DOI 10.1681/ASN.2008080873; Delaine-Smith RM, 2014, FASEB J, V28, P430, DOI 10.1096/fj.13-231894; Delling M, 2016, NATURE, V531, P656, DOI 10.1038/nature17426; Dimke H, 2011, J PHYSIOL-LONDON, V589, P1535, DOI 10.1113/jphysiol.2010.199869; Flores D, 2012, AM J PHYSIOL-RENAL, V303, pF632, DOI 10.1152/ajprenal.00169.2012; Flores D, 2011, NEPHRON PHYSIOL, V117, P27, DOI 10.1159/000321640; Hill-Eubanks DC, 2014, PHYSIOLOGY, V29, P343, DOI 10.1152/physiol.00009.2014; Hoenderop JGJ, 2002, FASEB J, V16, P1398, DOI 10.1096/fj.02-0225com; Hoenderop JGJ, 2001, J PHYSIOL-LONDON, V537, P747; Hofmeister MV, 2009, AM J PHYSIOL-RENAL, V296, pF194, DOI 10.1152/ajprenal.90495.2008; Jang KJ, 2013, INTEGR BIOL-UK, V5, P1119, DOI 10.1039/c3ib40049b; KUNAU RT, 1974, J CLIN INVEST, V54, P1488, DOI 10.1172/JCI107897; Lambers TT, 2006, EMBO J, V25, P2978, DOI 10.1038/sj.emboj.7601186; Lambers TT, 2006, KIDNEY INT, V69, P650, DOI 10.1038/sj.ki.5000169; Liu W, 2003, AM J PHYSIOL-RENAL, V285, pF998, DOI 10.1152/ajprenal.00067.2003; Liu Y, 2014, AM J PHYSIOL-RENAL, V306, pF214, DOI 10.1152/ajprenal.00327.2013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyon-Roberts B, 2011, AM J PHYSIOL-RENAL, V300, pF650, DOI 10.1152/ajprenal.00530.2010; Markadieu N, 2012, AM J PHYSIOL-RENAL, V303, pF886, DOI 10.1152/ajprenal.00114.2012; MILLS JN, 1951, J PHYSIOL-LONDON, V113, P528, DOI 10.1113/jphysiol.1951.sp004593; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nauli SM, 2008, CIRCULATION, V117, P1161, DOI 10.1161/CIRCULATIONAHA.107.710111; Nauli SM, 2006, J AM SOC NEPHROL, V17, P1015, DOI 10.1681/ASN.2005080830; Nilius B, 2001, BRIT J PHARMACOL, V134, P453, DOI 10.1038/sj.bjp.0704272; O'Neil RG, 2005, PFLUG ARCH EUR J PHY, V451, P193, DOI 10.1007/s00424-005-1424-4; Pandit MM, 2015, AM J PHYSIOL-RENAL, V308, pF541, DOI 10.1152/ajprenal.00456.2014; Patel A, 2015, PFLUG ARCH EUR J PHY, V467, P157, DOI 10.1007/s00424-014-1516-0; Pluznick JL, 2015, CLIN J AM SOC NEPHRO, V10, P1626, DOI 10.2215/CJN.00730114; Pochynyuk O, 2013, PFLUG ARCH EUR J PHY, V465, P177, DOI 10.1007/s00424-012-1190-z; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P69, DOI 10.1007/s00232-002-1042-4; Praetorius HA, 2015, AM J PHYSIOL-CELL PH, V308, pC198, DOI 10.1152/ajpcell.00336.2014; Praetorius HA, 2013, SEMIN CELL DEV BIOL, V24, P3, DOI 10.1016/j.semcdb.2012.10.003; Raghavan V, 2014, P NATL ACAD SCI USA, V111, P8506, DOI 10.1073/pnas.1402195111; Renkema KY, 2008, ANN MED, V40, P82, DOI 10.1080/07853890701689645; RESNICK N, 1995, FASEB J, V9, P874, DOI 10.1096/fasebj.9.10.7615157; Rydholm S, 2010, AM J PHYSIOL-RENAL, V298, pF1096, DOI 10.1152/ajprenal.00657.2009; Satlin LM, 2006, AM J PHYSIOL-RENAL, V291, pF923, DOI 10.1152/ajprenal.00192.2006; Satlin LM, 2001, AM J PHYSIOL-RENAL, V280, pF1010, DOI 10.1152/ajprenal.2001.280.6.F1010; Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534; SIROTA JH, 1950, J CLIN INVEST, V29, P187, DOI 10.1172/JCI102245; Sooy K, 2000, CURR OPIN NEPHROL HY, V9, P341, DOI 10.1097/00041552-200007000-00004; Srivastava T, 2014, AM J PHYSIOL-RENAL, V307, pF1323, DOI 10.1152/ajprenal.00335.2014; van der Hagen EAE, 2014, PFLUG ARCH EUR J PHY, V466, P2077, DOI 10.1007/s00424-014-1470-x; van Loon EPM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0153483; vanBaal J, 1996, J PHYSIOL-LONDON, V497, P229, DOI 10.1113/jphysiol.1996.sp021763; Weimbs T, 2007, AM J PHYSIOL-RENAL, V293, pF1423, DOI 10.1152/ajprenal.00275.2007; Weinbaum S, 2007, ANNU REV BIOMED ENG, V9, P121, DOI 10.1146/annurev.bioeng.9.060906.151959; Weinbaum S, 2010, AM J PHYSIOL-RENAL, V299, pF1220, DOI 10.1152/ajprenal.00453.2010; Woda CB, 2001, AM J PHYSIOL-RENAL, V280, pF786, DOI 10.1152/ajprenal.2001.280.5.F786; Woudenberg-Vrenken TE, 2009, NAT REV NEPHROL, V5, P441, DOI 10.1038/nrneph.2009.100; Zhou XZ, 2010, J BIOMECH, V43, P1598, DOI 10.1016/j.jbiomech.2009.12.028	57	12	12	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1796	1806		10.1096/fj.201600687RRR	http://dx.doi.org/10.1096/fj.201600687RRR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28100643				2022-12-28	WOS:000399195500005
J	Fu, WY; Hu, WH; Shi, L; Mundra, JJ; Xiao, GZ; Dustin, ML; Liu, CJ				Fu, Wenyu; Hu, Wenhuo; Shi, Lei; Mundra, Jyoti Joshi; Xiao, GuoZhi; Dustin, Michael L.; Liu, Chuan-ju			Foxo4-and Stat3-dependent IL-10 production by progranulin in regulatory T cells restrains inflammatory arthritis	FASEB JOURNAL			English	Article						TNFR2; JNK; Treg	GRANULIN-EPITHELIN PRECURSOR; COLLAGEN-INDUCED ARTHRITIS; OLIGOMERIC MATRIX PROTEIN; RHEUMATOID-ARTHRITIS; TRANSCRIPTION FACTOR; GROWTH-FACTOR; HOST-DEFENSE; TNF-ALPHA; MICE; DIFFERENTIATION	Progranulin (PGRN) restrains inflammation and is therapeutic against inflammatory arthritis; however, the underlying immunological mechanism remains unknown. In this study, we demonstrated that antiinflammatory cytokine IL-10 was a critical mediator for PGRN-mediated anti-inflammation in collagen-induced arthritisbyusingPGRNandIL-10geneticallymodifiedmousemodels. IL-10greenfluorescentproteinreportermice revealed that regulatory T (Treg) cells were the predominant source of IL-10 in response to PGRN. In addition, PGRN-mediated expansion and activation of Treg cells, as well as IL-10 production, depends on JNK signaling, but not on known PGRN-activated ERK and PI3K pathways. Furthermore, microarray and chromatin immunoprecipitation sequencing screens led to the discovery of forkhead box protein O4 and signal transducer and activator of transcription 3 as the transcription factors required for PGRNinduction of IL-10 in(Treg) cells. These findings define a previously unrecognized signaling pathway that underlies IL-10 production byPGRNin Treg cells and present new insights into the mechanisms by which PGRN resolves inflammation in inflammatory conditions and autoimmune diseases, particularly inflammatory arthritis.-Fu, W., Hu, W., Shi, L., Mundra, J. J. Xiao, G., Dustin, M. L., Liu, C. Foxo4-and Stat3-dependent IL-10 production by progranulin in regulatory T cells restrains inflammatory arthritis.	[Fu, Wenyu; Shi, Lei; Mundra, Jyoti Joshi; Liu, Chuan-ju] NYU, Med Ctr, Dept Orthopaed Surg, New York, NY 10016 USA; [Dustin, Michael L.] NYU, Med Ctr, Skirball Inst Biomol Med, New York, NY 10016 USA; [Hu, Wenhuo] Mem Hosp Res Labs, New York, NY USA; [Xiao, GuoZhi] South Univ Sci & Technol China, Dept Biol, Shenzhen, Peoples R China; [Xiao, GuoZhi] South Univ Sci & Technol China, Shenzhen Key Lab Cell Microenvironm, Shenzhen, Peoples R China; [Xiao, GuoZhi] Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Dustin, Michael L.] Univ Oxford, Kennedy Inst Rheumatol, Oxford, England; [Liu, Chuan-ju] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Shi, Lei] Shanxi Med Univ, Hosp 2, Taiyuan, Shanxi Sheng, Peoples R China	New York University; New York University; Southern University of Science & Technology; Southern University of Science & Technology; Rush University; University of Oxford; New York University; Shanxi Medical University	Liu, CJ (corresponding author), NYU, Med Ctr, 301 East 17th St, New York, NY 10003 USA.	chuanju.liu@nyumc.org	Liu, Chuan-ju/AAT-8165-2021; Dustin, Michael/AAM-4611-2020	Dustin, Michael/0000-0003-4983-6389; liu, chuanju/0000-0002-7181-8032	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR062207, R01-AR061484, R56-AI100901]; U.S. Department of Defense [W81XWH-16-1-0482]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI100901] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062207, R01AR061484] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); U.S. Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases for Grants R01-AR062207, R01-AR061484, and R56-AI100901, as well as W81XWH-16-1-0482 from the U.S. Department of Defense.	Alzabin S, 2012, ANN RHEUM DIS, V71, P1741, DOI 10.1136/annrheumdis-2011-201024; Asquith DL, 2009, EUR J IMMUNOL, V39, P2040, DOI 10.1002/eji.200939578; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Brand DD, 2007, NAT PROTOC, V2, P1269, DOI 10.1038/nprot.2007.173; Brennan F, 2007, CURR OPIN RHEUMATOL, V19, P296, DOI 10.1097/BOR.0b013e32805e87f1; Campbell DJ, 2011, NAT REV IMMUNOL, V11, P119, DOI 10.1038/nri2916; Camps M, 2005, NAT MED, V11, P936, DOI 10.1038/nm1284; Cretney E, 2011, NAT IMMUNOL, V12, P304, DOI 10.1038/ni.2006; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Daniel R, 2000, J HISTOCHEM CYTOCHEM, V48, P999, DOI 10.1177/002215540004800713; Egashira Y, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-105; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Finnegan A, 2003, ARTHRITIS RES THER, V5, pR18, DOI 10.1186/ar601; Fontenot JD, 2003, NAT IMMUNOL, V4, P330, DOI 10.1038/ni904; Guo FJ, 2010, ARTHRITIS RHEUM-US, V62, P2023, DOI 10.1002/art.27491; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; He ZH, 2002, CANCER RES, V62, P5590; Hedrich CM, 2014, P NATL ACAD SCI USA, V111, P13457, DOI 10.1073/pnas.1408023111; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huber S, 2006, FRONT BIOSCI-LANDMRK, V11, P1014, DOI 10.2741/1859; Jian JL, 2013, FEBS LETT, V587, P3428, DOI 10.1016/j.febslet.2013.09.024; Jian JL, 2013, J LEUKOCYTE BIOL, V93, P199, DOI 10.1189/jlb.0812429; Kamrava M, 2005, ONCOGENE, V24, P7084, DOI 10.1038/sj.onc.1208857; Kawase R, 2013, CARDIOVASC RES, V100, P125, DOI 10.1093/cvr/cvt178; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Konopka J, 2014, FRONT BIOSCI-LANDMRK, V19, P662, DOI 10.2741/4234; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lu LF, 2009, GENE DEV, V23, P1270, DOI 10.1101/gad.1791009; Madan R, 2009, J IMMUNOL, V183, P2312, DOI 10.4049/jimmunol.0900185; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; McGovern JL, 2012, ARTHRITIS RHEUM-US, V64, P3129, DOI 10.1002/art.34565; Monte K, 2008, ARTHRITIS RHEUM-US, V58, P3730, DOI 10.1002/art.24048; Niu Q, 2012, RHEUMATOL INT, V32, P2731, DOI 10.1007/s00296-011-1984-x; Ouyang W, 2010, NAT IMMUNOL, V11, P618, DOI 10.1038/ni.1884; Pandiyan P, 2007, NAT IMMUNOL, V8, P1353, DOI 10.1038/ni1536; Petkau TL, 2014, TRENDS NEUROSCI, V37, P388, DOI 10.1016/j.tins.2014.04.003; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Shoemaker J, 2006, J IMMUNOL, V176, P3470, DOI 10.4049/jimmunol.176.6.3470; Stewart CA, 2013, J CLIN INVEST, V123, P4859, DOI 10.1172/JCI65180; Stumhofer JS, 2007, NAT IMMUNOL, V8, P1363, DOI 10.1038/ni1537; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tsuji-Takayama K, 2008, J IMMUNOL, V181, P3897, DOI 10.4049/jimmunol.181.6.3897; Wang WH, 2012, RHEUMATOL INT, V32, P887, DOI 10.1007/s00296-010-1710-0; Wei FH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112110; Wei FH, 2014, SCI REP-UK, V4, DOI 10.1038/srep07023; Williams A, 2016, ARTHRITIS RHEUMATOL, V68, P2845, DOI 10.1002/art.39816; Xu K, 2007, J BIOL CHEM, V282, P11347, DOI 10.1074/jbc.M608744200; Yan WJ, 2016, J IMMUNOL, V197, P3393, DOI 10.4049/jimmunol.1600862; Ye L, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4544; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhao YP, 2015, ANN RHEUM DIS, V74, P2244, DOI 10.1136/annrheumdis-2014-205779; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8; Zhu XF, 2007, GRAEF ARCH CLIN EXP, V245, P1549, DOI 10.1007/s00417-007-0591-8; Ziegler-Heitbrock L, 2003, J IMMUNOL, V171, P285, DOI 10.4049/jimmunol.171.1.285	60	30	31	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1354	1367		10.1096/fj.201601134R	http://dx.doi.org/10.1096/fj.201601134R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28011648	Green Published			2022-12-28	WOS:000398504300009
J	McKenzie, JA; Buettmann, E; Abraham, AC; Gardner, MJ; Silva, MJ; Killian, ML				McKenzie, Jennifer A.; Buettmann, Evan; Abraham, Adam C.; Gardner, Michael J.; Silva, Matthew J.; Killian, Megan L.			Loss of scleraxis in mice leads to geometric and structural changes in cortical bone, as well as asymmetry in fracture healing	FASEB JOURNAL			English	Article						skeletal repair; callus; development; transcription factors; tendon	REFERENCE-POINT INDENTATION; MORPHOGENETIC PROTEIN-2; TISSUE DIFFERENTIATION; ADULT MICE; MODEL; LIMB; EXPRESSION; PROGENITORS; OSTEOTOMY; TENDONS	Scleraxis (Scx) is a known regulator of tendon development, and recent work has identified the role of Scx in bone modeling. However, the role of Scx in fracture healing has not yet been explored. This study was conducted to identify the role of Scx in cortical bone development and fracture healing. Scx green fluorescent protein-labeled (ScxGFP) reporter and Scx-knockout (Scx-mutant) mice were used to assess bone morphometry and the effects of fracture healing on Scx localization and gene expression, as well as callus healing response. Botulinum toxin (BTX) was used to investigate muscle unloading effects on callus shape. Scx-mutant long bones had structural and mechanical defects. Scx gene expression was elevated and bmp4 was decreased at 24 h after fracture. ScxGFP + cells were localized throughout the healing callus after fracture. Scx-mutant mice demonstrated disrupted callus healing and asymmetry. Asymmetry of Scx-mutant callus was not due to muscle unloading. Wild-type littermates (age matched) served as controls. This is the first study to explore the role of Scx in cortical bone mechanics and fracture healing. Deletion of Scx during development led to altered long bone properties and callus healing. This study also demonstrated that Scx may play a role in the periosteal response during fracture healing.-McKenzie, J. A., Buettmann, E., Abraham, A. C., Gardner, M. J., Silva, M. J., Killian, M. L. Loss of scleraxis in mice leads to geometric and structural changes in cortical bone, as well as asymmetry in fracture healing.	[McKenzie, Jennifer A.; Buettmann, Evan; Abraham, Adam C.; Silva, Matthew J.; Killian, Megan L.] Washington Univ, Sch Med, Dept Orthoped Surg, St Louis, MO USA; [Gardner, Michael J.] Stanford Univ, Dept Orthoped Surg, Redwood City, CA USA; [Killian, Megan L.] Univ Delaware, Dept Biomed Engn, 5 Innovat Way,Suite 200, Newark, DE 19716 USA	Washington University (WUSTL); Stanford University; University of Delaware	Killian, ML (corresponding author), Univ Delaware, Dept Biomed Engn, 5 Innovat Way,Suite 200, Newark, DE 19716 USA.	killianm@udel.edu	Killian, Megan L./K-2442-2015; Buettmann, Evan/Q-2411-2019	Killian, Megan L./0000-0001-6868-5550; Buettmann, Evan/0000-0001-8439-477X; Silva, Matthew/0000-0001-7375-4522; Abraham, Adam/0000-0003-2131-5178	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS [F32 AR064652, R21 AR066798]; Washington University Musculoskeletal Research Center Grant [NIH-P30 AR057235]; Orthopaedic Research and Education Foundation; Children's Discovery Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR066798, R01AR050211, F32AR064652, P30AR057235] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [T32EB018266] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS; Washington University Musculoskeletal Research Center Grant; Orthopaedic Research and Education Foundation; Children's Discovery Institute; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	This work was funded by the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) Grants F32 AR064652 (to M.L.K.), and R21 AR066798 (to M.J.S. and M.J.G.); Washington University Musculoskeletal Research Center Grant NIH-P30 AR057235; the Orthopaedic Research and Education Foundation, and the Children's Discovery Institute (Postdoctoral Fellowship to M.L.K.). The authors thank Daniel Leib and Crystal Idleburg (Musculoskeletal Research Center) for microCT and histology assistance. The authors declare no conflicts of interest.	Abe E, 2000, J BONE MINER RES, V15, P663, DOI 10.1359/jbmr.2000.15.4.663; Abraham AC, 2016, BONE, V87, P37, DOI 10.1016/j.bone.2016.03.013; Blitz E, 2013, DEVELOPMENT, V140, P2680, DOI 10.1242/dev.093906; Blitz E, 2009, DEV CELL, V17, P861, DOI 10.1016/j.devcel.2009.10.010; CARTER DR, 1988, J ORTHOP RES, V6, P736, DOI 10.1002/jor.1100060517; Cho TJ, 2002, J BONE MINER RES, V17, P513, DOI 10.1359/jbmr.2002.17.3.513; Claes LE, 1999, J BIOMECH, V32, P255, DOI 10.1016/S0021-9290(98)00153-5; Dudley AT, 2002, NATURE, V418, P539, DOI 10.1038/nature00945; Edwards RB, 2004, J BONE JOINT SURG AM, V86A, P1425, DOI 10.2106/00004623-200407000-00010; Epari DR, 2010, P I MECH ENG H, V224, P1543, DOI 10.1243/09544119JEIM808; Eyal S, 2015, DEVELOPMENT, V142, P1831, DOI 10.1242/dev.121970; Fischer C, 2016, INJURY, V47, P342, DOI 10.1016/j.injury.2015.11.007; Gallant MA, 2013, BONE, V53, P301, DOI 10.1016/j.bone.2012.12.015; Gardner MJ, 2011, J ORTHOP SCI, V16, P298, DOI 10.1007/s00776-011-0051-5; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Guimaraes JM, 2013, J ORTHOP RES, V31, P1971, DOI 10.1002/jor.22455; Gulotta LV, 2011, AM J SPORT MED, V39, P1282, DOI 10.1177/0363546510395485; Hofbauer LC, 1998, BIOCHEM BIOPH RES CO, V250, P776, DOI 10.1006/bbrc.1998.9394; Holguin N., 2016, J BONE MINER RES; Huang AH, 2008, ANN BIOMED ENG, V36, P1909, DOI 10.1007/s10439-008-9562-4; Kempen DHR, 2008, BIOMATERIALS, V29, P3245, DOI 10.1016/j.biomaterials.2008.04.031; Killian ML, 2016, FASEB J, V30, P301, DOI 10.1096/fj.14-258236; Lacroix D, 2002, J BIOMECH, V35, P1163, DOI 10.1016/S0021-9290(02)00086-6; Li RH, 2003, J ORTHOP RES, V21, P997, DOI 10.1016/S0736-0266(03)00082-2; LIND M, 1993, ACTA ORTHOP SCAND, V64, P553, DOI 10.3109/17453679308993691; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Marsell R, 2011, INJURY, V42, P551, DOI 10.1016/j.injury.2011.03.031; McBride-Gagyi SH, 2015, BONE, V81, P533, DOI 10.1016/j.bone.2015.09.003; Murchison ND, 2007, DEVELOPMENT, V134, P2697, DOI 10.1242/DEV.001933; Niswander L, 2003, NAT REV GENET, V4, P133, DOI 10.1038/nrg1001; Oka K, 2008, DEV BIOL, V321, P303, DOI 10.1016/j.ydbio.2008.03.046; Ouimette JF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1036; Porter SM, 2016, J ORTHOP RES, V34, P1224, DOI 10.1002/jor.23146; Pryce BA, 2007, DEV DYNAM, V236, P1677, DOI 10.1002/dvdy.21179; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Ritchie RO, 2006, STRAIN, V42, P225, DOI 10.1111/j.1475-1305.2006.00282.x; Rodriguez-Esteban C, 1999, NATURE, V398, P814, DOI 10.1038/19769; Rosier RN, 1998, CLIN ORTHOP RELAT R, pS294; Rot C, 2014, DEV CELL, V31, P159, DOI 10.1016/j.devcel.2014.08.026; Scammell BE, 1996, J BONE MINER RES, V11, P737; Schweitzer R, 2001, DEVELOPMENT, V128, P3855; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Seeherman HJ, 2004, J BONE JOINT SURG AM, V86A, P1961, DOI 10.2106/00004623-200409000-00015; Seeherman HJ, 2010, J BONE JOINT SURG AM, V92A, P411, DOI 10.2106/JBJS.H.01732; Sugimoto Y, 2013, DEVELOPMENT, V140, P2280, DOI 10.1242/dev.096354; Thomopoulos S, 2010, J MUSCULOSKEL NEURON, V10, P35; Thomopoulos S, 2011, TISSUE ENG PT A, V17, P1039, DOI [10.1089/ten.tea.2009.0499, 10.1089/ten.TEA.2009.0499]; Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006; Tsuji K, 2008, J BONE JOINT SURG AM, V90A, P14, DOI 10.2106/JBJS.G.01109; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; Zelzer E, 2014, BIRTH DEFECTS RES C, V102, P101, DOI 10.1002/bdrc.21056; Zimmermann G, 2005, BONE, V36, P779, DOI 10.1016/j.bone.2005.02.011	52	13	13	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					882	+		10.1096/fj.201600969R	http://dx.doi.org/10.1096/fj.201600969R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27864378	Green Published			2022-12-28	WOS:000395671200005
J	Slim, KE; Vauzour, D; Tejera, N; Voshol, PJ; Cassidy, A; Minihane, AM				Slim, Kenna E.; Vauzour, David; Tejera, Noemi; Voshol, Peter J.; Cassidy, Aedin; Minihane, Anne Marie			The effect of dietary fish oil on weight gain and insulin sensitivity is dependent on APOE genotype in humanized targeted replacement mice	FASEB JOURNAL			English	Article						diabetes; glucose; Glut4; IL-10; IPGTT	CORONARY-HEART-DISEASE; APOLIPOPROTEIN-E POLYMORPHISM; ENDOPLASMIC-RETICULUM STRESS; POLYUNSATURATED FATTY-ACIDS; ADIPOSE-TISSUE; E GENE; GLUCOSE-TRANSPORTER; METABOLIC SYNDROME; BODY-COMPOSITION; SKELETAL-MUSCLE	We investigated the independent and interactive impact of the common APOE genotype and marine n-3 polyunsaturated fatty acids (PUFAs) on the development of obesity and associated cardiometabolic dysfunction in a murine model. Human APOE3 and APOE4 targeted replacement mice were fed either a control high-fat diet (HFD) or an HFD supplemented with 3% n-3 PUFAs from fish oil (HFD + FO) for 8 wk. We established the impact of intervention on food intake, body weight, and visceral adipose tissue (VAT) mass; plasma, lipids (cholesterol and triglycerides), liver enzymes, and adipokines; glucose and insulin during an intraperitoneal glucose tolerance test; and Glut4 and ApoE expression in VAT. HFD feeding induced more weight gain and higher plasma lipids in APOE3 compared to APOE4 mice (P < 0.05), along with a 2-fold higher insulin and impaired glucose tolerance. Supplementing APOE3, but not APOE4, animals with dietary n-3 PUFAs decreased body-weight gain, plasma lipids, and insulin (P < 0.05) and improved glucose tolerance, which was associated with increased VAT Glut4 mRNA levels (P< 0.05). Our findings demonstrate that an APOE3 genotype predisposes mice to develop obesity and its metabolic complications, which was attenuated by n-3 PUFA supplementation.	[Slim, Kenna E.; Vauzour, David; Tejera, Noemi; Cassidy, Aedin; Minihane, Anne Marie] Univ East Anglia, Norwich Med Sch, Dept Nutr & Prevent Med, Norwich NR4 7UQ, Norfolk, England; [Voshol, Peter J.] Louis Bolk Inst, Dept Nutr & Hlth, Driebergen, Netherlands; [Voshol, Peter J.] Univ Cambridge, Inst Metab Sci, Cambridge, England	University of East Anglia; University of Cambridge	Minihane, AM (corresponding author), Univ East Anglia, Norwich Med Sch, Dept Nutr & Prevent Med, Norwich NR4 7UQ, Norfolk, England.	a.minihane@uea.ac.uk	Vauzour, Dr David/C-2245-2008	Vauzour, Dr David/0000-0001-5952-8756; Tejera, Noemi/0000-0001-8100-6022	University of East Anglia Faculty of Medicine and Health Sciences Graduate School studentship; Biotechnology and Biological Sciences Research Council Institute Strategic Program grant [BB/J004545/1]	University of East Anglia Faculty of Medicine and Health Sciences Graduate School studentship; Biotechnology and Biological Sciences Research Council Institute Strategic Program grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This project was funded by a University of East Anglia Faculty of Medicine and Health Sciences Graduate School studentship and a Biotechnology and Biological Sciences Research Council Institute Strategic Program grant (BB/ J004545/1).	Akinkuolie AO, 2011, CLIN NUTR, V30, P702, DOI 10.1016/j.clnu.2011.08.013; Arbones-Mainar JM, 2008, INT J OBESITY, V32, P1595, DOI 10.1038/ijo.2008.143; Ayala JE, 2010, DIS MODEL MECH, V3, P525, DOI 10.1242/dmm.006239; Beekman M, 2013, AGING CELL, V12, P184, DOI 10.1111/acel.12039; BELL GI, 1990, DIABETES CARE, V13, P198, DOI 10.2337/diacare.13.3.198; Bender N, 2014, OBES REV, V15, P657, DOI 10.1111/obr.12189; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Carvalho-Wells AL, 2012, AM J CLIN NUTR, V96, P1447, DOI 10.3945/ajcn.112.043240; Cash JG, 2012, J BIOL CHEM, V287, P27876, DOI 10.1074/jbc.M112.377549; Chouinard-Watkins R, 2013, BRIT J NUTR, V110, P1751, DOI 10.1017/S0007114513001268; Chouinard-Watkins R, 2015, AM J CLIN NUTR, V102, P505, DOI 10.3945/ajcn.114.103507; Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503; Conway V, 2014, PROSTAG LEUKOTR ESS, V91, P261, DOI 10.1016/j.plefa.2014.09.007; Dose J, 2016, FREE RADICAL BIO MED, V96, P264, DOI 10.1016/j.freeradbiomed.2016.04.031; Ellis JA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026679; Elosua R, 2003, OBES RES, V11, P1502, DOI 10.1038/oby.2003.201; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; Flachs P, 2005, DIABETOLOGIA, V48, P2365, DOI 10.1007/s00125-005-1944-7; Flachs P, 2009, CLIN SCI, V116, P1, DOI 10.1042/CS20070456; FOLCH J, 1957, J BIOL CHEM, V226, P497; Gagnon RC, 1998, J PHARMACOKINET BIOP, V26, P87, DOI 10.1023/A:1023228925137; Golubic R, 2013, INT J OBESITY, V37, P404, DOI 10.1038/ijo.2012.58; Harris WS, 2008, CURR ATHEROSCLER REP, V10, P503, DOI 10.1007/s11883-008-0078-z; Hofmann SM, 2008, DIABETES, V57, P5, DOI 10.2337/db07-0403; HORWITZ W, 1980, METHODS ANAL; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Huang ZH, 2015, J LIPID RES, V56, P215, DOI 10.1194/jlr.M050567; Huang ZH, 2006, DIABETES, V55, P3394, DOI 10.2337/db06-0354; Huebbe P, 2015, MOL NUTR FOOD RES, V59, P334, DOI 10.1002/mnfr.201400636; Kalupahana NS, 2012, MOL ASPECTS MED, V33, P26, DOI 10.1016/j.mam.2011.10.011; Karelis AD, 2004, J CLIN ENDOCR METAB, V89, P2569, DOI 10.1210/jc.2004-0165; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kofler BM, 2012, ATHEROSCLEROSIS, V221, P467, DOI 10.1016/j.atherosclerosis.2012.01.042; Kolaczynski JW, 1996, DIABETES, V45, P699, DOI 10.2337/diabetes.45.5.699; Kolovou GD, 2009, IN VIVO, V23, P33; Kuda O, 2009, DIABETOLOGIA, V52, P941, DOI 10.1007/s00125-009-1305-z; Lorente-Cebrian S, 2013, J PHYSIOL BIOCHEM, V69, P633, DOI 10.1007/s13105-013-0265-4; Lumeng CN, 2007, J CLIN INVEST, V117, P175, DOI 10.1172/JCI29881; Marques-Vidal P, 2003, OBES RES, V11, P1200, DOI 10.1038/oby.2003.165; Matualatupauw JC, 2016, MOL NUTR FOOD RES, V60, P1649, DOI 10.1002/mnfr.201500941; Minihane AM, 2007, P NUTR SOC, V66, P183, DOI 10.1017/S0029665107005435; NEUFER PD, 1993, J BIOL CHEM, V268, P13824; Oh JY, 2001, CLIN GENET, V60, P132, DOI 10.1034/j.1399-0004.2001.600207.x; Ouyang QF, 2015, MOL MED REP, V12, P2589, DOI 10.3892/mmr.2015.3774; Puglisi MJ, 2011, J NUTR BIOCHEM, V22, P101, DOI 10.1016/j.jnutbio.2010.07.003; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Sima A, 2007, CLIN CHEM LAB MED, V45, P1149, DOI 10.1515/CCLM.2007.258; Slim K, 2014, CURR CARDIOVASC RISK, V8, DOI 10.1007/s12170-014-0411-8; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Sullivan PM, 1997, J BIOL CHEM, V272, P17972, DOI 10.1074/jbc.272.29.17972; Vauzour D, 2015, J NUTR BIOCHEM, V26, P211, DOI 10.1016/j.jnutbio.2014.09.005; Virtue S, 2012, CELL METAB, V16, P665, DOI 10.1016/j.cmet.2012.10.008; Volcik KA, 2006, AM J EPIDEMIOL, V164, P342, DOI 10.1093/aje/kwj202; Yue L, 2009, J BIOL CHEM, V284, P10453, DOI 10.1074/jbc.M808482200; ZECHNER R, 1991, J BIOL CHEM, V266, P10583	56	10	11	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					989	997		10.1096/fj.201600921RR	http://dx.doi.org/10.1096/fj.201600921RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27895108	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000395671200015
J	Barloscio, D; Cerri, E; Domenici, L; Longhi, R; Dallanoce, C; Moretti, M; Vilella, A; Zoli, M; Gotti, C; Origlia, N				Barloscio, Davide; Cerri, Elisa; Domenici, Luciano; Longhi, Renato; Dallanoce, Clelia; Moretti, Milena; Vilella, Antonietta; Zoli, Michele; Gotti, Cecilia; Origlia, Nicola			In vivo study of the role of alpha 6-containing nicotinic acetylcholine receptor in retinal function using subtype-specific RDP-MII(E11R) toxin	FASEB JOURNAL			English	Article						retina; ganglion cell layer; flash electroretinogram; visual-evoked potential; pattern electroretinogram	LATERAL GENICULATE-NUCLEUS; STARBURST AMACRINE CELLS; ALPHA-CONOTOXIN; GANGLION-CELLS; MICE LACKING; DIRECTIONAL SELECTIVITY; BETA-2 SUBUNIT; OPTIC-NERVE; CHOLINERGIC-RECEPTORS; DOPAMINE RELEASE	Although alpha 6-contaning (alpha 6*) nicotinic acetylcholine receptors (nAChRs) are densely expressed in the visual system, their role is not well known. We have characterized a family of toxins that are antagonists for alpha 6 beta 2* receptors and used one of these [RDP-MII(E11R)] to localize alpha 6* nAChRs and investigate their impact on retinal function in adult Long-Evans rats. The alpha 6* nAChRs in retinal tissue were localized using either a fluorescently tagged [RDP-MII(E11R)] or anti-alpha 6-specific antibodies and found to be predominantly at the level of the ganglion cell layer. After intraocular injection of RDP-MII(E11R) in one eye and vehicle or inactive MII in contralateral eyes as controls, we recorded flash electroretinograms (F-ERGs), pattern ERGs (P-ERGs), and cortical visual-evoked potential (VEPs). There was no significant difference in F-ERG between the RDP-MII(E11R)-treated and control eyes. In contrast, P-ERG response amplitude was significantly reduced in the RDP-MII(E11R)-injected eye. Blocking alpha 6* nAChRs at retinal level also decreased the VEP amplitude recorded in the visual cortex contralateral to the injected eye. Because both the cortical and inner retina output were affected by RDP-MII(E11R), whereas photoreceptor output was preserved, we conclude that the reduced visual response was due to an alteration in the function of alpha 6* nAChRs present in the ganglion cell layer.-Barloscio, D., Cerri, E., Domenici, L., Longhi, R., Dallanoce, C., Moretti, M., Vilella, A., Zoli, M., Gotti, C., and Origlia, N. In vivo study of the roleof alpha 6-containing nicotinic acetylcholine receptor in retinal function using subtype-specific RDP-MII(E11R) toxin.	[Barloscio, Davide; Cerri, Elisa; Domenici, Luciano; Origlia, Nicola] Natl Res Council CNR, Neurosci Inst Pisa, Pisa, Italy; [Longhi, Renato] CNR Inst Chem Mol Recognit, Milan, Italy; [Dallanoce, Clelia] Univ Milan, Sect Med Chem Pietro Pratesi, Dept Pharmaceut Sci, Milan, Italy; [Moretti, Milena; Gotti, Cecilia] Biometra Univ Milan, CNR Neurosci Inst Milano, Milan, Italy; [Vilella, Antonietta; Zoli, Michele] Univ Modena & Reggio Emilia, Dept Biomed Metab & Neural Sci, Ctr Neurosci & Neurotechnol, Modena, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Chimica del Riconoscimento Molecolare (ICRM-CNR); University of Milan; Universita di Modena e Reggio Emilia	Gotti, C (corresponding author), CNR, Inst Neurosci, Via Vanvitelli 32, I-20129 Milan, Italy.; Origlia, N (corresponding author), CNR, Inst Neurosci, Via Giuseppe Moruzzi 1, I-56100 Pisa, Italy.	c.gotti@in.cnr.it; origlia@in.cnr.it	VILELLA, ANTONIETTA/AAU-3373-2021; Vilella, Antonietta/AAF-2084-2019	Vilella, Antonietta/0000-0003-3820-0115; Domenici, Luciano/0000-0003-2923-9421	European Union [HEALTH-F2-2008-202088]; CNR Research Project on Aging; Fondazione Vollaro; Fondazione Monzino	European Union(European Commission); CNR Research Project on Aging(Consiglio Nazionale delle Ricerche (CNR)); Fondazione Vollaro(Fondazione CarifeFondazione Caritro); Fondazione Monzino	This work was supported by the European Union Seventh Framework Programme (Grant HEALTH-F2-2008-202088 "NeuroCypres" project), by the CNR Research Project on Aging, and by the Fondazione Vollaro and Fondazione Monzino. The authors thank Dr. Enrica Strettoi for helpful discussion, Mr. Renzo Di Renzo for technical assistance, and Dr. Francesca Biondi for the excellent animal care, all from the CNR Neuroscience Institute-Pisa.	Amthor FR, 2002, VISUAL NEUROSCI, V19, P495, DOI 10.1017/S0952523802194119; ARIEL M, 1982, J PHYSIOL-LONDON, V324, P135, DOI 10.1113/jphysiol.1982.sp014104; Azam L, 2010, FASEB J, V24, P5113, DOI 10.1096/fj.10-166272; Bansal A, 2000, J NEUROSCI, V20, P7672; Briggman KL, 2011, NATURE, V471, P183, DOI 10.1038/nature09818; Cartier GE, 1996, J BIOL CHEM, V271, P7522, DOI 10.1074/jbc.271.13.7522; Cerri E, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.6.1; Champtiaux N, 2003, J NEUROSCI, V23, P7820; Champtiaux N, 2002, J NEUROSCI, V22, P1208, DOI 10.1523/JNEUROSCI.22-04-01208.2002; Chen YC, 2008, J COMP NEUROL, V508, P175, DOI 10.1002/cne.21677; Cohen BN, 2012, NEUROSCIENCE, V200, P31, DOI 10.1016/j.neuroscience.2011.10.047; Cox BC, 2008, J NEUROCHEM, V105, P1924, DOI 10.1111/j.1471-4159.2008.05282.x; Criscuolo C, 2015, NEUROSCIENCE, V294, P166, DOI 10.1016/j.neuroscience.2015.03.022; DOMENICI L, 1991, EXP BRAIN RES, V86, P579; Euler T, 2002, NATURE, V418, P845, DOI 10.1038/nature00931; Feller MB, 2002, J NEUROBIOL, V53, P556, DOI 10.1002/neu.10140; Fried SI, 2005, NEURON, V46, P117, DOI 10.1016/j.neuron.2005.02.007; Fried SI, 2002, NATURE, V420, P411, DOI 10.1038/nature01179; Gotti C, 2005, MOL PHARMACOL, V68, P1162, DOI 10.1124/mol.105.015925; Gotti C, 2007, BIOCHEM PHARMACOL, V74, P1102, DOI 10.1016/j.bcp.2007.05.023; Gotti C, 2010, J NEUROSCI, V30, P5311, DOI 10.1523/JNEUROSCI.5095-09.2010; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; Grubb MS, 2003, NEURON, V40, P1161, DOI 10.1016/S0896-6273(03)00789-X; Grzywacz NM, 1998, VISUAL NEUROSCI, V15, P1119, DOI 10.1017/S0952523898156109; Hamel CP, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-7; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hone AJ, 2012, MOL PHARMACOL, V82, P972, DOI 10.1124/mol.112.080853; Kim HJ, 2014, EXP EYE RES, V122, P54, DOI 10.1016/j.exer.2014.02.021; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Lee BB, 2010, PROG RETIN EYE RES, V29, P622, DOI 10.1016/j.preteyeres.2010.08.004; Lena C, 1999, P NATL ACAD SCI USA, V96, P12126, DOI 10.1073/pnas.96.21.12126; Mackey EDW, 2012, J NEUROSCI, V32, P10226, DOI 10.1523/JNEUROSCI.0007-12.2012; MAFFEI L, 1981, SCIENCE, V211, P953, DOI 10.1126/science.7466368; MAFFEI L, 1984, DOC OPHTHALMOL, V58, P97, DOI 10.1007/BF00140905; MALIK S, 1986, INVEST OPHTH VIS SCI, V27, P164; Marritt AM, 2005, MOL PHARMACOL, V68, P1656, DOI 10.1124/mol.105.012380; MASLAND RH, 1976, J NEUROPHYSIOL, V39, P1220, DOI 10.1152/jn.1976.39.6.1220; MASUDA K, 1995, INVEST OPHTH VIS SCI, V36, P2142; McClure-Begley TD, 2012, J NEUROCHEM, V122, P48, DOI 10.1111/j.1471-4159.2012.07759.x; McReynolds J S, 1986, Neurosci Res Suppl, V4, pS153; MILLER RF, 1970, J NEUROPHYSIOL, V33, P323, DOI 10.1152/jn.1970.33.3.323; Moretti M, 2004, MOL PHARMACOL, V66, P85, DOI 10.1124/mol.66.1.85; Origlia N, 2012, INVEST OPHTH VIS SCI, V53, P1211, DOI 10.1167/iovs.11-8007; Pistillo F, 2015, PROG NEUROBIOL, V124, P1, DOI 10.1016/j.pneurobio.2014.10.002; Porciatti V, 1996, P NATL ACAD SCI USA, V93, P14955, DOI 10.1073/pnas.93.25.14955; Porciatti V, 1999, VISION RES, V39, P3071, DOI 10.1016/S0042-6989(99)00022-X; Porciatti V, 2007, DOC OPHTHALMOL, V115, P145, DOI 10.1007/s10633-007-9059-8; Porciatti V, 2012, J NEURO-OPHTHALMOL, V32, P354, DOI 10.1097/WNO.0b013e3182745600; Pucci L, 2011, FASEB J, V25, P3775, DOI 10.1096/fj.10-179853; Reed BT, 2004, VISUAL NEUROSCI, V21, P861, DOI 10.1017/S0952523804216066; Rossi FM, 2001, P NATL ACAD SCI USA, V98, P6453, DOI 10.1073/pnas.101120998; Shih PY, 2014, J NEUROSCI, V34, P9789, DOI 10.1523/JNEUROSCI.0476-14.2014; Strang CE, 2015, J NEUROPHYSIOL, V113, P203, DOI 10.1152/jn.00405.2014; Sugawara T, 2000, EXP EYE RES, V70, P693, DOI 10.1006/exer.2000.0842; Taylor WR, 2003, TRENDS NEUROSCI, V26, P379, DOI 10.1016/S0166-2236(03)00167-X; Wang LP, 2009, J NEUROSCI, V29, P12909, DOI 10.1523/JNEUROSCI.2128-09.2009; Yoshida K, 2001, NEURON, V30, P771, DOI 10.1016/S0896-6273(01)00316-6; Zoli M, 1997, STROKE, V28, P1049, DOI 10.1161/01.STR.28.5.1049; Zoli M, 2002, J NEUROSCI, V22, P8785; Zoli M, 2015, NEUROPHARMACOLOGY, V96, P302, DOI 10.1016/j.neuropharm.2014.11.003	60	1	1	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					192	202		10.1096/fj.201600855R	http://dx.doi.org/10.1096/fj.201600855R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27682206				2022-12-28	WOS:000392177600020
J	Goetzl, EJ; Kapogiannis, D; Schwartz, JB; Lobach, IV; Goetzl, L; Abner, EL; Jicha, GA; Karydas, AM; Boxer, A; Miller, BL				Goetzl, Edward J.; Kapogiannis, Dimitrios; Schwartz, Janice B.; Lobach, Iryna V.; Goetzl, Laura; Abner, Erin L.; Jicha, Gregory A.; Karydas, Anna M.; Boxer, Adam; Miller, Bruce L.			Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease	FASEB JOURNAL			English	Article						cognition; proteinopathy; neurotransmission; biomarkers	CEREBROSPINAL-FLUID BIOMARKER; CLINICAL-TRIALS; BLOOD EXOSOMES; SYNAPSIN-I; ADAS-COG; SYNAPTOPHYSIN; NEUROGRANIN; IDENTIFICATION; PLASTICITY; CRITERIA	Synaptic dysfunction occurs early in senile dementias, presumably as a result of decreased levels of functional synaptic proteins as found in autopsied brains of patients with Alzheimer's disease (AD) or frontotemporal dementia (FTD). Plasma neuronal-derived exosomes (NDEs) were recovered by precipitation and immunoabsorption from 12 patients with AD, 16 with FTD, and 28 controls in a cross-sectional study, and from 9 patients with AD, 10 with FTD, and 19 controls in a longitudinal study. Six synaptic proteins in NDE extracts were quantified by ELISAs and normalized for exosome amounts. NDE levels of synaptophysin, synaptopodin, synaptotagmin-2, and neurogranin were significantly lower in patients with FTD and AD than in controls, but those of growth-associated protein 43 and synapsin 1 were reduced only in patients with AD. Functionally relevant phosphorylation of synapsin 1 serine 9 was reduced in patients with FTD and AD, although total synapsin 1 protein was higher in FTD than in controls. NDE levels of synaptotagmin, synaptophysin, and neurogranin were decreased years before dementia inpatients with FTD and AD. NDE levels of synaptopodin, synaptotagmin, and synaptophysin, but not of amyloid beta-peptide 42 or P-T181-tau, were correlated significantly with cognition assessed by mini-mental state examination or AD assessment scale-cognitive subscale. NDE synaptic proteins may be useful preclinical indices and progression measures in senile dementias.	[Goetzl, Edward J.; Schwartz, Janice B.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Schwartz, Janice B.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Lobach, Iryna V.] Univ Calif San Francisco, Clin Translat Sci Inst, San Francisco, CA 94143 USA; [Karydas, Anna M.; Boxer, Adam; Miller, Bruce L.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Goetzl, Edward J.; Schwartz, Janice B.] Jewish Home San Francisco, San Francisco, CA USA; [Kapogiannis, Dimitrios] NIA, Lab Neurosci, Baltimore, MD 21224 USA; [Goetzl, Laura] Temple Univ, Dept Obstet Gynecol & Reprod Sci, Philadelphia, PA 19122 USA; [Abner, Erin L.; Jicha, Gregory A.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Kentucky	Goetzl, EJ (corresponding author), Univ Calif San Francisco, Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Kapogiannis, Dimitrios/AAW-4934-2020; Schwartz, Janice/K-6354-2019	Kapogiannis, Dimitrios/0000-0003-2181-3118; Goetzl, Laura/0000-0003-4130-2809	BAND2 Program of the Michael J. Fox Foundation for Parkinson's Research; Alzheimer's Association; Weston Brain Institute (Toronto, ON, Canada); Nanosomix; Intramural Program of the U.S. National Institutes of Health, National Institute on Aging (NIA); NIA [P30 AG028383]; Acetylon; iPierian; Archer Biosciences; Alzheimer's Research UK; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS092089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038791, P30AG028383, ZIAAG000975] Funding Source: NIH RePORTER	BAND2 Program of the Michael J. Fox Foundation for Parkinson's Research; Alzheimer's Association(Alzheimer's Association); Weston Brain Institute (Toronto, ON, Canada); Nanosomix; Intramural Program of the U.S. National Institutes of Health, National Institute on Aging (NIA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Acetylon; iPierian; Archer Biosciences; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Sonya Anderson (University of Kentucky Alzheimer's Disease Center) for organizing and distributing biospecimens and Judith H. Goetzl (Jewish Home of San Francisco) for expert production of graphic illustrations. This work was supported by a grant from the BAND2 Program of the Michael J. Fox Foundation for Parkinson's Research, the Alzheimer's Association, Alzheimer's Research UK, and the Weston Brain Institute (Toronto, ON, Canada), by a grant for methodological development from Nanosomix (to E.J.G.), the Intramural Program of the U.S. National Institutes of Health, National Institute on Aging (NIA; to D.K.), and NIA Grant P30 AG028383 (to E.L.A.). E.J.G. has filed an application with the U.S. Patent Office for the platform and methodologies described in this report; he is a founder of Nanosomix, but now receives no salary or consulting fees, but only support for laboratory supplies. E.L.A. received travel support from Nanosomix for the 2015 annual meeting of the American Association for the Advancement of Science. A.B. declares that outside the submitted studies, he has grants from the NIA, Tau Research Consortium, Allon Therapeutics, Genentech, Bristol-Myers Squibb, TauRx, Alzheimer's Association, Bluefield Project to Cure FTD, the Association for Frontotemporal Degeneration, Alzheimer's Drug Discovery Foundation, EnVivo, C2N Diagnostics, Pfizer, Eli Lilly, and Corticobasal Degeneration Solutions; grants, personal fees, and nonfinancial support from Archer Biosciences; personal fees from Acetylon; and personal fees from iPierian. The remaining authors declare no conflicts of interest.	Bacaj T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002267; Baker K, 2015, J CLIN INVEST, V125, P1670, DOI 10.1172/JCI79765; Cano SJ, 2010, J NEUROL NEUROSUR PS, V81, P1363, DOI 10.1136/jnnp.2009.204008; Clare R, 2010, J NEUROSCI RES, V88, P2083, DOI 10.1002/jnr.22392; Daly C, 2002, J BIOL CHEM, V277, P9010, DOI 10.1074/jbc.M110815200; Davidsson P, 1998, Int Psychogeriatr, V10, P11, DOI 10.1017/S1041610298005110; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Glavan G, 2009, ANAT REC, V292, P1849, DOI 10.1002/ar.21026; Goetzl EJ, 2015, ANN CLIN TRANSL NEUR, V2, P769, DOI 10.1002/acn3.211; Goetzl EJ, 2015, NEUROLOGY, V85, P40, DOI 10.1212/WNL.0000000000001702; Gordon SL, 2013, J NEUROSCI, V33, P13695, DOI 10.1523/JNEUROSCI.0636-13.2013; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Haruta T, 1997, BIOCHEM J, V325, P455, DOI 10.1042/bj3250455; Irizarry MC, 2008, J ALZHEIMERS DIS, V14, P301; Jackman SL, 2016, NATURE, V529, P88, DOI 10.1038/nature16507; Kalia M, 2008, METABOLISM, V57, pS2, DOI 10.1016/j.metabol.2008.07.009; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Kester MI, 2015, JAMA NEUROL, V72, P1275, DOI 10.1001/jamaneurol.2015.1867; Kvartsberg H, 2015, ALZHEIMERS DEMENT, V11, P1180, DOI 10.1016/j.jalz.2014.10.009; MASLIAH E, 1991, AM J PATHOL, V138, P235; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miyakawa T, 2001, HIPPOCAMPUS, V11, P763, DOI 10.1002/hipo.1092; PARKS KM, 1991, MOL BRAIN RES, V9, P125, DOI 10.1016/0169-328X(91)90137-M; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Reddy PH, 2005, J ALZHEIMERS DIS, V7, P103, DOI 10.3233/jad-2005-7203; Regan P, 2017, NEUROSCIENTIST, V23, P137, DOI 10.1177/1073858416633439; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012	36	217	226	7	49	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4141	4148		10.1096/fj.201600816R	http://dx.doi.org/10.1096/fj.201600816R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27601437	Green Published			2022-12-28	WOS:000388201500020
J	Mustafi, SB; Aznar, N; Dwivedi, SKD; Chakraborty, PK; Basak, R; Mukherjee, P; Ghosh, P; Bhattacharya, R				Mustafi, Soumyajit Banerjee; Aznar, Nicolas; Dwivedi, Shailendra Kumar Dhar; Chakraborty, Prabir Kumar; Basak, Rumki; Mukherjee, Priyabrata; Ghosh, Pradipta; Bhattacharya, Resham			Mitochondrial BMI1 maintains bioenergetic homeostasis in cells	FASEB JOURNAL			English	Article						electron transport chain; mitochondrial mRNA; PNPase	HUMAN POLYNUCLEOTIDE PHOSPHORYLASE; SELF-RENEWAL; MEDIATED PHOSPHORYLATION; RNA-POLYMERASE; CANCER GROWTH; DNA-DAMAGE; STEM-CELLS; STAT3; TRANSFORMATION; P53	The polycomb complex proto-oncogene BMI1 [B lymphoma Mo-MLV insertion region 1 homolog (mouse)] is essential for self-renewal of normal and cancer stem cells. BMI1-nullmice show severe defects ingrowth, development, and survival. Although BMI1 is known to exert its effect in the nucleus via repression of 2 potent cell-cycle regulators that are encoded by the Ink4a/Arf locus, deletion of this locus only partially rescues BMI1-null phenotypes, which is indicative of alternate mechanisms of action of BMI1. Here, we show that an extranuclear pool of BMI1 localizes to inner mitochondrial membrane and directly regulates mitochondrial RNA (mtRNA) homeostasis and bioenergetics. These mitochondrial functions of BMI1 are independent of its previously described nuclear functions because a nuclear localization-defective mutant BMI1 rescued several bioenergetic defects that we observed in BMI1-depleted cells, for example, mitochondrial respiration, cytochrome c oxidase activity, and ATP production. Mechanistically, BMI1 coprecipitated with polynucleotide phosphorylase, a ribonuclease that is responsible for decay of mtRNA transcripts. Loss of BMI1 enhanced ribonuclease activity of polynucleotide phosphorylase and reduced mtRNA stability. These findings not only establish a novel extranuclear role ofBMI1 in the regulation of mitochondrial bioenergetics, but also provide new mechanistic insights into the role of this protooncogene in stem cell differentiation, neuronal aging, and cancer.	[Mustafi, Soumyajit Banerjee; Dwivedi, Shailendra Kumar Dhar; Basak, Rumki; Bhattacharya, Resham] Univ Oklahoma, Hlth Sci Ctr, Dept Obstet & Gynecol, Stephenson Canc Ctr, Oklahoma City, OK 73190 USA; [Chakraborty, Prabir Kumar; Mukherjee, Priyabrata] Univ Oklahoma, Hlth Sci Ctr, Dept Pathol, Stephenson Canc Ctr, Oklahoma City, OK USA; [Aznar, Nicolas] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Bhattacharya, Resham] Univ Oklahoma, Coll Med, Dept Cell Biol, Oklahoma City, OK 73190 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California San Diego; University of Oklahoma System; University of Oklahoma Health Sciences Center	Bhattacharya, R (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, 975 NE 10th St,BRC 1409B, Oklahoma City, OK 73104 USA.	resham-bhattacharya@ouhsc.edu	Dwivedi, Shailendra Kumar Dhar/Q-2204-2019	Aznar, Nicolas/0000-0003-3338-9932	U.S. National Institutes of Health (NIH) National Cancer Institute [CA157481, CA160911]; NIH National Heart, Lung, and Blood Institute [HL120585]; NATIONAL CANCER INSTITUTE [R01CA160911, R01CA100768, R01CA157481] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120585] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Timo Meerloo and Dr. Marilyn G. Farquhar (University of California, San Diego Electron Microscopy Core Facility). The Stephenson Cancer Functional Genomics Core of Oklahoma University Health Science Center assisted in the mitostress (XF) assay. This study was supported by the U.S. National Institutes of Health (NIH) National Cancer Institute Grants CA157481 (to R.Bh.) and CA160911 (to P.G.), and NIH National Heart, Lung, and Blood Institute Grant HL120585 (to P.M.).	Abd El Hafez A, 2014, ANN DIAGN PATHOL, V18, P58, DOI 10.1016/j.anndiagpath.2013.11.004; Allegra E, 2012, WORLD J SURG ONCOL, V10, DOI 10.1186/1477-7819-10-206; Bhattacharya R, 2009, CANCER RES, V69, P9090, DOI 10.1158/0008-5472.CAN-09-2552; Boengler K, 2010, BASIC RES CARDIOL, V105, P771, DOI 10.1007/s00395-010-0124-1; Borowski LS, 2013, NUCLEIC ACIDS RES, V41, P1223, DOI 10.1093/nar/gks1130; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Chazotte Brad, 2011, Cold Spring Harb Protoc, V2011, P895, DOI 10.1101/pdb.prot5641; Chen HW, 2007, TRENDS CELL BIOL, V17, P600, DOI 10.1016/j.tcb.2007.09.006; Chen HW, 2006, MOL CELL BIOL, V26, P8475, DOI 10.1128/MCB.01002-06; Chujo T, 2012, NUCLEIC ACIDS RES, V40, P8033, DOI 10.1093/nar/gks506; Cohen KJ, 1996, MOL CELL BIOL, V16, P5527; Demaria M, 2011, CELL CYCLE, V10, P3221, DOI 10.4161/cc.10.19.17379; Demaria M, 2010, AGING-US, V2, P823, DOI 10.18632/aging.100232; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; Ding WX, 2012, BIOL CHEM, V393, P547, DOI 10.1515/hsz-2012-0119; Dinur-Mills M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002161; Fan C, 2008, BBA-MOL BASIS DIS, V1782, P642, DOI 10.1016/j.bbadis.2008.08.009; Frezza C, 2007, NAT PROTOC, V2, P287, DOI 10.1038/nprot.2006.478; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Gough DJ, 2009, SCIENCE, V324, P1713, DOI 10.1126/science.1171721; Hayakawa T, 1998, J BIOL CHEM, V273, P20300, DOI 10.1074/jbc.273.32.20300; Honig A, 2010, ANTICANCER RES, V30, P1559; Horner SM, 2011, P NATL ACAD SCI USA, V108, P14590, DOI 10.1073/pnas.1110133108; Ishiwata T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042118; Ismail IH, 2012, NUCLEIC ACIDS RES, V40, P5497, DOI 10.1093/nar/gks222; Iwama A, 2004, IMMUNITY, V21, P843, DOI 10.1016/j.immuni.2004.11.004; Jheng HF, 2012, MOL CELL BIOL, V32, P309, DOI 10.1128/MCB.05603-11; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kalb R, 2014, NAT STRUCT MOL BIOL, V21, P569, DOI 10.1038/nsmb.2833; Lagouge M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005423; Lanza IR, 2009, METHOD ENZYMOL, V457, P349, DOI 10.1016/S0076-6879(09)05020-4; LaPak KM, 2014, MOL CANCER RES, V12, P167, DOI 10.1158/1541-7786.MCR-13-0350; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Li DW, 2010, J CANCER RES CLIN, V136, P997, DOI 10.1007/s00432-009-0745-7; Lin CS, 2014, MOL BIOL CELL, V25, P3654, DOI 10.1091/mbc.E14-05-0978; Liou W, 1996, HISTOCHEM CELL BIOL, V106, P41, DOI 10.1007/BF02473201; Lopez-Sanchez I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5451; Marchenko ND, 2007, EMBO J, V26, P923, DOI 10.1038/sj.emboj.7601560; Marcu R, 2012, JOVE-J VIS EXP, DOI 10.3791/4131; Mihara M, 2003, MOL CELL, V11, P577, DOI 10.1016/S1097-2765(03)00050-9; Mihara Motohiro, 2003, Methods Mol Biol, V234, P203; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Mourgues L, 2015, LEUKEMIA, V29, P1993, DOI 10.1038/leu.2015.112; Mourier A, 2014, HUM MOL GENET, V23, P2580, DOI 10.1093/hmg/ddt652; Mustafi SB, 2014, ANTIOXID REDOX SIGN, V20, P2891, DOI 10.1089/ars.2013.5340; Nacerddine K, 2012, J CLIN INVEST, V122, P1920, DOI 10.1172/JCI57477; Nemajerova A, 2005, CELL DEATH DIFFER, V12, P197, DOI 10.1038/sj.cdd.4401526; Nicholls David G, 2010, J Vis Exp, DOI 10.3791/2511; Palikaras K, 2015, NATURE, V521, P525, DOI 10.1038/nature14300; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Piwowarski J, 2003, J MOL BIOL, V329, P853, DOI 10.1016/S0022-2836(03)00528-X; Proctor E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055820; Rorbach J, 2012, BIOCHEM J, V444, P357, DOI 10.1042/BJ20112208; Samudio I, 2009, CANCER RES, V69, P2163, DOI 10.1158/0008-5472.CAN-08-3722; Shoubridge EA, 2001, HUM MOL GENET, V10, P2277, DOI 10.1093/hmg/10.20.2277; Siddique HR, 2012, STEM CELLS, V30, P372, DOI 10.1002/stem.1035; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Surovtseva YV, 2013, NUCLEIC ACIDS RES, V41, P2479, DOI 10.1093/nar/gks1447; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tao Zhou, 2009, PROGR NATURAL SCI, V01, P1, DOI DOI 10.1371/J0URNAL.PBI0.1000139; TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956; VANCE JE, 1990, J BIOL CHEM, V265, P7248; VANDERLUGT NMT, 1994, GENE DEV, V8, P757, DOI 10.1101/gad.8.7.757; Vaseva Angelina V, 2013, Methods Mol Biol, V962, P75, DOI 10.1007/978-1-62703-236-0_6; Voncken JW, 2005, J BIOL CHEM, V280, P5178, DOI 10.1074/jbc.M407155200; Wang DDH, 2014, J BIOL CHEM, V289, P16727, DOI 10.1074/jbc.M113.536540; Wang DDH, 2009, J BIOL CHEM, V284, P20812, DOI 10.1074/jbc.M109.009605; Wang EF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017918; Wang G, 2012, BBA-GENE REGUL MECH, V1819, P998, DOI 10.1016/j.bbagrm.2011.10.001; Wang RL, 2015, J BIOMOL SCREEN, V20, P422, DOI 10.1177/1087057114557621; Wegrzyn J, 2009, SCIENCE, V323, P793, DOI 10.1126/science.1164551; Wieckowski MR, 2009, NAT PROTOC, V4, P1582, DOI 10.1038/nprot.2009.151; Yin CQ, 2012, CRIT REV EUKAR GENE, V22, P17, DOI 10.1615/CritRevEukarGeneExpr.v22.i1.20; Yogev O, 2011, BBA-BIOMEMBRANES, V1808, P1012, DOI 10.1016/j.bbamem.2010.07.004; Yu YL, 2012, J BIOL CHEM, V287, P31015, DOI 10.1074/jbc.M112.358077; Zhang J, 2008, PROTEOMICS, V8, P1564, DOI 10.1002/pmic.200700851; Zhang QF, 2013, J BIOL CHEM, V288, P31280, DOI 10.1074/jbc.M113.505057	78	16	16	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4042	4055		10.1096/fj.201600321R	http://dx.doi.org/10.1096/fj.201600321R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27613804	Green Published			2022-12-28	WOS:000388201500012
J	Luck, AN; Yuan, XJ; Voronin, D; Slatko, BE; Hamza, I; Foster, JM				Luck, Ashley N.; Yuan, Xiaojing; Voronin, Denis; Slatko, Barton E.; Hamza, Iqbal; Foster, Jeremy M.			Heme acquisition in the parasitic filarial nematode Brugia malayi	FASEB JOURNAL			English	Article						iron metabolism; infectious disease; parasite metabolism	SACCHAROMYCES-CEREVISIAE; IRON-UPTAKE; WOLBACHIA-ENDOSYMBIONT; CAENORHABDITIS-ELEGANS; FERRIC REDUCTASE; IN-VITRO; RNA-SEQ; PROTEIN; HOMEOSTASIS; QUANTITATION	Nematodes lack a heme biosynthetic pathway and must acquire heme from exogenous sources. Given the indispensable role of heme, this auxotrophy may be exploited to develop drugs that interfere with heme uptake in parasites. Although multiple heme-responsive genes (HRGs) have been characterized within the free-living nematode Caenorhabditis elegans, we have undertaken the first study of heme transport in Brugia malayi, a causative agent of lymphatic filariasis. Through functional assays in yeast, as well as heme analog, RNAi, and transcriptomic experiments, we have shown that the heme transporter B. malayi HRG-1 (BmHRG-1) is indeed functional in B. malayi. In addition, BmHRG-1 localizes both to the endocytic compartments and cell membrane when expressed in yeast cells. Transcriptomic sequencing revealed that BmHRG-1, BmHRG-2, and BmMRP-5 (all orthologs of HRGs in C. elegans) are down-regulated in heme-treated B. malayi, as compared to non-heme-treated control worms. Likely because of short gene lengths, multiple exons, other HRGs in B. malayi (BmHRG-3-6) remain unidentified. Although the precise mechanisms of heme homeostasis in a nematode with the ability to acquire heme remains unknown, this study clearly demonstrates that the filarial nematode B. malayi is capable of transporting exogenous heme.	[Luck, Ashley N.; Slatko, Barton E.; Foster, Jeremy M.] New England Biolabs Inc, Genome Biol Div, Ipswich, MA USA; [Yuan, Xiaojing; Hamza, Iqbal] Univ Maryland, Dept Anim & Avian Sci, College Pk, MD 20742 USA; [Yuan, Xiaojing; Hamza, Iqbal] Univ Maryland, Dept Cell Biol & Mol Genet, College Pk, MD 20742 USA; [Voronin, Denis] New York Blood Ctr, Lindsley F Kimball Res Inst, New York, NY 10021 USA	New England Biolabs; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park; New York Blood Center	Foster, JM (corresponding author), New England Biolabs Inc, 240 Cty Rd, Ipswich, MA 01938 USA.	foster@neb.com	Yuan, Xiaojing/V-6882-2019	Yuan, Xiaojing/0000-0002-0969-5748; Hamza, Iqbal/0000-0003-0045-0610	New England BioLabs, Inc.; New York Blood Center; U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases [R01DK85035, R01DK074797]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074797, R01DK085035] Funding Source: NIH RePORTER	New England BioLabs, Inc.; New York Blood Center; U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Drs. Donald Comb, William Jack, Clotilde Carlow, and James Ellard (New England BioLabs, Inc.) for their continued scientific support. This work was supported by New England BioLabs, Inc., New York Blood Center intramural funding, and U.S. National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases Grants R01DK85035 and R01DK074797 (to I.H.). The authors declare no conflicts of interest.	Adams A., 2000, METHODS YEAST GENETI; Alves JMP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023518; Andrews NC, 2007, ANNU REV PHYSIOL, V69, P69, DOI 10.1146/annurev.physiol.69.031905.164337; Andrews S., 2010, FASTQC QUALITY CONTR; Blankenberg Daniel, 2010, Curr Protoc Mol Biol, VChapter 19, DOI 10.1002/0471142727.mb1910s89; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Huynh C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002795; Chen CY, 2012, J BIOL CHEM, V287, P9601, DOI 10.1074/jbc.M111.307694; Chen CY, 2011, CELL, V145, P720, DOI 10.1016/j.cell.2011.04.025; CHEN SN, 1979, PARASITOLOGY, V78, P343, DOI 10.1017/S0031182000051209; Choi YJ, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001409; COMLEY JCW, 1989, INT J PARASITOL, V19, P77, DOI 10.1016/0020-7519(89)90024-6; Crisp RJ, 2003, J BIOL CHEM, V278, P45499, DOI 10.1074/jbc.M307229200; DANCIS A, 1990, MOL CELL BIOL, V10, P2294, DOI 10.1128/MCB.10.5.2294; Flannery AR, 2013, CURR OPIN MICROBIOL, V16, P716, DOI 10.1016/j.mib.2013.07.018; Foster J, 2005, PLOS BIOL, V3, P599, DOI 10.1371/journal.pbio.0030121; GEORGATSOU E, 1994, MOL CELL BIOL, V14, P3065, DOI 10.1128/MCB.14.5.3065; Ghedin E, 2007, SCIENCE, V317, P1756, DOI 10.1126/science.1145406; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983; Kelson AB, 2013, CURR OPIN PHARMACOL, V13, P707, DOI 10.1016/j.coph.2013.07.001; KITAGAWA T, 1976, J BIOCHEM-TOKYO, V79, P233, DOI 10.1093/oxfordjournals.jbchem.a131053; Koreny L, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003088; Koreny L, 2010, INT J PARASITOL, V40, P149, DOI 10.1016/j.ijpara.2009.11.007; Korolnek T, 2014, CELL METAB, V19, P1008, DOI 10.1016/j.cmet.2014.03.030; Kremer N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000630; Landmann F, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-16; Luck AN, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-2083-2; Luck AN, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1041; Munn Edward A., 2002, P211; Nagaraj VA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003522; Osei-Atweneboana MY, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0000998; PAUL KG, 1953, ACTA CHEM SCAND, V7, P1284, DOI 10.3891/acta.chem.scand.07-1284; Protchenko O, 2008, EUKARYOT CELL, V7, P859, DOI 10.1128/EC.00414-07; Rajagopal A, 2008, NATURE, V453, P1127, DOI 10.1038/nature06934; Rao AU, 2005, P NATL ACAD SCI USA, V102, P4270, DOI 10.1073/pnas.0500877102; Runyen-Janecky LJ, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00055; RUTILI G, 1977, ACTA PHYSIOL SCAND, V99, P1, DOI 10.1111/j.1748-1716.1977.tb10345.x; Schryvers AB, 1999, MOL MICROBIOL, V32, P1117, DOI 10.1046/j.1365-2958.1999.01411.x; Schultz IJ, 2010, J BIOL CHEM, V285, P26753, DOI 10.1074/jbc.R110.119503; Scott AL, 2000, TROP MED SCI PRACT, V1, P5; Shatwell KP, 1996, J BIOL CHEM, V271, P14240, DOI 10.1074/jbc.271.24.14240; SHERMAN F, 1991, METHOD ENZYMOL, V194, P3; Sinclair J, 2015, BIOMETALS, V28, P481, DOI 10.1007/s10534-015-9841-0; Sinclair J, 2010, J BIOL CHEM, V285, P39536, DOI 10.1074/jbc.M110.167619; Stojiljkovic I, 1999, MOL MICROBIOL, V31, P429, DOI 10.1046/j.1365-2958.1999.01175.x; Sun L, 2003, J IMMUNOL METHODS, V282, P45, DOI 10.1016/j.jim.2003.07.005; Taylor MJ, 2010, LANCET, V376, P1175, DOI 10.1016/S0140-6736(10)60586-7; Taylor MJ, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-7; Theil EC, 2009, CHEM REV, V109, P4568, DOI 10.1021/cr900052g; Townson Simon, 2006, Filaria J, V5, P4, DOI 10.1186/1475-2883-5-4; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; WHO, 2010, PROGR REP 2000 2009; Wu B, 2013, P NATL ACAD SCI USA, V110, P7748, DOI 10.1073/pnas.1304049110; Wu B, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000475; Yuan XJ, 2012, J BIOL CHEM, V287, P4914, DOI 10.1074/jbc.M111.326785	58	9	12	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3501	3514		10.1096/fj.201600603R	http://dx.doi.org/10.1096/fj.201600603R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27363426	Green Published, hybrid			2022-12-28	WOS:000384329800020
J	Bomhof, MR; Paul, HA; Geuking, MB; Eller, LK; Reimer, RA				Bomhof, Marc R.; Paul, Heather A.; Geuking, Markus B.; Eller, Lindsay K.; Reimer, Raylene A.			Improvement in adiposity with oligofructose is modified by antibiotics in obese rats	FASEB JOURNAL			English	Article						Bifidobacterium; gut microbiota; Lactobacillus; prebiotics	DIET-INDUCED OBESITY; GLUCAGON-LIKE PEPTIDE-1; INULIN-TYPE FRUCTANS; GUT MICROBIOTA; INSULIN-RESISTANCE; SATIETY HORMONES; LIPID-METABOLISM; PPAR-GAMMA; INFLAMMATION; PREBIOTICS	Given the intimate link between gut microbiota and host physiology, there is growing interest in understanding the mechanisms by which diet influences gut microbiota and affects human metabolic health. Using antibiotics and the prebiotic oligofructose, which has been shown to counteract excess fat mass, we explored the gut microbiota-dependent effects of oligofructose on body composition and host metabolism. Diet-induced obese male Sprague Dawley rats, fed a background high-fat/sucrose diet, were randomized to one of the following diets for 6 wk:1) high-energy control; 2) 10% oligofructose; 3) ampicillin; 4) ampicillin + 10% oligofructose; 5) ampicillin/neomycin; or 6) ampicillin/neomycin + 10% oligofructose. Combining oligofructose with ampicillin treatment blunted the decrease in adiposity seen with oligofructose. Although ampicillin did not affect total bacteria, ampicillin impeded oligofructose-induced increases in Bifidobacterium and Lactobacillus. In contrast, the combination of ampicillin and neomycin reduced total bacteria but did not abrogate the oligofructose-induced decrease in adiposity. Oligofructose-mediated effects on host adiposity and metabolic health appear to be in part dependent on the presence of specific microbial species within the gut.	[Bomhof, Marc R.; Eller, Lindsay K.; Reimer, Raylene A.] Univ Calgary, Fac Kinesiol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada; [Paul, Heather A.; Reimer, Raylene A.] Univ Calgary, Dept Biochem & Mol Biol, Calgary, AB, Canada; [Geuking, Markus B.] Univ Bern, Div Gastroenterol, Dept Clin Res, Univ Clin Visceral Surg & Med, Bern, Switzerland	University of Calgary; University of Calgary; University of Bern; University Hospital of Bern	Reimer, RA (corresponding author), Univ Calgary, Fac Kinesiol, 2500 Univ Dr NW, Calgary, AB T2N 1N4, Canada.	reimer@ucalgary.ca		Reimer, Raylene/0000-0001-5088-7947	Canadian Institutes of Health Research (CIHR) [MOP 115076]; Natural Sciences and Engineering Research Council of Canada; Alberta Innovates Health Solutions (AIHS); Izaak Walton Killam Doctoral Scholarship; AIHS; CIHR; Beneo-Orafti, Inc.	Canadian Institutes of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Alberta Innovates Health Solutions (AIHS); Izaak Walton Killam Doctoral Scholarship; AIHS; CIHR(Canadian Institutes of Health Research (CIHR)); Beneo-Orafti, Inc.	The authors thank K. Lee (Faculty of Kinesiology, University of Calgary) for technical assistance, and S. Wegener, R. Pon, and P. Gordon (University Core DNA Services and Alberta Children's Hospital Research Institute, University of Calgary) for technical assistance and support with the 16S rRNA gene sequencing and analysis. The authors also thank Chieh Jason Chou (Nestle Institute of Health Sciences, Lausanne, Switzerland) for valuable discussion regarding antibiotics. This work was supported by a research grant from the Canadian Institutes of Health Research (CIHR) (MOP 115076). M.R.B. is supported by the Natural Sciences and Engineering Research Council of Canada, Alberta Innovates Health Solutions (AIHS), and an Izaak Walton Killam Doctoral Scholarship. H.A.P. is supported by AIHS and CIHR. R. A. R. previously held a research grant from Beneo-Orafti, Inc., manufacturer of Orafti P95, for a project unrelated to the current work.	Alligier M, 2014, OBESITY, V22, P1653, DOI 10.1002/oby.20733; Anhe FF, 2015, GUT, V64, P872, DOI 10.1136/gutjnl-2014-307142; Bermudez-Brito M, 2015, MOL NUTR FOOD RES, V59, P698, DOI 10.1002/mnfr.201400811; Bomhof MR, 2014, OBESITY, V22, P763, DOI 10.1002/oby.20632; Brockman DA, 2014, J NUTR, V144, P1415, DOI 10.3945/jn.114.191577; Brownawell AM, 2012, J NUTR, V142, P962, DOI 10.3945/jn.112.158147; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2007, BRIT J NUTR, V98, P32, DOI 10.1017/S0007114507691648; Cani PD, 2004, BRIT J NUTR, V92, P521, DOI 10.1079/BJN20041225; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chou CJ, 2008, NESTLE NUTR WORKS SE, V62, P127, DOI 10.1159/000146256; Collins KH, 2015, OSTEOARTHR CARTILAGE, V23, P1989, DOI 10.1016/j.joca.2015.03.014; David LA, 2014, NATURE, V505, P559, DOI 10.1038/nature12820; De Filippo C, 2010, P NATL ACAD SCI USA, V107, P14691, DOI 10.1073/pnas.1005963107; Delzenne NM, 2005, BRIT J NUTR, V93, pS157, DOI 10.1079/BJN20041342; Dewulf EM, 2011, J NUTR BIOCHEM, V22, P712, DOI 10.1016/j.jnutbio.2010.05.009; Di Luccia B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134893; Dominguez-Bello MG, 2010, P NATL ACAD SCI USA, V107, P11971, DOI 10.1073/pnas.1002601107; Dubourg G, 2013, INT J ANTIMICROB AG, V41, P149, DOI 10.1016/j.ijantimicag.2012.10.012; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Everard A, 2013, BEST PRACT RES CL GA, V27, P73, DOI 10.1016/j.bpg.2013.03.007; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Everard A, 2011, DIABETES, V60, P2775, DOI 10.2337/db11-0227; Ferrier L, 2006, AM J PATHOL, V168, P1148, DOI 10.2353/ajpath.2006.050617; Ge HF, 2008, ENDOCRINOLOGY, V149, P4519, DOI 10.1210/en.2008-0059; Geuking MB, 2014, GUT MICROBES, V5, P411, DOI 10.4161/gmic.29330; Gibson G. R., 2010, Food Science and Technology Bulletin: Functional Foods, V7, P1; GIBSON GR, 1995, J NUTR, V125, P1401, DOI 10.1093/jn/125.6.1401; Hepple RT, 2005, FASEB J, V19, P1320, DOI 10.1096/fj.04-3535fje; Hong YH, 2005, ENDOCRINOLOGY, V146, P5092, DOI 10.1210/en.2005-0545; Johnson LP, 2015, NUTRIENTS, V7, P4480, DOI 10.3390/nu7064480; Li TG, 2010, HEPATOLOGY, V52, P678, DOI 10.1002/hep.23721; Louie TJ, 2012, CLIN INFECT DIS, V55, pS132, DOI 10.1093/cid/cis338; Marchesi JR, 2016, GUT, V65, P330, DOI 10.1136/gutjnl-2015-309990; Maurer AD, 2009, J PHYSIOL-LONDON, V587, P679, DOI 10.1113/jphysiol.2008.161844; Membrez M, 2008, FASEB J, V22, P2416, DOI 10.1096/fj.07-102723; Miyauchi S, 2010, J PHARMACOL SCI, V112, P19, DOI 10.1254/jphs.09R09FM; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Nobel YR, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8486; Parnell JA, 2012, BRIT J NUTR, V107, P601, DOI 10.1017/S0007114511003163; Parnell JA, 2010, BRIT J NUTR, V103, P1577, DOI 10.1017/S0007114509993539; Parnell JA, 2009, AM J CLIN NUTR, V89, P1751, DOI 10.3945/ajcn.2009.27465; Picca A, 2015, MITOCHONDRION, V25, P67, DOI 10.1016/j.mito.2015.10.001; Rampelli S, 2015, CURR BIOL, V25, P1682, DOI 10.1016/j.cub.2015.04.055; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Roberfroid M, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003363; Rune I, 2013, J DIABETES RES, V2013, DOI 10.1155/2013/319321; Schroeder N, 2013, NUTRIENTS, V5, P2093, DOI 10.3390/nu5062093; Sonnenburg ED, 2014, CELL METAB, V20, P779, DOI 10.1016/j.cmet.2014.07.003; Stoddard SF, 2015, NUCLEIC ACIDS RES, V43, pD593, DOI 10.1093/nar/gku1201; Tolhurst G, 2012, DIABETES, V61, P364, DOI 10.2337/db11-1019; Vijay-Kumar M, 2010, SCIENCE, V328, P228, DOI 10.1126/science.1179721; Vogt L, 2015, CRIT REV FOOD SCI, V55, P414, DOI 10.1080/10408398.2012.656772; Woting A, 2015, MOL NUTR FOOD RES, V59, P2267, DOI 10.1002/mnfr.201500249; Zenhom M, 2011, J NUTR, V141, P971, DOI 10.3945/jn.110.136176; Zhang JJ, 2014, BIOINFORMATICS, V30, P614, DOI 10.1093/bioinformatics/btt593	57	28	28	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2720	2732		10.1096/fj.201600151R	http://dx.doi.org/10.1096/fj.201600151R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27059718				2022-12-28	WOS:000380994000009
J	Elajami, TK; Colas, RA; Dalli, J; Chiang, N; Serhan, CN; Welty, FK				Elajami, Tarec K.; Colas, Romain A.; Dalli, Jesmond; Chiang, Nan; Serhan, Charles N.; Welty, Francine K.			Specialized proresolving lipid mediators in patients with coronary artery disease and their potential for clot remodeling	FASEB JOURNAL			English	Article						metabololipidomics; resolvins; lipoxins; n-3 fatty acids; inflammation	POLYUNSATURATED FATTY-ACIDS; RHEUMATOID-ARTHRITIS; CARDIOVASCULAR OUTCOMES; MYOCARDIAL-INFARCTION; RISK-FACTORS; OLIVE OIL; INFLAMMATION; RESOLUTION; SUPPLEMENTATION; TRIAL	Inflammation in arterial walls leads to coronary artery disease (CAD). Because specialized proresolving lipid mediators (SPMs; lipoxins, resolvins, and protectins) stimulate resolution of inflammation in animal models, we tested whether n-3 fatty acids impact SPM profiles in patients with CAD and promote clot remodeling. Six patients with stable CAD were randomly assigned to either treatment with daily 3.36 g Lovaza for 1 yr or without. Targeted lipid mediator-metabololipidomics showed that both groups had absence of resolvin D1 (RvD1), RvD2, RvD3, RvD5 and resolvin E1-all of which are present in healthy patients. Those not taking Lovaza had an absence of aspirin-triggered resolvin D3 (AT-RvD3) and aspirin-triggered lipoxin B-4 (AT-LXB4). Lovaza treatment restored AT-RvD3 and AT-LXB4 and gave levels of RvD6 and aspirin-triggered protectin D1(AT-PD1) twice as high (resolvin E2 similar to 5 fold) as well as lower prostaglandins. Principal component analysis indicated positive relationships for patients with CAD who were receiving Lovaza with increased AT-RvD3, RvD6, AT-PD1, and AT-LXB4. SPMs identified in Lovaza-treated patients with CAD enhanced similar to 50% at 1 nM macrophage uptake of blood clots. These results indicate that patients with CAD have lower levels and/or absence of specific SPMs that were restored with Lovaza; these SPMs promote macrophage phagocytosis of blood clots. Together, they suggest that low vascular SPMs may enable progression of chronic vascular inflammation predisposing to coronary atherosclerosis and to thrombosis.	[Elajami, Tarec K.; Welty, Francine K.] Harvard Med Sch, Brigham & Womens Hosp, Beth Israel Deaconess Med Ctr, Div Cardiovasc Med,Dept Internal Med, Boston, MA USA; [Colas, Romain A.; Dalli, Jesmond; Chiang, Nan; Serhan, Charles N.] Harvard Med Sch, Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med,Harvard In, Boston, MA USA	Harvard University; Beth Israel Deaconess Medical Center; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Welty, FK (corresponding author), Harvard Med Sch, Beth Israel Deaconess Med Ctr, Dept Med, Div Cardiovasc Med, 330 Brookline Ave,SL423, Boston, MA 02215 USA.	fwelty@bidmc.harvard.edu	Chiang, Nan/ABA-4924-2021	Chiang, Nan/0000-0003-1963-1585; Dalli, Jesmond/0000-0001-6328-3640	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [P01GM095467, RO1GM03865]; NIH National Heart, Lung, and Blood Institute [P50HL083813]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P50HL083813] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765, P01GM095467] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences Grants P01GM095467 and RO1GM03865 (to C.N.S.), and NIH National Heart, Lung, and Blood Institute Grant P50HL083813 (to F.K.W.). C.N.S. is an inventor of patents (resolvins) assigned to the Brigham and Women's Hospital, and licensed to Resolvyx Pharmaceuticals. C.N.S. is a scientific founder of Resolvyx Pharmaceuticals and owns equity in the company. The interests of C.N.S. were reviewed and are managed by the Brigham and Women's Hospital and Partners HealthCare in accordance with their conflicts of interest policies. The remaining authors declare no conflicts of interests.	Akagi D, 2015, FASEB J, V29, P2504, DOI 10.1096/fj.14-265363; Amano T, 2011, ATHEROSCLEROSIS, V218, P110, DOI 10.1016/j.atherosclerosis.2011.05.030; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Assimes TL, 2008, ATHEROSCLEROSIS, V198, P136, DOI 10.1016/j.atherosclerosis.2007.09.003; Barden A, 2014, J LIPID RES, V55, P2401, DOI 10.1194/jlr.M045583; Barden AE, 2016, CURR OPIN LIPIDOL, V27, P26, DOI 10.1097/MOL.0000000000000262; Birnbaum Y, 2006, CIRCULATION, V114, P929, DOI 10.1161/CIRCULATIONAHA.106.629907; Bosch J, 2012, NEW ENGL J MED, V367, P309, DOI 10.1056/NEJMoa1203859; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Casula M, 2013, ATHEROSCLEROSIS SUPP, V14, P243, DOI 10.1016/S1567-5688(13)70005-9; Chatterjee A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113480; Chiang N, 2004, P NATL ACAD SCI USA, V101, P15178, DOI 10.1073/pnas.0405445101; Cleland LG, 2006, J RHEUMATOL, V33, P1973; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Covas MI, 2006, ANN INTERN MED, V145, P333, DOI 10.7326/0003-4819-145-5-200609050-00006; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; De Caterina R, 2011, NEW ENGL J MED, V364, P2439, DOI 10.1056/NEJMra1008153; de Oliveira Otto MC, 2013, J AM HEART ASS, V2; Dona M, 2008, BLOOD, V112, P848, DOI 10.1182/blood-2007-11-122598; Fredman G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024422; Haeggstrom JZ, 2011, CHEM REV, V111, P5866, DOI 10.1021/cr200246d; Harris W S, 1997, J Cardiovasc Risk, V4, P385, DOI 10.1097/00043798-199710000-00011; Hasturk H, 2015, ARTERIOSCL THROM VAS, V35, P1123, DOI 10.1161/ATVBAHA.115.305324; Ho KJ, 2010, AM J PATHOL, V177, P2116, DOI 10.2353/ajpath.2010.091082; Hong S, 2008, J IMMUNOL, V180, P3512, DOI 10.4049/jimmunol.180.5.3512; James MJ, 2003, PROSTAG LEUKOTR ESS, V68, P399, DOI 10.1016/S0952-3278(03)00064-4; Kain V, 2015, J MOL CELL CARDIOL, V84, P24, DOI 10.1016/j.yjmcc.2015.04.003; Karp CL, 2004, NAT IMMUNOL, V5, P388, DOI 10.1038/ni1056; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; Kumar V., 2015, ROBBINS COTRAN PATHO, P69; Lee YH, 2012, ARCH MED RES, V43, P356, DOI 10.1016/j.arcmed.2012.06.011; Leeb BF, 2006, LIPIDS, V41, P29, DOI 10.1007/11745-006-5066-x; Levy BD, 2005, AM J RESP CRIT CARE, V172, P824, DOI 10.1164/rccm.200410-1413OC; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Libby P, 2014, CIRC RES, V114, P1867, DOI 10.1161/CIRCRESAHA.114.302699; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Miyahara T, 2013, FASEB J, V27, P2220, DOI 10.1096/fj.12-225615; Mozaffarian D, 2013, ANN INTERN MED, V158, P515, DOI 10.7326/0003-4819-158-7-201304020-00003; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Samuelsson B, 2012, J BIOL CHEM, V287, P10070, DOI 10.1074/jbc.X112.351437; Sasaki A, 2015, ANAL BIOANAL CHEM, V407, P1625, DOI 10.1007/s00216-014-8412-5; Schwingshackl L, 2015, NUTRIENTS, V7, P7651, DOI 10.3390/nu7095356; Scoditti E, 2012, ARCH BIOCHEM BIOPHYS, V527, P81, DOI 10.1016/j.abb.2012.05.003; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Valagussa F, 1999, LANCET, V354, P447, DOI 10.1016/S0140-6736(99)07072-5; Wittwer J, 2007, CLIN CHEM LAB MED, V45, P487, DOI 10.1515/CCLM.2007.103; World Health Organization, CARDIOVASCULAR DIS; Yacoubian S, 2007, NAT CLIN PRACT RHEUM, V3, P570, DOI 10.1038/ncprheum0616	50	85	87	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2792	2801		10.1096/fj.201500155R	http://dx.doi.org/10.1096/fj.201500155R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27121596	Green Published			2022-12-28	WOS:000380994000015
J	Neverisky, DL; Abbott, GW				Neverisky, Daniel L.; Abbott, Geoffrey W.			KCNQ-SMIT complex formation facilitates ion channel-solute transporter cross talk	FASEB JOURNAL			English	Article						myo-inositol; PIP2; sciatic nerve; SMIT1; SMIT2	I-KS; K+ CHANNEL; PIP2; FORM; IDENTIFICATION; DISRUPTION; ACTIVATION; K(V)LQT1; PROTEINS	Voltage-gated potassium channels formed by KCNQ2 and KCNQ3 are essential for normal neuronal excitability. KCNQ2/3 channel activity is augmented in vivo by phosphatidylinositol 4,5-bisphosphate (PIP2), which is generated from myo-inositol, an osmolyte transported into cells by sodium-dependent myo-inositol transporters (SMITs). Here, we discovered that KCNQ2/3 channels isoform-specifically colocalize with SMIT1 and SMIT2 at sciatic nerve nodes of Ranvier and in axon initial segments, and form channel transporter complexes in vitro and in vivo. KCNQ2/3 coexpression protected SMIT1 activity from the otherwise inhibitory effects of cellular depolarization imposed by elevating extracellular [K+], and KCNQ2 was required for potentiation of SMIT activity by myo-inositol preincubation. Cytoskeletal disruption, which speeds PIP2 dispersion, attenuated potentiation of KCNQ2/3 currents by SMIT1-mediated myo-inositol uptake, suggesting close channel transporter juxtaposition ensures KCNQ2/3 exposure to locally high myo-inositol-derived PIP2 concentrations. Thus, KCNQ2/3-SMIT1/2 coassembly permits cross talk via physical interaction, and may also be required for optimal, reciprocal indirect regulation via membrane potential and PIP2, especially within the specialized architecture of axons. Neverisky, D. L., Abbott, G. W. KCNQ-SMIT complex formation facilitates ion channel-solute transporter cross talk.	[Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Pharmacol, Bioelect Lab, Room 360,Med Surge 2, Irvine, CA 92697 USA; Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Dept Pharmacol, Bioelect Lab, Room 360,Med Surge 2, Irvine, CA 92697 USA.	abbottg@uci.edu		Neverisky, Dan/0000-0002-5459-1032	U.S. National Institutes of Health, National Institute of General Medical Sciences [GM115189]; American Heart Association [14PRE20040013]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115189] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors gratefully acknowledge the generous gifts of GFP-tagged wild-type KCNQ2 cDNA from N. Hoshi (University of California, Irvine), SMIT2 cDNA from M. Coady (GEPROM, Universite de Montreal, Montreal, QC, Canada), and Slc5a3<SUP>-/-</SUP> mice from G. Berry (Harvard Medical School, Boston, MA, USA). This work was funded by the U.S. National Institutes of Health, National Institute of General Medical Sciences (GM115189 to G.W.A.) and American Heart Association (Predoctoral Fellowship 14PRE20040013 to D.L.N.).	Abbott GW, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005025; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; BERRY GT, 1995, GENOMICS, V25, P507, DOI 10.1016/0888-7543(95)80052-N; Berry GT, 2003, J BIOL CHEM, V278, P18297, DOI 10.1074/jbc.M213176200; Chau JFL, 2005, FASEB J, V19, P1887, DOI 10.1096/fj.05-4192fje; Cho H, 2005, P NATL ACAD SCI USA, V102, P15241, DOI 10.1073/pnas.0408851102; Coady MJ, 2002, J BIOL CHEM, V277, P35219, DOI 10.1074/jbc.M204321200; Dai GC, 2016, P NATL ACAD SCI USA, V113, pE3290, DOI 10.1073/pnas.1606348113; Devaux JJ, 2004, J NEUROSCI, V24, P1236, DOI 10.1523/JNEUROSCI.4512-03.2004; Feng MY, 2010, CELL, V143, P84, DOI 10.1016/j.cell.2010.08.040; Kim KS, 2016, BIOPHYS J, V110, P1089, DOI 10.1016/j.bpj.2016.01.006; Ko SBH, 2004, NAT CELL BIOL, V6, P343, DOI 10.1038/ncb1115; Lee MP, 2000, J CLIN INVEST, V106, P1447, DOI 10.1172/JCI10897; Li Y, 2011, P NATL ACAD SCI USA, V108, P9095, DOI 10.1073/pnas.1100872108; Mistry AC, 2016, BIOCHEM J, V473, P3237, DOI 10.1042/BCJ20160312; Pan ZM, 2006, J NEUROSCI, V26, P2599, DOI 10.1523/JNEUROSCI.4314-05.2006; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; Park JY, 2016, CURR BIOL, V26, P1965, DOI 10.1016/j.cub.2016.05.076; Purtell K, 2012, FASEB J, V26, P3252, DOI 10.1096/fj.12-206110; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schwarz JR, 2006, J PHYSIOL-LONDON, V573, P17, DOI 10.1113/jphysiol.2006.106815; Selyanko AA, 2001, J PHYSIOL-LONDON, V534, P15, DOI 10.1111/j.1469-7793.2001.00015.x; Shcheynikov Nikolay, 2006, Novartis Found Symp, V273, P177; Singh H, 2016, NEUROSCIENCE, V317, P76, DOI 10.1016/j.neuroscience.2015.12.058; Suh BC, 2008, ANNU REV BIOPHYS, V37, P175, DOI 10.1146/annurev.biophys.37.032807.125859; Wang HS, 1998, SCIENCE, V282, P1890, DOI 10.1126/science.282.5395.1890; Watanabe H, 2000, J NEUROCHEM, V75, P28, DOI 10.1046/j.1471-4159.2000.0750028.x; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang HL, 2003, NEURON, V37, P963, DOI 10.1016/S0896-6273(03)00125-9; Zhang QS, 2013, P NATL ACAD SCI USA, V110, P20093, DOI 10.1073/pnas.1312483110	32	14	14	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2828	2838		10.1096/fj.201601334R	http://dx.doi.org/10.1096/fj.201601334R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28283543	Green Submitted, Green Published			2022-12-28	WOS:000405931000010
J	Rah, SY; Lee, YH; Kim, UH				Rah, So-Young; Lee, Young-Hoon; Kim, Uh-Hyun			NAADP-mediated Ca2+ signaling promotes autophagy and protects against LPS-induced liver injury	FASEB JOURNAL			English	Article						calcium; CD38; TFEB; gene expression; hepatocytes	DINUCLEOTIDE PHOSPHATE NAADP; REGULATES AUTOPHAGY; MOBILIZES CA2+; CALCIUM; TRAFFICKING; CONTRIBUTES; CHANNEL; CELLS; FLUX; LC3	LPS has been shown to induce hepatocyte autophagy, but little is known about how LPS is able to do this during acute toxic liver injury. Our aim was to determine the existence of any selective Ca2+ signaling coupling to hepatocyte autophagy in response to LPS. LPS increased the autophagic process in hepatocytes, and CD38 knockdown prevented this response. Ned19, a specific inhibitor for nicotinic acid adenine dinucleotide phosphate (NAADP), prevented LPS-mediated Ca2+ signaling and autophagosome formation in hepatocytes. CD38 over expression protected the liver from LPS/D-galactosamine (Ga1N)-induced injury, and NAADP administration promoted autophagosome formation and protected hepatocytes from injury induced by LPS/Ga1N. Autophagy was promoted by the up-regulation of autophagy-related gene expression via NAADP-mediated Ca2+ signaling in response to LPS. However, CD38-knockout mice displayed down-regulation in hepatocyte gene expression. Ned19 also inhibited the NAADP-stimulated induction of gene expression by inhibiting the LPS-induced nuclear trans location of transcription factor EB (TFEB). Hepatocyte autophagy protects against LPS-induced liver injury via the CD38/NAADP/Ca2+/TFEB pathway. The role of NAADP-mediated Ca2+ signaling in the autophagic process will help elucidate the complexities of autophagy regulation, which is essential toward the discovery of new therapeutic tools against acute liver injury. Rah, S.-Y., Lee, Y.-H., Kim, U.-H. NAADP-mediated Ca2+ signaling promotes autophagy and protects against LPS-induced liver injury.	[Rah, So-Young; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561182, South Korea; [Rah, So-Young; Kim, Uh-Hyun] Chonbuk Natl Univ, Sch Med, Natl Creat Res Lab Signaling Network Ca2, Jeonju, South Korea; [Lee, Young-Hoon] Chonbuk Natl Univ, Sch Dent, Dept Oral Anat, Jeonju, South Korea; [Kim, Uh-Hyun] Chonbuk Natl Univ, Inst Cardiovasc Res, Jeonju, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University	Kim, UH (corresponding author), Chonbuk Natl Univ, Sch Med, Dept Biochem, Jeonju 561182, South Korea.	uhkim@chonbuk.ac.kr		Kim, Uh-Hyun/0000-0003-3304-7190; Rah, So-Young/0000-0002-0255-1960	Korean National Research Foundation [2012R1A3A2026453]	Korean National Research Foundation(National Research Foundation of Korea)	This work was supported by a Korean National Research Foundation Grant 2012R1A3A2026453 (to U.-H.K.). The authors thank Dr. Young June Kim (Indiana University, Bloomington, IN, USA), Dr. Donghee Kim (Rosalind Franklin University, North Chicago, IL, USA), and Chansu Park (Chonbuk National University) for critical reading of the manuscript. The authors declare no conflicts of interest.	Amir M, 2013, CELL DEATH DIFFER, V20, P878, DOI 10.1038/cdd.2013.21; Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Brailoiu E, 2005, J BIOL CHEM, V280, P5646, DOI 10.1074/jbc.M408746200; Cancela JM, 1999, NATURE, V398, P74, DOI 10.1038/18032; Cardenas C, 2010, CELL, V142, P270, DOI 10.1016/j.cell.2010.06.007; Churchill GC, 2002, CELL, V111, P703, DOI 10.1016/S0092-8674(02)01082-6; Decuypere JP, 2011, CELL CALCIUM, V50, P242, DOI 10.1016/j.ceca.2011.04.001; Galione A, 2006, BIOCHEM SOC T, V34, P922, DOI 10.1042/BST0340922; Guse AH, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.144re10; Hansen TE, 2011, BMC BIOL, V9, DOI 10.1186/1741-7007-9-39; Hoyer-Hansen M, 2007, MOL CELL, V25, P193, DOI 10.1016/j.molcel.2006.12.009; Ilyas G, 2016, J HEPATOL, V64, P118, DOI 10.1016/j.jhep.2015.08.019; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kim HJ, 2009, TRAFFIC, V10, P1157, DOI 10.1111/j.1600-0854.2009.00924.x; Kim UH, 2014, MESSENGER, V3, P6, DOI [DOI 10.1166/MSR.2014.1030, 10.1166/msr.2014.1030]; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2003, DEV CELL, V5, P539, DOI 10.1016/S1534-5807(03)00296-X; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lalazar G, 2016, AM J PHYSIOL-GASTR L, V311, pG377, DOI 10.1152/ajpgi.00124.2016; Lee HC, 2012, J BIOL CHEM, V287, P31633, DOI 10.1074/jbc.R112.349464; Loos B, 2014, AUTOPHAGY, V10, P2087, DOI 10.4161/15548627.2014.973338; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Mizushima Noboru, 2010, J Cell Biol, V190, P946, DOI 10.1083/jcb.1906pi; Ni HM, 2011, AUTOPHAGY, V7, P188, DOI 10.4161/auto.7.2.14181; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Park KH, 2015, J INVEST DERMATOL, V135, P1692, DOI 10.1038/jid.2015.43; Parys JB, 2012, CELL COMMUN SIGNAL, V10, DOI 10.1186/1478-811X-10-17; Pereira GJS, 2011, J BIOL CHEM, V286, P27875, DOI 10.1074/jbc.C110.216580; Rah SY, 2015, SCI REP-UK, V5, DOI 10.1038/srep10741; Reggiori F, 2002, EUKARYOT CELL, V1, P11, DOI 10.1128/EC.01.1.11-21.2002; Ryter Stefan W, 2010, Proc Am Thorac Soc, V7, P40, DOI 10.1513/pats.200909-100JS; Schmocker C, 2007, HEPATOLOGY, V45, P864, DOI 10.1002/hep.21626; Song EK, 2012, CELL REP, V2, P1607, DOI 10.1016/j.celrep.2012.10.018; Wang KW, 2016, EXPERT REV MOL MED, V18, DOI 10.1017/erm.2016.14; Xie ZP, 2007, NAT CELL BIOL, V9, P1102, DOI 10.1038/ncb1007-1102; Zhang Y, 2014, CARDIOVASC RES, V102, P68, DOI 10.1093/cvr/cvu011	36	27	29	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3126	3137		10.1096/fj.201601290R	http://dx.doi.org/10.1096/fj.201601290R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28386045	Green Published, hybrid			2022-12-28	WOS:000405931000036
J	Val-Laillet, D; Besson, M; Guerin, S; Coquery, N; Randuineau, G; Kanzari, A; Quesnel, H; Bonhomme, N; Bolhuis, JE; Kemp, B; Blat, S; Le Huerou-Luron, I; Clouard, C				Val-Laillet, David; Besson, Marie; Guerin, Sylvie; Coquery, Nicolas; Randuineau, Gwenaelle; Kanzari, Ameni; Quesnel, Helene; Bonhomme, Nathalie; Bolhuis, J. Elizabeth; Kemp, Bas; Blat, Sophie; Le Huerou-Luron, Isabelle; Clouard, Caroline			A maternal Western diet during gestation and lactation modifies offspring's microbiota activity, blood lipid levels, cognitive responses, and hippocampal neurogenesis in Yucatan pigs	FASEB JOURNAL			English	Article						early nutrition; development; eating behavior; metabolism; brain	GUT-BRAIN AXIS; HIGH-FAT DIET; BIRTH-WEIGHT PIGLETS; DISCRIMINATION TASK; FOOD PREFERENCES; SUS-SCROFA; OBESITY; PERFORMANCE; LIFE; HOLEBOARD	A suboptimal early nutritional environment (i.e., excess of energy, sugar, and fat intake) can increase susceptibility to diseases and neurocognitive disorders. The purpose of this study was to investigate in nonobese Yucatan minipigs (Sus scrofa) the impact of maternal diet [standard diet (SD) vs. Western diet (WD)] during gestation and 25 d of lactation on milk composition, blood metabolism, and microbiota activity of sows (n = 17) and their piglets (n= 65), andonspatial cognition(n= 51), hippocampal plasticity(n= 17), and food preferences/motivation(n= 51) in the progeny. Milk dry matter and lipid content, as well as plasma total cholesterol and free fatty acid (FFA) concentrations (P < 0.05) were higher in WD than in SD sows. Microbiota activity decreased in both WD sows and 100-d-old piglets (P < 0.05 or P < 0.10, depending on short-chain FAs [SCFAs]). At weaning [postnatal day (PND) 25], WD piglets had increased blood triglyceride and FFA levels (P<0.01). Both SD and WD piglets consumed more of a known SD than an unknown high-fat and -sucrose (HFS) diet (P < 0.0001), but were quicker to obtain HFS rewards compared with SD rewards (P < 0.01). WD piglets had higher working memory (P = 0.015) and reference memory (P< 0.001) scores, which may reflect better cognitive abilities in the task context and a higher motivation for the food rewards. WD piglets had a smaller hippocampal granular cell layer (P=0.03) and decreased neurogenesis (P< 0.005), but increased cell proliferation (P < 0.001). A maternal WD during gestation and lactation, even in the absence of obesity, has significant consequences for piglets' blood lipid levels, microbiota activity, gut-brain axis, and neurocognitive abilities after weaning.-Val-Laillet, D., Besson, M., Guerin, S., Coquery, N., Randuineau, G., Kanzari, A., Quesnel, H., Bonhomme, N., Bolhuis, J. E., Kemp, B., Blat, S., Le Huerou-Luron, I., Clouard, C. A maternal Western diet during gestation and lactation modifies offspring's microbiota activity, blood lipid levels, cognitive responses, and hippocampal neurogenesis in Yucatan pigs.	[Val-Laillet, David; Besson, Marie; Guerin, Sylvie; Coquery, Nicolas; Randuineau, Gwenaelle; Kanzari, Ameni; Blat, Sophie; Le Huerou-Luron, Isabelle] INRA, Unite Rech 1341, Alimentat & Adaptat Digest Nerveuses & Comporteme, St Gilles, France; [Quesnel, Helene; Bonhomme, Nathalie] INRA, PEGASE, UMR 1348, St Gilles, France; [Quesnel, Helene; Bonhomme, Nathalie] Agrocampus Ouest, UMR PEGASE 1348, Rennes, France; [Bolhuis, J. Elizabeth; Kemp, Bas; Clouard, Caroline] Wageningen Univ Res, Dept Anim Sci, Adaptat Physiol Grp, Wageningen, Netherlands	INRAE; INRAE; Institut Agro; Agrocampus Ouest; Wageningen University & Research	Val-Laillet, D (corresponding author), INRA, UR ADNC 1341, F-35590 St Gilles, France.	david.val-laillet@inra.fr	coquery, nicolas/N-9206-2019; Val-Laillet, David/B-4328-2008; coquery, nicolas/GQP-5662-2022; Clouard, Caroline/K-1255-2014; VAL-LAILLET, David/AAH-6454-2021	coquery, nicolas/0000-0002-4687-5924; Val-Laillet, David/0000-0002-6256-7737; coquery, nicolas/0000-0002-4687-5924; Clouard, Caroline/0000-0002-5562-6057; Luron, Isabelle/0000-0002-1769-5246	INRA Diet Impact and Determinants: Interactions and Transitions (DID'IT) Metaprogramme; University of Tunis (Tunis, Tunisia)	INRA Diet Impact and Determinants: Interactions and Transitions (DID'IT) Metaprogramme; University of Tunis (Tunis, Tunisia)	The authors thank Walter Gerrits (Animal Nutrition Group, Wageningen University) and Franz Josef van der Staay (Department of Farm Animal Health, Utrecht University, the Netherlands) for valuable methodological suggestions. The authors also thank the efforts and cooperation of the technical staff at Institut National de la Recherche Agronomique (INRA), St Gilles, and especially Isabelle Nogret, Veronique Rome, Thibaud Le Mouel, Eric Bobillier, Armel Delalande, Mickael Genissel, Julien Georges, Regis Janvier, Alain Chauvin, Francis Le Gouevec, and Vincent Piedvache in conducting laboratory analyses and taking care of the animals, and Coraline Ladoues for her investment in the brain immunohistochemistry work. This study was funded by the INRA Diet Impact and Determinants: Interactions and Transitions (DID'IT) Metaprogramme in the context of the SweetLipKid project coordinated by Sophie Nicklaus. A. K. received a grant from the University of Tunis (Tunis, Tunisia). The authors declare no conflicts of interest.	Albuquerque KT, 2006, NUTRITION, V22, P820, DOI 10.1016/j.nut.2006.04.009; Antonides A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00291; Antonides A, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00043; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 2001, BRIT MED BULL, V60, P69, DOI 10.1093/bmb/60.1.69; Bienenstock J, 2015, NUTR REV, V73, P28, DOI 10.1093/nutrit/nuv019; Bilbo SD, 2010, FASEB J, V24, P2104, DOI 10.1096/fj.09-144014; Bolhuis JE, 2013, ANIM COGN, V16, P845, DOI 10.1007/s10071-013-0646-7; Carabotti M, 2015, ANN GASTROENTEROL, V28, P203; Clouard C, 2012, ANIMAL, V6, P118, DOI 10.1017/S1751731111001315; Clouard C, 2016, FASEB J, V30, P2466, DOI 10.1096/fj.201500208R; Clouard C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154698; De Jonge FH, 2008, APPL ANIM BEHAV SCI, V114, P93, DOI 10.1016/j.applanim.2008.01.004; Du Y, 2012, GENE DEV, V26, P1306, DOI 10.1101/gad.191031.112; Dyer JS, 2011, SEMIN REPROD MED, V29, P266, DOI 10.1055/s-0031-1275521; Farr S, 2016, CURR OPIN LIPIDOL, V27, P1, DOI 10.1097/MOL.0000000000000254; Galley JD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113026; Gareau MG, 2014, ADV EXP MED BIOL, V817, P357, DOI 10.1007/978-1-4939-0897-4_16; Gieling ET, 2012, PEDIATR RES, V71, P71, DOI 10.1038/pr.2011.5; Haagensen AMJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079429; Haggarty P., PLACENTA SA, V23, pS28; Helrich K., 1990, ASS OFFICIAL ANAL CH; Hermans MP, 1999, DIABETES, V48, P1779, DOI 10.2337/diabetes.48.9.1779; Knoth R, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008809; Kornum BR, 2011, NEUROSCI BIOBEHAV R, V35, P437, DOI 10.1016/j.neubiorev.2010.05.004; Le Bourgot C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107508; McGuire W, 2010, SEMIN FETAL NEONAT M, V15, P108, DOI 10.1016/j.siny.2009.09.005; Monk C, 2013, J CHILD PSYCHOL PSYC, V54, P115, DOI 10.1111/jcpp.12000; Murphy E, 2013, APPL ANIM BEHAV SCI, V148, P64, DOI 10.1016/j.applanim.2013.07.011; Myles IA, 2013, J IMMUNOL, V191, P3200, DOI 10.4049/jimmunol.1301057; Naef L, 2011, NEUROSCIENCE, V176, P225, DOI 10.1016/j.neuroscience.2010.12.037; Neeb ZP, 2010, COMPARATIVE MED, V60, P300; Ochoa M, 2015, EUR J NUTR, V54, P1, DOI 10.1007/s00394-014-0776-y; Ong ZY, 2014, ACTA PHYSIOL, V210, P127, DOI 10.1111/apha.12132; Patten AR, 2013, NEUROSCIENCE, V254, P173, DOI 10.1016/j.neuroscience.2013.09.024; Peleg-Raibstein D, 2012, BEHAV BRAIN RES, V233, P398, DOI 10.1016/j.bbr.2012.05.027; Prinz M, 2014, NAT REV NEUROSCI, V15, P300, DOI 10.1038/nrn3722; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Roura E, 2016, NUTR RES REV, V29, P60, DOI 10.1017/S0954422416000020; Sebert SP, 2005, INT J OBESITY, V29, P324, DOI 10.1038/sj.ijo.0802823; Sefcikova Z, 2011, PHYSIOL RES, V60, P337, DOI 10.33549/physiolres.931939; Sola-Oriol D, 2009, J ANIM SCI, V87, P571, DOI 10.2527/jas.2008-0951; Teegarden SL, 2009, NEUROSCIENCE, V162, P924, DOI 10.1016/j.neuroscience.2009.05.029; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; Val-Laillet D, 2010, BRIT J NUTR, V104, P1719, DOI 10.1017/S0007114510002667; Val-Laillet D, 2011, OBESITY, V19, P749, DOI 10.1038/oby.2010.292; Vallet JL, 2014, J ANIM SCI BIOTECHNO, V5, DOI 10.1186/2049-1891-5-55; van der Staay FJ, 2012, NEUROSCI BIOBEHAV R, V36, P379, DOI 10.1016/j.neubiorev.2011.07.008; White CL, 2009, NEUROBIOL DIS, V35, P3, DOI 10.1016/j.nbd.2009.04.002; Williams L, 2014, BBA-MOL BASIS DIS, V1842, P507, DOI 10.1016/j.bbadis.2013.07.006	51	50	51	0	43	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2037	2049		10.1096/fj.201601015R	http://dx.doi.org/10.1096/fj.201601015R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28167496				2022-12-28	WOS:000399195500024
J	Huo, MY; Huang, YH; Qu, D; Zhang, HS; Wong, WT; Chawla, A; Huang, Y; Tian, XY				Huo, Mingyu; Huang, Yuhong; Qu, Dan; Zhang, Hongsong; Wong, Wing Tak; Chawla, Ajay; Huang, Yu; Tian, Xiao Yu			Myeloid Bmal1 deletion increases monocyte recruitment and worsens atherosclerosis	FASEB JOURNAL			English	Article						molecular clock; chronic inflammation; macrophage	CIRCADIAN CLOCK; MYOCARDIAL-INFARCTION; INNATE IMMUNITY; BONE-MARROW; MACROPHAGES; TISSUE; CELLS; INFLAMMATION; METABOLISM; MICE	BMAL1, the nonredundant transcription factor in the core molecular clock, has been implicated in cardiometabolic diseases in mice and humans. BMAL1 controls the cyclic trafficking of Ly6c(hi) monocytes to sites of acute inflammation. Myeloid deficiency of Bmal1 also worsens chronic inflammation in diet-induced obesity. We studied whether myeloid Bmal1 deletion promotes atherosclerosis by enhancing monocyte recruitment to atherosclerotic lesions. By generating Bmal1(FloxP/Floxp) ; LysM(Cre) mice on the Apoe(-/-) background, we showed that Bmal1 deletion in myeloid cells increased the size of atherosclerotic lesions. Bmal1 deficiency in monocytes and macrophages resulted in an increased total number of lesional macrophages in general and Ly6c(hi) infiltrating monocyte-macrophages in particular, accompanied by skewed M2 to M1 macrophage phenotype. Ly6c(hi) and/or Ly6c(lo) monocyte subsets in blood, spleen, and bone marrow were not altered. Cell tracking and adoptive transfer of Ly6c(hi) monocytes showed Bmal1 deficiency induced more trafficking of Ly6c(hi) monocytes to atherosclerotic lesions, preferential differentiation of Ly6c(hi) monocytes into M1 macrophages, and increased macrophage content and lesion size in the carotid arteries. We demonstrated that Bmal1 deficiency in macrophages promotes atherosclerosis by enhancing recruitment of Ly6c(hi) monocytes to atherosclerotic lesions.	[Huo, Mingyu; Huang, Yuhong; Qu, Dan; Zhang, Hongsong; Huang, Yu; Tian, Xiao Yu] Chinese Univ Hong Kong, Inst Vasc Med, Hong Kong, Peoples R China; [Huo, Mingyu; Huang, Yuhong; Qu, Dan; Zhang, Hongsong; Huang, Yu; Tian, Xiao Yu] Chinese Univ Hong Kong, Li Ka Shing Inst Hlth Sci, Hong Kong, Peoples R China; [Huo, Mingyu; Huang, Yuhong; Qu, Dan; Zhang, Hongsong; Huang, Yu; Tian, Xiao Yu] Chinese Univ Hong Kong, Sch Biomed Sci, Room 223A,LIBSB, Hong Kong, Peoples R China; [Wong, Wing Tak] Chinese Univ Hong Kong, Sch Life Sci, Hong Kong, Peoples R China; [Chawla, Ajay] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Chawla, Ajay] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; Chinese University of Hong Kong; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Tian, XY (corresponding author), Chinese Univ Hong Kong, Sch Biomed Sci, Room 223A,LIBSB, Hong Kong, Peoples R China.	xytian@cuhk.edu.hk	Huang, Yu/K-2866-2017; Tian, Xiao Yu/P-1092-2016; Wong, Wing Tak Jack/Q-4512-2018; Zhang, Hongsong/AGH-4158-2022; Huo, Mingyu/AAK-5990-2021	Huang, Yu/0000-0002-1277-6784; Tian, Xiao Yu/0000-0003-3472-9898; Wong, Wing Tak Jack/0000-0002-4514-3780; Zhang, Hongsong/0000-0003-4251-7609; 	Chinese University of Hong Kong (CUHK) [4054321]; CUHK ViceChancellor's Discretionary Fund; Hong Kong Research Grants Council [GRF464712]; Hong Kong Food and Health Bureau [Health and Medical Research Fund (HMRF) Research Fellowship Scheme] [01150057]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK094641, R01DK101064] Funding Source: NIH RePORTER	Chinese University of Hong Kong (CUHK)(Chinese University of Hong Kong); CUHK ViceChancellor's Discretionary Fund; Hong Kong Research Grants Council(Hong Kong Research Grants Council); Hong Kong Food and Health Bureau [Health and Medical Research Fund (HMRF) Research Fellowship Scheme]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Chinese University of Hong Kong (CUHK) Direct Grant 4054321 (to X.Y.T.), CUHK ViceChancellor's Discretionary Fund (to Y.H. and X.Y.T.), the Hong Kong Research Grants Council Grant GRF464712 (to Y.H.), and Hong Kong Food and Health Bureau [Health and Medical Research Fund (HMRF) Research Fellowship Scheme 01150057] (to X.Y.T.). The authors thank Dr. Khoa Nguyen (Stanford University Blood Center, Stanford, CA, USA) for advice on flow cytometry experiments; Dr. D. Rowlands and C. Cheng (CUHK) for animal care; and Dr. X. Cui, Francis Chen, and J. Park (University of California, San Francisco) for technical assistance.	Akhtar S, 2013, ARTERIOSCL THROM VAS, V33, P679, DOI 10.1161/ATVBAHA.112.301162; Aldridge JR, 2009, P NATL ACAD SCI USA, V106, P5306, DOI 10.1073/pnas.0900655106; Ammirati E, 2013, CIRC RES, V112, pE110, DOI 10.1161/CIRCRESAHA.112.300778; Asher G, 2015, CELL, V161, P84, DOI 10.1016/j.cell.2015.03.015; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P9897, DOI 10.1073/pnas.1120636110; Belliere J, 2015, J AM SOC NEPHROL, V26, P1363, DOI 10.1681/ASN.2014040320; Butcher MJ, 2011, JOVE-J VIS EXP, DOI 10.3791/2848; Carter SJ, 2016, J LEUKOCYTE BIOL, V99, P549, DOI 10.1189/jlb.3RU1015-451R; Cheng B, 2011, P NATL ACAD SCI USA, V108, P17147, DOI 10.1073/pnas.1112998108; Curtis AM, 2015, P NATL ACAD SCI USA, V112, P7231, DOI 10.1073/pnas.1501327112; Davies LC, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2877; Dutta P, 2012, NATURE, V487, P325, DOI 10.1038/nature11260; Fink LN, 2014, OBESITY, V22, P747, DOI 10.1002/oby.20615; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Gordon S, 2007, J CLIN INVEST, V117, P89, DOI 10.1172/JCI30992; Irvine KM, 2009, J LEUKOCYTE BIOL, V85, P278, DOI 10.1189/jlb.0808497; Li XF, 2014, CIRCULATION, V129, P1244, DOI 10.1161/CIRCULATIONAHA.113.006840; McAlpine CS, 2016, CIRC RES, V119, P131, DOI 10.1161/CIRCRESAHA.116.308034; Mendez-Ferrer S, 2008, NATURE, V452, P442, DOI 10.1038/nature06685; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Pan XY, 2013, CIRCULATION, V128, P1758, DOI 10.1161/CIRCULATIONAHA.113.002885; Perez-Rial S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072975; Robbins CS, 2013, NAT MED, V19, P1166, DOI 10.1038/nm.3258; Scheiermann C, 2013, NAT REV IMMUNOL, V13, P190, DOI 10.1038/nri3386; Sitaula S, 2015, BIOCHEM BIOPH RES CO, V460, P566, DOI 10.1016/j.bbrc.2015.03.070; Spengler ML, 2012, P NATL ACAD SCI USA, V109, pE2457, DOI 10.1073/pnas.1206274109; Subramanian M, 2013, J CLIN INVEST, V123, P179, DOI 10.1172/JCI64617; Tabas I, 2016, CIRC RES, V118, P653, DOI 10.1161/CIRCRESAHA.115.306256; Tacke F, 2006, J EXP MED, V203, P583, DOI 10.1084/jem.20052119; Tacke F, 2007, J CLIN INVEST, V117, P185, DOI 10.1172/JCI28549; Takahashi JS, 2015, DIABETES OBES METAB, V17, P6, DOI 10.1111/dom.12514; Tian XY, 2016, CELL METAB, V23, P165, DOI 10.1016/j.cmet.2015.10.003; VANROOIJEN N, 1994, J IMMUNOL METHODS, V174, P83; Yang G, 2016, MATH PROBL ENG, V2016, DOI 10.1155/2016/6581204; Yang GR, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007225; Yang L, 2015, INT IMMUNOPHARMACOL, V28, P525, DOI 10.1016/j.intimp.2015.07.001; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhu BK, 2015, MOL CELL, V60, P769, DOI 10.1016/j.molcel.2015.10.024	39	45	46	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1097	+		10.1096/fj.201601030R	http://dx.doi.org/10.1096/fj.201601030R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27927724	Green Published			2022-12-28	WOS:000395671200023
J	Mahajan, N; Wu, HJ; Bennett, RL; Troche, C; Licht, JD; Weber, JD; Maggi, LB; Tomasson, MH				Mahajan, Nitin; Wu, Hua-Jun; Bennett, Richard L.; Troche, Catalina; Licht, Jonathan D.; Weber, Jason D.; Maggi, Leonard B., Jr.; Tomasson, Michael H.			Sabotaging of the oxidative stress response by an oncogenic noncoding RNA	FASEB JOURNAL			English	Article						ACA11; multiple myeloma; NRF2; ROS; snoRNA	MULTIPLE-MYELOMA; GENE-EXPRESSION; TRANSLOCATION; MMSET; FGFR3	Overexpression of the multiple myeloma set domain (MMSET) Wolf-Hirschhorn syndrome candidate 1 gene, which contains an orphan box H/ACA class small nucleolar RNA, ACA11, in an intron, is associated with several cancer types, including multiple myeloma (MM). ACA11 and MMSET are overexpressed cotranscriptionally as a result of the t(4; 14) chromosomal translocation in a subset of patients with MM. RNA sequencing of CD138(+) tumor cells from t(4; 14)-positive and -negativeMMpatient bone marrow samples revealed an enhanced oxidative phosphorylation mRNA signature. Supporting these data, ACA11 overexpression in a t(4; 14)-negative MM cell line, MM1. S, demonstrated enhanced reactive oxygen species (ROS) levels. In addition, an enhancement of cell proliferation, increased soft agar colony size, and elevated ERK1/2 phosphorylation were observed. This ACA11-driven hyperproliferative phenotype depended on increased ROS levels as exogenously added antioxidants attenuate the increased proliferation. A major transcriptional regulator of the cellular antioxidant response, nuclear factor (erythroid-derived 2)-like 2 (NRF2), shuttled to the nucleus, as expected, in response to ACA11-driven increases in ROS; however, transcriptional up-regulation of some of NRF2's antioxidant target genes was abrogated in the presence of ACA11 overexpression. These data show for the first time that ACA11 promotes proliferation through inhibition of NRF2 function resulting in sustained ROS levels driving cancer cell proliferation.-Mahajan, N., Wu, H.-J., Bennett, R. L., Troche, C., Licht, J. D., Weber, J. D., Maggi, L. B., Jr., Tomasson, M. H. Sabotaging of the oxidative stress response by an oncogenic noncoding RNA.	[Mahajan, Nitin; Weber, Jason D.; Maggi, Leonard B., Jr.; Tomasson, Michael H.] Washington Univ, Siteman Canc Ctr, Sch Med, Dept Med,Div Oncol, Box 8069,660 South Euclid Ave, St Louis, MO 63110 USA; [Wu, Hua-Jun] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Bennett, Richard L.; Troche, Catalina; Licht, Jonathan D.] Univ Florida, Coll Med, Univ Florida Hlth Canc Ctr, Dept Med,Div Hematol & Oncol, Gainesville, FL USA	Siteman Cancer Center; Washington University (WUSTL); Harvard University; Dana-Farber Cancer Institute; State University System of Florida; University of Florida	Maggi, LB; Tomasson, MH (corresponding author), Washington Univ, Siteman Canc Ctr, Sch Med, Dept Med,Div Oncol, Box 8069,660 South Euclid Ave, St Louis, MO 63110 USA.	lmaggi@dom.wustl.edu; tomasson@dom.wustl.edu	Maggi, Leonard/L-5217-2019; Bennett, Richard/ABF-9211-2021; Licht, Jonathan/AAL-9184-2020; Licht, Jonathan/L-4239-2019	Maggi, Leonard/0000-0003-0138-0984; Licht, Jonathan/0000-0002-3942-1369; Weber, Jason/0000-0002-1069-6983; Tomasson, Michael/0000-0003-4518-7123; Bennett, Richard/0000-0002-0243-2443	U.S. National Institutes of Health, National Cancer Institute [R01-CA174743, R01-CA-175349]; NATIONAL CANCER INSTITUTE [P30CA091842, R01CA175349, P30CA086862, R01CA174743] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by the U.S. National Institutes of Health, National Cancer Institute (Grants R01-CA174743 to M.H.T. and L.B.M., and R01-CA-175349 to M.H.T.). The authors thank M. Bates (University of Iowa, Iowa City, IA, USA) for her critical review. The authors also thank all the members of the M.H.T. laboratory for discussion and suggestions, and the Genome Technology Access Center (Department of Genetics, Washington University School of Medicine) for help with genomic analysis.	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Avet-Loiseau H, 2011, J CLIN ONCOL, V29, P1893, DOI 10.1200/JCO.2010.32.8435; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertolotti M, 2010, ANTIOXID REDOX SIGN, V13, P1133, DOI 10.1089/ars.2009.3079; Bratkovic T, 2014, BBA-GENE REGUL MECH, V1839, P438, DOI 10.1016/j.bbagrm.2014.04.009; Cech TR, 2014, CELL, V157, P77, DOI 10.1016/j.cell.2014.03.008; Chesi M, 1998, BLOOD, V92, P3025, DOI 10.1182/blood.V92.9.3025.421k53_3025_3034; Chu L, 2012, J CLIN INVEST, V122, P2793, DOI 10.1172/JCI63051; Desbarats L, 1996, EXPERIENTIA, V52, P1123, DOI 10.1007/BF01952111; Forys JT, 2014, CELL REP, V7, P514, DOI 10.1016/j.celrep.2014.03.026; HALPRIN KM, 1967, J INVEST DERMATOL, V48, P149, DOI 10.1038/jid.1967.24; He ZW, 2016, EXP HEMATOL, V44, P161, DOI 10.1016/j.exphem.2015.11.006; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Kuehl WM, 2002, NAT REV CANCER, V2, P175, DOI 10.1038/nrc746; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Mahajan N, 2013, J BIOL CHEM, V288, P11611, DOI 10.1074/jbc.M112.410852; Makarova JA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P638, DOI 10.1134/S0006297913060096; Mannoor K, 2012, BBA-REV CANCER, V1826, P121, DOI 10.1016/j.bbcan.2012.03.005; Martinez-Garcia E, 2011, BLOOD, V117, P211, DOI 10.1182/blood-2010-07-298349; Mirabella F, 2013, BLOOD CANCER J, V3, DOI 10.1038/bcj.2013.9; Nerini-Molteni S, 2008, BRIT J HAEMATOL, V141, P494, DOI 10.1111/j.1365-2141.2008.07066.x; Santra M, 2003, BLOOD, V101, P2374, DOI 10.1182/blood-2002-09-2801; Schieber M, 2014, CURR BIOL, V24, pR453, DOI 10.1016/j.cub.2014.03.034; Sharma A, 2009, LEUKEMIA LYMPHOMA, V50, P809, DOI 10.1080/10428190902802323; Siprashvili Z, 2016, NAT GENET, V48, P53, DOI 10.1038/ng.3452; Sporn MB, 2012, NAT REV CANCER, V12, P564, DOI 10.1038/nrc3278; Su H, 2014, ONCOGENE, V33, P1348, DOI 10.1038/onc.2013.89; Sullivan LB, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-17; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Williams GT, 2012, NAT REV CANCER, V12, P84, DOI 10.1038/nrc3195	31	5	6	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					482	490		10.1096/fj.201600654R	http://dx.doi.org/10.1096/fj.201600654R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	28148777	Green Published			2022-12-28	WOS:000394235400005
J	Naninck, EFG; Oosterink, JE; Yam, KY; de Vries, LP; Schierbeek, H; van Goudoever, JB; Verkaik-Schakel, RN; Plantinga, JA; Plosch, T; Lucassen, PJ; Korosi, A				Naninck, Eva F. G.; Oosterink, J. Efraim; Yam, Kit-Yi; de Vries, Lennart P.; Schierbeek, Henk; van Goudoever, Johannes B.; Verkaik-Schakel, Rikst-Nynke; Plantinga, Josee A.; Plosch, Torsten; Lucassen, Paul J.; Korosi, Aniko			Early micronutrient supplementation protects against early stress-induced cognitive impairments	FASEB JOURNAL			English	Article						1-carbon metabolism; HPA-axis; hippocampus; limited nesting material; cognition	EARLY-LIFE STRESS; DNA METHYLATION; ADULT NEUROGENESIS; MATERNAL-CARE; HOMOCYSTEINE METABOLISM; INHIBITS PROLIFERATION; EMERGING ROLES; DENTATE GYRUS; FOLATE; METHIONINE	Early-life stress (ES) impairs cognition later in life. Because ES prevention is problematic, intervention is needed, yet the mechanisms that underlie ES remain largely unknown. So far, the role of early nutrition in brain programming has been largely ignored. Here, we demonstrate that essential 1-carbon metabolism-associated micronutrients (1-CMAMs; i.e., methionine and B vitamins) early in life are crucial in programming later cognition by ES. ES was induced in male C57Bl/6 mice from postnatal d (P) 2-9. 1-CMAM levels were measured centrally and peripherally by using liquid chromatography-mass spectroscopy. Next, we supplemented the maternal diet with 1-CMAM only during the ES period and studied cognitive, neuroendocrine, neurogenic, transcriptional, and epigenetic changes in adult offspring. We demonstrate that ES specifically reduces methionine in offspring plasma and brain. Of note, dietary 1-CMAM enrichment during P2-9 restored methionine levels and rescued ES-induced adult cognitive impairments. Beneficial effects of this early dietary enrichment were associated with prevention of the ES-induced rise in corticosterone and adrenal gland hypertrophy did not involve changes in maternal care, hippocampal volume, neurogenesis, or global/Nr3c1-specific DNA methylation. In summary, nutrition is important in brain programming by ES. A short, early supplementation with essential micronutrients can already prevent lasting effects of ES. This concept opens new avenues for nutritional intervention.-Naninck, E. F. G., Oosterink, J. E., Yam, K.-Y., deVries, L. P., Schierbeek, H., vanGoudoever, J. B., Verkaik-Schakel, R.-N., Plantinga, J. A., Plosch, T., Lucassen, P. J., Korosi, A. Early micronutrient supplementation protects against early stress-induced cognitive impairments.	[Naninck, Eva F. G.; Yam, Kit-Yi; de Vries, Lennart P.; Lucassen, Paul J.; Korosi, Aniko] Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Amsterdam, Netherlands; [Oosterink, J. Efraim; Schierbeek, Henk; van Goudoever, Johannes B.] Emma Childrens Hosp, Acad Med Ctr, Dept Mother & Child, Amsterdam, Netherlands; [Verkaik-Schakel, Rikst-Nynke; Plantinga, Josee A.; Plosch, Torsten] Univ Groningen, Univ Med Ctr Groningen, Dept Obstet & Gynecol, Groningen, Netherlands	University of Amsterdam; Emma Children's Hospital; University of Amsterdam; Academic Medical Center Amsterdam; University of Groningen	Korosi, A (corresponding author), Univ Amsterdam, Ctr Neurosci, Swammerdam Inst Life Sci, Brain Plast Grp, Sci Pk 904, NL-1098 XH Amsterdam, Netherlands.	a.korosi@uva.nl	Lucassen, Paul/ABA-3113-2020; van Goudoever, Johannes Bernard/Y-4520-2018; Plösch, Torsten/X-6808-2019	Lucassen, Paul/0000-0001-9708-9133; Plösch, Torsten/0000-0002-9305-4045; Yam, Kit-Yi/0000-0002-9181-5605; van Goudoever, Johannes (Hans)/0000-0003-3960-1703; Korosi, Aniko/0000-0001-9701-3331	Netherlands Organization for Scientific Research (NWO; Meervoud; Food, Cognition and Brain); HersenStichting, Internationale Stichting Alzheimer Onderzoek (ISAO); Alzheimer Nederland; ZonMW TOP grant	Netherlands Organization for Scientific Research (NWO; Meervoud; Food, Cognition and Brain); HersenStichting, Internationale Stichting Alzheimer Onderzoek (ISAO); Alzheimer Nederland; ZonMW TOP grant	A.K. is supported by grants from the Netherlands Organization for Scientific Research (NWO; Meervoud; Food, Cognition and Brain). P.J.L. is supported by HersenStichting, Internationale Stichting Alzheimer Onderzoek (ISAO), and Alzheimer Nederland. T.P. is supported by a ZonMW TOP grant.	Allen LH, 2005, AM J CLIN NUTR, V81, p1206S; Amarger V, 2014, NUTRIENTS, V6, P4200, DOI 10.3390/nu6104200; Bale TL, 2010, BIOL PSYCHIAT, V68, P314, DOI 10.1016/j.biopsych.2010.05.028; Benton D, 2010, MOL NUTR FOOD RES, V54, P457, DOI 10.1002/mnfr.200900158; Bjelland I, 2003, ARCH GEN PSYCHIAT, V60, P618, DOI 10.1001/archpsyc.60.6.618; Blaise SA, 2007, AM J PATHOL, V170, P667, DOI 10.2353/ajpath.2007.060339; Bockmuhl Y, 2015, EPIGENETICS-US, V10, P247, DOI 10.1080/15592294.2015.1017199; Boku S, 2015, BIOL PSYCHIAT, V77, P335, DOI 10.1016/j.biopsych.2014.07.008; Borre YE, 2014, TRENDS MOL MED, V20, P509, DOI 10.1016/j.molmed.2014.05.002; Cao XJ, 2008, EUR J PHARMACOL, V595, P30, DOI 10.1016/j.ejphar.2008.07.061; Cattaneo A, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00040; Chehadeh SE, 2014, BRIT J NUTR, V111, P1021, DOI 10.1017/S0007114513003553; Craciunescu CN, 2004, J NUTR, V134, P162, DOI 10.1093/jn/134.1.162; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; de Oliveira AC, 2004, PHARMACOL BIOCHEM BE, V77, P269, DOI 10.1016/j.pbb.2003.11.003; de Souza FG, 2006, PHARMACOL BIOCHEM BE, V85, P400, DOI 10.1016/j.pbb.2006.09.008; Deacon RMJ, 2006, NAT PROTOC, V1, P7, DOI 10.1038/nprot.2006.2; Fan GQ, 2010, TOXICOLOGY, V272, P23, DOI 10.1016/j.tox.2010.03.018; Feil R, 2012, NAT REV GENET, V13, P97, DOI 10.1038/nrg3142; Feldman R, 2010, DEVELOPMENTAL SCI, V13, P271, DOI 10.1111/j.1467-7687.2009.00890.x; Francis D, 1999, SCIENCE, V286, P1155, DOI 10.1126/science.286.5442.1155; Freitag N, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.353; Friso S, 2002, J NUTR, V132, p2382S, DOI 10.1093/jn/132.8.2382S; Gunanti IR, 2014, J NUTR, V144, P2027, DOI 10.3945/jn.114.201202; Hanson JL, 2015, BIOL PSYCHIAT, V77, P314, DOI 10.1016/j.biopsych.2014.04.020; Herpfer I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046004; Hoeijmakers L, 2015, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00103; Hu P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046224; Ishii D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105750; Ivy AS, 2010, J NEUROSCI, V30, P13005, DOI 10.1523/JNEUROSCI.1784-10.2010; Kohl C, 2015, PSYCHONEUROENDOCRINO, V55, P128, DOI 10.1016/j.psyneuen.2015.02.016; Korosi A, 2012, BEHAV BRAIN RES, V227, P400, DOI 10.1016/j.bbr.2011.07.037; KOZAK M, 1983, MICROBIOL REV, V47, P1; Kruman II, 2005, NEUROREPORT, V16, P1055, DOI 10.1097/00001756-200507130-00005; Liu D, 1997, SCIENCE, V277, P1659, DOI 10.1126/science.277.5332.1659; Lok A, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2013.60; Lucassen PJ, 2013, TRENDS NEUROSCI, V36, P621, DOI 10.1016/j.tins.2013.08.002; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; McClelland S, 2011, NEUROBIOL LEARN MEM, V96, P79, DOI 10.1016/j.nlm.2011.02.008; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Mitchell LE, 2005, AM J MED GENET C, V135C, P88, DOI 10.1002/ajmg.c.30057; Molet J, 2014, DEV PSYCHOBIOL, V56, P1675, DOI 10.1002/dev.21230; Morris MJ, 2014, DIALOGUES CLIN NEURO, V16, P359; Mulligan CJ, 2012, EPIGENETICS-US, V7, P853, DOI 10.4161/epi.21180; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Murgatroyd CA, 2015, BEHAV PHARMACOL, V26, P642, DOI 10.1097/FBP.0000000000000147; Naninck E. F. G., 2013, OXFORD HDB MOL PSYCH, P311; Naninck EFG, 2015, HIPPOCAMPUS, V25, P309, DOI 10.1002/hipo.22374; Niculescu MD, 2006, FASEB J, V20, P43, DOI 10.1096/fj.05-4707com; Nijhout HF, 2006, EPIGENETICS-US, V1, P81, DOI 10.4161/epi.1.2.2677; Oomen CA, 2011, PSYCHOPHARMACOLOGY, V214, P249, DOI 10.1007/s00213-010-1922-8; Oosterink JE, 2015, J CHROMATOGR B, V998, P106, DOI 10.1016/j.jchromb.2015.07.008; Parrish RR, 2015, ANN CLIN TRANSL NEUR, V2, P401, DOI 10.1002/acn3.183; Pena CJ, 2014, J MOL BIOL, V426, P3389, DOI 10.1016/j.jmb.2014.03.016; Pesonen AK, 2013, NEUROBIOL AGING, V34, P1674, DOI 10.1016/j.neurobiolaging.2012.12.012; Rabaneda LG, 2008, FASEB J, V22, P3823, DOI 10.1096/fj.08-109306; Ramaekers VT, 2004, DEV MED CHILD NEUROL, V46, P843, DOI 10.1017/S0012162204001471; Rice CJ, 2008, ENDOCRINOLOGY, V149, P4892, DOI 10.1210/en.2008-0633; Romens SE, 2015, CHILD DEV, V86, P303, DOI 10.1111/cdev.12270; Sarabdjitsingh RA, 2014, NEUROPHARMACOLOGY, V81, P231, DOI 10.1016/j.neuropharm.2014.01.042; Spencer SJ, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00109; Stoney CM, 2000, LIFE SCI, V66, P2267, DOI 10.1016/S0024-3205(00)00556-7; Struber N, 2014, NEUROSCI BIOBEHAV R, V38, P17, DOI 10.1016/j.neubiorev.2013.10.015; Sugden C, 2006, NUTR RES REV, V19, P117, DOI 10.1079/NRR2006119; Suri D, 2013, BIOL PSYCHIAT, V73, P658, DOI 10.1016/j.biopsych.2012.10.023; Teicher MH, 2012, P NATL ACAD SCI USA, V109, pE563, DOI 10.1073/pnas.1115396109; Tian WP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033435; Tomizawa H, 2015, GENES BRAIN BEHAV, V14, P301, DOI 10.1111/gbb.12207; Troen AM, 2008, J NUTR, V138, P2502, DOI 10.3945/jn.108.093641; Uchida S, 2010, J NEUROSCI, V30, P15007, DOI 10.1523/JNEUROSCI.1436-10.2010; van Oers HJJ, 1998, J NEUROSCI, V18, P10171; Wang XD, 2011, J NEUROSCI, V31, P13625, DOI 10.1523/JNEUROSCI.2259-11.2011; Weaver ICG, 2005, J NEUROSCI, V25, P11045, DOI 10.1523/JNEUROSCI.3652-05.2005; Weaver ICG, 2006, P NATL ACAD SCI USA, V103, P3480, DOI 10.1073/pnas.0507526103; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wolff GL, 1998, FASEB J, V12, P949, DOI 10.1096/fasebj.12.11.949; Wright KN, 2015, J NEUROSCI, V35, P8948, DOI 10.1523/JNEUROSCI.5227-14.2015; Zhang Y, 2013, NEUROPSYCHOPHARMACOL, V38, P111, DOI 10.1038/npp.2012.149	78	33	34	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					505	518		10.1096/fj.201600834R	http://dx.doi.org/10.1096/fj.201600834R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27770020	Green Published			2022-12-28	WOS:000394235400007
J	Zhao, WM; Wang, XY; Ransohoff, RM; Zhou, L				Zhao, Wanming; Wang, Xingyu; Ransohoff, Richard M.; Zhou, Lan			CCR2 deficiency does not provide sustained improvement of muscular dystrophy in mdx(5cv) mice	FASEB JOURNAL			English	Article						fibrosis; inflammation; macrophages; regeneration	SKELETAL-MUSCLE INJURY; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; TISSUE-RESIDENT MACROPHAGES; CHEMOKINE RECEPTOR 2; GROWTH-FACTOR-I; MDX MICE; FIBROSIS; EXPRESSION; MONOCYTES; CELLS	Genetic ablation or pharmacologic inhibition of CC chemokine receptor type 2 (CCR2) reduced macrophage (MP) infiltration and improved muscle pathology and function in mdx diaphragm muscle at early stages. We addressed whether CCR2 deficiency resulted in sustained improvement of mdx(5cv)-Ccr2(-/-) diaphragm. Compared to mdx(5cv) controls, CCR2 deficiency in mdx(5cv)-Ccr2(-/-) mice markedly reduced intramuscular Ly6C(hi) MPs at all stages, but it reduced Ly6C(low) MPs only at early stages (4 and 9 wk). CCR2 deficiency reduced quadriceps and diaphragm muscle damage and fibrosis at 14 wk but not at 6 mo, and it improved diaphragm muscle regeneration and respiratory function at 14 wk but not at 6 mo. Intramuscular MPs in mdx(5cv)-Ccr2(-/-) diaphragm expressed a low level of IL-1 beta, IL-6, and IFN-gamma genes, a similar level of TNF-alpha, TGF-beta 1, and platelet-derived growth factor a genes, and a high level of IGF-1 and osteopontin genes compared to mdx5cv controls. Diaphragm fibroblasts at 14 wk showed a similar cell number with a similar level of collagen and profibrogenic growth factor gene expression in mdx(5cv)-Ccr2(-/-) and mdx5cv mice. Diaphragm MPs from both mdx(5cv)-Ccr2(-/-) and mdx5cv mice stimulated collagen gene expression by cocultured fibroblasts. The findings suggest that CCR2 deficiency does not provide a sustained benefit and that Ly6C(low) MPs may contribute to the progressive fibrosis and dysfunction of mdx(5cv) diaphragm.	[Zhao, Wanming; Wang, Xingyu; Zhou, Lan] Icahn Sch Med Mt Sinai, Dept Neurol, 1468 Madison Ave,Box 1052, New York, NY 10029 USA; [Ransohoff, Richard M.] Biogen, Neuroimmunol, Cambridge, MA USA	Icahn School of Medicine at Mount Sinai; Biogen	Zhou, L (corresponding author), Icahn Sch Med Mt Sinai, Dept Neurol, 1468 Madison Ave,Box 1052, New York, NY 10029 USA.	lan.zhou@mssm.edu			U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR059702]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059702] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported in part by U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant R01AR059702 (to L.Z.). The authors thank the Flow Cytometry Core at the Icahn School of Medicine at Mount Sinai for technical support.	Arnold L, 2007, J EXP MED, V204, P1057, DOI 10.1084/jem.20070075; Beastrom N, 2011, AM J PATHOL, V179, P2464, DOI 10.1016/j.ajpath.2011.07.009; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Brigitte M, 2010, ARTHRITIS RHEUM-US, V62, P268, DOI 10.1002/art.27183; Capote J, 2016, J CELL BIOL, V213, P275, DOI 10.1083/jcb.201510086; Carter PH, 2013, EXPERT OPIN THER PAT, V23, P549, DOI 10.1517/13543776.2013.771168; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Contreras-Shannon V, 2007, AM J PHYSIOL-CELL PH, V292, pC953, DOI 10.1152/ajpcell.00154.2006; Cordier L, 2000, MOL THER, V1, P119, DOI 10.1006/mthe.1999.0019; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Desguerre I, 2009, J NEUROPATH EXP NEUR, V68, P762, DOI 10.1097/NEN.0b013e3181aa31c2; DUPONTVERSTEEGDEN EE, 1992, MUSCLE NERVE, V15, P1105, DOI 10.1002/mus.880151008; Emery A E, 1991, Neuromuscul Disord, V1, P19, DOI 10.1016/0960-8966(91)90039-U; Emery A.E.H., 1993, DUCHENNE MUSCULAR DY; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Gargioli C, 2008, NAT MED, V14, P973, DOI 10.1038/nm.1852; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Huang P, 2011, MUSCLE NERVE, V43, P263, DOI 10.1002/mus.21848; Huang P, 2009, FASEB J, V23, P2539, DOI 10.1096/fj.09-129833; Huebner KD, 2008, AM J PHYSIOL-HEART C, V294, pH1550, DOI 10.1152/ajpheart.01253.2007; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Krein PM, 2002, CHEST, V122, p289S, DOI 10.1378/chest.122.6_suppl.289S; Krempen K, 1999, GENE EXPRESSION, V8, P151; Lin SL, 2008, AM J PATHOL, V173, P1617, DOI 10.2353/ajpath.2008.080433; Lu HY, 2011, FASEB J, V25, P3344, DOI 10.1096/fj.10-178939; Lu HY, 2011, FASEB J, V25, P358, DOI 10.1096/fj.10-171579; Mann CJ, 2011, SKELET MUSCLE, V1, DOI 10.1186/2044-5040-1-21; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Mojumdar K, 2014, EMBO MOL MED, V6, P1476, DOI 10.15252/emmm.201403967; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Perdiguero EG, 2015, IMMUNITY, V43, P1023, DOI 10.1016/j.immuni.2015.11.022; Porter JD, 2002, HUM MOL GENET, V11, P263, DOI 10.1093/hmg/11.3.263; Quinones MP, 2004, J CLIN INVEST, V113, P856, DOI 10.1172/JCI200420126; Saederup N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013693; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Spencer MJ, 2001, CLIN IMMUNOL, V98, P235, DOI 10.1006/clim.2000.4966; Spurney CF, 2011, J CARDIOVASC PHARM T, V16, P87, DOI 10.1177/1074248410381757; STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0; Sun DX, 2009, FASEB J, V23, P382, DOI 10.1096/fj.07-095901; Taniguti APT, 2011, MUSCLE NERVE, V43, P82, DOI 10.1002/mus.21869; Tidball JG, 2005, AM J PHYSIOL-REG I, V288, pR345, DOI 10.1152/ajpregu.00454.2004; Turgeman T, 2008, NEUROMUSCULAR DISORD, V18, P857, DOI 10.1016/j.nmd.2008.06.386; Villalta SA, 2009, HUM MOL GENET, V18, P482, DOI 10.1093/hmg/ddn376; Wang HZ, 2014, AM J PATHOL, V184, P1167, DOI 10.1016/j.ajpath.2013.12.020; Wehling M, 2001, J CELL BIOL, V155, P123, DOI 10.1083/jcb.200105110; Yata Y, 2003, HEPATOLOGY, V37, P267, DOI 10.1053/jhep.2003.50067; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zhou L, 2006, NEUROMUSCULAR DISORD, V16, P32, DOI 10.1016/j.nmd.2005.09.009; Zhou L, 2008, J NEUROL SCI, V264, P106, DOI 10.1016/j.jns.2007.08.029	51	19	19	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					35	46		10.1096/fj.201600619R	http://dx.doi.org/10.1096/fj.201600619R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27655900	Green Published			2022-12-28	WOS:000392177600007
J	Mediero, A; Wilder, T; Reddy, VSR; Cheng, Q; Tovar, N; Coelho, PG; Witek, L; Whatling, C; Cronstein, BN				Mediero, Aranzazu; Wilder, Tuere; Reddy, Vishnu S. R.; Cheng, Qian; Tovar, Nick; Coelho, Paulo G.; Witek, Lukasz; Whatling, Carl; Cronstein, Bruce N.			Ticagrelor regulates osteoblast and osteoclast function and promotes bone formation in vivo via an adenosine-dependent mechanism	FASEB JOURNAL			English	Article						antiplatelet drugs; A(2A)R; bone regeneration; 3-D HA; -TCP scaffolds	ACTIVE METABOLITE; P2X7 RECEPTORS; A(2A) RECEPTOR; A2A RECEPTOR; PROTEIN-2; REGENERATION; INFLAMMATION; SUPPRESSION; ACTIVATION; EXPRESSION	As many as 10% of bone fractures heal poorly, and large bone defects resulting from trauma, tumor, or infection may not heal without surgical intervention. Activation of adenosine A(2A) receptors (A(2A)Rs) stimulates bone formation. Ticagrelor and dipyridamole inhibit platelet function by inhibiting P2Y(12) receptors and platelet phosphodiesterase, respectively, but share the capacity to inhibit cellular uptake of adenosine and thereby increase extracellular adenosine levels. Because dipyridamole promotes bone regeneration by an A(2A)R-mediated mechanism we determined whether ticagrelor could regulate the cells involved in bone homeostasis and regeneration in a murine model and whether inhibition of P2Y(12) or indirect A(2A)R activation via adenosine was involved. Ticagrelor, dipyridamole and the active metabolite of clopidogrel (CAM), an alternative P2Y(12) antagonist, inhibited osteoclast differentiation and promoted osteoblast differentiation in vitro. A(2A)R blockade abrogated the effects of ticagrelor and dipyridamole on osteoclast and osteoblast differentiation whereas A(2B)R blockade abrogated the effects of CAM. Ticagrelor and CAM, when applied to a 3-dimentional printed resorbable calcium-triphosphate/hydroxyapatite scaffold implanted in a calvarial bone defect, promoted significantly more bone regeneration than the scaffold alone and as much bone regeneration as BMP-2, a growth factor currently used to promote bone regeneration. These results suggest novel approaches to targeting adenosine receptors in the promotion of bone regeneration.Mediero, A., Wilder, T., Reddy, V. S. R., Cheng, Q., Tovar, N., Coelho, P. G., Witek, L., Whatling, C., Cronstein, B. N. Ticagrelor regulates osteoblast and osteoclast function and promotes bone formation in vivo via an adenosine-dependent mechanism.	[Mediero, Aranzazu] Univ Autonoma Madrid, Inst Invest Sanitaria, Bone & Joint Res Unit, Fdn Jimenez Diaz, Madrid, Spain; [Wilder, Tuere; Cheng, Qian; Cronstein, Bruce N.] NYU, Dept Med, Div Translat Med, Langone Med Ctr, 550 1St Ave, New York, NY 10016 USA; [Reddy, Vishnu S. R.; Tovar, Nick; Coelho, Paulo G.; Witek, Lukasz] NYU Coll Dent, Dept Biomat & Biomimet, New York, NY USA; [Whatling, Carl] AstraZeneca R&D, Cardiovasc & Metab Dis Innovat Med Unit, Translat Sci, Molndal, Sweden	Autonomous University of Madrid; Fundacion Jimenez Diaz; New York University; NYU Langone Medical Center; New York University; AstraZeneca	Cronstein, BN (corresponding author), NYU Sch Med, Div Translat Med, Dept Med, 550 First Ave,MSB251, New York, NY 10016 USA.	bruce.cronstein@nyumc.org	Mediero, Aranzazu/AAA-8362-2020; Witek, Lukasz/AAU-5689-2020; Coelho, Paulo G/B-2999-2014	Witek, Lukasz/0000-0003-1458-6527; Coelho, Paulo G/0000-0001-8347-6124; Cronstein, Bruce/0000-0002-4295-7383; Pintor, Jesus/0000-0002-9191-7679; Mediero, Aranzazu/0000-0002-5368-574X	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR56672, AR54897, AR046121]; NIH National Heart, Lung, and Blood Institute [RC1HL100815]; NYU-HHC Clinical and Translational Science Institute [UL1TR000038]; NYU Georgia Family Support Program [9NIH/NCI 5 P30CA16087-310]; AstraZeneca; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038, UL1TR001445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [RC1HL100815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046121, R01AR056672, R01AR068593, R56AR056672, R01AR054897] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NYU-HHC Clinical and Translational Science Institute; NYU Georgia Family Support Program; AstraZeneca(AstraZeneca); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grants AR56672, AR54897, and AR046121 to B.N.C.) and the NIH National Heart, Lung, and Blood Institute (Grant RC1HL100815 to B.N.C.); the NYU-HHC Clinical and Translational Science Institute (Grant UL1TR000038 to B.N.C.) and the NYU Georgia Family Support Program (Grant 9NIH/NCI 5 P30CA16087-310 to B.N.C.); and by a grant from AstraZeneca. A.M. and B.N.C. have filed a patent on the use of adenosine A<INF>2A</INF>R agonists to prevent prosthesis loosening (pending) and a patent on the use of antibodies against Netrin-1 for the treatment of bone diseases. B.N.C. holds patents numbers 5,932,558; 6,020,321; 6,555,545; 7,795,427; adenosine A<INF>1</INF>R and A<INF>2B</INF>R antagonists to treat fatty liver (pending); adenosine A<INF>2A</INF>R agonists to prevent prosthesis loosening (pending). B.N.C. is a consultant for Bristol-Myers Squibb, AstraZeneca, Novartis, CanFite Biopharmaceuticals, Cypress Laboratories, Regeneron (Westat, DSMB), Endocyte, Protalex, Allos, Inc., Savient, Gismo Therapeutics, Antares Pharmaceutical, Medivector, King Pharmaceutical, Celizome, Tap Pharmaceuticals, Prometheus Laboratories, Sepracor, Amgen, Combinatorx, Kyowa Hakka, Hoffman-LaRoche, and Avidimer Therapeutics. B.N.C. has stock in CanFite Biopharmaceuticals. The remaining authors declare no conflicts of interest.	Armstrong D, 2014, J CARDIOVASC PHARM T, V19, P209, DOI 10.1177/1074248413511693; Bonello L, 2014, J AM COLL CARDIOL, V63, P872, DOI 10.1016/j.jacc.2013.09.067; Carragee EJ, 2011, SPINE J, V11, P471, DOI 10.1016/j.spinee.2011.04.023; Cattaneo M, 2014, J AM COLL CARDIOL, V63, P2503, DOI 10.1016/j.jacc.2014.03.031; EINHORN TA, 1995, J BONE JOINT SURG AM, V77A, P940, DOI 10.2106/00004623-199506000-00016; Elsalanty ME, 2009, CRANIOMAX TRAUM REC, V2, P125, DOI 10.1055/s-0029-1215875; Gartland A, 2012, FRONT BIOSCI-LANDMRK, V17, P16, DOI 10.2741/3912; Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x; Glassman SD, 2011, SPINE, V36, P1849, DOI 10.1097/BRS.0b013e3181d133d0; Grol MW, 2009, PURINERG SIGNAL, V5, P205, DOI 10.1007/s11302-009-9139-1; He WJ, 2013, FASEB J, V27, P3446, DOI 10.1096/fj.13-231233; Husted S, 2009, CARDIOVASC THER, V27, P259, DOI 10.1111/j.1755-5922.2009.00096.x; Ishack S, 2017, J BIOMED MATER RES B, V105, P366, DOI 10.1002/jbm.b.33561; Kanakaris Nikolaos K, 2008, J Surg Orthop Adv, V17, P133; Korcok J, 2004, J BONE MINER RES, V19, pS418; Lee SS, 2013, BIOMATERIALS, V34, P452, DOI 10.1016/j.biomaterials.2012.10.005; Mckay WF, 2007, INT ORTHOP, V31, P729, DOI 10.1007/s00264-007-0418-6; Mediero A, 2015, FASEB J, V29, P1577, DOI 10.1096/fj.14-265066; Mediero A, 2013, BRIT J PHARMACOL, V169, P1372, DOI 10.1111/bph.12227; Mediero A, 2013, TRENDS ENDOCRIN MET, V24, P290, DOI 10.1016/j.tem.2013.02.001; Mediero A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003393; Mediero A, 2012, AM J PATHOL, V180, P775, DOI 10.1016/j.ajpath.2011.10.017; Michna S, 2005, BIOMATERIALS, V26, P5632, DOI 10.1016/j.biomaterials.2005.02.040; Montesinos MC, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1914; Moriyama K, 2010, J BIOL CHEM, V285, P39271, DOI 10.1074/jbc.M109.098293; Noe L, 2010, CURR MED CHEM, V17, P2897, DOI 10.2174/092986710792065018; Nylander S, 2013, J THROMB HAEMOST, V11, P1867, DOI 10.1111/jth.12360; Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18; Panupinthu N, 2008, J CELL BIOL, V181, P859, DOI 10.1083/jcb.200708037; Pape HC, 2010, J ORTHOP TRAUMA, V24, P522, DOI 10.1097/BOT.0b013e3181ed1361; Pereillo JM, 2002, DRUG METAB DISPOS, V30, P1288, DOI 10.1124/dmd.30.11.1288; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Riley EH, 1996, CLIN ORTHOP RELAT R, P39, DOI 10.1097/00003086-199603000-00006; Savi P, 2000, THROMB HAEMOSTASIS, V84, P891, DOI 10.1055/s-0037-1614133; SAVI P, 1992, BIOCHEM PHARMACOL, V44, P527, DOI 10.1016/0006-2952(92)90445-O; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Siddiqui NA, 2013, CURR STEM CELL RES T, V8, P192; Silva NRFA, 2011, J PROSTHODONT, V20, P93, DOI 10.1111/j.1532-849X.2010.00623.x; Spiro AS, 2010, J ORTHOP RES, V28, P785, DOI 10.1002/jor.21044; Sterling JA, 2014, CURR OSTEOPOROS REP, V12, P48, DOI 10.1007/s11914-014-0187-2; Su XM, 2012, J CLIN INVEST, V122, P3579, DOI 10.1172/JCI38576; Syberg S, 2012, J BONE MINER RES, V27, P2373, DOI 10.1002/jbmr.1690; Szpalski C, 2012, J CRANIOFAC SURG, V23, P638, DOI 10.1097/SCS.0b013e31824db8d4; Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS), 2010, Eur Heart J, V31, P2501, DOI 10.1093/eurheartj/ehq277; Tsiridis E, 2007, INJURY, V38, pS11, DOI 10.1016/j.injury.2007.02.006; Tsuji K, 2006, NAT GENET, V38, P1424, DOI 10.1038/ng1916; van Giezen JJJ, 2012, J CARDIOVASC PHARM T, V17, P164, DOI 10.1177/1074248411410883; Wesselius A, 2011, FRONT BIOSCI-LANDMRK, V16, P2572, DOI 10.2741/3873; Wiebe SH, 1999, CELL PHYSIOL BIOCHEM, V9, P323, DOI 10.1159/000016326; Witek L, 2013, J ADV CERAM, V2, P274, DOI 10.1007/s40145-013-0072-y; Wittfeldt A, 2013, J AM COLL CARDIOL, V61, P723, DOI 10.1016/j.jacc.2012.11.032; Yasuda H, 1999, BONE, V25, P109, DOI 10.1016/S8756-3282(99)00121-0	52	28	30	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3887	3900		10.1096/fj.201600616R	http://dx.doi.org/10.1096/fj.201600616R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27511945	Green Published			2022-12-28	WOS:000386474700023
J	Best, CM; Pressman, EK; Cao, C; Cooper, E; Guillet, R; Yost, OL; Galati, J; Kent, TR; O'Brien, KO				Best, Cora M.; Pressman, Eva K.; Cao, Chang; Cooper, Elizabeth; Guillet, Ronnie; Yost, Olivia L.; Galati, Jonathan; Kent, Tera R.; O'Brien, Kimberly O.			Maternal iron status during pregnancy compared with neonatal iron status better predicts placental iron transporter expression in humans	FASEB JOURNAL			English	Article						anemia; heme; TfR1 hepcidin; adolescents	FETAL IRON; MOLECULAR-BASIS; HEME EXPORTER; IDENTIFICATION; HEPCIDIN; RECEPTOR; METABOLISM; ANEMIA; DEFICIENCY; PROTEINS	The placenta richly expresses nonheme and heme Fe transport proteins. To address the impact of maternal and neonatal Fe status and hepcidin on the regulation of these proteins, mRNA expression and protein abundance of nonheme and heme Fe transport proteins were evaluated in placental tissue from 154 adolescents. Regression analyses found maternal Fe status was significantly associated with multiple placental nonheme and heme transporters, whereas neonatal Fe status was related to only 3 heme transporters. Across statistical analyses, maternal Fe status was consistently associated with the placental nonheme Fe importer transferrin receptor 1 (TfR1). Protein abundance of TfR1 was related to midgestation maternal serum ferritin (SF) (beta = -0.32; P = 0.005) and serum TfR (beta = 0.25; P = 0.024). Protein abundance of the heme importer, proton-coupled folate transporter, was related to neonatal SF (beta = 0.30; P = 0.016) and serum TfR (beta = -0.46; P < 0.0001). Neonatal SF was also related to mRNA expression of the heme exporter feline leukemia virus subgroup C receptor 1 (beta = -0.30; P = 0.004). In summary, maternal Fe insufficiency during pregnancy predicts increased expression of the placental nonheme Fe transporter TfR1. Associations between placental heme Fe transporters and neonatal Fe status require further study.	[Best, Cora M.; Yost, Olivia L.; Galati, Jonathan; Kent, Tera R.; O'Brien, Kimberly O.] Cornell Univ, Div Nutr Sci, 230 Savage Hall, Ithaca, NY 14853 USA; [Pressman, Eva K.; Cooper, Elizabeth; Guillet, Ronnie] Univ Rochester, Sch Med & Dent, Rochester, NY USA; [Cao, Chang] Boston Childrens Hosp, Dept Pathol, Boston, MA USA	Cornell University; University of Rochester; Harvard University; Boston Children's Hospital	O'Brien, KO (corresponding author), Cornell Univ, Div Nutr Sci, 230 Savage Hall, Ithaca, NY 14853 USA.	koo4@cornell.edu	Cao, Chang/AAP-6072-2021; Pressman, Eva K/AAG-5564-2020	Cao, Chang/0000-0003-3625-8807; Pressman, Eva K/0000-0002-2556-9290; Best, Cora/0000-0001-8400-9288	U.S. Department of Agriculture [2005-35200, 2008-01857]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [T32-DK007158]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007158] Funding Source: NIH RePORTER	U.S. Department of Agriculture(United States Department of Agriculture (USDA)); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. Department of Agriculture Grants 2005-35200 and 2008-01857, and by the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant T32-DK007158. The authors thank Francoise Vermeylen and Dr. Erika Mudrak (Cornell University) for technical assistance with statistical analyses and Ann Lei for work to create Supplemental Fig. 1. The authors also thank Dr. Iqbal Hamza (University of Maryland, College Park, MD, USA) for the gift of HRG1 antibody, and Dr. Janis Abkowitz (University of Washington, Seattle, WA, USA) for the gift of the FLVCR1 antibody. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDDK or the NIH. The authors declare no conflicts of interest.	Balesaria S, 2012, HAEMATOL-HEMATOL J, V97, P661, DOI 10.3324/haematol.2011.055046; Bastin J, 2006, BRIT J HAEMATOL, V134, P532, DOI 10.1111/j.1365-2141.2006.06216.x; Bradley J, 2004, AM J PHYSIOL-REG I, V287, pR894, DOI 10.1152/ajpregu.00525.2003; Cao C, 2014, REPRODUCTION, V148, P295, DOI 10.1530/REP-14-0053; Cao C, 2013, NUTR REV, V71, P35, DOI 10.1111/j.1753-4887.2012.00550.x; CARPENTER CE, 1992, CRIT REV FOOD SCI, V31, P333, DOI 10.1080/10408399209527576; Carter AM, 2012, PHYSIOL REV, V92, P1543, DOI 10.1152/physrev.00040.2011; Center for Disease Control and Prevention, 1998, MMWR MORB MORTAL WKL, V47, P1; Chen HJ, 2010, J NUTR, V140, P1728, DOI 10.3945/jn.109.117531; Earl R., 1993, IRON DEFICIENCY ANEM; Evans P, 2011, MOL HUM REPROD, V17, P227, DOI 10.1093/molehr/gaq101; Fuchs R, 2004, TRAFFIC, V5, P725, DOI 10.1111/j.1600-0854.2004.00221.x; Gambling L, 2001, BIOCHEM J, V356, P883, DOI 10.1042/0264-6021:3560883; Gambling L, 2009, AM J PHYSIOL-REG I, V296, pR1063, DOI 10.1152/ajpregu.90793.2008; Ganz T, 2003, BLOOD, V102, P783, DOI 10.1182/blood-2003-03-0672; Garcia-Valdes L, 2015, INT J OBESITY, V39, P571, DOI 10.1038/ijo.2015.3; Georgieff MK, 2007, AM J CLIN NUTR, V85, p614S; Georgieff MK, 2000, PLACENTA, V21, P799, DOI 10.1053/plac.2000.0566; Gleason PM, 2015, J ACAD NUTR DIET, V115, P1072, DOI 10.1016/j.jand.2015.03.011; Hurrell R, 2010, AM J CLIN NUTR, V91, p1461S, DOI 10.3945/ajcn.2010.28674F; Hvidberg V, 2005, BLOOD, V106, P2572, DOI 10.1182/blood-2005-03-1185; Institute of Medicine Panel on Micronutrients, 2001, DIET REF INT VIT A V; Jaacks LM, 2011, J NUTR, V141, P1267, DOI 10.3945/jn.110.135798; Keel SB, 2008, SCIENCE, V319, P825, DOI 10.1126/science.1151133; Latunde-Dada GO, 2006, FEBS LETT, V580, P6865, DOI 10.1016/j.febslet.2006.11.048; Le Blanc S, 2012, AM J PHYSIOL-CELL PH, V302, pC1780, DOI 10.1152/ajpcell.00080.2012; Lee S. M., 2014, ICAN: Infant, Child & Adolescent Nutrition, V6, P152, DOI 10.1177/1941406414525993; Lee S, 2016, PEDIATR RES, V79, P42, DOI 10.1038/pr.2015.183; Lee S, 2014, J NUTR, V144, P1524, DOI 10.3945/jn.114.191445; Martin ME, 2004, FEBS LETT, V574, P187, DOI 10.1016/j.febslet.2004.08.010; Muehlenbachs A, 2007, J IMMUNOL, V179, P557, DOI 10.4049/jimmunol.179.1.557; Nathan DG, 2009, HEMATOLOGY INFANCY C, V7th; Nemeth E, 2006, ANNU REV NUTR, V26, P323, DOI 10.1146/annurev.nutr.26.061505.111303; Nicolas G, 2002, P NATL ACAD SCI USA, V99, P4596, DOI 10.1073/pnas.072632499; O'Brien KO, 2014, J CLIN ENDOCR METAB, V99, P1348, DOI 10.1210/jc.2013-1366; Ohgami RS, 2006, BLOOD, V108, P1388, DOI 10.1182/blood-2006-02-003681; Qiu AD, 2006, CELL, V127, P917, DOI 10.1016/j.cell.2006.09.041; Quigley JG, 2004, CELL, V118, P757, DOI 10.1016/j.cell.2004.08.014; Rao R, 2007, SEMIN FETAL NEONAT M, V12, P54, DOI 10.1016/j.siny.2006.10.007; Shayeghi M, 2005, CELL, V122, P789, DOI 10.1016/j.cell.2005.06.025; VITERI FE, 1994, ADV EXP MED BIOL, V352, P127; Whisner CM, 2014, J BONE MINER RES, V29, P2109, DOI 10.1002/jbmr.2233; Young BE, 2014, FASEB J, V28, P2029, DOI 10.1096/fj.13-246736; Young MF, 2010, PLACENTA, V31, P1010, DOI 10.1016/j.placenta.2010.08.009; Young ME, 2012, J NUTR, V142, P33, DOI 10.3945/jn.111.145961	45	25	25	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3541	3550		10.1096/fj.201600069R	http://dx.doi.org/10.1096/fj.201600069R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27402672	Green Published			2022-12-28	WOS:000384329800023
J	Li, DJ; Wang, CJ; Yao, Y; Chen, L; Liu, GY; Zhang, RX; Liu, Q; Shi, FD; Hao, JW				Li, Daojing; Wang, Chunjiong; Yao, Yang; Chen, Li; Liu, Guiyou; Zhang, Rongxin; Liu, Qiang; Shi, Fu-Dong; Hao, Junwei			mTORC1 pathway disruption ameliorates brain inflammation following stroke via a shift in microglia phenotype from M1 type to M2 type	FASEB JOURNAL			English	Article						ischemia; glia cells; polarization	FOCAL CEREBRAL-ISCHEMIA; MICROGLIA/MACROPHAGE POLARIZATION; MACROPHAGE POLARIZATION; OXIDATIVE STRESS; ARTERY OCCLUSION; INJURY; RAPAMYCIN; CELLS; ACTIVATION; EVEROLIMUS	Inflammatory factors secreted by microglia play an important role in focal ischemic stroke. The mammalian target of rapamycin (mTOR) pathway is a known regulator of immune responses, but the role that mTORC1 signaling plays in poststroke neuroinflammation is not clear. To explore the relationship between microglial action in the mTORC1 pathway and the impact on stroke, we administered the mTORC1 inhibitors sirolimus and everolimus to mice. Presumably, disrupting the mTORC1 pathway after focal ischemic stroke should clarify the subsequent activity of microglia. For that purpose, we generated mice deficient in the regulatory associated protein of mTOR (Raptor) in microglia, whose mTORC1 signaling was blocked, by crossing Raptor loxed (Raptor(flox/flox)) mice with CX3CR1(CreER) mice, which express Cre recombinase under the control of the CX3C chemokine receptor 1 promoter. mTORC1 blockade reduced lesion size, improved motor function, dramatically decreased production of proinflammatory cytokines and chemokines, and reduced the number of M1 type microglia. Thus, mTORC1 blockade apparently attenuated behavioral deficits and poststroke inflammation after middle cerebral artery occlusion by preventing microglia polarization toward the M1 type.	[Li, Daojing; Yao, Yang; Chen, Li; Liu, Qiang; Shi, Fu-Dong; Hao, Junwei] Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin 300052, Peoples R China; [Li, Daojing; Yao, Yang; Chen, Li; Liu, Qiang; Shi, Fu-Dong; Hao, Junwei] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Wang, Chunjiong] Tianjin Med Univ, Dept Physiol & Pathophysiol, Tianjin, Peoples R China; [Zhang, Rongxin] Tianjin Med Univ, Dept Immunol, Tianjin, Peoples R China; [Liu, Guiyou] Chinese Acad Sci, Tianjin Inst Ind Biotechnol, Tianjin, Peoples R China; [Liu, Qiang; Shi, Fu-Dong] St Josephs Hosp, Barrow Neurol Inst, Dept Neurol, Phoenix, AZ USA	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Chinese Academy of Sciences; Tianjin Institute of Industrial Biotechnology, CAS; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Hao, JW (corresponding author), Tianjin Med Univ, Gen Hosp, Dept Neurol, Tianjin 300052, Peoples R China.; Hao, JW (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Tianjin 300052, Peoples R China.	hjw@tmu.edu.cn	Zhang, Rongxin/ABG-3679-2021; Liu, Qiang/HHZ-3181-2022	Liu, Guiyou/0000-0002-1126-2888; Zhang, Rongxin/0000-0002-4083-374X; Hao, Junwei/0000-0002-3075-5434	National Basic Research Program of China [2013CB966900]; National Natural Science Foundation of China [81571600, 81322018, 81273287, 81100887]; Youth Top-notch Talent Support Program; National Key Clinical Specialty Construction Project of China	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Top-notch Talent Support Program; National Key Clinical Specialty Construction Project of China	The authors thank Professor Ding Ai (Tianjin Medical University) for kindly providing us with the transgenic mice. This work was supported by National Basic Research Program of China Grant 2013CB966900 (to F.D.S); National Natural Science Foundation of China Grants 81571600, 81322018, 81273287, and 81100887 (to J.W.H.); the Youth Top-notch Talent Support Program; and the National Key Clinical Specialty Construction Project of China. The authors declare no conflicts of interest.	Ahmad A, 2011, NEUROCHEM RES, V36, P1360, DOI 10.1007/s11064-011-0458-6; Amantea D, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00147; Banerjee S, 2011, MOL CANCER THER, V10, P279, DOI 10.1158/1535-7163.MCT-10-0654; Chauhan A, 2015, EUR J PHARMACOL, V757, P28, DOI 10.1016/j.ejphar.2015.03.006; Chauhan A, 2011, BEHAV BRAIN RES, V225, P603, DOI 10.1016/j.bbr.2011.08.035; Chen L, 2015, SCI REP-UK, V5, DOI 10.1038/srep14308; Colton CA, 2009, J NEUROIMMUNE PHARM, V4, P399, DOI 10.1007/s11481-009-9164-4; Derecki NC, 2013, TRENDS IMMUNOL, V34, P144, DOI 10.1016/j.it.2012.10.002; Dheen ST, 2007, CURR MED CHEM, V14, P1189, DOI 10.2174/092986707780597961; Ding K, 2014, NEUROCHEM INT, V76, P23, DOI 10.1016/j.neuint.2014.06.015; Doeppner TR, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00338; Fletcher L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068281; Fu Y, 2015, NAT REV NEUROL, V11, P524, DOI 10.1038/nrneurol.2015.144; Gelosa P, 2014, J CEREBR BLOOD F MET, V34, P979, DOI 10.1038/jcbfm.2014.45; Hu XM, 2012, STROKE, V43, P3063, DOI 10.1161/STROKEAHA.112.659656; Hucke S, 2012, BRAIN, V135, P1586, DOI 10.1093/brain/aws058; Ito M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8360; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Kroner A, 2014, NEURON, V83, P1098, DOI 10.1016/j.neuron.2014.07.027; Kumar A., 2015, J NEUROTRAUMA; Lisi L, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-1; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MacKeigan JP, 2015, NEURO-ONCOLOGY, V17, P1550, DOI 10.1093/neuonc/nov152; Mantovani A, 2004, SEMIN CANCER BIOL, V14, P155, DOI 10.1016/j.semcancer.2003.10.001; Meng LH, 2015, ACTA PHARMACOL SIN, V36, P1163, DOI 10.1038/aps.2015.68; Moes DJAR, 2015, DRUG DISCOV TODAY, V20, P1243, DOI 10.1016/j.drudis.2015.05.006; Pan J, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0270-3; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Saran U, 2015, CLIN SCI, V129, P895, DOI 10.1042/CS20150149; Saura J, 2003, GLIA, V44, P183, DOI 10.1002/glia.10274; Schilling M, 2009, NEUROSCIENCE, V161, P806, DOI 10.1016/j.neuroscience.2009.04.025; Sosunov AA, 2012, EPILEPSIA, V53, P78, DOI 10.1111/j.1528-1167.2012.03478.x; Varnum MM, 2012, ARCH IMMUNOL THER EX, V60, P251, DOI 10.1007/s00005-012-0181-2; Wang GH, 2015, P NATL ACAD SCI USA, V112, P2853, DOI 10.1073/pnas.1501441112; Wang Q, 2007, J NEUROIMMUNOL, V184, P53, DOI 10.1016/j.jneuroim.2006.11.014; Wolf Y, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00026; Xia CY, 2015, INT IMMUNOPHARMACOL, V25, P377, DOI 10.1016/j.intimp.2015.02.019; Xie LK, 2014, J IMMUNOL, V192, P6009, DOI 10.4049/jimmunol.1303492; Yao Y, 2014, INT J MOL SCI, V15, P20913, DOI 10.3390/ijms151120913; Zhu LN, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5696; Zhu XX, 2014, J CEREBR BLOOD F MET, V34, P1531, DOI 10.1038/jcbfm.2014.113	41	94	96	1	46	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3388	3399		10.1096/fj.201600495R	http://dx.doi.org/10.1096/fj.201600495R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27342766				2022-12-28	WOS:000384329800011
J	Hoeksema, MA; Laan, LC; Postma, JJ; Cummings, RD; de Winther, MPJ; Dijkstra, CD; van Die, I; Kooij, G				Hoeksema, Marten A.; Laan, Lisa C.; Postma, Juliette J.; Cummings, Richard D.; de Winther, Menno P. J.; Dijkstra, Christine D.; van Die, Irma; Kooij, Gijs			Treatment with Trichuris suis soluble products during monocyte-to-macrophage differentiation reduces inflammatory responses through epigenetic remodeling	FASEB JOURNAL			English	Article						helminth; multiple sclerosis; autoimmunity; TNF; IL-10	MATRIX METALLOPROTEINASES; MULTIPLE-SCLEROSIS; HELMINTH THERAPY; BOWEL-DISEASE; POLARIZATION; ACTIVATION; COLITIS; EXPRESSION; INFECTION; PROTEINS	Helminths have strong immunoregulatory properties that may be exploited in treatment of chronic immune disorders, such as multiple sclerosis and inflammatory bowel disease. Essential players in the pathogenesis of these diseases are proinflammatory macrophages. We present evidence that helminths modulate the function and phenotype of these innate immune cells. We found that soluble products derived from the Trichuris suis (TsSP) significantly affect the differentiation of monocytes into macrophages and their subsequent polarization. TsSPs reduce the expression and production of inflammatory cytokines, including IL-6 and TNF, in human proinflammatory M1 macrophages. TsSPs induce a concomitant anti-inflammatory M2 signature, with increased IL-10 production. Furthermore, they suppress CHIT activity and enhance secretion of matrix metalloproteinase 9. Shortterm triggering of monocytes with TsSPs early during monocyte-to-macrophage differentiation imprinted these phenotypic alterations, suggesting long-lasting epigenetic changes. The TsSP-induced effects in M1 macrophages were completely reversed by inhibiting histone deacetylases, which corresponded with decreased histone acetylation at the TNF and IL6 promoters. These results demonstrate that TsSPs have a potent and sustained immunomodulatory effect on human macrophage differentiation and polarization through epigenetic remodeling and provide new insights into the mechanisms by which helminths modulate human immune responses.	[Hoeksema, Marten A.; de Winther, Menno P. J.] Univ Amsterdam, Acad Med Ctr, Dept Med Biochem, NL-1012 WX Amsterdam, Netherlands; [Laan, Lisa C.; Postma, Juliette J.; Dijkstra, Christine D.; van Die, Irma; Kooij, Gijs] Vrije Univ Amsterdam, Med Ctr, Dept Mol Cell Biol & Immunol, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Cummings, Richard D.] Harvard Med Sch, Natl Ctr Funct Glyc, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA USA	University of Amsterdam; Academic Medical Center Amsterdam; Vrije Universiteit Amsterdam; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Kooij, G (corresponding author), Vrije Univ Amsterdam, Med Ctr, VUmc MS Ctr Amsterdam, Dept Mol Cell Biol & Immunol, Neurosci Campus Amsterdam,OI2 Bldg,Room 11E41, NL-1007 MB Amsterdam, Netherlands.	g.kooij@vumc.nl	Kooij, Gijs/AAA-4268-2020	de Winther, Menno/0000-0002-4038-6636; Hoeksema, Marten/0000-0001-5981-121X; Kooij, Gijs/0000-0002-9488-2918	Dutch Multiple Sclerosis Research Foundation [MS11-771]; U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases Grant [AI101982]; Netherlands Heart Foundation [2007T067, 2010B022]; NWO Grant [TOP91208001]; Netherlands Cardiovascular Research Initiative Grant [CVON2011-19]; European Union Grant Horizon2020 ITN (EPIMAC); Academisch Medisch Centrum (AMC) fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101982] Funding Source: NIH RePORTER	Dutch Multiple Sclerosis Research Foundation; U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases Grant; Netherlands Heart Foundation(Netherlands Heart Foundation); NWO Grant; Netherlands Cardiovascular Research Initiative Grant; European Union Grant Horizon2020 ITN (EPIMAC); Academisch Medisch Centrum (AMC) fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Dr. Helene Kringel (University of Copenhagen, Copenhagen, Denmark) for providing the Trichuris suis worms. This work was supported by Dutch Multiple Sclerosis Research Foundation Grant MS11-771 (to I.vD.), and by U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases Grant AI101982 (to R.D.C.). M.P.J.D.W. is an established investigator of the Netherlands Heart Foundation (2007T067), supported by Netherlands Heart Foundation Grant 2010B022, NWO Grant TOP91208001, Netherlands Cardiovascular Research Initiative Grant CVON2011-19 (GENIUS), and European Union Grant Horizon2020 ITN (EPIMAC), and holds an Academisch Medisch Centrum (AMC) fellowship. The authors declare no conflicts of interest.	Alvarez-Errico D, 2015, NAT REV IMMUNOL, V15, P7, DOI 10.1038/nri3777; Avolio C, 2003, J NEUROIMMUNOL, V136, P46, DOI 10.1016/S0165-5728(03)00006-7; Bogie JFJ, 2014, ACTA NEUROPATHOL, V128, P191, DOI 10.1007/s00401-014-1310-2; Comabella M, 2010, BRAIN, V133, P1082, DOI 10.1093/brain/awq035; Correale J, 2011, MULT SCLER J, V17, P521, DOI 10.1177/1352458510392619; Donnelly S, 2005, INFECT IMMUN, V73, P166, DOI 10.1128/IAI.73.1.166-173.2005; Donnelly S, 2008, FASEB J, V22, P4022, DOI 10.1096/fj.08-106278; Ebner F, 2014, ALLERGY, V69, P1489, DOI 10.1111/all.12496; Elliott DE, 2012, ANN NY ACAD SCI, V1247, P83, DOI 10.1111/j.1749-6632.2011.06292.x; Faubion WA, 2013, AM J GASTROENTEROL, V108, P1891, DOI 10.1038/ajg.2013.354; Fleming JO, 2015, PARASITE IMMUNOL, V37, P277, DOI 10.1111/pim.12175; Fleming JO, 2013, INT J PARASITOL, V43, P259, DOI 10.1016/j.ijpara.2012.10.025; Fleming JO, 2011, MULT SCLER J, V17, P743, DOI 10.1177/1352458511398054; Foster SL, 2007, NATURE, V447, P972, DOI 10.1038/nature05836; Gao Q, 2007, INFLAMM BOWEL DIS, V13, P693, DOI 10.1002/ibd.20100; Garcia-Vallejo JJ, 2008, MOL IMMUNOL, V45, P2359, DOI 10.1016/j.molimm.2007.11.001; Garg SK, 2014, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD009400.PUB2; Gause WC, 2013, NAT REV IMMUNOL, V13, P607, DOI 10.1038/nri3476; Han SB, 2009, ARCH PHARM RES, V32, P613, DOI 10.1007/s12272-009-1418-4; Hoeksema MA, 2012, CURR ATHEROSCLER REP, V14, P254, DOI 10.1007/s11883-012-0240-5; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Klaver EJ, 2013, INT J PARASITOL, V43, P191, DOI 10.1016/j.ijpara.2012.10.021; Kooij G, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0223-1; Kreider T, 2007, CURR OPIN IMMUNOL, V19, P448, DOI 10.1016/j.coi.2007.07.002; Kuijk LM, 2012, MOL IMMUNOL, V51, P210, DOI 10.1016/j.molimm.2012.03.020; Kzhyshkowska J, 2007, BIOMARK INSIGHTS, V2, P128; Liu HC, 2013, AM J PHYSIOL-GASTR L, V304, pG793, DOI 10.1152/ajpgi.00249.2012; Maizels RM, 2014, CLIN EXP IMMUNOL, V177, P38, DOI 10.1111/cei.12353; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Mizoguchi E, 2006, GASTROENTEROLOGY, V130, P398, DOI 10.1053/j.gastro.2005.12.007; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Murray PJ, 2011, NAT REV IMMUNOL, V11, P723, DOI 10.1038/nri3073; Nance JP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002990; Neele AE, 2015, EUR J PHARMACOL, V763, P79, DOI 10.1016/j.ejphar.2015.03.101; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Ottow MK, 2014, GENES IMMUN, V15, P477, DOI 10.1038/gene.2014.38; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Ravi A, 2007, INFLAMM BOWEL DIS, V13, P97, DOI 10.1002/ibd.20011; Reyes JL, 2011, CELL IMMUNOL, V267, P77, DOI 10.1016/j.cellimm.2010.11.006; Rosenberg GA, 2009, LANCET NEUROL, V8, P205, DOI 10.1016/S1474-4422(09)70016-X; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Smith P, 2007, J IMMUNOL, V178, P4557, DOI 10.4049/jimmunol.178.7.4557; Summers RW, 2005, GASTROENTEROLOGY, V128, P825, DOI 10.1053/j.gastro.2005.01.005; Summers RW, 2005, GUT, V54, P87, DOI 10.1136/gut.2004.041749; Takeuch O, 2011, EUR J IMMUNOL, V41, P2490, DOI 10.1002/eji.201141792; Van den Bossche J, 2014, CURR OPIN LIPIDOL, V25, P367, DOI 10.1097/MOL.0000000000000109; van Stijn CMW, 2009, MOL IMMUNOL, V46, P3292, DOI 10.1016/j.molimm.2009.07.026; Vogel DYS, 2014, IMMUNOBIOLOGY, V219, P695, DOI 10.1016/j.imbio.2014.05.002; Weinstock JV, 2009, INFLAMM BOWEL DIS, V15, P128, DOI 10.1002/ibd.20633; Wolfs IMJ, 2014, FASEB J, V28, P288, DOI 10.1096/fj.13-235911; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yazdanbakhsh M, 2002, SCIENCE, V296, P490, DOI 10.1126/science.296.5567.490; Zaccone P, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/795210	56	23	23	2	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2826	2836		10.1096/fj.201600343R	http://dx.doi.org/10.1096/fj.201600343R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27095802	Green Published			2022-12-28	WOS:000380994000018
J	Holzem, KM; Vinnakota, KC; Ravikumar, VK; Madden, EJ; Ewald, GA; Dikranian, K; Beard, DA; Efimov, IR				Holzem, Katherine M.; Vinnakota, Kalyan C.; Ravikumar, Vinod K.; Madden, Eli J.; Ewald, Gregory A.; Dikranian, Krikor; Beard, Daniel A.; Efimov, Igor R.			Mitochondrial structure and function are not different between nonfailing donor and end-stage failing human hearts	FASEB JOURNAL			English	Article						oxidative respiration; electron microscopy; energy substrate; lipid droplet; perilipin 5	HUMAN SKELETAL-MUSCLE; METABOLIC GENE-EXPRESSION; PERILIPIN 5; OXIDATIVE-PHOSPHORYLATION; ULTRASTRUCTURAL FEATURES; FAILURE; MYOCARDIUM; CARDIOMYOPATHY; PROTEIN; DYSFUNCTION	During human heart failure, the balance of cardiac energy use switches from predominantly fatty acids (FAs) to glucose. We hypothesized that this substrate shift was the result of mitochondrial degeneration; therefore, we examined mitochondrial oxidation and ultrastructure in the failing human heart by using respirometry, transmission electron microscopy, and gene expression studies of demographically matched donor and failing human heart left ventricular (LV) tissues. Surprisingly, respiratory capacities for failing LV isolated mitochondria (n = 9) were not significantly diminished compared with donor LV isolated mitochondria (n = 7) for glycolysis (pyruvate + malate)- or FA (palmitoylcarnitine)-derived substrates, and mitochondrial densities, assessed via citrate synthase activity, were consistent between groups. Transmission electron microscopy images also showed no ultrastructural remodeling for failing vs. donor mitochondria; however, the fraction of lipid droplets (LDs) in direct contact with a mitochondrion was reduced, and the average distance between an LD and its nearest neigh boring mitochondrion was increased. Analysis of FA processing gene expression between donor and failing LVs revealed 0.64-fold reduced transcript levels for the mitochondrial-LD tether, perilipin 5, in the failing myocardium (P = 0.003). Thus, reduced FA use in heart failure may result from improper delivery, potentially via decreased perilipin 5 expression and mitochondrial-LD tethering, and not from intrinsic mitochondrial dysfunction.	[Ewald, Gregory A.; Dikranian, Krikor] Washington Univ, Sch Med, St Louis, MO USA; [Holzem, Katherine M.; Ravikumar, Vinod K.; Madden, Eli J.; Efimov, Igor R.] Washington Univ, Dept Biomed Engn, St Louis, MO USA; [Vinnakota, Kalyan C.; Beard, Daniel A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA; [Efimov, Igor R.] George Washington Univ, Washington, DC USA	Washington University (WUSTL); Washington University (WUSTL); University of Michigan System; University of Michigan; George Washington University	Efimov, IR (corresponding author), George Washington Univ, Dept Biomed Engn, 5000C Sci & Engn Hall,800 22nd St NW, Washington, DC 20052 USA.	efimov@gwu.edu	Efimov, Igor/R-5544-2017; Efimov, Igor R/B-8040-2010; Efimov, Igor R./AAJ-3234-2021; Vinnakota, Kalyan/G-4706-2010	Efimov, Igor/0000-0002-1483-5039; Efimov, Igor R/0000-0002-1483-5039; Vinnakota, Kalyan/0000-0003-2185-2213	U.S. National Institutes of Health (NIH) Clinical and Translational Science Awards program [UL1TR000448]; Richard J. Wilkinson Trust; NIH National Heart, Lung, and Blood Institute [R01HL114395, F30HL114310]; American Heart Association [12PRE12050315]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000448] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL126802, R01HL114395, F30HL114310, R01HL072011] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Clinical and Translational Science Awards program; Richard J. Wilkinson Trust; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank the surgical teams at Barnes-Jewish Hospital and Mid-America Transplant Services for their assistance with human heart procurement, most notably Drs. Scott Silvestry and Michael Pasque. The authors recognize the Translational Cardiovascular Biobank and Repository (Washington University in St. Louis), which is supported by the U.S. National Institutes of Health (NIH) Clinical and Translational Science Awards program (Grant UL1TR000448), and the Richard J. Wilkinson Trust, for the provision of patient records. The authors also recognize the Nutrition and Obesity Research Center for the use of their Orobos Oxygraph-O2k, and the laboratories of Jan Bieschke and Jeanne Nerbonne for the use of the NanoPhotometer P-Class and 7900HT equipment, respectively. The authors thank Marlyn Levy (Washington University Department of Cell Biology and Physiology Electron Microscopy Facility) for processing samples. This work was supported by the NIH National Heart, Lung, and Blood Institute [Grants R01HL114395 and F30HL114310 (to K.H.)], and by the American Heart Association [Grant 12PRE12050315 (to K.H.)]. The authors declare no conflicts of interest.	Ahuja P, 2013, CIRCULATION, V127, P1957, DOI 10.1161/CIRCULATIONAHA.112.001219; Anson RM, 2000, J AM AGING ASSOC, V23, P199, DOI 10.1007/s11357-000-0020-y; Barrientos A, 1996, BIOCHEM BIOPH RES CO, V229, P536, DOI 10.1006/bbrc.1996.1839; BOFFOLI D, 1994, BBA-MOL BASIS DIS, V1226, P73, DOI 10.1016/0925-4439(94)90061-2; Bosma M, 2012, HISTOCHEM CELL BIOL, V137, P205, DOI 10.1007/s00418-011-0888-x; Brattelid T, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-22; CHIDSEY CA, 1966, J CLIN INVEST, V45, P40, DOI 10.1172/JCI105322; Chokshi A, 2012, CIRCULATION, V125, P2844, DOI 10.1161/CIRCULATIONAHA.111.060889; Chretien D, 1998, BIOCHEM J, V329, P249, DOI 10.1042/bj3290249; Cordero-Reyes AM, 2014, J MOL CELL CARDIOL, V68, P98, DOI 10.1016/j.yjmcc.2013.12.029; FERRANS VJ, 1972, CIRCULATION, V45, P769, DOI 10.1161/01.CIR.45.4.769; Fillmore N, 2013, BBA-MOL CELL RES, V1833, P857, DOI 10.1016/j.bbamcr.2012.08.014; Goldberg IJ, 2012, CELL METAB, V15, P805, DOI 10.1016/j.cmet.2012.04.006; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Jarreta D, 2000, CARDIOVASC RES, V45, P860, DOI 10.1016/S0008-6363(99)00388-0; Kuramoto K, 2012, J BIOL CHEM, V287, P23852, DOI 10.1074/jbc.M111.328708; Lemieux H, 2011, INT J BIOCHEM CELL B, V43, P1729, DOI 10.1016/j.biocel.2011.08.008; Lenaz G, 1998, BBA-BIOENERGETICS, V1366, P53, DOI 10.1016/S0005-2728(98)00120-0; LEYTON RA, 1969, AM J MED SCI, V258, P304; Marin-Garcia J, 2008, HEART FAIL REV, V13, P137, DOI 10.1007/s10741-007-9079-1; MARON BJ, 1978, PROG CARDIOVASC DIS, V21, P207, DOI 10.1016/0033-0620(78)90026-9; MARON BJ, 1975, AM J PATHOL, V79, P387; Mason RR, 2015, TRENDS ENDOCRIN MET, V26, P144, DOI 10.1016/j.tem.2015.01.005; Milger K, 2006, J CELL SCI, V119, P4678, DOI 10.1242/jcs.03280; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Ng FS, 2014, CIRC-ARRHYTHMIA ELEC, V7, P875, DOI 10.1161/CIRCEP.113.001477; Picard M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018317; Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x; Pollak NM, 2015, J BIOL CHEM, V290, P1295, DOI 10.1074/jbc.M114.604744; Rasmussen UF, 2003, EXP GERONTOL, V38, P877, DOI 10.1016/S0531-5565(03)00092-5; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Roger VL, 2013, CIRC RES, V113, P646, DOI 10.1161/CIRCRESAHA.113.300268; Rosca MG, 2008, CARDIOVASC RES, V80, P30, DOI 10.1093/cvr/cvn184; Rossi M A, 2001, Med Sci Monit, V7, P820; SABBAH HN, 1992, J MOL CELL CARDIOL, V24, P1333, DOI 10.1016/0022-2828(92)93098-5; SEKIGUCHI M, 1974, J MOL CELL CARDIOL, V6, P111, DOI 10.1016/0022-2828(74)90015-7; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Sharov VG, 1998, J MOL CELL CARDIOL, V30, P1757, DOI 10.1006/jmcc.1998.0739; Sharov VG, 2000, J MOL CELL CARDIOL, V32, P2361, DOI 10.1006/jmcc.2000.1266; Smith JR, 2008, PROTEOMICS, V8, P446, DOI 10.1002/pmic.200701009; SMITH MN, 1976, AM HEART J, V91, P563, DOI 10.1016/S0002-8703(76)80140-8; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Stride N, 2013, EUR J HEART FAIL, V15, P150, DOI 10.1093/eurjhf/hfs172; TROUNCE I, 1989, LANCET, V1, P637, DOI 10.1016/S0140-6736(89)92143-0; Wang H, 2013, J LIPID RES, V54, P953, DOI 10.1194/jlr.M032466; Wang H, 2011, J LIPID RES, V52, P2159, DOI 10.1194/jlr.M017939; Wang H, 2011, TRENDS ENDOCRIN MET, V22, P197, DOI 10.1016/j.tem.2011.03.008; Yagyu H, 2003, J CLIN INVEST, V111, P419, DOI [10.1172/JCI200316751, 10.1172/JCI16751]; Zick M, 2009, BBA-MOL CELL RES, V1793, P5, DOI 10.1016/j.bbamcr.2008.06.013	49	16	18	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2698	2707		10.1096/fj.201500118R	http://dx.doi.org/10.1096/fj.201500118R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27075244	Green Published, Green Submitted			2022-12-28	WOS:000380994000007
J	Karwad, MA; Couch, DG; Theophilidou, E; Sarmad, S; Barrett, DA; Larvin, M; Wright, KL; Lund, JN; O'Sullivan, SE				Karwad, Mustafa A.; Couch, Daniel G.; Theophilidou, Elena; Sarmad, Sarir; Barrett, David A.; Larvin, Michael; Wright, Karen L.; Lund, Jonathan N.; O'Sullivan, Saoirse E.			The role of CB1 in intestinal permeability and inflammation	FASEB JOURNAL			English	Article						gut; endocannabinoids; anandamide; 2-ag	ENDOGENOUS CANNABINOID SYSTEM; EVOKED MUCOSAL DAMAGE; COLONIC EXPLANT MODEL; 2-ARACHIDONOYLGLYCEROL RECEPTOR; ENDOCANNABINOID SYSTEM; BARRIER FUNCTION; TIGHT JUNCTIONS; NG108-15 CELLS; BOWEL-DISEASE; ANANDAMIDE	The endocannabinoid system has previously been shown to play a role in the permeability and inflammatory response of the human gut. The goal of our study was to determine the effects of endogenous anandamide (AEA) and 2-arachidonoyl glycerol (2-AG) on the permeability and inflammatory response of intestinal epithelium under normal, inflammatory, and hypoxic conditions. Human intestinal mucosa was modeled using Caco-2 cells. Human tissue was collected from planned colorectal resections. Accumulation of AEA and 2-AG was achieved by inhibiting their metabolizing enzymes URB597 (a fatty acid amide hydrolase inhibitor) and JZL184 (a monoacylglycerol lipase inhibitor). Inflammation and ischemia were simulated with TNF-alpha and IFN-gamma and oxygen deprivation. Permeability changes were measured by transepithelial electrical resistance. The role of the CB1 receptor was explored using CB1-knockdown (CB(1)Kd) intestinal epithelial cells. Endocannabinoid levels were measured using liquid chromatography-mass spectrometry. Cytokine secretion was measured using multiplex and ELISA. URB597 and JZL184 caused a concentration-dependent increase in permeability via CB1 (P < 0.0001) and decreased cytokine production. Basolateral application of JZL184 decreased permeability via CB1 (P < 0.0001). URB597 and JZL184 increased the enhanced (worsened) permeability caused by inflammation and hypoxia (P < 0.0001 and P<0.05). CB(1)Kd cells showed reduced permeability response to inflammation (P<0.01) but not hypoxia. 2-AG levels were increased in response to inflammation and hypoxia in Caco-2 cells. In human mucosal tissue, inflammation increased the secretion of granulocyte macrophage-colony stimulating factor, IL-12, -13, and -15, which was prevented with ex vivo treatment with URB597 and JZL184, and was inhibited by a CB1 antagonist. The results of this study show that endogenous AEA and 2-AG production and CB1 activation play a key modulatory roles in normal intestinal mucosa permeability and in inflammatory and hypoxic conditions.	[Karwad, Mustafa A.; Couch, Daniel G.; Theophilidou, Elena; Lund, Jonathan N.; O'Sullivan, Saoirse E.] Univ Nottingham, Sch Med, Royal Derby Hosp, Nottingham, England; [Sarmad, Sarir; Barrett, David A.] Univ Nottingham, Ctr Analyt Biosci, Sch Pharm, Nottingham, England; [Larvin, Michael] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [Wright, Karen L.] Univ Lancaster, Div Biomed & Life Sci, Fac Hlth & Med, Lancaster, England	University of Nottingham; University of Nottingham; University of Limerick; Lancaster University	O'Sullivan, SE (corresponding author), Univ Nottingham, Sch Med, Royal Derby Hosp, Derby DE22 3DT, England.	couch27@gmail.com	Wright, Karen Leslie/C-7959-2011; Larvin, Michael/AAE-4674-2019; O'Sullivan, Saoirse Elizabeth/GQZ-1894-2022; Lund, Jonathan/K-6631-2019; Barrett, David/C-9922-2011	Wright, Karen Leslie/0000-0003-0040-9247; O'Sullivan, Saoirse Elizabeth/0000-0002-1672-6610; Lund, Jonathan/0000-0001-5195-2181; Barrett, David/0000-0001-6900-9474				Alhamoruni A, 2012, BRIT J PHARMACOL, V165, P2598, DOI 10.1111/j.1476-5381.2011.01589.x; Alhamoruni A, 2010, J PHARMACOL EXP THER, V335, P92, DOI 10.1124/jpet.110.168237; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Caraceni P, 2009, GUT, V58, P1135, DOI 10.1136/gut.2007.147652; Coskun M, 2014, FRONT MED, V1, DOI 10.3389/fmed.2014.00024; D'Argenio G, 2006, FASEB J, V20, P568, DOI 10.1096/fj.05-4943fje; D'Argenio G, 2007, J MOL MED, V85, P523, DOI 10.1007/s00109-007-0192-3; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2006, GUT, V55, P1373, DOI 10.1136/gut.2005.090472; Di Marzo V, 2015, NEUROTHERAPEUTICS, V12, P692, DOI 10.1007/s13311-015-0374-6; Di Sabatino A, 2011, MUCOSAL IMMUNOL, V4, P574, DOI 10.1038/mi.2011.18; Elkouby-Naor L, 2010, INT REV CEL MOL BIO, V279, P1, DOI 10.1016/S1937-6448(10)79001-8; Engel MA, 2008, J PHYSIOL PHARMACOL, V59, P673; Fasano A, 2004, ADV DRUG DELIVER REV, V56, P795, DOI 10.1016/j.addr.2003.10.045; Freund TF, 2003, PHYSIOL REV, V83, P1017, DOI 10.1152/physrev.00004.2003; Godlewski G, 2004, BRIT J PHARMACOL, V142, P701, DOI 10.1038/sj.bjp.0705839; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Guagnini F, 2006, GUT, V55, P946, DOI 10.1136/gut.2005.076372; Harvey BS, 2014, CYTOKINE, V65, P236, DOI 10.1016/j.cyto.2013.10.006; Harvey BS, 2013, CYTOKINE, V63, P209, DOI 10.1016/j.cyto.2013.04.032; Ho WSV, 2008, BRIT J PHARMACOL, V155, P837, DOI 10.1038/bjp.2008.324; Jonsson KO, 2001, BRIT J PHARMACOL, V133, P1263, DOI 10.1038/sj.bjp.0704199; Kathuria S, 2003, NAT MED, V9, P76, DOI 10.1038/nm803; Kim Young S, 2010, Curr Gastroenterol Rep, V12, P319, DOI 10.1007/s11894-010-0131-2; Koay LC, 2014, AM J PHYSIOL-GASTR L, V307, pG140, DOI 10.1152/ajpgi.00317.2013; Lee Y., 2016, AM J PHYSIOL-GASTR L, V4, pG655; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; Matsuda K, 2005, TOHOKU J EXP MED, V207, P99, DOI 10.1620/tjem.207.99; Muccioli GG, 2010, DRUG DISCOV TODAY, V15, P474, DOI 10.1016/j.drudis.2010.03.007; Nicotra LL, 2013, PROSTAG OTH LIPID M, V100, P22, DOI 10.1016/j.prostaglandins.2013.01.003; Rojo OP, 2007, INFLAMM BOWEL DIS, V13, P269, DOI 10.1002/ibd.20019; Peterson LW, 2014, NAT REV IMMUNOL, V14, P141, DOI 10.1038/nri3608; Piomelli D, 2006, CNS DRUG REV, V12, P21, DOI 10.1111/j.1527-3458.2006.00021.x; Richardson D, 2007, ANAL BIOCHEM, V360, P216, DOI 10.1016/j.ab.2006.10.039; Salaga M, 2014, J CROHNS COLITIS, V8, P998, DOI 10.1016/j.crohns.2014.01.025; Shamran H, 2017, BRAIN BEHAV IMMUN, V59, P10, DOI 10.1016/j.bbi.2016.06.008; Shen L, 2012, ANN NY ACAD SCI, V1258, P9, DOI 10.1111/j.1749-6632.2012.06613.x; Shore DM, 2014, J BIOL CHEM, V289, P5828, DOI 10.1074/jbc.M113.478495; Smart D, 2002, BRIT J PHARMACOL, V136, P452, DOI 10.1038/sj.bjp.0704732; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Sugiura T, 1999, J BIOL CHEM, V274, P2794, DOI 10.1074/jbc.274.5.2794; Sugiura T, 1996, BIOCHEM BIOPH RES CO, V229, P58, DOI 10.1006/bbrc.1996.1757; Sugiura T, 1997, J BIOCHEM-TOKYO, V122, P890; Troy-Fioramonti S, 2015, DIABETES, V64, P808, DOI 10.2337/db14-0721; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; Villanueva A, 2009, SHOCK, V32, P614, DOI 10.1097/SHK.0b013e3181a4fd8f	46	37	37	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3267	3277		10.1096/fj.201601346R	http://dx.doi.org/10.1096/fj.201601346R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28404744	Green Accepted			2022-12-28	WOS:000405932400007
J	Deepak, V; Kayastha, P; McNamara, LM				Deepak, Vishwa; Kayastha, Pushpalata; McNamara, Laoise M.			Estrogen deficiency attenuates fluid flow-induced [Ca2+](i) oscillations and mechanoresponsiveness of MLO-Y4 osteocytes	FASEB JOURNAL			English	Article						E-2; mechanobiology; fluid shear stress; osteoporosis; menopause	DENTIN MATRIX PROTEIN-1; SERUM SCLEROSTIN LEVELS; STRESS IN-VITRO; BONE-CELLS; NITRIC-OXIDE; MECHANICAL STRAIN; RECEPTOR-ALPHA; POSTMENOPAUSAL WOMEN; GENE-EXPRESSION; OSTEOBLASTS	It has been proposed that estrogen regulates the mechanosensitivity of osteocytes; however, the effects of estrogen deficiency that arises during postmenopausal osteoporosis on mechanical stimulation induced calcium signaling in osteocytes remain elusive. Here, we pretreated MLO-Y4 osteocytes with 10 nM E2 for 2, 3 and 5 d, then simulated postmenopausal conditions either by estrogen withdrawal (EW) from culture medium, or by inhibiting the estrogen receptor by using fulvestrant and estrogen (FE; ICI 182,780) in vitro. We investigated [Ca2+](i) oscillations and mechanobiologic responses of osteocytes (EW and FE) that were exposed to oscillatory fluid flow (OFF; 1 Pa, 0.5 Hz). We demonstrated that estrogen treatment enhanced OFF-induced [Ca2+](i) oscillations and that this effect was abrogated both by FE and EW. Moreover, osteocytes in both estrogen-depleted groups (EW and FE) had reduced levels of NO and prostaglandin E2 release, down-regulated dentin matrix protein-1, sclerostin, osteopontin, osteocalcin, and alkaline phosphatase mRNA expression, and reduced F-actin fiber formation after OFF stimulation compared with estrogen-treated cells. We propose a link between estrogen deficiency and alterations in [Ca2+](i)-mediated mechanosensitivity of osteocytes, which ultimately alter osteocyte function and differentiation. Deepak, V., Kayastha, P., McNamara, L. M. Estrogen deficiency attenuates fluid flow induced [Ca2+](i) oscillations and mechanoresponsiveness of MLO-Y4 osteocytes.	[Deepak, Vishwa; Kayastha, Pushpalata; McNamara, Laoise M.] Natl Univ Ireland Galway, Coll Engn & Informat, Mechanobiol & Med Device Res Grp, Biomech Res Ctr,Biomed Engn, Galway, Ireland	Ollscoil na Gaillimhe-University of Galway	McNamara, LM (corresponding author), Natl Univ Ireland Galway, Biomed Engn, Coll Engn & Informat, Galway, Ireland.	laoise.mcnamara@nuigalway.ie		Kayastha, Pushpalata/0000-0002-3452-1790	Science Foundation Ireland [RSF1352]; European Research Council [258992]	Science Foundation Ireland(Science Foundation IrelandEuropean Commission); European Research Council(European Research Council (ERC)European Commission)	This study was supported by grants from the Science Foundation Ireland (Grant RSF1352) and the European Research Council (Grant 258992) to L.M.M. The authors declare no conflicts of interest.	Aguirre JI, 2007, J BIOL CHEM, V282, P25501, DOI 10.1074/jbc.M702231200; Ajubi NE, 1996, BIOCHEM BIOPH RES CO, V225, P62, DOI 10.1006/bbrc.1996.1131; Ajubi NE, 1999, AM J PHYSIOL-ENDOC M, V276, pE171, DOI 10.1152/ajpendo.1999.276.1.E171; Alenghat Francis J, 2002, Sci STKE, V2002, ppe6, DOI 10.1126/stke.2002.119.pe6; Bakker AD, 2006, OSTEOPOROSIS INT, V17, P827, DOI 10.1007/s00198-006-0072-7; Bakker AD, 2005, OSTEOPOROSIS INT, V16, P983, DOI 10.1007/s00198-004-1785-0; Balemans W, 2001, HUM MOL GENET, V10, P537, DOI 10.1093/hmg/10.5.537; Balla B, 2008, CALCIFIED TISSUE INT, V82, P12, DOI 10.1007/s00223-007-9092-3; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Birmingham E, 2012, EUR CELLS MATER, V23, P13, DOI 10.22203/eCM.v023a02; Boudaoud A, 2014, NAT PROTOC, V9, P457, DOI 10.1038/nprot.2014.024; Brennan MA, 2014, HORM METAB RES, V46, P537, DOI 10.1055/s-0033-1363265; Cappariello A, 2014, ARCH BIOCHEM BIOPHYS, V558, P70, DOI 10.1016/j.abb.2014.06.017; Chen NX, 2000, AM J PHYSIOL-CELL PH, V278, pC989, DOI 10.1152/ajpcell.2000.278.5.C989; Chen NX, 2003, BONE, V33, P399, DOI 10.1016/S8756-3282(03)00159-5; Cheng BX, 2001, ENDOCRINOLOGY, V142, P3464, DOI 10.1210/en.142.8.3464; Cheng BX, 2001, J BONE MINER RES, V16, P249, DOI 10.1359/jbmr.2001.16.2.249; Cherian PP, 2005, MOL BIOL CELL, V16, P3100, DOI 10.1091/mbc.E04-10-0912; Compston J., 2010, ATLAS POSTMENOPAUSAL, P33; Damien E, 2000, J BONE MINER RES, V15, P2169, DOI 10.1359/jbmr.2000.15.11.2169; Donahue SW, 2001, AM J PHYSIOL-CELL PH, V281, pC1635, DOI 10.1152/ajpcell.2001.281.5.C1635; Drake MT, 2017, BONE, V96, P8, DOI 10.1016/j.bone.2016.12.004; Etherington J, 1996, J BONE MINER RES, V11, P1333; Feng JQ, 2006, NAT GENET, V38, P1310, DOI 10.1038/ng1905; Franz-Odendaal TA, 2006, DEV DYNAM, V235, P176, DOI 10.1002/dvdy.20603; Galea Gabriel L, 2013, Bonekey Rep, V2, P413, DOI 10.1038/bonekey.2013.147; Gluhak-Heinrich J, 2003, J BONE MINER RES, V18, P807, DOI 10.1359/jbmr.2003.18.5.807; Haisenleder DJ, 2011, ENDOCRINOLOGY, V152, P4443, DOI 10.1210/en.2011-1501; Han YF, 2004, P NATL ACAD SCI USA, V101, P16689, DOI 10.1073/pnas.0407429101; Haugh MG, 2015, J MECH BEHAV BIOMED, V42, P67, DOI 10.1016/j.jmbbm.2014.11.001; Heino TJ, 2008, J ENDOCRINOL, V197, pR1, DOI 10.1677/JOE-07-0629; Iqbal J, 2005, BIOCHEM BIOPH RES CO, V328, P751, DOI 10.1016/j.bbrc.2004.12.087; Jastrzebski S, 2013, J BONE MINER RES, V28, P618, DOI 10.1002/jbmr.1773; Jessop HL, 2001, J BONE MINER RES, V16, P1045, DOI 10.1359/jbmr.2001.16.6.1045; Klein-Nulend J, 2013, BONE, V54, P182, DOI 10.1016/j.bone.2012.10.013; KleinNulend J, 1995, BIOCHEM BIOPH RES CO, V217, P640, DOI 10.1006/bbrc.1995.2822; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; Krassas G. E., 2001, Journal of Musculoskeletal & Neuronal Interactions, V2, P143; Lara-Castillo N, 2015, BONE, V76, P58, DOI 10.1016/j.bone.2015.03.019; Lee K, 2003, NATURE, V424, P389, DOI 10.1038/424389a; Lee KCL, 2004, J ENDOCRINOL, V182, P193, DOI 10.1677/joe.0.1820193; Lee Kristen L, 2015, Cilia, V4, P7, DOI 10.1186/s13630-015-0016-y; Lu XL, 2012, BONE, V51, P466, DOI 10.1016/j.bone.2012.05.021; Lu XL, 2012, J BONE MINER RES, V27, P563, DOI 10.1002/jbmr.1474; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Mann V, 2007, BONE, V40, P674, DOI 10.1016/j.bone.2006.10.014; Marino M, 1998, BIOCHEM BIOPH RES CO, V245, P254, DOI 10.1006/bbrc.1998.8413; McCloy RA, 2014, CELL CYCLE, V13, P1400, DOI 10.4161/cc.28401; McGarry JG, 2005, BIOCHEM BIOPH RES CO, V330, P341, DOI 10.1016/j.bbrc.2005.02.175; McNamara LM, 2010, J R SOC INTERFACE, V7, P353, DOI 10.1098/rsif.2009.0282; McNamara LM, 2009, ANAT REC, V292, P355, DOI 10.1002/ar.20869; Mirza FS, 2010, J CLIN ENDOCR METAB, V95, P1991, DOI 10.1210/jc.2009-2283; Miyauchi A, 2006, J BONE MINER METAB, V24, P498, DOI 10.1007/s00774-006-0716-x; Modder UI, 2011, J BONE MINER RES, V26, P373, DOI 10.1002/jbmr.217; Osborne CK, 2004, BRIT J CANCER, V90, pS2, DOI 10.1038/sj.bjc.6601629; Poole KES, 2005, FASEB J, V19, P1842, DOI 10.1096/fj.05-4221fje; Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518; Randell KM, 2002, J BONE MINER RES, V17, P528, DOI 10.1359/jbmr.2002.17.3.528; Ren J, 2012, CALCIFIED TISSUE INT, V90, P411, DOI 10.1007/s00223-012-9581-x; Riggs BL, 2002, ENDOCR REV, V23, P279, DOI 10.1210/er.23.3.279; Robling AG, 2008, J BIOL CHEM, V283, P5866, DOI 10.1074/jbc.M705092200; Rosser J, 2012, METHODS MOL BIOL, V816, P67, DOI 10.1007/978-1-61779-415-5_6; RUBIN CT, 1984, J BONE JOINT SURG AM, V66A, P397, DOI 10.2106/00004623-198466030-00012; Saxon LK, 2012, ENDOCRINOLOGY, V153, P2254, DOI 10.1210/en.2011-1977; Schaffler MB, 2012, CURR OSTEOPOROS REP, V10, P118, DOI 10.1007/s11914-012-0105-4; Shang ZZ, 2014, INT J ORAL SCI, V6, P142, DOI 10.1038/ijos.2014.2; Simon AM, 2002, J BONE MINER RES, V17, P963, DOI 10.1359/jbmr.2002.17.6.963; Sterck JGH, 1998, AM J PHYSIOL-ENDOC M, V274, pE1113, DOI 10.1152/ajpendo.1998.274.6.E1113; Szatkowski C, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-156; Tan SD, 2008, BIOCHEM BIOPH RES CO, V369, P1150, DOI 10.1016/j.bbrc.2008.03.007; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; Turner CH, 1996, AM J PHYSIOL-ENDOC M, V270, pE634, DOI 10.1152/ajpendo.1996.270.4.E634; van Bezooijen RL, 2004, J EXP MED, V199, P805, DOI 10.1084/jem.20031454; Verbruggen SW, 2015, BIOPHYS J, V108, P1587, DOI 10.1016/j.bpj.2015.02.031; Verbruggen SW, 2014, BIOMECH MODEL MECHAN, V13, P85, DOI 10.1007/s10237-013-0487-y; Verbruggen SW, 2012, J R SOC INTERFACE, V9, P2735, DOI 10.1098/rsif.2012.0286; WAKELING AE, 1987, J ENDOCRINOL, V112, pR7, DOI 10.1677/joe.0.112R007; Wang YL, 2007, P NATL ACAD SCI USA, V104, P15941, DOI 10.1073/pnas.0707246104; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; Zaman G, 2006, J BONE MINER RES, V21, P1297, DOI 10.1359/JBMR.060504	81	30	31	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3027	3039		10.1096/fj.201601280R	http://dx.doi.org/10.1096/fj.201601280R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28363954				2022-12-28	WOS:000405931000027
J	Lee, Y; Fluckey, JD; Chakraborty, S; Muthuchamy, M				Lee, Yang; Fluckey, James D.; Chakraborty, Sanjukta; Muthuchamy, Mariappan			Hyperglycemia- and hyperinsulinemia-induced insulin resistance causes alterations in cellular bioenergetics and activation of inflammatory signaling in lymphatic muscle	FASEB JOURNAL			English	Article						metabolism; lymphatic contractility; insulin signaling; glycolysis; signal transduction	VASCULAR SMOOTH-MUSCLE; GLUCOSE-TRANSPORTER GLUT4; PERINUCLEAR STORAGE COMPARTMENT; OXIDATIVE STRESS; SKELETAL-MUSCLE; PROTEIN-KINASE; ADIPOSE-TISSUE; METABOLIC SYNDROME; MICE LACKING; RAT MODEL	Insulin resistance is a well-known risk factor for obesity, metabolic syndrome (MetSyn) and associated cardiovascular diseases, but its mechanisms are undefined in the lymphatics. Mesenteric lymphatic vessels from MetSyn or LPS-injected rats exhibited impaired intrinsic contractile activity and associated inflammatory changes. Hence, we hypothesized that insulin resistance in lymphatic muscle cells (LMCs) affects cell bioenergetics and signaling pathways that consequently alter contractility. LMCs were treated with different concentrations of insulin or glucose or both at various time points to determine insulin resistance. Onset of insulin resistance significantly impaired glucose uptake, mitochondrial function, oxygen consumption rates, glycolysis, lactic acid, and ATP production in LMCs. Hyperglycemia and hyperinsulinemia also impaired the PI3K/Akt while enhancing the ERK/p38MAPK/JNK pathways in LMCs. Increased NF-kappa B nuclear translocation and macrophage chemoattractant protein-1 and VCAM-1 levels in insulin-resistant LMCs indicated activation of inflammatory mechanisms. In addition, increased phosphorylation of myosin light chain-20, a key regulator of lymphatic muscle contraction, was observed in insulin-resistant LMCs. Therefore, our data elucidate the mechanisms of insulin resistance in LMCs and provide the first evidence that hyperglycemia and hyperinsulinemia promote insulin resistance and impair lymphatic contractile status by reducing glucose uptake, altering cellular metabolic pathways, and activating inflammatory signaling cascades.-Lee, Y., Fluckey, J.D., Chakraborty, S., Muthuchamy, M. Hyperglycemia- and hyperinsulinemia-induced insulin resistance causes alterations in cellular bioenergetics and activation of inflammatory signaling in lymphatic muscle.	[Lee, Yang; Chakraborty, Sanjukta; Muthuchamy, Mariappan] Texas A&M Univ, Dept Med Physiol, College Stn, TX USA; [Fluckey, James D.] Texas A&M Univ, Dept Hlth & Kinesiol, College Stn, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Chakraborty, S; Muthuchamy, M (corresponding author), Texas A&M Hlth Sci Ctr, Coll Med, Dept Med Physiol, College Stn, TX 77843 USA.	schakraborty@medicine.tamhsc.edu; marim@tamu.edu	Chakraborty, Sanjukta/AFO-9240-2022	Chakraborty, Sanjukta/0000-0002-4869-3198; Lee, Yang/0000-0002-8004-338X	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [RO1 DK99221]; Department of Medical Physiology, Lymphatic Graduate Student Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099221] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Department of Medical Physiology, Lymphatic Graduate Student Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank the Texas A&M Health Science Center Integrated Microscopy and Imaging Laboratory, Texas A&M Image Analysis Laboratory, and Texas A&M Qualitative Biology Facility Core for their technical support. This work was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant RO1 DK99221 (to M.M.) and Department of Medical Physiology, Lymphatic Graduate Student Fellowship (to Y.L.). The authors declare no conflicts of interest.	Arngrim N, 2013, INT J OBESITY, V37, P748, DOI 10.1038/ijo.2012.98; Aroor AR, 2014, DIABETES, V63, P2216, DOI 10.2337/db14-0424; Avogaro A, 2008, FREE RADICAL BIO MED, V44, P1209, DOI 10.1016/j.freeradbiomed.2007.12.021; Baluk P, 2007, J EXP MED, V204, P2349, DOI 10.1084/jem.20062596; Chakraborty S, 2015, AM J PHYSIOL-HEART C, V309, pH2042, DOI 10.1152/ajpheart.00467.2015; Chakraborty S, 2015, AM J PHYSIOL-CELL PH, V309, pC680, DOI 10.1152/ajpcell.00122.2015; Chakraborty S, 2015, SEMIN CELL DEV BIOL, V38, P55, DOI 10.1016/j.semcdb.2015.01.005; Chakraborty S, 2011, MICROCIRCULATION, V18, P24, DOI 10.1111/j.1549-8719.2010.00064.x; Chakraborty S, 2010, ANN NY ACAD SCI, V1207, pE94, DOI 10.1111/j.1749-6632.2010.05752.x; Chen RC, 2015, DIABETES RES CLIN PR, V108, P235, DOI 10.1016/j.diabres.2015.02.012; Cho H, 2001, J BIOL CHEM, V276, P38349, DOI 10.1074/jbc.C100462200; Cho H, 2001, SCIENCE, V292, P1728, DOI 10.1126/science.292.5522.1728; Davidoff AJ, 2004, MOL CELL BIOCHEM, V262, P155, DOI 10.1023/B:MCBI.0000038231.68078.4b; Davidoff AJ, 1997, AM J PHYSIOL-HEART C, V272, pH159, DOI 10.1152/ajpheart.1997.272.1.H159; de Figueiredo ASP, 2015, J BIOL CHEM, V290, P13427, DOI 10.1074/jbc.M114.626077; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P372, DOI 10.1089/ars.2012.4886; Egawa K, 2001, J BIOL CHEM, V276, P10207, DOI 10.1074/jbc.M009489200; Fulton DJR, 2009, CIRC RES, V104, P1035, DOI 10.1161/CIRCRESAHA.109.198028; Gardner SE, 2015, ARTERIOSCL THROM VAS, V35, P1963, DOI 10.1161/ATVBAHA.115.305896; Garofalo RS, 2003, J CLIN INVEST, V112, P197, DOI 10.1172/JCI200316885; Harvey NL, 2005, NAT GENET, V37, P1072, DOI 10.1038/ng1642; HENRY RR, 1990, DIABETES, V39, P149, DOI 10.2337/diabetes.39.2.149; Hermann C, 2000, ARTERIOSCL THROM VAS, V20, P402, DOI 10.1161/01.ATV.20.2.402; Huang PL, 2009, DIS MODEL MECH, V2, P231, DOI 10.1242/dmm.001180; Hwang SL, 2013, BRIT J PHARMACOL, V169, P69, DOI 10.1111/bph.12124; International Diabetes Federation Task Force on Epidemiology and Prevention, 2009, CIRCULATION; Izawa Y, 2005, EXP CELL RES, V308, P291, DOI 10.1016/j.yexcr.2005.04.028; Jiang ZY, 1999, J CLIN INVEST, V104, P447, DOI 10.1172/JCI5971; KAISER N, 1993, DIABETES, V42, P80, DOI 10.2337/diabetes.42.1.80; Karlsson HKR, 2005, DIABETES, V54, P1692, DOI 10.2337/diabetes.54.6.1692; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Lee JH, 2006, AM J PHYSIOL-CELL PH, V291, pC1355, DOI 10.1152/ajpcell.00125.2006; Lee JH, 2012, AM J PHYSIOL-CELL PH, V302, pC1371, DOI 10.1152/ajpcell.00254.2011; Lee JH, 2009, AM J PHYSIOL-CELL PH, V296, pC327, DOI 10.1152/ajpcell.00254.2008; Li H, 2014, EXP BIOL MED, V239, P954, DOI 10.1177/1535370214527903; Li Y, 2004, J BIOL CHEM, V279, P45304, DOI 10.1074/jbc.C400186200; Liu YH, 2013, BIOCHEM BIOPH RES CO, V438, P78, DOI 10.1016/j.bbrc.2013.07.029; Lloyd PG, 1999, PHYSIOL RES, V48, P401; Lowell BB, 2005, SCIENCE, V307, P384, DOI 10.1126/science.1104343; Martinez-Arca S, 2000, J CELL SCI, V113, P1705; Martinez-Hervas S, 2014, CARDIOVASC RES, V103, P324, DOI 10.1093/cvr/cvu115; Merdzo I, 2016, AM J PHYSIOL-HEART C, V310, pH830, DOI 10.1152/ajpheart.00964.2015; Muthuchamy M, 2003, FASEB J, V17, P920, DOI 10.1096/fj.02-0626fje; Muthuchamy M, 2008, ANN NY ACAD SCI, V1131, P89, DOI 10.1196/annals.1413.008; Nadler ST, 2001, AM J PHYSIOL-ENDOC M, V281, pE1249, DOI 10.1152/ajpendo.2001.281.6.E1249; Nepiyushchikh ZV, 2011, J PHYSIOL-LONDON, V589, P5415, DOI 10.1113/jphysiol.2011.218446; Niu PG, 2013, PLANTA MED, V79, P452, DOI 10.1055/s-0032-1328325; Norrmen C, 2011, CIRCULATION, V123, P1335, DOI 10.1161/CIRCULATIONAHA.107.704098; Nurmi H, 2015, EMBO MOL MED, V7, P1418, DOI 10.15252/emmm.201505731; Palacios S, 2001, J BIOL CHEM, V276, P3371, DOI 10.1074/jbc.M006739200; Pandey G, 2015, J BIOL CHEM, V290, P5582, DOI 10.1074/jbc.M114.592741; Patsouris D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110653; PAUL RJ, 1983, AM J PHYSIOL, V244, pC399, DOI 10.1152/ajpcell.1983.244.5.C399; PAUL RJ, 1979, SCIENCE, V206, P1414, DOI 10.1126/science.505014; Perez J, 2010, BIOCHEM J, V428, P255, DOI 10.1042/BJ20100090; Ploug T, 1998, J CELL BIOL, V142, P1429, DOI 10.1083/jcb.142.6.1429; Qi YJ, 2015, CIRC-HEART FAIL, V8, P198, DOI 10.1161/CIRCHEARTFAILURE.114.001457; Rasmussen JC, 2014, OBESITY, V22, P2186, DOI 10.1002/oby.20836; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Robichaux JL, 2010, ANAT REC, V293, P1629, DOI 10.1002/ar.21195; Saltiel AR, 1996, AM J PHYSIOL-ENDOC M, V270, pE375, DOI 10.1152/ajpendo.1996.270.3.E375; Sandu OA, 2000, DIABETES, V49, P2178, DOI 10.2337/diabetes.49.12.2178; Sartipy P, 2003, P NATL ACAD SCI USA, V100, P7265, DOI 10.1073/pnas.1133870100; Savetsky IL, 2014, AM J PHYSIOL-HEART C, V307, pH165, DOI 10.1152/ajpheart.00244.2014; Schmitz-Peiffer C, 2003, IUBMB LIFE, V55, P367, DOI 10.1080/1521654031000138569; Sen S, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0224-9; SHIMOJO N, 1993, CLIN CHEM, V39, P2312; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Styskal J, 2012, FREE RADICAL BIO MED, V52, P46, DOI 10.1016/j.freeradbiomed.2011.10.441; Suhane S, 2013, BIOL OPEN, V2, P295, DOI 10.1242/bio.20133244; Summers SA, 1998, MOL CELL BIOL, V18, P5457, DOI 10.1128/MCB.18.9.5457; Tan Y, 2011, DIABETES, V60, P625, DOI 10.2337/db10-1164; Tang X, 2011, ACTA PHARMACOL SIN, V32, P1138, DOI 10.1038/aps.2011.75; TeSlaa T, 2014, METHOD ENZYMOL, V542, P91, DOI 10.1016/B978-0-12-416618-9.00005-4; Tomas E, 2002, ANN NY ACAD SCI, V967, P43; Vaidyula VR, 2006, DIABETES, V55, P202, DOI 10.2337/diabetes.55.1.202; Vinciguerra Manlio, 2006, Archives of Physiology and Biochemistry, V112, P89, DOI 10.1080/13813450600711359; von der Weid Pierre-Yves, 2010, Pathophysiology, V17, P263, DOI 10.1016/j.pathophys.2009.10.005; Vuorio T, 2014, ARTERIOSCL THROM VAS, V34, P1162, DOI 10.1161/ATVBAHA.114.302528; Wang CCL, 2003, DIABETES, V52, P2562, DOI 10.2337/diabetes.52.10.2562; Wang W, 2009, AM J PHYSIOL-HEART C, V297, pH726, DOI 10.1152/ajpheart.00312.2009; Weitman ES, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070703; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Zawieja SD, 2016, MICROCIRCULATION, V23, P558, DOI 10.1111/micc.12307; Zawieja SD, 2016, AM J PHYSIOL-HEART C, V310, pH385, DOI 10.1152/ajpheart.00664.2015; Zawieja SD, 2012, AM J PHYSIOL-HEART C, V302, pH643, DOI 10.1152/ajpheart.00606.2011; Zheng YB, 2009, J ENDOCRINOL, V203, P337, DOI 10.1677/JOE-09-0181; Zick Yehiel, 2005, Sci STKE, V2005, ppe4, DOI 10.1126/stke.2682005pe4; Zielonka J, 2008, NAT PROTOC, V3, P8, DOI 10.1038/nprot.2007.473	89	32	33	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2744	2759		10.1096/fj.201600887R	http://dx.doi.org/10.1096/fj.201600887R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28298335	Green Published			2022-12-28	WOS:000405931000004
J	Lee, SA; Suh, Y; Lee, S; Jeong, J; Kim, SJ; Kim, SJ; Park, SK				Lee, Seol-Ae; Suh, Yeongjun; Lee, Saebom; Jeong, Jaehoon; Kim, Soo Jeong; Kim, So Jung; Park, Sang Ki			Functional expression of dopamine D2 receptor is regulated by tetraspanin 7-mediated postendocytic trafficking	FASEB JOURNAL			English	Article						endocytosis; cell surface trafficking; dopaminergic signaling	PROTEIN-PROTEIN INTERACTIONS; TRANSMEMBRANE 4 SUPERFAMILY; MEDIUM SPINY NEURONS; DEFICIENT MICE; INTERNALIZATION; LYSOSOMES; GENE; D-1; IDENTIFICATION; SCHIZOPHRENIA	The dopaminergic system plays an essential role in various functions of the brain, including locomotion, memory, and reward, and the deregulation of dopaminergic signaling as a result of altered functionality of dopamine D2 receptor (DRD2) is implicated in multiple neurologic and psychiatric disorders. Tetraspanin-7 (TSPAN7) is expressed to variable degrees in different tissues, with the highest level in the brain, and multiple mutations in TSPAN7 have been implicated in intellectual disability. Here, we tested the hypothesis that TSPAN7 may be a binding partner of DRD2 that is involved in the regulation of its functional activity. Our results showed that TSPAN7 was associated with DRD2 and reduced its surface expression by enhancing DRD2 internalization. Immunocytochemical analysis revealed that TSPAN7 that resides in the plasma membrane and early and late endosomes promoted internalization of DRD2 and its localization to endosomal compartments of the endocytic pathway. Furthermore, we observed that TSPAN7 deficiency increased surface localization of DRD2 concurrent with the decrease of its endocytosis, regardless of dopamine treatment. Finally, TSPAN7 negatively affects DRD2-mediated signaling. These results disclosed a previously uncharacterized role of TSPAN7 in the regulation of the expression and functional activity of DRD2 by postendocytic trafficking.	[Lee, Seol-Ae; Suh, Yeongjun; Lee, Saebom; Jeong, Jaehoon; Kim, Soo Jeong; Kim, So Jung; Park, Sang Ki] Pohang Univ Sci & Technol, Dept Life Sci, 77 Cheongam Ro, Pohang 790784, South Korea; [Jeong, Jaehoon] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA	Pohang University of Science & Technology (POSTECH); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Park, SK (corresponding author), Pohang Univ Sci & Technol, Dept Life Sci, 77 Cheongam Ro, Pohang 790784, South Korea.	skpark@postech.ac.kr		Kim, Soo Jeong/0000-0002-6640-9445; Suh, Yeongjun/0000-0002-1841-4792	South Korea Ministry of Science, ICT and Future Planning (MSIP) [NRF-2012R1A4A1028200, NRF-2015M3C7A1030964]; Pohang, South Korea (POSCO) Green Science Fund	South Korea Ministry of Science, ICT and Future Planning (MSIP); Pohang, South Korea (POSCO) Green Science Fund	This work was supported by South Korea Ministry of Science, ICT and Future Planning (MSIP) Grants NRF-2012R1A4A1028200 and NRF-2015M3C7A1030964. This work was also supported, in part, by the Pohang, South Korea (POSCO) Green Science Fund.	Abidi FE, 2002, J MED GENET, V39, P430, DOI 10.1136/jmg.39.6.430; Bartlett SE, 2005, P NATL ACAD SCI USA, V102, P11521, DOI 10.1073/pnas.0502418102; Bassani S, 2012, NEURON, V73, P1143, DOI 10.1016/j.neuron.2012.01.021; Beom SR, 2004, J BIOL CHEM, V279, P28304, DOI 10.1074/jbc.M403899200; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Bergson C, 2003, TRENDS PHARMACOL SCI, V24, P486, DOI 10.1016/S0165-6147(03)00232-3; Berlanga ML, 2011, BRAIN RES, V1390, P41, DOI 10.1016/j.brainres.2011.03.044; Blum K, 1996, J ROY SOC MED, V89, P396, DOI 10.1177/014107689608900711; Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800; Borroto-Escuela DO, 2010, BIOCHEM BIOPH RES CO, V401, P605, DOI 10.1016/j.bbrc.2010.09.110; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Carlsson A, 2000, BRAIN RES REV, V31, P342, DOI 10.1016/S0165-0173(99)00050-8; Carlsson A, 2001, SCIENCE, V294, P1021, DOI 10.1126/science.1066969; Duffield A, 2003, P NATL ACAD SCI USA, V100, P15560, DOI 10.1073/pnas.2536699100; Dumartin B, 2000, P NATL ACAD SCI USA, V97, P1879, DOI 10.1073/pnas.97.4.1879; FISHBURN CS, 1995, J BIOL CHEM, V270, P29819; Free RB, 2007, J BIOL CHEM, V282, P21285, DOI 10.1074/jbc.M701555200; Fuxe K, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00071; GUAN XM, 1992, J BIOL CHEM, V267, P21995; Guo MX, 2008, BIOCHEM BIOPH RES CO, V365, P154, DOI 10.1016/j.bbrc.2007.10.160; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Hosokawa Y, 1999, NEUROSCI RES, V35, P281, DOI 10.1016/S0168-0102(99)00093-0; Iizuka Y, 2007, J NEUROSCI, V27, P12390, DOI 10.1523/JNEUROSCI.1689-07.2007; Iwata K, 1999, EUR J BIOCHEM, V263, P596, DOI 10.1046/j.1432-1327.1999.00549.x; Jeong J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084482; Jia JM, 2013, NAT NEUROSCI, V16, P1627, DOI 10.1038/nn.3542; Jost M, 1998, CURR BIOL, V8, P1399, DOI 10.1016/S0960-9822(98)00022-0; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kabbani N, 2004, CELL SIGNAL, V16, P497, DOI 10.1016/j.cellsig.2003.09.011; Kamiya T, 2003, BIOCHEM BIOPH RES CO, V306, P544, DOI 10.1016/S0006-291X(03)00991-4; KEBABIAN JW, 1979, NATURE, V277, P93, DOI 10.1038/277093a0; Kim JH, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-05-j0003.2001; Kim OJ, 2008, J NEUROCHEM, V106, P83, DOI 10.1111/j.1471-4159.2008.05348.x; Koschatzky S, 2011, ACS CHEM NEUROSCI, V2, P308, DOI 10.1021/cn200020y; Laruelle M, 1996, P NATL ACAD SCI USA, V93, P9235, DOI 10.1073/pnas.93.17.9235; Lee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045618; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Li Y, 2012, J NEUROSCI, V32, P7178, DOI 10.1523/JNEUROSCI.0008-12.2012; Macey TA, 2004, MOL PHARMACOL, V66, P1635, DOI 10.1124/mol.104.001495; Marley A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009325; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Morris SJ, 2007, EUR J PHARMACOL, V577, P44, DOI 10.1016/j.ejphar.2007.08.027; Mousavi SA, 2004, BIOCHEM J, V377, P1, DOI 10.1042/BJ20031000; Neely MD, 2007, NEUROSCIENCE, V149, P457, DOI 10.1016/j.neuroscience.2007.06.044; Nestler EJ, 2001, AM J ADDICTION, V10, P201, DOI 10.1080/105504901750532094; Park SK, 2005, CELL, V122, P275, DOI 10.1016/j.cell.2005.05.031; Paspalas CD, 2006, EUR J NEUROSCI, V24, P1395, DOI 10.1111/j.1460-9568.2006.05023.x; Paumi CM, 2007, MOL CELL, V26, P15, DOI 10.1016/j.molcel.2007.03.011; Quan WY, 2008, BIOCHEM BIOPH RES CO, V377, P705, DOI 10.1016/j.bbrc.2008.10.044; REYNOLDS GP, 1983, NATURE, V305, P527, DOI 10.1038/305527a0; Rous BA, 2002, MOL BIOL CELL, V13, P1071, DOI 10.1091/mbc.01-08-0409; SEEMAN P, 1992, NEUROPSYCHOPHARMACOL, V7, P261; Spano P F, 1978, Adv Biochem Psychopharmacol, V19, P155; Swanson JM, 2000, NEUROSCI BIOBEHAV R, V24, P21, DOI 10.1016/S0149-7634(99)00062-7; Thaminy S, 2003, GENOME RES, V13, P1744, DOI 10.1101/gr.1276503; Vickery RG, 1999, J CELL BIOL, V144, P31, DOI 10.1083/jcb.144.1.31; Volkow ND, 2009, NEUROPHARMACOLOGY, V56, P3, DOI 10.1016/j.neuropharm.2008.05.022; Volkow ND, 1999, J PSYCHOPHARMACOL, V13, P337, DOI 10.1177/026988119901300406; Wang CH, 2005, J NEUROCHEM, V93, P899, DOI 10.1111/j.1471-4159.2005.03055.x; Wise RA, 2002, NEURON, V36, P229, DOI 10.1016/S0896-6273(02)00965-0; Wrighton KH, 2014, NAT REV MOL CELL BIO, V15, DOI 10.1038/nrm3863; Xiao MF, 2009, J NEUROSCI, V29, P14752, DOI 10.1523/JNEUROSCI.4860-09.2009; Xu CF, 2009, FASEB J, V23, P3273, DOI 10.1096/fj.08-123414; Yauch RL, 2000, BIOCHEM J, V351, P629, DOI 10.1042/0264-6021:3510629; Zemni R, 2000, NAT GENET, V24, P167, DOI 10.1038/72829; Zhou QY, 1995, CELL, V83, P1197, DOI 10.1016/0092-8674(95)90145-0	67	19	19	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2301	2313		10.1096/fj.201600755RR	http://dx.doi.org/10.1096/fj.201600755RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28223337				2022-12-28	WOS:000401553400008
J	Zhang, YY; Rogers, HM; Zhang, XJ; Noguchi, CT				Zhang, Yuanyuan; Rogers, Heather M.; Zhang, Xiaojie; Noguchi, Constance Tom			Sex difference in mouse metabolic response to erythropoietin	FASEB JOURNAL			English	Article						adipose tissue; estrogen; nonhematopoietic; weight loss	RECOMBINANT-HUMAN-ERYTHROPOIETIN; HYPOXIC VENTILATION; FEMALE MICE; OBESITY; RECEPTOR; ESTROGEN; ISCHEMIA/REPERFUSION; INFLAMMATION; EXPRESSION; INDUCTION	Erythropoietin (EPO) is the cytokine that regulates red blood cell production. Less understood is the nonerythroid action of EPO, including metabolic regulation of fat accumulation and glucose homeostasis. Although EPO treatment increased hematocrit and improved glucose tolerance in male and female mice, we observed a gender difference in EPO effects in weight control. EPO treatment reduced diet-induced weight gain from 9.6 +/- 1.5 to 4.2 +/- 1.4 g in male mice (P < 0.001), while the weight gain in female mice was similar (4.7 +/- 2.0 g with PBS treatment and 3.3 +/- 2.1 g with EPO treatment). EPO treatment also reduced weight gain in ovariectomized female mice, while the effect was abrogated with estradiol supplementation, suggesting that the sex-differential response to EPO was associated with estrogen. Furthermore, mice with targeted deletion of EPO receptor in white adipose tissue exhibited sex-differential phenotype in weight control and glucose sensitivity, and EPO receptor gene expression was reduced in wild-type female mice, suggesting that white adipose tissue plays an integral role in mediating the metabolic effects of EPO. Our data provide evidence for a sex-differential response to EPO in weight control in mice and underscore the potential for gender specific EPO action beyond erythropoiesis.	[Zhang, Yuanyuan; Rogers, Heather M.; Noguchi, Constance Tom] Natl Inst Diabet & Digest & Kidney Dis, Mol Med Branch, NIH, Bldg 10,Room 9N319,10 Ctr Dr,MSC 1822, Bethesda, MD 20892 USA; [Zhang, Xiaojie] Natl Inst Diabet & Digest & Kidney Dis, Lab Anim Sci Sect, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Noguchi, CT (corresponding author), Natl Inst Diabet & Digest & Kidney Dis, Mol Med Branch, NIH, Bldg 10,Room 9N319,10 Ctr Dr,MSC 1822, Bethesda, MD 20892 USA.	connien@helix.nih.gov	zhang, yuanyuan/GYA-4428-2022		National Institute of Diabetes and Digestive and Kidney Diseases; U.S. National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK025061] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the Intramural Research Program of the National Institute of Diabetes and Digestive and Kidney Diseases and the U.S. National Institutes of Health.	Alnaeeli M, 2015, ADIPOCYTE, V4, P153, DOI 10.4161/21623945.2014.978654; Ballot O, 2015, J APPL PHYSIOL, V118, P1386, DOI 10.1152/japplphysiol.00143.2015; Beleslin-Cokic BB, 2004, BLOOD, V104, P2073, DOI 10.1182/blood-2004-02-0744; Beleslin-Cokic BB, 2011, CYTOKINE, V54, P129, DOI 10.1016/j.cyto.2011.01.015; BOFILL C, 1994, METABOLISM, V43, P614, DOI 10.1016/0026-0495(94)90204-6; Caillaud C, 2015, J ENDOCRINOL, V225, P77, DOI 10.1530/JOE-15-0010; Chen LN, 2015, MOL MED REP, V12, P5391, DOI 10.3892/mmr.2015.4006; Chikuma M, 2000, AM J PHYSIOL-ENDOC M, V279, pE1242, DOI 10.1152/ajpendo.2000.279.6.E1242; Choi D, 2010, J EXP MED, V207, P2831, DOI 10.1084/jem.20100665; Christensen B, 2012, J APPL PHYSIOL, V112, P1114, DOI 10.1152/japplphysiol.01391.2011; Ehrenreich H, 2011, MOL MED, V17, P1306, DOI 10.2119/molmed.2011.00259; Ehrenreich H, 2009, STROKE, V40, pE647, DOI 10.1161/STROKEAHA.109.564872; Eshraghi-Jazi F, 2013, IRAN J KIDNEY DIS, V7, P383; Foskett A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/373781; Gassmann M, 2010, AM J PHYSIOL-REG I, V299, pR1511, DOI 10.1152/ajpregu.00205.2010; Gassmann M, 2009, ANN NY ACAD SCI, V1177, P151, DOI 10.1111/j.1749-6632.2009.05028.x; Hong J, 2009, NUTR J, V8, DOI 10.1186/1475-2891-8-11; Karas RH, 2001, CIRC RES, V89, P534, DOI 10.1161/hh1801.097239; Katz O, 2010, J ENDOCRINOL, V205, P87, DOI 10.1677/JOE-09-0425; Lifshitz L, 2010, HAEMATOL-HEMATOL J, V95, P1823, DOI 10.3324/haematol.2010.025015; Mak RHK, 1996, J PEDIATR-US, V129, P97, DOI 10.1016/S0022-3476(96)70195-6; Mak RHK, 1998, PEDIATR NEPHROL, V12, P660, DOI 10.1007/s004670050524; Meng R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053557; Mikolas E, 2012, HORM METAB RES, V44, P279, DOI 10.1055/s-0032-1301901; Mukundan H, 2002, AM J PHYSIOL-REG I, V283, pR496, DOI 10.1152/ajpregu.00573.2001; Nairz M, 2011, IMMUNITY, V34, P61, DOI 10.1016/j.immuni.2011.01.002; Parsa CJ, 2003, J CLIN INVEST, V112, P999, DOI 10.1172/JCI200318200; Prokai A, 2011, SURGERY, V150, P39, DOI 10.1016/j.surg.2011.02.019; Reinhardt M, 2016, OBESITY, V24, P1530, DOI 10.1002/oby.21537; Rui T, 2005, CARDIOVASC RES, V65, P719, DOI 10.1016/j.cardiores.2004.11.019; Soliz J, 2009, AM J PHYSIOL-REG I, V296, pR1837, DOI 10.1152/ajpregu.90967.2008; Stubbins RE, 2012, EUR J NUTR, V51, P861, DOI 10.1007/s00394-011-0266-4; Suzuki N, 2002, BLOOD, V100, P2279, DOI 10.1182/blood-2002-01-0124; Teng RF, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1526; Teng RF, 2011, BASIC RES CARDIOL, V106, P343, DOI 10.1007/s00395-011-0158-z; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Wang L, 2013, DIABETES, V62, P4122, DOI 10.2337/db13-0518; Wang RY, 1998, MECH AGEING DEV, V103, P81, DOI 10.1016/S0047-6374(98)00031-1; Wen TC, 2006, NEUROSCIENCE, V139, P803, DOI 10.1016/j.neuroscience.2006.02.057; Wright GL, 2004, FASEB J, V18, P1031, DOI 10.1096/fj.03-1289fje; Yasuda Y, 1998, J BIOL CHEM, V273, P25381, DOI 10.1074/jbc.273.39.25381; Zhang YY, 2014, INT J MOL SCI, V15, P10296, DOI 10.3390/ijms150610296	42	17	18	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2661	2673		10.1096/fj.201601223RRR	http://dx.doi.org/10.1096/fj.201601223RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28283542	Green Published			2022-12-28	WOS:000401553400036
J	Kononenko, O; Galatenko, V; Andersson, M; Bazov, I; Watanabe, H; Zhou, XW; Iatsyshyna, A; Mityakina, I; Yakovleva, T; Sarkisyan, D; Ponomarev, I; Krishtal, O; Marklund, N; Tonevitsky, A; Adkins, DL; Bakalkin, G				Kononenko, Olga; Galatenko, Vladimir; Andersson, Malin; Bazov, Igor; Watanabe, Hiroyuki; Zhou, Xing Wu; Iatsyshyna, Anna; Mityakina, Irina; Yakovleva, Tatiana; Sarkisyan, Daniil; Ponomarev, Igor; Krishtal, Oleg; Marklund, Niklas; Tonevitsky, Alex; Adkins, DeAnna L.; Bakalkin, Georgy			Intra- and interregional coregulation of opioid genes: broken symmetry in spinal circuits	FASEB JOURNAL			English	Article						neuropeptides; spinal cord; lateralization	CONTROLLED CORTICAL IMPACT; TRAUMATIC BRAIN-INJURY; DROPLET DIGITAL PCR; COEXPRESSION NETWORKS; POSTURAL ASYMMETRY; INDUCED ARTHRITIS; NEURAL CIRCUITS; RECEPTOR GENE; RAT; EXPRESSION	Regulation of the formation and rewiring of neural circuits by neuropeptides may require coordinated production of these signaling molecules and their receptors that may be established at the transcriptional level. Here, we address this hypothesis by comparing absolute expression levels of opioid peptides with their receptors, the largest neuropeptide family, and by characterizing coexpression (transcriptionally coordinated) patterns of these genes. We demonstrated that expression patterns of opioid genes highly correlate within and across functionally and anatomically different areas. Opioid peptide genes, compared with their receptor genes, are transcribed at much greater absolute levels, which suggests formation of a neuropeptide cloud that covers the receptor-expressed circuits. Surprisingly, we found that both expression levels and the proportion of opioid receptors are strongly lateralized in the spinal cord, interregional coexpression patterns are side specific, and intraregional coexpression profiles are affected differently by left-and right-side unilateral body injury. We propose that opioid genes are regulated as interconnected components of the same molecular system distributed between distinct anatomic regions. The striking feature of this system is its asymmetric coexpression patterns, which suggest side-specific regulation of selective neural circuits by opioid neurohormones.-Kononenko, O., Galatenko, V., Andersson, M., Bazov, I., Watanabe, H., Zhou, X. W., Iatsyshyna, A., Mityakina, I., Yakovleva, T., Sarkisyan, D., Ponomarev, I., Krishtal, O., Marklund, N., Tonevitsky, A., Adkins, D. L., Bakalkin, G. Intra-and interregional coregulation of opioid genes: broken symmetry in spinal circuits.	[Kononenko, Olga; Andersson, Malin; Bazov, Igor; Watanabe, Hiroyuki; Zhou, Xing Wu; Iatsyshyna, Anna; Yakovleva, Tatiana; Sarkisyan, Daniil; Bakalkin, Georgy] Uppsala Univ, Dept Pharmaceut Biosci, Uppsala, Sweden; [Kononenko, Olga; Krishtal, Oleg] Bogomoletz Inst Physiol, Key State Lab, Kiev, Ukraine; [Galatenko, Vladimir; Mityakina, Irina; Tonevitsky, Alex] Moscow MV Lomonosov State Univ, Moscow, Russia; [Iatsyshyna, Anna] Inst Mol Biol & Genet, Dept Human Genet, Kiev, Ukraine; [Ponomarev, Igor] Univ Texas Austin, Waggoner Ctr Alcohol & Addict Res, Austin, TX 78712 USA; [Ponomarev, Igor] Univ Texas Austin, Coll Pharm, Austin, TX 78712 USA; [Marklund, Niklas] Uppsala Univ Hosp, Sect Neurosurg, Dept Neurosci, Uppsala, Sweden; [Adkins, DeAnna L.] Med Univ South Carolina, Coll Hlth Profess, Dept Neurosci, Coll Med, Charleston, SC USA; [Adkins, DeAnna L.] Med Univ South Carolina, Coll Hlth Profess, Dept Hlth Sci & Res, Charleston, SC USA	Uppsala University; National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology; Lomonosov Moscow State University; National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Uppsala University; Uppsala University Hospital; Medical University of South Carolina; Medical University of South Carolina	Bazov, I (corresponding author), Uppsala Univ, Div Biol Res Drug Dependence, Dept Pharmaceut Biosci, Husargatan 3,Box 591, S-75124 Uppsala, Sweden.	igor.bazov@farmbio.uu.se	Tonevitsky, Alexander/R-5596-2019; Galatenko, Vladimir V./E-5139-2014; Galatenko, Vladimir/ABB-7514-2020; Andersson, Malin/A-9930-2009; Iatsyshyna, Anna/M-3648-2015	Galatenko, Vladimir V./0000-0003-3029-3628; Galatenko, Vladimir/0000-0003-3029-3628; Andersson, Malin/0000-0002-1450-8046; Adkins, DeAnna L/0000-0002-3063-5731; Iatsyshyna, Anna/0000-0002-8175-6955; Bazov, Igor/0000-0003-4388-1656; Bakalkin, Georgy/0000-0002-8074-9833; Marklund, Niklas/0000-0002-9797-5626	Swedish Science Research Council (VR); Swedish Council for Working Life and Social Research (FORTE); Swedish Research Council Formas; Swedish Institute (Visby Program); European Union, Swedish Brain Foundation; Uppsala University Hospital Research Fund (ALF); U. S. National Institutes of Health National Institute of Neurological Disorders and Stroke [NS065866]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS065866] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R28AA012725] Funding Source: NIH RePORTER	Swedish Science Research Council (VR)(Swedish Research Council); Swedish Council for Working Life and Social Research (FORTE); Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Institute (Visby Program); European Union, Swedish Brain Foundation; Uppsala University Hospital Research Fund (ALF); U. S. National Institutes of Health National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This work was supported, in part, by grants from the Swedish Science Research Council (VR), the Swedish Council for Working Life and Social Research (FORTE), and the Swedish Research Council Formas (to G. B.); the Swedish Institute (Visby Program; to O. K. and G. B.); the European Union, Swedish Brain Foundation, and Uppsala University Hospital Research Fund (ALF; to N. M.); and U. S. National Institutes of Health National Institute of Neurological Disorders and Stroke Grant NS065866 (to D. L. A.). The authors thank Prof. Olga Korosteleva (Statistics at California State University, Long Beach, Long Beach, CA, USA) for discussion and correction of the manuscript. The authors declare no conflicts of interest.	BAKALKIN GJ, 1980, DOKL AKAD NAUK SSSR+, V252, P762; BAKALKIN GY, 1989, BRAIN RES, V480, P268, DOI 10.1016/0006-8993(89)90192-3; BAKALKIN GY, 1986, PEPTIDES, V7, P551, DOI 10.1016/0196-9781(86)90025-2; BAKALKIN GY, 1989, BRAIN RES, V480, P277, DOI 10.1016/0006-8993(89)90193-5; Bardoni R, 2014, NEURON, V81, P1312, DOI 10.1016/j.neuron.2014.01.044; Bargmann CI, 2013, NAT METHODS, V10, P483, DOI 10.1038/NMETH.2451; Bargmann CI, 2012, BIOESSAYS, V34, P458, DOI 10.1002/bies.201100185; Barrios A, 2012, NAT NEUROSCI, V15, P1675, DOI 10.1038/nn.3253; CHAMBERLAIN TJ, 1963, J NEUROPHYSIOL, V26, P662, DOI 10.1152/jn.1963.26.4.662; Chavkin C, 2013, MOL PHARMACOL, V83, P729, DOI 10.1124/mol.112.083337; CHAZOV EI, 1981, EXPERIENTIA, V37, P887, DOI 10.1007/BF01985696; Clarke RW, 2004, BRAIN RES REV, V46, P163, DOI 10.1016/j.brainresrev.2004.07.005; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Combs HL, 2016, J NEUROTRAUM, V33, P741, DOI 10.1089/neu.2015.4136; Concha ML, 2012, NAT REV NEUROSCI, V13, P832, DOI 10.1038/nrn3371; DiGiorgio A., 1942, ARCH FISIOL, V42, P25; DiGiorgio AM., 1929, ARCH FISIOL, V27, P518; Drake CT, 2007, PROG BRAIN RES, V163, P245, DOI 10.1016/S0079-6123(07)63015-5; Duan B, 2014, CELL, V159, P1417, DOI 10.1016/j.cell.2014.11.003; Duboc V, 2015, ANNU REV GENET, V49, P647, DOI 10.1146/annurev-genet-112414-055322; Ferguson SM, 2011, NAT NEUROSCI, V14, P22, DOI 10.1038/nn.2703; Francks C, 2015, ANN NY ACAD SCI, V1359, P1, DOI 10.1111/nyas.12770; Friedman J, 2008, BIOSTATISTICS, V9, P432, DOI 10.1093/biostatistics/kxm045; Gaiteri C, 2014, GENES BRAIN BEHAV, V13, P13, DOI 10.1111/gbb.12106; Gao CJ, 2012, NEUROSCIENCE, V202, P352, DOI 10.1016/j.neuroscience.2011.11.060; Georganta EM, 2010, NEUROPHARMACOLOGY, V59, P139, DOI 10.1016/j.neuropharm.2010.04.010; Grange P, 2014, P NATL ACAD SCI USA, V111, P5397, DOI 10.1073/pnas.1312098111; Hauser KF, 2005, FRONT BIOSCI-LANDMRK, V10, P216, DOI 10.2741/1522; Hausmann M, 2013, NEUROPSYCHOLOGIA, V51, P1734, DOI 10.1016/j.neuropsychologia.2013.05.017; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; HERKENHAM M, 1987, NEUROSCIENCE, V23, P1, DOI 10.1016/0306-4522(87)90268-5; Hindson CM, 2013, NAT METHODS, V10, P1003, DOI 10.1038/nmeth.2633; Hong S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086851; Hu Zhenjun, 2014, Curr Protoc Bioinformatics, V45, DOI 10.1002/0471250953.bi0808s45; Hu ZJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-17; Hussain ZM, 2012, J NEUROTRAUM, V29, P1785, DOI 10.1089/neu.2011.2286; Jefferson SC, 2016, NEUROREHAB NEURAL RE, V30, P155, DOI 10.1177/1545968315600274; JENNRICH RI, 1970, J AM STAT ASSOC, V65, P904, DOI 10.2307/2284596; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Kim KI, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-114; Kraus J, 2001, J BIOL CHEM, V276, P43901, DOI 10.1074/jbc.M107543200; Kuzmin A, 2000, J PHARMACOL EXP THER, V295, P1031; Leinwand Sarah G, 2014, Worm, V3, pe27730, DOI 10.4161/worm.27730; LEVIN BE, 1995, BRAIN RES, V674, P307, DOI 10.1016/0006-8993(95)00032-L; Li Q, 2003, MOL BRAIN RES, V114, P46, DOI 10.1016/S0169-328X(03)00131-1; Li YP, 2015, G3-GENES GENOM GENET, V5, P1075, DOI 10.1534/g3.115.018127; Lopez-Kleine L, 2013, BRIEF FUNCT GENOMICS, V12, P457, DOI 10.1093/bfgp/elt003; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; MacNeilage PF, 2009, SCI AM, V301, P60, DOI 10.1038/scientificamerican0709-60; Madsen KS, 2012, NEUROIMAGE, V63, P95, DOI 10.1016/j.neuroimage.2012.06.071; Marcoli M, 2015, REV NEUROSCIENCE, V26, P489, DOI 10.1515/revneuro-2015-0007; Marlin BJ, 2015, NATURE, V520, P499, DOI 10.1038/nature14402; MATTHEWS SG, 1995, DEV BRAIN RES, V86, P259, DOI 10.1016/0165-3806(95)00032-9; McDermott GP, 2013, ANAL CHEM, V85, P11619, DOI 10.1021/ac403061n; MORROW L, 1981, NEUROPSYCHOLOGIA, V19, P65, DOI 10.1016/0028-3932(81)90045-2; Park SW, 2008, NEUROSCIENCE, V151, P1034, DOI 10.1016/j.neuroscience.2007.12.015; PEARLSON GD, 1981, BRAIN RES, V218, P233, DOI 10.1016/0006-8993(81)91303-2; PERSSON S, 1994, NEUROSCIENCE, V63, P313, DOI 10.1016/0306-4522(94)90026-4; Remage-Healey L, 2014, HORM BEHAV, V66, P552, DOI 10.1016/j.yhbeh.2014.07.014; Reznikov K, 1999, EUR J NEUROSCI, V11, P2711, DOI 10.1046/j.1460-9568.1999.00680.x; Schaefer SY, 2009, NEUROPSYCHOLOGIA, V47, P2953, DOI 10.1016/j.neuropsychologia.2009.06.025; Schweickert A, 2008, DEV DYNAM, V237, P3557, DOI 10.1002/dvdy.21638; Steffens H, 2011, NEUROSCI RES, V70, P44, DOI 10.1016/j.neures.2011.01.011; Stoop R, 2012, NEURON, V76, P142, DOI 10.1016/j.neuron.2012.09.025; Sun T, 2006, NAT REV NEUROSCI, V7, P655, DOI 10.1038/nrn1930; THAI L, 1992, MOL BRAIN RES, V16, P150, DOI 10.1016/0169-328X(92)90205-P; Nguyen TV, 2013, CEREB CORTEX, V23, P1424, DOI 10.1093/cercor/bhs125; Ulrich JD, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.365197; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Watanabe H, 2015, CEREB CORTEX, V25, P97, DOI 10.1093/cercor/bht204; Williams JT, 2013, PHARMACOL REV, V65, P223, DOI 10.1124/pr.112.005942; Wu YX, 2014, NEUROSCI LETT, V580, P7, DOI 10.1016/j.neulet.2013.11.055; Yuen JWF, 2004, NEUROREPORT, V15, P1431, DOI 10.1097/01.wnr.0000130433.90962.6e; Zaringhalam J, 2008, CLIN EXP PHARMACOL P, V35, P1309, DOI 10.1111/j.1440-1681.2008.05009.x; Zink CF, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.2	76	18	18	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1953	1963		10.1096/fj.201601039R	http://dx.doi.org/10.1096/fj.201601039R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28122917	Green Published			2022-12-28	WOS:000399195500017
J	Rose, S; Bennuri, SC; Wynne, R; Melnyk, S; James, SJ; Frye, RE				Rose, Shannon; Bennuri, Sirish C.; Wynne, Rebecca; Melnyk, Stepan; James, S. Jill; Frye, Richard E.			Mitochondrial and redox abnormalities in autism lymphoblastoid cells: a sibling control study	FASEB JOURNAL			English	Article						autistic disorder; bioenergetics; glutathione; oxidative stress; UCP2	OXIDATIVE STRESS; DYSFUNCTION; BIOMARKERS; CHILDREN	Autism spectrum disorder (ASD) is associated with physiological abnormalities including abnormal redox and mitochondrial metabolism. Lymphoblastoid cell lines (LCLs) from some children with ASD exhibit increased oxidative stress, decreased glutathione redox capacity, and highly active mitochondria with increased vulnerability to reactive oxygen species (ROS). Because unaffected siblings (Sibs) of individuals with ASD share some redox abnormalities, we sought to determine whether LCLs from Sibs share ASD-associated mitochondrial abnormalities. We evaluated mitochondrial bioenergetics in 10 sets of LCLs from children with ASD, Sib, and unrelated/unaffected controls (Cons) after acute increases in ROS. Additionally, intracellular glutathione and uncoupling protein 2 (UCP2) gene expressions were quantified. Compared to sib, ASD LCLs exhibited significantly higher ATP-linked respiration, higher maximal and reserve respiratory capacity, and greater glycolysis and glycolytic reserve. ASD LCLs exhibited a significantly greater change in these parameters, with acute increases in ROS compared to both Sib and Con LCLs. Compared to Con, both ASD and Sib LCLs exhibited significantly higher proton leak respiration. Consistent with this, intracellular glutathione redox capacity was decreased and UCP2 gene expression was increased in both ASD and Sib compared to Con LCLs. These data indicate that mitochondrial respiratory function, not abnormal redox homeostasis, distinguishes ASD from unaffected LCLs.Rose, S., Bennuri, S. C., Wynne, R., Melnyk, S., James, S. J., Frye, R. E. Mitochondrial and redox abnormalities in autism lymphoblastoid cells: a sibling control study.	[Rose, Shannon; Bennuri, Sirish C.; Wynne, Rebecca; Melnyk, Stepan; James, S. Jill; Frye, Richard E.] Arkansas Childrens Res Inst, 13 Childrens Way,Slot 512-41B, Little Rock, AR 72202 USA; [Rose, Shannon; Bennuri, Sirish C.; Wynne, Rebecca; Melnyk, Stepan; James, S. Jill; Frye, Richard E.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Rose, S (corresponding author), Arkansas Childrens Res Inst, 13 Childrens Way,Slot 512-41B, Little Rock, AR 72202 USA.	srose@uams.edu	Frye, Richard/AAB-5543-2020	Rose, Shannon/0000-0003-0595-4367	Arkansas Biosciences Institute (Little Rock, AR, USA); Jane Botsford Johnson Foundation (New York, NY, USA); Arkansas Children's Research Institute	Arkansas Biosciences Institute (Little Rock, AR, USA); Jane Botsford Johnson Foundation (New York, NY, USA); Arkansas Children's Research Institute	The authors thank the individuals who participated in the Autism Genetic Resource Exchange and Coriell Cell Repository. Support for this study was provided the Arkansas Biosciences Institute (Little Rock, AR, USA), the Jane Botsford Johnson Foundation (New York, NY, USA), and Arkansas Children's Research Institute. The authors declare no conflicts of interest.	Azzu V, 2010, BBA-BIOENERGETICS, V1797, P785, DOI 10.1016/j.bbabio.2010.02.035; Dengjel J, 2017, CELL TISSUE RES, V367, P95, DOI 10.1007/s00441-016-2472-0; Dranka BP, 2010, FREE RADICAL BIO MED, V48, P905, DOI 10.1016/j.freeradbiomed.2010.01.015; Frye RE, 2013, TRANSL PSYCHIAT, V3, DOI 10.1038/tp.2012.143; Frye RE, 2012, N AM J MED SCI, V5, P141; Frye RE, 2012, J PEDIATR NEUROL, V10, P35, DOI 10.3233/JPN-2012-0530; Frye RE, 2011, J PEDIATR NEUROL, V9, P427, DOI 10.3233/JPN-2011-0507; Frye RE, 2011, PEDIATR RES, V69, p41R, DOI 10.1203/PDR.0b013e318212f16b; Giardina TM, 2008, BBA-BIOENERGETICS, V1777, P118, DOI 10.1016/j.bbabio.2007.11.006; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Graf WD, 2000, J CHILD NEUROL, V15, P357, DOI 10.1177/088307380001500601; Han CY, 2016, ARCH PHARM RES, V39, P1062, DOI 10.1007/s12272-016-0812-y; James SJ, 2009, FASEB J, V23, P2374, DOI 10.1096/fj.08-128926; Kramer PA, 2014, REDOX BIOL, V2, P206, DOI 10.1016/j.redox.2013.12.026; Li LX, 2001, BIOCHEM BIOPH RES CO, V282, P273, DOI 10.1006/bbrc.2001.4577; Lindsley JE, 2004, COMP BIOCHEM PHYS B, V139, P543, DOI 10.1016/j.cbpc.2004.06.014; Melnyk S, 2012, J AUTISM DEV DISORD, V42, P367, DOI 10.1007/s10803-011-1260-7; Napoli E, 2014, PEDIATRICS, V133, pE1405, DOI 10.1542/peds.2013-1545; Palmieri L, 2010, MOL PSYCHIATR, V15, P38, DOI 10.1038/mp.2008.63; Puigserver P, 2005, INT J OBESITY, V29, pS5, DOI 10.1038/sj.ijo.0802905; Rose S, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.15; Rose S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085436; Rossignol DA, 2012, MOL PSYCHIATR, V17, P389, DOI 10.1038/mp.2011.165; Rossignol DA, 2012, MOL PSYCHIATR, V17, P290, DOI 10.1038/mp.2010.136	24	39	39	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					904	909		10.1096/fj.201601004R	http://dx.doi.org/10.1096/fj.201601004R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27864377	Green Published, hybrid			2022-12-28	WOS:000395671200007
J	Aguer, C; Piccolo, BD; Fiehn, O; Adams, SH; Harper, ME				Aguer, Celine; Piccolo, Brian D.; Fiehn, Oliver; Adams, Sean H.; Harper, Mary-Ellen			A novel amino acid and metabolomics signature in mice overexpressing muscle uncoupling protein 3	FASEB JOURNAL			English	Article						mitochondria; bioenergetics; UCP3; glutathione; redox	OXYGEN SPECIES PRODUCTION; SKELETAL-MUSCLE; UCP3 OVEREXPRESSION; MITOCHONDRIAL ROS; INCREASES; TISSUE	Uncoupling protein 3 (UCP3) is highly selectively expressed in skeletal muscle and is known to lower mitochondrial reactive oxygen species and promote fatty acid oxidation; however, the global impact of UCP3 activity on skeletal muscle and whole-body metabolism have not been extensively studied. We utilized untargeted metabolomics to identify novel metabolites that distinguish mice overexpressing UCP3 in muscle, both at rest and after exercise regimens that challenged muscle metabolism, to potentially unmask subtle phenotypes. Male wild-type (WT) and muscle-specific UCP3-overexpressing transgenic (UCP3 Tg) C57BL/6J mice were compared with or without a 5 wk endurance training protocol at rest or after an acute exercise bout (EB). Skeletal muscle, liver, and plasma samples were analyzed by gas chromatography time-of-flight mass spectrometry. Discriminant metabolites were considered if within the top 99th percentile of variable importance measurements obtained from partial least-squares discriminant analysis models. A total of 80 metabolites accurately discriminated UCP3 Tg mice from WT when modeled within a specific exercise condition (i.e., untrained/rested, endurance trained/rested, untrained/EB, and endurance trained/EB). Results revealed that several amino acids and amino acid derivatives in skeletal muscle and plasma of UCP3 Tg mice (e.g., Asp, Glu, Lys, Tyr, Ser, Met) were significantly reduced after an EB; that metabolites associated with skeletal muscle glutathione/Met/Cys metabolism (2-hydroxybutanoic acid, oxoproline, Gly, and Glu) were altered in UCP3 Tg mice across all training and exercise conditions; and that muscle metabolite indices of dehydrogenase activity were increased in UCP3 Tg mice, suggestive of a shift in tissue NADH/NAD(+) ratio. The results indicate that mitochondrial UCP3 activity affects metabolism well beyond fatty acid oxidation, regulating biochemical pathways associated with amino acid metabolism and redox status. That select metabolites were altered in liver of UCP3 Tg mice highlights that changes in muscle UCP3 activity can also affect other organ systems, presumably through changes in systemic metabolite trafficking.	[Aguer, Celine; Harper, Mary-Ellen] Univ Ottawa, Fac Med, Dept Biochem Microbiol & Immunol, Ottawa, ON, Canada; [Harper, Mary-Ellen] Univ Ottawa, Ottawa Inst Syst Biol, Ottawa, ON, Canada; [Aguer, Celine] Inst Rech Hop Montfort, Ottawa, ON, Canada; [Piccolo, Brian D.; Adams, Sean H.] Arkansas Childrens Nutr Ctr, Little Rock, AR USA; [Piccolo, Brian D.; Adams, Sean H.] Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA; [Fiehn, Oliver] Univ Calif Davis, Genome Ctr, West Coast Metabol Ctr, Davis, CA 95616 USA; [Fiehn, Oliver] King Abdulaziz Univ, Dept Biochem, Jeddah, Saudi Arabia	University of Ottawa; University of Ottawa; University of Arkansas System; University of Arkansas Medical Sciences; University of California System; University of California Davis; King Abdulaziz University	Adams, SH (corresponding author), Univ Arkansas Med Sci, Arkansas Childrens Nutr Ctr, Dept Pediat, Little Rock, AR 72205 USA.; Harper, ME (corresponding author), Univ Ottawa, Dept Biochem Microbiol & Immunol, Ottawa, ON K1H 8M5, Canada.	shadams@uams.edu; mharper@uottawa.ca	Aguer, Celine/U-7848-2019; ADAMS, SEAN/N-9262-2018	Aguer, Celine/0000-0001-8828-8472; ADAMS, SEAN/0000-0002-9515-2319	Canadian Institutes of Health Research [FDN 143278]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01DK078328-01]; U.S. Department of Agriculture, Agricultural Research Service [5306-51530-019-00, 6026-51000-010-5S]; Heart and Stroke Foundation of Canada Postdoctoral Fellowship; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078328] Funding Source: NIH RePORTER; ARS [ARS-0426492] Funding Source: Federal RePORTER	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Department of Agriculture, Agricultural Research Service(United States Department of Agriculture (USDA)USDA Agricultural Research Service); Heart and Stroke Foundation of Canada Postdoctoral Fellowship(Heart & Stroke Foundation of Canada); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	The authors acknowledge financial support from the Canadian Institutes of Health Research (FDN 143278; to M.E.H.), U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant R01DK078328-01 (to S.H.A., M.E.H., and O.F.), U.S. Department of Agriculture, Agricultural Research Service Intramural Projects 5306-51530-019-00 and 6026-51000-010-5S (to S.H.A.), and a Heart and Stroke Foundation of Canada Postdoctoral Fellowship (to C.A.). The authors thank M. Salkhordeh, J. Xuan, A. Daniels, M. Dysart, K. Kim (all from the University of Ottawa) and, M. Palazoglu, M. Atta, K. Cloos, and W. Tan (all from UC Davis) for technical assistance.	Aguer C, 2013, FASEB J, V27, P4213, DOI 10.1096/fj.13-234302; Anderson EJ, 2007, J BIOL CHEM, V282, P31257, DOI 10.1074/jbc.M706129200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bezaire V, 2005, FASEB J, V19, P977, DOI 10.1096/fj.04-2765fje; Bezaire V, 2007, FASEB J, V21, P312, DOI 10.1096/fj.06-6966rev; Boss O, 1997, FEBS LETT, V408, P39, DOI 10.1016/S0014-5793(97)00384-0; Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Clapham JC, 2000, NATURE, V406, P415, DOI 10.1038/35019082; Costford SR, 2008, AM J PHYSIOL-ENDOC M, V295, pE1018, DOI 10.1152/ajpendo.00779.2007; Enerback S, 1997, NATURE, V387, P90, DOI 10.1038/387090a0; Fiehn Oliver, 2007, V358, P3, DOI 10.1007/978-1-59745-244-1_1; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Goglia F, 2003, FASEB J, V17, P1585, DOI 10.1096/fj.03-0159hyp; LANOUE KF, 1971, METABOLISM, V20, P119, DOI 10.1016/0026-0495(71)90087-4; Lex A, 2014, NAT METHODS, V11, P779, DOI 10.1038/nmeth.3033; MacLellan JD, 2005, DIABETES, V54, P2343, DOI 10.2337/diabetes.54.8.2343; Mailloux RJ, 2013, TRENDS BIOCHEM SCI, V38, P592, DOI 10.1016/j.tibs.2013.09.001; Mailloux RJ, 2013, J BIOL CHEM, V288, P8365, DOI 10.1074/jbc.M112.442905; Mailloux RJ, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.393538; Mailloux RJ, 2011, J BIOL CHEM, V286, P21865, DOI 10.1074/jbc.M111.240242; Makinen KK, 2000, MED HYPOTHESES, V54, P603, DOI 10.1054/mehy.1999.0904; Mills EM, 2004, J MOL MED, V82, P787, DOI 10.1007/s00109-004-0591-7; Mills EM, 2003, NATURE, V426, P403, DOI 10.1038/426403a; Nabben M, 2011, FEBS LETT, V585, P4010, DOI 10.1016/j.febslet.2011.11.012; Nabben M, 2008, FEBS LETT, V582, P4147, DOI 10.1016/j.febslet.2008.11.016; Pecqueur C, 2001, J MOL MED, V79, P48, DOI 10.1007/s001090000150; Picard M, 2015, P NATL ACAD SCI USA, V112, pE6614, DOI 10.1073/pnas.1515733112; QUADFLIEG KH, 1976, Z ERNAHRUNGSWISS, V15, P345, DOI 10.1007/BF02020503; Riley CL, 2016, J PHYSIOL-LONDON, V594, P7455, DOI 10.1113/JP272971; Ronchi JA, 2013, FREE RADICAL BIO MED, V63, P446, DOI 10.1016/j.freeradbiomed.2013.05.049; Scholz M, 2007, PACIFIC SYMPOSIUM ON BIOCOMPUTING 2007, P169; Seifert EL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009834; Senese R, 2011, PFLUG ARCH EUR J PHY, V461, P153, DOI 10.1007/s00424-010-0892-3; Toime LJ, 2010, FREE RADICAL BIO MED, V49, P606, DOI 10.1016/j.freeradbiomed.2010.05.010; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	37	10	14	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					814	827		10.1096/fj.201600914R	http://dx.doi.org/10.1096/fj.201600914R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27871066	Green Published			2022-12-28	WOS:000394235400033
J	Crossland, H; Atherton, PJ; Stromberg, A; Gustafsson, T; Timmons, JA				Crossland, Hannah; Atherton, Philip J.; Stromberg, Anna; Gustafsson, Thomas; Timmons, James A.			A reverse genetics cell-based evaluation of genes linked to healthy human tissue age	FASEB JOURNAL			English	Article						epigenetic; neuromuscular; rapamycin; siRNA	EXTENDS LIFE-SPAN; CALORIC RESTRICTION; CD36 EXPRESSION; SKELETAL-MUSCLE; RESVERATROL; RAPAMYCIN; COMPLEX; ACTIVATORS; SURVIVAL; PROFILE	We recently developed a binary (i.e., young vs. old) classifier using human muscle RNA profiles that accurately distinguished the age of multiple tissue types. Pathway analysis did not reveal regulators of these 150 genes, so we used reverse genetics and pharmacologic methods to explore regulation of gene expression. Using small interfering RNA, well-studied age-related factors (i.e., rapamycin, resveratrol, TNF-alpha, and staurosporine), quantitative real-time PCR and clustering analysis, we studied gene-gene interactions in human skeletal muscle andrenal epithelial cells. Individual knockdown of 10 different age genes yielded a consistent pattern of gene expression in muscle and renal cells, similar to in vivo. Potential epigenetic interactions included HIST1H3E knockdown, leading to decreased PHF19 and PCDH9, and increased ICAM5 in muscle and renal cells, while ICAM5 knockdown reduced HIST1H3E expression. Resveratrol, staurosporine, and TNF-alpha significantly regulated the in vivo aging genes, while only rapamycin perturbed the healthy-age gene expression signature in a manner consistent with in vivo. In vitro coordination of gene expression for this in vivo tissue age signature indicates a degree of direct coordination, and the observed link with mTOR activity suggests a direct link between a robust biomarker of healthy neuromuscular age and a major axis of life span in model systems.-Crossland, H., Atherton, P. J., Stromberg, A., Gustafsson, T., Timmons, J. A. A reverse genetics cell-based evaluation of genes linked to healthy human tissue age.	[Crossland, Hannah; Timmons, James A.] Kings Coll London, Guys Hosp, Div Genet & Mol Med, 8th Floor,Tower Wing, London SE1 9RT, England; [Atherton, Philip J.] Univ Nottingham, Royal Derby Hosp, Sch Med, Derby, England; [Stromberg, Anna; Gustafsson, Thomas] Karolinska Univ Hosp, Clin Physiol, Dept Lab Med, Stockholm, Sweden	Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of Nottingham; Karolinska Institutet; Karolinska University Hospital	Timmons, JA (corresponding author), Kings Coll London, Guys Hosp, Div Genet & Mol Med, 8th Floor,Tower Wing, London SE1 9RT, England.	james.timmons@kcl.ac.uk	Timmons, James A/J-4698-2014; Timmons, James A/M-6350-2019; Gustafsson, Thomas/AAH-1056-2019; Crossland, Hannah/GMW-8128-2022	Timmons, James A/0000-0002-2255-1220; Timmons, James A/0000-0002-2255-1220; Atherton, Philip/0000-0002-7286-046X; Gustafsson, Thomas/0000-0002-1559-4206	Medical Research Council [G1100015]; MRC [G1100015] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported, in part, by a Medical Research Council grant (G1100015), studying muscle aging(to J.T.).	Ashok BT, 1999, EXP GERONTOL, V34, P293, DOI 10.1016/S0531-5565(99)00005-4; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Brien GL, 2012, NAT STRUCT MOL BIOL, V19, P1273, DOI 10.1038/nsmb.2449; Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; de Magalhaes JP, 2009, BIOINFORMATICS, V25, P875, DOI 10.1093/bioinformatics/btp073; Deelen J, 2011, AGING CELL, V10, P686, DOI 10.1111/j.1474-9726.2011.00705.x; Doonan R, 2008, GENE DEV, V22, P3236, DOI 10.1101/gad.504808; Edwards MG, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-80; Feser J, 2011, FEBS LETT, V585, P2041, DOI 10.1016/j.febslet.2010.11.016; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Glass D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r75; Greer EL, 2010, NATURE, V466, P383, DOI 10.1038/nature09195; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Hekimi S, 2011, TRENDS CELL BIOL, V21, P569, DOI 10.1016/j.tcb.2011.06.008; Horvath S, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-10-r115; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Kayo T, 2001, P NATL ACAD SCI USA, V98, P5093, DOI 10.1073/pnas.081061898; Keller P, 2011, J APPL PHYSIOL, V110, P46, DOI 10.1152/japplphysiol.00634.2010; Kim JY, 2002, P NATL ACAD SCI USA, V99, P7912, DOI 10.1073/pnas.122110199; Koonen DPY, 2007, CIRCULATION, V116, P2139, DOI 10.1161/CIRCULATIONAHA.107.712901; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu CY, 2004, P NATL ACAD SCI USA, V101, P11767, DOI 10.1073/pnas.0401588101; Miller RA, 2011, J GERONTOL A-BIOL, V66, P191, DOI 10.1093/gerona/glq178; Peleg S, 2010, SCIENCE, V328, P753, DOI 10.1126/science.1186088; Peter I, 2014, MED SCI SPORT EXER, V46, P302, DOI 10.1249/MSS.0b013e3182a66155; Peters MJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9570; Phillips BE, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003389; Picard E, 2010, AGING-US, V2, P981, DOI 10.18632/aging.100218; Pojednic RM, 2015, CALCIFIED TISSUE INT, V96, P256, DOI 10.1007/s00223-014-9932-x; Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406; Puig-Kroger A, 2006, J IMMUNOL, V177, P2107, DOI 10.4049/jimmunol.177.4.2107; Salminen A, 2012, AGING-US, V4, P166, DOI 10.18632/aging.100444; Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029; Scaffidi P, 2006, SCIENCE, V312, P1059, DOI 10.1126/science.1127168; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Siebold AP, 2010, P NATL ACAD SCI USA, V107, P169, DOI 10.1073/pnas.0907739107; Sood S, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0750-x; Timmers S, 2011, CELL METAB, V14, P612, DOI 10.1016/j.cmet.2011.10.002; van den Akker EB, 2014, AGING CELL, V13, P216, DOI 10.1111/acel.12160; Van Remmen H, 2003, PHYSIOL GENOMICS, V16, P29, DOI 10.1152/physiolgenomics.00122.2003; Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Zethelius B, 2008, NEW ENGL J MED, V358, P2107, DOI 10.1056/NEJMoa0707064	47	7	7	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					96	108		10.1096/fj.201600296RRR	http://dx.doi.org/10.1096/fj.201600296RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27698205	Green Published, hybrid			2022-12-28	WOS:000392177600012
J	Yuan, XX; Wei, G; You, YL; Huang, YY; Lee, HJ; Dong, M; Lin, J; Hu, T; Zhang, HL; Zhang, CH; Zhou, HQ; Ye, RC; Qi, XL; Zhai, BQ; Huang, WD; Liu, SN; Xie, W; Liu, QS; Liu, XM; Cui, CB; Li, DH; Zhan, JC; Cheng, J; Yuan, ZQ; Jin, WZ				Yuan, Xiaoxue; Wei, Gang; You, Yilin; Huang, Yuanyuan; Lee, Hyuek Jong; Dong, Meng; Lin, Jun; Hu, Tao; Zhang, Hanlin; Zhang, Chuanhai; Zhou, Huiqiao; Ye, Rongcai; Qi, Xiaolong; Zhai, Baiqiang; Huang, Weidong; Liu, Shunai; Xie, Wen; Liu, Qingsong; Liu, Xiaomeng; Cui, Chengbi; Li, Donghao; Zhan, Jicheng; Cheng, Jun; Yuan, Zengqiang; Jin, Wanzhu			Rutin ameliorates obesity through brown fat activation	FASEB JOURNAL			English	Article						brown adipose tissue; rutin; obesity; energy expenditure; mitochondria	ADIPOSE-TISSUE THERMOGENESIS; DIET-INDUCED OBESITY; GLUCOSE-HOMEOSTASIS; WHITE FAT; SIRT1; MOUSE; COLD; MITOCHONDRIA; INFLAMMATION; STIMULATION	Increasing energy expenditure through activation of brown adipose tissue (BAT) is a critical approach to treating obesity and diabetes. In this study, rutin, a natural compound extracted from mulberry and a drug used as a capillary stabilizer clinically for many years without any side effects, regulated whole-body energy metabolism by enhancing BAT activity. Rutin treatment significantly reduced adiposity, increased energy expenditure, and improved glucose homeostasis in both genetically obese (Db/Db) and diet-induced obesity (DIO) mice. Rutin also induced brown-like adipocyte (beige) formation in subcutaneous adipose tissue in both obesity mouse models. Mechanistically, we found that rutin directly bound to and stabilized SIRT1, leading to hypoacetylation of peroxisome proliferator-activated receptor gamma coactivator-1 alpha protein, which stimulated Tfam transactivation and eventually augmented the number of mitochondria and UCP1 activity in BAT. These findings reveal that rutin is a novel small molecule that activates BAT and may provide a novel therapeutic approach to the treatment of metabolic disorders.-Yuan, X., Wei, G., You, Y., Huang, Y., Lee, H. J., Dong, M., Lin, J., Hu, T., Zhang, H., Zhang, C., Zhou, H., Ye, R., Qi, X., Zhai, B., Huang, W., Liu, S., Xie, W., Liu, Q., Liu, X., Cui, C., Li, D., Zhan, J., Cheng, J., Yuan, Z., Jin, W. Rutin ameliorates obesity through brown fat activation.	[Yuan, Xiaoxue; Wei, Gang; Huang, Yuanyuan; Lee, Hyuek Jong; Dong, Meng; Lin, Jun; Hu, Tao; Zhang, Hanlin; Zhang, Chuanhai; Zhou, Huiqiao; Ye, Rongcai; Jin, Wanzhu] Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing 100101, Peoples R China; [Qi, Xiaolong; Yuan, Zengqiang] Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China; [Yuan, Xiaoxue; Wei, Gang; Huang, Yuanyuan; Dong, Meng; Lin, Jun; Hu, Tao; Zhou, Huiqiao; Ye, Rongcai; Qi, Xiaolong; Yuan, Zengqiang] Univ Chinese Acad Sci, Beijing, Peoples R China; [You, Yilin; Zhai, Baiqiang; Huang, Weidong; Zhan, Jicheng] China Agr Univ, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Coll Food Sci & Nutr Engn, Beijing, Peoples R China; [Liu, Shunai; Xie, Wen; Cheng, Jun] Capital Med Univ, Beijing Ditan Hosp, Inst Infect Dis, Beijing, Peoples R China; [Liu, Qingsong] Chinese Acad Sci, High Magnet Field Lab, Hefei, Peoples R China; [Liu, Xiaomeng] Zhoukou Normal Univ, Coll Life Sci, Zhoukou, Henan, Peoples R China; [Cui, Chengbi; Li, Donghao] Yanbian Univ, Key Lab Nat Resources Changbai Mt & Funct Mol, Minist Educ, Yanji, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; China Agricultural University; Capital Medical University; Chinese Academy of Sciences; Hefei Institutes of Physical Science, CAS; Zhoukou Normal University; Yanbian University	Jin, WZ (corresponding author), Chinese Acad Sci, Inst Zool, Key Lab Anim Ecol & Conservat Biol, Beijing 100101, Peoples R China.; Yuan, ZQ (corresponding author), Chinese Acad Sci, Inst Biophys, State Key Lab Brain & Cognit Sci, Beijing 100101, Peoples R China.	zqyuan@ibp.ac.cn; jinw@ioz.ac.cn	Zhang, Chuanhai/O-3137-2018; Lee, Hyuek Jong/AAP-9190-2021; Zhan, Jicheng/ABF-8501-2021; Jin, Wanzhu/B-5699-2012; xiaomeng, liu/GLN-4189-2022; Dong, Meng/AAI-6235-2021; Zhang, Chuanhai/N-6655-2019	Zhang, Chuanhai/0000-0001-7644-2436; Jin, Wanzhu/0000-0002-5860-2958; Zhang, Chuanhai/0000-0001-7644-2436; Yuan, Zengqiang/0000-0001-5739-2867; yuan, xiaoxue/0000-0002-2886-4703	Strategic Priority Research Program [XDB13030000]; Key Research Program [KJZD-EW-L01-3]; CAS, One Hundred Talents Program of the CAS; Ministry of Science and Technology of China [2012CBA01301, 2015CB943102, 2012CB944701]; National Natural Science Foundation of China [31171131, 81370951, 81500659]; National Basic Research Program of China [2012CB910701, 2013DFA31990]; Beijing Municipal Administration of Hospitals [ZYLX201402]; National "Twelfth Five-Year" Plan for Science and Technology Support Grants [2012BAD31B07, 2012BAD31B05]; Special Fund for Agro-scientific Research in the Public Interest Grant [201303073-2]	Strategic Priority Research Program(Chinese Academy of Sciences); Key Research Program; CAS, One Hundred Talents Program of the CAS; Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Beijing Municipal Administration of Hospitals; National "Twelfth Five-Year" Plan for Science and Technology Support Grants; Special Fund for Agro-scientific Research in the Public Interest Grant	The authors thank Dr. Ruiming Xu [Institute of Biophysics, Chinese Academy of Sciences (CAS)] for generously providing us with the SIRT1 proteins. This work was supported by the Strategic Priority Research Program XDB13030000 (to W.J.); Key Research Program KJZD-EW-L01-3 (to W.J.); CAS, One Hundred Talents Program of the CAS (to W.J.); Ministry of Science and Technology of China Grants 2012CBA01301, 2015CB943102, and 2012CB944701 (to W.J.); National Natural Science Foundation of China Grants 31171131 and 81370951 (to W.J.); National Basic Research Program of China Grants 2012CB910701 and 2013DFA31990 (to Z.Y.); National Natural Science Foundation of China Grant 81500659 (to X.L); Beijing Municipal Administration of Hospitals Grant ZYLX201402 (to J.C.); National "Twelfth Five-Year" Plan for Science and Technology Support Grants 2012BAD31B07 and 2012BAD31B05 (to W.H.); and Special Fund for Agro-scientific Research in the Public Interest Grant 201303073-2 (to J.Z.). The authors declare no conflicts of interest.	Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bartness TJ, 2010, INT J OBESITY, V34, pS36, DOI 10.1038/ijo.2010.182; Bostrom P, 2012, NATURE, V481, P463, DOI 10.1038/nature10777; Boutant M, 2015, MOL METAB, V4, P118, DOI 10.1016/j.molmet.2014.12.008; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cao DF, 2015, GENE DEV, V29, P1316, DOI 10.1101/gad.265462.115; Chalkiadaki A, 2012, CELL METAB, V16, P180, DOI 10.1016/j.cmet.2012.07.003; Chi QS, 2011, J COMP PHYSIOL B, V181, P91, DOI 10.1007/s00360-010-0506-6; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Gao MM, 2013, PHARM RES-DORDR, V30, P2940, DOI 10.1007/s11095-013-1125-1; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hsu CL, 2009, J AGR FOOD CHEM, V57, P425, DOI 10.1021/jf802715t; Hubbard BP, 2013, SCIENCE, V339, P1216, DOI 10.1126/science.1231097; Jin WZ, 2009, CLIN SCI, V116, P99, DOI 10.1042/CS20080090; Kajimura S, 2015, CELL METAB, V22, P546, DOI 10.1016/j.cmet.2015.09.007; Korkmaz A, 2010, J SURG RES, V164, P309, DOI 10.1016/j.jss.2009.03.022; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Larsson NG, 1997, MAMM GENOME, V8, P139, DOI 10.1007/s003359900373; Li R, 2012, REGUL PEPTIDES, V178, P16, DOI 10.1016/j.regpep.2012.06.002; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Liew CW, 2013, NAT MED, V19, P217, DOI 10.1038/nm.3056; Liu XM, 2015, ENDOCRINOLOGY, V156, P2461, DOI 10.1210/en.2014-1598; Liu XM, 2013, CELL RES, V23, P851, DOI 10.1038/cr.2013.64; LONCAR D, 1986, J ULTRA MOL STRUCT R, V97, P119, DOI 10.1016/S0889-1605(86)80012-X; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Matsushita M, 2014, INT J OBESITY, V38, P812, DOI 10.1038/ijo.2013.206; Andrade JMO, 2014, EUR J NUTR, V53, P1503, DOI 10.1007/s00394-014-0655-6; Ozawa Hikaru, 2003, Yakushigaku Zasshi, V38, P93; Pfannenberg C, 2010, DIABETES, V59, P1789, DOI 10.2337/db10-0004; Prince PSM, 2006, J BIOCHEM MOL TOXIC, V20, P96, DOI 10.1002/jbt.20117; Qiang L, 2012, CELL, V150, P620, DOI 10.1016/j.cell.2012.06.027; Ravussin E, 2011, ANNU REV NUTR, V31, P33, DOI 10.1146/annurev-nutr-072610-145209; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; Shabalina IG, 2013, CELL REP, V5, P1196, DOI 10.1016/j.celrep.2013.10.044; Sleeman MW, 2003, P NATL ACAD SCI USA, V100, P14297, DOI 10.1073/pnas.2335926100; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; TRAYHURN P, 1979, PFLUG ARCH EUR J PHY, V380, P227, DOI 10.1007/BF00582901; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Virtanen KA, 2009, NEW ENGL J MED, V361, P1123; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang S, 2015, INT J OBESITY, V39, P967, DOI 10.1038/ijo.2015.23; Whittle AJ, 2012, CELL, V149, P871, DOI 10.1016/j.cell.2012.02.066; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Xu C, 2013, AM J TRANSL RES, V5, P412; Yoneshiro T, 2013, J CLIN INVEST, V123, P3404, DOI 10.1172/JCI67803; You YL, 2015, FOOD FUNCT, V6, P401, DOI 10.1039/c4fo00719k; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	52	103	106	4	81	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					333	+		10.1096/fj.201600459RR	http://dx.doi.org/10.1096/fj.201600459RR			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	28049156				2022-12-28	WOS:000392177600031
J	Carrell, EM; Coppola, AR; McBride, HJ; Dirksen, RT				Carrell, Ellie M.; Coppola, Aundrea R.; McBride, Helen J.; Dirksen, Robert T.			Orai1 enhances muscle endurance by promoting fatigue-resistant type I fiber content but not through acute store-operated Ca2+ entry	FASEB JOURNAL			English	Article						development; exercise; myosin; skeletal muscle	SKELETAL-MUSCLE; FREQUENCY FATIGUE; CALCIUM-CHANNELS; GENE-EXPRESSION; MICE LACKING; CRAC CHANNEL; T-CELL; STIM1; MOUSE; RELEASE	Orai1 is a transmembrane protein that forms homomeric, calcium-selective channels activated by stromal interaction molecule 1 (STIM1) after depletion of intracellular calcium stores. In adult skeletal muscle, depletion of sarcoplasmic reticulum calcium activates STIM1/Orai1-dependent store-operated calcium entry. Here, we used constitutive and inducible muscle-specific Orai1-knockout (KO) mice to determine the acute and long-term developmental effects of Orai1 ablation on muscle structure and function. Skeletal muscles from constitutive, muscle specific Orai-KO mice exhibited normal postnatal growth and fiber type differentiation. However, a significant reduction in fiber cross-sectional area occurred by 3 mo of age, with the most profound reduction observed in oxidative, fatigue-resistant fiber types. Soleus muscles of constitutive Orai-KO mice exhibited a reduction in unique type I fibers, concomitant with an increase in hybrid fibers expressing both type I and type IIA myosins. Additionally, ex vivo force measurements showed reduced maximal specific force and in vivo exercise assays revealed reduced endurance in constitutive muscle-specific Orai-KO mice. Using tamoxifen-inducible, muscle specific Orai-KO mice, these functional deficits were found to be the result of the delayed fiber changes resulting from an early developmental loss of Orai1 and not the result of an acute loss of Orai1-dependent store-operated calcium entry.	[Carrell, Ellie M.; Dirksen, Robert T.] Univ Rochester, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA; [Coppola, Aundrea R.; McBride, Helen J.] Amgen Inc, Dept Inflammat Res, Thousand Oaks, CA 91320 USA	University of Rochester; Amgen	Dirksen, RT (corresponding author), Univ Rochester, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.	robert_dirksen@urmc.rochester.edu		McBride, Helen/0000-0003-3428-2846	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR059646]; M. D. Anderson Cancer Center [MDA275574]; National Science Foundation Graduate Research Fellowship Award [DGE-1419118]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059646] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); M. D. Anderson Cancer Center; National Science Foundation Graduate Research Fellowship Award(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases grant (AR059646 to R.T.D.), an M. D. Anderson Cancer Center grant (MDA275574 to R.T.D.), and a National Science Foundation Graduate Research Fellowship Award (DGE-1419118 to E.M.C.).	Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; BUTLERBROWNE GS, 1984, DEV BIOL, V102, P324, DOI 10.1016/0012-1606(84)90197-0; Chin ER, 1996, J PHYSIOL-LONDON, V491, P813, DOI 10.1113/jphysiol.1996.sp021259; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Cully TR, 2013, CLIN EXP PHARMACOL P, V40, P338, DOI 10.1111/1440-1681.12078; Darbellay B, 2009, J BIOL CHEM, V284, P5370, DOI 10.1074/jbc.M806726200; Dirksen RT, 2009, J PHYSIOL-LONDON, V587, P3139, DOI 10.1113/jphysiol.2009.172148; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dutka TL, 2005, AM J PHYSIOL-CELL PH, V289, pC1502, DOI 10.1152/ajpcell.00273.2005; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Germinario E, 2008, EUR J APPL PHYSIOL, V104, P445, DOI 10.1007/s00421-008-0796-5; Gupta Anu, 2013, Indian J Endocrinol Metab, V17, P913, DOI 10.4103/2230-8210.117215; Guzman R, 2014, J HISTOCHEM CYTOCHEM, V62, P864, DOI 10.1369/0022155414554926; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hakim CH, 2011, METHODS MOL BIOL, V709, P75, DOI 10.1007/978-1-61737-982-6_5; Hooper R, 2013, PFLUG ARCH EUR J PHY, V465, P1383, DOI 10.1007/s00424-013-1270-8; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Lacruz RS, 2015, ANN NY ACAD SCI, V1356, P45, DOI 10.1111/nyas.12938; Launikonis BS, 2010, PFLUG ARCH EUR J PHY, V460, P813, DOI 10.1007/s00424-010-0856-7; Li HL, 2010, J BIOL CHEM, V285, P39171, DOI 10.1074/jbc.M110.149690; Li TY, 2012, MOL CELL BIOL, V32, P3009, DOI 10.1128/MCB.06599-11; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; LYONS GE, 1991, DEVELOPMENT, V113, P1017; McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; McCullagh KJA, 2004, P NATL ACAD SCI USA, V101, P10590, DOI 10.1073/pnas.0308035101; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Somasundaram A, 2014, J NEUROSCI, V34, P9107, DOI 10.1523/JNEUROSCI.0263-14.2014; Srikanth S, 2013, MOL CELLS, V35, P182, DOI 10.1007/s10059-013-0073-2; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wei-LaPierre L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3805; Yarotskyy V, 2012, BIOPHYS J, V103, P202, DOI 10.1016/j.bpj.2012.06.001; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009; Zhang WenJun, 2011, Proceedings of the International Academy of Ecology and Environmental Sciences, V1, P1	41	30	31	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4109	4119		10.1096/fj.201600621R	http://dx.doi.org/10.1096/fj.201600621R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27587568	Green Published			2022-12-28	WOS:000388201500017
J	Hu, YB; Sosso, D; Qu, XQ; Chen, LQ; Ma, L; Chermak, D; Zhang, DC; Frommer, WB				Hu, Yi-Bing; Sosso, Davide; Qu, Xiao-Qing; Chen, Li-Qing; Ma, Lai; Chermak, Diane; Zhang, De-Chun; Frommer, Wolf B.			Phylogenetic evidence for a fusion of archaeal and bacterial SemiSWEETs to form eukaryotic SWEETs and identification of SWEET hexose transporters in the amphibian chytrid pathogen Batrachochytrium dendrobatidis	FASEB JOURNAL			English	Article						transporter evolution; oomycete; sugar transport; gene conversion; LECA	XANTHOMONAS-ORYZAE; GENE DUPLICATION; EVOLUTION; FAMILY; ORIGIN; NUTRITION; HOMOLOGS; SEQUENCE; LIMITS	SWEETs represent a new class of sugar transporters first described in plants, animals, and humans and later in prokaryotes. Plant SWEETs play key roles in phloem loading, seed filling, and nectar secretion, whereas the role of archaeal, bacterial, and animal transporters remains elusive. Structural analyses show that eukaryotic SWEETs are composed of 2 triple-helix bundles (THBs) fused via an inversion linker helix, whereas prokaryotic SemiSWEETs contain only a single THB and require homodimerization to form transport pores. This study indicates that SWEETs retained sugar transport activity in all kingdoms of life, and that SemiSWEETs are likely their ancestral units. Fusion of oligomeric subunits into single polypeptides during evolution of eukaryotes is commonly found for transporters. Phylogenetic analyses indicate that THBs of eukaryotic SWEETs may not have evolved by tandem duplication of an open reading frame, but rather originated by fusion between an archaeal and a bacterial SemiSWEET, which potentially explains the asymmetry of eukaryotic SWEETs. Moreover, despite the ancient ancestry, SWEETs had not been identified in fungi or oomycetes. Here, we report the identification of SWEETs in oomycetes as well as SWEETs and a potential SemiSWEET in primitive fungi. BdSWEET1 and BdSWEET2 from Batrachochytrium dendrobatidis, a nonhyphal zoosporic fungus that causes global decline in amphibians, showed glucose and fructose transport activities.-Hu, Y.-B., Sosso, D., Qu, X.-Q., Chen, L.-Q., Ma, L., Chermak, D., Zhang, D.-C., Frommer, W. B. Phylogenetic evidence for a fusion of archaeal and bacterial SemiSWEETs to form eukaryotic SWEETs and identification of SWEET hexose transporters in the amphibian chytrid pathogen Batrachochytrium dendrobatidis.	[Hu, Yi-Bing; Ma, Lai] Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; [Hu, Yi-Bing; Sosso, Davide; Qu, Xiao-Qing; Chen, Li-Qing; Chermak, Diane; Frommer, Wolf B.] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA; [Chen, Li-Qing] Univ Illinois, Dept Plant Biol, Urbana, IL USA; [Chen, Li-Qing] Univ Illinois, Carl R Woese Inst Genom Biol, Urbana, IL USA; [Zhang, De-Chun] China Three Gorges Univ, Biotechnol Res Ctr, Yichang, Peoples R China	Nanjing Agricultural University; Carnegie Institution for Science; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign; China Three Gorges University	Hu, YB (corresponding author), Nanjing Agr Univ, Coll Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China.; Frommer, WB (corresponding author), Stanford Univ, Dept Plant Biol, Carnegie Inst Sci, Stanford, CA 94305 USA.	huyb@njau.edu.cn; wfrommer@stanford.edu	Frommer, Wolf B/K-5042-2017; Frommer, Wolf B/A-8256-2008	Frommer, Wolf B/0000-0001-6465-0115; Frommer, Wolf B/0000-0001-6465-0115; Hu, Yibing/0000-0002-7835-2319	Natural Science Foundation of China [31371596]; State Key Laboratory of Soil and Sustainable Agricultural, Chinese Academy of Sciences [Y412201445]; Natural Science Foundation of Jiangsu Province [BK20151424]; Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy [DOE DE-FG02-04ER15542]; National Science Foundation [IOS-1258018]; Division Of Integrative Organismal Systems [1258018] Funding Source: National Science Foundation	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Soil and Sustainable Agricultural, Chinese Academy of Sciences; Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy(United States Department of Energy (DOE)); National Science Foundation(National Science Foundation (NSF)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the Natural Science Foundation of China (31371596), State Key Laboratory of Soil and Sustainable Agricultural, Chinese Academy of Sciences (Y412201445), and Natural Science Foundation of Jiangsu Province (BK20151424). Work in the laboratory of W.B.F. was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences, U.S. Department of Energy (Grant DOE DE-FG02-04ER15542) and the National Science Foundation (IOS-1258018). The authors thank Eckhard Boles (Goethe University, Frankfurt, Germany) for allowing the use of EBY4000. The authors declare no conflicts of interest.	Adams KL, 2003, MOL PHYLOGENET EVOL, V29, P380, DOI 10.1016/S1055-7903(03)00194-5; Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Chen HY, 2015, PLANT J, V83, P1046, DOI 10.1111/tpj.12948; Chen LQ, 2015, PLANT CELL, V27, P607, DOI 10.1105/tpc.114.134585; Chen LQ, 2012, SCIENCE, V335, P207, DOI 10.1126/science.1213351; Chen LQ, 2010, NATURE, V468, P527, DOI 10.1038/nature09606; Cheng Q, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1151; Cox CJ, 2008, P NATL ACAD SCI USA, V105, P20356, DOI 10.1073/pnas.0810647105; Da Lage JL, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-40; de Klein N, 2015, INT J GENOMICS, V2015, DOI 10.1155/2015/734147; Eom JS, 2015, CURR OPIN PLANT BIOL, V25, P53, DOI 10.1016/j.pbi.2015.04.005; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Feng L, 2015, TRENDS BIOCHEM SCI, V40, P480, DOI 10.1016/j.tibs.2015.05.005; Gietz R Daniel, 2006, Methods Mol Biol, V313, P107; Haas BJ, 2009, NATURE, V461, P393, DOI 10.1038/nature08358; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Irimia M, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a016071; Jezegou A, 2012, P NATL ACAD SCI USA, V109, pE3434, DOI 10.1073/pnas.1211198109; JONES DT, 1992, COMPUT APPL BIOSCI, V8, P275, DOI 10.1093/bioinformatics/8.3.275; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Koonin EV, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0333; Koonin EV, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-5-209; Koonin EV, 2010, CELL, V140, P606, DOI 10.1016/j.cell.2010.02.022; Lara E, 2010, PROTIST, V161, P116, DOI 10.1016/j.protis.2009.06.005; Le SQ, 2008, MOL BIOL EVOL, V25, P1307, DOI 10.1093/molbev/msn067; Lee Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7112; Lin IW, 2014, NATURE, V508, P1, DOI 10.1038/nature13082; Liu QS, 2011, PLANT CELL ENVIRON, V34, P1958, DOI 10.1111/j.1365-3040.2011.02391.x; Longcore JE, 1999, MYCOLOGIA, V91, P219, DOI 10.2307/3761366; Martin W, 2006, NATURE, V440, P41, DOI 10.1038/nature04531; Martin W, 1998, NATURE, V392, P37, DOI 10.1038/32096; McInerney JO, 2014, NAT REV MICROBIOL, V12, P449, DOI 10.1038/nrmicro3271; Moitra K, 2011, BIOL CHEM, V392, P29, DOI 10.1515/BC.2011.006; Moss AS, 2008, MYCOLOGIA, V100, P1, DOI 10.3852/mycologia.100.1.1; Patil G, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1730-y; Penny D, 2014, J MOL EVOL, V79, P228, DOI 10.1007/s00239-014-9643-y; Piotrowski JS, 2004, MYCOLOGIA, V96, P9, DOI 10.2307/3761981; Schell JC, 2014, MOL CELL, V56, P400, DOI 10.1016/j.molcel.2014.09.026; Sosso D, 2015, NAT GENET, V47, P1489, DOI 10.1038/ng.3422; Sun MX, 2013, PLANT REPROD, V26, P83, DOI 10.1007/s00497-012-0208-1; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tao YY, 2015, NATURE, V527, P259, DOI 10.1038/nature15391; Timmis JN, 2004, NAT REV GENET, V5, P123, DOI 10.1038/nrg1271; Voyles J, 2009, SCIENCE, V326, P582, DOI 10.1126/science.1176765; Wieczorke R, 1999, FEBS LETT, V464, P123, DOI 10.1016/S0014-5793(99)01698-1; Xiong J, 2015, SCI REP-UK, V5, DOI 10.1038/srep16724; Xu Y, 2014, NATURE, V515, P448, DOI 10.1038/nature13670; Xuan YH, 2013, P NATL ACAD SCI USA, V110, pE3685, DOI 10.1073/pnas.1311244110; [玄元虎 Xuan Yuanhu], 2014, [中国科学. 生命科学, Scientia Sinica Vitae], V44, P676; Yuan M, 2013, MOL PLANT, V6, P665, DOI 10.1093/mp/sst035; Yuan M, 2010, PLANT CELL, V22, P3164, DOI 10.1105/tpc.110.078022; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094210	53	23	24	1	34	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3644	3654		10.1096/fj.201600576R	http://dx.doi.org/10.1096/fj.201600576R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27411857				2022-12-28	WOS:000384329800031
J	Fang, XF; Poulsen, RR; Wang-Hu, J; Shi, O; Calvo, NS; Simmons, CS; Rivkees, SA; Wendler, CC				Fang, Xiefan; Poulsen, Ryan R.; Wang-Hu, John; Shi, Olivia; Calvo, Nicholas S.; Simmons, Chelsey S.; Rivkees, Scott A.; Wendler, Christopher C.			Knockdown of DNA methyltransferase 3a alters gene expression and inhibits function of embryonic cardiomyocytes	FASEB JOURNAL			English	Article						DNA methylation; cellular morphology; contractility; transcriptome	METHYLATION; DNMT3A; HEART; ASSOCIATION; PACKAGE	We previously found that in utero caffeine exposure causes down-regulation of DNA methyltransferases (DNMTs) in embryonic heart and results in impaired cardiac function in adulthood. To assess the role of DNMTs in these events, we investigated the effects of reduced DNMT expression on embryonic cardiomyocytes. siRNAs were used to knock down individual DNMT expression in primary cultures of mouse embryonic cardiomyocytes. Immunofluorescence staining was conducted to evaluate cell morphology. A video-based imaging assay and multielectrode array were used to assess cardiomyocyte contractility and electrophysiology, respectively. RNA-Seq and multiplex bisulfite sequencing were performed to examine gene expression and promoter methylation, respectively. At 72 h after transfection, reduced DNMT3a expression, but not DNMT1 or -3b, disrupted sarcomere assembly and decreased beating frequency, contractile movement, amplitude of field action potential, and cytosolic calcium signaling of cardiomyocytes. RNA-Seq analysis revealed that the DNMT3a-deficient cells had deactivated gene networks involved in calcium, endothelin-1, renin-angiotensin, and cardiac -adrenergic receptor signaling, which were not inhibited by DNMT3b siRNA. Moreover, decreased methylation levels were found in the promoters of Myh7, Myh7b, Tnni3, and Tnnt2, consistent with the up-regulation of these genes by DNMT3a siRNA. These data show that DNMT3a plays an important role in regulating embryonic cardiomyocyte gene expression, morphology and function.Fang, X., Poulsen, R. R., Wang-Hu, J., Shi, O., Calvo, N. S., Simmons, C. S., Rivkees, S. A., Wendler, C. C. Knockdown of DNA methyltransferase 3a alters gene expression and inhibits function of embryonic cardiomyocytes.	[Fang, Xiefan; Poulsen, Ryan R.; Wang-Hu, John; Shi, Olivia; Rivkees, Scott A.; Wendler, Christopher C.] Univ Florida, Coll Med, Dept Pediat, Child Hlth Res Inst, 1200 Newell Dr,ARB R1-148, Gainesville, FL 32610 USA; [Calvo, Nicholas S.; Simmons, Chelsey S.] Univ Florida, Coll Engn, Dept Mech & Aerosp Engn, Gainesville, FL 32611 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Wendler, CC (corresponding author), Univ Florida, Coll Med, Dept Pediat, Child Hlth Res Inst, 1200 Newell Dr,ARB R1-148, Gainesville, FL 32610 USA.	cwendler@ufl.edu	Simmons, Chelsey/AAG-8859-2020	Simmons, Chelsey/0000-0001-6973-9813	U.S. National Institutes of Health, National Institute of Child Health and Human Development [R01 HD058086]; Children's Miracle Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD058086] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Children's Miracle Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	The authors thank Dr. Jason Coleman (University of Florida) for technical assistance in analyzing the calcium signaling data. This work was supported by U.S. National Institutes of Health, National Institute of Child Health and Human Development Grant R01 HD058086 (to S.A.R. and C.C.W.), and by the Children's Miracle Network. Author contributions: X. Fang, S. Rivkees, and C. Wendler designed the research; X. Fang, J. Wang-Hu, O. Shi, and N. Calvo performed the research; X. Fang and R. R. Poulsen analyzed the data; X. Fang and C. Wendler wrote the paper; and N. Calvo and C. Simmons developed the software necessary to perform and record the experiments.	Akalin A, 2012, GENOME BIOL, V13, DOI [10.1186/gb-2012-13-10-R87, 10.1186/gb-2012-13-10-r87]; Akazawa H, 2003, CIRC RES, V92, P1079, DOI 10.1161/01.RES.0000072977.86706.23; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2012, GENOME RES, V22, P2008, DOI 10.1101/gr.133744.111; Burridge PW, 2014, AM J TRANSL RES, V6, P724; Buscariollo DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087547; Castillo P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044139; Chamberlain AA, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000976; Evans SM, 2010, CIRC RES, V107, P1428, DOI 10.1161/CIRCRESAHA.110.227405; Fang XF, 2015, AM J PHYSIOL-CELL PH, V309, pC425, DOI 10.1152/ajpcell.00058.2015; Fang XF, 2015, TOXICOL SCI, V146, P395, DOI 10.1093/toxsci/kfv105; Fang XF, 2014, AM J PHYSIOL-REG I, V307, pR1471, DOI 10.1152/ajpregu.00307.2014; Fang XF, 2013, ENVIRON TOXICOL PHAR, V36, P40, DOI 10.1016/j.etap.2013.02.014; Feng Y, 2013, J NUTR BIOCHEM, V24, P1373, DOI 10.1016/j.jnutbio.2012.11.005; Flores K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-480; Gilsbach R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6288; Goecks J, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-8-r86; Haas J, 2013, EMBO MOL MED, V5, P413, DOI 10.1002/emmm.201201553; Hu JL, 2016, ONCOL REP, V35, P1443, DOI 10.3892/or.2015.4480; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Janky R, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003731; Kass SU, 1997, TRENDS GENET, V13, P444, DOI 10.1016/S0168-9525(97)01268-7; Koczor CA, 2013, PHYSIOL GENOMICS, V45, P597, DOI 10.1152/physiolgenomics.00013.2013; Krueger F, 2011, BIOINFORMATICS, V27, P1571, DOI 10.1093/bioinformatics/btr167; Kuwahara K, 2012, J PHARMACOL SCI, V119, P198, DOI 10.1254/jphs.12R04CP; Lachance G, 2014, P NATL ACAD SCI USA, V111, P7783, DOI 10.1073/pnas.1322909111; Lei H, 1996, DEVELOPMENT, V122, P3195; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Savolainen SM, 2009, TOXICOL PATHOL, V37, P395, DOI 10.1177/0192623309335060; Sheng W, 2013, INT J MOL MED, V32, P694, DOI 10.3892/ijmm.2013.1427; Tao H, 2014, TOXICOLOGY, V323, P42, DOI 10.1016/j.tox.2014.06.006; Tatton-Brown K, 2014, NAT GENET, V46, P385, DOI 10.1038/ng.2917; van Berlo JH, 2013, J CLIN INVEST, V123, P37, DOI 10.1172/JCI62839; Vujic A, 2015, J MOL CELL CARDIOL, V82, P174, DOI 10.1016/j.yjmcc.2015.03.007; Xu SH, 2014, CURR PHARM DESIGN, V20, P1881, DOI 10.2174/13816128113199990527	39	20	20	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3238	3255		10.1096/fj.201600346R	http://dx.doi.org/10.1096/fj.201600346R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27306334	Green Published			2022-12-28	WOS:000382816300023
J	Marttila-Ichihara, F; Elima, K; Auvinen, K; Veres, TZ; Rantakari, P; Weston, C; Miyasaka, M; Adams, D; Jalkanen, S; Salmi, M				Marttila-Ichihara, Fumiko; Elima, Kati; Auvinen, Kaisa; Veres, Tibor Z.; Rantakari, Pia; Weston, Christopher; Miyasaka, Masayuki; Adams, David; Jalkanen, Sirpa; Salmi, Marko			Amine oxidase activity regulates the development of pulmonary fibrosis	FASEB JOURNAL			English	Article						IPF; AOC3 enzyme; myofibroblasts; reactive oxygen species	VASCULAR ADHESION PROTEIN-1; INTERSTITIAL LUNG-DISEASE; INNATE LYMPHOID-CELLS; MYOFIBROBLAST DIFFERENTIATION; IN-VIVO; FIBROGENIC RESPONSES; RESIDENT FIBROBLASTS; LEUKOCYTE MIGRATION; SMOOTH-MUSCLE; INFLAMMATION	In pulmonary fibrosis, an inflammatory reaction and differentiation of myofibroblasts culminate in pathologic deposition of collagen. Amine oxidase copper containing-3 (AOC3) is a cell-surface-expressed oxidase that regulates leukocyte extravasation. Here we analyzed the potential role of AOC3 using gene-modified and inhibitor-treatedmice in a bleomycin-induced pulmonary fibrosis model. Inflammation and fibrosis of lungswere assessed by histologic, flow cytometric, and quantitative PCR analysis. AOC3-deficient mice showed a 30-50% reduction in fibrosis, collagen synthesis, numbers ofmyofibroblasts, and accumulation of CD4(+) lymphocytes, NK T cells, macrophages, andtype 2 innate lymphoidcells compared with wild-type controlmice. AOC3-knock-inmice, which express a catalytically inactive form of AOC3, were also protected from lung fibrosis. In wild-type mice, a small-moleculeAOC3inhibitor treatment reduced leukocyte infiltration, myofibroblast differentiation, andfibrotic injury both in prophylactic and early therapeutic settings by about 50% but was unable to reverse the established fibrosis. AOC3 was also induced in myofibroblasts in human idiopathic pulmonary fibrosis. Thus, the oxidase activity of AOC3 contributes to the development of lung fibrosis mainly by regulating the accumulation of pathogenic leukocyte subtypes, which drive the fibrotic response.-Marttila-Ichihara, F., Elima, K., Auvinen, K., Veres, T. Z., Rantakari, P., Weston, C., Miyasaka, M., Adams, D., Jalkanen, S., Salmi, M. Amine oxidase activity regulates the development of pulmonary fibrosis.	[Marttila-Ichihara, Fumiko; Elima, Kati; Auvinen, Kaisa; Veres, Tibor Z.; Rantakari, Pia; Miyasaka, Masayuki; Jalkanen, Sirpa; Salmi, Marko] Univ Turku, MediC Res Lab, Tykistokatu 6 A, FIN-20520 Turku, Finland; [Elima, Kati] Univ Turku, Dept Med Biochem & Genet, Turku, Finland; [Jalkanen, Sirpa; Salmi, Marko] Univ Turku, Dept Med Microbiol & Immunol, Turku, Finland; [Weston, Christopher; Adams, David] Univ Birmingham, Ctr Liver Res, Birmingham, W Midlands, England; [Weston, Christopher; Adams, David] Univ Birmingham, NIHR Birmingham Biomed Res Unit, Birmingham, W Midlands, England; [Miyasaka, Masayuki] Osaka Univ, WPI Immunol Frontier Res Ctr, Suita, Osaka, Japan	University of Turku; University of Turku; University of Turku; University of Birmingham; University of Birmingham; Osaka University	Marttila-Ichihara, F (corresponding author), Univ Turku, MediC Res Lab, Tykistokatu 6 A, FIN-20520 Turku, Finland.	fumiko.marttila@utu.fi	Miyasaka, Masayuki/AAM-6343-2020; Adams, David H/C-9092-2009	Adams, David H/0000-0001-6776-0336; Weston, Chris/0000-0002-9651-1264; Rantakari, Pia/0000-0003-1638-5075	Finnish Academy; Sigrid Juselius Foundation; Medical Research Council [G0300101, MR/M009157/1, G0300102, MC_PC_14123, G0700301, G0802577, G0400496] Funding Source: researchfish; National Institute for Health Research [NF-SI-0616-10012, NF-SI-0512-10080] Funding Source: researchfish; MRC [MR/M009157/1, G0400496, G0300101, G0700301, G0300102, MC_PC_14123, G0802577] Funding Source: UKRI	Finnish Academy(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Finnish Academy and the Sigrid Juselius Foundation. The authors thank Biotie Therapies (Turku, Finland) for providing the SSAO knock-in mice; Joona Valtonen for advice; Heidi Gerke, Ruth Fair-Makela, Norma Jappinen, Emmi Lokka, and Laura Kahari for help with an animal experiment; and Sari Maki, Riikka Sjoroos, and Maritta Pohjansalo (all from MediCity Research Laboratory, University of Turku) for expert technical assistance.	Aalto K, 2011, BLOOD, V118, P3725, DOI 10.1182/blood-2010-09-311076; Ahluwalia N, 2014, AM J RESP CRIT CARE, V190, P867, DOI 10.1164/rccm.201403-0509PP; ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Barron L, 2016, AM J PATHOL, V186, P2519, DOI 10.1016/j.ajpath.2016.07.004; Bocchino M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014003; Bonder CS, 2005, IMMUNITY, V23, P153, DOI 10.1016/j.immuni.2005.06.007; Bono P, 1999, AM J PATHOL, V155, P1613, DOI 10.1016/S0002-9440(10)65477-6; Borthwick LA, 2013, BBA-MOL BASIS DIS, V1832, P1049, DOI 10.1016/j.bbadis.2012.09.014; Byers DE, 2013, J CLIN INVEST, V123, P3967, DOI 10.1172/JCI65570; Cai GQ, 2012, AM J PHYSIOL-LUNG C, V303, pL692, DOI 10.1152/ajplung.00390.2011; Della Latta V, 2015, PHARMACOL RES, V97, P122, DOI 10.1016/j.phrs.2015.04.012; Dunkel J, 2014, EUR J IMMUNOL, V44, P3232, DOI 10.1002/eji.201444563; Fischer A, 2012, LANCET, V380, P689, DOI 10.1016/S0140-6736(12)61079-4; Foot JS, 2013, J PHARMACOL EXP THER, V347, P365, DOI 10.1124/jpet.113.207613; Foot JS, 2012, BIOORG MED CHEM LETT, V22, P3935, DOI 10.1016/j.bmcl.2012.04.111; Hams E, 2014, P NATL ACAD SCI USA, V111, P367, DOI 10.1073/pnas.1315854111; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Henderson WR, 2007, J EXP MED, V204, P865, DOI 10.1084/jem.20070029; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hsia LT, 2016, P NATL ACAD SCI USA, V113, pE2162, DOI 10.1073/pnas.1603534113; Hung C, 2013, AM J RESP CRIT CARE, V188, P820, DOI 10.1164/rccm.201212-2297OC; Ishii T, 2006, EUR RESPIR J, V27, P300, DOI 10.1183/09031936.06.00090405; Jalkanen S, 2007, BLOOD, V110, P1864, DOI 10.1182/blood-2007-01-069674; Jarnicki AG, 2016, BRIT J PHARMACOL, V173, P3161, DOI 10.1111/bph.13573; Karikoski M, 2014, CLIN CANCER RES, V20, P6452, DOI 10.1158/1078-0432.CCR-14-1236; Katagiri D, 2016, KIDNEY INT, V89, P374, DOI 10.1038/ki.2015.327; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kiss J, 2008, EUR J IMMUNOL, V38, P3041, DOI 10.1002/eji.200838651; Kivi E, 2009, BLOOD, V114, P5385, DOI 10.1182/blood-2009-04-219253; Kliment CR, 2010, FREE RADICAL BIO MED, V49, P707, DOI 10.1016/j.freeradbiomed.2010.04.036; Koskinen K, 2004, BLOOD, V103, P3388, DOI 10.1182/blood-2003-09-3275; Langenbach SY, 2007, CAN J PHYSIOL PHARM, V85, P727, DOI 10.1139/Y07-065; Li D, 2014, J ALLERGY CLIN IMMUN, V134, P1422, DOI 10.1016/j.jaci.2014.05.011; Manoury B, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-11; Marttila-Ichihara F, 2006, ARTHRITIS RHEUM-US, V54, P2852, DOI 10.1002/art.22061; Marttila-Ichihara F, 2010, J IMMUNOL, V184, P3164, DOI 10.4049/jimmunol.0901794; Marttila-Ichihara F, 2009, CANCER RES, V69, P7875, DOI 10.1158/0008-5472.CAN-09-1205; Merinen M, 2005, AM J PATHOL, V166, P793, DOI 10.1016/S0002-9440(10)62300-0; Moeller A, 2008, INT J BIOCHEM CELL B, V40, P362, DOI 10.1016/j.biocel.2007.08.011; Nanthakumar CB, 2015, NAT REV DRUG DISCOV, V14, P693, DOI 10.1038/nrd4592; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nourshargh S, 2014, IMMUNITY, V41, P694, DOI 10.1016/j.immuni.2014.10.008; O'Rourke AM, 2008, J PHARMACOL EXP THER, V324, P867, DOI 10.1124/jpet.107.131672; Roybal JD, 2011, MOL CANCER RES, V9, P25, DOI 10.1158/1541-7786.MCR-10-0497; Salmi M, 2005, NAT REV IMMUNOL, V5, P760, DOI 10.1038/nri1705; SALMI M, 1992, SCIENCE, V257, P1407, DOI 10.1126/science.1529341; Salmi M, 2014, SEMIN IMMUNOPATHOL, V36, P163, DOI 10.1007/s00281-014-0417-9; Salter-Cid LM, 2005, J PHARMACOL EXP THER, V315, P553, DOI 10.1124/jpet.105.089649; Schilter HC, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0200-z; Schwaiblmair Martin, 2012, Open Respir Med J, V6, P63, DOI 10.2174/1874306401206010063; Smith DJ, 1998, J EXP MED, V188, P17, DOI 10.1084/jem.188.1.17; Spagnolo P, 2014, EXPERT REV CLIN IMMU, V10, P1005, DOI 10.1586/1744666X.2014.917050; Stolen CM, 2005, IMMUNITY, V22, P105, DOI 10.1016/j.immuni.2004.12.006; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Tumelty KE, 2014, J BIOL CHEM, V289, P2526, DOI 10.1074/jbc.M113.502617; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449; Watcharotayangul J, 2012, J NEUROCHEM, V123, P116, DOI 10.1111/j.1471-4159.2012.07950.x; Weber SC, 2011, PEDIATR RES, V70, P236, DOI 10.1203/PDR.0b013e318225f748; Weston CJ, 2015, J CLIN INVEST, V125, P501, DOI 10.1172/JCI73722; Williamson JD, 2015, EXP LUNG RES, V41, P57, DOI 10.3109/01902148.2014.979516; Wong M, 2014, AM J PHYSIOL-RENAL, V307, pF908, DOI 10.1152/ajprenal.00698.2013; Xu HL, 2006, J PHARMACOL EXP THER, V317, P19, DOI 10.1124/jpet.105.096958; Yanaba K, 2013, INT J RHEUM DIS, V16, P442, DOI 10.1111/1756-185X.12094; Yang SZ, 2013, FASEB J, V27, P2382, DOI 10.1096/fj.12-219493; Yu PH, 2006, AM J PATHOL, V168, P718, DOI 10.2353/ajpath.2006.050970	67	6	8	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2477	2491		10.1096/fj.201600935R	http://dx.doi.org/10.1096/fj.201600935R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28251930				2022-12-28	WOS:000401553400022
J	Lee, JH; Kang, M; Wang, H; Naik, G; Mobley, JA; Sonpavde, G; Garvey, WT; Darley-Usmar, VM; Ponnazhagan, S				Lee, Joo Hyoung; Kang, Minsung; Wang, Hong; Naik, Gurudatta; Mobley, James A.; Sonpavde, Guru; Garvey, W. Timothy; Darley-Usmar, Victor M.; Ponnazhagan, Selvarangan			Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress	FASEB JOURNAL			English	Article						androgen-deprivation therapy; reactive oxygen species; androgen receptor; glucocorticoid receptor; castration resistance	GLUCOCORTICOID-RECEPTOR; RESISTANCE; THERAPY; CELLS; MODEL; DIFFERENTIATION; ENZALUTAMIDE; CHEMOTHERAPY; DEPRIVATION; ABIRATERONE	Androgen-deprivation therapy has been identified to induce oxidative stress in prostate cancer (PCa), leading to reactivation of androgen receptor (AR) signaling in a hormone-refractory manner. Thus, antioxidant therapies have gained attention as adjuvants for castration-resistant PCa. Here, we report for the first time that human endostatin (ES) prevents androgen-independent growth phenotype in PCa cells through its molecular targeting of AR and glucocorticoid receptor (GR) and downstream pro-oxidant signaling. This reversal after ES treatment significantly decreased PCa cell proliferation through down-regulation of GR and up-regulation of manganese superoxide dismutase and reduced glutathione levels. Proteome and biochemical analyses of ES-treated PCa cells further indicated a significant up-regulation of enzymes in the major reactive oxygen species (ROS) scavenging machinery, including catalase, glutathione synthetase, glutathione reductase, NADPH-cytochrome P450 reductase, biliverdin reductase, and thioredoxin reductase, resulting in a concomitant reduction of intracellular ROS. ES further augmented the antioxidant system through up-regulation of glucose influx, the pentose phosphate pathway, and NAD salvaging pathways. This shift in cancer cell redox homeostasis by ES significantly decreased the effect of protumorigenic oxidative machinery on androgen-independent PCa growth, suggesting that ES can suppress GR-induced resistant phenotype upon AR antagonism and that the dual targeting action of ES on AR and GR can be further translated to PCa therapy.-Lee, J. H., Kang, M., Wang, H., Naik, G., Mobley, J. A., Sonpavde, G., Garvey, W. T., Darley-Usmar, V. M., Ponnazhagan, S. Endostatin inhibits androgen-independent prostate cancer growth by suppressing nuclear receptor-mediated oxidative stress.	[Lee, Joo Hyoung; Wang, Hong; Darley-Usmar, Victor M.; Ponnazhagan, Selvarangan] Univ Alabama Birmingham, Dept Pathol, Birmingham, AL 35294 USA; [Kang, Minsung; Garvey, W. Timothy] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL 35294 USA; [Naik, Gurudatta; Sonpavde, Guru] Univ Alabama Birmingham, Comprehens Canc Ctr, Birmingham, AL USA; [Mobley, James A.] Univ Alabama Birmingham, Dept Surg, Birmingham, AL 35294 USA; [Garvey, W. Timothy] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Ponnazhagan, S (corresponding author), Univ Alabama Birmingham, Dept Pathol, 1825 Univ Blvd,SHEL 814, Birmingham, AL 35294 USA.	pons@uab.edu	naik, Gurudatta/O-7284-2015; Sonpavde/L-7107-2019; Lee, Joo Hyoung/A-7713-2017	naik, Gurudatta/0000-0001-7265-6605; Sonpavde/0000-0002-1010-9611; Lee, Joo Hyoung/0000-0003-4450-3067; Darley-Usmar, Victor/0000-0001-8921-7086	U.S. National Institutes of Health, National Cancer Institute [R01CA184770, P30CA013148]; NATIONAL CANCER INSTITUTE [P30CA013148, R01CA184770] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U.S. National Institutes of Health, National Cancer Institute Grants R01CA184770 (to S.P.) and P30CA013148 (to J.A.M.). The authors thank UAB Mass Spectrometry/Proteomics Shared Facility for proteome analysis. The authors declare no conflicts of interest.	Abdollahi A, 2004, MOL CELL, V13, P649, DOI 10.1016/S1097-2765(04)00102-9; Acharya A, 2010, OXID MED CELL LONGEV, V3, P23, DOI 10.4161/oxim.3.1.10095; Antonarakis ES, 2014, NEW ENGL J MED, V371, P1028, DOI 10.1056/NEJMoa1315815; Arora VK, 2013, CELL, V155, P1309, DOI 10.1016/j.cell.2013.11.012; Attard G, 2016, LANCET, V387, P70, DOI 10.1016/S0140-6736(14)61947-4; Beer TM, 2014, NEW ENGL J MED, V371, P424, DOI 10.1056/NEJMoa1405095; Bjelakovic G, 2007, J Basic Clin Physiol Pharmacol, V18, P115; Bowlby SC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040195; Cha HR, 2016, PROSTATE, V76, P624, DOI 10.1002/pros.23155; Ciccarese C, 2016, CANCER TREAT REV, V43, P27, DOI 10.1016/j.ctrv.2015.12.003; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Godoy A, 2008, ENDOCRINOLOGY, V149, P2959, DOI 10.1210/en.2007-1078; Godoy A, 2011, AM J PHYSIOL-ENDOC M, V300, pE263, DOI 10.1152/ajpendo.00210.2010; Isayeva T, 2007, CANCER RES, V67, P5789, DOI 10.1158/0008-5472.CAN-06-3637; Isikbay M, 2014, HORM CANCER-US, V5, P72, DOI 10.1007/s12672-014-0173-2; Iuchi T, 2003, CIRC RES, V92, P81, DOI 10.1161/01.RES.0000050588.35034.3C; Kang MS, 2015, AM J PHYSIOL-CELL PH, V309, pC767, DOI 10.1152/ajpcell.00101.2015; Kassi E, 2011, CANCER LETT, V302, P1, DOI 10.1016/j.canlet.2010.10.020; Katsogiannou M, 2015, CANCER TREAT REV, V41, P588, DOI 10.1016/j.ctrv.2015.05.003; Khandrika L, 2009, CANCER LETT, V282, P125, DOI 10.1016/j.canlet.2008.12.011; Lee JH, 2015, P NATL ACAD SCI USA, V112, P1392, DOI 10.1073/pnas.1417660112; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig MR, 2016, PROTEOMICS, V16, P516, DOI 10.1002/pmic.201500133; Pelekanou V, 2016, J CELL BIOCHEM, V117, P2224, DOI 10.1002/jcb.25572; Raciti M, 2016, NEUROPHARMACOLOGY, V107, P422, DOI 10.1016/j.neuropharm.2016.03.022; Ripple MO, 1997, JNCI-J NATL CANCER I, V89, P40, DOI 10.1093/jnci/89.1.40; Ryan CJ, 2013, NEW ENGL J MED, V368, P138, DOI 10.1056/NEJMoa1209096; Sato H, 2010, J CLIN BIOCHEM NUTR, V47, P224, DOI 10.3164/jcbn.10-58; Sharifi N, 2008, CLIN CANCER RES, V14, P6073, DOI 10.1158/1078-0432.CCR-08-0591; Shiota M, 2012, ENDOCR-RELAT CANCER, V19, pR243, DOI 10.1530/ERC-12-0232; Shiota M, 2012, J UROLOGY, V187, P707, DOI 10.1016/j.juro.2011.09.147; Shiota M, 2011, FREE RADICAL BIO MED, V51, P1320, DOI 10.1016/j.freeradbiomed.2011.07.011; Spiers JG, 2015, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00456; Taplin ME, 2008, BJU INT, V101, P1084, DOI 10.1111/j.1464-410X.2008.07509.x; Teply BA, 2016, CURR OPIN ENDOCRINOL, V23, P279, DOI 10.1097/MED.0000000000000254; Thomas R, 2012, MOL CANCER THER, V11, P87, DOI 10.1158/1535-7163.MCT-11-0540; Wang S, 2015, MOL CANCER THER, V14, P1192, DOI 10.1158/1535-7163.MCT-14-0836; Wang TT, 2014, NEURON, V83, P616, DOI 10.1016/j.neuron.2014.07.003; Watson PA, 2015, NAT REV CANCER, V15, P701, DOI 10.1038/nrc4016; Xie N, 2015, INT J CANCER, V136, pE27, DOI 10.1002/ijc.29147; Yemelyanov A, 2007, ONCOGENE, V26, P1885, DOI 10.1038/sj.onc.1209991; You JM, 2009, CAN J PHYSIOL PHARM, V87, P440, DOI [10.1139/y09-027, 10.1139/Y09-027]	42	7	7	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1608	1619		10.1096/fj.201601178R	http://dx.doi.org/10.1096/fj.201601178R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28069826	Green Published			2022-12-28	WOS:000398504300027
J	Brocks, T; Fedorchenko, O; Schliermann, N; Stein, A; Moll, UM; Seegobin, S; Dewor, M; Hallek, M; Marquardt, Y; Fietkau, K; Heise, R; Huth, S; Pfister, H; Bernhagen, J; Bucala, R; Baron, JM; Fingerle-Rowson, G				Brocks, Tania; Fedorchenko, Oleg; Schliermann, Nicola; Stein, Astrid; Moll, Ute M.; Seegobin, Seth; Dewor, Manfred; Hallek, Michael; Marquardt, Yvonne; Fietkau, Katharina; Heise, Ruth; Huth, Sebastian; Pfister, Herbert; Bernhagen, Juergen; Bucala, Richard; Baron, Jens M.; Fingerle-Rowson, Guenter			Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin	FASEB JOURNAL			English	Article						skin carcinogenesis; chemokine; CD74; CD44; DMBA/TPA	ULTRAVIOLET-B RADIATION; FACTOR MIF; DENDRITIC CELLS; LANGERHANS CELLS; RECEPTOR COMPLEX; DNA-DAMAGE; T-CELLS; CANCER; EXPRESSION; INFLAMMATION	The response of the skin to harmful environmental agents is shaped decisively by the status of the immune system. Keratinocytes constitutively express and secrete the chemokine-like mediator, macrophage migration inhibitory factor (MIF), more strongly than dermal fibroblasts, thereby creating a MIF gradient in skin. By using global and epidermis-restricted Mif-knockout (Mif(-1-) and K14-Cre(+ltg) ;Mif(fllft)) mice, we found that MIF both recruits and maintains antigen-presenting cells in the dermis/epidermis. The reduced presence of antigen-presenting cells in the absence of MIF was associated with accelerated and increased formation of nonmelanoma skin tumors during chemical carcinogenesis. Our results demonstrate that MIF is essential for maintaining innate immunity in skin. Loss of keratinocyte-derived MIF leads to a loss of control of epithelial skin tumor formation in chemical skin carcinogenesis, which highlights an unexpected tumor-suppressive activity of MIF in murine skin.- Brocks, T., Fedorchenko, O., Schliermann, N., Stein, A., Moll, U. M., Seegobin, S., Dewor, M., Hallek, M., Marquardt, Y., Fietkau, K., Heise, R., Huth, S., Pfister, H., Bernhagen, J., Bucala, R., Baron, J. M., Fingerle-Rowson, G. Macrophage migration inhibitory factor protects from nonmelanoma epidermal tumors by regulating the number of antigen-presenting cells in skin.	[Brocks, Tania; Fedorchenko, Oleg; Schliermann, Nicola; Hallek, Michael; Fingerle-Rowson, Guenter] Univ Hosp, Dept Internal Med 1, Kerpener Str 62, D-50937 Cologne, Germany; [Stein, Astrid] Univ Hosp, Inst Pathol & Cytol, Cologne, Germany; [Pfister, Herbert] Univ Hosp, Inst Virol, Cologne, Germany; [Brocks, Tania; Fedorchenko, Oleg; Schliermann, Nicola; Hallek, Michael; Fingerle-Rowson, Guenter] Ctr Integrated Oncol Koln Bonn, Cologne, Germany; [Moll, Ute M.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Moll, Ute M.] Georg August Univ, Gottingen Ctr Mol Biosci, Dept Mol Oncol, Ernst Caspari Haus, Gottingen, Germany; [Seegobin, Seth] Guys Hosp, Kings Coll London, Sch Med, Dept Med & Mol Genet, London, England; [Dewor, Manfred; Bernhagen, Juergen] Rhein Westfal TH Aachen, Inst Biochem & Mol Cell Biol, Aachen, Germany; [Marquardt, Yvonne; Fietkau, Katharina; Heise, Ruth; Huth, Sebastian; Baron, Jens M.] Rhein Westfal TH Aachen, Dept Dermatol, Aachen, Germany; [Bernhagen, Juergen] Ludwig Maximilians Univ Munchen, Klinikum Univ Munchen, Inst Stroke & Dementia Res, Dept Vasc Biol, Munich, Germany; [Bernhagen, Juergen] Munich Cluster Syst Neurol SyNergy, Munich, Germany; [Bucala, Richard] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA	University of Cologne; University of Cologne; University of Cologne; University of Cologne; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of Gottingen; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; RWTH Aachen University; RWTH Aachen University; University of Munich; University of Munich; Yale University	Fingerle-Rowson, G (corresponding author), Univ Hosp, Dept Internal Med 1, Kerpener Str 62, D-50937 Cologne, Germany.	g.fingerle-rowson@gmx.de	Baron, Jens M/N-2934-2016; Hallek, Michael/Y-3191-2019; Fedorchenko, Oleg/AAA-6533-2021	Baron, Jens M/0000-0002-1174-6946; Hallek, Michael/0000-0002-7425-4455; 	Deutsche Forschungsgemeinschaft (German Research Council) [Fi 712/2, BA1803/7-1, BE1977/4-2, SFB1123-A03, SFB 832]; German Jose Carreras Leukemia Foundation [R06/20, AI042310]; START programs of the Medical Faculty of the Rheinisch-Westfalische Technische Hochschule Aachen; NATIONAL CANCER INSTITUTE [P30CA016359] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI042310, R56AI042310] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (German Research Council)(German Research Foundation (DFG)); German Jose Carreras Leukemia Foundation; START programs of the Medical Faculty of the Rheinisch-Westfalische Technische Hochschule Aachen; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank Prof. A. Sharpe (Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA) for helping with BALB/c blastocyst injections and the generation of chimaeric conditional MIF mice. The K14-Cre transgenic mice were obtained from Drs. C. Niessen and A. Roers (University Hospital Cologne), and from Prof. Dr. I. Forster (University of Dusseldorf, Dusseldorf, Germany). This work was supported by the Deutsche Forschungsgemeinschaft (German Research Council) Grant Fi 712/2 (to G.F.-R.), Grant BA1803/7-1 (to J.M.B.), Grant BE1977/4-2 and SFB1123-A03 (to J.B.), Grant A16 of SFB 832 (to M.H.), Grant R06/20 of the German Jose Carreras Leukemia Foundation (to G.F.-R.), Grant AI042310 (to R.B.), and by the START programs of the Medical Faculty of the Rheinisch-Westfalische Technische Hochschule Aachen (to J.M.B., R.H., and J.B.). The authors declare no conflicts of interest.	Allen SJ, 2007, ANNU REV IMMUNOL, V25, P787, DOI 10.1146/annurev.immunol.24.021605.090529; Bernhagen J, 1996, J EXP MED, V183, P277, DOI 10.1084/jem.183.1.277; Bernhagen J, 2007, NAT MED, V13, P587, DOI 10.1038/nm1567; Bifulco C, 2008, CURR PHARM DESIGN, V14, P3790, DOI 10.2174/138161208786898608; Bucala R, 2007, IMMUNITY, V26, P281, DOI 10.1016/j.immuni.2007.03.005; Conroy H, 2010, QJM-INT J MED, V103, P831, DOI 10.1093/qjmed/hcq148; Cornelissen C, 2011, BRIT J DERMATOL, V165, P966, DOI 10.1111/j.1365-2133.2011.10487.x; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Feijoo E, 2005, INT J CANCER, V116, P275, DOI 10.1002/ijc.21046; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Fingerle-Rowson G, 2003, AM J PATHOL, V162, P47, DOI 10.1016/S0002-9440(10)63797-2; Gilliver SC, 2011, EXP DERMATOL, V20, P1, DOI 10.1111/j.1600-0625.2010.01194.x; Girardi M, 2003, J EXP MED, V198, P747, DOI 10.1084/jem.20021282; Gore Y, 2008, J BIOL CHEM, V283, P2784, DOI 10.1074/jbc.M703265200; Greven D, 2010, EXPERT OPIN THER TAR, V14, P253, DOI 10.1517/14728220903551304; Hafner M, 2004, GENESIS, V38, P176, DOI 10.1002/gene.20016; Heise R, 2012, PHOTOCHEM PHOTOBIOL, V88, P1157, DOI 10.1111/j.1751-1097.2012.01108.x; Honda A, 2009, CARCINOGENESIS, V30, P1597, DOI 10.1093/carcin/bgp160; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Imhof BA, 2004, NAT REV IMMUNOL, V4, P432, DOI 10.1038/nri1375; Kabashima K, 2007, AM J PATHOL, V171, P1249, DOI 10.2353/ajpath.2007.070225; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; Koch S, 2006, J ALLERGY CLIN IMMUN, V117, P163, DOI 10.1016/j.jaci.2005.10.003; Leng L, 2003, J EXP MED, V197, P1467, DOI 10.1084/jem.20030286; Lewis J, 2010, TRENDS IMMUNOL, V31, P460, DOI 10.1016/j.it.2010.10.001; Lue H, 2007, ONCOGENE, V26, P5046, DOI 10.1038/sj.onc.1210318; Lue HQ, 2006, CELL SIGNAL, V18, P688, DOI 10.1016/j.cellsig.2005.06.013; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Martin J, 2009, FASEB J, V23, P720, DOI 10.1096/fj.08-119628; Mitchell RA, 2002, P NATL ACAD SCI USA, V99, P345, DOI 10.1073/pnas.012511599; Modi BG, 2012, SCIENCE, V335, P104, DOI 10.1126/science.1211600; MOON D C, 1992, Journal of Dermatology (Tokyo), V19, P146; Mueller MM, 2006, EUR J CANCER, V42, P735, DOI 10.1016/j.ejca.2006.01.014; Muller WA, 2001, J EXP MED, V194, pF47, DOI 10.1084/jem.194.9.f47; Neis MM, 2010, SKIN PHARMACOL PHYS, V23, P29, DOI 10.1159/000257261; Petrenko O, 2005, MOL CELL, V17, P225, DOI 10.1016/j.molcel.2004.11.052; Petrenko O, 2003, J BIOL CHEM, V278, P11078, DOI 10.1074/jbc.M211985200; Randolph GJ, 2008, ANNU REV IMMUNOL, V26, P293, DOI 10.1146/annurev.immunol.26.021607.090254; Reinart N, 2013, BLOOD, V121, P812, DOI 10.1182/blood-2012-05-431452; Roberts SJ, 2007, P NATL ACAD SCI USA, V104, P6770, DOI 10.1073/pnas.0604982104; RUGGERI B, 1993, P NATL ACAD SCI USA, V90, P1013, DOI 10.1073/pnas.90.3.1013; Santos LL, 2011, ARTHRITIS RHEUM-US, V63, P960, DOI 10.1002/art.30203; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Schaper ID, 2005, CANCER RES, V65, P1394, DOI 10.1158/0008-5472.CAN-04-3263; Schulz R, 2012, J EXP MED, V209, P275, DOI 10.1084/jem.20111117; Shi XR, 2006, IMMUNITY, V25, P595, DOI 10.1016/j.immuni.2006.08.020; Shimizu T, 1999, J INVEST DERMATOL, V112, P210, DOI 10.1046/j.1523-1747.1999.00486.x; Shimizu T, 2005, J DERMATOL SCI, V37, P65, DOI 10.1016/j.jdermsci.2004.08.007; Shimizu T, 2003, EUR J IMMUNOL, V33, P1478, DOI 10.1002/eji.200323751; Shimizu T, 1996, FEBS LETT, V381, P199, DOI 10.1016/0014-5793(96)00120-2; Sperling T, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002833; Talos F, 2005, CELL DEATH DIFFER, V12, P1319, DOI 10.1038/sj.cdd.4401653; Taylor JA, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-135; Timares L, 2008, PHOTOCHEM PHOTOBIOL, V84, P422, DOI 10.1111/j.1751-1097.2007.00284.x; Vesely MD, 2011, ANNU REV IMMUNOL, V29, P235, DOI 10.1146/annurev-immunol-031210-101324; Wang LC, 2008, J IMMUNOL, V180, P4722, DOI 10.4049/jimmunol.180.7.4722; Weber C, 2008, P NATL ACAD SCI USA, V105, P16278, DOI 10.1073/pnas.0804017105; Wilson JM, 2005, GASTROENTEROLOGY, V129, P1485, DOI 10.1053/j.gastro.2005.07.061; Yoshihisa Y, 2011, J INVEST DERMATOL, V131, P925, DOI 10.1038/jid.2010.418; Zhang SL, 1998, P NATL ACAD SCI USA, V95, P2429, DOI 10.1073/pnas.95.5.2429	60	14	14	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					526	543		10.1096/fj.201600860R	http://dx.doi.org/10.1096/fj.201600860R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27825106	Green Published			2022-12-28	WOS:000394235400009
J	Carnemolla, R; Villa, CH; Greineder, CF; Zaitsev, S; Patel, KR; Kowalska, MA; Atochin, DN; Cines, DB; Siegel, DL; Esmon, CT; Muzykantov, VR				Carnemolla, Ronald; Villa, Carlos H.; Greineder, Colin F.; Zaitsev, Sergei; Patel, Kruti R.; Kowalska, M. Anna; Atochin, Dmitriy N.; Cines, Douglas B.; Siegel, Don L.; Esmon, Charles T.; Muzykantov, Vladimir R.			Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury	FASEB JOURNAL			English	Article						sepsis; inflammation; coagulation; pharmacokinetics; drug delivery	ACTIVATED PROTEIN-C; HUMAN SOLUBLE THROMBOMODULIN; DISSEMINATED INTRAVASCULAR COAGULATION; REDUCES INFARCT VOLUME; LECTIN-LIKE DOMAIN; SEVERE SEPSIS; MEMBRANE RIGIDITY; FUSION PROTEIN; IN-VITRO; THROMBOSIS	Endothelial thrombomodulin (TM) regulates coagulation and inflammation via several mechanisms, including production of activated protein C (APC). Recombinant APC and soluble fragments of TM (sTM) have been tested in settings associated with insufficiency of the endogenous TM/APC pathway, such as sepsis. We previously designed a fusion protein of TM [single-chain variable fragment antibody (scFv)/TM] targeted to red blood cells (RBCs) to improve pharmacokinetics and antithrombotic effects without increasing bleeding. Here, scFv/TM was studied in mouse models of systemic inflammation and ischemia-reperfusion injury. Injected concomitantly with or before endotoxin, scFv/TM provided more potent protection against liver injury and release of pathological mediators than sTM, showing similar efficacy at up to 50-fold lower doses. scFv/TM provided protection when injected after endotoxin, whereas sTM did not, and augmented APC production by thrombin similar to 50-fold more than sTM. However, scFv/TM injected after endotoxin did not reduce thrombin/antithrombin complexes; nor did antibodies that block APC anticoagulant activity suppress the prophylactic anti-inflammatory effect of scFv/TM. Therefore, similar to endogenous TM, RBC-anchored scFv/TM activates several protective pathways. Finally, scFv/TM was more effective at reducing cerebral infarct volume and alleviated neurological deficits than sTM after cerebral ischemia/reperfusion injury. These results indicate that RBC-targeted scFv/TM exerts multifaceted cytoprotective effects and may find utility in systemic and focal inflammatory and ischemic disorders.	[Carnemolla, Ronald; Villa, Carlos H.; Greineder, Colin F.; Zaitsev, Sergei; Muzykantov, Vladimir R.] Univ Penn, Perelman Sch Med, Dept Pharmacol, Philadelphia, PA 19104 USA; [Carnemolla, Ronald; Villa, Carlos H.; Greineder, Colin F.; Zaitsev, Sergei; Esmon, Charles T.; Muzykantov, Vladimir R.] Univ Penn, Ctr Targeted Therapeut & Translat Nanomed, Inst Translat Med & Therapeut, Philadelphia, PA 19104 USA; [Villa, Carlos H.; Zaitsev, Sergei; Cines, Douglas B.; Siegel, Don L.] Univ Penn, Dept Pathol, Philadelphia, PA 19104 USA; [Villa, Carlos H.; Zaitsev, Sergei; Cines, Douglas B.; Siegel, Don L.] Univ Penn, Lab Med, Philadelphia, PA 19104 USA; [Patel, Kruti R.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Kowalska, M. Anna] Childrens Hosp Philadelphia, Dept Pediat, Div Hematol, Philadelphia, PA 19104 USA; [Kowalska, M. Anna] Polish Acad Sci, Inst Med Biol, Lodz, Poland; [Atochin, Dmitriy N.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Div Cardiol, Charlestown, MA USA; [Esmon, Charles T.] Oklahoma Med Res Fdn, Dept Pathol, Oklahoma City, OK USA; [Esmon, Charles T.] Oklahoma Med Res Fdn, Dept Biochem & Mol Biol, Coagulat Biol Lab, Oklahoma City, OK USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Pennsylvania; Harvard University; Brigham & Women's Hospital; University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia; Polish Academy of Sciences; Institute of Medical Biology of the Polish Academy of Sciences; Harvard University; Massachusetts General Hospital; Oklahoma Medical Research Foundation; Oklahoma Medical Research Foundation	Muzykantov, VR (corresponding author), Univ Penn, Perelman Sch Med, TRC 10-125,3400 Civ Ctr Blvd,Bldg 421, Philadelphia, PA 19104 USA.	muzykant@mail.med.upenn.edu	Atochin, Dmitriy/Q-3150-2016; Atochin, Dmitriy/AAH-8843-2020	Cines, Douglas/0000-0001-5986-504X; Atochin, Dmitriy/0000-0002-2405-2070; Patel, Kruti/0000-0002-4303-8717; Greineder, Colin/0000-0001-9740-7672	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01 HL121134, R01 HL125462, R01 HL116916-01, R01 HL091950, K08-HL 130430, 7UM1 HL120877-TACTIC]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007439, R01HL121134, R01HL116916, K08HL130430, T32HL007775, R01HL125462, T32HL007971, R01HL091950, UM1HL120877] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. Mortimer Poncz, The Children's Hospital of Philadelphia, for his scientific counsel and support of the study. This work was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants R01 HL121134, R01 HL125462, R01 HL116916-01, R01 HL091950, K08-HL 130430, and 7UM1 HL120877-TACTIC. The authors declare no conflicts of interest.	Abeyama K, 2005, J CLIN INVEST, V115, P1267, DOI 10.1172/JCI200522782; Aikawa N, 2011, SHOCK, V35, P349, DOI 10.1097/SHK.0b013e318204c019; Andreou AP, 2011, J THROMB HAEMOST, V9, P1171, DOI 10.1111/j.1538-7836.2011.04292.x; Angus DC, 2012, CRIT CARE, V16, DOI 10.1186/cc11152; Annane D, 2013, AM J RESP CRIT CARE, V187, P1091, DOI 10.1164/rccm.201211-2020OC; Atochin DN, 2016, NEUROSCI LETT, V618, P45, DOI 10.1016/j.neulet.2016.02.033; Bernard GR, 2001, NEW ENGL J MED, V344, P699, DOI 10.1056/NEJM200103083441001; Bongoni AK, 2016, TRANSPLANTATION, V100, P1871, DOI 10.1097/TP.0000000000001188; Bouwens EAM, 2013, J THROMB HAEMOST, V11, P242, DOI 10.1111/jth.12247; Carnemolla R, 2013, J PHARMACOL EXP THER, V347, P339, DOI 10.1124/jpet.113.205104; Carnemolla R, 2012, J IMMUNOL METHODS, V384, P21, DOI 10.1016/j.jim.2012.06.012; Chan SH, 2006, INT J CARDIOL, V111, P280, DOI 10.1016/j.ijcard.2005.09.015; CHASIS JA, 1985, J CLIN INVEST, V75, P1919, DOI 10.1172/JCI111907; Conway EM, 2012, SEMIN IMMUNOPATHOL, V34, P107, DOI 10.1007/s00281-011-0282-8; Delvaeye M, 2009, NEW ENGL J MED, V361, P345, DOI 10.1056/NEJMoa0810739; Dietrich S, 2013, BIOL BLOOD MARROW TR, V19, P22, DOI 10.1016/j.bbmt.2012.09.018; Ding BS, 2009, AM J RESP CRIT CARE, V180, P247, DOI 10.1164/rccm.200809-1433OC; Esmon CT, 2004, J THROMB HAEMOST, V2, P209, DOI 10.1046/j.1538-7933.2003.00537.x; Esmon CT, 2001, CRIT CARE MED, V29, pS48, DOI 10.1097/00003246-200107001-00018; Faust SN, 2001, CRIT CARE MED, V29, pS62, DOI 10.1097/00003246-200107001-00022; Fink MP, 2013, CRIT CARE MED, V41, P2221, DOI 10.1097/CCM.0b013e3182964037; Ganguly K, 2005, J PHARMACOL EXP THER, V312, P1106, DOI 10.1124/jpet.104.075770; Ganguly K, 2007, J PHARMACOL EXP THER, V321, P158, DOI 10.1124/jpet.106.114405; Geiger H, 2012, NAT MED, V18, P1123, DOI 10.1038/nm.2813; Greineder CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080110; Hanly AM, 2007, SEMIN THROMB HEMOST, V33, P673, DOI 10.1055/s-2007-991969; Ikezoe T, 2015, BONE MARROW TRANSPL, V50, P113, DOI 10.1038/bmt.2014.208; Ito T, 2011, J THROMB HAEMOST, V9, P168, DOI 10.1111/j.1538-7836.2011.04319.x; Ito T, 2008, ARTERIOSCL THROM VAS, V28, P1825, DOI 10.1161/ATVBAHA.107.150631; Khoory J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0141206; Laszik ZG, 2001, AM J PATHOL, V159, P797, DOI 10.1016/S0002-9440(10)61753-1; Lattenist L, 2015, THROMB RES, V136, P1325, DOI 10.1016/j.thromres.2015.11.004; Levi M, 2015, J THROMB HAEMOST, V13, P505, DOI 10.1111/jth.12868; Li YH, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-34; Liaw PCY, 2003, J THROMB HAEMOST, V1, P662, DOI 10.1046/j.1538-7836.2003.00153.x; Ma CY, 2015, J IMMUNOL, V194, P1905, DOI 10.4049/jimmunol.1400923; Marti-Carvajal AJ, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004388.pub5; Morris GP, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148503; Morser J, 2012, CURR DRUG TARGETS, V13, P421, DOI 10.2174/138945012799424606; Mosnier LO, 2007, BLOOD, V109, P3161, DOI 10.1182/blood-2006-09-003004; Moxon CA, 2015, J THROMB HAEMOST, V13, P1653, DOI 10.1111/jth.13060; Murciano JC, 2003, NAT BIOTECHNOL, V21, P891, DOI 10.1038/nbt846; Murciano JC, 2009, J CONTROL RELEASE, V139, P190, DOI 10.1016/j.jconrel.2009.07.003; Opal SM, 2013, AM J RESP CRIT CARE, V187, P1041, DOI 10.1164/rccm.201303-0505ED; PAULITSCHKE M, 1995, BLOOD, V86, P342, DOI 10.1182/blood.V86.1.342.bloodjournal861342; Pawlinski R, 2010, BLOOD, V116, P806, DOI 10.1182/blood-2009-12-259267; Ranieri VM, 2012, NEW ENGL J MED, V366, P2055, DOI 10.1056/NEJMoa1202290; Rao LVM, 2014, BLOOD, V124, P1553, DOI 10.1182/blood-2014-05-578328; Ryang YM, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-113; Sapru A, 2015, INTENS CARE MED, V41, P470, DOI 10.1007/s00134-015-3648-x; Schouten M, 2015, THROMB RES, V135, P537, DOI 10.1016/j.thromres.2014.12.020; Shbaklo H, 2009, THROMB HAEMOSTASIS, V101, P505, DOI 10.1160/TH08-08-0511; Shuvaev VV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077002; Su EJ, 2011, J THROMB HAEMOST, V9, P1174, DOI 10.1111/j.1538-7836.2011.04269.x; Sun P, 2013, WORLD J EMERG MED, V4, P210, DOI [10.5847/wjem.j.issn.1920-8642.2013.03.010, 10.5847/wjem.j.1920-8642.2013.03.010]; Suyama K, 2015, NEPHROL DIAL TRANSPL, V30, P969, DOI 10.1093/ndt/gfv004; Tanaka J, 2013, BRIT J PHARMACOL, V170, P1233, DOI 10.1111/bph.12396; Tanemura A, 2014, TRANSPL P, V46, P1107, DOI 10.1016/j.transproceed.2013.11.128; TSIANG M, 1992, J BIOL CHEM, V267, P6164; van Iersel T, 2011, THROMB HAEMOSTASIS, V105, P302, DOI 10.1160/TH10-05-0287; Villa C. H., 2016, ADV DRUG DELIV REV, VS0169-409X; Villa CH, 2016, ISBT SCI SER, V11, P158; Vincent JL, 2013, CRIT CARE MED, V41, P2069, DOI 10.1097/CCM.0b013e31828e9b03; Wei HJ, 2011, CARDIOVASC RES, V92, P317, DOI 10.1093/cvr/cvr220; Xu J, 2009, J THROMB HAEMOST, V7, P851, DOI 10.1111/j.1538-7836.2009.03333.x; Yamakawa K, 2015, J THROMB HAEMOST, V13, P508, DOI 10.1111/jth.12841; Zaitsev S, 2012, BLOOD, V119, P4779, DOI 10.1182/blood-2011-12-398149; Zaitsev S, 2010, BLOOD, V115, P5241, DOI 10.1182/blood-2010-01-261610	68	18	18	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					761	770		10.1096/fj.201600912R	http://dx.doi.org/10.1096/fj.201600912R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27836986	Green Published			2022-12-28	WOS:000394235400028
J	Franco, OE; Tyson, DR; Konvinse, KC; Udyavar, AR; Estrada, L; Quaranta, V; Crawford, SE; Hayward, SW				Franco, Omar E.; Tyson, Darren R.; Konvinse, Katherine C.; Udyavar, Akshata R.; Estrada, Lourdes; Quaranta, Vito; Crawford, Susan E.; Hayward, Simon W.			Altered TGF-alpha/beta signaling drives cooperation between breast cancer cell populations	FASEB JOURNAL			English	Article						epithelial paracrine interactions; intratumor cooperation; tumor heterogeneity	TUMOR PROGRESSION; INTRATUMOR HETEROGENEITY; STEM-CELLS; EVOLUTION; MICROENVIRONMENT; LINE; CARCINOGENESIS; COMPETITION; DISEASE; MODEL	The role of tumor heterogeneity in regulating disease progression is poorly understood. We hypothesized that interactions between subpopulations of cancer cells can affect the progression of tumors selecting for a more aggressive phenotype. We developed an in vivo assay based on the immortalized nontumorigenic breast cell line MCF10A and its Ras-transformed derivatives AT1 (mildly tumorigenic) and CA1d (highly tumorigenic). CA1d cells outcompeted MCF10A, forming invasive tumors. AT1 grafts were approximately 1% the size of CA1d tumors when initiated using identical cell numbers. In contrast, CA1d/AT1 mixed tumors were larger than tumors composed of AT1 alone (100-fold) or CA1d (3-fold), suggesting cooperation in tumor growth. One of the mechanisms whereby CA1d and AT1 were found to cooperate was by modulation of TGF-alpha and TGF-beta signaling. Both of these molecules were sufficient to induce changes in AT1 proliferative potential in vitro. Reisolation of AT1 tumor-derived (AT1(-TD)) cells from these mixed tumors revealed that AT1(-TD) cells grew in vivo, forming tumors as large as tumorigenic CA1d cells. Cooperation between subpopulations of cancer epithelium is an understudied mechanism of tumor growth and invasion that may have implications on tumor resistance to current therapies.	[Franco, Omar E.; Crawford, Susan E.; Hayward, Simon W.] NorthShore Univ HealthSyst, Dept Surg, 1001 Univ Pl, Evanston, IL 60201 USA; [Konvinse, Katherine C.; Hayward, Simon W.] Vanderbilt Univ, Med Ctr, Dept Urol Surg, Nashville, TN USA; [Tyson, Darren R.; Udyavar, Akshata R.; Estrada, Lourdes; Quaranta, Vito; Hayward, Simon W.] Vanderbilt Univ, Med Ctr, Dept Canc Biol, Nashville, TN USA	NorthShore University Health System; Vanderbilt University; Vanderbilt University	Hayward, SW (corresponding author), NorthShore Univ HealthSyst, Dept Surg, 1001 Univ Pl, Evanston, IL 60201 USA.	shayward@northshore.org	Tyson, Darren/Z-2815-2019	Tyson, Darren/0000-0002-3272-4308; Estrada, Lourdes/0000-0002-3645-4456; Konvinse, Katherine/0000-0003-2451-9256; Hayward, Simon/0000-0002-6059-6550	U.S. National Institutes of Health/National Cancer Institute Integrative Cancer Biology Program [5U54 CA113007, 5U01 CA151924]; NATIONAL CANCER INSTITUTE [U54CA113007, U01CA151924] Funding Source: NIH RePORTER	U.S. National Institutes of Health/National Cancer Institute Integrative Cancer Biology Program; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank L. Chin (University of Texas System at Austin, Austin, TX, USA), A. Protopopov (University of Texas M. D. Anderson Cancer Center), and Y. Xiao (Lion Bioscience, Heidelberg, Germany) for help with the array-CGH experiments and analysis. The authors also thank J. R. Nevins and M. West (Duke University Durham, NC, USA) for performing the cDNA microarray experiments and for their guidance on the analysis. The authors are grateful to J. Jourquin (Susan G. Komen, Nashville, TN, USA) for his help in the analysis of microarray expression data and pathway enrichment analysis. This work was supported by the U.S. National Institutes of Health/National Cancer Institute Integrative Cancer Biology Program (5U54 CA113007 and 5U01 CA151924).	Aguirre AJ, 2004, P NATL ACAD SCI USA, V101, P9067, DOI 10.1073/pnas.0402932101; Almendro V, 2013, ANNU REV PATHOL-MECH, V8, P277, DOI 10.1146/annurev-pathol-020712-163923; Anderson ARA, 2006, CELL, V127, P905, DOI 10.1016/j.cell.2006.09.042; Anderson ARA, 2009, CANCER RES, V69, P8797, DOI 10.1158/0008-5472.CAN-09-0437; ARTEAGA CL, 1993, J CLIN INVEST, V92, P2569, DOI 10.1172/JCI116871; Axelrod R, 2012, J THEOR BIOL, V299, P21, DOI 10.1016/j.jtbi.2011.04.015; Ayala G, 2003, CLIN CANCER RES, V9, P4792; Bessette DC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125232; Bhowmick NA, 2004, SCIENCE, V303, P848, DOI 10.1126/science.1090922; Calbo J, 2011, CANCER CELL, V19, P244, DOI 10.1016/j.ccr.2010.12.021; Chapman A, 2014, CELL REP, V8, P688, DOI 10.1016/j.celrep.2014.06.045; Cleary AS, 2014, NATURE, V508, P113, DOI 10.1038/nature13187; Coussens LM, 2013, SCIENCE, V339, P286, DOI 10.1126/science.1232227; Ene CI, 2011, CANCER CELL, V20, P695, DOI 10.1016/j.ccr.2011.11.018; Franco OE, 2011, CANCER RES, V71, P1272, DOI 10.1158/0008-5472.CAN-10-3142; Franco OE, 2010, SEMIN CELL DEV BIOL, V21, P33, DOI 10.1016/j.semcdb.2009.10.010; Franses JW, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001542; Gerlinger M, 2012, NEW ENGL J MED, V366, P883, DOI 10.1056/NEJMoa1113205; Haeusgen W, 2011, EUR J CELL BIOL, V90, P536, DOI 10.1016/j.ejcb.2010.11.008; Hanahan D, 2012, CANCER CELL, V21, P309, DOI 10.1016/j.ccr.2012.02.022; Hayward SW, 2001, CANCER RES, V61, P8135; HEPPNER GH, 1993, STEM CELLS, V11, P199, DOI 10.1002/stem.5530110306; Ivanovic V, 2003, EUR J CANCER, V39, P454, DOI 10.1016/S0959-8049(02)00502-6; Kaiser J, 2013, SCIENCE, V339, P1543, DOI 10.1126/science.339.6127.1543; Kajita M, 2015, J BIOCHEM, V158, P15, DOI 10.1093/jb/mvv050; Kiskowski MA, 2011, CANCER RES, V71, P3459, DOI 10.1158/0008-5472.CAN-10-2999; Li Jian, 2010, BMC Res Notes, V3, P321, DOI 10.1186/1756-0500-3-321; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; Mancino M, 2011, BBA-REV CANCER, V1816, P105, DOI 10.1016/j.bbcan.2011.04.005; MILLER BE, 1980, CANCER RES, V40, P3977; Miller FR, 2000, J MAMMARY GLAND BIOL, V5, P379, DOI 10.1023/A:1009577811584; Olumi AF, 1999, CANCER RES, V59, P5002; Phillips JL, 2001, CANCER RES, V61, P8143; Polyak K, 2011, J CLIN INVEST, V121, P3786, DOI 10.1172/JCI60534; Protopopov Alexei, 2008, V439, P87, DOI 10.1007/978-1-59745-188-8_6; Rhee J, 2011, BREAST CANCER RES TR, V125, P107, DOI 10.1007/s10549-010-1200-9; Santner SJ, 2001, BREAST CANCER RES TR, V65, P101, DOI 10.1023/A:1006461422273; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Shackleton M, 2009, CELL, V138, P822, DOI 10.1016/j.cell.2009.08.017; Shibata D, 2012, SCIENCE, V336, P304, DOI 10.1126/science.1222361; SOULE HD, 1990, CANCER RES, V50, P6075; Strickland LB, 2000, BREAST CANCER RES TR, V64, P235, DOI 10.1023/A:1026562720218; Sugimoto H, 2006, CANCER BIOL THER, V5, P1640, DOI 10.4161/cbt.5.12.3354; Swanton C, 2012, CANCER RES, V72, P4875, DOI 10.1158/0008-5472.CAN-12-2217; Tamori Y, 2011, J GENET GENOMICS, V38, P483, DOI 10.1016/j.jgg.2011.09.006	45	5	5	0	0	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3441	3452		10.1096/fj.201500187RR	http://dx.doi.org/10.1096/fj.201500187RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27383183	Green Published			2022-12-28	WOS:000384329800015
J	Tanner, MR; Pennington, MW; Laragione, T; Gulko, PS; Beeton, C				Tanner, Mark R.; Pennington, Michael W.; Laragione, Teresina; Gulko, Percio S.; Beeton, Christine			KCa1.1 channels regulate beta(1)-integrin function and cell adhesion in rheumatoid arthritis fibroblast-like synoviocytes	FASEB JOURNAL			English	Article						migration; synovial fibroblast; invasion	PROTEIN-PROTEIN INTERACTIONS; GATED POTASSIUM CHANNELS; SYNOVIAL FIBROBLASTS; INTEGRIN ACTIVATION; LARGE-CONDUCTANCE; PLASMA-MEMBRANE; MATRIX PROTEINS; FLOW-CYTOMETRY; SMOOTH-MUSCLE; BETA-1 CHAIN	Large-conductance calcium-activated potassium channel (KCa1.1; BK, Slo1, MaxiK, KCNMA1) is the predominant potassium channel expressed at the plasma membrane of rheumatoid arthritis fibroblast-like synoviocytes (RA-FLSs) isolated from the synovium of patients with RA. It is a critical regulator of RA-FLS migration and invasion and therefore represents an attractive target for the therapy of RA. However, the molecular mechanisms by which KCa1.1 regulates RA-FLS invasiveness have remained largely unknown. Here, we demonstrate that KCa1.1 regulates RA-FLS adhesion through controlling the plasma membrane expression and activation of beta(1) integrins, but not alpha(4), alpha(5), or alpha(6) integrins. Blocking KCa1.1 disturbs calcium homeostasis, leading to the sustained phosphorylation of Akt and the recruitment of talin to beta(1) integrins. Interestingly, the pore-forming a subunit of KCa1.1 coimmunoprecipitates with beta(1) integrins, suggesting that this physical association underlies the functional interaction between these molecules. Together, these data outline a new signaling mechanism by which KCa1.1 regulates beta(1)-integrin function and therefore invasiveness of RA-FLSs.	[Tanner, Mark R.; Beeton, Christine] Baylor Univ, Dept Mol Physiol & Biophys, Mail Stop BCM335, Houston, TX 77030 USA; [Tanner, Mark R.] Baylor Coll Med, Grad Sch Biomed Sci, Houston, TX 77030 USA; [Beeton, Christine] Baylor Coll Med, Biol Inflammat Ctr, Houston, TX 77030 USA; [Beeton, Christine] Baylor Coll Med, Ctr Drug Discovery, Houston, TX 77030 USA; [Pennington, Michael W.] Peptides Int Inc, Louisville, KY USA; [Laragione, Teresina; Gulko, Percio S.] Icahn Sch Med Mt Sinai, Dept Med, Div Rheumatol, New York, NY 10029 USA	Baylor University; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai	Beeton, C (corresponding author), Baylor Univ, Dept Mol Physiol & Biophys, Mail Stop BCM335, Houston, TX 77030 USA.	beeton@bcm.edu		Tanner, Mark/0000-0002-6516-0166; pennington, michael/0000-0001-5446-3447	Baylor College of Medicine; U.S. National Institutes of Health (NIH) F31 Award [AR069960]; U.S. National Institutes of Health (NIH) T32 Award [GM088129, AI053831]; NIH [RR024574, AI036211, CA125123]; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211, T32AI053831] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F31AR069960] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM088129] Funding Source: NIH RePORTER	Baylor College of Medicine; U.S. National Institutes of Health (NIH) F31 Award; U.S. National Institutes of Health (NIH) T32 Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by funding from the Baylor College of Medicine (to C.B.). M.R.T. was supported by U.S. National Institutes of Health (NIH) F31 Award AR069960 (National Institute of Arthritis and Musculoskeletal and Skin Diseases), and T32 Awards GM088129 [National Institute of General Medical Sciences (NIGMS)] and AI053831 [National Institute of Allergy and Infectious Diseases (NIAID)]. The Cytometry and Cell Sorting Core at Baylor College of Medicine is supported, in part, by the NIH [Grants RR024574 (NIGMS), AI036211 (NIAID), and CA125123 (National Cancer Institute)].	Agarwal SK, 2006, CURR OPIN RHEUMATOL, V18, P268, DOI 10.1097/01.bor.0000218948.42730.39; Ah Kioon Marie-Dominique, 2010, Arthritis Res Ther, V12, pR190, DOI 10.1186/ar3160; Aletaha D, 2010, ANN RHEUM DIS, V69, P1580, DOI [10.1136/ard.2010.138461, 10.1002/art.27584]; Arcangeli A, 2004, BIOCHEM SOC T, V32, P826, DOI 10.1042/BST0320826; Artym VV, 2002, J GEN PHYSIOL, V120, P29, DOI 10.1085/jgp.20028607; Bartok B, 2012, AM J PATHOL, V180, P1906, DOI 10.1016/j.ajpath.2012.01.030; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Bida AT, 2012, METHODS, V56, P154, DOI 10.1016/j.ymeth.2011.09.005; BODARY SC, 1990, J BIOL CHEM, V265, P5938; Bridgeman JS, 2010, CYTOM PART A, V77A, P338, DOI 10.1002/cyto.a.20840; Calderwood DA, 2004, BIOCHEM SOC T, V32, P434, DOI 10.1042/BST0320434; CANDIA S, 1992, BIOPHYS J, V63, P583, DOI 10.1016/S0006-3495(92)81630-2; Cao FF, 2014, CYTOM PART A, V85, P359, DOI 10.1002/cyto.a.22421; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Cheung SY, 2015, ENDOCRINOLOGY, V156, P2074, DOI 10.1210/en.2014-1831; Ching LC, 2011, CARDIOVASC RES, V91, P492, DOI 10.1093/cvr/cvr104; Ciurtin C, 2010, BMC MUSCULOSKEL DIS, V11, DOI 10.1186/1471-2474-11-111; Coticchia CM, 2009, BREAST CANCER RES TR, V115, P545, DOI 10.1007/s10549-008-0097-z; Cunningham CA, 2013, EUR J IMMUNOL, V43, P3361, DOI 10.1002/eji.201343635; Danciu TE, 2003, FEBS LETT, V536, P193, DOI 10.1016/S0014-5793(03)00055-3; Davis TR, 2010, JOVE-J VIS EXP, V46, P2066; Deb TB, 2004, J BIOL CHEM, V279, P38903, DOI 10.1074/jbc.M405314200; Dehart GW, 2008, P NATL ACAD SCI USA, V105, P7188, DOI 10.1073/pnas.0708044105; Deswal S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022928; Doerner JF, 2011, J GEN PHYSIOL, V137, P271, DOI 10.1085/jgp.200910388; Gradilone SA, 2010, GASTROENTEROLOGY, V139, P304, DOI 10.1053/j.gastro.2010.04.010; Grimm C, 2005, MOL PHARMACOL, V67, P798, DOI 10.1124/mol.104.006734; Hood JD, 2002, NAT REV CANCER, V2, P91, DOI 10.1038/nrc727; Hu XY, 2012, J BIOL CHEM, V287, P4014, DOI 10.1074/jbc.M111.312264; HUMPHRIES MJ, 1986, J CELL BIOL, V103, P2637, DOI 10.1083/jcb.103.6.2637; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Kim W, 2003, FASEB J, V17, P1937, DOI 10.1096/fj.02-1209fje; Kochukov MY, 2006, AM J PHYSIOL-CELL PH, V291, pC424, DOI 10.1152/ajpcell.00553.2005; Kochukov MY, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-49; Krutzik PO, 2003, CYTOM PART A, V55A, P61, DOI 10.1002/cyto.a.10072; Kwan HY, 2009, CIRC RES, V104, P670, DOI 10.1161/CIRCRESAHA.108.188748; Laragione T, 2015, CLIN IMMUNOL, V158, P183, DOI 10.1016/j.clim.2015.04.001; Laragione T, 2010, MOL MED, V16, P352, DOI 10.2119/molmed.2010.00049; LAWSON MA, 1995, NATURE, V377, P75, DOI 10.1038/377075a0; Lee EG, 2011, INFLAMMATION, V34, P335, DOI 10.1007/s10753-010-9239-7; Levite M, 2000, J EXP MED, V191, P1167, DOI 10.1084/jem.191.7.1167; Lowin T, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3464; Lowin T, 2009, ARTHRITIS RHEUM-US, V60, P3623, DOI 10.1002/art.24985; Luque A, 1996, J BIOL CHEM, V271, P11067, DOI 10.1074/jbc.271.19.11067; Matheu MP, 2008, IMMUNITY, V29, P602, DOI 10.1016/j.immuni.2008.07.015; Matta JA, 2007, J PHYSIOL-LONDON, V585, P469, DOI 10.1113/jphysiol.2007.144287; McGarry T, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0664-8; MORGAN AJ, 1994, BIOCHEM J, V300, P665, DOI 10.1042/bj3000665; MullerLadner U, 1997, J RHEUMATOL, V24, P1873; NIKKARI L, 1995, J RHEUMATOL, V22, P16; Nishizuka M, 2014, INT J MOL SCI, V15, P22743, DOI 10.3390/ijms151222743; Patra AK, 2004, J IMMUNOL, V172, P4812, DOI 10.4049/jimmunol.172.8.4812; PELLEGRINI R, 1992, TUMORI, V78, P1; Pennington MW, 1996, BIOCHEMISTRY-US, V35, P16407, DOI 10.1021/bi962463g; Petho Z, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1003-4; Pirila L, 2001, J RHEUMATOL, V28, P478; Rinaldi N, 1997, ANN RHEUM DIS, V56, P45, DOI 10.1136/ard.56.1.45; Roberts MS, 2004, MOL CELL BIOL, V24, P1505, DOI 10.1128/MCB.24.4.1505-1515.2004; Ruoslahti E, 1996, ANNU REV CELL DEV BI, V12, P697, DOI 10.1146/annurev.cellbio.12.1.697; Sanchez M, 1996, NEUROPHARMACOLOGY, V35, P963, DOI 10.1016/0028-3908(96)00137-2; Sarkissian M, 1999, J IMMUNOL, V162, P1772; Schedel J, 2004, SCAND J IMMUNOL, V60, P514, DOI 10.1111/j.0300-9475.2004.01507.x; Schrum Adam G, 2007, Sci STKE, V2007, ppl2, DOI 10.1126/stke.3892007pl2; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Singh K, 2008, J IMMUNOL, V180, P1971, DOI 10.4049/jimmunol.180.3.1971; Smith SEP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045722; Somanath PR, 2007, J BIOL CHEM, V282, P22964, DOI 10.1074/jbc.M700241200; Sureshbabu A, 2012, J CELL SCI, V125, P1693, DOI 10.1242/jcs.092882; Tajhya RB, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.324; Tanner MR, 2015, ARTHRITIS RHEUMATOL, V67, P96, DOI 10.1002/art.38883; Wan X, 2014, PFLUG ARCH EUR J PHY, V466, P1273, DOI 10.1007/s00424-013-1345-6; Wu X, 2008, J PHYSIOL-LONDON, V586, P1699, DOI 10.1113/jphysiol.2007.149500; Wu Y, 2013, INT J DISTRIB SENS N, DOI 10.1155/2013/912873; Xu SZ, 2008, NATURE, V451, P69, DOI 10.1038/nature06414; Yang Y, 2010, J BIOL CHEM, V285, P131, DOI 10.1074/jbc.M109.033506; Yarwood SJ, 2001, P NATL ACAD SCI USA, V98, P4472, DOI 10.1073/pnas.081069098; Yoeli-Lerner M, 2005, MOL CELL, V20, P539, DOI 10.1016/j.molcel.2005.10.033; Yoon HJ, 2011, ARTHRITIS RHEUM-US, V63, P1843, DOI 10.1002/art.30229; Zanou N, 2012, J BIOL CHEM, V287, P14524, DOI 10.1074/jbc.M112.341784; Zhou Y, 2014, J GEN PHYSIOL, V144, P415, DOI 10.1085/jgp.201411259	80	18	18	2	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3309	3320		10.1096/fj.201601097R	http://dx.doi.org/10.1096/fj.201601097R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28428266	Green Published			2022-12-28	WOS:000405932400011
J	de Leve, S; Wirsdorfer, F; Cappuccini, F; Schutze, A; Meyer, AV; Rock, K; Thompson, LF; Fischer, JW; Stuschke, M; Jendrossek, V				de Leve, Simone; Wirsdoerfer, Florian; Cappuccini, Federica; Schuetze, Alexandra; Meyer, Alina V.; Roeck, Katharina; Thompson, Linda F.; Fischer, Jens W.; Stuschke, Martin; Jendrossek, Verena			Loss of CD73 prevents accumulation of alternatively activated macrophages and the formation of prefibrotic macrophage clusters in irradiated lungs	FASEB JOURNAL			English	Article						pulmonary fibrosis; adenosine; hyaluronan; pneumonitis; thorax irradiation	OBSTRUCTIVE PULMONARY-DISEASE; TOTAL-BODY IRRADIATION; GROWTH-FACTOR-BETA; THORACIC IRRADIATION; ALVEOLAR MACROPHAGES; ADENOSINE PRODUCTION; RADIATION PNEUMONITIS; HYALURONAN SYNTHASES; IMMUNE SUPPRESSION; GENE-EXPRESSION	While radiotherapy is a mainstay for cancer therapy, pneumonitis and fibrosis constitute dose-limiting side effects of thorax and whole body irradiation. So far, the contribution of immune cells to disease progression is largely unknown. Here we studied the role of ecto-5'-nucelotidase (CD73)/adenosine-induced changes in the myeloid compartment in radiation-induced lung fibrosis. C57BL/6 wild-type or CD73(-/-) mice received a single dose of whole thorax irradiation (WTI, 15 Gy). Myeloid cells were characterized in flow cytometric, histologic, and immunohistochemical analyses as well as RNA analyses. WTI induced a pronounced reduction of alveolar macrophages in both strains that recovered within 6 wk. Fibrosis development in wild-type mice was associated with a time-dependent deposition of hyaluronic acid (HA) and increased expression of markers for alternative activation on alveolar macrophages. These include the antiinflammatory macrophage mannose receptor and arginase-1. Further, macrophages accumulated in organized clusters and expressed profibrotic mediators at Z25 wk after irradiation (fibrotic phase). Irradiated CD73(-/-) mice showed an altered regulation of components of the HA system and no clusters of alternatively activated macrophages. We speculate that accumulation of alternatively activated macrophages in organized clusters represents the origins of fibrotic foci after WTI and is promoted by a cross-talk between HA, CD73/adenosine signaling, and other profibrotic mediators. De Leve, S., Wirsdorfer, F., Cappuccini, F., Schiitze, A., Meyer, A. V., Rock, K., Thompson, L. F., Fischer, J. W., Stuschke, M., Jendrossek, V. Loss of CD73 prevents accumulation of alternatively activated macrophages and the formation of prefibrotic macrophage clusters in irradiated lungs.	[de Leve, Simone; Wirsdoerfer, Florian; Cappuccini, Federica; Meyer, Alina V.; Jendrossek, Verena] Univ Hosp Essen, Inst Cell Biol Canc Res, Virchowstr 173, D-45122 Essen, Germany; [Stuschke, Martin] Univ Hosp Essen, Dept Radiat Oncol, Essen, Germany; [Schuetze, Alexandra; Roeck, Katharina; Fischer, Jens W.] Heinrich Heine Univ, Univ Hosp, Pharmacol & Clin Pharmacol, Dusseldorf, Germany; [Thompson, Linda F.] Oklahoma Med Res Fdn, Arthrit & Clin Immunol Program, 825 NE 13th St, Oklahoma City, OK 73104 USA	University of Duisburg Essen; University of Duisburg Essen; Heinrich Heine University Dusseldorf; Oklahoma Medical Research Foundation	Jendrossek, V (corresponding author), Univ Hosp Essen, Inst Cell Biol Canc Res, Virchowstr 173, D-45122 Essen, Germany.	verena.jendrossek@uni-due.de	Jendrossek, Verena/AAH-4967-2019; Jendrossek, Verena/ABD-2190-2021	Jendrossek, Verena/0000-0003-1058-2107; Jendrossek, Verena/0000-0003-1058-2107	Deutsche Forschungsgemeinschaft (DFG) [GRK1739/1, JE275/4-1]; Bundesministerium fur Bildung and Forschung (BMBF) [02NUK024D]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018220] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bundesministerium fur Bildung and Forschung (BMBF)(Federal Ministry of Education & Research (BMBF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank M. Groneberg and E. Gau (both from the University Hospital Essen) for excellent technical support. The work was supported by the Deutsche Forschungsgemeinschaft (DFG; Grants GRK1739/1 and JE275/4-1 to V.J.), and the Bundesministerium fur Bildung and Forschung (BMBF; Grant 02NUK024D to V.J.).	Arpin D, 2005, J CLIN ONCOL, V23, P8748, DOI 10.1200/JCO.2005.01.7145; Begg AC, 2011, NAT REV CANCER, V11, P239, DOI 10.1038/nrc3007; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Cappuccini F, 2011, RADIOTHER ONCOL, V101, P86, DOI 10.1016/j.radonc.2011.05.064; Chavez-Galan L, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00263; Chiang CS, 2005, INT J RADIAT ONCOL, V62, P862, DOI 10.1016/j.ijrobp.2005.02.037; Chunn JL, 2005, J IMMUNOL, V175, P1937, DOI 10.4049/jimmunol.175.3.1937; Cronstein Bruce N, 2011, F1000 Biol Rep, V3, P21, DOI 10.3410/B3-21; Csoka B, 2012, FASEB J, V26, P376, DOI 10.1096/fj.11-190934; Deaglio S, 2007, J EXP MED, V204, P1257, DOI 10.1084/jem.20062512; Eldh T, 2012, STRAHLENTHER ONKOL, V188, P274, DOI 10.1007/s00066-011-0046-3; Ferrante CJ, 2013, INFLAMMATION, V36, P921, DOI 10.1007/s10753-013-9621-3; Franko AJ, 1997, RADIAT RES, V147, P245, DOI 10.2307/3579426; FRANKO AJ, 1994, RADIAT RES, V140, P347, DOI 10.2307/3579112; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Gordon S, 2003, NAT REV IMMUNOL, V3, P23, DOI 10.1038/nri978; Graves PR, 2010, SEMIN RADIAT ONCOL, V20, P201, DOI 10.1016/j.semradonc.2010.01.010; Groves AM, 2016, INT J RADIAT BIOL, V92, P754, DOI 10.1080/09553002.2016.1222094; Groves AM, 2015, RADIAT RES, V184, P639, DOI 10.1667/RR14178.1; Hasko G, 2008, NAT REV DRUG DISCOV, V7, P759, DOI 10.1038/nrd2638; Hasko G, 2012, ARTERIOSCL THROM VAS, V32, P865, DOI 10.1161/ATVBAHA.111.226852; Hong ZY, 2015, LUNG, V193, P409, DOI 10.1007/s00408-015-9705-y; Horton JA, 2013, STEM CELLS, V31, P2231, DOI 10.1002/stem.1483; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Johnston CJ, 2004, EXP LUNG RES, V30, P369, DOI 10.1080/01902140490438915; Johnston CJ, 1998, EXP LUNG RES, V24, P321, DOI 10.3109/01902149809041538; Kaku H, 2014, J IMMUNOL, V193, P5904, DOI 10.4049/jimmunol.1400336; Kalash R, 2014, IN VIVO, V28, P147; Karmouty-Quintana H, 2015, FASEB J, V29, P50, DOI 10.1096/fj.14-260182; Karmouty-Quintana H, 2013, AM J RESP CELL MOL, V49, P1038, DOI 10.1165/rcmb.2013-0089OC; Kelsey CR, 2011, INT J RADIAT ONCOL, V81, P812, DOI 10.1016/j.ijrobp.2010.06.058; Kessel CHG, 2008, MUCOSAL IMMUNOL, V1, P442, DOI 10.1038/mi.2008.39; KHALIL N, 1989, J EXP MED, V170, P727, DOI 10.1084/jem.170.3.727; Klein D., 2016, ANTIOXID REDOX SIGNA; Kong FM, 2005, SEMIN ONCOL, V32, pS42, DOI 10.1053/j.seminoncol.2005.03.009; Koscso B, 2013, J LEUKOCYTE BIOL, V94, P1309, DOI 10.1189/jlb.0113043; Leibovich SJ, 2002, AM J PATHOL, V160, P2231, DOI 10.1016/S0002-9440(10)61170-4; Macedo L, 2007, AM J PATHOL, V171, P1774, DOI 10.2353/ajpath.2007.061048; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Matute-Bello G, 2004, J IMMUNOL METHODS, V292, P25, DOI 10.1016/j.jim.2004.05.010; McKee CM, 1996, J CLIN INVEST, V98, P2403, DOI 10.1172/JCI119054; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Mosser DM, 2008, NAT REV IMMUNOL, V8, P958, DOI 10.1038/nri2448; Murray PJ, 2014, IMMUNITY, V41, P14, DOI 10.1016/j.immuni.2014.06.008; Nawroth I, 2013, ACTA ONCOL, V52, P1730, DOI 10.3109/0284186X.2012.726373; Osterholzer JJ, 2012, J PATHOL, V228, P170, DOI 10.1002/path.3992; Paun A, 2010, RADIAT RES, V173, P512, DOI 10.1667/RR1798.1; Perez-Aso M, 2016, FASEB J, V30, P457, DOI 10.1096/fj.15-280388; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; RUBIN P, 1995, INT J RADIAT ONCOL, V33, P99, DOI 10.1016/0360-3016(95)00095-G; Savani RC, 2000, AM J RESP CELL MOL, V23, P475, DOI 10.1165/ajrcmb.23.4.3944; Scharpfenecker M, 2012, RADIOTHER ONCOL, V105, P313, DOI 10.1016/j.radonc.2012.08.021; Scheibner KA, 2009, AM J RESP CELL MOL, V40, P251, DOI 10.1165/rcmb.2008-0168OC; Schneider DJ, 2010, FASEB J, V24, P70, DOI 10.1096/fj.09-140772; Shaikh G, 2016, PURINERG SIGNAL, V12, P191, DOI 10.1007/s11302-016-9498-3; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Thompson LF, 2004, J EXP MED, V200, P1395, DOI 10.1084/Jem.20040915; Todd NW, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-11; Vermaelen K, 2004, CYTOM PART A, V61A, P170, DOI 10.1002/cyto.a.20064; Volmer JB, 2006, J IMMUNOL, V176, P4449, DOI 10.4049/jimmunol.176.7.4449; Weigel PH, 1997, J BIOL CHEM, V272, P13997, DOI 10.1074/jbc.272.22.13997; Wirsdorfer F, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00591; Wirsdorfer F, 2016, CANCER RES, V76, P3045, DOI 10.1158/0008-5472.CAN-15-2310; Wirsdorfer F, 2014, RADIAT ONCOL, V9, DOI 10.1186/1748-717X-9-98; Wynn TA, 2016, IMMUNITY, V44, P450, DOI 10.1016/j.immuni.2016.02.015; Zhang F, 2016, ONCOTARGET, V7, P52294, DOI 10.18632/oncotarget.10561; Zhang H, 2011, J RADIAT RES, V52, P717, DOI 10.1269/jrr.11054; Zhang-Hoover J, 2000, IMMUNOLOGY, V101, P501, DOI 10.1046/j.1365-2567.2000.00143.x; Zhou Y, 2011, J IMMUNOL, V186, P1097, DOI 10.4049/jimmunol.1002907; Zhou Y, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009224	70	15	15	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2869	2880		10.1096/fj.201601228R	http://dx.doi.org/10.1096/fj.201601228R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28325757	Green Published			2022-12-28	WOS:000405931000013
J	Li, CH; Zhang, JT; Baylink, DJ; Wang, XH; Goparaju, NB; Xu, Y; Wasnik, S; Cheng, YM; Berumen, EC; Qin, XZ; Lau, KHW; Tang, XL				Li, Chih-Huang; Zhang, Jintao; Baylink, David J.; Wang, Xiaohua; Goparaju, Naga Bharani; Xu, Yi; Wasnik, Samiksha; Cheng, Yanmei; Berumen, Edmundo Carreon; Qin, Xuezhong; Lau, Kin-Hing William; Tang, Xiaolei			Dendritic cells, engineered to overexpress 25-hydroxyvitamin D 1 alpha-hydroxylase and pulsed with a myelin antigen, provide myelin-specific suppression of ongoing experimental allergic encephalomyelitis	FASEB JOURNAL			English	Article						multiple sclerosis; regulatory T cells; T-reg; 1,25(OH)(2)D; foxp3	REGULATORY T-CELLS; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; TRANSCRIPTION FACTOR FOXP3; MULTIPLE-SCLEROSIS; VITAMIN-D; 1,25-DIHYDROXYVITAMIN D-3; LYMPH-NODES; IN-VIVO; EXPRESSION; MIGRATION	Multiple sclerosis (MS) is caused by immune_mediated damage of myelin sheath. Current therapies aim to block such immune responses. However, this blocking is not sufficiently specific and hence compromises immunity, leading to severe side effects. In addition, blocking medications usually provide transient effects and require frequent administration, which further increases the chance to compromise immunity. In this regard, myelin specific therapy may provide the desired specificity and a long-lasting therapeutic effect by inducing myelin specific regulatory T (T-reg) cells. Tolerogenic dendritic cells (To1DCs) are one such therapy. However, ex vivo generated To1DCs may be converted into immunogenic DCs in a proinflammatory environment. In this study, we identified a potential novel myelin_specific therapy that works with immunogenic DCs, hence without the in vivo conversion concern. We showed that immunization with DCs, engineered to overexpress 25-hydroxyvitamin D l alpha-hydroxylase for de novo synthesis of a focally high 1,25-dihydroxyvitamin D concentration in the peripheral lymphoid tissues, induced T-reg cells. In addition, such engineered DCs, when pulsed with a myelin antigen, led to myelin_specific suppression of ongoing experimental allergic encephalomyelitis (an MS animal model), and the disease suppression depended on forkhead-box-protein-P3(foxp3)(+) T-reg cells. Our data support a novel concept that immunogenic DCs can be engineered for myelin_specific therapy for MS. Li, C._H., Zhang, J., Baylink, D. J., Wang, X., Goparaju, N. B., Xu, Y., Wasnik, S., Cheng, Y., Berumen, E. C., Qin, X., Lau, K._H. W., Tang, X. Dendritic cells, engineered to overexpress 25-hydroxyvitamin D la-hydroxylase and pulsed with a myelin antigen, provide myelin_specific suppression of ongoing experimental allergic encephalomyelitis.	[Li, Chih-Huang; Zhang, Jintao; Baylink, David J.; Wang, Xiaohua; Goparaju, Naga Bharani; Xu, Yi; Wasnik, Samiksha; Cheng, Yanmei; Berumen, Edmundo Carreon; Qin, Xuezhong; Lau, Kin-Hing William; Tang, Xiaolei] Loma Linda Univ, Dept Med, Div Regenerat Med, Loma Linda, CA 92354 USA; [Qin, Xuezhong; Lau, Kin-Hing William] Loma Linda Univ, Musculoskeletal Dis Ctr, Jerry L Pettis Mem Vet Affairs Med Ctr, Loma Linda, CA 92354 USA; [Li, Chih-Huang] Chang Gung Mem Hosp, Linkou Med Ctr, Dept Emergency Med, Taoyuan, Taiwan; [Li, Chih-Huang] Chang Gung Univ, Grad Inst Clin Med Sci, Sch Med, Taoyuan, Taiwan; [Zhang, Jintao] Zhengzhou Univ, Inst Med & Pharmaceut Sci, Zhengzhou, Henan, Peoples R China; [Wang, Xiaohua] Shandong Univ, Jinan Infect Dis Hosp, Div Infect Dis, Jinan, Peoples R China; [Cheng, Yanmei] Shanghai Univ Tradit Chinese Med, Yue Yang Hosp Tradit Chinese & Western Med, Shanghai, Peoples R China	Loma Linda University; Loma Linda University; Chang Gung Memorial Hospital; Chang Gung University; Zhengzhou University; Shandong University; Shanghai University of Traditional Chinese Medicine	Tang, XL (corresponding author), Loma Linda Univ, Dept Med, Div Regenerat Med, Loma Linda, CA 92354 USA.	xitang@llu.edu	Tang, Xiaolei/AAT-7669-2021; Wasnik, Samiksha/I-1063-2019	Tang, Xiaolei/0000-0003-1492-9622; Wasnik, Samiksha/0000-0001-6097-0517; wasnik, samiksha/0000-0001-6680-996X	Research Innovation Grant from Department of Medicine at Loma Linda University [681205-2967]; Chang-Gung Memorial Hospital [CMRPG3E0041, CMRPG3C1431]; Veterans Affairs [IK6BX003782] Funding Source: NIH RePORTER	Research Innovation Grant from Department of Medicine at Loma Linda University; Chang-Gung Memorial Hospital(Chang Gung Memorial Hospital); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Dr. David Lo (University of California, Riverside, Riverside, CA, USA) for a critical reading of the manuscript and Penelope Garcia (Loma Linda University) for technical assistance. This work was supported by Research Innovation Grant 681205-2967 from the Department of Medicine at Loma Linda University (to X.T.), and was partially funded by Chang-Gung Memorial Hospital Research Grant CMRPG3E0041 and CMRPG3C1431. The authors declare no conflicts of interest.	Adorini L, 2003, J CELL BIOCHEM, V88, P227, DOI 10.1002/jcb.10340; Ben-Nun A, 2014, J AUTOIMMUN, V54, P33, DOI 10.1016/j.jaut.2014.06.004; Brockmann L, 2017, J IMMUNOL, V198, P1130, DOI 10.4049/jimmunol.1601045; Carbone F, 2014, NAT MED, V20, P69, DOI 10.1038/nm.3411; Clifford DB, 2010, LANCET NEUROL, V9, P438, DOI 10.1016/S1474-4422(10)70028-4; Creusot RJ, 2009, BLOOD, V113, P6638, DOI 10.1182/blood-2009-02-204321; Farias AS, 2013, CNS NEUROSCI THER, V19, P269, DOI 10.1111/cns.12071; Fernando V, 2014, INT J MOL SCI, V15, P1700, DOI 10.3390/ijms15021700; Ferreira GB, 2015, CELL REP, V10, P711, DOI 10.1016/j.celrep.2015.01.013; Flayer CH, 2017, ALLERGY, V72, P679, DOI 10.1111/all.13130; FRASER DR, 1970, NATURE, V228, P764, DOI 10.1038/228764a0; Grimm AJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep15907; Grishkan IV, 2013, P NATL ACAD SCI USA, V110, P21101, DOI 10.1073/pnas.1306072110; Gross CC, 2012, EUR J IMMUNOL, V42, P569, DOI 10.1002/eji.201242402; Hardenberg G, 2011, SEMIN IMMUNOL, V23, P130, DOI 10.1016/j.smim.2011.01.012; Hersh CM, 2014, IMMUNOTHERAPY-UK, V6, P249, DOI 10.2217/imt.14.7; Hwang SS, 2017, ALLERGY, V72, P772, DOI 10.1111/all.13078; Ilarregui JM, 2009, NAT IMMUNOL, V10, P981, DOI 10.1038/ni.1772; Kang SW, 2012, J IMMUNOL, V188, P5276, DOI 10.4049/jimmunol.1101211; Kim HJ, 2015, SCIENCE, V350, P334, DOI 10.1126/science.aad0616; Kozovska ME, 1999, NEUROLOGY, V53, P1692, DOI 10.1212/WNL.53.8.1692; Lee HW, 2015, SCI REP-UK, V5, DOI 10.1038/srep09865; Li B, 2015, MOL THER, V23, P339, DOI 10.1038/mt.2014.201; Lim DS, 2009, EUR J IMMUNOL, V39, P1334, DOI 10.1002/eji.200838987; Linda H, 2009, NEW ENGL J MED, V361, P1081, DOI 10.1056/NEJMoa0810316; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Martin-Fontecha A, 2003, J EXP MED, V198, P615, DOI 10.1084/jem.20030448; Matarese G, 2005, P NATL ACAD SCI USA, V102, P5150, DOI 10.1073/pnas.0408995102; Mayo L, 2016, BRAIN, V139, P1939, DOI 10.1093/brain/aww113; McNally JP, 2014, J IMMUNOL, V192, P73, DOI 10.4049/jimmunol.1301891; Melcon MO, 2014, J NEUROL SCI, V344, P171, DOI 10.1016/j.jns.2014.06.051; Miller A, 1998, J NEUROIMMUNOL, V92, P113, DOI 10.1016/S0165-5728(98)00191-X; Murai M, 2009, NAT IMMUNOL, V10, P1178, DOI 10.1038/ni.1791; Nashold FE, 2013, J NEUROIMMUNOL, V263, P64, DOI 10.1016/j.jneuroim.2013.07.016; Ohl L, 2004, IMMUNITY, V21, P279, DOI 10.1016/j.immuni.2004.06.014; Okada N, 2001, BRIT J CANCER, V84, P1564, DOI 10.1054/bjoc.2001.1801; Palanichamy A, 2014, J IMMUNOL, V193, P580, DOI 10.4049/jimmunol.1400118; Tenorio EP, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/786078; Pennati A, 2016, J NEUROSCI, V36, P12598, DOI 10.1523/JNEUROSCI.1994-16.2016; Prietl B, 2014, EUR J NUTR, V53, P751, DOI 10.1007/s00394-013-0579-6; Raker VK, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00569; Randolph GJ, 2005, NAT REV IMMUNOL, V5, P617, DOI 10.1038/nri1670; Ritter U, 2004, J LEUKOCYTE BIOL, V76, P472, DOI 10.1189/jlb.0104037; Rosenblum MD, 2016, NAT REV IMMUNOL, V16, P90, DOI 10.1038/nri.2015.1; Schmitt EG, 2012, J IMMUNOL, V189, P5638, DOI 10.4049/jimmunol.1200936; Setiady YY, 2010, EUR J IMMUNOL, V40, P780, DOI 10.1002/eji.200939613; Shen ZH, 1997, J IMMUNOL, V158, P2723; Sigmundsdottir H, 2007, NAT IMMUNOL, V8, P285, DOI 10.1038/ni1433; Spanier JA, 2015, J NEUROIMMUNOL, V286, P48, DOI 10.1016/j.jneuroim.2015.06.015; Steinman L, 2015, MULT SCLER J, V21, P1223, DOI 10.1177/1352458515581441; Szeles L, 2009, J IMMUNOL, V182, P2074, DOI 10.4049/jimmunol.0803345; Tsuji M, 2009, SCIENCE, V323, P1488, DOI 10.1126/science.1169152; Viglietta V, 2004, J EXP MED, V199, P971, DOI 10.1084/jem.20031579; Voigylander C, 2006, J IMMUNOTHER, V29, P407, DOI 10.1097/01.cji.0000210081.60178.b4; Xu LL, 2007, J IMMUNOL, V178, P6725, DOI 10.4049/jimmunol.178.11.6725; Yeste A, 2012, P NATL ACAD SCI USA, V109, P11270, DOI 10.1073/pnas.1120611109; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774	57	7	7	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2996	3006		10.1096/fj.201601243R	http://dx.doi.org/10.1096/fj.201601243R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28363955	Green Published, hybrid			2022-12-28	WOS:000405931000024
J	Bond, ST; Howlett, KF; Kowalski, GM; Mason, S; Connor, T; Cooper, A; Streltsov, V; Bruce, CR; Walder, KR; McGee, SL				Bond, Simon T.; Howlett, Kirsten F.; Kowalski, Greg M.; Mason, Shaun; Connor, Timothy; Cooper, Adrian; Streltsov, Victor; Bruce, Clinton R.; Walder, Ken R.; McGee, Sean L.			Lysine post-translational modification of glyceraldehyde-3-phosphate dehydrogenase regulates hepatic and systemic metabolism	FASEB JOURNAL			English	Article						glycolysis; gluconeogenesis; liver metabolism; ketones; lysine acetylation	GLUCOSE-PRODUCTION; PROTEOMIC ANALYSIS; TRANSCRIPTIONAL REGULATION; GLUCONEOGENESIS; ACETYLATION; LIVER; INSULIN; ENZYMES; HUMANS; CELLS	Reciprocal regulation of hepatic glycolysis and gluconeogenesis contributes to systemic metabolic homeostasis. Recent evidence from lower order organisms has found that reversible post-translational modification of glyceraldehyde-3-phosphate dehydrogenase (GAPDH), particularly acetylation, contributes to the reciprocal regulation of glycolysis/gluconeogenesis. However, whether this occurs in mammalian hepatocytes in vitro or in vivo is unknown. Several proteomics studies have identified 4 lysine residues in critical regions of mammalian GAPDH that are altered by multiple post-translational modifications. In FAO hepatoma cells, mutation of all 4 lysine residues (4K-RGAPDH) to mimic their unmodified state reduced GAPDH glycolytic activity and glycolytic flux and increased gluconeogenic GAPDH activity and glucose production. Hepatic expression of 4K-R GAPDH in mice increased GAPDH gluconeogenic activity and the contribution of gluconeogenesis to endogenous glucose production in the unfed state. Consistent with the increased reliance on the energy-consuming gluconeogenic pathway, plasma free fatty acids and ketones were elevated inmice expressing 4K-RGAPDH, suggesting enhanced lipolysis and hepatic fatty acid oxidation. In normal mice, food with holding and refeeding, as well as hormonal regulators of reciprocal glycolysis/gluconeogenesis, such as insulin, glucagon, and norepinephrine, had no effect on global GAPDH acetylation. However, GAPDH acetylation was reduced in obese and type 2 diabetic db/db mice. These findings show that post-translational modification of GAPDH lysine residues regulates hepatic and systemic metabolism, revealing an unappreciated role for hepatic GAPDH in substrate selection and utilization.-Bond, S. T., Howlett, K. F., Kowalski, G. M., Mason, S., Connor, T., Cooper, A., Streltsov, V., Bruce, C. R., Walder, K. R., McGee, S. L. Lysine post-translational modification of glyceraldehyde-3-phosphate dehydrogenase regulates hepatic and systemic metabolism.	[Bond, Simon T.; Connor, Timothy; Cooper, Adrian; Walder, Ken R.; McGee, Sean L.] Deakin Univ, Metab Res Unit, Sch Med, Geelong, Vic, Australia; [Bond, Simon T.; Connor, Timothy; Cooper, Adrian; Walder, Ken R.; McGee, Sean L.] Deakin Univ, Ctr Mol & Med Res, Geelong, Vic, Australia; [Howlett, Kirsten F.; Kowalski, Greg M.; Mason, Shaun; Bruce, Clinton R.] Deakin Univ, Sch Exercise & Nutr Sci, Burwood, NSW, Australia; [Howlett, Kirsten F.; Kowalski, Greg M.; Mason, Shaun; Bruce, Clinton R.] Deakin Univ, Inst Phys Act & Nutr, Burwood, NSW, Australia; [Streltsov, Victor] CSIRO Mfg Flagship, Parkville, Vic, Australia	Deakin University; Deakin University; Deakin University; Deakin University; Commonwealth Scientific & Industrial Research Organisation (CSIRO)	McGee, SL (corresponding author), Deakin Univ, Sch Med, Metab Res Unit, Metab Remodelling Lab, Waurn Ponds, Vic, Australia.	sean.mcgee@deakin.edu.au	Streltsov, Victor/M-9446-2019; bond, simon/L-9781-2019	Streltsov, Victor/0000-0002-7846-4396; bond, simon/0000-0003-1551-8614; Kowalski, Greg/0000-0002-1599-017X; Bruce, Clinton/0000-0002-0515-3343; Mason, Shaun/0000-0002-6138-2239	National Health and Medical Research Council of Australia [APP1127059]; Diabetes Australia Research Program; Centre for Molecular and Medical Research (Deakin University); Institute for Physical Activity and Nutrition	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Diabetes Australia Research Program; Centre for Molecular and Medical Research (Deakin University); Institute for Physical Activity and Nutrition	This study was supported by National Health and Medical Research Council of Australia Grant APP1127059, the Diabetes Australia Research Program, the Centre for Molecular and Medical Research (Deakin University; to S.L.M.), and funding from the Institute for Physical Activity and Nutrition (to C.R.B.). The authors declare no conflicts of interest.	Allick G, 2006, AM J PHYSIOL-ENDOC M, V290, pE1212, DOI 10.1152/ajpendo.00279.2005; CHAN TM, 1975, AM J PHYSIOL, V229, P1702, DOI 10.1152/ajplegacy.1975.229.6.1702; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Daran-Lapujade P, 2004, J BIOL CHEM, V279, P9125, DOI 10.1074/jbc.M309578200; Deribe YL, 2010, NAT STRUCT MOL BIOL, V17, P666, DOI 10.1038/nsmb.1842; Desvergne B, 2006, PHYSIOL REV, V86, P465, DOI 10.1152/physrev.00025.2005; Erion DM, 2009, P NATL ACAD SCI USA, V106, P11288, DOI 10.1073/pnas.0812931106; FEHLMANN M, 1983, BIOCHEM J, V214, P845, DOI 10.1042/bj2140845; Fujimoto H, 2012, J COMPUT CHEM, V33, P239, DOI 10.1002/jcc.21956; Gastaldelli A, 2001, DIABETES, V50, P1807, DOI 10.2337/diabetes.50.8.1807; GROEN AK, 1986, BIOCHEM J, V237, P379, DOI 10.1042/bj2370379; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Herman MA, 2006, J CLIN INVEST, V116, P1767, DOI 10.1172/JCI29027; Kamimura N, 2011, OBESITY, V19, P1396, DOI 10.1038/oby.2011.6; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; King AJF, 2012, BRIT J PHARMACOL, V166, P877, DOI 10.1111/j.1476-5381.2012.01911.x; Kobayashi K, 2000, METABOLISM, V49, P22, DOI 10.1016/S0026-0495(00)90588-2; Kowalski GM, 2015, BBA-MOL CELL BIOL L, V1851, P210, DOI 10.1016/j.bbalip.2014.12.002; Kowalski GM, 2014, AM J PHYSIOL-ENDOC M, V307, pE859, DOI 10.1152/ajpendo.00165.2014; Kuriyama H, 2002, DIABETES, V51, P2915, DOI 10.2337/diabetes.51.10.2915; LAURENZA A, 1989, TRENDS PHARMACOL SCI, V10, P442, DOI 10.1016/S0165-6147(89)80008-2; LEMAIGRE FP, 1994, BIOCHEM J, V303, P1; Li TT, 2014, J BIOL CHEM, V289, P3775, DOI 10.1074/jbc.M113.531640; Locasale JW, 2011, CELL METAB, V14, P443, DOI 10.1016/j.cmet.2011.07.014; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; MAGNUSSON I, 1995, DIABETES, V44, P185, DOI 10.2337/diabetes.44.2.185; Martin SD, 2014, MOL METAB, V3, P408, DOI 10.1016/j.molmet.2014.02.001; McGee SL, 2014, FASEB J, V28, P3384, DOI 10.1096/fj.14-249359; McGee SL, 2004, DIABETES, V53, P1208, DOI 10.2337/diabetes.53.5.1208; McGee SL, 2003, DIABETES, V52, P926, DOI 10.2337/diabetes.52.4.926; Mertins P, 2013, NAT METHODS, V10, P634, DOI 10.1038/nmeth.2518; Mihaylova MM, 2011, CELL, V145, P607, DOI 10.1016/j.cell.2011.03.043; Nagle CA, 2009, J LIPID RES, V50, pS74, DOI 10.1194/jlr.R800053-JLR200; Nicholls C, 2012, CLIN EXP PHARMACOL P, V39, P674, DOI 10.1111/j.1440-1681.2011.05599.x; Nuttall FQ, 2008, DIABETES-METAB RES, V24, P438, DOI 10.1002/dmrr.863; Olsen JB, 2016, MOL CELL PROTEOMICS, V15, P892, DOI 10.1074/mcp.M115.053280; PRIPBUUS C, 1992, EUR J BIOCHEM, V209, P291, DOI 10.1111/j.1432-1033.1992.tb17288.x; Roden M, 2003, BEST PRACT RES CL EN, V17, P365, DOI 10.1016/S1521-690X(03)00031-9; Roden M, 2000, DIABETES, V49, P701, DOI 10.2337/diabetes.49.5.701; Saltiel AR, 2001, NATURE, V414, P799, DOI 10.1038/414799a; Seidler N. W., 2012, GAPDH BIOL PROPERTIE, P985; Seidler NW, 2013, ADV EXP MED BIOL, V985, P179, DOI 10.1007/978-94-007-4716-6_6; Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747; Seo J, 2004, J BIOCHEM MOL BIOL, V37, P35; Simon GM, 2012, P NATL ACAD SCI USA, V109, P11133, DOI 10.1073/pnas.1208669109; Staehr P, 2003, DIABETES, V52, P260, DOI 10.2337/diabetes.52.2.260; Sun Z, 2012, NAT MED, V18, P934, DOI 10.1038/nm.2744; TAUNTON OD, 1974, J BIOL CHEM, V249, P7228; Ventura M, 2010, INT J BIOCHEM CELL B, V42, P1672, DOI 10.1016/j.biocel.2010.06.014; Wang QJ, 2010, SCIENCE, V327, P1004, DOI 10.1126/science.1179687; Washizu T, 1999, RES VET SCI, V67, P205, DOI 10.1053/rvsc.1998.0305; Weinert BT, 2013, CELL REP, V4, P842, DOI 10.1016/j.celrep.2013.07.024; Yun M, 2000, BIOCHEMISTRY-US, V39, P10702, DOI 10.1021/bi9927080; Zannat MT, 2011, BIOCHEM BIOPH RES CO, V409, P171, DOI 10.1016/j.bbrc.2011.04.094; Zeng XY, 2012, BIOCHEM PHARMACOL, V84, P830, DOI 10.1016/j.bcp.2012.07.003; Zhang JY, 2015, CANCER BIOL MED, V12, P10, DOI 10.7497/j.issn.2095-3941.2014.0019; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	58	21	22	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2592	2602		10.1096/fj.201601215R	http://dx.doi.org/10.1096/fj.201601215R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28258188				2022-12-28	WOS:000401553400030
J	Didiasova, M; Singh, R; Wilhelm, J; Kwapiszewska, G; Wujak, L; Zakrzewicz, D; Schaefer, L; Markart, P; Seeger, W; Lauth, M; Wygrecka, M				Didiasova, Miroslava; Singh, Rajeev; Wilhelm, Jochen; Kwapiszewska, Grazyna; Wujak, Lukasz; Zakrzewicz, Dariusz; Schaefer, Liliana; Markart, Philipp; Seeger, Werner; Lauth, Matthias; Wygrecka, Malgorzata			Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors	FASEB JOURNAL			English	Article						idiopathic pulmonary fibrosis; hedgehog signaling; TGF-beta signaling	IDIOPATHIC PULMONARY-FIBROSIS; INDUCED LUNG FIBROSIS; GROWTH-FACTOR-BETA; SONIC HEDGEHOG; TGF-BETA; EXPRESSION; INVOLVEMENT; ACTIVATION; SUPPRESSOR; CROSSTALK	Pirfenidone is an antifibrotic drug, recently approved for the treatment of patients with idiopathic pulmonary fibrosis (IPF). Although pirfenidone exhibits anti-inflammatory, antioxidant, and antifibrotic properties, the molecular mechanis munderlying its protective effects remains unknown. Here, we link pirfenidone action with the regulation of the profibrotic hedgehog (Hh) signaling pathway. We demonstrate that pirfenidone selectively destabilizes the glioma-associated oncogene homolog (GLI) 2 protein, the primary activator of Hh-mediated gene transcription. Consequently, pirfenidone decreases overall Hh pathway activity in patients with IPF and in patient-derived primary lung fibroblasts and leads to diminished levels of Hh target genes, such as GLI1, Hh receptor Patched-1, alpha-smooth muscle actin, and fibronectin, and to reduced cell migration and proliferation. Interestingly, Hh-triggered TGF-beta 1 expression potentiated Hh responsiveness of primary lung fibroblasts by elevating the available pool of glioma-associated oncogene homolog (GLI) 1/GLI2, thus creating a vicious cycle of amplifying fibrotic processes. Because GLI transcription factors are not only crucial for Hh-mediated changes but are also required as mediators of TGF-beta signaling, our findings suggest that pirfenidone exerts its clinically beneficial effects through dual Hh/TGF-beta inhibitionby targeting the GLI2 protein.-Didiasova, M., Singh, R., Wilhelm, J., K wapiszewska, G., Wujak, L., Zakrzewicz, D., Schaefer, L., Markart, P., Seeger, W., Lauth, M., Wygrecka, M. Pirfenidone exerts antifibrotic effects through inhibition of GLI transcription factors.	[Didiasova, Miroslava; Wujak, Lukasz; Zakrzewicz, Dariusz; Wygrecka, Malgorzata] Univ Giessen & Marburg Lung Ctr, Dept Biochem, Friedrichstr 24, D-35392 Giessen, Germany; [Wilhelm, Jochen; Markart, Philipp; Seeger, Werner] Univ Giessen & Marburg Lung Ctr, Dept Internal Med, Giessen, Germany; [Singh, Rajeev; Lauth, Matthias] Philipps Univ, Inst Mol Biol & Tumor Res IMT, Ctr Tumor Biol & Immunol, Marburg, Germany; [Wilhelm, Jochen; Markart, Philipp; Seeger, Werner; Wygrecka, Malgorzata] Justus Liebig Univ, German Ctr Lung Res, Giessen, Germany; [Kwapiszewska, Grazyna] Ludwig Boltzmann Inst Lung Vasc Res, Graz, Austria; [Schaefer, Liliana] Goethe Univ, Inst Pharmacol & Toxicol, Sch Med, Frankfurt, Germany	Philipps University Marburg; Justus Liebig University Giessen; Ludwig Boltzmann Institute; Goethe University Frankfurt	Wygrecka, M (corresponding author), Univ Giessen & Marburg Lung Ctr, Dept Biochem, Friedrichstr 24, D-35392 Giessen, Germany.	malgorzata.wygrecka@innere.med.uni-giessen.de	Wilhelm, Jochen/AAX-4302-2021; Wygrecka, Malgorzata/AAZ-3679-2020	Wilhelm, Jochen/0000-0001-5544-9647; Wygrecka, Malgorzata/0000-0002-3656-2932; Zakrzewicz, Dariusz/0000-0003-3292-9706; Seeger, Werner/0000-0003-1946-0894; Lauth, Matthias/0000-0001-5922-5384; Kwapiszewska, grazyna/0000-0003-0518-9079; Schaefer, Liliana/0000-0002-3318-3005	Von-Behring-Rontgen Foundation; German Research Foundation [WY119/1-3]; Oskar Helene Heim Foundation; German Center for Lung Research	Von-Behring-Rontgen Foundation; German Research Foundation(German Research Foundation (DFG)); Oskar Helene Heim Foundation; German Center for Lung Research	This study was funded by the Von-Behring-Rontgen Foundation (to M.L. and M.W.), the German Research Foundation (Grant WY119/1-3; to M.W.), the Oskar Helene Heim Foundation (to P.M.), and the German Center for Lung Research (to P.M. and M.W.).The authors thank Y. Horn, M. Schwinn, and H. Thiele (all from the Department of Biochemistry, Universities of Giessen and Marburg Lung Center, Giessen, Germany) for excellent technical assistance. J.W., P.M., W.S., and M. W. are members of the German Center for Lung Research. The authors declare no conflicts of interest.	Amano K, 2014, J BIOL CHEM, V289, P24898, DOI 10.1074/jbc.M114.570507; Azuma A, 2005, AM J RESP CRIT CARE, V171, P1040, DOI 10.1164/rccm.200404-571OC; Chen SJ, 1999, J INVEST DERMATOL, V112, P49, DOI 10.1046/j.1523-1747.1999.00477.x; Cho ME, 2010, EXPERT OPIN INV DRUG, V19, P275, DOI 10.1517/13543780903501539; Choi K, 2012, MOL VIS, V18, P1010; Cigna N, 2012, AM J PATHOL, V181, P2126, DOI 10.1016/j.ajpath.2012.08.019; Coon DR, 2006, EXP MOL PATHOL, V80, P119, DOI 10.1016/j.yexmp.2005.12.003; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; Fitch PM, 2011, INT J EXP PATHOL, V92, P8, DOI 10.1111/j.1365-2613.2010.00743.x; Giri Shri N., 1999, Journal of Environmental Pathology Toxicology and Oncology, V18, P169; Hanna A, 2016, MOL CANCER, V15, DOI 10.1186/s12943-016-0509-3; Hisatomi K, 2012, BMC PULM MED, V12, DOI 10.1186/1471-2466-12-24; Hu BA, 2015, AM J RESP CELL MOL, V52, P418, DOI 10.1165/rcmb.2014-0108OC; Humke EW, 2010, GENE DEV, V24, P670, DOI 10.1101/gad.1902910; IYER SN, 1995, J LAB CLIN MED, V125, P779; Iyer SN, 2000, INFLAMMATION, V24, P477, DOI 10.1023/A:1007068313370; Javelaud D, 2012, FEBS LETT, V586, P2016, DOI 10.1016/j.febslet.2012.05.011; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Kozono S, 2013, CANCER RES, V73, P2345, DOI 10.1158/0008-5472.CAN-12-3180; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Lipinski RJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-49; Louro ID, 2002, CANCER RES, V62, P5867; Bolanos AL, 2012, AM J PHYSIOL-LUNG C, V303, pL978, DOI 10.1152/ajplung.00184.2012; Maitah MY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016068; Miura Y, 2014, EUR RESPIR J, V44; Moshai EF, 2014, AM J RESP CELL MOL, V51, P11, DOI 10.1165/rcmb.2013-0154OC; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Okamoto Tatsuya, 2006, Nihon Kokyuki Gakkai Zasshi, V44, P359; Pardo A, 2002, INT J BIOCHEM CELL B, V34, P1534, DOI 10.1016/S1357-2725(02)00091-2; Raghu G, 2015, AM J RESP CRIT CARE, V192, pE3, DOI 10.1164/rccm.201506-1063ST; Regl G, 2002, ONCOGENE, V21, P5529, DOI 10.1038/sj.onc.1205748; Schaefer CJ, 2011, EUR RESPIR REV, V20, P85, DOI 10.1183/09059180.00001111; Selman M, 2001, ANN INTERN MED, V134, P136, DOI 10.7326/0003-4819-134-2-200101160-00015; Shi Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028134; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Taniguchi H, 2010, EUR RESPIR J, V35, P821, DOI 10.1183/09031936.00005209; Wilson CW, 2010, DEVELOPMENT, V137, P2079, DOI 10.1242/dev.045021; Wygrecka M, 2011, AM J RESP CRIT CARE, V183, P1703, DOI 10.1164/rccm.201009-1479OC; Yoo YA, 2008, CARCINOGENESIS, V29, P480, DOI 10.1093/carcin/bgm281	39	55	55	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1916	1928		10.1096/fj.201600892RR	http://dx.doi.org/10.1096/fj.201600892RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28148565				2022-12-28	WOS:000399195500014
J	Heller, S; Penrose, HM; Cable, C; Biswas, D; Nakhoul, H; Baddoo, M; Flemington, E; Crawford, SE; Savkovic, SD				Heller, Sandra; Penrose, Harrison M.; Cable, Chloe; Biswas, Debjani; Nakhoul, Hani; Baddoo, Melody; Flemington, Erik; Crawford, Susan E.; Savkovic, Suzana D.			Reduced mitochondrial activity in colonocytes facilitates AMPK alpha 2-dependent inflammation	FASEB JOURNAL			English	Article						intestine; RNA-seq; inflammatory bowel disease; rho(0) cells	OXIDATIVE-PHOSPHORYLATION SYSTEM; OXYGEN SPECIES PRODUCTION; BOWEL-DISEASE; INTESTINAL INFLAMMATION; UNCOUPLING PROTEIN-2; ULCERATIVE-COLITIS; NLRP3 INFLAMMASOME; LACKING MTDNA; RHO(0) CELLS; MICE	Intestinal inflammation is associated with low levels of mucosal ATP, highlighting the importance of mitochondrial function associated with ATP production in the pathophysiology of the disease. In the inflamed colon of humans and mice, we found decreased levels of mitochondrial complex cytochromec oxidase I/IV and lower ATP levels. Thus, we generated colonic rho(0) cells with reduced mitochondrial function linked to ATP production by selective depletion of mitochondrial DNA. In these cells, RNA sequencing revealed a substantial number of differentially expressed transcripts, among which 240 belonged to inflammatory pathways activated in human inflamed colon and TNF-alpha-treated cells (false discovery rate < 0.05). TNF-alpha treatment of colonic rho(0) cells augmented IL-8 expression by 9-fold (P < 0.01) via NF-kappa B compared to TNF-alpha-treated control. Moreover, reduced mitochondrial function facilitated TNF-alpha-mediated NF-kappa B luciferase promoter activity as a result of lowered inhibitory I kappa B alpha (nuclear factor of kappa light polypeptide gene enhancer in B-cell inhibitor, a), leading to elevated NF-kappa B. In cells with reduced mitochondrial function, TNF-alpha facilitated AMPK alpha 2 activation by 8-fold (P < 0.01), which was involved in NF-kappa B-dependent IL-8 expression. Last, in human and mouse colon, anti-TNF-alpha treatment restored reduced mitochondria-dependent inflammation. We propose that selective targeting of this novel mechanism provides new treatment opportunities for intestinal inflammation.-Heller, S., Penrose, H. M., Cable, C., Biswas, D., Nakhoul, H., Baddoo, M., Flemington, E., Crawford, S. E., Savkovic, S. D. Reduced mitochondrial activity incolonocytes facilitates AMPK alpha 2-dependent inflammation.	[Heller, Sandra; Penrose, Harrison M.; Cable, Chloe; Biswas, Debjani; Nakhoul, Hani; Baddoo, Melody; Flemington, Erik; Savkovic, Suzana D.] Tulane Univ, Dept Pathol & Lab Med, 1430 Tulane Ave SL-79, New Orleans, LA 70112 USA; [Crawford, Susan E.] Univ Chicago, Pritzker Sch Med, NorthShore Res Inst, Dept Surg, Evanston, IL USA	Tulane University; NorthShore University Health System; University of Chicago	Savkovic, SD (corresponding author), Tulane Univ, Dept Pathol & Lab Med, 1430 Tulane Ave SL-79, New Orleans, LA 70112 USA.	ssavkovi@tulane.edu		Cable, Chloe/0000-0002-6878-5698; Heller, Sandra/0000-0002-8704-2646; Penrose, Harrison/0000-0001-7957-5066	U.S. National Institutes of Health, National Cancer Institute RO1 [CA160809]; NATIONAL CANCER INSTITUTE [P01CA214091, R01CA160809] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI106676] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute RO1; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by a U.S. National Institutes of Health, National Cancer Institute RO1 award (CA160809). The authors thank the University of Wisconsin Biotechnology Center DNA Sequencing Facility for providing next-generation sequencing facilities and services.	Arnould T, 2003, FASEB J, V17, P2145, DOI 10.1096/fj.03-0075fje; Arsenijevic D, 2000, NAT GENET, V26, P435, DOI 10.1038/82565; Bar F, 2013, GASTROENTEROLOGY, V145, P1055, DOI 10.1053/j.gastro.2013.07.015; Bai AP, 2010, J PHARMACOL EXP THER, V333, P717, DOI 10.1124/jpet.109.164954; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Barroso E, 2011, BIOCHEM PHARMACOL, V81, P534, DOI 10.1016/j.bcp.2010.12.004; Bell EL, 2007, J CELL BIOL, V177, P1029, DOI 10.1083/jcb.200609074; Beltran B, 2010, INFLAMM BOWEL DIS, V16, P76, DOI 10.1002/ibd.21027; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boekema EJ, 2007, J BIOL CHEM, V282, P1, DOI 10.1074/jbc.R600031200; BUFFINTON GD, 1995, FREE RADICAL RES, V22, P131, DOI 10.3109/10715769509147535; Chang KW, 2015, FOOD FUNCT, V6, P3334, DOI [10.1039/C5FO00513B, 10.1039/c5fo00513b]; Chevallet M, 2006, ELECTROPHORESIS, V27, P1574, DOI 10.1002/elps.200500704; Cunningham KE, 2016, J BIOL CHEM, V291, P10184, DOI 10.1074/jbc.M115.688812; Dashdorj A, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-178; Garcia JJ, 2000, J BIOL CHEM, V275, P11075, DOI 10.1074/jbc.275.15.11075; Gardet A, 2012, CURR OPIN IMMUNOL, V24, P522, DOI 10.1016/j.coi.2012.08.001; Garg AK, 2002, MOL IMMUNOL, V39, P509, DOI 10.1016/S0161-5890(02)00207-9; Geremia A, 2014, AUTOIMMUN REV, V13, P3, DOI 10.1016/j.autrev.2013.06.004; HARADA A, 1994, J LEUKOCYTE BIOL, V56, P559, DOI 10.1002/jlb.56.5.559; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; Heller S, 2016, AM J PHYSIOL-GASTR L, V310, pG844, DOI 10.1152/ajpgi.00407.2015; Heller S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073207; Hsieh SY, 2006, PROTEOMICS, V6, P5322, DOI 10.1002/pmic.200500541; Kepp O, 2011, NAT IMMUNOL, V12, P199, DOI 10.1038/ni0311-199; Kim A, 2015, TOX RESEARCH, V31, P323, DOI 10.5487/TR.2015.31.4.323; Kim I, 2007, ARCH BIOCHEM BIOPHYS, V462, P245, DOI 10.1016/j.abb.2007.03.034; KING MP, 1989, SCIENCE, V246, P500, DOI 10.1126/science.2814477; Kmiez Zbigniew, 1998, Archivum Immunologiae et Therapiae Experimentalis, V46, P143; Koh SJ, 2014, J GASTROEN HEPATOL, V29, P502, DOI 10.1111/jgh.12435; Kowaltowski AJ, 2009, FREE RADICAL BIO MED, V47, P333, DOI 10.1016/j.freeradbiomed.2009.05.004; Kucharzik T, 2005, GUT, V54, P1565, DOI 10.1136/gut.2004.061168; Kukat A, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn124; Leng N, 2013, BIOINFORMATICS, V29, P1035, DOI 10.1093/bioinformatics/btt087; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Li JX, 2013, ADV IMMUNOL, V119, P135, DOI 10.1016/B978-0-12-407707-2.00005-9; LI K, 1995, AM J PHYSIOL-CELL PH, V269, pC1265, DOI 10.1152/ajpcell.1995.269.5.C1265; Lister R, 2005, MOL MEMBR BIOL, V22, P87, DOI 10.1080/09687860500041247; MEYER RR, 1969, BIOCHEM BIOPH RES CO, V34, P238, DOI 10.1016/0006-291X(69)90637-8; MUKAIDA N, 1991, ADV EXP MED BIOL, V305, P31; Oz HS, 2005, J NUTR BIOCHEM, V16, P297, DOI 10.1016/j.jnutbio.2004.09.007; Pagliarini DJ, 2013, GENE DEV, V27, P2615, DOI 10.1101/gad.229724.113; Park DW, 2014, AM J PHYSIOL-LUNG C, V307, pL735, DOI 10.1152/ajplung.00165.2014; Podolsky DK, 1997, J GASTROENTEROL, V32, P122, DOI 10.1007/BF01213309; Rena G, 2013, DIABETOLOGIA, V56, P1898, DOI 10.1007/s00125-013-2991-0; ROEDIGER WEW, 1980, LANCET, V2, P712; Samavati L, 2008, J BIOL CHEM, V283, P21134, DOI 10.1074/jbc.M801954200; Scharl M, 2009, J BIOL CHEM, V284, P27952, DOI 10.1074/jbc.M109.046292; Shekhawat PS, 2007, MOL GENET METAB, V92, P315, DOI 10.1016/j.ymgme.2007.08.002; Shkoda A, 2007, J PROTEOME RES, V6, P1114, DOI 10.1021/pr060433m; Sidoti-de Fraisse C, 1998, ONCOGENE, V17, P1639, DOI 10.1038/sj.onc.1202094; Smeitink JA, 2006, CELL METAB, V3, P9, DOI 10.1016/j.cmet.2005.12.001; Snoeks L, 2008, INFECT IMMUN, V76, P4677, DOI 10.1128/IAI.00227-08; Snoeks L, 2009, LAB INVEST, V89, P1053, DOI 10.1038/labinvest.2009.66; Szczepanowska J, 2012, BBA-BIOENERGETICS, V1817, P1740, DOI 10.1016/j.bbabio.2012.02.028; Tang GJ, 2011, FREE RADICAL BIO MED, V50, P1492, DOI 10.1016/j.freeradbiomed.2011.02.030; Vogler S, 2006, AM J PATHOL, V168, P1570, DOI 10.2353/ajpath.2006.051069; Yu X, 2009, GENES IMMUN, V10, P601, DOI 10.1038/gene.2009.29; Zhang HJ, 2012, J GASTROEN HEPATOL, V27, P603, DOI 10.1111/j.1440-1746.2011.06879.x; Zhang XZ, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-4	61	15	17	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2013	2025		10.1096/fj.201600976R	http://dx.doi.org/10.1096/fj.201600976R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28183804	Green Published			2022-12-28	WOS:000399195500022
J	Qian, Q; Liu, QJ; Zhou, DM; Pan, HY; Liu, ZW; He, FP; Ji, SY; Wang, DP; Bao, WX; Liu, XY; Liu, ZL; Zhang, H; Zhang, XQ; Zhang, L; Wang, MK; Xu, Y; Huang, FD; Luo, BY; Sun, BG				Qian, Qi; Liu, Qiuji; Zhou, Dongming; Pan, Hongyu; Liu, Zhiwei; He, Fangping; Ji, Suying; Wang, Dongpi; Bao, Wangxiao; Liu, Xinyi; Liu, Zhaoling; Zhang, Heng; Zhang, Xiaoqin; Zhang, Ling; Wang, Mingkai; Xu, Ying; Huang, Fude; Luo, Benyan; Sun, Binggui			Brain-specific ablation of Efr3a promotes adult hippocampal neurogenesis via the brain-derived neurotrophic factor pathway	FASEB JOURNAL			English	Article						Efr3; BDNF; dentate gyrus; development; mouse	FORKHEAD TRANSCRIPTION FACTOR; PLASMA-MEMBRANE; DROSOPHILA-MELANOGASTER; SIGNAL-TRANSDUCTION; ROLLING BLACKOUT; CELL-SURVIVAL; PROTEIN; KINASE; AKT; PHOSPHORYLATION	Efr3 is a newly identified plasma membrane protein and plays an important role in the phosphoinositide metabolism on the plasma membrane. However, although it is highly expressed in the brain, the functional significance of Efr3 in the brain is not clear. In the present study, we generated Efr3a(f/f) mice and then crossed them with Nestin-Cre mice to delete Efr3a, one of the Efr3 isoforms, specifically in the brain. We found that brain-specific ablation of Efr3a promoted adult hippocampal neurogenesis by increasing survival and maturation of newborn neurons without affecting their dendritic tree morphology. Moreover, the brain-derived neurotrophic factor (BDNF)-tropomyosin-related kinase B (TrkB) signaling pathway was significantly enhanced in the hippocampus of Efr3a-deficient mice, as reflected by increased expression of BDNF, TrkB, and the downstream molecules, including phospho-MAPK and phospho-Akt. Furthermore, the number of TUNEL+ cells was decreased in the subgranular zone of dentate gyrus in Efr3a-deficient mice compared with that of control mice. Our data suggest that brain-specific deletion of Efr3a could promote adult hippocampal neurogenesis, presumably by upregulating the expression of BDNF and its receptor, TrkB, and therefore provide new insight into the roles of Efr3 in the brain.Qian, Q., Liu, Q., Zhou, D., Pan, H., Liu, Z., He, F., Ji, S., Wang, D., Bao, W., Liu, X., Liu, Z., Zhang, H., Zhang, X., Zhang, L., Wang, M., Xu, Y., Huang, F., Luo, B., Sun B. Brain-specific ablation of Efr3a promotes adult hippocampal neurogenesis via the brain-derived neurotrophic factor pathway.	[Qian, Qi; He, Fangping; Luo, Benyan; Sun, Binggui] Minist Hlth China, Dept Neurobiol, Key Lab Med Neurobiol, Beijing, Peoples R China; [Ji, Suying; Bao, Wangxiao; Zhang, Xiaoqin; Xu, Ying] Key Lab Neurobiol Zhejiang Prov, Beijing, Peoples R China; [Liu, Qiuji; Zhou, Dongming; Pan, Hongyu; Bao, Wangxiao; Zhang, Xiaoqin; Xu, Ying; Luo, Benyan] Zhejiang Univ, First Affiliated Hosp, Dept Neurol, Collaborat Innovat Ctr Brain Sci,Sch Med, Hangzhou, Zhejiang, Peoples R China; [Wang, Dongpi; Huang, Fude] Univ Chinese Acad Sci, Shanghai Adv Res Inst, Shanghai, Peoples R China; [Wang, Dongpi; Zhang, Ling; Luo, Benyan] Nanjing Univ, Model Anim Res Ctr, Minist Educ MOE Key Lab Model Anim Dis Study, Nanjing, Jiangsu, Peoples R China	Zhejiang University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS; University of Chinese Academy of Sciences, CAS; Nanjing University	Luo, BY; Sun, BG (corresponding author), Minist Hlth China, Dept Neurobiol, Key Lab Med Neurobiol, Beijing, Peoples R China.	luobenyan@zju.edu.cn; bsun@zju.edu.cn	liu, xinyi/GWZ-8739-2022; Xu, Ying/AAF-3081-2019; Xu, Ying/A-3009-2013; Sun, Binggui/J-9028-2016	Xu, Ying/0000-0002-6689-7768; Xu, Ying/0000-0002-6689-7768; Sun, Binggui/0000-0002-0386-6569	Major State Basic Research Program of China [2014CB964602]; National Natural Science Foundation of China [91132713, 81371400, 81471284]; Zhejiang Province Natural Science Foundation of China [LR13H090001]; Research Fund for the Doctoral Program of Higher Education of China [20110101120094]; Zhejiang Province Medical Science and Technology Project [2016152769]	Major State Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Province Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Zhejiang Province Medical Science and Technology Project	The authors thank Dr. Fred Gage (Salk Institute, La Jolla, CA, USA) for the MoMLV-based vector; Dr. Jianwei Jiao (Institute of Zoology, Chinese Academy of Sciences, Beijing, China) for the Nestin-cre mice; and Drs. Yudong Zhou and Xiaodong Wang (Zhejiang University School of Medicine) for some of the reagents. This work was supported by Grant 2014CB964602 from the Major State Basic Research Program of China, Grants 91132713, 81371400, and 81471284 from the National Natural Science Foundation of China, Grant LR13H090001 from the Zhejiang Province Natural Science Foundation of China, Grant 20110101120094 from the Research Fund for the Doctoral Program of Higher Education of China, and Grant 2016152769 from the Zhejiang Province Medical Science and Technology Project. The authors declare no conflicts of interest.	Ahn JY, 2006, EMBO J, V25, P2083, DOI 10.1038/sj.emboj.7601111; Aimone JB, 2016, CSH PERSPECT BIOL, V8, DOI 10.1101/cshperspect.a018960; Apple DM, 2017, BRAIN RES, V1655, P270, DOI 10.1016/j.brainres.2016.01.023; Baird D, 2008, J CELL BIOL, V183, P1061, DOI 10.1083/jcb.200804003; Baskin JM, 2016, NAT CELL BIOL, V18, P132, DOI 10.1038/ncb3271; Bekinschtein P, 2011, SEMIN CELL DEV BIOL, V22, P536, DOI 10.1016/j.semcdb.2011.07.002; BERRIDGE MJ, 1984, NATURE, V312, P315, DOI 10.1038/312315a0; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Bojjireddy N, 2015, J CELL SCI, V128, P118, DOI 10.1242/jcs.157495; Bojjireddy N, 2014, J BIOL CHEM, V289, P6120, DOI 10.1074/jbc.M113.531426; Bonni A, 1999, SCIENCE, V286, P1358, DOI 10.1126/science.286.5443.1358; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Butler AA, 1998, COMP BIOCHEM PHYS B, V121, P19, DOI 10.1016/S0305-0491(98)10106-2; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; CHANDRASHEKARAN S, 1993, GENETICA, V90, P61, DOI 10.1007/BF01435179; Chung J, 2015, SCIENCE, V349, P428, DOI 10.1126/science.aab1370; COWLEY S, 1994, CELL, V77, P841, DOI 10.1016/0092-8674(94)90133-3; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; delPeso L, 1997, SCIENCE, V278, P687; Faulkner DL, 1998, DEV GENET, V23, P264, DOI 10.1002/(SICI)1520-6408(1998)23:4<264::AID-DVG2>3.0.CO;2-6; Galea LAM, 2008, BRAIN RES REV, V57, P332, DOI 10.1016/j.brainresrev.2007.05.008; Gupta AR, 2014, MOL AUTISM, V5, DOI 10.1186/2040-2392-5-31; Huang FD, 2006, J NEUROSCI, V26, P2369, DOI 10.1523/JNEUROSCI.3770-05.2006; Huang FD, 2004, NAT NEUROSCI, V7, P1070, DOI 10.1038/nn1313; Kops GJPL, 1999, NATURE, V398, P630, DOI 10.1038/19328; Leuner B, 2006, HIPPOCAMPUS, V16, P216, DOI 10.1002/hipo.20153; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Middleton G, 2001, DEVELOPMENT, V128, P4715; Ming GL, 2005, ANNU REV NEUROSCI, V28, P223, DOI 10.1146/annurev.neuro.28.051804.101459; MIYASHITA T, 1995, CELL, V80, P293; Nakatsu F, 2012, J CELL BIOL, V199, P1003, DOI 10.1083/jcb.201206095; Pencea V, 2001, J NEUROSCI, V21, P6706, DOI 10.1523/JNEUROSCI.21-17-06706.2001; Riccio A, 1999, SCIENCE, V286, P2358, DOI 10.1126/science.286.5448.2358; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; SHYNGLE J, 1985, INDIAN J EXP BIOL, V23, P235; Takahashi J, 1999, J NEUROBIOL, V38, P65, DOI 10.1002/(SICI)1097-4695(199901)38:1<65::AID-NEU5>3.3.CO;2-H; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; van Praag H, 2008, NEUROMOL MED, V10, P128, DOI 10.1007/s12017-008-8028-z; Yamaguchi A, 2001, J BIOL CHEM, V276, P5256, DOI 10.1074/jbc.M008552200; Ye KQ, 2000, CELL, V103, P919, DOI 10.1016/S0092-8674(00)00195-1; Zhao CM, 2006, J NEUROSCI, V26, P3, DOI 10.1523/JNEUROSCI.3648-05.2006; Zheng WH, 2002, J NEUROCHEM, V80, P1049, DOI 10.1046/j.0022-3042.2002.00783.x	43	5	5	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2104	2113		10.1096/fj.201601207R	http://dx.doi.org/10.1096/fj.201601207R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28193719				2022-12-28	WOS:000399195500029
J	Rink, C; Gnyawali, S; Stewart, R; Teplitsky, S; Harris, H; Roy, S; Sen, CK; Khanna, S				Rink, Cameron; Gnyawali, Surya; Stewart, Richard; Teplitsky, Seth; Harris, Hallie; Roy, Sashwati; Sen, Chandan K.; Khanna, Savita			Glutamate oxaloacetate transaminase enables anaplerotic refilling of TCA cycle intermediates in stroke-affected brain	FASEB JOURNAL			English	Article						anaplerosis; hypoglycemia; ischemia; oxygen	ACUTE ISCHEMIC-STROKE; NEURONAL CELL-LINE; CITRIC-ACID CYCLE; INDUCED NEURODEGENERATION; OXIDATIVE STRESS; HYPOGLYCEMIA; DEATH; NEUROPROTECTION; 12-LIPOXYGENASE; METABOLISM	Ischemic stroke results in excessive release of glutamate, which contributes to neuronal cell death. Here, we test the hypothesis that otherwise neurotoxic glutamate can be productively metabolized by glutamate oxaloacetate transaminase (GOT) to maintain cellular energetics and protect the brain from ischemic stroke injury. The GOT-dependent metabolismof glutamatewas studied in primary neural cells and in stroke-affected C57-BL6mice usingmagnetic resonance spectroscopy andGC-MS. ExtracellularGlu sustained cell viability under hypoglycemic conditions and increased GOT-mediated metabolism in vitro. Correction of stroke-induced hypoxia using supplemental oxygen in vivo lowered Glu levels as measured by 1H magnetic resonance spectroscopy. GOT knockdown abrogated this effect and caused ATP loss in the stroke-affected brain. GOT overexpression increased anaplerotic refilling of tricarboxylic acid cycle intermediates in mouse brain during ischemic stroke. Furthermore, GOT overexpression not only reduced ischemic stroke lesion volume but also attenuated neurodegeneration and improved poststroke sensorimotor function. Taken together, our results show that GOT enables metabolism of otherwise neurotoxic extracellular Glu through a truncated tricarboxylic acid cycle under hypoglycemic conditions.-Rink, C., Gnyawali, S., Stewart, R., Teplitsky, S., Harris, H., Roy, S., Sen, C. K., Khanna, S. Glutamate oxaloacetate transaminase enables anaplerotic refilling of TCA cycle intermediates in stroke-affected brain. FASEB J. 31, 1709-1718 (2017). www.fasebj.org	[Rink, Cameron; Gnyawali, Surya; Stewart, Richard; Teplitsky, Seth; Harris, Hallie; Roy, Sashwati; Sen, Chandan K.; Khanna, Savita] Ohio State Univ, Dept Surg, Davis Heart & Lung Res Inst, Wexner Med Ctr, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Rink, C; Khanna, S (corresponding author), 473 W 12th Ave, Columbus, OH 43210 USA.	cameron.rink@osumc.edu; savita.khanna@osumc.edu	Gnyawali, Surya/AAC-3082-2020; Rink, Cameron/AAA-4484-2021; Gnyawali, Surya/AAC-3082-2020	Gnyawali, Surya/0000-0001-8980-4889; Rink, Cameron/0000-0002-3149-3624; Gnyawali, Surya/0000-0002-4214-8068; Teplitsky, Seth/0000-0001-9242-1360	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke [R01NS085272]; American Heart Association [12SDG11780023, NS42617]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS085272, R01NS042617] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grant R01NS085272 (to C.R. and S.K.), and by American Heart Association Grants 12SDG11780023 (to C.R.) and NS42617 (to C.K.S.). The authors thank Jessica Weist (The Ohio State University Wexner Medical Center) for technical support with in vivo experiments.	Bakken IJ, 1998, J NEUROSCI RES, V51, P636, DOI 10.1002/(SICI)1097-4547(19980301)51:5<636::AID-JNR11>3.0.CO;2-0; BUTCHER SP, 1987, NEUROSCI LETT, V76, P296, DOI 10.1016/0304-3940(87)90418-6; Campos F, 2011, J CEREBR BLOOD F MET, V31, P1378, DOI 10.1038/jcbfm.2011.3; ENGELSEN B, 1986, J NEUROCHEM, V47, P1634, DOI 10.1111/j.1471-4159.1986.tb00806.x; Fukui M, 2009, EUR J PHARMACOL, V617, P1, DOI 10.1016/j.ejphar.2009.06.059; HAYASHI T, 1954, KEIO J MED, V3, P192, DOI DOI 10.2302/KJM.3.183; Hofmeijer J, 2012, STROKE, V43, P607, DOI 10.1161/STROKEAHA.111.632943; Jamaluddin MS, 2009, ARTERIOSCL THROM VAS, V29, P2146, DOI 10.1161/ATVBAHA.109.194134; Khanna S, 2005, STROKE, V36, pE144, DOI 10.1161/01.STR.0000181082.70763.22; Khanna S, 2003, J BIOL CHEM, V278, P43508, DOI 10.1074/jbc.M307075200; Khanna S, 2002, METHOD ENZYMOL, V352, P191; Khanna S, 2007, J BIOL CHEM, V282, P23482, DOI 10.1074/jbc.M611269200; Khanna S, 2015, FASEB J, V29, P828, DOI 10.1096/fj.14-263723; Khanna S, 2015, ANTIOXID REDOX SIGN, V22, P175, DOI 10.1089/ars.2014.6106; Khanna S, 2013, J CEREBR BLOOD F MET, V33, P1197, DOI 10.1038/jcbfm.2013.68; KREBS HANS ADOLF, 1935, BIOCHEM JOUR, V29, P1620; Lai TW, 2014, PROG NEUROBIOL, V115, P157, DOI 10.1016/j.pneurobio.2013.11.006; MIYAMOTO M, 1989, J PHARMACOL EXP THER, V250, P1132; MURPHY TH, 1990, FASEB J, V4, P1624, DOI 10.1096/fasebj.4.6.2180770; MURPHY TH, 1989, NEURON, V2, P1547, DOI 10.1016/0896-6273(89)90043-3; Olney J W, 1986, Adv Exp Med Biol, V203, P631; Park HA, 2009, CELL DEATH DIFFER, V16, P1167, DOI 10.1038/cdd.2009.37; Park HA, 2011, STROKE, V42, P2308, DOI 10.1161/STROKEAHA.110.608547; Perez-Mato M, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.507; Puchowicz MA, 2008, J CEREBR BLOOD F MET, V28, P1907, DOI 10.1038/jcbfm.2008.79; Rink C, 2011, ANTIOXID REDOX SIGN, V14, P1777, DOI 10.1089/ars.2011.3930; Rink C, 2010, J CEREBR BLOOD F MET, V30, P1275, DOI 10.1038/jcbfm.2010.7; Sherwood TW, 2011, J NEUROSCI, V31, P9723, DOI 10.1523/JNEUROSCI.1665-11.2011; Sonnewald U, 1996, NEUROCHEM RES, V21, P987, DOI 10.1007/BF02532408; Tan Shirlee, 2001, Current Topics in Medicinal Chemistry, V1, P497, DOI 10.2174/1568026013394741; Tang YX, 2009, BLOOD, V113, P744, DOI 10.1182/blood-2008-03-145219; WIELOCH T, 1985, SCIENCE, V230, P681, DOI 10.1126/science.2996146; Yang LL, 2008, J BIOL CHEM, V283, P21988, DOI 10.1074/jbc.M803455200; Yang L, 2006, METABOLOMICS, V2, P85, DOI 10.1007/s11306-006-0019-1; Zhu MY, 2003, CELL MOL NEUROBIOL, V23, P865, DOI 10.1023/A:1025069407173	35	23	25	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1709	1718		10.1096/fj.201601033R	http://dx.doi.org/10.1096/fj.201601033R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28096234	Green Published			2022-12-28	WOS:000398504300035
J	Ruan, CC; Ma, Y; Ge, Q; Li, Y; Zhu, LM; Zhang, Y; Kong, LR; Wu, QH; Li, FH; Cheng, LX; Zhao, AZ; Zhu, DL; Gao, PJ				Ruan, Cheng-Chao; Ma, Yu; Ge, Qian; Li, Yan; Zhu, Li-Min; Zhang, Ying; Kong, Ling-Ran; Wu, Qi-Hong; Li, Fanghong; Cheng, Lixian; Zhao, Allan Z.; Zhu, Ding-Liang; Gao, Ping-Jin			Complement-mediated inhibition of adiponectin regulates perivascular inflammation and vascular injury in hypertension	FASEB JOURNAL			English	Article						perivascular adipose tissue; macrophage; adipocyte	ADIPOSE-TISSUE; MACROPHAGE POLARIZATION; ANGIOTENSIN-II; INSULIN SENSITIVITY; RECEPTOR-BINDING; EXPRESSION; PHENOTYPE; MICE; C5A; DYSFUNCTION	Perivascular adipose tissue (PVAT)-derived adiponectin (APN) is a secreted adipokine that protects against hypertension-related cardiovascular injury. However, the regulation of APN expression in hypertension remains to be explored. In this study, we demonstrated that down-regulation of APN was associated with complement activation in the PVAT of desoxycorticosterone acetate (DOCA)-salt hypertensive mice. Complement 3-deficient hypertensive mice were protected from ANP decrease in the PVAT. APN deficiency blockaded the protective effects of complement inhibition against hypertensive vascular injury. Mechanistically, complement 5a (C5a)-induced TNF-alpha secretion from macrophages is required for inhibiting APN expression in adipocytes. Macrophage depletion reversed C5a agonist peptide-induced TNF-alpha up-regulation and APN down-regulation in the PVAT of DOCA mice. Moreover, we detected increased macrophage infiltration and C5a expression associated with decreased APN expression in adipose tissue from patients with aldosterone-producing adenoma. These results identify a novel interaction between macrophages and adipocytes in the PVAT, where complement-mediated inhibition of APN acts as a potential risk factor for hypertensive vascular inflammation.	[Ruan, Cheng-Chao; Ma, Yu; Ge, Qian; Zhu, Li-Min; Zhang, Ying; Kong, Ling-Ran; Wu, Qi-Hong; Zhu, Ding-Liang; Gao, Ping-Jin] Shanghai Jiao Tong Univ, State Key Lab Med Gen, Shanghai, Peoples R China; [Ruan, Cheng-Chao; Ma, Yu; Ge, Qian; Zhu, Li-Min; Zhang, Ying; Kong, Ling-Ran; Wu, Qi-Hong; Zhu, Ding-Liang; Gao, Ping-Jin] Shanghai Jiao Tong Univ, Ruijin Hosp, Shanghai Key Lab Hypertens, Shanghai, Peoples R China; [Ruan, Cheng-Chao; Ma, Yu; Ge, Qian; Zhu, Li-Min; Zhang, Ying; Kong, Ling-Ran; Wu, Qi-Hong; Zhu, Ding-Liang; Gao, Ping-Jin] Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hypertens, Shanghai, Peoples R China; [Ruan, Cheng-Chao; Gao, Ping-Jin] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Key Lab Stem Cell Biol, Shanghai, Peoples R China; [Li, Yan] Ruijin Hospital, Dept Cardiol, Luwan Branch, Shanghai, Peoples R China; [Li, Fanghong; Cheng, Lixian; Zhao, Allan Z.] Nanjing Med Univ, Ctr Metab Dis Res, Nanjing, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Nanjing Medical University	Gao, PJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Hypertens, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China.; Gao, PJ (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Inst Hypertens, 197 Ruijin 2nd Rd, Shanghai 200025, Peoples R China.	gaopingjin@sibs.ac.cn		Ruan, Cheng-Chao/0000-0001-5229-9428	National Natural Science Foundation of China [81230071, 81570221, 91539202]; National High-Tech Research and Developement Program [2012AA02A516]; Shanghai Municipal Commission of Health and Family Planning [201540222]; Science and Technology Commission of Shanghai Municipality [15140901800]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High-Tech Research and Developement Program; Shanghai Municipal Commission of Health and Family Planning; Science and Technology Commission of Shanghai Municipality(Science & Technology Commission of Shanghai Municipality (STCSM))	The authors thank Dr. N. van Rooijen (Vrije University, Amsterdam, The Netherlands) for providing clodronate liposomes and Professor Chen Yan (University of Rochester School of Medicine and Dentistry, Rochester, NY, USA) for valuable suggestions and critical reading of the manuscript. This work was supported by the National Natural Science Foundation of China (Grants 81230071, 81570221, and 91539202), the National High-Tech Research and Developement Program (Grant 2012AA02A516), the Shanghai Municipal Commission of Health and Family Planning (Grant 201540222), and the Science and Technology Commission of Shanghai Municipality (Grant 15140901800). The authors declare no conflicts of interest.	Aurelie NDC, 2011, HYPERTENSION, V58, P479, DOI 10.1161/HYPERTENSIONAHA.110.168872; Bakker ENTP, 2006, CIRC RES, V99, P86, DOI 10.1161/01.RES.0000229657.83816.a7; Brown NK, 2014, ARTERIOSCL THROM VAS, V34, P1621, DOI 10.1161/ATVBAHA.114.303029; Bykov I, 2007, J HEPATOL, V46, P907, DOI 10.1016/j.jhep.2006.11.020; Dunkelberger JR, 2010, CELL RES, V20, P34, DOI 10.1038/cr.2009.139; Finch AM, 1997, J MED CHEM, V40, P877, DOI 10.1021/jm960727r; Greenstein AS, 2009, CIRCULATION, V119, P1661, DOI 10.1161/CIRCULATIONAHA.108.821181; Hajer GR, 2008, EUR HEART J, V29, P2959, DOI 10.1093/eurheartj/ehn387; Iyer A, 2011, J CARDIOVASC PHARM, V58, P479, DOI 10.1097/FJC.0b013e31822a7a09; Jadhav A, 2012, FREE RADICAL BIO MED, V53, P2277, DOI 10.1016/j.freeradbiomed.2012.10.529; Langer HF, 2010, BLOOD, V116, P4395, DOI 10.1182/blood-2010-01-261503; Lee YC, 2011, CIRCULATION, V124, P1160, DOI 10.1161/CIRCULATIONAHA.111.027375; Lin ZH, 2004, HYPERTENSION, V44, P42, DOI 10.1161/01.HYP.0000129540.83284.ca; Lynch L, 2012, IMMUNITY, V37, P574, DOI 10.1016/j.immuni.2012.06.016; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Mikolajczyk TP, 2016, FASEB J, V30, P1987, DOI 10.1096/fj.201500088R; Nawrocki AR, 2006, J BIOL CHEM, V281, P2654, DOI 10.1074/jbc.M505311200; Ndisang JF, 2010, J PHARMACOL EXP THER, V334, P87, DOI 10.1124/jpet.109.164871; Ohashi K, 2010, J BIOL CHEM, V285, P6153, DOI 10.1074/jbc.M109.088708; Omar A, 2014, ARTERIOSCL THROM VAS, V34, P1631, DOI 10.1161/ATVBAHA.114.303030; RAIJ L, 1989, KIDNEY INT, V36, P582, DOI 10.1038/ki.1989.234; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Ruan CC, 2015, ARTERIOSCL THROM VAS, V35, P598, DOI 10.1161/ATVBAHA.114.304927; Shagdarsuren E, 2005, CIRC RES, V97, P716, DOI 10.1161/01.RES.0000182677.89816.38; Szasz T, 2012, CLIN SCI, V122, P1, DOI 10.1042/CS20110151; Tano JY, 2014, ARTERIOSCL THROM VAS, V34, P1827, DOI 10.1161/ATVBAHA.114.303032; Tsioufis C, 2007, EUR HEART J, V28, P1162, DOI 10.1093/eurheartj/ehm089; Uemura Y, 2015, FASEB J, V29, P141, DOI 10.1096/fj.14-258129; van Stijn CMW, 2015, FASEB J, V29, P636, DOI 10.1096/fj.14-253831; Verlohren S, 2004, HYPERTENSION, V44, P271, DOI 10.1161/01.HYP.0000140058.28994.ec; Vogen SM, 1999, J PEPT RES, V53, P8, DOI 10.1111/j.1399-3011.1999.tb01612.x; Wagner E, 2010, NAT REV DRUG DISCOV, V9, P43, DOI 10.1038/nrd3011; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Withers SB, 2014, ARTERIOSCL THROM VAS, V34, P1637, DOI 10.1161/ATVBAHA.114.303031; Withers SB, 2011, ARTERIOSCL THROM VAS, V31, P908, DOI 10.1161/ATVBAHA.110.221705; Zappala G, 2009, BIOCHEM BIOPH RES CO, V382, P785, DOI 10.1016/j.bbrc.2009.03.112; Zhang CC, 2014, ARTERIOSCL THROM VAS, V34, P1240, DOI 10.1161/ATVBAHA.113.303120; Zhang CC, 2014, AM J HYPERTENS, V27, P857, DOI 10.1093/ajh/hpt274; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	40	11	12	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1120	+		10.1096/fj.201600780R	http://dx.doi.org/10.1096/fj.201600780R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27974594				2022-12-28	WOS:000395671200025
J	Kanzaki, H; Shinohara, F; Itohiya, K; Yamaguchi, Y; Katsumata, Y; Matsuzawa, M; Fukaya, S; Miyamoto, Y; Wada, S; Nakamura, Y				Kanzaki, Hiroyuki; Shinohara, Fumiaki; Itohiya, Kanako; Yamaguchi, Yuuki; Katsumata, Yuta; Matsuzawa, Masazumi; Fukaya, Sari; Miyamoto, Yutaka; Wada, Satoshi; Nakamura, Yoshiki			RANKL induces Bach1 nuclear import and attenuates Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular reactive oxygen species signaling and osteoclastogenesis in mice	FASEB JOURNAL			English	Article						heme; JNK; bone destruction; NQO1; aminolevulinic acid	TRANSCRIPTIONAL REPRESSOR BACH1; RESISTANT ACID-PHOSPHATASE; HEME OXYGENASE-1; OXIDATIVE STRESS; RESPONSE ELEMENT; GENE-EXPRESSION; BONE-RESORPTION; DIFFERENTIATION; NRF2; INDUCTION	Reactive oxygen species (ROS) play a role in intracellular signaling during osteoclastogenesis. We previously reported that transcriptional factor nuclear factor E2-related factor 2 (Nrf2) was exported from the nucleus to the cytoplasm by receptor activator of nuclear factor-B ligand (RANKL), and that Nrf2 negatively regulated osteoclastogenesis via antioxidant enzyme up-regulation. Knockout mice of BTB and CNC homology 1 (Bach1)the competitor for Nrf2 in transcriptional regulationwas known to attenuate RANKL-mediated osteoclastogenesis, although the mechanism remains unclear. Therefore, we hypothesized that RANKL could be involved in the nuclear translocation of Bach1, which would attenuate Nrf2-mediated antioxidant enzymes, thereby augmenting intracellular ROS signaling in osteoclasts. RANKL induced Bach1 nuclear import and Nrf2 nuclear export. Induction of Bach1 nuclear export increased Nrf2 nuclear import, augmented antioxidant enzyme expression, and, thus, diminished RANKL-mediated osteoclastogenesis via attenuated intracellular ROS signaling. Finally, an in vivo mouse bone destruction model clearly demonstrated that induction of Bach1 nuclear export inhibited bone destruction. In this study, we report that RANKL favors osteoclastogenesis via attenuation of Nrf2-mediated antioxidant enzyme expression by competing with Bach1 nuclear accumulation. Of importance, induction of Bach1 nuclear export activates Nrf2-dependent antioxidant enzyme expression, thereby attenuating osteoclastogenesis. Bach1 nuclear export might be a therapeutic target for such bone destructive diseases as rheumatoid arthritis, osteoporosis, and periodontitis.	[Kanzaki, Hiroyuki] Tohoku Univ Hosp, Maxillooral Disorders, Sendai, Miyagi, Japan; [Kanzaki, Hiroyuki; Itohiya, Kanako; Yamaguchi, Yuuki; Katsumata, Yuta; Matsuzawa, Masazumi; Fukaya, Sari; Miyamoto, Yutaka; Wada, Satoshi; Nakamura, Yoshiki] Tsurumi Univ, Sch Dent Med, Dept Orthodont, Yokohama, Kanagawa, Japan; [Shinohara, Fumiaki] Tohoku Univ, Grad Sch, Oral Microbiol, Sendai, Miyagi, Japan	Tohoku University; Tsurumi University; Tohoku University	Kanzaki, H (corresponding author), Tsurumi Univ, Sch Dent Med, Dept Orthodont, Tsurumi Ku, 2-1-3 Tsurumi, Yokohama, Kanagawa 2308501, Japan.	kanzaki-h@tsurumi-u.ac.jp	Kanzaki, Hiroyuki/M-2764-2019; Kanzaki, Hiroyuki/C-7942-2018	Kanzaki, Hiroyuki/0000-0003-3473-1218; Kanzaki, Hiroyuki/0000-0003-3473-1218	Japan Society for the Promotion of Science [23689081, 25670841, 15K11376]; Nestle Nutrition Council of Japan; Ministry of Education, Culture, Sports, Science and Technology of Japan [A-03]; Adaptable and Seamless Technology Transfer Program through Target-Driven Research and Development from the Japan Science and Technology Agency [AS231Z01205G]; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research [16K11797] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Nestle Nutrition Council of Japan(Nestle SA); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Adaptable and Seamless Technology Transfer Program through Target-Driven Research and Development from the Japan Science and Technology Agency; Astellas Foundation for Research on Metabolic Disorders; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science (23689081, 25670841, and 15K11376); the Nestle Nutrition Council of Japan; Translational Research Network Program from the Ministry of Education, Culture, Sports, Science and Technology of Japan (A-03); Adaptable and Seamless Technology Transfer Program through Target-Driven Research and Development from the Japan Science and Technology Agency (AS231Z01205G); and the Astellas Foundation for Research on Metabolic Disorders. The authors thank Eisai Food and Chemical for providing sodium ferrous citrate. Finally, H.K. and F.S. give their heartfelt appreciation to the experimental reagent companies and instrument companies for their various support in the rehabilitation from the damage caused by the Tohoku earthquake on March 11, 2011. The authors declare no conflicts of interest.	Alam J, 1999, J BIOL CHEM, V274, P26071, DOI 10.1074/jbc.274.37.26071; BAX BE, 1992, BIOCHEM BIOPH RES CO, V183, P1153, DOI 10.1016/S0006-291X(05)80311-0; Chiurchiu V, 2011, ANTIOXID REDOX SIGN, V15, P2605, DOI 10.1089/ars.2010.3547; Dhakshinamoorthy S, 2005, J BIOL CHEM, V280, P16891, DOI 10.1074/jbc.M500166200; Dohl Y, 2006, ANTIOXID REDOX SIGN, V8, P60, DOI 10.1089/ars.2006.8.60; ESTERBAUER H, 1991, FREE RADICAL BIO MED, V11, P81, DOI 10.1016/0891-5849(91)90192-6; FAVREAU LV, 1991, J BIOL CHEM, V266, P4556; Feng X, 2005, IUBMB LIFE, V57, P389, DOI 10.1080/15216540500137669; Goven D, 2009, FEBS LETT, V583, P3508, DOI 10.1016/j.febslet.2009.10.010; Ha H, 2004, EXP CELL RES, V301, P119, DOI 10.1016/j.yexcr.2004.07.035; Hama M, 2012, ARTHRITIS RHEUM-US, V64, P1518, DOI 10.1002/art.33497; Haro ERA, 2011, J PERIODONTAL RES, V46, P361, DOI 10.1111/j.1600-0765.2011.01352.x; Hotokezaka H, 2002, J BIOL CHEM, V277, P47366, DOI 10.1074/jbc.M208284200; Igarashi K, 2006, ANTIOXID REDOX SIGN, V8, P107, DOI 10.1089/ars.2006.8.107; Igarashi K, 1998, J BIOL CHEM, V273, P11783, DOI 10.1074/jbc.273.19.11783; Ikeda F, 2004, J CLIN INVEST, V114, P475, DOI 10.1172/JCI200419657; Ishikawa M, 2005, FREE RADICAL BIO MED, V38, P1344, DOI 10.1016/j.freeradbiomed.2005.01.021; Kanzaki H, 2015, J DENT RES, V94, P787, DOI 10.1177/0022034515577814; Kanzaki H, 2016, REDOX BIOL, V8, P186, DOI 10.1016/j.redox.2016.01.006; Kanzaki H, 2014, FREE RADICAL BIO MED, V77, P239, DOI 10.1016/j.freeradbiomed.2014.09.006; Kanzaki H, 2013, J BIOL CHEM, V288, P23009, DOI 10.1074/jbc.M113.478545; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Kim MS, 2006, J BIOL CHEM, V281, P1274, DOI 10.1074/jbc.M510156200; Kwak HB, 2008, BIOCHEM BIOPH RES CO, V377, P1, DOI 10.1016/j.bbrc.2008.05.048; Lacey DL, 1998, CELL, V93, P165, DOI 10.1016/S0092-8674(00)81569-X; Lamp EC, 2000, LEUKEMIA LYMPHOMA, V39, P477, DOI 10.3109/10428190009113378; Nishio Y, 2014, INT IMMUNOPHARMACOL, V19, P300, DOI 10.1016/j.intimp.2014.02.003; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Roodman GD, 1996, ENDOCR REV, V17, P308, DOI 10.1210/er.17.4.308; Ruxton GD, 2008, BEHAV ECOL, V19, P690, DOI 10.1093/beheco/arn020; Sun JY, 2002, EMBO J, V21, P5216, DOI 10.1093/emboj/cdf516; Suzuki H, 2004, EMBO J, V23, P2544, DOI 10.1038/sj.emboj.7600248; Suzuki H, 2003, J BIOL CHEM, V278, P49246, DOI 10.1074/jbc.M306764200; Thimmulappa RK, 2002, CANCER RES, V62, P5196; Tsubaki M, 2010, J CELL BIOCHEM, V111, P1661, DOI 10.1002/jcb.22907; Wells PG, 2009, TOXICOL SCI, V108, P4, DOI 10.1093/toxsci/kfn263; Wild AC, 1998, BIOCHEM J, V332, P373, DOI 10.1042/bj3320373; Yadav Jessica, 2013, Open Orthop J, V7, P605, DOI 10.2174/1874325001307010605; Zhao HY, 2015, CYTOKINE, V71, P199, DOI 10.1016/j.cyto.2014.10.007	39	39	40	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					781	792		10.1096/fj.201600826R	http://dx.doi.org/10.1096/fj.201600826R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27836987				2022-12-28	WOS:000394235400030
J	Salta, E; De Strooper, B				Salta, Evgenia; De Strooper, Bart			microRNA-132: a key noncoding RNA operating in the cellular phase of Alzheimer's disease	FASEB JOURNAL			English	Article						small RNA; amyloid/TAU pathology; neurodegeneration; neuroprotection; therapy	ELEMENT-BINDING PROTEIN; NEUROTROPHIC FACTOR; AMYLOID-BETA; IN-VIVO; NEURODEGENERATIVE DISORDERS; MIR-132 EXPRESSION; NEURONAL APOPTOSIS; SIGNALING PATHWAY; CIRCADIAN-CLOCK; DOWN-REGULATION	With the consideration of the broad involvement ofmicroRNAs (miRNAs) in the regulation ofmolecular networks in the brain, it is not surprising thatmiRNA dysregulation causes neurodegeneration in animalmodels. miRNA profiling in the human brain has revealedmiR- 132 as one of the most severely down- regulatedmiRNAs at the intermediate and late Braak stages ofAlzheimer's disease (AD), aswell as in other neurodegenerative disorders. Suppression ofmiR- 132 aggravates multiple layers of pathology at the molecular and functional level. We describe the potential therapeutic implications of these findings and suggest miRNA targeting or replacement as a realistic multi- hit, therapeutic strategy for AD. Salta, E., De Strooper, B. microRNA- 132: a key noncoding RNA operating in the cellular phase of Alzheimer's disease.	[Salta, Evgenia; De Strooper, Bart] VIB Leuven, Ctr Brain & Dis, VIB, Leuven, Belgium; [Salta, Evgenia; De Strooper, Bart] Univ Ziekenhuizen, Ctr Human Genet, Herestr 49, B-3000 Leuven, Belgium; [Salta, Evgenia; De Strooper, Bart] Katholieke Univ Leuven, Leuven Res Inst Neurosci & Dis, Leuven, Belgium; [De Strooper, Bart] UCL, Inst Neurol, London, England	Flanders Institute for Biotechnology (VIB); KU Leuven; University of London; University College London	Salta, E; De Strooper, B (corresponding author), Univ Ziekenhuizen, Ctr Human Genet, Herestr 49, B-3000 Leuven, Belgium.; Salta, E; De Strooper, B (corresponding author), Katholieke Univ Leuven, LIND, B-3000 Leuven, Belgium.	evgenia.salta@cme.vib-kuleuven.be; bart.destrooper@cme.vib-kuleuven.be	de+Strooper, Bart/Z-1638-2019		Fonds voor Wetenschappelijk Onderzoek (FWO); Alzheimer's Association; European Research Council (ERC) [ERC-2010-AG_268675]; FWO; KU Leuven; VIB; VIND; Methusalem grant from KU Leuven; Flemish government; Bax-Vanluffelen Chair for Alzheimer's disease; Opening the Future campaign of the Leuven Universiteit Fonds (LUF); MRC [MC_PC_17116] Funding Source: UKRI; Medical Research Council [MC_PC_17116] Funding Source: researchfish	Fonds voor Wetenschappelijk Onderzoek (FWO)(FWO); Alzheimer's Association(Alzheimer's Association); European Research Council (ERC)(European Research Council (ERC)European Commission); FWO(FWO); KU Leuven(KU Leuven); VIB; VIND; Methusalem grant from KU Leuven; Flemish government(European Commission); Bax-Vanluffelen Chair for Alzheimer's disease; Opening the Future campaign of the Leuven Universiteit Fonds (LUF); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	E.S. received funding from the Fonds voor Wetenschappelijk Onderzoek (FWO) and the Alzheimer's Association. Work in the B.D.S. laboratory was supported by the European Research Council (ERC) Grant ERC-2010-AG_268675, FWO, KU Leuven, VIB, VIND, and a Methusalem grant from KU Leuven and the Flemish government. B.D.S. is the Bax-Vanluffelen Chair for Alzheimer's disease and is directly supported by the Opening the Future campaign of the Leuven Universiteit Fonds (LUF).	Alvarez-Saavedra M, 2011, HUM MOL GENET, V20, P731, DOI 10.1093/hmg/ddq519; Anand S, 2010, NAT MED, V16, P909, DOI 10.1038/nm.2186; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Bosson AD, 2014, MOL CELL, V56, P347, DOI 10.1016/j.molcel.2014.09.018; Buggele WA, 2012, J BIOL CHEM, V287, P31027, DOI 10.1074/jbc.M112.387670; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Catapano F, 2016, MOL THER-NUCL ACIDS, V5, DOI 10.1038/mtna.2016.47; Chen-Plotkin AS, 2012, J NEUROSCI, V32, P11213, DOI 10.1523/JNEUROSCI.0521-12.2012; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Clovis YM, 2012, DEVELOPMENT, V139, P3332, DOI 10.1242/dev.078063; Cochran JN, 2014, BRAIN RES BULL, V103, P18, DOI 10.1016/j.brainresbull.2013.12.004; Cogswell JP, 2008, J ALZHEIMERS DIS, V14, P27, DOI 10.3233/jad-2008-14103; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; Coppieters N, 2014, NEUROBIOL AGING, V35, P1334, DOI 10.1016/j.neurobiolaging.2013.11.031; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; Edbauer D, 2010, NEURON, V65, P373, DOI 10.1016/j.neuron.2010.01.005; Formosa A, 2013, ONCOGENE, V32, P127, DOI 10.1038/onc.2012.14; Freischmidt A, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-42; Gascon E, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00048; Gillardon F, 2008, PROTEOM CLIN APPL, V2, P697, DOI 10.1002/prca.200780025; Gonzales ED, 2016, HUM MOL GENET, V25, P837, DOI 10.1093/hmg/ddv482; Grasso M, 2014, MOLECULES, V19, P6891, DOI 10.3390/molecules19056891; Gubern C, 2013, FEBS J, V280, P6233, DOI 10.1111/febs.12546; Hancock ML, 2014, J NEUROSCI, V34, P66, DOI 10.1523/JNEUROSCI.3371-13.2014; Hansen KF, 2013, BRAIN STRUCT FUNCT, V218, P817, DOI 10.1007/s00429-012-0431-4; Hebert SS, 2013, J ALZHEIMERS DIS, V35, P335, DOI 10.3233/JAD-122350; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Heppner FL, 2015, NAT REV NEUROSCI, V16, P358, DOI 10.1038/nrn3880; Hernandez-Rapp J, 2016, SCI REP-UK, V6, DOI 10.1038/srep30953; Hernandez-Rapp J, 2015, BEHAV BRAIN RES, V287, P15, DOI 10.1016/j.bbr.2015.03.032; Huang YY, 2011, J NEUROSCI, V31, P18048, DOI 10.1523/JNEUROSCI.4067-11.2011; Hwang JY, 2014, J MOL BIOL, V426, P3454, DOI 10.1016/j.jmb.2014.07.032; Impey S, 2010, MOL CELL NEUROSCI, V43, P146, DOI 10.1016/j.mcn.2009.10.005; Jiang YJ, 2015, EXPERT OPIN DRUG DEL, V12, P1717, DOI 10.1517/17425247.2015.1065812; Johnson R, 2009, NEUROMOL MED, V11, P183, DOI 10.1007/s12017-009-8063-4; Karran E, 2016, J NEUROCHEM, V139, P237, DOI 10.1111/jnc.13632; Kawashima H, 2010, NEUROSCIENCE, V165, P1301, DOI 10.1016/j.neuroscience.2009.11.057; Klein ME, 2007, NAT NEUROSCI, V10, P1513, DOI 10.1038/nn2010; Kong HM, 2015, J MOL NEUROSCI, V57, P28, DOI 10.1007/s12031-015-0574-x; Kuwabara T, 2004, CELL, V116, P779, DOI 10.1016/S0092-8674(04)00248-X; Lagos D, 2010, NAT CELL BIOL, V12, P513, DOI 10.1038/ncb2054; Lau P, 2014, AGEING RES REV, V17, P43, DOI 10.1016/j.arr.2014.02.006; Lau P, 2013, EMBO MOL MED, V5, P1613, DOI 10.1002/emmm.201201974; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee ST, 2012, ANN NEUROL, V72, P269, DOI 10.1002/ana.23588; Li SM, 2009, NEURON, V62, P788, DOI 10.1016/j.neuron.2009.05.012; Ljungberg MC, 2012, HUM MOL GENET, V21, P251, DOI 10.1093/hmg/ddr492; Lu LF, 2015, IMMUNITY, V43, P52, DOI 10.1016/j.immuni.2015.04.022; Lu T, 2014, NATURE, V507, P448, DOI 10.1038/nature13163; Luikart BW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019077; Magill ST, 2010, P NATL ACAD SCI USA, V107, P20382, DOI 10.1073/pnas.1015691107; Majer A, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003002; MANDELKOW EM, 1995, NEUROBIOL AGING, V16, P355, DOI 10.1016/0197-4580(95)00025-A; Mellios N, 2011, NAT NEUROSCI, V14, P1240, DOI 10.1038/nn.2909; Mu YL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-85; Nahid MA, 2013, J IMMUNOL, V190, P1250, DOI 10.4049/jimmunol.1103060; Nudelman AS, 2010, HIPPOCAMPUS, V20, P492, DOI 10.1002/hipo.20646; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Pathania M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038174; Peng SY, 2005, J NEUROCHEM, V93, P1412, DOI 10.1111/j.1471-4159.2005.03135.x; Pichler S, 2017, NEUROBIOL AGING, V50, DOI 10.1016/j.neurobiolaging.2016.09.019; Pimentel-Coelho PM, 2012, EUR J NEUROSCI, V35, P1917, DOI 10.1111/j.1460-9568.2012.08126.x; Pizzorusso T, 2000, J NEUROSCI, V20, P2809; Polydoro M, 2014, ACTA NEUROPATHOL, V127, P257, DOI 10.1007/s00401-013-1215-5; Remenyi J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062509; Remenyi J, 2010, BIOCHEM J, V428, P281, DOI 10.1042/BJ20100024; Rosa E, 2015, NEUROBIOL AGING, V36, P2406, DOI 10.1016/j.neurobiolaging.2015.04.014; Salta E, 2016, EMBO MOL MED, V8, P1005, DOI 10.15252/emmm.201606520; Salta E, 2014, DEV CELL, V30, P423, DOI 10.1016/j.devcel.2014.07.006; Salta E, 2012, LANCET NEUROL, V11, P189, DOI 10.1016/S1474-4422(11)70286-1; Scott HL, 2012, EUR J NEUROSCI, V36, P2941, DOI 10.1111/j.1460-9568.2012.08220.x; Shaked I, 2009, IMMUNITY, V31, P965, DOI 10.1016/j.immuni.2009.09.019; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Smith PY, 2015, HUM MOL GENET, V24, P6721, DOI 10.1093/hmg/ddv377; Smith PY, 2011, HUM MOL GENET, V20, P4016, DOI 10.1093/hmg/ddr330; Sopova K, 2014, CURR ALZHEIMER RES, V11, P27, DOI 10.2174/1567205010666131120100743; Spires-Jones TL, 2014, NEURON, V82, P756, DOI 10.1016/j.neuron.2014.05.004; Sun M, 2015, CELL TRANSPLANT, V24, P367, DOI 10.3727/096368915X686869; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tognini P, 2012, INT J BIOCHEM CELL B, V44, P6, DOI 10.1016/j.biocel.2011.10.015; van Rooij E, 2012, CIRC RES, V110, P496, DOI 10.1161/CIRCRESAHA.111.247916; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wanet A, 2012, NUCLEIC ACIDS RES, V40, P4742, DOI 10.1093/nar/gks151; Wang RY, 2013, HIPPOCAMPUS, V23, P625, DOI 10.1002/hipo.22123; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Webster SJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00088; Wong HKA, 2013, HUM MOL GENET, V22, P3077, DOI 10.1093/hmg/ddt164; Xiao J, 2014, NEUROSCIENCE, V268, P128, DOI 10.1016/j.neuroscience.2014.03.015; Yamamoto-Sasaki M, 1999, BRAIN RES, V824, P300, DOI 10.1016/S0006-8993(99)01220-2; Yang DH, 2012, J CELL SCI, V125, P1673, DOI 10.1242/jcs.086421; Yu LP, 2014, PARASITOL RES, V113, P91, DOI 10.1007/s00436-013-3630-x; Zhang SY, 2011, CARCINOGENESIS, V32, P1183, DOI 10.1093/carcin/bgr105; Zhao YH, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00059; Zhu QB, 2016, BRAIN, V139, P908, DOI 10.1093/brain/awv383	97	65	67	0	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					424	433		10.1096/fj.201601308	http://dx.doi.org/10.1096/fj.201601308			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER1XY	28148775				2022-12-28	WOS:000398589700001
J	Sarkar, A; Volff, JN; Vaury, C				Sarkar, Arpita; Volff, Jean-Nicolas; Vaury, Chantal			piRNAs and their diverse roles: a transposable element-driven tactic for gene regulation?	FASEB JOURNAL			English	Review						RNA silencing; co-option; genomic functions	SMALL RNAS; PIWI PROTEINS; C. ELEGANS; MESSENGER-RNAS; MOUSE TESTES; PARAMECIUM-TETRAURELIA; GENOME REARRANGEMENT; DROSOPHILA-PIWI; MOBILE ELEMENTS; GERMLINE	P-element-inducedwimpy testis ( PIWI)-interacting RNAs( piRNAs) are small, noncoding RNAs known for silencing transposable elements ( TEs) in the germline of animals. Most genomes host TEs, which are notorious for mobilizing themselves and endangering survival of the host if not controlled. By silencing TEs in the germline, piRNAs prevent harmful mutations from being passed on to the next generation. How piRNAs are generated and how they silence TEs were the focus of researchers ever since their discovery. Now a spate of recent papers are beginning to tell us that piRNAs can play roles beyond TE silencing and are involved in diverse cellular processes fromm RNA regulation to development or genome rearrangement. In this review, we discuss some of these recently reported roles. Data on these new roles are often rudimentary, and the involvement of piRNAs in these processes is yet to be definitely established. What is interesting is that the reports are on animals widely separated on the phylogenetic tree of life and thatpiRNAs were also found outside the gonadal tissues. Some of these piRNAs map to TE sequences, prompting us to hypothesize that genomes may have co-optedtheTE-derived piRNA system for their own regulation.-Sarkar, A., Volff, J.-N., Vaury, C. piRNAs and their diverse roles: a transposable element-driven tactic for gene regulation?	[Sarkar, Arpita; Vaury, Chantal] Univ Clermont Auvergne, CNRS, INSERM, Lab Genet Reprod & Dev,GReD, Clermont Ferrand, France; [Volff, Jean-Nicolas] Ecole Normale Super Lyon, Inst Genom Fonct Lyon, Lyon, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Centre National de la Recherche Scientifique (CNRS); Ecole Normale Superieure de Lyon (ENS de LYON)	Vaury, C (corresponding author), Univ Clermont Auvergne, CNRS, INSERM, GReD, BP 10448, F-63001 Clermont Ferrand, France.	chantal.vaury@udamail.fr		Sarkar, Arpita/0000-0001-5061-2505	Agence Nationale pour la Recherche (ANR-Plastisipi Project); Universite Clermont Auvergne	Agence Nationale pour la Recherche (ANR-Plastisipi Project)(French National Research Agency (ANR)); Universite Clermont Auvergne	The authors thank S. Jenson (Universite Clermont Auvergne) for helpful comments. The authors dedicate this review to their late friend, Christophe Terzian (1959-2016). The work was supported by grants from the Agence Nationale pour la Recherche (ANR-Plastisipi Project), and the Universite Clermont Auvergne (to A.S.).	Arama E, 2000, ONCOGENE, V19, P3706, DOI 10.1038/sj.onc.1203706; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916; Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Ashe A, 2012, CELL, V150, P88, DOI 10.1016/j.cell.2012.06.018; Barckmann B, 2015, CELL REP, V12, P1205, DOI 10.1016/j.celrep.2015.07.030; Blaise S, 2003, P NATL ACAD SCI USA, V100, P13013, DOI 10.1073/pnas.2132646100; Bouhouche K, 2011, NUCLEIC ACIDS RES, V39, P4249, DOI 10.1093/nar/gkq1283; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chirn GW, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005652; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Feschotte C, 2008, NAT REV GENET, V9, P397, DOI 10.1038/nrg2337; Garnier O, 2004, MOL CELL BIOL, V24, P7370, DOI 10.1128/MCB.24.17.7370-7379.2004; Gavis ER, 1996, DEV BIOL, V176, P36, DOI 10.1006/dbio.1996.9996; Gebert D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124860; George P, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0041-5; Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917; Goh WSS, 2015, GENE DEV, V29, P1032, DOI 10.1101/gad.260455.115; Goriaux C, 2014, EMBO REP, V15, P411, DOI 10.1002/embr.201337898; Gou LT, 2014, CELL RES, V24, P680, DOI 10.1038/cr.2014.41; Graff J, 2013, NAT REV NEUROSCI, V14, P97, DOI 10.1038/nrn3427; Ha H, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-545; Harding JL, 2014, GENOME RES, V24, P96, DOI 10.1101/gr.144469.112; Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030; Jin ZG, 2013, CURR BIOL, V23, P1442, DOI 10.1016/j.cub.2013.06.021; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Keam SP, 2014, NUCLEIC ACIDS RES, V42, P8984, DOI 10.1093/nar/gku620; Khurana JS, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001246; Kirino Yohei, 2007, Nucleic Acids Symp Ser (Oxf), P417, DOI 10.1093/nass/nrm209; Kiuchi T, 2014, NATURE, V509, P633, DOI 10.1038/nature13315; Klattenhoff C, 2009, CELL, V138, P1137, DOI 10.1016/j.cell.2009.07.014; Lee EJ, 2011, RNA, V17, P1090, DOI 10.1261/rna.2565011; Lee HC, 2012, CELL, V150, P78, DOI 10.1016/j.cell.2012.06.016; Lerat E, 2010, HEREDITY, V104, P520, DOI 10.1038/hdy.2009.165; Li XZG, 2013, MOL CELL, V50, P67, DOI 10.1016/j.molcel.2013.02.016; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Mohn F, 2014, CELL, V157, P1364, DOI 10.1016/j.cell.2014.04.031; Palakodeti D, 2008, RNA, V14, P1174, DOI 10.1261/rna.1085008; Pires-daSilva A, 2003, NAT REV GENET, V4, P39, DOI 10.1038/nrg977; Post C, 2014, RNA, V20, P1977, DOI 10.1261/rna.046300.114; Rajasethupathy P, 2012, CELL, V149, P693, DOI 10.1016/j.cell.2012.02.057; Robine N, 2009, CURR BIOL, V19, P2066, DOI 10.1016/j.cub.2009.11.064; Roovers EF, 2015, CELL REP, V10, P2069, DOI 10.1016/j.celrep.2015.02.062; Rouget C, 2010, NATURE, V467, P1128, DOI 10.1038/nature09465; Rouhana L, 2014, DEVELOPMENT, V141, P2592, DOI 10.1242/dev.101618; Saito K, 2009, NATURE, V461, P1296, DOI 10.1038/nature08501; Seth M, 2013, DEV CELL, V27, P656, DOI 10.1016/j.devcel.2013.11.014; Singh DP, 2014, NATURE, V509, P447, DOI 10.1038/nature13318; Smit A., 2013, REPEATMASKER OPEN VE; Theron E, 2014, MOBILE DNA-UK, V5, DOI 10.1186/s13100-014-0028-y; Vagin VV, 2009, CELL CYCLE, V8, P4003, DOI 10.4161/cc.8.24.10146; Watanabe T, 2015, GENOME RES, V25, P368, DOI 10.1101/gr.180802.114; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Wedeles CJ, 2013, DEV CELL, V27, P664, DOI 10.1016/j.devcel.2013.11.016; White TB, 2014, MOBILE DNA-UK, V5, DOI 10.1186/s13100-014-0030-4; Zanni V, 2013, P NATL ACAD SCI USA, V110, P19842, DOI 10.1073/pnas.1313677110; Zhang P, 2015, CELL RES, V25, P193, DOI [10.1038/cr.2015.14, 10.1038/cr.2015.4]	60	29	30	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					436	446		10.1096/fj.201600637RR	http://dx.doi.org/10.1096/fj.201600637RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27799346				2022-12-28	WOS:000394235400001
J	Hisamichi, M; Kamijo-Ikemori, A; Sugaya, T; Ichikawa, D; Natsuki, T; Hoshino, S; Kimura, K; Shibagaki, Y				Hisamichi, Mikako; Kamijo-Ikemori, Atsuko; Sugaya, Takeshi; Ichikawa, Daisuke; Natsuki, Takayuki; Hoshino, Seiko; Kimura, Kenjiro; Shibagaki, Yugo			Role of angiotensin II type 1a receptor in renal injury induced by deoxycorticosterone acetate-salt hypertension	FASEB JOURNAL			English	Article						Ang II AT1a receptor; DOCA; hypertension; L-FABP	ACID-BINDING PROTEIN; CHRONIC KIDNEY-DISEASE; URINARY-EXCRETION; IMMUNOHISTOCHEMICAL LOCALIZATION; DIFFERENTIAL EXPRESSION; MORPHOMETRIC-ANALYSIS; BLOOD-FLOW; RENIN; PROGRESSION; AT(1)	The aim of this study was to investigate the in vivo role of angiotensin II type 1a (AT1a) receptor in renal damage as a result of hypertension by using transgenic mice with AT1a receptor gene disruption. Transgenic mice that express human liver-type fatty acid binding protein (L-FABP) with or without disruption of the AT1a receptor gene (L-FABP(+/-) AT1a(-/-), and L-FABP(+/-) AT1a(+/+), respectively) were used with urinary L-FABP as an indicator of tubulointerstitial damage. Those female mice were administered subcutaneously deoxycorticosterone acetate (DOCA)-salt tablets plus drinking water that contained 1% saline for 28 d after uninephrectomy. InL-FABP(+/-) AT1a(+/+) mice that received DOCA-salt treatment, hypertension was induced and slight expansion of glomerular area, glomerular sclerosis, and tubulointerstitial damage were observed. In L-FABP(+/-) AT1a(-/-) mice that received DOCA-salt treatment, hypertension was similarly induced and the degree of glomerular damage was significantly more severe than in L-FABP(+/-) AT1a(+/+)-DOCAmice. Urinary L-FABP levels were significantly higher in L-FABP(+/-) AT1a(-/-)-DOCA mice compared with those in L-FABP(+/-) AT1a(+/+)-DOCAmice. Hydralazine treatment significantly attenuated renal damage that was found in L-FABP(+/-) AT1a(-/-)-DOCA mice along with a reduction in blood pressure. In summary, activation of the AT1a receptor may contribute to maintenance of the glomerular structure against hypertensive renal damage.	[Hisamichi, Mikako; Kamijo-Ikemori, Atsuko; Sugaya, Takeshi; Ichikawa, Daisuke; Shibagaki, Yugo] St Marianna Univ, Sch Med, Dept Internal Med, Div Nephrol & Hypertens, Kawasaki, Kanagawa, Japan; [Kamijo-Ikemori, Atsuko; Hoshino, Seiko] St Marianna Univ, Sch Med, Dept Anat, Kawasaki, Kanagawa, Japan; [Natsuki, Takayuki] St Marianna Univ, Sch Med, Inst Ultrastruct Morphol, Kawasaki, Kanagawa, Japan; [Kimura, Kenjiro] Tokyo Takanawa Hosp, Japan Community Hlth Care Org, Dept Internal Med, Tokyo, Japan	Saint Marianna University; Saint Marianna University; Saint Marianna University	Kamijo-Ikemori, A (corresponding author), St Marianna Univ, Sch Med, Miyamae Ku, 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	a2kamijo@marianna-u.ac.jp			Naito Foundation; Takeda Science Foundation	Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF))	The authors thank Kimie Katayama, Jyunko Asano, and Keiichi Ohata (Division of Nephrology and Hypertension, Department of Internal Medicine, St. Marianna University School of Medicine) for technical assistance. This work was supported by the Naito Foundation and Takeda Science Foundation.	Agodoa LY, 2001, JAMA-J AM MED ASSOC, V285, P2719, DOI 10.1001/jama.285.21.2719; Appel LJ, 2008, ARCH INTERN MED, V168, P832, DOI 10.1001/archinte.168.8.832; Ardaillou R, 1999, J AM SOC NEPHROL, V10, pS40; Bergijk EC, 1998, J PATHOL, V184, P307; Blodow S, 2014, PFLUG ARCH EUR J PHY, V466, P1343, DOI 10.1007/s00424-013-1372-3; Bouby N, 1997, J AM SOC NEPHROL, V8, P1658; Burke M, 2014, CURR VASC PHARMACOL, V12, P845, DOI 10.2174/15701611113116660149; Chen XM, 1997, AM J PHYSIOL-RENAL, V272, pF299, DOI 10.1152/ajprenal.1997.272.3.F299; Crowley SD, 2005, J CLIN INVEST, V115, P1092, DOI 10.1172/JCI200523378; Crowley SD, 2009, J CLIN INVEST, V119, P943, DOI 10.1172/JCI34862; DEGASPARO M, 1995, HYPERTENSION, V25, P924, DOI 10.1161/01.HYP.25.5.924; Elgendy IY, 2015, AM J HYPERTENS, V28, P576, DOI 10.1093/ajh/hpu209; GAVRAS H, 1975, CIRC RES, V36, P300, DOI 10.1161/01.RES.36.2.300; Giachini FR, 2010, HYPERTENSION, V55, P172, DOI 10.1161/HYPERTENSIONAHA.109.140459; GOODWIN FJ, 1969, AM J PHYSIOL, V216, P1476, DOI 10.1152/ajplegacy.1969.216.6.1476; HarrisonBernard LM, 1997, AM J PHYSIOL-RENAL, V273, pF170, DOI 10.1152/ajprenal.1997.273.1.F170; Hisada Y, 1999, J CLIN INVEST, V103, P627, DOI 10.1172/JCI2454; Ichikawa D, 2015, AM J PHYSIOL-RENAL, V308, pF114, DOI 10.1152/ajprenal.00469.2014; Ichikawa D, 2014, AM J PHYSIOL-RENAL, V306, pF655, DOI 10.1152/ajprenal.00460.2013; Ichikawa D, 2012, HYPERTENSION, V60, P973, DOI 10.1161/HYPERTENSIONAHA.112.199828; Inokuchi S, 1998, VIRCHOWS ARCH, V433, P349, DOI 10.1007/s004280050259; KAKINUMA Y, 1992, KIDNEY INT, V42, P46, DOI 10.1038/ki.1992.259; Kamijo A, 2005, J LAB CLIN MED, V145, P125, DOI 10.1016/j.lab.2004.12.003; Kamijo A, 2004, AM J PATHOL, V165, P1243, DOI 10.1016/S0002-9440(10)63384-6; Kamijo A, 2004, J LAB CLIN MED, V143, P23, DOI 10.1016/j.lab.2003.08.001; KIM S, 1994, HYPERTENSION, V24, P195, DOI 10.1161/01.HYP.24.2.195; KIMURA K, 1989, VIRCHOWS ARCH A, V415, P565, DOI 10.1007/BF00718651; KIMURA K, 1990, VIRCHOWS ARCH A, V417, P319, DOI 10.1007/BF01605783; Kimura K, 1997, KIDNEY INT, pS201; Kobori H, 2007, PHARMACOL REV, V59, P251, DOI 10.1124/pr.59.3.3; Lee GSL, 1998, KIDNEY INT, V53, P1389, DOI 10.1046/j.1523-1755.1998.00871.x; Ma LJ, 2011, AM J PHYSIOL-RENAL, V300, pF1203, DOI 10.1152/ajprenal.00468.2010; MAKRIDES SC, 1988, HYPERTENSION, V12, P405, DOI 10.1161/01.HYP.12.4.405; Matsui K, 2011, AM J PATHOL, V178, P1021, DOI 10.1016/j.ajpath.2010.12.002; Schnitzler MMY, 2008, EMBO J, V27, P3092, DOI 10.1038/emboj.2008.233; Miyata N, 1999, AM J PHYSIOL-RENAL, V277, pF437, DOI 10.1152/ajprenal.1999.277.3.F437; NATH KA, 1992, AM J KIDNEY DIS, V20, P1; PAXTON WG, 1993, AM J PHYSIOL, V264, pF989, DOI 10.1152/ajprenal.1993.264.6.F989; Remuzzi G, 1998, NEW ENGL J MED, V339, P1448, DOI 10.1056/NEJM199811123392007; RISDON RA, 1968, LANCET, V2, P363; Schleifenbaum J, 2014, CIRC RES, V115, P263, DOI 10.1161/CIRCRESAHA.115.302882; Sparks MA, 2015, J AM SOC NEPHROL, V26, P2953, DOI 10.1681/ASN.2014080816; Storch U, 2015, ARTERIOSCL THROM VAS, V35, P121, DOI 10.1161/ATVBAHA.114.304844; SUGAYA T, 1995, J BIOL CHEM, V270, P18719, DOI 10.1074/jbc.270.32.18719; Taneda S, 2003, J AM SOC NEPHROL, V14, P968, DOI 10.1097/01.ASN.0000054498.83125.90; Yang CW, 1997, LAB INVEST, V76, P467; Yokoyama T, 2009, AM J PATHOL, V174, P2096, DOI 10.2353/ajpath.2009.080780; Zou YZ, 2004, NAT CELL BIOL, V6, P499, DOI 10.1038/ncb1137	48	4	4	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					72	84		10.1096/fj.201600684RR	http://dx.doi.org/10.1096/fj.201600684RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27663860	Green Published, hybrid			2022-12-28	WOS:000392177600010
J	Yang, F; Ma, HW; Belcher, J; Butler, MR; Redmond, TM; Boye, SL; Hauswirth, WW; Ding, XQ				Yang, Fan; Ma, Hongwei; Belcher, Joshua; Butler, Michael R.; Redmond, T. Michael; Boye, Sanford L.; Hauswirth, William W.; Ding, Xi-Qin			Targeting iodothyronine deiodinases locally in the retina is a therapeutic strategy for retinal degeneration	FASEB JOURNAL			English	Article						thyroid hormone; photoreceptor; cone degeneration; iopanoic acid	THYROID-HORMONE RECEPTOR; ENDOPLASMIC-RETICULUM STRESS; CONE CELL-DEATH; TYPE-3 DEIODINASE; GENE DELIVERY; MOUSE MODEL; PHOTORECEPTOR DEGENERATION; EXPRESSION; RPE65; MICE	Recent studies have implicated thyroid hormone (TH) signaling in cone photoreceptor viability. Using mouse models of retinal degeneration, we found that antithyroid treatment preserves cones. This work investigates the significance of targeting intracellular TH components locally in the retina. The cellular TH level is mainly regulated by deiodinase iodothyronine (DIO)-2 and -3. DIO2 converts thyroxine (T4) to triiodothyronine (T3), which binds to the TH receptor, whereas DIO3 degrades T3 and T4. We examined cone survival after overexpression of DIO3 and inhibition of DIO2 and demonstrated the benefits of these manipulations. Subretinal delivery of AAV5-IRBP/GNAT2-DIO3, which directs expression of human DIO3 specifically in cones, increased cone density by 30-40% in a Rpe65(-/-) mouse model of Lebers congenital amaurosis (LCA) and in a Cpfl1 mouse with Pde6c defect model of achromatopsia, compared with their respective untreated controls. Intravitreal and topical delivery of the DIO2 inhibitor iopanoic acid also significantly improved cone survival in the LCA model mice. Moreover, the expression levels of DIO2 and Slc16a2 were significantly higher in the diseased retinas, suggesting locally elevated TH signaling. We show that targeting DIOs protects cones, and intracellular inhibition of TH components locally in the retina may represent a novel strategy for retinal degeneration management.	[Yang, Fan; Ma, Hongwei; Belcher, Joshua; Butler, Michael R.; Ding, Xi-Qin] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA; [Butler, Michael R.] NEI, Lab Retinal Cell & Mol Biol, Bethesda, MD 20892 USA; [Boye, Sanford L.; Hauswirth, William W.] Univ Florida, Dept Ophthalmol, Gainesville, FL USA; [Hauswirth, William W.] Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); State University System of Florida; University of Florida; State University System of Florida; University of Florida	Ding, XQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA.	xi-qin-ding@ouhsc.edu	Yang, Fan/I-5735-2019	hauswirth, william/0000-0002-3244-4947; Redmond, T. Michael/0000-0002-1813-5291	NIH NEI [P30EY021725, P30EY021721, T32EY023202, R01EY019490, R21EY024583]; Research to Prevent Blindness; Foundation Fighting Blindness; Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE [T32EY023202, P30EY021721, R01EY019490, P30EY021725, R21EY024583] Funding Source: NIH RePORTER	NIH NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Foundation Fighting Blindness(European Commission); Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The authors thank Dr. Anand Swaroop [U.S. National Institutes of Health (NIH) National Eye Institute (NEI)] for the Nrl<SUP>-/-</SUP> mouse line; Dr. P. Reed Larsen (Brigham and Women's Hospital Boston, MA, USA) for human DIO3 cDNA; Bruce Baretz (Lipoid LLC, Newark, NJ, USA) for phospholipon 90G; Dr. Cheryl Craft (The University of Southern California, Los Angeles, CA, USA) for anti-M-opsin and anti-cone arrestin antibodies; Dr. Muna Naash (University of Houston, Houston, TX, USA) for anti-S-opsin antibody; Dr. Robert Molday (University of British Columbia, Vancouver, BC, Canada) for mouse anti-rhodopsin antibody 1D4; and Imaging Core Facility of the Department of Cell Biology at the University of Oklahoma Health Sciences Center for technical assistance. This work was supported by NIH NEI Grants P30EY021725, P30EY021721, T32EY023202, R01EY019490, and R21EY024583; an unrestricted grant to the Department of Ophthalmology, University of Florida, from Research to Prevent Blindness; the Foundation Fighting Blindness; and the Knights Templar Eye Foundation. The authors declare no conflicts of interest.	Bernal J, 2013, BBA-GEN SUBJECTS, V1830, P3893, DOI 10.1016/j.bbagen.2012.04.014; Bhumika S, 2015, MOL CELL NEUROSCI, V68, P92, DOI 10.1016/j.mcn.2015.04.002; Bianco AC, 2002, ENDOCR REV, V23, P38, DOI 10.1210/er.23.1.38; Bianco AC, 2006, J CLIN INVEST, V116, P2571, DOI 10.1172/JCI29812; Bianco AC, 2011, ENDOCRINOLOGY, V152, P3306, DOI 10.1210/en.2011-1104; Bouzaffour M, 2010, GEN COMP ENDOCR, V168, P88, DOI 10.1016/j.ygcen.2010.04.006; Boye SL, 2013, HUM GENE THER, V24, P189, DOI 10.1089/hum.2012.193; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Ceresini G, 2009, J AM GERIATR SOC, V57, P89, DOI 10.1111/j.1532-5415.2008.02080.x; Chaker L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0329-0; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Chen Y, 2006, INVEST OPHTH VIS SCI, V47, P1177, DOI 10.1167/iovs.05-0965; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Curcio C, 2001, J BIOL CHEM, V276, P30183, DOI 10.1074/jbc.C100325200; de Jesus LA, 2001, J CLIN INVEST, V108, P1379, DOI 10.1172/JCI200113803; Deeb SS, 2010, OPHTHAL PHYSL OPT, V30, P446, DOI 10.1111/j.1475-1313.2010.00735.x; Dentice M, 2014, CELL METAB, V20, P1038, DOI 10.1016/j.cmet.2014.10.009; Dentice M, 2010, J CLIN INVEST, V120, P4021, DOI 10.1172/JCI43670; Ding XQ, 2009, HUM MOL GENET, V18, P4770, DOI 10.1093/hmg/ddp440; Dyka FM, 2014, ADV EXP MED BIOL, V801, P695, DOI 10.1007/978-1-4614-3209-8_87; Feathers KL, 2008, INVEST OPHTH VIS SCI, V49, P1126, DOI 10.1167/iovs.07-1234; Friesema ECH, 2003, J BIOL CHEM, V278, P40128, DOI 10.1074/jbc.M300909200; Glaschke A, 2010, INVEST OPHTH VIS SCI, V51, P1719, DOI 10.1167/iovs.09-3592; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Huang SA, 2008, NAT CLIN PRACT ENDOC, V4, P148, DOI 10.1038/ncpendmet0727; Jo SR, 2012, J NEUROSCI, V32, P8491, DOI 10.1523/JNEUROSCI.6514-11.2012; Kalmijn S, 2000, CLIN ENDOCRINOL, V53, P733, DOI 10.1046/j.1365-2265.2000.01146.x; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Kuiper GGJM, 2003, ENDOCRINOLOGY, V144, P2505, DOI 10.1210/en.2003-0084; Kunchithapautham K, 2009, INVEST OPHTH VIS SCI, V50, P4858, DOI 10.1167/iovs.08-3008; Liu Y, 2007, VISION RES, V47, P2314, DOI 10.1016/j.visres.2007.04.023; Lu AL, 2009, ENDOCRINOLOGY, V150, P1536, DOI 10.1210/en.2008-1092; Ma HW, 2015, J BIOL CHEM, V290, P20880, DOI 10.1074/jbc.M115.641159; Ma HW, 2014, P NATL ACAD SCI USA, V111, P3602, DOI 10.1073/pnas.1317041111; Ma HW, 2013, HUM MOL GENET, V22, P3906, DOI 10.1093/hmg/ddt245; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Meulenbelt I, 2008, HUM MOL GENET, V17, P1867, DOI 10.1093/hmg/ddn082; Murakami Y, 2012, P NATL ACAD SCI USA, V109, P14598, DOI 10.1073/pnas.1206937109; Ng L, 2004, P NATL ACAD SCI USA, V101, P3474, DOI 10.1073/pnas.0307402101; Ng L, 2001, NAT GENET, V27, P94, DOI 10.1038/83829; Ng L, 2010, J NEUROSCI, V30, P3347, DOI 10.1523/JNEUROSCI.5267-09.2010; Ng L, 2009, ENDOCRINOLOGY, V150, P1952, DOI 10.1210/en.2008-1419; Olivares EL, 2007, ENDOCRINOLOGY, V148, P4786, DOI 10.1210/en.2007-0043; PASCUAL A, 1987, ENDOCRINOLOGY, V120, P1089, DOI 10.1210/endo-120-3-1089; Peeters RP, 2013, ENDOCRINOLOGY, V154, P550, DOI 10.1210/en.2012-1738; Peeters RP, 2003, J CLIN ENDOCR METAB, V88, P3202, DOI 10.1210/jc.2002-022013; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Rowe-Rendleman CL, 2014, INVEST OPHTH VIS SCI, V55, P2714, DOI 10.1167/iovs.13-13707; Safer JD, 2009, THYROID, V19, P181, DOI 10.1089/thy.2008.0227; Sagar GDV, 2008, MOL ENDOCRINOL, V22, P1382, DOI 10.1210/me.2007-0490; SALVATORE D, 1995, J CLIN INVEST, V96, P2421, DOI 10.1172/JCI118299; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Schaeferhoff K, 2010, CELL MOL LIFE SCI, V67, P3173, DOI 10.1007/s00018-010-0376-9; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; Simonides WS, 2008, J CLIN INVEST, V118, P975, DOI 10.1172/JCI32824; Thapa A, 2012, J BIOL CHEM, V287, P18018, DOI 10.1074/jbc.M112.342220; Tsai TI, 2009, DOC OPHTHALMOL, V119, P199, DOI 10.1007/s10633-009-9191-8; Ueta CB, 2011, ENDOCRINOLOGY, V152, P3571, DOI 10.1210/en.2011-1066; Wassen FWJS, 2002, ENDOCRINOLOGY, V143, P2812, DOI 10.1210/en.143.7.2812; Wenzel A, 2007, INVEST OPHTH VIS SCI, V48, P534, DOI 10.1167/iovs.06-0652; Xu Jia-peng, 2011, COLLECTED ESSAYS FIN, V3, P3, DOI DOI 10.3791/3612; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Xu XLL, 2009, CELL, V137, P1018, DOI 10.1016/j.cell.2009.03.051; Yamaguchi S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2088; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; YOSHIZUMI MO, 1988, RETINA-J RET VIT DIS, V8, P210, DOI 10.1097/00006982-198808030-00012	67	13	13	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4313	4325		10.1096/fj.201600715R	http://dx.doi.org/10.1096/fj.201600715R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27623928	Green Published			2022-12-28	WOS:000388201500035
J	Samarakoon, R; Rehfuss, A; Khakoo, NS; Falke, LL; Dobberfuhl, AD; Helo, S; Overstreet, JM; Goldschmeding, R; Higgins, PJ				Samarakoon, Rohan; Rehfuss, Alexandra; Khakoo, Nidah S.; Falke, Lucas L.; Dobberfuhl, Amy D.; Helo, Sevann; Overstreet, Jessica M.; Goldschmeding, Roel; Higgins, Paul J.			Loss of expression of protein phosphatase magnesium-dependent 1A during kidney injury promotes fibrotic maladaptive repair	FASEB JOURNAL			English	Article						TGF-beta; PAI-1; CTGF; PTEN; renal fibrosis	ARISTOLOCHIC ACID NEPHROPATHY; RENAL FIBROSIS; OBSTRUCTIVE NEPHROPATHY; DOWN-REGULATION; TARGET GENES; DISEASE; TGF-BETA-1; SMAD; RESPONSES; DEGRADATION	Protein phosphatase magnesium-dependent-1A (PPM1A) dephosphorylates SMAD2/3, which suppresses TGF-beta signaling in keratinocytes and during Xenopus development; however, potential involvement of PPM1A in chronic kidney disease is unknown. PPM1A expression was dramatically decreased in the tubulointerstitium in obstructive and aristolochic acid nephropathy, which correlates with progression of fibrotic disease. Stable silencing of PPM1A in human kidney-2 human renal epithelial cells increased SMAD3 phosphorylation, stimulated expression of fibrotic genes, induced dedifferentiation, and orchestrated epithelial cell-cycle arrest via SMAD3-mediated connective tissue growth factor and plasminogen activator inhibitor-1 up-regulation. PPM1A stable suppression in normal rat kidney-49 renal fibroblasts, in contrast, promoted a SMAD3-dependent connective tissue growth factor and plasminogen activator inhibitor-1-induced proliferative response. Paracrine factors secreted by PPM1A-depleted epithelial cells augmented fibroblast proliferation (>50%) compared with controls. PPM1A suppression in renal cells further enhanced TGF-beta 1-induced SMAD3 phosphorylation and fibrotic gene expression, whereas PPM1A overexpression inhibited both responses. Moreover, phosphate tensin homolog on chromosome 10 depletion in human kidney-2 cells resulted in loss of expression and decreased nuclear levels of PPM1A, which enhanced SMAD3-mediated fibrotic gene induction and growth arrest that were reversed by ectopic PPM1A expression. Thus, phosphate tensin homolog on chromosome 10 is an upstream regulator of renal PPM1A deregulation. These findings establish PPM1A as a novel repressor of the SMAD3 pathway in renal fibrosis and as a new therapeutic target in patients with chronic kidney disease.-Samarakoon, R., Rehfuss, A., Khakoo, N. S., Falke, L. L., Dobberfuhl, A. D., Helo, S., Overstreet, J. M., Goldschmeding, R., Higgins, P. J. Loss of expression of protein phosphatase magnesium-dependent 1A during kidney injury promotes fibrotic maladaptive repair.	[Samarakoon, Rohan; Khakoo, Nidah S.; Higgins, Paul J.] Albany Med Ctr, Ctr Cell Biol & Canc Res, Albany, NY USA; [Rehfuss, Alexandra; Helo, Sevann] Albany Med Ctr, Div Urol, Albany, NY USA; [Falke, Lucas L.; Goldschmeding, Roel] Univ Med Ctr Utrecht, Dept Pathol, Utrecht, Netherlands; [Dobberfuhl, Amy D.] Stanford Univ, Sch Med, Dept Urol, Stanford, CA 94305 USA; [Overstreet, Jessica M.] Vanderbilt Univ Sch Med, Div Nephrol & Hypertens, Nashville, TN USA	Albany Medical College; Albany Medical College; Utrecht University; Utrecht University Medical Center; Stanford University; Vanderbilt University	Samarakoon, R; Higgins, PJ (corresponding author), Albany Med Coll, Ctr Cell Biol & Canc Res, 47 New Scotland Ave, Albany, NY 12208 USA.	samarar@mail.amc.edu; higginp@mail.amc.edu	Dobberfuhl, Amy/M-9285-2018; Falke, Lucas L/D-5288-2017	Dobberfuhl, Amy/0000-0003-3451-3878; Falke, Lucas L/0000-0003-0020-433X; Helo, Sevann/0000-0002-3274-3672	Charlotte Graver Foundation; Friedman Cancer Research Foundation; U.S. National Institutes of Health, National Institute of General Medical Sciences [GM057242]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057242] Funding Source: NIH RePORTER	Charlotte Graver Foundation; Friedman Cancer Research Foundation; U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the Charlotte Graver Foundation, the Friedman Cancer Research Foundation, and the U.S. National Institutes of Health, National Institute of General Medical Sciences Grant GM057242 ( to P.J.H.). R.G. was previously employed (2008-2009 by, performs contract research for, and receives reagents for CTGF-related research from FibroGen.	Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bu S, 2008, J BIOL CHEM, V283, P19593, DOI 10.1074/jbc.M802417200; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Couser WG, 2011, KIDNEY INT, V80, P1258, DOI 10.1038/ki.2011.368; Dendooven A, 2011, AM J PATHOL, V178, P1069, DOI 10.1016/j.ajpath.2010.12.005; Duffield JS, 2013, ANNU REV PATHOL-MECH, V8, P241, DOI 10.1146/annurev-pathol-020712-163930; Dvashi Z, 2014, AM J PATHOL, V184, P2936, DOI 10.1016/j.ajpath.2014.07.022; Falke LL, 2014, NEPHROL DIAL TRANSPL, V29, pI30, DOI 10.1093/ndt/gft430; Friedman SL, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3004700; Fukasawa H, 2006, KIDNEY INT, V69, P1733, DOI 10.1038/sj.ki.5000261; Fukasawa H, 2004, P NATL ACAD SCI USA, V101, P8687, DOI 10.1073/pnas.0400035101; Gokmen MR, 2013, ANN INTERN MED, V158, P469, DOI 10.7326/0003-4819-158-6-201303190-00006; Itoh S, 2007, CURR OPIN CELL BIOL, V19, P176, DOI 10.1016/j.ceb.2007.02.015; Jha V, 2013, LANCET, V382, P260, DOI 10.1016/S0140-6736(13)60687-X; Lan HY, 2003, J AM SOC NEPHROL, V14, P1535, DOI 10.1097/01.ASN.0000067632.04658.B8; Lin X, 2006, CELL, V125, P915, DOI 10.1016/j.cell.2006.03.044; Loeffler I, 2014, NEPHROL DIAL TRANSPL, V29, pI37, DOI 10.1093/ndt/gft267; Massague J, 2012, NAT REV MOL CELL BIO, V13, P616, DOI 10.1038/nrm3434; Overstreet JM, 2015, FASEB J, V29, P1258, DOI 10.1096/fj.14-262527; Overstreet JM, 2014, CELL SIGNAL, V26, P1427, DOI 10.1016/j.cellsig.2014.02.017; Perico N, 2012, NEPHROL DIAL TRANSPL, V27, P19, DOI 10.1093/ndt/gfs284; Samarakoon R, 2015, J PATHOL, V236, P421, DOI 10.1002/path.4538; Samarakoon R, 2013, CELL SIGNAL, V25, P2198, DOI 10.1016/j.cellsig.2013.07.007; Samarakoon R, 2013, CELL SIGNAL, V25, P264, DOI 10.1016/j.cellsig.2012.10.003; Samarakoon R, 2012, CELL TISSUE RES, V347, P117, DOI 10.1007/s00441-011-1181-y; Samarakoon R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022896; Samarakoon R, 2008, THROMB HAEMOSTASIS, V100, P976, DOI 10.1160/TH08-05-0273; Strutz F, 2003, SPRINGER SEMIN IMMUN, V24, P459, DOI 10.1007/s00281-003-0123-5; Yang JW, 2003, J AM SOC NEPHROL, V14, P3167, DOI 10.1097/01.ASN.0000099373.33259.B2; Yang L, 2011, CONTRIB NEPHROL, V174, P149, DOI 10.1159/000329385; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Yang X, 2011, J BIOL CHEM, V286, P42267, DOI 10.1074/jbc.M111.292284; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888; Zhou L, 2010, AM J PHYSIOL-RENAL, V298, pF1006, DOI 10.1152/ajprenal.00675.2009	34	18	18	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3308	3320		10.1096/fj.201500105R	http://dx.doi.org/10.1096/fj.201500105R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27328942	Green Published			2022-12-28	WOS:000384329800005
J	Fey, T; Schubert, KM; Schneider, H; Fein, E; Kleinert, E; Pohl, U; Dendorfer, A				Fey, Theres; Schubert, Kai Michael; Schneider, Holger; Fein, Evelyn; Kleinert, Eike; Pohl, Ulrich; Dendorfer, Andreas			Impaired endothelial shear stress induces podosome assembly via VEGF up-regulation	FASEB JOURNAL			English	Article						blood flow; matrix metalloproteinases; proteolysis; vascular remodeling	GROWTH-FACTOR; MATRIX METALLOPROTEINASES; CELL-PROLIFERATION; IN-VIVO; MIGRATION; EXPRESSION; ROSETTES; DEGRADATION; INVADOPODIA; INHIBITOR	Podosomes are dynamic cytoskeletal membrane structures with local adhesive and proteolytic activity. They are critically involved in angiogenesis and vascular adaptive growth. Here, we studied in HUVECs and murine small vessels whether shear stress controls podosome assembly and local proteolytic activity. Podosomes were characterized by immunohistochemistry, and their proteolytic activity was assessed as degradation imprints in fluorescent gelatin that was used as growth substrate. Compared with controls (10 dyn/cm(2)), the number of podosomes formed per time was doubled when cells were exposed to low shear stress (0.3 dyn/cm(2)) or even increased 5-fold under static conditions. This was a result of an enhanced expression of VEGF after reduction of shear stress. Consequently, enhanced podosome formation could be prevented by a VEGF receptor antagonist as well by interruption of VEGF signaling via inhibition of PI3K, Src, or p38. Increase of podosome assembly went along with significantly augmented cell motility. In vivo experiments in mouse arteries confirmed increased endothelial podosome numbers when shear stress was abolished by vessel occlusion. We conclude that shear stress, by reducing VEGF release, inhibits podosome assembly. Hence, endothelial cell-mediated matrix proteolysis and migratory activity are inhibited, thereby stabilizing the structure of the vessel wall.	[Fey, Theres; Schubert, Kai Michael; Schneider, Holger; Fein, Evelyn; Kleinert, Eike; Pohl, Ulrich; Dendorfer, Andreas] Univ Munich, Walter Brendel Ctr Expt Med, Marchioninistr 27, D-81377 Munich, Germany; [Pohl, Ulrich; Dendorfer, Andreas] German Ctr Cardiovasc Res DZHK, Munich Heart Alliance, Munich, Germany; [Pohl, Ulrich] Munich Cluster Syst Neurol, Munich, Germany	University of Munich; German Centre for Cardiovascular Research; Munich Heart Alliance	Fey, T (corresponding author), Univ Munich, Walter Brendel Ctr Expt Med, Marchioninistr 27, D-81377 Munich, Germany.	theres.fey@med.uni-muenchen.de			BioImaging Network of the Ludwig-Maximilians-Universitat Munich; German Centre for Cardiovascular Research (DZHK); Marie Curie Initial Training Network on Small Artery Remodeling (ITN/SMART) of the European Commission [PITN-GA-2013-606998]	BioImaging Network of the Ludwig-Maximilians-Universitat Munich; German Centre for Cardiovascular Research (DZHK); Marie Curie Initial Training Network on Small Artery Remodeling (ITN/SMART) of the European Commission	The authors thank Dr. Elisabeth Deindl, Omary Chillo, and Amelia Caballero-Martinez for providing the ligated and sham-surgery arteries, and Dr. Stephanie Blodow for help with associated experiments. The authors also thank Mei Ping Wu for excellent technical assistance, and Prof. John Davis and Dr. Julian Kirsch for critically reading the manuscript. This work was supported by the BioImaging Network of the Ludwig-Maximilians-Universitat Munich, German Centre for Cardiovascular Research (DZHK), and the Marie Curie Initial Training Network on Small Artery Remodeling (ITN/SMART; Grant PITN-GA-2013-606998) of the European Commission.	Abumiya T, 2002, ARTERIOSCL THROM VAS, V22, P907, DOI 10.1161/01.ATV.0000018300.43492.83; Akimoto S, 2000, CIRC RES, V86, P185, DOI 10.1161/01.RES.86.2.185; Artym Vira V., 2009, V522, P211, DOI 10.1007/978-1-59745-413-1_15; Bassiouny HS, 1998, CIRCULATION, V98, P157, DOI 10.1161/01.CIR.98.2.157; Billottet C, 2008, EUR J CELL BIOL, V87, P543, DOI 10.1016/j.ejcb.2008.02.006; Bolz SS, 2000, AM J PHYSIOL-HEART C, V279, pH1434, DOI 10.1152/ajpheart.2000.279.3.H1434; Collin O, 2008, CURR BIOL, V18, P1288, DOI 10.1016/j.cub.2008.07.046; Conklin BS, 2002, J SURG RES, V102, P13, DOI 10.1006/jsre.2001.6295; deWit C, 1997, PFLUG ARCH EUR J PHY, V434, P354, DOI 10.1007/s004240050408; Gan LM, 2000, BIOCHEM BIOPH RES CO, V272, P490, DOI 10.1006/bbrc.2000.2663; Garcia-Touchard A, 2005, ARTERIOSCL THROM VAS, V25, P1119, DOI 10.1161/01.ATV.0000164311.48592.da; Gimona M, 2006, INT J BIOCHEM CELL B, V38, P1875, DOI 10.1016/j.biocel.2006.05.003; Glen K, 2012, J CELL PHYSIOL, V227, P2710, DOI 10.1002/jcp.23015; Gloe T, 2002, J BIOL CHEM, V277, P23453, DOI 10.1074/jbc.M203889200; Godin D, 2000, CIRCULATION, V102, P2861; Goto T, 2002, J BONE MINER METAB, V20, P98, DOI 10.1007/s007740200013; Guiet R, 2012, J BIOL CHEM, V287, P13051, DOI 10.1074/jbc.M111.307124; Haas TL, 2007, AM J PHYSIOL-HEART C, V293, pH2429, DOI 10.1152/ajpheart.00100.2007; Hennig T, 2011, J VASC RES, V48, P453, DOI 10.1159/000327009; Hsu PP, 2001, BIOCHEM BIOPH RES CO, V285, P751, DOI 10.1006/bbrc.2001.5221; Hu YL, 2002, J VASC RES, V39, P465, DOI 10.1159/000067202; Inoue M, 1998, CIRCULATION, V98, P2108, DOI 10.1161/01.CIR.98.20.2108; Kaverina I, 2003, J CELL SCI, V116, P4915, DOI 10.1242/jcs.00818; Koskinas KC, 2013, ARTERIOSCL THROM VAS, V33, P1494, DOI 10.1161/ATVBAHA.112.300827; Kremerskothen J, 2011, FASEB J, V25, P505, DOI 10.1096/fj.10-155598; Lin K, 2000, P NATL ACAD SCI USA, V97, P9385, DOI 10.1073/pnas.170282597; Linder S, 2007, TRENDS CELL BIOL, V17, P107, DOI 10.1016/j.tcb.2007.01.002; Linder S, 2011, ANNU REV CELL DEV BI, V27, P185, DOI 10.1146/annurev-cellbio-092910-154216; Maharaj ASR, 2006, AM J PATHOL, V168, P639, DOI 10.2353/ajpath.2006.050834; Moreau V, 2003, MOL CELL BIOL, V23, P6809, DOI 10.1128/MCB.23.19.6809-6822.2003; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Osiak AE, 2005, EXP CELL RES, V307, P342, DOI 10.1016/j.yexcr.2005.03.035; Pagel JI, 2012, THROMB HAEMOSTASIS, V107, P562, DOI 10.1160/TH11-07-0490; Papaioannou Theodoros G, 2005, Hellenic J Cardiol, V46, P9; Platt MO, 2006, J HEART VALVE DIS, V15, P622; Platt MO, 2006, ARTERIOSCL THROM VAS, V26, P1784, DOI 10.1161/01.ATV.0000227470.72109.2b; Platt MO, 2016, BIOCHIMIE, V122, P314, DOI 10.1016/j.biochi.2015.10.010; Quintavalle M, 2010, J CELL BIOL, V189, P13, DOI 10.1083/jcb.200912096; Rottiers P, 2009, J CELL SCI, V122, P4311, DOI 10.1242/jcs.057448; Schachtner H, 2013, CYTOSKELETON, V70, P572, DOI 10.1002/cm.21119; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Seano G, 2015, CELL CYCLE, V14, P1370, DOI 10.1080/15384101.2015.1026523; Seano G, 2014, NAT CELL BIOL, V16, P931, DOI 10.1038/ncb3036; Song JW, 2011, P NATL ACAD SCI USA, V108, P15342, DOI 10.1073/pnas.1105316108; TANGELDER GJ, 1988, AM J PHYSIOL, V254, pH1059, DOI 10.1152/ajpheart.1988.254.6.H1059; Tatin F, 2006, J CELL SCI, V119, P769, DOI 10.1242/jcs.02787; Tressel SL, 2007, ARTERIOSCL THROM VAS, V27, P2150, DOI 10.1161/ATVBAHA.107.150920; Tu C, 2008, CANCER RES, V68, P9147, DOI 10.1158/0008-5472.CAN-07-5127; van Hinsbergh VWM, 2006, ARTERIOSCL THROM VAS, V26, P716, DOI 10.1161/01.ATV.0000209518.58252.17; Varon C, 2006, MOL CELL BIOL, V26, P3582, DOI 10.1128/MCB.26.9.3582-3594.2006; WALTENBERGER J, 1994, J BIOL CHEM, V269, P26988; Wang J, 2009, ARTERIOSCL THROM VAS, V29, P202, DOI 10.1161/ATVBAHA.108.174391; Warren CM, 2014, NAT CELL BIOL, V16, P928, DOI 10.1038/ncb3044; Watanabe Noboru, 2004, Curr Atheroscler Rep, V6, P112, DOI 10.1007/s11883-004-0099-1; Xiao HL, 2013, J CELL PHYSIOL, V228, P416, DOI 10.1002/jcp.24146; Yao Y, 2007, AM J PHYSIOL-HEART C, V293, pH1023, DOI 10.1152/ajpheart.00162.2007; Zakrzewicz A, 2002, NEWS PHYSIOL SCI, V17, P197, DOI 10.1152/nips.01395.2001	57	9	10	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2755	2766		10.1096/fj.201500091R	http://dx.doi.org/10.1096/fj.201500091R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27103579				2022-12-28	WOS:000380994000012
J	Bodmann, EL; Krett, AL; Bunemann, M				Bodmann, Eva-Lisa; Krett, Anna-Lena; Buenemann, Moritz			Potentiation of receptor responses induced by prolonged binding of G alpha(13) and leukemia-associated RhoGEF	FASEB JOURNAL			English	Article						ARHGEF12; G protein; thromboxane; FRET; Rho	NUCLEOTIDE EXCHANGE FACTOR; G-PROTEIN ACTIVATION; PDZ-RHOGEF; DYNAMICS; LARG; RHOA; OLIGOMERIZATION; IDENTIFICATION; P115-RHOGEF; EXPRESSION	Diverse cellular functions are controlled by RhoA-GTPases, which are activated by trimeric G proteins via RhoGEFs, among others. In this study, we focused on the signaling from GPCRs to RhoA via G alpha(13) and leukemia-associated RhoGEF (LARG). The activation of G alpha(13) was elucidated in living cells with high temporal and spatial resolution by means of FRET. The inactivation after agonist withdrawal occurred in the same range (t(1/2)=25.3 +/- 2.2 s; mean +/- SEM; n=22) as described for other G alpha proteins. The interaction of G alpha(13) and LARG and the thereby-induced LARG translocation to the plasma membrane were at least 1 order of magnitude more stable after agonist withdrawal, exceeding G alpha(13) deactivation in the absence of LARG several fold. Consequently, we observed an almost 100-fold higher agonist sensitivity of the G alpha(13) LARG interaction compared to the G alpha(13) activation in the absence of LARG.	[Bodmann, Eva-Lisa; Krett, Anna-Lena; Buenemann, Moritz] Philipps Univ Marburg, Dept Pharmacol & Clin Pharm, Marburg, Germany	Philipps University Marburg	Bunemann, M (corresponding author), Philipps Univ Marburg, Dept Pharmacol & Clin Pharm, Marburg, Germany.; Bunemann, M (corresponding author), Karl von Frisch Str 1, D-35043 Marburg, Germany.	moritz.buenemann@staff.uni-marburg.de		Buenemann, Moritz/0000-0002-2259-4378	U.S. National Institutes of Health, National Institute of General Medical Sciences [P41-GM103311]; Deutsche Forschungsgemeinschaft [SFB 593]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103311] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The pcDNA3-mRFP plasmid was kindly provided by Doug Golenbock (University of Massachusetts Medical School, Worcester, MA, USA), the pSRE.L was kindly provided by Barbara Moepps (Institute of Pharmacology and Toxicology, University of Ulm, Ulm, Germany), and the pHyg-LARG was a gift from T. Wieland (University of Heidelberg, Mannheim, Germany). The University of California, San Francisco (UCSF; San Francisco, CA, USA) chimera was developed by the Resource for Biocomputing, Visualization, and Informatics at UCSF (supported by U.S. National Institutes of Health, National Institute of General Medical Sciences Grant P41-GM103311). Mouse thrombocytes were kindly provided by Prof. Dr. Bernhard Nieswandt (Rudolf Virchow Research Center for Experimental Biomedicine, University of Wurzburg, Wurzburg, Germany). This work was funded by the Deutsche Forschungsgemeinschaft as part of the project A13 as part of the SFB 593. The authors declare no conflicts of interest.	Aittaleb M, 2010, MOL PHARMACOL, V77, P111, DOI 10.1124/mol.109.061234; Banerjee J, 2004, MOL BIOL CELL, V15, P1760, DOI 10.1091/mbc.E03-07-0527; Bodmann EL, 2014, BIOCHEM J, V458, P131, DOI 10.1042/BJ20130782; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Bunemann M, 2001, J BIOL CHEM, V276, P47512, DOI 10.1074/jbc.M108652200; Carter AM, 2014, J BIOL CHEM, V289, P19737, DOI 10.1074/jbc.M114.564930; Chen Z, 2012, J BIOL CHEM, V287, P25490, DOI 10.1074/jbc.M111.333716; Chikumi H, 2002, J BIOL CHEM, V277, P27130, DOI 10.1074/jbc.M204715200; Digby GJ, 2006, P NATL ACAD SCI USA, V103, P17789, DOI 10.1073/pnas.0607116103; Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]; Doupnik CA, 1997, P NATL ACAD SCI USA, V94, P10461, DOI 10.1073/pnas.94.19.10461; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Frank M, 2005, J BIOL CHEM, V280, P24584, DOI 10.1074/jbc.M414630200; Gales C, 2006, NAT STRUCT MOL BIOL, V13, P778, DOI 10.1038/nsmb1134; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Goedhart J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1738; Gohla A, 2000, CIRC RES, V87, P221, DOI 10.1161/01.RES.87.3.221; Grabocka E, 2007, MOL PHARMACOL, V72, P993, DOI 10.1124/mol.107.035162; Hein P, 2005, EMBO J, V24, P4106, DOI 10.1038/sj.emboj.7600870; Hein P, 2006, J BIOL CHEM, V281, P33345, DOI 10.1074/jbc.M606713200; HILL CS, 1995, CELL, V81, P1159, DOI 10.1016/S0092-8674(05)80020-0; Kourlas PJ, 2000, P NATL ACAD SCI USA, V97, P2145, DOI 10.1073/pnas.040569197; Kreutz B, 2006, BIOCHEMISTRY-US, V45, P167, DOI 10.1021/bi051729t; Kuner R, 2002, EUR J NEUROSCI, V16, P2333, DOI 10.1046/j.1460-9568.2002.02402.x; Lutz S, 2004, N-S ARCH PHARMACOL, V369, P540, DOI 10.1007/s00210-004-0926-5; Mao JH, 1998, J BIOL CHEM, V273, P27118, DOI 10.1074/jbc.273.42.27118; Marinissen MJ, 2003, J BIOL CHEM, V278, P46814, DOI 10.1074/jbc.M305709200; Meyer BH, 2008, J CELL BIOCHEM, V104, P1660, DOI 10.1002/jcb.21732; Milde M, 2013, BIOCHEM J, V454, P515, DOI 10.1042/BJ20130554; Miralles F, 2003, CELL, V113, P329, DOI 10.1016/S0092-8674(03)00278-2; Moers A, 2003, NAT MED, V9, P1418, DOI 10.1038/nm943; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pfreimer M, 2012, CELL SIGNAL, V24, P652, DOI 10.1016/j.cellsig.2011.10.014; Reuther GW, 2001, J BIOL CHEM, V276, P27145, DOI 10.1074/jbc.M103565200; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Siehler S, 2009, BRIT J PHARMACOL, V158, P41, DOI 10.1111/j.1476-5381.2009.00121.x; Sivaraj KK, 2013, DEV CELL, V25, P427, DOI 10.1016/j.devcel.2013.04.008; Suzuki N, 2003, P NATL ACAD SCI USA, V100, P733, DOI 10.1073/pnas.0234057100; Takefuji M, 2013, J EXP MED, V210, P665, DOI 10.1084/jem.20122126; Wachter RM, 1998, STRUCTURE, V6, P1267, DOI 10.1016/S0969-2126(98)00127-0; Wolters V, 2015, MOL PHARMACOL, V87, P9, DOI 10.1124/mol.114.094722; Worzfeld T, 2008, TRENDS PHARMACOL SCI, V29, P582, DOI 10.1016/j.tips.2008.08.002; Zhang L, 2009, MOL PHARMACOL, V75, P235, DOI 10.1124/mol.108.050906; Zou SY, 2016, THROMB HAEMOSTASIS, V116, P506, DOI 10.1160/TH15-11-0848	44	10	10	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3663	3676		10.1096/fj.201700026R	http://dx.doi.org/10.1096/fj.201700026R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28465324	Green Published			2022-12-28	WOS:000405932400037
J	Ma, HW; Yang, F; Butler, MR; Belcher, J; Redmond, TM; Placzek, AT; Scanlan, TS; Ding, XQ				Ma, Hongwei; Yang, Fan; Butler, Michael R.; Belcher, Joshua; Redmond, T. Michael; Placzek, Andrew T.; Scanlan, Thomas S.; Ding, Xi-Qin			Inhibition of thyroid hormone receptor locally in the retina is a therapeutic strategy for retinal degeneration	FASEB JOURNAL			English	Article						cone degeneration; Leber congenital amaurosis; cone dystrophy; TR antagonist	ENDOPLASMIC-RETICULUM STRESS; CONE OPSIN EXPRESSION; PHOTORECEPTOR DEGENERATION; CELL-DEATH; DEVELOPMENTAL EXPRESSION; TOPICAL APPLICATION; TYPE-3 DEIODINASE; GENE-EXPRESSION; DOWN-REGULATION; ANTAGONIST	Thyroid hormone (TH) signaling regulates cell proliferation, differentiation, and metabolism. Recent studies have implicated TH signaling in cone photoreceptor viability. Using mouse models of retinal degeneration, we demonstrated that antithyroid drug treatment and targeting iodothyronine deiodinases (DIOs) to suppress cellular tri-iodothyronine (T3) production or increase T3 degradation preserves cones. In this work, we investigated the effectiveness of inhibition of the TH receptor (TR). Two genes, THRA and THRB, encode TRs; THRB2 has been associated with cone viability. Using TR antagonists and Thrb2 deletion, we examined the effects of TR inhibition. Systemic and ocular treatment with the TR antagonists NH-3 and 1-850 increased cone density by 30-40% in the Rpe65(-/-) mouse model of Leber congenital amaurosis and reduced the number of TUNEL+ cells. Cone survival was significantly improved in Rpe65(-/-) and Cpfl1 (a model of achromatopsia with Pde6c defect) mice with Thrb2 deletion. Ventral cone density in Cpfl1/Thrb2(-/-) and Rpe65(-/-)/Thrb2(-/-) mice was increased by 1- to 4-fold, compared with age-matched controls. Moreover, the expression levels of TR were significantly higher in the cone-degeneration retinas, suggesting locally elevated TR signaling. This work shows that the effects of antithyroid treatment or targeting DIOs were likely mediated by TRs and that suppressing TR protects cones. Our findings support the view that inhibition of TR locally in the retina is a therapeutic strategy for retinal degeneration management.	[Ma, Hongwei; Yang, Fan; Butler, Michael R.; Belcher, Joshua; Ding, Xi-Qin] Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA; [Redmond, T. Michael] NEI, Lab Retinal Cell & Mol Biol, NIH, Bethesda, MD 20892 USA; [Placzek, Andrew T.; Scanlan, Thomas S.] Oregon Hlth & Sci Univ, Dept Physiol & Pharmacol, Portland, OR 97201 USA	University of Oklahoma System; University of Oklahoma Health Sciences Center; National Institutes of Health (NIH) - USA; NIH National Eye Institute (NEI); Oregon Health & Science University	Ding, XQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, 940 Stanton L Young Blvd,BMSB 553, Oklahoma City, OK 73104 USA.	xi-qin-ding@ouhsc.edu	Yang, Fan/I-5735-2019	Redmond, T. Michael/0000-0002-1813-5291	U.S. NIH/NEI [P30EY021725, T32EY023202, R01EY019490, R21EY024583]; NIH/ NIDDK [DK-52798]; Foundation Fighting Blindness; Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE [R21EY024583, P30EY021725, T32EY023202, R01EY019490] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052798, R56DK052798] Funding Source: NIH RePORTER	U.S. NIH/NEI; NIH/ NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Foundation Fighting Blindness(European Commission); Knights Templar Eye Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Anand Swaroop [U.S. National Institutes of Health (NIH) National Eye Institute (NEI)] for Nrl<SUP>-/-</SUP> mouse line, Dr. Douglas Forrest [NIH National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)] for Thrb2<SUP>-/-</SUP> mouse line, Dr. Bruce Baretz (Lipoid LLC, Newark, NJ, USA) for Phospholipon 90G, and Drs. Cheryl Craft (University of Southern California, Los Angeles, CA, USA), Douglas Forrest, and Muna Naash (University of Houston, Houston, TX, USA) for antibodies against M-opsin, cone arrestin, THRB2, and S-opsin; Dr. Douglas Forrest for a critical reading of the manuscript; and the Imaging Core Facility of the Department of Cell Biology at the University of Oklahoma Health Sciences Center for technical assistance. This work was supported by U.S. NIH/NEI Grants P30EY021725, T32EY023202 (to H.M.), R01EY019490, and R21EY024583 (to X.-Q.D.), NIH/ NIDDK Grant DK-52798 (to T.S.S.), the Foundation Fighting Blindness (to X.-Q.D.), and the Knights Templar Eye Foundation (to H.M.).	Applebury ML, 2007, DEV DYNAM, V236, P1203, DOI 10.1002/dvdy.21155; Brent GA, 2012, J CLIN INVEST, V122, P3035, DOI 10.1172/JCI60047; Ceresini G, 2009, J AM GERIATR SOC, V57, P89, DOI 10.1111/j.1532-5415.2008.02080.x; Chaker L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0329-0; Chang B, 2009, P NATL ACAD SCI USA, V106, P19581, DOI 10.1073/pnas.0907720106; Cheng SY, 2010, ENDOCR REV, V31, P139, DOI 10.1210/er.2009-0007; Chiloeches A, 2008, MOL ENDOCRINOL, V22, P2466, DOI 10.1210/me.2008-0107; Deeb SS, 2010, OPHTHAL PHYSL OPT, V30, P446, DOI 10.1111/j.1475-1313.2010.00735.x; Ding XQ, 2009, HUM MOL GENET, V18, P4770, DOI 10.1093/hmg/ddp440; Dunaief JL, 2002, ARCH OPHTHALMOL-CHIC, V120, P1435, DOI 10.1001/archopht.120.11.1435; Feathers KL, 2008, INVEST OPHTH VIS SCI, V49, P1126, DOI 10.1167/iovs.07-1234; Flamant F, 2006, PHARMACOL REV, V58, P705, DOI 10.1124/pr.58.4.3; Forrest D, 2002, CURR OPIN NEUROBIOL, V12, P49, DOI 10.1016/S0959-4388(02)00289-1; Glaschke A, 2011, J NEUROSCI, V31, P4844, DOI 10.1523/JNEUROSCI.6181-10.2011; Glaschke A, 2010, INVEST OPHTH VIS SCI, V51, P1719, DOI 10.1167/iovs.09-3592; Gopinath B, 2016, INVEST OPHTH VIS SCI, V57, P5273, DOI 10.1167/iovs.16-19735; Gorbatyuk MS, 2010, P NATL ACAD SCI USA, V107, P5961, DOI 10.1073/pnas.0911991107; Grover GJ, 2007, J PHARMACOL EXP THER, V322, P385, DOI 10.1124/jpet.106.116152; Hiroi Y, 2006, P NATL ACAD SCI USA, V103, P14104, DOI 10.1073/pnas.0601600103; Hwang JY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.200436; Kalmijn S, 2000, CLIN ENDOCRINOL, V53, P733, DOI 10.1046/j.1365-2265.2000.01146.x; Kalyanaraman H, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004911; Komeima K, 2006, P NATL ACAD SCI USA, V103, P11300, DOI 10.1073/pnas.0604056103; Kunchithapautham K, 2009, INVEST OPHTH VIS SCI, V50, P4858, DOI 10.1167/iovs.08-3008; Leaderer D, 2015, EXP EYE RES, V140, P171, DOI 10.1016/j.exer.2015.09.005; Lim W, 2002, J BIOL CHEM, V277, P35664, DOI 10.1074/jbc.M205608200; Liu Y, 2007, VISION RES, V47, P2314, DOI 10.1016/j.visres.2007.04.023; Lu AL, 2009, ENDOCRINOLOGY, V150, P1536, DOI 10.1210/en.2008-1092; Ma HW, 2015, J BIOL CHEM, V290, P20880, DOI 10.1074/jbc.M115.641159; Ma HW, 2014, P NATL ACAD SCI USA, V111, P3602, DOI 10.1073/pnas.1317041111; Ma HW, 2013, HUM MOL GENET, V22, P3906, DOI 10.1093/hmg/ddt245; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Mihara S, 1999, J CLIN ENDOCR METAB, V84, P1378, DOI 10.1210/jc.84.4.1378; Ng L, 2010, J NEUROSCI, V30, P3347, DOI 10.1523/JNEUROSCI.5267-09.2010; Ng L, 2009, NEUROREPORT, V20, P627, DOI 10.1097/WNR.0b013e32832a2c63; Ng L, 2009, ENDOCRINOLOGY, V150, P1952, DOI 10.1210/en.2008-1419; Nguyen NH, 2005, J AM CHEM SOC, V127, P4599, DOI 10.1021/ja0440093; Nguyen NH, 2002, J MED CHEM, V45, P3310, DOI 10.1021/jm0201013; Peeters RP, 2013, ENDOCRINOLOGY, V154, P550, DOI 10.1210/en.2012-1738; Redmond TM, 1998, NAT GENET, V20, P344, DOI 10.1038/3813; Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103; Rohrer B, 2005, INVEST OPHTH VIS SCI, V46, P3876, DOI 10.1167/iovs.05-0533; Rowe-Rendleman CL, 2014, INVEST OPHTH VIS SCI, V55, P2714, DOI 10.1167/iovs.13-13707; Sanges D, 2006, P NATL ACAD SCI USA, V103, P17366, DOI 10.1073/pnas.0606276103; Sar P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020861; Schaeferhoff K, 2010, CELL MOL LIFE SCI, V67, P3173, DOI 10.1007/s00018-010-0376-9; Schapira M, 2003, P NATL ACAD SCI USA, V100, P7354, DOI 10.1073/pnas.1131854100; Scheppke L, 2008, J CLIN INVEST, V118, P2337, DOI [10.1172/JC133361, 10.1172/JCI33361]; Schopf LR, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.3.11; Shah V, 2008, MOL CELL ENDOCRINOL, V296, P69, DOI 10.1016/j.mce.2008.09.016; Shahrara S, 1999, AM J VET RES, V60, P848; Shen JK, 2005, J CELL PHYSIOL, V203, P457, DOI 10.1002/jcp.20346; SJOBERG M, 1992, DEVELOPMENT, V114, P39; Thapa A, 2012, J BIOL CHEM, V287, P18018, DOI 10.1074/jbc.M112.342220; Wang S, 2012, CURR DIABETES REP, V12, P355, DOI 10.1007/s11892-012-0289-0; Xu JH, 2013, J NEUROSCI, V33, P14939, DOI 10.1523/JNEUROSCI.0909-13.2013; Xu JH, 2011, INVEST OPHTH VIS SCI, V52, P3557, DOI 10.1167/iovs.10-6358; Yamada-Okabe T, 2003, EUR J BIOCHEM, V270, P3064, DOI 10.1046/j.1432-1033.2003.03686.x; Yamaguchi S, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2088; Yang F, 2016, FASEB J, V30, P4313, DOI 10.1096/fj.201600715R; Yang LP, 2007, INVEST OPHTH VIS SCI, V48, P5191, DOI 10.1167/iovs.07-0512; Yoshida T, 2012, EXP EYE RES, V94, P41, DOI 10.1016/j.exer.2011.11.003; Zhang T, 2015, HUM MOL GENET, V24, P1755, DOI 10.1093/hmg/ddu588; Zhang T, 2011, P NATL ACAD SCI USA, V108, P8879, DOI 10.1073/pnas.1017127108; Znoiko SL, 2005, INVEST OPHTH VIS SCI, V46, P1473, DOI 10.1167/iovs.04-0653	65	6	6	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3425	3438		10.1096/fj.201601166RR	http://dx.doi.org/10.1096/fj.201601166RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28428265	Green Published			2022-12-28	WOS:000405932400021
J	Michelucci, A; Paolini, C; Boncompagni, S; Canato, M; Reggiani, C; Protasi, F				Michelucci, Antonio; Paolini, Cecilia; Boncompagni, Simona; Canato, Marta; Reggiani, Carlo; Protasi, Feliciano			Strenuous exercise triggers a life-threatening response in mice susceptible to malignant hyperthermia	FASEB JOURNAL			English	Article						calsequestrin-1; excitation-contraction coupling; ryanodine receptor; sarcoplasmic reticulum; skeletal muscle	SKELETAL-MUSCLE FIBERS; OPERATED CA2+ ENTRY; SARCOPLASMIC-RETICULUM; CALCIUM-RELEASE; INTRACELLULAR CALCIUM; RYANODINE RECEPTORS; OXIDATIVE STRESS; GENE-EXPRESSION; BINDING-SITES; SUDDEN-DEATH	In humans, hyperthermic episodes can be triggered by halogenated anesthetics [malignant hyperthermia (MH) susceptibility] and by high temperature [environmental heat stroke (HS)]. Correlation between MH susceptibility and HS is supported by extensive work in mouse models that carry a mutation in ryanodine receptor type-1 (RYR1(Y522S/WT)) and calsequestrin-1 knockout (CASQ1-null), 2 proteins that control Ca2+ release in skeletal muscle. As overheating episodes in humans have also been described during exertion, here we subjected RYR1(Y522S/WT) and CASQ1-null mice to an exertional-stress protocol (incremental running on a treadmill at 34 degrees C and 40% humidity). The mortality rate was 80 and 78.6% in RYR1(Y522S/WT) and CASQ1-null mice, respectively, vs. 0% in wild-type mice. Lethal crises were characterized by hyperthermia and rhabdomyolysis, classic features of MH episodes. Of importance, pretreatment with azumolene, an analog of the drug used in humans to treat MH crises, reduced mortality to 0 and 12.5% in RYR1(Y522S/WT) and CASQ1-null mice, respectively, thanks to a striking reduction of hyperthermia and rhabdomyolysis. At the molecular level, azumolene strongly prevented Ca2+-dependent activation of calpains and NF-kappa B by lowering myoplasmic Ca2+ concentration and nitro-oxidative stress, parameters that were elevated in RYR1(Y522S/WT) and CASQ1-null mice. These results suggest that common molecular mechanisms underlie MH crises and exertional HS in mice.	[Michelucci, Antonio; Paolini, Cecilia; Boncompagni, Simona; Protasi, Feliciano] Univ G dAnnunzio Chieti, Dept Neurosci Imaging & Clin Sci DNICS, Ctr Res Ageing & Translat Med CeSI MeT, Chieti, Italy; [Protasi, Feliciano] Univ G dAnnunzio Chieti, Dept Med & Aging Sci, Chieti, Italy; [Canato, Marta; Reggiani, Carlo] Univ Padua, Dept Biomed Sci, Padua, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; University of Padua	Protasi, F (corresponding author), Univ G dAnnunzio Chieti, Ctr Res Ageing & Translat Med, CeSI MeT, I-66100 Chieti, Italy.	feliciano.protasi@unich.it	Paolini, Cecilia/AAI-4444-2021; Michelucci, Antonio/AAG-4579-2021		Italian Telethon Organizzazione non Lucrativa di Utilita Sociale (ONLUS) Foundation (Rome, Italy) [GGP13213]; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR053349-06]; Italian Ministry of Education, University and Research (Rome, Italy) [RBFR13A20K]; Italian Ministry of Health (Rome, Italy) [GR-2011-02350912]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR053349] Funding Source: NIH RePORTER	Italian Telethon Organizzazione non Lucrativa di Utilita Sociale (ONLUS) Foundation (Rome, Italy)(Fondazione Telethon); U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Italian Ministry of Education, University and Research (Rome, Italy)(Ministry of Education, Universities and Research (MIUR)); Italian Ministry of Health (Rome, Italy)(Ministry of Health, Italy); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by the following grants: GGP13213 from the Italian Telethon Organizzazione non Lucrativa di Utilita Sociale (ONLUS) Foundation (Rome, Italy; to F.P. and C.R.); AR053349-06 from the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (subcontract to F.P.); RBFR13A20K from the Italian Ministry of Education, University and Research (Rome, Italy; to S.B.); and GR-2011-02350912 from the Italian Ministry of Health (Rome, Italy; to C.P.). The authors thank Dr. S. L. Hamilton (Baylor College of Medicine, Houston, TX, USA), who generated and kindly provided the RYR1<SUP>Y522S/WT</SUP> mouse line.	ADNET PJ, 1991, ANESTHESIOLOGY, V75, P413, DOI 10.1097/00000542-199109000-00006; Altamirano F, 2012, J BIOL CHEM, V287, P20876, DOI 10.1074/jbc.M112.344929; Badalamente MA, 2000, MUSCLE NERVE, V23, P106, DOI 10.1002/(SICI)1097-4598(200001)23:1<106::AID-MUS14>3.0.CO;2-D; Beard NA, 2002, BIOPHYS J, V82, P310, DOI 10.1016/S0006-3495(02)75396-4; Boncompagni S, 2009, P NATL ACAD SCI USA, V106, P21996, DOI 10.1073/pnas.0911496106; Bouchama A, 2002, NEW ENGL J MED, V346, P1978, DOI 10.1056/NEJMra011089; BOURDON L, 1995, MED HYPOTHESES, V45, P268, DOI 10.1016/0306-9877(95)90116-7; Canato M, 2010, P NATL ACAD SCI USA, V107, P22326, DOI 10.1073/pnas.1009168108; Capacchione JF, 2010, ANESTHESIOLOGY, V112, P239, DOI 10.1097/ALN.0b013e3181c29504; Carpenter D, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-104; Chelu MG, 2006, FASEB J, V20, P329, DOI 10.1096/fj.05-4497fje; Cherednichenko G, 2008, MOL PHARMACOL, V73, P1203, DOI 10.1124/mol.107.043299; Dainese M, 2009, FASEB J, V23, P1710, DOI 10.1096/fj.08-121335; Davis M, 2002, BRIT J ANAESTH, V88, P508, DOI 10.1093/bja/88.4.508; Defranchi E, 2005, MICROSC RES TECHNIQ, V67, P27, DOI 10.1002/jemt.20177; DENBOROUGH MA, 1962, BRIT J ANAESTH, V34, P395, DOI 10.1093/bja/34.6.395; DENBOROUGH MA, 1988, BRIT MED J, V296, P1442, DOI 10.1136/bmj.296.6634.1442-a; Di Blasi C, 2015, J MED GENET, V52, P617, DOI 10.1136/jmedgenet-2014-102882; Diaz-Sylvester PL, 2008, AM J PHYSIOL-CELL PH, V294, pC1103, DOI 10.1152/ajpcell.90642.2007; do Carmo PL, 2010, FUND CLIN PHARMACOL, V24, P491, DOI 10.1111/j.1472-8206.2009.00787.x; Duke AM, 2010, J BIOL CHEM, V285, P25645, DOI 10.1074/jbc.M110.104976; DUNCAN CJ, 1978, EXPERIENTIA, V34, P1531, DOI 10.1007/BF02034655; Durham WJ, 2008, CELL, V133, P53, DOI 10.1016/j.cell.2008.02.042; ELLIS FR, 1984, BRIT J ANAESTH, V56, P1267; Finsterer Josef, 2002, J Clin Neuromuscul Dis, V4, P64, DOI 10.1097/00131402-200212000-00004; FLETCHER JE, 1990, CAN J ANAESTH, V37, P695, DOI 10.1007/BF03006495; FranziniArmstrong C, 1997, PHYSIOL REV, V77, P699, DOI 10.1152/physrev.1997.77.3.699; Fruen BR, 1997, J BIOL CHEM, V272, P26965, DOI 10.1074/jbc.272.43.26965; Galli L, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9442; Glahn KPE, 2010, BRIT J ANAESTH, V105, P417, DOI 10.1093/bja/aeq243; Goll DE, 2003, PHYSIOL REV, V83, P731, DOI 10.1152/physrev.00029.2002; Groom L, 2011, ANESTHESIOLOGY, V115, P938, DOI 10.1097/ALN.0b013e3182320068; HARTREE EF, 1972, ANAL BIOCHEM, V48, P422, DOI 10.1016/0003-2697(72)90094-2; Henriquez-Olguin C, 2015, BBA-MOL BASIS DIS, V1852, P1410, DOI 10.1016/j.bbadis.2015.03.012; Hopkins PM, 2011, BRIT J ANAESTH, V107, P48, DOI 10.1093/bja/aer132; HOPKINS PM, 1991, LANCET, V338, P1491, DOI 10.1016/0140-6736(91)92304-K; Huang J, 1998, P NATL ACAD SCI USA, V95, P12100, DOI 10.1073/pnas.95.21.12100; JONES EW, 1972, ANESTHESIOLOGY, V36, P42, DOI 10.1097/00000542-197201000-00008; Kobayashi S, 2005, J BIOL CHEM, V280, P6580, DOI 10.1074/jbc.M408375200; Kochling A, 1998, ANAESTH INTENS CARE, V26, P315, DOI 10.1177/0310057X9802600317; Kraeva N, 2013, ANESTHESIOLOGY, V118, P344, DOI [10.1097/01.anes.0000530185.78660.da, 10.1097/ALN.0b013e318279f925]; Kumar A, 2003, FASEB J, V17, P386, DOI 10.1096/fj.02-0542com; LARACH MG, 1989, ANESTH ANALG, V69, P511; LEDBETTER MW, 1994, J BIOL CHEM, V269, P31544; Lehmann-Horn F, 2011, ANESTHESIOLOGY, V115, P915, DOI 10.1097/ALN.0b013e318232008f; MACLENNAN DH, 1992, SCIENCE, V256, P789, DOI 10.1126/science.1589759; Michelucci A, 2015, ANESTHESIOLOGY, V123, P603, DOI 10.1097/ALN.0000000000000748; Monnier N, 1997, AM J HUM GENET, V60, P1316, DOI 10.1086/515454; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Murphy RM, 2010, CLIN EXP PHARMACOL P, V37, P385, DOI 10.1111/j.1440-1681.2009.05310.x; NELSON TE, 1975, ANESTHESIOLOGY, V42, P301, DOI 10.1097/00000542-197503000-00011; NELSON TE, 1983, J CLIN INVEST, V72, P862, DOI 10.1172/JCI111057; NELSON TE, 1972, ANESTHESIOLOGY, V36, P52, DOI 10.1097/00000542-197201000-00009; Ogino K, 2007, ACTA MED OKAYAMA, V61, P181; Palnitkar SS, 1997, BIOCHEM J, V326, P847, DOI 10.1042/bj3260847; Paolini C, 2007, J PHYSIOL-LONDON, V583, P767, DOI 10.1113/jphysiol.2007.138024; Paolini C, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0035-9; PARNESS J, 1995, J BIOL CHEM, V270, P18465, DOI 10.1074/jbc.270.31.18465; Powers SK, 2012, CURR OPIN CLIN NUTR, V15, P240, DOI 10.1097/MCO.0b013e328352b4c2; Protasi F, 2009, J PHYSIOL-LONDON, V587, P3095, DOI 10.1113/jphysiol.2009.171967; Rando TA, 1998, NEUROMUSCULAR DISORD, V8, P14, DOI 10.1016/S0960-8966(97)00124-7; Richard I, 2000, J CELL BIOL, V151, P1583, DOI 10.1083/jcb.151.7.1583; Robinson RL, 1997, HUM MOL GENET, V6, P953, DOI 10.1093/hmg/6.6.953; Rosenberg H, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-21; Rosenberg H, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0310-1; Rossi D, 2014, HUM MUTAT, V35, P1163, DOI 10.1002/humu.22631; SCHNEIDER MF, 1994, ANNU REV PHYSIOL, V56, P463, DOI 10.1146/annurev.ph.56.030194.002335; Smuder AJ, 2010, FREE RADICAL BIO MED, V49, P1152, DOI 10.1016/j.freeradbiomed.2010.06.025; Spencer MJ, 2002, HUM MOL GENET, V11, P2645, DOI 10.1093/hmg/11.21.2645; Tidball JG, 2000, INT J BIOCHEM CELL B, V32, P1, DOI 10.1016/S1357-2725(99)00095-3; Tobin JR, 2001, JAMA-J AM MED ASSOC, V286, P168, DOI 10.1001/jama.286.2.168; Wappler F, 2001, ANESTHESIOLOGY, V94, P95, DOI 10.1097/00000542-200101000-00019; WEDEL DJ, 1995, MAYO CLIN PROC, V70, P241, DOI 10.4065/70.3.241; Wei L, 2011, FASEB J, V25, P3068, DOI 10.1096/fj.11-187252; Wu SW, 2006, BRAIN, V129, P1470, DOI 10.1093/brain/awl077; Yang TZ, 2006, ANESTHESIOLOGY, V105, P1164, DOI 10.1097/00000542-200612000-00016; Yarotskyy V, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077633; Zhang YF, 2005, J PHARMACOL EXP THER, V314, P94, DOI 10.1124/jpet.105.084046; Zhao XL, 2006, J BIOL CHEM, V281, P33477, DOI 10.1074/jbc.M602306200; Zhao XL, 2010, BIOPHYS J, V99, P1556, DOI 10.1016/j.bpj.2010.06.050	80	28	29	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3649	3662		10.1096/fj.201601292R	http://dx.doi.org/10.1096/fj.201601292R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28465322	Green Published			2022-12-28	WOS:000405932400036
J	Sheng, WW; Dong, M; Chen, CP; Wang, ZX; Li, YW; Wang, KW; Li, YJ; Zhou, JP				Sheng, Weiwei; Dong, Ming; Chen, Chuanping; Wang, Zixin; Li, Yunwei; Wang, Kewei; Li, Yuji; Zhou, Jianping			Cooperation of Musashi-2, Numb, MDM2, and P53 in drug resistance and malignant biology of pancreatic cancer	FASEB JOURNAL			English	Article						chemosensitivity; cell invasion; tumor growth; clinical significance	RNA-BINDING PROTEIN; CELL LUNG-CANCER; COLORECTAL-CANCER; MYELOID-LEUKEMIA; STEM-CELLS; IN-VITRO; CARCINOMA; PATHWAY; PROGRESSION; EXPRESSION	Our earlier work showed thatMusashi (MSI)-2 promoted the development of pancreatic cancer (PC) by down-regulating Numb, which prevented murine double-minute (MDM)-2-mediated p53 ubiquitin degradation. Thus, we investigate the relationship amongMSI2, Numb, MDM2, and p53 in PCin vitro and in vivo, anassociation that has not been reported to our knowledge. MSI2 had no relationship with mutant p53 (mtp53) andwild-type p53 (wtp53) in normal PC cells. However, in response to gemcitabine or cisplatin treatment, MSI2 silencing simultaneously down-regulated MDM2 and up-regulated Numb and wtp53 protein levels. Moreover, these 4 endogenous proteins can be coimmuno precipitated as a quaternary complex. Numb small interferingRNA(siRNA) reversed the MSI2 silencing-induced p53 increase. During treatment with chemical agents, MSI2 silencing decreased drug resistance and cellmotility in vitro and inhibited tumor growth in vivo, all of which were significantly reversed by p53 siRNA. MSI2 was also negatively associated with Numb and positively associated with MDM2 expression in tissue. Overexpression of MSI2, MDM2, and mtp53 and weak expression of Numb were closely associated with aggressive clinicopathologic characteristics and poor prognosis for patients with PC. MSI2 negatively regulates wtp53 protein by up-regulating MDM2 and down-regulating Numb after treatment with chemical agents. MSI2 promotes drug resistance andmalignant biology ofPCina p53-dependent manner.	[Sheng, Weiwei; Dong, Ming; Wang, Zixin; Li, Yunwei; Wang, Kewei; Li, Yuji; Zhou, Jianping] China Med Univ, Hosp 1, Dept Gastrointestinal & Hernia & Abdominal Wall S, Shenyang 110001, Peoples R China; [Chen, Chuanping] Sixth Peoples Hosp Shenyang City, Clin Lab, Shenyang, Peoples R China	China Medical University	Dong, M (corresponding author), China Med Univ, Hosp 1, Dept Gastrointestinal & Hernia & Abdominal Wall S, Shenyang 110001, Peoples R China.	dongming@cmu.edu.cn	Wang, Kewei/J-8974-2019; Wang, Zhiquan/HHS-6768-2022	Wang, Kewei/0000-0002-3816-1024; 	Chinese National Science Foundation [81672835]; Shenyang Science and Technology Bureau (Social Development Program) [F15-139-9-19]	Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Shenyang Science and Technology Bureau (Social Development Program)	This work was supported by the Chinese National Science Foundation (Grant 81672835 to M.D.) and the Shenyang Science and Technology Bureau (Social Development Program Grant F15-139-9-19). The authors declare no conflicts of interest.	BARTON CM, 1991, BRIT J CANCER, V64, P1076, DOI 10.1038/bjc.1991.467; Bergman AM, 1996, CLIN CANCER RES, V2, P521; Blagosklonny MV, 2000, FASEB J, V14, P1901, DOI 10.1096/fj.99-1078rev; Branch P, 2000, ONCOGENE, V19, P3138, DOI 10.1038/sj.onc.1203668; Brighenti E, 2014, ONCOGENE, V33, P4396, DOI 10.1038/onc.2014.1; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Byers RJ, 2011, BLOOD, V118, P2857, DOI 10.1182/blood-2011-04-346767; Chen B, 2013, BIOCHEM BIOPH RES CO, V437, P526, DOI 10.1016/j.bbrc.2013.06.103; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Cox JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062857; de Andres-Aguayo L, 2012, CURR OPIN HEMATOL, V19, P268, DOI 10.1097/MOH.0b013e328353c778; Emadi-Baygi M, 2013, PATHOL RES PRACT, V209, P689, DOI 10.1016/j.prp.2013.07.008; Glazer RI, 2008, CELL CYCLE, V7, P2635, DOI 10.4161/cc.7.17.6522; Han YX, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136484; He L, 2014, J CELL MOL MED, V18, P49, DOI 10.1111/jcmm.12158; Hope KJ, 2010, CELL STEM CELL, V7, P101, DOI 10.1016/j.stem.2010.06.007; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Jiang WL, 2016, CANCER LETT, V371, P314, DOI 10.1016/j.canlet.2015.12.002; Kubbutat MHG, 1997, NATURE, V387, P299, DOI 10.1038/387299a0; Kudinov AE, 2016, P NATL ACAD SCI USA, V113, P6955, DOI 10.1073/pnas.1513616113; Lavarino C, 1997, LANCET, V349, P1556, DOI 10.1016/S0140-6736(05)62140-X; Lim LY, 2009, BRIT J CANCER, V101, P1606, DOI 10.1038/sj.bjc.6605335; Liu H, 2015, CANCER LETT, V361, P218, DOI 10.1016/j.canlet.2015.03.001; Momand J, 1996, ONCOGENE, V12, P2279; Moore PS, 2001, VIRCHOWS ARCH, V439, P798, DOI 10.1007/s004280100474; Munro AJ, 2005, BRIT J CANCER, V92, P434, DOI 10.1038/sj.bjc.6602358; Okano H, 2005, EXP CELL RES, V306, P349, DOI 10.1016/j.yexcr.2005.02.021; Oren M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001107; Owonikoko TK, 2014, CANCER MED-US, V3, P1579, DOI 10.1002/cam4.317; Paajarvi G, 2004, FASEB J, V18, P476, DOI 10.1096/fj.04-2745fje; REDSTON MS, 1994, CANCER RES, V54, P3025; Sakakibara S, 2002, P NATL ACAD SCI USA, V99, P15194, DOI 10.1073/pnas.232087499; Sheng W., 2016, ONCOTARGET; Sheng WW, 2014, J CELL PHYSIOL, V229, P887, DOI 10.1002/jcp.24519; Sheng WW, 2013, CELL TISSUE RES, V354, P521, DOI 10.1007/s00441-013-1679-6; Sui XB, 2015, ONCOTARGET, V6, P22869, DOI 10.18632/oncotarget.5137; Wang MH, 2015, AM J CANCER RES, V5, P1089; Wang S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7517; Waning DL, 2011, J BIOL CHEM, V286, P216, DOI 10.1074/jbc.M110.183012; Wuebben EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034827; Yang CL, 2016, LAB INVEST, V96, P950, DOI 10.1038/labinvest.2016.71	41	34	36	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2429	2438		10.1096/fj.201601240R	http://dx.doi.org/10.1096/fj.201601240R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28223335				2022-12-28	WOS:000401553400018
J	Venu, VKP; Adijiang, A; Seibert, T; Chen, YX; Shi, C; Batulan, Z; O'Brien, ER				Venu, Vivek Krishna Pulakazhi; Adijiang, Ayinuer; Seibert, Tara; Chen, Yong-Xiang; Shi, Chunhua; Batulan, Zarah; O'Brien, Edward R.			Heat shock protein 27-derived atheroprotection involves reverse cholesterol transport that is dependent on GM-CSF to maintain ABCA1 and ABCG1 expression in ApoE(-/-) mice	FASEB JOURNAL			English	Article						atherosclerosis; macrophages; NF-kappa B; Toll-like receptors	COLONY-STIMULATING FACTOR; CORONARY-ARTERY-DISEASE; ATHEROSCLEROTIC LESION DEVELOPMENT; RECEPTOR SIGNALING PATHWAY; E-DEFICIENT MICE; COLLATERAL GROWTH; INFLAMMATORY DISEASES; MACROPHAGE BURDEN; ENDOTHELIAL-CELLS; DENDRITIC CELLS	Recently, we demonstrated that heat shock protein (HSP)-27 is protective against the development of experimental atherosclerosis, reducing plaque cholesterol content by more than 30%. Moreover, elevated HSP-27 levels are predictive of relative freedom from clinical cardiovascular events. HSP-27 signaling occurs via the activation of NF-kappa B, which induces a marked up-regulation in expression of granulocyte-monocyte colony-stimulating factor (GM-CSF), a cytokine that is known to alter ABC transporters involved in reverse cholesterol transport (RCT). Therefore, we hypothesized that HSP-27-derivedGM-CSF has a potent role in impeding plaque formation by promoting macrophage RCT and sought to better characterize this pathway. Treatment of THP-1 cells, RAW-Blue cells, and primary macrophages with recombinant HSP-27 resulted in NF-kB activation via TLR-4 and was inhibited by various pharmacologic blockers of this pathway. Moreover, HSP-27-induced upregulation of GM-CSF expression was dependent on TLR-4 signaling. Recombinant (r) HSP-27 treatment of ApoE(-/-) female (but not male) mice for 4 wk yielded reductions in plaque area andcholesterol clefts of 33 and 47%, respectively, with no effect onGM-CSF(-/-)ApoE(-/-) mice. With 12 wk of rHSP-27 treatment, both female and male mice showed reductions inplaque burden(55 and42%, respectively) and a 60% reduction in necrotic core area but no treatment effect inGM-CSF-/- ApoE(-/-) mice. In vitro functional studies revealed that HSP-27 enhanced the expression of ABCA1 and ABCG1, as well as facilitated cholesterol efflux in vitro by similar to 10%. These novel findings establish a paradigm for HSP-27-mediated RCT and set the stage for the development of HSP-27 atheroprotective therapeutics.	[Venu, Vivek Krishna Pulakazhi; Adijiang, Ayinuer; Seibert, Tara; Chen, Yong-Xiang; Shi, Chunhua; Batulan, Zarah; O'Brien, Edward R.] Univ Calgary, Cumming Sch Med, Libin Cardiovasc Inst Alberta, Dept Cardiac Sci, Calgary, AB, Canada	Libin Cardiovascular Institute Of Alberta; University of Calgary	O'Brien, ER (corresponding author), Libin Cardiovasc Inst Alberta, Hlth Res Innovat Ctr, Dept Cardiac Sci, Room GC68,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	ermobrie@ucalgary.ca	O'Brien, Edward R/J-6621-2013; Pulakazhi Venu, Vivek Krishna/F-9374-2014	O'Brien, Edward R/0000-0003-1039-9425; Pulakazhi Venu, Vivek Krishna/0000-0003-2129-5453	Heart and Stroke Foundation of Canada [G-13-0001599]; Canadian Institute for Health Research (CIHR)/Medtronic Canada [ISO 110836]; CIHR; Medtronic peer-reviewed Research Chair [IRC 57093]; Eyes High Fellowship from the University of Calgary	Heart and Stroke Foundation of Canada(Heart & Stroke Foundation of Canada); Canadian Institute for Health Research (CIHR)/Medtronic Canada; CIHR(Canadian Institutes of Health Research (CIHR)); Medtronic peer-reviewed Research Chair; Eyes High Fellowship from the University of Calgary	This work was supported by the Heart and Stroke Foundation of Canada (Operating Grant G-13-0001599); Canadian Institute for Health Research (CIHR)/Medtronic Canada (Grant ISO 110836); CIHR and Medtronic peer-reviewed Research Chair (Grant IRC 57093 to E.O.B.); and an Eyes High Fellowship from the University of Calgary (to V.K.P.V.). The authors declare no conflicts of interest.	Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Arques O., 2012, NAT PROTOC, DOI [10.1038/protex.2012.008, DOI 10.1038/PROTEX.2012.008]; Baldan A, 2006, ARTERIOSCL THROM VAS, V26, P2301, DOI 10.1161/01.ATV.0000240051.22944.dc; Banach M, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0459-4; Barter PJ, 2007, NEW ENGL J MED, V357, P2109, DOI 10.1056/NEJMoa0706628; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chousterman BG, 2015, INT IMMUNOL, V27, P537, DOI 10.1093/intimm/dxv028; Cuerrier CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055867; Curtiss LK, 2009, J LIPID RES, V50, pS340, DOI 10.1194/jlr.R800056-JLR200; De AK, 2000, J IMMUNOL, V165, P3951, DOI 10.4049/jimmunol.165.7.3951; Ditiatkovski M, 2006, ARTERIOSCL THROM VAS, V26, P2337, DOI 10.1161/01.ATV.0000238357.60338.90; DUFF GW, 1982, J IMMUNOL METHODS, V52, P333, DOI 10.1016/0022-1759(82)90005-9; Fisher EA, 2016, ARTERIOSCL THROM VAS, V36, P226, DOI 10.1161/ATVBAHA.115.301926; Haghighat A, 2007, CIRCULATION, V115, P2049, DOI 10.1161/CIRCULATIONAHA.106.665570; Han S, 2006, CELL METAB, V3, P257, DOI 10.1016/j.cmet.2006.02.008; Han YH, 2009, ONCOL REP, V22, P215, DOI 10.3892/or_00000427; Harari OA, 2006, CIRC RES, V98, P1134, DOI 10.1161/01.RES.0000220105.85182.28; Harrington SC, 2007, CIRC RES, V100, P1696, DOI 10.1161/CIRCRESAHA.106.146183; Hilgendorf I, 2014, CIRCULATION, V129, P1677, DOI 10.1161/CIRCULATIONAHA.113.006381; Iqbal AJ, 2016, ELIFE, V5, DOI 10.7554/eLife.15190; ISHIBASHI T, 1994, ARTERIOSCLER THROMB, V14, P1534, DOI 10.1161/01.ATV.14.10.1534; Kawamoto T, 2008, EUR J PHARMACOL, V584, P40, DOI 10.1016/j.ejphar.2008.01.026; Kazawa T, 2009, PATHOL INT, V59, P152, DOI 10.1111/j.1440-1827.2009.02343.x; Kohro Takahide, 2004, J Atheroscler Thromb, V11, P88; Landray MJ, 2014, NEW ENGL J MED, V371, P203, DOI 10.1056/NEJMoa1300955; Laudanski K, 2007, EUR J IMMUNOL, V37, P2812, DOI 10.1002/eji.200636993; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Martin-Ventura JL, 2004, CIRCULATION, V110, P2216, DOI 10.1161/01.CIR.0000136814.87170.B1; Martin-Ventura JL, 2006, ARTERIOSCL THROM VAS, V26, P1337, DOI 10.1161/01.ATV.0000220108.97208.67; NIMER SD, 1988, JAMA-J AM MED ASSOC, V260, P3297, DOI 10.1001/jama.260.22.3297; Out R, 2006, ARTERIOSCL THROM VAS, V26, P2295, DOI 10.1161/01.ATV.0000237629.29842.4c; Pagler TA, 2011, CIRC RES, V108, P194, DOI 10.1161/CIRCRESAHA.110.228619; Powers JP, 2006, BIOORG MED CHEM LETT, V16, P2842, DOI 10.1016/j.bmcl.2006.03.020; Raizman JE, 2013, BBA-MOL CELL BIOL L, V1831, P1721, DOI 10.1016/j.bbalip.2013.07.015; RAJAVASHISTH TB, 1990, NATURE, V344, P254, DOI 10.1038/344254a0; Ranalletta M, 2006, ARTERIOSCL THROM VAS, V26, P2308, DOI 10.1161/01.ATV.0000242275.92915.43; Randolph GJ, 1998, SCIENCE, V282, P480, DOI 10.1126/science.282.5388.480; Randolph GJ, 2014, CIRC RES, V114, P1757, DOI 10.1161/CIRCRESAHA.114.301174; Ray Avijit, 2010, J Vis Exp, DOI 10.3791/1488; Rayner K, 2008, CIRC RES, V103, P133, DOI 10.1161/CIRCRESAHA.108.172155; Rayner K, 2008, J STEROID BIOCHEM, V108, P72, DOI 10.1016/j.jsbmb.2007.07.006; Rayner K, 2009, ARTERIOSCL THROM VAS, V29, P1751, DOI 10.1161/ATVBAHA.109.193656; Salari S, 2013, CELL STRESS CHAPERON, V18, P53, DOI 10.1007/s12192-012-0356-0; Seibert TA, 2013, J AM COLL CARDIOL, V62, P1446, DOI 10.1016/j.jacc.2013.05.041; Seiler C, 2001, CIRCULATION, V104, P2012, DOI 10.1161/hc4201.097835; Shaposhnik Z, 2007, ARTERIOSCL THROM VAS, V27, P621, DOI 10.1161/01.ATV.0000254673.55431.e6; Shindo J, 1999, CIRCULATION, V99, P2150, DOI 10.1161/01.CIR.99.16.2150; Song W, 2015, MOL MED REP, V12, P5989, DOI 10.3892/mmr.2015.4154; Subramanian M, 2015, CIRC RES, V116, pE13, DOI 10.1161/CIRCRESAHA.116.304794; Tabas I, 2016, CIRC RES, V118, P653, DOI 10.1161/CIRCRESAHA.115.306256; Trouplin V, 2013, JOVE-J VIS EXP, DOI 10.3791/50966; Vabulas RM, 2001, J BIOL CHEM, V276, P31332, DOI 10.1074/jbc.M103217200; Van Eck M, 2002, P NATL ACAD SCI USA, V99, P6298, DOI 10.1073/pnas.092327399; Venu VKP, 2015, THROMB HAEMOSTASIS, V114, P186, DOI 10.1160/TH14-09-0790; Wang M, 2014, ARTERIOSCL THROM VAS, V34, P976, DOI 10.1161/ATVBAHA.113.303097; Werner GS, 2002, CIRCULATION, V105, pE175, DOI 10.1161/01.CIR.0000016154.35658.00; Wicks IP, 2016, NAT REV RHEUMATOL, V12, P37, DOI 10.1038/nrrheum.2015.161; Yamamoto M, 2003, SCIENCE, V301, P640, DOI 10.1126/science.1087262; Yu MJ, 2014, J EXP MED, V211, P887, DOI 10.1084/jem.20131314; Yvan-Charvet L, 2010, ARTERIOSCL THROM VAS, V30, P139, DOI 10.1161/ATVBAHA.108.179283; Zbinden S, 2005, J AM COLL CARDIOL, V46, P1636, DOI 10.1016/j.jacc.2005.01.068	62	19	19	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2364	2379		10.1096/fj.201601188R	http://dx.doi.org/10.1096/fj.201601188R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28232480				2022-12-28	WOS:000401553400013
J	Vineis, P; Chatziioannou, A; Cunliffe, VT; Flanagan, JM; Hanson, M; Kirsch-Volders, M; Kyrtopoulos, S				Vineis, Paolo; Chatziioannou, Aristotelis; Cunliffe, Vincent T.; Flanagan, James M.; Hanson, Mark; Kirsch-Volders, Micheline; Kyrtopoulos, Soterios			Epigenetic memory in response to environmental stressors	FASEB JOURNAL			English	Article						environmental exposures; DNA methylation; genes	DIFFERENTIAL DNA METHYLATION; MATERNAL SMOKING; TOBACCO-SMOKING; MICRONUTRIENT SUPPLEMENTATION; PRENATAL EXPOSURE; BUCCAL MUCOSA; EPIGENOME; NUTRITION; GENOME; CANCER	Exposure to environmental stressors, toxicants, and nutrient deficiencies can affect DNA in several ways. Some exposures cause damage and alter the structure of DNA, but there is increasing evidence that the same or other environmental exposures, including those that occur during fetal development in utero, can cause epigenetic effects that modulate DNA function and gene expression. Some epigenetic changes to DNA that affect gene transcription are at least partially reversible (i.e., they can be enzymatically reversed after cessation of exposure to environmental agents), but some epigenetic modifications seem to persist, even for decades. To explain the effects of early life experiences (such as famine and exposures to other stressors) on the long-term persistence of specific patterns of epigenetic modifications, such as DNA methylation, we propose an analogy with immune memory. We propose that an epigenetic memory can be established and maintained in self-renewing stem cell compartments. We suggest that the observations on early life effects on adult diseases and the persistence of methylation changes in smokers support our hypothesis, for which a mechanistic basis, however, needs to be further clarified. We outline a new model based on methylation changes. Although these changes seem to be mainly adaptive, they are also implicated in the pathogenesis and onset of diseases, depending on individual genotypic background and types of subsequent exposures. Elucidating the relationships between the adaptive and maladaptive consequences of the epigenetic modifications that result from complex environmental exposures is a major challenge for current and future research in epigenetics.	[Vineis, Paolo] Imperial Coll London, MRC, Publ Hlth England Ctr Environm & Hlth, London W2 1PG, England; [Flanagan, James M.] Imperial Coll London, Dept Surg & Canc, Epigenet Unit, London, England; [Chatziioannou, Aristotelis; Kyrtopoulos, Soterios] Natl Hellen Res Fdn, Inst Biol Med Chem & Biotechnol, Athens, Greece; [Cunliffe, Vincent T.] Univ Sheffield, Dept Biomed Sci, Sheffield, S Yorkshire, England; [Hanson, Mark] Univ Southampton, Univ Hosp Southampton, Inst Dev Sci, Southampton, Hants, England; [Kirsch-Volders, Micheline] Vrije Univ Brussels, Lab Cell Genet, Brussels, Belgium	Imperial College London; Public Health England; Imperial College London; National Hellenic Research Foundation; University of Sheffield; University of Southampton; Vrije Universiteit Brussel	Vineis, P (corresponding author), Imperial Coll London, MRC, PHE Ctr Environm & Hlth, Norfolk Pl, London W21PG, England.	p.vineis@imperial.ac.uk	Kyrtopoulos, Soterios/AAI-6426-2020; Hanson, Mark/AAE-8236-2019	Hanson, Mark/0000-0002-6907-613X; Cunliffe, Vincent/0000-0001-7483-7610; Kyrtopoulos, Soterios/0000-0002-6821-6532; Flanagan, James/0000-0003-4955-1383	Enhanced Exposure Assessment and Omic Profiling for High Priority Environmental Exposures in Europe (EXPOSOMICS) - EC FP7 [308610]; European Union's Horizon 2020 Research and Innovation Programme [633666]; Cancer Research UK (CRUK) Centres; Experimental Cancer Medicine Centre (ECMC); National Institute for Health Research (NIHR) Biomedical Research Centre (BRC); ESRC [ES/N000528/1] Funding Source: UKRI; British Heart Foundation [RG/15/17/31749] Funding Source: researchfish; Economic and Social Research Council [ES/N000528/1] Funding Source: researchfish	Enhanced Exposure Assessment and Omic Profiling for High Priority Environmental Exposures in Europe (EXPOSOMICS) - EC FP7; European Union's Horizon 2020 Research and Innovation Programme; Cancer Research UK (CRUK) Centres; Experimental Cancer Medicine Centre (ECMC); National Institute for Health Research (NIHR) Biomedical Research Centre (BRC)(National Institute for Health Research (NIHR)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); British Heart Foundation(British Heart Foundation); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supported by the Enhanced Exposure Assessment and Omic Profiling for High Priority Environmental Exposures in Europe (EXPOSOMICS) funded by EC FP7 Grant 308610, and by the European Union's Horizon 2020 Research and Innovation Programme (Grant 633666 to P.V.). The authors acknowledge support from Cancer Research UK (CRUK) Centres, the Experimental Cancer Medicine Centre (ECMC), and the National Institute for Health Research (NIHR) Biomedical Research Centre (BRC) based at Imperial College Healthcare NHS Trust, Imperial College London, and at University of Southampton. The authors declare no conflicts of interest.	Alexandrov LB, 2016, SCIENCE, V354, P618, DOI 10.1126/science.aag0299; Ambatipudi S, 2016, EPIGENOMICS-UK, V8, P599, DOI 10.2217/epi-2016-0001; Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Anderson OS, 2012, ENVIRON MOL MUTAGEN, V53, P334, DOI 10.1002/em.21692; Basham KJ, 2014, BIOORG MED CHEM LETT, V24, P2473, DOI 10.1016/j.bmcl.2014.04.013; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Bouwland-Both MI, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0115-z; Breitling LP, 2011, AM J HUM GENET, V88, P450, DOI 10.1016/j.ajhg.2011.03.003; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Burdge GC, 2008, BRIT J NUTR, V99, P540, DOI 10.1017/S0007114507815819; Burdge GC, 2010, ANNU REV NUTR, V30, P315, DOI 10.1146/annurev.nutr.012809.104751; Burdge GC, 2009, J NUTR, V139, P1054, DOI 10.3945/jn.109.104653; Cohn M, 2007, NAT REV IMMUNOL, V7, P823, DOI 10.1038/nri2177; Cooper WN, 2012, FASEB J, V26, P1782, DOI 10.1096/fj.11-192708; Dobrin R, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-5-r55; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Dominguez-Salas P, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4746; Du Q, 2015, EPIGENOMICS-UK, V7, P1051, DOI 10.2217/epi.15.39; Dudley JT, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.66; Elliott E, 2010, NAT NEUROSCI, V13, P1351, DOI 10.1038/nn.2642; Elliott HR, 2014, CLIN EPIGENETICS, V6, DOI 10.1186/1868-7083-6-4; Fournier A, 2012, BRIEF FUNCT GENOMICS, V11, P251, DOI 10.1093/bfgp/elr040; Gabriel HE, 2006, AM J CLIN NUTR, V83, P835, DOI 10.1093/ajcn/83.4.835; Georgiadis P, 2016, SCI REP-UK, V6, DOI 10.1038/srep20544; Guida F, 2015, HUM MOL GENET, V24, P2349, DOI 10.1093/hmg/ddu751; Hahn ME, 2009, BIOCHEM PHARMACOL, V77, P485, DOI 10.1016/j.bcp.2008.09.016; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Hao N, 2013, BIOCHEM PHARMACOL, V86, P561, DOI 10.1016/j.bcp.2013.07.004; Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105; Hoile SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021668; Holbrook JD, 2016, EPIGENOMICS-UK, V8, P741, DOI 10.2217/epi-2016-0023; Huang T, 2011, OMICS, V15, P665, DOI 10.1089/omi.2011.0034; Jarosz DF, 2010, SCIENCE, V330, P1820, DOI 10.1126/science.1195487; Joubert BR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10577; Joubert BR, 2012, ENVIRON HEALTH PERSP, V120, P1425, DOI 10.1289/ehp.1205412; Khulan B, 2012, HUM MOL GENET, V21, P2086, DOI 10.1093/hmg/dds026; Kim JH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-30; Koutsandreas T., 2015, IEEE 15 INT C BIOINF, P1; Kuhnen P, 2016, CELL METAB, V24, P502, DOI 10.1016/j.cmet.2016.08.001; Kundakovic M, 2013, P NATL ACAD SCI USA, V110, P9956, DOI 10.1073/pnas.1214056110; Kupers LK, 2015, INT J EPIDEMIOL, V44, P1224, DOI 10.1093/ije/dyv048; Ladd-Acosta C, 2016, ENVIRON RES, V144, P139, DOI 10.1016/j.envres.2015.11.014; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Li GD, 2013, TRENDS IMMUNOL, V34, P460, DOI 10.1016/j.it.2013.03.006; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Ma J, 2015, TOXICOL APPL PHARM, V289, P193, DOI 10.1016/j.taap.2015.09.024; Ma YY, 2016, AM J CLIN NUTR, V103, P567, DOI 10.3945/ajcn.115.112987; Marco A, 2016, DIABETES, V65, P2258, DOI 10.2337/db15-1608; Murgatroyd C, 2009, NAT NEUROSCI, V12, P1559, DOI 10.1038/nn.2436; Novakovic B, 2014, EPIGENETICS-US, V9, P377, DOI 10.4161/epi.27248; Panni T, 2016, ENVIRON HEALTH PERSP, V124, P983, DOI 10.1289/ehp.1509966; Papoutsis AJ, 2015, MOL CARCINOGEN, V54, P261, DOI 10.1002/mc.22095; Philibert RA, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-19; Reese SE, 2017, ENVIRON HEALTH PERSP, V125, P760, DOI 10.1289/EHP333; Richmond RC, 2015, HUM MOL GENET, V24, P2201, DOI 10.1093/hmg/ddu739; Roth TL, 2009, BIOL PSYCHIAT, V65, P760, DOI 10.1016/j.biopsych.2008.11.028; Sawarkar R, 2013, TRENDS CELL BIOL, V23, P193, DOI 10.1016/j.tcb.2012.11.007; Shen H, 2013, CELL, V153, P38, DOI 10.1016/j.cell.2013.03.008; Shenker NS, 2013, HUM MOL GENET, V22, P843, DOI 10.1093/hmg/dds488; Silver MJ, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0660-y; Teschendorff AE, 2015, JAMA ONCOL, V1, P476, DOI 10.1001/jamaoncol.2015.1053; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; US Department of Health and Human Services, 2014, HLTH CONS SMOK 50 YE; WADDINGTON CH, 1959, NATURE, V183, P1654, DOI 10.1038/1831654a0; Wan ES, 2015, AM J RESP CELL MOL, V53, P246, DOI 10.1165/rcmb.2014-0103OC; Waterland RA, 2006, GENESIS, V44, P401, DOI 10.1002/dvg.20230; Waterland RA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001252; Weaver ICG, 2004, NAT NEUROSCI, V7, P847, DOI 10.1038/nn1276; Zeilinger S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063812	69	42	44	0	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2241	2251		10.1096/fj.201601059RR	http://dx.doi.org/10.1096/fj.201601059RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28280003	Green Accepted			2022-12-28	WOS:000401553400003
J	Draberova, E; Sulimenko, V; Vinopal, S; Sulimenko, T; Sladkova, V; D'Agostino, L; Sobol, M; Hozak, P; Kren, L; Katsetos, CD; Draber, P				Draberova, Eduarda; Sulimenko, Vadym; Vinopal, Stanislav; Sulimenko, Tetyana; Sladkova, Vladimira; D'Agostino, Luca; Sobol, Margaryta; Hozak, Pavel; Kren, Leos; Katsetos, Christos D.; Draber, Pavel			Differential expression of human gamma-tubulin isotypes during neuronal development and oxidative stress points to a gamma-tubulin-2 prosurvival function	FASEB JOURNAL			English	Article						microtubules; mitochondria; neuroblastoma differentiation; neurons	ALPHA-BETA-TUBULIN; MICROTUBULE NUCLEATION; PROTEIN; COMPLEXES; INTERACTS; COMPONENT; GENE; ORGANIZATION; CENTROSOME; MEMBRANES	gamma-Tubulins are highly conserved members of the tubulin superfamily essential for microtubule nucleation. Humans possess 2 gamma-tubulin genes. It is thought that gamma-tubulin-1 represents aubiquitous isotype, whereas gamma-tubulin-2 is found predominantly in the brain, where it may be endowed with divergent functions beyond microtubule nucleation. The molecular basis of the purported functional differences between gamma-tubulins is unknown. We report discrimination of human gamma-tubulins according to their electrophoretic and immunochemical properties. In vitro mutagenesis revealed that the differences in electrophoretic mobility originate in the C-terminal regions of the gamma-tubulins. Using epitope mapping, we discovered mouse monoclonal antibodies that can discriminate between human gamma-tubulin isotypes. Real time quantitative RT-PCR and 2-dimensional-PAGE showed that gamma-tubulin-1 is the dominant isotype in fetal neurons. Although gamma-tubulin-2 accumulates in the adult brain, gamma-tubulin-1 remains the major isotype in various brain regions. Localization of gamma-tubulin-1 in mature neurons was confirmed by immunohistochemistry and immunofluorescence microscopy on clinical samples and tissue microarrays. Differentiation of SH-SY5Y human neuroblastoma cells by all-trans retinoic acid, or oxidative stress induced by mitochondrial inhibitors, resulted in upregulation of gamma-tubulin-2, whereas the expression of gamma-tubulin-1 was unchanged. Fractionation experiments and immunoelectron microscopy revealed an association of gamma-tubulins with mitochondrial membranes. These data indicate that in the face of predominant nu-tubulin-1 expression, the accumulation of gamma-tubulin-2 in mature neurons and neuroblastoma cells during oxidative stress may denote a prosurvival role of gamma-tubulin-2 in neurons.-Draberova, E., Sulimenko, V., Vinopal, S., Sulimenko, T., Sladkova, V., D'Agostino, L., Sobol, M., Hozak, P., Kren, L., Katsetos, C. D., Draber, P. Differential expression of human gamma-tubulin isotypes during neuronal development and oxidative stress points to gamma-tubulin-2 prosurvival function.	[Draberova, Eduarda; Sulimenko, Vadym; Vinopal, Stanislav; Sulimenko, Tetyana; Sladkova, Vladimira; Draber, Pavel] Acad Sci Czech Republ, Dept Biol Cytoskeleton, Inst Mol Genet, Videnska 1083, Prague 14220 4, Czech Republic; [Sobol, Margaryta; Hozak, Pavel] Acad Sci Czech Republ, Dept Nucleus, Inst Mol Genet, Prague, Czech Republic; [D'Agostino, Luca; Katsetos, Christos D.] Drexel Univ, Coll Med, St Christophers Hosp Children, Dept Pediat, Philadelphia, PA 19104 USA; [D'Agostino, Luca; Kren, Leos; Katsetos, Christos D.] Drexel Univ, Coll Med, St Christophers Hosp Children, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Kren, Leos] Med Coll Penn & Hahnemann Univ, Philadelphia, PA 19104 USA; Univ Hosp Brno, Dept Pathol, Brno, Czech Republic	Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences; Drexel University; Drexel University; Drexel University; University Hospital Brno	Draber, P (corresponding author), Acad Sci Czech Republ, Dept Biol Cytoskeleton, Inst Mol Genet, Videnska 1083, Prague 14220 4, Czech Republic.	paveldra@img.cas.cz	Sladkova, Vladimira/G-7706-2019; Sulimenko, Vadym/G-3549-2014; Vinopal, Stanislav/GLR-3200-2022; Vinopal, Stanislav/ABG-4322-2021; Hozak, Pavel/AAB-5359-2021; Draber, Pavel/C-7735-2012	Vinopal, Stanislav/0000-0001-9352-4580; Hozak, Pavel/0000-0003-1901-1394; Draber, Pavel/0000-0001-9625-5013; Sulimenko, Vadym/0000-0003-2153-4485	Ministry of Education, Youth, and Sports of the Czech Republic [LH 12050, LM 2015062]; Ministry of Health of the Czech Republic [NT14467]; Grant Agency of the Czech Republic [302/12/1673, 15-22194S, 16-25159S]; Academy of Sciences of the Czech Republic [M200521203PIP]; Technological Grant Agency of the Czech Republic [TE01020118]; Institutional Research Support Program [RVO 68378050]	Ministry of Education, Youth, and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic); Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Technological Grant Agency of the Czech Republic; Institutional Research Support Program	The authors thank Dr. B. R. Oakley (University of Kansas, Lawrence, KS, USA) for the pH3-16 vector encoding human TUBG1; Dr. R.Y. Tsien (Howard Hughes Medical Institute, University of California, San Diego, La Jolla, CA, USA) for the pcDNA3.1-TagRFP vector, and Dr. Petr Draber (Department of Signal Transduction, Institute of Molecular Genetics, Academy of Sciences of the Czech Republic) for the Ab against GST; Dr. Eleni Mahera (Department of Pathology, General Hospital of Attica KAT, Athens, Greece) and Dr. Theodoros Maraziotis (Department of Neurosurgery, University of Patras Hospital, Rion, Greece) for providing sections from existing paraffin blocks of clinical specimens used in this study; and Ivana Mlchova, Ladislav Cupak, Ivana Novakova, and Zuzana Lubovska (all from the Institute of Molecular Genetics, Academy of Sciences of the Czech Republic) for excellent technical work. The microscopic data were produced at the Institute of Molecular Genetics Microscopy Centre. This work was supported, in part, by Grants LH 12050 (to P.D.) and LM 2015062 (CzechBioImaging Large Research Infrastructure Project) from the Ministry of Education, Youth, and Sports of the Czech Republic; Grant NT14467 from the Ministry of Health of the Czech Republic (to P.D.); Grants 302/12/1673, 15-22194S, and 16-25159S from the Grant Agency of the Czech Republic (all to P.D.); Grant M200521203PIP from the Academy of Sciences of the Czech Republic (to P.D.); Grant TE01020118 from the Technological Grant Agency of the Czech Republic (to P.H.); and Institutional Research Support Program RVO 68378050. The authors declare no conflicts of interest.	Borland MK, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-21; Cabezas R, 2012, NEUROSCI RES, V74, P80, DOI 10.1016/j.neures.2012.07.008; Carre M, 2002, J BIOL CHEM, V277, P33664, DOI 10.1074/jbc.M203834200; Chabin-Brion K, 2001, MOL BIOL CELL, V12, P2047, DOI 10.1091/mbc.12.7.2047; DENIZOT F, 1986, J IMMUNOL METHODS, V89, P271, DOI 10.1016/0022-1759(86)90368-6; Diaz-Corrales FJ, 2005, NEUROSCIENCE, V133, P117, DOI 10.1016/j.neuroscience.2005.01.044; DRABER P, 1988, HISTOCHEMISTRY, V89, P485, DOI 10.1007/BF00492606; DRABER P, 1991, ELECTROPHORESIS, V12, P453, DOI 10.1002/elps.1150120617; Draberova E, 1998, HISTOCHEM CELL BIOL, V109, P231; DRABEROVA E, 1993, J CELL SCI, V106, P1263; Draberova E, 1999, FOLIA BIOL-PRAGUE, V45, P163; Draberova E, 2015, J NEUROPATH EXP NEUR, V74, P723, DOI 10.1097/NEN.0000000000000212; Drykova D, 2003, PLANT CELL, V15, P465, DOI 10.1105/tpc.007005; Hajkova Z, 2011, J IMMUNOL, V186, P913, DOI 10.4049/jimmunol.1002074; Hehnly H, 2014, DEV CELL, V28, P497, DOI 10.1016/j.devcel.2014.01.014; Horejsi B, 2012, J CELL PHYSIOL, V227, P367, DOI 10.1002/jcp.22772; Inclan YF, 2001, J CELL SCI, V114, P413; Katsetos CD, 2006, J NEUROPATH EXP NEUR, V65, P465, DOI 10.1097/01.jnen.0000229235.20995.6e; Keck JM, 2011, SCIENCE, V332, P1557, DOI 10.1126/science.1205193; Kollman JM, 2011, NAT REV MOL CELL BIO, V12, P709, DOI 10.1038/nrm3209; Kubo A., 2011, MOL BIOL CELL, V22, P3555; Kukharskyy V, 2004, EXP CELL RES, V298, P218, DOI 10.1016/j.yexcr.2004.04.016; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lin TC, 2015, TRENDS CELL BIOL, V25, P296, DOI 10.1016/j.tcb.2014.12.002; LINHARTOVA I, 1992, BIOCHEM J, V288, P919, DOI 10.1042/bj2880919; Macurek L, 2008, BIOCHEM J, V416, P421, DOI 10.1042/BJ20080909; McNaught KSP, 2002, EUR J NEUROSCI, V16, P2136, DOI 10.1046/j.1460-9568.2002.02301.x; MEADS T, 1995, CELL MOTIL CYTOSKEL, V32, P273, DOI 10.1002/cm.970320404; Nishimura N., 2014, BIO PROTOC, V4, pe1299; Novakova M, 1996, CELL MOTIL CYTOSKEL, V33, P38, DOI 10.1002/(SICI)1097-0169(1996)33:1<38::AID-CM5>3.0.CO;2-E; Oakley BR, 2015, MOL BIOL CELL, V26, P2957, DOI 10.1091/mbc.E14-11-1514; OAKLEY BR, 1990, CELL, V61, P1289, DOI 10.1016/0092-8674(90)90693-9; Ohashi T, 2016, FEBS LETT, V590, P1053, DOI 10.1002/1873-3468.12163; Ori-McKenney KM, 2012, NEURON, V76, P921, DOI 10.1016/j.neuron.2012.10.008; Parker AL, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00153; Remy MH, 2013, PROG MOL BIOL TRANSL, V117, P511, DOI 10.1016/B978-0-12-386931-9.00019-2; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Rostovtseva TK, 2008, P NATL ACAD SCI USA, V105, P18746, DOI 10.1073/pnas.0806303105; Samantaray S, 2007, NEUROSCIENCE, V146, P741, DOI 10.1016/j.neuroscience.2007.01.056; Schneider L, 2011, FREE RADICAL BIO MED, V51, P2007, DOI 10.1016/j.freeradbiomed.2011.08.030; Sherer TB, 2003, J NEUROSCI, V23, P10756, DOI 10.1523/jneurosci.23-34-10756.2003; Sobol MA, 2012, HISTOCHEM CELL BIOL, V138, P167, DOI 10.1007/s00418-012-0931-6; Starita LM, 2004, MOL CELL BIOL, V24, P8457, DOI 10.1128/MCB.24.19.8457-8466.2004; STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K; Sulimenko V, 2002, BIOCHEM J, V365, P889, DOI 10.1042/BJ20020175; Sun Anyang, 2009, Int J Physiol Pathophysiol Pharmacol, V2, P29; Teixido-Travesa N, 2012, J CELL SCI, V125, P4445, DOI 10.1242/jcs.106971; Tsui-Pierchala BA, 2002, TRENDS NEUROSCI, V25, P412, DOI 10.1016/S0166-2236(02)02215-4; Tsutsumi K., 2010, MOL BIOL CELL, V21, P4299; Vinopal S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029919; Vogel J, 2001, DEV CELL, V1, P621, DOI 10.1016/S1534-5807(01)00073-9; Wise DO, 2000, GENOMICS, V67, P164, DOI 10.1006/geno.2000.6247; Yonezawa S, 2015, ACTA HISTOCHEM CYTOC, V48, P145, DOI 10.1267/ahc.15023; Yuba-Kubo A, 2005, DEV BIOL, V282, P361, DOI 10.1016/j.ydbio.2005.03.031; ZHENG YX, 1991, CELL, V65, P817, DOI 10.1016/0092-8674(91)90389-G	55	20	20	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1828	1846		10.1096/fj.201600846RR	http://dx.doi.org/10.1096/fj.201600846RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28119396				2022-12-28	WOS:000399195500007
J	Yang, GL; Zhao, ZL; Qin, TT; Wang, D; Chen, LJ; Xiang, R; Xi, Z; Jiang, RC; Zhang, ZS; Zhang, JN; Li, LY				Yang, Gui-Li; Zhao, Zilong; Qin, Ting-Ting; Wang, Dong; Chen, Lijuan; Xiang, Rong; Xi, Zhen; Jiang, Rongcai; Zhang, Zhi-Song; Zhang, Jianning; Li, Lu-Yuan			TNFSF15 inhibits VEGF-stimulated vascular hyperpermeability by inducing VEGFR2 dephosphorylation	FASEB JOURNAL			English	Article						DR3; vascular integrity; SHP-1	ENDOTHELIAL GROWTH-FACTOR; NITRIC-OXIDE SYNTHASE; INDUCED ANGIOGENESIS; CELL; PERMEABILITY; EXPRESSION; ACTIVATION; PHOSPHORYLATION; RECEPTOR-2; SUPPRESSES	Vascular hyperpermeability is critical in ischemic diseases, including stroke and myocardial infarction, as well as in inflammation and cancer. It is well known that the VEGF-VEGFR2 signaling pathways are pivotal in promoting vascular permeability; however, counterbalancing mechanisms that restrict vascular permeability to maintain the integrity of blood vessels are not yet fully understood. We report that TNF superfamily member 15 (TNFSF15), a cytokine largely produced by vascular endothelial cells and a specific inhibitor of the proliferation of these same cells, can inhibit VEGF-induced vascular permeability in vitro and in vivo, and that death receptor 3 (DR3), a cell surface receptor of TNFSF15, mediates TNFSF15-induced dephosphorylation of VEGFR2. Src homology region 2 domain-containing phosphatase-1 (SHP-1) becomes associated with DR3 upon TNFSF15 interaction with the latter. In addition, a protein complex consisting of VEGFR2, DR3, and SHP-1 is formed in response to the effects of TNFSF15 and VEGF on endothelial cells. It is plausible that this protein complex provides a structural basis for the molecular mechanism in which TNFSF15 induces the inhibition of VEGF-stimulated vascular hyperpermeability.-Yang, G.-L., Zhao, Z., Qin, T.-T., Wang, D., Chen, L., Xiang, R., Xi, Z., Jiang, R., Zhang, Z.-S., Zhang, J., Li. L.-Y. TNFSF15 inhibits VEGF-stimulated vascular hyperpermeability by inducing VEGFR2 dephosphorylation.	[Yang, Gui-Li; Qin, Ting-Ting; Zhang, Zhi-Song; Li, Lu-Yuan] Nankai Univ, Collaborat Innovat Ctr Biotherapy, Coll Pharm, Key Lab Med Chem Biol, Tianjin, Peoples R China; [Yang, Gui-Li; Qin, Ting-Ting; Zhang, Zhi-Song; Li, Lu-Yuan] Nankai Univ, Tianjin Key Lab Mol Drug Res, Tianjin, Peoples R China; [Xiang, Rong] Nankai Univ, Sch Med, Dept Immunol, Tianjin, Peoples R China; [Xi, Zhen] Nankai Univ, Dept Biol Chem, Coll Chem, Tianjin, Peoples R China; [Yang, Gui-Li; Zhao, Zilong; Wang, Dong; Jiang, Rongcai; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Key Lab Post Neuroinjury Repair & Regenerat Cent, Minist Educ & Tianjin City,Tianjin Neurol Inst, Tianjin, Peoples R China; [Chen, Lijuan] Sichuan Univ, West China Hosp, State Key Lab Biotherapy, Chengdu, Peoples R China	Nankai University; Nankai University; Nankai University; Nankai University; Tianjin Medical University; Sichuan University	Zhang, ZS (corresponding author), Nankai Univ, Coll Pharm, Room 306,38 Tongyan Rd, Tianjin 300350, Peoples R China.; Li, LY (corresponding author), Nankai Univ, State Key Lab Med Chem Biol Bldg, Room 325,38 Tongyan Rd, Tianjin 300350, Peoples R China.	zzs@nankai.edu.cn; liluyuan@nankai.edu.cn	Zhao, Zilong/AAZ-2196-2020		Natural Science Foundation of China [81272356, 81330029, 81501069, 81271359, 81671221, 81672740, 81671380, 81601068]; Tianjin Research Program of Application Foundation and Advanced Technology [14ZCZDSY00179]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Research Program of Application Foundation and Advanced Technology	The authors thank Tairan Bai (Nankai University College of Pharmacy) for skillful technical assistance.This study is supported, in part, by Natural Science Foundation of China Grants 81272356 (to L.-Y.L.), 81330029 (to J.Z.), 81501069 (to G.- L.Y.), 81271359 and 81671221 (to R.J.), 81672740 (to Z.- S.Z.), 81671380 (to D.W.), and 81601068 (to Z.Z.); and Tianjin Research Program of Application Foundation and Advanced Technology Grant 14ZCZDSY00179 (to R.J.).The authors declare no conflicts of interest.	Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Bhattacharya Resham, 2008, J Mol Signal, V3, P8, DOI 10.1186/1750-2187-3-8; Chew LJ, 2002, FASEB J, V16, P742, DOI 10.1096/fj.01-0757fje; Chinnaiyan AM, 1996, SCIENCE, V274, P990, DOI 10.1126/science.274.5289.990; Chu LY, 2013, BLOOD, V122, P1822, DOI 10.1182/blood-2013-01-482315; Daigle I, 2002, NAT MED, V8, P61, DOI 10.1038/nm0102-61; Deng WM, 2012, ANGIOGENESIS, V15, P71, DOI 10.1007/s10456-011-9244-y; Dougher M, 1999, ONCOGENE, V18, P1619, DOI 10.1038/sj.onc.1202478; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Fukumura D, 2001, P NATL ACAD SCI USA, V98, P2604, DOI 10.1073/pnas.041359198; Gao WW, 2015, BRAIN RES, V1622, P230, DOI 10.1016/j.brainres.2015.04.035; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayes AJ, 2000, BRIT J CANCER, V83, P1154, DOI 10.1054/bjoc.2000.1437; Hedl M, 2014, P NATL ACAD SCI USA, V111, P13451, DOI 10.1073/pnas.1404178111; HELDIN CH, 1995, CELL, V80, P213, DOI 10.1016/0092-8674(95)90404-2; Holmqvist K, 2004, J BIOL CHEM, V279, P22267, DOI 10.1074/jbc.M312729200; Hou W, 2005, CLIN CANCER RES, V11, P5595, DOI 10.1158/1078-0432.CCR-05-0384; Jain RK, 2005, SCIENCE, V307, P58, DOI 10.1126/science.1104819; Jiang F, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17050615; Kim SH, 2012, BLOOD, V120, P4892, DOI 10.1182/blood-2012-05-428243; Kirton JP, 2010, MICROVASC RES, V79, P193, DOI 10.1016/j.mvr.2010.02.009; Lal BK, 2001, MICROVASC RES, V62, P252, DOI 10.1006/mvre.2001.2338; Lamalice L, 2004, ONCOGENE, V23, P434, DOI 10.1038/sj.onc.1207034; Lazarus Alon, 2011, Proc Am Thorac Soc, V8, P508, DOI 10.1513/pats.201102-021MW; Lee SJ, 2010, LAB INVEST, V90, P374, DOI 10.1038/labinvest.2009.136; Lu Y, 2014, ANGIOGENESIS, V17, P529, DOI 10.1007/s10456-013-9397-y; Marti HH, 2000, AM J PATHOL, V156, P965, DOI 10.1016/S0002-9440(10)64964-4; Matsumoto T, 2005, EMBO J, V24, P2342, DOI 10.1038/sj.emboj.7600709; Matsumoto T, 2001, Sci STKE, V2001, pre21, DOI 10.1126/stke.2001.112.re21; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Nagy JA, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006544; Olsson AK, 2006, NAT REV MOL CELL BIO, V7, P359, DOI 10.1038/nrm1911; Qi JW, 2013, P NATL ACAD SCI USA, V110, P13863, DOI 10.1073/pnas.1304529110; Qin TT, 2015, J PATHOL, V237, P307, DOI 10.1002/path.4577; Sakurai Y, 2005, P NATL ACAD SCI USA, V102, P1076, DOI 10.1073/pnas.0404984102; Satchi-Fainaro R, 2005, CANCER CELL, V7, P251, DOI 10.1016/j.ccr.2005.02.007; SENGER DR, 1993, CANCER METAST REV, V12, P303, DOI 10.1007/BF00665960; Seo DW, 2003, CELL, V114, P171, DOI 10.1016/S0092-8674(03)00551-8; Sinha S, 2009, J CELL SCI, V122, P3385, DOI 10.1242/jcs.053124; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Takahashi T, 2001, EMBO J, V20, P2768, DOI 10.1093/emboj/20.11.2768; Tian F, 2007, J IMMUNOL, V179, P3742, DOI 10.4049/jimmunol.179.6.3742; Tian F, 2009, BLOOD, V113, P5352, DOI 10.1182/blood-2008-08-173773; Tian XY, 2014, J BIOL CHEM, V289, P5168, DOI 10.1074/jbc.M113.493924; Vohra PK, 2012, AM J PHYSIOL-LUNG C, V302, pL185, DOI 10.1152/ajplung.00274.2010; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Weis SM, 2008, J CELL BIOL, V181, P43, DOI 10.1083/jcb.200710038; Weis SM, 2005, NATURE, V437, P497, DOI 10.1038/nature03987; Wu HM, 1999, AM J PHYSIOL-HEART C, V276, pH535, DOI 10.1152/ajpheart.1999.276.2.H535; Xu LX, 2014, INT J BIOCHEM CELL B, V55, P109, DOI 10.1016/j.biocel.2014.08.015; Yancopoulos GD, 2000, NATURE, V407, P242, DOI 10.1038/35025215; Yu JY, 2001, CIRC RES, V89, P1161, DOI 10.1161/hh2401.101909; Yuksel H, 2013, NEUROL SCI, V34, P1941, DOI 10.1007/s10072-013-1411-z; Zhai YF, 1999, INT J CANCER, V82, P131, DOI 10.1002/(SICI)1097-0215(19990702)82:1<131::AID-IJC22>3.3.CO;2-F; Zhai YF, 1999, FASEB J, V13, P181, DOI 10.1096/fasebj.13.1.181; Zhang K, 2016, ONCOTARGET, V7, P69436, DOI 10.18632/oncotarget.11683; Zhang WJ, 2012, P NATL ACAD SCI USA, V109, P10388, DOI 10.1073/pnas.1205210109; Zhang XF, 2009, FASEB J, V23, P3368, DOI 10.1096/fj.09-131649	60	12	13	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2001	2012		10.1096/fj.201600800R	http://dx.doi.org/10.1096/fj.201600800R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28183800				2022-12-28	WOS:000399195500021
J	Chen, JR; Lazarenko, OP; Blackburn, ML; Shankar, K				Chen, Jin-Ran; Lazarenko, Oxana P.; Blackburn, Michael L.; Shankar, Kartik			Dietary factors during early life program bone formation in female rats	FASEB JOURNAL			English	Article						soy protein isolate; bone loss; p53; senescence	SOY PROTEIN ISOLATE; SENESCENCE PATHWAYS; FOREARM FRACTURES; CELL SENESCENCE; ISOFLAVONES; EXPRESSION; DIFFERENTIATION; OSTEOPOROSIS; CONSUMPTION; OSTEOBLASTS	Nutritional status during intrauterine and early postnatal life impacts the risk of chronic diseases; however, evidence for an association between early-life dietary factors and bone health in adults is limited. Soy protein isolate (SPI) may be one such dietary factor that promotes bone accretion during early life with persistent effects into adulthood. In the present study, we fed postnatal day (PND) 24 weanling female rats an SPI diet for 30 d [short-term SPI (ST-SPI)], and on PND 55, we switched SPI diet to control Cas diet until age 6 mo. Rats then underwent either ovariectomy (OVX) or sham surgery and thereafter either continued to be fed an SPI diet or control diet for 1 or 3 wk. We showed significantly increased bone mass in 30-d SPI-fed young rats compared with controls. OVX-induced bone loss was associated with increased osteoblastic cell senescence. On the one hand, both long-term SPI (continuous SPI diet throughout life) and ST-SPI diet only in early life protected against 1 wk post-OVX-associated bone loss. On the other hand, long-term SPI diet diminished the loss of total, trabecular, and cortical bone mineral density, whereas ST-SPI diet only reduced cortical bone mineral density loss 3wk post-OVX. Persistent and protective effects of SPI diets on OVX-induced bone loss were associated with down-regulation of the caveolin-1/p53-mediated senescence pathway in bone. We recapitulated these results in cell cultures. Reprogramming of cellular senescence signaling by SPI-associated isoflavones in osteoblastic cells may explain the persistent effects of SPI on bone. These results suggest that OVX-induced bone loss, in part, is a result of increased osteoblastic cell senescence, and that ST-SPI diet early in life has modest but persistent programming effects on bone formation to prevent OVX-induced bone loss in adult female rats.-Chen, J.-R., Lazarenko, O. P., Blackburn, M. L., Shankar, K. Dietary factors during early life program bone formation in female rats.	[Chen, Jin-Ran] Arkansas Childrens Nutr Ctr, Slot 512-20B,15 Childrens Way, Little Rock, AR 72202 USA; Univ Arkansas Med Sci, Dept Pediat, Little Rock, AR 72205 USA	University of Arkansas System; University of Arkansas Medical Sciences	Chen, JR (corresponding author), Arkansas Childrens Nutr Ctr, Slot 512-20B,15 Childrens Way, Little Rock, AR 72202 USA.	chenjinran@uams.edu			U.S. Department of Agriculture/Agricultural Research Service Project Grant [6026-51000-010-05S]	U.S. Department of Agriculture/Agricultural Research Service Project Grant	The authors thank Matt Ferguson and Hoy Pittman (Arkansas Children's Hospital Research Institution, Little Rock, AR, USA) for their technical assistance. This work was supported, in part, by U.S. Department of Agriculture/Agricultural Research Service Project Grant 6026-51000-010-05S to the Arkansas Children's Nutrition Center.	Alekel DL, 2015, MENOPAUSE, V22, P185, DOI [10.1097/GME.0000000000000280, 10.1097/gme.0000000000000280]; Arjmandi BH, 1996, J NUTR, V126, P161, DOI 10.1093/jn/126.1.161; Badger TM, 2009, AM J CLIN NUTR, V89, pS1668, DOI 10.3945/ajcn.2009.26736U; Badger TM, 2002, J NUTR, V132, p559S, DOI 10.1093/jn/132.3.559S; Baker N, 2012, J CELL BIOCHEM, V113, P3773, DOI 10.1002/jcb.24252; Bitto A, 2010, CURR MED CHEM, V17, P3007, DOI 10.2174/092986710791959738; Bonjour JP, 2009, SALUD PUBLICA MEXICO, V51, pS5; Chen JR, 2008, EXP BIOL MED, V233, P1348, DOI 10.3181/0802-RM-63; Chen JR, 2015, ENDOCRINOLOGY, V156, P475, DOI 10.1210/en.2014-1427; Chen JR, 2013, FASEB J, V27, P3514, DOI 10.1096/fj.12-226464; Chen JR, 2010, J BONE MINER RES, V25, P2399, DOI 10.1002/jbmr.137; Chen JR, 2009, J NUTR, V139, P1839, DOI 10.3945/jn.109.109041; Chen JR, 2009, J BONE MINER RES, V24, P221, DOI 10.1359/JBMR.081011; Cho KA, 2003, J BIOL CHEM, V278, P27789, DOI 10.1074/jbc.M208105200; Connelly KJ, 2015, ENDOCRINOLOGY, V156, P193, DOI 10.1210/en.2014-1324; Fazeli PK, 2014, CURR OSTEOPOROS REP, V12, P82, DOI 10.1007/s11914-013-0186-8; Finch CE, 2014, J STEROID BIOCHEM, V142, P132, DOI 10.1016/j.jsbmb.2013.03.010; Gandarillas A, 2000, EXP GERONTOL, V35, P53, DOI 10.1016/S0531-5565(99)00088-1; Gu LW, 2006, J NUTR, V136, P1215, DOI 10.1093/jn/136.5.1215; Kaludjerovic J, 2010, J NUTR, V140, P766, DOI 10.3945/jn.109.116343; Khosla S, 2003, JAMA-J AM MED ASSOC, V290, P1479, DOI 10.1001/jama.290.11.1479; Kuiper GGJM, 1998, ENDOCRINOLOGY, V139, P4252, DOI 10.1210/en.139.10.4252; Kulak CAM, 1998, INT J FERTIL WOMEN M, V43, P56; Lecka-Czernik B, 1999, J CELL BIOCHEM, V74, P357, DOI 10.1002/(SICI)1097-4644(19990901)74:3<357::AID-JCB5>3.0.CO;2-7; Lovekamp-Swan T, 2007, NEUROSCIENCE, V148, P644, DOI 10.1016/j.neuroscience.2007.06.046; Messina M, 2010, J NUTR, V140, p2289S, DOI 10.3945/jn.110.124107; Petersen SB, 2015, NUTRIENTS, V7, P2382, DOI 10.3390/nu7042382; Prisby RD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048564; Pudenz M, 2014, NUTRIENTS, V6, P4218, DOI 10.3390/nu6104218; REEVES PG, 1993, J NUTR, V123, P1939, DOI 10.1093/jn/123.11.1939; Reinwald S, 2010, J NUTR, V140, p2312S, DOI 10.3945/jn.110.124008; Ronis MJJ, 2012, ENDOCRINOLOGY, V153, P6021, DOI 10.1210/en.2012-1591; Rubin J, 2007, J BONE MINER RES, V22, P1408, DOI 10.1359/jbmr.070601; Setchell KDR, 2001, J AM COLL NUTR, V20, p354S, DOI 10.1080/07315724.2001.10719168; Shankar K, 2012, ENDOCRINOLOGY, V153, P1999, DOI 10.1210/en.2011-1833; Shivshankar P, 2012, AM J RESP CELL MOL, V47, P28, DOI 10.1165/rcmb.2011-0349OC; Tai TY, 2012, OSTEOPOROSIS INT, V23, P1571, DOI 10.1007/s00198-011-1750-7; Volonte D, 2011, J BIOL CHEM, V286, P28657, DOI 10.1074/jbc.C111.235119; WEST MD, 1989, EXP CELL RES, V184, P138, DOI 10.1016/0014-4827(89)90372-8; Williams TM, 2004, ANN MED, V36, P584, DOI 10.1080/07853890410018899; Zhang J, 2014, FASEB J, V28, P3134, DOI 10.1096/fj.13-243659; Zhang J, 2013, AGE, V35, P807, DOI 10.1007/s11357-012-9412-z; Zhang JX, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0039076, 10.1371/journal.pone.0030621]	43	10	10	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					376	+		10.1096/fj.201600703R	http://dx.doi.org/10.1096/fj.201600703R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27733448				2022-12-28	WOS:000392177600035
J	Dickens, JA; Ordonez, A; Chambers, JE; Beckett, AJ; Patel, V; Malzer, E; Dominicus, CS; Bradley, J; Peden, AA; Prior, IA; Lomas, DA; Marciniak, SJ				Dickens, Jennifer A.; Ordonez, Adriana; Chambers, Joseph E.; Beckett, Alison J.; Patel, Vruti; Malzer, Elke; Dominicus, Caia S.; Bradley, Jayson; Peden, Andrew A.; Prior, Ian A.; Lomas, David A.; Marciniak, Stefan J.			The endoplasmic reticulum remains functionally connected by vesicular transport after its fragmentation in cells expressing Z-alpha(1)-antitrypsin	FASEB JOURNAL			English	Article						ER stress; homotypic fusion; serpin; SNARE	UNFOLDED PROTEIN RESPONSE; NF-KAPPA-B; ALPHA(1)-ANTITRYPSIN DEFICIENCY; MAMMALIAN-CELLS; RUSSELL BODIES; ER; ALPHA-1-ANTITRYPSIN; ACCUMULATION; POLYMERS; FUSION	alpha(1)-Antitrypsin is a serine protease inhibitor produced in the liver that is responsible for the regulation of pulmonary inflammation. The commonest pathogenic genemutation yields Z-alpha(1)-antitrypsin, which has a propensity to self-associate forming polymers that become trapped in inclusions of endoplasmic reticulum (ER). It is unclear whether these inclusions are connected to the main ER network in Z-alpha(1)-antitrypsin-expressing cells. Using live cell imaging, we found that despite inclusions containing an immobile matrix of polymeric alpha(1)-antitrypsin, small ER resident proteins can diffuse freely within them. Inclusions have many features to suggest they represent fragmented ER, and some are physically separated from the tubular ER network, yet we observed cargo to be transported between them in a cytosol-dependent fashion that is sensitive to N-ethylmaleimide and dependent on Sar1 and sec22B. We conclude that protein recycling occurs between ER inclusions despite their physical separation.	[Dickens, Jennifer A.; Ordonez, Adriana; Chambers, Joseph E.; Patel, Vruti; Malzer, Elke; Dominicus, Caia S.; Bradley, Jayson; Marciniak, Stefan J.] Cambridge Inst Med Res, Cambridge, England; [Dickens, Jennifer A.; Chambers, Joseph E.; Marciniak, Stefan J.] Univ Cambridge, Dept Med, Cambridge, England; [Beckett, Alison J.; Peden, Andrew A.] Univ Sheffield, Dept Biomed Sci, Sheffield, S Yorkshire, England; [Prior, Ian A.] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England; [Lomas, David A.] UCL, UCL Resp, London, England	University of Cambridge; University of Cambridge; University of Sheffield; University of Liverpool; University of London; University College London	Marciniak, SJ (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	sjm20@cam.ac.uk	Chambers, Joseph/Z-5212-2019	Chambers, Joseph/0000-0003-4675-0053; Marciniak, Stefan/0000-0001-8472-7183; Peden, Andrew/0000-0003-0144-7712; Prior, Ian/0000-0002-4055-5161	Medical Research Council (MRC) Clinical Research Training Fellowship; Academy of Medical Sciences; MRC; University College London Hospitals National Institute for Health Research (NIHR) Biomedical Research Centre (London, United Kingdom); Alphal Foundation; Wellcome Trust Strategic Award [100140]; Wellcome Trust equipment grant [093026]; Biotechnology and Biological Sciences Research Council [BB/L014416/1, BB/L002841/1] Funding Source: researchfish; Medical Research Council [MR/N024842/1, G1000277, G0901786, G1002610, G0601840] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10070] Funding Source: researchfish; BBSRC [BB/L002841/1, BB/L014416/1] Funding Source: UKRI; MRC [G0601840, G1002610, MR/N024842/1, G0901786, G1000277] Funding Source: UKRI	Medical Research Council (MRC) Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences(Academy of Medical Sciences (AMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University College London Hospitals National Institute for Health Research (NIHR) Biomedical Research Centre (London, United Kingdom); Alphal Foundation; Wellcome Trust Strategic Award(Wellcome Trust); Wellcome Trust equipment grant(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	J.A.D. was funded by a Medical Research Council (MRC) Clinical Research Training Fellowship and a starter grant from the Academy of Medical Sciences; S.J.M. is a MRC Senior Clinical Research Fellow. D.A.L. is funded by the MRC and by the University College London Hospitals National Institute for Health Research (NIHR) Biomedical Research Centre (London, United Kingdom), and is an NIHR Senior Investigator. The work was also supported by the Alphal Foundation. The Cambridge Institute for Medical Research microscopy core facility is supported by a Wellcome Trust Strategic Award (100140) and a Wellcome Trust equipment grant (093026).	Anwar K, 2012, J CELL BIOL, V197, P209, DOI 10.1083/jcb.201111115; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Belorgey D, 2011, METHODS, V53, P255, DOI 10.1016/j.ymeth.2010.11.008; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Breusegem SY, 2014, METHOD ENZYMOL, V534, P155, DOI 10.1016/B978-0-12-397926-1.00009-3; Costantini LM, 2012, TRAFFIC, V13, P643, DOI 10.1111/j.1600-0854.2012.01336.x; Davies MJ, 2009, J BIOL CHEM, V284, P18202, DOI 10.1074/jbc.M109.010744; Dickens JA, 2011, DRUG DES DEV THER, V5, P391, DOI 10.2147/DDDT.S14018; Donaldson JG, 2005, BBA-MOL CELL RES, V1744, P364, DOI 10.1016/j.bbamcr.2005.03.001; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; ERIKSSON S, 1986, NEW ENGL J MED, V314, P736, DOI 10.1056/NEJM198603203141202; ERIKSSON S, 1964, ACTA MED SCAND, V175, P197; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; Gordon DE, 2010, TRAFFIC, V11, P1191, DOI 10.1111/j.1600-0854.2010.01087.x; GRAHAM KS, 1990, J BIOL CHEM, V265, P20463; Granell S, 2008, MOL BIOL CELL, V19, P572, DOI 10.1091/mbc.E07-06-0587; Hay JC, 1997, CELL, V89, P149, DOI 10.1016/S0092-8674(00)80191-9; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; HSU SM, 1982, AM J CLIN PATHOL, V77, P26; Kroeger H, 2009, J BIOL CHEM, V284, P22793, DOI 10.1074/jbc.M109.027102; Kucharz K, 2011, J CEREBR BLOOD F MET, V31, P1663, DOI 10.1038/jcbfm.2011.37; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; LIEBERMAN J, 1972, SCIENCE, V175, P63, DOI 10.1126/science.175.4017.63; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Lomas DA, 2006, AM J RESP CRIT CARE, V173, P1072, DOI 10.1164/rccm.200511-1797PP; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Malzer E, 2013, J CELL SCI, V126, P1406, DOI 10.1242/jcs.117614; Miranda E, 2010, HEPATOLOGY, V52, P1078, DOI 10.1002/hep.23760; Ordonez A, 2013, HEPATOLOGY, V57, P2049, DOI 10.1002/hep.26173; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Ostrovsky O, 2009, P NATL ACAD SCI USA, V106, P11600, DOI 10.1073/pnas.0902626106; Roussel BD, 2013, HUM MOL GENET, V22, P4616, DOI 10.1093/hmg/ddt310; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Schmidt BZ, 2005, AM J PHYSIOL-GASTR L, V289, pG444, DOI 10.1152/ajpgi.00237.2004; Shim SH, 2012, P NATL ACAD SCI USA, V109, P13978, DOI 10.1073/pnas.1201882109; VALETTI C, 1991, J CELL BIOL, V115, P983, DOI 10.1083/jcb.115.4.983; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; West JB, 2010, RESP PHYSIOL NEUROBI, V170, P202, DOI 10.1016/j.resp.2009.12.010; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200	41	18	18	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4083	4097		10.1096/fj.201600430R	http://dx.doi.org/10.1096/fj.201600430R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27601439	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000388201500015
J	Nie, YH; Sato, Y; Wang, C; Yue, F; Kuang, S; Gavin, TP				Nie, Yaohui; Sato, Yoriko; Wang, Chao; Yue, Feng; Kuang, Shihuan; Gavin, Timothy P.			Impaired exercise tolerance, mitochondrial biogenesis, and muscle fiber maintenance in miR-133a-deficient mice	FASEB JOURNAL			English	Article						miRNA; mitochondrial function; skeletal muscle adaptation; exercise resistance; Igf1R-Akt signaling	ACUTE ENDURANCE EXERCISE; SKELETAL-MUSCLE; MEDIATED PHOSPHORYLATION; NUCLEAR EXCLUSION; GENE-EXPRESSION; PGC-1-ALPHA; MICRORNA; ADAPTATION; PROLIFERATION; MECHANISMS	Exercise promotes multiple beneficial effects on muscle function, including induction of mitochondrial biogenesis. miR-133a is a muscle-enriched microRNA that regulates muscle development and function. The role of miR-133a in exercise tolerance has not been fully elucidated. In the current study, mice that were deficient in miR-133a demonstrated low maximal exercise capacity and low resting metabolic rate. Transcription of the mitochondrial biogenesis regulators peroxisome proliferator-activated receptor- coactivator 1-, peroxisome proliferator-activated receptor- coactivator 1-, nuclear respiratory factor-1, and transcription factor A, mitochondrial were lower in miR-133a-deficient muscle, which was consistent with lower mitochondrial mass and impaired exercise capacity. Six weeks of endurance exercise training increased the transcriptional level of miR-133a and stimulated mitochondrial biogenesis in wild-type mice, but failed to improve mitochondrial function in miR-133a-deficient mice. Further mechanistic analysis showed an increase in the miR-133a potential target, IGF-1 receptor, along with hyperactivation of Akt signaling, in miR-133a-deficient mice, which was consistent with lower transcription of the mitochondrial biogenesis regulators. These findings indicate an essential role of miR-133a in skeletal muscle mitochondrial biogenesis, exercise tolerance, and response to exercise training.Nie, Y., Sato, Y., Wang, C., Yue, F., Kuang, S., Gavin, T. P. Impaired exercise tolerance, mitochondrial biogenesis, and muscle fiber maintenance in miR-133a-deficient mice.	[Nie, Yaohui; Sato, Yoriko; Gavin, Timothy P.] Purdue Univ, Dept Hlth & Kinesiol, W Lafayette, IN 47907 USA; [Nie, Yaohui; Sato, Yoriko] Purdue Univ, Max E Wastl Human Performance Lab, W Lafayette, IN 47907 USA; [Nie, Yaohui; Wang, Chao; Yue, Feng; Kuang, Shihuan] Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA; [Sato, Yoriko] Tokyo Univ Agr & Technol, Dept United Grad Sch Agr Sci, Tokyo, Japan	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Tokyo University of Agriculture & Technology	Kuang, S (corresponding author), Purdue Univ, 174B Smith Hall,901 W State St, W Lafayette, IN 47907 USA.; Gavin, TP (corresponding author), Purdue Univ, 800 W Stadium Ave,363 Ward Sports Med Bldg, W Lafayette, IN 47907 USA.	skuang@purdue.edu; gavin1@purdue.edu	Yue, Feng/S-6565-2017; Wang, Chao/V-8994-2019	Wang, Chao/0000-0002-4051-364X	Purdue University Research Initiative funds; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR060652]; NATIONAL CANCER INSTITUTE [P30CA023168] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR060652] Funding Source: NIH RePORTER	Purdue University Research Initiative funds; U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by Purdue University Research Initiative funds (to T.P.G.), and by U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant R01-AR060652 (to S.K). The authors thank Dr. Eric Olson (University of Texas Southwestern Medical Center, Dallas, TX, USA) for providing the miR-133a-1/a-2 KO mice, and Alanna Fennimore, Kyoungrae Kim, Zifang Liu, and Zachary Hettinger (all from Purdue University) for their assistance. The authors declare no conflicts of interest.	Allen DG, 2008, PHYSIOL REV, V88, P287, DOI 10.1152/physrev.00015.2007; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anderson EJ, 2006, AM J PHYSIOL-CELL PH, V290, pC844, DOI 10.1152/ajpcell.00402.2005; Aoi W, 2010, AM J PHYSIOL-ENDOC M, V298, pE799, DOI 10.1152/ajpendo.00448.2009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Biggs WH, 1999, P NATL ACAD SCI USA, V96, P7421, DOI 10.1073/pnas.96.13.7421; Booth FW, 2015, PROG MOL BIOL TRANSL, V135, P129, DOI 10.1016/bs.pmbts.2015.07.016; Callis TE, 2008, EXP BIOL MED, V233, P131, DOI 10.3181/0709-MR-237; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Coffey VG, 2005, FASEB J, V19, P190, DOI 10.1096/fj.05-4809fje; CRISWELL D, 1993, MED SCI SPORT EXER, V25, P1135; Daitoku H, 2003, DIABETES, V52, P642, DOI 10.2337/diabetes.52.3.642; Dogra C, 2006, J CELL PHYSIOL, V208, P575, DOI 10.1002/jcp.20696; Drake JC, 2016, FASEB J, V30, P13, DOI 10.1096/fj.15-276337; Fernandes T, 2012, HYPERTENSION, V59, P513, DOI 10.1161/HYPERTENSIONAHA.111.185801; Filomeni G, 2015, CELL DEATH DIFFER, V22, P377, DOI 10.1038/cdd.2014.150; Hamilton AJ, 1999, SCIENCE, V286, P950, DOI 10.1126/science.286.5441.950; Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200; Heestand BN, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003651; Huang MB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029173; Jornayvaz FR, 2010, ESSAYS BIOCHEM, V47, P69, DOI [10.1042/BSE0470069, 10.1042/bse0470069]; Keller P, 2011, J APPL PHYSIOL, V110, P46, DOI 10.1152/japplphysiol.00634.2010; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kuznetsov AV, 1998, MOL CELL BIOCHEM, V183, P87, DOI 10.1023/A:1006868130002; Laughlin MH, 2008, J PHYSIOL PHARMACOL, V59, P71; LAWLER JM, 1994, RESP PHYSIOL, V96, P139, DOI 10.1016/0034-5687(94)90122-8; Leick L, 2009, AM J PHYSIOL-ENDOC M, V297, pE92, DOI 10.1152/ajpendo.00076.2009; Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu N, 2007, P NATL ACAD SCI USA, V104, P20844, DOI 10.1073/pnas.0710558105; Liu N, 2011, J CLIN INVEST, V121, P3258, DOI 10.1172/JCI46267; Liu N, 2008, GENE DEV, V22, P3242, DOI 10.1101/gad.1738708; Marini M, 2010, EUR J TRANSL MYOL, V20, P105, DOI 10.4081/bam.2010.3.105; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; McCarthy JJ, 2008, BBA-GENE REGUL MECH, V1779, P682, DOI 10.1016/j.bbagrm.2008.03.001; Murphy MP, 2009, BIOCHEM J, V417, P1, DOI 10.1042/BJ20081386; Nie Y, 2015, BIOPROTOC, V5, pe1602; Nielsen S, 2010, J PHYSIOL-LONDON, V588, P4029, DOI 10.1113/jphysiol.2010.189860; Pette D, 2002, CAN J APPL PHYSIOL, V27, P423, DOI 10.1139/h02-023; Pitkanen S, 1996, J CLIN INVEST, V98, P345, DOI 10.1172/JCI118798; POWERS SK, 1994, AM J PHYSIOL, V266, pR375, DOI 10.1152/ajpregu.1994.266.2.R375; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Risson V, 2009, J CELL BIOL, V187, P859, DOI 10.1083/jcb.200903131; Rossiter HB, 2005, J PHYSIOL-LONDON, V565, P993, DOI 10.1113/jphysiol.2004.080663; Russell AP, 2013, J PHYSIOL-LONDON, V591, P4637, DOI 10.1113/jphysiol.2013.255695; Safdar A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005610; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Southgate RJ, 2005, FASEB J, V19, P2072, DOI 10.1096/fj.05-3993fje; Takaishi H, 1999, P NATL ACAD SCI USA, V96, P11836, DOI 10.1073/pnas.96.21.11836; Tanner CB, 2013, AM J PHYSIOL-ENDOC M, V305, pE1018, DOI 10.1152/ajpendo.00227.2013; Valentine RJ, 2014, ARCH BIOCHEM BIOPHYS, V562, P62, DOI 10.1016/j.abb.2014.08.013; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; van Wessel T, 2010, EUR J APPL PHYSIOL, V110, P665, DOI 10.1007/s00421-010-1545-0; Wada S, 2015, PFLUG ARCH EUR J PHY, V467, P389, DOI 10.1007/s00424-014-1517-z; Wilkinson SB, 2008, J PHYSIOL-LONDON, V586, P3701, DOI 10.1113/jphysiol.2008.153916; Yin H, 2013, CELL METAB, V17, P210, DOI 10.1016/j.cmet.2013.01.004; Zhang D, 2014, J CELL BIOL, V207, P753, DOI 10.1083/jcb.201406068; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	60	47	51	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3745	3758		10.1096/fj.201600529R	http://dx.doi.org/10.1096/fj.201600529R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27458245	Green Published			2022-12-28	WOS:000386474700010
J	Sasaki, N; Nakamura, M; Kodama, A; Urata, Y; Shiokawa, N; Hayashi, T; Sano, A				Sasaki, Natsuki; Nakamura, Masayuki; Kodama, Akiko; Urata, Yuka; Shiokawa, Nari; Hayashi, Takehiro; Sano, Akira			Chorein interacts with -tubulin and histone deacetylase 6, and overexpression preserves cell viability during nutrient deprivation in human embryonic kidney 293 cells	FASEB JOURNAL			English	Article						chorea-acanthocytosis; starvation; autophagy; acetylated tubulin; VPS13A	HDAC6-MEDIATED DEACETYLATION; ACANTHOCYTOSIS; AUTOPHAGY; PROTEIN; HDAC6; LOCALIZATION; GENE; NEURODEGENERATION; DICTYOSTELIUM; MICROTUBULES	The autophagy pathway has recently been implicated in several neurodegenerative diseases. Recently, it was reported that chorein-depleted cells showed accumulation of autophagic markers and impaired autophagic flux. Here, we demonstrate that chorein overexpression preserves cell viability from starvation-induced cell death in human embryonic kidney 293 (HEK293) cells. Subsequent coimmunoprecipitation and reverse coimmunoprecipitation assays using extracts from chorein that stably overexpressed HEK293 cells revealed that chorein interacts with -tubulin and histone deacetylase 6, a known -tubulin deacetylater and central component of basal autophagy. Indeed, acetylated -tubulin immunoreactivity was significantly decreased in chorein that stably overexpressed HEK293 cells. These results suggest that chorein/histone deacetylase 6/-tubulin interactions may play an important role in starvation-induced cell stress, and their disruption may be one of the molecular pathogenic mechanisms of chorea-acanthocytosis.Sasaki, N., Nakamura, M., Kodama, A., Urata, Y., Shiokawa, N., Hayashi, T., Sano, A. Chorein interacts with -tubulin and histone deacetylase 6, and overexpression preserves cell viability during nutrient deprivation in human embryonic kidney 293 cells.	[Sasaki, Natsuki; Nakamura, Masayuki; Kodama, Akiko; Urata, Yuka; Shiokawa, Nari; Hayashi, Takehiro; Sano, Akira] Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychiat, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan	Kagoshima University	Nakamura, M (corresponding author), Kagoshima Univ, Grad Sch Med & Dent Sci, Dept Psychiat, 8-35-1 Sakuragaoka, Kagoshima 8908520, Japan.	nakamu36@m.kufm.kagoshima-u.ac.jp		Sano, Akira/0000-0001-5843-9786	Research Committee of CNS Degenerative Diseases; Ministry of Health, Labour, and Welfare of Japan [33361215]; Ministry of Education, Culture, Sports, Science, and Technology of Japan [24591685]	Research Committee of CNS Degenerative Diseases(Ministry of Health, Labour and Welfare, Japan); Ministry of Health, Labour, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by Grants-in-Aid from the Research Committee of CNS Degenerative Diseases, the Ministry of Health, Labour, and Welfare of Japan (Grant 33361215 to A.S.), and, in part, by a Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan (Grant 24591685 to M.N.). The authors thank H. Hiwatashi, C. Shimomura, I. Yokoyama, M. Oshima, and Y. Nishimura for technical assistance (Kagoshima University Graduate School of Medical and Dental Sciences). The authors are grateful to Dr. H. Sakimoto and Dr. O. Nagata (Kagoshima University Graduate School of Medical and Dental Sciences) for helpful discussions and technical support. The authors thank the Joint Research Laboratory (Kagoshima University Graduate School of Mental and Dental Sciences), for use of their facilities. The authors thank all staff members of the Institute of Laboratory Animal Sciences (Frontier Science Research Center, Kagoshima University), who kept the animals in good condition.	Ageta-Ishihara N, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3532; Brickner JH, 1997, J CELL BIOL, V139, P23, DOI 10.1083/jcb.139.1.23; Dobson-Stone C, 2004, ANN NEUROL, V56, P299, DOI 10.1002/ana.20200; Geeraert C, 2010, J BIOL CHEM, V285, P24184, DOI 10.1074/jbc.M109.091553; Haggarty SJ, 2003, P NATL ACAD SCI USA, V100, P4389, DOI 10.1073/pnas.0430973100; Hayashi T, 2012, BIOCHEM BIOPH RES CO, V419, P511, DOI 10.1016/j.bbrc.2012.02.047; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Jaeger PA, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-16; Kurano Y, 2007, BIOCHEM BIOPH RES CO, V353, P431, DOI 10.1016/j.bbrc.2006.12.059; Mackeh R, 2013, J CELL SCI, V126, P1071, DOI 10.1242/jcs.115626; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Munoz-Braceras S, 2015, AUTOPHAGY, V11, P918, DOI 10.1080/15548627.2015.1034413; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Perez M, 2009, J NEUROCHEM, V109, P1756, DOI 10.1111/j.1471-4159.2009.06102.x; Rampoldi L, 2001, NAT GENET, V28, P119, DOI 10.1038/88821; Samaranayake HS, 2011, EUKARYOT CELL, V10, P1207, DOI 10.1128/EC.05089-11; Shiokawa N, 2013, BIOCHEM BIOPH RES CO, V441, P96, DOI 10.1016/j.bbrc.2013.10.011; Simoes-Pires C, 2013, MOL NEURODEGENER, V8, DOI 10.1186/1750-1326-8-7; Stege JT, 1999, DEV GENET, V25, P64, DOI 10.1002/(SICI)1520-6408(1999)25:1<64::AID-DVG7>3.0.CO;2-1; Tomemori Y, 2005, J NEUROCHEM, V92, P759, DOI 10.1111/j.1471-4159.2004.02924.x; Tomiyasu A, 2011, AM J MED GENET B, V156B, P620, DOI 10.1002/ajmg.b.31206; Ueno S, 2001, NAT GENET, V28, P121, DOI 10.1038/88825; Walker RH, 2007, NEUROLOGY, V68, P92, DOI 10.1212/01.wnl.0000250356.78092.cc	26	3	3	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3726	3732		10.1096/fj.201500191RR	http://dx.doi.org/10.1096/fj.201500191RR			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27468757				2022-12-28	WOS:000386474700008
J	Pongsakul, N; Vinaiphat, A; Chanchaem, P; Fong-ngern, K; Thongboonkerd, V				Pongsakul, Nutkridta; Vinaiphat, Arada; Chanchaem, Prangwalai; Fong-ngern, Kedsarin; Thongboonkerd, Visith			Lamin A/C in renal tubular cells is important for tissue repair, cell proliferation, and calcium oxalate crystal adhesion, and is associated with potential crystal receptors	FASEB JOURNAL			English	Article						kidney stone; LMNA; nephrolithiasis; prevention; protein network	NUCLEAR; PROTEINS; SURFACE; IDENTIFICATION; NESPRIN-2; MEMBRANE; GROWTH	A previous study reported that lamin A/C (LMNA) expression was increased in renal tubular cells adhered with calcium oxalate monohydrate (COM) crystals; however, its functional significance in kidney stone disease remained unknown. In the present study, increased levels of LMNA and its partner, nesprin-1 (SYNE1), in Madin-Darby canine kidney cells upon COM crystal adhesion were confirmed by Western blotting and immunofluorescence staining. LMNA was then knocked down by small interfering RNA. Immunofluorescence staining confirmed the efficiency of small interfering RNA of LMNA (si-LMNA), which also reduced expression of its partner, SYNE1. Scratch assay and total cell count revealed defects in tissue repair and cell proliferation, respectively, whereas cell death quantitation showed no cytotoxicity in si-LMNA-transfected cells. Crystal-binding assay highlighted the role of LMNA in crystal adhesion, whereas protein network analysis revealed interactions between LMNA and potential COM crystal receptors. Their associations were confirmed by reduced levels of these proteins, including vimentin, tubulin, enolase, S100, and annexin A2, in si-LMNA-transfected cells. These data have demonstrated for the first time, to our knowledge, that LMNA in renal tubular cells is important for tissue repair, cell proliferation, and COM crystal adhesion and is associated with potential COM crystal receptors. Therefore, LMNA may serve as a potential target for prevention of kidney stone disease and its recurrence.	Mahidol Univ, Siriraj Hosp, Fac Med, Med Prote Unit,Off Res & Dev, Bangkok, Thailand; Mahidol Univ, Ctr Res Complex Syst Sci, Bangkok, Thailand	Mahidol University; Mahidol University	Thongboonkerd, V (corresponding author), Siriraj Hosp, Off Res & Dev, Med Prote Unit, SiMR Bldg 6th Floor,2 Wanglang Rd, Bangkok 10700, Thailand.	thongboonkerd@dr.com	Thongboonkerd, Visith/C-6920-2009	Thongboonkerd, Visith/0000-0001-7865-0765	Mahidol University research grant; Mahidol University; Thailand Research Fund [RTA5680004]; Chalermphrakiat and Research Staff grants; Faculty of Medicine Siriraj Hospital; Office of the Higher Education Commission	Mahidol University research grant; Mahidol University; Thailand Research Fund(Thailand Research Fund (TRF)); Chalermphrakiat and Research Staff grants; Faculty of Medicine Siriraj Hospital; Office of the Higher Education Commission	This work was supported by a Mahidol University research grant, Office of the Higher Education Commission, and Mahidol University under the National Research Universities Initiative and The Thailand Research Fund (RTA5680004). V.T. received Chalermphrakiat and Research Staff grants, and K.F. and P.C. are supported by Faculty of Medicine Siriraj Hospital. The authors declare no conflicts of interest.	Andres V, 2009, J CELL BIOL, V187, P945, DOI 10.1083/jcb.200904124; Chutipongtanate S, 2012, J PROTEOME RES, V11, P3650, DOI 10.1021/pr3000738; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Farell G, 2004, J AM SOC NEPHROL, V15, P3052, DOI 10.1097/01.ASN.0000144205.49134.64; Favale NO, 2007, BIOCHEM BIOPH RES CO, V364, P443, DOI 10.1016/j.bbrc.2007.10.054; Fong-ngern K, 2011, J PROTEOME RES, V10, P4463, DOI 10.1021/pr2006878; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502; Kanlaya R, 2013, J PROTEOMICS, V80, P55, DOI 10.1016/j.jprot.2013.01.001; Khatau SB, 2012, SCI REP-UK, V2, DOI 10.1038/srep00488; KOK DJ, 1994, KIDNEY INT, V46, P847, DOI 10.1038/ki.1994.341; Kong L, 2012, CARCINOGENESIS, V33, P751, DOI 10.1093/carcin/bgs022; Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009; Lieske JC, 1996, SEMIN NEPHROL, V16, P458; Mandel N, 1996, SEMIN NEPHROL, V16, P364; Nikolova-Krstevski V, 2011, J MOL CELL CARDIOL, V50, P479, DOI 10.1016/j.yjmcc.2010.12.001; Padmakumar VC, 2005, J CELL SCI, V118, P3419, DOI 10.1242/jcs.02471; Rodriguez Luis G., 2004, V294, P23; Semangoen T, 2008, PROTEOM CLIN APPL, V2, P1099, DOI 10.1002/prca.200780136; Skvortsov S, 2011, J PROTEOME RES, V10, P259, DOI 10.1021/pr100921j; STICK R, 1985, CELL, V41, P191, DOI 10.1016/0092-8674(85)90073-X; Szklarczyk D, 2011, NUCLEIC ACIDS RES, V39, pD561, DOI 10.1093/nar/gkq973; Thongboonkerd V, 2006, CLIN CHIM ACTA, V367, P120, DOI 10.1016/j.cca.2005.11.033; Thongboonkerd V, 2008, J UROLOGY, V179, P1615, DOI 10.1016/j.juro.2007.11.041; Verkoelen CF, 1999, KIDNEY INT, V55, P1426, DOI 10.1046/j.1523-1755.1999.00383.x; Verkoelen CF, 2000, KIDNEY INT, V58, P1045, DOI 10.1046/j.1523-1755.2000.00262.x	26	23	23	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3368	3377		10.1096/fj.201600426R	http://dx.doi.org/10.1096/fj.201600426R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27358390				2022-12-28	WOS:000384329800009
J	Tammimies, K; Bieder, A; Lauter, G; Sugiaman-Trapman, D; Torchet, R; Hokkanen, ME; Burghoorn, J; Castren, E; Kere, J; Tapia-Paez, I; Swoboda, P				Tammimies, Kristiina; Bieder, Andrea; Lauter, Gilbert; Sugiaman-Trapman, Debora; Torchet, Rachel; Hokkanen, Marie-Estelle; Burghoorn, Jan; Castren, Eero; Kere, Juha; Tapia-Paez, Isabel; Swoboda, Peter			Ciliary dyslexia candidate genes DYX1C1 and DCDC2 are regulated by Regulatory Factor X (RFX) transcription factors through X-box promoter motifs	FASEB JOURNAL			English	Article						reading disorder; ciliopathies; gene regulation; hTERT-RPE1 cell line; ciliary proteins	NEURONAL MIGRATION; DEVELOPMENTAL DYSLEXIA; READING-DISABILITY; C. ELEGANS; CELL-TYPES; H1T GENE; CILIOGENESIS; EXPRESSION; VERTEBRATE; POPULATION	DYX1C1, DCDC2, and KIAA0319 are three of the most replicated dyslexia candidate genes (DCGs). Recently, these DCGs were implicated in functions at the cilium. Here, we investigate the regulation of these DCGs by Regulatory Factor X transcription factors (RFX TFs), a gene family known for transcriptionally regulating ciliary genes. We identify conserved X-box motifs in the promoter regions of DYX1C1, DCDC2, and KIAA0319 and demonstrate their functionality, as well as the ability to recruit RFX TFs using reporter gene and electrophoretic mobility shift assays. Furthermore, we uncover a complex regulation pattern between RFX1, RFX2, and RFX3 and their significant effect on modifying the endogenous expression of DYX1C1 and DCDC2 in a human retinal pigmented epithelial cell line immortalized with hTERT (hTERT-RPE1). In addition, induction of ciliogenesis increases the expression of RFX TFs and DCGs. At the protein level, we show that endogenous DYX1C1 localizes to the base of the cilium, whereas DCDC2 localizes along the entire axoneme of the cilium, thereby validating earlier localization studies using overexpression models. Our results corroborate the emerging role of DCGs in ciliary function and characterize functional noncoding elements, X-box promoter motifs, in DCG promoter regions, which thus can be targeted for mutation screening in dyslexia and ciliopathies associated with these genes.	[Tammimies, Kristiina; Bieder, Andrea; Lauter, Gilbert; Sugiaman-Trapman, Debora; Torchet, Rachel; Burghoorn, Jan; Kere, Juha; Tapia-Paez, Isabel; Swoboda, Peter] Karolinska Inst, Dept Biosci & Nutr, Huddinge, Sweden; [Tammimies, Kristiina] Karolinska Inst, Dept Womens & Childrens Hlth, Pediat Neuropsychiat Unit, Ctr Neurodev Disorders KIND, Stockholm, Sweden; [Hokkanen, Marie-Estelle; Castren, Eero] Univ Helsinki, Neurosci Ctr, Helsinki, Finland; [Kere, Juha] Univ Helsinki, Mol Neurol Res Program, Helsinki, Finland; [Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland	Karolinska Institutet; Karolinska Institutet; University of Helsinki; University of Helsinki	Tapia-Paez, I; Swoboda, P (corresponding author), Karolinska Inst, Halsovagen 7-9,Plan 7, S-14157 Huddinge, Sweden.	isabel.tapia@ki.se; peter.swoboda@ki.se	TORCHET, Rachel/AAO-8300-2020; Tapia-Páez, Isabel/N-1210-2013; Kere, Juha/AAX-9117-2021; Kere, Juha/A-9179-2008; Tapia-Páez, Isabel/ABD-7197-2021	TORCHET, Rachel/0000-0002-2306-5566; Kere, Juha/0000-0003-1974-0271; Kere, Juha/0000-0003-1974-0271; Castren, Eero/0000-0002-1402-2791; Swoboda, Peter/0000-0001-6416-8572; Tapia-Paez, Isabel/0000-0002-0535-4233; Tammimies, Kristiina/0000-0002-8324-4697; Bieder, Andrea/0000-0002-4566-050X	Swedish Brain Foundation (Hjarnfonden); Swedish Research Council; Torsten Soderberg Foundation; Lars Hiertas Minne Foundation; Sigrid Juselius Foundation; Ahlen Foundation; Swedish Foundation for Strategic Research; Karolinska Institutet (KI) Strategic Neuroscience Program; Academy of Finland; Knut and Alice Wallenberg Foundation; KI Center for Innovative Medicine	Swedish Brain Foundation (Hjarnfonden); Swedish Research Council(Swedish Research CouncilEuropean Commission); Torsten Soderberg Foundation; Lars Hiertas Minne Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Ahlen Foundation; Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Karolinska Institutet (KI) Strategic Neuroscience Program; Academy of Finland(Academy of Finland); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); KI Center for Innovative Medicine	This study was supported by the Swedish Brain Foundation (Hjarnfonden), the Swedish Research Council, the Torsten Soderberg, Ahlen, Lars Hiertas Minne, and Sigrid Juselius Foundations, the Swedish Foundation for Strategic Research, the Karolinska Institutet (KI) Strategic Neuroscience Program, and the Academy of Finland. This study was performed, in part, at the Live Cell Imaging Unit/Nikon Center of Excellence at the KI Department of Biosciences and Nutrition, which is supported by grants from the Knut and Alice Wallenberg Foundation, the Swedish Research Council, the KI Center for Innovative Medicine, and the Jonasson donation to the School of Technology and Health, Royal Institute of Technology.	Abdelhamed ZA, 2013, HUM MOL GENET, V22, P1358, DOI 10.1093/hmg/dds546; Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Andersson R, 2014, NATURE, V507, P455, DOI 10.1038/nature12787; Ashique AM, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000602; Bae BI, 2014, SCIENCE, V343, P764, DOI 10.1126/science.1244392; Bisgrove BW, 2012, DEV BIOL, V363, P166, DOI 10.1016/j.ydbio.2011.12.030; Bonnafe E, 2004, MOL CELL BIOL, V24, P4417, DOI 10.1128/MCB.24.10.4417-4427.2004; Brandler WM, 2014, TRENDS MOL MED, V20, P83, DOI 10.1016/j.molmed.2013.10.008; Burghoorn J, 2012, DEV BIOL, V368, P415, DOI 10.1016/j.ydbio.2012.05.033; Casey JP, 2015, EUR J HUM GENET, V23, P210, DOI 10.1038/ejhg.2014.79; Chandrasekar G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063123; Choksi SP, 2014, DEVELOPMENT, V141, P1427, DOI 10.1242/dev.074666; Chung MI, 2014, ELIFE, V3, DOI 10.7554/eLife.01439; Chung MI, 2012, DEV BIOL, V363, P155, DOI 10.1016/j.ydbio.2011.12.029; Darki F, 2012, BIOL PSYCHIAT, V72, P671, DOI 10.1016/j.biopsych.2012.05.008; Dennis MY, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000436; Devaiah BN, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00476; Efimenko E, 2005, DEVELOPMENT, V132, P1923, DOI 10.1242/dev.01775; Feng CZ, 2012, J BIOL CHEM, V287, P22730, DOI 10.1074/jbc.M111.338590; Forrest ARR, 2014, NATURE, V507, P462, DOI 10.1038/nature13182; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; GALABURDA AM, 1979, ANN NEUROL, V6, P94, DOI 10.1002/ana.410060203; GALABURDA AM, 1985, ANN NEUROL, V18, P222, DOI 10.1002/ana.410180210; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Grati M, 2015, HUM MOL GENET, V24, P2482, DOI 10.1093/hmg/ddv009; Guo JM, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8857; Henriksson J, 2013, METHOD ENZYMOL, V525, P327, DOI 10.1016/B978-0-12-397944-5.00016-X; Hildebrandt F, 2011, NEW ENGL J MED, V364, P1533, DOI 10.1056/NEJMra1010172; Hoh RA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052166; Hsu YC, 2012, J CELL BIOCHEM, V113, P2511, DOI 10.1002/jcb.24127; Ivliev AE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035618; Jolma A, 2010, GENOME RES, V20, P861, DOI 10.1101/gr.100552.109; Katusic SK, 2001, MAYO CLIN PROC, V76, P1081, DOI 10.4065/76.11.1081; Kellis M, 2014, P NATL ACAD SCI USA, V111, P6131, DOI 10.1073/pnas.1318948111; Kere J, 2014, BIOCHEM BIOPH RES CO, V452, P236, DOI 10.1016/j.bbrc.2014.07.102; Laurencon A, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r195; Lee JH, 2012, SCIENCE, V335, P966, DOI 10.1126/science.1213506; Lee JH, 2010, NEUROBIOL DIS, V38, P167, DOI 10.1016/j.nbd.2009.12.022; Lubelsky Y, 2005, MOL CELL BIOL, V25, P10665, DOI 10.1128/MCB.25.23.10665-10673.2005; Massinen S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020580; Meng HY, 2005, P NATL ACAD SCI USA, V102, P17053, DOI 10.1073/pnas.0508591102; Paracchini S, 2006, HUM MOL GENET, V15, P1659, DOI 10.1093/hmg/ddl089; Piasecki BP, 2010, P NATL ACAD SCI USA, V107, P12969, DOI 10.1073/pnas.0914241107; Purvis TL, 2010, GENE, V460, P20, DOI 10.1016/j.gene.2010.03.015; Reith W, 2001, ANNU REV IMMUNOL, V19, P331, DOI 10.1146/annurev.immunol.19.1.331; Rosen GD, 2007, CEREB CORTEX, V17, P2562, DOI 10.1093/cercor/bhl162; Sarkisian MR, 2015, NEUROSCIENTIST, V21, P136, DOI 10.1177/1073858414531074; Schueler M, 2015, AM J HUM GENET, V96, P81, DOI 10.1016/j.ajhg.2014.12.002; Schumacher J, 2006, AM J HUM GENET, V78, P52, DOI 10.1086/498992; Senti G, 2008, MOL BIOL CELL, V19, P5517, DOI 10.1091/mbc.E08-04-0416; SHAYWITZ SE, 1990, JAMA-J AM MED ASSOC, V264, P998, DOI 10.1001/jama.264.8.998; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Swoboda P, 2000, MOL CELL, V5, P411, DOI 10.1016/S1097-2765(00)80436-0; Taipale M, 2003, P NATL ACAD SCI USA, V100, P11553, DOI 10.1073/pnas.1833911100; Tammimies K, 2013, BIOL PSYCHIAT, V73, P583, DOI 10.1016/j.biopsych.2012.08.012; Tammimies K, 2012, MOL ENDOCRINOL, V26, P619, DOI 10.1210/me.2011-1376; Tapia-Paez I, 2008, FASEB J, V22, P3001, DOI 10.1096/fj.07-104455; Tarkar A, 2013, NAT GENET, V45, P995, DOI 10.1038/ng.2707; Thomas J, 2010, BIOL CELL, V102, P499, DOI 10.1042/BC20100035; Valente EM, 2014, NAT REV NEUROL, V10, P27, DOI 10.1038/nrneurol.2013.247; Wang Y, 2006, NEUROSCIENCE, V143, P515, DOI 10.1016/j.neuroscience.2006.08.022; Wolfe SA, 2008, J CELL BIOCHEM, V105, P61, DOI 10.1002/jcb.21793; Wolfe SA, 2006, J CELL BIOCHEM, V99, P735, DOI 10.1002/jcb.20959; Zeisel A, 2015, SCIENCE, V347, P1138, DOI 10.1126/science.aaa1934	64	16	16	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3578	3587		10.1096/fj.201500124RR	http://dx.doi.org/10.1096/fj.201500124RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27451412	Green Published, hybrid			2022-12-28	WOS:000384329800026
J	Nouar, R; Breuzard, G; Bastonero, S; Gorokhova, S; Barbier, P; Devred, F; Kovacic, H; Peyrot, V				Nouar, Roqiya; Breuzard, Gilles; Bastonero, Sonia; Gorokhova, Svetlana; Barbier, Pascale; Devred, Francois; Kovacic, Herve; Peyrot, Vincent			Direct evidence for the interaction of stathmin along the length and the plus end of microtubules in cells	FASEB JOURNAL			English	Article						oncoprotein 18; tubulin; binding; immuno-FRET; FRAP	CYCLE-REGULATED PHOSPHORYLATION; MULTISITE PHOSPHORYLATION; ENERGY-TRANSFER; ONCOPROTEIN 18; IN-VITRO; FLUORESCENCE RECOVERY; PHOSPHOPROTEIN FAMILY; DYNAMIC INSTABILITY; TUBULIN INTERACTION; PROTEIN-KINASE	Stathmin is a prominent destabilizer of microtubules (MTs). Extensive in vitro studies have strongly suggested that stathmin could act by sequestering tubulin and/or by binding to MT tips. In cells, the molecular mechanisms of stathmin binding to tubulin and/or MTs and its implications for the MT dynamics remain unexplored. By using immunofluorescence resonance energy transfer and fluorescence recovery after photobleaching, we analyzed the ability of stathmin and its phosphorylated forms (on Ser16, -25, -38, and -63) to interact with tubulin and MTs in A549 cells. Consistent with in vitro studies, we detected stathmin-tubulin interactions at the MT plus ends and in the cytosol. Of interest, we also observed a novel pool of stathmin bound along the MT. Expression of truncated stathmin and use of MT-stabilizing taxol further showed that the C-terminal domain of stathmin is the main contributor to this binding and that the phosphorylation state of stathmin plays a role in its binding along the MT wall. Our findings demonstrate that stathmin binds directly along the MT wall. This pool of stathmin would be readily available to participate in protofilament dissociation when the moving plus end of a depolymerizing MT reaches stathmin molecules.Nouar, R., Breuzard, G., Bastonero, S., Gorokhova, S., Barbier, P., Devred, F., Kovacic, H., Peyrot, V. Direct evidence for the interaction of stathmin along the length and the plus end of microtubules in cells.	[Nouar, Roqiya; Breuzard, Gilles; Bastonero, Sonia; Barbier, Pascale; Devred, Francois; Kovacic, Herve; Peyrot, Vincent] Aix Marseille Univ, INSERM, Fac Pharm, CRO2,UMR 911, Marseille, France; [Gorokhova, Svetlana] Aix Marseille Univ, INSERM, Fac Med, GMGF,UMR 910, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite	Breuzard, G; Peyrot, V (corresponding author), Aix Marseille Univ, INSERM, Fac Pharm, CRO2,UMR 911, Marseille, France.	gilles.breuzard@univ-amu.fr; vincent.peyrot@univ-amu.fr	breuzard, gilles/C-4735-2013; Devred, Francois/AAO-6337-2020; Barbier, Pascale/AAE-1781-2019; kovacic, hervé/ABF-2451-2020; Gorokhova, Svetlana/L-9380-2019	Devred, Francois/0000-0001-5990-8898; Gorokhova, Svetlana/0000-0001-6870-4061; breuzard, gilles/0000-0001-8178-2080	Institut National du Cancer, INSERM, and Direction Generale de l'Offre de Soin (DGOS) [Integrated Cancer Research Site (SIRIC) label]; Region Provence Alpes Cotes d'Azur and from ONET Technologies	Institut National du Cancer, INSERM, and Direction Generale de l'Offre de Soin (DGOS) [Integrated Cancer Research Site (SIRIC) label]; Region Provence Alpes Cotes d'Azur and from ONET Technologies(Region Provence-Alpes-Cote d'Azur)	The authors acknowledge the financial support of Institut National du Cancer, INSERM, and Direction Generale de l'Offre de Soin (DGOS) [Integrated Cancer Research Site (SIRIC) label]. R.N. received fellowships from Region Provence Alpes Cotes d'Azur and from ONET Technologies. The authors thank Prof. Andre Sobel (INSERM UMR 839, Universite Pierre et Marie Curie, Paris, France) for the gift of antisera containing rabbit polyclonal anti-pSer16, anti-pSer25, and anti-pSer38 antibodies. V.P. gratefully acknowledges the help of his private relationship, S. Boulay. Author contributions: R. Nouar, G. Breuzard, and S. Bastonero carried out the experimental work; S. Gorokhova generated plasmids Delta Cter-stathmin and Delta Nter-stathmin; R. Nouar, G. Breuzard, S. Bastonero, P. Barbier, F. Devred, and V. Peyrot participated in the data analysis and interpretation; R. Nouar, G. Breuzard, F. Devred, and V. Peyrot participated in the concept and design of the research; and R. Nouar, G. Breuzard, P. Barbier, F. Devred, H. Kovacic, and V. Peyrot wrote the paper. The authors declare no conflicts of interest.	Adebiyi A, 2010, CIRC RES, V106, P1603, DOI 10.1161/CIRCRESAHA.110.216804; Barbier P, 2010, J BIOL CHEM, V285, P31672, DOI 10.1074/jbc.M110.141929; Belletti B, 2011, EXPERT OPIN THER TAR, V15, P1249, DOI 10.1517/14728222.2011.620951; Belmont LD, 1996, CELL, V84, P623, DOI 10.1016/S0092-8674(00)81037-5; BRATTSAND G, 1994, EUR J BIOCHEM, V220, P359, DOI 10.1111/j.1432-1033.1994.tb18632.x; Breuzard G, 2013, J CELL SCI, V126, P2810, DOI 10.1242/jcs.120832; Cassimeris L, 2002, CURR OPIN CELL BIOL, V14, P18, DOI 10.1016/S0955-0674(01)00289-7; Charbaut E, 2001, J BIOL CHEM, V276, P16146, DOI 10.1074/jbc.M010637200; Curmi PA, 1997, J BIOL CHEM, V272, P25029, DOI 10.1074/jbc.272.40.25029; Curmi PA, 1999, CELL STRUCT FUNCT, V24, P345; Devred F, 2008, FEBS LETT, V582, P2484, DOI 10.1016/j.febslet.2008.06.035; Dompierre JP, 2007, J NEUROSCI, V27, P3571, DOI 10.1523/JNEUROSCI.0037-07.2007; Downing KH, 1998, EUR BIOPHYS J BIOPHY, V27, P431, DOI 10.1007/s002490050153; Feige JN, 2005, MICROSC RES TECHNIQ, V68, P51, DOI 10.1002/jemt.20215; Gavet O, 1998, J CELL SCI, V111, P3333; Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; GREEN KJ, 1983, CELL MOTIL CYTOSKEL, V3, P283, DOI 10.1002/cm.970030402; Gupta KK, 2013, P NATL ACAD SCI USA, V110, P20449, DOI 10.1073/pnas.1309958110; Hallen MA, 2008, BIOPHYS J, V95, P3048, DOI 10.1529/biophysj.108.134593; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Honnappa S, 2006, J BIOL CHEM, V281, P16078, DOI 10.1074/jbc.M513524200; Howell B, 1999, MOL BIOL CELL, V10, P105, DOI 10.1091/mbc.10.1.105; Jourdain L, 1997, BIOCHEMISTRY-US, V36, P10817, DOI 10.1021/bi971491b; Kenworthy AK, 2001, METHODS, V24, P289, DOI 10.1006/meth.2001.1189; Konig P, 2006, LAB INVEST, V86, P853, DOI 10.1038/labinvest.3700443; Krouglova T, 2003, FEBS LETT, V546, P365, DOI 10.1016/S0014-5793(03)00636-7; Kuntziger T, 2001, MOL BIOL CELL, V12, P437, DOI 10.1091/mbc.12.2.437; LARSSON N, 1995, J BIOL CHEM, V270, P14175, DOI 10.1074/jbc.270.23.14175; Larsson N, 1997, MOL CELL BIOL, V17, P5530, DOI 10.1128/MCB.17.9.5530; Leo MD, 2014, P NATL ACAD SCI USA, V111, P2361, DOI 10.1073/pnas.1317527111; Malesinski S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128704; MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977; Manna T, 2006, J BIOL CHEM, V281, P2071, DOI 10.1074/jbc.M510661200; Manna T, 2009, J BIOL CHEM, V284, P15640, DOI 10.1074/jbc.M900343200; MARKLUND U, 1993, J BIOL CHEM, V268, P15039; Marklund U, 1996, EMBO J, V15, P5290, DOI 10.1002/j.1460-2075.1996.tb00914.x; Martello LA, 2003, CANCER RES, V63, P1207; Mistry SJ, 1998, BIOCHEM J, V334, P23, DOI 10.1042/bj3340023; Niethammer P, 2004, SCIENCE, V303, P1862, DOI 10.1126/science.1094108; NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0; OSTLUND RE, 1979, ANAL BIOCHEM, V96, P155, DOI 10.1016/0003-2697(79)90568-2; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Phair RD, 2004, METHOD ENZYMOL, V375, P393; SAMMAK PJ, 1988, NATURE, V332, P724, DOI 10.1038/332724a0; Siegel R M, 2000, Sci STKE, V2000, ppl1, DOI 10.1126/stke.2000.38.pl1; SOBEL A, 1991, TRENDS BIOCHEM SCI, V16, P301, DOI 10.1016/0968-0004(91)90123-D; Sprague BL, 2004, BIOPHYS J, V86, P3473, DOI 10.1529/biophysj.103.026765; Steinmetz MO, 2000, EMBO J, V19, P572, DOI 10.1093/emboj/19.4.572; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; WALKER RA, 1988, J CELL BIOL, V107, P1437, DOI 10.1083/jcb.107.4.1437; Wang YL, 2007, J MICROSC-OXFORD, V228, P123, DOI 10.1111/j.1365-2818.2007.01834.x; Wilson L., 2010, MICROTUBULES; Wouters FS, 2001, TRENDS CELL BIOL, V11, P203, DOI 10.1016/S0962-8924(01)01982-1; Youvan D. C., 1997, BIOTECHNOLOGY, V3, P1	55	11	11	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3202	3215		10.1096/fj.201500125R	http://dx.doi.org/10.1096/fj.201500125R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27284003	Green Submitted			2022-12-28	WOS:000382816300020
J	Vazquez-Medina, JP; Dodia, C; Weng, LW; Mesaros, C; Blair, IA; Feinstein, SI; Chatterjee, S; Fisher, AB				Vazquez-Medina, Jose Pablo; Dodia, Chandra; Weng, Liwei; Mesaros, Clementina; Blair, Ian A.; Feinstein, Sheldon I.; Chatterjee, Shampa; Fisher, Aron B.			The phospholipase A(2) activity of peroxiredoxin 6 modulates NADPH oxidase 2 activation via lysophosphatidic acid receptor signaling in the pulmonary endothelium and alveolar macrophages	FASEB JOURNAL			English	Article						autotaxin; G-protein-coupled receptors; lysophosphatidylcholine; lysophospholipase D; rac	VASCULAR SMOOTH-MUSCLE; OXYGEN SPECIES PRODUCTION; UNSATURATED FATTY-ACIDS; EXCHANGE FACTOR TIAM1; CELL-FREE SYSTEM; HUMAN-NEUTROPHILS; SUPEROXIDE-PRODUCTION; LYSOPHOSPHOLIPASE-D; OXIDATIVE STRESS; RESPIRATORY BURST	Peroxiredoxin 6 (Prdx6) is essential for activation of NADPH oxidase type 2 (NOX2) in pulmonary microvascular endothelial cells (PMVECs), alveolar macrophages (AMs), and polymorphonuclear leukocytes. Angiotensin II and phorbol ester increased superoxide/H2O2 generation in PMVECs, AMs, and isolated lungs from wild-type (WT) mice, but had much less effect on cells or lungs from Prdx6-null or Prdx6-D140A-knock-in mice that lack the phospholipase A(2) activity (PLA(2)) of Prdx6; addition of either lysophosphatidylcholine (LPC) or lysophosphatidic acid (LPA) to cells restored their oxidant generation. The generation of LPC by PMVECs required Prdx6-PLA(2). We propose that Prdx6-PLA2 modulates NOX2 activation by generation of LPC that is converted to LPA by the lysophospholipase D activity of autotaxin (ATX/lysoPLD). Inhibition of lysoPLD with HA130 (cells, 10 mu M; lungs, 20 mM; IC50, 29 nM) decreased agonist-induced oxidant generation. LPA stimulates pathways regulated by small GTPases through binding to G-protein-coupled LPA receptors (LPARs). The LPAR blocker Ki16425 (cells, 10 mu M; lungs, 25 mu M; K-i, 0.34 mu M) or cellular knockdown of LPAR type 1 decreased oxidant generation and blocked translocation of rac1 to plasma membrane. Thus, Prdx6-PLA(2) modulates NOX2 activation through generation of LPC for conversion to LPA; binding of LPA to LPAR1 signals rac activation.	[Vazquez-Medina, Jose Pablo; Dodia, Chandra; Feinstein, Sheldon I.; Chatterjee, Shampa; Fisher, Aron B.] Univ Penn, Perelman Sch Med, Inst Environm Med, Dept Physiol, Philadelphia, PA USA; [Weng, Liwei; Mesaros, Clementina; Blair, Ian A.] Univ Penn, Perelman Sch Med, Ctr Canc Pharmacol, Philadelphia, PA USA; [Weng, Liwei; Mesaros, Clementina; Blair, Ian A.] Univ Penn, Perelman Sch Med, Ctr Excellence Environm Toxicol, Dept Pharmacol, Philadelphia, PA USA	University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; Pennsylvania Medicine	Fisher, AB (corresponding author), Univ Penn, Inst Environm Med, 3620 Hamilton Walk,1 John Morgan Bldg, Philadelphia, PA 19104 USA.	abf@mail.med.upenn.edu	Vazquez-Medina, Jose Pablo/AAH-8432-2020	Vazquez-Medina, Jose Pablo/0000-0003-1014-5214	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL-R01-105509, 1F32HL127972]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL102016, F32HL127972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES013508, T32ES019851] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Drs. Viswanathan Natarajan (University of Illinois at Chicago, Chicago, IL, USA) for helpful criticism and advice, Su Nguyen (University of Pennsylvania) for performing the initial studies for the project, Suiping Zhou (University of Pennsylvania) for advice regarding shRNA, Madesh Muniswamy (Temple University, Philadelphia, PA, USA) for sharing the HyPer-expressing PMVECs, Jian-Qin Tao (University of Pennsylvania) for isolation of AMs, and Elena Sorokina (University of Pennsylvania) for assistance with multiphoton imaging. Presented in part at the 2014 and 2015 Experimental Biology Meetings, the 2014 meeting of the Society for Free Radicals in Biology and Medicine, and the 2015 FASEB conference on Lysophospholipids and Related Mediators. Research was funded by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute grant HL-R01-105509 (to A.B.F.) and 1F32HL127972 (to J.P.V.-M.).	Akiba S, 1998, COMP BIOCHEM PHYS B, V120, P393, DOI 10.1016/S0305-0491(98)10046-9; Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Ambruso DR, 2012, BBA-MOL CELL RES, V1823, P306, DOI 10.1016/j.bbamcr.2011.11.014; Babior BM, 1999, BLOOD, V93, P1464, DOI 10.1182/blood.V93.5.1464.405a32_1464_1476; BADWEY JA, 1981, J BIOL CHEM, V256, P2640; Bedard K, 2007, PHYSIOL REV, V87, P245, DOI 10.1152/physrev.00044.2005; Benipal B, 2015, REDOX BIOL, V4, P321, DOI 10.1016/j.redox.2015.01.011; Bernard K, 2014, ANTIOXID REDOX SIGN, V20, P2838, DOI 10.1089/ars.2013.5608; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Bostan M, 2003, J CELL MOL MED, V7, P57, DOI 10.1111/j.1582-4934.2003.tb00203.x; Brandes RP, 2008, TRENDS CARDIOVAS MED, V18, P15, DOI 10.1016/j.tcm.2007.11.001; Brandes RP, 2014, FREE RADICAL BIO MED, V76, P208, DOI 10.1016/j.freeradbiomed.2014.07.046; Brault S, 2007, AM J PHYSIOL-REG I, V292, pR1174, DOI 10.1152/ajpregu.00619.2006; BROMBERG Y, 1984, CELL IMMUNOL, V88, P213, DOI 10.1016/0008-8749(84)90066-2; BROMBERG Y, 1983, CELL IMMUNOL, V79, P240, DOI 10.1016/0008-8749(83)90067-9; Buchanan FG, 2000, J BIOL CHEM, V275, P9742, DOI 10.1074/jbc.275.13.9742; Burke JE, 2009, J LIPID RES, V50, pS237, DOI 10.1194/jlr.R800033-JLR200; Chatterjee S, 2011, J BIOL CHEM, V286, P11696, DOI 10.1074/jbc.M110.206623; Chen CG, 2012, ATHEROSCLEROSIS, V222, P74, DOI 10.1016/j.atherosclerosis.2012.02.010; Cheng GJ, 2001, GENE, V269, P131, DOI 10.1016/S0378-1119(01)00449-8; Damico R, 2012, AM J RESP CELL MOL, V47, P129, DOI 10.1165/rcmb.2010-0331RT; DANA R, 1994, BIOCHEM J, V297, P217, DOI 10.1042/bj2970217; Dana R, 1998, J BIOL CHEM, V273, P441, DOI 10.1074/jbc.273.1.441; Dikalov SI, 2014, ANTIOXID REDOX SIGN, V20, P281, DOI 10.1089/ars.2012.4918; Fan LM, 2014, CIRCULATION, V129, P2661, DOI 10.1161/CIRCULATIONAHA.113.005062; Fisher AB, 2005, J LIPID RES, V46, P1248, DOI 10.1194/jlr.M400499-JLR200; Fisher AB, 2001, AM J PHYSIOL-LUNG C, V280, pL748, DOI 10.1152/ajplung.2001.280.4.L748; Fisher AB, 1996, J LIPID RES, V37, P1057; FORMAN HJ, 1980, J BIOL CHEM, V255, P9879; Idzko M, 2004, J IMMUNOL, V172, P4480, DOI 10.4049/jimmunol.172.7.4480; Inoue N, 2001, ATHEROSCLEROSIS, V155, P45, DOI 10.1016/S0021-9150(00)00530-X; Itagaki K, 2005, J LEUKOCYTE BIOL, V77, P181, DOI 10.1189/jlb.0704390; Jia SJ, 2006, VASC PHARMACOL, V44, P143, DOI 10.1016/j.vph.2005.09.005; Kalari S, 2009, AM J PHYSIOL-LUNG C, V296, pL328, DOI 10.1152/ajplung.90431.2008; Kaneyuki U, 2007, VASC PHARMACOL, V46, P286, DOI 10.1016/j.vph.2006.11.002; Kim TS, 1997, J BIOL CHEM, V272, P2542; Klomsiri C, 2014, FREE RADICAL BIO MED, V71, P49, DOI 10.1016/j.freeradbiomed.2014.03.017; Kuhlmann CRW, 2004, J MOL CELL CARDIOL, V36, P675, DOI 10.1016/j.yjmcc.2004.03.001; Lee I, 2014, AM J PHYSIOL-LUNG C, V306, pL635, DOI 10.1152/ajplung.00374.2013; Lee I, 2013, J PHARMACOL EXP THER, V345, P284, DOI 10.1124/jpet.112.201079; Lee Z, 2008, MOL BIOL CELL, V19, P5435, DOI 10.1091/mbc.E08-03-0316; Li H, 2015, FREE RADICAL BIO MED, V87, P356, DOI 10.1016/j.freeradbiomed.2015.06.009; Liu G, 2010, FREE RADICAL BIO MED, V49, P1172, DOI 10.1016/j.freeradbiomed.2010.07.002; MALLILANKARAMAN K, 2011, JOVE-J VIS EXP, V21, P3511; Manevich Y, 2007, J LIPID RES, V48, P2306, DOI 10.1194/jlr.M700299-JLR200; Mankelow TJ, 2003, BIOCHEM J, V374, P315, DOI 10.1042/BJ20030495; Matono R, 2014, J BIOL CHEM, V289, P24874, DOI 10.1074/jbc.M114.581785; Mayeenuddin LH, 2006, J BIOL CHEM, V281, P1921, DOI 10.1074/jbc.M506035200; Mo YQ, 2003, FEBS LETT, V555, P192, DOI 10.1016/S0014-5793(03)01199-2; Moolenaar WH, 2011, NAT REV MOL CELL BIO, V12, P674, DOI 10.1038/nrm3188; Murakami M, 2002, J BIOCHEM, V131, P285, DOI 10.1093/oxfordjournals.jbchem.a003101; Nishioka H, 1998, FEBS LETT, V441, P63, DOI 10.1016/S0014-5793(98)01526-9; O'Donnell RW, 2003, ENDOTHELIUM-J ENDOTH, V10, P291, DOI 10.1080/10623320390272280; OHARA Y, 1994, ARTERIOSCLER THROMB, V14, P1007, DOI 10.1161/01.ATV.14.6.1007; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Pick E, 2014, METHODS MOL BIOL, V1124, P339, DOI 10.1007/978-1-62703-845-4_22; Rubin BB, 2005, J BIOL CHEM, V280, P7519, DOI 10.1074/jbc.M407438200; Schmitz U, 2002, BIOCHEM BIOPH RES CO, V291, P687, DOI 10.1006/bbrc.2002.6493; Sevastou I, 2013, BBA-MOL CELL BIOL L, V1831, P42, DOI 10.1016/j.bbalip.2012.07.019; Shlyonsky V, 2014, PULM CIRC, V4, P471, DOI 10.1086/677362; SHPUNGIN S, 1989, J BIOL CHEM, V264, P9195; Silliman CC, 2003, J LEUKOCYTE BIOL, V73, P511, DOI 10.1189/jlb.0402179; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Staiculescu MC, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00413; Swaney JS, 2010, BRIT J PHARMACOL, V160, P1699, DOI 10.1111/j.1476-5381.2010.00828.x; Tager AM, 2008, NAT MED, V14, P45, DOI 10.1038/nm1685; Takeshita S, 2000, J Atheroscler Thromb, V7, P238; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Leeuwen FN, 2003, J BIOL CHEM, V278, P400, DOI 10.1074/jbc.M210151200; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Wu Y, 2009, BIOCHEM J, V419, P669, DOI 10.1042/BJ20082061; Yamakawa T, 2002, ARTERIOSCL THROM VAS, V22, P752, DOI 10.1161/01.ATV.0000015903.02749.71; Yung YC, 2014, J LIPID RES, V55, P1192, DOI 10.1194/jlr.R046458; Zhao XX, 2002, J BIOL CHEM, V277, P25385, DOI 10.1074/jbc.M203630200	75	47	47	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2885	2898		10.1096/fj.201500146R	http://dx.doi.org/10.1096/fj.201500146R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27178323	Green Published			2022-12-28	WOS:000380994000023
J	Wu, JJ; Gao, B; Zhu, SY				Wu, Jiajia; Gao, Bin; Zhu, Shunyi			Single-point mutation-mediated local amphipathic adjustment dramatically enhances antibacterial activity of a fungal defensin	FASEB JOURNAL			English	Article						micasin; peptide structure; MRSA	PRECURSOR LIPID II; ANTIMICROBIAL PEPTIDES; STAPHYLOCOCCUS-WARNERI; EPITHELIAL-CELLS; NATURAL-PRODUCTS; CYSTIC-FIBROSIS; ALPHA-DEFENSINS; BINDING; ANTIBIOTICS; PLECTASIN	The emergence and rapid spread of multiresistant bacteria has lead to an urgent need for novel anti-microbials. Based on single-point substitutions, we generated a series of mutants of micasin, a dermatophytic defensin, with enhanced activities against multiple clinical isolates of Staphylococcus species, including 4 antibiotic-resistant strains. We first mapped the functional surface of micasin by alanine-scanning mutational analysis of its highly exposed residues, through which we found that substitution of site 8 (acidic Glu) dramatically enhanced bacterial killing of this peptide. Structural analysis indicates that this single point mutation could result in a functional local amphipathic architecture. Four different types of side chains (hydrophobic, cationic polar, neutral polar, and acidic polar) were introduced at site 8 to clarify the role of this local architecture in micasin function. The results show that all mutants displayed increased antibacterial activity with the exception of the acidic replacement. These mutants with enhanced activity exhibited low hemolysis and cytotoxicity and showed high serum stability, indicating their therapeutic potential. Our work represents the first example of structural fine-tuning to largely improve the antibacterial potency of a dermatophytic defensin.	[Wu, Jiajia; Gao, Bin; Zhu, Shunyi] Chinese Acad Sci, Inst Zool, State Key Lab Integrated Management Pest Insects, Grp Peptide Biol & Evolut, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS	Zhu, SY (corresponding author), Chinese Acad Sci, 1 Beichen West Rd, Beijing 100101, Peoples R China.	zhusy@ioz.ac.cn			National Natural Science Foundation of China [31570773]; State Key Laboratory of Integrated Management of Pest Insects and Rodents [ChineseIPM1307, ChineseIPM1405, ChineseIPM1512]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Key Laboratory of Integrated Management of Pest Insects and Rodents	This work was supported by National Natural Science Foundation of China (Grant 31570773) and State Key Laboratory of Integrated Management of Pest Insects and Rodents (Grants ChineseIPM1307, ChineseIPM1405, and ChineseIPM1512). The authors declare no conflicts of interest.	Announ N, 2004, JOINT BONE SPINE, V71, P240, DOI 10.1016/S1297-319X(03)00126-X; Ashitani J, 2004, LIFE SCI, V75, P1123, DOI 10.1016/j.lfs.2004.01.028; Breukink E, 2006, NAT REV DRUG DISCOV, V5, P321, DOI 10.1038/nrd2004; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Butler MS, 2006, BIOCHEM PHARMACOL, V71, P919, DOI 10.1016/j.bcp.2005.10.012; Carlier L, 2015, BIOPHYS CHEM, V196, P40, DOI 10.1016/j.bpc.2014.09.004; Clinical and Laboratory Standards Institute, 2006, M7A7 CLIN LAB STAND; Coates ARM, 2011, BRIT J PHARMACOL, V163, P184, DOI 10.1111/j.1476-5381.2011.01250.x; DAN M, 1984, CAN MED ASSOC J, V131, P211; Dathe M, 1999, BBA-BIOMEMBRANES, V1462, P71, DOI 10.1016/S0005-2736(99)00201-1; Deslouches B, 2005, ANTIMICROB AGENTS CH, V49, P316, DOI 10.1128/AAC.49.1.316-322.2005; Eckert R, 2011, FUTURE MICROBIOL, V6, P635, DOI [10.2217/fmb.11.27, 10.2217/FMB.11.27]; Fjell CD, 2012, NAT REV DRUG DISCOV, V11, P37, DOI 10.1038/nrd3591; Gao B, 2010, DEV COMP IMMUNOL, V34, P659, DOI 10.1016/j.dci.2010.01.012; Gao B, 2009, FASEB J, V23, P1230, DOI 10.1096/fj.08-122317; Hancock REW, 2006, NAT BIOTECHNOL, V24, P1551, DOI 10.1038/nbt1267; Hasper HE, 2006, SCIENCE, V313, P1636, DOI 10.1126/science.1129818; Hsu STD, 2004, NAT STRUCT MOL BIOL, V11, P963, DOI 10.1038/nsmb830; HULTMARK D, 1982, EUR J BIOCHEM, V127, P207, DOI 10.1111/j.1432-1033.1982.tb06857.x; Hultmark D., 1998, TECHNIQUES INSECT IM, P103; Jain VP, 2011, INT J MOL SCI, V12, P1431, DOI 10.3390/ijms12031431; JENSEN T, 1987, J ANTIMICROB CHEMOTH, V19, P831, DOI 10.1093/jac/19.6.831; KAMATH U, 1992, J CLIN MICROBIOL, V30, P261, DOI 10.1128/JCM.30.2.261-264.1992; Landon C, 2008, PROTEINS, V72, P229, DOI 10.1002/prot.21912; LEHRER RI, 1993, ANNU REV IMMUNOL, V11, P105, DOI 10.1146/annurev.iy.11.040193.000541; Ling LL, 2015, NATURE, V517, P455, DOI 10.1038/nature14098; Marr AK, 2006, CURR OPIN PHARMACOL, V6, P468, DOI 10.1016/j.coph.2006.04.006; Matsuzaki K, 1999, BBA-BIOMEMBRANES, V1462, P1, DOI 10.1016/S0005-2736(99)00197-2; Mishra B, 2012, J AM CHEM SOC, V134, P12426, DOI 10.1021/ja305644e; Monk BC, 2014, P NATL ACAD SCI USA, V111, P3865, DOI 10.1073/pnas.1324245111; Mukae H, 2002, THORAX, V57, P623, DOI 10.1136/thorax.57.7.623; Mygind PH, 2005, NATURE, V437, P975, DOI 10.1038/nature04051; NEU HC, 1992, SCIENCE, V257, P1064, DOI 10.1126/science.257.5073.1064; Oeemig JS, 2012, J BIOL CHEM, V287, P42361, DOI 10.1074/jbc.M112.382028; OKRENT DG, 1990, AM REV RESPIR DIS, V141, P179, DOI 10.1164/ajrccm/141.1.179; Romestand B, 2003, EUR J BIOCHEM, V270, P2805, DOI 10.1046/j.1432-1033.2003.03657.x; Schneider T, 2010, SCIENCE, V328, P1168, DOI 10.1126/science.1185723; Schroeder BO, 2011, NATURE, V469, P419, DOI 10.1038/nature09674; Shai Y, 1999, BBA-BIOMEMBRANES, V1462, P55, DOI 10.1016/S0005-2736(99)00200-X; Shi N, 2014, ONCOTARGET, V5, P11333, DOI 10.18632/oncotarget.2416; Singh SB, 2006, BIOCHEM PHARMACOL, V71, P1006, DOI 10.1016/j.bcp.2005.12.016; Smrt ST, 2015, J BIOL CHEM, V290, P228, DOI 10.1074/jbc.M114.611657; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Vaara M, 2009, CURR OPIN PHARMACOL, V9, P571, DOI 10.1016/j.coph.2009.08.002; VanWetering S, 1997, J LEUKOCYTE BIOL, V62, P217, DOI 10.1002/jlb.62.2.217; vanWetering S, 1997, AM J PHYSIOL-LUNG C, V272, pL888, DOI 10.1152/ajplung.1997.272.5.L888; WEISS MA, 1990, NATURE, V347, P575, DOI 10.1038/347575a0; Wiedemann I, 2001, J BIOL CHEM, V276, P1772, DOI 10.1074/jbc.M006770200; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xiong YQ, 2011, ANTIMICROB AGENTS CH, V55, P5325, DOI 10.1128/AAC.00453-11; Yount NY, 2006, BBA-BIOMEMBRANES, V1758, P1373, DOI 10.1016/j.bbamem.2006.03.027; Yount NY, 2004, P NATL ACAD SCI USA, V101, P7363, DOI 10.1073/pnas.0401567101; Zhang LJ, 2005, ANTIMICROB AGENTS CH, V49, P2921, DOI 10.1128/AAC.49.7.2921-2927.2005; Zhu SY, 2008, MOL IMMUNOL, V45, P828, DOI 10.1016/j.molimm.2007.06.354; Zhu SY, 2012, P NATL ACAD SCI USA, V109, P8495, DOI 10.1073/pnas.1201263109	55	14	15	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2602	2614		10.1096/fj.201500157	http://dx.doi.org/10.1096/fj.201500157			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27084888				2022-12-28	WOS:000379249500015
J	Egawa, J; Schilling, JM; Cui, WH; Posadas, E; Sawada, A; Alas, B; Zemljic-Harpf, AE; Fannon-Pavlich, MJ; Mandyam, CD; Roth, DM; Patel, HH; Patel, PM; Head, BP				Egawa, Junji; Schilling, Jan M.; Cui, Weihua; Posadas, Edmund; Sawada, Atsushi; Alas, Basheer; Zemljic-Harpf, Alice E.; Fannon-Pavlich, McKenzie J.; Mandyam, Chitra D.; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.; Head, Brian P.			Neuron-specific caveolin-1 overexpression improves motor function and preserves memory in mice subjected to brain trauma	FASEB JOURNAL			English	Article						neuroprotection; MLRs; hippocampus; fear conditioning; inverted grid	MEMBRANE-LIPID RAFTS; ALZHEIMERS-DISEASE; INJURY; EXPRESSION; NEUROINFLAMMATION; MODULATION; ACTIVATION; IMPAIRMENT; PLASTICITY; PROTECTION	Studies in vitro and in vivo demonstrate that membrane/lipid rafts and caveolin (Cav) organize progrowth receptors, and, when overexpressed specifically in neurons, Cav-1 augments neuronal signaling and growth and improves cognitive function in adult and aged mice; however, whether neuronal Cav-1 overexpression can preserve motor and cognitive function in the brain trauma setting is unknown. Here, we generated a neuron-targeted Cav-1-overexpressing transgenic (Tg) mouse [synapsin-driven Cav-1 (SynCav1 Tg)] and subjected it to a controlled cortical impact model of brain trauma and measured biochemical, anatomic, and behavioral changes. SynCav1 Tg mice exhibited increased hippocampal expression of Cav-1 and membrane/lipid raft localization of postsynaptic density protein 95, NMDA receptor, and tropomyosin receptor kinase B. When subjected to a controlled cortical impact, SynCav1 Tg mice demonstrated preserved hippocampus-dependent fear learning and memory, improved motor function recovery, and decreased brain lesion volume compared with wild-type controls. Neuron-targeted overexpression of Cav-1 in the adult brain prevents hippocampus-dependent learning and memory deficits, restores motor function after brain trauma, and decreases brain lesion size induced by trauma. Our findings demonstrate that neuron-targeted Cav-1 can be used as a novel therapeutic strategy to restore brain function and prevent trauma associated maladaptive plasticity.	[Egawa, Junji; Schilling, Jan M.; Cui, Weihua; Posadas, Edmund; Sawada, Atsushi; Alas, Basheer; Zemljic-Harpf, Alice E.; Fannon-Pavlich, McKenzie J.; Mandyam, Chitra D.; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.; Head, Brian P.] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Egawa, Junji; Schilling, Jan M.; Cui, Weihua; Posadas, Edmund; Sawada, Atsushi; Alas, Basheer; Zemljic-Harpf, Alice E.; Roth, David M.; Patel, Hemal H.; Patel, Piyush M.; Head, Brian P.] Univ Calif San Diego, Sch Med, Dept Anesthesiol, La Jolla, CA 92093 USA; [Egawa, Junji] Nara Med Univ, Dept Anesthesiol, Kashihara, Nara, Japan; [Cui, Weihua] Capital Med Univ, Beijing Tiantan Hosp, Dept Anesthesiol, Beijing, Peoples R China	US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System; University of California System; University of California San Diego; Nara Medical University; Capital Medical University	Head, BP (corresponding author), Univ Calif San Diego, Dept Anesthesiol, VASDHS 9125,3350 La Jolla Village Dr, San Diego, CA 92161 USA.	bhead@ucsd.edu	mandyam, chitra/C-9189-2013; Patel, Hemal/C-7325-2019	mandyam, chitra/0000-0002-7354-205X; Patel, Hemal/0000-0001-6722-9625	Department of Veterans Affairs [BX001225, BX000783, BX001963]; U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant [NS073653]; NIH National Heart, Lung, and Blood Institute [HL091071, HL107200, HL066941, HL115933]; NIH National Institute on Drug Abuse Grant [DA034140]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL091071, R01HL107200, P01HL066941, R01HL115933] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS073653] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA034140] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000783, I01BX003671, I01BX001963, I01BX001225] Funding Source: NIH RePORTER	Department of Veterans Affairs(US Department of Veterans Affairs); U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute on Drug Abuse Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by the Department of Veterans Affairs (Grants BX001225 to B.P.H., BX000783 to D.M.R., and BX001963 to H.H.P.), the U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant NS073653 (to B.P.H.), NIH National Heart, Lung, and Blood Institute Grants HL091071 (to H.H.P.), HL107200, HL066941, and HL115933 (to H.H.P. and D.M.R.), and NIH National Institute on Drug Abuse Grant DA034140 (to C.D.M.). The authors declare no conflicts of interest.	Atkins CM, 2007, EXP NEUROL, V208, P145, DOI 10.1016/j.expneurol.2007.08.011; Atkins CM, 2013, NEUROSCI LETT, V532, P1, DOI 10.1016/j.neulet.2012.10.019; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Butler CW, 2015, LEARN MEMORY, V22, P370, DOI 10.1101/lm.037663.114; Carlson CG, 2010, J NEUROSCI METH, V186, P226, DOI 10.1016/j.jneumeth.2009.11.006; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Egawa J, 2016, J PHYSIOL-LONDON, V594, P4565, DOI 10.1113/JP270590; English AW, 2013, P NATL ACAD SCI USA, V110, P16217, DOI 10.1073/pnas.1303646110; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Glover CPJ, 2002, MOL THER, V5, P509, DOI 10.1006/mthe.2002.0588; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guirland C, 2007, ADV EXP MED BIOL, V621, P144, DOI 10.1007/978-0-387-76715-4_11; Head BP, 2008, FASEB J, V22, P828, DOI 10.1096/fj.07-9299com; Head BP, 2014, BBA-BIOMEMBRANES, V1838, P532, DOI 10.1016/j.bbamem.2013.07.018; Head BP, 2011, J BIOL CHEM, V286, P33310, DOI 10.1074/jbc.M111.255976; Huot P, 2014, NEUROPHARMACOLOGY, V82, P76, DOI 10.1016/j.neuropharm.2014.01.012; Institute of Medicine of the National Academies, 2006, AMY LAT SCLER VET RE; Israelsson C, 2014, RESTOR NEUROL NEUROS, V32, P717, DOI 10.3233/RNN-140419; Kaminska K, 2013, PHARMACOL REP, V65, P1144, DOI 10.1016/S1734-1140(13)71472-5; Kassan A, 2017, J NEUROPHYSIOL, V117, P436, DOI 10.1152/jn.00481.2016; King PR, 2015, MIL MED, V180, P863, DOI 10.7205/MILMED-D-14-00472; Krajewska M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024341; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lew HL, 2009, J REHABIL RES DEV, V46, P819, DOI 10.1682/JRRD.2008.09.0129; Lew HL, 2009, J REHABIL RES DEV, V46, P697, DOI 10.1682/JRRD.2009.01.0006; Ma J, 2013, NEUROCHEM INT, V62, P84, DOI 10.1016/j.neuint.2012.11.010; Ma MR, 2012, J NEUROTRAUM, V29, P445, DOI 10.1089/neu.2011.2060; Mandyam CD, 2004, J NEUROSCI RES, V76, P783, DOI 10.1002/jnr.20090; Mandyam CD, 2017, BIOL PSYCHIAT, V81, P101, DOI 10.1016/j.biopsych.2015.09.020; Niesman IR, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-39; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Sharp DJ, 2014, INT PSYCHOGERIATR, V26, P1591, DOI 10.1017/S1041610214001689; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Suzuki S, 2004, J CELL BIOL, V167, P1205, DOI 10.1083/jcb.200404106; Suzuki S, 2007, J NEUROSCI, V27, P6417, DOI 10.1523/JNEUROSCI.0690-07.2007; Titus DJ, 2013, J NEUROSCI, V33, P5216, DOI 10.1523/JNEUROSCI.5133-12.2013; Tsutsumi YM, 2008, CIRCULATION, V118, P1979, DOI 10.1161/CIRCULATIONAHA.108.788331; Vincent AS, 2014, ALZHEIMERS DEMENT, V10, pS174, DOI 10.1016/j.jalz.2014.04.006; Zonta Barbara, 2013, Front Synaptic Neurosci, V5, P9, DOI 10.3389/fnsyn.2013.00009	43	16	17	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3403	3411		10.1096/fj.201601288RRR	http://dx.doi.org/10.1096/fj.201601288RRR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28450301	Green Published			2022-12-28	WOS:000405932400019
J	Fusco, R; Gugliandolo, E; Biundo, F; Campolo, M; Di Paola, R; Cuzzocrea, S				Fusco, Roberta; Gugliandolo, Enrico; Biundo, Flavia; Campolo, Michela; Di Paola, Rosanna; Cuzzocrea, Salvatore			Inhibition of inflammasome activation improves lung acute injury induced by carrageenan in a mouse model of pleurisy	FASEB JOURNAL			English	Article						BAY 11-7082; BBG; pathway; Nf-kappa B	KAPPA-B ACTIVATION; NLRP3 INFLAMMASOME; OXIDATIVE STRESS; P2X(7) RECEPTOR; P2X7 RECEPTOR; NITRIC-OXIDE; SYNTHASE; RELEASE; DISEASE; ASTHMA	The inflammasome NLRP3 is a molecular pathway activated by a wide range of cellular insults to elicit innate immune defenses through the activation of caspase-1 and the maturation of proinflammatory cytokines, such as IL-1 beta and IL-18. The expression of NRLP3 is abnormally elevated in numerous human inflammatory diseases, including pulmonary diseases. An injection of carrageenan (CAR) into the pleural cavity triggered an acute inflammatory response, leading to tissue damage, inflammatory exudates, leukocyte infiltration, and increased myeloperoxidase activity. The aim of this study was to assess the effect of the inflammasome blocking agents BAY 11-7082 (30 mg/kg, i.p.) and Brilliant Blue G (BBG) (45.5 mg/kg, i.p.) in a mouse model of CAR-induced pleurisy. Treatment with BAY 11-7082 or BBG 1 h after CAR injection attenuated pulmonary membrane thickening and polymorphonuclear leukocyte infiltration, reduced NF-kappa B translocation in the nucleus, and inhibited the assembly of the NRLP3/ASC/caspase-1 complex. Treatment with BAY 11-7082 or BBG also down-regulated iNOS, nitrotyrosine, and poly-ADP-ribosyl polymerase expression and inhibited CAR-induced apoptosis. Our results demonstrate that treatment with inflammasome-blocking agents can significantly reduce the development of acute CAR-induced lung injury.	[Fusco, Roberta; Gugliandolo, Enrico; Biundo, Flavia; Campolo, Michela; Di Paola, Rosanna; Cuzzocrea, Salvatore] Univ Messina, Dept Chem Biol Pharmaceut & Environm Sci, Messina, Italy; [Cuzzocrea, Salvatore] St Louis Univ, Sch Med, Dept Pharmacol & Physiol Sci, St Louis, MO 63104 USA	University of Messina; Saint Louis University	Di Paola, R; Cuzzocrea, S (corresponding author), Univ Messina, Dept Biol & Environm Sci, Viale Ferdinando Stagno DAlcontres, I-98166 Messina, Italy.	dipaolar@unime.it; salvator@unime.it	Gugliandolo, Enrico/AAB-9972-2019; di paola, rosanna/U-4356-2019; Campolo, Michela/K-6432-2016; FUSCO, Roberta/AAC-1745-2019	Gugliandolo, Enrico/0000-0001-6840-3154; di paola, rosanna/0000-0001-6725-8581; FUSCO, Roberta/0000-0003-0223-1403; Cuzzocrea, Salvatore/0000-0001-6131-3690; Campolo, Michela/0000-0002-5124-3876				Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Belete HA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027469; Bowie A, 2000, BIOCHEM PHARMACOL, V59, P13, DOI 10.1016/S0006-2952(99)00296-8; Burnstock G, 2011, ADV PHARMACOL, V61, P333, DOI 10.1016/B978-0-12-385526-8.00011-4; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Cuzzocrea S, 1998, EUR J PHARMACOL, V342, P67, DOI 10.1016/S0014-2999(97)01417-9; Cuzzocrea S, 2000, AM J RESP CRIT CARE, V162, P1859, DOI 10.1164/ajrccm.162.5.9912125; Cuzzocrea S, 2006, J LEUKOCYTE BIOL, V79, P999, DOI 10.1189/jlb.0605341; Denlinger LC, 2009, AM J RESP CRIT CARE, V179, P265, DOI 10.1164/rccm.200802-293OC; Diaz-Hernandez M, 2009, FASEB J, V23, P1893, DOI 10.1096/fj.08-122275; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Dostert C, 2008, SCIENCE, V320, P674, DOI 10.1126/science.1156995; Eltom S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024097; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Ferrari D, 2006, J IMMUNOL, V176, P3877, DOI 10.4049/jimmunol.176.7.3877; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Grailer JJ, 2014, J IMMUNOL, V192, P5974, DOI 10.4049/jimmunol.1400368; Gu Y, 1997, SCIENCE, V275, P206, DOI 10.1126/science.275.5297.206; Impellizzeri D, 2011, EUR J PHARMACOL, V668, P305, DOI 10.1016/j.ejphar.2011.06.049; Impellizzeri D, 2011, CLIN NUTR, V30, P533, DOI 10.1016/j.clnu.2011.02.004; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kon OM, 2001, EUR RESPIR J, V18, P45, DOI 10.1183/09031936.01.00064101; Martinon F, 2005, TRENDS IMMUNOL, V26, P447, DOI 10.1016/j.it.2005.06.004; Minutoli L, 2015, J PHARMACOL EXP THER, V355, P370, DOI 10.1124/jpet.115.226936; Moncao-Ribeiro LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110185; Moncao-Ribeiro LC, 2011, RESP PHYSIOL NEUROBI, V179, P314, DOI 10.1016/j.resp.2011.09.015; MULLANE KM, 1985, J PHARMACOL METHOD, V14, P157, DOI 10.1016/0160-5402(85)90029-4; Oliveira C, 2010, BRIT J PHARMACOL, V161, P899, DOI 10.1111/j.1476-5381.2010.00924.x; Proell M, 2013, BIOCHEM J, V449, P613, DOI 10.1042/BJ20121198; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Said-Sadier Najwane, 2012, Biomed J, V35, P437, DOI 10.4103/2319-4170.104408; Salvemini D, 1996, BRIT J PHARMACOL, V118, P829, DOI 10.1111/j.1476-5381.1996.tb15475.x; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Stutz Andrea, 2013, Methods Mol Biol, V1040, P91, DOI 10.1007/978-1-62703-523-1_8; THORNBERRY NA, 1992, NATURE, V356, P768, DOI 10.1038/356768a0; Uberti D, 2004, BIOCHEM PHARMACOL, V67, P1743, DOI 10.1016/j.bcp.2004.01.012; Wang Cheng-yi, 2015, Zhongguo Yi Xue Ke Xue Yuan Xue Bao, V37, P618, DOI 10.3881/j.issn.1000-503X.2015.05.022; Ward PA, 2010, ANN NY ACAD SCI, V1203, P53, DOI 10.1111/j.1749-6632.2010.05552.x; Woods LT, 2012, AM J PHYSIOL-CELL PH, V303, pC790, DOI 10.1152/ajpcell.00072.2012; Yamin TT, 1996, J BIOL CHEM, V271, P13273, DOI 10.1074/jbc.271.22.13273; Zhao JJ, 2013, INT IMMUNOPHARMACOL, V17, P116, DOI 10.1016/j.intimp.2013.05.027	41	40	41	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3497	3511		10.1096/fj.201601349R	http://dx.doi.org/10.1096/fj.201601349R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28461340				2022-12-28	WOS:000405932400026
J	Sahu, I; Pelzl, L; Sukkar, B; Fakhri, H; Al-Maghout, T; Cao, H; Hauser, S; Gutti, R; Gawaz, M; Lang, F				Sahu, Itishri; Pelzl, Lisann; Sukkar, Basma; Fakhri, Hajar; al-Maghout, Tamer; Cao, Hang; Hauser, Stefan; Gutti, Ravi; Gawaz, Meinrad; Lang, Florian			NFAT5-sensitive Orai1 expression and store-operated Ca2+ entry in megakaryocytes	FASEB JOURNAL			English	Article						SOCE; STIM1; platelets; dehydration; hyperosmolarity	GLUCOCORTICOID-INDUCIBLE KINASE; CRAC CHANNEL; CELL-PROLIFERATION; PLASMA-MEMBRANE; ION CHANNELS; TGF-BETA; CALCIUM; SERUM; STIM1; SGK1	The transcription factor nuclear factor of activated T cells 5 (NFAT5) is up-regulated in several clinical disorders, including dehydration. NFAT5-sensitive genes include serum and glucocorticoid-inducible kinase 1 (SGK1). The kinase is a powerful regulator of Orai1, a Ca2+ channel accomplishing store-operated Ca2+ entry (SOCE). Orai1 is stimulated after intracellular store depletion by the Ca2+ sensors stromal interaction molecule 1 (STIM1), or STIM2, or both. In the present study, we explored whether nuclear factor of activated T cell (NFAT)-5 influences Ca2+ signaling in megakaryocytes. To this end, human megakaryocytic (MEG-01) cells were transfected with NFAT5 or with siNFAT5. Platelets and megakaryocytes were isolated from wild-type mice with either access to water ad libitum or dehydration by 36 h of water deprivation. Transcript levels were determined with quantitative RT-PCR and protein abundance by Western blot analysis and flow cytometry, cytosolic (intracellular) Ca2+ concentration ([Ca2+](i)) by fura-2-fluorescence. SOCE was estimated from the increase of [Ca2+](i) following readdition of extracellular Ca2+ after store depletion with thapsigargin (1 mu M). Platelet degranulation was estimated from P-selectin abundance and integrin activation from alpha(IIb)beta(3) integrin abundance determined by flow cytometry. As a result, NFAT5 transfection or exposure to hypertonicity (+40 mu M NaCl) of MEG-01 cells increased Orai1, Orai2, STIM1, and STIM2 transcript levels. Orai1 transcript levels were decreased by NFAT5 silencing. NFAT5 transfection and I kappa B inhibitor BMS 345541 (5 mu M) increased SOCE, whereas NFAT5 silencing and SGK1 inhibitor GSK650394 (10 mu M) decreased SOCE. In the mice, dehydration increased NFAT5 and Orai1 protein abundance in megakaryocytes and NFAT5, Orai1, and Orai2 abundance in platelets. Dehydration further augmented the degranulation and integrin activation by thrombin and collagen-related peptide. In summary, NFAT5 is a powerful regulator of Orai1-expression and SOCE in megakaryocytes.	[Sahu, Itishri; Pelzl, Lisann; Sukkar, Basma; Fakhri, Hajar; al-Maghout, Tamer; Cao, Hang; Gawaz, Meinrad; Lang, Florian] Univ Tubingen, Dept Cardiol & Vasc Med & Physiol, Tubingen, Germany; [Sahu, Itishri; Gutti, Ravi] Univ Hyderabad, Sch Life Sci, Dept Biochem, Hyderabad, Andhra Pradesh, India; [Hauser, Stefan] German Ctr Neurodegenerat Dis, Tubingen, Germany	Eberhard Karls University of Tubingen; University of Hyderabad; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Lang, F (corresponding author), Univ Tubingen, Dept Physiol, Gmelinstr 5, D-72076 Tubingen, Germany.	florian.lang@uni-tuebingen.de	Sukkar, Basma/AAZ-1187-2020	Gutti, Ravi Kumar/0000-0002-0912-5796; Sukkar, Basma/0000-0003-4945-9333; Hauser, Stefan/0000-0002-1022-7482; Sahu, Itishri/0000-0002-6069-656X	Deutsche Forschungsgemeinschaft (DFG) [La315-15]; Klinische Forschergruppe KFO "Platelets-Basic Mechanisms and Translational Implications"; Council of Scientific and Industrial Research (CSIR-SRF) fellowship, Government of India; Deutscher Akademischer Austauschdienst (DAAD); Brigitte-Schlieben-Lange-Programm; Open Access Publishing Fund of the University of Tubingen	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Klinische Forschergruppe KFO "Platelets-Basic Mechanisms and Translational Implications"; Council of Scientific and Industrial Research (CSIR-SRF) fellowship, Government of India; Deutscher Akademischer Austauschdienst (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Brigitte-Schlieben-Lange-Programm; Open Access Publishing Fund of the University of Tubingen	The authors acknowledge the meticulous preparation of the manuscript by Tanja Loch and Lejla Subasic (both from the University of Tubingen). This work was supported in part by Deutsche Forschungsgemeinschaft (DFG) Grant La315-15 and Klinische Forschergruppe KFO "Platelets-Basic Mechanisms and Translational Implications" (to F.L.), by a Council of Scientific and Industrial Research (CSIR-SRF) fellowship, the Government of India, a Deutscher Akademischer Austauschdienst (DAAD) bi-nationally supervised Ph.D. Fellowship (to I.S.), the Brigitte-Schlieben-Lange-Programm (to L.P.), and the Open Access Publishing Fund of the University of Tubingen. The sponsors had no role in study design, the collection, analysis, and interpretation of data, the writing of the report; or the decision to submit the article for publication. The authors declare no conflicts of interest.	Becchetti A, 2010, ADV EXP MED BIOL, V674, P107; Bergmeier W, 2013, CHANNELS, V7, P379, DOI 10.4161/chan.24302; Bock O, 2005, J PATHOL, V205, P548, DOI 10.1002/path.1744; Borst O, 2015, ARTERIOSCL THROM VAS, V35, P547, DOI 10.1161/ATVBAHA.114.304454; Borst O, 2012, BLOOD, V119, P251, DOI 10.1182/blood-2011-06-359976; Braun A, 2009, BLOOD, V113, P2056, DOI 10.1182/blood-2008-07-171611; Burgoyne RD, 2007, NAT REV NEUROSCI, V8, P182, DOI 10.1038/nrn2093; Capiod T, 2013, RECENT PAT ANTI-CANC, V8, P4; Chen SC, 2009, J CLIN INVEST, V119, P1647, DOI 10.1172/JCI35314; Courjaret Raphael, 2012, Front Biosci (Elite Ed), V4, P331; Dong JC, 2015, CELL PHYSIOL BIOCHEM, V35, P160, DOI 10.1159/000369684; Eylenstein A, 2012, J BIOL CHEM, V287, P2719, DOI 10.1074/jbc.M111.275925; Eylenstein A, 2011, FASEB J, V25, P2012, DOI 10.1096/fj.10-178210; Fahmer M, 2009, IMMUNOL REV, V231, P99, DOI 10.1111/j.1600-065X.2009.00815.x; Handler JS, 2001, KIDNEY INT, V60, P408, DOI 10.1046/j.1523-1755.2001.060002408.x; Hernandez-Ochoa EO, 2012, EXP BIOL MED, V237, P1068, DOI 10.1258/ebm.2012.012052; Lang F, 2015, ACTA PHYSIOL, V213, P181, DOI 10.1111/apha.12334; Lang F, 2013, THROMB HAEMOSTASIS, V110, P925, DOI 10.1160/TH13-02-0176; Lang F, 2013, EXPERT OPIN INV DRUG, V22, P701, DOI 10.1517/13543784.2013.778971; Lang F, 2013, FASEB J, V27, P3, DOI 10.1096/fj.12-218230; Leibrock CB, 2015, J AM SOC NEPHROL, V26, P2423, DOI 10.1681/ASN.2014030230; Liu GL, 2015, CELL PHYSIOL BIOCHEM, V37, P1759, DOI 10.1159/000438539; Moccia F, 2012, CURR MED CHEM, V19, P5802, DOI 10.2174/092986712804143240; Neuhofer W, 2010, CURR GENOMICS, V11, P584, DOI 10.2174/138920210793360961; Orrenius S, 2003, NAT REV MOL CELL BIO, V4, P552, DOI 10.1038/nrm1150; Parekh AB, 2010, NAT REV DRUG DISCOV, V9, P399, DOI 10.1038/nrd3136; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Penna A, 2008, NATURE, V456, P116, DOI 10.1038/nature07338; Ponce CC, 2012, MED ONCOL, V29, P2337, DOI 10.1007/s12032-011-0144-1; Prakriya M, 2006, NATURE, V443, P230, DOI 10.1038/nature05122; Prevarskaya N, 2011, NAT REV CANCER, V11, P609, DOI 10.1038/nrc3105; Putney JW, 2007, J CELL SCI, V120, P1959, DOI 10.1242/jcs.03462; Roderick HL, 2008, NAT REV CANCER, V8, P361, DOI 10.1038/nrc2374; Sakamaki S, 1999, BLOOD, V94, P1961, DOI 10.1182/blood.V94.6.1961.418k17_1961_1970; Salter RD, 2009, IMMUNOL REV, V231, P278, DOI 10.1111/j.1600-065X.2009.00806.x; Schmid E, 2012, CELL PHYSIOL BIOCHEM, V30, P1423, DOI 10.1159/000343330; Shivdasani R. A., 2005, CURR PROTOC IMMUNOL, V67; Smyth JT, 2010, J CELL MOL MED, V14, P2337, DOI 10.1111/j.1582-4934.2010.01168.x; Vig M, 2006, SCIENCE, V312, P1220, DOI 10.1126/science.1127883; Waldegger S, 1999, GASTROENTEROLOGY, V116, P1081, DOI 10.1016/S0016-5085(99)70011-9; Yan J, 2015, BIOCHEM BIOPH RES CO, V461, P8, DOI 10.1016/j.bbrc.2015.03.159; Yeromin AV, 2006, NATURE, V443, P226, DOI 10.1038/nature05108; Zhang SYL, 2008, J BIOL CHEM, V283, P17662, DOI 10.1074/jbc.M801536200; Zhang SYL, 2005, NATURE, V437, P902, DOI 10.1038/nature04147; Zhou Xiaoming, 2016, World J Nephrol, V5, P20, DOI 10.5527/wjn.v5.i1.20	45	13	13	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3439	3448		10.1096/fj.201601211R	http://dx.doi.org/10.1096/fj.201601211R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28446591				2022-12-28	WOS:000405932400022
J	Collins, PJ; McCully, ML; Martinez-Munoz, L; Santiago, C; Wheeldon, J; Caucheteux, S; Thelen, S; Cecchinato, V; Laufer, JM; Purvanov, V; Monneau, YR; Lortat-Jacob, H; Legler, DF; Uguccioni, M; Thelen, M; Piguet, V; Mellado, M; Moser, B				Collins, Paul J.; McCully, Michelle L.; Martinez-Munoz, Laura; Santiago, Cesar; Wheeldon, James; Caucheteux, Stephan; Thelen, Sylvia; Cecchinato, Valentina; Laufer, Julia M.; Purvanov, Vladimir; Monneau, Yoan R.; Lortat-Jacob, Hugues; Legler, Daniel F.; Uguccioni, Mariagrazia; Thelen, Marcus; Piguet, Vincent; Mellado, Mario; Moser, Bernhard			Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4	FASEB JOURNAL			English	Article						CXCR4; signal transduction; synergism; allosteric receptor modulation	CENTRAL-NERVOUS-SYSTEM; DENDRITIC CELLS; RECEPTOR 4; FACTOR-I; CONSTITUTIVE EXPRESSION; EMBRYONIC-DEVELOPMENT; SIGNAL-TRANSDUCTION; NMR-SPECTROSCOPY; B-CELL; MIGRATION	The chemokine receptor, CXC chemokine receptor 4 (CXCR4), is selective for CXC chemokine ligand 12 (CXCL12), is broadly expressed in blood and tissue cells, and is essential during embryogenesis and hematopoiesis. CXCL14 is a homeostatic chemokine with unknown receptor selectivity and preferential expression in peripheral tissues. Here, we demonstrate that CXCL14 synergized with CXCL12 in the induction of chemokine responses in primary human lymphoid cells and cell lines that express CXCR4. Combining subactive concentrations of CXCL12 with 100-300 nM CXCL14 resulted in chemotaxis responses that exceeded maximal responses that were obtained with CXCL12 alone. CXCL14 did not activate CXCR4-expressing cells (i.e., failed to trigger chemotaxis and Ca2+ mobilization, as well as signaling via ERK1/2 and the small GTPase Rac1); however, CXCL14 bound to CXCR4 with high affinity, induced redistribution of cell-surface CXCR4, and enhanced HIV-1 infection by >3-fold. We postulate that CXCL14 is a positive allosteric modulator of CXCR4 that enhances the potency of CXCR4 ligands. Our findings provide new insights that will inform the development of novel therapeutics that target CXCR4 in a range of diseases, including cancer, autoimmunity, and HIV. Collins, P. J., McCully, M. L., Martinez-Mufioz, L., Santiago, C., Wheeldon, J., Caucheteux, S., Thelen, S., Cecchinato, V., Laufer, J. M., Purvanov, V., Monneau, Y. R., Lortat-Jacob, H., Legler, D. F., Uguccioni, M., Thelen, M., Piguet, V., Mellado, M., Moser, B. Epithelial chemokine CXCL14 synergizes with CXCL12 via allosteric modulation of CXCR4.	[Collins, Paul J.; McCully, Michelle L.; Wheeldon, James; Caucheteux, Stephan; Piguet, Vincent; Moser, Bernhard] Cardiff Univ, Sch Med, Div Infect & Immun, Cardiff, S Glam, Wales; [Martinez-Munoz, Laura; Santiago, Cesar; Mellado, Mario] CSIC, Ctr Nacl Biotecnol, Dept Immunol & Oncol, Madrid, Spain; [Thelen, Sylvia; Cecchinato, Valentina; Uguccioni, Mariagrazia; Thelen, Marcus] Univ Svizzera Italiana, Inst Res Biomed, Bellinzona, Switzerland; [Laufer, Julia M.; Purvanov, Vladimir; Legler, Daniel F.] Univ Konstanz, Biotechnol Inst Thurgau, Kreuzlingen, Switzerland; [Laufer, Julia M.; Purvanov, Vladimir; Legler, Daniel F.] Univ Konstanz, Konstanz Res Sch Chem Biol, Constance, Germany; [Monneau, Yoan R.; Lortat-Jacob, Hugues] Univ Grenoble Alpes, CNRS, CEA, Inst Biol Struct,Unite Mixtes Rech 5075, Grenoble, France; [Uguccioni, Mariagrazia] Univ Milan, Dept Med Biotechnol & Translat Med, Milan, Italy; [Collins, Paul J.] Univ Birmingham, Birmingham, W Midlands, England	Cardiff University; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro Nacional de Biotecnologia (CNB); Universita della Svizzera Italiana; University of Konstanz; UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA); CEA; Centre National de la Recherche Scientifique (CNRS); University of Milan; University of Birmingham	Moser, B (corresponding author), Cardiff Univ, Sch Med, Inst Infect & Immun, Henry Wellcome Bldg Heath Pk, Cardiff CF14 4XN, S Glam, Wales.	moserb@cardiff.ac.uk	Martínez-Muñoz, Laura/C-2719-2017; Mellado, Mario/M-9893-2014; Monneau, Yoan Rocky/GQQ-2938-2022; Santiago, Cesar/K-4240-2014	Martínez-Muñoz, Laura/0000-0003-3098-279X; Mellado, Mario/0000-0001-6325-1630; Monneau, Yoan Rocky/0000-0003-0773-6603; Cecchinato, Valentina/0000-0001-7415-8706; Legler, Daniel F./0000-0001-8610-4764; Piguet, Vincent/0000-0001-6079-4517; Uguccioni, Mariagrazia/0000-0002-9570-7011; Santiago, Cesar/0000-0002-5149-1722; Collins, Paul/0000-0003-2325-3265; Moser, Bernhard/0000-0002-4354-4572	Medical Research Council [MR/L018284/1]; Spanish Ministry of Economy and Competitiveness [SAF-2014-53416-R]; Networks for Cooperative Research in Health Program (RETICS) [RD 12/0009/009 RIER]; ComFuturo Program from Spanish Research Council General Foundation; Swiss National Science Foundation [SNF 31003A_169936, SNF3100A0-143718/1]; Agence Nationale de la Recherche [ANR-NT05-4-41968-Chemoglycan]; Grenoble Instruct Centre (CNRS-CEA-UJF-EMBL) [UMS 3518]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-02]; Grenoble Alliance for Structural Biology Funding (GRAL) [ANR-10-LABX-49-01]; Cardiff University Infection and Immunity Institutional Ph.D. Scholarship; Royal Society Wolfson Research Merit Award; MRC [MR/L018284/1] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Spanish Ministry of Economy and Competitiveness(Spanish Government); Networks for Cooperative Research in Health Program (RETICS); ComFuturo Program from Spanish Research Council General Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Agence Nationale de la Recherche(French National Research Agency (ANR)); Grenoble Instruct Centre (CNRS-CEA-UJF-EMBL); French Infrastructure for Integrated Structural Biology (FRISBI); Grenoble Alliance for Structural Biology Funding (GRAL); Cardiff University Infection and Immunity Institutional Ph.D. Scholarship; Royal Society Wolfson Research Merit Award(Royal Society of London); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This work was supported by the Medical Research Council (MR/L018284/1 to B.M.), the Spanish Ministry of Economy and Competitiveness (SAF-2014-53416-R), and the Networks for Cooperative Research in Health Program (RETICS; RD 12/0009/009 RIER to M.M., L.M.-M., and C.S.). L.M.-M. is supported by the ComFuturo Program from the Spanish Research Council General Foundation, the Swiss National Science Foundation (SNF 31003A_169936 to D.F.L., and SNF3100A0-143718/1 to M.U.), the Agence Nationale de la Recherche (ANR-NT05-4-41968-Chemoglycan to H.L.-J.), with additional support from the Grenoble Instruct Centre (UMS 3518 CNRS-CEA-UJF-EMBL), the French Infrastructure for Integrated Structural Biology (FRISBI; ANR-10-INSB-05-02), and Grenoble Alliance for Structural Biology Funding (GRAL; ANR-10-LABX-49-01). P.J.C. is a recipient of a Cardiff University Infection and Immunity Institutional Ph.D. Scholarship, and B.M. is the recipient of a Royal Society Wolfson Research Merit Award.	Agace WW, 2000, CURR BIOL, V10, P325, DOI 10.1016/S0960-9822(00)00380-8; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; Cao XT, 2000, J IMMUNOL, V165, P2588, DOI 10.4049/jimmunol.165.5.2588; Cecchinato V, 2016, J LEUKOCYTE BIOL, V99, P851, DOI 10.1189/jlb.1MR1015-457R; Christopoulos A, 2014, MOL PHARMACOL, V86, P463, DOI 10.1124/mol.114.094342; Crump MP, 1997, EMBO J, V16, P6996, DOI 10.1093/emboj/16.23.6996; De Clercq E, 2009, BIOCHEM PHARMACOL, V77, P1655, DOI 10.1016/j.bcp.2008.12.014; Dror RO, 2011, P NATL ACAD SCI USA, V108, P18684, DOI 10.1073/pnas.1110499108; Frederick MJ, 2000, AM J PATHOL, V156, P1937, DOI 10.1016/S0002-9440(10)65067-5; Garcia-Andres C, 2010, DEV DYNAM, V239, P2769, DOI 10.1002/dvdy.22413; Gordon CT, 2011, INT J DEV BIOL, V55, P335, DOI 10.1387/ijdb.103258cg; Gouwy M, 2012, IMMUNOL LETT, V145, P10, DOI 10.1016/j.imlet.2012.04.005; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Handel TM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00282; Hara T, 2012, J BIOCHEM, V151, P469, DOI 10.1093/jb/mvs030; Hauser MA, 2016, IMMUNITY, V44, P59, DOI 10.1016/j.immuni.2015.12.010; Hevezi P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006395; Hromas R, 1999, BIOCHEM BIOPH RES CO, V255, P703, DOI 10.1006/bbrc.1999.0257; Kleist AB, 2016, BIOCHEM PHARMACOL, V114, P53, DOI 10.1016/j.bcp.2016.04.007; Koenen RR, 2009, NAT MED, V15, P97, DOI 10.1038/nm.1898; Kurth I, 2001, J EXP MED, V194, P855, DOI 10.1084/jem.194.6.855; Laguri C, 2011, J AM CHEM SOC, V133, P9642, DOI 10.1021/ja201753e; Loetscher P, 2001, J LEUKOCYTE BIOL, V69, P881; Loetscher P, 1998, J BIOL CHEM, V273, P22279, DOI 10.1074/jbc.273.35.22279; Lu J, 2016, J INFLAMM-LOND, V13, DOI 10.1186/s12950-015-0109-9; Maerki C, 2009, J IMMUNOL, V182, P507, DOI 10.4049/jimmunol.182.1.507; Martinez LB, 2009, J NEUROIMMUNE PHARM, V4, P116, DOI 10.1007/s11481-008-9140-4; Martinez-Munoz L, 2014, P NATL ACAD SCI USA, V111, pE1960, DOI 10.1073/pnas.1322887111; Mazzucchelli L, 1999, J CLIN INVEST, V104, pR49, DOI 10.1172/JCI7830; McCully ML, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00033; Meuter S, 2007, MOL CELL BIOL, V27, P983, DOI 10.1128/MCB.01648-06; Meuter S, 2008, CYTOKINE, V44, P248, DOI 10.1016/j.cyto.2008.08.009; Mokhtar NM, 2010, MOL HUM REPROD, V16, P170, DOI 10.1093/molehr/gap100; Moser B, 2004, TRENDS IMMUNOL, V25, P75, DOI 10.1016/j.it.2003.12.005; Moser B, 1997, TRENDS MICROBIOL, V5, P88, DOI 10.1016/S0966-842X(97)01019-6; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nagasawa T, 2014, J MOL MED, V92, P433, DOI 10.1007/s00109-014-1123-8; Nara N, 2007, J BIOL CHEM, V282, P30794, DOI 10.1074/jbc.M700412200; Niggli V, 2014, INT REV CEL MOL BIO, V312, P201, DOI 10.1016/B978-0-12-800178-3.00007-5; Nomiyama H, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-222; Oberlin E, 1996, NATURE, V382, P833, DOI 10.1038/382833a0; Ogilvie P, 2004, J IMMUNOL, V172, P6715, DOI 10.4049/jimmunol.172.11.6715; Ojeda AF, 2013, GENE EXPR PATTERNS, V13, P303, DOI 10.1016/j.gep.2013.05.006; Otte M, 2014, FEBS LETT, V588, P4769, DOI 10.1016/j.febslet.2014.11.009; Pitzalis C, 2014, NAT REV IMMUNOL, V14, P447, DOI 10.1038/nri3700; Proudfoot AEI, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00183; Salogni L, 2009, BLOOD, V113, P5848, DOI 10.1182/blood-2008-12-194597; Schaerli P, 2005, IMMUNITY, V23, P331, DOI 10.1016/j.immuni.2005.08.012; Shellenberger TD, 2004, CANCER RES, V64, P8262, DOI 10.1158/0008-5472.CAN-04-2056; Shurin GV, 2005, J IMMUNOL, V174, P5490, DOI 10.4049/jimmunol.174.9.5490; Sleeman MA, 2000, INT IMMUNOL, V12, P677, DOI 10.1093/intimm/12.5.677; Stanford MM, 2003, J LEUKOCYTE BIOL, V74, P791, DOI 10.1189/jlb.1102547; Starnes T, 2006, EXP HEMATOL, V34, P1101, DOI 10.1016/j.exphem.2006.05.015; Struyf S, 2005, EUR J IMMUNOL, V35, P1583, DOI 10.1002/eji.200425753; Tan SY, 2015, IMMUNOL CELL BIOL, V93, P337, DOI 10.1038/icb.2015.16; Tanegashima K, 2013, FEBS LETT, V587, P3770, DOI 10.1016/j.febslet.2013.10.017; Tanegashima K, 2013, FEBS LETT, V587, P1731, DOI 10.1016/j.febslet.2013.04.046; Tanegashima K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010321; Thelen M, 2008, NAT IMMUNOL, V9, P953, DOI 10.1038/ni.f.207; Thelen M, 2010, CURR OPIN PHARMACOL, V10, P38, DOI 10.1016/j.coph.2009.09.004; Tilton B, 2000, J EXP MED, V192, P313, DOI 10.1084/jem.192.3.313; Vega B, 2011, J LEUKOCYTE BIOL, V90, P399, DOI 10.1189/jlb.1010565; Venetz D, 2010, INT J CANCER, V127, P2300, DOI 10.1002/ijc.25236; Wescott MP, 2016, P NATL ACAD SCI USA, V113, P9928, DOI 10.1073/pnas.1601278113; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; Wisler JW, 2014, CURR OPIN CELL BIOL, V27, P18, DOI 10.1016/j.ceb.2013.10.008; Wolf M, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00213; Zlotnik A, 2012, IMMUNITY, V36, P705, DOI 10.1016/j.immuni.2012.05.008; Zuiderweg ERP, 2002, BIOCHEMISTRY-US, V41, P1, DOI 10.1021/bi011870b; Zwijnenburg PJG, 2003, IMMUNOL LETT, V85, P1, DOI 10.1016/S0165-2478(02)00200-6	70	37	38	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3084	3097		10.1096/fj.201700013R	http://dx.doi.org/10.1096/fj.201700013R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28360196	hybrid, Green Published, Green Accepted			2022-12-28	WOS:000405931000032
J	Zhao, N; Wu, J; Xiong, SM; Zhang, LY; Lu, X; Chen, SL; Wu, QF; Wang, HL; Liu, Y; Chen, ZL; Zuo, DM				Zhao, Na; Wu, Jie; Xiong, Simin; Zhang, Liyun; Lu, Xiao; Chen, Shangliang; Wu, Qifeng; Wang, Hailan; Liu, Ying; Chen, Zhengliang; Zuo, Daming			Mannan-binding lectin, a serum collectin, suppresses T-cell proliferation via direct interaction with cell surface calreticulin and inhibition of proximal T-cell receptor signaling	FASEB JOURNAL			English	Article						T-cell activation; cell cycle; silicosis	COAL-WORKERS PNEUMOCONIOSIS; LYMPHOCYTE-PROLIFERATION; PROTEIN-A; ACTIVATION; KINASES; C1Q; INTERLEUKIN-2; INTEGRIN; SILICA; PHASE	Mannan binding lectin (MBL), initially reported to activate the complement pathway, is also known to be involved in the pathogenesis of autoimmune diseases. We report a thus far unknown function of MBL as a suppressor of T-cell activation. MBL markedly inhibited T-cell proliferation induced by anti-CD3 and anti-CD28 antibodies. Moreover, the presence ofMBL during T-cell priming interfered with proximal T-cell receptor signaling by decreasing phosphorylation of Lck, ZAP-70, and LAT. MBL bound to T cells through interaction between the collagen-like region ofMBLand calreticulin (CRT) expressed on theT-cell surface. The neutralizing antibody against CRT abrogated MBL mediated suppression of T-cell proliferation, suggesting thatMBL down-modulates T-cell proliferation via cell surface CRT. We further demonstrated that the feature of MBL-mediatedT-cell suppression is shared by other serum collectins (e.g., C1q and collectin 11). The concentrations of MBL correlated negatively with in vivo T-cell activation status in patients with early-stage silicosis. Furthermore, MBL efficiently inhibited activation and proliferation of autoreactive T cells derived from patients with silicosis, indicating that MBL serves as a negative feedback control of the T-cell responses.	[Zhao, Na; Xiong, Simin; Zhang, Liyun; Lu, Xiao; Chen, Shangliang; Liu, Ying; Chen, Zhengliang; Zuo, Daming] Southern Med Univ, Dept Immunol, Sch Basic Med Sci, Guangzhou 510515, Guangdong, Peoples R China; [Chen, Zhengliang; Zuo, Daming] Southern Med Univ, Guangdong Prov Key Lab Prote, Guangzhou, Guangdong, Peoples R China; [Zhao, Na; Wu, Jie; Wu, Qifeng; Wang, Hailan] Guangdong Prov Hosp Occupat Dis Prevent & Treatme, Dept Occupat Med, Guangzhou, Guangdong, Peoples R China; [Wu, Jie; Wang, Hailan] Shanxi Med Univ, Sch Publ Hlth, Taiyuan, Peoples R China	Southern Medical University - China; Southern Medical University - China; Shanxi Medical University	Chen, ZL; Zuo, DM (corresponding author), Southern Med Univ, Dept Immunol, Sch Basic Med Sci, Guangzhou 510515, Guangdong, Peoples R China.	zhlchen@smu.edu.cn; zdaming@smu.edu.cn	Zuo, Daming/AAO-8461-2021	chen, zhengliang/0000-0002-2657-7970	Natural Science Foundation of China [31070784, 81571608, 81671568]; Natural Science Foundation of Guangdong [2016A030313537]; Foundation for Distinguished Young Teacher in Higher Education of Guangdong [Yq2013034]; Science and Technology Planning Project of Guangdong Province [2016A020215106]; Science and Technology Planning Project of Guangzhou [201607010195]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong(National Natural Science Foundation of Guangdong Province); Foundation for Distinguished Young Teacher in Higher Education of Guangdong; Science and Technology Planning Project of Guangdong Province; Science and Technology Planning Project of Guangzhou	This work was supported, in part, by grants from the Natural Science Foundation of China (31070784 to Y.L.; 81571608 to Z.C.; 81671568 to D.Z.), Natural Science Foundation of Guangdong (2016A030313537 to Z.C.), Foundation for Distinguished Young Teacher in Higher Education of Guangdong (Yq2013034 to D.Z.), Science and Technology Planning Project of Guangdong Province (2016A020215106 to D.Z.), and Science and Technology Planning Project of Guangzhou (201607010195 to D.Z.). The authors declare no conflicts of interest.	Arosa FA, 1999, J BIOL CHEM, V274, P16917, DOI 10.1074/jbc.274.24.16917; Borron P, 1996, AM J RESP CELL MOL, V15, P115, DOI 10.1165/ajrcmb.15.1.8679215; Borron PJ, 1998, J IMMUNOL, V161, P4599; Brennan P, 1999, MOL CELL BIOL, V19, P4729; CHEN A, 1994, J IMMUNOL, V153, P1430; Cope AP, 2007, CLIN EXP RHEUMATOL, V25, pS4; Cui K, 2015, INT J ENV RES PUB HE, V12, P7444, DOI 10.3390/ijerph120707444; Dean MM, 2011, IMMUNOLOGY, V132, P296, DOI 10.1111/j.1365-2567.2010.03365.x; EGGLETON P, 1994, CLIN IMMUNOL IMMUNOP, V72, P405, DOI 10.1006/clin.1994.1160; Goicoechea S, 2000, J BIOL CHEM, V275, P36358, DOI 10.1074/jbc.M005951200; Graudal NA, 1998, J RHEUMATOL, V25, P629; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Hansen TK, 2003, J CLIN ENDOCR METAB, V88, P4857, DOI 10.1210/jc.2003-030742; HAREGEWOIN A, 1984, IMMUNOL REV, V80, P77, DOI 10.1111/j.1600-065X.1984.tb00495.x; Jacobsen S, 2001, J RHEUMATOL, V28, P935; Konya C, 2014, CURR OPIN RHEUMATOL, V26, P493, DOI 10.1097/BOR.0000000000000082; Krishna S, 2012, J IMMUNOL, V189, P1209, DOI 10.4049/jimmunol.1102429; Lee S, 2014, ENVIRON HEALTH PREV, V19, P322, DOI 10.1007/s12199-014-0403-9; Li SS, 2006, BLOOD, V108, P3112, DOI 10.1182/blood-2006-04-016832; Li SS, 2005, J IMMUNOL, V174, P654, DOI 10.4049/jimmunol.174.2.654; Li ZQ, 2002, J CELL BIOL, V157, P509, DOI 10.1083/jcb.200109098; Lockyer HM, 2007, J IMMUNOL, V179, P5301, DOI 10.4049/jimmunol.179.8.5301; MODIANO JF, 1994, J BIOL CHEM, V269, P32972; NIGG EA, 1995, BIOESSAYS, V17, P471, DOI 10.1002/bies.950170603; Ogden CA, 2001, J EXP MED, V194, P781, DOI 10.1084/jem.194.6.781; Otsuki T, 2007, CELL MOL IMMUNOL, V4, P261; Owa T, 2001, CURR MED CHEM, V8, P1487, DOI 10.2174/0929867013371996; Pagh R, 2008, FEBS J, V275, P515, DOI 10.1111/j.1742-4658.2007.06218.x; Pastva Amy M, 2007, Proc Am Thorac Soc, V4, P252, DOI 10.1513/pats.200701-018AW; Pernis Benvenuto, 2005, Acta Biomed, V76 Suppl 2, P38; Porcellini S, 2006, J EXP MED, V203, P461, DOI 10.1084/jem.20051519; Seelen MA, 2005, RHEUMATOLOGY, V44, P111, DOI 10.1093/rheumatology/keh417; Shi M, 2009, J IMMUNOL, V183, P4493, DOI 10.4049/jimmunol.0804339; THIEL S, 1992, CLIN EXP IMMUNOL, V90, P31; Torii S, 2006, CANCER SCI, V97, P697, DOI 10.1111/j.1349-7006.2006.00244.x; Turner M W, 2000, Rev Immunogenet, V2, P305; Wang HP, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002279; Wang MY, 2011, CELL MOL IMMUNOL, V8, P265, DOI 10.1038/cmi.2011.1; Wang MY, 2011, BMC IMMUNOL, V12, DOI 10.1186/1471-2172-12-1; Wang XT, 2008, AM J IND MED, V51, P548, DOI 10.1002/ajim.20587; Wang Y, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0050175, 10.1371/journal.pone.0064617]; Wiersma VR, 2015, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00007; Xiao GQ, 1999, MOL BRAIN RES, V72, P121, DOI 10.1016/S0169-328X(99)00188-6; YOKOTA Y, 1995, J BIOCHEM-TOKYO, V117, P414, DOI 10.1093/jb/117.2.414; Zhang YL, 2005, CELL MOL IMMUNOL, V2, P20; Zuo DM, 2010, PROTEIN PEPTIDE LETT, V17, P131, DOI 10.2174/092986610789909566	46	21	22	4	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2405	2417		10.1096/fj.201601200RR	http://dx.doi.org/10.1096/fj.201601200RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28209773				2022-12-28	WOS:000401553400016
J	Chand, KK; Lee, KM; Lavidis, NA; Noakes, PG				Chand, Kirat K.; Lee, Kah Meng; Lavidis, Nickolas A.; Noakes, Peter G.			Loss of laminin-alpha 4 results in pre-and postsynaptic modifications at the neuromuscular junction	FASEB JOURNAL			English	Article						basal lamina; neuromuscular synapses; neurotransmission; skeletal muscle	READILY RELEASABLE POOL; MOTOR-NERVE TERMINALS; SYNAPTIC VESICLE POOLS; END-PLATE POTENTIALS; ACTIVE ZONES; TRANSMITTER RELEASE; CALCIUM-CHANNELS; NEUROTRANSMITTER RELEASE; FUNCTIONAL-ANALYSIS; AXON WITHDRAWAL	Synaptic basal lamina such as laminin-421 (alpha 4 beta 2 gamma 1) mediate differentiation of the neuromuscular junction (NMJ). Laminins interact with their pre-or postsynaptic receptors to provide stability and alignment of the pre-to postsynaptic specializations. Knockout of the laminin-alpha 4 gene (lama(4)) does not alter gross NMJ morphogenesis. However, mice deficient in laminin-a4 (lama4-/- mice) display disruptions in the alignment of the active zones and postsynaptic folds at the NMJ, although the physiological consequences of this loss have not been examined. The present study investigated the differences in neurotransmission during the early development and maturation of the NMJ in lama4-/-and wild-typemice. Lama4-/- NMJs demonstrated a decrease inminiature end-plate potential (EPP) frequency and increased amplitude of miniature EPPs and evoked EPPs. Binomial parameters analysis of neurotransmitter release revealed a decrease in quantal release, the result of a decrease in the number of active release sites, but not in the probability of transmitter release. Lama4-/- NMJs displayed higher levels of synaptic depression under high-frequency stimulation and altered facilitation, suggesting compromised delivery of synaptic vesicles. This idea is supported by ourmolecular investigations of lama4-/- NMJs, where we see altered distribution of Bassoon, amolecular component of active zones, presumably resulting from perturbed neurotransmission.-Chand, K. K., Lee, K. M., Lavidis, N. A., Noakes, P. G. Loss of laminin-alpha 4 results in pre-and postsynaptic modifications at the neuromuscular junction.	[Chand, Kirat K.; Lee, Kah Meng; Lavidis, Nickolas A.; Noakes, Peter G.] Univ Queensland, Sch Biomed Sci, Res Rd, St Lucia, Qld 4072, Australia; [Noakes, Peter G.] Univ Queensland, Queensland Brain Inst, St Lucia, Qld, Australia	University of Queensland; University of Queensland	Noakes, PG (corresponding author), Univ Queensland, Sch Biomed Sci, Res Rd, St Lucia, Qld 4072, Australia.	p.noakes@uq.edu.au	Noakes, Peter/X-9825-2019	Noakes, Peter/0000-0001-9821-8478; Chand, Kirat/0000-0001-7739-2098; Lee, Kah Meng/0000-0002-1659-0178	Australian National Health and Medical Research Council [569680]; Motor Neuron Disease Research Institute Australia [GIA1429, GIA1547]; University of Queensland	Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Motor Neuron Disease Research Institute Australia; University of Queensland(University of Queensland)	This work was supported, in part, by Australian National Health and Medical Research Council Grant 569680 (to P.G.N.), Motor Neuron Disease Research Institute Australia Grants GIA1429 and GIA1547 (both to P.G.N.), and internal funds from The University of Queensland. The authors thank B. Patton (Oregon Health and Science University School of Medicine, Portland, OR, USA) for providing the knockout mouse line used in this study, S. Meriney (Center for Neuroscience, University of Pittsburgh, Pittsburgh, PA, USA) for technical assistance in optimization of Bassoon staining, and S. Ngo (School of Biomedical Sciences, The University of Queensland) for the modified fiber staining protocol. The authors also thank M. White and M. Shayegh (School of Biomedical Sciences, The University of Queensland) for technical assistance with genotyping. K.K.C. and K.M.L are co-first authors, and N.A.L. and P.G.N. are co-senior authors.	Abr?moff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100; ALDERDICE MT, 1979, BRAIN RES, V178, P596, DOI 10.1016/0006-8993(79)90721-2; BALICEGORDON RJ, 1993, NEURON, V11, P801, DOI 10.1016/0896-6273(93)90110-D; BaliceGordon RJ, 1997, MUSCLE NERVE, pS83; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; Bennett MR, 2001, NEUROREPORT, V12, pA15, DOI 10.1097/00001756-200103050-00003; BENNETT MR, 1974, J PHYSIOL-LONDON, V238, P93, DOI 10.1113/jphysiol.1974.sp010512; Bloom O, 2003, J CELL BIOL, V161, P737, DOI 10.1083/jcb.200212140; Caillol G, 2012, EUR J NEUROSCI, V36, P2400, DOI 10.1111/j.1460-9568.2012.08164.x; Cano R, 2013, MOL NEUROBIOL, V47, P209, DOI 10.1007/s12035-012-8347-9; Carlson SS, 2010, J NEUROCHEM, V115, P654, DOI 10.1111/j.1471-4159.2010.06965.x; Chai RJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028090; Chand KK, 2016, SCI REP-UK, V6, DOI 10.1038/srep29446; Chand KK, 2015, J PHYSIOL-LONDON, V593, P245, DOI 10.1113/jphysiol.2014.284133; Chen J, 2011, J NEUROSCI, V31, P512, DOI 10.1523/JNEUROSCI.3771-10.2011; Chi P, 2001, NAT NEUROSCI, V4, P1187, DOI 10.1038/nn756; Cho SI, 1998, J NEUROBIOL, V37, P339, DOI 10.1002/(SICI)1097-4695(19981115)37:3<339::AID-NEU1>3.3.CO;2-0; Cohen MW, 2000, J NEUROSCI, V20, P4912; Coleman WL, 2007, NEUROSCIENCE, V148, P1, DOI 10.1016/j.neuroscience.2007.06.011; Coleman WL, 2009, SYNAPSE, V63, P531, DOI 10.1002/syn.20635; Cousin MA, 2003, J BIOL CHEM, V278, P29065, DOI 10.1074/jbc.M302386200; Culican SM, 1998, J NEUROSCI, V18, P4953; DELCASTILLO J, 1954, J PHYSIOL-LONDON, V124, P560, DOI 10.1113/jphysiol.1954.sp005129; Dyar KA, 2014, MOL METAB, V3, P29, DOI 10.1016/j.molmet.2013.10.005; ELMQVIST D, 1965, J PHYSIOL-LONDON, V178, P505, DOI 10.1113/jphysiol.1965.sp007639; ERXLEBEN C, 1988, J PHYSIOL-LONDON, V400, P645, DOI 10.1113/jphysiol.1988.sp017141; Farchi N, 2003, J PHYSIOL-LONDON, V546, P165, DOI 10.1113/jphysiol.2002.030841; Fogarty MJ, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00153; Fourcaudot E, 2008, P NATL ACAD SCI USA, V105, P15130, DOI 10.1073/pnas.0806938105; Fujiwara H, 2001, J BIOL CHEM, V276, P17550, DOI 10.1074/jbc.M010155200; GERTLER RA, 1978, BRAIN RES, V142, P160, DOI 10.1016/0006-8993(78)90186-5; Gitler D, 2004, J NEUROSCI, V24, P11368, DOI 10.1523/JNEUROSCI.3795-04.2004; Hosaka M, 1999, NEURON, V24, P377, DOI 10.1016/S0896-6273(00)80851-X; Knight D, 2003, J PHYSIOL-LONDON, V546, P789, DOI 10.1113/jphysiol.2002.030924; LI C, 1994, NEURON, V13, P885, DOI 10.1016/0896-6273(94)90254-2; Liu JX, 2011, INVEST OPHTH VIS SCI, V52, P4842, DOI 10.1167/iovs.10-7132; Mantilla CB, 2007, NEUROSCIENCE, V146, P178, DOI 10.1016/j.neuroscience.2007.01.048; Mantilla CB, 2009, RESP PHYSIOL NEUROBI, V169, P133, DOI 10.1016/j.resp.2009.09.002; Marques MJ, 2000, J NEUROSCI, V20, P3663, DOI 10.1523/JNEUROSCI.20-10-03663.2000; Massoulie J, 2009, CURR OPIN PHARMACOL, V9, P316, DOI 10.1016/j.coph.2009.04.004; MCLACHLAN EM, 1981, J PHYSIOL-LONDON, V311, P307, DOI 10.1113/jphysiol.1981.sp013586; MILEDI R, 1960, J PHYSIOL-LONDON, V154, P190, DOI 10.1113/jphysiol.1960.sp006573; Nishimune H, 2004, NATURE, V432, P580, DOI 10.1038/nature03112; Nishimune H, 2008, J CELL BIOL, V182, P1201, DOI 10.1083/jcb.200805095; Nishimune H, 2016, SCI REP-UK, V6, DOI 10.1038/srep27935; NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0; Patton BL, 2000, MICROSC RES TECHNIQ, V51, P247, DOI 10.1002/1097-0029(20001101)51:3<247::AID-JEMT5>3.0.CO;2-Z; Patton BL, 2001, NAT NEUROSCI, V4, P597, DOI 10.1038/88414; Patton BL, 1998, NATURE, V393, P698, DOI 10.1038/31502; Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507; PIERIBONE VA, 1995, NATURE, V375, P493, DOI 10.1038/375493a0; Poort JE, 2016, HUM MOL GENET, V25, P3768, DOI 10.1093/hmg/ddw222; Prakash YS, 1999, MUSCLE NERVE, V22, P307, DOI 10.1002/(SICI)1097-4598(199903)22:3<307::AID-MUS3>3.3.CO;2-D; Rasi K, 2010, J NEUROSCI, V30, P14490, DOI 10.1523/JNEUROSCI.2644-10.2010; Reid B, 1999, J NEUROSCI, V19, P2511; Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583; Rizzoli SO, 2004, SCIENCE, V303, P2037, DOI 10.1126/science.1094682; Rocha MC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073846; Rosato-Siri MD, 2002, EUR J NEUROSCI, V15, P1874, DOI 10.1046/j.1460-9568.2002.02015.x; Ruiz R, 2014, NEUROPHARMACOLOGY, V76, P106, DOI 10.1016/j.neuropharm.2013.08.032; Ruiz R, 2011, J NEUROSCI, V31, P2000, DOI 10.1523/JNEUROSCI.4663-10.2011; Samuel MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046663; Sellin LC, 1996, PFLUG ARCH EUR J PHY, V431, P325, DOI 10.1007/BF02207269; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Sudhof TC, 1997, NEURON, V18, P519, DOI 10.1016/S0896-6273(00)80292-5; Sugita S, 2016, SKELET MUSCLE, V6, DOI 10.1186/s13395-016-0105-7; Suzuki N, 2005, CONNECT TISSUE RES, V46, P142, DOI 10.1080/03008200591008527; Talts JF, 2000, J BIOL CHEM, V275, P35192, DOI 10.1074/jbc.M003261200; Valdez G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034640; Valdez G, 2010, P NATL ACAD SCI USA, V107, P14863, DOI 10.1073/pnas.1002220107; Wallquist W, 2005, J NEUROSCI, V25, P3692, DOI 10.1523/JNEUROSCI.5225-04.2005; WEINSTEIN SP, 1980, J PHYSIOL-LONDON, V307, P453, DOI 10.1113/jphysiol.1980.sp013446; Yamagata T, 1997, Nihon Jibiinkoka Gakkai Kaiho, V100, P244	73	9	9	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1323	1336		10.1096/fj.201600899R	http://dx.doi.org/10.1096/fj.201600899R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	27998908				2022-12-28	WOS:000398504300007
J	Song, M; Lee, H; Nam, MH; Jeong, E; Kim, S; Hong, Y; Kim, N; Yim, HY; Yoo, YJ; Kim, JS; Kim, JS; Cho, YY; Mills, GB; Kim, WY; Yoon, S				Song, Mee; Lee, Hani; Nam, Myung-Hee; Jeong, Euna; Kim, Somin; Hong, Yourae; Kim, Nayoung; Yim, Hwa Young; Yoo, Young-Ji; Kim, Jung Seok; Kim, Jin-Seok; Cho, Yong-Yeon; Mills, Gordon B.; Kim, Woo-Young; Yoon, Sukjoon			Loss-of-function screens of druggable targetome against cancer stem-like cells	FASEB JOURNAL			English	Article						CSLC sphere culture; lipid profile; network analysis; siRNA screening	METABOLISM	Cancer stem-like cells (CSLCs) contribute to the initiation and recurrence of tumors and to their resistance to conventional therapies. In this study, small interfering RNA (siRNA)-based screening of approximate to 4800 druggable genes in 3-dimensional CSLC cultures in comparison to 2-dimensional bulk cultures of U87 glioma cells revealed 3 groups of genes essential for the following: survival of the CSLC population only, bulk-cultured population only, or both populations. While diverse biologic processes were associated with siRNAs reducing the bulk-cultured population, CSLC-eliminating siRNAs were enriched in a few functional categories, such as lipid metabolism, protein metabolism, and gene expression. Interestingly, siRNAs that selectively reduced CSLC only were found to target genes for cholesterol and unsaturated fatty acid synthesis. The lipidomic profile of CSLCs revealed increased levels of monounsaturated lipids. Pharmacologic blockage of these target pathways reduced CSLCs, and this effect was eliminated by addition of downstream metabolite products. The present CSLC-sensitive target categories provide a useful resource that can be exploited for the selective elimination of CSLCs.	[Song, Mee; Jeong, Euna; Kim, Somin; Kim, Nayoung; Yim, Hwa Young; Yoon, Sukjoon] Sookmyung Womens Univ, Ctr Adv Bioinformat & Syst Med, Cheongpa Ro 47 Gil, Seoul 04310, South Korea; [Lee, Hani; Yoo, Young-Ji; Kim, Jung Seok; Kim, Jin-Seok; Kim, Woo-Young] Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Cheongpa Ro 47 Gil, Seoul 04310, South Korea; [Hong, Yourae; Kim, Nayoung; Yoon, Sukjoon] Sookmyung Womens Univ, Dept Biol Sci, Seoul, South Korea; [Nam, Myung-Hee] Korea Basic Sci Inst, Environm Risk & Welf Res Team, Seoul, South Korea; [Cho, Yong-Yeon] Catholic Univ Korea, Coll Pharm, Gyeonggi Do, South Korea; [Mills, Gordon B.] Univ Texas Houston, MD Anderson Canc Ctr, Syst Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA	Sookmyung Women's University; Sookmyung Women's University; Sookmyung Women's University; Korea Basic Science Institute (KBSI); Catholic University of Korea; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center	Yoon, S (corresponding author), Sookmyung Womens Univ, Ctr Adv Bioinformat & Syst Med, Cheongpa Ro 47 Gil, Seoul 04310, South Korea.; Kim, WY (corresponding author), Sookmyung Womens Univ, Coll Pharm, Res Ctr Cell Fate Control, Cheongpa Ro 47 Gil, Seoul 04310, South Korea.	wykim@sookmyung.ac.kr; yoonsj@sookmyung.ac.kr	Cho, Yong-Yeon/AAD-4263-2020	Cho, Yong-Yeon/0000-0003-1107-2651; Mills, Gordon/0000-0002-0144-9614; Hong, Yourae/0000-0001-6683-433X	National Research Foundation (NRF) of Korea - Korean government (MEST) [NRF-2012M3A9B6055398, NRF-2012M3A9B6055466, NRF-2016R1A5A1011974, NRF-2013R1A1A2059115, NRF-2015R1D1A1A01056594]	National Research Foundation (NRF) of Korea - Korean government (MEST)	This work was supported by grants from the National Research Foundation (NRF) of Korea, including the Bio and Medical Technology Development Program (NRF-2012M3A9B6055398 and NRF-2012M3A9B6055466), the Science Research Center Program (NRF-2016R1A5A1011974), and Basic Science Research Program (NRF-2013R1A1A2059115 and NRF-2015R1D1A1A01056594), funded by the Korean government (MEST).	Beck B, 2013, NAT REV CANCER, V13, P727, DOI 10.1038/nrc3597; Beloribi-Djefaflia S, 2016, ONCOGENESIS, V5, DOI 10.1038/oncsis.2015.49; Ben-David U, 2013, CELL STEM CELL, V12, P167, DOI 10.1016/j.stem.2012.11.015; Das UN, 2011, CANCER METAST REV, V30, P311, DOI 10.1007/s10555-011-9316-x; Gilbert CA, 2009, J CELL BIOCHEM, V108, P1031, DOI 10.1002/jcb.22350; Ginestier C, 2012, STEM CELLS, V30, P1327, DOI 10.1002/stem.1122; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Horai H, 2010, J MASS SPECTROM, V45, P703, DOI 10.1002/jms.1777; Ivanova PT, 2009, CURR OPIN CHEM BIOL, V13, P526, DOI 10.1016/j.cbpa.2009.08.011; Jung Y, 2015, ARCH PHARM RES, V38, P414, DOI 10.1007/s12272-015-0570-2; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Liu SL, 2010, J CLIN ONCOL, V28, P4006, DOI 10.1200/JCO.2009.27.5388; Matchett KB, 2014, STEM CELLS, V32, P2563, DOI 10.1002/stem.1798; Mazur S, 2012, RNA BIOL, V9, P624, DOI 10.4161/rna.19759; Mollinedo Faustino, 2015, Adv Biol Regul, V57, P130, DOI 10.1016/j.jbior.2014.10.003; Santos CR, 2012, FEBS J, V279, P2610, DOI 10.1111/j.1742-4658.2012.08644.x; Song M, 2015, COMPUT BIOL CHEM, V58, P192, DOI 10.1016/j.compbiolchem.2015.07.005; Sun C, 2014, NATURE, V508, P118, DOI 10.1038/nature13121; Tirinato L, 2015, STEM CELLS, V33, P35, DOI 10.1002/stem.1837; van Vugt MATM, 2005, ONCOGENE, V24, P2844, DOI 10.1038/sj.onc.1208617; Vidal SJ, 2014, ONCOGENE, V33, P4451, DOI 10.1038/onc.2013.411; Wicha MS, 2006, CANCER RES, V66, P1883, DOI 10.1158/0008-5472.CAN-05-3153; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065	23	24	24	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					625	635		10.1096/fj.201600953	http://dx.doi.org/10.1096/fj.201600953			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27811063	Green Published, hybrid			2022-12-28	WOS:000394235400016
J	Imasawa, T; Obre, E; Bellance, N; Lavie, J; Imasawa, T; Rigothier, C; Delmas, Y; Combe, C; Lacombe, D; Benard, G; Claverol, S; Bonneu, M; Rossignol, R				Imasawa, Toshiyuki; Obre, Emilie; Bellance, Nadege; Lavie, Julie; Imasawa, Tomoko; Rigothier, Claire; Delmas, Yahsou; Combe, Christian; Lacombe, Didier; Benard, Giovanni; Claverol, Stephane; Bonneu, Marc; Rossignol, Rodrigue			High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy	FASEB JOURNAL			English	Article						mitochondria; MEF2C; human kidney	FOCAL SEGMENTAL GLOMERULOSCLEROSIS; FREE FATTY-ACIDS; MITOCHONDRIAL DYSFUNCTION; MOLECULAR-MECHANISMS; SKELETAL-MUSCLE; KIDNEY-DISEASE; MESSENGER-RNA; ATP SYNTHASE; ACTIVATION; EXPRESSION	Podocytes play a key role in diabetic nephropathy pathogenesis, but alteration of their metabolism remains unknown in human kidney. By using a conditionally differentiating human podocyte cell line, we addressed the functional and molecular changes in podocyte energetics during in vitro development or under high glucose conditions. In 5 mM glucose medium, we observed a stepwise activation of oxidative metabolism during cell differentiation that was characterized by peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha)-dependent stimulation of mitochondrial biogenesis and function, with concomitant reduction of the glycolytic enzyme content. Conversely, when podocytes were cultured in high glucose (20 mM), stepwise oxidative phosphorylation biogenesis was aborted, and a glycolytic switch occurred, with consecutive lactic acidosis. Expression of the master regulators of oxidative metabolism transcription factor A mitochondrial, PGC-1 alpha, AMPK, and serine-threonine liver kinase B1 was altered by high glucose, as well as their downstream signaling networks. Focused transcriptomics revealed that myocyte-specific enhancer factor 2C (MEF2C) and myogenic factor 5(MYF5) expression was inhibited by high glucose levels, and endoribo nuclease-prepared small interfering RNA-mediated combined inhibition of those transcription factors phenocopied the glycolytic shift that was observed in high glucose conditions. Accordingly, a reduced expression of MEF2C, MYF5, and PGC-1 alpha was found in kidney tissue sections that were obtained from patients with diabetic nephropathy. These findings obtained in human samples demonstrate that MEF2C-MYF5-dependent bioenergetic dedifferentiation occurs in podocytes that are confronted with a high-glucose milieu.-Imasawa, T., Obre, E., Bellance, N., Lavie, J., Imasawa, T., Rigothier, C., Delmas, Y., Combe, C., Lacombe, D., Benard, G., Claverol, S., Bonneu, M., Rossignol, R. High glucose repatterns human podocyte energy metabolism during differentiation and diabetic nephropathy.	[Imasawa, Toshiyuki] Chiba East Hosp, Kidney Ctr, Natl Hosp Org, Chiba, Japan; [Obre, Emilie; Bellance, Nadege; Lavie, Julie; Imasawa, Tomoko; Lacombe, Didier; Benard, Giovanni; Rossignol, Rodrigue] INSERM, U1211, Lab Rare Dis Metab & Genet, Bordeaux, France; [Claverol, Stephane; Bonneu, Marc] Bordeaux Univ, Ctr Funct Genom, Bordeaux, France; [Obre, Emilie; Rossignol, Rodrigue] Ctr Hosp Univ Pellegrin, Cellomet, Bordeaux, France; [Rigothier, Claire; Delmas, Yahsou; Combe, Christian] Bordeaux Univ Hosp Ctr, Dept Nephrol Transplantat & Dialysis, Bordeaux, France	Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; CHU Bordeaux	Imasawa, T (corresponding author), Univ Bordeaux, Ctr Hosp Univ Pellegrin, INSERM, Ecole Sages Femmes,U1211, Pl Amelie Raba Leon, F-33000 Bordeaux, France.	imasawa@cehpnet.com; rodrigue.rossignol@u-bordeaux.fr	Bénard, Giovanni/M-3485-2014; Combe, Christian/N-3726-2015	Bénard, Giovanni/0000-0003-0036-9425; Lacombe, Didier/0000-0002-8956-2207; Lavie, Julie/0000-0002-7208-3154; bellance, nadege/0000-0002-8868-8596; Combe, Christian/0000-0002-0360-573X	Japan Society for the Promotion of Science (KAKENHI) [80348276]; National Hospital Organization of Japan; French Association Against Myopathies; Grants-in-Aid for Scientific Research [16K09638] Funding Source: KAKEN	Japan Society for the Promotion of Science (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); National Hospital Organization of Japan; French Association Against Myopathies; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Welsh GI, Academic and Children's Renal Unit (Bristol University, Southmead Hospital, Bristol, United Kingdom) for providing the human podocytes, and Dr. Akira Hiwatashi (Tsukuba University, Tsukuba, Japan) and Mori Tachibana (National Hospital Organization Chiba-East Hospital) for valuable technical advice and assistance. This work was supported by the Japan Society for the Promotion of Science (KAKENHI) Grant 80348276 (to T.I), a grant from the National Hospital Organization of Japan (to T.I.), and the French Association Against Myopathies. The authors declare no conflicts of interest.	Abe Y, 2010, AM J PHYSIOL-CELL PH, V299, pC464, DOI 10.1152/ajpcell.00563.2009; Ahmed M, 2010, ISLETS, V2, P283, DOI 10.4161/isl.2.5.12639; Benard G, 2007, J CELL SCI, V120, P838, DOI 10.1242/jcs.03381; Carraro M, 2014, J BIOL CHEM, V289, P15980, DOI 10.1074/jbc.C114.559633; Cheval L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046876; Coimbra TM, 2000, KIDNEY INT, V57, P167, DOI 10.1046/j.1523-1755.2000.00836.x; Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100; Diomedi-Camassei F, 2007, J AM SOC NEPHROL, V18, P2773, DOI 10.1681/ASN.2006080833; Dronavalli S, 2008, NAT CLIN PRACT ENDOC, V4, P444, DOI 10.1038/ncpendmet0894; Emma F, 2016, NAT REV NEPHROL, V12, P267, DOI 10.1038/nrneph.2015.214; Fessart D, 2014, J MOL CELL CARDIOL, V66, P41, DOI 10.1016/j.yjmcc.2013.10.015; Gao CL, 2010, MOL CELL ENDOCRINOL, V320, P25, DOI 10.1016/j.mce.2010.01.039; Gassler N, 2001, KIDNEY INT, V60, P106, DOI 10.1046/j.1523-1755.2001.00777.x; Godel M, 2011, J CLIN INVEST, V121, P2197, DOI 10.1172/JCI44774; Gucer S, 2005, PEDIATR DEVEL PATHOL, V8, P710, DOI 10.1007/s10024-005-0058-z; Hara M, 2012, DIABETOLOGIA, V55, P2913, DOI 10.1007/s00125-012-2661-7; Heerspink HJL, 2013, BRIT J CLIN PHARMACO, V76, P536, DOI 10.1111/bcp.12195; Hock MB, 2009, ANNU REV PHYSIOL, V71, P177, DOI 10.1146/annurev.physiol.010908.163119; Ihalmo P, 2008, DIABETOLOGIA, V51, P86, DOI 10.1007/s00125-007-0854-2; Imasawa T, 2013, INT J BIOCHEM CELL B, V45, P2109, DOI 10.1016/j.biocel.2013.06.013; Inoki K, 2011, J CLIN INVEST, V121, P2181, DOI 10.1172/JCI44771; Johanson M, 1999, BIOCHEM BIOPH RES CO, V265, P222, DOI 10.1006/bbrc.1999.1390; Jose C, 2011, BBA-BIOENERGETICS, V1807, P552, DOI 10.1016/j.bbabio.2010.10.012; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lee MJ, 2010, CELL SIGNAL, V22, P65, DOI 10.1016/j.cellsig.2009.09.011; Leinninger GM, 2006, NAT CLIN PRACT NEURO, V2, P620, DOI 10.1038/ncpneuro0320; Li JJ, 2007, KIDNEY INT, V72, pS36, DOI 10.1038/sj.ki.5002384; Li SY, 2014, KIDNEY INT, V86, P358, DOI 10.1038/ki.2014.67; Lizcano JM, 2004, EMBO J, V23, P833, DOI 10.1038/sj.emboj.7600110; Marfella R, 2001, J CLIN INVEST, V108, P635, DOI 10.1172/JCI13727; May CJ, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00148; McGee SL, 2006, CLIN EXP PHARMACOL P, V33, P395, DOI 10.1111/j.1440-1681.2006.04362.x; Medja F, 2009, MITOCHONDRION, V9, P331, DOI 10.1016/j.mito.2009.05.001; Melser S, 2013, CELL METAB, V17, P719, DOI 10.1016/j.cmet.2013.03.014; Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180; Nishikawa T, 2007, ANTIOXID REDOX SIGN, V9, P343, DOI 10.1089/ars.2006.1458; O'Brien LL, 2016, DEVELOPMENT, V143, P595, DOI 10.1242/dev.127175; Ostojic J, 2013, CELL METAB, V18, P567, DOI 10.1016/j.cmet.2013.08.017; Panda AC, 2016, NUCLEIC ACIDS RES, V44, P2393, DOI 10.1093/nar/gkw023; Paumard P, 2002, EMBO J, V21, P221, DOI 10.1093/emboj/21.3.221; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Rigothier C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037695; Russell NDF, 2015, DIABETOLOGIA, V58, P1708, DOI 10.1007/s00125-015-3600-1; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sharma K, 2013, J AM SOC NEPHROL, V24, P1901, DOI 10.1681/ASN.2013020126; Sieber J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00186; Stieger N, 2012, METABOLISM, V61, P1073, DOI 10.1016/j.metabol.2011.12.003; Velpula KK, 2013, CANCER RES, V73, P7277, DOI 10.1158/0008-5472.CAN-13-1868; Walkin L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-18; Wang WJ, 2012, CELL METAB, V15, P186, DOI 10.1016/j.cmet.2012.01.009; Xu JX, 2006, BIOCHEM BIOPH RES CO, V344, P827, DOI 10.1016/j.bbrc.2006.03.211; Yan K, 2012, CELL CYCLE, V11, P1504, DOI 10.4161/cc.19825; Yang LC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5436; Yuan YG, 2012, KIDNEY INT, V82, P771, DOI 10.1038/ki.2012.188; Zong HH, 2002, P NATL ACAD SCI USA, V99, P15983, DOI 10.1073/pnas.252625599	55	51	60	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					294	307		10.1096/fj.201600293R	http://dx.doi.org/10.1096/fj.201600293R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27825100	hybrid, Green Published			2022-12-28	WOS:000392177600028
J	Samakai, E; Hooper, R; Martin, KA; Shmurak, M; Zhang, Y; Kappes, DJ; Tempera, I; Soboloff, J				Samakai, Elsie; Hooper, Robert; Martin, Kayla A.; Shmurak, Maya; Zhang, Yi; Kappes, Dietmar J.; Tempera, Italo; Soboloff, Jonathan			Novel STIM1-dependent control of Ca2+ clearance regulates NFAT activity during T-cell activation	FASEB JOURNAL			English	Article						calcium; EGR1; EGR4; Jurkat; PMCA4; SOCe	STIM1; AUTOPHAGY; ORAI1; ENTRY	Antigen presentation to the T-cell receptor leads to sustained cytosolic Ca2+ elevation, which is critical for T-cell activation. We previously showed that in activated T cells, Ca2+ clearance is inhibited by the endoplasmic reticulum Ca2+ sensor stromal interacting molecule 1 (STIM1) via association with the plasma membrane Ca2+/ATPase 4 (PMCA4) Ca2+ pump. Having further observed that expression of both proteins is increased in activated T cells, the current study focused on mechanisms regulating both up-regulation of STIM1 and PMCA4 and assessing how this up-regulation contributes to control of Ca2+ clearance. Using a STIM1 promoter luciferase vector, we found that the zinc finger transcription factors early growth response (EGR) 1 and EGR4, but not EGR2 or EGR3, drive luciferase activity. We further found that neither STIM1 nor PMCA4 is up-regulated when both EGR1 and EGR4 are knocked down using RNA interference. Further, under these conditions, activation-induced Ca2+ clearance inhibition was eliminated with little effect on Ca2+ entry. Finally, we found that nuclear factor of activated T-cell (NFAT) activity is profoundly attenuated if Ca2+ clearance is not inhibited by STIM1. These findings reveal a critical role for STIM1-mediated control of Ca2+ clearance in NFAT induction during T-cell activation.Samakai, E., Hooper, R., Martin, K. A., Shmurak, M., Zhang, Y., Kappes, D. J., Tempera, I., Soboloff, J. Novel STIM1-dependent control of Ca2+ clearance regulates NFAT activity during T-cell activation.	[Samakai, Elsie; Hooper, Robert; Martin, Kayla A.; Shmurak, Maya; Zhang, Yi; Tempera, Italo; Soboloff, Jonathan] Temple Univ, Fels Inst Canc Res & Mol Biol, Sch Med, 3307 North Broad St, Philadelphia, PA 19140 USA; [Samakai, Elsie; Hooper, Robert; Shmurak, Maya; Soboloff, Jonathan] Temple Univ, Sch Med, Dept Med Genet & Mol Biochem, Philadelphia, PA 19140 USA; [Kappes, Dietmar J.] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Fox Chase Cancer Center	Soboloff, J (corresponding author), Temple Univ, Fels Inst Canc Res & Mol Biol, Sch Med, 3307 North Broad St, Philadelphia, PA 19140 USA.	soboloff@temple.edu	Soboloff, Jonathan/I-6995-2012; Tempera, Italo/N-2495-2019	Soboloff, Jonathan/0000-0001-5192-1297; Tempera, Italo/0000-0001-7893-2914	National Institutes of Health, National Institute of General Medical Sciences [R01GM097335, R01GM117907, F31GM103731]; NATIONAL CANCER INSTITUTE [R01CA172106, P30CA006927] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM097335, R01GM117907] Funding Source: NIH RePORTER	National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank J. Kedra (Temple University) for technical support with this project, M. Ritchie (Champions Oncology, New York, NY, USA) for his efforts developing the STIM1 luciferase construct, J. Pomerantz (Johns Hopkins University) for the NFAT luciferase vector and J. Huang (Temple University) for his assistance with CRISPR/Cas9. This work was supported by National Institutes of Health, National Institute of General Medical Sciences grants R01GM097335 and R01GM117907 (to J.S.), and F31GM103731 (to E.S.).	Bronietzki AW, 2015, IMMUNOL CELL BIOL, V93, P25, DOI 10.1038/icb.2014.81; Deretic V, 2013, NAT REV IMMUNOL, V13, P722, DOI 10.1038/nri3532; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Lin J, 2001, J CELL SCI, V114, P243; Mercer JC, 2006, J BIOL CHEM, V281, P24979, DOI 10.1074/jbc.M604589200; Oh-Hora M, 2008, NAT IMMUNOL, V9, P432, DOI 10.1038/ni1574; Oh-hora M, 2013, IMMUNITY, V38, P881, DOI 10.1016/j.immuni.2013.02.008; Peinelt C, 2006, NAT CELL BIOL, V8, P771, DOI 10.1038/ncb1435; Puleston DJ, 2014, IMMUNOLOGY, V141, P1, DOI 10.1111/imm.12165; Quintana A, 2011, EMBO J, V30, P3895, DOI 10.1038/emboj.2011.289; Ritchie MF, 2012, EMBO J, V31, P1123, DOI 10.1038/emboj.2011.495; Ritchie MF, 2010, J BIOL CHEM, V285, P10591, DOI 10.1074/jbc.M109.083493; Smith-Garvin JE, 2009, ANNU REV IMMUNOL, V27, P591, DOI 10.1146/annurev.immunol.021908.132706; Soboloff J, 2006, CURR BIOL, V16, P1465, DOI 10.1016/j.cub.2006.05.051; Soboloff J, 2006, J BIOL CHEM, V281, P20661, DOI 10.1074/jbc.C600126200; Soboloff J, 2012, NAT REV MOL CELL BIO, V13, P549, DOI 10.1038/nrm3414; Tempera I, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002180; Tempera I, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001048; Tourtellotte WG, 2000, MOL CELL BIOL, V20, P5261, DOI 10.1128/MCB.20.14.5261-5268.2000; Valdor R, 2014, NAT IMMUNOL, V15, P1046, DOI 10.1038/ni.3003	20	7	8	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3878	3886		10.1096/fj.201600532R	http://dx.doi.org/10.1096/fj.201600532R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27528628	Green Published			2022-12-28	WOS:000386474700022
J	Tang, N; Sun, B; Gupta, A; Rempel, H; Pulliam, L				Tang, Norina; Sun, Bing; Gupta, Archana; Rempel, Hans; Pulliam, Lynn			Monocyte exosomes induce adhesion molecules and cytokines via activation of NF-B in endothelial cells	FASEB JOURNAL			English	Article						CCL2; ICAM-1; atherosclerosis; HIV; miRNA	KAPPA-B; INTERFERON-ALPHA; GENE-EXPRESSION; HIV-INFECTION; MICROPARTICLES; ATHEROSCLEROSIS; MICRORNA-155; INFLAMMATION; BLOOD; DIFFERENTIATION	HIV-infected individuals have activated monocytes with an IFN phenotype and elevated levels of circulating LPS. These individuals also have a risk of premature cardiovascular disease. The effect of activated monocyte exosomes (Exos) on endothelial cells is unknown. To determine whether Exos from immune-activated monocytes could alter endothelial cell expression and contribute to monocyte/macrophage transmigration and adhesion, we isolated Exos from monocytes stimulated with IFN, LPS, or both (I/L). We show that monocyte Exos contain different inflammatory microRNA cargo depending on stimulation. When LPS Exos or I/L Exos were added to HUVECs, we found a significant increase in adhesion molecule ICAM-1, chemokine ligand (CCL)-2, and cytokine IL-6 mRNAs and proteins compared with cells treated with IFN Exos or Exos derived from unstimulated monocytes. Inhibition of transcription factor NF-B, a common inflammatory cytokine pathway, prevented induction of CCL2, IL6, and ICAM1. Inhibition of TLR4 resulted in differential blockage of the targets. Our results demonstrate for the first time that primary human monocyte Exos enter endothelial cells and cause dysfunction via the TLR4 and NF-B pathways, which may contribute to heart disease in HIV infection and other diseases involving chronic immune activation.Tang, N., Sun, B., Gupta, A., Rempel, H., Pulliam, L. Monocyte exosomes induce adhesion molecules and cytokines via activation of NF-B in endothelial cells.	[Tang, Norina; Sun, Bing; Rempel, Hans; Pulliam, Lynn] Vet Adm Med Ctr, Dept Lab Med, San Francisco, CA 94121 USA; [Gupta, Archana] Syst Biosci Inc, Mountain View, CA USA; [Pulliam, Lynn] Univ Calif San Francisco, Dept Lab Med, San Francisco, CA 94143 USA; [Pulliam, Lynn] Univ Calif San Francisco, Dept Med, San Francisco, CA USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); University of California System; University of California San Francisco; University of California System; University of California San Francisco	Pulliam, L (corresponding author), Vet Affairs Med Ctr 113A, Dept Lab Med, San Francisco, CA 94121 USA.	lynn.pulliam@ucsf.edu			U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R21HL129853]; NIH National Institute of Mental Health [R01MH096673]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL129853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH112483, R01MH096673] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors thank Ivy Hsieh (Veterans Administration Medical Center) for performing the electron microscopy, Dr. Kang Li [University of California, San Francisco (UCSF)] for technical assistance with the NF-kappa B microscopy studies, Dr. Robert Raffai (UCSF) for helpful discussions, and Dr. Craig Meyer (UCSF) for assistance with statistical analyses. These studies were supported in part by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R21HL129853 and NIH National Institute of Mental Health Grant R01MH096673 (both to L.P.). Author contributions: N. Tang, B. Sun, and A. Gupta performed the research; N. Tang, H. Rempel, and L. Pulliam analyzed the data; N. Tang and L. Pulliam wrote the manuscript; and B. Sun performed the statistical analyses. The authors declare no conflicts of interest.	Aharon A, 2008, THROMB HAEMOSTASIS, V100, P878, DOI 10.1160/TH07-11-0691; Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; Bhatnagar S, 2007, BLOOD, V110, P3234, DOI 10.1182/blood-2007-03-079152; Boccara F, 2013, J AM COLL CARDIOL, V61, P511, DOI 10.1016/j.jacc.2012.06.063; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Chen QY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0037149, 10.1371/journal.pone.0042971]; Conti L, 1997, CELL GROWTH DIFFER, V8, P435; de Jong OG, 2012, J EXTRACELL VESICLES, V1, DOI 10.3402/jev.v1i0.18396; Distler JHW, 2005, ARTHRITIS RHEUM, V52, P3337, DOI 10.1002/art.21350; Faure E, 2000, J BIOL CHEM, V275, P11058, DOI 10.1074/jbc.275.15.11058; Goetzl EJ, 2016, FASEB J, V30, P2058, DOI 10.1096/fj.201500150R; Golias C, 2007, IN VIVO, V21, P757; Gupta A, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-68; Hehner SP, 1998, J BIOL CHEM, V273, P1288, DOI 10.1074/jbc.273.3.1288; Huber HJ, 2015, CURR OPIN LIPIDOL, V26, P412, DOI 10.1097/MOL.0000000000000214; Huber SA, 1999, ARTERIOSCL THROM VAS, V19, P2364, DOI 10.1161/01.ATV.19.10.2364; Ilhan F, 2015, WORLD J CLIN CASES, V3, P345, DOI 10.12998/wjcc.v3.i4.345; Ismail N, 2013, BLOOD, V121, P984, DOI 10.1182/blood-2011-08-374793; Ma XD, 2011, J MOL CELL BIOL, V3, P159, DOI 10.1093/jmcb/mjr007; Mallat Z, 2000, CIRCULATION, V101, P841, DOI 10.1161/01.CIR.101.8.841; Marques-Rocha JL, 2015, FASEB J, V29, P3595, DOI 10.1096/fj.14-260323; Matsunaga N, 2011, MOL PHARMACOL, V79, P34, DOI 10.1124/mol.110.068064; Mause SF, 2010, CIRC RES, V107, P1047, DOI 10.1161/CIRCRESAHA.110.226456; McDonald MK, 2014, PAIN, V155, P1527, DOI 10.1016/j.pain.2014.04.029; Montoro-Garcia S, 2011, BASIC RES CARDIOL, V106, P911, DOI 10.1007/s00395-011-0198-4; Nazari-Jahantigh M, 2012, J CLIN INVEST, V122, P4190, DOI 10.1172/JCI61716; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Post WS, 2014, ANN INTERN MED, V160, P458, DOI 10.7326/M13-1754; Pulliam L, 2015, DNA CELL BIOL, V34, P459, DOI 10.1089/dna.2015.2884; Pulliam L, 2014, J INTERF CYTOK RES, V34, P822, DOI 10.1089/jir.2013.0152; Ramakrishnan DP, 2016, ARTERIOSCL THROM VAS, V36, P534, DOI 10.1161/ATVBAHA.115.307085; Rangrez A.Y., 2013, MICRORNAS CARDIOVASC, V1, P23, DOI 10.2478/micrnacr-2013-0003; Raposo G, 1996, J EXP MED, V183, P1161, DOI 10.1084/jem.183.3.1161; Record M, 2011, BIOCHEM PHARMACOL, V81, P1171, DOI 10.1016/j.bcp.2011.02.011; Rempel H, 2010, AIDS, V24, P1415, DOI 10.1097/QAD.0b013e32833ac623; ROLLINS BJ, 1990, AM J PATHOL, V136, P1229; Schildberger A, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/697972; SICA A, 1990, J IMMUNOL, V144, P3034; Ssinabulya I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089537; Swaminathan G, 2014, J MOL BIOL, V426, P1178, DOI 10.1016/j.jmb.2013.12.017; Tabet F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4292; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Thery C, 2009, NAT REV IMMUNOL, V9, P581, DOI 10.1038/nri2567; Thery Clotilde, 2006, Curr Protoc Cell Biol, VChapter 3, DOI 10.1002/0471143030.cb0322s30; Tian FJ, 2014, CARDIOVASC RES, V103, P100, DOI 10.1093/cvr/cvu070; Tilton JC, 2006, J VIROL, V80, P11486, DOI 10.1128/JVI.00324-06; Villarroya-Beltri C, 2014, SEMIN CANCER BIOL, V28, P3, DOI 10.1016/j.semcancer.2014.04.009; Wang JG, 2011, BLOOD, V118, P2366, DOI 10.1182/blood-2011-01-330878; Zhang YJ, 2010, MOL CELL, V39, P133, DOI 10.1016/j.molcel.2010.06.010; Zitvogel L, 1998, NAT MED, V4, P594, DOI 10.1038/nm0598-594	52	109	115	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3097	3106		10.1096/fj.201600368RR	http://dx.doi.org/10.1096/fj.201600368RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27226520	Green Published			2022-12-28	WOS:000382816300010
J	Wang, YG; Hu, YA; Sun, CX; Zhuo, S; He, ZS; Wang, H; Yan, MH; Liu, J; Luan, Y; Dai, CG; Yang, YG; Huang, R; Zhou, B; Zhang, F; Zhai, QW				Wang, Yuangao; Hu, Yanan; Sun, Chenxia; Zhuo, Shu; He, Zhishui; Wang, Hui; Yan, Menghong; Liu, Jun; Luan, Yi; Dai, Changgui; Yang, Yonggang; Huang, Rui; Zhou, Ben; Zhang, Fang; Zhai, Qiwei			Down-regulation of Risa improves insulin sensitivity by enhancing autophagy	FASEB JOURNAL			English	Article						lncRNA; insulin resistance; glucose homeostasis; ob; ob mice	LONG NONCODING RNAS; ACTIVATES AUTOPHAGY; SIRT1; PHOSPHORYLATION; METABOLISM; OBESITY; STRESS; OVEREXPRESSION; EXPRESSION; SELECTION	It has been reported that some small noncoding RNAs are involved in the regulation of insulin sensitivity. However, whether long noncoding RNAs also participate in the regulation of insulin sensitivity is still largely unknown. We identified and characterized a long noncoding RNA, regulator of insulin sensitivity and autophagy (Risa), which is a poly(A)(+) cytoplasmic RNA. Overexpression of Risa in mouse primary hepatocytes or C2C12 myotubes attenuated insulin-stimulated phosphorylation of insulin receptor, Akt, and Gsk3, and knockdown of Risa alleviated insulin resistance. Further studies showed that overexpression of Risa in hepatocytes or myotubes decreased autophagy, and knockdown of Risa up-regulated autophagy. Moreover, knockdown of Atg7 or -5 significantly inhibited the effect of knockdown of Risa on insulin resistance, suggesting that knockdown of Risa alleviated insulin resistance via enhancing autophagy. In addition, tail vein injection of adenovirus to knock down Risa enhanced insulin sensitivity and hepatic autophagy in both C57BL/6 and ob/ob mice. Taken together, the data demonstrate that Risa regulates insulin sensitivity by affecting autophagy and suggest that Risa is a potential target for treating insulin-resistance-related diseases.Wang, Y., Hu, Y., Sun, C., Zhuo, S., He, Z., Wang, H., Yan, M., Liu, J., Luan, Y., Dai, C., Yang, Y., Huang, R., Zhou, B., Zhang, F., Zhai, Q. Down-regulation of Risa improves insulin sensitivity by enhancing autophagy.	[Wang, Yuangao; Hu, Yanan; Sun, Chenxia; Zhuo, Shu; He, Zhishui; Wang, Hui; Yan, Menghong; Liu, Jun; Luan, Yi; Dai, Changgui; Yang, Yonggang; Huang, Rui; Zhou, Ben; Zhang, Fang; Zhai, Qiwei] Chinese Acad Sci, Univ Chinese Acad Sci, CAS Ctr Excellence Mol Cell Sci,Inst Nutr Sci, Key Lab Nutr & Metab,Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Zhai, Qiwei] ShanghaiTech Univ, Sch Life Sci & Technol, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; University of Chinese Academy of Sciences, CAS; ShanghaiTech University	Zhai, QW (corresponding author), Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Nutr Sci, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	qwzhai@sibs.ac.cn	Zhou, Ben/R-9844-2019; Zhou, Ben/G-1850-2017; Zhou, Ben/AAB-5808-2020	Zhou, Ben/0000-0001-7177-2882; Zhou, Ben/0000-0001-7177-2882; Zhai, Qiwei/0000-0002-9617-7403; Zhang, Fang/0000-0002-7000-554X; Luan, Yi/0000-0002-2511-0359	National Basic Research Program of China [2014CB542300]; Strategic Priority Research Program of the Chinese Academy of Sciences [XDA12030204]; National Natural Science Foundation of China [31470768, 81321062, 31200595, 31200591, 81472181]; Knowledge Innovation Program of Shanghai Institutes for Biological Sciences; Chinese Academy of Sciences [2014KIP106]	National Basic Research Program of China(National Basic Research Program of China); Strategic Priority Research Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program of Shanghai Institutes for Biological Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences); Chinese Academy of Sciences(Chinese Academy of Sciences)	This work was supported by Grant 2014CB542300 from the National Basic Research Program of China; Grant XDA12030204 from the Strategic Priority Research Program of the Chinese Academy of Sciences; Grants 31470768, 81321062, 31200595, 31200591, and 81472181 from the National Natural Science Foundation of China; the Knowledge Innovation Program of Shanghai Institutes for Biological Sciences; and Grant 2014KIP106 from the Chinese Academy of Sciences. Author contributions: Y. Wang, F. Zhang, and Q. Zhai designed the research; Y. Wang, Y. Hu, B. Zhou, Z. He, and Q. Zhai analyzed the data; Y. Wang, C. Sun, Y. Hu, S. Zhuo, H. Wang, Z. He, M. Yan, J. Liu, Y. Luan, C. Dai, Y. Yang, and R. Huang performed the research; and Y. Wang and Q. Zhai wrote the paper. The authors declare no conflicts of interest.	Abdelmohsen K, 2014, NUCLEIC ACIDS RES, V42, P10099, DOI 10.1093/nar/gku686; Atianand MK, 2014, TRENDS MOL MED, V20, P623, DOI 10.1016/j.molmed.2014.09.002; Bernard M, 2014, AUTOPHAGY, V10, P2193, DOI 10.4161/15548627.2014.981786; Chen L, 2012, NAT REV ENDOCRINOL, V8, P228, DOI 10.1038/nrendo.2011.183; Chooniedass-Kothari S, 2004, FEBS LETT, V566, P43, DOI 10.1016/j.febslet.2004.03.104; Diederichs S, 2014, TRENDS GENET, V30, P121, DOI 10.1016/j.tig.2014.01.004; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Egan DF, 2011, SCIENCE, V331, P456, DOI 10.1126/science.1196371; Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Ge D, 2014, AUTOPHAGY, V10, P957, DOI 10.4161/auto.28363; Grammatikakis I, 2014, AGING-US, V6, P992, DOI 10.18632/aging.100710; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; He CC, 2012, NATURE, V481, P511, DOI 10.1038/nature10758; Jager L, 2009, NAT PROTOC, V4, P547, DOI 10.1038/nprot.2009.4; Johnson AMF, 2013, CELL, V152, P673, DOI 10.1016/j.cell.2013.01.041; Kim J, 2011, CELL CYCLE, V10, P1337, DOI 10.4161/cc.10.9.15291; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kim KH, 2014, NAT REV ENDOCRINOL, V10, P322, DOI 10.1038/nrendo.2014.35; Kornfeld JW, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00057; Kornfeld JW, 2013, NATURE, V494, P111, DOI 10.1038/nature11793; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lanz RB, 1999, CELL, V97, P17, DOI 10.1016/S0092-8674(00)80711-4; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Li P, 2015, CELL METAB, V21, P455, DOI 10.1016/j.cmet.2015.02.004; Liang FX, 2009, NAT REV ENDOCRINOL, V5, P367, DOI 10.1038/nrendo.2009.101; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Liu S, 2014, J BIOL CHEM, V289, P13000, DOI 10.1074/jbc.M114.564658; Liu Y, 2015, DIABETES, V64, P36, DOI 10.2337/db14-0267; Meijer AJ, 2011, CURR BIOL, V21, pR227, DOI 10.1016/j.cub.2011.02.007; Mizushima N, 2010, NAT CELL BIOL, V12, P823, DOI 10.1038/ncb0910-823; Mizushima N, 2010, CELL, V140, P313, DOI 10.1016/j.cell.2010.01.028; Moran I, 2012, CELL METAB, V16, P435, DOI 10.1016/j.cmet.2012.08.010; Murrow L, 2013, ANNU REV PATHOL-MECH, V8, P105, DOI 10.1146/annurev-pathol-020712-163918; Palmer Donna J., 2008, V433, P33, DOI 10.1007/978-1-59745-237-3_3; Ponjavic J, 2007, GENOME RES, V17, P556, DOI 10.1101/gr.6036807; Pyo JO, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3300; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Smith MA, 2013, NUCLEIC ACIDS RES, V41, P8220, DOI 10.1093/nar/gkt596; Sullivan BP, 2013, BLOOD, V121, P1868, DOI 10.1182/blood-2012-09-455436; Sun C, 2007, CELL METAB, V6, P307, DOI 10.1016/j.cmet.2007.08.014; Takahashi W, 2013, CRIT CARE, V17, DOI 10.1186/cc12839; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Uchida S, 2015, CIRC RES, V116, P737, DOI 10.1161/CIRCRESAHA.116.302521; Ulitsky I, 2011, CELL, V147, P1537, DOI 10.1016/j.cell.2011.11.055; Wang JQ, 2009, CURR BIOL, V19, P640, DOI 10.1016/j.cub.2009.02.061; Xu B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014199; Yamada E, 2012, DIABETES, V61, P272, DOI 10.2337/db11-1199; Yang L, 2010, CELL METAB, V11, P467, DOI 10.1016/j.cmet.2010.04.005; Yin DD, 2015, CELL PHYSIOL BIOCHEM, V35, P1892, DOI 10.1159/000373999; Ying L, 2013, MOL BIOSYST, V9, P407, DOI 10.1039/c2mb25386k; Zhou B, 2012, DIABETOLOGIA, V55, P2032, DOI 10.1007/s00125-012-2539-8	54	25	29	0	22	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3133	3145		10.1096/fj.201500058R	http://dx.doi.org/10.1096/fj.201500058R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27251173				2022-12-28	WOS:000382816300014
J	Leblanc, C; Langlois, MJ; Coulombe, G; Vaillancourt-Lavigueur, V; Jones, C; Carrier, JC; Boudreau, F; Rivard, N				Leblanc, Caroline; Langlois, Marie-Josee; Coulombe, Genevieve; Vaillancourt-Lavigueur, Vanessa; Jones, Christine; Carrier, Julie C.; Boudreau, Francois; Rivard, Nathalie			Epithelial Src homology region 2 domain-containing phosphatase-1 restrains intestinal growth, secretory cell differentiation, and tumorigenesis	FASEB JOURNAL			English	Article						Shp-1; intestinal epithelial cells; PI3K; beta-catenin; secretory cell fate	PROTEIN-TYROSINE-PHOSPHATASE; BETA-CATENIN; MOTH-EATEN; STEM-CELLS; WNT/BETA-CATENIN; GENE-EXPRESSION; T-CELLS; SHP-1; RECEPTOR; PANETH	Shp-1 (Src homology region 2 domain-containing protein tyrosine phosphatase-1) is a phosphatase that is highly expressed in hematopoietic and epithelial cells. Whereas its function is largely characterized in hematopoietic cells, its role in epithelial cells, such as intestinal epithelial cells (IECs), is not well known. Here, we generated mice with an IEC-specific knockout of Shp-1 (Srchomology region 2 domain-containing phosphatase-1; Shp-1(IEC-KO)). We showed that the loss of epithelial Shp-1 leads to an intestinalomegaly that is associated with an increase in epithelial cell proliferation and size. Histologic analysis demonstrates significant perturbation of the crypt-villus architecture with an apparent increase in the number of goblet and Paneth cells and increased expression of their respective markers {Muc2 (mucin 2), alpha Def, and Sox9 [SRY (sex determining region Y)-box 9]}. Expansion of intermediate cells-common progenitors of goblet and Paneth cell lineages-is also observed in Shp-1(IEC-KO) mice. Although sustained activation of Wnt/beta-catenin and PI3K/Akt/mammalian target of rapamycin signaling is observed, Shp-1(IEC-KO) mice fail to develop any intestinal tumors after 15 mo; however, the loss of Shp-1 in IECs markedly enhances tumor load Apc(Min/+) mice. These findings show a novel role for Shp-1 in the regulation of IEC growth and secretory lineage allocation, possibly via modulation of PI3K/Akt-dependent signaling pathways. Finally, Shp-1 does not function as a classic tumor suppressor gene in the intestinal epithelium.	[Leblanc, Caroline; Langlois, Marie-Josee; Coulombe, Genevieve; Vaillancourt-Lavigueur, Vanessa; Jones, Christine; Carrier, Julie C.; Boudreau, Francois; Rivard, Nathalie] Univ Sherbrooke, Fac Med & Hlth Sci, Dept Anat & Biol Cellulaire, Canc Res Pavil,3201 Jean Mignault, Sherbrooke, PQ J1E 4K8, Canada	University of Sherbrooke	Rivard, N (corresponding author), Univ Sherbrooke, Fac Med & Hlth Sci, Dept Anat & Biol Cellulaire, Canc Res Pavil,3201 Jean Mignault, Sherbrooke, PQ J1E 4K8, Canada.	nathalie.rivard@usherbrooke.ca			Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes of Health Research; Fonds de la Recherche en Sante du Quebec; Canadian Research Chair in colorectal cancer and inflammatory cell signaling	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); Canadian Research Chair in colorectal cancer and inflammatory cell signaling	This work was supported by a grant from Natural Sciences and Engineering Research Council of Canada (NSERC; to N.R.). The biobank of colorectal cancer specimens was supported by a team grant on digestive epithelium from the Canadian Institutes of Health Research. C.L. is a NSERC Alexander Graham Bell student scholar. N.R., J.C.C., and F.B. are members of the Fonds de la Recherche en Sante du Quebec-funded Centre de Recherche du Centre Hospitalier Universitaire de Sherbrooke. N.R. is a recipient of a Canadian Research Chair in colorectal cancer and inflammatory cell signaling. The authors thank Gerald Bernatchez (Universite de Sherbrooke) for technical assistance. The authors thank the RNomics and Electron Microscopy and Histology Platforms of the Faculte de Medecine et des Sciences de la Sante at the Universite de Sherbrooke for their services. The authors declare no conflicts of interest.	Abram CL, 2013, IMMUNITY, V38, P489, DOI 10.1016/j.immuni.2013.02.018; Andreu P, 2005, DEVELOPMENT, V132, P1443, DOI 10.1242/dev.01700; Andreu P, 2008, DEV BIOL, V324, P288, DOI 10.1016/j.ydbio.2008.09.027; Bergeron S, 2011, ENDOCRINOLOGY, V152, P4581, DOI 10.1210/en.2011-1268; Bian B, 2016, MOL CARCINOGEN, V55, P671, DOI 10.1002/mc.22312; Boudreau F, 2007, FASEB J, V21, P3853, DOI 10.1096/fj.07-8113com; Brockdorff J, 1999, EUR J IMMUNOL, V29, P2539, DOI 10.1002/(SICI)1521-4141(199908)29:08<2539::AID-IMMU2539>3.0.CO;2-M; Bruecher-Encke B, 2001, LEUKEMIA, V15, P1424, DOI 10.1038/sj.leu.2402214; CALVERT R, 1988, ANAT REC, V220, P291, DOI 10.1002/ar.1092200310; CAMPBELL MA, 1995, EUR J IMMUNOL, V25, P1573, DOI 10.1002/eji.1830250616; Chen HE, 1996, MOL CELL BIOL, V16, P3685, DOI 10.1128/mcb.16.7.3685; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; Crackower MA, 2002, CELL, V110, P737, DOI 10.1016/S0092-8674(02)00969-8; Cuevas B, 1999, J BIOL CHEM, V274, P27583, DOI 10.1074/jbc.274.39.27583; Diez-Villanueva A, 2015, EPIGENET CHROMATIN, V8, DOI 10.1186/s13072-015-0014-8; Dubois MJ, 2006, NAT MED, V12, P549, DOI 10.1038/nm1397; Duchesne C, 2003, J BIOL CHEM, V278, P14274, DOI 10.1074/jbc.M300425200; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Farin HF, 2012, GASTROENTEROLOGY, V143, P1518, DOI 10.1053/j.gastro.2012.08.031; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Gao N, 2010, GENE DEV, V24, P1295, DOI 10.1101/gad.1921510; Garneau H, 2009, J CELL PHYSIOL, V221, P350, DOI 10.1002/jcp.21859; Gonneaud A, 2016, SCI REP-UK, V6, DOI 10.1038/srep38195; Goodman CA, 2014, REV PHYSIOL BIOCH P, V166, P43, DOI 10.1007/112_2013_17; Goodman CA, 2011, FASEB J, V25, P1028, DOI 10.1096/fj.10-168799; GREEN MC, 1975, J HERED, V66, P250, DOI 10.1093/oxfordjournals.jhered.a108625; Grothey A, 2013, LANCET, V381, P303, DOI 10.1016/S0140-6736(12)61900-X; Jiao HY, 1997, EXP HEMATOL, V25, P592; Jiao HY, 1996, MOL CELL BIOL, V16, P6985; Kamal M, 2001, CLIN EXP IMMUNOL, V126, P117, DOI 10.1046/j.1365-2249.2001.01589.x; Katz JP, 2002, DEVELOPMENT, V129, P2619; Kenerson HL, 2013, GASTROENTEROLOGY, V144, P1055, DOI 10.1053/j.gastro.2013.01.053; Kim KA, 2005, SCIENCE, V309, P1256, DOI 10.1126/science.1112521; KLINGMULLER U, 1995, CELL, V80, P729, DOI 10.1016/0092-8674(95)90351-8; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kozlowski M, 1998, MOL CELL BIOL, V18, P2089, DOI 10.1128/MCB.18.4.2089; Krausova M, 2014, CELL SIGNAL, V26, P570, DOI 10.1016/j.cellsig.2013.11.032; Kwon CH, 2006, NEURON, V50, P377, DOI 10.1016/j.neuron.2006.03.023; Langlois MJ, 2009, FASEB J, V23, P1835, DOI 10.1096/fj.08-123125; Li YH, 2014, ONCOL REP, V31, P2438, DOI 10.3892/or.2014.3098; Liu B, 2013, AM J PHYSIOL-GASTR L, V305, pG573, DOI 10.1152/ajpgi.00071.2013; Lowry WE, 2005, GENE DEV, V19, P1596, DOI 10.1101/gad.1324905; Ma XZ, 2003, EXP HEMATOL, V31, P131, DOI 10.1016/S0301-472X(02)01025-1; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mizuno K, 2005, EUR J IMMUNOL, V35, P644, DOI 10.1002/eji.200425465; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Noah TK, 2010, EXP CELL RES, V316, P452, DOI 10.1016/j.yexcr.2009.09.020; Oka T, 2001, AM J PATHOL, V159, P1495, DOI 10.1016/S0002-9440(10)62535-7; Onuma K, 2013, P NATL ACAD SCI USA, V110, P11127, DOI 10.1073/pnas.1221926110; Pao LI, 2007, IMMUNITY, V27, P35, DOI 10.1016/j.immuni.2007.04.016; Perreault N, 2005, GENE DEV, V19, P311, DOI 10.1101/gad.1260605; PLUTZKY J, 1992, P NATL ACAD SCI USA, V89, P1123, DOI 10.1073/pnas.89.3.1123; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sato H, 2010, AM J PATHOL, V176, P402, DOI 10.2353/ajpath.2010.090236; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; SHULTZ LD, 1993, CELL, V73, P1445, DOI 10.1016/0092-8674(93)90369-2; Siminovitch KA, 1999, CURR TOP MICROBIOL, V246, P291; Simoneau M, 2011, CELL SIGNAL, V23, P269, DOI 10.1016/j.cellsig.2010.09.011; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Suzuki A, 2003, CANCER RES, V63, P674; TSUI HW, 1993, NAT GENET, V4, P124, DOI 10.1038/ng0693-124; Van Der Flier LG, 2007, GASTROENTEROLOGY, V132, P628, DOI 10.1053/j.gastro.2006.08.039; Van der Flier LG, 2009, GASTROENTEROLOGY, V137, P15, DOI 10.1053/j.gastro.2009.05.035; van Es JH, 2005, NAT CELL BIOL, V7, P381, DOI 10.1038/ncb1240; Wang SY, 2004, J HISTOCHEM CYTOCHEM, V52, P53, DOI 10.1177/002215540405200106; Winterford CM, 1999, J HISTOCHEM CYTOCHEM, V47, P1063, DOI 10.1177/002215549904700811; Wu CY, 2003, GENE, V306, P1, DOI 10.1016/S0378-1119(03)00400-1; Wu YF, 2015, ONCOTARGETS THER, V8, P2577, DOI 10.2147/OTT.S82225; Yu ZB, 1998, J BIOL CHEM, V273, P3687, DOI 10.1074/jbc.273.6.3687; Zatelli MC, 2005, ENDOCRINOLOGY, V146, P2692, DOI 10.1210/en.2005-0001	72	5	5	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3512	3526		10.1096/fj.201601378R	http://dx.doi.org/10.1096/fj.201601378R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28465325				2022-12-28	WOS:000405932400027
J	Overmiller, AM; Pierluissi, JA; Wermuth, PJ; Sauma, S; Martinez-Outschoorn, U; Tuluc, M; Luginbuhl, A; Curry, J; Harshyne, LA; Wahl, JK; South, AP; Mahoney, MG				Overmiller, Andrew M.; Pierluissi, Jennifer A.; Wermuth, Peter J.; Sauma, Sami; Martinez-Outschoorn, Ubaldo; Tuluc, Madalina; Luginbuhl, Adam; Curry, Joseph; Harshyne, Larry A.; Wahl, James K., III; South, Andrew P.; Mahoney, My G.			Desmoglein 2 modulates extracellular vesicle release from squamous cell carcinoma keratinocytes	FASEB JOURNAL			English	Article						EGFR; exosome; fibroblast; HNSCC	TUMOR MICROENVIRONMENT; EXOSOMES; HEAD; CAVEOLIN-1; EXPRESSION; EGFR; DSG2; PROLIFERATION; ENVIRONMENT; ENDOCYTOSIS	Extracellular vesicles (EVs) are nanoscale membrane-derived vesicles that serve as intercellular messengers carrying lipids, proteins, and genetic material. Substantial evidence has shown that cancer-derived EVs, secreted by tumor cells into the blood and other bodily fluids, play a critical role in modulating the tumor micro-environment and affecting the pathogenesis of cancer. Here we demonstrate for the first time that squamous cell carcinoma (SCC) EVs were enriched with the C-terminal fragment of desmoglein 2 (Dsg2), a desmosomal cadherin often overexpressed in malignancies. Overexpression of Dsg2 increased EV release and mitogenic content including epidermal growth factor receptor and c-Src. Inhibiting ectodomain shedding of Dsg2 with the matrix metalloproteinase inhibitor GM6001 resulted in accumulation of full-length Dsg2 in EVs and reduced EV release. When cocultured with Dsg2/green fluorescence protein-expressing SCC cells, green fluorescence protein signal was detected by fluorescence-activated cell sorting analysis in the CD90(+) fibroblasts. Furthermore, SCC EVs activated Erk1/2 and Akt signaling and enhanced fibroblast cell proliferation. In vivo, Dsg2 was highly up-regulated in the head and neck SCCs, and EVs isolated from sera of patients with SCC were enriched in Dsg2 C-terminal fragment and epidermal growth factor receptor. This study defines a mechanism by which Dsg2 expression in cancer cells can modulate the tumor microenvironment, a step critical for tumor progression.	[Overmiller, Andrew M.; Pierluissi, Jennifer A.; Wermuth, Peter J.; South, Andrew P.; Mahoney, My G.] Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, 233 S 10th St,Suite 428 BLSB, Philadelphia, PA 19107 USA; [Sauma, Sami; Harshyne, Larry A.] Thomas Jefferson Univ, Dept Neurol Surg, Philadelphia, PA 19107 USA; [Martinez-Outschoorn, Ubaldo] Thomas Jefferson Univ, Dept Med Oncol, Philadelphia, PA 19107 USA; [Tuluc, Madalina; Luginbuhl, Adam; Curry, Joseph] Thomas Jefferson Univ, Dept Otolaryngol Head & Neck Surg, Philadelphia, PA 19107 USA; [Wahl, James K., III] Univ Nebraska, Dept Oral Biol, Lincoln, NE USA	Jefferson University; Jefferson University; Jefferson University; Jefferson University; University of Nebraska System; University of Nebraska Lincoln	Mahoney, MG (corresponding author), Thomas Jefferson Univ, Dept Dermatol & Cutaneous Biol, 233 S 10th St,Suite 428 BLSB, Philadelphia, PA 19107 USA.	my.mahoney@jefferson.edu		Wermuth, Peter/0000-0002-0242-7265; Sauma, Sami/0000-0001-7278-341X; Curry, Joseph/0000-0001-9507-4237; Harshyne, Larry/0000-0002-8699-3028; Martinez-Outschoorn, Ubaldo/0000-0003-1483-4551	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR056067]; Thomas Jefferson University Dean's Transformational Science Award; NATIONAL CANCER INSTITUTE [P30CA056036] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR056067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Thomas Jefferson University Dean's Transformational Science Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by the U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grant AR056067 to M.G.M.), and the Thomas Jefferson University Dean's Transformational Science Award (to M.G.M.). Confocal microscopy was performed in the Bioimaging Core (SKCC; NCI 5 P30 CA-56036). Special thanks to M. Y. Covarrubias (Bioimaging Shared Resource of the Sidney Kimmel Cancer Center, Thomas Jefferson University) for technical assistance and advice. The authors declare no conflicts of interest.	Barber AG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098786; Beckler MD, 2013, MOL CELL PROTEOMICS, V12, P343, DOI 10.1074/mcp.M112.022806; Biedermann K, 2005, J PATHOL, V207, P199, DOI 10.1002/path.1821; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Brennan D, 2012, ONCOGENE, V31, P1636, DOI 10.1038/onc.2011.346; Brennan D, 2007, J CELL SCI, V120, P758, DOI 10.1242/jcs.03392; Brennan D, 2009, CELL ADHES MIGR, V3, P148, DOI 10.4161/cam.3.2.7539; Brennan-Crispi DM, 2015, ONCOTARGET, V6, P8593, DOI 10.18632/oncotarget.3309; Brooke MA, 2014, HUM MOL GENET, V23, P4064, DOI 10.1093/hmg/ddu120; Cassell A, 2010, EXPERT OPIN INV DRUG, V19, P709, DOI 10.1517/13543781003769844; Chen WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095240; Colombo M, 2014, ANNU REV CELL DEV BI, V30, P255, DOI 10.1146/annurev-cellbio-101512-122326; Curry JM, 2014, SEMIN ONCOL, V41, P217, DOI 10.1053/j.seminoncol.2014.03.003; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Eshkind L, 2002, EUR J CELL BIOL, V81, P592, DOI 10.1078/0171-9335-00278; Goruppi S, 2013, TRENDS CELL BIOL, V23, P593, DOI 10.1016/j.tcb.2013.08.006; Greening DW, 2015, METHODS MOL BIOL, V1295, P179, DOI 10.1007/978-1-4939-2550-6_15; Harshyne LA, 2016, NEURO-ONCOLOGY, V18, P206, DOI 10.1093/neuonc/nov107; Hayer A, 2010, J CELL BIOL, V191, P615, DOI 10.1083/jcb.201003086; Hood JL, 2011, CANCER RES, V71, P3792, DOI 10.1158/0008-5472.CAN-10-4455; Huang YC, 2014, INT J BIOL SCI, V10, P702, DOI 10.7150/ijbs.9326; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Keim SA, 2008, HYBRIDOMA, V27, P249, DOI 10.1089/hyb.2008.0020; Kharaziha P, 2015, ONCOTARGET, V6, P21740, DOI 10.18632/oncotarget.3226; Klessner JL, 2009, MOL BIOL CELL, V20, P328, DOI 10.1091/mbc.E08-04-0356; Kolegraff K, 2011, CELL ADHES MIGR, V5, P306, DOI 10.4161/cam.5.4.16911; Kurzen H, 2003, J CUTAN PATHOL, V30, P621, DOI 10.1034/j.1600-0560.2003.00122.x; Leemans CR, 2011, NAT REV CANCER, V11, P9, DOI 10.1038/nrc2982; Liang B, 2013, J PROTEOMICS, V80, P171, DOI 10.1016/j.jprot.2012.12.029; Logozzi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005219; Meckes DG, 2010, P NATL ACAD SCI USA, V107, P20370, DOI 10.1073/pnas.1014194107; Nanbo A, 2013, J VIROL, V87, P10334, DOI 10.1128/JVI.01310-13; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; Ni SS, 2013, TUMOR BIOL, V34, P1813, DOI 10.1007/s13277-013-0721-3; Oh ST, 2016, DERM-ENDOCRINOL, V8, DOI 10.1080/19381980.2016.1228499; Ostrowski M, 2010, NAT CELL BIOL, V12, P19, DOI 10.1038/ncb2000; Overmiller AM, 2016, ONCOTARGET, V7, P37536, DOI 10.18632/oncotarget.7675; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; Peterson MF, 2015, METHODS, V87, P31, DOI 10.1016/j.ymeth.2015.04.015; Phuyal S, 2014, FEBS J, V281, P2214, DOI 10.1111/febs.12775; Pilichou K, 2006, CIRCULATION, V113, P1171, DOI 10.1161/CIRCULATIONAHA.105.583674; Rothenberg SM, 2012, J CLIN INVEST, V122, P1951, DOI 10.1172/JCI59889; Sanderson MP, 2008, J CELL BIOCHEM, V103, P1783, DOI 10.1002/jcb.21569; SCHAFER S, 1994, EXP CELL RES, V211, P391, DOI 10.1006/excr.1994.1103; Schmitz S, 2016, CURR TREAT OPTION ON, V17, DOI 10.1007/s11864-016-0412-6; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Svensson KJ, 2013, J BIOL CHEM, V288, P17713, DOI 10.1074/jbc.M112.445403; Tan LY, 2016, ONCOTARGET, V7, P46492, DOI 10.18632/oncotarget.10216; Tan SS, 2013, J EXTRACELL VESICLES, V2, DOI 10.3402/jev.v2i0.22614; Teh MT, 2011, J ORAL PATHOL MED, V40, P67, DOI 10.1111/j.1600-0714.2010.00951.x; Vered M, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1030-6; Wang HJ, 2015, J VIROL, V89, P10841, DOI 10.1128/JVI.01425-15; Watt SA, 2011, ONCOGENE, V30, P4666, DOI 10.1038/onc.2011.180; Ng YZ, 2012, CANCER RES, V72, P3522, DOI 10.1158/0008-5472.CAN-11-2996	54	45	45	0	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3412	3424		10.1096/fj.201601138RR	http://dx.doi.org/10.1096/fj.201601138RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28438789	Green Published			2022-12-28	WOS:000405932400020
J	Gosselin-Badaroudine, P; Chahine, M				Gosselin-Badaroudine, Pascal; Chahine, Mohamed			Biophysical characterization of the Varroa destructor Na(V)1 sodium channel and its affinity for tau-fluvalinate insecticide	FASEB JOURNAL			English	Article						Xenopus oocytes; Na(v)1; voltage-gated sodium channels	ACARI; HYMENOPTERA; JACOBSONI; TOXICITY; APIDAE	The decline of the western honeybee (Apis mellifera) has been reported to be due to parasitism by Varroa destructor mites and to colony collapse disorder in which these mites may be involved. In-hive chemicals such as T-fluvalinate are being used to control V. destructor populations. This approach may lead to the chronic exposure of bees to this liposoluble chemical, which tends to accumulate in hives. We cloned a variant of the V. destructor voltage-dependent sodium (VdNav1) channel and studied its biophysical characteristics and sensitivity to r-fluvalinate using the Xenopus oocyte expression system and the 2-microelectrode voltage-clamp technique. We compared the affinity of VdNav1 for r-fluvalinate with the honeybee voltage-dependent sodium ortholog. Our results showed that the honeybee sodium channel is more sensitive to r-fluvalinate than the V. destructor channel, suggesting that care must be taken when treating hives with this chemical. Gosselin-Badaroudine, P., Chahine, M. Biophysical characterization of the Varroa destructor Nav1 sodium channel and its affinity for r-fluvalinate insecticide.	[Gosselin-Badaroudine, Pascal; Chahine, Mohamed] Inst Univ Sante Mentale Quebec, Ctr Rech, 2601 Chemin Canardiere, Quebec City, PQ G1J 2G3, Canada; [Chahine, Mohamed] Univ Laval, Dept Med, Quebec City, PQ, Canada	Laval University; Laval University	Chahine, M (corresponding author), Inst Univ Sante Mentale Quebec, Ctr Rech, 2601 Chemin Canardiere, Quebec City, PQ G1J 2G3, Canada.	mohamed.chahine@phc.ulaval.ca			Natural Sciences and Engineering Research Council of Canada [(NSERC)]; NSERC	Natural Sciences and Engineering Research Council of Canada [(NSERC)](Natural Sciences and Engineering Research Council of Canada (NSERC)); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This study was funded by the Natural Sciences and Engineering Research Council of Canada [(NSERC) Discovery Grant]. P.G.-B. was supported by an NSERC Postgraduate Scholarship. The authors thank Valerie Pouliot and Karine Drapeau for technical assistance and Pierre Giovenazzo (all from the Universite Laval) for providing the mites used in the study.	Calderone, 2000, BEE CULT, V128, P1, DOI DOI 10.3896/IBRA.1.49.1.01; Catterall WA, 2005, PHARMACOL REV, V57, P397, DOI 10.1124/pr.57.4.4; CHAHINE M, 1992, J MOL CELL CARDIOL, V24, P1231, DOI 10.1016/0022-2828(92)93090-7; Charreton M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144879; Dong K, 2014, INSECT BIOCHEM MOLEC, V50, P1, DOI 10.1016/j.ibmb.2014.03.012; Du YZ, 2013, P NATL ACAD SCI USA, V110, P11785, DOI 10.1073/pnas.1305118110; Du YZ, 2009, J BIOL CHEM, V284, P33869, DOI 10.1074/jbc.M109.045690; Frazier J, 2011, AM BEE J, V151, P779; Gosselin-Badaroudine P, 2015, SCI REP-UK, V5, DOI 10.1038/srep12475; Johnson RM, 2006, J ECON ENTOMOL, V99, P1046, DOI 10.1603/0022-0493-99.4.1046; Johnson RM, 2010, INT J ACAROL, V36, P1, DOI 10.1080/01647950903468273; Mullin CA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009754; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Oldroyd BP, 1999, TRENDS ECOL EVOL, V14, P312, DOI 10.1016/S0169-5347(99)01613-4; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; Sammataro D, 2005, INT J ACAROL, V31, P67, DOI 10.1080/01647950508684419; Santiago GP, 2000, FLA ENTOMOL, V83, P468, DOI 10.2307/3496722; Soderlund DM, 2010, PESTIC BIOCHEM PHYS, V97, P78, DOI 10.1016/j.pestbp.2009.06.010; Song WZ, 2004, J BIOL CHEM, V279, P32554, DOI 10.1074/jbc.M402392200; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Wang RW, 2003, INSECT BIOCHEM MOLEC, V33, P733, DOI 10.1016/S0965-1748(03)00068-7	22	6	6	1	19	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3066	3071		10.1096/fj.201601338R	http://dx.doi.org/10.1096/fj.201601338R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28356346				2022-12-28	WOS:000405931000030
J	Gu, LL; Larson-Casey, JL; Carter, AB				Gu, Linlin; Larson-Casey, Jennifer L.; Carter, A. Brent			Macrophages utilize the mitochondrial calcium uniporter for profibrotic polarization	FASEB JOURNAL			English	Article						MCU; asbestos; reactive oxygen species; pulmonary fibrosis; ATP	PULMONARY-FIBROSIS; ALTERNATIVE ACTIVATION; GENE-EXPRESSION; LIVER-INJURY; CA2+ UPTAKE; RESPONSES; RECEPTOR; CELLS; INFLAMMATION; RECRUITMENT	Fibrosis in multiple organs, including the liver, kidney, and lung, often occurs secondary to environmental exposure. Asbestos exposure is one important environmental cause of lung fibrosis. The mechanisms that mediate fibrosis is not fully understood, although mitochondrial oxidative stress in alveolar macrophages is critical for fibrosis development. Mitochondrial Ca2+ levels can be associated with production of reactive oxygen species. Here, we show that patients with asbestosis have higher levels of mitochondrial Ca2+ compared with normal patients. The mitochondrial calcium uniporter (MCU) is a highly selective ion channel that transports Ca2+ into the mitochondrial matrix to modulate metabolism. Asbestos exposure increased mitochondrial Ca2+ influx in alveolar macrophages from wild-type, but not MCLI+/-, mice. MCU expression polarized macrophages to a profibrotic phenotype after exposure to asbestos, and the profibrotic polarization was regulated by MCU-mediated ATP production. Profibrotic polarization was abrogated when MCU was absent or its activity was blocked. Of more importance, mice that were deficient in MCU were protected from pulmonary fibrosis. Regulation of mitochondrial Ca2+ suggests that MCU may play a pivotal role in the development of fibrosis and could potentially be a therapeutic target for pulmonary fibrosis. Gu, L., Larson-Casey, J. L., Carter, A. B. Macrophages utilize the mitochondrial calcium uniporter for profibrotic polarization.	[Gu, Linlin; Larson-Casey, Jennifer L.; Carter, A. Brent] Univ Alabama Birmingham, Dept Med, Div Pulm Allergy & Crit Care Med, Birmingham, AL 35294 USA; [Carter, A. Brent] Birmingham Vet Affairs Med Ctr, Birmingham, AL USA	University of Alabama System; University of Alabama Birmingham; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Birmingham	Carter, AB (corresponding author), Univ Alabama Birmingham, Dept Med, 1918 Univ Blvd,404 MCLM, Birmingham, AL 35294 USA.	bcarter1@uab.edu	Casey, Jennifer/N-8385-2019	Casey, Jennifer/0000-0001-7238-7986	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences [2R01-E5015981-10]; U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (Biomedical Laboratory Research and Development Grant) [1BX001135-04]; NIH National Institute of Diabetes and Digestive and Kidney Diseases [P30-DK079626]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES015981] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001135] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (Biomedical Laboratory Research and Development Grant); NIH National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported, in whole or in part, by the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (Grant 2R01-E5015981-10). This work was also supported by a Merit Review from the U.S. Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development (Biomedical Laboratory Research and Development Grant 1BX001135-04). OCR assays were supported by NIH National Institute of Diabetes and Digestive and Kidney Diseases (Grant P30-DK079626). The authors thank the Diabetes Research Center Bio-Analytical Redox Biology Core, Douglas R. Moellering, and Praveen Vayalill (both from the University of Alabama at Birmingham) for technical assistance on the Seahorse assay.	De Stefani D, 2011, NATURE, V476, P336, DOI 10.1038/nature10230; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Gizatullina ZZ, 2003, BIOCHEM BIOPH RES CO, V304, P643, DOI 10.1016/S0006-291X(03)00654-5; Glancy B, 2013, BIOCHEMISTRY-US, V52, P2793, DOI 10.1021/bi3015983; Griffiths EJ, 2009, BBA-BIOENERGETICS, V1787, P1324, DOI 10.1016/j.bbabio.2009.01.019; Hansson MJ, 2008, FREE RADICAL BIO MED, V45, P284, DOI 10.1016/j.freeradbiomed.2008.04.021; He C, 2016, AM J RESP CELL MOL, V55, P58, DOI 10.1165/rcmb.2015-0183OC; He C, 2013, J BIOL CHEM, V288, P20745, DOI 10.1074/jbc.M112.410720; He C, 2011, J BIOL CHEM, V286, P15597, DOI 10.1074/jbc.M110.187377; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Iwata Y, 2012, J IMMUNOL, V188, P4568, DOI 10.4049/jimmunol.1102154; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kawamura K, 2009, PATHOL INT, V59, P300, DOI 10.1111/j.1440-1827.2009.02369.x; Kirichok Y, 2004, NATURE, V427, P360, DOI 10.1038/nature02246; Kovac S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.390; Larson-Casey JL, 2016, IMMUNITY, V44, P582, DOI 10.1016/j.immuni.2016.01.001; Larson-Casey JL, 2014, J BIOL CHEM, V289, P36204, DOI 10.1074/jbc.M114.593285; Liu T, 2008, CIRC RES, V103, P279, DOI 10.1161/CIRCRESAHA.108.175919; Mallilankaraman K, 2012, CELL, V151, P630, DOI 10.1016/j.cell.2012.10.011; Mammucari C, 2015, CELL REP, V10, P1269, DOI 10.1016/j.celrep.2015.01.056; McGowan TA, 2002, AM J PHYSIOL-RENAL, V282, pF910, DOI 10.1152/ajprenal.00252.2001; Murthy S, 2015, FASEB J, V29, P3527, DOI 10.1096/fj.15-271304; Murthy S, 2010, J BIOL CHEM, V285, P25062, DOI 10.1074/jbc.M109.099655; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; Nesti LJ, 2007, J CELL BIOCHEM, V101, P348, DOI 10.1002/jcb.21180; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; O'Hagan KA, 2009, P NATL ACAD SCI USA, V106, P2188, DOI 10.1073/pnas.0808801106; Osborn-Heaford HL, 2015, FREE RADICAL BIO MED, V86, P47, DOI 10.1016/j.freeradbiomed.2015.04.031; Osborn-Heaford HL, 2012, J BIOL CHEM, V287, P3301, DOI 10.1074/jbc.M111.308387; Ouimet M, 2015, J CLIN INVEST, V125, P4334, DOI 10.1172/JCI81676; Patron M, 2014, MOL CELL, V53, P726, DOI 10.1016/j.molcel.2014.01.013; Patron M, 2013, J BIOL CHEM, V288, P10750, DOI 10.1074/jbc.R112.420752; Rasmussen TP, 2015, P NATL ACAD SCI USA, V112, P9129, DOI 10.1073/pnas.1504705112; Redente EF, 2014, AM J RESP CELL MOL, V50, P825, DOI 10.1165/rcmb.2013-0386OC; Rimessi A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7201; Riteau N, 2010, AM J RESP CRIT CARE, V182, P774, DOI 10.1164/rccm.201003-0359OC; Rodriguez-Prados JC, 2010, J IMMUNOL, V185, P605, DOI 10.4049/jimmunol.0901698; Ryan AJ, 2014, J BIOL CHEM, V289, P33391, DOI 10.1074/jbc.M114.579870; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Shaughnessy LM, 2007, FRONT BIOSCI-LANDMRK, V12, P2683, DOI 10.2741/2364; Stahl M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081382; Tarasov AI, 2012, CELL CALCIUM, V52, P28, DOI 10.1016/j.ceca.2012.03.003; Westphalen K, 2014, NATURE, V506, P503, DOI 10.1038/nature12902; Wu YJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7081; Yan HY, 2015, MOL NEUROBIOL, V52, P1637, DOI 10.1007/s12035-014-8942-z	45	24	24	1	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3072	3083		10.1096/fj.201601371R	http://dx.doi.org/10.1096/fj.201601371R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28351840	Green Published			2022-12-28	WOS:000405931000031
J	He, YD; Sun, YC; Zhang, XB				He, Yaodong; Sun, Yuechao; Zhang, Xiaobo			Noncoding miRNAs bridge virus infection and host autophagy in shrimp in vivo	FASEB JOURNAL			English	Article						WWSV; target gene; interaction; rapamycin	PATHWAY REGULATES APOPTOSIS; MICRORNA; CRUSTACEAN; KNICKKOPF; PROTECTS; GROWTH; CHITIN; CELLS	Autophagy is known to be involved in viral infection. However, the relationship between autophagy and viral infection has not been characterized. MicroRNAs (miRNAs), important regulators of gene transcription, play central roles in many biologic processes, including autophagy and viral infection. It was therefore of interest to investigate the miRNAs regulating viral infection and host autophagy. In this study the viral infection (white spot syndrome virus, WSSV) correlated positively with the host autophagy in shrimp. Two host miRNAs (miR-71 and-13b) had significant effects on viral infection and host autophagy. MiR-71 regulated the viral infection and host autophagy by targeting the host calcification-associated peptide-1 (cap-1) gene. MiR-13b targeted the host knickkopf gene to simultaneously regulate viral infection and host autophagy. When the expressions of miR-71 and-13b were silenced in shrimp, the autophagy could not be induced by WSSV infection and the autophagy induction did not influence the virus replication, indicating that miR-71 and-13b were necessary for the viral infection and host autophagy. In this context, the findings of this study revealed a novel mechanism of miRNAs bridging the viral infection and host autophagy in vivo. He, Y., Sun, Y., Zhang, X. Noncoding miRNAs bridge virus infection and host autophagy in shrimp in vivo.	Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Zhang, Xiaobo] Zhejiang Univ, Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Qingdao National Laboratory for Marine Science & Technology; Zhejiang University	Zhang, XB (corresponding author), Zhejiang Univ, Qingdao Natl Lab Marine Sci & Technol, Lab Marine Biol & Biotechnol, Hangzhou 310058, Zhejiang, Peoples R China.	zxb0812@zju.edu.cn	He, Yaodong/AAX-3307-2021	He, Yaodong/0000-0003-0961-4079; Zhang, Xiaobo/0000-0003-4606-212X	National Natural Science Foundation of China [31430089]; Major State Basic Research Development Program Grant [2015CB755903]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major State Basic Research Development Program Grant(National Basic Research Program of China)	This work was supported by National Natural Science Foundation of China Grant 31430089 and Major State Basic Research Development Program Grant 2015CB755903. The authors declare no conflicts of interest.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Boya P, 2013, NAT CELL BIOL, V15, P713, DOI 10.1038/ncb2788; Chaudhari SS, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004537; Chaudhari SS, 2011, P NATL ACAD SCI USA, V108, P17028, DOI 10.1073/pnas.1112288108; Cheng Y. J., 2013, CIRCULATION S22, V128; Cui YL, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150126; Dreux M, 2010, CELL CYCLE, V9, P1295, DOI 10.4161/cc.9.7.11109; Frankel LB, 2012, CARCINOGENESIS, V33, P2018, DOI 10.1093/carcin/bgs266; Fullgrabe J, 2013, NATURE, V500, P468, DOI 10.1038/nature12313; Gong Y, 2015, FISH SHELLFISH IMMUN, V46, P516, DOI 10.1016/j.fsi.2015.07.022; He YD, 2015, MOL IMMUNOL, V68, P399, DOI 10.1016/j.molimm.2015.07.008; He YD, 2014, J VIROL, V88, P1104, DOI 10.1128/JVI.02455-13; Heaton NS, 2010, CELL HOST MICROBE, V8, P422, DOI 10.1016/j.chom.2010.10.006; Huang TZ, 2014, J VIROL, V88, P2544, DOI 10.1128/JVI.03575-13; Huang TZ, 2012, J VIROL, V86, P12997, DOI 10.1128/JVI.01702-12; Huang TZ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-159; Jordan TX, 2012, MICROBES INFECT, V14, P126, DOI 10.1016/j.micinf.2011.09.007; Kim J, 2013, CELL, V152, P290, DOI 10.1016/j.cell.2012.12.016; Klionsky DJ, 2016, AUTOPHAGY, V12, P1, DOI 10.1080/15548627.2015.1100356; Krol J, 2010, NAT REV GENET, V11, P597, DOI 10.1038/nrg2843; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Mikhaylova O, 2012, CANCER CELL, V21, P532, DOI 10.1016/j.ccr.2012.02.019; Mizushima N, 2011, ANNU REV CELL DEV BI, V27, P107, DOI 10.1146/annurev-cellbio-092910-154005; Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177; Nagasawa H, 2013, BIOSCI BIOTECH BIOCH, V77, P1991, DOI 10.1271/bbb.130464; Orvedahl A, 2010, CELL HOST MICROBE, V7, P115, DOI 10.1016/j.chom.2010.01.007; Ren Q, 2015, SCI REP-UK, V5, DOI 10.1038/srep18384; Wang PH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024773; Wu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068209; Xu PZ, 2004, TRENDS GENET, V20, P617, DOI 10.1016/j.tig.2004.09.010; Yang G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039015; Yang L, 2014, FISH SHELLFISH IMMUN, V40, P146, DOI 10.1016/j.fsi.2014.06.019; Yordy B, 2011, CURR OPIN VIROL, V1, P196, DOI 10.1016/j.coviro.2011.05.016; Yu Y, 2012, LEUKEMIA, V26, P1752, DOI 10.1038/leu.2012.65; Zou ZY, 2012, J BIOL CHEM, V287, P4148, DOI 10.1074/jbc.M111.307405	35	24	25	1	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2854	2868		10.1096/fj.201601141RR	http://dx.doi.org/10.1096/fj.201601141RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28330853				2022-12-28	WOS:000405931000012
J	Sanchez-Carrera, D; Bravo-Navas, S; Cabezon, E; Arechaga, I; Cabezas, M; Yanez, L; Pipaon, C				Sanchez-Carrera, Damaso; Bravo-Navas, Sara; Cabezon, Elena; Arechaga, Ignacio; Cabezas, Matilde; Yanez, Lucrecia; Pipaon, Carlos			Fludarabine resistance mediated by aminoglycoside-3'-phosphotransferase-IIa and the structurally related eukaryotic cAMP-dependent protein kinase	FASEB JOURNAL			English	Article						purine analogues; protein kinase A; DNA damage; FANC proteins	CHRONIC LYMPHOCYTIC-LEUKEMIA; NUCLEOTIDE EXCISION-REPAIR; ANTIBIOTIC-RESISTANCE; NUCLEOSIDE ANALOGS; CRYSTAL-STRUCTURES; DNA; INHIBITION; 9-BETA-D-ARABINOFURANOSYL-2-FLUOROADENINE; ENZYME; CYTOTOXICITY	While working with G418-resistant stably transfected cells, we realized the neomycin resistance (NeoR) gene, which encodes the aminoglycoside-3'-phosphotransferase-IIa [APH(3')-IIa], also confers resistance to the nucleoside analog fludarabine. Fludarabine is a cytostatic drug widely used in the treatment of hematologic and solid tumors, as well as in the conditioning of patients before transplantation of hematopoietic progenitors. We present evidence that NeoR-transfected cells do not incorporate fludarabine, thus avoiding DNA damage caused by the drug, evidenced by a lack of FANCD2 monoubiquitination and impaired apoptosis. A screening of other nucleoside analogs revealed that APH(3')-IIa only protects against ATP purine analogs. Moreover, APH(3')-IIa ATPase activity is inhibited by fludarabine monophosphate, suggesting that APH(3')-IIa blocks fludarabine incorporation into DNA by dephosphorylating its active fludarabine triphosphate form. Furthermore, overexpression of the catalytic subunit of the eukaryotic kinase PKA, which is structurally related to APHs, also provides resistance to fludarabine, anticipating its putative utility as a response marker to the drug. Our results preclude the use of Neo marker plasmids in the study of purine analogs and unveils a new resistance mechanism against these chemotherapeuticals. Sanchez-Carrera, D., Bravo-Navas, S., Cabezon, E., Arechaga, I., Cabezas, M., Yaiiez, L., Pipaon, C. Fludarabine resistance mediated by aminoglycoside-3'-phosphotransferase-IIa and the structurally related eukaryotic cAMP-dependent protein kinase.	[Sanchez-Carrera, Damaso; Bravo-Navas, Sara; Yanez, Lucrecia; Pipaon, Carlos] Hosp Univ Marques Valdecilla, Inst Invest Marques Valdecilla IDIVAL, Lab Hematol Mol, Serv Hematol & Hemoterapia, Santander, Spain; [Cabezon, Elena; Arechaga, Ignacio; Cabezas, Matilde] Univ Cantabria, CSIC, Dept Biol Mol, Santander, Spain; [Cabezon, Elena; Arechaga, Ignacio; Cabezas, Matilde] Univ Cantabria, CSIC, Inst Biomed & Biotecnol Cantabria IBBTEC, Santander, Spain	Hospital Universitario Marques de Valdecilla (HUMV); Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Cantabria; CSIC - Instituto de Biomedicina y Biotecnologia de Cantabria (IBBTEC)	Pipaon, C (corresponding author), Hosp Univ Marques Valdecilla, Lab Hematol Mol, Pabellon 20,Bajo Avda Valdecilla S-N, Santander 39008, Spain.	cpipaon@humv.es	Pipaon, Carlos/L-4922-2014; Cabezon, Elena/K-5874-2014; Yáñez San Segundo, Lucrecia/G-4662-2016	Pipaon, Carlos/0000-0002-3851-6710; Yáñez San Segundo, Lucrecia/0000-0001-9925-3048; Cabezon, Elena/0000-0002-6177-5016; Bravo Navas, Sara/0000-0002-7166-0191	Hematology Service of the Hospital Marques de Valdecilla; Spanish Ministerio de Economia y Competitividad [BFU2011-22874]	Hematology Service of the Hospital Marques de Valdecilla; Spanish Ministerio de Economia y Competitividad(Spanish Government)	This work was supported by the Hematology Service of the Hospital Marques de Valdecilla and Spanish Ministerio de Economia y Competitividad (Grant BFU2011-22874 to E.C and I.A). Fibroblast cell lines were kindly provided by Dr. Jordi Surralles (Universidad de Barcelona, Barcelona, Spain). The authors thank Virgina Martinez Callejo (Hospital Marques de Valdecilla) for providing many of the nucleoside analogues, and Gerardo Carranza [Institute de Biomedicina y Biotecnologia de Cantabria (IBBTEC)] for his help. The authors declare no conflicts of interest.	Amigo-Jimenez I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099993; Chang XB, 1998, J BIOL CHEM, V273, P23844, DOI 10.1074/jbc.273.37.23844; Daigle DM, 1997, J BIOL CHEM, V272, P24755, DOI 10.1074/jbc.272.40.24755; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Galmarini CM, 2001, LEUKEMIA, V15, P875, DOI 10.1038/sj.leu.2402114; GANDHI V, 1994, LEUKEMIA LYMPHOMA, V14, P3, DOI 10.3109/10428199409052689; GANDHI V, 1993, LEUKEMIA LYMPHOMA, V10, P49, DOI 10.3109/10428199309147356; Grosdidier A, 2011, J COMPUT CHEM, V32, P2149, DOI 10.1002/jcc.21797; Hao WH, 2014, J FOOD DRUG ANAL, V22, P236, DOI 10.1016/j.jfda.2013.09.008; Hon WC, 1997, CELL, V89, P887, DOI 10.1016/S0092-8674(00)80274-3; Huang P, 2000, LEUKEMIA, V14, P1405, DOI 10.1038/sj.leu.2401845; HUANG P, 1990, J BIOL CHEM, V265, P16617; Kim C, 2006, J BIOL CHEM, V281, P6964, DOI 10.1074/jbc.M513257200; KREUZER KN, 1983, METHOD ENZYMOL, V100, P144; Li L, 1997, CANCER RES, V57, P1487; Michl J, 2016, EMBO J, V35, P909, DOI 10.15252/embj.201693860; Miroux B, 1996, J MOL BIOL, V260, P289, DOI 10.1006/jmbi.1996.0399; Moufarij MA, 2006, BLOOD, V108, P4187, DOI 10.1182/blood-2006-05-023259; Nurizzo D, 2003, J MOL BIOL, V327, P491, DOI 10.1016/S0022-2836(03)00121-9; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ricci Francesca, 2009, Ther Clin Risk Manag, V5, P187; Sanchez-Carrera D, 2015, BIOSCIENCE REP, V35, DOI 10.1042/BSR20150039; Sandoval A, 1996, CLIN CANCER RES, V2, P1731; SHAW KJ, 1993, MICROBIOL REV, V57, P138, DOI 10.1128/MMBR.57.1.138-163.1993; SPRIGGS D, 1986, BIOCHEM PHARMACOL, V35, P247, DOI 10.1016/0006-2952(86)90521-6; Van Den Neste E, 2005, INT J ONCOL, V27, P1113; Wright Gerard D., 1999, Frontiers in Bioscience, V4, pD9, DOI 10.2741/Wright; Yamauchi T, 2014, BMC CANCER, V14, P547; YANG SW, 1992, J BIOL CHEM, V267, P2345; Young PG, 2009, J BACTERIOL, V191, P4133, DOI 10.1128/JB.00149-09; Zecevic A, 2011, CLIN CANCER RES, V17, P4731, DOI 10.1158/1078-0432.CCR-10-2561; ZHENG JH, 1993, PROTEIN SCI, V2, P1559, DOI 10.1002/pro.5560021003	32	1	1	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3007	3017		10.1096/fj.201601245R	http://dx.doi.org/10.1096/fj.201601245R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28373209				2022-12-28	WOS:000405931000025
J	Tang, C; Zhou, X; Nguyen, PT; Zhang, YX; Hu, ZT; Zhang, CX; Yarov-Yarovoy, V; DeCaen, PG; Liang, SP; Liu, ZH				Tang, Cheng; Zhou, Xi; Phuong Tran Nguyen; Zhang, Yunxiao; Hu, Zhaotun; Zhang, Changxin; Yarov-Yarovoy, Vladimir; DeCaen, Paul G.; Liang, Songping; Liu, Zhonghua			A novel tarantula toxin stabilizes the deactivated voltage sensor of bacterial sodium channel	FASEB JOURNAL			English	Article						peptide toxin; deactivated state; Ns(v)Ba	PROTEIN-PROTEIN DOCKING; CRYSTAL-STRUCTURE; DOMAIN-II; MOLECULAR DETERMINANTS; CONFORMATIONAL-CHANGE; SELECTIVITY FILTER; FAST INACTIVATION; JINGZHAOTOXIN-I; K+ CHANNEL; ACTIVATION	Voltage-gated sodium channels (Na(V)s) are activated by transiting the voltage sensor from the deactivated to the activated state. The crystal structures of several bacterial Na(V)s have captured the voltage sensor module (VSM) in an activated state, but structure of the deactivated voltage sensor remains elusive. In this study, we sought to identify peptide toxins stabilizing the deactivated VSM of bacterial Na(V)s. We screened fractions from several venoms and characterized a cystine knot toxin called JZTx-27 from the venom of tarantula Chilobrachys jingzhao as a high-affinity antagonist of the prokaryotic Na(V)s NsyBa (nonselective voltage-gated Bacillus alcalophilus) and NaChBac (bacterial sodium channel from Bacillus halodurans) (IC50 = 112 nM and 30 nM, respectively). JZTx-27 was more efficacious at weaker depolarizing voltages and significantly slowed the activation but accelerated the deactivation of NsyBa, whereas the local anesthetic drug lidocaine was shown to antagonize NsyBa without affecting channel gating. Mutation analysis confirmed that JZTx-27 bound to S34 linker of NsyBa, with F98 being the critical residue in determining toxin affinity. All electrophysiological data and in silico analysis suggested that JZTx-27 trapped VSM of NsyBa in one of the deactivated states. In mammalian Na(V)s, JZTx-27 preferably inhibited the inactivation of Nay1.5 by targeting the fourth transmembrane domain. To our knowledge, this is the first report of peptide antagonist for prokaryotic Na(V)s. More important, we proposed that JZTx-27 stabilized the NsyBa VSM in the deactivated state and may be used as a probe to determine the structure of the deactivated VSM of Na(V)s. Tang, C., Zhou, X., Nguyen, P. T., Zhang, Y., Hu, Z., Zhang, C., Yarov-Yarovoy, V., DeCaen, P. G., Liang, S., Liu, Z. A novel tarantula toxin stabilizes the deactivated voltage sensor of bacterial sodium channel.	[Tang, Cheng; Zhou, Xi; Zhang, Yunxiao; Hu, Zhaotun; Zhang, Changxin; Liang, Songping; Liu, Zhonghua] Hunan Normal Univ, Coll Life Sci, Natl & Local Joint Engn Lab Anim Peptide Drug Dev, Changsha 410081, Hunan, Peoples R China; [Phuong Tran Nguyen; Yarov-Yarovoy, Vladimir] Univ Calif Davis, Dept Physiol & Membrane Biol, Davis, CA 95616 USA; [DeCaen, Paul G.] Northwestern Univ, Dept Pharmacol, Feinberg Sch Med, Chicago, IL 60611 USA	Hunan Normal University; University of California System; University of California Davis; Northwestern University; Feinberg School of Medicine	Liang, SP; Liu, ZH (corresponding author), Hunan Normal Univ, Coll Life Sci, Natl & Local Joint Engn Lab Anim Peptide Drug Dev, Changsha 410081, Hunan, Peoples R China.	liangsp@hunnu.edu.cn; liuzh@hunnu.edu.cn	Yarov-Yarovoy, Vladimir/ABE-5454-2020; Nguyen, Phuong T./AAT-6194-2020	Yarov-Yarovoy, Vladimir/0000-0002-2325-4834; tang, cheng/0000-0002-5848-2458	National Basic Research Program of China (973 Program) [2010CB529801]; National Science Foundation [31370783, 31370817]; Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province [20134486]	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Science Foundation(National Science Foundation (NSF)); Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province	This work was supported by the National Basic Research Program of China (973 Program; Grant 2010CB529801); the National Science Foundation Project (Grants 31370783 and 31370817 to Z.L.); and the Cooperative Innovation Center of Engineering and New Products for Developmental Biology of Hunan Province (Grant 20134486). The authors declare no conflicts of interest.	Baconguis I, 2014, CELL, V156, P717, DOI 10.1016/j.cell.2014.01.011; Baconguis I, 2012, NATURE, V489, P400, DOI 10.1038/nature11375; Bagneris C., 2014, P NATL ACAD SCI US; Bagneris C, 2014, P NATL ACAD SCI USA, V111, P8428, DOI 10.1073/pnas.1406855111; Barth P, 2007, P NATL ACAD SCI USA, V104, P15682, DOI 10.1073/pnas.0702515104; Bosmans F, 2008, NATURE, V456, P202, DOI 10.1038/nature07473; Bosmans F, 2010, TRENDS PHARMACOL SCI, V31, P175, DOI 10.1016/j.tips.2009.12.007; Campos FV, 2008, J GEN PHYSIOL, V132, P251, DOI 10.1085/jgp.200809995; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Capes DL, 2013, J GEN PHYSIOL, V142, P101, DOI 10.1085/jgp.201310998; Capes DL, 2012, P NATL ACAD SCI USA, V109, P2648, DOI 10.1073/pnas.1115575109; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2007, TOXICON, V49, P124, DOI 10.1016/j.toxicon.2006.09.022; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Cestele S, 1998, NEURON, V21, P919, DOI 10.1016/S0896-6273(00)80606-6; Chanda B, 2002, J GEN PHYSIOL, V120, P629, DOI 10.1085/jgp.20028679; Conway P, 2014, PROTEIN SCI, V23, P47, DOI 10.1002/pro.2389; Corry Ben, 2014, Handb Exp Pharmacol, V221, P251, DOI 10.1007/978-3-642-41588-3_12; DeCaen PG, 2014, ELIFE, V3, DOI 10.7554/eLife.04387; DeCaen PG, 2011, P NATL ACAD SCI USA, V108, P18825, DOI 10.1073/pnas.1116449108; DeCaen PG, 2009, P NATL ACAD SCI USA, V106, P22498, DOI 10.1073/pnas.0912307106; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; George AL, 2005, J CLIN INVEST, V115, P1990, DOI 10.1172/JCI25505; Gray JJ, 2003, J MOL BIOL, V331, P281, DOI 10.1016/S0022-2836(03)00670-3; Jurkat-Rott K, 2000, P NATL ACAD SCI USA, V97, P9549, DOI 10.1073/pnas.97.17.9549; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; Lee HC, 2003, NEURON, V40, P527, DOI 10.1016/S0896-6273(03)00636-6; Lee S, 2012, CHANNELS, V6, P403, DOI 10.4161/chan.21807; Lee S, 2012, J GEN PHYSIOL, V139, P507, DOI 10.1085/jgp.201210779; Li-Smerin Y, 2000, J GEN PHYSIOL, V115, P673, DOI 10.1085/jgp.115.6.673; Mandell DJ, 2009, NAT METHODS, V6, P551, DOI 10.1038/nmeth0809-551; Martin LJ, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003688; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; Meisler MH, 2005, J CLIN INVEST, V115, P2010, DOI 10.1172/JCI25466; Naylor CE, 2016, EMBO J, V35, P820, DOI 10.15252/embj.201593285; Payandeh J, 2012, NATURE, V486, P135, DOI 10.1038/nature11077; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Phillips LR, 2005, NATURE, V436, P857, DOI 10.1038/nature03873; Qu YX, 1997, J PROTEIN CHEM, V16, P565, DOI 10.1023/A:1026314722607; Raju SG, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003090; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Scheuer Todd, 2014, Handb Exp Pharmacol, V221, P269, DOI 10.1007/978-3-642-41588-3_13; Sheets MF, 2003, J GEN PHYSIOL, V121, P163, DOI 10.1085/jgp.20028651; Spampanato J, 2001, J NEUROSCI, V21, P7481, DOI 10.1523/JNEUROSCI.21-19-07481.2001; Stevens M, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00071; Struyk AF, 2000, J NEUROSCI, V20, P8610; Swartz KJ, 2007, TOXICON, V49, P213, DOI 10.1016/j.toxicon.2006.09.024; Tang C, 2015, SCI REP-UK, V5, DOI 10.1038/srep09241; Tao H, 2013, TOXICON, V63, P129, DOI 10.1016/j.toxicon.2012.12.001; Tao X, 2010, SCIENCE, V328, P67, DOI 10.1126/science.1185954; Terahara N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046248; Wang C, 2007, J MOL BIOL, V373, P503, DOI 10.1016/j.jmb.2007.07.050; Wang JT, 2011, P NATL ACAD SCI USA, V108, P15426, DOI 10.1073/pnas.1112320108; Xiao YC, 2005, J BIOL CHEM, V280, P12069, DOI 10.1074/jbc.M411651200; Xiao YC, 2008, J BIOL CHEM, V283, P27300, DOI 10.1074/jbc.M708447200; Yarov-Yarovoy V, 2006, PROTEINS, V62, P1010, DOI 10.1002/prot.20817; Yarov-Yarovoy V, 2012, P NATL ACAD SCI USA, V109, pE93, DOI 10.1073/pnas.1118434109; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; Zhou YF, 2003, J MOL BIOL, V333, P965, DOI 10.1016/j.jmb.2003.09.022; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	60	5	5	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3167	3178		10.1096/fj.201600882R	http://dx.doi.org/10.1096/fj.201600882R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28400471	Green Submitted, Bronze			2022-12-28	WOS:000405931000039
J	McKee, SE; Grissom, NM; Herdt, CT; Reyes, TM				McKee, Sarah E.; Grissom, Nicola M.; Herdt, Christopher T.; Reyes, Teresa M.			Methyl donor supplementation alters cognitive performance and motivation in female offspring from high-fat diet-fed dams	FASEB JOURNAL			English	Article						folate; one carbon metabolism; vitamin B-12; choline; operant	ONE-CARBON METABOLISM; PREFRONTAL CORTEX; MATERNAL OBESITY; DNA METHYLATION; BRAIN SYNAPSES; MEMORY; FOLATE; DISORDERS; MICE; AGE	During gestation, fetal nutrition is entirely dependent on maternal diet. Maternal consumption of excess fat during pregnancy has been linked to an increased risk of neurologic disorders in offspring, including attention deficit/hyperactivity disorder, autism, and schizophrenia. In a mouse model, high-fat diet (HFD)-fed offspring have cognitive and executive function deficits as well as whole-genome DNA and promoter-specific hypomethylation in multiple brain regions. Dietary methyl donor supplementation during pregnancy or adulthood has been used to alter DNA methylation and behavior. Given that extensive brain development occurs during early postnatal life-particularly within the prefrontal cortex (PFC), a brain region critical for executive function-we examined whether early life methyl donor supplementation (e.g., during adolescence) could ameliorate executive function deficits observed in offspring that were exposed to maternal HFD. By using operant testing, progressive ratio, and the PFC-dependent 5-choice serial reaction timed task (5-CSRTT), we determined that F1 female offspring (B6D2F1/J) from HFD-fed dams have decreased motivation (decreased progressive ratio breakpoint) and require a longer stimulus length to complete the 5-CSRTT task successfully, whereas early life methyl donor supplementation increased motivation and shortened the minimum stimulus length required for a correct response in the 5-CSRTT. Of interest, we found that expression of 2 chemokines, CCL2 andCXCL10, correlated with the median stimulus length in the 5-CSRTT. Furthermore, we found that acute adult supplementation of methyl donors increased motivation in HFD-fed offspring and those who previously received supplementation with methyl donors. These data point to early life as a sensitive time during which dietary methyl donor supplementation can alter PFC-dependent cognitive behaviors.	[McKee, Sarah E.; Herdt, Christopher T.] Univ Penn, Dept Pharmacol, Perelman Sch Med, Philadelphia, PA 19104 USA; [Grissom, Nicola M.] Univ Minnesota, Coll Liberal Arts, Dept Psychol, Minneapolis, MN 55455 USA; [Reyes, Teresa M.] Univ Cincinnati, Coll Med, Dept Psychiat & Behav Neurosci, 2120 East Galbraith Rd,A-129, Cincinnati, OH 45237 USA	University of Pennsylvania; Pennsylvania Medicine; University of Minnesota System; University of Minnesota Twin Cities; University System of Ohio; University of Cincinnati	Reyes, TM (corresponding author), Univ Cincinnati, Coll Med, Dept Psychiat & Behav Neurosci, 2120 East Galbraith Rd,A-129, Cincinnati, OH 45237 USA.	reyesta@ucmail.uc.edu	Grissom, Nicola/AAW-4022-2021; Grissom, Nicola/GQO-7655-2022; Reyes, Teresa/GYI-8942-2022	Reyes, Teresa/0000-0003-3009-3749	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences [ES019851]; NIH National Institute of Mental Health [MH087978]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES019851] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH087978] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; NIH National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	The authors acknowledge the technical support of Landis Walsh, Matt Marini (both from the University of Pennsylvania), and Amanda Fritsch (University of Cincinnati). This work was supported by the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (Grant ES019851 to S.E.M.) and NIH National Institute of Mental Health (Grant MH087978 to T.M.R.). The authors declare no conflicts of interest.	Anderson OS, 2012, J NUTR BIOCHEM, V23, P853, DOI 10.1016/j.jnutbio.2012.03.003; Anderson RI, 2013, BEHAV BRAIN RES, V257, P83, DOI 10.1016/j.bbr.2013.09.021; [Anonymous], 2009, NCHS DATA BRIEF; Bari A, 2013, PROG NEUROBIOL, V108, P44, DOI 10.1016/j.pneurobio.2013.06.005; BEATTY WW, 1979, HORM BEHAV, V12, P112, DOI 10.1016/0018-506X(79)90017-5; Berrocal-Zaragoza MI, 2014, BRIT J NUTR, V112, P1323, DOI 10.1017/S0007114514002116; Camprubi Robles M., 2015, PLOS ONE, V10; Cansev M, 2008, ALZHEIMERS DEMENT, V4, pS153, DOI 10.1016/j.jalz.2007.10.005; Carlin J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063549; COHEN EL, 1976, SCIENCE, V191, P561, DOI 10.1126/science.1251187; Cooney CA, 2002, J NUTR, V132, p2393S; Cordero P, 2013, MOL GENET METAB, V110, P388, DOI 10.1016/j.ymgme.2013.08.022; Craciunescu CN, 2003, J NUTR, V133, P3614, DOI 10.1093/jn/133.11.3614; da Silva VR, 2013, INT J OBESITY, V37, P1608, DOI 10.1038/ijo.2013.41; Desai A, 2017, MOL PSYCHIATR, V22, P1291, DOI 10.1038/mp.2016.153; Duncan J, 2013, NEURON, V80, P35, DOI 10.1016/j.neuron.2013.09.015; Floresco SB, 2011, NEUROPSYCHOPHARMACOL, V36, P227, DOI 10.1038/npp.2010.158; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; Frye RE, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00080; Fujii A, 1996, GEN PHARMACOL, V27, P995, DOI 10.1016/0306-3623(95)02072-1; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Goodspeed D, 2015, FASEB J, V29, P807, DOI 10.1096/fj.14-259614; Gosselin RD, 2005, J NEUROCHEM, V95, P1023, DOI 10.1111/j.1471-4159.2005.03431.x; Grissom N, 2014, MAMM GENOME, V25, P41, DOI 10.1007/s00335-013-9487-6; Grissom NM, 2015, NEUROPSYCHOPHARMACOL, V40, P1353, DOI 10.1038/npp.2014.313; Grissom NM, 2013, INT J DEV NEUROSCI, V31, P406, DOI 10.1016/j.ijdevneu.2012.11.006; Guyon A, 2009, NEUROSCIENCE, V162, P1072, DOI 10.1016/j.neuroscience.2009.05.048; Guyon A, 2009, PEPTIDES, V30, P2031, DOI 10.1016/j.peptides.2009.05.028; Hatanaka Y, 2016, NEUROCHEM INT, V97, P99, DOI 10.1016/j.neuint.2016.03.008; Jiang XN, 2016, NEUROBIOL DIS, V92, P3, DOI 10.1016/j.nbd.2015.07.007; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Kavaliers M, 2001, HORM BEHAV, V40, P497, DOI 10.1006/hbeh.2001.1714; Kavaliers M, 2013, ARCH SEX BEHAV, V42, P331, DOI 10.1007/s10508-013-0069-1; Kiyota T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006197; Klinkenberg I, 2011, BEHAV BRAIN RES, V221, P430, DOI 10.1016/j.bbr.2010.11.033; Krakowiak P, 2012, PEDIATRICS, V129, pE1121, DOI 10.1542/peds.2011-2583; Loke YJ, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00107; Lu J, 2011, BRAIN BEHAV IMMUN, V25, P1658, DOI 10.1016/j.bbi.2011.06.009; Martin SAL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099226; Martin TJ, 2015, J NEUROSCI METH, V241, P37, DOI 10.1016/j.jneumeth.2014.12.007; Masho SW, 2016, BMC PREGNANCY CHILDB, V16, DOI 10.1186/s12884-016-1002-0; Mattson MP, 2003, TRENDS NEUROSCI, V26, P137, DOI 10.1016/S0166-2236(03)00032-8; Mayford M., 2012, COLD SPRING HARB PER, V4; Melik-Parsadaniantz S, 2008, J NEUROIMMUNOL, V198, P62, DOI 10.1016/j.jneuroim.2008.04.022; Morris MS, 2012, ADV NUTR, V3, P801, DOI 10.3945/an.112.002535; O'Neill RJ, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00289; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Poon K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077668; Ramaekers VT, 2014, MOL GENET METAB, V113, P307, DOI 10.1016/j.ymgme.2014.10.002; Rivera HM, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00194; Rocha NP, 2014, PARKINSONS DIS-US, V2014, DOI 10.1155/2014/903796; Sakurai Y, 2004, EUR J NEUROSCI, V20, P1069, DOI 10.1111/j.1460-9568.2004.03525.x; Savelkoul PJM, 2012, J NEUROCHEM, V120, P631, DOI 10.1111/j.1471-4159.2011.07616.x; Schack-Nielsen L, 2010, INT J OBESITY, V34, P67, DOI 10.1038/ijo.2009.206; Schuch V, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00126; Seferovic MD, 2015, FASEB J, V29, P2640, DOI 10.1096/fj.14-266387; Selhub J, 2011, BIOFACTORS, V37, P269, DOI 10.1002/biof.173; Sen S, 2014, J PERINATOL, V34, P105, DOI 10.1038/jp.2013.153; Sequeira JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152249; Shoji H, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0191-9; Sowell ER, 2001, J INT NEUROPSYCH SOC, V7, P312, DOI 10.1017/S135561770173305X; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Tozuka Y, 2010, NEUROCHEM INT, V57, P235, DOI 10.1016/j.neuint.2010.05.015; Valenta JP, 2016, ALCOHOL CLIN EXP RES, V40, P187, DOI 10.1111/acer.12928; Van Lieshout RJ, 2011, OBES REV, V12, pe548, DOI 10.1111/j.1467-789X.2010.00850.x; van Wijk N, 2014, J ALZHEIMERS DIS, V38, P459, DOI 10.3233/JAD-130998; Vucetic Z, 2010, ENDOCRINOLOGY, V151, P4756, DOI 10.1210/en.2010-0505; Warden CH, 2008, CELL METAB, V7, P277, DOI 10.1016/j.cmet.2008.03.014; Waterland RA, 2003, MOL CELL BIOL, V23, P5293, DOI 10.1128/MCB.23.15.5293-5300.2003; Weng YL, 2013, NEUROTHERAPEUTICS, V10, P556, DOI 10.1007/s13311-013-0223-4; Westin K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030525; Wurtman RJ, 2010, NUTR REV, V68, pS88, DOI 10.1111/j.1753-4887.2010.00344.x; Young JW, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004227; Yu LX, 2016, J ALZHEIMERS DIS, V54, P297, DOI 10.3233/JAD-160329	74	21	21	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2352	2363		10.1096/fj.201601172R	http://dx.doi.org/10.1096/fj.201601172R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28209774	Green Published			2022-12-28	WOS:000401553400012
J	Xu, JG; Gong, T; Heng, BC; Zhang, CF				Xu, Jianguang; Gong, Ting; Heng, Boon Chin; Zhang, Cheng Fei			A systematic review: differentiation of stem cells into functional pericytes	FASEB JOURNAL			English	Review						stem cell therapy; adult stem cells; ESC; iPSC; transdifferentiation	SMOOTH-MUSCLE-CELL; ENDOTHELIAL-CELLS; PERIVASCULAR CELLS; GENERATE PERICYTES; NG2 PROTEOGLYCAN; SKELETAL-MUSCLE; STROMAL CELLS; PDGF-B; RECRUITMENT; POPULATION	Pericytes are an integral cellular component of vascular structures. Numerous studies have investigated various stemcell types as potential sources of pericytes for application in cell-based therapy. The diverse stem cell types and variable experimental protocols of these studies make it imperative to evaluate the relevant scientific literature on the basis of a unified standard. The purpose of this systematic review is to rigorously evaluate the relevant scientific literature for conclusive evidence that stem cells can differentiate into functional pericytes. An online literature search was conducted up to July 2016. Eligible papers were evaluated on 4 pertinent criteria: 1) appropriate controls, 2) markers to confirm pericyte phenotype, 3) techniques for assessing pericyte functionality, and 4) differentiation efficiency of the protocol. Our search yielded 20 eligible studies (from 2006 to 2016), 12 of which were published in the past 5 yr. Of these 20 articles, only 1 had positive control, and 5 papers evaluated differentiation efficiency. Themost commonly used pericyte markers were neuron-glial antigen 2, platelet-derived growth factor receptor-beta, and alpha-smoothmuscle actin. Three articles were associated with adipose stemcells, 4 with mesenchymal stem cells, and 7 with pluripotent stem cells, whereas the remaining 6 articles were based on other miscellaneous stem cell types. Stem cells can serve as a potential source of pericytes, but there should be standardized guidelines in future studies for assessing pericyte differentiation.-Xu, J., Gong, T., Heng, B. C., Zhang, C. F. A systematic review: differentiation of stem cells into functional pericytes.	[Xu, Jianguang; Gong, Ting; Heng, Boon Chin; Zhang, Cheng Fei] Univ Hong Kong, Fac Dent, Comprehens Dent Care, Endodont, Hong Kong, Hong Kong, Peoples R China; [Zhang, Cheng Fei] Univ Hong Kong, Shenzhen Inst Res & Innovat, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong	Zhang, CF (corresponding author), Univ Hong Kong, Comprehens Dent Care, Fac Dent, Prince Philip Dent Hosp, Floor 3A,34 Hosp Rd, Sai Ying Pun, Hong Kong, Peoples R China.	zhangcf@hku.hk	Zhang, Cheng/GRS-8698-2022; Heng, Boon Chin/E-5462-2016	Heng, Boon Chin/0000-0003-2541-3699	National Nature Science Foundation of China [81470735]; General Research Fund-Research Grants Council of Hong Kong [HKU17126914]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); General Research Fund-Research Grants Council of Hong Kong(Hong Kong Research Grants Council)	This work was supported by the National Nature Science Foundation of China (Grant 81470735) and the General Research Fund-Research Grants Council of Hong Kong (Grant HKU17126914; to C.F.Z).	Amos PJ, 2008, STEM CELLS, V26, P2682, DOI 10.1634/stemcells.2008-0030; Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Asada N, 2011, J CLIN INVEST, V121, P3981, DOI 10.1172/JCI57301; Ayres-Sander CE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060025; Bababeygy SR, 2008, STEM CELLS DEV, V17, P11, DOI 10.1089/scd.2007.0117; Berger M, 2005, BLOOD, V105, P1094, DOI 10.1182/blood-2004-06-2315; Blocki A, 2013, STEM CELLS DEV, V22, P2347, DOI 10.1089/scd.2012.0415; Bondjers C, 2003, AM J PATHOL, V162, P721, DOI 10.1016/S0002-9440(10)63868-0; Boscolo E, 2011, ARTERIOSCL THROM VAS, V31, P2181, DOI 10.1161/ATVBAHA.111.232934; Cai J, 2008, INVEST OPHTH VIS SCI, V49, P2163, DOI 10.1167/iovs.07-1206; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Chan-Ling T, 2004, AM J PATHOL, V165, P1301, DOI 10.1016/S0002-9440(10)63389-5; Chen CW, 2013, STEM CELLS, V31, P305, DOI 10.1002/stem.1285; Cheng L, 2013, CELL, V153, P139, DOI 10.1016/j.cell.2013.02.021; Corselli M, 2012, STEM CELLS DEV, V21, P1299, DOI 10.1089/scd.2011.0200; Costa M, 2013, STEM CELL RES, V10, P103, DOI 10.1016/j.scr.2012.10.003; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Crisan M, 2012, J CELL MOL MED, V16, P2851, DOI 10.1111/j.1582-4934.2012.01617.x; Dar A, 2012, CIRCULATION, V125, P87, DOI 10.1161/CIRCULATIONAHA.111.048264; Dellavalle A, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1508; Dellavalle A, 2007, NAT CELL BIOL, V9, P255, DOI 10.1038/ncb1542; Dhar K, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-209; Diaz-Flores L, 2009, HISTOL HISTOPATHOL, V24, P909, DOI 10.14670/HH-24.909; Faggion Clovis Mariano Jr, 2012, J Evid Based Dent Pract, V12, P182, DOI 10.1016/j.jebdp.2012.10.001; Farrington-Rock C, 2004, CIRCULATION, V110, P2226, DOI 10.1161/01.CIR.0000144457.55518.E5; Flanagan K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040443; Gerhardt H, 2003, CELL TISSUE RES, V314, P15, DOI 10.1007/s00441-003-0745-x; Gore A, 2011, NATURE, V471, P63, DOI 10.1038/nature09805; Greenwood-Goodwin M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24403; Guichet PO, 2015, STEM CELLS, V33, P21, DOI 10.1002/stem.1767; He W, 2010, BIOMATERIALS, V31, P8235, DOI 10.1016/j.biomaterials.2010.07.034; Hellstrom M, 1999, DEVELOPMENT, V126, P3047; James AW, 2012, STEM CELL TRANSL MED, V1, P510, DOI 10.5966/sctm.2012-0002; Kacem K, 1996, HISTOCHEM J, V28, P53, DOI 10.1007/BF02331427; Keating A, 2012, CELL STEM CELL, V10, P709, DOI 10.1016/j.stem.2012.05.015; Kilkenny C, 2010, BRIT J PHARMACOL, V160, P1577, DOI [10.1111/j.1476-5381.2010.00872.x, 10.1113/expphysiol.2010.053793, 10.1113/jphysiol.2010.192278]; Klein D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020540; Kusuma S, 2013, P NATL ACAD SCI USA, V110, P12601, DOI 10.1073/pnas.1306562110; Lin P, 2014, MOL THER, V22, P160, DOI 10.1038/mt.2013.221; Lindskog H, 2006, ARTERIOSCL THROM VAS, V26, P1457, DOI 10.1161/01.ATV.0000222925.49817.17; Loibl M., 2014, BIOMED RES INT, V2014, DOI DOI 10.1155/2014/395781; Mendel TA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065691; Moher D, 2009, ANN INTERN MED, V151, P264, DOI 10.7326/0003-4819-151-4-200908180-00135; Murfee WL, 2005, MICROCIRCULATION, V12, P151, DOI 10.1080/10739680590904955; Nakagawa S, 2009, NEUROCHEM INT, V54, P253, DOI 10.1016/j.neuint.2008.12.002; Natesan S, 2011, TISSUE ENG PT A, V17, P941, DOI [10.1089/ten.tea.2010.0294, 10.1089/ten.TEA.2010.0294]; NAYAK RC, 1988, J EXP MED, V167, P1003, DOI 10.1084/jem.167.3.1003; NEHLS V, 1993, HISTOCHEMISTRY, V99, P1, DOI 10.1007/BF00268014; NOMURA M, 1995, J BIOL CHEM, V270, P28316; Okita K, 2007, NATURE, V448, P313, DOI 10.1038/nature05934; Orlova VV, 2014, NAT PROTOC, V9, P1514, DOI 10.1038/nprot.2014.102; Orlova VV, 2014, ARTERIOSCL THROM VAS, V34, P177, DOI 10.1161/ATVBAHA.113.302598; OWENS GK, 1995, PHYSIOL REV, V75, P487; Ozerdem U, 2001, DEV DYNAM, V222, P218, DOI 10.1002/dvdy.1200; Ramamoorthi M, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/378368; Rufaihah AJ, 2011, ARTERIOSCL THROM VAS, V31, pE72, DOI 10.1161/ATVBAHA.111.230938; Schulz KF, 2010, TRIALS, V11, DOI 10.1186/1745-6215-11-32; Shieh SJ, 2005, SURGERY, V137, P1, DOI 10.1016/j.surg.2004.04.002; Song S, 2005, NAT CELL BIOL, V7, P870, DOI 10.1038/ncb1288; Sorrell JM, 2009, TISSUE ENG PT A, V15, P1751, DOI 10.1089/ten.tea.2008.0254; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tawonsawatruk T, 2016, SCI REP-UK, V6, DOI 10.1038/srep22779; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Vats A, 2002, CLIN OTOLARYNGOL, V27, P227, DOI 10.1046/j.1365-2273.2002.00579.x; Vidal M, 2015, STEM CELLS, V33, P2011, DOI 10.1002/stem.1997; Wang HH, 2016, CANCER LETT, V375, P349, DOI 10.1016/j.canlet.2016.02.033; Wanjare M, 2014, STEM CELL REP, V2, P561, DOI 10.1016/j.stemcr.2014.03.004; White MP, 2013, STEM CELLS, V31, P92, DOI 10.1002/stem.1267; Xu G, 2013, NEUROSCIENCE, V238, P195, DOI 10.1016/j.neuroscience.2013.02.021; Yamada Y, 2006, J EXP MED, V203, P1055, DOI 10.1084/jem.20050373; Zhang XM, 2011, J TROP METEOROL, V17, P1, DOI 10.3969/j.issn.1006-8775.2011.01.001	72	27	28	0	31	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1775	1786		10.1096/fj.201600951RRR	http://dx.doi.org/10.1096/fj.201600951RRR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28119398				2022-12-28	WOS:000399195500002
J	Yaseen, S; Demopulos, G; Dudler, T; Yabuki, M; Wood, CL; Cummings, WJ; Tjoelker, LW; Fujita, T; Sacks, S; Garred, P; Andrew, P; Sim, RB; Lachmann, PJ; Wallis, R; Lynch, N; Schwaeble, WJ				Yaseen, Sadam; Demopulos, Gregory; Dudler, Thomas; Yabuki, Munehisa; Wood, Christi L.; Cummings, W. Jason; Tjoelker, Larry W.; Fujita, Teizo; Sacks, Steven; Garred, Peter; Andrew, Peter; Sim, Robert B.; Lachmann, Peter J.; Wallis, Russell; Lynch, Nicholas; Schwaeble, Wilhelm J.			Lectin pathway effector enzyme mannan-binding lectin-associated serine protease-2 can activate native complement C3 in absence of C4 and/or C2	FASEB JOURNAL			English	Article						innate immunity; opsonization; post-ischemic inflammation; activation bypass	PATTERN-RECOGNITION MOLECULES; COLLECTIN LIVER 1; INITIATION COMPLEX; REPERFUSION INJURY; PROTEIN; MASP-1; COMPONENT; AND-2; MBL; DEFICIENCY	All 3 activation pathways of complement-the classic pathway (CP), the alternative pathway, and the lectin pathway (LP)-converge into a common central event: the cleavage and activation of the abundant third complement component, C3, via formation of C3-activating enzymes (C3 convertases). The fourth complement component, C4, and the second component, C2, are indispensable constituents of the C3 convertase complex, C4bC2a, which is formed by both the CP and the LP. Whereas in the absence of C4, CP can no longer activate C3, LP retains a residual but physiologically critical capacity to convert native C3 into its activation fragments, C3a and C3b. This residual C4 and/or C2 bypass route is dependent on LP-specific mannan-binding lectin-associated serine protease-2. By using various serum sources with defined complement deficiencies, we demonstrate that, under physiologic conditions LP-specific C4 and/or C2 bypass activation of C3 is mediated by direct cleavage of native C3 by mannan-binding lectin-associated serine protease-2 bound to LP-activation complexes captured on ligand-coated surfaces.-Yaseen, S., Demopulos, G., Dudler, T., Yabuki, M., Wood, C. L., Cummings, W. J., Tjoelker, L. W., Fujita, T., Sacks, S., Garred, P., Andrew, P., Sim, R. B., Lachmann, P. J., Wallis, R., Lynch, N., Schwaeble, W. J. Lectin pathway effector enzyme mannan-binding lectin-associated serine protease-2 can activate native complement C3 in absence of C4 and/or C2.	[Yaseen, Sadam; Andrew, Peter; Sim, Robert B.; Wallis, Russell; Lynch, Nicholas; Schwaeble, Wilhelm J.] Univ Leicester, Dept Infect Immun & Inflammat, MSB Univ Rd, Leicester LE1 9HN, Leics, England; [Yaseen, Sadam; Demopulos, Gregory; Dudler, Thomas; Yabuki, Munehisa; Wood, Christi L.; Cummings, W. Jason; Tjoelker, Larry W.] Omeros Corp, Seattle, WA USA; [Yaseen, Sadam] Univ Mosul, Dept Biol, Mosul, Iraq; [Fujita, Teizo] Fukushima Med Univ, Fukushima Prefectural Gen Hyg Inst, Fukushima, Japan; [Sacks, Steven] Kings Coll London, MRC, Ctr Transplantat, Guys Campus, London, England; [Garred, Peter] Univ Copenhagen, Dept Clin Immunol, Lab Mol Med, Rigshosp, Copenhagen, Denmark; [Lachmann, Peter J.] Univ Cambridge, Dept Vet Med, Cambridge, England	University of Leicester; University of Mosul; Fukushima Medical University; University of London; King's College London; Rigshospitalet; University of Copenhagen; University of Cambridge	Schwaeble, WJ (corresponding author), Univ Leicester, Dept Infect Immun & Inflammat, MSB Univ Rd, Leicester LE1 9HN, Leics, England.	ws5@le.ac.uk	Thielens, Nicole M/F-2512-2013; Lachmann, P J/I-7968-2019; Andrew, Peter W/G-7526-2012	Thielens, Nicole M/0000-0002-7354-0302; Lachmann, P J/0000-0003-2849-3524; Lynch, Nicholas/0000-0003-3803-3329; Wallis, Russell/0000-0002-8705-5295; Garred, Peter/0000-0002-2876-8586; Schwaeble, Wilhelm/0000-0001-8927-0864; Sacks, Steven/0000-0001-6361-9095	Medical Research Council [G0801952]; Omeros Corp.; Medical Research Council [G0700859] Funding Source: researchfish; Novo Nordisk Fonden [NNF13SA0009309] Funding Source: researchfish; MRC [G0700859, G0801952] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Omeros Corp.; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Novo Nordisk Fonden(Novo Nordisk Foundation); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors are grateful to Drs. Peter Gal and Geza Ambrus (Institute of Enzymology, Biological Research Center, Hungarian Academy of Sciences, Budapest, Hungary) for providing enzymatically active recombinant truncated MASP-1 and MASP-2 expressed in E. coli. This work was supported by Medical Research Council Grant G0801952 (to W.S.) and Omeros Corp. Omeros Corp. developed the MASP-2 inhibitor mAb HG4 and the clinical candidate inhibitor OMS721 that successfully completed stage 2 of clinical trials and is advancing clinical-stage development programs focused on complement- related thrombotic microangiopathies and complement- mediated renal pathologies. G.D. is the founder and CEO,and owns an equity interest in Omeros Corp. S.Y., T.D., M.Y., C.L. W.,W. J.C., and L.W. T.are employees of, and each owns an equity interest in, Omeros Corp. W. J.S. is a member of the scientific advisory board and owns an equity interest in Omeros Corp. P.J.L. is a member of the scientific advisory board of Omeros Corp.	Ali YM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002793; Ambrus G, 2003, J IMMUNOL, V170, P1374, DOI 10.4049/jimmunol.170.3.1374; Asgari E, 2014, FASEB J, V28, P3996, DOI 10.1096/fj.13-246306; Axelgaard E, 2013, J BIOL CHEM, V288, P23407, DOI 10.1074/jbc.M113.492603; Botto M, 1998, NAT GENET, V19, P56, DOI 10.1038/ng0598-56; Chen CB, 2004, J BIOL CHEM, V279, P26058, DOI 10.1074/jbc.M401318200; Collard CD, 2000, AM J PATHOL, V156, P1549, DOI 10.1016/S0002-9440(10)65026-2; Degn SE, 2014, P NATL ACAD SCI USA, V111, P13445, DOI 10.1073/pnas.1406849111; Degn SE, 2009, J IMMUNOL, V183, P7371, DOI 10.4049/jimmunol.0902388; Dieudonne-Vatran A, 2009, J IMMUNOL, V182, P7865, DOI 10.4049/jimmunol.0802376; Dobo J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31877; Farrar CA, 2016, J CLIN INVEST, V126, P1911, DOI 10.1172/JCI83000; Fischer MB, 1996, J IMMUNOL, V157, P549; Fujita T, 2002, NAT REV IMMUNOL, V2, P346, DOI 10.1038/nri800; Hajela K, 2002, IMMUNOBIOLOGY, V205, P467, DOI 10.1078/0171-2985-00147; Hansen S, 2010, J IMMUNOL, V185, P6096, DOI 10.4049/jimmunol.1002185; Harboe M, 2009, MOL IMMUNOL, V47, P373, DOI 10.1016/j.molimm.2009.09.005; Heja D, 2012, J BIOL CHEM, V287, P20290, DOI 10.1074/jbc.M112.354332; Henriksen ML, 2013, J IMMUNOL, V191, P6117, DOI 10.4049/jimmunol.1302121; Herbert AP, 2015, J IMMUNOL, V195, P4986, DOI 10.4049/jimmunol.1501388; Iwaki D, 2006, J IMMUNOL, V177, P8626, DOI 10.4049/jimmunol.177.12.8626; Iwaki D, 2011, J IMMUNOL, V187, P3751, DOI 10.4049/jimmunol.1100280; Kenawy HI, 2012, IMMUNOBIOLOGY, V217, P272, DOI 10.1016/j.imbio.2011.10.001; Kocsis A, 2010, J IMMUNOL, V185, P4169, DOI 10.4049/jimmunol.1001819; Lachmann PJ, 2009, ADV IMMUNOL, V104, P115, DOI 10.1016/S0065-2776(08)04004-2; Lin T, 2006, AM J PATHOL, V168, P1241, DOI 10.2353/ajpath.2006.050360; Ma YJ, 2013, J INNATE IMMUN, V5, P242, DOI 10.1159/000345356; Matsushita M, 2000, J IMMUNOL, V164, P2281, DOI 10.4049/jimmunol.164.5.2281; MATSUSHITA M, 1995, IMMUNOBIOLOGY, V194, P443, DOI 10.1016/S0171-2985(11)80110-5; May J E, 1973, J Immunol, V111, P1671; Moller-Kristensen M, 2007, INT IMMUNOL, V19, P141, DOI 10.1093/intimm/dxl131; Orsini F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0684-6; Orsini F, 2012, CIRCULATION, V126, P1484, DOI 10.1161/CIRCULATIONAHA.112.103051; Petersen SV, 2001, J IMMUNOL METHODS, V257, P107, DOI 10.1016/S0022-1759(01)00453-7; Rossi V, 2001, J BIOL CHEM, V276, P40880, DOI 10.1074/jbc.M105934200; Schwaeble W, 2002, IMMUNOBIOLOGY, V205, P455, DOI 10.1078/0171-2985-00146; Schwaeble W. J., 2013, International Patent, Patent No. [WO2013/192240, 2013192240]; Schwaeble W. J., 2013, International Patent, Patent No. [WO2013/180834, 2013180834]; Schwaeble WJ, 2011, P NATL ACAD SCI USA, V108, P7523, DOI 10.1073/pnas.1101748108; Selander B, 2006, J CLIN INVEST, V116, P1425, DOI 10.1172/JCI25982; Skjoedt MO, 2010, J BIOL CHEM, V285, P8234, DOI 10.1074/jbc.M109.065805; Stengaard-Pedersen K, 2003, NEW ENGL J MED, V349, P554, DOI 10.1056/NEJMoa022836; STEUER KLK, 1989, J IMMUNOL, V143, P2256; Stover CM, 1999, J IMMUNOL, V162, P3481; Takahashi M, 1999, INT IMMUNOL, V11, P859, DOI 10.1093/intimm/11.5.859; Takahashi M, 2008, J IMMUNOL, V180, P6132, DOI 10.4049/jimmunol.180.9.6132; Takahashi M, 2010, J EXP MED, V207, P29, DOI 10.1084/jem.20090633; Thiel S, 2000, J IMMUNOL, V165, P878, DOI 10.4049/jimmunol.165.2.878; Thiel S, 1997, NATURE, V386, P506, DOI 10.1038/386506a0; Thiel S, 2012, CLIN EXP IMMUNOL, V169, P38, DOI 10.1111/j.1365-2249.2012.04584.x; Vorup-Jensen T, 2000, J IMMUNOL, V165, P2093, DOI 10.4049/jimmunol.165.4.2093; Wallis R, 1999, J IMMUNOL, V163, P4953; Wallis R, 2007, J BIOL CHEM, V282, P7844, DOI 10.1074/jbc.M606326200; Wallis R, 2010, IMMUNOBIOLOGY, V215, P1, DOI 10.1016/j.imbio.2009.08.006; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Walsh MC, 2005, J IMMUNOL, V175, P541, DOI 10.4049/jimmunol.175.1.541; WESSELS MR, 1995, P NATL ACAD SCI USA, V92, P11490, DOI 10.1073/pnas.92.25.11490	57	32	32	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2210	2219		10.1096/fj.201601306R	http://dx.doi.org/10.1096/fj.201601306R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28188176	Green Submitted			2022-12-28	WOS:000399195500038
J	Bai, J; Chow, BKC				Bai, Juan; Chow, Billy K. C.			Secretin is involved in sodium conservation through the renin-angiotensin-aldosterone system	FASEB JOURNAL			English	Article						SCTR; epithelial sodium channels; CYP11B2	EPITHELIAL NA+ CHANNEL; PY MOTIF; ENAC; CHOLESTEROL; METABOLISM; DISORDERS; MECHANISM	Secretin (SCT) and its receptor (SCTR) are important in fluid regulation at multiple levels via the modulation of expression and translocation of renal aquaporin 2 and functions of central angiotensin II (ANGII). The functional interaction of SCT with peripheral ANGII, however, remains unknown. As the ANGII-aldosterone axis dominates the regulation of renal epithelial sodium channel (ENaC) function, we therefore tested whether SCT/SCTR can regulate sodium homeostasis via the renin-angiotensin-aldosterone system. SCTR-knockout (SCTR2/2) mice showed impaired aldosterone synthase (CYP11B2) expression and, consequently, aldosterone release upon intraperitoneal injection of ANGII. Endogenous ANGII production induced by dietary sodium restriction was higher in SCTR2/2 than in C57BL/6N [wild-type (WT)] mice, but CYP11B2 and aldosterone synthesis were not elevated. Reduced accumulation of cholesteryl ester-theprecursor of aldosterone-wasobservedinadrenal glands ofSCTR2/2 mice that were fed a low-sodium diet. Absence ofSCTRresulted in elevated basal transcript levels of adrenal CYP11B2 and renal ENaCs. Although transcript and protein levels of ENaCs were similar in WT and SCTR2/2 mice under sodium restriction, ENaCs in SCTR2/2 mice were less sensitive to amiloride hydrochloride. In summary, the SCT/SCTR axis is involved in aldosterone precursor uptake, and the knockout of SCTR results in defective aldosterone biosynthesis/release and altered sensitivity of ENaCs to amiloride.- Bai, J., Chow, B. K. C. Secretin is involved in sodiumconservation through the renin-angiotensin-aldosterone system. FASEBJ. 31, 1689-1697 ( 2017). www.fasebj.org	[Bai, Juan; Chow, Billy K. C.] Univ Hong Kong, Sch Biol Sci, 4N-12,Kardoorie Biol Sci Bldg,Pokfulam Rd, Sai Ying Pun, Hong Kong, Peoples R China	University of Hong Kong	Chow, BKC (corresponding author), Univ Hong Kong, Sch Biol Sci, 4N-12,Kardoorie Biol Sci Bldg,Pokfulam Rd, Sai Ying Pun, Hong Kong, Peoples R China.	bkcc@hku.hk	Chow, Billy/D-3064-2009	Chow, Billy/0000-0003-3390-0307	Hong Kong Research Council [764510M, 765011M, 764812M, 765113M]; Collaborative Research Fund [HKU6/CRF/11G]	Hong Kong Research Council(Hong Kong Research Grants Council); Collaborative Research Fund	This work was supported by Hong Kong Research Council Grants (GRF 764510M, 765011M, 764812M, and 765113M) and Collaborative Research Fund Grant HKU6/CRF/11G (to B.K.C.C.). The authors thank Sharon Mar (University of British Columbia, Vancouver, BC, Canada) and Chong Tan (University of Hong Kong) for their help in editing the manuscript.	Bader M, 2010, ANNU REV PHARMACOL, V50, P439, DOI 10.1146/annurev.pharmtox.010909.105610; Bai JJ, 2017, AM J PHYSIOL-RENAL, V312, pF852, DOI 10.1152/ajprenal.00191.2015; Bassett MH, 2004, MOL CELL ENDOCRINOL, V217, P67, DOI 10.1016/j.mce.2003.10.011; Calhoun DA, 2006, PROG CARDIOVASC DIS, V48, P387, DOI 10.1016/j.pcad.2006.02.002; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Capponi AM, 2004, MOL CELL ENDOCRINOL, V217, P113, DOI 10.1016/j.mce.2003.10.055; Cherradi N, 1998, EUR J ENDOCRINOL, V139, P249, DOI 10.1530/eje.0.1390249; Chu JYS, 2007, MOL CELL BIOL, V27, P2499, DOI 10.1128/MCB.01088-06; Chu JYS, 2009, P NATL ACAD SCI USA, V106, P15961, DOI 10.1073/pnas.0903695106; Epstein M, 2011, J CLIN HYPERTENS, V13, P644, DOI 10.1111/j.1751-7176.2011.00511.x; Fitzsimons JT, 1998, PHYSIOL REV, V78, P583, DOI 10.1152/physrev.1998.78.3.583; GWYNNE JT, 1980, J BIOL CHEM, V255, P875; Hattangady NG, 2012, MOL CELL ENDOCRINOL, V350, P151, DOI 10.1016/j.mce.2011.07.034; Kaiser E., 1880, BOTANISCH ZENTRALB, V180, P25; Kleyman TR, 2009, J BIOL CHEM, V284, P20447, DOI 10.1074/jbc.R800083200; Kraemer FB, 2002, J LIPID RES, V43, P1585, DOI 10.1194/jlr.R200009-JLR200; Kraemer FB, 2007, MOL CELL ENDOCRINOL, V265, P42, DOI 10.1016/j.mce.2006.12.001; Lee LTO, 2014, FASEB J, V28, P2632, DOI 10.1096/fj.13-246868; Lee VHY, 2010, FASEB J, V24, P5024, DOI 10.1096/fj.10-165399; Lu B, 2009, NEUROSCIENCE, V164, P1303, DOI 10.1016/j.neuroscience.2009.08.064; Lu C, 2007, TRAFFIC, V8, P1246, DOI 10.1111/j.1600-0854.2007.00602.x; Lumbers ER, 1999, REGUL PEPTIDES, V80, P91, DOI 10.1016/S0167-0115(99)00026-9; Malendowicz K, 1996, HORM METAB RES, V28, P613, DOI 10.1055/s-2007-979865; Malendowicz LK, 1997, BIOMED RES-TOKYO, V18, P139, DOI 10.2220/biomedres.18.139; Mamenko M, 2012, J BIOL CHEM, V287, P660, DOI 10.1074/jbc.M111.298919; Masilamani S, 1999, J CLIN INVEST, V104, pR19, DOI 10.1172/JCI7840; McEwan PE, 1999, AM J PHYSIOL-ENDOC M, V276, pE303, DOI 10.1152/ajpendo.1999.276.2.E303; Mecawi AS, 2013, J NEUROENDOCRINOL, V25, P281, DOI 10.1111/j.1365-2826.2012.02388.x; Mironova E, 2012, P NATL ACAD SCI USA, V109, P10095, DOI 10.1073/pnas.1201978109; Noda M, 2013, TRENDS NEUROSCI, V36, P661, DOI 10.1016/j.tins.2013.08.004; Nogueira EF, 2009, MOL CELL ENDOCRINOL, V302, P230, DOI 10.1016/j.mce.2008.08.024; Oh YS, 1999, J CLIN INVEST, V104, P849, DOI 10.1172/JCI8378; Okubo S, 1997, J CLIN INVEST, V99, P855, DOI 10.1172/JCI119249; Paul M, 2006, PHYSIOL REV, V86, P747, DOI 10.1152/physrev.00036.2005; Payne AH, 2004, ENDOCR REV, V25, P947, DOI 10.1210/er.2003-0030; Peters J, 2012, PEPTIDES, V34, P427, DOI 10.1016/j.peptides.2012.01.023; Reynolds RM, 2006, BMJ-BRIT MED J, V332, P702, DOI 10.1136/bmj.332.7543.702; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Rossier BC, 2013, FEBS LETT, V587, P1929, DOI 10.1016/j.febslet.2013.05.013; Schild L, 1996, EMBO J, V15, P2381, DOI 10.1002/j.1460-2075.1996.tb00594.x; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sekar R, 2014, J LIPID RES, V55, P190, DOI 10.1194/jlr.M038042; Spyroglou A, 2009, J MOL ENDOCRINOL, V42, P407, DOI 10.1677/JME-08-0167; Verbalis JG, 2003, BEST PRACT RES CL EN, V17, P471, DOI 10.1016/S1521-690X(03)00049-6; VIDT DG, 1981, PHARMACOTHERAPY, V1, P179; Xing YW, 2011, ENDOCRINOLOGY, V152, P751, DOI 10.1210/en.2010-1049; Xue C, 2005, HYPERTENSION, V46, P584, DOI 10.1161/01.HYP.0000175814.18550.c0; Ye P, 2003, ENDOCRINOLOGY, V144, P3321, DOI 10.1210/en.2003-0109; Zhou ZH, 2001, AM J PHYSIOL-CELL PH, V281, pC1118, DOI 10.1152/ajpcell.2001.281.4.C1118	49	4	4	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1689	1697		10.1096/fj.201600911R	http://dx.doi.org/10.1096/fj.201600911R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28082350				2022-12-28	WOS:000398504300033
J	Wu, HB; Song, C; Zhang, JC; Zhao, JM; Fu, BB; Mao, TC; Zhang, Y				Wu, Haibo; Song, Chao; Zhang, Jingcheng; Zhao, Jiamin; Fu, Beibei; Mao, Tingchao; Zhang, Yong			Melatonin-mediated upregulation of GLUT1 blocks exit from pluripotency by increasing the uptake of oxidized vitamin C in mouse embryonic stem cells	FASEB JOURNAL			English	Article						dehydroascorbic acid; glucose transporter 1; signaling pathway; differentiation	REPROGRAMMING EFFICIENCY; CANCER-CELLS; IMPROVES; EXPRESSION; NANOG	Melatonin and vitamin C are powerful antioxidants that improve the reprogramming efficiency of induced pluripotent stemcells (iPSCs). However, the effects of the combined treatment of vitamin C andmelatonin on the differentiation of embryonic stem cells (ESCs) have not yet been examined. In this study, we showed that melatonin synergizes with vitamin C to derail exit from pluripotency of mouse ESCs. This effect is related to the increased uptake of dehydroascorbate, the oxidized form of vitamin C, through glucose transporter 1 (Glut1) transporter, which in turn, is upregulated by melatonin treatment. Analysis of the cell signaling pathway profiling systems andspecificpathwayinhibitionindicatedthatmelatoninenhancesGlut1 expressionby activating thePI3K/AKT andMAPK/ERK signaling pathways. Our findings provide a theoretical basis for application ofmelatonin in research on ESCs and iPSCs and for further investigation of the effect of combinatorial compounds on cell reprogramming.- Wu, H., Song, C., Zhang, J., Zhao, J., Fu, B., Mao, T., Zhang, Y. Melatonin-mediated upregulation of GLUT1 blocks exit frompluripotency by increasing the uptake of oxidized vitamin C in mouse embryonic stem cells. FASEB J. 31, 1731-1743 (2017). www.fasebj.org	[Wu, Haibo; Song, Chao; Zhang, Jingcheng; Zhao, Jiamin; Fu, Beibei; Mao, Tingchao; Zhang, Yong] Northwest Agr & Forestry A&F Univ, Coll Vet Med, Yangling, Shaanxi, Peoples R China; [Wu, Haibo; Song, Chao; Zhang, Jingcheng; Zhao, Jiamin; Fu, Beibei; Mao, Tingchao; Zhang, Yong] Northwest A&F Univ, Minist Agr, Key Lab Anim Biotechnol, Yangling, Shaanxi, Peoples R China	Ministry of Agriculture & Rural Affairs; Northwest A&F University - China	Wu, HB; Zhang, Y (corresponding author), Northwest A&F Univ, 3rd Taicheng Rd, Yangling 712100, Shaanxi, Peoples R China.	hbwu029@nwsuaf.edu.cn; zhangy1956@sina.com		Wu, Haibo/0000-0002-5961-2947	Fourth Military Medical University, Xi'an, China; State Key Program of the National Natural Science Foundation of China [31530075]; China Postdoctoral Science Foundation [2016M590978]	Fourth Military Medical University, Xi'an, China; State Key Program of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation)	The authors thank Prof. Zhang (Fourth Military Medical University, Xi'an, China) for the support in feeding nude mice and H&E analysis. This work was funded by State Key Program grant 31530075 of the National Natural Science Foundation of China and the China Postdoctoral Science Foundation Grant 2016M590978. The authors declare no conflicts of interest.	Bai CY, 2016, J PINEAL RES, V61, P154, DOI 10.1111/jpi.12334; Boiani M, 2005, NAT REV MOL CELL BIO, V6, P872, DOI 10.1038/nrm1744; Calder PC, 2002, BRIT J NUTR, V88, pS165, DOI 10.1079/BJN2002682; Calvo JR, 2013, J PINEAL RES, V55, P103, DOI 10.1111/jpi.12075; Caplan AI, 2006, J CELL BIOCHEM, V98, P1076, DOI 10.1002/jcb.20886; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chen JK, 2013, NAT GENET, V45, P1504, DOI 10.1038/ng.2807; Czesnikiewicz-Guzik M, 2007, J PHYSIOL PHARMACOL, V58, P5; Debolt S, 2007, ANN BOT-LONDON, V99, P3, DOI 10.1093/aob/mcl236; Desbaillets I, 2000, EXP PHYSIOL, V85, P645, DOI 10.1017/S0958067000021047; Dubocovich ML, 2003, FRONT BIOSCI-LANDMRK, V8, pD1093, DOI 10.2741/1089; Esposito E, 2010, CURR NEUROPHARMACOL, V8, P228, DOI 10.2174/157015910792246155; Esteban MA, 2012, NAT GENET, V44, P366, DOI 10.1038/ng.2222; Esteban MA, 2010, CELL STEM CELL, V6, P71, DOI 10.1016/j.stem.2009.12.001; Gao S, 2013, J PINEAL RES, V55, P31, DOI 10.1111/jpi.12047; Glenister R., 2013, TRANSL GASTROINTEST, V2, P2; Grant SG, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000982; Iyer LM, 2004, TRENDS GENET, V20, P292, DOI 10.1016/j.tig.2004.05.007; Kobylecki CJ, 2015, AM J CLIN NUTR, V101, P1135, DOI 10.3945/ajcn.114.104497; Kumar A, 2012, IN VITRO CELL DEV-AN, V48, P625, DOI 10.1007/s11626-012-9556-2; Levi B, 2011, STEM CELLS, V29, P576, DOI 10.1002/stem.612; Liang WJ, 2001, MOL MEMBR BIOL, V18, P87, DOI 10.1080/09687680120706; Matsa E, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008921; Nakano M, 2012, ZYGOTE, V20, P199, DOI 10.1017/S0967199411000190; Reiter RJ, 2013, MINI-REV MED CHEM, V13, P373; Robinton DA, 2012, NATURE, V481, P295, DOI 10.1038/nature10761; Rodriguez C, 2004, J PINEAL RES, V36, P1, DOI 10.1046/j.1600-079X.2003.00092.x; Sagun KC, 2005, FASEB J, V19, P1657, DOI 10.1096/fj.05-4107com; Sainz RM, 2003, CELL MOL LIFE SCI, V60, P1407, DOI 10.1007/s00018-003-2319-1; Smirnoff N, 2000, CURR OPIN PLANT BIOL, V3, P229, DOI 10.1016/S1369-5266(00)00069-8; Tan Dun-Xian, 2002, Current Topics in Medicinal Chemistry, V2, P181, DOI 10.2174/1568026023394443; Tan DX, 2012, J EXP BOT, V63, P577, DOI 10.1093/jxb/err256; Tian WH, 2014, J BIOL CHEM, V289, P3339, DOI 10.1074/jbc.M113.538157; Turek FW, 2004, SLEEP MED, V5, P523, DOI 10.1016/j.sleep.2004.07.009; Wang QO, 2011, PHARMACOL BIOCHEM BE, V98, P140, DOI 10.1016/j.pbb.2010.12.006; Wang T, 2011, CELL STEM CELL, V9, P575, DOI 10.1016/j.stem.2011.10.005; Wilson JX, 2005, ANNU REV NUTR, V25, P105, DOI 10.1146/annurev.nutr.25.050304.092647; Wu HB, 2014, STEM CELLS, V32, P166, DOI 10.1002/stem.1523; Yoe YM, 2011, BRAIN RES, V1385, P1, DOI 10.1016/j.brainres.2011.02.047; Yun J, 2015, SCIENCE, V350, P1391, DOI 10.1126/science.aaa5004; Zhang LM, 2013, J PINEAL RES, V54, P24, DOI 10.1111/j.1600-079X.2012.01016.x	41	16	17	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1731	1743		10.1096/fj.201601085R	http://dx.doi.org/10.1096/fj.201601085R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28069827				2022-12-28	WOS:000398504300037
J	Zhao, LJ; Ni, Y; Yu, HY; Zhang, P; Zhao, AH; Bao, YQ; Liu, JJ; Chen, TL; Xie, GX; Panee, J; Chen, WL; Rajani, C; Wei, RM; Su, MM; Jia, WP; Jia, W				Zhao, Linjing; Ni, Yan; Yu, Haoyong; Zhang, Pin; Zhao, Aihua; Bao, Yuqian; Liu, Jiajian; Chen, Tianlu; Xie, Guoxiang; Panee, Jun; Chen, Wenlian; Rajani, Cynthia; Wei, Runmin; Su, Mingming; Jia, Weiping; Jia, Wei			Serum stearic acid/palmitic acid ratio as a potential predictor of diabetes remission after Roux-en-Y gastric bypass in obesity	FASEB JOURNAL			English	Article						bariatric surgery; fatty acid metabolism; elovl6; UPLC/QTOFMS; targeted metabolomics	POLYUNSATURATED FATTY-ACIDS; HUMAN ADIPOSE-TISSUE; BODY-MASS INDEX; INSULIN SENSITIVITY; DESATURASE ACTIVITY; BARIATRIC SURGERY; DELTA-6 DESATURASE; WEIGHT-LOSS; RISK; ASSOCIATION	Endogenous fatty acid metabolism that results in elongation and desaturation lipid products is thought to play a role in the development of type 2 diabetes mellitus (T2DM). In this study, we evaluated the potential of estimated elongase and desaturase activities for use as predictive markers for T2DM remission after Roux-en-Y gastric bypass (RYGB). The results of a targeted metabolomics approach from 2 independent studies were used to calculate 24 serum FA concentration ratios (product/precursor). Gene expression data from an open public data set was also analyzed. In a longitudinal study of 38 obese diabetic patients with RYGB, we found higher baseline stearic acid/palmitic acid(S/P) ratio. This ratio reflects anelovl6-encoded elongase enzyme activity that has been found to be associated with greater possibility for diabetes remission after RYGB [ odds ratio, 2.16 (95% CI 1.10-4.26)], after adjustment for age, gender, body mass index, diabetes duration, glycosylated hemoglobin A1c, and fasting C-peptide. Our results were validated by examination of postsurgical elovl6 gene expression in morbidly obese patients. The association of S/P with the metabolic status of obese individuals was further validated in a crosssectional cohort of 381 participants. In summary, higher baseline S/P was associated with greater probability of diabetes remission after RYGB and may serve as a diagnostic marker in preoperative patient assessment.-Zhao, L., Ni, Y., Yu, H., Zhang, P., Zhao, A., Bao, Y., Liu, J., Chen, T., Xie, G., Panee, J., Chen, W., Rajani, C., Wei, R., Su, M., Jia, W., Jia, W. Serum stearic acid/palmitic acid ratio as a potential predictor of diabetes remission after Roux-en-Y gastric bypass in obesity. FASEB J. 31, 1449-1460 (2017). www.fasebj.org	[Zhao, Linjing; Ni, Yan; Zhao, Aihua; Bao, Yuqian; Liu, Jiajian; Chen, Tianlu; Jia, Weiping; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai, Peoples R China; [Zhao, Linjing; Ni, Yan; Zhao, Aihua; Bao, Yuqian; Liu, Jiajian; Chen, Tianlu; Jia, Weiping; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Translat Med, Shanghai, Peoples R China; [Zhao, Linjing] Shanghai Univ Engn Sci, Coll Chem & Chem Engn, Shanghai, Peoples R China; [Ni, Yan; Xie, Guoxiang; Chen, Wenlian; Rajani, Cynthia; Wei, Runmin; Su, Mingming; Jia, Wei] Univ Hawaii, Canc Ctr, 701 Ilalo St, Honolulu, HI 96813 USA; [Yu, Haoyong; Bao, Yuqian; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai, Peoples R China; [Zhang, Pin] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Gen Surg, Shanghai, Peoples R China; [Panee, Jun] Univ Hawaii Manoa, John A Burns Sch Med, Dept Cell & Mol Biol, Honolulu, HI 96822 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai University of Engineering Science; Cancer Research Center of Hawaii; University of Hawaii System; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Hawaii System; University of Hawaii Manoa	Jia, W (corresponding author), Univ Hawaii, Canc Ctr, 701 Ilalo St, Honolulu, HI 96813 USA.; Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, 600 Yishan Rd, Shanghai 200233, Peoples R China.	wpjia@sjtu.edu.cn; wjia@cc.hawaii.edu	Jia, Wei/AAN-5102-2020; Xie, Guoxiang/F-3022-2016; Wei, Runmin/J-6128-2019	Jia, Wei/0000-0002-3739-8994; Xie, Guoxiang/0000-0002-0951-4150; Wei, Runmin/0000-0001-7707-0160	International Science and Technology Cooperation Program of China [2014DFA31870]; China Scholarship Council [201408310049]; GEO [GSE53376]; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	International Science and Technology Cooperation Program of China; China Scholarship Council(China Scholarship Council); GEO; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This study was supported by grants from International Science and Technology Cooperation Program of China (2014DFA31870) and China Scholarship Council (201408310049). The authors thank Dr. F. J. Ortega and Dr. J. M. Fernandez-Real for sharing the clinical data of microarray datasets, GEO GSE53376. The authors declare no conflicts of interest.	Aarts EO, 2013, OBES SURG, V23, P867, DOI 10.1007/s11695-013-0872-8; Arora T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126401; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Buse JB, 2009, DIABETES CARE, V32, P2133, DOI 10.2337/dc09-9036; Campos GM, 2014, SURG OBES RELAT DIS, V10, P1, DOI 10.1016/j.soard.2013.07.010; Chen WL, 2014, BLOOD, V124, P1645, DOI 10.1182/blood-2014-02-554204; Courcoulas AP, 2013, JAMA-J AM MED ASSOC, V310, P2416, DOI 10.1001/jama.2013.280928; Curry TB, 2011, AM J PHYSIOL-ENDOC M, V300, pE746, DOI 10.1152/ajpendo.00596.2010; de Antueno RJ, 2001, FEBS LETT, V509, P77, DOI 10.1016/S0014-5793(01)03135-0; Dixon JB, 2013, DIABETES CARE, V36, P20, DOI 10.2337/dc12-0779; EVANS DJ, 1984, J CLIN INVEST, V74, P1515, DOI 10.1172/JCI111565; Ferrannini E, 2013, DIABETES, V62, P1730, DOI 10.2337/db12-0707; Fiehn O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015234; Flowers MT, 2008, CURR OPIN LIPIDOL, V19, P248, DOI 10.1097/MOL.0b013e3282f9b54d; Forouhi NG, 2014, LANCET DIABETES ENDO, V2, P810, DOI 10.1016/S2213-8587(14)70146-9; Gonzalez-Plaza JJ, 2016, SURG OBES RELAT DIS, V12, P257, DOI 10.1016/j.soard.2015.07.007; Halliwell KJ, 1996, J LIPID RES, V37, P1842; Hayes MT, 2011, OBES SURG, V21, P910, DOI 10.1007/s11695-011-0370-9; Hellerstein MK, 1996, ANNU REV NUTR, V16, P523, DOI 10.1146/annurev.nu.16.070196.002515; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Huang CK, 2011, OBES SURG, V21, P1344, DOI 10.1007/s11695-011-0408-z; Hudgins LC, 1996, J CLIN INVEST, V97, P2081, DOI 10.1172/JCI118645; Jacobs S, 2015, AM J CLIN NUTR, V102, P155, DOI 10.3945/ajcn.114.102707; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Johansson LE, 2012, AM J CLIN NUTR, V96, P196, DOI 10.3945/ajcn.111.020578; Kegg Pathway Database, BIOS UNS FATT AC; Kim MK, 2011, OBESITY, V19, P1835, DOI 10.1038/oby.2011.205; Kroger J, 2011, AM J CLIN NUTR, V93, P127, DOI 10.3945/ajcn.110.005447; Lankinen MA, 2015, DIABETOLOGIA, V58, P2533, DOI 10.1007/s00125-015-3730-5; Lee WJ, 2015, SURG OBES RELAT DIS, V11, P991, DOI 10.1016/j.soard.2014.12.027; Li SW, 2016, J TRANSL MED, V14, DOI 10.1186/s12967-016-0834-8; Liang ZW, 2013, DIABETES RES CLIN PR, V101, P50, DOI 10.1016/j.diabres.2013.04.005; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Luo P, 2016, J PROTEOME RES, V15, P1288, DOI 10.1021/acs.jproteome.6b00022; Mahendran Y, 2014, AM J CLIN NUTR, V99, P79, DOI 10.3945/ajcn.113.069740; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Moon YA, 2001, J BIOL CHEM, V276, P45358, DOI 10.1074/jbc.M108413200; Mor A, 2014, SURG ENDOSC, V28, P1489, DOI 10.1007/s00464-013-3338-0; Ni Y, 2015, EBIOMEDICINE, V2, P1513, DOI 10.1016/j.ebiom.2015.09.004; Ortega F.J., 2014, ADIPOSE TRANSCRIPTOM; PUTTMANN M, 1993, CLIN CHEM, V39, P825; Reynoso R, 2003, MOL CELL BIOCHEM, V246, P155, DOI 10.1023/A:1023423005187; Robert M, 2013, OBES SURG, V23, P770, DOI 10.1007/s11695-013-0868-4; Rubino F, 2006, CURR OPIN CLIN NUTR, V9, P497, DOI 10.1097/01.mco.0000232914.14978.c5; Schauer PR, 2003, ANN SURG, V238, P467, DOI 10.1097/01.sla.0000089851.41115.1b; Sieber J, 2010, AM J PHYSIOL-RENAL, V299, pF821, DOI 10.1152/ajprenal.00196.2010; Still CD, 2014, LANCET DIABETES ENDO, V2, P38, DOI 10.1016/S2213-8587(13)70070-6; Thyfault JP, 2004, AM J PHYSIOL-ENDOC M, V287, pE1076, DOI 10.1152/ajpendo.00177.2004; Vaittinen M, 2016, J LIPID RES, V57, P56, DOI 10.1194/jlr.M059113; van den Berg SAA, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-24; VANDERVUSSE GJ, 1985, J MOL CELL CARDIOL, V17, P527, DOI 10.1016/S0022-2828(85)80059-6; VESSBY B, 1994, DIABETES, V43, P1353, DOI 10.2337/diabetes.43.11.1353; Weigert C, 2004, J BIOL CHEM, V279, P23942, DOI 10.1074/jbc.M312692200; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655; Yary T, 2016, AM J CLIN NUTR, V103, P1337, DOI 10.3945/ajcn.115.128629; Yu HY, 2015, J CLIN ENDOCR METAB, V100, P4222, DOI 10.1210/jc.2015-2884; Yu HY, 2015, SURG OBES RELAT DIS, V11, P6, DOI 10.1016/j.soard.2014.06.019; Zhou BF, 2002, BIOMED ENVIRON SCI, V15, P245	58	25	27	3	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1449	1460		10.1096/fj.201600927R	http://dx.doi.org/10.1096/fj.201600927R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28007782	Green Published			2022-12-28	WOS:000398504300015
J	Parisi, S; Passaro, F; Russo, L; Musto, A; Navarra, A; Romano, S; Petrosino, G; Russo, T				Parisi, Silvia; Passaro, Fabiana; Russo, Luigi; Musto, Anna; Navarra, Angelica; Romano, Simona; Petrosino, Giuseppe; Russo, Tommaso			Lin28 is induced in primed embryonic stem cells and regulates let-7-independent events	FASEB JOURNAL			English	Article						differentiation; Hmga2; Otx2; pluripotency; RNA-binding proteins	MESSENGER-RNAS; LET-7 MICRORNA; SELF-RENEWAL; PLURIPOTENCY; TRANSITION; PROTEINS; HMGA2; IDENTIFICATION; TRANSFORMATION; SUPPRESSOR	Lin28 RNA-binding proteins play important roles in pluripotent stem cells, but the regulation of their expression and the mechanisms underlying their functions are still not definitively understood. Here we address the above-mentioned issues in the first steps of mouse embryonic stem cell (ESC) differentiation. We observed that the expression of Lin28 genes is transiently induced soon after the exit of ESCs from the naive ground state and that this induction is due to the Hmga2-dependent engagement of Otx2 with enhancers present at both Lin28 gene loci. These mechanisms are crucial for Lin28 regulation, as demonstrated by the abolishment of the Lin28 accumulationin Otx2 or Hmga2-knockout cells compared to the control cells. We have also found that Lin28 controls Hmga2 expression levels during ESC differentiation through a let-7-independent mechanism. Indeed, we found that Lin28 proteins bind a highly conserved element in the 3' UTR of Hmga2 mRNA, and this provokes a down-regulation of its translation. This mechanism prevents the inappropriate accumulation of Hmga2 that would modify the proliferation and physiological apoptosis of differentiating ESCs. In summary, we demonstrated that during ESC differentiation, Lin28 transient induction is dependent on Otx2 and Hmga2 and prevents an inappropriate excessive rise of Hmga2 levels.	[Parisi, Silvia; Passaro, Fabiana; Russo, Luigi; Musto, Anna; Navarra, Angelica; Romano, Simona] Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Via S Pansini 5, I-80131 Naples, Italy; [Petrosino, Giuseppe] BioMed X Innovat Ctr, Heidelberg, Germany	University of Naples Federico II	Parisi, S (corresponding author), Univ Naples Federico II, Dipartimento Med Mol & Biotecnol Med, Via S Pansini 5, I-80131 Naples, Italy.	silvia.parisi@unina.it	Passaro, Fabiana/I-5941-2012; RUSSO, Tommaso/K-1331-2016	Passaro, Fabiana/0000-0003-0150-5302; RUSSO, Tommaso/0000-0003-4426-0106; RUSSO, Luigi/0000-0002-1577-176X; Petrosino, Giuseppe/0000-0002-2835-4308	Italian Ministry of University and Research [RBFR13YZ2Y, CESMA]; Regione Campania (Special Projects Movie); Associazione Italiana per la Ricerca sul Cancro [IG11508]	Italian Ministry of University and Research(Ministry of Education, Universities and Research (MIUR)); Regione Campania (Special Projects Movie); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	The authors are grateful to A. Simeone and D. Acampora (National Research Council, Naples, Italy) for Otx2-KO cells, and to M. Caiazzo (University of Utrecht, Utrecht The Netherlands) for Lin28 plasmid. This work was supported by grants from the Italian Ministry of University and Research (RBFR13YZ2Y and CESMA), from Regione Campania (Special Projects Movie), and from the Associazione Italiana per la Ricerca sul Cancro (IG11508).	Acampora D, 2016, CELL REP, V15, P2651, DOI 10.1016/j.celrep.2016.05.041; Acampora D, 2013, DEVELOPMENT, V140, P43, DOI 10.1242/dev.085290; Alam M, 2015, MOL CANCER RES, V13, P449, DOI 10.1158/1541-7786.MCR-14-0363; Balzer E, 2010, DEVELOPMENT, V137, P891, DOI 10.1242/dev.042895; Buecker C, 2014, CELL STEM CELL, V14, P838, DOI 10.1016/j.stem.2014.04.003; Cacchiarelli D, 2015, CELL, V162, P412, DOI 10.1016/j.cell.2015.06.016; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Cho J, 2012, CELL, V151, P765, DOI 10.1016/j.cell.2012.10.019; Copley MR, 2013, NAT CELL BIOL, V15, P916, DOI 10.1038/ncb2783; Fusco A, 2007, NAT REV CANCER, V7, P899, DOI 10.1038/nrc2271; Guo L, 2013, ONCOGENE, V32, P5272, DOI 10.1038/onc.2012.573; Hafner M, 2013, RNA, V19, P613, DOI 10.1261/rna.036491.112; Hanna J, 2009, NATURE, V462, P595, DOI 10.1038/nature08592; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Kumar RM, 2014, NATURE, V516, P56, DOI 10.1038/nature13920; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lorenz R, 2011, ALGORITHM MOL BIOL, V6, DOI 10.1186/1748-7188-6-26; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Musto A, 2015, CELL DEATH DIFFER, V22, P1047, DOI 10.1038/cdd.2014.198; Navarra A, 2016, BMC BIOL, V14, DOI 10.1186/s12915-016-0246-5; Peng SP, 2011, STEM CELLS, V29, P496, DOI 10.1002/stem.591; Piskounova E, 2011, CELL, V147, P1066, DOI 10.1016/j.cell.2011.10.039; Reeves R, 2010, BBA-GENE REGUL MECH, V1799, P3, DOI 10.1016/j.bbagrm.2009.09.001; Tsialikas J, 2015, DEVELOPMENT, V142, P2397, DOI 10.1242/dev.117580; Van Wynsberghe PM, 2011, NAT STRUCT MOL BIOL, V18, P302, DOI 10.1038/nsmb.1986; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yang SH, 2014, CELL REP, V7, P1968, DOI 10.1016/j.celrep.2014.05.037; Zhang J, 2016, CELL STEM CELL, V19, P66, DOI 10.1016/j.stem.2016.05.009; Zhou JB, 2013, INT J BIOCHEM CELL B, V45, P973, DOI 10.1016/j.biocel.2013.02.006	33	22	24	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1046	+		10.1096/fj.201600848R	http://dx.doi.org/10.1096/fj.201600848R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27920151				2022-12-28	WOS:000395671200019
J	Shimura, M; Shindou, H; Szyrwiel, L; Tokuoka, SM; Hamano, F; Matsuyama, S; Okamoto, M; Matsunaga, A; Kita, Y; Ishizaka, Y; Yamauchi, K; Kohmura, Y; Lobinski, R; Shimizu, I; Shimizu, T				Shimura, Mari; Shindou, Hideo; Szyrwiel, Lukasz; Tokuoka, Suzumi M.; Hamano, Fumie; Matsuyama, Satoshi; Okamoto, Mayumi; Matsunaga, Akihiro; Kita, Yoshihiro; Ishizaka, Yukihito; Yamauchi, Kazuto; Kohmura, Yoshiki; Lobinski, Ryszard; Shimizu, Isao; Shimizu, Takao			Imaging of intracellular fatty acids by scanning X-ray fluorescence microscopy	FASEB JOURNAL			English	Article						glycerophospholipid; labeling; cellular membrane; lipid metabolism; visualization	LIPID MEDIATORS; METABOLISM; MEMBRANE; CELLS; INFLAMMATION; DYNAMICS; DISEASES; TARGETS; ENZYMES; SYSTEM	Fatty acids are taken up by cells and incorporated into complex lipids such as neutral lipids and glycerophospholipids. Glycerophospholipids are major constituents of cellular membranes. More than 1000 molecular species of glycerophospholipids differ in their polar head groups and fatty acid compositions. They are related to cellular functions and diseases and have been well analyzed by mass spectrometry. However, intracellular imaging of fatty acids and glycerophospholipids has not been successful due to insufficient resolution using conventional methods. Here, we developed a method for labeling fatty acids with bromine (Br) and applied scanning X-ray fluorescence microscopy (SXFM) to obtain intracellular Br mapping data with submicrometer resolution. Mass spectrometry showed that cells took up Br-labeled fatty acids and metabolized them mainly into glycerophospholipids in CHO cells. Most Br signals observed by SXFM were in the perinuclear region. Higher resolution revealed a spot-like distribution of Br in the cytoplasm. The current method enabled successful visualization of intracellular Br-labeled fatty acids. Single-element labeling combined with SXFM technology facilitates the intracellular imaging of fatty acids, which provides a new tool to determine dynamic changes in fatty acids and their derivatives at the single-cell level.	[Shimura, Mari; Matsunaga, Akihiro; Ishizaka, Yukihito] Natl Ctr Global Hlth & Med, Dept Intractable Dis, Tokyo 1628655, Japan; [Shindou, Hideo; Shimizu, Takao] Natl Ctr Global Hlth & Med, Lipid Signaling Res Inst, Tokyo, Japan; [Shimura, Mari; Szyrwiel, Lukasz; Kohmura, Yoshiki] Riken SPring 8 Ctr, Sayo, Hyogo, Japan; [Shindou, Hideo] Agcy Med Res & Development Core Res Evolutionary, Tokyo, Japan; [Szyrwiel, Lukasz; Lobinski, Ryszard] UPPA, CNRS, LCABIE, Unite Mixte Rech 5254, Pau, France; [Szyrwiel, Lukasz] Wroclaw Med Univ, Dept Chem Drugs, Wroclaw, Poland; [Tokuoka, Suzumi M.; Hamano, Fumie; Kita, Yoshihiro; Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Lipid, Tokyo, Japan; [Hamano, Fumie; Kita, Yoshihiro] Univ Tokyo, Grad Sch Med, Life Sci Core Facil, Tokyo, Japan; [Matsuyama, Satoshi; Yamauchi, Kazuto] Osaka Univ, Grad Sch Engn, Dept Precis Sci & Technol, Osaka, Japan; [Okamoto, Mayumi; Shimizu, Isao] Waseda Univ, Sch Adv Sci & Engn, Res Inst Sci & Engn, Tokyo, Japan; [Okamoto, Mayumi] Natl Ctr Global Hlth & Med, Dept Pathol & Immunol, Res Inst, Chiba, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; RIKEN; Centre National de la Recherche Scientifique (CNRS); Universite de Pau et des Pays de l'Adour; Wroclaw Medical University; University of Tokyo; University of Tokyo; Osaka University; Waseda University; National Center for Global Health & Medicine - Japan	Shimura, M (corresponding author), Natl Ctr Global Hlth & Med, Dept Intractable Dis, Tokyo 1628655, Japan.; Shindou, H (corresponding author), Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Res Inst, Tokyo 1628655, Japan.	mshimura@ri.ncgm.go.jp; hsindou-tky@umin.net	Okamoto, Mayumi/L-5885-2017; Matsunaga, Akihiro/AAU-3255-2021; Shimizu, Takao/AAV-7052-2021	Okamoto, Mayumi/0000-0001-7708-3455; Lobinski, Ryszard/0000-0003-1908-2029; Szyrwiel, Lukasz/0000-0003-1983-2950	Japan Society for the Promotion of Science (JSPS) [24229003, 26460380]; National Center for Global Health and Medicine Grant [24-001]; Takeda Science Foundation; Core Research for Evolutionary Science and Technology (CREST) from the Japan Science and Technology Agency; Agency for Medical Research and Development (AMED)-CREST; Shimadzu Co.; ONO Pharmaceutical Co., Ltd.; European Union [PIEF-GA-2012-329969]; Grants-in-Aid for Scientific Research [26286077] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Center for Global Health and Medicine Grant; Takeda Science Foundation(Takeda Science Foundation (TSF)); Core Research for Evolutionary Science and Technology (CREST) from the Japan Science and Technology Agency; Agency for Medical Research and Development (AMED)-CREST(Japan Agency for Medical Research and Development (AMED)); Shimadzu Co.; ONO Pharmaceutical Co., Ltd.(Ono Pharmaceutical Co Ltd); European Union(European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Daisuke Hishikawa and Yoshikazu Takahashi [National Center for Global Health and Medicine (NCGM), Tokyo, Japan] and Ayako Kobayashi (University of Tokyo) for providing technical support, Tetsuya Ishikawa (Riken) for providing advice and encouragement during this study, and Keizo Waku (Teikyo University, Itabashi, Japan) for constructive comments. This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) Grants 24229003 (to T.S.) and 26460380 (to H.S.); National Center for Global Health and Medicine Grant 24-001 (to T.S.); the Takeda Science Foundation (T.S.); Core Research for Evolutionary Science and Technology (CREST) from the Japan Science and Technology Agency (to M.S., S.M., and K.Y.); and Agency for Medical Research and Development (AMED)-CREST (to H.S.). S.M.-T., F.H., Y.K., and T.S. are affiliated with the Department of Lipidomics, the University of Tokyo, which is financially supported by Shimadzu Co. and ONO Pharmaceutical Co., Ltd. L.S. is supported by a Marie Curie Intra-European Fellowship from the European Union (PIEF-GA-2012-329969). None of the authors received support from any organization or has a financial relationship with any organization that might have an interest in the submitted work. There are no other relationships or activities that could have influenced this research.	Antonny B, 2015, TRENDS CELL BIOL, V25, P427, DOI 10.1016/j.tcb.2015.03.004; Bankaitis VA, 2012, CURR BIOL, V22, pR414, DOI 10.1016/j.cub.2012.03.004; Burkemper JL, 2015, J MED CHEM, V58, P8542, DOI 10.1021/acs.jmedchem.5b01035; Chilton FH, 2014, NUTRIENTS, V6, P1993, DOI 10.3390/nu6051993; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Elvington SM, 2005, J BIOL CHEM, V280, P40957, DOI 10.1074/jbc.M507926200; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Harayama T., 2014, METABOLISM, V20, P295; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jindal A, 2014, J LABELLED COMPD RAD, V57, P463, DOI 10.1002/jlcr.3205; Lang L., 2011, THERANOSTICS, V1; Matsuyama S, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2349594; Matsuyama S, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2358699; Matsuyama S, 2009, X-RAY SPECTROM, V38, P89, DOI 10.1002/xrs.1123; Mimura H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4539; Mimura H, 2010, NAT PHYS, V6, P122, DOI 10.1038/NPHYS1457; Palonpon AF, 2013, CURR OPIN CHEM BIOL, V17, P708, DOI 10.1016/j.cbpa.2013.05.021; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Scaglia N, 2014, CELL CYCLE, V13, P859, DOI 10.4161/cc.27767; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shimura M, 2005, CANCER RES, V65, P4998, DOI 10.1158/0008-5472.CAN-05-0373; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Varnai P, 2006, BBA-MOL CELL BIOL L, V1761, P957, DOI 10.1016/j.bbalip.2006.03.019; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Yabashi M, 2014, J SYNCHROTRON RADIAT, V21, P976, DOI 10.1107/S1600577514016415; Yalcin EB, 2015, J HISTOCHEM CYTOCHEM, V63, P762, DOI 10.1369/0022155415596202; Zhao FJ, 2014, TRENDS PLANT SCI, V19, P183, DOI 10.1016/j.tplants.2013.12.001	33	13	15	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4149	4158		10.1096/fj.201600569R	http://dx.doi.org/10.1096/fj.201600569R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27601443	Green Published, hybrid			2022-12-28	WOS:000388201500021
J	Markworth, JF; Kaur, G; Miller, EG; Larsen, AE; Sinclair, AJ; Maddipati, KR; Cameron-Smith, D				Markworth, James F.; Kaur, Gunveen; Miller, Eliza G.; Larsen, Amy E.; Sinclair, Andrew J.; Maddipati, Krishna Rao; Cameron-Smith, David			Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid	FASEB JOURNAL			English	Article						eicosanoids; fish oil; inflammation; lipidomics; omega-3 fatty acids	FOOD-FREQUENCY QUESTIONNAIRE; POLYUNSATURATED FATTY-ACID; CHAIN OMEGA-3-FATTY-ACID SUPPLEMENTATION; DOCOSAHEXAENOIC ACID; ANTIINFLAMMATORY PROPERTIES; STEREOCHEMICAL ASSIGNMENT; MYOCARDIAL-INFARCTION; PLATELET-AGGREGATION; BIOACTIVE PRODUCTS; HUMAN PLASMA	In contrast to the well-characterized effects of specialized proresolving lipid mediators (SPMs) derived from eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), little is known about the metabolic fate of the intermediary long-chain (LC) n-3 polyunsaturated fatty acid (PUFA) docosapentaenoic acid (DPA). In this double blind crossover study, shifts in circulating levels of n-3 and n-6 PUFA-derived bioactive lipid mediators were quantified by an unbiased liquid chromatography-tandem mass spectrometry lipidomic approach. Plasma was obtained from human subjects before and after 7 d of supplementation with pure n-3 DPA, n-3 EPA or placebo (olive oil). DPA supplementation increased the SPM resolvin D5(n-3DPA) (RvD5(n-3DPA)) and maresin (MaR)-1, the DHA vicinal diol 19,20-dihydroxy-DPA and n-6 PUFA derived 15-keto-PG E-2 (15-keto-PGE(2)). EPA supplementation had no effect on any plasma DPA or DHA derived mediators, but markedly elevated monohydroxy-eicosapentaenoic acids (HEPEs), including the e-series resolvin (RvE) precursor 18-HEPE; effects not observed with DPA supplementation. These data show that dietary n-3 DPA and EPA have highly divergent effects on human lipid mediator profile, with no overlap in PUFA metabolites formed. The recently uncovered biologic activity of n-3 DPA docosanoids and their marked modulation by dietary DPA intake reveals a unique and specific role of n-3 DPA in human physiology.Markworth, J. F., Kaur, G., Miller, E. G., Larsen, A. E., Sinclair, A. J., Maddipati, K. R., Cameron-Smith, D. Divergent shifts in lipid mediator profile following supplementation with n-3 docosapentaenoic acid and eicosapentaenoic acid.	[Markworth, James F.; Cameron-Smith, David] Univ Auckland, Liggins Inst, Private Bag 92019,85 Pk Rd, Auckland 1142, New Zealand; [Kaur, Gunveen; Miller, Eliza G.] Deakin Univ, Sch Exercise & Nutr Sci, Ctr Phys Act & Nutr Res, Melbourne, Vic, Australia; [Larsen, Amy E.] La Trobe Univ, Dept Physiol Anat & Microbiol, Melbourne, Vic, Australia; [Sinclair, Andrew J.] Deakin Univ, Sch Med, Geelong, Vic, Australia; [Maddipati, Krishna Rao] Wayne State Univ, Dept Pathol, Lipid Core Facil, Detroit, MI 48202 USA; [Maddipati, Krishna Rao] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA	University of Auckland; Deakin University; La Trobe University; Deakin University; Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Cameron-Smith, D (corresponding author), Univ Auckland, Liggins Inst, Private Bag 92019,85 Pk Rd, Auckland 1142, New Zealand.	d.cameron-smith@auckland.ac.nz	Maddipati, Krishna Rao/H-3569-2019; Maddipati, Krishna Rao/G-1859-2011	Maddipati, Krishna Rao/0000-0003-1445-791X; Maddipati, Krishna Rao/0000-0003-1445-791X; Cameron-Smith, David/0000-0002-0144-5816	Food and Health Program (University of Auckland); Meat and Livestock Australia; Strategic Research Centre for Molecular Medicine (Deakin University); National Center for Research Resources, U.S. National Institutes of Health, National Center for Research Resources [S10RR027926]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027926] Funding Source: NIH RePORTER	Food and Health Program (University of Auckland); Meat and Livestock Australia(Meat and Livestock Australia); Strategic Research Centre for Molecular Medicine (Deakin University); National Center for Research Resources, U.S. National Institutes of Health, National Center for Research Resources; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors thank Dr. Marissa Caldow (University of Melbourne, Melbourne, VIC, Australia) for assistance with the clinical trial, Mr. Senlin Zhou (Lipidomics Core Facility, Wayne State University) for assistance in sample preparation for LC-MS analyses, and the study participants. The study was supported in part by funding received from the Food and Health Program (University of Auckland), Meat and Livestock Australia, the Strategic Research Centre for Molecular Medicine (Deakin University). Equateq, Ltd. (Breasclete, United Kingdom) generously provided the pure supplements and the National Center for Research Resources, U.S. National Institutes of Health, National Center for Research Resources Grant S10RR027926 (to K.R.M.). The authors declare no conflicts of interest.	Akiba S, 2000, BIOL PHARM BULL, V23, P1293, DOI 10.1248/bpb.23.1293; [Anonymous], 2012, EFSA J, V10, P2815; Arita M, 2005, BIOCHEM BIOPH RES CO, V338, P149, DOI 10.1016/j.bbrc.2005.07.181; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arnold C, 2010, J BIOL CHEM, V285, P32720, DOI 10.1074/jbc.M110.118406; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Barden A, 2014, J LIPID RES, V55, P2401, DOI 10.1194/jlr.M045583; Chen JN, 2012, ATHEROSCLEROSIS, V221, P397, DOI 10.1016/j.atherosclerosis.2012.01.005; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Dalli J, 2013, SCI REP-UK, V3, DOI 10.1038/srep01940; Dawczynski C, 2013, CLIN NUTR, V32, P686, DOI 10.1016/j.clnu.2012.12.010; Fischer R, 2014, J LIPID RES, V55, P1150, DOI 10.1194/jlr.M047357; Flachs P, 2014, PHYSIOL RES, V63, pS93, DOI 10.33549/physiolres.932715; Gerber PA, 2013, CURR PHARM DESIGN, V19, P3074, DOI 10.2174/1381612811319170016; Ghasemifard S, 2014, PROG LIPID RES, V56, P92, DOI 10.1016/j.plipres.2014.09.001; Gomolka B, 2011, PROSTAG OTH LIPID M, V94, P81, DOI 10.1016/j.prostaglandins.2010.12.006; Gotoh N, 2009, J AGR FOOD CHEM, V57, P11047, DOI 10.1021/jf9026553; Harmon GS, 2010, NAT MED, V16, P313, DOI 10.1038/nm.2101; Holub BJ, 2011, LIPIDS, V46, P399, DOI 10.1007/s11745-011-3535-3; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Isobe Y, 2013, J BIOCHEM, V153, P355, DOI 10.1093/jb/mvs151; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Janssen CIF, 2014, PROG LIPID RES, V53, P1, DOI 10.1016/j.plipres.2013.10.002; KanayasuToyoda T, 1996, PROSTAG LEUKOTR ESS, V54, P319, DOI 10.1016/S0952-3278(96)90045-9; Kaur G, 2011, PROSTAG LEUKOTR ESS, V85, P155, DOI 10.1016/j.plefa.2011.06.002; Kaur G, 2011, PROG LIPID RES, V50, P28, DOI 10.1016/j.plipres.2010.07.004; Kaur G, 2010, BRIT J NUTR, V103, P32, DOI 10.1017/S0007114509991334; Keenan AH, 2012, J LIPID RES, V53, P1662, DOI 10.1194/jlr.P025577; Kelly L, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.001; Lorente-Cebrian S, 2013, J PHYSIOL BIOCHEM, V69, P633, DOI 10.1007/s13105-013-0265-4; Lu D, 2014, ONCOGENE, V33, P1101, DOI 10.1038/onc.2013.69; Lu Y, 2010, J LIPID RES, V51, P923, DOI 10.1194/jlr.M000059; Lundstrom SL, 2013, MOL NUTR FOOD RES, V57, P1378, DOI 10.1002/mnfr.201200827; Maddipati KR, 2011, PROSTAG OTH LIPID M, V94, P59, DOI 10.1016/j.prostaglandins.2011.01.003; Marcheselli VL, 2003, J BIOL CHEM, V278, P43807, DOI 10.1074/jbc.M305841200; Markworth JF, 2013, AM J PHYSIOL-REG I, V305, pR1281, DOI 10.1152/ajpregu.00128.2013; Mas E, 2016, CLIN NUTR, V35, P331, DOI 10.1016/j.clnu.2015.04.004; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Miller E, 2013, EUR J NUTR, V52, P895, DOI 10.1007/s00394-012-0396-3; Morin C, 2013, PROSTAG LEUKOTR ESS, V89, P203, DOI 10.1016/j.plefa.2013.07.004; Morisseau C, 2013, ANNU REV PHARMACOL, V53, P37, DOI 10.1146/annurev-pharmtox-011112-140244; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Murphy RC, 2015, J LIPID RES, V56, P1641, DOI 10.1194/jlr.C062356; Oda E, 2005, INT HEART J, V46, P583, DOI 10.1536/ihj.46.583; Oh SF, 2012, J IMMUNOL, V188, P4527, DOI 10.4049/jimmunol.1103652; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Paganelli F, 2001, INT J CARDIOL, V78, P27, DOI 10.1016/S0167-5273(00)00442-3; Phang M, 2009, PROSTAG LEUKOTR ESS, V81, P35, DOI 10.1016/j.plefa.2009.05.001; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Rissanen T, 2000, CIRCULATION, V102, P2677, DOI 10.1161/01.CIR.102.22.2677; Schebb NH, 2014, PROSTAG OTH LIPID M, V113, P21, DOI 10.1016/j.prostaglandins.2014.05.002; Schmitz G, 2008, PROG LIPID RES, V47, P147, DOI 10.1016/j.plipres.2007.12.004; Schuchardt JP, 2014, PROSTAG OTH LIPID M, V109, P23, DOI 10.1016/j.prostaglandins.2014.03.001; Schuchardt JP, 2014, PROSTAG LEUKOTR ESS, V90, P27, DOI 10.1016/j.plefa.2013.12.008; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2004, PROSTAG OTH LIPID M, V73, P155, DOI 10.1016/j.prostaglandins.2004.03.005; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Shearer GC, 2010, J LIPID RES, V51, P2074, DOI 10.1194/M900193-JLR200; Skarke C, 2015, J LIPID RES, V56, P1808, DOI 10.1194/jlr.M060392; Stables MJ, 2011, PROG LIPID RES, V50, P35, DOI 10.1016/j.plipres.2010.07.005; Sullivan BL, 2006, LIPIDS, V41, P845, DOI 10.1007/s11745-006-5039-0; Sullivan BL, 2008, BRIT J NUTR, V99, P660, DOI 10.1017/S0007114507837408; Sun Q, 2008, AM J CLIN NUTR, V88, P216, DOI 10.1093/ajcn/88.1.216; Swierk M, 2011, NUTRITION, V27, P641, DOI 10.1016/j.nut.2010.06.011; Tjonahen E, 2006, CHEM BIOL, V13, P1193, DOI 10.1016/j.chembiol.2006.09.011; Tsuji M, 2003, PROSTAG LEUKOTR ESS, V68, P337, DOI 10.1016/S0952-3278(03)00025-5; Urabe D, 2012, TETRAHEDRON, V68, P3210, DOI 10.1016/j.tet.2012.02.045; US Department of Agriculture Agricultural Research Service, 2015, USDA NAT NUTR DAT ST; Westphal C, 2011, PROSTAG OTH LIPID M, V96, P99, DOI 10.1016/j.prostaglandins.2011.09.001; Yamada H, 2014, J LIPID RES, V55, P895, DOI 10.1194/jlr.M047514; Yanai R, 2014, P NATL ACAD SCI USA, V111, P9603, DOI 10.1073/pnas.1401191111; Zulyniak MA, 2013, METABOLISM, V62, P1107, DOI 10.1016/j.metabol.2013.02.004	74	57	57	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3714	3725		10.1096/fj.201600360R	http://dx.doi.org/10.1096/fj.201600360R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27461565	Green Published			2022-12-28	WOS:000386474700007
J	Veprik, A; Laufer, D; Weiss, S; Rubins, N; Walker, MD				Veprik, Anna; Laufer, Dana; Weiss, Sara; Rubins, Nir; Walker, Michael D.			GPR41 modulates insulin secretion and gene expression in pancreatic -cells and modifies metabolic homeostasis in fed and fasting states	FASEB JOURNAL			English	Article						diabetes; SCFA; glucose; islet; FFAR3; fasting	PROTEIN-COUPLED RECEPTOR; FATTY-ACID RECEPTORS; GLUCOSE-TOLERANCE; ENCODING GPR40; PROPIONATE; MICROBIOTA; TARGETS; ETHANOL; ISLETS; FFA2	Insulin secretion by pancreatic -cells is primarily regulated by glucose; however, hormones and additional nutrients, such as long-chain fatty acids, also play an important role in adjusting insulin output to physiologic needs. To examine the role of short-chain fatty acids (SCFAs) in -cell function, we analyzed mouse models of gain and loss of function of GPR41 (FFAR3), a receptor for SCFAs, vs. wild-type control mice. GPR41 gain of function [GPR41-overexpressing transgenic (41 Tg) model] and GPR41 loss of function [GPR41-knockout (KO 41) model] resulted in complementary changes in glucose tolerance, without significant effects on insulin sensitivity. KO 41 mice showed fasting hypoglycemia, which was consistent with increased basal and glucose-induced insulin secretion by islets in vitro. Mirroring this, 41 Tg islets showed impaired glucose responsiveness in vitro. Microarray analysis of islets from 41 Tg mice indicated significant alterations in gene expression patterns; several of the altered genes were chosen for further analysis and were also observed to change upon incubation of islets and cultured -cells with SCFAs in a GPR41-dependent manner. Taken together, our results indicate that GPR41 and its ligands, SCFAs, may play an important role in the fine-tuning of insulin secretion in fed and fasting states.Veprik, A., Laufer, D., Weiss, S., Rubins, N., Walker, M. D. GPR41 modulates insulin secretion and gene expression in pancreatic -cells and modifies metabolic homeostasis in fed and fasting states.	[Veprik, Anna; Laufer, Dana; Weiss, Sara; Rubins, Nir; Walker, Michael D.] Weizmann Inst Sci, Dept Biomol Sci, POB 26, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Walker, MD (corresponding author), Weizmann Inst Sci, Dept Biomol Sci, POB 26, IL-76100 Rehovot, Israel.	m.walker@weizmann.ac.il		Veprik, Anna/0000-0002-3904-7151				Ahren B, 2009, NAT REV DRUG DISCOV, V8, P369, DOI 10.1038/nrd2782; Bartoov-Shifman R, 2007, J BIOL CHEM, V282, P23561, DOI 10.1074/jbc.M702115200; Bellahcene M, 2013, BRIT J NUTR, V109, P1755, DOI 10.1017/S0007114512003923; Boni-Schnetzler M, 2009, ENDOCRINOLOGY, V150, P5218, DOI 10.1210/en.2009-0543; Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Brown AJ, 2003, J BIOL CHEM, V278, P11312, DOI 10.1074/jbc.M211609200; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; De Vadder F, 2014, CELL, V156, P84, DOI 10.1016/j.cell.2013.12.016; Ehses JA, 2007, DIABETES, V56, P2356, DOI 10.2337/db06-1650; Halpern KB, 2012, J BIOL CHEM, V287, P20154, DOI 10.1074/jbc.M112.358887; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Hudson BD, 2012, J BIOL CHEM, V287, P41195, DOI 10.1074/jbc.M112.396259; Ichimura A, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00236; Kassem S, 2010, NEW ENGL J MED, V362, P1348, DOI 10.1056/NEJMc0909845; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Layden BT, 2012, DIABET METAB SYND OB, V5, P49, DOI 10.2147/DMSO.S29244; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Lin HV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035240; MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126; Newman JC, 2014, TRENDS ENDOCRIN MET, V25, P42, DOI 10.1016/j.tem.2013.09.002; PATEL DG, 1979, METABOLISM, V28, P85, DOI 10.1016/0026-0495(79)90173-2; Porat S, 2011, CELL METAB, V13, P440, DOI 10.1016/j.cmet.2011.02.012; Priyadarshini M, 2015, ISLETS, V7, DOI 10.1080/19382014.2015.1045182; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; SHAH JH, 1977, DIABETES, V26, P271, DOI 10.2337/diabetes.26.4.271; Tang C, 2015, NAT MED, V21, P173, DOI 10.1038/nm.3779; Teutsch CA, 2014, DIABETOLOGIA, V57, P776, DOI 10.1007/s00125-014-3161-8; Wolever TMS, 1997, METABOLISM, V46, P805, DOI 10.1016/S0026-0495(97)90127-X; Won YJ, 2013, J NEUROSCI, V33, P19314, DOI 10.1523/JNEUROSCI.3102-13.2013; Ximenes HMA, 2007, CELL BIOCHEM FUNCT, V25, P173, DOI 10.1002/cbf.1297	31	53	55	3	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3860	3869		10.1096/fj.201500030R	http://dx.doi.org/10.1096/fj.201500030R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27550964	Green Submitted			2022-12-28	WOS:000386474700020
J	Yoshihisa, Y; Rehman, MU; Kondo, T; Shimizu, T				Yoshihisa, Yoko; Rehman, Mati Ur; Kondo, Takashi; Shimizu, Tadamichi			Role of macrophage migration inhibitory factor in heat-induced apoptosis in keratinocytes	FASEB JOURNAL			English	Article						MIF; p53; hyperthermia; JNK signaling; skin	HUMAN EPIDERMAL-KERATINOCYTES; SYSTEMIC-LUPUS-ERYTHEMATOSUS; PROGRAMMED CELL-DEATH; FACTOR MIF; DNA-DAMAGE; HUMAN SKIN; IN-VITRO; CYTOKINE; GROWTH; ANGIOGENESIS	In human skin, keratinocytes are constantly challenged by adverse influences, such as hot and cold temperatures; however, the effects of heat on apoptosis induction in keratinocytes are not well understood. Macrophage migration inhibitory factor (MIF) is a potent cytokine that overcomes p53 function by suppressing its transcriptional activity. Here, we evaluated the effects of MIF on hyperthermia (HT)-induced apoptosis in MIF-deficient [knockout (KO)] and MIF-transgenic (Tg) mouse keratinocytes. Cells were exposed to HT at 44 degrees C, and increased apoptosis was observed in MIF-KO and wild-type (WT) cells compared with MIF-Tg cells. To determine the mechanism, MIF-mediated changes in the cellular p53 level and its effects on p53-dependent death signaling (Bax and p21) and JNK signaling (p-JNK, JNK, p-Bad, and Bad) were investigated. MIF-Tg cells exhibited substantially decreased levels of p53 after HT treatment compared with WT and MIF-KO cells. In addition, HT treatment caused decreased expression of p-JNK and p-Bad in MIF-Tg cells; however, no such changes were observed in MIF-KO and WT cells. These results showed that the activation of JNK (p-JNK and p-Bad) and p53 may be involved in HT-induced apoptosis in keratinocytes and that enhanced endogenous MIF expression suppressed apoptosis.Yoshihisa, Y., Rehman, M. U., Kondo, T., Shimizu, T. Role of macrophage migration inhibitory factor in heat-induced apoptosis in keratinocytes.	[Yoshihisa, Yoko; Rehman, Mati Ur; Shimizu, Tadamichi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Dermatol, Sugitani 2630, Toyama 9300194, Japan; [Rehman, Mati Ur; Kondo, Takashi] Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Radiol Sci, Toyama, Japan	University of Toyama; University of Toyama	Shimizu, T (corresponding author), Toyama Univ, Grad Sch Med & Pharmaceut Sci, Dept Dermatol, Sugitani 2630, Toyama 9300194, Japan.	shimizut@med.u-toyama.ac.jp	Rehman, Mati Ur/AAE-6885-2019	Shimizu, Tadamichi/0000-0002-3231-0279	Japan Society for the Promotion of Science [15K09761, 15K19681]; Grants-in-Aid for Scientific Research [15K09761] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for Scientific Research (15K09761 and 15K19681) from the Japan Society for the Promotion of Science. The authors declare no conflicts of interest.	Akagi Y, 1997, KIDNEY INT, V51, P1265, DOI 10.1038/ki.1997.172; BERNHAGEN J, 1993, NATURE, V365, P756, DOI 10.1038/365756a0; Bick RJ, 2004, BURNS, V30, P329, DOI 10.1016/j.burns.2003.12.009; BLOOM BR, 1966, SCIENCE, V153, P80, DOI 10.1126/science.153.3731.80; Boehm I, 2006, CURR MOL MED, V6, P375, DOI 10.2174/156652406777435390; Bowman PD, 1997, AM J PHYSIOL-CELL PH, V272, pC1988, DOI 10.1152/ajpcell.1997.272.6.C1988; Brock SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099795; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Chesney J, 1999, MOL MED, V5, P181, DOI 10.1007/BF03402061; DAVID JR, 1966, P NATL ACAD SCI USA, V56, P72, DOI 10.1073/pnas.56.1.72; Diker-Cohen T, 2006, APOPTOSIS, V11, P519, DOI 10.1007/s10495-006-5115-1; Fingerle-Rowson G, 2003, P NATL ACAD SCI USA, V100, P9354, DOI 10.1073/pnas.1533295100; Foote A, 2004, J RHEUMATOL, V31, P268; Gasparrini A, 2012, OCCUP ENVIRON MED, V69, P56, DOI 10.1136/oem.2010.059782; Hagemann T, 2007, MOL CANCER THER, V6, P1993, DOI 10.1158/1535-7163.MCT-07-0118; Hall EJ, 2012, RADIOBIOLOGY RADIOLO, P490; HARMON BV, 1990, INT J RADIAT BIOL, V58, P845, DOI 10.1080/09553009014552221; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Hoi AY, 2003, IMMUNOL CELL BIOL, V81, P367, DOI 10.1046/j.1440-1711.2003.01183.x; Honda A, 2009, CARCINOGENESIS, V30, P1597, DOI 10.1093/carcin/bgp160; Honma N, 2000, IMMUNOLOGY, V100, P84, DOI 10.1046/j.1365-2567.2000.00011.x; Hudson JD, 1999, J EXP MED, V190, P1375, DOI 10.1084/jem.190.10.1375; Jung HY, 2008, J BIOL CHEM, V283, P20383, DOI 10.1074/jbc.M800050200; Kleemann R, 2000, NATURE, V408, P211, DOI 10.1038/35041591; LANAHAN A, 1992, MOL CELL BIOL, V12, P3919, DOI 10.1128/MCB.12.9.3919; Lippens S, 2009, APOPTOSIS, V14, P549, DOI 10.1007/s10495-009-0324-z; Martin J, 2009, FASEB J, V23, P720, DOI 10.1096/fj.08-119628; Matylevitch NP, 1998, AM J PATHOL, V153, P567, DOI 10.1016/S0002-9440(10)65599-X; MAYTIN EV, 1992, J BIOL CHEM, V267, P23189; Merk M, 2012, CYTOKINE, V59, P10, DOI 10.1016/j.cyto.2012.03.014; Metz CN, 1997, ADV IMMUNOL, V66, P197, DOI 10.1016/S0065-2776(08)60598-2; Nemajerova A, 2007, EMBO J, V26, P987, DOI 10.1038/sj.emboj.7601564; Nguyen MT, 2003, J IMMUNOL, V170, P3337, DOI 10.4049/jimmunol.170.6.3337; Qi D, 2009, J CLIN INVEST, V119, P3807, DOI 10.1172/JCI39738; Raj D, 2006, J INVEST DERMATOL, V126, P243, DOI 10.1038/sj.jid.5700008; Saegusa J, 2008, J INVEST DERMATOL, V128, P2403, DOI 10.1038/jid.2008.119; SAKAGUCHI Y, 1995, CANCER RES, V55, P5459; Schmidt-Rose T, 1999, J PHOTOCH PHOTOBIO B, V53, P144, DOI 10.1016/S1011-1344(99)00141-4; Segrelles C, 2011, BMC DERMATOL, V11, DOI 10.1186/1471-5945-11-9; Shimizu T, 1999, J INVEST DERMATOL, V112, P210, DOI 10.1046/j.1523-1747.1999.00486.x; Shimizu T, 1999, BIOCHEM BIOPH RES CO, V264, P751, DOI 10.1006/bbrc.1999.1584; Shimizu T, 1996, FEBS LETT, V381, P199, DOI 10.1016/0014-5793(96)00120-2; Sun B, 2005, CLIN CANCER RES, V11, P1050; TAMADA Y, 1994, BRIT J DERMATOL, V131, P521; Wang XQ, 2009, APOPTOSIS, V14, P721, DOI 10.1007/s10495-009-0344-8; Weisfelner Michelle Emily, 2003, J Drugs Dermatol, V2, P385; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Yoshihisa Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089569; Yoshihisa Y, 2011, J INVEST DERMATOL, V131, P925, DOI 10.1038/jid.2010.418	49	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3870	3877		10.1096/fj.201600408RR	http://dx.doi.org/10.1096/fj.201600408RR			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27528627				2022-12-28	WOS:000386474700021
J	Granata, C; Oliveira, RSF; Little, JP; Renner, K; Bishop, DJ				Granata, Cesare; Oliveira, Rodrigo S. F.; Little, Jonathan P.; Renner, Kathrin; Bishop, David J.			Mitochondrial adaptations to high-volume exercise training are rapidly reversed after a reduction in training volume in human skeletal muscle	FASEB JOURNAL			English	Article						mitochondrial biogenesis; mitochondrial respiration; p53; PGC-1 alpha; PHF20	EXPRESSION; INTENSITY; PROTEIN; PGC-1-ALPHA; PERFORMANCE; BIOGENESIS; INTERVAL; IMPROVEMENTS; ACTIVATION; RESPONSES	Increased mitochondrial content and respiration have both been reported after exercise training. However, no study has directly compared how different training volumes influence mitochondrial respiration and markers of mitochondrial biogenesis. Ten healthy men performed high-intensity interval cycling during 3 consecutive training phases; 4 wk of normal-volume training (NVT; 3/wk), followed by 20 d of high-volume training (HVT; 2/d) and 2 wk of reduced-volume training (RVT; 5 sessions). Resting biopsy samples (vastus lateralis) were obtained at baseline and after each phase. No mitochondrial parameter changed after NVT. After HVT, mitochondrial respiration and citrate synthase activity (similar to 40-50%), as well as the protein content of electron transport system (ETS) subunits (similar to 10-40%), and that of peroxisome proliferator-activated receptor gamma coactivator-1 (PGC-1 alpha), NRF1, mitochondrial transcription factor A (TFAM), PHF20, and p53 (similar to 65-170%) all increased compared to baseline; mitochondrial specific respiration remained unchanged. After RVT, all the mitochondrial parameters measured except citrate synthase activity (similar to 36% above initial) were not significantly different compared to baseline (all P > 0.05). Our findings demonstrate that training volume is an important determinant of training-induced mitochondrial adaptations and highlight the rapid reversibility of human skeletal muscle to a reduction in training volume.	[Granata, Cesare; Oliveira, Rodrigo S. F.; Bishop, David J.] Victoria Univ, Coll Sport & Exercise Sci, Inst Sport Exercise & Act Living, PB140,Footscray Pk Campus, Melbourne, Vic 3011, Australia; [Little, Jonathan P.] Univ British Columbia Okanagan, Sch Hlth & Exercise Sci, Kelowna, BC, Canada; [Renner, Kathrin] Univ Hosp Regensburg, Dept Internal Med 3, Regensburg, Germany	Victoria University; University of British Columbia; University of British Columbia Okanagan; University of Regensburg	Bishop, DJ (corresponding author), Victoria Univ, Coll Sport & Exercise Sci, Inst Sport Exercise & Act Living, PB140,Footscray Pk Campus, Melbourne, Vic 3011, Australia.	david.bishop@vu.edu.au	Renner, Kathrin/H-3211-2013; Little, Jonathan P./T-4076-2019; Granata, Cesare/J-9738-2016; Bishop, David John/X-9826-2019	Little, Jonathan P./0000-0002-9796-2008; Granata, Cesare/0000-0002-3509-6001; Bishop, David John/0000-0002-6956-9188; Renner, Kathrin/0000-0002-7116-1368	ANZ-MASON foundation	ANZ-MASON foundation	The authors acknowledge the participants who took part in this research for their time and commitment. They also thank E. Brentnall (Victoria University, Melbourne, VIC, Australia) for her valuable help in data collection. This study was funded by a grant from the ANZ-MASON foundation provided to D.J.B. Data collection and analysis took place at Victoria University.	Adhihetty PJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE672, DOI 10.1152/ajpendo.00043.2007; Baldwin J, 2000, MED SCI SPORT EXER, V32, P1648; Bartlett JD, 2015, EUR J SPORT SCI, V15, P3, DOI 10.1080/17461391.2014.920926; Bishop D, 2000, MED SCI SPORT EXER, V32, P1088, DOI 10.1097/00005768-200006000-00008; Bishop DJ, 2014, BBA-GEN SUBJECTS, V1840, P1266, DOI 10.1016/j.bbagen.2013.10.012; BOOTH FW, 1977, J BIOL CHEM, V252, P416; COSTILL DL, 1985, MED SCI SPORT EXER, V17, P339; Cui GF, 2012, NAT STRUCT MOL BIOL, V19, P916, DOI 10.1038/nsmb.2353; Daussin FN, 2008, AM J PHYSIOL-REG I, V295, pR264, DOI 10.1152/ajpregu.00875.2007; Gibala MJ, 2012, J PHYSIOL-LONDON, V590, P1077, DOI 10.1113/jphysiol.2011.224725; Granata C, 2016, FASEB J, V30, P959, DOI 10.1096/fj.15-276907; Halson SL, 2004, J APPL PHYSIOL, V97, P1245, DOI 10.1152/japplphysiol.01368.2003; Halson SL, 2002, J APPL PHYSIOL, V93, P947, DOI 10.1152/japplphysiol.01164.2001; Irrcher I, 2003, AM J PHYSIOL-CELL PH, V284, pC1669, DOI 10.1152/ajpcell.00409.2002; Jeppesen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029391; Kadaja L, 2010, EXP CLIN CARDIOL, V15, pE116; Larsen S, 2012, J PHYSIOL-LONDON, V590, P3349, DOI 10.1113/jphysiol.2012.230185; Lehmann MJ, 1997, J SPORT MED PHYS FIT, V37, P7; Luden N, 2012, SCAND J MED SCI SPOR, V22, P662, DOI 10.1111/j.1600-0838.2011.01305.x; LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731; MADSEN K, 1993, J APPL PHYSIOL, V75, P1444, DOI 10.1152/jappl.1993.75.4.1444; MCCOY M, 1994, J APPL PHYSIOL, V77, P1532, DOI 10.1152/jappl.1994.77.3.1532; Meex RCR, 2010, DIABETES, V59, P572, DOI 10.2337/db09-1322; MOORE RL, 1987, J APPL PHYSIOL, V63, P1719, DOI 10.1152/jappl.1987.63.5.1719; Mujika Inigo, 2004, Sports Med, V34, P891, DOI 10.2165/00007256-200434130-00003; Ferraresso RLP, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/935483; Perry CGR, 2010, J PHYSIOL-LONDON, V588, P4795, DOI 10.1113/jphysiol.2010.199448; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850; Rowe GC, 2013, CELL REP, V3, P1449, DOI 10.1016/j.celrep.2013.04.023; Saleem A, 2011, EXERC SPORT SCI REV, V39, P199, DOI 10.1097/JES.0b013e31822d71be; SHEPLEY B, 1992, J APPL PHYSIOL, V72, P706, DOI 10.1152/jappl.1992.72.2.706; Tonkonogi M, 2000, J PHYSIOL-LONDON, V528, P379, DOI 10.1111/j.1469-7793.2000.00379.x; Vincent G, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00051; VIRBASIUS JV, 1994, P NATL ACAD SCI USA, V91, P1309, DOI 10.1073/pnas.91.4.1309; Wang CH, 2010, ANN NY ACAD SCI, V1201, P157, DOI 10.1111/j.1749-6632.2010.05625.x; Welinder C, 2011, J PROTEOME RES, V10, P1416, DOI 10.1021/pr1011476; WIBOM R, 1992, J APPL PHYSIOL, V73, P2004, DOI 10.1152/jappl.1992.73.5.2004; Wright DC, 2007, J BIOL CHEM, V282, P194, DOI 10.1074/jbc.M606116200	39	76	77	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3413	3423		10.1096/fj.201500100R	http://dx.doi.org/10.1096/fj.201500100R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27402675				2022-12-28	WOS:000384329800013
J	Goralczyk, A; van Vijven, M; Koch, M; Badowski, C; Yassin, MS; Toh, SA; Shabbir, A; Franco-Obregon, A; Raghunath, M				Goralczyk, Anna; van Vijven, Marc; Koch, Mathilde; Badowski, Cedric; Yassin, M. Shabeer; Toh, Sue-Anne; Shabbir, Asim; Franco-Obregon, Alfredo; Raghunath, Michael			TRP channels in brown and white adipogenesis from human progenitors: new therapeutic targets and the caveats associated with the common antibiotic, streptomycin	FASEB JOURNAL			English	Article						TRPM8; TRPP3; browning; adipogenesis; aminoglycoside antibiotics	ADIPOSE-TISSUE; TRANSIENT RECEPTOR; ION CHANNELS; STEM-CELLS; COLD; ACTIVATION; EXPRESSION; THERMOGENESIS; BLOCK; METABOLISM	Transient receptor potential (TRP) channels are polymodal cell sensors responding to diverse stimuli and widely implicated in the developmental programs of numerous tissues. The evidence for an involvement of TRP family members in adipogenesis, however, is scant. We present the first comprehensive expression profile of all known 27 human TRP genes in mesenchymal progenitors cells during white or brown adipogenesis. Using positive trilineage differentiation as an exclusion criterion, TRP polycystic (P)3, and TPR melastatin (M)8 were found to be uniquely adipospecific. Knockdown of TRPP3 repressed the expression of the brown fat signature genes uncoupling protein (UCP)-1 and peroxisome proliferator-activated receptor gamma coactivator (PGC)-1 alpha as well as attenuated forskolin-stimulated uncoupled respiration. However, indices of generalized adipogenesis, such as lipid droplet morphology and fatty acid binding protein (FAPB)-4 expression, were not affected, indicating a principal mitochondrial role of TRPP3. Conversely, activating TRPM8 with menthol up-regulated UCP-1 expression and augmented uncoupled respiration predominantly in white adipocytes (browning), whereas streptomycin antagonized-TRPM8-mediated calcium entry, downregulated UCP-1 expression, and mitigated uncoupled respiration; menthol was less capable of augmenting uncoupled respiration (thermogenesis) in brown adipocytes. TRPP3 and TRPM8 hence appear to be involved in the priming of mitochondria to perform uncoupled respiration downstream of adenylate cyclase. Our results also underscore the developmental caveats of using antibiotics in adipogenic studies.	[Goralczyk, Anna; Raghunath, Michael] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biomed Engn, Singapore, Singapore; [Goralczyk, Anna; van Vijven, Marc; Koch, Mathilde; Raghunath, Michael] Natl Univ Singapore, Yong Loo Lin Sch Med, Inst Life Sci, Singapore, Singapore; [Yassin, M. Shabeer; Toh, Sue-Anne] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore, Singapore; [Franco-Obregon, Alfredo] Natl Univ Singapore, Yong Loo Lin Sch Med, BioIon Currents Electromagnet Pulsing Syst Lab, Dept Surg, Singapore, Singapore; [Raghunath, Michael] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [van Vijven, Marc] Eindhoven Univ Technol, Dept Biomed Engn, Eindhoven, Netherlands; [van Vijven, Marc] Eindhoven Univ Technol, Inst Complex Mol Syst, Eindhoven, Netherlands; [Koch, Mathilde] Ecole Polytech, Dept Biol, Palaiseau, France; [Badowski, Cedric] ASTAR, Inst Med Biol, Singapore, Singapore; [Toh, Sue-Anne] Natl Univ Hlth Syst, Dept Med, Singapore, Singapore; [Toh, Sue-Anne] Duke NUS Grad Med Sch, Singapore, Singapore; [Toh, Sue-Anne] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA; [Shabbir, Asim; Franco-Obregon, Alfredo] Natl Univ Singapore Hosp, Dept Surg, Singapore 119074, Singapore; [Raghunath, Michael] Zurich Univ Appl Sci, Ctr Cell Biol & Tissue Engn, Competence Ctr Tissue Engn TEDD, Inst Chem & Biotechnol, Wadenswil, Switzerland	National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; National University of Singapore; Eindhoven University of Technology; Eindhoven University of Technology; Institut Polytechnique de Paris; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Medical Biology (IMB); National University of Singapore; National University of Singapore; University of Pennsylvania; Pennsylvania Medicine; National University of Singapore; Zurich University of Applied Sciences	Franco-Obregon, A (corresponding author), Natl Univ Singapore Hosp, Dept Surg, Singapore 119074, Singapore.; Raghunath, M (corresponding author), Zurich Univ Appl Sci, Inst Chem & Biotechnol, Ctr Cell Biol & Tissue Engn, CH-8820 Wadenswil, Switzerland.	suraf@nus.edu.sg; ragh@zhaw.ch	Raghunath, Michael/E-6483-2010; Shabbir, Asim/W-3259-2017; Franco-Obregon, Alfredo/F-3056-2019; Raghunath, Michael/M-2727-2019	Raghunath, Michael/0000-0002-2138-6614; Shabbir, Asim/0000-0002-2490-6478; Franco-Obregon, Alfredo/0000-0002-2514-1083; Koch, Mathilde/0000-0002-8924-3513	NUS Tissue Engineering Programme (NUSTEP); NUS Faculty Research Committee [R-397-000-081-112]; NUS Life Sciences Institute (MetaTEC) [R711-000-032101]; Lee Foundation; National Medical Research Council [NMRC/CSA034/2012]; Singapore International Graduate Award	NUS Tissue Engineering Programme (NUSTEP); NUS Faculty Research Committee; NUS Life Sciences Institute (MetaTEC); Lee Foundation; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Singapore International Graduate Award	The authors thank Sun Lei [Duke-National University of Singapore (NUS)] for the cDNA of BAs differentiated from human fetal interscapular tissue, Dr. Amri Ez Zoubir (Universite Nice Sophia Antipolis, Nice France) for human multipotent adipose-derived stem cells, Reshma Taneja (NUS) for RNA of human skeletal muscle myoblasts, Shu Ying Lee for help with confocal microscope setup, Stella Min Ling Chee for help with the Western blots, and the NUS Tissue Engineering Programme (NUSTEP) for their continued support. This study was supported by the NUS Faculty Research Committee (Grant R-397-000-081-112 to M.R.), the NUS Life Sciences Institute (MetaTEC; Grant R711-000-032101 to M.R.), the Lee Foundation (to A.F.-O.), the National Medical Research Council (Grant NMRC/CSA034/2012 to S.-A.T.), and a Singapore International Graduate Award (to A.G.). The authors declare no conflicts of interest.	Andrews MD, 2015, ACS MED CHEM LETT, V6, P419, DOI 10.1021/ml500479v; Ang XM, 2014, TISSUE ENG PT A, V20, P966, DOI [10.1089/ten.TEA.2013.0337, 10.1089/ten.tea.2013.0337]; Baboota RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103093; Bartelt A, 2011, NAT MED, V17, P200, DOI 10.1038/nm.2297; Bernardini M, 2015, INT J DEV BIOL, V59, P399, DOI 10.1387/ijdb.150232dg; Bishnoi M, 2013, PHARMACOL REP, V65, P751, DOI 10.1016/S1734-1140(13)71055-7; Carson C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127498; Chaudhuri P, 2008, MOL BIOL CELL, V19, P3203, DOI 10.1091/mbc.E07-08-0765; Chen J, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0183-6; Christensen AP, 2007, NAT REV NEUROSCI, V8, P510, DOI 10.1038/nrn2149; Cohen S, 2006, TISSUE ENG, V12, P2025, DOI 10.1089/ten.2006.12.2025; Crocetti S, 2014, CYTOM PART A, V85A, P525, DOI 10.1002/cyto.a.22461; Cypess AM, 2013, NAT MED, V19, P635, DOI 10.1038/nm.3112; Cypess AM, 2012, P NATL ACAD SCI USA, V109, P10001, DOI 10.1073/pnas.1207911109; Desai BN, 2012, DEV CELL, V22, P1149, DOI 10.1016/j.devcel.2012.04.006; GANNIER F, 1994, CARDIOVASC RES, V28, P1193, DOI 10.1093/cvr/28.8.1193; Giamarchi Aurelie, 2007, P189; Green BG, 2007, BEHAV BRAIN RES, V176, P284, DOI 10.1016/j.bbr.2006.10.013; Hasegawa Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005428; Hilton JK, 2015, BIOCHEMISTRY-US, V54, P2401, DOI 10.1021/acs.biochem.5b00071; Horio N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020007; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; Keeling KM, 2002, J MOL MED-JMM, V80, P367, DOI 10.1007/s00109-001-0317-z; Kunert-Keil C, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-159; Kusudo T, 2012, J APPL PHYSIOL, V112, P1223, DOI 10.1152/japplphysiol.01070.2011; Laing RJ, 2016, NEUROSCIENTIST, V22, P171, DOI 10.1177/1073858414567884; Lee MH, 2016, SCI REP-UK, V6, DOI 10.1038/srep21173; Liberati S, 2014, CELLS-BASEL, V3, P660, DOI 10.3390/cells3020660; Lin SY, 2005, CURR OPIN NEUROBIOL, V15, P350, DOI 10.1016/j.conb.2005.05.012; Llobet L, 2015, TISSUE ENG PART C-ME, V21, P1143, DOI [10.1089/ten.tec.2015.0062, 10.1089/ten.TEC.2015.0062]; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; Ma ST, 2012, J MOL CELL BIOL, V4, P88, DOI 10.1093/jmcb/mjs001; Matsumura CY, 2011, AM J PHYSIOL-CELL PH, V301, pC1344, DOI 10.1152/ajpcell.00056.2011; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Michlig S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20795; Nedergaard J, 2007, AM J PHYSIOL-ENDOC M, V293, pE444, DOI 10.1152/ajpendo.00691.2006; Osaka T, 1998, PFLUG ARCH EUR J PHY, V437, P36, DOI 10.1007/s004240050743; Pan Zan, 2011, Human Genomics, V5, P108; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pichler M, 1996, BIOCHEMISTRY-US, V35, P14659, DOI 10.1021/bi961657t; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Raisinghani M, 2005, PAIN, V113, P123, DOI 10.1016/j.pain.2004.09.042; Rossato M, 2014, MOL CELL ENDOCRINOL, V383, P137, DOI 10.1016/j.mce.2013.12.005; Seiler SE, 2015, ADIPOCYTE, V4, P303, DOI 10.1080/21623945.2015.1042192; Sidossis LS, 2015, CELL METAB, V22, P219, DOI 10.1016/j.cmet.2015.06.022; Stock K, 2014, STEM CELLS, V32, P3183, DOI 10.1002/stem.1805; Sukumar P, 2012, CIRC RES, V111, P191, DOI [10.1161/CIRCRESAHA.112.270751, 10.1161/circresaha.112.270751]; Tajeddine N, 2012, J BIOL CHEM, V287, P16146, DOI 10.1074/jbc.M112.340034; TAKEUCHI S, 1993, HEARING RES, V67, P13, DOI 10.1016/0378-5955(93)90227-R; Thoppil RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep14257; Tonelli FMP, 2012, ADV EXP MED BIOL, V740, P891, DOI 10.1007/978-94-007-2888-2_40; Tseng YH, 2010, NAT REV DRUG DISCOV, V9, P465, DOI 10.1038/nrd3138; Ursino MG, 2009, PHARMACOL RES, V59, P221, DOI 10.1016/j.phrs.2009.01.002; Villarroya F, 2013, CELL METAB, V17, P638, DOI 10.1016/j.cmet.2013.02.020; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang WY, 2015, P NATL ACAD SCI USA, V112, pE1373, DOI 10.1073/pnas.1419669112; Wei CL, 2009, NATURE, V457, P901, DOI 10.1038/nature07577; Winegar BD, 1996, J GEN PHYSIOL, V107, P433, DOI 10.1085/jgp.107.3.433; Ye L, 2012, CELL, V151, P96, DOI 10.1016/j.cell.2012.08.034; Yen M, 2012, J MED TOXICOL, V8, P145, DOI 10.1007/s13181-012-0213-7; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105; Zhang LL, 2007, CIRC RES, V100, P1063, DOI 10.1161/01.RES.0000262653.84850.8b	63	24	25	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3251	3266		10.1096/fj.201601081RR	http://dx.doi.org/10.1096/fj.201601081RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28416581				2022-12-28	WOS:000405932400006
J	Zheng, MG; Jiao, LY; Tang, XL; Xiang, XH; Wan, XM; Yan, Y; Li, XJ; Zhang, GF; Li, YL; Jiang, B; Cai, HB; Lin, X				Zheng, Meige; Jiao, Luyan; Tang, Xiaolu; Xiang, Xianhong; Wan, Xiaomei; Yan, Yan; Li, Xingjian; Zhang, Guofeng; Li, Yonglin; Jiang, Bin; Cai, Huaibin; Lin, Xian			Tau haploinsufficiency causes prenatal loss of dopaminergic neurons in the ventral tegmental area and reduction of transcription factor orthodenticle homeobox 2 expression	FASEB JOURNAL			English	Article						tau deficiency; midbrain development; compensation effect; MAP1A	IMMUNO-CYTOCHEMICAL LOCALIZATION; PROGRESSIVE SUPRANUCLEAR PALSY; DEVELOPMENTAL CELL-DEATH; GENOME-WIDE ASSOCIATION; TYROSINE-HYDROXYLASE; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; SUBSTANTIA-NIGRA; ALPHA-SYNUCLEIN; RAT-BRAIN	Homozygous tau knockout (Mapt(-/-)) mice develop age-dependent dopaminergic (DA) neuronal loss in the substantia nigra (SN) and ventral tegmental area (VTA), supporting an important function of tau in maintaining the survival of midbrain dopaminergic neurons (mDANs) during aging. However, it remains to be determined whether the microtubule-associated protein tau regulates the differentiation and survival of mDANs during embryonic developmental stages. Here, we show that tau haploinsufficiency in postnatal day 0 (P0) heterozygous (Mapt(+/-)) pups, but not a complete loss of tau in the Mapt(-/-) littermates, led to a significant reduction of DA neurons in the VTA. This selective loss of DA neurons correlated with a similar reduction in orthodenticle homeobox 2 (Otx2), which is restricted to VTA neurons at the postmitotic stage and selectively controls the neurogenesis and survival of specific neuronal subtypes of VTA. Moreover, the prenatal developmental cell death in the Mapt(+/-) VTA specifically increased, and the expression of microtubule-associated protein (MAP)-1A was significantly up-regulated in the P0 Mapt(-/-), but not the Mapt(+/-), pups. These results suggest that tau haploinsufficiency, without the compensation effect of MAP1A, induces reduction of Otx2 expression, increases prenatal cell death, and accordingly leads to selective loss of VTA DA neurons in the early postnatal stage. Our findings highlight the impact of tau haploinsufficiency on the survival of mDANs and indicate that tau may participate in midbrain development in a dose-dependent way.	[Zheng, Meige; Jiao, Luyan; Tang, Xiaolu; Wan, Xiaomei; Yan, Yan; Li, Xingjian; Zhang, Guofeng; Li, Yonglin; Lin, Xian] Sun Yat Sen Univ, Dept Anat, Neurobiol Res Ctr, Guangzhou, Guangdong, Peoples R China; [Jiang, Bin] Sun Yat Sen Univ, Dept Physiol, Guangzhou, Guangdong, Peoples R China; [Lin, Xian] Sun Yat Sen Univ, Guangdong Prov Key Lab Brain Funct & Dis, Zhongshan Sch Med, Guangzhou, Guangdong, Peoples R China; [Xiang, Xianhong] Sun Yat Sen Univ, Dept Intervent Radiol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China; [Cai, Huaibin] NIA, Neurogenet Lab, Transgen Sect, NIH, Bethesda, MD 20892 USA	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA)	Lin, X (corresponding author), Sun Yat Sen Univ, Dept Anat, Zhongshan Sch Med, 74,Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.; Lin, X (corresponding author), Sun Yat Sen Univ, Neurobiol Res Ctr, 74,Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	linxian3@mail.sysu.edu.cn	Cai, Huaibin/H-3359-2013	Cai, Huaibin/0000-0002-8596-6108	National Natural Science Foundation of China [31271555, 81171211]; Guangdong Province Special Project of Collaborative Innovation and Platform Environment Construction Grant [2016A050502009]; Scientific Research Foundation for the Returned Overseas Chinese Scholar, State Education Ministry [2012-1707]; U.S. National Institutes of Health, National Institute on Aging [AG000928]; NATIONAL INSTITUTE ON AGING [ZIAAG000944, ZIAAG000945, ZIAAG000928] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Special Project of Collaborative Innovation and Platform Environment Construction Grant; Scientific Research Foundation for the Returned Overseas Chinese Scholar, State Education Ministry(Scientific Research Foundation for the Returned Overseas Chinese Scholars); U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This project was supported, in part, by National Natural Science Foundation of China Grants 31271555 and 81171211 (to X.L.); Guangdong Province Special Project of Collaborative Innovation and Platform Environment Construction Grant 2016A050502009 (to X.L.); Scientific Research Foundation for the Returned Overseas Chinese Scholar, State Education Ministry Grant 2012-1707 (to X.L.); and the Intramural Research Program of the U.S. National Institutes of Health, National Institute on Aging Grant AG000928 (to H.C.). The authors declare no conflicts of interest.	Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; BAYER SA, 1995, EXP BRAIN RES, V105, P191; Borgkvist A, 2006, MOL CELL NEUROSCI, V31, P293, DOI 10.1016/j.mcn.2005.09.018; Burke RE, 2003, ANN NY ACAD SCI, V991, P69; Chung CY, 2010, BRAIN, V133, P2022, DOI 10.1093/brain/awq142; Dawson HN, 2001, J CELL SCI, V114, P1179; Di Giovannantonio LG, 2013, DEV BIOL, V373, P176, DOI 10.1016/j.ydbio.2012.10.022; Di Salvio M, 2010, NAT NEUROSCI, V13, P1481, DOI 10.1038/nn.2661; Di Salvio M, 2010, INT J DEV BIOL, V54, P939, DOI 10.1387/ijdb.092974ms; Dickson DW, 2010, CURR OPIN NEUROL, V23, P394, DOI 10.1097/WCO.0b013e32833be924; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; HARADA A, 1994, NATURE, V369, P488, DOI 10.1038/369488a0; Hegarty SV, 2013, DEV BIOL, V379, P123, DOI 10.1016/j.ydbio.2013.04.014; Hoglinger GU, 2011, NAT GENET, V43, P699, DOI 10.1038/ng.859; Jackson-Lewis V, 2000, J COMP NEUROL, V424, P476, DOI 10.1002/1096-9861(20000828)424:3<476::AID-CNE6>3.0.CO;2-0; Johnson GVW, 2004, J CELL SCI, V117, P5721, DOI 10.1242/jcs.01558; Kampers T, 1999, FEBS LETT, V451, P39, DOI 10.1016/S0014-5793(99)00522-0; Kaufman M.H., 1992, ATLAS MOUSE DEV; Kouri N, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8247; Lei P, 2012, NAT MED, V18, P291, DOI 10.1038/nm.2613; Lei P, 2010, INT J BIOCHEM CELL B, V42, P1775, DOI 10.1016/j.biocel.2010.07.016; Lieb K, 1996, DEV BRAIN RES, V94, P37, DOI 10.1016/0165-3806(96)00063-6; Lin X, 2012, J NEUROSCI, V32, P9248, DOI 10.1523/JNEUROSCI.1731-12.2012; Oo TF, 1997, DEV BRAIN RES, V98, P191, DOI 10.1016/S0165-3806(96)00173-3; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.ne.14.030191.002321; Paxinos G, 2007, ATLAS DEV MOUSE BRAI; Schapira AHV, 1997, BAILLIERE CLIN NEUR, V6, P15; Schneider JA, 1997, NEUROLOGY, V48, P959, DOI 10.1212/WNL.48.4.959; Simeone A, 2011, DEV NEUROBIOL, V71, P665, DOI 10.1002/dneu.20877; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; SPECHT LA, 1981, J COMP NEUROL, V199, P255, DOI 10.1002/cne.901990208; SPECHT LA, 1981, J COMP NEUROL, V199, P233, DOI 10.1002/cne.901990207; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Takuma H, 2003, DEV BRAIN RES, V142, P121, DOI 10.1016/S0165-3806(03)00056-7	34	7	8	2	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3349	3358		10.1096/fj.201601303R	http://dx.doi.org/10.1096/fj.201601303R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28424350	Green Published			2022-12-28	WOS:000405932400014
J	Agnihotri, SK; Shen, RF; Li, JH; Gao, X; Bueler, H				Agnihotri, Sandeep Kumar; Shen, Ruifang; Li, Jihong; Gao, Xu; Bueler, Hansruedi			Loss of PINK1 leads to metabolic deficits in adult neural stem cells and impedes differentiation of newborn neurons in the mouse hippocampus	FASEB JOURNAL			English	Article						PTEN-induced kinase; mitochondria; Parkinson's disease; adult neurogenesis	SPARE RESPIRATORY CAPACITY; MITOCHONDRIAL COMPLEX-I; OXIDATIVE STRESS; PARKINSONS-DISEASE; DENTATE GYRUS; NEUROGENESIS; PATHWAY; PROLIFERATION; DOUBLECORTIN; EXPRESSION	Emerging evidence suggests that mitochondrial dynamics regulates adult hippocampal neurogenesis (AHN). Although abnormal AHN has been linked to depression, anxiety, and cognitive dysfunction, which are features of neurodegenerative conditions, including Parkinson's disease (PD), the impact of mitochondrial deficits on AHN have not been explored previously in a model of neurodegeneration. Here, we used PTEN-induced kinase 1-deficient (PINK1(-/-)) mice that lacked a mitochondrial kinase mutated in recessive familial PD. We show that mitochondrial defects, elevated glycolysis, and increased apoptosis are associated with impaired but not abrogated differentiation of PINK1-deficient neural stem cells (NSCs) in culture. In the dentate gyrus of PINK1(-/-) mice, newly generated doublecortin-positive neurons show aberrant dendritic morphology, and their maturation is compromised compared with wild-type mice. In addition, in vivo labeling of NSCs with 5-ethynyl-2'-deoxyuridine shows that proliferating NSC numbers are normal, but the differentiation of NSCs to doublecortin-positive neuroblasts and mature NeuN+ neurons is impeded in PINK1(-/-) mice. Finally, we demonstrate that home cage activity and corticosterone levels of PINK1(-/-) mice are normal, thereby excluding reduced physical activity and increased stress as causes of neurogenesis defects. Our results reveal a new and important relationship between mitochondrial dysfunction and impaired AHN in a genetic PD model. Targeting mitochondrial function and metabolism to increase AHN may hold promise for the treatment of affective disorders and the mitigation of related symptoms in PD and other neurodegenerative conditions. Agnihotri, S. K., Shen, R., Li, J., Gao, X., Bileler, H. Loss of PINK1 leads to metabolic deficits in adult neural stem cells and impedes differentiation of newborn neurons in the mouse hippocampus.	[Agnihotri, Sandeep Kumar; Shen, Ruifang; Bueler, Hansruedi] Harbin Inst Technol, Sch Life Sci & Technol, 2 Yi Kuang St, Harbin 150001, Heilongjiang Pr, Peoples R China; [Li, Jihong; Gao, Xu] Harbin Med Univ, Dept Biochem & Mol Biol, Harbin, Peoples R China	Harbin Institute of Technology; Harbin Medical University	Bueler, H (corresponding author), Harbin Inst Technol, Sch Life Sci & Technol, 2 Yi Kuang St, Harbin 150001, Heilongjiang Pr, Peoples R China.	hbueler@hit.edu.cn	gao, xu/U-4765-2019; Büeler, Hansruedi/J-6965-2017	Büeler, Hansruedi/0000-0002-4892-7177				Agathocleous M, 2013, TRENDS CELL BIOL, V23, P484, DOI 10.1016/j.tcb.2013.05.004; Akundi RS, 2013, NEURODEGENER DIS, V12, P136, DOI 10.1159/000345689; Akundi RS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016038; Babu H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000388; Babu H, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00089; Barodia SK, 2017, BRAIN RES BULL, V133, P51, DOI 10.1016/j.brainresbull.2016.12.004; Beckervordersandforth R, 2017, NEURON, V93, P560, DOI 10.1016/j.neuron.2016.12.017; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Brown JP, 2003, J COMP NEUROL, V467, P1, DOI 10.1002/cne.10874; Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018; Cheng AW, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2238; Christie BR, 2006, HIPPOCAMPUS, V16, P199, DOI 10.1002/hipo.20151; Chuang TT, 2010, BBA-MOL BASIS DIS, V1802, P872, DOI 10.1016/j.bbadis.2009.12.008; Cooper O, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003985; Couillard-Despres S, 2005, EUR J NEUROSCI, V21, P1, DOI 10.1111/j.1460-9568.2004.03813.x; Crews L, 2008, J NEUROSCI, V28, P4250, DOI 10.1523/JNEUROSCI.0066-08.2008; Feligioni M, 2016, SYNAPSE, V70, P223, DOI 10.1002/syn.21894; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; Gegg ME, 2010, HUM MOL GENET, V19, P4861, DOI 10.1093/hmg/ddq419; Hamalainen RH, 2015, CELL REP, V11, P1614, DOI 10.1016/j.celrep.2015.05.009; Karl C, 2005, J NEUROCHEM, V92, P264, DOI 10.1111/j.1471-4159.2004.02879.x; Khacho M, 2016, CELL STEM CELL, V19, P232, DOI 10.1016/j.stem.2016.04.015; Kitada T, 2007, P NATL ACAD SCI USA, V104, P11441, DOI 10.1073/pnas.0702717104; Kohl Z, 2016, NEUROBIOL DIS, V85, P206, DOI 10.1016/j.nbd.2015.10.021; Le Belle JE, 2011, CELL STEM CELL, V8, P59, DOI 10.1016/j.stem.2010.11.028; Le Grand JN, 2015, CELL MOL LIFE SCI, V72, P773, DOI 10.1007/s00018-014-1774-1; Limoli CL, 2004, P NATL ACAD SCI USA, V101, P16052, DOI 10.1073/pnas.0407065101; Marschallinger J, 2014, EXP GERONTOL, V57, P149, DOI 10.1016/j.exger.2014.05.011; Martinez-Canabal A, 2013, HIPPOCAMPUS, V23, P66, DOI 10.1002/hipo.22054; Marxreiter F, 2013, CELL MOL LIFE SCI, V70, P459, DOI 10.1007/s00018-012-1062-x; Maryanovich M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8901; Miettinen TP, 2016, DEV CELL, V39, P370, DOI 10.1016/j.devcel.2016.09.004; Miller BR, 2015, CURR OPIN NEUROBIOL, V30, P51, DOI 10.1016/j.conb.2014.08.012; Ming GL, 2011, NEURON, V70, P687, DOI 10.1016/j.neuron.2011.05.001; Mitra K, 2013, BIOESSAYS, V35, P955, DOI 10.1002/bies.201300011; Morais VA, 2014, SCIENCE, V344, P203, DOI 10.1126/science.1249161; Murata H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142438; Narendra DP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000298; Opendak M, 2015, TRENDS COGN SCI, V19, P151, DOI 10.1016/j.tics.2015.01.001; Orogo AM, 2015, J BIOL CHEM, V290, P22061, DOI 10.1074/jbc.M115.649657; Pan Y. -W., 2013, CURRENT PROTOCOLS TO; Paus M, 2013, BRAIN RES, V1497, P85, DOI 10.1016/j.brainres.2012.12.024; Peng J, 2011, AGING CELL, V10, P255, DOI 10.1111/j.1474-9726.2010.00656.x; Poole AC, 2008, P NATL ACAD SCI USA, V105, P1638, DOI 10.1073/pnas.0709336105; Pridgeon JW, 2007, PLOS BIOL, V5, P1494, DOI 10.1371/journal.pbio.0050172; Prigione A, 2010, STEM CELLS, V28, P721, DOI 10.1002/stem.404; Rakovic A, 2013, J BIOL CHEM, V288, P2223, DOI 10.1074/jbc.M112.391680; Ransome MI, 2013, MOL CELL NEUROSCI, V54, P93, DOI 10.1016/j.mcn.2013.01.005; Ray J, 2006, MOL CELL NEUROSCI, V31, P560, DOI 10.1016/j.mcn.2005.11.010; Rharass T, 2014, J BIOL CHEM, V289, P27937, DOI 10.1074/jbc.M114.573519; Rodriguez JJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002935; Ryan BJ, 2015, TRENDS BIOCHEM SCI, V40, P200, DOI 10.1016/j.tibs.2015.02.003; Salic A, 2008, P NATL ACAD SCI USA, V105, P2415, DOI 10.1073/pnas.0712168105; Seibler P, 2011, J NEUROSCI, V31, P5970, DOI 10.1523/JNEUROSCI.4441-10.2011; Simpson JM, 2011, NEUROBIOL DIS, V41, P249, DOI 10.1016/j.nbd.2010.09.012; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Steib K, 2014, J NEUROSCI, V34, P6624, DOI 10.1523/JNEUROSCI.4972-13.2014; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Tamm C, 2008, APOPTOSIS, V13, P354, DOI 10.1007/s10495-007-0172-7; Valente EM, 2004, SCIENCE, V304, P1158, DOI 10.1126/science.1096284; Walton NM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035264; Wilkins HM, 2014, HUM MOL GENET, V23, P6528, DOI 10.1093/hmg/ddu371; Winner B, 2011, NEUROBIOL DIS, V41, P706, DOI 10.1016/j.nbd.2010.12.008; Winner B, 2008, NEUROBIOL AGING, V29, P913, DOI 10.1016/j.neurobiolaging.2006.12.016; Xu XL, 2013, CELL METAB, V18, P325, DOI 10.1016/j.cmet.2013.06.005; Xun Z, 2012, MECH AGEING DEV, V133, P176, DOI 10.1016/j.mad.2012.01.008; Yadava N, 2007, J NEUROSCI, V27, P7310, DOI 10.1523/JNEUROSCI.0212-07.2007; Yan MH, 2013, FREE RADICAL BIO MED, V62, P90, DOI 10.1016/j.freeradbiomed.2012.11.014; Yu WD, 2011, HUM MOL GENET, V20, P3227, DOI 10.1093/hmg/ddr235; Zeng CB, 2010, BRAIN RES, V1319, P21, DOI 10.1016/j.brainres.2009.12.092; Zhang LH, 2014, PULM CIRC, V4, P387, DOI 10.1086/677353; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zheng X, 2016, ELIFE, V5, DOI [10.7554/eLife.18638, 10.7554/eLife.13374]; Zuo L, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/604658	74	35	35	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2839	2853		10.1096/fj.201600960RR	http://dx.doi.org/10.1096/fj.201600960RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28325755				2022-12-28	WOS:000405931000011
J	Giraldez, S; Galindo-Moreno, M; Limon-Mortes, MC; Rivas, AC; Herrero-Ruiz, J; Mora-Santos, M; Saez, C; Japon, MA; Tortolero, M; Romero, F				Giraldez, Servando; Galindo-Moreno, Maria; Cristina Limon-Mortes, M.; Cristina Rivas, A.; Herrero-Ruiz, Joaquin; Mora-Santos, Mar; Saez, Carmen; Japon, Miguel A.; Tortolero, Maria; Romero, Francisco			G(1)/S phase progression is regulated by PLK1 degradation through the CDK1/beta TrCP axis	FASEB JOURNAL			English	Article						cell cycle; HSP90; protein degradation; ubiquitin ligase	POLO-LIKE KINASE-1; CELL-CYCLE PROGRESSION; SCF-BETA-TRCP; UBIQUITIN LIGASE; MAMMALIAN-CELLS; GENE-EXPRESSION; PROTEIN-KINASE; CHECKPOINT; CANCER; HSP90	Polo-like kinase 1 (PLK1) is a serine/threonine kinase involved in several stages of the cell cycle, including the entry and exit from mitosis, and cytokinesis. Furthermore, it has an essential role in the regulation of DNA replication. Together with cyclin A, PLK1 also promotes CDH1 phosphorylation to trigger its ubiquitination and degradation, allowing cell cycle progression. The PLK1 levels in different type of tumors are very high compared to normal tissues, which is consistent with its role in promoting proliferation. Therefore, several PLK1 inhibitors have been developed and tested for the treatment of cancer. Here, we further analyzed PLK1 degradation and found that cytoplasmic PLK1 is ubiquitinated and subsequently degraded by the SCF1mcP/proteasome. This procedure is triggered when heat shock protein (HSP) 90 is inhibited with geldanamycin, which results in misfolding of PLK1. We also identified CDK1 as the major kinase involved in this degradation. Our work shows for the first time that HSP90 inhibition arrests cell cycle progression at the Gi/S transition. This novel mechanism inhibits CDH1 degradation through CDK1-dependent PLK1 destruction by the SCF beta TrcP/proteasome. In these conditions, CDH1 substrates do not accumulate and cell cycle arrests, providing a novel pathway for regulation of the cell cycle at the G1-to-S boundary. Giraldez, S., Galindo-Moreno, M., Limon-Mortes, M. C., Rivas, A. C., Herrero-Ruiz, J., Mora Santos, M., Saez, C., Japon, M. A., Tortolero, M., Romero, F. Gi/S phase progression is regulated by PLK1 degradation through the CDK1/beta TrCP axis.	[Giraldez, Servando; Galindo-Moreno, Maria; Cristina Limon-Mortes, M.; Cristina Rivas, A.; Herrero-Ruiz, Joaquin; Mora-Santos, Mar; Tortolero, Maria; Romero, Francisco] Univ Seville, Fac Biol, Dept Microbiol, Seville, Spain; [Saez, Carmen; Japon, Miguel A.] Univ Seville, CSIC, Hosp Univ Virgen del Rocio, Inst Biomed Sevilla IBIS, Seville, Spain; [Saez, Carmen; Japon, Miguel A.] Hosp Univ Virgen del Rocio, Dept Anat Patol, Seville, Spain	University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; Virgen del Rocio University Hospital	Romero, F (corresponding author), Fac Biol, Dept Microbiol, Ave Reina Mercedes 6, Seville 41012, Spain.	frport@us.es	Ruiz, Joaquin Herrero/AAP-5598-2020; Moreno, María Galindo/AAA-5574-2020; Sáez, Carmen/B-9468-2015; del Mar Mora-Santos, Maria/V-3495-2017; Sáez, CARMEN/AAH-6431-2021; Romero, Francisco/K-2101-2014; Japón, Miguel A/L-2555-2017; Tortolero, Maria/K-5744-2014; GIRALDEZ, SERVANDO/K-3927-2014	Ruiz, Joaquin Herrero/0000-0002-4120-139X; Moreno, María Galindo/0000-0003-3201-4098; Sáez, Carmen/0000-0002-8600-0508; del Mar Mora-Santos, Maria/0000-0002-8042-0886; Sáez, CARMEN/0000-0002-4657-4048; Romero, Francisco/0000-0002-9588-6881; Japón, Miguel A/0000-0002-5980-5044; Tortolero, Maria/0000-0003-1797-9940; GIRALDEZ, SERVANDO/0000-0001-9543-9347	Ministerio de Economia y Competitividad (MINECO) [SAE2014-53799]; Institute de Salud Carlos III [FIS PI13/02282]	Ministerio de Economia y Competitividad (MINECO); Institute de Salud Carlos III(Instituto de Salud Carlos III)	This work was supported, in part, by grants from the Ministerio de Economia y Competitividad (MINECO; SAE2014-53799) and the Institute de Salud Carlos III (FIS PI13/02282)	Aberle H, 1997, EMBO J, V16, P3797, DOI 10.1093/emboj/16.13.3797; Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401; Bassermann F, 2008, CELL, V134, P256, DOI 10.1016/j.cell.2008.05.043; Bruinsma W, 2012, TRENDS BIOCHEM SCI, V37, P534, DOI 10.1016/j.tibs.2012.09.005; Butler LM, 2015, MOL CANCER RES, V13, P1445, DOI 10.1158/1541-7786.MCR-15-0234; de Carcer G, 2004, CANCER RES, V64, P5106, DOI 10.1158/0008-5472.CAN-03-2214; de Carcer G, 2001, EMBO J, V20, P2878, DOI 10.1093/emboj/20.11.2878; Deshpande A, 2005, ONCOGENE, V24, P2909, DOI 10.1038/sj.onc.1208618; Engelbert D, 2008, ONCOGENE, V27, P907, DOI 10.1038/sj.onc.1210703; FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0; Fukushima H, 2013, CELL REP, V4, P803, DOI 10.1016/j.celrep.2013.07.031; Giraldez S, 2014, ONCOTARGET, V5, P4370, DOI 10.18632/oncotarget.2021; GOLSTEYN RM, 1995, J CELL BIOL, V129, P1617, DOI 10.1083/jcb.129.6.1617; Ho A, 2002, CURR OPIN GENET DEV, V12, P47, DOI 10.1016/S0959-437X(01)00263-5; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Kang T, 2008, CANCER CELL, V13, P36, DOI 10.1016/j.ccr.2007.12.002; Lee JY, 2007, MOL CELL BIOL, V27, P3187, DOI 10.1128/MCB.01461-06; Lee KS, 2005, CELL CYCLE, V4, P1346, DOI 10.4161/cc.4.10.2049; Li W, 2013, INT REV CEL MOL BIO, V303, P203, DOI 10.1016/B978-0-12-407697-6.00005-2; Limon-Mortes MC, 2008, J CELL SCI, V121, P1825, DOI 10.1242/jcs.020552; Lindon C, 2004, J CELL BIOL, V164, P233, DOI 10.1083/jcb.200309035; Liu T, 2011, J BIOL CHEM, V286, P36352, DOI 10.1074/jbc.M111.250175; Liu XQ, 2015, TRANSL ONCOL, V8, P185, DOI 10.1016/j.tranon.2015.03.010; Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683; Lyman SK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017692; Machida YJ, 2007, GENE DEV, V21, P184, DOI 10.1101/gad.1495007; Macurek L, 2008, NATURE, V455, P119, DOI 10.1038/nature07185; Mailand N, 2006, MOL CELL, V23, P307, DOI 10.1016/j.molcel.2006.06.016; Malhotra V, 2001, AM J RESP CELL MOL, V25, P92, DOI 10.1165/ajrcmb.25.1.4384; Margottin F, 1998, MOL CELL, V1, P565, DOI 10.1016/S1097-2765(00)80056-8; Medema RH, 2011, CLIN CANCER RES, V17, P6459, DOI 10.1158/1078-0432.CCR-11-0541; Metzger MB, 2012, J CELL SCI, V125, P531, DOI 10.1242/jcs.091777; Nakai A, 2001, EMBO J, V20, P2885, DOI 10.1093/emboj/20.11.2885; Romero F, 1998, J BIOL CHEM, V273, P7776, DOI 10.1074/jbc.273.13.7776; Romero F, 2004, MOL CELL BIOL, V24, P2720, DOI 10.1128/MCB.24.7.2720-2733.2004; Santaguida S, 2015, NAT REV MOL CELL BIO, V16, P473, DOI 10.1038/nrm4025; Seki A, 2008, SCIENCE, V320, P1655, DOI 10.1126/science.1157425; Sigl R, 2009, J CELL SCI, V122, P4208, DOI 10.1242/jcs.054197; Simizu S, 2000, NAT CELL BIOL, V2, P852, DOI 10.1038/35041102; Skaar JR, 2008, NAT CELL BIOL, V10, P755, DOI 10.1038/ncb0708-755; SLEBOS RJC, 1994, P NATL ACAD SCI USA, V91, P5320, DOI 10.1073/pnas.91.12.5320; Song B, 2012, CELL DIV, V7, DOI 10.1186/1747-1028-7-3; Sorensen CS, 2001, MOL CELL BIOL, V21, P3692, DOI 10.1128/MCB.21.11.3692-3703.2001; Srethapakdi M, 2000, CANCER RES, V60, P3940; Stancato LF, 1997, J BIOL CHEM, V272, P4013, DOI 10.1074/jbc.272.7.4013; Strebhardt K, 2006, NAT REV CANCER, V6, P321, DOI 10.1038/nrc1841; Sutherland C., 2011, INT J ALZHEIMERS DIS, V2011; Takai N, 2005, ONCOGENE, V24, P287, DOI 10.1038/sj.onc.1208272; van Drogen F, 2006, MOL CELL, V23, P37, DOI 10.1016/j.molcel.2006.05.020; Wang BW, 2006, P NATL ACAD SCI USA, V103, P33, DOI 10.1073/pnas.0509927103; Watanabe N, 2004, P NATL ACAD SCI USA, V101, P4419, DOI 10.1073/pnas.0307700101; WATANABE N, 1995, EMBO J, V14, P1878, DOI 10.1002/j.1460-2075.1995.tb07180.x; Winkles JA, 2005, ONCOGENE, V24, P260, DOI 10.1038/sj.onc.1208219; Winston JT, 1999, GENE DEV, V13, P270, DOI 10.1101/gad.13.3.270; XUE S, 1981, J CELL SCI, V51, P163	56	9	9	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2925	2936		10.1096/fj.201601108R	http://dx.doi.org/10.1096/fj.201601108R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28360195				2022-12-28	WOS:000405931000018
J	Novakovic, B; Evain-Brion, D; Murthi, P; Fournier, T; Saffery, R				Novakovic, Boris; Evain-Brion, Daniele; Murthi, Padma; Fournier, Thiery; Saffery, Richard			Variable DAXX gene methylation is a common feature of placental trophoblast differentiation, preeclampsia, and response to hypoxia	FASEB JOURNAL			English	Article						DNA methylation; placenta; Infinium HM450	EMBRYONIC STEM-CELLS; DNA METHYLATION; UP-REGULATION; PROTEIN DAXX; INVASION; ATRX; H3.3; SYNCYTIOTROPHOBLAST; HYPOMETHYLATION; MICROARRAY	Placental functioning relies on the appropriate differentiation of progenitor villous cytotrophoblasts (CTBs) into extravillous cytotrophoblasts (EVCTs), including invasive EVCTs, and the multinucleated syncytiotrophoblast (ST) layer. This is accompanied by a general move away from a proliferative, immature phenotype. Genome-scale expression studies have provided valuable insight into genes that are associated with the shift to both an invasive EVCT and ST phenotype, whereas genome-scale DNA methylation analysis has shown that differentiation to ST involves wide spread methylation shifts, which are counteracted by low oxygen. In the current study, we sought to identify DNA methylation variation that is associated with transition from CTB to ST in vitro and from a noninvasive to invasive EVCT phenotype after culture on Matrigel. Of the several hundred differentially methylated regions that were identified in each comparison, the majority showed a loss of methylation with differentiation. This included a large differentially methylated region (DMR) in the gene body of death domain-associated protein 6 (DAXX), which lost methylation during both CTB syncytialization to ST and EVCT differentiation to invasive EVCT. Comparison to publicly available methylation array data identified the same DMR as among the most consistently differentially methylated genes in placental samples from preeclampsia pregnancies. Of interest, in vitro culture of CTB or ST in low oxygen increases methylation in the same region, which correlates with delayed differentiation. Analysis of combined epigenomics signatures confirmed DAXX DMR as a likely regulatory element, and direct gene expression analysis identified a positive association between methylation at this site and DAXX expression levels. The widespread dynamic nature of DAXX methylation in association with trophoblast differentiation and placenta-associated pathologies is consistent with an important role for this gene in proper placental development and function.	[Novakovic, Boris; Saffery, Richard] Murdoch Childrens Res Inst, Canc & Dis Epigenet, Parkville, Vic, Australia; [Novakovic, Boris; Saffery, Richard] Univ Melbourne, Dept Paediat, Parkville, Vic, Australia; [Murthi, Padma] Univ Melbourne, Dept Obstet & Gynaecol, Parkville, Vic, Australia; [Evain-Brion, Daniele; Fournier, Thiery] Univ Paris 05, Sorbonne Paris Cite, INSERM, Unite Mixte Rech S1139, Paris, France; [Evain-Brion, Daniele; Fournier, Thiery] PremUp Fdn, Paris, France; [Murthi, Padma] Monash Univ, Sch Clin Sci, Dept Med, Clayton, Vic, Australia	Murdoch Children's Research Institute; University of Melbourne; University of Melbourne; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Monash University	Saffery, R (corresponding author), Murdoch Childrens Res Inst, Flemington Rd, Parkville, Vic 3052, Australia.	richard.saffery@mcri.edu.au	Fournier, Thierry C/E-5836-2016; Saffery, Richard/GLS-1976-2022; Novakovic, Boris/D-8018-2013; Murthi, Padma/AAY-5395-2021	Saffery, Richard/0000-0002-9510-4181; Novakovic, Boris/0000-0002-5623-9008; Fournier, Thierry/0000-0002-7515-339X	Australian National Health and Medical Research Council (NHMRC) C. J. Martin Early Career Fellowship; NHMRC Senior Research Fellowship; Victorian Government's Operational Infrastructure Support Program; NHMRC Project [509140]	Australian National Health and Medical Research Council (NHMRC) C. J. Martin Early Career Fellowship(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government's Operational Infrastructure Support Program; NHMRC Project(National Health and Medical Research Council (NHMRC) of Australia)	The authors thank Dr. Alexandra Sexton-Oates (Murdoch Childrens Research Institute) for critical reading of this manuscript. B.N. is supported by an Australian National Health and Medical Research Council (NHMRC) C. J. Martin Early Career Fellowship. R.S. is supported by an NHMRC Senior Research Fellowship. The Murdoch Children's Research Institute is supported by the Victorian Government's Operational Infrastructure Support Program. P.M. was supported by NHMRC Project Grant 509140. The authors declare no conflicts of interest.	APLIN JD, 1991, J CELL SCI, V99, P681; Apps R, 2011, PLACENTA, V32, P33, DOI 10.1016/j.placenta.2010.10.010; Aryee MJ, 2014, BIOINFORMATICS, V30, P1363, DOI 10.1093/bioinformatics/btu049; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Bilban M, 2009, ENDOCRINOLOGY, V150, P1000, DOI 10.1210/en.2008-0456; Blair JD, 2013, MOL HUM REPROD, V19, P697, DOI 10.1093/molehr/gat044; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Dahl JA, 2016, NATURE, V537, P548, DOI 10.1038/nature19360; Drane P, 2010, GENE DEV, V24, P1253, DOI 10.1101/gad.566910; Ehrich M, 2005, P NATL ACAD SCI USA, V102, P15785, DOI 10.1073/pnas.0507816102; Elsasser SJ, 2012, NATURE, V491, P560, DOI 10.1038/nature11608; Elsasser SJ, 2015, NATURE, V522, P240, DOI 10.1038/nature14345; Ferretti C, 2007, HUM REPROD UPDATE, V13, P121, DOI 10.1093/humupd/dml048; Fogarty NME, 2015, PLACENTA, V36, P796, DOI 10.1016/j.placenta.2015.05.006; Goldberg AD, 2010, CELL, V140, P678, DOI 10.1016/j.cell.2010.01.003; Handschuh K, 2007, PLACENTA, V28, P175, DOI 10.1016/j.placenta.2006.01.019; Handschuh K, 2007, ENDOCRINOLOGY, V148, P5011, DOI 10.1210/en.2007-0286; He QY, 2015, CELL STEM CELL, V17, P273, DOI 10.1016/j.stem.2015.07.022; Heinz S, 2010, MOL CELL, V38, P576, DOI 10.1016/j.molcel.2010.05.004; Hellman A, 2007, SCIENCE, V315, P1141, DOI 10.1126/science.1136352; Hu Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep32280; Hu YX, 2015, MOL HUM REPROD, V21, P452, DOI 10.1093/molehr/gav007; Huppertz B, 2009, J ANAT, V215, P14, DOI 10.1111/j.1469-7580.2008.01036.x; Januar V, 2015, AM J OBSTET GYNECOL, V213, pS182, DOI 10.1016/j.ajog.2015.07.011; Kliman HJ, 2000, AM J PATHOL, V157, P1759, DOI 10.1016/S0002-9440(10)64813-4; Lan X., 2016, REPROD FERTIL DEV; Lecarpentier E, 2016, HYPERTENSION, V68, P1438, DOI 10.1161/HYPERTENSIONAHA.116.07890; Lee HJ, 2014, CELL STEM CELL, V14, P710, DOI 10.1016/j.stem.2014.05.008; Lin CW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13867; Liu XY, 2016, NATURE, V537, P558, DOI 10.1038/nature19362; Lovejoy CA, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002772; Maksimovic J, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-6-r44; Maltepe E, 2015, ANNU REV CELL DEV BI, V31, P523, DOI 10.1146/annurev-cellbio-100814-125620; Martino D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-5-r42; Novakovic B, 2016, MOL HUM REPROD, V22, P791, DOI 10.1093/molehr/gaw053; Novakovic Boris, 2013, Frontiers in Genetics, V4, P285, DOI 10.3389/fgene.2013.00285; Novakovic B, 2009, J BIOL CHEM, V284, P14838, DOI 10.1074/jbc.M809542200; Renaud SJ, 2015, P NATL ACAD SCI USA, V112, pE6175, DOI 10.1073/pnas.1507397112; Sadic D, 2015, EMBO REP, V16, P836, DOI 10.15252/embr.201439937; Segond N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079413; Shalginskikh N, 2013, J VIROL, V87, P2137, DOI 10.1128/JVI.02026-12; Shankar K, 2015, PLACENTA, V36, P1342, DOI 10.1016/j.placenta.2015.10.010; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Smyth GK, 2005, BIOINFORMATICS, V21, P2067, DOI 10.1093/bioinformatics/bti270; Tarrade A, 2001, LAB INVEST, V81, P1199, DOI 10.1038/labinvest.3780334; van Dijk Marie, 2012, Frontiers in Genetics, V3, P22, DOI 10.3389/fgene.2012.00022; Voon HPJ, 2015, CELL REP, V11, P405, DOI 10.1016/j.celrep.2015.03.036; Wong LH, 2010, GENOME RES, V20, P351, DOI 10.1101/gr.101477.109; Wong NC, 2008, CANCER LETT, V268, P56, DOI 10.1016/j.canlet.2008.03.033; Yuen RKC, 2013, EPIGENETICS-US, V8, P192, DOI 10.4161/epi.23400; Zhou Y, 2013, J CLIN INVEST, V123, P2862, DOI 10.1172/JCI66966	52	18	18	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2380	2392		10.1096/fj.201601189RR	http://dx.doi.org/10.1096/fj.201601189RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28223336				2022-12-28	WOS:000401553400014
J	Cirillo, F; Resmini, G; Ghiroldi, A; Piccoli, M; Bergante, S; Tettamanti, G; Anastasia, L				Cirillo, Federica; Resmini, Giulia; Ghiroldi, Andrea; Piccoli, Marco; Bergante, Sonia; Tettamanti, Guido; Anastasia, Luigi			Activation of the hypoxia-inducible factor 1 alpha promotes myogenesis through the noncanonical Wnt pathway, leading to hypertrophic myotubes	FASEB JOURNAL			English	Article						HIF-1 alpha; MyoD; skeletal muscle differentiation; myoblasts	SKELETAL-MUSCLE; O-2 HOMEOSTASIS; CELL BIOLOGY; STEM-CELLS; FACTOR-I; MYOD; DIFFERENTIATION; OXYGEN; DEGRADATION; HIF-1-ALPHA	satellite cells, which are resident in hypoxic niches in the tissue. Hypoxia has been recognized as a key factor to maintain stem cells in an undifferentiated state. Herein we report that hypoxia plays a fundamental role also in activating myogenesis. In particular, we found that the activation of the hypoxia-inducible factor (HIF)-1 alpha under hypoxia, in murine skeletal myoblasts, leads to activation of MyoD through the noncanonical Wnt/beta-catenin pathway. Moreover, chemical inhibition of HIF-1 alpha activity significantly reduces differentiation, thus confirming its crucial role in the process. Furthermore, hypoxia-preconditioned myoblasts, once induced to differentiate under normoxic conditions, tend to form hypertrophic myotubes. These results support the notion that hypoxia plays a pivotal role in activating the regeneration process by directly inducing myogenesis through HIF-1 alpha. Although preliminary, these findings may suggest new perspective for novel therapeutic targets in the treatment of several muscle diseases.-Cirillo, F., Resmini, G., Ghiroldi, A., Piccoli, M., Bergante, S., Tettamanti, G., Anastasia, L. Activation of the hypoxia-inducible factor 1 alpha promotes myogenesis through the noncanonical Wnt pathway, leading to hypertrophic myotubes.	[Cirillo, Federica; Resmini, Giulia; Ghiroldi, Andrea; Piccoli, Marco; Bergante, Sonia; Tettamanti, Guido; Anastasia, Luigi] IRCCS, Policlin San Donato, Lab Stem Cells Tissue Engn, Milan, Italy; [Anastasia, Luigi] Univ Milan, Dept Biomed Sci Hlth, Piazza Malan 2, I-20097 Milan, Italy	IRCCS Policlinico San Donato; University of Milan	Anastasia, L (corresponding author), Univ Milan, Dept Biomed Sci Hlth, Piazza Malan 2, I-20097 Milan, Italy.	luigi.anastasia@unimi.it	Anastasia, Luigi/AAN-1964-2020; bergante, sonia/AAI-1215-2019; Cirillo, Federica/ABE-3480-2020; Ghiroldi, Andrea/AAO-4409-2020; Piccoli, Marco/S-3731-2019	Anastasia, Luigi/0000-0002-0712-2161; Cirillo, Federica/0000-0002-0196-5977; Ghiroldi, Andrea/0000-0002-2896-7390; Piccoli, Marco/0000-0002-9461-2715; Resmini, Giulia/0000-0002-7494-7673	The Italian Ministry of Health [GR-2010-2321515]	The Italian Ministry of Health(Ministry of Health, Italy)	This work was supported by Grant GR-2010-2321515 from The Italian Ministry of Health (to L.A.). The authors declare no conflicts of interest.	Abraham ST, 2016, IN VITRO CELL DEV-AN, V52, P935, DOI 10.1007/s11626-016-0058-5; Bareja A, 2013, SKELET MUSCLE, V3, DOI 10.1186/2044-5040-3-2; Belizario JE, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-016-2197-2; BENEZRA R, 1990, CELL, V61, P49, DOI 10.1016/0092-8674(90)90214-Y; Bentzinger CF, 2014, J CELL BIOL, V205, P97, DOI 10.1083/jcb.201310035; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Bernard P, 2008, BIOL CELL, V100, P167, DOI 10.1042/BC20070072; Di Carlo A, 2004, J BIOL CHEM, V279, P16332, DOI 10.1074/jbc.M313931200; Floyd ZE, 2001, J BIOL CHEM, V276, P22468, DOI 10.1074/jbc.M009388200; Francetic T, 2011, TRANSCR-AUSTIN, V2, P109, DOI 10.4161/trns.2.3.15829; Francis KR, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2009.22; Giaccia AJ, 2004, GENE DEV, V18, P2183, DOI 10.1101/gad.1243304; Groulx I, 2002, MOL CELL BIOL, V22, P5319, DOI 10.1128/MCB.22.15.5319-5336.2002; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Iyer NV, 1998, GENE DEV, V12, P149, DOI 10.1101/gad.12.2.149; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Majmundar AJ, 2015, DEVELOPMENT, V142, P2405, DOI 10.1242/dev.123026; Majmundar AJ, 2012, MOL CELL BIOL, V32, P36, DOI 10.1128/MCB.05857-11; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Pampin JB, 2006, J FORENSIC SCI, V51, P120, DOI 10.1111/j.1556-4029.2005.00014.x; Parker MH, 2003, NAT REV GENET, V4, P497, DOI 10.1038/nrg1109; Price FD, 2007, BBA-MOL BASIS DIS, V1772, P272, DOI 10.1016/j.bbadis.2006.08.011; Pugh CW, 2003, NAT MED, V9, P677, DOI 10.1038/nm0603-677; Ridgeway AG, 2000, J BIOL CHEM, V275, P32398, DOI 10.1074/jbc.M004349200; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Semenza GL, 2000, GENE DEV, V14, P1983; Semenza GL, 1998, CURR OPIN GENET DEV, V8, P588, DOI 10.1016/S0959-437X(98)80016-6; Sethi JK, 2010, BIOCHEM J, V427, P1, DOI 10.1042/BJ20091866; Tajbakhsh S, 1998, DEVELOPMENT, V125, P4155; Tanaka Shingo, 2011, J Mol Signal, V6, P12, DOI 10.1186/1750-2187-6-12; Vlaminck B, 2007, FEBS J, V274, P5533, DOI 10.1111/j.1742-4658.2007.06072.x; von Maltzahn J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3869; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; von Maltzahn J, 2012, NAT CELL BIOL, V14, P186, DOI 10.1038/ncb2404; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yablonka-Reuveni Z, 2011, J HISTOCHEM CYTOCHEM, V59, P1041, DOI 10.1369/0022155411426780	43	18	20	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2146	2156		10.1096/fj.201600878R	http://dx.doi.org/10.1096/fj.201600878R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28188178				2022-12-28	WOS:000399195500033
J	Molino, Y; David, M; Varini, K; Jabes, F; Gaudin, N; Fortoul, A; Bakloul, K; Masse, M; Bernard, A; Drobecq, L; Lecorche, P; Temsamani, J; Jacquot, G; Khrestchatisky, M				Molino, Yves; David, Marion; Varini, Karine; Jabes, Francoise; Gaudin, Nicolas; Fortoul, Aude; Bakloul, Karima; Masse, Maxime; Bernard, Anne; Drobecq, Lucile; Lecorche, Pascaline; Temsamani, Jamal; Jacquot, Guillaume; Khrestchatisky, Michel			Use of LDL receptor-targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier	FASEB JOURNAL			English	Article						receptor-mediated transcytosis; intracellular trafficking; lysosome; endosome; CNS drug delivery	LOW-DENSITY-LIPOPROTEIN; CAPILLARY ENDOTHELIAL-CELLS; CENTRAL-NERVOUS-SYSTEM; LYSOSOMAL-ENZYME; UP-REGULATION; AMYLOID-BETA; DELIVERY; TRANSCYTOSIS; TRANSFERRIN; ANTIBODIES	The blood-brain barrier (BBB) prevents the entry of many drugs into the brain and, thus, is a major obstacle in the treatment of CNS diseases. There is some evidence that the LDL receptor (LDLR) is expressed at the BBB and may participate in the transport of endogenous ligands from blood to brain, a process referred to as receptor-mediated transcytosis. We previously described a family of peptide vectors that were developed to target the LDLR. In the present study, in vitro BBB models that were derived from wild-type and LDLR-knockout animals (ldlr(-/-)) were used to validate the specific LDLR-dependent transcytosis of LDL via a nondegradative route. We next showed that LDLR-targeting peptide vectors, whether in fusion or chemically conjugated to an Ab Fc fragment, promote binding to apical LDLR and transendothelial transfer of the Fc fragment across BBB monolayers via the same route as LDL. Finally, we demonstrated in vivo that LDLR significantly contributes to the brain uptake of vectorized Fc. We thus provide further evidence that LDLR is a relevant receptor for CNS drug delivery via receptor-mediated transcytosis and that the peptide vectors we developed have the potential to transport drugs, including proteins or Ab based, across the BBB.-Molino, Y., David, M., Varini, K., Jabes, F., Gaudin, N., Fortoul, A., Bakloul, K., Masse, M., Bernard, A., Drobecq, L., Lecorche, P., Temsamani, J., Jacquot, G., Khrestchatisky, M. Use of LDL receptor-targeting peptide vectors for in vitro and in vivo cargo transport across the blood-brain barrier.	[Molino, Yves; David, Marion; Jabes, Francoise; Fortoul, Aude; Bakloul, Karima; Masse, Maxime; Drobecq, Lucile; Lecorche, Pascaline; Temsamani, Jamal; Jacquot, Guillaume] Vect Horus SAS, Fac Med, Marseille, France; [Varini, Karine; Gaudin, Nicolas; Bernard, Anne; Khrestchatisky, Michel] Aix Marseille Univ, CNRS, Neurobiol Interact Cellulaires & Neurophysiopatho, Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Khrestchatisky, M (corresponding author), Fac Med Marseille, Sect Nord, Unite Mixte Rech 7259, Neurobiol Interact Cellulaires & Neurophysiopatho, 51 Bd Pierre Dramard,CS80011, F-13344 Marseille 15, France.	michel.khrestchatisky@univ-amu.fr			Centre National de la Recherche Scientifique; Aix-Marseille Universite; Fonds Unique Interministeriel; Agence Nationale de la Recherche; A*MIDEX; Vect-Horus biotechnology company; UMR7259 Laboratory	Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Aix-Marseille Universite; Fonds Unique Interministeriel; Agence Nationale de la Recherche(French National Research Agency (ANR)); A*MIDEX(French National Research Agency (ANR)); Vect-Horus biotechnology company; UMR7259 Laboratory	This work was supported by the Centre National de la Recherche Scientifique and Aix-Marseille Universite to the Unite Mixte de Recherche (UMR) 7259 Laboratory; the Fonds Unique Interministeriel to Vect-Horus for the MEDUL project; the Agence Nationale de la Recherche to the UMR7259 Laboratory, and Vect-Horus for the TIMPAD, ADHOC, PREVENTAD, VECtoBrain, VEC2Brain, NANOVECTOR collaborative projects, and to the DHUNE project supported by A*MIDEX; LECMA (to M.K.). M.K. is director of the UMR7259 Laboratory, and cofounder, shareholder, and scientific counsel of the Vect-Horus biotechnology company. The remaining authors declare no conflicts of interest.	Boado RJ, 2007, BIOTECHNOL BIOENG, V96, P381, DOI 10.1002/bit.21120; Bockenhoff A, 2014, J NEUROSCI, V34, P3122, DOI 10.1523/JNEUROSCI.4785-13.2014; Calvo D, 1997, ARTERIOSCL THROM VAS, V17, P2341, DOI 10.1161/01.ATV.17.11.2341; Camargo N, 2012, FASEB J, V26, P4302, DOI 10.1096/fj.12-205807; Candela P, 2008, ENDOTHELIUM-J ENDOTH, V15, P254, DOI 10.1080/10623320802487759; Cooper PR, 2013, BRAIN RES, V1534, P13, DOI 10.1016/j.brainres.2013.08.035; Cucullo L, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-18; Dehouck B, 1997, J CELL BIOL, V138, P877, DOI 10.1083/jcb.138.4.877; DEHOUCK B, 1994, J CELL BIOL, V126, P465, DOI 10.1083/jcb.126.2.465; Demeule M, 2008, J PHARMACOL EXP THER, V324, P1064, DOI 10.1124/jpet.107.131318; Descamps L, 1996, AM J PHYSIOL-HEART C, V270, pH1149, DOI 10.1152/ajpheart.1996.270.4.H1149; Dietschy JM, 2004, J LIPID RES, V45, P1375, DOI 10.1194/jlr.R400004-JLR200; Duan SM, 1999, J NEUROSCI, V19, P10193; DUNN KW, 1989, J CELL BIOL, V109, P3303, DOI 10.1083/jcb.109.6.3303; Friden PM, 1996, J PHARMACOL EXP THER, V278, P1491; Georgieva Julia V, 2014, Pharmaceutics, V6, P557, DOI 10.3390/pharmaceutics6040557; Goti D, 2002, J BIOL CHEM, V277, P28537, DOI 10.1074/jbc.M203989200; Goti D, 2001, J NEUROCHEM, V76, P498, DOI 10.1046/j.1471-4159.2001.00100.x; Hussain MM, 1999, ANNU REV NUTR, V19, P141, DOI 10.1146/annurev.nutr.19.1.141; Jacquot G., 2014, US Patent, Patent No. [WO 2014/060601, 2014060601]; Jacquot G, 2016, MOL PHARMACEUT, V13, P4094, DOI 10.1021/acs.molpharmaceut.6b00687; Jefferies W. A., 2015, US Patent, Patent No. [2015/0056218, 20150056218]; Jones AR, 2007, PHARM RES-DORDR, V24, P1759, DOI 10.1007/s11095-007-9379-0; Kannan R, 1999, J NEUROCHEM, V73, P390, DOI 10.1046/j.1471-4159.1999.0730390.x; Karkan D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002469; KENAGY R, 1984, ARTERIOSCLEROSIS, V4, P365, DOI 10.1161/01.ATV.4.4.365; Khrestchatisky M, 2010, PCT patent Pub., Patent No. [WO2010046588, 2010046588, WO/2010/046588]; Macdonald JA, 2010, J NEUROSCI RES, V88, P1457, DOI 10.1002/jnr.22316; Malcor JD, 2012, J MED CHEM, V55, P2227, DOI 10.1021/jm2014919; MERESSE S, 1989, J NEUROCHEM, V53, P340, DOI 10.1111/j.1471-4159.1989.tb07340.x; Molino Y, 2014, JOVE-J VIS EXP, DOI 10.3791/51278; Niewoehner J, 2014, NEURON, V81, P49, DOI 10.1016/j.neuron.2013.10.061; O'Kane RL, 1999, J BIOL CHEM, V274, P31891, DOI 10.1074/jbc.274.45.31891; Pan WH, 2004, J CELL SCI, V117, P5071, DOI 10.1242/jcs.01381; Pardridge WM, 2012, METHOD ENZYMOL, V503, P269, DOI 10.1016/B978-0-12-396962-0.00011-2; Ramanathan A, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00136; RAUB TJ, 1991, J CELL PHYSIOL, V149, P141, DOI 10.1002/jcp.1041490118; Regina A, 2015, MOL CANCER THER, V14, P129, DOI 10.1158/1535-7163.MCT-14-0399; ROBERTS RL, 1993, J CELL SCI, V104, P521; Sade H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096340; Shamenkov DA, 2006, B EXP BIOL MED+, V142, P703, DOI 10.1007/s10517-006-0456-x; Simionescu M, 2009, CELL TISSUE RES, V335, P27, DOI 10.1007/s00441-008-0688-3; Sorrentino NC, 2013, EMBO MOL MED, V5, P675, DOI 10.1002/emmm.201202083; Spencer B, 2014, J BIOL CHEM, V289, P17917, DOI 10.1074/jbc.M114.557439; Temsamani J, 2004, DRUG DISCOV TODAY, V9, P1012, DOI 10.1016/S1359-6446(04)03279-9; Valenza M, 2010, J NEUROSCI, V30, P10844, DOI 10.1523/JNEUROSCI.0917-10.2010; Vance JE, 2012, DIS MODEL MECH, V5, P746, DOI 10.1242/dmm.010124; Vlieghe P., 2011, US Patent, Patent No. [WO 2011/131896, 2011131896]; Vlieghe P, 2013, MED RES REV, V33, P457, DOI 10.1002/med.21252; Vlieghe P, 2010, THER DELIV, V1, P489, DOI 10.4155/TDE.10.44; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wang DR, 2013, P NATL ACAD SCI USA, V110, P2999, DOI 10.1073/pnas.1222742110; Watts RJ, 2013, CURR OPIN CHEM BIOL, V17, P393, DOI 10.1016/j.cbpa.2013.03.023; Wilhelmus MMM, 2007, AM J PATHOL, V171, P1989, DOI 10.2353/ajpath.2007.070050; Yu YJ, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002230; Zensi A, 2009, J CONTROL RELEASE, V137, P78, DOI 10.1016/j.jconrel.2009.03.002; Zhang B, 2013, BIOMATERIALS, V34, P9171, DOI 10.1016/j.biomaterials.2013.08.039; Zhang Y, 2004, J PHARMACOL EXP THER, V311, P449, DOI 10.1124/jpet.104.068528	58	53	53	2	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1807	1827		10.1096/fj.201600827R	http://dx.doi.org/10.1096/fj.201600827R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28108572				2022-12-28	WOS:000399195500006
J	Makino, A; Abe, M; Ishitsuka, R; Murate, M; Kishimoto, T; Sakai, S; Hullin-Matsuda, F; Shimada, Y; Inaba, T; Miyatake, H; Tanaka, H; Kurahashi, A; Pack, CG; Kasai, RS; Kubo, S; Schieber, NL; Dohmae, N; Tochio, N; Hagiwara, K; Sasaki, Y; Aida, Y; Fujimori, F; Kigawa, T; Nishibori, K; Parton, RG; Kusumi, A; Sako, Y; Anderluh, G; Yamashita, M; Kobayashi, T; Greimel, P; Kobayashi, T				Makino, Asami; Abe, Mitsuhiro; Ishitsuka, Reiko; Murate, Motohide; Kishimoto, Takuma; Sakai, Shota; Hullin-Matsuda, Francoise; Shimada, Yukiko; Inaba, Takehiko; Miyatake, Hideyuki; Tanaka, Hideko; Kurahashi, Atsushi; Pack, Chan-Gi; Kasai, Rinshi S.; Kubo, Shuku; Schieber, Nicole L.; Dohmae, Naoshi; Tochio, Naoya; Hagiwara, Kyoji; Sasaki, Yutaka; Aida, Yoko; Fujimori, Fumihiro; Kigawa, Takanori; Nishibori, Kozo; Parton, Robert G.; Kusumi, Akihiro; Sako, Yasushi; Anderluh, Gregor; Yamashita, Makoto; Kobayashi, Tetsuyuki; Greimel, Peter; Kobayashi, Toshihide			A novel sphingomyelin/cholesterol domain-specific probe reveals the dynamics of the membrane domains during virus release and in Niemann- Pick type C	FASEB JOURNAL			English	Article						lipid binding protein; lipid raft; membrane lipids; sphingolipid	FREE PROTEIN-SYNTHESIS; LIPID RAFTS; PLASMA-MEMBRANE; SEA-ANEMONE; ELECTRON-MICROSCOPY; CLEAVAGE FURROW; EQUINATOXIN-II; H-RAS; STICHOLYSIN-II; CHOLESTEROL	We identified a novel, nontoxicmushroomprotein that specifically binds to a complex of sphingomyelin (SM), a major sphingolipid in mammalian cells, and cholesterol (Chol). The purified protein, termed nakanori, labeled cell surface domains in an SM-and Chol-dependent manner and decorated specific lipid domains that colocalized with inner leaflet small GTPase H-Ras, but not K-Ras. The use of nakanori as a lipid-domain-specific probe revealed altered distribution and dynamics of SM/Chol on the cell surface of Niemann-Pick type C fibroblasts, possibly explaining some of the disease phenotype. In addition, that nakanori treatment of epithelial cells after influenza virus infection potently inhibited virus release demonstrates the therapeutic value of targeting specific lipid domains for anti-viral treatment.-Makino, A., Abe, M., Ishitsuka, R., Murate, M., Kishimoto, T., Sakai, S., Hullin-Matsuda, F., Shimada, Y., Inaba, T., Miyatake, H., Tanaka, H., Kurahashi, A., Pack, C.-G., Kasai, R. S., Kubo, S., Schieber, N. L., Dohmae, N., Tochio, N., Hagiwara, K., Sasaki, Y., Aida, Y., Fujimori, F., Kigawa, T., Nishibori, K., Parton, R. G., Kusumi, A., Sako, Y., Anderluh, G., Yamashita, M., Kobayashi, T., Greimel, P., Kobayashi, T. A novel sphingomyelin/cholesterol domain-specific probe reveals the dynamics of the membrane domains during virus release and in Niemann-Pick type C. =	[Makino, Asami; Abe, Mitsuhiro; Ishitsuka, Reiko; Murate, Motohide; Kishimoto, Takuma; Sakai, Shota; Hullin-Matsuda, Francoise; Shimada, Yukiko; Inaba, Takehiko; Miyatake, Hideyuki; Pack, Chan-Gi; Dohmae, Naoshi; Tochio, Naoya; Hagiwara, Kyoji; Sasaki, Yutaka; Aida, Yoko; Kigawa, Takanori; Greimel, Peter; Kobayashi, Toshihide] Rikagaku Kenkyusho RIKEN, Saitama, Japan; [Hullin-Matsuda, Francoise] Univ Lyon 1, INSERM, Unite 1060, Villeurbanne, France; [Tanaka, Hideko] Ochanomizu Univ, Fac Core Res, Nat Sci Div, Tokyo, Japan; [Kurahashi, Atsushi] Yukiguni Maitake Co Ltd, Niigata, Japan; [Kasai, Rinshi S.; Kusumi, Akihiro] Kyoto Univ, Inst Frontier Med Sci, Kyoto, Japan; [Kusumi, Akihiro] Kyoto Univ, Inst Integrated Cellmat Sci WPI iCeMS, Kyoto, Japan; [Kubo, Shuku; Yamashita, Makoto] Daiichi Sankyo Co Ltd, Tokyo, Japan; [Schieber, Nicole L.] Univ Queensland, Inst Mol Biosci, St Lucia, Qld, Australia; [Parton, Robert G.] Univ Queensland, Ctr Microscopy & Microanal, St Lucia, Qld, Australia; [Fujimori, Fumihiro] Tokyo Kasei Univ, Grad Sch Humanities & Life Sci, Tokyo, Japan; [Anderluh, Gregor] Natl Inst Chem, Ljubljana, Slovenia; [Anderluh, Gregor] Univ Ljubljana, Dept Biol, Biotech Fac, Ljubljana, Slovenia; [Kobayashi, Toshihide] Univ Strasbourg, Unit Mixte Rech 7213, CNRS, Illkirch Graffenstaden, France	RIKEN; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Ochanomizu University; Kyoto University; Kyoto University; Daiichi Sankyo Company Limited; University of Queensland; University of Queensland; National Institute of Chemistry - Slovenia; University of Ljubljana; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Kobayashi, T (corresponding author), Univ Strasbourg, UMR 7213, CNRS, F-67401 Illkirch Graffenstaden, France.	toshihide.kobayashi@unistra.fr	Kishimoto, Takuma/AAP-1813-2021; hideyuki, miyatake/S-4993-2019; Anderluh, Gregor/C-6905-2014; Sako, Yasushi/B-3253-2015; Dohmae, Naoshi/C-2040-2011; KOBAYASHI, TOSHIHIDE/S-8313-2019; Kasai, Rinshi S./ABA-7656-2021; Carmen, Team1/Y-7382-2019; Hullin-Matsuda, Françoise/N-3880-2017; Kobayashi, Tetsuyuki/AAH-2985-2020; Abe, Mitsuhiro/C-3602-2017; Kigawa, Takanori/A-7679-2010; Parton, Robert/C-5673-2009	hideyuki, miyatake/0000-0001-8872-9784; Anderluh, Gregor/0000-0002-9916-8465; Sako, Yasushi/0000-0002-5707-5455; Dohmae, Naoshi/0000-0002-5242-9410; KOBAYASHI, TOSHIHIDE/0000-0002-4811-7270; Kasai, Rinshi S./0000-0002-9234-3283; Carmen, Team1/0000-0003-4234-1746; Hullin-Matsuda, Françoise/0000-0002-6042-2841; Kobayashi, Tetsuyuki/0000-0002-9285-0859; Kigawa, Takanori/0000-0003-0146-9719; Greimel, Peter/0000-0002-4931-6183; Kurahashi, Atsushi/0000-0003-4427-193X; Inaba, Takehiko/0000-0002-8770-4662; Parton, Robert/0000-0002-7494-5248; Abe, Mitsuhiro/0000-0002-6244-1771; Lab, Carmen/0000-0002-5935-3236; Schieber, Nicole L./0000-0002-3212-5057	Ministry of Education, Culture, Sports, Science, and Technology of Japan [23790115, 23590251, 24770135, 22390018, 25293015]; Technology of Japan and Naito Foundation; National Health and Medical Research Council of Australia [569542, 1037320]; Slovenian Research Agency; Grants-in-Aid for Scientific Research [17K07333, 17H03666] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Technology of Japan and Naito Foundation; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Slovenian Research Agency(Slovenian Research Agency - Slovenia); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the Integrated Lipidology Program of RIKEN, Grants-in-Aid for Scientific Research 23790115 (to A.M.), 23590251 (to M.M), 24770135 (to T.Ki), and 22390018 and 25293015 (to To.K.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan and Naito Foundation. This work was supported by fellowships and Grants 569542 and 1037320 from the National Health and Medical Research Council of Australia (to R.G.P.). The authors acknowledge the facilities and the scientific and technical assistance of the Australian Microscopy and Microanalysis Research Facility at the Centre for Microscopy and Microanalysis (The University of Queensland). G.A. acknowledges the support of the Slovenian Research Agency. The authors thank G. Bricogne, P. Adams, and R. Read for their support and assistance in correctly solving the X-ray structure; all other involved members of the structural biology community, for critical review of the manuscript; and M. Podobnik, for her constructive comments.	Abe M, 2014, BBA-MOL CELL BIOL L, V1841, P720, DOI 10.1016/j.bbalip.2013.07.003; Abe M, 2012, MOL CELL BIOL, V32, P1396, DOI 10.1128/MCB.06113-11; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alvarez C, 2009, TOXICON, V54, P1135, DOI 10.1016/j.toxicon.2009.02.022; Anderluh G, 2002, TOXICON, V40, P111, DOI 10.1016/S0041-0101(01)00191-X; Aoki M, 2009, PROTEIN EXPRES PURIF, V68, P128, DOI 10.1016/j.pep.2009.07.017; Bakrac B, 2008, J BIOL CHEM, V283, P18665, DOI 10.1074/jbc.M708747200; Bakrac B, 2010, J BIOL CHEM, V285, P22186, DOI 10.1074/jbc.M110.105122; Bhat HB, 2015, FASEB J, V29, P3920, DOI 10.1096/fj.15-272112; Bhat HB, 2013, J LIPID RES, V54, P2933, DOI 10.1194/jlr.D041731; Blom TS, 2001, BIOCHEMISTRY-US, V40, P14635, DOI 10.1021/bi0156714; Carquin M, 2014, J LIPID RES, V55, P1331, DOI 10.1194/jlr.M048538; Chang TH, 2012, VIROLOGY, V422, P205, DOI 10.1016/j.virol.2011.10.029; Cheng JL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4207; de Haan L, 2004, MOL MEMBR BIOL, V21, P77, DOI 10.1080/09687680410001663267; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Duran JM, 2012, EMBO J, V31, P4535, DOI 10.1038/emboj.2012.317; Eisenberg S, 2006, MOL CELL BIOL, V26, P7190, DOI 10.1128/MCB.01059-06; Emoto K, 2005, J BIOL CHEM, V280, P37901, DOI 10.1074/jbc.M504282200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fairn GD, 2011, J CELL BIOL, V194, P257, DOI 10.1083/jcb.201012028; Field SJ, 2005, CURR BIOL, V15, P1407, DOI 10.1016/j.cub.2005.06.059; Fujita A, 2007, MOL BIOL CELL, V18, P2112, DOI 10.1091/mbc.E07-01-0071; Fujiwara T, 2002, J CELL BIOL, V157, P1071, DOI 10.1083/jcb.200202050; Gerl MJ, 2012, J CELL BIOL, V196, P213, DOI 10.1083/jcb.201108175; Hammond GRV, 2014, J CELL BIOL, V205, P113, DOI 10.1083/jcb.201312072; Hancock JF, 2005, BIOCHEM J, V389, P1, DOI 10.1042/BJ20050231; Hess ST, 2005, J CELL BIOL, V169, P965, DOI 10.1083/jcb.200412058; Higaki K, 2001, J BIOCHEM-TOKYO, V129, P875, DOI 10.1093/oxfordjournals.jbchem.a002932; Hong Q, 2002, J BIOL CHEM, V277, P41916, DOI 10.1074/jbc.M204625200; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; IPSEN JH, 1987, BIOCHIM BIOPHYS ACTA, V905, P162; Ishitsuka R, 2004, BIOPHYS J, V86, P296, DOI 10.1016/S0006-3495(04)74105-3; Ishitsuka R., 2008, USE LIPID BINDING TO; Jin L, 2006, BIOPHYS J, V90, P2563, DOI 10.1529/biophysj.105.072884; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Kahya N, 2003, J BIOL CHEM, V278, P28109, DOI 10.1074/jbc.M302969200; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kasai RS, 2011, J CELL BIOL, V192, P463, DOI 10.1083/jcb.201009128; Kiyokawa E, 2005, J BIOL CHEM, V280, P24072, DOI 10.1074/jbc.M502244200; Kiyokawa E, 2004, BIOCHEMISTRY-US, V43, P9766, DOI 10.1021/bi049561j; Kobayashi N, 2007, J BIOMOL NMR, V39, P31, DOI 10.1007/s10858-007-9175-5; Kobayashi T, 1999, NAT CELL BIOL, V1, P113, DOI 10.1038/10084; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200; KOBAYASHI T, 1992, FEBS LETT, V300, P227, DOI 10.1016/0014-5793(92)80851-7; Kraft ML, 2014, BBA-MOL CELL BIOL L, V1841, P1108, DOI 10.1016/j.bbalip.2014.03.003; Laliberte JP, 2007, J VIROL, V81, P10636, DOI 10.1128/JVI.01119-07; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Maekawa M, 2014, J CELL SCI, V127, P4801, DOI 10.1242/jcs.150524; Makino A, 2003, J BIOL CHEM, V278, P3204, DOI 10.1074/jbc.M210347200; Makino A, 2015, FASEB J, V29, P477, DOI 10.1096/fj.13-247585; Malovrh P, 2000, BIOCHEM J, V346, P223, DOI 10.1042/0264-6021:3460223; Mancheno JM, 2003, STRUCTURE, V11, P1319, DOI 10.1016/j.str.2003.09.019; Marsh D, 2009, BBA-BIOMEMBRANES, V1788, P2114, DOI 10.1016/j.bbamem.2009.08.004; Martinez D, 2007, TOXICON, V49, P68, DOI 10.1016/j.toxicon.2006.09.019; Matsuda T, 2007, J BIOMOL NMR, V37, P225, DOI 10.1007/s10858-006-9127-5; Maxfield FR, 2002, CURR OPIN CELL BIOL, V14, P483, DOI 10.1016/S0955-0674(02)00351-4; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Meier A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004343; Mizuno H, 2011, CHEM SCI, V2, P1548, DOI 10.1039/c1sc00169h; Mobius W, 2002, J HISTOCHEM CYTOCHEM, V50, P43; Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256; Munro S, 2003, CELL, V115, P377, DOI 10.1016/S0092-8674(03)00882-1; Murate M, 2015, J CELL SCI, V128, P1627, DOI 10.1242/jcs.163105; Murate M, 2010, BIOCHEMISTRY-US, V49, P4732, DOI 10.1021/bi100007u; Nishioka T, 2010, J BIOL CHEM, V285, P35979, DOI 10.1074/jbc.M110.153007; Niv H, 2002, J CELL BIOL, V157, P865, DOI 10.1083/jcb.200202009; Nixon SJ, 2009, TRAFFIC, V10, P131, DOI 10.1111/j.1600-0854.2008.00859.x; OHNO K, 1993, CELL STRUCT FUNCT, V18, P231, DOI 10.1247/csf.18.231; Ohsaki Y, 2004, HISTOCHEM CELL BIOL, V121, P263, DOI 10.1007/s00418-004-0643-7; Ohvo-Rekila H, 2002, PROG LIPID RES, V41, P66, DOI 10.1016/S0163-7827(01)00020-0; Okazaki N, 2008, J SYNCHROTRON RADIAT, V15, P288, DOI 10.1107/S0909049507064679; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pack C, 2006, BIOPHYS J, V91, P3921, DOI 10.1529/biophysj.106.079467; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Pike LJ, 2006, J LIPID RES, V47, P1597, DOI 10.1194/jlr.E600002-JLR200; Prior IA, 2001, NAT CELL BIOL, V3, P368, DOI 10.1038/35070050; Rojko N, 2013, J BIOL CHEM, V288, P23704, DOI 10.1074/jbc.M113.481572; Salzmann M, 1998, P NATL ACAD SCI USA, V95, P13585, DOI 10.1073/pnas.95.23.13585; SANKARAM MB, 1990, BIOCHEMISTRY-US, V29, P10670, DOI 10.1021/bi00499a014; Sato M, 2006, NAT METHODS, V3, P797, DOI 10.1038/nmeth930; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Shields JM, 2000, TRENDS CELL BIOL, V10, P147, DOI 10.1016/S0962-8924(00)01740-2; Skocaj M, 2013, CURR MED CHEM, V20, P491; Skocaj M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092783; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Tang YY, 2009, J VIROL, V83, P7982, DOI 10.1128/JVI.00259-09; Tokunaga M, 2008, NAT METHODS, V5, P159, DOI 10.1038/nmeth1171; Tomita T, 2004, J BIOL CHEM, V279, P26975, DOI 10.1074/jbc.M402676200; Ueno Go, 2006, Journal of Structural and Functional Genomics, V7, P15, DOI 10.1007/s10969-005-9005-5; Vainio S, 2005, BIOCHEM J, V391, P465, DOI 10.1042/BJ20050460; Valcarcel CA, 2001, BIOPHYS J, V80, P2761, DOI 10.1016/S0006-3495(01)76244-3; van Galen J, 2014, J CELL BIOL, V206, P609, DOI 10.1083/jcb.201405009; Varnai P, 2006, BBA-MOL CELL BIOL L, V1761, P957, DOI 10.1016/j.bbalip.2006.03.019; Yabuki Takashi, 2007, Journal of Structural and Functional Genomics, V8, P173, DOI 10.1007/s10969-007-9038-z; Yamaji A, 1998, J BIOL CHEM, V273, P5300, DOI 10.1074/jbc.273.9.5300; Yamaji-Hasegawa A, 2003, J BIOL CHEM, V278, P22762, DOI 10.1074/jbc.M213209200; Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066; Yokoyama J, 2011, ANAL BIOCHEM, V411, P223, DOI 10.1016/j.ab.2011.01.017; Zhang J, 2000, J VIROL, V74, P4634, DOI 10.1128/JVI.74.10.4634-4644.2000; Zhu G, 2000, J MAGN RESON, V143, P423, DOI 10.1006/jmre.2000.2022	104	23	23	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1301	1322		10.1096/fj.201500075R	http://dx.doi.org/10.1096/fj.201500075R			22	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	27492925				2022-12-28	WOS:000398504300006
J	Bedau, T; Peters, F; Prox, J; Arnold, P; Schmidt, F; Finkernagel, M; Kollmann, S; Wichert, R; Otte, A; Ohler, A; Stirnberg, M; Lucius, R; Koudelka, T; Tholey, A; Biasin, V; Pietrzik, CU; Kwapiszewska, G; Becker-Pauly, C				Bedau, Tillmann; Peters, Florian; Prox, Johannes; Arnold, Philipp; Schmidt, Frederike; Finkernagel, Malin; Koellmann, Sandra; Wichert, Rielana; Otte, Anna; Ohler, Anke; Stirnberg, Marit; Lucius, Ralph; Koudelka, Tomas; Tholey, Andreas; Biasin, Valentina; Pietrzik, Claus U.; Kwapiszewska, Grazyna; Becker-Pauly, Christoph			Ectodomain shedding of CD99 within highly conserved regions is mediated by the metalloprotease meprin beta and promotes transendothelial cell migration	FASEB JOURNAL			English	Article						proteolysis; inflammation; TEM; adhesion molecule	INTESTINAL INFLAMMATION; EXTRACELLULAR-MATRIX; LEUKOCYTE DIAPEDESIS; MIC2 EXPRESSION; EWINGS-SARCOMA; CLEAVAGE SITE; IN-VIVO; PEPTIDE; SURFACE; ADAM17	The adhesion molecule CD99 is essential for the transendothelial migration of leukocytes. In this study, we used biochemical and cellular assays to show that CD99 undergoes ectodomain shedding by the metalloprotease meprin beta and subsequent intramembrane proteolysis by gamma-secretase. The cleavage site in CD99 was identified by mass spectrometry within an acidic region highly conserved through different vertebrate species. This finding fits perfectly to the unique cleavage specificity of meprin beta with a strong preference for aspartate residues and suggests coevolution of protease and substrate. We hypothesized that limited CD99 cleavage by meprin beta would alter cellular transendothelial migration (TEM) behavior in tissue remodeling processes, such as inflammation and cancer. Indeed, meprin beta induced cell migration of Lewis lung carcinoma cells in an in vitro TEM assay. Accordingly, deficiency of meprin beta in Mep1b(-/-) mice resulted in significantly increased CD99 protein levels in the lung. Therefore, meprin beta could serve as a therapeutic target, given that in aproof-of-concept approach we showed accumulation of CD99 protein in lungs of meprin beta inhibitortreated mice.- Bedau, T., Peters, F., Prox, J., Arnold, P., Schmidt, F., Finkernagel, M., Kollmann, S., Wichert, R., Otte, A., Ohler, A., Stirnberg, M., Lucius, R., Koudelka, T., Tholey, A., Biasin, V., Pietrzik, C. U., Kwapiszewska, G., Becker- Pauly, C. Ectodomain shedding of CD99 within highly conserved regions is mediated by the metalloprotease meprin b and promotes transendothelial cell migration.	[Bedau, Tillmann; Peters, Florian; Prox, Johannes; Schmidt, Frederike; Finkernagel, Malin; Koellmann, Sandra; Wichert, Rielana; Otte, Anna; Becker-Pauly, Christoph] Univ Kiel, Inst Biochem, Unit Degrad ProteaseWeb, Kiel, Germany; [Arnold, Philipp; Lucius, Ralph] Univ Kiel, Inst Anat, Kiel, Germany; [Koudelka, Tomas; Tholey, Andreas] Univ Kiel, Inst Expt Med, Kiel, Germany; [Pietrzik, Claus U.] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Inst Pathobiochem, Mainz, Germany; [Stirnberg, Marit] Univ Bonn, Inst Pharmaceut, Bonn, Germany; [Biasin, Valentina; Kwapiszewska, Grazyna] Ludwig Boltzmann Inst, Lung Vasc Res, Graz, Austria	University of Kiel; University of Kiel; University of Kiel; Johannes Gutenberg University of Mainz; University of Bonn; Ludwig Boltzmann Institute	Becker-Pauly, C (corresponding author), Otto Hahn Pl 9, D-24118 Kiel, Germany.	cbeckerpauly@biochem.uni-kiel.de	Tholey, Andreas/B-3407-2010; Becker-Pauly, Christoph/B-7569-2011; Biasin, Valentina/AAG-7780-2020; Lucius, Ralph/B-1614-2010	Tholey, Andreas/0000-0002-8687-6817; Biasin, Valentina/0000-0002-6277-1463; Kwapiszewska, grazyna/0000-0003-0518-9079; Trabold, Malin/0000-0001-6458-0567	Deutsche Forschungsgemeinschaft (DFG) [SFB877]; Proteolysis as a Regulatory Event in Pathophysiology [PI379/6-1, PI379/5-2, BE4086/2-1, BE4086/5-1]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Proteolysis as a Regulatory Event in Pathophysiology	The authors thank Dietmar Vestweber (Max Planck Institute of Molecular Biomedicine, Munster, Germany) for the murine CD99 antibody and cDNA, Dominique Mazzocut (Institut de Biologie et Chimie des Proteines, Lyon, France) for the N-terminal Edman sequencing; Stefan Dusterhoft (University of Oxford, Oxford, United Kingdom) for technical help with HPLC, and Dirk Schmidt-Arras (University of Kiel) for LLC cells. This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grant SFB877, "Proteolysis as a Regulatory Event in Pathophysiology" (Projects A9 and Z2), Grants PI379/6-1 and PI379/5-2 (to C.U.P.) and Grants BE4086/2-1 and BE4086/5-1 (to C.B.P.). The authors declare no conflicts of interest.	AMBROS IM, 1991, CANCER, V67, P1886, DOI 10.1002/1097-0142(19910401)67:7<1886::AID-CNCR2820670712>3.0.CO;2-U; Arnold P, 2015, FASEB J, V29, P3549, DOI 10.1096/fj.15-272310; Arolas JL, 2012, P NATL ACAD SCI USA, V109, P16131, DOI 10.1073/pnas.1211076109; Banerjee S, 2008, J BIOL CHEM, V283, P31371, DOI 10.1074/jbc.M802814200; Becker C, 2003, BIOL CHEM, V384, P825, DOI 10.1515/BC.2003.092; Becker-Pauly C, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.009233; Biasin V, 2014, J PATHOL, V233, P7, DOI 10.1002/path.4303; Bien J, 2012, J BIOL CHEM, V287, P33304, DOI 10.1074/jbc.M112.395608; Bixel G, 2004, BLOOD, V104, P3205, DOI 10.1182/blood-2004-03-1184; Bixel MG, 2010, BLOOD, V116, P1172, DOI 10.1182/blood-2009-12-256388; Brandenburg LO, 2008, J NEUROPATH EXP NEUR, V67, P1041, DOI 10.1097/NEN.0b013e31818b4801; Broder C, 2013, P NATL ACAD SCI USA, V110, P14219, DOI 10.1073/pnas.1305464110; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Crisman JM, 2004, J IMMUNOL, V172, P4510, DOI 10.4049/jimmunol.172.7.4510; Dreymueller D, 2015, AM J PHYSIOL-LUNG C, V308, pL325, DOI 10.1152/ajplung.00294.2014; Dreymueller D, 2012, EMBO MOL MED, V4, P412, DOI 10.1002/emmm.201200217; Dufour EM, 2008, CELL COMMUN ADHES, V15, P351, DOI 10.1080/15419060802442191; DWORZAK MN, 1994, BLOOD, V83, P415, DOI 10.1182/blood.V83.2.415.bloodjournal832415; Eldering JA, 1997, EUR J BIOCHEM, V247, P920, DOI 10.1111/j.1432-1033.1997.00920.x; FELLINGER EJ, 1991, CANCER RES, V51, P336; Herzog C, 2009, BIOCHEM BIOPH RES CO, V379, P904, DOI 10.1016/j.bbrc.2008.12.161; Huguenin M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002153; Jackle F, 2015, BIOCHEM J, V470, P91, DOI 10.1042/BJ20141417; Jefferson T, 2013, CELL MOL LIFE SCI, V70, P309, DOI 10.1007/s00018-012-1106-2; Keiffer TR, 2014, J BIOL CHEM, V289, P7580, DOI 10.1074/jbc.M113.546309; Kleifeld O, 2010, NAT BIOTECHNOL, V28, P281, DOI 10.1038/nbt.1611; Kronenberg D, 2010, J INVEST DERMATOL, V130, P2727, DOI 10.1038/jid.2010.202; Lou O, 2007, J IMMUNOL, V178, P1136, DOI 10.4049/jimmunol.178.2.1136; Manara MC, 2006, MOL BIOL CELL, V17, P1910, DOI 10.1091/mbc.E05-10-0971; Manes TD, 2011, J IMMUNOL, V186, P1763, DOI 10.4049/jimmunol.1002835; Muller WA, 2016, CURR OPIN IMMUNOL, V38, P24, DOI 10.1016/j.coi.2015.10.006; Norman LP, 2003, MOL CELL BIOL, V23, P1221, DOI 10.1128/MCB.23.4.1221-1230.2003; Park SH, 2005, GENE, V353, P177, DOI 10.1016/j.gene.2005.04.023; Rocchi A, 2010, J CLIN INVEST, V120, P668, DOI 10.1172/JCI36667; Schenkel AR, 2002, NAT IMMUNOL, V3, P143, DOI 10.1038/ni749; Schonherr C, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0084-5; Schutte A, 2014, P NATL ACAD SCI USA, V111, P12396, DOI 10.1073/pnas.1407597111; Scotlandi K, 2007, ONCOGENE, V26, P6604, DOI 10.1038/sj.onc.1210481; Sohn HW, 2001, J IMMUNOL, V166, P787, DOI 10.4049/jimmunol.166.2.787; Suh YH, 2003, GENE, V307, P63, DOI 10.1016/S0378-1119(03)00401-3; Tucher J, 2014, J PROTEOME RES, V13, P2205, DOI 10.1021/pr401135u; Vestweber D, 2015, NAT REV IMMUNOL, V15, P692, DOI 10.1038/nri3908; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Watson RL, 2015, J EXP MED, V212, P1021, DOI 10.1084/jem.20150354; Winger RC, 2016, J IMMUNOL, V196, P1443, DOI 10.4049/jimmunol.1501634	45	24	24	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1226	+		10.1096/fj.201601113R	http://dx.doi.org/10.1096/fj.201601113R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	28003343				2022-12-28	WOS:000395671200034
J	Feigerlova, E; Battaglia-Hsu, SF				Feigerlova, Eva; Battaglia-Hsu, Shyue-Fang			Role of post-transcriptional regulation of mRNA stability in renal pathophysiology: focus on chronic kidney disease	FASEB JOURNAL			English	Review						RNA binding factor; noncoding RNA; P-body; stress granule; RNA-exosome	BINDING PROTEIN HUR; PH-RESPONSIVE STABILIZATION; LONG NONCODING RNAS; ANGIOTENSIN-II; GENE-EXPRESSION; TRANSLATIONAL REPRESSION; METABOLIC-ACIDOSIS; OSMOTIC-STRESS; UP-REGULATION; BICAUDAL C	Chronic kidney disease (CKD) represents an important public health problem. Its progression to end-stage renal disease is associated with increased morbidity and mortality. The determinants of renal function decline are not fully understood. Recent progress in the understanding of post-transcriptional regulation of mRNA stability has helped the identification of both the trans-and cis-acting elements of mRNA as potential markers and therapeutic targets for difficult-to-diagnose and -treat diseases, including CKDs such as diabetic nephropathy. Human antigen R (HuR), a trans-acting element of mRNA, is an RNA binding factor (RBF) best known for its ability to stabilize AU-rich-element-containing mRNAs. Deregulated HuR subcellular localization or expression occurs in a wide range of renal diseases, such as metabolic acidosis, ischemia, and fibrosis. Besides RBFs, recent evidence revealed that noncoding RNA, such as microRNA and long noncoding RNA, participates in regulating mRNA stability and that aberrant noncoding RNA expression accounts for many pathologic renal conditions. The goal of this review is to provide an overview of our current understanding of the post-transcriptional regulation of mRNA stability in renal pathophysiology and to offer perspectives for this class of diseases. We use examples of diverse renal diseases to illustrate different mRNA stability pathways in specific cellular compartments and discuss the roles and impacts of both the cis- and trans-activating factors on the regulation of mRNA stability in these diseases.-Feigerlova a, E., Battaglia-Hsu, S.-F. Role of post-transcriptional regulation of mRNA stability in renal pathophysiology: focus on chronic kidney disease.	[Feigerlova, Eva] CHU Poitiers, Serv Endocrinol, Pole DUNE, Poitiers, France; [Feigerlova, Eva] Univ Poitiers, Unite Format & Rech Med Pharm, Poitiers, France; [Feigerlova, Eva] INSERM, Clin Invest Ctr 1402, Unite 1082, Poitiers, France; [Battaglia-Hsu, Shyue-Fang] Univ Lorraine, INSERM Unite 954, Nutr Genet & Exposit Risques Environm, Vandoeuvre Les Nancy, France; [Battaglia-Hsu, Shyue-Fang] Ctr Hosp Reg Univ Nancy, Vandoeuvre Ies Nancy, France	CHU Poitiers; Universite de Poitiers; Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Poitiers; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy	Feigerlova, E (corresponding author), CHU Poitiers, Serv Endocrinol, Pole DUNE, Poitiers, France.	eva.feigerlova@fulbrightmail.org			Etudes Maladies Metaboliques et Systemiques, [Service d'Endocrinologie, Centre Hospitalier Universitaire de Poitiers (GEMMS)]	Etudes Maladies Metaboliques et Systemiques, [Service d'Endocrinologie, Centre Hospitalier Universitaire de Poitiers (GEMMS)]	The authors thank Etudes Maladies Metaboliques et Systemiques, [Service d'Endocrinologie, Centre Hospitalier Universitaire de Poitiers (GEMMS)] for financial support. The authors also thank Dr. Battaglia (Laboratoire Interdisciplinaire des Environnements Continentaux, UMR 7360 CNRS/Universite de Lorraine) for critical reading of the manuscript.	Akool ES, 2003, MOL CELL BIOL, V23, P4901, DOI 10.1128/MCB.23.14.4901-4916.2003; Angrand PO, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00165; Ayupova DA, 2009, AM J PHYSIOL-RENAL, V297, pF95, DOI 10.1152/ajprenal.90632.2008; Bakheet T, 2003, NUCLEIC ACIDS RES, V31, P421, DOI 10.1093/nar/gkg023; Balkrishna S, 2014, CELL PHYSIOL BIOCHEM, V33, P1591, DOI 10.1159/000358722; Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106; Bhatt K, 2016, AM J PHYSIOL-RENAL, V310, pF109, DOI 10.1152/ajprenal.00387.2015; Boffa JJ, 2003, J AM SOC NEPHROL, V14, P1132, DOI 10.1097/01.ASN.0000060574.38107.3B; Bounedjah O, 2012, J BIOL CHEM, V287, P2446, DOI 10.1074/jbc.M111.292748; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Capowski EE, 2001, J IMMUNOL, V167, P5970, DOI 10.4049/jimmunol.167.10.5970; Carpenter S, 2014, NAT REV IMMUNOL, V14, P361, DOI 10.1038/nri3682; Cheng YC, 2013, MOL CANCER THER, V12, P1202, DOI 10.1158/1535-7163.MCT-12-0778; Cherry J, 2006, IN VIVO, V20, P17; Cording A, 2017, RNA BIOL, V14, P611, DOI 10.1080/15476286.2015.1137422; Curthoys NP, 2001, AM J PHYSIOL-RENAL, V281, pF381, DOI 10.1152/ajprenal.2001.281.3.F381; D'Agostino VG, 2015, SCI REP-UK, V5, DOI 10.1038/srep16478; Devenport D, 2014, J CELL BIOL, V207, P171, DOI 10.1083/jcb.201408039; Ding L, 2007, TRENDS CELL BIOL, V17, P411, DOI 10.1016/j.tcb.2007.06.003; Doller A, 2008, MOL CELL BIOL, V28, P2608, DOI 10.1128/MCB.01530-07; Doller A, 2015, EXP CELL RES, V330, P66, DOI 10.1016/j.yexcr.2014.09.010; Doller A, 2009, AM J PATHOL, V174, P1252, DOI 10.2353/ajpath.2009.080652; Eberhardt W, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00251; Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Feliers D, 2007, AM J PHYSIOL-RENAL, V293, pF607, DOI 10.1152/ajprenal.00497.2006; Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Forgac M, 1999, J BIOL CHEM, V274, P12951, DOI 10.1074/jbc.274.19.12951; Fraser D, 2008, KIDNEY INT, V73, P724, DOI 10.1038/sj.ki.5002719; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gerich JE, 2001, DIABETES CARE, V24, P382, DOI 10.2337/diacare.24.2.382; Gherzi R, 2004, MOL CELL, V14, P571, DOI 10.1016/j.molcel.2004.05.002; Grosset C, 2000, CELL, V103, P29, DOI 10.1016/S0092-8674(00)00102-1; Gummadi L, 2012, AM J PHYSIOL-RENAL, V303, pF1545, DOI 10.1152/ajprenal.00400.2012; Hansen WR, 1996, AM J PHYSIOL-RENAL, V271, pF126, DOI 10.1152/ajprenal.1996.271.1.F126; Hiesberger T, 2004, J CLIN INVEST, V113, P814, DOI 10.1172/JCI200420083; Huang WF, 2011, NUCLEIC ACIDS RES, V39, P475, DOI 10.1093/nar/gkq818; Huwiler A, 2003, J BIOL CHEM, V278, P51758, DOI 10.1074/jbc.M305722200; Ibrahim H, 2008, KIDNEY INT, V73, P11, DOI 10.1038/sj.ki.5002581; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Jaimes EA, 2005, KIDNEY INT, V68, P2143, DOI 10.1111/j.1523-1755.2005.00670.x; Jeyaraj S, 2005, J BIOL CHEM, V280, P37957, DOI 10.1074/jbc.M502883200; Jimbo M, 2015, ONCOTARGET, V6, P27312, DOI 10.18632/oncotarget.4743; Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038; Karet FE, 1999, NAT GENET, V21, P84, DOI 10.1038/5022; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group, 2009, Kidney Int Suppl, pS1, DOI 10.1038/ki.2009.188; Kuzmiak HA, 2006, TRENDS MOL MED, V12, P306, DOI 10.1016/j.molmed.2006.05.005; Lang S, 2000, J AM SOC NEPHROL, V11, P1398, DOI 10.1681/ASN.V1181398; Laterza OF, 2000, AM J PHYSIOL-RENAL, V278, pF970, DOI 10.1152/ajprenal.2000.278.6.F970; Lenz O, 2000, J AM SOC NEPHROL, V11, P574, DOI 10.1681/ASN.V113574; Lopez-Rodriguez C, 2004, P NATL ACAD SCI USA, V101, P2392, DOI 10.1073/pnas.0308703100; Lorenzen JM, 2016, NAT REV NEPHROL, V12, P360, DOI 10.1038/nrneph.2016.51; Lovci MT, 2016, ADV EXP MED BIOL, V907, P297, DOI 10.1007/978-3-319-29073-7_12; Luyten A, 2010, J AM SOC NEPHROL, V21, P1521, DOI 10.1681/ASN.2010010127; Lykke-Andersen J, 2005, GENE DEV, V19, P351, DOI 10.1101/gad.1282305; Maisonneuve C, 2009, DEVELOPMENT, V136, P3019, DOI 10.1242/dev.038174; Mendell JT, 2004, NAT GENET, V36, P1073, DOI 10.1038/ng1429; Mufti J, 2011, AM J PHYSIOL-RENAL, V301, pF1066, DOI 10.1152/ajprenal.00303.2011; Naguro I, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2283; Navar LG, 1996, PHYSIOL REV, V76, P425, DOI 10.1152/physrev.1996.76.2.425; Nechama M, 2008, FASEB J, V22, P3458, DOI 10.1096/fj.08-107250; Nechama M, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-70; Nechama M, 2009, J CLIN INVEST, V119, P3102, DOI 10.1172/JCI39522; Patel V, 2013, P NATL ACAD SCI USA, V110, P10765, DOI 10.1073/pnas.1301693110; Patel V, 2012, J AM SOC NEPHROL, V23, P1941, DOI 10.1681/ASN.2012030321; Paziewska A, 2004, FEBS LETT, V577, P134, DOI 10.1016/j.febslet.2004.08.086; Peer D, 2008, SCIENCE, V319, P627, DOI 10.1126/science.1149859; PFEILSCHIFTER J, 1990, BIOCHEM BIOPH RES CO, V169, P585, DOI 10.1016/0006-291X(90)90371-S; Piazzon N, 2012, J MOL CELL BIOL, V4, P398, DOI 10.1093/jmcb/mjs027; Praetorius HA, 2003, CURR OPIN NEPHROL HY, V12, P517, DOI 10.1097/00041552-200309000-00006; ROMERO JC, 1989, MAYO CLIN PROC, V64, P1406, DOI 10.1016/S0025-6196(12)65383-X; Saburi S, 2008, NAT GENET, V40, P1010, DOI 10.1038/ng.179; SASTRASINH S, 1989, AM J PHYSIOL, V257, pF1050, DOI 10.1152/ajprenal.1989.257.6.F1050; Sataranatarajan K, 2008, CELL SIGNAL, V20, P969, DOI 10.1016/j.cellsig.2008.01.016; Schmid M, 2008, TRENDS BIOCHEM SCI, V33, P501, DOI 10.1016/j.tibs.2008.07.003; Schnaper HW, 2003, AM J PHYSIOL-RENAL, V284, pF243, DOI 10.1152/ajprenal.00300.2002; Sen GL, 2005, NAT CELL BIOL, V7, P633, DOI 10.1038/ncb1265; Senthil D, 2003, KIDNEY INT, V64, P468, DOI 10.1046/j.1523-1755.2003.00135.x; Shang J, 2015, FREE RADICAL BIO MED, V79, P217, DOI 10.1016/j.freeradbiomed.2014.12.013; SHIMKETS RA, 1994, CELL, V79, P407, DOI 10.1016/0092-8674(94)90250-X; Solbu TT, 2005, J AM SOC NEPHROL, V16, P869, DOI 10.1681/ASN.2004060433; Stoecklin G, 2013, ADV EXP MED BIOL, V768, P197, DOI 10.1007/978-1-4614-5107-5_12; Tang A, 2001, J BIOL CHEM, V276, P21375, DOI 10.1074/jbc.M101941200; Tao XZ, 2015, MOL CELL BIOL, V35, P3921, DOI 10.1128/MCB.00845-15; Tran U, 2010, DEVELOPMENT, V137, P1107, DOI 10.1242/dev.046045; Trionfini P, 2015, NAT REV NEPHROL, V11, P23, DOI 10.1038/nrneph.2014.202; Van Nostrand EL, 2016, NAT METHODS, V13, P508, DOI [10.1038/NMETH.3810, 10.1038/nmeth.3810]; Viengchareun S, 2009, MOL ENDOCRINOL, V23, P1948, DOI 10.1210/me.2009-0095; Wang GQ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21865; Wang ZH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138780; Wei QQ, 2013, IUBMB LIFE, V65, P602, DOI 10.1002/iub.1174; Wessely O, 2001, MECH DEVELOP, V101, P267, DOI 10.1016/S0925-4773(00)00568-2; White EJF, 2013, BBA-GENE REGUL MECH, V1829, P680, DOI 10.1016/j.bbagrm.2012.12.002; Wu XY, 2012, GENE, V500, P10, DOI 10.1016/j.gene.2012.03.021; Yang JQ, 2009, J BIOL CHEM, V284, P27025, DOI 10.1074/jbc.R109.040543; Yu C, 2014, MOL BIOL REP, V41, P1141, DOI 10.1007/s11033-013-2960-1; Yu Q, 2003, J BIOL CHEM, V278, P1579, DOI 10.1074/jbc.M203526200; Zhang P, 2009, HUM MOL GENET, V18, P1238, DOI 10.1093/hmg/ddp024	101	18	19	3	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					457	468		10.1096/fj.201601087RR	http://dx.doi.org/10.1096/fj.201601087RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27849555				2022-12-28	WOS:000394235400003
J	Laan, LC; Williams, AR; Stavenhagen, K; Giera, M; Kooij, G; Vlasakov, I; Kalay, H; Kringel, H; Nejsum, P; Thamsborg, SM; Wuhrer, M; Dijkstra, CD; Cummings, RD; van Die, I				Laan, Lisa C.; Williams, Andrew R.; Stavenhagen, Kathrin; Giera, Martin; Kooij, Gijs; Vlasakov, Iliyan; Kalay, Hakan; Kringel, Helene; Nejsum, Peter; Thamsborg, Stig M.; Wuhrer, Manfred; Dijkstra, Christine D.; Cummings, Richard D.; van Die, Irma			The whipworm (Trichuris suis) secretes prostaglandin E2 to suppress proinflammatory properties in human dendritic cells	FASEB JOURNAL			English	Article						multiple sclerosis; inflammatory bowel disease; helminth therapy; immune regulation; lipids	OESOPHAGOSTOMUM-DENTATUM; INFLAMMATORY RESPONSES; EICOSANOID PRODUCTION; IMMUNE-RESPONSES; SOLUBLE PRODUCTS; LIPID MEDIATORS; RECEPTOR; DIFFERENTIATION; MODULATION; HELMINTHS	Clinical trials have shown that administration of the nematode Trichuris suis can be beneficial in treating various immune disorders. To provide insight into the mechanisms by which this worm suppresses inflammatory responses, an active component was purified from T. suis soluble products (TsSPs) that suppress TNF and IL-12 secretion from LPS-activated human dendritic cells (DCs). Analysis by liquid chromatography tandem mass spectrometry identified this compound as prostaglandin (PG)E2. The purified compound showed similar properties compared with TsSPs and commercial PGE2 in modulating LPS-induced expression of many cytokines and chemokines and in modulating Rab7B and P2RX7 expression in human DCs. Furthermore, the TsSP-induced reduction of TNF secretion from DCs is reversed by receptor antagonists for EP2 and EP4, indicating PGE2 action. T. suis secretes extremely high amounts of PGE2 (45-90 ng/mg protein) within their excretory/secretory products but few related lipid mediators as established by metabololipidomic analysis. Culture of T. suis with several cyclooxygenase (COX) inhibitors that inhibit mammalian prostaglandin synthesis affected the worm's motility but did not inhibit PGE2 secretion, suggesting that the worms can synthesize PGE2 via a COX-independent pathway. We conclude that T. suis secretes PGE2 to suppress proinflammatory responses in human DCs, thereby modulating the host's immune response.	[Laan, Lisa C.; Kooij, Gijs; Kalay, Hakan; Dijkstra, Christine D.; van Die, Irma] Vrije Univ, Med Ctr Amsterdam, Dept Mol Cell Biol & Immunol, Neurosci Campus Amsterdam, Amsterdam, Netherlands; [Williams, Andrew R.; Kringel, Helene; Nejsum, Peter; Thamsborg, Stig M.] Univ Copenhagen, Dept Vet Dis Biol, Sect Parasitol Hlth & Dev, DK-1168 Copenhagen, Denmark; [Stavenhagen, Kathrin; Wuhrer, Manfred] Vrije Univ Amsterdam, Div BioAnalyt Chem, Amsterdam, Netherlands; [Stavenhagen, Kathrin; Giera, Martin; Wuhrer, Manfred] Leiden Univ, Med Ctr, Ctr Prote & Metabol, Leiden, Netherlands; [Kooij, Gijs; Vlasakov, Iliyan] Brigham & Womens Hosp, Harvard Inst Med, Ctr Expt Therapeut & Reperfus Injury, Boston, MA 02115 USA; [Kooij, Gijs; Vlasakov, Iliyan] Harvard Med Sch, Boston, MA USA; [Cummings, Richard D.] Harvard Med Sch, Ctr Glycosci, Beth Israel Deaconess Med Ctr, Dept Surg, Boston, MA USA	Vrije Universiteit Amsterdam; University of Copenhagen; Vrije Universiteit Amsterdam; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	van Die, I (corresponding author), Dept Mol Cell Biol & Immunol, OI2 Bldg,Room 11 E 41,POB 7057, NL-1007 MB Amsterdam, Netherlands.	im.vandie@vumc.nl	Giera, Martin/Y-2413-2018; Kringel, Helene/Z-2392-2019; Kooij, Gijs/AAA-4268-2020; Wuhrer, Manfred/ABE-9168-2020; Williams, Andrew R/A-3057-2013	Giera, Martin/0000-0003-1684-1894; Kringel, Helene/0000-0003-4682-1114; Wuhrer, Manfred/0000-0002-0814-4995; Williams, Andrew R/0000-0002-8231-282X; Nejsum, Peter/0000-0002-6673-8505; Kooij, Gijs/0000-0002-9488-2918	DutchMS [multiple sclerosis] Research Foundation [MS11-771, MS14-878]; U.S. National Institute of Health (NIH) National Institute of Allergy and Infectious Diseases [AI101982]; Lundbeck Foundation [14-3670A]; NIH National Institute of General Medical Sciences Grant [P01GM095467]; Lundbeck Foundation [R171-2014-309] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI101982] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	DutchMS [multiple sclerosis] Research Foundation; U.S. National Institute of Health (NIH) National Institute of Allergy and Infectious Diseases; Lundbeck Foundation(Lundbeckfonden); NIH National Institute of General Medical Sciences Grant; Lundbeck Foundation(Lundbeckfonden); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the DutchMS [multiple sclerosis] Research Foundation (MS11-771 to I.V.D. and C.D.) and (MS14-878 to G.K.), and from the U.S. National Institute of Health (NIH) National Institute of Allergy and Infectious Diseases (Grant AI101982 to R.D.C.). A.R.W. was supported by the Lundbeck Foundation (Grant 14-3670A). The authors thank Dr. Paul Norris and Charles N. Serhan (NIH National Institute of General Medical Sciences Grant P01GM095467 (Center for Experimental Therapeutics and Reperfusion Injury, Harvard Institutes of Medicine, Brigham and Women's Hospital and Harvard Medical School) for help in metabololipidomic analysis and editorial assistance. The authors declare no conflicts of interest.	Alvarado R, 2015, IMMUNOBIOLOGY, V220, P262, DOI 10.1016/j.imbio.2014.11.008; Bager P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022346; BELLEY A, 1995, PARASITOL TODAY, V11, P327, DOI 10.1016/0169-4758(95)80185-5; Boniface K, 2009, J EXP MED, V206, P535, DOI 10.1084/jem.20082293; Cohn SM, 1997, J CLIN INVEST, V99, P1367, DOI 10.1172/JCI119296; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Daugschies A, 1998, INT J PARASITOL, V28, P355, DOI 10.1016/S0020-7519(97)00153-7; De Keijzer S, 2013, INT J MOL SCI, V14, P6542, DOI 10.3390/ijms14046542; Duffin R, 2016, SCIENCE, V351, P1333, DOI 10.1126/science.aad9903; Ebner F, 2014, ALLERGY, V69, P1489, DOI 10.1111/all.12496; Esaki Y, 2010, P NATL ACAD SCI USA, V107, P12233, DOI 10.1073/pnas.0915112107; Everts B, 2010, EUR J IMMUNOL, V40, P1525, DOI 10.1002/eji.200940109; Fleming JO, 2015, PARASITE IMMUNOL, V37, P277, DOI 10.1111/pim.12175; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; FUSCO AC, 1985, EXP PARASITOL, V59, P44, DOI 10.1016/0014-4894(85)90055-4; Garg SK, 2014, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD009400.PUB2; Grencis RK, 2015, ANNU REV IMMUNOL, V33, P201, DOI 10.1146/annurev-immunol-032713-120218; Hansen TVA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002752; Harn DA, 2009, IMMUNOL REV, V230, P247, DOI 10.1111/j.1600-065X.2009.00799.x; Harnett MM, 2008, ANN RHEUM DIS, V67, P518, DOI 10.1136/ard.2007.073502; Hiemstra IH, 2014, MOL IMMUNOL, V60, P1, DOI 10.1016/j.molimm.2014.03.003; Hoang HD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003271; Hoeksema MA, 2016, FASEB J, V30, P2826, DOI 10.1096/fj.201600343R; Iizuka Y, 2014, J PHYSIOL SCI, V64, P85, DOI 10.1007/s12576-013-0295-2; Joachim A, 2001, PARASITOL INT, V50, P211, DOI 10.1016/S1383-5769(01)00077-0; Kalinski P, 2012, J IMMUNOL, V188, P21, DOI 10.4049/jimmunol.1101029; Kapsenberg ML, 1999, CLIN EXP ALLERGY, V29, P33, DOI 10.1046/j.1365-2222.1999.00006.x-i2; Khan WI, 2004, PARASITE IMMUNOL, V26, P319, DOI 10.1111/j.0141-9838.2004.00715.x; Kihara Y, 2009, P NATL ACAD SCI USA, V106, P21807, DOI 10.1073/pnas.0906891106; Klaver EJ, 2015, GENES IMMUN, V16, P378, DOI 10.1038/gene.2015.18; Klaver EJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124089; Klaver EJ, 2013, INT J PARASITOL, V43, P191, DOI 10.1016/j.ijpara.2012.10.021; Kooij G, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0223-1; Kradin RL, 2006, ARCH PATHOL LAB MED, V130, P718; Kringel H, 2002, ACTA VET SCAND, V43, P185; Kuijk LM, 2012, MOL IMMUNOL, V51, P210, DOI 10.1016/j.molimm.2012.03.020; LEID RW, 1983, PROSTA LEUKOTR MED, V11, P317, DOI 10.1016/0262-1746(83)90043-4; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; LIU LX, 1990, J EXP MED, V172, P993, DOI 10.1084/jem.172.3.993; Maizels Rick M., 2008, V94, P112, DOI 10.1159/000154944; Nakanishi M, 2013, SEMIN IMMUNOPATHOL, V35, P123, DOI 10.1007/s00281-012-0342-8; Nyame AK, 2003, EXP PARASITOL, V104, P1, DOI 10.1016/S0014-4894(03)00110-3; Ottow MK, 2014, GENES IMMUN, V15, P477, DOI 10.1038/gene.2014.38; PAPPO R, 1956, J ORG CHEM, V21, P478, DOI 10.1021/jo01110a606; Pineda MA, 2015, LUPUS, V24, P400, DOI 10.1177/0961203314560004; Poloso NJ, 2013, MOL IMMUNOL, V54, P284, DOI 10.1016/j.molimm.2012.12.010; Schlegel M, 2016, HEPATOLOGY, V63, P1689, DOI 10.1002/hep.28347; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Stavenhagen K, 2015, ANAL CHEM, V87, P11691, DOI 10.1021/acs.analchem.5b02366; van Die I, 2010, GLYCOBIOLOGY, V20, P2, DOI 10.1093/glycob/cwp140; Weinstock JV, 2014, J IMMUNOL, V193, P3239, DOI 10.4049/jimmunol.1400927; Williams AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097053; Yao CC, 2009, NAT MED, V15, P633, DOI 10.1038/nm.1968; Zhang YY, 2015, SCIENCE, V348, DOI 10.1126/science.aaa2340	54	34	34	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					719	731		10.1096/fj.201600841R	http://dx.doi.org/10.1096/fj.201600841R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27806992	Green Published			2022-12-28	WOS:000394235400024
J	Sato, K; Fujita, S; Iemitsu, M				Sato, Koji; Fujita, Satoshi; Iemitsu, Motoyuki			Dioscorea esculenta-induced increase in muscle sex steroid hormones is associated with enhanced insulin sensitivity in a type 2 diabetes rat model	FASEB JOURNAL			English	Article						diosgenin; insulin resistance; exercise; DHT	SKELETAL-MUSCLE; IMPROVES HYPERGLYCEMIA; GLUCOSE-METABOLISM; CANCER CELLS; DHEA; EXERCISE; RESISTANCE; PATHWAY; DIOSGENIN; RECEPTOR	The effects of chronic Dioscorea esculenta administration and exercise training on muscle sex steroid hormone levels and insulin resistance in type 2 diabetes rats was assessed. Twenty-week-old male Otsuka Long Evans Tokushima Fatty (OLETF) rats were assigned randomly to the control, D. esculenta treatment, D. esculenta with 5-reductase inhibitor treatment, or the exercise training groups (running at 25 m/min for 1 h, 5 d/wk; n = 10 each group). Eight weeks of D. esculenta treatment or exercise training significantly attenuated the increase in plasma insulin and fasting glucose levels. Plasma and muscle concentrations of dehydroepiandrosterone and 5-dihydrotestosterone (DHT) and the expression of 5-reductase increased significantly in the D. esculenta-treated and exercise training groups, and both treatments led to the upregulation of glucose transporter-4 translocation with concomitant increases in PKB and PKC-/ phosphorylation. Furthermore, the glucose metabolic clearance rate, which represents insulin sensitivity, increased significantly in both the D. esculenta-treated and exercise training groups. These effects were suppressed by administration of the DHT synthetic inhibitor. Together, these findings suggest that the D. esculenta-induced increase in muscle sex steroid hormone levels helps decrease insulin resistance in type 2 diabetes.	[Sato, Koji; Fujita, Satoshi; Iemitsu, Motoyuki] Ritsumeikan Univ, Fac Sport & Hlth Sci, Kusatsu, Japan; [Sato, Koji] Kobe Univ, Grad Sch Human Dev & Environm, Kobe, Hyogo, Japan	Ritsumeikan University; Kobe University	Sato, K (corresponding author), Kobe Univ, Grad Sch Human Dev & Environm, Nada Ku, 3-11 Tsurukabuto, Kobe, Hyogo, Japan.	sato712@people.kobe-u.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology of Japan [15H03091]	Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	The authors thank Prof. Noboru Mesaki, University of Tsukuba, for his support during the study. This work was supported by Grant-in-Aid for Scientific Research 15H03091 (to M.N.) from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. The authors declare no conflicts of interest.	Aizawa K, 2010, STEROIDS, V75, P219, DOI 10.1016/j.steroids.2009.12.002; Awad AE, 2010, AM J PHYSIOL-CELL PH, V298, pC679, DOI 10.1152/ajpcell.00351.2009; Campbell CSG, 2004, LIFE SCI, V76, P57, DOI 10.1016/j.lfs.2004.06.017; Fujita S, 2007, DIABETES, V56, P1615, DOI 10.2337/db06-1566; Han DH, 1998, J GERONTOL A-BIOL, V53, pB19, DOI 10.1093/gerona/53A.1.B19; Jessen N, 2003, J APPL PHYSIOL, V94, P1373, DOI 10.1152/japplphysiol.00250.2002; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Mukasa K, 1998, J STEROID BIOCHEM, V67, P355, DOI 10.1016/S0960-0760(98)00126-5; Raju J, 2004, CANCER EPIDEM BIOMAR, V13, P1392; Sato K, 2014, J STEROID BIOCHEM, V143, P152, DOI 10.1016/j.jsbmb.2014.02.020; Sato K, 2009, ACTA PHYSIOL, V197, P217, DOI 10.1111/j.1748-1716.2009.02011.x; Sato K., 2013, J DIAB METAB, V4, P1; Sato K, 2008, AM J PHYSIOL-ENDOC M, V294, pE961, DOI 10.1152/ajpendo.00678.2007; Sato K, 2011, AM J PHYSIOL-ENDOC M, V301, pE274, DOI 10.1152/ajpendo.00564.2010; Sato Y, 2003, EXP BIOL MED, V228, P1208, DOI 10.1177/153537020322801017; SHEPHERD A, 1984, AM J PHYSIOL, V246, pE123, DOI 10.1152/ajpendo.1984.246.2.E123; Tworoger SS, 2008, AM J EPIDEMIOL, V167, P211, DOI 10.1093/aje/kwm278; Villareal DT, 2004, JAMA-J AM MED ASSOC, V292, P2243, DOI 10.1001/jama.292.18.2243; Weiss EP, 2011, AGING-US, V3, P533, DOI 10.18632/aging.100327; Zheng YC, 2011, ENDOCR-RELAT CANCER, V18, P451, DOI 10.1530/ERC-11-0010; Zierath JR, 2002, J APPL PHYSIOL, V93, P773, DOI 10.1152/japplphysiol.00126.2002	21	14	16	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					793	801		10.1096/fj.201600874R	http://dx.doi.org/10.1096/fj.201600874R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27871063				2022-12-28	WOS:000394235400031
J	Selagea, L; Mishra, A; Anand, M; Ross, J; Tucker-Burden, C; Kong, J; Brat, DJ				Selagea, Ligia; Mishra, Alok; Anand, Monika; Ross, James; Tucker-Burden, Carol; Kong, Jun; Brat, Daniel J.			EGFR and C/EBP-beta oncogenic signaling is bidirectional in human glioma and varies with the C/EBP-beta isoform	FASEB JOURNAL			English	Article						glioblastoma; cell signaling; LIP; LAP	EPIDERMAL-GROWTH-FACTOR; BINDING-PROTEIN-BETA; TRANSCRIPTIONAL INHIBITORY PROTEIN; NF-KAPPA-B; FACTOR RECEPTOR; GENE-EXPRESSION; MESSENGER-RNA; LIP; ACTIVATION; LAP	We investigated the intersection of epidermal growth factor receptor (EGFR) and CCAAT enhancer binding protein (C/EBP)-beta signaling in glioblastoma (GBM), given that both gene products strongly influence neoplastic behavior. C/EBP-beta is known to drive themesenchymal transcriptional signature in GBM, likely through strong microenvironmental influences, whereas the genetic contributions to its up-regulation in this disease are not well described. We demonstrated that stable overexpression and activation of WT EGFR (U87MG-WT) led to elevated C/EBP-beta expression, as well as enhanced nuclear translocation and DNA-beta inding activity, leading to upregulation of C/EBP-beta transcription and translation. Deeper investigation identified bidirectional regulation, with C/EBP-beta also causing up-regulation of EGFR that was at least partially dependent on the STAT3. Based on ChIP-based studies, we also found that that the translational isoforms of C/EBP-beta [liver-enriched transcription-activating protein (LAP)-1/2 and liver inhibitory protein (LIP)] have differential occupancy on STAT3 promoter and opposing roles in transcriptional regulation of STAT3 and EGFR. We further demonstrated that the shorter C/EBP-beta isoform, LIP, promoted proliferation and migration of U87MG glioma cells, potentially via induction of cytokine IL-6. Our molecular dissection of EGFR and C/EBP-beta pathway interactions uncovered a complex signaling network in which increased activity of either EGFRorC/EBP-beta leads to the up-regulation of the other, enhancing oncogenic signaling. Disrupting the EGFR-C/EBP-beta signaling axis could attenuate malignant behavior of glioblastoma.	[Selagea, Ligia; Mishra, Alok; Anand, Monika; Ross, James; Tucker-Burden, Carol; Brat, Daniel J.] Emory Univ, Dept Pathol & Lab Med, Atlanta, GA 30322 USA; [Kong, Jun; Brat, Daniel J.] Emory Univ, Dept Biomed Informat, Winship Canc Inst, Atlanta, GA 30322 USA; [Ross, James] Emory Univ, Grad Div Biol & Biomed Sci, Atlanta, GA 30322 USA; [Selagea, Ligia] Agnes Scott Coll, Dept Biol, Decatur, GA 30030 USA	Emory University; Emory University; Emory University	Brat, DJ (corresponding author), Emory Univ Hosp, Dept Pathol & Lab Med, H-195,1364 Clifton Rd NE, Atlanta, GA 30322 USA.	dbrat@emory.edu			U.S. Public Health Service through U.S. National Institutes of Health, National Cancer Institute (NCI) [R01CA176659, K25CA181503]; Winship Cancer Institute NCI Cancer Center Support Grant [P30CA138292]; NATIONAL CANCER INSTITUTE [P30CA138292, K25CA181503, R01CA176659] Funding Source: NIH RePORTER	U.S. Public Health Service through U.S. National Institutes of Health, National Cancer Institute (NCI); Winship Cancer Institute NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank the Tissue Procurement Service and the Research Pathology Laboratory of the Cancer Tissue and Pathology Shared Resource at the Winship Cancer Institute. The U.S. Public Health Service supported this work through U.S. National Institutes of Health, National Cancer Institute (NCI) Grants R01CA176659 (to D.J.B.), K25CA181503 (to J.K.), and the Winship Cancer Institute NCI Cancer Center Support Grant P30CA138292. The authors declare no conflicts of interest.	Arcidiacono MV, 2008, J AM SOC NEPHROL, V19, P310, DOI 10.1681/ASN.2007040406; Baldwin BR, 2004, MOL CELL BIOL, V24, P3682, DOI 10.1128/MCB.24.9.3682-3691.2004; Begay V, 2015, J MOL MED, V93, P39, DOI 10.1007/s00109-014-1215-5; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Calkhoven CF, 2000, GENE DEV, V14, P1920; Carro MS, 2010, NATURE, V463, P318, DOI 10.1038/nature08712; Cooper LAD, 2012, AM J PATHOL, V180, P2108, DOI 10.1016/j.ajpath.2012.01.040; Dearth LR, 2001, J CELL BIOCHEM, V82, P357, DOI 10.1002/jcb.1167; Derer S, 2012, NEOPLASIA, V14, P190, DOI 10.1593/neo.111636; DESCOMBES P, 1991, CELL, V67, P569, DOI 10.1016/0092-8674(91)90531-3; EKSTRAND AJ, 1991, CANCER RES, V51, P2164; EKSTRAND AJ, 1992, P NATL ACAD SCI USA, V89, P4309, DOI 10.1073/pnas.89.10.4309; Furnari FB, 2015, NAT REV CANCER, V15, P302, DOI 10.1038/nrc3918; Gomis RR, 2006, CANCER CELL, V10, P203, DOI 10.1016/j.ccr.2006.07.019; He DH, 2008, BIOCHEM J, V412, P153, DOI 10.1042/BJ20071649; Jundt F, 2005, BLOOD, V106, P1801, DOI 10.1182/blood-2004-11-4513; Kagan BL, 2003, CANCER RES, V63, P1696; Laag E, 2006, INT J CANCER, V119, P1547, DOI 10.1002/ijc.21987; LANDSCHULZ WH, 1988, GENE DEV, V2, P786, DOI 10.1101/gad.2.7.786; Li HL, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-100; Li Y, 2008, J BIOL CHEM, V283, P22443, DOI 10.1074/jbc.M801046200; Luedde T, 2004, HEPATOLOGY, V40, P356, DOI 10.1002/hep.20333; Oh HS, 1998, J INVEST DERMATOL, V110, P939, DOI 10.1046/j.1523-1747.1998.00199.x; Ondrey FG, 1999, MOL CARCINOGEN, V26, P119, DOI 10.1002/(SICI)1098-2744(199910)26:2<119::AID-MC6>3.0.CO;2-N; OSSIPOW V, 1993, P NATL ACAD SCI USA, V90, P8219, DOI 10.1073/pnas.90.17.8219; Oya M, 2003, CLIN CANCER RES, V9, P1021; Perry C, 2004, NEOPLASIA, V6, P279, DOI 10.1593/neo.03424; Quesnelle KM, 2007, J CELL BIOCHEM, V102, P311, DOI 10.1002/jcb.21475; Rask K, 2000, INT J CANCER, V86, P337, DOI 10.1002/(SICI)1097-0215(20000501)86:3<337::AID-IJC6>3.3.CO;2-V; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Sebastian T, 2006, CELL CYCLE, V5, P953, DOI 10.4161/cc.5.9.2733; Smink JJ, 2009, EMBO J, V28, P1769, DOI 10.1038/emboj.2009.127; Sundfeldt K, 1999, BRIT J CANCER, V79, P1240, DOI 10.1038/sj.bjc.6690199; Timchenko NA, 1999, NUCLEIC ACIDS RES, V27, P4517, DOI 10.1093/nar/27.22.4517; Tyagi A, 2003, ONCOGENE, V22, P1302, DOI 10.1038/sj.onc.1206265; Zahnow CA, 2002, BREAST CANCER RES, V4, P109, DOI 10.1186/bcr428; Zahnow CA, 1997, J NATL CANCER I, V89, P1887, DOI 10.1093/jnci/89.24.1887	37	6	7	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4098	4108		10.1096/fj.201600550R	http://dx.doi.org/10.1096/fj.201600550R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27572958	Green Published			2022-12-28	WOS:000388201500016
J	Gualdoni, GA; Mayer, KA; Goschl, L; Boucheron, N; Ellmeier, W; Zlabinger, GJ				Gualdoni, Guido A.; Mayer, Katharina A.; Goschl, Lisa; Boucheron, Nicole; Ellmeier, Wilfried; Zlabinger, Gerhard J.			The AMP analog AICAR modulates the T-reg/T(h)17 axis through enhancement of fatty acid oxidation	FASEB JOURNAL			English	Article						AMPK; immunometabolism; regulatory T cell; T cell; T-h cell differentiation	REGULATORY T; CELL-GROWTH; MTOR; EFFECTOR; PATHWAY; DIFFERENTIATION; AMPK-ALPHA-1; STIMULATION; METABOLISM; ACTIVATION	T cells must tightly regulate their metabolic processes to cope with varying bioenergetic demands depending on their state of differentiation. The metabolic sensor AMPK is activated in states of low energy supply and modulates cellular metabolism toward a catabolic state. Although this enzyme is known to be particularly active in regulatory T (T-reg) cells, its impact on T helper (T-h)-cell differentiation is poorly understood. We investigated the impact of several AMPK activators on T-reg-cell differentiation and found that the direct activator AICAR (5-aminoimidazole-4-carboxamide ribonucleotide), but not the indirect activators metformin and 2-deoxyglucose, strongly enhanced T-reg-cell induction by specifically enhancing T-reg-cell expansion. Conversely, T(h)17 generation was impaired by the agent. Further investigation of the metabolic background of our observations revealed that AICAR enhanced both cellular mitochondrogenesis and fatty acid uptake. Consistently, increased T-reg induction was entirely reversible on inhibition of fatty acid oxidation, thus confirming the dependence of AICAR's effects on metabolic pathways alterations. Translating our findings to an in vivo model, we found that the substance enhanced T-reg cell generation on IL-2 complex-induced immune stimulation. We provide a previously unrecognized insight into the delicate interplay between immune cell function and metabolism and delineate a potential novel strategy for metabolism-targeting immunotherapy.Gualdoni, G. A., Mayer, K. A., Goschl, L., Boucheron, N., Ellmeier, W., Zlabinger, G. J. The AMP analog AICAR modulates the T-reg/T(h)17 axis through enhancement of fatty acid oxidation.	[Gualdoni, Guido A.; Mayer, Katharina A.; Goschl, Lisa; Boucheron, Nicole; Ellmeier, Wilfried; Zlabinger, Gerhard J.] Med Univ Vienna, Inst Immunol, Ctr Pathophysiol Infectiol & Immunol, Vienna, Austria; [Goschl, Lisa] Med Univ Vienna, Dept Internal Med 3, Div Rheumatol, Vienna, Austria	Medical University of Vienna; Medical University of Vienna	Zlabinger, GJ (corresponding author), Med Univ Vienna, Inst Immunol, Lazarettgasse 19, A-1090 Vienna, Austria.	gerhard.zlabinger@meduniwien.ac.at		Mayer, Katharina/0000-0003-2495-790X; Zlabinger, Gerhard/0000-0002-7478-4173; Ellmeier, Wilfried/0000-0001-8192-8481; Boucheron, Nicole/0000-0002-4979-8311; Gualdoni, Guido/0000-0001-9490-0197				Bae HB, 2011, FASEB J, V25, P4358, DOI 10.1096/fj.11-190587; Bai AP, 2010, BIOCHEM PHARMACOL, V80, P1708, DOI 10.1016/j.bcp.2010.08.009; Bai AP, 2010, J PHARMACOL EXP THER, V333, P717, DOI 10.1124/jpet.109.164954; Battaglia M, 2005, BLOOD, V105, P4743, DOI 10.1182/blood-2004-10-3932; Beier UH, 2015, FASEB J, V29, P2315, DOI 10.1096/fj.14-268409; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Blagih J, 2015, IMMUNITY, V42, P41, DOI 10.1016/j.immuni.2014.12.030; Boucheron N, 2010, J IMMUNOL, V185, P5111, DOI 10.4049/jimmunol.1001734; Boyman O, 2006, SCIENCE, V311, P1924, DOI 10.1126/science.1122927; Carroll KC, 2013, J LEUKOCYTE BIOL, V94, P1113, DOI 10.1189/jlb.0313157; Chen WJ, 2003, J EXP MED, V198, P1875, DOI 10.1084/jem.20030152; Dang EV, 2011, CELL, V146, P772, DOI 10.1016/j.cell.2011.07.033; Delgoffe GM, 2011, NAT IMMUNOL, V12, P295, DOI 10.1038/ni.2005; Delgoffe GM, 2009, IMMUNITY, V30, P832, DOI 10.1016/j.immuni.2009.04.014; Dwarakanath BS, 2009, FUTURE ONCOL, V5, P581, DOI 10.2217/FON.09.44; Foretz M, 2014, CELL METAB, V20, P953, DOI 10.1016/j.cmet.2014.09.018; Foretz M, 2010, J CLIN INVEST, V120, P2355, DOI 10.1172/JCI40671; Gabrysova L, 2011, EUR J IMMUNOL, V41, P1242, DOI 10.1002/eji.201041073; Galic S, 2011, J CLIN INVEST, V121, P4903, DOI 10.1172/JCI58577; Klintmalm GB, 2014, J TRANSPLANT, V2014, DOI 10.1155/2014/845438; Lee SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135858; MacIver NJ, 2013, ANNU REV IMMUNOL, V31, P259, DOI 10.1146/annurev-immunol-032712-095956; Man K, 2013, NAT IMMUNOL, V14, P1155, DOI 10.1038/ni.2710; Michalek RD, 2011, J IMMUNOL, V186, P3299, DOI 10.4049/jimmunol.1003613; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Miskov-Zivanov N, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004217; Moes DJAR, 2015, DRUG DISCOV TODAY, V20, P1243, DOI 10.1016/j.drudis.2015.05.006; Newton R, 2016, NAT IMMUNOL, V17, P618, DOI 10.1038/ni.3466; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Park DW, 2013, MOL MED, V19, P387, DOI 10.2119/molmed.2013.00065; Pearce Erika L, 2013, Science, V342, P1242454, DOI 10.1126/science.1242454; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Poot M, 1996, J HISTOCHEM CYTOCHEM, V44, P1363, DOI 10.1177/44.12.8985128; Rolf J, 2013, EUR J IMMUNOL, V43, P889, DOI 10.1002/eji.201243008; Sauer S, 2008, P NATL ACAD SCI USA, V105, P7797, DOI 10.1073/pnas.0800928105; Serr I, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10991; Shi LZ, 2011, J EXP MED, V208, P1367, DOI 10.1084/jem.20110278; Suzuki J, 2012, INVEST OPHTH VIS SCI, V53, P4158, DOI 10.1167/iovs.11-9323; Vincent EE, 2015, ONCOGENE, V34, P3627, DOI 10.1038/onc.2014.301; Weichhart T, 2009, TRENDS IMMUNOL, V30, P218, DOI 10.1016/j.it.2009.02.002; Wilson MS, 2008, J IMMUNOL, V181, P6942, DOI 10.4049/jimmunol.181.10.6942; Yin YM, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa0835; Zeng H, 2013, NATURE, V499, P485, DOI 10.1038/nature12297; Zeng H, 2013, CURR OPIN IMMUNOL, V25, P347, DOI 10.1016/j.coi.2013.05.002	45	65	71	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3800	3809		10.1096/fj.201600522R	http://dx.doi.org/10.1096/fj.201600522R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27492924				2022-12-28	WOS:000386474700014
J	Sakellariou, GK; Pearson, T; Lightfoot, AP; Nye, GA; Wells, N; Giakoumaki, II; Griffiths, RD; McArdle, A; Jackson, MJ				Sakellariou, Giorgos K.; Pearson, Timothy; Lightfoot, Adam P.; Nye, Gareth A.; Wells, Nicola; Giakoumaki, Ifigeneia I.; Griffiths, Richard D.; McArdle, Anne; Jackson, Malcolm J.			Long-term administration of the mitochondria-targeted antioxidant mitoquinone mesylate fails to attenuate age-related oxidative damage or rescue the loss of muscle mass and function associated with aging of skeletal muscle	FASEB JOURNAL			English	Article						heat shock protein; NF-B; NOX4; SOD; superoxide	CU,ZN SUPEROXIDE-DISMUTASE; CONTRACTILE ACTIVITY; REACTIVE OXYGEN; COMPLEX-I; LIFE-SPAN; ADAPTIVE RESPONSES; INSULIN-RESISTANCE; RESPIRATORY-CHAIN; CELL-DEATH; MICE	Age-related skeletal muscle dysfunction is the underlying cause of morbidity that affects up to half the population aged 80 and over. Considerable evidence indicates that oxidative damage and mitochondrial dysfunction contribute to the sarcopenic phenotype that occurs with aging. To examine this, we administered the mitochondria-targeted antioxidant mitoquinone mesylate {[10-(4,5-dimethoxy-2-methyl-3,6-dioxo-1,4-cyclohexadien-1-yl)decyl] triphenylphosphonium; 100 M} to wild-type C57BL/6 mice for 15 wk (from 24 to 28 mo of age) and investigated the effects on age-related loss of muscle mass and function, changes in redox homeostasis, and mitochondrial organelle integrity and function. We found that mitoquinone mesylate treatment failed to prevent age-dependent loss of skeletal muscle mass associated with myofiber atrophy or alter a variety of in situ and ex vivo muscle function analyses, including maximum isometric tetanic force, decline in force after a tetanic fatiguing protocol, and single-fiber-specific force. We also found evidence that long-term mitoquinone mesylate administration did not reduce mitochondrial reactive oxygen species or induce significant changes in muscle redox homeostasis, as assessed by changes in 4-hydroxynonenal protein adducts, protein carbonyl content, protein nitration, and DNA damage determined by the content of 8-hydroxydeoxyguanosine. Mitochondrial membrane potential, abundance, and respiration assessed in permeabilized myofibers were not significantly altered in response to mitoquinone mesylate treatment. Collectively, these findings demonstrate that long-term mitochondria-targeted mitoquinone mesylate administration failed to attenuate age-related oxidative damage in skeletal muscle of old mice or provide any protective effect in the context of muscle aging.Sakellariou, G. K., Pearson, T., Lightfoot, A. P., Nye, G. A., Wells, N., Giakoumaki, I. I., Griffiths, R. D., McArdle, A., Jackson, M. J. Long-term administration of the mitochondria-targeted antioxidant mitoquinone mesylate fails to attenuate age-related oxidative damage or rescue the loss of muscle mass and function associated with aging of skeletal muscle.	[Sakellariou, Giorgos K.; Pearson, Timothy; Lightfoot, Adam P.; Nye, Gareth A.; Wells, Nicola; Giakoumaki, Ifigeneia I.; Griffiths, Richard D.; McArdle, Anne; Jackson, Malcolm J.] Univ Liverpool, Med Res Council, Arthrit Res UK Ctr Integrated Res Musculoskeletal, Dept Musculoskeletal Biol,Inst Ageing & Chron Dis, Liverpool, Merseyside, England; [Sakellariou, Giorgos K.] GeneFirst Ltd, Culham Sci Ctr, Abingdon, Oxon, England	UK Research & Innovation (UKRI); Medical Research Council UK (MRC); University of Liverpool; Culham Science Centre; UK Atomic Energy Authority	Jackson, MJ (corresponding author), Univ Liverpool, Inst Ageing & Chron Dis, Liverpool L69 3GA, Merseyside, England.	mjj@liverpool.ac.uk	Lightfoot, Adam/H-1292-2016; nye, gareth/M-1293-2019	Lightfoot, Adam/0000-0003-1501-7879; nye, gareth/0000-0003-4508-0406; Jackson, Malcolm/0000-0003-3683-8297; Pearson, Tim/0000-0002-3653-4421	UK Medical Research Council (Moscow, Russia) [G1002120]; U.S. National Institutes of Health, National Institute on Aging [AG-20591]; MRC [MR/K006312/1, G1002120] Funding Source: UKRI; Medical Research Council [MR/K006312/1, G1002120] Funding Source: researchfish; NATIONAL INSTITUTE ON AGING [P01AG020591] Funding Source: NIH RePORTER	UK Medical Research Council (Moscow, Russia); U.S. National Institutes of Health, National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank C. S. Davis and S. V. Brooks (University of Michigan, Ann Arbor, MI, USA), M. E. Walsh (University of Texas Health Science Center, Houston, TX, USA), H. Van Remmen (Oklahoma Medical Research Foundation, Oklahoma City, OK, USA), R. T. Hepple (McGill University Health Centre, Montreal, QC, Canada), M. Picard (Center for Mitochondrial and Epigenomic Medicine, Philadelphia, PA, USA), M. Brand (Buck Institute for Research on Aging, Novato, CA, USA), V. P. Skulachev (Moscow State University), S. I. Dikalov (Vanderbilt University Medical Center), and W. I. Sivitz (University of Iowa Carver College of Medicine). This work was supported by the UK Medical Research Council (Moscow, Russia; Grant G1002120) and the U.S. National Institutes of Health, National Institute on Aging (Grant AG-20591).	Anderson EJ, 2009, J CLIN INVEST, V119, P573, DOI 10.1172/JCI37048; Asin-Cayuela J, 2004, FEBS LETT, V571, P9, DOI 10.1016/j.febslet.2004.06.045; Broome CS, 2006, FASEB J, V20, P1549, DOI 10.1096/fj.05-4935fje; Chabi B, 2008, AGING CELL, V7, P2, DOI 10.1111/j.1474-9726.2007.00347.x; Changou CA, 2014, P NATL ACAD SCI USA, V111, P14147, DOI 10.1073/pnas.1404171111; Chen HC, 2010, CELL, V141, P280, DOI 10.1016/j.cell.2010.02.026; Chouchani ET, 2013, NAT MED, V19, P753, DOI 10.1038/nm.3212; Degens H, 2010, PFLUG ARCH EUR J PHY, V460, P863, DOI 10.1007/s00424-010-0866-5; Dikalov S, 2002, J BIOL CHEM, V277, P25480, DOI 10.1074/jbc.M203271200; Dimauro Ivan, 2012, BMC Res Notes, V5, P513, DOI 10.1186/1756-0500-5-513; Doughan AK, 2007, ANTIOXID REDOX SIGN, V9, P1825, DOI 10.1089/ars.2007.1693; Fink BD, 2012, J PHARMACOL EXP THER, V342, P709, DOI 10.1124/jpet.112.195586; Goncalves RLS, 2015, J BIOL CHEM, V290, P209, DOI 10.1074/jbc.M114.619072; Gouspillou G, 2014, FASEB J, V28, P1621, DOI 10.1096/fj.13-242750; Gouspillou G, 2014, AGING CELL, V13, P39, DOI 10.1111/acel.12147; Houot V, 2001, J EXP BOT, V52, P1721, DOI 10.1093/jexbot/52.361.1721; Jackson MJ, 2013, ANTIOXID REDOX SIGN, V19, P804, DOI 10.1089/ars.2013.5383; James AM, 2004, ARCH BIOCHEM BIOPHYS, V423, P47, DOI 10.1016/j.abb.2003.12.025; Jang YC, 2010, FASEB J, V24, P1376, DOI 10.1096/fj.09-146308; Janssen AJM, 2007, CLIN CHEM, V53, P729, DOI 10.1373/clinchem.2006.078873; King MS, 2009, BIOCHEMISTRY-US, V48, P2053, DOI 10.1021/bi802282h; Kirkendall DT, 1998, AM J SPORT MED, V26, P598, DOI 10.1177/03635465980260042401; Klungland A, 1999, P NATL ACAD SCI USA, V96, P13300, DOI 10.1073/pnas.96.23.13300; Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61; Lee HY, 2010, CELL METAB, V12, P668, DOI 10.1016/j.cmet.2010.11.004; Lee IH, 2008, P NATL ACAD SCI USA, V105, P3374, DOI 10.1073/pnas.0712145105; Lustgarten MS, 2009, AM J PHYSIOL-CELL PH, V297, pC1520, DOI 10.1152/ajpcell.00372.2009; McDonagh B, 2014, J PROTEOME RES, V13, P5008, DOI 10.1021/pr5006394; McDonagh B, 2014, BIOCHEM SOC T, V42, P965, DOI 10.1042/BST20140085; McManus MJ, 2011, J NEUROSCI, V31, P15703, DOI 10.1523/JNEUROSCI.0552-11.2011; Mecocci P, 1999, FREE RADICAL BIO MED, V26, P303, DOI 10.1016/S0891-5849(98)00208-1; Melov S, 2000, SCIENCE, V289, P1567, DOI 10.1126/science.289.5484.1567; Miro O, 2000, CARDIOVASC RES, V47, P624, DOI 10.1016/S0008-6363(00)00122-X; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Mukherjee TK, 2007, J IMMUNOL, V178, P1835, DOI 10.4049/jimmunol.178.3.1835; Muller FL, 2006, FREE RADICAL BIO MED, V40, P1993, DOI 10.1016/j.freeradbiomed.2006.01.036; O'Malley Y, 2006, J BIOL CHEM, V281, P39766, DOI 10.1074/jbc.M608268200; Patkova J, 2014, CELL PHYSIOL BIOCHEM, V33, P1439, DOI 10.1159/000358709; Perez VI, 2009, AGING CELL, V8, P73, DOI 10.1111/j.1474-9726.2008.00449.x; Picard Martin, 2010, Aging Cell, V9, P1032, DOI 10.1111/j.1474-9726.2010.00628.x; Plecita-Hlavata L, 2009, INT J BIOCHEM CELL B, V41, P1697, DOI 10.1016/j.biocel.2009.02.015; Pollack M, 2001, J GERONTOL A-BIOL, V56, pB475, DOI 10.1093/gerona/56.11.B475; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Rodriguez-Cuenca S, 2010, FREE RADICAL BIO MED, V48, P161, DOI 10.1016/j.freeradbiomed.2009.10.039; Sakellariou GK, 2014, FREE RADICAL RES, V48, P12, DOI 10.3109/10715762.2013.830718; Sakellariou GK, 2014, FASEB J, V28, P1666, DOI 10.1096/fj.13-240390; Sakellariou GK, 2011, AGING CELL, V10, P749, DOI 10.1111/j.1474-9726.2011.00709.x; Sakellariou GK, 2013, ANTIOXID REDOX SIGN, V18, P603, DOI 10.1089/ars.2012.4623; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Sataranatarajan K, 2015, REDOX BIOL, V5, P140, DOI 10.1016/j.redox.2015.04.005; Schriner SE, 2005, SCIENCE, V308, P1909, DOI 10.1126/science.1106653; Severin FF, 2010, P NATL ACAD SCI USA, V107, P663, DOI 10.1073/pnas.0910216107; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Umanskaya A, 2014, P NATL ACAD SCI USA, V111, P15250, DOI 10.1073/pnas.1412754111; Vasilaki A, 2006, MECH AGEING DEV, V127, P830, DOI 10.1016/j.mad.2006.08.004; Vasilaki A, 2006, AGING CELL, V5, P109, DOI 10.1111/j.1474-9726.2006.00198.x; Vasilaki A, 2004, FASEB J, V18, pA344; Vasilaki A, 2010, AGING CELL, V9, P979, DOI 10.1111/j.1474-9726.2010.00635.x; Wanagat J, 2015, EXP GERONTOL, V61, P15, DOI 10.1016/j.exger.2014.11.012; Wang AL, 2010, NEUROBIOL AGING, V31, P2002, DOI 10.1016/j.neurobiolaging.2008.10.019; Zhang YQ, 2013, FASEB J, V27, P3536, DOI 10.1096/fj.13-228130; Zielonka J, 2010, FREE RADICAL BIO MED, V48, P983, DOI 10.1016/j.freeradbiomed.2010.01.028	62	30	30	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3771	3785		10.1096/fj.201600450R	http://dx.doi.org/10.1096/fj.201600450R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27550965	Green Accepted, Green Published, hybrid			2022-12-28	WOS:000386474700012
J	Wang, HY; Guo, J; Lin, ZL; Namgoong, S; Oh, JS; Kim, NH				Wang, HaiYang; Guo, Jing; Lin, ZiLi; Namgoong, Suk; Oh, Jeong Su; Kim, Nam-Hyung			Filamin A is required for spindle migration and asymmetric division in mouse oocytes	FASEB JOURNAL			English	Article						FLNA; actin; cofilin; ROCK	ACTIN-BINDING PROTEIN; MEIOTIC SPINDLE; LIM-KINASE; COFILIN PHOSPHORYLATION; CYTOKINESIS; MATURATION; MEIOSIS; ROCK; FILAMENTS; RHO	Dynamic changes in the actin network are crucial for the cortical migration of spindles and establishment of polarity, to ensure asymmetric division during meiotic maturation. In this study, filamin A (FLNA) was found to be an essential actin regulator that controlled spindle migration and asymmetric division during oocyte meiosis. FLNA was localized in the cytoplasm and enriched at the cortex and near the chromosomes. Knockdown of FLNA impaired meiotic asymmetric division and spindle migration with a decrease in the amount of cytoplasmic actin mesh and cortical actin levels. Moreover, FLNA knockdown reduced the phosphorylation of cofilin and Rho kinase (ROCK) near the spindle. Similar phenotypes, such as decreased filament actin levels, impaired spindle migration and polar body extrusion, were observed when active cofilin (S3A) was overexpressed or ROCK was inhibited. Notably, we found that FLNA and ROCK interacted directly in mouse oocytes. Taken together, our results show that FLNA plays crucial roles in asymmetric division during meiotic maturation by regulating ROCK-cofilin-mediated actin reorganization.	[Wang, HaiYang; Guo, Jing; Namgoong, Suk; Kim, Nam-Hyung] Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea; [Lin, ZiLi] Tsinghua Univ, Sch Life Sci, Beijing, Peoples R China; [Oh, Jeong Su] Sungkyunkwan Univ, Dept Genet Engn, Coll Biotechnol & Bioengn, Suwon, Gyeonggi Do, South Korea	Chungbuk National University; Tsinghua University; Sungkyunkwan University (SKKU)	Kim, NH (corresponding author), Chungbuk Natl Univ, Dept Anim Sci, Cheongju, South Korea.; Oh, JS (corresponding author), Sungkyunkwan Univ, Dept Genet Engn, Coll Biotechnol & Bioengn, Suwon, Gyeonggi Do, South Korea.	ohjs@skku.edu; nhkim@chungbuk.ac.kr		WANG, HAIYANG/0000-0002-6362-6022	Next-Generation BioGreen 21 Program (Republic of Korea Rural Development Administration) [PJ011126]	Next-Generation BioGreen 21 Program (Republic of Korea Rural Development Administration)	This study was supported by Next-Generation BioGreen 21 Program PJ011126 (Republic of Korea Rural Development Administration). The authors declare no conflicts of interest.	Almonacid M, 2014, J CELL SCI, V127, P477, DOI 10.1242/jcs.142711; Azoury J, 2008, CURR BIOL, V18, P1514, DOI 10.1016/j.cub.2008.08.044; Azoury J, 2009, BIOL CELL, V101, P69, DOI 10.1042/BC20080003; Bernstein BW, 2010, TRENDS CELL BIOL, V20, P187, DOI 10.1016/j.tcb.2010.01.001; Brunet S, 2011, HUM REPROD UPDATE, V17, P68, DOI 10.1093/humupd/dmq044; Chaigne A, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7027; Chaigne A, 2013, NAT CELL BIOL, V15, P958, DOI 10.1038/ncb2799; Clift D, 2013, NAT REV MOL CELL BIO, V14, P549, DOI 10.1038/nrm3643; Conti M, 2012, MOL CELL ENDOCRINOL, V356, P65, DOI 10.1016/j.mce.2011.11.002; CUNNINGHAM CC, 1992, SCIENCE, V255, P325, DOI 10.1126/science.1549777; Dehapiot B, 2013, DEV BIOL, V377, P202, DOI 10.1016/j.ydbio.2013.01.029; Deng MQ, 2007, DEV CELL, V12, P301, DOI 10.1016/j.devcel.2006.11.008; Duan X, 2016, CELL CYCLE, V15, P471, DOI 10.1080/15384101.2015.1128590; Duan X, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.113522; Dumont J, 2007, DEV BIOL, V301, P254, DOI 10.1016/j.ydbio.2006.08.044; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Halet G, 2007, DEV CELL, V12, P309, DOI 10.1016/j.devcel.2006.12.010; HARTWIG JH, 1986, J CELL BIOL, V103, P1007, DOI 10.1083/jcb.103.3.1007; HARTWIG JH, 1989, J CELL BIOL, V108, P467, DOI 10.1083/jcb.108.2.467; Jang WI, 2014, CELL CYCLE, V13, P2359, DOI 10.4161/cc.29333; Jay D, 2000, ARCH BIOCHEM BIOPHYS, V377, P80, DOI 10.1006/abbi.2000.1762; Jo YJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep29204; Jo YJ, 2015, J CELL SCI, V128, P160, DOI 10.1242/jcs.163576; Kaji N, 2008, J BIOL CHEM, V283, P4983, DOI 10.1074/jbc.M708644200; Leader B, 2002, NAT CELL BIOL, V4, P921, DOI 10.1038/ncb880; Lee SR, 2015, MOL REPROD DEV, V82, P849, DOI 10.1002/mrd.22524; Liu M, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-149; Maekawa M, 1999, SCIENCE, V285, P895, DOI 10.1126/science.285.5429.895; Namgoong S, 2016, CELL CYCLE, V15, P1830, DOI 10.1080/15384101.2016.1181239; Ohashi K, 2000, J BIOL CHEM, V275, P3577, DOI 10.1074/jbc.275.5.3577; Ono S, 2002, J CELL BIOL, V156, P1065, DOI 10.1083/jcb.200110013; Pfender S, 2011, CURR BIOL, V21, P955, DOI 10.1016/j.cub.2011.04.029; Savoy RM, 2013, ENDOCR-RELAT CANCER, V20, pR341, DOI 10.1530/ERC-13-0364; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; Sun SC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018392; Thomas JAI, 2008, CELL MOTIL CYTOSKEL, V65, P979, DOI 10.1002/cm.20320; Tigges U, 2003, J BIOL CHEM, V278, P23561, DOI 10.1074/jbc.M302302200; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; WALLACH D, 1978, J BIOL CHEM, V253, P4739; Wang F, 2015, CELL CYCLE, V14, P2835, DOI 10.1080/15384101.2015.1031438; Wang ZB, 2013, MOL BIOL CELL, V24, P3832, DOI 10.1091/mbc.E13-03-0123; Xu YJ, 2010, J EXP MED, V207, P2421, DOI 10.1084/jem.20100433; YASUTAKA O, 1995, BIOCHEMISTRY-US, V34, P6745, DOI 10.1021/bi00020a020; Yi K, 2011, NAT CELL BIOL, V13, P1252, DOI 10.1038/ncb2320; Zhang Y, 2014, THERIOGENOLOGY, V82, P49, DOI 10.1016/j.theriogenology.2014.02.020; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	47	9	9	3	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3677	3688		10.1096/fj.201700056R	http://dx.doi.org/10.1096/fj.201700056R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28487281				2022-12-28	WOS:000405932400038
J	Schuett, J; Schuett, H; Oberoi, R; Koch, AK; Pretzer, S; Luchtefeld, M; Schieffer, B; Grote, K				Schuett, Jutta; Schuett, Harald; Oberoi, Raghav; Koch, Ann-Kathrin; Pretzer, Silke; Luchtefeld, Maren; Schieffer, Bernhard; Grote, Karsten			NADPH oxidase NOX2 mediates TLR2/6-dependent release of GM-CSF from endothelial cells	FASEB JOURNAL			English	Article						pattern recognition receptors; reactive oxygen species; immune factors; innate immunity; endothelial cell biology	NF-KAPPA-B; OXYGEN SPECIES PRODUCTION; RECEPTOR FAMILY; ACTIVATION; EXPRESSION; SUPEROXIDE; DISEASE; TLR2; ANGIOGENESIS; LIPOPEPTIDE	NADPH oxidase-generated reactive oxygen species (ROS) from immune cells are well known to be important for pathogen killing in response to TLR ligands. Here, we investigated a new aspect of NADPH oxidase in the TLR2/6-induced release of the immunologically relevant GM-CSF by endothelial cells. Stimulation of human endothelial cells with TLR2/6 agonist, MALP-2 (macrophage-activating lipopeptide of 2 kDa), induced NADPH oxidase activation and ROS formation. Inhibition by ROS scavengers and NADPH oxidase inhibitors blocked MALP-2-induced GM-CSF release. NADPH oxidase activators or ROS donors alone did not result in GM-CSF secretion; however, additional superoxide supply augmented MALP-2-induced GM-CSF secretion and restored GM-CSF levels after NADPH oxidase inhibition. MALP-2-dependent NF-kappa B activation was suppressed by NADPH oxidase inhibition, and inhibition of NF-kB completely blunted MALP-2-induced GM-CSF release. Vascular explants from mice that were deficient for the NADPH oxidase subunit p47(phox) showed diminished intimal superoxide production and GM-CSF release after ex vivo stimulation with MALP-2. Moreover, an increase in circulating progenitor cells after MALP-2 injection was completely abolished in p47(phox)-knockout mice. Finally, MALP-2 stimulation increased mRNA expression of the major subunit NADPH oxidase, (Nox)2, in endothelial cells, and Nox2 inhibition prevented MALP-2-induced GM-CSF release. Our findings identify a Nox2-containing NADPH oxidase as a crucial regulator of the immunologic important growth factor GM-CSF after TLR2/6 stimulation in endothelial cells.	[Schuett, Jutta; Schuett, Harald; Oberoi, Raghav; Koch, Ann-Kathrin; Luchtefeld, Maren; Schieffer, Bernhard; Grote, Karsten] Philipps Univ, Dept Cardiol & Angiol, Hans Meerwein Str 2, D-35043 Marburg, Germany; [Pretzer, Silke] Hannover Med Sch, Dept Cardiol & Angiol, Hannover, Germany	Philipps University Marburg; Hannover Medical School	Grote, K (corresponding author), Philipps Univ, Dept Cardiol & Angiol, Hans Meerwein Str 2, D-35043 Marburg, Germany.	karsten.grote@staff.uni-marburg.de		Vlacil, Ann-Kathrin/0000-0001-9743-0290; Grote, Karsten/0000-0001-7914-3159	German Research Foundation (DFG); Clinical Research Group [KFO 136, GR 2717/3-1]	German Research Foundation (DFG)(German Research Foundation (DFG)); Clinical Research Group	The authors thank Prof. Schinzel (Vasopharm GmbH, Wurzburg, Germany) for providing VAS2870. The authors also thank Danial Beppler (Philipps-University) and Mirja Sirisko (Hannover Medical School) for excellent technical assistance. This work was supported by a grant from the German Research Foundation (DFG), Clinical Research Group (KFO 136), GR 2717/3-1 (to K.G. and B.S.).	BABIOR BM, 1976, J CLIN INVEST, V58, P989, DOI 10.1172/JCI108553; BABIOR BM, 1973, J CLIN INVEST, V52, P741, DOI 10.1172/JCI107236; Baldridge CW, 1933, AM J PHYSIOL, V103, P235, DOI 10.1152/ajplegacy.1932.103.1.235; Bosco EE, 2012, CHEM BIOL, V19, P228, DOI 10.1016/j.chembiol.2011.12.017; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Dinauer MC, 1997, J IMMUNOL, V158, P5581; Dupre-Crochet S, 2013, J LEUKOCYTE BIOL, V94, P657, DOI 10.1189/jlb.1012544; Fan J, 2003, J CLIN INVEST, V112, P1234, DOI 10.1172/JCI200318696; Grote K, 2013, EUR CELLS MATER, V26, P66, DOI 10.22203/eCM.v026a05; Grote K, 2013, ARTERIOSCL THROM VAS, V33, P2097, DOI 10.1161/ATVBAHA.113.301799; Grote K, 2010, BLOOD, V115, P2543, DOI 10.1182/blood-2009-05-224402; Hercus TR, 2012, GROWTH FACTORS, V30, P63, DOI 10.3109/08977194.2011.649919; JACKSON SH, 1995, J EXP MED, V182, P751, DOI 10.1084/jem.182.3.751; Jin MS, 2008, IMMUNITY, V29, P182, DOI 10.1016/j.immuni.2008.07.007; Jones SA, 1996, AM J PHYSIOL-HEART C, V271, pH1626, DOI 10.1152/ajpheart.1996.271.4.H1626; Kim JH, 2008, FREE RADICAL BIO MED, V45, P885, DOI 10.1016/j.freeradbiomed.2008.06.019; Lassegue B, 2012, CIRC RES, V110, P1364, DOI 10.1161/CIRCRESAHA.111.243972; Lelli A, 2013, GLIA, V61, P1542, DOI 10.1002/glia.22540; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Muhlradt PF, 1997, J EXP MED, V185, P1951, DOI 10.1084/jem.185.11.1951; Park HS, 2004, J IMMUNOL, V173, P3589, DOI 10.4049/jimmunol.173.6.3589; Park HS, 2006, CARDIOVASC RES, V72, P447, DOI 10.1016/j.cardiores.2006.09.012; QUESENBERRY PJ, 1980, BLOOD, V56, P1060, DOI 10.1182/blood.V56.6.1060.1060; SASADA M, 1983, J BIOL CHEM, V258, P9631; Seki E, 2005, HEPATOLOGY, V41, P443, DOI 10.1002/hep.20603; Shimizu T, 2002, EUR J HAEMATOL, V68, P382, DOI 10.1034/j.1600-0609.2002.01627.x; Simon F, 2009, J HYPERTENS, V27, P1202, DOI 10.1097/HJH.0b013e328329e31c; Spiekermann S, 2003, CIRCULATION, V107, P1383, DOI 10.1161/01.CIR.0000056762.69302.46; Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Takeuchi O, 2001, INT IMMUNOL, V13, P933, DOI 10.1093/intimm/13.7.933; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; van Nieuwenhuijze A, 2013, MOL IMMUNOL, V56, P675, DOI 10.1016/j.molimm.2013.05.002; West XZ, 2010, NATURE, V467, P972, DOI 10.1038/nature09421; Yang CS, 2009, J IMMUNOL, V182, P3696, DOI 10.4049/jimmunol.0802217; Yu L, 2010, J CELL MOL MED, V14, P2592, DOI 10.1111/j.1582-4934.2010.01127.x; Zhang XC, 2006, J CLIN INVEST, V116, P3050, DOI 10.1172/JCI28139	37	15	17	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2612	2624		10.1096/fj.201600729R	http://dx.doi.org/10.1096/fj.201600729R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28274989				2022-12-28	WOS:000401553400032
J	Li, S; O'Neill, SRS; Zhang, Y; Holtzman, MJ; Takemaru, KI; Korach, KS; Winuthayanon, W				Li, Shuai; O'Neill, Sofia R. S.; Zhang, Yong; Holtzman, Michael J.; Takemaru, Ken-Ichi; Korach, Kenneth S.; Winuthayanon, Wipawee			Estrogen receptor alpha is required for oviductal transport of embryos	FASEB JOURNAL			English	Article						cilia; epithelial cells; fertility	SCANNING-ELECTRON-MICROSCOPY; CILIATED EPITHELIAL-CELLS; FALLOPIAN-TUBE EPITHELIUM; BETA-CATENIN; CLOMIPHENE CITRATE; EGG TRANSPORT; KARTAGENERS-SYNDROME; MOUSE EMBRYOS; RABBIT OVIDUCT; PROGESTERONE	Newly fertilized embryos spend the first few days within the oviduct and are transported to the uterus, where they implant onto the uterine wall. An implantation of the embryo before reaching the uterus could result in ectopic pregnancy and lead to maternal death. Estrogen is necessary for embryo transport in mammals; however, the mechanism involved in estrogen-mediated cellular function within the oviduct remains unclear. In this study, we show in mouse models that ciliary length and beat frequency of the oviductal epithelial cells are regulated through estrogen receptor alpha (ESR1) but not estrogen receptor beta (ESR2). Gene profiling indicated that transcripts in the WNT/beta-catenin (WNT/CTNNB1) signaling pathway were regulated by estrogen in mouse oviduct, and inhibition of this pathway in a whole oviduct culture system resulted in a decreased embryo transport distance. However, selective ablation of CTNNB1 from the oviductal ciliated cells did not affect embryo transport, possibly because of a compensatory mechanism via intact CTNNB1 in the adjacent secretory cells. In summary, we demonstrated that disruption of estrogen signaling in oviductal epithelial cells alters ciliary function and impairs embryo transport. Therefore, our findings may provide a better understanding of etiology of the ectopic pregnancy that is associated with alteration of estrogen signals.-Li, S., O'Neill, S. R. S., Zhang, Y., Holtzman, M. J., Takemaru, K.-I., Korach, K. S., Winuthayanon, W. Estrogen receptor alpha is required for oviductal transport of embryos.	[Li, Shuai; O'Neill, Sofia R. S.; Winuthayanon, Wipawee] Washington State Univ, Coll Vet Med, Sch Mol Biosci, Pullman, WA 99164 USA; [Zhang, Yong; Holtzman, Michael J.] Washington Univ, Sch Med, Dept Med, Pulm & Crit Care Med, St Louis, MO 63110 USA; [Takemaru, Ken-Ichi] SUNY Stony Brook, Sch Med, Dept Pharmacol Sci, Stony Brook, NY 11794 USA; [Korach, Kenneth S.] NIEHS, Reprod & Dev Biol Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	Washington State University; Washington University (WUSTL); State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Winuthayanon, W (corresponding author), Washington State Univ, Sch Mol Biosci Life Sci BLS202, Pullman, WA 99164 USA.	winuthayanonw@vetmed.wsu.edu	Winuthayanon, Wipawee/U-2153-2019	Winuthayanon, Wipawee/0000-0002-5196-8471; Korach, Kenneth/0000-0002-7765-418X; Li, Shuai/0000-0001-5889-3655	College of Veterinary Medicine (Washington State University); NIEHS [1ZIAES70065]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI130591, U19AI070489] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZICES102445, ZIAES070065] Funding Source: NIH RePORTER	College of Veterinary Medicine (Washington State University); NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Sylvia Hewitt and Karina Rodriguez [U.S. National Institutes of Health, National Institute of Environmental Health Sciences (NIEHS)] for critical reading of this manuscript, Carmen Williams (NIEHS) for constructive advice for the project, Page Myers (NIEHS) for the oviduct transfer procedure, Jeff Tucker (NIEHS) for technical assistance, NIEHS Histology Core for ESR2 IHC staining, and Research Histology Core Facility (Department of Pathology, Stony Brook University School of Medicine) for the human fallopian tube samples. This work is supported by the start-up fund from College of Veterinary Medicine (Washington State University; to W.W.) and Intramural research Grant 1ZIAES70065 from NIEHS (to K.S.K.). The authors declare no conflicts of interest.	Afzelius BA, 2004, J PATHOL, V204, P470, DOI 10.1002/path.1652; AFZELIUS BA, 1978, FERTIL STERIL, V29, P72; Allen E, 1922, AM J ANAT, V30, P297, DOI 10.1002/aja.1000300303; Bae SM, 2014, MOL CELL ENDOCRINOL, V382, P46, DOI 10.1016/j.mce.2013.09.010; Behrens J, 1996, NATURE, V382, P638, DOI 10.1038/382638a0; BLANDAU RJ, 1974, FERTIL STERIL, V25, P61; Brechbuhl HM, 2011, AM J PATHOL, V179, P367, DOI 10.1016/j.ajpath.2011.03.016; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; CROW J, 1994, HUM REPROD, V9, P2224, DOI 10.1093/oxfordjournals.humrep.a138428; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Deroo BJ, 2009, MOL ENDOCRINOL, V23, P955, DOI 10.1210/me.2008-0213; Deutseher E, 2007, DEV BIOL, V307, P227, DOI 10.1016/j.ydbio.2007.04.036; DIRKSEN ER, 1972, TISSUE CELL, V4, P389, DOI 10.1016/S0040-8166(72)80017-X; ELIASSON R, 1977, NEW ENGL J MED, V297, P1, DOI 10.1056/NEJM197707072970101; GADDUMROSSE P, 1976, BIOL REPROD, V14, P605, DOI 10.1095/biolreprod14.5.605; Gifford JAH, 2009, BIOL REPROD, V80, P1282, DOI 10.1095/biolreprod.108.072280; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; GREENWALD GS, 1967, ANAT RECORD, V157, P163, DOI 10.1002/ar.1091570207; Guirao B, 2010, NAT CELL BIOL, V12, P341, DOI 10.1038/ncb2040; Gupta Nibedita, 2011, Cancers (Basel), V3, P2990, DOI 10.3390/cancers3032990; HAEGEL H, 1995, DEVELOPMENT, V121, P3529; Hagiwara H, 2008, MED MOL MORPHOL, V41, P193, DOI 10.1007/s00795-008-0421-z; HALBERT SA, 1976, GYNECOL OBSTET INVES, V7, P306, DOI 10.1159/000301391; HALBERT SA, 1976, SCIENCE, V191, P1052, DOI 10.1126/science.1251215; Halbert SA, 1997, HUM REPROD, V12, P55, DOI 10.1093/humrep/12.1.55; HALBERT SA, 1989, BIOL REPROD, V40, P1131, DOI 10.1095/biolreprod40.6.1131; HARRISON K, 1993, HUM REPROD, V8, P981, DOI 10.1093/oxfordjournals.humrep.a138178; Hess RA, 2000, J ANDROL, V21, P107; Hou XN, 2004, MOL ENDOCRINOL, V18, P3035, DOI 10.1210/me.2004-0259; HUMPHREY KW, 1968, J ENDOCRINOL, V40, P267, DOI 10.1677/joe.0.0400267; KERIN JF, 1985, J CLIN ENDOCR METAB, V61, P265, DOI 10.1210/jcem-61-2-265; Khong S Y, 2005, J Obstet Gynaecol, V25, P611, DOI 10.1080/01443610500242630; Krege JH, 1998, P NATL ACAD SCI USA, V95, P15677, DOI 10.1073/pnas.95.26.15677; LEESE HJ, 1988, J REPROD FERTIL, V82, P843, DOI 10.1530/jrf.0.0820843; Li P, 2013, HUM REPROD, V28, P2363, DOI 10.1093/humrep/det246; LIPPES J, 1981, FERTIL STERIL, V36, P623; Love D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013600; LURIE M, 1989, CHEST, V95, P578, DOI 10.1378/chest.95.3.578; Lyons RA, 2006, HUM REPROD UPDATE, V12, P363, DOI 10.1093/humupd/dml012; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Mathew M, 2004, SAUDI MED J, V25, P2058; MCCOMB P, 1986, FERTIL STERIL, V46, P412; Nishimura A, 2010, EXP PHYSIOL, V95, P819, DOI 10.1113/expphysiol.2010.052555; Niwa S, 2012, DEV CELL, V23, P1167, DOI 10.1016/j.devcel.2012.10.016; Ohm L. A., 2009, FERTIL STERIL, V92, pS116; Okada A, 2004, J MOL ENDOCRINOL, V32, P615, DOI 10.1677/jme.0.0320615; Okada A, 2003, J MOL ENDOCRINOL, V30, P301, DOI 10.1677/jme.0.0300301; Orihuela PA, 2003, BIOL REPROD, V68, P1225, DOI 10.1095/biolreprod.102.011395; Orihuela PA, 2001, BIOL REPROD, V65, P1238, DOI 10.1095/biolreprod65.4.1238; Plouffe L, 2000, J SOC GYNECOL INVEST, V7, pS38; Rider V, 2006, J ENDOCRINOL, V191, P537, DOI 10.1677/joe.1.07030; Rizos D, 2010, THERIOGENOLOGY, V73, P777, DOI 10.1016/j.theriogenology.2009.10.001; ROBLERO LS, 1979, J REPROD FERTIL, V57, P91, DOI 10.1530/jrf.0.0570091; ROBLERO LS, 1987, CONTRACEPTION, V36, P549, DOI 10.1016/0010-7824(87)90007-2; RUMERY RE, 1974, ANAT RECORD, V178, P83, DOI 10.1002/ar.1091780108; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shao RJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE147, DOI 10.1152/ajpendo.00101.2007; Shao RJ, 2009, BIOL REPROD, V80, P1262, DOI 10.1095/biolreprod.108.074237; Talbot P, 1999, MOL BIOL CELL, V10, P5, DOI 10.1091/mbc.10.1.5; Teilmann SC, 2006, J ENDOCRINOL, V191, P525, DOI 10.1677/joe.1.06565; Tichelaar JW, 1999, J HISTOCHEM CYTOCHEM, V47, P823, DOI 10.1177/002215549904700612; Voronina VA, 2009, J CELL BIOL, V185, P225, DOI 10.1083/jcb.200809144; Wallingford JB, 2011, GENE DEV, V25, P201, DOI 10.1101/gad.2008011; Westwood FR, 2008, TOXICOL PATHOL, V36, P375, DOI 10.1177/0192623308315665; Winuthayanon W, 2015, ELIFE, V4; Winuthayanon W, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.120170; Winuthayanon W, 2010, P NATL ACAD SCI USA, V107, P19272, DOI 10.1073/pnas.1013226107; Yang XZ, 2008, B MATH BIOL, V70, P1192, DOI 10.1007/s11538-008-9296-3; YANG YQ, 1990, CONTRACEPTION, V41, P551, DOI 10.1016/0010-7824(90)90063-2; Zhang Y, 2007, AM J RESP CELL MOL, V36, P515, DOI 10.1165/rcmb.2006-0475RC	70	34	35	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1595	1607		10.1096/fj.201601128R	http://dx.doi.org/10.1096/fj.201601128R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28082352	Green Published			2022-12-28	WOS:000398504300026
J	Kumar, R; Hazan, A; Geron, M; Steinberg, R; Livni, L; Matzner, H; Priel, A				Kumar, Rakesh; Hazan, Adina; Geron, Matan; Steinberg, Rebbeca; Livni, Lital; Matzner, Henry; Priel, Avi			Activation of transient receptor potential vanilloid 1 by lipoxygenase metabolites depends on PKC phosphorylation	FASEB JOURNAL			English	Article						eicosanoids; inflammatory pain; TRP channels; endovanilloids; Gq-GPCR	RAT SENSORY NEURONS; CAPSAICIN RECEPTOR; TRPV1 CHANNELS; ION-CHANNEL; PAIN; BRADYKININ; INHIBITION; HEAT; SENSITIZATION; NOCICEPTORS	Peripheral neuronal activation by inflammatory mediators is a multifaceted physiological response that involves a multitude of regulated cellular functions. One key pathway that has been shown to be involved in inflammatory pain isGq/GPCR, whose activation by inflammatory mediators is followed by the regulated response of the cation channel transient receptor potential vanilloid 1 (TRPV1). However, the mechanism that underlies TRPV1 activation downstream of the Gq/GPCR pathway has yet to be fully defined. In this study, we employ pharmacological and molecular biology tools to dissect this activation mechanism via perforated-patch recordings and calcium imaging of both neurons and a heterologous system. We showed that TRPV1 activity downstream of Gq/GPCR activation only produced a subdued current, which was noticeably different from the robust current that is typical of TRPV1 activation by exogenous stimuli. Moreover, we specifically demonstrated that 2 pathways downstream of Gq/GPCR signaling, namely endovanilloid production by lipoxygenases and channel phosphorylation by PKC, converge on TRPV1 to evoke a tightly regulated response. Of importance, we show that only when both pathways are acting on TRPV1 is the inflammatory-mediated response achieved. We propose that the requirement of multiple signaling events allows subdued TRPV1 activation to evoke regulated neuronal response during inflammation.- KumarR., Hazan, A., Geron, M., Steinberg, R., Livni, L., Matzner, H., Priel, A. Activation of transient receptor potential vanilloid 1 by lipoxygenase metabolites depends on PKC phosphorylation.	[Kumar, Rakesh; Hazan, Adina; Geron, Matan; Steinberg, Rebbeca; Livni, Lital; Matzner, Henry; Priel, Avi] Hebrew Univ Jerusalem, Fac Med, Inst Drug Res, Sch Pharm, Jerusalem, Israel	Hebrew University of Jerusalem	Priel, A (corresponding author), Hebrew Univ Jerusalem, Sch Pharm, Fac Med, Inst Drug Res,Pharmacol Sect, Pharm Bldg,2nd Floor,Room 231,Ein Karem Campus, IL-91120 Jerusalem, Israel.	avip@ekmd.huji.ac.il	Priel, Avi/ABB-1721-2020; kumar, rakesh/ABE-8708-2020	Priel, Avi/0000-0002-6105-5035; kumar, rakesh/0000-0001-9693-4374; Geron, Matan/0000-0001-5609-1480	Israel Science Foundation [1721/12, 1368/12, 1444/16]; Brettler Center; David R. Bloom Center; School of Pharmacy (The Hebrew University of Jerusalem); Jerusalem Brain Committee Postdoctoral Fellowship	Israel Science Foundation(Israel Science Foundation); Brettler Center; David R. Bloom Center; School of Pharmacy (The Hebrew University of Jerusalem); Jerusalem Brain Committee Postdoctoral Fellowship	The authors thank A.P.'s laboratory for insightful comments. This work was supported by the Israel Science Foundation (Grants 1721/12, 1368/12, and 1444/16; to A.P.), the Brettler Center and David R. Bloom Center, School of Pharmacy (The Hebrew University of Jerusalem; to A.P.), a Jerusalem Brain Committee Postdoctoral Fellowship (to R.K.),	AKAIKE N, 1994, JPN J PHYSIOL, V44, P433, DOI 10.2170/jjphysiol.44.433; Bae C, 2016, ELIFE, V5, DOI 10.7554/eLife.11273; Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Berjukow S, 1996, BRIT J PHARMACOL, V118, P748, DOI 10.1111/j.1476-5381.1996.tb15463.x; Bhave G, 2003, P NATL ACAD SCI USA, V100, P12480, DOI 10.1073/pnas.2032100100; Blair NT, 2003, J NEUROSCI, V23, P10338; Bohlen CJ, 2010, CELL, V141, P834, DOI 10.1016/j.cell.2010.03.052; CAHALAN M, 1992, METHOD ENZYMOL, V207, P3; Cao E, 2013, NEURON, V77, P667, DOI 10.1016/j.neuron.2012.12.016; CARDENAS CG, 1995, J NEUROPHYSIOL, V74, P1870, DOI 10.1152/jn.1995.74.5.1870; Carr MJ, 2003, J PHARMACOL EXP THER, V304, P1275, DOI 10.1124/jpet.102.043422; Caterina MJ, 2000, SCIENCE, V288, P306, DOI 10.1126/science.288.5464.306; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Colton C. K., 2007, V179, P173; Cummins TR, 2009, NAT PROTOC, V4, P1103, DOI 10.1038/nprot.2009.91; Di Marzo V, 2002, CURR OPIN NEUROBIOL, V12, P372, DOI 10.1016/S0959-4388(02)00340-9; DICKENSON AH, 1991, BRIT J PHARMACOL, V104, P1045, DOI 10.1111/j.1476-5381.1991.tb12547.x; Gudes S, 2015, J NEUROPHYSIOL, V113, P601, DOI 10.1152/jn.00652.2014; Hazan A, 2015, SCI REP-UK, V5, DOI 10.1038/srep12278; HORN R, 1992, METHOD ENZYMOL, V207, P149; Hwang SW, 2000, P NATL ACAD SCI USA, V97, P6155, DOI 10.1073/pnas.97.11.6155; JORDT SE, 2002, Patent No. 108421; Julius D, 2013, ANNU REV CELL DEV BI, V29, P355, DOI 10.1146/annurev-cellbio-101011-155833; KORN SJ, 1990, MOL PHARMACOL, V38, P524; Kumar R, 2016, J BIOL CHEM, V291, P13855, DOI 10.1074/jbc.M116.726372; Le Pichon CE, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00021; Lee HM, 2014, DRUG DISCOV TODAY, V19, P469, DOI 10.1016/j.drudis.2013.10.018; Liang YF, 2001, J PHYSIOL-LONDON, V532, P229, DOI 10.1111/j.1469-7793.2001.0229g.x; Linley JE, 2010, PFLUG ARCH EUR J PHY, V459, P657, DOI 10.1007/s00424-010-0784-6; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Lundius EG, 2010, J NEUROSCI, V30, P4369, DOI 10.1523/JNEUROSCI.0378-10.2010; Mandadi S, 2006, PAIN, V123, P106, DOI 10.1016/j.pain.2006.02.016; Minke B, 2002, PHYSIOL REV, V82, P429, DOI 10.1152/physrev.00001.2002; Minke B, 2010, J NEUROGENET, V24, P216, DOI 10.3109/01677063.2010.514369; Nilius B, 2008, EMBO J, V27, P2809, DOI 10.1038/emboj.2008.217; Petho G, 2001, EUR J NEUROSCI, V14, P210, DOI 10.1046/j.0953-816x.2001.01651.x; Petho G, 2012, PHYSIOL REV, V92, P1699, DOI 10.1152/physrev.00048.2010; Priel A, 2004, J GEN PHYSIOL, V123, P281, DOI 10.1085/jgp.200308986; Priel A, 2006, NEURON, V52, P1037, DOI 10.1016/j.neuron.2006.12.006; Roberson DP, 2013, NAT NEUROSCI, V16, P910, DOI 10.1038/nn.3404; Rohacs T, 2008, MOL NEUROBIOL, V37, P153, DOI 10.1007/s12035-008-8027-y; Rohacs T, 2015, PFLUG ARCH EUR J PHY, V467, P1851, DOI 10.1007/s00424-015-1695-3; Roth BL, 2016, NEURON, V89, P683, DOI 10.1016/j.neuron.2016.01.040; Shim WS, 2007, J NEUROSCI, V27, P2331, DOI 10.1523/JNEUROSCI.4643-06.2007; Shin J, 2002, P NATL ACAD SCI USA, V99, P10150, DOI 10.1073/pnas.152002699; Sisignano M, 2014, PROG LIPID RES, V53, P93, DOI 10.1016/j.plipres.2013.11.002; Studer M, 2010, J PHYSIOL-LONDON, V588, P3743, DOI 10.1113/jphysiol.2010.190611; Sugiura T, 2002, J NEUROPHYSIOL, V88, P544, DOI 10.1152/jn.2002.88.1.544; Tappe-Theodor A, 2012, PAIN, V153, P184, DOI 10.1016/j.pain.2011.10.014; Ufret-Vincenty CA, 2015, J GEN PHYSIOL, V145, P431, DOI 10.1085/jgp.201511354; van der Stelt M, 2004, EUR J BIOCHEM, V271, P1827, DOI 10.1111/j.1432-1033.2004.04081.x; van Rossum DB, 2009, CELL CALCIUM, V45, P535, DOI 10.1016/j.ceca.2009.02.008; Veldhuis NA, 2015, PHARMACOL REV, V67, P36, DOI 10.1124/pr.114.009555; Vellani V, 2008, NEUROPHARMACOLOGY, V55, P1274, DOI 10.1016/j.neuropharm.2008.01.010; Woo DH, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-42; Xu ZZ, 2010, NAT MED, V16, P592, DOI 10.1038/nm.2123; Yeung J, 2012, MOL PHARMACOL, V81, P420, DOI 10.1124/mol.111.075630; Zhang XM, 2012, NAT CELL BIOL, V14, P850, DOI 10.1038/ncb2529; Zygmunt PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081618	59	17	18	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1238	+		10.1096/fj.201601132R	http://dx.doi.org/10.1096/fj.201601132R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27986808				2022-12-28	WOS:000395671200035
J	Cheng, F; Twardowski, L; Fehr, S; Aner, C; Schaeffeler, E; Joos, T; Knorpp, T; Dorweiler, B; Laufer, S; Schwab, M; Torzewski, M				Cheng, Fei; Twardowski, Laura; Fehr, Sarah; Aner, Christoph; Schaeffeler, Elke; Joos, Thomas; Knorpp, Thomas; Dorweiler, Bernhard; Laufer, Stefan; Schwab, Matthias; Torzewski, Michael			Selective p38 alpha MAP kinase/MAPK14 inhibition in enzymatically modified LDL-stimulated human monocytes: implications for atherosclerosis	FASEB JOURNAL			English	Article						cardiovascular research; IL-8; MIP-1 beta/CCL4; modified lipoproteins; scavenger receptor CD36	LOW-DENSITY-LIPOPROTEIN; ACTIVATED PROTEIN-KINASE; FOAM CELL-FORMATION; SMOOTH-MUSCLE-CELLS; ENDOTHELIAL-CELLS; FATTY-ACIDS; MACROPHAGE PROLIFERATION; COMPLEMENT ACTIVATION; DEGRADED LDL; OXIDIZED LDL	The first ATP-competitive p38 alpha MAPK/MAPK14 inhibitor with excellent in vivo efficacy and selectivity, skepinone-L, is now available. We investigated the impact of selective p38 alpha MAPK/MAPK14 inhibition on enzymatically modified LDL (eLDL) stimulated human monocytes with its implications for atherosclerosis. Among the different p38 MAPK isoforms, p38 alpha/MAPK14 was the predominantly expressed and activated isoform in isolated human peripheral blood monocytes. Moreover, eLDL colocalized with macrophages positive for p38 alpha MAPK/MAPK14 in human carotid endarterectomy specimens. Using the human leukemia cell line THP-1 and/or primary monocyte-derived macrophages, skepinone-L inhibited eLDL-induced activation of the p38 MAPK pathway, inhibited eLDL induced expression of both cluster of differentiation 36 (CD36) and ATP-binding cassette, subfamily A, member 1 (ABCA1), without a net effect on foam cell formation, had a cell- and time-dependent effect on eLDL-triggered apoptosis, and inhibited eLDL-stimulated secretion of IL-8 and MIP-1 beta/CCL4 (macrophage inflammatory protein-1 beta/chemokine, CC motif, ligand 4). Inhibition of a key signaling molecule of the p38 MAPK pathway, p38 alpha MAPK/MAPK14, by selective inhibitors like skepinone-L, conclusively facilitates elucidation of the impact of the complex network of p38 MAPK signaling on atherogenesis and might provide a promising therapeutic tool to prevent inflammatory cascades in atherosclerosis.	[Cheng, Fei; Twardowski, Laura; Torzewski, Michael] Robert Bosch Krankenhaus, Dept Lab Med, Auerbachstr 110, D-70736 Stuttgart, Germany; [Fehr, Sarah; Aner, Christoph; Schaeffeler, Elke; Schwab, Matthias; Torzewski, Michael] Univ Tubingen, Dr Margarete Fischer Bosch Inst Clin Pharmacol, Stuttgart, Germany; [Joos, Thomas; Knorpp, Thomas] Univ Tubingen, Nat & Med Sci Inst, Reutlingen, Germany; [Dorweiler, Bernhard] Johannes Gutenberg Univ Mainz, Univ Med Ctr, Dept Cardiothorac & Vasc Surg, Div Vasc Surg, Mainz, Germany; [Laufer, Stefan; Schwab, Matthias] Univ Tubingen, Inst Pharm, Tubingen, Germany; [Schwab, Matthias] Univ Hosp Tubingen, Dept Clin Pharmacol, Tubingen, Germany	Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Johannes Gutenberg University of Mainz; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Torzewski, M (corresponding author), Robert Bosch Krankenhaus, Dept Lab Med, Auerbachstr 110, D-70736 Stuttgart, Germany.	michael.torzewski@rbk.de	Schwab, Matthias/ABH-7449-2020	Laufer, Stefan/0000-0001-6952-1486	Robert Bosch Stiftung, Stuttgart, Germany; IZEPHA Grant Tubingen-Stuttgart, Germany; EU-Cinazept Grant	Robert Bosch Stiftung, Stuttgart, Germany; IZEPHA Grant Tubingen-Stuttgart, Germany; EU-Cinazept Grant	The authors thank K. Winter for expert technical assistance and U. Hofmann, S. Kath, and H. van der Kuip (all from University of Tubingen) for excellent technical support. This work was supported, in part, by the Robert Bosch Stiftung, Stuttgart, Germany; the IZEPHA Grant Tubingen-Stuttgart, Germany; and the EU-Cinazept Grant. The authors also thank S. Bhakdi (University Medical Center, Johannes Gutenberg University Mainz), for pointing out the physiological relevance of the eLDL concentrations used.	Andres V, 2012, CURR OPIN LIPIDOL, V23, P429, DOI 10.1097/MOL.0b013e328357a379; Apostolopoulos J, 1996, ARTERIOSCL THROM VAS, V16, P1007, DOI 10.1161/01.ATV.16.8.1007; BHAKDI S, 1995, J EXP MED, V182, P1959, DOI 10.1084/jem.182.6.1959; Bhakdi S, 2004, THROMB HAEMOSTASIS, V91, P639, DOI 10.1160/TH-03-12-d733; Bhakdi S, 2004, CIRCULATION, V109, P1870, DOI 10.1161/01.CIR.0000124228.08972.26; Bhakdi S, 1999, ARTERIOSCL THROM VAS, V19, P2348, DOI 10.1161/01.ATV.19.10.2348; Boisvert WA, 1998, J CLIN INVEST, V101, P353, DOI 10.1172/JCI1195; Cheng B, 2014, MICROB PATHOGENESIS, V69-70, P1, DOI 10.1016/j.micpath.2014.03.001; Dersch K, 2005, CELL DEATH DIFFER, V12, P1107, DOI 10.1038/sj.cdd.4401633; Dobreva I, 2006, CURR OPIN LIPIDOL, V17, P110, DOI 10.1097/01.mol.0000217891.92993.53; Dobreva I, 2006, J BIOL CHEM, V281, P199, DOI 10.1074/jbc.M508857200; Dorweiler B, 2006, THROMB HAEMOSTASIS, V95, P182, DOI 10.1160/TH05-05-0357; Dorweiler B, 2014, EUR J VASC ENDOVASC, V48, P248, DOI 10.1016/j.ejvs.2014.06.038; Eder K, 2008, IMMUNOL LETT, V116, P178, DOI 10.1016/j.imlet.2007.12.011; Fenske D, 2008, THROMB HAEMOSTASIS, V100, P1146, DOI 10.1160/TH08-03-0166; Gerszten RE, 1999, NATURE, V398, P718, DOI 10.1038/19546; Hakala JK, 2006, ARTERIOSCL THROM VAS, V26, P2504, DOI 10.1161/01.ATV.0000245796.97133.ad; Jing Q, 1999, CIRC RES, V84, P831; Kang YJ, 2008, J IMMUNOL, V180, P5075, DOI 10.4049/jimmunol.180.7.5075; Kapinsky M, 2001, ARTERIOSCL THROM VAS, V21, P1004, DOI 10.1161/01.ATV.21.6.1004; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kardakaris R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021055; Klouche M, 1998, ARTERIOSCL THROM VAS, V18, P1376, DOI 10.1161/01.ATV.18.9.1376; KOCH AE, 1993, AM J PATHOL, V142, P1423; Koeberle SC, 2012, NAT CHEM BIOL, V8, P141, DOI 10.1038/nchembio.761; Kumar S, 2003, NAT REV DRUG DISCOV, V2, P717, DOI 10.1038/nrd1177; Lee SA, 2011, BIOCHEM BIOPH RES CO, V408, P132, DOI 10.1016/j.bbrc.2011.03.136; Liu Y, 1997, ARTERIOSCL THROM VAS, V17, P317, DOI 10.1161/01.ATV.17.2.317; Mei S, 2012, J BIOL CHEM, V287, P11761, DOI 10.1074/jbc.M111.333575; Moreau M, 1999, CIRCULATION, V99, P420, DOI 10.1161/01.CIR.99.3.420; Proctor BM, 2008, CIRCULATION, V118, P658, DOI 10.1161/CIRCULATIONAHA.107.734848; Reiss K, 2011, J BIOL CHEM, V286, P26931, DOI 10.1074/jbc.M111.243485; Rus HG, 1996, ATHEROSCLEROSIS, V127, P263, DOI 10.1016/S0021-9150(96)05968-0; Seimon TA, 2009, J CLIN INVEST, V119, P886, DOI 10.1172/JCI37262; Senokuchi T, 2004, ATHEROSCLEROSIS, V176, P233, DOI 10.1016/j.atherosclerosis.2004.05.019; Skalen K, 2002, NATURE, V417, P750, DOI 10.1038/nature00804; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Stary HC, 2000, ARTERIOSCL THROM VAS, V20, P1177, DOI 10.1161/01.ATV.20.5.1177; Steinberg D, 1997, J BIOL CHEM, V272, P20963, DOI 10.1074/jbc.272.34.20963; Suriyaphol P, 2002, CIRCULATION, V106, P2581, DOI 10.1161/01.CIR.0000038366.11851.D0; Torzewski M, 2004, ARTERIOSCL THROM VAS, V24, P2130, DOI 10.1161/01.ATV.0000144016.85221.66; Torzewski M, 1998, ARTERIOSCL THROM VAS, V18, P369, DOI 10.1161/01.ATV.18.3.369; Torzewski M, 2006, CLIN CHEM LAB MED, V44, P1389, DOI 10.1515/CCLM.2006.259; Torzewski M, 2013, CLIN BIOCHEM, V46, P20, DOI 10.1016/j.clinbiochem.2012.09.012; Twardowski L, 2015, J AM HEART ASSOC, V4, DOI 10.1161/JAHA.115.002156; Vistnes M, 2012, CARDIOLOGY, V121, P149, DOI 10.1159/000336484; Westerterp M, 2014, CIRC RES, V114, P157, DOI 10.1161/CIRCRESAHA.114.300738; Winzen R, 1999, EMBO J, V18, P4969, DOI 10.1093/emboj/18.18.4969; YUE TL, 1994, CIRC RES, V75, P1, DOI 10.1161/01.RES.75.1.1; Zernecke A, 2014, ARTERIOSCL THROM VAS, V34, P742, DOI 10.1161/ATVBAHA.113.301655; Zhao M, 2002, APMIS, V110, P458, DOI 10.1034/j.1600-0463.2002.100604.x; Zhu Y, 2001, ARTERIOSCL THROM VAS, V21, P1159, DOI 10.1161/hq0701.092473	52	15	16	2	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					674	686		10.1096/fj.201600669R	http://dx.doi.org/10.1096/fj.201600669R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27871059				2022-12-28	WOS:000394235400020
J	Buxbaum, JN				Buxbaum, Joel N.			Alzheimer's Disease: It's More Than A beta	FASEB JOURNAL			English	Editorial Material							PROTEIN-TAU; HYPOTHESIS; DEMENTIA		[Buxbaum, Joel N.] Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA; [Buxbaum, Joel N.] Scintillon Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA	Scripps Research Institute	Buxbaum, JN (corresponding author), Scripps Res Inst, Dept Mol & Expt Med, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.; Buxbaum, JN (corresponding author), Scintillon Inst, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	jbux@scripps.edu						Alzheimer A., 1907, ALLGEMEINE Z PSYCHIA, V64, P146, DOI DOI 10.1002/CA.980080612; [Anonymous], 1611, PSALM, V90, P10; Bartus RT, 2000, EXP NEUROL, V163, P495, DOI 10.1006/exnr.2000.7397; BRION JP, 1985, ARCH BIOL, V96, P229; De Strooper B, 2016, CELL, V164, P603, DOI 10.1016/j.cell.2015.12.056; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Goedert M, 2009, BRAIN, V132, P1102, DOI 10.1093/brain/awn256; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Herrup K, 2015, NAT NEUROSCI, V18, P794, DOI 10.1038/nn.4017; Kalden JR, 2016, RHEUMATOL THER, V3, P31, DOI 10.1007/s40744-016-0032-4; Krstic D, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-62; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; PALMER AM, 1990, FASEB J, V4, P2745, DOI 10.1096/fasebj.4.10.2165009; Raina P, 2008, ANN INTERN MED, V148, P379, DOI 10.7326/0003-4819-148-5-200803040-00009; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Winslow BT, 2011, AM FAM PHYSICIAN, V83, P1403	17	6	6	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					2	4		10.1096/fj.201601179	http://dx.doi.org/10.1096/fj.201601179			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	28049154				2022-12-28	WOS:000392177600002
J	Mitani, Y; Vagnozzi, RJ; Millay, DP				Mitani, Yasuyuki; Vagnozzi, Ronald J.; Millay, Douglas P.			In vivo myomaker-mediated heterologous fusion and nuclear reprogramming	FASEB JOURNAL			English	Article						cell therapy; membrane fusion; muscular dystrophy	DUCHENNE MUSCULAR-DYSTROPHY; HEMATOPOIETIC STEM-CELLS; SKELETAL-MUSCLE REGENERATION; MESENCHYMAL STROMAL CELLS; MDX MOUSE; GLYCOPROTEIN COMPLEX; MYOBLAST FUSION; SATELLITE CELLS; GENE-THERAPY; EXPRESSION	Knowledge regarding cellular fusion and nuclear reprogramming may aid in cell therapy strategies for skeletal muscle diseases. An issue with cell therapy approaches to restore dystrophin expression in muscular dystrophy is obtaining a sufficient quantity of cells that normally fuse with muscle. Here we conferred fusogenic activity without transdifferentiation to multiple non-muscle cell types and tested dystrophin restoration inmouse models of muscular dystrophy. We previously demonstrated that myomaker, a skeletal muscle-specific transmembrane protein necessary for myoblast fusion, is sufficient to fuse 10T 1/2 fibroblasts to myoblasts in vitro. Whether myomaker-mediated heterologous fusion is functional in vivo and whether the newly introduced nonmuscle nuclei undergoes nuclear reprogramming has not been investigated. We showed that mesenchymal stromal cells, cortical bone stem cells, and tail-tip fibroblasts fuse to skeletal muscle when they express myomaker. These cells restored dystrophin expression in a fraction of dystrophin-deficient myotubes after fusion in vitro. However, dystrophin restoration was not detected in vivo although nuclear reprogramming of the muscle-specific myosin light chain promoter did occur. Despite the lack of detectable dystrophin reprogramming by immunostaining, this study indicated that myomaker could be used in nonmuscle cells to induce fusion with muscle in vivo, thereby providing a platform to deliver therapeutic material.-Mitani, Y., Vagnozzi, R. J., Millay, D. P. In vivo myomaker-mediated heterologous fusion and nuclear reprogramming.	[Mitani, Yasuyuki; Vagnozzi, Ronald J.; Millay, Douglas P.] Cincinnati Childrens Hosp Med Ctr, Dept Mol Cardiovasc Biol, 240 Albert Sabin Way,MLC 7020, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center	Millay, DP (corresponding author), Cincinnati Childrens Hosp Med Ctr, Dept Mol Cardiovasc Biol, 240 Albert Sabin Way,MLC 7020, Cincinnati, OH 45229 USA.	douglas.millay@cchmc.org	Vagnozzi, Ronald/AAR-6891-2020	Vagnozzi, Ronald/0000-0002-8027-1809	Cincinnati Children's Hospital Research Foundation; U.S. National Institutes of Health; National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01AR068286]; Muscular Dystrophy Association; Pew Charitable Trusts; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068286] Funding Source: NIH RePORTER	Cincinnati Children's Hospital Research Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Muscular Dystrophy Association(Muscular Dystrophy Association); Pew Charitable Trusts; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank J. Cancelas (Cincinnati Children's Hospital Medical Center) for mouse MSCs. This work was supported, in part, by grants to D.P.M. from the Cincinnati Children's Hospital Research Foundation, U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR068286), the Muscular Dystrophy Association, and Pew Charitable Trusts.	Bajek A, 2015, CRIT REV EUKAR GENE, V25, P1, DOI 10.1615/CritRevEukaryotGeneExpr.2015011074; Bothe GWM, 2000, GENESIS, V26, P165, DOI 10.1002/(SICI)1526-968X(200002)26:2<165::AID-GENE22>3.0.CO;2-F; Camargo FD, 2003, NAT MED, V9, P1520, DOI 10.1038/nm963; CAPLAN AI, 1991, J ORTHOP RES, V9, P641, DOI 10.1002/jor.1100090504; CHIU CP, 1984, CELL, V37, P879, DOI 10.1016/0092-8674(84)90423-9; Chretien F, 2005, AM J PATHOL, V166, P1741, DOI 10.1016/S0002-9440(10)62484-4; Corbel SY, 2003, NAT MED, V9, P1528, DOI 10.1038/nm959; Cossu G, 2015, EMBO MOL MED, V7, P1513, DOI 10.15252/emmm.201505636; Duan DS, 2016, CURR OPIN VIROL, V21, P16, DOI 10.1016/j.coviro.2016.07.006; Dumont NA, 2015, COMPR PHYSIOL, V5, P1027, DOI 10.1002/cphy.c140068; Duran JM, 2013, CIRC RES, V113, P539, DOI 10.1161/CIRCRESAHA.113.301202; Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X; Filareto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2550; Folker ES, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00363; Godfrey C, 2015, HUM MOL GENET, V24, P4225, DOI 10.1093/hmg/ddv155; Gonzalez-Nieto D, 2012, BLOOD, V119, P5144, DOI 10.1182/blood-2011-07-368506; Gregorevic P, 2008, MOL THER, V16, P657, DOI 10.1038/mt.2008.28; Gussoni E, 1999, NATURE, V401, P390, DOI 10.1038/43919; Hoogduijn MJ, 2014, CURR OPIN ORGAN TRAN, V19, P41, DOI 10.1097/MOT.0000000000000036; Johansson CB, 2008, NAT CELL BIOL, V10, P575, DOI 10.1038/ncb1720; Lalu MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047559; Lapidos KA, 2004, J CLIN INVEST, V114, P1577, DOI 10.1172/JCI200423071; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Li DJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015286; Long CZ, 2016, SCIENCE, V351, P400, DOI 10.1126/science.aad5725; Long MA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026381; Looney TJ, 2014, GENOME RES, V24, P267, DOI 10.1101/gr.143891.112; Millay DP, 2016, P NATL ACAD SCI USA, V113, P2116, DOI 10.1073/pnas.1600101113; Millay DP, 2014, GENE DEV, V28, P1641, DOI 10.1101/gad.247205.114; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Miller RG, 1997, MUSCLE NERVE, V20, P469, DOI 10.1002/(SICI)1097-4598(199704)20:4<469::AID-MUS10>3.3.CO;2-1; MONACO AP, 1986, NATURE, V323, P646, DOI 10.1038/323646a0; Muir LA, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.25; Najar M, 2016, CYTOTHERAPY, V18, P160, DOI 10.1016/j.jcyt.2015.10.011; Nelson CE, 2016, SCIENCE, V351, P403, DOI 10.1126/science.aad5143; Patel SA, 2008, ARCH IMMUNOL THER EX, V56, P1, DOI 10.1007/s00005-008-0001-x; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Pomerantz JH, 2009, J CELL SCI, V122, P1045, DOI 10.1242/jcs.041376; Quattrocelli M, 2015, J CLIN INVEST, V125, P4463, DOI 10.1172/JCI82735; Rinaldi F, 2014, TRANSL RES, V163, P409, DOI 10.1016/j.trsl.2013.11.006; Sampaolesi M, 2003, SCIENCE, V301, P487, DOI 10.1126/science.1082254; Sanges D, 2013, CELL REP, V4, P271, DOI 10.1016/j.celrep.2013.06.015; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shimizu-Motohashi Y, 2016, AM J TRANSL RES, V8, P2471; Tabebordbar M, 2016, SCIENCE, V351, P407, DOI 10.1126/science.aad5177; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Young CS, 2016, CELL STEM CELL, V18, P533, DOI 10.1016/j.stem.2016.01.021; Yue YP, 2003, CIRCULATION, V108, P1626, DOI 10.1161/01.CIR.0000089371.11664.27; Zhu H, 2010, NAT PROTOC, V5, P550, DOI 10.1038/nprot.2009.238	50	11	14	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					400	+		10.1096/fj.201600945R	http://dx.doi.org/10.1096/fj.201600945R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27825107	Green Published			2022-12-28	WOS:000392177600037
J	Zhao, P; Yang, XX; Yang, L; Li, MS; Wood, K; Liu, Q; Zhu, XD				Zhao, Peng; Yang, Xiaoxia; Yang, Liu; Li, Minshu; Wood, Kristofer; Liu, Qiang; Zhu, Xiaodong			Neuroprotective effects of fingolimod in mouse models of Parkinson's disease	FASEB JOURNAL			English	Article						S1PR; neurotoxicity; neuroprotection	NATURAL-KILLER-CELLS; MULTIPLE-SCLEROSIS; ISCHEMIC-STROKE; ANIMAL-MODELS; BRAIN; FTY720; SPHINGOSINE-1-PHOSPHATE; NEURONS; RECEPTORS; MODULATION	Parkinson's disease (PD) is characterized by a progressive loss of dopaminergic neurons with limited treatment options. Emerging evidence shows that FTY720 protects against neural injury via modulation of the sphingosine-1-phosphate 1 receptor (S1PR1). However, it remains unclear whether FTY720 could influence neurodegeneration in PD. Therefore, the present study was designed to determine the impact of fingolimod (FTY720), a sphingosine-1-phosphate receptor (S1PR) agonist, on 2 mouse models of PD. We found that FTY720 significantly reduced the deficit of motor function, diminished the loss of tyrosine hydroxylase-positive neurons in the substantia nigra, and attenuated the decrease of striatal dopamine and metabolite levels in mice receiving 6-hydroxydopamine (6-OHDA) or rotenone to simulate PD. An S1PR1-selective antagonist, W146, blocked the neuroprotective effects of FTY720. Of note, FTY720 retained the phosphorylation of ERK, together with a decreased expression of cleaved caspase-3 in mice treated with 6-OHDA or rotenone. In vitro studies revealed that FTY720 also attenuated 6-OHDA-or rotenone-induced toxicity in SH-SY5Y cells. These findings suggest the potential of S1PR modulation as a treatment for PD.-Zhao, P., Yang, X., Yang, L., Li, M., Wood, K., Liu, Q., Zhu, X. Neuroprotective effects of fingolimod in mouse models of Parkinson's disease.	[Zhao, Peng; Yang, Xiaoxia; Yang, Liu; Li, Minshu; Liu, Qiang; Zhu, Xiaodong] Tianjin Med Univ, Dept Neurol, Gen Hosp, Tianjin Neurol Inst, Tianjin 300052, Peoples R China; [Li, Minshu; Wood, Kristofer; Liu, Qiang; Zhu, Xiaodong] St Josephs Hosp, Barrow Neurol Inst, Div Neurol, Phoenix, AZ USA	Tianjin Medical University; Barrow Neurological Institute; St. Joseph's Hospital and Medical Center	Liu, Q; Zhu, XD (corresponding author), Tianjin Med Univ, Dept Neurol, Gen Hosp, Tianjin Neurol Inst, Tianjin 300052, Peoples R China.	qliu@tmu.edu.cn; zxd3516@163.com	Liu, Qiang/HHZ-3181-2022		American Heart Association [16SDG27250236]; National Science Foundation of China [81471535]; Tianjin Education Commission Foundation [14JCYBJC42000, 15JCYBJC50000]	American Heart Association(American Heart Association); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Education Commission Foundation	This study was supported in part by American Heart Association Grant 16SDG27250236 (to Q.L.), National Science Foundation of China Grant 81471535 (to Q.L.). and Tianjin Education Commission Foundation Grants 14JCYBJC42000 (to Q.L.) and 15JCYBJC50000 (to X.Z.).	Abbott A, 2010, NATURE, V466, pS6, DOI 10.1038/466S6a; Athauda D, 2015, NAT REV NEUROL, V11, P25, DOI 10.1038/nrneurol.2014.226; Beal MF, 2001, NAT REV NEUROSCI, V2, P325, DOI 10.1038/35072550; Blandini F, 2012, FEBS J, V279, P1156, DOI 10.1111/j.1742-4658.2012.08491.x; Bove J, 2012, NEUROSCIENCE, V211, P51, DOI 10.1016/j.neuroscience.2011.10.057; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Choi JW, 2011, P NATL ACAD SCI USA, V108, P751, DOI 10.1073/pnas.1014154108; Cipriani R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0308-6; Colombo E, 2014, ANN NEUROL, V76, P325, DOI 10.1002/ana.24217; Avila-Gomez IC, 2010, BASIC CLIN PHARMACOL, V106, P53, DOI 10.1111/j.1742-7843.2009.00472.x; da Conceicao Fabio S L, 2010, J Vis Exp, DOI 10.3791/1376; Damier P, 1999, BRAIN, V122, P1437, DOI 10.1093/brain/122.8.1437; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Dev KK, 2008, PHARMACOL THERAPEUT, V117, P77, DOI 10.1016/j.pharmthera.2007.08.005; Duty S, 2011, BRIT J PHARMACOL, V164, P1357, DOI 10.1111/j.1476-5381.2011.01426.x; Gan Y, 2014, P NATL ACAD SCI USA, V111, P2704, DOI 10.1073/pnas.1315943111; Gong L, 2012, J NEUROCHEM, V123, P876, DOI 10.1111/jnc.12038; Guadano A, 1998, MUTAT RES-GEN TOX EN, V414, P1, DOI 10.1016/S1383-5718(98)00032-1; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hasegawa Y, 2010, STROKE, V41, P368, DOI 10.1161/STROKEAHA.109.568899; Jin WN, 2016, J CEREBR BLOOD F MET, V36, P1464, DOI 10.1177/0271678X15611137; Liu Q, 2014, NEUROSCIENCE, V256, P170, DOI 10.1016/j.neuroscience.2013.10.049; Liu Q, 2016, NAT NEUROSCI, V19, P243, DOI 10.1038/nn.4211; Liu Q, 2015, NEUROPHARMACOLOGY, V97, P457, DOI 10.1016/j.neuropharm.2015.04.025; Liu Q, 2013, J NEUROSCI, V33, P7253, DOI 10.1523/JNEUROSCI.3235-12.2013; Liu Q, 2009, J NEUROSCI, V29, P918, DOI 10.1523/JNEUROSCI.3952-08.2009; Olanow CW, 2013, ANN NEUROL, V74, P337, DOI 10.1002/ana.24011; Pyszko J, 2014, MOL NEUROBIOL, V50, P38, DOI 10.1007/s12035-013-8622-4; Schapira AHV, 2010, NAT REV NEUROL, V6, P309, DOI 10.1038/nrneurol.2010.52; Sivasubramanian M, 2015, NEUROSCIENCE, V290, P636, DOI 10.1016/j.neuroscience.2015.01.032; Sun N, 2016, STROKE, V47, P1899, DOI 10.1161/STROKEAHA.115.012236; Tieu K, 2011, CSH PERSPECT MED, V1, DOI 10.1101/cshperspect.a009316	33	59	61	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					172	179		10.1096/fj.201600751R	http://dx.doi.org/10.1096/fj.201600751R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27671228				2022-12-28	WOS:000392177600018
J	Rauzi, F; Kirkby, NS; Edin, ML; Whiteford, J; Zeldin, DC; Mitchell, JA; Warner, TD				Rauzi, Francesca; Kirkby, Nicholas S.; Edin, Matthew L.; Whiteford, James; Zeldin, Darryl C.; Mitchell, Jane A.; Warner, Timothy D.			Aspirin inhibits the production of proangiogenic 15(S)-HETE by platelet cyclooxygenase-1	FASEB JOURNAL			English	Article						angiogenesis; eicosanoids; endothelium; prostaglandins	ANGIOGENESIS; ACID; AGGREGOMETRY; METABOLITES; MECHANISM	Regular consumption of low-dose aspirin reduces the occurrence of colorectal, esophageal, stomach, and gastrointestinal cancers. The underlying mechanism is unknown but may be linked to inhibition of angiogenesis. Because the effective doses of aspirin are consistent with the inhibition of cyclooxygenase-1 in platelets, we used liquid chromatography with tandem mass spectrometry analyses and immunoassays of human platelet releasates coupled with angiogenesis assays to search for the mediators of these effects. Blood or platelet-rich plasma from healthy volunteers stimulated with platelet activators produced a broad range of eicosanoids. Notably, preincubation of platelets with aspirin, but not with a P2Y12 receptor antagonist, caused a marked reduction in the production of 11-hydroxyeicosatetraenoic acid (HETE) and 15(S)-HETE, in addition to prostanoids such as thromboxane A(2). Releasates from activated platelets caused cell migration and tube formation in cultured human endothelial cells and stimulated the sprouting of rat aortic rings in culture. These proangiogenic effects were absent when platelets were treated with aspirin but returned by coincubation with exogenous 15(S)-HETE. These results reveal 15(S)-HETE as a major platelet cyclooxygenase-1 product with strong proangiogenic effects. Thus, 15(S)-HETE represents a potential target for the development of novel antiangiogenic therapeutics, and blockade of its production may provide a mechanism for the anticancer effects of aspirin.	[Rauzi, Francesca; Kirkby, Nicholas S.; Whiteford, James; Warner, Timothy D.] Queen Mary Univ London, William Harvey Res Inst, Barts & London Sch Med & Dent, London, England; [Kirkby, Nicholas S.; Mitchell, Jane A.] Imperial Coll London, Natl Heart & Lung Inst, London, England; [Edin, Matthew L.; Zeldin, Darryl C.] NIEHS, NIH, POB 12233, Res Triangle Pk, NC 27709 USA	University of London; Queen Mary University London; Imperial College London; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS)	Warner, TD (corresponding author), Barts & London Queen Marys Sch Med & Dent, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	t.d.warner@qmul.ac.uk	Edin, Matthew/AAI-1934-2019; Zeldin, Darryl C/Y-7091-2018	Zeldin, Darryl C/0000-0002-2087-7307; Whiteford, James/0000-0002-8967-7389; Edin, Matthew/0000-0002-7042-500X; Kirkby, Nicholas/0000-0003-3509-8549	Wellcome Trust [085255/Z/08/Z]; British Heart Foundation [FS/10/033/28271]; William Harvey Research Foundation; Intramural Research Program of the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences [Z01-025034]; British Heart Foundation [FS/16/1/31699, FS/10/33/28271] Funding Source: researchfish; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES025043] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); British Heart Foundation(British Heart Foundation); William Harvey Research Foundation; Intramural Research Program of the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; British Heart Foundation(British Heart Foundation); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research was supported by the Wellcome Trust (Grant 085255/Z/08/Z), the British Heart Foundation (Grant FS/10/033/28271), the William Harvey Research Foundation, and the Intramural Research Program of the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences (Grant Z01-025034).	Abdulnour REE, 2014, P NATL ACAD SCI USA, V111, P16526, DOI 10.1073/pnas.1407123111; Armstrong PCJ, 2008, J THROMB HAEMOST, V6, P1933, DOI 10.1111/j.1538-7836.2008.03133.x; Armstrong PCJ, 2009, THROMB HAEMOSTASIS, V102, P772, DOI 10.1160/TH09-04-0215; Brooke MA, 2014, GUT, V63, P96, DOI 10.1136/gutjnl-2012-303581; Chan MV, 2011, PLATELETS, V22, P485, DOI 10.3109/09537104.2011.592958; Collins R, 2009, LANCET, V373, P1849, DOI 10.1016/S0140-6736(09)60503-1; Cuzick J, 2015, ANN ONCOL, V26, P47, DOI 10.1093/annonc/mdu225; Etulain J, 2013, BRIT J PHARMACOL, V170, P255, DOI 10.1111/bph.12250; GOETZL EJ, 1980, J IMMUNOL, V125, P1789; Harrison P, 2009, SEMIN THROMB HEMOST, V35, P150, DOI 10.1055/s-0029-1220323; Kirkby NS, 2015, FASEB J, V29, P4568, DOI 10.1096/fj.15-275065; Kirkby NS, 2013, P NATL ACAD SCI USA, V110, P15782, DOI 10.1073/pnas.1218880110; Kundumani-Sridharan V, 2010, BLOOD, V115, P2105, DOI 10.1182/blood-2009-09-241802; Langley RE, 2014, CURR OPIN ONCOL, V26, P441, DOI 10.1097/CCO.0000000000000098; Newman JW, 2002, J LIPID RES, V43, P1563, DOI 10.1194/jlr.D200018-JLR200; O'Donnell VB, 2014, CIRC RES, V114, P1185, DOI 10.1161/CIRCRESAHA.114.301597; Rothwell PM, 2013, ANN INTERN MED, V159, P148, DOI 10.7326/0003-4819-159-2-201307160-00013; Schuck RN, 2013, ATHEROSCLEROSIS, V227, P442, DOI 10.1016/j.atherosclerosis.2013.01.034; Soumya SJ, 2012, INFLAMM RES, V61, P707, DOI 10.1007/s00011-012-0463-5; Srivastava K, 2007, CANCER RES, V67, P4328, DOI 10.1158/0008-5472.CAN-06-3594; Thun MJ, 2012, NAT REV CLIN ONCOL, V9, P259, DOI 10.1038/nrclinonc.2011.199; Thuresson ED, 2000, J BIOL CHEM, V275, P8501, DOI 10.1074/jbc.275.12.8501; Vane JR, 2003, THROMB RES, V110, P255, DOI 10.1016/S0049-3848(03)00379-7; VANE JR, 1971, NATURE-NEW BIOL, V231, P232, DOI 10.1038/newbio231232a0; Warner TD, 2011, BRIT J CLIN PHARMACO, V72, P619, DOI 10.1111/j.1365-2125.2011.03943.x; Zhang BL, 2005, CANCER RES, V65, P7283, DOI 10.1158/0008-5472.CAN-05-0633	26	33	35	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4256	4266		10.1096/fj.201600530R	http://dx.doi.org/10.1096/fj.201600530R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27633788	Green Published, hybrid			2022-12-28	WOS:000388201500030
J	Zhou, Y; Wang, X; Sun, L; Zhou, L; Ma, TC; Song, L; Wu, JG; Li, JL; Ho, WZ				Zhou, Yu; Wang, Xu; Sun, Li; Zhou, Li; Ma, Tong-Cui; Song, Li; Wu, Jian-Guo; Li, Jie-Liang; Ho, Wen-Zhe			Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes	FASEB JOURNAL			English	Article						exosomes; miRNA; hepatitis C virus	HEPATITIS-C VIRUS; MHC CLASS-II; IMMUNE-RESPONSES; NS3/4A PROTEASE; T-CELLS; INFECTION; INTERFERON; EXPRESSION; INDUCTION; MICRORNAS	Exosomes are a class of cell-released small vesicles that mediate intercellular communication by delivering functional factors to recipient cells. During hepatitis C virus (HCV) infection, the interaction between liver resident macrophages and hepatocytes is a key component in liver innate immunity. In this study, we explored the role of exosomes in the delivery of innate anti-HCV factors to hepatocytes from macrophages. We showed that supernatant from TLR3-activated macrophage cultures could efficiently inhibit HCV replication in Huh7 cells. This macrophage-mediated anti-HCV activity was through exosomes because inhibiting exosomes could abrogate the action of macrophages. Further analyses demonstrated that TLR3-activated macrophages release exosomes that contain anti-HCV microRNA (miRNA)-29 family members. Inhibiting miRNA29 could restore HCV replication. These findings suggest a novel antiviral mechanism in liver innate immunity against HCV infection and provide insights to support further studies on developing exosome-based delivery system for disease treatment.	[Zhou, Yu; Ho, Wen-Zhe] Temple Univ, Lewis Katz Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19140 USA; [Wang, Xu; Sun, Li; Zhou, Li; Ma, Tong-Cui; Song, Li; Wu, Jian-Guo; Li, Jie-Liang; Ho, Wen-Zhe] Wuhan Univ, Sch Basic Med Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Wuhan University	Zhou, Y; Ho, WZ (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19140 USA.	yu.zhou@temple.edu; wenzheho@temple.edu		Wu, Jianguo/0000-0002-8326-2895	U.S. National Institutes of Health, National Institute on Drug Abuse [DA022177, DA041302, DA040329]; National Natural Science Foundation of China [81271334, 81571962]; Development Program (973) from Ministry of Science and Technology of China [2012CB518901]; National Science and Technology Major Project of China [2014ZX10001003-005]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA041302, R21DA040329, R01DA022177] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Development Program (973) from Ministry of Science and Technology of China(National Basic Research Program of China); National Science and Technology Major Project of China; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Grants DA022177 and DA041302 (to W.-Z.H.) and Grant DA040329 (to J.-L.L.) from the U.S. National Institutes of Health, National Institute on Drug Abuse, Grants 81271334 and 81571962 from National Natural Science Foundation of China, Grant 2012CB518901 from the Development Program (973) from Ministry of Science and Technology of China, and Grant 2014ZX10001003-005 from the National Science and Technology Major Project of China. The authors declare no conflicts of interest.	Abusamra AJ, 2005, BLOOD CELL MOL DIS, V35, P169, DOI 10.1016/j.bcmd.2005.07.001; Bandyopadhyay S, 2011, J INFECT DIS, V203, P1753, DOI 10.1093/infdis/jir186; Battaglia AM, 2000, ANN PHARMACOTHER, V34, P487, DOI 10.1345/aph.19183; Buschow SI, 2010, IMMUNOL CELL BIOL, V88, P851, DOI 10.1038/icb.2010.64; De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203; Federici C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088193; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Heydtmann M, 2009, J VIROL, V83, P2796, DOI 10.1128/JVI.00996-08; Hoffmann TW, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-109; Horner SM, 2012, J VIROL, V86, P3112, DOI 10.1128/JVI.06727-11; Hu Guoku, 2012, Frontiers in Genetics, V3, P56, DOI 10.3389/fgene.2012.00056; Jaworski E, 2014, J BIOL CHEM, V289, P22284, DOI 10.1074/jbc.M114.549659; Jaworski E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096778; Joyce DP, 2016, INT J CANCER, V139, P1443, DOI 10.1002/ijc.30179; Kanda T, 2007, J VIROL, V81, P12375, DOI 10.1128/JVI.01695-07; Kaukinen P, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-66; Koziel MJ, 2005, CLIN INFECT DIS, V41, pS25, DOI 10.1086/429492; Lemon SM, 2010, J BIOL CHEM, V285, P22739, DOI 10.1074/jbc.R109.099556; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Park SH, 2014, IMMUNITY, V40, P13, DOI 10.1016/j.immuni.2013.12.010; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Revie D, 2014, WORLD J GASTROENTERO, V20, P2777, DOI 10.3748/wjg.v20.i11.2777; Sampey GC, 2014, J NEUROVIROL, V20, P199, DOI 10.1007/s13365-014-0238-6; Schorey JS, 2008, TRAFFIC, V9, P871, DOI 10.1111/j.1600-0854.2008.00734.x; Stone Louise, 2016, Nat Rev Urol, V13, P297, DOI 10.1038/nrurol.2016.88; Stone Louise, 2016, Nat Rev Urol, V13, P298, DOI 10.1038/nrurol.2016.78; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Wang Y, 2013, J VIRAL HEPATITIS, V20, P385, DOI 10.1111/jvh.12040; Wang YZ, 2015, HEPAT MON, V15, DOI 10.5812/hepatmon.29282; Wang YZ, 2014, INNATE IMMUN-LONDON, V20, P3, DOI 10.1177/1753425913478991; Yang L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00138; Ye L, 2009, HEPATOLOGY, V49, P753, DOI 10.1002/hep.22715; Zhou Y, 2010, IMMUNOLOGY, V131, P40, DOI 10.1111/j.1365-2567.2010.03270.x; Zhu X, 2015, CELL MICROBIOL, V17, P105, DOI 10.1111/cmi.12339	46	34	39	1	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4132	4140		10.1096/fj.201600696R	http://dx.doi.org/10.1096/fj.201600696R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27605546	Green Published			2022-12-28	WOS:000388201500019
J	Halle, M; Christersdottir, T; Back, M				Halle, Martin; Christersdottir, Tinna; Back, Magnus			Chronic adventitial inflammation, vasa vasorum expansion, and 5-lipoxygenase up-regulation in irradiated arteries from cancer survivors	FASEB JOURNAL			English	Article						radiotherapy; cardiovascular disease; leukotrienes	RADIATION; PATHWAY; RADIOTHERAPY; RECEPTOR; ATHEROSCLEROSIS; EXPRESSION; THERAPIES; DISEASE; INJURY; COHORT	Radiation-induced cardiovascular disease is an emerging problem in a steadily increasing population of survivors of cancer. However, the underlying biology is poorly described, and the late onset, which occurs several years after exposure, precludes adequate investigations in animal and cell culture models. We investigated the role of the 5-lipoxygenase (5-LO)/leukotriene pathway in radiation-induced vascular changes. Use of paired samples of irradiated arteries and nonirradiated internal control arteries from the same patient that were harvested during surgery for cancer reconstruction 10 yr after radiotherapy provides a unique human model of chronic radiation-induced vascular changes. Immunohistochemical stainings and perioperative inspection revealed an adventitial inflammatory response, with vasa vasorum expansion and chronic infiltration of CD68(+) macrophages. These macrophages stained positive for the leukotriene-forming enzyme 5-LO. Messenger RNA levels of 5-LO and leukotriene B-4 receptor 1 were increased in irradiated arterial segments compared with control vessels. These results point to targeting the 5-LO/leukotriene pathway as a therapeutic adjunct to prevent late adverse vascular effects of radiotherapy.Halle, M., Christersdottir, T., Back, M. Chronic adventitial inflammation, vasa vasorum expansion, and 5-lipoxygenase up-regulation in irradiated arteries from cancer survivors.	[Halle, Martin; Christersdottir, Tinna] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Back, Magnus] Karolinska Inst, Dept Med, Stockholm, Sweden; [Halle, Martin] Karolinska Univ Hosp, Dept Reconstruct Plast Surg, Stockholm, Sweden; [Back, Magnus] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Back, M (corresponding author), Karolinska Univ Hosp, Ctr Mol Med, L8 03, S-17176 Stockholm, Sweden.	magnus.back@ki.se			Funds of Radiumhemmet [111122]; Swedish Society of Medicine [SLS-408771]; Stockholm County Council [20140170, 20140222]; Swedish Research Council [2014-2312]; Swedish Heart and Lung Foundation [20150600, 20150683]	Funds of Radiumhemmet; Swedish Society of Medicine; Stockholm County Council(Stockholm County Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation)	The authors thank Linda Haglund (Department of Medicine, Karolinska Institutet) for excellent technical support. M.H. is supported by Funds of Radiumhemmet (Grant 111122), the Swedish Society of Medicine (Grant SLS-408771), and the Stockholm County Council (Grant 20140170). M.B. is supported by the Swedish Research Council (Grant 2014-2312), the Swedish Heart and Lung Foundation (Grants 20150600 and 20150683), and the Stockholm County Council (Grant 20140222).	Altena R, 2009, LANCET ONCOL, V10, P391, DOI 10.1016/S1470-2045(09)70042-7; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Back M, 2015, NAT REV CARDIOL, V12, P199, DOI 10.1038/nrcardio.2015.5; Back M, 2011, PHARMACOL REV, V63, P539, DOI 10.1124/pr.110.004184; Back M, 2009, CURR PHARM DESIGN, V15, P3116, DOI 10.2174/138161209789058020; Bjorklund TC, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-223; Busseuil D, 2003, INT J RADIAT BIOL, V79, P787, DOI 10.1080/09553000310001610970; COLE AT, 1993, GUT, V34, P1210, DOI 10.1136/gut.34.9.1210; Darby SC, 2013, NEW ENGL J MED, V368, P987, DOI 10.1056/NEJMoa1209825; Fajardo LF, 2002, INT J RADIAT ONCOL, V53, P714, DOI 10.1016/S0360-3016(02)02759-1; GROSS NJ, 1991, RADIAT RES, V127, P317, DOI 10.2307/3577947; Halle M, 2010, J AM COLL CARDIOL, V55, P1227, DOI 10.1016/j.jacc.2009.10.047; Herrmann J, 2016, CIRCULATION, V133, P1272, DOI 10.1161/CIRCULATIONAHA.115.018347; Houard X, 2009, FASEB J, V23, P1376, DOI 10.1096/fj.08-116202; Ingelsson E, 2012, J ALLERGY CLIN IMMUN, V129, P702, DOI 10.1016/j.jaci.2011.11.052; Kollum M, 2001, INT J RADIAT ONCOL, V50, P495, DOI 10.1016/S0360-3016(01)01497-3; Michel JB, 2007, ARTERIOSCL THROM VAS, V27, P1259, DOI 10.1161/ATVBAHA.106.137851; Mulligan-Kehoe MJ, 2014, CIRCULATION, V129, P2557, DOI 10.1161/CIRCULATIONAHA.113.007189; Mulrooney DA, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4606; Nagy E, 2011, CIRCULATION, V123, P1316, DOI 10.1161/CIRCULATIONAHA.110.966846; Panes J, 2000, ALIMENT PHARM THERAP, V14, P841; Plummer C, 2011, STROKE, V42, P2410, DOI 10.1161/STROKEAHA.111.615203; Powers BE, 1999, INT J RADIAT ONCOL, V45, P753, DOI 10.1016/S0360-3016(99)00219-9; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Spanbroek R, 2003, P NATL ACAD SCI USA, V100, P1238, DOI 10.1073/pnas.242716099; Zhao L, 2004, NAT MED, V10, P966, DOI 10.1038/nm1099	26	12	13	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3845	3852		10.1096/fj.201600620R	http://dx.doi.org/10.1096/fj.201600620R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27530979	Green Published, hybrid			2022-12-28	WOS:000386474700018
J	Hou, XW; Snarski, P; Higashi, Y; Yoshida, T; Jurkevich, A; Delafontaine, P; Sukhanov, S				Hou, Xuwei; Snarski, Patricia; Higashi, Yusuke; Yoshida, Tadashi; Jurkevich, Alexander; Delafontaine, Patrick; Sukhanov, Sergiy			Nuclear complex of glyceraldehyde-3-phosphate dehydrogenase and DNA repair enzyme apurinic/apyrimidinic endonuclease I protect smooth muscle cells against oxidant-induced cell death	FASEB JOURNAL			English	Article						apoptosis; oxidative stress; GAPDH	BASE EXCISION-REPAIR; LOW-DENSITY-LIPOPROTEIN; CYTOCHROME-C RELEASE; ACID HEPTELIDIC ACID; KONINGIC ACID; OXIDATIVE STRESS; MYOCARDIAL-INFARCTION; APOPTOSIS; GAPDH; DAMAGE	Atherosclerotic plaque destabilization is the major determinant of most acute coronary events. Smooth muscle cell (SMC) death contributes to plaque destabilization. Here, we describe a novel antiapoptotic mechanism in vascular SMCs that involves interaction of nuclear glyceraldehyde-3-phosphate dehydrogenase (GAPDH) with apurinic/apyrimidinic endonuclease 1 (Ape1), the major oxidized DNA repair enzyme. GAPDH down-regulation potentiated H2O2-induced DNA damage and SMC apoptosis. Conversely, GAPDH overexpression decreased DNA damage and protected SMCs against apoptosis. Ape1 down-regulation reversed the resistance of GAPDHoverexpressing cells to DNA damage and apoptosis, which indicated that Ape1 is indispensable for GAPDH-dependent protective effects. GAPDH bound Ape1 in the SMC nucleus, and blocking (or oxidation) of GAPDH active site cysteines suppressed GAPDH/Ape1 interaction and potentiated apoptosis. GAPDH up regulated Ape1 via a transcription factor homeobox protein Hox-A5 dependent mechanism. GAPDH levels were reduced in atherosclerotic plaque SMCs, and this effect correlated with oxidative stress and SMC apoptosis. Thus, we demonstrated that nuclear GAPDH/Ape1 interaction preserved Ape1 activity, reduced DNA damage, and prevented SMC apoptosis. Suppression of SMC apoptosis by maintenance of nuclear GAPDH/Ape1 interactions may be a novel therapy to increase atherosclerotic plaque stability. Hou, X., Snarski, P., Higashi, Y., Yoshida, T., Jurkevich, A., Delafontaine, P., Sukhanov, S. Nuclear complex of glyceraldehyde-3-phosphate dehydrogenase and DNA repair enzyme apurinic/apyrimidinic endonuclease I protect smooth muscle cells against oxidant-induced cell death.	[Hou, Xuwei; Snarski, Patricia; Higashi, Yusuke; Yoshida, Tadashi; Delafontaine, Patrick; Sukhanov, Sergiy] Univ Missouri, Sch Med, Dept Med, Columbia, MO 65212 USA; [Higashi, Yusuke; Yoshida, Tadashi; Delafontaine, Patrick; Sukhanov, Sergiy] Univ Missouri, Sch Med, Dept Physiol & Med Pharmacol, Columbia, MO USA; [Jurkevich, Alexander] Univ Missouri, Mol Cytol Core, Columbia, MO USA	University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia	Sukhanov, S (corresponding author), Univ Missouri, Dept Med, Sch Med, Div Cardiol, 1 Hosp Dr, Columbia, MO 65211 USA.	sukhanovs@health.missouri.edu		Yoshida, Tadashi/0000-0002-4544-1497; Jurkevich, Alexander/0000-0002-1161-0918	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01-HL070241, R01-HL080682, R21-HL113705]; American Heart Association [13GRNT17230069]; COBRE Cardiovascular Research Program (NIH National Institute of General Medical Sciences) [P20-RR018766]; Molecular Cytology Core of University of Missouri; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL113705, R01HL080682, R01HL070241] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); COBRE Cardiovascular Research Program (NIH National Institute of General Medical Sciences); Molecular Cytology Core of University of Missouri; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants R01-HL070241, R01-HL080682 (to P.D.), and R21-HL113705 (to S.S.), as well as American Heart Association Grant-in-Aid 13GRNT17230069 (to S.S.). The project has received funds from COBRE Cardiovascular Research Program (NIH National Institute of General Medical Sciences P20-RR018766; principal investigator, Dr. Daniel Kapusta, Louisiana Health Sciences Center, New Orleans, LA, USA). All authors had full access to all of the data in the study and had final responsibility for the decision to submit for Publication. The authors thank to Dr. Daniel Green (St. Jude Children's Research Hospital, Memphis, TN, USA) for providing GAPDH retroviral expression vector (pLZRS-GAPDH). The authors also thank to Dr. Karen Kirby (Charles W. Gehrke Proteomics Center, University of Missouri) for assistance with SPR experiments. The authors are grateful for the support provided by the Molecular Cytology Core of University of Missouri.	AMBROSE JA, 1988, J AM COLL CARDIOL, V12, P56, DOI 10.1016/0735-1097(88)90356-7; Aonuma T, 2016, STEM CELL TRANSL MED, V5, P1067, DOI 10.5966/sctm.2015-0281; Azam S, 2008, J BIOL CHEM, V283, P30632, DOI 10.1074/jbc.M801401200; Batthyany C, 2006, J BIOL CHEM, V281, P20450, DOI 10.1074/jbc.M602814200; Blackstock CD, 2014, J BIOL CHEM, V289, P7264, DOI 10.1074/jbc.M113.518951; Cai RQ, 2015, FASEB J, V29, P2749, DOI 10.1096/fj.14-265801; Cervelli T, 2012, INT J MOL SCI, V13, P16929, DOI 10.3390/ijms131216929; Colell A, 2009, CELL DEATH DIFFER, V16, P1573, DOI 10.1038/cdd.2009.137; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Dastoor Z, 2001, J CELL SCI, V114, P1643; Demple B, 2005, DNA REPAIR, V4, P1442, DOI 10.1016/j.dnarep.2005.09.004; Dunn J, 2015, INT J BIOCHEM CELL B, V67, P167, DOI 10.1016/j.biocel.2015.05.001; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; ENDO A, 1985, J ANTIBIOT, V38, P920, DOI 10.7164/antibiotics.38.920; Freitas AA, 2011, MUTAT RES-REV MUTAT, V728, P12, DOI 10.1016/j.mrrev.2011.05.001; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268; Huang HP, 2016, INT J MOL MED, V37, P669, DOI 10.3892/ijmm.2016.2480; Hwang IK, 2007, NEUROCHEM RES, V32, P1530, DOI 10.1007/s11064-007-9345-6; Hwang NR, 2009, BIOCHEM J, V423, P253, DOI 10.1042/BJ20090854; Jacquin MA, 2013, CELL DEATH DIFFER, V20, P1043, DOI 10.1038/cdd.2013.32; Jarosz AP, 2015, FREE RADICAL BIO MED, V89, P512, DOI 10.1016/j.freeradbiomed.2015.09.007; Jiang YL, 2009, DNA REPAIR, V8, P1273, DOI 10.1016/j.dnarep.2009.08.003; Kachgal S, 2012, CELL ADHES MIGR, V6, P457, DOI 10.4161/cam.22164; Kam MKM, 2015, DEV GROWTH DIFFER, V57, P158, DOI 10.1111/dgd.12199; KATO M, 1992, BIOCHIM BIOPHYS ACTA, V1120, P113, DOI 10.1016/0167-4838(92)90431-C; Kim HW, 2009, NEUROSCI LETT, V460, P166, DOI 10.1016/j.neulet.2009.05.062; Li MX, 2012, CANCER SCI, V103, P882, DOI 10.1111/j.1349-7006.2012.02239.x; Li YX, 2003, ARTERIOSCL THROM VAS, V23, P2178, DOI 10.1161/01.ATV.0000099788.31333.DB; Littlewood TD, 2003, CURR OPIN LIPIDOL, V14, P469, DOI 10.1097/00041433-200310000-00007; MacDonald Laura, 2015, Methods Mol Biol, V1270, P255, DOI 10.1007/978-1-4939-2309-0_19; Martinet W, 2011, BRIT J PHARMACOL, V164, P1, DOI 10.1111/j.1476-5381.2011.01342.x; Masuda Y, 1998, J BIOL CHEM, V273, P30360, DOI 10.1074/jbc.273.46.30360; Mazzola JL, 2005, BBA-GEN SUBJECTS, V1722, P168, DOI 10.1016/j.bbagen.2004.12.010; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Nakajima H, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704199200; Nakazawa M, 1997, J NEUROCHEM, V68, P2493; Okura Y, 2000, CIRCULATION, V102, P2680, DOI 10.1161/01.CIR.102.22.2680; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; Park WH, 2016, MOL MED REP, V14, P936, DOI 10.3892/mmr.2016.5307; Roos WP, 2013, CANCER LETT, V332, P237, DOI 10.1016/j.canlet.2012.01.007; SAKAI K, 1988, BIOCHIM BIOPHYS ACTA, V952, P297, DOI 10.1016/0167-4838(88)90130-6; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; SCHRAUFSTATTER I, 1988, J CLIN INVEST, V82, P1040, DOI 10.1172/JCI113660; Shah NR, 2015, J MOL CELL CARDIOL, V86, P147, DOI 10.1016/j.yjmcc.2015.07.005; Shatilla A, 2002, BIOCHEM J, V365, P547, DOI 10.1042/BJ20020375; Sirover MA, 2005, J CELL BIOCHEM, V95, P45, DOI 10.1002/jcb.20399; Suarez S, 2015, J BIOL CHEM, V290, P28311, DOI 10.1074/jbc.M115.682385; Sukhanov S, 2006, CIRC RES, V99, P191, DOI 10.1161/01.RES.0000232319.02303.8c; Sukhanov S, 2011, FEBS LETT, V585, P3065, DOI 10.1016/j.febslet.2011.08.029; Swain U, 2012, MECH AGEING DEV, V133, P186, DOI 10.1016/j.mad.2012.01.001; Takaoka Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep05204; Torregrosa-Munmer R, 2016, BIOGERONTOLOGY, V17, P325, DOI 10.1007/s10522-015-9612-x; Tristan C, 2011, CELL SIGNAL, V23, P317, DOI 10.1016/j.cellsig.2010.08.003; Unnikrishnan A, 2009, FREE RADICAL BIO MED, V46, P1488, DOI 10.1016/j.freeradbiomed.2009.02.021; van der Wal AC, 1999, CARDIOVASC RES, V41, P334, DOI 10.1016/S0008-6363(98)00276-4; Vigelso A, 2015, J APPL PHYSIOL, V118, P386, DOI 10.1152/japplphysiol.00840.2014; You B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058697; Zhang JY, 2015, CANCER BIOL MED, V12, P10, DOI 10.7497/j.issn.2095-3941.2014.0019; Zheng L, 2003, CELL, V114, P255, DOI 10.1016/S0092-8674(03)00552-X; Zhu H, 2000, CELL DEATH DIFFER, V7, P773, DOI 10.1038/sj.cdd.4400721	61	11	11	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3179	3192		10.1096/fj.201601082R	http://dx.doi.org/10.1096/fj.201601082R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28404743	Green Published			2022-12-28	WOS:000405931000040
J	Tobin, SW; Li, SH; Li, J; Wu, J; Yeganeh, A; Yu, P; Weisel, RD; Li, RK				Tobin, Stephanie W.; Li, Shu-Hong; Li, Jiao; Wu, Jun; Yeganeh, Azadeh; Yu, Pan; Weisel, Richard D.; Li, Ren-Ke			Dual roles for bone marrow-derived Sca-1 cells in cardiac function	FASEB JOURNAL			English	Article						aging; cardiovascular disease; stem cells	SERUM RESPONSE FACTOR; PROGENITOR CELLS; STEM-CELLS; INFLAMMATORY RESPONSE; MYOCARDIAL-INFARCTION; TRANSCRIPTION FACTORS; STEM/PROGENITOR CELL; PRESSURE-OVERLOAD; ANGIOGENESIS; DEFECTS	Recruitment of stem cells from the bone marrow (BM) is an important aspect of cardiac healing that becomes inefficient with age. We investigated the role of young stem cell antigen 1 (Sca-1)-positive BM cells on the aged heart by microarray analysis after BM reconstitution. Sca-1(+) and Sca-1- BM cells from young green fluorescent protein (GFP)-positive mice were used to reconstitute the BM of aged mice. Myocardial infarction (MI) was induced 3 mo later. GFP(+) cells were more abundant in the BM, blood, and heart of Sca-1(+) mice, which corresponded to preserved cardiac function after MI. At baseline, Sca-1(+) BM reconstitution increased cardiac expression of serum response factor, vascular endothelial growth factor A, and myogenic genes, but reduced the expression of 1-1-113. After MI, inflammation was identified as a key difference between Sca-1(+) and Sca-1(+) groups, as cytokine expression and cell surface markers associated with inflammatory cells were up-regulated with Sca-1(+) reconstitution. Mac-3 and F4/80 staining showed that the postinfarction heart was composed of a mixture of GFP(+) (donor) macrophages, GFP(host) macrophages, and GFP(+) cells that did not contribute to the macrophage population. This study demonstrates that Sca-1(+) BM cells regulate cardiac healing though an acute inflammatory response and also before injury by stimulating formation of a beneficial cardiac niche. Tobin, S. W., Li, S.-H., Li, J., Wu, J., Yeganeh, A., Yu, P., Weisel, R. D., Li, R.-K. Dual roles for bone marrow-derived Sca-1 cells in cardiac function.	[Tobin, Stephanie W.; Li, Shu-Hong; Li, Jiao; Wu, Jun; Yeganeh, Azadeh; Yu, Pan; Weisel, Richard D.; Li, Ren-Ke] Univ Hlth Network, Toronto Gen Res Inst, Div Cardiovasc Surg, Toronto, ON, Canada; [Li, Jiao] Guangzhou Med Univ, Affiliated Hosp 2, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Weisel, Richard D.; Li, Ren-Ke] Univ Toronto, Dept Surg, Div Cardiac Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Guangzhou Medical University; University of Toronto	Li, RK (corresponding author), Toronto Med Discovery Tower,Room 3-702, Toronto, ON M5G 1L7, Canada.	renkeli@uhnres.utoronto.ca		Tobin, Stephanie/0000-0002-5780-6238; Li, Ren-Ke/0000-0002-2584-060X	Canadian Institutes of Health Research [332652]; Bureau of Education of Guangzhou Municipality [1201581618]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Bureau of Education of Guangzhou Municipality	The authors thank M. M. Lee (University of Toronto) for technical assistance and L. Body (Toronto General Research Insititute) for help with manuscript preparation and editing. This work was supported by a grant from the Canadian Institutes of Health Research (332652 to R-K.L.). R-K.L. holds a Tier 1 Canada Research Chair in cardiac regeneration. J.L. is supported by the Bureau of Education of Guangzhou Municipality (Grant 1201581618).	Al Mheid I, 2016, CIRC RES, V119, P801, DOI 10.1161/CIRCRESAHA.116.308461; Bailey B, 2012, CIRC RES, V111, P750, DOI 10.1161/CIRCRESAHA.112.274662; Ballard VLT, 2007, CIRC RES, V100, P1116, DOI 10.1161/01.RES.0000261964.19115.e3; Boeckel JN, 2011, P NATL ACAD SCI USA, V108, P3276, DOI 10.1073/pnas.1008098108; Bradfute SB, 2005, EXP HEMATOL, V33, P836, DOI 10.1016/j.exphem.2005.04.001; Bujak M, 2008, J AM COLL CARDIOL, V51, P1384, DOI 10.1016/j.jacc.2008.01.011; Cohen M, 2014, EMBO J, V33, P2906, DOI 10.15252/embj.201489293; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Dey D, 2013, CIRC RES, V112, P1253, DOI 10.1161/CIRCRESAHA.112.300779; Dimmeler S, 2008, CIRC RES, V102, P1319, DOI 10.1161/CIRCRESAHA.108.175943; Feser J, 2011, FEBS LETT, V585, P2041, DOI 10.1016/j.febslet.2010.11.016; Franco CA, 2008, DEV CELL, V15, P448, DOI 10.1016/j.devcel.2008.07.019; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hu XQ, 2011, J CELL MOL MED, V15, P1865, DOI 10.1111/j.1582-4934.2010.01182.x; Ito CY, 2003, BLOOD, V101, P517, DOI 10.1182/blood-2002-06-1918; Jackson KA, 2001, J CLIN INVEST, V107, P1395, DOI 10.1172/JCI12150; Jaskelioff M, 2011, NATURE, V469, P102, DOI 10.1038/nature09603; Keniry Megan, 2014, Discoveries (Craiova), V2, pe15; Kensler TW, 2007, ANNU REV PHARMACOL, V47, P89, DOI 10.1146/annurev.pharmtox.46.120604.141046; Lavine KJ, 2016, P NATL ACAD SCI USA, V113, pE1414, DOI 10.1073/pnas.1602039113; Li SH, 2017, SCI REP-UK, V7, DOI 10.1038/srep41756; Li SH, 2013, EUR HEART J, V34, P1157, DOI 10.1093/eurheartj/ehs072; Liu N, 2016, SCI REP-UK, V6, DOI 10.1038/srep28739; Nahrendorf M, 2007, J EXP MED, V204, P3037, DOI 10.1084/jem.20070885; Nishioka K, 2002, MOL CELL, V9, P1201, DOI 10.1016/S1097-2765(02)00548-8; Noseda M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7930; Novoyatleva T, 2010, CARDIOVASC RES, V85, P681, DOI 10.1093/cvr/cvp360; Parlakian A, 2004, MOL CELL BIOL, V24, P5281, DOI 10.1128/MCB.24.12.5281-5289.2004; Popa ER, 2006, J MOL CELL CARDIOL, V41, P86, DOI 10.1016/j.yjmcc.2006.04.021; Rebo J, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms13363; Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979; Rosenblatt-Velin N, 2012, FASEB J, V26, P229, DOI 10.1096/fj.11-189605; Sadoun E, 2003, J HISTOCHEM CYTOCHEM, V51, P1119, DOI 10.1177/002215540305100902; Shi XB, 2007, MOL CELL, V27, P636, DOI 10.1016/j.molcel.2007.07.012; Smart N, 2008, CIRC RES, V102, P1155, DOI 10.1161/CIRCRESAHA.108.175158; Takeda K, 2000, CYTOKINE GROWTH F R, V11, P199, DOI 10.1016/S1359-6101(00)00005-8; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Urbanek K, 2006, P NATL ACAD SCI USA, V103, P9226, DOI 10.1073/pnas.0600635103; Yang F, 2012, EMBO J, V31, P110, DOI 10.1038/emboj.2011.364; Zhang G, 2013, NATURE, V497, P211, DOI 10.1038/nature12143; Zhou H, 2012, HYPERTENSION, V60, P802, DOI 10.1161/HYPERTENSIONAHA.112.198895	41	6	6	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2905	2915		10.1096/fj.201601363RR	http://dx.doi.org/10.1096/fj.201601363RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28336524				2022-12-28	WOS:000405931000016
J	Dossat, AM; Sanchez-Gonzalez, MA; Koutnik, AP; Leitner, S; Ruiz, EL; Griffin, B; Rosenberg, JT; Grant, SC; Fincham, FD; Pinto, JR; Kabbaj, M				Dossat, Amanda M.; Sanchez-Gonzalez, Marcos A.; Koutnik, Andrew P.; Leitner, Stefano; Ruiz, Edda L.; Griffin, Brittany; Rosenberg, Jens T.; Grant, Samuel C.; Fincham, Francis D.; Pinto, Jose R.; Kabbaj, Mohamed			Pathogenesis of depression- and anxiety-like behavior in an animal model of hypertrophic cardiomyopathy	FASEB JOURNAL			English	Article						adrenal gland; heart rate variability; mood disorder; sarcomeric protein; troponin	HEART-RATE-VARIABILITY; MAJOR DEPRESSION; MYOCARDIAL-INFARCTION; MOUSE MODEL; MOOD DISORDERS; CARDIOVASCULAR HEALTH; CARDIAC DYSFUNCTION; NEUROTROPHIC FACTOR; PROTEIN-KINASE; LIMBIC SYSTEM	Cardiovascular dysfunction is highly comorbid with mood disorders, such as anxiety and depression. However, the mechanisms linking cardiovascular dysfunction with the core behavioral features of mood disorder remain poorly understood. In this study, we usedmice bearing a knock-in sarcomeric mutation, which is exhibited in human hypertrophic cardiomyopathy (HCM), to investigate the influence of HCM over the development of anxiety and depression. We employed behavioral, MRI, and biochemical techniques in young (3-4 mo) and aged adult (7-8 mo) female mice to examine the effects of HCM on the development of anxiety-and depression-like behaviors. We focused on females because in both humans and rodents, they experience a 2-fold increase in mood disorder prevalence vs. males. Our results showed that young and aged HCM mice displayed echocardiographic characteristics of the heart disease condition, yet only aged HCM females displayed anxiety-and depression-like behaviors. Electrocardiographic parameters of sympathetic nervous system activation were increased in aged HCM females vs. controls and correlated with mood disorder-related symptoms. In addition, when compared with controls, aged HCM females exhibited adrenal gland hypertrophy, reduced volume in mood-related brain regions, and reduced hippocampal signaling proteins, such as brain-derived neurotrophic factor and its downstream targets vs. controls. In conclusion, prolonged systemic HCM stress can lead to development of mood disorders, possibly through inducing structural and functional brain changes, and thus, mood disorders in patients with heart disease should not be considered solely a psychologic or situational condition.-Dossat, A. M., Sanchez-Gonzalez, M. A., Koutnik, A. P., Leitner, S., Ruiz, E. L., Griffin, B., Rosenberg, J. T., Grant, S. C., Fincham, F. D., Pinto, J. R. Kabbaj, M. Pathogenesis of depression-and anxiety-like behavior in an animal model of hypertrophic cardiomyopathy.	[Dossat, Amanda M.; Koutnik, Andrew P.; Leitner, Stefano; Ruiz, Edda L.; Griffin, Brittany; Pinto, Jose R.; Kabbaj, Mohamed] Florida State Univ, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Rosenberg, Jens T.; Grant, Samuel C.] Florida State Univ, Natl High Magnet Field Lab, Ctr Interdisciplinary Magnet Resonance, Tallahassee, FL 32306 USA; [Fincham, Francis D.] Florida State Univ, Family Inst, Tallahassee, FL 32306 USA; [Sanchez-Gonzalez, Marcos A.] Larkin Community Hosp, Div Clin & Translat Res, South Miami, FL USA	State University System of Florida; Florida State University; State University System of Florida; Florida State University; State University System of Florida; Florida State University	Pinto, JR (corresponding author), Florida State Univ, 1350-H, Tallahassee, FL 32304 USA.; Kabbaj, M (corresponding author), Florida State Univ, 3300-H, Tallahassee, FL 32304 USA.	jose.pinto@med.fsu.edu; mohamed.kabbaj@med.fsu.edu	Grant, Samuel Colles/D-8744-2013; Fincham, Frank/A-2357-2008; Kabbaj, Mohamed/M-9240-2016; Stefanadis, Christodoulos/ABH-2232-2020; Pinto, Jose Renato/H-2631-2017; Koutnik, Andrew/U-5194-2017	Grant, Samuel Colles/0000-0001-7738-168X; Fincham, Frank/0000-0001-5081-2283; Stefanadis, Christodoulos/0000-0001-5974-6454; Pinto, Jose Renato/0000-0001-9092-4976; Koutnik, Andrew/0000-0002-5491-3919	U.S. National Institutes of Health, Heart, Lung, and Blood Institute Grants [HL103840, HL128683]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL128683, K99HL103840, R00HL103840] Funding Source: NIH RePORTER	U.S. National Institutes of Health, Heart, Lung, and Blood Institute Grants; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported by U.S. National Institutes of Health, Heart, Lung, and Blood Institute Grants HL103840 and HL128683 (to J.R.P.). The authors declare no conflicts of interest.	Agid R, 2003, INT J NEUROPSYCHOPH, V6, P215, DOI 10.1017/S146114570300347X; Almeida OP, 2013, EUR J HEART FAIL, V15, P850, DOI 10.1093/eurjhf/hft029; BARBACID M, 1995, CURR OPIN CELL BIOL, V7, P148, DOI 10.1016/0955-0674(95)80022-0; Bay-Richter C, 2012, CYTOKINE, V60, P749, DOI 10.1016/j.cyto.2012.08.016; Belzung C, 2011, BIOL MOOD ANXIETY DI, V1, DOI 10.1186/2045-5380-1-9; Bhupathy P, 2010, WOMENS HEALTH, V6, P77, DOI [10.2217/whe.09.80, 10.2217/WHE.09.80]; Blanquet PR, 2003, NEUROSCIENCE, V118, P477, DOI 10.1016/S0306-4522(02)00963-6; Blenck CL, 2016, CIRC RES, V118, P1294, DOI 10.1161/CIRCRESAHA.116.307509; Butters MA, 2009, AM J GERIAT PSYCHIAT, V17, P4, DOI 10.1097/JGP.0b013e31816ff72b; Coupland C, 2016, BMJ-BRIT MED J, V352, DOI 10.1136/bmj.i1350; Cox S, 1997, HEART, V78, P182, DOI 10.1136/hrt.78.2.182; Das UN, 2000, MOL CELL BIOCHEM, V215, P145, DOI 10.1023/A:1026579422132; David DJ, 2009, NEURON, V62, P479, DOI 10.1016/j.neuron.2009.04.017; de Kloet ER, 2005, NAT REV NEUROSCI, V6, P463, DOI 10.1038/nrn1683; Drevets WC, 2008, BRAIN STRUCT FUNCT, V213, P93, DOI 10.1007/s00429-008-0189-x; Drevets WC, 2007, ANN NY ACAD SCI, V1121, P499, DOI 10.1196/annals.1401.029; Duman CH, 2007, BIOL PSYCHIAT, V61, P661, DOI 10.1016/j.biopsych.2006.05.047; Dunn AJ, 2005, NEUROSCI BIOBEHAV R, V29, P891, DOI 10.1016/j.neubiorev.2005.03.023; Duric V, 2010, NAT MED, V16, P1328, DOI 10.1038/nm.2219; Dweck D, 2014, J BIOL CHEM, V289, P23097, DOI 10.1074/jbc.M114.561472; ERONDU NE, 1985, J NEUROSCI, V5, P3270; Fatkin D, 2014, CSH PERSPECT MED, V4, DOI 10.1101/cshperspect.a021063; Florea VG, 2014, CIRC RES, V114, P1815, DOI 10.1161/CIRCRESAHA.114.302589; Force T, 2010, CIRCULATION, V122, P1130, DOI 10.1161/CIRCULATIONAHA.110.950089; FRASURESMITH N, 1993, JAMA-J AM MED ASSOC, V270, P1819, DOI 10.1001/jama.270.15.1819; Frey A, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00376; GeisterferLowrance AAT, 1996, SCIENCE, V272, P731, DOI 10.1126/science.272.5262.731; Gerges NZ, 2004, HIPPOCAMPUS, V14, P402, DOI 10.1002/hipo.10193; Girotti M, 2006, NEUROSCIENCE, V138, P1067, DOI 10.1016/j.neuroscience.2005.12.002; Golkar A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048107; Gottlieb SS, 2004, J AM COLL CARDIOL, V43, P1542, DOI 10.1016/j.jacc.2003.10.064; Grieve SM, 2013, NEUROIMAGE-CLIN, V3, P332, DOI 10.1016/j.nicl.2013.08.016; Grippo AJ, 2006, BIOL PSYCHIAT, V59, P309, DOI 10.1016/j.biopsych.2005.07.010; Grippo AJ, 2012, PSYCHOSOM MED, V74, P612, DOI 10.1097/PSY.0b013e31825ca8e5; Harvey PA, 2011, J CELL BIOL, V194, P355, DOI 10.1083/jcb.201101100; Henze M, 2008, AM J PHYSIOL-HEART C, V295, pH29, DOI 10.1152/ajpheart.01373.2007; Henze M, 2013, AM J PHYSIOL-HEART C, V304, pH444, DOI 10.1152/ajpheart.00763.2012; Hollis F, 2014, ILAR J, V55, P221, DOI 10.1093/ilar/ilu002; HUSAIN MM, 1991, PSYCHIAT RES-NEUROIM, V40, P95, DOI 10.1016/0925-4927(91)90001-7; Igoumenou A, 2012, HEART ASIA, V4, P44, DOI 10.1136/heartasia-2012-010099; Ingles J, 2008, GENET MED, V10, P117, DOI 10.1097/GIM.0b013e3181612cc7; Ito K, 2013, J CARDIOVASC PHARM, V62, P222, DOI 10.1097/FJC.0b013e3182970b15; Jaafar Nawel, 2015, Glob Cardiol Sci Pract, V2015, P16, DOI 10.5339/gcsp.2015.16; James J, 2000, CIRC RES, V87, P805, DOI 10.1161/01.RES.87.9.805; Jefferson AL, 2010, J ALZHEIMERS DIS, V20, P813, DOI 10.3233/JAD-2010-100081; Jiang W, 2001, ARCH INTERN MED, V161, P1849, DOI 10.1001/archinte.161.15.1849; Kemp AH, 2010, BIOL PSYCHIAT, V67, P1067, DOI [10.1016/j.biopsych.2009.11.019, 10.1016/j.biopsych.2009.12.012]; Kessler RC, 2012, INT J METH PSYCH RES, V21, P169, DOI 10.1002/mpr.1359; Kim JJ, 1998, TRENDS NEUROSCI, V21, P505, DOI 10.1016/S0166-2236(98)01322-8; Klainin-Yobas P, 2016, PATIENT EDUC COUNS, V99, P512, DOI 10.1016/j.pec.2015.10.020; Knollmann BC, 2001, J BIOL CHEM, V276, P10039, DOI 10.1074/jbc.M006745200; KRISHNAN KRR, 1992, ARCH GEN PSYCHIAT, V49, P553; Krivoy A, 2015, BRIT J PSYCHIAT, V206, P297, DOI 10.1192/bjp.bp.114.155820; Kumar R, 2011, EUR J HEART FAIL, V13, P651, DOI 10.1093/eurjhf/hfr012; Kuusisto J, 2012, HEART, V98, P1007, DOI 10.1136/heartjnl-2011-300960; Landstrom AP, 2008, J MOL CELL CARDIOL, V45, P281, DOI 10.1016/j.yjmcc.2008.05.003; Lesperance F, 2002, CIRCULATION, V105, P1049, DOI 10.1161/hc0902.104707; Liu WX, 2016, PSYCHOPHARMACOLOGY, V233, P405, DOI 10.1007/s00213-015-4128-2; Magida JA, 2014, EMBO MOL MED, V6, P482, DOI 10.1002/emmm.201302852; Mallik S, 2006, ARCH INTERN MED, V166, P876, DOI 10.1001/archinte.166.8.876; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; Martins AS, 2015, CIRC-CARDIOVASC GENE, V8, P653, DOI 10.1161/CIRCGENETICS.114.000957; Mastrogiannis D, 2012, CARDIOL RES PRACT, V2012, DOI 10.1155/2012/794762; Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678; McEwen Bruce S, 2004, Dialogues Clin Neurosci, V6, P119; Menazza S, 2016, CIRC RES, V118, P994, DOI 10.1161/CIRCRESAHA.115.305376; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Morgan JF, 2008, GEN HOSP PSYCHIAT, V30, P49, DOI 10.1016/j.genhosppsych.2007.09.005; Morita H, 2008, NEW ENGL J MED, V358, P1899, DOI 10.1056/NEJMoa075463; Moussavi S, 2007, LANCET, V370, P851, DOI 10.1016/S0140-6736(07)61415-9; NEMEROFF CB, 1992, ARCH GEN PSYCHIAT, V49, P384; Oh JK, 2006, J AM COLL CARDIOL, V47, P500, DOI 10.1016/j.jacc.2005.09.032; Olsson MC, 2001, AM J PHYSIOL-HEART C, V280, pH1136, DOI 10.1152/ajpheart.2001.280.3.H1136; Ouyang P, 2016, BIOL SEX DIFFER, V7, DOI 10.1186/s13293-016-0073-y; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Parissis JT, 2004, AM J CARDIOL, V94, P1326, DOI 10.1016/j.amjcard.2004.07.127; Paxinos G, 2012, MOUSE BRAIN STEREOTA; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Ploski R, 2016, AM J MED GENET A, V170, P3241, DOI 10.1002/ajmg.a.37860; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Rahman A, 2011, AUST FAM PHYSICIAN, V40, P791; Reichardt LF, 2006, PHILOS T R SOC B, V361, P1545, DOI 10.1098/rstb.2006.1894; Rhebergen D, 2015, PSYCHONEUROENDOCRINO, V51, P341, DOI 10.1016/j.psyneuen.2014.10.005; RUBIN RT, 1995, ARCH GEN PSYCHIAT, V52, P213; Russo SJ, 2013, NAT REV NEUROSCI, V14, P609, DOI 10.1038/nrn3381; Rutledge T, 2006, J AM COLL CARDIOL, V48, P1527, DOI 10.1016/j.jacc.2006.06.055; Schneider B, 2011, PROG NEUROBIOL, V95, P703, DOI 10.1016/j.pneurobio.2011.08.001; Scott KM, 2007, J AFFECT DISORDERS, V103, P113, DOI 10.1016/j.jad.2007.01.015; Seidman CE, 2011, CIRC RES, V108, P743, DOI 10.1161/CIRCRESAHA.110.223834; Semsarian C, 2015, J AM COLL CARDIOL, V65, P1249, DOI 10.1016/j.jacc.2015.01.019; Sgoifo A, 1997, AM J PHYSIOL-HEART C, V273, pH1754, DOI 10.1152/ajpheart.1997.273.4.H1754; Sgoifo A, 2014, NEUROSCI BIOBEHAV R, V39, P51, DOI 10.1016/j.neubiorev.2013.12.005; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; STEIN PK, 1994, AM HEART J, V127, P1376, DOI 10.1016/0002-8703(94)90059-0; Tank AW, 2015, COMPR PHYSIOL, V5, P1, DOI 10.1002/cphy.c140007; Tardiff JC, 1999, J CLIN INVEST, V104, P469, DOI 10.1172/JCI6067; Thireau J, 2008, EXP PHYSIOL, V93, P83, DOI 10.1113/expphysiol.2007.040733; Thoenen H, 2000, PROG BRAIN RES, V128, P183; Tiraboschi E, 2004, NEUROREPORT, V15, P2393, DOI 10.1097/00001756-200410250-00018; Vaccarino V, 2001, J AM COLL CARDIOL, V38, P199, DOI 10.1016/S0735-1097(01)01334-1; Wann BP, 2009, J PSYCHOPHARMACOL, V23, P451, DOI 10.1177/0269881108089820; Wann BP, 2007, J PSYCHIATR NEUROSCI, V32, P11; Wann BP, 2010, HORM BEHAV, V58, P907, DOI 10.1016/j.yhbeh.2010.09.001; Westermann D, 2006, EUR J HEART FAIL, V8, P115, DOI 10.1016/j.ejheart.2005.07.012; Willott RH, 2010, J MOL CELL CARDIOL, V48, P882, DOI 10.1016/j.yjmcc.2009.10.031; Woo MA, 2015, EUR J HEART FAIL, V17, P494, DOI 10.1002/ejhf.241; Woo MA, 2015, J NEUROSCI RES, V93, P678, DOI 10.1002/jnr.23525; Woo MA, 2009, J CARD FAIL, V15, P214, DOI 10.1016/j.cardfail.2008.10.020; ZIMMERMA.E, 1967, P SOC EXP BIOL MED, V125, P658	109	6	7	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2492	2506		10.1096/fj.201600955RR	http://dx.doi.org/10.1096/fj.201600955RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28235781	Green Published			2022-12-28	WOS:000401553400023
J	Jolly, AL; Agarwal, P; Metruccio, MME; Spiciarich, DR; Evans, DJ; Bertozzi, CR; Fleiszig, SMJ				Jolly, Amber L.; Agarwal, Paresh; Metruccio, Matteo M. E.; Spiciarich, David R.; Evans, David J.; Bertozzi, Carolyn R.; Fleiszig, Suzanne M. J.			Corneal surface glycosylation is modulated by IL-1R and Pseudomonas aeruginosa challenge but is insufficient for inhibiting bacterial binding	FASEB JOURNAL			English	Article						GalNAz metabolic label; imaging; mass spectrometry; Muc4; MyD88	MEMBRANE-ASSOCIATED MUCINS; OCULAR SURFACE; EPITHELIAL-CELLS; O-GLYCANS; CONJUNCTIVAL EPITHELIA; INTERLEUKIN-1 RECEPTOR; TEAR FLUID; PROTEIN-D; KAPPA-B; ADHERENCE	Cell surface glycosylation is thought to be involved in barrier function against microbes at mucosal surfaces. Previously we showed that the epithelium of healthy mouse corneas becomes vulnerable to Pseudomonas aeruginosa adhesion if it lacks the innate defense proteinMyD88 (myeloid differentiation primary response gene 88), or after superficial injury by blotting with tissue paper. Here we explored their effect on corneal surface glycosylation using ametabolic label, tetra-acetylated N-azidoacetyl galactosamine (Ac(4)GalNAz).Ac(4)GalNAz treatment labeled the surface of healthy mouse corneas, leaving most cells viable, and bacteria preferentially associated with GalNAz-labeled regions. Surprisingly, corneas from My D88(-/-) mice displayed similar GalNAz labeling to wild-type corneas, but labeling was reduced and patchy on IL-1 receptor (IL-1R)-knockout mouse corneas (P < 0.05, ANOVA). Tissue paper blotting removed GalNAz-labeled surface cells, causingDAPI labeling (permeabilization) of underlying cells. MS of material collected on the tissue paper blots revealed 67 GalNAz-labeled proteins, including intracellular proteins. These data show that the normal distribution of surface glycosylation requires IL-1R, but not MyD88, and is not sufficient to prevent bacterial binding. They also suggest increased P. aeruginosa adhesion to MyD88(-/-) and blotted corneas is not due to reduction in total surface glycosylation, and for tissue paper blotting is likely due to cell permeabilization.	[Jolly, Amber L.; Metruccio, Matteo M. E.; Evans, David J.; Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA; [Agarwal, Paresh; Spiciarich, David R.; Bertozzi, Carolyn R.] Univ Calif Berkeley, Coll Chem, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA; [Bertozzi, Carolyn R.] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Grad Div Vis Sci, Berkeley, CA 94720 USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Grad Div Microbiol, Berkeley, CA 94720 USA; [Fleiszig, Suzanne M. J.] Univ Calif Berkeley, Grad Div Infect Dis & Immun, Berkeley, CA 94720 USA; [Evans, David J.] Touro Univ Calif, Coll Pharm, Vallejo, CA USA; [Bertozzi, Carolyn R.] Stanford Univ, Dept Chem, Stanford, CA 94305 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Howard Hughes Medical Institute; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; Touro University California; Stanford University	Fleiszig, SMJ (corresponding author), Univ Calif Berkeley, Sch Optometry, Berkeley, CA 94720 USA.	fleiszig@berkeley.edu	Jolly, Amber/T-2644-2019; Metruccio, Matteo/I-1467-2019	Metruccio, Matteo/0000-0002-2456-2652; Evans, David/0000-0002-6885-2053; Fleiszig, Suzanne/0000-0001-6324-3462	National Institutes of Health (National Eye Institute) [EY011221, EY024060]; National Institutes of Health (National Cancer Institute) [CA200423]; National Institutes of Health (National Institute of General Medical Sciences) [GM058867]; National Science Foundation; NATIONAL CANCER INSTITUTE [R01CA200423] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY011221, R01EY024060] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM058867, R01GM058867, T32GM066698] Funding Source: NIH RePORTER	National Institutes of Health (National Eye Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); National Institutes of Health (National Cancer Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institutes of Health (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); National Science Foundation(National Science Foundation (NSF)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by the National Institutes of Health (National Eye Institute Grants EY011221 and EY024060 to S.M.J.F.; National Cancer Institute Grant CA200423 to C.R.B.; and National Institute of General Medical Sciences Grant GM058867 to C.R.B.). D.R.S. was supported by a predoctoral fellowship from the National Science Foundation. The authors thank J. Singer (University of Maine, Orono, ME, USA) for providing the plasmid construct p67T1 (dTomato), G. Barton (University of California, Berkeley) for providing gene-knockout mice, and M. Gadjeva (Harvard Medical School, Boston, MA, USA) for helpful discussions.	Ablamowicz AF, 2016, OCUL SURF, V14, P331, DOI 10.1016/j.jtos.2016.03.003; Alarcon I, 2011, INVEST OPHTH VIS SCI, V52, P1368, DOI 10.1167/iovs.10-6125; Argueso P, 2009, J BIOL CHEM, V284, P23037, DOI 10.1074/jbc.M109.033332; Augustin DK, 2011, INFECT IMMUN, V79, P595, DOI 10.1128/IAI.00854-10; Bielory BP, 2016, CURR OPIN ALLERGY CL, V16, P477, DOI 10.1097/ACI.0000000000000309; Boyce M, 2011, P NATL ACAD SCI USA, V108, P3141, DOI 10.1073/pnas.1010045108; Braeuer L, 2007, INVEST OPHTH VIS SCI, V48, P3945, DOI 10.1167/iovs.07-0201; Bucior I, 2010, INFECT IMMUN, V78, P939, DOI 10.1128/IAI.01215-09; Cahill CM, 2008, J BIOL CHEM, V283, P25900, DOI 10.1074/jbc.M707692200; Desseyn JL, 2002, EUR J BIOCHEM, V269, P3150, DOI 10.1046/j.1432-1033.2002.02988.x; FLEISZIG SMJ, 1994, INFECT IMMUN, V62, P1799, DOI 10.1128/IAI.62.5.1799-1804.1994; Fleiszig SMJ, 1997, INFECT IMMUN, V65, P2861, DOI 10.1128/IAI.65.7.2861-2867.1997; Frantz AL, 2012, MUCOSAL IMMUNOL, V5, P501, DOI 10.1038/mi.2012.23; GIPSON IK, 1992, INVEST OPHTH VIS SCI, V33, P218; Gipson IK, 2004, EXP EYE RES, V78, P379, DOI 10.1016/S0014-4835(03)00204-5; Gipson IK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100393; Govindarajan B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032418; Gupta SK, 1997, INFECT IMMUN, V65, P2747, DOI 10.1128/IAI.65.7.2747-2753.1997; Guzman-Aranguez A, 2010, OCUL SURF, V8, P8, DOI 10.1016/S1542-0124(12)70213-6; Hang HC, 2003, P NATL ACAD SCI USA, V100, P14846, DOI 10.1073/pnas.2335201100; Hori Y, 2004, INVEST OPHTH VIS SCI, V45, P114, DOI 10.1167/iovs.03-0903; Hou JZ, 2013, P NATL ACAD SCI USA, V110, P3913, DOI 10.1073/pnas.1217996110; INATOMI T, 1995, INVEST OPHTH VIS SCI, V36, P1818; Janssens S, 2002, TRENDS BIOCHEM SCI, V27, P474, DOI 10.1016/S0968-0004(02)02145-X; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Laughlin ST, 2008, SCIENCE, V320, P664, DOI 10.1126/science.1155106; Lomako J, 2010, J CELL PHYSIOL, V223, P209, DOI 10.1002/jcp.22028; Masinick SA, 1997, INVEST OPHTH VIS SCI, V38, P910; McDermott AM, 2003, INVEST OPHTH VIS SCI, V44, P1859, DOI 10.1167/iovs.02-0787; Mun JJ, 2011, SCI REP-UK, V1, DOI 10.1038/srep00008; Mun JJ, 2009, INFECT IMMUN, V77, P2392, DOI 10.1128/IAI.00173-09; Navabi N, 2013, INFECT IMMUN, V81, P829, DOI 10.1128/IAI.01000-12; Ng ALK, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/769436; Ni M, 2005, INFECT IMMUN, V73, P2147, DOI 10.1128/IAI.73.4.2147-2156.2005; Peter-Katalinic J, 2005, METHOD ENZYMOL, V405, P139, DOI 10.1016/S0076-6879(05)05007-X; Pflugfelder SC, 2000, INVEST OPHTH VIS SCI, V41, P1316; Plotkowski MC, 1996, INFECT IMMUN, V64, P600, DOI 10.1128/IAI.64.2.600-605.1996; Reddy SAG, 2004, BIOCHEM BIOPH RES CO, V316, P1022, DOI 10.1016/j.bbrc.2004.02.155; Reddy SAG, 1997, J BIOL CHEM, V272, P29167, DOI 10.1074/jbc.272.46.29167; Redfern RL, 2011, EXP EYE RES, V92, P209, DOI 10.1016/j.exer.2010.12.005; Ricciuto J, 2008, INFECT IMMUN, V76, P5215, DOI 10.1128/IAI.00708-08; Roger P, 1999, EUR RESPIR J, V13, P1301, DOI 10.1183/09031936.99.13613109; Singer JT, 2010, APPL ENVIRON MICROB, V76, P3467, DOI 10.1128/AEM.01679-09; Sullivan AB, 2015, INFECT IMMUN, V83, P1629, DOI 10.1128/IAI.02329-14; Sumiyoshi M, 2008, INVEST OPHTH VIS SCI, V49, P197, DOI 10.1167/iovs.07-1038; Swan JS, 2002, CURR EYE RES, V24, P397, DOI 10.1076/ceyr.24.5.397.8521; Takeuchi O, 2002, CURR TOP MICROBIOL, V270, P155; Tam C, 2012, J CLIN INVEST, V122, P3665, DOI 10.1172/JCI64416; Tam C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024008; Thornton DJ, 2008, ANNU REV PHYSIOL, V70, P459, DOI 10.1146/annurev.physiol.70.113006.100702; TSANG KWT, 1994, EUR RESPIR J, V7, P1746, DOI 10.1183/09031936.94.07101746; Vijmasi T, 2013, MOL VIS, V19, P1957; Williamson YM, 2008, MICROB PATHOGENESIS, V44, P175, DOI 10.1016/j.micpath.2007.08.016; Woodward AM, 2014, INVEST OPHTH VIS SCI, V55, P6132, DOI 10.1167/iovs.14-15269	54	7	7	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2393	2404		10.1096/fj.201601198R	http://dx.doi.org/10.1096/fj.201601198R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28223334	Green Published			2022-12-28	WOS:000401553400015
J	Hifumi, E; Taguchi, H; Kato, R; Uda, T				Hifumi, Emi; Taguchi, Hiroaki; Kato, Ryuichi; Uda, Taizo			Role of the constant region domain in the structural diversity of human antibody light chains	FASEB JOURNAL			English	Article						molecular heterogeneity; electrical charge; molecular size; cation-exchange chromatography; 2D electrophoresis	BIOCHEMICAL FEATURES; MONOCLONAL-ANTIBODY; FACTOR-VIII; HETEROGENEITY; ELECTROPHORESIS; TRASTUZUMAB; HEMOPHILIA; HYDROLYSIS; SITES; HIV	Issues regarding the structural diversity (heterogeneity) of anantibody molecule have beenthe subject of discussion along with the development of antibody drugs. Research on heterogeneity has been extensive in recent years, butno clear solutionhas been reached. Heterogeneity is also observed incatalytic antibodyk light chains (CLs). In this study, we investigated how the constant region domain of CLs concerns structural diversity because it is a simple and good example for elucidating heterogeneity. Bymeans of cation-exchange chromatography, SDS-PAGE, and 2-dimensional electrophoresis for the CL, multimolecular forms consisting of different electrical charges and molecular sizes coexisted in the solution, resulting in the similar heterogeneity of the full length ofCLs. The addition of copper ion could cause the multimolecular forms to change to monomolecular forms. Copper ion contributed greatly to the enrichment of the dimer form of CL and the homogenization of the differently charged CLs. Two molecules of the CL protein bound one copper ion. The binding affinity of the ion was 48.0 mu M-1. Several divalent metal ions were examined, but only zinc showed a similar effect.-Hifumi, E., Taguchi, H., Kato, R., Uda, T. Role of the constant region domain in the structural diversity of human antibody light chains. FASEB J. 31, 1668-1677 (2017). www.fasebj.org	[Hifumi, Emi] Oita Univ, Res Promot Inst, 700 Dannoharu, Oita, Oita 8701192, Japan; [Uda, Taizo] Oita Univ, Fac Engn, Dept Appl Chem, Oita, Oita, Japan; [Taguchi, Hiroaki] Suzuka Univ Med Sci, Fac Pharmaceut Sci, Suzuka, Japan; [Kato, Ryuichi] High Energy Accelerator Res Org KEK, Inst Mat Struct Sci, Tsukuba, Ibaraki, Japan; [Uda, Taizo] Inst Syst Informat Technol & Nanotechnol, Nanotechnol Lab, Fukuoka, Japan	Oita University; Oita University; High Energy Accelerator Research Organization (KEK)	Hifumi, E (corresponding author), Oita Univ, Res Promot Inst, 700 Dannoharu, Oita, Oita 8701192, Japan.	e-hifumi@oita-u.ac.jp		Kato, Ryuichi/0000-0003-2087-2896; Uda, Taizo/0000-0001-8146-7902	Japan Science and Technology Agency (CREST/Establishment of Innovative Manufacturing Technology Based on Nanoscience); Ministry of Education, Culture, Sports, Science and Technology of Japan [24350085, 16II02282]; "Super Highway," the accelerated research	Japan Science and Technology Agency (CREST/Establishment of Innovative Manufacturing Technology Based on Nanoscience); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); "Super Highway," the accelerated research	This study was supported by the Japan Science and Technology Agency (CREST/Establishment of Innovative Manufacturing Technology Based on Nanoscience), by "Super Highway," the accelerated research to bridge university IPs and practical use, and by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology of Japan (24350085 and 16II02282). The authors thank Mr. S. Itonaga and Ms. Y. Akiyoshi (Oita University) for assistance with this study. The authors declare no conflicts of interest.	Bezuglova AM, 2011, J MOL RECOGNIT, V24, P960, DOI 10.1002/jmr.1143; Durova OM, 2009, MOL IMMUNOL, V47, P87, DOI 10.1016/j.molimm.2008.12.020; Fujimoto N., 2009, P J1 52 ANN M CHEM S; Glassy Mark C., 2009, Human Antibodies, V18, P127, DOI 10.3233/HAB-2009-0209; Harris RJ, 2001, J CHROMATOGR B, V752, P233, DOI 10.1016/S0378-4347(00)00548-X; Hifumi E, 2002, J IMMUNOL METHODS, V269, P283, DOI 10.1016/S0022-1759(02)00242-9; Hifumi E, 2008, J BIOL CHEM, V283, P899, DOI 10.1074/jbc.M705674200; Hifumi E, 2016, FASEB J, V30, P895, DOI 10.1096/fj.15-276394; Hifumi E, 2015, FASEB J, V29, P2347, DOI 10.1096/fj.14-264275; Hifumi E, 2013, J BIOL CHEM, V288, P19558, DOI 10.1074/jbc.M113.454579; Hifumi E, 2012, FASEB J, V26, P1607, DOI 10.1096/fj.11-195339; Hifumi E, 2010, FEBS J, V277, P3823, DOI 10.1111/j.1742-4658.2010.07785.x; Holm RH, 1996, CHEM REV, V96, P2239, DOI 10.1021/cr9500390; Hortobagyi GN, 2005, NEW ENGL J MED, V353, P1734, DOI 10.1056/NEJMe058196; Hunt G, 1996, J CHROMATOGR A, V744, P295, DOI 10.1016/0021-9673(96)00437-2; Kou JH, 2015, MOL NEUROBIOL, V51, P43, DOI 10.1007/s12035-014-8691-z; Lacroix-Desmazes S, 1999, NAT MED, V5, P1044, DOI 10.1038/12483; Matsuura K, 1998, BIOCHEM BIOPH RES CO, V243, P719, DOI 10.1006/bbrc.1998.8164; Meza-Junco Judith, 2011, Cancer Manag Res, V3, P57, DOI 10.2147/CMR.S12698; Nebija D, 2014, INT J MOL SCI, V15, P6399, DOI 10.3390/ijms15046399; Nishiyama Y, 2014, J BIOTECHNOL, V180, P17, DOI 10.1016/j.jbiotec.2014.03.026; Odintsova ES, 2011, J MOL RECOGNIT, V24, P45, DOI 10.1002/jmr.1022; Ohara K, 2004, BIOCHEM BIOPH RES CO, V315, P612, DOI 10.1016/j.bbrc.2004.01.094; Parkhomenko TA, 2010, BIOCHIMIE, V92, P545, DOI 10.1016/j.biochi.2010.01.022; Paul S, 2004, J BIOL CHEM, V279, P39611, DOI 10.1074/jbc.M406719200; Planque S, 2008, AUTOIMMUN REV, V7, P473, DOI 10.1016/j.autrev.2008.04.002; Radulescu RT, 1998, IMMUNOL TODAY, V19, P288, DOI 10.1016/S0167-5699(98)01262-6; RADULESCU RT, 1995, MED HYPOTHESES, V44, P137, DOI 10.1016/0306-9877(95)90087-X; Smirnov I, 2011, P NATL ACAD SCI USA, V108, P15954, DOI 10.1073/pnas.1108460108; Solomon EI, 2006, INORG CHEM, V45, P8012, DOI 10.1021/ic060450d; STEVENS FJ, 1988, P NATL ACAD SCI USA, V85, P6895, DOI 10.1073/pnas.85.18.6895; Wootla B, 2009, FEBS LETT, V583, P2565, DOI 10.1016/j.febslet.2009.07.009	32	5	5	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1668	1677		10.1096/fj.201600819R	http://dx.doi.org/10.1096/fj.201600819R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28096233				2022-12-28	WOS:000398504300031
J	Katsiougiannis, S; Chia, D; Kim, Y; Singh, RP; Wong, DTW				Katsiougiannis, Stergios; Chia, David; Kim, Yong; Singh, Ram P.; Wong, David T. W.			Saliva exosomes from pancreatic tumor-bearing mice modulate NK cell phenotype and antitumor cytotoxicity	FASEB JOURNAL			English	Article						extracellular vesicles; immune surveillance; cancer	NATURAL-KILLER-CELL; EXTRACELLULAR VESICLES; CANCER EXOSOMES; EMERGING ROLE; MARKERS; BIOMARKERS; INNATE	Tumor exosomes are emerging as antitumor immunity regulators; however, their effects on secondary exosome secretion by distal organs have not been explored. We have previously demonstrated that suppression of exosomes at the distal tumor site of pancreatic ductal adenocarcinoma (PDAC) ablated the development of salivary biomarker profile. Here, we explore the function of salivary exosomes from tumor-bearing mice in immune surveillance. We provide evidence that salivary exosomes from mice with PDA Cexhibit a suppressive effect that results in reduced tumor-killing capacity by NK cells. Salivary exosomes from mice with PDAC where pancreatic tumors were engineered to suppress exosome biogenesis failed to suppress NK cell cytotoxic potential against tumor cells, as opposed to salivary exosomes from mice with PDAC with normal tumor exosome biogenesis. These results reveal an important and previously unknown mechanism of antitumor immune regulation and provide new in sights into our understanding of the alterations of this biofluid during tumor development.	[Katsiougiannis, Stergios; Kim, Yong; Wong, David T. W.] Univ Calif Los Angeles, Sch Dent, Ctr Oral Head & Neck Oncol Res, 10833 Le Conte Ave,Box 951668, Los Angeles, CA 90024 USA; [Chia, David; Kim, Yong; Wong, David T. W.] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA; [Kim, Yong] Univ Calif Los Angeles, Lab Stem Cell & Canc Epigenet Res, Los Angeles, CA USA; [Chia, David] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA USA; [Singh, Ram P.] Univ Calif Los Angeles, David Geffen Sch Med, Div Rheumatol, Los Angeles, CA 90095 USA; [Singh, Ram P.] Vet Affairs Greater Los Angeles Healthcare Syst, Los Angeles, CA USA	University of California System; University of California Los Angeles; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Greater Los Angeles Healthcare System	Wong, DTW (corresponding author), Univ Calif Los Angeles, Sch Dent, Ctr Oral Head & Neck Oncol Res, 10833 Le Conte Ave,Box 951668, Los Angeles, CA 90024 USA.	dwong@dentistry.ucla.edu	Katsiougiannis, Stergios/ABB-8564-2020	Singh, Ram/0000-0002-3203-4454	NCATS NIH HHS [UH2 TR000923, UH3 TR000923] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UH3TR000923, UH2TR000923] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))		An TX, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.27522; Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Borrego F, 1999, IMMUNOLOGY, V97, P159, DOI 10.1046/j.1365-2567.1999.00738.x; Buzas EI, 2014, NAT REV RHEUMATOL, V10, P356, DOI 10.1038/nrrheum.2014.19; Clark CE, 2007, CANCER RES, V67, P9518, DOI 10.1158/0008-5472.CAN-07-0175; Costa-Silva B, 2015, NAT CELL BIOL, V17, P816, DOI 10.1038/ncb3169; Elashoff D, 2012, CANCER EPIDEM BIOMAR, V21, P664, DOI 10.1158/1055-9965.EPI-11-1093; Gallo A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030679; Guerra N, 2008, IMMUNITY, V28, P571, DOI 10.1016/j.immuni.2008.02.016; Gyorgy B, 2011, CELL MOL LIFE SCI, V68, P2667, DOI 10.1007/s00018-011-0689-3; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Humeau M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130996; Jakobsen KR, 2015, J EXTRACELL VESICLES, V4, DOI 10.3402/jev.v4.26659; Kanada M, 2015, P NATL ACAD SCI USA, V112, pE1433, DOI 10.1073/pnas.1418401112; Kowal J, 2016, P NATL ACAD SCI USA, V113, pE968, DOI 10.1073/pnas.1521230113; Lau C, 2013, J BIOL CHEM, V288, P26888, DOI 10.1074/jbc.M113.452458; Melo SA, 2015, NATURE, V523, P177, DOI 10.1038/nature14581; Morvan MG, 2016, NAT REV CANCER, V16, P7, DOI 10.1038/nrc.2015.5; Navarro AG, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00202; Orange JS, 2013, J ALLERGY CLIN IMMUN, V132, P515, DOI 10.1016/j.jaci.2013.07.020; Peinado H, 2012, NAT MED, V18, P883, DOI 10.1038/nm.2753; PROSS HF, 1993, NAT IMMUN, V12, P279; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; Whiteside TL, 2016, J CLIN INVEST, V126, P1216, DOI 10.1172/JCI81136; Wong DTW, 2015, CLIN THER, V37, P540, DOI 10.1016/j.clinthera.2015.02.017; Yang JP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110641; Zhang L, 2012, CELL MOL LIFE SCI, V69, P3341, DOI 10.1007/s00018-012-1027-0; Zhang L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015573	29	48	54	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					998	+		10.1096/fj.201600984R	http://dx.doi.org/10.1096/fj.201600984R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27895106	Green Published			2022-12-28	WOS:000395671200016
J	Ma, SB; Ming, ZP; Gong, AY; Wang, Y; Chen, XQ; Hu, GK; Zhou, R; Shibata, A; Swanson, PC; Chen, XM				Ma, Shibin; Ming, Zhenping; Gong, Ai-Yu; Wang, Yang; Chen, Xiqiang; Hu, Guoku; Zhou, Rui; Shibata, Annemarie; Swanson, Patrick C.; Chen, Xian-Ming			A long noncoding RNA, lincRNA-Tnfaip3, acts as a coregulator of NF-kappa B to modulate inflammatory gene transcription in mouse macrophages	FASEB JOURNAL			English	Article						lincRNAs; Hmgb1; inflammation; histone modifications	PROTEIN-CHROMATIN INTERACTIONS; MEDIATED DOWN-REGULATION; HMGB1; COMPLEXES; LOC100130476; DYNAMICS; INSIGHTS; REVEALS; BINDING; SWI/SNF	Long intergenic noncoding RNAs (lincRNAs) are long noncoding transcripts (>200 nt) from the intergenic regions of annotated protein-coding genes. We report here that the lincRNA gene lincRNA-Tnfaip3, located at mouse chromosome 10 proximal to the tumor necrosis factor alpha-induced protein 3 (Tnfaip3) gene, is an early-primary response gene controlled by nuclear factor-kappa B (NF-kappa B) signaling in murine macrophages. Functionally, lincRNA-Tnfaip3 appears to mediate both the activation and repression of distinct classes of inflammatory genes in macrophages. Specifically, induction of lincRNA-Tnfaip3 is required for the transactivation of NF-kappa B-regulated inflammatory genes in response to bacterial LPSs stimulation. LincRNA-Tnfaip3 physically interacts with the high-mobility group box 1 (Hmgb1), assembling a NF-kappa B/Hmgb1/lincRNA-Tnfaip3 complex in macrophages after LPS stimulation. This resultantNF-kappa B/Hmgb1/lincRNA-Tnfaip3 complex can modulate Hmgb1-associated histone modifications and, ultimately, transactivation of inflammatory genes in mouse macrophages in response to microbial challenge. Therefore, our data indicate a new regulatory role of NF-kappa Binduced lincRNA-Tnfaip3 to act as a coactivator of NF-kappa B for the transcription of inflammatory genes in innate immune cells throughmodulation of epigenetic chromatin remodeling.- Ma, S., Ming, Z., Gong, A.- Y., Wang, Y., Chen, X., Hu, G., Zhou, R., Shibata, A., Swanson, P. C., Chen, X.- M. A long noncoding RNA, LincRNA- Tnfaip3, acts as a coregulator of NF- kB to modulate inflammatory gene transcription in mouse macrophages.	[Ma, Shibin; Ming, Zhenping; Gong, Ai-Yu; Wang, Yang; Chen, Xiqiang; Hu, Guoku; Swanson, Patrick C.; Chen, Xian-Ming] Creighton Univ, Sch Med, Dept Med Microbiol & Immunol, Omaha, NE USA; [Shibata, Annemarie] Creighton Univ, Dept Biol, Coll Arts & Sci, Omaha, NE 68178 USA; [Ming, Zhenping; Zhou, Rui] Wuhan Univ, Sch Basic Med Sci, Dept Med Parasitol, Wuhan, Hubei, Peoples R China; [Hu, Guoku] Univ Nebraska, Med Ctr, Dept Pharmacol & Expt Neurosci, Omaha, NE USA	Creighton University; Creighton University; Wuhan University; University of Nebraska System; University of Nebraska Medical Center	Chen, XM (corresponding author), Creighton Univ, Sch Med, Med Microbiol & Immunol, Criss 2,Room 529,2500 Calif Plaza, Omaha, NE 68178 USA.	xianmingchen@creighton.edu	Hu, Guoku/AAG-7233-2019	Hu, Guoku/0000-0002-4792-0416	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [AI095532, AI116323]; Creighton University through the Nebraska Department of Health and Human Services [LB595]; NIH National Center for Research Resources [G20RR024001]; NATIONAL CENTER FOR RESEARCH RESOURCES [G20RR024001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI116323, U01AI095532] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM103509] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Creighton University through the Nebraska Department of Health and Human Services; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Andrew D. Badley (Mayo Clinic, Rochester, NY, USA) for providing the p65 and Ikk alpha-mutant plasmids and Barbara L. Bittner (Creighton University) for assistance in writing the manuscript. This work was supported by funding from the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (Grants AI095532 and AI116323), by revenue from Nebraska's excise tax on cigarettes awarded to Creighton University through the Nebraska Department of Health and Human Services (DHHS; LB595 to X.-M.C.), and by Grant G20RR024001 from the NIH National Center for Research Resources. The content of this research is solely the responsibility of the authors and does not necessarily represent the official views of the State of Nebraska, DHHS, National Center for Research Resources, or the NIH. The authors declare no conflicts of interest.	Agresti A, 2005, MOL CELL, V18, P109, DOI 10.1016/j.molcel.2005.03.005; Agresti A, 2003, BIOCHEM BIOPH RES CO, V302, P421, DOI 10.1016/S0006-291X(03)00184-0; Ando H, 2000, J PHARMACOL EXP THER, V294, P1043; Barton GM, 2008, J CLIN INVEST, V118, P413, DOI 10.1172/JCI34431; Bhatt DM, 2012, CELL, V150, P279, DOI 10.1016/j.cell.2012.05.043; Bianchi ME, 2007, IMMUNOL REV, V220, P35, DOI 10.1111/j.1600-065X.2007.00574.x; Bohrer H, 1997, J CLIN INVEST, V100, P972, DOI 10.1172/JCI119648; Bonaldi T, 2003, EMBO J, V22, P5551, DOI 10.1093/emboj/cdg516; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carpenter S, 2013, SCIENCE, V341, P789, DOI 10.1126/science.1240925; Castello A, 2012, CELL, V149, P1393, DOI 10.1016/j.cell.2012.04.031; Catez F, 2004, MOL CELL BIOL, V24, P4321, DOI 10.1128/MCB.24.10.4321-4328.2004; Chu C, 2011, MOL CELL, V44, P667, DOI 10.1016/j.molcel.2011.08.027; Dempsey L. A., 2013, NAT IMMUNOL, V14, P1036; Fowler T, 2011, MOL CELL, V44, P348, DOI 10.1016/j.molcel.2011.09.014; Garmire LX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024051; Gerlitz G, 2009, BIOCHEM CELL BIOL, V87, P127, DOI 10.1139/O08-110; Guo W, 2016, DIGEST LIVER DIS, V48, P961, DOI 10.1016/j.dld.2016.05.010; Guo W, 2016, CLIN EXP METASTAS, V33, P497, DOI 10.1007/s10585-016-9794-x; Guttman M, 2011, NATURE, V477, P295, DOI 10.1038/nature10398; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Haddad JJ, 2011, CELL IMMUNOL, V271, P5, DOI 10.1016/j.cellimm.2011.06.021; Ho L, 2009, P NATL ACAD SCI USA, V106, P5181, DOI 10.1073/pnas.0812889106; Hu GK, 2016, J IMMUNOL, V196, P2799, DOI 10.4049/jimmunol.1502146; Khalil AM, 2009, P NATL ACAD SCI USA, V106, P11667, DOI 10.1073/pnas.0904715106; Kimura H, 2013, J HUM GENET, V58, P439, DOI 10.1038/jhg.2013.66; Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521; Moran VA, 2012, NUCLEIC ACIDS RES, V40, P6391, DOI 10.1093/nar/gks296; Natoli G, 2005, NAT IMMUNOL, V6, P439, DOI 10.1038/ni1196; Natoli G, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000224; Peng XX, 2010, MBIO, V1, DOI 10.1128/mBio.00206-10; Phair RD, 2004, MOL CELL BIOL, V24, P6393, DOI 10.1128/MCB.24.14.6393-6402.2004; Ramirez-Carrozzi VR, 2006, GENE DEV, V20, P282, DOI 10.1101/gad.1383206; Rapicavoli NA, 2013, ELIFE, V2, DOI 10.7554/eLife.00762; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; Sen R, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000257; Stros M, 2010, BBA-GENE REGUL MECH, V1799, P101, DOI 10.1016/j.bbagrm.2009.09.008; Tan BCM, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-57; Tong Q, 2016, FASEB J, V30, P1187, DOI 10.1096/fj.15-279166; Ulitsky I, 2013, CELL, V154, P26, DOI 10.1016/j.cell.2013.06.020; Wan FY, 2007, CELL, V131, P927, DOI 10.1016/j.cell.2007.10.009; Wang HH, 2001, AM J RESP CRIT CARE, V164, P1768, DOI 10.1164/ajrccm.164.10.2106117; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	43	51	57	0	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1215	1225		10.1096/fj.201601056R	http://dx.doi.org/10.1096/fj.201601056R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27979905	Green Published			2022-12-28	WOS:000395671200033
J	Andrianifahanana, M; Hernandez, DM; Yin, XQ; Kang, JH; Jung, MY; Wang, YL; Yi, ES; Roden, AC; Limper, AH; Leof, EB				Andrianifahanana, Mahefatiana; Hernandez, Danielle M.; Yin, Xueqian; Kang, Jeong-Han; Jung, Mi-Yeon; Wang, Youli; Yi, Eunhee S.; Roden, Anja C.; Limper, Andrew H.; Leof, Edward B.			Profibrotic up-regulation of glucose transporter 1 by TGF- involves activation of MEK and mammalian target of rapamycin complex 2 pathways	FASEB JOURNAL			English	Article						fibrosis; signaling; metabolism	GROWTH-FACTOR-BETA; STIMULATES GLUCOSE-UPTAKE; IDIOPATHIC PULMONARY-FIBROSIS; PHOSPHATIDYLINOSITOL 3-KINASE; MESANGIAL CELLS; MAP KINASE; MYOFIBROBLAST DIFFERENTIATION; P21-ACTIVATED KINASE-2; MESENCHYMAL TRANSITION; DIABETIC-NEPHROPATHY	TGF- plays a central role in the pathogenesis of fibroproliferative disorders. Defining the exact underlying molecular basis is therefore critical for the development of viable therapeutic strategies. Here, we show that expression of the facilitative glucose transporter 1 (GLUT1) is induced by TGF- in fibroblast lines and primary cells and is required for the profibrotic effects of TGF-. In addition, enhanced GLUT1 expression is observed in fibrotic areas of lungs of both patients with idiopathic pulmonary fibrosis and mice that are subjected to a fibrosis-inducing bleomycin treatment. By using pharmacologic and genetic approaches, we demonstrate that up-regulation of GLUT1 occurs via the canonical Smad2/3 pathway and requires autocrine activation of the receptor tyrosine kinases, platelet-derived and epidermal growth factor receptors. Engagement of the common downstream effector PI3K subsequently triggers activation of the MEK and mammalian target of rapamycin complex 2, which cooperate in regulating GLUT1 expression. Of note, inhibition of GLUT1 activity and/or expression is shown to impair TGF--driven fibrogenic processes, including cell proliferation and production of profibrotic mediators. These findings provide new perspectives on the interrelation of metabolism and profibrotic TGF- signaling and present opportunities for potential therapeutic intervention.Andrianifahanana, M., Hernandez, D. M., Yin, X., Kang, J.-H., Jung, M.-Y., Wang, Y., Yi, E. S., Roden, A. C., Limper, A. H., Leof, E. B. Profibrotic up-regulation of glucose transporter 1 by TGF- involves activation of MEK and mammalian target of rapamycin complex 2 pathways.	[Andrianifahanana, Mahefatiana; Hernandez, Danielle M.; Yin, Xueqian; Kang, Jeong-Han; Jung, Mi-Yeon; Wang, Youli; Limper, Andrew H.; Leof, Edward B.] Mayo Clin, Coll Med, Dept Biochem & Mol Biol, Thorac Dis Res Unit,Div Pulm & Crit Care Med, Rochester, MN USA; [Yi, Eunhee S.; Roden, Anja C.] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [Wang, Youli] Augusta Univ, Div Nephrol, Augusta, GA USA	Mayo Clinic; Mayo Clinic; University System of Georgia; Augusta University	Leof, EB (corresponding author), Mayo Clin, Coll Med, Thorac Dis Res Unit, 8-58 Stabile,200 Second St SW, Rochester, MN 55905 USA.	leof.edward@mayo.edu	Kang, Jeong-Han/J-3541-2019	Kang, Jeong-Han/0000-0002-9693-0696; Hernandez, Danielle M./0000-0003-0867-4950	Public Health Service from the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [GM-55816, GM-54200]; Caerus Foundation; Mayo Foundation; NIH National Heart Lung and Blood Lung Tissue Research Consortium [268201100020C-7-0-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM055816, R37GM055816, R01GM054200] Funding Source: NIH RePORTER	Public Health Service from the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; Caerus Foundation; Mayo Foundation; NIH National Heart Lung and Blood Lung Tissue Research Consortium; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Public Health Service grants GM-55816 and GM-54200 from the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences, the Caerus Foundation, and the Mayo Foundation (to E.B.L.). A majority of IPF cases were obtained through the NIH National Heart Lung and Blood Lung Tissue Research Consortium (Contract No. 268201100020C-7-0-1). The authors declare no conflicts of interest.	ADAMSON IYR, 1974, AM J PATHOL, V77, P185; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Pereira KMA, 2013, ONCOL LETT, V6, P311, DOI 10.3892/ol.2013.1371; Andrianifahanana M, 2013, FASEB J, V27, P4444, DOI 10.1096/fj.12-224907; Andrianifahanana M, 2010, CANCER RES, V70, P7421, DOI 10.1158/0008-5472.CAN-10-0232; Barron CC, 2016, METABOLISM, V65, P124, DOI 10.1016/j.metabol.2015.10.007; Basu RK, 2011, AM J PHYSIOL-RENAL, V300, pF898, DOI 10.1152/ajprenal.00335.2010; Bhowmick NA, 2001, MOL BIOL CELL, V12, P27, DOI 10.1091/mbc.12.1.27; Blackwell TS, 2014, AM J RESP CRIT CARE, V189, P214, DOI 10.1164/rccm.201306-1141WS; Bruna A, 2007, CANCER CELL, V11, P147, DOI 10.1016/j.ccr.2006.11.023; Chen LQ, 2015, ANNU REV BIOCHEM, V84, P865, DOI 10.1146/annurev-biochem-060614-033904; Chen YJ, 2002, KIDNEY INT, V62, P1149, DOI 10.1111/j.1523-1755.2002.kid567.x; DANIEL TO, 1987, J BIOL CHEM, V262, P11893; Daniels CE, 2004, J CLIN INVEST, V114, P1308, DOI 10.1175/JCI200419603; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; El-Chemaly S, 2013, CHEST, V143, P1685, DOI 10.1378/chest.12-1359; Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018; Garud MS, 2014, CURR DIABETES REV, V10, P182, DOI 10.2174/1573399810666140606103645; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hanna C, 2013, AM J PHYSIOL-RENAL, V305, pF1323, DOI 10.1152/ajprenal.00155.2013; Harris VM, 2012, J ENDOCRINOL, V212, P139, DOI 10.1530/JOE-11-0359; Heilig CW, 2013, AM J NEPHROL, V38, P39, DOI 10.1159/000351989; Hong M, 2011, J BIOL CHEM, V286, P17841, DOI 10.1074/jbc.M111.233676; Inoki K, 1999, KIDNEY INT, V55, P1704, DOI 10.1046/j.1523-1755.1999.00438.x; KITAGAWA T, 1991, J BIOL CHEM, V266, P18066; Kolosova I, 2011, J CELL PHYSIOL, V226, P1248, DOI 10.1002/jcp.22448; Kottmann RM, 2012, AM J RESP CRIT CARE, V186, P740, DOI 10.1164/rccm.201201-0084OC; KOZMA L, 1993, P NATL ACAD SCI USA, V90, P4460, DOI 10.1073/pnas.90.10.4460; Lamouille S, 2007, J CELL BIOL, V178, P437, DOI 10.1083/jcb.200611146; Leask A, 2010, CIRC RES, V106, P1675, DOI 10.1161/CIRCRESAHA.110.217737; LEOF EB, 1986, P NATL ACAD SCI USA, V83, P2453, DOI 10.1073/pnas.83.8.2453; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Macheda ML, 2005, J CELL PHYSIOL, V202, P654, DOI 10.1002/jcp.20166; Marin-Hernandez A, 2009, MINI-REV MED CHEM, V9, P1084, DOI 10.2174/138955709788922610; Masoud GN, 2015, ACTA PHARM SIN B, V5, P378, DOI 10.1016/j.apsb.2015.05.007; Massague J, 2000, CELL, V103, P295, DOI 10.1016/S0092-8674(00)00121-5; Morrison DK, 2003, ANNU REV CELL DEV BI, V19, P91, DOI 10.1146/annurev.cellbio.19.111401.091942; MOSELEY PL, 1986, J CLIN INVEST, V78, P1150, DOI 10.1172/JCI112695; MOSES HL, 1981, CANCER RES, V41, P2842; Mu YB, 2012, CELL TISSUE RES, V347, P11, DOI 10.1007/s00441-011-1201-y; Mueckler M, 2013, MOL ASPECTS MED, V34, P121, DOI 10.1016/j.mam.2012.07.001; Nakerakanti Sashidhar, 2012, Open Rheumatol J, V6, P156, DOI 10.2174/1874312901206010156; Nose A, 2003, HYPERTENS RES, V26, P67; Olsen JM, 2014, J CELL BIOL, V207, P365, DOI 10.1083/jcb.201403080; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Pinzani M, 2008, CLIN LIVER DIS, V12, P901, DOI 10.1016/j.cld.2008.07.006; Prud'homme GJ, 2007, LAB INVEST, V87, P1077, DOI 10.1038/labinvest.3700669; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Rahimi RA, 2009, CANCER RES, V69, P84, DOI 10.1158/0008-5472.CAN-08-2146; Ramos JW, 2008, INT J BIOCHEM CELL B, V40, P2707, DOI 10.1016/j.biocel.2008.04.009; Rizvi S, 2014, WORLD J DIABETES, V5, P809, DOI 10.4239/wjd.v5.i6.809; ROBERTS AB, 1981, P NATL ACAD SCI-BIOL, V78, P5339, DOI 10.1073/pnas.78.9.5339; Rosenbloom J, 2010, ANN INTERN MED, V152, P159, DOI 10.7326/0003-4819-152-3-201002020-00007; Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006; Santalucia T, 2003, CARDIOVASC RES, V59, P639, DOI 10.1016/S0008-6363(03)00472-3; Schena FP, 2005, J AM SOC NEPHROL, V16, pS30, DOI 10.1681/ASN.2004110970; Sime PJ, 2001, CLIN IMMUNOL, V99, P308, DOI 10.1006/clim.2001.5008; Sivakumar P, 2012, CURR OPIN PULM MED, V18, P462, DOI 10.1097/MCP.0b013e328356800f; Suzuki K, 2007, CANCER RES, V67, P3673, DOI 10.1158/0008-5472.CAN-06-3211; Szablewski L, 2013, BBA-REV CANCER, V1835, P164, DOI 10.1016/j.bbcan.2012.12.004; Tallquist M, 2004, CYTOKINE GROWTH F R, V15, P205, DOI 10.1016/j.cytogfr.2004.03.003; Taylor LM, 2000, J BIOL CHEM, V275, P16709, DOI 10.1074/jbc.275.22.16709; Thorens B, 1996, AM J PHYSIOL-GASTR L, V270, pG541, DOI 10.1152/ajpgi.1996.270.4.G541; Thorens B, 2010, AM J PHYSIOL-ENDOC M, V298, pE141, DOI 10.1152/ajpendo.00712.2009; Todd NW, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-11; Ueno M, 2011, AM J PHYSIOL-LUNG C, V300, pL740, DOI 10.1152/ajplung.00146.2010; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; WARBURG O, 1956, SCIENCE, V124, P269; Warburg O, 1927, J GEN PHYSIOL, V8, P519, DOI 10.1085/jgp.8.6.519; Wilkes MC, 2006, J BIOL CHEM, V281, P27846, DOI 10.1074/jbc.M603721200; Wilkes MC, 2005, CANCER RES, V65, P10431, DOI 10.1158/0008-5472.CAN-05-1522; Wilkes MC, 2003, MOL CELL BIOL, V23, P8878, DOI 10.1128/MCB.23.23.8878-8889.2003; Wright EM, 2004, PHYSIOLOGY, V19, P370, DOI 10.1152/physiol.00026.2004; WRIGHT EM, 1994, J EXP BIOL, V196, P197; Wu LY, 2009, DEV CELL, V17, P35, DOI 10.1016/j.devcel.2009.05.010; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xie N, 2015, AM J RESP CRIT CARE, V192, P1462, DOI 10.1164/rccm.201504-0780OC; Xie T, 2011, PHYSIOL GENOMICS, V43, P479, DOI 10.1152/physiolgenomics.00222.2010; Yang L, 2014, HEPATOLOGY, V59, P483, DOI 10.1002/hep.26698; Yarden Y, 2001, EUR J CANCER, V37, pS3; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang YE, 2009, CELL RES, V19, P128, DOI 10.1038/cr.2008.328; Zhao FQ, 2014, J MAMMARY GLAND BIOL, V19, P3, DOI 10.1007/s10911-013-9310-8	85	39	40	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3733	3744		10.1096/fj.201600428R	http://dx.doi.org/10.1096/fj.201600428R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27480571	Green Published			2022-12-28	WOS:000386474700009
J	Blasum, BS; Schroter, R; Neugebauer, U; Hofschroer, V; Pavenstadt, H; Ciarimboli, G; Schlatter, E; Edemir, B				Blasum, Britta Schulze; Schroeter, Rita; Neugebauer, Ute; Hofschroeer, Verena; Pavenstaedt, Hermann; Ciarimboli, Guiliano; Schlatter, Eberhard; Edemir, Bayram			The kidney-specific expression of genes can be modulated by the extracellular osmolality	FASEB JOURNAL			English	Article						tissue specific; gene expression; microarray	RENAL COLLECTING DUCT; TONICITY-RESPONSIVE ENHANCER; STIMULATES TRANSCRIPTION; BETAINE TRANSPORTER; BINDING PROTEIN; CELLS; HYPERTONICITY; VASOPRESSIN; CONTRIBUTES; APELIN	With this study, we wanted to prove the hypothesis that the unique extracellular osmolality within the renal medulla modulates a specific gene expression pattern. The physiologic functions of the kidneys are mediated by the segment-specific expression of key proteins. So far, we have limited knowledge about the mechanisms that control this gene expression pattern. The hyperosmolality in the renal medullary interstitium is of major importance as a driving force for urine concentration. We made use of primarily cultured rat renal inner medullary collecting-duct cells and microarray analysis to identify genes affected by the environmental osmolality of the culture medium. We identified hundreds of genes that were either induced or repressed in expression by hyperosmolality in a time- and osmolality-dependent fashion. Further analysis demonstrated that many of them, physiologically, showed a kidney- and even collecting-duct-specific expression, including secreted proteins, kinases, and transcription factors. On the other hand, we identified factors, down-regulated in expression, that have a diuretic effect. In conclusion, the kidney is the only organ that has such a hyperosmotic environment, and study provides an excellent method for controlling tissue-specific gene expression.	[Blasum, Britta Schulze; Schroeter, Rita; Neugebauer, Ute; Pavenstaedt, Hermann; Ciarimboli, Guiliano; Schlatter, Eberhard; Edemir, Bayram] Univ Munster, Dept Internal Med D, Expt Nephrol, Munster, Germany; [Hofschroeer, Verena] Univ Munster, Inst Physiol 2, Munster, Germany; [Edemir, Bayram] Univ Halle Wittenberg, Dept Med Hematol & Oncol, Fac Med, Halle, Saale, Germany; [Edemir, Bayram] Univ Clin Halle Saale, Clin Internal Med Hematol & Oncol 4, Halle, Germany	University of Munster; University of Munster; Martin Luther University Halle Wittenberg; Martin Luther University Halle Wittenberg	Edemir, B (corresponding author), Univ Halle Wittenberg, Albert Schweitzer Campus 1,A14, D-48149 Halle, Saale, Germany.	bayram.edemir@uk-halle.de	Edemir, Bayram/AAF-6845-2020		Else Kroner-Fresenius Stiftung	Else Kroner-Fresenius Stiftung	The authors thank Prof. Mark A. Knepper (Epithelial Systems Biology Laboratory, National Institutes of Health, Bethesda, MD, USA) for supporting this project by addition of our data to the IMCD transcriptome database and Astrid Dirks (University of Munster) for technical assistance. This study was supported by the Else Kroner-Fresenius Stiftung (to E.S. and B.E.). The authors declare no conflicts of interest.	Azizi M, 2008, J AM SOC NEPHROL, V19, P1015, DOI 10.1681/ASN.2007070816; Berl Tomas, 2009, Trans Am Clin Climatol Assoc, V120, P389; Bortner CD, 1996, AM J PHYSIOL-CELL PH, V271, pC950, DOI 10.1152/ajpcell.1996.271.3.C950; Burg MB, 2007, PHYSIOL REV, V87, P1441, DOI 10.1152/physrev.00056.2006; Cheng CW, 2005, KIDNEY INT, V68, P2694, DOI 10.1111/j.1523-1755.2005.00740.x; De Mota N, 2004, P NATL ACAD SCI USA, V101, P10464, DOI 10.1073/pnas.0403518101; DiRocco DP, 2013, J AM SOC NEPHROL, V24, P1399, DOI 10.1681/ASN.2012050512; Fujiu K, 2011, J CLIN INVEST, V121, P3425, DOI 10.1172/JCI57582; Gonzalez J, 2013, BIOCHEM BIOPH RES CO, V438, P257, DOI 10.1016/j.bbrc.2013.07.025; Grunewald RW, 1998, CELL PHYSIOL BIOCHEM, V8, P293, DOI 10.1159/000016291; Hasler U, 2006, J AM SOC NEPHROL, V17, P1521, DOI 10.1681/ASN.2005121317; Hus-Citharel A, 2014, ENDOCRINOLOGY, V155, P4483, DOI 10.1210/en.2014-1257; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ito T, 2004, BIOCHEM J, V382, P177, DOI 10.1042/BJ20031838; Izumi Y, 2015, PHYSIOL GENOMICS, V47, P500, DOI 10.1152/physiolgenomics.00057.2015; Jeon US, 2006, ACTA PHYSIOL, V187, P241, DOI 10.1111/j.1748-1716.2006.01551.x; Kamsteeg EJ, 2007, P NATL ACAD SCI USA, V104, P16696, DOI 10.1073/pnas.0708023104; Klokkers J, 2009, AM J PHYSIOL-RENAL, V297, pF693, DOI 10.1152/ajprenal.00136.2009; Kuper C, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00293; Lee JW, 2015, J AM SOC NEPHROL, V26, P2669, DOI 10.1681/ASN.2014111067; Miyakawa H, 1999, BBA-GENE STRUCT EXPR, V1446, P359, DOI 10.1016/S0167-4781(99)00122-0; Nakayama Y, 2000, J BIOL CHEM, V275, P38275, DOI 10.1074/jbc.M004678200; Petryszak R, 2014, NUCLEIC ACIDS RES, V42, pD926, DOI 10.1093/nar/gkt1270; Riethmuller C, 2008, BIOPHYS J, V94, P671, DOI 10.1529/biophysj.107.104893; Rinschen MM, 2011, PFLUG ARCH EUR J PHY, V462, P611, DOI 10.1007/s00424-011-0994-6; Rozenfeld J, 2011, CELL PHYSIOL BIOCHEM, V28, P385, DOI 10.1159/000335100; Schenk LK, 2010, CELL PHYSIOL BIOCHEM, V26, P887, DOI 10.1159/000323998; Soleimani M, 2015, NEPHROL DIAL TRANSPL, V30, P1257, DOI 10.1093/ndt/gfu307; Uchida S, 1997, BIOCHEM BIOPH RES CO, V232, P65, DOI 10.1006/bbrc.1997.6236; Uehara T, 2013, TOXICOLOGY, V303, P1, DOI 10.1016/j.tox.2012.09.012; Wagner CA, 2009, PFLUG ARCH EUR J PHY, V458, P137, DOI 10.1007/s00424-009-0657-z; Wong YF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045725; Woo SK, 2002, MOL CELL BIOL, V22, P5753, DOI 10.1128/MCB.22.16.5753-5760.2002; YAMAUCHI A, 1992, J BIOL CHEM, V267, P649; YAMAUCHI A, 1993, AM J PHYSIOL, V264, pF20, DOI 10.1152/ajprenal.1993.264.1.F20; Yu L, 2014, MOL CELL BIOL, V34, P1929, DOI 10.1128/MCB.01659-13; Yu MJ, 2009, P NATL ACAD SCI USA, V106, P2441, DOI 10.1073/pnas.0813002106; Zhou L, 2015, PHYSIOL GENOMICS, V47, P541, DOI 10.1152/physiolgenomics.00066.2015	38	19	19	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3588	3597		10.1096/fj.201600319R	http://dx.doi.org/10.1096/fj.201600319R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27464968				2022-12-28	WOS:000384329800027
J	Jiang, QF; Liu, ZQ; Zhou, Z; Wang, LL; Wang, LL; Yue, F; Wang, JJ; Wang, H; Song, LS				Jiang, Qiufen; Liu, Zhaoqun; Zhou, Zhi; Wang, Lingling; Wang, Leilei; Yue, Feng; Wang, Jingjing; Wang, Hao; Song, Linsheng			Transcriptional activation and translocation of ancient NOS during immune response	FASEB JOURNAL			English	Article						nitric oxide synthase; NF-kappa B; STAT	NITRIC-OXIDE SYNTHASE; NF-KAPPA-B; NERVOUS-SYSTEM; TNF-ALPHA; MOLECULAR CHARACTERIZATION; CRASSOSTREA-GIGAS; PROTEIN-KINASES; INDUCIBLE-TYPE; EXPRESSION; CELLS	NOS is the key component of the NO system, which plays an indispensable role in many physiologic and immunologic processes; however, the process that underlies the activation of ancient NOSs and their functions remains unclear. Expression of Crassostrea gigas NOS (CgNOS) mRNA in hemocytes was examined after stimulating oysters with LPS and TNF-alpha Expression level of CgNOS mRNA was increased significantly, by 2.61-fold (P < 0.05), at 24 h poststimulation. A positive CgNOS signal was detected via immunoprecipitation, and only one protein was detected in oyster hemocytes. Shifting and supershifting bands were observed in EMSAs between the CgNOS promoter and the transcription factors CgNF-kappa B1 and Cg-signal transducer and activator of transcription (STAT). CgNF-kappa B1 was detected in the nucleus only at 12 h, whereas CgSTAT was observed in the cytoplasm and nucleus at 12 and 24 h. Expression levels of tyrosine-protein kinase receptor Tie-1, phosphatidylinositide phosphatase SAC2, phosphatidylinositol-4-phosphate 5-kinase type-1, diacylglycerol kinase , LPS-induced TNF-alpha factor-like protein, cAMP-dependent transcription factor-2, NF-kappa B1, and STAT6 were significantly elevated in a transcriptome analysis after 12 h of LPS and TNF-alpha stimulation. An immunoreactive CgNOS signal was observed in both the cell membrane and cytoplasm at 12 h, whereas it was mainly localized to the cytoplasm at 24 h post-LPS and -TNF-alpha stimulation. These findings revealed that CgNOS could be transcriptionally activated by CgNF-kappa B1 and CgSTAT via the PI3K-Akt pathway, similar to what occurs for iNOS, but CgNOS translocated to the cytoplasm, similar to neuronal NOS, to modulate downstream signals during an immune defense. These results collectively provide crucial knowledge about the evolution of NOS structure and function.	[Jiang, Qiufen; Liu, Zhaoqun; Zhou, Zhi; Wang, Lingling; Wang, Leilei; Yue, Feng; Wang, Jingjing; Wang, Hao] Chinese Acad Sci, Inst Oceanol, Key Lab Expt Marine Biol, Qingdao, Peoples R China; [Jiang, Qiufen; Liu, Zhaoqun; Wang, Leilei; Yue, Feng; Wang, Jingjing] Univ Chinese Acad Sci, Beijing, Peoples R China; [Wang, Lingling; Song, Linsheng] Dalian Ocean Univ, Key Lab Mariculture & Stock Enhancement North Chi, Minist Agr, Dalian, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Dalian Ocean University; Ministry of Agriculture & Rural Affairs	Wang, LL (corresponding author), Chinese Acad Sci, Inst Oceanol, 7 Nanhai Rd, Qingdao 266071, Peoples R China.	wanglingling@ms.qdio.ac.cn	Yue, Feng/S-6565-2017		Chinese Ministry of Science and Technology [2014AA093501]; National Science Foundation of China [31530069]; earmarked funds for Modern Agro-Industry Technology Research System [CARS-48]	Chinese Ministry of Science and Technology(Ministry of Science and Technology, China); National Science Foundation of China(National Natural Science Foundation of China (NSFC)); earmarked funds for Modern Agro-Industry Technology Research System	This research was supported by the High Technology Project (863 Project, No. 2014AA093501) from the Chinese Ministry of Science and Technology, Grant 31530069 from National Science Foundation of China, and earmarked funds for Modern Agro-Industry Technology Research System (CARS-48). The authors thank Dr. Qiang Gao for his guidance on the operations of the equipment and Dr. Dahai Gao and Dr. Zhanhui Hou for help in the bioinformatical analysis. The authors declare no competing financial interests.	Alderton WK, 2001, BIOCHEM J, V357, P593, DOI 10.1042/0264-6021:3570593; Andreakis N, 2011, MOL BIOL EVOL, V28, P163, DOI 10.1093/molbev/msq179; Barcia R., 2008, ISJ, V5, P43; Bhat NR, 2002, J BIOL CHEM, V277, P29584, DOI 10.1074/jbc.M204994200; Bi XL, 2005, INT IMMUNOPHARMACOL, V5, P185, DOI 10.1016/j.intimp.2004.08.008; Bogdan C, 2001, NAT IMMUNOL, V2, P907, DOI 10.1038/ni1001-907; Bogdan CT, 2000, IMMUNOL REV, V173, P17, DOI 10.1034/j.1600-065X.2000.917307.x; Brenman JE, 1996, CELL, V84, P757, DOI 10.1016/S0092-8674(00)81053-3; Caivano M, 1998, FEBS LETT, V429, P249, DOI 10.1016/S0014-5793(98)00578-X; Chan ED, 1999, J IMMUNOL, V162, P415; Cioni C, 2012, J COMP NEUROL, V520, P364, DOI 10.1002/cne.22729; Cole AG, 2002, J EXP BIOL, V205, P3143; de Lorgeril J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023142; Fujie S, 2005, J NEUROBIOL, V62, P14, DOI 10.1002/neu.20046; Fulton D, 2002, J BIOL CHEM, V277, P4277, DOI 10.1074/jbc.M106302200; Gao Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058453; Geller DA, 1998, CANCER METAST REV, V17, P7, DOI 10.1023/A:1005940202801; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; GILBERT RS, 1993, J CELL PHYSIOL, V157, P128, DOI 10.1002/jcp.1041570117; Groves JT, 2000, CURR OPIN CHEM BIOL, V4, P687, DOI 10.1016/S1367-5931(00)00146-0; Hedgecock D, 2007, P NATL ACAD SCI USA, V104, P2313, DOI 10.1073/pnas.0610880104; Jiang QF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069158; Jiang QF, 2013, FISH SHELLFISH IMMUN, V34, P100, DOI 10.1016/j.fsi.2012.10.011; Kizaki T, 2001, BIOCHEM BIOPH RES CO, V289, P1031, DOI 10.1006/bbrc.2001.6123; Kleinert H, 2004, EUR J PHARMACOL, V500, P255, DOI 10.1016/j.ejphar.2004.07.030; Kleinert H, 2003, BIOL CHEM, V384, P1343, DOI 10.1515/BC.2003.152; KNOWLES RG, 1994, BIOCHEM J, V298, P249, DOI 10.1042/bj2980249; KOIDE M, 1993, J BIOL CHEM, V268, P24959; Korneev SA, 1998, J NEUROBIOL, V35, P65, DOI 10.1002/(SICI)1097-4695(199804)35:1<65::AID-NEU6>3.0.CO;2-9; Korneev SA, 2005, J NEUROSCI, V25, P1188, DOI 10.1523/JNEUROSCI.4671-04.2005; Kristof AS, 2001, J BIOL CHEM, V276, P8445, DOI 10.1074/jbc.M009563200; Laird MHW, 2009, J LEUKOCYTE BIOL, V85, P966, DOI 10.1189/jlb.1208763; Lee SJ, 1998, J BIOL CHEM, V273, P27430, DOI 10.1074/jbc.273.42.27430; Li HX, 2008, CYTOKINE, V41, P1, DOI 10.1016/j.cyto.2007.09.016; Li L, 2004, MAR BIOTECHNOL, V6, P26, DOI 10.1007/s10126-003-0001-0; Marcus JS, 2003, GLIA, V41, P152, DOI 10.1002/glia.10168; MESSMER UK, 1994, CELL SIGNAL, V6, P17; MICHEL T, 1993, P NATL ACAD SCI USA, V90, P6252, DOI 10.1073/pnas.90.13.6252; Miller BW, 1997, AM J PHYSIOL-CELL PH, V273, pC130, DOI 10.1152/ajpcell.1997.273.1.C130; Montgomery HJ, 2000, J BIOL CHEM, V275, P5052, DOI 10.1074/jbc.275.7.5052; Moroz LL, 2006, CELL, V127, P1453, DOI 10.1016/j.cell.2006.09.052; Naude PJW, 2011, FEBS J, V278, P888, DOI 10.1111/j.1742-4658.2011.08017.x; Oess S, 2006, BIOCHEM J, V396, P401, DOI 10.1042/BJ20060321; OGURA T, 1993, BIOCHEM BIOPH RES CO, V193, P1014, DOI 10.1006/bbrc.1993.1726; Perez-Sala D, 2001, AM J PHYSIOL-RENAL, V280, pF466, DOI 10.1152/ajprenal.2001.280.3.F466; Peri F, 2010, BIOCHEM SOC T, V38, P1390, DOI 10.1042/BST0381390; REGULSKI M, 1995, P NATL ACAD SCI USA, V92, P9072, DOI 10.1073/pnas.92.20.9072; Roszer T, 2010, CELL TISSUE RES, V342, P191, DOI 10.1007/s00441-010-1063-8; Scheinker V, 2005, BIOCHEM BIOPH RES CO, V338, P1204, DOI 10.1016/j.bbrc.2005.10.069; SCHINDLER C, 1995, ANNU REV BIOCHEM, V64, P621, DOI 10.1146/annurev.bi.64.070195.003201; Smith P. K., 1989, GOOGLE PATENTS; Stasiv Y, 2004, GENE DEV, V18, P1812, DOI 10.1101/gad.298004; Stasiv Y, 2001, J BIOL CHEM, V276, P42241, DOI 10.1074/jbc.M105066200; Stuehr DJ, 1997, ANNU REV PHARMACOL, V37, P339, DOI 10.1146/annurev.pharmtox.37.1.339; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Vig M, 2004, J CLIN INVEST, V113, P1734, DOI 10.1172/JCI200420225; Weisz A, 1996, BIOCHEM J, V316, P209, DOI 10.1042/bj3160209; Wright B, 2006, BIOL CELL, V98, P265, DOI 10.1042/BC20050066; Yao Y, 2003, MOL PHARMACOL, V63, P383, DOI 10.1124/mol.63.2.383; Yu ZY, 2002, BIOCHEM J, V367, P97, DOI 10.1042/BJ20020588; Zhang GF, 2012, NATURE, V490, P49, DOI 10.1038/nature11413; Zhang Y, 2011, FISH SHELLFISH IMMUN, V30, P954, DOI 10.1016/j.fsi.2011.01.031	62	14	15	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3527	3540		10.1096/fj.201500193RR	http://dx.doi.org/10.1096/fj.201500193RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27402673				2022-12-28	WOS:000384329800022
J	Subramaniam, S; Ozdener, MH; Abdoul-Azize, S; Saito, K; Malik, B; Maquart, G; Hashimoto, T; Marambaud, P; Aribi, M; Tordoff, MG; Besnard, P; Khan, NA				Subramaniam, Selvakumar; Ozdener, Mehmet Hakan; Abdoul-Azize, Souleymane; Saito, Katsuyoshi; Malik, Bilal; Maquart, Guillaume; Hashimoto, Toshihiro; Marambaud, Philippe; Aribi, Mourad; Tordoff, Michael G.; Besnard, Philippe; Khan, Naim Akhtar			ERK1/2 activation in human taste bud cells regulates fatty acid signaling and gustatory perception of fat in mice and humans	FASEB JOURNAL			English	Article						MAPK; CALHM1; lipids	PROTEIN-TYROSINE KINASES; ION-CHANNEL; SRC KINASE; CD36; PREFERENCE; CALHM1; OBESE; INVOLVEMENT; SENSITIVITY; HOMEOSTASIS	Obesity is a major public health problem. An in-depth knowledge of the molecular mechanisms of oro-sensory detection of dietary lipids may help fight it. Humans and rodents can detect fatty acids via lipido-receptors, such as CD36 and GPR120. We studied the implication of the MAPK pathways, in particular, ERK1/2, in the gustatory detection of fatty acids. Linoleic acid, a dietary fatty acid, induced via CD36 the phosphorylation of MEK1/2-ERK1/2-ETS-like transcription factor-1 cascade, which requires Fyn-Src kinase and lipid rafts in human taste bud cells (TBCs). ERK1/2 cascade was activated by Ca2+ signaling via opening of the calcium-homeostasis modulator-1 (CALHM1) channel. Furthermore, fatty acid-evoked Ca2+ signaling and ERK1/2 phosphorylation were decreased in both human TBCs after small interfering RNA knockdown of CALHM1 channel and in TBCs from Calhm1(-/-) mice. Targeted knockdown of ERK1/2 by small interfering RNA or PD0325901 (MEK1/2 inhibitor) in the tongue and genetic ablation of Erk1 or Calhm1 genes impaired preference for dietary fat in mice. Lingual inhibition of ERK1/2 in healthy volunteers also decreased orogustatory sensitivity for linoleic acid. Our data demonstrate that ERK1/2-MAPK cascade is regulated by the opening of CALHM1 Ca2+ channel in TBCs to modulate orogustatory detection of dietary lipids in mice and humans.	[Subramaniam, Selvakumar; Abdoul-Azize, Souleymane; Maquart, Guillaume; Besnard, Philippe; Khan, Naim Akhtar] Univ Bourgogne, AgroSup, Unite Mixte Rech INSERM U866, Dijon, France; [Ozdener, Mehmet Hakan; Malik, Bilal; Tordoff, Michael G.] Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA; [Saito, Katsuyoshi] Kao Corp, Tokyo, Japan; [Hashimoto, Toshihiro] Tokushima Bunri Univ, Tokushima, Japan; [Marambaud, Philippe] Feinstein Inst Med Res, Litwin Zucker Res Ctr Study Alzheimers Dis, Manhasset, NY USA; [Aribi, Mourad] Abou Bekr Bel Kaid Univ, Lab Appl Mol Biol & Immunol, Tilimsen, Algeria; [Subramaniam, Selvakumar] Bharathiar Univ, Coimbatore, Tamil Nadu, India	Institut Agro; AgroSup Dijon; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Monell Chemical Senses Center; KAO Corporation; Tokushima Bunri University; Northwell Health; Bharathiar University	Khan, NA (corresponding author), Univ Bourgogne, AgroSup, Physiol Nutr & Toxicol, Unite Mixte Rech INSERM U866, 6 Blvd Gabriel, F-21000 Dijon, France.	naim.khan@u-bourgogne.fr	Selvakumar, Subramaniam/AAI-2163-2020; Aribi, Mourad/M-9790-2018; Ozdener, Mehmet Hakan/I-4097-2019; Aribi, Mourad/Q-1290-2016; Abdoul-Azize, Souleymane/AAB-2181-2021	Selvakumar, Subramaniam/0000-0001-9471-7632; Aribi, Mourad/0000-0002-6522-7252; Aribi, Mourad/0000-0002-6522-7252; Khan, Naim Akhtar/0000-0002-8930-9332; Abdoul-Azize, Souleymane/0000-0003-2065-9091	French Ministry of Higher Education and Research, Region Bourgogne "Innovation PARI"; ANR SensoFat-2 [ANR-12-BSV1-0027-01]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK46791]; NIH National Institute on Aging [R01-AG042508]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046791] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG042508] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [S10OD018125] Funding Source: NIH RePORTER	French Ministry of Higher Education and Research, Region Bourgogne "Innovation PARI"(Region Bourgogne-Franche-Comte); ANR SensoFat-2(French National Research Agency (ANR)); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the French Ministry of Higher Education and Research, Region Bourgogne "Innovation PARI" (Post Doctoral; to S.S.), ANR SensoFat-2 (ANR-12-BSV1-0027-01; to P.B.), and U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant R01-DK46791 (to M.G.T.) and NIH National Institute on Aging Grant R01-AG042508 (to P.M.). The authors thank Dr. Gilles Pages and Dr. Jacques Pouyssegur (Institute for Research on Cancer and Aging, Nice, France) for providing Erk<SUP>-/-</SUP> mice. The authors also sincerely thank Dr. A. Hichami (INSERM U866, Dijon, France), and N. Remla, Z. Tarhda, and Dr. Ghezzaz (Universite Aboubekr Belkaid, Tlemcen, Algeria) for helping with orosensorial detection of fatty acids in human volunteers. The authors declare no conflicts of interest.	Abumrad NA, 2005, J CLIN INVEST, V115, P2965, DOI 10.1172/JCI26955; Ayorinde FO, 2000, RAPID COMMUN MASS SP, V14, P608, DOI 10.1002/(SICI)1097-0231(20000415)14:7<608::AID-RCM918>3.0.CO;2-4; Babnigg G, 1997, J BIOL CHEM, V272, P29434, DOI 10.1074/jbc.272.47.29434; Baillie AGS, 1996, J MEMBRANE BIOL, V153, P75, DOI 10.1007/s002329900111; Besnard P, 2016, PHYSIOL REV, V96, P151, DOI 10.1152/physrev.00002.2015; BULL HA, 1994, FEBS LETT, V351, P41, DOI 10.1016/0014-5793(94)00814-0; Cartoni C, 2010, J NEUROSCI, V30, P8376, DOI 10.1523/JNEUROSCI.0496-10.2010; Chale-Rush A, 2007, CHEM SENSES, V32, P423, DOI 10.1093/chemse/bjm007; Chen K, 2008, CIRC RES, V102, P1512, DOI 10.1161/CIRCRESAHA.108.172064; Chevrot M, 2013, J LIPID RES, V54, P2485, DOI 10.1194/jlr.M039446; Dramane G, 2012, J CLIN INVEST, V122, P2267, DOI 10.1172/JCI59953; Dreses-Werringloer U, 2008, CELL, V133, P1149, DOI 10.1016/j.cell.2008.05.048; Dreses-Werringloer U, 2013, J CELL SCI, V126, P1199, DOI 10.1242/jcs.117135; El-Yassimi A, 2008, J BIOL CHEM, V283, P12949, DOI 10.1074/jbc.M707478200; Fukuwatari T, 1997, FEBS LETT, V414, P461, DOI 10.1016/S0014-5793(97)01055-7; Gaillard D, 2008, FASEB J, V22, P1458, DOI 10.1096/fj.07-8415com; Gilbertson TA, 2005, PHYSIOL BEHAV, V86, P681, DOI 10.1016/j.physbeh.2005.08.057; Gilbertson TA, 1997, AM J PHYSIOL-CELL PH, V272, pC1203, DOI 10.1152/ajpcell.1997.272.4.C1203; Gilbertson TA, 2014, PROG LIPID RES, V53, P82, DOI 10.1016/j.plipres.2013.11.001; Goto J, 2010, CELL CALCIUM, V47, P1, DOI 10.1016/j.ceca.2009.10.004; Gurevich-Panigrahi T, 2009, CURR MED CHEM, V16, P506, DOI 10.2174/092986709787315568; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Hirasawa A, 2008, BIOL PHARM BULL, V31, P1847, DOI 10.1248/bpb.31.1847; Hisatsune C, 2004, J BIOL CHEM, V279, P18887, DOI 10.1074/jbc.M311274200; HUANG MM, 1991, P NATL ACAD SCI USA, V88, P7844, DOI 10.1073/pnas.88.17.7844; Kulkarni B, 2013, CHEM SENSES, V38, P119, DOI 10.1093/chemse/bjs095; Laugerette F, 2005, J CLIN INVEST, V115, P3177, DOI 10.1172/JCI25299; Ma ZM, 2012, P NATL ACAD SCI USA, V109, pE1963, DOI 10.1073/pnas.1204023109; Martin C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024014; Matsumura S, 2009, NEUROSCI LETT, V450, P186, DOI 10.1016/j.neulet.2008.11.056; Mattes RD, 2009, CHEM SENSES, V34, P415, DOI 10.1093/chemse/bjp015; Maulon L, 2001, ONCOGENE, V20, P1964, DOI 10.1038/sj.onc.1204266; MELA DJ, 1991, AM J CLIN NUTR, V53, P908, DOI 10.1093/ajcn/53.4.908; Moyer BD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007682; Ozdener MH, 2014, GASTROENTEROLOGY, V146, P995, DOI 10.1053/j.gastro.2014.01.006; Ozdener MH, 2011, CHEM SENSES, V36, P601, DOI 10.1093/chemse/bjr012; Pages G, 1999, SCIENCE, V286, P1374, DOI 10.1126/science.286.5443.1374; Pepino MY, 2012, J LIPID RES, V53, P561, DOI 10.1194/jlr.M021873; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Sayed A, 2015, INT J OBESITY, V39, P920, DOI 10.1038/ijo.2015.20; Sclafani A, 2007, AM J PHYSIOL-REG I, V293, pR1823, DOI 10.1152/ajpregu.00211.2007; Taruno A, 2013, NATURE, V495, P223, DOI 10.1038/nature11906; Vazquez G, 2004, J BIOL CHEM, V279, P40521, DOI 10.1074/jbc.M405280200; Zhu XD, 2002, J LEUKOCYTE BIOL, V72, P1046	44	21	22	0	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3489	3500		10.1096/fj.201600422R	http://dx.doi.org/10.1096/fj.201600422R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27358389	Green Published			2022-12-28	WOS:000384329800019
J	Belinsky, GS; Sreekumar, B; Andrejecsk, JW; Saltzman, WM; Gong, JJ; Herzog, RI; Lin, S; Horsley, V; Carpenter, TO; Chung, CH				Belinsky, Glenn S.; Sreekumar, Bharath; Andrejecsk, Jillian W.; Saltzman, W. Mark; Gong, Jingjing; Herzog, Raimund I.; Lin, Samantha; Horsley, Valerie; Carpenter, Thomas O.; Chung, Chuhan			Pigment epithelium-derived factor restoration increases bone mass and improves bone plasticity in a model of osteogenesis imperfecta type VI via Wnt3a blockade	FASEB JOURNAL			English	Article						PEDF; Wnt signaling; mesenchymal stem cell	MESENCHYMAL STEM-CELLS; FACTOR PEDF; PROMOTES PROLIFERATION; SUPPRESSES; DIFFERENTIATION; EXPRESSION; SERPINF1; MUTATION; GENES; MINERALIZATION	Null mutations in for pigment epithelium-derived factor (PEDF), the protein product of the SERPINF1 gene, are the cause of osteogenesis imperfecta (OI) type VI. The PEDF-knockout (KO) mouse captures crucial elements of the human disease, including diminished bone mineralization and propensity to fracture. Our group and others have demonstrated that PEDF directs human mesenchymal stem cell (hMSC) commitment to the osteoblast lineage and modulates Wnt/beta-catenin signaling, a major regulator of bone development; however, the ability of PEDF to restore bone mass in a mouse model of OI type VI has not been determined. In this study, PEDF delivery increased trabecular bone volume/total volume by 52% in 6-mo-old PEDF-KO mice but not in wild-type mice. In young (19-d-old) PEDF-KO mice, PEDF restoration increased bone volume fraction by 35% and enhanced biomechanical parameters of bone plasticity. A Wnt-green fluorescent protein reporter demonstrated dynamic changes in Wnt/beta-catenin signaling characterized by early activation and marked suppression during terminal differentiation of hMSCs. Continuous Wnt3a exposure impeded mineralization of hMSCs, whereas the combination of Wnt3a and PEDF potentiated mineralization. Interrogation of the PEDF sequence identified a conserved motif found in other Wnt modulators, such as the dickkopf proteins. Mutation of a single amino acid on a 34-mer PEDF peptide increased mineralization of hMSC cultures compared with the native peptide sequence. These results indicate that PEDF counters Wnt signaling to allow for osteoblast differentiation and provides a mechanistic insight into how the PEDF null state results in OI type VI.	[Belinsky, Glenn S.; Sreekumar, Bharath; Gong, Jingjing; Herzog, Raimund I.; Chung, Chuhan] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Carpenter, Thomas O.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Andrejecsk, Jillian W.; Saltzman, W. Mark] Yale Univ, Dept Biomed Engn, New Haven, CT USA; [Lin, Samantha; Horsley, Valerie] Yale Univ, Dept Mol Cellular & Dev Biol, New Haven, CT USA; [Chung, Chuhan] Vet Affairs Connecticut Healthcare Syst, West Haven, CT USA	Yale University; Yale University; Yale University; Yale University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Connecticut Healthcare System	Chung, CH (corresponding author), Yale Univ, Sch Med, Dept Med, Sect Digest Dis, 1080 LMP, New Haven, CT 06520 USA.	chuhan.chung@yale.edu			Yale Core Center for Musculoskeletal Disorders/NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant [P30-AR46032]; NIH Liver Center Core Grant [DK34989]; Veterans Affairs Merit Grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [KL2TR001862, UL1TR000142, TL1TR001864, UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR046032] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101984, R37DK020495, P30DK034989, P30DK045735, R03DK100709] Funding Source: NIH RePORTER	Yale Core Center for Musculoskeletal Disorders/NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant; NIH Liver Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs Merit Grant(US Department of Veterans Affairs); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Drs. Joan Marini [U.S. National Institutes of Health (NIH)] and Caren Gundberg (Yale University School of Medicine) for a thorough reading of the manuscript and helpful suggestions. The authors also thank Drs. Ben-hua Sun and Steven Tommasini (Yale University School of Medicine) for technical support. This work was supported by the Yale Core Center for Musculoskeletal Disorders/NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant P30-AR46032 (to C.C. and T.O.C.), NIH Liver Center Core Grant DK34989 (to C.C.), and Veterans Affairs Merit Grant (to C.C.).	Akiyama T, 2010, BIOCHEM BIOPH RES CO, V391, P789, DOI 10.1016/j.bbrc.2009.11.139; Apte RS, 2004, INVEST OPHTH VIS SCI, V45, P4491, DOI 10.1167/iovs.04-0172; Becker J, 2011, AM J HUM GENET, V88, P362, DOI 10.1016/j.ajhg.2011.01.015; Bogan R, 2013, J BONE MINER RES, V28, P1531, DOI 10.1002/jbmr.1892; Boland GM, 2004, J CELL BIOCHEM, V93, P1210, DOI 10.1002/jcb.20284; Bourhis E, 2011, STRUCTURE, V19, P1433, DOI 10.1016/j.str.2011.07.005; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Caparros-Martin JA, 2013, AM J MED GENET A, V161A, P1354, DOI 10.1002/ajmg.a.35938; Cho HH, 2006, TISSUE ENG, V12, P111, DOI 10.1089/ten.2006.12.111; Chung CH, 2009, GASTROENTEROLOGY, V136, P331, DOI 10.1053/j.gastro.2008.09.065; Crowe S, 2009, CELL METAB, V10, P40, DOI 10.1016/j.cmet.2009.06.001; Cruciat CM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a015081; Doll JA, 2003, NAT MED, V9, P774, DOI 10.1038/nm870; Farber CR, 2014, J BONE MINER RES, V29, P1402, DOI 10.1002/jbmr.2173; Forlino A, 2016, LANCET, V387, P1657, DOI 10.1016/S0140-6736(15)00728-X; Gattu AK, 2014, ENDOCRINOLOGY, V155, P1373, DOI 10.1210/en.2013-1785; Gattu AK, 2013, FASEB J, V27, P4384, DOI 10.1096/fj.13-232900; Glorieux FH, 2002, J BONE MINER RES, V17, P30, DOI 10.1359/jbmr.2002.17.1.30; Homan EP, 2011, J BONE MINER RES, V26, P2798, DOI 10.1002/jbmr.487; Jay SM, 2010, BIOMATERIALS, V31, P3054, DOI 10.1016/j.biomaterials.2010.01.014; Krishnan V, 2006, J CLIN INVEST, V116, P1202, DOI 10.1172/JCI28551; Land C, 2007, BONE, V40, P638, DOI 10.1016/j.bone.2006.10.010; Li F, 2015, J CELL PHYSIOL, V230, P1243, DOI 10.1002/jcp.24859; Li F, 2013, STEM CELLS, V31, P2714, DOI 10.1002/stem.1505; Ling L, 2009, GENE, V433, P1, DOI 10.1016/j.gene.2008.12.008; Liu GZ, 2009, J CELL BIOL, V185, P67, DOI 10.1083/jcb.200810137; Mao BY, 2003, GENE, V302, P179, DOI 10.1016/S0378-1119(02)01106-X; Marini JC, 2013, J CLIN ENDOCR METAB, V98, P3095, DOI 10.1210/jc.2013-1505; Minillo RM, 2014, MOL SYNDROMOL, V5, P268, DOI 10.1159/000369108; Park K, 2011, MOL CELL BIOL, V31, P3038, DOI 10.1128/MCB.01211-10; Petersen SV, 2003, BIOCHEM J, V374, P199, DOI 10.1042/BJ20030313; Protiva P, 2015, CELL MOL GASTROENTER, V1, P535, DOI 10.1016/j.jcmgh.2015.06.006; Rajagopal A, 2016, MOL GENET METAB, V117, P378, DOI 10.1016/j.ymgme.2015.11.015; Rauch F, 2012, J CLIN ENDOCR METAB, V97, pE1550, DOI 10.1210/jc.2012-1827; Schmitz JC, 2011, AM J PATHOL, V179, P2990, DOI 10.1016/j.ajpath.2011.08.009; Shaheen R, 2012, J MED GENET, V49, P630, DOI 10.1136/jmedgenet-2012-101142; Stephen J, 2014, AM J MED GENET A, V164, P1482, DOI 10.1002/ajmg.a.36481; Tombran-Tink J, 1996, Mol Vis, V2, P11; Tucker T, 2012, AM J MED GENET A, V158A, P1422, DOI 10.1002/ajmg.a.35319; Uhlen M, 2015, SCIENCE, V347, DOI 10.1126/science.1260419; van der Horst G, 2005, J BONE MINER RES, V20, P1867, DOI 10.1359/JBMR.050614; Venturi G, 2012, J BONE MINER RES, V27, P723, DOI 10.1002/jbmr.1480; Wang M, 2009, AM J PHYSIOL-ENDOC M, V297, pE1378, DOI 10.1152/ajpendo.00252.2009; Yamagishi S, 2006, J CLIN ENDOCR METAB, V91, P2447, DOI 10.1210/jc.2005-2654; Zheng CH, 2004, BIOCHEM BIOPH RES CO, V323, P1321, DOI 10.1016/j.bbrc.2004.09.007	45	27	28	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2837	2848		10.1096/fj.201500027R	http://dx.doi.org/10.1096/fj.201500027R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27127101	Green Published			2022-12-28	WOS:000380994000019
J	Lopez-Ramirez, MA; Reijerkerk, A; de Vries, HE; Romero, IA				Lopez-Ramirez, Miguel Alejandro; Reijerkerk, Arie; de Vries, Helga E.; Romero, Ignacio Andres			Regulation of brain endothelial barrier function by microRNAs in health and neuroinflammation	FASEB JOURNAL			English	Review						regulatory mechanisms; multiple sclerosis; stroke; neurovascular unit; inflammation	MULTIPLE-SCLEROSIS LESIONS; KAPPA-B ACTIVATION; GENE-EXPRESSION; VASCULAR INTEGRITY; DOWN-REGULATION; CELL-ADHESION; VE-CADHERIN; ANGIOGENESIS; TARGETS; MIR-155	Brain endothelial cells constitute the major cellular element of the highly specialized blood-brain barrier (BBB) and thereby contribute to CNS homeostasis by restricting entry of circulating leukocytes and blood-borne molecules into the CNS. Therefore, compromised function of brain endothelial cells has serious consequences for BBB integrity. This has been associated with early events in the pathogenesis of several disorders that affect the CNS, such as multiple sclerosis, HIV-associated neurologic disorder, and stroke. Recent studies demonstrate that brain endothelial microRNAs play critical roles in the regulation of BBB function under normal and neuro-inflammatory conditions. This review will focus on emerging evidence that indicates that brain endothelial microRNAs regulate barrier function and orchestrate various phases of the neuro-inflammatory response, including endothelial activation in response to cytokines as well as restoration of inflamed endothelium into a quiescent state. In particular, we discuss novel micro RNA regulatory mechanisms and their contribution to cellular interactions at the neurovascular unit that influence the overall function of the BBB in health and during neuroinflammation. -Lopez-Ramirez, M.A., Reijerkerk, A., de Vries, H.E., Romero, I. A. Regulation of brain endothelial barrier function by microRNAs in health and neuroinflammation.	[Lopez-Ramirez, Miguel Alejandro] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Reijerkerk, Arie] Pluriomics BV, Leiden, Netherlands; [de Vries, Helga E.] Vrije Univ Amsterdam Med Ctr, Blood Brain Barrier Res Grp, Mol Cell Biol & Immunol, Amsterdam, Netherlands; [Romero, Ignacio Andres] Open Univ, Biomed Res Network, Dept Life Hlth & Chem Sci, Walton Hall, Milton Keynes MK7 6AA, Bucks, England	University of California System; University of California San Diego; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Open University - UK	Romero, IA (corresponding author), Open Univ, Biomed Res Network, Dept Life Hlth & Chem Sci, Walton Hall, Milton Keynes MK7 6AA, Bucks, England.	i.romero@open.ac.uk		Romero, Ignacio/0000-0002-0322-9180; de Vries, Helga/0000-0001-7904-7124	Multiple Sclerosis Society of Great Britain; Biotechnology and Biological Sciences Research Council [BB/K009184/1]; Multiple Sclerosis Society of Northern Ireland; BBSRC [BB/K009184/1] Funding Source: UKRI	Multiple Sclerosis Society of Great Britain; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Multiple Sclerosis Society of Northern Ireland; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Bart-Jan de Kreuk for critical reading of this manuscript. This work was funded by the Multiple Sclerosis Society of Great Britain and Northern Ireland, and by the Biotechnology and Biological Sciences Research Council (Grant BB/K009184/1).	Abbott AL, 2005, DEV CELL, V9, P403, DOI 10.1016/j.devcel.2005.07.009; Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Lopez-Ramirez MA, 2012, J IMMUNOL, V189, P3130, DOI 10.4049/jimmunol.1103460; Altuvia Y, 2005, NUCLEIC ACIDS RES, V33, P2697, DOI 10.1093/nar/gki567; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; BRADBURY MWB, 1993, EXP PHYSIOL, V78, P453, DOI 10.1113/expphysiol.1993.sp003698; Bridge G, 2012, BLOOD, V120, P5063, DOI 10.1182/blood-2012-04-423004; Caballero-Garrido E, 2015, J NEUROSCI, V35, P12446, DOI 10.1523/JNEUROSCI.1641-15.2015; CANNELLA B, 1995, ANN NEUROL, V37, P424, DOI 10.1002/ana.410370404; Cano A, 2000, NAT CELL BIOL, V2, P76, DOI 10.1038/35000025; Chat M, 1997, LIFE SCI, V62, P151, DOI 10.1016/S0024-3205(97)01061-8; Che P, 2014, AGING CELL, V13, P926, DOI 10.1111/acel.12252; Chen CY, 2008, BLOOD, V112, P3205, DOI 10.1182/blood-2008-03-143479; Cheng HS, 2013, EMBO MOL MED, V5, P1017, DOI 10.1002/emmm.201202318; Cheng WW, 2011, INT J MOL MED, V27, P393, DOI 10.3892/ijmm.2011.598; Cichon C, 2014, TISSUE BARRIERS, V2, DOI 10.4161/21688362.2014.944446; Cowan C, 2014, INVEST OPHTH VIS SCI, V55, P4944, DOI 10.1167/iovs.13-13631; Csiszar A, 2014, AM J PHYSIOL-HEART C, V307, pH292, DOI 10.1152/ajpheart.00307.2014; Eadon MT, 2014, IMMUNOLOGY, V143, P363, DOI 10.1111/imm.12314; Elmen J, 2008, NATURE, V452, P896, DOI 10.1038/nature06783; Engelhardt B, 2005, TRENDS IMMUNOL, V26, P485, DOI 10.1016/j.it.2005.07.004; Fang Z, 2016, FASEB J, V30, P2097, DOI 10.1096/fj.201500126; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Ge SJ, 2005, J NEUROSCI RES, V79, P421, DOI 10.1002/jnr.20313; Ge XT, 2014, SCI REP-UK, V4, DOI 10.1038/srep06718; Ge XT, 2015, BRAIN RES, V1603, P150, DOI 10.1016/j.brainres.2015.01.009; Girolamo F, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0084-z; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Guo L, 2010, COMPUT BIOL CHEM, V34, P165, DOI 10.1016/j.compbiolchem.2010.06.001; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Harris TA, 2010, ARTERIOSCL THROM VAS, V30, P1990, DOI 10.1161/ATVBAHA.110.211706; Heusschen R, 2010, BBA-REV CANCER, V1805, P87, DOI 10.1016/j.bbcan.2009.09.005; Hou J, 2009, J IMMUNOL, V183, P2150, DOI 10.4049/jimmunol.0900707; Hu GK, 2010, AM J PHYSIOL-GASTR L, V298, pG542, DOI 10.1152/ajpgi.00490.2009; Ikenouchi J, 2003, J CELL SCI, V116, P1959, DOI 10.1242/jcs.00389; Ingram G, 2009, CLIN EXP IMMUNOL, V155, P128, DOI 10.1111/j.1365-2249.2008.03830.x; Joglekar MV, 2009, ISLETS, V1, P137, DOI 10.4161/isl.1.2.9578; Joo F, 1996, PROG NEUROBIOL, V48, P255, DOI 10.1016/0301-0082(95)00046-1; JOO F, 1992, J NEUROCHEM, V58, P1, DOI 10.1111/j.1471-4159.1992.tb09272.x; Junker A, 2009, BRAIN, V132, P3342, DOI 10.1093/brain/awp300; Kalani A, 2014, J CEREBR BLOOD F MET, V34, P1212, DOI 10.1038/jcbfm.2014.74; Kim VN, 2006, TRENDS GENET, V22, P165, DOI 10.1016/j.tig.2006.01.003; Kim YK, 2009, NUCLEIC ACIDS RES, V37, P1672, DOI 10.1093/nar/gkp002; Kluiver J, 2007, ONCOGENE, V26, P3769, DOI 10.1038/sj.onc.1210147; Kong W, 2008, MOL CELL BIOL, V28, P6773, DOI 10.1128/MCB.00941-08; Kuhnert F, 2010, BLOOD, V115, P4631, DOI 10.1182/blood-2010-03-276428; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Landskroner-Eiger S, 2015, P NATL ACAD SCI USA, V112, P12812, DOI 10.1073/pnas.1507094112; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Lindberg RLP, 2010, EUR J IMMUNOL, V40, P888, DOI 10.1002/eji.200940032; Lopez-Ramirez MA, 2014, FASEB J, V28, P2551, DOI 10.1096/fj.13-248880; Lopez-Ramirez MA, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-27; Ma J, 2014, J CEREBR BLOOD F MET, V34, P1826, DOI 10.1038/jcbfm.2014.152; Macdonald JA, 2010, J NEUROSCI RES, V88, P1457, DOI 10.1002/jnr.22316; Maes OC, 2009, CURR GENOMICS, V10, P154, DOI 10.2174/138920209788185252; Matouk CC, 2008, CIRC RES, V102, P873, DOI 10.1161/CIRCRESAHA.107.171025; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Minami T, 2005, TRENDS CARDIOVAS MED, V15, P174, DOI 10.1016/j.tcm.2005.06.002; Mishra R, 2013, J NEUROSCI, V33, P5992, DOI 10.1523/JNEUROSCI.4796-12.2013; Moore CS, 2013, ANN NEUROL, V74, P709, DOI 10.1002/ana.23967; Muramatsu F, 2013, ONCOGENE, V32, P414, DOI 10.1038/onc.2012.68; Murugaiyan G, 2011, J IMMUNOL, V187, P2213, DOI 10.4049/jimmunol.1003952; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; Nikaki A, 2012, EXPERT OPIN INV DRUG, V21, P1475, DOI 10.1517/13543784.2012.710199; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; O'Connell RM, 2010, IMMUNITY, V33, P607, DOI 10.1016/j.immuni.2010.09.009; Obeid R, 2006, FEBS LETT, V580, P2994, DOI 10.1016/j.febslet.2006.04.088; Olive V, 2010, INT J BIOCHEM CELL B, V42, P1348, DOI 10.1016/j.biocel.2010.03.004; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Perry MM, 2009, FEBS LETT, V583, P3349, DOI 10.1016/j.febslet.2009.09.038; Poliseno L, 2006, BLOOD, V108, P3068, DOI 10.1182/blood-2006-01-012369; Qin B, 2012, MOL BIOL REP, V39, P4509, DOI 10.1007/s11033-011-1241-0; Rau CS, 2014, TOXICOL SCI, V140, P315, DOI 10.1093/toxsci/kfu097; Reijerkerk A, 2013, J NEUROSCI, V33, P6857, DOI 10.1523/JNEUROSCI.3965-12.2013; Rom S, 2015, J CEREBR BLOOD F MET, V35, P1957, DOI 10.1038/jcbfm.2015.154; Schmidt M, 2007, DEVELOPMENT, V134, P2913, DOI 10.1242/dev.002576; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sethupathy P, 2007, AM J HUM GENET, V81, P405, DOI 10.1086/519979; Shen WF, 2008, MOL CELL BIOL, V28, P4609, DOI 10.1128/MCB.01652-07; Smits M, 2012, FASEB J, V26, P2639, DOI 10.1096/fj.11-202820; Soon D, 2007, MULT SCLER J, V13, P884, DOI 10.1177/1352458507076970; Stamatovic SM, 2008, CURR NEUROPHARMACOL, V6, P179, DOI 10.2174/157015908785777210; Suarez Y, 2007, CIRC RES, V100, P1164, DOI 10.1161/01.RES.0000265065.26744.17; Suarez Y, 2010, J IMMUNOL, V184, P21, DOI 10.4049/jimmunol.0902369; Sun HX, 2012, HYPERTENSION, V60, P1407, DOI 10.1161/HYPERTENSIONAHA.112.197301; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Tam W, 2001, GENE, V274, P157, DOI 10.1016/S0378-1119(01)00612-6; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tuccoli A, 2006, CELL CYCLE, V5, P2473, DOI 10.4161/cc.5.21.3422; Ueda R, 2009, P NATL ACAD SCI USA, V106, P10746, DOI 10.1073/pnas.0811817106; Wang HQ, 2011, J PATHOL, V225, P232, DOI 10.1002/path.2931; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Weber M, 2014, AM J PHYSIOL-HEART C, V306, pH1192, DOI 10.1152/ajpheart.00521.2013; Weiss N, 2009, BBA-BIOMEMBRANES, V1788, P842, DOI 10.1016/j.bbamem.2008.10.022; Wojtowicz EE, 2014, EXP HEMATOL, V42, P909, DOI 10.1016/j.exphem.2014.06.010; Wu DS, 2015, J CEREBR BLOOD F MET, V35, P412, DOI 10.1038/jcbfm.2014.207; Wu FS, 2009, BIOCHEM BIOPH RES CO, V386, P549, DOI 10.1016/j.bbrc.2009.06.075; Wu Y, 2010, BRIT J CANCER, V102, P639, DOI 10.1038/sj.bjc.6605530; Yeligar S, 2009, J IMMUNOL, V183, P5232, DOI 10.4049/jimmunol.0901084; Yin KJ, 2014, NEUROCHEM INT, V77, P9, DOI 10.1016/j.neuint.2014.03.013; Zhao W, 2015, MOL BIOL CELL, V26, P1786, DOI 10.1091/mbc.E14-10-1474; Zhu N, 2011, ATHEROSCLEROSIS, V215, P286, DOI 10.1016/j.atherosclerosis.2010.12.024	106	46	47	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2662	2672		10.1096/fj.201600435RR	http://dx.doi.org/10.1096/fj.201600435RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27118674	Green Accepted, hybrid			2022-12-28	WOS:000380994000004
J	Goetzl, EJ; Schwartz, JB; Mustapic, M; Lobach, IV; Daneman, R; Abner, EL; Jicha, GA				Goetzl, Edward J.; Schwartz, Janice B.; Mustapic, Maja; Lobach, Iryna V.; Daneman, Richard; Abner, Erin L.; Jicha, Gregory A.			Altered cargo proteins of human plasma endothelial cell-derived exosomes in atherosclerotic cerebrovascular disease	FASEB JOURNAL			English	Article						blood biomarkers; stroke; platelets; cellular adhesion; angiogenesis	BLOOD-BRAIN-BARRIER; ALZHEIMERS-DISEASE	Plasma endothelial cell-derived exosomes (EDEs) and platelet-derived exosomes (PDEs) were precipitated and enriched separately by immunospecific absorption procedures for analyses of cargo proteins relevant to atherosclerosis. EDEs had usual exosome size and marker protein content, and significantly higher levels than PDEs of the endothelial proteins vascular cell adhesion molecule-1 (VCAM-1) and endothelial nitric oxide synthase, whereas PDEs had significantly higher levels of platelet glycoprotein VI. EDE levels of VCAM-1, von Willebrand factor, platelet-derived growth factor (PDGF)-BB, angiopoietin-1, and lysyl oxidase-2 and the cerebrovascular-selective proteins glucose transporter 1, permeability-glycoprotein, and large neutral amino acid transporter 1 were significantly higher for 18 patients with cerebrovascular disease (CeVD) than for 18 age-and gender-matched control subjects. PDE levels of PDGF-AA, platelet glycoprotein VI, integrin-linked kinase-1, high mobility group box-1 protein, chemokine CXCL4, and thrombospondin-1 were significantly higher in patients with CeVD than in control subjects, but differences were less with greater overlaps than for EDE proteins. EDE levels of Yes-associated protein (YAP) were higher and of P(S127)-YAP lower in patients with CeVD than in control subjects, consistent with heightened activity of this mechanical force-sensitive system in atherosclerosis. Elevated EDE and PDE levels of atherosclerosis-promoting proteins in CeVD justify clinical studies of their potential value as biomarkers.	[Goetzl, Edward J.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Schwartz, Janice B.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Lobach, Iryna V.] Univ Calif San Francisco, Clin Translat Sci Inst, San Francisco, CA 94143 USA; [Goetzl, Edward J.; Schwartz, Janice B.] Jewish Home San Francisco, San Francisco, CA USA; [Mustapic, Maja] NIA, Neurosci Lab, Baltimore, MD 21224 USA; [Daneman, Richard] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Daneman, Richard] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Abner, Erin L.; Jicha, Gregory A.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); University of California System; University of California San Diego; University of California System; University of California San Diego; University of Kentucky	Goetzl, EJ (corresponding author), Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Schwartz, Janice/K-6354-2019; Mustapic, Maja/AAV-3212-2020	Mustapic, Maja/0000-0003-0511-2047	Biomarkers Across Neurodegenerative Diseases 2 (BAND2) Program of the Michael J. Fox Foundation for Parkinson's Research; Alzheimer's Association; Alzheimer's Research UK; Weston Brain Institute; U.S. National Institutes of Health (NIH) National Institute for Nursing Research [R01 NR014189]; Intramural Research Program of the NIH National Institute on Aging; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR014189] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P30AG028383] Funding Source: NIH RePORTER	Biomarkers Across Neurodegenerative Diseases 2 (BAND2) Program of the Michael J. Fox Foundation for Parkinson's Research; Alzheimer's Association(Alzheimer's Association); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Weston Brain Institute; U.S. National Institutes of Health (NIH) National Institute for Nursing Research; Intramural Research Program of the NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the Biomarkers Across Neurodegenerative Diseases 2 (BAND2) Program of the Michael J. Fox Foundation for Parkinson's Research, Alzheimer's Association, Alzheimer's Research UK and the Weston Brain Institute (to E.J.G.), and by Grant R01 NR014189 from the U.S. National Institutes of Health (NIH) National Institute for Nursing Research (to G.A.J.). M.M. was supported by the Intramural Research Program of the NIH National Institute on Aging. The authors thank Judith H. Goetzl (Jewish Home of San Francisco) for expert preparation of the illustrations. E.J.G. has filed an application with the U.S. Patent Office for the platform and methodologies described in this report. All remaining authors declare no conflicts of interest.	Boado RJ, 1999, P NATL ACAD SCI USA, V96, P12079, DOI 10.1073/pnas.96.21.12079; Chakraborty S, 2017, J BIOL CHEM, V292, P6600, DOI 10.1074/jbc.M116.742627; Chironi GN, 2009, CELL TISSUE RES, V335, P143, DOI 10.1007/s00441-008-0710-9; de Jong OG, 2016, J CELL MOL MED, V20, P342, DOI 10.1111/jcmm.12730; Gaengel K, 2009, ARTERIOSCL THROM VAS, V29, P630, DOI 10.1161/ATVBAHA.107.161521; Gimbrone MA, 2016, CIRC RES, V118, P620, DOI 10.1161/CIRCRESAHA.115.306301; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Goetzl EJ, 2016, FASEB J, V30, P2058, DOI 10.1096/fj.201500150R; Haqqani AS, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-4; Jakobi AJ, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1385; Ju R, 2014, J BIOL CHEM, V289, P510, DOI 10.1074/jbc.M113.506899; Pircher A, 2016, ATHEROSCLEROSIS, V253, P247, DOI 10.1016/j.atherosclerosis.2016.08.011; Rautou PE, 2011, CIRC RES, V109, P593, DOI 10.1161/CIRCRESAHA.110.233163; Rautou PE, 2011, CIRC RES, V108, P335, DOI 10.1161/CIRCRESAHA.110.237420; Schinkel AH, 1999, ADV DRUG DELIVER REV, V36, P179, DOI 10.1016/S0169-409X(98)00085-4; Seidner G, 1998, NAT GENET, V18, P188, DOI 10.1038/ng0298-188; Tabas I, 2015, J CELL BIOL, V209, P13, DOI 10.1083/jcb.201412052; Wang J, 2016, STEM CELLS INT, V2016; Wang L, 2016, NATURE, V540, P579, DOI 10.1038/nature20602; Winston Charisse N, 2016, Alzheimers Dement (Amst), V3, P63, DOI 10.1016/j.dadm.2016.04.001	21	56	58	2	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3689	3694		10.1096/fj.201700149	http://dx.doi.org/10.1096/fj.201700149			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28476896	Green Submitted, Green Published			2022-12-28	WOS:000405932400039
J	Woldetsadik, AD; Vogel, MC; Rabeh, WM; Magzoub, M				Woldetsadik, Abiy D.; Vogel, Maria C.; Rabeh, Wael M.; Magzoub, Mazin			Hexokinase II-derived cell-penetrating peptide targets mitochondria and triggers apoptosis in cancer cells	FASEB JOURNAL			English	Article						ATP; cytochrome c; cytotoxicity; glycolysis; oxidative phosphorylation	PERMEABILITY TRANSITION PORE; ARGININE-RICH PEPTIDES; CARBON NANOTUBES; SUBCELLULAR-LOCALIZATION; MAMMALIAN HEXOKINASE; BROMIDE MTT; ANNEXIN-V; GLUCOSE; BINDING; INVOLVEMENT	Overexpression of mitochondria-bound hexokinase II (HKII) in cancer cells plays an important role in their metabolic reprogramming and protects them against apoptosis, thereby facilitating their growth and proliferation. Here, we show that covalently coupling a peptide that corresponds to the mitochondrial membrane-binding N-terminal domain of HKII (pHK) to a short, penetration-accelerating sequence (PAS) enhances the cellular uptake, mitochondrial localization, and cytotoxicity of the peptide in HeLa cells. Further analysis revealed that pHK-PAS depolarized mitochondrial membrane potential, inhibited mitochondrial respiration and glycolysis, and depleted intracellular ATP levels. The effects of pHK-PAS were correlated with dissociation of endogenous full-length HKII from mitochondria and release of cytochrome c Of significance, pHK-PAS treatment of noncancerous HEK293 cells resulted in substantially lower cytotoxicity. Thus, pHK-PAS effectively disrupted the mitochondria-HKII association in cancer cells, which led to mitochondrial dysfunction and, finally, apoptosis. Our results demonstrate the potential of the pHK-PAS cell-penetrating peptide as a novel therapeutic strategy in cancer.-Woldetsadik, A. D., Vogel, M. C., Rabeh, W. M., Magzoub, M. Hexokinase II-derived cell-penetrating peptide targets mitochondria and triggers apoptosis in cancer cells.	[Woldetsadik, Abiy D.; Vogel, Maria C.; Rabeh, Wael M.; Magzoub, Mazin] New York Univ Abu Dhabi, Div Sci, Abu Dhabi, U Arab Emirates		Magzoub, M (corresponding author), New York Univ Abu Dhabi, Biol Program, POB 129188,Saadiyat Isl Campus, Abu Dhabi, U Arab Emirates.	mazin.magzoub@nyu.edu	Rabeh, Wael/AAO-4647-2020	Rabeh, Wael/0000-0001-6071-8581	NYU Abu Dhabi	NYU Abu Dhabi	The authors thank Khulood Alawadi [Department of Laboratories, New York University (NYU) Abu Dhabi] for preparing the graphic illustration (Fig. 9). Confocal imaging experiments were carried out by using the Core Technology Platform resources at NYU Abu Dhabi. This work was supported by a start-up fund from NYU Abu Dhabi (to M. M.). The authors declare no competing financial interests.	Ahn KJ, 2009, BMB REP, V42, P350, DOI 10.5483/BMBRep.2009.42.6.350; Alshehri R, 2016, J MED CHEM, V59, P8149, DOI 10.1021/acs.jmedchem.5b01770; Amand HL, 2012, BBA-BIOMEMBRANES, V1818, P2669, DOI 10.1016/j.bbamem.2012.06.006; Anderson RGW, 1998, ANNU REV BIOCHEM, V67, P199, DOI 10.1146/annurev.biochem.67.1.199; ARORA KK, 1988, J BIOL CHEM, V263, P17422; BARLTROP JA, 1991, BIOORG MED CHEM LETT, V1, P611, DOI 10.1016/S0960-894X(01)81162-8; Bernardi P, 2006, FEBS J, V273, P2077, DOI 10.1111/j.1742-4658.2006.05213.x; BERRIDGE MV, 1993, ARCH BIOCHEM BIOPHYS, V303, P474, DOI 10.1006/abbi.1993.1311; Botzer LE, 2016, BRIT J CANCER, V114, P759, DOI 10.1038/bjc.2016.26; Calmettes G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081988; Chiara F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001852; CROUCH SPM, 1993, J IMMUNOL METHODS, V160, P81, DOI 10.1016/0022-1759(93)90011-U; Dranka BP, 2011, FREE RADICAL BIO MED, V51, P1621, DOI 10.1016/j.freeradbiomed.2011.08.005; Dunn KW, 2011, AM J PHYSIOL-CELL PH, V300, pC723, DOI 10.1152/ajpcell.00462.2010; Dupont E, 2011, METHODS MOL BIOL, V683, P21, DOI 10.1007/978-1-60761-919-2_2; EHRENBERG B, 1988, BIOPHYS J, V53, P785, DOI 10.1016/S0006-3495(88)83158-8; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; ESKO JD, 1985, P NATL ACAD SCI USA, V82, P3197, DOI 10.1073/pnas.82.10.3197; Flescher E, 2007, CANCER LETT, V245, P1, DOI 10.1016/j.canlet.2006.03.001; Fulda S, 2010, NAT REV DRUG DISCOV, V9, P447, DOI 10.1038/nrd3137; Ganapathy-Kanniappan S, 2010, CURR PHARM BIOTECHNO, V11, P510, DOI 10.2174/138920110791591427; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jekabsons MB, 2004, J BIOL CHEM, V279, P32989, DOI 10.1074/jbc.M401540200; John S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017674; JOLIOT A, 1991, P NATL ACAD SCI USA, V88, P1864, DOI 10.1073/pnas.88.5.1864; KAPLAN O, 1990, CANCER RES, V50, P544; KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415; Le Roy C, 2005, NAT REV MOL CELL BIO, V6, P112, DOI 10.1038/nrm1571; Levy AG, 2012, INVEST NEW DRUG, V30, P191, DOI 10.1007/s10637-010-9551-y; Liu NQ, 2002, J VIROL, V76, P6689, DOI 10.1128/JVI.76.13.6689-6700.2002; Lunt SY, 2011, ANNU REV CELL DEV BI, V27, P441, DOI 10.1146/annurev-cellbio-092910-154237; LYON RC, 1988, CANCER RES, V48, P870; Machida K, 2006, J BIOL CHEM, V281, P14314, DOI 10.1074/jbc.M513297200; Madani Fatemeh, 2011, J Biophys, V2011, P414729, DOI 10.1155/2011/414729; Magzoub M, 2004, Q REV BIOPHYS, V37, P147, DOI 10.1017/S0033583505004014; Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014; Manceur AP, 2009, MOL THER, V17, P500, DOI 10.1038/mt.2008.271; Mathupala SP, 2006, ONCOGENE, V25, P4777, DOI 10.1038/sj.onc.1209603; Mathupala SP, 2009, SEMIN CANCER BIOL, V19, P17, DOI 10.1016/j.semcancer.2008.11.006; Mathupala SP, 2001, J BIOL CHEM, V276, P43407, DOI 10.1074/jbc.M108181200; Nakase I, 2004, MOL THER, V10, P1011, DOI 10.1016/j.ymthe.2004.08.010; Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824; NAKASHIMA RA, 1986, BIOCHEMISTRY-US, V25, P1015, DOI 10.1021/bi00353a010; Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Pan R, 2016, MOL PHARMACEUT, V13, P1366, DOI 10.1021/acs.molpharmaceut.6b00030; Pastorino JG, 2002, J BIOL CHEM, V277, P7610, DOI 10.1074/jbc.M109950200; Patra KC, 2013, CANCER CELL, V24, P213, DOI 10.1016/j.ccr.2013.06.014; Pedersen PL, 2008, J BIOENERG BIOMEMBR, V40, P123, DOI 10.1007/s10863-008-9165-7; Pedersen PL, 2002, BBA-BIOENERGETICS, V1555, P14, DOI 10.1016/S0005-2728(02)00248-7; Rasola A, 2007, APOPTOSIS, V12, P815, DOI 10.1007/s10495-007-0723-y; Rezgui R, 2016, BBA-BIOMEMBRANES, V1858, P1499, DOI 10.1016/j.bbamem.2016.03.023; Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200; Robey RB, 2006, ONCOGENE, V25, P4683, DOI 10.1038/sj.onc.1209595; Sajid MI, 2016, INT J PHARMACEUT, V501, P278, DOI 10.1016/j.ijpharm.2016.01.064; SAMPATH P, 1991, BIOCHEMISTRY-US, V30, P1973, DOI 10.1021/bi00221a034; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; SCHNITZER JE, 1994, J CELL BIOL, V127, P1217, DOI 10.1083/jcb.127.5.1217; Schulze A, 2012, NATURE, V491, P364, DOI 10.1038/nature11706; Shimizu S, 2000, J BIOL CHEM, V275, P12321, DOI 10.1074/jbc.275.16.12321; Sui DX, 1997, ARCH BIOCHEM BIOPHYS, V345, P111, DOI 10.1006/abbi.1997.0241; Sun L, 2008, MOL CELL BIOL, V28, P1007, DOI 10.1128/MCB.00224-07; Takayama K, 2012, MOL PHARMACEUT, V9, P1222, DOI 10.1021/mp200518n; Takayama K, 2009, J CONTROL RELEASE, V138, P128, DOI 10.1016/j.jconrel.2009.05.019; van Engeland M, 1998, CYTOMETRY, V31, P1, DOI 10.1002/(SICI)1097-0320(19980101)31:1<1::AID-CYTO1>3.0.CO;2-R; Wadia JS, 2004, NAT MED, V10, P310, DOI 10.1038/nm996; WANG LH, 1993, J CELL BIOL, V123, P1107, DOI 10.1083/jcb.123.5.1107; Wilson JE, 2003, J EXP BIOL, V206, P2049, DOI 10.1242/jeb.00241; Wu M, 2007, AM J PHYSIOL-CELL PH, V292, pC125, DOI 10.1152/ajpcell.00247.2006; Yoong SL, 2015, NANOSCALE, V7, P13907, DOI 10.1039/c5nr00980d; Zhou J, 2012, AMINO ACIDS, V42, P1253, DOI 10.1007/s00726-010-0817-7	72	44	45	2	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2168	2184		10.1096/fj.201601173R	http://dx.doi.org/10.1096/fj.201601173R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28183803	hybrid, Green Published			2022-12-28	WOS:000399195500035
J	Choi, S; Chung, H; Hong, H; Kim, SY; Kim, SE; Seoh, JY; Moon, CM; Yang, EG; Oh, ES				Choi, Sojoong; Chung, Heesung; Hong, Heejeong; Kim, So Yeon; Kim, Seong-Eun; Seoh, Ju-Young; Moon, Chang Mo; Yang, Eun Gyeong; Oh, Eok-Soo			Inflammatory hypoxia induces syndecan-2 expression through IL-1 beta-mediated FOXO3a activation in colonic epithelia	FASEB JOURNAL			English	Article						colon cancer; FOXO3a; IL-1 beta	INTESTINAL INFLAMMATION; CYTOKINE REGULATION; COLORECTAL-CANCER; CELL-MIGRATION; COLITIS; PROMOTES; PHOSPHORYLATION; CARCINOGENESIS; PROLIFERATION; STRESS	Chronic inflammation is known to be a key causative factor in tumor progression, but we do not yet fully understand the molecular mechanism through which inflammation leads to cancer. Here, we report that the dextran sulfate sodium (DSS)-induced mouse model of chronic colitis is associated with increases in the serum level of IL-1 beta and the colonic epithelial expression of the cell-surface heparan sulfate proteoglycan, syndecan-2. We further show that IL-1b stimulated the transcription of syndecan-2 via NF-kappa B-dependent FOXO3a activation in CCD841CoN normal colonic epithelial cells and early-stage HT29 colon cancer cells. Inflammatory hypoxia was observed in the colonic epithelia of mice with chronic colitis, suggesting that hypoxic stress is involved in the regulation of syndecan-2 expression. Consistently, experimental inflammatory hypoxia induced hypoxia inducible factor-1 alpha-dependent FOXO3a expression and the p38 MAPK-mediated nuclear localization of FOXO3a. FOXO3a directly mediated syndecan-2 expression in both cell lines and the colonic epithelia of mice with DSS-induced colitis. Moreover, syndecan-2 expression was detected in azoxymethane/ DSS-induced colon tumors. Together, these data demonstrate that inflammatory hypoxia upregulates syndecan-2 via the IL-1 beta-NF-kappa B-FOXO3a pathway. These findings provide new mechanistic insights into inflammatory hypoxia-mediated syndecan-2 expression to connect chronic inflammation and the development of colon cancer.-Choi, S., Chung, H., Hong, H., Kim, S. Y., Kim, S.-E., Seoh, J.-Y., Moon, C. M., Yang, E. G., Oh, E.-S. Inflammatory hypoxia induces syndecan-2 expression through IL-1b-mediated FOXO3a activation in colonic epithelia. FASEB J. 31, 1516-1530 (2017). www.fasebj.org	[Choi, Sojoong; Kim, So Yeon; Yang, Eun Gyeong] Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Hwarangno 14 Gil 5, Seoul 02792, South Korea; [Chung, Heesung; Hong, Heejeong; Oh, Eok-Soo] Ewha Womans Univ, Sch Med, Dept Life Sci, Seoul, South Korea; [Chung, Heesung; Hong, Heejeong; Oh, Eok-Soo] Ewha Womans Univ, Sch Med, Res Ctr Cellular Homeostasis, Seoul, South Korea; [Kim, Seong-Eun; Moon, Chang Mo] Ewha Womans Univ, Sch Med, Dept Internal Med, Seoul, South Korea; [Seoh, Ju-Young] Ewha Womans Univ, Grad Sch Med, Dept Microbiol, Seoul, South Korea	Korea Institute of Science & Technology (KIST); Ewha Womans University; Ewha Womans University; Ewha Womans University; Ewha Womans University	Yang, EG (corresponding author), Korea Inst Sci & Technol, Biomed Res Inst, Ctr Theragnosis, Hwarangno 14 Gil 5, Seoul 02792, South Korea.; Oh, ES (corresponding author), Ewha Womans Univ, Dept Life Sci, 52 Ewhayeodae Gil, Seoul 03760, South Korea.	eunyang@kist.re.kr; ohes@ewha.ac.kr		Kim, So Yeon/0000-0001-9167-5182	National Research Foundation of Korea [2012R1A5A1048236, 2014K1A3A7A03075056, 2012M3A9B9028156]; Korean Ministry of Science, Information and Communications Technology (ICT) and Future Planning [NRF2012M3A9C4048761]; Korea Institute of Science and Technology grant	National Research Foundation of Korea(National Research Foundation of Korea); Korean Ministry of Science, Information and Communications Technology (ICT) and Future Planning; Korea Institute of Science and Technology grant	The authors thank the National Research Foundation of Korea for Grants 2012R1A5A1048236 and 2014K1A3A7A03075056 (to E.-S.O.), and Grant 2012M3A9B9028156 (to E.G.Y.), Korean Ministry of Science, Information and Communications Technology (ICT) and Future Planning Grant NRF2012M3A9C4048761 (to E.-S.O.), and a Korea Institute of Science and Technology grant. The construct of dominant negative p38 was kindly provided by Dr. Y.J. Oh (Yonsei University, Seoul, South Korea). The syndecan-2 promoter constructs, wild p3.62kb-LUC, and mutant p3.62kb-LUC (in which FOXO3a binding was abolished) were kindly provided by Dr. D. Modrowski (Laboratory of Osteoblast Biology and Pathology, INSERM U606, Paris, France). The authors declare no competing financial interests.	Alexopoulou AN, 2007, INT J BIOCHEM CELL B, V39, P505, DOI 10.1016/j.biocel.2006.10.014; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; Bamba S, 2006, J PATHOL, V209, P265, DOI 10.1002/path.1967; Bauer C, 2010, GUT, V59, P1192, DOI 10.1136/gut.2009.197822; Chen LG, 2004, J BIOL CHEM, V279, P15715, DOI 10.1074/jbc.C300430200; Choi WS, 2004, J BIOL CHEM, V279, P20451, DOI 10.1074/jbc.M311164200; Choi Y, 2010, BIOCHEM BIOPH RES CO, V391, P921, DOI 10.1016/j.bbrc.2009.11.165; Chou CC, 2014, CANCER RES, V74, P4783, DOI 10.1158/0008-5472.CAN-14-0135; Chung H, 2012, J BIOL CHEM, V287, P19326, DOI 10.1074/jbc.M111.334730; Clasper S, 1999, J BIOL CHEM, V274, P24113, DOI 10.1074/jbc.274.34.24113; Clevers H, 2004, CELL, V118, P671, DOI 10.1016/j.cell.2004.09.005; Colgan SP, 2010, NAT REV GASTRO HEPAT, V7, P281, DOI 10.1038/nrgastro.2010.39; Cooks T, 2013, CANCER CELL, V23, P634, DOI 10.1016/j.ccr.2013.03.022; Couchman JR, 2015, INT J EXP PATHOL, V96, P1, DOI 10.1111/iep.12112; De Francesco MA, 2011, J BIOL CHEM, V286, P19541, DOI 10.1074/jbc.M110.191270; Dieudonne FX, 2012, J BONE MINER RES, V27, P2118, DOI 10.1002/jbmr.1650; Du C, 2014, SCI REP-UK, V4, DOI 10.1038/srep06096; Dyson JK, 2012, WORLD J GASTROENTERO, V18, P3839, DOI 10.3748/wjg.v18.i29.3839; Eltzschig HK, 2014, NAT REV DRUG DISCOV, V13, P852, DOI 10.1038/nrd4422; Essner JJ, 2006, INT J BIOCHEM CELL B, V38, P152, DOI 10.1016/j.biocel.2005.08.012; Foersch S, 2014, CELL MOL LIFE SCI, V71, P3523, DOI 10.1007/s00018-014-1636-x; Francescone R, 2015, INFLAMM BOWEL DIS, V21, P409, DOI 10.1097/MIB.0000000000000236; Gotte M, 2003, FASEB J, V17, P575, DOI 10.1096/fj.02-0739rev; Hagland HR, 2015, CANCER LETT, V356, P273, DOI 10.1016/j.canlet.2014.02.026; Halden Y, 2004, BIOCHEM J, V377, P533, DOI 10.1042/BJ20030729; Ho KK, 2012, J BIOL CHEM, V287, P1545, DOI 10.1074/jbc.M111.284224; Hoshi N, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2113; Kabat AM, 2014, TRENDS IMMUNOL, V35, P507, DOI 10.1016/j.it.2014.07.010; Kaur C, 2009, GLIA, V57, P336, DOI 10.1002/glia.20764; Kennedy RJ, 2000, BRIT J SURG, V87, P1346, DOI 10.1046/j.1365-2168.2000.01615.x; Lee H, 2011, BIOCHEM BIOPH RES CO, V409, P148, DOI 10.1016/j.bbrc.2011.04.135; Lee JH, 2009, J BIOL CHEM, V284, P27167, DOI 10.1074/jbc.M109.034678; Lin YZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079299; Link W, 2009, J BIOL CHEM, V284, P28392, DOI 10.1074/jbc.M109.038984; Lopez-Bojorquez LN, 2004, INFLAMM RES, V53, P567, DOI 10.1007/s00011-004-1297-6; Ning C, 2015, MUCOSAL IMMUNOL, V8, P1275, DOI 10.1038/mi.2015.18; Noguer O, 2009, EXP CELL RES, V315, P795, DOI 10.1016/j.yexcr.2008.11.016; Nowacki TM, 2015, DIGEST DIS SCI, V60, P492, DOI 10.1007/s10620-014-3373-2; Palazon A, 2014, IMMUNITY, V41, P518, DOI 10.1016/j.immuni.2014.09.008; Park H, 2002, J BIOL CHEM, V277, P29730, DOI 10.1074/jbc.M202435200; Perse M, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/718617; Ryu HY, 2009, J BIOL CHEM, V284, P35692, DOI 10.1074/jbc.M109.054254; Sebestyen A, 2000, CYTOKINE, V12, P1557, DOI 10.1006/cyto.2000.0754; Shouval DS, 2016, GASTROENTEROLOGY, V151, P1100, DOI 10.1053/j.gastro.2016.08.055; Teixe T, 2008, MOL IMMUNOL, V45, P2905, DOI 10.1016/j.molimm.2008.01.033; Ullman TA, 2011, GASTROENTEROLOGY, V140, P1807, DOI 10.1053/j.gastro.2011.01.057; Vela JM, 2002, MOL CELL NEUROSCI, V20, P489, DOI 10.1006/mcne.2002.1127; Worapamorn W, 2002, J PERIODONTAL RES, V37, P273, DOI 10.1034/j.1600-0765.2002.01610.x; Zhou X., 2016, INT J AUDIOL, V1, P1, DOI DOI 10.18632/0NC0TARGET.6418; Zoratto F, 2014, TUMOR BIOL, V35, P6195, DOI 10.1007/s13277-014-1845-9	50	23	24	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1516	1530		10.1096/fj.201601098R	http://dx.doi.org/10.1096/fj.201601098R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28031321				2022-12-28	WOS:000398504300020
J	Fucho, R; Casals, N; Serra, D; Herrero, L				Fucho, Raquel; Casals, Nuria; Serra, Dolors; Herrero, Laura			Ceramides and mitochondrial fatty acid oxidation in obesity	FASEB JOURNAL			English	Review						C16:0 ceramide; carnitine palmitoyltransferase 1; energy expenditure; insulin resistance	INDUCED INSULIN-RESISTANCE; MECHANISMS LINKING OBESITY; PLECKSTRIN HOMOLOGY DOMAIN; HUMAN SKELETAL-MUSCLE; LONG-CHAIN CERAMIDES; DIET-INDUCED OBESITY; PROTEIN-KINASE-B; RESPIRATORY-CHAIN; BETA-OXIDATION; CARNITINE PALMITOYLTRANSFERASE	Obesity is an epidemic, complex disease that is characterized by increased glucose, lipids, and low-grade inflammation in the circulation, among other factors. It creates the perfect scenario for the production of ceramide, the building block of the sphingolipid family of lipids, which is involved in metabolic disorders such as obesity, diabetes, and cardiovascular disease. In addition, obesity causes a decrease in fatty acid oxidation (FAO), which contributes tolipid accumulationwithin the cells, conferringmore susceptibility to celldysfunction. C16:0 ceramide, a specific ceramide species, has been identified recently as the principal mediator of obesity- derived insulin resistance, impaired fatty acid oxidation, and hepatic steatosis. In this review, we have sought to cover the importance of the ceramide species and their metabolism, the main ceramide signaling pathways in obesity, and the link between C16:0 ceramide, FAO, and obesity.-Fucho, R., Casals, N., Serra, D., Herrero, L. Ceramides and mitochondrial fatty acid oxidation in obesity.	[Fucho, Raquel; Serra, Dolors; Herrero, Laura] Univ Barcelona, Inst Biomed, Sch Pharm, Dept Biochem & Physiol, Av Joan 23 27-31, E-08028 Barcelona, Spain; [Casals, Nuria] Univ Int Catalunya, Basic Sci Dept, Fac Med & Hlth Sci, Barcelona, Spain; [Casals, Nuria; Serra, Dolors; Herrero, Laura] Inst Salud Carlos III, Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Madrid, Spain; [Fucho, Raquel] Hosp Clin Barcelona, Ctr Invest Biomed Red, Liver Unit, Inst Invest Biomed August Pi i Sunyer, Barcelona, Spain	University of Barcelona; Universitat Internacional de Catalunya (UIC); CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Instituto de Salud Carlos III; CIBER - Centro de Investigacion Biomedica en Red; University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS	Serra, D; Herrero, L (corresponding author), Univ Barcelona, Inst Biomed, Sch Pharm, Dept Biochem & Physiol, Av Joan 23 27-31, E-08028 Barcelona, Spain.	dserra@ub.edu; lherrero@ub.edu	Casals, Nuria/L-3378-2014; Herrero, Laura/D-4011-2014; Serra, Dolors/L-3657-2014	Casals, Nuria/0000-0002-6719-4300; Herrero, Laura/0000-0003-4244-4673; Serra, Dolors/0000-0002-4936-4206	Ministry of Spain (MINECO) [SAF2013-45887-R, SAF2014-52223-C2-1-R, SAF2014-52223-C2-2-R]; Fondos Europeos de Desarrollo Regional (FEDER); Centro de Investigaci on Biomedica en Red de Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN) [CB06/03/0001]; Government of Catalonia [2014SGR465]; Marato TV3 Foundation; European Foundation for the Study of Diabetes (EFSD)/Janssen-Rising Star; L'Oreal-UNESCO "For Women in Science"	Ministry of Spain (MINECO); Fondos Europeos de Desarrollo Regional (FEDER)(European Commission); Centro de Investigaci on Biomedica en Red de Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN); Government of Catalonia(Generalitat de Catalunya); Marato TV3 Foundation; European Foundation for the Study of Diabetes (EFSD)/Janssen-Rising Star; L'Oreal-UNESCO "For Women in Science"	This work was supported by the Ministry of Spain (MINECO) Grants SAF2013-45887-R (to L.H.), SAF2014-52223-C2-1-R (to D.S.), and SAF2014-52223-C2-2-R (to N.C.), and cofunded by the Fondos Europeos de Desarrollo Regional (FEDER); and by Centro de Investigaci on Biomedica en Red de Fisiopatologia de la Obesidad y la Nutricion (CIBEROBN) Grant CB06/03/0001 (to D.S.); Government of Catalonia Grant 2014SGR465 (to D.S.); Marato TV3 Foundation (to D.S., N.C.); and the European Foundation for the Study of Diabetes (EFSD)/Janssen-Rising Star and L'Oreal-UNESCO "For Women in Science" research fellowships (to L.H.) The authors declare no conflicts of interest.	Adams SH, 2009, J NUTR, V139, P1073, DOI 10.3945/jn.108.103754; Ahima RS, 2011, J CLIN INVEST, V121, P2076, DOI 10.1172/JCI58719; Bajpeyi S, 2014, OBESITY, V22, P426, DOI 10.1002/oby.20556; Bartke N, 2009, J LIPID RES, V50, pS91, DOI 10.1194/jlr.R800080-JLR200; Bikman BT, 2011, J CLIN INVEST, V121, P4222, DOI 10.1172/JCI57144; Blachnio-Zabielska AU, 2012, OBESITY, V20, P2341, DOI 10.1038/oby.2012.126; Blachnio-Zabielska AU, 2012, LIPIDS, V47, P1131, DOI 10.1007/s11745-012-3722-x; Boslem E, 2011, BIOCHEM J, V435, P267, DOI 10.1042/BJ20101867; Boyle KE, 2012, INT J OBESITY, V36, P1025, DOI 10.1038/ijo.2011.201; Brown N. F., 1997, BIOCHEM J, V231, P225; Bruce CR, 2006, AM J PHYSIOL-ENDOC M, V291, pE99, DOI 10.1152/ajpendo.00587.2005; Bruce CR, 2009, DIABETES, V58, P550, DOI 10.2337/db08-1078; Chalfant CE, 1999, J BIOL CHEM, V274, P20313, DOI 10.1074/jbc.274.29.20313; Chaurasia B, 2015, TRENDS ENDOCRIN MET, V26, P538, DOI 10.1016/j.tem.2015.07.006; Chavez JA, 2003, J BIOL CHEM, V278, P10297, DOI 10.1074/jbc.M212307200; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Chen LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103033; Choo HJ, 2006, DIABETOLOGIA, V49, P784, DOI 10.1007/s00125-006-0170-2; Cinar R, 2014, HEPATOLOGY, V59, P143, DOI 10.1002/hep.26606; Contreras C, 2014, CELL REP, V9, P366, DOI 10.1016/j.celrep.2014.08.057; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Di Paola M, 2000, BIOCHEMISTRY-US, V39, P6660, DOI 10.1021/bi9924415; DOBROWSKY RT, 1993, J BIOL CHEM, V268, P15523; Fabrias G, 2012, PROG LIPID RES, V51, P82, DOI 10.1016/j.plipres.2011.12.002; FROMENTY B, 1995, PHARMACOL THERAPEUT, V67, P101, DOI 10.1016/0163-7258(95)00012-6; Gao S, 2011, P NATL ACAD SCI USA, V108, P9691, DOI 10.1073/pnas.1103267108; Gao XF, 2011, BIOCHEM J, V435, P723, DOI 10.1042/BJ20101680; GarciaRuiz C, 1997, J BIOL CHEM, V272, P11369; Ginkel C, 2012, J BIOL CHEM, V287, P41888, DOI 10.1074/jbc.M112.413500; Gosejacob D, 2016, J BIOL CHEM, V291, P6989, DOI 10.1074/jbc.M115.691212; Grosch S, 2012, PROG LIPID RES, V51, P50, DOI 10.1016/j.plipres.2011.11.001; Gudz TI, 1997, J BIOL CHEM, V272, P24154, DOI 10.1074/jbc.272.39.24154; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Heneghan HM, 2013, SURG OBES RELAT DIS, V9, P100, DOI 10.1016/j.soard.2011.11.018; Henique C, 2010, J BIOL CHEM, V285, P36818, DOI 10.1074/jbc.M110.170431; Herrero L, 2005, DIABETES, V54, P462, DOI 10.2337/diabetes.54.2.462; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Houmard JA, 2008, AM J PHYSIOL-REG I, V294, pR1111, DOI 10.1152/ajpregu.00396.2007; Huang H, 2011, OBESITY, V19, P2235, DOI 10.1038/oby.2011.107; Imgrund S, 2009, J BIOL CHEM, V284, P33549, DOI 10.1074/jbc.M109.031971; Jennemann R, 2012, HUM MOL GENET, V21, P586, DOI 10.1093/hmg/ddr494; Jiang WH, 2014, BBA-MOL CELL BIOL L, V1841, P783, DOI 10.1016/j.bbalip.2013.09.005; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kelley DE, 2002, DIABETES, V51, P2944, DOI 10.2337/diabetes.51.10.2944; Kogot-Levin A, 2014, BIOCHIMIE, V100, P88, DOI 10.1016/j.biochi.2013.07.027; Koh IU, 2012, BIOL PHARM BULL, V35, P369, DOI 10.1248/bpb.35.369; Lei X, 2010, DIABETES OBES METAB, V12, P93, DOI 10.1111/j.1463-1326.2010.01270.x; Lightle S, 2003, ARCH BIOCHEM BIOPHYS, V419, P120, DOI 10.1016/j.abb.2003.08.031; Malandrino MI, 2015, AM J PHYSIOL-ENDOC M, V308, pE756, DOI 10.1152/ajpendo.00362.2014; Mamtani M, 2014, OBESITY, V22, P950, DOI 10.1002/oby.20598; Mathis D, 2013, CELL METAB, V17, P851, DOI 10.1016/j.cmet.2013.05.008; Mcilroy GD, 2013, DIABETES, V62, P825, DOI 10.2337/db12-0458; Monsenego J, 2012, J HEPATOL, V56, P632, DOI 10.1016/j.jhep.2011.10.008; Mukhopadhyay A, 2009, FASEB J, V23, P751, DOI 10.1096/fj.08-120550; Mullen TD, 2012, BIOCHEM J, V441, P789, DOI 10.1042/BJ20111626; Mullen TD, 2011, J LIPID RES, V52, P68, DOI 10.1194/jlr.M009142; Namgaladze D, 2014, DIABETOLOGIA, V57, P1067, DOI 10.1007/s00125-014-3173-4; Novgorodov SA, 2016, J BIOL CHEM, V291, P1957, DOI 10.1074/jbc.M115.668228; Oaks J, 2015, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00388; Orellana-Gavalda JM, 2011, HEPATOLOGY, V53, P821, DOI 10.1002/hep.24140; Pan H, 2001, GENOMICS, V77, P58, DOI 10.1006/geno.2001.6614; Peraldi P, 1996, J BIOL CHEM, V271, P13018, DOI 10.1074/jbc.271.22.13018; Perdomo G, 2004, J BIOL CHEM, V279, P27177, DOI 10.1074/jbc.M403566200; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Pewzner-Jung Y, 2010, J BIOL CHEM, V285, P10902, DOI 10.1074/jbc.M109.077594; Powell DJ, 2003, MOL CELL BIOL, V23, P7794, DOI 10.1128/MCB.23.21.7794-7808.2003; Price NT, 2002, GENOMICS, V80, P433, DOI 10.1006/geno.2002.6845; Raichur S, 2014, CELL METAB, V20, P687, DOI 10.1016/j.cmet.2014.09.015; Ramirez S, 2013, DIABETES, V62, P2329, DOI 10.2337/db12-1451; Ritov VB, 2005, DIABETES, V54, P8, DOI 10.2337/diabetes.54.1.8; Rodriguez-Cuenca S, 2015, BBA-MOL CELL BIOL L, V1851, P40, DOI 10.1016/j.bbalip.2014.09.021; Saddoughi SA, 2013, EMBO MOL MED, V5, P105, DOI 10.1002/emmm.201201283; Salinas M, 2000, MOL CELL NEUROSCI, V15, P156, DOI 10.1006/mcne.1999.0813; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Sassa T, 2016, J BIOL CHEM, V291, P7477, DOI 10.1074/jbc.M115.695858; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Schiffmann S, 2012, BIOCHIMIE, V94, P558, DOI 10.1016/j.biochi.2011.09.007; Sebastian D, 2007, AM J PHYSIOL-ENDOC M, V292, pE677, DOI 10.1152/ajpendo.00360.2006; Sentelle RD, 2012, NAT CHEM BIOL, V8, P831, DOI 10.1038/NCHEMBIO.1059; Serra D, 2013, ANTIOXID REDOX SIGN, V19, P269, DOI 10.1089/ars.2012.4875; Setoyama D, 2013, GENES CELLS, V18, P1107, DOI 10.1111/gtc.12098; Shah C, 2008, J BIOL CHEM, V283, P13538, DOI 10.1074/jbc.M709950200; Shiffman D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106631; Shoelson SE, 2006, J CLIN INVEST, V116, P1793, DOI 10.1172/JCI29069; Simoneau JA, 1999, FASEB J, V13, P2051, DOI 10.1096/fasebj.13.14.2051; Sims K, 2010, J BIOL CHEM, V285, P38568, DOI 10.1074/jbc.M110.170621; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Stefanovic-Racic M, 2008, AM J PHYSIOL-ENDOC M, V294, pE969, DOI 10.1152/ajpendo.00497.2007; Stratford S, 2004, J BIOL CHEM, V279, P36608, DOI 10.1074/jbc.M406499200; Stratford S, 2001, BIOCHEM J, V354, P359, DOI 10.1042/0264-6021:3540359; Sun BC, 2012, J HEPATOL, V56, P704, DOI 10.1016/j.jhep.2011.09.020; Teruel T, 2001, DIABETES, V50, P2563, DOI 10.2337/diabetes.50.11.2563; Tidhar R, 2013, BBA-MOL CELL RES, V1833, P2511, DOI 10.1016/j.bbamcr.2013.04.010; TURINSKY J, 1990, J BIOL CHEM, V265, P16880; Turpin SM, 2014, CELL METAB, V20, P678, DOI 10.1016/j.cmet.2014.08.002; Ussher JR, 2010, DIABETES, V59, P2453, DOI 10.2337/db09-1293; Uysal KT, 1997, NATURE, V389, P610, DOI 10.1038/39335; Van Gaal LF, 2006, NATURE, V444, P875, DOI 10.1038/nature05487; Veluthakal R, 2005, APOPTOSIS, V10, P841, DOI 10.1007/s10495-005-0431-4; Virtue S, 2010, BBA-MOL CELL BIOL L, V1801, P338, DOI 10.1016/j.bbalip.2009.12.006; Weir JM, 2013, J LIPID RES, V54, P2898, DOI 10.1194/jlr.P035808; Yang G, 2009, AM J PHYSIOL-ENDOC M, V297, pE211, DOI 10.1152/ajpendo.91014.2008; Zhao LH, 2015, P NATL ACAD SCI USA, V112, P12962, DOI 10.1073/pnas.1516733112; Zigdon H, 2013, J BIOL CHEM, V288, P4947, DOI 10.1074/jbc.M112.402719; Zinda MJ, 2001, BIOCHEM BIOPH RES CO, V280, P1107, DOI 10.1006/bbrc.2000.4248	107	64	66	4	43	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1263	1272		10.1096/fj.201601156R	http://dx.doi.org/10.1096/fj.201601156R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28003342	Green Submitted			2022-12-28	WOS:000398504300003
J	Hu, XT; Zhu, BL; Zhao, LG; Wang, JW; Liu, L; Lai, YJ; He, L; Deng, XJ; Chen, GJ				Hu, Xiao-Tong; Zhu, Bing-Lin; Zhao, Li-Ge; Wang, Jing-Wen; Liu, Lu; Lai, Yu-Jie; He, Ling; Deng, Xiao-Juan; Chen, Guo-Jun			Histone deacetylase inhibitor apicidin increases expression of the alpha-secretase ADAM10 through transcription factor USF1-mediated mechanisms	FASEB JOURNAL			English	Article						Alzheimer's disease; HDAC2/3; ERK	UPSTREAM STIMULATORY FACTOR; DISEASE MOUSE MODEL; A-BETA PRODUCTION; ALZHEIMERS-DISEASE; GENE-TRANSCRIPTION; CORTICAL-NEURONS; DIFFERENTIAL REGULATION; SYNAPTIC PLASTICITY; OXIDATIVE STRESS; DRUG DEVELOPMENT	ADAM10 (a disintegrin and metalloproteinase domain-containing protein 10) is the alpha-secretase that is involved in APP(beta-amyloid precursor protein) processing. Enhancement of the nonamyloidogenic APP pathway by ADAM10 provides therapeutic potential for Alzheimer's disease (AD). By using high-throughput screening that targeted ADAM10, we determined that apicidin-an inhibitor of HDACs(histone deacetylases)-significantly increased mRNA and protein levels of ADAM10 in SH-SY5Y cells. A luciferase assay revealed that the nucleotides 2444 to 2300 in the ADAM10 promoter were sufficient to mediate this effect. In addition, knockdown of USF1 (upstream transcription factor 1) and HDAC2/3 prevented apicidin regulation of ADAM10. Moreover, USF1 acetylation was increased by apicidin, which enhanced the association of USF1 with HDAC2/3 and with the ADAM10 promoter. We further found that apicidin did not affect the phosphorylation of ERK or USF1; however, ERK inhibitor U0126 blocked the effect of apicidin on ADAM10. Finally, apicidin increased the level of a-site C-terminal fragment from APP and reduced the production of b-amyloid peptide 1-42. Collectively, our study provides evidence that ADAM10 expression can be regulated by HDAC2/3 inhibitor apicidin via USF1-dependent mechanisms in which ERK signaling plays an important role. Thus, HDAC regulation of ADAM10 might shed new light on the understanding of AD pathology.-Hu, X.-T., Zhu, B.-L., Zhao, L.-G., Wang, J.-W., Liu, L., Lai, Y.-J., He, L., Deng, X.-J., Chen, G.-J. Histone deacetylase inhibitor apicidin increases expression of the a-secretase ADAM10 through transcription factor USF1-mediated mechanisms. FASEB J. 31, 1482-1493 (2017). www.fasebj.org	[Hu, Xiao-Tong; Zhu, Bing-Lin; Zhao, Li-Ge; Wang, Jing-Wen; Liu, Lu; Lai, Yu-Jie; He, Ling; Deng, Xiao-Juan; Chen, Guo-Jun] Chongqing Med Univ, Dept Neurol, Chongqing Key Lab Neurol, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China	Chongqing Medical University	Chen, GJ (corresponding author), Chongqing Med Univ, Dept Neurol, Chongqing Key Lab Neurol, Affiliated Hosp 1, 1 Youyi Rd, Chongqing 400016, Peoples R China.	woodchen2015@163.com	wang, jing/GRS-7509-2022	Chen, Guo-Jun/0000-0001-8148-9810; Zhu, Binglin/0000-0002-3244-1754	National Natural Science Foundation of China [81171197, 81220108010]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Grants 81171197 and 81220108010 from the National Natural Science Foundation of China. The authors declare no conflicts of interest.	Ahn MY, 2011, ORAL ONCOL, V47, P1032, DOI 10.1016/j.oraloncology.2011.07.027; Ballard C, 2011, LANCET, V377, P1019, DOI 10.1016/S0140-6736(10)61349-9; Bang SY, 2015, STEM CELLS DEV, V24, P520, DOI 10.1089/scd.2014.0218; Bardai FH, 2011, J NEUROSCI, V31, P1746, DOI 10.1523/JNEUROSCI.5704-10.2011; Bauden M, 2015, TOXICOL LETT, V236, P8, DOI 10.1016/j.toxlet.2015.03.017; Chami B, 2016, METAB BRAIN DIS, V31, P497, DOI 10.1007/s11011-016-9806-1; Chen WG, 2003, J NEUROSCI, V23, P2572; Chuang DM, 2009, TRENDS NEUROSCI, V32, P591, DOI 10.1016/j.tins.2009.06.002; Citron BA, 2008, J NEUROSCI RES, V86, P2499, DOI 10.1002/jnr.21695; Corre S, 2005, PIGM CELL RES, V18, P337, DOI 10.1111/j.1600-0749.2005.00262.x; Corre S, 2009, J BIOL CHEM, V284, P18851, DOI 10.1074/jbc.M808605200; Cortes-Mendoza J, 2013, INT J DEV NEUROSCI, V31, P359, DOI 10.1016/j.ijdevneu.2013.04.003; Dickson ME, 2008, CIRC RES, V103, P940, DOI 10.1161/CIRCRESAHA.108.180653; Donmez G, 2010, CELL, V142, P320, DOI 10.1016/j.cell.2010.06.020; Edwards DR, 2008, MOL ASPECTS MED, V29, P258, DOI 10.1016/j.mam.2008.08.001; Endres K, 2012, EXP BRAIN RES, V217, P343, DOI 10.1007/s00221-011-2885-7; Endres K, 2010, FEBS J, V277, P1585, DOI 10.1111/j.1742-4658.2010.07566.x; Ferri CP, 2005, LANCET, V366, P2112, DOI 10.1016/S0140-6736(05)67889-0; Fukuchi M, 2009, NEUROSCI RES, V65, P35, DOI 10.1016/j.neures.2009.05.002; Grinan-Ferre C, 2016, AGING-US, V8, P664, DOI 10.18632/aging.100906; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Heneka MT, 2007, J NEUROIMMUNOL, V184, P69, DOI 10.1016/j.jneuroim.2006.11.017; Holz MK, 2005, CELL, V123, P569, DOI 10.1016/j.cell.2005.10.024; HUNT DF, 1992, SCIENCE, V256, P1817, DOI 10.1126/science.1319610; Izzo A, 2010, BRIEF FUNCT GENOMICS, V9, P429, DOI 10.1093/bfgp/elq024; Jouannet S, 2016, CELL MOL LIFE SCI, V73, P1895, DOI 10.1007/s00018-015-2111-z; Juttner S, 2003, CELL MICROBIOL, V5, P821, DOI 10.1046/j.1462-5822.2003.00324.x; Kim J, 2010, J BIOL CHEM, V285, P22917, DOI 10.1074/jbc.M110.126649; KOVACS DM, 1995, HUM MOL GENET, V4, P1527, DOI 10.1093/hmg/4.9.1527; Kutz SM, 2006, EXP CELL RES, V312, P1093, DOI 10.1016/j.yexcr.2005.12.027; Kyrylenko S, 2003, CELL MOL LIFE SCI, V60, P1990, DOI 10.1007/s00018-003-3090-z; Lauffer BEL, 2013, J BIOL CHEM, V288, P26926, DOI 10.1074/jbc.M113.490706; Lichtenthaler SF, 2011, J NEUROCHEM, V116, P10, DOI 10.1111/j.1471-4159.2010.07081.x; Liu SJ, 2008, BLOOD, V111, P2364, DOI 10.1182/blood-2007-08-110171; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; Marcinkiewicz M, 2000, J NEUROCHEM, V75, P2133, DOI 10.1046/j.1471-4159.2000.0752133.x; Marinova Z, 2011, NEUROPHARMACOLOGY, V60, P1109, DOI 10.1016/j.neuropharm.2010.09.022; Marinova Z, 2009, J NEUROCHEM, V111, P976, DOI 10.1111/j.1471-4159.2009.06385.x; Mizuno M, 2000, J NEUROSCI, V20, P7116, DOI 10.1523/JNEUROSCI.20-18-07116.2000; Moss ML, 2007, J BIOL CHEM, V282, P35712, DOI 10.1074/jbc.M703231200; Nagai K, 2015, NEUROTOXICOL TERATOL, V48, P33, DOI 10.1016/j.ntt.2015.01.006; Nam K, 2015, CELL SIGNAL, V27, P1882, DOI 10.1016/j.cellsig.2015.05.002; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Park KY, 2008, J BIOL CHEM, V283, P5441, DOI 10.1074/jbc.M708662200; Penney J, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.aaa0069; Plum L, 2005, TRENDS ENDOCRIN MET, V16, P59, DOI 10.1016/j.tem.2005.01.008; Postina R, 2004, J CLIN INVEST, V113, P1456, DOI 10.1172/JCI200420864; Postina R, 2012, J NEUROCHEM, V120, P46, DOI 10.1111/j.1471-4159.2011.07459.x; Prinzen C, 2005, FASEB J, V19, P1522, DOI 10.1096/fj.04-3619fje; Qing H, 2008, J EXP MED, V205, P2781, DOI 10.1084/jem.20081588; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; Renault MA, 2005, J BIOL CHEM, V280, P2708, DOI 10.1074/jbc.M411786200; Ricobaraza A, 2009, NEUROPSYCHOPHARMACOL, V34, P1721, DOI 10.1038/npp.2008.229; Ryu H, 2003, J NEUROSCI, V23, P3597; Schneider LS, 2014, J INTERN MED, V275, P251, DOI 10.1111/joim.12191; Schuck F, 2016, J ALZHEIMERS DIS, V50, P817, DOI 10.3233/JAD-150737; Shimazu T, 2013, SCIENCE, V339, P211, DOI 10.1126/science.1227166; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Spilsbury A, 2015, J NEUROSCI, V35, P1659, DOI 10.1523/JNEUROSCI.2925-14.2015; Tippmann F, 2009, FASEB J, V23, P1643, DOI 10.1096/fj.08-121392; van der Heide LP, 2006, PROG NEUROBIOL, V79, P205, DOI 10.1016/j.pneurobio.2006.06.003; Villemagne VL, 2015, LANCET NEUROL, V14, P114, DOI 10.1016/S1474-4422(14)70252-2; Wang Meijuan, 2015, Shanghai Arch Psychiatry, V27, P263, DOI 10.11919/j.issn.1002-0829.215100; Wang X, 2014, NEUROENDOCRINOL LETT, V35, P224; Xiao QX, 2002, AM J PHYSIOL-HEART C, V283, pH213, DOI 10.1152/ajpheart.01085.2001; Yamanaka T, 2016, FEBS J, V283, P1077, DOI 10.1111/febs.13650	66	18	18	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1482	1493		10.1096/fj.201600961RR	http://dx.doi.org/10.1096/fj.201600961RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28003340				2022-12-28	WOS:000398504300017
J	Hemming, S; Cakouros, D; Codrington, J; Vandyke, K; Arthur, A; Zannettino, A; Gronthos, S				Hemming, Sarah; Cakouros, Dimitrios; Codrington, John; Vandyke, Kate; Arthur, Agneiszka; Zannettino, Andrew; Gronthos, Stan			EZH2 deletion in early mesenchyme compromises postnatal bone micro architecture and structural integrity and accelerates remodeling	FASEB JOURNAL			English	Article						mesenchymal stem cells; skeletal development; differentiation; epigenetics; conditional knockout	GROUP GENE EZH2; STEM-CELLS; OSTEOGENIC DIFFERENTIATION; EPIGENETIC CONTROL; PAGETS-DISEASE; POLYCOMB; METHYLATION; EXPRESSION; GUIDELINES; RESORPTION	In this study, we examined the functional importance of EZH2 during skeletal development and homeo stasis using the conditional deletion of Ezh2 (Ezh2(fl/fl)) in early mesenchyme with the use of a Prrx-1-cre driver mouse (Ezh2(+/+)). Heterozygous (Ezh2(+/-)) newborn and 4-wk-old mice exhibited increased skeletal size, growth plate size, and weight when compared to the wild-type control (Ezh2(+/+)), whereas homozygous deletion of Ezh2 (Ezh2(-7-)) resulted in skeletal deformities and reduced skeletal size, growth plate size, and weight in newborn and 4-wk-old mice. Ezh2(-/-) mice exhibited enhanced trabecular patterning. Osteogenic cortical and trabecular bone formation was enhanced in Ezh2(+/-) and Ezh2(-/-) animals. Ezh2(+/-) and Ezh2(-/-) mice displayed thinner cortical bone and decreased mechanical strength compared to the wild-type control. Differences in cortical bone thickness were attributed to an increased number of osteoclasts, corresponding with elevated levels of the bone turnover markers cross-linked C-telopeptide-1 and tartrate-resistant acid phosphatase, detected within serum. Moreover, Ezh2(+/-) mice displayed increased osteoclastogenic potential coinciding with an up regulation of Rankl and M-csf expression by mesenchymal stem cells (MSCs). MSCs isolated from Ezh2(+/-) mice also exhibited increased trilineage potential compared with wild-type bone marrow stromal/stemcells (BMSCs). Gene expression studies confirmed the upregulation of known Ezh2 target genes in Ezh2(-/-) bone tissue, many of which are involved in Wnt/BMP signaling as promoters of osteogenesis and inhibitors of adipogenesis. In summary, EZH2 appears to be an important orchestrator of skeletal development, postnatal bone remodelling and BMSC fate determination in vitro and in vivo.	[Hemming, Sarah; Cakouros, Dimitrios; Arthur, Agneiszka; Gronthos, Stan] Univ Adelaide, Fac Hlth Sci, Sch Med, Mesenchymal Stem Cell Lab, Adelaide, SA, Australia; [Vandyke, Kate; Zannettino, Andrew] Univ Adelaide, Fac Hlth Sci, Sch Med, Myeloma Res Lab, Adelaide, SA, Australia; [Codrington, John] Univ Adelaide, Sch Mech Engn, Adelaide, SA, Australia; [Hemming, Sarah; Cakouros, Dimitrios; Vandyke, Kate; Arthur, Agneiszka; Zannettino, Andrew; Gronthos, Stan] South Australian Hlth & Med Res Inst, Canc Theme, Adelaide, SA, Australia; [Vandyke, Kate] South Australia Pathol, Adelaide, SA, Australia	University of Adelaide; University of Adelaide; University of Adelaide; South Australian Health & Medical Research Institute (SAHMRI)	Gronthos, S (corresponding author), Univ Adelaide, Fac Hlth Sci, Sch Med, Adelaide, SA 5005, Australia.	stan.gronthos@adelaide.edu.au	Vandyke, Kate/G-6280-2010; Gronthos, Stan/Y-4419-2019	Vandyke, Kate/0000-0002-1033-849X; Gronthos, Stan/0000-0002-6225-3084; Arthur, Agnes/0000-0002-0539-8797; Zannettino, Andrew/0000-0002-6646-6167	National Health and Medical Research Council Project Grant [APP1046053]; Australia Postgraduate Award; Dawes Top-up scholarship;  [APP1042677]	National Health and Medical Research Council Project Grant(National Health and Medical Research Council (NHMRC) of Australia); Australia Postgraduate Award; Dawes Top-up scholarship; 	The authors thank the University of Adelaide's Microscopy Service for their technical support with micro-CT imaging and analysis. The authors also thank David Haynes, Kencana Dharmapatni, and Julia Kuliwaba for the use of their laboratory facilities (Adelaide Medical School, University of Adelaide, Adelaide, SA, Australia). This study was partially supported by National Health and Medical Research Council Project Grant APP1046053 (to S.G.), Fellowship APP1042677 (to S.G.), Australia Postgraduate Award (to S.H.), and Dawes Top-up scholarship (to S.H.). D.C. and S.G. are co-senior authors. The authors declare no conflicts of interest.	Aloia L, 2013, DEVELOPMENT, V140, P2525, DOI 10.1242/dev.091553; Arthur A, 2013, J BONE MINER RES, V28, P926, DOI 10.1002/jbmr.1821; Bi WM, 1999, NAT GENET, V22, P85, DOI 10.1038/8792; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; Bulger M, 1999, GENE DEV, V13, P2465, DOI 10.1101/gad.13.19.2465; Cakouros D, 2015, STEM CELLS DEV, V24, P1297, DOI 10.1089/scd.2014.0471; Cakouros D, 2012, MOL CELL BIOL, V32, P1433, DOI 10.1128/MCB.06315-11; Cantley MD, 2011, J CELL PHYSIOL, V226, P3233, DOI 10.1002/jcp.22684; Caretti G, 2004, GENE DEV, V18, P2627, DOI 10.1101/gad.1241904; de Haan G, 2007, ANN NY ACAD SCI, V1106, P233, DOI 10.1196/annals.1392.008; DENELL RE, 1978, GENETICS, V90, P277; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Dudakovic A, 2015, J BIOL CHEM, V290, P27604, DOI 10.1074/jbc.M115.672345; Fitter S., 2013, J CLIN ENDOCR METAB, V95, P3763; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Geoffroy V, 2002, MOL CELL BIOL, V22, P6222, DOI 10.1128/MCB.22.17.6222-6233.2002; Gibson WT, 2012, AM J HUM GENET, V90, P110, DOI 10.1016/j.ajhg.2011.11.018; Gronthos S, 2003, J CELL SCI, V116, P1827, DOI 10.1242/jcs.00369; Hemming S, 2016, STEM CELLS DEV, V25, P909, DOI 10.1089/scd.2015.0384; Hemming S, 2014, STEM CELLS, V32, P802, DOI 10.1002/stem.1573; Hirabayashi Y, 2009, NEURON, V63, P600, DOI 10.1016/j.neuron.2009.08.021; HOSKING DJ, 1981, BRIT MED J, V283, P686, DOI 10.1136/bmj.283.6293.686; Huang XJ, 2014, REPROD FERT DEVELOP, V26, P1166, DOI 10.1071/RD13169; Isenmann S, 2009, STEM CELLS, V27, P2457, DOI 10.1002/stem.181; JALAGUIER J, 1983, J GENET HUM, V31, P385; Jepsen KJ, 2015, J BONE MINER RES, V30, P951, DOI 10.1002/jbmr.2539; Jing H, 2016, MOL THER, V24, P217, DOI 10.1038/mt.2015.152; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Kouzarides T, 2007, CELL, V131, DOI 10.1016/j.cell.2007.11.005; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; McNeil PJ, 1997, J HISTOTECHNOL, V20, P307; Mikalef P, 2010, HIPPOKRATIA, V14, P212; Nemoto E, 2012, BIOCHEM BIOPH RES CO, V422, P627, DOI 10.1016/j.bbrc.2012.05.039; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; Pearson OM, 2004, YEARB PHYS ANTHROPOL, V47, P63, DOI 10.1002/ajpa.20155; Richly H, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.84; Sabharwal Robin, 2014, Niger J Surg, V20, P9, DOI 10.4103/1117-6806.127098; Schriefer JL, 2005, J BIOMECH, V38, P467, DOI 10.1016/j.jbiomech.2004.04.020; Schwarz D, 2014, DEVELOPMENT, V141, P867, DOI 10.1242/dev.094342; Sher F, 2008, STEM CELLS, V26, P2875, DOI 10.1634/stemcells.2008-0121; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Vandamme J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002642; Vandyke K, 2009, LEUKEMIA, V23, P2155, DOI 10.1038/leu.2009.150; Vandyke K, 2010, J BONE MINER RES, V25, P1759, DOI 10.1002/jbmr.85; Wang LF, 2010, P NATL ACAD SCI USA, V107, P7317, DOI 10.1073/pnas.1000031107; Wei YK, 2011, NAT CELL BIOL, V13, P87, DOI 10.1038/ncb2139; Wyngaarden LA, 2011, DEVELOPMENT, V138, P3759, DOI 10.1242/dev.063180; YATES AJP, 1988, BAILLIERE CLIN ENDOC, V2, P267, DOI 10.1016/S0950-351X(88)80015-6	51	41	41	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1011	+		10.1096/fj.201600748R	http://dx.doi.org/10.1096/fj.201600748R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27934660				2022-12-28	WOS:000395671200017
J	Lu, YF; Liu, Y; Fu, WM; Xu, J; Wang, B; Sun, YX; Wu, TY; Xu, LL; Chan, KM; Zhang, JF; Li, G				Lu, Ying-Fei; Liu, Yang; Fu, Wei-Ming; Xu, Jia; Wang, Bin; Sun, Yu-Xin; Wu, Tian-Yi; Xu, Liang-Liang; Chan, Kai-Ming; Zhang, Jin-Fang; Li, Gang			Long noncoding RNA H19 accelerates tenogenic differentiation and promotes tendon healing through targeting miR-29b-3p and activating TGF-beta 1 signaling	FASEB JOURNAL			English	Article						tendon differentiation; pathway; lncRNA; miRNA	MESENCHYMAL STEM-CELLS; OSTEOBLAST DIFFERENTIATION; EXTRACELLULAR-MATRIX; CANCER METASTASIS; ACHILLES-TENDON; EXPRESSION; REPAIR; FIBROSIS; FIBROBLASTS; BIOLOGY	Tendon injures are common orthopedic conditions, but tendon development and the pathogenesis of tendon injures, such as tendinopathy, remain largely unknown and have limited the development of clinical therapy. Studies on tenogenic differentiation at the molecular level may help in developing novel therapeutic strategies. As novel regulators, long noncoding RNAs (lncRNAs) have been found to have widespread biological functions, and emerging evidence demonstrates that lncRNAs may play important regulatory roles in cell differentiation and tissue regeneration. In this study, we found that lncRNA H19 stimulated tenogenesis of human tendon-derived stem cells. Stable overexpression of H19 significantly accelerated TGF-beta 1-induced tenogenic differentiation in vitro and accelerated tendon healing in a mouse tendon defect model. H19 directly targeted miR-29b-3p, which is considered to be a negative regulator of tenogenesis. Furthermore, miR-29b-3p directly suppressed the expression of TGF-beta 1 and type I collagen, thereby forming a novel regulatory feedback loop between H19 and TGF-beta 1 to mediate tenogenic differentiation. Our study demonstrated that H19 promotes tenogenic differentiation both in vitro and in vivo by targeting miR-29b-3p and activating TGF-beta 1 signaling. Regulation of the TGF-beta 1/H19/miR-29b-3p regulatory loop may be a new strategy for treating tendon injury.-Lu, Y.-F., Liu, Y., Fu, W.-M., Xu, J., Wang, B., Sun, Y.-X., Wu, T.-Y., Xu, L.-L, Chan, K.-M., Zhang, J.-F., Li, G. Long noncoding RNA H19 accelerates tenogenic differentiation and promotes tendon healing through targeting miR-29b-3p and activating TGF-beta 1 signaling.	[Lu, Ying-Fei; Liu, Yang; Xu, Jia; Wang, Bin; Sun, Yu-Xin; Wu, Tian-Yi; Xu, Liang-Liang; Chan, Kai-Ming; Zhang, Jin-Fang; Li, Gang] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Orthoped & Traumatol, Hong Kong, Hong Kong, Peoples R China; [Chan, Kai-Ming; Zhang, Jin-Fang; Li, Gang] Chinese Univ Hong Kong, Lui Che Woo Inst Innovat Med, Hong Kong, Hong Kong, Peoples R China; [Chan, Kai-Ming; Zhang, Jin-Fang; Li, Gang] Chinese Univ Hong Kong, Fac Med, Li Ka Shing Inst Hlth Sci, Stem Cells & Regenerat Med Lab, Hong Kong, Hong Kong, Peoples R China; [Fu, Wei-Ming] Southern Med Univ, Sch Pharmaceut Sci, Guangzhouv, Peoples R China; [Xu, Jia] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthopaed Surg, Shanghai, Peoples R China	Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Chinese University of Hong Kong; Southern Medical University - China; Shanghai Jiao Tong University	Zhang, JF; Li, G (corresponding author), Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Room 904,9-F, Shatin, Hong Kong, Peoples R China.	zhangjf06@cuhk.edu.hk; gangli@cuhk.edu.hk	Liangliang, XU/K-9185-2019; WANG, BIN/O-2346-2019; Li, Gang/J-7830-2018	Liangliang, XU/0000-0002-5249-7480; WANG, BIN/0000-0002-1348-1494; Li, Gang/0000-0002-3981-2239	Young Scientist Mentorship and Research Training (SMART) program; Lui Che Woo Institute of Innovation Medicine (The Chinese University of Hong Kong)	Young Scientist Mentorship and Research Training (SMART) program; Lui Che Woo Institute of Innovation Medicine (The Chinese University of Hong Kong)	This work is partially supported by the Young Scientist Mentorship and Research Training (SMART) program and the Lui Che Woo Institute of Innovation Medicine (The Chinese University of Hong Kong). The authors declare no conflicts of interest.	Andres BM, 2008, CLIN ORTHOP RELAT R, V466, P1539, DOI 10.1007/s11999-008-0260-1; Bi YM, 2007, NAT MED, V13, P1219, DOI 10.1038/nm1630; Chen Q, 2014, INT J CLIN EXP PATHO, V7, P8462; Cheng J, 2013, AM J MED SCI, V346, P98, DOI 10.1097/MAJ.0b013e318267680d; Clayton RAE, 2008, INJURY, V39, P1338, DOI 10.1016/j.injury.2008.06.021; Cushing L, 2015, BIOCHEM CELL BIOL, V93, P109, DOI 10.1139/bcb-2014-0095; Dey BK, 2014, GENE DEV, V28, P491, DOI 10.1101/gad.234419.113; Farhat YM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051411; GOSHEN R, 1993, MOL REPROD DEV, V34, P374, DOI 10.1002/mrd.1080340405; Guerquin MJ, 2013, J CLIN INVEST, V123, P3564, DOI 10.1172/JCI67521; Guo J, 2016, EXP CELL RES, V341, P1, DOI 10.1016/j.yexcr.2016.01.007; HAO Y, 1993, NATURE, V365, P764, DOI 10.1038/365764a0; Havis E, 2014, DEVELOPMENT, V141, P3683, DOI 10.1242/dev.108654; He Y, 2013, BIOCHIMIE, V95, P1355, DOI 10.1016/j.biochi.2013.03.010; Huang YP, 2015, STEM CELLS, V33, P3481, DOI 10.1002/stem.2225; Isfort RJ, 1997, MOL CARCINOGEN, V20, P189, DOI 10.1002/(SICI)1098-2744(199710)20:2<189::AID-MC5>3.3.CO;2-8; Kallen AN, 2013, MOL CELL, V52, P101, DOI 10.1016/j.molcel.2013.08.027; Keniry A, 2012, NAT CELL BIOL, V14, P659, DOI 10.1038/ncb2521; KVIST M, 1994, SPORTS MED, V18, P173, DOI 10.2165/00007256-199418030-00004; Li H, 2014, ONCOTARGET, V5, P2318, DOI 10.18632/oncotarget.1913; Li JX, 2016, MOL MED REP, V13, P4229, DOI 10.3892/mmr.2016.5062; Li JX, 2016, REPROD SCI, V23, P386, DOI 10.1177/1933719115602768; Liang WC, 2016, SCI REP-UK, V6, DOI 10.1038/srep20121; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Luo M, 2013, CANCER LETT, V333, P213, DOI 10.1016/j.canlet.2013.01.033; LUSTIG O, 1994, MOL REPROD DEV, V38, P239, DOI 10.1002/mrd.1080380302; Ma CC, 2014, TUMOR BIOL, V35, P9163, DOI 10.1007/s13277-014-2185-5; Ni M, 2012, J ORTHOP RES, V30, P613, DOI 10.1002/jor.21559; Nourissat G, 2015, NAT REV RHEUMATOL, V11, P223, DOI 10.1038/nrrheum.2015.26; Pathak S, 2010, REPROD FERT DEVELOP, V22, P939, DOI 10.1071/RD09154; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Poliseno L, 2010, NATURE, V465, P1033, DOI 10.1038/nature09144; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Prockop DJ, 1997, SCIENCE, V276, P71, DOI 10.1126/science.276.5309.71; Pryce BA, 2009, DEVELOPMENT, V136, P1351, DOI 10.1242/dev.027342; Qin W, 2011, J AM SOC NEPHROL, V22, P1462, DOI 10.1681/ASN.2010121308; Qiu YW, 2013, CELLS TISSUES ORGANS, V197, P27, DOI 10.1159/000341426; Rinn JL, 2012, ANNU REV BIOCHEM, V81, P145, DOI 10.1146/annurev-biochem-051410-092902; Rui YF, 2010, TISSUE ENG PT A, V16, P1549, DOI 10.1089/ten.TEA.2009.0529; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Schweitzer R, 2010, DEVELOPMENT, V137, P2807, DOI 10.1242/dev.047498; Sharma P, 2005, J BONE JOINT SURG AM, V87A, P187, DOI 10.2106/JBJS.D.01850; Tsang WP, 2010, CARCINOGENESIS, V31, P350, DOI 10.1093/carcin/bgp181; Wang B, 2016, EXP CELL RES, V347, P360, DOI 10.1016/j.yexcr.2016.08.018; Wang Y, 2013, DEV CELL, V25, P69, DOI 10.1016/j.devcel.2013.03.002; Winbanks CE, 2011, J BIOL CHEM, V286, P13805, DOI 10.1074/jbc.M110.192625; Yang T, 2013, J CELL BIOCHEM, V114, P1336, DOI 10.1002/jcb.24474; Yin Z, 2016, STEM CELL TRANSL MED, V5, P1106, DOI 10.5966/sctm.2015-0215; Zhang Y, 2014, MOL THER, V22, P974, DOI 10.1038/mt.2014.25; Zhu L, 2013, BIOCHEM BIOPH RES CO, V432, P612, DOI 10.1016/j.bbrc.2013.02.036; Zhu ZJ, 2015, INT J CLIN EXP PATHO, V8, P10082; Zuo CQ, 2013, MOL MED REP, V8, P463, DOI 10.3892/mmr.2013.1540	52	58	61	0	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					954	964		10.1096/fj.201600722R	http://dx.doi.org/10.1096/fj.201600722R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27895107				2022-12-28	WOS:000395671200012
J	van der Veen, DR; Gerkema, MP				van der Veen, Daan R.; Gerkema, Menno P.			Unmasking ultradian rhythms in gene expression	FASEB JOURNAL			English	Article						biological rhythm; circadian; metabolism; cell culture; transcriptome	COMMON VOLE; CIRCADIAN CLOCK; SUPRACHIASMATIC NUCLEUS; MICROTUS-ARVALIS; IN-VITRO; MOUSE; MECHANISMS; COMPONENT; LESIONS; ROLES	Biological oscillations with an ultradian time scale of 1 to several hours include cycles in behavioral arousal, episodic glucocorticoid release, and gene expression. Ultradian rhythms are thought to have an extrinsic origin because of a perceived absence of ultradian rhythmicity in vitro and a lack of known molecular ultradian oscillators. We designed a novel, non-spectral-analysis method of separating ultradian from circadian components and applied it to a published gene expression dataset with an ultradian sampling resolution. Ultradian rhythms in mouse hepatocytes in vivo have been published, and we validated our approach using this control by confirming 175 of 323 ultradian genes identified in a prior study and found 862 additional ultradian genes. For the first time, we now report ultradian expression of >900 genes in vitro. Sixty genes exhibited ultradian transcriptional rhythmicity, both in vivo and in vitro, including 5 genes involved in the cell cycle. Within these 60 genes, we identified significant enrichment of specific DNA motifs in the 1000 bp proximal promotor, some of which associate with known transcriptional factors. These findings are in strong support of instrinsically driven ultradian rhythms and expose potential molecular mechanisms and functions underlying ultradian rhythms that remain unknown.	[van der Veen, Daan R.] Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England; [Gerkema, Menno P.] Univ Groningen, Groningen Inst Evolutionary Life Sci, Dept Chronobiol, NL-9700 AB Groningen, Netherlands	University of Surrey; University of Groningen	van der Veen, DR (corresponding author), Univ Surrey, Fac Hlth & Med Sci, Guildford GU2 7XH, Surrey, England.	d.vanderveen@surrey.ac.uk	van der Veen, Daan R/T-1013-2017; gerkema, menno/GLN-3200-2022	van der Veen, Daan R/0000-0001-8037-1407; 				ASCHOFF J., 1954, PFLTLGERS ARCH GES PHYSIOL, V260, P81, DOI 10.1007/BF00363781; ASERINSKY E, 1953, SCIENCE, V118, P273, DOI 10.1126/science.118.3062.273; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Barrett T, 2013, NUCLEIC ACIDS RES, V41, pD991, DOI 10.1093/nar/gks1193; Bass J, 2012, NATURE, V491, P348, DOI 10.1038/nature11704; Bechtel W, 2015, FRONT PSYCHIATRY, V6, DOI 10.3389/fpsyt.2015.00118; Blum ID, 2014, ELIFE, V3, DOI 10.7554/eLife.05105; Brodsky VY, 2014, BIOCHEMISTRY-MOSCOW+, V79, P483, DOI 10.1134/S0006297914060017; Brodsky VY, 2010, CELL BIOL INT, V34, P1199, DOI 10.1042/CBI20100036; Bunger MK, 2000, CELL, V103, P1009, DOI 10.1016/S0092-8674(00)00205-1; Chaix A, 2016, J CELL BIOL, V215, P15, DOI 10.1083/jcb.201603076; DEPRINS J, 1993, CHRONOBIOL INT, V10, P395, DOI 10.3109/07420529309064493; Dowse H, 2010, J EXP BIOL, V213, P1788, DOI 10.1242/jeb.038877; DOWSE HB, 1987, BEHAV GENET, V17, P19, DOI 10.1007/BF01066008; Duncan D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-S4-P10; DUTILLEUL P, 1995, BIOL RHYTHM RES, V26, P173, DOI 10.1080/09291019509360334; ENRIGHT JT, 1989, J BIOL RHYTHM, V4, P295; Feillet C, 2014, P NATL ACAD SCI USA, V111, P9828, DOI 10.1073/pnas.1320474111; Fu LN, 2013, PROG MOL BIOL TRANSL, V119, P221, DOI 10.1016/B978-0-12-396971-2.00009-9; Gerkema M, 1985, EXP BRAIN RES S, V12, P321, DOI DOI 10.1007/978-3-642-70483-3; GERKEMA MP, 1991, J COMP PHYSIOL A, V168, P591, DOI 10.1007/BF00215081; GERKEMA MP, 1990, J BIOL RHYTHM, V5, P81, DOI 10.1177/074873049000500201; Hughes ME, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000442; Hunt T, 2007, CELL, V129, P461, DOI 10.1016/j.cell.2007.04.015; IXART G, 1991, EXP BRAIN RES, V87, P153; Lightman SL, 2010, NAT REV NEUROSCI, V11, P710, DOI 10.1038/nrn2914; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Mauvoisin D, 2014, P NATL ACAD SCI USA, V111, P167, DOI 10.1073/pnas.1314066111; MERSHON JL, 1992, ENDOCRINOLOGY, V130, P2991, DOI 10.1210/en.130.5.2991; Ono D, 2015, SCI REP-UK, V5, DOI 10.1038/srep12310; Partch CL, 2014, TRENDS CELL BIOL, V24, P90, DOI 10.1016/j.tcb.2013.07.002; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Schenda J, 2000, CELL MOL LIFE SCI, V57, P1785, DOI 10.1007/PL00000658; SCHWARTZ WJ, 1991, PHYSIOL BEHAV, V49, P1283, DOI 10.1016/0031-9384(91)90364-T; Seki Y, 2014, J BIOSCIENCES, V39, P585, DOI 10.1007/s12038-014-9450-z; Shen MH, 1997, P NATL ACAD SCI USA, V94, P13618, DOI 10.1073/pnas.94.25.13618; Strijkstra AM, 1999, CHRONOBIOL INT, V16, P431, DOI 10.3109/07420529908998718; Tu BP, 2005, SCIENCE, V310, P1152, DOI 10.1126/science.1120499; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; van der Veen DR, 2011, CHRONOBIOL INT, V28, P563, DOI 10.3109/07420528.2011.591953; van der Veen DR, 2006, P NATL ACAD SCI USA, V103, P3393, DOI 10.1073/pnas.0507825103; van Oort BEH, 2007, NATURWISSENSCHAFTEN, V94, P183, DOI 10.1007/s00114-006-0174-2; Ventre S, 2015, J MOL BIOL, V427, P1887, DOI 10.1016/j.jmb.2015.03.007; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Zhang R, 2014, P NATL ACAD SCI USA, V111, P16219, DOI 10.1073/pnas.1408886111; Zheng BH, 2001, CELL, V105, P683, DOI 10.1016/S0092-8674(01)00380-4; Zheng BH, 1999, NATURE, V400, P169, DOI 10.1038/22118	47	19	20	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					743	750		10.1096/fj.201600872R	http://dx.doi.org/10.1096/fj.201600872R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27871062	Green Published, hybrid			2022-12-28	WOS:000394235400026
J	Zhang, F; Liu, GY; Wei, CJ; Gao, C; Hao, JW				Zhang, Fang; Liu, Guiyou; Wei, Changjuan; Gao, Chao; Hao, Junwei			Linc-MAF-4 regulates T(h)1/T(h)2 differentiation and is associated with the pathogenesis of multiple sclerosis by targeting MAF	FASEB JOURNAL			English	Article						CD4(+) T cell; long noncoding RNAs; autoimmune diseases	CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LONG NONCODING RNAS; IMMUNE-SYSTEM; IFN-BETA; CELLS; EXPRESSION; RESPONSES	In this study, we strove to substantiate the ability of linc-MAF-4 to act as a regulator of pathogenesis during multiple sclerosis (MS). We recruited 34 patients who were diagnosed with MS according to the revised McDonald criteria. Six patients with MS and 5 healthy volunteers contributed peripheral blood mononuclear cells for microarray analysis. Subsequent knockdown and overexpression of linc-MAF-4 in naive CD4(+) T cells from the additional 28 patients with MS was performed to track changes in CD4+ T-cell subsets and their function, as well as to confirm results from the prior microarray analysis. Expression of linc-MAF-4 increased significantly in peripheral blood mononuclear cells of patients with MS compared with those of control participants. In addition, linc-MAF-4 regulated encephalitogenic T helper (Th) 1-cell differentiation in patients with MS. Transfection of synthetic linc-MAF-4 into naive CD4+ T cells facilitated T(h)1-cell differentiation and inhibited T(h)2-cell differentiation by directly inhibiting MAF, which is T(h)2-cell transcription factor. Linc-MAF-4 also promoted activation of CD4(+) Tcells from patients with MS. Expression level of linc-MAF-4 correlated with the annual relapse rate in patients with MS. Our results suggest that linc-MAF-4 is involved in the pathogenesis of MS, specifically via regulation of encephalitogenic T cells. Zhang, F., Liu, G., Wei, C., Gao, C., Hao, J. Linc-MAF-4 regulates T(h)1/T(h)2 differentiation and is associated with the pathogenesis of multiple sclerosis by targeting MAF.	[Zhang, Fang; Wei, Changjuan; Gao, Chao; Hao, Junwei] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Anshan Rd, Tianjin 300052, Peoples R China; [Liu, Guiyou] Harbin Inst Technol, Sch Life Sci & Technol, Harbin, Peoples R China	Tianjin Medical University; Harbin Institute of Technology	Hao, JW (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Anshan Rd, Tianjin 300052, Peoples R China.	hjw@tmu.edu.cn		Liu, Guiyou/0000-0002-1126-2888; Hao, Junwei/0000-0002-3075-5434	National Natural Science Foundation of China [81571600, 81322018, 81273287, 81100887]; Youth Top-notch Talent Support Program; National Key Clinical Specialty Construction Project of China	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Youth Top-notch Talent Support Program; National Key Clinical Specialty Construction Project of China	The authors thank their patients for participating in this study. This work supported by the National Natural Science Foundation of China (Grants 81571600, 81322018, 81273287, and 81100887; to J.H.), the Youth Top-notch Talent Support Program, and the National Key Clinical Specialty Construction Project of China. The authors declare no conflicts of interest.	Aharoni R, 2000, P NATL ACAD SCI USA, V97, P11472, DOI 10.1073/pnas.97.21.11472; Atianand MK, 2016, CELL, V165, P1672, DOI 10.1016/j.cell.2016.05.075; Bettelli E, 2008, NATURE, V453, P1051, DOI 10.1038/nature07036; Cao YH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa8038; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Goverman J, 2009, NAT REV IMMUNOL, V9, P393, DOI 10.1038/nri2550; Iaffaldano P, 2011, EXPERT REV NEUROTHER, V11, P1683, DOI [10.1586/ERN.11.154, 10.1586/ern.11.154]; Iiott NE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4979; Jager A, 2009, J IMMUNOL, V183, P7169, DOI 10.4049/jimmunol.0901906; Kasper LH, 2010, NEUROLOGY, V74, pS2, DOI 10.1212/WNL.0b013e3181c97c8f; Kieseier BC, 2003, SEMIN NEUROL, V23, P133; McFarland HF, 2007, NAT IMMUNOL, V8, P913, DOI 10.1038/ni1507; Meira M, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/897249; Necsulea A, 2014, NATURE, V505, P635, DOI 10.1038/nature12943; O'Connor RA, 2008, J IMMUNOL, V181, P3750, DOI 10.4049/jimmunol.181.6.3750; Ranzani V, 2015, NAT IMMUNOL, V16, P318, DOI 10.1038/ni.3093; Rasouli J, 2015, J IMMUNOL, V194, P5085, DOI 10.4049/jimmunol.1403243; Satpathy AT, 2015, IMMUNITY, V42, P792, DOI 10.1016/j.immuni.2015.05.004; Schmitt Nathalie, 2015, J Nat Sci, V1, pe139; Tao YZ, 2014, J IMMUNOL, V192, P5610, DOI 10.4049/jimmunol.1302580; Turner M, 2014, NAT IMMUNOL, V15, P484, DOI 10.1038/ni.2887; Wan GH, 2013, EMBO J, V32, P2833, DOI 10.1038/emboj.2013.221; Zhang F, 2016, CNS NEUROSCI THER, V22, P298, DOI 10.1111/cns.12498	23	60	67	2	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					519	525		10.1096/fj.201600838R	http://dx.doi.org/10.1096/fj.201600838R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27756768				2022-12-28	WOS:000394235400008
J	Gunness, P; Michiels, J; Vanhaecke, L; De Smet, S; Kravchuk, O; Van de Meene, A; Gidley, MJ				Gunness, Purnima; Michiels, Joris; Vanhaecke, Lynn; De Smet, Stefaan; Kravchuk, Olena; Van de Meene, Allison; Gidley, Michael J.			Reduction in circulating bile acid and restricted diffusion across the intestinal epithelium are associated with a decrease in blood cholesterol in the presence of oat beta-glucan	FASEB JOURNAL			English	Article						Ussing chamber; microscopy; nonstarch polysaccharides; deoxycholic acid; soluble dietary fiber	DIETARY FIBER; EXCRETION; MODEL; PIG; TRIGLYCERIDES; PERMEABILITY; ARABINOXYLAN; MODULATION; MECHANISMS; DIGESTION	Although oat (1,3: 1,4)-beta-glucan (BG) has been shown to decrease blood cholesterol in intervention trials, the detailed mechanism is not yet defined, but restricted reabsorption of bile acids (BAs) has been hypothesized. Using pigs as a model for humans we demonstrated that, compared to the control, BG added to the diet for 26 d caused decreases of 24% in blood total BAs (TBAs), 34% in total cholesterol (TC), and 57% in LDL cholesterol (LDL-C) (P < 0.01); decreases of 20% TBA in the midjejunumand terminal ileum(P < 0.01); increases of 80% in cecal total neutral sterols (TNSs) including cholesterol (P < 0.01); a 50% reduction in BA active transport across ex vivo ileum after 40 min (P < 0.001); and 32% decrease in jejunal microvillus heights with apparent increased goblet cell activity. The results suggest that BG not only physically hinders the active reabsorption of BAs and uptake of cholesterol, but also changes the BAs profile with lower circulating levels without excess excretion in the feces, thus resulting in reduced blood TC and LDL-C. Fermentation of sterols reaching the colon enhanced production of therapeutic ursodeoxycholic acid, suppressed toxic lithocholic acid, and decreased the possibility of cholesterol absorption by transforming the latter into coprostanol, a nonabsorbable NS.	[Gunness, Purnima; Gidley, Michael J.] Univ Queensland, Australian Res Council, Ctr Excellence Plant Cell Walls, Ctr Nutr & Food Sci,Queensland Alliance Agr & Foo, Hartley Teakle Bldg 83, Brisbane, Qld 4072, Australia; [Michiels, Joris] Univ Ghent, Dept Appl Biosci, Fac Biosci Engn, Ghent, Belgium; [Vanhaecke, Lynn] Univ Ghent, Fac Biosci Engn, Dept Anim Prod, Melle, Belgium; [De Smet, Stefaan] Univ Ghent, Dept Vet Publ Hlth & Food Safety, Fac Vet Med, Merelbeke, Belgium; [Kravchuk, Olena] Univ Adelaide, Sch Agr Food & Wine, Biometry Hub, Glen Osmond, SA, Australia; [Van de Meene, Allison] Univ Melbourne, Australian Res Council, Ctr Excellence Plant Cell Walls, Sch Biosci Bot, Parkville, Vic, Australia	University of Queensland; Ghent University; Ghent University; Ghent University; University of Adelaide; University of Melbourne	Gunness, P (corresponding author), Univ Queensland, Australian Res Council, Ctr Excellence Plant Cell Walls, Ctr Nutr & Food Sci,Queensland Alliance Agr & Foo, Hartley Teakle Bldg 83, Brisbane, Qld 4072, Australia.	nimagunness@uq.edu.au	Gidley, Mike/AAT-9543-2021; Gunness, Purnima/A-7915-2011; DeSmet, Stefaan/N-7576-2017; Vanhaecke, Lynn/N-1061-2017	DeSmet, Stefaan/0000-0003-1422-805X; Vanhaecke, Lynn/0000-0003-0400-2188; Kravchuk, Olena/0000-0001-5291-3600	Australian Research Council [CE110001007]	Australian Research Council(Australian Research Council)	The authors thank the staff of the Departments of Applied Biosciences and Animal Production (Faculty of Bioscience Engineering, Ghent University), for setting up of the animal facilities and pens and their help with experiments. This study was supported by Australian Research Council Grant CE110001007 to the Centre of Excellence in Plant Cell Walls.	Ajouz H, 2014, WORLD J SURG ONCOL, V12, DOI 10.1186/1477-7819-12-164; Brown L, 1999, AM J CLIN NUTR, V69, P30; Cullen P, 2000, AM J CARDIOL, V86, P943, DOI 10.1016/S0002-9149(00)01127-9; Davis HR, 2011, CURR OPIN LIPIDOL, V22, P467, DOI 10.1097/MOL.0b013e32834c7c28; Dawson PA, 2015, J LIPID RES, V56, P1085, DOI 10.1194/jlr.R054114; Dillard A, 2010, NUTR METAB, V7, DOI 10.1186/1743-7075-7-89; Ellegard L, 2007, EUR J CLIN NUTR, V61, P938, DOI 10.1038/sj.ejcn.1602607; Gerard P, 2007, APPL ENVIRON MICROB, V73, P5742, DOI 10.1128/AEM.02806-06; Gerard P, 2014, PATHOGENS, V3, P14, DOI 10.3390/pathogens3010014; Gunness P, 2016, MOL NUTR FOOD RES, V60, P642, DOI 10.1002/mnfr.201500686; Gunness P, 2010, FOOD FUNCT, V1, P149, DOI 10.1039/c0fo00080a; Heinritz SN, 2013, NUTR RES REV, V26, P191, DOI 10.1017/S0954422413000152; Hofmann AF, 2004, DRUG METAB REV, V36, P703, DOI 10.1081/DMR-200033475; Jenkins DJA, 2002, AM J CLIN NUTR, V75, P834, DOI 10.1093/ajcn/75.5.834; Kuipers F, 2004, REV ENDOCR METAB DIS, V5, P319, DOI 10.1023/B:REMD.0000045103.00467.9a; LIA A, 1995, AM J CLIN NUTR, V62, P1245, DOI 10.1093/ajcn/62.6.1245; Mackie A, 2016, J FUNCT FOODS, V26, P418, DOI 10.1016/j.jff.2016.08.018; Marlett JA, 2002, J NUTR, V132, P2638, DOI 10.1093/jn/132.9.2638; Martin SS, 2013, JAMA-J AM MED ASSOC, V310, P2061, DOI 10.1001/jama.2013.280532; MCCARTHY JF, 1974, CAN J ANIM SCI, V54, P107, DOI 10.4141/cjas74-016; MILLER ER, 1987, ANNU REV NUTR, V7, P361, DOI 10.1146/annurev.nu.07.070187.002045; NABUURS MJA, 1993, RES VET SCI, V55, P78, DOI 10.1016/0034-5288(93)90038-H; Nejdfors P, 2000, SCAND J GASTROENTERO, V35, P501, DOI 10.1080/003655200750023769; Pearson TA, 2002, CIRCULATION, V106, P388, DOI 10.1161/01.CIR.0000020190.45892.75; Tanghe S, 2013, J ANIM SCI, V91, P3253, DOI 10.2527/jas.2012-5874; Tsang HG, 2016, CELL BIOCHEM FUNCT, V34, P113, DOI 10.1002/cbf.3173; van der Gronde T, 2016, FOOD CHEM, V199, P746, DOI 10.1016/j.foodchem.2015.12.050; VSN International Ltd, 2015, GENSTAT WINDOWS, V15; Wolever TMS, 2010, AM J CLIN NUTR, V92, P723, DOI 10.3945/ajcn.2010.29174; Zhang DG, 2015, NUTRITION, V31, P1141, DOI 10.1016/j.nut.2015.03.006; ZHANG JX, 1993, BRIT J NUTR, V70, P525, DOI 10.1079/BJN19930146	31	49	52	1	48	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4227	4238		10.1096/fj.201600465R	http://dx.doi.org/10.1096/fj.201600465R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27630168	hybrid			2022-12-28	WOS:000388201500028
J	Dunkel, Y; Diao, KX; Aznar, N; Swanson, L; Liu, L; Zhu, WH; Mi, XY; Ghosh, P				Dunkel, Ying; Diao, Kexin; Aznar, Nicolas; Swanson, Lee; Liu, Lawrence; Zhu, Wenhong; Mi, Xiao-yi; Ghosh, Pradipta			Prognostic impact of total and tyrosine phosphorylated GIV/Girdin in breast cancers	FASEB JOURNAL			English	Article						prognostication biomarker; guanidine exchange factor; HER-2; neu; survival analysis; triple negative	G-PROTEINS; CLINICAL-IMPLICATIONS; EMERGING BIOMARKERS; GIRDIN EXPRESSION; GIV; ACTIVATION; THERAPY; SURVIVAL; MOTILITY; SIGNALS	G-interacting vesicle-associated protein (GIV, aka Girdin) is a guanine exchange factor (GEF) for the trimeric G protein Gi and a bona fide metastasis-related gene that serves as a platform for amplification of tyrosine-based signals via G-protein intermediates. Here we present the first exploratory biomarker study conducted on a cohort of 187 patients with breast cancer to evaluate the prognostic role of total GIV (tGIV) and tyrosine phosphorylated GIV (pYGIV) across the various molecular subtypes. A Kaplan-Meier analysis of recurrence-free survival showed that the presence of tGIV, either cytoplasmic or nuclear, carried poor prognosis, but that nuclear tGIV had a greater prognostic impact (P = 0.007 in early and P = 0.0048 in late clinical stages). Activated pYGIV in the cytoplasm had the greatest prognostic impact in late clinical stages (P = 0.006). Furthermore, we found that the prognostic impacts of cytoplasmic pYGIV and nuclear tGIV were additive (hazard ratio 19.0548; P = 0.0002). Surprisingly, this additive effect of nuclear tGIV/cytoplasmic pYGIV was observed in human epidermal growth factor receptor 2-positive tumors (hazard ratio 16.918; P = 0.0005) but not in triple-negative breast cancers. In triple-negative breast cancers, tGIV and cytoplasmic pYGIV had no prognostic impact; however, membrane-association of pYGIV carried a poor prognosis (P = 0.026). Both tGIV and pYGIV showed no correlation with clinical stage, tumor size, pathologic type, lymph node involvement, and BRCA1/2 status. We conclude that immunocytochemical detection of pYGIV and tGIV can serve as an effective prognosticator. On the basis of the differential prognostic impact of tGIV/pYGIV within each molecular subtype, we propose a diagnostic algorithm. Further studies on larger cohorts are essential to rigorously assess the effectiveness and robustness of this algorithm in prognosticating outcome among patients with breast cancer.Dunkel, Y., Diao, K., Aznar, N., Swanson, L., Liu, L., Zhu, W., Mi, X.-Y., Ghosh, P. Prognostic impact of total and tyrosine phosphorylated GIV/Girdin in breast cancers.	[Dunkel, Ying; Aznar, Nicolas; Swanson, Lee; Liu, Lawrence; Ghosh, Pradipta] China Med Univ, Dept Med, Shenyang, Peoples R China; [Dunkel, Ying; Aznar, Nicolas; Swanson, Lee; Liu, Lawrence; Ghosh, Pradipta] China Med Univ, Dept Cell & Mol Med, Shenyang, Peoples R China; [Diao, Kexin; Mi, Xiao-yi] China Med Univ, Dept Pathol, Shenyang, Peoples R China; [Zhu, Wenhong] Univ Calif San Diego, Div Biomed Informat, La Jolla, CA 92093 USA	China Medical University; China Medical University; China Medical University; University of California System; University of California San Diego	Mi, XY (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Pathol, 77 Puhe Rd, Shenyang 110001, Liaoning Provin, Peoples R China.; Mi, XY (corresponding author), China Med Univ, Coll Basic Med Sci, 77 Puhe Rd, Shenyang 110001, Liaoning Provin, Peoples R China.; Ghosh, P (corresponding author), Univ Calif San Diego, Dept Med, George Palade Labs Cellular & Mol Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	mixiaoyi2005@163.com; prghosh@ucsd.edu		Aznar, Nicolas/0000-0003-3338-9932	U.S. National Institutes of Health (NIH) National Cancer Institute [CA100768, CA160911]; National Natural Science Foundation of China [8157102286]; Burroughs Wellcome Fund Career Awards for Medical Scientists (CAMS) award; American Cancer Society [ACS-IRG 70-002]; University of California, San Diego Moores Cancer Center [P30CA23100]; predoctoral training award from the NIH National Institute of Diabetes and Digestive and Kidney Diseases [T32DK0070202]; NATIONAL CANCER INSTITUTE [P30CA023100, R01CA100768, R01CA160911] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007202] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Burroughs Wellcome Fund Career Awards for Medical Scientists (CAMS) award; American Cancer Society(American Cancer Society); University of California, San Diego Moores Cancer Center; predoctoral training award from the NIH National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported in part by U.S. National Institutes of Health (NIH) National Cancer Institute Grants CA100768 and CA160911 (to P.G), and by National Natural Science Foundation of China Grant 8157102286 (to X.M). P.G. was also supported by the Burroughs Wellcome Fund Career Awards for Medical Scientists (CAMS) award, the American Cancer Society (ACS-IRG 70-002), and the University of California, San Diego Moores Cancer Center (P30CA23100). L.S. was supported by a predoctoral training award from the NIH National Institute of Diabetes and Digestive and Kidney Diseases (T32DK0070202).	Abe O, 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Abe O, 1998, LANCET, V352, P930; Aznar N, 2016, BIOESSAYS, V38, P379, DOI 10.1002/bies.201500133; Cao K, 2015, INT J CLIN EXP PATHO, V8, P551; Dowsett M, 2008, CLIN CANCER RES, V14, P8019, DOI 10.1158/1078-0432.CCR-08-0974; Dunkel Y, 2012, J BIOL CHEM, V287, P41667, DOI 10.1074/jbc.M112.390781; Enomoto A, 2005, DEV CELL, V9, P389, DOI 10.1016/j.devcel.2005.08.001; Garcia-Marcos M, 2015, J BIOL CHEM, V290, P6697, DOI 10.1074/jbc.R114.613414; Garcia-Marcos M, 2011, FASEB J, V25, P590, DOI 10.1096/fj.10-167304; Garcia-Marcos M, 2009, P NATL ACAD SCI USA, V106, P3178, DOI 10.1073/pnas.0900294106; Ghosh P, 2008, J CELL BIOL, V182, P381, DOI 10.1083/jcb.200712066; Ghosh P, 2016, PHARMACOL RES, V105, P99, DOI 10.1016/j.phrs.2016.01.017; Ghosh P, 2015, AGING-US, V7, P469, DOI 10.18632/aging.100781; Ghosh P, 2015, CELL CYCLE, V14, P2561, DOI 10.1080/15384101.2015.1066538; Ghosh P, 2011, CELL ADHES MIGR, V5, P237, DOI 10.4161/cam.5.3.15909; Jiang P, 2008, CANCER RES, V68, P1310, DOI 10.1158/0008-5472.CAN-07-5111; Jiang P, 2013, TUMORI J, V99, P530, DOI 10.1700/1361.15106; Jin F, 2013, ONCOL LETT, V5, P1549, DOI 10.3892/ol.2013.1249; Jun BY, 2013, DIS COLON RECTUM, V56, P51, DOI 10.1097/DCR.0b013e31826b9b7e; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Le-Niculescu H, 2005, J BIOL CHEM, V280, P22012, DOI 10.1074/jbc.M501833200; Lin CS, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2002049; Ling Y, 2011, CANCER INVEST, V29, P405, DOI 10.3109/07357907.2011.568568; Liu CG, 2012, MED ONCOL, V29, P1554, DOI 10.1007/s12032-011-0087-6; Lopez-Sanchez I, 2015, MOL BIOL CELL, V26, P4313, DOI 10.1091/mbc.E15-07-0496; Lopez-Sanchez I, 2015, BIOCHEM BIOPH RES CO, V468, P287, DOI 10.1016/j.bbrc.2015.10.111; Lopez-Sanchez I, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5451; Ma GS, 2015, MOL BIOL CELL, V26, P4209, DOI 10.1091/mbc.E15-08-0553; Ma GS, 2015, P NATL ACAD SCI USA, V112, pE2602, DOI 10.1073/pnas.1505543112; Menju T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025301; Nishimae K, 2015, BREAST CANCER-TOKYO, V22, P445, DOI 10.1007/s12282-013-0501-3; Peng WT, 2014, ANN SURG ONCOL, V21, pS648, DOI 10.1245/s10434-014-3746-y; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Shapiro CL, 2001, NEW ENGL J MED, V344, P1997, DOI 10.1056/NEJM200106283442607; Song JY, 2014, ONCOL LETT, V7, P337, DOI 10.3892/ol.2013.1745; Wang AL, 2015, MOL MED REP, V11, P3635, DOI 10.3892/mmr.2015.3211; Wang CH, 2014, MOL CLIN ONCOL, V2, P425, DOI 10.3892/mco.2014.265; Weigel MT, 2010, ENDOCR-RELAT CANCER, V17, pR245, DOI 10.1677/ERC-10-0136; Weng L, 2010, CANCER SCI, V101, P836, DOI 10.1111/j.1349-7006.2010.01487.x; Yamamura Y, 2015, CANCER RES, V75, P813, DOI 10.1158/0008-5472.CAN-14-1317	40	6	6	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3702	3713		10.1096/fj.201600500	http://dx.doi.org/10.1096/fj.201600500			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27440794	Green Published			2022-12-28	WOS:000386474700006
J	McMillin, M; DeMorrow, S				McMillin, Matthew; DeMorrow, Sharon			Effects of bile acids on neurological function and disease	FASEB JOURNAL			English	Review						FXR; TGR5; cholesterol; metabolism; neuroinflammation	VITAMIN-D-RECEPTOR; SPHINGOSINE 1-PHOSPHATE RECEPTOR; PITUITARY-ADRENAL AXIS; TRAUMATIC BRAIN-INJURY; 7 ALPHA-HYDROXYLASE; CEREBROTENDINOUS-XANTHOMATOSIS; TAUROURSODEOXYCHOLIC ACID; LITHOCHOLIC ACID; CHOLESTEROL 24-HYDROXYLASE; GLUCOCORTICOID-RECEPTOR	Bile acids are synthesized from cholesterol and are known to be involved with the emulsification and digestion of dietary lipids and fat-soluble vitamins. Outside of this role, bile acids can act as cell signaling effectors through binding and activating receptors on both the cell membrane and nucleus. Numerous reports have investigated these signaling pathways in conditions where the liver is damaged. More recently, effort has been made to investigate the role of bile acids in diseases outside of those associated with liver damage. This review summarizes recent findings on the influences that bile acids can exert in normal neurological function and their contribution to diseases of the nervous system, with the intent of highlighting the role of these metabolites as potential players in neurological disorders.McMillin, M., DeMorrow, S. Effects of bile acids on neurological function and disease.	Texas A&M Univ, Coll Med, Hlth Sci Ctr, Dept Internal Med, Temple, TX 76508 USA; Cent Texas Vet Hlth Care Syst, Temple, TX USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center	DeMorrow, S (corresponding author), 1901 S First St,Bldg 205, Temple, TX 76504 USA.	demorrow@medicine.tamhsc.edu	McMillin, Matthew/I-3090-2019	McMillin, Matthew/0000-0002-5980-0921	U.S. Veterans Health Administration; U. S. National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK082435]; VA Merit award from the VA Biomedical Laboratory Research and Development Service [BX002638-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082435] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002638] Funding Source: NIH RePORTER	U.S. Veterans Health Administration; U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); VA Merit award from the VA Biomedical Laboratory Research and Development Service(US Department of Veterans Affairs); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was completed with support from the U.S. Veterans Health Administration and with the resources and the use of facilities at the Central Texas Veterans Health Care System (Temple, TX, USA). The views are those of the authors and do not necessarily represent the views of the U.S. Department of Veterans Affairs (VA). This study was funded by U. S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant R01 DK082435, and VA Merit award BX002638-01 from the VA Biomedical Laboratory Research and Development Service (to S.D.). The authors declare no conflicts of interest.	Adachi R, 2004, MOL ENDOCRINOL, V18, P43, DOI 10.1210/me.2003-0244; Bavner A, 2010, J LIPID RES, V51, P2722, DOI 10.1194/jlr.M008326; Beilke LD, 2009, DRUG METAB DISPOS, V37, P1035, DOI 10.1124/dmd.108.023317; Bjorkhem I, 2010, BIOCHEM BIOPH RES CO, V396, P46, DOI 10.1016/j.bbrc.2010.02.140; Bonifati V, 2006, EUR J HUM GENET, V14, P1061, DOI 10.1038/sj.ejhg.5201695; Bookout AL, 2006, CELL, V126, P789, DOI 10.1016/j.cell.2006.06.049; BRON B, 1977, GUT, V18, P692, DOI 10.1136/gut.18.9.692; Butterworth RF, 2013, NAT REV GASTRO HEPAT, V10, P522, DOI 10.1038/nrgastro.2013.99; Calkin AC, 2012, NAT REV MOL CELL BIO, V13, P213, DOI 10.1038/nrm3312; Cash WJ, 2010, QJM-INT J MED, V103, P9, DOI 10.1093/qjmed/hcp152; Chang TKH, 2009, AAPS J, V11, P590, DOI 10.1208/s12248-009-9135-y; Cheng CY, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000001468; Dawson PA, 2011, HANDB EXP PHARMACOL, V201, P169, DOI 10.1007/978-3-642-14541-4_4; Dawson PA, 2009, J LIPID RES, V50, P2340, DOI 10.1194/jlr.R900012-JLR200; Ding L, 2015, ACTA PHARM SIN B, V5, P135, DOI 10.1016/j.apsb.2015.01.004; Dionisio PA, 2015, NEUROBIOL AGING, V36, P228, DOI 10.1016/j.neurobiolaging.2014.08.034; Durk MR, 2014, J NEUROSCI, V34, P7091, DOI 10.1523/JNEUROSCI.2711-13.2014; Elia AE, 2016, EUR J NEUROL, V23, P45, DOI 10.1111/ene.12664; Erickson SK, 2003, J LIPID RES, V44, P1001, DOI 10.1194/jlr.M200489-JLR200; Frye CA, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00060; Gaspar JM, 2013, NEUROSCIENCE, V253, P380, DOI 10.1016/j.neuroscience.2013.08.053; Ginanneschi F, 2013, J NEUROL, V260, P268, DOI 10.1007/s00415-012-6630-3; Gohlke H, 2013, HEPATOLOGY, V57, P1117, DOI 10.1002/hep.25992; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Ho PP, 2016, P NATL ACAD SCI USA, V113, P1600, DOI 10.1073/pnas.1524890113; Hofmann AF, 1999, ARCH INTERN MED, V159, P2647, DOI 10.1001/archinte.159.22.2647; Huang F, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00070; Ishibashi S, 1996, J BIOL CHEM, V271, P18017, DOI 10.1074/jbc.271.30.18017; Jang W, 2015, MOL NEUROBIOL, V51, P558, DOI 10.1007/s12035-014-8835-1; Jurutka PW, 2005, J CELL BIOCHEM, V94, P917, DOI 10.1002/jcb.20359; Kageyama Y, 2012, HEPATOLOGY, V56, P1427, DOI 10.1002/hep.25780; Kalsotra A, 2003, J NEUROTRAUM, V20, P1339, DOI 10.1089/089771503322686139; Kawamata Y, 2003, J BIOL CHEM, V278, P9435, DOI 10.1074/jbc.M209706200; Keitel V, 2010, GLIA, V58, P1794, DOI 10.1002/glia.21049; Kim HJ, 2010, NEUROBIOL DIS, V37, P349, DOI 10.1016/j.nbd.2009.10.013; Kotti TJ, 2006, P NATL ACAD SCI USA, V103, P3869, DOI 10.1073/pnas.0600316103; KURIYAMA M, 1994, J NEUROL SCI, V125, P22, DOI 10.1016/0022-510X(94)90237-2; Lamba JK, 2004, J PHARMACOL EXP THER, V311, P811, DOI 10.1124/jpet.104.069310; Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703; Lemmen J, 2013, BRAIN RES, V1501, P68, DOI 10.1016/j.brainres.2013.01.025; Lewis ND, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100883; Litwa E, 2016, J STEROID BIOCHEM, V156, P43, DOI 10.1016/j.jsbmb.2015.11.018; Lorbek G, 2012, FEBS J, V279, P1516, DOI 10.1111/j.1742-4658.2011.08432.x; Lorincz MT, 2005, ARCH NEUROL-CHICAGO, V62, P1459, DOI 10.1001/archneur.62.9.1459; Lund EG, 1999, P NATL ACAD SCI USA, V96, P7238, DOI 10.1073/pnas.96.13.7238; Lund EG, 2003, J BIOL CHEM, V278, P22980, DOI 10.1074/jbc.M303415200; MacLennan AJ, 2001, EUR J NEUROSCI, V14, P203, DOI 10.1046/j.0953-816x.2001.01634.x; Mano N, 2004, J LIPID RES, V45, P295, DOI 10.1194/jlr.M300369-JLR200; Marchetti G, 2010, EUR J NEUROSCI, V31, P399, DOI 10.1111/j.1460-9568.2009.07072.x; Maruyama T, 2002, BIOCHEM BIOPH RES CO, V298, P714, DOI 10.1016/S0006-291X(02)02550-0; McMillin M, 2016, AM J PATHOL, V186, P312, DOI 10.1016/j.ajpath.2015.10.005; McMillin M, 2015, MOL ENDOCRINOL, V29, P1720, DOI 10.1210/me.2015-1087; McMillin M, 2015, J NEUROCHEM, V135, P565, DOI 10.1111/jnc.13243; McNeilly AD, 2010, J HEPATOL, V52, P705, DOI 10.1016/j.jhep.2009.10.037; Mortiboys H, 2015, NEUROLOGY, V85, P846, DOI 10.1212/WNL.0000000000001905; NAQVI SHM, 1970, STEROIDS, V16, P297; NAQVI SHM, 1970, LIPIDS, V5, P578; NAQVI SHM, 1969, J LIPID RES, V10, P115; Nie SK, 2014, ORPHANET J RARE DIS, V9, DOI 10.1186/s13023-014-0179-4; Norman AW, 2006, ENDOCRINOLOGY, V147, P5542, DOI 10.1210/en.2006-0946; Nunes AF, 2012, MOL NEUROBIOL, V45, P440, DOI 10.1007/s12035-012-8256-y; Pilo-de-la-Fuente B, 2011, EUR J NEUROL, V18, P1203, DOI 10.1111/j.1468-1331.2011.03439.x; Pols TWH, 2011, CELL METAB, V14, P747, DOI 10.1016/j.cmet.2011.11.006; Pullingr CR, 2002, J CLIN INVEST, V110, P109, DOI 10.1172/JCI200215387; Quinn M, 2014, DIGEST LIVER DIS, V46, P527, DOI 10.1016/j.dld.2014.01.159; Quinn M, 2012, AM J PHYSIOL-GASTR L, V302, pG182, DOI 10.1152/ajpgi.00205.2011; Raghupathi R, 2000, J NEUROTRAUM, V17, P927, DOI 10.1089/neu.2000.17.927; Ramalho RM, 2006, J NEUROCHEM, V98, P1610, DOI 10.1111/j.1471-4159.2006.04007.x; Ramalho RM, 2004, J NEUROCHEM, V90, P567, DOI 10.1111/j.1471-4159.2004.02517.x; Repa JJ, 2000, J BIOL CHEM, V275, P39685, DOI 10.1074/jbc.M007653200; Roberts J, 2015, J CEREB BLOOD FLOW M; Rodrigues CMP, 2003, P NATL ACAD SCI USA, V100, P6087, DOI 10.1073/pnas.1031632100; Rodrigues CMP, 2000, MOL MED, V6, P936, DOI 10.1007/BF03401828; Rodrigues TMP, 2002, J CEREBR BLOOD F MET, V22, P463, DOI 10.1097/00004647-200204000-00010; Rosen H, 1998, J BIOL CHEM, V273, P14805, DOI 10.1074/jbc.273.24.14805; Russell DW, 2003, ANNU REV BIOCHEM, V72, P137, DOI 10.1146/annurev.biochem.72.121801.161712; Schmidt DR, 2010, J BIOL CHEM, V285, P14486, DOI 10.1074/jbc.M110.116004; Schubring SR, 2012, NEUROSCI LETT, V506, P322, DOI 10.1016/j.neulet.2011.11.036; Schwarz M, 1996, J BIOL CHEM, V271, P18024, DOI 10.1074/jbc.271.30.18017; Schweingruber N, 2012, J NEUROENDOCRINOL, V24, P174, DOI 10.1111/j.1365-2826.2011.02161.x; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698; Studer E, 2012, HEPATOLOGY, V55, P267, DOI 10.1002/hep.24681; Sun XC, 2016, J STEROID BIOCHEM, V155, P94, DOI 10.1016/j.jsbmb.2015.09.040; SWAIN MG, 1993, J CLIN INVEST, V91, P1903, DOI 10.1172/JCI116408; Takigawa T, 2013, AM J PHYSIOL-GASTR L, V305, pG427, DOI 10.1152/ajpgi.00205.2012; Theofilopoulos S, 2013, NAT CHEM BIOL, V9, P126, DOI [10.1038/NCHEMBIO.1156, 10.1038/nchembio.1156]; Toman RE, 2004, J CELL BIOL, V166, P381, DOI 10.1083/jcb.200402016; Tonge DA, 2012, BRAIN RES, V1453, P8, DOI 10.1016/j.brainres.2012.03.024; Tripodi V, 2012, ANN HEPATOL, V11, P930, DOI 10.1016/S1665-2681(19)31420-6; Uno Y, 2014, J VET MED SCI, V76, P1647, DOI 10.1292/jvms.14-0313; Vassileva G, 2006, BIOCHEM J, V398, P423, DOI 10.1042/BJ20060537; Vaz AR, 2015, MOL NEUROBIOL, V51, P864, DOI 10.1007/s12035-014-8731-8; Ved R, 2005, J BIOL CHEM, V280, P42655, DOI 10.1074/jbc.M505910200; Wang HB, 1999, MOL CELL, V3, P543, DOI 10.1016/S1097-2765(00)80348-2; Yang AH, 2002, BBA-MOL CELL BIOL L, V1582, P197, DOI 10.1016/S1388-1981(02)00172-5; Yanovsky Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042512; Zhang JY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056658; Zhao C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112212	100	84	88	5	35	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3658	3668		10.1096/fj.201600275R	http://dx.doi.org/10.1096/fj.201600275R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27468758	Green Published			2022-12-28	WOS:000386474700002
J	Cole, MA; Jamil, AHA; Heather, LC; Murray, AJ; Sutton, ER; Slingo, M; Sebag-Montefiore, L; Tan, SC; Aksentijevic, D; Gildea, OS; Stuckey, DJ; Yeoh, KK; Carr, CA; Evans, RD; Aasum, E; Schofield, CJ; Ratcliffe, PJ; Neubauer, S; Robbins, PA; Clarke, K				Cole, Mark A.; Jamil, Amira H. Abd; Heather, Lisa C.; Murray, Andrew J.; Sutton, Elizabeth R.; Slingo, Mary; Sebag-Montefiore, Liam; Tan, Suat Cheng; Aksentijevic, Dunja; Gildea, Ottilie S.; Stuckey, Daniel J.; Yeoh, Kar Kheng; Carr, Carolyn A.; Evans, Rhys D.; Aasum, Ellen; Schofield, Christopher J.; Ratcliffe, Peter J.; Neubauer, Stefan; Robbins, Peter A.; Clarke, Kieran			On the pivotal role of PPAR alpha in adaptation of the heart to hypoxia and why fat in the diet increases hypoxic injury	FASEB JOURNAL			English	Article						cardiac contractile function; HIF; myocardial energy metabolism; P-31 MRS; substrate metabolism	ACTIVATED-RECEPTOR-ALPHA; PATHOLOGICAL CARDIAC-HYPERTROPHY; CHRONIC HYPOBARIC HYPOXIA; HIGH-ALTITUDE ADAPTATION; RETINOID-X-RECEPTOR; INFARCTED RAT-HEART; ENERGY-METABOLISM; DECREASED EFFICIENCY; UNCOUPLING PROTEINS; INSULIN-RESISTANCE	The role of peroxisome proliferator-activated receptor alpha (PPAR alpha)-mediated metabolic remodeling in cardiac adaptation to hypoxia has yet to be defined. Here, mice were housed in hypoxia for 3 wk before in vivo contractile function was measured using cine MRI. In isolated, perfused hearts, energetics were measured using P-31 magnetic resonance spectroscopy (MRS), and glycolysis and fatty acid oxidation were measured using [H-3] labeling. Compared with a nor-moxic, chow-fed control mouse heart, hypoxia decreased PPAR alpha expression, fatty acid oxidation, and mitochondrial uncouplingprotein 3 (UCP3) levels, while increasing glycolysis, all of which served to maintain normal ATP concentrations ([ATP]) and thereby, ejection fractions. A high-fat diet increased cardiac PPAR alpha expression, fatty acid oxidation, and UCP3 levels with decreased glycolysis. Hypoxia was unable to alter the high PPAR alpha expression or reverse the metabolic changes caused by the high-fat diet, with the result that [ATP] and contractile function decreased significantly. The adaptive metabolic changes caused by hypoxia in control mouse hearts were found to have occurred already in PPAR alpha-deficient (PPAR alpha(-/-)) mouse hearts and sustained function in hypoxia despite an inability for further metabolic remodeling. We conclude that decreased cardiac PPAR alpha expression is essential for adaptive metabolic remodeling in hypoxia, but is prevented by dietary fat.	[Cole, Mark A.; Jamil, Amira H. Abd; Heather, Lisa C.; Murray, Andrew J.; Sutton, Elizabeth R.; Slingo, Mary; Tan, Suat Cheng; Gildea, Ottilie S.; Stuckey, Daniel J.; Carr, Carolyn A.; Evans, Rhys D.; Aasum, Ellen; Robbins, Peter A.; Clarke, Kieran] Univ Oxford, Wellcome Trust Ctr Human Genet, Dept Physiol Anat & Genet, Oxford, England; [Sebag-Montefiore, Liam; Aksentijevic, Dunja; Neubauer, Stefan] Univ Oxford, Wellcome Trust Ctr Human Genet, Chem Res Lab, Oxford, England; [Ratcliffe, Peter J.] Univ Oxford, Wellcome Trust Ctr Human Genet, Nuffield Dept Clin Med, Oxford, England; [Sebag-Montefiore, Liam; Aksentijevic, Dunja; Neubauer, Stefan] Univ Oxford, Wellcome Trust Ctr Human Genet, Div Cardiovasc Med, Radcliffe Dept Med, Oxford, England; [Cole, Mark A.] Univ Nottingham, Sch Med, Queens Med Ctr, Nottingham, England; [Jamil, Amira H. Abd] Int Islamic Univ Malaysia, Fac Pharm, Dept Basic Med Sci, Med Campus, Pahang, Malaysia; [Murray, Andrew J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge, England; [Sutton, Elizabeth R.] Univ Oxford, Dept Zool, Oxford, England; [Tan, Suat Cheng] Univ Sains Malaysia, Sch Hlth Sci, Hlth Campus, Kelantan, Malaysia; [Aksentijevic, Dunja] St Thomas Hosp, Kings Coll London, British Heart Fdn Ctr Res Excellence, Rayne Inst, London, England; [Stuckey, Daniel J.] UCL, Ctr Adv Biomed Engn, London, England; [Yeoh, Kar Kheng] Univ Sains Malaysia, Sch Chem Sci, George Town, Malaysia; [Aasum, Ellen] UiT Arctic Univ Norway, Cardiovasc Res Grp, Dept Med Biol, Fac Hlth Sci, Tromso, Norway	University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; University of Oxford; Wellcome Centre for Human Genetics; University of Nottingham; International Islamic University Malaysia; University of Cambridge; University of Oxford; Universiti Sains Malaysia; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; University of London; University College London; Universiti Sains Malaysia; UiT The Arctic University of Tromso	Clarke, K (corresponding author), Univ Oxford, Dept Physiol Anat & Genet, Sherrington Bldg,Parks Rd, Oxford OX1 3PT, England.	kieran.clarke@dpag.ox.ac.uk	Abd Jamil, Amira Hajirah/N-7519-2015	Abd Jamil, Amira Hajirah/0000-0002-3999-1505; Schofield, Christopher/0000-0002-0290-6565; Murray, Andrew/0000-0002-0929-9315; Aksentijevic, Dunja/0000-0002-8480-6727; Heather, Lisa/0000-0002-7246-1338; stuckey, daniel/0000-0001-8888-627X; Ratcliffe, Peter/0000-0002-2853-806X; Cole, Mark/0000-0002-0727-7833; Tan, Suat Cheng/0000-0001-5869-6096	British Heart Foundation [RG/07/004/22659]; Diabetes UK [11/0004175]; Wellcome Trust; Malaysian Ministry of Higher Education; Biotechnology and Biological Sciences Research Council [BB/D011523/1] Funding Source: researchfish; British Heart Foundation [RG/11/1/28684, FS/15/33/31608, PG/13/34/30216] Funding Source: researchfish; Cancer Research UK [18245] Funding Source: researchfish; BBSRC [BB/D011523/1] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Diabetes UK(Diabetes UK); Wellcome Trust(Wellcome TrustEuropean Commission); Malaysian Ministry of Higher Education; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Cancer Research UK(Cancer Research UK); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was funded by the British Heart Foundation Grant RG/07/004/22659, Diabetes UK Grant 11/0004175, and the Wellcome Trust. A.H.A.J. was funded by the Malaysian Ministry of Higher Education. P.J.R. and C.J.S. are scientific cofounders of, and hold equity in, ReOx, Ltd., a University of Oxford spin-out company that is developing HIF hydroxylase inhibitors. The remaining authors declare no conflicts of interest.	Aksentijevic D, 2010, EUR J HEART FAIL, V12, P1282, DOI 10.1093/eurjhf/hfq174; Aragones J, 2008, NAT GENET, V40, P170, DOI 10.1038/ng.2007.62; Belanger AJ, 2007, BIOCHEM BIOPH RES CO, V364, P567, DOI 10.1016/j.bbrc.2007.10.062; Bernardo BC, 2010, PHARMACOL THERAPEUT, V128, P191, DOI 10.1016/j.pharmthera.2010.04.005; Boehm EA, 2001, AM J PHYSIOL-HEART C, V280, pH977, DOI 10.1152/ajpheart.2001.280.3.H977; Braissant O, 1996, ENDOCRINOLOGY, V137, P354, DOI 10.1210/en.137.1.354; Burkart EM, 2007, J CLIN INVEST, V117, P3930, DOI 10.1172/JCI32578; Caudwell Xtreme Everest Research Group, 2014, PLOS ONE, V9; Chen RL, 2014, J NEUROCHEM, V131, P177, DOI 10.1111/jnc.12804; Clark R, 2012, DIABETOLOGIA, V55, P1195, DOI 10.1007/s00125-011-2428-6; CLARKE K, 1987, AM J PHYSIOL, V253, pH412, DOI 10.1152/ajpheart.1987.253.2.H412; Cole MA, 2011, BASIC RES CARDIOL, V106, P447, DOI 10.1007/s00395-011-0156-1; Essop MF, 2007, J PHYSIOL-LONDON, V584, P715, DOI 10.1113/jphysiol.2007.143511; Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI200214080; Ge RL, 2012, MOL GENET METAB, V106, P244, DOI 10.1016/j.ymgme.2012.03.003; GULICK T, 1994, P NATL ACAD SCI USA, V91, P11012, DOI 10.1073/pnas.91.23.11012; Heather LC, 2006, CARDIOVASC RES, V72, P430, DOI 10.1016/j.cardiores.2006.08.020; Hochachka PW, 1996, P NATL ACAD SCI USA, V93, P1215, DOI 10.1073/pnas.93.3.1215; HOLDEN JE, 1995, J APPL PHYSIOL, V79, P222, DOI 10.1152/jappl.1995.79.1.222; Holloway CJ, 2011, FASEB J, V25, P792, DOI 10.1096/fj.10-172999; Holloway CJ, 2011, AM J CLIN NUTR, V93, P748, DOI 10.3945/ajcn.110.002758; Hoppeler H, 2001, J EXP BIOL, V204, P3133; HURFORD WE, 1990, J NUCL MED, V31, P1344; Huss JM, 2001, J BIOL CHEM, V276, P27605, DOI 10.1074/jbc.M100277200; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; KASHIWAYA Y, 1994, J BIOL CHEM, V269, P25502; Kennedy SL, 2001, J APPL PHYSIOL, V90, P17, DOI 10.1152/jappl.2001.90.1.17; Krishnan J, 2009, CELL METAB, V9, P512, DOI 10.1016/j.cmet.2009.05.005; Lee SH, 2000, NEW ENGL J MED, V342, P626, DOI 10.1056/NEJM200003023420904; Lei L, 2008, MOL CELL BIOL, V28, P3790, DOI 10.1128/MCB.01580-07; Levett DZ, 2012, FASEB J, V26, P1431, DOI 10.1096/fj.11-197772; Luptak I, 2005, CIRCULATION, V112, P2339, DOI 10.1161/CIRCULATIONAHA.105.534594; Matsushima S, 2013, CIRC RES, V112, P1135, DOI 10.1161/CIRCRESAHA.111.300171; McCarthy J, 2011, J CELL PHYSIOL, V226, P2457, DOI 10.1002/jcp.22592; Murray AJ, 2008, J MOL CELL CARDIOL, V44, P694, DOI 10.1016/j.yjmcc.2008.01.008; Murray AJ, 2006, CARDIOVASC RES, V71, P149, DOI 10.1016/j.cardiores.2006.02.031; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Ngumbela KC, 2003, MOL CELL BIOCHEM, V250, P151, DOI 10.1023/A:1024921329885; Panagia M, 2005, AM J PHYSIOL-HEART C, V288, pH2677, DOI 10.1152/ajpheart.00200.2004; Razeghi P, 2001, BIOCHEM BIOPH RES CO, V287, P5, DOI 10.1006/bbrc.2001.5541; Roberts AC, 1996, J APPL PHYSIOL, V81, P1762, DOI 10.1152/jappl.1996.81.4.1762; Sambandam N, 2006, AM J PHYSIOL-HEART C, V290, pH87, DOI 10.1152/ajpheart.00285.2005; Sidell RJ, 2002, DIABETES, V51, P1110, DOI 10.2337/diabetes.51.4.1110; Simonson TS, 2010, SCIENCE, V329, P72, DOI 10.1126/science.1189406; Smeets PJH, 2008, CARDIOVASC RES, V78, P79, DOI 10.1093/cvr/cvn001; Stubbs CJ, 2009, J MED CHEM, V52, P2799, DOI 10.1021/jm900285r; Thalhammer A., 2012, DRUG DISCOV TODAY TH, V9, pe91; Tian YM, 2011, J BIOL CHEM, V286, P13041, DOI 10.1074/jbc.M110.211110; Willam C, 2006, J MOL CELL CARDIOL, V41, P68, DOI 10.1016/j.yjmcc.2006.04.009; Wu RX, 2014, J CLIN INVEST, V124, P4795, DOI 10.1172/JCI76737; Young ME, 2001, J BIOL CHEM, V276, P44390, DOI 10.1074/jbc.M103826200	52	39	40	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2684	2697		10.1096/fj.201500094R	http://dx.doi.org/10.1096/fj.201500094R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27103577	Green Published, Green Submitted, hybrid			2022-12-28	WOS:000380994000006
J	Kelly, M; Widjaja-Adhi, MAK; Palczewski, G; von Lintig, J				Kelly, Mary; Widjaja-Adhi, M. Airanthi K.; Palczewski, Grzegorz; von Lintig, Johannes			Transport of vitamin A across blood-tissue barriers is facilitated by STRA6	FASEB JOURNAL			English	Article						vision; retinoids; RBP4	RETINOL-BINDING-PROTEIN; MATTHEW-WOOD-SYNDROME; CELLULAR UPTAKE; MOUSE SPERMATOGENESIS; MEMBRANE-RECEPTOR; GENE-EXPRESSION; PLASMA RETINOL; SELF-RENEWAL; MICE LACKING; ACID	Vitamin A bound to retinol binding protein 4 (RBP4) constitutes the major transport mode for retinoids in fasting circulation. Emerging evidence suggests that membrane protein, STRA6 (stimulated by retinoic acid 6), is the RBP4 receptor and vitamin A channel; however, the role of STRA6 in vitamin A homeostasis remains to be defined in vivo. We subjected Stra6-knockout mice to diets sufficient and insufficient for vitamin A and used heterozygous siblings as controls. We determined vitamin A levels of the eyes, brain, and testis, which highly express Stra6, as well as of tissues with low expression, such as lung and fat. We also studied the consequence of STRA6 deficiency on retinoid-dependent processes in tissues. Furthermore, we examined how STRA6 deficiency affected retinoid homeostasis of the aging mouse. The picture that emerged indicates a c ritical role for STRA6 in the transport of vitamin A across blood-tissue barriers in the eyes, brain, and testis. Concurrently, fat and lung rely on dietary vitamin A. In testis and brain, Stra6 expression was regulated by vitamin A. In controls, this regulation reduced vitamin A consumption when the dietary supply was limited, sequestering it for the eye. Thus, STRA6 is critical for vitamin A homeostasis and the adaption of this process to the fluctuating supply of the vitamin.	[Kelly, Mary; Widjaja-Adhi, M. Airanthi K.; Palczewski, Grzegorz; von Lintig, Johannes] Case Western Reserve Univ, Sch Med, Dept Pharmacol, 2109 Adelbert Rd,W341, Cleveland, OH 44106 USA	Case Western Reserve University	von Lintig, J (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 2109 Adelbert Rd,W341, Cleveland, OH 44106 USA.	johannes.vonlintig@case.edu		von Lintig, Johannes/0000-0002-2079-2143; Widjaja-Adhi, Made Airanthi K./0000-0002-0589-2605	U.S. National Institutes of Health (NIH) National Eye Institute [EY020551]; NIH Visual Sciences Training Program [T32 EY007157]; NIH [P30-EY11373]; NATIONAL EYE INSTITUTE [T32EY007157, R01EY019641, P30EY011373, R01EY020551] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH Visual Sciences Training Program; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by U.S. National Institutes of Health (NIH) National Eye Institute (Grant EY020551); NIH Visual Sciences Training Program (Grant T32 EY007157; to M.K.); and histology was performed by the Visual Sciences Research Center core (Case Western Reserve University; NIH Grant P30-EY11373).	Alapatt P, 2013, J BIOL CHEM, V288, P1250, DOI 10.1074/jbc.M112.369132; Amengual J, 2014, HUM MOL GENET, V23, P5402, DOI 10.1093/hmg/ddu258; Amengual J, 2012, J BIOL CHEM, V287, P24216, DOI 10.1074/jbc.M112.353979; Anderson EL, 2008, P NATL ACAD SCI USA, V105, P14976, DOI [10.1073/pnas.0807297105, 10.1038/s41598-019-45839-z]; Berry DC, 2013, J BIOL CHEM, V288, P24528, DOI 10.1074/jbc.M113.484014; Berry DC, 2011, P NATL ACAD SCI USA, V108, P4340, DOI 10.1073/pnas.1011115108; BLOMHOFF R, 1990, SCIENCE, V250, P399, DOI 10.1126/science.2218545; BOK D, 1976, EXP EYE RES, V22, P395, DOI 10.1016/0014-4835(76)90177-9; Boucheron-Houston C, 2013, J NUTR BIOCHEM, V24, P1123, DOI 10.1016/j.jnutbio.2012.08.013; Bouillet P, 1997, MECH DEVELOP, V63, P173, DOI 10.1016/S0925-4773(97)00039-7; Casey J, 2011, HUM MUTAT, V32, P1417, DOI 10.1002/humu.21590; Chassaing N, 2009, HUM MUTAT, V30, pE673, DOI 10.1002/humu.21023; Chen SR, 2015, REPRODUCTION, V149, pR159, DOI 10.1530/REP-14-0481; Chou CM, 2015, CELL, V161, P634, DOI 10.1016/j.cell.2015.03.006; Clagett-Dame M, 2011, NUTRIENTS, V3, P385, DOI 10.3390/nu3040385; D'Ambrosio DN, 2011, NUTRIENTS, V3, P63, DOI 10.3390/nu3010063; Elahy M, 2015, IMMUN AGEING, V12, DOI 10.1186/s12979-015-0029-9; EPISKOPOU V, 1993, P NATL ACAD SCI USA, V90, P2375, DOI 10.1073/pnas.90.6.2375; Golczak M, 2008, J BIOL CHEM, V283, P9543, DOI 10.1074/jbc.M708982200; Golzio C, 2007, AM J HUM GENET, V80, P1179, DOI 10.1086/518177; HELLER J, 1976, AM J OPHTHALMOL, V81, P93, DOI 10.1016/0002-9394(76)90198-7; Hogarth CA, 2010, J CLIN INVEST, V120, P956, DOI 10.1172/JCI41303; Isken A, 2008, CELL METAB, V7, P258, DOI 10.1016/j.cmet.2008.01.009; Kawaguchi R, 2007, SCIENCE, V315, P820, DOI 10.1126/science.1136244; Kawaguchi R, 2011, ACS CHEM BIOL, V6, P1041, DOI 10.1021/cb200178w; Kelly M, 2015, HEPATOL SURG NUTR, V4, P229, DOI 10.3978/j.issn.2304-3881.2015.01.12; Laursen KB, 2015, J BIOL CHEM, V290, P4356, DOI 10.1074/jbc.M114.613968; Li H, 2011, BIOL REPROD, V84, P336, DOI 10.1095/biolreprod.110.086157; Liu Li, 2008, J Vis Exp, DOI 10.3791/960; Muenzner M, 2013, MOL CELL BIOL, V33, P4068, DOI 10.1128/MCB.00221-13; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Oatley MJ, 2011, BIOL REPROD, V85, P347, DOI 10.1095/biolreprod.111.091330; ONG DE, 1987, J BIOL CHEM, V262, P2729; Pasutto F, 2007, AM J HUM GENET, V80, P550, DOI 10.1086/512203; Quadro L, 1999, EMBO J, V18, P4633, DOI 10.1093/emboj/18.17.4633; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Ruiz A, 2012, INVEST OPHTH VIS SCI, V53, P3027, DOI 10.1167/iovs.11-8476; Seeliger MW, 1999, INVEST OPHTH VIS SCI, V40, P3; SIVAPRASADARAO A, 1988, BIOCHEM J, V255, P561; Suzuki H, 2012, DEV BIOL, V361, P301, DOI 10.1016/j.ydbio.2011.10.027; Terra R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082808; von Lintig J, 2012, J BIOL CHEM, V287, P1627, DOI 10.1074/jbc.R111.303990; Wu LL, 2010, J LIPID RES, V51, P378, DOI 10.1194/jlr.M001222; YOSHINAGA K, 1991, DEVELOPMENT, V113, P689; Young PA, 2016, DIABETES-METAB RES, V32, P379, DOI 10.1002/dmrr.2764; Zemany L, 2014, MOL CELL BIOL, V34, P1170, DOI 10.1128/MCB.01106-13	46	31	32	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2985	+		10.1096/fj.201600446R	http://dx.doi.org/10.1096/fj.201600446R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27189978	Green Published			2022-12-28	WOS:000380994000030
J	Meng, T; Bu, WM; Ren, XF; Chen, XZ; Yu, JG; Eckenhoff, RG; Gao, WD				Meng, Tao; Bu, Weiming; Ren, Xianfeng; Chen, Xinzhong; Yu, Jingui; Eckenhoff, Roderic G.; Gao, Wei Dong			Molecular mechanism of anesthetic-induced depression of myocardial contraction	FASEB JOURNAL			English	Article						anesthetic agents; calcium; myofilament proteins; photolabeling	MYOFILAMENT CA2+ SENSITIVITY; RAT CARDIAC-MUSCLE; FERRET VENTRICULAR MYOCARDIUM; REGULATORY LIGHT-CHAIN; SARCOPLASMIC-RETICULUM; FILAMENT REGULATION; FORCE DEVELOPMENT; MYOSIN COMPLEX; ISOFLURANE; PROPOFOL	Isoflurane and propofol are known to depress cardiac contraction, but the molecular mechanisms involved are not known. In this study, we determined whether decreasing myofilament Ca2+ responsiveness underlies anesthesia-induced depression of contraction and uncovered the molecular targets of isoflurane and propofol. Force and intracellular Ca2+ ([Ca2+](i)) were measured in rat trabeculae superfused with Krebs-Henseleit solution, with or without propofol or isoflurane. Photoaffinity labeling of myofilament proteins with meta-Azi-propofol (AziPm) and Azi-isoflurane (Azi-iso) and molecular docking were also used. Both propofol and isoflurane dose dependently depressed force from low doses (propofol, 27 +/- 6 mu M; isoflurane, 1.0 +/- 0.1%) to moderate doses (propofol, 87 6 4 mu M; isoflurane, 3.0 +/- 0.25%), without significant alteration [Ca2+](i). During steady-state activations in both intact and skinned preparations, propofol and isoflurane depressed maximum Ca2+-activated force and increased the [Ca2+](i) required for 50% of activation. Myofibrils photolabeled with AziPm and Azi-iso identified myosin, actin, and myosin light chain as targets of the anesthetics. Several adducted residues in those proteins were located in conformationally sensitive regions that underlie contractile function. Thus, propofol and isoflurane decrease force development by directly depressing myofilament Ca2+ responsiveness and have binding sites in key regions for contraction in both actin and myosin.	[Meng, Tao; Yu, Jingui] Shandong Univ, Qilu Hosp, Dept Anesthesiol, Jinan, Shandong, Peoples R China; [Bu, Weiming; Eckenhoff, Roderic G.] Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, 311A John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA; [Ren, Xianfeng] China Japan Friendship Hosp, Dept Anesthesiol, Beijing, Peoples R China; [Chen, Xinzhong] Tongji Univ, Med Ctr, Dept Cardiac Surg, Wuhan, Peoples R China; [Gao, Wei Dong] Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Zayed 6208,1800 Orleans St, Baltimore, MD 21287 USA	Shandong University; University of Pennsylvania; Pennsylvania Medicine; China-Japan Friendship Hospital; Tongji University; Johns Hopkins University	Eckenhoff, RG (corresponding author), Univ Penn, Perelman Sch Med, Dept Anesthesiol & Crit Care, 311A John Morgan Bldg,3620 Hamilton Walk, Philadelphia, PA 19104 USA.; Gao, WD (corresponding author), Johns Hopkins Univ, Sch Med, Dept Anesthesiol & Crit Care Med, Zayed 6208,1800 Orleans St, Baltimore, MD 21287 USA.	roderic.eckenhoff@uphs.upenn.edu; wgao3@jhmi.edu	Gao, Wei/GXH-0380-2022	Eckenhoff, Roderic/0000-0002-5581-746X	American Heart Association [13GRNT16920028]; National Natural Science Foundation of China [81270174]; U.S. National Institutes of Health, Institute of General Medical Sciences [GM055876, GM008076]; Institute of Neurological Disorders and Stroke Grant [NS080519]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM055876, T32GM008076] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS080519] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); U.S. National Institutes of Health, Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Institute of Neurological Disorders and Stroke Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by American Heart Association Grant 13GRNT16920028 (to W.D.G.), National Natural Science Foundation of China Grant 81270174 (to T.M. and J.Y.), U.S. National Institutes of Health, Institute of General Medical Sciences Grants GM055876 and GM008076, and Institute of Neurological Disorders and Stroke Grant NS080519 (to R.G.E.). This article does not describe clinical studies or patient data. The authors declare no conflicts of interest.	Bartunek AE, 2000, J APPL PHYSIOL, V89, P1778, DOI 10.1152/jappl.2000.89.5.1778; Behrmann E, 2012, CELL, V150, P327, DOI 10.1016/j.cell.2012.05.037; Bertaccini EJ, 2007, ANESTH ANALG, V104, P318, DOI 10.1213/01.ane.0000253029.67331.8d; Bobkov AA, 1996, P NATL ACAD SCI USA, V93, P2285, DOI 10.1073/pnas.93.6.2285; BOSNJAK ZJ, 1992, ANESTHESIOLOGY, V76, P123, DOI 10.1097/00000542-199201000-00018; Chen WZ, 2006, BIOPHYS J, V90, P1308, DOI 10.1529/biophysj.105.064634; Colson BA, 2010, J PHYSIOL-LONDON, V588, P981, DOI 10.1113/jphysiol.2009.183897; COOK DJ, 1994, ANESTHESIOLOGY, V80, P859, DOI 10.1097/00000542-199404000-00020; Cui TX, 2012, BBA-BIOMEMBRANES, V1818, P617, DOI 10.1016/j.bbamem.2011.11.021; Dai TY, 2007, J PHYSIOL-LONDON, V580, P951, DOI 10.1113/jphysiol.2007.129254; Davies LA, 2000, ANESTHESIOLOGY, V93, P1034, DOI 10.1097/00000542-200010000-00027; de Tombe PP, 2012, J MUSCLE RES CELL M, V33, P431, DOI 10.1007/s10974-012-9310-0; Ding WG, 2011, J PHARMACOL EXP THER, V339, P825, DOI 10.1124/jpet.111.185272; Dominguez R, 2011, ANNU REV BIOPHYS, V40, P169, DOI 10.1146/annurev-biophys-042910-155359; Eckenhoff RG, 2010, METHODS MOL BIOL, V617, P437, DOI 10.1007/978-1-60327-323-7_31; FABIATO A, 1981, J GEN PHYSIOL, V78, P457, DOI 10.1085/jgp.78.5.457; Gao WD, 1996, CIRCULATION, V94, P2597, DOI 10.1161/01.CIR.94.10.2597; GAO WD, 1994, CIRC RES, V74, P408, DOI 10.1161/01.RES.74.3.408; Gao WD, 1998, J PHYSIOL-LONDON, V507, P175, DOI 10.1111/j.1469-7793.1998.175bu.x; Gao WD, 2012, CIRC RES, V111, P1002, DOI 10.1161/CIRCRESAHA.112.270827; Gordon AM, 2000, PHYSIOL REV, V80, P853, DOI 10.1152/physrev.2000.80.2.853; Graham MD, 2005, BRIT J ANAESTH, V94, P279, DOI 10.1093/bja/aei053; Hall MA, 2010, J MED CHEM, V53, P5667, DOI 10.1021/jm1004072; Hanley PJ, 2004, ANESTHESIOLOGY, V101, P999, DOI 10.1097/00000542-200410000-00027; Hanley PJ, 1998, J PHYSIOL-LONDON, V506, P231, DOI 10.1111/j.1469-7793.1998.231bx.x; Hanley PJ, 1999, J PHYSIOL-LONDON, V517, P831, DOI 10.1111/j.1469-7793.1999.0831s.x; Hannon JD, 2001, ANESTHESIOLOGY, V94, P856, DOI 10.1097/00000542-200105000-00025; Hemmings HC, 2005, TRENDS PHARMACOL SCI, V26, P503, DOI 10.1016/j.tips.2005.08.006; Housmans PR, 2000, ANESTHESIOLOGY, V93, P189, DOI 10.1097/00000542-200007000-00030; Janssen PML, 1997, AM J PHYSIOL-HEART C, V272, pH1892, DOI 10.1152/ajpheart.1997.272.4.H1892; Jiang YD, 1998, AM J PHYSIOL-HEART C, V274, pH106, DOI 10.1152/ajpheart.1998.274.1.H106; Jiang YD, 1998, AM J PHYSIOL-HEART C, V275, pH1360, DOI 10.1152/ajpheart.1998.275.4.H1360; Kampourakis T, 2015, J MOL CELL CARDIOL, V85, P199, DOI 10.1016/j.yjmcc.2015.06.002; Kanaya N, 2001, ANESTHESIOLOGY, V94, P1096, DOI 10.1097/00000542-200106000-00026; Korman VL, 1999, J BIOL CHEM, V274, P22191, DOI 10.1074/jbc.274.32.22191; Li GD, 2006, J NEUROSCI, V26, P11599, DOI 10.1523/JNEUROSCI.3467-06.2006; LUK HN, 1995, J ELECTROCARDIOL, V28, P332, DOI 10.1016/S0022-0736(05)80052-4; MURPHY AM, 1990, PEDIATR RES, V28, P46, DOI 10.1203/00006450-199007000-00011; Murphy CT, 1999, BIOCHEMISTRY-US, V38, P3785, DOI 10.1021/bi9826815; Nakae Y, 2000, ANESTH ANALG, V90, P1286, DOI 10.1097/00000539-200006000-00006; PAGEL PS, 1993, ANESTHESIOLOGY, V78, P100, DOI 10.1097/00000542-199301000-00015; Pancrazio JJ, 1996, J PHYSIOL-LONDON, V494, P91, DOI 10.1113/jphysiol.1996.sp021478; Rarick HM, 1997, J BIOL CHEM, V272, P26887, DOI 10.1074/jbc.272.43.26887; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; RAYMENT I, 1993, SCIENCE, V261, P50, DOI 10.1126/science.8316857; Sanbe A, 1999, J BIOL CHEM, V274, P21085, DOI 10.1074/jbc.274.30.21085; Sheikh F, 2014, TRENDS CARDIOVAS MED, V24, P133, DOI 10.1016/j.tcm.2013.07.004; Sheikh F, 2012, J CLIN INVEST, V122, P1209, DOI 10.1172/JCI61134; Sprung J, 2001, ANESTH ANALG, V93, P550, DOI 10.1097/00000539-200109000-00006; Stadnicka A, 2000, ANESTH ANALG, V90, P824, DOI 10.1213/00000539-200004000-00010; STOWE DF, 1992, ANESTH ANALG, V74, P547; TERRAR DA, 1988, ANESTHESIOLOGY, V69, P742, DOI 10.1097/00000542-198811000-00017; Xu C, 1999, BIOPHYS J, V77, P985, DOI 10.1016/S0006-3495(99)76949-3; Yuki K, 2012, FASEB J, V26, P4408, DOI 10.1096/fj.12-212746	54	14	14	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2915	2925		10.1096/fj.201600290RR	http://dx.doi.org/10.1096/fj.201600290RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27170289	Green Published			2022-12-28	WOS:000380994000025
J	Bedi, B; Maurice, NM; Ciavatta, VT; Lynn, KS; Yuan, ZH; Molina, SA; Joo, M; Tyor, WR; Goldberg, JB; Koval, M; Hart, CM; Sadikot, RT				Bedi, Brahmchetna; Maurice, Nicholas M.; Ciavatta, Vincent T.; Lynn, K. Sabrina; Yuan, Zhihong; Molina, Samuel A.; Joo, Myungsoo; Tyor, William R.; Goldberg, Joanna B.; Koval, Michael; Hart, C. Michael; Sadikot, Ruxana T.			Peroxisome proliferator-activated receptor-gamma agonists attenuate biofilm formation by Pseudomonas aeruginosa	FASEB JOURNAL			English	Article						Pseudomonas aeruginosa; biofilms; PPAR gamma; lung epithelium	KAPPA-B ACTIVATION; PPAR-GAMMA; EPITHELIAL-CELLS; HOST-DEFENSE; EXPRESSION; INFLAMMATION; INDUCTION; PATHWAY; ROLES; CYCLOOXYGENASE-2	Pseudomonas aeruginosa is a significant contributor to recalcitrant multidrug-resistant infections, especially in immunocompromised and hospitalized patients. The pathogenic profile of P. aeruginosa is related to its ability to secrete a variety of virulence factors and to promote biofilm formation. Quorum sensing (QS) is a mechanism where in P. aeruginosa secretes small diffusible molecules, specifically acyl homo serine lactones, such as N-(3-oxo-dodecanoyl)l-homoserine lactone (3O-C12-HSL), that promote biofilm formation and virulence via interbacterial communication. Strategies that strengthen the host's ability to inhibit bacterial virulence would enhance host defenses and improve the treatment of resistant infections. We have recently shown that peroxisome proliferator-activated receptor gamma (PPAR gamma) agonists are potent immunostimulators that play a pivotal role in host response to virulent P. aeruginosa. Here, we show that QS genes in P. aeruginosa (strain PAO1) and 3O-C12-HSL attenuate PPAR gamma expression in bronchial epithelial cells. PAO1 and 3O-C12-HSL induce barrier derangements in bronchial epithelial cells by lowering the expression of junctional proteins, such as zonula occludens-1, occludin, and claudin-4. Expression of these proteins was restored in cells that were treated with pioglitazone, a PPAR gamma agonist, before infection with PAO1 and 3O-C12-HSL. Barrier function and bacterial permeation studies that have been performed in primary human epithelial cells showed that PPAR gamma agonists are able to restore barrier integrity and function that are disrupted by PAO1 and 3O-C12-HSL. Mechanistically, we show that these effects are dependent on the induction of paraoxonase-2, a QS hydrolyzing enzyme, that mitigates the effects of QS molecules. Importantly, our data show that pioglitazone, a PPAR gamma agonist, significantly inhibits biofilm formation on epithelial cells by a mechanism that is mediated via paraoxonase-2. These findings elucidate a novel role for PPAR gamma in host defense against P. aeruginosa. Strategies that activate PPAR gamma can provide a therapeutic complement for treatment of resistant P. aeruginosa infections.	[Bedi, Brahmchetna; Maurice, Nicholas M.; Ciavatta, Vincent T.; Yuan, Zhihong; Tyor, William R.; Hart, C. Michael; Sadikot, Ruxana T.] Atlanta Vet Affairs Med Ctr, Decatur, GA USA; [Bedi, Brahmchetna; Maurice, Nicholas M.; Lynn, K. Sabrina; Yuan, Zhihong; Molina, Samuel A.; Koval, Michael; Hart, C. Michael; Sadikot, Ruxana T.] Emory Univ, Div Pulm Allergy Crit Care & Sleep Med, Atlanta, GA 30322 USA; [Ciavatta, Vincent T.] Emory Univ, Dept Ophthalmol, Atlanta, GA 30322 USA; [Tyor, William R.] Emory Univ, Dept Neurol, Atlanta, GA 30322 USA; [Goldberg, Joanna B.] Emory Univ, Dept Pediat, Atlanta, GA 30322 USA; [Koval, Michael] Emory Univ, Dept Cell Biol, Atlanta, GA 30322 USA; [Koval, Michael] Emory Univ, Emory Childrens Ctr Cyst Fibrosis & Airway Dis Re, Atlanta, GA 30322 USA; [Joo, Myungsoo] Pusan Univ, Dept Immunol, Yangsan, South Korea	US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; Emory University; Emory University; Emory University; Emory University; Emory University; Emory University; Pusan National University; Pusan National University Hospital	Sadikot, RT (corresponding author), Emory Univ, Atlanta Vet Affairs Med Ctr, Div Pulm Allergy Crit Care & Sleep Med, 1670 Clairmont Rd, Decatur, GA 30033 USA.	ruxana.sadikot@emory.edu	Koval, Michael/C-6366-2015	Koval, Michael/0000-0002-5422-5614; Yuan, Zhihong/0000-0002-2300-0463	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [R01-HL116958]; U.S. Veterans Health Administration Merit Award [5I01BX001786-05]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL116958, R01HL102167] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008367] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001786] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); U.S. Veterans Health Administration Merit Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	Cells were provided by the CF@LANTA RDP Experimental Models Core (CF@LANTA RDP Center Grant MCCART15R0) as part of the Emory Children's Center for Cystic Fibrosis and Airways Disease Research. M.K. was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant R01-HL116958. B.B., Z.Y., N.M.M. and R.T.S. were supported by U.S. Veterans Health Administration Merit Award: 5I01BX001786-05.	Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Bedi B, 2016, INFECT IMMUN, V84, P1975, DOI 10.1128/IAI.00164-16; Camp HS, 1999, ENDOCRINOLOGY, V140, P392, DOI 10.1210/en.140.1.392; Chen SM, 2008, CLIN EXP IMMUNOL, V153, P420, DOI 10.1111/j.1365-2249.2008.03707.x; Cho HY, 2010, AM J RESP CRIT CARE, V182, P170, DOI 10.1164/rccm.200907-1047OC; Corzo C, 2013, DIABETES METAB J, V37, P395, DOI 10.4093/dmj.2013.37.6.395; Coste A, 2008, J IMMUNOL, V180, P4939, DOI 10.4049/jimmunol.180.7.4939; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; Davies DG, 1998, SCIENCE, V280, P295, DOI 10.1126/science.280.5361.295; Daynes RA, 2002, NAT REV IMMUNOL, V2, P748, DOI 10.1038/nri912; de Kievit TR, 2009, ENVIRON MICROBIOL, V11, P279, DOI 10.1111/j.1462-2920.2008.01792.x; De Paula Rogerio A., 2015, BIOMED RES, V2015; Dekkers JF, 2012, TRENDS MOL MED, V18, P283, DOI 10.1016/j.molmed.2012.03.004; Devarajan A, 2013, MOL GENET METAB, V110, P362, DOI 10.1016/j.ymgme.2013.07.003; Fan X, 2011, ALCOHOL CLIN EXP RES, V35, P1866, DOI 10.1111/j.1530-0277.2011.01531.x; Fanning AS, 2012, MOL BIOL CELL, V23, P577, DOI 10.1091/mbc.E11-09-0791; Floyd ZE, 2004, OBES RES, V12, P921, DOI 10.1038/oby.2004.112; Fricks-Lima J, 2011, INT J ANTIMICROB AG, V37, P309, DOI 10.1016/j.ijantimicag.2010.12.017; Gautier EL, 2012, J IMMUNOL, V189, P2614, DOI 10.4049/jimmunol.1200495; Glass CK, 2006, NAT REV IMMUNOL, V6, P44, DOI 10.1038/nri1748; Hendricks MR, 2016, P NATL ACAD SCI USA, V113, P1642, DOI 10.1073/pnas.1516979113; Higgins G, 2016, AM J PHYSIOL-LUNG C, V310, pL1053, DOI 10.1152/ajplung.00368.2015; Horke S, 2015, INFECT IMMUN, V83, P3369, DOI 10.1128/IAI.00141-15; Jennewein C, 2010, J BIOL CHEM, V285, P11846, DOI 10.1074/jbc.M109.066399; Jiang CY, 1998, NATURE, V391, P82, DOI 10.1038/34184; Joo M, 2007, J IMMUNOL, V179, P2565, DOI 10.4049/jimmunol.179.4.2565; Kleinhenz JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139756; Kojima T, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/947072; Koval M, 2013, ANNU REV PHYSIOL, V75, P551, DOI 10.1146/annurev-physiol-030212-183809; Lakshmi SP, 2014, J BIOL CHEM, V289, P6383, DOI 10.1074/jbc.M113.536805; Liu XF, 2012, AM J PATHOL, V180, P599, DOI 10.1016/j.ajpath.2011.10.036; Liu YR, 2011, J EXP MED, V208, P1473, DOI 10.1084/jem.20102041; Losa D, 2015, AM J RESP CELL MOL, V53, P265, DOI 10.1165/rcmb.2014-0405OC; Lu XH, 2013, FREE RADICAL BIO MED, V63, P151, DOI 10.1016/j.freeradbiomed.2013.05.013; Lu XH, 2010, AM J PHYSIOL-LUNG C, V299, pL559, DOI 10.1152/ajplung.00090.2010; Molina SA, 2015, AM J PHYSIOL-LUNG C, V309, pL475, DOI 10.1152/ajplung.00060.2015; O'Toole GA, 2011, JOVE-J VIS EXP, DOI 10.3791/2437; Ogasawara N, 2010, PHARMACOL RES, V61, P489, DOI 10.1016/j.phrs.2010.03.002; Park GY, 2007, CLIN EXP IMMUNOL, V150, P245, DOI 10.1111/j.1365-2249.2007.03478.x; Pesci EC, 1999, P NATL ACAD SCI USA, V96, P11229, DOI 10.1073/pnas.96.20.11229; PETERSEN NT, 1981, ACTA PAEDIATR SCAND, V70, P623, DOI 10.1111/j.1651-2227.1981.tb05757.x; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Rasamiravaka T, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/759348; Ricote M, 1998, NATURE, V391, P79, DOI 10.1038/34178; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Sadikot RT, 2004, J IMMUNOL, V172, P1801, DOI 10.4049/jimmunol.172.3.1801; Sadikot RT, 2003, J IMMUNOL, V170, P1091, DOI 10.4049/jimmunol.170.2.1091; Sadikot RT, 2001, AM J RESP CRIT CARE, V164, P873, DOI 10.1164/ajrccm.164.5.2008059; Sadikot RT, 2007, EUR J IMMUNOL, V37, P1001, DOI 10.1002/eji.200636636; Sadikot RT, 2006, J IMMUNOL, V176, P4923, DOI 10.4049/jimmunol.176.8.4923; Schlingmann B, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12276; SCHNEEBERGER EE, 1992, AM J PHYSIOL, V262, pL647, DOI 10.1152/ajplung.1992.262.6.L647; Shiner M, 2007, ATHEROSCLEROSIS, V195, P313, DOI 10.1016/j.atherosclerosis.2007.01.007; Simet SM, 2012, ALCOHOL CLIN EXP RES, V36, P432, DOI 10.1111/j.1530-0277.2011.01640.x; Singh PK, 2002, NATURE, V417, P552, DOI 10.1038/417552a; Singh PK, 2000, NATURE, V407, P762, DOI 10.1038/35037627; Stoltz DA, 2007, AM J PHYSIOL-LUNG C, V292, pL852, DOI 10.1152/ajplung.00370.2006; Syed MA, 2010, EXP CELL RES, V316, P3140, DOI 10.1016/j.yexcr.2010.08.009; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; van Beekum O, 2009, OBESITY, V17, P213, DOI 10.1038/oby.2008.473; Van Delden C, 1998, EMERG INFECT DIS, V4, P551, DOI 10.3201/eid0404.980405; Vikstrom E, 2010, EUR J CELL BIOL, V89, P584, DOI 10.1016/j.ejcb.2010.03.002; Wahjudi M, 2011, MICROBIOL-SGM, V157, P2042, DOI 10.1099/mic.0.043935-0; Walker TS, 2005, INFECT IMMUN, V73, P3693, DOI 10.1128/IAI.73.6.3693-3701.2005; Yamashita D, 2004, GENES CELLS, V9, P1017, DOI 10.1111/j.1365-2443.2004.00786.x; Yki-Jarvinen H, 2004, NEW ENGL J MED, V351, P1106, DOI 10.1056/NEJMra041001; Yuan ZH, 2017, SCI REP-UK, V7, DOI 10.1038/srep42028; Yuan ZH, 2013, J IMMUNOL, V191, P3810, DOI 10.4049/jimmunol.1300883; Zhang LJ, 2015, SCIENCE, V347, P67, DOI 10.1126/science.1260972	70	22	22	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3608	3621		10.1096/fj.201700075R	http://dx.doi.org/10.1096/fj.201700075R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28442545	Green Published			2022-12-28	WOS:000405932400033
J	Gao, HS; Zhao, Q; Song, ZW; Yang, ZC; Wu, Y; Tang, SS; Alahdal, M; Zhang, YF; Jin, L				Gao, Huashan; Zhao, Qian; Song, Ziwei; Yang, Zhaocong; Wu, You; Tang, Shanshan; Alahdal, Murad; Zhang, Yanfeng; Jin, Liang			PGLP-1, a novel long-acting dual-function GLP-1 analog, ameliorates streptozotocin-induced hyperglycemia and inhibits body weight loss	FASEB JOURNAL			English	Article						beta-cell mass; beta-oxidation; gluconeogenesis; insulinomimetic; insulinotropic	GLUCAGON-LIKE PEPTIDE-1; BETA-CELL MASS; HEPATIC GLUCONEOGENESIS; INSULIN SENSITIVITY; DIABETES-MELLITUS; CLEAVAGE PRODUCT; LIPID-METABOLISM; OBESE MICE; 9-36 AMIDE; IN-VIVO	It is well known that glucagon-like peptide 1 (GLP-1) has antidiabetic action. It has 2 distinct functions, an insulinotropic effect dependent on GLP-1 receptor (GLP-1R) and an insulinomimetic effect independent of GLP-1R. However, use of GLP-1 in vivo is limited by its short half-life. Therefore, our lab designed PGLP-1, a novel 2-function candidate peptide as a potential substitute. Using a streptozotocin-induced hyperglycemic mouse model, we demonstrated in vitro and in vivo that PGLP-1 had insulinotropic actions dependent on GLP-1R and insulinomimetic functions independent of GLP-1R. PGLP-1 treatment increased islet beta-cell mass, plasma insulin, and C-peptide levels and Ki-67-immunoreactive beta-cell numbers, verifying that PGLP-1 can work as a short GLP-1R agonist, similar to commercially available exendin-4. Additionally, PGLP-1 improved insulin sensitivity, inhibited gluconeogenesis by increasing expression of AMPK and receptor subfamily 0, group B, member 2 (SHP), and inhibited body weight loss by inhibiting beta-oxidation, suggesting that PGLP-1 had insulinomimetic action. Taken together, these data indicated that PGLP-1, as a dual-function peptide, improved glycemic control and inhibited body weight loss, suggesting it could be useful for type 1 diabetes mellitus patients as an adjunctive therapy to insulin.	[Gao, Huashan; Zhao, Qian; Song, Ziwei; Yang, Zhaocong; Wu, You; Tang, Shanshan; Alahdal, Murad; Zhang, Yanfeng; Jin, Liang] China Pharmaceut Univ, Sch Life Sci & Technol, State Key Lab Nat Med, Jiangsu Key Lab Drug Screening, Nanjing, Jiangsu, Peoples R China; [Gao, Huashan] Pingdingshan Univ, Coll Chem & Chem Engn, Pingdingshan, Peoples R China	China Pharmaceutical University; Pingdingshan University	Jin, L (corresponding author), China Pharmaceut Univ, Sch Life Sci & Technol, State Key Lab Nat Med, Jiangsu Key Lab Drug Screening, 24 Tongjia Alley, Nanjing Shi 210009, Jiangsu Sheng, Peoples R China.	liangjin1975@cpu.edu.cm	Alahdal, Murad/AAO-2213-2020	Alahdal, Murad/0000-0003-1444-6014	National High Technology Research and Development Program of China (863 Program) [2015AA020314]; National Natural Science Foundation of China [81570696, 31270985]; Excellent Youth Foundation of Jiangsu Scientific Committee [BK20140029]; Fundamental Research Funds for the Central Universities [Z114037]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Top-Notch Academic Programs Project of Jiangsu Higher Education Institutions [PPZY2015A057]	National High Technology Research and Development Program of China (863 Program)(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Excellent Youth Foundation of Jiangsu Scientific Committee; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Top-Notch Academic Programs Project of Jiangsu Higher Education Institutions	This work was supported, in part, by a project funded by National High Technology Research and Development Program of China (863 Program; 2015AA020314), National Natural Science Foundation of China (81570696 and 31270985), Excellent Youth Foundation of Jiangsu Scientific Committee (BK20140029), Fundamental Research Funds for the Central Universities (Z114037), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD), and Top-Notch Academic Programs Project of Jiangsu Higher Education Institutions (PPZY2015A057).	Abu-Hamdah R, 2009, J CLIN ENDOCR METAB, V94, P1843, DOI 10.1210/jc.2008-1296; Ban K, 2008, CIRCULATION, V117, P2340, DOI 10.1161/CIRCULATIONAHA.107.739938; Bojic LA, 2014, J LIPID RES, V55, P1254, DOI 10.1194/jlr.M046037; Cai EP, 2012, DIABETES, V61, P1708, DOI 10.2337/db11-1344; Collombat P, 2003, GENE DEV, V17, P2591, DOI 10.1101/gad.269003; DEACON CF, 1995, DIABETES, V44, P1126, DOI 10.2337/diabetes.44.9.1126; Devendra D, 2004, BMJ-BRIT MED J, V328, P750, DOI 10.1136/bmj.328.7442.750; Drucker DJ, 2003, ENDOCRINOLOGY, V144, P5145, DOI 10.1210/en.2003-1147; Elahi D, 2008, OBESITY, V16, P1501, DOI 10.1038/oby.2008.229; Farilla L, 2002, ENDOCRINOLOGY, V143, P4397, DOI 10.1210/en.2002-220405; Fitzgerald LR, 1999, ANAL BIOCHEM, V275, P54, DOI 10.1006/abio.1999.4295; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Giorda CB, 2014, ENDOCRINE, V46, P406, DOI 10.1007/s12020-014-0179-0; Giorda CB, 2014, ENDOCRINE, V46, P420, DOI 10.1007/s12020-014-0240-z; Holst JJ, 1999, TRENDS ENDOCRIN MET, V10, P229, DOI 10.1016/S1043-2760(99)00157-5; Hui HX, 2005, DIABETES-METAB RES, V21, P313, DOI 10.1002/dmrr.553; Ip W, 2013, AM J PHYSIOL-ENDOC M, V305, pE1348, DOI 10.1152/ajpendo.00376.2013; Kieffer TJ, 1999, ENDOCR REV, V20, P876, DOI 10.1210/er.20.6.876; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Lee JM, 2010, J BIOL CHEM, V285, P32182, DOI 10.1074/jbc.M110.134890; Lee YS, 2007, DIABETES, V56, P1671, DOI 10.2337/db06-1182; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Liu ZG, 2012, J ENDOCRINOL, V213, P143, DOI 10.1530/JOE-11-0328; MADSBAD S, 1980, ACTA ENDOCRINOL-COP, V95, P359, DOI 10.1530/acta.0.0950359; Meeran K, 1999, ENDOCRINOLOGY, V140, P244, DOI 10.1210/en.140.1.244; O'Harte FPM, 2000, BBA-GEN SUBJECTS, V1474, P13, DOI 10.1016/S0304-4165(99)00214-7; Oh KJ, 2013, ARCH PHARM RES, V36, P189, DOI 10.1007/s12272-013-0018-5; Perseghin G, 2005, DIABETOLOGIA, V48, P2615, DOI 10.1007/s00125-005-0014-5; ROSSINI AA, 1978, ENDOCRINOLOGY, V103, P1518, DOI 10.1210/endo-103-4-1518; Shao WJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE1263, DOI 10.1152/ajpendo.00600.2012; Sonne DP, 2008, REGUL PEPTIDES, V146, P243, DOI 10.1016/j.regpep.2007.10.001; Stefan N, 2008, ENDOCR REV, V29, P939, DOI 10.1210/er.2008-0009; Szayna M, 2000, ENDOCRINOLOGY, V141, P1936, DOI 10.1210/en.141.6.1936; Taniguchi C. M., 2006, CELL METAB; Taniguchi CM, 2006, CELL METAB, V3, P343, DOI 10.1016/j.cmet.2006.04.005; Tiwary P, 2015, P NATL ACAD SCI USA, V112, pE386, DOI 10.1073/pnas.1424461112; Tomas E, 2011, DIABETES OBES METAB, V13, P26, DOI 10.1111/j.1463-1326.2010.01316.x; Tomas E, 2010, HORM METAB RES, V42, P657, DOI 10.1055/s-0030-1253421; Tomas E, 2015, DIABETES, V64, P2409, DOI 10.2337/db14-1708; Tomas E, 2010, TRENDS ENDOCRIN MET, V21, P59, DOI 10.1016/j.tem.2009.11.007; Turton MD, 1996, NATURE, V379, P69, DOI 10.1038/379069a0; Underwood CR, 2010, J BIOL CHEM, V285, P723, DOI 10.1074/jbc.M109.033829; Wan M, 2011, CELL METAB, V14, P516, DOI 10.1016/j.cmet.2011.09.001; Zhang JY, 2015, P NATL ACAD SCI USA, V112, P7954, DOI 10.1073/pnas.1506792112	44	12	13	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3527	3539		10.1096/fj.201700002R	http://dx.doi.org/10.1096/fj.201700002R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28461341				2022-12-28	WOS:000405932400028
J	Reiman, M; Laan, M; Rull, K; Sober, S				Reiman, Mario; Laan, Maris; Rull, Kristiina; Sober, Siim			Effects of RNA integrity on transcript quantification by total RNA sequencing of clinically collected human placental samples	FASEB JOURNAL			English	Article						RNA-Seq; RNA degradation; RIN; gene expression	FACTOR-BINDING PROTEIN-1; MESSENGER-RNA; GENE-EXPRESSION; MICROARRAY ANALYSIS; GENOME-WIDE; QUALITY; SEQ; PROFILE; SITE	RNA degradation is a ubiquitous process that occurs in living and dead cells, as well as during handling and storage of extracted RNA. Reduced RNA quality caused by degradation is an established source of uncertainty for all RNA-based gene expression quantification techniques. RNA sequencing is an increasingly preferred method for transcriptome analyses, and dependence of its results on input RNA integrity is of significant practical importance. This study aimed to characterize the effects of varying input RNA integrity [estimated as RNA integrity number (RIN)] on transcript level estimates and delineate the characteristic differences between transcripts that differ in degradation rate. The study used ribodepleted total RNA sequencing data from a real-life clinically collected set (n=32) of human solid tissue (placenta) samples. RIN-dependent alterations in gene expression profiles were quantified by using DESeq2 software. Our results indicate that small differences in RNA integrity affect gene expression quantification by introducing a moderate and pervasive bias in expression level estimates that significantly affected 8.1% of studied genes. The rapidly degrading transcript pool was enriched in pseudogenes, short noncoding RNAs, and transcripts with extended 39 untranslated regions. Typical slowly degrading transcripts (median length, 2389 nt) represented protein coding genes with 4-10 exons and high guanine-cytosine content.	[Reiman, Mario; Laan, Maris; Rull, Kristiina; Sober, Siim] Univ Tartu, Human Mol Genet Res Grp, Inst Mol & Cell Biol, Tartu, Estonia; [Laan, Maris; Sober, Siim] Univ Tartu, Inst Biomed & Translat Med, Tartu, Estonia; [Rull, Kristiina] Univ Tartu, Dept Obstet & Gynecol, Tartu, Estonia; [Rull, Kristiina] Tartu Univ Hosp, Womens Clin, Tartu, Estonia	University of Tartu; University of Tartu; University of Tartu	Sober, S (corresponding author), Univ Tartu, Inst Mol & Cell Biol, Riia St 23, EE-51010 Tartu, Estonia.	siims@ut.ee	Rull, Kristiina/H-9555-2013; Laan, Maris/A-4100-2011	Rull, Kristiina/0000-0002-3396-0716; Laan, Maris/0000-0002-8519-243X	European Union; European Regional Development Fund [3.2.0701.12-0047]; Estonian Research Council [IUT34-12, ETF9030]	European Union(European Commission); European Regional Development Fund(European Commission); Estonian Research Council(Estonian Research Council)	The authors thank Dr. Pille Vaas, Pille Teesalu and the assisting clinical personnel at the Women's Clinic (Tartu University Hospital) for the collection of Reprogrammed Fetal and/or Maternal Metabolism (REPROMETA) study samples. This work was supported by the European Union through the European Regional Development Fund (Project Happy Pregnancy; Grant 3.2.0701.12-0047 to M.L. and K.R.), and Estonian Research Council (Grants IUT34-12 and ETF9030 to M.L.). The authors declare no conflicts of interest.	Adiconis X, 2013, NAT METHODS, V10, P623, DOI 10.1038/nmeth.2483; Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Ardlie KG, 2015, SCIENCE, V348, P648, DOI 10.1126/science.1262110; Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a; Buckberry S, 2014, MOL HUM REPROD, V20, P810, DOI 10.1093/molehr/gau035; Conesa A, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-0881-8; Conte C, 2002, CYTOGENET GENOME RES, V98, P45, DOI 10.1159/000068546; Duan JB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01318; Durinck S, 2009, NAT PROTOC, V4, P1184, DOI 10.1038/nprot.2009.97; Durrenberger PF, 2010, J NEUROPATH EXP NEUR, V69, P70, DOI 10.1097/NEN.0b013e3181c7e32f; Enquobahrie DA, 2009, AM J OBSTET GYNECOL, V200, DOI 10.1016/j.ajog.2008.08.022; Feng HJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8816; Fleige Simone, 2006, Molecular Aspects of Medicine, V27, P126, DOI 10.1016/j.mam.2005.12.003; Fordyce Sarah L, 2013, Investig Genet, V4, P7, DOI 10.1186/2041-2223-4-7; Garneau NL, 2007, NAT REV MOL CELL BIO, V8, P113, DOI 10.1038/nrm2104; Gay E, 2000, BIOCHEM BIOPH RES CO, V267, P509, DOI 10.1006/bbrc.1999.2000; Imbeaud S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni054; Janssen AB, 2015, PLACENTA, V36, P790, DOI 10.1016/j.placenta.2015.06.011; Kappil MA, 2015, EPIGENETICS-US, V10, P842, DOI 10.1080/15592294.2015.1073881; Kersey PJ, 2016, NUCLEIC ACIDS RES, V44, pD574, DOI 10.1093/nar/gkv1209; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Koutsaki M, 2011, GROWTH HORM IGF RES, V21, P31, DOI 10.1016/j.ghir.2010.12.002; Li Meijuan, 2008, J Biomol Tech, V19, P122; Li S, 2014, NAT BIOTECHNOL, V32, P915, DOI 10.1038/nbt.2972; Lonsdale J, 2013, NAT GENET, V45, P580, DOI 10.1038/ng.2653; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Ma Y, 2012, ANAL BIOCHEM, V423, P229, DOI 10.1016/j.ab.2012.02.003; Popova T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-91; R Development Core Team, 2011, R FDN STAT COMP; Reimand J, 2007, NUCLEIC ACIDS RES, V35, pW193, DOI 10.1093/nar/gkm226; Romero IG, 2014, BMC BIOL, V12, DOI 10.1186/1741-7007-12-42; Schroeder A, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-3; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sharova LV, 2009, DNA RES, V16, P45, DOI 10.1093/dnares/dsn030; Sober S, 2015, SCI REP-UK, V5, DOI 10.1038/srep13336; Streit S, 2009, NAT PROTOC, V4, P37, DOI 10.1038/nprot.2008.216; Stuart CA, 1999, METABOLISM, V48, P876, DOI 10.1016/S0026-0495(99)90222-6; Sugawara J, 2000, J CLIN ENDOCR METAB, V85, P3821, DOI 10.1210/jc.85.10.3821; Sundrani DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029855; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wolfle U, 2016, MOLECULES, V21, DOI 10.3390/molecules21030306; Wyatt SM, 2005, PLACENTA, V26, P372, DOI 10.1016/j.placenta.2004.07.003	43	30	30	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3298	3308		10.1096/fj.201601031RR	http://dx.doi.org/10.1096/fj.201601031RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28446590				2022-12-28	WOS:000405932400010
J	Wright, JD; An, SW; Xie, J; Yoon, J; Nischan, N; Kohler, JJ; Oliver, N; Lim, C; Huang, CL				Wright, Jon D.; An, Sung-Wan; Xie, Jian; Yoon, Joonho; Nischan, Nicole; Kohler, Jennifer J.; Oliver, Noelynn; Lim, Carmay; Huang, Chou-Long			Modeled structural basis for the recognition of alpha 2-3-sialyllactose by soluble Klotho	FASEB JOURNAL			English	Article						KL1 domain; TRPC6; PI3K	CATALYTIC MECHANISM; FUNCTIONAL VARIANT; ENHANCES COGNITION; PROTEIN; ASSOCIATION; INSIGHTS; DOCKING; MICE; GENE; POLYMORPHISM	Soluble Klotho (sKlotho) is the shed ectodomain of antiaging membrane Klotho that contains 2 extracellular domains KL1 and KL2, each of which shares sequence homology to glycosyl hydrolases. sKlotho elicits pleiotropic cellular responses with a poorly understood mechanism of action. Notably, in injury settings, sKlotho confers cardiac and renal protection by down-regulating calcium-permeable transient receptor potential canonical type isoform 6 (TRPC6) channels in cardiomyocytes and glomerular podocytes. Inhibition of PI3K-dependent exocytosis of TRPC6 is thought to be the underlying mechanism, and recent studies showed that sKlotho interacts with alpha 2-3-sialyllactose-containing gangliosides enriched in lipid rafts to inhibit raft-dependent PI3K signaling. However, the structural basis for binding and recognition of alpha 2-3-sialyllactose by sKlotho is unknown. Using homology modeling followed by docking, we identified key protein residues in the KL1 domain that are likely involved in binding sialyllactose. Functional experiments based on the ability of Klotho to down-regulate TRPC6 channel activity confirm the importance of these residues. Furthermore, KL1 domain binds alpha 2-3-sialyllactose, downregulates TRPC6 channels, and exerts protection against stress-induced cardiac hypertrophy in mice. Our results support the notion that sialogangliosides and lipid rafts are membrane receptors for sKlotho and that the KL1 domain is sufficient for the tested biologic activities. These findings can help guide the design of a simpler Klotho mimetic.	[Wright, Jon D.; Lim, Carmay] Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan; [An, Sung-Wan; Xie, Jian; Yoon, Joonho; Huang, Chou-Long] Univ Texas Southwestern Med Ctr Dallas, Dept Internal Med, Dallas, TX USA; [Nischan, Nicole; Kohler, Jennifer J.] Univ Texas Southwestern Med Ctr Dallas, Dept Biochem, Dallas, TX USA; [Oliver, Noelynn] Boehringer Ingelheim Pharmaceut Inc, Cardiometab Dis Res, 90 E Ridge POB 368, Ridgefield, CT 06877 USA; [Lim, Carmay] Natl Tsing Hua Univ, Dept Chem, Hsinchu, Taiwan	Academia Sinica - Taiwan; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Boehringer Ingelheim; National Tsing Hua University	Lim, C (corresponding author), Acad Sinica, Inst Biomed Sci, Taipei 11529, Taiwan.; Huang, CL (corresponding author), Univ Texas Southwestern Med Ctr Dallas, Dept Med, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	carmay@gate.sinica.edu.tw; chou-long.huang@utsouthwestern.edu	Wright, Jon D/C-9541-2019; Lim, Carmay/N-9648-2015; Kohler, Jennifer/B-6589-2009	Lim, Carmay/0000-0001-9077-7769; Xie, Jian/0000-0001-9454-1358; Kohler, Jennifer/0000-0001-5373-3329	Academia Sinica; Ministry of Science and Technology (MOST) of Taiwan [98-2113-M-001-011]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK109887, DK100605]; Welch Foundation [I-1686]; University of Texax Southwestern; Boehringer Ingelheim Pharmaceuticals Inc. (BIPI); German Academic Exchange Service (DAAD); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK100605, R01DK109887] Funding Source: NIH RePORTER	Academia Sinica(Academia Sinica - Taiwan); Ministry of Science and Technology (MOST) of Taiwan(Ministry of Science and Technology, Taiwan); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Welch Foundation(The Welch Foundation); University of Texax Southwestern; Boehringer Ingelheim Pharmaceuticals Inc. (BIPI)(Boehringer Ingelheim); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by the Academia Sinica and Ministry of Science and Technology (MOST) of Taiwan (Grant 98-2113-M-001-011), the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Grants DK109887 and DK100605), the Welch Foundation (Grant I-1686), and by a sponsored research agreement between University of Texax Southwestern and Boehringer Ingelheim Pharmaceuticals Inc. (BIPI). BIPI provided purified recombinant KL1 domain protein. N.N. is supported by a postdoctoral fellowship from the German Academic Exchange Service (DAAD). The authors thank M. Diamond and J. Vaquer-Alicea (both from the University of Texas Southwestern Medical Center, Dallas, TX, USA) for provision of the Octet.	Allen WJ, 2015, J COMPUT CHEM, V36, P1132, DOI 10.1002/jcc.23905; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Amaya MF, 2004, STRUCTURE, V12, P775, DOI 10.1016/j.str.2004.02.036; Arking DE, 2005, CIRC RES, V96, P412, DOI 10.1161/01.RES.0000157171.04054.30; Arking DE, 2002, P NATL ACAD SCI USA, V99, P856, DOI 10.1073/pnas.022484299; Ashkenazy H, 2016, NUCLEIC ACIDS RES, V44, pW344, DOI 10.1093/nar/gkw408; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Cha SK, 2008, P NATL ACAD SCI USA, V105, P9805, DOI 10.1073/pnas.0803223105; Connaris H, 2014, P NATL ACAD SCI USA, V111, P6401, DOI 10.1073/pnas.1404205111; CONNOLLY ML, 1983, J APPL CRYSTALLOGR, V16, P548, DOI 10.1107/S0021889883010985; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; Dalton G, 2017, P NATL ACAD SCI USA, V114, P752, DOI 10.1073/pnas.1620301114; Doi S, 2011, J BIOL CHEM, V286, P8655, DOI 10.1074/jbc.M110.174037; Dubal DB, 2015, J NEUROSCI, V35, P2358, DOI 10.1523/JNEUROSCI.5791-12.2015; Dubal DB, 2014, CELL REP, V7, P1065, DOI 10.1016/j.celrep.2014.03.076; Frisch M. J., 2009, GAUSSIAN 09 REVISION; Hayashi Y, 2007, J BIOL CHEM, V282, P30889, DOI 10.1074/jbc.M700832200; Imura A, 2004, FEBS LETT, V565, P143, DOI 10.1016/j.febslet.2004.03.090; Ito S, 2002, BBA-GENE STRUCT EXPR, V1576, P341, DOI 10.1016/S0167-4781(02)00281-6; Jeng WY, 2012, ACTA CRYSTALLOGR D, V68, P829, DOI 10.1107/S0907444912013224; KUNTZ ID, 1982, J MOL BIOL, V161, P269, DOI 10.1016/0022-2836(82)90153-X; Kuroo M, 1997, NATURE, V390, P45, DOI 10.1038/36285; Kurosu H, 2006, J BIOL CHEM, V281, P6120, DOI 10.1074/jbc.C500457200; Kurosu H, 2005, SCIENCE, V309, P1829, DOI 10.1126/science.1112766; Liu F, 2011, NAT CELL BIOL, V13, P254, DOI 10.1038/ncb2167; Liu HJ, 2007, SCIENCE, V317, P803, DOI 10.1126/science.1143578; Maier JA, 2015, J CHEM THEORY COMPUT, V11, P3696, DOI 10.1021/acs.jctc.5b00255; MENG EC, 1992, J COMPUT CHEM, V13, P505, DOI 10.1002/jcc.540130412; Mills JEJ, 1996, J COMPUT AID MOL DES, V10, P607, DOI 10.1007/BF00134183; Morishita K, 2001, J NUTR, V131, P3182, DOI 10.1093/jn/131.12.3182; Ogata N, 2002, BONE, V31, P37, DOI 10.1016/S8756-3282(02)00786-X; Owen CD, 2015, J BIOL CHEM, V290, P27736, DOI 10.1074/jbc.M115.673632; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; REED AE, 1985, J CHEM PHYS, V83, P735, DOI 10.1063/1.449486; RICHARDS FM, 1977, ANNU REV BIOPHYS BIO, V6, P151, DOI 10.1146/annurev.bb.06.060177.001055; Ruiz FM, 2015, CHEM-EUR J, V21, P13558, DOI 10.1002/chem.201501961; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606; SHOICHET BK, 1992, J COMPUT CHEM, V13, P380, DOI 10.1002/jcc.540130311; Simons K, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004697; Tohyama O, 2004, J BIOL CHEM, V279, P9777, DOI 10.1074/jbc.M312392200; Urakawa I, 2006, NATURE, V444, P770, DOI 10.1038/nature05315; White KE, 2000, NAT GENET, V26, P345, DOI 10.1038/81664; Wolf I, 2008, ONCOGENE, V27, P7094, DOI 10.1038/onc.2008.292; Xie J, 2015, J AM SOC NEPHROL, V26, P1150, DOI 10.1681/ASN.2014040325; Xie J, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2240; Yuan P, 2005, STRUCTURE, V13, P803, DOI 10.1016/j.str.2005.02.019; Zhou TBT, 2013, J BIOL CHEM, V288, P36302, DOI 10.1074/jbc.M113.490052	48	18	19	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3574	3586		10.1096/fj.201700043R	http://dx.doi.org/10.1096/fj.201700043R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28442546	Green Published			2022-12-28	WOS:000405932400031
J	Li, XG; Eberhardt, A; Hansen, JN; Bohmann, D; Li, HT; Schor, NF				Li, Xingguo; Eberhardt, Allison; Hansen, Jeanne N.; Bohmann, Dirk; Li, Haitao; Schor, Nina F.			Methylation of the phosphatase-transcription activator EYA1 by protein arginine methyltransferase 1: mechanistic, functional, and structural studies	FASEB JOURNAL			English	Article						protein phosphatase; post-translational modification; protein arginine methylation; gamma-H2A.X; Drosophila eye development	EYES ABSENT GENE; CELL-SURVIVAL; DEPHOSPHORYLATION; PROLIFERATION; MUTATIONS; COMPLEX; FORM	The eyes absent (EYA) family proteins are conserved transcriptional coactivators with intrinsic protein phosphatase activity. They play an essential role in the development of various organs in metazoans. These functions are associated with a unique combination of phosphatase and transactivation activities. However, it remains poorly understood how these activities and the consequent biologic functions of EYA are regulated. Here, we demonstrate that 2 conserved arginine residues, R304 and R306, of EYA1 are essential for its in vitro phosphatase activity and in vivo function during Drosophila eye development. EYA1 physically interacts with protein arginine methyltransferase 1, which methylates EYA1 at these residues both in vitro and in cultured mammalian and insect cells. Moreover, we show that wild-type, but not methylation-defective, EYA1 associates with gamma-H2A.X in response to ionizing radiation. Taken together, our results identify the conserved arginine residues of EYA1 that play an important role for its activity, thus implicating arginine methylation as a novel regulatory mechanism of EYA function.	[Li, Xingguo; Eberhardt, Allison; Hansen, Jeanne N.; Schor, Nina F.] Univ Rochester, Med Ctr, Dept Pediat, 601 Elmwood Ave,POB 777, Rochester, NY 14642 USA; [Bohmann, Dirk] Univ Rochester, Med Ctr, Dept Biomed Genet, Rochester, NY 14642 USA; [Li, Haitao] Tsinghua Univ, Key Lab Prot Sci, Minist Educ MOE, Ctr Struct Biol,Sch Life Sci, Beijing, Peoples R China; [Li, Haitao] Tsinghua Univ, Sch Med, Beijing, Peoples R China	University of Rochester; University of Rochester; Tsinghua University; Tsinghua University	Li, XG; Schor, NF (corresponding author), Univ Rochester, Med Ctr, Dept Pediat, 601 Elmwood Ave,POB 777, Rochester, NY 14642 USA.	xingguo_li@urmc.rochester.edu; nina_schor@urmc.rochester.edu	Li, Haitao/B-2668-2012; Li, Xingguo/T-9582-2019	Li, Haitao/0000-0001-6741-293X; Li, Xingguo/0000-0002-2801-7555; Li, Xing-Guo/0000-0003-1952-3445; Schor, Nina/0000-0002-3817-7376	Crosby's Fund for Neuroblastoma Pediatric Cancer Research; Strong Children's Research Center Small Grants Program; William H. Eilinger Endowment	Crosby's Fund for Neuroblastoma Pediatric Cancer Research; Strong Children's Research Center Small Grants Program; William H. Eilinger Endowment	This work was funded by Crosby's Fund for Neuroblastoma Pediatric Cancer Research and the William H. Eilinger Endowment (to N.F.S.), and by a grant from the Strong Children's Research Center Small Grants Program (to X.L.). The authors thank Drs. Stephane Richard (McGill University, Montreal, QC, Canada) and Ailan Guo (Cell Signaling Technology, Danvers, MA, USA) for providing Prmt1<SUP>fl/-</SUP>ER-Cre MEF cells and asymmetric dimethyl-arginine antibody D6A8, respectively; Fanju Meng, Drs. Benoit Biteau, and Nirmalya Chatterjee (University of Rochester) for helpful discussion; and Simeng Wang and Louis Lotta (both from the University of Rochester) for technical assistance. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. The authors declare no conflicts of interest.	Abdelhak S, 1997, NAT GENET, V15, P157, DOI 10.1038/ng0297-157; Bicker KL, 2011, MOL BIOSYST, V7, P48, DOI 10.1039/c0mb00015a; Blanc RS, 2017, MOL CELL BIOL, V37, DOI 10.1128/MCB.00457-16; BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7; Boulanger MC, 2004, BIOCHEM J, V379, P283, DOI 10.1042/BJ20031176; Bui QT, 2000, GENETICS, V155, P709; Buller C, 2001, HUM MOL GENET, V10, P2775, DOI 10.1093/hmg/10.24.2775; Chatterjee N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034063; Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X; Cook PJ, 2009, NATURE, V458, P591, DOI 10.1038/nature07849; Davies CC, 2013, EMBO J, V32, P1556, DOI 10.1038/emboj.2013.98; Eberhardt A, 2016, ONCOTARGET, V7, P63629, DOI 10.18632/oncotarget.11556; Farabaugh SM, 2012, ONCOGENE, V31, P552, DOI 10.1038/onc.2011.259; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Guo CS, 2011, J CLIN INVEST, V121, P1585, DOI 10.1172/JCI44630; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Jin M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058818; Jung SK, 2010, FASEB J, V24, P560, DOI 10.1096/fj.09-143891; Krishnan N, 2009, J BIOL CHEM, V284, P16066, DOI 10.1074/jbc.C900032200; Krueger AB, 2013, J BIOMOL SCREEN, V18, P85, DOI 10.1177/1087057112453936; Li J, 2016, MOL CELL BIOL, V37; Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083; Li XG, 2010, BLOOD, V115, P2028, DOI 10.1182/blood-2009-07-236059; Nishioka K, 2003, METHODS, V31, P49, DOI 10.1016/S1046-2023(03)00087-2; Ohto H, 1999, MOL CELL BIOL, V19, P6815; Pandey RN, 2010, ONCOGENE, V29, P3715, DOI 10.1038/onc.2010.122; Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8; Rayapureddi JP, 2006, FEBS LETT, V580, P3853, DOI 10.1016/j.febslet.2006.06.009; Rayapureddi JP, 2003, NATURE, V426, P295, DOI 10.1038/nature02093; Robin TP, 2012, MOL CANCER RES, V10, P1098, DOI 10.1158/1541-7786.MCR-12-0086; Sun Y, 2015, ONCOGENE, V34, P2527, DOI 10.1038/onc.2014.179; Sun Y, 2014, MOL CELL BIOL, V34, P2409, DOI 10.1128/MCB.00104-14; Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097; Wooderchak WL, 2008, BIOCHEMISTRY-US, V47, P9456, DOI 10.1021/bi800984s; Wu KM, 2013, CANCER RES, V73, P4488, DOI 10.1158/0008-5472.CAN-12-4078; Xu PX, 1999, NAT GENET, V23, P113, DOI 10.1038/12722; Yamagata K, 2008, MOL CELL, V32, P221, DOI 10.1016/j.molcel.2008.09.013; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409; Yu ZB, 2009, MOL CELL BIOL, V29, P2982, DOI 10.1128/MCB.00042-09	39	0	1	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2327	2339		10.1096/fj.201601050RR	http://dx.doi.org/10.1096/fj.201601050RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28213359				2022-12-28	WOS:000401553400010
J	Kaludjerovic, J; Komaba, H; Sato, T; Erben, RG; Baron, R; Olauson, H; Larsson, TE; Lanske, B				Kaludjerovic, Jovana; Komaba, Hirotaka; Sato, Tadatoshi; Erben, Reinhold G.; Baron, Roland; Olauson, Hannes; Larsson, Tobias E.; Lanske, Beate			Klotho expression in long bones regulates FGF23 production during renal failure	FASEB JOURNAL			English	Article						bone metabolism; chronic kidney disease; fibroblast growth factor 23	CHRONIC KIDNEY-DISEASE; GROWTH-FACTOR 23; VITAMIN-D METABOLISM; LEFT-VENTRICULAR HYPERTROPHY; SECONDARY HYPERPARATHYROIDISM; HEMODIALYSIS-PATIENTS; KNOCKOUT MICE; ALPHA-KLOTHO; RECEPTOR 1; IN-VIVO	Circulating levels of bone-derived fibroblast growth factor 23 (FGF23) increase early during acute and chronic kidney disease and are associated with adverse outcomes. Membrane-bound Klotho acts as a permissive coreceptor for FGF23, and its expression was recently found in osteoblasts/osteocytes. We hypothesized that Klotho in bone cells is part of an autocrine feedback loop that regulates FGF23 expression during renal failure. Thus, we induced renal failure in mice with targeted deletion of Klotho in long bones. Uremic wild-type (KLfl/fl ) and knockout (Prx1-Cre;KLfl/fl ) mice both responded with reduced body weight, kidney atrophy, hyperphosphatemia, and increased bone turnover. Importantly, long bones of Prx1-Cre;KLfl/fl mice but not their axial skeleton failed to increase FGF23 expression as observed in uremic KLfl/fl mice. Consequently, Prx1-Cre;KLfl/fl mice had significantly lower serum FGF23 and parathyroid hormone levels, and higher renal 1-a-hydroxylase expression, serum 1,25-dihydroxyvitamin D, and calcium levels than KLfl/fl mice. These results were confirmed in two independent models of renal failure, adenine diet induced and 5/6 nephrectomy. Moreover, FGF23-treated bone cells required Klotho to increase FGF23 mRNA and ERK phosphorylation. In summary, our novel findings show that Klotho in bone is crucial for inducing FGF23 production upon renal failure. We propose the presence of an autocrine feedback loop in which Klotho senses the need for FGF23.-Kaludjerovic, J., Komaba, H., Sato, T., Erben, R. G., Baron, R., Olauson, H., Larsson, T. E., Lanske, B. Klotho expression in long bones regulates FGF23 production during renal failure.	[Kaludjerovic, Jovana; Komaba, Hirotaka; Sato, Tadatoshi; Baron, Roland; Lanske, Beate] Harvard Sch Dent Med, Dept Oral Med Infect & Immun, Div Bone & Mineral Res, 188 Longwood Ave, Boston, MA 02115 USA; [Erben, Reinhold G.] Univ Vet Med, Unit Physiol Pathophysiol & Expt Endocrinol, Vienna, Austria; [Baron, Roland; Lanske, Beate] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Baron, Roland; Lanske, Beate] Harvard Med Sch, Boston, MA USA; [Olauson, Hannes; Larsson, Tobias E.] Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Renal Med, Stockholm, Sweden	Harvard University; Harvard School of Dental Medicine; University of Veterinary Medicine Vienna; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Karolinska Institutet	Lanske, B (corresponding author), Harvard Sch Dent Med, Dept Oral Med Infect & Immun, Div Bone & Mineral Res, 188 Longwood Ave, Boston, MA 02115 USA.	beate_lanske@hsdm.harvard.edu	Erben, Reinhold/AAG-8007-2020; Komaba, Hirotaka/C-9199-2011	Erben, Reinhold/0000-0003-0801-6958; Komaba, Hirotaka/0000-0002-1704-4507; Lanske, Beate/0000-0003-4638-804X	U.S. Department of Defense [DOD-PR120411]	U.S. Department of Defense(United States Department of Defense)	This work was supported, in part, by a grant from the U.S. Department of Defense (DOD-PR120411 to B.L.). J.K. is a Canadian Institutes of Health Research Fellow. H.K. is a Japan Society for the Promotion of Science Postdoctoral Fellow for Research Abroad. The authors thank H. Wang (Harvard School of Dental Medicine) for assisting with mouse maintenance and genotyping. The authors also thank K. Amano and J.- I. Hanai (both from Harvard Medical School) for assistance with cell culture experiments.	Andrukhova O, 2014, EMBO J, V33, P229, DOI 10.1002/embj.201284188; Andrukhova O, 2012, BONE, V51, P621, DOI 10.1016/j.bone.2012.05.015; Ben-Dov IZ, 2007, J CLIN INVEST, V117, P4003, DOI 10.1172/JCI32409; Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; Cejka D, 2016, KIDNEY INT, V90, P828, DOI 10.1016/j.kint.2016.06.019; Christov M, 2014, CURR OPIN NEPHROL HY, V23, P340, DOI 10.1097/01.mnh.0000447021.51722.2f; Christov M, 2013, KIDNEY INT, V84, P776, DOI 10.1038/ki.2013.150; de Jager DJ, 2009, JAMA-J AM MED ASSOC, V302, P1782, DOI 10.1001/jama.2009.1488; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Durland JL, 2008, J ANAT, V212, P590, DOI 10.1111/j.1469-7580.2008.00879.x; Erben RG, 2005, J BONE MINER RES, V20, P1149, DOI 10.1359/JBMR.050212; Faul C, 2011, J CLIN INVEST, V121, P4393, DOI 10.1172/JCI46122; Ferrari GO, 2014, BMC NEPHROL, V15, DOI 10.1186/1471-2369-15-69; Fried LF, 2007, J AM SOC NEPHROL, V18, P282, DOI 10.1681/ASN.2006050546; Fyfe-Johnson AL, 2016, J HYPERTENS, V34, P1266, DOI 10.1097/HJH.0000000000000936; Galitzer H, 2010, KIDNEY INT, V77, P211, DOI 10.1038/ki.2009.464; Gattineni J, 2009, AM J PHYSIOL-RENAL, V297, pF282, DOI 10.1152/ajprenal.90742.2008; Gutierrez O, 2005, J AM SOC NEPHROL, V16, P2205, DOI 10.1681/ASN.2005010052; Houston J, 2013, J RENAL NUTR, V23, P12, DOI 10.1053/j.jrn.2011.12.009; Hu MC, 2013, CONTRIB NEPHROL, V180, P47, DOI 10.1159/000346778; Hu MC, 2011, J AM SOC NEPHROL, V22, P124, DOI 10.1681/ASN.2009121311; Imura A, 2007, SCIENCE, V316, P1615, DOI 10.1126/science.1135901; Isakova T, 2011, CLIN J AM SOC NEPHRO, V6, P2688, DOI 10.2215/CJN.04290511; Isakova T, 2011, JAMA-J AM MED ASSOC, V305, P2432, DOI 10.1001/jama.2011.826; Isakova T, 2009, J AM SOC NEPHROL, V20, P388, DOI 10.1681/ASN.2008060609; Jean G, 2009, NEPHROL DIAL TRANSPL, V24, P2792, DOI 10.1093/ndt/gfp191; Jia T, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-116; Koh N, 2001, BIOCHEM BIOPH RES CO, V280, P1015, DOI 10.1006/bbrc.2000.4226; Komaba H, 2010, KIDNEY INT, V77, P232, DOI 10.1038/ki.2009.414; Lanske B, 2014, KIDNEY INT, V86, P1071, DOI 10.1038/ki.2014.316; Lau WL, 2013, NEPHROL DIAL TRANSPL, V28, P62, DOI 10.1093/ndt/gfs333; Lindberg K, 2014, J AM SOC NEPHROL, V25, P2169, DOI 10.1681/ASN.2013111209; Logan M, 2002, GENESIS, V33, P77, DOI 10.1002/gene.10092; Lysaght AC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107681; Martin JF, 2000, GENESIS, V26, P225, DOI 10.1002/(SICI)1526-968X(200004)26:4<225::AID-GENE10>3.0.CO;2-F; Moe SM, 2015, CIRCULATION, V132, P27, DOI 10.1161/CIRCULATIONAHA.114.013876; Nasrallah MM, 2010, NEPHROL DIAL TRANSPL, V25, P2679, DOI 10.1093/ndt/gfq089; Nikolov IG, 2010, BONE, V47, P156, DOI 10.1016/j.bone.2010.04.600; Ohnishi M, 2009, KIDNEY INT, V75, P1166, DOI 10.1038/ki.2009.24; Olauson H, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003975; Olauson H, 2012, J AM SOC NEPHROL, V23, P1641, DOI 10.1681/ASN.2012010048; Pereira RC, 2009, BONE, V45, P1161, DOI 10.1016/j.bone.2009.08.008; Pulskens WP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142510; Quarles LD, 2012, NAT REV ENDOCRINOL, V8, P276, DOI 10.1038/nrendo.2011.218; Raimann A, 2013, CONNECT TISSUE RES, V54, P108, DOI 10.3109/03008207.2012.753879; Rhee Y, 2011, BONE, V49, P636, DOI 10.1016/j.bone.2011.06.025; Shalhoub V, 2012, J CLIN INVEST, V122, P2543, DOI 10.1172/JCI61405; Shigematsu T, 2004, AM J KIDNEY DIS, V44, P250, DOI 10.1053/j.ajkd.2004.04.029; Shimada T, 2004, J CLIN INVEST, V113, P561, DOI 10.1172/JCI200419081; Shimada T, 2005, AM J PHYSIOL-RENAL, V289, pF1088, DOI 10.1152/ajprenal.00474.2004; Sitara D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000154; Smith K, 2013, AM J KIDNEY DIS, V61, P67, DOI 10.1053/j.ajkd.2012.06.022; Smith RC, 2012, J CLIN INVEST, V122, P4710, DOI 10.1172/JCI64986; Su N, 2014, BONE RES, V2, DOI 10.1038/boneres.2014.3; Suzuki H, 2005, ARCH HISTOL CYTOL, V68, P371, DOI 10.1679/aohc.68.371; Tamagaki K, 2006, NEPHROL DIAL TRANSPL, V21, P651, DOI 10.1093/ndt/gfi273; van Husen M, 2010, KIDNEY INT, V78, P200, DOI 10.1038/ki.2010.107; Walmsley SJ, 2010, AM J PHYSIOL-RENAL, V298, pF1323, DOI 10.1152/ajprenal.00711.2009; Wesseling-Perry K, 2009, J CLIN ENDOCR METAB, V94, P511, DOI 10.1210/jc.2008-0326; Wohrle S, 2011, J BONE MINER RES, V26, P2486, DOI 10.1002/jbmr.478; Wright CB, 2016, STROKE, V47, P923, DOI 10.1161/STROKEAHA.115.012379; Xiao ZJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101251; Yu XJ, 2005, THER APHER DIAL, V9, P308, DOI 10.1111/j.1744-9987.2005.00287.x; Yuan Q, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002726; Yuan Q, 2011, ENDOCRINOLOGY, V152, P4053, DOI 10.1210/en.2011-1113; Yuan Q, 2011, J BONE MINER RES, V26, P2026, DOI 10.1002/jbmr.433; Zou HW, 2013, BONE, V56, P410, DOI 10.1016/j.bone.2013.07.014	67	25	27	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2050	2064		10.1096/fj.201601036R	http://dx.doi.org/10.1096/fj.201601036R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28183805				2022-12-28	WOS:000399195500025
J	Martinez-Fernandez, L; Gonzalez-Muniesa, P; Laiglesia, LM; Sainz, N; Prieto-Hontoria, PL; Escote, X; Odriozola, L; Corrales, FJ; Arbones-Mainar, JM; Martinez, JA; Moreno-Aliaga, MJ				Martinez-Fernandez, Leyre; Gonzalez-Muniesa, Pedro; Laiglesia, Laura M.; Sainz, Neira; Prieto-Hontoria, Pedro L.; Escote, Xavier; Odriozola, Leticia; Corrales, Fernando J.; Arbones-Mainar, Jose M.; Martinez, Jose A.; Moreno-Aliaga, Maria J.			Maresin 1 improves insulin sensitivity and attenuates adipose tissue inflammation in ob/ob and diet-induced obese mice	FASEB JOURNAL			English	Article						DHA; n-3 PUFAs derivatives; adipokines; macrophages; glucose metabolism	PRORESOLVING LIPID MEDIATORS; POLYUNSATURATED FATTY-ACIDS; RESOLVIN D1; MACROPHAGE POLARIZATION; GLUCOSE-HOMEOSTASIS; RESISTANCE; MUSCLE; LIVER; AMPK; OMEGA-3-FATTY-ACIDS	The beneficial actions of n-3 fatty acids on obesity-induced insulin resistance and inflammation have been related to the synthesis of specialized proresolving lipid mediators (SPMs) like resolvins. The aim of this study was to evaluate the ability of one of these SPMs, maresin 1 (MaR1), to reverse adipose tissue inflammation and/or insulin resistance in two models of obesity: diet-induced obese (DIO) mice and genetic (ob/ob) obese mice. In DIO mice, MaR1 (2 mu g/kg; 10 d) reduced F4/80-positive cells and expression of the proinflammatory M1 macrophage phenotype marker Cd11c in white adipose tissue (WAT). Moreover, MaR1 decreased Mcp-1, Tnf-alpha, and Il-1 beta expression, upregulated adiponectin and Glut-4, and increased Akt phosphorylation in WAT. MaR1 administration (2 mg/kg; 20 d) to ob/ob mice did not modify macrophage recruitment but increased the M2 macrophage markers Cd163 and Il-10. MaR1 reduced Mcp-1, Tnf-alpha, Il-1 beta, and Dpp-4 and increased adiponectin gene expression in WAT. MaR1 treatment also improved the insulin tolerance test of ob/ob mice and increased Akt and AMPK phosphorylation in WAT. These data suggest that treatment with MaR1 can counteract the dysfunctional inflamed WAT and could be useful to improve insulin sensitivity in murine models of obesity.-Martinez-Fernandez, L., Gonzalez-Muniesa, P., Laiglesia, L. M., Sainz, N., Prieto-Hontoria, P. L., Escote, X., Odriozola, L., Corrales, F. J., Arbones-Mainar, J. M., Martinez, J. A., Moreno-Aliaga, M. J. Maresin 1 improves insulin sensitivity and attenuates adipose tissue inflammation in ob/ob and diet-induced obese mice.	[Martinez-Fernandez, Leyre; Gonzalez-Muniesa, Pedro; Prieto-Hontoria, Pedro L.; Martinez, Jose A.; Moreno-Aliaga, Maria J.] Univ Navarra, Dept Nutr Food Sci & Physiol, Pamplona, Spain; [Martinez-Fernandez, Leyre; Gonzalez-Muniesa, Pedro; Laiglesia, Laura M.; Sainz, Neira; Escote, Xavier; Martinez, Jose A.; Moreno-Aliaga, Maria J.] Univ Navarra, Ctr Nutr Res, Sch Pharm & Nutr, Pamplona, Spain; [Odriozola, Leticia; Corrales, Fernando J.] Univ Navarra, Prote & Bioinformat Unit, Pamplona, Spain; [Corrales, Fernando J.] Univ Navarra, Div Hepatol, Ctr Appl Med Res, Pamplona, Spain; [Gonzalez-Muniesa, Pedro; Arbones-Mainar, Jose M.; Martinez, Jose A.; Moreno-Aliaga, Maria J.] Ctr Biomed Res Network Physiopathol Obes & Nutr C, Madrid, Spain; [Gonzalez-Muniesa, Pedro; Martinez, Jose A.; Moreno-Aliaga, Maria J.] Hlth Res Inst Navarra IDISNA, Pamplona, Spain; [Arbones-Mainar, Jose M.] Hosp Univ Miguel Servet, Inst Aragon Ciencias Salud, Inst Invest Sanitaria Aragon, Adipocyte & Fat Biol Lab AdipoFat, Zaragoza, Spain; [Prieto-Hontoria, Pedro L.] Univ SEK, Fac Hlth & Phys Act Sci, Santiago, Chile	University of Navarra; University of Navarra; University of Navarra; University of Navarra; Miguel Servet University Hospital; Universidad Internacional SEK	Moreno-Aliaga, MJ (corresponding author), Univ Navarra, Ctr Nutr Res, Dept Nutr Food Sci & Physiol, Sch Pharm & Nutr, C Irunlarrea 1, Pamplona 31008, Spain.	mjmoreno@unav.es	Sáinz, Neira/AAA-4624-2019; González-Muniesa, Pedro/H-2158-2015; Escote, Xavier/AAC-6335-2019; Moreno-Aliaga, Maria J/M-7015-2018; Escoté, Xavier/AAH-2973-2020; Arbones-Mainar, Jose M/AGL-8624-2022; Martínez, Leyre/H-3463-2015	González-Muniesa, Pedro/0000-0002-3130-2496; Escote, Xavier/0000-0003-1172-3995; Moreno-Aliaga, Maria J/0000-0002-2018-6434; Arbones-Mainar, Jose M/0000-0002-8982-3737; Martínez, Leyre/0000-0002-3048-6131; Laiglesia, Laura/0000-0002-4636-1421; Corrales, Fernando/0000-0002-0231-5159	Spanish Ministry of Economy and Competitiveness [BFU2012-36089, BFU2015-65937-R]; Navarra Department of Health [67-2015]; Physiopathology of Obesity and Nutrition; Carlos III Health Research Institute [CB12/03/30002]; Formacion de Personal Investigador predoctoral fellowship; Asociacion de Amigos	Spanish Ministry of Economy and Competitiveness(Spanish Government); Navarra Department of Health; Physiopathology of Obesity and Nutrition; Carlos III Health Research Institute(Instituto de Salud Carlos III); Formacion de Personal Investigador predoctoral fellowship; Asociacion de Amigos	This work was supported by the Spanish Ministry of Economy and Competitiveness (Grants BFU2012-36089 and BFU2015-65937-R), the Navarra Department of Health (Grant 67-2015), Physiopathology of Obesity and Nutrition, and the Carlos III Health Research Institute (Grant CB12/03/30002). L.M.-F. is supported by a Formacion de Personal Investigador predoctoral fellowship, and by a predoctoral fellowship from Asociacion de Amigos (to L.M.L.). The authors thank Asuncion Redin, Maria Zabala, David Garcia, and Javier Garcia (all from the University of Navarra) for their valuable technical support on this project. The authors declare no conflicts of interest.	Abraham NG, 2006, CIRC RES, V99, P911, DOI 10.1161/01.RES.0000249616.10603.d6; Bergeron R, 1999, AM J PHYSIOL-ENDOC M, V276, pE938, DOI 10.1152/ajpendo.1999.276.5.E938; Borgeson E, 2015, CELL METAB, V22, P125, DOI 10.1016/j.cmet.2015.05.003; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Calder PC, 2006, AM J CLIN NUTR, V83, p1505S, DOI 10.1093/ajcn/83.6.1505S; Claria J, 2013, AM J PHYSIOL-CELL PH, V304, pC1141, DOI 10.1152/ajpcell.00351.2012; Claria J, 2012, J IMMUNOL, V189, P2597, DOI 10.4049/jimmunol.1201272; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; de Luca C, 2008, FEBS LETT, V582, P97, DOI 10.1016/j.febslet.2007.11.057; Favero G, 2015, NUTR RES, V35, P891, DOI 10.1016/j.nutres.2015.07.001; Ferrante CJ, 2012, ADV WOUND CARE, V1, P10, DOI 10.1089/wound.2011.0307; Flachs P, 2014, PHYSIOL RES, V63, pS93, DOI 10.33549/physiolres.932715; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; Hardie DG, 2016, TRENDS CELL BIOL, V26, P190, DOI 10.1016/j.tcb.2015.10.013; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Iglesias MA, 2002, DIABETES, V51, P2886, DOI 10.2337/diabetes.51.10.2886; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Kalupahana NS, 2010, J NUTR, V140, P1915, DOI 10.3945/jn.110.125732; Lackey DE, 2016, NAT REV ENDOCRINOL, V12, P15, DOI 10.1038/nrendo.2015.189; Leon-Cabrera S, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/493409; Liong S, 2015, J PHYSIOL BIOCHEM, V71, P703, DOI 10.1007/s13105-015-0435-7; Lopategi A, 2016, MOL CELL ENDOCRINOL, V419, P44, DOI 10.1016/j.mce.2015.09.033; Marcon R, 2013, J IMMUNOL, V191, P4288, DOI 10.4049/jimmunol.1202743; Martinez-Fernandez L, 2015, PROSTAG OTH LIPID M, V121, P24, DOI 10.1016/j.prostaglandins.2015.07.003; Masoodi M, 2015, BBA-MOL CELL BIOL L, V1851, P503, DOI 10.1016/j.bbalip.2014.09.023; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; Nakata M, 2016, INT J OBESITY, V40, P425, DOI 10.1038/ijo.2015.201; Neuhofer A, 2013, DIABETES, V62, P1945, DOI 10.2337/db12-0828; Ng M, 2014, LANCET, V384, P766, DOI 10.1016/S0140-6736(14)60460-8; Olefsky JM, 2010, ANNU REV PHYSIOL, V72, P219, DOI 10.1146/annurev-physiol-021909-135846; Organization WH, 2000, WHO TECHN REP SER, DOI DOI 10.1016/J.BBI.2016.02.019; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; Perez-Diaz S, 2017, AM J PHYSIOL-CELL PH, V312, pC83, DOI 10.1152/ajpcell.00246.2016; Sag D, 2008, J IMMUNOL, V181, P8633, DOI 10.4049/jimmunol.181.12.8633; Sell H, 2013, DIABETES CARE, V36, P4083, DOI 10.2337/dc13-0496; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Song XM, 2002, DIABETOLOGIA, V45, P56, DOI 10.1007/s125-002-8245-8; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Titos E, 2016, J IMMUNOL, V197, P3360, DOI 10.4049/jimmunol.1502522; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Torres-Perez E, 2015, CARDIOVASC DIABETOL, V14, DOI 10.1186/s12933-015-0203-6; Trayhurn P, 2005, ACTA PHYSIOL SCAND, V184, P285, DOI 10.1111/j.1365-201X.2005.01468.x; Welty FK, 2016, TRANSL RES, V167, P257, DOI 10.1016/j.trsl.2015.06.017; White PJ, 2014, NAT MED, V20, P664, DOI 10.1038/nm.3549; Wu H, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/1943918; Yates CM, 2014, PHARMACOL THERAPEUT, V141, P272, DOI 10.1016/j.pharmthera.2013.10.010; Yu X, 2004, DIABETOLOGIA, V47, P2012, DOI 10.1007/s00125-004-1570-9	50	61	62	1	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2135	2145		10.1096/fj.201600859R	http://dx.doi.org/10.1096/fj.201600859R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28188173				2022-12-28	WOS:000399195500032
J	Fong-ngern, K; Vinaiphat, A; Thongboonkerd, V				Fong-ngern, Kedsarin; Vinaiphat, Arada; Thongboonkerd, Visith			Microvillar injury in renal tubular epithelial cells induced by calcium oxalate crystal and the protective role of epigallocatechin-3-gallate	FASEB JOURNAL			English	Article						EGCG; ezrin; kidney stone; microvilli; oxidative stress	KIDNEY-STONE FORMATION; OXIDATIVE STRESS; MONOHYDRATE CRYSTAL; PROXIMAL TUBULE; DIFFERENTIATED PROPERTIES; PROTEOMIC-ANALYSIS; ENDOTHELIAL-CELLS; APICAL MEMBRANE; LINE MDCK; EZRIN	Pathogenic mechanisms of kidney stone disease remained unclear. This study investigated its initial cellular/molecular mechanisms when calcium oxalate monohydrate (COM) crystal adhered to renal tubular cells. Transmission electron microscopy revealed decreased length and density of microvilli, whereas Western blot analysis showed that whole-cell ezrin (a microvillus-stabilizing protein), not beta-actin, was decreased in COM-treated cells. Immunofluorescence staining, followed by laser-scanning confocal microscopy and subcellular fractionations, revealed decreases in both ezrin and F-/beta-actin at apical membrane. Cytoskeletal extraction by Triton X-100 showed reduced cytoskeleton-associated ezrin, consistent with colocalization data of ezrin/F-actin. Thr(567)-phosphorylated ezrin and RhoA increased in COM-treated cells. A protein oxidation blot assay showed an increase in oxidized proteins in COM-treated cells that could be prevented by epigallocatechin-3-gallate (EGCG), which also preserved the whole-cell ezrin level, stabilized apical membrane ezrin/F-actin colocalization, and maintained microvillar structure in COM-treated and H2O2-treated cells. Our data clearly demonstrated the reduction of ezrin and actin expression at the apical membrane of COM-treated cells, most likely because of oxidative stress, which could be prevented by EGCG. These findings provide a novel approach to better understanding of the pathogenesis of kidney stone disease in its initial phase and offer potential preventive strategy against microvillar injury induced by COM crystals in patients with kidney stones.-Fong-ngern, K., Vinaiphat, A., Thongboonkerd, V. Microvillar injury in renal tubular epithelial cells induced by calcium oxalate crystal and the protective role of epigallocatechin-3-gallate.	Siriraj Hosp, Med Prote Unit, Off Res & Dev, Fac Med, Bangkok, Thailand; Mahidol Univ, Ctr Res Complex Syst Sci, Bangkok, Thailand	Mahidol University; Mahidol University	Thongboonkerd, V (corresponding author), Mahidol Univ, Med Prote Unit, Off Res & Dev, Siriraj Hosp, 6th Floor,SiMR Bldg,2 Wanglang Rd, Bangkok 10700, Thailand.	thongboonkerd@dr.com	Thongboonkerd, Visith/C-6920-2009	Thongboonkerd, Visith/0000-0001-7865-0765	Mahidol University; Office of the Higher Education Commission; Mahidol University, under the National Research Universities Initiative; Thailand Research Fund [RTA5680004, TRG5680008]; "Chalermphrakiat" grant; Faculty of Medicine, Siriraj Hospital	Mahidol University; Office of the Higher Education Commission; Mahidol University, under the National Research Universities Initiative; Thailand Research Fund(Thailand Research Fund (TRF)); "Chalermphrakiat" grant; Faculty of Medicine, Siriraj Hospital	The authors thank Ms. Nusara Chomanee (Faculty of Medicine Siriraj Hospital) for technical support. This study was supported by a Mahidol University research grant; the Office of the Higher Education Commission and Mahidol University, under the National Research Universities Initiative; and Thailand Research Fund Grants RTA5680004 and TRG5680008. V.T. is supported by a "Chalermphrakiat" grant, and K.F.-N. is supported by a research staff grant from the Faculty of Medicine, Siriraj Hospital. The authors declare no conflicts of interest.	BERRYMAN M, 1993, J CELL SCI, V105, P1025; Bonfili L, 2011, BIOCHIMIE, V93, P931, DOI 10.1016/j.biochi.2011.02.003; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Brown D, 1997, AM J PHYSIOL-RENAL, V273, pF1003, DOI 10.1152/ajprenal.1997.273.6.F1003; Brown JW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009406; Casaletto JB, 2011, P NATL ACAD SCI USA, V108, P11924, DOI 10.1073/pnas.1103418108; Chaiyarit S, 2012, J PROTEOME RES, V11, P3269, DOI 10.1021/pr300018c; Coe FL, 2010, UROL RES, V38, P147, DOI 10.1007/s00240-010-0271-8; Davalos M, 2010, J ENDOUROL, V24, P339, DOI 10.1089/end.2009.0205; Evan AP, 2015, UROLITHIASIS, V43, pS19, DOI 10.1007/s00240-014-0701-0; Evan AP, 2003, J CLIN INVEST, V111, P607, DOI 10.1172/JCI200317038; Fidalgo M, 2012, J BIOL CHEM, V287, P11556, DOI 10.1074/jbc.M111.320259; Fong-ngern K, 2011, J PROTEOME RES, V10, P4463, DOI 10.1021/pr2006878; Fong-ngern K, 2009, ANAL BIOCHEM, V395, P25, DOI 10.1016/j.ab.2009.08.007; Grune T, 2002, FASEB J, V16, P1602, DOI 10.1096/fj.02-0015com; Hirose M, 2008, UROL RES, V36, P139, DOI 10.1007/s00240-008-0143-7; Hirose M, 2010, INT J UROL, V17, P83, DOI 10.1111/j.1442-2042.2009.02410.x; Hobbs G.A., 2014, SMALL GTPASES, V5; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Khan SR, 2014, TRANSL ANDROL UROL, V3, P256, DOI 10.3978/j.issn.2223-4683.2014.06.04; Kim HS, 2014, REDOX BIOL, V2, P187, DOI 10.1016/j.redox.2013.12.022; KOK DJ, 1994, KIDNEY INT, V46, P847, DOI 10.1038/ki.1994.341; Lieske JC, 1999, J AM SOC NEPHROL, V10, pS422; LIESKE JC, 1994, P NATL ACAD SCI USA, V91, P6987, DOI 10.1073/pnas.91.15.6987; Parks JH, 1997, KIDNEY INT, V51, P894, DOI 10.1038/ki.1997.126; Parnell E, 2015, BBA-MOL CELL RES, V1853, P1749, DOI 10.1016/j.bbamcr.2015.04.009; Rabinovich YI, 2006, J COLLOID INTERF SCI, V300, P131, DOI 10.1016/j.jcis.2006.03.070; Randall A, 1937, ANN SURG, V105, P1009, DOI 10.1097/00000658-193706000-00014; RINDLER MJ, 1979, J CELL BIOL, V81, P635, DOI 10.1083/jcb.81.3.635; SAIER MH, 1981, AM J PHYSIOL, V240, pC106, DOI 10.1152/ajpcell.1981.240.3.C106; Semangoen T, 2008, PROTEOM CLIN APPL, V2, P1099, DOI 10.1002/prca.200780136; Tang FQ, 2009, J BIOL CHEM, V284, P27456, DOI 10.1074/jbc.M109.033795; Thongboonkerd V, 2006, CLIN CHIM ACTA, V367, P120, DOI 10.1016/j.cca.2005.11.033; Thongboonkerd V, 2008, J PROTEOME RES, V7, P4689, DOI 10.1021/pr8002408; Thongboonkerd V, 2008, CONTRIB NEPHROL, V160, P142, DOI 10.1159/000125972; Thongboonkerd V, 2008, J UROLOGY, V179, P1615, DOI 10.1016/j.juro.2007.11.041; Tsujihata M, 2008, INT J UROL, V15, P115, DOI 10.1111/j.1442-2042.2007.01953.x; White P, 2000, AM J PHYSIOL-RENAL, V278, pF886, DOI 10.1152/ajprenal.2000.278.6.F886; Worcester EM, 2013, AM J PHYSIOL-RENAL, V305, pF1574, DOI 10.1152/ajprenal.00382.2013; Wu YX, 2000, J CELL BIOCHEM, V79, P311, DOI 10.1002/1097-4644(20001101)79:2<311::AID-JCB140>3.0.CO;2-Z; Xiao YJ, 2014, RHEUMATOLOGY, V53, P1291, DOI 10.1093/rheumatology/keu013; Xiong Y, 2007, PLANT PHYSIOL, V143, P291, DOI 10.1104/pp.106.092106; Zhai W, 2013, BMC COMPLEM ALTERN M, V13, DOI 10.1186/1472-6882-13-228; Zwaenepoel I, 2012, MOL BIOL CELL, V23, P1080, DOI 10.1091/mbc.E11-07-0588	44	22	23	2	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					120	131		10.1096/fj.201600543R	http://dx.doi.org/10.1096/fj.201600543R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27825102				2022-12-28	WOS:000392177600014
J	Zhou, LN; Dai, HF; Wu, J; Zhou, M; Yuan, H; Du, J; Yang, L; Wu, XW; Xu, H; Hua, YJ; Xu, J; Zheng, L; Shen, BH				Zhou, Lina; Dai, Huifang; Wu, Jian; Zhou, Mian; Yuan, Hua; Du, Juan; Yang, Lu; Wu, Xiwei; Xu, Hong; Hua, Yuejin; Xu, Jian; Zheng, Li; Shen, Binghui			Role of FEN1 S187 phosphorylation in counteracting oxygen-induced stress and regulating postnatal heart development	FASEB JOURNAL			English	Article						flap endonuclease 1; p53 signaling; G(1)-phase arrest; dilated heart	BASE EXCISION-REPAIR; HUMAN FLAP ENDONUCLEASE-1; OXIDATIVE DNA-DAMAGE; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; AP ENDONUCLEASE-1; GENOME STABILITY; REPLICATION FORK; GAMMA-RADIATION; 3 EXONUCLEASE	Flap endonuclease 1 (FEN1) phosphorylation is proposed to regulate the action of FEN1 in DNA repair as well as Okazaki fragment maturation. However, the biologic significance of FEN1 phosphorylation in response to DNA damage remains unknown. Here, we report an in vivo role for FEN1 phosphorylation, using a mouse line carrying S187A FEN1, which abolishes FEN1 phosphorylation. Although S187A mouse embryonic fibroblast cells showed normal proliferation under low oxygen levels (2%), the mutant cells accumulated oxidative DNA damage, activated DNA damage checkpoints, and showed G1-phase arrest at atmospheric oxygen levels (21%). This suggests an essential role for FEN1 phosphorylation in repairing oxygen-induced DNA damage and maintaining proper cell cycle progression. Consistently, the mutant cardiomyocytes showed G1-phase arrest due to activation of the p53-mediated DNA damage response at the neonatal stage, which reduces the proliferation potential of the cardiomyocytes and impairs heart development. Nearly 50% of newborns with the S187 A mutant died in the first week due to failure to undergo the peroxisome proliferator-activated receptor signaling-dependent switch from glycolysis to fatty acid oxidation. The adult mutant mice developed dilated hearts and showed significantly shorter life spans. Altogether, our results reveal an important role of FEN1 phosphorylation to counteract oxygen-induced stress in the heart during the fetal-to-neonatal transition.-Zhou, L., Dai, H., Wu, J., Zhou, M., Yuan, H., Du, J., Yang, L., Wu, X., Xu, H., Hua, Y., Xu, J., Zheng, L., Shen, B. Role of FEN1S187 phosphorylation in counteracting oxygen-induced stress and regulating postnatal heart development.	[Zhou, Lina] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Xu, Hong; Hua, Yuejin] Zhejiang Univ, Inst Nucl Agr Sci, Key Lab, Chinese Minist Agr Nucl Agr Sci, Hangzhou, Zhejiang, Peoples R China; [Zhou, Lina; Dai, Huifang; Zhou, Mian; Du, Juan; Zheng, Li; Shen, Binghui] Beckman Res Inst City Hope, Dept Canc Genet & Epigenet, 1500 East Duarte Rd, Duarte, CA 91010 USA; [Yang, Lu; Wu, Xiwei] Beckman Res Inst City Hope, Dept Mol & Cellular Biol, Duarte, CA USA; [Wu, Jian; Xu, Jian] Univ Southern Calif, Herman Ostrow Sch Dent, Ctr Craniofacial Mol Biol, Los Angeles, CA USA; [Yuan, Hua] Shaoxing Women & Childrens Hosp, Dept Diagnost Ultrasound, Shaoxing, Peoples R China	Zhejiang University; Zhejiang University; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; University of Southern California	Zheng, L; Shen, BH (corresponding author), Beckman Res Inst City Hope, Dept Canc Genet & Epigenet, 1500 East Duarte Rd, Duarte, CA 91010 USA.	lzheng@coh.org; bshen@coh.org	Wu, Jian/H-9404-2019; Xu, Jian/AAE-1415-2019	Wu, Jian/0000-0002-9272-5732; Shen, Binghui/0000-0002-4408-407X	U.S. National Institutes of Health (NIH), National Cancer Institute (NCI) [R01 CA073764]; National Natural Sciences Foundation of China [31210103904]; NIH/NCI-designated Comprehensive Cancer Center support Grant [P30 CA033572]; NATIONAL CANCER INSTITUTE [R50CA211397, P30CA033572, R01CA073764] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); NIH/NCI-designated Comprehensive Cancer Center support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank W. Tsark for technical assistance in generation of transgenic mice, Lufen Chang for technical assistance and stimulating discussion, the Light Microscopy/Digital Imaging Core at City of Hope for microscopic analysis, and Nancy Linford (all from City of Hope) for editorial assistance. This work was supported by U.S. National Institutes of Health (NIH), National Cancer Institute (NCI) Grant R01 CA073764 (to B.H.S.), and by an international corporation grant from National Natural Sciences Foundation of China (Grant 31210103904) (to Y.J.H.). The core facilities at City of Hope used in the current study are supported by NIH/NCI-designated Comprehensive Cancer Center support Grant P30 CA033572. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The authors declare no conflicts of interest.	Aguilera A, 2008, NAT REV GENET, V9, P204, DOI 10.1038/nrg2268; Ahuja P, 2007, PHYSIOL REV, V87, P521, DOI 10.1152/physrev.00032.2006; Biswas EE, 1997, BIOCHEMISTRY-US, V36, P5955, DOI 10.1021/bi962890u; Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351; Branzei D, 2010, NAT REV MOL CELL BIO, V11, P208, DOI 10.1038/nrm2852; Brosh RM, 2002, BIOCHEMISTRY-US, V41, P12204, DOI 10.1021/bi026031j; Brosh RM, 2001, EMBO J, V20, P5791; Camporeale A, 2014, CANCERS, V6, P1579, DOI 10.3390/cancers6031579; Chai Q, 2003, BIOCHEMISTRY-US, V42, P15045, DOI 10.1021/bi035364t; Chung L, 2015, ONCOGENE, V34, P902, DOI 10.1038/onc.2014.19; Dianova II, 2001, BIOCHEMISTRY-US, V40, P12639, DOI 10.1021/bi011117i; Djouadi F, 1999, PROSTAG LEUKOTR ESS, V60, P339, DOI 10.1016/S0952-3278(99)80009-X; Ferguson AM, 2005, MOL CELL BIOL, V25, P2853, DOI 10.1128/MCB.25.7.2853-2860.2005; Giordano FJ, 2005, J CLIN INVEST, V115, P500, DOI 10.1172/JCI200524408; Guo ZG, 2008, MOL CELL BIOL, V28, P4310, DOI 10.1128/MCB.00200-08; Guo ZG, 2012, MOL CELL, V47, P444, DOI 10.1016/j.molcel.2012.05.042; Guo ZG, 2010, NAT CHEM BIOL, V6, P766, DOI [10.1038/NCHEMBIO.422, 10.1038/nchembio.422]; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hartlova A, 2015, IMMUNITY, V42, P332, DOI 10.1016/j.immuni.2015.01.012; Hasan S, 2001, MOL CELL, V7, P1221, DOI 10.1016/S1097-2765(01)00272-6; Hegde ML, 2008, J BIOL CHEM, V283, P27028, DOI 10.1074/jbc.M802712200; Henneke G, 2003, ONCOGENE, V22, P4301, DOI 10.1038/sj.onc.1206606; Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3; JOHNSON RE, 1995, SCIENCE, V269, P238, DOI 10.1126/science.7618086; Klungland A, 1997, EMBO J, V16, P3341, DOI 10.1093/emboj/16.11.3341; Klungland A, 1999, MOL CELL, V3, P33, DOI 10.1016/S1097-2765(00)80172-0; Kucherlapati M, 2002, P NATL ACAD SCI USA, V99, P9924, DOI 10.1073/pnas.152321699; Larsen E, 2003, MOL CELL BIOL, V23, P5346, DOI 10.1128/MCB.23.15.5346-5353.2003; LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109; Lieber MR, 1997, BIOESSAYS, V19, P233, DOI 10.1002/bies.950190309; Liu P, 2008, MOL CELL BIOL, V28, P4975, DOI 10.1128/MCB.00457-08; Liu SB, 2015, EMBO J, V34, P1829, DOI 10.15252/embj.201489865; Liu Y, 2004, ANNU REV BIOCHEM, V73, P589, DOI 10.1146/annurev.biochem.73.012803.092453; Lombard DB, 2005, CELL, V120, P497, DOI 10.1016/j.cell.2005.01.028; Lopaschuk GD, 2010, J CARDIOVASC PHARM, V56, P130, DOI 10.1097/FJC.0b013e3181e74a14; Mahmoud AI, 2013, NATURE, V497, P249, DOI 10.1038/nature12054; McCool KW, 2012, IMMUNOL REV, V246, P311, DOI 10.1111/j.1600-065X.2012.01101.x; Nakamura K, 2008, J BIOL CHEM, V283, P17702, DOI 10.1074/jbc.M802589200; Ohno M, 2009, METHODS MOL BIOL, V554, P199, DOI 10.1007/978-1-59745-521-3_13; Porrello ER, 2011, SCIENCE, V331, P1078, DOI 10.1126/science.1200708; Pouget JP, 2002, RADIAT RES, V157, P589, DOI 10.1667/0033-7587(2002)157[0589:FOMDBI]2.0.CO;2; Puente BN, 2014, CELL, V157, P565, DOI 10.1016/j.cell.2014.03.032; Querol-Audi J, 2012, P NATL ACAD SCI USA, V109, P8528, DOI 10.1073/pnas.1121116109; Ranalli TA, 2002, J BIOL CHEM, V277, P41715, DOI 10.1074/jbc.M207207200; Rancourt RC, 2002, J CELL PHYSIOL, V193, P26, DOI 10.1002/jcp.10146; REAGAN MS, 1995, J BACTERIOL, V177, P364, DOI 10.1128/jb.177.2.364-371.1995; Sano M, 2007, NATURE, V446, P444, DOI 10.1038/nature05602; Schorl C, 2007, METHODS, V41, P143, DOI 10.1016/j.ymeth.2006.07.022; SIEGAL G, 1992, P NATL ACAD SCI USA, V89, P9377, DOI 10.1073/pnas.89.20.9377; Takano H, 2000, CIRC RES, V87, P596, DOI 10.1161/01.RES.87.7.596; Tishkoff DX, 1997, P NATL ACAD SCI USA, V94, P7487, DOI 10.1073/pnas.94.14.7487; WALDMAN T, 1995, CANCER RES, V55, P5187; Wang WS, 2004, P NATL ACAD SCI USA, V101, P16762, DOI 10.1073/pnas.0407686101; Xu H, 2011, ONCOGENE, V30, P1072, DOI 10.1038/onc.2010.482; Yucel D, 1998, CLIN CHEM, V44, P148; Zheng L, 2005, EMBO REP, V6, P83, DOI 10.1038/sj.embor.7400313; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599; Zheng L, 2007, MOL CELL BIOL, V27, P3176, DOI 10.1128/MCB.01652-06; Zheng L, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1825; Zheng L, 2011, CELL RES, V21, P1052, DOI 10.1038/cr.2011.35; Zhu FX, 1997, BIOCHEMISTRY-US, V36, P5947, DOI 10.1021/bi962889v	61	5	6	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					132	+		10.1096/fj.201600631R	http://dx.doi.org/10.1096/fj.201600631R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27694478	Green Published			2022-12-28	WOS:000392177600015
J	Tian, JJ; Yang, GX; Chen, HY; Hsu, DK; Tomilov, A; Olson, KA; Dehnad, A; Fish, SR; Cortopassi, G; Zhao, B; Liu, FT; Gershwin, ME; Torok, NJ; Jiang, JX				Tian, Jijing; Yang, Guoxiang; Chen, Huan-Yuan; Hsu, Daniel K.; Tomilov, Alexey; Olson, Kristin A.; Dehnad, Ali; Fish, Sarah R.; Cortopassi, Gino; Zhao, Bin; Liu, Fu-Tong; Gershwin, M. Eric; Torok, Natalie J.; Jiang, Joy X.			Galectin-3 regulates inflammasome activation in cholestatic liver injury	FASEB JOURNAL			English	Article						primary biliary cholangitis; NLRP3; galectin-3; IL-17	PRIMARY BILIARY-CIRRHOSIS; GROWTH-FACTOR-BETA; DEOXYCHOLIC-ACID DCA; IGE-BINDING PROTEIN; T-CELLS; URSODEOXYCHOLIC ACID; ANTIMITOCHONDRIAL ANTIBODIES; KAPPA-B; EXPRESSION; RECEPTOR	Macrophage activation is an important feature of primary biliary cholangitis (PBC) pathogenesis and other cholestatic liver diseases. Galectin-3 (Gal3), a pleiotropic lectin, is produced by monocytic cells and macrophages. However, its role in PBC has not been addressed. We hypothesized that Gal3 is a key to induce NOD-like receptor family, pyrin domain containing 3 (NLRP3) inflammasome in macrophages and in turn to propagate proinflammatory IL-17 signaling. In liver tissues from patients with PBC and dnTGF-beta RII mice, a model of autoimmune cholangitis, the expression of Gal3, NLRP3, and the adaptor protein adaptor apoptosis-associated speck-like protein was induced, with the down stream activation of caspase-1 and IL-1 beta. In wild-type hepatic macrophages, deoxycholic acid induced the association of Gal3 and NLRP3 with direct activation of the inflammasome, resulting in an increase in IL-1b. Downstream retinoid-related orphan receptor C mRNA, IL-17A, and IL-17F were induced. In Gal3(-/-) macrophages, no inflammasome activation was detected. To confirm the key role of Gal3 in the pathogenesis of cholestatic liver injury, we generated dnTGF-bRII/galectin-3(-/-) (dn/Gal3(-/-)) mice, which showed impaired inflammasome activation along with significantly improved inflammation and fibrosis. Taken together, our data point to a novel role of Gal3 as an initiator of inflammatory signaling in autoimmune cholangitis, mediating the activation of NLRP3 inflammasome and inducing IL-17 proinflammatory cascades. These studies provide a rationale to target Gal3 in autoimmune cholangitis and potentially other cholestatic diseases.	[Tian, Jijing; Dehnad, Ali; Fish, Sarah R.; Jiang, Joy X.] Univ Calif Davis, Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, Sacramento, CA 95817 USA; [Yang, Guoxiang; Gershwin, M. Eric] Univ Calif Davis, Med Ctr, Dept Internal Med, Div Rheumatol Allergy & Clin Immunol, Sacramento, CA 95817 USA; [Chen, Huan-Yuan; Hsu, Daniel K.; Liu, Fu-Tong] Univ Calif Davis, Med Ctr, Dept Dermatol, Sacramento, CA 95817 USA; [Olson, Kristin A.] Univ Calif Davis, Med Ctr, Dept Pathol, Sacramento, CA 95817 USA; [Tomilov, Alexey; Cortopassi, Gino] Univ Calif Davis, Dept Mol Biosci, Sacramento, CA 95817 USA; [Tian, Jijing] Chinese Acad Sci, State Key Lab Environm Chem & Ecotoxicol, Ctr Ecoenvironm Sci, Beijing, Peoples R China; [Chen, Huan-Yuan; Liu, Fu-Tong] Acad Sinica, Inst Biomed Sci, Taipei, Taiwan; [Torok, Natalie J.] Vet Adm Northern Calif Med Ctr, Mather, CA USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; Chinese Academy of Sciences; Academia Sinica - Taiwan	Jiang, JX (corresponding author), UC Davis Med Ctr, Dept Internal Med, Div Gastroenterol & Hepatol, PSSB, 4150,5 St,Suite 3500, Sacramento, CA 95817 USA.	joyjiang@ucdavis.edu	Liu, FU-TONG/A-5749-2019	Liu, FU-TONG/0000-0002-3354-1001	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK090121, DK106467, DK083283, DK39588, DK090019]; U.S. Veterans Administration [BX002418]; National Natural Science Foundation of China [NNSFC21525730]; NIH National Institute on Aging [AG025532]; Taiwan Ministry of Science and Technology [MOST104-2321-B-001-036]; NATIONAL CANCER INSTITUTE [P30CA093373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R37DK039588, R01DK090019, R01DK083283, K01DK090121, R03DK106467, R01DK039588] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG025532] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002418] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Veterans Administration(US Department of Veterans Affairs); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Taiwan Ministry of Science and Technology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Veterans Affairs(US Department of Veterans Affairs)	This study was supported by the U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants DK090121 and DK106467 (to J.X.J.), DK083283 (to N.J.T.), DK39588 and DK090019 (to M.E.G.); U.S. Veterans Administration Grant BX002418 (to N.J.T.); National Natural Science Foundation of China Grant NNSFC21525730 (to B.Z.); and NIH National Institute on Aging Grant AG025532 (to G.C.); and Taiwan Ministry of Science and Technology Grant MOST104-2321-B-001-036 (to H.-Y.C.). The authors declare no conflicts of interest.	Acosta-Rodriguez EV, 2007, NAT IMMUNOL, V8, P942, DOI 10.1038/ni1496; Besnard AG, 2012, J MOL CELL BIOL, V4, P3, DOI 10.1093/jmcb/mjr042; Beuers U, 1998, HEPATOLOGY, V28, P1449, DOI 10.1002/hep.510280601; Bosmann M, 2012, FASEB J, V26, P1640, DOI 10.1096/fj.11-199216; Chang CH, 2014, CLIN EXP IMMUNOL, V177, P373, DOI 10.1111/cei.12298; Chen HY, 2009, P NATL ACAD SCI USA, V106, P14496, DOI 10.1073/pnas.0903497106; Chuang YH, 2008, HEPATOLOGY, V47, P571, DOI 10.1002/hep.22052; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Eisa NH, 2015, J ONCOL PHARM PRACT, V21, P323, DOI 10.1177/1078155214532698; Ferreira DMS, 2014, MOL CELL BIOL, V34, P1100, DOI 10.1128/MCB.00420-13; Geerts A, 1998, HEPATOLOGY, V27, P590, DOI 10.1002/hep.510270238; GELLER DA, 1995, J IMMUNOL, V155, P4890; Gorelik L, 2000, IMMUNITY, V12, P171, DOI 10.1016/S1074-7613(00)80170-3; He XS, 2006, CELL IMMUNOL, V239, P1, DOI 10.1016/j.cellimm.2006.04.006; Henderson NC, 2006, P NATL ACAD SCI USA, V103, P5060, DOI 10.1073/pnas.0511167103; Hsu DK, 2009, IMMUNOL REV, V230, P114, DOI 10.1111/j.1600-065X.2009.00798.x; Hsu DK, 2000, AM J PATHOL, V156, P1073, DOI 10.1016/S0002-9440(10)64975-9; HSU DK, 1992, J BIOL CHEM, V267, P14167; Hsu DK, 1996, AM J PATHOL, V148, P1661; Hsu DK, 1999, INT J CANCER, V81, P519, DOI 10.1002/(SICI)1097-0215(19990517)81:4<519::AID-IJC3>3.0.CO;2-0; Iacobini C, 2011, J HEPATOL, V54, P975, DOI 10.1016/j.jhep.2010.09.020; Jenkins GJS, 2004, CARCINOGENESIS, V25, P317, DOI 10.1093/carcin/bgh032; Jiang JX, 2012, AM J PHYSIOL-GASTR L, V302, pG439, DOI 10.1152/ajpgi.00257.2011; Kawata K, 2013, HEPATOLOGY, V58, P1094, DOI 10.1002/hep.26418; Kim K, 2003, BBA-MOL CELL RES, V1641, P13, DOI 10.1016/S0167-4889(03)00045-4; Lalor SJ, 2011, J IMMUNOL, V186, P5738, DOI 10.4049/jimmunol.1003597; Lan RYZ, 2009, J AUTOIMMUN, V32, P43, DOI 10.1016/j.jaut.2008.11.001; Leicester KL, 2006, LIVER INT, V26, P559, DOI 10.1111/j.1478-3231.2006.01255.x; LIU FT, 1990, CRIT REV IMMUNOL, V10, P289; Liu L, 2004, BIOCHEM J, V380, P31, DOI 10.1042/BJ20031300; Ljubuncic P, 1996, GUT, V39, P475, DOI 10.1136/gut.39.3.475; Lleo A, 2010, HEPATOLOGY, V52, P987, DOI 10.1002/hep.23783; Looby E, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-190; MacKinnon AC, 2008, J IMMUNOL, V180, P2650, DOI 10.4049/jimmunol.180.4.2650; Mao TK, 2005, HEPATOLOGY, V42, P802, DOI 10.1002/hep.20859; Meng F., 2012, GASTROENTEROLOGY, V143; Nomoto K, 2012, SCI WORLD J, P1, DOI 10.1100/2012/959824; Oertelt S, 2006, J IMMUNOL, V177, P1655, DOI 10.4049/jimmunol.177.3.1655; Qiao L, 2001, MOL BIOL CELL, V12, P2629, DOI 10.1091/mbc.12.9.2629; Rodrigues CMP, 1998, MOL MED, V4, P165, DOI 10.1007/BF03401914; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Sanz-Cameno P, 2002, J HEPATOL, V37, P723, DOI 10.1016/S0168-8278(02)00266-0; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Traber PG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083481; Tsai HF, 2016, J MOL MED, V94, P545, DOI 10.1007/s00109-015-1368-x; Wang JJ, 2014, SEMIN LIVER DIS, V34, P285, DOI 10.1055/s-0034-1383728; Wijesundera KK, 2014, EXP MOL PATHOL, V96, P382, DOI 10.1016/j.yexmp.2014.04.003; Wree A, 2014, J MOL MED, V92, P1069, DOI 10.1007/s00109-014-1170-1; Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592; Yang CY, 2014, HEPATOLOGY, V59, P1944, DOI 10.1002/hep.26979; Zhang WC, 2010, HEPATOLOGY, V52, P215, DOI 10.1002/hep.23664; Zhu P, 2011, HUM GENE THER, V22, P853, DOI 10.1089/hum.2010.145	52	35	35	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4202	4213		10.1096/fj.201600392RR	http://dx.doi.org/10.1096/fj.201600392RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27630169	Green Published			2022-12-28	WOS:000388201500026
J	Becattini, B; Zani, F; Breasson, L; Sardi, C; D'Agostino, VG; Choo, MK; Provenzani, A; Park, JM; Solinas, G				Becattini, Barbara; Zani, Fabio; Breasson, Ludovic; Sardi, Claudia; D'Agostino, Vito Giuseppe; Choo, Min-Kyung; Provenzani, Alessandro; Park, Jin Mo; Solinas, Giovanni			JNK1 ablation in mice confers long-term metabolic protection from diet-induced obesity at the cost of moderate skin oxidative damage	FASEB JOURNAL			English	Article						type-2 diabetes; insulin resistance; metabolic inflammation; antioxidants; oxidative stress tolerance	EXTENDS LIFE-SPAN; INSULIN-RECEPTOR SUBSTRATE-1; HEME OXYGENASE-1 GENE; PROMOTES OBESITY; PROTEIN-KINASE; IN-VIVO; RESISTANCE; INFLAMMATION; PHOSPHORYLATION; ACTIVATION	Obesity and insulin resistance are associated with oxidative stress, which may be implicated in the progression of obesity-related diseases. The kinase JNK1 has emerged as a promising drug target for the treatment of obesity and type 2 diabetes. JNK1 is also a key mediator of the oxidative stress response, which can promote cell death or survival, depending on the magnitude and context of its activation. In this article, we describe a study in which the long-term effects of JNK1 inactivation on glucose homeostasis and oxidative stress in obese mice were investigated for the first time. Mice lacking JNK1 (JNK1(-/-)) were fed an obesogenic high-fat diet (HFD) for a long period. JNK1(-/-) mice fed an HFD for the long term had reduced expression of antioxidant genes in their skin, more skin oxidative damage, and increased epidermal thickness and inflammation compared with the effects in control wild-type mice. However, we also observed that the protection from obesity, adipose tissue inflammation, steatosis, and insulin resistance, conferred by JNK1 ablation, was sustained over a long period and was paralleled by decreased oxidative damage in fat and liver. We conclude that compounds targeting JNK1 activity in brain and adipose tissue, which do not accumulate in the skin, may be safer and most effective.Becattini, B., Zani, F., Breasson, L., Sardi, C., D'Agostino, V. G., Choo, M.-K., Provenzani, A., Park, J. M., Solinas, G. JNK1 ablation in mice confers long-term metabolic protection from diet-induced obesity at the cost of moderate skin oxidative damage.	[Becattini, Barbara; Zani, Fabio; Breasson, Ludovic; Sardi, Claudia; Solinas, Giovanni] Univ Fribourg, Dept Med, Lab Metab Stress Biol, Fribourg, Switzerland; [D'Agostino, Vito Giuseppe; Provenzani, Alessandro] Univ Trento, Ctr Integrat Biol, Trento, Italy; [Choo, Min-Kyung; Park, Jin Mo] Massachusetts Gen Hosp, Cutaneous Biol Res Ctr, Charlestown, MA USA; [Choo, Min-Kyung; Park, Jin Mo] Harvard Med Sch, Charlestown, MA USA; [Becattini, Barbara; Breasson, Ludovic; Sardi, Claudia; Solinas, Giovanni] Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, S-41345 Gothenburg, Sweden	University of Fribourg; University of Trento; Harvard University; Massachusetts General Hospital; University of Gothenburg	Solinas, G (corresponding author), Univ Gothenburg, Dept Mol & Clin Med, Wallenberg Lab, S-41345 Gothenburg, Sweden.	giovanni.solinas@wlab.gu.se	Solinas, Giovanni/P-6596-2017; Solinas, Giovanni/R-4777-2019; D'Agostino, Vito/AAS-4260-2020	Solinas, Giovanni/0000-0002-0140-2621; Solinas, Giovanni/0000-0002-0140-2621; D'Agostino, Vito/0000-0003-3379-2254; Becattini, Barbara/0000-0002-1002-6891; Breasson, Ludovic/0000-0003-2168-976X; Provenzani, Alessandro/0000-0003-1652-3415	Swiss National Science Foundation; Swedish Diabetes Foundation; Swedish Research Council; University of Gothenburg; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [T32AR007098] Funding Source: NIH RePORTER	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swedish Diabetes Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); University of Gothenburg; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from the Swiss National Science Foundation, the Swedish Diabetes Foundation, the Swedish Research Council, and a startup package from the University of Gothenburg (to G.S.). Author contributions: B. Becattini and F. Zani performed most of the experiments, analyzed data, and contributed to the discussion; L. Breasson and C. Sardi performed experiments; V. G. D'Agostino and A. Provenzani performed the DNA microarray analysis; M.-K. Choo and J. M. Park performed the skin histopathological analysis and discussed the skin data; G. Solinas conceived the project, the experimental design, and wrote the manuscript; B. Becattini, F. Zani, A. Provenzani, M.-K. Choo and J. M. Park, significantly contributed to the writing of the manuscript with their comments; and all authors approved the paper. The authors declare no conflicts of interest.	Aguirre V, 2002, J BIOL CHEM, V277, P1531, DOI 10.1074/jbc.M101521200; Aguirre V, 2000, J BIOL CHEM, V275, P9047, DOI 10.1074/jbc.275.12.9047; Becattini B, 2011, P NATL ACAD SCI USA, V108, pE854, DOI 10.1073/pnas.1106698108; Belgardt BF, 2010, P NATL ACAD SCI USA, V107, P6028, DOI 10.1073/pnas.1001796107; Donath MY, 2014, NAT REV DRUG DISCOV, V13, P465, DOI 10.1038/nrd4275; Eijkelenboom A, 2013, NAT REV MOL CELL BIO, V14, P83, DOI 10.1038/nrm3507; Fisher GJ, 1998, J CLIN INVEST, V101, P1432, DOI 10.1172/JCI2153; Furukawa S, 2004, J CLIN INVEST, V114, P1752, DOI [10.1172/JCI21625, 10.1172/JCI20042162S]; Han MS, 2013, SCIENCE, V339, P218, DOI 10.1126/science.1227568; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kauser S, 2011, J INVEST DERMATOL, V131, P979, DOI 10.1038/jid.2010.397; Kietzmann T, 2003, J BIOL CHEM, V278, P17927, DOI 10.1074/jbc.M203929200; Lao Y, 2014, CELL BIOL TOXICOL, V30, P147, DOI 10.1007/s10565-014-9276-3; Lee JH, 2013, CELL METAB, V18, P792, DOI 10.1016/j.cmet.2013.08.018; Luo JL, 2005, J CLIN INVEST, V115, P2625, DOI 10.1172/JCI26322; Maresca V, 2008, PIGM CELL MELANOMA R, V21, P200, DOI 10.1111/j.1755-148X.2007.00432.x; Oh SW, 2005, P NATL ACAD SCI USA, V102, P4494, DOI 10.1073/pnas.0500749102; Patel SA, 2014, ANTIOXID REDOX SIGN, V20, P2997, DOI 10.1089/ars.2013.5671; Perry RJ, 2015, CELL, V160, P745, DOI 10.1016/j.cell.2015.01.012; Ray PD, 2015, BBA-GENE REGUL MECH, V1849, P1277, DOI 10.1016/j.bbagrm.2015.08.004; Sabio G, 2010, GENE DEV, V24, P256, DOI 10.1101/gad.1878510; Sabio G, 2009, CELL METAB, V10, P491, DOI 10.1016/j.cmet.2009.09.007; Shaukat Z, 2016, CURR DRUG TARGETS, V17, P154, DOI 10.2174/1389450116666150126111055; Solinas G, 2012, OBES REV, V13, P69, DOI 10.1111/j.1467-789X.2012.01047.x; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; Solinas G, 2006, P NATL ACAD SCI USA, V103, P16454, DOI 10.1073/pnas.0607626103; Solinas G, 2010, FASEB J, V24, P2596, DOI 10.1096/fj.09-151340; Son YO, 2011, TOXICOL SCI, V119, P335, DOI 10.1093/toxsci/kfq335; Tsaousidou E, 2014, CELL REP, V9, P1495, DOI 10.1016/j.celrep.2014.10.045; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; Uno M, 2013, CELL REP, V3, P79, DOI 10.1016/j.celrep.2012.12.018; Urakawa H, 2003, J CLIN ENDOCR METAB, V88, P4673, DOI 10.1210/jc.2003-030202; Ventura JJ, 2004, GENE DEV, V18, P2905, DOI 10.1101/gad.1223004; Vernia S, 2016, CELL REP, V14, P2273, DOI 10.1016/j.celrep.2016.02.026; Virtue S, 2008, PLOS BIOL, V6, P1819, DOI 10.1371/journal.pbio.0060237; Wagner EF, 2009, NAT REV CANCER, V9, P537, DOI 10.1038/nrc2694; Wang MC, 2005, CELL, V121, P115, DOI 10.1016/j.cell.2005.02.030; Wang MC, 2003, DEV CELL, V5, P811, DOI 10.1016/S1534-5807(03)00323-X; Zhang XY, 2013, CELL SIGNAL, V25, P150, DOI 10.1016/j.cellsig.2012.09.004; Zheng RJ, 2014, TOXICOL APPL PHARM, V275, P113, DOI 10.1016/j.taap.2014.01.001; Zheng RJ, 2014, FREE RADICAL BIO MED, V67, P1, DOI 10.1016/j.freeradbiomed.2013.10.011	44	10	10	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3124	3132		10.1096/fj.201600393R	http://dx.doi.org/10.1096/fj.201600393R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27230858	Green Submitted, Green Published			2022-12-28	WOS:000382816300013
J	Leisner, TM; Freeman, TC; Black, JL; Parise, LV				Leisner, Tina M.; Freeman, Thomas C.; Black, Justin L.; Parise, Leslie V.			CIB1: a small protein with big ambitions	FASEB JOURNAL			English	Review						structure; signaling; kinase; cancer; cardiovascular	INTEGRIN-BINDING-PROTEIN; ALPHA(IIB) CYTOPLASMIC DOMAIN; BREAST-CANCER CELLS; POLO-LIKE KINASE; CALCIUM-BINDING; EF-HAND; P21-ACTIVATED KINASE; CARDIAC-HYPERTROPHY; TUMOR-GROWTH; ACTIVATION	Calcium- and integrin-binding protein 1 (CIB1) is a small, ubiquitously expressed protein that was first identified as an intracellular binding partner of a platelet-specific alpha-integrin cytoplasmic tail. Although early studies revealed a role for CIB1 in regulating platelet integrin activity, recent studies have indicated a more diverse role for CIB1 in many different cell types and processes, including calcium signaling, migration, adhesion, proliferation, and survival. Increasing evidence also points to a novel role for CIB1 in cancer and cardiovascular disease. In addition, an array of CIB1 binding partners has been identified that provide important insight into how CIB1 may regulate these processes. Some of these binding partners include the serine/threonine kinases, p21-activated kinase 1 (PAK1), apoptosis signal-regulating kinase 1 (ASK1), and polo-like kinase 3 (PLK3). Structural and mutational studies indicate that CIB1 binds most or all of its partners via a well-defined hydrophobic cleft. Although CIB1 itself lacks known enzymatic activity, it supports the PI3K/AKT and MEK/ERK oncogenic signaling pathways, in part, by directly modulating enzymes in these pathways. In this review, we discuss our current understanding of CIB1 and key questions regarding structure and function and how this seemingly diminutive protein impacts important signaling pathways and cellular processes in human health and disease.-Leisner, T.M., Freeman, T.C., Black, J.L., Parise, L.V. CIB1: a small protein with big ambitions.	[Leisner, Tina M.; Freeman, Thomas C.; Black, Justin L.; Parise, Leslie V.] Univ N Carolina, Dept Biochem & Biophys, 120 Mason Farm Rd,CB 7260, Chapel Hill, NC 27599 USA; [Parise, Leslie V.] Univ N Carolina, McAllister Heart Inst, Chapel Hill, NC USA; [Parise, Leslie V.] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA	University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Parise, LV (corresponding author), Univ N Carolina, Dept Biochem & Biophys, 120 Mason Farm Rd,CB 7260, Chapel Hill, NC 27599 USA.	parise@med.unc.edu			U.S. National Institutes of Health National Heart, Lung, and Blood Institute [1R01-HL092544]; National Cancer Institute [1R41CA200189]; University of North Carolina TraCS [4DR11410]; American Heart Association Predoctoral Award [13PRE16470024]; NATIONAL CANCER INSTITUTE [R41CA200189] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM000678] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of North Carolina TraCS; American Heart Association Predoctoral Award(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank the University of North Carolina graduate students in Biochem 706, Class of 2015, for their helpful comments and critical review. This work was supported by U.S. National Institutes of Health National Heart, Lung, and Blood Institute Grant 1R01-HL092544 and National Cancer Institute Grant 1R41CA200189 (L.V.P.), University of North Carolina TraCS Grant 4DR11410 (L.V.P.), and American Heart Association Predoctoral Award 13PRE16470024 (J.L.B.). T.M.L., J.L.B., and L.V.P. are cofounders of Reveris Therapeutics LLC.	Alshaker H, 2013, ADV CANCER RES, V117, P143, DOI 10.1016/B978-0-12-394274-6.00006-6; Ames JB, 1997, NATURE, V389, P198, DOI 10.1038/38310; Armacki M, 2014, ONCOGENE, V33, P1167, DOI 10.1038/onc.2013.43; Bandyopadhyay C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003941; Barry WT, 2002, J BIOL CHEM, V277, P28877, DOI 10.1074/jbc.M202983200; Black JL, 2015, BREAST CANCER RES TR, V152, P337, DOI 10.1007/s10549-015-3458-4; Blamey CJ, 2005, PROTEIN SCI, V14, P1214, DOI 10.1110/ps.041270805; Blazejczyk M, 2006, BBA-MOL BASIS DIS, V1762, P66, DOI 10.1016/j.bbadis.2005.09.006; Braunewell KH, 1999, CELL TISSUE RES, V295, P1, DOI 10.1007/s004410051207; Bueno OF, 2002, CARDIOVASC RES, V53, P806, DOI 10.1016/S0008-6363(01)00493-X; Burgoyne RD, 2004, TRENDS NEUROSCI, V27, P203, DOI 10.1016/j.tins.2004.01.010; Causeret F, 2009, CEREB CORTEX, V19, P861, DOI 10.1093/cercor/bhn133; Czeredys M, 2013, FRONT MOL NEUROSCI, V6, DOI 10.3389/fnmol.2013.00042; Dai C, 2007, CELL, V130, P1005, DOI 10.1016/j.cell.2007.07.020; Das U, 2012, CURR CANCER DRUG TAR, V12, P667, DOI 10.2174/156800912801784857; Demorest ZL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011660; DeNofrio JC, 2008, THROMB HAEMOSTASIS, V100, P847, DOI 10.1160/TH08-06-0351; Estevez B, 2015, ARTERIOSCL THROM VAS, V35, P24, DOI 10.1161/ATVBAHA.114.303411; Fang XD, 2001, THROMB RES, V102, P177, DOI 10.1016/S0049-3848(01)00229-8; Freeman Jr T. C., 2013, BIOCH, V52, P7082; Gentry HR, 2005, J BIOL CHEM, V280, P8407, DOI 10.1074/jbc.M411515200; Ginsberg MH, 2014, BMB REP, V47, P655, DOI 10.5483/BMBRep.2014.47.12.241; Grabarek Z, 2011, BBA-MOL CELL RES, V1813, P913, DOI 10.1016/j.bbamcr.2011.01.017; Haas TA, 2008, THROMB RES, V122, P507, DOI 10.1016/j.thromres.2008.01.006; Haataja L, 2002, J BIOL CHEM, V277, P8321, DOI 10.1074/jbc.M105363200; Hattori K, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-9; Heineke J, 2010, NAT MED, V16, P872, DOI 10.1038/nm.2181; Henderson MJ, 2002, J BIOL CHEM, V277, P26468, DOI 10.1074/jbc.M203527200; Hennigs J. K., 2008, J NEUROCHEM, V106, P2249; Hollenbach AD, 2002, BBA-GENE STRUCT EXPR, V1574, P321, DOI 10.1016/S0167-4781(02)00230-0; Holtrich U, 2000, ONCOGENE, V19, P4832, DOI 10.1038/sj.onc.1203845; Huang H, 2012, J AM CHEM SOC, V134, P3864, DOI 10.1021/ja2111306; Huang H, 2011, J BIOL CHEM, V286, P17181, DOI 10.1074/jbc.M110.179028; Hui L, 2009, BRAIN RES, V1265, P24, DOI 10.1016/j.brainres.2009.02.021; Hwang PM, 2000, J MOL RECOGNIT, V13, P83, DOI 10.1002/(SICI)1099-1352(200003/04)13:2<83::AID-JMR491>3.0.CO;2-A; Ito A, 2000, FEBS LETT, V470, P360, DOI 10.1016/S0014-5793(00)01351-X; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Jogi A, 2012, UPSALA J MED SCI, V117, P217, DOI 10.3109/03009734.2012.659294; Kauselmann G, 1999, EMBO J, V18, P5528, DOI 10.1093/emboj/18.20.5528; Kawarazaki Y, 2014, EXPERT OPIN THER TAR, V18, P651, DOI 10.1517/14728222.2014.896903; Khadka P, 2014, BIOCHEM J, V463, P19, DOI 10.1042/BJ20131395; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Kleiman NS, 2008, PLATELETS, V19, P239, DOI 10.1080/09537100801947442; Kostyak JC, 2012, BLOOD, V119, P838, DOI 10.1182/blood-2011-04-346098; KRETSINGER RH, 1973, J BIOL CHEM, V248, P3313; Lau TL, 2009, EMBO J, V28, P1351, DOI 10.1038/emboj.2009.63; Lee GE, 2004, J BIOL CHEM, V279, P34750, DOI 10.1074/jbc.M401843200; Leisner TM, 2013, ONCOGENE, V32, P4017, DOI 10.1038/onc.2012.408; Leisner TM, 2005, J CELL BIOL, V170, P465, DOI 10.1083/jcb.200502090; Levy D, 1996, JAMA-J AM MED ASSOC, V275, P1557, DOI 10.1001/jama.275.20.1557; Li CM, 2011, J BIOL CHEM, V286, P6354, DOI 10.1074/jbc.M110.173724; Luo J, 2009, CELL, V136, P823, DOI 10.1016/j.cell.2009.02.024; Ma S, 2003, MOL CANCER RES, V1, P376; McCubrey JA, 2006, ADV ENZYME REGUL, V46, P249, DOI 10.1016/j.advenzreg.2006.01.004; Melendez AJ, 2000, GENE, V251, P19, DOI 10.1016/S0378-1119(00)00205-5; Minino AM, 2012, NCHS DATA BRIEF, V99, P1; Naik MU, 2009, J THROMB HAEMOST, V7, P1906, DOI 10.1111/j.1538-7836.2009.03581.x; Naik MU, 2011, J CELL BIOCHEM, V112, P3289, DOI 10.1002/jcb.23255; Naik MU, 2011, INT J CANCER, V128, P587, DOI 10.1002/ijc.25388; Naik MU, 2003, BLOOD, V102, P3629, DOI 10.1182/blood-2003-05-1703; Naik UP, 1997, J BIOL CHEM, V272, P4651, DOI 10.1074/jbc.272.8.4651; Raab M, 2010, BIOCHEM BIOPH RES CO, V392, P258, DOI 10.1016/j.bbrc.2009.12.088; Schafer G, 2015, VIRUSES-BASEL, V7, P2592, DOI 10.3390/v7052592; Sedlmaier A, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-457; Sells MA, 1999, J CELL BIOL, V145, P837, DOI 10.1083/jcb.145.4.837; Shock DD, 1999, BIOCHEM J, V342, P729, DOI 10.1042/0264-6021:3420729; Shrestha Y, 2012, ONCOGENE, V31, P3397, DOI 10.1038/onc.2011.515; Sobczak A, 2011, BBA-MOL CELL RES, V1813, P1025, DOI 10.1016/j.bbamcr.2010.12.023; Son SM, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.129; Stabler SM, 1999, J CELL BIOL, V145, P1277, DOI 10.1083/jcb.145.6.1277; Stefansson A, 2004, J BIOL CHEM, V279, P21200, DOI 10.1074/jbc.M400771200; Stofega MR, 2004, MOL BIOL CELL, V15, P2965, DOI 10.1091/mbc.E03-08-0604; Sun W, 2014, J ASSIST REPROD GEN, V31, P541, DOI 10.1007/s10815-014-0177-4; Tahara E, 2005, CANCER IMMUNOL IMMUN, V54, P729, DOI 10.1007/s00262-004-0645-2; Tang N, 2007, J MUSCLE RES CELL M, V28, P285, DOI 10.1007/s10974-007-9124-7; Tong JR, 2011, J BIOSCIENCES, V36, P659, DOI 10.1007/s12038-011-9101-6; Tsuboi S, 2006, EMBO REP, V7, P506, DOI 10.1038/sj.embor.7400665; Tsuboi S, 2002, J BIOL CHEM, V277, P1919, DOI 10.1074/jbc.M110643200; Vallar L, 1999, J BIOL CHEM, V274, P17257, DOI 10.1074/jbc.274.24.17257; Weljie AM, 2003, PROTEIN SCI, V12, P228, DOI 10.1110/ps.0226203; White C, 2006, J BIOL CHEM, V281, P20825, DOI 10.1074/jbc.M602175200; Whitehouse C, 2002, EUR J BIOCHEM, V269, P538, DOI 10.1046/j.0014-2956.2001.02681.x; Wilkins BJ, 2004, CIRC RES, V94, P110, DOI 10.1161/01.RES.0000109415.17511.18; Wright Megan H, 2010, J Chem Biol, V3, P19, DOI 10.1007/s12154-009-0032-8; Wu XT, 1997, MUTAT RES-DNA REPAIR, V385, P13, DOI 10.1016/S0921-8777(97)00035-9; Yamniuk AP, 2008, BIOCHEMISTRY-US, V47, P1696, DOI 10.1021/bi701494m; Yamniuk AP, 2007, BIOCHEMISTRY-US, V46, P7088, DOI 10.1021/bi700200z; Yamniuk AP, 2006, J BIOL CHEM, V281, P26455, DOI 10.1074/jbc.M603963200; Yamniuk AP, 2009, PROTEIN SCI, V18, P1128, DOI 10.1002/pro.104; Yamniuk AP, 2005, PROTEIN SCI, V14, P1429, DOI 10.1110/ps.041312805; Yamniuk AP, 2004, BIOCHEMISTRY-US, V43, P2558, DOI 10.1021/bi035432b; Yang J, 2009, P NATL ACAD SCI USA, V106, P17729, DOI 10.1073/pnas.0909589106; Yoon KW, 2009, P NATL ACAD SCI USA, V106, P17389, DOI 10.1073/pnas.0812259106; Yoshida K., 2014, ADV BIOL CHEM, V4, P59, DOI DOI 10.4236/ABC.2014.41009; Yuan W, 2006, MOL CELL BIOL, V26, P8507, DOI 10.1128/MCB.01488-06; Yuan WP, 2006, J CELL BIOL, V172, P169, DOI 10.1083/jcb.200505131; Zayed MA, 2007, CIRC RES, V101, P1185, DOI 10.1161/CIRCRESAHA.107.157586; Zayed MA, 2010, VASC CELL, V2, DOI 10.1186/2040-2384-2-17; Zhang J, 2014, J CONTROL RELEASE, V182, P90, DOI 10.1016/j.jconrel.2014.03.016; Zhao B., 2007, THESIS	100	37	39	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2640	2650		10.1096/fj.201500073R	http://dx.doi.org/10.1096/fj.201500073R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27118676	Green Published			2022-12-28	WOS:000380994000002
J	Lupu, DS; Orozco, LD; Wang, Y; Cullen, JM; Pellegrini, M; Zeisel, SH				Lupu, Daniel S.; Orozco, Luz D.; Wang, Ying; Cullen, John M.; Pellegrini, Matteo; Zeisel, Steven H.			Altered methylation of specific DNA loci in the liver of Bhmt-null mice results in repression of Iqgap2 and F2rl2 and is associated with development of preneoplastic foci	FASEB JOURNAL			English	Article						betaine; folate; epigenetics; methylome	HEPATOCELLULAR-CARCINOMA; GST-P; EPIGENETIC ALTERATIONS; S-ADENOSYLMETHIONINE; MASS-SPECTROMETRY; DEFICIENT DIET; IN-VITRO; HOMOCYSTEINE; CANCER; CELLS	Folate B-12-dependent remethylation of homocysteine is important, but less is understood about the importance of the alternative betaine-dependent methylation pathway-catalyzed by betaine-homocysteine methyltransferase (BHMT)-for establishing and maintaining adequate DNA methylation across the genome. We studied C57Bl/6J Bhmt (betaine-homocysteine methyltransferase)-null mice at age 4, 12, 24, and 52 wk (N = 8) and observed elevation of S-adenosylhomocysteine concentrations and development of preneoplastic foci in the liver (increased placental glutathione S-transferase and cytokeratin 8-18 activity; starting at 12 wk). At 4 wk, we identified 63 differentially methylated CpGs (DMCs; false discovery rate < 5%) proximal to 81 genes (across 14 chromosomes), of which 18 were differentially expressed. Of these DMCs, 52% were located in one 15.5-Mb locus on chromosome 13, which encompassed the Bhmt gene and defined a potentially sensitive region with mostly decreased methylation. Analyzing Hybrid Mouse Diversity Panel data, which consisted of 100 inbred strains of mice, we identified 97 DMCs that were affected by Bhmt genetic variation in the same region, with 7 overlapping those found in Bhmt-null mice (P < 0.001). At all time points, we found a hypomethylated region mapping to Iqgap2 (IQ motif-containing GTPase activating protein 2) and F2rl2 (proteinase-activated receptor-3), 2 genes that were also silenced and underexpressed, respectively.-Lupu, D. S., Orozco, L. D., Wang, Y., Cullen, J. M., Pellegrini, M., Zeisel, S. H. Altered methylation of specific DNA loci in the liver of Bhmt-null mice results in repression of Iqgap2 and F2rl2 and is associated with development of preneoplastic foci.	[Lupu, Daniel S.; Zeisel, Steven H.] Univ N Carolina, Inst Nutr Res, Dept Nutr, Kannapolis, NC USA; [Orozco, Luz D.; Pellegrini, Matteo] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Wang, Ying; Cullen, John M.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Shanghai, Peoples R China	University of North Carolina; University of California System; University of California Los Angeles	Zeisel, SH (corresponding author), Univ N Carolina, 500 Laureate Way, Kannapolis, NC 28081 USA.	steven_zeisel@unc.edu	LUPU, DANIEL/A-6004-2011; Cullen, John M/I-2051-2019; LUPU, DANIEL/K-1990-2014	Pellegrini, Matteo/0000-0001-9355-9564; LUPU, DANIEL/0000-0001-8174-5482	University of North Carolina Nutrition Research Institute; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK56350]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056350] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES010126] Funding Source: NIH RePORTER	University of North Carolina Nutrition Research Institute; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was funded by the University of North Carolina Nutrition Research Institute and by a U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK56350. The authors thank Jennifer Owen, for assisting with blinded analysis of GSTP-positive cells in liver, and Scott Jaworski, for help with figure editing (both from University of North Carolina at Chapel Hill).	Avila MA, 2002, ALCOHOL, V27, P163, DOI 10.1016/S0741-8329(02)00228-8; Bennett BJ, 2010, GENOME RES, V20, P281, DOI 10.1101/gr.099234.109; Berman BP, 2012, NAT GENET, V44, P40, DOI 10.1038/ng.969; Briggs MW, 2003, EMBO REP, V4, P571, DOI 10.1038/sj.embor.embor867; Clarke S, 2001, HOMOCYSTEINE IN HEALTH AND DISEASE, P63; Ducros V, 2006, CLIN CHEM LAB MED, V44, P987, DOI 10.1515/CCLM.2006.178; Fernandez AF, 2015, GENOME RES, V25, P27, DOI 10.1101/gr.169011.113; FINKELSTEIN JD, 1984, J BIOL CHEM, V259, P9508; Gnatenko DV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071826; Guo XJ, 2016, CLIN EXP MED, V16, P357, DOI 10.1007/s10238-015-0365-2; Hansen KD, 2011, NAT GENET, V43, P768, DOI 10.1038/ng.865; Ittrich C, 2003, TOXICOL PATHOL, V31, P60, DOI 10.1080/01926230390173888; Jiang SM, 2015, J HEPATOL, V62, P371, DOI 10.1016/j.jhep.2014.09.026; Kakehashi A, 2010, TOXICOL APPL PHARM, V242, P47, DOI 10.1016/j.taap.2009.09.013; Kakehashi A, 2009, TOXICOL APPL PHARM, V238, P71, DOI 10.1016/j.taap.2009.04.018; Khetchoumian K, 2007, NAT GENET, V39, P1500, DOI 10.1038/ng.2007.15; Koc H, 2002, ANAL CHEM, V74, P4734, DOI 10.1021/ac025624x; Kok DEG, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0154-5; Koushik A, 2006, CANCER EPIDEM BIOMAR, V15, P2408, DOI 10.1158/1055-9965.EPI-06-0624; Kushida M, 2011, TOXICOL PATHOL, V39, P776, DOI 10.1177/0192623311409596; Lin NN, 2014, FEBS J, V281, P2088, DOI 10.1111/febs.12764; Ly A, 2012, ANTIOXID REDOX SIGN, V17, P302, DOI 10.1089/ars.2012.4554; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Megger DA, 2013, MOL CELL PROTEOMICS, V12, P2006, DOI 10.1074/mcp.M113.028027; MOLLOY AM, 1990, BIOMED CHROMATOGR, V4, P257, DOI 10.1002/bmc.1130040611; Moore LD, 2013, NEUROPSYCHOPHARMACOL, V38, P23, DOI 10.1038/npp.2012.112; National Research Council, 1995, NUTR REQ LAB AN; Ni M, 2013, GENE DEV, V27, P734, DOI 10.1101/gad.209569.112; Niculescu MD, 2013, FASEB J, V27, P350, DOI 10.1096/fj.12-210724; Nilsson E, 2015, J CLIN ENDOCR METAB, V100, pE1491, DOI 10.1210/jc.2015-3204; Odom DT, 2004, SCIENCE, V303, P1378, DOI 10.1126/science.1089769; Orozco LD, 2015, CELL METAB, V21, P905, DOI 10.1016/j.cmet.2015.04.025; Orozco LD, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-5-r68; Pellanda H, 2012, INT J BIOCHEM CELL B, V44, P385, DOI 10.1016/j.biocel.2011.11.014; Petrossian TC, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000976; Pogribny IP, 2009, MUTAT RES-FUND MOL M, V669, P56, DOI 10.1016/j.mrfmmm.2009.05.003; Pogribny IP, 2008, BRAIN RES, V1237, P25, DOI 10.1016/j.brainres.2008.07.077; Salbaum JM, 2012, PROG MOL BIOL TRANSL, V108, P129, DOI 10.1016/B978-0-12-398397-8.00006-X; Satoh K, 2002, CARCINOGENESIS, V23, P1193, DOI 10.1093/carcin/23.7.1193; Saw SM, 2001, AM J CLIN NUTR, V73, P232; Schmidt VA, 2008, MOL CELL BIOL, V28, P1489, DOI 10.1128/MCB.01090-07; Segal L, 2014, PANCREAS, V43, P103, DOI 10.1097/MPA.0b013e31829f0b81; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Takumi S, 2015, J APPL TOXICOL, V35, P1550, DOI 10.1002/jat.3117; TATEMATSU M, 1987, TOXICOL PATHOL, V15, P60, DOI 10.1177/019262338701500107; Tehlivets O, 2013, BBA-MOL BASIS DIS, V1832, P204, DOI 10.1016/j.bbadis.2012.09.007; Teng YW, 2011, J BIOL CHEM, V286, P36258, DOI 10.1074/jbc.M111.265348; Thoolen B, 2010, TOXICOL PATHOL, V38, p5S, DOI 10.1177/0192623310386499; Tsuda H, 2003, TOXICOL PATHOL, V31, P80, DOI 10.1080/01926230390173879; Vaitheesvaran B, 2014, METABOLOMICS, V10, P920, DOI 10.1007/s11306-014-0639-9; Warner DR, 2003, FEBS LETT, V539, P167, DOI 10.1016/S0014-5793(03)00155-8; Zhang B, 2005, NUCLEIC ACIDS RES, V33, pW741, DOI 10.1093/nar/gki475	53	6	6	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2090	2103		10.1096/fj.201601169R	http://dx.doi.org/10.1096/fj.201601169R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28179424	Green Published, Green Submitted			2022-12-28	WOS:000399195500028
J	Dancs, PT; Ruisanchez, E; Balogh, A; Panta, CR; Miklos, Z; Nusing, RM; Aoki, J; Chun, J; Offermanns, S; Tigyi, G; Benyo, Z				Dancs, Peter Tibor; Ruisanchez, Eva; Balogh, Andrea; Panta, Cecilia Rita; Miklos, Zsuzsanna; Nuesing, Rolf M.; Aoki, Junken; Chun, Jerold; Offermanns, Stefan; Tigyi, Gabor; Benyo, Zoltan			LPA(1) receptor-mediated thromboxane A(2) release is responsible for lysophosphatidic acid-induced vascular smooth muscle contraction	FASEB JOURNAL			English	Article						LPA; vasoconstriction; endothelial dysfunction; platelet activation; TP receptor	SPONTANEOUSLY HYPERTENSIVE-RATS; AORTIC ENDOTHELIAL-CELLS; BLOOD-PRESSURE; CEREBRAL VASOSPASM; CA2+ INFLUX; IN-SITU; MOUSE; ANTAGONIST; ACTIVATION; DISCOVERY	Lysophosphatidic acid (LPA) has been recognized recently as an endothelium-dependent vasodilator, but several lines of evidence indicate that it may also stimulate vascular smooth muscle cells (VSMCs), thereby contributing to vasoregulation and remodeling. In the present study, mRNA expression of all 6 LPA receptor genes was detected in murine aortic VSMCs, with the highest levels of LPA(1), LPA(2), LPA(4), and LPA(6). In endothelium-denuded thoracic aorta (TA) and abdominal aorta (AA) segments, 1-oleoyl-LPA and the LPA(1-3) agonist VPC31143 induced dose-dependent vasoconstriction. VPC31143-induced AA contraction was sensitive to pertussis toxin (PTX), the LPA(1&3) antagonist Ki16425, and genetic deletion of LPA(1) but not that of LPA(2) or inhibition of LPA(3), by diacylglycerol pyrophosphate. Surprisingly, vasoconstriction was also diminished in vessels lacking cyclooxygenase-1 [COX1 knockout (KO)] or the thromboxane prostanoid (TP) receptor (TPKO). VPC31143 increased thromboxane A(2)(TXA(2)) release from TA of wild-type, TP-KO, and LPA(2)-KO mice but not from LPA(1)-KO or COX1-KO mice, and PTX blocked this effect. Our findings indicate that LPA causes vasoconstriction in VSMCs, mediated by LPA(1)-, G(i)-, and COX1-dependent autocrine/paracrine TXA(2) release and consequent TP activation. We propose that this new-found interaction between the LPA/LPA(1) and TXA(2)/TP pathways plays significant roles in vasoregulation, hemostasis, thrombosis, and vascular remodeling.-Dancs, P. T., Ruisanchez, E., Balogh, A., Panta, C. R., Miklos, Z., N " using, R. M., Aoki, J., Chun, J., Offermanns, S., Tigyi, G., Beny ' o, Z. LPA(1) receptor-mediated thromboxane A(2) release is responsible for lysophosphatidic acid-induced vascular smooth muscle contraction.	[Dancs, Peter Tibor; Ruisanchez, Eva; Panta, Cecilia Rita; Miklos, Zsuzsanna; Benyo, Zoltan] Semmelweis Univ, Inst Expt Clin Res, Budapest, Hungary; [Balogh, Andrea; Tigyi, Gabor] Univ Tennessee, Dept Physiol, Hlth Sci Ctr, 894 Union Ave, Memphis, TN 38163 USA; [Nuesing, Rolf M.] Goethe Univ, Inst Clin Pharmacol, Frankfurt, Germany; [Aoki, Junken] Tohoku Univ, Grad Sch Pharmaceut Sci, Sendai, Miyagi, Japan; [Chun, Jerold] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA; [Offermanns, Stefan] Max Planck Inst Heart & Lung Res, Bad Nauheim, Germany	Semmelweis University; University of Tennessee System; University of Tennessee Health Science Center; Goethe University Frankfurt; Tohoku University; Sanford Burnham Prebys Medical Discovery Institute; Max Planck Society	Tigyi, G (corresponding author), Univ Tennessee, Dept Physiol, Hlth Sci Ctr, 894 Union Ave, Memphis, TN 38163 USA.; Benyo, Z (corresponding author), Semmelweis Univ, Inst Human Physiol & Clin Expt Res, POB 2, H-1428 Budapest, Hungary.	gtigyi@uthsc.edu; benyo.zoltan@med.semmelweis-univ.hu	Chun, Jerold/Y-4670-2019; MiklÃs, Zsuzsanna/AAZ-2597-2021; Offermanns, Stefan/L-3313-2017	MiklÃs, Zsuzsanna/0000-0001-8577-4475; Panta, Cecilia Rita/0000-0003-4162-0882; Offermanns, Stefan/0000-0001-8676-6805	Hungarian Scientific Research Fund [K-101775, K-112964]; Fulbright Specialist Program [6458]; U.S. National Institutes of Health (NIH) National Cancer Institute [CA092160]; NIH National Institute of Neurological Disorders and Stroke [NS084398]; NATIONAL CANCER INSTITUTE [R01CA092160] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI107331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS084398] Funding Source: NIH RePORTER	Hungarian Scientific Research Fund(Orszagos Tudomanyos Kutatasi Alapprogramok (OTKA)); Fulbright Specialist Program; U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the Hungarian Scientific Research Fund (K-101775 and K-112964; to Z.B.), the Fulbright Specialist Program (Project ID 6458; to G.T.), the U.S. National Institutes of Health (NIH) National Cancer Institute (Grant CA092160; to G.T.), and the NIH National Institute of Neurological Disorders and Stroke (Grant NS084398; to J.C.). The authors thank Margit Kerek, Laszlo Hricisak, Ildiko Muranyi, and Agnes Fulop (Institute of Clinical Experimental Research, Semmelweis University, Budapest, Hungary) for expert technical assistance and for managing the transgenic mouse colonies and Andras Kucsa (Semmelweis University) for graphic artwork of Figure 7.	Blaho VA, 2011, CHEM REV, V111, P6299, DOI 10.1021/cr200273u; Bot M, 2010, AM J PATHOL, V176, P3073, DOI 10.2353/ajpath.2010.090009; CHAN RC, 1984, J NEUROSURG, V61, P1120, DOI 10.3171/jns.1984.61.6.1120; Chrencik JE, 2015, CELL, V161, P1633, DOI 10.1016/j.cell.2015.06.002; Contos JJA, 2000, P NATL ACAD SCI USA, V97, P13384, DOI 10.1073/pnas.97.24.13384; Contos JJA, 2002, MOL CELL BIOL, V22, P6921, DOI 10.1128/MCB.22.19.6921-6929.2002; Fischer DJ, 2001, MOL PHARMACOL, V60, P776; Hecht JH, 1996, J CELL BIOL, V135, P1071, DOI 10.1083/jcb.135.4.1071; Heise CE, 2001, MOL PHARMACOL, V60, P1173, DOI 10.1124/mol.60.6.1173; Horvath B, 2005, J CARDIOVASC PHARM, V45, P225, DOI 10.1097/01.fjc.0000154377.90069.b9; Kihara Y, 2015, EXP CELL RES, V333, P171, DOI 10.1016/j.yexcr.2014.11.020; Kingsbury MA, 2003, NAT NEUROSCI, V6, P1292, DOI 10.1038/nn1157; LaBelle EF, 1998, AM J PHYSIOL-CELL PH, V274, pC1129, DOI 10.1152/ajpcell.1998.274.4.C1129; Li H, 2009, MOL CANCER THER, V8, P1692, DOI 10.1158/1535-7163.MCT-08-1106; Mallem Y, 2005, AUTON NEUROSCI-BASIC, V118, P61, DOI 10.1016/j.autneu.2005.01.003; McIntyre TM, 2003, P NATL ACAD SCI USA, V100, P131, DOI 10.1073/pnas.0135855100; MONG S, 1986, J PHARMACOL EXP THER, V239, P63; Moolenaar WH, 2011, NAT REV MOL CELL BIO, V12, P674, DOI 10.1038/nrm3188; NEBIGIL C, 1993, J PHARMACOL EXP THER, V266, P1113; Niioka T, 2013, J CARDIOVASC PHARM, V62, P530, DOI 10.1097/FJC.0000000000000013; Ohata H, 2001, CIRC RES, V88, P925, DOI 10.1161/hh0901.090300; OHATA H, 1995, BIOCHEM BIOPH RES CO, V208, P19, DOI 10.1006/bbrc.1995.1299; Ohata H, 1996, LIFE SCI, V58, P2217, DOI 10.1016/0024-3205(96)00216-0; Ohata H, 2011, EXP PHYSIOL, V96, P468, DOI 10.1113/expphysiol.2011.056416; Ohta H, 2003, MOL PHARMACOL, V64, P994, DOI 10.1124/mol.64.4.994; Panchatcharam M, 2008, CIRC RES, V103, P662, DOI 10.1161/CIRCRESAHA.108.180778; Petitcolin MA, 2001, BIOCHEM PHARMACOL, V61, P485, DOI 10.1016/S0006-2952(00)00547-5; Ruisanchez E, 2014, FASEB J, V28, P880, DOI 10.1096/fj.13-234997; SASAKI T, 1982, J NEUROSURG, V57, P74, DOI 10.3171/jns.1982.57.1.0074; Schober A, 2012, BRIT J PHARMACOL, V167, P465, DOI 10.1111/j.1476-5381.2012.02021.x; SCHUMACHER KA, 1979, THROMB HAEMOSTASIS, V42, P631; Sellers MM, 2008, AM J PHYSIOL-HEART C, V294, pH1978, DOI 10.1152/ajpheart.01318.2007; SEN S, 1968, AM J PHYSIOL, V214, P337, DOI 10.1152/ajplegacy.1968.214.2.337; Sheng XY, 2015, DEVELOPMENT, V142, P1390, DOI 10.1242/dev.121723; Shibata K, 2011, J CARDIOVASC PHARM, V57, P604, DOI 10.1097/FJC.0b013e3182144174; Siess W, 1999, P NATL ACAD SCI USA, V96, P6931, DOI 10.1073/pnas.96.12.6931; Smyth SS, 2014, ARTERIOSCL THROM VAS, V34, P479, DOI 10.1161/ATVBAHA.113.302737; Tamaruya Y, 2004, ANGEW CHEM INT EDIT, V43, P2834, DOI 10.1002/anie.200454065; TIGYI G, 1995, AM J PHYSIOL-HEART C, V268, pH2048, DOI 10.1152/ajpheart.1995.268.5.H2048; Tigyi G, 2010, BRIT J PHARMACOL, V161, P241, DOI 10.1111/j.1476-5381.2010.00815.x; TOKUMURA A, 1991, J PHARM PHARMACOL, V43, P774, DOI 10.1111/j.2042-7158.1991.tb03480.x; Tokumura A, 2002, J BIOL CHEM, V277, P39436, DOI 10.1074/jbc.M205623200; TOKUMURA A, 1995, RES COMMUN MOL PATH, V90, P96; TOKUMURA A, 1978, LIPIDS, V13, P572, DOI 10.1007/BF02533598; TOKUMURA A, 1982, J PHARM PHARMACOL, V34, P514, DOI 10.1111/j.2042-7158.1982.tb04776.x; van Meijeren CE, 2004, EUR J PHARMACOL, V488, P127, DOI 10.1016/j.ejphar.2004.02.003; Yakubu M. A., 1997, AM J PHYS COMP INTEG, V42, pR703; Yanagida K, 2013, BBA-MOL CELL BIOL L, V1831, P33, DOI 10.1016/j.bbalip.2012.08.003; Yang AH, 2002, BBA-MOL CELL BIOL L, V1582, P197, DOI 10.1016/S1388-1981(02)00172-5; Ye XQ, 2005, NATURE, V435, P104, DOI 10.1038/nature03505; Yung YC, 2015, NEURON, V85, P669, DOI 10.1016/j.neuron.2015.01.009; Yung YC, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002095; Zhang CX, 2004, J EXP MED, V199, P763, DOI 10.1084/jem.20031619	53	15	15	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1547	1555		10.1096/fj.201600735R	http://dx.doi.org/10.1096/fj.201600735R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28069828	Green Published			2022-12-28	WOS:000398504300022
J	Lesage, J; Suarez-Carmona, M; Neyrinck-Leglantier, D; Grelet, S; Blacher, S; Hunziker, W; Birembaut, P; Noel, A; Nawrocki-Raby, B; Gilles, C; Polette, M				Lesage, Julien; Suarez-Carmona, Meggy; Neyrinck-Leglantier, Deborah; Grelet, Simon; Blacher, Silvia; Hunziker, Walter; Birembaut, Philippe; Noel, Agnes; Nawrocki-Raby, Beatrice; Gilles, Christine; Polette, Myriam			Zonula occludens-1/NF-kappa B/CXCL8: a new regulatory axis for tumor angiogenesis	FASEB JOURNAL			English	Article						EMT; tumor progression; ZO-1; IL-8	EPITHELIAL-MESENCHYMAL TRANSITION; MATRIX-METALLOPROTEINASE EXPRESSION; NF-KAPPA-B; LUNG-CANCER; VIMENTIN EXPRESSION; TIGHT JUNCTIONS; BETA-CATENIN; CELL-LINE; IN-VIVO; INTERLEUKIN-8	Zonula occludens-1 (ZO-1) is a submembrane scaffolding protein thatmay display proinvasive functions when it relocates from tight junctions into the cytonuclear compartment. This article examines the functional involvement of ZO-1 in CXCL8/ IL-8 chemokine expression in lung and breast tumor cells. ZO-1 small interfering RNA and cDNA transfection experiments emphasized regulation of CXCL8/ IL-8 expression via a cytonuclear pool of ZO-1. Luciferase reporter assays highlighted a 173-bp region of CXCL8/ IL-8 promoter that responded to ZO-1. Moreover, by using mutated promoter constructs, we identified a NF-kappa B site as critical in this activation. Furthermore, NF-kappa Bpathwaysignaling analysis revealedboth IkBaandp65phosphorylationinZO-1-overexpressingcells, and subsequent p65 silencing validated its requirement for CXCL8/ IL-8 induction. Investigation of the functional implication of this regulatory axis next showed the proangiogenic activity of ZO-1 in both ex vivo and in vivo angiogenesis assays. Finally, we found that non-small-cell lung carcinoma that presented a cytonuclear ZO-1 pattern was significantly more angiogenic that that without detectable cytonuclear ZO-1 expression. Taken together, our results demonstrate that ZO-1 regulatesCXCL8/IL-8 expression via theNF-kappa B signaling pathway and its p65 subunit, which subsequently modulates the transcription of IL-8. We also provide evidence of a newly identified regulatory pathway that could promote angiogenesis. Thus, our results support the concept that the ZO-1 shuttle from the cell junction to the cytonuclear compartment may affect both the intrinsic invasive properties of tumor cells and the establishment of the protumoral microenvironment.-Lesage, J., Suarez-Carmona, M., Neyrinck-Leglantier, D., Grelet, S., Blacher, S., Hunziker, W., Birembaut, P., No " el, A., Nawrocki-Raby, B., Gilles, C., Polette, M. Zonula occludens-1/ NF-kappa B/ CXCL8: a new regulatory axis for tumor angiogenesis. FASEB J. 31, 1678-1688 (2017). www.fasebj.org	[Lesage, Julien; Neyrinck-Leglantier, Deborah; Birembaut, Philippe; Nawrocki-Raby, Beatrice; Polette, Myriam] Univ Reims, Struct Federat Rech Champagne Ardennes Picardie S, INSERM, UMR S 903, Reims, France; [Suarez-Carmona, Meggy; Blacher, Silvia; Noel, Agnes; Gilles, Christine] Univ Liege, Lab Tumor & Dev Biol, Grappe Interdisciplinaire Genoproteom Appl GIGA C, Liege, Belgium; [Grelet, Simon] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC USA; [Hunziker, Walter] Inst Mol & Cell Biol, Epithelial Cell Biol Lab, Singapore, Singapore; [Birembaut, Philippe; Polette, Myriam] Ctr Hosp Univ, Lab Biopathol, Reims, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Reims Champagne-Ardenne; University of Liege; Medical University of South Carolina; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Molecular & Cell Biology (IMCB); CHU de Reims; Universite de Reims Champagne-Ardenne	Polette, M (corresponding author), INSERM, UMR S 903, 45 Rue Cognacq Jay, F-51100 Reims, France.	myriam.polette@univ-reims.fr	Raby, Beatrice/P-5666-2016; Hunziker, Walter/B-3140-2010; Hunziker, Walter/GSM-8190-2022	Raby, Beatrice/0000-0002-3163-8619; Hunziker, Walter/0000-0002-5265-4933; Noel, Agnes/0000-0002-7670-6179; Deborah, Neyrinck-Leglantier/0000-0001-9139-8680	Region Champagne-Ardenne, La Ligue Contre le Cancer; Lions Club of Soissons; Villers-Cotterets, Chateau-Thierry and Crepy en Valois, Fond National Pour la Sante ACI INCa (Canceropole Grand-Est Project); Fonds National de la Recherche Scientifique (FRS-FNRS); Partenariat Hubert Curien-Tournesol	Region Champagne-Ardenne, La Ligue Contre le Cancer; Lions Club of Soissons; Villers-Cotterets, Chateau-Thierry and Crepy en Valois, Fond National Pour la Sante ACI INCa (Canceropole Grand-Est Project); Fonds National de la Recherche Scientifique (FRS-FNRS)(Fonds de la Recherche Scientifique - FNRS); Partenariat Hubert Curien-Tournesol	This work was supported by Region Champagne-Ardenne, La Ligue Contre le Cancer (Comites de la Marne, HauteMarne, Meurthe-et-Moselle et Yonne), Lions Club of Soissons, Villers-Cotterets, Chateau-Thierry and Crepy en Valois, Fond National Pour la Sante ACI 2004-2010 INCa (Canceropole Grand-Est Project), Fonds National de la Recherche Scientifique (FRS-FNRS), and Partenariat Hubert Curien-Tournesol. The authors thank Marie Dehuy, Erika Konradowski, and Isabelle Dasoul (Laboratory of Tumor and Development Biology, University of Liege) for technical assistance. The authors also thank Christine Terryn (Plateforme en Imagerie Cellulaire et Tissulaire, University of Reims Champagne-Ardenne).	Arenberg DA, 1996, J CLIN INVEST, V97, P2792, DOI 10.1172/JCI118734; Balda MS, 2008, J CELL SCI, V121, P3677, DOI 10.1242/jcs.023887; Berndt S, 2009, J CLIN ENDOCR METAB, V94, P4567, DOI 10.1210/jc.2009-0443; Bonnomet A, 2012, ONCOGENE, V31, P3741, DOI 10.1038/onc.2011.540; Brabletz T, 2005, CELLS TISSUES ORGANS, V179, P56, DOI 10.1159/000084509; Brysse A, 2012, MOL CANCER RES, V10, P121, DOI 10.1158/1541-7786.MCR-11-0180; Chavey C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1648; De Larco JE, 2001, AM J PATHOL, V158, P639, DOI 10.1016/S0002-9440(10)64005-9; Detry B, 2013, INVEST OPHTH VIS SCI, V54, P3082, DOI 10.1167/iovs.12-10856; Eck M, 2003, CLIN EXP IMMUNOL, V134, P508, DOI 10.1111/j.1365-2249.2003.02305.x; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Gilles C, 1996, J PATHOL, V180, P175, DOI 10.1002/(SICI)1096-9896(199610)180:2<175::AID-PATH630>3.0.CO;2-G; Gilles C, 2003, CANCER RES, V63, P2658; Gonzalez-Mariscal L, 2007, PROG HISTOCHEM CYTO, V42, P1, DOI 10.1016/j.proghi.2007.01.001; Gottardi CJ, 1996, P NATL ACAD SCI USA, V93, P10779, DOI 10.1073/pnas.93.20.10779; Heidemann J, 2003, J BIOL CHEM, V278, P8508, DOI 10.1074/jbc.M208231200; Kalluri R, 2009, J CLIN INVEST, V119, P1417, DOI 10.1172/JCI39675; Lenoir B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092715; Levy L, 2002, J BIOL CHEM, V277, P42386, DOI 10.1074/jbc.M207418200; Luczka E, 2013, CLIN EXP METASTAS, V30, P833, DOI 10.1007/s10585-013-9583-8; Maekawa K, 1999, BIOCHEM J, V337, P179, DOI 10.1042/0264-6021:3370179; Martin TA, 2009, BBA-BIOMEMBRANES, V1788, P872, DOI 10.1016/j.bbamem.2008.11.005; Murayama T, 1997, J VIROL, V71, P5692, DOI 10.1128/JVI.71.7.5692-5695.1997; Nawrocki-Raby B, 2003, AM J PATHOL, V163, P653, DOI 10.1016/S0002-9440(10)63692-9; Ning Y, 2011, INT J CANCER, V128, P2038, DOI 10.1002/ijc.25562; Nozawa H, 2006, P NATL ACAD SCI USA, V103, P12493, DOI 10.1073/pnas.0601807103; OKAMOTO SI, 1994, J BIOL CHEM, V269, P8582; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Polette M, 2005, CANCER RES, V65, P7691, DOI 10.1158/0008-5472.CAN-04-4230; Polette M, 2007, CELLS TISSUES ORGANS, V185, P61, DOI 10.1159/000101304; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Pulyaeva H, 1997, CLIN EXP METASTAS, V15, P111, DOI 10.1023/A:1018444609098; Reichert M, 2000, J BIOL CHEM, V275, P9492, DOI 10.1074/jbc.275.13.9492; Reka AK, 2014, CARCINOGENESIS, V35, P1292, DOI 10.1093/carcin/bgu041; Resnick MB, 2005, HUM PATHOL, V36, P886, DOI 10.1016/j.humpath.2005.05.019; Singh S, 2010, FUTURE ONCOL, V6, P111, DOI 10.2217/FON.09.128; Smalley KSM, 2005, AM J PATHOL, V166, P1541, DOI 10.1016/S0002-9440(10)62370-X; SMITH DR, 1994, J EXP MED, V179, P1409, DOI 10.1084/jem.179.5.1409; SOMMERS CL, 1992, CANCER RES, V52, P5190; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; STEVENSON BR, 1986, J CELL BIOL, V103, P755, DOI 10.1083/jcb.103.3.755; STRIETER RM, 1995, J BIOL CHEM, V270, P27348, DOI 10.1074/jbc.270.45.27348; Suarez-Carmona M, 2015, J PATHOL, V236, P491, DOI 10.1002/path.4546; Sunaga N, 2012, INT J CANCER, V130, P1733, DOI 10.1002/ijc.26164; Tazzyman S, 2009, INT J EXP PATHOL, V90, P222, DOI 10.1111/j.1365-2613.2009.00641.x; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; van Roy F, 2008, CELL MOL LIFE SCI, V65, P3756, DOI 10.1007/s00018-008-8281-1; Vicari AP, 2002, CYTOKINE GROWTH F R, V13, P143, DOI 10.1016/S1359-6101(01)00033-8; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wilson J, 2002, SEMIN CANCER BIOL, V12, P113, DOI 10.1006/scbi.2001.0419; Wu S, 2012, CANCER MED-US, V1, P306, DOI 10.1002/cam4.28; Wu SH, 2013, MOL CELL BIOCHEM, V375, P69, DOI 10.1007/s11010-012-1529-y; Youmba SB, 2012, J PEDIATR GASTR NUTR, V54, P463, DOI 10.1097/MPG.0b013e318247240d	54	23	24	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1678	1688		10.1096/fj.201600890R	http://dx.doi.org/10.1096/fj.201600890R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28057697				2022-12-28	WOS:000398504300032
J	Liu, Q; Chen, YW; Shen, C; Xiao, YT; Wang, YT; Liu, ZG; Liu, XB				Liu, Qian; Chen, Yuwei; Shen, Chun; Xiao, Yating; Wang, Yutang; Liu, Zhigang; Liu, Xuebo			Chicoric acid supplementation prevents systemic inflammation- induced memory impairment and amyloidogenesis via inhibition of NF-kappa B	FASEB JOURNAL			English	Article						amyloid peptides accumulation; lipopolysaccharide; natural phenolic acid; neuroinflammation; NF-kappa B transcriptional pathway	ALZHEIMERS-DISEASE; AMYLOID-BETA; COGNITIVE IMPAIRMENT; TRANSGENIC MOUSE; NEUROINFLAMMATION; CELLS; RESPONSES; PATHWAY; INACTIVATION; HIPPOCAMPUS	Chicoric acid (CA), a natural phenolic acid extracted from chicory and the echinacea (purple coneflower) plant (Echinacea purpurea), has been regarded as a nutraceutical that has powerful antioxidant and antiobesity activities. We investigated the inhibitory effects of CA on systemic inflammation-induced neuroinflammation, amyloidogenesis, and cognitive impairment. C57BL/6J mice were treated with 0.05% CA in the drinking water for 45 d. The mice were then treated by intraperitoneal injection of lipopolysaccharide (LPS). It was found that CA prevented LPS-induced memory impairment and neuronal loss through behavioral tests and histological examination. Furthermore, amyloidogenesis in the CNS was detected. The results showed that CA prevented LPS-induced increases in amyloid beta (1-42 specific) (A beta(1-42)) accumulation, levels of amyloid precursor protein, and neuronal beta-secretase 1 (BACE1), aswell as the equilibrium cholinergic system in mouse brain. Moreover, CA down regulated LPS-induced glial overactivation by inhibiting the MAPK and NF-kappa B pathway. Consequently, CA reduced the levels of NF-kappa B transcriptionally regulated inflammatory mediators and cytokines such as iNOS, cyclooxygenase-2 (COX-2), IL-1 beta, and TNF-alpha in both mouse brain and BV2 microglial cells. These results demonstrated that CA alleviated memory impairment and amyloidogenesis triggered by LPS through suppressing NF-kB transcriptional pathway, suggesting that CA might be a plausible therapeutic intervention for neuroinflammationrelated diseases such as Alzheimer disease.-Liu, Q., Chen, Y., Shen, C., Xiao, Y., Wang, Y., Liu, Z., Liu, X. Chicoric acid supplementation prevents systemic inflammation-induced memory impairment and amyloidogenesis via inhibition of NF-kB. FASEB J. 31, 1494-1507 (2017). www.fasebj.org	[Liu, Qian; Chen, Yuwei; Shen, Chun; Xiao, Yating; Wang, Yutang; Liu, Zhigang; Liu, Xuebo] Northwest A&F Univ, Coll Food Sci & Engn, Lab Funct Chem & Nutr Food, Yangling, Peoples R China	Northwest A&F University - China	Liu, ZG; Liu, XB (corresponding author), Northwest A&F Univ, Coll Food Sci & Engn, Xinong Rd 22, Yangling 712100, Peoples R China.	zhigangliu@nwsuaf.edu.cn; xueboliu@aliyun.com	Liu, Zhigang/H-4818-2016	Liu, Zhigang/0000-0002-6863-6561; Chen, Yuwei/0000-0001-5329-2180	National Key Research and Development Program of China [2016YFD0400601]; National Natural Science Foundation of China [31671859]; Scientific Startup Funds for Doctors of Northwest Agriculture and Forestry University [Z109021611]	National Key Research and Development Program of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Scientific Startup Funds for Doctors of Northwest Agriculture and Forestry University	The authors thank the National Key Research and Development Program of China (Grant 2016YFD0400601), the National Natural Science Foundation of China (Grant 31671859), and Scientific Startup Funds for Doctors of Northwest Agriculture and Forestry University (Grant Z109021611).	Baker-Nigh A, 2015, BRAIN, V138, P1722, DOI 10.1093/brain/awv024; Chen CH, 2012, INT J NEUROPSYCHOPH, V15, P77, DOI 10.1017/S1461145711000149; Da Mesquita S, 2016, NEUROSCI BIOBEHAV R, V68, P547, DOI 10.1016/j.neubiorev.2016.06.014; Dupret D, 2007, PLOS BIOL, V5, P1683, DOI 10.1371/journal.pbio.0050214; Fernandez-Perez EJ, 2016, CURR PHARM DESIGN, V22, P1295, DOI 10.2174/138161282210160304111702; Foley AM, 2015, J ALZHEIMERS DIS, V44, P787, DOI 10.3233/JAD-142208; Gu SM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0344-2; He XL, 2016, PHARMACOL REP, V68, P975, DOI 10.1016/j.pharep.2016.05.006; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hernandez-Guillamon M, 2015, J BIOL CHEM, V290, P15078, DOI 10.1074/jbc.M114.610931; Hooten KG, 2015, NEUROTHERAPEUTICS, V12, P364, DOI 10.1007/s13311-014-0329-3; Jiang YM, 2008, MOL IMMUNOL, V45, P1557, DOI 10.1016/j.molimm.2007.10.008; Kour K, 2011, PHARMACOL BIOCHEM BE, V99, P342, DOI 10.1016/j.pbb.2011.05.008; Lee JW, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-37; Lee JW, 2012, KOREAN J PHYSIOL PHA, V16, P107, DOI 10.4196/kjpp.2012.16.2.107; Lee M, 2015, NEUROBIOL AGING, V36, P42, DOI 10.1016/j.neurobiolaging.2014.07.024; Liu Q, 2015, FOOD FUNCT, V6, P1928, DOI 10.1039/c5fo00073d; Lloret A, 2015, FREE RADICAL BIO MED, V83, P186, DOI 10.1016/j.freeradbiomed.2015.02.028; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; Minter MR, 2016, J NEUROCHEM, V136, P457, DOI 10.1111/jnc.13411; Catorce MN, 2016, CURR NEUROPHARMACOL, V14, P155, DOI 10.2174/1570159X14666151204122017; Okun E, 2011, TRENDS NEUROSCI, V34, P269, DOI 10.1016/j.tins.2011.02.005; Park CM, 2011, EUR J PHARMACOL, V660, P454, DOI 10.1016/j.ejphar.2011.04.007; Petrov D, 2016, MOL NEUROBIOL, V53, P6183, DOI 10.1007/s12035-015-9522-6; PLOTKIN DA, 1986, PROG BRAIN RES, V65, P91, DOI 10.1016/S0079-6123(08)60644-5; Ruxton K, 2015, BRIT J CLIN PHARMACO, V80, P209, DOI 10.1111/bcp.12617; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shi ZM, 2016, J NEUROL SCI, V366, P127, DOI 10.1016/j.jns.2016.05.022; Silverman HA, 2014, MOL MED, V20, P601, DOI 10.2119/molmed.2014.00147; Siwak-Tapp CT, 2007, NEUROBIOL LEARN MEM, V88, P249, DOI 10.1016/j.nlm.2007.05.001; Soreq H, 2015, TRENDS NEUROSCI, V38, P448, DOI 10.1016/j.tins.2015.05.007; Spagnuolo C, 2016, CURR TOP MED CHEM, V16, P1943, DOI 10.2174/1568026616666160204122449; Szwajgier D, 2013, Z NATURFORSCH C, V68, P125, DOI 10.5560/ZNC.2013.68c0125; Tata AM, 2014, CNS NEUROL DISORD-DR, V13, P1294, DOI 10.2174/1871527313666140917121132; Terrando N, 2010, P NATL ACAD SCI USA, V107, P20518, DOI 10.1073/pnas.1014557107; Triaca V, 2016, AGING CELL, V15, P661, DOI 10.1111/acel.12473; Villegas-Llerena C, 2016, CURR OPIN NEUROBIOL, V36, P74, DOI 10.1016/j.conb.2015.10.004; Wang YT, 2016, J CHROMATOGR B, V1031, P139, DOI 10.1016/j.jchromb.2016.07.045; Wu WQ, 2015, MOL NUTR FOOD RES, V59, P1663, DOI 10.1002/mnfr.201500109; Xiao HF, 2013, FOOD RES INT, V54, P345, DOI 10.1016/j.foodres.2013.07.033; Xiao HF, 2013, J AGR FOOD CHEM, V61, P1509, DOI 10.1021/jf3050268; Zhu D, 2015, J AGR FOOD CHEM, V63, P10903, DOI 10.1021/acs.jafc.5b04533	42	81	85	4	49	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1494	1507		10.1096/fj.201601071R	http://dx.doi.org/10.1096/fj.201601071R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28003341				2022-12-28	WOS:000398504300018
J	Papacleovoulou, G; Nikolova, V; Oduwole, O; Chambers, J; Vazquez-Lopez, M; Jansen, E; Nicolaides, K; Parker, M; Williamson, C				Papacleovoulou, Georgia; Nikolova, Vanya; Oduwole, Olayiwola; Chambers, Jenny; Vazquez-Lopez, Marta; Jansen, Eugene; Nicolaides, Kypros; Parker, Malcolm; Williamson, Catherine			Gestational disruptions in metabolic rhythmicity of the liver, muscle, and placenta affect fetal size	FASEB JOURNAL			English	Article						circadian clock; metabolism; pregnancy; macrosomia; triglycerides	REV-ERB-ALPHA; LIPID-METABOLISM; CIRCADIAN CLOCK; SKELETAL-MUSCLE; CARBOHYDRATE-METABOLISM; LIPOPROTEIN-LIPASE; GLUCOSE-METABOLISM; NORMAL-PREGNANCY; GENE-EXPRESSION; SHIFT WORK	Maternal metabolic adaptations are essential for successful pregnancy outcomes. We investigated how metabolic gestational processes are coordinated, whether there is a functional linkwithinternal clocks, andwhether disruptions are related to metabolic abnormalities in pregnancy, by studying day/night metabolic pathways in murine models and samples from pregnant women with normally grown and large-for-gestational age infants. In early mouse pregnancy, expression of hepatic lipogenic genes was up-regulated and uncoupled from the hepatic clock. In latemouse pregnancy, rhythmicity of energymetabolism-relatedgenes inthemuscle followed the patterns of internal clock genes in this tissue, and coincided with enhanced lipid transporter expression in the fetoplacental unit. Diurnal triglyceride patterns were disrupted in human placentas from pregnancies with large-for-gestational age infants and this overlapped with an increase in BMAL1 expression. Metabolic adaptations in early pregnancy are uncoupled fromthe circadian clock, whereas in late pregnancy, energy availability is mediated by coordinated muscle-placenta metabolic adjustments linked to internal clocks. Placental triglyceride oscillations in the third trimester of human pregnancy are lost in large-for-gestational age infants and may be regulated by BMAL1. In summary, disruptions in metabolic and circadian rhythmicity are associated with increased fetal size, with implications for the pathogenesis of macrosomia.-Papacleovoulou, G., Nikolova, V., Oduwole, O., Chambers, J., Vazquez-Lopez, M., Jansen, E., Nicolaides, K., Parker, M., Williamson, C. Gestational disruptions in metabolic rhythmicity of the liver, muscle, and placenta affect fetal size. FASEB J. 31, 1698-1708 (2017). www.fasebj.org	[Papacleovoulou, Georgia; Nikolova, Vanya; Williamson, Catherine] Kings Coll London, Div Womens Hlth, Guys Campus, London, England; [Nicolaides, Kypros] Kings Coll London, Harris Birthright Ctr Fetal Med, London, England; [Oduwole, Olayiwola; Parker, Malcolm; Williamson, Catherine] Imperial Coll London, Inst Reprod & Dev Biol, London, England; [Chambers, Jenny; Vazquez-Lopez, Marta] Imperial Coll London, Fac Med, Hammersmith Hosp, Womens Hlth Res Ctr,Surg & Canc, London, England; [Jansen, Eugene] Natl Inst Publ Hlth & Environm, Ctr Hlth Protect, Bilthoven, Netherlands	University of London; King's College London; University of London; King's College London; Imperial College London; Imperial College London; Netherlands National Institute for Public Health & the Environment	Williamson, C (corresponding author), Maternal & Fetal Dis Grp, Hodgkin Bldg,Guys Campus, London SE1 1UL, England.	catherine.williamson@kcl.ac.uk		Nicolaides, Kypros/0000-0003-1266-0711; Oduwole, Olayiwola/0000-0003-3840-7335; Williamson, Catherine/0000-0002-6226-7611	Wellcome Trust; National Institute for Health Research (NIHR) Clinical Research Facilities and Biomedical Research Centers based at Imperial College; Guy's and St. Thomas' National Health Service (NHS) Foundation Trust	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (NIHR) Clinical Research Facilities and Biomedical Research Centers based at Imperial College; Guy's and St. Thomas' National Health Service (NHS) Foundation Trust	This project was supported by the Wellcome Trust, and by the National Institute for Health Research (NIHR) Clinical Research Facilities and Biomedical Research Centers based at Imperial College, and Guy's and St. Thomas' National Health Service (NHS) Foundation Trust. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health. The elective cesarean placentas were obtained from the Baby Bio Bank (Project Code 524578.100.15682; University College London), under the Material Transfer Agreement (Reference TTA0715). The authors declare no conflicts of interest.	Alvarez JJ, 1996, J LIPID RES, V37, P299; Angueira AR, 2015, DIABETES, V64, P327, DOI 10.2337/db14-0877; Baron KG, 2011, OBESITY, V19, P1374, DOI 10.1038/oby.2011.100; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Belo L, 2004, ATHEROSCLEROSIS, V177, P391, DOI 10.1016/j.atherosclerosis.2004.07.023; Bisanti L, 1996, J OCCUP ENVIRON MED, V38, P352, DOI 10.1097/00043764-199604000-00012; Brett KE, 2014, INT J MOL SCI, V15, P16153, DOI 10.3390/ijms150916153; Bugge A, 2012, GENE DEV, V26, P657, DOI 10.1101/gad.186858.112; Casey TM, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.116137; CATALANO PM, 1993, AM J PHYSIOL, V264, pE60, DOI 10.1152/ajpendo.1993.264.1.E60; Cetin I, 2005, ACTA PAEDIATR, V94, P7, DOI 10.1080/08035320510043709; Cetin I, 2002, PEDIATR RES, V52, P750, DOI 10.1203/00006450-200211000-00023; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; COUSINS L, 1980, AM J OBSTET GYNECOL, V136, P483, DOI 10.1016/0002-9378(80)90675-4; Di Cianni G, 2005, DIABETIC MED, V22, P21, DOI 10.1111/j.1464-5491.2004.01336.x; Esquirol Y, 2009, CHRONOBIOL INT, V26, P544, DOI 10.1080/07420520902821176; Frise CJ, 2013, EUR J OBSTET GYN R B, V167, P1, DOI 10.1016/j.ejogrb.2012.10.005; Gauster M, 2007, J CLIN ENDOCR METAB, V92, P2256, DOI 10.1210/jc.2006-2403; Herrera E, 2006, HORM RES, V65, P59, DOI 10.1159/000091507; HERRERA E, 1988, AM J OBSTET GYNECOL, V158, P1575, DOI 10.1016/0002-9378(88)90193-7; Herrera E, 2006, INT J VITAM NUTR RES, V76, P216, DOI 10.1024/0300-9831.76.4.216; Herrera E, 2014, CURR PHARM BIOTECHNO, V15, P24, DOI 10.2174/1389201015666140330192345; Hodge BA, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-015-0039-5; Kamana KC, 2015, ANN NUTR METAB, V66, P14, DOI 10.1159/000371628; Knutsson A, 2003, OCCUP MED-OXFORD, V53, P103, DOI 10.1093/occmed/kqg048; LANZAJACOBY S, 1986, J NUTR, V116, P1798, DOI 10.1093/jn/116.9.1798; Le Martelot G, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000181; LIN DS, 1977, AM J OBSTET GYNECOL, V128, P735, DOI 10.1016/0002-9378(77)90713-X; Linder N, 2014, ARCH DIS CHILD-FETAL, V99, pF353, DOI 10.1136/archdischild-2013-305032; Liu SH, 2013, NATURE, V502, P550, DOI 10.1038/nature12710; Milona A, 2010, HEPATOLOGY, V52, P1341, DOI 10.1002/hep.23849; Musial B, 2016, DIABETES, V65, P851, DOI 10.2337/db15-1531; Nakamura TJ, 2010, STEROIDS, V75, P203, DOI 10.1016/j.steroids.2010.01.007; Papacleovoulou G, 2013, J CLIN INVEST, V123, P3172, DOI 10.1172/JCI68927; Papacleovoulou G, 2011, BBA-MOL BASIS DIS, V1812, P879, DOI 10.1016/j.bbadis.2010.11.001; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Perez S, 2015, SYST BIOL REPROD MED, V61, P360, DOI 10.3109/19396368.2015.1069420; PHELPS RL, 1981, AM J OBSTET GYNECOL, V140, P730, DOI 10.1016/0002-9378(81)90731-6; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248; Shimba S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025231; Smith JL, 1998, J LIPID RES, V39, P2237; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Sones JL, 2016, PHYSIOL GENOMICS, V48, P565, DOI 10.1152/physiolgenomics.00125.2015; Sugden MC, 2000, BIOCHEM J, V346, P651, DOI 10.1042/0264-6021:3460651; Timlin MT, 2008, PEDIATRICS, V121, pE638, DOI 10.1542/peds.2007-1035; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Vrijkotte TGM, 2012, J CLIN ENDOCR METAB, V97, P3917, DOI 10.1210/jc.2012-1295; Wharfe MD, 2016, AM J PHYSIOL-ENDOC M, V311, pE575, DOI 10.1152/ajpendo.00060.2016; Wharfe MD, 2016, ENDOCRINOLOGY, V157, P3320, DOI 10.1210/en.2016-1177; Woldt E, 2013, NAT MED, V19, P1039, DOI 10.1038/nm.3213; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050; Yoshida S, 2005, J LIPID RES, V46, P2168, DOI 10.1194/jlr.M500096-JLR200; Zhu LR, 2015, ENDOCRINOLOGY, V156, P2114, DOI 10.1210/en.2014-1922	54	12	12	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1698	1708		10.1096/fj.201601032R	http://dx.doi.org/10.1096/fj.201601032R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28082353	Green Published			2022-12-28	WOS:000398504300034
J	Trumble, BC; Stieglitz, J; Blackwell, AD; Allayee, H; Beheim, B; Finch, CE; Gurven, M; Kaplan, H				Trumble, Benjamin C.; Stieglitz, Jonathan; Blackwell, Aaron D.; Allayee, Hooman; Beheim, Bret; Finch, Caleb E.; Gurven, Michael; Kaplan, Hillard			Apolipoprotein E4 is associated with improved cognitive function in Amazonian forager-horticulturalists with a high parasite burden	FASEB JOURNAL			English	Article						antagonistic pleiotropy; mismatch; cognitive decline; Tsimane; Alzheimer's disease	CARDIOVASCULAR-DISEASE; ALLELE FREQUENCIES; E GENOTYPES; E GENE; APOE; EVOLUTIONARY; INFECTION; CHILDREN; TSIMANE; RISK	The apolipoprotein E4 (E4) allele is present worldwide, despite its associations with higher risk of cardiovascular morbidity, accelerated cognitive decline during aging, and Alzheimer's disease (AD). The E4 allele is especially prevalent in some tropical regions with a high parasite burden. Equatorial populations also face a potential dual burden of high E4 prevalence combined with parasitic infections that can also reduce cognitive performance. We examined the interactions of E4, parasite burden, and cognitive performance in a traditional, nonindustrialized population of Amazonian forager-horticulturalists (N = 372) to test whether E4 protects against cognitive decline in environments with a heavy pathogen burden. Contrary to observations in industrial populations, older adult E4 carriers with high parasite burdens either maintained or showed slight improvements in cognitive performance, whereas non-E4 carriers with a high parasite burden showed reduced cognitive performance. Being an E4 carrier is the strongest risk factor to date of AD and cognitive decline in industrial populations; it is associated with greater cognitive performance in individuals facing a high parasite and pathogen load, suggesting advantages to the E4 allele under certain environmental conditions. The current mismatch between postindustrial hygienic lifestyles and active parasite-rich environs may be critical for understanding genetic risk for cognitive aging.-Trumble, B. C., Stieglitz, J., Blackwell, A. D., Allayee, H., Beheim, B., Finch, C. E., Gurven, M., Kaplan, H. Apolipoprotein E4 is associated with improved cognitive function in Amazonian forager-horticulturalists with a high parasite burden. FASEB J. 31, 1508-1515 (2017). www.fasebj.org	[Trumble, Benjamin C.] Arizona State Univ, Sch Human Evolut & Social Change, 900 Cady Mall, Tempe, AZ 85287 USA; [Trumble, Benjamin C.] Arizona State Univ, Ctr Evolut & Med, Tempe, AZ USA; [Stieglitz, Jonathan] Inst Adv Study Toulouse, Toulouse, France; [Stieglitz, Jonathan; Kaplan, Hillard] Univ New Mexico, Dept Anthropol, Albuquerque, NM 87131 USA; [Blackwell, Aaron D.; Gurven, Michael] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Allayee, Hooman] Univ Southern Calif, Dept Prevent Med, Keck Sch Med, Los Angeles, CA USA; [Allayee, Hooman] Univ Southern Calif, Inst Med Genet, Keck Sch Med, Los Angeles, CA USA; [Finch, Caleb E.] Univ Southern Calif, Leonard Davis Sch Gerontol, Los Angeles, CA USA; [Finch, Caleb E.] Univ Southern Calif, Dornsife Coll, Los Angeles, CA USA; [Beheim, Bret] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany	Arizona State University; Arizona State University-Tempe; Arizona State University; Arizona State University-Tempe; University of New Mexico; University of California System; University of California Santa Barbara; University of Southern California; University of Southern California; University of Southern California; University of Southern California; Max Planck Society	Trumble, BC (corresponding author), Arizona State Univ, Sch Human Evolut & Social Change, 900 Cady Mall, Tempe, AZ 85287 USA.	trumble@asu.edu	Blackwell, Aaron/B-5258-2008; Finch, Caleb/AAA-7250-2022	Blackwell, Aaron/0000-0002-5871-9865; Trumble, Benjamin/0000-0003-3201-0628; Gurven, Michael/0000-0002-5661-527X; Kaplan, Hillard/0000-0002-7398-7358	U.S. National Institutes of Health (NIH)/National Institute on Aging (NIA) [R01AG024119, R56AG024119]; National Science Foundation (NSF) [BCS-0422690]; Agence Nationale de la Recherche (ANR)-Labex IAST; NATIONAL INSTITUTE ON AGING [R01AG024119, RF1AG054442, R56AG024119, P50AG005142] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Institute on Aging (NIA); National Science Foundation (NSF)(National Science Foundation (NSF)); Agence Nationale de la Recherche (ANR)-Labex IAST(French National Research Agency (ANR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank the U.S. National Institutes of Health (NIH)/National Institute on Aging (NIA) for Grants R01AG024119 and R56AG024119, and the National Science Foundation (NSF) for Grant BCS-0422690. J.S. also thanks the Agence Nationale de la Recherche (ANR)-Labex IAST for financial support. The authors declare no conflicts of interest.	Altmann A, 2014, ANN NEUROL, V75, P563, DOI 10.1002/ana.24135; Alzheimer's Association, 2016, Alzheimers Dement, V12, P459; Azevedo OGR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089562; Bennet AM, 2007, JAMA-J AM MED ASSOC, V298, P1300, DOI 10.1001/jama.298.11.1300; Blackwell AD, 2016, ANN HUM BIOL, V43, P382, DOI 10.1080/03014460.2016.1189963; Blackwell AD, 2015, SCIENCE, V350, P970, DOI 10.1126/science.aac7902; Bowles S, 2001, AM ECON REV, V91, P155, DOI 10.1257/aer.91.2.155; Cacciottolo M, 2016, NEUROBIOL AGING, V37, P47, DOI 10.1016/j.neurobiolaging.2015.10.010; Dietschy JM, 2001, CURR OPIN LIPIDOL, V12, P105, DOI 10.1097/00041433-200104000-00003; Eichner JE, 2002, AM J EPIDEMIOL, V155, P487, DOI 10.1093/aje/155.6.487; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Ewbank DC, 2004, J GERONTOL A-BIOL, V59, P16; Finch CE, 2009, NEUROBIOL AGING, V30, P515, DOI 10.1016/j.neurobiolaging.2008.11.011; Finch CE, 2004, Q REV BIOL, V79, P3, DOI 10.1086/381662; Finch CE, 2001, ANNU REV GENOM HUM G, V2, P435, DOI 10.1146/annurev.genom.2.1.435; Fullerton SM, 2000, AM J HUM GENET, V67, P881, DOI 10.1086/303070; Gale SD, 2016, BRAIN BEHAV IMMUN, V52, P161, DOI 10.1016/j.bbi.2015.10.014; Gale SD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116874; Ghasemian R. F., 2005, IRAN J PUBLIC HEALTH, V34, P62; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; Gurven M, 2007, AM J HUM BIOL, V19, P376, DOI 10.1002/ajhb.20600; Gurven M, 2006, J HUM EVOL, V51, P454, DOI 10.1016/j.jhevol.2006.05.003; Gurven M, 2017, DEV PSYCHOL, V53, P160, DOI 10.1037/dev0000175; Gurven M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006590; Hagberg JM, 2000, PHYSIOL GENOMICS, V4, P101, DOI 10.1152/physiolgenomics.2000.4.2.101; Hall A, 2008, MATERN CHILD NUTR, V4, P118, DOI 10.1111/j.1740-8709.2007.00127.x; Hawkes K, 1998, P NATL ACAD SCI USA, V95, P1336, DOI 10.1073/pnas.95.3.1336; Hooper PL, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2808; Kaplan HS, 2009, PHILOS T R SOC B, V364, P3289, DOI 10.1098/rstb.2009.0115; Katan M, 2013, NEUROLOGY, V80, P1209, DOI 10.1212/WNL.0b013e3182896e79; Kulminski AM, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004141; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; Kuzawa CW, 2014, P NATL ACAD SCI USA, V111, P13010, DOI 10.1073/pnas.1323099111; Maheshwari P, 2015, J ALZHEIMERS DIS, V43, P957, DOI 10.3233/JAD-140621; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mitter SS, 2012, CLINICS, V67, P11, DOI 10.6061/clinics/2012(01)03; Mueller T, 2016, LIVER INT, V36, P1267, DOI 10.1111/liv.13094; Nair MG, 2016, IMMUNOLOGY, V148, P115, DOI 10.1111/imm.12601; Nichol K, 2009, ALZHEIMERS DEMENT, V5, P287, DOI 10.1016/j.jalz.2009.02.006; O'Connell EM, 2015, IMMUNOL ALLERGY CLIN, V35, P493, DOI 10.1016/j.iac.2015.05.003; Oria RB, 2010, BRAZ J MED BIOL RES, V43, P249, DOI 10.1590/S0100-879X2010007500003; Oria RB, 2005, PEDIATR RES, V57, P310, DOI 10.1203/01.PDR.0000148719.82468.CA; Oria RB, 2007, MED HYPOTHESES, V68, P1099, DOI 10.1016/j.mehy.2006.09.036; Panizzon MS, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2013.12.025; Prieto Ricardo, 2013, Curr Gastroenterol Rep, V15, P324, DOI 10.1007/s11894-013-0324-6; Prince M, 2013, ALZHEIMERS DEMENT, V9, P63, DOI 10.1016/j.jalz.2012.11.007; Rocha MOC, 1996, TROP MED INT HEALTH, V1, P213; Singh PP, 2006, ANN HUM BIOL, V33, P279, DOI 10.1080/03014460600594513; Small GW, 2000, P NATL ACAD SCI USA, V97, P6037, DOI 10.1073/pnas.090106797; Soerensen M, 2013, AGE, V35, P487, DOI 10.1007/s11357-011-9373-7; Song YQ, 2004, ANN INTERN MED, V141, P137, DOI 10.7326/0003-4819-141-2-200407200-00013; Strenze T, 2007, INTELLIGENCE, V35, P401, DOI 10.1016/j.intell.2006.09.004; Trumble BC, 2015, AM J HUM BIOL, V27, P582, DOI 10.1002/ajhb.22665; van Exel E, 2009, ARCH GEN PSYCHIAT, V66, P1263, DOI 10.1001/archgenpsychiatry.2009.146; Vasunilashorn S, 2011, BIODEMOGR SOC BIOL, V57, P33, DOI 10.1080/19485565.2011.564475; Weiner Michael W, 2015, Alzheimers Dement, V11, pe1, DOI 10.1016/j.jalz.2014.11.001; WILLIAMS GC, 1957, EVOLUTION, V11, P398, DOI 10.1111/j.1558-5646.1957.tb02911.x; Williamson LL, 2016, BRAIN BEHAV IMMUN, V51, P14, DOI 10.1016/j.bbi.2015.07.006; Wright RO, 2003, PEDIATR RES, V54, P819, DOI 10.1203/01.PDR.0000090927.53818.DE; Yaffe K, 2000, NEUROLOGY, V54, P1949, DOI 10.1212/WNL.54.10.1949	60	56	56	0	15	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1508	1515		10.1096/fj.201601084R	http://dx.doi.org/10.1096/fj.201601084R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28031319	Green Published			2022-12-28	WOS:000398504300019
J	Cross, M; Lepage, R; Rajan, S; Biberacher, S; Young, ND; Kim, BN; Coster, MJ; Gasser, RB; Kim, JS; Hofmann, A				Cross, Megan; Lepage, Romain; Rajan, Siji; Biberacher, Sonja; Young, Neil D.; Kim, Bo-Na; Coster, Mark J.; Gasser, Robin B.; Kim, Jeong-Sun; Hofmann, Andreas			Probing function and structure of trehalose-6phosphate phosphatases from pathogenic organisms suggests distigroupingsnct molecular	FASEB JOURNAL			English	Article						drug targets; enzyme inhibitors; molecular mechanism	TREHALOSE-6-PHOSPHATE PHOSPHATASE; TREHALOSE-PHOSPHATE; MYCOBACTERIUM-SMEGMATIS; SACCHAROMYCES-CEREVISIAE; PROTEIN; CLONING; GENE; PURIFICATION; SUPERFAMILY; EXPRESSION	The trehalose biosynthetic pathway is of great interest for the development of novel therapeutics because trehalose is an essential disaccharide in many pathogens but is neither required nor synthesized in mammalian hosts. As such, trehalose-6-phosphate phosphatase (TPP), a key enzyme in trehalose biosynthesis, is likely an attractive target for novel chemotherapeutics. Based on a survey of genomes from a panel of parasitic nematodes and bacterial organisms and by way of a structure-based amino acid sequence alignment, we derive the topological structure of monoenzyme TPPs and classify them into 3 groups. Comparison of the functional roles of amino acid residues located in the active site for TPPs belonging to different groups reveal nuanced variations. Because current literature on this enzyme family shows a tendency to infer functional roles for individual amino acid residues, we investigated the roles of the strictly conserved aspartate tetrad in TPPs of the nematode Brugia malayi by using a conservative mutation approach. In contrast to aspartate-213, the residue inferred to carry out the nucleophilic attack on the substrate, we found that aspartate-215 and aspartate-428 of BmTPP are involved in the chemistry steps of enzymatic hydrolysis of the substrate. Therefore, we suggest that homology-based inference of functionally important amino acids by sequence comparison for monoenzyme TPPs should only be carried out for each of the 3 groups.-Cross, M.,Lepage, R.,Rajan, S., Biberacher, S.,Young, N.D.,Kim, B.-N., Coster, M.J., Gasser, R.B., Kim, J.-S., Hofmann, A. Probing function and structure of trehalose-6-phosphate phosphatases from pathogenic organisms suggests distinct molecular groupings.	[Cross, Megan; Lepage, Romain; Rajan, Siji; Biberacher, Sonja; Coster, Mark J.; Hofmann, Andreas] Griffith Univ, Eskitis Inst Drug Discovery, Nathan, Qld, Australia; [Young, Neil D.; Gasser, Robin B.; Hofmann, Andreas] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia; [Kim, Bo-Na; Kim, Jeong-Sun] Chonnam Natl Univ, Dept Chem, Gwangju, South Korea; [Hofmann, Andreas] Queensland Trop Hlth Alliance, Smithfield, Qld, Australia	Griffith University; University of Melbourne; Chonnam National University	Hofmann, A (corresponding author), N75 Don Young Rd, Nathan, Qld 4111, Australia.	a.hofmann@griffith.edu.au	Gasser, Robin/ABH-6185-2020; Young, Neil David/AAU-4572-2020; Hofmann, Andreas/M-9870-2019; Coster, Mark/C-4621-2008	Gasser, Robin/0000-0002-4423-1690; Young, Neil David/0000-0001-8756-229X; Hofmann, Andreas/0000-0003-4408-5467; Coster, Mark/0000-0002-0910-6819; Cross, Megan/0000-0001-7512-7223; Rajan, Siji/0000-0002-2142-0042; Lepage, Romain/0000-0001-6384-3142; /0000-0003-3370-0444	Australian Research Council; National Health and Medical Research Council (NHMRC); Chonnam National University [2015-0597]; NHMRC; Rebecca L.Cooper Medical Research Foundation; Equity Trustees PhD Scholarship	Australian Research Council(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Chonnam National University; NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Rebecca L.Cooper Medical Research Foundation; Equity Trustees PhD Scholarship	This work was supported by grants from the Australian Research Council, the National Health and Medical Research Council (NHMRC) (to A.H., R.B.G., and N.D.Y.), the Rebecca L.Cooper Medical Research Foundation (to A.H.), and Chonnam National University (Grant 2015-0597 to J.- S.K.); by an Equity Trustees PhD Scholarship ( to M. C.); and by the NHMRC Career Development Fellowship (to N. D. Y.). The authors thank Robert Huber (Max Planck Institute of Biochemistry, Martinsried, Germany) for fruitful discussions during this study and James Cameron (Griffith University) for help with the inductively coupled plasma atomic emission spectroscopy measurements. Mass spectrometric analysis was undertaken at the Australian Proteome Analysis Facility provided by the Australian Government through the National Collaborative Research Infrastructure Strategy.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; BELL W, 1992, EUR J BIOCHEM, V209, P951, DOI 10.1111/j.1432-1033.1992.tb17368.x; Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410; Burroughs AM, 2006, J MOL BIOL, V361, P1003, DOI 10.1016/j.jmb.2006.06.049; CABIB E, 1958, J BIOL CHEM, V231, P259; DEVIRGILIO C, 1993, EUR J BIOCHEM, V212, P315; Edavana VK, 2004, ARCH BIOCHEM BIOPHYS, V426, P250, DOI 10.1016/j.abb.2004.02.014; Farelli JD, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004245; Jones P, 2014, BIOINFORMATICS, V30, P1236, DOI 10.1093/bioinformatics/btu031; Klutts S, 2003, J BIOL CHEM, V278, P2093, DOI 10.1074/jbc.M209937200; Kormish JD, 2005, DEV BIOL, V287, P35, DOI 10.1016/j.ydbio.2005.08.027; Kushwaha S, 2011, ACTA TROP, V119, P151, DOI 10.1016/j.actatropica.2011.05.008; Lahiri SD, 2003, SCIENCE, V299, P2067, DOI 10.1126/science.1082710; LAPP D, 1971, J BIOL CHEM, V246, P4567; Lobley A, 2009, BIOINFORMATICS, V25, P1761, DOI 10.1093/bioinformatics/btp302; Lu Z, 2008, P NATL ACAD SCI USA, V105, P5687, DOI 10.1073/pnas.0710800105; MATULA M, 1971, J BACTERIOL, V107, P217, DOI 10.1128/JB.107.1.217-222.1971; MCDOUGALL J, 1993, FEMS MICROBIOL LETT, V107, P25, DOI 10.1111/j.1574-6968.1993.tb05998.x; Miao Y, 2016, P NATL ACAD SCI USA, V113, P7148, DOI 10.1073/pnas.1601774113; Rao KN, 2006, PROTEIN SCI, V15, P1735, DOI 10.1110/ps.062096606; Reinders A, 1997, MOL MICROBIOL, V24, P687, DOI 10.1046/j.1365-2958.1997.3861749.x; RONNOW TECL, 1994, CARBOHYD RES, V260, P323, DOI 10.1016/0008-6215(94)84050-4; Shan S, 2016, FASEB J, V30, P3989, DOI 10.1096/fj.201600463R; Wang CK, 2012, BIOINFORMATICS, V28, P1026, DOI 10.1093/bioinformatics/bts035	24	8	8	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					920	+		10.1096/fj.201601149R	http://dx.doi.org/10.1096/fj.201601149R			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27864376				2022-12-28	WOS:000395671200009
J	Montenegro, MF; Cabezas-Herrera, J; Campoy, FJ; Munoz-Delgado, E; Vidal, CJ				Fernanda Montenegro, Maria; Cabezas-Herrera, Juan; Javier Campoy, F.; Munoz-Delgado, Encarnacion; Vidal, Cecilio J.			Lipid rafts of mouse liver contain nonextended and extended acetylcholinesterase variants along with M3 muscarinic receptor	FASEB JOURNAL			English	Article						AChE transcripts; N-AChE variants; acetylcholine; cholinergic signaling; GPI anchorage	MEMBRANE-ANCHOR PRIMA; MUSCULAR-DYSTROPHY; READTHROUGH ACETYLCHOLINESTERASE; CHOLINESTERASE ACTIVITY; PROTEIN INTERACTIONS; MEROSIN DEFICIENCY; ALZHEIMERS-DISEASE; MYASTHENIA-GRAVIS; INDUCED APOPTOSIS; RAT-LIVER	The observation of acetylcholinesterase (AChE) type H (AChE(H)), which is the predominant AChE variant in visceral organs and immune cells, in lipid rafts of muscle supports functional reasons for the raft targeting of glypiated AChE(H). The search for these reasons revealed that liver AChE activity is mostly confined to rafts and that the liver is able to make N-extended AChE variants and target them to rafts. These results prompted us to test whether AChE and muscarinic receptors existed in the same raft. Isolation of flotillin-2-rich raft fractions by their buoyancy in sucrose gradients, followed by immunoadsorption and matrix-assisted laser desorption ionization-time of flight-mass spectrometry application, gave the following results: 1) most hepatic AChE activity emanates from AChE-HmRNA, and its product, glypiated AChE(H), accumulates in rafts; 2) N-extended N-AChE readthrough variant, nonglypiated N-AChE(H), and N-AChE tailed variant were all identified in liver rafts; and 3) M3 AChRs were observed in rafts, and coprecipitation of raft-confined N-AChE and M3 receptors by using anti-M3 antibodies showed that enzyme and receptor reside in the same raft unit. A raft domain that harbors tightly packed muscarinic receptor and AChE may represent a molecular device that, by means of which, the intensity and duration of cholinergic inputs are regulated.- Montenegro, M. F., Cabezas-Herrera, J., Campoy, F. J., Munoz-Delgado, E., Vidal, C. J. Lipid rafts of mouse liver contain nonextended and extended acetylcholinesterase variants along with M3 muscarinic receptors.	[Fernanda Montenegro, Maria; Javier Campoy, F.; Munoz-Delgado, Encarnacion; Vidal, Cecilio J.] Univ Murcia, IMIB, Dept Bioquim & Biol Mol A, Reg Campus Int Excellence Campus Mare Nostrum, Murcia, Spain; [Cabezas-Herrera, Juan] Univ Hosp Virgen Arrixaca, IMIB Arrixaca, Clin Anal Serv, Mol Therapy & Biomarkers Res Grp, Murcia, Spain	University of Murcia; Hospital Clinico Universitario Virgen de la Arrixaca	Vidal, CJ (corresponding author), Univ Murcia, Dept Bioquim & Biol Mol A, Edificio Vet,Apdo 4021, E-30071 Murcia, Spain.	cevidal@um.es	Muñoz-Delgado, Encarnación/P-3490-2014; CABEZAS-HERRERA, JUAN/J-9434-2015; Montenegro, Maria Fernanda/AAF-2695-2021	Muñoz-Delgado, Encarnación/0000-0002-5874-6708; CABEZAS-HERRERA, JUAN/0000-0001-9053-5380; Vidal, Cecilio J./0000-0002-0769-5955; Campoy, Francisco Javier/0000-0002-4901-5524; Montenegro, Maria Fernanda/0000-0002-0064-0484	Fundacion Seneca de la Region de Murcia [PI83/00840/FS01]; University of Murcia	Fundacion Seneca de la Region de Murcia(Fundacion Seneca); University of Murcia	The authors thank Dr. Alejandro Torrecillas (University of Murcia) for help with MALDI-TOF-MS experiments, Dr. Nigel M. Hooper (University of Leeds, Leeds, United Kingdom) for providing us with a sample of PIPLC of Bacillus thuringiensis, and Dr. Hermona Soreq (The Hebrew University, Jerusalem, Israel) for critical reading of and useful comments on the manuscript. This research was supported by the Fundacion Seneca de la Region de Murcia (PI83/00840/FS01) and institutional funds of the University of Murcia.	Allen JA, 2007, NAT REV NEUROSCI, V8, P128, DOI 10.1038/nrn2059; Berson A, 2008, BRAIN, V131, P109, DOI 10.1093/brain/awm276; Berson A, 2010, RAMBAM MAIMONIDES ME, V1, DOI 10.5041/RMMJ.10014; Brenner T, 2003, FASEB J, V17, P214, DOI 10.1096/fj.02-0609com; Cartaud A, 2011, BIOL CELL, V103, P287, DOI 10.1042/BC20110018; Cassiman D, 2002, AM J PATHOL, V161, P521, DOI 10.1016/S0002-9440(10)64208-3; Cserzo M, 2004, BIOINFORMATICS, V20, P136, DOI 10.1093/bioinformatics/btg394; Cuddy LK, 2014, J NEUROCHEM, V128, P725, DOI 10.1111/jnc.12490; Dewar BJ, 2002, J PHARMACOL EXP THER, V301, P930, DOI 10.1124/jpet.301.3.930; Diaz-Rohrer B, 2014, BBA-BIOMEMBRANES, V1838, P3003, DOI 10.1016/j.bbamem.2014.07.029; Ekman M, 2012, EUR J PHARMACOL, V683, P238, DOI 10.1016/j.ejphar.2012.02.039; Montenegro MF, 2014, CHEM-BIOL INTERACT, V216, P1, DOI 10.1016/j.cbi.2014.03.008; Feron O, 1999, LIFE SCI, V64, P471, DOI 10.1016/S0024-3205(98)00590-6; Garcia-Ayllon MS, 2014, NEUROBIOL AGING, V35, P1526, DOI 10.1016/j.neurobiolaging.2014.01.147; Garcia-Ayllon MS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044598; Garcia-Ayllon MS, 1999, NEUROSCI LETT, V265, P211, DOI 10.1016/S0304-3940(99)00252-9; Garcia-Ayllon MS, 2006, HEPATOLOGY, V43, P444, DOI 10.1002/hep.21071; Gomez JL, 2000, J NEUROSCI RES, V62, P134, DOI 10.1002/1097-4547(20001001)62:1<134::AID-JNR14>3.0.CO;2-T; Gomez V, 2010, J BIOL CHEM, V285, P20683, DOI 10.1074/jbc.M110.130591; Gurezka R, 1999, J BIOL CHEM, V274, P9265, DOI 10.1074/jbc.274.14.9265; Hicks D, 2011, J NEUROCHEM, V116, P742, DOI 10.1111/j.1471-4159.2010.07032.x; Hicks DA, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00189; Hiramoto T, 2008, GASTROENTEROLOGY, V134, P2122, DOI 10.1053/j.gastro.2008.03.005; Fernandez-Gomez FJ, 2010, J NEUROSCI RES, V88, P155, DOI 10.1002/jnr.22177; Kelley LA, 2015, NAT PROTOC, V10, P845, DOI 10.1038/nprot.2015.053; Khurana S, 2010, J PHARMACOL EXP THER, V333, P639, DOI 10.1124/jpet.109.165118; Lee J, 2007, J VIROL, V81, P9121, DOI 10.1128/JVI.00136-07; Levental I, 2010, BIOCHEMISTRY-US, V49, P6305, DOI 10.1021/bi100882y; Levitan I, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00065; Li JH, 2009, DIABETES, V58, P2776, DOI 10.2337/db09-0522; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lucero HA, 2004, ARCH BIOCHEM BIOPHYS, V426, P208, DOI 10.1016/j.abb.2004.03.020; Marzioni M, 2009, CLIN REV ALLERG IMMU, V36, P13, DOI 10.1007/s12016-008-8090-1; Masson P, 2010, ARCH BIOCHEM BIOPHYS, V494, P107, DOI 10.1016/j.abb.2009.12.005; Massoulie J, 2008, CHEM-BIOL INTERACT, V175, P30, DOI 10.1016/j.cbi.2008.04.039; Meshorer E, 2004, J BIOL CHEM, V279, P29740, DOI 10.1074/jbc.M402752200; Meshorer E, 2006, TRENDS NEUROSCI, V29, P216, DOI 10.1016/j.tins.2006.02.005; Mor I, 2008, J CELL MOL MED, V12, P479, DOI 10.1111/j.1582-4934.2008.00231.x; Mor I, 2008, CHEM-BIOL INTERACT, V175, P11, DOI 10.1016/j.cbi.2008.05.019; Munoz-Delgado E, 2010, FEBS J, V277, P4519, DOI 10.1111/j.1742-4658.2010.07861.x; Nieto-Ceron S, 2005, J NEUROCHEM, V95, P1035, DOI 10.1111/j.1471-4159.2005.03433.x; Ohno K, 2014, J MOL NEUROSCI, V53, P359, DOI 10.1007/s12031-013-0170-x; Oldfield S, 2009, MOL PHARMACOL, V76, P1279, DOI 10.1124/mol.109.058008; Oshikawa J, 2003, AM J PHYSIOL-CELL PH, V285, pC567, DOI 10.1152/ajpcell.00422.2002; Paulick MG, 2008, BIOCHEMISTRY-US, V47, P6991, DOI 10.1021/bi8006324; Perez-Aguilar B, 2015, BBA-MOL BASIS DIS, V1852, P1380, DOI 10.1016/j.bbadis.2015.04.003; Perry C, 2007, LEUKEMIA, V21, P1472, DOI 10.1038/sj.leu.2404722; Ponce J, 2010, PROTEOMICS, V10, P1954, DOI 10.1002/pmic.200900055; Ruiz-Espejo F, 2002, BREAST CANCER RES TR, V72, P11, DOI 10.1023/A:1014904701723; Schlenz H, 2010, AM J PHYSIOL-LUNG C, V298, pL626, DOI 10.1152/ajplung.00261.2009; Shakirova Y, 2010, EUR J PHARMACOL, V634, P142, DOI 10.1016/j.ejphar.2010.02.017; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shiota M, 2000, AM J PHYSIOL-ENDOC M, V278, pE544, DOI 10.1152/ajpendo.2000.278.3.E544; Soeda J, 2012, BIOCHEM BIOPH RES CO, V417, P17, DOI 10.1016/j.bbrc.2011.10.151; Stuermer CAO, 2011, J NEUROCHEM, V116, P708, DOI 10.1111/j.1471-4159.2010.07007.x; Moral-Naranjo MT, 2010, BBA-MOL BASIS DIS, V1802, P754, DOI 10.1016/j.bbadis.2010.05.011; Toiber D, 2009, J NEURAL TRANSM, V116, P1435, DOI 10.1007/s00702-009-0249-2; Toiber D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003108; Torrent J, 2015, ACTA NEUROPATHOL COM, V3, DOI 10.1186/s40478-015-0188-0; Vatamaniuk MZ, 2003, LIFE SCI, V72, P1871, DOI 10.1016/S0024-3205(02)02506-7; Vidal CJ, 2013, CHEM-BIOL INTERACT, V203, P330, DOI 10.1016/j.cbi.2012.08.001; Borroni MV, 2016, BBA-BIOMEMBRANES, V1858, P2662, DOI 10.1016/j.bbamem.2016.07.005; Watt NT, 2014, FRONT CELL DEV BIOL, V2, DOI 10.3389/fcell.2014.00041; Xie HDQ, 2010, J BIOL CHEM, V285, P11537, DOI 10.1074/jbc.M109.038711; Zhao YJ, 2011, HEPATOLOGY, V53, P493, DOI 10.1002/hep.24079; Zimmerman G, 2006, CELL TISSUE RES, V326, P655, DOI 10.1007/s00441-006-0239-8	66	3	3	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					544	555		10.1096/fj.201600609R	http://dx.doi.org/10.1096/fj.201600609R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	28148778				2022-12-28	WOS:000394235400010
J	Khayati, K; Antikainen, H; Bonder, EM; Weber, GF; Kruger, WD; Jakubowski, H; Dobrowolski, R				Khayati, Khoosheh; Antikainen, Henri; Bonder, Edward M.; Weber, Gregory F.; Kruger, Warren D.; Jakubowski, Hieronim; Dobrowolski, Radek			The amino acid metabolite homocysteine activates mTORC1 to inhibit autophagy and form abnormal proteins in human neurons and mice	FASEB JOURNAL			English	Article						metabolism; lysosomal clearance; signaling; Alzheimer's disease	CYSTATHIONINE BETA-SYNTHASE; TRANSFER-RNA-SYNTHETASE; ALZHEIMERS-DISEASE; RAG GTPASES; PATHOLOGICAL CONSEQUENCES; PRESENILIN DEFICIENCY; POSSIBLE MECHANISM; ESCHERICHIA-COLI; LYSOSOME; LEUCINE	The molecular mechanisms leading to and responsible for age-related, sporadic Alzheimer's disease (AD) remain largely unknown. It is well documented that aging patients with elevated levels of the amino acid metabolite homocysteine (Hcy) are at high risk of developing AD. We investigated the impact of Hcy on molecular clearance pathways in mammalian cells, including in vitro cultured induced pluripotent stem cell-derived forebrain neurons and in vivo neurons in mouse brains. Exposure to Hcy resulted in up-regulation of the mechanistic target of rapamycin complex 1 (mTORC1) activity, one of the major kinases in cells that is tightly linked to anabolic and catabolic pathways. Hcy is sensed by a constitutive protein complex composed of leucyl-tRNA-synthetase and folliculin, which regulates mTOR tethering to lysosomal membranes. In hyperhomocysteinemic human cells and cystathionine -synthase-deficient mouse brains, we find an acute and chronic inhibition of the molecular clearance of protein products resulting in a buildup of abnormal proteins, including -amyloid and phospho-Tau. Formation of these protein aggregates leads to AD-like neurodegeneration. This pathology can be prevented by inhibition of mTORC1 or by induction of autophagy. We conclude that an increase of intracellular Hcy levels predisposes neurons to develop abnormal protein aggregates, which are hallmarks of AD and its associated onset and pathophysiology with age.	[Khayati, Khoosheh; Antikainen, Henri; Bonder, Edward M.; Weber, Gregory F.; Dobrowolski, Radek] Rutgers State Univ, New Jersey Inst Technol, Federated Dept Biol Sci, Life Sci Ctr, 225 Univ Ave, Newark, NJ 07102 USA; [Kruger, Warren D.] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA; [Jakubowski, Hieronim] Int Ctr Publ Hlth, Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Newark, NJ USA; [Jakubowski, Hieronim] Inst Bioorgan Chem, Poznan, Poland; [Jakubowski, Hieronim] Univ Life Sci, Dept Biochem & Biotechnol, Poznan, Poland	New Jersey Institute of Technology; Rutgers State University Newark; Rutgers State University New Brunswick; Fox Chase Cancer Center; Rutgers State University New Brunswick; Rutgers State University Medical Center; Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Poznan University of Life Sciences	Dobrowolski, R (corresponding author), Rutgers State Univ, New Jersey Inst Technol, Federated Dept Biol Sci, Life Sci Ctr, 225 Univ Ave, Newark, NJ 07102 USA.	r.dobrowolski@rutgers.edu	Jakubowski, Hieronim/AAA-6834-2019; Kruger, Warren/Y-2541-2018; Jakubowski, Hieronim/A-2510-2017	Jakubowski, Hieronim/0000-0001-5845-4409; kruger, warren/0000-0002-4990-3695; Dobrowolski, Radek/0000-0002-1805-5806	Polish National Science Center [2012/07/B/NZ7/01178, 2013/09/B/NZ5/02794, 2013/11/B/NZ1/00091]; Rutgers University-Newark Research Office; New Jersey Brain Health Institute	Polish National Science Center; Rutgers University-Newark Research Office; New Jersey Brain Health Institute	This work was supported by grants from the Polish National Science Center (2012/07/B/NZ7/01178, 2013/09/B/NZ5/02794, and 2013/11/B/NZ1/00091) and the Rutgers University-Newark Research Office and the New Jersey Brain Health Institute (to H.J. and R.D.). The authors thank Drs. Andrea Ballabio (TIGEM, Pozzuoli, Italy) for the CLEAR-Luciferase, David Sabatini (Whitehead Institute, Massachusetts Institute of Technology, Cambridge, MA, USA) for pRK5-HA GST RagC and Flag-Leucyl tRNA synthetase pRK5, Tamotsu Yoshimori (Osaka University, Osaka, Japan) for ptfLC3, and Shawn Ferguson (Yale School of Medicine, New Haven, CT, USA) for ptdTomato-N1-FLCN constructs, and the members of our laboratory for their helpful comments.	Akchiche N, 2012, FASEB J, V26, P3980, DOI 10.1096/fj.12-205757; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Beyer K, 2004, CURR ALZHEIMER RES, V1, P127, DOI 10.2174/1567205043332243; Borowczyk K, 2012, J ALZHEIMERS DIS, V30, P225, DOI 10.3233/JAD-2012-111940; Chung YC, 2016, J THROMB HAEMOST, V14, P1442, DOI 10.1111/jth.13340; Coppede F, 2010, CURR GENOMICS, V11, P246, DOI 10.2174/138920210791233090; Dobrowolski R, 2012, CELL REP, V2, P1316, DOI 10.1016/j.celrep.2012.09.026; Dobrowolski R, 2012, NAT REV MOL CELL BIO, V13, P53, DOI 10.1038/nrm3244; ENGLISCH S, 1986, NUCLEIC ACIDS RES, V14, P7529, DOI 10.1093/nar/14.19.7529; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Hamilton N, 2009, TRAFFIC, V10, P951, DOI 10.1111/j.1600-0854.2009.00938.x; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Jakubowski H, 1997, J BIOL CHEM, V272, P1935; JAKUBOWSKI H, 1990, P NATL ACAD SCI USA, V87, P4504, DOI 10.1073/pnas.87.12.4504; Jakubowski H, 1999, FASEB J, V13, P2277, DOI 10.1096/fasebj.13.15.2277; Jakubowski H., 2013, HOMOCYSTEINE PROTEIN; Jakubowski H, 2012, WIRES RNA, V3, P295, DOI 10.1002/wrna.122; Jakubowski H, 2008, FASEB J, V22, P4071, DOI 10.1096/fj.08-112086; Jakubowski H, 2009, FASEB J, V23, P1721, DOI 10.1096/fj.08-127548; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Lipinski MM, 2010, P NATL ACAD SCI USA, V107, P14164, DOI 10.1073/pnas.1009485107; Martina JA, 2012, AUTOPHAGY, V8, P903, DOI 10.4161/auto.19653; Medina DL, 2015, NAT CELL BIOL, V17, P288, DOI 10.1038/ncb3114; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; MUDD SH, 1985, AM J HUM GENET, V37, P1; Nazio F, 2013, NAT CELL BIOL, V15, P406, DOI 10.1038/ncb2708; Nixon RA, 2011, NEUROBIOL DIS, V43, P38, DOI 10.1016/j.nbd.2011.01.021; Nnah I.C., 2015, CELL DEATH THER, V1, P11; Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Petit CS, 2013, J CELL BIOL, V202, P1107, DOI 10.1083/jcb.201307084; Reddy K, 2016, CELL REP, V14, P2166, DOI 10.1016/j.celrep.2016.02.006; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Sardiello M, 2009, SCIENCE, V325, P473, DOI 10.1126/science.1174447; Settembre C, 2013, NAT REV MOL CELL BIO, V14, P283, DOI 10.1038/nrm3565; Settembre C, 2012, EMBO J, V31, P1095, DOI 10.1038/emboj.2012.32; Shoji-Kawata S, 2013, NATURE, V494, P201, DOI 10.1038/nature11866; Smith AD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012244; Sorkin A, 2009, NAT REV MOL CELL BIO, V10, P609, DOI 10.1038/nrm2748; Strauss KA, 2007, MOL GENET METAB, V91, P165, DOI 10.1016/j.ymgme.2007.02.012; Suszynska J, 2010, J ALZHEIMERS DIS, V19, P1177, DOI 10.3233/JAD-2010-1311; Tsun ZY, 2013, MOL CELL, V52, P495, DOI 10.1016/j.molcel.2013.09.016; Tucker KL, 2005, AM J CLIN NUTR, V82, P627; Wang LQ, 2005, HUM MOL GENET, V14, P2201, DOI 10.1093/hmg/ddi224; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Yates Sharon C, 2013, Acta Neuropathol Commun, V1, P3, DOI 10.1186/2051-5960-1-3; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	53	34	35	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					598	609		10.1096/fj.201600915R	http://dx.doi.org/10.1096/fj.201600915R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	28148781				2022-12-28	WOS:000394235400014
J	Gong, YX; Zhang, Y; Feng, SL; Liu, XF; Lu, SQ; Long, M				Gong, Yixin; Zhang, Yan; Feng, Shiliang; Liu, Xiaofeng; Lu, Shouqin; Long, Mian			Dynamic contributions of P- and E-selectins to beta(2)-integrin-induced neutrophil transmigration	FASEB JOURNAL			English	Article						PSGL-1; CD44; synergic mechanisms	CELL-ADHESION; CONFORMATIONAL-CHANGES; GLYCOPROTEIN LIGAND-1; CYTOSKELETAL REGULATION; 2-DIMENSIONAL KINETICS; VASCULAR ENDOTHELIUM; LEUKOCYTE ADHESION; CYTOPLASMIC DOMAIN; CATCH BONDS; ICAM-1	Leukocyte transendothelial migrationis a key step in their recruitment to sites of inflammation. However, synergic regulation of endothelium-expressed selectins on leukocyte transmigration remains unclear. In this study, an in vitro model was developed to investigate the dynamic contributions of P- and E-selectin to polymorphonuclear neutrophil (PMN) transmigration under static conditions. Human umbilical vein endothelial cells (HUVECs) were treated with LPS for 4 or 12 h to induce different expression of selectins and intercellular adhesion molecule (ICAM)-1. PMN transmigration was increased significantly by LPS stimulation, which was higher on 4-h than on 12-h LPS treated HUVECs. Blocking and competitive tests indicated that P-selectin engages PSGL-1 to activate beta(2)-integrin and initiate PMN transmigration within the first 15 min, whereas E-selectin engages CD44 to influence PMN transmigration after 15 min. P-and E-selectin-induced beta(2)-integrin activation is likely conducted through the spleen tyrosine kinase signaling pathway. Complicated complementary and competitive mechanisms are involved in the interaction of P-/E-selectins and their ligands to promote PMN transmigration. These results provide direct evidence of the distinct and dynamic contribution of P- and E-selectins inmediating PMN transmigration and give new insight into PMN interaction with the vessel wall.-Gong, Y., Zhang, Y., Feng, S., Liu, X., Lu, S., Long, M. Dynamic contributions of P-and E-selectins to beta(2)-integrin-induced neutrophil transmigration.	[Gong, Yixin; Zhang, Yan; Feng, Shiliang; Liu, Xiaofeng; Lu, Shouqin; Long, Mian] Chinese Acad Sci, Ctr Biomech & Bioengn, 15 North 4th Ring Rd, Beijing 100190, Peoples R China; [Gong, Yixin; Zhang, Yan; Feng, Shiliang; Liu, Xiaofeng; Lu, Shouqin; Long, Mian] Chinese Acad Sci, Key Lab Micrograv, Natl Micrograv Lab, Beijing, Peoples R China; [Gong, Yixin; Zhang, Yan; Feng, Shiliang; Liu, Xiaofeng; Lu, Shouqin; Long, Mian] Chinese Acad Sci, Inst Mech, Beijing Key Lab Engn Construct & Mechanobiol, Beijing, Peoples R China; [Zhang, Yan; Lu, Shouqin; Long, Mian] Univ Chinese Acad Sci, Sch Engn Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Long, M (corresponding author), Chinese Acad Sci, Ctr Biomech & Bioengn, 15 North 4th Ring Rd, Beijing 100190, Peoples R China.; Long, M (corresponding author), Chinese Acad Sci, Inst Mech, Key Lab Micrograv, Natl Micrograv Lab, 15 North 4th Ring Rd, Beijing 100190, Peoples R China.	mlong@imech.ac.cn		gong, yixin/0000-0001-7681-9619	National Natural Science Foundation of China [31230027, 91539119, 31270994]; National Key Basic Research Foundation of China [2011CB710904]; Strategic Priority Research Program Grant [XDA01030102]; National High Technology Research and Development Program of China [2011AA020109]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research Foundation of China(National Basic Research Program of China); Strategic Priority Research Program Grant; National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	This work was supported by National Natural Science Foundation of China Grants 31230027, 91539119 and 31270994; National Key Basic Research Foundation of China Grant 2011CB710904; Strategic Priority Research Program Grant XDA01030102; and National High Technology Research and Development Program of China Grant 2011AA020109. The authors declare no conflicts of interest.	Adamson P, 1999, J IMMUNOL, V162, P2964; Allingham MJ, 2007, J IMMUNOL, V179, P4053, DOI 10.4049/jimmunol.179.6.4053; Alon R, 2003, MICROCIRCULATION, V10, P297, DOI 10.1038/sj.mn.7800195; Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; BEVILACQUA MP, 1994, ANNU REV MED, V45, P361, DOI 10.1146/annurev.med.45.1.361; Borau C, 2011, PHYS BIOL, V8, DOI 10.1088/1478-3975/8/6/066008; Cairo CW, 2006, IMMUNITY, V25, P297, DOI 10.1016/j.immuni.2006.06.012; Chatterjee A, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/579830; Dokukina IV, 2010, BIOPHYS J, V98, P2794, DOI 10.1016/j.bpj.2010.03.026; Elosegui-Artola A, 2014, NAT MATER, V13, P631, DOI [10.1038/NMAT3960, 10.1038/nmat3960]; Eutamene H, 2005, EUR RESPIR J, V25, P789, DOI 10.1183/09031936.05.00064704; Feng D, 2004, J HISTOCHEM CYTOCHEM, V52, P87, DOI 10.1177/002215540405200109; Ghibaudo M, 2008, SOFT MATTER, V4, P1836, DOI 10.1039/b804103b; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; KAPLANSKI G, 1994, J CELL SCI, V107, P2449; Katayama Y, 2005, J EXP MED, V201, P1183, DOI 10.1084/jem.20042014; Kelly M, 2007, J ALLERGY CLIN IMMUN, V120, P3, DOI 10.1016/j.jaci.2007.05.017; Kong D, 2010, J BIOMECH, V43, P2524, DOI 10.1016/j.jbiomech.2010.05.019; Laszik Z, 1996, BLOOD, V88, P3010, DOI 10.1182/blood.V88.8.3010.bloodjournal8883010; Lawson C, 2009, PHARMACOL REP, V61, P22, DOI 10.1016/S1734-1140(09)70004-0; Li N, 2013, J IMMUNOL, V190, P4371, DOI 10.4049/jimmunol.1201374; Lorenzon P, 1998, J CELL BIOL, V142, P1381, DOI 10.1083/jcb.142.5.1381; Lou O, 2007, J IMMUNOL, V178, P1136, DOI 10.4049/jimmunol.178.2.1136; Ma YQ, 2004, BLOOD, V104, P2549, DOI 10.1182/blood-2004-03-1108; Mao DB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024188; Marshall BT, 2003, NATURE, V423, P190, DOI 10.1038/nature01605; McEver RP, 2010, ANNU REV CELL DEV BI, V26, P363, DOI 10.1146/annurev.cellbio.042308.113238; MCEVER RP, 1994, CURR OPIN IMMUNOL, V6, P75, DOI 10.1016/0952-7915(94)90037-X; McEver RP, 2002, CURR OPIN CELL BIOL, V14, P581, DOI 10.1016/S0955-0674(02)00367-8; Milstone DS, 1998, MICROCIRCULATION-LON, V5, P153, DOI 10.1080/713773857; Miner JJ, 2008, BLOOD, V112, P2035, DOI 10.1182/blood-2008-04-149468; MULLER WA, 1995, J LEUKOCYTE BIOL, V57, P523, DOI 10.1002/jlb.57.4.523; Nacher M, 2011, AM J PATHOL, V178, P2437, DOI 10.1016/j.ajpath.2011.01.039; NORMAN KE, 1995, BLOOD, V86, P4417, DOI 10.1182/blood.V86.12.4417.bloodjournal86124417; O'Brien CD, 2003, BLOOD, V101, P2816, DOI 10.1182/blood-2002-08-2396; Ohno N, 1997, INFLAMMATION, V21, P313, DOI 10.1023/A:1027349900279; Roca-Cusachs P, 2012, J CELL SCI, V125, P3025, DOI 10.1242/jcs.095794; Roldan V, 2003, THROMB HAEMOSTASIS, V90, P1007, DOI 10.1160/TH02-09-0083; Sans E, 2001, J IMMUNOL, V166, P544, DOI 10.4049/jimmunol.166.1.544; Schwarz US, 2006, BIOSYSTEMS, V83, P225, DOI 10.1016/j.biosystems.2005.05.019; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; SIMON SI, 1995, J IMMUNOL, V155, P1502; Varma R, 2006, IMMUNITY, V25, P117, DOI 10.1016/j.immuni.2006.04.010; Wang HB, 2007, NAT IMMUNOL, V8, P882, DOI 10.1038/ni1491; Wang Y, 2014, J BIOL CHEM, V289, P35159, DOI 10.1074/jbc.M114.600767; Williams M, 2003, CRIT CARE MED, V31, pA45; Wittchen ES, 2009, FRONT BIOSCI-LANDMRK, V14, P2522, DOI 10.2741/3395; Wu L, 2007, J BIOL CHEM, V282, P9846, DOI 10.1074/jbc.M609219200; Yago T, 2010, BLOOD, V116, P485, DOI 10.1182/blood-2009-12-259556; Yago T, 2010, P NATL ACAD SCI USA, V107, P9204, DOI 10.1073/pnas.1003110107; Yang L, 2005, BLOOD, V106, P584, DOI 10.1182/blood-2004-12-4942; Yoshida M, 1996, J CELL BIOL, V133, P445, DOI 10.1083/jcb.133.2.445; Zarbock A, 2008, J EXP MED, V205, P2339, DOI 10.1084/jem.20072660; Zarbock A, 2012, J MOL MED, V90, P353, DOI 10.1007/s00109-011-0835-2; Zarbock A, 2011, BLOOD, V118, P6743, DOI 10.1182/blood-2011-07-343566; Zhang F, 2005, J BIOL CHEM, V280, P42207, DOI 10.1074/jbc.M510407200; Zhong Y, 2014, EUR PHYS J-SPEC TOP, V223, P1373, DOI 10.1140/epjst/e2014-02196-8; Zhu C, 2005, BIORHEOLOGY, V42, P443	58	18	18	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					212	+		10.1096/fj.201600398RRR	http://dx.doi.org/10.1096/fj.201600398RRR			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27825101	Green Submitted			2022-12-28	WOS:000392177600022
J	Park, JK; Peng, H; Yang, WD; Katsnelson, J; Volpert, O; Lavker, RM				Park, Jong Kook; Peng, Han; Yang, Wending; Katsnelson, Julia; Volpert, Olga; Lavker, Robert M.			miR-184 exhibits angiostatic properties via regulation of Akt and VEGF signaling pathways	FASEB JOURNAL			English	Article						corneal epithelium; limbal epithelium; FOG2; PDGF-beta; PPAP2B	EPITHELIAL STEM-CELLS; LIPID PHOSPHATASE SHIP2; SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR; GLYCOGEN-METABOLISM; BASAL-CELLS; EXPRESSION; ANGIOGENESIS; KERATOCONUS; MICRORNAS	Corneal a vascularity is critical for achieving transparency necessary for proper transmission of light to the lens and visual acuity. Although much is known about angiogenesis and angiostasis, the precise regulation of these processes in the cornea is unclear. MicroRNA (miR)-184, the most abundant corneal epithelial miRNA, has been suggested to function in corneal angiostasis by altering VEGF signaling; however, the mechanism(s) underlying this regulation have not been addressed. Using a combination of in vitro and in vivo assays to evaluate angiogenesis, we demonstrated that human limbal epithelial keratinocytes (HLEKs) engineered to overexpress miR-184 secreted lower amounts of angiogenic mitogens. Human dermal microvascular cells exposedto conditioned medium from miR-184-overexpressing HLEKs were less proliferative and failed to seal linear scratch wounds. The in vivo Matrigel plug assay showed that conditioned medium from miR-184-expressing HLEKs elicited a lesser degree of neovascularization compared with controls. We found that miR-184 directly targets and represses the proangiogenic factors, friend of Gata 2 (FOG2), platelet-derived growth factor (PDGF)-b, and phosphatidic acid phosphatase 2b (PPAP2B). FOG2 regulates VEGF expression, whereas PDGF-band PPAP2B regulate Akt activity. By attenuating both VEGF and Akt signaling, miR-184 acts as a broad-spectrum negative regulator of corneal angiogenesis.Park, J. K., Peng, H., Yang, W., Katsnelson, J., Volpert, O., Lavker, R. M. miR-184 exhibits angiostatic properties via regulation of Akt and VEGF signaling pathways.	[Park, Jong Kook; Peng, Han; Yang, Wending; Lavker, Robert M.] Northwestern Univ, Feinberg Sch Med, Dept Dermatol, 303 E Chicago Ave.,Ward 9-124, Chicago, IL 60611 USA; [Volpert, Olga] Northwestern Univ, Feinberg Sch Med, Dept Urol, Chicago, IL 60611 USA; [Katsnelson, Julia] New York Metropolitan Hosp, Dept Dermatol, New York, NY USA	Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine	Lavker, RM (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Dermatol, 303 E Chicago Ave.,Ward 9-124, Chicago, IL 60611 USA.	r-lavker@northwestern.edu		Park, Jong Kook/0000-0002-3946-5687; Peng, Han/0000-0002-1105-8254	U.S. National Institutes of Health (NIH) National Eye Institute [EY017536, EY019463]; NIH National Cancer Institute [CA172669]; Dermatology Foundation; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR057216]; NATIONAL CANCER INSTITUTE [P30CA060553, R01CA172669] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R21EY017536, R01EY019463] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR057216] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Dermatology Foundation; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by U.S. National Institutes of Health (NIH) National Eye Institute Grants EY017536 and EY019463 (to R.M.L.), EY019463 (to O.V.), and NIH National Cancer Institute Grant CA172669 (to O.V.); and by a Dermatology Foundation Career Development Award (to H.P.). The NU-SDRC is supported by NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant AR057216. The authors thank Drs. Spiro Getsios and Nihal Kaplan (Northwestern University) for helpful discussions.	Abramsson A, 2003, J CLIN INVEST, V112, P1142, DOI 10.1172/JCI200318549; Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Amitai-Lange A, 2015, STEM CELLS, V33, P230, DOI 10.1002/stem.1840; An JH, 2015, INVEST OPHTH VIS SCI, V56, P3673, DOI 10.1167/iovs.15-16467; Balasubramanian SA, 2010, CURR EYE RES, V35, P185, DOI 10.3109/02713680903477824; CINTRON C, 1983, INVEST OPHTH VIS SCI, V24, P543; Collier SA, 2000, CURR EYE RES, V21, P662, DOI 10.1076/0271-3683(200008)21:2;1-V;FT662; COTSARELIS G, 1989, CELL, V57, P201, DOI 10.1016/0092-8674(89)90958-6; Davidson AE, 2014, EYE, V28, P189, DOI 10.1038/eye.2013.278; DILLY PN, 1985, T OPHTHAL SOC UK, V104, P381; Dimmeler S, 2000, CIRC RES, V86, P4, DOI 10.1161/01.RES.86.1.4; Ecoiffier T, 2010, INVEST OPHTH VIS SCI, V51, P2436, DOI 10.1167/iovs.09-4505; Foley NH, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-83; Funari VA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084425; Getsios S, 2009, J CELL BIOL, V185, P1243, DOI 10.1083/jcb.200809044; Hammond SM, 2006, CURR OPIN GENET DEV, V16, P4, DOI 10.1016/j.gde.2005.12.005; Hoffmann A, 2012, MOL MED, V18, P528, DOI 10.2119/molmed.2011.00463; Hughes AE, 2011, AM J HUM GENET, V89, P628, DOI 10.1016/j.ajhg.2011.09.014; Humtsoe JO, 2003, EMBO J, V22, P1539, DOI 10.1093/emboj/cdg165; Jiang BH, 2000, P NATL ACAD SCI USA, V97, P1749, DOI 10.1073/pnas.040560897; Karar J, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00051; Kymionis GD, 2012, SEMIN OPHTHALMOL, V27, P19, DOI 10.3109/08820538.2011.588646; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Lavker RM, 2004, EXP EYE RES, V78, P433, DOI 10.1016/j.exer.2003.09.008; Lechner J, 2013, INVEST OPHTH VIS SCI, V54, P5266, DOI 10.1167/iovs.13-12035; Ljubimov AV, 2015, PROG RETIN EYE RES, V49, P17, DOI 10.1016/j.preteyeres.2015.07.002; Malzkorn B, 2010, BRAIN PATHOL, V20, P539, DOI 10.1111/j.1750-3639.2009.00328.x; Morgan CP, 2012, BIOL SEX DIFFER, V3, DOI 10.1186/2042-6410-3-22; National Eye Institute, 2012, VIS RES NEEDS GAPS O; Panchatcharam M, 2014, ARTERIOSCL THROM VAS, V34, P837, DOI 10.1161/ATVBAHA.113.302335; Peng H, 2015, STEM CELLS, V33, P1642, DOI 10.1002/stem.1962; Peng H, 2013, INVEST OPHTH VIS SCI, V54, P2781, DOI 10.1167/iovs.12-11512; Peng H, 2012, P NATL ACAD SCI USA, V109, P14030, DOI 10.1073/pnas.1111292109; Peng H, 2012, FASEB J, V26, P3140, DOI 10.1096/fj.11-198515; Phua YW, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0593-0; Raza A, 2010, AM J HEMATOL, V85, P593, DOI 10.1002/ajh.21745; Risinger GM, 2006, J BIOL CHEM, V281, P25915, DOI 10.1074/jbc.M513513200; Ryan D, 2006, MOL VIS, V12, P1175; Salido-Guadarrama I, 2014, ONCOTARGETS THER, V7, P1327, DOI 10.2147/OTT.S61562; Sasaoka T, 2003, ENDOCRINOLOGY, V144, P4204, DOI 10.1210/en.2003-0190; SCHERMER A, 1986, J CELL BIOL, V103, P49, DOI 10.1083/jcb.103.1.49; Shah S., 1989, INT CONTACT LENS CLI, V25, P128; Shalom-Feuerstein R, 2012, STEM CELLS, V30, P898, DOI 10.1002/stem.1068; Sharrard RM, 2007, CELL SIGNAL, V19, P129, DOI 10.1016/j.cellsig.2006.05.029; Sleeman MW, 2005, NAT MED, V11, P199, DOI 10.1038/nm1178; Tevosian SG, 2000, CELL, V101, P729, DOI 10.1016/S0092-8674(00)80885-5; Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400; Wecker T, 2016, INVEST OPHTH VIS SCI, V57, P1706, DOI 10.1167/iovs.15-17828; WEI ZG, 1993, INVEST OPHTH VIS SCI, V34, P1814; Yu J, 2010, FASEB J, V24, P3950, DOI 10.1096/fj.10-157404; Yu J, 2008, P NATL ACAD SCI USA, V105, P19300, DOI 10.1073/pnas.0803992105; Zhang DL, 2004, J BIOL CHEM, V279, P19683, DOI 10.1074/jbc.M313145200; Zhang DL, 2003, ONCOGENE, V22, P974, DOI 10.1038/sj.onc.1206197; Zhang HB, 2007, J CLIN INVEST, V117, P730, DOI 10.1172/JCI28984; Zhou B, 2009, J CLIN INVEST, V119, P1462, DOI 10.1172/JCI38723; Zhou MY, 2006, J BIOL CHEM, V281, P19600, DOI 10.1074/jbc.M600777200; Zhuang GL, 2012, EMBO J, V31, P3513, DOI 10.1038/emboj.2012.183; Zong RR, 2016, INVEST OPHTH VIS SCI, V57, P1398, DOI 10.1167/iovs.15-17417	59	35	38	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					257	+		10.1096/fj.201600746R	http://dx.doi.org/10.1096/fj.201600746R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27825105	Green Published			2022-12-28	WOS:000392177600025
J	Ren, HX; Luo, CM; Feng, YQ; Yao, XL; Shi, Z; Liang, FY; Kang, JX; Wan, JB; Pei, Z; Su, HX				Ren, Huixia; Luo, Chuanming; Feng, Yanqing; Yao, Xiaoli; Shi, Zhe; Liang, Fengyin; Kang, Jing X.; Wan, Jian-Bo; Pei, Zhong; Su, Huanxing			Omega-3 polyunsaturated fatty acids promote amyloid-beta clearance from the brain through mediating the function of the glymphatic system	FASEB JOURNAL			English	Article						extracellular solutes clearance; DHA; perivascular pathways; fish oil; AQP4 polarization	RECEPTOR-RELATED PROTEIN-1; MILD COGNITIVE IMPAIRMENT; DOCOSAHEXAENOIC ACID; ALZHEIMERS-DISEASE; TRANSGENIC MICE; RAT-BRAIN; FISH CONSUMPTION; TAU PATHOLOGY; DOUBLE-BLIND; MOUSE MODEL	Impairment of amyloid-beta (A beta) clearance leads to A beta accumulation in the brain during the development of Alzheimer's disease (AD). Strategies that can restore or improve the clearance function hold great promise in delaying or preventing the onset of AD. Here, we show that n-3 polyunsaturated fatty acids (PUFAs), by use of fat-1 transgenic mice and oral administration of fish oil, significantly promote interstitial A beta clearance from the brain and resist A beta injury. Such beneficial effects were abolished in Aqp4-knockout mice, suggesting that the AQP4-dependent glymphatic system is actively involved in the promoting the effects of n-3 PUFAs on the clearance of extracellular A beta. Imaging on clarified brain tissues clearly displayed that n-3 PUFAs markedly inhibit the activation of astrocytes and protect the AQP4 polarization in the affected brain region after A beta injection. The results of the present study prove a novel mechanism by which n-3 PUFAs exert protective roles in reducing A beta accumulation via mediating the glymphatic system function.-Ren, H., Luo, C., Feng, Y., Yao, X., Shi, Z., Liang, F., Kang, J. X., Wan, J.-B., Pei, Z., Su, H. Omega-3 polyunsaturated fatty acids promote amyloid-b clearance from the brain through mediating the function of the glymphatic system.	[Ren, Huixia; Shi, Zhe; Wan, Jian-Bo; Su, Huanxing] Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Macau, Peoples R China; [Luo, Chuanming; Liang, Fengyin] Guangdong Med Univ, Dept Neurol, Clin Med Coll 2, Dongguan, Peoples R China; [Feng, Yanqing; Yao, Xiaoli; Pei, Zhong] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Kang, Jing X.] Massachusetts Gen Hosp, Dept Med, Lab Lipid Med & Technol, Boston, MA 02114 USA; [Kang, Jing X.] Harvard Med Sch, Boston, MA USA	University of Macau; Guangdong Medical University; Sun Yat Sen University; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Su, HX (corresponding author), Univ Macau, State Key Lab Qual Res Chinese Med, Inst Chinese Med Sci, Macau, Peoples R China.	huanxingsu@umac.mo	Su, Huanxing/X-3980-2019; Liang, Feng/GZK-4305-2022; Liang, Fenghua/HHM-3798-2022; Su, Huanxing/X-3954-2019; Wan, Jian-Bo/D-8368-2014	Su, Huanxing/0000-0002-0513-4943; Su, Huanxing/0000-0003-3254-825X; Wan, Jian-Bo/0000-0002-6750-2617	Macau Science and Technology Development Fund [018/2013/A1, 063/2015/A2]; University of Macau [MYRG122 (Y1-L3)-ICMS12-SHX, MYRG110 (Y1-L2)-ICMS13-SHX]	Macau Science and Technology Development Fund; University of Macau	This study was supported by Macau Science and Technology Development Fund (Grants 018/2013/A1 and 063/2015/A2) and by multiyear research Grants MYRG122 (Y1-L3)-ICMS12-SHX and MYRG110 (Y1-L2)-ICMS13-SHX (University of Macau).	Arsenault D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017397; Barberger-Gateau P, 2007, NEUROLOGY, V69, P1921, DOI 10.1212/01.wnl.0000278116.37320.52; Barberger-Gateau P, 2002, BRIT MED J, V325, P932, DOI 10.1136/bmj.325.7370.932; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Broersen LM, 2013, J ALZHEIMERS DIS, V33, P177, DOI 10.3233/JAD-2012-112039; Brouillette J, 2012, J NEUROSCI, V32, P7852, DOI 10.1523/JNEUROSCI.5901-11.2012; Calon F, 2004, NEURON, V43, P633, DOI 10.1016/j.neuron.2004.08.013; Chiu CC, 2008, PROG NEURO-PSYCHOPH, V32, P1538, DOI 10.1016/j.pnpbp.2008.05.015; Chung K, 2013, NAT METHODS, V10, P508, DOI [10.1038/nmeth.2481, 10.1038/NMETH.2481]; Green KN, 2007, J NEUROSCI, V27, P4385, DOI 10.1523/JNEUROSCI.0055-07.2007; Grimm MOW, 2011, J BIOL CHEM, V286, P14028, DOI 10.1074/jbc.M110.182329; Guemez-Gamboa A, 2015, NAT GENET, V47, P809, DOI 10.1038/ng.3311; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; He CW, 2009, P NATL ACAD SCI USA, V106, P11370, DOI 10.1073/pnas.0904835106; Hossain S, 2009, J NEUROCHEM, V111, P568, DOI 10.1111/j.1471-4159.2009.06336.x; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2013, J NEUROSCI, V33, P18190, DOI 10.1523/JNEUROSCI.1592-13.2013; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Kalmijn S, 1997, ANN NEUROL, V42, P776, DOI 10.1002/ana.410420514; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kim HY, 2000, J BIOL CHEM, V275, P35215, DOI 10.1074/jbc.M004446200; Kotani S, 2006, NEUROSCI RES, V56, P159, DOI 10.1016/j.neures.2006.06.010; Kress BT, 2014, ANN NEUROL, V76, P845, DOI 10.1002/ana.24271; Ledo JH, 2013, MOL PSYCHIATR, V18, P1053, DOI 10.1038/mp.2012.168; Lee LK, 2013, PSYCHOPHARMACOLOGY, V225, P605, DOI 10.1007/s00213-012-2848-0; Lim GP, 2005, J NEUROSCI, V25, P3032, DOI 10.1523/JNEUROSCI.4225-04.2005; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Luo CM, 2014, J LIPID RES, V55, P1288, DOI 10.1194/jlr.M046466; Marteinsdottir I, 1998, PROG NEURO-PSYCHOPH, V22, P1007, DOI 10.1016/S0278-5846(98)00052-9; Mawuenyega KG, 2010, SCIENCE, V330, P1774, DOI 10.1126/science.1197623; Morris MC, 2005, ARCH NEUROL-CHICAGO, V62, P1849, DOI 10.1001/archneur.62.12.noc50161; Morris MC, 2003, ARCH NEUROL-CHICAGO, V60, P940, DOI 10.1001/archneur.60.7.940; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Nielsen S, 1997, J NEUROSCI, V17, P171; Oksman M, 2006, NEUROBIOL DIS, V23, P563, DOI 10.1016/j.nbd.2006.04.013; Orr SK, 2008, CURR OPIN INVEST DR, V9, P735; Perez SE, 2010, J NEUROSCI RES, V88, P1026, DOI 10.1002/jnr.22266; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Potter R, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005615; Rashid MA, 2013, J NEUROCHEM, V125, P869, DOI 10.1111/jnc.12255; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Russo I, 2012, J NEUROCHEM, V122, P1181, DOI 10.1111/j.1471-4159.2012.07846.x; Shibata M, 2000, J CLIN INVEST, V106, P1489, DOI 10.1172/JCI10498; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Thal DR, 2008, J CELL MOL MED, V12, P1848, DOI 10.1111/j.1582-4934.2008.00411.x; van Gelder BM, 2007, AM J CLIN NUTR, V85, P1142, DOI 10.1093/ajcn/85.4.1142; Willard AM, 2015, ELIFE, V4, DOI 10.7554/eLife.11409; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224; Zheng HY, 2016, BRAIN STRUCT FUNCT, V221, P2375, DOI 10.1007/s00429-015-1020-0; Zlokovic BV, 2010, J NEUROCHEM, V115, P1077, DOI 10.1111/j.1471-4159.2010.07002.x; Zlokovic BV, 2000, NAT MED, V6, P718, DOI 10.1038/77397	51	62	66	1	40	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					282	293		10.1096/fj.201600896	http://dx.doi.org/10.1096/fj.201600896			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27789520				2022-12-28	WOS:000392177600027
J	Guo, Y; Tang, CY; Man, XF; Tang, HN; Tang, J; Wang, F; Zhou, CL; Tan, SW; Feng, YZ; Zhou, HD				Guo, Yue; Tang, Chen-Yi; Man, Xiao-Fei; Tang, Hao-Neng; Tang, Jun; Wang, Fang; Zhou, Ci-La; Tan, Shu-Wen; Feng, Yun-Zhi; Zhou, Hou-De			Insulin receptor substrate-1 time-dependently regulates bone formation by controlling collagen I alpha 2 expression via miR-342	FASEB JOURNAL			English	Article						insulin receptor substrate; bone formation; collagen 1 alpha 2; miR-342	OSTEOGENIC DIFFERENTIATION; EXTRACELLULAR-MATRIX; ANABOLIC FUNCTION; MINERAL DENSITY; DOWN-REGULATION; ADIPOSE-TISSUE; MARROW; GROWTH; ROLES; CELLS	Insulin promotes bone formation via a well-studied canonical signaling pathway. An adapter in this pathway, insulin-receptor substrate (IRS)-1, has been implicated in the diabetic osteopathy provoked by impaired insulin signaling. To further investigate IRS-1's role in the bone metabolism, we generated Irs-1-deficient Irs-1(smla/smla) mice. These null mice developed a spontaneous mutation that led to an increase in trabecular thickness (Tb.Th) in 12-mo-old, but not in 2-mo-old mice. Analyses of the bone marrow stromal cells (BMSCs) from these mice revealed their differential expression of osteogenesis-related genes and miRNAs. The expression of miR-342, predicted and then proven to target the gene encoding collagen type I alpha 2 (COL1A2), was reduced in BMSCs derived from Irs-1-null mice. COL1A2expressionwas then shown to be age dependent in osteoblasts and BMSCs derived from Irs-1(smla/smla) mice. After the induction of osteogenesis in BMSCs, miR-342 expression correlated inversely with that of Col1a2. Further, Col1a2-specific small interfering RNA (siRNA) reduced alkaline phosphatase (ALP) activity and inhibited BMSC differentiation into osteocyte-like cells, both in wild-type (WT) and Irs-1(smla/smla) mice. Conversely, in Irs-1(smla/smla) osteocytes overexpressing COL1A2, ALP-positive staining was stronger than in WT osteocytes. In summary, we uncovered a temporal regulation of BMSC differentiation/bone formation, controlled via Irs-1/miR-342 mediated regulation of Col1a2 expression.	[Guo, Yue; Tang, Chen-Yi; Man, Xiao-Fei; Tang, Hao-Neng; Tang, Jun; Wang, Fang; Zhou, Ci-La; Tan, Shu-Wen; Zhou, Hou-De] Cent S Univ, Natl Clin Res Ctr Metab Dis, Dept Endocrinol & Metab, Xiangya Hosp 2, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China; [Feng, Yun-Zhi] Cent S Univ, Dept Stomatol, Xiangya Hosp 2, Changsha, Hunan, Peoples R China	Central South University; Central South University	Zhou, HD (corresponding author), Cent S Univ, Natl Clin Res Ctr Metab Dis, Dept Endocrinol & Metab, Xiangya Hosp 2, 139 Renmin Middle Rd, Changsha 410011, Hunan, Peoples R China.	houdezhou@csu.edu.cn		Zhou, Hou-De/0000-0001-9131-4141; Tang, Jun/0000-0002-6908-1027	National Natural Scientific Foundation of China [81370975, 81070278]; Science and Technology Department of Hunan Province [2015JC3012, 100JJ1007]	National Natural Scientific Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Department of Hunan Province	This work was supported by National Natural Scientific Foundation of China Grants 81370975 and 81070278, and Science and Technology Department of Hunan Province Grants 2015JC3012 and 100JJ1007. The authors declare no conflicts of interest.	Akune T, 2002, J CELL BIOL, V159, P147, DOI 10.1083/jcb.200204046; Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Barrow AD, 2011, J CLIN INVEST, V121, P3505, DOI 10.1172/JCI45913; Bu YH, 2009, J ENDOCRINOL INVEST, V32, P682, DOI [10.1007/BF03345741, 10.3275/6328]; Bu YH, 2010, J ENDOCRINOL, V206, P271, DOI 10.1677/JOE-10-0064; de Paula FJA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129764; Dhaliwal R, 2014, OSTEOPOROSIS INT, V25, P1969, DOI 10.1007/s00198-014-2704-7; Egusa H, 2007, TISSUE ENG, V13, P2589, DOI 10.1089/ten.2007.0080; Ell Brian, 2014, Bonekey Rep, V3, P549, DOI 10.1038/bonekey.2014.44; Fowlkes JL, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.S1-003; Fulzele K, 2010, CELL, V142, P309, DOI 10.1016/j.cell.2010.06.002; Hernandez JL, 2011, MATURITAS, V68, P217, DOI 10.1016/j.maturitas.2010.12.010; Hoshi K, 2004, J BONE MINER RES, V19, P214, DOI 10.1359/JBMR.0301221; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Kalajzic I, 2002, ENDOCRINOLOGY, V143, P1594, DOI 10.1210/en.143.5.1594; Kitamura M, 2016, J BONE MINER RES, V31, P806, DOI 10.1002/jbmr.2738; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Li EQ, 2014, MOL CELL BIOCHEM, V390, P69, DOI 10.1007/s11010-013-1957-3; Lian J B, 1995, Iowa Orthop J, V15, P118; Liao L, 2016, STEM CELLS, V34, P1054, DOI 10.1002/stem.2274; Ma H, 2015, EXP CLIN ENDOCR DIAB, V123, P126, DOI 10.1055/s-0034-1390422; Mathen PG, 2015, J CLIN DIAGN RES, V9, pOC8, DOI 10.7860/JCDR/2015/14390.6450; Ogata N, 2000, J CLIN INVEST, V105, P935, DOI 10.1172/JCI9017; Ornstrup MJ, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0792; Papaioannou G, 2014, CELL MOL LIFE SCI, V71, P4747, DOI 10.1007/s00018-014-1700-6; Pramojanee SN, 2014, ENDOCR RES, V39, P144, DOI 10.3109/07435800.2013.879168; Rios H. F., 2005, Journal of Musculoskeletal & Neuronal Interactions, V5, P325; Sacchetti B, 2007, CELL, V131, P324, DOI 10.1016/j.cell.2007.08.025; Schultz HS, 2015, J IMMUNOL, V194, P3169, DOI 10.4049/jimmunol.1402800; Selman C, 2008, FASEB J, V22, P807, DOI 10.1096/fj.07-9261com; Shimoaka T, 2004, J BIOL CHEM, V279, P15314, DOI 10.1074/jbc.M312525200; Shu A, 2012, OSTEOPOROSIS INT, V23, P635, DOI 10.1007/s00198-011-1595-0; Sun QL, 2015, BONE RES, V3, DOI 10.1038/boneres.2015.26; Szulc P, 2010, J BONE MINER RES, V25, P1446, DOI 10.1002/jbmr.13; Thrailkill K, 2014, J DIABETES RES, V2014, DOI 10.1155/2014/703589; Titorencu I, 2014, CELL TISSUE RES, V355, P23, DOI 10.1007/s00441-013-1750-3; Wang Su-Fang, 2012, Enzyme Res, V2012, P192867, DOI 10.1155/2012/192867; Wang T, 2015, J BONE MINER RES, V30, P1572, DOI 10.1002/jbmr.2510; Yamaguchi M, 2005, ENDOCRINOLOGY, V146, P2620, DOI 10.1210/en.2004-1511; Zappitelli T, 2015, MOL BIOL CELL, V26, P832, DOI 10.1091/mbc.E14-06-1136; Zhang H, 2007, J CELL BIOCHEM, V102, P1011, DOI 10.1002/jcb.21337	41	20	20	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4214	4226		10.1096/fj.201600445RR	http://dx.doi.org/10.1096/fj.201600445RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27623927	Green Published, hybrid			2022-12-28	WOS:000388201500027
J	Haldar, D; Henderson, NC; Hirschfield, G; Newsome, PN				Haldar, Debashis; Henderson, Neil C.; Hirschfield, Gideon; Newsome, Philip N.			Mesenchymal stromal cells and liver fibrosis: a complicated relationship	FASEB JOURNAL			English	Article						stem; cirrhosis; inflammation; licensing	HEPATIC STELLATE CELLS; HUMAN BONE-MARROW; STEM-CELLS; UMBILICAL-CORD; CELLULAR-THERAPY; NONALCOHOLIC STEATOHEPATITIS; INTERSTITIAL COLLAGENASE; MACROPHAGE INFILTRATION; INTERNATIONAL-SOCIETY; IMPROVE FUNCTION	Mesenchymal stromal cell (MSC) therapy demands the attention of clinicians and scientists because of its potential in clinical fields that are bereft of medical options, but also because of the controversies that underlie its mode of action. MSCs are potent immune modulators, yet their biologic activity may not be innate, requiring licensing by their microenvironment. This property has prompted researchers to explore unique ways in which MSCs may be able to exert distinct biologic effects in different pathologic settings. More than 400 clinical trials have investigated the therapeutic capacity of MSCs in different pathologies, including liver disease. Along with their antiinflammatory action, there are data to suggest that MSCs may exert direct antifibrotic effects, although enthusiasm for their use in patients has been tempered by concerns of a possible profibrotic role of endogenous MSCs in response to injury. There is a significant need for antifibrotic therapy to combat the increasing burden of patients with cirrhosis, and a concerted effort is required to determine the mechanisms by which MSCs modulate the liver's response to injury, both endogenously and after adoptive transfer. This review critically appraises the preclinical published data with regard to the capacity of MSCs to influence fibrotic response to liver injury and will explore the potential mechanisms that underpin the reported beneficial effects of MSC therapy in the context of liver injury and fibrosis. Haldar, D., Henderson, N. C., Hirschfield, G., Newsome, P. N. Mesenchymal stromal cells and liver fibrosis: a complicated relationship.	[Haldar, Debashis; Hirschfield, Gideon; Newsome, Philip N.] Univ Birmingham, Natl Inst Hlth Res, Birmingham Liver Biomed Res Unit, 5th Floor,Vincent Dr, Birmingham B15 2TT, W Midlands, England; [Haldar, Debashis; Hirschfield, Gideon; Newsome, Philip N.] Univ Birmingham, Liver Res Ctr, Birmingham, W Midlands, England; [Haldar, Debashis; Hirschfield, Gideon; Newsome, Philip N.] Univ Hosp Birmingham Natl Hlth Serv NHS Fdn Trust, Liver Unit, Birmingham, W Midlands, England; [Henderson, Neil C.] Univ Edinburgh, Queens Med Res Inst, Ctr Inflammat Res, MRC, Edinburgh, Midlothian, Scotland	University of Birmingham; University of Birmingham; University of Edinburgh	Haldar, D; Newsome, PN (corresponding author), Univ Birmingham, Natl Inst Hlth Res, Birmingham Liver Biomed Res Unit, 5th Floor,Vincent Dr, Birmingham B15 2TT, W Midlands, England.; Haldar, D; Newsome, PN (corresponding author), Univ Birmingham, Liver Res Ctr, Inst Biomed Res, 5th Floor,Vincent Dr, Birmingham B15 2TT, W Midlands, England.	d.haldar@bham.ac.uk; p.n.newsome@bham.ac.uk	Newsome, Philip N/D-4495-2018; Hirschfield, Gideon/M-2143-2015	Newsome, Philip N/0000-0001-6085-3652; Hirschfield, Gideon/0000-0002-6736-2255	Wellcome Trust; National Institute for Health Research (NIHR) Biomedical Research Unit; NIHR Biomedical Research Unit; NIHR; MRC [MR/L022699/1, G0901697] Funding Source: UKRI; Medical Research Council [G0901697, MR/L022699/1] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); National Institute for Health Research (NIHR) Biomedical Research Unit(National Institute for Health Research (NIHR)); NIHR Biomedical Research Unit(National Institute for Health Research (NIHR)); NIHR(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	D.H. is supported by the Wellcome Trust and National Institute for Health Research (NIHR) Biomedical Research Unit; P.N.N. and G.M.H. are supported by the NIHR Biomedical Research Unit; and N.C.H. is supported by the Wellcome Trust. This article presents independent research funded by the NIHR. The views expressed are those of the authors and not necessarily those of the National Health Service, the NIHR, or the UK Department of Health.	Abdel Aziz Mt, 2012, J Stem Cells Regen Med, V8, P28; Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Aldridge V, 2012, HEPATOLOGY, V56, P1063, DOI 10.1002/hep.25716; Amer MEM, 2011, EUR J GASTROEN HEPAT, V23, P936, DOI 10.1097/MEG.0b013e3283488b00; Anderson JD, 2016, STEM CELLS, V34, P601, DOI 10.1002/stem.2298; [Anonymous], 2010, REFL PAP STEM CELL B, V44, P1; Baba S, 2004, J HEPATOL, V40, P255, DOI 10.1016/j.jhep.2003.10.012; Baeck C, 2014, HEPATOLOGY, V59, P1060, DOI 10.1002/hep.26783; Baligar P, 2016, STEM CELLS, V34, P135, DOI 10.1002/stem.2210; Benyon RC, 1999, HEPATOLOGY, V30, P977, DOI 10.1002/hep.510300431; Briquet A, 2014, CYTOTHERAPY, V16, P1511, DOI 10.1016/j.jcyt.2014.07.003; British Standards Institution, 2011, PAS 93 CHAR HUM CELL; Caliari SR, 2016, INTEGR BIOL-UK, V8, P720, DOI 10.1039/c6ib00027d; Caplan A, 2009, J PATHOL, V217, P318, DOI 10.1002/path.2469; Caplan AI, 2011, CELL STEM CELL, V9, P11, DOI 10.1016/j.stem.2011.06.008; Carvalho AB, 2008, STEM CELLS, V26, P1307, DOI 10.1634/stemcells.2007-0941; Chang YJ, 2009, LIFE SCI, V85, P517, DOI 10.1016/j.lfs.2009.08.003; Chen S, 2011, LIFE SCI, V89, P975, DOI 10.1016/j.lfs.2011.10.012; Chen X, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2013.537; Cho KA, 2012, CELL BIOL INT, V36, P1267, DOI 10.1042/CBI20110634; Dazzi F, 2008, EUR J IMMUNOL, V38, P1479, DOI 10.1002/eji.200838433; Di Bonzo LV, 2008, GUT, V57, P223, DOI 10.1136/gut.2006.111617; Di Nicola M, 2002, BLOOD, V99, P3838, DOI 10.1182/blood.V99.10.3838; Dominici M, 2006, CYTOTHERAPY, V8, P315, DOI 10.1080/14653240600855905; Duffield JS, 2005, J CLIN INVEST, V115, P56, DOI 10.1172/JCI200522675; Dufour JF, 1997, ANN INTERN MED, V127, P981, DOI 10.7326/0003-4819-127-11-199712010-00006; El-Ansary M, 2012, STEM CELL REV REP, V8, P972, DOI 10.1007/s12015-011-9322-y; Elsharkawy AM, 2005, APOPTOSIS, V10, P927, DOI 10.1007/s10495-005-1055-4; Eseonu OI, 2015, RHEUMATOLOGY, V54, P210, DOI 10.1093/rheumatology/keu377; Ezquer M, 2011, J HEPATOL, V55, P1112, DOI 10.1016/j.jhep.2011.02.020; Falize L, 2006, HEPATOLOGY, V44, P472, DOI 10.1002/hep.21260; Fallowfield JA, 2007, J IMMUNOL, V178, P5288, DOI 10.4049/jimmunol.178.8.5288; Fang BJ, 2004, TRANSPLANTATION, V78, P83, DOI 10.1097/01.TP.0000128326.95294.14; Forbes SJ, 2004, GASTROENTEROLOGY, V126, P955, DOI 10.1053/j.gastro.2004.02.025; Glennie S, 2005, BLOOD, V105, P2821, DOI 10.1182/blood-2004-09-3696; Gressner AM, 2002, FRONT BIOSCI-LANDMRK, V7, pD793, DOI 10.2741/gressner; Hammel P, 2001, NEW ENGL J MED, V344, P418, DOI 10.1056/NEJM200102083440604; Harichandan A, 2011, BEST PRACT RES CL HA, V24, P25, DOI 10.1016/j.beha.2011.01.001; Henderson NC, 2007, CLIN SCI, V112, P265, DOI 10.1042/CS20060242; Higashiyama R, 2009, GASTROENTEROLOGY, V137, P1459, DOI 10.1053/j.gastro.2009.07.006; Hong F, 2002, ONCOGENE, V21, P32, DOI 10.1038/sj.onc.1205016; Hong JX, 2014, MOL MED REP, V9, P1103, DOI 10.3892/mmr.2014.1927; Hoogduijn MJ, 2016, STEM CELLS DEV, V25, P586, DOI 10.1089/scd.2015.0329; Horwitz EM, 1999, NAT MED, V5, P309, DOI 10.1038/6529; Horwitz EM, 2005, CYTOTHERAPY, V7, P393, DOI 10.1080/14653240500319234; Houlihan DD, 2008, GASTROENTEROLOGY, V135, P438, DOI 10.1053/j.gastro.2008.05.040; Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971; Huebert RC, 2014, MAYO CLIN PROC, V89, P414, DOI 10.1016/j.mayocp.2013.10.023; Ide M, 2005, J COMP PATHOL, V133, P92, DOI 10.1016/j.jcpa.2005.01.011; Imamura M, 2005, GASTROENTEROLOGY, V128, P138, DOI 10.1053/j.gastro.2004.10.005; Iredale JP, 2013, BBA-MOL BASIS DIS, V1832, P876, DOI 10.1016/j.bbadis.2012.11.002; Iredale JP, 1996, HEPATOLOGY, V24, P176, DOI 10.1002/hep.510240129; Ishikawa T, 2012, HEPATOLOGY, V55, P1215, DOI 10.1002/hep.24796; Issa R, 2001, GUT, V48, P548, DOI 10.1136/gut.48.4.548; Issa R, 2004, GASTROENTEROLOGY, V126, P1795, DOI 10.1053/j.gastro.2004.03.009; Jang YO, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0198-6; Jiao JJ, 2012, HEPATOLOGY, V55, P243, DOI 10.1002/hep.24621; Jung KH, 2009, LIVER INT, V29, P898, DOI 10.1111/j.1478-3231.2009.02031.x; Kamada Y, 2009, AM J PHYSIOL-GASTR L, V296, pG157, DOI 10.1152/ajpgi.90463.2008; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kharaziha P, 2009, EUR J GASTROEN HEPAT, V21, P1199, DOI 10.1097/MEG.0b013e32832a1f6c; Kisseleva T, 2006, J HEPATOL, V45, P429, DOI 10.1016/j.jhep.2006.04.014; Kisseleva T, 2012, P NATL ACAD SCI USA, V109, P9448, DOI 10.1073/pnas.1201840109; Kisseleva T, 2012, J HEPATOL, V56, P965, DOI 10.1016/j.jhep.2011.09.021; Kong YX, 2014, INFLAMMATION, V37, P1326, DOI 10.1007/s10753-014-9877-2; Kramann R, 2015, CELL STEM CELL, V16, P51, DOI 10.1016/j.stem.2014.11.004; Krampera M, 2011, LEUKEMIA, V25, P1408, DOI 10.1038/leu.2011.108; Krampera M, 2003, BLOOD, V101, P3722, DOI 10.1182/blood-2002-07-2104; Krampera M, 2006, STEM CELLS, V24, P386, DOI 10.1634/stemcells.2005-0008; Kwong GA, 2013, NAT BIOTECHNOL, V31, P63, DOI 10.1038/nbt.2464; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Le Blanc K, 2012, NAT REV IMMUNOL, V12, P383, DOI 10.1038/nri3209; Lei M, 2014, BIOMATERIALS, V35, P6332, DOI 10.1016/j.biomaterials.2014.04.071; Li Changjian, 2009, ACAD EXPLORATION, V1, P50; Li TF, 2013, STEM CELLS DEV, V22, P845, DOI 10.1089/scd.2012.0395; Liaskou E, 2013, HEPATOLOGY, V57, P385, DOI 10.1002/hep.26016; Liaw YF, 2004, NEW ENGL J MED, V351, P1521, DOI 10.1056/NEJMoa033364; Liaw YF, 2013, J HEPATOL, V59, P880, DOI 10.1016/j.jhep.2013.05.007; Liedtke C, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-19; Liu JP, 2014, INT J MED SCI, V11, P626, DOI 10.7150/ijms.8228; Liu Xiao, 2013, Curr Pathobiol Rep, V1, P209; Luedde T, 2014, GASTROENTEROLOGY, V147, P765, DOI 10.1053/j.gastro.2014.07.018; Magness ST, 2004, HEPATOLOGY, V40, P1151, DOI 10.1002/hep.20427; Mannheimer EG, 2011, CLIN TRANSPLANT, V25, P54, DOI 10.1111/j.1399-0012.2009.01191.x; Marcellin P, 2013, LANCET, V381, P468, DOI 10.1016/S0140-6736(12)61425-1; Martel C, 2012, CURR PHARM BIOTECHNO, V13, P726, DOI 10.2174/138920112799857558; Maylin S, 2008, GASTROENTEROLOGY, V135, P821, DOI 10.1053/j.gastro.2008.05.044; Mazza G, 2015, SCI REP-UK, V5, DOI 10.1038/srep13079; Mederacke I, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3823; Meier RPH, 2015, J HEPATOL, V62, P634, DOI 10.1016/j.jhep.2014.10.030; Miryounesi M, 2013, CELL BIOL INT, V37, P340, DOI 10.1002/cbin.10048; Miyata E, 2008, BLOOD, V111, P2427, DOI 10.1182/blood-2007-07-101261; Mohamadnejad M, 2007, ARCH IRAN MED, V10, P459; Mohamadnejad M, 2013, LIVER INT, V33, P1490, DOI 10.1111/liv.12228; Mokdad AA, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0145-y; Motawi TMK, 2014, CELL BIOCHEM BIOPHYS, V68, P111, DOI 10.1007/s12013-013-9698-1; Murray IR, 2014, CELL MOL LIFE SCI, V71, P1353, DOI 10.1007/s00018-013-1462-6; Nemeth K, 2010, P NATL ACAD SCI USA, V107, P5652, DOI 10.1073/pnas.0910720107; Newby AC, 2008, ARTERIOSCL THROM VAS, V28, P2108, DOI 10.1161/ATVBAHA.108.173898; Nielsen MJ, 2015, LIVER INT, V35, P429, DOI 10.1111/liv.12700; Ogata Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129096; Ortiz LA, 2007, P NATL ACAD SCI USA, V104, P11002, DOI 10.1073/pnas.0704421104; Otsuru S, 2015, CYTOTHERAPY, V17, P262, DOI 10.1016/j.jcyt.2014.10.013; Oyagi S, 2006, J HEPATOL, V44, P742, DOI 10.1016/j.jhep.2005.10.026; Ozturker C., 2016, ULTRASOUND MED BIOL; Pan RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.194498; Parekkadan B, 2007, BIOCHEM BIOPH RES CO, V363, P247, DOI 10.1016/j.bbrc.2007.05.150; Pellicoro A, 2014, NAT REV IMMUNOL, V14, P181, DOI 10.1038/nri3623; Pellicoro A, 2012, HEPATOLOGY, V55, P1965, DOI 10.1002/hep.25567; Peng L, 2011, HEPATOLOGY, V54, P820, DOI 10.1002/hep.24434; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Pradere JP, 2013, HEPATOLOGY, V58, P1461, DOI 10.1002/hep.26429; Quintanilha LF, 2014, HEPATOL RES, V44, pE206, DOI 10.1111/hepr.12204; Raafat N, 2015, INT J BIOCHEM CELL B, V68, P109, DOI 10.1016/j.biocel.2015.09.003; Rabani V, 2010, CELL BIOL INT, V34, P601, DOI 10.1042/CBI20090386; Radaeva S, 2006, GASTROENTEROLOGY, V130, P435, DOI 10.1053/j.gastro.2005.10.055; Ramachandran P, 2012, QJM-INT J MED, V105, P813, DOI 10.1093/qjmed/hcs069; Rasmusson I, 2007, J LEUKOCYTE BIOL, V82, P887, DOI 10.1189/jlb.0307140; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ren GW, 2009, STEM CELLS, V27, P1954, DOI 10.1002/stem.118; Ricciardi M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035639; Russo FP, 2006, GASTROENTEROLOGY, V130, P1807, DOI 10.1053/j.gastro.2006.01.036; Rustad KC, 2012, ADV WOUND CARE, V1, P147, DOI 10.1089/wound.2011.0314; Salama H, 2014, STEM CELL RES THER, V8, DOI 10.1186/scrt459; Schu S, 2012, J CELL MOL MED, V16, P2094, DOI 10.1111/j.1582-4934.2011.01509.x; Seki A, 2013, HEPATOLOGY, V58, P1133, DOI 10.1002/hep.26470; Shi M, 2012, STEM CELL TRANSL MED, V1, P725, DOI 10.5966/sctm.2012-0034; Shi ZD, 1997, P NATL ACAD SCI USA, V94, P10663, DOI 10.1073/pnas.94.20.10663; Siller-Lopez F, 2004, GASTROENTEROLOGY, V126, P1122, DOI 10.1053/j.gastro.2003.12.045; Sobrevals L, 2010, HEPATOLOGY, V51, P912, DOI 10.1002/hep.23412; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Taouli B, 2009, AM J ROENTGENOL, V193, P14, DOI 10.2214/AJR.09.2601; Teo GSL, 2015, STEM CELLS, V33, P265, DOI 10.1002/stem.1848; Thomas JA, 2011, HEPATOLOGY, V53, P2003, DOI 10.1002/hep.24315; Tsai PC, 2009, LIVER TRANSPLANT, V15, P484, DOI 10.1002/lt.21715; Tse WT, 2003, TRANSPLANTATION, V75, P389, DOI 10.1097/01.TP.0000045055.63901.A9; Wang DD, 2014, ARTHRITIS RHEUMATOL, V66, P2234, DOI 10.1002/art.38674; Wang LF, 2013, J GASTROEN HEPATOL, V28, P85, DOI 10.1111/jgh.12029; Watanabe T, 2000, J HEPATOL, V33, P224, DOI 10.1016/S0168-8278(00)80363-3; Wijesundera KK, 2014, EXP MOL PATHOL, V96, P382, DOI 10.1016/j.yexmp.2014.04.003; Williams R, 2014, LANCET, V384, P1953, DOI 10.1016/S0140-6736(14)61838-9; WINWOOD PJ, 1995, HEPATOLOGY, V22, P304; Wright MC, 2001, GASTROENTEROLOGY, V121, P685, DOI 10.1053/gast.2001.27188; Wu CX, 2013, THERANOSTICS, V3, P448, DOI 10.7150/thno.6592; Zhang Z, 2012, J GASTROEN HEPATOL, V27, P112, DOI 10.1111/j.1440-1746.2011.07024.x; Zhao DC, 2005, WORLD J GASTROENTERO, V11, P3431, DOI 10.3748/wjg.v11.i22.3431; Zhou XY, 2004, J BIOL CHEM, V279, P23996, DOI 10.1074/jbc.M311668200; Zinocker S, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00062	149	54	58	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					3905	3928		10.1096/fj.201600433R	http://dx.doi.org/10.1096/fj.201600433R			24	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27601441				2022-12-28	WOS:000388201500002
J	Ronquillo, CC; Hanke-Gogokhia, C; Revelo, MP; Frederick, JM; Jiang, L; Baehr, W				Ronquillo, Cecinio C.; Hanke-Gogokhia, Christin; Revelo, Monica P.; Frederick, Jeanne M.; Jiang, Li; Baehr, Wolfgang			Ciliopathy-associated IQCB1/NPHP5 protein is required for mouse photoreceptor outer segment formation	FASEB JOURNAL			English	Article						Senior-LOken syndrome; nephronophthisis; Leber congenital amaurosis; nephrocystins	SENIOR-LOKEN-SYNDROME; PIGMENTOSA GTPASE REGULATOR; LEBER CONGENITAL AMAUROSIS; RETINAL DEGENERATION; CILIARY TRAFFICKING; TRANSITION ZONE; DOMAIN PROTEIN; PRIMARY CILIUM; NPHP6 GENE; MUTATIONS	Null mutations in the human IQCB1/NPHP5 (nephrocystin-5) gene that encodes NPHP5 are the most frequent cause of Senior-LOken syndrome, a ciliopathy that is characterized by Leber congenital amaurosis and nephronophthisis. We generated germline Nphp5-knockout mice by placing a -Geo gene trap in intron 4, thereby truncating NPHP5 at Leu87 and removing all known functional domains. At eye opening, Nphp5(-/-) mice exhibited absence of scotopic and photopic electroretinogram responses, a phenotype that resembles Leber congenital amaurosis. Outer segment transmembrane protein accumulation in Nphp5(-/-) endoplasmic reticulum was evident as early as postnatal day (P)6. EGFP-CETN2, a centrosome and transition zone marker, identified basal bodies in Nphp5(-/-) photoreceptors, but without fully developed transition zones. Ultrastructure of P6 and 10 Nphp5(-/-) photoreceptors revealed aberrant transition zones of reduced diameter. Nphp5(-/-) photoreceptor degeneration was complete at 1 mo of age but was delayed significantly in Nphp5(-/-);Nrl(-/-) (cone only) retina. Nphp5(-/-) mouse embryonic fibroblast developed normal cilia, and Nphp5(-/-) kidney histology at 1 yr of age showed no significant pathology. Results establish that nephrocystin-5 is essential for photoreceptor outer segment formation but is dispensable for kidney and mouse embryonic fibroblast ciliary formation.	[Ronquillo, Cecinio C.; Hanke-Gogokhia, Christin; Frederick, Jeanne M.; Jiang, Li; Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, John A Moran Eye Ctr, Salt Lake City, UT 84132 USA; [Baehr, Wolfgang] Univ Utah, Hlth Sci Ctr, Dept Neurobiol & Anat, Salt Lake City, UT USA; [Hanke-Gogokhia, Christin] Univ Potsdam, Dept Biochem & Biol, Potsdam, Germany; [Revelo, Monica P.] Univ Utah, Dept Pathol, Salt Lake City, UT USA; [Baehr, Wolfgang] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Jiang, Li] Sichuan Acad Med Sci, Chengdu, Peoples R China; [Jiang, Li] Sichuan Prov Peoples Hosp, Chengdu, Peoples R China	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; University of Potsdam; Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah; Sichuan Provincial People's Hospital; Sichuan Provincial People's Hospital	Jiang, L; Baehr, W (corresponding author), Univ Utah, Hlth Sci Ctr, Dept Ophthalmol, 65 Mario Capecchi Dr, Salt Lake City, UT 84132 USA.	li.jiang@hsc.utah.edu; wbaehr@hsc.utah.edu			U.S. National Institutes of Health (NIH), National Eye Institute (NEI) National Research Service Award Grant [1F31EY021972-01A1]; NIH NEI [EY08123, EY019298, EY014800-039003]; Research to Prevent Blindness; Retina Research Foundation (Houston, TX, USA); Foundation for Retina Research; Nelson Trust Award	U.S. National Institutes of Health (NIH), National Eye Institute (NEI) National Research Service Award Grant; NIH NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Retina Research Foundation (Houston, TX, USA); Foundation for Retina Research; Nelson Trust Award	This work was supported by a U.S. National Institutes of Health (NIH), National Eye Institute (NEI) National Research Service Award Grant 1F31EY021972-01A1 (to C.C.R.), NIH NEI Grants EY08123 and EY019298 (to W.B.) and Grant EY014800-039003 (NEI Core Grant), and unrestricted grants to the Department of Ophthalmology (University of Utah) from Research to Prevent Blindness, the Retina Research Foundation (Houston, TX, USA), and the Foundation for Retina Research. W.B. is a recipient of a Research to Prevent Blindness Senior Investigator and Nelson Trust Award. This work was part of a Ph.D. thesis for the Interdepartmental Graduate Program in Neuroscience (University of Utah Health Science Center) (C.C.R.). The authors declare no conflicts of interest.	ALUBAIDI MR, 1990, J BIOL CHEM, V265, P20563; Anand M, 2012, EXPERT OPIN THER TAR, V16, P541, DOI 10.1517/14728222.2012.680956; Avasthi P, 2012, DIFFERENTIATION, V83, pS30, DOI 10.1016/j.diff.2011.11.015; Avasthi P, 2009, J NEUROSCI, V29, P14287, DOI 10.1523/JNEUROSCI.3976-09.2009; Baehr W., 2007, V45, P71; Barbelanne M, 2015, HUM MOL GENET, V24, P2185, DOI 10.1093/hmg/ddu738; Barbelanne M, 2013, HUM MOL GENET, V22, P2482, DOI 10.1093/hmg/ddt100; Bizet AA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9666; Chaki M, 2012, CELL, V150, P533, DOI 10.1016/j.cell.2012.06.028; Chaki M, 2011, KIDNEY INT, V80, P1239, DOI 10.1038/ki.2011.284; Chang B, 2006, HUM MOL GENET, V15, P1847, DOI 10.1093/hmg/ddl107; Cideciyan AV, 2011, HUM MOL GENET, V20, P1411, DOI 10.1093/hmg/ddr022; Collin GB, 2012, INVEST OPHTH VIS SCI, V53, P967, DOI 10.1167/iovs.11-8766; Cook SA, 2009, J AM SOC NEPHROL, V20, P753, DOI 10.1681/ASN.2008040412; Czarnecki PG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7023; den Hollander AI, 2008, PROG RETIN EYE RES, V27, P391, DOI 10.1016/j.preteyeres.2008.05.003; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; Donaldson JC, 2002, J BIOL CHEM, V277, P29028, DOI 10.1074/jbc.M111697200; Estrada-Cuzcano A, 2011, INVEST OPHTH VIS SCI, V52, P834, DOI 10.1167/iovs.10-5221; Friedel Roland H., 2007, Briefings in Functional Genomics & Proteomics, V6, P180, DOI 10.1093/bfgp/elm022; Gerner M, 2010, KIDNEY INT, V77, P891, DOI 10.1038/ki.2010.27; Goldstein O, 2013, INVEST OPHTH VIS SCI, V54, P7005, DOI 10.1167/iovs.13-12915; Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181; Halbritter J, 2013, AM J HUM GENET, V93, P915, DOI 10.1016/j.ajhg.2013.09.012; Halbritter J, 2013, HUM GENET, V132, P865, DOI 10.1007/s00439-013-1297-0; Hanke-Gogokhia C, 2016, J BIOL CHEM, V291, P7142, DOI 10.1074/jbc.M115.710954; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Higginbotham H, 2004, TRANSGENIC RES, V13, P155, DOI 10.1023/B:TRAG.0000026071.41735.8e; Hildebrandt F, 1997, NAT GENET, V17, P149, DOI 10.1038/ng1097-149; Jaszai J, 2007, EXP EYE RES, V85, P585, DOI 10.1016/j.exer.2006.03.022; Jiang L, 2015, FASEB J, V29, P4866, DOI 10.1096/fj.15-275677; Jiang L, 2015, J BIOL CHEM, V290, P12765, DOI 10.1074/jbc.M115.638437; Jiang ST, 2008, HUM MOL GENET, V17, P3368, DOI 10.1093/hmg/ddn231; Jiang ST, 2009, HUM MOL GENET, V18, P1566, DOI 10.1093/hmg/ddp068; Jones BW, 2011, J COMP NEUROL, V519, P2713, DOI 10.1002/cne.22703; Joo K, 2013, P NATL ACAD SCI USA, V110, P5987, DOI 10.1073/pnas.1220927110; Mattapallil MJ, 2012, INVEST OPHTH VIS SCI, V53, P2921, DOI 10.1167/iovs.12-9662; McEwen DP, 2007, P NATL ACAD SCI USA, V104, P15917, DOI 10.1073/pnas.0704140104; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Morrow EM, 1998, TRENDS CELL BIOL, V8, P353, DOI 10.1016/S0962-8924(98)01341-5; Murga-Zamalloa CA, 2010, MOL VIS, V16, P1373; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Otto EA, 2005, NAT GENET, V37, P282, DOI 10.1038/ng1520; Rachel R, 2012, CILIA, V1, P1; Rachel RA, 2015, HUM MOL GENET, V24, P3775, DOI 10.1093/hmg/ddv123; Rachel RA, 2012, J CLIN INVEST, V122, P1233, DOI 10.1172/JCI60981; Ronquillo CC, 2012, VISION RES, V75, P88, DOI 10.1016/j.visres.2012.07.003; Ronquillo C, 2013, INVEST OPHTH VIS SCI, V54; Sang LY, 2011, CELL, V145, P513, DOI 10.1016/j.cell.2011.04.019; Satir P, 2010, J CELL SCI, V123, P499, DOI 10.1242/jcs.050377; Schafer T, 2008, HUM MOL GENET, V17, P3655, DOI 10.1093/hmg/ddn260; Schuermann MJ, 2002, AM J HUM GENET, V70, P1240, DOI 10.1086/340317; Shiba D, 2012, DIFFERENTIATION, V83, pS91, DOI 10.1016/j.diff.2011.11.006; Sillibourne JE, 2013, BIOL OPEN, V2, P535, DOI 10.1242/bio.20134457; Stone EM, 2011, ARCH OPHTHALMOL-CHIC, V129, P81, DOI 10.1001/archophthalmol.2010.330; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Wolf MTF, 2011, PEDIATR NEPHROL, V26, P181, DOI 10.1007/s00467-010-1585-z; Won J, 2011, HUM MOL GENET, V20, P482, DOI 10.1093/hmg/ddq494; Yau KW, 2009, CELL, V139, P246, DOI 10.1016/j.cell.2009.09.029; Ying GX, 2014, J NEUROSCI, V34, P6377, DOI 10.1523/JNEUROSCI.0067-14.2014; Zacchigna S, 2009, J NEUROSCI, V29, P2297, DOI 10.1523/JNEUROSCI.2034-08.2009; Zhang H, 2007, P NATL ACAD SCI USA, V104, P8857, DOI 10.1073/pnas.0701681104; Zhang HB, 2015, FASEB J, V29, P932, DOI 10.1096/fj.14-257915; Zhao CT, 2011, EMBO J, V30, P2532, DOI 10.1038/emboj.2011.165	64	27	27	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3400	3412		10.1096/fj.201600511R	http://dx.doi.org/10.1096/fj.201600511R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27328943	Green Published			2022-12-28	WOS:000384329800012
J	Cousins, FL; Kirkwood, PM; Murray, AA; Collins, F; Gibson, DA; Saunders, PTK				Cousins, Fiona L.; Kirkwood, Phoebe M.; Murray, Alison A.; Collins, Frances; Gibson, Douglas A.; Saunders, Philippa T. K.			Androgens regulate scarless repair of the endometrial "wound" in a mouse model of menstruation	FASEB JOURNAL			English	Article						mesenchyme; epithelium; SNAI3; metalloproteinase; dihydrotestosterone	MATRIX METALLOPROTEINASE-3; INTRAUTERINE ADHESIONS; EXPRESSION; RECEPTOR; TISSUE; SKIN; TESTOSTERONE; ESTROGEN; CYCLE; CELL	The human endometrium undergoes regular cycles of synchronous tissue shedding (wounding) and repair that occur during menstruation before estrogen-dependent regeneration. Endometrial repair is normally both rapid and scarless. Androgens regulate cutaneous wound healing, but their role in endometrial repair is unknown. We used a murine model of simulated menses; mice were treated with a single dose of the nonaromatizable androgen dihydrotestosterone (DHT; 200 mu g/mouse) to coincide with initiation of tissue breakdown. DHT altered the duration of vaginal bleeding and delayed restoration of the luminal epithelium. Analysis of uterine mRNAs 24 h after administration of DHT identified significant changes in metalloproteinases (Mmp3 and -9; P < 0.01), a snail family member (Snai3; P < 0.001), and osteopontin (Spp1; P < 0.001). Chromatin immunoprecipitation analysis identified putative androgen receptor (AR) binding sites in the proximal promoters of Mmp9, Snai3, and Spp1. Striking spatial and temporal changes in immunoexpression of matrix metalloproteinase (MMP) 3/9 and caspase 3 were detected after DHT treatment. These data represent a paradigm shift in our understanding of the role of androgens in endometrial repair and suggest that androgens may have direct impacts on endometrial tissue integrity. These studies provide evidence that the AR is a potential target for drug therapy to treat conditions associated with aberrant endometrial repair processes.	[Cousins, Fiona L.; Kirkwood, Phoebe M.; Collins, Frances; Gibson, Douglas A.; Saunders, Philippa T. K.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland; [Murray, Alison A.] Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh	Saunders, PTK (corresponding author), Univ Edinburgh, Queens Med Res Inst, MRC, Ctr Inflammat Res, 47 Little France Crescent, Edinburgh EH16 4TJ, Midlothian, Scotland.	p.saunders@ed.ac.uk	Cousins, Fiona L/K-3790-2016; Saunders, Philippa TK/C-7489-2013	Cousins, Fiona L/0000-0002-7064-8596; Saunders, Philippa TK/0000-0001-9051-9380; Kirkwood, Phoebe/0000-0002-5245-718X; Gibson, Douglas/0000-0002-9949-1983	Medical Research Council (MRC) [G1100356/1]; MRC Ph.D. studentship; MRC Centenary Award Postdoctoral Fellowship; Medical Research Council [G1100356, 1576764, MR/N024524/1] Funding Source: researchfish; MRC [MR/N024524/1, G1100356] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Ph.D. studentship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC Centenary Award Postdoctoral Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	This study was funded by a Medical Research Council (MRC) Programme Grant (G1100356/1; to P.T.K.S.). F.L.C. was funded by an MRC Ph.D. studentship and an MRC Centenary Award Postdoctoral Fellowship. The authors declare no conflicts of interest.	ABRAHAM GE, 1974, J CLIN ENDOCR METAB, V39, P340, DOI 10.1210/jcem-39-2-340; Alawadhi F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096662; Angadi PV, 2010, ORAL MAXILLOFAC SURG, V14, P133, DOI 10.1007/s10006-010-0209-x; Bauman WA, 2013, ANN INTERN MED, V158, P718, DOI 10.7326/0003-4819-158-10-201305210-00006; Bhasin S, 2006, NAT CLIN PRACT ENDOC, V2, P146, DOI 10.1038/ncpendmet0120; Brasted M, 2003, BIOL REPROD, V69, P1273, DOI 10.1095/biolreprod.103.016550; Bui HN, 2013, STEROIDS, V78, P96, DOI 10.1016/j.steroids.2012.10.010; Chang Chawnshang, 2013, Nucl Recept Signal, V11, pe001, DOI 10.1621/nrs.11001; Chevronnay HPG, 2012, BBA-PROTEINS PROTEOM, V1824, P146, DOI 10.1016/j.bbapap.2011.09.003; Chevronnay HPG, 2009, ENDOCRINOLOGY, V150, P5094, DOI 10.1210/en.2009-0750; Cloke B, 2012, MOL CELL ENDOCRINOL, V358, P166, DOI 10.1016/j.mce.2011.06.031; Collins F, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-330; Cousins FL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086378; Cox KE, 2000, J SOC GYNECOL INVEST, V7, P242, DOI 10.1016/S1071-5576(00)00062-9; Dalton JT, 2011, J CACHEXIA SARCOPENI, V2, P153, DOI 10.1007/s13539-011-0034-6; Davison SL, 2005, J CLIN ENDOCR METAB, V90, P3847, DOI 10.1210/jc.2005-0212; DAWOOD MY, 1976, AM J OBSTET GYNECOL, V126, P430, DOI 10.1016/0002-9378(76)90632-3; Garry R, 2010, BJOG-INT J OBSTET GY, V117, P1175, DOI 10.1111/j.1471-0528.2010.02630.x; Garry R, 2009, HUM REPROD, V24, P1393, DOI 10.1093/humrep/dep036; Gibson DA, 2016, SCI REP-UK, V6, DOI 10.1038/srep19970; Gill SE, 2008, INT J BIOCHEM CELL B, V40, P1334, DOI 10.1016/j.biocel.2007.10.024; Gilliver SC, 2009, J PATHOL, V217, P73, DOI 10.1002/path.2444; Gilliver SC, 2006, J CELL SCI, V119, P722, DOI 10.1242/jcs.02786; Gilliver SC, 2007, LAB INVEST, V87, P871, DOI 10.1038/labinvest.3700627; HAMPTON AL, 1994, J ENDOCRINOL, V141, pR1, DOI 10.1677/joe.0.141R001; Hart R, 2015, J CLIN ENDOCR METAB, V100, P911, DOI 10.1210/jc.2014-3886; Hewitt SC, 2016, J MOL ENDOCRINOL, V56, pR55, DOI 10.1530/JME-15-0254; Hooker AB, 2014, HUM REPROD UPDATE, V20, P262, DOI 10.1093/humupd/dmt045; Hu JG, 2015, INT J CLIN EXP PATHO, V8, P1525; Kaitu'u-Lino TJ, 2007, ENDOCRINOLOGY, V148, P5105, DOI 10.1210/en.2007-0716; Kajihara T, 2012, FERTIL STERIL, V97, P185, DOI 10.1016/j.fertnstert.2011.10.017; Konerding MA, 2012, INT J MOL MED, V30, P271, DOI 10.3892/ijmm.2012.1005; Kundu S, 2012, J ENDOCRINOL, V215, P151, DOI 10.1530/JOE-11-0486; Kuramoto G, 2015, HUM REPROD, V30, P406, DOI 10.1093/humrep/deu326; Lai JJ, 2009, J CLIN INVEST, V119, P3739, DOI 10.1172/JCI39335; Laplante AF, 2001, FASEB J, V15, P2377, DOI 10.1096/fj.01-0250com; Larson BJ, 2010, PLAST RECONSTR SURG, V126, P1172, DOI 10.1097/PRS.0b013e3181eae781; MARBAIX E, 1992, P NATL ACAD SCI USA, V89, P11789, DOI 10.1073/pnas.89.24.11789; Marinescu VD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-79; Markova MS, 2004, J INVEST DERMATOL, V123, P1052, DOI 10.1111/j.0022-202X.2004.23494.x; Marshall E, 2011, J CLIN ENDOCR METAB, V96, pE1746, DOI 10.1210/jc.2011-0272; Massafra C, 2000, J ENDOCRINOL, V167, P447, DOI 10.1677/joe.0.1670447; Matsuura-Sawada R, 2005, HUM REPROD, V20, P1477, DOI 10.1093/humrep/deh783; Minjarez D, 2001, BIOL REPROD, V65, P1378, DOI 10.1095/biolreprod65.5.1378; Narayanan Ramesh, 2008, Nucl Recept Signal, V6, pe010, DOI 10.1621/nrs.06010; OGATA Y, 1992, J BIOL CHEM, V267, P3581; Patterson AL, 2013, STEM CELLS DEV, V22, P964, DOI 10.1089/scd.2012.0435; Salamonsen LA, 1998, TRENDS ENDOCRIN MET, V9, P305, DOI 10.1016/S1043-2760(98)00078-2; SHAPIRO SD, 1995, J BIOL CHEM, V270, P6351, DOI 10.1074/jbc.270.11.6351; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Simitsidellis I, 2016, ENDOCRINOLOGY, V157, P2116, DOI 10.1210/en.2015-2032; SMID A, 1980, ZBL GYNAKOL, V102, P380; Toraldo G, 2012, WOUND REPAIR REGEN, V20, P61, DOI 10.1111/j.1524-475X.2011.00757.x; WAHI PN, 1966, BRIT J CANCER, V20, P676, DOI 10.1038/bjc.1966.79; Wilgus TA, 2008, PHARMACOL RES, V58, P112, DOI 10.1016/j.phrs.2008.07.009; Wong JW, 2009, WOUND REPAIR REGEN, V17, P717, DOI 10.1111/j.1524-475X.2009.00531.x; Yu D, 2008, FERTIL STERIL, V89, P759, DOI 10.1016/j.fertnstert.2008.02.096; Zhang X, 1996, BIOL REPROD, V55, P519, DOI 10.1095/biolreprod55.3.519	58	20	21	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2802	2811		10.1096/fj.201600078R	http://dx.doi.org/10.1096/fj.201600078R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27121597	Green Published, hybrid			2022-12-28	WOS:000380994000016
J	Kong, L; Zhao, YP; Tian, QY; Feng, JQ; Kobayashi, T; Merregaert, J; Liu, CJ				Kong, Li; Zhao, Yun-Peng; Tian, Qing-Yun; Feng, Jian-Quan; Kobayashi, Tatsuya; Merregaert, Joseph; Liu, Chuan-Ju			Extracellular matrix protein 1, a direct targeting molecule of parathyroid hormone-related peptide, negatively regulates chondrogenesis and endochondral ossification via associating with progranulin growth factor	FASEB JOURNAL			English	Article						ECM1; PTHrP; PGRN	GRANULIN-EPITHELIN PRECURSOR; LIPOID PROTEINOSIS; INDIAN HEDGEHOG; PTH/PTHRP RECEPTOR; HOST-DEFENSE; GENE; ECM1; ADAMTS-7; AUTOANTIBODIES; MUTATIONS	Chondrogenesis and endochondral ossification are precisely controlled by cellular interactions with surrounding matrix proteins and growth factors that mediate cellular signaling pathways. Here, we report that extracellular matrix protein 1 (ECM1) is a previously unrecognized regulator of chondrogenesis. ECM1 is induced in the course of chondrogenesis and its expression in chondrocytes strictly depends on parathyroid hormone-related peptide (PTHrP) signaling pathway. Overexpression of ECM1 suppresses, whereas suppression of ECM1 enhances, chondrocyte differentiation and hypertrophy in vitro and ex vivo. In addition, target transgene of ECM1 in chondrocytes or osteoblasts in mice leads to striking defects in cartilage development and endochondral bone formation. Of importance, ECM1 seems to be critical for PTHrP action in chondrogenesis, as blockage of ECM1 nearly abolishes PTHrP regulation of chondrocyte hypertrophy, and overexpression of ECM1 rescues disorganized growth plates of PTHrP-null mice. Furthermore, ECM1 and progranulin chondrogenic growth factor constitute an interaction network and act in concert in the regulation of chondrogenesis.	[Kong, Li; Zhao, Yun-Peng; Tian, Qing-Yun; Liu, Chuan-Ju] NYU, Sch Med, Dept Orthoped Surg, New York, NY USA; [Liu, Chuan-Ju] NYU, Sch Med, Dept Cell Biol, New York, NY 10016 USA; [Feng, Jian-Quan] Texas A&M Baylor Coll Dent, Dept Biomed Sci, Dallas, TX USA; [Kobayashi, Tatsuya] Massachusetts Gen Hosp, Endocrine Unit, Boston, MA 02114 USA; [Merregaert, Joseph] Univ Antwerp, Mol Biotechnol Lab, Antwerp, Belgium	New York University; New York University; Harvard University; Massachusetts General Hospital; University of Antwerp	Liu, CJ (corresponding author), NYU, Med Ctr, Dept Orthoped Surg, Rm 1608,HJD,301 E 17th St, New York, NY 10003 USA.	chuanju.liu@med.nyu.edu	Liu, Chuan-ju/AAT-8165-2021	liu, chuanju/0000-0002-7181-8032; Kobayashi, Tatsuya/0000-0003-4264-5117	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01-AR062207, R01-AR061484]; Rheumatology Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR061484, R01AR062207, R01AR056645] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); Rheumatology Research Foundation; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank Dr. Brendan Lee (Baylor College of Medicine, Houston, TX, USA) for providing both Col II- and Col I-specific transgenic constructs used for generating ECM1 transgenic mice in this study, and Aubryanna Hettinghouse (New York University School of Medicine) for assistance in preparing the manuscript. This work was supported in part by U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grants R01-AR062207 and R01-AR061484), and a Disease Targeted Research Grant from the Rheumatology Research Foundation (to C.-J.L.).	AMIZUKA N, 1994, J CELL BIOL, V126, P1611, DOI 10.1083/jcb.126.6.1611; Bai XH, 2009, MOL CELL BIOL, V29, P4201, DOI 10.1128/MCB.00056-09; Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bateman A, 2009, BIOESSAYS, V31, P1245, DOI 10.1002/bies.200900086; Buckland Jenny, 2013, Nat Rev Rheumatol, V9, P566, DOI 10.1038/nrrheum.2013.135; Chamoto K, 2013, STEM CELL RES, V10, P267, DOI 10.1016/j.scr.2012.12.006; Chan I, 2004, CLIN EXP DERMATOL, V29, P499, DOI 10.1111/j.1365-2230.2004.01573.x; Correa D, 2010, DEV CELL, V19, P533, DOI 10.1016/j.devcel.2010.09.008; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Deckers MML, 2001, BONE, V28, P14, DOI 10.1016/S8756-3282(00)00428-2; Edmonds E, 2011, INT J EXP PATHOL, V92, P320, DOI 10.1111/j.1365-2613.2011.00779.x; Feng JAQ, 2010, FASEB J, V24, P1879, DOI 10.1096/fj.09-144659; Fisher SA, 2008, NAT GENET, V40, P710, DOI 10.1038/ng.145; Fujimoto N, 2006, EXP DERMATOL, V15, P300, DOI 10.1111/j.0906-6705.2006.00409.x; Guo FJ, 2010, ARTHRITIS RHEUM-US, V62, P2023, DOI 10.1002/art.27491; Guo J, 2002, DEV CELL, V3, P183, DOI 10.1016/S1534-5807(02)00218-6; Guo J, 2010, ENDOCRINOLOGY, V151, P3502, DOI 10.1210/en.2009-1494; Hamada T, 2003, J INVEST DERMATOL, V120, P345, DOI 10.1046/j.1523-1747.2003.12073.x; Hamada T, 2002, HUM MOL GENET, V11, P833, DOI 10.1093/hmg/11.7.833; He ZH, 2003, NAT MED, V9, P225, DOI 10.1038/nm816; Hirai T, 2011, P NATL ACAD SCI USA, V108, P191, DOI 10.1073/pnas.1005011108; Hoogendam J, 2007, HORM RES, V67, P159, DOI 10.1159/000096586; Jung C, 2009, GASTROEN CLIN BIOL, V33, pS123, DOI 10.1016/S0399-8320(09)73147-1; KARAPLIS AC, 1994, GENE DEV, V8, P277, DOI 10.1101/gad.8.3.277; Karaplis AC, 1996, VITAM HORM, V52, P177, DOI 10.1016/S0083-6729(08)60411-2; Kessenbrock K, 2008, J CLIN INVEST, V118, P2438, DOI 10.1172/JCI34694; Kobayashi T, 2002, DEVELOPMENT, V129, P2977; Kong L, 2010, MATRIX BIOL, V29, P276, DOI 10.1016/j.matbio.2010.01.007; Kronenberg HM, 2003, NATURE, V423, P332, DOI 10.1038/nature01657; Lai YJ, 2014, ANN RHEUM DIS, V73, P1575, DOI 10.1136/annrheumdis-2013-203561; Lanske B, 1996, SCIENCE, V273, P663, DOI 10.1126/science.273.5275.663; Li ZH, 2011, NAT IMMUNOL, V12, P178, DOI 10.1038/ni.1983; Liu CJ, 2012, PHARMACOL THERAPEUT, V133, P124, DOI 10.1016/j.pharmthera.2011.10.003; Liu CJ, 2011, FEBS LETT, V585, P3675, DOI 10.1016/j.febslet.2011.04.065; Luan Y, 2008, OSTEOARTHR CARTILAGE, V16, P1413, DOI 10.1016/j.joca.2008.03.017; Mongiat M, 2003, J BIOL CHEM, V278, P17491, DOI 10.1074/jbc.M210529200; Napierala D, 2012, J BONE MINER RES, V27, P1735, DOI 10.1002/jbmr.1636; Oyama N, 2004, J CLIN INVEST, V113, P1550, DOI 10.1172/GCI200420373; Oyama N, 2003, LANCET, V362, P118, DOI 10.1016/S0140-6736(03)13863-9; Paroly SS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084155; Quirici MB, 2013, NEUROLOGY, V80, pE93, DOI 10.1212/WNL.0b013e3182840741; Sercu S, 2008, CANCER INVEST, V26, P375, DOI 10.1080/07357900701788148; Sercu S, 2008, J INVEST DERMATOL, V128, P1397, DOI 10.1038/sj.jid.5701231; Tang W, 2011, SCIENCE, V332, P478, DOI 10.1126/science.1199214; Tian QY, 2012, JOVE-J VIS EXP, DOI 10.3791/3562; Vortkamp A, 1996, SCIENCE, V273, P613, DOI 10.1126/science.273.5275.613; Wils H, 2012, J PATHOL, V228, P67, DOI 10.1002/path.4043; Wu H, 2011, SCIENCE, V332, P427, DOI 10.1126/science.1205992; Xu K, 2007, J BIOL CHEM, V282, P11347, DOI 10.1074/jbc.M608744200; Yin FF, 2010, J EXP MED, V207, P117, DOI 10.1084/jem.20091568; Zhao YP, 2013, FEBS LETT, V587, P1805, DOI 10.1016/j.febslet.2013.04.037; Zhao YP, 2013, BIOMATERIALS, V34, P6412, DOI 10.1016/j.biomaterials.2013.05.030; Zhu J, 2002, CELL, V111, P867, DOI 10.1016/S0092-8674(02)01141-8	53	10	10	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2741	2754		10.1096/fj.201600261R	http://dx.doi.org/10.1096/fj.201600261R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27075243	Green Published			2022-12-28	WOS:000380994000011
J	Miralem, T; Lerner-Marmarosh, N; Gibbs, PEM; Jenkins, JL; Heimiller, C; Maines, MD				Miralem, Tihomir; Lerner-Marmarosh, Nicole; Gibbs, Peter E. M.; Jenkins, Jermaine L.; Heimiller, Chelsea; Maines, Mahin D.			Interaction of human biliverdin reductase with Akt/protein kinase B and phosphatidylinositol-dependent kinase 1 regulates glycogen synthase kinase 3 activity: a novel mechanism of Akt activation	FASEB JOURNAL			English	Article						activation of hBVR; Akt/hBVR/GSK3 axis; bilirubin; heme oxygenase 1	NF-KAPPA-B; TRANSCRIPTION FACTOR NRF2; IX-ALPHA REDUCTASE; PROTEIN-KINASE; HEME OXYGENASE-1; CRYSTAL-STRUCTURE; SIGNALING PATHWAYS; PEPTIDE-FRAGMENTS; ENDOTHELIAL-CELLS; INSULIN-RECEPTOR	Biliverdin reductase A(BVR) and Akt isozymes have overlapping pleiotropic functions in the insulin/PI3K/MAPK pathway. Human BVR (hBVR) also reduces the hemeoxygenase activity product biliverdin to bilirubin and is directly activated by insulin receptor kinase (IRK). Akt isoenzymes (Akt1-3) are downstream of IRK and are activated by phosphatidylinositol-dependent kinase 1 (PDK1) phosphorylating T-308 before S-473 autophosphorylation. Akt (RxRxxSF) and PDK1 (RFxFPxFS) binding motifs are present in hBVR. Phosphorylation of glycogen synthase kinase 3 (GSK3) isoforms alpha/beta by Akts inhibits their activity; nonphosphorylated GSK3 beta inhibits activation of various genes. We examined the role of hBVR in PDK1/Akt1/GSK3 signaling and Akt1 in hBVR phosphorylation. hBVR activates phosphorylation of Akt1 at S-473 independent of hBVR's kinase competency. hBVR and Akt1 coimmunoprecipitated, and in-cell Forster resonance energy transfer (FRET) and glutathione S-transferase pulldown analyses identified Akt1 pleckstrin homology domain as the interactive domain. hBVR activates phosphorylation of Akt1 at S-473 independent of hBVR's kinase competency. Site-directed mutagenesis, mass spectrometry, and kinetic analyses identified S-230 in hBVR (RNRYLSF)-R-225 sequence as the Akt1 target. Underlined amino acids are the essential residues of the signaling motifs. In cells, hBVR-activated Akt1 increased both GSK3 alpha/beta and forkhead box of theOclass transcription class 3(FoxO3) phosphorylation and inhibited total GSK3 activity; depletion of hBVR released inhibition and stimulated glucose uptake. Immunoprecipitation analysis showed that PDK1 and hBVR interact through hBVR's PDK1 binding (161)RFGFPAFS motif and formation of the PDK1/hBVR/Akt1 complex. sihBVR blocked complex formation. Findings identify hBVR as a previously unknown coactivator of Akt1 and as a key mediator of Akt1/GSK3 pathway, as well as define a key role for hBVR in Akt1 activation by PDK1.	[Miralem, Tihomir; Lerner-Marmarosh, Nicole; Gibbs, Peter E. M.; Jenkins, Jermaine L.; Heimiller, Chelsea; Maines, Mahin D.] Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA	University of Rochester	Maines, MD (corresponding author), Univ Rochester, Sch Med & Dent, Dept Biochem & Biophys, Rochester, NY 14642 USA.	mahin_maines@urmc.rochester.edu		Jenkins, Jermaine/0000-0003-2548-3275	U.S. National Institutes of Health, National Institute of Environmental Health Sciences [ES004066]; University of Rochester Environmental Health Sciences Center [P30ES001247]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES004066, P30ES001247] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); University of Rochester Environmental Health Sciences Center; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the U.S. National Institutes of Health, National Institute of Environmental Health Sciences (Grant ES004066) and funding from the University of Rochester Environmental Health Sciences Center (P30ES001247). The authors are particularly indebted to L. Callahan (Director of the Confocal and Conventional Microscopy Resource, University of Rochester) for her guidance and assistance with the in-cell FRET measurements. The authors also thank the University of Rochester Clinical and Translational Science Institute for purchase of the incubator chamber and Binder incubator, which facilitated these studies. Thanks are also due to S. Ghaemmeghami, K. Welle, and J. Hryhorenko (University of Rochester Proteomics Core Facility) for the mass spectrometry analyses.	Agamasu C, 2015, J BIOL CHEM, V290, P27403, DOI 10.1074/jbc.M115.673939; Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9; Ali A, 2001, CHEM REV, V101, P2527, DOI 10.1021/cr000110o; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Barone E, 2014, NEUROBIOL DIS, V62, P144, DOI 10.1016/j.nbd.2013.09.018; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bisht K, 2014, BIOCHEM BIOPH RES CO, V449, P94, DOI 10.1016/j.bbrc.2014.04.150; Bitar MS, 2011, AM J PHYSIOL-ENDOC M, V301, pE1119, DOI 10.1152/ajpendo.00047.2011; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Brodbeck D, 1999, J BIOL CHEM, V274, P9133, DOI 10.1074/jbc.274.14.9133; Brunet A, 2002, J CELL BIOL, V156, P817, DOI 10.1083/jcb.200112059; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Coffer PJ, 1998, BIOCHEM J, V335, P1; Dansen TB, 2008, TRENDS CELL BIOL, V18, P421, DOI 10.1016/j.tcb.2008.07.004; Datta SR, 1999, GENE DEV, V13, P2905, DOI 10.1101/gad.13.22.2905; Dillon RL, 2009, CANCER RES, V69, P5057, DOI 10.1158/0008-5472.CAN-08-4287; Doble BW, 2007, DEV CELL, V12, P957, DOI 10.1016/j.devcel.2007.04.001; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Florczyk U, 2014, ANTIOXID REDOX SIGN, V20, P1693, DOI 10.1089/ars.2013.5219; Gibbs PEM, 2007, INT J CANCER, V121, P2567, DOI 10.1002/ijc.22978; Gibbs PEM, 2014, FASEB J, V28, P2478, DOI 10.1096/fj.13-247015; Gibbs PEM, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00031; Gibbs PEM, 2012, J BIOL CHEM, V287, P1066, DOI 10.1074/jbc.M111.279612; Gibbs PEM, 2010, FASEB J, V24, P3239, DOI 10.1096/fj.09-144592; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Grivennikov SI, 2010, CELL, V140, P883, DOI 10.1016/j.cell.2010.01.025; Hanada M, 2004, BBA-PROTEINS PROTEOM, V1697, P3, DOI 10.1016/j.bbapap.2003.11.009; Hayes JD, 2015, BIOCHEM SOC T, V43, P611, DOI 10.1042/BST20150011; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Heron-Milhavet L, 2006, MOL CELL BIOL, V26, P8267, DOI 10.1128/MCB.00201-06; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Jacobs D, 1999, GENE DEV, V13, P163, DOI 10.1101/gad.13.2.163; JONES PF, 1991, P NATL ACAD SCI USA, V88, P4171, DOI 10.1073/pnas.88.10.4171; Jozkowicz A, 2003, ANTIOXID REDOX SIGN, V5, P155, DOI 10.1089/152308603764816514; Kapitulnik J, 2009, TRENDS PHARMACOL SCI, V30, P129, DOI 10.1016/j.tips.2008.12.003; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; KEYSE SM, 1989, P NATL ACAD SCI USA, V86, P99, DOI 10.1073/pnas.86.1.99; Khan A, 2015, NEUROSCIENCE, V287, P66, DOI 10.1016/j.neuroscience.2014.12.018; Kikuchi A, 2001, NAT STRUCT BIOL, V8, P221, DOI 10.1038/84955; Kitamura T, 2008, NAT CELL BIOL, V10, P329, DOI 10.1038/ncb1695; Kravets A, 2004, J BIOL CHEM, V279, P19916, DOI 10.1074/jbc.M314251200; Kumar CC, 2005, ONCOGENE, V24, P7493, DOI 10.1038/sj.onc.1209087; KUTTY RK, 1981, J BIOL CHEM, V256, P3956; Laine J, 2000, MOL CELL, V6, P395, DOI 10.1016/S1097-2765(00)00039-3; Laine J, 2002, J BIOL CHEM, V277, P3743, DOI 10.1074/jbc.M107069200; Lerner-Marmarosh N, 2005, P NATL ACAD SCI USA, V102, P7109, DOI 10.1073/pnas.0502173102; Lerner-Marmarosh N, 2008, P NATL ACAD SCI USA, V105, P6870, DOI 10.1073/pnas.0800750105; Lerner-Marmarosh N, 2007, FASEB J, V21, P3949, DOI 10.1096/fj.07-8544com; Maines MD, 2007, ANTIOXID REDOX SIGN, V9, P2187, DOI 10.1089/ars.2007.1805; Maines MD, 2007, J BIOL CHEM, V282, P8110, DOI 10.1074/jbc.M513427200; MAINES MD, 1993, ARCH BIOCHEM BIOPHYS, V300, P320, DOI 10.1006/abbi.1993.1044; Maines MD, 1996, EUR J BIOCHEM, V235, P372, DOI 10.1111/j.1432-1033.1996.00372.x; MAINES MD, 1986, J BIOL CHEM, V261, P411; MAINES MD, 2013, HDB PORPHYRIN SCI, V26, P380; Miralem T, 2005, J BIOL CHEM, V280, P17084, DOI 10.1074/jbc.M413121200; Miralem T, 2012, J BIOL CHEM, V287, P24698, DOI 10.1074/jbc.M111.326504; Miralem T, 2010, J BIOL CHEM, V285, P12551, DOI 10.1074/jbc.M109.032771; Naidu S, 2008, J IMMUNOL, V181, P4113, DOI 10.4049/jimmunol.181.6.4113; Najafov A, 2012, BIOCHEM J, V448, P285, DOI 10.1042/BJ20121287; O'Brien L, 2015, TRENDS ENDOCRIN MET, V26, P212, DOI 10.1016/j.tem.2015.02.001; Ogg S, 1997, NATURE, V389, P994, DOI 10.1038/40194; Alok SP, 2007, J MOL CELL CARDIOL, V43, P580, DOI 10.1016/j.yjmcc.2007.08.003; Paine A, 2010, BIOCHEM PHARMACOL, V80, P1895, DOI 10.1016/j.bcp.2010.07.014; Parekh DB, 2000, EMBO J, V19, P496, DOI 10.1093/emboj/19.4.496; Periasamy A, 2008, METHOD CELL BIOL, V89, P569, DOI 10.1016/S0091-679X(08)00622-5; Periasamy A, 1998, J BIOMED OPT, V3, P154, DOI 10.1117/1.429872; Rayasam GV, 2009, BRIT J PHARMACOL, V156, P885, DOI 10.1111/j.1476-5381.2008.00085.x; Salazar M, 2006, J BIOL CHEM, V281, P14841, DOI 10.1074/jbc.M513737200; Salim M, 2001, J BIOL CHEM, V276, P10929, DOI 10.1074/jbc.M010753200; Sedlak TW, 2009, J BIOL CHEM, V284, pLE11, DOI 10.1074/jbc.L109.037119; SHIBAHARA S, 1987, J BIOL CHEM, V262, P12889; Shinohara M, 2010, J BIOL CHEM, V285, P8244, DOI 10.1074/jbc.M109.054999; Singh A, 2010, MOL BIOL CELL, V21, P1140, DOI 10.1091/mbc.E09-09-0795; Stephens L, 1998, SCIENCE, V279, P710, DOI 10.1126/science.279.5351.710; Stocker R, 2004, ANTIOXID REDOX SIGN, V6, P841, DOI 10.1089/1523086041797999; STOCKER R, 1987, SCIENCE, V235, P1043, DOI 10.1126/science.3029864; Stokoe D, 1997, SCIENCE, V277, P567, DOI 10.1126/science.277.5325.567; Toker Alex, 2014, Advances in Biological Regulation, V55, P28, DOI 10.1016/j.jbior.2014.04.001; Tschopp O, 2005, DEVELOPMENT, V132, P2943, DOI 10.1242/dev.01864; Tudor C, 2008, BIOCHEM J, V413, P405, DOI 10.1042/BJ20080018; VIRGILIO L, 1994, P NATL ACAD SCI USA, V91, P12530, DOI 10.1073/pnas.91.26.12530; Vitek L, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00055; Wang L, 2008, INVEST OPHTH VIS SCI, V49, P1671, DOI 10.1167/iovs.07-1099; Wegiel B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00047; Wegiel B, 2009, J BIOL CHEM, V284, P21369, DOI 10.1074/jbc.M109.027433; Whitby FG, 2002, J MOL BIOL, V319, P1199, DOI 10.1016/S0022-2836(02)00383-2; Wijayanti N, 2004, ANTIOXID REDOX SIGN, V6, P802, DOI 10.1089/1523086041798132; Xu C, 2009, CELL CYCLE, V8, P4032, DOI 10.4161/cc.8.24.10111; Yang ZZ, 2004, BIOCHEM SOC T, V32, P350, DOI 10.1042/BST0320350; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zhang JS, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.102; Zimmermann K, 2015, FREE RADICAL BIO MED, V88, P417, DOI 10.1016/j.freeradbiomed.2015.03.030	93	29	31	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2926	2944		10.1096/fj.201600330RR	http://dx.doi.org/10.1096/fj.201600330RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27166089	Green Published			2022-12-28	WOS:000380994000026
J	Unachukwu, U; Trischler, J; Goldklang, M; Xiao, R; D'Armiento, J				Unachukwu, Uchenna; Trischler, Jordis; Goldklang, Monica; Xiao, Rui; D'Armiento, Jeanine			Maternal smoke exposure decreases mesenchymal proliferation and modulates Rho-GTPase-dependent actin cytoskeletal signaling in fetal lungs	FASEB JOURNAL			English	Article						apoptosis; cigarette smoke; in utero; proliferation; Wnt/beta-catenin	ENDOTHELIAL BARRIER FUNCTION; FRIZZLED-RELATED PROTEIN-1; PARENTAL SMOKING; IN-VITRO; RNA-SEQ; GROWTH; PREGNANCY; MORPHOGENESIS; EMPHYSEMA; TOBACCO	The present study tested the hypothesis that maternal smoke exposure results in fetal lung growth retardation due to dysregulation in various signaling pathways, including the Wnt (wingless-related integration site)/beta-catenin pathway. Pregnant female C57BL/6J mice were exposed to cigarette smoke (100-150mg/m(3)) or room air, and offspring were humanely killed on 12.5, 14.5, 16.5, and 18.5 d post coitum (dpc). We assessed lung stereology with Cavalieri estimation; apoptosis with proliferating cell nuclear antigen, TUNEL, and caspase assays; and gene expression with quantitative PCR (qPCR) and RNA sequencing on lung epithelium and mesenchyme retrieved by laser capture microdissection. Results demonstrated a significant decrease in body weight and lung volume of smoke-exposed embryos. At 16.5 dpc, the reduction in lung volume was due to loss of lung mesenchymal tissue correlating with a decrease in cell proliferation (n = 10; air: 61.65% vs. smoke: 44.21%, P < 0.05). RNA sequence analysis demonstrated an alteration in the Wnt pathway, and qPCR confirmed an increased expression of secreted frizzled-related protein 1 (sFRP-1) [n = 12; relative quantification (RQ) 1 vs. 2.33, P < 0.05] and down-regulation ofCyclinD1 (n= 7; RQ1vs. 0.61, P < 0.05) inmesenchymal tissue. Furthermore, genome expression studies revealed a smoke-induced up-regulation of Rho-GTPase-dependent actin cytoskeletal signaling that can lead to loss of tissue integrity.	[Unachukwu, Uchenna; Trischler, Jordis; Goldklang, Monica; Xiao, Rui; D'Armiento, Jeanine] Columbia Univ, Dept Anesthesiol, Ctr Pulm Dis, Coll Phys & Surg, 630 West 168th St, New York, NY 10032 USA	Columbia University	D'Armiento, J (corresponding author), Columbia Univ, Dept Anesthesiol, Ctr Pulm Dis, Coll Phys & Surg, 630 West 168th St, New York, NY 10032 USA.	jmd12@cumc.columbia.edu		Goldklang, Monica/0000-0002-7019-3130; unachukwu, uchenna/0000-0001-8248-5723	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL086936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008464] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL086936] Funding Source: Medline; NIGMS NIH HHS [T32 GM008464] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Anblagan D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067223; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Blacquiere MJ, 2010, THORAX, V65, P553, DOI 10.1136/thx.2009.120154; Blacquiere MJ, 2009, EUR RESPIR J, V33, P1133, DOI 10.1183/09031936.00129608; Bogatcheva NV, 2009, MICROVASC RES, V77, P64, DOI 10.1016/S0026-2862(09)00021-1; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Caleyachetty R, 2014, LANCET GLOB HEALTH, V2, pE513, DOI 10.1016/S2214-109X(14)70283-9; Cloonan SM, 2016, NAT MED, V22, P163, DOI 10.1038/nm.4021; COLLINS MH, 1985, PEDIATR RES, V19, P408, DOI 10.1203/00006450-198519040-00018; De Langhe Stijn P, 2008, Organogenesis, V4, P100; Elliot J, 1998, AM J RESP CRIT CARE, V158, P802, DOI 10.1164/ajrccm.158.3.9709055; Elliot J, 2001, AM J RESP CRIT CARE, V163, P140, DOI 10.1164/ajrccm.163.1.9805099; Esposito ER, 2008, TOXICOLOGY, V246, P193, DOI 10.1016/j.tox.2008.01.014; Foronjy R, 2010, AM J PATHOL, V177, P598, DOI 10.2353/ajpath.2010.090803; Garcia JGN, 2009, MICROVASC RES, V77, P1, DOI 10.1016/j.mvr.2009.01.001; Gilliland FD, 2000, THORAX, V55, P271, DOI 10.1136/thorax.55.4.271; Hsia CCW, 2010, AM J RESP CRIT CARE, V181, P394, DOI 10.1164/rccm.200809-1522ST; Iniguez C, 2013, AM J EPIDEMIOL, V178, P1067, DOI 10.1093/aje/kwt085; Kasahara Y, 2000, J CLIN INVEST, V106, P1311, DOI 10.1172/JCI10259; Kawkitinarong K, 2004, AM J RESP CELL MOL, V31, P517, DOI 10.1165/rcmb.2003-0432OC; Kim BM, 2005, DEV CELL, V8, P611, DOI 10.1016/j.devcel.2005.01.015; Kim HY, 2012, ORGANOGENESIS, V8, P56, DOI 10.4161/org.19813; Kneidinger N, 2011, AM J RESP CRIT CARE, V183, P723, DOI 10.1164/rccm.200910-1560OC; Komarova Yulia A, 2007, Sci STKE, V2007, pre8; Larcombe AN, 2011, EUR RESPIR J, V38, P932, DOI 10.1183/09031936.00156910; Li CG, 2002, DEV BIOL, V248, P68, DOI 10.1006/dbio.2002.0729; Li CG, 2015, STEM CELLS, V33, P999, DOI 10.1002/stem.1911; Li XY, 1996, THORAX, V51, P465, DOI 10.1136/thx.51.5.465; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Manoli SE, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-42; Minoo P, 1995, DEV BIOL, V172, P694, DOI 10.1006/dbio.1995.8080; Morrison D, 1999, AM J RESP CRIT CARE, V159, P473, DOI 10.1164/ajrccm.159.2.9804080; Moshammer H, 2006, AM J RESP CRIT CARE, V173, P1255, DOI 10.1164/rccm.200510-1552OC; Mukhametshina RT, 2013, J PROTEOME RES, V12, P5598, DOI 10.1021/pr400573k; Olivera DS, 2007, INHAL TOXICOL, V19, P13, DOI 10.1080/08958370600985768; Ornitz DM, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008318; Pattenden S, 2006, TOB CONTROL, V15, DOI 10.1136/tc.2005.015065; Petre MA, 2011, INT J TOXICOL, V30, P244, DOI 10.1177/1091581810395332; Pollack D, 2015, TOXICOL LETT, V234, P120, DOI 10.1016/j.toxlet.2015.02.006; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Rajagopal J, 2008, DEVELOPMENT, V135, P1625, DOI 10.1242/dev.015495; Rehan VK, 2009, LUNG, V187, P281, DOI 10.1007/s00408-009-9158-2; Rogers JM, 2009, REPROD TOXICOL, V28, P152, DOI 10.1016/j.reprotox.2009.03.012; Salaets T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136569; Scavo LM, 1998, AM J RESP CELL MOL, V18, P21, DOI 10.1165/ajrcmb.18.1.2744; Schamberger AC, 2014, AM J RESP CELL MOL, V50, P1040, DOI 10.1165/rcmb.2013-0090OC; Schweitzer KS, 2011, AM J PHYSIOL-LUNG C, V301, pL836, DOI 10.1152/ajplung.00385.2010; Sekhon HS, 1999, J CLIN INVEST, V103, P637, DOI 10.1172/JCI5232; Shtutman M, 1999, P NATL ACAD SCI USA, V96, P5522, DOI 10.1073/pnas.96.10.5522; Tamamura Y, 2005, J BIOL CHEM, V280, P19185, DOI 10.1074/jbc.M414275200; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang A, 2015, J CLIN INVEST, V125, P4021, DOI 10.1172/JCI80457; Wang R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014793; Wang T, 2010, AM J RESP CELL MOL, V42, P442, DOI 10.1165/rcmb.2008-0402OC; Warburton D, 2010, CURR TOP DEV BIOL, V90, P73, DOI 10.1016/S0070-2153(10)90003-3; Xiao R, 2012, AM J RESP CELL MOL, V47, P843, DOI 10.1165/rcmb.2012-0241OC; Yanagi S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/573210	58	7	8	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2340	2351		10.1096/fj.201601063R	http://dx.doi.org/10.1096/fj.201601063R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28209772	Green Published			2022-12-28	WOS:000401553400011
J	Codagnone, M; Recchiuti, A; Lanuti, P; Pierdomenico, AM; Cianci, E; Patruno, S; Mari, VC; Simiele, F; Di Tomo, P; Pandolfi, A; Romano, M				Codagnone, Marilina; Recchiuti, Antonio; Lanuti, Paola; Pierdomenico, Anna Maria; Cianci, Eleonora; Patruno, Sara; Mari, Veronica Cecilia; Simiele, Felice; Di Tomo, Pamela; Pandolfi, Assunta; Romano, Mario			Lipoxin A(4) stimulates endothelial miR-126-5p expression and its transfer via microvesicles	FASEB JOURNAL			English	Article						proresolving mediators; vascular repair; microRNA; intercellular signaling; inflammation	HUMAN ATHEROSCLEROTIC PLAQUES; FORMYL PEPTIDE RECEPTOR; 15-EPI-LIPOXIN A(4); MEDIATED TRANSFER; MICRORNA MIR-126; CUTTING EDGE; CELLS; MICROPARTICLES; INFLAMMATION; ANGIOGENESIS	The proresolution lipid mediator lipoxin (LX) A(4) bestows protective bioactions on endothelial cells. We examined the impact of LXA(4) on transcellular endothelial signaling via microRNA(miR)-containing microvesicles. We report LXA(4) inhibition of MV release by TNF-alpha-treated HUVECs, associated with the down-regulation of 18 miR in endothelial microvesicles (EMVs) and the up-regulation of miR-126-5p, both in HUVECs and in EMVs. LXA(4) upregulated miR-126-5p by similar to 5-fold in HUVECs and promoted a release of microvesicles (LXA(4)-EMVs) that enhanced miR-126-5p by similar to 7-fold in recipient HUVECs. In these cells, LXA(4)-EMVs abrogated the up-regulation of VCAM-1, induced in recipient HUVECs by EMVs released by untreated or TNF-alpha-treatedHUVECs. LXA(4)-EMVs also reduced by similar to 40% the expression of SPRED1, which we validated as an miR-126-5p target, whereas they stimulated monolayer repair in an in vitro wound assay. This effect was lost when the EMVs were depleted of miR-126-5p. These results provide evidence that changes in miR expression and microvesicle packaging and transfer represent a mechanism of action of LXA(4), which may be relevant in vascular biology and inflammation.-Codagnone, M., Recchiuti, A., Lanuti, P., Pierdomenico, A. M., Cianci, E., Patruno, S., Mari, V. C., Simiele, F., Di Tomo, P., Pandolfi, A., Romano, M. Lipoxin A(4) stimulates endothelial miR-126-5p expression and its transfer via microvesicles.	[Codagnone, Marilina; Recchiuti, Antonio; Cianci, Eleonora; Patruno, Sara; Simiele, Felice; Di Tomo, Pamela; Pandolfi, Assunta; Romano, Mario] G DAnnunzio Univ Chieti Pescara, Dept Med Oral & Biotechnol Sci, Chieti, Italy; [Codagnone, Marilina; Recchiuti, Antonio; Lanuti, Paola; Pierdomenico, Anna Maria; Cianci, Eleonora; Patruno, Sara; Mari, Veronica Cecilia; Simiele, Felice; Di Tomo, Pamela; Pandolfi, Assunta; Romano, Mario] G DAnnunzio Univ Chieti Pescara, Ctr Aging Sci & Translat Med CeSI MeT, Chieti, Italy; [Lanuti, Paola; Pierdomenico, Anna Maria] G DAnnunzio Univ Chieti Pescara, Dept Med & Aging Sci, Chieti, Italy	G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Romano, M (corresponding author), Univ G dAnnunzio, CeSI Met, Dept Med Oral & Biotechnol Sci, Mol Med Lab, Via Luigi Polacchi 11-13, I-66013 Chieti, Italy.	mromano@unich.it	patruno, sara/P-7868-2018; Romano, Mario/I-7986-2012; PANDOLFI, Assunta/K-4595-2016	patruno, sara/0000-0002-8425-7844; Romano, Mario/0000-0001-8512-1458; PANDOLFI, Assunta/0000-0003-4135-7631	Italian Ministry of Education, University and Research [2010YK7Z5K_ 002]	Italian Ministry of Education, University and Research(Ministry of Education, Universities and Research (MIUR))	The authors thank Sara Di Silvestre (Department of Medical, Oral, and Biotechnological Sciences, G. D'Annunzio University) for technical assistance with umbilical cords collection and HUVEC isolation. This work was supported, in part, by a grant from the Italian Ministry of Education, University and Research (PRIN 2010YK7Z5K_ 002; to M. R.). The authors declare no conflicts of interest.	Baker N, 2009, J IMMUNOL, V182, P3819, DOI 10.4049/jimmunol.0803175; Barry OP, 1997, J CLIN INVEST, V99, P2118, DOI 10.1172/JCI119385; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bena S, 2012, J BIOL CHEM, V287, P24690, DOI 10.1074/jbc.M112.377101; Birnbaum Y, 2006, CIRCULATION, V114, P929, DOI 10.1161/CIRCULATIONAHA.106.629907; Boulanger CM, 2010, CURR OPIN NEPHROL HY, V19, P177, DOI 10.1097/MNH.0b013e32833640fd; Brennan EP, 2013, J AM SOC NEPHROL, V24, P627, DOI 10.1681/ASN.2012060550; Cantaluppi V, 2012, KIDNEY INT, V82, P412, DOI 10.1038/ki.2012.105; Cezar-de-Mello PFT, 2006, ONCOGENE, V25, P122, DOI 10.1038/sj.onc.1209002; Chamorro-Jorganes A, 2016, CIRC RES, V118, P38, DOI 10.1161/CIRCRESAHA.115.307408; Chiang N, 2004, P NATL ACAD SCI USA, V101, P15178, DOI 10.1073/pnas.0405445101; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; Dahlgren C, 2000, BLOOD, V95, P1810, DOI 10.1182/blood.V95.5.1810.005k06_1810_1818; Dalli J, 2008, BLOOD, V112, P2512, DOI 10.1182/blood-2008-02-140533; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Diehl P, 2012, CARDIOVASC RES, V93, P633, DOI 10.1093/cvr/cvs007; Doebele C, 2010, BLOOD, V115, P4944, DOI 10.1182/blood-2010-01-264812; Fierro IM, 2003, J IMMUNOL, V170, P2688, DOI 10.4049/jimmunol.170.5.2688; Fierro IM, 2002, J PHARMACOL EXP THER, V300, P385, DOI 10.1124/jpet.300.2.385; FIORE S, 1993, BLOOD, V81, P3395; GIMBRONE MA, 1995, ANN NY ACAD SCI, V748, P122; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Gutierrez J, 2012, ARCH INTERN MED, V172, P909, DOI 10.1001/archinternmed.2012.2145; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; HIGGS EA, 1978, PROSTAGLANDINS, V16, P153, DOI 10.1016/0090-6980(78)90018-7; Jansen F, 2013, CIRCULATION, V128, P2026, DOI 10.1161/CIRCULATIONAHA.113.001720; Jansen F, 2012, ARTERIOSCL THROM VAS, V32, P1925, DOI 10.1161/ATVBAHA.112.253229; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Kuhnert F, 2008, DEVELOPMENT, V135, P3989, DOI 10.1242/dev.029736; Kumar V, 2014, ROBBINS COTRAN PATHO; Lanuti P, 2012, J IMMUNOL METHODS, V380, P16, DOI 10.1016/j.jim.2012.03.007; Le YY, 1999, J IMMUNOL, V163, P6777; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Leroyer AS, 2008, J AM COLL CARDIOL, V52, P1302, DOI 10.1016/j.jacc.2008.07.032; Leroyer AS, 2007, J AM COLL CARDIOL, V49, P772, DOI 10.1016/j.jacc.2006.10.053; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loyer X, 2014, CIRC RES, V114, P434, DOI 10.1161/CIRCRESAHA.114.302213; Maddox JE, 1996, J EXP MED, V183, P137, DOI 10.1084/jem.183.1.137; Mathivanan S, 2010, J PROTEOMICS, V73, P1907, DOI 10.1016/j.jprot.2010.06.006; McCall MN, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-78; Molin DGM, 2010, CARDIOVASC RES, V86, P6, DOI 10.1093/cvr/cvq054; Norling LV, 2013, CURR OPIN PHARMACOL, V13, P570, DOI 10.1016/j.coph.2013.05.008; Norling LV, 2011, J IMMUNOL, V186, P5543, DOI 10.4049/jimmunol.1003865; Pierdomenico AM, 2015, J BIOL CHEM, V290, P3592, DOI 10.1074/jbc.M114.592352; Planaguma A, 2010, MUCOSAL IMMUNOL, V3, P270, DOI 10.1038/mi.2009.141; Recchiuti A, 2014, FASEB J, V28, P3090, DOI 10.1096/fj.13-248393; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Romano M, 2015, EUR J PHARMACOL, V760, P49, DOI 10.1016/j.ejphar.2015.03.083; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Schober A, 2014, NAT MED, V20, P368, DOI 10.1038/nm.3487; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; SERHAN CN, 1984, P NATL ACAD SCI-BIOL, V81, P5335, DOI 10.1073/pnas.81.17.5335; Shin EH, 2006, BIOCHEM BIOPH RES CO, V341, P1317, DOI 10.1016/j.bbrc.2006.01.098; Simiele F, 2012, FASEB J, V26, P1323, DOI 10.1096/fj.11-198069; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; Urbich C, 2012, BLOOD, V119, P1607, DOI 10.1182/blood-2011-08-373886; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; Vion AC, 2013, CIRC RES, V112, P1323, DOI 10.1161/CIRCRESAHA.112.300818; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Zernecke A, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000610; Zhang Q, 2016, CIVIL ENGINEERING AND URBAN PLANNING IV, P25	62	21	22	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1856	1866		10.1096/fj.201600952R	http://dx.doi.org/10.1096/fj.201600952R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28100645				2022-12-28	WOS:000399195500009
J	Thannesberger, J; Hellinger, HJ; Klymiuk, I; Kastner, MT; Rieder, FJJ; Schneider, M; Fister, S; Lion, T; Kosulin, K; Laengle, J; Bergmann, M; Rattei, T; Steininger, C				Thannesberger, Jakob; Hellinger, Hans-Joerg; Klymiuk, Ingeborg; Kastner, Marie-Theres; Rieder, Franz J. J.; Schneider, Martina; Fister, Susanne; Lion, Thomas; Kosulin, Karin; Laengle, Johannes; Bergmann, Michael; Rattei, Thomas; Steininger, Christoph			Viruses comprise an extensive pool of mobile genetic elements in eukaryote cell cultures and human clinical samples	FASEB JOURNAL			English	Article						viral microbiome; next-generation sequencing; viral dark matter; bacteriophages	OUTER-MEMBRANE VESICLES; HUMAN GUT VIROME; CYTOMEGALOVIRUS-INFECTION; SEQUENCING DATA; TRANSPLANT RECIPIENTS; REVERSE TRANSCRIPTION; METAGENOMIC ANALYSIS; VIRAL METAGENOMICS; DNA VIRUSES; PCR METHOD	Viruses shape a diversity of ecosystems by modulating their microbial, eukaryotic, or plant host metabolism. The complexity of virus-host interaction networks is progressively fathomed by novel metagenomic approaches. By using a novel metagenomic method, we explored the virome in mammalian cell cultures and clinical samples to identify an extensive pool of mobile genetic elements in all of these ecosystems. Despite aseptic treatment, cell cultures harbored extensive and diverse phage populations with a high abundance of as yet unknown and uncharacterized viruses (viral dark matter). Unknown phages also predominated in the oropharynx and urine of healthy individuals and patients infected with cytomegalovirus despite demonstration of active cytomegalovirus replication. The novelty of viral sequences correlated primarily with the individual evaluated, whereas relative abundance of encoded protein functions was associated with the ecologic niches probed. Together, these observations demonstrate the extensive presence of viral dark matter in human and artificial ecosystems.-Thannesberger, J., Hellinger, H.-J., Klymiuk, I., Kastner, M.-T., Rieder, F. J. J., Schneider, M., Fister, S., Lion, T., Kosulin, K., Laengle, J., Bergmann, M., Rattei, T., Steininger, C. Viruses comprise an extensive pool of mobile genetic elements in eukaryote cell cultures and human clinical samples.	[Thannesberger, Jakob; Kastner, Marie-Theres; Rieder, Franz J. J.; Schneider, Martina; Steininger, Christoph] Med Univ Vienna, Div Infect Dis, Dept Med 1, Vienna, Austria; [Laengle, Johannes; Bergmann, Michael] Med Univ Vienna, Dept Surg, Vienna, Austria; [Hellinger, Hans-Joerg; Rattei, Thomas] Univ Vienna, CUBE Div Computat Syst Biol, Dept Microbiol & Ecosyst Sci, Vienna, Austria; [Klymiuk, Ingeborg] Med Univ Graz, Ctr Med Res, Core Facil Mol Biol, Graz, Austria; [Fister, Susanne] Univ Vet Med, Christian Doppler Lab Monitoring Microbial Contam, Vienna, Austria; [Lion, Thomas; Kosulin, Karin] Childrens Canc Res Inst, Vienna, Austria	Medical University of Vienna; Medical University of Vienna; University of Vienna; Medical University of Graz; University of Veterinary Medicine Vienna; Saint Anna Children's Hospital	Steininger, C (corresponding author), Med Univ Vienna, Dept Med 1, Wahringer Gurtel 18-20, A-1090 Vienna, Austria.	christoph.steininger@meduniwien.ac.at	Laengle, Johannes/D-5794-2019; Rattei, Thomas/F-1366-2011; Steininger, Christoph/U-8815-2019; Kosulin, Karin/AAB-2471-2019; Bergmann, Michael/GZK-7700-2022; Klymiuk, Ingeborg/ABG-9952-2021; Lion, MD, PhD, Professor, Thomas/C-3241-2016	Laengle, Johannes/0000-0003-4771-1398; Rattei, Thomas/0000-0002-0592-7791; Steininger, Christoph/0000-0003-3500-7205; Kosulin, Karin/0000-0001-7397-9692; Thannesberger, Jakob/0000-0002-3738-0356; Klymiuk, Ingeborg/0000-0001-8755-0037; Lion, MD, PhD, Professor, Thomas/0000-0001-9346-0994; Bergmann, Michael/0000-0001-8529-1166	Austrian Science Fund [P25353-B21]; Austrian Federal Ministry of Science, Research, and Economy; National Foundation of Research, Technology, and Development; Austrian Science Fund (FWF) [P 25353] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Federal Ministry of Science, Research, and Economy; National Foundation of Research, Technology, and Development; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by a research grant from the Austrian Science Fund P25353-B21. Financial support by the Austrian Federal Ministry of Science, Research, and Economy and the National Foundation of Research, Technology, and Development is gratefully acknowledged. The authors declare no conflicts of interest.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1006/jmbi.1990.9999; Bachrach G, 2003, LETT APPL MICROBIOL, V36, P50, DOI 10.1046/j.1472-765X.2003.01262.x; Barr JJ, 2013, P NATL ACAD SCI USA, V110, P10771, DOI 10.1073/pnas.1305923110; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Binetti AG, 2008, INT J FOOD MICROBIOL, V124, P147, DOI 10.1016/j.ijfoodmicro.2008.03.006; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; Brister JR, 2015, NUCLEIC ACIDS RES, V43, pD571, DOI 10.1093/nar/gku1207; Britt William J, 2010, Curr Protoc Microbiol, VChapter 14, DOI 10.1002/9780471729259.mc14e03s18; Brum JR, 2015, NAT REV MICROBIOL, V13, P147, DOI 10.1038/nrmicro3404; Brussow H, 2004, MICROBIOL MOL BIOL R, V68, P560, DOI 10.1128/MMBR.68.3.560-602.2004; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Canchaya C, 2003, MICROBIOL MOL BIOL R, V67, P238, DOI 10.1128/MMBR.67.2.238-276.2003; Casjens S, 2003, MOL MICROBIOL, V49, P277, DOI 10.1046/j.1365-2958.2003.03580.x; Church DM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001091; Daly GM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028879; de Vries M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016118; Do Anh Ha Lien, 2011, PLoS One, V6, pe18176, DOI 10.1371/journal.pone.0018176; DORWARD DW, 1989, J BACTERIOL, V171, P2499, DOI 10.1128/jb.171.5.2499-2505.1989; Dreier J, 2005, J CLIN MICROBIOL, V43, P4551, DOI 10.1128/JCM.43.9.4551-4557.2005; Ebner K, 2005, J CLIN MICROBIOL, V43, P3049, DOI 10.1128/JCM.43.7.3049-3053.2005; Edlund A, 2015, J ORAL MICROBIOL, V7, DOI 10.3402/jom.v7.27423; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Endoh D, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni064; Faruque SM, 2005, P NATL ACAD SCI USA, V102, P1702, DOI 10.1073/pnas.0408992102; Fister S, 2015, SEP PURIF TECHNOL, V155, P38, DOI 10.1016/j.seppur.2015.03.035; Forterre P, 2013, CURR OPIN VIROL, V3, P558, DOI 10.1016/j.coviro.2013.06.013; Fu LM, 2012, BIOINFORMATICS, V28, P3150, DOI 10.1093/bioinformatics/bts565; Geetha V, 2012, J CYTOL, V29, P133, DOI 10.4103/0970-9371.97157; George MJ, 1997, AM J MED, V103, P106, DOI 10.1016/S0002-9343(97)80021-6; Gorski A, 2005, CELL MOL LIFE SCI, V62, P511, DOI 10.1007/s00018-004-4403-6; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Hall RJ, 2014, J VIROL METHODS, V195, P194, DOI 10.1016/j.jviromet.2013.08.035; Hurwitz BL, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-11-r123; Kim KH, 2011, APPL ENVIRON MICROB, V77, P7663, DOI 10.1128/AEM.00289-11; Kleiner M, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-014-1207-4; Kopylova E, 2012, BIOINFORMATICS, V28, P3211, DOI 10.1093/bioinformatics/bts611; Kristensen DM, 2013, J BACTERIOL, V195, P941, DOI 10.1128/JB.01801-12; Kropinski Andrew M., 2009, V501, P69, DOI 10.1007/978-1-60327-164-6_7; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Ly M, 2014, MBIO, V5, DOI 10.1128/mBio.01133-14; Machida U, 2000, J CLIN MICROBIOL, V38, P2536, DOI 10.1128/JCM.38.7.2536-2542.2000; Mangul S, 2014, BIOINFORMATICS, V30, P329, DOI 10.1093/bioinformatics/btu295; Manning AJ, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-258; Marine R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-3; Methe BA, 2012, NATURE, V486, P215, DOI 10.1038/nature11209; Milne I, 2013, BRIEF BIOINFORM, V14, P193, DOI 10.1093/bib/bbs012; Minot S, 2012, P NATL ACAD SCI USA, V109, P3962, DOI 10.1073/pnas.1119061109; Minot S, 2011, GENOME RES, V21, P1616, DOI 10.1101/gr.122705.111; Naidu M, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-175; Ng TFF, 2009, J VIROL, V83, P2500, DOI 10.1128/JVI.01946-08; Nogusa S, 2008, MECH AGEING DEV, V129, P223, DOI 10.1016/j.mad.2008.01.003; Norman JM, 2014, GASTROENTEROLOGY, V146, P1459, DOI 10.1053/j.gastro.2014.02.001; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; Park EJ, 2011, APPL ENVIRON MICROB, V77, P1284, DOI 10.1128/AEM.01859-10; Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2; Powell S, 2014, NUCLEIC ACIDS RES, V42, pD231, DOI 10.1093/nar/gkt1253; Rasko DA, 2011, NEW ENGL J MED, V365, P709, DOI 10.1056/NEJMoa1106920; Reyes A, 2012, NAT REV MICROBIOL, V10, P607, DOI 10.1038/nrmicro2853; Reyes A, 2010, NATURE, V466, P334, DOI 10.1038/nature09199; Rodriguez-Valera F, 2009, NAT REV MICROBIOL, V7, P828, DOI 10.1038/nrmicro2235; Rohwer F, 2009, NATURE, V459, P207, DOI 10.1038/nature08060; Rosario K, 2009, ENVIRON MICROBIOL, V11, P2806, DOI 10.1111/j.1462-2920.2009.01964.x; Rossmanith P, 2006, RES MICROBIOL, V157, P763, DOI 10.1016/j.resmic.2006.03.003; Roux S, 2015, ELIFE, V4, DOI 10.7554/eLife.08490; Rumbo C, 2011, ANTIMICROB AGENTS CH, V55, P3084, DOI 10.1128/AAC.00929-10; Sagar K, 2014, J MICROBIOL METH, V97, P68, DOI 10.1016/j.mimet.2013.11.008; Schmieder R, 2011, BIOINFORMATICS, V27, P863, DOI 10.1093/bioinformatics/btr026; Shaukat S, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-146; Sia IG, 2000, CLIN MICROBIOL REV, V13, P83, DOI 10.1128/CMR.13.1.83-121.2000; Silander OK, 2005, P NATL ACAD SCI USA, V102, P19009, DOI 10.1073/pnas.0503074102; Steininger C, 2007, CLIN MICROBIOL INFEC, V13, P953, DOI 10.1111/j.1469-0691.2007.01781.x; STEVENS RH, 1994, FEMS MICROBIOL LETT, V119, P329; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Theze J, 2013, J VIROL, V87, P7992, DOI 10.1128/JVI.00453-13; Torsvik V, 2002, SCIENCE, V296, P1064, DOI 10.1126/science.1071698; Tsumoto K, 2003, BIOCHEM BIOPH RES CO, V312, P1383, DOI 10.1016/j.bbrc.2003.11.055; van der Hoek L, 2006, FEMS MICROBIOL REV, V30, P760, DOI 10.1111/j.1574-6976.2006.00032.x; Wang XX, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1146; Willner D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007370; Yan Qing-guo, 2003, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V17, P262; Yaron S, 2000, APPL ENVIRON MICROB, V66, P4414, DOI 10.1128/AEM.66.10.4414-4420.2000; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003; Zhu WH, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq275	84	25	26	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1987	2000		10.1096/fj.201601168R	http://dx.doi.org/10.1096/fj.201601168R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28179422				2022-12-28	WOS:000399195500020
J	Niazy, N; Temme, S; Bocuk, D; Giesen, C; Konig, A; Temme, N; Ziegfeld, A; Gregers, TF; Bakke, O; Lang, T; Eis-Hubinger, AM; Koch, N				Niazy, Naima; Temme, Sebastian; Bocuk, Derya; Giesen, Carmen; Koenig, Angelika; Temme, Nadine; Ziegfeld, Angelique; Gregers, Tone F.; Bakke, Oddmund; Lang, Thorsten; Eis-Huebinger, Anna M.; Koch, Norbert			Misdirection of endosomal trafficking mediated by herpes simplex virus-encoded glycoprotein B	FASEB JOURNAL			English	Article						HSV-1; giant endosomal vesicles; HLA class II; antigen processing compartments; signal sequences	MHC CLASS-II; RAB5 EFFECTOR EEA1; CELL-CELL FUSION; 1 GB CYTODOMAIN; CYTOPLASMIC TAIL; MONOCLONAL-ANTIBODIES; ANTIGEN PRESENTATION; TYPE-1 GB; WILD-TYPE; HLA-DM	Herpes simplex virus (HSV)-encoded glycoprotein B (gB) is the most abundant protein in the viral envelope and promotes fusion of the virus with the cellular membrane. In the present study, we found that gB impacts on the major histocompatibility complex (MHC)-II pathway of antigen presentation by fostering homotypic fusion of early endosomes and trapping MHC-II molecules in these altered endosomes. By using an overexpression approach, we demonstrated that transient expression of gB induces giant vesicles of early endosomal origin, which contained Rab5, early endosomal antigen 1 (EEA1), and large amounts of MHC-II molecules [human leukocyte antigen (HLA)-DR, and HLA-DM], but no CD63. In HSV-1-infected and stably transfected cell lines that expressed lower amounts of gB, giant endosomes were not observed, but strongly increased amounts of HLA-DR and HLA-DM were found in EEA1(+) early endosomes. We used these giant vesicles as a model system and revealed that gB interacts with Rab5 and EEA1, and that gB-induced homotypic fusion of early endosomes to giant endosomes requires phosphatidylinositol 3-phosphate, the activity of soluble N-ethylmaleimide-sensitive factor attachment protein receptors, and the cytosolic gB sequence 889YTQVPN894 We conclude that gB expression alters trafficking of molecules of the HLA-II processing pathway, which leads to increased retention of MHC-II molecules in early endosomal compartments, thereby intercepting antigen presentation.-Niazy, N., Temme, S., Bocuk, D., Giesen, C., Konig, A., Temme, N., Ziegfeld, A., Gregers, T. F., Bakke, O., Lang, T., Eis-Hubinger, A. M., Koch, N. Misdirection of endosomal trafficking mediated by herpes simplex virus-encoded glycoprotein B.	[Niazy, Naima; Temme, Sebastian; Bocuk, Derya; Giesen, Carmen; Koenig, Angelika; Temme, Nadine; Ziegfeld, Angelique; Koch, Norbert] Univ Bonn, Med Ctr, Sect Immunobiol, Inst Genet, Bonn, Germany; [Lang, Thorsten] Univ Bonn, Med Ctr, Membrane Biochem, Life & Med Sci Inst, Bonn, Germany; [Eis-Huebinger, Anna M.] Univ Bonn, Med Ctr, Inst Virol, Bonn, Germany; [Gregers, Tone F.] Univ Oslo, Dept Biosci, Oslo, Norway; [Temme, Sebastian] Univ Dusseldorf, Dept Mol Cardiol, Moorenstr 5, D-40225 Dusseldorf, Germany	University of Bonn; University of Bonn; University of Bonn; University of Oslo; Heinrich Heine University Dusseldorf	Temme, S (corresponding author), Univ Dusseldorf, Dept Mol Cardiol, Moorenstr 5, D-40225 Dusseldorf, Germany.	sebastian.Temme@uni-duesseldorf.de		Bakke, Oddmund/0000-0003-4843-7626	Deutsche Forschungsgemeinschaft [KO 810/8-1]; Research Council of Norway through its Centre of Excellence [179573/V40]; University of Bonn	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Research Council of Norway through its Centre of Excellence(Research Council of Norway); University of Bonn	This work was supported by the Deutsche Forschungsgemeinschaft (KO 810/8-1) and, in part, by the Research Council of Norway through its Centre of Excellence funding scheme (Project 179573/V40). The authors thank Dr. W. Witke (University of Bonn) for support, Dr. P. Gleeson (University of Melbourne, Melbourne, Australia) for helpful discussion, and Dr. G. Moldenhauer (German Cancer Research Center, Heidelberg, Germany) for providing cells and reagents. The authors declare no conflicts of interest.	Atanasiu D, 2013, MBIO, V4, DOI 10.1128/mBio.00046-13; Avitabile E, 2004, J VIROL, V78, P8015, DOI 10.1128/JVI.78.15.8015-8025.2004; BAGHIAN A, 1993, J VIROL, V67, P2396, DOI 10.1128/JVI.67.4.2396-2401.1993; BAKKE O, 1990, CELL, V63, P707, DOI 10.1016/0092-8674(90)90137-4; Barcy S, 2001, J IMMUNOL, V166, P6242, DOI 10.4049/jimmunol.166.10.6242; Bergeland T, 2008, EMBO REP, V9, P171, DOI 10.1038/sj.embor.7401152; BZIK DJ, 1984, VIROLOGY, V133, P301, DOI 10.1016/0042-6822(84)90397-0; Calistri A, 2007, J VIROL, V81, P11468, DOI 10.1128/JVI.01364-07; Carpp LN, 2006, J CELL BIOL, V173, P927, DOI 10.1083/jcb.200512024; Chotard L, 2010, MOL BIOL CELL, V21, P2285, DOI 10.1091/mbc.E09-11-0947; Chowdary TK, 2010, J VIROL, V84, P4923, DOI 10.1128/JVI.00206-10; Christoforidis S, 1999, NATURE, V397, P621, DOI 10.1038/17618; Corey L, 2009, NEW ENGL J MED, V361, P1376, DOI 10.1056/NEJMra0807633; de Zarate IBO, 2004, J VIROL, V78, P1540, DOI 10.1128/JVI.78.3.1540-1551-2004; de Zarate IBO, 2007, J VIROL, V81, P13889, DOI 10.1128/JVI.01231-07; Duclos S, 2000, J CELL SCI, V113, P3531; Eathiraj S, 2005, NATURE, V436, P415, DOI 10.1038/nature03798; Edgar JR, 2014, TRAFFIC, V15, P197, DOI 10.1111/tra.12139; Egan KP, 2013, J NEUROVIROL, V19, P328, DOI 10.1007/s13365-013-0189-3; Eisenberg RJ, 2012, VIRUSES-BASEL, V4, P800, DOI 10.3390/v4050800; EISHUBINGER AM, 1993, J GEN VIROL, V74, P379, DOI 10.1099/0022-1317-74-3-379; Engering AJ, 1998, INT IMMUNOL, V10, P1713, DOI 10.1093/intimm/10.11.1713; Fan ZH, 2002, J VIROL, V76, P9271, DOI 10.1128/JVI.76.18.9271-9283.2002; Fatahzadeh M, 2007, J AM ACAD DERMATOL, V57, P737, DOI 10.1016/j.jaad.2007.06.027; Favoreel HW, 2002, J VIROL, V76, P6845, DOI 10.1128/JVI.76.13.6845-6851.2002; Ferrante A, 2013, IMMUNOLOGY, V138, P85, DOI 10.1111/imm.12030; Gallagher JR, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004373; Garcia NJ, 2013, MBIO, V4, DOI 10.1128/mBio.00571-12; Gianni T, 2004, J VIROL, V78, P12268, DOI 10.1128/JVI.78.22.12268-12276.2004; GORVEL JP, 1991, CELL, V64, P915, DOI 10.1016/0092-8674(91)90316-Q; Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360; Heineman TC, 2004, VIROLOGY, V328, P131, DOI 10.1016/j.virol.2004.07.011; Heldwein EE, 2006, SCIENCE, V313, P217, DOI 10.1126/science.1126548; Herget GW, 2005, PATHOL RES PRACT, V201, P123, DOI 10.1016/j.prp.2004.12.003; Huotari J, 2011, EMBO J, V30, P3481, DOI 10.1038/emboj.2011.286; Jiang Y, 2016, ADV MECH ENG, V8, DOI 10.1177/1687814016636796; Johnson DC, 2011, J VIROL, V85, P4910, DOI 10.1128/JVI.00011-11; Kennedy PGE, 2005, J NEUROL, V252, P268, DOI 10.1007/s00415-005-0770-7; KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071; Kummel D, 2014, CURR OPIN CELL BIOL, V29, P61, DOI 10.1016/j.ceb.2014.04.007; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Landsverk OJB, 2009, SCAND J IMMUNOL, V70, P184, DOI 10.1111/j.1365-3083.2009.02301.x; Landsverk OJB, 2011, IMMUNOL CELL BIOL, V89, P619, DOI 10.1038/icb.2010.143; LANIER LL, 1982, HYBRIDOMA, V1, P125, DOI 10.1089/hyb.1.1982.1.125; Liu XQ, 2015, VIROLOGY, V479, P568, DOI 10.1016/j.virol.2015.02.040; LOPEZ C, 1977, J IMMUNOL, V118, P895; Navaroli DM, 2012, P NATL ACAD SCI USA, V109, pE471, DOI 10.1073/pnas.1115495109; Neumann J, 2003, J IMMUNOL, V171, P3075, DOI 10.4049/jimmunol.171.6.3075; Nicola AV, 2004, J VIROL, V78, P7508, DOI 10.1128/JVI.78.14.7508-7517.2004; Nicola AV, 2003, J VIROL, V77, P5324, DOI 10.1128/JVI.77.9.5324-5332.2003; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Nordeng TW, 2002, MOL BIOL CELL, V13, P1846, DOI 10.1091/mbc.01-10-0478; PELLETT PE, 1985, J VIROL, V53, P243, DOI 10.1128/JVI.53.1.243-253.1985; Poteryaev D, 2010, CELL, V141, P497, DOI 10.1016/j.cell.2010.03.011; Progida C, 2010, J CELL SCI, V123, P1480, DOI 10.1242/jcs.051474; QUARANTA V, 1984, J IMMUNOL, V132, P1900; Rahajeng J, 2010, EXP CELL RES, V316, P859, DOI 10.1016/j.yexcr.2009.11.007; Rajasagi NK, 2009, J VIROL, V83, P5256, DOI 10.1128/JVI.01997-08; Ramachandra L, 2000, J IMMUNOL, V164, P5103, DOI 10.4049/jimmunol.164.10.5103; Ramanathan HN, 2012, CELL RES, V22, P346, DOI 10.1038/cr.2011.80; Rao P, 2011, J VIROL, V85, P8093, DOI 10.1128/JVI.02689-10; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Rogalin HB, 2015, J VIROL, V89, P12262, DOI 10.1128/JVI.02391-15; Sanderson F, 1996, IMMUNITY, V4, P87, DOI 10.1016/S1074-7613(00)80301-5; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Shen JS, 2007, CELL, V128, P183, DOI 10.1016/j.cell.2006.12.016; SIEGAL FP, 1981, NEW ENGL J MED, V305, P1439, DOI 10.1056/NEJM198112103052403; Sievers E, 2002, IMMUNOLOGY, V107, P129, DOI 10.1046/j.1365-2567.2002.01472.x; Sievers E., 2002, THESIS; Silverman JL, 2012, J VIROL, V86, P8171, DOI 10.1128/JVI.00932-12; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Skjeldal FM, 2012, J CELL SCI, V125, P1910, DOI 10.1242/jcs.092569; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; STAM NJ, 1990, INT IMMUNOL, V2, P113, DOI 10.1093/intimm/2.2.113; Stang E, 1997, EXP CELL RES, V235, P79, DOI 10.1006/excr.1997.3617; Steiner I, 1996, IMMUNOL REV, V152, P157, DOI 10.1111/j.1600-065X.1996.tb00915.x; Stern LJ, 2006, CURR OPIN IMMUNOL, V18, P64, DOI 10.1016/j.coi.2005.11.005; Suazo PA, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/593757; Temme S, 2010, J IMMUNOL, V184, P236, DOI 10.4049/jimmunol.0902192; Tiwari A, 2011, J BIOL CHEM, V286, P36749, DOI 10.1074/jbc.M111.260828; Trgovcich J, 2002, J VIROL, V76, P6974, DOI 10.1128/JVI.76.14.6974-6986.2002; Wang TL, 2011, CELL SIGNAL, V23, P516, DOI 10.1016/j.cellsig.2010.09.012; WATANABE M, 1983, TRANSPLANTATION, V36, P712, DOI 10.1097/00007890-198336060-00025; Whitley RJ, 2006, ANTIVIR RES, V71, P141, DOI 10.1016/j.antiviral.2006.04.002; Whitley RJ, 2001, LANCET, V357, P1513, DOI 10.1016/S0140-6736(00)04638-9; Yuan WM, 2006, NAT IMMUNOL, V7, P835, DOI 10.1038/ni1364; Zeigerer A, 2012, NATURE, V485, P465, DOI 10.1038/nature11133; Zuo JM, 2012, VIRUSES-BASEL, V4, P1335, DOI 10.3390/v4081335	89	11	11	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1650	1667		10.1096/fj.201600521R	http://dx.doi.org/10.1096/fj.201600521R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28119397				2022-12-28	WOS:000398504300030
J	Serhan, CN				Serhan, Charles N.			Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms	FASEB JOURNAL			English	Review						omega-3 PUFA; leukocytes; resolvins; lipoxins; protectins; maresins	RESOLVING LIPID MEDIATORS; FATTY-ACID SUPPLEMENTATION; ASPIRIN-TRIGGERED LIPOXIN; INHALED CARBON-MONOXIDE; PRORESOLVING MEDIATORS; DOCOSAHEXAENOIC ACID; HUMAN MACROPHAGES; DRY EYE; ANTIINFLAMMATORY PROPERTIES; ACCELERATES RESOLUTION	Practitionersof ancient societies from the time of Hippocrates and earlier recognizedand treatedthe signs of inflammation, heat, redness, swelling, and pain with agents that block or inhibit proinflammatory chemical mediators. More selective drugs are available today, but this therapeutic concept has not changed. Because the acute inflammatory response is host protective to contain foreign invaders, much of today's pharmacopeia can cause serious unwanted side effects, such as immune suppression. Uncontrolled inflammation is now considered pathophysiologic and is associated with many widely occurring diseases such as cardiovascular disease, neurodegenerative diseases, diabetes, obesity, and asthma, as well as classic inflammatory diseases (e. g., arthritis and periodontal diseases). The inflammatory response, when self-limited, produces a superfamily of chemical mediators that stimulate resolution of the response. Specialized proresolvingmediators (SPMs), identified in recent years, are endogenous mediators that include the n-3-derived families resolvins, protectins, and maresins, as well as arachidonic acid-derived (n-6) lipoxins, which promote resolution of inflammation, clearance of microbes, reduction of pain, and promotion of tissue regeneration via novel mechanisms. Aspirin and statins have a positive impact on these resolution pathways, producing epimeric forms of specific SPMs, whereas other drugs can disrupt timely resolution. In this article, evidence fromrecent human and preclinical animal studies is reviewed, indicating that SPMs are physiologic mediators and pharmacologic agonists that stimulate resolution of inflammation and infection. The findings suggest that it is time to challenge current treatment practices-namely, using inhibitors and antagonists alone-and to develop immunoresolvents as agonists to test resolution pharmacology and their role in catabasis for their therapeutic potential.-Serhan, C. N. Treatinginflammationandinfectioninthe 21st century: new hints from decoding resolution mediators and mechanisms. =	[Serhan, Charles N.] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA; [Serhan, Charles N.] Harvard Med Sch, Boston, MA USA	Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Serhan, CN (corresponding author), Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Bldg Transformat Med,60 Fenwood Rd,Suite 3-016, Boston, MA 02115 USA.	cserhan@bwh.harvard.edu			U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences [R01GM38765, P01GM095467]; NIH National Institute of Dental and Craniofacial Research [R01DE025020]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE025020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038765, P01GM095467] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences; NIH National Institute of Dental and Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The author thanks Mary Halm Small (Brigham and Women's Hospital) for expert assistance in manuscript preparation. Research in the C.N.S. laboratory was supported, in part, by grants from the U.S. National Institutes of Health (NIH) National Institute of General Medical Sciences (R01GM38765, P01GM095467) and NIH National Institute of Dental and Craniofacial Research (R01DE025020). The author declares no conflict of interest.	Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Arnardottir H, 2016, MUCOSAL IMMUNOL, V9, P757, DOI 10.1038/mi.2015.99; Arnardottir HH, 2016, J IMMUNOL, V197, P2362, DOI 10.4049/jimmunol.1502268; Aursnes M, 2015, J NAT PROD, V78, P2924, DOI 10.1021/acs.jnatprod.5b00574; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Barden AE, 2016, PROSTAG LEUKOTR ESS, V107, P24, DOI 10.1016/j.plefa.2016.03.004; Barden AE, 2016, CURR OPIN LIPIDOL, V27, P26, DOI 10.1097/MOL.0000000000000262; Basil MC, 2016, NAT REV IMMUNOL, V16, P51, DOI 10.1038/nri.2015.4; Bazan NG, 2012, EXP NEUROL, V236, P122, DOI 10.1016/j.expneurol.2012.04.007; Biteman B, 2007, FASEB J, V21, P2257, DOI 10.1096/fj.06-7918com; Borgeson E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00318; Borgeson E, 2012, FASEB J, V26, P4287, DOI 10.1096/fj.12-208249; Bouatra S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073076; Bracco U., 1992, POLYUNSATURATED FATT; BREZINSKI DA, 1992, CIRCULATION, V86, P56, DOI 10.1161/01.CIR.86.1.56; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Campbell EL, 2011, J IMMUNOL, V187, P3475, DOI 10.4049/jimmunol.1100150; Chan MMY, 2010, J IMMUNOL, V184, P6418, DOI 10.4049/jimmunol.0903816; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Chiang N, 2013, J IMMUNOL, V190, P6378, DOI 10.4049/jimmunol.1202969; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Chiurchiu V, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf7483; Claria J, 2012, J IMMUNOL, V189, P2597, DOI 10.4049/jimmunol.1201272; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Cooray SN, 2013, P NATL ACAD SCI USA, V110, P18232, DOI 10.1073/pnas.1308253110; Cortina MS, 2011, CURR OPIN CLIN NUTR, V14, P132, DOI 10.1097/MCO.0b013e328342bb1a; Dalli J, 2017, CRIT CARE MED, V45, P58, DOI 10.1097/CCM.0000000000002014; Dalli J, 2016, P NATL ACAD SCI USA, V113, P12232, DOI 10.1073/pnas.1607003113; Dalli J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149319; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; Dalli J, 2015, AM J RESP CELL MOL, V53, P314, DOI 10.1165/rcmb.2014-0299OC; Dalli J, 2015, FASEB J, V29, P2120, DOI 10.1096/fj.14-268441; Dalli J, 2014, P NATL ACAD SCI USA, V111, pE4753, DOI 10.1073/pnas.1415006111; Dalli J, 2013, FASEB J, V27, P2573, DOI 10.1096/fj.13-227728; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; Dartt DA, 2011, J IMMUNOL, V186, P4455, DOI 10.4049/jimmunol.1000833; de Paiva CS, 2012, CORNEA, V31, P1299, DOI 10.1097/ICO.0b013e31823f789e; Devchand PR, 2003, FASEB J, V17, P652, DOI 10.1096/fj.02-0770com; Dinarello CA, 2010, CELL, V140, P935, DOI 10.1016/j.cell.2010.02.043; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; Elajami TK, 2016, FASEB J, V30, P2792, DOI 10.1096/fj.201500155R; Erdinest N, 2014, J INFLAMM-LOND, V11, DOI 10.1186/1476-9255-11-6; Felton JM, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00302; Fialkow J, 2016, AM J CARDIOVASC DRUG, V16, P229, DOI 10.1007/s40256-016-0170-7; Filep JG, 2013, P NATL ACAD SCI USA, V110, P18033, DOI 10.1073/pnas.1317798110; Flannigan KL, 2015, FASEB J, V29, P1591, DOI 10.1096/fj.14-266015; Flower R. J., 1985, PROSTAGLANDINS LEUKO, P583; Frediani JK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108854; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Gao Y, 2015, J IMMUNOL, V195, P3086, DOI 10.4049/jimmunol.1500610; Gilroy DW, 2004, NAT REV DRUG DISCOV, V3, P401, DOI 10.1038/nrd1383; Godson C, 2000, J IMMUNOL, V164, P1663, DOI 10.4049/jimmunol.164.4.1663; Gonzalez-Periz A, 2009, FASEB J, V23, P1946, DOI 10.1096/fj.08-125674; GRIFFITHS RJ, 1999, INFLAMMATION BASIC P, P349; Gronert K, 2010, EXP EYE RES, V91, P478, DOI 10.1016/j.exer.2010.07.004; Haas-Stapleton EJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001316; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Hasturk H, 2015, ARTERIOSCL THROM VAS, V35, P1123, DOI 10.1161/ATVBAHA.115.305324; Hellmann J, 2011, FASEB J, V25, P2399, DOI 10.1096/fj.10-178657; Henson P. M., 1991, CHEST S, V99, p2S; Herrera BS, 2015, INFECT IMMUN, V83, P792, DOI 10.1128/IAI.02444-14; Hiram R, 2014, AM J PHYSIOL-HEART C, V307, pH1547, DOI 10.1152/ajpheart.00452.2014; Ho KJ, 2010, AM J PATHOL, V177, P2116, DOI 10.2353/ajpath.2010.091082; Hodges RR, 2017, MUCOSAL IMMUNOL, V10, P46, DOI 10.1038/mi.2016.33; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Hong S, 2014, AM J PHYSIOL-CELL PH, V307, pC1058, DOI 10.1152/ajpcell.00270.2014; Imai Y, 2015, BBA-MOL CELL BIOL L, V1851, P496, DOI 10.1016/j.bbalip.2015.01.006; Isobe Y, 2012, J BIOL CHEM, V287, P10525, DOI 10.1074/jbc.M112.340612; Jin SW, 2007, ANESTH ANALG, V104, P369, DOI 10.1213/01.ane.0000252414.00363.c4; Jones CN, 2012, P NATL ACAD SCI USA, V109, P20560, DOI 10.1073/pnas.1210269109; Jones HR, 2016, SEMIN IMMUNOL, V28, P137, DOI 10.1016/j.smim.2016.03.007; Jones ML, 2013, J LIPID RES, V54, P2247, DOI 10.1194/jlr.M039842; Kang JW, 2016, BBA-MOL CELL BIOL L, V1861, P1025, DOI 10.1016/j.bbalip.2016.06.002; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; Keelan JA, 2015, REPRODUCTION, V149, P171, DOI 10.1530/REP-14-0549; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lands W., 2005, FISH OMEGA 3 HUMAN H; Le Faouder P, 2013, J CHROMATOGR B, V932, P123, DOI 10.1016/j.jchromb.2013.06.014; Leslie M, 2015, SCIENCE, V349, P18, DOI 10.1126/science.347.6217.18; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Levy BD, 2014, ANNU REV PHYSIOL, V76, P467, DOI 10.1146/annurev-physiol-021113-170408; Li D, 2013, MUCOSAL IMMUNOL, V6, P1119, DOI 10.1038/mi.2013.7; Li N, 2010, J OCUL PHARMACOL TH, V26, P431, DOI 10.1089/jop.2010.0019; Libby P, 2014, CIRC RES, V114, P1867, DOI 10.1161/CIRCRESAHA.114.302699; Liu Guanghao, 2012, Am J Neurodegener Dis, V1, P60; Luo BW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12177; Maddox JE, 1996, J EXP MED, V183, P137, DOI 10.1084/jem.183.1.137; Majno G., 2004, CELLS TISSUES DIS PR; Markworth JF, 2013, AM J PHYSIOL-REG I, V305, pR1281, DOI 10.1152/ajpregu.00128.2013; Martins V, 2009, J IMMUNOL, V182, P5374, DOI 10.4049/jimmunol.0802259; Mas E, 2016, CLIN NUTR, V35, P331, DOI 10.1016/j.clnu.2015.04.004; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Montanaro G, 2013, BIOORGAN MED CHEM, V21, P2107, DOI 10.1016/j.bmc.2013.01.009; Moreland LW., 2005, ARTHRITIS ALLIED CON; Morris T, 2010, P NATL ACAD SCI USA, V107, P8842, DOI 10.1073/pnas.1000373107; Motta JP, 2015, INFLAMM BOWEL DIS, V21, P1006, DOI 10.1097/MIB.0000000000000345; Mozurkewich EL, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00274; Mukherjee PK, 2004, P NATL ACAD SCI USA, V101, P8491, DOI 10.1073/pnas.0402531101; Nathan C, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003081; Neuhofer A, 2013, DIABETES, V62, P1945, DOI 10.2337/db12-0828; Norling LV, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85922; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Norris PC, 2014, P NATL ACAD SCI USA, V111, P12746, DOI 10.1073/pnas.1404372111; Oh SF, 2012, J IMMUNOL, V188, P4527, DOI 10.4049/jimmunol.1103652; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; Perretti M, 2015, TRENDS PHARMACOL SCI, V36, P737, DOI 10.1016/j.tips.2015.07.007; Perretti M, 2015, SEMIN IMMUNOL, V27, P145, DOI 10.1016/j.smim.2015.06.001; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; Pierdomenico AM, 2015, J BIOL CHEM, V290, P3592, DOI 10.1074/jbc.M114.592352; Polus A, 2016, BBA-MOL CELL BIOL L, V1861, P1746, DOI 10.1016/j.bbalip.2016.08.005; Primdahl KG, 2016, J NAT PROD, V79, P2693, DOI 10.1021/acs.jnatprod.6b00634; Qiu WH, 2014, EXP THER MED, V7, P1481, DOI 10.3892/etm.2014.1641; Qu XL, 2012, J PATHOL, V228, P506, DOI 10.1002/path.4050; Ramon S, 2016, AM J PATHOL, V186, P962, DOI 10.1016/j.ajpath.2015.12.012; Ramon S, 2012, J IMMUNOL, V189, P1036, DOI 10.4049/jimmunol.1103483; Rao NL, 2007, J PHARMACOL EXP THER, V321, P1154, DOI 10.1124/jpet.106.115436; Rathod KS, 2017, J CLIN INVEST, V127, P169, DOI 10.1172/JCI89429; Recchiuti A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00298; Rius B, 2014, FASEB J, V28, P836, DOI 10.1096/fj.13-235614; Robb CT, 2016, SEMIN IMMUNOPATHOL, V38, P425, DOI 10.1007/s00281-016-0560-6; Robbins SL, 1979, PATHOLOGIC BASIS DIS, V2nd; Russell CD, 2014, IMMUNOLOGY, V141, P166, DOI 10.1111/imm.12206; Saito T, 2015, ANESTHESIOLOGY, V123, P1420, DOI 10.1097/ALN.0000000000000892; Salic K, 2016, ATHEROSCLEROSIS, V250, P158, DOI 10.1016/j.atherosclerosis.2016.05.001; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; SAMUELSSON B, 1987, SCIENCE, V237, P1171, DOI 10.1126/science.2820055; Sasaki A, 2015, ANAL BIOANAL CHEM, V407, P2939, DOI 10.1007/s00216-015-8512-x; Sasaki A, 2015, ANAL BIOANAL CHEM, V407, P1625, DOI 10.1007/s00216-014-8412-5; SAVILL JS, 1989, J CLIN INVEST, V83, P865, DOI 10.1172/JCI113970; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Serhan CN, 2007, FASEB J, V21, P325, DOI 10.1096/fj.06-7227rev; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Serhan CN, 2015, BBA-MOL CELL BIOL L, V1851, P397, DOI 10.1016/j.bbalip.2014.08.006; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2013, CURR OPIN PHARMACOL, V13, P632, DOI 10.1016/j.coph.2013.05.012; Serhan CN, 2012, FASEB J, V26, P1755, DOI 10.1096/fj.11-201442; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Serhan CN, 2011, CHEM BIOL, V18, P976, DOI 10.1016/j.chembiol.2011.06.008; Serhan CN, 2011, FASEB J, V25, P1441, DOI 10.1096/fj.11-0502ufm; Serhan CN, 2009, J EXP MED, V206, P15, DOI 10.1084/jem.20081880; Serhan CN, 2003, J IMMUNOL, V171, P6856, DOI 10.4049/jimmunol.171.12.6856; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Shevalye H, 2015, J NEUROPHYSIOL, V114, P199, DOI 10.1152/jn.00224.2015; Shinohara M, 2014, AM J PHYSIOL-LUNG C, V307, pL746, DOI 10.1152/ajplung.00166.2014; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Sun YP, 2007, J BIOL CHEM, V282, P9323, DOI 10.1074/jbc.M609212200; Tabas I, 2016, NATURE, V536, P33, DOI 10.1038/nature18916; Tabas I, 2013, SCIENCE, V339, P166, DOI 10.1126/science.1230720; Tang YN, 2013, DIABETES, V62, P618, DOI 10.2337/db12-0684; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Tungen JE, 2014, J NAT PROD, V77, P2241, DOI 10.1021/np500498j; Van Dyke T.E., 2006, SCI AM ORAL WHOLE BO, P42; Van Dyke TE, 2008, J PERIODONTOL, V79, P1601, DOI 10.1902/jop.2008.080173; Viola JR, 2016, CIRC RES, V119, P1030, DOI 10.1161/CIRCRESAHA.116.309492; Wang SB, 2012, FASEB J, V26, P1506, DOI 10.1096/fj.11-198036; Wang XZ, 2015, ALZHEIMERS DEMENT, V11, P40, DOI 10.1016/j.jalz.2013.12.024; Weiss GA, 2013, LIPIDS HEALTH DIS, V12, DOI 10.1186/1476-511X-12-89; White PJ, 2014, NAT MED, V20, P664, DOI 10.1038/nm.3549; Winkler JW, 2016, SCI REP-UK, V6, DOI 10.1038/srep18972; Winyard P. G., 2003, INFLAMMATION PROTOCO; Wu SH, 2013, BRIT J DERMATOL, V168, P172, DOI 10.1111/j.1365-2133.2012.11177.x; Yang J, 2012, FREE RADICAL BIO MED, V53, P160, DOI 10.1016/j.freeradbiomed.2012.05.001; Zhu MQ, 2015, J ALZHEIMERS DIS, V43, P1237, DOI 10.3233/JAD-141233	167	327	331	6	133	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1273	1288		10.1096/fj.201601222R	http://dx.doi.org/10.1096/fj.201601222R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28087575	Green Published			2022-12-28	WOS:000398504300004
J	Carter, JJ; Fretwell, LV; Woolard, J				Carter, Joanne J.; Fretwell, Laurice V.; Woolard, Jeanette			Effects of 4 multitargeted receptor tyrosine kinase inhibitors on regional hemodynamics in conscious, freely moving rats	FASEB JOURNAL			English	Article						cancer therapy; hypertension; RTKI; VEGF; regional hemodynamics	GROWTH-FACTOR RECEPTOR; SIGNALING PATHWAY INHIBITORS; FACTOR VEGF RECEPTORS; RENAL-CELL CARCINOMA; BLOOD-PRESSURE; INDUCED HYPERTENSION; TARGETED THERAPIES; SUNITINIB; CANCER; TOXICITY	VEGF inhibitors, including receptor tyrosine kinase inhibitors, are used as adjunct therapies in a number of cancer treatments. An emerging issue with these drugs is that most cause hypertension. To gain insight into the physiological mechanisms involved, we evaluated their regional hemodynamic effects in conscious rats. Male Sprague Dawley rats (350-450 g) were chronically implanted with pulsed Doppler flow probes (renal and mesenteric arteries, and the descending abdominal aorta) and catheters (jugular vein, peritoneal cavity, and distal abdominal aorta). Regional hemodynamics were measured over 4 d, before and after daily administration of cediranib (3 and 6 mg/kg, 3 and 6 mg/kg/h for 1 h, i.v.), sorafenib (10 and 20 mg/kg, 10 and 20 mg kg/h for 1 h, i.v.), pazopanib (30 and100mg/kg, i.p.), or vandetanib (12.5 and 25mg/kg, i.p.). All drugs evoked significant increases (P < 0.05; n = 7-8) in mean arterial pressure, which were generally accompanied by significant mesenteric and hindquarters, but not renal, vasoconstrictions. The hypertensive effects of cediranib were unaffected by losartan (10 mg/kg/h), bosentan (20 mg/kg/h), or a combination of phentolamine and propranolol (each 1 mg/kg/h), suggesting a need for new strategies to overcome them.- Carter, J. J., Fretwell, L. V., Woolard, J. Effects of 4 multitargetedreceptor tyrosinekinase inhibitors on regional hemodynamics in conscious, freelymoving rats.	[Carter, Joanne J.] Univ Nottingham, Queens Med Ctr, Sch Med, Sch Life Sci,Cell Signalling Res Grp, Nottingham, England; [Fretwell, Laurice V.; Woolard, Jeanette] De Montfort Univ, Fac Hlth & Life Sci, Leicester, Leics, England	University of Nottingham; De Montfort University	Woolard, J (corresponding author), Queens Med Ctr, Sch Life Sci, Sch Med, Nottingham NG7 2UH, England.	jeanette.woolard@nottingham.ac.uk		Fretwell, Laurice/0000-0001-7860-8751; Woolard, Jeanette/0000-0001-5406-6847	Biotechnology and Biological Sciences Research Council [BB/L19418]; University of Nottingham; School of Biomedical Sciences	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); University of Nottingham; School of Biomedical Sciences	This work was supported by the Biotechnology and Biological Sciences Research Council (Grant BB/L19418); the authors thank the University of Nottingham and the School of Biomedical Sciences for financial support. The authors also thank Professor Emerita S. Gardiner and Professor S. Hill (University of Nottingham) for critical reading.	Aad SA, 2015, CRIT REV ONCOL HEMAT, V93, P28, DOI 10.1016/j.critrevonc.2014.08.004; Bie P, 2017, ACTA PHYSIOL, V219, P288, DOI 10.1111/apha.12718; Blasi E, 2012, CARDIOVASC THER, V30, P287, DOI 10.1111/j.1755-5922.2011.00278.x; BOUDIER HAJS, 1992, J HYPERTENS, V10, pS147; Carter JJ, 2015, BRIT J PHARMACOL, V172, P3141, DOI 10.1111/bph.13116; Chu TF, 2007, LANCET, V370, P2011, DOI 10.1016/S0140-6736(07)61865-0; Curwen JO, 2008, CLIN CANCER RES, V14, P3124, DOI 10.1158/1078-0432.CCR-07-4783; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Eschenhagen T, 2011, EUR J HEART FAIL, V13, P1, DOI 10.1093/eurjhf/hfq213; Eskens FALM, 2006, EUR J CANCER, V42, P3127, DOI 10.1016/j.ejca.2006.09.015; Facemire CS, 2009, HYPERTENSION, V54, P652, DOI 10.1161/HYPERTENSIONAHA.109.129973; Ferrara N, 2009, EUR CYTOKINE NETW, V20, P158, DOI 10.1684/ecn.2009.0170; Fretwell LV, 2013, BRIT J PHARMACOL, V169, P1279, DOI 10.1111/bph.12203; Gardiner SM, 2010, BRIT J PHARMACOL, V161, P92, DOI 10.1111/j.1476-5381.2010.00867.x; Gardiner S M, 1993, Blood Press, V2, P228, DOI 10.3109/08037059309077556; Gardiner SM, 1996, BRIT J PHARMACOL, V118, P352, DOI 10.1111/j.1476-5381.1996.tb15409.x; Grossman E, 2012, AM J MED, V125, P14, DOI 10.1016/j.amjmed.2011.05.024; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Isobe T, 2014, J TOXICOL SCI, V39, P237, DOI 10.2131/jts.39.237; Kappers MHW, 2011, HYPERTENSION, V58, P295, DOI 10.1161/HYPERTENSIONAHA.111.173559; Kappers MHW, 2010, HYPERTENSION, V56, P675, DOI 10.1161/HYPERTENSIONAHA.109.149690; Kappers MHW, 2009, J HYPERTENS, V27, P2297, DOI 10.1097/HJH.0b013e3283309b59; Kruzliak P, 2013, ANGIOGENESIS, V16, P289, DOI 10.1007/s10456-012-9327-4; Lankhorst S, 2015, HYPERTENSION, V66, P543, DOI 10.1161/HYPERTENSIONAHA.115.05435; Lankhorst S, 2014, HYPERTENSION, V64, P1282, DOI 10.1161/HYPERTENSIONAHA.114.04187; Maitland ML, 2010, JNCI-J NATL CANCER I, V102, P596, DOI 10.1093/jnci/djq091; Matsumoto T, 2006, J ATHEROSCLER THROMB, V13, P130, DOI 10.5551/jat.13.130; Motzer RJ, 2006, J CLIN ONCOL, V24, P16, DOI 10.1200/JCO.2005.02.2574; Musumeci F, 2012, J MED CHEM, V55, P10797, DOI 10.1021/jm301085w; Noon JP, 1997, J CLIN INVEST, V99, P1873, DOI 10.1172/JCI119354; Pouessel D, 2008, EUR UROL, V53, P376, DOI 10.1016/j.eururo.2007.08.053; Riely G, 2007, CLIN CANCER RES, V13, p4623S, DOI 10.1158/1078-0432.CCR-07-0544; Robinson ES, 2010, HYPERTENSION, V56, P1131, DOI 10.1161/HYPERTENSIONAHA.110.160481; Sane David C., 2004, Angiogenesis, V7, P193, DOI 10.1007/s10456-004-2699-3; Schmidt C, 2015, JNCI-J NATL CANCER I, V107, P6; Shibuya Masabumi, 2011, Genes Cancer, V2, P1097, DOI 10.1177/1947601911423031; Snider KL, 2009, TARGET ONCOL, V4, P67, DOI 10.1007/s11523-009-0106-0; Stone RL, 2010, LANCET ONCOL, V11, P465, DOI 10.1016/S1470-2045(09)70362-6; THEODORSSONNORHEIM E, 1987, COMPUT BIOL MED, V17, P85, DOI 10.1016/0010-4825(87)90003-5; Vaklavas C, 2010, ONCOLOGIST, V15, P130, DOI 10.1634/theoncologist.2009-0252; Veronese ML, 2006, J CLIN ONCOL, V24, P1363, DOI 10.1200/JCO.2005.02.0503; Viola D, 2016, ENDOCR-RELAT CANCER, V23, pR185, DOI 10.1530/ERC-15-0555; Widakowich C, 2007, ONCOLOGIST, V12, P1443, DOI 10.1634/theoncologist.12-12-1443; WIDDOP RE, 1993, BRIT J PHARMACOL, V108, P684, DOI 10.1111/j.1476-5381.1993.tb12861.x; Woolard J, 2004, J PHARMACOL EXP THER, V308, P1102, DOI 10.1124/jpet.103.061259; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491	46	15	16	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1193	1203		10.1096/fj.201600749R	http://dx.doi.org/10.1096/fj.201600749R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27986807	hybrid, Green Published			2022-12-28	WOS:000395671200031
J	Santo-Domingo, J; Chareyron, I; Dayon, L; Galindo, AN; Cominetti, O; Gimenez, MPG; De Marchi, U; Canto, C; Kussmann, M; Wiederkehr, A				Santo-Domingo, Jaime; Chareyron, Isabelle; Dayon, Loic; Galindo, Antonio Nunez; Cominetti, Ornella; Gimenez, Maria Pilar Giner; De Marchi, Umberto; Canto, Carles; Kussmann, Martin; Wiederkehr, Andreas			Coordinated activation of mitochondrial respiration and exocytosis mediated by PKC signaling in pancreatic beta cells	FASEB JOURNAL			English	Article						human islets; energy metabolism; ERK signaling; phosphoproteome	PROTEIN-KINASE-C; INDUCED INSULIN-SECRETION; NEONATAL CARDIAC MYOCYTES; OXIDASE SUBUNIT-IV; PHORBOL-ESTER; B-CELLS; ELECTRICAL-ACTIVITY; ION CHANNELS; GLUCOSE; ISLETS	Mitochondria play a central role in pancreatic beta-cell nutrient sensing by coupling their metabolism to plasma membrane excitability and insulin granule exocytosis. Whether non-nutrient secretagogues stimulate mitochondria as part of the molecular mechanism to promote insulin secretion is not known. Here, we show that PKC signaling, which is employed by many non-nutrient secretagogues, augments mitochondrial respiration in INS-1E (rat insulinoma cell line clone 1E) and human pancreatic beta cells. The phorbol ester, phorbol 12-myristate 13-acetate, accelerates mitochondrial respiration at both resting and stimulatory glucose concentrations. A range of inhibitors of novel PKC is forms prevent phorbol ester-induced respiration. Respiratory response was blocked by oligomycin that demonstrated PKC-dependent acceleration of mitochondrial ATP synthesis. Enhanced respiration was observed even when glycolysis was bypassed or fatty acid transport was blocked, which suggested that PKC regulates mitochondrial processes rather than upstream catabolic fluxes. A phosphoproteome study of phorbol ester stimulated INS-1E cells maintained under resting (2.5 mM) glucose revealed a large number of phosphorylation sites that were altered during short-termactivation of PKC signaling. The data set was enriched for proteins that are involved in gene expression, cytoskeleton remodeling, secretory vesicle transport, and exocytosis. Inter actome analysis identified PKC, C-Raf, and ERK1/2 as the central phosphointeraction cluster. Prevention of ERK1/2 signaling by using a MEK1 inhibitor caused a marked decreased in phorbol 12-myristate 13-acetate-induced mitochondrial respiration. ERK1/2 signaling module therefore links PKC activation to downstream mitochondrial activation. We conclude that non-nutrient secretagogues act, in part, via PKC and downstream ERK1/2 signaling to stimulate mitochondrial energy production to compensate for energy expenditure that is linked to beta-cell activation.	[Santo-Domingo, Jaime; Chareyron, Isabelle; De Marchi, Umberto; Wiederkehr, Andreas] Nestle Inst Hlth Sci, Mitochondrial Funct, Lausanne, Switzerland; [Dayon, Loic; Galindo, Antonio Nunez; Cominetti, Ornella; Gimenez, Maria Pilar Giner; Kussmann, Martin] Nestle Inst Hlth Sci, Syst Nutr Metabon & Prote, Lausanne, Switzerland; [Canto, Carles] Nestle Inst Hlth Sci, Diabet & Metab Hlth, Lausanne, Switzerland	Nestle SA; Nestle SA; Nestle SA	Wiederkehr, A (corresponding author), Nestle Inst Hlth Sci, Quartier Innovat Batiment G, CH-1015 Lausanne, Switzerland.	andreas.wiederkehr@rd.nestle.com	Domingo, Jaime Santo/AAA-4995-2020; Kussmann, Martin/AAB-7453-2022; Cominetti, Ornella/GQA-4684-2022; Cominetti, Ornella/AFV-1516-2022; Dayon, Loïc/J-2499-2019	Domingo, Jaime Santo/0000-0001-5501-0482; Kussmann, Martin/0000-0002-0966-2313; Cominetti, Ornella/0000-0001-8564-1963; Dayon, Loïc/0000-0002-8499-270X; De Marchi, Umberto/0000-0002-6011-5446; Canto, Carles/0000-0002-5167-7922				Acin-Perez R, 2010, FASEB J, V24, P5033, DOI 10.1096/fj.10-166934; Acin-Perez R, 2010, FASEB J, V24, P627, DOI 10.1096/fj.09-142281; AMMALA C, 1994, P NATL ACAD SCI USA, V91, P4343, DOI 10.1073/pnas.91.10.4343; Baines CP, 2003, CIRC RES, V92, P873, DOI 10.1161/01.RES.0000069215.36389.8D; BOZEM M, 1987, PFLUG ARCH EUR J PHY, V410, P457, DOI 10.1007/BF00586525; BOZEM M, 1987, ENDOCRINOLOGY, V121, P1025, DOI 10.1210/endo-121-3-1025; Braun M, 2008, DIABETES, V57, P1618, DOI 10.2337/db07-0991; Burant CF, 2013, DIABETES CARE, V36, pS175, DOI 10.2337/dcS13-2037; CASTAGNA M, 1982, J BIOL CHEM, V257, P7847; De Marchi U, 2014, J BIOL CHEM, V289, P9182, DOI 10.1074/jbc.M113.513184; Detimary P, 1996, ENDOCRINOLOGY, V137, P4671, DOI 10.1210/en.137.11.4671; Ferdaoussi M, 2012, DIABETOLOGIA, V55, P2682, DOI 10.1007/s00125-012-2650-x; Fransson U, 2006, DIABETOLOGIA, V49, P1578, DOI 10.1007/s00125-006-0263-y; Galindo AN, 2015, ANAL CHEM, V87, P10755, DOI 10.1021/acs.analchem.5b02748; GANESAN S, 1992, J CELL BIOL, V119, P313, DOI 10.1083/jcb.119.2.313; Gautam D, 2006, CELL METAB, V3, P449, DOI 10.1016/j.cmet.2006.04.009; Gilon P, 2001, ENDOCR REV, V22, P565, DOI 10.1210/er.22.5.565; Gonelle-Gispert C, 2002, BIOCHEM J, V368, P223, DOI 10.1042/BJ20020896; Guo DH, 2007, AM J PHYSIOL-HEART C, V293, pH2219, DOI 10.1152/ajpheart.01306.2006; Harris TE, 1996, MOL CELL ENDOCRINOL, V121, P133, DOI 10.1016/0303-7207(96)03858-0; Harris TE, 1996, BIOCHEM BIOPH RES CO, V227, P672, DOI 10.1006/bbrc.1996.1567; HELLMAN B, 1974, P NATL ACAD SCI USA, V71, P3405, DOI 10.1073/pnas.71.9.3405; Henquin JC, 2009, DIABETOLOGIA, V52, P739, DOI 10.1007/s00125-009-1314-y; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Ishihara H, 1999, J CLIN INVEST, V104, P1621, DOI 10.1172/JCI7515; Jing YL, 2011, NUTR METAB CARDIOVAS, V21, P398, DOI 10.1016/j.numecd.2009.11.004; JONES PM, 1991, J MOL ENDOCRINOL, V6, P121, DOI 10.1677/jme.0.0060121; Kalwat MA, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.73; Kawasaki E, 1996, BIOCHEM BIOPH RES CO, V227, P440, DOI 10.1006/bbrc.1996.1526; KOMATSU M, 1995, P NATL ACAD SCI USA, V92, P10728, DOI 10.1073/pnas.92.23.10728; Kristinsson H, 2015, BBA-MOL CELL RES, V1853, P3248, DOI 10.1016/j.bbamcr.2015.09.022; Liang BT, 1997, AM J PHYSIOL-HEART C, V273, pH847, DOI 10.1152/ajpheart.1997.273.2.H847; Ljubicic S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068255; Malhotra A, 2005, MOL CELL BIOCHEM, V268, P169, DOI 10.1007/s11010-005-3858-6; Mangat R, 2006, AM J PHYSIOL-HEART C, V291, pH854, DOI 10.1152/ajpheart.01205.2005; Montero M, 2003, J BIOL CHEM, V278, P49972, DOI 10.1074/jbc.M308378200; Morgan D, 2007, J PHYSIOL-LONDON, V579, P327, DOI 10.1113/jphysiol.2006.124248; Nesher R, 2002, DIABETES, V51, pS68, DOI 10.2337/diabetes.51.2007.S68; Nesher R, 2001, DIABETES, V50, P308, DOI 10.2337/diabetes.50.2.308; Nguyen T, 2008, J BIOL CHEM, V283, P29831, DOI 10.1074/jbc.M801642200; Nowak G, 2015, J BIOL CHEM, V290, P7054, DOI 10.1074/jbc.M114.588244; Ogbi M, 2004, BIOCHEM J, V382, P923, DOI 10.1042/BJ20040468; Pagliarini DJ, 2006, TRENDS BIOCHEM SCI, V31, P26, DOI 10.1016/j.tibs.2005.11.005; Pinton P, 2004, J CELL BIOL, V165, P223, DOI 10.1083/jcb.200311061; Pinton P, 2002, J BIOL CHEM, V277, P37702, DOI 10.1074/jbc.M204478200; RORSMAN P, 1994, DIABETES METAB, V20, P138; Sadoul K, 1997, J BIOL CHEM, V272, P33023, DOI 10.1074/jbc.272.52.33023; Schleifenbaum A, 2004, J AM CHEM SOC, V126, P11786, DOI 10.1021/ja0460155; Schmitz-Peiffer C, 2007, CELL METAB, V6, P320, DOI 10.1016/j.cmet.2007.08.012; Shu YL, 2008, J NEUROSCI, V28, P21, DOI 10.1523/JNEUROSCI.2352-07.2008; Suckalel J, 2010, TRENDS ENDOCRIN MET, V21, P599, DOI 10.1016/j.tem.2010.06.003; THAMS P, 1990, BIOCHEM J, V265, P777, DOI 10.1042/bj2650777; Tomas A, 2006, J CELL SCI, V119, P2156, DOI 10.1242/jcs.02942; Warwar N, 2006, DIABETES, V55, P590, DOI 10.2337/diabetes.55.03.06.db05-0001; Wiederkehr A, 2004, J CELL BIOL, V167, P875, DOI 10.1083/jcb.200408001; Wiederkehr A, 2012, MOL CELL ENDOCRINOL, V353, P128, DOI 10.1016/j.mce.2011.07.016; Wiederkehr A, 2011, CELL METAB, V13, P601, DOI 10.1016/j.cmet.2011.03.015; Wikstrom JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033023; Wu-Zhang AX, 2013, BIOCHEM J, V452, P195, DOI 10.1042/BJ20130220; Wu-Zhang AX, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.412635; Yamazaki H, 2010, J NUTR SCI VITAMINOL, V56, P1, DOI 10.3177/jnsv.56.1; Yu W, 2000, DIABETES, V49, P945, DOI 10.2337/diabetes.49.6.945; Zawalich WS, 2001, MOL CELL ENDOCRINOL, V177, P95, DOI 10.1016/S0303-7207(01)00422-1; Zielonka J, 2014, J BIOL CHEM, V289, P16176, DOI 10.1074/jbc.M114.548693	64	12	14	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1028	+		10.1096/fj.201600837R	http://dx.doi.org/10.1096/fj.201600837R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27927723				2022-12-28	WOS:000395671200018
J	Jarve, A; Muhlstedt, S; Qadri, F; Nickl, B; Schulz, H; Hubner, N; Ozcelik, C; Bader, M				Jaerve, Anne; Muehlstedt, Silke; Qadri, Fatimunnisa; Nickl, Bernadette; Schulz, Herbert; Huebner, Norbert; Oezcelik, Cemil; Bader, Michael			Adverse left ventricular remodeling by glycoprotein nonmetastatic melanoma protein B in myocardial infarction	FASEB JOURNAL			English	Article						heart; DBA; 2J; inflammation; osteoactivin; macrophages	TRANSCRIPTION FACTOR MITF; EXTRACELLULAR-MATRIX; DC-HIL; DILATED CARDIOMYOPATHY; NEUROPROTECTIVE FACTOR; TRANSMEMBRANE PROTEIN; MMP-3 EXPRESSION; SKELETAL-MUSCLE; UP-REGULATION; CELL-LINES	Cardiac diseases are the leading cause of death. Available treatment approaches are not sufficient to reverse persistent cardiac damage after injury; thus, the search for new therapeutic targets is essential. Our microarray-based screening in rat hearts 24 h after myocardial infarction (MI) yielded glycoprotein nonmetastatic melanoma protein B (GPNMB), which is known to be involved in inflammation and fibrosis after tissue injury. However, its role in the heart was elusive. We found increased cardiac expression levels of GPNMB in rats and mice after MI. Analysis of DBA/2J mice, which lack functional GPNMB due to a spontaneous point mutation, showed that systemic GPNMB deficiency was associated with preserved cardiac function and less left ventricular dilation after MI compared with DBA/2J mice with reconstituted GPNMB expression. These improvements were associated with decreased expression of matrix metalloproteinase 9, the cardiac stress genes for natriuretic peptides (atrial natriuretic peptide and brain natriuretic peptide), and -myosin heavy chain after MI. Moreover, GPNMB deficiency attenuated the dilated cardiomyopathy in muscle lim protein knockout mice but could not prevent cardiac hypertrophy induced by isoprenaline infusion. This is the first experimental study to show that GPNMB adversely influences myocardial remodeling.	[Jaerve, Anne; Muehlstedt, Silke; Qadri, Fatimunnisa; Nickl, Bernadette; Schulz, Herbert; Huebner, Norbert; Bader, Michael] Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany; [Jaerve, Anne] Berlin Brandenburg Sch Regenerat Therapies, Berlin, Germany; [Muehlstedt, Silke; Bader, Michael] Humboldt Univ, Fac Math & Nat Sci 1, Berlin, Germany; [Muehlstedt, Silke; Nickl, Bernadette; Bader, Michael] Berlin Inst Hlth, Berlin, Germany; [Oezcelik, Cemil; Bader, Michael] Charit Univ Med, Berlin, Germany; [Bader, Michael] German Ctr Cardiovasc Res DZHK, Berlin, Germany; [Bader, Michael] Univ Lubeck, Inst Biol, Lubeck, Germany; [Schulz, Herbert] Univ Cologne, Cologne Ctr Genom, Cologne, Germany	Helmholtz Association; Max Delbruck Center for Molecular Medicine; Humboldt University of Berlin; Berlin Institute of Health; German Centre for Cardiovascular Research; University of Lubeck; University of Cologne	Bader, M (corresponding author), Max Delbruck Ctr Mol Med, Robert Rossle Str 10, D-13125 Berlin, Germany.	mbader@mdc-berlin.de	Bader, Michael/K-2124-2013	Jarve, Anne/0000-0003-2096-0706; Bader, Michael/0000-0003-4780-4164; Nickl, Bernadette/0000-0002-1998-8157	Berlin-Brandenburg School of Regenerative Therapies	Berlin-Brandenburg School of Regenerative Therapies	This work was supported by a fellowship from the Berlin-Brandenburg School of Regenerative Therapies (to A.J.). The authors thank the following collaborators at the Max Delbruck Center for Molecular Medicine: Martin Taube and Stefanie Schelenz for assistance with echocardiography, Tanja Filipowski for technical assistance, Astrid Schiche for technical assistance in experimental MI induction, and Gabriele Born and Lisa Mallis for technical assistance in microarray hybridization and histological procedures, respectively. The authors declare no conflicts of interest.	Abe H, 2007, BIOCHEM BIOPH RES CO, V356, P610, DOI 10.1016/j.bbrc.2007.03.035; Anderson MG, 2002, NAT GENET, V30, P81, DOI 10.1038/ng794; Anderson MG, 2008, BMC GENET, V9, DOI 10.1186/1471-2156-9-30; Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Bachner Dietmar, 2002, Brain Res Gene Expr Patterns, V1, P159; Bandari PS, 2003, REGUL PEPTIDES, V111, P169, DOI 10.1016/S0167-0115(02)00288-4; Boerrigter Guido, 2009, Heart Fail Clin, V5, P501, DOI 10.1016/j.hfc.2009.04.002; Brule S, 2006, GLYCOBIOLOGY, V16, P488, DOI 10.1093/glycob/cwj098; Carvalho JS, 1996, EUR HEART J, V17, P1233; Ceriani L, 2007, CLIN CHEM LAB MED, V45, P226, DOI 10.1515/CCLM.2007.040; Chung JS, 2007, BLOOD, V109, P4320, DOI 10.1182/blood-2006-11-053769; Chung JS, 2009, J IMMUNOL, V183, P5190, DOI 10.4049/jimmunol.0901319; Creemers EEJM, 2003, AM J PHYSIOL-HEART C, V284, pH364, DOI 10.1152/ajpheart.00511.2002; Dalal S, 2014, AM J PHYSIOL-HEART C, V306, pH1182, DOI 10.1152/ajpheart.00954.2013; Deten A, 2001, J MOL CELL CARDIOL, V33, P1191, DOI 10.1006/jmcc.2001.1383; Ducharme A, 2000, J CLIN INVEST, V106, P55, DOI 10.1172/JCI8768; Fan D, 2012, FIBROGENESIS TISSUE, V5, DOI 10.1186/1755-1536-5-15; Fiorentini C, 2014, EXP CELL RES, V323, P100, DOI 10.1016/j.yexcr.2014.02.025; Freund C, 2005, CIRCULATION, V111, P2319, DOI 10.1161/01.CIR.0000164237.58200.5A; Furochi Harumi, 2007, J Med Invest, V54, P248, DOI 10.2152/jmi.54.248; Furochi H, 2007, FEBS LETT, V581, P5743, DOI 10.1016/j.febslet.2007.11.036; Gabriel TL, 2014, DIABETES, V63, P3310, DOI 10.2337/db13-1720; Garcia LF, 2015, EINSTEIN-SAO PAULO, V13, P89, DOI 10.1590/S1679-45082015AO2970; Gutknecht M, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0099-5; Herum KM, 2013, J MOL CELL CARDIOL, V54, P73, DOI 10.1016/j.yjmcc.2012.11.006; Hoashi T, 2010, FASEB J, V24, P1616, DOI 10.1096/fj.09-151019; Howell GR, 2007, BMC GENET, V8, DOI 10.1186/1471-2156-8-45; Hutchinson KR, 2011, J APPL PHYSIOL, V111, P1778, DOI 10.1152/japplphysiol.00691.2011; Iwabu A, 2002, BASIC RES CARDIOL, V97, P214, DOI 10.1007/s003950200014; Iyer RP, 2016, AM J PHYSIOL-HEART C, V311, pH190, DOI 10.1152/ajpheart.00243.2016; Kojima T, 2001, THROMB HAEMOSTASIS, V85, P793; Krenz M, 2004, J AM COLL CARDIOL, V44, P2390, DOI 10.1016/j.jacc.2004.09.044; Kumagai K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143413; Li B, 2010, FASEB J, V24, P4767, DOI 10.1096/fj.10-154757; Maric G, 2013, ONCOTARGETS THER, V6, P839, DOI 10.2147/OTT.S44906; Mill JG, 2011, BRAZ J MED BIOL RES, V44, P890, DOI 10.1590/S0100-879X2011000900010; Nagahara Y, 2015, J NEUROSCI RES, V93, P1552, DOI 10.1002/jnr.23619; Nakano Y, 2014, NEUROSCIENCE, V277, P123, DOI 10.1016/j.neuroscience.2014.06.065; Ogawa T, 2005, AM J PHYSIOL-CELL PH, V289, pC697, DOI 10.1152/ajpcell.00565.2004; Omura S, 2014, CIRC-CARDIOVASC GENE, V7, DOI 10.1161/CIRCGENETICS.114.000505; Osadchii OE, 2007, HEART FAIL REV, V12, P66, DOI 10.1007/s10741-007-9007-4; Pahl MV, 2010, CLIN J AM SOC NEPHRO, V5, P56, DOI 10.2215/CJN.03390509; Pal-Ghosh S, 2011, J CELL SCI, V124, P2666, DOI 10.1242/jcs.085480; Phatharajaree W, 2007, CAN J CARDIOL, V23, P727, DOI 10.1016/S0828-282X(07)70818-8; Podesser BK, 2001, AM J PHYSIOL-HEART C, V280, pH984, DOI 10.1152/ajpheart.2001.280.3.H984; Psarras S, 2012, EUR HEART J, V33, P1954, DOI 10.1093/eurheartj/ehr119; Ramachandran P, 2012, P NATL ACAD SCI USA, V109, pE3186, DOI 10.1073/pnas.1119964109; Rich JN, 2003, J BIOL CHEM, V278, P15951, DOI 10.1074/jbc.M211498200; Ripoll VM, 2007, J IMMUNOL, V178, P6557, DOI 10.4049/jimmunol.178.10.6557; Rose AAN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012093; Rundell VLM, 2005, AM J PHYSIOL-HEART C, V288, pH896, DOI 10.1152/ajpheart.00407.2004; Scholer J, 2015, J BIOL CHEM, V290, P8154, DOI 10.1074/jbc.M114.615922; Selim AA, 2009, MED SCI MONITOR, V15, pMT19; Shi FY, 2014, J MOL NEUROSCI, V54, P234, DOI 10.1007/s12031-014-0280-0; Shikano S, 2001, J BIOL CHEM, V276, P8125, DOI 10.1074/jbc.M008539200; Shyy JYJ, 1997, CURR OPIN CELL BIOL, V9, P707, DOI 10.1016/S0955-0674(97)80125-1; Solinas G, 2010, J IMMUNOL, V185, P642, DOI 10.4049/jimmunol.1000413; Takahashi R, 2011, J CARDIOL, V57, P325, DOI 10.1016/j.jjcc.2011.01.012; Tanaka H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00573; Vaisar T, 2009, MOL CELL PROTEOMICS, V8, P1044, DOI 10.1074/mcp.M800449-MCP200; Weirather J, 2014, CIRC RES, V115, P55, DOI 10.1161/CIRCRESAHA.115.303895; WETERMAN MAJ, 1995, INT J CANCER, V60, P73, DOI 10.1002/ijc.2910600111; World Health Organization, 2008, GLOB BURD DIS 2004 U; Yu B, 2016, J CELL BIOCHEM, V117, P1511, DOI 10.1002/jcb.25394; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83	65	10	10	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					556	568		10.1096/fj.201600613R	http://dx.doi.org/10.1096/fj.201600613R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	28148779				2022-12-28	WOS:000394235400011
J	Woodward, DF; Wang, JW; Ni, M; Bauer, A; Martos, JL; Carling, RW; Poloso, NJ				Woodward, David F.; Wang, Jenny W.; Ni, Ming; Bauer, Alex; Martos, Jose L.; Carling, Robert W.; Poloso, Neil J.			In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti- inflammatory effects	FASEB JOURNAL			English	Article						uveitis; retina; neovascularization; polypharmacology; antagonist	CHOROIDAL NEOVASCULARIZATION; S-ANTIGEN; AUTOIMMUNE UVEITIS; VASCULAR LEAKAGE; ANTAGONIST; ANGIOGENESIS; POTENT; KETOROLAC; NEPAFENAC; VEGF	The purpose of these studies was to test the hypothesis that a selected polypharmacological approach for treating the prostanoid-mediated component of inflammatory diseases would produce a therapeutic effect superior to global inhibition of prostaglandin (PG) biosynthesis by aspirin-like drugs. The compound studied was AGN 211377, which had been previously shown to produce a superior effect on cytokine release from human macrophages compared with cyclooxygenase (COX) inhibitors. AGN 211377 antagonizes prostanoid prostaglandin D-2 (DP)(1), DP2, prostaglandin E2 (EP)(1), EP4, prostaglandin F-2 alpha, and thromboxane A(2) receptors but not anti-inflammatory EP2, prostaglandin I-2, or EP3 receptors. Established rodent models of ocular inflammatory diseases were used to determine therapeutic effects in living animals. The drugs were administered systemically after predetermination of their blood levels to ensure bioavailability at an appropriate dose level. Whereas compounds selective for a single prostanoid receptor typically exhibited modest but statistically significant inhibition, AGN 211377 profoundly inhibited S-antigen-induced uveitis and laser-induced retinal neovascularization. Consistent with previous polypharmacological studies on chemokine/cytokine release from human macrophages, the prostanoid EP1 receptor played a permissive role in suppressing neovascularization and inflammation in vivo. Comparing AGN211377 with a close structural congener lacking EP1 antagonism(AGN 197727), AGN 197727 was much less active than AGN211377, but pronounced anti-inflammatory and angiostatic effects were achieved by adding the EP1 antagonist compound (SC51322) to AGN 197727 in the systemic dosing regimen. Further, AGN 211377 produced superior anti-inflammatory activity compared with the nonsteroidal anti-inflammatory agent ketorolac. These results indicate the value of using a polypharmacological approach in the design of novel therapeutic agents in preference to compounds targeting a single receptor or enzyme. A compound such as AGN 211377 may represent more effective therapy than COX inhibitors in treating uveitis and ocular diseases where neovascularization is a significant part of the pathology.-Woodward, D. F., Wang, J. W., Ni, M., Bauer, A., Martos, J. L., Carling, R. W., Poloso, N. J. In vivo studies validating multitargeting of prostanoid receptors for achieving superior anti-inflammatory effects.	[Woodward, David F.; Wang, Jenny W.; Ni, Ming; Bauer, Alex; Poloso, Neil J.] Allergan PLC, Dept Biol Sci, Irvine, CA 92612 USA; [Martos, Jose L.; Carling, Robert W.] Selcia Ltd, Discovery Dept, Fyfield, England; [Woodward, David F.] Imperial Coll London, Dept Bioengn, London, England; [Wang, Jenny W.] JeviVision Inc, Irvine, CA USA; [Ni, Ming] Adverum Biotechnol Inc, Menlo Pk, CA USA	AbbVie; Allergan; Imperial College London	Poloso, NJ (corresponding author), Allergan PLC, Dept Biol Sci, Irvine, CA 92612 USA.	poloso_neil@allergan.com			intramural research program at Allergan	intramural research program at Allergan	This work was supported by the intramural research program at Allergan.	Adjunctive Diclofenac with Verteporfin (ADD-V) Study Group, 2007, Retina, V27, P693; af Forselles KJ, 2011, BRIT J PHARMACOL, V164, P1847, DOI 10.1111/j.1476-5381.2011.01495.x; Agarwal R.K., 2012, METHOD MOL BIOL, V2012, P900; Aguirre SA, 2009, TOXICOL PATHOL, V37, P911, DOI 10.1177/0192623309351724; Amrite AC, 2006, INVEST OPHTH VIS SCI, V47, P1149, DOI 10.1167/iovs.05-0531; Barnett JM, 2010, INVEST OPHTH VIS SCI, V51, P1136, DOI 10.1167/iovs.09-3691; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Browning AC, 2012, BRIT J OPHTHALMOL, V96, P128, DOI 10.1136/bjophthalmol-2011-300572; Caspi RR, 2010, J CLIN INVEST, V120, P3073, DOI 10.1172/JCI42440; CASPI RR, 1992, CURR EYE RES, V11, P81, DOI 10.3109/02713689208999515; CASPI RR, 1994, AUTOIMMUNE DIS MODEL, P57; Castro MR, 2004, EXP EYE RES, V79, P275, DOI 10.1016/j.exer.2004.04.008; Cillirio R., 2007, AM J OBSTET GYNECOL, V197, p54e; Cryan LM, 2009, PROSTAG LEUKOTR ESS, V81, P401, DOI 10.1016/j.plefa.2009.08.001; DONOSO LA, 1987, CURR EYE RES, V6, P1151, DOI 10.3109/02713688709034888; FLACH AJ, 1992, SURV OPHTHALMOL, V36, P259, DOI 10.1016/0039-6257(92)90095-B; Fujita I, 2012, J PHARM PHARMACOL, V64, P747, DOI 10.1111/j.2042-7158.2012.01468.x; Gery I., 1985, ADV IMMUNOLOGY IMMUN, P242; GILES H, 1989, BRIT J PHARMACOL, V96, P291, DOI 10.1111/j.1476-5381.1989.tb11816.x; GOH Y, 1987, BIOCHIM BIOPHYS ACTA, V921, P302; HALLINAN EA, 1994, BIOORG MED CHEM LETT, V4, P509, DOI 10.1016/0960-894X(94)80027-8; Heier JS, 2009, RETINA-J RET VIT DIS, V29, P1310, DOI 10.1097/IAE.0b013e3181b094e6; HIROSE S, 1990, JPN J OPHTHALMOL, V34, P298; Hoang KG, 2015, MICROVASC RES, V101, P127, DOI 10.1016/j.mvr.2015.07.004; Inada M, 2015, J BIOL CHEM, V290, P29781, DOI 10.1074/jbc.M115.669481; Ishizuka T, 2004, CARDIOVASC DRUG REV, V22, P71; Kim SJ, 2010, EXP EYE RES, V91, P537, DOI 10.1016/j.exer.2010.07.011; Kim SJ, 2010, ARCH OPHTHALMOL-CHIC, V128, P596, DOI 10.1001/archophthalmol.2010.69; Kuwano T, 2004, FASEB J, V18, P300, DOI 10.1096/fj.03-0473com; Mathiesen JM, 2006, MOL PHARMACOL, V69, P1441, DOI 10.1124/mol.105.017681; Nakanishi M, 2012, AM J RESP CELL MOL, V46, P217, DOI 10.1165/rcmb.2010-0115OC; NI M, 1992, GRAEF ARCH CLIN EXP, V230, P547, DOI 10.1007/BF00181777; OGLETREE ML, 1985, J PHARMACOL EXP THER, V234, P435; Rao R, 2007, J BIOL CHEM, V282, P16959, DOI 10.1074/jbc.M701214200; Schoenberger SD, 2012, INVEST OPHTH VIS SCI, V53, P5906, DOI 10.1167/iovs.12-10410; SHINOHARA T, 1990, EXP EYE RES, V50, P751, DOI 10.1016/0014-4835(90)90125-E; Takahashi H, 2004, BIOCHEM BIOPH RES CO, V325, P461, DOI 10.1016/j.bbrc.2004.10.054; Takahashi K, 2003, INVEST OPHTH VIS SCI, V44, P409, DOI 10.1167/iovs.02-0346; Wang JW, 2016, FASEB J, V30, P394, DOI 10.1096/fj.15-275610; Wilson NM, 2016, PAIN RES TREAT, V2016, DOI 10.1155/2016/8364762; Wilson RJ, 2006, BRIT J PHARMACOL, V148, P326, DOI 10.1038/sj.bjp.0706726; Woodward DF, 2011, PHARMACOL REV, V63, P471, DOI 10.1124/pr.110.003517; Wright WS, 2009, EXP EYE RES, V89, P532, DOI 10.1016/j.exer.2009.05.008; Yanni SE, 2010, BRAIN RES BULL, V81, P310, DOI 10.1016/j.brainresbull.2009.10.018; Yanni SE, 2009, INVEST OPHTH VIS SCI, V50, P5479, DOI 10.1167/iovs.09-3652	45	8	8	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					368	375		10.1096/fj.201600604R	http://dx.doi.org/10.1096/fj.201600604R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27770021				2022-12-28	WOS:000392177600034
J	Feigerlova, E; Demarquet, L; Melhem, H; Ghemrawi, R; Battaglia-Hsu, SF; Ewu, E; Alberto, JM; Helle, D; Weryha, G; Gueant, JL				Feigerlova, Eva; Demarquet, Lea; Melhem, Hassan; Ghemrawi, Rose; Battaglia-Hsu, Shyue-Fang; Ewu, Essi; Alberto, Jean-Marc; Helle, Deborah; Weryha, Georges; Gueant, Jean-Louis			Methyl donor deficiency impairs bone development via peroxisome proliferator-activated receptor-gamma coactivator-1 alpha-dependent vitamin D receptor pathway	FASEB JOURNAL			English	Article						osteoblast differentiation; bone development; 1,25-dihydroxyvitamin D-3; folate; vitamin B-12	HOMOCYSTEINE LEVELS; DIFFERENTIATION; PROTEINS; GROWTH; GENE; BINDING; ALPHA; CELLS; D-3; HYPERHOMOCYSTEINEMIA	Deficiency in methyl donor (folate and vitamin B-12) and in vitamin D is independently associated with altered bone development. Previously, methyl donor deficiency (MDD) was shown to weaken the activity of nuclear receptor coactivator, peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC1 alpha), for nuclear signaling in rat pups, including estrogen receptor- alpha and estrogen-related receptor-alpha; its effect on vitamin D receptor (VDR) signaling, however, is unknown. We studied bone development under MDD in rat pups and used human MG-63 preosteoblast cells to better understand the associated molecular mechanism. In young rats, MDD decreased total body bone mineral density, reduced tibia length, and impaired growth plate maturation, and in preosteoblasts, MDD slowed cellular proliferation. Mechanistic studies revealed decreased expression of VDR, estrogen receptor-alpha, PGC1, arginine methyltransferase 1, and sirtuin 1 in both rat proximal diaphysis of femur and in MG-63, as well as decreased nuclear VDR-PGC1 alpha interaction in MG-63 cells. The weaker VDR-PGC1 alpha interaction could be attributed to the reduced protein expression, imbalanced PGC1 alpha methylation/acetylation, and nuclear VDR sequestration by heat shock protein 90 (HSP90). These together compromised bone development, which is reflected by lowered bone alkaline phosphatase and increased proadipogenic peroxisome proliferator-activated receptor-gamma, adiponectin, and estrogen-related receptor-alpha expression. Of interest, under MDD, the bone development effects of 1,25-dihydroxyvitamin D-3 were ineffectual and these could be rescued by the addition of S-adenosylmethionine, which restored expression of arginine methyltransferase 1, PGC1 alpha, adiponectin, and HSP90. In conclusion, MDD inactivates vitamin D signaling via both disruption of VDR-PGC1 alpha interaction and sequestration of nuclear VDR attributable to HSP90 overexpression. These data suggest that vitamin D treatment may be ineffective under MDD.	[Feigerlova, Eva; Demarquet, Lea; Melhem, Hassan; Ghemrawi, Rose; Battaglia-Hsu, Shyue-Fang; Ewu, Essi; Alberto, Jean-Marc; Helle, Deborah; Gueant, Jean-Louis] Univ Lorraine, Fac Med, Nutr Genet & Exposit Risques Environm, INSERM,U954, Vandoeuvre Les Nancy, France; [Feigerlova, Eva; Weryha, Georges] Reg Univ Hosp Ctr Nancy, Div Endocrinol, Vandoeuvre Les Nancy, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy	Feigerlova, E; Gueant, JL (corresponding author), INSERM, U954, Fac Med, 9 Ave Foret Haye,BP 184, F-54500 Nancy, France.	eva.feigerlova@chu-poitiers.fr; jean-louis.gueant@medecine.uhp-nancy.fr			Region Lorraine	Region Lorraine(Region Grand-Est)	Institutional grants were received from the Region Lorraine. The authors thank Dr. James Stevenin (Institut Genetique Biologie Moleculaire Cellulaire, Strasbourg, France), for providing NPM antibody. The authors declare no conflicts of interest.	Al-Tahan J, 2006, NUTR HOSP, V21, P452; Amer M, 2014, J CLIN ENDOCR METAB, V99, P633, DOI 10.1210/jc.2013-3262; Angelo G, 2008, BIOCHEM BIOPH RES CO, V367, P578, DOI 10.1016/j.bbrc.2007.12.179; Auwerx J, 1999, CELL, V97, P161; Azizi ZA, 2010, BONE, V46, P1344, DOI 10.1016/j.bone.2009.11.027; Battaglia-Hsu SF, 2009, P NATL ACAD SCI USA, V106, P21930, DOI 10.1073/pnas.0811794106; BONEWALD LF, 1992, J BIOL CHEM, V267, P8943; CARLBERG C, 1993, NATURE, V361, P657, DOI 10.1038/361657a0; Carlberg C, 1998, CRIT REV EUKAR GENE, V8, P19, DOI 10.1615/CritRevEukarGeneExpr.v8.i1.20; CARMEL R, 1988, NEW ENGL J MED, V319, P70, DOI 10.1056/NEJM198807143190202; Carmel Ralph, 2003, Hematology Am Soc Hematol Educ Program, P62; CHANDAR N, 1992, BRIT J CANCER, V65, P208, DOI 10.1038/bjc.1992.43; CHESKIS B, 1994, MOL CELL BIOL, V14, P3329, DOI 10.1128/MCB.14.5.3329; CLOVER J, 1994, BONE, V15, P585, DOI 10.1016/8756-3282(94)90305-0; Compston J, 2002, J CLIN ENDOCR METAB, V87, P5398, DOI 10.1210/jc.2002-021420; Crider KS, 2011, AM J CLIN NUTR, V93, P1365, DOI 10.3945/ajcn.110.004671; Csermely P, 1998, PHARMACOL THERAPEUT, V79, P129, DOI 10.1016/S0163-7258(98)00013-8; Dadi S, 2012, CANCER CELL, V21, P563, DOI 10.1016/j.ccr.2012.02.013; Delhon I, 2009, ENDOCRINOLOGY, V150, P4463, DOI 10.1210/en.2009-0121; Dhonukshe-Rutten RAM, 2005, EUR J NUTR, V44, P341, DOI 10.1007/s00394-004-0531-x; Engelbrecht Y, 2003, ENDOCRINOLOGY, V144, P412, DOI 10.1210/en.2002-220769; Finch JL, 2001, J AM SOC NEPHROL, V12, P1468, DOI 10.1681/ASN.V1271468; FRANCESCHI RT, 1985, J CELL PHYSIOL, V123, P401, DOI 10.1002/jcp.1041230316; Gacad MA, 1998, J CLIN ENDOCR METAB, V83, P1264, DOI 10.1210/jc.83.4.1264; Gacad MA, 1997, J BIOL CHEM, V272, P8433, DOI 10.1074/jbc.272.13.8433; Gallet M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054837; Garcia MM, 2011, J PATHOL, V225, P324, DOI 10.1002/path.2881; Ghemrawi R, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.69; GOERSS JB, 1992, J BONE MINER RES, V7, P573; Gradosova I, 2011, PHARMAZIE, V66, P606, DOI 10.1691/ph.2011.1525; Herrmann M, 2009, BONE, V44, P467, DOI 10.1016/j.bone.2008.10.051; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kriebitzsch C, 2011, J BONE MINER RES, V26, P2991, DOI 10.1002/jbmr.493; Levasseur R, 2009, JOINT BONE SPINE, V76, P234, DOI 10.1016/j.jbspin.2008.11.002; Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; Marcinkowska E, 2010, J STEROID BIOCHEM, V121, P114, DOI 10.1016/j.jsbmb.2010.01.013; Merriman NA, 2010, GASTROENTEROLOGY, V138, P1330, DOI 10.1053/j.gastro.2009.12.007; POCKWINSE SM, 1992, J CELL BIOCHEM, V49, P310, DOI 10.1002/jcb.240490315; Pons L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006325; Pooya S, 2012, J HEPATOL, V57, P344, DOI 10.1016/j.jhep.2012.03.028; Pourie G, 2015, FASEB J, V29, P3713, DOI 10.1096/fj.14-264267; Pratt WB, 2004, CELL SIGNAL, V16, P857, DOI 10.1016/j.cellsig.2004.02.004; Reinholz MM, 2010, BONE, V47, P12, DOI 10.1016/j.bone.2010.03.006; Roman-Garcia P, 2014, J CLIN INVEST, V124, P2988, DOI 10.1172/JCI72606; Savkur RS, 2005, MOL PHARMACOL, V68, P511, DOI 10.1124/mol.105.012708.; SELHUB J, 1993, JAMA-J AM MED ASSOC, V270, P2693, DOI 10.1001/jama.270.22.2693; Shen Q, 2005, J BIOL CHEM, V280, P40589, DOI 10.1074/jbc.M504166200; Trepel J, 2010, NAT REV CANCER, V10, P537, DOI 10.1038/nrc2887; UBBINK JB, 1993, AM J CLIN NUTR, V57, P47, DOI 10.1093/ajcn/57.1.47; Vaisman DN, 2005, BIOL TRACE ELEM RES, V104, P131, DOI 10.1385/BTER:104:2:131; van Driel M, 2006, J CELL BIOCHEM, V99, P922, DOI 10.1002/jcb.20875; van Meurs JBJ, 2004, NEW ENGL J MED, V350, P2033, DOI 10.1056/NEJMoa032546; Vaughn JD, 2004, J NUTR, V134, P2985, DOI 10.1093/jn/134.11.2985; Wang HB, 2013, CELL BIOL INT, V37, P1259, DOI 10.1002/cbin.10148; Wei W, 2010, CELL METAB, V11, P503, DOI 10.1016/j.cmet.2010.04.015; Wolf IM, 2008, J CELL BIOCHEM, V104, P1580, DOI 10.1002/jcb.21755; Wu SX, 2000, MOL ENDOCRINOL, V14, P1387, DOI 10.1210/me.14.9.1387	58	2	2	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3598	3612		10.1096/fj.201600332R	http://dx.doi.org/10.1096/fj.201600332R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27435264				2022-12-28	WOS:000384329800028
J	Hwang, IH; Park, J; Kim, JM; Kim, SI; Choi, JS; Lee, KB; Yun, SH; Lee, MG; Park, SJ; Jang, IS				Hwang, In-Hu; Park, Junsoo; Kim, Jung Min; Kim, Seung Il; Choi, Jong-Soon; Lee, Kyung-Bok; Yun, Sung Ho; Lee, Min-Goo; Park, Soo Jung; Jang, Ik-Soon			Tetraspanin-2 promotes glucotoxic apoptosis by regulating the JNK/-catenin signaling pathway in human pancreatic cells	FASEB JOURNAL			English	Article						Bax; glucose toxicity; TSPAN2	THIOREDOXIN-INTERACTING PROTEIN; WNT; PHOSPHORYLATION; TRANSCRIPTION; GSK3-BETA; MECHANISM; SURVIVAL; BAX	Diabetes mellitus is a complex and heterogeneous disease, which has -cell dysfunction at its core. Glucotoxicity affects pancreatic islets, causing -cell apoptosis. However, the role of JNK/-catenin signaling in glucotoxic -cell apoptosis is not well understood. Recently, we identified tetraspanin-2 (TSPAN2) protein as a proapoptotic -cell factor induced by glucose, suggesting that TSPAN2 might contribute to pancreatic -cell glucotoxicity. To investigate the effects of glucose concentration on TSPAN2 expression and apoptosis, we used reverted immortalized RNAKT-15 human pancreatic cells. High TSPAN2 levels up-regulated phosphorylated (p) JNK and induced apoptosis. p-JNK enhanced the phosphorylation of -catenin and Dickkopf-1 (Dkk1). Dkk1 knockdown by small interfering (si)RNA up-regulated nuclear -catenin, suggesting that it is a JNK/-catenin-dependent pathway. siRNA-mediated TSPAN2 depletion in RNAKT-15 cells increased nuclear -catenin. This decreased BCL2-associated X protein (Bax) activation, leading to marked protection against high glucose-induced apoptosis. Bax subfamily proteins induced apoptosis through caspase-3. Thus, TSPAN2 might have induced Bax translocation and caspase-3 activation in pancreatic cells, thereby promoting the apoptosis of RNAKT-15 cells by regulating the JNK/-catenin pathway in response to high glucose concentrations. Targeting TSPAN2 could be a potential therapeutic strategy to treat glucose toxicity-induced -cell failure.Hwang, I.-H., Park, J., Kim, J. M., Kim, S. I., Choi, J.-S., Lee, K.-B., Yun, S. H., Lee, M.-G., Park, S. J., Jang, I.-S. Tetraspanin-2 promotes glucotoxic apoptosis by regulating the JNK/-catenin signaling pathway in human pancreatic cells.	[Hwang, In-Hu; Lee, Min-Goo] Korea Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Park, Junsoo] Yonsei Univ, Div Biol Sci & Technol, Wonju, South Korea; [Kim, Jung Min] Daejeon Univ, Daejeon Oriental Hosp, NAR Ctr Inc, Daejeon, South Korea; [Kim, Seung Il; Choi, Jong-Soon; Lee, Kyung-Bok; Yun, Sung Ho; Jang, Ik-Soon] Korea Basic Sci Inst, Div Bioconvergence, Daejeon 305333, South Korea; [Park, Soo Jung] Sangji Univ, Coll Korean Med, Wonju 220702, South Korea	Korea University; Korea University Medicine (KU Medicine); Yonsei University; Daejeon University; Korea Basic Science Institute (KBSI); Sangji University	Jang, IS (corresponding author), Korea Basic Sci Inst, Div Bioconvergence, Daejeon 305333, South Korea.; Park, SJ (corresponding author), Sangji Univ, Coll Korean Med, Wonju 220702, South Korea.	taorgi@hanmail.net; jangiksn@kbsi.re.kr		Lee, Kyung-Bok/0000-0003-1495-3462; Kim, Jung Min/0000-0001-6319-0217	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A01058744, 2014R1A1A2058114]; Korea Basic Science Institute [D36403]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Korea Basic Science Institute	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by Ministry of Education Grants 2015R1D1A1A01058744 and 2014R1A1A2058114, and supported by Korea Basic Science Institute Grant D36403. Author contributions: I.-H. Hwang and J. Park performed the experiments, including cell culture, Western blot analyses, and confocal microscopy, and analyzed the data; J. M. Kim and S. I. Kim performed microarray and Gene Ontology analyses; J.-S. Choi, K.-B. Lee, S. H. Yun, and M.-G. Lee supported the experiments and prepared the figures; and S. J. Park and I.-S. Jang conceived and designed the experiments, contributed reagents, sourced materials, provided analysis tools, and wrote the paper. The authors declare no conflicts of interest.	Adams JM, 2007, CURR OPIN IMMUNOL, V19, P488, DOI 10.1016/j.coi.2007.05.004; Chen J, 2008, DIABETES, V57, P938, DOI 10.2337/db07-0715; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Gardai SJ, 2004, J BIOL CHEM, V279, P21085, DOI 10.1074/jbc.M400063200; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Hu D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006640; Hu D, 2008, CARCINOGENESIS, V29, P2317, DOI 10.1093/carcin/bgn239; Kang BPS, 2003, AM J PHYSIOL-RENAL, V284, pF455, DOI 10.1152/ajprenal.00137.2002; Khera T, 2006, LAB INVEST, V86, P566, DOI 10.1038/labinvest.3700418; Kim WH, 2005, DIABETES, V54, P2602, DOI 10.2337/diabetes.54.9.2602; Lee MH, 2009, FASEB J, V23, P3874, DOI 10.1096/fj.08-117804; Liao GH, 2006, P NATL ACAD SCI USA, V103, P16313, DOI 10.1073/pnas.0602557103; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Narushima M, 2005, NAT BIOTECHNOL, V23, P1274, DOI 10.1038/nbt1145; Niida A, 2004, ONCOGENE, V23, P8520, DOI 10.1038/sj.onc.1207892; Saadeddin A, 2009, MOL CANCER RES, V7, P1189, DOI 10.1158/1541-7786.MCR-09-0027; Sinha D, 2005, AM J PHYSIOL-RENAL, V288, pF703, DOI 10.1152/ajprenal.00189.2004; Todd SC, 1998, BBA-GENE STRUCT EXPR, V1399, P101, DOI 10.1016/S0167-4781(98)00087-6; Wang ZB, 2005, CELL BIOL INT, V29, P489, DOI 10.1016/j.cellbi.2005.04.001; Wang ZY, 2009, J AM SOC NEPHROL, V20, P1919, DOI 10.1681/ASN.2009030253; Xu GL, 2013, NAT MED, V19, P1141, DOI 10.1038/nm.3287; Yamanaka H, 2002, EMBO REP, V3, P69, DOI 10.1093/embo-reports/kvf008; Zhang QG, 2008, J NEUROSCI, V28, P8430, DOI 10.1523/JNEUROSCI.2752-08.2008	24	11	13	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3107	3116		10.1096/fj.201600240RR	http://dx.doi.org/10.1096/fj.201600240RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27247127	hybrid, Green Published			2022-12-28	WOS:000382816300011
J	Almuzzaini, B; Sarshad, AA; Rahmanto, AS; Hansson, ML; Von Euler, A; Sangfelt, O; Visa, N; Farrants, AKO; Percipalle, P				Almuzzaini, Bader; Sarshad, Aishe A.; Rahmanto, Aldwin S.; Hansson, Magnus L.; Von Euler, Anne; Sangfelt, Olle; Visa, Neus; Farrants, Ann-Kristin Ostlund; Percipalle, Piergiorgio			In beta-actin knockouts, epigenetic reprogramming and rDNA transcription inactivation lead to growth and proliferation defects	FASEB JOURNAL			English	Article						genome-wide analysis; NM1; nuclear actin; rRNA synthesis	POLYMERASE-I TRANSCRIPTION; NUCLEOLAR TRANSCRIPTION; NUCLEAR ACTIN; CELL-GROWTH; FACTOR UBF; FACTOR SL1; MYOSIN-I; RNA; COMPLEX; CONFORMATION	Actin and nuclear myosin 1 (NM1) are regulators of transcription and chromatin organization. Using a genome-wide approach, we report here that beta-actin binds intergenic and genic regions across the mammalian genome, associated with both protein-coding and rRNA genes. Within the rDNA, the distribution of beta-actin correlated with NM1 and the other subunits of the B-WICH complex, WSTF and SNF2h. In beta-actin(-/-) mouse embryonic fibroblasts (MEFs), we found that rRNA synthesis levels decreased concomitantly with drops in RNA polymerase I (Pol I) and NM1 occupancies across the rRNA gene. Reintroduction of wild-type beta-actin, in contrast to mutated forms with polymerization defects, efficiently rescued rRNA synthesis underscoring the direct role for a polymerization-competent form of beta-actin in Pol I transcription. The rRNA synthesis defects in the beta-actin(-/-) MEFs are a consequence of epigenetic reprogramming with up-regulation of the repressive mark H3K4me1 (mono-methylation of lys4 on histone H3) and enhanced chromatin compaction at promoter-proximal enhancer (T0 sequence), which disturb binding of the transcription factor TTF1. We propose a novel genome-wide mechanism where the polymerase-associated beta-actin synergizes with NM1 to coordinate permissive chromatin with Pol I transcription, cell growth, and proliferation.	[Almuzzaini, Bader; Sarshad, Aishe A.; Rahmanto, Aldwin S.; Hansson, Magnus L.; Sangfelt, Olle; Percipalle, Piergiorgio] Karolinska Inst, Dept Cell & Mol Biol, Stockholm, Sweden; [Almuzzaini, Bader] King Abdullah Int Med Res Ctr, Natl Guard Hlth Affairs, Riyadh, Saudi Arabia; [Von Euler, Anne; Visa, Neus; Farrants, Ann-Kristin Ostlund; Percipalle, Piergiorgio] Stockholm Univ, Wenner Gren Inst, Dept Mol Biosci, Stockholm, Sweden; [Percipalle, Piergiorgio] New York Univ Abu Dhabi, Dept Biol, Div Sci, Abu Dhabi, U Arab Emirates; [Sarshad, Aishe A.] NIAMSD, NIH, Bethesda, MD USA	Karolinska Institutet; King Saud Bin Abdulaziz University for Health Sciences; King Abdulaziz Medical City - Riyadh; King Abdullah International Medical Research Center (KAIMRC); Ministry of National Guard - Health Affairs; National Guard Health Affairs - Saudi Arabia; Stockholm University; National Institutes of Health (NIH) - USA; NIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)	Percipalle, P (corresponding author), New York Univ Abu Dhabi, Saadyiat Campus, Abu Dhabi 129188, U Arab Emirates.	pp69@nyu.edu	Visa, Neus/C-9459-2016; Visa, Neus/R-8037-2019	Visa, Neus/0000-0003-3145-3953; Visa, Neus/0000-0003-3145-3953; Almuzzaini, Bader/0000-0003-1176-9037; Sarshad, Aishe/0000-0001-7153-5959	Swedish Research Council; Swedish Cancer Society; National Guard Health Affairs-King Abdullah International Medical Research Center; Karolinska Institute doctoral fellowship; Swedish Society for Medical Research; Radiumhemmets Forskningsfonder	Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Cancer Society(Swedish Cancer Society); National Guard Health Affairs-King Abdullah International Medical Research Center; Karolinska Institute doctoral fellowship; Swedish Society for Medical Research; Radiumhemmets Forskningsfonder	The authors thank C. Ampe (University of Ghent, Ghent, Belgium) and R. Treissman (London Research Institute, London, United Kingdom) for kindly providing the beta-actin<SUP>+/+</SUP> MEFs, beta-actin<SUP>-/-</SUP> MEFs, and beta-actin constructs. The authors also thank M. Corcoran and M. Rahman (both from the Karolinska Institute) for technical help. This work was supported by grants from the Swedish Research Council and the Swedish Cancer Society to P.P., O.S., and N.V. B.A.M. was cofunded by National Guard Health Affairs-King Abdullah International Medical Research Center, and A.A.S. was cofunded by a Karolinska Institute doctoral fellowship. M.H. was supported by a postdoctoral fellowship from the Swedish Society for Medical Research. A.S.R. was supported by funds from Radiumhemmets Forskningsfonder.	Almuzzaini B, 2015, BMC BIOL, V13, DOI 10.1186/s12915-015-0147-z; Belmont LD, 1999, P NATL ACAD SCI USA, V96, P29, DOI 10.1073/pnas.96.1.29; Belmont LD, 1998, J CELL BIOL, V142, P1289, DOI 10.1083/jcb.142.5.1289; Bunnell TM, 2011, MOL BIOL CELL, V22, P4047, DOI 10.1091/mbc.E11-06-0582; Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200; Chen TW, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-539; CHEN X, 1995, J BIOL CHEM, V270, P11415, DOI 10.1074/jbc.270.19.11415; CHEN X, 1995, J BIOL CHEM, V270, P11406, DOI 10.1074/jbc.270.19.11406; Cheng J, 2014, MOL CELL, V53, P979, DOI 10.1016/j.molcel.2014.02.032; Cheung TH, 2013, NAT REV MOL CELL BIO, V14, P329, DOI 10.1038/nrm3591; Diermeier SD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003786; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Grummt I, 2006, CURR OPIN GENET DEV, V16, P191, DOI 10.1016/j.gde.2006.02.001; Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R; Grummt I, 2007, HUM MOL GENET, V16, pR21, DOI 10.1093/hmg/ddm020; Hanada K, 1996, EMBO J, V15, P2217, DOI 10.1002/j.1460-2075.1996.tb00575.x; Heix J, 1998, EMBO J, V17, P7373, DOI 10.1093/emboj/17.24.7373; Klein J, 1999, P NATL ACAD SCI USA, V96, P6096, DOI 10.1073/pnas.96.11.6096; Kuhn A, 1998, J MOL BIOL, V284, P1, DOI 10.1006/jmbi.1998.2164; Langst G, 1998, EMBO J, V17, P3135, DOI 10.1093/emboj/17.11.3135; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Nemeth A, 2008, EMBO J, V27, P1255, DOI 10.1038/emboj.2008.57; Panov KI, 2006, EMBO J, V25, P3310, DOI 10.1038/sj.emboj.7601221; Percipalle P, 2006, EMBO REP, V7, P525, DOI 10.1038/sj.embor.7400657; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190; Posern G, 2002, MOL BIOL CELL, V13, P4167, DOI 10.1091/mbc.02-05-0068; Prieto JL, 2005, BIOCHEM SOC T, V33, P1441, DOI 10.1042/BST0331441; Rosner M, 2013, NAT PROTOC, V8, P602, DOI 10.1038/nprot.2013.011; Russell J, 2006, BIOCHEM SOC SYMP, V73, P203; Sarshad A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003397; Sarshad AA, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004390; Sarshad AA, 2014, INT REV CEL MOL BIO, V311, P183, DOI 10.1016/B978-0-12-800179-0.00004-0; Schneider A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052007; Sirri V, 2008, HISTOCHEM CELL BIOL, V129, P13, DOI 10.1007/s00418-007-0359-6; Spencer VA, 2011, J CELL SCI, V124, P123, DOI 10.1242/jcs.073197; Tondeleir D, 2012, MOL CELL PROTEOMICS, V11, P255, DOI 10.1074/mcp.M111.015099; Vintermist A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019184; Visa N, 2005, EMBO REP, V6, P218, DOI 10.1038/sj.embor.7400362; Visa N, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000620; Xu YZ, 2010, MOL BIOL CELL, V21, P811, DOI 10.1091/mbc.E09-06-0534; Ye J, 2008, GENE DEV, V22, P322, DOI 10.1101/gad.455908; Zentner GE, 2011, NUCLEIC ACIDS RES, V39, P4949, DOI 10.1093/nar/gkq1326; ZETTERBERG A, 1985, P NATL ACAD SCI USA, V82, P5365, DOI 10.1073/pnas.82.16.5365; Zhang Q, 2014, SCIENCE, V343, P298, DOI 10.1126/science.1246384	48	22	22	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2860	2873		10.1096/fj.201600280R	http://dx.doi.org/10.1096/fj.201600280R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27127100				2022-12-28	WOS:000380994000021
J	McGregor, G; Irving, AJ; Harvey, J				McGregor, Gemma; Irving, Andrew J.; Harvey, Jenni			Canonical JAK-STAT signaling is pivotal for long-term depression at adult hippocampal temporoammonic-CA1 synapses	FASEB JOURNAL			English	Article						AMPA receptor trafficking; gene transcription; synaptic plasticity	AMPA RECEPTOR TRAFFICKING; CA1 PYRAMIDAL NEURONS; PERFORANT PATH INPUT; SYNAPTIC PLASTICITY; POSTSYNAPTIC DENSITY; TRANSCRIPTION FACTOR; GLUTAMATE RECEPTORS; DORSAL HIPPOCAMPUS; JAK2/STAT3 AXIS; AMYLOID-BETA	The Janus kinase (JAK)-signal transducer and activator of transcription (STAT) signaling pathway is involved in numerous cellular processes and it is implicated in neurodegenerative disorders, like Alzheimer disease. Recent studies identified a crucial role for this pathway in activity-dependent long-term depression (LTD) at hippocampal Schaffer collateral (SC)-CA1 synapses. However, it is unclear whether JAK-STAT signaling also regulates excitatory synaptic function at the anatomically distinct temporoammonic (TA) input to CA1 neurons. Here we demonstrate that LTD at adult TA-CA1 synapses involves JAK-STAT signaling, but unlike SC-CA1 synapses, requires rapid gene transcription. TA-CA1 LTD requires NMDA receptor activation and is independent of PI3K or ERK signaling. JAK-STAT signaling was critical for TA-CA1 LTD as inhibition of JAK or STAT blocked LTD induction and prevented NMDA-induced AMPA (alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid) receptor internalization in hippocampal neurons. Moreover, an increase in phosphorylated JAK2 and STAT3 accompanied chemical induction of LTD and AMPA receptor internalization. STAT3-driven gene transcription was required for LTD as inhibition of STAT3-DNA binding, nuclear export, and gene transcription all prevented LTD induction. These data indicate an essential role for canonical JAK-STAT signaling in activity-dependent LTD at TA-CA1 synapses and provide valuable insight into the role of the TA input in hippocampal synaptic plasticity.	[McGregor, Gemma; Harvey, Jenni] Univ Dundee, Ninewells Hosp & Med Sch, Sch Med, Div Neurosci, Dundee DD1 9SY, Scotland; [Irving, Andrew J.] Univ Coll Dublin, Conway Inst, Sch Biomol & Biomed Sci, Dublin, Ireland	University of Dundee; University College Dublin	Harvey, J (corresponding author), Univ Dundee, Ninewells Hosp & Med Sch, Sch Med, Div Neurosci, Dundee DD1 9SY, Scotland.	j.z.harvey@dundee.ac.uk			Tenovus; BBSRC EASTBIO studentship	Tenovus; BBSRC EASTBIO studentship(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	J.H. is funded by the Anonymous Trust and Tenovus. G.M. is supported by a BBSRC EASTBIO studentship. The authors thank K.-A. Bollan (University of Dundee) for her technical assistance with the surface biotinylation assay and the members of W. Fuller's laboratory (University of Dundee) for use of the Bio-Rad ChemiDoc XRS imaging system and their technical help. The authors declare no conflicts of interest.	Ahmed MS, 2009, NEURON, V63, P372, DOI 10.1016/j.neuron.2009.07.013; Aksoy-Aksel Ayla, 2013, Front Synaptic Neurosci, V5, P5, DOI 10.3389/fnsyn.2013.00005; Anderson WW, 2007, J NEUROSCI METH, V162, P346, DOI 10.1016/j.jneumeth.2006.12.018; Anwyl R, 1999, BRAIN RES REV, V29, P83, DOI 10.1016/S0165-0173(98)00050-2; Bear MF, 1996, ANNU REV NEUROSCI, V19, P437, DOI 10.1146/annurev.ne.19.030196.002253; Beattie EC, 2000, NAT NEUROSCI, V3, P1291, DOI 10.1038/81823; Bhouri M, 2014, J NEUROSCI, V34, P12223, DOI 10.1523/JNEUROSCI.0753-14.2014; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Chiba T, 2009, MOL PSYCHIATR, V14, P206, DOI 10.1038/mp.2008.105; Chiba T, 2009, EXPERT OPIN THER TAR, V13, P1155, DOI 10.1517/14728220903213426; Choquet D, 2010, EUR J NEUROSCI, V32, P250, DOI 10.1111/j.1460-9568.2010.07350.x; Collingridge GL, 2004, NAT REV NEUROSCI, V5, P952, DOI 10.1038/nrn1556; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; De-Fraja C, 1998, J NEUROSCI RES, V54, P320, DOI 10.1002/(SICI)1097-4547(19981101)54:3<320::AID-JNR3>3.0.CO;2-R; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Doherty GH, 2013, NEUROBIOL AGING, V34, P226, DOI 10.1016/j.neurobiolaging.2012.08.003; Duan Z, 2007, MOL PHARMACOL, V72, P1137, DOI 10.1124/mol.107.038117; Dvorak-Carbone H, 1999, J NEUROPHYSIOL, V81, P1036, DOI 10.1152/jn.1999.81.3.1036; English JD, 1997, J BIOL CHEM, V272, P19103, DOI 10.1074/jbc.272.31.19103; Fitzjohn SM, 1998, NEUROPHARMACOLOGY, V37, P1445, DOI 10.1016/S0028-3908(98)00145-2; Hu ZH, 2015, J CELL BIOL, V208, P949, DOI 10.1083/jcb.201404092; Hu ZH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4263; IHLE JN, 1995, NATURE, V377, P591, DOI 10.1038/377591a0; Kallarackal AJ, 2013, J NEUROSCI, V33, P15669, DOI 10.1523/JNEUROSCI.2588-13.2013; Kandler K, 1998, NAT NEUROSCI, V1, P119, DOI 10.1038/368; Kauderer BS, 2000, P NATL ACAD SCI USA, V97, P13342, DOI 10.1073/pnas.97.24.13342; Kemp A, 2013, BEHAV BRAIN RES, V254, P83, DOI 10.1016/j.bbr.2013.04.036; Kemp N, 2001, PROG NEUROBIOL, V65, P339, DOI 10.1016/S0301-0082(01)00013-2; Kimura T, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0144; Lee HK, 1998, NEURON, V21, P1151, DOI 10.1016/S0896-6273(00)80632-7; Lee SH, 2002, NEURON, V36, P661, DOI 10.1016/S0896-6273(02)01024-3; Levy WB, 1998, LEARN MEMORY, V4, P510, DOI 10.1101/lm.4.6.510; Li WX, 2008, TRENDS CELL BIOL, V18, P545, DOI 10.1016/j.tcb.2008.08.008; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Lindecke A, 2006, EUR J NEUROSCI, V24, P555, DOI 10.1111/j.1460-9568.2006.04909.x; Luo X, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0007-15.2015; Malekizadeh Y, 2017, CEREB CORTEX, V27, P4769, DOI 10.1093/cercor/bhw272; Man HY, 2003, NEURON, V38, P611, DOI 10.1016/S0896-6273(03)00228-9; Manabe T, 1997, REV NEUROSCIENCE, V8, P179, DOI 10.1515/REVNEURO.1997.8.3-4.179; Massey PV, 2007, TRENDS NEUROSCI, V30, P176, DOI 10.1016/j.tins.2007.02.005; Meydan N, 1996, NATURE, V379, P645, DOI 10.1038/379645a0; Moult PR, 2011, NEUROPHARMACOLOGY, V61, P924, DOI 10.1016/j.neuropharm.2011.06.021; Moult PR, 2010, J NEUROSCI, V30, P4088, DOI 10.1523/JNEUROSCI.3614-09.2010; Moutoussamy S, 1998, EUR J BIOCHEM, V255, P1, DOI 10.1046/j.1432-1327.1998.2550001.x; MULKEY RM, 1993, SCIENCE, V261, P1051, DOI 10.1126/science.8394601; MULKEY RM, 1994, NATURE, V369, P486, DOI 10.1038/369486a0; Murata S, 2000, MOL BRAIN RES, V78, P80, DOI 10.1016/S0169-328X(00)00077-2; Nelson EA, 2008, BLOOD, V112, P5095, DOI 10.1182/blood-2007-12-129718; Nicholls RE, 2008, NEURON, V58, P104, DOI 10.1016/j.neuron.2008.01.039; Nicholson DA, 2006, NEURON, V50, P431, DOI 10.1016/j.neuron.2006.03.022; Nicolas Celine S, 2013, JAKSTAT, V2, pe22925, DOI 10.4161/jkst.22925; Nicolas CS, 2012, NEURON, V73, P374, DOI 10.1016/j.neuron.2011.11.024; Otmakhova NA, 1999, J NEUROSCI, V19, P1437; Palmer MJ, 1997, NEUROPHARMACOLOGY, V36, P1517, DOI 10.1016/S0028-3908(97)00181-0; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Pickard L, 2001, NEUROPHARMACOLOGY, V41, P700, DOI 10.1016/S0028-3908(01)00127-7; Remondes M, 2003, LEARN MEMORY, V10, P247, DOI 10.1101/lm.59103; Remondes M, 2002, NATURE, V416, P736, DOI 10.1038/416736a; SAMPEDRO MN, 1981, J CELL BIOL, V90, P675, DOI 10.1083/jcb.90.3.675; Sandberg EM, 2005, J MED CHEM, V48, P2526, DOI 10.1021/jm049470k; Schust J, 2006, CHEM BIOL, V13, P1235, DOI 10.1016/j.chembiol.2006.09.018; Shanley LJ, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-24-j0001.2001; Stokes J, 2015, J COGNITIVE NEUROSCI, V27, P546, DOI 10.1162/jocn_a_00736; Vago DR, 2008, BEHAV BRAIN RES, V189, P273, DOI 10.1016/j.bbr.2008.01.002; Vago DR, 2007, HIPPOCAMPUS, V17, P977, DOI 10.1002/hipo.20329; Yamaoka K, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-253; Yassa MA, 2010, P NATL ACAD SCI USA, V107, P12687, DOI 10.1073/pnas.1002113107; Zhang M, 2013, BRAIN RES, V1503, P43, DOI 10.1016/j.brainres.2013.01.052	69	21	21	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3449	3466		10.1096/fj.201601293RR	http://dx.doi.org/10.1096/fj.201601293RR			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28461339				2022-12-28	WOS:000405932400023
J	Chen, TH; Chen, CY; Wen, HC; Chang, CC; Wang, HD; Chuu, CP; Chang, CH				Chen, Ting-Huan; Chen, Chen-Yu; Wen, Hui-Chin; Chang, Chia-Chu; Wang, Horng-Dar; Chuu, Chih-Pin; Chang, Chung-Ho			YAP promotes myogenic differentiation via the MEK5-ERK5 pathway	FASEB JOURNAL			English	Article						myogenesis; C2C12 myoblasts; Src; TAZ; Abl	SKELETAL-MUSCLE; TARGETED INACTIVATION; SIGNALING PATHWAY; HIPPO PATHWAY; WW DOMAIN; ERK5; ACTIVATION; PROLIFERATION; COACTIVATOR; GROWTH	Yes-associated protein (YAP) is a transcriptional coactivator in the Hippo pathway that regulates cell proliferation, differentiation, and apoptosis. The MEK5/ERK5 MAPK cascade is essential for the early step of myogenesis. In this study, we generated C2C12 stable cell lines that expressed YAP (C2C12-YAP cells) and found that ERK5 and MEK5 were activated in C2C12-YAP cells compared with control C2C12 (C2C12-vector) cells. C2C12YAP stable cells also differentiated into myotubes better than C2C12-vector cells, and expressed elevated levels of myogenin, a transcription factor that regulates myogenesis, as well as elevated levels of myosin heavy chain, a skeletal muscle marker. Western blot analysis revealed that Src and c-Abl (Abelson murine leukemia viral oncogene homolog 1) activation were enhanced in C2C12-YAP cells. Conversely, treatment of inhibitors of c-Abl, Src, or MEK5 inhibited activation of MEK5 and ERK5 and myogenesis of C2C12 myoblasts. Specific interactions between YAP and proteins in the ERK5 pathway, such as MEK kinase 3 (MEKK3) and ERK5, were illustrated by coimmunoprecipitation experiments. MEKK3 contains the PPGY motif (aa 178-181), which may interact with YAP. Site-directed mutagenesis experiments revealed that expression of MEKK3 Y181F mutant inhibited MEK5/ERK5 activation and myogenic differentiation. These results suggest that YAP promotes muscle differentiation by activating the Abl/Src/MEKK3/MEK5/ERK5 kinase cascade. Chen, T.-H., Chen, C.-Y., Wen, H.-C., Chang, C.-C., Wang, H.-D., Chuu, C.-P., Chang, C.-H. YAP promotes myogenic differentiation via the MEK5-ERK5 pathway.	[Chen, Ting-Huan; Wang, Horng-Dar] Natl Tsing Hua Univ, Dept Life Sci, Hsinchu, Taiwan; [Chen, Ting-Huan; Chen, Chen-Yu; Wen, Hui-Chin; Chuu, Chih-Pin; Chang, Chung-Ho] Natl Hlth Res Inst, Inst Cellular & Syst Med, Zhunan, Taiwan; [Chang, Chia-Chu; Chang, Chung-Ho] Changhua Christian Hosp, Dept Internal Med, Changhua, Taiwan	National Tsing Hua University; National Health Research Institutes - Taiwan; Changhua Christian Hospital	Chuu, CP; Chang, CH (corresponding author), Natl Hlth Res Inst, Inst Cellular & Syst Med, 35 Keyan Rd, Zhunan Town 350, Miaoli County, Taiwan.	cpchuu@nhri.org.tw; changch@nhri.org.tw	Chuu, Chih-Pin/N-6697-2019	Wang, Horng-Dar/0000-0001-9570-3611	Ministry of Science and Technology [MOST 104-2320-B-400-008, 105-2314-B-371-005]; National Health Research Institutes [GS-PP03]	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes(National Health Research Institutes, Japan)	This work was supported by the Ministry of Science and Technology (Grants MOST 104-2320-B-400-008 and 105-2314-B-371-005), and by an intramural grant from the National Health Research Institutes (GS-PP03) to C.-H.G.	Arnold HH, 1996, INT J DEV BIOL, V40, P345; Buckingham M, 2003, J ANAT, V202, P59, DOI 10.1046/j.1469-7580.2003.00139.x; BUCKINGHAM M, 1993, CR ACAD SCI III-VIE, V316, P1040; Carter EJ, 2009, J CELL SCI, V122, P3104, DOI 10.1242/jcs.045757; CHEN HI, 1995, P NATL ACAD SCI USA, V92, P7819, DOI 10.1073/pnas.92.17.7819; Cuenda A, 1999, J BIOL CHEM, V274, P4341, DOI 10.1074/jbc.274.7.4341; di Bari MG, 2006, EMBO REP, V7, P727, DOI 10.1038/sj.embor.7400700; Dinev D, 2001, EMBO REP, V2, P829, DOI 10.1093/embo-reports/kve177; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Einbond A, 1996, FEBS LETT, V384, P1, DOI 10.1016/0014-5793(96)00263-3; Golubovskaya VM, 2005, J BIOL CHEM, V280, P25008, DOI 10.1074/jbc.M414172200; Hall CA, 2010, CANCER RES, V70, P8517, DOI 10.1158/0008-5472.CAN-10-1242; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Hong JH, 2005, SCIENCE, V309, P1074, DOI 10.1126/science.1110955; Hossain Z, 2007, P NATL ACAD SCI USA, V104, P1631, DOI 10.1073/pnas.0605266104; Jeong H, 2010, FASEB J, V24, P3310, DOI 10.1096/fj.09-151324; LASSAR AB, 1994, CURR OPIN CELL BIOL, V6, P788, DOI 10.1016/0955-0674(94)90046-9; Lian I, 2010, GENE DEV, V24, P1106, DOI 10.1101/gad.1903310; Lin YT, 2012, EXP CELL RES, V318, P1877, DOI 10.1016/j.yexcr.2012.05.005; Liu AM, 2010, EXPERT OPIN THER TAR, V14, P855, DOI 10.1517/14728222.2010.499361; Lu HG, 2002, J BIOL CHEM, V277, P46687, DOI 10.1074/jbc.M209643200; Makita R, 2008, AM J PHYSIOL-RENAL, V294, pF542, DOI 10.1152/ajprenal.00201.2007; Mauro A, 2002, J CELL SCI, V115, P3587, DOI 10.1242/jcs.00037; Menconi M, 2008, J CELL BIOCHEM, V105, P353, DOI 10.1002/jcb.21833; Mermelstein CS, 2007, DIFFERENTIATION, V75, P184, DOI 10.1111/j.1432-0436.2006.00129.x; Molkentin JD, 1996, P NATL ACAD SCI USA, V93, P9366, DOI 10.1073/pnas.93.18.9366; Morin-Kensicki EM, 2006, MOL CELL BIOL, V26, P77, DOI 10.1128/MCB.26.1.77-87.2006; Nakamura K, 2003, J BIOL CHEM, V278, P36989, DOI 10.1074/jbc.C300313200; Oka T, 2008, J BIOL CHEM, V283, P27534, DOI 10.1074/jbc.M804380200; OLSON EN, 1995, DEV BIOL, V172, P2, DOI 10.1006/dbio.1995.0002; Posthaus H, 2002, J CELL SCI, V115, P4587, DOI 10.1242/jcs.00141; Scapoli L, 2004, ONCOGENE, V23, P805, DOI 10.1038/sj.onc.1207163; Shih-Ting Y., 2013, COMP MATH MATH PHYS, V2013, P1, DOI DOI 10.1109/NSSMIC.2013.6829689; SUDOL M, 1994, ONCOGENE, V9, P2145; SUDOL M, 1995, J BIOL CHEM, V270, P14733, DOI 10.1074/jbc.270.24.14733; Sunadome K, 2011, DEV CELL, V20, P192, DOI 10.1016/j.devcel.2010.12.005; Suzaki Y, 2002, J BIOL CHEM, V277, P9614, DOI 10.1074/jbc.M111790200; Vlug EJ, 2013, CELL ONCOL, V36, P375, DOI 10.1007/s13402-013-0143-7; von Gise A, 2012, P NATL ACAD SCI USA, V109, P2394, DOI 10.1073/pnas.1116136109; Watt KI, 2010, BIOCHEM BIOPH RES CO, V393, P619, DOI 10.1016/j.bbrc.2010.02.034; Yagi R, 2007, DEVELOPMENT, V134, P3827, DOI 10.1242/dev.010223; YEE SP, 1993, GENE DEV, V7, P1277, DOI 10.1101/gad.7.7a.1277; Zhang HY, 2011, P NATL ACAD SCI USA, V108, P2270, DOI 10.1073/pnas.1019603108; Zhang HQ, 2012, DEV BIOL, V361, P103, DOI 10.1016/j.ydbio.2011.10.017; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhou Z, 2011, ONCOGENE, V30, P2181, DOI 10.1038/onc.2010.606	46	19	20	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2963	2972		10.1096/fj.201601090R	http://dx.doi.org/10.1096/fj.201601090R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28356344				2022-12-28	WOS:000405931000021
J	Bertier, L; Boucherie, C; Zwaenepoel, O; Vanloo, B; Van Troys, M; Van Audenhove, I; Gettemans, J				Bertier, Laurence; Boucherie, Ciska; Zwaenepoel, Olivier; Vanloo, Berlinda; Van Troys, Marleen; Van Audenhove, Isabel; Gettemans, Jan			Inhibitory cortactin nanobodies delineate the role of NTA- and SH3-domain-specific functions during invadopodium formation and cancer cell invasion	FASEB JOURNAL			English	Article						single domain antibody; intrabody; actin; Arp2/3 complex; matrix metalloprotease	SMALL-MOLECULE INHIBITORS; ARP2/3 COMPLEX; N-WASP; MATRIX-METALLOPROTEINASE; INTRACELLULAR ANTIBODIES; ACTIN POLYMERIZATION; FAMILY PROTEINS; PROMOTES; MIGRATION; ACTIVATION	Cancer cells exploit different strategies to escape from the primary tumor, gain access to the circulation, disseminate throughout the body, and form metastases, the leading cause of death by cancer. Invadopodia, proteolytically active plasma membrane extensions, are essential in this escape mechanism. Cortactin is involved in every phase of invadopodia formation, and its overexpression is associated with increased invadopodia formation, extracellular matrix degradation, and cancer cell invasion. To analyze endogenous cortactin domain function in these processes, we characterized the effects of nanobodies that are specific for the N-terminal acidic domain of cortactin and expected to target small epitopes within this domain. These nanobodies inhibit cortactin-mediated actin-related protein (Arp) 2/3 activation, and, after their intracellular expression in cancer cells, decrease invadopodia formation, extracellular matrix degradation, and cancer cell invasion. In addition, one of the nanobodies affects Arp2/3 interaction and invadopodium stability, and a nanobody targeting the Src homology 3 domain of cortactin enabled comparison of 2 functional regions in invadopodium formation or stability. Given their common and distinct effects, we validate cortactin nanobodies as an instrument to selectively block and study distinct domains within a protein with unprecedented precision, aiding rational future generation of protein domain-selective therapeutic compounds.-Bertier, L., Boucherie, C., Zwaenepoel, O., Vanloo, B., Van Troys, M., Van Audenhove, I., Gettemans, J. Inhibitory cortactin nanobodies delineate the role of NTA-and SH3-domain-specific functions during invadopodium formation and cancer cell invasion.	[Bertier, Laurence; Boucherie, Ciska; Zwaenepoel, Olivier; Vanloo, Berlinda; Van Troys, Marleen; Van Audenhove, Isabel; Gettemans, Jan] Univ Ghent, Dept Biochem, Fac Med & Hlth Sci, Campus Rommelaere, Ghent, Belgium	Ghent University	Gettemans, J (corresponding author), Univ Ghent, Dept Biochem, Nanobody Lab, Fac Med & Hlth Sci, Campus Rommelaere,Albert Baertsoenkaai 3, B-9000 Ghent, Belgium.	jan.gettemans@ugent.be		Bertier, Laurence/0000-0002-8852-4153; Van Troys, Marleen/0000-0003-4283-8103	Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek Vlaanderen); Ghent University (BOF-GOA); Interuniversity Attraction Poles Programme of the Belgian State, Federal Office for Scientific, Technical and Cultural Affairs [IUAP P7/13]; Emmanuel van der Schueren grant of the Flemish League Against Cancer (VLK); Agency for Innovation by Science and Technology in Flanders (IWT Vlaanderen)	Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek Vlaanderen)(FWO); Ghent University (BOF-GOA)(Ghent University); Interuniversity Attraction Poles Programme of the Belgian State, Federal Office for Scientific, Technical and Cultural Affairs; Emmanuel van der Schueren grant of the Flemish League Against Cancer (VLK); Agency for Innovation by Science and Technology in Flanders (IWT Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT))	This work was supported by grants from the Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek Vlaanderen), Ghent University (BOF-GOA), and the Interuniversity Attraction Poles Programme of the Belgian State, Federal Office for Scientific, Technical and Cultural Affairs (IUAP P7/13); by an Emmanuel van der Schueren grant of the Flemish League Against Cancer (VLK) (to L.B.); by the Agency for Innovation by Science and Technology in Flanders (IWT Vlaanderen); and by the Research Foundation Flanders (Fonds Wetenschappelijk Onderzoek Vlaanderen) (to I.V.A). The authors thank Dr. Gholamreza Hassanzadeh-Ghassabeh (Nanobody Service Facility, Vlaams Instituut voor Biotechnologie, Brussels, Belgium) for the generation and isolation of cortactin-specific nanobodies. The authors declare no conflicts of interest.	Abella JVG, 2016, NAT CELL BIOL, V18, P76, DOI 10.1038/ncb3286; Alexander NR, 2008, CURR BIOL, V18, P1295, DOI 10.1016/j.cub.2008.07.090; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Ayala I, 2008, J CELL SCI, V121, P369, DOI 10.1242/jcs.008037; Beaty BT, 2013, MOL BIOL CELL, V24, P1661, DOI 10.1091/mbc.E12-12-0908; Bethuyne J, 2014, NUCLEIC ACIDS RES, V42, P12928, DOI 10.1093/nar/gku962; Branch KM, 2012, BIOL OPEN, V1, P711, DOI 10.1242/bio.20121867; Bryce NS, 2005, CURR BIOL, V15, P1276, DOI 10.1016/j.cub.2005.06.043; Burke TA, 2014, CURR BIOL, V24, P579, DOI 10.1016/j.cub.2014.01.072; Cai JH, 2010, J GASTROINTEST SURG, V14, P1248, DOI 10.1007/s11605-010-1247-2; Cao T, 2005, ANN CLIN LAB SCI, V35, P227; Clark ES, 2009, ONCOGENE, V28, P431, DOI 10.1038/onc.2008.389; Clark ES, 2007, CANCER RES, V67, P4227, DOI 10.1158/0008-5472.CAN-06-3928; Cortesio CL, 2008, J CELL BIOL, V180, P957, DOI 10.1083/jcb.200708048; De Clercq S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078108; Delanote V, 2010, FASEB J, V24, P105, DOI 10.1096/fj.09-134304; Garcia E, 2016, SCI REP-UK, V6, DOI 10.1038/srep23590; Gligorijevic B, 2012, J CELL SCI, V125, P724, DOI 10.1242/jcs.092726; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hayes KE, 2013, ONCOGENE, V32, P4766, DOI 10.1038/onc.2012.513; Helgeson LA, 2014, J BIOL CHEM, V289, P28856, DOI 10.1074/jbc.M114.587527; Helgeson LA, 2013, ELIFE, V2, DOI 10.7554/eLife.00884; Hetrick B, 2013, CHEM BIOL, V20, P701, DOI 10.1016/j.chembiol.2013.03.019; Hoshino D, 2013, J CELL SCI, V126, P2979, DOI 10.1242/jcs.079475; Isogai T, 2015, J CELL SCI, V128, P3796, DOI 10.1242/jcs.176768; Kempiak SJ, 2005, J BIOL CHEM, V280, P5836, DOI 10.1074/jbc.M410713200; Kirkbride KC, 2011, CELL ADHES MIGR, V5, P187, DOI 10.4161/cam.5.2.14773; Koromyslova AD, 2015, J VIROL, V89, P2718, DOI 10.1128/JVI.03176-14; Kowalski JR, 2005, J CELL SCI, V118, P79, DOI 10.1242/jcs.01586; Lai FPL, 2009, MOL BIOL CELL, V20, P3209, DOI 10.1091/mbc.E08-12-1180; Leong HS, 2014, CELL REP, V8, P1558, DOI 10.1016/j.celrep.2014.07.050; Li A, 2010, CURR BIOL, V20, P339, DOI 10.1016/j.cub.2009.12.035; Lizarraga F, 2009, CANCER RES, V69, P2792, DOI 10.1158/0008-5472.CAN-08-3709; Magalhaes MAO, 2011, J CELL BIOL, V195, P903, DOI 10.1083/jcb.201103045; Masuzzo P, 2013, BIOINFORMATICS, V29, P2661, DOI 10.1093/bioinformatics/btt437; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nolen BJ, 2009, NATURE, V460, P1031, DOI 10.1038/nature08231; Oser M, 2009, J CELL BIOL, V186, P571, DOI 10.1083/jcb.200812176; Overall CM, 2007, NAT REV MOL CELL BIO, V8, P245, DOI 10.1038/nrm2120; Packard BZ, 2009, MATRIX BIOL, V28, P3, DOI 10.1016/j.matbio.2008.10.001; Perez-Martinez D, 2010, BIOESSAYS, V32, P589, DOI 10.1002/bies.201000009; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Rothsschild BL, 2006, CANCER RES, V66, P8017, DOI 10.1158/0008-5472.CAN-05-4490; Rotty JD, 2015, DEV CELL, V32, P54, DOI 10.1016/j.devcel.2014.10.026; Rotty JD, 2013, NAT REV MOL CELL BIO, V14, P7, DOI 10.1038/nrm3492; Rudolph MJ, 2014, J MOL BIOL, V426, P3057, DOI 10.1016/j.jmb.2014.05.026; Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schoumacher M, 2010, J CELL BIOL, V189, P541, DOI 10.1083/jcb.200909113; SCHUURING E, 1995, GENE, V159, P83, DOI 10.1016/0378-1119(94)00562-7; Shangary S, 2009, ANNU REV PHARMACOL, V49, P223, DOI 10.1146/annurev.pharmtox.48.113006.094723; Sharma VP, 2013, CURR BIOL, V23, P2079, DOI 10.1016/j.cub.2013.08.044; Steffen A, 2008, CURR BIOL, V18, P926, DOI 10.1016/j.cub.2008.05.044; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Uruno T, 2001, NAT CELL BIOL, V3, P259, DOI 10.1038/35060051; Van Audenhove I, 2014, FASEB J, V28, P1805, DOI 10.1096/fj.13-242537; van den Abbeele A, 2007, CANCER LETT, V255, P57, DOI 10.1016/j.canlet.2007.03.023; Van den Abbeele A, 2010, CELL MOL LIFE SCI, V67, P1519, DOI 10.1007/s00018-010-0266-1; Van Impe K, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3585; Van Overbeke W, 2014, MOL THER, V22, P1768, DOI 10.1038/mt.2014.132; Veillat V, 2015, INT J BIOCHEM CELL B, V65, P52, DOI 10.1016/j.biocel.2015.05.020; Vercruysse T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060259; Weaver AM, 2002, CURR BIOL, V12, P1270, DOI 10.1016/S0960-9822(02)01035-7; Weaver AM, 2001, CURR BIOL, V11, P370, DOI 10.1016/S0960-9822(01)00098-7; Webb BA, 2007, EUR J CELL BIOL, V86, P189, DOI 10.1016/j.ejcb.2007.01.003; Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006; Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616; Xu XP, 2012, EMBO J, V31, P236, DOI 10.1038/emboj.2011.343; Yamaguchi H, 2005, J CELL BIOL, V168, P441, DOI 10.1083/jcb.200407076; Zheng CH, 2007, BIOORGAN MED CHEM, V15, P6407, DOI 10.1016/j.bmc.2007.06.052	72	18	19	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2460	2476		10.1096/fj.201600810RR	http://dx.doi.org/10.1096/fj.201600810RR			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28235780				2022-12-28	WOS:000401553400021
J	Lee, SM; Baik, JM; Nguyen, D; Nguyen, V; Liu, SW; Hu, ZY; Abbott, GW				Lee, Soo Min; Baik, Jasmine; Nguyen, Dara; Nguyen, Victoria; Liu, Shiwei; Hu, Zhaoyang; Abbott, Geoffrey W.			Kcne2 deletion impairs insulin secretion and causes type 2 diabetes mellitus	FASEB JOURNAL			English	Article						KCNQ1; Kv1.5; K(v)2.1; potassium channel	GATED POTASSIUM CHANNELS; PANCREATIC BETA-CELL; K+ CHANNEL; ENDOPLASMIC-RETICULUM; CARDIAC-ARRHYTHMIA; I-KS; KCNQ1; SUBUNIT; KV2.1; RESISTANCE	Type 2 diabetes mellitus (T2DM) represents a rapidly increasing threat to global public health. T2DM arises largely from obesity, poor diet, and lack of exercise, but it also involves genetic predisposition. Here we report that the KCNE2 potassium channel transmembrane regulatory subunit is expressed in human and mouse pancreatic beta cells. Kcne2 deletion in mice impaired glucose tolerance as early as 5 wk of age in pups fed a Western diet, ultimately causing diabetes. In adult mice fed normal chow, skeletal muscle expression of insulin receptor beta and insulin receptor substrate 1 were down-regulated 2-fold by Kcne2 deletion, characteristic of T2DM. Kcne2 deletion also caused extensive pancreatic transcriptome changes consistent with facets of T2DM, including endoplasmic reticulum stress, inflammation, and hyperproliferation. Kcne2 deletion impaired beta-cell insulin secretion in vitro up to 8-fold and diminished beta-cell peak outward K+ current at positive membrane potentials, but also left-shifted its voltage dependence and slowed inactivation. Interestingly, we also observed an aging-dependent reduction in beta-cell outward currents in both Kcne2(+/+) and Kcne2(-/-) mice. Our results demonstrate that KCNE2 is required for normal beta-cell electrical activity and insulin secretion, and that Kcne2 deletion causes T2DM. KCNE2 may regulate multiple K+ channels in beta cells, including the T2DM-linked KCNQ1 potassium channel alpha subunit.	[Lee, Soo Min; Baik, Jasmine; Nguyen, Dara; Nguyen, Victoria; Liu, Shiwei; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Pharmacol, Bioelect Lab, Irvine, CA 92717 USA; [Lee, Soo Min; Baik, Jasmine; Nguyen, Dara; Nguyen, Victoria; Liu, Shiwei; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Bioelect Lab, Irvine, CA 92717 USA; [Hu, Zhaoyang] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Lab Anesthesiol & Crit Care Med, Chengdu, Peoples R China	University of California System; University of California Irvine; University of California System; University of California Irvine; Sichuan University	Abbott, GW (corresponding author), Univ Calif Irvine, Med Sch, 360 Med Surge 2, Irvine, CA 92697 USA.	abbottg@uci.edu			University of California; Irvine setup funds	University of California(University of California System); Irvine setup funds	This work was supported by University of California, Irvine setup funds (to G.W.A.). The authors gratefully acknowledge H. Ishii (University of California, Irvine) for helpful technical advice, and N. B. Doan (University of California, Los Angeles, Los Angeles, CA, USA) for performing human pancreas immunostaining.	Abbott GW, 2015, GENE, V569, P162, DOI 10.1016/j.gene.2015.06.061; Abbott GW, 2012, CHANNELS, V6, P1, DOI 10.4161/chan.19126; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Asahara S, 2015, P NATL ACAD SCI USA, V112, P8332, DOI 10.1073/pnas.1422104112; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Boini KM, 2009, AM J PHYSIOL-REG I, V296, pR1695, DOI 10.1152/ajpregu.90839.2008; CARO JF, 1987, J CLIN INVEST, V79, P1330, DOI 10.1172/JCI112958; Cerf Marlon E, 2013, Front Endocrinol (Lausanne), V4, P37, DOI 10.3389/fendo.2013.00037; Chiasson JL, 2004, DIABETES, V53, pS34, DOI 10.2337/diabetes.53.suppl_3.S34; Dai XQ, 2012, DIABETOLOGIA, V55, P1709, DOI 10.1007/s00125-012-2512-6; DEFRONZO RA, 1991, DIABETES CARE, V14, P173, DOI 10.2337/diacare.14.3.173; Donath MY, 2009, PHYSIOLOGY, V24, P325, DOI 10.1152/physiol.00032.2009; Eletto D, 2010, SEMIN CELL DEV BIOL, V21, P479, DOI 10.1016/j.semcdb.2010.03.004; Gerich JE, 1999, DIABETES OBES METAB, V1, P257, DOI 10.1046/j.1463-1326.1999.00027.x; Gordon E, 2008, CARDIOVASC RES, V77, P98, DOI 10.1093/cvr/cvm030; Harding HP, 2002, DIABETES, V51, pS455, DOI 10.2337/diabetes.51.2007.S455; Heitzmann D, 2004, J PHYSIOL-LONDON, V561, P547, DOI 10.1113/jphysiol.2004.075168; Hu ZY, 2016, CARDIOVASC RES, V110, P227, DOI 10.1093/cvr/cvw048; Hu ZY, 2014, CIRC-CARDIOVASC GENE, V7, P33, DOI 10.1161/CIRCGENETICS.113.000315; Isbrandt D, 2002, J MOL MED-JMM, V80, P524, DOI 10.1007/s00109-002-0364-0; Kanda VA, 2011, BIOPHYS J, V101, P1354, DOI 10.1016/j.bpj.2011.08.015; Kanda VA, 2011, BIOPHYS J, V101, P1364, DOI 10.1016/j.bpj.2011.08.014; Kerouz NJ, 1997, J CLIN INVEST, V100, P3164, DOI 10.1172/JCI119872; Kim SJ, 2013, BIOCHEM J, V451, P227, DOI 10.1042/BJ20121669; Lee SM, 2016, SCI REP-UK, V6, DOI 10.1038/srep23118; Lee SM, 2015, J MOL CELL CARDIOL, V87, P148, DOI 10.1016/j.yjmcc.2015.08.013; Leung YM, 2003, J BIOL CHEM, V278, P17532, DOI 10.1074/jbc.M213088200; Lewis A, 2004, J BIOL CHEM, V279, P7884, DOI 10.1074/jbc.M310501200; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Li XY, 2013, J PHARMACOL EXP THER, V344, P407, DOI 10.1124/jpet.112.199083; Li Y, 2013, P NATL ACAD SCI USA, V110, P18922, DOI 10.1073/pnas.1315649110; Liu L., 2014, INT J PHOTOENERGY, V2014, P1, DOI DOI 10.1371/J0URNAL.P0NE.0094160; MacDonald PE, 2002, MOL ENDOCRINOL, V16, P2452, DOI 10.1210/me.2002-0058; Marcu MG, 2002, MOL CELL BIOL, V22, P8506, DOI 10.1128/MCB.22.24.8506-8513.2002; McCrossan ZA, 2009, J MEMBRANE BIOL, V228, P1, DOI 10.1007/s00232-009-9154-8; Nichols CG, 2002, AM J PHYSIOL-ENDOC M, V283, pE403, DOI 10.1152/ajpendo.00168.2002; OLEFSKY JM, 1995, AM J CLIN NUTR, V61, p980S, DOI 10.1093/ajcn/61.4.980S; Panaghie G, 2006, CURR PHARM DESIGN, V12, P2285, DOI 10.2174/138161206777585175; Ramos RR, 2007, P NATL ACAD SCI USA, V104, P10470, DOI 10.1073/pnas.0701114104; Reutens AT, 2013, NEPHROL DIAL TRANSPL, V28, P1820, DOI 10.1093/ndt/gfs561; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Roura-Ferrer M, 2010, J CELL PHYSIOL, V225, P692, DOI 10.1002/jcp.22265; Su JP, 2001, PFLUG ARCH EUR J PHY, V442, P49, DOI 10.1007/s004240000508; Tarasov AI, 2006, DIABETES, V55, P3075, DOI 10.2337/db06-0637; Thierry M, 2015, EXP EYE RES, V135, P37, DOI 10.1016/j.exer.2015.04.012; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Tucker SJ, 1997, NATURE, V387, P179, DOI 10.1038/387179a0; Ullrich S, 2005, PFLUG ARCH EUR J PHY, V451, P428, DOI 10.1007/s00424-005-1479-2; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; WARRAM JH, 1990, ANN INTERN MED, V113, P909, DOI 10.7326/0003-4819-113-12-909; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Yamagata K, 2011, BIOCHEM BIOPH RES CO, V407, P620, DOI 10.1016/j.bbrc.2011.03.083; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zhang M, 2001, CIRC RES, V88, P1012, DOI 10.1161/hh1001.090839	56	20	20	1	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2674	2685		10.1096/fj.201601347	http://dx.doi.org/10.1096/fj.201601347			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28280005				2022-12-28	WOS:000401553400037
J	Cabrita, I; Benedetto, R; Fonseca, A; Wanitchakool, P; Sirianant, L; Skryabin, BV; Schenk, LK; Pavenstadt, H; Schreiber, R; Kunzelmann, K				Cabrita, Ines; Benedetto, Roberta; Fonseca, Ana; Wanitchakool, Podchanart; Sirianant, Lalida; Skryabin, Boris V.; Schenk, Laura K.; Pavenstaedt, Hermann; Schreiber, Rainer; Kunzelmann, Karl			Differential effects of anoctamins on intracellular calcium signals	FASEB JOURNAL			English	Article						TMEM16A; TMEM16D; TMEM16F; anoctamin; Ca2+ signaling	CA2+-ACTIVATED CL-CHANNEL; OPERATED CA2+ ENTRY; ACTIVATED CHLORIDE CHANNELS; RAT SENSORY NEURONS; PHOSPHATIDYLINOSITOL 4,5-BISPHOSPHATE; INTERSTITIAL-CELLS; LIPID RAFTS; SECRETION; CURRENTS; TMEM16	The Ca2+-activated Cl- channel TMEM16A[anoctamin(ANO)1] is homologous to yeast Ist2 and has been shown to tether the cortical endoplasmic reticulum(ER) to the plasma membrane. We therefore examined whether ANO1 and other members of the ANO family affect intracellular Ca2+ ([Ca2+](i)) signals. It is shown that expression of ANO1 augments Ca2+ store release upon stimulation of GPCRs, whereas knockdown of ANO1, or lack of Ano1 expression in Ano1(-/-) animals, as shown in an earlier report, inhibits Ca2+ release. ANO6, and -10 show similar effects, whereas expression of ANO4, -8, and -9 attenuate filling of the ER store. The impact of ANO1 and -4 were examined in more detail. ANO1 colocalized and interacted with IP3R, where as ANO4 colocalized with SERCA Ca2+ pumps and interacted with ORAI-1 channels, respectively. ANO1 Cl currents were rapidly activated exclusively through Ca2+ store release, and remained untouched by influx of extracellular Ca2+. In contrast expression of ANO4 caused a delayed activation of membrane-localized ANO6 channels, solely through store-operated Ca2+ entry via ORAI. Ca2+ signals were inhibited by knocking down expression of endogenous ANO1, -5, -6, and -10 and were also reduced in epithelial cells from Ano10(-/-) mice. The data suggest that ANOs affect compartmentalized [Ca2+](i) signals, which may explain some of the cellular defects related to ANO mutations.-Cabrita, I., Benedetto, R., Fonseca, A., Wanitchakool, P., Sirianant, L., Skryabin, B. V., Schenk, L. K., Pavenstadt, H., Schreiber, R., Kunzelmann, K. Differential effects of anoctamins on intracellular calcium signals.	[Cabrita, Ines; Benedetto, Roberta; Fonseca, Ana; Wanitchakool, Podchanart; Sirianant, Lalida; Schreiber, Rainer; Kunzelmann, Karl] Univ Regensburg, Physiol Inst, Univ Str 31, D-93053 Regensburg, Germany; [Skryabin, Boris V.] Univ Munster, Dept Med TRAM, Munster, Germany; [Schenk, Laura K.; Pavenstaedt, Hermann] Univ Klinikum Munster, Dept Internal Med D, Albert Schweitzer Campus, Munster, Germany	University of Regensburg; University of Munster; University of Munster	Cabrita, I; Kunzelmann, K (corresponding author), Univ Regensburg, Physiol Inst, Univ Str 31, D-93053 Regensburg, Germany.	karl.kunzelmann@ur.de	Skryabin, Boris/AAL-3100-2020	Skryabin, Boris/0000-0002-4392-185X; Fonseca, Ana/0000-0002-7920-9477; Sievers, Laura Katharina/0000-0002-4677-5181; Cabrita, Ines/0000-0002-1349-7605	Deutsche Forschungsgemeinschaft (DFG) [SFB699-A7/A12, KU756/12-1]; Cystic Fibrosis Trust SRC, INOVCF [003]; Cystic Fibrosis Trust [SRC003] Funding Source: researchfish	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Cystic Fibrosis Trust SRC, INOVCF; Cystic Fibrosis Trust	The authors thank B.Wild, P.Seeberger, and E.Tartler (Physiological Institute, University of Regensburg) for excellent technical assistance. This work was supported by Deutsche Forschungsgemeinschaft (DFG) Grants SFB699-A7/A12 (to K.K. and R.S.) and KU756/12-1 (to K.K.), and Cystic Fibrosis Trust SRC 003, INOVCF (to K.K.).I.C.and R.B.are co-first authors. R.S. and K.K. are co-senior authors. The authors declare no conflicts of interest.	Almaca J, 2009, J BIOL CHEM, V284, P28571, DOI 10.1074/jbc.M109.010074; Balreira A, 2014, J NEUROL, V261, P2192, DOI 10.1007/s00415-014-7476-7; Barro-Soria R, 2010, PFLUG ARCH EUR J PHY, V459, P485, DOI 10.1007/s00424-009-0745-0; Billet A, 2013, J PHYSIOL-LONDON, V591, P5273, DOI 10.1113/jphysiol.2013.261909; Concepcion AR, 2016, J CLIN INVEST, V126, P4303, DOI 10.1172/JCI89056; Courjaret R, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4916; Derler I, 2013, CELL CALCIUM, V53, P139, DOI 10.1016/j.ceca.2012.11.005; Diaz O, 2005, J IMMUNOL, V175, P8077, DOI 10.4049/jimmunol.175.12.8077; Duvvuri U, 2012, CANCER RES, V72, P3270, DOI 10.1158/0008-5472.CAN-12-0475-T; Ehlen HWA, 2013, J BONE MINER RES, V28, P246, DOI 10.1002/jbmr.1751; Fischer KG, 1996, PFLUG ARCH EUR J PHY, V432, P735, DOI 10.1007/s004240050192; Fischer MA, 2009, TRAFFIC, V10, P1084, DOI 10.1111/j.1600-0854.2009.00926.x; Griffin DA, 2016, HUM MOL GENET, V25, P1900, DOI 10.1093/hmg/ddw063; Grubb S, 2013, J GEN PHYSIOL, V141, P585, DOI 10.1085/jgp.201210861; Hammer C, 2015, MOL MED, V21, DOI 10.2119/molmed.2014.00219; Heinze C, 2014, J CLIN INVEST, V124, P675, DOI 10.1172/JCI70025; Huang F, 2013, NAT NEUROSCI, V16, P1284, DOI 10.1038/nn.3468; Huang F, 2012, P NATL ACAD SCI USA, V109, P16354, DOI 10.1073/pnas.1214596109; Huang WC, 2012, NEURON, V74, P179, DOI 10.1016/j.neuron.2012.01.033; Jin X, 2016, J PHYSIOL-LONDON, V594, P19, DOI 10.1113/jphysiol.2014.275107; Jin X, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004184; Kabouridis PS, 2000, EUR J IMMUNOL, V30, P954, DOI 10.1002/1521-4141(200003)30:3<954::AID-IMMU954>3.3.CO;2-P; Kunzelmann K, 2016, PFLUG ARCH EUR J PHY, V468, P475, DOI 10.1007/s00424-015-1767-4; Kunzelmann K, 2012, EXP PHYSIOL, V97, P184, DOI 10.1113/expphysiol.2011.058206; Lee MY, 2006, P NATL ACAD SCI USA, V103, P13232, DOI 10.1073/pnas.0605757103; Liu BY, 2010, J CLIN INVEST, V120, P1240, DOI 10.1172/JCI41084; Maass K, 2009, J CELL SCI, V122, P625, DOI 10.1242/jcs.036012; Maniero C, 2015, LANCET, V385, P62; Namkung W, 2010, MOL BIOL CELL, V21, P2639, DOI 10.1091/mbc.E09-12-1004; Ohga K, 2008, INT IMMUNOPHARMACOL, V8, P1787, DOI 10.1016/j.intimp.2008.08.016; Ousingsawat J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7245; Pedemonte N, 2014, PHYSIOL REV, V94, P419, DOI 10.1152/physrev.00039.2011; Pritchard HAT, 2014, BRIT J PHARMACOL, V171, P4311, DOI 10.1111/bph.12778; Ruppersburg CC, 2014, MOL BIOL CELL, V25, P1793, DOI 10.1091/mbc.E13-10-0599; Schreiber R, 2015, PFLUG ARCH EUR J PHY, V467, P1203, DOI 10.1007/s00424-014-1559-2; Schreiber R, 2010, J BIOL CHEM, V285, P7838, DOI 10.1074/jbc.M109.065367; Singh RD, 2014, J PHYSIOL-LONDON, V592, P4051, DOI 10.1113/jphysiol.2014.277152; Sirianant L, 2016, PFLUG ARCH EUR J PHY, V468, P335, DOI 10.1007/s00424-015-1739-8; Sirianant L, 2014, CELL SIGNAL, V26, P2826, DOI 10.1016/j.cellsig.2014.09.001; Sones WR, 2010, CARDIOVASC RES, V87, P476, DOI 10.1093/cvr/cvq057; Suzuki J, 2013, J BIOL CHEM, V288, P13305, DOI 10.1074/jbc.M113.457937; Suzuki J, 2010, NATURE, V468, P834, DOI 10.1038/nature09583; Szentpetery Z, 2009, BMC CELL BIOL, V10, DOI 10.1186/1471-2121-10-67; Takayama Y, 2015, P NATL ACAD SCI USA, V112, P5213, DOI 10.1073/pnas.1421507112; Takayama Y, 2014, FASEB J, V28, P2238, DOI 10.1096/fj.13-243436; Tian YM, 2012, J CELL SCI, V125, P4991, DOI 10.1242/jcs.109553; TONES MA, 1989, FEBS LETT, V252, P105, DOI 10.1016/0014-5793(89)80898-1; Vocke K, 2013, J GEN PHYSIOL, V142, P381, DOI 10.1085/jgp.201311015; Wan NK, 2011, FASEB J, V25, P4048, DOI 10.1096/fj.11-191627; Wanitchakool P, 2017, CELL SIGNAL, V30, P41, DOI 10.1016/j.cellsig.2016.11.006; Watts SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035373; Yang HH, 2012, CELL, V151, P111, DOI 10.1016/j.cell.2012.07.036; Yang YD, 2008, NATURE, V455, P1210, DOI 10.1038/nature07313; Zhang CH, 2013, AM J RESP CRIT CARE, V187, P374, DOI 10.1164/rccm.201207-1303OC; Zhang WM, 2003, AM J PHYSIOL-LUNG C, V285, pL680, DOI 10.1152/ajplung.00067.2003; Zhu MH, 2015, AM J PHYSIOL-CELL PH, V308, pC608, DOI 10.1152/ajpcell.00360.2014	56	59	59	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2123	2134		10.1096/fj.201600797RR	http://dx.doi.org/10.1096/fj.201600797RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28183802				2022-12-28	WOS:000399195500031
J	Dagdeviren, S; Jung, DY; Friedline, RH; Noh, HL; Kim, JH; Patel, PR; Tsitsilianos, N; Inashima, K; Tran, DA; Hu, XD; Loubato, MM; Craige, SM; Kwon, JY; Lee, KW; Kim, JK				Dagdeviren, Sezin; Jung, Dae Young; Friedline, Randall H.; Noh, Hye Lim; Kim, Jong Hun; Patel, Payal R.; Tsitsilianos, Nicholas; Inashima, Kunikazu; Tran, Duy A.; Hu, Xiaodi; Loubato, Marilia M.; Craige, Siobhan M.; Kwon, Jung Yeon; Lee, Ki Won; Kim, Jason K.			IL-10 prevents aging-associated inflammation and insulin resistance in skeletal muscle	FASEB JOURNAL			English	Article						cytokines; interleukins; aging; type 2 diabetes; glucose metabolism	CYTOKINE PRODUCTION; ADIPOSE-TISSUE; IN-VIVO; OBESITY; INTERLEUKIN-10; MICE; AGE; DISEASE; HUMANS; CELLS	Altered energy balance and insulin resistance are important characteristics of aging. Skeletal muscle is a major site of glucose disposal, and the role of aging-associated inflammation in skeletal muscle insulin resistance remains unclear. To investigate, we examined glucose metabolism in 18-mo-old transgenic mice with muscle-specific overexpression of IL-10 (M-IL10) and in wild-type mice during hyperinsulinemic-euglycemic clamping. Despite similar fat mass and energy balance, M-IL10 mice were protected from aging-associated insulin resistance with significant increases in glucose infusion rates, whole-body glucose turnover, and skeletal muscle glucose uptake (similar to 60%; P < 0.05), as compared to age-matched WT mice. This protective effect was associated with decreased muscle inflammation, but no changes in adipose tissue inflammation in aging M-IL10 mice. These results demonstrate the importance of skeletal muscle inflammation in aging-mediated insulin resistance, and our findings further implicate a potential therapeutic role of anti-inflammatory cytokine in the treatment of aging-mediated insulin resistance.	[Dagdeviren, Sezin; Jung, Dae Young; Friedline, Randall H.; Noh, Hye Lim; Kim, Jong Hun; Patel, Payal R.; Tsitsilianos, Nicholas; Inashima, Kunikazu; Tran, Duy A.; Hu, Xiaodi; Loubato, Marilia M.; Kwon, Jung Yeon; Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Mol Med, Worcester, MA 01655 USA; [Craige, Siobhan M.] Univ Massachusetts, Sch Med, Div Cardiovasc Med, Worcester, MA 01655 USA; [Kim, Jason K.] Univ Massachusetts, Sch Med, Dept Med, Div Endocrinol Metab & Diabet, Worcester, MA 01655 USA; [Kim, Jong Hun; Kwon, Jung Yeon; Lee, Ki Won] Seoul Natl Univ, Adv Inst Convergence Technol, Wellness Emergence Ctr, Suwon, South Korea; [Lee, Ki Won; Kim, Jason K.] Seoul Natl Univ, Dept Agr Biotechnol, Seoul, South Korea	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester; Seoul National University (SNU); Seoul National University (SNU)	Kim, JK (corresponding author), Univ Massachusetts, Sch Med, Program Mol Med, 368 Plantat St,AS9-1041, Worcester, MA 01605 USA.	jason.kim@umassmed.edu	Dagdeviren, Sezin/CAI-5833-2022; Dagdeviren, Sezin/I-9277-2019; Lee, Ki Won/M-4114-2018	Kim, Jason/0000-0002-7185-042X	Institute of Diabetes and Digestive and Kidney Diseases [R01-DK080756, R01-DK079999, R24-DK0909, UC2-DK09300063]; American Diabetes Association Research Award [707-RA-80]; South Korean Midcareer Researcher Program Grant from the National Research Foundation, Ministry of Science, Information and Communications Technology, and Future Planning [2015R1A2A1A10053567]; High Value-Added Food Technology Development Program Grant through Korean Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries,Ministry of Agriculture, Food and Rural Affairs [116030-3]; U.S. National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK093000, R01DK080756, R01DK079999, R24DK090963, U24DK093000] Funding Source: NIH RePORTER	Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Diabetes Association Research Award(American Diabetes Association); South Korean Midcareer Researcher Program Grant from the National Research Foundation, Ministry of Science, Information and Communications Technology, and Future Planning; High Value-Added Food Technology Development Program Grant through Korean Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries,Ministry of Agriculture, Food and Rural Affairs; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by U.S. National Institutes of Health, Institute of Diabetes and Digestive and Kidney Diseases Grants R01-DK080756, R01-DK079999, R24-DK090963, and UC2-DK093000 (to J.K.K.); American Diabetes Association Research Award 707-RA-80 (to J.K.K.); South Korean Midcareer Researcher Program Grant 2015R1A2A1A10053567 from the National Research Foundation, Ministry of Science, Information and Communications Technology, and Future Planning (to K.W.L.); High Value-Added Food Technology Development Program Grant 116030-3 through the Korean Institute of Planning and Evaluation for Technology in Food, Agriculture, Forestry and Fisheries, Ministry of Agriculture, Food and Rural Affairs (to K.W.L.).	Akki A, 2014, AGE, V36, P21, DOI 10.1007/s11357-013-9540-0; Alvarez B, 2002, CANCER LETT, V175, P181, DOI 10.1016/S0304-3835(01)00717-0; Asadullah K, 2003, PHARMACOL REV, V55, P241, DOI 10.1124/pr.55.2.4; Bernstein ED, 1998, VACCINE, V16, P1722, DOI 10.1016/S0264-410X(98)00140-6; Brett JO, 2014, CURR OPIN GENET DEV, V26, P33, DOI 10.1016/j.gde.2014.05.004; Bruunsgaard H, 2000, CLIN EXP IMMUNOL, V119, P433, DOI 10.1046/j.1365-2249.2000.01146.x; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Conley KE, 2000, J PHYSIOL-LONDON, V526, P211, DOI 10.1111/j.1469-7793.2000.00211.x; Dagdeviren S, 2011, J ORTHOP RES, V29, P275, DOI 10.1002/jor.21226; FINK RI, 1983, J CLIN INVEST, V71, P1523, DOI 10.1172/JCI110908; Franceschi C, 2014, J GERONTOL A-BIOL, V69, pS4, DOI 10.1093/gerona/glu057; Gonzalez-Rodriguez A, 2012, AGING CELL, V11, P284, DOI 10.1111/j.1474-9726.2011.00786.x; Hacham M, 2004, EUR CYTOKINE NETW, V15, P37; Hawkins SA, 2003, SPORTS MED, V33, P877, DOI 10.2165/00007256-200333120-00002; Hong EG, 2009, DIABETES, V58, P2525, DOI 10.2337/db08-1261; Houtkooper RH, 2011, SCI REP-UK, V1, DOI 10.1038/srep00134; Houtkooper RH, 2010, CELL, V142, P9, DOI 10.1016/j.cell.2010.06.029; Karakelides H, 2010, DIABETES, V59, P89, DOI 10.2337/db09-0591; Khabour OF, 2010, INT J IMMUNOGENET, V37, P293, DOI 10.1111/j.1744-313X.2010.00925.x; Kim HJ, 2004, DIABETES, V53, P1060, DOI 10.2337/diabetes.53.4.1060; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; Kim JK, 2001, P NATL ACAD SCI USA, V98, P7522, DOI 10.1073/pnas.121164498; KREISBERG RA, 1987, AM J MED, V82, P54, DOI 10.1016/0002-9343(87)90272-5; Leclercq IA, 2007, J HEPATOL, V47, P142, DOI 10.1016/j.jhep.2007.04.002; Levast B, 2015, CYTOKINE, V75, P291, DOI 10.1016/j.cyto.2014.11.027; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; Llorente L, 1997, SCAND J IMMUNOL, V45, P401, DOI 10.1046/j.1365-3083.1997.d01-409.x; Meador BM, 2008, J APPL PHYSIOL, V104, P991, DOI 10.1152/japplphysiol.01079.2007; Mittal SK, 2015, CURR OPIN IMMUNOL, V34, P22, DOI 10.1016/j.coi.2014.12.009; Moller N, 1998, J CLIN ENDOCR METAB, V83, P931, DOI 10.1210/jc.83.3.931; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Rajala MW, 2003, J CLIN INVEST, V111, P225, DOI 10.1172/JCI200316521; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sziksz E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/764641; van der Geest KSM, 2016, EXP GERONTOL, V75, P24, DOI 10.1016/j.exger.2015.12.009; Wang JL, 2001, DIABETES, V50, P2786, DOI 10.2337/diabetes.50.12.2786; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; Wellen KE, 2003, J CLIN INVEST, V112, P1785, DOI 10.1172/JCI20514; Yamauchi T, 2001, NAT MED, V7, P941, DOI 10.1038/90984; Zhou XH, 2004, COMPARATIVE MED, V54, P176	42	74	75	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					701	710		10.1096/fj.201600832R	http://dx.doi.org/10.1096/fj.201600832R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27811060	Green Published			2022-12-28	WOS:000394235400022
J	Deflorio, C; Blanchard, S; Carisi, MC; Bohl, D; Maskos, U				Deflorio, Cristina; Blanchard, Stephane; Carisi, Maria Carla; Bohl, Delphine; Maskos, Uwe			Human polymorphisms in nicotinic receptors: a functional analysis in iPS-derived dopaminergic neurons	FASEB JOURNAL			English	Article						electrophysiology; stem cells; GWAS; smoking; screening system	PLURIPOTENT STEM-CELLS; GENOME-WIDE ASSOCIATION; ACETYLCHOLINE-RECEPTORS; LUNG-CANCER; HUMAN ES; PHYSIOLOGICAL DIVERSITY; SUSCEPTIBILITY LOCUS; PARKINSONS-DISEASE; ALZHEIMERS-DISEASE; MOTOR-NEURONS	Tobacco smoking is a public health problem, with similar to 5 million deaths per year, representing a heavy burden for many countries. No effective therapeutic strategies are currently available for nicotine addiction, and it is therefore crucial to understand the etiological and pathophysiological factors contributing to this addiction. The neuronal 5 nicotinic acetylcholine receptor (nAChR) subunit is critically involved in nicotine dependence. In particular, the human polymorphism 5D398N corresponds to the strongest correlation with nicotine dependence risk found to date in occidental populations, according to meta-analysis of genome-wide association studies. To understand the specific contribution of this subunit in the context of nicotine addiction, an efficient screening system for native human nAChRs is needed. We have differentiated human induced pluripotent stem (iPS) cells into midbrain dopaminergic (DA) neurons and obtained a comprehensive characterization of these neurons by quantitative RT-PCR. The functional properties of nAChRs expressed in these human DA neurons, with or without the polymorphism in the 5 subunit, were studied with the patch-clamp electrophysiological technique. Our results in human DA neurons carrying the polymorphism in the 5 subunit showed an increase in EC50, indicating that, in the presence of the polymorphism, more nicotine or acetylcholine chloride is necessary to obtain the same effect. This human cell culturing system can now be used in drug discovery approaches to screen for compounds that interact specifically with human native and polymorphic nAChRs.	[Deflorio, Cristina; Blanchard, Stephane; Carisi, Maria Carla; Bohl, Delphine; Maskos, Uwe] Inst Pasteur, Dept Neurosci, Unite Neurobiol Integrat Syst Cholinerg, F-75724 Paris 15, France; [Maskos, Uwe] CNRS, Inst Pasteur, UMR 3731, Paris, France; [Bohl, Delphine] Univ Paris 06, CNRS, INSERM, Inst Cerveau & La Moelle Epiniere,Unite 1127,UMR, Paris, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite	Maskos, U (corresponding author), Inst Pasteur, Dept Neurosci, Unite Neurobiol Integrat Syst Cholinerg, F-75724 Paris 15, France.	umaskos@pasteur.fr	Bohl, Delphine/L-8709-2016	Bohl, Delphine/0000-0001-8262-5642	PasteurInnov; Fondation de la Recherche Medicale (FRM) [SPF20140129365, DPA20140629803]; French National Cancer Institute [CANCEROPOLE IDF 2016-1-TABAC-01-IP-1]; Centre National de la Recherche Scientifique, Unite Mixte de Recherche [3571]	PasteurInnov; Fondation de la Recherche Medicale (FRM)(Fondation pour la Recherche Medicale); French National Cancer Institute(Institut National du Cancer (INCA) France); Centre National de la Recherche Scientifique, Unite Mixte de Recherche(Centre National de la Recherche Scientifique (CNRS))	The authors thank Thomas Lemonnier and Matthias Groszer (Sorbonne Universites, Paris, France) for constant support, and Stephanie Pons, Stefania Tolu and Martine Soudant (all from Institut Pasteur) for the Th-eGFP lentiviral vector. U.M. is a member of the Laboratory of Excellence, LabEx Bio-Psy. This work was supported by PasteurInnov 2013, Fondation de la Recherche Medicale (FRM; Grants SPF20140129365 and DPA20140629803), the French National Cancer Institute Grant CANCEROPOLE IDF 2016-1-TABAC-01-IP-1 (to U.M.), and Centre National de la Recherche Scientifique, Unite Mixte de Recherche 3571. The laboratory of U.M. is part of the Ecole des Neurosciences de Paris Ile-de-France Thematic Network for Advanced Research (RTRA). The authors declare no conflicts of interest.	Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Bierut LJ, 2010, TRENDS PHARMACOL SCI, V31, P46, DOI 10.1016/j.tips.2009.10.004; Chambers SM, 2009, NAT BIOTECHNOL, V27, P275, DOI 10.1038/nbt.1529; Changeux JP, 2010, NAT REV NEUROSCI, V11, P389, DOI 10.1038/nrn2849; Chatterjee S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068300; Chatzidaki A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125116; Cho MH, 2014, LANCET RESP MED, V2, P214, DOI 10.1016/S2213-2600(14)70002-5; Cooper O, 2010, MOL CELL NEUROSCI, V45, P258, DOI 10.1016/j.mcn.2010.06.017; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Di Chiara G, 2000, EUR J PHARMACOL, V393, P295, DOI 10.1016/S0014-2999(00)00122-9; Dimos JT, 2008, SCIENCE, V321, P1218, DOI 10.1126/science.1158799; ELGOYHEN AB, 1994, CELL, V79, P705, DOI 10.1016/0092-8674(94)90555-X; Fallon James H., 1995, P215; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Fucile S, 1997, NEUROREPORT, V8, P2433, DOI 10.1097/00001756-199707280-00005; Furberg H, 2010, NAT GENET, V42, P441, DOI 10.1038/ng.571; George AA, 2012, J BIOL CHEM, V287, P25151, DOI 10.1074/jbc.M112.379339; Gerzanich V, 1998, J PHARMACOL EXP THER, V286, P311; Groot-Kormelink PJ, 2001, BRIT J PHARMACOL, V134, P789, DOI 10.1038/sj.bjp.0704313; Gundisch D, 2011, EXPERT OPIN THER PAT, V21, P1867, DOI 10.1517/13543776.2011.637919; Hahn J, 2006, J NEUROSCI, V26, P5240, DOI 10.1523/JNEUROSCI.4976-05.2006; Hartfield EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087388; Hatsukami DK, 2008, LANCET, V371, P2027, DOI 10.1016/S0140-6736(08)60871-5; HAUSSER M, 1995, NEURON, V15, P637, DOI 10.1016/0896-6273(95)90152-3; Haydar SN, 2010, CURR TOP MED CHEM, V10, P144, DOI 10.2174/156802610790410983; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Improgo MRD, 2010, PROG NEUROBIOL, V92, P212, DOI 10.1016/j.pneurobio.2010.05.003; Jiang HB, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1669; Kaiser P, 1998, GENE DEV, V12, P2587, DOI 10.1101/gad.12.16.2587; Klink R, 2001, J NEUROSCI, V21, P1452, DOI 10.1523/JNEUROSCI.21-05-01452.2001; Kriks S, 2011, NATURE, V480, P547, DOI 10.1038/nature10648; Kulak JM, 1997, J NEUROSCI, V17, P5263; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Kuryatov A, 2008, MOL PHARMACOL, V74, P132, DOI 10.1124/mol.108.046789; Lemonnier T, 2011, HUM MOL GENET, V20, P3653, DOI 10.1093/hmg/ddr285; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; Maus ADJ, 1998, MOL PHARMACOL, V54, P779, DOI 10.1124/mol.54.5.779; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; Morel C, 2014, MOL PSYCHIATR, V19, P930, DOI 10.1038/mp.2013.158; Murray CJL, 1997, LANCET, V349, P1498, DOI 10.1016/S0140-6736(96)07492-2; OBrien CP, 1996, LANCET, V347, P237, DOI 10.1016/S0140-6736(96)90409-2; Parri HR, 2011, BIOCHEM PHARMACOL, V82, P931, DOI 10.1016/j.bcp.2011.06.039; Pillai SG, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000421; RamirezLatorre J, 1996, NATURE, V380, P347, DOI 10.1038/380347a0; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Saccone NL, 2009, AM J MED GENET B, V150B, P453, DOI 10.1002/ajmg.b.30828; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; Sanchez-Danes A, 2012, HUM GENE THER, V23, P56, DOI 10.1089/hum.2011.054; Schneider BL, 2007, HUM MOL GENET, V16, P651, DOI 10.1093/hmg/ddm008; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Sciaccaluga M, 2015, FASEB J, V29, P3389, DOI 10.1096/fj.14-268102; Steinlein OK, 2008, BIOCHEM PHARMACOL, V76, P1175, DOI 10.1016/j.bcp.2008.07.012; STROMBERG I, 1991, EXP NEUROL, V112, P140, DOI 10.1016/0014-4886(91)90064-J; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Tammimaki A, 2012, NEUROPHARMACOLOGY, V63, P1002, DOI 10.1016/j.neuropharm.2012.07.022; Tapia L, 2007, MOL PHARMACOL, V71, P769, DOI 10.1124/mol.106.030445; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Toli D, 2015, NEUROBIOL DIS, V82, P269, DOI 10.1016/j.nbd.2015.06.011; Tolu S, 2013, MOL PSYCHIATR, V18, P382, DOI 10.1038/mp.2012.83; Tolu S, 2010, FASEB J, V24, P723, DOI 10.1096/fj.09-139790; Ungless MA, 2012, TRENDS NEUROSCI, V35, P422, DOI 10.1016/j.tins.2012.02.003; Wang Y, 2001, MOL PHARMACOL, V60, P1201, DOI 10.1124/mol.60.6.1201; Wilens TE, 2007, BIOCHEM PHARMACOL, V74, P1212, DOI 10.1016/j.bcp.2007.07.002; Wu J, 2004, J PHARMACOL EXP THER, V311, P80, DOI 10.1124/jpet.104.070417; Yang KC, 2009, J PHYSIOL-LONDON, V587, P345, DOI 10.1113/jphysiol.2008.162743; Zhang PB, 2014, JOVE-J VIS EXP, DOI 10.3791/51737	69	14	14	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					828	839		10.1096/fj.201600932R	http://dx.doi.org/10.1096/fj.201600932R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27856558				2022-12-28	WOS:000394235400034
J	Miller, LR; Marks, C; Becker, JB; Hurn, PD; Chen, WJ; Woodruff, T; McCarthy, MM; Sohrabji, F; Schiebinger, L; Wetherington, CL; Makris, S; Arnold, AP; Einstein, G; Miller, VM; Sandberg, K; Maier, S; Cornelison, TL; Clayton, JA				Miller, Leah R.; Marks, Cheryl; Becker, Jill B.; Hurn, Patricia D.; Chen, Wei-Jung; Woodruff, Teresa; McCarthy, Margaret M.; Sohrabji, Farida; Schiebinger, Londa; Wetherington, Cora Lee; Makris, Susan; Arnold, Arthur P.; Einstein, Gillian; Miller, Virginia M.; Sandberg, Kathryn; Maier, Susan; Cornelison, Terri L.; Clayton, Janine A.			Considering sex as a biological variable in preclinical research	FASEB JOURNAL			English	Review						gender; methods; sex influences; sex differences	MOUSE MODELS; BRAIN; BEHAVIOR; DISEASE; NUMBER; GENES	In June 2015, the National Institutes of Health (NIH) released a Guide notice (NOT-OD-15-102) that highlighted the expectation of the NIH that the possible role of sex as a biologic variable be factored into research design, analyses, and reporting of vertebrate animal and human studies. Anticipating these guidelines, the NIH Office of Research on Women's Health, in October 2014, convened key stakeholders to discuss methods and techniques for integrating sex as a biologic variable in preclinical research. The workshop focused on practical methods, experimental design, and approaches to statistical analyses in the use of both male and female animals, cells, and tissues in preclinical research. Workshop participants also considered gender as a modifier of biology. This article builds on the workshop and is meant as a guide to preclinical investigators as they consider methods and techniques for inclusion of both sexes in preclinical research and is not intended to prescribe exhaustive/specific approaches for compliance with the new NIH policy.-Miller, L.R., Marks, C., Becker, J. B., Hurn, P. D., Chen, W.-J., Woodruff, T., McCarthy, M. M., Sohrabji, F., Schiebinger, L., Wetherington, C. L., Makris, S., Arnold, A. P., Einstein, G., Miller, V. M., Sandberg, K., Maier, S., Cornelison, T. L., Clayton, J. A. Considering sex as a biological variable in preclinical research.	[Miller, Leah R.; Maier, Susan; Cornelison, Terri L.; Clayton, Janine A.] NCI, Off Res Womens Hlth, Bethesda, MD 20892 USA; [Marks, Cheryl] NCI, Div Canc Biol, Bethesda, MD 20892 USA; [Wetherington, Cora Lee] NIDA, NIH, Bethesda, MD 20892 USA; [Becker, Jill B.] Univ Michigan, Mol & Behav Neurosci Inst, Ann Arbor, MI 48109 USA; [Hurn, Patricia D.] Univ Michigan, Sch Nursing, Ann Arbor, MI 48109 USA; [Chen, Wei-Jung; Sohrabji, Farida] Texas A&M Hlth Sci Ctr, Dept Neurosci & Expt Therapeut, Bryan, TX USA; [Woodruff, Teresa] Northwestern Univ, Womens Hlth Res Inst, Chicago, IL 60611 USA; [McCarthy, Margaret M.] Univ Maryland, Dept Pharmacol, Baltimore, MD 21201 USA; [Schiebinger, Londa] Stanford Univ, Hist Sci, Stanford, CA 94305 USA; [Makris, Susan] US EPA, Off Res & Dev, Natl Ctr Environm Assessment, Washington, DC 20460 USA; [Arnold, Arthur P.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA USA; [Arnold, Arthur P.] Univ Calif Los Angeles, Brain Res Inst, Neuroendocrinol Lab, Los Angeles, CA 90024 USA; [Einstein, Gillian] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Einstein, Gillian] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Einstein, Gillian] Womens Coll Res Inst, Toronto, ON, Canada; [Miller, Virginia M.] Mayo Clin, Dept Surg & Physiol, Rochester, MN USA; [Miller, Virginia M.] Mayo Clin, Dept Biomed Engn, Rochester, MN USA; [Sandberg, Kathryn] Georgetown Univ, Med Ctr, Dept Med, Washington, DC 20007 USA; [Sandberg, Kathryn] Georgetown Univ, Med Ctr, Ctr Study Sex Differences Hlth Aging & Dis, Washington, DC 20007 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute on Drug Abuse (NIDA); University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Northwestern University; University System of Maryland; University of Maryland Baltimore; Stanford University; United States Environmental Protection Agency; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Womens College Hospital; Mayo Clinic; Mayo Clinic; Georgetown University; Georgetown University	Miller, LR (corresponding author), NIH, Off Res Womens Hlth, 6707 Democracy Blvd,Suite 400, Bethesda, MD 20892 USA.	leah.miller@nih.gov	McCarthy, Margaret/O-2059-2017	McCarthy, Margaret/0000-0003-2243-4726; Einstein, Gillian/0000-0002-0770-5471; Woodruff, Teresa/0000-0002-1197-3399; Schiebinger, Londa/0000-0003-3438-3081; Arnold, Arthur/0000-0002-9908-9767; Sohrabji, Farida/0000-0002-6960-3411	NCATS NIH HHS [UL1 TR001422] Funding Source: Medline; NHLBI NIH HHS [R01 HL119380, R01 HL131182] Funding Source: Medline; NIA NIH HHS [P50 AG044170] Funding Source: Medline; NICHD NIH HHS [R01 HD076125] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076125] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119380] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P50AG044170] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Arnold AP, 2014, EXP NEUROL, V259, P2, DOI 10.1016/j.expneurol.2014.01.021; Arnold AP, 2013, DEV DYNAM, V242, P371, DOI 10.1002/dvdy.23936; Bailoo JD, 2014, ILAR J, V55, P383, DOI 10.1093/ilar/ilu037; Becker JB, 2005, ENDOCRINOLOGY, V146, P1650, DOI 10.1210/en.2004-1142; Case LK, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0591-7; Clayton JA, 2016, FASEB J, V30, P519, DOI 10.1096/fj.15-279554; Collins FS, 2014, NATURE, V505, P612, DOI 10.1038/505612a; Cox KH, 2014, FRONT NEUROENDOCRIN, V35, P405, DOI 10.1016/j.yfrne.2013.12.004; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Francia G, 2011, NAT REV CANCER, V11, P135, DOI 10.1038/nrc3001; Francia G, 2009, CLIN CANCER RES, V15, P6358, DOI 10.1158/1078-0432.CCR-09-0931; Freedman LP, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002165; Howell DC, 2007, STAT METHODS PSYCHOL; Landis SC, 2012, NATURE, V490, P187, DOI 10.1038/nature11556; Li JY, 2014, CARDIOVASC RES, V102, DOI 10.1093/cvr/cvu064; McCarthy MM, 2012, J NEUROSCI, V32, P2241, DOI 10.1523/JNEUROSCI.5372-11.2012; McCarthy MM, 2011, NAT NEUROSCI, V14, P677, DOI 10.1038/nn.2834; Mcewen BS, 1999, ENDOCR REV, V20, P279, DOI 10.1210/er.20.3.279; National Institutes of Health, 2015, CONSIDERATION; National Research Council, 2001, EXPLORING BIOL CONTR; Ruiz-Cortes Z. T., 2012, GONADAL; Zucker I, 2010, NATURE, V465, P690, DOI 10.1038/465690a	22	164	165	1	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					29	34		10.1096/fj.201600781R	http://dx.doi.org/10.1096/fj.201600781R			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27682203	Green Submitted, Green Published			2022-12-28	WOS:000392177600006
J	Chaillou, T; Lanner, JT				Chaillou, Thomas; Lanner, Johanna T.			Regulation of myogenesis and skeletal muscle regeneration: effects of oxygen levels on satellite cell activity	FASEB JOURNAL			English	Article						hypoxia; muscle damage; hyperbaric oxygen therapy; ischemia; cell transplantation	HYPERBARIC-OXYGEN; OXIDATIVE STRESS; CONTRACTILE FUNCTION; HYPOBARIC HYPOXIA; AMBIENT OXYGEN; DIFFERENTIATION; PROLIFERATION; EXPRESSION; THERAPY; MECHANISMS	Reduced oxygen (O-2) levels (hypoxia) are present during embryogenesis and exposure to altitude and in pathologic conditions. During embryogenesis, myogenic progenitor cells reside in a hypoxic microenvironment, which may regulate their activity. Satellite cells are myogenic progenitor cells localized in a local environment, suggesting that the O-2 level could affect their activity during muscle regeneration. In this review, we present the idea that O-2 levels regulate myogenesis and muscle regeneration, we elucidate the molecular mechanisms underlying myogenesis and muscle regeneration in hypoxia and depict therapeutic strategies using changes in O-2 levels to promote muscle regeneration. Severe hypoxia (<= 1% O-2) appears detrimental for myogenic differentiation in vitro, whereas a 3-6% O-2 level could promote myogenesis. Hypoxia impairs the regenerative capacity of injured muscles. Although it remains to be explored, hypoxia may contribute to the muscle damage observed in patients with pathologies associated with hypoxia (chronic obstructive pulmonary disease, and peripheral arterial disease). Hypoxia affects satellite cell activity and myogenesis through mechanisms dependent and independent of hypoxia inducible factor-1 alpha. Finally, hyperbaric oxygen therapy and transplantation of hypoxia-conditioned myoblasts are beneficial procedures to enhance muscle regeneration in animals. These therapies may be clinically relevant to treatment of patients with severe muscle damage.-Chaillou, T. Lanner, J. T. Regulation of myogenesis and skeletal muscle regeneration: effects of oxygen levels on satellite cell activity.	[Chaillou, Thomas; Lanner, Johanna T.] Karolinska Inst, Dept Physiol & Pharmacol, Von Eulervag 8, S-17177 Stockholm, Sweden	Karolinska Institutet	Chaillou, T (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Von Eulervag 8, S-17177 Stockholm, Sweden.	th.chaillou@gmail.com		Chaillou, Thomas/0000-0002-5322-4150	Wenner-Gren Foundations (Stockholm, Sweden)	Wenner-Gren Foundations (Stockholm, Sweden)	This work was supported by a postdoctoral fellowship from the Wenner-Gren Foundations (Stockholm, Sweden; to T.C.). The authors declare no conflicts of interest.	Asano T, 2007, CIRC J, V71, P405, DOI 10.1253/circj.71.405; Atesalp AS, 2009, ARCH ORTHOP TRAUM SU, V129, P13, DOI 10.1007/s00402-007-0525-2; Bennett MH, 2014, COCHRANE DB SYST REV, V11; Best TM, 1998, AM J SPORT MED, V26, P367, DOI 10.1177/03635465980260030401; Bigard AX, 2000, J APPL PHYSIOL, V88, P479, DOI 10.1152/jappl.2000.88.2.479; Borselli C, 2010, P NATL ACAD SCI USA, V107, P3287, DOI 10.1073/pnas.0903875106; Caron MA, 2009, FEBS LETT, V583, P1528, DOI 10.1016/j.febslet.2009.04.006; Chaillou T, 2014, PFLUG ARCH EUR J PHY, V466, P587, DOI 10.1007/s00424-013-1336-7; Chaillou T, 2013, ACTA PHYSIOL, V209, P272, DOI 10.1111/apha.12110; Chaillou T, 2014, MOL CELL BIOCHEM, V390, P31, DOI 10.1007/s11010-013-1952-8; Chaillou T, 2012, AM J PHYSIOL-REG I, V302, pR643, DOI 10.1152/ajpregu.00262.2011; Chakravarthy MV, 2001, CELL MOL LIFE SCI, V58, P1150, DOI 10.1007/PL00000929; Chang NC, 2014, CURR TOP DEV BIOL, V107, P161, DOI 10.1016/B978-0-12-416022-4.00006-8; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Csete M, 2001, J CELL PHYSIOL, V189, P189, DOI 10.1002/jcp.10016; de Theije C, 2011, CURR OPIN CLIN NUTR, V14, P548, DOI 10.1097/MCO.0b013e32834b6e79; Debigare R, 2003, CHEST, V124, P83, DOI 10.1378/chest.124.1.83; Di Carlo A, 2004, J BIOL CHEM, V279, P16332, DOI 10.1074/jbc.M313931200; Duguez S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043853; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Favier FB, 2015, CELL MOL LIFE SCI, V72, P4681, DOI 10.1007/s00018-015-2025-9; Favier FB, 2010, AM J PHYSIOL-REG I, V298, pR1659, DOI 10.1152/ajpregu.00550.2009; Feldmeier JJ, 2002, UNDERSEA HYPERBAR M, V29, P4; Fermoselle C, 2012, EUR RESPIR J, V40, P851, DOI 10.1183/09031936.00137211; Fujita N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115685; Garvey JF, 2009, EUR RESPIR J, V33, P1195, DOI 10.1183/09031936.00111208; Ge YJ, 2009, AM J PHYSIOL-CELL PH, V297, pC1434, DOI 10.1152/ajpcell.00248.2009; Greco S, 2009, FASEB J, V23, P3335, DOI 10.1096/fj.08-128579; Gregorevic P, 2000, J APPL PHYSIOL, V89, P1477, DOI 10.1152/jappl.2000.89.4.1477; Gregorevic P, 2002, MED SCI SPORT EXER, V34, P630, DOI 10.1097/00005768-200204000-00011; Gustafsson MV, 2005, DEV CELL, V9, P617, DOI 10.1016/j.devcel.2005.09.010; Halepoto DM, 2014, JCPSP-J COLL PHYSICI, V24, P508, DOI 07.2014/JCPSP.508514; Harris JB, 2003, TOXICON, V42, P933, DOI 10.1016/j.toxicon.2003.11.011; Harrison BC, 2001, MED SCI SPORT EXER, V33, P36; Hidalgo M, 2014, CELL PHYSIOL BIOCHEM, V33, P67, DOI 10.1159/000356650; Hidalgo M, 2012, J CELL SCI, V125, P3989, DOI 10.1242/jcs.097998; Horie M, 2014, J APPL PHYSIOL, V116, P149, DOI 10.1152/japplphysiol.00235.2013; James P., 1983, PHYSIOTHERAPY, V3, P571; Jash S, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/961307; Keren A, 2006, MOL CELL ENDOCRINOL, V252, P224, DOI 10.1016/j.mce.2006.03.017; Kizer KW, 2008, UNDERSEA HYPERBAR M, V35, P455; Koning M, 2011, TISSUE ENG PT A, V17, P1747, DOI 10.1089/ten.tea.2010.0624; Kook SH, 2008, CELL BIOL INT, V32, P871, DOI 10.1016/j.cellbi.2008.03.017; Kranke P, 2004, COCHRANE DB SYST REV, V2, DOI DOI 10.1002/14651858.CD004123.PUB2; Kubis HP, 2005, BBA-MOL CELL RES, V1745, P187, DOI 10.1016/j.bbamcr.2005.05.007; Langen RCJ, 2013, INT J BIOCHEM CELL B, V45, P2245, DOI 10.1016/j.biocel.2013.06.015; Launay T, 2010, CELL PROLIFERAT, V43, P1, DOI 10.1111/j.1365-2184.2009.00648.x; Lees SJ, 2008, CELL PROLIFERAT, V41, P193, DOI 10.1111/j.1365-2184.2008.00512.x; Liu WY, 2012, DEVELOPMENT, V139, P2857, DOI 10.1242/dev.079665; Majmundar AJ, 2015, DEVELOPMENT, V142, P2405, DOI 10.1242/dev.123026; Majmundar AJ, 2012, MOL CELL BIOL, V32, P36, DOI 10.1128/MCB.05857-11; Malavaki CJ, 2015, J MUSCLE RES CELL M, V36, P405, DOI 10.1007/s10974-015-9439-8; Mancinelli R, 2011, J BIOL REG HOMEOS AG, V25, P635; Matsubara Y, 2015, J VASC SURG, V61, P945, DOI 10.1016/j.jvs.2014.10.094; Mekjavic IB, 2000, MED SCI SPORT EXER, V32, P558, DOI 10.1097/00005768-200003000-00002; Ono Y, 2006, J CELL BIOCHEM, V98, P642, DOI 10.1002/jcb.20804; Paoni NF, 2002, PHYSIOL GENOMICS, V11, P263, DOI 10.1152/physiolgenomics.00110.2002; Parmar K, 2007, P NATL ACAD SCI USA, V104, P5431, DOI 10.1073/pnas.0701152104; Plafki C, 2000, AVIAT SPACE ENVIR MD, V71, P119; Pomies P, 2015, J CELL MOL MED, V19, P175, DOI 10.1111/jcmm.12390; Provot S, 2007, J CELL BIOL, V177, P451, DOI 10.1083/jcb.200612023; Reinke C, 2011, J APPL PHYSIOL, V111, P881, DOI 10.1152/japplphysiol.00492.2011; Ren HX, 2010, P NATL ACAD SCI USA, V107, P5857, DOI 10.1073/pnas.0909570107; Ribon A, 2016, RESP PHYSIOL NEUROBI, V223, P23, DOI 10.1016/j.resp.2015.12.008; Richardson RS, 2006, J PHYSIOL-LONDON, V571, P415, DOI 10.1113/jphysiol.2005.102327; RICHARDSON RS, 1995, J CLIN INVEST, V96, P1916, DOI 10.1172/JCI118237; ROSE MS, 1988, J APPL PHYSIOL, V65, P2545, DOI 10.1152/jappl.1988.65.6.2545; Ryall JG, 2008, BIOGERONTOLOGY, V9, P213, DOI 10.1007/s10522-008-9131-0; Selcuk CT, 2013, J BURN CARE RES, V34, pE237, DOI 10.1097/BCR.0b013e318270092e; Semenza GL, 2014, ANNU REV PATHOL-MECH, V9, P47, DOI 10.1146/annurev-pathol-012513-104720; Semenza GL, 2010, WIRES SYST BIOL MED, V2, P336, DOI 10.1002/wsbm.69; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Staples JR, 1999, AM J SPORT MED, V27, P600, DOI 10.1177/03635465990270050901; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Theriault ME, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-35; Theriault ME, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039124; Urbani L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049860; Vogiatzis I, 2010, EUR RESPIR J, V36, P301, DOI 10.1183/09031936.00112909; von Maltzahn J, 2012, TRENDS CELL BIOL, V22, P602, DOI 10.1016/j.tcb.2012.07.008; Wang C, 2015, J BIOL CHEM, V290, P29707, DOI 10.1074/jbc.M115.688671; WEST JB, 1987, J APPL PHYSIOL, V63, P3, DOI 10.1152/jappl.1987.63.1.3; Wilson EM, 2007, J BIOL CHEM, V282, P5106, DOI 10.1074/jbc.C600315200; Wouters BG, 2005, SEMIN CELL DEV BIOL, V16, P487, DOI 10.1016/j.semcdb.2005.03.009; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Yun Z, 2005, MOL CELL BIOL, V25, P3040, DOI 10.1128/MCB.25.8.3040-3055.2005; Yusuf F, 2012, HISTOCHEM CELL BIOL, V138, P187, DOI 10.1007/s00418-012-0972-x	86	47	51	1	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					3929	3941		10.1096/fj.201600757R	http://dx.doi.org/10.1096/fj.201600757R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27601440				2022-12-28	WOS:000388201500003
J	Peng, XY; Moore, M; Mathur, A; Zhou, Y; Sun, HX; Gan, Y; Herazo-Maya, JD; Kaminski, N; Hu, XY; Pan, HY; Ryu, CW; Osafo-Addo, A; Homer, RJ; Feghali-Bostwick, C; Fares, WH; Gulati, M; Hu, BQ; Lee, CG; Elias, JA; Herzog, EL				Peng, Xueyan; Moore, Meagan; Mathur, Aditi; Zhou, Yang; Sun, Huanxing; Gan, Ye; Herazo-Maya, Jose D.; Kaminski, Naftali; Hu, Xinyuan; Pan, Hongyi; Ryu, Changwan; Osafo-Addo, Awo; Homer, Robert J.; Feghali-Bostwick, Carol; Fares, Wassim H.; Gulati, Mridu; Hu, Buqu; Lee, Chun-Geun; Elias, Jack A.; Herzog, Erica L.			Plexin C1 deficiency permits synaptotagmin 7-mediated macrophage migration and enhances mammalian lung fibrosis	FASEB JOURNAL			English	Article						idiopathic pulmonary fibrosis; immunology; semaphorin 7a; scleroderma; interstitial lung disease	IDIOPATHIC PULMONARY-FIBROSIS; SEMAPHORIN 7A; SYSTEMIC-SCLEROSIS; GROWTH-FACTOR; MONOCYTES; RECEPTOR; CELLS; MECHANISMS; MEMBRANE; BETA	Pulmonary fibrosis is a progressive and often fatal condition that is believed to be partially orchestrated by macrophages. Mechanisms that control migration of these cells into and within the lung remain undefined. We evaluated the contributions of the semaphorin receptor, plexin C1 (PLXNC1), and the exocytic calcium sensor, synaptotagmin 7 (Syt7), in these processes. We evaluated the role of PLXNC1 in macrophage migration by using Boyden chambers and scratch tests, characterized its contribution to experimentally induced lung fibrosis in mice, and defined the mechanism for our observations. Our findings reveal that relative to control participants, patients with idiopathic pulmonary fibrosis demonstrate excessive monocyte migration and underexpression of PLXNC1 in the lungs and circulation, a finding that is recapitulated in the setting of scleroderma-related interstitial lung disease. Relative to wild type, PLXNC1(-/-) mouse macrophages are excessively migratory, and PLXNC1(-/-) mice show exacerbated collagen accumulation in response to either inhaled bleomycin or inducible lung targeted TGF-beta 1 overexpression. These findings are ameliorated by replacement of PLXNC1 on bone marrow-derived cells or by genetic deletion of Syt7. These data demonstrate the previously unrecognized observation that PLXNC1 deficiency permits Syt7-mediated macrophage migration and enhances mammalian lung fibrosis.	[Peng, Xueyan; Moore, Meagan; Mathur, Aditi; Sun, Huanxing; Gan, Ye; Herazo-Maya, Jose D.; Kaminski, Naftali; Hu, Xinyuan; Pan, Hongyi; Ryu, Changwan; Osafo-Addo, Awo; Fares, Wassim H.; Gulati, Mridu; Hu, Buqu; Herzog, Erica L.] Yale Sch Med, Dept Pulm Crit Care & Sleep Med, New Haven, CT USA; [Homer, Robert J.] Yale Sch Med, Dept Pathol, New Haven, CT USA; [Zhou, Yang; Lee, Chun-Geun; Elias, Jack A.] Brown Univ, Warren Alpert Sch Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; [Feghali-Bostwick, Carol] Med Univ South Carolina, Sch Med, Dept Med, Charleston, SC USA	Yale University; Yale University; Brown University; Medical University of South Carolina	Herzog, EL (corresponding author), Yale Univ, Sch Med, Yale Ctr Interstitial Lung Dis, Dept Internal Med,Sect Pulm Crit Care & Sleep Med, 300 Cedar St,POB 208057,TAC 441 South, New Haven, CT 06520 USA.	erica.herzog@yale.edu	homer, robert/P-3884-2019; Herazo-Maya, Jose/ABG-7214-2021; Lee, Chun Geun/AAC-2838-2021	homer, robert/0000-0002-2055-5885; Lee, Chun Geun/0000-0002-9514-3658; ryu, changwan/0000-0001-6211-4327; Fares, Wassim/0000-0001-9462-8103; Kaminski, Naftali/0000-0001-5917-4601	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [R01-HL109233, U01-HL112702, R01-HL125850-01A1]; American Thoracic Society; Scleroderma Foundation; Greenfield Foundation; Yale Interstitial Lung Disease Center of Excellence; NIH NHLBI Grants [R01-HL115813, P01-HL114501, U01-HL108638, UH2-HL123876-01, U01-HL108642, RC2-HL 101715]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL108642, U01HL112702, R01HL115813, R01HL109233, T32HL007778, P01HL114501, R01HL125850, U01HL108638, RC2HL101715, UH2HL123876] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Thoracic Society; Scleroderma Foundation; Greenfield Foundation; Yale Interstitial Lung Disease Center of Excellence; NIH NHLBI Grants; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Grants R01-HL109233, U01-HL112702, and R01-HL125850-01A1 (to E.L.H.); grants from the American Thoracic Society, Scleroderma Foundation, Greenfield Foundation, and Yale Interstitial Lung Disease Center of Excellence (to E.L.H.); and by NIH NHLBI Grants R01-HL115813 (to C.G.L), P01-HL114501 (to J.A.E.), U01-HL108638 (to J.A.E.), UH2-HL123876-01 (to J.A.E); U01-HL108642 (to N.K.), and RC2-HL 101715 (to N.K).	Abid SH, 2001, CURR OPIN ONCOL, V13, P242, DOI 10.1097/00001622-200107000-00006; Bacaj T, 2013, NEURON, V80, P947, DOI 10.1016/j.neuron.2013.10.026; Bauer Y, 2015, AM J RESP CELL MOL, V52, P217, DOI 10.1165/rcmb.2013-0310OC; Becker SM, 2009, IMMUNOBIOLOGY, V214, P495, DOI 10.1016/j.imbio.2008.11.006; Blackwell TS, 2014, AM J RESP CRIT CARE, V189, P214, DOI 10.1164/rccm.201306-1141WS; Chabbert-de Ponnat I, 2005, INT IMMUNOL, V17, P439, DOI 10.1093/intimm/dxh224; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; Czibener C, 2006, J CELL BIOL, V174, P997, DOI 10.1083/jcb.200605004; Czopik AK, 2006, IMMUNITY, V24, P591, DOI 10.1016/j.immuni.2006.03.013; Davies John Q, 2005, Methods Mol Biol, V290, P105; Gan Y, 2011, ARTHRITIS RHEUM-US, V63, P2484, DOI 10.1002/art.30386; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Granja T, 2014, MUCOSAL IMMUNOL, V7, P879, DOI 10.1038/mi.2013.104; Herzog EL, 2014, ARTHRITIS RHEUMATOL, V66, P1967, DOI 10.1002/art.38702; Huebner RH, 2008, BIOTECHNIQUES, V44, P507, DOI 10.2144/000112729; Kang SJ, 2012, J IMMUNOL, V188, P1108, DOI 10.4049/jimmunol.1102084; Karmouty-Quintana H, 2015, FASEB J, V29, P50, DOI 10.1096/fj.14-260182; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Lazova R, 2009, AM J DERMATOPATH, V31, P177, DOI 10.1097/DAD.0b013e318196672d; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Lewis Myra J, 2003, Am J Clin Pathol, V120 Suppl, pS3; Li YY, 2007, BIOCHEM BIOPH RES CO, V362, P658, DOI 10.1016/j.bbrc.2007.08.023; Liu H, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-7; Ma B, 2015, CANCER RES, V75, P487, DOI 10.1158/0008-5472.CAN-13-3339; Majumdar S, 1999, EUR RESPIR J, V14, P251, DOI 10.1034/j.1399-3003.1999.14b03.x; Mathai SK, 2010, LAB INVEST, V90, P812, DOI 10.1038/labinvest.2010.73; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Neuland K, 2014, J CELL SCI, V127, P5218, DOI 10.1242/jcs.153742; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Reilkoff RA, 2013, AM J RESP CRIT CARE, V187, P180, DOI 10.1164/rccm.201206-1109OC; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Scott GA, 2008, J INVEST DERMATOL, V128, P151, DOI 10.1038/sj.jid.5700974; Scott GA, 2009, J INVEST DERMATOL, V129, P954, DOI 10.1038/jid.2008.329; STEEN VD, 1985, ARTHRITIS RHEUM-US, V28, P759, DOI 10.1002/art.1780280706; Sultana H, 2012, J IMMUNOL, V189, P3150, DOI 10.4049/jimmunol.1201140; Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652; Tashkin DP, 2006, NEW ENGL J MED, V354, P2655, DOI 10.1056/NEJMoa055120; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; Tourkina E, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-15; VANHEE D, 1994, AM J RESP CRIT CARE, V150, P1049, DOI 10.1164/ajrccm.150.4.7921435; Vogel DYS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-23; Wagner GR, 1997, LANCET, V349, P1311, DOI 10.1016/S0140-6736(96)07336-9; Zhou Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007096; Zhu S, 2009, AM J PHYSIOL-LUNG C, V297, pL97, DOI 10.1152/ajplung.90283.2008	47	32	33	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4056	4070		10.1096/fj.201600373R	http://dx.doi.org/10.1096/fj.201600373R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27609773	Green Published			2022-12-28	WOS:000388201500013
J	Borowiec, AS; Sion, B; Chalmel, F; Rolland, AD; Lemonnier, L; De Clerck, T; Bokhobza, A; Derouiche, S; Dewailly, E; Slomianny, C; Mauduit, C; Benahmed, M; Roudbaraki, M; Jegou, B; Prevarskaya, N; Bidaux, G				Borowiec, Anne-Sophie; Sion, Benoit; Chalmel, Frederic; Rolland, Antoine D.; Lemonnier, Loic; De Clerck, Tatiana; Bokhobza, Alexandre; Derouiche, Sandra; Dewailly, Etienne; Slomianny, Christian; Mauduit, Claire; Benahmed, Mohamed; Roudbaraki, Morad; Jegou, Bernard; Prevarskaya, Natalia; Bidaux, Gabriel			Cold/menthol TRPM8 receptors initiate the cold-shock response and protect germ cells from cold-shock-induced oxidation	FASEB JOURNAL			English	Article						hypothermia; spermatogenesis; apoptosis	HYDROPEROXIDE GLUTATHIONE-PEROXIDASE; BIOLOGICAL SIGNIFICANCE; REGULATORY MECHANISM; SPERMATOGENIC CELLS; DNA-DAMAGE; EXPRESSION; APOPTOSIS; STRESS; CHANNEL; TRANSCRIPTOME	Testes of most male mammals present the particularity of being externalized from the body and are consequently slightly cooler than core body temperature (4-8 degrees C below). Although, hypothermia of the testis is known to increase germ cells apoptosis, little is known about the underlying molecular mechanisms, including cold sensors, transduction pathways, and apoptosis triggers. In this study, using a functional knockout mouse model of the cold and menthol receptors, dubbed transient receptor potential melastatine 8 (TRPM8) channels, we found that TRPM8 initiated the cold-shock response by differentially modulating cold- and heat-shock proteins. Besides, apoptosis of germ cells increased in proportion to the cooling level in control mice but was independent of temperature in knockout mice. We also observed that the rate of germ cell death correlated positively with the reactive oxygen species level and negatively with the expression of the detoxifying enzymes. This result suggests that the TRPM8 sensor is a key determinant of germ cell fate under hypothermic stimulation.Borowiec, A.-S., Sion, B., Chalmel, F., Rolland, A. D., Lemonnier, L., De Clerck, T., Bokhobza, A., Derouiche, S., Dewailly, E., Slomianny, C., Mauduit, C., Benahmed, M., Roudbaraki, M., Jegou, B., Prevarskaya, N., Bidaux, G. Cold/menthol TRPM8 receptors initiate the cold-shock response and protect germ cells from cold-shock-induced oxidation.	[Borowiec, Anne-Sophie; Lemonnier, Loic; De Clerck, Tatiana; Bokhobza, Alexandre; Derouiche, Sandra; Dewailly, Etienne; Slomianny, Christian; Roudbaraki, Morad; Prevarskaya, Natalia; Bidaux, Gabriel] Univ Lille, INSERM, Physiol Cellulaire PHYCEL, U1003, Lille, France; [Sion, Benoit] Univ Auvergne, Clermont Univ, Pharmacol Fondamentale & Clin Douleur, INSERM,U1107,Neurodol, Clermont Ferrand, France; [Chalmel, Frederic; Rolland, Antoine D.; Jegou, Bernard] INSERM, Irset U1085, Campus Beaulieu, Rennes, France; [Mauduit, Claire; Benahmed, Mohamed] INSERM, Ctr Mediterraneen Med Mol C3M, Team 5, U1065, Nice, France; [Bidaux, Gabriel] Biophoton Team, UMR8523, Lab Phys Lasers Atomes & Mol PhLAM, Villeneuve Dascq, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Clermont Auvergne (UCA); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Cote d'Azur; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP)	Bidaux, G (corresponding author), Grp Hosp EST, INSERM, U1060, IHU Opera,CarMeN Lab, Batiment B13,59 Blvd Pinel, F-69500 Bron, France.	gabriel.bidaux@univ-lyon1.fr	Chalmel, Frédéric/AAM-1079-2021; ROLLAND, Antoine D/B-2611-2012; Chalmel, Frederic/M-1297-2016; Carmen, Team3/Y-7384-2019; Lemonnier, Loic/L-7289-2018; Chalmel, Frédéric/L-5360-2018; Slomianny, Christian/L-8285-2018; Bidaux, Gabriel/F-1294-2016	Chalmel, Frédéric/0000-0002-0535-3628; ROLLAND, Antoine D/0000-0002-9758-4406; Carmen, Team3/0000-0002-3614-0924; Lemonnier, Loic/0000-0001-6200-5382; Chalmel, Frédéric/0000-0002-0535-3628; JEGOU, Bernard/0000-0003-0623-3609; Lab, Carmen/0000-0002-5935-3236; bokhobza, Alexandre/0000-0001-7953-4328; Bidaux, Gabriel/0000-0002-6162-3223; Morad, Roudbaraki/0000-0001-5751-3323; Prevarskaya, natacha/0000-0003-0316-197X	Genoway team and Charles River Laboratories (Lyon, France); INSERM; Ministere de l'Education Nationale; Ligue Nationale Contre le Cancer; Region Nord-Pas-de-Calais; ANR [TRPM8/REPROD]; Fondation pour la recherche medicale	Genoway team and Charles River Laboratories (Lyon, France); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Ministere de l'Education Nationale; Ligue Nationale Contre le Cancer(Ligue nationale contre le cancer); Region Nord-Pas-de-Calais(Region Hauts-de-FranceEuropean Commission); ANR(French National Research Agency (ANR)); Fondation pour la recherche medicale(Fondation pour la Recherche Medicale)	The authors thank the whole Genoway team and Charles River Laboratories (Lyon, France) for their support and their expertise; and Delphine Taillieu and Melanie Besegher for technical assistance in animal housing at Animalerie High-Tech de l'Institut de Medecine Predictive et de Recherche Therapeutique de Lille. The Trpm8<SUP>-/-</SUP> mouse line was designed by G.B. and Genoway Inc. The Trpm8<SUP>-/-</SUP> mouse line was established by Genoway Inc. and housed at Charles River Laboratories. This work was supported by grants from INSERM, Ministere de l'Education Nationale, Ligue Nationale Contre le Cancer, Region Nord-Pas-de-Calais, and ANR Grant TRPM8/REPROD. A.-S.B. was supported by Fondation pour la recherche medicale. Author Contributions: A.-S. Borowiec and G. Bidaux designed research; A.-S. Borowiec, B. Sion, F. Chalmel, A. D. Rolland, L. Lemonnier, T. De Clerck, A. Bokhobza, S. Derouiche, E. Dewailly, C. Slomianny, C. Mauduit, and G. Bidaux performed research; A.-S. Borowiec, B. Sion, F. Chalmel, A. D. Rolland, L. Lemonnier, C. Slomianny, M. Benahmed, M. Roudbaraki, B. Jegou, and G. Bidaux analyzed data; and A.-S. Borowiec, B. Sion, F. Chalmel, A. D. Rolland, L. Lemonnier, B. Jegou, N. Prevarskaya, and G. Bidaux wrote the paper. The authors declare no conflicts of interest.	Abeele FV, 2006, J BIOL CHEM, V281, P40174, DOI 10.1074/jbc.M605779200; Aitken RJ, 2013, INT J DEV BIOL, V57, P265, DOI 10.1387/ijdb.130146ja; Aitken RJ, 2012, J BIOL CHEM, V287, P33048, DOI 10.1074/jbc.M112.366690; Andersson DA, 2007, J NEUROSCI, V27, P3347, DOI 10.1523/JNEUROSCI.4846-06.2007; Avivar-Valderas A, 2011, MOL CELL BIOL, V31, P3616, DOI 10.1128/MCB.05164-11; Bidaux G, 2005, ENDOCR-RELAT CANCER, V12, P367, DOI 10.1677/erc.1.00969; Bidaux G, 2007, J CLIN INVEST, V117, P1647, DOI 10.1172/JCI30168; Bidaux G, 2016, CHANNELS, V10, P320, DOI 10.1080/19336950.2016.1168551; Bidaux G, 2015, P NATL ACAD SCI USA, V112, pE3345, DOI 10.1073/pnas.1423357112; BlancoRodriguez J, 1997, J ANDROL, V18, P535; Brauchi S, 2006, J NEUROSCI, V26, P4835, DOI 10.1523/JNEUROSCI.5080-05.2006; Brauchi S, 2004, P NATL ACAD SCI USA, V101, P15494, DOI 10.1073/pnas.0406773101; Chabory E, 2010, J ANIM SCI, V88, P1321, DOI 10.2527/jas.2009-2583; Chabory E, 2009, J CLIN INVEST, V119, P2074, DOI 10.1172/JCI38940; Chalmel F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-86; Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104; CHOWDHURY AK, 1970, J REPROD FERTIL, V22, P205, DOI 10.1530/jrf.0.0220205; Danno S, 2000, AM J PATHOL, V156, P1685, DOI 10.1016/S0002-9440(10)65039-0; Darde TA, 2015, NUCLEIC ACIDS RES, V43, pW109, DOI 10.1093/nar/gkv345; De Blas GA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006095; Denda M, 2010, EXP DERMATOL, V19, P791, DOI 10.1111/j.1600-0625.2010.01154.x; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Gan HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2995; Gibbs GM, 2011, P NATL ACAD SCI USA, V108, P7034, DOI 10.1073/pnas.1015935108; GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440; Hofmann S, 2012, MOL BIOL CELL, V23, P3786, DOI 10.1091/mbc.E12-04-0296; Imai H, 2003, FREE RADICAL BIO MED, V34, P145, DOI 10.1016/S0891-5849(02)01197-8; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ishii T, 2005, FREE RADICAL RES, V39, P697, DOI 10.1080/10715760500130517; Kaushik S, 2003, CLIN CHIM ACTA, V333, P69, DOI 10.1016/S0009-8981(03)00171-2; Lardenois A, 2010, DATABASE-OXFORD, DOI 10.1093/database/baq030; Liu DJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036994; MACDONALD J, 1954, FERTIL STERIL, V5, P205; Martinez-Lopez P, 2011, J CELL PHYSIOL, V226, P1620, DOI 10.1002/jcp.22493; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Namekawa SH, 2006, CURR BIOL, V16, P660, DOI 10.1016/j.cub.2006.01.066; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Nocchi L, 2014, AGING CELL, V13, P540, DOI 10.1111/acel.12208; Ohdate T, 2010, GENES CELLS, V15, P59, DOI 10.1111/j.1365-2443.2009.01365.x; Papa S, 1997, MOL CELL BIOCHEM, V174, P305, DOI 10.1023/A:1006873518427; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Pino JA, 2013, REPRODUCTION, V145, P203, DOI 10.1530/REP-12-0330; Ray PD, 2012, CELL SIGNAL, V24, P981, DOI 10.1016/j.cellsig.2012.01.008; Schneider M, 2009, FASEB J, V23, P3233, DOI 10.1096/fj.09-132795; Schultz N, 2003, P NATL ACAD SCI USA, V100, P12201, DOI 10.1073/pnas.1635054100; Selman C, 2000, FREE RADICAL BIO MED, V28, P1279, DOI 10.1016/S0891-5849(00)00263-X; Shima JE, 2004, BIOL REPROD, V71, P319, DOI 10.1095/biolreprod.103.026880; Soumillon M, 2013, CELL REP, V3, P2179, DOI 10.1016/j.celrep.2013.05.031; Thebault S, 2005, J BIOL CHEM, V280, P39423, DOI 10.1074/jbc.M503544200; Tsuzi D, 2004, FEBS LETT, V569, P301, DOI 10.1016/j.febslet.2004.05.077; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Voets T, 2004, NATURE, V430, P748, DOI 10.1038/nature02732; Voituron Y, 2006, CRYOBIOLOGY, V52, P74, DOI 10.1016/j.cryobiol.2005.09.006; Wang X, 2003, FERTIL STERIL, V80, P531, DOI 10.1016/S0015-0282(03)00756-8; WHO, 2001, ANN I SUPER SANITA, V37, pI; Yazawa T, 2003, MOL REPROD DEV, V66, P60, DOI 10.1002/mrd.10328; Zhang KY, 2007, BIOCHEM BIOPH RES CO, V360, P327, DOI 10.1016/j.bbrc.2007.06.071; Zhang Z, 2004, J ANDROL, V25, P57; Zhu SY, 2014, EUR J PHARMACOL, V725, P1, DOI 10.1016/j.ejphar.2014.01.001; Zhu X., 2016, FASEB J, V30, P624	60	14	14	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3155	3170		10.1096/fj.201600257R	http://dx.doi.org/10.1096/fj.201600257R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27317670	hybrid, Green Published			2022-12-28	WOS:000382816300016
J	Abbott, GW				Abbott, Geoffrey W.			Novel exon 1 protein-coding regions N-terminally extend human KCNE3 and KCNE4	FASEB JOURNAL			English	Article						arrhythmia; KCNQ1; KCNQ4; Kv4.2; potassium channel	GATED POTASSIUM CHANNELS; MINK-RELATED PEPTIDES; BETA-SUBUNIT KCNE3; LONG QT SYNDROME; K+ CHANNEL; VENTRICULAR REPOLARIZATION; ATRIAL-FIBRILLATION; CARDIAC-ARRHYTHMIA; INHIBITORY SUBUNIT; ANCILLARY SUBUNITS	The 5 human (h) KCNE beta subunits each regulate various cation channels and are linked to inherited cardiac arrhythmias. Reported here are previously undiscovered protein-coding regions in exon 1 of hKCNE3 and hKCNE4 that extend their encoded extracellular domains by 44 and 51 residues, which yields full-length proteins of 147 and 221 residues, respectively. Full-length hKCNE3 and hKCNE4 transcript and protein are expressed in multiple human tissues; for hKCNE4, only the longer protein isoform is detectable. Two-electrode voltage-clamp electrophysiology revealed that, when coexpressed in Xenopus laevis oocytes with various potassium channels, the newly discovered segment preserved conversion of KCNQ1 by hKCNE3 to a constitutively open channel, but prevented its inhibition of Kv4.2 and KCNQ4. hKCNE4 slowing of Kv4.2 inactivation and positive-shifted steady-state inactivation were also preserved in the longer form. In contrast, full-length hKCNE4 inhibition of KCNQ1 was limited to 40% at +40 m Vvs. 80% inhibition by the shorter form, and augmentation of KCNQ4 activity by hKCNE4 was entirely abolished by the additional segment. Among the genome databases analyzed, the longer KCNE3 is confined to primates; full-length KCNE4 is widespread in vertebrates but is notably absent from Mus musculus. Findings highlight unexpected KCNE gene diversity, raise the possibility of dynamic regulation of KCNE partner modulation via splice variation, and suggest that the longer hKCNE3 and hKCNE4 proteins should be adopted in future mechanistic and genetic screening studies.	[Abbott, Geoffrey W.] Univ Calif Irvine, Dept Pharmacol, Bioelect Lab, Irvine, CA 92717 USA; [Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, Irvine, CA 92717 USA	University of California System; University of California Irvine; University of California System; University of California Irvine	Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Dept Pharmacol, 360 Med Surge 2, Irvine, CA 92697 USA.	abbottg@uci.edu			U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [DK41544]; U.S. National Institutes of Health (National Institute of General Medical Sciences) [GM115189]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK041544] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115189] Funding Source: NIH RePORTER	U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Institutes of Health (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The author is grateful for helpful discussions with Dr. Alex Mercer, Daniel Neverisky (University of California, Irvine) and Dr. Nancy Carrasco (Yale University, New Haven, CT, USA). The author thanks Dr. David Christini and Lala Tanmoy Das (Weill Cornell Medical College, New York, NY, USA) for invaluable tissue samples. This work was supported by the U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases Grant DK41544, and National Institute of General Medical Sciences Grant GM115189).	Abbott GW, 2007, J ELECTROCARDIOL, V40, pS42, DOI 10.1016/j.jelectrocard.2007.05.021; Abbott GW, 2016, GENE, V576, P1, DOI 10.1016/j.gene.2015.09.059; Abbott GW, 2015, GENE, V569, P162, DOI 10.1016/j.gene.2015.06.061; Abbott GW, 2012, CHANNELS, V6, P1, DOI 10.4161/chan.19126; Abbott GW, 2008, EXPERT REV CLIN PHAR, V1, P93, DOI 10.1586/17512433.1.1.93; Abbott GW, 1998, Q REV BIOPHYS, V31, P357, DOI 10.1017/S0033583599003467; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; Barhanin J, 1996, NATURE, V384, P78, DOI 10.1038/384078a0; Crump SM, 2016, FASEB J, V30, P360, DOI 10.1096/fj.15-278754; Crump SM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00003; De Angioletti M, 2004, BRIT J HAEMATOL, V124, P224, DOI 10.1046/j.1365-2141.2003.04754.x; Gordon E, 2008, CARDIOVASC RES, V77, P98, DOI 10.1093/cvr/cvm030; Grunnet M, 2005, BIOCHEM BIOPH RES CO, V328, P1146, DOI 10.1016/j.bbrc.2005.01.071; Grunnet M, 2003, BIOPHYS J, V85, P1525, DOI 10.1016/S0006-3495(03)74585-8; Grunnet M, 2002, J PHYSIOL-LONDON, V542, P119, DOI 10.1113/jphysiol.2002.017301; Hu ZY, 2014, CIRC-CARDIOVASC GENE, V7, P33, DOI 10.1161/CIRCGENETICS.113.000315; ISACOFF EY, 1990, NATURE, V345, P530, DOI 10.1038/345530a0; Jepps TA, 2015, J PHYSIOL-LONDON, V593, P5325, DOI 10.1113/JP271286; Kanda VA, 2011, BIOPHYS J, V101, P1354, DOI 10.1016/j.bpj.2011.08.015; Kanda VA, 2011, BIOPHYS J, V101, P1364, DOI 10.1016/j.bpj.2011.08.014; Levy DI, 2008, AM J PHYSIOL-RENAL, V295, pF380, DOI 10.1152/ajprenal.00598.2007; Levy DI, 2010, J PHYSIOL-LONDON, V588, P2657, DOI 10.1113/jphysiol.2010.191395; Liu WJ, 2014, J MOL CELL CARDIOL, V72, P208, DOI 10.1016/j.yjmcc.2014.03.013; Lundby A, 2008, CELL PHYSIOL BIOCHEM, V21, P47, DOI 10.1159/000113746; Lundquist AL, 2006, GENOMICS, V87, P119, DOI 10.1016/j.ygeno.2005.09.004; McCrossan ZA, 2004, NEUROPHARMACOLOGY, V47, P787, DOI 10.1016/j.neuropharm.2004.06.018; Nakajima T, 2012, CIRC J, V76, P2763, DOI 10.1253/circj.CJ-12-0551; Niwa N, 2010, J MOL CELL CARDIOL, V48, P12, DOI 10.1016/j.yjmcc.2009.07.013; Ohno S, 2011, CIRC-ARRHYTHMIA ELEC, V4, P352, DOI 10.1161/CIRCEP.110.959619; Ohno S, 2009, HUM MUTAT, V30, P557, DOI 10.1002/humu.20834; Panaghie G, 2006, CURR PHARM DESIGN, V12, P2285, DOI 10.2174/138161206777585175; Preston P, 2010, J BIOL CHEM, V285, P7165, DOI 10.1074/jbc.M109.047829; Roepke TK, 2008, FASEB J, V22, P3648, DOI 10.1096/fj.08-110171; Roepke TK, 2006, J BIOL CHEM, V281, P23740, DOI 10.1074/jbc.M604155200; Roepke TK, 2011, FASEB J, V25, P4264, DOI 10.1096/fj.11-187609; Roepke TK, 2011, FASEB J, V25, P727, DOI 10.1096/fj.10-173682; Roepke TK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011451; Roepke TK, 2009, NAT MED, V15, P1186, DOI 10.1038/nm.2029; Sanguinetti MC, 1996, NATURE, V384, P80, DOI 10.1038/384080a0; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Splawski I, 1997, NAT GENET, V17, P338, DOI 10.1038/ng1197-338; Strutz-Seebohm N, 2006, CELL PHYSIOL BIOCHEM, V18, P57, DOI 10.1159/000095158; Teng SY, 2003, BIOCHEM BIOPH RES CO, V303, P808, DOI 10.1016/S0006-291X(03)00433-9; Tinel N, 2000, EMBO J, V19, P6326, DOI 10.1093/emboj/19.23.6326; Wang WY, 2014, J BIOL CHEM, V289, P16802, DOI 10.1074/jbc.M113.545236; Yu H, 2001, CIRC RES, V88, pE84, DOI 10.1161/hh1201.093511; Zeng Zhi-yu, 2005, Zhonghua Xinxueguanbing Zazhi, V33, P987; Zeng ZY, 2007, CARDIOLOGY, V108, P97, DOI 10.1159/000095943	50	9	9	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2959	2969		10.1096/fj.201600467R	http://dx.doi.org/10.1096/fj.201600467R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27162025	Green Published			2022-12-28	WOS:000380994000028
J	Mason, JL; Johnston, E; Berndt, S; Segal, K; Lei, M; Wiest, JS				Mason, Julie L.; Johnston, Elizabeth; Berndt, Sam; Segal, Katie; Lei, Ming; Wiest, Jonathan S.			Labor and skills gap analysis of the biomedical research workforce	FASEB JOURNAL			English	Article						training; education; occupation; graduate students; postdoctoral fellows		The United States has experienced an unsustainable increase of the biomedical research workforce over the past 3 decades. This expansion has led to a myriad of consequences, including an imbalance in the number of researchers and available tenure-track faculty positions, extended postdoctoral training periods, increasing age of investigators at first U.S. National Institutes of Health R01 grant, and exodus of talented individuals seeking careers beyond traditional academe. Without accurate data on the biomedical research labor market, challenges will remain in resolving these problems and in advising trainees of viable career options and the skills necessary to be productive in their careers. We analyzed workforce trends, integrating both traditional labor market information and real-time job data. We generated a profile of the current biomedical research workforce, performed labor gap analyses of occupations in the workforce at regional and national levels, and assessed skill transferability between core and complementary occupations. We conclude that although supply into the workforce and the number of job postings for occupations within that workforce have grown over the past decade, supply continues to outstrip demand. Moreover, we identify practical skill sets from real-time job postings to optimally equip trainees for an array of careers to effectively meet future workforce demand.	[Mason, Julie L.; Lei, Ming; Wiest, Jonathan S.] NCI, Ctr Canc Training, NIH, Bethesda, MD 20892 USA; [Johnston, Elizabeth; Segal, Katie] ICF Int, Cambridge, MA USA; [Berndt, Sam] ICF Int, Fairfax, VA USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Mason, JL (corresponding author), NCI, Ctr Canc Training, 9609 Med Ctr Dr,2W-120, Bethesda, MD 20892 USA.	masonjl@mail.nih.gov			NCI/NIH; NIH [HHSN261201200010I, HHSN261201500149P]; NATIONAL CANCER INSTITUTE [ZIJBC011133] Funding Source: NIH RePORTER	NCI/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Misty Heggeness [U.S. National Institutes of Health (NIH) Office of the Director, Division of Biomedical Research Workforce), Patricia Labosky (NIH Office of the Director, Office of Strategic Coordination), and Randall Ribaudo (Human Workflows, LLC) for guidance and suggestions on this analysis, and Erika Ginsburg [NIH National Cancer Institute (NCI) Center for Cancer Training] for critically reviewing the manuscript. This research was supported by the Office of the Director, NCI/NIH. All authors are employees or contractors of NIH. ICF International acknowledges support from NIH Contract HHSN261201200010I. Access to Labor Insight, Burning Glass Technologies, was available through NIH Contract HHSN261201500149P. Any views expressed are those of the authors and not necessarily those of the NIH. The authors declare no conflicts of interest.	Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; Allum JR, 2015, GRADUATE ENROLLMENT; Callier V., 2015, NATURE, V519, P121, DOI DOI 10.1038/NJ7541-121A; Carnevale AP, 2014, UNDERSTANDING ONLINE; Daniels RJ, 2015, P NATL ACAD SCI USA, V112, P313, DOI 10.1073/pnas.1418761112; Educational Testing Service, 2015, AM SKILLS CHALL MILL; Educational Testing Service and Council of Graduate Schools, 2012, PATHW GRAD SCH CAR; Federation of American Societies for Experimental Biology, 2015, SUST DISC BIOL MED S; Garrison HH, 2016, FASEB J, V30, P41, DOI 10.1096/fj.15-280552; Georgia Power Community and Economic Development, 2012, BIOSC IND GEORG; Gould J., 2015, NATUREJOBS BLOG; Jones Lang LaSalle Inc., 2014, LIF SCI CLUST REP; Kimble J, 2015, ELIFE, V4, DOI 10.7554/eLife.09305; McDowell Gary S, 2014, F1000Res, V3, P291, DOI 10.12688/f1000research.5878.2; Meyers FJ, 2016, FASEB J, V30, P507, DOI 10.1096/fj.15-276139; National Academies of Sciences Engineering and Medicine, 2016, DEV NAT STEM WORKF S; National Cancer Institue, 2013, NCI FUND RES PORTF; National Center for Science and Engineering Statistics (NCSES), 2021, SURV DOCT REC; National Institutes of Health, 2014, NEW EARL STAG INV PO; National Institutes of Health, 2012, BIOM RES WORKF WORK; National Institutes of Health, CLASS NSF NIH SURV G; National Science Foundation, 2014, 14315 NSF; National Science Foundation, 2013, NSF NIH SURV GRAD ST; National Science Foundation, EARL CAR DOCT SURV; Rockey S., 2012, ROCK TALK; State of California Employment Development Department, 2013, BIOT CAL; Teitelbaum M. S., 2014, FALLING BEHIND; Teitelbaum MS, 2008, SCIENCE, V321, P644, DOI 10.1126/science.1160272; Templin R, 2013, ONLINE JOB ADS PREDI; U.S. Office of Personnel Management, 2014, MAJ WORK LOC EX BRAN; Working Group on Diversity in the Biomedical Research Workforce, 2012, REP ADV COMM DIR WOR; Zolas N, 2015, SCIENCE, V350, P1367, DOI 10.1126/science.aac5949	32	20	20	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2673	2683		10.1096/fj.201500067R	http://dx.doi.org/10.1096/fj.201500067R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27075242	Green Published			2022-12-28	WOS:000380994000005
J	Haining, AWM; Lieberthal, TJ; Hernandez, AD				Haining, Alexander W. M.; Lieberthal, Tyler J.; Hernandez, Armando del Rio			Talin: a mechanosensitive molecule in health and disease	FASEB JOURNAL			English	Review						mechanobiology; mechanotransduction; cancer	FOCAL ADHESION KINASE; SUPPRESSES CELL MOTILITY; VINCULIN BINDING-SITES; INTEGRIN ACTIVATION; TUMOR-SUPPRESSOR; BREAST-CANCER; NA+/H+ EXCHANGER; NANOSCALE ARCHITECTURE; PROTEOME ANALYSIS; LEUKOCYTE ARREST	Talin is a ubiquitous, large focal adhesion protein that links intracellular networks with the extracellular matrix (ECM) via its connection with the actin cytoskeleton and membrane integrins. It is one of a handful molecules that can expose new recognition sites when undergoing force-induced mechanical unfolding, and it can bind and recruit cytoskeletal proteins that are involved in mechanotransduction. Talin has attracted great interest in the field of mechanobiology because of its plasticity in undergoing conformational changes under force stimulation as well as its cellular localization that bridges the cytoskeleton with the ECM. In addition to these roles in healthy cells, the dysregulation of talin activators can lead to disease states in which aberrant integrin activation and mechanotransduction precipitate changes in cell spreading, migration, and survival. New data have implicated a role for talin in diseases that are highly regulated by mechanical cues. In this review, we present the current understanding of talin structure, its relationship to binding partners, and its role in disease states.Haining, A. W. M., Lieberthal, T. J., del Rio Hernandez, A. Talin: a mechanosensitive molecule in health and disease.	[Haining, Alexander W. M.; Lieberthal, Tyler J.; Hernandez, Armando del Rio] Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, 308 Bessemer Bldg,South Kensington Campus, London SW7 2AZ, England	Imperial College London	Hernandez, AD (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Bioengn, 308 Bessemer Bldg,South Kensington Campus, London SW7 2AZ, England.	a.del-rio-hernandez@imperial.ac.uk	del Río Hernández, Armando E/D-3555-2012; del rio hernandez, armando e/N-4262-2013	del Río Hernández, Armando E/0000-0001-5062-8910; del rio hernandez, armando e/0000-0001-5062-8910; Lieberthal, Tyler/0000-0002-3250-8162	European Research Council [282051]; Whitaker International Program; James Dyson Foundation Fellowship	European Research Council(European Research Council (ERC)European Commission); Whitaker International Program; James Dyson Foundation Fellowship	This work was supported by the European Research Council Grant 282051 ( to A. D. R. H.); and by a Whitaker International Program and James Dyson Foundation Fellowship ( to T.J.L.).	Alon R, 2008, CURR OPIN CELL BIOL, V20, P525, DOI 10.1016/j.ceb.2008.04.003; Alon R, 2007, IMMUNITY, V26, P17, DOI 10.1016/j.immuni.2007.01.002; Alon R, 2012, CURR OPIN CELL BIOL, V24, P670, DOI 10.1016/j.ceb.2012.06.001; Ambros V, 2001, CELL, V107, P823, DOI 10.1016/S0092-8674(01)00616-X; Amith SR, 2015, ONCOTARGET, V6, P1262, DOI 10.18632/oncotarget.2860; Andersen AP, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0098; Astrof NS, 2006, BIOCHEMISTRY-US, V45, P15020, DOI 10.1021/bi061566o; Atherton P, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10038; Austen K, 2015, NAT CELL BIOL, V17, P1597, DOI 10.1038/ncb3268; Balaban NQ, 2001, NAT CELL BIOL, V3, P466, DOI 10.1038/35074532; Beaty BT, 2014, J CELL BIOL, V205, P737, DOI 10.1083/jcb.201312046; Bois PRJ, 2006, J BIOL CHEM, V281, P7228, DOI 10.1074/jbc.M510397200; Bourguignon LYW, 2004, J BIOL CHEM, V279, P26991, DOI 10.1074/jbc.M311838200; BURRIDGE K, 1983, J CELL BIOL, V97, P359, DOI 10.1083/jcb.97.2.359; Busco G, 2010, FASEB J, V24, P3903, DOI 10.1096/fj.09-149518; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Cardone RA, 2005, NAT REV CANCER, V5, P786, DOI 10.1038/nrc1713; Cardone RA, 2015, NEOPLASIA, V17, P155, DOI 10.1016/j.neo.2014.12.003; Carisey A, 2013, CURR BIOL, V23, P271, DOI 10.1016/j.cub.2013.01.009; Carragher NO, 2004, NEOPLASIA, V6, P53, DOI 10.1016/S1476-5586(04)80053-8; Casari C, 2013, J CLIN INVEST, V123, P5071, DOI 10.1172/JCI69458; Case LB, 2015, NAT CELL BIOL, V17, P880, DOI 10.1038/ncb3180; CHEN HC, 1995, J BIOL CHEM, V270, P16995, DOI 10.1074/jbc.270.28.16995; Choquet D, 1997, CELL, V88, P39, DOI 10.1016/S0092-8674(00)81856-5; Ciobanasu C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4095; Conti FJ, 2009, DEVELOPMENT, V136, P3597, DOI 10.1242/dev.035857; Debrand E, 2012, BIOCHEM BIOPH RES CO, V426, P190, DOI 10.1016/j.bbrc.2012.08.061; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Durkin ME, 2007, J CELL MOL MED, V11, P1185, DOI 10.1111/j.1582-4934.2007.00098.x; Eberle KE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021496; Engler AJ, 2006, CELL, V126, P677, DOI 10.1016/j.cell.2006.06.044; Evans EA, 2007, SCIENCE, V316, P1148, DOI 10.1126/science.1137592; FERNANDEZ JLR, 1992, CELL MOTIL CYTOSKEL, V22, P127, DOI 10.1002/cm.970220206; Fernandez-Sanchez ME, 2015, NATURE, V523, P92, DOI 10.1038/nature14329; Fillingham I, 2005, STRUCTURE, V13, P65, DOI 10.1016/j.str.2004.11.006; Formosa A, 2013, ONCOGENE, V32, P127, DOI 10.1038/onc.2012.14; Franco SJ, 2004, NAT CELL BIOL, V6, P977, DOI 10.1038/ncb1175; Frobel J, 2013, MOL CELL PROTEOMICS, V12, P1272, DOI 10.1074/mcp.M112.023168; Geiger B, 2009, NAT REV MOL CELL BIO, V10, P21, DOI 10.1038/nrm2593; GILMORE AP, 1995, HUM GENET, V96, P221, DOI 10.1007/BF00207384; Gingras AR, 2008, EMBO J, V27, P458, DOI 10.1038/sj.emboj.7601965; Gingras AR, 2010, J BIOL CHEM, V285, P29577, DOI 10.1074/jbc.M109.095455; Gingras AR, 2009, J BIOL CHEM, V284, P8857, DOI 10.1074/jbc.M805937200; Gingras AR, 2005, J BIOL CHEM, V280, P37217, DOI 10.1074/jbc.M508060200; Goldacre MJ, 2008, EUR J GASTROEN HEPAT, V20, P384, DOI 10.1097/MEG.0b013e3282f4489f; Goult BT, 2013, J STRUCT BIOL, V184, P21, DOI 10.1016/j.jsb.2013.05.014; Goult BT, 2013, J BIOL CHEM, V288, P8238, DOI 10.1074/jbc.M112.438119; Goult BT, 2010, EMBO J, V29, P1069, DOI 10.1038/emboj.2010.4; Goult BT, 2009, J BIOL CHEM, V284, P15097, DOI 10.1074/jbc.M900078200; Grashoff C, 2010, NATURE, V466, P263, DOI 10.1038/nature09198; Greco MR, 2014, ONCOL REP, V31, P940, DOI 10.3892/or.2013.2923; Haling JR, 2011, BLOOD, V117, P1719, DOI 10.1182/blood-2010-09-305433; Han JW, 2006, CURR BIOL, V16, P1796, DOI 10.1016/j.cub.2006.08.035; Hemmings L, 1996, J CELL SCI, V109, P2715; Hensley PJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086238; Hirata H, 2014, AM J PHYSIOL-CELL PH, V306, pC607, DOI 10.1152/ajpcell.00122.2013; Hudis CA, 2007, NEW ENGL J MED, V357, P39, DOI 10.1056/NEJMra043186; Hyduk SJ, 2011, J IMMUNOL, V187, P4360, DOI 10.4049/jimmunol.1003725; Hytonen VP, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040024; Janostiak R, 2014, CELL MOL LIFE SCI, V71, P727, DOI 10.1007/s00018-013-1450-x; Jevnikar Z, 2013, J BIOL CHEM, V288, P2201, DOI 10.1074/jbc.M112.436394; Jiang GY, 2003, NATURE, V424, P334, DOI 10.1038/nature01805; Jin JK, 2015, ONCOGENE, V34, P1811, DOI 10.1038/onc.2014.116; Kalli AC, 2011, P NATL ACAD SCI USA, V108, P11890, DOI 10.1073/pnas.1104505108; Kanamori H, 2011, ONCOLOGY-BASEL, V80, P406, DOI 10.1159/000330734; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Kaushik S, 2014, CYTOSKELETON, V71, P677, DOI 10.1002/cm.21201; Kim CH, 2012, J CELL BIOL, V197, P605, DOI 10.1083/jcb.201112141; Kim SK, 1997, CANCER RES, V57, P400; Klapholz B, 2015, CURR BIOL, V25, P847, DOI 10.1016/j.cub.2015.01.043; Klapproth S, 2015, BLOOD, V126, P2704, DOI 10.1182/blood-2015-05-647453; Kopp PM, 2010, EUR J CELL BIOL, V89, P661, DOI 10.1016/j.ejcb.2010.05.003; Lafuente EM, 2004, DEV CELL, V7, P585, DOI 10.1016/j.devcel.2004.07.021; Lagarrigue F, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9492; Lai MT, 2011, J PATHOL, V224, P367, DOI 10.1002/path.2867; Lauritzen G, 2010, EXP CELL RES, V316, P2538, DOI 10.1016/j.yexcr.2010.06.005; Le XF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041170; Lee HS, 2013, MOL BIOL CELL, V24, P1354, DOI 10.1091/mbc.E12-09-0695; Lee HS, 2009, J BIOL CHEM, V284, P5119, DOI 10.1074/jbc.M807117200; Lee YC, 2013, MOL CANCER RES, V11, P405, DOI 10.1158/1541-7786.MCR-12-0551; Lefort CT, 2012, BLOOD, V119, P4275, DOI 10.1182/blood-2011-08-373118; Levental KR, 2009, CELL, V139, P891, DOI 10.1016/j.cell.2009.10.027; Li GR, 2011, P NATL ACAD SCI USA, V108, P17129, DOI 10.1073/pnas.1112122108; Liu JR, 2015, P NATL ACAD SCI USA, V112, pE4864, DOI 10.1073/pnas.1512025112; Manevich E, 2007, J BIOL CHEM, V282, P25338, DOI 10.1074/jbc.M700089200; Margadant F, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001223; Martel V, 2001, J BIOL CHEM, V276, P21217, DOI 10.1074/jbc.M102373200; Menasche G, 2007, MOL CELL BIOL, V27, P4070, DOI 10.1128/MCB.02011-06; Michelson AD, 2010, NAT REV DRUG DISCOV, V9, P154, DOI 10.1038/nrd2957; Monkley SJ, 2001, BIOCHEM BIOPH RES CO, V286, P880, DOI 10.1006/bbrc.2001.5497; Montresor A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00127; Nieswandt B, 2007, J EXP MED, V204, P3113, DOI 10.1084/jem.20071827; Orlowski A, 2015, J PHYS CHEM B, V119, P12381, DOI 10.1021/acs.jpcb.5b06457; Papagrigoriou E, 2004, EMBO J, V23, P2942, DOI 10.1038/sj.emboj.7600285; Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010; Praekelt U, 2012, EUR J CELL BIOL, V91, P180, DOI 10.1016/j.ejcb.2011.12.003; Reshkin SJ, 2003, CLIN CANCER RES, V9, P2366; Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175; Rubashkin MG, 2014, CANCER RES, V74, P4597, DOI 10.1158/0008-5472.CAN-13-3698; Sakamoto S, 2010, CANCER RES, V70, P1885, DOI 10.1158/0008-5472.CAN-09-2833; Sansing HA, 2011, BIOCHEM BIOPH RES CO, V406, P171, DOI 10.1016/j.bbrc.2011.01.109; Sen S, 2012, J R SOC INTERFACE, V9, P1311, DOI 10.1098/rsif.2011.0567; Shamri R, 2005, NAT IMMUNOL, V6, P497, DOI 10.1038/ni1194; Shimaoka M, 2003, CELL, V112, P99, DOI 10.1016/S0092-8674(02)01257-6; Singel SM, 2013, CLIN CANCER RES, V19, P2061, DOI 10.1158/1078-0432.CCR-13-0082; Snijders AM, 2005, ONCOGENE, V24, P4232, DOI 10.1038/sj.onc.1208601; Stolla M, 2011, BLOOD, V117, P1005, DOI 10.1182/blood-2010-07-297713; Stricker J, 2011, BIOPHYS J, V100, P2883, DOI 10.1016/j.bpj.2011.05.023; Stritt S, 2015, BLOOD, V125, P219, DOI 10.1182/blood-2014-08-597542; Stuwe L, 2007, J PHYSIOL-LONDON, V585, P351, DOI 10.1113/jphysiol.2007.145185; Su WJ, 2015, BLOOD, V126, P2695, DOI 10.1182/blood-2015-05-644104; Sun N, 2008, EXP CELL RES, V314, P1839, DOI 10.1016/j.yexcr.2008.01.034; Tadokoro S, 2003, SCIENCE, V302, P103, DOI 10.1126/science.1086652; Tang HS, 2013, INT J MOL MED, V32, P381, DOI 10.3892/ijmm.2013.1400; Tian X, 2014, J CLIN INVEST, V124, P1098, DOI 10.1172/JCI69778; Vahle AK, 2014, INT J ONCOL, V44, P78, DOI 10.3892/ijo.2013.2158; Vanamala J, 2011, PROTEOME SCI, V9, DOI 10.1186/1477-5956-9-49; Vinogradova O, 2002, CELL, V110, P587, DOI 10.1016/S0092-8674(02)00906-6; Wang XF, 2013, SCIENCE, V340, P991, DOI 10.1126/science.1231041; Wegener KL, 2007, CELL, V128, P171, DOI 10.1016/j.cell.2006.10.048; Wozniak MA, 2004, BBA-MOL CELL RES, V1692, P103, DOI 10.1016/j.bbamcr.2004.04.007; Xu YF, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1351-5; Xue W, 2008, GENE DEV, V22, P1439, DOI 10.1101/gad.1672608; Yamashita H, 2014, J CELL SCI, V127, P1875, DOI 10.1242/jcs.133645; Yao MX, 2014, SCI REP-UK, V4, DOI 10.1038/srep04610; Ye F, 2014, FRONT MED-PRC, V8, P6, DOI 10.1007/s11684-014-0317-3; Zhang W, 2015, CANCER CELL INT, V15, DOI 10.1186/s12935-015-0189-x; Zhang X, 2008, NAT CELL BIOL, V10, P1062, DOI 10.1038/ncb1765; Zhu JH, 2008, MOL CELL, V32, P849, DOI 10.1016/j.molcel.2008.11.018	130	46	50	1	30	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2016	30	6					2073	2085		10.1096/fj.201500080R	http://dx.doi.org/10.1096/fj.201500080R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DN2FA	27252130				2022-12-28	WOS:000376878300002
J	Yamazaki, R; Kasuya, Y; Fujita, T; Umezawa, H; Yanagihara, M; Nakamura, H; Yoshino, I; Tatsumi, K; Murayama, T				Yamazaki, Risa; Kasuya, Yoshitoshi; Fujita, Tetsuo; Umezawa, Hiroki; Yanagihara, Madoka; Nakamura, Hiroyuki; Yoshino, Ichiro; Tatsumi, Koichiro; Murayama, Toshihiko			Antifibrotic effects of cyclosporine A on TGF-beta 1-treated lung fibroblasts and lungs from bleomycin-treated mice: role of hypoxia-inducible factor-1 alpha	FASEB JOURNAL			English	Article						pulmonary fibrosis; immunosuppressants; dedifferentiation	IDIOPATHIC PULMONARY-FIBROSIS; SMOOTH MUSCLE ACTIN; TGF-BETA; MYOFIBROBLAST DIFFERENTIATION; PROSTAGLANDIN E-2; HIF-1-ALPHA; AZATHIOPRINE; MACROPHAGES; INHIBITION; PREDNISONE	Idiopathic pulmonary fibrosis (IPF) is a chronic lung disorder that is characterized by aberrant tissue remodeling and the formation of fibroblastic foci that are composed of fibrogenic myofibroblasts. TGF-beta 1 is one of the factors that are responsible for fibrosis as it promotes fibroblast to myofibroblast differentiation (FMD) and is associated with up-regulation of a-smooth muscle actin. Therefore, inhibition of FMD may represent an effective strategy for the treatment of IPF. Here, we describe the treatment of human lung fibroblasts (WI-38 and HFL-1 cells) with cyclosporine A (CsA), which reduces TGF-beta 1-induced FMD via degradation of hypoxia-inducible factor-1 alpha (HIF-1 alpha). In addition, in primary myofibroblast-like cells that were obtained from a patient with pulmonary fibrosis, treatment with CsA and an HIF-1 alpha inhibitor (HIFi) decreased the expression levels of a-smooth muscle actin and fibronectin, which indicated that CsA and HIFi promote dedifferentiation of myofibroblasts. In mice intratracheally administered CsA or HIFi at an early fibrotic stage [ 7, 8, and 9 d postinstillation (dpi) of bleomycin], marked alleviation of lung fibrosis was observed at 14 dpi. These results suggest that CsA exhibits antifibrotic effects by degrading HIF-1 alpha and that the CsA-HIF-1 alpha axis provides new insights into therapeutic options for the treatment of IPF.	[Yamazaki, Risa; Yanagihara, Madoka; Nakamura, Hiroyuki; Murayama, Toshihiko] Chiba Univ, Chem Pharmacol Lab, Grad Sch Pharmaceut Sci, Chiba, Chiba, Japan; [Kasuya, Yoshitoshi; Fujita, Tetsuo; Umezawa, Hiroki] Chiba Univ, Dept Mol Pharmacol & Biochem, Grad Sch Med, Chiba, Chiba, Japan; [Kasuya, Yoshitoshi; Umezawa, Hiroki] Chiba Univ, Dept Biomed Sci, Grad Sch Med, Chiba, Chiba, Japan; [Fujita, Tetsuo; Umezawa, Hiroki; Tatsumi, Koichiro] Chiba Univ, Dept Respirol, Grad Sch Med, Chiba, Chiba, Japan; [Yoshino, Ichiro] Chiba Univ, Dept Gen Thorac Surg, Grad Sch Med, Chiba, Chiba, Japan	Chiba University; Chiba University; Chiba University; Chiba University; Chiba University	Kasuya, Y (corresponding author), Chiba Univ, Dept Biomed Sci, Grad Sch Med, Chuo Ku, Inohana 1-8-1, Chiba, Chiba 2608675, Japan.; Murayama, T (corresponding author), Chiba Univ, Chem Pharmacol Lab, Grad Sch Pharmaceut Sci, Chuo Ku, Inohana 1-8-1, Chiba, Chiba 2608675, Japan.	kasuya@faculty.chiba-u.jp; murayama-toshi@faculty.chiba-u.jp	Nakamura, Hiroyuki/B-4089-2015; Ichiro, Yoshino/HCH-1137-2022; Nakamura, Hiroyuki/AFV-2078-2022	Nakamura, Hiroyuki/0000-0001-6328-9727; Nakamura, Hiroyuki/0000-0001-6328-9727; Kasuya, Yoshitoshi/0000-0003-0614-5836; Yamazaki, Risa/0000-0001-9717-6763	Ministry of Education, Culture, Sports, Sciences, and Technology, Japan [23590106, 24390137]; Sasakawa Scientific Research Grant from Japan Science Society [26-509]	Ministry of Education, Culture, Sports, Sciences, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Sasakawa Scientific Research Grant from Japan Science Society	This work was supported by Grants 23590106 (to T.M.) and 24390137 (to Y.K.) from the Ministry of Education, Culture, Sports, Sciences, and Technology, Japan, and the Sasakawa Scientific Research Grant 26-509 (to R.Y.) from The Japan Science Society. The authors thank Drs. Tatsuo Kawashima and Yasuo Matsuzawa (Sakura Hospital Toho University, Sakura, Japan) for supplying reagents and information. The authors also thank Dr. Masahiko Hatano (Chiba University) for conceptual advice.	Abdul-Hafez A, 2009, FASEB J, V23, P1655, DOI 10.1096/fj.08-114611; Amer Thoracic Soc, 2000, AM J RESP CRIT CARE, V161, P646; Bardos JI, 2005, BBA-REV CANCER, V1755, P107, DOI 10.1016/j.bbcan.2005.05.001; Berchner-Pfannschmidt U, 2008, J BIOL CHEM, V283, P31745, DOI 10.1074/jbc.M804390200; D'Angelo G, 2003, J BIOL CHEM, V278, P15406, DOI 10.1074/jbc.M211293200; Dackor RT, 2011, AM J PHYSIOL-LUNG C, V301, pL645, DOI 10.1152/ajplung.00176.2011; Driesen RB, 2014, CARDIOVASC RES, V101, P411, DOI 10.1093/cvr/cvt338; du Bois RM, 2010, NAT REV DRUG DISCOV, V9, P129, DOI 10.1038/nrd2958; Evans RA, 2003, EXP CELL RES, V282, P90, DOI 10.1016/S0014-4827(02)00015-0; Garrison G, 2013, AM J RESP CELL MOL, V48, P550, DOI 10.1165/rcmb.2012-0262OC; Geng JJ, 2014, BBA-MOL BASIS DIS, V1842, P1770, DOI 10.1016/j.bbadis.2014.06.008; GURUJEYALAKSHMI G, 1995, EXP LUNG RES, V21, P791, DOI 10.3109/01902149509050842; Han WQ, 2013, BBA-MOL CELL RES, V1833, P1454, DOI 10.1016/j.bbamcr.2013.02.029; Hashimoto S, 2001, AM J RESP CRIT CARE, V163, P152, DOI 10.1164/ajrccm.163.1.2005069; Hecker L, 2011, EXP CELL RES, V317, P1914, DOI 10.1016/j.yexcr.2011.03.016; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hu B, 2003, AM J RESP CELL MOL, V29, P397, DOI 10.1165/rcmb.2003-0063OC; Huebner RH, 2008, BIOTECHNIQUES, V44, P507, DOI 10.2144/000112729; Kasai H, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-56; Kawashima T, 2012, EUR J PHARMACOL, V696, P120, DOI 10.1016/j.ejphar.2012.09.038; Kendall RT, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00123; Kim KE, 2008, IMMUNOPHARM IMMUNOT, V30, P105, DOI [10.1080/08923970701812662, 10.1080/08923970701812662 ]; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; King TE, 2001, AM J RESP CRIT CARE, V164, P1171, DOI 10.1164/ajrccm.164.7.2003140; King TE, 2001, AM J RESP CRIT CARE, V164, P1025, DOI 10.1164/ajrccm.164.6.2001056; Kobayashi T, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0261-z; Kosla J, 2013, EUR J CELL BIOL, V92, P363, DOI 10.1016/j.ejcb.2013.10.013; Kottmann RM, 2012, AM J RESP CRIT CARE, V186, P740, DOI 10.1164/rccm.201201-0084OC; McMahon S, 2006, J BIOL CHEM, V281, P24171, DOI 10.1074/jbc.M604507200; Meltzer EB, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-8; Papiris SA, 2015, BMC PULM MED, V15, DOI 10.1186/s12890-015-0146-4; Penke LRK, 2014, J BIOL CHEM, V289, P17151, DOI 10.1074/jbc.M114.558130; RAGHU G, 1991, AM REV RESPIR DIS, V144, P291, DOI 10.1164/ajrccm/144.2.291; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Rahimi RA, 2007, J CELL BIOCHEM, V102, P593, DOI 10.1002/jcb.21501; Reddy AT, 2014, FASEB J, V28, P5299, DOI 10.1096/fj.14-256263; Sakamoto S, 2010, INTERNAL MED, V49, P109, DOI 10.2169/internalmedicine.49.2359; Staitieh BS, 2015, ANN MED, V47, P100, DOI 10.3109/07853890.2014.991751; Tanaka K, 2014, LAB INVEST, V94, P1247, DOI 10.1038/labinvest.2014.109; Thannickal Victor J, 2006, Proc Am Thorac Soc, V3, P350, DOI 10.1513/pats.200601-001TK; Tomasek JJ, 2002, NAT REV MOL CELL BIO, V3, P349, DOI 10.1038/nrm809; Ueno M, 2011, AM J PHYSIOL-LUNG C, V300, pL740, DOI 10.1152/ajplung.00146.2010; Verma S, 2007, NEW ENGL J MED, V356, P1370, DOI 10.1056/NEJMcibr070490; Watanabe T, 2014, ARCH ORAL BIOL, V59, P595, DOI 10.1016/j.archoralbio.2014.03.003; Wettlaufer SH, 2016, AM J RESP CELL MOL, V54, P114, DOI 10.1165/rcmb.2014-0468OC; Yamauchi K, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-131; Zhou QY, 2011, FASEB J, V25, P3032, DOI 10.1096/fj.10-177824; Zhu Y, 2016, J CELL MOL MED, V20, P688, DOI 10.1111/jcmm.12769	48	24	25	0	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3359	3371		10.1096/fj.201601357R	http://dx.doi.org/10.1096/fj.201601357R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28446589				2022-12-28	WOS:000405932400015
J	Geng, PY; Zhang, Y; Liu, XQ; Zhang, N; Liu, YQ; Liu, X; Lin, C; Yan, X; Li, ZW; Wang, GN; Li, YX; Tan, J; Liu, DX; Huang, BQ; Lu, J				Geng, Pengyu; Zhang, Yu; Liu, Xiaoqing; Zhang, Na; Liu, Yingqi; Liu, Xin; Lin, Cong; Yan, Xu; Li, Zhongwei; Wang, Guannan; Li, Yuxin; Tan, Jiang; Liu, Dong-Xu; Huang, Baiqu; Lu, Jun			Automethylation of protein arginine methyltransferase 7 and its impact on breast cancer progression	FASEB JOURNAL			English	Article						migration; invasion; E-cadherin; YY1	TO-MESENCHYMAL TRANSITION; MASS-SPECTROMETRY; METHYLATION; PRMT7; TRANSCRIPTION; METASTASIS; EXPRESSION; YY1; CONTRIBUTES; SPECIFICITY	Protein arginine methyltransferases (PRMTs) catalyze protein arginine methylation and are linked to carcinogenesis and metastasis. Some members of PRMTs have been found to undergo automethylation; however, the biologic significance of this self-modification is not entirely clear. In this report, we demonstrate that R531 of PRMT7 is self-methylated, both in vitro and in vivo. Automethylation of PRMT7 plays a key role in inducing the epithelial-mesenchymal transition (EMT) program and in promoting the migratory and invasive behavior of breast cancer cells. We also prove in a nude mouse model that expression of wild-type PRMT7 in MCF7 breast cancer cells promotes metastasis in vivo, in contrast to the PRMT7 R531K mutant (a mimic of the unmethylated status). Moreover, our immunohistochemical data unravel a close link between PRMT7 automethylation and the clinical outcome of breast carcinomas. Mechanistically, we determine that loss of PRMT7 automethylation leads to the reduction of its recruitment to the E-cadherin promoter by YY1, which consequently derepresses the E-cadherin expression through decreasing the H4R3me2s level. The findings in this work define a novel post-translational modification of PRMT7 that has a promoting impacton breast cancer metastasis.	[Geng, Pengyu; Zhang, Yu; Zhang, Na; Liu, Xin; Tan, Jiang; Lu, Jun] Northeast Normal Univ, Inst Genet & Cytol, 5268 Renmin St, Changchun 130024, Peoples R China; [Liu, Xiaoqing; Liu, Yingqi; Lin, Cong; Li, Zhongwei; Huang, Baiqu] Northeast Normal Univ, Key Lab Mol Epigenet, Minist Educ, Changchun, Peoples R China; [Wang, Guannan; Li, Yuxin] Northeast Normal Univ, Natl Engn Lab Druggable Gene & Prot Screening, Changchun, Peoples R China; [Yan, Xu] Jilin Univ, Hosp 1, Pathol Diagnost Ctr, Changchun, Peoples R China; [Liu, Dong-Xu] Auckland Univ Technol, Sch Sci, Fac Hlth & Environm Sci, Auckland, New Zealand	Northeast Normal University - China; Northeast Normal University - China; Northeast Normal University - China; Jilin University; Auckland University of Technology	Lu, J (corresponding author), Northeast Normal Univ, Inst Genet & Cytol, 5268 Renmin St, Changchun 130024, Peoples R China.; Huang, BQ (corresponding author), Normal Univ, Key Lab Mol Epigenet, Minist Educ, Beijing, Peoples R China.	huangbq705@nenu.edu.cn; luj809@nenu.edu.cn	li, Yu/HCI-9086-2022; Li, yu/HHZ-5236-2022; Li, yuxin/GSD-1668-2022; li, yu/HGL-9518-2022	Li, Zhongwei/0000-0003-1014-4238	Natural Science Foundation of China [31570718, 31571317, 31571478, 31401105, 31371294]; Jilin Scientific and Technological Development Program [20140520003JH]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jilin Scientific and Technological Development Program	The authors thank Dr. Graydon B. Gonsalvez (Case Western Reserve University, Cleveland, OH, USA) for providing the plasmids. This work was supported in part by Natural Science Foundation of China Grants 31570718, 31571317, 31571478, 31401105, and 31371294; and Jilin Scientific and Technological Development Program Grant 20140520003JH. The authors declare no conflicts of interest.	Baldwin RM, 2015, ONCOTARGET, V6, P3013, DOI 10.18632/oncotarget.3072; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bedford MT, 2005, MOL CELL, V18, P263, DOI 10.1016/j.molcel.2005.04.003; Blanc RS, 2016, CELL REP, V14, P1528, DOI 10.1016/j.celrep.2016.01.022; Blanchet F, 2005, J EXP MED, V202, P371, DOI 10.1084/jem.20050176; Boisvert Francois-Michel, 2005, Sci STKE, V2005, pre2, DOI 10.1126/stke.2712005re2; Casas E, 2011, CANCER RES, V71, P245, DOI 10.1158/0008-5472.CAN-10-2330; Debler EW, 2016, P NATL ACAD SCI USA, V113, P2068, DOI 10.1073/pnas.1525783113; Dhar SS, 2012, GENE DEV, V26, P2749, DOI 10.1101/gad.203356.112; Dillon MBC, 2013, J BIOL CHEM, V288, P27872, DOI 10.1074/jbc.M113.491092; Fang Y., 2014, COMPLEXITY, V2014, P1, DOI DOI 10.1016/J.CELREP.2014.03.032; Feng Y, 2013, J BIOL CHEM, V288, P37010, DOI 10.1074/jbc.M113.525345; Gary JD, 1998, PROG NUCLEIC ACID RE, V61, P65, DOI 10.1016/S0079-6603(08)60825-9; Guo AL, 2014, MOL CELL PROTEOMICS, V13, P372, DOI 10.1074/mcp.O113.027870; Hasegawa M, 2014, FEBS LETT, V588, P1942, DOI 10.1016/j.febslet.2014.03.053; Hou P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.249; Huq MDM, 2006, EMBO J, V25, P5094, DOI 10.1038/sj.emboj.7601389; Karkhanis V, 2012, J BIOL CHEM, V287, P29801, DOI 10.1074/jbc.M112.378281; Kuhn P, 2011, NUCLEIC ACIDS RES, V39, P2717, DOI 10.1093/nar/gkq1246; Kuhn P, 2009, PROTEIN SCI, V18, P1272, DOI 10.1002/pro.139; Lee SH, 2016, NUCLEIC ACIDS RES, V44, P10603, DOI 10.1093/nar/gkw788; Liu X, 2016, BBA-MOL CELL RES, V1863, P2093, DOI 10.1016/j.bbamcr.2016.05.009; Miranda TB, 2004, J BIOL CHEM, V279, P22902, DOI 10.1074/jbc.M312904200; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; Niu LF, 2012, PROTEIN CELL, V3, P450, DOI 10.1007/s13238-012-2935-3; Peinado HC, 2004, INT J DEV BIOL, V48, P365, DOI 10.1387/ijdb.041794hp; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; SETO E, 1991, NATURE, V354, P241, DOI 10.1038/354241a0; Shi JM, 2015, CURR CANCER DRUG TAR, V15, P145, DOI 10.2174/1568009615666150131124200; Shi Y, 1997, BBA-REV CANCER, V1332, pF49, DOI 10.1016/S0304-419X(96)00044-3; SHI Y, 1991, CELL, V67, P377, DOI 10.1016/0092-8674(91)90189-6; Singhroy DN, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-73; Trask MC, 2012, DEV BIOL, V368, P273, DOI 10.1016/j.ydbio.2012.05.031; Wang X, 2008, ONCOGENE, V27, P1894, DOI 10.1038/sj.onc.1210821; WILLIAMSASHMAN HG, 1982, BIOCHEM PHARMACOL, V31, P277, DOI 10.1016/0006-2952(82)90171-X; Yao RS, 2014, CANCER RES, V74, P5656, DOI 10.1158/0008-5472.CAN-14-0800; Ying ZZ, 2015, J IMMUNOL, V195, P1538, DOI 10.4049/jimmunol.1500224; Zhang JC, 2012, CANCER RES, V72, P4597, DOI 10.1158/0008-5472.CAN-12-1045; Zhang WJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep21718; Zhao L, 2015, CELL DEATH DIFFER, V22, P1630, DOI 10.1038/cdd.2015.6; Zurita-Lopez CI, 2012, J BIOL CHEM, V287, P7859, DOI 10.1074/jbc.M111.336271	41	35	36	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2287	2300		10.1096/fj.201601196R	http://dx.doi.org/10.1096/fj.201601196R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28188177				2022-12-28	WOS:000401553400007
J	Honjo, K; Munakata, S; Tashiro, Y; Salama, Y; Shimazu, H; Eiamboonsert, S; Dhahri, D; Ichimura, A; Dan, T; Miyata, T; Takeda, K; Sakamoto, K; Hattori, K; Heissig, B				Honjo, Kumpei; Munakata, Shinya; Tashiro, Yoshihiko; Salama, Yousef; Shimazu, Hiroshi; Eiamboonsert, Salita; Dhahri, Douaa; Ichimura, Atsuhiko; Dan, Takashi; Miyata, Toshio; Takeda, Kazuyoshi; Sakamoto, Kazuhiro; Hattori, Koichi; Heissig, Beate			Plasminogen activator inhibitor-1 regulates macrophage-dependent postoperative adhesion by enhancing EGF-HER1 signaling in mice	FASEB JOURNAL			English	Article						small bowel obstruction; epidermal growth factor; PAI-1; plasminogen activator; mesothelial cell	MESOTHELIAL CELLS; PAI-1 EXPRESSION; PREVENTION; MIGRATION; MATRIX; MOLECULE; FIBROSIS; RELEASE	Adhesive small bowel obstruction remains a common problem for surgeons. After surgery, platelet aggregation contributes to coagulation cascade and fibrin clot formation. With clotting, fibrin degradation is simultaneously enhanced, driven by tissue plasminogen activator-mediated cleavage of plasminogen to form plasmin. The aim of this study was to investigate the cellular events and proteolytic responses that surround plasminogen activator inhibitor (PAI-1; Serpine1) inhibition of postoperative adhesion. Peritoneal adhesion was induced by gauze deposition in the abdominal cavity in C57BL/6 mice and those that were deficient in fibrinolytic factors, such as Plat(-/-) and Serpine1(-/-) . In addition, C57BL/6 mice were treated with the novel PAI-1 inhibitor, TM5275. Some animals were treated with clodronate to deplete macrophages. Epidermal growth factor (EGF) experiments were performed to understand the role of macrophages and how EGF contributes to adhesion. In the early phase of adhesive small bowel obstruction, increased PAI-1 activity was observed in the peritoneal cavity. Genetic and pharmacologic PAI-1 inhibition prevented progression of adhesion and increased circulating plasmin. Whereas Serpine1(-/-) mice showed intra-abdominal bleeding, mice that were treated with TM5275 did not. Mechanistically, PAI-1, in combination with tissue plasminogen activator, served as a chemoattractant for macrophages that, in turn, secreted EGF and up-regulated the receptor, HER1, on peritoneal mesothelial cells, which led to PAI-1 secretion, further fueling the vicious cycle of impaired fibrinolysis at the adhesive site. Controlled inhibition of PAI-1 not only enhanced activation of the fibrinolytic system, but also prevented recruitment of EGF-secreting macrophages. Pharmacologic PAI-1 inhibition ameliorated adhesion formation in a macrophage-dependent manner.	[Honjo, Kumpei; Munakata, Shinya; Tashiro, Yoshihiko; Salama, Yousef; Shimazu, Hiroshi; Eiamboonsert, Salita; Dhahri, Douaa; Hattori, Koichi; Heissig, Beate] Univ Tokyo, Inst Med Sci, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Dynam, Tokyo, Japan; [Honjo, Kumpei; Munakata, Shinya; Tashiro, Yoshihiko; Sakamoto, Kazuhiro] Juntendo Univ, Grad Sch Med, Dept Coloproctol Surg, Tokyo, Japan; [Hattori, Koichi] Juntendo Univ, Grad Sch Med, Fac Med, Ctr Genom & Regenerat Med, Tokyo, Japan; [Takeda, Kazuyoshi; Heissig, Beate] Juntendo Univ, Grad Sch Med, Dept Immunol, Tokyo, Japan; [Takeda, Kazuyoshi; Heissig, Beate] Juntendo Univ, Grad Sch Med, Atopy Ctr, Tokyo, Japan; [Ichimura, Atsuhiko; Dan, Takashi; Miyata, Toshio] Tohoku Univ, Grad Sch Med, United Ctr Adv Res & Translat Med, Sendai, Miyagi, Japan	University of Tokyo; Juntendo University; Juntendo University; Juntendo University; Juntendo University; Tohoku University	Heissig, B (corresponding author), IMSUT, Ctr Stem Cell Biol & Regenerat Med, Div Stem Cell Dynam, Minato Ku, 4-6-1 Shirokanedai, Tokyo 1088639, Japan.	heissig@ims.u-tokyo.ac.jp	Miyata, Toshio/A-4872-2010; Heissig, Beate/AAF-6771-2021; Hattori, Koichi/AAF-6862-2021; Al-Dhahri, Douaa/AAA-8324-2019; salama, Yousef/AAP-8365-2021	Heissig, Beate/0000-0002-0348-5934; Shimazu, Hiroshi/0000-0002-1240-936X; Ichimura, Atsuhiko/0000-0003-0366-5211; AL-Dhahri, Douaa/0000-0003-0141-1728; Salama, Yousef/0000-0001-6254-6381	Japan Society for the Promotion of Science [16K09821, 26461415]; Start-Up Grant [15H06603]; Wakate B Grant [15K21373]; Ministry of Education, Culture, Sports, Science and Technology [18013021];  [22112007]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Start-Up Grant; Wakate B Grant; Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); 	The authors thank Robert Whittier (Juntendo University Faculty of Medicine) for kindly providing editorial assistance to the authors during the preparation of this manuscript. The authors thank the Division of Molecular and Biochemical Research, Research Support Center (Juntendo University Graduate School of Medicine) for technical assistance. This work was supported, in part, by Grants-in-Aid for Scientific Research from the Japan Society for the Promotion of Science [Kiban-C Grant 16K09821 (to B.H.), Grant 26461415 (to K.H.), Start-Up Grant 15H06603 (to S.M.), and Wakate B Grant 15K21373 (to Y.T.)], and by Grants-in-Aid for Scientific Research from The Ministry of Education, Culture, Sports, Science and Technology (Grant 18013021; to B.H.), and Grants-in-Aid for Scientific Research on Innovative Areas (Grant 22112007; to B.H.).	Asano T, 2005, BJU INT, V96, P1409, DOI 10.1111/j.1464-410X.2005.05816.x; Bauman KA, 2010, J CLIN INVEST, V120, P1950, DOI 10.1172/JCI38369; Burnett SH, 2006, J SURG RES, V131, P296, DOI 10.1016/j.jss.2005.08.026; Cao CZ, 2006, EMBO J, V25, P1860, DOI 10.1038/sj.emboj.7601082; Cho HJ, 2009, J CELL BIOCHEM, V107, P335, DOI 10.1002/jcb.22130; diZeregal GS, 2001, HUM REPROD UPDATE, V7, P547, DOI 10.1093/humupd/7.6.547; Eddy AA, 2009, THROMB HAEMOSTASIS, V101, P656, DOI 10.1160/TH08-12-0779; Ergul Emre, 2008, Int J Surg, V6, P253, DOI 10.1016/j.ijsu.2007.05.010; FUKASAWA M, 1989, J SURG RES, V46, P256, DOI 10.1016/0022-4804(89)90067-X; Heissig B, 2016, ADV DRUG DELIVER REV, V99, P172, DOI 10.1016/j.addr.2015.11.010; Higgins Stephen P, 2009, Cell Commun Insights, V2, P1; HillWest JL, 1995, J SURG RES, V59, P759, DOI 10.1006/jsre.1995.1236; Holmdahl L, 1997, EUR J SURG, V163, P24; Holmdahl L, 2001, SURGERY, V129, P626, DOI 10.1067/msy.2001.113039; Ichimura A, 2013, ARTERIOSCL THROM VAS, V33, P935, DOI 10.1161/ATVBAHA.113.301224; Izuhara Y, 2010, J CEREBR BLOOD F MET, V30, P904, DOI 10.1038/jcbfm.2009.272; Jankun Jerzy, 2013, Cardiovascular & Hematological Disorders - Drug Targets, V13, P144; Kalff JC, 1998, ANN SURG, V228, P652, DOI 10.1097/00000658-199811000-00004; Kosaka H, 2008, NAT MED, V14, P437, DOI 10.1038/nm1733; Lin L, 2014, AM J PATHOL, V184, P2757, DOI 10.1016/j.ajpath.2014.06.013; Maciver AH, 2011, INT J SURG, V9, P589, DOI 10.1016/j.ijsu.2011.08.008; MENZIES D, 1991, SURG GYNECOL OBSTET, V172, P362; Munakata S, 2015, GASTROENTEROLOGY, V148, P565, DOI 10.1053/j.gastro.2014.12.001; Ohki M, 2010, BLOOD, V115, P4302, DOI 10.1182/blood-2009-08-236851; Paugh BS, 2008, FASEB J, V22, P455, DOI 10.1096/fj.07-8276com; Samarakoon R, 2005, J CELL PHYSIOL, V204, P236, DOI 10.1002/jcp.20279; Sato A, 2015, LEUKEMIA, V29, P145, DOI 10.1038/leu.2014.151; Schultz GS, 2009, WOUND REPAIR REGEN, V17, P153, DOI 10.1111/j.1524-475X.2009.00466.x; Sulaiman H, 2002, BIOCHEM SOC T, V30, P126, DOI 10.1042/BST0300126; Szaba FM, 2002, BLOOD, V99, P1053, DOI 10.1182/blood.V99.3.1053; Tjarnstrom J, 1999, EUR J SURG, V165, P834; VANHINSBERGH VWM, 1990, BLOOD, V75, P1490; Wang L, 2016, J AM SOC NEPHROL, V27, P2631, DOI 10.1681/ASN.2015030299; Wirtz S, 2007, NAT PROTOC, V2, P541, DOI 10.1038/nprot.2007.41; Wyrzykowska P, 2010, BBA-GENE REGUL MECH, V1799, P616, DOI 10.1016/j.bbagrm.2010.08.004	36	30	31	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2625	2637		10.1096/fj.201600871RR	http://dx.doi.org/10.1096/fj.201600871RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28270519	Green Submitted			2022-12-28	WOS:000401553400033
J	Deb, DK; Bao, RY; Li, YC				Deb, Dilip K.; Bao, Riyue; Li, Yan Chun			Critical role of the cAMP-PKA pathway in hyperglycemia-induced epigenetic activation of fibrogenic program in the kidney	FASEB JOURNAL			English	Article						diabetic complication; renal fibrosis; histone acetylation; ChIP-Seq; protein kinase A	VITAMIN-D-RECEPTOR; EMBRYONIC STEM-CELLS; MODEL-BASED ANALYSIS; CHIP-SEQ MACS; DIABETIC-NEPHROPATHY; HISTONE ACETYLATION; GENE-EXPRESSION; MESANGIAL CELLS; HUMAN MONOCYTES; GROWTH-FACTOR	Hyperglycemia is a major pathogenic factor that promotes diabetic nephropathy, but the underlying mechanism remains incompletely understood. Here, we show that high glucose induced cAMP response element-binding protein (CREB)-binding protein (CBP)-mediated H3K9/14 hyperacetylation in approximately 5000 gene promoters in glomerular mesangial cells, including those of Tgfb1, Tgfb3, and Ctgf, the major profibrotic factors that are known to drive diabetic renal fibrogenesis. In these promoters, H3K9/14 hyperacetylation was closely associated with NF-kappa B or CREB motifs. Chromatin immunoprecipitation assays confirmed that hyperglycemia promoted phospho-p65 or phospho-CREB and CBP bindings and RNA polymerase II recruitment to these promoters in mesangial cells as well as in glomeruli that were purified from type I and type II diabetic mice. Under hyperglycemia, cAMP production and PKA activity were markedly increased as a result of glucose transporter 1-mediated glucose influx that drives glucose metabolism and ATP production, which led to increased phosphorylation of p65 and CREB. Inhibition of adenylyl cyclase or PKA activity blocked p65 and CREB phosphorylation, CBP recruitment, and histone acetylation in these promoters. Collectively, these data demonstrate that the cAMP-PKA pathway plays a key role in epigenetic regulation of key profibrotic factors in diabetes.-Deb, D. K., Bao, R., Li, Y. C. Critical role of the cAMP-PKA pathway in hyperglycemia-induced epigenetic activation of fibrogenic program in the kidney.	[Deb, Dilip K.; Li, Yan Chun] Univ Chicago, Dept Med, 900 E 57th St,KCBD 9110, Chicago, IL 60637 USA; [Bao, Riyue] Univ Chicago, Ctr Res Informat, Div Biol Sci, Chicago, IL 60637 USA	University of Chicago; University of Chicago	Li, YC (corresponding author), Univ Chicago, Dept Med, 900 E 57th St,KCBD 9110, Chicago, IL 60637 USA.	cyan@medicine.bsd.uchicago.edu			Genzyme Corp.; U.S. National Institutes of Health (NIH) Clinical and Translational Science [CTSA-NIH UL1 TR000430]; Center for Research Informatics of The University of Chicago Biological Science Division; NIH Institute for Translational Medicine [CTSA-NIH UL1 RR024999]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000430] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024999] Funding Source: NIH RePORTER	Genzyme Corp.(Sanofi-AventisGenzyme Corporation); U.S. National Institutes of Health (NIH) Clinical and Translational Science; Center for Research Informatics of The University of Chicago Biological Science Division; NIH Institute for Translational Medicine; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported in part by a Genzyme Renal Innovations Program research grant from the Genzyme Corp., U.S. National Institutes of Health (NIH) Clinical and Translational Science Award Grant CTSA-NIH UL1 TR000430, the Center for Research Informatics of The University of Chicago Biological Science Division, and the NIH Institute for Translational Medicine Grant CTSA-NIH UL1 RR024999. The authors declare no conflicts of interest.	Bedford DC, 2010, EPIGENETICS-US, V5, P9, DOI 10.4161/epi.5.1.10449; Birukova AA, 2004, AM J PHYSIOL-LUNG C, V287, pL86, DOI 10.1152/ajplung.00441.2003; Brasacchio D, 2009, DIABETES, V58, P1229, DOI 10.2337/db08-1666; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Centers for Disease Control and Prevention, 2014, 2014 NAT DIAB STAT R; Chen Y, 2013, J BIOL CHEM, V288, P19450, DOI 10.1074/jbc.M113.467670; Cooper ME, 1998, LANCET, V352, P213, DOI 10.1016/S0140-6736(98)01346-4; de Boer IH, 2011, ARCH INTERN MED, V171, P412, DOI 10.1001/archinternmed.2011.16; Eberharter A, 2002, EMBO REP, V3, P224, DOI 10.1093/embo-reports/kvf053; El-Osta A, 2008, J EXP MED, V205, P2409, DOI 10.1084/jem.20081188; GILBERT SF, 1975, CELL, V5, P11, DOI 10.1016/0092-8674(75)90086-0; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Gupta S, 2000, KIDNEY INT, V58, P1389, DOI 10.1046/j.1523-1755.2000.00301.x; HEILIG C, 1995, LAB INVEST, V73, P674; Heilig CW, 1997, DIABETES, V46, P1030, DOI 10.2337/diabetes.46.6.1030; Hudkins KL, 2010, J AM SOC NEPHROL, V21, P1533, DOI 10.1681/ASN.2009121290; Kamenetsky M, 2006, J MOL BIOL, V362, P623, DOI 10.1016/j.jmb.2006.07.045; Karmodiya K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-424; Kato M, 2014, NAT REV NEPHROL, V10, P517, DOI 10.1038/nrneph.2014.116; Kharchenko PV, 2008, NAT BIOTECHNOL, V26, P1351, DOI 10.1038/nbt.1508; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; KURTZ A, 1983, P NATL ACAD SCI-BIOL, V80, P4008, DOI 10.1073/pnas.80.13.4008; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Li YC, 2001, AM J PHYSIOL-ENDOC M, V281, pE558, DOI 10.1152/ajpendo.2001.281.3.E558; Liu T, 2014, METHODS MOL BIOL, V1150, P81, DOI 10.1007/978-1-4939-0512-6_4; MARCUS RG, 1994, AM J PHYSIOL-RENAL, V267, pF816, DOI 10.1152/ajprenal.1994.267.5.F816; Mathelier A, 2014, NUCLEIC ACIDS RES, V42, pD142, DOI 10.1093/nar/gkt997; Miao F, 2008, J IMMUNOL, V180, P2264, DOI 10.4049/jimmunol.180.4.2264; Miao F, 2007, J BIOL CHEM, V282, P13854, DOI 10.1074/jbc.M609446200; Miao F, 2008, DIABETES, V57, P3189, DOI 10.2337/db08-0645; Montminy M, 1997, ANNU REV BIOCHEM, V66, P807, DOI 10.1146/annurev.biochem.66.1.807; Murata H, 1997, J INVEST DERMATOL, V108, P258, DOI 10.1111/1523-1747.ep12286451; Pichaiwong W, 2013, J AM SOC NEPHROL, V24, P1088, DOI 10.1681/ASN.2012050445; Pirola L, 2010, NAT REV ENDOCRINOL, V6, P665, DOI 10.1038/nrendo.2010.188; Qi ZH, 2005, DIABETES, V54, P2628, DOI 10.2337/diabetes.54.9.2628; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Ramos LS, 2008, J GEN PHYSIOL, V132, P329, DOI 10.1085/jgp.200810044; Reddy MA, 2015, DIABETOLOGIA, V58, P443, DOI 10.1007/s00125-014-3462-y; Reidy K, 2014, J CLIN INVEST, V124, P2333, DOI 10.1172/JCI72271; Schaan BD, 2001, HORM METAB RES, V33, P664, DOI 10.1055/s-2001-18683; Schiltz RL, 1999, J BIOL CHEM, V274, P1189, DOI 10.1074/jbc.274.3.1189; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Steffes MW, 2003, JAMA-J AM MED ASSOC, V290, P2159, DOI 10.1001/jama.290.16.2159; Sun GD, 2010, J AM SOC NEPHROL, V21, P2069, DOI 10.1681/ASN.2010060633; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Taylor SS, 2012, NAT REV MOL CELL BIO, V13, P646, DOI 10.1038/nrm3432; Wellen KE, 2009, SCIENCE, V324, P1076, DOI 10.1126/science.1164097; Yu L, 2003, KIDNEY INT, V64, P844, DOI 10.1046/j.1523-1755.2003.00162.x; Yuan WH, 2007, J BIOL CHEM, V282, P29821, DOI 10.1074/jbc.M705495200; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhang Z, 2008, KIDNEY INT, V73, P163, DOI 10.1038/sj.ki.5002572; Zhong HH, 1998, MOL CELL, V1, P661, DOI 10.1016/S1097-2765(00)80066-0; Ziyadeh FN, 2004, J AM SOC NEPHROL, V15, pS55, DOI 10.1097/01.ASN.0000093460.24823.5B; ZIYADEH FN, 1994, J CLIN INVEST, V93, P536, DOI 10.1172/JCI117004	57	32	36	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2065	2075		10.1096/fj.201601116R	http://dx.doi.org/10.1096/fj.201601116R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28148567	Green Published			2022-12-28	WOS:000399195500026
J	Fukuta, T; Asai, T; Yanagida, Y; Namba, M; Koide, H; Shimizu, K; Oku, N				Fukuta, Tatsuya; Asai, Tomohiro; Yanagida, Yosuke; Namba, Mio; Koide, Hiroyuki; Shimizu, Kosuke; Oku, Naoto			Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke	FASEB JOURNAL			English	Article						blood-brain barrier; drug delivery system; fasudil; photochemically induced thrombosis; liposome	MIDDLE CEREBRAL-ARTERY; RHO-KINASE; HEMORRHAGIC TRANSFORMATION; TIME WINDOW; MATRIX METALLOPROTEINASES; PEGYLATED LIPOSOMES; REPERFUSION THERAPY; THROMBOSIS MODEL; BRAIN; INJURY	For ischemic stroke treatment, extension of the therapeutic time window(TTW) of thrombolytic therapy with tissue plasminogen activator (tPA) and amelioration of secondary ischemia/reperfusion (I/R) injury are most desirable. Our previous studies have indicated that liposomal delivery of neuroprotectants into an ischemic region is effective for stroke treatment. In the present study, for solving the above problems in the clinical setting, the usefulness of combination therapy with tPA and liposomal fasudil (fasudil-Lip) was investigated in ischemic stroke model rats with photochemically induced thrombosis, with clots that were dissolved by tPA. Treatment with tPA3 h after occlusion markedly increased blood-brain barrier permeability and activated matrix metalloproteinase (MMP)-2 and -9, which are involved in cerebralhemorrhage. However, an intravenous administration of fasudil-Lip before tPA markedly suppressed the increase in permeability and the MMP activation stemming from tPA. The combination treatment showed significantly larger neuroprotective effects, even in the case of delayed tPA administration compared with each treatment alone or the tPA/fasudil-treated group. These findings suggest that treatment with fasudil-Lip before tPA could decrease the risk of tPA-derived cerebral hemorrhage and extend the TTW of tPA and that the combination therapy could be a useful therapeutic option for ischemic stroke.-Fukuta, T., Asai, T., Yanagida, Y., Namba, M., Koide, H., Shimizu, K., Oku, N. Combination therapy with liposomal neuroprotectants and tissue plasminogen activator for treatment of ischemic stroke.	[Fukuta, Tatsuya; Asai, Tomohiro; Yanagida, Yosuke; Namba, Mio; Koide, Hiroyuki; Shimizu, Kosuke; Oku, Naoto] Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Shizuoka, Japan; [Fukuta, Tatsuya] Japan Soc Promot Sci, Tokyo, Japan	University of Shizuoka; Japan Society for the Promotion of Science	Oku, N (corresponding author), Univ Shizuoka, Sch Pharmaceut Sci, Dept Med Biochem, Suruga Ku, 52-1 Yada, Shizuoka 4228526, Japan.	oku@u-shizuoka-ken.ac.jp		Fukuta, Tatsuya/0000-0001-8878-8602; Shimizu, Kosuke/0000-0003-3789-2447	Japan Society for the Promotion of Science [14J10730, 16H05081]; Research Grants in the Natural Sciences of the Mitsubishi Foundation; Grants-in-Aid for Scientific Research [15H02569] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Research Grants in the Natural Sciences of the Mitsubishi Foundation; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Asahi Kasei Pharma Corp. (Tokyo, Japan) for the gift of fasudil; Norihiro Harada and Dai Fukumoto (Hamamatsu Photonics PET Center, Minamisoma, Japan) for their technical guidance in preparing MCAO rats by the PIT method. This research was supported by Grants-in-Aid for Scientific Research 14J10730 and 16H05081 from the Japan Society for the Promotion of Science, and by the Research Grants in the Natural Sciences of the Mitsubishi Foundation.	Chamorro A, 2016, LANCET NEUROL, V15, P869, DOI 10.1016/S1474-4422(16)00114-9; Cuadrado E, 2008, J LEUKOCYTE BIOL, V84, P207, DOI 10.1189/jlb.0907606; del Zoppo GJ, 2003, J CEREBR BLOOD F MET, V23, P879, DOI 10.1097/01.WCB.0000078322.96027.78; del Zoppo GJ, 2009, CEREBROVASC DIS, V27, P65, DOI 10.1159/000200442; Emberson J, 2014, LANCET, V384, P1929, DOI 10.1016/S0140-6736(14)60584-5; Fagan SC, 2004, STROKE, V35, P2220, DOI 10.1161/01.STR.0000138023.60272.9e; Fukuta T, 2016, INT J PHARMACEUT, V506, P129, DOI 10.1016/j.ijpharm.2016.04.046; Fukuta T, 2015, EUR J PHARM BIOPHARM, V97, P1, DOI 10.1016/j.ejpb.2015.09.020; Fukuta T, 2014, ARTIF ORGANS, V38, P662, DOI 10.1111/aor.12350; Gibson CL, 2014, J NEUROCHEM, V129, P816, DOI 10.1111/jnc.12681; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Iadecola C, 2011, NAT NEUROSCI, V14, P1363, DOI 10.1038/nn.2953; Iadecola C, 2011, NAT MED, V17, P796, DOI 10.1038/nm.2399; Ishiguro M, 2012, NEUROSCIENCE, V220, P302, DOI 10.1016/j.neuroscience.2012.06.015; Ishii T, 2013, FASEB J, V27, P1362, DOI 10.1096/fj.12-221325; Ishii T, 2012, J CONTROL RELEASE, V160, P81, DOI 10.1016/j.jconrel.2012.02.004; Jickling GC, 2015, J CEREBR BLOOD F MET, V35, P888, DOI 10.1038/jcbfm.2015.45; Jickling GC, 2014, J CEREBR BLOOD F MET, V34, P185, DOI 10.1038/jcbfm.2013.203; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Justicia C, 2003, J CEREBR BLOOD F MET, V23, P1430, DOI 10.1097/01.WCB.0000090680.07515.C8; Lakhan SE, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00032; Lo EH, 2002, J NEUROSCI RES, V69, P1, DOI 10.1002/jnr.10270; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; Maeda M, 2002, J CEREBR BLOOD F MET, V22, P1205, DOI 10.1097/01.wcb.0000037993.34930.72; Mueller BK, 2005, NAT REV DRUG DISCOV, V4, P387, DOI 10.1038/nrd1719; Murata Y, 2008, STROKE, V39, P3372, DOI 10.1161/STROKEAHA.108.514026; NAGASAWA H, 1989, STROKE, V20, P1037, DOI 10.1161/01.STR.20.8.1037; Niego B, 2012, BLOOD, V119, P4752, DOI 10.1182/blood-2011-07-369512; O'Collins VE, 2012, J CEREBR BLOOD F MET, V32, P585, DOI 10.1038/jcbfm.2011.203; Rogalewski A, 2006, STROKE, V37, P1129, DOI 10.1161/01.STR.0000209330.73175.34; Satoh SI, 2008, BRAIN RES, V1193, P102, DOI 10.1016/j.brainres.2007.11.050; Shibuya M, 2005, J NEUROL SCI, V238, P31, DOI 10.1016/j.jns.2005.06.003; Shichita T, 2012, NAT MED, V18, P911, DOI 10.1038/nm.2749; Su EJ, 2008, NAT MED, V14, P731, DOI 10.1038/nm1787; Sutherland BA, 2012, INT J STROKE, V7, P407, DOI 10.1111/j.1747-4949.2012.00770.x; Tsukada H, 2014, J NUCL MED, V55, P473, DOI 10.2967/jnumed.113.125328; UMEMURA K, 1993, STROKE, V24, P1077, DOI 10.1161/01.STR.24.7.1077; Umemura K, 2007, PATHOPHYSIOL HAEMO T, V36, P245, DOI 10.1159/000252820; Vivien D, 2011, J CEREBR BLOOD F MET, V31, P2119, DOI 10.1038/jcbfm.2011.127; Wang W, 2015, MOL NEUROBIOL, V52, P1572, DOI 10.1007/s12035-014-8952-x; Wang XY, 2004, STROKE, V35, P2726, DOI 10.1161/01.STR.0000143219.16695.af; Yagita Y, 2007, J NEUROSCI RES, V85, P2460, DOI 10.1002/jnr.21375; Yemisci M, 2009, NAT MED, V15, P1031, DOI 10.1038/nm.2022	44	57	57	2	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1879	1890		10.1096/fj.201601209R	http://dx.doi.org/10.1096/fj.201601209R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28082354				2022-12-28	WOS:000399195500011
J	Gaviglio, AL; Knelson, EH; Blobe, GC				Gaviglio, Angela L.; Knelson, Erik H.; Blobe, Gerard C.			Heparin-binding epidermal growth factor-like growth factor promotes neuroblastoma differentiation	FASEB JOURNAL			English	Article						HBEGF; heparan sulfate; cancer; signaling; stroma	GENE-EXPRESSION; NEURONAL DIFFERENTIATION; NEUROTROPHIC FACTOR; SCHWANNIAN STROMA; MICROARRAY DATA; RETINOIC ACID; AURORA KINASE; IN-VITRO; RNA-SEQ; HB-EGF	High-risk neuroblastoma is characterized by undifferentiated neuroblasts and low schwannian stroma content. The tumor stroma contributes to the suppression of tumor growth by releasing soluble factors that promote neuroblast differentiation. Here we identify heparin-binding epidermal growth factor-like growth factor (HBEGF) as a potent prodifferentiating factor in neuroblastoma. HBEGF mRNA expression is decreased in human neuroblastoma tumors compared with benign tumors, with loss correlating with decreased survival. HBEGF protein is expressed only in stromal compartments of human neuroblastoma specimens, with tissue from high-stage disease containing very little stroma orHBEGF expression. In 3 human neuroblastoma cell lines (SK-N-AS, SK-N-BE2, and SH-SY5Y), soluble HBEGF is sufficient to promote neuroblast differentiation and decrease proliferation. Heparan sulfate proteoglycans and heparin derivatives further enhance HBEGF-induced differentiation by forming a complex with the epidermal growth factor receptor, leading to activation of the ERK1/2 and STAT3 pathways and up-regulation of the inhibitor of DNA binding transcription factor. These data support a role for loss of HBEGF in the neuroblastoma tumor microenvironment in neuroblastoma pathogenesis.-Gaviglio, A. L., Knelson, E. H., Blobe, G. C. Heparin-binding epidermal growth factor-like growth factor promotes neuroblastoma differentiation.	[Gaviglio, Angela L.; Blobe, Gerard C.] Duke Univ, Dept Pharmacol & Canc Biol, Durham, NC USA; [Knelson, Erik H.] Brigham & Womens Hosp, Dept Med, 75 Francis St, Boston, MA 02115 USA; [Blobe, Gerard C.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA	Duke University; Harvard University; Brigham & Women's Hospital; Duke University	Blobe, GC (corresponding author), Duke Univ, Med Ctr, Box 91004, Durham, NC 27708 USA.	gerard.blobe@duke.edu	Blobe, Gerard/AAJ-5945-2020	Blobe, Gerard/0000-0002-4274-8901; Knelson, Erik/0000-0003-4087-2017	U.S. National Institutes of Health, National Cancer Institute [F31CA192558]; Alex's Lemonade Stand Foundation Reach and Innovation; NATIONAL CANCER INSTITUTE [F31CA192558] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Alex's Lemonade Stand Foundation Reach and Innovation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in part, by U.S. National Institutes of Health, National Cancer Institute Grant F31CA192558 (to A.L.G.), and by a grant from the Alex's Lemonade Stand Foundation Reach and Innovation Grants (to G.C.B.). The authors thank Michael Armstrong (Duke University), the Children's Oncology Group Neuroblastoma Biology Subcommittee, Wendy London, and Evan Plunkett (both from the Children's Oncology Group) for assistance in obtaining patient tissue samples; Jennifer Huang for technical help with the animal experiment; David MacAlpine, Donald McDonnell, Ann Marie Pendergast, and Daniel Wechsler for crucial mentoring throughout this project; Elaine Justice for technical assistance; and Cheryl Alles (all from Duke University) for clerical assistance. The authors declare no conflicts of interest.	Albino D, 2008, CANCER-AM CANCER SOC, V113, P1412, DOI 10.1002/cncr.23720; Ashikari-Hada S, 2004, J BIOL CHEM, V279, P12346, DOI 10.1074/jbc.M313523200; AVIEZER D, 1994, P NATL ACAD SCI USA, V91, P12173, DOI 10.1073/pnas.91.25.12173; BENNETT KL, 1995, J CELL BIOL, V128, P687, DOI 10.1083/jcb.128.4.687; BROWN TA, 1991, J CELL BIOL, V113, P207, DOI 10.1083/jcb.113.1.207; Celie JWAM, 2012, KIDNEY INT, V81, P651, DOI 10.1038/ki.2011.425; Chu CL, 2005, BIOCHEMISTRY-US, V44, P12203, DOI 10.1021/bi050241p; Ciana P, 2003, J BIOL CHEM, V278, P31737, DOI 10.1074/jbc.M301525200; Cole CL, 2014, J BIOL CHEM, V289, P10488, DOI 10.1074/jbc.M113.534263; COOK PW, 1991, MOL CELL BIOL, V11, P2547, DOI 10.1128/MCB.11.5.2547; David M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097771; Du WL, 2008, AM J PATHOL, V173, P1153, DOI 10.2353/ajpath.2008.070309; Edsjo A, 2007, SEMIN CANCER BIOL, V17, P248, DOI 10.1016/j.semcancer.2006.04.005; Edwards JP, 2009, J IMMUNOL, V182, P1929, DOI 10.4049/jimmunol.0802703; Encinas M, 2000, J NEUROCHEM, V75, P991, DOI 10.1046/j.1471-4159.2000.0750991.x; Evangelopoulos ME, 2009, J NEUROSCI RES, V87, P2138, DOI 10.1002/jnr.22025; Evangelopoulos ME, 2005, ONCOGENE, V24, P3309, DOI 10.1038/sj.onc.1208494; Gershon TR, 2005, NEOPLASIA, V7, P575, DOI 10.1593/neo.04637; Hahn CK, 2008, P NATL ACAD SCI USA, V105, P9751, DOI 10.1073/pnas.0710413105; Hanks BA, 2013, J CLIN INVEST, V123, P3925, DOI 10.1172/JCI65745; Henrich KO, 2011, CANCER RES, V71, P3142, DOI 10.1158/0008-5472.CAN-10-3014; Hienola A, 2006, J CELL BIOL, V174, P569, DOI 10.1083/jcb.200602043; HIGASHIYAMA S, 1993, J CELL BIOL, V122, P933, DOI 10.1083/jcb.122.4.933; HIGASHIYAMA S, 1992, J BIOL CHEM, V267, P6205; Ho R, 2005, CANCER RES, V65, P9868, DOI 10.1158/0008-5472.CAN-04-2426; JACKSON DG, 1995, J CELL BIOL, V128, P673, DOI 10.1083/jcb.128.4.673; Kaneko M, 2006, EXP CELL RES, V312, P2028, DOI 10.1016/j.yexcr.2006.03.005; Kelsh RN, 2006, BIOESSAYS, V28, P788, DOI 10.1002/bies.20445; Kleeff J, 1998, J CLIN INVEST, V102, P1662, DOI 10.1172/JCI4105; Knelson EH, 2014, J CLIN INVEST, V124, P3016, DOI 10.1172/JCI74270; Knelson EH, 2013, J CLIN INVEST, V123, P4786, DOI 10.1172/JCI69657; Kwiatkowski JL, 1998, CANCER RES, V58, P4602; LELI U, 1992, J NEUROCHEM, V58, P1191, DOI 10.1111/j.1471-4159.1992.tb11328.x; Liu SQ, 2005, CANCER LETT, V228, P125, DOI 10.1016/j.canlet.2005.01.056; LOEB JA, 1995, J CELL BIOL, V130, P127, DOI 10.1083/jcb.130.1.127; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Maris JM, 2010, NEW ENGL J MED, V362, P2202, DOI 10.1056/NEJMra0804577; Maris JM, 2010, PEDIATR BLOOD CANCER, V55, P26, DOI 10.1002/pbc.22430; Matsuda K, 2001, CANCER RES, V61, P5562; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Meier T, 1998, J CELL BIOL, V141, P715, DOI 10.1083/jcb.141.3.715; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Miyata K, 2014, CANCER MED-US, V3, P1159, DOI 10.1002/cam4.301; Monaghan TK, 2008, J NEUROCHEM, V104, P74, DOI 10.1111/j.1471-4159.2007.05018.x; Mosse YP, 2012, CLIN CANCER RES, V18, P6058, DOI 10.1158/1078-0432.CCR-11-3251; Mullassery D, 2009, ARCH DIS CHILDHOOD-E, V94, P177, DOI 10.1136/adc.2008.143909; Munro SA, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6125; Mythreye K, 2013, ONCOGENE, V32, P1416, DOI 10.1038/onc.2012.157; Nam SO, 2015, ANTICANCER RES, V35, P4433; Passiatore G, 2011, J CELL PHYSIOL, V226, P1763, DOI 10.1002/jcp.22505; Qiao JB, 2012, BIOCHEM BIOPH RES CO, V424, P421, DOI 10.1016/j.bbrc.2012.06.125; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; Richards KN, 2010, CANCER-AM CANCER SOC, V116, P3233, DOI 10.1002/cncr.25073; Robertson D, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-13; Ross RA, 2003, CANCER LETT, V197, P35, DOI 10.1016/S0304-3835(03)00079-X; Scarpa S, 1996, EXP CELL RES, V229, P147, DOI 10.1006/excr.1996.0352; SHISHIDO Y, 1995, J BIOL CHEM, V270, P29578, DOI 10.1074/jbc.270.49.29578; Su ZQ, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0523-y; Su ZQ, 2014, NAT BIOTECHNOL, V32, P903, DOI 10.1038/nbt.2957; Tamura S, 2007, BIOCHEM BIOPH RES CO, V358, P226, DOI 10.1016/j.bbrc.2007.04.124; Wang C, 2014, NAT BIOTECHNOL, V32, P926, DOI 10.1038/nbt.3001; Wang XH, 2011, BBA-MOL CELL RES, V1813, P827, DOI 10.1016/j.bbamcr.2011.01.027; Wei JS, 2004, CANCER RES, V64, P6883, DOI 10.1158/0008-5472.CAN-04-0695; Whitelock JM, 2005, CHEM REV, V105, P2745, DOI 10.1021/cr010213m; Yan S, 2013, ONCOTARGET, V4, P433, DOI 10.18632/oncotarget.930; Yu HY, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6218; Zhou Y, 2010, NEUROSIGNALS, V18, P141, DOI 10.1159/000319823	67	11	11	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1903	1915		10.1096/fj.201600828R	http://dx.doi.org/10.1096/fj.201600828R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28174207	Green Published			2022-12-28	WOS:000399195500013
J	He, CY; Zhang, GY; Zhang, JG; Zeng, YF; Liu, JJ				He, Caiyun; Zhang, Guoyun; Zhang, Jianguo; Zeng, Yanfei; Liu, Juanjuan			Integrated analysis of multiomic data reveals the role of the antioxidant network in the quality of sea buckthorn berry	FASEB JOURNAL			English	Article						ascorbic acid; berry colorcarotenoids; flavonoids; UDP-glucuronosyltransferase	REGULATES PROANTHOCYANIDIN SYNTHESIS; MYB TRANSCRIPTION FACTOR; ASCORBIC-ACID; FRUIT-DEVELOPMENT; CAROTENOID BIOSYNTHESIS; VITAMIN-C; HIPPOPHAE-RHAMNOIDES; GENE-EXPRESSION; MESSENGER-RNA; BETA-CAROTENE	Berries of sea buckthorn, known as the "king of vitamin C," are abundant in antioxidants, have attractive colors, and are an excellent material with which to study the relationships between berry color, antioxidants, and berry quality. No study has yet determined the molecular basis of the relationship between sea buckhorn berries and their color and antioxidant levels. By using RNA-seq, LC-MS/MS, and LC/GC-MS technology and selecting red (darkest colored) and yellow (lightest colored) sea buckthorn berries at different development stages, this study showed that the red and yellow berry resulted from a higher ratio of lycopene to beta-carotene and of b-carotene to lycopene content, respectively. The uronic acid pathway-a known animal pathway-in ascorbic acid synthesis was found in sea buckthorn berries, and the higher expression of UDP-glucuronosyltransferase in red berries was consistent with the higher content of ascorbic acid. In summary, multiomic data showed that the color of sea buckthorn berries is mainly determined by b-carotene and lycopene; red sea buckthorn berries were richer than yellow berries in antioxidants, such as carotenoids, flavonoids, and ascorbic acid; and the animal pathway might be operating in sea buckthorn.-He, C., Zhang, G., Zhang, J., Zeng, Y., Liu, J. Integrated analysis of multiomic data reveals the role of the antioxidant network in the quality of sea buckthorn berry.	[He, Caiyun; Zhang, Guoyun; Zhang, Jianguo; Zeng, Yanfei; Liu, Juanjuan] Chinese Acad Forestry, State Key Lab Tree Genet & Breeding, Key Lab Tree Breeding & Cultivat, State Forestry Adm,Res Inst Forestry, Beijing, Peoples R China; [Zhang, Jianguo] Nanjing Forestry Univ, Collaborat Innovat Ctr Sustainable Forestry South, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Forestry; Research Institute of Forestry, CAF; State Key Laboratory of Tree Genetics & Breeding, CAF; Nanjing Forestry University	Zhang, JG (corresponding author), Chinese Acad Forestry, Xianshan Rd, Beijing 100091, Peoples R China.	zhangjg@caf.ac.cn			Basic Research Fund of Rapid Innovation Fund (RIF) [RIF-2014-04]; National Natural Science Foundation of China [31470616]; Special Fund for Forest Scientific Research in the Public Welfare [201504103]	Basic Research Fund of Rapid Innovation Fund (RIF); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Forest Scientific Research in the Public Welfare	The authors thank Hongmei Luo (Chinese Academy of Forestry) for helping with the sampling. This work was supported by the Basic Research Fund of Rapid Innovation Fund (RIF; Grant RIF-2014-04), National Natural Science Foundation of China (31470616), and the Special Fund for Forest Scientific Research in the Public Welfare (201504103). RNA-seq data have been deposited at the European Nucleotide Archive under accession PRJEB12839. MS proteomics data have been deposited to the ProteomeXchange Consortium via the Proteomics Identifications (PRIDE) partner repository with data set identifier PXD004251. The authors declare no conflicts of interest.	Abbott JA, 1999, POSTHARVEST BIOL TEC, V15, P207, DOI 10.1016/S0925-5214(98)00086-6; Abu-Reidah IM, 2014, ELECTROPHORESIS, V35, P1571, DOI 10.1002/elps.201300646; Agius F, 2003, NAT BIOTECHNOL, V21, P177, DOI 10.1038/nbt777; Alos E, 2014, PLANTA, V239, P1113, DOI 10.1007/s00425-014-2044-z; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bogs J, 2007, PLANT PHYSIOL, V143, P1347, DOI 10.1104/pp.106.093203; Borovsky Y, 2013, THEOR APPL GENET, V126, P557, DOI 10.1007/s00122-012-2001-9; Castro SM, 2008, FOOD CHEM, V107, P1436, DOI 10.1016/j.foodchem.2007.09.074; CHATTERJEE I, 1961, ANN NY ACAD SCI, V92, P36, DOI 10.1111/j.1749-6632.1961.tb46105.x; Conklin PL, 2004, PLANT CELL ENVIRON, V27, P959, DOI 10.1111/j.1365-3040.2004.01203.x; Di Vaio C, 2015, J SCI FOOD AGR, V95, P2124, DOI 10.1002/jsfa.6929; Dowdle J, 2007, PLANT J, V52, P673, DOI 10.1111/j.1365-313X.2007.03266.x; Espley RV, 2007, PLANT J, V49, P414, DOI 10.1111/j.1365-313X.2006.02964.x; Farre G, 2010, PLANT SCI, V179, P28, DOI 10.1016/j.plantsci.2010.03.009; Gallie DR, 2013, J EXP BOT, V64, P433, DOI 10.1093/jxb/ers330; Giovannoni JJ, 2004, PLANT CELL, V16, pS170, DOI 10.1105/tpc.019158; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; He CY, 2016, PROTEOMICS, V16, P2688, DOI 10.1002/pmic.201600160; Hosseinian FS, 2007, J AGR FOOD CHEM, V55, P10832, DOI 10.1021/jf072529m; Isaacson T, 2002, PLANT CELL, V14, P333, DOI 10.1105/tpc.010303; Jakobek L, 2007, DEUT LEBENSM-RUNDSCH, V103, P58; Jeong ST, 2006, PLANT SCI, V170, P61, DOI 10.1016/j.plantsci.2005.07.025; Kang BS, 2014, PLANTA, V240, P1011, DOI 10.1007/s00425-014-2052-z; Kang CY, 2013, PLANT CELL, V25, P1960, DOI 10.1105/tpc.113.111732; Kang K, 2009, PLANT PHYSIOL, V150, P1380, DOI 10.1104/pp.109.138552; Kim Y, 2007, FOOD CHEM, V105, P1327, DOI 10.1016/j.foodchem.2007.03.050; King MC, 2002, J AMER POMOLOG SOC, V56, P223; Krejcarova J, 2015, ACTA VET BRNO, V84, P257, DOI 10.2754/avb201584030257; Li AL, 2014, PLANT CELL, V26, P1878, DOI 10.1105/tpc.114.124388; Ling Y, 2013, J PHARMACEUT BIOMED, V85, P1, DOI 10.1016/j.jpba.2013.06.011; Liu BL, 2015, PLANT PHYSIOL BIOCH, V86, P181, DOI 10.1016/j.plaphy.2014.12.003; Liu YM, 2011, ANAL BIOANAL CHEM, V400, P1405, DOI 10.1007/s00216-011-4880-z; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Mellway RD, 2009, PLANT PHYSIOL, V150, P924, DOI 10.1104/pp.109.139071; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Park H, 2002, PLANT CELL, V14, P321, DOI 10.1105/tpc.010302; Raj Kumar, 2011, Research Journal of Medicinal Plant, V5, P491, DOI 10.3923/rjmp.2011.491.499; Ronen G, 1999, PLANT J, V17, P341, DOI 10.1046/j.1365-313X.1999.00381.x; Simonne A. H., 1997, Journal of Food Composition and Analysis, V10, P299, DOI 10.1006/jfca.1997.0544; Smimoff N, 2003, NAT BIOTECHNOL, V21, P134, DOI 10.1038/nbt0203-134; Smirnoff N, 2001, ANNU REV PLANT PHYS, V52, P437, DOI 10.1146/annurev.arplant.52.1.437; Smita S, 2013, J GENET, V92, P363, DOI 10.1007/s12041-013-0275-6; Sun DQ, 2010, AFR J BIOTECHNOL, V9, P3272; Toledo-Ortiz G, 2010, P NATL ACAD SCI USA, V107, P11626, DOI 10.1073/pnas.0914428107; Vimolmangkang S, 2014, GENE, V534, P78, DOI 10.1016/j.gene.2013.10.007; Wang H. L., 1994, CHINAS FOREIGN TRADE, V5, P17; Wheeler GL, 1998, NATURE, V393, P365, DOI 10.1038/30728; Wolucka BA, 2003, J BIOL CHEM, V278, P47483, DOI 10.1074/jbc.M309135200; Yu KQ, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-10; Zeb A, 2004, PAK J NUTR, V3, P99, DOI DOI 10.3923/PJN.2004.99.106; Zhou BY, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0038827, 10.1371/journal.pone.0038241]; Zifkin M, 2012, PLANT PHYSIOL, V158, P200, DOI 10.1104/pp.111.180950	52	13	16	2	31	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1929	1938		10.1096/fj.201600974R	http://dx.doi.org/10.1096/fj.201600974R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28126735				2022-12-28	WOS:000399195500015
J	Lee, H; Park, JR; Kim, WJ; Sundar, IK; Rahman, I; Park, SM; Yang, SR				Lee, Hanbyeol; Park, Jeong-Ran; Kim, Woo Jin; Sundar, Isaac K.; Rahman, Irfan; Park, Sung-Min; Yang, Se-Ran			Blockade of RAGE ameliorates elastase-induced emphysema development and progression via RAGE-DAMP signaling	FASEB JOURNAL			English	Article						FPS-ZM1; Nrf2; COPD; emphysema	GLYCATION END-PRODUCTS; OBSTRUCTIVE PULMONARY-DISEASE; SOLUBLE RECEPTOR; LUNG-FUNCTION; MICE; INFLAMMATION; COPD; EXPRESSION; LIGANDS; NRF2	The receptor for advanced glycan end products (RAGE) has been identified as a susceptibility gene for chronic obstructive pulmonary disease (COPD) in genome-wide association studies (GWASs). However, less is known about how RAGE is involved in the pathogenesis of COPD. To determine the molecular mechanism by which RAGE influences COPD in experimental COPD models, we investigated the efficacy of the RAGE-specific antagonist FPS-ZM1 administration in in vivo and in vitro COPD models. We injected elastase intratracheally and the RAGE antagonist FPS-ZM1 in mice, and the infiltrated inflammatory cells and cytokines were assessed by ELISA. Cellular expression of RAGE was determined in protein, serum, and bronchoalveolar lavage fluid of mice and lungs and serum of human donors and patients with COPD. Downstream damage-associated molecular pattern (DAMP) pathway activation in vivo and in vitro and in patients with COPD was assessed by immunofluorescence staining, Western blot analysis, and ELISA. The expression of membrane RAGE in initiating the inflammatory response and of soluble RAGE acting as a decoy were associated with up-regulation of the DAMP-related signaling pathway via Nrf2. FPS-ZM1 administration significantly reversed emphysema in the lung of mice. Moreover, FPS-ZM1 treatment significantly reduced lung inflammation in Nrf2(+/+) , but not in Nrf2(-/-) mice. Thus, our data indicate for the first time that RAGE inhibition has an essential protective role in COPD. Our observation of RAGE inhibition provided novel insight into its potential as a therapeutic target in emphysema/COPD.-Lee, H., Park, J.-R., Kim, W. J., Sundar, I. K., Rahman, I., Park, S.-M., Yang. S.-R. Blockade of RAGE ameliorates elastase-induced emphysema development and progression via RAGE-DAMP signaling.	[Lee, Hanbyeol; Park, Jeong-Ran; Park, Sung-Min; Yang, Se-Ran] Kangwon Natl Univ, Dept Thorac & Cardiovasc Surg, Chunchon, South Korea; [Kim, Woo Jin] Kangwon Natl Univ, Dept Internal Med, Chunchon, South Korea; [Sundar, Isaac K.; Rahman, Irfan] Univ Rochester, Med Ctr, Dept Environm Med, Rochester, NY 14642 USA	Kangwon National University; Kangwon National University; University of Rochester	Yang, SR (corresponding author), Kangwon Natl Univ, Sch Med, 1 Kangwondaehak Gil, Chunchon 200701, Gangwon, South Korea.; Yang, SR (corresponding author), Kangwon Natl Univ, Stem Cell Inst, 1 Kangwondaehak Gil, Chunchon 200701, Gangwon, South Korea.	seran.yang@gmail.com	Sundar, Isaac K/F-8764-2012; Kim, Woo Jin/A-8216-2019	Sundar, Isaac K/0000-0001-6742-3460; Kim, Woo Jin/0000-0003-2927-370X	National Research Foundation of Korea (NRF) - Korean government [NRF2014R1A2A2A01003737]; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [1R01HL085613]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085613] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF) - Korean government; U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The biospecimens and data used for this study were provided by the Biobank of Soonchunhyang, Kyungpook and the Korea University Guro Hospital, a member of the National Biobank of Korea. This work was supported by the National Research Foundation of Korea (NRF; Grant NRF2014R1A2A2A01003737) funded by the Korean government (to S.-R.Y.) and U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grant 1R01HL085613 (to I.R.). The authors declare no conflicts of interest.	Abdelsalam RM, 2015, J NEUROCHEM, V133, P700, DOI 10.1111/jnc.13087; Alzheimer's Disease Cooperative Study, 2014, NEUROLOGY, V82, P1536; Biswal Shyam, 2012, Proc Am Thorac Soc, V9, P47, DOI 10.1513/pats.201201-009MS; Bodine BG, 2014, RESP RES, V15, DOI 10.1186/s12931-014-0133-y; Cheng DT, 2013, AM J RESP CRIT CARE, V188, P948, DOI 10.1164/rccm.201302-0247OC; Chuah YK, 2013, INT J INFLAMM, V2013, DOI 10.1155/2013/403460; Davis BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033304; Deane R, 2003, NAT MED, V9, P907, DOI 10.1038/nm890; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Ferhani N, 2010, AM J RESP CRIT CARE, V181, P917, DOI 10.1164/rccm.200903-0340OC; Fineschi S, 2013, AM J RESP CELL MOL, V48, P164, DOI 10.1165/rcmb.2012-0111OC; Harashima A, 2006, BIOCHEM J, V396, P109, DOI 10.1042/BJ20051573; Hunt WR, 2016, J CYST FIBROS, V15, P681, DOI 10.1016/j.jcf.2015.12.011; Iwamoto H, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-68; Kierdorf K, 2013, J LEUKOCYTE BIOL, V94, P55, DOI 10.1189/jlb.1012519; Kim WJ, 2015, INT J CHRONIC OBSTR, V10, DOI 10.2147/COPD.S80227; Kim WJ, 2014, LUNG, V192, P473, DOI 10.1007/s00408-014-9579-4; Lee H, 2016, TOXICOL LETT, V240, P140, DOI 10.1016/j.toxlet.2015.10.030; Lee H, 2014, IN VITRO CELL DEV-AN, V50, P731, DOI 10.1007/s11626-014-9763-0; Li M, 2015, RESPIROLOGY, V20, P998, DOI 10.1111/resp.12557; Mo CF, 2014, ANTIOXID REDOX SIGN, V20, P574, DOI 10.1089/ars.2012.5116; Morbini P, 2006, MODERN PATHOL, V19, P1437, DOI 10.1038/modpathol.3800661; Motz GT, 2010, AM J RESP CRIT CARE, V181, P1223, DOI 10.1164/rccm.200910-1485OC; Ott C, 2014, REDOX BIOL, V2, P411, DOI 10.1016/j.redox.2013.12.016; Pahwa R, 2016, J DIABETES COMPLICAT, V30, P1186, DOI 10.1016/j.jdiacomp.2016.03.005; Park JR, 2016, IN VITRO CELL DEV-AN, V52, P545, DOI 10.1007/s11626-016-0008-2; Pouwels SD, 2015, EUR RESPIR J, V45, P1482, DOI 10.1183/09031936.00158414; Rahman I, 2006, NAT PROTOC, V1, P3159, DOI 10.1038/nprot.2006.378; Ramasamy R, 2011, ANN NY ACAD SCI, V1243, P88, DOI 10.1111/j.1749-6632.2011.06320.x; Reynolds PR, 2011, AM J RESP CELL MOL, V45, P411, DOI 10.1165/rcmb.2010-0231OC; Riehl A, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-12; Riuzzi F, 2012, J CELL SCI, V125, P1440, DOI 10.1242/jcs.092163; Robinson AB, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00301; Sambamurthy N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118979; Schlueter C, 2003, BBA-GENE STRUCT EXPR, V1630, P1, DOI 10.1016/j.bbaexp.2003.08.008; Schmidt AM, 2001, J CLIN INVEST, V108, P949, DOI 10.1172/JCI200114002; Sparvero LJ, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-17; Stogsdill JA, 2012, AM J RESP CELL MOL, V47, P60, DOI 10.1165/rcmb.2011-0385OC; Stogsdill MP, 2013, AM J RESP CELL MOL, V49, P128, DOI 10.1165/rcmb.2013-0013OC; Sukkar MB, 2013, AM J RESP CRIT CARE, V188, P893, DOI 10.1164/rccm.201308-1489ED; Sukkar MB, 2012, BRIT J PHARMACOL, V167, P1161, DOI 10.1111/j.1476-5381.2012.01984.x; Sussan TE, 2009, P NATL ACAD SCI USA, V106, P250, DOI 10.1073/pnas.0804333106; Ueno M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7332; Wood TT, 2014, AM J PHYSIOL-LUNG C, V307, pL758, DOI 10.1152/ajplung.00185.2014; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yang SR, 2009, AM J RESP CELL MOL, V40, P147, DOI 10.1165/rcmb.2008-0207OC; Yao HW, 2008, AM J PHYSIOL-LUNG C, V294, pL1174, DOI 10.1152/ajplung.00439.2007; Yao HW, 2012, J CLIN INVEST, V122, P2032, DOI 10.1172/JCI60132; Yao HW, 2010, P NATL ACAD SCI USA, V107, P15571, DOI 10.1073/pnas.1007625107; Young RP, 2011, EUR RESPIR J, V38, P743, DOI 10.1183/09031936.00041711; Zabini D, 2015, J CELL MOL MED, V19, P1151, DOI 10.1111/jcmm.12519; Zhang HY, 2008, AM J RESP CRIT CARE, V178, P356, DOI 10.1164/rccm.200707-1069OC; Zhang YH, 2014, J THORAC DIS, V6, P734, DOI 10.3978/j.issn.2072-1439.2014.04.31	54	37	37	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2076	2089		10.1096/fj.201601155R	http://dx.doi.org/10.1096/fj.201601155R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28148566	Green Published			2022-12-28	WOS:000399195500027
J	Liu, TQ; Wang, Q; Li, WQ; Mao, FY; Yue, SS; Liu, S; Liu, XN; Xiao, S; Xia, LX				Liu, Tianqi; Wang, Qi; Li, Wenqing; Mao, Feiyu; Yue, Shanshan; Liu, Sun; Liu, Xiaona; Xiao, Shan; Xia, Laixin			Gcn5 determines the fate of Drosophila germline stem cells through degradation of Cyclin A	FASEB JOURNAL			English	Article						gametogenesis; development; cell cycle; ubiquitination	ANAPHASE-PROMOTING COMPLEX; BAG-OF-MARBLES; FEMALE GERMLINE; OVARIAN GERMLINE; DIVISION; NICHE; MAINTENANCE; GENE; TRANSCRIPTION; ACETYLATION	The fluctuating CDK-CYCLIN complex plays a general role in cell-cycle control. Many types of stem cells use unique features of the cell cycle to facilitate asymmetric division. However, the manner in which these features are established remains poorly understood. The cell cycle of Drosophila female germline stem cells (GSCs) is characterized by short G(1) and very long G(2) phases, making it an excellent model for the study of cell cycle control in stem cell fate determination. Using a Drosophila female GSCs model, we found Gcn5, the first discovered histone acetyltransferase, to maintain germline stem cells in Drosophila ovaries. Results showed that Gcn5 is dispensable for the transcriptional silencing of bam, but interacts with Cyclin A to facilitate proper turnover in GSCs. Results also showed that Gcn5 promotes Cyclin A ubiquitination, which is dependent on its acetylating activity. Finally, results showed that knockdown of Cyclin A rescued the GSC-loss phenotype caused by lack of Gcn5. Collectively, these findings support the conclusion that Gcn5 acts through acetylation to facilitate Cyclin A ubiquitination and proper turnover, thereby determining the fate of GSCs.-Liu, T., Wang, Q., Li, W., Mao, F., Yue, S., Liu, S., Liu, X., Xiao, S., Xia, L. Gcn5 determines the fate of Drosophila germline stem cells through degradation of Cyclin A.	[Liu, Tianqi; Wang, Qi; Li, Wenqing; Mao, Feiyu; Yue, Shanshan] Chinese Acad Sci, Inst Zool, State Key Lab Stem Cell & Reprod Biol, Beijing, Peoples R China; [Liu, Tianqi; Liu, Sun; Liu, Xiaona; Xiao, Shan; Xia, Laixin] Southern Med Univ, Sch Basic Med Sci, Dept Dev Biol, 1023 Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China	Chinese Academy of Sciences; Institute of Zoology, CAS; Southern Medical University - China	Xiao, S; Xia, LX (corresponding author), Southern Med Univ, Sch Basic Med Sci, Dept Dev Biol, 1023 Shatai Rd, Guangzhou 510515, Guangdong, Peoples R China.	asdfg@smu.edu.cn; xialx@smu.edu.cn		Xia, Laixin/0000-0003-2735-9518	National Basic Research Program of China [2014CB943202]; Natural Science Foundation of China [31371494, 31500660, 31571485]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank Dr. Dahua Chen (Institute of Zoology, Chinese Academy of Sciences, Beijing, China) for critical reading of the manuscript and for help with its preparation. This work was supported by the National Basic Research Program of China (Grant 2014CB943202 to L. Xia) and the Natural Science Foundation of China (Grants 31371494 to L. X., 31500660 to S. X., and 31571485 to L. X.). The authors declare no conflicts of interest.	Ables ET, 2013, DEVELOPMENT, V140, P530, DOI 10.1242/dev.088583; Ables ET, 2010, CELL STEM CELL, V7, P581, DOI 10.1016/j.stem.2010.10.001; Bu P, 2007, MOL CELL BIOL, V27, P3405, DOI 10.1128/MCB.00066-07; Carre C, 2005, MOL CELL BIOL, V25, P8228, DOI 10.1128/MCB.25.18.8228-8238.2005; Chen DH, 2005, CURR BIOL, V15, P179, DOI 10.1016/j.cub.2005.01.004; Chen DH, 2003, CURR BIOL, V13, P1786, DOI 10.1016/j.cub.2003.09.033; Chen DS, 2009, DEVELOPMENT, V136, P4133, DOI 10.1242/dev.039032; Cox DN, 2000, DEVELOPMENT, V127, P503; DAWSON IA, 1995, J CELL BIOL, V129, P725, DOI 10.1083/jcb.129.3.725; Forbes A, 1998, DEVELOPMENT, V125, P679; Fox PM, 2011, DEVELOPMENT, V138, P2223, DOI 10.1242/dev.059535; GLOTZER M, 1991, NATURE, V349, P132, DOI 10.1038/349132a0; Grant PA, 1997, GENE DEV, V11, P1640, DOI 10.1101/gad.11.13.1640; Guo Z, 2009, DEVELOPMENT, V136, P3627, DOI 10.1242/dev.036939; Hsu HJ, 2009, P NATL ACAD SCI USA, V106, P1117, DOI 10.1073/pnas.0809144106; Huang HD, 2014, J CELL BIOL, V206, P217, DOI 10.1083/jcb.201401002; Huang SJ, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001721; Jin ZG, 2007, CURR BIOL, V17, P539, DOI 10.1016/j.cub.2007.01.050; Kalaszczynska I, 2009, CELL, V138, P352, DOI 10.1016/j.cell.2009.04.062; Kapinas K, 2013, J CELL PHYSIOL, V228, P9, DOI 10.1002/jcp.24104; Kashevsky H, 2002, P NATL ACAD SCI USA, V99, P11217, DOI 10.1073/pnas.172391099; Li Y, 2012, DEVELOPMENT, V139, P1547, DOI 10.1242/dev.077412; Lin HF, 1997, DEVELOPMENT, V124, P2463; Mateo F, 2009, ONCOGENE, V28, P2654, DOI 10.1038/onc.2009.127; Mateo F, 2010, BIOCHEM SOC T, V38, P83, DOI 10.1042/BST0380083; MCKEARIN D, 1995, DEVELOPMENT, V121, P2937; Nagy Z, 2007, ONCOGENE, V26, P5341, DOI 10.1038/sj.onc.1210604; Orpinell M, 2010, EMBO J, V29, P2381, DOI 10.1038/emboj.2010.125; Parry DH, 2001, CURR BIOL, V11, P671, DOI 10.1016/S0960-9822(01)00204-4; Peters JM, 2002, MOL CELL, V9, P931, DOI 10.1016/S1097-2765(02)00540-3; Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9; RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436; Ruiz S, 2011, CURR BIOL, V21, P45, DOI 10.1016/j.cub.2010.11.049; Singh AM, 2009, CELL STEM CELL, V5, P141, DOI 10.1016/j.stem.2009.07.003; Song XQ, 2004, DEVELOPMENT, V131, P1353, DOI 10.1242/dev.01026; Wang HL, 2011, CELL RES, V21, P700, DOI 10.1038/cr.2011.44; Wang Z, 2005, CURR BIOL, V15, P328, DOI 10.1016/j.cub.2005.02.016; Xia LX, 2012, CURR BIOL, V22, P515, DOI 10.1016/j.cub.2012.01.056; Xia LX, 2010, CELL, V143, P978, DOI 10.1016/j.cell.2010.11.022; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; XU T, 1993, DEVELOPMENT, V117, P1223; Xu WT, 2000, NAT GENET, V26, P229, DOI 10.1038/79973; Yamauchi T, 2000, P NATL ACAD SCI USA, V97, P11303, DOI 10.1073/pnas.97.21.11303; Zachariae W, 1999, GENE DEV, V13, P2039, DOI 10.1101/gad.13.16.2039; Zhang GQ, 2015, CELL, V161, P893, DOI 10.1016/j.cell.2015.04.018	45	19	20	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2185	2194		10.1096/fj.201601217R	http://dx.doi.org/10.1096/fj.201601217R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28188175				2022-12-28	WOS:000399195500036
J	Yang, CC; Zheng, ST; Liu, T; Liu, Q; Dai, F; Zhou, J; Chen, YM; Sheyhidin, I; Lu, XM				Yang, Chenchen; Zheng, Shutao; Liu, Tao; Liu, Qing; Dai, Fang; Zhou, Jian; Chen, Yumei; Sheyhidin, Ilyar; Lu, Xiaomei			Down-regulated miR-26a promotes proliferation, migration, and invasion via negative regulation of MTDH in esophageal squamous cell carcinoma	FASEB JOURNAL			English	Article						ESCC; malignant phenotype; regulatory mechanism	TUMOR-SUPPRESSING FUNCTIONS; CANCER PROGRESSION; METASTASIS; MICRORNA; METADHERIN	Numerous studies have reported that the role played by miR-26a in cancer is controversial, but whether miR-26a regulates metadherin (MTDH) expression in esophageal squamous cell carcinoma (ESCC) is unclear. We performed this study to investigate the clinical relevance of miR-26a expression in ESCC. miR-26a was detected by using the in situ hybridization method. To functionally analyze the role of miR-26a in ESCC cell lines in vitro, KYSE-450 and Eca109 cells were employed, whose endogenous miR-26a was artificially down- or up-regulated, respectively, by using lentiviral-based transfection. There was significant association between miR-26a expression and clinical stage (P = 0.049), lymph node metastasis (P = 0.023), tumor volume (P = 0.003), and poor overall prognosis (P = 0.026). miR-26a was able to suppress proliferation and migration of ESCC cells in vitro Moreover, we have confirmed that miR-26a can negatively regulate MTDH in ESCC cells by using luciferase reporter assay. In addition, to investigate the role miR-26a plays in cell proliferation, we nude mice were xenografted with ESCC cells whose miR-26a was stably down- and up-regulated. Together, our results show that miR-26a is capable of suppressing the proliferation and migration of ESCC cells via negative regulation of MTDH. Moreover, miR-26a expression was clinically relevant in cancer progression and poor prognosis, which supports the idea that miR-26a acts as a tumor suppressor in ESCC.-Yang, C., Zheng, S., Liu, T., Liu, Q., Dai, F., Zhou, J., Chen, Y., Sheyhidin, I., Lu, X. Down-regulated miR-26a promotes proliferation, migration, and invasion via negative regulation of MTDH in esophageal squamous cell carcinoma.	[Yang, Chenchen; Zheng, Shutao; Liu, Tao; Liu, Qing; Dai, Fang; Zhou, Jian; Chen, Yumei; Lu, Xiaomei] Xinjiang Med Univ, Affiliated Hosp 1, Clin Med Res Inst, Urumqi, Peoples R China; [Yang, Chenchen; Zheng, Shutao; Liu, Tao; Liu, Qing; Dai, Fang; Zhou, Jian; Chen, Yumei; Sheyhidin, Ilyar; Lu, Xiaomei] Xinjiang Med Univ, Affiliated Hosp 1, State Key Lab Incubat Base Xinjiang Major Dis Res, Urumqi, Peoples R China	Xinjiang Medical University; Xinjiang Medical University	Lu, XM (corresponding author), Xinjiang Med Univ, Affiliated Hosp 1, State Key Lab Breeding Base Xinjiang Major Dis Re, Clin Med Res Inst, Urumqi 830054, Xinjiang, Peoples R China.	luxiaomei88@163.com	Zheng, Shutao/GRX-1737-2022	Zheng, Shutao/0000-0002-9000-0148	Natural Science Foundation of China [81160303, 81260359, U1303321]; Major Science and Technology Projects of the Xinjiang Uygur Autonomous Region [201430123-1]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Major Science and Technology Projects of the Xinjiang Uygur Autonomous Region	This work was supported by grants from the Natural Science Foundation of China (81160303, 81260359, U1303321), and from the Major Science and Technology Projects of the Xinjiang Uygur Autonomous Region (Grant 201430123-1). The authors thank Prof. Qian Zhao (State Key Laboratory for Oncogenes and Related Genes, Shanghai Jiao-Tong University School of Medicine) for plasmid presentation.	Acunzo M, 2015, J INFECT DIS, V212, pS74, DOI 10.1093/infdis/jiv197; Borno ST, 2012, CANCER DISCOV, V2, P1024, DOI 10.1158/2159-8290.CD-12-0041; Chen B, 2015, BIOMED PHARMACOTHER, V75, P1, DOI 10.1016/j.biopha.2015.08.012; Chen J, 2016, TUMOR BIOL, V37, P7095, DOI 10.1007/s13277-016-5017-y; Chen XB, 2015, GYNECOL ONCOL, V139, P513, DOI 10.1016/j.ygyno.2015.10.008; Deng M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072662; Arnal MJD, 2015, WORLD J GASTROENTERO, V21, P7933, DOI 10.3748/wjg.v21.i26.7933; Fukumoto I, 2016, J HUM GENET, V61, P109, DOI 10.1038/jhg.2015.120; Gong C, 2015, ONCOGENE, V34, P84, DOI 10.1038/onc.2013.525; Huang QY, 2016, J THORAC ONCOL, V11, P583, DOI 10.1016/j.jtho.2015.12.109; Lin RK, 2014, BIOMED PHARMACOTHER, V68, P929, DOI 10.1016/j.biopha.2014.10.003; Liu BN, 2012, BBA-MOL BASIS DIS, V1822, P1692, DOI 10.1016/j.bbadis.2012.07.019; Liu P, 2015, CANCER LETT, V357, P384, DOI 10.1016/j.canlet.2014.11.050; Ma J, 2014, ONCOL REP, V32, P2744, DOI 10.3892/or.2014.3517; Mallick R, 2016, DIGEST DIS SCI, V61, P1039, DOI 10.1007/s10620-015-3959-3; Okada N, 2016, SURGERY, V159, P441, DOI 10.1016/j.surg.2015.06.044; Sandhu R, 2014, INT J ONCOL, V44, P563, DOI 10.3892/ijo.2013.2197; Shao Y, 2016, ONCOTARGET, V7, P15173, DOI 10.18632/oncotarget.7908; Shen WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086871; Tang WR, 2015, INT J HYG ENVIR HEAL, V218, P12, DOI 10.1016/j.ijheh.2014.10.004; Torre LA, 2015, CA-CANCER J CLIN, V65, P87, DOI 10.3322/caac.21262; Wang G, 2015, GENET TEST MOL BIOMA, V19, P30, DOI 10.1089/gtmb.2014.0245; Yang CC, 2015, TRANSL RES, V166, P614, DOI 10.1016/j.trsl.2015.05.004; Yu L, 2013, ONCOL LETT, V5, P1223, DOI 10.3892/ol.2013.1173; Zhang B, 2011, CARCINOGENESIS, V32, P2, DOI 10.1093/carcin/bgq209; Zhang JQ, 2012, GASTROENTEROLOGY, V143, P246, DOI 10.1053/j.gastro.2012.03.045; Zhao SJ, 2014, TUMOR BIOL, V35, P9725, DOI 10.1007/s13277-014-2206-4; Zhao XX, 2015, INT J CLIN EXP PATHO, V8, P368	28	22	23	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2114	2122		10.1096/fj.201601237	http://dx.doi.org/10.1096/fj.201601237			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28174206				2022-12-28	WOS:000399195500030
J	Lu, YZ; Wan, J; Yang, ZF; Lei, XL; Niu, Q; Jiang, LX; Passtoors, WM; Zang, AP; Fraering, PC; Wu, F				Lu, Yinzhong; Wan, Jun; Yang, Zhifeng; Lei, Xiling; Niu, Qi; Jiang, Lanxin; Passtoors, Willemijn M.; Zang, Aiping; Fraering, Patrick C.; Wu, Fang			Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells	FASEB JOURNAL			English	Article						receptor tyrosine kinase; presenilin; gamma-secretase; protein processing; nuclear translocation	NUCLEOTIDE-BINDING SITE; TYROSINE KINASE; GAMMA-SECRETASE; ALZHEIMERS-DISEASE; BREAST-CANCER; DOWN-REGULATION; LUNG-CANCER; RESISTANCE; CLEAVAGE; THERAPY	Deregulation of the TAM (TYRO3, AXL, and MERTK) family of receptor tyrosine kinases (RTKs) has recently been demonstrated to predominately promote survival and chemoresistance of cancer cells. Intramembrane proteolysis mediated by presenilin/gamma-secretase is known to regulate the homeostasis of some RTKs. In the present study, we demonstrate that AXL, but not TYRO3 or MERTK, is efficiently and sequentially cleaved by alpha-and g-secretases in various types of cancer cell lines. Proteolytic processing of AXL redirected signaling toward a secretase-mediated pathway, away from the classic, well-known, ligand-dependent canonical RTK signaling pathway. TheAXL intracellular domain cleavage product, but not full-length AXL, was further shown to translocate into the nucleus via a nuclear localization sequence that harbored a basic HRRKK motif. Of interest, we found that the g-secretase-uncleavable AXL mutant caused an elevated chemoresistance in non-small-cell lung cancer cells. Altogether, our findings suggest thatAXL can undergo sequential processing mediated by various proteases kept in a homeostatic balance. This newly discovered post-translational processing ofAXL may provide an explanation for the diverse functions of AXL, especially in the context of drug resistance in cancer cells.-Lu, Y., Wan, J., Yang, Z., Lei, X., Niu, Q., Jiang, L., Passtoors, W. M., Zang, A., Fraering, P. C., Wu, F. Regulated intramembrane proteolysis of the AXL receptor kinase generates an intracellular domain that localizes in the nucleus of cancer cells. FASEB J. 31, 1382-1397 (2017). www.fasebj.org	[Lu, Yinzhong; Wan, Jun; Lei, Xiling; Niu, Qi; Passtoors, Willemijn M.; Zang, Aiping; Wu, Fang] Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, Minist Educ, Key Lab Syst Biomed, Shanghai, Peoples R China; [Yang, Zhifeng; Jiang, Lanxin] Shanghai Jiao Tong Univ, Sch Life Sci & Biotechnol, Shanghai, Peoples R China; [Fraering, Patrick C.] Ecole Polytech Fed Lausanne, Brain Mind Inst, Sch Life Sci, Lausanne, Switzerland; [Fraering, Patrick C.] Fdn Eclos, Plan Les Ouates, Switzerland; [Fraering, Patrick C.] Campus Biotech Innovat Pk, Geneva, Switzerland	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Wu, F (corresponding author), Shanghai Jiao Tong Univ, Shanghai Ctr Syst Biomed, 800 Dongchuan Rd, Shanghai 200240, Peoples R China.	fang.wu@sjtu.edu.cn	Wu, Fang/B-1945-2008	Wu, Fang/0000-0002-4194-2243; LU, Yinzhong/0000-0003-2164-0157; Fraering, Patrick/0000-0002-5841-5327	National Natural Science Foundation of China [31270853, 31300640]; Research Fund of Medicine and Engineering of Shanghai Jiao Tong University [YG2013MS22]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund of Medicine and Engineering of Shanghai Jiao Tong University	This work was supported by the National Natural Science Foundation of China (31270853, 31300640) and the Research Fund of Medicine and Engineering of Shanghai Jiao Tong University (Grant YG2013MS22). The authors thank Dr. B. De Strooper (University of Leuven) for providing WT and PS1 KO, PS2 KO, and PS DKO mouse embryonic fibroblasts; Dr. X. Lin (Institute of Oceanology, Chinese Academy of Sciences, Qingdao, China) for Panc-28 cells; Dr. H. Gehring (University of Zurich, Zurich, Switzerland) for HEK293T, Hela, LN-18, and LN-229 cells; and Dr. Y. Zhang (Shanghai Jiao Tong University) for SGC7901 and A549 cells. The authors also thank Dr. Rik Derynck (University of California San Francisco, San Francisco, CA, USA) for pRK5F-TACE and pRK5M-ADAM10 plasmids. The authors declare no conflicts of interest.	Axelrod H, 2014, ONCOTARGET, V5, P1, DOI 10.18632/oncotarget.2422; Bae SY, 2015, ONCOTARGET, V6, P10146, DOI 10.18632/oncotarget.3380; Brand TM, 2014, CANCER RES, V74, P5152, DOI 10.1158/0008-5472.CAN-14-0294; Braunger J, 1997, ONCOGENE, V14, P2619, DOI 10.1038/sj.onc.1201123; Budagian V, 2005, MOL CELL BIOL, V25, P9324, DOI 10.1128/MCB.25.21.9324-9339.2005; Cacquevel M, 2008, J NEUROCHEM, V104, P210, DOI 10.1111/j.1471-4159.2007.05041.x; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Carpenter G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008979; Carpenter G, 2009, EXP CELL RES, V315, P1556, DOI 10.1016/j.yexcr.2008.09.027; Doody RS, 2013, NEW ENGL J MED, V369, P341, DOI 10.1056/NEJMoa1210951; Dovey HF, 2001, J NEUROCHEM, V76, P173, DOI 10.1046/j.1471-4159.2001.00012.x; Flood F, 2005, BIOCHEM J, V385, P545, DOI 10.1042/BJ20041145; Foveau B, 2009, MOL BIOL CELL, V20, P2495, DOI 10.1091/mbc.E08-09-0969; Fraering PC, 2005, J BIOL CHEM, V280, P41987, DOI 10.1074/jbc.M501368200; Gjerdrum C, 2010, P NATL ACAD SCI USA, V107, P1124, DOI 10.1073/pnas.0909333107; Graham DK, 2014, NAT REV CANCER, V14, P769, DOI 10.1038/nrc3847; Guo L, 2002, MOL CELL PROTEOMICS, V1, P30, DOI 10.1074/mcp.M100020-MCP200; Gutwein P, 2010, J BIOMED SCI, V17, DOI 10.1186/1423-0127-17-3; Herreman A, 2003, J CELL SCI, V116, P1127, DOI 10.1242/jcs.00292; Herreman A, 1999, P NATL ACAD SCI USA, V96, P11872, DOI 10.1073/pnas.96.21.11872; Holland SJ, 2010, CANCER RES, V70, P1544, DOI 10.1158/0008-5472.CAN-09-2997; Kao SC, 2004, J BIOL CHEM, V279, P1942, DOI 10.1074/jbc.M309219200; Koorstra JBM, 2009, CANCER BIOL THER, V8, P618, DOI 10.4161/cbt.8.7.7923; Kopan R, 2004, NAT REV MOL CELL BIO, V5, P499, DOI 10.1038/nrm1406; Korshunov VA, 2012, CLIN SCI, V122, P361, DOI 10.1042/CS20110411; Krishnamoorthy GP, 2013, J BIOL CHEM, V288, P17481, DOI 10.1074/jbc.M112.439422; Lemke G, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009076; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Liu C, 2009, MOL CELL, V35, P26, DOI 10.1016/j.molcel.2009.06.018; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lyu J, 2008, DEV CELL, V15, P773, DOI 10.1016/j.devcel.2008.10.004; Maretzky T, 2005, P NATL ACAD SCI USA, V102, P9182, DOI 10.1073/pnas.0500918102; Miller MA, 2016, CANCER DISCOV, V6, P382, DOI 10.1158/2159-8290.CD-15-0933; OBRYAN JP, 1995, J BIOL CHEM, V270, P551, DOI 10.1074/jbc.270.2.551; Paolino M, 2014, NATURE, V507, P508, DOI 10.1038/nature12998; Pomara N, 2013, NEW ENGL J MED, V369, P1661, DOI 10.1056/NEJMc1310845; Sardi SP, 2006, CELL, V127, P185, DOI 10.1016/j.cell.2006.07.037; Scaltriti M, 2016, CLIN CANCER RES, V22, P1313, DOI 10.1158/1078-0432.CCR-15-1458; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; Song SM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009001; Song XZ, 2011, CANCER-AM CANCER SOC, V117, P734, DOI 10.1002/cncr.25483; Vahidi A, 2014, BIOCHEM BIOPH RES CO, V450, P782, DOI 10.1016/j.bbrc.2014.06.061; Valverde P, 2005, BIOCHEM BIOPH RES CO, V333, P180, DOI 10.1016/j.bbrc.2005.05.086; Vuoriluoto K, 2011, ONCOGENE, V30, P1436, DOI 10.1038/onc.2010.509; Wang JH, 2001, J IMMUNOL, V167, P289, DOI 10.4049/jimmunol.167.1.289; Wu F, 2010, FASEB J, V24, P2464, DOI 10.1096/fj.09-148031; Wu XL, 2014, ONCOTARGET, V5, P9546, DOI 10.18632/oncotarget.2542; Zagorska A, 2014, NAT IMMUNOL, V15, P920, DOI 10.1038/ni.2986; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661; Zhang ZF, 2012, NAT GENET, V44, P852, DOI 10.1038/ng.2330	50	21	21	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1382	1397		10.1096/fj.201600702R	http://dx.doi.org/10.1096/fj.201600702R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28034848	Green Published, hybrid			2022-12-28	WOS:000398504300011
J	Cheng, D; Zhao, YJ; Wang, SW; Zhang, F; Russo, M; McMahon, SB; Zhu, JY				Cheng, De; Zhao, Yuanjun; Wang, Shuwen; Zhang, Fan; Russo, Mariano; McMahon, Steven B.; Zhu, Jiyue			Repression of telomerase gene promoter requires human-specific genomic context and is mediated by multiple HDAC1-containing corepressor complexes	FASEB JOURNAL			English	Article							CATALYTIC SUBUNIT HTERT; REVERSE-TRANSCRIPTASE GENE; NORMAL HUMAN-CELLS; HISTONE DEACETYLATION; COMPARATIVE BIOLOGY; HUMAN CANCER; LIFE-SPAN; C-MYC; ACTIVATION; ROLES	The human telomerase reverse transcriptase (hTERT) gene is repressed in most somatic cells, whereas the expression of the mouse mTert gene is widely detected. To understand the mechanisms of this human-specific repression, we constructed bacterial artificial chromosome(BAC) reporters using human and mouse genomic DNAs encompassing the TERT genes and neighboring loci. Upon chromosomal integration, the hTERT, but not the mTert, reporter was stringently repressed in telomerase-negative human cells in a histone deacetylase (HDAC)-dependent manner, replicating the expression of their respective endogenous genes. In chimeric BACs, the mTert promoter became strongly repressed in the human genomic context, but the hTERT promoter was highly active in the mouse genomic context. Furthermore, an unrelated herpes simplex virus-thymidine kinase (HSV-TK) promoter was strongly repressed in the human, but not in the mouse, genomic context. These results demonstrated that the repression of hTERT gene was dictated by distal elements and its chromatin environment. This repression depended on class I HDACs and involved multiple corepressor complexes, including HDAC1/2-containing Sin3B, nucleosome remodeling and histone deacetylase (NuRD), and corepressor of RE1 silencing transcription factor (CoREST) complexes. Together, our data indicate that the lack of telomerase expression in most human somatic cells results from its repressive genomic environment, providing new insight into the mechanism of long-recognized differential telomerase regulation in mammalian species.-Cheng, D., Zhao, Y., Wang, S., Zhang, F., Russo, M., McMahon, S. B., Zhu, J. Repression of telomerase gene promoter requires human-specific genomic context and is mediated by multiple HDAC1-containing corepressor complexes.	[Cheng, De; Wang, Shuwen; Zhang, Fan; Zhu, Jiyue] Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, PBS 323, POB 1495, Spokane, WA 99210 USA; [Zhao, Yuanjun; Russo, Mariano] Penn State Univ, Coll Med, Dept Cellular & Mol Physiol, University Pk, PA 16802 USA; [McMahon, Steven B.] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA	Washington State University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health; Pennsylvania State University - University Park; Jefferson University	Zhu, JY (corresponding author), Washington State Univ, Coll Pharm, Dept Pharmaceut Sci, PBS 323, POB 1495, Spokane, WA 99210 USA.	jiyue.zhu@wsu.edu	zhu, ji/HDM-1538-2022; Zhang, Fan/AAB-1175-2020	ZHANG, FAN/0000-0002-7186-6317; McMahon, Steven/0000-0002-3405-1768	NIH Institute of General Medical Sciences [R01GM071725]; Spokane County Health Sciences and Services Authority (Spokane, WA, USA);  [R21OD021432]; NATIONAL CANCER INSTITUTE [R01CA164834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071725] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R21OD021432] Funding Source: NIH RePORTER	NIH Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Spokane County Health Sciences and Services Authority (Spokane, WA, USA); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Weidong Wang [U.S. National Institutes of Health (NIH) National Institute on Aging] for the generous gift of CHD3 and -4 antibodies. This work was supported by NIH Institute of General Medical Sciences Grant R01GM071725, and Grant R21OD021432 from the Office of the Director (both to J.Z.); and the Spokane County Health Sciences and Services Authority (Spokane, WA, USA). The authors declare no conflicts of interest.	Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; Cheng D, 2015, J BIOL CHEM, V290, P30193, DOI 10.1074/jbc.M115.662221; Chiba K, 2015, ELIFE, V4, DOI 10.7554/eLife.07918; Cobrinik D, 2013, GENE CHROMOSOME CANC, V52, P1150, DOI 10.1002/gcc.22110; Cong YS, 2000, J BIOL CHEM, V275, P35665, DOI 10.1074/jbc.C000637200; Crowe DL, 2001, NUCLEIC ACIDS RES, V29, P2789, DOI 10.1093/nar/29.13.2789; Devereux TR, 1999, CANCER RES, V59, P6087; Fujimoto K, 2000, NUCLEIC ACIDS RES, V28, P2557, DOI 10.1093/nar/28.13.2557; Gomes NMV, 2011, AGING CELL, V10, P761, DOI 10.1111/j.1474-9726.2011.00718.x; Guilleret I, 2002, INT J CANCER, V101, P335, DOI 10.1002/ijc.10593; Gunes C, 2000, CANCER RES, V60, P2116; Hayakawa T, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/129383; Heidenreich B, 2014, CURR OPIN GENET DEV, V24, P30, DOI 10.1016/j.gde.2013.11.005; Horikawa L, 2005, P NATL ACAD SCI USA, V102, P18437, DOI 10.1073/pnas.0508964102; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Jia WW, 2011, FASEB J, V25, P979, DOI 10.1096/fj.10-173989; Kelly RDW, 2013, BIOCHEM SOC T, V41, P741, DOI 10.1042/BST20130010; KIPLING D, 1990, NATURE, V347, P400, DOI 10.1038/347400a0; Lewis KA, 2016, FRONT GENET, V7, DOI 10.3389/fgene.2016.00083; Li YH, 2015, NAT CELL BIOL, V17, P1327, DOI 10.1038/ncb3240; Mathew R, 2010, FASEB J, V24, P2702, DOI 10.1096/fj.09-148973; Nagel I, 2010, BLOOD, V116, P1317, DOI 10.1182/blood-2009-09-240440; Peifer M, 2015, NATURE, V526, P700, DOI 10.1038/nature14980; Perissi V, 2010, NAT REV GENET, V11, P109, DOI 10.1038/nrg2736; Rangarajan A, 2003, NAT REV CANCER, V3, P952, DOI 10.1038/nrc1235; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Takakura M, 1999, CANCER RES, V59, P551; Venteicher AS, 2009, SCIENCE, V323, P644, DOI 10.1126/science.1165357; Wang SW, 2007, MOL BIOL CELL, V18, P669, DOI 10.1091/mbc.E06-09-0840; Wang SW, 2010, MOL BIOL CELL, V21, P821, DOI 10.1091/mbc.E09-06-0456; Wang SW, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp511; Wang SW, 2009, NUCLEIC ACIDS RES, V37, P2618, DOI 10.1093/nar/gkp125; Wang SW, 2009, MOL BIOTECHNOL, V42, P110, DOI 10.1007/s12033-009-9142-3; Wang SW, 2004, GENE, V343, P69, DOI 10.1016/j.gene.2004.09.006; Wang SW, 2003, J BIOL CHEM, V278, P18842, DOI 10.1074/jbc.M209544200; Witt O, 2009, CANCER LETT, V277, P8, DOI 10.1016/j.canlet.2008.08.016; Wu KJ, 1999, NAT GENET, V21, P220, DOI 10.1038/6010; Xu M, 2008, MOL CELL BIOL, V28, P4819, DOI 10.1128/MCB.01969-07; Zhao YJ, 2014, NUCLEIC ACIDS RES, V42, P10385, DOI 10.1093/nar/gku721; Zhao Yuanjun, 2011, Int J Biochem Mol Biol, V2, P199; Zhao YJ, 2009, GENE CHROMOSOME CANC, V48, P963, DOI 10.1002/gcc.20698; Zhu JY, 2010, PROTEIN CELL, V1, P22, DOI 10.1007/s13238-010-0014-1; Zhu JY, 1999, P NATL ACAD SCI USA, V96, P3723, DOI 10.1073/pnas.96.7.3723; Zhu QJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001446	45	12	12	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1165	+		10.1096/fj.201601111R	http://dx.doi.org/10.1096/fj.201601111R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27940549	Green Published			2022-12-28	WOS:000395671200029
J	Saini, V; Zhao, HG; Petit, ET; Gori, F; Demay, MB				Saini, Vaibhav; Zhao, Hengguang; Petit, Elizabeth T.; Gori, Francesca; Demay, Marie B.			Absence of vitamin D receptor (VDR)-mediated PPAR gamma suppression causes alopecia in VDR-null mice	FASEB JOURNAL			English	Article						hair cycle; vitamin D-resistant rickets; keratinocyte stem cell; mouse model	HAIR FOLLICLE MORPHOGENESIS; KNOCKOUT MICE; STEM-CELLS; TARGETED ABLATION; SIGNALING PATHWAY; ANIMAL-MODEL; EXPRESSION; DIFFERENTIATION; RICKETS; SKIN	Vitamin D receptor (VDR) mutations in humans and mice cause alopecia. VDR-null (VDR-/-) mice exhibit lack of postmorphogenic hair cycles as a result of impaired keratinocyte stem cell (KSC) function. To identify the molecular basis for abnormal KSC function, RNA sequencing of wild-type(WT) and VDR-/- KSCs was performed. These studies demonstrated that >80% of differentially expressed genes are up-regulated in VDR-/- KSCs; thus, the VDR is a transcriptional suppressor in WT KSCs. Peroxisome proliferator-activated receptor gamma (PPAR gamma), PPAR gamma coactivator 1 beta (PGC1 beta), and lipoprotein lipase (LPL) were among the up-regulated genes identified. Chromatin immunoprecipitation analyses demonstrated that these genes are direct VDR targets in WT keratinocytes. Notably, VDR occupancy of the PPAR gamma regulatory region precludes PPAR gamma occupancy of this site, based on the observation that PPAR gamma interacts with these sequences in VDR-/- but not WT keratinocytes. This contrasts with the VDR and PPAR gamma co-occupancy observed on PGC1 beta and LPL gene regulatory regions identified. Studies in mice with keratinocyte-specific PPAR gamma haploinsufficiency were performed to identify the functional consequences of enhanced PPAR gamma expression. PPAR gamma haploinsufficiency normalized PPAR gamma mRNA levels in VDR-/- keratinocytes and restored anagen responsiveness in vivo in VDR-/- mice, resulting in hair regrowth. Thus, absence of VDR-mediated PPAR gamma suppression underlies alopecia in VDR-/- mice.	[Saini, Vaibhav; Zhao, Hengguang; Petit, Elizabeth T.; Gori, Francesca; Demay, Marie B.] Harvard Med Sch, Massachusetts Gen Hosp, Endocrine Unit, Boston, MA USA	Harvard University; Harvard Medical School; Massachusetts General Hospital	Demay, MB (corresponding author), Massachusetts Gen Hosp, 50 Blossom St,Thier 11, Boston, MA 02114 USA.	demay@helix.mgh.harvard.edu	Gori, Francesca/S-9422-2019		U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK46974]; Center for Skeletal Research Core (NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases) [P30 AR066261]; Endocrine Unit at Massachusetts General Hospital; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR066261] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK046974] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Center for Skeletal Research Core (NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases); Endocrine Unit at Massachusetts General Hospital; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grant DK46974 (to M.B.D). The authors thank the Center for Skeletal Research Core (NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases; P30 AR066261), and the Endocrine Unit at Massachusetts General Hospital, for supporting histological analyses.	Alimirah F, 2012, EXP CELL RES, V318, P2490, DOI 10.1016/j.yexcr.2012.07.020; Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Andl T, 2002, DEV CELL, V2, P643, DOI 10.1016/S1534-5807(02)00167-3; Chen CH, 2001, ENDOCRINOLOGY, V142, P5386, DOI 10.1210/en.142.12.5386; Cianferotti L, 2007, P NATL ACAD SCI USA, V104, P9428, DOI 10.1073/pnas.0702884104; Dardenne O, 2001, ENDOCRINOLOGY, V142, P3135, DOI 10.1210/en.142.7.3135; Ding N, 2013, CELL, V153, P601, DOI 10.1016/j.cell.2013.03.028; Feldman David, 2014, Bonekey Rep, V3, P510, DOI 10.1038/bonekey.2014.5; Festa E, 2011, CELL, V146, P761, DOI 10.1016/j.cell.2011.07.019; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hsu YC, 2014, NAT MED, V20, P847, DOI 10.1038/nm.3643; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; HUGHES MR, 1988, SCIENCE, V242, P1702, DOI 10.1126/science.2849209; Karnik P, 2009, J INVEST DERMATOL, V129, P1243, DOI 10.1038/jid.2008.369; Kishimoto J, 2000, GENE DEV, V14, P1181; Lee SM, 2014, ENDOCRINOLOGY, V155, P4137, DOI 10.1210/en.2014-1417; Li YC, 1997, P NATL ACAD SCI USA, V94, P9831, DOI 10.1073/pnas.94.18.9831; Li YC, 1998, ENDOCRINOLOGY, V139, P4391, DOI 10.1210/en.139.10.4391; Lim XH, 2013, SCIENCE, V342, P1226, DOI 10.1126/science.1239730; Lim XH, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008029; Lim YY, 2014, CLIN EXP DERMATOL, V39, P368, DOI 10.1111/ced.12241; Lisse TS, 2014, MOL ENDOCRINOL, V28, P1698, DOI 10.1210/me.2014-1043; Luderer HF, 2011, J BIOL CHEM, V286, P18444, DOI 10.1074/jbc.M110.188219; Niemann C, 2002, DEVELOPMENT, V129, P95; Palmer HG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001483; Panda DK, 2001, P NATL ACAD SCI USA, V98, P7498, DOI 10.1073/pnas.131029498; Reddy S, 2001, MECH DEVELOP, V107, P69, DOI 10.1016/S0925-4773(01)00452-X; REICHRATH J, 1994, BRIT J DERMATOL, V131, P477; Rieusset J, 2004, MOL ENDOCRINOL, V18, P2363, DOI 10.1210/me.2003-0325; Rivier M, 1998, J INVEST DERMATOL, V111, P1116, DOI 10.1046/j.1523-1747.1998.00439.x; Sakai Y, 2001, J CLIN INVEST, V107, P961, DOI 10.1172/JCI11676; Sakai Y, 2000, ENDOCRINOLOGY, V141, P2043, DOI 10.1210/en.141.6.2043; Sherman MH, 2014, CELL, V159, P80, DOI 10.1016/j.cell.2014.08.007; Skorija K, 2005, MOL ENDOCRINOL, V19, P855, DOI 10.1210/me.2004-0415; Teichert A, 2010, J CELL PHYSIOL, V225, P482, DOI 10.1002/jcp.22227; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Wakabayashi K, 2009, MOL CELL BIOL, V29, P3544, DOI 10.1128/MCB.01856-08; Wang FF, 2013, P NATL ACAD SCI USA, V110, P18656, DOI 10.1073/pnas.1314863110; Wang L, 2016, SCIENCE, V351, P613, DOI 10.1126/science.aad5440; Yoshizawa T, 1997, NAT GENET, V16, P391, DOI 10.1038/ng0897-391	40	6	6	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1059	+		10.1096/fj.201600863R	http://dx.doi.org/10.1096/fj.201600863R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27932380	Green Published			2022-12-28	WOS:000395671200020
J	Mathews, CK				Mathews, Christopher K.			Oxidized deoxyribonucleotides, mutagenesis, and cancer	FASEB JOURNAL			English	Editorial Material							ESCHERICHIA-COLI; NUCLEOTIDE POOL; DNTP POOL; MTH1; PROTEIN; POTENT; CELLS		[Mathews, Christopher K.] Oregon State Univ, Dept Biochem & Biophys, 2750 SW Campus Way, Corvallis, OR 97331 USA	Oregon State University	Mathews, CK (corresponding author), Oregon State Univ, Dept Biochem & Biophys, 2750 SW Campus Way, Corvallis, OR 97331 USA.	mathewsc@oregonstate.edu						BJURSELL G, 1973, J BIOL CHEM, V248, P3904; Colussi C, 2002, CURR BIOL, V12, P912, DOI 10.1016/S0960-9822(02)00863-1; Einolf HJ, 1998, BIOCHEMISTRY-US, V37, P13300, DOI 10.1021/bi981346d; FOWLER RG, 1994, J BACTERIOL, V176, P7727, DOI 10.1128/JB.176.24.7727-7729.1994; Friedberg E. C., 2006, DNA REPAIR MUTAGENES; FRIEDBERG EC, 1995, DNA REPAIR MUTAGENES; Gad H, 2014, NATURE, V508, P215, DOI 10.1038/nature13181; Huber KVM, 2014, NATURE, V508, P222, DOI 10.1038/nature13194; Kamiya H., 2007, GENES ENV, V29, P133; Kettle JG, 2016, J MED CHEM, V59, P2346, DOI 10.1021/acs.jmedchem.5b01760; MAKI H, 1992, NATURE, V355, P273, DOI 10.1038/355273a0; MICHAELS ML, 1992, J BACTERIOL, V174, P6321, DOI 10.1128/JB.174.20.6321-6325.1992; MO JY, 1992, P NATL ACAD SCI USA, V89, P11021, DOI 10.1073/pnas.89.22.11021; Pursell Z. F., 2008, NUCLEIC ACIDS RES, V36, P4990; Setoyama D, 2011, MUTAT RES-FUND MOL M, V707, P9, DOI 10.1016/j.mrfmmm.2010.12.001; Tassotto ML, 2002, J BIOL CHEM, V277, P15807, DOI 10.1074/jbc.M200965200; TOPAL MD, 1982, P NATL ACAD SCI-BIOL, V79, P2211, DOI 10.1073/pnas.79.7.2211; Tsuzuki T, 2001, P NATL ACAD SCI USA, V98, P11456, DOI 10.1073/pnas.191086798	18	2	2	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					11	13		10.1096/fj.201601100	http://dx.doi.org/10.1096/fj.201601100			3	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27729413				2022-12-28	WOS:000392177600004
J	Zurier, RB; Burstein, SH				Zurier, Robert B.; Burstein, Sumner H.			Cannabinoids, inflammation, and fibrosis	FASEB JOURNAL			English	Review						endocannabinoids; specialized proresolving mediators; anti-inflammatory; antifibrotic	ACTIVATED-RECEPTOR-GAMMA; SYSTEMIC-LUPUS-ERYTHEMATOSUS; COLLAGEN-INDUCED ARTHRITIS; AJULEMIC ACID; ANTIINFLAMMATORY PROPERTIES; RHEUMATOID-ARTHRITIS; MULTIPLE-SCLEROSIS; NEUROPATHIC PAIN; LIPID MEDIATORS; NERVOUS-SYSTEM	Cannabinoids apparently act on inflammation through mechanisms different from those of agents such as nonsteroidal anti-inflammatory drugs (NSAIDs). As a class, the cannabinoids are generally free from the adverse effects associated with NSAIDs. Their clinical development thus provides a new approach to treatment of diseases characterized by acute and chronic inflammation and fibrosis. A concise survey of the anti-inflammatory actions of the phytocannabinoids (9)-tetrahydrocannabinol (THC), cannabidiol, cannabichromene, and cannabinol is presented. Mention is also made of the noncannabinoid plant components and pyrolysis products, followed by a discussion of 3 synthetic preparationsCesamet (nabilone; Meda Pharmaceuticals, Somerset, NJ, USA), Marinol (dronabinol; THC; AbbVie, Inc., North Chicago, IL, USA), and Sativex (Cannabis extract; GW Pharmaceuticals, Cambridge United Kingdom)that have anti-inflammatory effects. A fourth synthetic cannabinoid, ajulemic acid (AJA; CT-3; Resunab; Corbus Pharmaceuticals, Norwood, MA, USA), is discussed in greater detail because it represents the most recent advance in this area and is currently undergoing 3 phase 2 clinical trials by Corbus Pharmaceuticals. The endogenous cannabinoids, including the closely related lipoamino acids, are then discussed. The review concludes with a presentation of a possible mechanism for the anti-inflammatory and antifibrotic actions of these substances. Thus, several cannabinoids may be considered candidates for development as anti-inflammatory and antifibrotic agents. Of special interest is their possible use for treatment of chronic inflammation, a major unmet medical need.Zurier, R. B., Burstein, S. H. Cannabinoids, inflammation, and fibrosis.	Univ Massachusetts, Sch Med, Dept Med, Worcester, MA USA; [Zurier, Robert B.] Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, 364 Plantat St, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester; University of Massachusetts System; University of Massachusetts Worcester	Zurier, RB (corresponding author), Univ Massachusetts, Sch Med, Dept Biochem & Mol Pharmacol, 364 Plantat St, Worcester, MA 01605 USA.	robert.zurier@umassmed.edu						Ambrosio ALB, 2007, J BIOL CHEM, V282, P18625, DOI 10.1074/jbc.M702538200; Aringer M, 2005, LUPUS, V14, P13, DOI 10.1191/0961203305lu2053oa; Aringer M, 2009, RHEUMATOLOGY, V48, P1451, DOI 10.1093/rheumatology/kep270; Badowski ME, 2016, HIV AIDS-RES PALLIAT, V8, P37, DOI 10.2147/HIV.S81420; Ball EMA, 2014, LUPUS, V23, P46, DOI 10.1177/0961203313512882; Ben-Shabat S, 2006, J MED CHEM, V49, P1113, DOI 10.1021/jm050709m; Bidinger B, 2003, CLIN IMMUNOL, V108, P95, DOI 10.1016/S1521-6616(03)00064-0; Blake DR, 2006, RHEUMATOLOGY, V45, P50, DOI 10.1093/rheumatology/kei183; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Burstein S, 2005, AAPS J, V7, pE143, DOI 10.1208/aapsj070115; BURSTEIN S, 1975, BIOCHEM PHARMACOL, V24, P1053, DOI 10.1016/0006-2952(75)90446-3; BURSTEIN S, 1976, BIOCHEM PHARMACOL, V25, P2003, DOI 10.1016/0006-2952(76)90057-5; BURSTEIN SH, 1992, J MED CHEM, V35, P3135, DOI 10.1021/jm00095a007; Burstein S, 2012, BIOORG MED CHEM LETT, V22, P872, DOI 10.1016/j.bmcl.2011.12.040; Burstein SH, 2014, BIOORGAN MED CHEM, V22, P2830, DOI 10.1016/j.bmc.2014.03.038; Burstein SH, 2011, J CELL BIOCHEM, V112, P3227, DOI 10.1002/jcb.23245; Castaneda JT, 2013, J NEUROIMMUNE PHARM, V8, P323, DOI 10.1007/s11481-012-9430-8; Centonze D, 2007, BRAIN, V130, P2543, DOI 10.1093/brain/awm160; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Costa B, 2004, BRIT J PHARMACOL, V143, P247, DOI 10.1038/sj.bjp.0705920; Dajani EZ, 1999, J PHARMACOL EXP THER, V291, P31; Diamond B, 2011, P NATL ACAD SCI USA, V108, P3461, DOI 10.1073/pnas.1100329108; Fimiani C, 1999, PROSTAG OTH LIPID M, V57, P23, DOI 10.1016/S0090-6980(98)00068-9; George KL, 2008, J CELL PHYSIOL, V214, P714, DOI 10.1002/jcp.21263; Gonzalez EG, 2012, ANN RHEUM DIS, V71, P1545, DOI 10.1136/annrheumdis-2011-200314; HAERTZEN CA, 1965, J NERV MENT DIS, V141, P300, DOI 10.1097/00005053-196509000-00006; Johnson DR, 2007, J CELL BIOCHEM, V100, P184, DOI 10.1002/jcb.21046; Karst M, 2003, JAMA-J AM MED ASSOC, V290, P1757, DOI 10.1001/jama.290.13.1757; Klein TW, 2007, ADV EXP MED BIOL, V601, P395; Kotake S, 1996, J BONE MINER RES, V11, P88; Li H.-L., 1975, CANNABIS CULTURE; Liu JL, 2003, MOL PHARMACOL, V63, P983, DOI 10.1124/mol.63.5.983; Lucas CD, 2014, MUCOSAL IMMUNOL, V7, P857, DOI 10.1038/mi.2013.102; Lucattelli M, 2016, RESP RES, V17, DOI 10.1186/s12931-016-0373-0; Mackie K, 2005, HANDB EXP PHARMACOL, V168, P299; Malfait AM, 2000, P NATL ACAD SCI USA, V97, P9561, DOI 10.1073/pnas.160105897; Massa F, 2004, J CLIN INVEST, V113, P1202, DOI 10.1172/JCI200419465; McHugh Douglas, 2012, J Mol Signal, V7, P10, DOI 10.1186/1750-2187-7-10; McHugh D, 2012, BRIT J PHARMACOL, V165, P2414, DOI 10.1111/j.1476-5381.2011.01497.x; McHugh D, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-44; Mikita N, 2011, J DERMATOL, V38, P839, DOI 10.1111/j.1346-8138.2011.01237.x; Monteleone AM, 2015, AM J CLIN NUTR, V101, P262, DOI 10.3945/ajcn.114.096164; Nakajima Y, 2006, FEBS LETT, V580, P613, DOI 10.1016/j.febslet.2005.12.079; O'Sullivan SE, 2010, IMMUNOBIOLOGY, V215, P611, DOI 10.1016/j.imbio.2009.09.007; Parker J, 2008, RHEUMATOL INT, V28, P631, DOI 10.1007/s00296-007-0489-0; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH610, DOI 10.1152/ajpheart.00236.2007; RAZDAN RK, 1986, PHARMACOL REV, V38, P75; Russo E, 2006, MED HYPOTHESES, V66, P234, DOI 10.1016/j.mehy.2005.08.026; Russo EB, 2007, CHEM BIODIVERS, V4, P1614, DOI 10.1002/cbdv.200790144; Russo M, 2016, PAIN MED, V17, P1145, DOI 10.1093/pm/pnv080; Sancho R, 2003, MOL PHARMACOL, V63, P429, DOI 10.1124/mol.63.2.429; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; SCHWARZ H, 1994, J NEUROIMMUNOL, V55, P107, DOI 10.1016/0165-5728(94)90152-X; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Skaper SD, 2012, PHILOS T R SOC B, V367, P3193, DOI 10.1098/rstb.2012.0313; SOFIA RD, 1974, LIFE SCI, V15, P251; SOFIA RD, 1973, RES COMMUN CHEM PATH, V6, P909; SPRONCK HJW, 1978, BIOCHEM PHARMACOL, V27, P607, DOI 10.1016/0006-2952(78)90403-3; Stebulis JA, 2008, LIFE SCI, V83, P666, DOI 10.1016/j.lfs.2008.09.004; Sumariwalla PF, 2004, ARTHRITIS RHEUM-US, V50, P985, DOI 10.1002/art.20050; Tepper MA, 2014, BIOORGAN MED CHEM, V22, P3245, DOI 10.1016/j.bmc.2014.04.062; Tsang CC, 2016, PHARMACOTHERAPY, V36, P273, DOI 10.1002/phar.1709; TURNER CE, 1981, J CLIN PHARMACOL, V21, pS283, DOI 10.1002/j.1552-4604.1981.tb02606.x; Williams EL, 2009, RHEUMATOLOGY, V48, P716, DOI 10.1093/rheumatology/kep080; WIRTH PW, 1980, J PHARM SCI, V69, P1359, DOI 10.1002/jps.2600691136; WIRTH PW, 1980, LIFE SCI, V26, P1991, DOI 10.1016/0024-3205(80)90631-1; Wu MH, 2009, AM J PATHOL, V174, P519, DOI 10.2353/ajpath.2009.080574; Zhang J, 2008, J BIOL CHEM, V283, P22601, DOI 10.1074/jbc.M800524200; Zurier RB, 2003, BIOCHEM PHARMACOL, V65, P649, DOI 10.1016/S0006-2952(02)01604-0; Zurier RB, 1998, ARTHRITIS RHEUM-US, V41, P163, DOI 10.1002/1529-0131(199801)41:1<163::AID-ART20>3.0.CO;2-9; Zurier RB, 2009, FASEB J, V23, P1503, DOI 10.1096/fj.08-118323	71	67	69	0	64	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3682	3689		10.1096/fj.201600646R	http://dx.doi.org/10.1096/fj.201600646R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27435265				2022-12-28	WOS:000386474700004
J	Betapudi, V; Shukla, M; Alluri, R; Merkulov, S; McCrae, KR				Betapudi, Venkaiah; Shukla, Meenal; Alluri, Ravi; Merkulov, Sergei; McCrae, Keith R.			Novel role for p56/Lck in regulation of endothelial cell survival and angiogenesis	FASEB JOURNAL			English	Article						apoptosis; kininogen; p53; tyrosine protein kinase Lck	MOLECULAR-WEIGHT KININOGEN; TYROSINE KINASE LCK; SRC-FAMILY KINASES; PLASMINOGEN-ACTIVATOR; BINDING-PROTEIN; CYTOKERATIN 1; VASCULAR-PERMEABILITY; SIGNAL-TRANSDUCTION; TUBE FORMATION; APOPTOSIS	Previous studies have demonstrated that cleaved high-molecular-weight kininogen (HKa) induces endothelial apoptosis and inhibits angiogenesis and have suggested that this occurs through inhibition of Src family kinases. This study assessed the role of tyrosine-protein kinase Lck (p56/Lck) in this pathway. We analyzed early events leading to apoptosis of human endothelial cells exposed to HKa. The role of p56/Lck was investigated using short interfering (si) RNA knockdown and lentivirus expression in assays of endothelial tube formation, sprouting of neovessels from murine aorta, and angiogenesis in Matrigel plugs. HKa stimulated expression and phosphorylation of p56/Lck. siRNA knockdown of p56/Lck promoted endothelial proliferation and blocked HKa-induced apoptosis and activation of p53, Bax, and Bak. Lentivirus expression of p56/Lck in endothelial cells induced apoptosis and blocked tube formation. Expression of p56/Lck in murine aortic rings blocked sprouting angiogenesis. Lentivirus expressing p56/Lck blocked angiogenesis in Matrigel plugs, while p56/Lck short hairpin RNA inhibited the antiangiogenic effect of HKa. Scrambled siRNAs and empty lentiviral vectors were used in all experiments. Apoptosis of proliferating endothelial cells and inhibition of angiogenesis by HKa requires p56/Lck. This suggests a novel role for p56/Lck in regulation of endothelial cell survival and angiogenesis.	[Betapudi, Venkaiah; Shukla, Meenal; Alluri, Ravi; Merkulov, Sergei; McCrae, Keith R.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44106 USA; [McCrae, Keith R.] Cleveland Clin, Taussig Canc Inst, R4-018,9500 Euclid Ave, Cleveland, OH 44195 USA; [Betapudi, Venkaiah] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH 44106 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Case Western Reserve University	McCrae, KR (corresponding author), Cleveland Clin, Taussig Canc Inst, R4-018,9500 Euclid Ave, Cleveland, OH 44195 USA.	mccraek@ccf.org			U.S. National Institutes of Health National Heart, Lung, and Blood Institute [R01-HL098796]	U.S. National Institutes of Health National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in part by the U.S. National Institutes of Health National Heart, Lung, and Blood Institute Grant R01-HL098796 (to K.R.M.).	ADAMIS AP, 1993, BIOCHEM BIOPH RES CO, V193, P631, DOI 10.1006/bbrc.1993.1671; Aleshin A, 2010, NEOPLASIA, V12, P599, DOI 10.1593/neo.10328; Allen KL, 2012, BLOOD, V119, P884, DOI 10.1182/blood-2011-03-344671; Baker M, 2012, NAT PROTOC, V7, P89, DOI 10.1038/nprot.2011.435; Belka C, 2003, ONCOGENE, V22, P176, DOI 10.1038/sj.onc.1206103; Berg NN, 1997, J IMMUNOL, V159, P1753; Bhagwat SS, 2009, PURINERG SIGNAL, V5, P107, DOI 10.1007/s11302-008-9117-z; Boehm T, 1997, NATURE, V390, P404, DOI 10.1038/37126; Bottsford-Miller JN, 2012, J CLIN ONCOL, V30, P4026, DOI 10.1200/JCO.2012.41.9242; BUGGE TH, 1995, J BIOL CHEM, V270, P16886, DOI 10.1074/jbc.270.28.16886; Cao DJ, 2004, CIRC RES, V94, P1227, DOI 10.1161/01.RES.0000126567.75232.46; Chapman NM, 2013, J IMMUNOL, V191, P6208, DOI 10.4049/jimmunol.1301587; Chavakis T, 2000, BLOOD, V96, P514; Colman RW, 1997, J CLIN INVEST, V100, P1481, DOI 10.1172/JCI119669; Colman RW, 2000, BLOOD, V95, P543, DOI 10.1182/blood.V95.2.543; Cooper JC, 2010, INT J ONCOL, V36, P1201, DOI 10.3892/ijo_00000603; Creedon Helen, 2012, Critical Reviews in Oncogenesis, V17, P145; Folkman J, 2004, APMIS, V112, P496, DOI 10.1111/j.1600-0463.2004.apm11207-0809.x; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Goldmann WH, 2002, CELL BIOL INT, V26, P567, DOI 10.1006/cbir.2002.0900; Gorska MM, 2012, BLOOD, V119, P1399, DOI 10.1182/blood-2011-04-350686; Gorska MM, 2004, J EXP MED, V199, P369, DOI 10.1084/jem.20030589; Gruber C, 2004, BIOCHEM PHARMACOL, V67, P1859, DOI 10.1016/j.bcp.2004.01.026; Guo YL, 2005, J THROMB HAEMOST, V3, P670, DOI 10.1111/j.1538-7836.2005.01218.x; Hardwick JM, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008722; Harr MW, 2010, CELL DEATH DIFFER, V17, P1381, DOI 10.1038/cdd.2010.25; Hasan AAK, 1998, P NATL ACAD SCI USA, V95, P3615, DOI 10.1073/pnas.95.7.3615; Herwald H, 1996, J BIOL CHEM, V271, P13040, DOI 10.1074/jbc.271.22.13040; Ion G, 2006, CELL SIGNAL, V18, P1887, DOI 10.1016/j.cellsig.2006.02.007; Joseph K, 1999, CLIN IMMUNOL, V92, P246, DOI 10.1006/clim.1999.4753; Kane LP, 2000, CURR OPIN IMMUNOL, V12, P242, DOI 10.1016/S0952-7915(00)00083-2; Kapoor M, 2000, ONCOGENE, V19, P358, DOI 10.1038/sj.onc.1203300; Kim MJ, 2008, BIOCHEM BIOPH RES CO, V370, P353, DOI 10.1016/j.bbrc.2008.03.084; Laham LE, 2000, ONCOGENE, V19, P3961, DOI 10.1038/sj.onc.1203738; Liu YC, 2008, AM J PHYSIOL-CELL PH, V295, pC257, DOI 10.1152/ajpcell.00569.2007; Liu Y, 2008, EXP CELL RES, V314, P774, DOI 10.1016/j.yexcr.2007.10.008; Ma KY, 2000, J BIOL CHEM, V275, P15541, DOI 10.1074/jbc.275.20.15541; Mahdi F, 2004, J BIOL CHEM, V279, P16621, DOI 10.1074/jbc.M313850200; Mancuso P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114713; Martin MW, 2010, EXPERT OPIN THER PAT, V20, P1573, DOI 10.1517/13543776.2010.517749; Martinou JC, 2011, DEV CELL, V21, P92, DOI 10.1016/j.devcel.2011.06.017; MOORE GL, 1981, BIOCHEM MED METAB B, V26, P167, DOI 10.1016/0006-2944(81)90043-0; Novak J, 2014, MOL IMMUNOL, V57, P302, DOI 10.1016/j.molimm.2013.10.010; OREILLY MS, 1994, CELL, V79, P315, DOI 10.1016/0092-8674(94)90200-3; Ostergaard HL, 1998, J BIOL CHEM, V273, P5692, DOI 10.1074/jbc.273.10.5692; Papatriantafyllou M, 2013, NAT REV IMMUNOL, V13, P222, DOI 10.1038/nri3429; Park HS, 2011, BIOCHEM PHARMACOL, V82, P1110, DOI 10.1016/j.bcp.2011.07.085; Park SI, 2007, EXPERT OPIN THER TAR, V11, P1207, DOI 10.1517/14728222.11.9.1207; Pixley RA, 2011, THROMB HAEMOSTASIS, V105, P1053, DOI 10.1160/TH10-09-0591; Prager GW, 2012, HAMOSTASEOLOGIE, V32, P105, DOI 10.5482/ha-1163; Renne T, 2000, J BIOL CHEM, V275, P33688, DOI 10.1074/jbc.M000313200; Salmond RJ, 2005, J IMMUNOL, V175, P6498, DOI 10.4049/jimmunol.175.10.6498; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Saunders AE, 2010, CELL SIGNAL, V22, P339, DOI 10.1016/j.cellsig.2009.10.003; Sen B., 2011, J SIGNAL TRANSDUCT, V2011; Shi MJ, 2006, MOL CANCER RES, V4, P39, DOI 10.1158/1541-7786.MCR-05-0202; Shibuya M, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a009092; Sun DY, 2006, BLOOD, V107, P4714, DOI 10.1182/blood-2005-09-3584; Svec A, 2008, PATHOL RES PRACT, V204, P785, DOI 10.1016/j.prp.2008.06.006; Umemura H, 2011, J GASTROENTEROL, V46, P577, DOI 10.1007/s00535-010-0369-3; Weis SM, 2011, NAT MED, V17, P1359, DOI 10.1038/nm.2537; Zhang JC, 2000, FASEB J, V14, P2589, DOI 10.1096/fj.99-1025com; Zhang JC, 2002, CAN J PHYSIOL PHARM, V80, P85, DOI 10.1139/Y02-011; Zhang W, 2011, BLOOD, V118	64	10	10	1	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3515	3526		10.1096/fj.201500040	http://dx.doi.org/10.1096/fj.201500040			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27402674	Green Published			2022-12-28	WOS:000384329800021
J	Meplan, C; Johnson, IT; Polley, ACJ; Cockell, S; Bradburn, DM; Commane, DM; Arasaradnam, RP; Mulholland, F; Zupanic, A; Mathers, JC; Hesketh, J				Meplan, Catherine; Johnson, Ian T.; Polley, Abigael C. J.; Cockell, Simon; Bradburn, David M.; Commane, Daniel M.; Arasaradnam, Ramesh P.; Mulholland, Francis; Zupanic, Anze; Mathers, John C.; Hesketh, John			Transcriptomics and proteomics show that selenium affects inflammation, cytoskeleton, and cancer pathways in human rectal biopsies	FASEB JOURNAL			English	Article						selenoprotein; NF kappa B; colorectal; cytokeratin; nutrigenomics	NF-KAPPA-B; GLUTATHIONE-PEROXIDASE 4; COLORECTAL-CANCER; SERUM SELENIUM; EXPRESSION; RISK; DISEASE; MUCOSA; HEALTH; GENES	Epidemiologic studies highlight the potential role of dietary selenium (Se) in colorectal cancer prevention. Our goal was to elucidate whether expression of factors crucial for colorectal homoeostasis is affected by physiologic differences in Se status. Using transcriptomics and proteomics followed by pathway analysis, we identified pathways affected by Se status in rectal biopsies from 22 healthy adults, including 11 controls with optimal status (mean plasma Se = 1.43 mu M) and 11 subjects with suboptimal status (mean plasma Se = 0.86 mu M). We observed that 254 genes and 26 proteins implicated in cancer (80%), immune function and inflammatory response (40%), cell growth and proliferation (70%), cellular movement, and cell death (50%) were differentially expressed between the 2 groups. Expression of 69 genes, including selenoproteins W1 and K, which are genes involved in cytoskeleton remodelling and transcription factor NF kappa B signaling, correlated significantly with Se status. Integrating proteomics and transcriptomics datasets revealed reduced inflammatory and immune responses and cytoskeleton remodelling in the suboptimal Se status group. This is the first study combining omics technologies to describe the impact of differences in Se status on colorectal expression patterns, revealing that suboptimal Se status could alter inflammatory signaling and cytoskeleton in human rectal mucosa and so influence cancer risk.	[Meplan, Catherine; Zupanic, Anze; Hesketh, John] Newcastle Univ, Inst Cell & Mol Biosci, Newcastle Upon Tyne, Tyne & Wear, England; [Meplan, Catherine; Arasaradnam, Ramesh P.] Newcastle Univ, Sch Biomed Sci, Newcastle Upon Tyne, Tyne & Wear, England; [Meplan, Catherine; Commane, Daniel M.; Mathers, John C.; Hesketh, John] Newcastle Univ, Human Nutr Res Ctr, Newcastle Upon Tyne, Tyne & Wear, England; [Meplan, Catherine; Hesketh, John] Newcastle Univ, Sch Med, Newcastle Upon Tyne, Tyne & Wear, England; [Cockell, Simon] Newcastle Univ, Bioinformat Support Unit, Newcastle Upon Tyne, Tyne & Wear, England; [Arasaradnam, Ramesh P.; Mathers, John C.] Newcastle Univ, Inst Cellular Med, Newcastle Upon Tyne, Tyne & Wear, England; [Johnson, Ian T.; Polley, Abigael C. J.; Mulholland, Francis] Inst Food Res, Norwich Res Pk, Norwich, Norfolk, England; [Arasaradnam, Ramesh P.] Wansbeck Gen Hosp, Ashingon, England	Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; Newcastle University - UK; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia	Meplan, C (corresponding author), Newcastle Univ, Sch Med, Sch Biomed Sci, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	catherine.meplan@ncl.ac.uk	Johnson, Ian T/D-2892-2012; Duarte, Graziela Biude Silva/Q-7728-2016; Zupanic, Anze/B-9396-2008	Johnson, Ian T/0000-0002-2353-4609; Zupanic, Anze/0000-0003-3303-9086; Cockell, Simon/0000-0002-6831-9806; Commane, Daniel/0000-0002-0154-8540; Arasaradnam, Ramesh/0000-0002-2231-3062	Newcastle Healthcare Charity; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/H011471/1]; United Kingdom Food Standards Agency [N12015]; BBSRC; Biotechnology and Biological Sciences Research Council [BB/H011471/1]; BBSRC [BBS/E/F/00042195, BB/H011471/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/F/00042195] Funding Source: researchfish	Newcastle Healthcare Charity; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); United Kingdom Food Standards Agency; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	C.M. was supported by the Newcastle Healthcare Charity and the Biotechnology and Biological Sciences Research Council (BBSRC) (BB/H011471/1). I.T.J., A.C.J.P., and F.M. were supported by a contract from the United Kingdom Food Standards Agency (N12015) and by a BBSRC strategic grant to the Institute of Food Research. A.Z. was supported by funds from Grant BB/H011471/1 from the Biotechnology and Biological Sciences Research Council (awarded to J.E.H. and J.C.M.). The authors declare no conflicts of interest.	Alfonso P, 2005, PROTEOMICS, V5, P2602, DOI 10.1002/pmic.200401196; Banan A, 1999, J PHARMACOL EXP THER, V291, P1075; Bellinger FP, 2009, BIOCHEM J, V422, P11, DOI 10.1042/BJ20090219; Besson D, 2011, MOL CELL PROTEOMICS, V10, DOI [10.1074/mcp.M111.009712-1, 10.1074/mcp.M111.009712]; Clark JA, 2007, SHOCK, V28, P384, DOI 10.1097/shk.0b013e31805569df; Cole-Ezea P, 2012, FREE RADICAL BIO MED, V53, P488, DOI 10.1016/j.freeradbiomed.2012.05.029; Finley JW, 2001, BIOFACTORS, V14, P191, DOI 10.1002/biof.5520140124; Gong G, 2012, GENES NUTR, V7, P167, DOI 10.1007/s12263-011-0256-4; Hasler R, 2012, GENOME RES, V22, P2130, DOI 10.1101/gr.138347.112; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hughes DJ, 2015, INT J CANCER, V136, P1149, DOI 10.1002/ijc.29071; Jacobs ET, 2004, J NATL CANCER I, V96, P1669, DOI 10.1093/jnci/djh310; Jin QY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066439; Kipp A, 2009, MOL NUTR FOOD RES, V53, P1561, DOI 10.1002/mnfr.200900105; Kipp AP, 2012, J NUTR BIOCHEM, V23, P1170, DOI 10.1016/j.jnutbio.2011.06.011; Laclaustra M, 2010, ATHEROSCLEROSIS, V210, P643, DOI 10.1016/j.atherosclerosis.2010.01.005; Lee J, 2000, BBA-GENE STRUCT EXPR, V1491, P355, DOI 10.1016/S0167-4781(00)00047-6; Legembre P, 2004, J BIOL CHEM, V279, P46742, DOI 10.1074/jbc.M404334200; Li YX, 2000, DNA CELL BIOL, V19, P113, DOI 10.1089/104454900314627; Lippman SM, 2009, JAMA-J AM MED ASSOC, V301, P39, DOI 10.1001/jama.2008.864; Meiler S, 2013, J LEUKOCYTE BIOL, V93, P771, DOI 10.1189/jlb.1212647; Meplan C, 2012, MUTAGENESIS, V27, P177, DOI 10.1093/mutage/ger058; Moon C, 2003, ONCOGENE, V22, P6699, DOI 10.1038/sj.onc.1206762; Niskar AS, 2003, BIOL TRACE ELEM RES, V91, P1, DOI 10.1385/BTER:91:1:1; Nutritional Prevention of Cancer Study Group, 1996, JAMA-J AM MED ASSOC, V276, P1957; Park MC, 2012, P NATL ACAD SCI USA, V109, pE640, DOI 10.1073/pnas.1200194109; Pasparakis M, 2009, NAT REV IMMUNOL, V9, P778, DOI 10.1038/nri2655; Peters U, 2008, CANCER EPIDEM BIOMAR, V17, P1144, DOI 10.1158/1055-9965.EPI-07-2947; Polley ACJ, 2006, CANCER RES, V66, P6553, DOI 10.1158/0008-5472.CAN-06-0534; Popp MWL, 2013, ANNU REV GENET, V47, P139, DOI 10.1146/annurev-genet-111212-133424; Rayman MP, 2012, LANCET, V379, P1256, DOI 10.1016/S0140-6736(11)61452-9; Reddy BS, 1997, JNCI-J NATL CANCER I, V89, P506, DOI 10.1093/jnci/89.7.506; ROGERS KR, 1992, ANN RHEUM DIS, V51, P565, DOI 10.1136/ard.51.4.565; Sakthianandeswaren A, 2011, CANCER RES, V71, P3709, DOI 10.1158/0008-5472.CAN-10-2342; Shinozaki S, 2001, GUT, V48, P623, DOI 10.1136/gut.48.5.623; Slattery ML, 2009, CANCER PREV RES, V2, P922, DOI 10.1158/1940-6207.CAPR-08-0191; Stein MP, 2002, TRENDS CELL BIOL, V12, P374, DOI 10.1016/S0962-8924(02)02331-0; Sunde RA, 2008, BRIT J NUTR, V99, pS37, DOI 10.1017/S0007114508006831; Takata Y, 2011, CANCER EPIDEM BIOMAR, V20, P1822, DOI 10.1158/1055-9965.EPI-11-0364; Takubo T, 2003, EUR J HISTOCHEM, V47, P345; Tapp HS, 2013, AGING CELL, V12, P148, DOI 10.1111/acel.12030; Verma S, 2011, J IMMUNOL, V186, P2127, DOI 10.4049/jimmunol.1002878; Vicente-Manzanares M, 2004, NAT REV IMMUNOL, V4, P110, DOI 10.1038/nri1268; Wapenaar MC, 2007, IMMUNOGENETICS, V59, P349, DOI 10.1007/s00251-007-0199-5; Zemolin APP, 2012, TOXICOLOGY, V302, P60, DOI 10.1016/j.tox.2012.07.013; Zhang B, 2014, NATURE, V513, P382, DOI 10.1038/nature13438	46	31	34	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2812	+		10.1096/fj.201600251R	http://dx.doi.org/10.1096/fj.201600251R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27103578	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000380994000017
J	Perez, RL; Best, G; Nicolay, NH; Greubel, C; Rossberger, S; Reindl, J; Dollinger, G; Weber, KJ; Cremer, C; Huber, PE				Perez, Ramon Lopez; Best, Gerrit; Nicolay, Nils H.; Greubel, Christoph; Rossberger, Sabrina; Reindl, Judith; Dollinger, Guenther; Weber, Klaus-Josef; Cremer, Christoph; Huber, Peter E.			Superresolution light microscopy shows nanostructure of carbon ion radiation-induced DNA double-strand break repair foci	FASEB JOURNAL			English	Article						nanoscopy; heavy ion radiation; gamma H2AX	STRUCTURED-ILLUMINATION MICROSCOPY; DEPLETION FLUORESCENCE MICROSCOPY; DIFFRACTION RESOLUTION LIMIT; GROUND-STATE-DEPLETION; LOCALIZATION MICROSCOPY; BLOOD-LYMPHOCYTES; DAMAGE RESPONSE; H2AX PHOSPHORYLATION; STIMULATED-EMISSION; SINGLE MOLECULES	Carbon ion radiation is a promising new form of radiotherapy for cancer, but the central question about the biologic effects of charged particle radiation is yet incompletely understood. Key to this question is the understanding of the interaction of ions with DNA in the cell's nucleus. Induction and repair of DNA lesions including double-strand breaks (DSBs) are decisive for the cell. Several DSB repair markers have been used to investigate these processes microscopically, but the limited resolution of conventional microscopy is insufficient to provide structural insights. We have applied superresolution microscopy to overcome these limitations and analyze the fine structure of DSB repair foci. We found that the conventionally detected foci of the widely used DSB marker gamma H2AX (empty set 700-1000nm) were composed of elongated subfoci with a size of similar to 100 nm consisting of even smaller subfocus elements (empty set 40-60 nm). The structural organization of the subfoci suggests that they could represent the local chromatin structure of elementary DSB repair units at the DSB damage sites. Subfocus clusters may indicate induction of densely spaced DSBs, which are thought to be associated with the high biologic effectiveness of carbon ions. Superresolution microscopy might emerge as a powerful tool to improve our knowledge of interactions of ionizing radiation with cells.	[Perez, Ramon Lopez; Nicolay, Nils H.; Weber, Klaus-Josef; Huber, Peter E.] German Canc Res Ctr, Clin Cooperat Unit, Heidelberg, Germany; [Perez, Ramon Lopez; Nicolay, Nils H.; Weber, Klaus-Josef; Huber, Peter E.] German Canc Res Ctr, Mol Radiat Oncol, Heidelberg, Germany; [Perez, Ramon Lopez; Nicolay, Nils H.; Weber, Klaus-Josef; Huber, Peter E.] Univ Heidelberg Hosp, Dept Radiat Oncol, Heidelberg, Germany; [Best, Gerrit] Univ Heidelberg Hosp, Dept Ophthalmol, Heidelberg, Germany; [Best, Gerrit; Rossberger, Sabrina; Cremer, Christoph] Heidelberg Univ, Kirchhoff Inst Phys, Heidelberg, Germany; [Greubel, Christoph; Reindl, Judith; Dollinger, Guenther] Univ Bundeswehr Munchen, Inst Angew Phys & Messtech, Neubiberg, Germany; [Cremer, Christoph] Inst Mol Biol, Superresolut Microscopy Funct Nucl Nanostruct, Mainz, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Ruprecht Karls University Heidelberg; Bundeswehr University Munich; Institute of Molecular Biology (IMB)	Perez, RL; Huber, PE (corresponding author), German Canc Res Ctr, CCU Mol & Radiat Oncol, D-69120 Heidelberg, Baden Wurttembe, Germany.	r.lopez@dkfz.de; p.huber@dkfz.de		Reindl, Judith/0000-0002-3238-8586; Lopez Perez, Ramon/0000-0002-6876-2074	Deutsche Forschungsgemeinschaft (DFG), National Priority Research Program the Tumor-Vessel Interface [SPP1190]; National Aeronautics and Space Administration Specialized Center of Research [NNJ04HJ12G]; Kompetenzverbund Strahlenforschung (KVSF) of the German Ministries for Education, Bundesministerien fur Bildung, Forschung und Umwelt (BMBF/BMU) [03NUK004A,C]	Deutsche Forschungsgemeinschaft (DFG), National Priority Research Program the Tumor-Vessel Interface; National Aeronautics and Space Administration Specialized Center of Research; Kompetenzverbund Strahlenforschung (KVSF) of the German Ministries for Education, Bundesministerien fur Bildung, Forschung und Umwelt (BMBF/BMU)	The authors thank A. Friedl, S. Drexler (Ludwig-Maximilians-Universitat Munchen, Munich, Germany), and M. Lautenbacher (Universitat der Bundeswehr Munchen, Neubiberg, Germany) for coordination of biologic experiments at the SNAKE facility; M. Hausmann and P. Muller (Heidelberg University) for helpful discussions; and R. Heintzmann (Friedrich Schiller University Jena, Jena, Germany) for providing algorithms for SIM image reconstruction. This work was supported in part by grants from the Deutsche Forschungsgemeinschaft (DFG), National Priority Research Program the Tumor-Vessel Interface (SPP1190); National Aeronautics and Space Administration Specialized Center of Research (NNJ04HJ12G); and Kompetenzverbund Strahlenforschung (KVSF) of the German Ministries for Education, Research and Environment, Bundesministerien fur Bildung, Forschung und Umwelt (BMBF/BMU; 03NUK004A,C). Funding for open access charge was provided by institutional funds.	Abbe E., 1873, ARCH F MIKROSK ANAT, V9, P413, DOI [10.1007/bf02956173, DOI 10.1007/BF02956173, 10.1007/ BF02956173]; Altmeyer M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9088; Baddeley D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020645; Baddeley D, 2010, MICROSC MICROANAL, V16, P64, DOI 10.1017/S143192760999122X; Barnard S, 2015, RADIAT PROT DOSIM, V164, P265, DOI 10.1093/rpd/ncu259; Beels L, 2009, CIRCULATION, V120, P1903, DOI 10.1161/CIRCULATIONAHA.109.880385; Best G, 2011, MICRON, V42, P330, DOI 10.1016/j.micron.2010.06.016; BETZIG E, 1995, OPT LETT, V20, P237, DOI 10.1364/OL.20.000237; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bewersdorf J, 2006, P NATL ACAD SCI USA, V103, P18137, DOI 10.1073/pnas.0608709103; Boker W, 2006, RADIAT RES, V165, P113, DOI 10.1667/RR3486.1; Bonner WM, 2008, NAT REV CANCER, V8, P957, DOI 10.1038/nrc2523; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Combs SE, 2010, RADIOTHER ONCOL, V95, P54, DOI 10.1016/j.radonc.2009.12.029; Costes SV, 2010, MUTAT RES-REV MUTAT, V704, P78, DOI 10.1016/j.mrrev.2009.12.006; Costes SV, 2006, RADIAT RES, V165, P505, DOI 10.1667/RR3538.1; CREMER C, 1978, MICROSC ACTA, V81, P31; Cremer C, 2013, EUR PHYS J H, V38, P281, DOI 10.1140/epjh/e2012-20060-1; Cremer T, 2015, FEBS LETT, V589, P2931, DOI 10.1016/j.febslet.2015.05.037; Desai N, 2005, RADIAT RES, V164, P518, DOI 10.1667/RR3431.1; Dickson RM, 1997, NATURE, V388, P355, DOI 10.1038/41048; Folling J, 2008, NAT METHODS, V5, P943, DOI 10.1038/nmeth.1257; Garty G, 2011, INT J RADIAT BIOL, V87, P754, DOI 10.3109/09553002.2011.583317; Greubel C, 2008, RADIAT ENVIRON BIOPH, V47, P415, DOI 10.1007/s00411-008-0181-0; Gunkel Manuel, 2009, Biotechnology Journal, V4, P927, DOI 10.1002/biot.200900005; Gustafsson MGL, 2000, J MICROSC-OXFORD, V198, P82, DOI 10.1046/j.1365-2818.2000.00710.x; Gustafsson MGL, 2005, P NATL ACAD SCI USA, V102, P13081, DOI 10.1073/pnas.0406877102; HANNINEN PE, 1995, APPL PHYS LETT, V66, P1698, DOI 10.1063/1.113897; Hauptner A, 2004, RADIAT ENVIRON BIOPH, V42, P237, DOI 10.1007/s00411-003-0222-7; Heilemann M, 2008, ANGEW CHEM INT EDIT, V47, P6172, DOI 10.1002/anie.200802376; Heilemann M, 2009, ANGEW CHEM INT EDIT, V48, P6903, DOI 10.1002/anie.200902073; Heintzmann R, 1999, P SOC PHOTO-OPT INS, V3568, P185, DOI 10.1117/12.336833; HELL SW, 1995, APPL PHYS B-LASERS O, V60, P495, DOI 10.1007/BF01081333; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; HELL SW, 1994, OPT LETT, V19, P222, DOI 10.1364/OL.19.000222; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Karadaglic D, 2008, MICRON, V39, P808, DOI 10.1016/j.micron.2008.01.017; Kaufmann R, 2011, J MICROSC-OXFORD, V242, P46, DOI 10.1111/j.1365-2818.2010.03436.x; Kaufmann R, 2009, PROC SPIE, V7185, DOI 10.1117/12.809109; KIEFER J, 1986, PHYS MED BIOL, V31, P1201, DOI 10.1088/0031-9155/31/11/002; Klar TA, 2000, P NATL ACAD SCI USA, V97, P8206, DOI 10.1073/pnas.97.15.8206; Kuefner MA, 2010, EUR RADIOL, V20, P2917, DOI 10.1007/s00330-010-1873-9; Kuefner MA, 2009, INVEST RADIOL, V44, P440, DOI 10.1097/RLI.0b013e3181a654a5; Kumar R, 2014, DNA REPAIR, V15, P54, DOI 10.1016/j.dnarep.2013.12.004; Lang M, 2010, J CELL SCI, V123, P392, DOI 10.1242/jcs.053496; Lemmer P, 2008, APPL PHYS B-LASERS O, V93, P1, DOI 10.1007/s00340-008-3152-x; Lemmer P, 2009, J MICROSC-OXFORD, V235, P163, DOI 10.1111/j.1365-2818.2009.03196.x; Lobrich M, 2005, P NATL ACAD SCI USA, V102, P8984, DOI 10.1073/pnas.0501895102; Lobrich M, 1996, INT J RADIAT BIOL, V70, P493, DOI 10.1080/095530096144680; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; McManus KJ, 2005, MOL BIOL CELL, V16, P5013, DOI 10.1091/mbc.E05-01-0065; Meyer B, 2013, NUCLEIC ACIDS RES, V41, P6109, DOI 10.1093/nar/gkt304; MOERNER WE, 1989, PHYS REV LETT, V62, P2535, DOI 10.1103/PhysRevLett.62.2535; Nakajima NI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070107; Nakamura AJ, 2010, CELL CYCLE, V9, P389, DOI 10.4161/cc.9.2.10475; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peschke P, 2011, INT J RADIAT ONCOL, V79, P239, DOI 10.1016/j.ijrobp.2010.07.1976; Redon CE, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015544; Reindl J, 2015, PHYS BIOL, V12, DOI 10.1088/1478-3975/12/6/066005; Rogakou EP, 1999, J CELL BIOL, V146, P905, DOI 10.1083/jcb.146.5.905; Rogakou EP, 1998, J BIOL CHEM, V273, P5858, DOI 10.1074/jbc.273.10.5858; Rossberger S, 2013, J OPTICS-UK, V15, DOI 10.1088/2040-8978/15/9/094003; Rothkamm K, 2003, P NATL ACAD SCI USA, V100, P5057, DOI 10.1073/pnas.0830918100; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Sak A, 2007, INT J RADIAT BIOL, V83, P639, DOI 10.1080/09553000701596118; Sedelnikova OA, 2002, RADIAT RES, V158, P486, DOI 10.1667/0033-7587(2002)158[0486:QDOIID]2.0.CO;2; Shah K, 2016, DIAGN CYTOPATHOL, V44, P141, DOI 10.1002/dc.23396; Sinnecker D, 2005, BIOCHEMISTRY-US, V44, P7085, DOI 10.1021/bi047881x; Stenerlow B, 2002, ADV SPACE RES, V30, P859, DOI 10.1016/S0273-1177(02)00403-9; WARD JF, 1988, PROG NUCLEIC ACID RE, V35, P95, DOI 10.1016/S0079-6603(08)60611-X; Zahnreich S, 2015, RADIAT RES, V183, P432, DOI 10.1667/RR13911.1	71	33	33	1	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2767	2776		10.1096/fj.201500106R	http://dx.doi.org/10.1096/fj.201500106R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27166088				2022-12-28	WOS:000380994000013
J	Zhang, SY; Zhou, R; Li, B; Li, HY; Wang, YY; Gu, XJ; Tang, LY; Wang, C; Zhong, DJ; Ge, YY; Huo, YQ; Lin, J; Liu, XL; Chen, JF				Zhang, Shuya; Zhou, Rong; Li, Bo; Li, Haiyan; Wang, Yanyan; Gu, Xuejiao; Tang, Lingyun; Wang, Cun; Zhong, Dingjuan; Ge, Yuanyuan; Huo, Yuqing; Lin, Jing; Liu, Xiao-Ling; Chen, Jiang-Fan			Caffeine preferentially protects against oxygen-induced retinopathy	FASEB JOURNAL			English	Article						retinopathy of prematurity; adenosine A2A receptor; vaso-obliteration; neovascularization	ENDOTHELIAL GROWTH-FACTOR; ADENOSINE RECEPTORS; RETINAL NEOVASCULARIZATION; SURVIVAL FACTOR; VESSEL LOSS; CELL-DEATH; PREMATURITY; MODEL; BRAIN; MOUSE	Retinopathy of prematurity (ROP) is the leading cause of childhood blindness, but current anti-VEGF therapy is concerned with delayed retinal vasculature, eye, and brain development of preterm infants. The clinical observation of reduced ROP severity in premature infants after caffeine treatment for apnea suggests that caffeine may protect against ROP. Here, we demonstrate that caffeine did not interfere with normal retinal vascularization development but selectively protected against oxygen-induced retinopathy (OIR) in mice. Moreover, caffeine attenuated not only hypoxia-induced pathologic angiogenesis, but also hyperoxia-induced vaso-obliteration, which suggests a novel protection window by caffeine. At the hyperoxic phase, caffeine reduced oxygen-induced neural apoptosis by adenosine A(2A) receptor (A(2A)R)-dependent mechanism, as revealed by combined caffeine and A(2A)R-knockout treatment. At the hypoxic phase, caffeine reduced microglial activation and enhanced tip cell formation by A(2A)R-dependent and -independent mechanisms, as combined caffeine and A(2A)R knockout produced additive and nearly full protection against OIR. Together with clinical use of caffeine in neonates, our demonstration of the selective protection against OIR, effective therapeutic window, adenosine receptor mechanisms, and neuroglial involvement provide the direct evidence of the novel effects of caffeine therapy in the prevention and treatment of ROP.	[Zhang, Shuya; Zhou, Rong; Li, Bo; Li, Haiyan; Wang, Yanyan; Gu, Xuejiao; Tang, Lingyun; Wang, Cun; Zhong, Dingjuan; Ge, Yuanyuan; Liu, Xiao-Ling; Chen, Jiang-Fan] Wenzhou Med Univ, Mol Neuropharmacol Lab, Sch Optometry & Ophthalmol, 270 Xueyuan Rd, Wenzhou, Zhejiang, Peoples R China; [Zhang, Shuya; Zhou, Rong; Li, Bo; Li, Haiyan; Wang, Yanyan; Gu, Xuejiao; Tang, Lingyun; Wang, Cun; Zhong, Dingjuan; Ge, Yuanyuan; Liu, Xiao-Ling; Chen, Jiang-Fan] Wenzhou Med Univ, Hosp Eye, 270 Xueyuan Rd, Wenzhou, Zhejiang, Peoples R China; [Lin, Jing] Wenzhou Med Univ, Dept Neonatol, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China; [Zhang, Shuya; Zhou, Rong; Li, Bo; Li, Haiyan; Wang, Yanyan; Gu, Xuejiao; Tang, Lingyun; Wang, Cun; Zhong, Dingjuan; Ge, Yuanyuan; Liu, Xiao-Ling; Chen, Jiang-Fan] Minist Hlth, State Key Lab Cultivat Base, Wenzhou, Peoples R China; [Zhang, Shuya; Zhou, Rong; Li, Bo; Li, Haiyan; Wang, Yanyan; Gu, Xuejiao; Tang, Lingyun; Wang, Cun; Zhong, Dingjuan; Ge, Yuanyuan; Liu, Xiao-Ling; Chen, Jiang-Fan] Minist Hlth, Key Lab Vis Sci, Wenzhou, Peoples R China; [Zhang, Shuya; Zhou, Rong; Li, Bo; Li, Haiyan; Wang, Yanyan; Gu, Xuejiao; Tang, Lingyun; Wang, Cun; Zhong, Dingjuan; Ge, Yuanyuan; Liu, Xiao-Ling; Chen, Jiang-Fan] Zhejiang Prov Key Lab Ophthalmol & Optometry, Wenzhou, Peoples R China; [Huo, Yuqing] Augusta Univ, Med Coll Georgia, Vasc Biol Ctr, Dept Cellular Biol & Anat, Augusta, GA USA; [Huo, Yuqing] Peking Univ, Shenzhen Grad Sch, Ctr Drug Discovery, Key Lab Chem Genom, Shenzhen, Peoples R China; [Lin, Jing] Icahn Sch Med Mt Sinai, Dept Pediat, New York, NY 10029 USA	Wenzhou Medical University; Wenzhou Medical University; Wenzhou Medical University; University System of Georgia; Augusta University; Peking University; University Town of Shenzhen; Icahn School of Medicine at Mount Sinai	Liu, XL; Chen, JF (corresponding author), Wenzhou Med Univ, Mol Neuropharmacol Lab, Sch Optometry & Ophthalmol, 270 Xueyuan Rd, Wenzhou, Zhejiang, Peoples R China.; Liu, XL (corresponding author), Wenzhou Med Univ, Hosp Eye, 270 Xueyuan Rd, Wenzhou, Zhejiang, Peoples R China.	lxl@mail.eye.ac.cn; chenjf555@gmail.com	Liu, Xiaoling/HGD-3566-2022; Lin, Jing/I-5293-2019	Lin, Jing/0000-0002-4405-134X; Chen, Jiang-Fan/0000-0002-0446-3956	Wenzhou Medical University [89211010, 89212012]; National Natural Science Foundation of China [81630040, 81600753, 81100672]; Zhejiang Provincial Special Funds [604161241]; Key Laboratory of Vision Science, Ministry of Health, China [601041241]; National Key Basic Research Program of China [2012CB910402]; Central Government Special Fund for Local Universities' Development [474091314]; Zhejiang Provincial Natural Science Foundation [LY12H12007]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [DK095862]; NIH National Heart, Lung, and Blood Institute [HL095556, HL108922]; Boston University School of Medicine Special Research Fund DTD [4-30-14]	Wenzhou Medical University; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Special Funds; Key Laboratory of Vision Science, Ministry of Health, China; National Key Basic Research Program of China(National Basic Research Program of China); Central Government Special Fund for Local Universities' Development; Zhejiang Provincial Natural Science Foundation(Natural Science Foundation of Zhejiang Province); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Boston University School of Medicine Special Research Fund DTD	This study was sponsored by the Start-up Fund from Wenzhou Medical University (Grants 89211010 and 89212012 to J.-F.C.), the National Natural Science Foundation of China (Grants 81630040 to J.-F.C., 81600753 to S.Z., and 81100672 to R.Z.), the Zhejiang Provincial Special Funds (Grant 604161241 to J.-F.C.), Key Laboratory of Vision Science, Ministry of Health, China (Grant 601041241 to J.-F.C.), the National Key Basic Research Program of China (Grant 2012CB910402 to J.-F.C.), the Central Government Special Fund for Local Universities' Development (Grant 474091314 to J.-F.C.), and Zhejiang Provincial Natural Science Foundation (Grant LY12H12007 to X.-L.L.). This study was also funded by U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases (Grant DK095862 to Y.H.), NIH National Heart, Lung, and Blood Institute (Grants HL095556 and HL108922 to Y.H.), and Boston University School of Medicine Special Research Fund DTD 4-30-14 (to J.-F.C.). The authors thank Dr. Zailong Chi (Wenzhou Medical University) for critical reading of the manuscript, and Drs. Zhe Wang and Congcong Wen (both from Wenzhou Medical University) for assistance in ultra-high-performance liquid chromatography-mass spectrometry analysis.	Abdel-Hady Hesham, 2015, World J Clin Pediatr, V4, P81, DOI 10.5409/wjcp.v4.i4.81; Afzal A, 2003, CIRC RES, V93, P500, DOI 10.1161/01.RES.0000091260.78959.BC; ALON T, 1995, NAT MED, V1, P1024, DOI 10.1038/nm1095-1024; Aranda JV, 2016, PEDIATR RES, V80, P554, DOI 10.1038/pr.2016.105; ARANDA JV, 1979, J PEDIATR-US, V94, P663, DOI 10.1016/S0022-3476(79)80047-5; ARANDA JV, 1977, J PEDIATR-US, V90, P467, DOI 10.1016/S0022-3476(77)80718-X; Back SA, 2006, ANN NEUROL, V60, P696, DOI 10.1002/ana.21008; BONA E, 1995, PEDIATR RES, V38, P312, DOI 10.1203/00006450-199509000-00007; BRAAS KM, 1987, P NATL ACAD SCI USA, V84, P3906, DOI 10.1073/pnas.84.11.3906; Cabral-Miranda F, 2011, NEUROSCI RES, V71, P99, DOI 10.1016/j.neures.2011.05.018; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Cavallaro G, 2014, ACTA OPHTHALMOL, V92, P2, DOI 10.1111/aos.12049; Chen JF, 1999, J NEUROSCI, V19, P9192, DOI 10.1523/jneurosci.19-21-09192.1999; Chen JF, 2013, NAT REV DRUG DISCOV, V12, P265, DOI 10.1038/nrd3955; Chen Y, 2008, BRIT J OPHTHALMOL, V92, P326, DOI 10.1136/bjo.2007.131813; Clark D, 2008, EARLY HUM DEV, V84, P95, DOI 10.1016/j.earlhumdev.2007.11.007; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Daly JW, 2007, CELL MOL LIFE SCI, V64, P2153, DOI 10.1007/s00018-007-7051-9; Day YJ, 2003, J CLIN INVEST, V112, P883, DOI 10.1172/JCI200315483; Dhaliwal C, 2009, BRIT J OPHTHALMOL, V93, P355, DOI 10.1136/bjo.2008.148908; Duan LJ, 2011, AM J PATHOL, V178, P1881, DOI 10.1016/j.ajpath.2010.12.016; Echeverri D, 2010, INT J VASC MED, V2010, DOI 10.1155/2010/834060; Elsherbiny NM, 2013, BIOCHEM BIOPH RES CO, V436, P355, DOI 10.1016/j.bbrc.2013.05.023; Fleck BW, 2008, EARLY HUM DEV, V84, P83, DOI 10.1016/j.earlhumdev.2007.11.008; Fredholm BB, 1999, PHARMACOL REV, V51, P83; Frick JS, 2009, J IMMUNOL, V182, P4957, DOI 10.4049/jimmunol.0801324; GEORGIEV V, 1993, BRAIN RES, V612, P271, DOI 10.1016/0006-8993(93)91672-F; Gilbert C, 2008, EARLY HUM DEV, V84, P77, DOI 10.1016/j.earlhumdev.2007.11.009; Hartnett ME, 2012, NEW ENGL J MED, V367, P2515, DOI 10.1056/NEJMra1208129; Hentges CR, 2010, J PEDIAT-BRAZIL, V86, P137, DOI [10.1590/S0021-75572010000200010, 10.2223/JPED.1990]; Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818; Hsu SJ, 2015, HEPATOLOGY, V61, P1672, DOI 10.1002/hep.27679; Hu J, 2012, ARCH OPHTHALMOL-CHIC, V130, P1000, DOI 10.1001/archophthalmol.2012.592; Huang QY, 2006, J NEUROSCI, V26, P11371, DOI 10.1523/JNEUROSCI.1907-06.2006; Ishida S, 2003, NAT MED, V9, P781, DOI 10.1038/nm877; Kornfield TE, 2014, J NEUROSCI, V34, P11504, DOI 10.1523/JNEUROSCI.1971-14.2014; Kvanta A, 1997, EXP EYE RES, V65, P595, DOI 10.1006/exer.1996.0352; LeBlanc KH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061355; LEGUENNEC JC, 1987, PEDIATRICS, V79, P264; Li H, 2013, ANAT CELL BIOL, V46, P57, DOI 10.5115/acb.2013.46.1.57; Liu XL, 2010, INVEST OPHTH VIS SCI, V51, P6625, DOI 10.1167/iovs.09-4900; Lobov IB, 2005, NATURE, V437, P417, DOI 10.1038/nature03928; Ludewig P, 2014, INVEST OPHTH VIS SCI, V55, P7950, DOI 10.1167/iovs.13-13403; Lutty GA, 2003, PROG RETIN EYE RES, V22, P95, DOI 10.1016/S1350-9462(02)00058-7; McCloskey M, 2013, INVEST OPHTH VIS SCI, V54, P2020, DOI 10.1167/iovs.13-11625; Merighi S, 2007, MOL PHARMACOL, V72, P395, DOI 10.1124/mol.106.032920; Mino RP, 2001, INVEST OPHTH VIS SCI, V42, P3320; Mintz-Hittner HA, 2011, NEW ENGL J MED, V364, P603, DOI 10.1056/NEJMoa1007374; Morin J, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3218; Narayanan SP, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.23; Nishijima K, 2007, AM J PATHOL, V171, P53, DOI 10.2353/ajpath.2007.061237; PARSONS WD, 1981, J PEDIATR-US, V98, P640, DOI 10.1016/S0022-3476(81)80784-6; PEARLMAN SA, 1989, DEV PHARMACOL THERAP, V12, P65, DOI 10.1159/000480966; Penn JS, 2008, PROG RETIN EYE RES, V27, P331, DOI 10.1016/j.preteyeres.2008.05.001; Rivkees SA, 2011, PEDIATR RES, V69, P271, DOI 10.1203/PDR.0b013e31820efbcf; Robinson GS, 2001, FASEB J, V15, P1215, DOI 10.1096/fj.00-0598fje; RYU JE, 1985, DEV PHARMACOL THERAP, V8, P329, DOI 10.1159/000457057; Ryzhov S, 2007, J PHARMACOL EXP THER, V320, P565, DOI 10.1124/jpet.106.114850; Saint-Geniez M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003554; Saura J, 2005, J NEUROCHEM, V95, P919, DOI 10.1111/j.1471-4159.2005.03395.x; Schingnitz U, 2010, J IMMUNOL, V184, P5271, DOI 10.4049/jimmunol.0903035; Schmidt B, 2007, NEW ENGL J MED, V357, P1893, DOI 10.1056/NEJMoa073679; Schoen K, 2014, PEDIATR DRUGS, V16, P169, DOI 10.1007/s40272-013-0063-z; Scott A, 2010, EYE, V24, P416, DOI 10.1038/eye.2009.306; Shoshan-Barmatz V, 2005, INT J BIOCHEM CELL B, V37, P1681, DOI 10.1016/j.biocel.2005.03.001; Shoshan-Barmatz V, 2007, EUR J NEUROSCI, V26, P3113, DOI 10.1111/j.1460-9568.2007.05931.x; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2010, INVEST OPHTH VIS SCI, V51, P2813, DOI 10.1167/iovs.10-5176; Surmeier DJ, 2012, NEURON, V75, P1, DOI 10.1016/j.neuron.2012.06.028; Takagi H, 1998, DIABETES, V47, P1480, DOI 10.2337/diabetes.47.9.1480; Takagi H, 1996, INVEST OPHTH VIS SCI, V37, P2165; Taomoto M, 2000, INVEST OPHTH VIS SCI, V41, P230; Tokunaga CC, 2014, INVEST OPHTH VIS SCI, V55, P1884, DOI 10.1167/iovs.13-13397; Xu ZH, 2012, AM J PATHOL, V180, P2548, DOI 10.1016/j.ajpath.2012.02.021; Yu LQ, 2008, ANN NEUROL, V63, P338, DOI 10.1002/ana.21313; Zhang SY, 2015, INVEST OPHTH VIS SCI, V56, P8108, DOI 10.1167/iovs.15-17202	77	22	23	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3334	3348		10.1096/fj.201601285R	http://dx.doi.org/10.1096/fj.201601285R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28420694	Green Published			2022-12-28	WOS:000405932400013
J	Lee, J; Wen, B; Carter, EA; Combes, V; Grau, GER; Lay, PA				Lee, Joonsup; Wen, Beryl; Carter, Elizabeth A.; Combes, Valery; Grau, Georges E. R.; Lay, Peter A.			Infrared spectroscopic characterization of monocytic microvesicles (microparticles) released upon lipopolysaccharide stimulation	FASEB JOURNAL			English	Article						extracellular vesicles; endotoxin; FTIR spectroscopy; cell signaling; immunology	MASS-SPECTROMETRY; PLATELET MICROPARTICLES; ENDOTHELIAL MICROPARTICLES; CELLS; MACROPHAGES; SYNCHROTRON; SPECTRA; PHOSPHATIDYLSERINE; MICROSPECTROSCOPY; INFLAMMATION	Microvesicles (MVs) are involved in cell-cell interactions, including disease pathogenesis. Non-destructive Fourier-transform infrared (FTIR) spectra from MVs were assessed as a technique to provide new biochemical insights into a LPS-induced monocyte model of septic shock. FTIR spectroscopy provided a quick method to investigate relative differences in biomolecular content of different MV populations that was complementary to traditional semiquantitative omics approaches, with which it is difficult to provide information on relative changes between classes (proteins, lipids, nucleic acids, carbohydrates) or protein conformations. Time dependent changes were detected in biomolecular contents of MVs and in the monocytes from which they were released. Differences in phosphatidylcholine and phosphatidylserine contents were observed in MVs released under stimulation, and higher relative concentrations of RNA and a-helical structured proteins were present in stimulated MVs compared with MVs from resting cells. FTIR spectra of stimulated monocytes displayed changes that were consistent with those observed in the corresponding MVs they released. LPS-stimulated monocytes had reduced concentrations of nucleic acids, a-helical structured proteins, and phosphatidylcholine compared with resting monocytes but had an increase in total lipids. FTIR spectra of MV biomolecular content will be important in shedding new light on the mechanisms of MVs and the different roles they play in physiology and disease pathogenesis. Lee, J., Wen, B., Carter, E. A., Combes, V., Grau, G. E. R., Lay, P. A. Infrared spectroscopic characterization of monocytic microvesicles (microparticles) released upon lipopolysaccharide stimulation.	[Lee, Joonsup; Carter, Elizabeth A.; Lay, Peter A.] Univ Sydney, Sch Chem, Room 307 Chem Bldg F11,City Rd, Sydney, NSW 2006, Australia; [Lee, Joonsup; Carter, Elizabeth A.; Lay, Peter A.] Univ Sydney, Vibrat Spect Core Facil, Sydney, NSW, Australia; [Wen, Beryl; Combes, Valery; Grau, Georges E. R.] Univ Sydney, Sch Med Sci, Bosch Inst, Vasc Immunopathol Unit, Sydney, NSW, Australia; [Grau, Georges E. R.; Lay, Peter A.] Univ Sydney, AINST, Sydney, NSW, Australia; [Combes, Valery] Univ Technol Sydney, Sch Life Sci, Fac Sci, Sydney, NSW, Australia	University of Sydney; University of Sydney; University of Sydney; University of Sydney; University of Technology Sydney	Lay, PA (corresponding author), Univ Sydney, Sch Chem, Room 307 Chem Bldg F11,City Rd, Sydney, NSW 2006, Australia.	peter.lay@sydney.edu.au	Grau, Georges/AGR-7139-2022; Lay, Peter A/B-4698-2014; Carter, Elizabeth/J-7365-2019	Grau, Georges/0000-0002-0442-0462; Lay, Peter A/0000-0002-3232-2720; Carter, Elizabeth/0000-0001-6318-7771; Combes, Valery/0000-0003-2178-3596	Australian Postgraduate Award; Australian Institute of Nuclear Science and Engineering (AINSE); Australian Research Council (ARC) [DP0984722, DP140100176]; National Health and Medical Research Council (NHMRC) [APP1009914, APP1028241]; ARC Linkage, Infrastructure, Equipment and Facilities (LIEF) grant [LE0883036]; University of Sydney NHMRC	Australian Postgraduate Award(Australian Government); Australian Institute of Nuclear Science and Engineering (AINSE); Australian Research Council (ARC)(Australian Research Council); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); ARC Linkage, Infrastructure, Equipment and Facilities (LIEF) grant(Australian Research Council); University of Sydney NHMRC	This research was supported by an Australian Postgraduate Award and an Australian Institute of Nuclear Science and Engineering (AINSE) postgraduate scholarship (to J.L.), Australian Research Council (ARC) Grants DP0984722 (including an ARC Professorial Fellowship), and DP140100176 (to PAL.), National Health and Medical Research Council (NHMRC) Grants APP1009914 and APP1028241 (to G.E.R.G.). The use of the FTIR equipment was made possible by an ARC Linkage, Infrastructure, Equipment and Facilities (LIEF) grant (LE0883036), and by University of Sydney NHMRC equipment grants. This research was conducted under the Australian Institute for Nanoscale Science and Technology (AINST) Flagship Program "New insights into disease and drug targets from endogenous biological nanoscale vesicles to engineered nano particles." The authors thank Amandine Bonhoure (University of Sydney) for assistance with the cell culturing work in this study. The authors declare no conflicts of interest.	Aitken JB, 2010, RADIAT PHYS CHEM, V79, P176, DOI 10.1016/j.radphyschem.2009.03.068; Al-Nedawi K, 2008, NAT CELL BIOL, V10, P619, DOI 10.1038/ncb1725; Andrews RK, 2008, BLOOD, V112, P2174, DOI 10.1182/blood-2008-06-163063; Antonio PD, 2012, BBA-BIOMEMBRANES, V1818, P3141, DOI 10.1016/j.bbamem.2012.08.001; Bader CA, 2016, MOL BIOSYST, V12, P2064, DOI 10.1039/c6mb00242k; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; BEVERS EM, 1983, BIOCHIM BIOPHYS ACTA, V736, P57, DOI 10.1016/0005-2736(83)90169-4; BHANDARE P, 1994, VIB SPECTROSC, V6, P363, DOI 10.1016/0924-2031(93)E0059-B; Bhandare P., 1992, P 18 IEEE ANN NE BIO, DOI [10.1109/NEBC.1992.285973, DOI 10.1109/NEBC.1992.285973]; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Burger D, 2013, CLIN SCI, V124, P423, DOI 10.1042/CS20120309; Capriotti AL, 2013, ANAL CHIM ACTA, V776, P57, DOI 10.1016/j.aca.2013.03.023; Carter EA, 2007, ACS SYM SER, V963, P64; Carter EA, 2010, MOL BIOSYST, V6, P1316, DOI 10.1039/c001499k; Carter Elizabeth A, 2009, Biophys Rev, V1, P95, DOI 10.1007/s12551-009-0012-9; CHOO LP, 1993, BIOCHIM BIOPHYS ACTA, V1182, P333, DOI 10.1016/0925-4439(93)90078-F; Combes V, 2004, JAMA-J AM MED ASSOC, V291, P2542, DOI 10.1001/jama.291.21.2542-b; Combes V, 2010, PROG NEUROBIOL, V91, P140, DOI 10.1016/j.pneurobio.2010.01.007; CRAWFORD N, 1971, BRIT J HAEMATOL, V21, P53, DOI 10.1111/j.1365-2141.1971.tb03416.x; Delabranche X, 2012, MED MALADIES INFECT, V42, P335, DOI 10.1016/j.medmal.2012.05.011; DeSouza LV, 2013, CLIN BIOCHEM, V46, P421, DOI 10.1016/j.clinbiochem.2012.10.025; DeWalt RI, 2013, BIOCHEM BIOPH RES CO, V432, P695, DOI 10.1016/j.bbrc.2013.01.122; Diem M, 2004, INFRARED PHYS TECHN, V45, P331, DOI 10.1016/j.infrared.2004.01.013; Distler JHW, 2005, ARTHRITIS RHEUM, V52, P3337, DOI 10.1002/art.21350; Distler JHW, 2006, AUTOIMMUNITY, V39, P683, DOI 10.1080/08916930601061538; Du Y, 2012, ANAL CHEM, V84, P6355, DOI 10.1021/ac3013362; Dumas P, 2003, J BIOL PHYS, V29, P201, DOI 10.1023/A:1024448910761; Eckel R, 2001, VIB SPECTROSC, V27, P165, DOI 10.1016/S0924-2031(01)00134-5; Faille D, 2012, J CELL MOL MED, V16, P1731, DOI 10.1111/j.1582-4934.2011.01434.x; Faille D, 2009, FASEB J, V23, P3449, DOI 10.1096/fj.09-135822; Feng L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038400; FIDLER IJ, 1988, BIOCHIM BIOPHYS ACTA, V948, P151, DOI 10.1016/0304-419X(88)90009-1; Freyssinet JM, 2003, J THROMB HAEMOST, V1, P1655, DOI 10.1046/j.1538-7836.2003.00309.x; Furse S, 2015, MOL MEMBR BIOL, V32, P55, DOI 10.3109/09687688.2015.1050468; GEORGE JN, 1982, BLOOD, V60, P834; Glish GL, 2003, NAT REV DRUG DISCOV, V2, P140, DOI 10.1038/nrd1011; Hackett MJ, 2011, NUCL INSTRUM METH B, V269, P2260, DOI 10.1016/j.nimb.2011.02.034; Hackett M. J., 2010, Classification of biological samples using spectroscopic analysis, Patent No. [PCT WO2010048678, 2010048678]; Hackett MJ, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500911; Hackett MJ, 2012, ACS CHEM NEUROSCI, V3, P1017, DOI 10.1021/cn300093g; Hackett MJ, 2011, ANALYST, V136, P2941, DOI 10.1039/c0an00269k; Jaiswal R, 2012, FASEB J, V26, P420, DOI 10.1096/fj.11-186817; Koppler B, 2006, EUR J IMMUNOL, V36, P648, DOI 10.1002/eji.200535435; Krilov D, 2009, SPECTROCHIM ACTA A, V73, P701, DOI 10.1016/j.saa.2009.03.015; Lasch P., 2008, BIOMEDICAL VIBRATION; Latham SL, 2013, FASEB J, V27, P672, DOI 10.1096/fj.12-216531; Lee J, 2013, NUCL INSTRUM METH B, V306, P129, DOI 10.1016/j.nimb.2012.11.045; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Mantsch HH, 2001, PRACT SPECTROSC SERI, V24, P1; MATIC M, 1991, CYTOKINE, V3, P576, DOI 10.1016/1043-4666(91)90484-U; McQuillan JA, 2011, INT J PARASITOL, V41, P155, DOI 10.1016/j.ijpara.2010.08.003; Merten M, 1999, CIRCULATION, V99, P2577, DOI 10.1161/01.CIR.99.19.2577; Messana I, 2008, J SEP SCI, V31, P1948, DOI 10.1002/jssc.200800100; Mfonkeu JBP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013415; Miller LM, 2003, J BIOL PHYS, V29, P219, DOI 10.1023/A:1024401027599; Miyoshi H, 1996, GASTROENTEROLOGY, V110, P1897, DOI 10.1053/gast.1996.v110.pm8964416; Movasaghi Z, 2008, APPL SPECTROSC REV, V43, P134, DOI 10.1080/05704920701829043; Nau R, 2002, TRENDS NEUROSCI, V25, P38, DOI 10.1016/S0166-2236(00)02024-5; Naumann D, 2001, PRACT SPECTROSC SERI, V24, P323; Nieuwland R, 2000, BLOOD, V95, P930, DOI 10.1182/blood.V95.3.930.003k46_930_935; Nomura S, 2001, ATHEROSCLEROSIS, V158, P277, DOI 10.1016/S0021-9150(01)00433-6; Perna G, 2011, VIB SPECTROSC, V57, P55, DOI 10.1016/j.vibspec.2011.05.002; Piccin A, 2007, BLOOD REV, V21, P157, DOI 10.1016/j.blre.2006.09.001; Pose S, 2012, CARBOHYD POLYM, V88, P882, DOI 10.1016/j.carbpol.2012.01.029; Reid VL, 2012, BRIT J ANAESTH, V109, P503, DOI 10.1093/bja/aes321; Sabatier F, 2002, BLOOD, V99, P3962, DOI 10.1182/blood.V99.11.3962; Salpin JY, 2007, CHEMPHYSCHEM, V8, P2235, DOI 10.1002/cphc.200700284; Schittmayer M, 2016, J PROTEOME RES, V15, P1222, DOI 10.1021/acs.jproteome.5b01105; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; SCHROIT AJ, 1984, BIOL CELL, V51, P227, DOI 10.1111/j.1768-322X.1984.tb00303.x; Seger C, 2012, WIEN MED WOCHENSCHR, V162, P499, DOI 10.1007/s10354-012-0147-3; Sims PJ, 2001, THROMB HAEMOSTASIS, V86, P266; Socrates G., 2004, INFRARED RAMAN CHARA; Tokes-Fuzesi M, 2013, J CRIT CARE, V28, P141, DOI 10.1016/j.jcrc.2012.05.006; Trinchieri G, 1997, CURR OPIN IMMUNOL, V9, P17, DOI 10.1016/S0952-7915(97)80154-9; Uddin MJ, 2012, VET IMMUNOL IMMUNOP, V147, P211, DOI 10.1016/j.vetimm.2012.04.020; Verrastro I, 2015, BIOMOLECULES, V5, P378, DOI 10.3390/biom5020378; Walters SB, 2013, J IMMUNOL, V190, P669, DOI 10.4049/jimmunol.1201856; Wen B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091597; Wolpert M, 2006, SPECTROCHIM ACTA A, V64, P987, DOI 10.1016/j.saa.2005.08.025; Woth G, 2012, ANN CLIN BIOCHEM, V49, P554, DOI 10.1258/acb.2012.011215; Zhao YY, 2015, BIOMARK MED, V9, P153, DOI [10.2217/bmm.14.81, 10.2217/BMM.14.81]; Zwaal RFA, 1997, BLOOD, V89, P1121, DOI 10.1182/blood.V89.4.1121; Zwaal RFA, 2005, CELL MOL LIFE SCI, V62, P971, DOI 10.1007/s00018-005-4527-3	84	18	18	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2817	2827		10.1096/fj.201601272R	http://dx.doi.org/10.1096/fj.201601272R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28314769				2022-12-28	WOS:000405931000009
J	do Carmo, JM; da Silva, AA; Romero, DG; Hall, JE				do Carmo, Jussara M.; da Silva, Alexandre A.; Romero, Damian G.; Hall, John E.			Changes in ambient temperature elicit divergent control of metabolic and cardiovascular actions by leptin	FASEB JOURNAL			English	Article						blood pressure; energy expenditure; food intake; heart rate	MESSENGER-RNA EXPRESSION; DIET-INDUCED OBESE; GENE-EXPRESSION; ARCUATE NUCLEUS; ENVIRONMENTAL CONTRIBUTIONS; ADRENERGIC ACTIVITY; ARTERIAL-PRESSURE; ENERGY-BALANCE; BLOOD-PRESSURE; POMC NEURONS	Interactions of hypothalamic signaling pathways that control body temperature (BT), blood pressure (BP), and energy balance are poorly understood. We investigated whether the chronic BP and metabolic actions of leptin are differentially modulated by changes in ambient temperature (T-A). Mean arterial pressure (MAP), heart rate (HR), BT, motor activity (MA), and oxygen consumption (VO2) were measured 24 h/d at normal laboratory T-A (23 degrees C), at thermoneutral zone (TNZ, 30 degrees C) for mice or during cold exposure (15 degrees C) in male wild-type mice. After control measurements, leptin (4 mu g/kg/min) or saline vehiclewas infused for 7 d. At TNZ, leptin reduced food intake (-11.0 +/- 0.5 g cumulative deficit) and body weight by 6% but caused no changes in MAP or HR. At 15 degrees C, leptin infusion did not alter food intake but increased MAP andHR(8 +/- 1mmHgand 33 +/- 7 bpm), while VO2 increased by similar to 10%. Leptin reduced plasma glucose and insulin levels at 15 degrees C but not at 30 degrees C. These results demonstrate that the chronic anorexic effects of leptin are enhanced at TNZ, while its effects on insulin and glucose levels are attenuated and its effects on BP and HR are abolished. Conversely, cold T-A caused resistance to leptin's anorexic effects but amplified its effects to raise BP and reduce insulin and glucose levels. Thus, the brain circuits by which leptin regulates food intake and cardiovascular function are differentially influenced by changes in T-A.	[do Carmo, Jussara M.; da Silva, Alexandre A.; Hall, John E.] Univ Mississippi, Med Ctr, Dept Physiol & Biophys, Mississippi Ctr Obes Res,Cardiovasc Renal Res Ctr, Jackson, MS 39216 USA; [Romero, Damian G.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA; [da Silva, Alexandre A.] Ctr Univ Barao de Maua, Ribeirao Preto, SP, Brazil	University of Mississippi; University of Mississippi Medical Center; University of Mississippi; University of Mississippi Medical Center	do Carmo, JM (corresponding author), Univ Mississippi, Med Ctr, Dept Physiol & Biophys, 2500 North State St, Jackson, MS 39216 USA.	jdocarmo@umc.edu	Silva, Alexandre A/K-8054-2014	Silva, Alexandre A/0000-0003-4504-0607; Hall, John/0000-0001-9867-5855	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [PO1 HL51971]; NIH National Institute of General Medical Sciences [P20 GM104357]; American Heart Association Scientist Development grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051971] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104357] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); American Heart Association Scientist Development grant(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in part, by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (Grant PO1 HL51971), the NIH National Institute of General Medical Sciences (Grant P20 GM104357), and by an American Heart Association Scientist Development grant (to J.M.D.C. and D.G.R.). The authors thank H. Zhang, S. E. Ebaady, P. O. Sessums, C. Torrey, and J. P. Ball (all from the University of Mississippi Medical Center) for technical assistance. The authors declare no conflicts of interest.	Bartfai Tamas, 2012, Frontiers in Genetics, V3, P184, DOI 10.3389/fgene.2012.00184; Cannon B, 2011, J EXP BIOL, V214, P242, DOI 10.1242/jeb.050989; Carlyle M, 2002, HYPERTENSION, V39, P496, DOI 10.1161/hy0202.104398; Cohen P, 2001, J CLIN INVEST, V108, P1113, DOI 10.1172/JCI200113914; Cone RD, 2001, INT J OBESITY, V25, pS63, DOI 10.1038/sj.ijo.0801913; Cowley MA, 2001, NATURE, V411, P480, DOI 10.1038/35078085; da Silva AA, 2006, AM J PHYSIOL-REG I, V291, pR1275, DOI 10.1152/ajpregu.00187.2006; do Carmo JM, 2014, INT J OBESITY, V38, P775, DOI 10.1038/ijo.2013.177; do Carmo JM, 2011, HYPERTENSION, V57, P918, DOI 10.1161/HYPERTENSIONAHA.110.161349; Dubinion JH, 2013, HYPERTENSION, V61, P1066, DOI 10.1161/HYPERTENSIONAHA.111.00020; Elias CF, 1999, NEURON, V23, P775, DOI 10.1016/S0896-6273(01)80035-0; Farooqi IS, 1999, NEW ENGL J MED, V341, P879, DOI 10.1056/NEJM199909163411204; Grill HJ, 2012, CELL METAB, V16, P296, DOI 10.1016/j.cmet.2012.06.015; Hall JE, 2015, CIRC RES, V116, P991, DOI 10.1161/CIRCRESAHA.116.305697; Hall JE, 2012, COMPR PHYSIOL, V2, P2393, DOI 10.1002/cphy.c110058; Hall JE, 2010, J BIOL CHEM, V285, P17271, DOI 10.1074/jbc.R110.113175; Haltiner AL, 2004, AM J PHYSIOL-REG I, V287, pR1250, DOI 10.1152/ajpregu.00313.2004; Haynes WG, 1997, J CLIN INVEST, V100, P270, DOI 10.1172/JCI119532; Heijboer AC, 2005, PEPTIDES, V26, P2554, DOI 10.1016/j.peptides.2005.05.013; Hill JO, 1998, SCIENCE, V280, P1371, DOI 10.1126/science.280.5368.1371; Hill JO, 1998, AM J CLIN NUTR, V68, P991, DOI 10.1093/ajcn/68.5.991; Horvath Tamas L., 2014, Yale Journal of Biology and Medicine, V87, P149; Huang XF, 2003, MOL BRAIN RES, V115, P21, DOI 10.1016/S0169-328X(03)00174-8; Knight WD, 2011, MECH AGEING DEV, V132, P220, DOI 10.1016/j.mad.2011.04.001; Lee AK, 2010, NUTRITION, V26, P411, DOI 10.1016/j.nut.2009.05.007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maloney SK, 2014, PHYSIOLOGY, V29, P413, DOI 10.1152/physiol.00029.2014; McMinn JE, 2005, AM J PHYSIOL-ENDOC M, V289, pE403, DOI 10.1152/ajpendo.00535.2004; Morrison CD, 2005, AM J PHYSIOL-ENDOC M, V289, pE1051, DOI 10.1152/ajpendo.00094.2005; Overton JM, 2010, INT J OBESITY, V34, pS53, DOI 10.1038/ijo.2010.240; Ozata M, 1999, J CLIN ENDOCR METAB, V84, P3686, DOI 10.1210/jc.84.10.3686; Pinto S, 2004, SCIENCE, V304, P110, DOI 10.1126/science.1089459; Ring LE, 2010, J CLIN INVEST, V120, P2931, DOI 10.1172/JCI41985; Romero DG, 2007, PHYSIOL GENOMICS, V32, P117, DOI 10.1152/physiolgenomics.00145.2007; Scarpace PJ, 1998, AM J PHYSIOL-ENDOC M, V275, pE259, DOI 10.1152/ajpendo.1998.275.2.E259; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schroder AL, 2009, ENDOCRINE, V35, P211, DOI 10.1007/s12020-009-9154-6; Scott MM, 2011, J CLIN INVEST, V121, P2413, DOI 10.1172/JCI43703; Shek EW, 1998, HYPERTENSION, V31, P409, DOI 10.1161/01.HYP.31.1.409; Speakman JR, 2013, MOL METAB, V2, P5, DOI 10.1016/j.molmet.2012.10.002; Sun Zhongjie, 2010, Front Biosci (Elite Ed), V2, P495, DOI 10.2741/e108; SUN ZJ, 1995, CAN J PHYSIOL PHARM, V73, P72, DOI 10.1139/y95-010; Swoap SJ, 2008, AM J PHYSIOL-HEART C, V294, pH1581, DOI 10.1152/ajpheart.01000.2007; Swoap SJ, 2004, AM J PHYSIOL-REG I, V287, pR391, DOI 10.1152/ajpregu.00731.2003; Tian DR, 2004, PEPTIDES, V25, P2147, DOI 10.1016/j.peptides.2004.08.009	45	5	5	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2418	2428		10.1096/fj.201601224R	http://dx.doi.org/10.1096/fj.201601224R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28228474	Green Published			2022-12-28	WOS:000401553400017
J	Li, Y; Zheng, XM; Yi, XL; Liu, CX; Kong, DX; Zhang, JN; Gong, M				Li, Ying; Zheng, Xuemin; Yi, Xiulin; Liu, Changxiao; Kong, Dexin; Zhang, Jianning; Gong, Min			Myricetin: a potent approach for the treatment of type 2 diabetes as a natural class B GPCR agonist	FASEB JOURNAL			English	Article						GLP-1 receptor; oral agonist; insulin secretagogue; glucose tolerance test	GLUCAGON-LIKE PEPTIDE-1; DEPENDENT INSULINOTROPIC POLYPEPTIDE; CARDIOVASCULAR-DISEASE; CELL-PROLIFERATION; METABOLIC SYNDROME; RAT ADIPOCYTES; BETA-CELLS; MOLECULE; GLP-1; DIFFERENTIATION	The physiologic properties of glucagon-like peptide 1 (GLP-1) make it a potent candidate drug target in the treatment of type 2 diabetes mellitus (T2DM). GLP-1 is capable of regulating the blood glucose level by insulin secretion after administration of oral glucose. The advantages of GLP-1 for the avoidance of hypoglycemia and the control of body weight are attractive despite its poor stability. The clinical efficacies of long-acting GLP-1 derivatives strongly support discovery pursuits aimed at identifying and developing orally active, small-molecule GLP-1 receptor (GLP-1R) agonists. The purpose of this study was to identify and characterize a novel oral agonist of GLP-1R (i.e., myricetin). The insulinotropic characterization of myricetin was performed in isolated islets and in Wistar rats. Long-termoral administration of myricetin demonstrated glucoregulatory activity. The data in this study suggest that myricetin might be a potential drug candidate for the treatment of T2DM as a GLP-1R agonist. Further structural modifications on myricetin might improve its pharmacology and pharmacokinetics.	[Li, Ying; Zhang, Jianning] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Tianjin, Peoples R China; [Kong, Dexin; Gong, Min] Tianjin Med Univ, Dept Pharm, Tianjin 300070, Peoples R China; [Zheng, Xuemin; Yi, Xiulin; Liu, Changxiao] Tianjin Inst Pharmaceut Res, State Key Lab Drug Delivery Technol & Pharmacokin, Tianjin, Peoples R China; [Gong, Min] Univ Oxford, Dept Oncol, Oxford, England	Tianjin Medical University; Tianjin Medical University; University of Oxford	Gong, M (corresponding author), Tianjin Med Univ, Dept Pharm, Tianjin 300070, Peoples R China.; Zhang, JN (corresponding author), Tianjin Med Univ, Tianjin Neurol Inst, Gen Hosp, 22 Qixiangtai Rd, Heping Qu 300070, Peoples R China.	kahongmg@hotmail.com; gongmin@tmu.edu.cn			Ministry of Science and Technology of China [2014ZX09507005-003]; National Natural Science [81400932]; Science and Technology of Tianjin [13RCGFSY19700]; Natural Science Foundation of Tianjin, China [12JCYBJC31500]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science(National Natural Science Foundation of China (NSFC)); Science and Technology of Tianjin; Natural Science Foundation of Tianjin, China(Natural Science Foundation of Tianjin)	This work was supported by the National Science and Technology Major Project of the Ministry of Science and Technology of China (2014ZX09507005-003), the National Natural Science Funding (81400932), Major Project of Science and Technology of Tianjin (13RCGFSY19700), and the Natural Science Foundation of Tianjin, China (12JCYBJC31500). The authors declare no conflicts of interest.	Brubaker PL, 2004, ENDOCRINOLOGY, V145, P2653, DOI 10.1210/en.2004-0015; Chen DS, 2007, P NATL ACAD SCI USA, V104, P943, DOI 10.1073/pnas.0610173104; Devigny C, 2011, J AM CHEM SOC, V133, P8927, DOI 10.1021/ja200160s; Drucker DJ, 2003, MOL ENDOCRINOL, V17, P161, DOI 10.1210/me.2002-0306; EISSELE R, 1994, CELL TISSUE RES, V276, P571; ELAHI D, 1994, REGUL PEPTIDES, V51, P63, DOI 10.1016/0167-0115(94)90136-8; Eldor Roy, 2010, J Diabetes Sci Technol, V4, P1516; FRIDOLF T, 1991, PANCREAS, V6, P208, DOI 10.1097/00006676-199103000-00013; GOKE B, 1994, EUR J CLIN INVEST, V24, P25; Guariguata L, 2013, DIABETES RES CLIN PR, V100, P280, DOI 10.1016/j.diabres.2013.02.006; Guariguata L, 2012, DIABETES RES CLIN PR, V98, P524, DOI 10.1016/j.diabres.2012.11.006; Harnly JM, 2006, J AGR FOOD CHEM, V54, P9966, DOI 10.1021/jf061478a; HOLST JJ, 1994, GASTROENTEROLOGY, V107, P1848, DOI 10.1016/0016-5085(94)90831-1; Irwin N, 2010, EUR J PHARMACOL, V628, P268, DOI 10.1016/j.ejphar.2009.11.022; Janghorbani M, 2011, DIABETES METAB SYND, V5, P201, DOI 10.1016/j.dsx.2012.02.010; Jansson SPO, 2016, DIABETIC MED, V33, P324, DOI 10.1111/dme.13019; Kandasamy N, 2014, TOXICOL APPL PHARM, V279, P173, DOI 10.1016/j.taap.2014.05.014; KIEFFER TJ, 1995, ENDOCRINOLOGY, V136, P3585, DOI 10.1210/en.136.8.3585; Kirtland KA, 2014, PREV CHRONIC DIS, V11, DOI 10.5888/pcd11.130300; KREYMANN B, 1987, LANCET, V2, P1300; Kwon O, 2007, FASEB J, V21, P366, DOI 10.1096/fj.06-6620com; Lin CY, 2012, CYTOKINE, V59, P65, DOI 10.1016/j.cyto.2012.04.011; Lin Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162733; Linn T, 1996, ACTA DIABETOL, V33, P19, DOI 10.1007/BF00571935; Linnenkamp U, 2014, DIABETES RES CLIN PR, V103, P186, DOI 10.1016/j.diabres.2013.11.004; Liu IM, 2007, LIFE SCI, V81, P1479, DOI 10.1016/j.lfs.2007.08.045; Manaharan T, 2013, FOOD CHEM, V136, P354, DOI 10.1016/j.foodchem.2012.08.056; Martell-Claros N, 2013, EUR J PREV CARDIOL, V20, P21, DOI 10.1177/1741826711423114; Nauck MA, 1997, EXP CLIN ENDOCR DIAB, V105, P187, DOI 10.1055/s-0029-1211750; Okerson T, 2012, CARDIOVASC THER, V30, pe146, DOI 10.1111/j.1755-5922.2010.00256.x; Ong KC, 1996, BIOCHEM PHARMACOL, V51, P423, DOI 10.1016/0006-2952(95)02195-7; Ong KC, 2000, LIFE SCI, V67, P1695, DOI 10.1016/S0024-3205(00)00758-X; OSHIMA I, 1991, HORM METAB RES, V23, P240, DOI 10.1055/s-2007-1003663; Park HK, 2015, DIABETES METAB J, V39, P478, DOI 10.4093/dmj.2015.39.6.478; ROTH KA, 1992, AM J PHYSIOL, V263, pG174, DOI 10.1152/ajpgi.1992.263.2.G174; RUIZGRANDE C, 1990, CAN J PHYSIOL PHARM, V68, P1568, DOI 10.1139/y90-239; Scott R, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-102; Semwal DK, 2016, NUTRIENTS, V8, DOI 10.3390/nu8020090; SHIMA K, 1988, REGUL PEPTIDES, V22, P245, DOI 10.1016/0167-0115(88)90037-7; Sloop KW, 2010, DIABETES, V59, P3099, DOI 10.2337/db10-0689; Song SH, 2016, LANCET DIABETES ENDO, V4, P87, DOI 10.1016/S2213-8587(15)00390-3; Strobel P, 2005, BIOCHEM J, V386, P471, DOI 10.1042/BJ20040703; SURWIT RS, 1988, DIABETES, V37, P1163, DOI 10.2337/diabetes.37.9.1163; Teng M, 2007, BIOORG MED CHEM LETT, V17, P5472, DOI 10.1016/j.bmcl.2007.06.086; Tong Y, 2009, ARCH PHARM RES, V32, P527, DOI 10.1007/s12272-009-1408-6; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; Wootten D, 2012, MOL PHARMACOL, V82, P281, DOI 10.1124/mol.112.079319	47	42	43	4	28	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2603	2611		10.1096/fj.201601339R	http://dx.doi.org/10.1096/fj.201601339R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28270518	Green Published, hybrid			2022-12-28	WOS:000401553400031
J	Zhao, JJ; Wu, W; Zhang, W; Lu, YW; Tou, E; Ye, JM; Gao, P; Jourd'heuil, D; Singer, HA; Wu, MF; Long, XC				Zhao, Jinjing; Wu, Wen; Zhang, Wei; Lu, Yao Wei; Tou, Emiley; Ye, Jiemei; Gao, Ping; Jourd'heuil, David; Singer, Harold A.; Wu, Mingfu; Long, Xiaochun			Selective expression of TSPAN2 in vascular smooth muscle is independently regulated by TGF-beta 1/SMAD and myocardin/serum response factor	FASEB JOURNAL			English	Article						differentiation; tetraspanins; phenotypic modulation; arteriovenous fistula	LONG NONCODING RNA; CELL DIFFERENTIATION; NEOINTIMAL HYPERPLASIA; AORTIC-ANEURYSM; GROWTH; GENE; PROTEIN; MICE; ATHEROSCLEROSIS; PHENOTYPE	Tetraspanins (TSPANs) comprise a large family of 4-trans membrane domain proteins. The importance of TSPANs in vascular smooth muscle cells (VSMCs) is unexplored. Given that TGF-beta 1 and myocardin (MYOCD) are potent activators for VSMC differentiation, we screened for TGF-beta 1 and MYOCD/serum response factor (SRF)regulated TSPANs in VSMC by using RNA-seq analyses and RNA-arrays. TSPAN2 was found to be the only TSPAN family gene induced by TGF-beta 1 and MYOCD, and reduced by SRF deficiency in VSMCs. We also found that TSPAN2 is highly expressed in smooth muscle-enriched tissues and down-regulated in in vitro models of VSMC phenotypic modulation. TSPAN2 expressionis attenuated in mouse carotid arteries after ligation injury and infailed human arteriovenous fistula samples after occlusion by dedifferentiated neointimal VSMC. In vitro functional studies showed that TSPAN2 suppresses VSMC proliferation and migration. Luciferase reporter and chromatin immunoprecipitation assays demonstrated that TSPAN2 is regulated by 2 parallel pathways, MYOCD/SRF and TGF-beta 1/SMAD, via distinct binding elements within the proximal promoter. Thus, we identified the first VSMC-enriched and MYOCD/SRFandTGF-beta 1/SMAD-dependentTSPANfamilymember, whose expression is intimately associated with VSMC differentiation and negatively correlated with vascular disease. Our results suggest that TSPAN2 may play important roles in vascular disease.-Zhao, J., Wu, W., Zhang, W., Lu, Y. W., Tou, E., Ye, J., Gao, P., Jourd'heuil, D., Singer, H. A., Wu, M., Long, X. Selective expression of TSPAN2 in vascular smooth muscle is independently regulated by TGF-beta 1/SMAD and myocardin/serum response factor.	[Zhao, Jinjing; Wu, Wen; Zhang, Wei; Lu, Yao Wei; Tou, Emiley; Ye, Jiemei; Gao, Ping; Jourd'heuil, David; Singer, Harold A.; Wu, Mingfu; Long, Xiaochun] Albany Med Coll, Dept Mol & Cellular Physiol, 47 New Scotland Ave, Albany, NY 12208 USA	Albany Medical College	Long, XC (corresponding author), Albany Med Coll, Dept Mol & Cellular Physiol, 47 New Scotland Ave, Albany, NY 12208 USA.	longx@mail.amc.edu	Lu, Yao Wei/AAV-2007-2021; Wu, Wen/V-7065-2017	Lu, Yao Wei/0000-0001-6200-2974; Jourd'heuil, David/0000-0002-6555-5061; Long, Xiaochun/0000-0001-9714-0023; Tou, Emiley/0000-0003-2992-4269	American Heart Association Scientist Development Grant [10SDG3670036, 13SDG16920099]; U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) [R01-HL122686]; Paul Teschan Research Fund [2015_04]; Albany Medical College faculty startup funding; NIH/NHLBI [R01-HL121700, R01-HL49426]; American Heart Association [16GRNT31280002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL049426, R01HL121700, R01HL122686] Funding Source: NIH RePORTER	American Heart Association Scientist Development Grant(American Heart Association); U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI); Paul Teschan Research Fund; Albany Medical College faculty startup funding; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by American Heart Association Scientist Development Grant 10SDG3670036, U.S. National Institutes of Health/National Heart, Lung, and Blood Institute (NIH/NHLBI) Grant R01-HL122686, Paul Teschan Research Fund #2015_04, and Albany Medical College faculty startup funding (to X.L.); American Heart Association Scientist Development Grant 13SDG16920099 and NIH/NHLBI Grant R01-HL121700 (to M.W.); NIH/NHLBI Grant R01-HL49426 (to H.A.S.); and American Heart Association Grant-in-Aid 16GRNT31280002 (to D.J.). The authors declare no conflicts of interest.	Ackers-Johnson M, 2015, ARTERIOSCL THROM VAS, V35, P817, DOI 10.1161/ATVBAHA.114.305218; Albinsson S, 2011, PHYSIOL GENOMICS, V43, P529, DOI 10.1152/physiolgenomics.00146.2010; Alexander MR, 2012, PHYSIOL GENOMICS, V44, P417, DOI 10.1152/physiolgenomics.00160.2011; Bell RD, 2014, ARTERIOSCL THROM VAS, V34, P1249, DOI 10.1161/ATVBAHA.114.303240; Bennett MR, 2016, CIRC RES, V118, P692, DOI 10.1161/CIRCRESAHA.115.306361; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Cai YJ, 2015, CIRC RES, V116, P1120, DOI 10.1161/CIRCRESAHA.116.304408; Chen JY, 2002, J MOL CELL CARDIOL, V34, P1345, DOI 10.1006/jmcc.2002.2086; Chen PY, 2016, EMBO MOL MED, V8, P712, DOI 10.15252/emmm.201506181; Cordes KR, 2009, NATURE, V460, P705, DOI 10.1038/nature08195; de Monasterio-Schrader P, 2013, GLIA, V61, P1832, DOI 10.1002/glia.22561; Delos Santos RC, 2015, CELL SIGNAL, V27, P1963, DOI 10.1016/j.cellsig.2015.07.004; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Geary RL, 2002, ARTERIOSCL THROM VAS, V22, P2010, DOI 10.1161/01.ATV.0000038147.93527.35; Halayko AJ, 2001, J APPL PHYSIOL, V90, P358, DOI 10.1152/jappl.2001.90.1.358; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2001, J CELL BIOL, V155, P1103, DOI 10.1083/jcb.200108061; Herr MJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106999; Herring BP, 2014, VASC CELL, V6, DOI 10.1186/2045-824X-6-21; Hu JH, 2015, ARTERIOSCL THROM VAS, V35, P2647, DOI 10.1161/ATVBAHA.115.306573; Huang JH, 2008, J CLIN INVEST, V118, P515, DOI [10.1172/JC133304, 10.1172/JCI33304]; Huang JH, 2015, P NATL ACAD SCI USA, V112, P4447, DOI 10.1073/pnas.1420363112; Hur J, 2016, CELL STEM CELL, V18, P508, DOI 10.1016/j.stem.2016.01.013; Hwang IH, 2016, FASEB J, V30, P3107, DOI 10.1096/fj.201600240RR; Junge HJ, 2009, CELL, V139, P299, DOI 10.1016/j.cell.2009.07.048; Kiene LS, 2016, ARTERIOSCL THROM VAS, V36, pE9, DOI 10.1161/ATVBAHA.115.306607; Kitchen CM, 2013, GENE, V513, P82, DOI 10.1016/j.gene.2012.10.073; Larsson E, 2008, MOL GENET GENOMICS, V280, P127, DOI 10.1007/s00438-008-0349-y; Li SJ, 2003, P NATL ACAD SCI USA, V100, P9366, DOI 10.1073/pnas.1233635100; Lilly B, 2001, DEV BIOL, V240, P531, DOI 10.1006/dbio.2001.0507; Long XC, 2013, ARTERIOSCL THROM VAS, V33, P378, DOI 10.1161/ATVBAHA.112.300645; Long XC, 2011, J BIOL CHEM, V286, P30119, DOI 10.1074/jbc.M111.258814; Long X, 2009, J BIOL CHEM, V284, P33671, DOI 10.1074/jbc.M109.050419; Mao X, 2012, ARTERIOSCL THROM VAS, V32, P2171, DOI 10.1161/ATVBAHA.112.253872; Miano JM, 2004, P NATL ACAD SCI USA, V101, P17132, DOI 10.1073/pnas.0406041101; Miano JM, 2015, CELL MOL LIFE SCI, V72, P3457, DOI 10.1007/s00018-015-1936-9; Miano JM, 2015, J BIOMED RES, V29, P3, DOI 10.7555/JBR.29.20140151; Otsubo C, 2014, CELL REP, V7, P527, DOI 10.1016/j.celrep.2014.03.027; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; PAULETTO P, 1994, AM J HYPERTENS, V7, P661, DOI 10.1093/ajh/7.7.661; Qiu P, 2005, CIRC RES, V97, P983, DOI 10.1161/01.RES.0000190604.90049.71; Rosand J, 2016, LANCET NEUROL, V15, P174, DOI 10.1016/S1474-4422(15)00338-5; ROSS R, 1973, SCIENCE, V180, P1332, DOI 10.1126/science.180.4093.1332; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; Thyberg J, 1998, HISTOL HISTOPATHOL, V13, P871, DOI 10.14670/HH-13.871; Wang XB, 2011, J BIOL CHEM, V286, P41589, DOI 10.1074/jbc.M111.250878; Wang ZG, 2003, P NATL ACAD SCI USA, V100, P7129, DOI 10.1073/pnas.1232341100; Wei Q, 2014, CIRCULATION, V130, P1493, DOI 10.1161/CIRCULATIONAHA.114.011096; Xiao QZ, 2009, AM J PHYSIOL-CELL PH, V296, pC711, DOI 10.1152/ajpcell.00442.2008; Yoshida T, 2007, AM J PHYSIOL-CELL PH, V292, pC886, DOI 10.1152/ajpcell.00449.2006; Zhang C, 2016, J CLIN INVEST, V126, P1282, DOI 10.1172/JCI82337; Zhang F, 2009, CARDIOVASC RES, V83, P7, DOI 10.1093/cvr/cvp080; Zhang P, 2016, CIRC RES, V118, P388, DOI 10.1161/CIRCRESAHA.115.308040; Zhao JJ, 2016, ARTERIOSCL THROM VAS, V36, P2088, DOI 10.1161/ATVBAHA.116.307879	55	16	18	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2576	2591		10.1096/fj.201601021R	http://dx.doi.org/10.1096/fj.201601021R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28258189	Green Published			2022-12-28	WOS:000401553400029
J	Sun, YJ; Dong, LN; Yu, SQ; Wang, XX; Zheng, H; Zhang, P; Meng, CC; Zhan, Y; Tan, L; Song, CP; Qiu, XS; Wang, GJ; Liao, Y; Ding, C				Sun, Yingjie; Dong, Luna; Yu, Shengqing; Wang, Xiaoxu; Zheng, Hang; Zhang, Pin; Meng, Chunchun; Zhan, Yuan; Tan, Lei; Song, Cuiping; Qiu, Xusheng; Wang, Guijun; Liao, Ying; Ding, Chan			Newcastle disease virus induces stable formation of bona fide stress granules to facilitate viral replication through manipulating host protein translation	FASEB JOURNAL			English	Article						stress granules; Newcastle disease virus; replication; TIA-1; TIAR	HEPATITIS-C VIRUS; MESSENGER-RNA; NUCLEOCAPSID PROTEIN; V-PROTEIN; P-PROTEIN; INITIATION; RECRUITMENT; ACTIVATION; INHIBITION; TIA-1	Mammalian cells respond to various environmental stressors to form stress granules (SGs) by arresting cytoplasmic mRNA, protein translation element, and RNA binding proteins. Virus-induced SGs function in different ways, depending on the species of virus; however, themechanismofSGregulation of virus replication is not well understood. In this study, Newcastle disease virus (NDV) triggered stable formation of bona fide SGs on HeLa cells through activating the protein kinase R (PKR)/eIF2a pathway. NDV-induced SGs contained classic SGmarkers T-cell internal antigen (TIA)(-1), RasGTPase-activatingprotein-binding protein (G3BP)(-1), eukaryotic initiation factors, andsmall ribosomal subunit, which could be disassembled in the presence of cycloheximide. Treatment with nocodazole, amicrotubule disruptiondrug, led to the formation of relatively small and circular granules, indicating that NDV infection induces canonical SGs. Furthermore, the role of SGs on NDV replication was investigated by knockdown of TIA(-1) and TIA(-1)-related (TIAR) protein, the 2 critical components involved in SG formation from the HeLa cells, followed by NDV infection. Results showed that depletion of TIA-1 orTIARinhibitedviral protein synthesis, reducedextracellularvirus yields, but increasedglobal protein translation. FISH revealed that NDV-induced SGs contained predominantly cellular mRNA rather than viral mRNA. Deletion of TIA(-1) or TIAR reduced NP mRNA levels in polysomes. These results demonstrate that NDV triggers stable formationofbonafideSGs, whichbenefit viralprotein translation andvirus replicationbyarresting cellularmRNA.-Sun, Y., Dong, L., Yu, S., Wang, X., Zheng, H., Zhang, P., Meng, C., Zhan, Y., Tan, L., Song, C., Qiu, X., Wang, G., Liao, Y., Ding, C. Newcastle disease virus induces stable formation of bona fide stress granules to facilitate viral replication through manipulating host protein translation.	[Sun, Yingjie; Dong, Luna; Yu, Shengqing; Wang, Xiaoxu; Zheng, Hang; Zhang, Pin; Meng, Chunchun; Zhan, Yuan; Tan, Lei; Song, Cuiping; Qiu, Xusheng; Liao, Ying; Ding, Chan] Chinese Acad Agr Sci, Dept Avian Infect Dis, Shanghai Vet Res Inst, Shanghai, Peoples R China; [Dong, Luna; Zheng, Hang] Jilin Agr Univ, Coll Anim Sci & Technol, Changchun, Peoples R China; [Wang, Xiaoxu; Wang, Guijun] Anhui Agr Univ, Coll Anim Sci & Technol, Hefei, Peoples R China; [Ding, Chan] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Chinese Academy of Agricultural Sciences; Shanghai Veterinary Research Institute, CAAS; Jilin Agricultural University; Anhui Agricultural University	Ding, C (corresponding author), 518 Ziyue Rd, Shanghai 200241, Peoples R China.	shoveldeen@shvri.ac.cn			National Natural Science Foundation of China [31530074, 31400144]; Chinese Special Fund for Agroscientific Research in the Public Interest [201303033]; Shanghai Youth Scientific and Technological Yang Fan Program [14YF1408000]; China Postdoctoral Special Science Foundation Funded Project [2014M550107]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Special Fund for Agroscientific Research in the Public Interest; Shanghai Youth Scientific and Technological Yang Fan Program; China Postdoctoral Special Science Foundation Funded Project	The authors thank Dr. Shilei Zhang (Tsinghua University, Beijing, China) and Dr. Hongjun Chen (Shanghai Veterinary Research Institute) for technical assistance. This work was funded by National Natural Science Foundation of China Grants 31530074 (to C.D.) and 31400144 (to Y.S.); Chinese Special Fund for Agroscientific Research in the Public Interest Grant 201303033 (to C.D.); Shanghai Youth Scientific and Technological Yang Fan Program Grant 14YF1408000 (to Y.S.); and China Postdoctoral Special Science Foundation Funded Project 2014M550107 (to Y.S.). The authors declare no conflicts of interest.	Alexander DJ, 2000, REV SCI TECH OIE, V19, P443, DOI 10.20506/rst.19.2.1231; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Boonyaratanakornkit J, 2011, J VIROL, V85, P1495, DOI 10.1128/JVI.01297-10; Burgui I, 2003, J GEN VIROL, V84, P3263, DOI 10.1099/vir.0.19487-0; Chernov KG, 2009, J BIOL CHEM, V284, P36569, DOI 10.1074/jbc.M109.042879; Curran J, 1996, VIROLOGY, V221, P130, DOI 10.1006/viro.1996.0359; Dinh PX, 2013, J VIROL, V87, P372, DOI 10.1128/JVI.02305-12; Emara MM, 2012, BIOCHEM BIOPH RES CO, V423, P763, DOI 10.1016/j.bbrc.2012.06.033; Fiola C, 2006, INT J CANCER, V119, P328, DOI 10.1002/ijc.21821; Gainey MD, 2008, J VIROL, V82, P828, DOI 10.1128/JVI.02023-07; Garaigorta U, 2012, J VIROL, V86, P11043, DOI 10.1128/JVI.07101-11; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; Horikami SM, 1996, VIROLOGY, V222, P383, DOI 10.1006/viro.1996.0435; Iseni F, 2002, EMBO J, V21, P5141, DOI 10.1093/emboj/cdf513; Ivanov PA, 2003, EXP CELL RES, V290, P227, DOI 10.1016/S0014-4827(03)00290-8; Jiang K, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-551; Katoh H, 2013, J VIROL, V87, P489, DOI 10.1128/JVI.02186-12; Kedersha N, 2000, J CELL BIOL, V151, P1257, DOI 10.1083/jcb.151.6.1257; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Khaperskyy DA, 2012, FASEB J, V26, P1629, DOI 10.1096/fj.11-196915; Kolakofsky D, 1998, J VIROL, V72, P891, DOI 10.1128/JVI.72.2.891-899.1998; Krishnamurthy S, 2006, J VIROL, V80, P5145, DOI 10.1128/JVI.02618-05; Li W, 2002, J VIROL, V76, P11989, DOI 10.1128/JVI.76.23.11989-12000.2002; Lindquist ME, 2010, J VIROL, V84, P12274, DOI 10.1128/JVI.00260-10; Liu J, 2015, J VIROL, V89, P1925, DOI 10.1128/JVI.02262-14; MASTERS PS, 1988, J VIROL, V62, P2658, DOI 10.1128/JVI.62.8.2658-2664.1988; Matsuki H, 2013, GENES CELLS, V18, P135, DOI 10.1111/gtc.12023; Mazroui R, 2006, MOL BIOL CELL, V17, P4212, DOI 10.1091/mbc.E06-04-0318; McInerney GM, 2005, MOL BIOL CELL, V16, P3753, DOI 10.1091/mbc.E05-02-0124; Meng CC, 2012, ARCH VIROL, V157, P1011, DOI 10.1007/s00705-012-1270-6; Meng G, 2014, ONCOTARGET, V5, P6365, DOI 10.18632/oncotarget.2219; Nadezhdina ES, 2010, BBA-MOL CELL RES, V1803, P361, DOI 10.1016/j.bbamcr.2009.12.004; Ng CS, 2013, J VIROL, V87, P9511, DOI 10.1128/JVI.03248-12; NOVER L, 1989, MOL CELL BIOL, V9, P1298, DOI 10.1128/MCB.9.3.1298; Oh SW, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005444; Okonski KM, 2013, J VIROL, V87, P756, DOI 10.1128/JVI.02270-12; Onomoto K, 2014, TRENDS IMMUNOL, V35, P420, DOI 10.1016/j.it.2014.07.006; Onomoto K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043031; Piotrowska J, 2010, J VIROL, V84, P3654, DOI 10.1128/JVI.01320-09; Qin QS, 2009, J VIROL, V83, P11090, DOI 10.1128/JVI.01239-09; Qiu Xusheng, 2014, ScientificWorldJournal, V2014, P934851, DOI 10.1155/2014/934851; REICHARD KW, 1992, J SURG RES, V52, P448, DOI 10.1016/0022-4804(92)90310-V; Robert F, 2006, MOL BIOL CELL, V17, P4632, DOI 10.1091/mbc.E06-06-0478; Romer-Oberdorfer A, 2003, J GEN VIROL, V84, P3121, DOI 10.1099/vir.0.19416-0; Rozelle DK, 2014, MOL CELL BIOL, V34, P2003, DOI 10.1128/MCB.01630-13; Schmidt EK, 2009, NAT METHODS, V6, P275, DOI [10.1038/NMETH.1314, 10.1038/nmeth.1314]; Schneider RJ, 2003, TRENDS BIOCHEM SCI, V28, P130, DOI 10.1016/S0968-0004(03)00029-X; Simpson-Holley M, 2011, J VIROL, V85, P1581, DOI 10.1128/JVI.02247-10; Smith EC, 2009, FEBS J, V276, P7217, DOI 10.1111/j.1742-4658.2009.07401.x; Sun YJ, 2014, J VIROL, V88, P525, DOI 10.1128/JVI.01849-13; Takeuchi K, 2008, J VIROL, V82, P10102, DOI 10.1128/JVI.00599-08; Wang XX, 2009, J VIROL, V83, P12462, DOI 10.1128/JVI.01546-09; WEISS SR, 1974, J VIROL, V13, P1220, DOI 10.1128/JVI.13.6.1220-1230.1974; White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006; Willcocks MM, 2011, J VIROL, V85, P4452, DOI 10.1128/JVI.01107-10; Zengel J, 2015, J VIROL, V89, P7338, DOI 10.1128/JVI.00686-15	59	25	32	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1337	1353		10.1096/fj.201600980R	http://dx.doi.org/10.1096/fj.201600980R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28011649				2022-12-28	WOS:000398504300008
J	Zhao, LM; Han, TT; Li, YS; Sun, JZ; Zhang, S; Liu, YX; Shan, BE; Zheng, DX; Shi, J				Zhao, Lianmei; Han, Taotao; Li, Yanshuang; Sun, Jiazeng; Zhang, Shang; Liu, Yanxin; Shan, Baoen; Zheng, Dexian; Shi, Juan			The lncRNA SNHG5/miR-32 axis regulates gastric cancer cell proliferation and migration by targeting KLF4	FASEB JOURNAL			English	Article						long noncoding RNA; ceRNA; GC	LONG NONCODING RNA; COMPETING ENDOGENOUS RNA; EXPRESSION; CARCINOMA; INVASION; GROWTH; CERNA; GENE; DIFFERENTIATION; PROGRESSION	Long noncoding RNAs (lncRNAs) are emerging as important regulators in cellular processes, including the development, proliferation, and migration of cancer cells. We have demonstrated in a prior study that small nucleolar RNA host gene 5 (SNHG5) is dysregulated in gastric cancer (GC). To further explore the underlying mechanisms of SNGH5 function in the development of GC, in this study, we screened the microRNAs interacting with SNHG5 and elucidated their roles in GC. We showed that SNHG5 contains a putative miR-32-binding site and that deletion of this site abolishes the responsiveness to miR-32. Suppression of SNHG5 expression by miR-32 was found to be Argonaute (Ago)2-dependent. Immunoprecipitation showed that SNHG5 could be pulled down from the Ago-2 complex with miR-32. Furthermore, it was reported that Kruppel-like factor 4 (KLF4) is a target gene of miR-32. In agreement with SNHG5 being a decoy for miR-32, we showed that KLF4 suppression by miR-32 could be partially rescued by SNHG5 overexpression, whereas miR-32 mimic rescued SNHG5 overexpression-mediated suppression of GC cell migration. In addition, we identified a negative correlation between the expression of SNHG5 and miR-32 in GC tissues. Furthermore, KLF4 expression was significantly downregulated in GC specimens, and a negative correlation between miR-32 and KLF4 expression and a positive correlation between KLF4 and SNHG5 expression levels were detected. Overall, this study demonstrated, for the first time, that the SNHG5/miR-32/KLF4 axis functions as an important player in GC cell migration and potentially contributes to the improvement of GC diagnosis and therapy.-Zhao, L., Han, T., Li, Y., Sun, J., Zhang, S., Liu, Y., Shan, B., Zheng D., Shi, J. The lncRNA SNHG5/miR-32 axis regulates gastric cancer cell proliferation and migration by targeting KLF4.	[Zhao, Lianmei; Han, Taotao; Li, Yanshuang; Sun, Jiazeng; Zhang, Shang; Liu, Yanxin; Zheng, Dexian; Shi, Juan] Chinese Acad Med Sci, Inst Basic Med Sci, Natl Lab Med Mol Biol, Beijing, Peoples R China; [Zhao, Lianmei; Han, Taotao; Li, Yanshuang; Sun, Jiazeng; Zhang, Shang; Liu, Yanxin; Zheng, Dexian; Shi, Juan] Peking Union Med Coll, Beijing, Peoples R China; [Zhao, Lianmei; Shan, Baoen] Hebei Med Univ, Hosp 4, Res Ctr, Shijiazhuang, Peoples R China	Chinese Academy of Medical Sciences - Peking Union Medical College; Institute of Basic Medical Sciences - CAMS; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College; Hebei Medical University	Zheng, DX; Shi, J (corresponding author), Inst Basic Med Sci, 5 Dong Dan San Tiao, Beijing 100005, Peoples R China.	zhengdx@pumc.edu.cn; shijuantt@163.com		Zheng, Dexian/0000-0003-3966-1212	State Key Basic Research Program of China [2013CB530805]; Natural Science Foundation of China [81372200, 81572755, 81502032]; Peking Union Medical College Youth Fund; Fundamental Research Funds for the Central Universities [3332013055, 3332014007]	State Key Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Peking Union Medical College Youth Fund; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was partially supported by State Key Basic Research Program of China Grant 2013CB530805; Natural Science Foundation of China Grants 81372200, 81572755, and 81502032; and the Peking Union Medical College Youth Fund and Fundamental Research Funds for the Central Universities Grants 3332013055 and 3332014007. The authors declare no conflicts of interest.	Arita T, 2013, ANTICANCER RES, V33, P3185; Bass AJ, 2014, NATURE, V513, P202, DOI 10.1038/nature13480; Bhan A, 2014, CHEMMEDCHEM, V9, P1932, DOI 10.1002/cmdc.201300534; Boreiri M, 2013, ARCH IRAN MED, V16, P343, DOI 013166/AIM.007; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Chen LX, 2016, MOL CELLS, V39, P330, DOI 10.14348/molcells.2016.2308; Cho YG, 2007, APMIS, V115, P802, DOI 10.1111/j.1600-0463.2007.apm_643.x; Ergun S, 2015, TUMOR BIOL, V36, P3129, DOI 10.1007/s13277-015-3346-x; Guo XQ, 2014, TUMOR BIOL, V35, P10591, DOI 10.1007/s13277-014-2548-y; Li JH, 2014, NUCLEIC ACIDS RES, V42, pD92, DOI 10.1093/nar/gkt1248; Liu Q, 2013, NUCLEIC ACIDS RES, V41, P4976, DOI 10.1093/nar/gkt182; Lu MH, 2016, ONCOGENE, V35, P3524, DOI 10.1038/onc.2015.413; Nakamura Y, 2008, CANCER GENET CYTOGEN, V182, P144, DOI 10.1016/j.cancergencyto.2008.01.013; Nana-Sinkam SP, 2011, MOL ONCOL, V5, P483, DOI 10.1016/j.molonc.2011.10.003; Pacilli A, 2013, INT J MOL SCI, V14, P14923, DOI 10.3390/ijms140714923; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Salmena L, 2011, CELL, V146, P353, DOI 10.1016/j.cell.2011.07.014; Satolli MA, 2015, WORLD J GASTRO ONCOL, V7, P303, DOI 10.4251/wjgo.v7.i11.303; Sumazin P, 2011, CELL, V147, P370, DOI 10.1016/j.cell.2011.09.041; Tan P, 2015, GASTROENTEROLOGY, V149, P1153, DOI 10.1053/j.gastro.2015.05.059; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Wei DY, 2006, CARCINOGENESIS, V27, P23, DOI 10.1093/carcin/bgi243; Wu WY, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-30; Xu JQ, 2014, TUMOR BIOL, V35, P9847, DOI 10.1007/s13277-014-2229-x; Yan C, 2015, BIOCHEM BIOPH RES CO, V467, P913, DOI 10.1016/j.bbrc.2015.10.044; Yan SY, 2015, TUMOR BIOL, V36, P4747, DOI 10.1007/s13277-015-3124-9; Zhao L, 2016, ONCOGENE, V35, P5770, DOI 10.1038/onc.2016.110	27	156	166	0	51	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					893	903		10.1096/fj.201600994R	http://dx.doi.org/10.1096/fj.201600994R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27871067				2022-12-28	WOS:000395671200006
J	Parker, A; Maclaren, OJ; Fletcher, AG; Muraro, D; Kreuzaler, PA; Byrne, HM; Maini, PK; Watson, AJM; Pin, C				Parker, Aimee; Maclaren, Oliver J.; Fletcher, Alexander G.; Muraro, Daniele; Kreuzaler, Peter A.; Byrne, Helen M.; Maini, Philip K.; Watson, Alastair J. M.; Pin, Carmen			Cell proliferation within small intestinal crypts is the principal driving force for cell migration on villi	FASEB JOURNAL			English	Article						mathematical model; epithelium; small intestine	CYTOSINE-ARABINOSIDE; EPITHELIAL RESTITUTION; STEM-CELLS; GASTROINTESTINAL-TRACT; POPULATION KINETICS; FEEDBACK-CONTROL; DNA-SYNTHESIS; MOUSE; MODEL; MICE	The functional integrity of the intestinal epithelial barrier relies on tight coordination of cell proliferation and migration, with failure to regulate these processes resulting in disease. It is not known whether cell proliferation is sufficient to drive epithelial cell migration during homoeostatic turnover of the epithelium. Nor is it known precisely how villus cell migration is affected when proliferation is perturbed. Some reports suggest that proliferation and migration may not be related while other studies support a direct relationship. We used established cell-tracking methods based on thymine analog cell labeling and developed tailored mathematical models to quantify cell proliferation and migration under normal conditions and when proliferation is reduced and when it is temporarily halted. We found that epithelial cell migration velocities along the villi are coupled to cell proliferation rates within the crypts in all conditions. Furthermore, halting and resuming proliferation results in the synchronized response of cell migration on the villi. We conclude that cell proliferation within the crypt is the primary force that drives cell migration along the villus. This methodology can be applied to interrogate intestinal epithelial dynamics and characterize situations in which processes involved in cell turnover become uncoupled, including pharmacological treatments and disease models.	[Parker, Aimee; Pin, Carmen] Inst Food Res, Gut Hlth & Food Safety Res Programme, Norwich NR4 7UA, Norfolk, England; [Maclaren, Oliver J.; Fletcher, Alexander G.; Muraro, Daniele; Byrne, Helen M.; Maini, Philip K.] Univ Oxford, Math Inst, Wolfson Ctr Math Biol, Oxford OX1 2JD, England; [Fletcher, Alexander G.] Univ Sheffield, Sch Math & Stat, Sheffield S10 2TN, S Yorkshire, England; [Fletcher, Alexander G.] Univ Sheffield, Bateson Ctr, Sheffield S10 2TN, S Yorkshire, England; [Kreuzaler, Peter A.] Univ Cambridge, Dept Biochem, Cambridge CB2 1TN, England; [Watson, Alastair J. M.] Univ East Anglia, Sch Med, Norwich NR4 7TJ, Norfolk, England; [Maclaren, Oliver J.] Univ Auckland, Dept Engn Sci, Auckland, New Zealand	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Quadram Institute; University of East Anglia; University of Oxford; University of Sheffield; University of Sheffield; University of Cambridge; University of East Anglia; University of Auckland	Pin, C (corresponding author), Inst Food Res, Gut Hlth & Food Safety Res Programme, Norwich NR4 7UA, Norfolk, England.	carmen.pin@ifr.ac.uk	Fletcher, Alexander/C-8908-2013	Fletcher, Alexander/0000-0003-0525-4336; Byrne, Helen/0000-0003-1771-5910; Parker, Aimee/0000-0003-1765-9656; Kreuzaler, Peter/0000-0001-8684-9424	Biotechnology and Biological Sciences Research Council (BBSRC)-UK [BB/K018256/1, BB/K017578/1, BB/K017144/1, BB/J004529/1]; EPSRC-UK [EP/I017909]; Biotechnology and Biological Sciences Research Council [BB/K017578/1, BBS/E/F/00044446, BB/K018256/1, BB/K017144/1] Funding Source: researchfish; BBSRC [BBS/E/F/00044446, BB/K017578/1, BB/K017144/1, BB/K018256/1] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council (BBSRC)-UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC-UK(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Gerard Evan and Trevor Littlewood (both from the University of Cambridge) for helpful discussions on cell biology and for kindly providing the Omomyc mouse model. This work was funded by Biotechnology and Biological Sciences Research Council (BBSRC)-UK projects BB/K018256/1, BB/K017578/1, BB/K017144/1, and BB/J004529/1 and the EPSRC-UK project EP/I017909. The authors declare no conflicts of interest.	ALDEWACHI HS, 1980, VIRCHOWS ARCH B, V34, P299, DOI 10.1007/BF02892427; ALNAFUSSI AI, 1982, VIRCHOWS ARCH B, V40, P63, DOI 10.1007/BF02932851; ANILKUMAR TV, 1992, BRIT J CANCER, V65, P552, DOI 10.1038/bjc.1992.113; Balakrishnan A, 2010, EXP CELL RES, V316, P3512, DOI 10.1016/j.yexcr.2010.07.007; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; BARTHOLD SW, 1979, CANCER RES, V39, P24; BOARDER TA, 1976, CELL TISSUE KINET, V9, P589, DOI 10.1111/j.1365-2184.1976.tb01308.x; BRITTON NF, 1982, J THEOR BIOL, V98, P531, DOI 10.1016/0022-5193(82)90135-7; Carothers AM, 2001, J BIOL CHEM, V276, P39094, DOI 10.1074/jbc.M103450200; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Dunn SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080516; EASTWOOD GL, 1981, CELL TISSUE KINET, V14, P405, DOI 10.1111/j.1365-2184.1981.tb00547.x; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; FEIL W, 1989, GASTROENTEROLOGY, V97, P685, DOI 10.1016/0016-5085(89)90640-9; GALJAARD H, 1972, EXP CELL RES, V73, P197, DOI 10.1016/0014-4827(72)90120-6; Gallagher AM, 2001, AM J PHYSIOL-GASTR L, V281, pG681, DOI 10.1152/ajpgi.2001.281.3.G681; Ghaleb AM, 2011, DEV BIOL, V349, P310, DOI 10.1016/j.ydbio.2010.11.001; GRAHAM FL, 1970, CANCER RES, V30, P2627; GRATZNER HG, 1982, SCIENCE, V218, P474, DOI 10.1126/science.7123245; HAGEMANN RF, 1970, AM J ANAT, V129, P41, DOI 10.1002/aja.1001290104; HAGEMANN RF, 1975, BRIT J RADIOL, V48, P545, DOI 10.1259/0007-1285-48-571-545; HAGEMANN RF, 1973, J NATL CANCER I, V50, P467, DOI 10.1093/jnci/50.2.467; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; HIRSCHMAN SZ, 1969, INT J CANCER, V4, P671, DOI 10.1002/ijc.2910040513; KAUR P, 1986, CELL TISSUE KINET, V19, P591, DOI 10.1111/j.1365-2184.1986.tb00760.x; KAUR P, 1986, CELL TISSUE KINET, V19, P611, DOI 10.1111/j.1365-2184.1986.tb00762.x; KLEIN RM, 1978, CELL TISSUE RES, V195, P239; LACY ER, 1988, J CLIN GASTROENTEROL, V10, pS72, DOI 10.1097/00004836-198812001-00012; LENAZ L, 1970, CANCER RES, V30, P1961; LENAZ L, 1969, CANCER RES, V29, P1790; Mahmoud NN, 1997, CANCER RES, V57, P5045; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; Mirams GR, 2012, J THEOR BIOL, V312, P143, DOI 10.1016/j.jtbi.2012.08.002; MOORE R, 1989, LAB INVEST, V60, P237; Moss SF, 1996, GUT, V39, P811, DOI 10.1136/gut.39.6.811; NOWAKOWSKI RS, 1989, J NEUROCYTOL, V18, P311, DOI 10.1007/BF01190834; Osborne JM, 2010, PHILOS T R SOC A, V368, P5013, DOI 10.1098/rsta.2010.0173; Pignatelli M, 1996, YALE J BIOL MED, V69, P131; Pin C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037115; Potten P. K. C., 1986, CELL TISSUE KINET, V19, P611; Rasband W., 2006, IMAGEJ; RICHARDS TC, 1981, ANAT RECORD, V200, P299, DOI 10.1002/ar.1092000309; RIJKE RPC, 1976, GASTROENTEROLOGY, V71, P786; SATO F, 1972, CELL TISSUE KINET, V5, P227, DOI 10.1111/j.1365-2184.1972.tb00361.x; Soucek L, 1998, ONCOGENE, V17, P2463, DOI 10.1038/sj.onc.1202199; Soucek L, 2008, NATURE, V455, P679, DOI 10.1038/nature07260; SYMONS LEA, 1965, GASTROENTEROLOGY, V49, P158; TSUBOUCHI S, 1983, CELL TISSUE KINET, V16, P441; van Leeuwen IMM, 2009, CELL PROLIFERAT, V42, P617, DOI 10.1111/j.1365-2184.2009.00627.x; VERBIN RS, 1972, CANCER RES, V32, P1476; Watson AJM, 2009, ANN NY ACAD SCI, V1165, P135, DOI 10.1111/j.1749-6632.2009.04027.x; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; WRIGHT NA, 1982, CELL TISSUE KINET, V15, P611, DOI 10.1111/j.1365-2184.1982.tb01067.x; Wright NA, 1984, BIOL EPITHELIAL CELL, V2	54	45	46	2	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					636	649		10.1096/fj.201601002	http://dx.doi.org/10.1096/fj.201601002			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27811059	Green Published, Green Accepted, hybrid			2022-12-28	WOS:000394235400017
J	Rawashdeh, O; Clough, SJ; Hudson, RL; Dubocovich, ML				Rawashdeh, Oliver; Clough, Shannon J.; Hudson, Randall L.; Dubocovich, Margarita L.			Learned motivation drives circadian physiology in the absence of the master circadian clock	FASEB JOURNAL			English	Article						methamphetamine; SCN lesions; running wheel	INDUCED LOCOMOTOR SENSITIZATION; SCN-LESIONED RATS; SUPRACHIASMATIC NUCLEUS; IN-VIVO; MELATONIN RECEPTORS; C3H/HEN MICE; HABENULAR NUCLEUS; GENETIC DELETION; PHASE-SHIFT; RHYTHMS	The suprachiasmatic nucleus (SCN)-often referred to as the master circadian clock-is essential in generating physiologic rhythms and orchestrating synchrony among circadian clocks. This study tested the hypothesis that periodic motivation induced by rhythmically pairing 2 reinforcing stimuli [methamphetamine (Meth) and running wheel (RW)] restores autonomous circadian activity in arrhythmic SCN-lesioned (SCNX) C3H/HeN mice. Sham-surgery and SCNX mice were treated with either Meth (1.2 mg/kg, i.p.) or vehicle in association, dissociation, or absence of an RW. Only the association of Meth treatment and restricted RW access successfully reestablished entrained circadian rhythms in mice with SCNX. RW-likely acting as a link between the circadian and reward systems-promotes circadian entrainment of activity. We conclude that a conditioned drug response is a powerful tool to entrain, drive, and restore circadian physiology. Furthermore, an RW should be recognized as a potent input signal in addition to the conventional use as an output signal.-Rawashdeh, O., Clough, S. J., Hudson, R. L., Dubocovich, M. L. Learned motivation drives circadian physiology in the absence of the master circadian clock.	[Rawashdeh, Oliver; Clough, Shannon J.; Dubocovich, Margarita L.] SUNY Buffalo, Dept Pharmacol & Toxicol, Jacobs Sch Med & Biomed Sci, 3435 Main St Farber Hall 102, Buffalo, NY 14214 USA; [Hudson, Randall L.] SUNY Buffalo, Dept Physiol & Biophys, Jacobs Sch Med & Biomed Sci, 3435 Main St Farber Hall 102, Buffalo, NY 14214 USA; [Rawashdeh, Oliver] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Queensland	Dubocovich, ML (corresponding author), SUNY Buffalo, Dept Pharmacol & Toxicol, Sch Med & Biomed Sci, 3435 Main St Farber Hall 102, Buffalo, NY 14214 USA.	mdubo@buffalo.edu	Rawashdeh, Oliver/N-7400-2016	Rawashdeh, Oliver/0000-0002-7147-4778	U.S. National Institutes of Health [DA021870]; National Institute of Drug Abuse; National Center for Advancing Translational Sciences [UL1TR001412]; Jacobs School of Medicine and Biomedical Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA021870] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Jacobs School of Medicine and Biomedical Science; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors acknowledge the technical assistance of Iwona Stepien and Michele Sveinsson (Jacobs School of Medicine and Biomedical Sciences, University at Buffalo). The authors thank Dr. Mathew J. Paul (College of Art and Science, University at Buffalo) and Dr. Jerrold C. Winter (Jacobs School of Medicine and Biomedical Science, University at Buffalo) for perspectives on data interpretation and critical feedback on earlier versions of the manuscript. This work was supported by grants from the U.S. National Institutes of Health under awards DA021870 from the National Institute of Drug Abuse (to M.L.D.) and UL1TR001412 from the National Center for Advancing Translational Sciences (to the University at Buffalo), and by funds from the Jacobs School of Medicine and Biomedical Science (to M.L.D. and R.L.H).	Abarca C, 2002, P NATL ACAD SCI USA, V99, P9026, DOI 10.1073/pnas.142039099; Abraham U, 2005, J NEUROSCI, V25, P8620, DOI 10.1523/JNEUROSCI.2225-05.2005; Adamah-Biassi EB, 2013, BEHAV BRAIN RES, V243, P306, DOI 10.1016/j.bbr.2013.01.003; Amat J, 2001, BRAIN RES, V917, P118, DOI 10.1016/S0006-8993(01)02934-1; Arnedt JT, 2007, J ADDICT DIS, V26, P41, DOI 10.1300/J069v26n04_06; Baird TJ, 2000, PHARMACOL BIOCHEM BE, V65, P289, DOI 10.1016/S0091-3057(99)00207-5; Belke TW, 1997, J EXP ANAL BEHAV, V67, P337, DOI 10.1901/jeab.1997.67-337; Blum ID, 2014, ELIFE, V3, DOI 10.7554/eLife.05105; Brower KJ, 2011, J CLIN PSYCHIAT, V72, P515, DOI 10.4088/JCP.09m05484gry; CHAPMAN CL, 1990, J SPORT MED PHYS FIT, V30, P283; CIPOLLANETO J, 1988, BRAZ J MED BIOL RES, V21, P653; Clough SJ, 2014, PHYSIOL BEHAV, V132, P79, DOI 10.1016/j.physbeh.2014.04.049; Dibner C, 2010, ANNU REV PHYSIOL, V72, P517, DOI 10.1146/annurev-physiol-021909-135821; Dubocovich ML, 2005, J PINEAL RES, V39, P113, DOI 10.1111/j.1600-079X.2005.00230.x; Ferreira A, 2006, EUR PSYCHIAT, V21, P580, DOI 10.1016/j.eurpsy.2005.02.003; FURST DM, 1993, PERCEPT MOTOR SKILL, V77, P192, DOI 10.2466/pms.1993.77.1.192; Gannon RL, 1995, J BIOL RHYTHM, V10, P196, DOI 10.1177/074873049501000303; Glass JD, 2012, AM J PHYSIOL-REG I, V302, pR740, DOI 10.1152/ajpregu.00602.2011; Granados-Fuentes D, 2004, J NEUROSCI, V24, P615, DOI 10.1523/JNEUROSCI.4002-03.2004; Greenwood BN, 2011, BEHAV BRAIN RES, V217, P354, DOI 10.1016/j.bbr.2010.11.005; HERKENHAM M, 1979, J COMP NEUROL, V187, P19, DOI 10.1002/cne.901870103; HOFFMANN P, 1987, BEHAV NEURAL BIOL, V47, P346, DOI 10.1016/S0163-1047(87)90461-4; HONMA K, 1986, BRAIN DEV-JPN, V8, P397, DOI 10.1016/S0387-7604(86)80060-2; HONMA K, 1987, PHYSIOL BEHAV, V40, P767, DOI 10.1016/0031-9384(87)90281-2; HONMA KI, 1986, PHYSIOL BEHAV, V38, P687, DOI 10.1016/0031-9384(86)90265-9; HONMA S, 1988, PHYSIOL BEHAV, V44, P247, DOI 10.1016/0031-9384(88)90146-1; HONMA S, 1995, BRAIN RES, V674, P283, DOI 10.1016/0006-8993(95)00027-N; Huang MC, 2010, ALCOHOL CLIN EXP RES, V34, P1899, DOI 10.1111/j.1530-0277.2010.01278.x; Hutchinson AJ, 2014, PSYCHOPHARMACOLOGY, V231, P257, DOI 10.1007/s00213-013-3228-0; Hutchinson AJ, 2012, J PINEAL RES, V53, P399, DOI 10.1111/j.1600-079X.2012.01010.x; Ibata Y, 1999, FRONT NEUROENDOCRIN, V20, P241, DOI 10.1006/frne.1999.0180; IBUKA N, 1975, BRAIN RES, V96, P76, DOI 10.1016/0006-8993(75)90574-0; Irwin MR, 2006, PSYCHOSOM MED, V68, P159, DOI 10.1097/01.psy.0000195743.60952.00; IVERSEN IH, 1993, J EXP ANAL BEHAV, V60, P219, DOI 10.1901/jeab.1993.60-219; Jones EM, 2003, AM FAM PHYSICIAN, V68, P1971; Kalsbeek A, 2006, J BIOL RHYTHM, V21, P458, DOI 10.1177/0748730406293854; KAUFMAN CM, 1993, J NEURAL TRANSP PLAS, V4, P257, DOI 10.1155/NP.1993.257; Kosobud AEK, 1998, NEUROSCI LETT, V250, P99, DOI 10.1016/S0304-3940(98)00439-X; Lett BT, 2000, APPETITE, V34, P87, DOI 10.1006/appe.1999.0274; Logan RW, 2014, BEHAV NEUROSCI, V128, P387, DOI 10.1037/a0036268; Meijer JH, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.0210; Mistlberger RE, 2005, BRAIN RES REV, V49, P429, DOI 10.1016/j.brainresrev.2005.01.005; Mohawk JA, 2009, P NATL ACAD SCI USA, V106, P3519, DOI 10.1073/pnas.0813366106; MOORE RY, 1972, BRAIN RES, V42, P201, DOI 10.1016/0006-8993(72)90054-6; Morgan PT, 2006, DRUG ALCOHOL DEPEN, V82, P238, DOI 10.1016/j.drugalcdep.2005.09.014; NAGAI K, 1978, BRAIN RES, V142, P384, DOI 10.1016/0006-8993(78)90648-0; Novak CM, 2012, NEUROSCI BIOBEHAV R, V36, P1001, DOI 10.1016/j.neubiorev.2011.12.012; PARENT A, 1981, BRAIN RES BULL, V6, P23, DOI 10.1016/S0361-9230(81)80066-4; Paxinos G, 2004, MOUSE BRAIN STEREOTA; Qu TY, 1996, BRAIN RES, V709, P251, DOI 10.1016/0006-8993(95)01306-7; RALPH MR, 1990, SCIENCE, V247, P975, DOI 10.1126/science.2305266; RAYMOND RC, 1992, J TOXICOL-CLIN TOXIC, V30, P467; Roenneberg T, 2003, J BIOL RHYTHM, V18, P183, DOI 10.1177/0748730403018003001; RONNEKLEIV OK, 1979, EXP BRAIN RES, V37, P551; Rudy E B, 1989, West J Nurs Res, V11, P548, DOI 10.1177/019394598901100504; SCHWARTZ WJ, 1991, PHYSIOL BEHAV, V49, P1283, DOI 10.1016/0031-9384(91)90364-T; Shabani S, 2012, NEUROPHARMACOLOGY, V62, P2169, DOI 10.1016/j.neuropharm.2012.01.002; Shibley HL, 2008, J PSYCHIATR PRACT, V14, P146, DOI 10.1097/01.pra.0000320113.30811.46; SHINOHARA K, 1995, P NATL ACAD SCI USA, V92, P7396, DOI 10.1073/pnas.92.16.7396; Spanagel R, 2005, ALCOHOL CLIN EXP RES, V29, P1550, DOI 10.1097/01.alc.0000175074.70807.fd; STEPHAN FK, 1972, P NATL ACAD SCI USA, V69, P1583, DOI 10.1073/pnas.69.6.1583; STEPHAN FK, 1977, BEHAV BIOL, V20, P1, DOI 10.1016/S0091-6773(77)90397-2; Stowie AC, 2015, NEUROSCIENCE, V284, P171, DOI 10.1016/j.neuroscience.2014.08.057; Sulzer D, 2005, PROG NEUROBIOL, V75, P406, DOI 10.1016/j.pneurobio.2005.04.003; Tataroglu O, 2006, J BIOL RHYTHM, V21, P185, DOI 10.1177/0748730406287529; Tavakoli-Nezhad M, 2006, CHRONOBIOL INT, V23, P217, DOI 10.1080/07420520500521947; Wasielewski JA, 2001, ALCOHOL RES HEALTH, V25, P94; Webb IC, 2015, PHYSIOL BEHAV, V143, P58, DOI 10.1016/j.physbeh.2015.02.034; Werme M, 2002, J NEUROSCI, V22, P8133; Yamazaki S, 1998, J NEUROSCI, V18, P10709; YOSHIDA M, 1992, NEUROSCI LETT, V139, P73, DOI 10.1016/0304-3940(92)90861-Z; Zhabenko N, 2012, ALCOHOL CLIN EXP RES, V36, P1600, DOI 10.1111/j.1530-0277.2012.01771.x; Zhao H, 2005, NEUROSCIENCE, V132, P519, DOI 10.1016/j.neuroscience.2005.01.012	73	1	1	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					388	399		10.1096/fj.201600926R	http://dx.doi.org/10.1096/fj.201600926R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27733449	Green Published			2022-12-28	WOS:000392177600036
J	Perla-Kajan, J; Utyro, O; Rusek, M; Malinowska, A; Sitkiewicz, E; Jakubowski, H				Perla-Kajan, Joanna; Utyro, Olga; Rusek, Marta; Malinowska, Agata; Sitkiewicz, Ewa; Jakubowski, Hieronim			N-Homocysteinylation impairs collagen cross-linking in cystathionine -synthase-deficient mice: a novel mechanism of connective tissue abnormalities	FASEB JOURNAL			English	Article						hyperhomocysteinemia; homocysteine thiolactone; collagen modification; pyridinoline cross-links; Col1A1	BETA-SYNTHASE; LYSYL OXIDASE; METHYLENETETRAHYDROFOLATE-REDUCTASE; PROTEIN HOMOCYSTEINYLATION; HUMAN SERUM; PATHOLOGICAL CONSEQUENCES; ENDOTHELIAL-CELLS; THIOLACTONE; HUMANS; PLASMA	Cystathionine -synthase (CBS) deficiency, a genetic disorder in homocysteine (Hcy) metabolism in humans, elevates plasma Hcy-thiolactone and leads to connective tissue abnormalities that affect the cardiovascular and skeletal systems. However, the underlying mechanism of these abnormalities is not understood. Hcy-thiolactone has the ability to form isopeptide bonds with protein lysine residues, which generates N-homocysteinylated protein. Because lysine residues are involved in collagen cross-linking, N-homocysteinylation of these lysines should impair cross-linking. Using a Tg-I278T Cbs(-/-) mouse model of hyperhomocysteinemia (HHcy) which replicates the connective tissue abnormalities observed in CBS-deficient patients, we found that N-Hcy-collagen was elevated in bone, tail, and heart of Cbs(-/-) mice, whereas pyridinoline cross-links were significantly reduced. Plasma deoxypyridinoline cross-link and cross-linked carboxyterminal telopeptide of type I collagen were also significantly reduced in the Cbs(-/-) mice. Lysine oxidase activity and mRNA level were not reduced by the Cbs(-/-) genotype. We also showed that collagen carries S-linked Hcy bound to the thiol of N-linked Hcy. In vitro experiments showed that Hcy-thiolactone modifies lysine residues in collagen type I -1 chain. Residue K-160, located in the nonhelical N-telopeptide region and involved in pyridinoline cross-link formation, was also N-homocysteinylated in vivo. Taken together, our findings showed that N-homocysteinylation of collagen in Cbs(-/-) mice impairs its cross-linking. These findings explain, at least in part, connective tissue abnormalities observed in HHcy.Pera-Kajan, J., Utyro, O., Rusek, M., Malinowska, A., Sitkiewicz, E., Jakubowski, H. N-Homocysteinylation impairs collagen cross-linking in cystathionine -synthase-deficient mice: a novel mechanism of connective tissue abnormalities.	[Perla-Kajan, Joanna; Jakubowski, Hieronim] Univ Life Sci, Dept Biochem & Biotechnol, Pozna, Poland; [Utyro, Olga; Jakubowski, Hieronim] Inst Bioorgan Chem, Poznan, Poland; [Rusek, Marta; Jakubowski, Hieronim] Rutgers State Univ, Rutgers New Jersey Med Sch, Dept Microbiol Biochem & Mol Genet, Int Ctr Publ Hlth, Newark, NJ USA; [Malinowska, Agata; Sitkiewicz, Ewa] Inst Biochem & Biophys, Dept Biophys, Prote Lab, Warsaw, Poland; [Rusek, Marta] Med Univ, Dept Pathophysiol, Lublin, Poland	Polish Academy of Sciences; Institute of Bioorganic Chemistry of the Polish Academy of Sciences; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Polish Academy of Sciences; Institute of Biochemistry & Biophysics - Polish Academy of Sciences; Medical University of Lublin	Jakubowski, H (corresponding author), Rutgers New Jersey Med Sch, Int Ctr Publ Hlth, Dept Microbiol Biochem & Mol Genet, 225 Warren St, Newark, NJ 07103 USA.	jakubows@rutgers.edu	Perla-Kajan, Joanna/F-2965-2010; Rusek, Marta/H-2321-2018; Jakubowski, Hieronim/A-2510-2017; Jakubowski, Hieronim/AAA-6834-2019	Perla-Kajan, Joanna/0000-0002-0791-5057; Rusek, Marta/0000-0001-9592-2478; Jakubowski, Hieronim/0000-0001-5845-4409; Malinowska, Agata/0000-0001-6599-901X; Utyro, Olga/0000-0002-9571-6057; Sitkiewicz, Ewa/0000-0002-9511-8575	National Science Center (Krakow, Poland) [2011/02/A/NZ1/00010, 2012/07/B/NZ7/01178, 2013/09/B/NZ5/02794, 2013/11/B/NZ1/00091, 2014/15/B/NZ2/01079]; American Heart Association [0855919D, 12GRNT9420014]	National Science Center (Krakow, Poland); American Heart Association(American Heart Association)	The authors thank Warren Kruger (Fox Chase Cancer Center, Philadelphia, PA, USA) for the breeding pair of Tg-I278T Cbs<SUP>+/-</SUP> mice. This study was supported in part by National Science Center (Krakow, Poland) (Grants 2011/02/A/NZ1/00010, 2012/07/B/NZ7/01178, 2013/09/B/NZ5/02794, 2013/11/B/NZ1/00091, and 2014/15/B/NZ2/01079), and American Heart Association (Grants 0855919D and 12GRNT9420014). The authors declare no conflicts of interest.	Abrahamsen B, 2006, BONE, V38, P215, DOI 10.1016/j.bone.2005.08.005; Bakun Magda, 2012, Clin Proteomics, V9, P13, DOI 10.1186/1559-0275-9-13; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chwatko G, 2005, CLIN CHEM, V51, P408, DOI 10.1373/clinchem.2004.042531; Chwatko G, 2005, ANAL BIOCHEM, V337, P271, DOI 10.1016/j.ab.2004.11.035; Chwatko G, 2007, FASEB J, V21, P1707, DOI 10.1096/fj.06-7435com; EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8; Eyre DR, 2008, METHODS, V45, P65, DOI 10.1016/j.ymeth.2008.01.002; Fledelius C, 1997, J BIOL CHEM, V272, P9755; FUJIMOTO D, 1978, BIOCHEM BIOPH RES CO, V84, P52, DOI 10.1016/0006-291X(78)90261-9; Gelse K, 2003, ADV DRUG DELIVER REV, V55, P1531, DOI 10.1016/j.addr.2003.08.002; Glowacki R, 2004, J BIOL CHEM, V279, P10864, DOI 10.1074/jbc.M313268200; GRIFFITHS R, 1976, CONNECT TISSUE RES, V4, P101, DOI 10.3109/03008207609152205; Gupta S, 2009, FASEB J, V23, P883, DOI 10.1096/fj.08-120584; Hornstra IK, 2003, J BIOL CHEM, V278, P14387, DOI 10.1074/jbc.M210144200; JAKUBOWSKI H, 1993, FEBS LETT, V317, P237, DOI 10.1016/0014-5793(93)81283-6; Jakubowski H, 2000, CIRC RES, V87, P45, DOI 10.1161/01.RES.87.1.45; Jakubowski H, 1997, J BIOL CHEM, V272, P1935; Jakubowski H, 2002, J BIOL CHEM, V277, P30425, DOI 10.1074/jbc.C200267200; Jakubowski H, 2002, ANAL BIOCHEM, V308, P112, DOI 10.1016/S0003-2697(02)00224-5; Jakubowski H, 1999, FASEB J, V13, P2277, DOI 10.1096/fasebj.13.15.2277; Jakubowski H, 2000, J NUTR, V130, p377S, DOI 10.1093/jn/130.2.377S; Jakubowski H, 2015, CIRCULATION, V132, DOI [10.1161/circ.132.suppl_3.19250, DOI 10.1161/CIRC.132.SUPPL_3.19250]; Jakubowski H., 2013, HOMOCYSTEINE PROTEIN; Jakubowski H, 2008, ANAL BIOCHEM, V380, P257, DOI 10.1016/j.ab.2008.05.049; Jakubowski H, 2006, CHEM-EUR J, V12, P8039, DOI 10.1002/chem.200600785; Jakubowski H, 2008, FASEB J, V22, P4071, DOI 10.1096/fj.08-112086; Jakubowski H, 2009, FASEB J, V23, P1721, DOI 10.1096/fj.08-127548; KANG AH, 1973, J CLIN INVEST, V52, P2571, DOI 10.1172/JCI107449; Lei WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130421; Liu GM, 1997, J BIOL CHEM, V272, P32370, DOI 10.1074/jbc.272.51.32370; Lubec B, 1996, BBA-MOL BASIS DIS, V1315, P159, DOI 10.1016/0925-4439(95)00119-0; Majors A, 1997, ARTERIOSCL THROM VAS, V17, P2074, DOI 10.1161/01.ATV.17.10.2074; Maki JM, 2002, CIRCULATION, V106, P2503, DOI 10.1161/01.CIR.0000038109.84500.1E; Marczak L, 2011, J PROTEOMICS, V74, P967, DOI 10.1016/j.jprot.2011.01.021; McKusick V. A., 1966, HERITABLE DISORDERS, P155; McLean RR, 2004, J BONE MINER RES, V19, P410, DOI 10.1359/JBMR.0301261; MUDD SH, 2001, METABOLIC MOL BASES, V2, P2007; Paoli P, 2010, J MOL BIOL, V400, P889, DOI 10.1016/j.jmb.2010.05.039; Pera-Kajan J, 2011, ANAL BIOANAL CHEM, V401, P2473, DOI 10.1007/s00216-011-5346-z; Perla-Kajan J, 2008, BIOMED PHARMACOTHER, V62, P473, DOI 10.1016/j.biopha.2008.04.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Raposo B, 2004, ATHEROSCLEROSIS, V177, P1, DOI 10.1016/j.atherosclerosis.2004.06.015; Robert K, 2005, ANAT REC PART A, V282A, P1, DOI 10.1002/ar.a.20145; Saito M, 2010, OSTEOPOROSIS INT, V21, P655, DOI 10.1007/s00198-009-0980-4; Sauls DL, 2006, BIOCHEMISTRY-US, V45, P2480, DOI 10.1021/bi052076j; Sikora M, 2014, AMINO ACIDS, V46, P235, DOI 10.1007/s00726-013-1617-7; Sikora M, 2010, ANAL BIOCHEM, V405, P132, DOI 10.1016/j.ab.2010.04.034; Takaluoma K, 2007, J BIOL CHEM, V282, P6588, DOI 10.1074/jbc.M608830200; TANZER ML, 1968, J BIOL CHEM, V243, P4045; TELSER A, 1980, BIOCHIM BIOPHYS ACTA, V624, P363, DOI 10.1016/0005-2795(80)90077-X; Thaler R, 2011, J BIOL CHEM, V286, P5578, DOI 10.1074/jbc.M110.166181; Undas A, 2005, THROMB HAEMOSTASIS, V93, P346, DOI 10.1160/TH04-08-0493; Undas A, 2004, STROKE, V35, P1299, DOI 10.1161/01.STR.0000128412.59768.6e; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Yang X, 2006, CLIN CHIM ACTA, V364, P230, DOI 10.1016/j.cccn.2005.07.007	56	26	26	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3810	3821		10.1096/fj.201600539	http://dx.doi.org/10.1096/fj.201600539			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27530978	Green Submitted			2022-12-28	WOS:000386474700015
J	Radreau, P; Porcherot, M; Ramiere, C; Mouzannar, K; Lotteau, V; Andre, P				Radreau, Pauline; Porcherot, Marine; Ramiere, Christophe; Mouzannar, Karim; Lotteau, Vincent; Andre, Patrice			Reciprocal regulation of farnesoid X receptor activity and hepatitis B virus replication in differentiated HepaRG cells and primary human hepatocytes	FASEB JOURNAL			English	Article						cccDNA; bile salt; nuclear receptor; FXR agonist	NUCLEAR RECEPTORS; OBETICHOLIC ACID; NATURAL-HISTORY; CCCDNA FUNCTION; FXR-ALPHA; AUTOPHAGY; TRANSCRIPTION; INFECTION; MINICHROMOSOME; PGC-1-ALPHA	Hepatitis B virus (HBV) and bile salt metabolism seem tightly connected. HBV enters hepatocytes by binding to sodium taurocholate cotransporting polypeptide (NTCP), the genome of which contains 2 active farnesoid X receptor (FXR) response elements that participate in HBV transcriptional activity. We investigated in differentiated HepaRG cells and in primary human hepatocytes (PHHs) effects of FXR activation on HBV replication and of infection on the FXR pathway. In HepaRG cells, FXR agonists (6-ethyl chenodeoxycholic acid and GW4064), but no antagonist, and an FXR-unrelated bile salt inhibited viral mRNA, DNA, and protein production (IC50, 0.1-0.5 M) and reduced covalently closed circular DNA pool size. These effects were independent of the NTCP inhibitor cyclosporine-A, which suggests inhibition occurred at a postentry step. Similar results were obtained in PHHs with GW4064. Infection of these cells increased expression of FXR and modified expression of FXR-regulated genes SHP, APOA1, NTCP, CYP7A1, and CYP8B1 with a more pronounced effect in PHHs than in HepaRG cells. FXR agonists reversed all but one of the HBV-induced FXR gene profile modifications. HBV replication and FXR regulation seem to be interdependent, and altered bile salt metabolism homeostasis might contribute to the persistence of HBV infection.Radreau, P., Porcherot, M., Ramiere, C., Mouzannar, K., Lotteau, V., Andre, P. Reciprocal regulation of farnesoid X receptor activity and hepatitis B virus replication in differentiated HepaRG cells and primary human hepatocytes.	[Radreau, Pauline; Porcherot, Marine; Ramiere, Christophe; Mouzannar, Karim; Lotteau, Vincent; Andre, Patrice] CNRS, INSERM, Ctr Int Rech Infectiol, UMR 5308,U1111, Lyon, France; [Radreau, Pauline; Porcherot, Marine; Ramiere, Christophe; Mouzannar, Karim; Lotteau, Vincent; Andre, Patrice] Ecole Normale Super Lyon, Lyon, France; [Radreau, Pauline; Porcherot, Marine; Ramiere, Christophe; Mouzannar, Karim; Lotteau, Vincent; Andre, Patrice] Univ Lyon 1, Villeurbanne, France; [Radreau, Pauline; Porcherot, Marine; Ramiere, Christophe; Mouzannar, Karim; Lotteau, Vincent; Andre, Patrice] Univ Lyon, Lyon, France; [Ramiere, Christophe; Andre, Patrice] Hosp Civils Lyon, Hop Croix Rousse, Virol Lab, Lyon, France; [Radreau, Pauline; Porcherot, Marine] EnyoPharma, Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Ecole Normale Superieure de Lyon (ENS de LYON); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon	Andre, P (corresponding author), INSERM, Ctr Int Rech Infectiol, U1111, 21 Ave Tony Garnier, F-69007 Lyon, France.	patrice.andre@inserm.fr	Sharma, Ashwani/AAK-3879-2020; Ramière, Christophe/M-8083-2014; André, Patrice/M-8139-2014; lotteau, vincent/M-8143-2014	Sharma, Ashwani/0000-0001-9835-1973; Ramière, Christophe/0000-0002-1981-7155; André, Patrice/0000-0002-5834-7395; Lotteau, Vincent/0000-0003-0997-3282	Agence Nationale de Recherche sur le Sida et les Hepatites [2AO 2013, 1AO 2015]; Finovi, FP7 EC Network SCRTox [266753]; EnyoPharma	Agence Nationale de Recherche sur le Sida et les Hepatites; Finovi, FP7 EC Network SCRTox; EnyoPharma	The authors thank Stephane Joly (EnyoPharma, Lyon, France) for technical assistance and expertise. This work was funded, in part, by grants from the Agence Nationale de Recherche sur le Sida et les Hepatites (2AO 2013 and 1AO 2015), Finovi, FP7 EC Network SCR&Tox (Grant Agreement 266753), and EnyoPharma. V.L. and P.A. are cofounders of EnyoPharma, Lyon. Author contributions: V. Lotteau and P. Andre designed research, analyzed data and wrote the manuscript; P. Radreau and M. Porcherot performed the experiments, analyzed data and contributed to the manuscript writing; and C. Ramiere and K. Mouzannar contributed reagents and experiments.	Bar-Yishay I, 2011, LIVER INT, V31, P282, DOI 10.1111/j.1478-3231.2010.02423.x; Belloni L, 2009, P NATL ACAD SCI USA, V106, P19975, DOI 10.1073/pnas.0908365106; Bock CT, 2001, J MOL BIOL, V307, P183, DOI 10.1006/jmbi.2000.4481; Boulias K, 2005, EMBO J, V24, P2624, DOI 10.1038/sj.emboj.7600728; Curtil C, 2014, FASEB J, V28, P1454, DOI 10.1096/fj.13-236372; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Hirschfield GM, 2015, GASTROENTEROLOGY, V148, P751, DOI 10.1053/j.gastro.2014.12.005; Kim SJ, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003722; Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961; Lefebvre P, 2009, PHYSIOL REV, V89, P147, DOI 10.1152/physrev.00010.2008; Levrero M, 2009, J HEPATOL, V51, P581, DOI 10.1016/j.jhep.2009.05.022; Li JH, 2011, J VIROL, V85, P6319, DOI 10.1128/JVI.02627-10; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Mao Y, 2011, BIOCHEM BIOPH RES CO, V415, P68, DOI 10.1016/j.bbrc.2011.10.013; Mudaliar S, 2013, GASTROENTEROLOGY, V145, P574, DOI 10.1053/j.gastro.2013.05.042; Nassal M, 2008, VIRUS RES, V134, P235, DOI 10.1016/j.virusres.2007.12.024; Nkongolo S, 2014, J HEPATOL, V60, P723, DOI 10.1016/j.jhep.2013.11.022; Oehler N, 2014, HEPATOLOGY, V60, P1483, DOI 10.1002/hep.27159; Papatheodoridis G, 2012, J HEPATOL, V57, P167, DOI 10.1016/j.jhep.2012.02.010; Parent R, 2004, GASTROENTEROLOGY, V126, P1147, DOI 10.1053/j.gastro.2004.01.002; Quasdorff M, 2010, J VIRAL HEPATITIS, V17, P527, DOI 10.1111/j.1365-2893.2010.01315.x; Rabe B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000563; Ramiere C, 2008, J VIROL, V82, P10832, DOI 10.1128/JVI.00883-08; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; SELLS MA, 1987, P NATL ACAD SCI USA, V84, P1005, DOI 10.1073/pnas.84.4.1005; Seok S, 2014, NATURE, V516, P108, DOI 10.1038/nature13949; Shlomai A, 2006, P NATL ACAD SCI USA, V103, P16003, DOI 10.1073/pnas.0607837103; Sir D, 2010, P NATL ACAD SCI USA, V107, P4383, DOI 10.1073/pnas.0911373107; Urban S, 2010, J HEPATOL, V52, P282, DOI 10.1016/j.jhep.2009.10.031; Werle-Lapostolle B, 2004, GASTROENTEROLOGY, V126, P1750, DOI 10.1053/j.gastro.2004.03.018; Yan H, 2014, J VIROL, V88, P3273, DOI 10.1128/JVI.03478-13; Yan H, 2012, ELIFE, V1, DOI 10.7554/eLife.00049	33	23	24	1	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3146	3154		10.1096/fj.201500134	http://dx.doi.org/10.1096/fj.201500134			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27251172				2022-12-28	WOS:000382816300015
J	Benrick, A; Kokosar, M; Hu, M; Larsson, M; Maliqueo, M; Marcondes, RR; Soligo, M; Protto, V; Jerlhag, E; Sazonova, A; Behre, CJ; Hojlund, K; Thoren, P; Stener-Victorin, E				Benrick, Anna; Kokosar, Milana; Hu, Min; Larsson, Martin; Maliqueo, Manuel; Marcondes, Rodrigo Rodrigues; Soligo, Marzia; Protto, Virginia; Jerlhag, Elisabet; Sazonova, Antonina; Behre, Carl Johan; Hojlund, Kurt; Thoren, Peter; Stener-Victorin, Elisabet			Autonomic nervous system activation mediates the increase in whole-body glucose uptake in response to electroacupuncture	FASEB JOURNAL			English	Article						glucose homeostasis; polycystic ovary syndrome; insulin resistance; muscle contraction	POLYCYSTIC-OVARY-SYNDROME; BLOOD-FLOW RESPONSES; INSULIN SENSITIVITY; GROWTH-FACTOR; STIMULATION; ACUPUNCTURE; FREQUENCY; PRONGF; EXPRESSION; PLASTICITY	A single bout of low-frequency electroacupuncture (EA) causing muscle contractions increases whole-body glucose uptake in insulin-resistant rats. We explored the underlying mechanism of this finding and whether it can be translated into clinical settings. Changes in glucose infusion rate (GIR) were measured by euglycemic-hyperinsulinemic clamp during and after 45 min of low-frequency EA in 21 overweight/obese women with polycystic ovary syndrome (PCOS) and 21 controls matched for age, weight, and body mass index (experiment 1) and in rats receiving autonomic receptor blockers (experiment 2). GIR was higher after EA in controls and women with PCOS. Plasma serotonin levels and homovanillic acid, markers of vagal activity, decreased in both controls and patients with PCOS. Adipose tissue expression of pro-nerve growth factor (proNGF) decreased, and the mature NGF/proNGF ratio increased after EA in PCOS, but not in controls, suggesting increased sympathetic-driven adipose tissue metabolism. Administration of alpha-/beta-adrenergic receptor blockers in rats blocked the increase in GIR in response to EA. Muscarinic and dopamine receptor antagonist also blocked the response but with slower onset. In conclusion, a single bout of EA increases whole-body glucose uptake by activation of the sympathetic and partly the parasympathetic nervous systems, which could have important clinical implications for the treatment of insulin resistance.	[Benrick, Anna; Kokosar, Milana; Hu, Min; Larsson, Martin; Thoren, Peter] Univ Gothenburg, Sahlgrenska Acad, Dept Physiol, Gothenburg, Sweden; [Jerlhag, Elisabet] Univ Gothenburg, Sahlgrenska Acad, Dept Pharmacol, Inst Neurosci & Physiol, Gothenburg, Sweden; [Sazonova, Antonina] Univ Gothenburg, Sahlgrenska Acad, Dept Obstet & Gynecol, Inst Clin Sci, Gothenburg, Sweden; [Behre, Carl Johan] Univ Gothenburg, Sahlgrenska Acad, Dept Cardiol, Inst Med, Gothenburg, Sweden; [Benrick, Anna] Univ Skovde, Sch Hlth & Educ, Skovde, Sweden; [Maliqueo, Manuel] Univ Chile, Endocrinol & Metab Lab, West Div, Sch Med, Santiago, Chile; [Marcondes, Rodrigo Rodrigues; Stener-Victorin, Elisabet] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Marcondes, Rodrigo Rodrigues] Univ Sao Paulo, Fac Med, Disciplina Ginecol, Lab Ginecol Estrutural & Mol LIM 58, Sao Paulo, Brazil; [Soligo, Marzia; Protto, Virginia] CNR, Inst Translat Pharmacol, Rome, Italy; [Hojlund, Kurt] Odense Univ Hosp, Dept Endocrinol, Odense, Denmark	University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Gothenburg; University of Skovde; Universidad de Chile; Karolinska Institutet; Universidade de Sao Paulo; Consiglio Nazionale delle Ricerche (CNR); Istituto di Farmacologia Traslazionale (IFT-CNR); University of Southern Denmark; Odense University Hospital	Stener-Victorin, E (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden.	elisabet.stener-victorin@ki.se	Soligo, Marzia/AAC-1543-2019; Stener-Victorin, Elisabet/W-6322-2018; Protto, Virginia/R-1117-2016; Marcondes, Rodrigo/Q-3510-2017	Stener-Victorin, Elisabet/0000-0002-3424-1502; Marcondes, Rodrigo/0000-0002-5391-0230; Protto, Virginia/0000-0003-1723-405X; Hojlund, Kurt/0000-0002-0891-4224; Hu, Min/0000-0002-7731-5874	Swedish Medical Research Council [2014-2775]; Jane and Dan Ohlsson Foundation; Wilhelm and Martina Lundgrens's Science Fund; Hjalmar Svensson Foundation; Adlerbert Research Foundation; Novo Nordisk Foundation [NNF16OC0020744]; Strategic Research Programme in Diabetes at Karolinska Institutet; Royal Society of Arts and Sciences in Gothenburg; Swedish federal government under the LUA/ALF [ALFGBG-429501]; Stockholm County Council; Karolinska Institutet; Becas Chile Programme; University of Chile; Italian National Research Council (CNR); Novo Nordisk Fonden [NNF16OC0020744, NNF16OC0021282, NNF17OC0026724, NNF15OC0015902] Funding Source: researchfish	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Jane and Dan Ohlsson Foundation; Wilhelm and Martina Lundgrens's Science Fund; Hjalmar Svensson Foundation; Adlerbert Research Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Strategic Research Programme in Diabetes at Karolinska Institutet; Royal Society of Arts and Sciences in Gothenburg; Swedish federal government under the LUA/ALF; Stockholm County Council(Stockholm County Council); Karolinska Institutet(Karolinska Institutet); Becas Chile Programme; University of Chile; Italian National Research Council (CNR)(Consiglio Nazionale delle Ricerche (CNR)); Novo Nordisk Fonden(Novo Nordisk Foundation)	The authors thank Carola Gustafsson (University of Gothenburg) for performing all euglycemic hyperinsulinemic clamp studies in the human experiment as well as tissue biopsies. Professor Elisabet Stener-Victorin (Karolinska Institutet) is the guarantor of this study and had full access to all the data and takes responsibility for the integrity of the data and the accuracy of the data analysis. This work was supported by the Swedish Medical Research Council (Project 2014-2775, to E.S.V.); the Jane and Dan Ohlsson Foundation (to E.S.V.); Wilhelm and Martina Lundgrens's Science Fund (to E.S.V. and A.B.); the Hjalmar Svensson Foundation (to E.S.V. and A.B.); the Adlerbert Research Foundation (to E.S.V. and A.B.); the Novo Nordisk Foundation (NNF16OC0020744) (to E.S.V.); Strategic Research Programme in Diabetes at Karolinska Institutet (to E.S.V.); The Royal Society of Arts and Sciences in Gothenburg (to A.B.), the Swedish federal government under the LUA/ALF agreement ALFGBG-429501 (to E.S.V.); and the regional agreement on medical training and clinical research (to A.L.F.) between Stockholm County Council and Karolinska Institutet (to E.S.V.). M.M. thanks the Becas Chile Programme and the University of Chile for financial support through a postdoctoral fellowship. M.S. and V.P. thank the Italian National Research Council (CNR) Short Mobility Program 2015 for mobility fellowships. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Al-Shawi R, 2008, EUR J NEUROSCI, V27, P2103, DOI 10.1111/j.1460-9568.2008.06152.x; Al-Shawi R, 2007, ANN NY ACAD SCI, V1119, P208, DOI 10.1196/annals.1404.024; Belivani M, 2015, ACUPUNCT MED, V33, P110, DOI 10.1136/acupmed-2014-010662; Bello NT, 2006, PHYSIOL BEHAV, V88, P138, DOI 10.1016/j.physbeh.2006.03.027; Benrick A, 2014, ACTA DIABETOL, V51, P963, DOI 10.1007/s00592-014-0645-4; BERGMAN RN, 1985, ENDOCR REV, V6, P45, DOI 10.1210/edrv-6-1-45; Bruno MA, 2006, P NATL ACAD SCI USA, V103, P6735, DOI 10.1073/pnas.0510645103; Chang J, 2004, FERTIL STERIL, V81, P19, DOI 10.1016/j.fertnstert.2003.10.004; Chang SL, 1999, DIABETOLOGIA, V42, P250, DOI 10.1007/s001250051146; CURRY DL, 1987, LIFE SCI, V40, P2053, DOI 10.1016/0024-3205(87)90097-X; DEFRONZO RA, 1979, AM J PHYSIOL, V237, pE214; Dehvari N, 2012, BRIT J PHARMACOL, V165, P1442, DOI 10.1111/j.1476-5381.2011.01647.x; Diamanti-Kandarakis E, 2012, ENDOCR REV, V33, P981, DOI 10.1210/er.2011-1034; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Hamada T, 2003, J APPL PHYSIOL, V94, P2107, DOI 10.1152/japplphysiol.00486.2002; Han JS, 2003, TRENDS NEUROSCI, V26, P17, DOI 10.1016/S0166-2236(02)00006-1; Hasegawa Y, 2002, THROMB RES, V107, P319, DOI 10.1016/S0049-3848(02)00348-1; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; Higashimura Y, 2009, AUTON NEUROSCI-BASIC, V150, P100, DOI 10.1016/j.autneu.2009.06.003; Holz RW, 2016, P NATL ACAD SCI USA, V113, P5766, DOI 10.1073/pnas.1605618113; Howard L, 2013, DEVELOPMENT, V140, P2108, DOI 10.1242/dev.085266; Ishizaki N, 2009, METABOLISM, V58, P1372, DOI 10.1016/j.metabol.2009.05.001; Johansson J, 2010, AM J PHYSIOL-ENDOC M, V299, pE551, DOI 10.1152/ajpendo.00323.2010; Kagitani F, 2010, AUTON NEUROSCI-BASIC, V157, P2, DOI 10.1016/j.autneu.2010.03.004; KAUFMAN MP, 1984, CARDIOVASC RES, V18, P663, DOI 10.1093/cvr/18.11.663; Lee YC, 2011, EXP DIABETES RES, DOI 10.1155/2011/947138; Liang F, 2010, DIABETES OBES METAB, V12, P555, DOI 10.1111/j.1463-1326.2009.01192.x; Lin JG, 2004, NEUROSCI LETT, V366, P39, DOI 10.1016/j.neulet.2004.05.003; Lorentz CU, 2013, EXP NEUROL, V249, P111, DOI 10.1016/j.expneurol.2013.08.015; Manneras L, 2009, AM J PHYSIOL-REG I, V296, pR1124, DOI 10.1152/ajpregu.90947.2008; Masoudi R, 2009, J BIOL CHEM, V284, P18424, DOI 10.1074/jbc.M109.007104; Nahin RL, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-217; NG TB, 1985, COMP BIOCHEM PHYS B, V81, P687, DOI 10.1016/0305-0491(85)90387-6; Nilsson ME, 2015, ENDOCRINOLOGY, V156, P2492, DOI 10.1210/en.2014-1890; ODEN A, 1975, ANN STAT, V3, P518, DOI 10.1214/aos/1176343082; Pedersen SB, 2001, BIOCHEM BIOPH RES CO, V283, P19, DOI 10.1006/bbrc.2001.4736; Prieto-Garcia L, 2015, PSYCHONEUROENDOCRINO, V62, P392, DOI 10.1016/j.psyneuen.2015.09.009; Schlaich M, 2015, LANCET DIABETES ENDO, V3, P148, DOI 10.1016/S2213-8587(14)70033-6; Shimoju-Kobayashi R, 2004, AUTON NEUROSCI-BASIC, V115, P7, DOI 10.1016/j.autneu.2004.07.002; Soligo M, 2015, BRAIN RES, V1624, P455, DOI 10.1016/j.brainres.2015.08.005; Stener-Victorin E, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-44; Stener-Victorin E, 2016, OBES SCI PRACT, V2, P426, DOI 10.1002/osp4.78; Stener-Victorin E, 2003, AUTON NEUROSCI-BASIC, V108, P50, DOI 10.1016/j.autneu.2003.08.006; Stener-Victorin E, 2006, J APPL PHYSIOL, V101, P84, DOI 10.1152/japplphysiol.01593.2005; Stener-Victorin E, 2009, AM J PHYSIOL-REG I, V297, pR387, DOI 10.1152/ajpregu.00197.2009; TABRIZCHI R, 1990, BRIT J PHARMACOL, V101, P358, DOI 10.1111/j.1476-5381.1990.tb12714.x; Thorens B, 2014, DIABETES OBES METAB, V16, P87, DOI 10.1111/dom.12346; Torres-Rosas R, 2014, NAT MED, V20, P291, DOI 10.1038/nm.3479; Wang MQ, 2016, P NATL ACAD SCI USA, V113, pE3029, DOI 10.1073/pnas.1517275113	49	26	27	0	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3288	3297		10.1096/fj.201601381R	http://dx.doi.org/10.1096/fj.201601381R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28404742	Green Submitted			2022-12-28	WOS:000405932400009
J	Pan, XF; De Aragao, CDP; Velasco-Martin, JP; Priestman, DA; Wu, HY; Takahashi, K; Yamaguchi, K; Sturiale, L; Garozzo, D; Platt, FM; Lamarche-Vane, N; Morales, CR; Miyagi, T; Pshezhetsky, AV				Pan, Xuefang; Para De Aragao, Camila De Britto; Velasco-Martin, Juan P.; Priestman, David A.; Wu, Harry Y.; Takahashi, Kohta; Yamaguchi, Kazunori; Sturiale, Luisella; Garozzo, Domenico; Platt, Frances M.; Lamarche-Vane, Nathalie; Morales, Carlos R.; Miyagi, Taeko; Pshezhetsky, Alexey V.			Neuraminidases 3 and 4 regulate neuronal function by catabolizing brain gangliosides	FASEB JOURNAL			English	Article						sialidase; lipofuscin; lysosomal storage; gangliosidosis; Tay-Sach disease; neuroinflammation	SIALIDASE ACTIVITY; NERVOUS-SYSTEM; PROTEIN; ACID; MICE; IDENTIFICATION; BINDING; ROLES	Gangliosides (sialylated glycolipids) play an essential role in the CNS by regulating recognition and signaling in neurons. Metabolic blocks in processing and catabolism of gangliosides result in the development of severe neurologic disorders, including gangliosidoses manifesting with neurodegeneration and neuro-inflammation. We demonstrate that 2 mammalian enzymes, neuraminidases 3 and 4, play important roles in catabolic processing of brain gangliosides by cleaving terminal sialic acid residues in their glycan chains. In neuraminidase 3 and 4 double-knockout mice, G(M3) ganglioside is stored in microglia, vascular pericytes, and neurons, causing micro- and astrogliosis, neuroinflammation, accumulation of lipofuscin bodies, and memory loss, whereas their cortical and hippocampal neurons have lower rate of neuritogenesis in vitro. Double-knockout mice also have reduced levels of G(M1) ganglioside and myelin in neuronal axons. Furthermore, neuraminidase 3 deficiency drastically increased storage of G(M2) in the brain tissues of an asymptomatic mouse model of Tay-Sachs disease, a severe human gangliosidosis, indicating that this enzyme is responsible for the metabolic bypass of beta-hexosaminidase A deficiency. Together, our results provide the first in vivo evidence that neuraminidases 3 and 4 have important roles in CNS function by catabolizing gangliosides and preventing their storage in lipofuscin bodies.	[Pan, Xuefang; Para De Aragao, Camila De Britto; Wu, Harry Y.; Pshezhetsky, Alexey V.] Univ Montreal, St Justine Univ Hosp, Res Ctr, Montreal, PQ, Canada; [Para De Aragao, Camila De Britto; Lamarche-Vane, Nathalie; Morales, Carlos R.; Pshezhetsky, Alexey V.] McGill Univ, Ctr Hlth, Res Inst, Dept Anat & Cell Biol, Montreal, PQ, Canada; [Velasco-Martin, Juan P.] Univ Autonoma Madrid, Fac Med, Dept Anat Histol & Neurociencia, Madrid, Spain; [Priestman, David A.; Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford, England; [Takahashi, Kohta] Tohoku Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Sendai, Miyagi, Japan; [Yamaguchi, Kazunori; Miyagi, Taeko] Miyagi Canc Ctr, Res Inst, Natori, Miyagi, Japan; [Sturiale, Luisella; Garozzo, Domenico] CNR, Inst Polymers Composites & Biomat, Catania, Italy	Universite de Montreal; McGill University; Autonomous University of Madrid; University of Oxford; Tohoku Medical & Pharmaceutical University; Miyagi Cancer Center; Consiglio Nazionale delle Ricerche (CNR); Istituto per i Polimeri, Compositi e Biomateriali (IPCB-CNR)	Pshezhetsky, AV (corresponding author), CHU St Justine, Dept Med Genet, 3175 Cote Ste Catherine, Montreal, PQ H3T 1C5, Canada.	alexei.pchejetski@umontreal.ca	Garozzo, Domenico/I-8839-2014	Garozzo, Domenico/0000-0002-9087-9818; Platt, Frances/0000-0001-7614-0403	Canadian Institutes of Health Research [111068]; Grants-in-Aid for Scientific Research [15K06848] Funding Source: KAKEN	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by Canadian Institutes of Health Research Grant 111068 from (to A.V.P). The authors thank Claire O'Leary (University of Manchester, Manchester, United Kingdom) for help with setting up the Y-maze test; Dr. Graziella Di Cristo [Centre Hospitalier Universitaire (CHU) Sainte-Justine] for helpful advice; Dr. Mila Ashmarina (CHU Ste-Justine), for critical reading of the manuscript; Dr. Nobuo Hanai, Dr. Akiko Furuya, and Kyowa Hakko Kirin Co., Ltd. (Tokyo, Japan), for a generous gift of monoclonal antibodies against G<INF>M2</INF> ganglioside; and Carmen Movila (CHU Ste-Justine), for help in preparation of the manuscript.	Akkerman S, 2012, BEHAV BRAIN RES, V232, P335, DOI 10.1016/j.bbr.2012.03.022; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Carvelli L, 2015, HISTOL HISTOPATHOL, V30, P647, DOI 10.14670/HH-30.647; Collins BE, 1997, J BIOL CHEM, V272, P16889, DOI 10.1074/jbc.272.27.16889; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; de Geest N, 2002, HUM MOL GENET, V11, P1455, DOI 10.1093/hmg/11.12.1455; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Grabrucker A, 2009, CELL TISSUE RES, V338, P333, DOI 10.1007/s00441-009-0881-z; Gravel R. A., 2001, METABOLIC MOL BASES, V3, P3827; Gray Douglas A, 2005, Sci Aging Knowledge Environ, V2005, pre1, DOI 10.1126/sageke.2005.5.re1; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Hata K, 2015, CANCER SCI, V106, P383, DOI 10.1111/cas.12627; Ichikawa N, 2009, J CELL SCI, V122, P289, DOI 10.1242/jcs.030338; Kawai H, 2001, J BIOL CHEM, V276, P6885, DOI 10.1074/jbc.C000847200; Lema PP, 2004, J VET PHARMACOL THER, V27, P321, DOI 10.1111/j.1365-2885.2004.00597.x; Manzi A. E., 2003, CURRENT PROTOCOLS MO, V3; Martins C, 2015, BRAIN, V138, P336, DOI 10.1093/brain/awu355; Miyagi T, 2012, GLYCOBIOLOGY, V22, P880, DOI 10.1093/glycob/cws057; Monti E, 2015, TOP CURR CHEM, V366, P183, DOI 10.1007/128_2012_328; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Palmano K, 2015, NUTRIENTS, V7, P3891, DOI 10.3390/nu7053891; Pshezhetsky AV, 2013, BIOCHEMISTRY-MOSCOW+, V78, P736, DOI 10.1134/S0006297913070067; Pshezhetsky AV, 2001, PROG NUCLEIC ACID RE, V69, P81, DOI 10.1016/S0079-6603(01)69045-7; Rodriguez JA, 2001, J NEUROSCI, V21, P8387, DOI 10.1523/JNEUROSCI.21-21-08387.2001; Sandhoff K, 2013, J NEUROSCI, V33, P10195, DOI 10.1523/JNEUROSCI.0822-13.2013; Schnaar RL, 2014, PHYSIOL REV, V94, P461, DOI 10.1152/physrev.00033.2013; SCHNEIDERJAKOB HR, 1991, BIOL CHEM H-S, V372, P443, DOI 10.1515/bchm3.1991.372.1.443; Seyrantepe V, 2008, HUM MOL GENET, V17, P1556, DOI 10.1093/hmg/ddn043; Seyrantepe V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001118; Smutova V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106320; Sturgill ER, 2012, GLYCOBIOLOGY, V22, P1289, DOI 10.1093/glycob/cws103; Takahashi K, 2012, J BIOL CHEM, V287, P14816, DOI 10.1074/jbc.M111.324186; TETTAMAN.G, 1973, BIOCHIM BIOPHYS ACTA, V296, P160, DOI 10.1016/0005-2760(73)90055-6; Yamaguchi K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041132; YAMANAKA S, 1994, P NATL ACAD SCI USA, V91, P9975, DOI 10.1073/pnas.91.21.9975; YAMANO T, 1983, ACTA NEUROPATHOL, V61, P15, DOI 10.1007/BF00688381; YU RK, 1988, J NEUROCHEM, V50, P1825, DOI 10.1111/j.1471-4159.1988.tb02484.x; Yu RK, 2012, NEUROCHEM RES, V37, P1230, DOI 10.1007/s11064-012-0744-y; Zhao Q, 2000, J BIOL CHEM, V275, P24829, DOI 10.1074/jbc.M003497200	39	35	34	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3467	3483		10.1096/fj.201601299R	http://dx.doi.org/10.1096/fj.201601299R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28442549				2022-12-28	WOS:000405932400024
J	Toriyama, M; Toriyama, M; Wallingford, JB; Finnell, RH				Toriyama, Manami; Toriyama, Michinori; Wallingford, John B.; Finnell, Richard H.			Folate-dependent methylation of septins governs ciliogenesis during neural tube closure	FASEB JOURNAL			English	Article						folate transport; epigenetics; septin2; neural tube defect	EARLY EMBRYONIC-DEVELOPMENT; PLANAR CELL POLARITY; MEMBRANE-TRANSPORT; DNA METHYLATION; PRIMARY CILIUM; DEFECTS; METABOLISM; MICE; GENE; NEURULATION	Periconception maternal folic acid(vitamin B-9) supplementation can reduce the prevalence of neural tube defects (NTDs), although just how folates benefit the developing embryo and promote closing of the neural tube and other morphologic processes during development remains unknown. Folate contributes to a 1-carbon metabolism, which is essential for purine biosynthesis and methionine recycling and affects methylation of DNA, histones, and nonhistone proteins. Herein, we used animal models and cultured mammalian cells to demonstrate that disruption of the methylation pathway mediated by folate compromises normal neural tube closure (NTC) and ciliogenesis. We demonstrate that the embryos with NTD failed to adequately methylate septin2, a key regulator of cilium structure and function. We report that methylation of septin2 affected its GTP binding activity and formation of the septin2-6-7 complex. We propose that folic acid promotes normal NTC in some embryos by regulating the methylation of septin2, which is critical for normal cilium formation during early embryonic development.	[Toriyama, Manami; Finnell, Richard H.] Univ Texas Austin, Dell Med Sch, Dell Pediat Res Inst, Dept Pediat, Austin, TX 78712 USA; [Toriyama, Michinori; Wallingford, John B.] Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA; [Toriyama, Manami] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka, Japan	University of Texas System; University of Texas Austin; University of Texas System; University of Texas Austin; Osaka University	Finnell, RH (corresponding author), Univ Texas Austin, Dell Med Sch, Dell Pediat Res Inst, 1400 Barbara Jordan Blvd, Austin, TX 78723 USA.	rfinnell@austin.utexas.edu	Finnell, Richard/D-8174-2018	Finnell, Richard/0000-0002-5962-8754; TORIYAMA, Michinori/0000-0003-2551-4334; Toriyama, Manami/0000-0002-2754-293X	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development [P01HD067244, R01HD083809, R01HD081216]; NIH National Institute of Neurological Disorders and Stroke [R01NS076465]; National Institute of Environmental Health Sciences [R01ES021006]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD067244, R01HD085901, R01HD083809, R01HD081216] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES021006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS076465] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [17H05003] Funding Source: KAKEN	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank the Proteomics Facility at The University of Texas at Austin who performed MS/MS analysis. This work was supported, in part, by U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grants P01HD067244, R01HD083809, and R01HD081216; NIH National Institute of Neurological Disorders and Stroke Grant R01NS076465, and National Institute of Environmental Health Sciences Grant R01ES021006 (to R.H.F). The authors declare no conflicts of interest.	Bai SM, 2005, MOL CELL BIOL, V25, P751, DOI 10.1128/MCB.25.2.751-766.2005; BARTEL RL, 1984, MOL PHARMACOL, V25, P418; Borgel J, 2010, NAT GENET, V42, P1093, DOI 10.1038/ng.708; Brault V, 2001, DEVELOPMENT, V128, P1253; Bueno O, 2016, J NUTR, V146, P1, DOI 10.3945/jn.115.223685; Cearns MD, 2016, J ANAT, V229, P63, DOI 10.1111/joa.12468; Chih B, 2012, NAT CELL BIOL, V14, P61, DOI 10.1038/ncb2410; Copp AJ, 2003, NAT REV GENET, V4, P784, DOI 10.1038/nrg1181; Cormier CY, 2010, NUCLEIC ACIDS RES, V38, pD743, DOI 10.1093/nar/gkp999; Cox BJ, 2010, GENOME RES, V20, P1154, DOI 10.1101/gr.105106.110; Danielian PS, 1998, CURR BIOL, V8, P1323, DOI 10.1016/S0960-9822(07)00562-3; Fuccillo M, 2006, NAT REV NEUROSCI, V7, P772, DOI 10.1038/nrn1990; Fukuda T, 2011, MOL CELL NEUROSCI, V46, P614, DOI 10.1016/j.mcn.2011.01.001; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; GOLDEN JA, 1993, TERATOLOGY, V47, P73, DOI 10.1002/tera.1420470112; Greene NDE, 2014, ANNU REV NEUROSCI, V37, P221, DOI 10.1146/annurev-neuro-062012-170354; Horswill MA, 2008, EXP EYE RES, V86, P586, DOI 10.1016/j.exer.2008.01.003; Hu QC, 2010, SCIENCE, V329, P436, DOI 10.1126/science.1191054; Ichi S, 2010, J BIOL CHEM, V285, P36922, DOI 10.1074/jbc.M110.126714; KARFUNKEL P, 1974, INT REV CYTOL, V38, P245, DOI 10.1016/S0074-7696(08)60927-4; Khoshnood B, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h5949; Kim SK, 2010, SCIENCE, V329, P1337, DOI 10.1126/science.1191184; Kobayakawa S, 2007, GENES CELLS, V12, P447, DOI 10.1111/j.1365-2443.2007.01063.x; Kwon GS, 2009, GENESIS, V47, P447, DOI 10.1002/dvg.20522; Liu JF, 2016, BIRTH DEFECTS RES A, V106, P267, DOI 10.1002/bdra.23486; Locasale JW, 2013, NAT REV CANCER, V13, P572, DOI 10.1038/nrc3557; MacFarlane AJ, 2015, MUTAT RES-FUND MOL M, V779, P105, DOI 10.1016/j.mrfmmm.2015.06.012; Martiniova L, 2015, AM J CLIN NUTR, V101, P860, DOI 10.3945/ajcn.114.097279; Matherly LH, 2003, VITAM HORM, V66, P403, DOI 10.1016/S0083-6729(03)01012-4; MILLER JW, 1994, BIOCHEM J, V298, P415, DOI 10.1042/bj2980415; Mostowy S, 2012, NAT REV MOL CELL BIO, V13, P183, DOI 10.1038/nrm3284; MULLER F, 1987, ANAT EMBRYOL, V176, P413, DOI 10.1007/BF00310083; Murdoch JN, 2010, BIRTH DEFECTS RES A, V88, P633, DOI 10.1002/bdra.20686; Okano M, 1999, CELL, V99, P247, DOI 10.1016/S0092-8674(00)81656-6; Pan LH, 2002, J IMMUNOL, V168, P3923, DOI 10.4049/jimmunol.168.8.3923; Pang CNI, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-92; Piedrahita JA, 1999, NAT GENET, V23, P228, DOI 10.1038/13861; Rampersaud GC, 2000, AM J CLIN NUTR, V72, P998; Salih Mustafa A M, 2014, Sudan J Paediatr, V14, P49; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Sirotnak FM, 1999, ANNU REV NUTR, V19, P91, DOI 10.1146/annurev.nutr.19.1.91; Toriyama M, 2012, J BIOL CHEM, V287, P12691, DOI 10.1074/jbc.M111.316307; Waes JGV, 2008, BIRTH DEFECTS RES A, V82, P494, DOI 10.1002/bdra.20453; Wallingford JB, 2013, SCIENCE, V339, P1011, DOI 10.1126/science.1222002; Wallingford JB, 2012, ANNU REV CELL DEV BI, V28, P627, DOI 10.1146/annurev-cellbio-092910-154208; Zou ZY, 2004, J BIOL CHEM, V279, P34302, DOI 10.1074/jbc.M405608200	49	24	26	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3622	3635		10.1096/fj.201700092R	http://dx.doi.org/10.1096/fj.201700092R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28432198	Green Published			2022-12-28	WOS:000405932400034
J	Arora, K; Sequeira, JM; Quadros, EV				Arora, Kaveri; Sequeira, Jeffrey M.; Quadros, Edward V.			Maternofetal transport of vitamin B-12: role of TCblR/CD320 and megalin	FASEB JOURNAL			English	Article						cobalamin; placenta; fetal development; yolk sac; brain	CENTRAL-NERVOUS-SYSTEM; TRANSCOBALAMIN-BOUND COBALAMIN; VISCERAL YOLK-SAC; MOUSE SPINAL-CORD; CELLULAR UPTAKE; CEREBROSPINAL-FLUID; DEFICIENCY; RECEPTOR; BINDING; GENE	Vitamin B-12 deficiency causes megaloblastic anemia and neurologic disorder in humans. Gene defects of transcobalamin (TC) and the transcobalamin receptor (TCb1R), needed for cellular uptake of the TC-bound B-12, do not confer embryonic lethality. TC deficiency can produce the hematologic and neurologic complications after birth, whereas TCb1R/CD320 gene defects appear to produce mild metabolic changes. Alternate maternofetal transport mechanisms appear to provide adequate B-12 to the fetus. To understand this mechanism, we evaluated the role of TC, TCb1R/CD320, and megalin in maternofetal transport of B-12 in a TCb1R/CD320-knockout (KO) mouse. Our results showed high expression of TCb1R/CD320 in the labyrinth of the placenta, embryonic brain, and spinal column in wild-type (WT) mice. Megalin expression was about the same in both WT and KO mouse visceral yolk sac, brain, and spinal column. Megalin mRNA was down-regulated in the KO embryonic spinal cord (SC) and kidneys. Megalin expression remained unaltered in adult WT and KO mouse brain, SC, and kidneys. Injected dsRed-TC-B-12 and TC-57CoBi2 accumulated in the visceral yolk sac of KO mice where megalin is expressed and provides an alternate mechanism for the maternofetal transport of Cbl during fetal development. Arora, K., Sequeira, J. M., Quadros, E. V. Maternofetal transport of vitamin B-12: role of TCb1R/CD320 and megalin.	[Arora, Kaveri] Suny Downstate Med Ctr, Sch Grad Studies, Dept Cell Biol, Brooklyn, NY 11203 USA; [Sequeira, Jeffrey M.; Quadros, Edward V.] Suny Downstate Med Ctr, Dept Med, Brooklyn, NY 11203 USA	State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Downstate Medical Center	Quadros, EV (corresponding author), Suny Downstate Med Ctr, 450 Clarkson Ave, Brooklyn, NY 11203 USA.	edward.quadros@downstate.edu		Pohlman, Kaveri/0000-0002-1154-1406	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK064732]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK064732, R01DK064732] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Scott Argraves (Medical University of South Carolina, Charleston, SC, USA) for the generous gift of antibody to megalin. This work was supported, in part, by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK064732 (to E.V.Q.). The recombinant mouse TCb1R was a gift from Dr. Jeffrey Browning (Biogen-Idec, Cambridge MA, USA). The authors declare no conflicts of interest.	Abuyaman O, 2015, SCAND J CLIN LAB INV, V75, P514, DOI 10.3109/00365513.2015.1057761; Birn H, 2002, AM J PHYSIOL-RENAL, V282, pF408, DOI 10.1152/ajprenal.00206.2000; CHANARIN I, 1985, BLOOD, V66, P479; Christensen EI, 2002, PEDIATR NEPHROL, V17, P993, DOI 10.1007/s00467-002-0956-5; Dali-Youcef N, 2009, QJM-INT J MED, V102, P17, DOI 10.1093/qjmed/hcn138; Drake CJ, 2004, ANAT REC PART A, V277A, P163, DOI 10.1002/ar.a.10123; FERNANDESCOSTA F, 1979, BRIT J HAEMATOL, V43, P625, DOI 10.1111/j.1365-2141.1979.tb03795.x; GRABER SE, 1971, J CLIN INVEST, V50, P1000, DOI 10.1172/JCI106569; HANSEN M, 1985, SCAND J HAEMATOL, V34, P209; HARTE RA, 1953, J NUTR, V49, P669, DOI 10.1093/jn/49.4.669; Jiang WX, 2011, DRUG DELIV, V18, P74, DOI 10.3109/10717544.2010.509745; JOLLIE WP, 1990, TERATOLOGY, V41, P361, DOI 10.1002/tera.1420410403; Komhoff M, 2013, PEDIATRICS, V132, pE540, DOI 10.1542/peds.2012-2581; Lachner C, 2012, J NEUROPSYCH CLIN N, V24, P5, DOI 10.1176/appi.neuropsych.11020052; Lai SC, 2013, FASEB J, V27, P2468, DOI 10.1096/fj.12-219055; Lai SC, 2011, EXP CELL RES, V317, P1603, DOI 10.1016/j.yexcr.2011.02.016; LAZAR GS, 1981, J LAB CLIN MED, V97, P123; LERMAN S, 1986, TERATOLOGY, V34, P335, DOI 10.1002/tera.1420340313; Lipton SA, 1997, P NATL ACAD SCI USA, V94, P5923, DOI 10.1073/pnas.94.11.5923; Lloyd JB, 1998, REPROD TOXICOL, V12, P193, DOI 10.1016/S0890-6238(97)00148-2; McCaddon A, 2013, BIOCHIMIE, V95, P1066, DOI 10.1016/j.biochi.2012.11.017; McCarthy RA, 2003, J CELL SCI, V116, P955, DOI 10.1242/jcs.00313; Moestrup SK, 1996, P NATL ACAD SCI USA, V93, P8612, DOI 10.1073/pnas.93.16.8612; Mossman HW, 1987, VERTEBRATE FETAL MEM; Obeid R, 2006, CLIN CHEM, V52, P263, DOI 10.1373/clinchem.2005.057810; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Prasad C, 2008, J INHERIT METAB DIS, V31, pS287, DOI 10.1007/s10545-008-0864-3; Quadros EV, 2010, HUM MUTAT, V31, P924, DOI 10.1002/humu.21297; Quadros EV, 2010, BRIT J HAEMATOL, V148, P195, DOI 10.1111/j.1365-2141.2009.07937.x; Quadros EV, 2009, BLOOD, V113, P186, DOI 10.1182/blood-2008-05-158949; QUADROS EV, 1986, J BIOL CHEM, V261, P5455; Rasmussen SA, 2001, J PEDIATR-US, V138, P10, DOI 10.1067/mpd.2001.112160; Ratschmann R, 2009, MOL GENET METAB, V98, P285, DOI 10.1016/j.ymgme.2009.06.003; ROSENBLATT DS, 1985, LANCET, V1, P1127; Rossant J, 2001, NAT REV GENET, V2, P538, DOI 10.1038/35080570; Scalabrino G, 2009, PROG NEUROBIOL, V88, P203, DOI 10.1016/j.pneurobio.2009.04.004; SCOTT JSD, 1984, CLIN SCI, V67, P299, DOI 10.1042/cs0670299; SHEVELL MI, 1992, CAN J NEUROL SCI, V19, P472, DOI 10.1017/S0317167100041676; Shipton MJ, 2015, CLIN MED, V15, P145, DOI 10.7861/clinmedicine.15-2-145; STABLER SP, 1990, BLOOD, V76, P871; Takeyama A, 2011, BIOCHEM BIOPH RES CO, V407, P108, DOI 10.1016/j.bbrc.2011.02.118; Unal S, 2014, INT J HEMATOL, V99, P659, DOI 10.1007/s12185-014-1545-7; Unal S, 2015, TURK J HEMATOL, V32, P317, DOI 10.4274/tjh.2014.0154; WADDELL WJ, 1981, PHARMACOL THERAPEUT, V14, P375, DOI 10.1016/0163-7258(81)90034-6; Wicher G, 2005, J COMP NEUROL, V492, P123, DOI 10.1002/cne.20673; Wicher G, 2008, NEUROREPORT, V19, P559, DOI 10.1097/WNR.0b013e3282f94267; Willnow TE, 1996, P NATL ACAD SCI USA, V93, P8460, DOI 10.1073/pnas.93.16.8460; ZHENG G, 1994, J HISTOCHEM CYTOCHEM, V42, P531, DOI 10.1177/42.4.7510321	48	19	20	1	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3098	3106		10.1096/fj.201700025R	http://dx.doi.org/10.1096/fj.201700025R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28351841	Green Published			2022-12-28	WOS:000405931000033
J	King, EC; Patel, V; Anand, M; Zhao, XL; Crump, SM; Hu, ZY; Weisleder, N; Abbott, GW				King, Elizabeth C.; Patel, Vishal; Anand, Marie; Zhao, Xiaoli; Crump, Shawn M.; Hu, Zhaoyang; Weisleder, Noah; Abbott, Geoffrey W.			Targeted deletion of Kcne3 impairs skeletal muscle function in mice	FASEB JOURNAL			English	Article						K(v)3.4; MiRP2; myotonia; periodic paralysis; potassium channel	HYPERKALEMIC PERIODIC PARALYSIS; POTASSIUM CHANNELS; ATRIAL-FIBRILLATION; FIBER-TYPE; MUTATION; MOUSE; EXPRESSION; KV3.4; GENE; DYSFUNCTION	KCNE3 (MiRP2) forms heteromeric voltage-gated K+ channels with the skeletal muscle-expressed KCNC4 (Kv3.4) alpha subunit. KCNE3 was the first reported skeletal muscle K+ channel disease gene, but the requirement for KCNE3 in skeletal muscle has been questioned. Here, we confirmed KCNE3 transcript and protein expression in mouse skeletal muscle using Kcne3(-/-) tissue as a negative control. Whole-transcript microarray analysis (770,317 probes, interrogating 28,853 transcripts) findings were consistent with Kcne3 deletion increasing gastrocnemius oxidative metabolic gene expression and the proportion of type Ila fast-twitch oxidative muscle fibers, which was verified using immunofluorescence. The down-regulated transcript set overlapped with muscle unloading gene expression profiles (>= 1.5-fold change; P < 0.05). Gastrocnemius K+ channel a subunit remodeling arising from Kcne3 deletion was highly specific, involving just 3 of 69 alpha subunit genes probed: known KCNE3 partners KCNC4 and KCNH2 (mERG) were down-regulated, and KCNK4 (TRAAK) was up-regulated (P < 0.05). Functionally, Kcne3(-/-) mice exhibited abnormal hind-limb clasping upon tail suspension (63% of Kcne3-1- mice 10-mo-old vs. 0% age-matched Kcne3(+/+) littermates). Whereas 5 of 5 Kcne3(+/+) mice exhibited the typical biphasic decline in contractile force with repetitive stimuli of hind-limb muscle, both in vivo and in vitro, this was absent in 6 of 6 Kcne3(-/-) mice tested. Finally, myoblasts isolated from Kcne3(-/-) mice exhibit faster-inactivating and smaller sustained outward currents than those from Kcne3(+/+) mice. Thus, Kcne3 deletion impairs skeletal muscle function in mice.	[King, Elizabeth C.] Cornell Univ, Weill Med Coll, Dept Pharmacol, New York, NY 10021 USA; [Patel, Vishal; Zhao, Xiaoli; Weisleder, Noah] Univ Med & Dent New Jersey, Robert Wood Johnson Med Sch, Dept Physiol & Biophys, Piscataway, NJ 08854 USA; [Anand, Marie; Crump, Shawn M.; Hu, Zhaoyang; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Pharmacol, 360 Med Surge 2, Irvine, CA 92697 USA; [Anand, Marie; Crump, Shawn M.; Hu, Zhaoyang; Abbott, Geoffrey W.] Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, 360 Med Surge 2, Irvine, CA 92697 USA; [Zhao, Xiaoli] Eastern Virginia Med Sch, Dept Physiol Sci, Norfolk, VA 23501 USA; [Weisleder, Noah] Ohio State Univ, Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, 473 W 12th Ave, Columbus, OH 43210 USA	Cornell University; Rutgers State University New Brunswick; Rutgers State University Medical Center; University of California System; University of California Irvine; University of California System; University of California Irvine; Eastern Virginia Medical School; University System of Ohio; Ohio State University	Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Dept Pharmacol, 360 Med Surge 2, Irvine, CA 92697 USA.; Abbott, GW (corresponding author), Univ Calif Irvine, Sch Med, Dept Physiol & Biophys, 360 Med Surge 2, Irvine, CA 92697 USA.; Weisleder, N (corresponding author), Ohio State Univ, Davis Heart & Lung Res Inst, Dept Physiol & Cell Biol, 473 W 12th Ave, Columbus, OH 43210 USA.	noah.weisleder@osumc.edu; abbottg@uci.edu		Weisleder, Noah/0000-0003-2710-3088	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [R01 HL079275]; University of California, Irvine setup funds; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases [R01 AR063084]; NIH NHLBI [R01 HL116826]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079275, R01HL116826] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI133465] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR063084] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); University of California, Irvine setup funds; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) (Grant R01 HL079275 to G.W.A.), and University of California, Irvine setup funds (to G.W.A.). N.W. was supported by the NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grant R01 AR063084). X.Z. is grateful for support from NIH NHLBI Grant R01 HL116826. The authors thank R. Kant and C. Cao (University of California, Irvine) for technical support.	Abbott GW, 2006, FASEB J, V20, P293, DOI 10.1096/fj.05-5070com; Abbott GW, 2016, FASEB J, V30, P2959, DOI 10.1096/fj.201600467R; Abbott GW, 1999, CELL, V97, P175, DOI 10.1016/S0092-8674(00)80728-X; Abbott GW, 2001, CELL, V104, P217, DOI 10.1016/S0092-8674(01)00207-0; Afzali AM, 2016, AM J PHYSIOL-CELL PH, V311, pC583, DOI 10.1152/ajpcell.00363.2015; Banzet S, 2007, BIOCHEM BIOPH RES CO, V353, P713, DOI 10.1016/j.bbrc.2006.12.074; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Delpon E, 2008, CIRC-ARRHYTHMIA ELEC, V1, P209, DOI 10.1161/CIRCEP.107.748103; EISENHART C, 1947, BIOMETRICS, V3, P1, DOI 10.2307/3001534; FONTAINE B, 1990, SCIENCE, V250, P1000, DOI 10.1126/science.2173143; GEORGE AL, 1995, KIDNEY INT, V48, P1180, DOI 10.1038/ki.1995.401; Hayasaki Hana, 2001, Cellular and Molecular Biology Online Papers, V47, pOL135; Hayward LJ, 2008, J CLIN INVEST, V118, P1437, DOI 10.1172/JCI32638; Joliffe I. T., 1986, PRINCIPAL COMPONENT; Jurkat-Rott K, 2004, NEUROLOGY, V62, P1012, DOI 10.1212/01.WNL.0000119392.29624.88; KOCH MC, 1992, SCIENCE, V257, P797, DOI 10.1126/science.1379744; Lee CS, 2015, SKELET MUSCLE, V5, DOI 10.1186/s13395-014-0027-1; Lewis A, 2004, J BIOL CHEM, V279, P7884, DOI 10.1074/jbc.M310501200; Lisewski U, 2016, FASEB J, V30, P2476, DOI 10.1096/fj.201600317R; Lundby A, 2008, CELL PHYSIOL BIOCHEM, V21, P47, DOI 10.1159/000113746; Mille M, 2009, PFLUG ARCH EUR J PHY, V457, P1023, DOI 10.1007/s00424-008-0570-x; MULLER KE, 1984, COMPUT STAT DATA AN, V2, P143, DOI 10.1016/0167-9473(84)90002-1; Nakajima T, 2012, CIRC J, V76, P2763, DOI 10.1253/circj.CJ-12-0551; Ohno S, 2009, HUM MUTAT, V30, P557, DOI 10.1002/humu.20834; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Preston P, 2010, J BIOL CHEM, V285, P7165, DOI 10.1074/jbc.M109.047829; PTACEK LJ, 1991, AM J HUM GENET, V49, P851; Ritter DM, 2015, CHANNELS, V9, P209, DOI 10.1080/19336950.2015.1056949; Roepke TK, 2011, FASEB J, V25, P727, DOI 10.1096/fj.10-173682; Ryan DP, 2010, CELL, V140, P88, DOI 10.1016/j.cell.2009.12.024; Sanchez JA, 2000, PFLUG ARCH EUR J PHY, V440, P34, DOI 10.1007/s004240000248; Schroeder BC, 2000, NATURE, V403, P196, DOI 10.1038/35003200; Sternberg D, 2003, NEUROLOGY, V61, P857, DOI 10.1212/01.WNL.0000082392.66713.E3; Tamhane AC, 2006, STAT DATA ANAL ELEME; Vullhorst D, 1998, FEBS LETT, V421, P259, DOI 10.1016/S0014-5793(97)01577-9; Wang X, 2006, FASEB J, V20, P1531, DOI 10.1096/fj.05-5350fje; Weber H, 2012, J APPL PHYSIOL, V112, P2087, DOI 10.1152/japplphysiol.00871.2011; Weisleder N, 2007, CELL CALCIUM, V42, P548, DOI 10.1016/j.ceca.2007.01.009; Weisleder N, 2006, J CELL BIOL, V174, P639, DOI 10.1083/jcb.200604166; Zhang DF, 2005, CHINESE MED J-PEKING, V118, P1735; Zhao XL, 2010, BIOPHYS J, V99, P1556, DOI 10.1016/j.bpj.2010.06.050	43	1	1	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2937	2947		10.1096/fj.201600965RR	http://dx.doi.org/10.1096/fj.201600965RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28356343	Green Submitted, Green Published			2022-12-28	WOS:000405931000019
J	Sociali, G; Magnone, M; Ravera, S; Damonte, P; Vigliarolo, T; Von Holtey, M; Vellone, VG; Millo, E; Caffa, I; Cea, M; Parenti, MD; Del Rio, A; Murone, M; Mostoslavsky, R; Grozio, A; Nencioni, A; Bruzzone, S				Sociali, Giovanna; Magnone, Mirko; Ravera, Silvia; Damonte, Patrizia; Vigliarolo, Tiziana; Von Holtey, Maria; Vellone, Valerio G.; Millo, Enrico; Caffa, Irene; Cea, Michele; Parenti, Marco Daniele; Del Rio, Alberto; Murone, Maximilien; Mostoslavsky, Raul; Grozio, Alessia; Nencioni, Alessio; Bruzzone, Santina			Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model	FASEB JOURNAL			English	Article						sirtuin inhibitors; glucose metabolism; glucose transporters	DEACETYLASE SIRT6; MICE; SECRETION; SIRTUINS; OBESITY; CELLS	Sirtuin 6 (SIRT6) is a sirtuin family member involved in a wide range of physiologic and disease processes, including cancer and glucose homeostasis. Based on the roles played by SIRT6 in different organs, including its ability to repress the expression of glucose transporters and glycolytic enzymes, inhibiting SIRT6 has been proposed as an approach for treating type 2 diabetes mellitus (T2DM). However, so far, the lack of small-molecule Sirt6 inhibitors has hampered the conduct of in vivo studies to assess the viability of this strategy. We took advantage of a recently identified SIRT6 inhibitor, compound 1, to study the effect of pharmacological Sirt6 inhibition in a mouse model of T2DM (i.e., in high-fat-diet fed animals). The administration of the Sirt6 inhibitor for 10 d was well tolerated and improved oral glucose tolerance, it increased the expression of the glucose transporters GLUT1 and 4 in the muscle and enhanced the activity of the glycolytic pathway. Sirt6 inhibition also resulted in reduced insulin, triglycerides, and cholesterol levels in plasma. This study represents the first in vivo study of a SIRT6 inhibitor and provides the proof-of concept that targeting SIRT6 maybe a viable strategy for improving glycemic control in T2DM. Sociali, G., Magnone, M., Ravera, S., Damonte, P., Vigliarolo, T., Von Holtey, M., Vellone, V. G., Millo, E., Caffa, I., Cea, M., Parenti, M. D., Del Rio, A., Murone, M., Mostoslaysky, R., Grozio, A., Nencioni, A., Bruzzone S. Pharmacological Sirt6 inhibition improves glucose tolerance in a type 2 diabetes mouse model.	[Sociali, Giovanna; Magnone, Mirko; Vigliarolo, Tiziana; Millo, Enrico; Grozio, Alessia; Bruzzone, Santina] Univ Genoa, CEBR, Dept Expt Med, Biochem Sect, Genoa, Italy; [Ravera, Silvia] Univ Genoa, Dept Pharm, Biochem Lab, Genoa, Italy; [Damonte, Patrizia; Caffa, Irene; Cea, Michele; Nencioni, Alessio] Univ Genoa, Dept Internal Med, Viale Benedetto 15,6, I-16132 Genoa, Italy; [Vellone, Valerio G.] Univ Genoa, Dept Surg Sci & Integrated Diagnost, Genoa, Italy; [Von Holtey, Maria; Murone, Maximilien] Debiopharm Int SA, Lausanne, Switzerland; [Parenti, Marco Daniele; Del Rio, Alberto] Natl Res Council CNR, Inst Organ Synth & Photoreact ISOF, Bologna, Italy; [Del Rio, Alberto] Innovamol Srls, Modena, Italy; [Murone, Maximilien] Cellestia Biotech AG, Basel, Switzerland; [Mostoslavsky, Raul] Harvard Med Sch, Massachusetts Gen Hosp, Ctr Canc, Boston, MA USA; [Nencioni, Alessio] Azienda Osped Univ San Martino, Ist Nazl Ric Canc IST, Ist Ricovero & Cura Carattere Sci, Genoa, Italy; [Bruzzone, Santina] CNR, Inst Prot Biochem, Naples, Italy	University of Genoa; University of Genoa; University of Genoa; University of Genoa; Debiopharm; Consiglio Nazionale delle Ricerche (CNR); Istituto per la Sintesi Organica e la Fotoreattivita (ISOF-CNR); Harvard University; Harvard Medical School; Massachusetts General Hospital; University of Genoa; IRCCS AOU San Martino IST; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR)	Nencioni, A (corresponding author), Univ Genoa, Dept Internal Med, Viale Benedetto 15,6, I-16132 Genoa, Italy.; Bruzzone, S (corresponding author), Univ Genoa, Dept Expt Med, Biochem Sect, Viale Benedetto 15,1, I-16132 Genoa, Italy.	alessio.nencioni@unige.it; santina.bruzzone@unige.it	Caffa, Irene/J-9835-2016; Vellone, Valerio Gaetano/M-6139-2019; Ravera, Silvia/AAA-7982-2019; Millo, Enrico/K-3218-2018; Bruzzone, Santina/A-4264-2015; Vellone, Valerio Gaetano/A-4342-2018; cea, Michele/K-3863-2018; Nencioni, Alessio/K-3692-2018	Caffa, Irene/0000-0003-1111-9915; Vellone, Valerio Gaetano/0000-0002-5107-1584; Ravera, Silvia/0000-0002-0803-1042; Millo, Enrico/0000-0002-4019-0051; Bruzzone, Santina/0000-0003-2034-3716; Vellone, Valerio Gaetano/0000-0002-5107-1584; cea, Michele/0000-0002-1530-6729; Del Rio, Alberto/0000-0002-1890-6797; NENCIONI, ALESSIO/0000-0001-5068-8884; Parenti, Marco Daniele/0000-0001-6837-8294; Grozio, Alessia/0000-0003-4699-3303	Collegio Ghislieri (Pavia, Italy); Italian Ministry of Health Grant [GR-2011-02347192]; University of Genova; Programme FP7 PANACREAS Grant [256986]; Athero-B-Cell Grant [602114]; Associazione Italiana per la Ricerca sul Cancro (AIRC) Grant [17736]; Fondazione Umberto Veronesi; NATIONAL CANCER INSTITUTE [R01CA175727] Funding Source: NIH RePORTER	Collegio Ghislieri (Pavia, Italy); Italian Ministry of Health Grant(Ministry of Health, Italy); University of Genova; Programme FP7 PANACREAS Grant; Athero-B-Cell Grant; Associazione Italiana per la Ricerca sul Cancro (AIRC) Grant(Fondazione AIRC per la ricerca sul cancro); Fondazione Umberto Veronesi(Fondazione Umberto Veronesi); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The authors thank Thierry Dupraz and Yogeshwar Bacchav (Debiopharm International SA) for technical support. G.S. is a recipient of a fellowship for young investigators granted by Collegio Ghislieri (Pavia, Italy). This work was supported by the Italian Ministry of Health Grant GR-2011-02347192 (to A.N., A.G., and A.D.R.); the University of Genova (to S.B. and AN.); Programme FP7 PANACREAS Grant 256986 (to A.N. and S.B.) and Athero-B-Cell, Grant 602114 (to AN.); Associazione Italiana per la Ricerca sul Cancro (AIRC) Grant 17736 (to AN.); and the Fondazione Umberto Veronesi (to A.N.). G.S. and M.M. contributed equally to this work as first authors. A.N. and S.B. contributed equally to this work as senior authors. The authors declare no conflicts of interest.	Anderson JG, 2015, MOL METAB, V4, P846, DOI 10.1016/j.molmet.2015.09.003; Atkinson BJ, 2013, DIABETES, V62, P2249, DOI 10.2337/db12-1146; Bianchi G, 2015, ONCOTARGET, V6, P11806, DOI 10.18632/oncotarget.3688; Dominy JE, 2012, MOL CELL, V48, P900, DOI 10.1016/j.molcel.2012.09.030; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Marin-Penalver JJ, 2016, WORLD J DIABETES, V7, P354, DOI 10.4239/wjd.v7.i17.354; Kanfi Y, 2010, AGING CELL, V9, P162, DOI 10.1111/j.1474-9726.2009.00544.x; Kim HS, 2010, CELL METAB, V12, P224, DOI 10.1016/j.cmet.2010.06.009; Kugel S, 2014, TRENDS BIOCHEM SCI, V39, P72, DOI 10.1016/j.tibs.2013.12.002; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Manco M, 2010, OBES SURG, V20, P1682, DOI 10.1007/s11695-010-0129-8; Miele L, 2009, TRANSL RES, V154, P194, DOI 10.1016/j.trsl.2009.06.007; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nolan CJ, 2011, LANCET, V378, P169, DOI 10.1016/S0140-6736(11)60614-4; Nonalcoholic Steatohepatitis Clinical Research Network, 2005, HEPATOLOGY, V41, P1313; Parenti MD, 2014, J MED CHEM, V57, P4796, DOI 10.1021/jm500487d; Ravera S, 2013, BIOCHIMIE, V95, P1991, DOI 10.1016/j.biochi.2013.07.003; Sociali G, 2016, ONCOTARGET, V7, P2968, DOI 10.18632/oncotarget.6502; Sociali G, 2015, EUR J MED CHEM, V102, P530, DOI 10.1016/j.ejmech.2015.08.024; Song MY, 2016, SCI REP-UK, V6, DOI 10.1038/srep30321; Tao RY, 2013, J LIPID RES, V54, P2745, DOI 10.1194/jlr.M039339; Xiao CY, 2010, J BIOL CHEM, V285, P36776, DOI 10.1074/jbc.M110.168039; Zhang XY, 2016, NAT CHEM BIOL, V12, P614, DOI [10.1038/NCHEMBIO.2106, 10.1038/nchembio.2106]; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041	26	44	45	2	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3138	3149		10.1096/fj.201601294R	http://dx.doi.org/10.1096/fj.201601294R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28386046	Green Published, Green Submitted			2022-12-28	WOS:000405931000037
J	Naruse, C; Shibata, S; Tamura, M; Kawaguchi, T; Abe, K; Sugihara, K; Kato, T; Nishiuchi, T; Wakana, S; Ikawa, M; Asano, M				Naruse, Chie; Shibata, Shinwa; Tamura, Masaru; Kawaguchi, Takayuki; Abe, Kanae; Sugihara, Kazushi; Kato, Tomoaki; Nishiuchi, Takumi; Wakana, Shigeharu; Ikawa, Masahito; Asano, Masahide			New insights into the role of Jmjd3 and Utx in axial skeletal formation in mice	FASEB JOURNAL			English	Article						homeotic transformation; histone demethylation; Hox; kyphosis; H3K27 methylation	EMBRYONIC STEM-CELLS; HOX GENE CLUSTERS; HISTONE H3; DEMETHYLASE JMJD3; DEVELOPMENTAL REGULATORS; NUCLEAR REORGANIZATION; POLYCOMB COMPLEXES; TARGET GENES; CHROMATIN; MOUSE	Jmjd3 and Utx are demethylases specific for lysine 27 of histone H3. Previous reports indicate that Jmjd3 is essential for differentiation of various cell types, such as macrophages and epidermal cells in mice, whereas Utx is involved in cancer and developmental diseases in humans and mice, as well as Hox regulation in zebrafish and nematodes. Here, we report that Jmjd3, but not Utx, is involved in axial skeletal formation in mice. A Jmjd3 mutant embryo (Jmjd3(Delta 18/Delta 18)), but not a catalytically inactive Utx truncation mutant (Utx(-/y)), showed anterior homeotic transformation. Quantitative RT-PCR and microarray analyses showed reduced Hox expression in both Jmjd3(Delta 18/Delta 18) embryos and tailbuds, whereas levels of Hox activators, such as Wnt signaling factors and retinoic acid synthases, did not decrease, which suggests that Jmjd3 plays a regulatory role in Hox expression during axial patterning. Chromatin immunoprecipitation analyses of embryo tailbud tissue showed trimethylated lysine 27 on histone H3 to be at higher levels at the Hox loci in Jmjd3(Delta 18/Delta 18) mutants compared with wild-type tailbuds. In contrast, trimethylated lysine 4 on histone H3 levels were found to be equivalent in wild-type and Jmjd3(Delta 18/Delta 18) tailbuds. Demethylase-inactive Jmjd3 mutant embryos showed the same phenotype as Jmjd3(Delta 18/Delta 18) mice. These results suggest that the demethylase activity of Jmjd3, but not that of Utx, affects mouse axial patterning in concert with alterations in Hox gene expression.	[Naruse, Chie; Sugihara, Kazushi; Asano, Masahide] Kyoto Univ, Inst Lab Anim, Grad Sch Med, Kyoto, Japan; [Naruse, Chie; Shibata, Shinwa; Kawaguchi, Takayuki; Abe, Kanae; Sugihara, Kazushi; Asano, Masahide] Kanazawa Univ, Div Transgen Anim Sci, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan; [Kato, Tomoaki; Nishiuchi, Takumi] Kanazawa Univ, Div Funct Genom, Adv Sci Res Ctr, Kanazawa, Ishikawa, Japan; [Tamura, Masaru; Wakana, Shigeharu] RIKEN, Technol & Dev Team Mouse Phenotype Anal, BioResource Ctr, Tsukuba, Ibaraki, Japan; [Ikawa, Masahito] Osaka Univ, Res Inst Microbial Dis, Anim Resource Ctr Infect Dis, Suita, Osaka, Japan	Kyoto University; Kanazawa University; Kanazawa University; RIKEN; Osaka University	Asano, M (corresponding author), Kyoto Univ, Sakyo Ku, Yoshida Konoe Cho, Kyoto 6068501, Japan.	asano@anim.med.kyoto-u.ac.jp	ikawa, masahito/A-5315-2009	ikawa, masahito/0000-0001-9859-6217; Kawaguchi, Takayuki/0000-0001-6688-3879; Nishiuchi, Takumi/0000-0001-9429-5396	Grants-in-Aid for Scientific Research [15K14360, 16H06276] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Abe K, 2011, BIOL REPROD, V85, P1013, DOI 10.1095/biolreprod.111.091512; Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Alexander T, 2009, ANNU REV CELL DEV BI, V25, P431, DOI 10.1146/annurev.cellbio.042308.113423; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Asano M, 1997, EMBO J, V16, P1850, DOI 10.1093/emboj/16.8.1850; Aulehla A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000869; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Biasini M, 2014, NUCLEIC ACIDS RES, V42, pW252, DOI 10.1093/nar/gku340; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; BRAUN T, 1992, CELL, V71, P369, DOI 10.1016/0092-8674(92)90507-9; Burgold T, 2012, CELL REP, V2, P1244, DOI 10.1016/j.celrep.2012.09.013; Cao R, 2004, CURR OPIN GENET DEV, V14, P155, DOI 10.1016/j.gde.2004.02.001; Chambeyron S, 2005, DEVELOPMENT, V132, P2215, DOI 10.1242/dev.01813; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Chen F, 1998, MECH DEVELOP, V77, P49, DOI 10.1016/S0925-4773(98)00126-9; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dahle O, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000841; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; De Santa F, 2009, EMBO J, V28, P3341, DOI 10.1038/emboj.2009.271; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; FromentalRamain C, 1996, DEVELOPMENT, V122, P461; Fukusumi Y, 2008, DEV DYNAM, V237, P618, DOI 10.1002/dvdy.21444; Glaser S, 2006, DEVELOPMENT, V133, P1423, DOI 10.1242/dev.02302; Henriquez B, 2013, MOL CELL NEUROSCI, V57, P130, DOI 10.1016/j.mcn.2013.07.012; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Hurley I, 2005, EVOL DEV, V7, P556, DOI 10.1111/j.1525-142X.2005.05059.x; Ito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029873; IZPISUABELMONTE JC, 1991, EMBO J, V10, P2279, DOI 10.1002/j.1460-2075.1991.tb07764.x; Kang SC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135276; Kappen C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146019; KUHN R, 1991, SCIENCE, V254, P707, DOI 10.1126/science.1948049; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; Lund AH, 2004, CURR OPIN CELL BIOL, V16, P239, DOI 10.1016/j.ceb.2004.03.010; Mallo M, 2013, DEVELOPMENT, V140, P3951, DOI 10.1242/dev.068346; Mashiko D, 2014, DEV GROWTH DIFFER, V56, P122, DOI 10.1111/dgd.12113; McIntyre DC, 2007, DEVELOPMENT, V134, P2981, DOI 10.1242/dev.007567; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Milne TA, 2002, MOL CELL, V10, P1107, DOI 10.1016/S1097-2765(02)00741-4; Nagy A., 2003, MANIPULATING MOUSE E; Niederreither K., 2008, NAT REV GENET; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; RANCOURT DE, 1995, GENE DEV, V9, P108, DOI 10.1101/gad.9.1.108; Santos-Rosa H, 2003, MOL CELL, V12, P1325, DOI 10.1016/S1097-2765(03)00438-6; Satoh T, 2010, NAT IMMUNOL, V11, P936, DOI 10.1038/ni.1920; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Sengoku T, 2011, GENE DEV, V25, P2266, DOI 10.1101/gad.172296.111; Shpargel KB, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004507; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Terranova R, 2006, P NATL ACAD SCI USA, V103, P6629, DOI 10.1073/pnas.0507425103; Theiler K, 1989, HOUSE MOUSE ATLAS EM, DOI 10.1007/978-3-642-88418-4; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; van den Akker E, 2001, DEVELOPMENT, V128, P1911; Vinagre T, 2010, DEV CELL, V18, P655, DOI 10.1016/j.devcel.2010.02.011; Wellik DM, 2007, DEV DYNAM, V236, P2454, DOI 10.1002/dvdy.21286; Wysocka J, 2005, CELL, V121, P859, DOI 10.1016/j.cell.2005.03.036; Zakany J, 1997, EMBO J, V16, P4393, DOI 10.1093/emboj/16.14.4393; Zhang F, 2015, J MOL CELL BIOL, V7, P23, DOI 10.1093/jmcb/mjv003	66	19	19	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2252	2266		10.1096/fj.201600642R	http://dx.doi.org/10.1096/fj.201600642R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28188179				2022-12-28	WOS:000401553400004
J	Castoria, G; Auricchio, F; Migliaccio, A				Castoria, Gabriella; Auricchio, Ferdinando; Migliaccio, Antimo			Extranuclear partners of androgen receptor: at the crossroads of proliferation, migration, and neuritogenesis	FASEB JOURNAL			English	Review						Src; filamin A; TrkA; cell cycle; cytoskeleton changes	RESISTANT PROSTATE-CANCER; SRC FAMILY KINASES; ALZHEIMERS-DISEASE; C-SRC; ESTRADIOL-RECEPTOR; PROTEIN-KINASES; HUMAN BREAST; DYRK FAMILY; GROWTH; FILAMIN	In this review, we focus on the role played by the protein partners of ligand- activated extranuclear androgen receptor (AR) in the final effects of hormone action, such as proliferation, migration, and neuritogenesis. The choice ofAR partner, at least in part, depends on cell type.Androgen-activated receptor directly associateswith cytoplasmic Src tyrosine kinase in epithelial cells, whereas in mesenchymal and neuronal cells, it prevalently interacts with filamin A. In the former, proliferation represents the final hormonal outcome, whereas in the latter, either migration or neuritogenesis, respectively, occurs. Furthermore, AR partner filamin A is replaced with Src whenmesenchymal cells are stimulatedwith very lowandrogen concentrations. Consequently, themigratory effect is replaced by mitogenesis. Use of peptides that prevent receptor/partner assembly abolishes the effects that are dependent on their association and offers new therapeutic approaches to AR-related diseases. Perturbation of migration is often associated with metastatic spreading in cancer. In turn, cell cycle aberration causes tumors to grow faster, whereas toxic signaling triggers neurodegenerative events in the CNS. Here, we provide examples of new tools that interfere in rapid androgen effects, including migration, proliferation, and neuronal differentiation, together with their potential therapeutic applications in AR-dependent diseases-mainly prostate cancer and neurodegenerativedisorders.-Castoria, G., Auricchio, F., Migliaccio, A. Extranuclearpartners of androgen receptor: at the crossroads of proliferation, migration, and neuritogenesis.	[Castoria, Gabriella; Auricchio, Ferdinando; Migliaccio, Antimo] Univ Campania Luigi Vanvitelli, Dept Biochem Biophys & Gen Pathol, Naples, Italy	Universita della Campania Vanvitelli	Castoria, G (corresponding author), Univ Campania L Vanvitelli, Dept Biochem Biophys & Gen Pathol, Via L de Crecchio 7, I-80138 Naples, Italy.	gabriella.castoria@unina2.it	Migliaccio, Antimo/AAB-3376-2019; Castoria, Gabriella/I-3349-2019	Castoria, Gabriella/0000-0002-0576-4494; Migliaccio, Antimo/0000-0002-4197-2055	Italian Ministry of University and Scientific Research [2015B7M39T_003]	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR))	This work was supported by grants from the Italian Ministry of University and Scientific Research (2015B7M39T_003; to G. C.).	Acconcia F, 2005, MOL BIOL CELL, V16, P231, DOI 10.1091/mbc.e04-07-0547; ANDERMANN E, 1994, NEUROLOGY, V44, P581, DOI 10.1212/WNL.44.3_Part_1.581; Antonarakis ES, 2014, NEW ENGL J MED, V371, P2234, DOI 10.1056/NEJMc1412594; Aranda S, 2011, FASEB J, V25, P449, DOI 10.1096/fj.10-165837; Baron S, 2004, J BIOL CHEM, V279, P14579, DOI 10.1074/jbc.M306143200; BEATO M, 1995, CELL, V83, P851, DOI 10.1016/0092-8674(95)90201-5; Becker W, 2012, CELL CYCLE, V11, P3389, DOI 10.4161/cc.21404; Bedolla RG, 2009, CLIN CANCER RES, V15, P788, DOI 10.1158/1078-0432.CCR-08-1402; Bennett NC, 2014, PROSTATE, V74, P478, DOI 10.1002/pros.22767; Biron E, 2016, J STEROID BIOCHEM, V161, P36, DOI 10.1016/j.jsbmb.2015.07.006; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Burns Lindsay H, 2010, Recent Pat CNS Drug Discov, V5, P210; Cai HJ, 2011, CANCER RES, V71, P862, DOI 10.1158/0008-5472.CAN-10-1605; Cardozo CP, 2003, ARCH BIOCHEM BIOPHYS, V410, P134, DOI 10.1016/S0003-9861(02)00680-X; Castoria G, 2001, EMBO J, V20, P6050, DOI 10.1093/emboj/20.21.6050; Castoria G, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.497; Castoria G, 2012, ONCOGENE, V31, P4868, DOI 10.1038/onc.2011.642; Castoria G, 2003, J CELL BIOL, V161, P547, DOI 10.1083/jcb.200211099; Castoria G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076899; Castoria G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017218; Cato A.C., 2002, SCI STKE, V2002, pre9, DOI [10.1126/stke.2002.138.re9, DOI 10.1126/STKE.2002.138.RE9]; Chang C, 2014, ONCOGENE, V33, P3225, DOI 10.1038/onc.2013.274; Chang CJ, 2013, MATH PROBL ENG, V2013, DOI 10.1155/2013/526806; Cornil CA, 2006, BRAIN RES, V1126, P2, DOI 10.1016/j.brainres.2006.07.098; De Strooper B, 2007, EMBO REP, V8, P141, DOI 10.1038/sj.embor.7400897; Deng Xiaobing, 2014, Genes Cancer, V5, P337; Di Donato M, 2015, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00225; Di Donato M, 2015, MOL BIOL CELL, V26, P2858, DOI 10.1091/mbc.E14-09-1352; Encinas M, 2001, J NEUROSCI, V21, P1464, DOI 10.1523/JNEUROSCI.21-05-01464.2001; Fargo KN, 2008, HORM BEHAV, V53, P716, DOI 10.1016/j.yhbeh.2008.01.014; Ferland RJ, 2006, AM J MED GENET A, V140A, P1305, DOI 10.1002/ajmg.a.31259; Feuillette S, 2010, BRAIN RES, V1345, P182, DOI 10.1016/j.brainres.2010.05.007; Fizazi K, 2007, ANN ONCOL, V18, P1765, DOI 10.1093/annonc/mdm086; Fizazi K, 2010, BJU INT, V105, P748, DOI 10.1111/j.1464-410X.2010.09236.x; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; Fuller SJ, 2007, J ALZHEIMERS DIS, V12, P129; Gorski J, 1997, PROG CLIN BIOL RES, V396, P233; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Hossain MI, 2013, J BIOL CHEM, V288, P9696, DOI 10.1074/jbc.M112.419713; Ishizawar R, 2004, CANCER CELL, V6, P209, DOI 10.1016/j.ccr.2004.09.001; Janel N, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.61; KENNEDY WR, 1968, NEUROLOGY, V18, P671, DOI 10.1212/WNL.18.7.671; Keramati AR, 2014, NEW ENGL J MED, V370, P1909, DOI 10.1056/NEJMoa1301824; Kettle JG, 2015, J MED CHEM, V58, P2834, DOI 10.1021/acs.jmedchem.5b00098; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Krygier S, 2002, INT J CANCER, V98, P1, DOI 10.1002/ijc.10160; LASPADA AR, 1991, NATURE, V352, P77, DOI 10.1038/352077a0; Lauth M, 2010, NAT STRUCT MOL BIOL, V17, P718, DOI 10.1038/nsmb.1833; Lee E, 2013, P NATL ACAD SCI USA, V110, P15710, DOI 10.1073/pnas.1218168110; Lee G, 2005, BBA-MOL BASIS DIS, V1739, P323, DOI 10.1016/j.bbadis.2004.09.002; Lee SR, 2002, MOL ENDOCRINOL, V16, P85, DOI 10.1210/me.16.1.85; Lehmann DJ, 2003, NEUROSCI LETT, V340, P87, DOI 10.1016/S0304-3940(03)00069-7; Lian GW, 2012, J NEUROSCI, V32, P7672, DOI 10.1523/JNEUROSCI.0894-12.2012; Litvinov IV, 2006, P NATL ACAD SCI USA, V103, P15085, DOI 10.1073/pnas.0603057103; Liu XY, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/789184; Lonskaya I, 2013, EMBO MOL MED, V5, P1247, DOI 10.1002/emmm.201302771; Loy CJ, 2003, P NATL ACAD SCI USA, V100, P4562, DOI 10.1073/pnas.0736237100; Lu ML, 2001, J BIOL CHEM, V276, P13442, DOI 10.1074/jbc.M006598200; Lu Q, 2010, J ALZHEIMERS DIS, V22, P235, DOI 10.3233/JAD-2010-100585; Ma QL, 2008, J BIOL CHEM, V283, P14132, DOI 10.1074/jbc.M708034200; MARTINZANCA D, 1989, MOL CELL BIOL, V9, P24, DOI 10.1128/MCB.9.1.24; Mehta AR, 2016, THER ADV UROL, V8, P9, DOI 10.1177/1756287215603558; Migliaccio A, 2007, ONCOGENE, V26, P6619, DOI 10.1038/sj.onc.1210487; Migliaccio A, 2005, CANCER RES, V65, P10585, DOI 10.1158/0008-5472.CAN-05-0912; Migliaccio A, 2000, EMBO J, V19, P5406, DOI 10.1093/emboj/19.20.5406; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Molloy Niamh H, 2011, Cancers (Basel), V3, P510, DOI 10.3390/cancers3010510; Mulders PF, 2015, CANCER IMMUNOL IMMUN, V64, P655, DOI 10.1007/s00262-015-1707-3; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Nead KT, 2016, J CLIN ONCOL, V34, P566, DOI 10.1200/JCO.2015.63.6266; Nygaard HB, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt238; Ozanne DM, 2000, MOL ENDOCRINOL, V14, P1618, DOI 10.1210/me.14.10.1618; Park SI, 2008, CANCER RES, V68, P3323, DOI 10.1158/0008-5472.CAN-07-2997; Pawson T, 2000, GENE DEV, V14, P1027; Pedram A, 2007, J BIOL CHEM, V282, P22278, DOI 10.1074/jbc.M611877200; Perez M, 1997, PROSTATE, V30, P274, DOI 10.1002/(SICI)1097-0045(19970301)30:4<274::AID-PROS8>3.0.CO;2-L; Peterziel H, 1999, ONCOGENE, V18, P6322, DOI 10.1038/sj.onc.1203032; Poletti A, 2005, ENDOCRINE, V28, P243, DOI 10.1385/ENDO:28:3:243; Poulard C, 2012, EMBO MOL MED, V4, P1200, DOI 10.1002/emmm.201201615; POWER RF, 1991, SCIENCE, V252, P1546, DOI 10.1126/science.2047861; POWER RF, 1991, SCIENCE, V254, P1636, DOI 10.1126/science.1749936; Saad F, 2010, CANCER TREAT REV, V36, P177, DOI 10.1016/j.ctrv.2009.11.005; Savoy RM, 2013, ENDOCR-RELAT CANCER, V20, pR341, DOI 10.1530/ERC-13-0364; Schwarzman AL, 1999, P NATL ACAD SCI USA, V96, P7932, DOI 10.1073/pnas.96.14.7932; Shatkina L, 2003, MOL CELL BIOL, V23, P7189, DOI 10.1128/MCB.23.20.7189-7197.2003; Shiota M, 2016, FRONT ONCOL, V5, DOI 10.3389/fonc.2015.00304; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Stark T, 2015, TRANSL ANDROL UROL, V4, P455, DOI 10.3978/j.issn.2223-4683.2015.04.12; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; SZEGO CM, 1967, P NATL ACAD SCI USA, V58, P1711, DOI 10.1073/pnas.58.4.1711; Tan J, 2015, NAT GENET, V47, P1341, DOI 10.1038/ng.3409; TEJEDOR F, 1995, NEURON, V14, P287, DOI 10.1016/0896-6273(95)90286-4; Unger S, 2007, AM J MED GENET A, V143A, P1876, DOI 10.1002/ajmg.a.31751; Unni E, 2004, CANCER RES, V64, P7156, DOI 10.1158/0008-5472.CAN-04-1121; Yepes RV, 2015, ENDOCRINOL NUTR, V62, P224, DOI 10.1016/j.endonu.2015.02.008; Varkaris A, 2014, CANCER METAST REV, V33, P595, DOI 10.1007/s10555-013-9481-1; Verdine GL, 2012, METHOD ENZYMOL, V503, P3, DOI 10.1016/B978-0-12-396962-0.00001-X; Wang HY, 2012, J NEUROSCI, V32, P9773, DOI 10.1523/JNEUROSCI.0354-12.2012; Wang Y, 2007, ONCOGENE, V26, P6061, DOI 10.1038/sj.onc.1210435; Wehling M, 1997, ANNU REV PHYSIOL, V59, P365, DOI 10.1146/annurev.physiol.59.1.365; Yabut O, 2010, J NEUROSCI, V30, P4004, DOI 10.1523/JNEUROSCI.4711-09.2010; Yang L, 2012, MOL ENDOCRINOL, V26, P550, DOI 10.1210/me.2011-1101; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Zarif JC, 2015, ONCOTARGET, V6, P6862, DOI 10.18632/oncotarget.3119; Zheng C, 2015, J NEUROCHEM, V133, P919, DOI 10.1111/jnc.13076; Zhou J, 2005, CANCER RES, V65, P9906, DOI 10.1158/0008-5472.CAN-05-1481; Zitzmann M, 2009, NAT REV ENDOCRINOL, V5, P673, DOI 10.1038/nrendo.2009.212	110	23	23	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1289	1300		10.1096/fj.201601047R	http://dx.doi.org/10.1096/fj.201601047R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28031322				2022-12-28	WOS:000398504300005
J	Scolnick, EM				Scolnick, Edward M.			The Path to New Therapies for Schizophrenia and Bipolar Illness	FASEB JOURNAL			English	Article						genetics; pharmacology; progress	DE-NOVO MUTATIONS; AUTISM; VARIANTS; DISORDER; FAMINE	Schizophrenia and bipolar illness are two of the most serious forms of mental illness. Until relatively recently, almost nothing was known about the molecular pathogenesis of either illness. The single largest risk factor that predisposes people to schizophrenia or bipolar illness is genetic risk. Heritability is high, and the incidence is significantly higher in identical twins than in nonidentical twins. Despite decades of work aimed at identifying the genes involved in these two illnesses, virtually no progress had beenmade until the past decade. With the knowledge and technologies that have been gained from theHumanGenome Project, ithas been possible to begin to understand the underlying genetics and to use the new information to begin the effort to discover new and better medicines to treat these illnesses. This articlewilldescribe the past decade of work toward this goal and articulate both the promise thatnowexists andwhat is still neededto bringdramatic andtangible change topatients-Scolnick, E. M. Thepath to new therapies for schizophrenia and bipolar illness.	[Scolnick, Edward M.] Broad Inst, Stanley Ctr Psychiat Res, 75 Ames St, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Scolnick, EM (corresponding author), Broad Inst, Stanley Ctr Psychiat Res, 75 Ames St, Cambridge, MA 02142 USA.	scolnick@broadinstitute.org						Andrade A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34233; Anonymous, 2016, MED LETT DRUGS THER, p1510b; Bundy H, 2011, ACTA PSYCHIAT SCAND, V123, P98, DOI 10.1111/j.1600-0447.2010.01623.x; Darnell JC, 2011, CELL, V146, P247, DOI 10.1016/j.cell.2011.06.013; Gabriel SB, 2002, SCIENCE, V296, P2225, DOI 10.1126/science.1069424; Genovese G, 2016, NAT NEUROSCI, V19, P1433, DOI 10.1038/nn.4402; Glausier JR, 2013, NEUROSCIENCE, V251, P90, DOI 10.1016/j.neuroscience.2012.04.044; Gulsuner S, 2013, CELL, V154, P518, DOI 10.1016/j.cell.2013.06.049; Hoek HW, 1998, SOC PSYCH PSYCH EPID, V33, P373, DOI 10.1007/s001270050068; Kim MJ, 2017, MOL PSYCHIATR, V22, P417, DOI 10.1038/mp.2016.98; Lichtenstein P, 2009, LANCET, V373, P234, DOI 10.1016/S0140-6736(09)60072-6; McCarthy SE, 2014, MOL PSYCHIATR, V19, P652, DOI 10.1038/mp.2014.29; Power RA, 2013, JAMA PSYCHIAT, V70, P22, DOI 10.1001/jamapsychiatry.2013.268; Ripke S, 2014, NATURE, V511, P421, DOI 10.1038/nature13595; Samocha KE, 2014, NAT GENET, V46, P944, DOI 10.1038/ng.3050; Sekar A, 2016, NATURE, V530, P177, DOI 10.1038/nature16549; Smoller JW, 2013, LANCET, V381, P1371, DOI 10.1016/S0140-6736(12)62129-1; Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036; Susser E, 1996, ARCH GEN PSYCHIAT, V53, P25; Tsuang MT, 2001, BRIT J PSYCHIAT, V178, pS18, DOI 10.1192/bjp.178.40.s18	20	2	2	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1254	1259		10.1096/fj.201700028	http://dx.doi.org/10.1096/fj.201700028			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28360375				2022-12-28	WOS:000398504300002
J	Balaji, S; Wang, X; King, A; Le, LD; Bhattacharya, SS; Moles, CM; Butte, MJ; Perez, VAD; Liechty, KW; Wight, TN; Crombleholme, TM; Bollyky, PL; Keswani, SG				Balaji, Swathi; Wang, Xinyi; King, Alice; Le, Louis D.; Bhattacharya, Sukanta S.; Moles, Chad M.; Butte, Manish J.; Perez, Vinicio A. de Jesus; Liechty, Kenneth W.; Wight, Thomas N.; Crombleholme, Timothy M.; Bollyky, Paul L.; Keswani, Sundeep G.			Interleukin-10-mediated regenerative postnatal tissue repair is dependent on regulation of hyaluronan metabolism via fibroblast-specific STAT3 signaling	FASEB JOURNAL			English	Article						fibrosis; scarless; wound healing; extracellular matrix; inflammatory cytokines	EXTRACELLULAR-MATRIX; COLLAGEN DEPOSITION; CULTURED FETAL; SCAR FORMATION; T-CELLS; ACID; INFLAMMATION; FIBROSIS; WOUNDS; SKIN	The cytokine IL-10 has potent antifibrotic effects in models of adult fibrosis, but the mechanisms of action are unclear. Here, we report a novel finding that IL-10 triggers a signal transducer and activator of transcription 3 (STAT3)-dependent signaling pathway that regulates hyaluronan (HA) metabolism and drives adult fibroblasts to synthesize an HA-rich pericellular matrix, which mimics the fetal regenerative wound healing phenotype with reduced fibrosis. By using cre-lox-mediated novel, inducible, fibroblast-,keratinocyte-, and wound-specific STAT3knockdown postnatal mice-plus syngeneic fibroblast cell-transplant models-we demonstrate that the regenerative effects of IL-10 in postnatal wounds are dependent on HA synthesis and fibroblast- specific STAT3-dependent signaling. The importance of IL-10-induced HA synthesis for regenerative wound healing is demonstrated by inhibition of HA synthesis in a murine wound model by administering 4-methylumbelliferone. Although IL-10 and STAT3 signaling were intact, the antifibrotic repair phenotype that is induced by IL-10 overexpression was abrogated in this model. Our data show a novel role for IL-10 beyond its accepted immune-regulatory mechanism. The opportunity for IL-10 to regulate a fibroblast- specific formation of a regenerative, HA-rich wound extracellular matrixmay lead to the development of innovative therapies to attenuate postnatal fibrosis in organ systems or diseases in which dysregulated inflammation and HA intersect.-Balaji, S., Wang, X., King, A., Le, L. D., Bhattacharya, S. S., Moles, C. M., Butte, M. J., de Jesus Perez, V. A., Liechty, K. W., Wight, T. N., Crombleholme, T. M., Bollyky, P. L., Keswani, S. G. Interleukin10- mediated regenerative postnatal tissue repair is dependent on regulation of hyaluronan metabolism via fibroblastspecific STAT3 signaling.	[Balaji, Swathi; Wang, Xinyi; King, Alice; Le, Louis D.; Bhattacharya, Sukanta S.; Moles, Chad M.; Keswani, Sundeep G.] Texas Childrens Hosp, Baylor Coll Med, Div Pediat Surg, Lab Regenerat Tissue Repair, Houston, TX 77030 USA; [Perez, Vinicio A. de Jesus] Stanford Univ, Div Pulm & Crit Care Med, Stanford, CA 94305 USA; [Perez, Vinicio A. de Jesus; Bollyky, Paul L.] Stanford Univ, Dept Med, Div Infect Dis, Stanford, CA 94305 USA; [Butte, Manish J.] Stanford Univ, Dept Pediat, Div Immunol, Stanford, CA 94305 USA; [Liechty, Kenneth W.; Crombleholme, Timothy M.] Univ Colorado, Sch Med, Childrens Hosp Colorado, Ctr Childrens Surg, Aurora, CO USA; [Wight, Thomas N.] Benaroya Res Inst, Matrix Biol Program, Seattle, WA USA	Baylor College of Medicine; Stanford University; Stanford University; Stanford University; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Benaroya Research Institute	Keswani, SG (corresponding author), Texas Childrens Hosp, Baylor Coll Med, Feigin Ctr, C450-06,1102 Bates Ave, Houston, TX 77030 USA.	keswani@bcm.edu	Butte, Manish/AAM-8604-2020; Crombleholme, Timothy/Y-1477-2019; Wang, Xinyi/AAN-4271-2020; Butte, Manish/T-8860-2019	Butte, Manish/0000-0002-4490-5595; Wang, Xinyi/0000-0003-1780-7719; Butte, Manish/0000-0002-4490-5595	U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences Grants [K08-GM098831-04, 1R01-GM111808-01]; Wound Healing Society Foundation 3M Award; NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant [1R01-DK096087]; NIH National Heart, Lung, and Blood Institute [1R01-HL113294-01A1]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL105884, R01HL139664, R01HL113294] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK096087] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K08GM098831, R01GM111808] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences Grants; Wound Healing Society Foundation 3M Award; NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Ana Maria Rodriguez and Chi-Han Lu for editorial help, and Dr. Rita Serda (all from Baylor College of Medicine) for help with the scanning electron microscopy. The authors also thank Elizabeth Sumner (Texas Children's Hospital Multimedia Team) for help with the schematic illustration of the mechanism; Dr. Jeffrey A. Whitsett, Dr. Christopher L. Karp, Dr. Michael A. Helmrath, and all the faculty members in the Center for Fetal Cellular and Molecular Therapy at the Cincinnati Children's Hospital Medical Center for scientific discussions. The authors also thank Charles Klanke, Stephanie A. Lang, and Nathaniel Han, (Cincinnati Children's Hospital Medical Center), and Dr. Hui Li and Dr. Pu Duann (Baylor College of Medicine) for technical help with immunohistochemistry and molecular biology work. This work was supported by the U.S. National Institutes of Health (NIH), National Institute of General Medical Sciences Grants K08-GM098831-04 and 1R01-GM111808-01 (to S.G.K.), the Wound Healing Society Foundation 3M Award (to S.G.K.), NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant 1R01-DK096087 (to P.L.B.), and NIH National Heart, Lung, and Blood Institute 1R01-HL113294-01A1 (to P.L.B.). The authors declare no conflicts of interest.	ADZICK NS, 1985, J PEDIATR SURG, V20, P315; Balaji S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124302; Barnes L, 2013, J INVEST DERMATOL, V133, P1017, DOI 10.1038/jid.2012.439; Bayat A, 2003, BRIT MED J, V326, P88, DOI 10.1136/bmj.326.7380.88; Cao YP, 2003, TRANSPLANTATION, V75, P1390, DOI 10.1097/01.TP.0000061599.24682.EC; Caskey RC, 2013, CELL TISSUE RES, V351, P117, DOI 10.1007/s00441-012-1504-7; CHEN WYJ, 1989, J CELL SCI, V94, P577; Csoka AB, 2001, MATRIX BIOL, V20, P499, DOI 10.1016/S0945-053X(01)00172-X; Cyktor JC, 2013, J IMMUNOL, V190, P2778, DOI 10.4049/jimmunol.1202722; Darby IA, 2007, INT REV CYTOL, V257, P143, DOI 10.1016/S0074-7696(07)57004-X; de la Motte C, 2009, AM J PATHOL, V174, P2254, DOI 10.2353/ajpath.2009.080831; DEPALMA RL, 1989, MATRIX, V9, P224; Gittes C, 2000, J PEDIATR SURG, V35, P872; Glowacka E, 2010, ADV MED SCI-POLAND, V55, P254, DOI 10.2478/v10039-010-0037-0; Gordon A, 2008, WOUND REPAIR REGEN, V16, P70, DOI 10.1111/j.1524-475X.2007.00326.x; Hadley HS, 2013, VET SURG, V42, P161, DOI 10.1111/j.1532-950X.2012.01048.x; Hiramatsu K, 2011, J CLIN INVEST, V121, P640, DOI 10.1172/JCI44605; Itano N, 1999, J BIOL CHEM, V274, P25085, DOI 10.1074/jbc.274.35.25085; Jin YM, 2013, LAB INVEST, V93, P801, DOI 10.1038/labinvest.2013.64; Juhlin L, 1997, J INTERN MED, V242, P61, DOI 10.1046/j.1365-2796.1997.00175.x; Kieran I, 2013, WOUND REPAIR REGEN, V21, P428, DOI 10.1111/wrr.12043; King A, 2013, J SURG RES, V184, P671, DOI 10.1016/j.jss.2013.04.009; King A, 2013, J PEDIATR SURG, V48, P1211, DOI 10.1016/j.jpedsurg.2013.03.014; Krishnamurthy P, 2009, CIRC RES, V104, pE9, DOI 10.1161/CIRCRESAHA.108.188243; KRUMMEL TM, 1987, J PEDIATR SURG, V22, P640, DOI 10.1016/S0022-3468(87)80117-3; Kultti A, 2009, EXP CELL RES, V315, P1914, DOI 10.1016/j.yexcr.2009.03.002; Kwan P, 2009, HAND CLIN, V25, P511, DOI 10.1016/j.hcl.2009.06.007; Lepperdinger G, 1998, J BIOL CHEM, V273, P22466, DOI 10.1074/jbc.273.35.22466; Liechty KW, 2000, J PEDIATR SURG, V35, P866, DOI 10.1053/jpsu.2000.6868; Liechty KW, 2000, CYTOKINE, V12, P671, DOI 10.1006/cyto.1999.0598; LONGAKER MT, 1990, J PEDIATR SURG, V25, P63, DOI 10.1016/S0022-3468(05)80165-4; Mack JA, 2012, J INVEST DERMATOL, V132, P198, DOI 10.1038/jid.2011.248; MAST BA, 1993, MATRIX, V13, P441, DOI 10.1016/S0934-8832(11)80110-1; MAST BA, 1992, PLAST RECONSTR SURG, V89, P503, DOI 10.1097/00006534-199203000-00019; McInnes IB, 2001, J IMMUNOL, V167, P4075, DOI 10.4049/jimmunol.167.7.4075; MEYER K, 1952, T NEW YORK ACAD SCI, V14, P164, DOI 10.1111/j.2164-0947.1952.tb01088.x; MEYER LJM, 1994, J INVEST DERMATOL, V102, P385, DOI 10.1111/1523-1747.ep12371800; Mir SA, 2012, J BIOL CHEM, V287, P2666, DOI 10.1074/jbc.M111.246173; Miyoshi K, 2011, J INVEST DERMATOL, V131, P108, DOI 10.1038/jid.2010.255; Moles C. M., 2015, SCARLESS SURG ARE WE; Moriarty Kevin P., 1996, Wound Repair and Regeneration, V4, P346, DOI 10.1046/j.1524-475X.1996.40311.x; Namazi MR, 2011, INT J DERMATOL, V50, P85, DOI 10.1111/j.1365-4632.2010.04678.x; O'Reilly S, 2014, J BIOL CHEM, V289, P9952, DOI 10.1074/jbc.M113.545822; Oba T, 2012, J AM COLL CARDIOL, V59, P838, DOI 10.1016/j.jacc.2011.10.887; Olutoye OO, 1996, J PEDIATR SURG, V31, P91, DOI 10.1016/S0022-3468(96)90326-7; Olutoye OO, 1997, J PEDIATR SURG, V32, P1037, DOI 10.1016/S0022-3468(97)90394-8; Park JC, 2001, YONSEI MED J, V42, P587, DOI 10.3349/ymj.2001.42.6.587; Peranteau WH, 2008, J INVEST DERMATOL, V128, P1852, DOI 10.1038/sj.jid.5701232; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rockey DC, 2015, NEW ENGL J MED, V372, P1138, DOI 10.1056/NEJMra1300575; Roncarolo MG, 2006, IMMUNOL REV, V212, P28; Shi JH, 2013, ARCH DERMATOL RES, V305, P341, DOI 10.1007/s00403-013-1314-0; Shi JH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098228; Stern R, 2007, J INVEST DERMATOL, V127, P512, DOI 10.1038/sj.jid.5700605; Sziksz E, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/764641; Takiishi T, 2012, J LEUKOCYTE BIOL, V92, P259, DOI 10.1189/jlb.1111569; Wulff BC, 2013, WOUND REPAIR REGEN, V21, P103, DOI 10.1111/j.1524-475X.2012.00860.x; Wynn TA, 2007, J CLIN INVEST, V117, P524, DOI 10.1172/JCI31487; Yoshida H, 2013, P NATL ACAD SCI USA, V110, P5612, DOI 10.1073/pnas.1215432110	59	38	41	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					868	881		10.1096/fj.201600856R	http://dx.doi.org/10.1096/fj.201600856R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27903619	Green Published, hybrid			2022-12-28	WOS:000395671200004
J	Heinemann, AS; Pirr, S; Fehlhaber, B; Mellinger, L; Burgmann, J; Busse, M; Ginzel, M; Friesenhagen, J; von Kockritz-Blickwede, M; Ulas, T; von Kaisenberg, CS; Johannes, R; Vogl, T; Viemann, D				Heinemann, Anna S.; Pirr, Sabine; Fehlhaber, Beate; Mellinger, Lara; Burgmann, Johanna; Busse, Mandy; Ginzel, Marco; Friesenhagen, Judith; von Koeckritz-Blickwede, Maren; Ulas, Thomas; von Kaisenberg, Constantin S.; Roth, Johannes; Vogl, Thomas; Viemann, Dorothee			In neonates S100A8/S100A9 alarmins prevent the expansion of a specific inflammatory monocyte population promoting septic shock	FASEB JOURNAL			English	Article						calprotectin; MDSC; myeloid cells; newborn; sepsis	HLA-DR EXPRESSION; SUPPRESSOR-CELLS; IMMUNE-RESPONSES; MYELOID CELLS; CANCER STAGE; INNATE; CORRELATE; DIFFERENTIATION; ACCUMULATION; INFECTION	The high susceptibility of newborn infants to sepsis is ascribed to an immaturity of the neonatal immune system, but the molecular mechanisms remain unclear. Newborn monocytes massively release the alarmins S100A8/S100A9. In adults, these are major regulators of immunosuppressive myeloid-derived suppressor cells (MDSCs). We investigated whether S100A8/S100A9 cause an expansion of monocytic MDSCs (Mo-MDSCs) in neonates, thereby contributing to an immunocompromised state. Mo-MDSCs have been assigned to CD14(+)/human leukocyte antigen (HLA)-DR-/low/CD33(+) monocytes in humans and to CD11b(+)/Gr-1(int)/Ly6G(-)/Ly6C(hi) cells in mice. We found monocytes with these phenotypes significantly expanded in their respective newborns. Functionally, however, they did not prove immunosuppressive but rather responded inflammatorily to microbial stimulation. Their expansion did not correlate with high S100A8/S100A9 levels in cord blood. Murine studies revealed an excessive expansion of CD11b(+)/Gr-1(int)/Ly6G(-)/ Ly6C(hi) monocytes in S100A9(-/-) neonates compared to wild-type neonates. This strong baseline expansion was associated with hyperinflammatory responses during endotoxemia and fatal septic courses. Treating S100A9(-/-) neonates directly after birth with S100A8/S100A9 alarmins prevented excessive expansion of this inflammatory monocyte population and death from septic shock. Our data suggest that a specific population of inflammatory monocytes promotes fatal courses of sepsis in neonates if its expansion is not regulated by S100A8/S100A9 alarmins.- Heinemann, A. S., Pirr, S., Fehlhaber, B., Mellinger, L., Burgmann, J., Busse, M., Ginzel, M., Friesenhagen, J., von Kockritz-Blickwede, M., Ulas, T., vonKaisenberg, C. S., Roth, J., Vogl, T., Viemann, D. InneonatesS100A8/S100A9alarminsprevent theexpansion of a specific inflammatorymonocyte population promoting septic shock.	[Heinemann, Anna S.; Pirr, Sabine; Fehlhaber, Beate; Mellinger, Lara; Burgmann, Johanna; Busse, Mandy; Ginzel, Marco; Friesenhagen, Judith; Viemann, Dorothee] Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, Carl Neuberg Str 1, D-30625 Hannover, Germany; [von Kaisenberg, Constantin S.] Hannover Med Sch, Dept Gynecol & Prenatal Med, Hannover, Germany; [von Koeckritz-Blickwede, Maren] Univ Vet Med Hannover, Dept Physiol Chem, Hannover, Germany; [von Koeckritz-Blickwede, Maren] Univ Vet Med Hannover, Res Ctr Emerging Infect & Zoonoses RIZ, Hannover, Germany; [Ulas, Thomas] Univ Bonn, Life & Med Sci Inst, Genom & Immunoregulat, Bonn, Germany; [Roth, Johannes; Vogl, Thomas] Univ Munster, Inst Immunol, Munster, Germany; [Roth, Johannes; Vogl, Thomas] Univ Munster, Interdisciplinary Ctr Clin Res, Munster, Germany	Hannover Medical School; Hannover Medical School; University of Veterinary Medicine Hannover, Foundation; University of Veterinary Medicine Hannover, Foundation; University of Bonn; University of Munster; University of Munster	Viemann, D (corresponding author), Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, Carl Neuberg Str 1, D-30625 Hannover, Germany.	viemann.dorothee@mh-hannover.de	von Kaisenberg, Constantin/AAR-2756-2021	Viemann, Dorothee/0000-0002-9009-3559; Ginzel, Marco/0000-0002-4439-1133	Appenrodt Foundation; German Research Foundation [VI 538/6-1]; Volkswagen Foundation; Interdisciplinary Center of Clinical Research of the University of Muenster [Vo2/004/14, Ro2/004/10]; German Federal Ministry of Education and Research	Appenrodt Foundation; German Research Foundation(German Research Foundation (DFG)); Volkswagen Foundation(Volkswagen); Interdisciplinary Center of Clinical Research of the University of Muenster; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF))	The authors thank A. Weitz (Hannover Medical School) and D. Lagemann (University of Munster) for technical support, and Dr. T. Price (Hannover Medical School) for critically reading the manuscript. This work was supported, in part, by grants from the Appenrodt Foundation, the German Research Foundation (VI 538/6-1), and the Volkswagen Foundation (to D.V.); by grants from the Interdisciplinary Center of Clinical Research of the University of Muenster (Vo2/004/14 and Ro2/004/10; to T.V. and J.R.); and by grants from the German Federal Ministry of Education and Research (AID-Net), and the German Research Foundation (CRC Transregio 128-A2, CRC 1009 B8 and B9; to T.V.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austermann J, 2015, CELL REP, V11, P849, DOI 10.1016/j.celrep.2015.04.040; Azizia M, 2012, PEDIATRICS, V129, pE967, DOI 10.1542/peds.2011-1579; Bao Y, 2015, MOL MED REP, V11, P2322, DOI 10.3892/mmr.2014.2927; Chen XH, 2013, J CLIN INVEST, V123, P4595, DOI 10.1172/JCI67580; Cheng PY, 2008, J EXP MED, V205, P2235, DOI 10.1084/jem.20080132; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; D'Aveni M, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010435; Damuzzo V, 2015, CYTOM PART B-CLIN CY, V88, P77, DOI [10.1002/cyto.b.21206, 10.1002/cytob.21206]; Delano MJ, 2007, J EXP MED, V204, P1463, DOI 10.1084/jem.20062602; Derive M, 2012, INTENS CARE MED, V38, P1040, DOI 10.1007/s00134-012-2574-4; Diaz-Montero CM, 2014, SEMIN ONCOL, V41, P174, DOI 10.1053/j.seminoncol.2014.02.003; Dowling DJ, 2014, TRENDS IMMUNOL, V35, P299, DOI 10.1016/j.it.2014.04.007; Drews-Elger K, 2014, BREAST CANCER RES TR, V148, P41, DOI 10.1007/s10549-014-3122-4; Duffy A, 2013, CANCER IMMUNOL IMMUN, V62, P299, DOI 10.1007/s00262-012-1332-3; Ehrchen JM, 2009, J LEUKOCYTE BIOL, V86, P557, DOI 10.1189/jlb.1008647; Frosch M, 2000, ARTHRITIS RHEUM-US, V43, P628, DOI 10.1002/1529-0131(200003)43:3<628::AID-ANR20>3.0.CO;2-X; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Genel F, 2010, J INFECTION, V60, P224, DOI 10.1016/j.jinf.2009.12.004; Gervassi A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107816; Gorgun GT, 2013, BLOOD, V121, P2975, DOI 10.1182/blood-2012-08-448548; Kalluri R, 2020, SCIENCE, V367, P640, DOI 10.1126/science.aau6977; Kanakoudi-Tsakalidou F, 2001, CLIN EXP IMMUNOL, V123, P402, DOI 10.1046/j.1365-2249.2001.01471.x; Kostlin N, 2014, EUR J IMMUNOL, V44, P2582, DOI 10.1002/eji.201344200; Kollmann TR, 2009, J IMMUNOL, V183, P7150, DOI 10.4049/jimmunol.0901481; Kotsakis A, 2012, J IMMUNOL METHODS, V381, P14, DOI 10.1016/j.jim.2012.04.004; Lee JA, 2008, CYTOM PART A, V73A, P926, DOI 10.1002/cyto.a.20623; Levy O, 2007, NAT REV IMMUNOL, V7, P379, DOI 10.1038/nri2075; Lewis DB, 1998, IMMUNOL ALLERGY CLIN, V18, P291, DOI 10.1016/S0889-8561(05)70006-0; Li HQ, 2009, J IMMUNOL, V182, P240, DOI 10.4049/jimmunol.182.1.240; Liu L, 2015, LANCET, V385, P430, DOI 10.1016/S0140-6736(14)61698-6; Luyckx A, 2012, CLIN IMMUNOL, V143, P83, DOI 10.1016/j.clim.2012.01.011; Manitz MP, 2003, MOL CELL BIOL, V23, P1034, DOI 10.1128/MCB.23.3.1034-1043.2003; Ng PC, 2006, BIOL NEONATE, V89, P75, DOI 10.1159/000088288; Nguyen M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010407; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Petersen B, 2013, EMBO J, V32, P100, DOI 10.1038/emboj.2012.309; Pradhan R, 2015, CYTOMETRY B; Rieber N, 2013, CLIN EXP IMMUNOL, V174, P45, DOI 10.1111/cei.12143; Rieber N, 2015, CELL HOST MICROBE, V17, P507, DOI 10.1016/j.chom.2015.02.007; Sander LE, 2010, J EXP MED, V207, P1453, DOI 10.1084/jem.20091474; Shane AL, 2014, J INFECTION, V68, pS24, DOI 10.1016/j.jinf.2013.09.011; Shen L, 2015, CANCER IMMUNOL RES, V3, P136, DOI 10.1158/2326-6066.CIR-14-0036; Srivastava MK, 2010, CANCER RES, V70, P68, DOI 10.1158/0008-5472.CAN-09-2587; Tissieres P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032863; Vasquez-Dunddel D, 2013, J CLIN INVEST, V123, P1580, DOI 10.1172/JCI60083; Viemann D, 2005, PEDIATR RES, V58, P654, DOI 10.1203/01.PDR.0000180544.02537.FD; Viemann D, 2005, BLOOD, V105, P2955, DOI 10.1182/blood-2004-07-2520; Viemann D, 2004, BLOOD, V103, P3365, DOI 10.1182/blood-2003-09-3296; Viemann D, 2007, BLOOD, V109, P2453, DOI 10.1182/blood-2006-08-040444; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Wang L, 2013, J IMMUNOL, V190, P794, DOI 10.4049/jimmunol.1202088; Wu LY, 2011, AM J PATHOL, V179, P2131, DOI 10.1016/j.ajpath.2011.06.028; Yeager ME, 2012, CHEST, V141, P944, DOI 10.1378/chest.11-0205; Youn JI, 2008, J IMMUNOL, V181, P5791, DOI 10.4049/jimmunol.181.8.5791; Youn JI, 2013, NAT IMMUNOL, V14, P211, DOI 10.1038/ni.2526; Yu JP, 2013, J IMMUNOL, V190, P3783, DOI 10.4049/jimmunol.1201449; Yuan XK, 2011, J INT MED RES, V39, P1381, DOI 10.1177/147323001103900424; Zhao J, 2008, P NATL ACAD SCI USA, V105, P7528, DOI 10.1073/pnas.0800152105	58	27	30	1	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1153	+		10.1096/fj.201601083R	http://dx.doi.org/10.1096/fj.201601083R			27	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27993995				2022-12-28	WOS:000395671200028
J	Madeira, MFM; Queiroz-Junior, CM; Montero-Melendez, T; Werneck, SMC; Correa, JD; Soriani, FM; Garlet, GP; Souza, DG; Teixeira, MM; Silva, TA; Perretti, M				Madeira, Mila F. M.; Queiroz-Junior, Celso M.; Montero-Melendez, Trinidad; Werneck, Silvia M. C.; Correa, Joice D.; Soriani, Frederico M.; Garlet, Gustavo P.; Souza, Daniele G.; Teixeira, Mauro M.; Silva, Tarcilia A.; Perretti, Mauro			Melanocortin agonism as a viable strategy to control alveolar bone loss induced by oral infection	FASEB JOURNAL			English	Article						osteoclasts; periodontitis; Aggregatibacter actinomycetemcomitans; inflammation; DTrp(8)-gamma MSH	MELANOCYTE-STIMULATING HORMONE; PERIODONTAL-DISEASE; RHEUMATOID-ARTHRITIS; RECEPTOR; INFLAMMATION; DESTRUCTION; CYTOKINES; SYSTEM; PROOPIOMELANOCORTIN; CHONDROCYTES	Alveolar bone loss is a result of an aggressive form of periodontal disease (PD) associated with Aggre-gatibacter actinomycetemcomitans (Aa) infection. PD is often observed with other systemic inflammatory conditions, including arthritis. Melanocortin peptides activate specific receptors to exert antiarthritic properties, avoiding excessing inflammation and modulating macrophage function. Recent work has indicated that melanocortin can control osteoclast development and function, butwhether such protection takes place in infection-induced alveolar bone loss has not been investigated. The purpose of this study was to evaluate the role of melanocortin in Aainduced PD. Mice were orally infected with Aa and treated with the melanocortin analog DTrp(8)-gamma MSH or vehicle daily for 30 d. Then, periodontal tissue was collected and analyzed. Aa-infected mice treated with DTrp(8)-gamma MSH presented decreased alveolar bone loss and a lower degree of neutrophil infiltration in the periodontium than vehicle-treated animals; these actionswere associated with reducedperiodontal levels ofTNF-alpha, IFN-gamma, and IL-17A. In vitro experiments with cells differentiated into osteoclasts showed that osteoclast formation and resorptive activity were attenuated after treatment with DTrp(8)-gamma MSH. Thus, melanocortin agonism could represent an innovativeway to tame overexuberant inflammation and, at the same time, preserve bone physiology, as seen afterAa infection.-Madeira, M. F. M., Queiroz-Junior, C. M., Montero-Melendez, T., Werneck, S. M. C., Correa, J. D., Soriani, F. M., Garlet, G. P., Souza, D. G., Teixeira, M. M., Silva, T. A., Perretti, M. Melanocortin agonismas a viable strategy to control alveolar bone loss induced by oral infection.	[Madeira, Mila F. M.; Werneck, Silvia M. C.; Souza, Daniele G.] Univ Fed Minas Gerais, Sch Dent, Inst Biol Sci, Dept Microbiol, Belo Horizonte, MG, Brazil; [Queiroz-Junior, Celso M.] Univ Fed Minas Gerais, Sch Dent, Inst Biol Sci, Dept Morphol, Belo Horizonte, MG, Brazil; [Soriani, Frederico M.] Univ Fed Minas Gerais, Sch Dent, Inst Biol Sci, Dept Gen Biol, Belo Horizonte, MG, Brazil; [Teixeira, Mauro M.] Univ Fed Minas Gerais, Sch Dent, Inst Biol Sci, Dept Biochem & Immunol, Belo Horizonte, MG, Brazil; [Madeira, Mila F. M.; Correa, Joice D.; Silva, Tarcilia A.] Univ Fed Minas Gerais, Sch Dent, Dept Oral Pathol, Belo Horizonte, MG, Brazil; [Montero-Melendez, Trinidad; Perretti, Mauro] Queen Mary Univ London, Barts & London Sch Med & Dent, William Harvey Res Inst, London, England; [Garlet, Gustavo P.] Univ Sao Paulo, Sch Dent Bauru, Dept Biol Sci, Bauru, SP, Brazil	Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; Universidade Federal de Minas Gerais; University of London; Queen Mary University London; Universidade de Sao Paulo	Madeira, MFM (corresponding author), Univ Fed Minas Gerais, Inst Biol Sci, Dept Microbiol, Ave Antonio Carlos 6627, Belo Horizonte, MG, Brazil.	madeiramila@gmail.com	Montero-Melendez, Trinidad/AAF-6345-2020; Garlet, Gustavo Pompermaier/E-6762-2012; da Silva, Tarcília Aparecida/O-7530-2015; Teixeira, Mauro M/A-4587-2008; Soriani, Frederico M/A-8896-2013; Corrêa, Jôice Dias/H-6868-2012; Queiroz-Junior, Celso/L-5438-2013; Madeira, Mila F M/A-9041-2015; Silva, Tarcilia/AAP-3760-2021	Garlet, Gustavo Pompermaier/0000-0002-5071-8382; da Silva, Tarcília Aparecida/0000-0001-9623-7835; Teixeira, Mauro M/0000-0002-6944-3008; Soriani, Frederico M/0000-0003-4720-6746; Corrêa, Jôice Dias/0000-0003-0170-6163; Queiroz-Junior, Celso/0000-0002-7884-7709; Madeira, Mila F M/0000-0002-1770-9978; Silva, Tarcilia/0000-0001-9623-7835; Montero-Melendez, Trinidad/0000-0002-3563-376X	Brazilian Ministry of Education (CAPES); Ministry of Science Technology and Innovation (CNPq); Minas Gerais Research Foundation (FAPEMIG; Belo Horizonte, Brazil); Instituto Nacional de Ciencia e Tecnologia (INCT; Dengue, Brazil); UK Medical Research Council [MR/K013068/1]	Brazilian Ministry of Education (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Ministry of Science Technology and Innovation (CNPq); Minas Gerais Research Foundation (FAPEMIG; Belo Horizonte, Brazil)(Fundacao de Amparo a Pesquisa do Estado de Minas Gerais (FAPEMIG)); Instituto Nacional de Ciencia e Tecnologia (INCT; Dengue, Brazil); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Dr. Osamu Fujise (Faculty of Dental Science, Kyushu University, Fukuoka, Japan) for providing the LPS from Aa. This work was supported by grants from the Brazilian Ministry of Education (CAPES), the Ministry of Science Technology and Innovation (CNPq), and the Minas Gerais Research Foundation (FAPEMIG; Belo Horizonte, Brazil); by financial support from the Instituto Nacional de Ciencia e Tecnologia (INCT; Dengue, Brazil); and by Grant MR/K013068/1 from The UK Medical Research Council. The authors declare no conflicts of interest.	Baehni P, 2010, EUR J DENT EDUC, V14, P2, DOI 10.1111/j.1600-0579.2010.00619.x; BLALOCK JE, 1985, J NEUROIMMUNOL, V10, P31, DOI 10.1016/0165-5728(85)90032-3; Bohm M, 2012, ENDOCR REV, V33, P623, DOI 10.1210/er.2011-1016; Chakravarti A, 2009, BLOOD, V114, P1633, DOI 10.1182/blood-2008-09-178301; Chen HH, 2013, ANN RHEUM DIS, V72, P1206, DOI 10.1136/annrheumdis-2012-201593; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Cochran DL, 2008, J PERIODONTOL, V79, P1569, DOI 10.1902/jop.2008.080233; Cornish J, 2003, AM J PHYSIOL-ENDOC M, V284, pE1181, DOI 10.1152/ajpendo.00412.2002; Dennison DK, 1997, PERIODONTOL 2000, V14, P54, DOI 10.1111/j.1600-0757.1997.tb00192.x; Di Benedetto A, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/503754; Erciyas K, 2013, ORAL DIS, V19, P394, DOI 10.1111/odi.12017; Garlet GP, 2010, J DENT RES, V89, P1349, DOI 10.1177/0022034510376402; Getting SJ, 2002, ARTHRITIS RHEUM, V46, P2765, DOI 10.1002/art.10526; Gonzalez SM, 2015, J PERIODONTOL, V86, P222, DOI 10.1902/jop.2014.140425; Grassel S, 2009, ARTHRITIS RHEUM-US, V60, P3017, DOI 10.1002/art.24846; Graves D, 2008, J PERIODONTOL, V79, P1585, DOI 10.1902/jop.2008.080183; Hajishengallis G, 2011, CELL HOST MICROBE, V10, P497, DOI 10.1016/j.chom.2011.10.006; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Holloway PM, 2015, ARTERIOSCL THROM VAS, V35, P1936, DOI 10.1161/ATVBAHA.115.305348; Kalsi Rupali, 2011, J Indian Soc Periodontol, V15, P304, DOI 10.4103/0972-124X.92559; Kaneva MK, 2014, BIOCHEM PHARMACOL, V92, P336, DOI 10.1016/j.bcp.2014.08.019; Kassebaum NJ, 2014, J DENT RES, V93, P1045, DOI 10.1177/0022034514552491; Kaur S, 2013, J DENT RES, V92, P399, DOI 10.1177/0022034513483142; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105858; Madeira MFM, 2013, MOL ORAL MICROBIOL, V28, P415, DOI 10.1111/omi.12034; Malle E, 2007, BRIT J PHARMACOL, V152, P838, DOI 10.1038/sj.bjp.0707358; Montero-Melendez T, 2015, SEMIN IMMUNOL, V27, P216, DOI 10.1016/j.smim.2015.02.003; Montero-Melendez T, 2014, AM J PATHOL, V184, P2333, DOI 10.1016/j.ajpath.2014.04.009; Montero-Melendez T, 2011, AM J PATHOL, V179, P259, DOI 10.1016/j.ajpath.2011.03.042; Montero-Melendez T, 2011, CURR RHEUMATOL REP, V13, P138, DOI 10.1007/s11926-011-0163-0; Madeira MFM, 2013, INFECT IMMUN, V81, P4244, DOI 10.1128/IAI.01046-13; Madeira MFM, 2012, MICROBES INFECT, V14, P198, DOI 10.1016/j.micinf.2011.09.005; Morita M, 2013, CELL, V153, P112, DOI 10.1016/j.cell.2013.02.027; Okada M, 2013, J PERIODONTOL, V84, pE74, DOI 10.1902/jop.2013.130079; Page RC, 1997, PERIODONTOL 2000, V14, P9, DOI 10.1111/j.1600-0757.1997.tb00189.x; PAGE RC, 1991, J PERIODONTAL RES, V26, P230, DOI 10.1111/j.1600-0765.1991.tb01649.x; Patel HB, 2010, FASEB J, V24, P4835, DOI 10.1096/fj.10-167759; Scher JU, 2012, ARTHRITIS RHEUM-US, V64, P3083, DOI 10.1002/art.34539; Schioth HB, 2001, VITAM HORM, V63, P195, DOI 10.1016/S0083-6729(01)63007-3; Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x; SUDA T, 1992, ENDOCR REV, V13, P66, DOI 10.1210/er.13.1.66; Teng YTA, 2003, CRIT REV ORAL BIOL M, V14, P237, DOI 10.1177/154411130301400402; Yu JJ, 2007, BLOOD, V109, P3794, DOI 10.1182/blood-2005-09-010116	45	2	2	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4033	4041		10.1096/fj.201600790R	http://dx.doi.org/10.1096/fj.201600790R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27535487				2022-12-28	WOS:000388201500011
J	Murray, AJ; Knight, NS; Cole, MA; Cochlin, LE; Carter, E; Tchabanenko, K; Pichulik, T; Gulston, MK; Atherton, HJ; Schroeder, MA; Deacon, RMJ; Kashiwaya, Y; King, MT; Pawlosky, R; Rawlins, JNP; Tyler, DJ; Griffin, JL; Robertson, J; Veech, RL; Clarke, K				Murray, Andrew J.; Knight, Nicholas S.; Cole, Mark A.; Cochlin, Lowri E.; Carter, Emma; Tchabanenko, Kirill; Pichulik, Tica; Gulston, Melanie K.; Atherton, Helen J.; Schroeder, Marie A.; Deacon, Robert M. J.; Kashiwaya, Yoshihiro; King, M. Todd; Pawlosky, Robert; Rawlins, J. Nicholas P.; Tyler, Damian J.; Griffin, Julian L.; Robertson, Jeremy; Veech, Richard L.; Clarke, Kieran			Novel ketone diet enhances physical and cognitive performance	FASEB JOURNAL			English	Article						metabolism; muscle; energetics; exercise; heart	BETA-HYDROXYBUTYRATE; EXERCISE PERFORMANCE; UNCOUPLING PROTEINS; KETOGENIC DIET; MITOCHONDRIAL BIOGENESIS; ENERGY-METABOLISM; FAILING HEART; ESTER; ALZHEIMERS; KETOSIS	Ketone bodies are the most energy-efficient fuel and yield more ATP per mole of substrate than pyruvate and increase the free energy released from ATP hydrolysis. Elevation of circulating ketones via high-fat, low carbohydrate diets has been used for the treatment of drug-refractory epilepsy and for neurodegenerative diseases, such as Parkinson's disease. Ketones may also be beneficial for muscle and brain in times of stress, such as endurance exercise. The challenge has been to raise circulating ketone levels by using a palatable diet without altering lipid levels. We found that blood ketone levels can be increased and cholesterol and triglycerides decreased by feeding rats a novel ketone ester diet: chow that is supplemented with (R)-3-hydroxybutyl (R)-3-hydroxybutyrate as 30% of calories. For 5 d, rats on the ketone diet ran 32% further on a treadmill than did control rats that ate an isocaloric diet that was supplemented with either corn starch or palm oil (P < 0.05). Ketone-fed rats completed an 8-arm radial maze test 38% faster than did those on the other diets, making more correct decisions before making a mistake (P < 0.05). Isolated, perfused hearts from rats that were fed the ketone diet had greater free energy available from ATP hydrolysis during increased work than did hearts from rats on the other diets as shown by using [P-31]-NMR spectroscopy. The novel ketone diet, therefore, improved physical performance and cognitive function in rats, and its energy-sparing properties suggest that it may help to treat a range of human conditions with metabolic abnormalities.-Murray, A. J., Knight, N. S., Cole, M. A., Cochlin, L. E., Carter, E., Tchabanenko, K., Pichulik, T., Gulston, M. K., Atherton, H. J., Schroeder, M. A., Deacon, R. M. J., Kashiwaya, Y., King, M. T., Pawlosky, R., Rawlins, J. N. P., Tyler, D. J., Griffin, J. L., Robertson, J., Veech, R. L., Clarke, K. Novel ketone diet enhances physical and cognitive performance.	[Murray, Andrew J.; Knight, Nicholas S.; Cochlin, Lowri E.; Carter, Emma; Pichulik, Tica; Atherton, Helen J.; Schroeder, Marie A.; Tyler, Damian J.; Clarke, Kieran] Univ Oxford, Dept Physiol Anat & Genet, Oxford, England; [Cole, Mark A.; Tchabanenko, Kirill; Robertson, Jeremy] Univ Oxford, Dept Chem, Oxford, England; [Deacon, Robert M. J.; Rawlins, J. Nicholas P.] Univ Oxford, Dept Expt Psychol, Oxford, England; [Murray, Andrew J.] Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England; [Gulston, Melanie K.; Griffin, Julian L.] Univ Cambridge, Dept Biochem, Cambridge, England; [Gulston, Melanie K.; Griffin, Julian L.] Univ Cambridge, Cambridge Syst Biol Ctr, Cambridge, England; [Kashiwaya, Yoshihiro; King, M. Todd; Pawlosky, Robert; Veech, Richard L.] NIAAA, Lab Metab Control, NIH, Rockville, MD 20852 USA; [Cole, Mark A.] Univ Nottingham, Fac Med & Hlth Sci, Nottingham, England; [Tchabanenko, Kirill] Queens Univ Belfast, Sch Chem & Chem Engn, Belfast, Antrim, North Ireland	University of Oxford; University of Oxford; University of Oxford; University of Cambridge; University of Cambridge; University of Cambridge; National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); University of Nottingham; Queens University Belfast	Murray, AJ (corresponding author), Univ Cambridge, Dept Physiol Dev & Neurosci, Downing St, Cambridge CB2 3EG, England.	ajm267@cam.ac.uk		Cole, Mark/0000-0002-0727-7833; Murray, Andrew/0000-0002-0929-9315; Tyler, Damian/0000-0002-0780-8905	Defense Advanced Research Projects Agency; Research Councils UK; Biotechnology and Biological Sciences Research Council [BB/H013539/1] Funding Source: researchfish; British Heart Foundation [FS/10/002/28078, FS/14/17/30634] Funding Source: researchfish; Medical Research Council [MC_UP_A090_1006, G0601490, MR/P011705/1] Funding Source: researchfish; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000110] Funding Source: NIH RePORTER; BBSRC [BB/H013539/1] Funding Source: UKRI; MRC [MC_UP_A090_1006, G0601490, MR/P011705/1] Funding Source: UKRI	Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); Research Councils UK(UK Research & Innovation (UKRI)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The authors thank Dr. Joseph Bielitsky, the late Dr. Catherine Golden, Dr. Brett Giroir, and Dr. Kerrie DeMarco (Defense Advanced Research Projects Agency, Arlington, VA, USA), whose constant support and advice made this study possible. A.J.M. thanks the Research Councils UK for supporting his Academic Fellowship. This work was supported by the Defense Advanced Research Projects Agency. The intellectual property covering the uses of ketone bodies and esters are owned by BTG, Ltd., the University of Oxford, and the U.S. National Institutes of Health. Should royalties ever accrue from these patents, A.J.M., R.L.V., M.T.K., and K.C., as named inventors, may receive a share of royalties as determined by the terms of the respective institutions. K.C. is director of T Delta S, Ltd., a company spun out of the University of Oxford to develop products on the basis of ketone ester nutrition.	Ashrafian H, 2007, CIRCULATION, V116, P434, DOI 10.1161/CIRCULATIONAHA.107.702795; Atherton HJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.18; Aubert G, 2016, CIRCULATION, V133, P698, DOI 10.1161/CIRCULATIONAHA.115.017355; Bedi KC, 2016, CIRCULATION, V133, P706, DOI 10.1161/CIRCULATIONAHA.115.017545; Bergqvist AGC, 2005, EPILEPSIA, V46, P1810, DOI 10.1111/j.1528-1167.2005.00282.x; BERGSTROM J, 1967, ACTA PHYSIOL SCAND, V71, P140, DOI 10.1111/j.1748-1716.1967.tb03720.x; Brand-Miller JC, 2002, AM J CLIN NUTR, V76, p281S, DOI 10.1093/ajcn/76.1.281S; Burgess SC, 2008, J BIOL CHEM, V283, P1670, DOI 10.1074/jbc.M706540200; Burke LM, 2006, J APPL PHYSIOL, V100, P7, DOI 10.1152/japplphysiol.01238.2005; Burke LM, 2015, SPORTS MED, V45, pS33, DOI 10.1007/s40279-015-0393-9; Cahill G., 1980, CEREBRAL METABOLISM, P234; Cahill G F Jr, 1970, N Engl J Med, V282, P668, DOI 10.1056/NEJM197003052821026; Cahill George F Jr, 2003, Trans Am Clin Climatol Assoc, V114, P149; Clarke K, 2012, REGUL TOXICOL PHARM, V63, P401, DOI 10.1016/j.yrtph.2012.04.008; Clarke K, 2012, REGUL TOXICOL PHARM, V63, P196, DOI 10.1016/j.yrtph.2012.04.001; Cole MA, 2011, BASIC RES CARDIOL, V106, P447, DOI 10.1007/s00395-011-0156-1; Cox PJ, 2014, EXTREME PHYSIOL MED, V3, DOI 10.1186/2046-7648-3-17; Deng CH, 2004, J CHROMATOGR B, V805, P235, DOI 10.1016/j.jchromb.2004.03.001; Desrois M, 2014, NMR BIOMED, V27, P529, DOI 10.1002/nbm.3088; Dodd MS, 2015, EMAGRES, V4, P811, DOI 10.1002/9780470034590.emrstm1460; Dorn GW, 2015, GENE DEV, V29, P1981, DOI 10.1101/gad.269894.115; Edwards LM, 2011, FASEB J, V25, P1088, DOI 10.1096/fj.10-171983; Holloway CJ, 2011, AM J CLIN NUTR, V93, P748, DOI 10.3945/ajcn.110.002758; Kashiwaya Y, 1997, AM J CARDIOL, V80, pA50, DOI 10.1016/S0002-9149(97)00458-X; Kashiwaya Y, 2000, P NATL ACAD SCI USA, V97, P5440, DOI 10.1073/pnas.97.10.5440; Kashiwaya Y, 2013, NEUROBIOL AGING, V34, P1530, DOI 10.1016/j.neurobiolaging.2012.11.023; Kashiwaya Y, 2010, J BIOL CHEM, V285, P25950, DOI 10.1074/jbc.M110.138198; Kemper MF, 2015, LIPIDS, V50, P1185, DOI 10.1007/s11745-015-4085-x; Kersten S, 2000, NATURE, V405, P421, DOI 10.1038/35013000; Kiens B, 2015, EXERC SPORT SCI REV, V43, P109, DOI 10.1249/JES.0000000000000053; Knapp DR, 1979, HDB ANAL DERIVATIZAT; Korbonits M, 2005, NEW ENGL J MED, V353, P2306, DOI 10.1056/NEJM200511243532124; KREBS H. A., 1937, Enzymologia, V4, P148; Kwiterovich PO, 2003, JAMA-J AM MED ASSOC, V290, P912, DOI 10.1001/jama.290.7.912; Lommi J, 1998, AM J CARDIOL, V81, P45, DOI 10.1016/S0002-9149(97)00804-7; MITCHELL P, 1967, NATURE, V213, P137, DOI 10.1038/213137a0; Murray AJ, 2005, DIABETES, V54, P3496, DOI 10.2337/diabetes.54.12.3496; Murray AJ, 2004, LANCET, V364, P1786, DOI 10.1016/S0140-6736(04)17402-3; Murray AJ, 2008, J MOL CELL CARDIOL, V44, P694, DOI 10.1016/j.yjmcc.2008.01.008; Murray AJ, 2006, CARDIOVASC RES, V71, P149, DOI 10.1016/j.cardiores.2006.02.031; Murray AJ, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-55; Murray AJ, 2009, FASEB J, V23, P4353, DOI 10.1096/fj.09-139691; Naressi A, 2001, COMPUT BIOL MED, V31, P269, DOI 10.1016/S0010-4825(01)00006-3; Neubauer S, 1997, CIRCULATION, V96, P2190; Neubauer S, 2007, NEW ENGL J MED, V356, P1140, DOI 10.1056/NEJMra063052; Newport MT, 2015, ALZHEIMERS DEMENT, V11, P99, DOI 10.1016/j.jalz.2014.01.006; OLTON DS, 1976, J EXP PSYCHOL-ANIM B, V2, P97, DOI 10.1037/0097-7403.2.2.97; OWEN OE, 1967, J CLIN INVEST, V46, P1589, DOI 10.1172/JCI105650; Pan JW, 1999, EPILEPSIA, V40, P703, DOI 10.1111/j.1528-1157.1999.tb00766.x; Paoli A, 2015, EXERC SPORT SCI REV, V43, P153, DOI 10.1249/JES.0000000000000050; PHINNEY SD, 1983, METABOLISM, V32, P757, DOI 10.1016/0026-0495(83)90105-1; Rajabi M, 2007, HEART FAIL REV, V12, P331, DOI 10.1007/s10741-007-9034-1; Rapoport BI, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000960; Reger MA, 2004, NEUROBIOL AGING, V25, P311, DOI 10.1016/S0197-4580(03)00087-3; SATO K, 1995, FASEB J, V9, P651, DOI 10.1096/fasebj.9.8.7768357; Schroeder MA, 2008, P NATL ACAD SCI USA, V105, P12051, DOI 10.1073/pnas.0805953105; Seymour AML, 1997, J MOL CELL CARDIOL, V29, P2771, DOI 10.1006/jmcc.1997.0512; Sharma S, 2004, FASEB J, V18, P1692, DOI 10.1096/fj.04-2263com; Srivastava S, 2012, FASEB J, V26, P2351, DOI 10.1096/fj.11-200410; Swink T D, 1997, Adv Pediatr, V44, P297; Tieu K, 2003, J CLIN INVEST, V112, P892, DOI 10.1172/JCI200318797; VanItallie TB, 2005, NEUROLOGY, V64, P728, DOI 10.1212/01.WNL.0000152046.11390.45; Veech RL, 2014, J LIPID RES, V55, P2004, DOI 10.1194/jlr.R046292; Veech RL, 2012, IUBMB LIFE, V64, P203, DOI 10.1002/iub.590; VEECH RL, 1979, J BIOL CHEM, V254, P6538; VEECH RL, 1974, TOXICOL APPL PHARM, V29, P196, DOI 10.1016/0041-008X(74)90056-8; Volek JS, 2016, METABOLISM, V65, P100, DOI 10.1016/j.metabol.2015.10.028	67	105	106	6	70	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4021	4032		10.1096/fj.201600773R	http://dx.doi.org/10.1096/fj.201600773R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27528626	hybrid, Green Accepted, Green Submitted, Green Published			2022-12-28	WOS:000388201500010
J	Pope, NH; Salmon, M; Davis, JP; Chatterjee, A; Su, G; Conte, MS; Ailawadi, G; Upchurch, GR				Pope, Nicolas H.; Salmon, Morgan; Davis, John P.; Chatterjee, Anuran; Su, Gang; Conte, Michael S.; Ailawadi, Gorav; Upchurch, Gilbert R., Jr.			D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization	FASEB JOURNAL			English	Article						inflammation; proresolving mediators; vascular biology	PRORESOLVING LIPID MEDIATORS; MATRIX METALLOPROTEINASES; INFLAMMATION; RESOLUTION; ACTIVATION; RECEPTOR; HYPERPLASIA; PROTECTS; ASPIRIN; MODEL	The role of resolvins in abdominal aortic aneurysm (AAA) has not been established. We hypothesized that treatment with D-series resolvins (RvD2 or RvD1) would attenuate murine AAA formation through alterations in macrophage polarization and cytokine expression. Male C57/B6 mice (n = 9 per group) 8 to 12 wk old received RvD2 (100 ng/kg/treatment), RvD1 (100 ng/kg/treatment), or vehicle only every third day beginning 3 d before abdominal aortic perfusion with elastase as prevention. Aortas were collected 14d after elastase perfusion. Cytokine analysis (n = 5 per group) or confocal microscopy (n = 4 per group) was performed. In a separate experiment, RvD2 was provided to mice with small AAAs 3 d after elastase treatment (n = 8 per group). Additionally, apolipoprotein E knockout mice treated with angiotensin II (1000ng/kg) were treated with RvD2 or vehicle alone (n = 10 per group) in a nonsurgical model of AAA. To determine the effect of RvD2 on macrophage polarization, confocal staining for macrophages, M1 and M2 macrophage subtypes, alpha-actin, and DAPI was performed. Mean aortic dilation was 96 +/- 13% for vehicle-treated mice, 57 +/- 9.7% for RvD2-treated mice, and 61 +/- 11% for RvD1-treated mice (P < 0.0001). Proinflammatory cytokines macrophage chemotactic protein 1, C-X-C motif ligand 1, and IL-1 beta were significantly elevated in control animals compared to RvD2- and RvD1-treated animals (P < 0.05), resulting in a reduction of matrix metalloproteinase 2 and 9 activity in resolvin-treated mice in both elastase and angiotensin II models. Treatment of existing small AAAs with RvD2 demonstrated a 25% reduction in aneurysm size at d 14 compared to vehicle alone (P = 0.018). Confocal histology demonstrated a prevalence of M2 macrophages within the aortic medium in mice treated with RvD2. Resolvin D2 exhibits a potent protective effect against experimental AAA formation. Treatment with RvD2 significantly influences macrophage polarization and decreases several important proinflammatory cytokines. Resolvins and the alteration of macrophage polarization represent potential future targets for prevention of AAA.	[Pope, Nicolas H.; Salmon, Morgan; Davis, John P.; Su, Gang; Ailawadi, Gorav; Upchurch, Gilbert R., Jr.] Univ Virginia, Dept Surg, POB 800679, Charlottesville, VA 22908 USA; [Chatterjee, Anuran; Conte, Michael S.] Univ Calif San Francisco, Dept Surg, Div Vasc & Endovasc Surg, San Francisco, CA USA	University of Virginia; University of California System; University of California San Francisco	Pope, NH (corresponding author), Univ Virginia, Dept Surg, POB 800679, Charlottesville, VA 22908 USA.	np7g@virginia.edu			U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [K08-HL098560, R01-HL081629]; NIH NHLBI Award [T32-HL007849]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL098560, T32HL007849, R01HL119508, R01HL126668, R01HL081629] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH NHLBI Award; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Grants K08-HL098560 (to G.A.) and R01-HL081629 (to G.R.U.). This project was supported by NIH NHLBI Award T32-HL007849 (to N.H.P., principal investigator: I.L. Kron). The content is solely the responsibility of the authors and does not necessarily represent the views of the NHLBI. The authors thank A. Herring, C. Dodson, and M. Bevard for their technical expertise.	Ailawadi G, 2003, J VASC SURG, V37, P1059, DOI 10.1067/mva.2003.163; Ailawadi G, 2003, J VASC SURG, V38, P584, DOI 10.1016/S0741-5214(03)00324-0; Akagi D, 2015, FASEB J, V29, P2504, DOI 10.1096/fj.14-265363; Ariel A, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00004; Arita M, 2005, P NATL ACAD SCI USA, V102, P7671, DOI 10.1073/pnas.0409271102; Arita M, 2005, J EXP MED, V201, P713, DOI 10.1084/jem.20042031; Blomkalns AL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000065; Brady AR, 2004, CIRCULATION, V110, P16, DOI 10.1161/01.CIR.0000133279.07468.9F; Daugherty A, 1999, ANN NY ACAD SCI, V892, P108, DOI 10.1111/j.1749-6632.1999.tb07789.x; Daugherty A, 2000, J CLIN INVEST, V105, P1605, DOI 10.1172/JCI7818; Daugherty A, 2004, ARTERIOSCL THROM VAS, V24, P429, DOI 10.1161/01.ATV.0000118013.72016.ea; Duffield JS, 2006, J IMMUNOL, V177, P5902, DOI 10.4049/jimmunol.177.9.5902; FREESTONE T, 1995, ARTERIOSCL THROM VAS, V15, P1145, DOI 10.1161/01.ATV.15.8.1145; Hasturk H, 2006, FASEB J, V20, P401, DOI 10.1096/fj.05-4724fje; Johnston W. F., 2014, J VASC SURG; Johnston WF, 2014, CIRCULATION, V130, pS51, DOI 10.1161/CIRCULATIONAHA.113.006800; Johnston WF, 2013, ARTERIOSCL THROM VAS, V33, P294, DOI 10.1161/ATVBAHA.112.300432; Kavazos K, 2015, HEART LUNG CIRC, V24, P377, DOI 10.1016/j.hlc.2014.11.005; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Lederle FA, 2000, ARCH INTERN MED, V160, P1425, DOI 10.1001/archinte.160.10.1425; Lederle FA, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1724; Lindholt JS, 2008, VASC ENDOVASC SURG, V42, P329, DOI 10.1177/1538574408315205; Mantovani A, 2005, IMMUNITY, V23, P344, DOI 10.1016/j.immuni.2005.10.001; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Miyahara T, 2013, FASEB J, V27, P2220, DOI 10.1096/fj.12-225615; Moehle CW, 2011, J THORAC CARDIOV SUR, V142, P1567, DOI 10.1016/j.jtcvs.2011.07.053; NEWMAN KM, 1994, CONNECT TISSUE RES, V30, P265, DOI 10.3109/03008209409015042; NEWMAN KM, 1994, CIRCULATION, V90, P224; Norman PE, 2004, BRIT MED J, V329, P1259, DOI 10.1136/bmj.38272.478438.55; Pillai PS, 2012, INFLAMMATION, V35, P98, DOI 10.1007/s10753-011-9294-8; Salmon M, 2013, CIRCULATION, V128, pS163, DOI 10.1161/CIRCULATIONAHA.112.000238; Scott RAP, 2002, BRIT J SURG, V89, P283, DOI 10.1046/j.0007-1323.2001.02014.x; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Shimizu K, 2006, ARTERIOSCL THROM VAS, V26, P987, DOI 10.1161/01.ATV.0000214999.12921.4f; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Titos E, 2011, J IMMUNOL, V187, P5408, DOI 10.4049/jimmunol.1100225; Wang J.H., 2014, J APPL MATH, V2014; Woodrum DT, 2005, J AM COLL SURGEONS, V201, P398, DOI 10.1016/j.jamcollsurg.2005.04.002; Yoshihara T, 2015, CIRC J, V79, P1470, DOI 10.1253/circj.CJ-14-0471	45	70	71	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4192	4201		10.1096/fj.201600144RR	http://dx.doi.org/10.1096/fj.201600144RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27619672	Green Published			2022-12-28	WOS:000388201500025
J	Pesta, DH; Tsirigotis, DN; Befroy, DE; Caballero, D; Jurczak, MJ; Rahimi, Y; Cline, GW; Dufour, S; Birkenfeld, AL; Rothman, DL; Carpenter, TO; Insogna, K; Petersen, KF; Bergwitz, C; Shulman, GI				Pesta, Dominik H.; Tsirigotis, Dimitrios N.; Befroy, Douglas E.; Caballero, Daniel; Jurczak, Michael J.; Rahimi, Yasmeen; Cline, Gary W.; Dufour, Sylvie; Birkenfeld, Andreas L.; Rothman, Douglas L.; Carpenter, Thomas O.; Insogna, Karl; Petersen, Kitt Falk; Bergwitz, Clemens; Shulman, Gerald I.			Hypophosphatemia promotes lower rates of muscle ATP synthesis	FASEB JOURNAL			English	Article						[P-31]MRS; saturation transfer; inorganic phosphate	OXIDATIVE-PHOSPHORYLATION; INORGANIC-PHOSPHATE; SKELETAL-MUSCLE; IN-VIVO; MITOCHONDRIAL; HYPERCALCIURIA; MICE; DYSFUNCTION; MUTATIONS; WEAKNESS	Hypophosphatemia can lead to muscle weakness and respiratory and heart failure, but the mechanism is unknown. To address this question, we noninvasively assessed rates of muscle ATP synthesis in hypophosphatemic mice by using in vivo saturation transfer [P-31]-magnetic resonance spectroscopy. By using this approach, we found that basal and insulin-stimulated rates of muscle ATP synthetic flux (V-ATP) and plasma inorganic phosphate (P-i) were reduced by 50% in mice with diet-induced hypophosphatemia as well as in sodium-dependent P-i transporter solute carrier family 34, member 1 (NaPi2a)-knockout (NaPi2a(-/-)) mice compared with their wild-type littermate controls. Rates of V-ATP normalized in both hypophosphatemic groups after restoring plasma P-i concentrations. Furthermore, V-ATP was directly related to cellular and mitochondrial P-i uptake in L6 and RC13 rodent myocytes and isolated muscle mitochondria. Similar findings were observed in a patient with chronic hypophosphatemia as a result of a mutation in SLC34A3 who had a 50% reduction in both serum P-i content and muscle V-ATP. After oral P-i repletion and normalization of serum P-i levels, muscle V-ATP completely normalized in the patient. Taken together, these data support the hypothesis that decreased muscle ATP synthesis, in part, may be caused by low blood P-i concentrations, which may explain some aspects of muscle weakness observed in patients with hypophosphatemia.-Pesta, D. H., Tsirigotis, D. N., Befroy, D. E., Caballero, D., Jurczak, M. J., Rahimi, Y., Cline, G. W., Dufour, S., Birkenfeld, A. L., Rothman, D. L., Carpenter, T. O., Insogna, K., Petersen, K. F., Bergwitz, C., Shulman, G. I. Hypophosphatemia promotes lower rates of muscle ATP synthesis.	[Pesta, Dominik H.; Caballero, Daniel; Jurczak, Michael J.; Rahimi, Yasmeen; Cline, Gary W.; Birkenfeld, Andreas L.; Insogna, Karl; Petersen, Kitt Falk; Bergwitz, Clemens; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Tsirigotis, Dimitrios N.; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT USA; [Befroy, Douglas E.; Rothman, Douglas L.] Yale Univ, Sch Med, Dept Radiol & Biomed Engn, New Haven, CT USA; [Carpenter, Thomas O.] Yale Univ, Sch Med, Dept Pediat, New Haven, CT 06510 USA; [Dufour, Sylvie; Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, 300 Cedar St, New Haven, CT 06510 USA; [Petersen, Kitt Falk; Shulman, Gerald I.] Univ Copenhagen, Novo Nordisk Fdn, Ctr Basic Metab Res, Copenhagen, Denmark	Yale University; Yale University; Yale University; Yale University; Howard Hughes Medical Institute; Yale University; Novo Nordisk Foundation; University of Copenhagen	Shulman, GI (corresponding author), Yale Univ, Sch Med, Howard Hughes Med Inst, 300 Cedar St, New Haven, CT 06510 USA.	gerald.shulman@yale.edu	Pesta, Dominik/AAV-7108-2020; Birkenfeld, Andreas L./U-3954-2019; Caballero, Daniel/GXV-3082-2022; Shulman, Gerald I./P-7176-2019	Pesta, Dominik/0000-0002-5089-3586; Birkenfeld, Andreas L./0000-0003-1407-9023; Shulman, Gerald I./0000-0003-1529-5668; Caballero, Daniel/0000-0001-9232-8991; Insogna, Karl/0000-0001-6973-5679	Austrian Science Fund (FWF) [J-3267]; German Science Association (DFG) [BI1292/ 4-2]; U.S. National Institutes of Health [DK-40936, DK-059635]; U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [DK-45735]; U.S. National Institutes of Health (National Institute on Aging) [AG-23686]; Novo Nordisk Foundation Center for Basic Metabolic Research (University of Copenhagen); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK040936, U24DK059635, P30DK045735] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R56AG023686, R01AG023686] Funding Source: NIH RePORTER	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); German Science Association (DFG)(German Research Foundation (DFG)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Institutes of Health (National Institute on Aging)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Novo Nordisk Foundation Center for Basic Metabolic Research (University of Copenhagen); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the Austrian Science Fund (FWF; J-3267); the German Science Association (DFG; BI1292/ 4-2); U.S. National Institutes of Health Grants DK-40936, DK-059635, and DK-45735 (National Institute of Diabetes and Digestive and Kidney Diseases), and AG-23686 (National Institute on Aging); and the Novo Nordisk Foundation Center for Basic Metabolic Research (University of Copenhagen). The authors thank Mario Kahn, Blas Guigni, Tomas Jelenik, John Stack, Gina Butrico, Ali Nasiri, Bryce Perler, and Maria Batsu for technical assistance and Oroboros Instruments for the loan of an Oxygraph-2k. The authors also thank the Hospital Research Unit (Yale-New Haven Hospital, New Haven, CT, USA) for help with clinical studies. The authors declare no conflicts of interest.	Amanzadeh J, 2006, NAT CLIN PRACT NEPHR, V2, P136, DOI 10.1038/ncpneph0124; Andersen H, 2004, DIABETES, V53, P1543, DOI 10.2337/diabetes.53.6.1543; Andreassen CS, 2006, DIABETES, V55, P806, DOI 10.2337/diabetes.55.03.06.db05-1237; Beard DA, 2006, PLOS COMPUT BIOL, V2, P1093, DOI 10.1371/journal.pcbi.0020107; Beck L, 1998, P NATL ACAD SCI USA, V95, P5372, DOI 10.1073/pnas.95.9.5372; Beck L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009148; Bergwitz C, 2006, AM J HUM GENET, V78, P179, DOI 10.1086/499409; Berndt T, 2007, ANNU REV PHYSIOL, V69, P341, DOI 10.1146/annurev.physiol.69.040705.141729; Brooks KJ, 2004, NMR BIOMED, V17, P28, DOI 10.1002/nbm.861; CAMP MA, 1990, MINER ELECTROL METAB, V16, P365; Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105; Cline GW, 2001, J BIOL CHEM, V276, P20240, DOI 10.1074/jbc.M102540200; FULLER TJ, 1976, J CLIN INVEST, V57, P1019, DOI 10.1172/JCI108343; Gariballa S, 2008, NUTRITION, V24, P604, DOI 10.1016/j.nut.2008.01.053; Geerse DA, 2010, CRIT CARE, V14, DOI 10.1186/cc9215; GRAVELYN TR, 1988, AM J MED, V84, P870, DOI 10.1016/0002-9343(88)90065-4; Haran M, 2014, MITOCHONDRION, V19, P3, DOI 10.1016/j.mito.2014.09.007; HETTLEMAN BD, 1983, J CLIN INVEST, V72, P582, DOI 10.1172/JCI111006; Imel EA, 2012, J CLIN ENDOCR METAB, V97, P696, DOI 10.1210/jc.2011-1319; Jensen N, 2013, J MOL NEUROSCI, V51, P994, DOI 10.1007/s12031-013-0085-6; Jones AO, 2001, J AM SOC NEPHROL, V12, P507, DOI 10.1681/ASN.V123507; Jucker BM, 2000, P NATL ACAD SCI USA, V97, P6880, DOI 10.1073/pnas.120131997; Jucker BM, 2000, J BIOL CHEM, V275, P39279, DOI 10.1074/jbc.M007760200; KHANANSHVILI D, 1985, BIOCHEMISTRY-US, V24, P2482, DOI 10.1021/bi00331a014; Khoshniat S, 2011, CELL MOL LIFE SCI, V68, P205, DOI 10.1007/s00018-010-0527-z; Kuro-o M, 2010, MECH AGEING DEV, V131, P270, DOI 10.1016/j.mad.2010.02.008; LARDY HA, 1952, J BIOL CHEM, V195, P215; Lebon V, 2001, J CLIN INVEST, V108, P733, DOI 10.1172/JCI11775; LEMASTERS JJ, 1979, J BIOL CHEM, V254, P1248; Lemos RR, 2015, HUM MUTAT, V36, P489, DOI 10.1002/humu.22778; Petersen KF, 2005, PLOS MED, V2, P879, DOI 10.1371/journal.pmed.0020233; Petersen KF, 2004, NEW ENGL J MED, V350, P664, DOI 10.1056/NEJMoa031314; Petersen KF, 2003, SCIENCE, V300, P1140, DOI 10.1126/science.1082889; Schubert L, 2010, ARCH BIOCHEM BIOPHYS, V500, P157, DOI 10.1016/j.abb.2010.05.029; Segawa H, 2009, BONE, V45, pS2, DOI 10.1016/j.bone.2009.02.003; Sinha A, 2013, J CLIN ENDOCR METAB, V98, pE509, DOI 10.1210/jc.2012-3592; SMITH R, 1984, CLIN SCI, V67, P505, DOI 10.1042/cs0670505; Soyoral Y, 2014, AM J EMERG MED, V32, DOI 10.1016/j.ajem.2014.04.011; TAGER JM, 1983, FEBS LETT, V151, P1, DOI 10.1016/0014-5793(83)80330-5; TANAKA A, 1989, J BIOL CHEM, V264, P10034; Veilleux LN, 2012, J CLIN ENDOCR METAB, V97, pE1492, DOI 10.1210/jc.2012-1336; Wang Cecilia C Low, 2007, Atherosclerosis, V195, pe65, DOI 10.1016/j.atherosclerosis.2007.02.032; WILSON DF, 1974, BIOCHEM J, V140, P57, DOI 10.1042/bj1400057; Zhang DY, 2010, CELL METAB, V11, P402, DOI 10.1016/j.cmet.2010.03.012	44	48	53	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3378	3387		10.1096/fj.201600473R	http://dx.doi.org/10.1096/fj.201600473R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27338702	Green Published, hybrid			2022-12-28	WOS:000384329800010
J	Joanisse, S; Nederveen, JP; Baker, JM; Snijders, T; Iacono, C; Parise, G				Joanisse, Sophie; Nederveen, Joshua P.; Baker, Jeff M.; Snijders, Tim; Iacono, Carlo; Parise, Gianni			Exercise conditioning in old mice improves skeletal muscle regeneration	FASEB JOURNAL			English	Article						exercise; aging; cardiotoxin; satellite cells	SATELLITE-CELL POOL; RAT PLANTARIS MUSCLE; ANGIOGENESIS; YOUNG; RESPONSES; VEGF; IMMOBILIZATION; EXPANSION; ATROPHY; MODEL	Skeletal muscle possesses the ability to regenerate after injury, but this ability is impaired or delayed with aging. Regardless of age, muscle retains the ability to positively respond to stimuli, such as exercise. We examined whether exercise is able to improve regenerative response in skeletal muscle of aged mice. Twenty-two-month-old male C57Bl/6J mice (n = 20) underwent an 8-wk progressive exercise training protocol [old exercised (O-Ex) group]. An old sedentary (O-Sed) and a sedentary young control (Y-Ctl) group were included. Animals were subjected to injections of cardiotoxin into the tibialis anterior muscle. The tibialis anterior were harvested before [O-Ex/O-Sed/Y-Ctl control (CTL); n = 6], 10 d (O-Ex/O-Sed/Y-Ctl d 10; n = 8), and 28 d (O-Ex/O-Sed/Y-Ctl d 28; n = 6) postinjection. Average fiber cross-sectional area was reduced in all groups at d 10 (CTL: O-Ex: 2499 +/- 140; O-Sed: 2320 +/- 165; Y-Ctl: 2474 +/- 269; d 10: O-Ex: 1191 +/- 100; O-Sed: 1125 +/- 99; Y-Ctl: 1481 +/- 167 mu m(2); P < 0.05), but was restored to control values in O-Ex and Y-Ctl groups at d 28 (O-Ex: 2257 +/- 181; Y-Ctl: 2398 +/- 171 mu m(2); P > 0.05). Satellite cell content was greater at CTL in O-Ex (2.6 +/- 0.4 satellite cells/100 fibers) compared with O-Sed (1.0 +/- 0.1% satellite cells/100 fibers; P < 0.05). Exercise conditioning appears to improve ability of skeletal muscle to regenerate after injury in aged mice.Joanisse, S., Nederveen, J. P., Baker, J. M., Snijders, T., Iacono, C., Parise, G. Exercise conditioning in old mice improves skeletal muscle regeneration.	[Joanisse, Sophie; Nederveen, Joshua P.; Baker, Jeff M.; Snijders, Tim; Iacono, Carlo; Parise, Gianni] McMaster Univ, Dept Kinesiol, Hamilton, ON L8S 4L8, Canada; [Parise, Gianni] McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON L8S 4L8, Canada	McMaster University; McMaster University	Parise, G (corresponding author), McMaster Univ, Dept Kinesiol, Hamilton, ON L8S 4L8, Canada.; Parise, G (corresponding author), McMaster Univ, Dept Med Phys & Appl Radiat Sci, Hamilton, ON L8S 4L8, Canada.	pariseg@mcmaster.ca	Snijders, Tim/U-4155-2017	Snijders, Tim/0000-0002-5874-1245; Joanisse, Sophie/0000-0001-9983-9401	Natural Sciences and Engineering Research Council of Canada Discovery; U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development	Natural Sciences and Engineering Research Council of Canada Discovery(Natural Sciences and Engineering Research Council of Canada (NSERC)); U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by an Natural Sciences and Engineering Research Council of Canada Discovery grant to G.P. Pax7 hybridoma cells developed by Dr. A. Kawakami (Tokyo Institute of Technology, Tokyo, Japan) were obtained from the Developmental Studies Hybridoma Bank, developed under the auspices of the U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development, and maintained by The University of Iowa, Department of Biology (Iowa City, IA, USA). Author contributions: S. Joanisse, J. M. Baker, and G. Parise conceived and designed the experiments; S. Joanisse, J. P. Nederveen, C. Iacono, and G. Parise performed the experiments; S. Joanisse analyzed the data; S. Joanisse, J. P. Nederveen, T. Snijders, and G. Parise interpreted results of experiments; S. Joanisse and G. Parise drafted the manuscript; and S. Joanisse, J. P. Nederveen, J. M. Baker, T. Snijders, C. Iacono, and G. Parise approved the final version of manuscript.	Adams GR, 2002, AM J PHYSIOL-CELL PH, V283, pC1182, DOI 10.1152/ajpcell.00173.2002; Amaral SL, 2001, AM J PHYSIOL-HEART C, V281, pH1163, DOI 10.1152/ajpheart.2001.281.3.H1163; Ambrose C, 2015, AGEING RES REV, V23, P139, DOI 10.1016/j.arr.2015.03.005; BODINEFOWLER S, 1994, J VOICE, V8, P53, DOI 10.1016/S0892-1997(05)80319-4; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Brack AS, 2005, J CELL SCI, V118, P4813, DOI 10.1242/jcs.02602; Catoire M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051066; Charge SBP, 2004, PHYSIOL REV, V84, P209, DOI 10.1152/physrev.00019.2003; Christov C, 2007, MOL BIOL CELL, V18, P1397, DOI 10.1091/mbc.E06-08-0693; Collins CA, 2007, STEM CELLS, V25, P885, DOI 10.1634/stemcells.2006-0372; Conboy IM, 2005, NATURE, V433, P760, DOI 10.1038/nature03260; Conboy IM, 2003, SCIENCE, V302, P1575, DOI 10.1126/science.1087573; Davidson YS, 1999, J GERONTOL A-BIOL, V54, pB448, DOI 10.1093/gerona/54.10.B448; Delmonico MJ, 2009, AM J CLIN NUTR, V90, P1579, DOI 10.3945/ajcn.2009.28047; Deng B, 2012, J IMMUNOL, V189, P3669, DOI 10.4049/jimmunol.1103180; Gavin TP, 2006, ACTA PHYSIOL, V188, P113, DOI 10.1111/j.1748-1716.2006.01609.x; Grefte S, 2007, STEM CELLS DEV, V16, P857, DOI 10.1089/scd.2007.0058; Hepple RT, 2001, J APPL PHYSIOL, V91, P2150, DOI 10.1152/jappl.2001.91.5.2150; Hvid L, 2010, J APPL PHYSIOL, V109, P1628, DOI 10.1152/japplphysiol.00637.2010; Johnston APW, 2011, AM J PHYSIOL-REG I, V301, pR363, DOI 10.1152/ajpregu.00766.2010; KLITGAARD H, 1988, J APPL PHYSIOL, V64, P1740, DOI 10.1152/jappl.1988.64.4.1740; KLITGAARD H, 1989, J APPL PHYSIOL, V67, P1401, DOI 10.1152/jappl.1989.67.4.1401; Kurosaka M, 2012, ACTA PHYSIOL, V205, P159, DOI 10.1111/j.1748-1716.2011.02381.x; Kurosaka M, 2009, J SPORT SCI MED, V8, P51; Lee Antonio S J, 2013, Bioarchitecture, V3, P25, DOI 10.4161/bioa.24966; Liu XH, 2015, INT J BIOL SCI, V11, P156, DOI 10.7150/ijbs.10283; McCarthy JJ, 2011, DEVELOPMENT, V138, P3657, DOI 10.1242/dev.068858; Mehlem A, 2013, NAT PROTOC, V8, P1149, DOI 10.1038/nprot.2013.055; Navarro A, 2004, AM J PHYSIOL-REG I, V286, pR505, DOI 10.1152/ajpregu.00208.2003; Ochoa O, 2007, AM J PHYSIOL-REG I, V293, pR651, DOI 10.1152/ajpregu.00069.2007; Plant DR, 2006, MUSCLE NERVE, V34, P577, DOI 10.1002/mus.20616; Rivard A, 1999, CIRCULATION, V99, P111, DOI 10.1161/01.CIR.99.1.111; SADEH M, 1988, J NEUROL SCI, V87, P67, DOI 10.1016/0022-510X(88)90055-X; Sambasivan R, 2011, DEVELOPMENT, V138, P3647, DOI 10.1242/dev.067587; Seale P, 2000, DEV BIOL, V218, P115, DOI 10.1006/dbio.1999.9565; Shavlakadze T, 2010, BIOGERONTOLOGY, V11, P363, DOI 10.1007/s10522-009-9260-0; SHEFER G, 2013, FEBS J, V280, P4063, DOI DOI 10.1111/FEBS.12228; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Shefer G, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013307; Smythe GM, 2008, EXP GERONTOL, V43, P550, DOI 10.1016/j.exger.2008.02.005; Snijders T, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00283; Snijders T, 2009, AGEING RES REV, V8, P328, DOI 10.1016/j.arr.2009.05.003; Suetta C, 2013, J PHYSIOL-LONDON, V591, P3789, DOI 10.1113/jphysiol.2013.257121; Suetta C, 2009, J APPL PHYSIOL, V107, P1172, DOI 10.1152/japplphysiol.00290.2009; Ten Broek RW, 2010, J CELL PHYSIOL, V224, P7, DOI 10.1002/jcp.22127	45	42	43	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3256	3268		10.1096/fj.201600143RR	http://dx.doi.org/10.1096/fj.201600143RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27306336	Green Accepted			2022-12-28	WOS:000382816300024
J	Lucas, CGDO; Matassoli, FL; Pecanha, LMT; Santillo, BT; Oliveira, LMD; Oshiro, TM; Marques, ETDA; Oxenius, A; de Arruda, LB				Lucas, Carolina G. D. O.; Matassoli, Flavio L.; Pecanha, Ligia M. T.; Santillo, Bruna Tereso; da Silva Oliveira, Luanda Mara; Oshiro, Telma Miyuki; Marques, Ernesto T. D. A., Jr.; Oxenius, Annette; de Arruda, Luciana B.			Dendritic cells primed with a chimeric plasmid containing HIV-1-gag associated with lysosomal-associated protein-1 (LAMP/gag) is a potential therapeutic vaccine against HIV	FASEB JOURNAL			English	Article						HIV immunotherapy; T-cell activation; dendritic cell vaccine	HUMAN-IMMUNODEFICIENCY-VIRUS; REGULATORY T-CELLS; 1-INFECTED INDIVIDUALS; VIROLOGICAL RESPONSES; MEMBRANE PROTEIN-1; II COMPARTMENT; GAG; INFECTION; ELICITS; CD4(+)	The decline in number and function of T cells is a hallmark of HIV infection, and preservation or restoration of HIV-specific cellular immune response is a major goal of AIDS treatment. Dendritic cells (DCs) play a key role in the initiation and maintenance of the immune response, and their use as a vaccine vehicle is a promising strategy for enhancing vaccine efficacy. We evaluated the potential of DC-mediated immunization with a DNA vaccine consisting of HIV-1-p55gag (gag, group-specific antigen) associated to lysosomal associated protein (LAMP) sequence (LAMP/gag vaccine). Immunization of mice with mouse DCs transfected with LAMP/gag (Lg-mDCs) stimulated more potent B-and T-cell responses than naked DNA or DCs pulsed with inactivated HIV. Anti-Gag antibody levels were sustained for at least 3 mo after immunization, and recall T-cell responses were also strongly detected at this time point. Human DCs transfected with LAMP/gag (Lg-hDCs) were also activated and able to stimulate greater T-cell response than native gag-transfected DCs. Coculture between Lg-hDCs and T lymphocytes obtained from patients with HIV resulted in upregulation of CD38, CD69, HLA-DR, and granzyme B by CD4(+) and CD8(+) T cells, and increased IFN-gamma and TNF-alpha production. These results indicate that the use of LAMP/gag-DC may be an efficient strategy for enhancing immune function in patients with HIV.	[Lucas, Carolina G. D. O.; Matassoli, Flavio L.; de Arruda, Luciana B.] Univ Fed Rio de Janeiro, Inst Microbiol, Dept Virol, Rio De Janeiro, Brazil; [Pecanha, Ligia M. T.] Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, Dept Imunol, Rio De Janeiro, Brazil; [Santillo, Bruna Tereso; da Silva Oliveira, Luanda Mara; Oshiro, Telma Miyuki] Univ Sao Paulo, Escola Med, Dept Dermatol, Lab Dermatol & Imunodeficiencias LIM 56, Sao Paulo, Brazil; [Santillo, Bruna Tereso; Oxenius, Annette] Swiss Fed Inst Technol, Inst Microbiol, Zurich, Switzerland; [Marques, Ernesto T. D. A., Jr.] Ctr Vaccine Res, Dept Infect Dis & Microbiol, Pittsburgh, PA USA; [Marques, Ernesto T. D. A., Jr.] Fundacao Oswaldo Cruz Fiocruz Pernambuco, Ctr Pesquisas Aggeu Magalhaes CPqAM, Dept Virol, Recife, PE, Brazil	Universidade Federal do Rio de Janeiro; Universidade Federal do Rio de Janeiro; Universidade de Sao Paulo; ETH Zurich; Fundacao Oswaldo Cruz	de Arruda, LB (corresponding author), Univ Fed Rio de Janeiro, Inst Microbiol Paulo de Goes, CCS, Lab I SS 048, Bloco 1,Av Carlos Chagas Filho,377 Cidade Univ, BR-21941902 Rio De Janeiro, RJ, Brazil.	arruda@micro.ufrj.br	Oshiro, Telma M/C-7152-2012; Arruda, Luciana B/N-9086-2013; da Silva Oliveira, Luanda Mara/E-7273-2013; Tereso Santillo, Bruna/P-6047-2016; Marques, Ernesto T. A/L-4967-2013	Oshiro, Telma M/0000-0002-8791-9233; da Silva Oliveira, Luanda Mara/0000-0003-0903-8219; Tereso Santillo, Bruna/0000-0003-2851-1657; Marques, Ernesto T. A/0000-0003-3826-9358; Lucas, Carolina/0000-0003-4590-2756	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Coordination for the Improvement of Higher Education Personnel); CAPES/Programa Professor Visitante do Exterior-Ciencias sem Fronteiras (CAPES-Special Visiting Researcher, Science Without Borders program); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; National Council for Scientific and Technological Development); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ; Research Support Foundation of the State of Rio de Janeiro); Swiss National Science Foundation [310030-113947]	Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Coordination for the Improvement of Higher Education Personnel)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES/Programa Professor Visitante do Exterior-Ciencias sem Fronteiras (CAPES-Special Visiting Researcher, Science Without Borders program); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; National Council for Scientific and Technological Development)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ; Research Support Foundation of the State of Rio de Janeiro)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	The authors thank Dr. James K. Hildreth (University of California-Davis, Davis, CA, USA) and Dr. J. Thomas August (The Johns Hopkins School of Medicine, Baltimore, MD, USA) for kindly providing the anti-Gag M1 and anti-LAMP-2 antibodies, respectively; Dr. Helio Dutra [Instituto de Ciencias Biomedicas, Universidade Federal do Rio de Janeiro (UFRJ)] for helpful assistance with flow cytometry; and Joao Baltazar (Instituto de Microbiologia Paulo de Goes, UFRJ) for technical support. This work was supported by Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES; Coordination for the Improvement of Higher Education Personnel), CAPES/Programa Professor Visitante do Exterior-Ciencias sem Fronteiras (CAPES-Special Visiting Researcher, Science Without Borders program), Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq; National Council for Scientific and Technological Development), Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (FAPERJ; Research Support Foundation of the State of Rio de Janeiro), and the Swiss National Science Foundation Grant 310030-113947 (to A.O.). C.G.D.O.L. and F.L.M. were the recipients of FAPERJ and CAPES fellowships. The authors declare no conflicts of interest.	Almeida JR, 2007, J EXP MED, V204, P2473, DOI 10.1084/jem.20070784; Andres C, 2015, J VIROL, V89, P9189, DOI 10.1128/JVI.01062-15; Arruda LB, 2006, J IMMUNOL, V177, P2265, DOI 10.4049/jimmunol.177.4.2265; Ayinde D, 2015, J VIROL, V89, P6994, DOI 10.1128/JVI.00069-15; Brandt L, 2011, JAIDS-J ACQ IMM DEF, V57, P101, DOI 10.1097/QAI.0b013e318215a991; Breton G, 2013, J IMMUNOL, V191, P2194, DOI 10.4049/jimmunol.1200646; Buisson S, 2009, J INFECT DIS, V199, P1862, DOI 10.1086/599122; Chen Wei-Ti, 2013, J AIDS Clin Res, V4, P218; Chikhlikar P, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000135; Chun TW, 2010, AIDS, V24, P2803, DOI 10.1097/QAD.0b013e328340a239; Connolly NC, 2008, CLIN VACCINE IMMUNOL, V15, P284, DOI 10.1128/CVI.00221-07; Costiniuk CT, 2013, AIDS RES HUM RETROV, V29, P266, DOI [10.1089/aid.2011.0343, 10.1089/AID.2011.0343]; Godinho RMD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099887; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; DCV2/MANON07-ORVACS Study Group, 2013, SCI TRANSL MED, V5; De Arruda LB, 2004, IMMUNOLOGY, V112, P126, DOI 10.1111/j.1365-2567.2004.01823.x; Donaghy H, 2001, BLOOD, V98, P2574, DOI 10.1182/blood.V98.8.2574; Erikstrup C, 2010, JAIDS-J ACQ IMM DEF, V53, P303, DOI 10.1097/QAI.0b013e3181ca3f7c; Favre D, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000632; Ferrando-Martinez S, 2012, J VIROL, V86, P3667, DOI 10.1128/JVI.07034-11; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; French MA, 2013, AIDS, V27, P519, DOI 10.1097/QAD.0b013e32835cb720; Gandhi RT, 2002, ANNU REV MED, V53, P149, DOI 10.1146/annurev.med.53.082901.104011; Garcia F, 1999, AIDS, V13, pF79, DOI 10.1097/00002030-199907300-00002; Hel Z, 2002, J IMMUNOL, V169, P4778, DOI 10.4049/jimmunol.169.9.4778; Kalams SA, 1999, J VIROL, V73, P6715, DOI 10.1128/JVI.73.8.6715-6720.1999; Kalams SA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029231; Kaushik S, 2013, AIDS RES HUM RETROV, V29, P501, DOI [10.1089/aid.2012.0200, 10.1089/AID.2012.0200]; Kim CJ, 2013, J IMMUNOL, V191, P2164, DOI 10.4049/jimmunol.1300829; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Klatt NR, 2012, MUCOSAL IMMUNOL, V5, P646, DOI 10.1038/mi.2012.38; Kovari H, 2013, CLIN INFECT DIS, V56, P870, DOI 10.1093/cid/cis919; Krathwohl MD, 2006, J INFECT DIS, V193, P494, DOI 10.1086/499597; Kulkarni V, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111085; Laguette N, 2011, NATURE, V474, P654, DOI 10.1038/nature10117; Levy Y, 2006, AIDS, V20, P405, DOI 10.1097/01.aids.0000206504.09159.d3; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Manel N, 2010, NATURE, V467, P214, DOI 10.1038/nature09337; Marques ETA, 2003, J BIOL CHEM, V278, P37926, DOI 10.1074/jbc.M303336200; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Mishra S, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0104606, 10.1371/journal.pone.0097881]; Piketty C, 2001, J INFECT DIS, V183, P1328, DOI 10.1086/319861; Presicce P, 2012, AIDS, V26, P263, DOI 10.1097/QAD.0b013e32834ed8df; Rossio JL, 1998, J VIROL, V72, P7992, DOI 10.1128/JVI.72.10.7992-8001.1998; Schenal M, 2005, AIDS, V19, P653, DOI 10.1097/01.aids.0000166088.85951.25; Sciaranghella G, 2013, AIDS, V27, P175, DOI 10.1097/QAD.0b013e32835bd1f0; Selvaraj A, 2013, PATHOG DIS, V69, P184, DOI 10.1111/2049-632X.12067; Serrano-Villar S, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004078; Simon GG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008574; Smed-Sorensen A, 2011, CURR OPIN HIV AIDS, V6, P405, DOI 10.1097/COH.0b013e328349b06b; Tan RM, 2008, JAIDS-J ACQ IMM DEF, V47, P553, DOI 10.1097/QAI.0b013e31816856c5; Turk G, 2013, J VIROL, V87, P7445, DOI 10.1128/JVI.00865-13; Van Gulck E, 2012, AIDS, V26, pF1, DOI 10.1097/QAD.0b013e32834f33e8; Wilgenhof S, 2011, J IMMUNOTHER, V34, P448, DOI 10.1097/CJI.0b013e31821dcb31; Yonkers NL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023884	55	1	1	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2970	2984		10.1096/fj.201500059	http://dx.doi.org/10.1096/fj.201500059			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27199296				2022-12-28	WOS:000380994000029
J	Ko, MH; Hwang, YS; Rim, JS; Han, HJ; Han, JY				Ko, Mee Hyun; Hwang, Young Sun; Rim, Jong Seop; Han, Ho Jae; Han, Jae Yong			Avian blastoderm dormancy arrests cells in G(2) and suppresses apoptosis	FASEB JOURNAL			English	Article						chicken; RNA sequencing; ER stress; SAPK signaling	ENDOPLASMIC-RETICULUM STRESS; TEMPERATURE-SENSITIVE MUTANT; CYCLE ARREST; EGG STORAGE; ALBUMIN CHARACTERISTICS; EXPRESSION ANALYSIS; DNA-DAMAGE; DEATH; PROTEIN; P53	In most avianspecies, the early embryo suspends development when the ambient temperature is too low; the resultant dormant state is called cold torpor. However, very little is known about dormant avian embryos at the cellular level. To investigate the molecular processes that occur in the chicken blastoderm during cold torpor, we performed transcriptome analysis and investigated cellular responses in dormant embryos. In embryos stored at low temperature, we observed up-regulation of genes and proteins related to endoplasmic reticulum stress and stress activated protein kinase signaling. In addition, the proportion of early apoptotic cells rose dramatically during torpor, whereas the proportion of late apoptotic cells was unchanged. Cell cycle analysis revealed that mitotic arrest occurred at the G(2) phase in a DNA damage-independent manner and that the arrest was alleviated after incubation at 37 degrees C. Our data suggest that the dormant avian embryo tolerates cold stress by inducing stress-tolerance pathways, inhibiting late apoptosis, and triggering cell cycle arrest at the G(2) phase.	[Ko, Mee Hyun; Hwang, Young Sun; Rim, Jong Seop; Han, Jae Yong] Seoul Natl Univ, Coll Agr & Life Sci, Res Inst Agr & Life Sci, Dept Agr Biotechnol, Seoul, South Korea; [Han, Ho Jae] Seoul Natl Univ, Dept Vet Physiol, Coll Vet Med, Seoul, South Korea; [Han, Jae Yong] Shinshu Univ, Inst Biomed Sci, Minamiminowa, Japan	Seoul National University (SNU); Seoul National University (SNU); Shinshu University	Han, HJ (corresponding author), Seoul Natl Univ, 1 Gwanak Ro, Seoul 08826, South Korea.	jaehan@snu.ac.kr		Ko, Meehyun/0000-0003-4412-5545; Hwang, Young Sun/0000-0002-6443-9579	National Research Foundation of Korea (NRF) [2015R1A3A2033826]; Korean Rural Development Administration [PJ0122362016]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean Rural Development Administration(Rural Development Administration (RDA), Republic of Korea)	This work was supported by National Research Foundation of Korea (NRF) Grant 2015R1A3A2033826 (Ministry of Science, Information and Communication Technology, and Future Planning; MSIP), and the Cooperative Research Program for Agriculture Science and Technology Development (Project PJ0122362016) from the Korean Rural Development Administration. The authors declare no conflicts of interest.	AGARWAL ML, 1995, P NATL ACAD SCI USA, V92, P8493, DOI 10.1073/pnas.92.18.8493; Bloom SE, 1998, CELL DEATH DIFFER, V5, P529, DOI 10.1038/sj.cdd.4400381; Bourougaa K, 2010, MOL CELL, V38, P78, DOI 10.1016/j.molcel.2010.01.041; Boyce M, 2006, CELL DEATH DIFFER, V13, P363, DOI 10.1038/sj.cdd.4401817; Chen YN, 2013, TRENDS CELL BIOL, V23, P547, DOI 10.1016/j.tcb.2013.06.005; Damaghi M, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00370; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Ebrahimi MR, 2012, POULTRY SCI, V91, P2970, DOI 10.3382/ps.2012-02246; Ewert M.A., 1991, P173, DOI 10.1017/CBO9780511585739.012; EYALGILADI H, 1976, DEV BIOL, V49, P321, DOI 10.1016/0012-1606(76)90178-0; Fasenko GM, 2007, POULTRY SCI, V86, P1020, DOI 10.1093/ps/86.5.1020; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Geske FJ, 2001, CELL DEATH DIFFER, V8, P182, DOI 10.1038/sj.cdd.4400786; Hamatani T, 2004, P NATL ACAD SCI USA, V101, P10326, DOI 10.1073/pnas.0402597101; Hans F, 2001, ONCOGENE, V20, P3021, DOI 10.1038/sj.onc.1204326; Hornik TC, 2016, J CELL SCI, V129, P65, DOI 10.1242/jcs.174631; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hwang YS, 2016, SCI REP-UK, V6, DOI 10.1038/srep36704; Kanehisa M, 2016, NUCLEIC ACIDS RES, V44, pD457, DOI 10.1093/nar/gkv1070; KOZUTSUMI Y, 1988, NATURE, V332, P462, DOI 10.1038/332462a0; Kuo LJ, 2008, IN VIVO, V22, P305; Lapao C, 1999, POULTRY SCI, V78, P640, DOI 10.1093/ps/78.5.640; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lobrich M, 2007, NAT REV CANCER, V7, P861, DOI 10.1038/nrc2248; Lopes FL, 2004, REPRODUCTION, V128, P669, DOI 10.1530/rep.1.00444; Marciniak SJ, 2004, GENE DEV, V18, P3066, DOI 10.1101/gad.1250704; MICHALOVITZ D, 1990, CELL, V62, P671, DOI 10.1016/0092-8674(90)90113-S; Mlynarczyk C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6067; MUNRO S, 1986, CELL, V46, P291, DOI 10.1016/0092-8674(86)90746-4; Muscarella DE, 1998, MOL REPROD DEV, V51, P130, DOI 10.1002/(SICI)1098-2795(199810)51:2&lt;130::AID-MRD2&gt;3.0.CO;2-R; Nishitoh H, 2012, J BIOCHEM, V151, P217, DOI 10.1093/jb/mvr143; OWENSCHAUB LB, 1995, MOL CELL BIOL, V15, P3032; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Oyadomari S, 2002, APOPTOSIS, V7, P335, DOI 10.1023/A:1016175429877; Padilla PA, 2012, CELL CYCLE, V11, P1672, DOI 10.4161/cc.19444; Patterson PH, 2008, POULTRY SCI, V87, P1182, DOI 10.3382/ps.2007-00242; Pietsch EC, 2008, ONCOGENE, V27, P6507, DOI 10.1038/onc.2008.315; Podrabsky JE, 2012, CELL CYCLE, V11, P1697, DOI 10.4161/cc.19881; Poon IKH, 2010, CELL DEATH DIFFER, V17, P381, DOI 10.1038/cdd.2009.195; Rieder CL, 2002, CELL CYCLE, V1, P169, DOI 10.4161/cc.1.3.119; Rocha JSR, 2013, WORLD POULTRY SCI J, V69, P35, DOI 10.1017/S0043933913000044; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Srivastava RK, 1999, MOL CELL BIOL, V19, P5659; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43, pD447, DOI 10.1093/nar/gku1003; Tang HL, 2009, BRIT J CANCER, V100, P118, DOI 10.1038/sj.bjc.6604802; Tang HL, 2012, MOL BIOL CELL, V23, P2240, DOI 10.1091/mbc.E11-11-0926; Thornberry NA, 1998, SCIENCE, V281, P1312, DOI 10.1126/science.281.5381.1312; Tournier C, 2000, SCIENCE, V288, P870, DOI 10.1126/science.288.5467.870; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Verma G, 2012, J CELL PHYSIOL, V227, P1791, DOI 10.1002/jcp.22903; Wada T, 2004, ONCOGENE, V23, P2838, DOI 10.1038/sj.onc.1207556; WALSH TJ, 1995, POULTRY SCI, V74, P1403, DOI 10.3382/ps.0741403; Winkler D.W., 1983, Current Ornithology, V1, P33; Xia WL, 2000, P NATL ACAD SCI USA, V97, P7494, DOI 10.1073/pnas.97.13.7494; Yang L, 2010, NAT MED, V16, P535, DOI 10.1038/nm.2144; Zhang Z, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.182; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982	58	6	6	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3240	3250		10.1096/fj.201601051RR	http://dx.doi.org/10.1096/fj.201601051RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28404741				2022-12-28	WOS:000405932400005
J	Chang, GJ; Mouillet, JF; Mishima, T; Chu, TJ; Sadovsky, E; Coyne, CB; Parks, WT; Surti, U; Sadovsky, Y				Chang, Guojing; Mouillet, Jean-Francois; Mishima, Takuya; Chu, Tianjiao; Sadovsky, Elena; Coyne, Carolyn B.; Parks, W. Tony; Surti, Urvashi; Sadovsky, Yoel			Expression and trafficking of placental microRNAs at the feto-maternal interface	FASEB JOURNAL			English	Article						pregnancy; placenta; trophoblasts; C19MC	GENE-EXPRESSION; IN-VIVO; INTERCELLULAR COMMUNICATION; CIRCULATING MICRORNAS; RNA INTERFERENCE; MATERNAL PLASMA; C19MC MICRORNAS; CLUSTER C19MC; LENTIVIRUS; CELLS	During pregnancy, placental trophoblasts at the feto-maternal interface produce a broad repertoire of microRNA (miRNA) species. These species include miRNA from the primate-specific chromosome 19 miRNA cluster (C19MC), which is expressed nearly exclusively in the placenta. Trafficking of these miRNAs among the maternal, placental, and fetal compartments is unknown. To determine miRNA expression and trafficking patterns during pregnancy, we sequenced miRNAs in triads of human placenta and of maternal and fetal blood and found large subject-to-subject variability, with C19MC exhibiting compartment-specific expression. We therefore created humanized mice that transgenically express the entire 160-kb human C19MC locus or lentivirally express C19MC miRNAmembers selectively in the placenta. C19MC transgenic mice expressed a low level of C19MC miRNAs in diverse organs. When pregnant, female C19MC mice exhibited a strikingly elevated(>40-fold) expression of C19MC miRNA in the placenta, compared with other organs, that resembled C19MC miRNAs patterns in humans. Our mouse models showed that placental miRNA traffic primarily to the maternal circulation and that maternal miRNA can traffic to the placenta and even into the fetal compartment. These findings define an extraordinary means of nonhormonal, miRNA-based communication between the placenta and feto-maternal compartments.-Chang, G., Mouillet, J.-F., Mishima, T., Chu, T., Sadovsky, E., Coyne, C.B., Parks, W.T., Surti, U., Sadovsky, Y. Expression and trafficking of placental microRNAs at the feto-maternal interface.	[Chang, Guojing; Mouillet, Jean-Francois; Mishima, Takuya; Chu, Tianjiao; Sadovsky, Elena; Coyne, Carolyn B.; Parks, W. Tony; Surti, Urvashi; Sadovsky, Yoel] Magee Womens Res Inst, 204 Craft Ave, Pittsburgh, PA 15213 USA; [Mouillet, Jean-Francois; Mishima, Takuya; Chu, Tianjiao; Sadovsky, Elena; Coyne, Carolyn B.; Parks, W. Tony; Surti, Urvashi; Sadovsky, Yoel] Univ Pittsburgh, Dept Obstet Gynecol & Reprod Sci, Pittsburgh, PA USA; [Coyne, Carolyn B.; Sadovsky, Yoel] Univ Pittsburgh, Dept Microbiol & Mol Genet, Pittsburgh, PA USA; [Surti, Urvashi] Univ Pittsburgh, Grad Sch Publ Hlth, Dept Human Genet, Pittsburgh, PA 15261 USA; [Parks, W. Tony] Univ Pittsburgh, Dept Pathol, Pittsburgh, PA USA; [Surti, Urvashi] Univ Pittsburgh, Med Ctr, Magee Womens Hosp, Pittsburgh Cytogenet Lab,Ctr Med Genet & Genom, Pittsburgh, PA USA; [Chang, Guojing] Tsinghua Univ, Sch Med, Beijing, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Magee-Womens Research Institute; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Tsinghua University	Sadovsky, Y (corresponding author), Magee Womens Res Inst, 204 Craft Ave, Pittsburgh, PA 15213 USA.	ysadovsky@mwri.magee.edu		Sadovsky, Yoel/0000-0003-2969-6737	University of Pittsburgh-Tsinghua University Education Program; Pennsylvania Department of Health Research Formula Funds; U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01-HD075665, R01-HD065893, R21-HD071707]; 25 Club of Magee Womens Hospital; NIH National Institute of General Medical Sciences [UL1-RR024153]; NIH [UL1-TR000005]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R21HD071707, R01HD065893, R01HD075665] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024153] Funding Source: NIH RePORTER	University of Pittsburgh-Tsinghua University Education Program; Pennsylvania Department of Health Research Formula Funds; U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development; 25 Club of Magee Womens Hospital; NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The authors thank Judy Ziegler for technical assistance, Lori Rideout for assistance in manuscript preparation, and Bruce Campbell for editing (all from Magee Womens Research Institute). This project was supported by the University of Pittsburgh-Tsinghua University Education Program (to G.C.), Pennsylvania Department of Health Research Formula Funds (to J.-F.M and T.C.), U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development (Grant R01-HD075665 to C.B.C. and Y.S., and Grants R01-HD065893 and R21-HD071707 to Y.S.), and the 25 Club of Magee Womens Hospital (to Y.S.). Generation of C19MC BAC was made possible by NIH National Institute of General Medical Sciences Grant UL1-RR024153 and NIH Cooperative Agreement Grant UL1-TR000005. C.C. and Y.S. are named inventors on a pending patent application that describes the use of C19MC microRNAs as therapeutics.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Arroyo JD, 2011, P NATL ACAD SCI USA, V108, P5003, DOI 10.1073/pnas.1019055108; Benirschke K., 2000, PATHOLOGY HUMAN PLAC; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bentwich I, 2005, FASEB J, V19, P875, DOI 10.1096/fj.04-3609hyp; Bentwich I, 2005, NAT GENET, V37, P766, DOI 10.1038/ng1590; Blaydes SM, 1999, MAMM GENOME, V10, P549, DOI 10.1007/s003359901042; Bortolin-Cavaille ML, 2009, NUCLEIC ACIDS RES, V37, P3464, DOI 10.1093/nar/gkp205; Bullerdiek J, 2012, MOL CYTOGENET, V5, DOI 10.1186/1755-8166-5-27; Chandler KJ, 2007, MAMM GENOME, V18, P693, DOI 10.1007/s00335-007-9056-y; Chen X, 2012, TRENDS CELL BIOL, V22, P125, DOI 10.1016/j.tcb.2011.12.001; Chim SSC, 2008, CLIN CHEM, V54, P482, DOI 10.1373/clinchem.2007.097972; Chu TJ, 2015, BIOINFORMATICS, V31, P1780, DOI 10.1093/bioinformatics/btv038; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; Delorme-Axford E, 2013, P NATL ACAD SCI USA, V110, P12048, DOI 10.1073/pnas.1304718110; Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013; Fornari F, 2012, J PATHOL, V227, P275, DOI 10.1002/path.3995; Gabriel JM, 1998, P NATL ACAD SCI USA, V95, P14857, DOI 10.1073/pnas.95.25.14857; Georgiades P, 2007, BIOTECHNIQUES, V42, P317, DOI 10.2144/000112341; Gong SC, 2003, NATURE, V425, P917, DOI 10.1038/nature02033; Hartigan J., 1975, CLUSTERING ALGORITHM; HOLM S, 1979, SCAND J STAT, V6, P65; Hu N, 2011, J BIOL CHEM, V286, P13714, DOI 10.1074/jbc.M110.204131; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; John RM, 1999, HUM MOL GENET, V8, P2211, DOI 10.1093/hmg/8.12.2211; Jones BK, 2002, HUM MOL GENET, V11, P411, DOI 10.1093/hmg/11.4.411; KINGDOM J, 2000, PLACENTA BASIC SCI C; Kleinman CL, 2014, NAT GENET, V46, P39, DOI 10.1038/ng.2849; Koh W, 2014, P NATL ACAD SCI USA, V111, P7361, DOI 10.1073/pnas.1405528111; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Li MH, 2009, CANCER CELL, V16, P533, DOI 10.1016/j.ccr.2009.10.025; Li X, 2011, BIOTECHNOL LETT, V33, P1723, DOI 10.1007/s10529-011-0633-5; Lin S, 2010, COMPUT BIOL CHEM, V34, P232, DOI 10.1016/j.compbiolchem.2010.08.001; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lois C, 2002, SCIENCE, V295, P868, DOI 10.1126/science.1067081; Luo SS, 2009, BIOL REPROD, V81, P717, DOI 10.1095/biolreprod.108.075481; Malashicheva A, 2007, GENESIS, V45, P456, DOI 10.1002/dvg.20313; Matsuda T, 2004, P NATL ACAD SCI USA, V101, P16, DOI 10.1073/pnas.2235688100; Mishima T, 2016, SCI REP-UK, V6, DOI 10.1038/srep33345; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Mittelbrunn M, 2012, NAT REV MOL CELL BIO, V13, P328, DOI 10.1038/nrm3335; Miura K, 2010, CLIN CHEM, V56, P1767, DOI 10.1373/clinchem.2010.147660; Noguer-Dance M, 2010, HUM MOL GENET, V19, P3566, DOI 10.1093/hmg/ddq272; Oh SY, 2011, PLACENTA, V32, P1004, DOI 10.1016/j.placenta.2011.09.010; Okada Y, 2007, NAT BIOTECHNOL, V25, P233, DOI 10.1038/nbt1280; R Core Team, 2018, R LANG ENV STAT COMP; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Reed SE, 2006, J VIROL METHODS, V138, P85, DOI 10.1016/j.jviromet.2006.07.024; Reiser J, 1996, P NATL ACAD SCI USA, V93, P15266, DOI 10.1073/pnas.93.26.15266; Sadovsky Y., 2015, PLACENTA PLACENTAL T, DOI [10.1016/B978-0-12-397175-3.00039-9, DOI 10.1016/B978-0-12-397175-3.00039-9]; Sadovsky Y, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023036; Vaira V, 2012, J MOL ENDOCRINOL, V49, P115, DOI 10.1530/JME-11-0189; Williams Z, 2013, P NATL ACAD SCI USA, V110, P4255, DOI 10.1073/pnas.1214046110; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Wyatt SM, 2005, PLACENTA, V26, P372, DOI 10.1016/j.placenta.2004.07.003; Zhang XY, 2004, J VIROL, V78, P1219, DOI 10.1128/JVI.78.3.1219-1229.2004	56	54	55	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2760	2770		10.1096/fj.201601146R	http://dx.doi.org/10.1096/fj.201601146R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28289056	Green Published			2022-12-28	WOS:000405931000005
J	Rueckert, C; Rand, U; Roy, U; Kasmapour, B; Strowig, T; Guzman, CA				Rueckert, Christine; Rand, Ulfert; Roy, Urmi; Kasmapour, Bahram; Strowig, Till; Guzman, Carlos A.			Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING	FASEB JOURNAL			English	Article						adjuvant; immune response; vaccine development; regulation inflammatory response; pathogen recognition receptor	C-DI-GMP; BETA INTERFERON; DNA SENSOR; KAPPA-B; AMP; 2ND-MESSENGER; ACTIVATION; CGAS; TBK1; PHOSPHORYLATION	The cyclic dinucleotides, GMP AMP (cGAMP) and c-di-AMP [bis-(3',5')-cyclic dimeric AMP], are potent type I IFN inducers via STING-TBK1-IRF3 cascade. They are promising adjuvants that promote antigen-specific humoral and cellular immune responses in different preclinical models; however, an optimal outcome of vaccination depends on a balanced immune activation. Here, we characterize the process of IFN-beta induction by c-di-AMP and cGAMP in an in vitro model on the basis of primary mouse dendritic cells. Results obtained show decreased IFN-beta production upon prolonged cell stimulation. We demonstrate that this effect depends on c-di-AMP/cGAMP-mediated down-regulation of stimulator of IFN gene (STING) protein levels. These results were confirmed by using human peripheral blood mononuclear cell derived dendritic cells. Studies performed to explore the potential mechanism of STING modulation suggested proteolytic degradation to be a contributing factor to the observed decrease in cellular STING levels. Our work contributes to the elucidation of the molecular mode of action of vaccine constituents, which, in turn, is a prerequisite for the rational design of vaccines with predictable efficacy and safety profiles Rueckert, C., Rand, U., Roy, U., Kasmapour, B., Strowig, T., Guzman, C. A. Cyclic dinucleotides modulate induced type I IFN responses in innate immune cells by degradation of STING.	[Rueckert, Christine; Guzman, Carlos A.] Helmholtz Ctr Infect Res, Vaccinol Res Grp, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Rand, Ulfert; Kasmapour, Bahram] Helmholtz Ctr Infect Res, Immune Aging & Chron Infect Res Grp, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Roy, Urmi; Strowig, Till] Helmholtz Ctr Infect Res, Microbial Immune Regulat Res Grp, Dept Vaccinol & Appl Microbiol, Braunschweig, Germany; [Rueckert, Christine] CureVac AG, Tubingen, Germany	Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; Helmholtz Association; Helmholtz-Center for Infection Research; CureVac N.V.	Guzman, CA (corresponding author), Helmholtz Ctr Infect Res, Dept Vaccinol & Appl Microbiol, Inhoffenstr 7, D-38124 Braunschweig, Germany.	carlos.guzman@helmholtz-hzi.de		Strowig, Till/0000-0003-0185-1459	German Research Foundation (DFG) [RA 2377/2-1]; European Union (UniVax) [601738]; Helmholtz Association (HAI-IDR) [SO-073]	German Research Foundation (DFG)(German Research Foundation (DFG)); European Union (UniVax); Helmholtz Association (HAI-IDR)	The authors thank Ulrich Kalinke (Twincore, Hannover, Germany) for providing IFNR<SUP>-/-</SUP> mice, Elena Reinhard for excellent technical assistance, Ivana Skrnjug for handling IFNR<SUP>-/-</SUP> mice, and Blair Prochnow (all from Hemholtz Centre for Infection Research) for critically reading the manuscript. This work was supported, in part, by the German Research Foundation (DFG; Grant RA 2377/2-1), European Union (UniVax; Grant 601738), and the Helmholtz Association (HAI-IDR; Grant SO-073). C.A.G. is named as inventor in a patent application covering the use of c-di-AMP as adjuvant (PCT/EP 2006010693)	Ablasser A, 2013, NATURE, V498, P380, DOI 10.1038/nature12306; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Burchill MA, 2003, INFECT IMMUN, V71, P3437, DOI 10.1128/IAI.71.6.3437-3442.2003; Burdette DL, 2011, NATURE, V478, P515, DOI 10.1038/nature10429; Chen LH, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004301; Chen ZH, 2012, NATURE, V488, P680, DOI 10.1038/nature11313; Clark K, 2009, J BIOL CHEM, V284, P14136, DOI 10.1074/jbc.M109.000414; Conlon J, 2013, J IMMUNOL, V190, P5216, DOI 10.4049/jimmunol.1300097; Corrales L, 2015, CELL REP, V11, P1018, DOI 10.1016/j.celrep.2015.04.031; Diner EJ, 2013, CELL REP, V3, P1355, DOI 10.1016/j.celrep.2013.05.009; Ebensen T, 2011, VACCINE, V29, P5210, DOI 10.1016/j.vaccine.2011.05.026; Fu J, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aaa4306; Gao P, 2013, CELL, V153, P1094, DOI 10.1016/j.cell.2013.04.046; Gonzalez-Navajas JM, 2012, NAT REV IMMUNOL, V12, P125, DOI 10.1038/nri3133; Gray EE, 2015, J IMMUNOL, V195, P1939, DOI 10.4049/jimmunol.1500969; Jin L, 2011, J IMMUNOL, V187, P2595, DOI 10.4049/jimmunol.1100088; Karaolis DKR, 2007, INFECT IMMUN, V75, P4942, DOI 10.1128/IAI.01762-06; Karaolis DKR, 2007, J IMMUNOL, V178, P2171, DOI 10.4049/jimmunol.178.4.2171; Karaolis DKR, 2005, ANTIMICROB AGENTS CH, V49, P1029, DOI 10.1128/AAC.49.3.1029-1038.2005; Konno H, 2013, CELL, V155, P688, DOI 10.1016/j.cell.2013.09.049; Lee DH, 1998, TRENDS CELL BIOL, V8, P397, DOI 10.1016/S0962-8924(98)01346-4; Libanova R, 2010, VACCINE, V28, P2249, DOI 10.1016/j.vaccine.2009.12.045; Liu SQ, 2015, SCIENCE, V347, P1217, DOI 10.1126/science.aaa2630; McWhirter SM, 2009, J EXP MED, V206, P1899, DOI 10.1084/jem.20082874; Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x; MULLER U, 1994, SCIENCE, V264, P1918, DOI 10.1126/science.8009221; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Reilly SM, 2013, NAT MED, V19, P313, DOI 10.1038/nm.3082; Rueckert C, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003001; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schwartz KT, 2012, INFECT IMMUN, V80, P1537, DOI 10.1128/IAI.06286-11; Skrnjug I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110150; Skrnjug I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095728; Stockinger S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000355; Sun LJ, 2013, SCIENCE, V339, P786, DOI 10.1126/science.1232458; Tsuchida T, 2010, IMMUNITY, V33, P765, DOI 10.1016/j.immuni.2010.10.013; Wang Q, 2014, IMMUNITY, V41, P919, DOI 10.1016/j.immuni.2014.11.011; Wang YM, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005012; Woodward JJ, 2010, SCIENCE, V328, P1703, DOI 10.1126/science.1189801; Wu JX, 2013, SCIENCE, V339, P826, DOI 10.1126/science.1229963; Yamamoto T, 2012, INFECT IMMUN, V80, P2323, DOI 10.1128/IAI.06162-11; Yi GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077846; Zhong B, 2009, IMMUNITY, V30, P397, DOI 10.1016/j.immuni.2009.01.008	43	12	13	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3107	3115		10.1096/fj.201601093R	http://dx.doi.org/10.1096/fj.201601093R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28396343				2022-12-28	WOS:000405931000034
J	Bhave, S; Gade, A; Kang, M; Hauser, KF; Dewey, WL; Akbarali, HI				Bhave, Sukhada; Gade, Aravind; Kang, Minho; Hauser, Kurt F.; Dewey, William L.; Akbarali, Hamid I.			Connexin-purinergic signaling in enteric glia mediates the prolonged effect of morphine on constipation	FASEB JOURNAL			English	Article						ATP; lipopolysaccharide; inflammation; electrophysiology	MU-OPIOID RECEPTOR; GUINEA-PIG ILEUM; EXPERIMENTAL COLITIS; NERVOUS-SYSTEM; TOLERANCE; RAT; ROLES; CELLS; P2X7; MICE	Morphine is one of the most widely used drugs for the treatment of pain. However, side effects, including persistent constipation and antinociceptive tolerance, limit its clinical efficacy. Prolonged morphine treatment results in a "leaky" gut, predisposing to colonic inflammation that is facilitated by microbial dysbiosis and associated bacterial translocation. In this study, we examined the role of enteric glia in mediating this secondary inflammatory response to prolonged treatment with morphine. We found that purinergic P2X receptor activity was significantly enhanced in enteric glia that were isolated from mice with long-term morphine treatment (in vivo) but not upon direct exposure of glia to morphine (in vitro). LPS, a major bacterial product, also increased ATP-induced currents, as well as expression of P2X4, P2X7, IL6, IL-1 beta mRNA in enteric glia. LPS increased connexin43 (Cx43) expression and enhanced ATP release from enteric glia cells. LPS-induced P2X currents and proinflammatory cytokine mRNA expression were blocked by the Cx43 blockers Gap26 and carbenoxolone. Likewise, colonic inflammation related to prolonged exposure to morphine was significantly attenuated by carbenoxolone (25mg/kg). Carbenoxolone also prevented gut wall disruption and significantly reduced morphine-induced constipation. These findings imply that enteric glia activation is a significant modulator of morphine-related inflammation and constipation.	[Bhave, Sukhada; Gade, Aravind; Kang, Minho; Hauser, Kurt F.; Dewey, William L.; Akbarali, Hamid I.] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, 1112 E Clay St,McGuire Hall 100D, Richmond, VA 23298 USA	Virginia Commonwealth University	Akbarali, HI (corresponding author), Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, 1112 E Clay St,McGuire Hall 100D, Richmond, VA 23298 USA.	hamid.akbarali@vcuhealth.org	Bhave, Sukhada/ABC-4954-2020; BHAVE, SUKHADA/AAM-3518-2020; Hauser, Kurt/AAX-8361-2020; Akbarali, Hamid/Q-9344-2019	Hauser, Kurt/0000-0001-7886-0332	U S. National Institutes of Health (NIH) National Institute on Drug Abuse [DA024009, DA036975]; NIH [P30033934]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024009, K02DA027374, R01DA036975, P30DA033934] Funding Source: NIH RePORTER	U S. National Institutes of Health (NIH) National Institute on Drug Abuse; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank David Stevens for technical assistance and Ryan Mischel, Charity Huang, and Aliyeen Khan (all from the Virginia Commonwealth University) for support with the double-blind studies. This study was supported by the U S. National Institutes of Health (NIH) National Institute on Drug Abuse Grants DA024009 (to H.I.A. and W.L.D.) and DA036975 (to H.I.A. and W.L.D.), and NIH Research Programs and Projects/Centers Grant P30033934 (to W.L.D.). The authors declare no conflicts of interest.	Antonioli L, 2013, PHARMACOL THERAPEUT, V139, P157, DOI 10.1016/j.pharmthera.2013.04.002; Aube AC, 2006, GUT, V55, P630, DOI 10.1136/gut.2005.067595; Bassotti G, 2006, HUM PATHOL, V37, P1252, DOI 10.1016/j.humpath.2006.04.027; Boesmans W, 2013, NEUROGASTROENT MOTIL, V25, pE151, DOI 10.1111/nmo.12065; Brookes SJH, 2001, ANAT RECORD, V262, P58; BROUSSARD DL, 1993, J NEUROSCI RES, V34, P24, DOI 10.1002/jnr.490340104; Brown IAM, 2016, CELL MOL GASTROENTER, V2, P77, DOI 10.1016/j.jcmgh.2015.08.007; Connors BW, 2012, EPILEPSY CURR, V12, P66, DOI 10.5698/1535-7511-12.2.66; Corder G, 2017, NAT MED, V23, P164, DOI 10.1038/nm.4262; Dbouk HA, 2009, CELL COMMUN SIGNAL, V7, DOI 10.1186/1478-811X-7-4; Diezmos EF, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00311; Guedia J, 2016, SCI REP-UK, V6, DOI 10.1038/srep31203; Gulbransen BD, 2012, NAT REV GASTRO HEPAT, V9, P625, DOI 10.1038/nrgastro.2012.138; Gulbransen BD, 2012, NAT MED, V18, P600, DOI 10.1038/nm.2679; Gulbransen BD, 2009, GASTROENTEROLOGY, V136, P1349, DOI 10.1053/j.gastro.2008.12.058; Guzman J, 2006, INFLAMM BOWEL DIS, V12, P766, DOI 10.1097/00054725-200608000-00014; Hanani M, 2000, AM J PHYSIOL-GASTR L, V278, pG644, DOI 10.1152/ajpgi.2000.278.4.G644; Hilburger ME, 1997, J INFECT DIS, V176, P183, DOI 10.1086/514021; Hutchinson Mark R, 2007, ScientificWorldJournal, V7, P98; Kang M, 2017, SCI REP-UK, V7, DOI 10.1038/srep42658; Kumar L, 2014, GASTROENT RES PRACT, V2014, DOI 10.1155/2014/141737; Maguma HT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103894; Marques CC, 2014, BBA-MOL BASIS DIS, V1842, P65, DOI 10.1016/j.bbadis.2013.10.012; McClain JL, 2014, GASTROENTEROLOGY, V146, P497, DOI 10.1053/j.gastro.2013.10.061; Meng JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054040; NORTH RA, 1977, BRIT J PHARMACOL, V61, P541, DOI 10.1111/j.1476-5381.1977.tb07546.x; Pappagallo M, 2001, AM J SURG, V182, p11S, DOI 10.1016/S0002-9610(01)00782-6; PATON WDM, 1957, BRIT J PHARM CHEMOTH, V12, P119, DOI 10.1111/j.1476-5381.1957.tb01373.x; PATRICK GA, 1978, J PHARMACOL EXP THER, V205, P556; Roberts JA, 2012, CURR OPIN PHARMACOL, V12, P659, DOI 10.1016/j.coph.2012.09.011; Rosenbaum C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151335; Ross GR, 2008, J PHARMACOL EXP THER, V327, P561, DOI 10.1124/jpet.108.143438; Roy S, 1998, MOL BRAIN RES, V61, P190, DOI 10.1016/S0169-328X(98)00212-5; Ruhl A, 2001, NEUROGASTROENT MOTIL, V13, P95, DOI 10.1046/j.1365-2982.2001.00246.x; RUNKEL NSF, 1993, DIGEST DIS SCI, V38, P1530, DOI 10.1007/BF01308616; Ruzicka BB, 1995, MOL BRAIN RES, V34, P209, DOI 10.1016/0169-328X(95)00165-O; Sharkey KA, 2015, J CLIN INVEST, V125, P918, DOI 10.1172/JCI76303; Smith TH., 2013, J VIS EXP, V78, P50688; Turchan-Cholewo J, 2008, J NEUROSCI RES, V86, P2100, DOI 10.1002/jnr.21653; Van Crombruggen K, 2007, NEUROPHARMACOLOGY, V53, P257, DOI 10.1016/j.neuropharm.2007.05.010; Vanderwinden JM, 2003, CELL TISSUE RES, V312, P149, DOI 10.1007/s00441-003-0716-2; Wang XH, 2012, P NATL ACAD SCI USA, V109, P6325, DOI 10.1073/pnas.1200130109	42	30	30	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2649	2660		10.1096/fj.201601068R	http://dx.doi.org/10.1096/fj.201601068R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28280004	Green Published			2022-12-28	WOS:000401553400035
J	Chen, HZ; Bai, JL; Dong, F; Fang, HZ; Zhang, Y; Meng, W; Liu, BL; Luo, Y; Liu, ML; Bai, YD; Abdul-Ghani, MA; Li, RX; Wu, JR; Zeng, R; Zhou, ZG; Dong, LQ; Liu, F				Chen, Hongzhi; Bai, Juli; Dong, Feng; Fang, Hezhi; Zhang, Yun; Meng, Wen; Liu, Bilian; Luo, Yan; Liu, Meilian; Bai, Yidong; Abdul-Ghani, Muhammad A.; Li, Rongxia; Wu, Jiarui; Zeng, Rong; Zhou, Zhiguang; Dong, Lily Q.; Liu, Feng			Hepatic DsbA-L protects mice from diet-induced hepatosteatosis and insulin resistance	FASEB JOURNAL			English	Article						NAFLD; mitochondria; oxidative stress	GLUTATHIONE-S-TRANSFERASE; HIGH-FAT DIET; ADIPONECTIN DOWN-REGULATION; KINASE SIGNALING PATHWAYS; OXIDATIVE STRESS; CLASS-KAPPA; NONALCOHOLIC STEATOHEPATITIS; LIVER-DISEASE; MITOCHONDRIA; LOCALIZATION	Hepatic insulin resistance and hepatosteatosis in diet-induced obesity are associated with various metabolic diseases, yet the underlying mechanisms remain to be fully elucidated. Here we show that the expression levels of the disulfide-bond A oxidoreductase-like protein (DsbA-L) are significantly reduced in the liver of obese mice and humans. Liver-specific knockout or adenovirus-mediated overexpression of DsbA-Lexacerbates or alleviates, respectively, high-fat diet-induced mitochondrial dysfunction, hepatosteatosis, and insulin resistance in mice. Mechanistically, we found that DsbA-L is localized in mitochondria and that its deficiency is associated with impairment of maximum respiratory capacity, elevated cellular oxidative stress, and increased JNK activity. Our results identify DsbA-Las a critical regulator of mitochondrial function, and its down-regulation in the liver may contribute to obesity-induced hepatosteatosis and whole body insulin resistance.	[Chen, Hongzhi; Bai, Juli; Zhang, Yun; Meng, Wen; Liu, Bilian; Luo, Yan; Liu, Meilian; Zhou, Zhiguang; Liu, Feng] Cent S Univ, Xiangya Hosp 2,Minist Educ, Dept Metab & Endocrinol,Natl Clin Res Ctr Metab D, Metab Syndrome Res Ctr,Key Lab Diabet Immunol, Changsha, Hunan, Peoples R China; [Chen, Hongzhi; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Bai, Juli; Liu, Feng] Univ Texas Hlth Sci Ctr San Antonio, Dept Pharmacol, San Antonio, TX 78229 USA; [Dong, Feng; Abdul-Ghani, Muhammad A.] Univ Texas Hlth Sci Ctr San Antonio, Dept Med, San Antonio, TX 78229 USA; [Fang, Hezhi; Bai, Yidong; Dong, Lily Q.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, San Antonio, TX 78229 USA; [Liu, Meilian] Univ New Mexico, Hlth Sci Ctr, Dept Biochem & Mol Biol, Albuquerque, NM 87131 USA; [Li, Rongxia; Wu, Jiarui; Zeng, Rong] Chinese Acad Sci, Shanghai Inst Biol Sci, Key Lab Syst Biol, Shanghai, Peoples R China	Central South University; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of New Mexico; University of New Mexico's Health Sciences Center; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Liu, F (corresponding author), Cent S Univ, Xiangya Hosp 2,Minist Educ, Dept Metab & Endocrinol,Natl Clin Res Ctr Metab D, Metab Syndrome Res Ctr,Key Lab Diabet Immunol, Changsha, Hunan, Peoples R China.	liuf@uthscsa.edu	Liu, Feng/CAG-8962-2022; Bai, Juli/AAR-8235-2020; Bai, Juli/AAY-1770-2020; Bai, Yidong/A-4959-2012	Bai, Juli/0000-0002-1193-8155; Zhou, Zhiguang/0000-0002-0374-1838; Chen, Hongzhi/0000-0001-6060-3776	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [DK76902, DK102965]; National Basic Research Program of China [2014CB910501]; Translational Science Training Across Disciplines program at the University of Texas Health Science Center at San Antonio; University of Texas System Graduate Programs Initiative; Owens Medical Research Foundation; National Nature Science Foundation of China [81500621]; American Heart Association [11PRE7970021]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK102965, R01DK076902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM109434] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); National Basic Research Program of China(National Basic Research Program of China); Translational Science Training Across Disciplines program at the University of Texas Health Science Center at San Antonio; University of Texas System Graduate Programs Initiative; Owens Medical Research Foundation; National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors appreciate helpful discussion with B. Fromenty (Universite de Rennes, Rennes, France) and acknowledge the help of H. Zhang and P. Zhou (Second Xiangya Hospital) for technical support. This work was supported, in part, by the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Grants DK76902 to F.L. and DK102965 to L.Q.D.), the National Basic Research Program of China (Grant 2014CB910501 to F. L.), and the National Nature Science Foundation of China (Grant 81500621 to H.Z.C.). H.Z.C. was supported by a predoctoral fellowship from the American Heart Association (11PRE7970021) and a fellowship from the Translational Science Training Across Disciplines program at the University of Texas Health Science Center at San Antonio, with funding provided by the University of Texas System Graduate Programs Initiative. Y.D.B. was supported by the Owens Medical Research Foundation.	Abdul-Ghani MA, 2009, DIABETOLOGIA, V52, P574, DOI 10.1007/s00125-009-1264-4; Abu-Elheiga L, 2000, P NATL ACAD SCI USA, V97, P1444, DOI 10.1073/pnas.97.4.1444; Benard O, 2016, J NUTR BIOCHEM, V31, P10, DOI 10.1016/j.jnutbio.2015.12.012; Blair AS, 1999, J BIOL CHEM, V274, P36293, DOI 10.1074/jbc.274.51.36293; Clerk A, 1998, J BIOL CHEM, V273, P7228, DOI 10.1074/jbc.273.13.7228; Fernandez-Vizarra E, 2010, MITOCHONDRION, V10, P253, DOI 10.1016/j.mito.2009.12.148; Fisher-Wellman KH, 2012, TRENDS ENDOCRIN MET, V23, P142, DOI 10.1016/j.tem.2011.12.008; Garcia-Ruiz I, 2014, DIS MODEL MECH, V7, P1287, DOI 10.1242/dmm.016766; Glick D, 2012, MOL CELL BIOL, V32, P2570, DOI 10.1128/MCB.00167-12; HARRIS JM, 1991, BIOCHEM J, V278, P137, DOI 10.1042/bj2780137; Hu F, 2011, CELL SIGNAL, V23, P1528, DOI 10.1016/j.cellsig.2011.05.008; Ladner JE, 2004, BIOCHEMISTRY-US, V43, P352, DOI 10.1021/bi035832z; Liu ML, 2015, J BIOL CHEM, V290, P10143, DOI 10.1074/jbc.M115.645416; Liu ML, 2012, DIABETES, V61, P2776, DOI 10.2337/db12-0169; Liu M, 2008, P NATL ACAD SCI USA, V105, P18302, DOI 10.1073/pnas.0806341105; Mao XM, 2006, NAT CELL BIOL, V8, P516, DOI 10.1038/ncb1404; Matsuzawa-Nagata N, 2008, METABOLISM, V57, P1071, DOI 10.1016/j.metabol.2008.03.010; Milic S, 2012, DIGEST DIS, V30, P158, DOI 10.1159/000336669; Montgomery MK, 2015, ENDOCR CONNECT, V4, DOI 10.1530/EC-14-0092; Nakamura S, 2009, J BIOL CHEM, V284, P14809, DOI 10.1074/jbc.M901488200; Nassir F, 2014, INT J MOL SCI, V15, P8713, DOI 10.3390/ijms15058713; Newberry EP, 2003, J BIOL CHEM, V278, P51664, DOI 10.1074/jbc.M309377200; Nishikawa T, 2007, DIABETES RES CLIN PR, V77, pS161, DOI 10.1016/j.diabres.2007.01.071; Pemble SE, 1996, BIOCHEM J, V319, P749, DOI 10.1042/bj3190749; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Raza H, 2011, FEBS J, V278, P4243, DOI 10.1111/j.1742-4658.2011.08358.x; Rother KI, 1998, J BIOL CHEM, V273, P17491, DOI 10.1074/jbc.273.28.17491; Ryu JY, 2014, CELL REP, V7, P1227, DOI 10.1016/j.celrep.2014.04.006; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Seki E, 2012, GASTROENTEROLOGY, V143, P307, DOI 10.1053/j.gastro.2012.06.004; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Tarantino G, 2010, WORLD J GASTROENTERO, V16, P4773, DOI 10.3748/wjg.v16.i38.4773; Thomson RE, 2004, J HISTOCHEM CYTOCHEM, V52, P653, DOI 10.1177/002215540405200509; Vernochet C, 2012, AGING-US, V4, P859, DOI 10.18632/aging.100518; Vial G, 2011, J HEPATOL, V54, P348, DOI 10.1016/j.jhep.2010.06.044; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Zhou LJ, 2010, DIABETES, V59, P2809, DOI 10.2337/db10-0412	37	17	17	1	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2314	2326		10.1096/fj.201600985R	http://dx.doi.org/10.1096/fj.201600985R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28232481	Green Published			2022-12-28	WOS:000401553400009
J	Jonscher, KR; Stewart, MS; Alfonso-Garcia, A; DeFelice, BC; Wang, XXX; Luo, YH; Levi, M; Heerwagen, MJR; Janssen, RC; de la Houssaye, BA; Wiitala, E; Florey, G; Jonscher, RL; Potma, EO; Fiehn, O; Friedman, JE				Jonscher, Karen R.; Stewart, Michael S.; Alfonso-Garcia, Alba; DeFelice, Brian C.; Wang, Xiaoxin X.; Luo, Yuhuan; Levi, Moshe; Heerwagen, Margaret J. R.; Janssen, Rachel C.; de la Houssaye, Becky A.; Wiitala, Ellen; Florey, Garrett; Jonscher, Raleigh L.; Potma, Eric O.; Fiehn, Oliver; Friedman, Jacob E.			Early PQQ supplementation has persistent long-term protective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice	FASEB JOURNAL			English	Article						antioxidant; PGC-1 alpha; ceramide; lipidomics; CARS	PYRROLOQUINOLINE QUINONE DISODIUM; FATTY LIVER-DISEASE; DIET-INDUCED OBESITY; MITOCHONDRIAL DYSFUNCTION; LIPID-ACCUMULATION; INSULIN-RESISTANCE; MASS-SPECTROMETRY; MATERNAL OBESITY; OXIDATIVE STRESS; KAPPA-B	Nonalcoholic fatty liver disease (NAFLD) is widespread in adults and children. Early exposure to maternal obesity or Western-style diet (WD) increases steatosis and oxidative stress in fetal liver and is associated with lifetime disease risk in the offspring. Pyrroloquinoline quinone (PQQ) is a natural antioxidant found in soil, enriched in human breast milk, and essential for development in mammals. We investigated whether a supplemental dose of PQQ, provided prenatally in amousemodel of diet-induced obesity during pregnancy, could protect obese offspring from progression of NAFLD. PQQ treatment given pre-and postnatally in WD-fed offspring had no effect on weight gain but increased metabolic flexibility while reducing body fat and liver lipids, compared with untreated obese offspring. Indices of NAFLD, including hepatic ceramide levels, oxidative stress, and expression of proinflammatory genes (Nos2, Nlrp3, Il6, and Ptgs2), were decreased in WD PQQ-fed mice, concomitant with increased expression of fatty acid oxidation genes and decreased Pparg expression. Notably, these changes persisted even after PQQ withdrawal at weaning. Our results suggest that supplementation with PQQ, particularly during pregnancy and lactation, protects offspring from WD-induced developmental programming of hepatic lipotoxicity and may help slow the advancing epidemic of NAFLD in the next generation.-Jonscher, K. R., Stewart, M. S., Alfonso-Garcia, A., DeFelice, B. C., Wang, X. X., Luo, Y., Levi, M., Heerwagen, M. J. R., Janssen, R. C., de laHoussaye, B. A., Wiitala, E., Florey, G., Jonscher, R. L., Potma, E. O., Fiehn, O. Friedman, J. E. Early PQQ supplementation has persistent long-termprotective effects on developmental programming of hepatic lipotoxicity and inflammation in obese mice. FASEB J. 31, 1434-1448 (2017). www.fasebj.org	[Jonscher, Karen R.] Univ Colorado, Dept Anesthesiol, Anschutz Med Campus, Aurora, CO USA; [Stewart, Michael S.; Heerwagen, Margaret J. R.; Janssen, Rachel C.; de la Houssaye, Becky A.; Wiitala, Ellen; Friedman, Jacob E.] Univ Colorado, Dept Pediat, Anschutz Med Campus, Aurora, CO USA; [Wang, Xiaoxin X.; Luo, Yuhuan; Levi, Moshe] Univ Colorado, Div Renal Dis & Hypertens, Dept Med, Anschutz Med Campus, Aurora, CO USA; [Alfonso-Garcia, Alba; Potma, Eric O.] Univ Calif Irvine, Beckman Laser Inst, Irvine, CA USA; [Potma, Eric O.] Univ Calif Irvine, Dept Biomed Engn, Irvine, CA USA; [DeFelice, Brian C.; Fiehn, Oliver] Univ Calif Davis, West Coast Metabol Ctr, Davis, CA 95616 USA; [Florey, Garrett; Jonscher, Raleigh L.] Univ Colorado, Dept Integrat Biol, Denver, CO 80202 USA; [Fiehn, Oliver] King Abdulaziz Univ, Biochem Dept, Jeddah, Saudi Arabia	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Davis; University of Colorado System; University of Colorado Denver; King Abdulaziz University	Jonscher, KR (corresponding author), Univ Colorado, Anschutz Med Campus,12801 E 17th Ave,MS 8016, Aurora, CO 80045 USA.	jonscher@ucdenver.edu		DeFelice, Brian/0000-0001-8243-0300; Alfonso-Garcia, Alba/0000-0002-6748-3751	U.S. National Institutes of Health (NIH)/National Center for Advancing Translational Science Colorado County Technical Services, University of Colorado Anschutz Medical Campus [UL1 TR001082]; Research Center Metabolic Phenotyping Core [NIH P30 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [DK48520, NIH P50]; National Institute of Child Health and Human Development [HD073063]; NIH NIDDK [R01 DK104351, U24 DK097154, 5R01DK098336, K25DK098615]; NIH National Institute of General Medical Sciences [S10RR031630]; NIH NIGMS [P41-RR01192]; Virtual, Augmented and Mixed Reality [1I01BX001954]; Mitsubishi Gas and Chemical Company; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P50HD073063] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031630, P41RR001192] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P41EB015890] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K25DK098615, P30DK048520, R24DK090964, U24DK097154, P30DK020593, R01DK104351, R01DK098336] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001954] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/National Center for Advancing Translational Science Colorado County Technical Services, University of Colorado Anschutz Medical Campus; Research Center Metabolic Phenotyping Core [NIH P30 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Virtual, Augmented and Mixed Reality; Mitsubishi Gas and Chemical Company; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	The authors thank Dr. Robert Rucker (University of California, Davis) for invaluable mentorship of K.R.J. and helpful discussions; Greg Glazner and Radu Moldovan [Advanced Light Microscopy Core Facility, U.S. National Institutes of Health (NIH)/National Center for Advancing Translational Science Colorado County Technical Services, University of Colorado Anschutz Medical Campus; Grant UL1 TR001082] for help with the CARS analysis; Matt Jackman and the Nutrition Obesity Research Center Metabolic Phenotyping Core [NIH P30 National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant DK48520 and NIH P50 and National Institute of Child Health and Human Development Grant HD073063, University of Colorado Anschutz Medical Campus] for aid with processing data from the metabolic chamber. Funding was received through NIH NIDDK Grant R01 DK104351 (to O.F., which provided funds for B.C.D.); NIH NIDDK Grant U24 DK097154, and the QTOF mass spectrometer was funded by NIH National Institute of General Medical Sciences Grant S10RR031630 (to O.F.); NIH NIGMS Grant P41-RR01192 (Laser Microbeam and Medical Program) (to A.A.G. and E.O.P.); NIH NIDDK Grant 5R01DK098336 and Virtual, Augmented and Mixed Reality Grant 1I01BX001954 (to X.X.W., Y.L., and M.L.); and NIH NIDDK Grant K25DK098615 and an unrestricted grant from the Mitsubishi Gas and Chemical Company (to K.R.J.) The authors declare no conflicts of interest.	Akagawa M, 2016, SCI REP-UK, V6, DOI 10.1038/srep26723; Akagawa M, 2016, BIOSCI BIOTECH BIOCH, V80, P13, DOI 10.1080/09168451.2015.1062715; Apostolopoulou M, 2016, DIABETOLOGIA, V59, P2203, DOI 10.1007/s00125-016-4038-9; Armstrong MJ, 2014, HEPATOLOGY, V59, P1174, DOI 10.1002/hep.26717; Bachmanov AA, 2002, BEHAV GENET, V32, P435, DOI 10.1023/A:1020884312053; Bauerly K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021779; Bikman BT, 2012, CELL MOL LIFE SCI, V69, P2135, DOI 10.1007/s00018-012-0917-5; Bruce KD, 2009, HEPATOLOGY, V50, P1796, DOI 10.1002/hep.23205; Brumbaugh DE, 2013, J PEDIATR-US, V162, P930, DOI 10.1016/j.jpeds.2012.11.017; Cerda S, 1997, MUTAT RES-REV MUTAT, V386, P141, DOI 10.1016/S1383-5742(96)00050-6; Chavez JA, 2014, J BIOL CHEM, V289, P723, DOI 10.1074/jbc.M113.522847; Chowanadisai W, 2010, J BIOL CHEM, V285, P142, DOI 10.1074/jbc.M109.030130; Giles ED, 2010, AM J PHYSIOL-REG I, V299, pR1634, DOI 10.1152/ajpregu.00219.2010; Harris CB, 2013, J NUTR BIOCHEM, V24, P2076, DOI 10.1016/j.jnutbio.2013.07.008; Hassanin A, 2014, EXP THER MED, V8, P1551, DOI 10.3892/etm.2014.1963; Hausler N, 2006, BIOCHEM J, V394, P465, DOI 10.1042/BJ20051174; Heerwagen MJR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067791; HERRERA PL, 1991, DEVELOPMENT, V113, P1257; Hitchler MJ, 2007, FREE RADICAL BIO MED, V43, P1023, DOI 10.1016/j.freeradbiomed.2007.06.027; Igosheva N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010074; Itoh Y, 2016, ADV EXP MED BIOL, V876, P319, DOI 10.1007/978-1-4939-3023-4_40; Iwakiri Y, 2015, CLIN MOL HEPATOL, V21, P319, DOI 10.3350/cmh.2015.21.4.319; Jackman MR, 2008, AM J PHYSIOL-REG I, V294, pR1117, DOI 10.1152/ajpregu.00808.2007; Jia DW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121939; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; KILLGORE J, 1989, SCIENCE, V245, P850, DOI 10.1126/science.2549636; Kind T, 2013, NAT METHODS, V10, P755, DOI 10.1038/nmeth.2551; Kumar N, 2015, CHEM-BIOL INTERACT, V240, P278, DOI 10.1016/j.cbi.2015.08.027; Lane M, 2015, TRENDS ENDOCRIN MET, V26, P84, DOI 10.1016/j.tem.2014.11.005; Lillycrop KA, 2008, BRIT J NUTR, V100, P278, DOI 10.1017/S0007114507894438; Lim RS, 2010, J LIPID RES, V51, P1729, DOI 10.1194/jlr.M003616; Liu WS, 2016, CELL MOL LIFE SCI, V73, P1969, DOI 10.1007/s00018-016-2161-x; Liu ZB, 2016, INFLAMMATION, V39, P248, DOI 10.1007/s10753-015-0245-7; Luo T, 2014, LIPIDS, V49, P495, DOI 10.1007/s11745-014-3889-4; Lytle KA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146942; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; MacLean PS, 2004, AM J PHYSIOL-REG I, V287, pR288, DOI 10.1152/ajpregu.00010.2004; Matyash V, 2008, J LIPID RES, V49, P1137, DOI 10.1194/jlr.D700041-JLR200; McCurdy CE, 2009, J CLIN INVEST, V119, P323, DOI 10.1172/JCI32661; Medina-Gomez G, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030064; Mitchell AE, 1999, ANAL BIOCHEM, V269, P317, DOI 10.1006/abio.1999.4039; Mouralidarane A, 2013, HEPATOLOGY, V58, P128, DOI 10.1002/hep.26248; Nakano M, 2015, J NUTR SCI VITAMINOL, V61, P241, DOI 10.3177/jnsv.61.241; Nakano M, 2015, J NUTR SCI VITAMINOL, V61, P233, DOI 10.3177/jnsv.61.233; Nakano M, 2013, REGUL TOXICOL PHARM, V67, P189, DOI 10.1016/j.yrtph.2013.07.007; Oben JA, 2010, J HEPATOL, V52, P913, DOI 10.1016/j.jhep.2009.12.042; Odkhuu E, 2012, IMMUNOL LETT, V142, P34, DOI 10.1016/j.imlet.2011.12.001; Pagadala M, 2012, TRENDS ENDOCRIN MET, V23, P365, DOI 10.1016/j.tem.2012.04.005; Perrone Serafina, 2016, World J Clin Pediatr, V5, P172, DOI 10.5409/wjcp.v5.i2.172; Pruis MGM, 2014, ACTA PHYSIOL, V210, P215, DOI 10.1111/apha.12197; Puigserver P, 2003, ENDOCR REV, V24, P78, DOI 10.1210/er.2002-0012; Rees WD, 2000, J NUTR, V130, P1821, DOI 10.1093/jn/130.7.1821; Roberts VHJ, 2014, FASEB J, V28, P2466, DOI 10.1096/fj.13-245472; Rucker R, 2009, ALTERN MED REV, V14, P268; Saben JL, 2016, CELL REP, V16, P1, DOI 10.1016/j.celrep.2016.05.065; Samuel KG, 2015, ANIMAL, V9, P409, DOI 10.1017/S1751731114002328; Samuelsson AM, 2008, HYPERTENSION, V51, P383, DOI 10.1161/HYPERTENSIONAHA.107.101477; Sen S, 2010, DIABETES, V59, P3058, DOI 10.2337/db10-0301; Shulman GI, 2014, NEW ENGL J MED, V371, P1131, DOI 10.1056/NEJMra1011035; Steig AJ, 2011, AM J PHYSIOL-REG I, V301, pR656, DOI 10.1152/ajpregu.00212.2011; Steinberg F, 2003, EXP BIOL MED, V228, P160, DOI 10.1177/153537020322800205; Sugden MC, 2010, J ENDOCRINOL, V204, P93, DOI 10.1677/JOE-09-0359; Tao R, 2015, INFLAMMATION, V38, P1546, DOI 10.1007/s10753-015-0129-x; Tchaparian E, 2010, BIOCHEM J, V429, P515, DOI 10.1042/BJ20091649; Thompson LP, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/582748; van de Weijer T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051648; Verbeek Jef, 2016, Curr Protoc Mouse Biol, V6, P201, DOI 10.1002/cpmo.1; Wesolowski SR, 2017, NAT REV GASTRO HEPAT, V14, P81, DOI 10.1038/nrgastro.2016.160; Wu LLY, 2010, ENDOCRINOLOGY, V151, P5438, DOI 10.1210/en.2010-0551; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Zhu BQ, 2006, J CARDIOVASC PHARM T, V11, P119, DOI 10.1177/1074248406288757	71	35	37	3	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1434	1448		10.1096/fj.201600906R	http://dx.doi.org/10.1096/fj.201600906R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28007783	Green Published			2022-12-28	WOS:000398504300014
J	Liu, HJ; Wan, CX; Ding, YA; Han, RR; He, YT; Xiao, JT; Hao, JW				Liu, Haijie; Wan, Chunxiao; Ding, Yanan; Han, Ranran; He, Yating; Xiao, Jinting; Hao, Junwei			PR-957, a selective inhibitor of immunoproteasome subunit low-MW polypeptide 7, attenuates experimental autoimmune neuritis by suppressing T(h)17-cell differentiation and regulating cytokine production	FASEB JOURNAL			English	Article						ONX-0914; inflammation; Guillain-Barre syndrome	GUILLAIN-BARRE-SYNDROME; PROTEASOME INHIBITORS; TH17 CELLS; T-CELLS; IMMUNOGLOBULIN; DISORDERS; MODELS	Experimental autoimmune neuritis (EAN) is a CD4+T-cell-mediated autoimmune inflammatory demyelinating disease of the peripheral nervous system. It has been replicated in an animal model of human inflammatory demyelinating polyradiculoneuropathy, Guillain-Barre syndrome. In this study, we evaluated the therapeutic efficacy of a selective inhibitor of the immunoproteasome subunit, low-MWpolypeptide 7 (PR-957) in rats with EAN. Our results showed that PR-957 significantly delayed onset day, reduced severity and shortened duration of EAN, and alleviated demyelination and inflammatory infiltration in sciatic nerves. In addition to significantly regulating expression of the cytokine profile, PR-957 treatment down-regulated the proportion of proinflammatory T-helper (T-h)17 cells in sciatic nerves and spleens of rats with EAN. Data presented showthe role of PR-957 in the signal transducer and activator of transcription 3(STAT3) pathway. PR-957 not only decreased expression of IL-6 and IL-23 but also led to down- regulation of STAT3 phosphorylation inCD4+T cells. Regulation of the STAT3 pathway led to a reduction in retinoid-related orphan nuclear receptor g t and IL-17 production. Furthermore, reduction of STAT3 phosphorylationmay have directly suppressed Th17-cell differentiation. Therefore, our study demonstrates that PR-957 couldpotently alleviate inflammationin rats withEANandthat itmaybe a likely candidate for treating Guillain-Barr ' e syndrome.-Liu, H., Wan, C., Ding, Y., Han, R., He, Y., Xiao, J., Hao, J. PR-957, a selective inhibitor of immunoproteasome subunit low- MW polypeptide 7, attenuates experimental autoimmune neuritis by suppressing Th17-cell differentiation and regulating cytokine production. FASEBJ. 31, 1756-1766 (2017). www. fasebj. org	[Liu, Haijie; Ding, Yanan; Han, Ranran; He, Yating; Xiao, Jinting; Hao, Junwei] Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Anshan Rd, Tianjin 300052, Peoples R China; [Liu, Haijie; Wan, Chunxiao] Tianjin Med Univ, Gen Hosp, Dept Phys Med & Rehabil, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University	Hao, JW (corresponding author), Tianjin Med Univ, Gen Hosp, Tianjin Neurol Inst, Dept Neurol, Anshan Rd, Tianjin 300052, Peoples R China.	hjw@tmu.edu.cn		Hao, Junwei/0000-0002-3075-5434	National Natural Science Foundation of China [81322018, 81273287, 81100887]; Program for New Century Excellent Talents in University of China [NCET 111067]; Key Project of Natural Science Foundation of Tianjin Province [12JCZDJC24200]; Key Project of Chinese Ministry of Education [212005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University of China(Program for New Century Excellent Talents in University (NCET)); Key Project of Natural Science Foundation of Tianjin Province; Key Project of Chinese Ministry of Education(Ministry of Education, China)	This work was funded by the National Natural Science Foundation of China (81322018, 81273287, and 81100887 to J.W.H), the Program for New Century Excellent Talents in University of China (NCET 111067 to J.W.H), the Key Project of Natural Science Foundation of Tianjin Province (12JCZDJC24200 to J.W.H), and the Key Project of Chinese Ministry of Education (212005 to J.W.H). The authors declare no conflicts of interest.	Basler M, 2015, CLIN EXP RHEUMATOL, V33, pS74; Basler M, 2004, J IMMUNOL, V173, P3925, DOI 10.4049/jimmunol.173.6.3925; Basler M, 2006, J IMMUNOL, V176, P6665, DOI 10.4049/jimmunol.176.11.6665; Basler M, 2014, EMBO MOL MED, V6, P226, DOI 10.1002/emmm.201303543; Basler M, 2013, CURR OPIN IMMUNOL, V25, P74, DOI 10.1016/j.coi.2012.11.004; Basler M, 2010, J IMMUNOL, V185, P634, DOI 10.4049/jimmunol.0903182; Bennett MK, 2008, CURR OPIN DRUG DISC, V11, P616; Burke MK, 2012, P ROY SOC B-BIOL SCI, V279, P5029, DOI 10.1098/rspb.2012.0799; De La Cour CD, 2005, MUSCLE NERVE, V31, P70, DOI 10.1002/mus.20240; Gold R, 2000, MOL MED TODAY, V6, P88, DOI 10.1016/S1357-4310(99)01639-1; Groettrup M, 2010, NAT REV IMMUNOL, V10, P72, DOI 10.1038/nri2687; Harrington LE, 2005, NAT IMMUNOL, V6, P1123, DOI 10.1038/ni1254; Hasinoff BB, 2016, CARDIOVASC TOXICOL; Huber EM, 2012, CELL, V148, P727, DOI 10.1016/j.cell.2011.12.030; Hughes RAC, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD002063.pub3; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Hughes RAC, 1999, J NEUROIMMUNOL, V100, P74, DOI 10.1016/S0165-5728(99)00195-2; Hughes RAC, 2007, BRAIN, V130, P2245, DOI 10.1093/brain/awm004; Ichikawa HT, 2012, ARTHRITIS RHEUM-US, V64, P493, DOI 10.1002/art.33333; Jaganathan A, 2014, MOL ENDOCRINOL, V28, P872, DOI 10.1210/me.2014-1055; Kalim KW, 2012, J IMMUNOL, V189, P4182, DOI 10.4049/jimmunol.1201183; Kieseier BC, 2004, MUSCLE NERVE, V30, P131, DOI 10.1002/mus.20076; Kimura H, 2015, J IMMUNOL RES, V2015, DOI 10.1155/2015/541984; Kloetzel PM, 2004, CURR OPIN IMMUNOL, V16, P76, DOI 10.1016/j.coi.2003.11.004; Kloetzel PM, 2001, NAT REV MOL CELL BIO, V2, P179, DOI 10.1038/35056572; Kuhn DJ, 2009, BLOOD, V113, P4667, DOI 10.1182/blood-2008-07-171637; Kunjappu MJ, 2014, BBA-MOL CELL RES, V1843, P2, DOI 10.1016/j.bbamcr.2013.03.008; Liang SL, 2012, IMMUNOPHARM IMMUNOT, V34, P1039, DOI 10.3109/08923973.2012.697469; Lu MO, 2011, J NEUROL, V258, P533, DOI 10.1007/s00415-010-5836-5; Moebius J, 2010, EUR J IMMUNOL, V40, P3439, DOI 10.1002/eji.201040620; Muchamuel T, 2009, NAT MED, V15, P781, DOI 10.1038/nm.1978; Nagayama Y, 2012, CLIN EXP IMMUNOL, V168, P268, DOI 10.1111/j.1365-2249.2012.04578.x; Nandi D, 1997, EMBO J, V16, P5363, DOI 10.1093/emboj/16.17.5363; Orlowski RZ, 1998, CANCER RES, V58, P4342; Raphael JC, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001798.pub2; Richardson PG, 2008, EXPERT REV ANTICANC, V8, P1053, DOI 10.1586/14737140.8.7.1053; ROPPER AH, 1992, NEW ENGL J MED, V326, P1130, DOI 10.1056/NEJM199204233261706; Stephanou A, 1998, BIOCHEM J, V330, P189, DOI 10.1042/bj3300189; Taylor JM, 2003, MUSCLE NERVE, V28, P344, DOI 10.1002/mus.10432; van Doorn Pieter A, 2013, Presse Med, V42, pe193, DOI 10.1016/j.lpm.2013.02.328; van Swieten PF, 2007, BIOORG MED CHEM LETT, V17, P3402, DOI 10.1016/j.bmcl.2007.03.092; Wang X, 2014, SCAND J IMMUNOL, V80, P180, DOI 10.1111/sji.12201; Willison HJ, 2016, LANCET, V388, P717, DOI 10.1016/S0140-6736(16)00339-1; Wu XJ, 2016, EXPERT OPIN THER TAR, V20, P209, DOI 10.1517/14728222.2016.1086751; Yang XXO, 2007, J BIOL CHEM, V282, P9358, DOI 10.1074/jbc.C600321200; Zhang CJ, 2014, IMMUNOL CELL BIOL, V92, P164, DOI 10.1038/icb.2013.81; Zhang HL, 2013, CYTOKINE GROWTH F R, V24, P443, DOI 10.1016/j.cytogfr.2013.05.005; Zhang ZY, 2009, NEUROPATH APPL NEURO, V35, P487, DOI 10.1111/j.1365-2990.2009.01016.x	49	27	30	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1756	1766		10.1096/fj.201601147R	http://dx.doi.org/10.1096/fj.201601147R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28096232				2022-12-28	WOS:000398504300039
J	Okuda, H; DeBoer, K; O'Connor, AE; Merriner, DJ; Jamsai, D; O'Bryan, MK				Okuda, Hidenobu; DeBoer, Kathleen; O'Connor, Anne E.; Merriner, D. Jo; Jamsai, Duangporn; O'Bryan, Moira K.			LRGUK1 is part of a multiprotein complex required for manchette function and male fertility	FASEB JOURNAL			English	Article						elongating spermatids; intracellular transport; cargo adaptor; spermatogenesis; sperm	KINESIN LIGHT-CHAIN; LEUCINE-RICH REPEAT; GENE SPECIFICITY; PROTEIN; FAMILY; CARGO; RECOGNITION; DOMAIN; CELLS; CILIA	Infertility occurs in 1 in 20 young men and is idiopathic in origin in most. We have reported that the leucine-rich repeat (LRR) and guanylate kinase-like domain containing, isoform (LRGUK)-1 is essential for sperm head shaping, via the manchette, and the initiation of sperm tail growth from the centriole/basal body, and thus, male fertility. Within this study we have used a yeast 2-hybrid screen of an adult testis library to identify LRGUK1binding partners, which were then validated with a range of techniques. The data indicate that LRGUK1 likely achieves its function in partnership with members of the HOOK family of proteins (HOOK-1-3), Rab3-interacting molecule binding protein (RIMBP)-3 and kinesin light chain (KLC)-3, all of which are associated with intracellular protein transport as cargo adaptor proteins and are localized to the manchette. LRGUK1 consists of 3 domains; an LRR, a guanylate kinase (GUK)-like and an unnamed domain. In the present study, we showed that the GUK-like domain is essential for binding to HOOK2 and RIMBP3, and the LRR domain is essential for binding to KLC3. These findings establish LRGUK1 as a key component of a multiprotein complex with an essential role in microtubule dynamics with in haploid male germ cells.- Okuda, H., DeBoer, K., O ' Connor, A. E., Merriner, D. J., Jamsai, D., O ' Bryan, M. K. LRGUK1 is part of a multiprotein complex required for manchette function and male fertility.	Monash Univ, Monash Biomed Discovery Inst, Clayton, Vic, Australia; Monash Univ, Dept Anat & Dev Biol, Clayton, Vic, Australia; [O'Bryan, Moira K.] Monash Univ, Monash Biomed Discovery Inst, Dev & Stem Cells Program, Clayton, Vic 3800, Australia	Monash University; Monash University; Monash University	O'Bryan, MK (corresponding author), Monash Univ, Monash Biomed Discovery Inst, Dev & Stem Cells Program, Clayton, Vic 3800, Australia.	moira.obryan@monash.edu	O'Connor, Anne/AAI-6479-2020; O'Bryan, Moira K/F-8256-2012	O'Connor, Anne/0000-0001-9334-4256; O'Bryan, Moira K/0000-0001-7298-4940	National Health and Medical Research Council (NHMRC) of Australia [606562]; NHMRC [APP1058356]; Japanese Society for the Promotion of Science	National Health and Medical Research Council (NHMRC) of Australia(National Health and Medical Research Council (NHMRC) of Australia); NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank Yan Liu (Monash University) for technical assistance in making the recombinant protein. This research was funded in part by Grant 606562 from the National Health and Medical Research Council (NHMRC) of Australia (to M.K.O.); by Research Fellowship APP1058356 from the NHMRC (M.K.O.); and by a Research Fellowship for Young Scientists from the Japanese Society for the Promotion of Science (to H.O.). The authors declare no conflicts of interest.	Adio S, 2006, J MUSCLE RES CELL M, V27, P153, DOI 10.1007/s10974-005-9054-1; Akhmanova A, 2005, GENE DEV, V19, P2501, DOI 10.1101/gad.344505; Arsov T, 2006, MOL ENDOCRINOL, V20, P1610, DOI 10.1210/me.2005-0494; Baker G., 2012, ENDOTEXT; Bell JK, 2003, TRENDS IMMUNOL, V24, P528, DOI 10.1016/S1471-4906(03)00242-4; Bhullar B, 2003, J BIOL CHEM, V278, P16159, DOI 10.1074/jbc.M213126200; Bielska E, 2014, J CELL BIOL, V204, P989, DOI 10.1083/jcb.201309022; BLOOM GS, 1994, PROTEIN PROFILE, V1, P1059; Caplan J, 2008, CELL HOST MICROBE, V3, P126, DOI 10.1016/j.chom.2008.02.010; Cianfrocco MA, 2015, ANNU REV CELL DEV BI, V31, P83, DOI 10.1146/annurev-cellbio-100814-125438; De Kretser DM, 1999, J CLIN ENDOCR METAB, V84, P3443, DOI 10.1210/jc.84.10.3443; De Masi F, 2005, PROTEOMICS, V5, P4070, DOI 10.1002/pmic.200401279; Dodds PN, 2006, P NATL ACAD SCI USA, V103, P8888, DOI 10.1073/pnas.0602577103; Ellis JG, 2007, ANNU REV PHYTOPATHOL, V45, P289, DOI 10.1146/annurev.phyto.45.062806.094331; Feng W, 2009, NAT REV NEUROSCI, V10, P87, DOI 10.1038/nrn2540; Firat-Karalar EN, 2014, J CELL SCI, V127, P4128, DOI 10.1242/jcs.157008; Gaillard CLB, 2011, MOL BIOL CELL, V22, P4549, DOI 10.1091/mbc.E11-05-0405; Harris EH, 2001, ANNU REV PLANT PHYS, V52, P363, DOI 10.1146/annurev.arplant.52.1.363; Hibino H, 2002, NEURON, V34, P411, DOI 10.1016/S0896-6273(02)00667-0; Holden CA, 2005, LANCET, V366, P218, DOI 10.1016/S0140-6736(05)66911-5; Jinek M, 2012, SCIENCE, V337, P816, DOI 10.1126/science.1225829; Junco A, 2001, BIOL REPROD, V64, P1320, DOI 10.1095/biolreprod64.5.1320; Kierszenbaum Abraham L, 2011, Spermatogenesis, V1, P221; Kierszenbaum AL, 2011, DEV DYNAM, V240, P723, DOI 10.1002/dvdy.22563; Kierszenbaum Abraham L, 2007, Soc Reprod Fertil Suppl, V65, P33; Kierszenbaum AL, 2004, ARCH HISTOL CYTOL, V67, P271, DOI 10.1679/aohc.67.271; Kierszenbaum AL, 2003, MOL BIOL CELL, V14, P4628, DOI 10.1091/mbc.E03-04-0226; Kierszenbaum AL, 2002, MOL REPROD DEV, V63, P1, DOI 10.1002/mrd.10179; Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4; Kramer H, 1996, J CELL BIOL, V133, P1205, DOI 10.1083/jcb.133.6.1205; Lehti MS, 2016, REPRODUCTION, V151, pR43, DOI 10.1530/REP-15-0310; Lehti MS, 2013, MOL CELL ENDOCRINOL, V377, P44, DOI 10.1016/j.mce.2013.06.030; Liu KSY, 2011, SCIENCE, V334, P1565, DOI 10.1126/science.1212991; Liu Y, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005090; Ma M, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/270805; Mai WY, 2005, MOL BIOL CELL, V16, P4398, DOI 10.1091/mbc.E04-11-1019; Maldonado-Baez L, 2013, J CELL BIOL, V201, P233, DOI 10.1083/jcb.201208172; McKenney RJ, 2014, SCIENCE, V345, P337, DOI 10.1126/science.1254198; MEISTRICH ML, 1990, AM J ANAT, V188, P74, DOI 10.1002/aja.1001880109; Mendoza-Lujambio I, 2002, HUM MOL GENET, V11, P1647, DOI 10.1093/hmg/11.14.1647; Mittelstaedt T, 2007, GENE, V403, P70, DOI 10.1016/j.gene.2007.08.004; Mochida K, 1999, MOL REPROD DEV, V52, P434, DOI 10.1002/(SICI)1098-2795(199904)52:4&lt;434::AID-MRD13&gt;3.0.CO;2-D; Moreno RD, 2000, CELL MOTIL CYTOSKEL, V46, P235, DOI 10.1002/1097-0169(200008)46:4<235::AID-CM1>3.0.CO;2-G; Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053; O'Donnell L, 2014, SEMIN CELL DEV BIOL, V30, P45, DOI 10.1016/j.semcdb.2014.01.003; Oliva C, 2012, DEV NEUROBIOL, V72, P57, DOI 10.1002/dneu.20949; Olsen B, 2005, MATRIX BIOL, V24, P449, DOI 10.1016/j.matbio.2005.09.003; Padmanabhan M, 2009, CELL MICROBIOL, V11, P191, DOI 10.1111/j.1462-5822.2008.01260.x; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Perrin A, 2013, ANDROLOGIA, V45, P1, DOI 10.1111/j.1439-0272.2012.01308.x; RATTNER JB, 1972, J ULTRA MOL STRUCT R, V41, P209, DOI 10.1016/S0022-5320(72)90065-2; ROMRELL LJ, 1976, DEV BIOL, V49, P119, DOI 10.1016/0012-1606(76)90262-1; Rosenbaum JL, 2002, NAT REV MOL CELL BIO, V3, P813, DOI 10.1038/nrm952; RUSSELL LD, 1991, AM J ANAT, V192, P97, DOI 10.1002/aja.1001920202; Salisbury JL, 2004, CURR BIOL, V14, pR765, DOI 10.1016/j.cub.2004.09.016; Schlager MA, 2014, EMBO J, V33, P1855, DOI 10.15252/embj.201488792; Scholey JM, 2008, J CELL BIOL, V180, P23, DOI 10.1083/jcb.200709133; STEHLE T, 1992, J MOL BIOL, V224, P1127, DOI 10.1016/0022-2836(92)90474-X; Szebenyi G, 2007, TRAFFIC, V8, P32, DOI 10.1111/j.1600-0854.2006.00511.x; Taulman PD, 2001, MOL BIOL CELL, V12, P589, DOI 10.1091/mbc.12.3.589; Walenta JH, 2001, J CELL BIOL, V152, P923, DOI 10.1083/jcb.152.5.923; Wang Y, 2000, J BIOL CHEM, V275, P20033, DOI 10.1074/jbc.M909008199; Xu L, 2008, MOL BIOL CELL, V19, P5059, DOI 10.1091/mbc.E08-05-0473; Zhang J, 2014, J CELL BIOL, V204, P1009, DOI 10.1083/jcb.201308009; Zhang Y, 2004, DEV BIOL, V275, P23, DOI 10.1016/j.ydbio.2004.07.014; Zhang Y, 2012, DEV BIOL, V366, P101, DOI 10.1016/j.ydbio.2012.04.026; Zhou J, 2009, DEVELOPMENT, V136, P373, DOI 10.1242/dev.030858	67	16	21	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1141	+		10.1096/fj.201600909R	http://dx.doi.org/10.1096/fj.201600909R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	28003339				2022-12-28	WOS:000395671200027
J	Ridiandries, A; Tan, JTM; Ravindran, D; Williams, H; Medbury, HJ; Lindsay, L; Hawkins, C; Prosser, HCG; Bursill, CA				Ridiandries, Anisyah; Tan, Joanne T. M.; Ravindran, Dhanya; Williams, Helen; Medbury, Heather J.; Lindsay, Laura; Hawkins, Clare; Prosser, Hamish C. G.; Bursill, Christina A.			CC-chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis	FASEB JOURNAL			English	Article						inflammation; ischemia; VEGF	SMOOTH-MUSCLE-CELLS; GROWTH-FACTOR GENE; ACTIVITY IN-VITRO; EXPRESSION; ATHEROSCLEROSIS; RECEPTORS; TRANSCRIPTION; PROGRESSION; RECRUITMENT; ACTIVATION	Increasing evidence shows that CC-chemokines promote inflammatory-driven angiogenesis, with little to no effect on hypoxia-mediated angiogenesis. Inhibition of the CC-chemokine class may therefore affect angiogenesis differently depending on the pathophysiological context. We compared the effect of CC-chemokine inhibition in inflammatory and physiological conditions. In vitro, the broad-spectrum CC-chemokine inhibitor '' 35K '' inhibited inflammatory-induced endothelial cell proliferation, migration, and tubulogenesis, with more modest effects in hypoxia. In vivo, adenoviruses were used to overexpress 35K (Ad35K) and GFP (AdGFP, control virus). Plasma chemokine activity was suppressed by Ad35K in both models. In the periarterial femoral cuff model of inflammatory-driven angiogenesis, overexpression of 35K inhibited adventitial neovessel formation compared with control AdGFP-infused mice. In contrast, 35K preserved neovascularization in the hindlimb ischemia model and had no effect on physiological neovascularization in the chick chorioallantoic membrane assay. Mechanistically, 2 key angiogenic proteins (VEGF and hypoxia-inducible factor-1 alpha) were conditionally regulated by 35K, such that expression was inhibited in inflammation but was unchanged in hypoxia. In conclusion, CC-chemokine inhibition by 35K suppresses inflammatory-driven angiogenesis while preserving physiological ischemia-mediated angiogenesis via conditional regulation of VEGF and hypoxia-inducible factor-1 alpha. CC-chemokine inhibition may be an alternative therapeutic strategy for suppressing diseases associated with inflammatory angiogenesis without inducing the side effects caused by global inhibition.- Ridiandries, A., Tan, J. T. M., Ravindran, D., Williams, H., Medbury, H. J., Lindsay, L., Hawkins, C., Prosser, H. C. G., Bursill, C. A. CC- chemokine class inhibition attenuates pathological angiogenesis while preserving physiological angiogenesis.	[Ridiandries, Anisyah; Tan, Joanne T. M.; Ravindran, Dhanya; Hawkins, Clare; Prosser, Hamish C. G.; Bursill, Christina A.] Heart Res Inst, Newtown, NSW, Australia; [Ridiandries, Anisyah; Tan, Joanne T. M.; Ravindran, Dhanya; Williams, Helen; Medbury, Heather J.; Hawkins, Clare; Prosser, Hamish C. G.; Bursill, Christina A.] Univ Sydney, Sydney Med Sch, Sch Med Sci, Sydney, NSW 2006, Australia; [Lindsay, Laura] Univ Sydney, Sch Med Sci, Dept Anat & Histol, Sydney, NSW 2006, Australia; [Williams, Helen; Medbury, Heather J.] Univ Sydney, Westmead Hosp, Vasc Biol Res Ctr, Dept Surg, Westmead, NSW 2145, Australia	University of Sydney; Heart Research Institute; University of Sydney; University of Sydney; University of Sydney	Bursill, CA (corresponding author), Heart Res Inst, Immunobiol Grp, 7 Eliza St, Washington, DC 20422 USA.	bursillc@hri.org.au	Medbury, Heather/H-6143-2019; Williams, Helen/AAW-9632-2021; Hawkins, Clare/AAV-7424-2021; Tan, Joanne Tsui Ming/Y-4423-2019; Ridiandries, Anisyah/I-4360-2017; Hawkins, Clare L/F-6696-2014; Tan, Ming-Jen/A-3862-2011	Medbury, Heather/0000-0002-1614-7213; Williams, Helen/0000-0001-8221-5766; Hawkins, Clare/0000-0003-2738-5089; Tan, Joanne Tsui Ming/0000-0003-1875-4882; Ridiandries, Anisyah/0000-0001-8996-6896; Hawkins, Clare L/0000-0003-2738-5089; Lindsay, Laura Ann/0000-0003-3139-0702; Tan, Ming-Jen/0000-0002-3583-1723; Bursill, Christina/0000-0002-0682-8760	Heart Research Institute; Heart Foundation of Australia Career Development Fellowship [CR07S3331]; Australian Research Council [FT120100682]	Heart Research Institute(University of Sydney); Heart Foundation of Australia Career Development Fellowship; Australian Research Council(Australian Research Council)	The authors thank the Heart Research Institute (Ph.D. scholarship to A.R.), the Heart Foundation of Australia Career Development Fellowship CR07S3331 (to C.A.B.), and the Australian Research Council Future Fellowship FT120100682 (to C.H). The authors declare no conflicts of interest.	Ali ZA, 2005, CIRCULATION, V112, pI235, DOI 10.1161/CIRCULATIONAHA.104.526129; Bachelerie F, 2014, PHARMACOL REV, V66, P1, DOI 10.1124/pr.113.007724; Beck CG, 2001, J BIOL CHEM, V276, P43270, DOI 10.1074/jbc.M106305200; Bergers G, 2005, NEURO-ONCOLOGY, V7, P452, DOI 10.1215/S1152851705000232; Berkhout TA, 1997, J BIOL CHEM, V272, P16404, DOI 10.1074/jbc.272.26.16404; Bhardwaj S, 2011, ATHEROSCLEROSIS, V219, P84, DOI 10.1016/j.atherosclerosis.2011.07.103; Bonello S, 2007, ARTERIOSCL THROM VAS, V27, P755, DOI 10.1161/01.ATV.0000258979.92828.bc; Boring L, 1998, NATURE, V394, P894, DOI 10.1038/29788; Bosco MC, 2004, J IMMUNOL, V172, P1681, DOI 10.4049/jimmunol.172.3.1681; Bursi CA, 2004, CURR OPIN LIPIDOL, V15, P145, DOI [10.1097/00041433-200404000-00007, 10.1097/01.mol.0000124526.75650.13]; Bursill CA, 2009, GENE THER, V16, P93, DOI 10.1038/gt.2008.141; Bursill CA, 2004, CIRCULATION, V110, P2460, DOI 10.1161/01.CIR.0000145122.58420.CO; Bursill CA, 2003, IMMUNOBIOLOGY, V207, P187, DOI 10.1078/0171-2985-00228; Bursill CA, 2006, J IMMUNOL, V177, P5567, DOI 10.4049/jimmunol.177.8.5567; Cabebe Elwyn, 2007, Curr Treat Options Oncol, V8, P15, DOI 10.1007/s11864-007-0022-4; Carfi A, 1999, P NATL ACAD SCI USA, V96, P12379, DOI 10.1073/pnas.96.22.12379; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Charo IF, 2006, NEW ENGL J MED, V354, P610, DOI 10.1056/NEJMra052723; Dohle Daniel S, 2009, J Vis Exp, DOI 10.3791/1620; Ema M, 1997, P NATL ACAD SCI USA, V94, P4273, DOI 10.1073/pnas.94.9.4273; FOLKMAN J, 1992, J BIOL CHEM, V267, P10931; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Galvez BG, 2005, J BIOL CHEM, V280, P1292, DOI 10.1074/jbc.M408673200; Gosling J, 1999, J CLIN INVEST, V103, P773, DOI 10.1172/JCI5624; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Halwani R, 2011, J IMMUNOL, V186, P4156, DOI 10.4049/jimmunol.1001210; Hayes IM, 1998, ARTERIOSCL THROM VAS, V18, P397, DOI 10.1161/01.ATV.18.3.397; Ilan Y, 1999, SEMIN LIVER DIS, V19, P49, DOI 10.1055/s-2007-1007097; Lazennec G, 2010, TRENDS MOL MED, V16, P133, DOI 10.1016/j.molmed.2010.01.003; LEVY AP, 1995, J BIOL CHEM, V270, P13333, DOI 10.1074/jbc.270.22.13333; Limbourg A, 2009, NAT PROTOC, V4, P1737, DOI 10.1038/nprot.2009.185; Lu X, 2009, J BIOL CHEM, V284, P29087, DOI 10.1074/jbc.M109.035899; Mourad JJ, 2008, ANN ONCOL, V19, P927, DOI 10.1093/annonc/mdm550; Reape TJ, 1999, AM J PATHOL, V154, P365, DOI 10.1016/S0002-9440(10)65283-2; Ribatti D, 2006, NAT PROTOC, V1, P85, DOI 10.1038/nprot.2006.13; Robinson SC, 2003, CANCER RES, V63, P8360; Salcedo R, 2001, J IMMUNOL, V166, P7571, DOI 10.4049/jimmunol.166.12.7571; Satchi-Fainaro R, 2004, NAT MED, V10, P255, DOI 10.1038/nm1002; Scholz D, 2003, MOL CELL BIOCHEM, V246, P57, DOI 10.1023/A:1023403928385; Shi Q, 2001, ONCOGENE, V20, P3751, DOI 10.1038/sj.onc.1204500; Shireman PK, 2006, J SURG RES, V134, P145, DOI 10.1016/j.jss.2005.12.003; Soria G, 2008, CANCER LETT, V267, P271, DOI 10.1016/j.canlet.2008.03.018; Stabile E, 2003, CIRCULATION, V108, P205, DOI 10.1161/01.CIR.0000079225.50817.71; Stamatovic SM, 2006, J IMMUNOL, V177, P2651, DOI 10.4049/jimmunol.177.4.2651; Strasly M, 2004, BLOOD, V103, P40, DOI 10.1182/blood-2003-05-1387; STRIETER RM, 1995, SHOCK, V4, P155, DOI 10.1097/00024382-199509000-00001; Tanaka T, 2005, CANCER SCI, V96, P317, DOI 10.1111/j.1349-7006.2005.00059.x; Turner L, 1999, EUR J IMMUNOL, V29, P2280, DOI 10.1002/(SICI)1521-4141(199907)29:07<2280::AID-IMMU2280>3.0.CO;2-C; Weber C, 2004, ARTERIOSCL THROM VAS, V24, P1997, DOI 10.1161/01.ATV.0000142812.03840.6f; Zhang J, 2010, JNCI-J NATL CANCER I, V102, P522, DOI 10.1093/jnci/djq044; Zhang L, 2006, P NATL ACAD SCI USA, V103, P13985, DOI 10.1073/pnas.0602142103	51	12	12	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1179	1192		10.1096/fj.201600540R	http://dx.doi.org/10.1096/fj.201600540R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27998907				2022-12-28	WOS:000395671200030
J	Pontrelli, P; Conserva, F; Papale, M; Oranger, A; Barozzino, M; Vocino, G; Rocchetti, MT; Gigante, M; Castellano, G; Rossini, M; Simone, S; Laviola, L; Giorgino, F; Grandaliano, G; Di Paolo, S; Gesualdo, L				Pontrelli, Paola; Conserva, Francesca; Papale, Massimo; Oranger, Annarita; Barozzino, Mariagrazia; Vocino, Grazia; Rocchetti, Maria Teresa; Gigante, Margherita; Castellano, Giuseppe; Rossini, Michele; Simone, Simona; Laviola, Luigi; Giorgino, Francesco; Grandaliano, Giuseppe; Di Paolo, Salvatore; Gesualdo, Loreto			Lysine 63 ubiquitination is involved in the progression of tubular damage in diabetic nephropathy	FASEB JOURNAL			English	Article						diabetic kidney; EMT; hyperglycemia; post-translational modifications	EPITHELIAL-MESENCHYMAL TRANSITION; HIGH GLUCOSE; CONJUGATING ENZYME; KIDNEY-DISEASE; THERAPEUTIC INTERVENTION; PROTEASOME SYSTEM; EXPRESSION; CELLS; MECHANISMS; PATHOGENESIS	The purpose of our study was to evaluate howhyperglycemia (HG) influences Lys63 protein ubiquitination and its involvement in tubular damage and fibrosis in diabetic nephropathy (DN). Gene and protein expression of UBE2v1, a ubiquitin-conjugating E2-enzyme variant that mediates Lys63-linked ubiquitination, and Lys63-ubiquitinated proteins increased in HK2 tubular cells under HG. Matrix-assisted laser desorption/ionization-time of flight/tandem mass spectrometry identified 30 Lys63-ubiquitinated proteins, mainly involved in cellular organization, such as beta-actin, whose Lys63 ubiquitination increased under HG, leading to cytoskeleton disorganization. This effect was reversed by the inhibitor of the Ubc13/UBE2v1 complexNSC697923. Western blot analysis confirmed that UBE2v1 silencing in HK2 under HG, restored Lys63-beta-actin ubiquitination levels to the basal condition. Immunohistochemistry on patients with type 2 diabetic (T2D) revealed an increase in UBE2v1- and Lys63-ubiquitinated proteins, particularly in kidneys of patients with DN compared with control kidneys and other nondiabetic renal diseases, such as membranous nephropathy. Increased Lys63 ubiquitination both in vivo in patients with DN and in vitro, correlated with alpha-SMA expression, whereas UBE2v1 silencing reduced HG-induced alpha-SMA protein levels, returning themto basal expression. In conclusion, UBE2v1- and Lys63-ubiquitinated proteins increase in vitro under HG, as well as in vivo in T2D, is augmented in patients with DN, and may affect cytoskeleton organization and influence epithelial-to-mesenchymal transition. This process may drive the progression of tubular damage and interstitial fibrosis in patients with DN.Pontrelli, P., Conserva, F., Papale, M., Oranger, A., Barozzino, M., Vocino, G., Rochetti, M. T., Gigante, M., Castellano, G., Rossini, M., Simone, S., Laviola, L., Giorgino, F., Grandaliano, G., DiPaolo, S., Gesualdo, L. Lysine 63 ubiquitination is involved in the progression of tubular damage in diabetic nephropathy.	[Pontrelli, Paola; Conserva, Francesca; Oranger, Annarita; Barozzino, Mariagrazia; Rocchetti, Maria Teresa; Gigante, Margherita; Castellano, Giuseppe; Rossini, Michele; Simone, Simona; Gesualdo, Loreto] Univ Bari, Div Nephrol Dialysis & Transplantat, Dept Emergency & Organ Transplantat, Bari, Italy; [Laviola, Luigi; Giorgino, Francesco] Univ Bari, Div Endocrinol, Dept Emergency & Organ Transplantat, Bari, Italy; [Conserva, Francesca] Sci Clin Inst Maugeri, Dept Cardiol & Cardiac Rehabil, Bari, Italy; [Papale, Massimo; Vocino, Grazia; Grandaliano, Giuseppe] Univ Foggia, Div Nephrol, Dept Med & Surg Sci, Foggia, Italy; [Di Paolo, Salvatore] Dimiccoli Hosp, Nephrol Unit, Barletta, Italy	Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; University of Foggia	Pontrelli, P (corresponding author), Univ Bari, Dept Emergency & Transplantat, Div Nephrol Dialysis & Transplantat, Piazza Giulio Cesare 11, I-70124 Bari, Italy.	paola.pontrelli@uniba.it	Gesualdo, Loreto/K-7751-2016; Grandaliano, Giuseppe/J-7822-2016; Papale, Massimo/AAQ-2370-2020; Rocchetti, Maria Teresa/N-2212-2018; Laviola, Luigi/AAC-2237-2022; Rocchetti, Maria Teresa/AAA-6771-2019; Conserva, Francesca/D-3681-2013; Pontrelli, Paola/K-5881-2016; Rocchetti, Maria Teresa/AAQ-1881-2021; Rossini, Michele/AAC-6516-2022; Castellano, Giuseppe/H-1626-2012; Di+Paolo, Salvatore/AAX-5463-2021	Gesualdo, Loreto/0000-0002-4861-0911; Grandaliano, Giuseppe/0000-0003-1213-2177; Papale, Massimo/0000-0002-8278-5045; Rocchetti, Maria Teresa/0000-0002-2397-6474; Conserva, Francesca/0000-0003-2863-864X; Pontrelli, Paola/0000-0002-7654-8318; Rocchetti, Maria Teresa/0000-0002-2397-6474; Rossini, Michele/0000-0002-5801-4136; Castellano, Giuseppe/0000-0002-0153-3795; Barozzino, Mariagrazia/0000-0001-7697-7115; Oranger, Annarita/0000-0003-4402-244X	Ministero della Salute Ricerca Finalizzata [2009: 245/RF-2009-1470765]	Ministero della Salute Ricerca Finalizzata(Ministry of Health, Italy)	The authors thank Dr. Chiara Divella and Mr. Vincenzo Gesualdo for excellent technical assistance and Dr. Annamaria Di Palma (all from the University of Bari) for helpful discussions of the histologic findings. This study was supported by Ministero della Salute Ricerca Finalizzata 2009: 245/RF-2009-1470765. The authors declare no conflicts of interest.	Aghdam SY, 2013, BIOCHEM BIOPH RES CO, V432, P339, DOI 10.1016/j.bbrc.2013.01.101; Akimoto Yoshihiro, 2011, Clin Proteomics, V8, P15, DOI 10.1186/1559-0275-8-15; Bogachek MV, 2015, CANCER RES, V75, P11, DOI 10.1158/0008-5472.CAN-14-2824; Brownlee M, 2005, DIABETES, V54, P1615, DOI 10.2337/diabetes.54.6.1615; Chen ZJJ, 2009, MOL CELL, V33, P275, DOI 10.1016/j.molcel.2009.01.014; Chen ZM, 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1186/S12929-015-0197-0; Clarkson MR, 2002, J BIOL CHEM, V277, P9707, DOI 10.1074/jbc.M109172200; Cybulsky AV, 2013, KIDNEY INT, V84, P25, DOI 10.1038/ki.2012.390; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dihazi H, 2007, CLIN CHEM, V53, P1636, DOI 10.1373/clinchem.2007.088260; Dlugosz JA, 2002, AM J PHYSIOL-RENAL, V282, pF151, DOI 10.1152/ajprenal.0055.2001; Gao CL, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/160692; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Ha TS, 2006, NEPHROLOGY, V11, P435, DOI 10.1111/j.1440-1797.2006.00668.x; Hale PJ, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-S3-S16; Hu C, 2015, CURR MED CHEM, V22, P2858, DOI 10.2174/0929867322666150625095407; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Kimura M, 2008, INTERNAL MED, V47, P1099, DOI 10.2169/internalmedicine.47.0352; Koesters R, 2010, AM J PATHOL, V177, P632, DOI 10.2353/ajpath.2010.091012; Komander D, 2012, ANNU REV BIOCHEM, V81, P203, DOI 10.1146/annurev-biochem-060310-170328; Li W, 2008, CELL MOL LIFE SCI, V65, P2397, DOI 10.1007/s00018-008-8090-6; Liu YH, 2004, J AM SOC NEPHROL, V15, P1, DOI 10.1097/01.ASN.0000106015.29070.E7; Loeffler I, 2015, CELLS-BASEL, V4, P631, DOI 10.3390/cells4040631; Luo ZF, 2011, LIFE SCI, V88, P512, DOI 10.1016/j.lfs.2010.12.023; Navarro-Gonzalez JF, 2011, NAT REV NEPHROL, V7, P327, DOI 10.1038/nrneph.2011.51; Neutzner M, 2012, ESSAYS BIOCHEM, V52, P37, DOI [10.1042/bse0520037, 10.1042/BSE0520037]; Papale M, 2010, DIABETES CARE, V33, P2409, DOI 10.2337/dc10-0345; Park SH, 2015, MOL CELLS, V38, P20, DOI 10.14348/molcells.2015.2120; Petroski MD, 2007, J BIOL CHEM, V282, P29936, DOI 10.1074/jbc.M703911200; Pulvino M, 2012, BLOOD, V120, P1668, DOI 10.1182/blood-2012-02-406074; Ray DM, 2010, BIOCHEM CELL BIOL, V88, P947, DOI 10.1139/O10-148; Renal Pathology Society, 2010, J AM SOC NEPHROL, V21, P556; Rocchetti MT, 2013, CLIN J AM SOC NEPHRO, V8, P1115, DOI 10.2215/CJN.05950612; RYAN MJ, 1994, KIDNEY INT, V45, P48, DOI 10.1038/ki.1994.6; Sadowski M, 2010, CELL DIV, V5, DOI 10.1186/1747-1028-5-19; Schaefer A, 2012, BIOCHEM J, V442, P13, DOI 10.1042/BJ20111815; Sengupta U, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008100; Soldatos G, 2008, DIABETES RES CLIN PR, V82, pS75, DOI 10.1016/j.diabres.2008.09.042; Soond SM, 2011, BIOESSAYS, V33, P749, DOI 10.1002/bies.201100057; Sun L, 2002, J BIOL CHEM, V277, P29953, DOI 10.1074/jbc.M204665200; Tang SCW, 2011, CONTRIB NEPHROL, V170, P124, DOI 10.1159/000325647; van Wijk SJL, 2010, FASEB J, V24, P981, DOI 10.1096/fj.09-136259; Voutsadakis IA, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-67; Woroniecka KI, 2011, DIABETES, V60, P2354, DOI 10.2337/db10-1181; Xu GQ, 2011, NAT BIOTECHNOL, V29, P1098, DOI 10.1038/nbt.2061; Xu GQ, 2010, NAT BIOTECHNOL, V28, P868, DOI 10.1038/nbt.1654; Yamagishi SI, 2007, CURR DRUG TARGETS, V8, P952; Yeo RWY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044988; Zeisberg M, 2010, J AM SOC NEPHROL, V21, P1247, DOI 10.1681/ASN.2010060616; Zhao L, 2016, PHYSIOL GENOMICS, V48, P580, DOI 10.1152/physiolgenomics.00058.2016	50	13	15	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					308	319		10.1096/fj.201600382RR	http://dx.doi.org/10.1096/fj.201600382RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27881486	Green Submitted			2022-12-28	WOS:000392177600029
J	Zhakupova, A; Debeuf, N; Krols, M; Toussaint, W; Vanhoutte, L; Alecu, I; Kutalik, Z; Vollenweider, P; Ernst, D; von Eckardstein, A; Lambrecht, BN; Janssens, S; Hornemann, T				Zhakupova, Assem; Debeuf, Nincy; Krols, Michiel; Toussaint, Wendy; Vanhoutte, Leen; Alecu, Irina; Kutalik, Zoltan; Vollenweider, Peter; Ernst, Daniela; von Eckardstein, Arnold; Lambrecht, Bart N.; Janssens, Sophie; Hornemann, Thorsten			ORMDL3 expression levels have no influence on the activity of serine palmitoyltransferase	FASEB JOURNAL			English	Article						asthma; ceramide; sphingolipid; metabolism; sphinganine	GENOME-WIDE ASSOCIATION; ENDOPLASMIC-RETICULUM MEMBRANE; SPHINGOLIPID BIOSYNTHESIS; SACCHAROMYCES-CEREVISIAE; SUSCEPTIBILITY LOCI; CHILDHOOD ASTHMA; PROTEINS MEDIATE; POPULATION; HOMEOSTASIS; COMPLEX	ORMDL proteins are believed to be negative regulators of serine palmitoyltransferase (SPT), which catalyzes the first and rate limiting step in sphingolipid (SL) de novo synthesis. Several single-nucleotide polymorphisms ( SNPs) that are close to the ORMDL3 locus have been reported to increase ORMDL3 expression and to be associated with an elevated risk for early childhood asthma; however, the direct effect of ORMDL3 expression on SPT activity and its link to asthma remains elusive. In this study, we investigated whether ORMDL3 expression is associated with changes in SPT activity and total SL levels. Ormdl3-knockout (Ormdl3(-/-)) and transgenic (Ormdl3(Tg/wt)) mice were generated to study the effect of ORMDL3 on total SL levels in plasma and tissues. Cellular SPT activity was measured in mouse embryonic fibroblasts from Ormdl3(-/-) mice, as well as in HEK293 cells in which ORMDL3 was overexpressed and silenced. Furthermore, we analyzed the association of the reported ORMDL3 asthma SNPs with plasma sphingoid bases in a population-based cohort of 971 individuals. Total C-18-long chain bases were not significantly altered in the plasma and tissues of Ormdl3(-/-) mice, whereas C-18-sphinganine showed a small and significant increase in plasma, lung, and liver tissues. Mouse embryonic fibroblast cells from Ormdl3(-/-) mice did not show an altered SPT activity compared with Ormdl3(+/-) and Ormdl3(+/+) mice. Overexpression or knockdown of ORMDL3 in HEK293 cells did not alter SPT activity; however, parallel knockdown of all 3 ORMDL isoforms increased enzyme activity significantly. A significant association of the annotated ORMDL3 asthma SNPs with plasma long-chain sphingoid base levels could not be confirmed. ORMDL3 expression levels seem not to be directly associated with changes in SPT activity. ORMDL3 might influence de novo sphingolipid metabolism downstream of SPT.	[Zhakupova, Assem; Alecu, Irina; Ernst, Daniela; von Eckardstein, Arnold; Hornemann, Thorsten] Univ Zurich, Univ Zurich Hosp, Inst Clin Chem, Zurich, Switzerland; [Debeuf, Nincy; Toussaint, Wendy; Vanhoutte, Leen; Lambrecht, Bart N.; Janssens, Sophie] Vlaams Inst Biotechnol, Inflammat Res Ctr, Lab Immunoregulat & Mucosal Immunol, Ghent, Belgium; [Debeuf, Nincy; Lambrecht, Bart N.; Janssens, Sophie] Univ Ghent, Dept Internal Med, Ghent, Belgium; [Krols, Michiel] Univ Antwerp VIB, Dept Mol Genet, Antwerp, Belgium; [Kutalik, Zoltan] Univ Lausanne, CHU Vaudois, Inst Social & Prevent Med, Lausanne, Switzerland; [Vollenweider, Peter] Univ Lausanne, CHU Vaudois, Dept Med, Internal Med, Lausanne, Switzerland; [Kutalik, Zoltan] Swiss Inst Bioinformat, Lausanne, Switzerland; [Lambrecht, Bart N.] Erasmus MC, Dept Pulm Med, Rotterdam, Netherlands	University of Zurich; University Zurich Hospital; Flanders Institute for Biotechnology (VIB); Ghent University; Flanders Institute for Biotechnology (VIB); University of Antwerp; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Swiss Institute of Bioinformatics; Erasmus University Rotterdam; Erasmus MC	Hornemann, T (corresponding author), Univ Zurich, Inst Clin Chem, Raemistr 100, CH-8091 Zurich, Switzerland.; Hornemann, T (corresponding author), Univ Zurich Hosp, Raemistr 100, CH-8091 Zurich, Switzerland.	thorsten.hornemann@usz.ch	Lambrecht, Bart N/K-2484-2014; Kutalik, Zoltan/HHZ-5697-2022; Janssens, Sophie/HHN-1756-2022; Colaus, PsyColaus/K-6607-2013	Lambrecht, Bart N/0000-0003-4376-6834; Kutalik, Zoltan/0000-0001-8285-7523; Alecu, Irina/0000-0002-7659-9190	Seventh Framework Program of the European Commission (RESOLVE) [305707]; Gebert Ruf Foundation [GRS-047/09]; Center of Integrated Human Physiology (ZIHP); Swiss National Foundation SNF [31003A_153390/1]; Hurka Foundation; Novartis Foundation; Rare Disease Initiative Zurich (RADIZ; Clinical Research Priority Program for Rare Diseases, University of Zurich); Fonds Wetenschappelijk Onderzoek Vlaanderenprogram (FWO) grants; Ghent University MRP grant (Group-ID); GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation [33CSCO-122661, 33CS30-139468, 33CS30-148401]	Seventh Framework Program of the European Commission (RESOLVE); Gebert Ruf Foundation; Center of Integrated Human Physiology (ZIHP); Swiss National Foundation SNF(Swiss National Science Foundation (SNSF)); Hurka Foundation; Novartis Foundation(Novartis); Rare Disease Initiative Zurich (RADIZ; Clinical Research Priority Program for Rare Diseases, University of Zurich); Fonds Wetenschappelijk Onderzoek Vlaanderenprogram (FWO) grants(FWO); Ghent University MRP grant (Group-ID); GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This work was supported by the Seventh Framework Program of the European Commission (RESOLVE, project number 305707), the Gebert Ruf Foundation (GRS-047/09), the Center of Integrated Human Physiology (ZIHP), the Swiss National Foundation SNF; Project 31003A_153390/1), the Hurka Foundation, the Novartis Foundation, and the Rare Disease Initiative Zurich (RADIZ; Clinical Research Priority Program for Rare Diseases, University of Zurich (to A.Z., I.A., D.E., A.V.E., and T.H.). N.D., B.N.L., and S.J. hold several Fonds Wetenschappelijk Onderzoek Vlaanderenprogram (FWO) grants. B.N.L. and S.J. are recipients of a Ghent University MRP grant (Group-ID). The Cohorte Lausannoise study was and is supported by research grants from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne, and the Swiss National Science Foundation (Grants 33CSCO-122661, 33CS30-139468, and 33CS30-148401). S.J. and T.H. are shared senior authors.	Antiochos P, 2015, NUTR METAB CARDIOVAS, V25, P1007, DOI 10.1016/j.numecd.2015.07.011; Antiochos P, 2016, ATHEROSCLEROSIS, V244, P59, DOI 10.1016/j.atherosclerosis.2015.10.104; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Cantero-Recasens G, 2010, HUM MOL GENET, V19, P111, DOI 10.1093/hmg/ddp471; Carreras-Sureda A, 2013, HUM MOL GENET, V22, P519, DOI 10.1093/hmg/dds450; Drake KA, 2008, PHARMACOGENOMICS, V9, P453, DOI 10.2217/14622416.9.4.453; Ferreira MAR, 2011, EUR J HUM GENET, V19, P458, DOI 10.1038/ejhg.2010.191; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Gururaj C, 2013, J BIOL CHEM, V288, P20453, DOI 10.1074/jbc.M113.472860; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hanada K, 1997, J BIOL CHEM, V272, P32108, DOI 10.1074/jbc.272.51.32108; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hirota T, 2008, J ALLERGY CLIN IMMUN, V121, P769, DOI 10.1016/j.jaci.2007.09.038; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Hornemann T, 2009, J BIOL CHEM, V284, P26322, DOI 10.1074/jbc.M109.023192; Hrdlickova B, 2011, HUM IMMUNOL, V72, P921, DOI 10.1016/j.humimm.2011.07.309; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; Karunas A S, 2011, Mol Biol (Mosk), V45, P992; Kihara A, 2004, J BIOL CHEM, V279, P49243, DOI 10.1074/jbc.M405915200; Leung TF, 2009, ALLERGY, V64, P621, DOI 10.1111/j.1398-9995.2008.01873.x; Levy M, 2010, IUBMB LIFE, V62, P347, DOI 10.1002/iub.319; Liu M, 2012, J CELL SCI, V125, P2428, DOI 10.1242/jcs.100578; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marques-Vidal P., 2016, EUR J NUTR; McGovern DPB, 2010, NAT GENET, V42, P332, DOI 10.1038/ng.549; Michel C, 1997, J BIOL CHEM, V272, P22432, DOI 10.1074/jbc.272.36.22432; Miller M, 2014, J IMMUNOL, V192, P3475, DOI 10.4049/jimmunol.1303047; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Othman A, 2012, DIABETOLOGIA, V55, P421, DOI 10.1007/s00125-011-2384-1; Oyeniran C, 2015, J ALLERGY CLIN IMMUN, V136, P1035, DOI 10.1016/j.jaci.2015.02.031; Penno A, 2010, J BIOL CHEM, V285, P11178, DOI 10.1074/jbc.M109.092973; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Quehenberger O, 2010, J LIPID RES, V51, P3299, DOI 10.1194/jlr.M009449; Roelants FM, 2011, P NATL ACAD SCI USA, V108, P19222, DOI 10.1073/pnas.1116948108; Shimobayashi M, 2013, MOL BIOL CELL, V24, P870, DOI 10.1091/mbc.E12-10-0753; Siow D, 2015, J LIPID RES, V56, P898, DOI 10.1194/jlr.M057539; Siow Deanna, 2015, Adv Biol Regul, V57, P42, DOI 10.1016/j.jbior.2014.09.002; Siow DL, 2012, J BIOL CHEM, V287, P40198, DOI 10.1074/jbc.C112.404012; Sleiman PMA, 2008, J ALLERGY CLIN IMMUN, V122, P1225, DOI 10.1016/j.jaci.2008.06.041; Sun YD, 2012, MOL BIOL CELL, V23, P2388, DOI 10.1091/mbc.E12-03-0209; Tafesse FG, 2010, NATURE, V463, P1028, DOI 10.1038/4631028a; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Van Veldhoven PP, 2000, BBA-MOL CELL BIOL L, V1487, P128, DOI 10.1016/S1388-1981(00)00079-2; Walther TC, 2010, P NATL ACAD SCI USA, V107, P5701, DOI 10.1073/pnas.1001503107; WANG E, 1991, J BIOL CHEM, V266, P14486; Worgall TS, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3005765; Yang FF, 2012, GENET MOL RES, V11, P4646, DOI 10.4238/2012.October.19.1; Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417; Ziv C, 2016, P NATL ACAD SCI USA, V113, pE1907, DOI 10.1073/pnas.1523168113	54	22	22	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4289	4300		10.1096/fj.201600639R	http://dx.doi.org/10.1096/fj.201600639R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27645259				2022-12-28	WOS:000388201500033
J	Biswas, D; Ghosh, M; Kumar, S; Chakrabarti, P				Biswas, Dipsikha; Ghosh, Mainak; Kumar, Subhankar; Chakrabarti, Partha			PPAR-ATGL pathway improves muscle mitochondrial metabolism: implication in aging	FASEB JOURNAL			English	Article						fenofibrate; metabolic reserve; mitochondria; oxidative muscle; oxphos	ADIPOSE TRIGLYCERIDE LIPASE; HUMAN SKELETAL-MUSCLE; PEROXISOME PROLIFERATOR; INSULIN SENSITIVITY; TRIACYLGLYCEROL HYDROLYSIS; EXERCISE PERFORMANCE; BETA-OXIDATION; IN-VIVO; ALPHA; PGC-1-ALPHA	Adipose triglyceride lipase (ATGL) maintains an optimum mitochondrial function putatively by generating cognate ligands for peroxisome proliferator-activated receptor (PPAR), which, together with PPAR coactivator-1 (PGC1), regulate muscle mitochondrial biogenesis. However, the cross-talk between ATGL and PPAR in skeletal muscle mitochondrial metabolism and its implication in chronological aging is poorly understood. The role of ATGL in muscle mitochondrial metabolism was studied by overexpressing and depleting the gene and studying its downstream effect in cultured myotubes and in murine skeletal muscle. We found that PPAR directly induces ATGL expression during myogenesis. Overexpression of ATGL significantly enhanced while depletion of ATGL attenuated mitochondrial oxidative phosphorylation and fatty acid oxidation without alteration in mitochondrial content, and it rendered PPAR and PGC1 redundant in promoting mitochondrial oxidative function. However, ATGL did not alter PPAR-dependent lipid accumulation and insulin sensitivity. In middle-aged rats, ATGL expression was higher and correlated with PPAR expression and sustained fatty acid oxidation in oxidative soleus muscle. Fenofibrate feeding further induced ATGL expression selectively in this muscle compartment. These findings illustrate that PPAR and ATGL constitute a regulatory pathway in skeletal muscle, suggesting their role as a mitochondrial metabolic reserve.Biswas, D., Ghosh, M., Kumar, S., Chakrabarti, P. PPAR-ATGL pathway improves muscle mitochondrial metabolism: implication in aging.	[Biswas, Dipsikha; Ghosh, Mainak; Chakrabarti, Partha] Indian Inst Chem Biol, Council Sci & Ind Res, Div Cell Biol & Physiol, Kolkata, India; [Kumar, Subhankar] Inst Postgrad Med Educ & Res, Dept Physiol, Kolkata, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); Institute of Post Graduate Medical Education & Research (IPGMER), Kolkata	Chakrabarti, P (corresponding author), Indian Inst Chem Biol, Council Sci & Ind Res, 4 Raja SC Mullick Rd, Kolkata 700032, India.	pc1@csiriicb.in	Biswas, Dipsikha/AAP-3682-2020	Biswas, Dipsikha/0000-0003-0990-9678	Department of Science and Technology (New Delhi, India) [SB/S0/BB/007/2013]; Council of Scientific and Industrial Research (CSIR) [BSC 0206]; University Grants Commission; CSIR	Department of Science and Technology (New Delhi, India)(Department of Science & Technology (India)); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission(University Grants Commission, India); CSIR(Council of Scientific & Industrial Research (CSIR) - India)	This work was supported in part by grants to P.C. by the Department of Science and Technology (New Delhi, India; SB/S0/BB/007/2013), and the Council of Scientific and Industrial Research (CSIR; BSC 0206). D.B. and M.G. received senior research fellowships from the University Grants Commission and the CSIR, respectively.	Alsted TJ, 2013, J PHYSIOL-LONDON, V591, P5141, DOI 10.1113/jphysiol.2013.260794; Alsted TJ, 2009, AM J PHYSIOL-ENDOC M, V296, pE445, DOI 10.1152/ajpendo.90912.2008; Aquilano K., 2016, ONCOTARGET; Atherton HJ, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.18; Badin PM, 2013, ENDOCRINOLOGY, V154, P1444, DOI 10.1210/en.2012-2029; Bua EA, 2002, J APPL PHYSIOL, V92, P2617, DOI 10.1152/japplphysiol.01102.2001; Castillero E, 2012, ENDOCR CONNECT, V1, P1, DOI 10.1530/EC-12-0003; Chakrabarti P, 2011, CURR DIABETES REV, V7, P270, DOI 10.2174/157339911796397866; Chakrabarti P, 2010, DIABETES, V59, P775, DOI 10.2337/db09-1602; Chen WL, 2012, BIOCHEM PHARMACOL, V84, P522, DOI 10.1016/j.bcp.2012.05.022; Doherty TJ, 2003, J APPL PHYSIOL, V95, P1717, DOI 10.1152/japplphysiol.00347.2003; Dube JJ, 2015, AM J PHYSIOL-ENDOC M, V308, pE879, DOI 10.1152/ajpendo.00530.2014; Fatani S, 2012, INT J GEN MED, V5, P573, DOI 10.2147/IJGM.S31819; Ferre P, 2004, DIABETES, V53, pS43, DOI 10.2337/diabetes.53.2007.S43; Finck BN, 2005, CELL METAB, V1, P133, DOI 10.1016/j.cmet.2005.01.006; Furuhashi M, 2002, J ENDOCRINOL, V174, DOI 10.1677/joe.0.1740321; Gouspillou G, 2014, AGING CELL, V13, P39, DOI 10.1111/acel.12147; Haemmerle G, 2011, NAT MED, V17, P1076, DOI 10.1038/nm.2439; Huijsman E, 2009, AM J PHYSIOL-ENDOC M, V297, pE505, DOI 10.1152/ajpendo.00190.2009; Jocken JWE, 2008, HISTOCHEM CELL BIOL, V129, P535, DOI 10.1007/s00418-008-0386-y; Johnson ML, 2013, TRENDS ENDOCRIN MET, V24, P247, DOI 10.1016/j.tem.2012.12.003; Kershaw EE, 2006, DIABETES, V55, P148, DOI 10.2337/diabetes.55.01.06.db05-0982; Khan SA, 2015, DIABETES, V64, P418, DOI 10.2337/db14-0325; Leick L, 2008, AM J PHYSIOL-ENDOC M, V294, pE463, DOI 10.1152/ajpendo.00666.2007; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Long YC, 2005, J GENE MED, V7, P494, DOI 10.1002/jgm.683; MANNAERTS GP, 1979, J BIOL CHEM, V254, P4585; Meex RCR, 2015, AM J PHYSIOL-ENDOC M, V308, pE960, DOI 10.1152/ajpendo.00598.2014; Muoio DM, 2002, DIABETES, V51, P901, DOI 10.2337/diabetes.51.4.901; Muoio DM, 2002, J BIOL CHEM, V277, P26089, DOI 10.1074/jbc.M203997200; Nunes PM, 2012, AM J PHYSIOL-ENDOC M, V303, pE71, DOI 10.1152/ajpendo.00597.2011; Obrowsky S, 2013, J LIPID RES, V54, P425, DOI 10.1194/jlr.M031716; Oosterveer MH, 2009, J BIOL CHEM, V284, P34036, DOI 10.1074/jbc.M109.051052; Picard M, 2012, AM J PHYSIOL-CELL PH, V302, pC629, DOI 10.1152/ajpcell.00368.2011; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Sapiro JM, 2009, J LIPID RES, V50, P1621, DOI 10.1194/jlr.M800614-JLR200; Schoiswohl G, 2010, J LIPID RES, V51, P490, DOI 10.1194/jlr.M001073; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Sitnick MT, 2013, DIABETES, V62, P3350, DOI 10.2337/db13-0500; Springer M.L., 2002, GENE DELIVERY MUSCLE, P13; Tang TY, 2013, CELL METAB, V18, P883, DOI 10.1016/j.cmet.2013.10.012; Venegas V., 2011, CURR PROTOC HUM GENE, V68, DOI [DOI 10.1002/0471142905.HG1907S68, 10.1002/0471142905.hg1907s68]; Vigelso A, 2015, J APPL PHYSIOL, V118, P386, DOI 10.1152/japplphysiol.00840.2014; Wenz T, 2009, P NATL ACAD SCI USA, V106, P20405, DOI 10.1073/pnas.0911570106; Wong KE, 2015, DIABETES, V64, P1532, DOI 10.2337/db14-0827; Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X; Wyckelsma VL, 2016, EXP GERONTOL, V75, P8, DOI 10.1016/j.exger.2015.12.010; Ye JM, 2001, DIABETES, V50, P411, DOI 10.2337/diabetes.50.2.411; Yu XX, 1997, J NUTR, V127, P1814, DOI 10.1093/jn/127.9.1814	49	25	25	2	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3822	3834		10.1096/fj.201600571RR	http://dx.doi.org/10.1096/fj.201600571RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27485820				2022-12-28	WOS:000386474700016
J	Huang, XP; Ludke, A; Dhingra, S; Guo, J; Sun, Z; Zhang, L; Weisel, RD; Li, RK				Huang, Xi-Ping; Ludke, Ana; Dhingra, Sanjiv; Guo, Jian; Sun, Zhuo; Zhang, Li; Weisel, Richard D.; Li, Ren-Ke			Class II transactivator knockdown limits major histocompatibility complex II expression, diminishes immune rejection, and improves survival of allogeneic bone marrow stem cells in the infarcted heart	FASEB JOURNAL			English	Article						myocardial infarction; cell therapy; immune privilege	POSEIDON RANDOMIZED-TRIAL; INTERFERON-GAMMA; TRANSENDOCARDIAL INJECTION; CARDIAC REPAIR; THERAPY; CIITA; ENGRAFTMENT; CHALLENGES; DELIVERY; DISEASE	This study was performed to investigate how to overcome immunorejection associated with allogeneic stem cell therapy in the infarcted heart. Allogeneic bone marrow mesenchymal stem cell (MSC) differentiation increases major histocompatibility complex II (MHC II) expression, inducing transition from immunoprivileged to immunogenic phenotype. MHC II expression is regulated by the class II transactivator (CIITA). We isolated and characterized mouse and human MSCs and knocked down CIITA expression. Wild-type (WT) or CIITA-knockout (CIITA(-)) mouse MSCs were implanted into infarcted mouse myocardia, and recipient allo-antibody formation, cell survival, and cardiac function were measured. WT mouse and human MSCs that were myogenically differentiated showed increased MHC II and CIITA expression. Differentiated CIITA(-) MSCs lacked MHC II induction and showed reduced cytotoxicity in allogeneic leukocyte coculture. Differentiation of human MSCs increased MHC II expression, which resulted in cytotoxicity in allogeneic leukocyte coculture and was prevented by CIITA small interfering RNA. In contrast to WT MSCs, CIITA(-) MSCs did not initiate recipient allo-antibody formation and instead survived in the injured myocardium and significantly improved ventricular function. Decreasing CIITA expression in allogeneic MSCs abolished MHC II induction during myogenic differentiation and prevented immunorejection of these cells from the infarcted myocardium, which enhanced beneficial functional effects of MSC implantation on myocardial repair.Huang, X.-P., Ludke, A., Dhingra, S., Guo, J., Sun, Z., Zhang, L., Weisel, R. D., Li, R.-K. Class II transactivator knockdown limits major histocompatibility complex II expression, diminishes immune rejection, and improves survival of allogeneic bone marrow stem cells in the infarcted heart.	[Huang, Xi-Ping; Ludke, Ana; Guo, Jian; Sun, Zhuo; Weisel, Richard D.; Li, Ren-Ke] Univ Hlth Network, Toronto Gen Res Inst, Div Cardiovasc Surg, Toronto, ON, Canada; [Dhingra, Sanjiv] Univ Manitoba, Dept Physiol, Winnipeg, MB, Canada; [Zhang, Li] Univ Toronto, Dept Pathobiol & Immunol, Toronto, ON, Canada; [Weisel, Richard D.; Li, Ren-Ke] Univ Toronto, Dept Surg, Div Cardiac Surg, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Manitoba; University of Toronto; University of Toronto	Li, RK (corresponding author), MaRS Ctr, Toronto Med Discovery Tower,Room 3-702, Toronto, ON M5G 1L7, Canada.	renkeli@uhnres.utoronto.ca	Dhingra, Sanjiv/D-8766-2014	Dhingra, Sanjiv/0000-0002-2664-7633; Li, Ren-Ke/0000-0002-2584-060X	Canadian Institutes of Health Research [332652]; Heart and Stroke Foundation of Canada Fellowship Award	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Canada Fellowship Award(Heart & Stroke Foundation of Canada)	The authors thank Dr. Leigh Botly (Department of Cardiovascular Surgery, Toronto General Research Institute, University Health Network) for help with manuscript preparation and editing. This study was supported by the Canadian Institutes of Health Research (Foundation Grant 332652 to R.-K.L.). A.L. is supported by a Heart and Stroke Foundation of Canada Fellowship Award. R.-K.L. holds a Canada Research Chair in Cardiac Regeneration. Author contributions: X.-P. Huang and A. Ludke designed and performed research, analyzed data and wrote the paper; S. Dhingra, J. Guo and Z. Sun performed research; L. Zhang contributed to data analysis and interpretation; and R. D. Weisel and R.-K. Li designed research and wrote the paper. The authors declare no conflicts of interest.	Alagesan S, 2014, CURR OPIN ORGAN TRAN, V19, P65, DOI 10.1097/MOT.0000000000000043; Amado LC, 2005, P NATL ACAD SCI USA, V102, P11474, DOI 10.1073/pnas.0504388102; Brickey WJ, 2002, TRANSPLANTATION, V74, P1341, DOI 10.1097/00007890-200211150-00024; Chan JL, 2006, BLOOD, V107, P4817, DOI 10.1182/blood-2006-01-0057; Chang CH, 1996, IMMUNITY, V4, P167, DOI 10.1016/S1074-7613(00)80681-0; Chapman HA, 1998, CURR OPIN IMMUNOL, V10, P93, DOI 10.1016/S0952-7915(98)80038-1; Cimini M, 2007, CIRCULATION, V116, pI77, DOI 10.1161/CIRCULATIONAHA.107.708107; Dhingra S, 2010, TRENDS CARDIOVAS MED, V20, P263, DOI 10.1016/j.tcm.2011.12.002; Grinnemo KH, 2004, J THORAC CARDIOV SUR, V127, P1293, DOI 10.1016/j.jtcvs.2003.07.037; Hare JM, 2012, JAMA-J AM MED ASSOC, V308, P2369, DOI 10.1001/jama.2012.25321; Huang XP, 2010, CIRCULATION, V122, P2419, DOI 10.1161/CIRCULATIONAHA.110.955971; Karantalis V, 2015, CIRC RES, V116, P1413, DOI 10.1161/CIRCRESAHA.116.303614; Laflamme MA, 2011, NATURE, V473, P326, DOI 10.1038/nature10147; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; Li SH, 2009, J THORAC CARDIOV SUR, V137, P1225, DOI 10.1016/j.jtcvs.2008.11.001; Liu L, 2011, J CELL BIOL, V193, P257, DOI 10.1083/jcb.201010131; McDevitt HO, 1998, CURR OPIN IMMUNOL, V10, P677, DOI 10.1016/S0952-7915(98)80088-5; Neefjes J, 2011, NAT REV IMMUNOL, V11, P823, DOI 10.1038/nri3084; Pearl JI, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3005090; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Sanganalmath SK, 2013, CIRC RES, V113, P810, DOI 10.1161/CIRCRESAHA.113.300219; Satoh A, 2004, ONCOGENE, V23, P8876, DOI 10.1038/sj.onc.1208144; STEIMLE V, 1994, SCIENCE, V265, P106, DOI 10.1126/science.8016643; Suncion VY, 2014, CIRC RES, V114, P1292, DOI 10.1161/CIRCRESAHA.114.302854; VADDI K, 1994, CIRCULATION, V90, P694, DOI 10.1161/01.CIR.90.2.694; Zhang H, 2005, AM J PHYSIOL-HEART C, V289, pH2089, DOI 10.1152/ajpheart.00019.2005	26	21	22	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3069	3082		10.1096/fj.201600331R	http://dx.doi.org/10.1096/fj.201600331R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27221978				2022-12-28	WOS:000382816300007
J	[Anonymous]				[Anonymous]			RETRACTION: Tissue-infiltrating mucosal-associated invariant T cells play an important role against Mycobacterium tuberculosis infection in tuberculosis pleurisy (vol 31, pg 4204, 2016) (Retraction of Vol 31, Pg 4204, 2016)	FASEB JOURNAL			English	Retraction																		Li JP, 2017, FASEB J, V31, P421, DOI 10.1096/fj.201600441RRET	1	0	0	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2017	31	9					4204	4204		10.1096/fj.201600441R	http://dx.doi.org/10.1096/fj.201600441R			1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FF2FM	27507648	Bronze			2022-12-28	WOS:000408713300043
J	Dai, XY; Okon, I; Liu, ZY; Wu, Y; Zhu, HP; Song, P; Zou, MH				Dai, Xiaoyan; Okon, Imoh; Liu, Zhaoyu; Wu, Yue; Zhu, Huaiping; Song, Ping; Zou, Ming-Hui			A novel role for myeloid cell-specific neuropilin 1 in mitigating sepsis	FASEB JOURNAL			English	Article						macrophage; LPS; inflammation	REGULATORY T-CELLS; INDUCED INSULIN-RESISTANCE; POLYMICROBIAL SEPSIS; IMMUNE-RESPONSE; INNATE IMMUNITY; SEMAPHORIN-III; TUMOR-CELLS; RECEPTOR 4; IN-VIVO; MACROPHAGES	Sepsis-typically caused by an uncontrolled and amplified host systemic inflammatory response to microbial infection-is a life-threatening complex clinical disorder and remains a major cause of infection-related deaths in the intensive care unit. Emerging evidence suggests that neuropilin 1 (Nrp1), an originally defined coreceptor for class 3 semaphorins and VEGF, plays important roles in the immune system; however, the function and regulation of macrophage Nrp1 in host immune defense against bacterial infection remain unknown. To address this problem, we generated myeloid cell specific Nrp1-knockout (Nrp1 mice and applied 2 stringent animal models of sepsis: cecal ligation and puncture as well as intraperitoneal injection of LPS. Here, we reported that myeloid cell specific Nrp1-deficient mice exhibited enhanced susceptibility to cecal ligation and puncture and LPS-induced sepsis, which correlated with significantly decreased survival rates and heightened levels of proinflammatory cytokines in both peritoneal lavage and serum. Mechanistically, LPS specifically attenuated the expression of Nrp1 in macrophages, which was mediated by TLR4 NF-KB p50 and-65 pathways. By using isolated primary macrophages, loss of Nrp1 consistently resulted in increased production of proinflammatory cytokines, including iNOS, TNF-alpha, and IL-6. Together, these findings demonstrate a novel role of macrophage Nrp1 in sepsis. Dai, X. Okon, I., Liu, Z., Wu, Y., Zhu, H., Song, P., Zou, M.-H. A novel role for myeloid cell specific neuropilin 1 in mitigating sepsis.	[Dai, Xiaoyan; Okon, Imoh; Liu, Zhaoyu; Zhu, Huaiping; Song, Ping; Zou, Ming-Hui] Georgia State Univ, Ctr Mol & Translat Med, Atlanta, GA 30303 USA; [Wu, Yue] Xi An Jiao Tong Univ, Affiliated Hosp 1, Cardiovasc Res Ctr, Dept Cardiol, Xian, Peoples R China	University System of Georgia; Georgia State University; Xi'an Jiaotong University	Zou, MH (corresponding author), Georgia State Univ, 157 Decatur St SE, Atlanta, GA 30303 USA.	mzou@gsu.edu	liu, zhao/GXV-6141-2022; Song, Ping/N-8456-2018	Song, Ping/0000-0002-6143-4270	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL079584, HL080499]; NIH National Cancer Institute [CA213022]; NIH National Institute on Aging [AG047776]; NATIONAL CANCER INSTITUTE [R01CA213022] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080499, R01HL079584] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG047776] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by funding from the following agencies: U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (Grants HL079584 and HL080499), NIH National Cancer Institute (Grant CA213022), and NIH National Institute on Aging (Grant AG047776). M.-H.Z. is the Eminent Scholar in Molecular and Translational Medicine of Georgia Research Alliance.	Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Angus DC, 2011, JAMA-J AM MED ASSOC, V306, P2614, DOI 10.1001/jama.2011.1853; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bruder D, 2004, EUR J IMMUNOL, V34, P623, DOI 10.1002/eji.200324799; Bruscia EM, 2011, J IMMUNOL, V186, P6990, DOI 10.4049/jimmunol.1100396; Casazza A, 2013, CANCER CELL, V24, P695, DOI 10.1016/j.ccr.2013.11.007; Catalano A, 2006, BLOOD, V107, P3321, DOI 10.1182/blood-2005-06-2445; Catalano A, 2010, J IMMUNOL, V185, P6373, DOI 10.4049/jimmunol.0903527; Cohen J, 2012, LANCET INFECT DIS, V12, P503, DOI 10.1016/S1473-3099(12)70136-6; Delgoffe GM, 2013, NATURE, V501, P252, DOI 10.1038/nature12428; Deutschman CS, 2014, IMMUNITY, V40, P464, DOI 10.1016/j.immuni.2014.04.001; Fantin A, 2010, BLOOD, V116, P829, DOI 10.1182/blood-2009-12-257832; Hansen W, 2012, J EXP MED, V209, P2001, DOI 10.1084/jem.20111497; Hayashi M, 2012, NATURE, V485, P69, DOI 10.1038/nature11000; He ZG, 1997, CELL, V90, P739, DOI 10.1016/S0092-8674(00)80534-6; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hubbard WJ, 2005, SHOCK, V24, P52, DOI 10.1097/01.shk.0000191414.94461.7e; Ji JD, 2009, HUM IMMUNOL, V70, P211, DOI 10.1016/j.humimm.2009.01.026; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kim F, 2007, CIRC RES, V100, P1589, DOI 10.1161/CIRCRESAHA.106.142851; Kolodkin AL, 1997, CELL, V90, P753, DOI 10.1016/S0092-8674(00)80535-8; Kong XN, 2007, J EXP MED, V204, P2719, DOI 10.1084/jem.20062611; Kumanogoh A, 2013, NAT REV IMMUNOL, V13, P802, DOI 10.1038/nri3545; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; Liu ZY, 2015, J BIOL CHEM, V290, P19011, DOI 10.1074/jbc.M115.649210; Miyauchi JT, 2016, ONCOTARGET, V7, P9801, DOI 10.18632/oncotarget.6877; Pal D, 2012, NAT MED, V18, P1279, DOI 10.1038/nm.2851; Plitas G, 2008, J EXP MED, V205, P1277, DOI 10.1084/jem.20080162; Pucci F, 2009, BLOOD, V114, P901, DOI 10.1182/blood-2009-01-200931; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Rolny C, 2011, CANCER CELL, V19, P31, DOI 10.1016/j.ccr.2010.11.009; Ruf W, 2010, J CLIN INVEST, V120, P3084, DOI 10.1172/JCI44266; Sheedy FJ, 2010, NAT IMMUNOL, V11, P141, DOI 10.1038/ni.1828; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Soker S, 1998, CELL, V92, P735, DOI 10.1016/S0092-8674(00)81402-6; Spiller S, 2008, J EXP MED, V205, P1747, DOI 10.1084/jem.20071990; Takahashi N, 2003, FEBS LETT, V550, P190, DOI 10.1016/S0014-5793(03)00859-7; Takeda Y, 2011, NATURE, V479, P122, DOI 10.1038/nature10507; Tordjman R, 2002, NAT IMMUNOL, V3, P477, DOI 10.1038/ni789; Tserel L, 2014, IMMUN AGEING, V11, DOI 10.1186/1742-4933-11-1; Ueno-Shuto K, 2014, J BIOL CHEM, V289, P18097, DOI 10.1074/jbc.M113.532093; van den Bosch MWM, 2014, J BIOL CHEM, V289, P22980, DOI 10.1074/jbc.M114.573089; Wallerius M, 2016, CANCER RES, V76, P3166, DOI 10.1158/0008-5472.CAN-15-2596; Wang SX, 2009, DIABETES, V58, P1893, DOI 10.2337/db09-0267; Wen HT, 2008, BLOOD, V111, P1797, DOI 10.1182/blood-2007-08-106443; Wen HT, 2010, J EXP MED, V207, P2943, DOI 10.1084/jem.20101138; Ye XB, 2007, BBA-MOL CELL RES, V1773, P243, DOI 10.1016/j.bbamcr.2006.09.013	47	12	14	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2881	2892		10.1096/fj.201601238R	http://dx.doi.org/10.1096/fj.201601238R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28325756	Green Published			2022-12-28	WOS:000405931000014
J	Leal-Lasarte, MM; Franco, JM; Labrador-Garrido, A; Pozo, D; Roodveldt, C				Leal-Lasarte, Maria M.; Franco, Jaime M.; Labrador-Garrido, Adahir; Pozo, David; Roodveldt, Cintia			Extracellular TDP-43 aggregates target MAPK/MAK/MRK overlapping kinase (MOK) and trigger caspase-3/IL-18 signaling in microglia	FASEB JOURNAL			English	Article						amyotrophic lateral sclerosis; neuroinflammation; heat-shock protein; neurodegeneration; innate immunity	AMYOTROPHIC-LATERAL-SCLEROSIS; FRONTOTEMPORAL LOBAR DEGENERATION; HEAT-SHOCK PROTEINS; DNA-BINDING PROTEIN; NF-KAPPA-B; PATHOLOGICAL TDP-43; NLRP3 INFLAMMASOME; SOD1 MUTATIONS; SPINAL-CORD; CELL-DEATH	Dysregulated microglial responses are central in neurodegenerative proteinopathies, including amyotrophic lateral sclerosis (ALS) and frontotemporal lobar disease (FTLD). Pathologic TDP-43, which is typically found in intracellular inclusions, is a misfolding protein with emerging roles in ALS and FTLD. Recently, TDP-43 species have been found in extracellular fluids of patients; however, the overall implications of TDP-43 mediated signaling linked to neuroinflammation are poorly understood. Our work the first, to our knowledge, to focus on innate immunity responses to TDP-43 aggregates shows that such species are internalized by microglia and cause abnormal mobilization of endogenous TDP-43. Exposure to TDP-43 aggregates elicited not only IL-113, but also NLRP3dependent and noncanonical IL-18 processing. Moreover, we report a link between TDP-43 and neuronal loss via the apoptosis-independent emerging roles of caspase-3 in neurotoxic inflammation. Our results further support the view of noncell autonomous neurodegenerative mechanisms in ALS. Remarkably, we demonstrate that TDP-43 aggregates bind to and colocalize with MAPK/MAK/MRK overlapping kinase (MOK) and show that its phosphorylation status is disrupted. Finally, we show that this TDP-43 caused activation state can be altered by exogenous Hsp27 and Hsp70 chaperones. Our study provides new insight into the immune phenotype, mechanisms, and signaling pathways that operate in microglial neurotoxic activation in ALS. Leal-Lasarte, M. M., Franco, J. M., Labrador-Garrido, A., Pozo, D., Roodveldt, C. Extracellular TDP-43 aggregates target MAPK/MAK/MRK overlapping kinase (MOK) and trigger caspase-3/IL-18 signaling in microglia.	[Leal-Lasarte, Maria M.; Franco, Jaime M.; Labrador-Garrido, Adahir; Pozo, David; Roodveldt, Cintia] Univ Paplo de Olavide, Univ Seville, Spanish Res Council CSIC, Andalusian Ctr Mol Biol & Regenerat Med CABIMER, Seville, Spain; [Franco, Jaime M.; Labrador-Garrido, Adahir; Pozo, David] Univ Seville, Sch Med, Dept Med Biochem Mol Biol & Immunol, Seville, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Pablo de Olavide; University of Sevilla; CSIC - Centro Andaluz de Biologia Molecular y Medicina Regenerativa (CABIMER); University of Sevilla	Roodveldt, C (corresponding author), Andalusian Ctr Mol Biol & Regenerat Med, Edificio CABIMER,Ave Americo Vespucio S-N, Seville 41092, Spain.	cintia.roodveldt@cabimer.es	Pozo, David/C-2149-2017; Lasarte, María Magdalena Leal/AAB-3380-2020; Muñoz Franco, Jaime/C-2141-2017; Roodveldt, Cintia/I-9118-2014	Pozo, David/0000-0002-3732-4960; Lasarte, María Magdalena Leal/0000-0001-5250-8680; Muñoz Franco, Jaime/0000-0002-4227-9391; Roodveldt, Cintia/0000-0003-4124-8769; Labrador-Garrido, Adahir/0000-0001-5098-9601	Spanish Ministry of Economy; Fonds Europeen de Developpement Economique et Regional (FEDER) [CP10/00527, SAF-2012-39720, RTC-2015-3309-1]; Regional Ministry of Economy [PS09-22524SCIII, P11-CTS8161]; Spanish Ministry of Economy (Institute de Salud Carlos III) - FEDER [CPII16/58]; Jorge Abarca's Reto4ELA; ETA Andalucia Foundation	Spanish Ministry of Economy(Spanish Government); Fonds Europeen de Developpement Economique et Regional (FEDER); Regional Ministry of Economy; Spanish Ministry of Economy (Institute de Salud Carlos III) - FEDER; Jorge Abarca's Reto4ELA; ETA Andalucia Foundation	The authors thank Prof. Yoshiaki Furukawa's group (Keio University, Yokohama, Japan) for kindly providing the pET15b/ TDP-43 construct for protein overexpression. This work was supported by the following grants from the Spanish Ministry of Economy, and cofunded by Fonds Europeen de Developpement Economique et Regional (FEDER): CP10/00527, SAF-2012-39720 and RTC-2015-3309-1 (to C.R.); PS09-22524SCIII (to D.P.); P11-CTS8161 from the Regional Ministry of Economy (to D.P.). C.R holds a senior Servet II contract (CPII16/58) from the Spanish Ministry of Economy (Institute de Salud Carlos III) cofounded by FEDER. This work was also supported by Jorge Abarca's Reto4ELA and ETA Andalucia Foundation.	Akita K, 1997, J BIOL CHEM, V272, P26595, DOI 10.1074/jbc.272.42.26595; Alboni S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-9; Arai T, 2006, BIOCHEM BIOPH RES CO, V351, P602, DOI 10.1016/j.bbrc.2006.10.093; Baloh RH, 2011, FEBS J, V278, P3539, DOI 10.1111/j.1742-4658.2011.08256.x; Binder RJ, 2014, J IMMUNOL, V193, P5765, DOI 10.4049/jimmunol.1401417; Borges TJ, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00095; Brownell SE, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00074; Bruinsma IB, 2011, J NEUROSCI, V31, P11992, DOI 10.1523/JNEUROSCI.0945-11.2011; Burguillos MA, 2011, NATURE, V472, P319, DOI 10.1038/nature09788; Calderwood SK, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00159; Capitini C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086720; Cascella R, 2016, J BIOL CHEM, V291, P19437, DOI 10.1074/jbc.M116.737726; Chang HY, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3757; Chen HJ, 2016, BRAIN, V139, P1417, DOI 10.1093/brain/aww028; Correia AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140248; Danzer KM, 2011, FASEB J, V25, P326, DOI 10.1096/fj.10-164624; De Maio A, 2013, SHOCK, V40, P239, DOI 10.1097/SHK.0b013e3182a185ab; Dinarello CA, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00289; Ding XB, 2015, ONCOTARGET, V6, P24178, DOI 10.18632/oncotarget.4680; Eichmuller S, 2002, EXP DERMATOL, V11, P292, DOI 10.1034/j.1600-0625.2002.110402.x; Feiler MS, 2015, J CELL BIOL, V211, P897, DOI 10.1083/jcb.201504057; Fong JJ, 2015, EMBO J, V34, P2775, DOI 10.15252/embj.201591407; Frakes AE, 2014, NEURON, V81, P1009, DOI 10.1016/j.neuron.2014.01.013; Fu J. Z., 2012, PROTEIN KINASES, P229; Garcia-Faroldi G, 2013, J IMMUNOL, V191, P1445, DOI 10.4049/jimmunol.1300216; Garlanda C, 2013, IMMUNITY, V39, P1003, DOI 10.1016/j.immuni.2013.11.010; Guzman-Lenis MS, 2008, NEUROSCIENCE, V155, P104, DOI 10.1016/j.neuroscience.2008.04.078; Hardiman O, 2011, NAT REV NEUROL, V7, P639, DOI 10.1038/nrneurol.2011.153; Hooten KG, 2015, NEUROTHERAPEUTICS, V12, P364, DOI 10.1007/s13311-014-0329-3; Igaz LM, 2008, AM J PATHOL, V173, P182, DOI 10.2353/ajpath.2008.080003; Iguchi Y, 2016, BRAIN, V139, P3187, DOI 10.1093/brain/aww237; Italiani P, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-94; Jain MR, 2008, PROTEOM CLIN APPL, V2, P670, DOI 10.1002/prca.200780023; Johann S, 2015, GLIA, V63, P2260, DOI 10.1002/glia.22891; Kadhim H, 2016, MED HYPOTHESES, V86, P14, DOI 10.1016/j.mehy.2015.11.022; Kasai T, 2009, ACTA NEUROPATHOL, V117, P55, DOI 10.1007/s00401-008-0456-1; Kavanagh E, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.514; Labrador-Garrido A, 2016, FASEB J, V30, P564, DOI 10.1096/fj.15-275131; Labrador-Garrido A, 2014, IMMUN INFLAMM DIS, V2, P226, DOI 10.1002/iid3.39; Lindberg I, 2015, J NEUROSCI, V35, P13853, DOI 10.1523/JNEUROSCI.2600-15.2015; Mackenzie IRA, 2007, ANN NEUROL, V61, P427, DOI 10.1002/ana.21147; Maekawa S, 2009, NEUROPATHOLOGY, V29, P672, DOI 10.1111/j.1440-1789.2009.01029.x; Mannini B, 2012, P NATL ACAD SCI USA, V109, P12479, DOI 10.1073/pnas.1117799109; Martinez-Fabregas J, 2014, MOL CELL PROTEOMICS, V13, P1439, DOI 10.1074/mcp.M113.034322; Mayo L, 2008, J IMMUNOL, V181, P92, DOI 10.4049/jimmunol.181.1.92; Mayo L, 2011, GLIA, V59, P397, DOI 10.1002/glia.21109; Miyata Y, 1999, GENES CELLS, V4, P299, DOI 10.1046/j.1365-2443.1999.00261.x; Miyazaki D, 2016, NEUROL SCI, V37, P1277, DOI 10.1007/s10072-016-2582-1; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Neumann M, 2009, ACTA NEUROPATHOL, V117, P137, DOI 10.1007/s00401-008-0477-9; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; Noto YI, 2011, AMYOTROPH LATERAL SC, V12, P140, DOI 10.3109/17482968.2010.541263; Omoto Y, 2006, J IMMUNOL, V177, P8315, DOI 10.4049/jimmunol.177.12.8315; Philips T, 2011, LANCET NEUROL, V10, P253, DOI 10.1016/S1474-4422(11)70015-1; Radford RA, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00414; Radons J, 2016, CELL STRESS CHAPERON, V21, P379, DOI 10.1007/s12192-016-0676-6; Ransohoff RM, 2016, SCIENCE, V353, P777, DOI 10.1126/science.aag2590; Ratti A, 2016, J NEUROCHEM, V138, P95, DOI 10.1111/jnc.13625; Roodveldt C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079160; Roodveldt C, 2009, EMBO J, V28, P3758, DOI 10.1038/emboj.2009.298; Salari S, 2013, CELL STRESS CHAPERON, V18, P53, DOI 10.1007/s12192-012-0356-0; Sheppard PW, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003471; Smethurst P, 2015, NEUROPATH APPL NEURO, V41, P578, DOI 10.1111/nan.12206; Steinacker P, 2008, ARCH NEUROL-CHICAGO, V65, P1481, DOI 10.1001/archneur.65.11.1481; Udan-Johns M, 2014, HUM MOL GENET, V23, P157, DOI 10.1093/hmg/ddt408; Venero JL, 2011, CELL DEATH DIFFER, V18, P1679, DOI 10.1038/cdd.2011.107; Zhang H, 2008, ACTA NEUROPATHOL, V115, P115, DOI 10.1007/s00401-007-0285-7; Zhao WH, 2015, EXP NEUROL, V273, P24, DOI 10.1016/j.expneurol.2015.07.019	68	29	31	2	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2797	2816		10.1096/fj.201601163R	http://dx.doi.org/10.1096/fj.201601163R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28336525				2022-12-28	WOS:000405931000008
J	Kelcher, AMH; Atanga, PA; Gamez, JD; Garcia, LMC; Teclaw, SJ; Pavelko, KD; Macura, SI; Johnson, AJ				Kelcher, April M. Huseby; Atanga, Pascal A.; Gamez, Jeffrey D.; Garcia, Luz M. Cumba; Teclaw, Stephanie J.; Pavelko, Kevin D.; Macura, Slobodan I.; Johnson, Aaron J.			Brain atrophy in picornavirus-infected FVB mice is dependent on the H-2D(b) class I molecule	FASEB JOURNAL			English	Article						neurodegeneration; MHC class I; viral clearance; TMEV; CD8 T cells	THEILERS VIRUS-INFECTION; T-CELL RESPONSE; RELAPSING MULTIPLE-SCLEROSIS; CENTRAL-NERVOUS-SYSTEM; MHC CLASS-I; INDUCED DEMYELINATION; PERSISTENT INFECTION; MURINE MODEL; AXONAL LOSS; PLASTICITY	Brain atrophy is a common feature of numerous neurologic diseases in which the role of neuro-inflammation remains ill-defined. In this study, we evaluated the contribution of major histocompatibility complex class I molecules to brain atrophy in Theiler's murine encephalomyelitis virus (TMEV)-infected transgenic FVB mice that express the D-b class I molecule. FVB/D-b and wild-type FVB mice were evaluated for changes in neuro-inflammation, virus clearance, neuropathology, and development of brain atrophy via T2-weighted MRI and subsequent 3-dimensional volumetric analysis. Significant brain atrophy and hippocampal neuronal loss were observed in TMEV-infected FVB/Db mice, but not in wild-type FVB mice. Brain atrophy was observed at 1 mo postinfection and persisted through the 4-mo observation period. Of importance, virus-infected FVB/D-b mice elicited a strong CD8 T-cell response toward the immunodominant D-b-restricted TMEV-derived peptide, VP2(121-130), and cleared TMEV from the CNS. In addition, immunofluorescence revealed CD8 T cells near virus-infected neurons; therefore, we hypothesize that class I restricted CD8 T-cell responses promote development of brain atrophy. This model provides an opportunity to analyze the contribution of immune cells to brain atrophy in a system where persistent virus infection and demyelination are not factors in long-term neuropathology.	[Kelcher, April M. Huseby; Garcia, Luz M. Cumba] Mayo Clin, Grad Sch Biomed Sci, Rochester, MN USA; [Kelcher, April M. Huseby; Garcia, Luz M. Cumba; Teclaw, Stephanie J.; Pavelko, Kevin D.; Johnson, Aaron J.] Mayo Clin, Dept Immunol, Guggenheim 4-11C,200 First St SW, Rochester, MN 55905 USA; [Atanga, Pascal A.; Gamez, Jeffrey D.; Johnson, Aaron J.] Mayo Clin, Dept Neurol, Rochester, MN USA; [Macura, Slobodan I.] Mayo Clin, Nucl Magnet Resonance Core Facil, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; Mayo Clinic	Johnson, AJ (corresponding author), Mayo Clin, Dept Immunol, Guggenheim 4-11C,200 First St SW, Rochester, MN 55905 USA.	johnson.aaron2@mayo.edu	Pavelko, Kevin D/K-7072-2019	Pavelko, Kevin D/0000-0001-7555-1315; Huseby Kelcher, April/0000-0002-9665-2921	U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke [R21 NS094765]; NIH [T32 AI07425-20]; Mayo Graduate School; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007425] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS094765] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Mayo Graduate School; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank and acknowledge the contributions of their former collaborator, Dr. Istvan Pirko (Department of Neurology, Mayo Clinic), who they will miss. The authors also thank Dr. Yong Guo (Department of Neurology, Mayo Clinic), for help with the histology aspects of this study. This work was supported by U.S. National Institutes of Health (NIH) National Institute of Neurological Disorders and Stroke Grant R21 NS094765 and intramural funds, as well as funding from NIH Ph.D. Training Grant in Basic Immunology (T32 AI07425-20) and the Mayo Graduate School. The authors declare no conflicts of interest.	ALTINTAS A, 1993, J IMMUNOL, V151, P2803; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; AZOULAY A, 1994, J VIROL, V68, P4049, DOI 10.1128/JVI.68.6.4049-4052.1994; Azoulay-Cayla A, 2001, J GEN VIROL, V82, P1043, DOI 10.1099/0022-1317-82-5-1043; Boulanger LM, 2009, NEURON, V64, P93, DOI 10.1016/j.neuron.2009.09.001; Brahic M, 2005, ANNU REV MICROBIOL, V59, P279, DOI 10.1146/annurev.micro.59.030804.121242; Chataway J, 2014, LANCET, V383, P2213, DOI 10.1016/S0140-6736(13)62242-4; Constantinescu SE, 2016, EXPERT REV CLIN PHAR, V9, P49, DOI 10.1586/17512433.2016.1108189; Dell'Orco JM, 2015, J NEUROSCI, V35, P11292, DOI 10.1523/JNEUROSCI.1357-15.2015; Denic Aleksandar, 2011, Pathophysiology, V18, P21, DOI 10.1016/j.pathophys.2010.04.004; Elmer BM, 2012, TRENDS NEUROSCI, V35, P660, DOI 10.1016/j.tins.2012.08.001; Farid N, 2012, RADIOLOGY, V264, P542, DOI 10.1148/radiol.12112638; Garcia LMC, 2016, J IMMUNOL METHODS, V439, P23, DOI 10.1016/j.jim.2016.09.002; Hainke U, 2016, EXPERT OPIN DRUG MET, V12, P701, DOI 10.1080/17425255.2016.1179279; Johnson AJ, 2007, INT REV NEUROBIOL, V79, P73, DOI 10.1016/S0074-7742(07)79004-9; Johnson AJ, 1999, J VIROL, V73, P3702, DOI 10.1128/JVI.73.5.3702-3708.1999; Johnson AJ, 2001, FASEB J, V15, P2760, DOI 10.1096/fj.01-0373fje; Johnson HL, 2012, J IMMUNOL, V189, P1937, DOI 10.4049/jimmunol.1200658; Kappos L, 2010, NEW ENGL J MED, V362, P387, DOI 10.1056/NEJMoa0909494; Lee HM, 2014, NATURE, V509, P195, DOI 10.1038/nature13154; Likeman M, 2005, ARCH NEUROL-CHICAGO, V62, P1410, DOI 10.1001/archneur.62.9.1410; Lin XQ, 2002, J VIROL, V76, P7799, DOI 10.1128/JVI.76.15.7799-7811.2002; Mandolesi G, 2015, NAT REV NEUROL, V11, DOI 10.1038/nrneurol.2015.222; McDole J, 2006, NEUROL RES, V28, P256, DOI 10.1179/016164106X98125; McDole JR, 2010, AM J PATHOL, V177, P1823, DOI 10.2353/ajpath.2010.100231; McGavern DB, 1999, J NEUROSCI RES, V58, P492, DOI 10.1002/(SICI)1097-4547(19991115)58:4<492::AID-JNR3>3.0.CO;2-P; McGavern DB, 2000, BRAIN, V123, P519, DOI 10.1093/brain/123.3.519; Mendez-Fernandez YV, 2005, J VIROL, V79, P3063, DOI 10.1128/JVI.79.5.3063-3070.2005; Mendez-Fernandez YV, 2003, EUR J IMMUNOL, V33, P2501, DOI 10.1002/eji.200324007; Miller SD, 2001, ADV EXP MED BIOL, V490, P99; Pavelko KD, 2007, BRAIN PATHOL, V17, P184, DOI 10.1111/j.1750-3639.2007.00062.x; Pavelko KD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002541; Pavelko KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020217; Penn AA, 1998, SCIENCE, V279, P2108, DOI 10.1126/science.279.5359.2108; Petito CK, 2006, J NEUROVIROL, V12, P272, DOI 10.1080/13550280600879204; Pirko I, 2011, NEUROIMAGE, V54, P802, DOI 10.1016/j.neuroimage.2010.08.055; Pirko I, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-31; Reed BK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137984; ROBB RA, 1989, IEEE T MED IMAGING, V8, P217, DOI 10.1109/42.34710; RODRIGUEZ M, 1985, J IMMUNOL, V135, P2145; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shatz CJ, 2009, NEURON, V64, P40, DOI 10.1016/j.neuron.2009.09.044; Siffrin V, 2010, TRENDS NEUROSCI, V33, P202, DOI 10.1016/j.tins.2010.01.002; Stadelmann C, 2011, CURR OPIN NEUROL, V24, P224, DOI 10.1097/WCO.0b013e328346056f; Tsunoda I, 2010, J NEUROIMMUNE PHARM, V5, P355, DOI 10.1007/s11481-009-9179-x; Vezzani A, 2013, EXP NEUROL, V244, P11, DOI 10.1016/j.expneurol.2011.09.033; Zamolodchikov D, 2016, THROMB RES, V141, pS59, DOI 10.1016/S0049-3848(16)30367-X	47	5	5	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2267	2275		10.1096/fj.201601055R	http://dx.doi.org/10.1096/fj.201601055R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28188174	Green Published			2022-12-28	WOS:000401553400005
J	Newton, J; Hait, NC; Maceyka, M; Colaco, A; Maczis, M; Wassif, CA; Cougnoux, A; Porter, FD; Milstien, S; Platt, N; Platt, FM; Spiegel, S				Newton, Jason; Hait, Nitai C.; Maceyka, Michael; Colaco, Alexandria; Maczis, Melissa; Wassif, Christopher A.; Cougnoux, Antony; Porter, Forbes D.; Milstien, Sheldon; Platt, Nicholas; Platt, Frances M.; Spiegel, Sarah			FTY720/fingolimod increases NPC1 and NPC2 expression and reduces cholesterol and sphingolipid accumulation in Niemann-Pick type C mutant fibroblasts	FASEB JOURNAL			English	Article						histone deacetylase inhibitor; glycosphingolipids; sphingosine kinase; lipid storage disease	HISTONE DEACETYLASE INHIBITORS; ABCA1-DEPENDENT LIPID EFFLUX; CENTRAL-NERVOUS-SYSTEM; NEURAL STEM-CELLS; DISEASE; TRANSPORT; FTY720; ACID; MICE; 2-HYDROXYPROPYL-BETA-CYCLODEXTRIN	Niemann-Pick type C (NPC) disease is a fatal neurodegenerative disorder caused bymutations in NPC1 or NPC2 with decreased functions leading to lysosomal accumulation of cholesterol and sphingolipids. FTY720/fingolimod, used for treatment ofmultiple sclerosis, is phosphorylatedby nuclear sphingosinekinase 2, andits active phosphorylated form (FTY720-P) is an inhibitor of class I histone deacetylases. In this study, administration of clinically relevant doses of FTY720 to mice increased expression of NPC1 and -2 in brain and liver and decreased cholesterol in an SphK2-dependent manner. FTY720 greatly increased expression of NPC1 and -2 in human NPC1 mutant fibroblasts that correlated with formation of FTY720-P and significantly reduced the accumulation of cholesterol and glycosphingolipids. In agreement with this finding, FTY720 pretreatment of human NPC1 mutant fibroblasts restored transport of the cholera toxin B subunit, which binds ganglioside GM1, to the Golgi apparatus. Together, these findings suggest that FTY720 administration can ameliorate cholesterol and sphingolipid storage and trafficking defects in NPC1 mutant fibroblasts. Because neurodegeneration is the main clinical feature of NPC disease, andFTY720 accumulates in theCNSandhas several advantages over availablehistonedeacetylase inhibitors now in clinical trials, our work provides a potential opportunity for treatment of this incurable disease.-Newton, J., Hait, N. C., Maceyka, M., Colaco, A., Maczis, M., Wassif, C. A., Cougnoux, A., Porter, F. D., Milstien, S., Platt, N., Platt, F. M., Spiegel, S. FTY720/fingolimod increasesNPC1 andNPC2expression and reduces cholesterol and sphingolipid accumulation in Niemann- Pick type C mutant fibroblasts. FASEB J. 31, 1719-1730 (2017). www.fasebj.org	[Newton, Jason; Hait, Nitai C.; Maceyka, Michael; Maczis, Melissa; Milstien, Sheldon; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, 2011 Sanger Hall,1101 E Marshall St, Richmond, VA 23298 USA; [Colaco, Alexandria; Platt, Nicholas; Platt, Frances M.] Univ Oxford, Dept Pharmacol, Oxford, England; [Wassif, Christopher A.; Cougnoux, Antony; Porter, Forbes D.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Div Translat Med, NIH, Bethesda, MD USA; [Hait, Nitai C.] Roswell Pk Canc Inst, Dept Oncol, Buffalo, NY 14263 USA	Virginia Commonwealth University; University of Oxford; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); Roswell Park Cancer Institute	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, 2011 Sanger Hall,1101 E Marshall St, Richmond, VA 23298 USA.	sarah.spiegel@vcuhealth.org	Maceyka, Michael/B-9277-2008; Newton, Jason/AAN-8428-2020	Platt, Frances/0000-0001-7614-0403; Newton, Jason/0000-0003-2952-2008; Colaco, Alexandria/0000-0001-8612-6357; Cougnoux, Antony/0000-0001-9407-7540	U.S. National Institutes of Health (NIH) National Cancer Institute [P30 CA016059]; University of Virginia, Charlottesville, VA, USA; University of Guelph, Guelph, ON, Canada; NIH; NIH Institute of Neurological Disorders and Stroke [R21NS087273]; NIH Institute of General Medical Science [R01GM043880]; NIH National Heart, Lung, and Blood Institute [T32 HL094290]; intramural research program of the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development; European Union Seventh Framework Programme [289278]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008824, ZIAHD000139] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016059] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL094290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS087273] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); University of Virginia, Charlottesville, VA, USA; University of Guelph, Guelph, ON, Canada; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Institute of Neurological Disorders and Stroke; NIH Institute of General Medical Science; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); intramural research program of the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development; European Union Seventh Framework Programme(European Commission); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	The authors thank Dr. Jeremy Allegood [Virginia Commonwealth University (VCU)] for skillful sphingolipid analyses; the VCU Lipidomics and Microscopy Cores, which are supported, in part, by funding from the U.S. National Institutes of Health (NIH) National Cancer Institute Support Grant P30 CA016059; Drs. J. White (University of Virginia, Charlottesville, VA, USA) and Frances J. Sharom (University of Guelph, Guelph, ON, Canada) for the CHO cell line; and Dr. Richard Proia (NIH) for generously providing the SphK2-knockout mice and SphK2 antibody. This work was supported by NIH Institute of Neurological Disorders and Stroke Grant R21NS087273, NIH Institute of General Medical Science Grant R01GM043880 (to S.S.), NIH National Heart, Lung, and Blood Institute Grant T32 HL094290 (to J. N.), and, in part, by the intramural research program of the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development (to F.D.P.); and The European Union Seventh Framework Programme (FP7 2007-2013) under Grant Agreement 289278-"Sphingonet" (to A. C. and F. M. P.). F.M.P. is a Royal Society Wolfson Research Merit Award holder and a Wellcome Trust Investigator in Science. The authors declare no conflicts of interest.	Alam MS, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aad9407; Berdyshev EV, 2009, J BIOL CHEM, V284, P5467, DOI 10.1074/jbc.M805186200; Blom T, 2010, CIRC RES, V106, P720, DOI 10.1161/CIRCRESAHA.109.204396; Boadu E, 2006, J MOL MED, V84, P266, DOI 10.1007/s00109-005-0001-9; Briard E, 2011, CHEMMEDCHEM, V6, P667, DOI 10.1002/cmdc.201000477; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Carstea ED, 1997, SCIENCE, V277, P228, DOI 10.1126/science.277.5323.228; Choi HY, 2003, J BIOL CHEM, V278, P32569, DOI 10.1074/jbc.M304553200; Choudhury A, 2002, J CLIN INVEST, V109, P1541, DOI 10.1172/JCI200215420; Cologna SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047845; Cougnoux A, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.16; Crumling MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053280; Davidson CD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006951; Efstathopoulos P, 2015, TRANSL PSYCHIAT, V5, DOI 10.1038/tp.2015.179; Fan M, 2013, J LIPID RES, V54, P2800, DOI 10.1194/jlr.M040618; Fischer A, 2010, TRENDS PHARMACOL SCI, V31, P605, DOI 10.1016/j.tips.2010.09.003; Foster CA, 2007, J PHARMACOL EXP THER, V323, P469, DOI 10.1124/jpet.107.127183; Garbes L, 2009, HUM MOL GENET, V18, P3645, DOI 10.1093/hmg/ddp313; Gardner NM, 2016, TOXICOL SCI, V150, P161, DOI 10.1093/toxsci/kfv321; Gholamnezhadjafari R, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-010114; Ginocchio VM, 2013, MOL GENET METAB, V110, P329, DOI 10.1016/j.ymgme.2013.07.019; Haberland M, 2009, NAT REV GENET, V10, P32, DOI 10.1038/nrg2485; Hait NC, 2015, ONCOGENESIS, V4, DOI 10.1038/oncsis.2015.16; Hait NC, 2014, NAT NEUROSCI, V17, P971, DOI 10.1038/nn.3728; Hait NC, 2009, SCIENCE, V325, P1254, DOI 10.1126/science.1176709; Hanson JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069964; Higaki K, 2001, J BIOCHEM-TOKYO, V129, P875, DOI 10.1093/oxfordjournals.jbchem.a002932; Hoglinger D, 2015, ELIFE, V4, DOI 10.7554/eLife.10616; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kazantsev AG, 2008, NAT REV DRUG DISCOV, V7, P854, DOI 10.1038/nrd2681; Kim SJ, 2007, BIOCHEM BIOPH RES CO, V360, P593, DOI 10.1016/j.bbrc.2007.06.116; Lahiri S, 2009, J BIOL CHEM, V284, P16090, DOI 10.1074/jbc.M807438200; Liu B, 2008, J LIPID RES, V49, P663, DOI 10.1194/jlr.M700525-JLR200; Liu B, 2010, J LIPID RES, V51, P933, DOI 10.1194/jlr.M000257; Liu B, 2009, P NATL ACAD SCI USA, V106, P2377, DOI 10.1073/pnas.0810895106; Lloyd-Evans E, 2008, NAT MED, V14, P1247, DOI 10.1038/nm.1876; Lloyd-Evans E, 2010, TRAFFIC, V11, P419, DOI 10.1111/j.1600-0854.2010.01032.x; Loftus SK, 1997, SCIENCE, V277, P232, DOI 10.1126/science.277.5323.232; Maarup TJ, 2015, MOL GENET METAB, V116, P75, DOI 10.1016/j.ymgme.2015.07.001; Maceyka M, 2013, FEBS J, V280, P6367, DOI 10.1111/febs.12505; Millat G, 1999, AM J HUM GENET, V65, P1321, DOI 10.1086/302626; Munkacsi AB, 2011, J BIOL CHEM, V286, P23842, DOI 10.1074/jbc.M111.227645; Nair Anroop B, 2016, J Basic Clin Pharm, V7, P27, DOI 10.4103/0976-0105.177703; Neufeld EB, 1999, J BIOL CHEM, V274, P9627, DOI 10.1074/jbc.274.14.9627; Neville DCA, 2004, ANAL BIOCHEM, V331, P275, DOI 10.1016/j.ab.2004.03.051; Ottinger EA, 2014, CURR TOP MED CHEM, V14, P330, DOI 10.2174/1568026613666131127160118; PENTCHEV PG, 1985, P NATL ACAD SCI USA, V82, P8247, DOI 10.1073/pnas.82.23.8247; Pipalia NH, 2011, P NATL ACAD SCI USA, V108, P5620, DOI 10.1073/pnas.1014890108; Platt N, 2016, J NEUROCHEM, V136, P74, DOI 10.1111/jnc.13138; Spiegel S, 2011, NAT REV IMMUNOL, V11, P403, DOI 10.1038/nri2974; Sugimoto Y, 2001, P NATL ACAD SCI USA, V98, P12391, DOI 10.1073/pnas.221181998; Sun YL, 2016, BRIT J PHARMACOL, V173, P2793, DOI 10.1111/bph.13557; Taylor AM, 2012, J LIPID RES, V53, P2331, DOI 10.1194/jlr.M028241; Tint GS, 1998, J INHERIT METAB DIS, V21, P853, DOI 10.1023/A:1005474803278; Van den Bossche J, 2014, BIOCHEM BIOPH RES CO, V455, P396, DOI 10.1016/j.bbrc.2014.11.029; Vanier MT, 2013, HAND CLINIC, V113, P1717, DOI 10.1016/B978-0-444-59565-2.00041-1; Vite CH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010101; Wang ML, 2010, CELL METAB, V12, P166, DOI 10.1016/j.cmet.2010.05.016; Xie XF, 2011, P NATL ACAD SCI USA, V108, P15330, DOI 10.1073/pnas.1112751108; Yanjanin NM, 2010, AM J MED GENET B, V153B, P132, DOI 10.1002/ajmg.b.30969; Yu T, 2012, HUM MOL GENET, V21, P3205, DOI 10.1093/hmg/dds145	61	29	30	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1719	1730		10.1096/fj.201601041R	http://dx.doi.org/10.1096/fj.201601041R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28082351	Green Published			2022-12-28	WOS:000398504300036
J	Peuchant, E; Bats, ML; Moranvillier, I; Lepoivre, M; Guitton, J; Wendum, D; Lacombe, ML; Moreau-Gaudry, F; Boissan, M; Dabernat, S				Peuchant, Evelyne; Bats, Marie-Lise; Moranvillier, Isabelle; Lepoivre, Michel; Guitton, Jerome; Wendum, Dominique; Lacombe, Marie-Lise; Moreau-Gaudry, Francois; Boissan, Mathieu; Dabernat, Sandrine			Metastasis suppressor NM23 limits oxidative stress in mammals by preventing activation of stress-activated protein kinases/JNKs through its nucleoside diphosphate kinase activity	FASEB JOURNAL			English	Article						NDPK; hepatocyte; keratinocyte; MAPK	REACTIVE-OXYGEN; HEPATOCELLULAR-CARCINOMA; SIGNAL-TRANSDUCTION; CELL-PROLIFERATION; ENHANCED TOLERANCE; MASS-SPECTROMETRY; CANCER-CELLS; MOUSE-LIVER; JNK; SENESCENCE	NME1 (nonmetastatic expressed 1) gene, which encodes nucleoside diphosphate kinase (NDPK) A [ also known as nonmetastatic clone 23 (NM23)-H1 in humans and NM23-M1 in mice], is a suppressor of metastasis, but several lines of evidence-mostly from plants-also implicate it in the regulation of the oxidative stress response. Here, our aim was to investigate the physiologic relevance of NDPK A with respect to the oxidative stress response in mammals and to study its molecular basis. NME1-knockout mice died sooner, suffered greater hepatocyte injury, and had lower superoxide dismutase activity than did wild-type (WT) mice in response to paraquat-induced acute oxidative stress. Deletion of NME1 reduced total NDPK activity and exacerbated activation of the stress-related MAPK, JNK, in the liver in response to paraquat. In a mouse transformed hepatocyte cell line and in primary cultures of normal human keratinocytes, MAPK activation in response to H2O2 and UVB, respectively, was dampened by expression of NM23-M1/NM23-H1, dependent on its NDPK catalytic activity. Furthermore, excess or depletion of NM23-M1/NM23-H1NDPK activity did not affect the intracellular bulk concentration of nucleoside di- and triphosphates. NME1-deficient mouse embryo fibroblasts grew poorly in culture, were more sensitive to stress than WT fibroblasts, and did not immortalize, which suggested that they senesce earlier than do WT fibroblasts. Collectively, these results indicate that the NDPK activity of NM23-M1/NM23-H1 protects cells from acute oxidative stress by inhibiting activation of JNK in mammal models.-Peuchant, E., Bats, M.-L., Moranvillier, I., Lepoivre, M., Guitton, J., Wendum, D., Lacombe, M.-L., Moreau-Gaudry, F., Boissan, M., Dabernat, S. Metastasis suppressor NM23 limits oxidative stress in mammals by preventing activation of stress-activated protein kinases/JNKs through its nucleoside diphosphate kinase activity.	[Peuchant, Evelyne; Bats, Marie-Lise; Moranvillier, Isabelle; Moreau-Gaudry, Francois; Dabernat, Sandrine] Univ Bordeaux, Coll Sante, Bordeaux, France; [Peuchant, Evelyne; Moranvillier, Isabelle; Moreau-Gaudry, Francois; Dabernat, Sandrine] INSERM 1035, Bordeaux, France; [Peuchant, Evelyne; Bats, Marie-Lise; Moreau-Gaudry, Francois; Dabernat, Sandrine] Ctr Hosp Univ Bordeaux, Bordeaux, France; [Lepoivre, Michel] Univ Paris 11, Commissariat Energie Atom & Energies, Unit Mixte Rech, CNRS 9198, Orsay, France; [Guitton, Jerome] Hosp Civils Lyon, Pierre Benite, France; [Guitton, Jerome] Univ Lyon, Lyon, France; [Wendum, Dominique; Lacombe, Marie-Lise; Boissan, Mathieu] Univ Paris 06, Univ Paris 06, INSERM, Unite Mixte Rech S938,St Antoine Res Ctr,Sorbonne, 184 Rue Faubourg,St Antoine Kourilsky Bldg, F-75012 Paris, France; [Wendum, Dominique] Hop St Antoine, Lab Anat Pathol, Paris, France; [Boissan, Mathieu] Hop Tenon, AP HP, Serv Biochim & Hormonol, Paris, France	UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); CHU Bordeaux; CEA; UDICE-French Research Universities; Universite Paris Saclay; CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Saint-Antoine - APHP; UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Tenon - APHP; UDICE-French Research Universities; Sorbonne Universite	Boissan, M (corresponding author), Univ Paris 06, Univ Paris 06, INSERM, Unite Mixte Rech S938,St Antoine Res Ctr,Sorbonne, 184 Rue Faubourg,St Antoine Kourilsky Bldg, F-75012 Paris, France.; Dabernat, S (corresponding author), Univ Bordeaux, INSERM U1035, 146 Rue Leo Saignat, F-33000 Bordeaux, France.	mathieu.boissan@inserm.fr; sandrine.dabernat@u-bordeaux.fr		Guitton, Jerome/0000-0001-6180-5708; Bats, Marie-Lise/0000-0002-8359-4662	Ligue Nationale contre le Cancer; Groupement des Entreprises Francaises contre le Cancer (GEFLUC)	Ligue Nationale contre le Cancer(Ligue nationale contre le cancer); Groupement des Entreprises Francaises contre le Cancer (GEFLUC)	The authors thank J. Y. Daniel (Universite de Bordeaux) for his enthusiastic commitment to the NM23 field and the enduring support he provided to our group. The authors also thank I. Lascu (Universite de Bordeaux) for his continuous interest in our work and Y. Chretien (Sorbonne Universites, Universite Pierre et Marie Curie) for help with infography. Carol Featherstone (Plume Scientific Communication Services) edited the manuscript. The authors are grateful to Martine Auclair (Sorbonne Universites, Universite Pierre et Marie Curie), who performed senescence markers Western blotting. Core funding for this work was provided by the Ligue Nationale contre le Cancer (to S.D.),and additional support was provided by grants of the Groupement des Entreprises Francaises contre le Cancer (GEFLUC; to M.B.).	Agarwal R P, 1978, Methods Enzymol, V51, P376; An R, 2008, ACTA PHARMACOL SIN, V29, P1451, DOI 10.1111/j.1745-7254.2008.00902.x; Arnaud-Dabernat S, 2003, J BIOENERG BIOMEMBR, V35, P19, DOI 10.1023/A:1023561821551; Arnaud-Dabernat S, 2004, EXP CELL RES, V301, P293, DOI 10.1016/j.yexcr.2004.07.026; Boissan M, 2005, JNCI-J NATL CANCER I, V97, P836, DOI 10.1093/jnci/dji143; Boissan M, 2006, J BIOENERG BIOMEMBR, V38, P169, DOI 10.1007/s10863-006-9031-4; Boissan M, 2014, SCIENCE, V344, P1510, DOI 10.1126/science.1253768; Boissan M, 2010, CANCER RES, V70, P7710, DOI 10.1158/0008-5472.CAN-10-1887; Boissan M, 2009, MOL CELL BIOCHEM, V329, P51, DOI 10.1007/s11010-009-0120-7; Bruneel A, 2011, N-S ARCH PHARMACOL, V384, P407, DOI 10.1007/s00210-011-0639-5; Cho SM, 2004, MOL CELLS, V18, P390; Choi CH, 2013, CELL MICROBIOL, V15, P961, DOI 10.1111/cmi.12089; Creighton T.E., 1992, PROTEINS STRUCTURES; Das M, 2007, P NATL ACAD SCI USA, V104, P15759, DOI 10.1073/pnas.0707782104; Davis RJ, 2000, CELL, V103, P239, DOI 10.1016/S0092-8674(00)00116-1; de Marval PM, 2011, CANCER PREV RES, V4, P851, DOI 10.1158/1940-6207.CAPR-10-0360; Deplagne C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018645; Diaz B, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000368; Dragin N, 2006, FEBS LETT, V580, P3845, DOI 10.1016/j.febslet.2006.06.006; Eaton P, 2002, J BIOL CHEM, V277, P9806, DOI 10.1074/jbc.M111454200; Ferbeyre G, 2002, MOL CELL BIOL, V22, P3497, DOI 10.1128/MCB.22.10.3497-3508.2002; Freije JMP, 1997, J BIOL CHEM, V272, P5525, DOI 10.1074/jbc.272.9.5525; Guo YL, 2010, STEM CELLS DEV, V19, P1321, DOI 10.1089/scd.2009.0313; HALEY TJ, 1979, CLIN TOXICOL, V14, P1; Hartsough MT, 2002, J BIOL CHEM, V277, P32389, DOI 10.1074/jbc.M203115200; Jarrett SG, 2013, CLIN EXP METASTAS, V30, P25, DOI 10.1007/s10585-012-9495-z; Kim MS, 2010, ACTA CRYSTALLOGR F, V66, P1490, DOI 10.1107/S1744309110036067; Kim MD, 2010, PHYSIOL PLANTARUM, V140, P153, DOI 10.1111/j.1399-3054.2010.01392.x; Kim YI, 2003, BIOCHEM BIOPH RES CO, V307, P281, DOI 10.1016/S0006-291X(03)01195-1; LASCU I, 1992, J BIOL CHEM, V267, P12775; LEONE A, 1991, CELL, V65, P25, DOI 10.1016/0092-8674(91)90404-M; LEVRAT F, 1993, EXP CELL RES, V209, P307, DOI 10.1006/excr.1993.1315; Machon C, 2014, ANAL BIOANAL CHEM, V406, P2925, DOI 10.1007/s00216-014-7711-1; Macip S, 2003, MOL CELL BIOL, V23, P8576, DOI 10.1128/MCB.23.23.8576-8585.2003; Marionnet C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012059; Miyaoka Y, 2013, CELL DIV, V8, DOI 10.1186/1747-1028-8-8; Moon H, 2003, P NATL ACAD SCI USA, V100, P358, DOI 10.1073/pnas.252641899; Pallavi SK, 2012, EMBO J, V31, P2895, DOI 10.1038/emboj.2012.129; Pani G, 2010, CANCER METAST REV, V29, P351, DOI 10.1007/s10555-010-9225-4; Qin ZQ, 2011, J VIROL, V85, P3596, DOI 10.1128/JVI.01596-10; Roy B, 2004, FREE RADICAL BIO MED, V36, P507, DOI 10.1016/j.freeradbiomed.2003.11.028; Salerno M, 2005, MOL CELL BIOL, V25, P1379, DOI 10.1128/MCB.25.4.1379-1388.2005; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; Smith SK, 2004, CYTOGENET GENOME RES, V105, P455, DOI 10.1159/000078219; Song EJ, 2000, BIOCHEMISTRY-US, V39, P10090, DOI 10.1021/bi000267a; STEEG PS, 1988, J NATL CANCER I, V80, P200, DOI 10.1093/jnci/80.3.200; Suntres ZE, 2002, TOXICOLOGY, V180, P65, DOI 10.1016/S0300-483X(02)00382-7; Tang L, 2008, TRANSGENIC RES, V17, P705, DOI 10.1007/s11248-007-9155-2; TODARO GJ, 1963, J CELL COMPAR PHYSL, V62, P257, DOI 10.1002/jcp.1030620305; Wada T, 2008, CELL DEATH DIFFER, V15, P89, DOI 10.1038/sj.cdd.4402222; Wei SJ, 2004, J BIOL CHEM, V279, P5993, DOI 10.1074/jbc.M310820200; Xie KM, 2010, REPRODUCTION, V139, P799, DOI 10.1530/REP-09-0490; Xu J, 1996, DEV BIOL, V177, P544, DOI 10.1006/dbio.1996.0184; Yegutkin GG, 2014, CRIT REV BIOCHEM MOL, V49, P473, DOI 10.3109/10409238.2014.953627; Yegutkin GG, 2003, FASEB J, V17, P1328, DOI 10.1096/fj.02-1136fje; Yokdang N, 2011, BRIT J CANCER, V104, P1628, DOI 10.1038/bjc.2011.134; Yoshida Y, 2006, FEBS LETT, V580, P3282, DOI 10.1016/j.febslet.2006.01.096; Zhang QB, 2011, INT J CANCER, V128, P40, DOI 10.1002/ijc.25307	58	7	7	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1531	1546		10.1096/fj.201600705R	http://dx.doi.org/10.1096/fj.201600705R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28077425				2022-12-28	WOS:000398504300021
J	Area-Gomez, E; Schon, EA				Area-Gomez, Estela; Schon, Eric A.			On the Pathogenesis of Alzheimer's Disease: The MAM Hypothesis	FASEB JOURNAL			English	Article						cholesterol; endoplasmic reticulum; lipid rafts; mitochondria; phospholipids	AMYLOID PRECURSOR PROTEIN; GAMMA-SECRETASE; ER MEMBRANES; MITOCHONDRIA; CHOLESTEROL; PRESENILIN-1; DOMAIN; APP	The pathogenesis of Alzheimer's disease (AD) is currently unclear and is the subject of much debate. The most widely accepted hypothesis designed to explain AD pathogenesis is the amyloid cascade, which invokes the accumulation of extracellular plaques and intracellular tangles as playing a fundamental role in the course and progression of the disease. However, besides plaques and tangles, other biochemical and morphological features are also present in AD, often manifesting early in the course of the disease before the accumulation of plaques and tangles. These include altered calcium, cholesterol, and phospholipid metabolism; altered mitochondrial dynamics; and reduced bioenergetic function. Notably, these other features of AD are associated with functions localized to a subdomain of the endoplasmic reticulum (ER), known as mitochondria-associated ER membranes (MAMs). The MAM region of the ER is a lipid raft-like domain closely apposed to mitochondria in such a way that the 2 organelles are able to communicate with each other, both physically and biochemically, thereby facilitating the functions of this region. We have found that MAM-localized functions are increased significantly in cellular and animal models of AD and in cells from patients with AD in a manner consistent with the biochemical findings noted above. Based on these and other observations, we propose that increased ER-mitochondrial apposition and perturbed MAM function lie at the heart of AD pathogenesis.-Area-Gomez, E., Schon, E. A. On the pathogenesis of Alzheimer's disease: the MAM hypothesis.	[Area-Gomez, Estela] Columbia Univ, Dept Neurol, New York, NY USA; [Schon, Eric A.] Columbia Univ, Dept Genet & Dev, New York, NY USA	Columbia University; Columbia University	Area-Gomez, E (corresponding author), Columbia Univ, Med Ctr, Dept Neurol, Room P&S 4-443,630 West 168th St, New York, NY 10032 USA.	eag2118@columbia.edu		Area, Estela/0000-0002-0962-1570	U.S. National Institutes of Health [K01-AG045335]; U.S. Department of Defense [W911F-15-1-0169]; Ellison Medical Foundation; Alice S. Marriott Foundation; NATIONAL INSTITUTE ON AGING [K01AG045335] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Defense(United States Department of Defense); Ellison Medical Foundation(Lawrence Ellison Foundation); Alice S. Marriott Foundation; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the U.S. National Institutes of Health, National Institute on Aging (K01-AG045335; to E.A.-G.) and by the U.S. Department of Defense (W911F-15-1-0169), the Ellison Medical Foundation, and the J. Willard and Alice S. Marriott Foundation (all to E.A.S.).	Alzheimer A, 1995, Clin Anat, V8, P429; Ankarcrona M, 2002, BIOCHEM BIOPH RES CO, V295, P766, DOI 10.1016/S0006-291X(02)00735-0; Annaert WG, 1999, J CELL BIOL, V147, P277, DOI 10.1083/jcb.147.2.277; Area-Gomez E, 2016, CURR OPIN GENET DEV, V38, P90, DOI 10.1016/j.gde.2016.04.006; Area-Gomez E, 2012, EMBO J, V31, P4106, DOI 10.1038/emboj.2012.202; Area-Gomez E, 2009, AM J PATHOL, V175, P1810, DOI 10.2353/ajpath.2009.090219; Barrett PJ, 2012, SCIENCE, V336, P1168, DOI 10.1126/science.1219988; Beel AJ, 2008, BIOCHEMISTRY-US, V47, P9428, DOI 10.1021/bi800993c; Bezprozvanny I, 2008, TRENDS NEUROSCI, V31, P454, DOI 10.1016/j.tins.2008.06.005; Blumcke I., 2003, HIST NEUROSCIENCE AL; de Brito OM, 2008, NATURE, V456, P605, DOI 10.1038/nature07534; Du H, 2008, NAT MED, V14, P1097, DOI 10.1038/nm.1868; Fraser T, 2010, NEUROCHEM RES, V35, P503, DOI 10.1007/s11064-009-0087-5; Gillardon F, 2007, PROTEOMICS, V7, P605, DOI 10.1002/pmic.200600728; Gomez-Ramos P, 2007, J ALZHEIMERS DIS, V11, P53; Hansson CA, 2004, J BIOL CHEM, V279, P51654, DOI 10.1074/jbc.M404500200; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hayashi H, 2012, FASEB J, V26, P2306, DOI 10.1096/fj.11-196063; Hayashi T, 2009, TRENDS CELL BIOL, V19, P81, DOI 10.1016/j.tcb.2008.12.002; Heeren J, 2004, J BIOL CHEM, V279, P55483, DOI 10.1074/jbc.M409324200; Heeren J, 2003, J BIOL CHEM, V278, P14370, DOI 10.1074/jbc.M209006200; Manczak M, 2013, J ALZHEIMERS DIS, V37, P679, DOI 10.3233/JAD-130761; Mosconi Lisa, 2005, Eur J Nucl Med Mol Imaging, V32, P486, DOI 10.1007/s00259-005-1762-7; Newman M, 2014, HUM MOL GENET, V23, P602, DOI 10.1093/hmg/ddt448; Nunomura A, 2001, J NEUROPATH EXP NEUR, V60, P759, DOI 10.1093/jnen/60.8.759; Pani A, 2009, J ALZHEIMERS DIS, V18, P829, DOI 10.3233/JAD-2009-1193; Pani A, 2009, BMC MED, V7, DOI 10.1186/1741-7015-7-66; Pettegrew JW, 2001, NEUROCHEM RES, V26, P771, DOI 10.1023/A:1011603916962; Puglielli L, 2004, J MOL NEUROSCI, V24, P93, DOI 10.1385/JMN:24:1:093; Puglielli L, 2001, NAT CELL BIOL, V3, P905, DOI 10.1038/ncb1001-905; RUSINOL AE, 1994, J BIOL CHEM, V269, P27494; Schon EA, 2013, MOL CELL NEUROSCI, V55, P26, DOI 10.1016/j.mcn.2012.07.011; Schon EA, 2010, J ALZHEIMERS DIS, V20, pS281, DOI 10.3233/JAD-2010-100495; Stefani M, 2009, CURR ALZHEIMER RES, V6, P15, DOI 10.2174/156720509787313899; Tambini MD, 2016, EMBO REP, V17, P27, DOI 10.15252/embr.201540614; Urano Y, 2005, J LIPID RES, V46, P904, DOI 10.1194/jlr.M400333-JLR200; Voelker DR, 2005, TRENDS BIOCHEM SCI, V30, P396, DOI 10.1016/j.tibs.2005.05.008; Wang XL, 2009, J NEUROCHEM, V109, P153, DOI 10.1111/j.1471-4159.2009.05867.x	38	84	89	0	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					864	867		10.1096/fj.201601309	http://dx.doi.org/10.1096/fj.201601309			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	28246299	Green Published			2022-12-28	WOS:000395671200003
J	Li, L; Newton, PT; Bouderlique, T; Sejnohova, M; Zikmund, T; Kozhemyakina, E; Xie, M; Krivanek, J; Kaiser, J; Qian, H; Dyachuk, V; Lassar, AB; Warman, ML; Barenius, B; Adameyko, I; Chagin, AS				Li, Lei; Newton, Phillip T.; Bouderlique, Thibault; Sejnohova, Marie; Zikmund, Tomas; Kozhemyakina, Elena; Xie, Meng; Krivanek, Jan; Kaiser, Jozef; Qian, Hong; Dyachuk, Vyacheslav; Lassar, Andrew B.; Warman, Matthew L.; Barenius, Bjorn; Adameyko, Igor; Chagin, Andrei S.			Superficial cells are self-renewing chondrocyte progenitors, which form the articular cartilage in juvenile mice	FASEB JOURNAL			English	Article						superficial zone; bone; adult stem cells; regeneration; osteoarthritis	STEM-CELLS; IN-VIVO; FATE; POPULATION; EXPRESSION; THYMIDINE; JOINT; BROMODEOXYURIDINE; DIFFERENTIATION; OSTEOARTHRITIS	Articular cartilage has little regenerative capacity. Recently, genetic lineage tracing experiments have revealed chondrocyte progenitors at the articular surface. We further characterized these progenitors by using in vivo genetic approaches. Histone H2B-green fluorescent protein retention revealed that superficial cells divide more slowly than underlying articular chondrocytes. Clonal genetic tracing combined with immunohistochemistry revealed that superficial cells renew their number by symmetric division, express mesenchymal stem cell markers, and generate chondrocytes via both asymmetric and symmetric differentiation. Quantitative analysis of cellular kinetics, in combination with phosphotungstic acid- enhanced micro-computed tomography, showed that superficial cells generate chondrocytes and contribute to the growth and reshaping of articular cartilage. Furthermore, we found that cartilage renewal occurs as the progeny of superficial cells fully replace fetal chondrocytes during early postnatal life. Thus, superficial cells are self-renewing progenitors that are capable of maintaining their own population and fulfilling criteria of unipotent adult stem cells. Furthermore, the progeny of these cells reconstitute adult articular cartilage de novo, entirely substituting fetal chondrocytes.	[Li, Lei; Newton, Phillip T.; Bouderlique, Thibault; Xie, Meng; Adameyko, Igor; Chagin, Andrei S.] Karolinska Inst, Dept Physiol & Pharmacol, Nanna Svartz vag 2, S-17177 Stockholm, Sweden; [Qian, Hong] Karolinska Inst, Ctr Hematol & Regenerat Med, Dept Med, Sodersjukhuset, Stockholm, Sweden; [Dyachuk, Vyacheslav] Karolinska Inst, Dept Neurosci, Sodersjukhuset, Stockholm, Sweden; [Barenius, Bjorn] Karolinska Inst, Dept Clin Sci & Educ, Orthopaed Sect, Sodersjukhuset, Stockholm, Sweden; [Sejnohova, Marie; Zikmund, Tomas; Kaiser, Jozef] Brno Univ Technol, Cent European Inst Technol, Brno, Czech Republic; [Kozhemyakina, Elena; Lassar, Andrew B.] Harvard Med Sch, Dept Biol Chem & Mol Pharmacol, Boston, MA USA; [Krivanek, Jan; Adameyko, Igor] Med Univ Vienna, Ctr Brain Res, Dept Mol Neurosci, Vienna, Austria; [Warman, Matthew L.] Boston Childrens Hosp, Orthoped Res Labs, Boston, MA USA	Karolinska Institutet; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Sodersjukhuset Hospital; Karolinska Institutet; Sodersjukhuset Hospital; Brno University of Technology; Harvard University; Harvard Medical School; Medical University of Vienna; Harvard University; Boston Children's Hospital	Chagin, AS (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Nanna Svartz vag 2, S-17177 Stockholm, Sweden.	andrei.chagin@ki.se	Krivanek, Jan/AAH-5871-2021; Kaiser, Jozef/D-6800-2012; Dyachuk, Vyacheslav/U-9115-2019; Kaiser, Jozef/P-4872-2019; Li, Lei/AAT-9135-2020; Zikmund, Tomas/G-9491-2014; Barenius, Björn/GQB-4107-2022; Chagin, Andrei/F-4080-2014; Qian, Hong/D-5588-2014	Krivanek, Jan/0000-0002-7590-187X; Kaiser, Jozef/0000-0002-7397-125X; Dyachuk, Vyacheslav/0000-0001-8100-7367; Bouderlique, Thibault/0000-0002-3926-990X; Adameyko, Igor/0000-0001-5471-0356; Chagin, Andrei/0000-0002-2696-5850; Newton, Phillip/0000-0003-2142-1798; Li, Lei/0000-0002-8026-3665; Qian, Hong/0000-0002-2512-9199; Zikmund, Tomas/0000-0003-2948-5198	Swedish Research Council [2016-02835, 2015-03387]; Karolinska Institutet; King Gustaf V's 80-year Jubileum Foundation; Swedish Foundation for Rheumatism; Chinese Scholarship Council; Stiftelsen Frimurare Barnhuset i Stockholm; Sallskapet Barnavard; EMBO long-term postdoctoral fellowship; StratNeuro; Bertil Hallsten Research Foundation; Ake Wiberg Foundation; Central European Institute of Technology 2020 project [LQ1601]; Ministry of Education, Youth, and Sports of the Czech Republic under the National Sustainability Programme II	Swedish Research Council(Swedish Research CouncilEuropean Commission); Karolinska Institutet(Karolinska Institutet); King Gustaf V's 80-year Jubileum Foundation; Swedish Foundation for Rheumatism; Chinese Scholarship Council(China Scholarship Council); Stiftelsen Frimurare Barnhuset i Stockholm; Sallskapet Barnavard; EMBO long-term postdoctoral fellowship(European Molecular Biology Organization (EMBO)); StratNeuro; Bertil Hallsten Research Foundation; Ake Wiberg Foundation; Central European Institute of Technology 2020 project; Ministry of Education, Youth, and Sports of the Czech Republic under the National Sustainability Programme II	The authors thank Susan Mackem (U.S. National Institutes of Health) for Col2-CreERt mouse strain, Bara Szarowska (Karolinska Institutet) for phosphotungstic acid contrasting, and Eugeniy Ivashkin (Karolinska Institutet) for assistance with Imaris software. This work was supported by The Swedish Research Council [2016-02835 (to A.S.C.), 2015-03387 (to V.D.)], Karolinska Institutet (including a FoAss extension grant, KID grant, Ulla och Gustaf af Ugglas Foundation and Karolinska Institutet Foundation for Rheumatism Research), King Gustaf V's 80-year Jubileum Foundation, and the Swedish Foundation for Rheumatism. L.L. was supported by the Chinese Scholarship Council; P.T.N. was supported by Stiftelsen Frimurare Barnhuset i Stockholm and Sallskapet Barnavard; M.X. was supported by EMBO long-term postdoctoral fellowship; V.D. was supported by StratNeuro; and I.A. was supported by Bertil Hallsten Research Foundation and Ake Wiberg Foundation. Tomographic analysis (M.S., T.Z., and Jo.K.) was carried out in connection with the Central European Institute of Technology 2020 project (LQ1601), with financial support from the Ministry of Education, Youth, and Sports of the Czech Republic under the National Sustainability Programme II. The authors declare no conflicts of interest.	ARCHER CW, 1994, ANN RHEUM DIS, V53, P624, DOI 10.1136/ard.53.10.624; Breunig JJ, 2007, CELL STEM CELL, V1, P612, DOI 10.1016/j.stem.2007.11.008; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; De Bari C, 2001, ARTHRITIS RHEUM-US, V44, P1928, DOI 10.1002/1529-0131(200108)44:8<1928::AID-ART331>3.0.CO;2-P; Doupe DP, 2010, DEV CELL, V18, P317, DOI 10.1016/j.devcel.2009.12.016; Dowthwaite GP, 2004, J CELL SCI, V117, P889, DOI 10.1242/jcs.00912; Driskell I, 2015, STEM CELLS, V33, P988, DOI 10.1002/stem.1910; Duque A, 2011, J NEUROSCI, V31, P15205, DOI 10.1523/JNEUROSCI.3092-11.2011; Goldring MB, 2012, THER ADV MUSCULOSKEL, V4, P269, DOI 10.1177/1759720X12448454; Hall B. K., 2015, BONES CARTILAGE DEV; HOLLIBAUGH JT, 1988, MAR ECOL PROG SER, V43, P19, DOI 10.3354/meps043019; Hunziker EB, 2007, OSTEOARTHR CARTILAGE, V15, P403, DOI 10.1016/j.joca.2006.09.010; Jiang YZ, 2015, NAT REV RHEUMATOL, V11, P206, DOI 10.1038/nrrheum.2014.200; Kahn J, 2009, DEV CELL, V16, P734, DOI 10.1016/j.devcel.2009.04.013; Kaucka M, 2016, SCI ADV, V2, DOI 10.1126/sciadv.1600060; Klein AM, 2010, CELL STEM CELL, V7, P214, DOI 10.1016/j.stem.2010.05.017; Kolb B, 1999, J NEUROSCI, V19, P2337; Korr H, 1998, BRAZ J MED BIOL RES, V31, P289, DOI 10.1590/S0100-879X1998000200012; Koyama E, 2008, DEV BIOL, V316, P62, DOI 10.1016/j.ydbio.2008.01.012; Kozhemyakina E, 2015, ARTHRITIS RHEUMATOL, V67, P1261, DOI 10.1002/art.39030; Kurth TB, 2011, ARTHRITIS RHEUM-US, V63, P1289, DOI 10.1002/art.30234; Lepper C, 2011, DEVELOPMENT, V138, P3639, DOI 10.1242/dev.067595; Livet J, 2007, NATURE, V450, P56, DOI 10.1038/nature06293; Lotz M, 2012, BONE, V51, P241, DOI 10.1016/j.bone.2012.03.023; Madry H, 2012, KNEE SURG SPORT TR A, V20, P407, DOI 10.1007/s00167-011-1705-8; MANKIN HJ, 1962, J BONE JOINT SURG AM, V44, P682, DOI 10.2106/00004623-196244040-00008; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Nakamura E, 2006, DEV DYNAM, V235, P2603, DOI 10.1002/dvdy.20892; Ogawa H, 2014, GENE DEV, V28, P127, DOI 10.1101/gad.231969.113; Pardo-Saganta A, 2015, NATURE, V523, P597, DOI 10.1038/nature14553; POLLARD DR, 1976, J EMBRYOL EXP MORPH, V35, P169; PRIBYLOVA E, 1971, Folia Morphologica (Prague), V19, P233; Ray A, 2015, DEVELOPMENT, V142, P1169, DOI 10.1242/dev.110940; Rhee DK, 2005, J CLIN INVEST, V115, P622, DOI 10.1172/JCI200522263; Rompolas P, 2013, NATURE, V502, P513, DOI 10.1038/nature12602; Rountree RB, 2004, PLOS BIOL, V2, P1815, DOI 10.1371/journal.pbio.0020355; Schoedel KB, 2016, BLOOD, V128, P2285, DOI 10.1182/blood-2016-03-706010; Shwartz Y, 2016, CELL REP, V15, P2577, DOI 10.1016/j.celrep.2016.05.055; Simons BD, 2011, CELL, V145, P851, DOI 10.1016/j.cell.2011.05.033; Snippert HJ, 2010, CELL, V143, P134, DOI 10.1016/j.cell.2010.09.016; STOCKWELL RA, 1967, J ANAT, V101, P753; Tata PR, 2013, NATURE, V503, P218, DOI 10.1038/nature12777; Tesarova M, 2016, J INSTRUM, V11, DOI 10.1088/1748-0221/11/03/C03006; Tian H, 2011, NATURE, V478, P255, DOI 10.1038/nature10408; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Yang L, 2014, P NATL ACAD SCI USA, V111, P12097, DOI 10.1073/pnas.1302703111; Yasuhara R, 2011, LAB INVEST, V91, P1739, DOI 10.1038/labinvest.2011.144; Zhang MJ, 2016, J CLIN INVEST, V126, P2893, DOI 10.1172/JCI83676	49	61	65	2	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1067	+		10.1096/fj.201600918R	http://dx.doi.org/10.1096/fj.201600918R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27965322	Green Published			2022-12-28	WOS:000395671200021
J	Fernandez-Verdejo, R; Vanwynsberghe, AM; Essaghir, A; Demoulin, JB; Hai, T; Deldicque, L; Francaux, M				Fernandez-Verdejo, Rodrigo; Vanwynsberghe, Aline M.; Essaghir, Ahmed; Demoulin, Jean-Baptiste; Hai, Tsonwin; Deldicque, Louise; Francaux, Marc			Activating transcription factor 3 attenuates chemokine and cytokine expression in mouse skeletal muscle after exercise and facilitates molecular adaptation to endurance training	FASEB JOURNAL			English	Article						inflammation; microarray; phenotype	ADAPTIVE-RESPONSE GENE; NEGATIVE REGULATOR; ATF3; MECHANISMS; BIOLOGY; STRESS; INFLAMMATION; METABOLISM; MACROPHAGE; RESISTANCE	Activating transcription factor (ATF)3 regulates the expression of inflammation-related genes in several tissues under pathological contexts. In skeletal muscle, atf3 expression increases after exercise, but its target genes remain unknown. We aimed to identify those genes and to determine the influence of ATF3 on muscle adaptation to training. Skeletal muscles of ATF3-knockout (ATF3-KO) and control mice were analyzed at rest, after exercise, and after training. In resting muscles, there was no difference between genotypes in enzymatic activities or fiber type. After exercise, a microarray analysis in quadriceps revealed ATF3 affects genes modulating chemotaxis and chemokine/cytokine activity. Quantitative PCR showed that the mRNA levels of chemokine C-C motif ligand (ccl)8 and chemokine C-X-C motif ligand (cxcl)13 were higher in quadriceps of ATF3-KO mice than in control mice. The same was observed for ccl9 and cxcl13 in soleus. Also in soleus, ccl2, interleukin (il)6, il1, and cluster of differentiation (cd)68 mRNA levels increased after exercise only in ATF3-KO mice. Endurance training increased the basal mRNA level of hexokinase-2, hormone sensitive lipase, glutathione peroxidase-1, and myosin heavy chain IIa in quadriceps of control mice but not in ATF3-KO mice. In summary, ATF3 attenuates the expression of inflammation-related genes after exercise and thus facilitates molecular adaptation to training.	[Fernandez-Verdejo, Rodrigo; Vanwynsberghe, Aline M.; Deldicque, Louise; Francaux, Marc] Catholic Univ Louvain, Inst Neurosci, Brussels, Belgium; [Essaghir, Ahmed; Demoulin, Jean-Baptiste] Catholic Univ Louvain, De Duve Inst, Brussels, Belgium; [Hai, Tsonwin] Ohio State Univ, Dept Biol Chem & Pharmacol, Columbus, OH 43210 USA	Universite Catholique Louvain; Universite Catholique Louvain; University System of Ohio; Ohio State University	Francaux, M (corresponding author), Pl Pierre Coubertin 1,Bte L8-10-01, B-1348 Louvain, Belgium.	marc.francaux@uclouvain.be	Hai, Tsonwin/E-3185-2011	Hai, Tsonwin/0000-0003-4510-0315; Francaux, Marc/0000-0001-8182-1588; Fernandez-Verdejo, Rodrigo/0000-0002-5948-2281; Deldicque, Louise/0000-0003-3393-5278	Belgian Fonds National de la Recherche Scientifique (FSR-FNRS) [23628981]; Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT)	Belgian Fonds National de la Recherche Scientifique (FSR-FNRS)(Fonds de la Recherche Scientifique - FNRS); Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT)(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT))	This work was supported by the Belgian Fonds National de la Recherche Scientifique (FSR-FNRS, No. 23628981) and by funds from the Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (CONICYT) (to R.F.-V.). The authors thank Damien Naslain (Universite Catholique de Louvain) for technical assistance and Tijs Vandoorne (Katholieke Universiteit Leuven, Leuven, Belgium) for collaboration with the fiber typing method.	Alter J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029498; Barash IA, 2004, AM J PHYSIOL-CELL PH, V286, pC355, DOI 10.1152/ajpcell.00211.2003; Bey L, 2003, PHYSIOL GENOMICS, V13, P157, DOI 10.1152/physiolgenomics.00001.2002; Bloemberg D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035273; Boespflug ND, 2014, BLOOD, V123, P2084, DOI 10.1182/blood-2013-06-510909; Nguyen CT, 2014, J INFECT DIS, V210, P1745, DOI 10.1093/infdis/jiu352; Darlyuk-Saadon I, 2012, BBA-GENE REGUL MECH, V1819, P1142, DOI 10.1016/j.bbagrm.2012.09.005; Deldicque L, 2008, J APPL PHYSIOL, V104, P371, DOI 10.1152/japplphysiol.00873.2007; Egan B, 2013, CELL METAB, V17, P162, DOI 10.1016/j.cmet.2012.12.012; Fueger PT, 2003, AM J PHYSIOL-ENDOC M, V285, pE958, DOI 10.1152/ajpendo.00190.2003; Garber CE, 2011, MED SCI SPORT EXER, V43, P1334, DOI 10.1249/MSS.0b013e318213fefb; Gilchrist M, 2006, NATURE, V441, P173, DOI 10.1038/nature04768; Gilchrist M, 2008, J EXP MED, V205, P2349, DOI 10.1084/jem.20072254; Gleeson M, 2011, NAT REV IMMUNOL, V11, P607, DOI 10.1038/nri3041; Griffin CA, 2010, J CELL SCI, V123, P3052, DOI 10.1242/jcs.066241; Hai T, 2001, GENE, V273, P1, DOI 10.1016/S0378-1119(01)00551-0; Hai T, 2010, GENE EXPRESSION, V15, P1, DOI 10.3727/105221610X12819686555015; Hartman MG, 2004, MOL CELL BIOL, V24, P5721, DOI 10.1128/MCB.24.13.5721-5732.2004; Hawley JA, 2014, CELL, V159, P738, DOI 10.1016/j.cell.2014.10.029; HOAGLIN DC, 1987, J AM STAT ASSOC, V82, P1147, DOI 10.1080/01621459.1987.10478551; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Jiang HY, 2004, MOL CELL BIOL, V24, P1365, DOI 10.1128/MCB.24.3.1365-1377.2004; Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004; Koya T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077788; LaFramboise WA, 2009, AM J PHYSIOL-CELL PH, V297, pC556, DOI 10.1152/ajpcell.00046.2009; Lai P. F., 2013, EVID-BASED COMPL ALT, V2013; Lancaster GI, 2014, TRENDS IMMUNOL, V35, P262, DOI 10.1016/j.it.2014.02.008; Le YY, 2004, CELL MOL IMMUNOL, V1, P95; Lim JH, 2006, DIABETOLOGIA, V49, P1924, DOI 10.1007/s00125-006-0278-4; Lu D, 2007, BIOCHEM J, V401, P559, DOI 10.1042/BJ20061081; MacNeil LG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010695; McCall GE, 1998, CAN J APPL PHYSIOL, V23, P594, DOI 10.1139/h98-034; McKenzie MJ, 2007, MED SCI SPORT EXER, V39, P1515, DOI 10.1249/mss.0b013e318074c256; McKenzie MJ, 2011, J SPORT SCI MED, V10, P385; McLean CS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127089; Noble WS, 2009, NAT BIOTECHNOL, V27, P1135, DOI 10.1038/nbt1209-1135; Paulsen G, 2012, EXERC IMMUNOL REV, V18, P42; Pillon NJ, 2013, AM J PHYSIOL-ENDOC M, V304, pE453, DOI 10.1152/ajpendo.00553.2012; Porter JD, 2003, NEUROMUSCULAR DISORD, V13, P223, DOI 10.1016/S0960-8966(02)00242-0; Powers SK, 2008, PHYSIOL REV, V88, P1243, DOI 10.1152/physrev.00031.2007; Rodriguez J, 2016, MED SCI SPORT EXER, V48, P227, DOI 10.1249/MSS.0000000000000756; Samaan MC, 2014, PHYSIOL REP, V2, DOI 10.14814/phy2.12012; Suganami T, 2009, CIRC RES, V105, P25, DOI 10.1161/CIRCRESAHA.109.196261; Takii R, 2010, J IMMUNOL, V184, P1041, DOI 10.4049/jimmunol.0902579; Turner MD, 2014, BBA-MOL CELL RES, V1843, P2563, DOI 10.1016/j.bbamcr.2014.05.014; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Warren GL, 2004, FASEB J, V18, P413, DOI 10.1096/fj.04-2421fje; Warren GL, 2004, AM J PHYSIOL-CELL PH, V286, pC1031, DOI 10.1152/ajpcell.00467.2003; Warren GL, 2007, J PHYSIOL-LONDON, V582, P825, DOI 10.1113/jphysiol.2007.132373; Wolford CC, 2013, J CLIN INVEST, V123, P2893, DOI 10.1172/JCI64410; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Zbinden-Foncea H, 2012, MED SCI SPORT EXER, V44, P1463, DOI 10.1249/MSS.0b013e31824e0d5d; Zhou H, 2014, INT J CARDIOL, V174, P838, DOI 10.1016/j.ijcard.2014.04.160; Zhou H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026744; Zmuda EJ, 2010, DIABETOLOGIA, V53, P1438, DOI 10.1007/s00125-010-1696-x; Zmuda EJ, 2010, MOL ENDOCRINOL, V24, P1423, DOI 10.1210/me.2009-0463	56	20	20	2	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					840	851		10.1096/fj.201600987R	http://dx.doi.org/10.1096/fj.201600987R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27856557	Green Submitted			2022-12-28	WOS:000394235400035
J	Khariv, V; Ni, L; Ratnayake, A; Sampath, S; Lutz, BM; Tao, XX; Heary, RF; Elkabes, S				Khariv, Veronika; Ni, Li; Ratnayake, Ayomi; Sampath, Sujitha; Lutz, Brianna M.; Tao, Xuan-Xiang; Heary, Robert F.; Elkabes, Stella			Impaired sensitivity to pain stimuli in plasma membrane calcium ATPase 2 (PMCA2) heterozygous mice: a possible modality- and sex-specific role for PMCA2 in nociception	FASEB JOURNAL			English	Article						ATP2b2; sensory function; spinal cord; glutamate; GABA	SPINAL GLUTAMATE TRANSPORTERS; NEUROPATHIC PAIN; DORSAL-HORN; NERVE INJURY; GENE-EXPRESSION; AMPA RECEPTORS; THERMAL HYPERALGESIA; GENDER-DIFFERENCES; INFLAMMATORY PAIN; GABA(B) RECEPTORS	Plasma membrane calcium ATPase 2 (PMCA2) is a calcium pump that plays important roles in neuronal function. Although it is expressed in pain-associated regions of the CNS, including in the dorsal horn (DH), its contribution to pain remains undefined. The present study assessed the role of PMCA2 in pain responsiveness and the link between PMCA2 and glutamate receptors, GABA receptors (GABARs), and glutamate transporters that have been implicated in pain processing in the DH of adult female and male PMCA2(+/+) and PMCA2(+/-) 2 mice. Behavioral assays evaluated mechanical and thermal pain responsiveness. Mechanical sensitivity was significantly increased by 52% and heat sensitivity was reduced by 29% in female, but not male, PMCA2(+/-) 2 mice compared with PMCA2(+/+) controls. There were female-specific changes in metabotropic glutamate receptor 1, NMDA receptor 2A, alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptor subunit GluR1, GABA(B)R1, and GABA(B)R2 levels, whereas metabotropic glutamate receptor 5, NMDA receptor 2B, GluR2, and GABA(A)R alpha 2 levels were not altered. Glutamate aspartate transporter levels were higher and glial glutamate transporter 1 levels were lower in the DH of female, but not male, PMCA2(+/-) 2 mice. These findings indicate a novel role for PMCA2 in modality- and sex-dependent pain responsiveness. Female-specific molecular changes potentially account for the altered pain responses.-Khariv, V., Ni, L., Ratnayake, A., Sampath, S., Lutz, B. M., Tao, X.-X., Heary, R. F., Elkabes, S. Impaired sensitivity to pain stimuli inplasmamembrane calciumATPase 2 (PMCA2) heterozygous mice: a possible modality and sex-specific role for PMCA2 in nociception.	[Khariv, Veronika; Ni, Li; Ratnayake, Ayomi; Sampath, Sujitha; Heary, Robert F.; Elkabes, Stella] State Univ New Jersey, New Jersey Med Sch Rutgers, Dept Neurol Surg, Reynolds Family Spine Lab, Newark, NJ USA; [Lutz, Brianna M.; Tao, Xuan-Xiang] State Univ New Jersey, New Jersey Med Sch Rutgers, Dept Anesthesiol, Newark, NJ USA; [Khariv, Veronika; Lutz, Brianna M.] State Univ New Jersey, New Jersey Med Sch Rutgers, Grad Sch Biomed Sci, Newark, NJ USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Elkabes, S (corresponding author), State Univ New Jersey, New Jersey Med Sch Rutgers, 205 South Orange Ave,Canc Ctr F-1204, Newark, NJ 07103 USA.	elkabest@njms.rutgers.edu	Elkabes, Stella/AAR-8212-2020; Elkabes, Stella/H-7823-2019	Elkabes, Stella/0000-0003-3513-8088	Reynolds Family Spine Laboratory Funds; U.S. National Institutes of Health [DA033390, NS094664, NS094224, HL117684]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL117684] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094664, F31NS092310, R01NS094224] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA033390] Funding Source: NIH RePORTER	Reynolds Family Spine Laboratory Funds; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the Reynolds Family Spine Laboratory Funds and by U.S. National Institutes of Health Grants DA033390 (National Institute on Drug Abuse), NS094664 and NS094224 (National Institute of Neurological Disorders and Stroke), and HL117684 (National Heart, Lung, and Blood Institute). G. Shull, Ph.D. (University of Cincinnati, College of Medicine, Cincinnati, OH, USA), first established PMCA2<SUP>+/-</SUP> and PMCA2<SUP>+/+</SUP> mice. The authors declare no conflicts of interest.	Basbaum AI, 2009, CELL, V139, P267, DOI 10.1016/j.cell.2009.09.028; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Berkley KJ, 2006, AM J PHYSIOL-REG I, V291, pR241, DOI 10.1152/ajpregu.00287.2006; Berkley KJ, 1997, BEHAV BRAIN SCI, V20, P473, DOI 10.1017/S0140525X97591497; Berkley KJ, 1997, BEHAV BRAIN SCI, V20, P371, DOI 10.1017/S0140525X97221485; Binns BC, 2005, BRAIN RES, V1041, P38, DOI 10.1016/j.brainres.2005.01.088; BONANNO G, 1992, J PHARMACOL EXP THER, V262, P114; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; BRANDT P, 1992, J BIOL CHEM, V267, P4376; Brini M, 2013, FEBS J, V280, P5385, DOI 10.1111/febs.12193; CAGGIULA AR, 1995, PSYCHOPHARMACOLOGY, V122, P301, DOI 10.1007/BF02246552; Cavaliere C, 2007, NEURON GLIA BIOL, V3, P141, DOI 10.1017/S1740925X07000695; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Chaplan SR, 1997, J PHARMACOL EXP THER, V280, P829; Chicka MC, 2003, J BIOL CHEM, V278, P18464, DOI 10.1074/jbc.M301482200; COYLE DE, 1995, NEUROSCI LETT, V186, P135, DOI 10.1016/0304-3940(95)11304-F; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DeLeo JA, 2006, J BONE JOINT SURG AM, V88A, P58, DOI 10.2106/JBJS.E.01286; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Duan B, 2014, CELL, V159, P1417, DOI 10.1016/j.cell.2014.11.003; Eljaja L, 2011, SCAND J PAIN, V2, P132, DOI 10.1016/j.sjpain.2011.03.003; Engelman HS, 1999, J NEUROSCI, V19, P2081; Enna SJ, 2006, ADV PHARMACOL, V54, P1, DOI 10.1016/S1054-3589(06)54001-3; Falnikar A, 2016, GLIA, V64, P396, DOI 10.1002/glia.22936; Fang L, 2002, J NEUROSCI, V22, P4196, DOI 10.1523/JNEUROSCI.22-10-04196.2002; Fang L, 2003, NEUROSCIENCE, V122, P237, DOI 10.1016/S0306-4522(03)00526-8; Fellin T, 2009, J NEUROCHEM, V108, P533, DOI 10.1111/j.1471-4159.2008.05830.x; Filoteo AG, 1997, J BIOL CHEM, V272, P23741, DOI 10.1074/jbc.272.38.23741; Fisher K, 1998, NEUROREPORT, V9, P1169, DOI 10.1097/00001756-199804200-00038; Fisher K, 1996, PAIN, V68, P255, DOI 10.1016/S0304-3959(96)03212-5; Fritschy JM, 2014, EUR J NEUROSCI, V39, P1845, DOI 10.1111/ejn.12534; Fundytus ME, 2001, CNS DRUGS, V15, P29, DOI 10.2165/00023210-200115010-00004; Fundytus ME, 2001, BRIT J PHARMACOL, V132, P354, DOI 10.1038/sj.bjp.0703810; Galan A, 2004, PAIN, V112, P315, DOI 10.1016/j.pain.2004.09.011; Garcia Michael L., 1999, Frontiers in Bioscience, V4, pd869, DOI 10.2741/Garcia; Garry EA, 2004, PAIN, V109, P210, DOI 10.1016/j.pain.2004.04.002; Gegelashvili G, 1997, J NEUROCHEM, V69, P2612; Greenspan JD, 2007, PAIN, V132, pS26, DOI 10.1016/j.pain.2007.10.014; Gwak YS, 2011, NEUROPHARMACOLOGY, V60, P799, DOI 10.1016/j.neuropharm.2010.12.030; HALEY JE, 1990, BRAIN RES, V518, P218, DOI 10.1016/0006-8993(90)90975-H; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; Heidinger V, 2002, J NEUROSCI, V22, P5452; Hobo S, 2011, NEUROSCI LETT, V502, P52, DOI 10.1016/j.neulet.2011.07.023; Hu YY, 2010, PAIN, V148, P284, DOI 10.1016/j.pain.2009.11.014; Inquimbert P, 2012, PAIN, V153, P2422, DOI 10.1016/j.pain.2012.08.011; JAKOWEC MW, 1995, NEUROSCIENCE, V67, P909, DOI 10.1016/0306-4522(95)00094-Y; Jones KA, 1998, NATURE, V396, P674, DOI 10.1038/25348; Karim F, 2001, J NEUROSCI, V21, P3771, DOI 10.1523/JNEUROSCI.21-11-03771.2001; Kayser V, 1996, BRAIN RES, V742, P352, DOI 10.1016/S0006-8993(96)01108-0; Kozel PJ, 1998, J BIOL CHEM, V273, P18693, DOI 10.1074/jbc.273.30.18693; Kroner-Herwig Birgit, 2012, Psychosoc Med, V9, pDoc01, DOI 10.3205/psm000079; Kubo K, 2009, J PHARMACOL EXP THER, V331, P162, DOI 10.1124/jpet.109.156034; Kuner R, 2010, NAT MED, V16, P1258, DOI 10.1038/nm.2231; Kurnellas MP, 2010, CELL DEATH DIFFER, V17, P1501, DOI 10.1038/cdd.2010.54; Kurnellas MP, 2007, MOL CELL NEUROSCI, V34, P178, DOI 10.1016/j.mcn.2006.10.010; Kurnellas MP, 2004, FASEB J, V18, P298, DOI 10.1096/fj.04-2549fje; Lan JY, 2001, J NEUROSCI, V21, P6058, DOI 10.1523/JNEUROSCI.21-16-06058.2001; Larsson M, 2008, J NEUROSCI, V28, P7084, DOI 10.1523/JNEUROSCI.5749-07.2008; Lawson JJ, 2008, J PAIN, V9, P298, DOI 10.1016/j.jpain.2007.12.001; Liaw WJ, 2005, PAIN, V115, P60, DOI 10.1016/j.pain.2005.02.006; Maeda S, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-65; MAO J, 1992, BRAIN RES, V598, P271, DOI 10.1016/0006-8993(92)90193-D; McCarson KE, 1999, NEUROPHARMACOLOGY, V38, P1767, DOI 10.1016/S0028-3908(99)00121-5; Minett MS, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1795; Mogil JS, 2012, NAT REV NEUROSCI, V13, P859, DOI 10.1038/nrn3360; MOGIL JS, 1993, PAIN, V53, P17, DOI 10.1016/0304-3959(93)90050-Y; Morel L, 2013, J BIOL CHEM, V288, P7105, DOI 10.1074/jbc.M112.410944; Negri L, 2006, J NEUROSCI, V26, P6716, DOI 10.1523/JNEUROSCI.5403-05.2006; Nicot A, 2003, BRAIN, V126, P398, DOI 10.1093/brain/awg041; Paixao S, 2010, CURR OPIN NEUROBIOL, V20, P466, DOI 10.1016/j.conb.2010.04.008; POTASHNER SJ, 1984, J NEUROCHEM, V42, P1135, DOI 10.1111/j.1471-4159.1984.tb12722.x; Putatunda R, 2014, BRAIN RES, V1581, P64, DOI 10.1016/j.brainres.2014.05.003; Schlag BD, 1998, MOL PHARMACOL, V53, P355, DOI 10.1124/mol.53.3.355; Sevostianova N, 2006, NEUROPHARMACOLOGY, V51, P623, DOI 10.1016/j.neuropharm.2006.05.004; Sorkin LS, 2001, ANESTHESIOLOGY, V95, P965, DOI 10.1097/00000542-200110000-00028; Sorkin LS, 1999, NEUROREPORT, V10, P3523, DOI 10.1097/00001756-199911260-00011; Souayah N, 2008, EXP NEUROL, V214, P341, DOI 10.1016/j.expneurol.2008.09.002; Spike RC, 1998, EUR J NEUROSCI, V10, P324, DOI 10.1046/j.1460-9568.1998.00048.x; Sung BK, 2003, J NEUROSCI, V23, P2899; Swanson RA, 1997, J NEUROSCI, V17, P932; Tabatadze N, 2015, J NEUROSCI, V35, P11252, DOI 10.1523/JNEUROSCI.1067-15.2015; Tao YX, 2010, ANESTHESIOLOGY, V112, P1259, DOI 10.1097/ALN.0b013e3181d3e1ed; Todd AJ, 2010, NAT REV NEUROSCI, V11, P823, DOI 10.1038/nrn2947; Unruh AM, 1996, PAIN, V65, P123, DOI 10.1016/0304-3959(95)00214-6; Weng HR, 2006, NEUROSCIENCE, V138, P1351, DOI 10.1016/j.neuroscience.2005.11.061; Wiesenfeld-Hallin Zsuzsanna, 2005, Gend Med, V2, P137, DOI 10.1016/S1550-8579(05)80042-7; Witschi R, 2011, J NEUROSCI, V31, P8134, DOI 10.1523/JNEUROSCI.6328-10.2011; Wu JZ, 2011, NEUROIMMUNOMODULAT, V18, P150, DOI 10.1159/000323141; Xin WJ, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-15; Young MR, 1998, J NEUROSCI, V18, P10180; Yowtak J, 2013, PAIN, V154, P2469, DOI 10.1016/j.pain.2013.07.024; Zhou HY, 2009, J NEUROCHEM, V108, P305, DOI 10.1111/j.1471-4159.2008.05772.x	92	10	10	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					224	237		10.1096/fj.201600541R	http://dx.doi.org/10.1096/fj.201600541R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27702770	Green Published			2022-12-28	WOS:000392177600023
J	Landrier, JF; Kasiri, E; Karkeni, E; Mihaly, J; Beke, G; Weiss, K; Lucas, R; Aydemir, G; Salles, J; Walrand, S; de Lera, AR; Ruhl, R				Landrier, Jean-Francois; Kasiri, Elnaz; Karkeni, Esma; Mihaly, Johanna; Beke, Gabriella; Weiss, Kathrin; Lucas, Renata; Aydemir, Gamze; Salles, Jerome; Walrand, Stephane; de Lera, Angel R.; Ruhl, Ralph			Reduced adiponectin expression after high-fat diet is associated with selective up-regulation of ALDH1A1 and further retinoic acid receptor signaling in adipose tissue	FASEB JOURNAL			English	Article						vitamin A; nuclear hormone receptor; obesity; diabetes; retinaldehyde dehydrogenase	ALDEHYDE DEHYDROGENASE 1; PPAR-GAMMA; GENE-EXPRESSION; VITAMIN-A; INDUCED OBESITY; X-RECEPTORS; IN-VITRO; METABOLISM; MOUSE; RXR	Adiponectin is an adipocyte-derived adipokine with potent antidiabetic, anti-inflammatory, and antiatherogenic activity. Long-term, high-fat diet results in gain of body weight, adiposity, further inflammatory-based cardiovascular diseases, and reduced adiponectin secretion. Vitamin A derivatives/retinoids are involved in several of these processes, which mainly take place in white adipose tissue (WAT). In this study, we examined adiponectin expression as a function of dietary high-fat and high-vitamin A conditions in mice. A decrease of adiponectin expression in addition to an up-regulation of aldehyde dehydrogenase A1 (ALDH1A1), retinoid signaling, and retinoic acid response element signaling was selectively observed inWAT of mice fed a normal-vitamin A, high-fat diet. Reduced adiponectin expression in WAT was also observed in mice fed a high-vitamin A diet. Adipocyte cell culture revealed that endogenous and synthetic retinoic acid receptor (RAR)alpha- and RAR gamma-selective agonists, as well as a synthetic retinoid X receptor agonist, efficiently reduced adiponectin expression, whereas ALDH1A1 expression only increased with RAR agonists. We conclude that reduced adiponectin expression under high-fat dietary conditions is dependent on 1) increased ALDH1A1 expression in adipocytes, which does not increase all-trans-retinoic acid levels; 2) further RAR ligand-induced, WAT-selective, increased retinoic acid response element-mediated signaling; and 3) RARligand-dependent reduction of adiponectin expression.-Landrier, J.-F., Kasiri, E., Karkeni, E., Mihaly, J., Beke, G., Weiss, K., Lucas, R., Aydemir, G., Salles, J., Walrand, S., de Lera, A. R., Ruhl, R. Reduced adiponectin expression after high-fat diet is associated with selective up-regulation of ALDH1A1 and further retinoic acid receptor signaling in adipose tissue.	[Landrier, Jean-Francois; Karkeni, Esma] INRA, Unites Mixtes Rech 1260, Marseille, France; [Landrier, Jean-Francois; Karkeni, Esma] INSERM, Unites Mixtes Rech 1062, Nutr Obesite & Risque Thrombot, Marseille, France; [Landrier, Jean-Francois; Karkeni, Esma] Aix Marseille Univ, Fac Med, Marseille, France; [Kasiri, Elnaz; Mihaly, Johanna; Beke, Gabriella; Weiss, Kathrin; Lucas, Renata; Aydemir, Gamze; Ruhl, Ralph] Univ Debrecen, Hungarian Acad Sci, Fac Publ Hlth, Dept Biochem & Mol Biol, Debrecen, Hungary; [Kasiri, Elnaz] Univ Debrecen, Hungarian Acad Sci, Fac Publ Hlth, MTA DE Publ Hlth Res Grp, Debrecen, Hungary; [Salles, Jerome; Walrand, Stephane] Ctr Rech INRA Clermont Ferrand Theix, INRA, Unites Mixtes Rech, Unite Nutr Humaine 1019, St Genes Champanelle, France; [de Lera, Angel R.] Univ Vigo, Dept Quim Organ, Fac Quim, Ctr Invest Biomed, Vigo, Spain; [de Lera, Angel R.] Inst Invest Biomed Vigo, Vigo, Spain; [Ruhl, Ralph] Paprika Bioanalyt BT, Debrecen, Hungary	INRAE; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Hungarian Academy of Sciences; University of Debrecen; Eotvos Lorand Research Network; Office for Supported Research Groups (ELKH); Hungarian Academy of Sciences; University of Debrecen; INRAE; Universidade de Vigo; CINBIO	Ruhl, R (corresponding author), Univ Debrecen, Fac Publ Hlth, Dept Prevent Med, Kassai U 26-B, H-4028 Debrecen, Hungary.	ralphruehl@web.de	Landrier, Jean-Francois/AAH-2757-2019	Landrier, Jean-Francois/0000-0002-8690-8014; Salles, Jerome/0000-0002-1787-5802; Walrand, Stephane/0000-0002-4349-3664; KARKENI, Esma/0000-0002-2450-9376; , IIS Galicia Sur/0000-0003-3812-7413				Ahima RS, 2006, OBESITY, V14, P242, DOI 10.1038/oby.2006.317; Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Amengual J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020644; Antonio G, 2005, DIGEST DIS SCI, V50, P1, DOI 10.1007/s10620-005-1268-y; Aydemir G., 2016, MOL NUTR FOOD RES, DOI 10.1002/mnfr.201600031; Aydemir G, 2013, MOL NUTR FOOD RES, V57, P739, DOI 10.1002/mnfr.201200548; Aydemir G, 2012, MOL NUTR FOOD RES, V56, P702, DOI 10.1002/mnfr.201100681; Blomhoff R, 2006, J NEUROBIOL, V66, P606, DOI 10.1002/neu.20242; Bonet ML, 1997, FEBS LETT, V406, P196, DOI 10.1016/S0014-5793(97)00274-3; Bonet ML, 2003, CELL MOL LIFE SCI, V60, P1311, DOI 10.1007/s00018-003-2290-x; Canas JA, 2012, J PEDIATR-US, V161, P58, DOI 10.1016/j.jpeds.2012.01.030; de Lera AR, 2016, CHEMMEDCHEM, V11, P1027, DOI 10.1002/cmdc.201600105; Desvergne B, 2007, VITAM HORM, V75, P1, DOI 10.1016/S0083-6729(06)75001-4; Dozsa A, 2016, CLIN EXP DERMATOL, V41, P547, DOI 10.1111/ced.12794; Dozsa A, 2014, J INVEST DERMATOL, V134, P910, DOI 10.1038/jid.2013.413; Eroglu A, 2012, J BIOL CHEM, V287, P15886, DOI 10.1074/jbc.M111.325142; Fasshauer M, 2002, BIOCHEM BIOPH RES CO, V290, P1084, DOI 10.1006/bbrc.2001.6307; Flachs P, 2009, CLIN SCI, V116, P1, DOI 10.1042/CS20070456; Frey SK, 2011, NUTRIENTS, V3, P27, DOI 10.3390/nu3010027; Gagnon I, 2003, BIOCHEM PHARMACOL, V65, P1685, DOI 10.1016/S0006-2952(03)00150-3; Gao MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119784; Gouranton E, 2011, BBA-MOL CELL BIOL L, V1811, P1105, DOI 10.1016/j.bbalip.2011.09.002; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Hallenborg P, 2016, PROG LIPID RES, V61, P149, DOI 10.1016/j.plipres.2015.11.002; Hallenborg P, 2010, MOL CELL BIOL, V30, P4077, DOI 10.1128/MCB.01806-08; Huq MDM, 2006, EMBO J, V25, P3203, DOI 10.1038/sj.emboj.7601181; Imai T, 2001, P NATL ACAD SCI USA, V98, P224, DOI 10.1073/pnas.011528898; Inoue M, 2005, BIOCHEM BIOPH RES CO, V336, P215, DOI 10.1016/j.bbrc.2005.08.070; Iwaki M, 2003, DIABETES, V52, P1655, DOI 10.2337/diabetes.52.7.1655; Jones JR, 2005, P NATL ACAD SCI USA, V102, P6207, DOI 10.1073/pnas.0306743102; Kane MA, 2008, ANAL CHEM, V80, P1702, DOI 10.1021/ac702030f; Karkeni E, 2015, ENDOCRINOLOGY, V156, P1782, DOI 10.1210/en.2014-1647; Karki S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028146; Kiefer FW, 2012, NAT MED, V18, P918, DOI 10.1038/nm.2757; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Lagishetty V, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-21; Landrier JF, 2008, FREE RADICAL RES, V42, P523, DOI 10.1080/10715760802098859; Landrier JF, 2009, ENDOCRINOLOGY, V150, P5318, DOI 10.1210/en.2009-0506; Larsen TM, 2003, INT J OBESITY, V27, P147, DOI 10.1038/sj.ijo.802223; Lobo GP, 2010, J BIOL CHEM, V285, P27891, DOI 10.1074/jbc.M110.132571; Bonet ML, 2015, ARCH BIOCHEM BIOPHYS, V572, P112, DOI 10.1016/j.abb.2015.02.022; Bonet ML, 2012, BBA-MOL CELL BIOL L, V1821, P177, DOI 10.1016/j.bbalip.2011.06.001; Maeda N, 2001, DIABETES, V50, P2094, DOI 10.2337/diabetes.50.9.2094; MANGELSDORF DJ, 1995, CELL, V83, P841, DOI 10.1016/0092-8674(95)90200-7; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Marcotorchino J, 2013, HORM MOL BIOL CLIN I, V15, P123, DOI 10.1515/hmbci-2013-0027; Marcotorchino J, 2012, MOL NUTR FOOD RES, V56, P1771, DOI 10.1002/mnfr.201200383; Masoodi M, 2015, BBA-MOL CELL BIOL L, V1851, P503, DOI 10.1016/j.bbalip.2014.09.023; Maury E, 2010, MOL CELL ENDOCRINOL, V314, P1, DOI 10.1016/j.mce.2009.07.031; Mcilroy GD, 2013, DIABETES, V62, P825, DOI 10.2337/db12-0458; Metzger D, 2005, PROSTAG LEUKOTR ESS, V73, P51, DOI 10.1016/j.plefa.2005.04.007; Mihaly J, 2012, DERMATOLOGY, V225, P304, DOI 10.1159/000345496; Moise AR, 2005, J BIOL CHEM, V280, P27815, DOI 10.1074/jbc.M503520200; Nagy L, 1998, CELL, V93, P229, DOI 10.1016/S0092-8674(00)81574-3; Napoli JL, 1999, BBA-MOL CELL BIOL L, V1440, P139, DOI 10.1016/S1388-1981(99)00117-1; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Noy N, 2013, ADIPOCYTE, V2, P184, DOI 10.4161/adip.23489; Obrochta KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099435; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; PERLMANN T, 1995, GENE DEV, V9, P769, DOI 10.1101/gad.9.7.769; Petrosino JM, 2014, NUTRIENTS, V6, P950, DOI 10.3390/nu6030950; Reichert B, 2011, MOL ENDOCRINOL, V25, P799, DOI 10.1210/me.2010-0465; Ruhl R, 2007, P NUTR SOC, V66, P458, DOI 10.1017/S002966510600509X; Ruhl R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005213; Ruhl R, 2006, REPROD FERT DEVELOP, V18, P339, DOI 10.1071/RD05056; Ruhl R, 2006, RAPID COMMUN MASS SP, V20, P2497, DOI 10.1002/rcm.2621; Sakurai Takuya, 2012, Environmental Health and Preventive Medicine, V17, P348, DOI 10.1007/s12199-012-0271-0; Shulman AI, 2005, NEW ENGL J MED, V353, P604, DOI 10.1056/NEJMra043590; Sima A, 2011, BIOCHEM CELL BIOL, V89, P578, DOI [10.1139/O11-062, 10.1139/o11-062]; Sun J, 2014, J BIOL CHEM, V289, P33118, DOI 10.1074/jbc.M114.610501; Swann R. T., 1996, U. S. Patent, Patent No. [5624957 A, 5624957]; Szanto A, 2004, CELL DEATH DIFFER, V11, pS126, DOI 10.1038/sj.cdd.4401533; Szklenar M, 2013, J VASC RES, V50, P372, DOI 10.1159/000350865; Tishinsky JM, 2011, OBESITY, V19, P262, DOI 10.1038/oby.2010.186; Tourniaire F, 2015, J LIPID RES, V56, P1100, DOI 10.1194/jlr.M053652; Tourniaire F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066515; Vermot J, 2000, ENDOCRINOLOGY, V141, P3638, DOI 10.1210/en.141.10.3638; Wang CX, 2015, ARCH BIOCHEM BIOPHYS, V572, P2, DOI 10.1016/j.abb.2015.01.009; Weiss K, 2014, GENES NUTR, V9, DOI 10.1007/s12263-013-0368-0; Yamauchi T, 2001, J CLIN INVEST, V108, P1001, DOI 10.1172/JCI12864; Yasmeen R, 2013, DIABETES, V62, P124, DOI 10.2337/db11-1779; Yasmeen R, 2012, BBA-MOL CELL BIOL L, V1821, P190, DOI 10.1016/j.bbalip.2011.06.004; Zhang M, 2015, J PHARMACOL SCI, V127, P430, DOI 10.1016/j.jphs.2015.03.001; Ziouzenkova O, 2007, NAT MED, V13, P695, DOI 10.1038/nm1587; Zusi F. C., 1998, European Patent, Patent No. [98912117. 3, 989121173]	85	31	32	0	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					203	211		10.1096/fj.201600263RR	http://dx.doi.org/10.1096/fj.201600263RR			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27729412	Green Published, hybrid			2022-12-28	WOS:000392177600021
J	Buler, M; Andersson, U; Hakkola, J				Buler, Marcin; Andersson, Ulf; Hakkola, Jukka			Who watches the watchmen? Regulation of the expression and activity of sirtuins	FASEB JOURNAL			English	Article						SIRT; deacetylation; transcriptional regulation; miRNA; post-translational modification	NF-KAPPA-B; FATTY-ACID OXIDATION; EPITHELIAL-MESENCHYMAL TRANSITION; NAD-DEPENDENT DEACETYLASE; GLUTAMATE-DEHYDROGENASE 1; SIRT1 GENE PROMOTER; CANCER-CELL GROWTH; CALORIE RESTRICTION; DOWN-REGULATION; HISTONE DEACETYLASE	Sirtuins (SIRT1-7) are a family of nicotine adenine dinucleotide (NAD(+))-dependent enzymes that catalyze post-translational modifications of proteins. Together, they regulate crucial cellular functions and are traditionally associated with aging and longevity. Dysregulation of sirtuins plays an important role in major diseases, including cancer and metabolic, cardiac, and neurodegerative diseases. They are extensively regulated in response to a wide range of stimuli, including nutritional and metabolic challenges, inflammatory signals or hypoxic and oxidative stress. Each sirtuin is regulated individually in a tissue-and cell-specific manner. The control of sirtuin expression involves all the major points of regulation, including transcriptional and post-translational mechanisms and microRNAs. Collectively, these mechanisms control the protein levels, localization, and enzymatic activity of sirtuins. In many cases, the regulators of sirtuin expression are also their substrates, which lead to formation of intricate regulatory networks and extensive feedback loops. In this review, we highlight the mechanisms mediating the physiologic and pathologic regulation of sirtuin expression and activity. We also discuss the consequences of this regulation on sirtuin function and cellular physiology.-Buler, M., Andersson, U., Hakkola, J. Who watches the watchmen? Regulation of the expression and activity of sirtuins.	[Buler, Marcin; Andersson, Ulf] AstraZeneca R&D, Drug Safety & Metab, Gothenburg, Sweden; [Hakkola, Jukka] Univ Oulu, Res Unit Biomed Pharmacol & Toxicol, POB 5000, FI-90014 Oulu, Finland; [Hakkola, Jukka] Oulu Univ Hosp, Med Res Ctr Oulu, Oulu, Finland; [Hakkola, Jukka] Univ Oulu, Oulu, Finland	AstraZeneca; University of Oulu; University of Oulu; University of Oulu	Hakkola, J (corresponding author), Univ Oulu, Res Unit Biomed Pharmacol & Toxicol, POB 5000, FI-90014 Oulu, Finland.	jukka.hakkola@oulu.fi		Hakkola, Jukka/0000-0001-5048-4363	Academy of Finland [286743]; Novo Nordisk Foundation [NNF15OC0015846]; Novo Nordisk Fonden [NNF14OC0010653, NNF15OC0015846] Funding Source: researchfish	Academy of Finland(Academy of Finland); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Novo Nordisk Fonden(Novo Nordisk Foundation)	The original research for this work has been financially supported by grants from the Academy of Finland (Grant 286743 to J.H.) and the Novo Nordisk Foundation (Grant NNF15OC0015846 to J.H.). The authors declare no conflicts of interest.	Acs Z, 2014, RESP PHYSIOL NEUROBI, V196, P33, DOI 10.1016/j.resp.2014.02.006; Ahn J, 2013, EMBO MOL MED, V5, P1602, DOI 10.1002/emmm.201302647; Ahuja N, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M705488200; Al-Bassam J, 2012, P NATL ACAD SCI USA, V109, P19515, DOI 10.1073/pnas.1217594109; Antoniali G, 2014, MOL BIOL CELL, V25, P532, DOI 10.1091/mbc.E13-05-0286; Arunachalam G, 2016, J PHARMACOL EXP THER, V356, P314, DOI 10.1124/jpet.115.226894; Bae HJ, 2014, ONCOGENE, V33, P2557, DOI 10.1038/onc.2013.216; Bao XC, 2014, ELIFE, V3, DOI 10.7554/eLife.02999; Barber MF, 2012, NATURE, V487, P114, DOI 10.1038/nature11043; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Boylston JA, 2015, J MOL CELL CARDIOL, V88, P73, DOI 10.1016/j.yjmcc.2015.09.005; Braidy N, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00167; Brandauer J, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00085; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Buler M, 2014, FASEB J, V28, P3225, DOI 10.1096/fj.13-245241; Buler M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049863; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Caito S, 2010, FASEB J, V24, P3145, DOI 10.1096/fj.09-151308; Cao Y, 2016, J DIABETES COMPLICAT, V30, P178, DOI 10.1016/j.jdiacomp.2015.08.022; Chen R, 2011, J BIOL CHEM, V286, P13869, DOI 10.1074/jbc.M110.175414; Chen WY, 2005, CELL, V123, P437, DOI 10.1016/j.cell.2005.08.011; Chen Y, 2015, FREE RADICAL RES, V49, P1275, DOI 10.3109/10715762.2015.1067806; Chen YR, 2010, BIOCHEM CELL BIOL, V88, P715, DOI 10.1139/O10-010; Choi YH, 2014, BIOCHEM BIOPH RES CO, V453, P557, DOI 10.1016/j.bbrc.2014.09.125; Choi YH, 2014, BIOCHEM BIOPH RES CO, V450, P1120, DOI 10.1016/j.bbrc.2014.06.117; Choi YH, 2013, BIOCHEM BIOPH RES CO, V437, P245, DOI 10.1016/j.bbrc.2013.06.053; Cifarelli V, 2015, DIABETES, V64, P1632, DOI 10.2337/db14-1132; Consiglio CR, 2014, MOL BIOL REP, V41, P4233, DOI 10.1007/s11033-014-3294-3; do Amaral MEC, 2011, J NUTR BIOCHEM, V22, P554, DOI 10.1016/j.jnutbio.2010.04.010; Csibi A, 2013, CELL, V153, P840, DOI 10.1016/j.cell.2013.04.023; Daitoku H, 2004, P NATL ACAD SCI USA, V101, P10042, DOI 10.1073/pnas.0400593101; Dan L, 2012, HAEMATOL-HEMATOL J, V97, P551, DOI 10.3324/haematol.2011.055236; Drygin D, 2010, ANNU REV PHARMACOL, V50, P131, DOI 10.1146/annurev.pharmtox.010909.105844; Du JT, 2011, SCIENCE, V334, P806, DOI 10.1126/science.1207861; Du JT, 2009, BIOCHEMISTRY-US, V48, P2878, DOI 10.1021/bi802093g; Elhanati S, 2016, CELL REP, V14, P234, DOI 10.1016/j.celrep.2015.12.023; Eskandarian HA, 2013, SCIENCE, V341, P525, DOI 10.1126/science.1238858; Fan J, 2014, MOL CELL, V53, P534, DOI 10.1016/j.molcel.2013.12.026; Feldman JL, 2013, J BIOL CHEM, V288, P31350, DOI 10.1074/jbc.C113.511261; Flick F, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00029; Ford E, 2006, GENE DEV, V20, P1075, DOI 10.1101/gad.1399706; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Frye RA, 1999, BIOCHEM BIOPH RES CO, V260, P273, DOI 10.1006/bbrc.1999.0897; Gertler AA, 2013, BIOGERONTOLOGY, V14, P629, DOI 10.1007/s10522-013-9478-8; Giralt A, 2011, J BIOL CHEM, V286, P16958, DOI 10.1074/jbc.M110.202390; Gomes P, 2015, TRENDS PHARMACOL SCI, V36, P756, DOI 10.1016/j.tips.2015.08.001; Grob A, 2009, J CELL SCI, V122, P489, DOI 10.1242/jcs.042382; Guo XM, 2010, J BIOL CHEM, V285, P13223, DOI 10.1074/jbc.M110.102574; Haigis MC, 2006, CELL, V126, P941, DOI 10.1016/j.cell.2006.06.057; Haigis MC, 2010, ANNU REV PATHOL-MECH, V5, P253, DOI 10.1146/annurev.pathol.4.110807.092250; Han LM, 2010, NUCLEIC ACIDS RES, V38, P7458, DOI 10.1093/nar/gkq609; Han QL, 2014, GENE, V546, P1, DOI 10.1016/j.gene.2014.05.058; Han YH, 2013, FEBS LETT, V587, P3875, DOI 10.1016/j.febslet.2013.10.023; Han Y, 2008, BIOCHEM BIOPH RES CO, V375, P576, DOI 10.1016/j.bbrc.2008.08.042; Hayashida S, 2010, MOL CELL BIOCHEM, V339, P285, DOI 10.1007/s11010-010-0391-z; Hebert AS, 2013, MOL CELL, V49, P186, DOI 10.1016/j.molcel.2012.10.024; Hiratsuka M, 2003, BIOCHEM BIOPH RES CO, V309, P558, DOI 10.1016/j.bbrc.2003.08.029; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Hirschey MD, 2010, NATURE, V464, P121, DOI 10.1038/nature08778; Hochegger H, 2008, NAT REV MOL CELL BIO, V9, P910, DOI 10.1038/nrm2510; Huang GY, 2016, ONCOL REP, V35, P2801, DOI 10.3892/or.2016.4685; Huang GY, 2015, BIOMED PHARMACOTHER, V72, P135, DOI 10.1016/j.biopha.2015.04.013; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Inui M, 2010, NAT REV MOL CELL BIO, V11, P252, DOI 10.1038/nrm2868; Iwahara T, 2012, MOL CELL BIOL, V32, P5022, DOI 10.1128/MCB.00822-12; Jeong SM, 2014, J BIOL CHEM, V289, P4135, DOI 10.1074/jbc.M113.525949; Jeong SM, 2013, CANCER CELL, V23, P450, DOI 10.1016/j.ccr.2013.02.024; Ji SP, 2011, J MOL CELL BIOL, V3, P351, DOI 10.1093/jmcb/mjr009; Jiang H, 2013, NATURE, V496, P110, DOI 10.1038/nature12038; Jiang WQ, 2011, MOL CELL, V43, P33, DOI 10.1016/j.molcel.2011.04.028; Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471; Jin L, 2016, ONCOGENE, V35, P3619, DOI 10.1038/onc.2015.447; Jin QH, 2010, CELL RES, V20, P470, DOI 10.1038/cr.2010.24; Jin YH, 2008, BIOCHEM BIOPH RES CO, V368, P690, DOI 10.1016/j.bbrc.2008.01.114; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kanfi Y, 2008, FEBS LETT, V582, P543, DOI [10.1016/j.febslet.2008.01.019, 10.1016/j.febslet.2008.06.005]; Kanfi Y, 2012, NATURE, V483, P218, DOI 10.1038/nature10815; Katsura A, 2015, INT J MOL MED, V35, P877, DOI 10.3892/ijmm.2015.2092; Katto J, 2013, CLIN EPIGENETICS, V5, DOI 10.1186/1868-7083-5-11; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kendrick AA, 2011, BIOCHEM J, V433, P505, DOI 10.1042/BJ20100791; Kern PA, 2001, AM J PHYSIOL-ENDOC M, V280, pE745; Kheir TB, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-29; Kilic U, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090428; Kim EJ, 2015, J BIOL CHEM, V290, P9604, DOI 10.1074/jbc.M114.633198; Kim H.T., 2010, INT C 2 COMP ENG TEC, V6, pV6, DOI DOI 10.1371/J0URNAL.PPAT.1000992; Kim HS, 2011, CANCER CELL, V20, P487, DOI 10.1016/j.ccr.2011.09.004; Kim JK, 2013, HEPATOLOGY, V57, P1055, DOI 10.1002/hep.26101; Koga T, 2015, J BIOL CHEM, V290, P30366, DOI 10.1074/jbc.M115.664169; Komlos D, 2013, GLIA, V61, P394, DOI 10.1002/glia.22442; Kong XX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011707; Krishnan J, 2012, GENE DEV, V26, P259, DOI 10.1101/gad.180406.111; Kubicka S, 1999, J BIOL CHEM, V274, P32137, DOI 10.1074/jbc.274.45.32137; Kugel S, 2014, TRENDS BIOCHEM SCI, V39, P72, DOI 10.1016/j.tibs.2013.12.002; Kumar S, 2015, ANTIOXID REDOX SIGN, V22, P1060, DOI 10.1089/ars.2014.6213; Kwon HS, 2008, TRENDS BIOCHEM SCI, V33, P517, DOI 10.1016/j.tibs.2008.08.001; Lage R, 2008, TRENDS MOL MED, V14, P539, DOI 10.1016/j.molmed.2008.09.007; Lai MG, 2015, MOL MED REP, V11, P3301, DOI 10.3892/mmr.2015.3182; Laine A, 2014, CLIN CANCER RES, V20, P3644, DOI 10.1158/1078-0432.CCR-13-1942; Lang A, 2016, AGING-US, V8, P484, DOI 10.18632/aging.100905; Lappas M, 2012, MEDIAT INFLAMM, V2012, DOI 10.1155/2012/597514; Laurent G, 2013, MOL CELL BIOL, V33, P4552, DOI 10.1128/MCB.00087-13; Laurent G, 2013, MOL CELL, V50, P686, DOI 10.1016/j.molcel.2013.05.012; Lefort K, 2013, EMBO J, V32, P2248, DOI 10.1038/emboj.2013.156; Lerrer B, 2016, CARCINOGENESIS, V37, P108, DOI 10.1093/carcin/bgv167; Li J, 2016, BIOCHEM BIOPH RES CO, V469, P15, DOI 10.1016/j.bbrc.2015.11.062; Li N, 2011, MECH AGEING DEV, V132, P75, DOI 10.1016/j.mad.2010.12.004; Li WB, 2007, J NEUROSCI, V27, P2606, DOI 10.1523/JNEUROSCI.4181-06.2007; Lieber CS, 2008, BIOCHEM BIOPH RES CO, V373, P246, DOI 10.1016/j.bbrc.2008.06.006; Lim JH, 2010, MOL CELL, V38, P864, DOI 10.1016/j.molcel.2010.05.023; Lin Zhenghong, 2013, Genes Cancer, V4, P97, DOI 10.1177/1947601912475079; Lin ZH, 2012, MOL CELL, V46, P484, DOI 10.1016/j.molcel.2012.03.024; Lin ZF, 2013, BIOCHEM BIOPH RES CO, V441, P191, DOI 10.1016/j.bbrc.2013.10.033; Liszt G, 2005, J BIOL CHEM, V280, P21313, DOI 10.1074/jbc.M413296200; Liu GF, 2016, BBA-GENE REGUL MECH, V1859, P348, DOI 10.1016/j.bbagrm.2015.12.004; Liu P, 2012, J CELL PHYSIOL, V227, P867, DOI 10.1002/jcp.22993; Liu XY, 2011, P NATL ACAD SCI USA, V108, P1925, DOI 10.1073/pnas.1019619108; Liu Y, 2015, GENE THER, V22, P729, DOI 10.1038/gt.2015.39; Lou GH, 2015, CELL PHYSIOL BIOCHEM, V35, P2192, DOI 10.1159/000374024; Lu WD, 2014, TUMOR BIOL, V35, P10699, DOI 10.1007/s13277-014-2372-4; Luo JY, 2001, CELL, V107, P137, DOI 10.1016/S0092-8674(01)00524-4; Mahjabeen I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146948; Mao ZY, 2011, SCIENCE, V332, P1443, DOI 10.1126/science.1202723; Mathias RA, 2014, CELL, V159, P1615, DOI 10.1016/j.cell.2014.11.046; Matsushima S, 2015, AM J PHYSIOL-HEART C, V309, pH1375, DOI 10.1152/ajpheart.00053.2015; Matsushita N, 2011, GENES CELLS, V16, P190, DOI 10.1111/j.1365-2443.2010.01475.x; Maxwell MM, 2011, HUM MOL GENET, V20, P3986, DOI 10.1093/hmg/ddr326; Menghini R, 2009, CIRCULATION, V120, P1524, DOI 10.1161/CIRCULATIONAHA.109.864629; Michaelis EK, 2011, NEUROCHEM INT, V59, P473, DOI 10.1016/j.neuint.2011.03.003; Michishita E, 2005, MOL BIOL CELL, V16, P4623, DOI 10.1091/mbc.E05-01-0033; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Min LH, 2012, NAT CELL BIOL, V14, P1203, DOI 10.1038/ncb2590; Ming M, 2014, CANCER RES, V74, P5925, DOI 10.1158/0008-5472.CAN-14-1308; Do MT, 2014, FREE RADICAL BIO MED, V74, P21, DOI [10.1016/j.freeradbiomed2014.06.010, 10.1016/j.freeradbiomed.2014.06.010]; Miyo M, 2015, BRIT J CANCER, V113, P492, DOI 10.1038/bjc.2015.226; Mohrin M, 2015, SCIENCE, V347, P1374, DOI 10.1126/science.aaa2361; Mootha VK, 2005, P NATL ACAD SCI USA, V102, P10405, DOI 10.1073/pnas.0505194102; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mortuza R, 2014, DIABETOLOGIA, V57, P1037, DOI 10.1007/s00125-014-3197-9; Mortuza R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054514; Moschen AR, 2013, J HEPATOL, V59, P1315, DOI 10.1016/j.jhep.2013.07.027; Mostoslavsky R, 2006, CELL, V124, P315, DOI 10.1016/J.CEL.2005.11.044; Nakagawa T, 2009, CELL, V137, P560, DOI 10.1016/j.cell.2009.02.026; Nasrin N, 2010, J BIOL CHEM, V285, P31995, DOI 10.1074/jbc.M110.124164; Nasrin N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008414; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Nishida Y, 2015, MOL CELL, V59, P321, DOI 10.1016/j.molcel.2015.05.022; Noriega LG, 2011, EMBO REP, V12, P1069, DOI 10.1038/embor.2011.151; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; North BJ, 2007, J BIOL CHEM, V282, P19546, DOI 10.1074/jbc.M702990200; Ogura M, 2010, BIOCHEM BIOPH RES CO, V393, P73, DOI 10.1016/j.bbrc.2010.01.081; Okada N, 2014, GENE DEV, V28, P438, DOI 10.1101/gad.233585.113; Okazaki M, 2010, ENDOCR J, V57, P403, DOI 10.1507/endocrj.K10E-004; Onyango P, 2002, P NATL ACAD SCI USA, V99, P13653, DOI 10.1073/pnas.222538099; Opitz CA, 2015, BIOCHEM SOC T, V43, P1127, DOI 10.1042/BST20150133; Palacios OM, 2009, AGING-US, V1, P771, DOI 10.18632/aging.100075; Pandithage R, 2008, J CELL BIOL, V180, P915, DOI 10.1083/jcb.200707126; Pardo PS, 2012, AGING-US, V4, P456, DOI 10.18632/aging.100470; Park JM, 2015, SCI REP-UK, V5, DOI 10.1038/srep17395; Peng LR, 2015, J BIOL CHEM, V290, P8904, DOI 10.1074/jbc.M114.612796; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; Poulose N, 2015, BBA-MOL BASIS DIS, V1852, P2442, DOI 10.1016/j.bbadis.2015.08.017; Qi F, 2015, WORLD J GASTROENTERO, V21, P9900, DOI 10.3748/wjg.v21.i34.9900; Qin Y, 2014, BBA-MOL BASIS DIS, V1842, P2439, DOI 10.1016/j.bbadis.2014.10.002; Rai E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048621; Ramalinga M, 2015, ONCOTARGET, V6, P34446, DOI 10.18632/oncotarget.5920; Rane S, 2009, CIRC RES, V104, P879, DOI 10.1161/CIRCRESAHA.108.193102; Rardin MJ, 2013, CELL METAB, V18, P920, DOI 10.1016/j.cmet.2013.11.013; Rardin MJ, 2013, P NATL ACAD SCI USA, V110, P6601, DOI 10.1073/pnas.1302961110; Raver-Shapira N, 2007, MOL CELL, V26, P731, DOI 10.1016/j.molcel.2007.05.017; Revollo JR, 2013, TRENDS BIOCHEM SCI, V38, P160, DOI 10.1016/j.tibs.2012.12.004; Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034; Ruggieri S, 2015, BBA-PROTEINS PROTEOM, V1854, P1138, DOI 10.1016/j.bbapap.2015.02.021; Sasaki T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004020; Satterstrom FK, 2015, AGING CELL, V14, P818, DOI 10.1111/acel.12360; Saunders LR, 2010, AGING-US, V2, P415, DOI 10.18632/aging.100176; Scarpulla RC, 2012, TRENDS ENDOCRIN MET, V23, P459, DOI 10.1016/j.tem.2012.06.006; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Seligson DB, 2009, AM J PATHOL, V174, P1619, DOI 10.2353/ajpath.2009.080874; Sharma A, 2013, J BIOL CHEM, V288, P18439, DOI 10.1074/jbc.M112.405928; Shi LY, 2015, ENDOCRINE, V50, P378, DOI 10.1007/s12020-015-0599-5; Shi T, 2005, J BIOL CHEM, V280, P13560, DOI 10.1074/jbc.M414670200; Shi Y, 2015, ONCOL REP, V34, P399, DOI 10.3892/or.2015.3986; Sidorova-Darmos E, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00333; Song YP, 2014, CHINESE MED J-PEKING, V127, P1523, DOI 10.3760/cma.j.issn.0366-6999.20132975; Strum JC, 2009, MOL ENDOCRINOL, V23, P1876, DOI 10.1210/me.2009-0117; Sun LN, 2013, JNCI-J NATL CANCER I, V105, P887, DOI 10.1093/jnci/djt118; Sung-E C., 2008, AGING CELL, V28, P4439; Takasaka N, 2014, J IMMUNOL, V192, P958, DOI 10.4049/jimmunol.1302341; Tan MJ, 2014, CELL METAB, V19, P605, DOI 10.1016/j.cmet.2014.03.014; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; Teng YB, 2015, SCI REP-UK, V5, DOI 10.1038/srep08529; Trapp J, 2006, CURR DRUG TARGETS, V7, P1553, DOI 10.2174/1389450110607011553; Vakhrusheva O, 2008, CIRC RES, V102, P703, DOI 10.1161/CIRCRESAHA.107.164558; Valle C, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.247; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaquero A, 2006, GENE DEV, V20, P1256, DOI 10.1101/gad.1412706; Vercauteren K, 2008, J BIOL CHEM, V283, P12102, DOI 10.1074/jbc.M710150200; Verdin E, 2015, SCIENCE, V350, P1208, DOI 10.1126/science.aac4854; Wang CG, 2006, NAT CELL BIOL, V8, P1025, DOI 10.1038/ncb1468; Wang F, 2007, AGING CELL, V6, P505, DOI 10.1111/j.1474-9726.2007.00304.x; Wang F, 2009, MOL BIOL CELL, V20, P801, DOI 10.1091/mbc.E08-06-0647; Wang JQ, 2016, SOFT COMPUT, V20, P1621, DOI 10.1007/s00500-015-1609-5; Wang L, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.587; Wang PX, 2015, J HEPATOL, V62, P111, DOI 10.1016/j.jhep.2014.08.022; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wang ZR, 2015, SCI REP-UK, V5, DOI 10.1038/srep12012; Watroba M, 2016, ADV MED SCI-POLAND, V61, P52, DOI 10.1016/j.advms.2015.09.003; Weir HJM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048225; Wong DW, 2015, FRONT GENET, V6, DOI 10.3389/fgene.2015.00281; Xiong SQ, 2011, J BIOL CHEM, V286, P5289, DOI 10.1074/jbc.M110.163667; Xu JQ, 2013, TUMOR BIOL, V34, P3871, DOI 10.1007/s13277-013-0974-x; Xu J, 2015, BIOCHEM BIOPH RES CO, V463, P1159, DOI 10.1016/j.bbrc.2015.06.076; Xu M., 2012, CHINESE SCI BULL, V58, P979; Xu Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8466; Yamakuchi M, 2008, P NATL ACAD SCI USA, V105, P13421, DOI 10.1073/pnas.0801613105; Yamakuchi M, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00068; Yamakuchi M, 2009, CELL CYCLE, V8, P712, DOI 10.4161/cc.8.5.7753; Yang SC, 2014, ADV METEOROL, V2014, DOI 10.1155/2014/581756; Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017057; Yang WX, 2015, NEUROCHEM RES, V40, P1576, DOI 10.1007/s11064-015-1630-1; Yang YH, 2007, NAT CELL BIOL, V9, P1253, DOI 10.1038/ncb1645; Yechoor VK, 2004, P NATL ACAD SCI USA, V101, P16525, DOI 10.1073/pnas.0407574101; Yeung F, 2004, EMBO J, V23, P2369, DOI 10.1038/sj.emboj.7600244; Yu X, 2015, CELL DEATH DIFFER, V22, P1170, DOI 10.1038/cdd.2014.206; Yu XY, 2012, MOLECULES, V17, P11216, DOI 10.3390/molecules170911216; Zhang AM, 2012, BIOCHEM BIOPH RES CO, V422, P693, DOI 10.1016/j.bbrc.2012.05.059; Zhang HY, 2014, INT J ONCOL, V45, P2143, DOI 10.3892/ijo.2014.2596; Zhang HN, 2010, BIOCHEM BIOPH RES CO, V397, P569, DOI 10.1016/j.bbrc.2010.05.160; Zhang LH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-290; Zhang LW, 2014, CARDIOVASC DRUG THER, V28, P303, DOI 10.1007/s10557-014-6533-x; Zhang P, 2014, P NATL ACAD SCI USA, V111, P10684, DOI 10.1073/pnas.1411026111; Zhang SC, 2013, ARCH VIROL, V158, P2443, DOI 10.1007/s00705-013-1744-1; Zhang SL, 2016, ONCOL REP, V35, P559, DOI 10.3892/or.2015.4333; Zhang S, 2015, SCI REP-UK, V5, DOI 10.1038/srep09787; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhou B, 2012, DIABETOLOGIA, V55, P2032, DOI 10.1007/s00125-012-2539-8; Zhou B, 2014, HEPATOLOGY, V59, P2196, DOI 10.1002/hep.26992; Zhu GY, 2014, EUR REV MED PHARMACO, V18, P205; Zhu HW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031431	240	56	57	0	24	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					3942	3960		10.1096/fj.201600410RR	http://dx.doi.org/10.1096/fj.201600410RR			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27591175				2022-12-28	WOS:000388201500004
J	Chen, HQ; Mruk, DD; Lee, WM; Cheng, CY				Chen, Haiqi; Mruk, Dolores D.; Lee, Will M.; Cheng, C. Yan			Regulation of spermatogenesis by a local functional axis in the testis: role of the basement membrane-derived noncollagenous 1 domain peptide	FASEB JOURNAL			English	Article						Sertoli cell; collagen; NC1 domain; ectoplasmic specialization; blood-testis barrier	EXTRACELLULAR-MATRIX COMPONENTS; TESTICULAR PERITUBULAR CELLS; RAT SERTOLI-CELLS; ECTOPLASMIC SPECIALIZATION DYNAMICS; NECROSIS-FACTOR-ALPHA; F-ACTIN ORGANIZATION; IV COLLAGEN CHAINS; IN-VITRO; BARRIER DYNAMICS; TUMOR-GROWTH	Spermatogenesis takes place in the epithelium of the seminiferous tubules of the testes, producing millions of spermatozoa per day in an adult male in rodents and humans. Thus, multiple cellular events that are regulated by an array of signaling molecules and pathways are tightly coordinated to support spermatogenesis. Here, we report findings of a local regulatory axis between the basement membrane (BM), the blood-testis barrier (BTB), and the apical ectoplasmic specialization (apical ES; a testis-specific, actin-rich adherens junction at the Sertoli cell-spermatid interface) to coordinate cellular events across the seminiferous epithelium during the epithelial cycle. In short, a biologically active fragment, noncollagenous 1 (NC1) domain that is derived from collagen chains in the BM, was found to modulate cell junction dynamics at the BTB and apical ES. NC1 domain from the collagen alpha 3(IV) chain was cloned into a mammalian expression vector, pCI-neo, with and without a collagen signal peptide. We also prepared a specific Ab against the purified recombinant NC1 domain peptide. These reagents were used to examine whether overexpression of NC1 domain with high transfection efficacy would perturb spermatogenesis, in particular, spermatid adhesion (i.e., inducing apical ES degeneration) and BTB function (i.e., basal ES and tight junction disruption, making the barrier leaky), in the testis in vivo. We report our findings that NC1 domain derived from collagen a3(IV) chain-a major structural component of the BM-was capable of inducing BTB remodeling, making the BTB leaky in studies in vivo. Furthermore, NC1 domain peptide was transported across the epithelium via a microtubule-dependent mechanism and is capable of inducing apical ES degeneration, which leads to germ cell exfoliation from the seminiferous epithelium. Of more importance, we show that NC1 domain peptide exerted its regulatory effect by disorganizing actin microfilaments and microtubules in Sertoli cells so that they failed to support cell adhesion and transport of germ cells and organelles (e.g., residual bodies, phagosomes) across the seminiferous epithelium. This local regulatory axis between the BM, BTB, and the apical ES thus coordinates cellular events that take place across the seminiferous epithelium during the epithelial cycle of spermatogenesis.	[Chen, Haiqi; Mruk, Dolores D.; Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA; [Lee, Will M.; Cheng, C. Yan] Univ Hong Kong, Sch Biol Sci, Pokfulam, Hong Kong, Peoples R China	Population Council; University of Hong Kong	Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA.	y-cheng@popcbr.rockefeller.edu	Chen, Haiqi/J-7468-2019	Chen, Haiqi/0000-0001-7179-3229; Cheng, C Yan/0000-0003-3117-3791	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01-HD056034, U54-HD029990]; Hong Kong Research Grants Council (RGC) General Research Fund (GRF) [771513]; National Natural Science Foundation of China (NSFC)/RGC [N_HKU 717/12]; University of Hong Kong CRCG; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD029990, R01HD056034] Funding Source: NIH RePORTER	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Hong Kong Research Grants Council (RGC) General Research Fund (GRF)(Hong Kong Research Grants Council); National Natural Science Foundation of China (NSFC)/RGC(Hong Kong Research Grants CouncilNational Natural Science Foundation of China (NSFC)); University of Hong Kong CRCG(University of Hong Kong); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grants R01-HD056034 (to C.Y.C.), U54-HD029990 Project 5 (to C.Y.C.), Hong Kong Research Grants Council (RGC) General Research Fund (GRF) 771513 (to W.M.L.), National Natural Science Foundation of China (NSFC)/RGC Joint Research Scheme N_HKU 717/12 (to W.M.L.), and University of Hong Kong CRCG Seed Funding (to W.M.L.). The authors declare no conflicts of interest.	Ahmed S, 2010, SEMIN CELL DEV BIOL, V21, P350, DOI 10.1016/j.semcdb.2009.11.008; Aikio M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051044; Barczyk M, 2010, CELL TISSUE RES, V339, P269, DOI 10.1007/s00441-009-0834-6; Chen HQ, 2016, ENDOCRINOLOGY, V157, P2140, DOI 10.1210/en.2015-1987; Chen YH, 1997, J CELL BIOL, V138, P891, DOI 10.1083/jcb.138.4.891; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cheng CY, 2011, BIOCHEM J, V435, P553, DOI 10.1042/BJ20102121; Cheng CY, 2010, NAT REV ENDOCRINOL, V6, P380, DOI 10.1038/nrendo.2010.71; Cheng CY, 2009, CRIT REV BIOCHEM MOL, V44, P245, DOI 10.1080/10409230903061207; Cooke VG, 2008, METHOD ENZYMOL, V444, P1, DOI 10.1016/S0076-6879(08)02801-2; DAVIS CM, 1990, BIOL REPROD, V43, P860, DOI 10.1095/biolreprod43.5.860; DENDUCHIS B, 1985, J REPROD IMMUNOL, V7, P59, DOI 10.1016/0165-0378(85)90021-X; DYM M, 1994, ENDOCR REV, V15, P102, DOI 10.1210/er.15.1.102; Frojdman K, 1998, DIFFERENTIATION, V63, P125, DOI 10.1046/j.1432-0436.1998.6330125.x; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gao Y, 2017, FASEB J, V31, P584, DOI 10.1096/fj.201600870R; Gao Y, 2016, ONCOTARGET, V7, P64203, DOI 10.18632/oncotarget.11887; GELLY JL, 1989, HISTOCHEMISTRY, V93, P31, DOI 10.1007/BF00266844; HADLEY MA, 1985, J CELL BIOL, V101, P1511, DOI 10.1083/jcb.101.4.1511; Hager M, 2005, AM J PATHOL, V167, P823, DOI 10.1016/S0002-9440(10)62054-8; Hamano Y, 2005, BIOCHEM BIOPH RES CO, V333, P292, DOI 10.1016/j.bbrc.2005.05.130; Hamano Y, 2003, CANCER CELL, V3, P589, DOI 10.1016/S1535-6108(03)00133-8; HEW KW, 1993, BIOL REPROD, V49, P840, DOI 10.1095/biolreprod49.4.840; Hu P, 2013, J CELL PHYSIOL, V228, P306, DOI 10.1002/jcp.24154; Ip CKM, 2011, ONCOGENE, V30, P2420, DOI 10.1038/onc.2010.615; Kahsai TZ, 1997, J BIOL CHEM, V272, P17023, DOI 10.1074/jbc.272.27.17023; Kamphaus GD, 2000, J BIOL CHEM, V275, P1209, DOI 10.1074/jbc.275.2.1209; Lee NPY, 2003, BIOL REPROD, V68, P489, DOI 10.1095/biolreprod.102.005793; LEMAGUERESSEBATTISTONI B, 1995, J ENDOCRINOL, V146, P501, DOI 10.1677/joe.0.1460501; Li MWM, 2009, INT J BIOCHEM CELL B, V41, P2302, DOI 10.1016/j.biocel.2009.05.016; Li N, 2016, ENDOCRINOLOGY, V157, P2894, DOI 10.1210/en.2016-1133; LUSTIG L, 1978, ARCH ANDROLOGY, V1, P333, DOI 10.3109/01485017808988354; Lustig L, 2000, BIOL REPROD, V62, P1505, DOI 10.1095/biolreprod62.6.1505; Ma Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep08894; Maeshima Y, 2000, J BIOL CHEM, V275, P21340, DOI 10.1074/jbc.M001956200; Maeshima Y, 2001, J BIOL CHEM, V276, P31959, DOI 10.1074/jbc.M103024200; Maeshima Y, 2001, J BIOL CHEM, V276, P15240, DOI 10.1074/jbc.M007764200; Marneros AG, 2001, MATRIX BIOL, V20, P337, DOI 10.1016/S0945-053X(01)00151-2; McLachlan RI, 2002, J ANDROL, V23, P149; Mok KW, 2015, ENDOCRINOLOGY, V156, P1900, DOI 10.1210/en.2014-1791; Mruk DD, 2011, METHODS MOL BIOL, V763, P237, DOI 10.1007/978-1-61779-191-8_16; Mundel TM, 2008, INT J CANCER, V122, P1738, DOI 10.1002/ijc.23269; O'Donnell Liza, 2011, Spermatogenesis, V1, P14; Ortega N, 2002, J CELL SCI, V115, P4201, DOI 10.1242/jcs.00106; Ozaki-Kuroda K, 2002, CURR BIOL, V12, P1145, DOI 10.1016/S0960-9822(02)00922-3; PALOMBI F, 1992, BIOL REPROD, V47, P1173, DOI 10.1095/biolreprod47.6.1173; Pasco S, 2000, J BIOL CHEM, V275, P32999, DOI 10.1074/jbc.M005235200; Pelletier RM, 2011, PROG HISTOCHEM CYTO, V46, P49, DOI 10.1016/j.proghi.2011.05.001; Pizarro-Cerda J, 2017, TRENDS CELL BIOL, V27, P93, DOI 10.1016/j.tcb.2016.08.001; Poluzzi C, 2016, ADV DRUG DELIVER REV, V97, P156, DOI 10.1016/j.addr.2015.10.012; Rehn M, 2001, P NATL ACAD SCI USA, V98, P1024, DOI 10.1073/pnas.031564998; RUSSELL LD, 1989, TISSUE CELL, V21, P361, DOI 10.1016/0040-8166(89)90051-7; Schlatt S, 2014, SEMIN CELL DEV BIOL, V29, P2, DOI 10.1016/j.semcdb.2014.03.007; Shen B, 2012, CURR OPIN CELL BIOL, V24, P600, DOI 10.1016/j.ceb.2012.08.011; Siu MKY, 2005, J BIOL CHEM, V280, P25029, DOI 10.1074/jbc.M501049200; Siu MKY, 2004, BIOESSAYS, V26, P978, DOI 10.1002/bies.20099; Siu MKY, 2004, BIOL REPROD, V70, P945, DOI 10.1095/biolreprod.103.023606; Siu MKY, 2003, ENDOCRINOLOGY, V144, P371, DOI 10.1210/en.2002-220786; SKINNER MK, 1985, J CELL BIOL, V100, P1941, DOI 10.1083/jcb.100.6.1941; SKINNER MK, 1985, J BIOL CHEM, V260, P1874; Su LL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2171; Sudhakar A, 2007, GENE REGUL SYST BIO, V1, P217; Sudhakar A, 2008, PHARM RES-DORD, V25, P2731, DOI 10.1007/s11095-008-9634-z; Tang EI, 2016, ENDOCRINOLOGY, V157, P1644, DOI 10.1210/en.2015-1962; TUNG PS, 1986, DEV BIOL, V113, P119, DOI 10.1016/0012-1606(86)90114-4; TUNG PS, 1993, J CELL PHYSIOL, V156, P1, DOI 10.1002/jcp.1041560102; Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4_11; Walia A, 2015, BBA-GEN SUBJECTS, V1850, P2422, DOI 10.1016/j.bbagen.2015.09.007; Wan HT, 2013, AM J PHYSIOL-ENDOC M, V305, pE687, DOI 10.1152/ajpendo.00254.2013; WEBER JE, 1983, AM J ANAT, V167, P163, DOI 10.1002/aja.1001670203; Winters SJ, 2004, REPRODUCTION, V128, P13, DOI 10.1530/rep.1.00195; Wong CH, 2004, J CELL SCI, V117, P783, DOI 10.1242/jcs.00900; Wong EW, 2013, SPERMATOGENESIS, V3, DOI DOI 10.4161/SPMG.25465; Xiao X, 2014, AM J PHYSIOL-ENDOC M, V307, pE553, DOI 10.1152/ajpendo.00176.2014; Xiao X, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004447; Xiao X, 2014, METHOD ENZYMOL, V534, P181, DOI 10.1016/B978-0-12-397926-1.00010-X; Yan HHN, 2008, P NATL ACAD SCI USA, V105, P8950, DOI 10.1073/pnas.0711264105; Yan HHN, 2006, J BIOL CHEM, V281, P17286, DOI 10.1074/jbc.M513218200; ZWAIN IH, 1994, MOL CELL ENDOCRINOL, V104, P213, DOI 10.1016/0303-7207(94)90124-4	79	32	32	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3587	3607		10.1096/fj.201700052R	http://dx.doi.org/10.1096/fj.201700052R			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28487282	Green Published			2022-12-28	WOS:000405932400032
J	He, JQ; Zhang, F; Tay, LWR; Boroda, S; Nian, WQ; Levental, KR; Levental, I; Harris, TE; Chang, JT; Du, GW				He, Jingquan; Zhang, Feng; Tay, Li Wei Rachel; Boroda, Salome; Nian, Weiqi; Levental, Kandice R.; Levental, Ilya; Harris, Thurl E.; Chang, Jeffrey T.; Du, Guangwei			Lipin-1 regulation of phospholipid synthesis maintains endoplasmic reticulum homeostasis and is critical for triple-negative breast cancer cell survival	FASEB JOURNAL			English	Article						TNBC; LPIN1; membrane biogenesis; IRE1 alpha; endoplasmic reticulum stress	UNFOLDED PROTEIN RESPONSE; PHOSPHATIDIC-ACID PHOSPHATASE; FATTY-ACIDS; TUMOR-GROWTH; ER STRESS; METABOLISM; PATHWAY; PHOSPHORYLATION; LOCALIZATION; ACTIVATION	Cancer cells reprogram their metabolism to increase the synthesis of macromolecules for rapid proliferation. Compared to fatty acids, much less is known about the synthesis of phospholipids, which is essential for membrane biogenesis in cancer cells. We found that LPIN1, which encodes lipin-1, a phosphatidic acid phosphatase (PAP) controlling the rate-limiting step in the phospholipid synthesis pathway, is highly up-regulated in basal-like triple-negative breast cancer (TNBC). Moreover, high LPIN1 expression correlates with the poor prognosis of these patients. Knockdown of LPIN1 increases apoptosis in basal-like TNBC cell lines, whereas it has minimal or less effect on normal human mammary gland epithelial cells (HMECs) and estrogen receptor-positive breast cancer cell lines. Fatty acid incorporation and lipidomics analyses showed that LPIN1 knockdown blocks phospholipid synthesis and changes membrane lipid compositions that ultimately induce the activation of 1 of the 3 branches of unfolded protein responses, the inositol-requiring enzyme-1 alpha pathway. We also show for the first time, to our knowledge, that lipin-1 knockdown significantly inhibits tumor growth in vivo using an orthotopic xenograft breast mouse model. Our results suggest that lipin-1 is a potential target for cancer therapy. He, J., Zhang, F., Tay, L. W. R., Boroda, S., Nian, W., Levental, K. R., Levental, I., Harris, T. E., Chang, J. T., Du, G. Lipin-1 regulation of phospholipid synthesis maintains endoplasmic reticulum homeostasis and is critical for triple-negative breast cancer cell survival.	[He, Jingquan; Zhang, Feng; Tay, Li Wei Rachel; Nian, Weiqi; Levental, Kandice R.; Levental, Ilya; Chang, Jeffrey T.; Du, Guangwei] Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA; [Chang, Jeffrey T.] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA; [Zhang, Feng] Quzhou Peoples Hosp, Dept Clin Lab, Core Facil, Quzhou, Peoples R China; [Boroda, Salome; Harris, Thurl E.] Univ Virginia Hlth Syst, Dept Pharmacol, Charlottesville, VA USA; [Nian, Weiqi] Chongqing Canc Hosp & Inst & Canc Ctr, Key Lab Oncol, Chongqing, Peoples R China	Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; University of Virginia	Du, GW (corresponding author), Univ Texas Hlth Sci Ctr Houston, Dept Integrat Biol & Pharmacol, 6431 Fannin St, Houston, TX 77030 USA.	guangwei.du@uth.tmc.edu	Levental, Ilya/F-4707-2011	Levental, Ilya/0000-0002-1206-9545; Du, Guangwei/0000-0003-4193-6975	Cancer Prevention and Research Institute of Texas (CPRIT) [RP130425, RP160775]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101946] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114282, T32GM007055] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas (CPRIT); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Symeon Siniossoglou (University of Cambridge, Cambridge, United Kingdom) for generously providing lipin-1 antibody and the pGEX-4T1-lipin-1 (aa 190-526) bacterial expression vector for lipin-1 antibody production. This study was supported by Cancer Prevention and Research Institute of Texas (CPRIT) Grants RP130425 and RP160775 (to G.D.). The authors declare no conflicts of interest.	Ackerman D, 2014, TRENDS CELL BIOL, V24, P472, DOI 10.1016/j.tcb.2014.06.001; Brohee L, 2015, ONCOTARGET, V6, P11264, DOI 10.18632/oncotarget.3595; Cai M, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.355; Chajes V, 2006, CANCER RES, V66, P5287, DOI 10.1158/0008-5472.CAN-05-1489; Chevet E, 2015, CANCER DISCOV, V5, P586, DOI 10.1158/2159-8290.CD-14-1490; Csaki LS, 2010, ANNU REV NUTR, V30, P257, DOI 10.1146/annurev.nutr.012809.104729; Currie E, 2013, CELL METAB, V18, P153, DOI 10.1016/j.cmet.2013.05.017; Eaton JM, 2013, J BIOL CHEM, V288, P9933, DOI 10.1074/jbc.M112.441493; Engebraaten O, 2013, AM J PATHOL, V183, P1064, DOI 10.1016/j.ajpath.2013.05.033; Fagone P, 2009, J LIPID RES, V50, pS311, DOI 10.1194/jlr.R800049-JLR200; Finck BN, 2006, CELL METAB, V4, P199, DOI 10.1016/j.cmet.2006.08.005; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Griffiths B, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-3; Grimsey N, 2008, J BIOL CHEM, V283, P29166, DOI 10.1074/jbc.M804278200; Han Gil-Soo, 2004, Methods Mol Biol, V284, P209; Harris TE, 2007, J BIOL CHEM, V282, P277, DOI 10.1074/jbc.M609537200; Harris TE, 2011, TRENDS ENDOCRIN MET, V22, P226, DOI 10.1016/j.tem.2011.02.006; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hermansson M, 2011, PROG LIPID RES, V50, P240, DOI 10.1016/j.plipres.2011.02.004; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hou NS, 2014, P NATL ACAD SCI USA, V111, pE2271, DOI 10.1073/pnas.1318262111; Iorio E, 2010, CANCER RES, V70, P2126, DOI 10.1158/0008-5472.CAN-09-3833; Kamphorst JJ, 2013, P NATL ACAD SCI USA, V110, P8882, DOI 10.1073/pnas.1307237110; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328; Levental KR, 2016, BIOPHYS J, V110, P1800, DOI 10.1016/j.bpj.2016.03.012; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Nieman KM, 2011, NAT MED, V17, P1498, DOI 10.1038/nm.2492; Padanad MS, 2016, CELL REP, V16, P1614, DOI 10.1016/j.celrep.2016.07.009; Peterson TR, 2011, CELL, V146, P408, DOI 10.1016/j.cell.2011.06.034; Sampaio JL, 2011, P NATL ACAD SCI USA, V108, P1903, DOI 10.1073/pnas.1019267108; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schweitzer GG, 2015, J LIPID RES, V56, P848, DOI 10.1194/jlr.M055962; Siniossoglou S, 2013, BBA-MOL CELL BIOL L, V1831, P575, DOI 10.1016/j.bbalip.2012.09.014; Sriburi R, 2004, J CELL BIOL, V167, P35, DOI 10.1083/jcb.200406136; Trousil S, 2014, CANCER RES, V74, P6867, DOI 10.1158/0008-5472.CAN-13-2409; Urra H, 2013, BBA-MOL CELL RES, V1833, P3507, DOI 10.1016/j.bbamcr.2013.07.024; Walter P, 2011, SCIENCE, V334, P1081, DOI 10.1126/science.1209038; Xu CY, 2005, J CLIN INVEST, V115, P2656, DOI 10.1172/JCI26373; Zaidi N, 2013, PROG LIPID RES, V52, P585, DOI 10.1016/j.plipres.2013.08.005; Zhang F, 2014, MOL CELL BIOL, V34, P84, DOI 10.1128/MCB.00987-13	41	33	33	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2893	2904		10.1096/fj.201601353R	http://dx.doi.org/10.1096/fj.201601353R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28347999	Green Published			2022-12-28	WOS:000405931000015
J	Maloney, JP; Branchford, BR; Brodsky, GL; Cosmic, MS; Calabrese, DW; Aquilante, CL; Maloney, KW; Gonzalez, JR; Zhang, WM; Moreau, KL; Wiggins, KL; Smith, NL; Broeckel, U; Di Paola, J				Maloney, James P.; Branchford, Brian R.; Brodsky, Gary L.; Cosmic, Maxwell S.; Calabrese, David W.; Aquilante, Christina L.; Maloney, Kelly W.; Gonzalez, Joseph R.; Zhang, Weiming; Moreau, Kerrie L.; Wiggins, Kerri L.; Smith, Nicholas L.; Broeckel, Ulrich; Di Paola, Jorge			The ENTPD1 promoter polymorphism-860 A > G (rs3814159) is associated with increased gene transcription, protein expression, CD39/NTPDase1 enzymatic activity, and thromboembolism risk	FASEB JOURNAL			English	Article						CD39 Denver; P2Y1; platelet aggregation; purinergic signaling	GENOME-WIDE ASSOCIATION; VENOUS THROMBOEMBOLISM; PULMONARY-HYPERTENSION; MOLECULAR-CLONING; P2Y(1) RECEPTOR; CD39; DIPHOSPHOHYDROLASE; ASPIRIN; DISEASE; THROMBOREGULATION	Ectonudeoside triphosphate diphosphohydrolase 1 (NTPDase1) degrades the purines ATP and ADP that are key regulators of inflammation and clotting. We hypothesized that NTPDase1 polymorphisms exist and that they regulate this pathway. We sequenced the ENTPDI gene (encoding NTPDase1) in 216 subjects then assessed genotypes in 2 cohorts comprising 2213 humans to identify ENTPDI polymorphisms associated with venous thromboembolism (VTE). The G allele of the intron 1 polymorphism rs3176891 was more common in VTE vs. controls (odds ratio 1.26-1.9); it did not affect RNA splicing, but it was in strong linkage disequilibrium with the G allele of the promoter polymorphism rs3814159, which increased transcriptional activity by 8-fold. Oligonucleotides containing the G allele of this promoter region bound nuclear extracts more avidly. Carriers of rs3176891 G had endothelial cells with increased NTPDase1 activity and protein expression, and had platelets with enhanced aggregation. Thus, the G allele of rs3176891 marks a haplotype associated with increased dotting and platelet aggregation attributable to a promoter variant associated with increased transcription, expression, and activity of NTPDase1. We term this gain-of-function phenotype observed with rs3814159 G "CD39 Denver." Maloney, J. P., Branchford, B. R., Brodsky, G. L., Cosmic, M. S., Calabrese, D. W., Aquilante, C. L, Maloney, K. W., Gonzalez, J. R., Zhang, W., Moreau, K. L., Wiggins, K. L., Smith, N. L., Broeckel, U., Di Paola, J. The ENTPDI promoter polymorphism 860 A > G (rs3814159) is associated with increased gene transcription, protein expression, CD39/NTPDase1 enzymatic activity, and thromboembolism risk	[Maloney, James P.; Calabrese, David W.] Univ Colorado Denver, Div Pulm & Crit Care Med, 12700 East 19th Ave,C-272, Aurora, CO 80045 USA; [Branchford, Brian R.; Brodsky, Gary L.; Maloney, Kelly W.; Di Paola, Jorge] Univ Colorado Denver, Ctr Canc & Blood Disorders, Aurora, CO USA; [Aquilante, Christina L.] Univ Colorado Denver, Sch Pharm, Pharmaceut Sci, Aurora, CO USA; [Gonzalez, Joseph R.] Univ Colorado Denver, Otolaryngol Head & Neck Surg, Aurora, CO USA; [Zhang, Weiming] Univ Colorado Denver, Colorado Sch Publ Hlth, Biostat & Informat, Aurora, CO USA; [Moreau, Kerrie L.] Univ Colorado Denver, Div Geriatr Med, Aurora, CO USA; [Maloney, James P.; Calabrese, David W.] Denver Vet Affairs Med Ctr, Denver, CO USA; [Cosmic, Maxwell S.] Chest Infect Dis & Crit Care Associates, Des Moines, IA USA; [Wiggins, Kerri L.] Univ Washington, Dept Med, Seattle, WA USA; [Smith, Nicholas L.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Smith, Nicholas L.] Seattle Epidemiol Res & Informat Ctr, Seattle, WA USA; [Smith, Nicholas L.] Vet Affairs Off Res & Dev, Seattle, WA USA; [Smith, Nicholas L.] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA USA; [Broeckel, Ulrich] Med Coll Wisconsin, Dept Med, Milwaukee, WI 53226 USA; [Broeckel, Ulrich] Med Coll Wisconsin, Dept Pediat, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA; [Broeckel, Ulrich] Med Coll Wisconsin, Human & Mol Genet Ctr, Milwaukee, WI 53226 USA	Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; Colorado School of Public Health; University of Colorado System; University of Colorado Anschutz Medical Campus; Children's Hospital Colorado; University of Colorado System; University of Colorado Anschutz Medical Campus; US Department of Veterans Affairs; Veterans Health Administration (VHA); Veterans Affairs Medical Center - Denver; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Group Health Cooperative; Medical College of Wisconsin; Medical College of Wisconsin; Medical College of Wisconsin	Maloney, JP (corresponding author), Univ Colorado Denver, Div Pulm & Crit Care Med, 12700 East 19th Ave,C-272, Aurora, CO 80045 USA.	james.maloney@ucdenver.edu	Branchford, Brian/H-7581-2019	Branchford, Brian/0000-0002-4076-270X; Wiggins, Kerri L/0000-0003-2749-1279	U.S. National Institutes of Health (NIH)/Heart, Lung, and Blood Institute (NHLBI) [RO1 HL071618]; NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development Child Health Research [K12 HD068372]; Hemostasis and Thrombosis Research Society (HTRS) Mentored Research Award; CSL Behring/Prof. Heim burger Award; American Society of Hematology (ASH) Scholar Award; NIH National Institute on Aging Grant [AG027678]; NIH/NHLBI [R01 HL084086, HL43201, HL60739, HL68986, HL73410, HL74745, HL85251, HL95080]; Postle Family Chair of Pediatric Cancer and Blood Disorders; NIH/National Center for Advancing Translational Sciences Colorado Clinical and Translational Sciences Institute (CTSA) [UL1 TR001082]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD068372] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001082] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL068986, R01HL071618, R01HL074745, R01HL095080, R01HL084086, R01HL043201, R01HL085251, R01HL073410] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027678] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH)/Heart, Lung, and Blood Institute (NHLBI); NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development Child Health Research; Hemostasis and Thrombosis Research Society (HTRS) Mentored Research Award; CSL Behring/Prof. Heim burger Award; American Society of Hematology (ASH) Scholar Award; NIH National Institute on Aging Grant; NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Postle Family Chair of Pediatric Cancer and Blood Disorders; NIH/National Center for Advancing Translational Sciences Colorado Clinical and Translational Sciences Institute (CTSA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank the patients and volunteers who agreed to participate in this study. The authors also thank W. Kohrt and S. Colgan (both from the University of Colorado at Denver) for their contributions of resources and helpful advice. This work was supported, in part, by the following: U.S. National Institutes of Health (NIH)/Heart, Lung, and Blood Institute (NHLBI) Grant RO1 HL071618 (to J.M.); NIH/Eunice Kennedy Shriver National Institute of Child Health and Human Development Child Health Research Career Development Award (K12 HD068372), Hemostasis and Thrombosis Research Society (HTRS) Mentored Research Award, CSL Behring/Prof. Heim burger Award, American Society of Hematology (ASH) Scholar Award (to B.B.); NIH National Institute on Aging Grant AG027678 (to K.L.M.); NIH/NHLBI Grant R01 HL084086 and Postle Family Chair of Pediatric Cancer and Blood Disorders (to J.D.); and NIH/National Center for Advancing Translational Sciences Colorado Clinical and Translational Sciences Institute (CTSA; Grant UL1 TR001082). The Heart and Vascular Health Study is supported by the NIH/NHLBI (Grants HL43201, HL60739, HL68986, HL73410, HL74745, HL85251, and HL95080).	Alvarado-Castillo C, 2005, MOL PHARMACOL, V67, P114, DOI 10.1124/mol.104.006908; Anderson DR, 2013, ANN INTERN MED, V158, P800, DOI 10.7326/0003-4819-158-11-201306040-00004; Antoni G, 2010, J THROMB HAEMOST, V8, P2671, DOI 10.1111/j.1538-7836.2010.04092.x; Aquilante CL, 2013, PHARMACOTHERAPY, V33, P1000, DOI 10.1002/phar.1292; Atkinson B, 2006, BLOOD CELL MOL DIS, V36, P217, DOI 10.1016/j.bcmd.2005.12.025; Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457; Bauer KA, 2011, JAMA-J AM MED ASSOC, V305, P1336, DOI 10.1001/jama.2011.361; Becattini C, 2012, NEW ENGL J MED, V366, P1959, DOI 10.1056/NEJMoa1114238; Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Brighton TA, 2012, NEW ENGL J MED, V367, P1979, DOI 10.1056/NEJMoa1210384; Colombo PC, 2002, J APPL PHYSIOL, V92, P1331, DOI 10.1152/japplphysiol.00680.2001; Corriden R, 2008, J BIOL CHEM, V283, P28480, DOI 10.1074/jbc.M800039200; Dwyer KM, 2010, AM J TRANSPLANT, V10, P2410, DOI 10.1111/j.1600-6143.2010.03291.x; Dwyer KM, 2004, J CLIN INVEST, V113, P1440, DOI 10.1172/JCI200419560; Enjyoji K, 1999, NAT MED, V5, P1010, DOI 10.1038/12447; Friedman DJ, 2009, P NATL ACAD SCI USA, V106, P16788, DOI 10.1073/pnas.0902869106; Friedman DJ, 2009, DIABETES, V58, P999, DOI 10.2337/db08-1214; ?GAYLEIII RB, 1998, J CLIN INVEST, V101, P1851; Germain M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025581; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Heit JA, 2012, J THROMB HAEMOST, V10, P1521, DOI 10.1111/j.1538-7836.2012.04810.x; Kaczmarek E, 1996, J BIOL CHEM, V271, P33116, DOI 10.1074/jbc.271.51.33116; Lewis Cathryn M, 2002, Brief Bioinform, V3, P146, DOI 10.1093/bib/3.2.146; Liao H, 2010, J BIOL CHEM, V285, P14791, DOI 10.1074/jbc.M110.116905; MALISZEWSKI CR, 1994, J IMMUNOL, V153, P3574; Maloney JP, 2012, AM J PHYSIOL-LUNG C, V302, pL541, DOI 10.1152/ajplung.00282.2011; Maloney JP, 1998, AM J PHYSIOL-HEART C, V275, pH1054, DOI 10.1152/ajpheart.1998.275.3.H1054; MARCUS AJ, 1991, J CLIN INVEST, V88, P1690, DOI 10.1172/JCI115485; Mizumoto N, 2002, NAT MED, V8, P358, DOI 10.1038/nm0402-358; Nikolova M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002110; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Piazza G, 2011, NEW ENGL J MED, V364, P351, DOI 10.1056/NEJMra0910203; Pinsky DJ, 2002, J CLIN INVEST, V109, P1031, DOI 10.1172/JCI200210649; Reitsma PH, 2012, ARTERIOSCL THROM VAS, V32, P563, DOI 10.1161/ATVBAHA.111.242818; Reutershan J, 2009, FASEB J, V23, P473, DOI 10.1096/fj.08-119701; Simone B, 2013, EUR J EPIDEMIOL, V28, P621, DOI 10.1007/s10654-013-9825-8; Takasaki J, 2001, MOL PHARMACOL, V60, P432; Tang WH, 2013, GENET EPIDEMIOL, V37, P512, DOI 10.1002/gepi.21731; Tregouet DA, 2009, BLOOD, V113, P5298, DOI 10.1182/blood-2008-11-190389	39	6	6	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2771	2784		10.1096/fj.201600344R	http://dx.doi.org/10.1096/fj.201600344R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28302652	Green Published			2022-12-28	WOS:000405931000006
J	Wang, FX; Xiong, XY; Zhong, Q; Meng, ZY; Yang, H; Yang, QW				Wang, Fa-Xiang; Xiong, Xiao-Yi; Zhong, Qi; Meng, Zhao-You; Yang, Hui; Yang, Qing-Wu			Foxp3 exhibits antiepileptic effects in ictogenesis involved in TLR4 signaling	FASEB JOURNAL			English	Article						NMDA receptor; epilepsy; inflammation; Toll-like receptors; glial cells	REGULATORY T-CELLS; TEMPORAL-LOBE EPILEPSY; CORTICAL-LESIONS; IMMUNE DYSREGULATION; STATUS EPILEPTICUS; NEURONAL-ACTIVITY; NMDA RECEPTOR; KAPPA-B; EXPRESSION; SEIZURES	Inflammatory processes play critical roles in epileptogenesis, but the exact mechanisms that underlie these processes are still not completely understood. In this study, we investigated the role of forkhead transcription factor 3 (Foxp3), a transcription factor that is involved in T-cell differentiation, in epileptogenesis. In both human epileptic tissues Foxp3(-/-) mice were susceptible to kainic acid-induced seizures, whereas overexpression of Foxp3 reduced acute seizure occurrence and decreased chronic seizure recurrence. In addition, in vitro experiments revealed that Foxp3 inhibited neuronal excitability via glial cells and not neurons. The protective effects of Foxp3 were manifested as a reduction in glial cell activation and proinflammatory cytokine production and increased neuronal survival. Moreover, we showed that beneficial effects of Foxp3 involved the attenuation of TLR4 signaling and inflammation, which led to the inactivation of NR2B-containing NMDA receptors. These results suggest that Foxp3 in glial cells may play an antiepileptic role in epileptogenesis and may act as a modulator of TLR4. Taken together, our results indicate that Foxp3 may represent a novel therapeutic target for achieving anticonvulsant effects in patients with epilepsy that is currently resistant to drugs. Wang, F.-X., Xiong, X.-Y., Zhong, Q., Meng, Z.-Y., Yang, H., Yang, Q.-W. Foxp3 exhibits antiepileptic effects in ictogenesis involved in TLR4 signaling.	[Wang, Fa-Xiang; Xiong, Xiao-Yi; Zhong, Qi; Meng, Zhao-You; Yang, Qing-Wu] Third Mil Med Univ, Xinqiao Hosp, Dept Neurol, 183 Xinqiao Zhengjie, Chongqing 400037, Peoples R China; [Yang, Hui] Third Mil Med Univ, Xinqiao Hosp, Dept Neurosurg, Chongqing, Peoples R China	Army Medical University; Army Medical University	Yang, QW (corresponding author), Third Mil Med Univ, Xinqiao Hosp, Dept Neurol, 183 Xinqiao Zhengjie, Chongqing 400037, Peoples R China.	yangqwmlys@hotmail.com	Xiong, Xiao-Yi/AAJ-5423-2020	Xiong, Xiao-Yi/0000-0003-0720-907X	National Basic Research Program of China (973 Program) [2014CB541605]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Basic Research Program of China (973 Program, 2014CB541605; to Q.-W.Y.). The authors declare no conflicts of interest.	[Anonymous], 1989, EPILEPSIA, V30, P389, DOI 10.1111/j.1528-1157.1989.tb05316.x; Balosso S, 2008, BRAIN, V131, P3256, DOI 10.1093/brain/awn271; Bell MP, 2007, J IMMUNOL, V179, P1893, DOI 10.4049/jimmunol.179.3.1893; Bennett CL, 2001, NAT GENET, V27, P20, DOI 10.1038/83713; Bouilleret V, 1999, NEUROSCIENCE, V89, P717, DOI 10.1016/S0306-4522(98)00401-1; Brustovetsky T, 2014, J BIOL CHEM, V289, P7470, DOI 10.1074/jbc.M113.518472; Cao AT, 2014, J LEUKOCYTE BIOL, V96, P895, DOI 10.1189/jlb.3A0114-056RR; Chen GY, 2008, J IMMUNOL, V180, P5163, DOI 10.4049/jimmunol.180.8.5163; Chenard BL, 1999, CURR PHARM DESIGN, V5, P381; Chiavegato A, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00155; Choi J, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-38; Chung HS, 2010, GLIA, V58, P1247, DOI 10.1002/glia.21006; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Fang H, 2014, J IMMUNOL, V192, P5984, DOI 10.4049/jimmunol.1400054; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Furtado MA, 2002, EPILEPSIA, V43, P37; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Gan N, 2014, MOL NEUROBIOL, V49, P337, DOI 10.1007/s12035-013-8522-7; Guo W, 2014, J NEUROPATH EXP NEUR, V73, P206, DOI 10.1097/NEN.0000000000000042; Hadjilambreva G, 2005, J NEUROPHYSIOL, V93, P843, DOI 10.1152/jn.01224.2003; Hashioka S, 2015, CNS NEUROL DISORD-DR, V14, P251, DOI 10.2174/1871527314666150217122305; He JJ, 2013, J NEUROPATH EXP NEUR, V72, P152, DOI 10.1097/NEN.0b013e318281262e; Holzer FJ, 2014, EXPERT REV NEUROTHER, V14, P1181, DOI 10.1586/14737175.2014.956457; Hong J, 2010, J BIOL CHEM, V285, P39447, DOI 10.1074/jbc.M110.132522; Hosford BE, 2016, J NEUROSCI, V36, P11013, DOI 10.1523/JNEUROSCI.1371-16.2016; Iori V, 2013, NEUROBIOL DIS, V58, P102, DOI 10.1016/j.nbd.2013.03.006; Jinde S, 2012, NEURON, V76, P1189, DOI 10.1016/j.neuron.2012.10.036; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kawai T, 2007, TRENDS MOL MED, V13, P460, DOI 10.1016/j.molmed.2007.09.002; Kim YB, 2010, BMC NEUROSCI, V11, DOI 10.1186/1471-2202-11-42; Kralic JE, 2005, EUR J NEUROSCI, V22, P1916, DOI 10.1111/j.1460-9568.2005.04386.x; Kubova H, 2002, EPILEPSIA, V43, P54, DOI 10.1046/j.1528-1157.43.s.5.36.x; Kumar VSS, 2014, CURR MED CHEM, V21, P2065, DOI 10.2174/0929867321666131228204246; Lee YH, 2000, J NEUROCHEM, V74, P2401, DOI 10.1046/j.1471-4159.2000.0742401.x; Li G, 2011, SEIZURE-EUR J EPILEP, V20, P249, DOI 10.1016/j.seizure.2010.12.005; Li Y, 2012, DEV CELL, V23, P1189, DOI 10.1016/j.devcel.2012.10.027; Liesz A, 2009, NAT MED, V15, P192, DOI 10.1038/nm.1927; Lin S, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-46; Liu SY, 2014, ANN NEUROL, V75, P614, DOI 10.1002/ana.24037; Losi G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00132; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; McGeachy MJ, 2005, J IMMUNOL, V175, P3025, DOI 10.4049/jimmunol.175.5.3025; Naziroglu M, 2015, NEUROSCIENCE, V293, P55, DOI 10.1016/j.neuroscience.2015.02.041; Pietranera L, 2010, J NEUROENDOCRINOL, V22, P1082, DOI 10.1111/j.1365-2826.2010.02058.x; Poirier JL, 2000, NEUROSCIENCE, V97, P59, DOI 10.1016/S0306-4522(00)00026-9; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Ravizza T, 2008, NEUROBIOL DIS, V29, P142, DOI 10.1016/j.nbd.2007.08.012; Ravizza T, 2011, NEUROSCI LETT, V497, P223, DOI 10.1016/j.neulet.2011.02.040; Riazi K, 2010, EPILEPSY RES, V89, P34, DOI 10.1016/j.eplepsyres.2009.09.004; Rivas MN, 2012, J CLIN INVEST, V122, P1933, DOI 10.1172/JCI40591; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Shu HF, 2010, J NEUROPATH EXP NEUR, V69, P838, DOI 10.1097/NEN.0b013e3181eaeae5; Smialowska M, 2012, NEUROTOX RES, V21, P379, DOI 10.1007/s12640-011-9293-4; Suri-Payer E, 2006, SPRINGER SEMIN IMMUN, V28, P3, DOI 10.1007/s00281-006-0021-8; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani Annamaria, 2007, Epilepsy Curr, V7, P45, DOI 10.1111/j.1535-7511.2007.00165.x; Vezzani A, 2011, EPILEPSIA, V52, P1, DOI 10.1111/j.1528-1167.2011.03028.x; Vezzani A, 2014, EPILEPSY CURR, V14, P3, DOI 10.5698/1535-7511-14.s2.3; Viviani B, 2003, J NEUROSCI, V23, P8692; Wang F., 2015, INT J DISTRIB SENS N, V2015, P1, DOI DOI 10.1007/S00425-015-2443-9; Wang PF, 2014, J IMMUNOL, V192, P4783, DOI 10.4049/jimmunol.1303108; Williams LM, 2007, NAT IMMUNOL, V8, P277, DOI 10.1038/ni1437	62	8	9	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2948	2962		10.1096/fj.201600989R	http://dx.doi.org/10.1096/fj.201600989R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28386044				2022-12-28	WOS:000405931000020
J	Kang, M; Kim, J; An, HT; Ko, J				Kang, Minsoo; Kim, Jeonghan; An, Hyoung-Tae; Ko, Jesang			Human leucine zipper protein promotes hepatic steatosis via induction of apolipoprotein A-IV	FASEB JOURNAL			English	Article						AKT signaling; Golgi stress; lipid homeostasis; phosphorylated LZIP	ELEMENT-BINDING PROTEINS; TRANSCRIPTION FACTOR; FATTY LIVER; NONALCOHOLIC STEATOHEPATITIS; STRESS; ACTIVATION; LUMAN; GENE; CREB; LIPOPROTEINS	The molecular mechanism of stress-induced hepatic steatosis is not well known. Human leucine zipper protein (LZIP) regulates the expression of genes involved in inflammation, cell migration, and stress response. The aim of this study was to determine the regulatory role of LZIP in stress-induced hepatic steatosis. We used a microarray analysis to identify LZIP-induced genes involved in hepatic lipid metabolism. LZIP increased the expression of apolipoprotein A-IV (APOA4) mRNA. In the presence of stress inducer, APOA4 promoter analysis was performed, and LZIP-induced lipid accumulation was monitored in mouse primary cells and human tissues. Under Golgi stress conditions, LZIP underwent proteolytic cleavage and was phosphorylated by AKT to protect against proteasome degradation. The stabilized N-terminal LZIP was translocated to the nucleus, where it directly bound to the APOA4 promoter, leading to APOA4 induction. LZIP-induced APOA4 expression resulted in increased absorption of surrounding free fatty acids. LZIP also promoted hepatic steatosis inmouse liver. Both LZIP and APOA4 were highly expressed in human steatosis samples. Our findings indicate that LZIP is a novel modulator of APOA4 expression and hepatic lipid metabolism. LZIP might be a therapeutic target for developing treatment strategies for hepatic steatosis and related metabolic diseases.-Kang, M., Kim, J., An, H.-T., Ko, J. Human leucine zipper protein promotes hepatic steatosis via induction of apolipoprotein A-IV.	[Kang, Minsoo; Kim, Jeonghan; An, Hyoung-Tae; Ko, Jesang] Korea Univ, Div Life Sci, Seoul 136701, South Korea	Korea University	Ko, J (corresponding author), Korea Univ, Div Life Sci, Seoul 136701, South Korea.	jesangko@korea.ac.kr		An, Hyoung-Tae/0000-0002-0732-2083	Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute - Republic of Korea Ministry of Health and Welfare [HI15C1906]	Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute - Republic of Korea Ministry of Health and Welfare	This work was supported, in part, by a grant of the Korea Health Technology Research and Development Project through the Korea Health Industry Development Institute, funded by the Republic of Korea Ministry of Health and Welfare (Grant HI15C1906).	Affo S, 2013, GUT, V62, P452, DOI 10.1136/gutjnl-2011-301146; Amarapurka D N, 2006, Ann Hepatol, V5, P30; Asada R, 2011, J BIOCHEM, V149, P507, DOI 10.1093/jb/mvr041; Audas TE, 2008, MOL CELL BIOL, V28, P3952, DOI 10.1128/MCB.01439-07; Boulon S, 2002, MOL CELL BIOL, V22, P7769, DOI 10.1128/MCB.22.22.7769-7779.2002; Cao GT, 2002, J HUM GENET, V47, P373, DOI 10.1007/s100380200053; Charlton N, 2002, HEPATOLOGY, V35, P898, DOI 10.1053/jhep.2002.32527; Chen SY, 2000, J BIOL CHEM, V275, P3733, DOI 10.1074/jbc.275.6.3733; DenBoer LM, 2005, BIOCHEM BIOPH RES CO, V331, P113, DOI 10.1016/j.bbrc.2005.03.141; Diraison F, 2003, DIABETES METAB, V29, P478, DOI 10.1016/S1262-3636(07)70061-7; Donnelly KL, 2005, J CLIN INVEST, V115, P1343, DOI 10.1172/JCI23621; Ferretti G, 2002, CHEM PHYS LIPIDS, V114, P45, DOI 10.1016/S0009-3084(01)00201-8; GOLDBERG IJ, 1990, J BIOL CHEM, V265, P4266; GREEN PHR, 1979, J CLIN INVEST, V64, P233, DOI 10.1172/JCI109444; GREEN PHR, 1980, J CLIN INVEST, V65, P911, DOI 10.1172/JCI109745; Hijona E, 2010, MEDIAT INFLAMM, V2010, DOI 10.1155/2010/837419; Honma Y, 1999, MOL BRAIN RES, V69, P93, DOI 10.1016/S0169-328X(99)00102-3; Jang SW, 2007, J CELL PHYSIOL, V211, P630, DOI 10.1002/jcp.20968; Kim J, 2014, CELL DEATH DIFFER, V21, P1642, DOI 10.1038/cdd.2014.80; LAGROST L, 1989, J LIPID RES, V30, P1525; Lee AH, 2008, SCIENCE, V320, P1492, DOI 10.1126/science.1158042; Lee JS, 2012, TOXICOL LETT, V211, P29, DOI 10.1016/j.toxlet.2012.02.017; Lee JH, 2011, NAT MED, V17, P812, DOI 10.1038/nm.2347; Liang GQ, 2006, MOL CELL BIOL, V26, P7999, DOI 10.1128/MCB.01046-06; Liu M, 2001, AM J PHYSIOL-REG I, V280, pR1382, DOI 10.1152/ajpregu.2001.280.5.R1382; Lopez-Vicario C, 2014, GUT, V63, P344, DOI 10.1136/gutjnl-2012-303179; Lu S, 2006, J BIOL CHEM, V281, P3473, DOI 10.1074/jbc.M502501200; Magana MM, 1996, J BIOL CHEM, V271, P32689, DOI 10.1074/jbc.271.51.32689; Matsuda Satoru, 2013, ISRN Endocrinol, V2013, P472432, DOI 10.1155/2013/472432; Omori Y, 2001, NUCLEIC ACIDS RES, V29, P2154, DOI 10.1093/nar/29.10.2154; Pihlajamaki J, 2009, J CLIN ENDOCR METAB, V94, P3521, DOI 10.1210/jc.2009-0212; Raggo C, 2002, MOL CELL BIOL, V22, P5639, DOI 10.1128/MCB.22.16.5639-5649.2002; Reiling JH, 2013, NAT CELL BIOL, V15, P1473, DOI 10.1038/ncb2865; ROHEIM PS, 1976, P NATL ACAD SCI USA, V73, P1757, DOI 10.1073/pnas.73.5.1757; Sanecka A, 2012, MOL IMMUNOL, V50, P66, DOI 10.1016/j.molimm.2011.12.003; Shimomura I, 1998, J BIOL CHEM, V273, P35299, DOI 10.1074/jbc.273.52.35299; Starmann J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046584; Stiles B, 2004, P NATL ACAD SCI USA, V101, P2082, DOI 10.1073/pnas.0308617100; Storlazzi CT, 2003, HUM MOL GENET, V12, P2349, DOI 10.1093/hmg/ddg237; Tabor DE, 1999, J BIOL CHEM, V274, P20603, DOI 10.1074/jbc.274.29.20603; VerHague MA, 2013, ARTERIOSCL THROM VAS, V33, P2501, DOI 10.1161/ATVBAHA.113.301948; Watanabe S, 2005, HEPATOL RES, V33, P161, DOI 10.1016/j.hepres.2005.09.026; Wong WMR, 2007, ATHEROSCLEROSIS, V192, P266, DOI 10.1016/j.atherosclerosis.2006.07.017; WU AL, 1979, J BIOL CHEM, V254, P7316; Xu X, 2014, J LIPID RES, V55, P850, DOI 10.1194/jlr.M045104; Yan CL, 2016, NEUROENDOCRINOLOGY, V103, P476, DOI 10.1159/000439436; Yang SQ, 1997, P NATL ACAD SCI USA, V94, P2557, DOI 10.1073/pnas.94.6.2557; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2011, EMBO J, V30, P1357, DOI 10.1038/emboj.2011.52	49	12	13	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2548	2561		10.1096/fj.201601227R	http://dx.doi.org/10.1096/fj.201601227R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28246167				2022-12-28	WOS:000401553400027
J	Campana, WM; Mantuano, E; Azmoon, P; Henry, K; Banki, MA; Kim, JH; Pizzo, DP; Gonias, SL				Campana, Wendy M.; Mantuano, Elisabetta; Azmoon, Pardis; Henry, Kenneth; Banki, Michael A.; Kim, John H.; Pizzo, Donald P.; Gonias, Steven L.			Ionotropic glutamate receptors activate cell signaling in response to glutamate in Schwann cells	FASEB JOURNAL			English	Article						NMDA receptor; AMPA receptor; kainate receptor; peripheral nerve injury; migration	NMDA RECEPTOR; PLASMINOGEN-ACTIVATOR; INDUCED NOCICEPTION; REGULATED KINASE; STRIATAL NEURONS; NEUROPATHIC PAIN; GENE KNOCKDOWN; PROTEIN; SUBUNIT; PROLIFERATION	In the peripheralnervous system, Schwann cells (SCs) demonstrate surveillance activity, detecting injury and undergoing trans-differentiation to support repair. SC receptors that detect peripheral nervous system injury remain incompletely understood. We used RT-PCR to profile ionotropic glutamate receptor expression in cultured SCs. We identified subunits required for assembly of N-methyl-D-aspartic acid (NMDA) receptors (NMDA-Rs), a-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors, and kainate receptors. Treatment of SCs with 40-100 mM glutamate or with 0.5- 1.0 mu M NMDA robustly activated Akt and ERK1/2. The response was transient and bimodal; glutamate concentrations that exceeded 250 mM failed to activate cell signaling. Phosphoprotein profiling identified diverse phosphorylated proteins in glutamate-treated SCs in addition to ERK1/2 and Akt, including p70 S6-kinase, glycogen synthase kinase-3, ribosomal S6 kinase, c-Jun, and cAMP response element binding protein. Activation of SC signaling by glutamate was blocked by EGTA and dizocilpine and by silencing expression of the NMDA-R NR1 subunit. Phosphoinositide 3-kinase/PI3K functioned as an essential upstream activator of Akt and ERK1/2 in glutamate-treated SCs. When glutamate or NMDA was injected directly into crush-injured rat sciatic nerves, ERK1/2 phosphorylation was observed in myelinated and nonmyelinating SCs. Glutamate promoted SC migration by a pathway that required PI3K and ERK1/2. These results identified ionotropic glutamate receptors and NMDA-Rs, specifically, as potentially important cell signaling receptors in SCs.-Campana, W. M., Mantuano, E., Azmoon, P., Henry, K., Banki, M. A., Kim, J. H., Pizzo, D. P., Gonias, S. L. Ionotropic glutamate receptors activate cell signaling in response to glutamate in Schwann cells. FASEB J. 31, 1744-1755 (2017). www. fasebj.org	[Campana, Wendy M.; Henry, Kenneth; Kim, John H.] Univ Calif San Diego, Sch Med, Dept Anesthesiol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Mantuano, Elisabetta; Azmoon, Pardis; Banki, Michael A.; Pizzo, Donald P.; Gonias, Steven L.] Univ Calif San Diego, Sch Med, Dept Pathol, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Mantuano, Elisabetta] Sapienza Univ Rome, Dept Expt Med, Rome, Italy	University of California System; University of California San Diego; University of California System; University of California San Diego; Sapienza University Rome	Campana, WM; Gonias, SL (corresponding author), Univ Calif San Diego, Sch Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	wcampana@ucsd.edu; sgonias@ucsd.edu		Azmoon, Pardis/0000-0002-1512-5581; Banki, Michael/0000-0002-8910-4695; Mantuano, Elisabetta/0000-0001-5728-9261	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [R01-HL60551]; FIRB from the Italian Ministry of Education, Universities, and Research [RBFR13RBK9]; NIH National Institute of Neurological Disorders and Stroke [P30-NS047101]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060551] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P30NS047101, R01NS097590] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); FIRB from the Italian Ministry of Education, Universities, and Research; NIH National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grant R01-HL60551 (to S.L.G.), and by FIRB 2013 (RBFR13RBK9) from the Italian Ministry of Education, Universities, and Research (to E.M.). The authors thank Katie Fichter [Department of Anesthesiology, University of California, San Diego (UCSD) School of Medicine] for technical assistance. IF microscopy was performed using the UCSD School of Medicine Light Microscopy Core Facility, sponsored by the NIH National Institute of Neurological Disorders and Stroke Grant P30-NS047101.	Akassoglou K, 2002, BIOL CHEM, V383, P37, DOI 10.1515/BC.2002.004; Allgaier C, 1999, BRIT J PHARMACOL, V126, P121, DOI 10.1038/sj.bjp.0702284; ANIS NA, 1983, BRIT J PHARMACOL, V79, P565, DOI 10.1111/j.1476-5381.1983.tb11031.x; Anjum R, 2008, NAT REV MOL CELL BIO, V9, P747, DOI 10.1038/nrm2509; Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007; BOTTENSTEIN JE, 1980, EXP CELL RES, V129, P361, DOI 10.1016/0014-4827(80)90504-2; Campana WM, 2006, J NEUROSCI, V26, P11197, DOI 10.1523/JNEUROSCI.2709-06.2006; Campana WM, 2007, BRAIN BEHAV IMMUN, V21, P522, DOI 10.1016/j.bbi.2006.12.008; Christensen PC, 2016, MUSCLE NERVE, V54, P451, DOI 10.1002/mus.25078; Crossthwaite AJ, 2004, J NEUROCHEM, V88, P1127, DOI 10.1046/j.1471-4159.2004.02257.x; EVANS PD, 1991, J EXP BIOL, V157, P593; Fayard E, 2010, CURR TOP MICROBIOL, V346, P31, DOI 10.1007/82_2010_58; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fink T, 1999, CAN J PHYSIOL PHARM, V77, P204, DOI 10.1139/cjpp-77-3-204; Ghasemi M, 2014, NEUROSCI BIOBEHAV R, V47, P336, DOI 10.1016/j.neubiorev.2014.08.017; Gill SS, 2001, TOXICOL PATHOL, V29, P208, DOI 10.1080/019262301317052486; Jessen KR, 2016, J PHYSIOL-LONDON, V594, P3521, DOI 10.1113/JP270874; Lau JCM, 2013, MOL VIS, V19, P1538; Lee MM, 1999, J NEUROSCI RES, V55, P702, DOI 10.1002/(SICI)1097-4547(19990315)55:6<702::AID-JNR5>3.3.CO;2-E; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; LIEBERMAN EM, 1989, GLIA, V2, P94, DOI 10.1002/glia.440020205; Liu GJ, 2003, NEUROREPORT, V14, P2079, DOI 10.1097/00001756-200311140-00014; Mantuano E, 2008, J NEUROSCI, V28, P11571, DOI 10.1523/JNEUROSCI.3053-08.2008; Mantuano E, 2008, J BIOL CHEM, V283, P19904, DOI 10.1074/jbc.M801762200; Mantuano E, 2015, J CELL SCI, V128, P3478, DOI 10.1242/jcs.173765; Mantuano E, 2013, J BIOL CHEM, V288, P34009, DOI 10.1074/jbc.M113.509133; Mantuano E, 2010, J BIOL CHEM, V285, P14259, DOI 10.1074/jbc.M109.085126; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mayr B, 2001, NAT REV MOL CELL BIO, V2, P599, DOI 10.1038/35085068; Meinhardt MW, 2013, J NEUROSCI, V33, P2794, DOI 10.1523/JNEUROSCI.4062-12.2013; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Micu I, 2016, EXP NEUROL, V276, P41, DOI 10.1016/j.expneurol.2015.10.006; Monje PV, 2006, GLIA, V53, P649, DOI 10.1002/glia.20330; Moskal JR, 2014, EXPERT OPIN INV DRUG, V23, P243, DOI 10.1517/13543784.2014.852536; Nacher J, 2006, HIPPOCAMPUS, V16, P267, DOI 10.1002/hipo.20160; Nicholson KM, 2002, CELL SIGNAL, V14, P381, DOI 10.1016/S0898-6568(01)00271-6; Nicole O, 2001, NAT MED, V7, P59, DOI 10.1038/83358; Nishi M, 2001, J NEUROSCI, V21, part. no., DOI 10.1523/JNEUROSCI.21-23-j0003.2001; Niswender CM, 2010, ANNU REV PHARMACOL, V50, P295, DOI 10.1146/annurev.pharmtox.011008.145533; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Orita S, 2013, J NEUROSCI, V33, P5590, DOI 10.1523/JNEUROSCI.3342-12.2013; Perkinton MS, 2002, J NEUROCHEM, V80, P239, DOI 10.1046/j.0022-3042.2001.00699.x; Rajan I, 1998, J NEUROSCI, V18, P7836; Robinson DM, 2006, DRUGS, V66, P1515, DOI 10.2165/00003495-200666110-00015; Saitoh F, 2016, SCI REP-UK, V6, DOI 10.1038/srep29856; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Sun LX, 1998, FEBS LETT, V441, P392, DOI 10.1016/S0014-5793(98)01590-7; Tan PH, 2005, GENE THER, V12, P59, DOI 10.1038/sj.gt.3302376; Tan PH, 2010, ANESTHESIOLOGY, V112, P1482, DOI 10.1097/ALN.0b013e3181d69494; Traynelis SF, 2010, PHARMACOL REV, V62, P405, DOI 10.1124/pr.109.002451; Triolo D, 2006, J CELL SCI, V119, P3981, DOI 10.1242/jcs.03168; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Weilinger NL, 2016, NAT NEUROSCI, V19, P432, DOI 10.1038/nn.4236; Xu JD, 2008, J BIOL CHEM, V283, P17503, DOI 10.1074/jbc.M800917200; Yamazaki T, 2009, J PERIPHER NERV SYST, V14, P165, DOI 10.1111/j.1529-8027.2009.00228.x; Yu H, 2015, J VET MED SCI, V77, P427, DOI 10.1292/jvms.14-0555; Zarate CA, 2006, ARCH GEN PSYCHIAT, V63, P856, DOI 10.1001/archpsyc.63.8.856	57	18	18	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1744	1755		10.1096/fj.201601121R	http://dx.doi.org/10.1096/fj.201601121R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28073836	Green Published			2022-12-28	WOS:000398504300038
J	Juks, C; Lorents, A; Arukuusk, P; Langel, U; Pooga, M				Juks, Carmen; Lorents, Annely; Arukuusk, Piret; Langel, Ulo; Pooga, Margus			Cell-penetrating peptides recruit type A scavenger receptors to the plasma membrane for cellular delivery of nucleic acids	FASEB JOURNAL			English	Article						SR-A3; SR-A5; Ca2+ signaling; PI3K	PHOSPHATIDYLINOSITOL 3-KINASE ACTIVITY; HAMSTER OVARY CELLS; PROTEIN CORONA; UP-REGULATION; IN-VIVO; OLIGONUCLEOTIDE DELIVERY; INTRACELLULAR CALCIUM; ENDOCYTIC PATHWAY; ENDOSOME FUSION; SURFACE	Scavenger receptors (SRs) are a large family of multifunctional receptors that are involved in a range of physiologic and pathologic processes. The ability of class A scavenger receptors (SR-As) to bind anionic ligands facilitates the internalization of negatively charged cell-penetrating peptide (CPP)-nucleic acid nanocomplexes and thus makes them attractive targets for delivery of various nucleic acids. Recently, we demonstrated that SR-A3 and SR-A5 are recruited from intracellular membranes to the plasma membrane after incubation with PepFect 14-splice-switching oligonucleotide complexes. Here, we examined the mechanisms responsible for translocation of SR-As to the cell surface. We demonstrate that, in addition to nanocomplexes, some amphipathic CPPs are able to induce externalization of SR-A3 and SR-A5, and this process requires the presence of calcium ions. Furthermore, translocation of SR-A3 and SR-A5 requires activity of phosphatidylinositol-3-kinase, intact actin cytoskeleton, and the presence of serum proteins in culture medium.	[Juks, Carmen; Lorents, Annely; Pooga, Margus] Univ Tartu, Inst Mol & Cell Biol, Tartu, Estonia; [Arukuusk, Piret; Langel, Ulo] Univ Tartu, Inst Technol, Mol Biotechnol Lab, Tartu, Estonia; [Langel, Ulo] Stockholm Univ, Dept Neurochem, Stockholm, Sweden	University of Tartu; University of Tartu; Stockholm University	Pooga, M (corresponding author), Inst Mol & Cell Biol, 23 Riia Str, EE-51010 Tartu, Estonia.	mpooga@ut.ee	Pooga, Margus/A-8575-2011; Langel, Ulo/K-9773-2018	Pooga, Margus/0000-0003-4532-4087; Lorents, Annely/0000-0002-2823-5202; Langel, Ulo/0000-0001-6107-0844	Estonian Science Foundation [ESF 8705]; Estonian Ministry of Education and Research [0180019s11]; European Union Regional Development Fund through the Competence Centre on Reproductive Medicine and Biology [EU30020]; Estonian Research Council [IUT20-26]	Estonian Science Foundation; Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia); European Union Regional Development Fund through the Competence Centre on Reproductive Medicine and Biology; Estonian Research Council	This study was supported by the Estonian Science Foundation (Grant ESF 8705), the Estonian Ministry of Education and Research (Grant 0180019s11), the European Union Regional Development Fund (Grant EU30020) through the Competence Centre on Reproductive Medicine and Biology, and the Estonian Research Council (IUT20-26). The authors declare no conflicts of interest.	Andaloussi SEL, 2011, NUCLEIC ACIDS RES, V39, P3972, DOI 10.1093/nar/gkq1299; Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249; Arukuusk P, 2013, BIOCONJUGATE CHEM, V24, P1721, DOI 10.1021/bc4002757; Caracciolo G, 2013, ACS APPL MATER INTER, V5, P13171, DOI 10.1021/am404171h; Chieregatti E, 2005, NAT REV MOL CELL BIO, V6, P181, DOI 10.1038/nrm1572; Choi CHJ, 2013, P NATL ACAD SCI USA, V110, P7625, DOI 10.1073/pnas.1305804110; Cholewa J, 2010, J LEUKOCYTE BIOL, V87, P443, DOI 10.1189/jlb.0509318; Coorssen JR, 1996, EMBO J, V15, P3787, DOI 10.1002/j.1460-2075.1996.tb00752.x; Crombez L, 2009, MOL THER, V17, P95, DOI 10.1038/mt.2008.215; Ezzat K, 2012, FASEB J, V26, P1172, DOI 10.1096/fj.11-191536; Ezzat K, 2011, NUCLEIC ACIDS RES, V39, P5284, DOI 10.1093/nar/gkr072; Falcone S, 2006, J CELL SCI, V119, P4758, DOI 10.1242/jcs.03238; Fittipaldi A, 2003, J BIOL CHEM, V278, P34141, DOI 10.1074/jbc.M303045200; Fleischer CC, 2014, ACCOUNTS CHEM RES, V47, P2651, DOI 10.1021/ar500190q; Fukuhara-Takaki K, 2005, J BIOL CHEM, V280, P3355, DOI 10.1074/jbc.M408715200; Jess TJ, 1996, CELL SIGNAL, V8, P297, DOI 10.1016/0898-6568(96)00054-X; JONES AT, 1995, BIOCHEM J, V311, P31, DOI 10.1042/bj3110031; Juks C, 2015, BBA-BIOMEMBRANES, V1848, P3205, DOI 10.1016/j.bbamem.2015.09.019; Kang SH, 1998, BIOCHEMISTRY-US, V37, P6235, DOI 10.1021/bi980300h; Kelley JL, 2014, CRIT REV IMMUNOL, V34, P241, DOI 10.1615/CritRevImmunol.2014010267; Kjeken R, 2001, BIOCHEM J, V357, P497, DOI 10.1042/0264-6021:3570497; Kosswig N, 2003, J BIOL CHEM, V278, P34219, DOI 10.1074/jbc.M303465200; Kundra A, 1998, J BIOL CHEM, V273, P3848, DOI 10.1074/jbc.273.7.3848; Kurreck J, 2003, EUR J BIOCHEM, V270, P1628, DOI 10.1046/j.1432-1033.2003.03555.x; LI GP, 1995, P NATL ACAD SCI USA, V92, P10207, DOI 10.1073/pnas.92.22.10207; Lindberg S, 2015, J CONTROL RELEASE, V206, P58, DOI 10.1016/j.jconrel.2015.03.009; Lindberg S, 2013, INT J PHARMACEUT, V441, P242, DOI 10.1016/j.ijpharm.2012.11.037; Lindmo K, 2006, J CELL SCI, V119, P605, DOI 10.1242/jcs.02855; Liu ZM, 2007, CELL MOL LIFE SCI, V64, P1428, DOI 10.1007/s00018-007-7107-x; Lorents A, 2012, J BIOL CHEM, V287, P16880, DOI 10.1074/jbc.M111.318063; Lu H, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-80; Lundin P, 2008, BIOCONJUGATE CHEM, V19, P2535, DOI 10.1021/bc800212j; Margus H, 2016, MOL PHARMACEUT, V13, P172, DOI 10.1021/acs.molpharmaceut.5b00598; Martys JL, 1996, J BIOL CHEM, V271, P10953, DOI 10.1074/jbc.271.18.10953; Melikov K, 2015, BIOCHEM J, V471, P221, DOI 10.1042/BJ20150272; Mietus-Snyder M, 2000, J BIOL CHEM, V275, P17661, DOI 10.1074/jbc.275.23.17661; Morimoto K, 1999, BIOL PHARM BULL, V22, P1022; Mortimer GM, 2014, ACS NANO, V8, P3357, DOI 10.1021/nn405830g; Murphy JE, 2005, ATHEROSCLEROSIS, V182, P1, DOI 10.1016/j.atherosclerosis.2005.03.036; Neher E, 2008, NEURON, V59, P861, DOI 10.1016/j.neuron.2008.08.019; Nellimarla S, 2015, J IMMUNOL, V195, P3858, DOI 10.4049/jimmunol.1501028; Padari K, 2005, BIOCONJUGATE CHEM, V16, P1399, DOI 10.1021/bc050125z; Padari K, 2011, METHODS MOL BIOL, V683, P181, DOI 10.1007/978-1-60761-919-2_13; Palm-Apergi C, 2009, FASEB J, V23, P214, DOI 10.1096/fj.08-110254; PEARSON AM, 1993, J BIOL CHEM, V268, P3546; Pozzi D, 2015, NANOSCALE, V7, P13958, DOI 10.1039/c5nr03701h; Reddy A S, 2001, BMC Genomics, V2, P2, DOI 10.1186/1471-2164-2-2; Rydstrom A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025924; Saalik P, 2009, BIOCONJUGATE CHEM, V20, P877, DOI 10.1021/bc800416f; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Shetty S, 2006, ARTERIOSCL THROM VAS, V26, P2125, DOI 10.1161/01.ATV.0000233335.26362.37; Simonsen A, 1998, NATURE, V394, P494, DOI 10.1038/28879; Song Z., 2013, FASEB J, V27; Soomets U, 2000, BBA-BIOMEMBRANES, V1467, P165, DOI 10.1016/S0005-2736(00)00216-9; Spiro DJ, 1996, MOL BIOL CELL, V7, P355, DOI 10.1091/mbc.7.3.355; van Asbeck AH, 2013, ACS NANO, V7, P3797, DOI 10.1021/nn305754c; van Dam EM, 2005, MOL ENDOCRINOL, V19, P1067, DOI 10.1210/me.2004-0413; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; Veiman KL, 2013, MOL PHARMACEUT, V10, P199, DOI 10.1021/mp3003557; Walkey CD, 2012, CHEM SOC REV, V41, P2780, DOI 10.1039/c1cs15233e; Yan Y, 2013, ACS NANO, V7, P10960, DOI 10.1021/nn404481f; Yang J, 1996, BIOCHEM J, V313, P125, DOI 10.1042/bj3130125	62	19	20	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					975	988		10.1096/fj.201600811R	http://dx.doi.org/10.1096/fj.201600811R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27881484				2022-12-28	WOS:000395671200014
J	Kulkarni, A; Khan, Y; Ray, K				Kulkarni, Anuttama; Khan, Yasmin; Ray, Krishanu			Heterotrimeric kinesin-2, together with kinesin-1, steers vesicular acetylcholinesterase movements toward the synapse	FASEB JOURNAL			English	Article						intracellular transport; lateral-chordotonal-neuron; Drosophila; mouse brain	DROSOPHILA-MELANOGASTER ACETYLCHOLINESTERASE; AXONAL-TRANSPORT; MOLECULAR-FORMS; CHOLINE-ACETYLTRANSFERASE; CYTOPLASMIC DYNEIN; PROTEIN; MOTORS; EXPRESSION; MUTANTS; SUBUNIT	Acetylcholinesterase (AChE), which is implicated in the pathophysiology of neurological disorders, is distributed along the axon and enriched at the presynaptic basal lamina. It hydrolyses the neurotransmitter acetylcholine, which inhibits synaptic transmission. Aberrant AChE activity and ectopic axonal accumulation of the enzyme are associated with neurodegenerative disorders, such as Alzheimer's disease. The molecular mechanism that underlies AChE transport is still unclear. Here, we show that expression of Drosophila AChE tagged with photoactivatable green fluorescent protein and m-Cherry (GPAC) in cholinergic neurons compensates for the RNA interference-mediated knockdown of endogenous AChE activity. GPAC-AChE, which is enriched in the neuropil region of the brain, moves in the apparently vesicular formin axons with an anterograde bias in Drosophila larvae. Two anterograde motors, kinesin-1 and -2, propel distinct aspects of GPAC-AChE movements. Total loss of kinesin-2 reduces the density of anterograde traffic and increases bidirectional movements of GPAC-AChE vesicles without altering their speed. A partial loss of kinesin-1 reduces both the density and speed of anterograde GPAC-AChE traffic and enhances the pool of stationary vesicles. Together, these results suggest that combining activity of a relatively weak kinesin-2 with that of a stronger kinesin-1 motor could steer AChE-containing vesicles toward synapse, and provides a molecular basis for the observed subcellular distribution of the enzyme.	[Kulkarni, Anuttama; Khan, Yasmin] Sophia Coll, Bombay, Maharashtra, India; [Kulkarni, Anuttama; Ray, Krishanu] Tata Inst Fundamental Res, Homi Bhabba Rd, Bombay 400005, Maharashtra, India	Tata Institute of Fundamental Research (TIFR)	Ray, K (corresponding author), Tata Inst Fundamental Res, Homi Bhabba Rd, Bombay 400005, Maharashtra, India.	krishanu@tifr.res.in	Kulkarni, Anuttama/GXZ-4979-2022	Kulkarni, Anuttama/0000-0002-2265-5820; Ray, Krishanu/0000-0001-6406-3199	University Grants Commission Fellowship (New Delhi, India); Department of Atomic Energy (Government of India Atomic Energy Commission)	University Grants Commission Fellowship (New Delhi, India); Department of Atomic Energy (Government of India Atomic Energy Commission)	The authors thank Akanksha Jain for the Klp68D<SUP>Bex2</SUP> stock; Arkadiuz Welman for the GPAC clone; Shital Suryavanshi, Megha Maheshwari, and Vidita Vaidya for providing mice brain sections and assistance with the immunohistochemistry; and Roop Mallik for useful suggestions on the manuscript (all from the Tata Institute for Fundamental Research). This study was supported by a University Grants Commission Fellowship (New Delhi, India) (to A.K.) and an intramural grant from the Department of Atomic Energy (Government of India Atomic Energy Commission) (to K.R.).	Alvarez A, 1995, NEUROSCI LETT, V201, P49, DOI 10.1016/0304-3940(94)12127-C; Andreasson JOL, 2015, CURR BIOL, V25, P1166, DOI 10.1016/j.cub.2015.03.013; Baqri R, 2006, J NEUROBIOL, V66, P378, DOI 10.1002/neu.20230; Bendayan M, 2001, J HISTOCHEM CYTOCHEM, V49, P29, DOI 10.1177/002215540104900104; BRIMIJOIN S, 1978, J PHYSIOL-LONDON, V285, P129, DOI 10.1113/jphysiol.1978.sp012562; COURAUD JY, 1980, J NEUROCHEM, V35, P1053, DOI 10.1111/j.1471-4159.1980.tb07859.x; COURAUD JY, 1983, EXP NEUROL, V80, P94, DOI 10.1016/0014-4886(83)90009-2; De Ferrari GV, 2001, BIOCHEMISTRY-US, V40, P10447, DOI 10.1021/bi0101392; De Vos KJ, 2008, ANNU REV NEUROSCI, V31, P151, DOI 10.1146/annurev.neuro.31.061307.090711; De Vos KJ, 2007, METHOD CELL BIOL, V80, P627, DOI 10.1016/S0091-679X(06)80030-0; Deacon SW, 2003, J CELL BIOL, V160, P297, DOI 10.1083/jcb.200210066; Doodhi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045981; Encalada SE, 2011, CELL, V144, P551, DOI 10.1016/j.cell.2011.01.021; FOURNIER D, 1989, J MOL BIOL, V210, P15, DOI 10.1016/0022-2836(89)90287-8; Fu MM, 2013, J CELL BIOL, V202, P495, DOI 10.1083/jcb.201302078; Granger E, 2014, SEMIN CELL DEV BIOL, V31, P20, DOI 10.1016/j.semcdb.2014.04.011; Greenfield SA, 2008, FEBS J, V275, P604, DOI 10.1111/j.1742-4658.2007.06235.x; GREENSPAN RJ, 1980, J COMP NEUROL, V189, P741, DOI 10.1002/cne.901890409; Grifman M, 1998, P NATL ACAD SCI USA, V95, P13935, DOI 10.1073/pnas.95.23.13935; HALL JC, 1976, GENETICS, V83, P517; Harel M, 2000, PROTEIN SCI, V9, P1063, DOI 10.1110/ps.9.6.1063; HASSIG R, 1991, J NEUROCHEM, V57, P1913, DOI 10.1111/j.1471-4159.1991.tb06403.x; Hirokawa N, 2008, PHYSIOL REV, V88, P1089, DOI 10.1152/physrev.00023.2007; Hoeprich GJ, 2014, BIOPHYS J, V106, P1691, DOI 10.1016/j.bpj.2014.02.034; Incardona JP, 1996, MOL BIOL CELL, V7, P595, DOI 10.1091/mbc.7.4.595; Kamal A, 2000, NEURON, V28, P449, DOI 10.1016/S0896-6273(00)00124-0; Kanai Y, 2000, J NEUROSCI, V20, P6374, DOI 10.1523/JNEUROSCI.20-17-06374.2000; KASA P, 1973, J NEUROCHEM, V21, P431; KASA P, 1968, NATURE, V218, P1265, DOI 10.1038/2181265a0; Ligon LA, 2004, J BIOL CHEM, V279, P19201, DOI 10.1074/jbc.M313472200; MACPHEEQUIGLEY K, 1985, J BIOL CHEM, V260, P2185; Maday S, 2012, J CELL BIOL, V196, P407, DOI 10.1083/jcb.201106120; MASSOULIE J, 1982, ANNU REV NEUROSCI, V5, P57, DOI 10.1146/annurev.ne.05.030182.000421; Massoulie J, 1998, J PHYSIOLOGY-PARIS, V92, P183, DOI 10.1016/S0928-4257(98)80007-7; Messitt TJ, 2008, DEV CELL, V15, P426, DOI 10.1016/j.devcel.2008.06.014; Murray JW, 2002, ANAL BIOCHEM, V305, P55, DOI 10.1006/abio.2002.5655; Pantelidou M, 2007, NEUROBIOL DIS, V26, P577, DOI 10.1016/j.nbd.2007.02.005; Paraoanu LE, 2008, FEBS J, V275, P618, DOI 10.1111/j.1742-4658.2007.06237.x; Perez-Aguilar B, 2015, BBA-MOL BASIS DIS, V1852, P1380, DOI 10.1016/j.bbadis.2015.04.003; Perrier AL, 2002, NEURON, V33, P275, DOI 10.1016/S0896-6273(01)00584-0; PESAVENTO PA, 1994, J CELL BIOL, V127, P1041, DOI 10.1083/jcb.127.4.1041; Rai A, 2016, CELL, V164, P722, DOI 10.1016/j.cell.2015.12.054; Ray K, 1999, J CELL BIOL, V147, P507, DOI 10.1083/jcb.147.3.507; Reis GF, 2012, MOL BIOL CELL, V23, P1700, DOI 10.1091/mbc.E11-11-0938; Rocha N, 2009, J CELL BIOL, V185, P1209, DOI 10.1083/jcb.200811005; Sadananda A, 2012, TRAFFIC, V13, P979, DOI 10.1111/j.1600-0854.2012.01361.x; Sarpal R, 2003, CURR BIOL, V13, P1687, DOI 10.1016/j.cub.2003.09.025; SAXTON WM, 1991, CELL, V64, P1093, DOI 10.1016/0092-8674(91)90264-Y; Schroeder HW, 2012, BIOPHYS J, V103, P48, DOI 10.1016/j.bpj.2012.05.037; Sharma KV, 2001, J NEUROSCI RES, V63, P165, DOI 10.1002/1097-4547(20010115)63:2<165::AID-JNR1008>3.0.CO;2-O; Silman I, 2005, CURR OPIN PHARMACOL, V5, P293, DOI 10.1016/j.coph.2005.01.014; Soppina V, 2009, P NATL ACAD SCI USA, V106, P19381, DOI 10.1073/pnas.0906524106; SVOBODA K, 1994, CELL, V77, P773, DOI 10.1016/0092-8674(94)90060-4; Twelvetrees AE, 2016, NEURON, V90, P1000, DOI 10.1016/j.neuron.2016.04.046; ZADOR E, 1995, BIOCHEM GENET, V33, P41, DOI 10.1007/BF00554557; Zaganas I, 2013, TOXICOLOGY, V307, P3, DOI 10.1016/j.tox.2013.02.002	56	7	7	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					965	974		10.1096/fj.201600759RRR	http://dx.doi.org/10.1096/fj.201600759RRR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27920150				2022-12-28	WOS:000395671200013
J	Currais, A; Fischer, W; Maher, P; Schubert, D				Currais, Antonio; Fischer, Wolfgang; Maher, Pamela; Schubert, David			Intraneuronal protein aggregation as a trigger for inflammation and neurodegeneration in the aging brain	FASEB JOURNAL			English	Article						neurodegenerative diseases; Alzheimer's disease; cell division	A-BETA ACCUMULATION; AMYLOID-BETA; OXIDATIVE STRESS; MEMORY PERFORMANCE; DAMAGE SEGREGATION; ALZHEIMER-DISEASE; TRANSGENIC MICE; NEURON LOSS; AGE; MITOCHONDRIA	Age is, by far, the greatest risk factor for Alzheimer's disease (AD), yet few AD drug candidates have been generated that target pathways specifically associated with the aging process itself. Two ubiquitous features of the aging brain are the intracellular accumulation of aggregated proteins and inflammation. As intraneuronal amyloid protein is detected before markers of inflammation, we argue that old, age-associated, aggregated proteins in neurons can induce inflammation, resulting in multiple forms of brain toxicities. The consequence is the increased risk of old, age-associated, neurodegenerative diseases. As most of these diseases are associated with the accumulation of aggregated proteins, it is possible that any therapeutic that reduces intracellular protein aggregation will benefit all.-Currais, A., Fischer, W., Maher, P., Schubert, D. Intraneuronal protein aggregation as a trigger for inflammation and neurodegeneration in the aging brain.	[Currais, Antonio; Fischer, Wolfgang; Maher, Pamela; Schubert, David] Salk Inst Biol Studies, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA	Salk Institute	Currais, A (corresponding author), Salk Inst Biol Studies, 10010 North Torrey Pines Rd, La Jolla, CA 92037 USA.	acurrais@salk.edu	Currais, Antonio/C-1149-2009	Currais, Antonio/0000-0003-4142-7054	Salk Nomis Fellowship Award; U.S. National Institutes of Health [RO1 AG046153]; Edward N. and Della L. Thome Memorial Foundation Award in Alzheimer's Disease Drug Discovery Research; California Institute of Regenerative Medicine grant; NATIONAL INSTITUTE ON AGING [R01AG046153, R01AG035055] Funding Source: NIH RePORTER	Salk Nomis Fellowship Award; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Edward N. and Della L. Thome Memorial Foundation Award in Alzheimer's Disease Drug Discovery Research; California Institute of Regenerative Medicine grant; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This study was supported by a Salk Nomis Fellowship Award (to A.C.), a grant from the U.S. National Institutes of Health (RO1 AG046153; to P.M. and D.S.), an Edward N. and Della L. Thome Memorial Foundation Award in Alzheimer's Disease Drug Discovery Research (to P.M.), and a California Institute of Regenerative Medicine grant (to D.S. and W.F.).	Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Baker-Nigh A, 2015, BRAIN, V138, P1722, DOI 10.1093/brain/awv024; Bayer TA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00008; Billings LM, 2005, NEURON, V45, P675, DOI 10.1016/j.neuron.2005.01.040; Bruunsgaard H, 2003, IMMUNOL ALLERGY CLIN, V23, P15, DOI 10.1016/S0889-8561(02)00056-5; Bukau B, 2006, CELL, V125, P443, DOI 10.1016/j.cell.2006.04.014; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Cao SS, 2012, CURR BIOL, V22, pR622, DOI 10.1016/j.cub.2012.07.004; Carrara M, 2015, ELIFE, V4, DOI 10.7554/eLife.03522; Castello MA, 2013, AGEING RES REV, V12, P282, DOI 10.1016/j.arr.2012.06.007; Chen B, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004374; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Chiti F, 2009, NAT CHEM BIOL, V5, P15, DOI 10.1038/nchembio.131; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; Chui DH, 1999, NAT MED, V5, P560, DOI 10.1038/8438; Chung HY, 2009, AGEING RES REV, V8, P18, DOI 10.1016/j.arr.2008.07.002; Clark IA, 2015, BRIT J PHARMACOL, V172, P3714, DOI 10.1111/bph.13181; Coelho M, 2015, BIOESSAYS, V37, P740, DOI 10.1002/bies.201400224; Coppe JP, 2010, ANNU REV PATHOL-MECH, V5, P99, DOI 10.1146/annurev-pathol-121808-102144; Craig-Schapiro R, 2009, NEUROBIOL DIS, V35, P128, DOI 10.1016/j.nbd.2008.10.003; Cuervo AM, 2000, J BIOL CHEM, V275, P31505, DOI 10.1074/jbc.M002102200; Currais A, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.12; Currais A, 2015, AGEING RES REV, V21, P30, DOI 10.1016/j.arr.2015.02.001; Desnues B, 2003, EMBO REP, V4, P400, DOI 10.1038/sj.embor.embor799; Di Marzo V, 2015, NAT REV NEUROSCI, V16, P30, DOI 10.1038/nrn3876; Evans SN, 2007, THEOR POPUL BIOL, V71, P473, DOI 10.1016/j.tpb.2007.02.004; Fang CJ, 2016, PROTEIN CELL, V7, P11, DOI 10.1007/s13238-015-0222-9; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Gentile MT, 2012, MOL NEUROBIOL, V45, P596, DOI 10.1007/s12035-012-8279-4; Gill R, 2010, FREE RADICAL BIO MED, V48, P1121, DOI 10.1016/j.freeradbiomed.2010.01.006; Gladyshev VN, 2013, TRENDS GENET, V29, P506, DOI 10.1016/j.tig.2013.05.004; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Goldschmidt L, 2010, P NATL ACAD SCI USA, V107, P3487, DOI 10.1073/pnas.0915166107; Gouras GK, 2005, NEUROBIOL AGING, V26, P1235, DOI 10.1016/j.neurobiolaging.2005.05.022; Green DR, 2011, SCIENCE, V333, P1109, DOI 10.1126/science.1201940; Hanzel CE, 2014, NEUROBIOL AGING, V35, P2249, DOI 10.1016/j.neurobiolaging.2014.03.026; Hermann PM, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00419; Himeno E, 2011, ANN NEUROL, V69, P248, DOI 10.1002/ana.22319; Howcroft TK, 2013, AGING-US, V5, P84, DOI 10.18632/aging.100531; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Jung CH, 2010, FEBS LETT, V584, P1287, DOI 10.1016/j.febslet.2010.01.017; Knowles TPJ, 2014, NAT REV MOL CELL BIO, V15, P384, DOI 10.1038/nrm3810; Kregel KC, 2007, AM J PHYSIOL-REG I, V292, pR18, DOI 10.1152/ajpregu.00327.2006; Lauritzen I, 2012, J NEUROSCI, V32, P16243, DOI 10.1523/JNEUROSCI.2775-12.2012; Lee YM, 2010, ARCH PHARM RES, V33, P231, DOI 10.1007/s12272-010-0207-4; Li F, 2008, MECH AGEING DEV, V129, P515, DOI 10.1016/j.mad.2008.04.007; Lopez-Armada MJ, 2013, MITOCHONDRION, V13, P106, DOI 10.1016/j.mito.2013.01.003; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Marin I, 2013, LEARN MEMORY, V20, P601, DOI 10.1101/lm.028357.112; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Minter MR, 2016, J NEUROCHEM, V136, P457, DOI 10.1111/jnc.13411; Morris GP, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0135-5; Nystrom T, 2007, PLOS GENET, V3, P2355, DOI 10.1371/journal.pgen.0030224; Nystrom T, 2014, CURR OPIN MICROBIOL, V18, P61, DOI 10.1016/j.mib.2014.02.003; Oakley H, 2006, J NEUROSCI, V26, P10129, DOI 10.1523/JNEUROSCI.1202-06.2006; Oddo S, 2006, J BIOL CHEM, V281, P1599, DOI 10.1074/jbc.M507892200; Opattova A, 2015, GEN PHYSIOL BIOPHYS, V34, P337, DOI 10.4149/gpb_2015024; ORGEL LE, 1963, P NATL ACAD SCI USA, V49, P517, DOI 10.1073/pnas.49.4.517; Pawelec G, 2014, CURR OPIN IMMUNOL, V29, P23, DOI 10.1016/j.coi.2014.03.007; Pellegrino MW, 2013, BBA-MOL CELL RES, V1833, P410, DOI 10.1016/j.bbamcr.2012.02.019; Porhomayon J, 2014, J CARDIOVASC THORAC, V6, P79, DOI 10.5681/jcvtr.2014.018; Powers ET, 2009, ANNU REV BIOCHEM, V78, P959, DOI 10.1146/annurev.biochem.052308.114844; Rang CU, 2011, CURR BIOL, V21, P1813, DOI 10.1016/j.cub.2011.09.018; Reed-Geaghan EG, 2009, J NEUROSCI, V29, P11982, DOI 10.1523/JNEUROSCI.3158-09.2009; Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742; Rujano MA, 2006, PLOS BIOL, V4, P2325, DOI 10.1371/journal.pbio.0040417; Schneider K, 2015, J CELL SCI, V128, P3861, DOI 10.1242/jcs.173047; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Starr ME, 2014, AGING DIS, V5, P126, DOI 10.14336/AD.2014.0500126; Steinkraus KA, 2008, ANNU REV CELL DEV BI, V24, P29, DOI 10.1146/annurev.cellbio.23.090506.123509; Stewart CR, 2010, NAT IMMUNOL, V11, P155, DOI 10.1038/ni.1836; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Tampellini D, 2010, J NEUROSCI, V30, P14299, DOI 10.1523/JNEUROSCI.3383-10.2010; Terman A, 2001, REDOX REP, V6, P15, DOI 10.1179/135100001101535996; Tonoki A, 2009, MOL CELL BIOL, V29, P1095, DOI 10.1128/MCB.01227-08; Toyama BH, 2013, CELL, V154, P971, DOI 10.1016/j.cell.2013.07.037; Toyama BH, 2013, NAT REV MOL CELL BIO, V14, P55, DOI 10.1038/nrm3496; Tschopp J, 2011, EUR J IMMUNOL, V41, P1196, DOI 10.1002/eji.201141436; Tyedmers J, 2010, NAT REV MOL CELL BIO, V11, P777, DOI 10.1038/nrm2993; Valera E, 2013, J NEUROSCI, V33, P10512, DOI 10.1523/JNEUROSCI.5183-12.2013; Vollmar P, 2010, J IMMUNOL, V185, P6338, DOI 10.4049/jimmunol.1001765; WEI J, 1992, LIFE SCI, V51, P1953, DOI 10.1016/0024-3205(92)90112-3; Wirths O, 2001, NEUROSCI LETT, V306, P116, DOI 10.1016/S0304-3940(01)01876-6; Wyss-Coray T, 2002, NEURON, V35, P419, DOI 10.1016/S0896-6273(02)00794-8; Wyss-Coray T, 2006, NAT MED, V12, P1005, DOI 10.1038/nml1484; Wyss-Coray T, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006346	89	58	59	1	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					5	10		10.1096/fj.201601184	http://dx.doi.org/10.1096/fj.201601184			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	28049155	Green Published			2022-12-28	WOS:000392177600003
J	Kalbitz, M; Fattahi, F; Grailer, JJ; Jajou, L; Malan, EA; Zetoune, FS; Huber-Lang, M; Russell, MW; Ward, PA				Kalbitz, Miriam; Fattahi, Fatemeh; Grailer, Jamison J.; Jajou, Lawrence; Malan, Elizabeth A.; Zetoune, Firas S.; Huber-Lang, Markus; Russell, Mark W.; Ward, Peter A.			Complement-induced activation of the cardiac NLRP3 inflammasome in sepsis	FASEB JOURNAL			English	Article						C5a; C5a receptors; IL-1 beta; CLP	ACUTE MYOCARDIAL-INFARCTION; NADPH OXIDASE; CECAL LIGATION; TNF-ALPHA; C5A; IL-1-BETA; INTERLEUKIN-1-BETA; PROMOTES; RELEASE; PROTEIN	Cardiac dysfunction develops during sepsis in humans and rodents. In the model of polymicrobial sepsis induced by cecal ligation and puncture (CLP), we investigated the role of the NLRP3 inflammasome in the heart. Mouse heart homogenates from sham-procedure mice contained high mRNA levels of NLRP3 and IL-1 beta. Using the inflammasome protocol, exposure of cardiomyocytes (CMs) to LPS followed by ATP or nigericin caused release of mature IL-1b. Immunostaining of left ventricular frozen sections before and 8 h after CLP revealed the presence of NLRP3 and IL-1b proteins in CMs. CLP caused substantial increases in mRNAs for IL-1 beta and NLRP3 in CMs which are reduced in the absence of either C5aR1 or C5aR2. After CLP, NLRP3(-/-) mice showed reduced plasma levels of IL-1 beta and IL-6. In vitro exposure of wild-type CMs to recombinant C5a (rC5a) caused elevations in both cytosolic and nuclear/mitochondrial reactive oxygen species (ROS), which were C5a-receptor dependent. Use of a selective NOX2 inhibitor prevented increased cytosolic and nuclear/mitochondrial ROS levels and release of IL-1 beta. Finally, NLRP3(-/-) mice had reduced defects in echo/Doppler parameters in heart after CLP. These studies establish that the NLRP3 inflammasome contributes to the cardiomyopathy of polymicrobial sepsis.-Kalbitz, M., Fattahi, F., Grailer, J. J., Jajou, L., Malan, E. A., Zetoune, F. S., Huber-Lang, M., Russell, M. W., Ward, P. A. Complement-induced activation of the cardiac NLRP3 inflammasome in sepsis.	[Kalbitz, Miriam; Fattahi, Fatemeh; Grailer, Jamison J.; Jajou, Lawrence; Malan, Elizabeth A.; Zetoune, Firas S.; Ward, Peter A.] Univ Michigan, Sch Med, Dept Pathol, 1301 Catherine Rd,7520 MSRB 1,Box 5602, Ann Arbor, MI 48109 USA; [Russell, Mark W.] Univ Michigan, Sch Med, Dept Pediat Cardiol, Ann Arbor, MI USA; [Kalbitz, Miriam; Huber-Lang, Markus] Univ Hosp Ulm, Dept Orthopaed Trauma Hand Plast & Reconstruct Su, Ulm, Germany	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Ulm University	Ward, PA (corresponding author), Univ Michigan, Sch Med, Dept Pathol, 1301 Catherine Rd,7520 MSRB 1,Box 5602, Ann Arbor, MI 48109 USA.	pward@umich.edu	Huber-Lang, Markus/AAJ-2209-2020		U.S. National Institutes of Health (NIH), Institute of General Medical Sciences [GM-29507, GM-61656]; NIH National Heart, Lung and Blood Institute Grant [T32-HL007517]; Deutsche Forschungsgemeinschaft Fellowship Project [KA 3740]; Endowment for the Basic Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007517] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM029507, R01GM061656, R37GM029507] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), Institute of General Medical Sciences; NIH National Heart, Lung and Blood Institute Grant; Deutsche Forschungsgemeinschaft Fellowship Project(German Research Foundation (DFG)); Endowment for the Basic Sciences; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Sue Scott and Michelle Possley (University of Michigan) for excellent assistance in the preparation of the manuscript; Peter Radermacher and Enrico Calcia (University of Ulm) for helpful suggestions; Kimber Converso-Baran, research sonographer and echocardiographic specialist (University of Michigan), for excellent services; and the Microscopy and Image-Analysis Laboratory, the Department of Pathology Flow Cytometry Core Facility, and the Department of Cell and Developmental Biology (University of Michigan Medical School) for the use of their facilities. Funding was received from The Endowment for the Basic Sciences. This study was supported by grants from the U.S. National Institutes of Health (NIH), Institute of General Medical Sciences Grants GM-29507 and GM-61656 (to P.A.W.), NIH National Heart, Lung and Blood Institute Grant T32-HL007517 (to J.J.G.), and Deutsche Forschungsgemeinschaft Fellowship Project KA 3740. The authors are responsible for the contents of this publication. The authors declare no conflicts of interest.	Abbate A, 2010, EUR J HEART FAIL, V12, P319, DOI 10.1093/eurjhf/hfq017; Asgari E, 2013, BLOOD, V122, P3473, DOI 10.1182/blood-2013-05-502229; Atefi G, 2011, FASEB J, V25, P2500, DOI 10.1096/fj.11-183236; Bae JY, 2011, J BIOL CHEM, V286, P39528, DOI 10.1074/jbc.M111.278812; BAKER CC, 1983, SURGERY, V94, P331; Boluyt MO, 2004, J APPL PHYSIOL, V96, P822, DOI 10.1152/japplphysiol.01026.2003; Boyd JH, 2006, CARDIOVASC RES, V72, P384, DOI 10.1016/j.cardiores.2006.09.011; Bracey NA, 2014, J BIOL CHEM, V289, P19571, DOI 10.1074/jbc.M114.550624; Bracey NA, 2013, EXP PHYSIOL, V98, P462, DOI 10.1113/expphysiol.2012.068338; Brandstetter C, 2015, J BIOL CHEM, V290, P31189, DOI 10.1074/jbc.M115.671180; Bulua AC, 2011, J EXP MED, V208, P519, DOI 10.1084/jem.20102049; Cave A, 2005, PHILOS T R SOC B, V360, P2327, DOI 10.1098/rstb.2005.1772; Cruz CM, 2007, J BIOL CHEM, V282, P2871, DOI 10.1074/jbc.M608083200; Dikalov S, 2011, FREE RADICAL BIO MED, V51, P1289, DOI 10.1016/j.freeradbiomed.2011.06.033; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fato R, 2009, BBA-BIOENERGETICS, V1787, P384, DOI 10.1016/j.bbabio.2008.11.003; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Gerard NP, 2005, J BIOL CHEM, V280, P39677, DOI 10.1074/jbc.C500287200; Goldhaber JI, 1996, AM J PHYSIOL-HEART C, V271, pH1449, DOI 10.1152/ajpheart.1996.271.4.H1449; Hingtgen SD, 2006, PHYSIOL GENOMICS, V26, P180, DOI 10.1152/physiolgenomics.00029.2005; Hoesel LM, 2007, J IMMUNOL, V178, P7902, DOI 10.4049/jimmunol.178.12.7902; Hopken UE, 1996, NATURE, V383, P86, DOI 10.1038/383086a0; Huber-Lang M, 2001, J IMMUNOL, V166, P1193, DOI 10.4049/jimmunol.166.2.1193; Hwang MW, 2001, J AM COLL CARDIOL, V38, P1546, DOI 10.1016/S0735-1097(01)01591-1; Kaestner L, 2009, JOVE-J VIS EXP, V31, P1433; Kalbitz M, 2016, J IMMUNOL, V197, P2353, DOI 10.4049/jimmunol.1600091; Kalbitz M, 2015, FASEB J, V29, P2185, DOI 10.1096/fj.14-268730; Kawaguchi M, 2011, CIRCULATION, V123, P594, DOI 10.1161/CIRCULATIONAHA.110.982777; Khan SA, 2011, ANTIOXID REDOX SIGN, V14, P533, DOI 10.1089/ars.2010.3213; Kim S, 2010, EUR J IMMUNOL, V40, P1545, DOI 10.1002/eji.201040425; Lacroix-Lamande S, 2012, J IMMUNOL, V188, P2805, DOI 10.4049/jimmunol.1101987; Laudisi F, 2013, J IMMUNOL, V191, P1006, DOI 10.4049/jimmunol.1300489; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Maass DL, 2002, SHOCK, V18, P360, DOI 10.1097/00024382-200210000-00012; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Mezzaroma E, 2011, P NATL ACAD SCI USA, V108, P19725, DOI 10.1073/pnas.1108586108; Munoz-Planillo R, 2009, J IMMUNOL, V183, P3942, DOI 10.4049/jimmunol.0900729; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Niederbichler AD, 2006, J EXP MED, V203, P53, DOI 10.1084/jem.20051207; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Pomerantz BJ, 2001, P NATL ACAD SCI USA, V98, P2871, DOI 10.1073/pnas.041611398; Rittirsch D, 2008, NAT MED, V14, P551, DOI 10.1038/nm1753; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; Sadek HA, 2004, BIOCHEMISTRY-US, V43, P8494, DOI 10.1021/bi049803f; Samstad EO, 2014, J IMMUNOL, V192, P2837, DOI 10.4049/jimmunol.1302484; Sandanger O, 2013, CARDIOVASC RES, V99, P164, DOI 10.1093/cvr/cvt091; Stutz A, 2009, J CLIN INVEST, V119, P3502, DOI 10.1172/JCI40599; Suzuki K, 2001, CIRCULATION, V104, pI308; Triantafilou K, 2013, J CELL SCI, V126, P2903, DOI 10.1242/jcs.124388; Wang Y, 2014, AM J PHYSIOL-HEART C, V307, pH1438, DOI 10.1152/ajpheart.00441.2014; Ward PA, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/427607; Witzenrath M, 2011, J IMMUNOL, V187, P434, DOI 10.4049/jimmunol.1003143; Xiang M, 2011, J IMMUNOL, V187, P4809, DOI 10.4049/jimmunol.1102093; Zhang WB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107639; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	56	71	75	2	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					3997	4006		10.1096/fj.201600728R	http://dx.doi.org/10.1096/fj.201600728R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27543123	Green Published, Green Submitted			2022-12-28	WOS:000388201500008
J	Shan, S; Min, HW; Liu, T; Jiang, DQ; Rao, ZH				Shan, Shan; Min, Haowei; Liu, Ting; Jiang, Dunquan; Rao, Zihe			Structural insight into dephosphorylation by trehalose 6-phosphate phosphatase (OtsB2) from Mycobacterium tuberculosis	FASEB JOURNAL			English	Article						crystal structure; drug discovery; MtbTPP	PHOSPHOSERINE PHOSPHATASE; CRYSTAL-STRUCTURE; 3 PATHWAYS; BIOSYNTHESIS; CLONING; CONSERVATION; PURIFICATION; SUPERFAMILY; EXPRESSION; PROTEIN	Trehalose serves as a key structural component in the cell wall of Mycobacterium tuberculosis. M. tuberculosis trehalose-6-phosphate phosphatase (MtbTPP), an essential enzyme in the trehalose biosynthesis OtsAB pathway, catalyzes the dephosphorylation of trehalose-6-phosphate (trehalose-6-P) to generate trehalose, and plays a critical role in M. tuberculosis survival-associated cell wall formation and permeability. Therefore, MtbTPP (OtsB2) is considered a promising potential target for discovery of antimicrobial drugs. However, the absence of structural information of MtbTPP restrains our understanding of its underlying catalytic mechanism. Here, we report the high-resolution crystal structures of apo active MtbTPP and its trehalose-6-P bound complex. The apo structure presents a canonical haloacid dehalogenase superfamily structural fold plus an extra N-terminal domain. The catalytic center is located in a positively charged cleft between the hydrolase domain and the cap domain, demonstrating a highly conserved substrate binding pocket. The role of residues interacting with the substrate in catalysis were probed by site-directed mutagenesis. Asp147, Asp149, Asp330, and Asp331 were found to be pivotal for the enzymatic activity of MtbTPP. The MtbTPP structures reported here provide insight into a key step in the biosynthesis of trehalose, which would facilitate future development of anti-TB therapeutics.-Shan, S., Min, H., Liu, T., Jiang, D., Rao, Z. Structural insight into dephosphorylation by trehalose 6-phosphate phosphatase (OtsB2) from Mycobacterium tuberculosis.	[Shan, Shan; Rao, Zihe] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China; [Min, Haowei] Chinese Acad Sci, State Key Lab Plant Genom, Beijing, Peoples R China; [Min, Haowei] Chinese Acad Sci, Inst Genet & Dev Biol, Natl Ctr Plant Gene Res Beijing, Beijing, Peoples R China; [Liu, Ting; Jiang, Dunquan; Rao, Zihe] Nankai Univ, Coll Life Sci, Tianjin, Peoples R China	Chinese Academy of Sciences; Institute of Biophysics, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Nankai University	Shan, S (corresponding author), Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, 15 Datun Rd, Beijing 100101, Peoples R China.	shanshan@moon.ibp.ac.cn	Rao, Zihe/HCH-6944-2022; Jiang, Quan/GQA-6586-2022					Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Ashkenazy H, 2010, NUCLEIC ACIDS RES, V38, pW529, DOI 10.1093/nar/gkq399; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bhatt A, 2007, P NATL ACAD SCI USA, V104, P5157, DOI 10.1073/pnas.0608654104; Comas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000600; Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131; De Smet KAL, 2000, MICROBIOL-UK, V146, P199, DOI 10.1099/00221287-146-1-199; DeLano W.L, PYMOL MOL GRAPHICS S; Edavana VK, 2004, ARCH BIOCHEM BIOPHYS, V426, P250, DOI 10.1016/j.abb.2004.02.014; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Friedland N, 2007, BIOCHEMISTRY-US, V46, P6733, DOI 10.1021/bi602546q; GIAEVER HM, 1988, J BACTERIOL, V170, P2841, DOI 10.1128/jb.170.6.2841-2849.1988; Goude R, 2008, FUTURE MICROBIOL, V3, P299, DOI 10.2217/17460913.3.3.299; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Huang H, 2011, BIOCHEMISTRY-US, V50, P8937, DOI 10.1021/bi201181q; Klutts S, 2003, J BIOL CHEM, V278, P2093, DOI 10.1074/jbc.M209937200; KOONIN EV, 1994, J MOL BIOL, V244, P125, DOI 10.1006/jmbi.1994.1711; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Lu ZB, 2005, BIOCHEMISTRY-US, V44, P8684, DOI 10.1021/bi050009j; Maruta K, 1996, BBA-GEN SUBJECTS, V1291, P177, DOI 10.1016/S0304-4165(96)00082-7; MATULA M, 1971, J BACTERIOL, V107, P217, DOI 10.1128/JB.107.1.217-222.1971; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murphy HN, 2005, J BIOL CHEM, V280, P14524, DOI 10.1074/jbc.M414232200; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Peeraer Y, 2003, ACTA CRYSTALLOGR D, V59, P971, DOI 10.1107/S0907444903005407; Rao KN, 2006, PROTEIN SCI, V15, P1735, DOI 10.1110/ps.062096606; Robert X, 2014, NUCLEIC ACIDS RES, V42, pW320, DOI 10.1093/nar/gku316; Ryll R, 2001, MICROBIOL IMMUNOL, V45, P801, DOI 10.1111/j.1348-0421.2001.tb01319.x; Shan S, 2011, ACTA CRYSTALLOGR F, V67, P821, DOI 10.1107/S1744309111019567; Takayama K, 2005, CLIN MICROBIOL REV, V18, P81, DOI 10.1128/CMR.18.1.81-101.2005; Wang WR, 2001, STRUCTURE, V9, P65, DOI 10.1016/S0969-2126(00)00558-X; Wolf A, 2003, MOL MICROBIOL, V49, P1119, DOI 10.1046/j.1365-2958.2003.03625.x; ZHANG MH, 2007, COMPUTER SCI, V6, P68; Zhao HY, 2009, ACTA CRYSTALLOGR F, V65, P719, DOI 10.1107/S1744309109022696	35	12	14	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					3989	3996		10.1096/fj.201600463R	http://dx.doi.org/10.1096/fj.201600463R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27572957				2022-12-28	WOS:000388201500007
J	Imbrici, P; Altamura, C; Camerino, GM; Mangiatordi, GF; Conte, E; Maggi, L; Brugnoni, R; Musaraj, K; Caloiero, R; Alberga, D; Marsano, RM; Ricci, G; Siciliano, G; Nicolotti, O; Mora, M; Bernasconi, P; Desaphy, JF; Mantegazza, R; Camerino, DC				Imbrici, Paola; Altamura, Concetta; Camerino, Giulia Maria; Mangiatordi, Giuseppe Felice; Conte, Elena; Maggi, Lorenzo; Brugnoni, Raffaella; Musaraj, Kejla; Caloiero, Roberta; Alberga, Domenico; Marsano, Rene Massimiliano; Ricci, Giulia; Siciliano, Gabriele; Nicolotti, Orazio; Mora, Marina; Bernasconi, Pia; Desaphy, Jean-Francois; Mantegazza, Renato; Camerino, Diana Conte			Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies	FASEB JOURNAL			English	Article						chloride channel; gene expression; molecular dynamics; patch-clamp; skeletal muscle	CHLORIDE CHANNEL; MOLECULAR-DYNAMICS; CLCN1 MUTATIONS; FUNCTIONAL-CHARACTERIZATION; MUSCLE CHANNELOPATHIES; GENE; DISEASE; PHENOTYPE; INSIGHTS; MECHANISMS	Myotonia congenita is an inherited disease that is characterized by impaired muscle relaxation after contraction caused by loss-of-function mutations in the skeletal muscle ClC-1 channel. We report a novel ClC-1 mutation, T335N, that is associated with a mild phenotype in 1 patient, located in the extracellular I-J loop. The purpose of this study was to provide a solid correlation between T335N dysfunction and clinical symptoms in the affected patient as well as to offer hints for drug development. Our multidisciplinary approach includes patch-clamp electrophysiology on T335N and ClC-1 wild-type channels expressed in tsA201 cells, Western blot and quantitative PCR analyses on muscle biopsies from patient and unaffected individuals, and molecular dynamics simulations using a homology model of the ClC-1 dimer. T335N channels display reduced chloride currents as a result of gating alterations rather than altered surface expression. Molecular dynamics simulations suggest that the I-J loop might be involved in conformational changes that occur at the dimer interface, thus affecting gating. Finally, the gene expression profile of T335N carrier showed a diverse expression of K+ channel genes, compared with control individuals, as potentially contributing to the phenotype. This experimental paradigm satisfactorily explained myotonia in the patient. Furthermore, it could be relevant to the study and therapy of any channelopathy.-Imbrici, P., Altamura, C., Camerino, G. M., Mangiatordi, G. F., Conte, E., Maggi, L., Brugnoni, R., Musaraj, K., Caloiero, R., Alberga, D., Marsano, R. M., Ricci, G., Siciliano, G., Nicolotti, O., Mora, M., Bernasconi, P., Desaphy, J.-F., Mantegazza, R., Camerino, D. C. Multidisciplinary study of a new ClC-1 mutation causing myotonia congenita: a paradigm to understand and treat ion channelopathies.	[Imbrici, Paola; Altamura, Concetta; Camerino, Giulia Maria; Mangiatordi, Giuseppe Felice; Conte, Elena; Musaraj, Kejla; Caloiero, Roberta; Nicolotti, Orazio; Camerino, Diana Conte] Ist Nazl Fis Nucl, Dept Pharm, Drug Sci, Bari, Italy; [Alberga, Domenico] Ist Nazl Fis Nucl, Dept Phys M Merlin, Bari, Italy; Ctr Tecnol Innovat Rilevaz & Elaboraz Segnale, Bari, Italy; [Marsano, Rene Massimiliano] Univ Bari Aldo Moro, Dept Biol, Bari, Italy; [Desaphy, Jean-Francois] Univ Bari Aldo Moro, Dept Biomed Sci & Human Oncol, Bari, Italy; [Maggi, Lorenzo; Brugnoni, Raffaella; Mora, Marina; Bernasconi, Pia; Mantegazza, Renato] Fdn Ist Neurol Carlo Besta, Ist Ricovero & Cura Carattere Sci, Div Neurol, Neuroimmunol & Neuromuscular Dis Unit, Milan, Italy; [Ricci, Giulia; Siciliano, Gabriele] Univ Pisa, Dept Clin & Expt Med, Neurol Sect, Pisa, Italy	Istituto Nazionale di Fisica Nucleare (INFN); Istituto Nazionale di Fisica Nucleare (INFN); Universita degli Studi di Bari Aldo Moro; Universita degli Studi di Bari Aldo Moro; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Istituto Neurologico Besta; University of Pisa	Imbrici, P (corresponding author), Univ Bari Aldo Moro, Dept Pharm, Drug Sci, Via Orabona 4, I-70125 Bari, Italy.		Bernasconi, Pia/AAB-7590-2019; Conte, Elena/AAF-4055-2019; Maggi, Lorenzo/K-3578-2018; Brugnoni, Raffaella/AAN-8039-2021; Desaphy, Jean-Francois/T-6191-2019; Alberga, Domenico/K-3272-2019; Conte, Elena/AAV-3153-2020; Marsano, René Massimiliano/B-9640-2012; Mantegazza, Renato/AAB-7569-2019; imbrici, paola/J-6855-2018; Mangiatordi, Giuseppe Felice/AAH-9527-2020; Mora, Marina/J-2883-2018	Conte, Elena/0000-0001-8571-5125; Maggi, Lorenzo/0000-0002-0932-5173; Brugnoni, Raffaella/0000-0003-1365-4508; Desaphy, Jean-Francois/0000-0001-8816-9369; Alberga, Domenico/0000-0002-9475-9602; Marsano, René Massimiliano/0000-0001-8450-1010; Mantegazza, Renato/0000-0002-9810-5737; imbrici, paola/0000-0001-9140-5350; Mangiatordi, Giuseppe Felice/0000-0003-4042-2841; Bernasconi, Pia/0000-0003-0869-2104; Camerino, Giulia Maria/0000-0003-1410-6327; Mora, Marina/0000-0002-5765-2320	Italian Health Ministry [GR-2009-1580433]; Telethon-Italy [GGP14096]	Italian Health Ministry(Ministry of Health, Italy); Telethon-Italy(Fondazione Telethon)	This work was supported by the Italian Health Ministry (Grant GR-2009-1580433 to P.I.) and Telethon-Italy (Grant GGP14096 to D.C.). The authors thank Brett Bennetts (St Vincent's Institute of Medical Research, Fitzroy, VIC, Australia) and Michael Parker (Department of Biochemistry and Molecular Biology, The University of Melbourne, Parkville, VIC, Australia) for kindly providing the homology model of hClC-1 that is based on the crystallographic coordinates of CmClC. The authors declare no competing financial interests.	Accardi A, 2000, J GEN PHYSIOL, V116, P433, DOI 10.1085/jgp.116.3.433; ADELMAN SA, 1976, J CHEM PHYS, V64, P2375, DOI 10.1063/1.432526; Alberga D, 2014, BBA-BIOMEMBRANES, V1838, P3052, DOI 10.1016/j.bbamem.2014.08.015; [Anonymous], 2013, SCHROD REL 2013 2 MA; Bennetts B, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3507; Brugnoni R, 2013, J HUM GENET, V58, P581, DOI 10.1038/jhg.2013.58; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Cederholm JM, 2010, INT J BIOCHEM CELL B, V42, P1182, DOI 10.1016/j.biocel.2010.04.004; Colding-Jorgensen E, 2005, MUSCLE NERVE, V32, P19, DOI 10.1002/mus.20295; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Desaphy JF, 2013, EXP NEUROL, V248, P530, DOI 10.1016/j.expneurol.2013.07.018; Duno M, 2004, EUR J HUM GENET, V12, P738, DOI 10.1038/sj.ejhg.5201218; Dutzler R, 2002, NATURE, V415, P287, DOI 10.1038/415287a; FAHLKE C, 1995, NEURON, V15, P463, DOI 10.1016/0896-6273(95)90050-0; Feng LA, 2010, SCIENCE, V330, P635, DOI 10.1126/science.1195230; Fialho D, 2007, BRAIN, V130, P3265, DOI 10.1093/brain/awm248; Furby A, 2014, NEUROMUSCULAR DISORD, V24, P953, DOI 10.1016/j.nmd.2014.06.439; GEORGE AL, 1993, NAT GENET, V3, P305, DOI 10.1038/ng0493-305; Gradogna A, 2014, BBA-BIOMEMBRANES, V1838, P2745, DOI 10.1016/j.bbamem.2014.07.021; Ha K, 2014, MOL CELLS, V37, P202, DOI 10.14348/molcells.2014.2267; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Imbrici P, 2015, J PHYSIOL-LONDON, V593, P4181, DOI 10.1113/JP270358; Imbrici P, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00156; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kearney JA, 2011, CURR OPIN GENET DEV, V21, P349, DOI 10.1016/j.gde.2010.12.007; Kullmann DM, 2010, J PHYSIOL-LONDON, V588, P1823, DOI 10.1113/jphysiol.2010.190652; Lo Monaco M, 2015, CLIN NEUROPHYSIOL, V126, P399, DOI 10.1016/j.clinph.2014.06.008; Lossin C, 2008, ADV GENET, V63, P25, DOI 10.1016/S0065-2660(08)01002-X; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; Mangiatordi GF, 2015, BBA-BIOMEMBRANES, V1848, P1462, DOI 10.1016/j.bbamem.2015.03.019; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; Meisler MH, 2010, J PHYSIOL-LONDON, V588, P1841, DOI 10.1113/jphysiol.2010.188482; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Papponen H, 2005, EXP NEUROL, V191, P163, DOI 10.1016/j.expneurol.2004.07.018; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Portaro S, 2015, NEUROMOL MED, V17, P285, DOI 10.1007/s12017-015-8356-8; Pusch M, 2002, HUM MUTAT, V19, P423, DOI 10.1002/humu.10063; Raheem O, 2012, NEUROLOGY, V79, P2194, DOI 10.1212/WNL.0b013e31827595e2; Ryan A, 2002, J PHYSIOL-LONDON, V545, P345, DOI 10.1113/jphysiol.2002.027037; RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5; Skalova D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082549; Stolting G, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00378; Suetterlin K, 2014, CURR OPIN NEUROL, V27, P583, DOI 10.1097/WCO.0000000000000127; Suetterlin KJ, 2015, JAMA NEUROL, V72, P1531, DOI 10.1001/jamaneurol.2015.2338; Swaggart KA, 2014, EXP PHYSIOL, V99, P621, DOI 10.1113/expphysiol.2013.075887; Tricarico D, 2004, FASEB J, V18, P760, DOI 10.1096/fj.03-0722fje; Trivedi JR, 2014, EXP NEUROL, V253, P28, DOI 10.1016/j.expneurol.2013.12.005; Ulzi G, 2012, J NEUROL SCI, V318, P65, DOI 10.1016/j.jns.2012.03.024; Weinberger S, 2012, J PHYSIOL-LONDON, V590, P3449, DOI 10.1113/jphysiol.2012.232785; Wu FF, 2002, BRAIN, V125, P2392, DOI 10.1093/brain/awf246; Zhang J, 2000, J BIOL CHEM, V275, P2999, DOI 10.1074/jbc.275.4.2999	51	17	17	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3285	3295		10.1096/fj.201500079R	http://dx.doi.org/10.1096/fj.201500079R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27324117	Green Published, hybrid			2022-12-28	WOS:000384329800003
J	Bohnert, KR; Gallot, YS; Sato, S; Xiong, GY; Hindi, SM; Kumar, A				Bohnert, Kyle R.; Gallot, Yann S.; Sato, Shuichi; Xiong, Guangyan; Hindi, Sajedah M.; Kumar, Ashok			Inhibition of ER stress and unfolding protein response pathways causes skeletal muscle wasting during cancer cachexia	FASEB JOURNAL			English	Article						Lewis lung carcinoma; PERK; XBP-1; mTOR; autophagy	ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE; TRANSCRIPTION FACTOR; UP-REGULATION; TWEAK-FN14 SYSTEM; MYOSIN ISOFORMS; TRANSGENIC MICE; IN-VIVO; ATROPHY; EXPRESSION	Cachexia is a devastating syndrome that causes morbidity and mortality in a large number of patients with cancer. However, the mechanisms of cancer cachexia remain poorly understood. Accumulation of misfolded proteins in the endoplasmic reticulum (ER) causes stress. The ER responds to this stress through activating certain pathways commonly known as the unfolding protein response (UPR). The main function of UPR is to restore homeostasis, but excessive or prolonged activation of UPR can lead to pathologic conditions. In this study, we examined the role of ER stress and UPR in regulation of skeletal muscle mass in naive conditions and during cancer cachexia. Our results demonstrate that multiple markers of ER stress are highly activated in skeletal muscle of Lewis lung carcinoma (LLC) and Apc(Min/+) mouse models of cancer cachexia. Treatment of mice with 4-phenylbutyrate (4-PBA), a chemical chaperon and a potent inhibitor of ER stress, significantly reduced skeletal muscle strength and mass in both control and LLC-bearing mice. Blocking the UPR also increased the proportion of fast-type fibers in soleus muscle of both control and LLC-bearing mice. Inhibition of UPR reduced the activity of Akt/mTOR pathway and increased the expression of the components of the ubiquitin-proteasome system and autophagy in LLC-bearing mice. Moreover, we found that the inhibition of UPR causes severe atrophy in cultured myotubes. Our study provides initial evidence that ER stress and UPR pathways are essential for maintaining skeletal muscle mass and strength and for protection against cancer cachexia.Bohnert, K. R., Gallot, Y. S., Sato, S., Xiong, G., Hindi, S. M., Kumar, A. Inhibition of ER stress and unfolding protein response pathways causes skeletal muscle wasting during cancer cachexia.	[Bohnert, Kyle R.; Gallot, Yann S.; Sato, Shuichi; Xiong, Guangyan; Hindi, Sajedah M.; Kumar, Ashok] Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, 500 South Preston St, Louisville, KY 40202 USA	University of Louisville	Kumar, A (corresponding author), Univ Louisville, Sch Med, Dept Anat Sci & Neurobiol, 500 South Preston St, Louisville, KY 40202 USA.	ashok.kumar@louisville.edu	Gallot, Yann Simon/GQI-2372-2022; Gallot, Yann Simon/GNO-9167-2022; Gallot, Yann Simon/ABC-1826-2021	Gallot, Yann Simon/0000-0003-4447-1448; Gallot, Yann Simon/0000-0003-4447-1448; Gallot, Yann Simon/0000-0003-4447-1448	National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR059810, AR068313]; National Institute on Aging [AG029623]; U.S. National Institutes of Health; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR068313, R01AR059810] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG029623] Funding Source: NIH RePORTER	National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases Grants AR059810 and AR068313 and National Institute on Aging Grant AG029623 (to A.K.). Author contributions: K. R. Bohnert, S. M. Hindi, and A. Kumar designed research and analyzed data; K. R. Bohnert, Y. S. Gallot, S. Sato, G. Xiong, and S. M. Hindi performed research; and K. R. Bohnert and A. Kumar wrote the manuscript. The authors report no conflicts of interest.	Acharyya S, 2004, J CLIN INVEST, V114, P370, DOI 10.1172/jci200420174; Baltgalvis KA, 2008, AM J PHYSIOL-REG I, V294, pR393, DOI 10.1152/ajpregu.00716.2007; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027; Caiozzo VJ, 1996, J APPL PHYSIOL, V81, P123, DOI 10.1152/jappl.1996.81.1.123; Chalil S, 2015, BIOCHEM BIOPH RES CO, V468, P702, DOI 10.1016/j.bbrc.2015.11.019; Cnop M, 2012, TRENDS MOL MED, V18, P59, DOI 10.1016/j.molmed.2011.07.010; Cornwell EW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087776; Diffee GM, 2002, AM J PHYSIOL-CELL PH, V283, pC1376, DOI 10.1152/ajpcell.00154.2002; Ebert SM, 2010, MOL ENDOCRINOL, V24, P790, DOI 10.1210/me.2009-0345; Egerman MA, 2014, CRIT REV BIOCHEM MOL, V49, P59, DOI 10.3109/10409238.2013.857291; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fearon KCH, 2012, CELL METAB, V16, P153, DOI 10.1016/j.cmet.2012.06.011; Flamment M, 2012, TRENDS ENDOCRIN MET, V23, P381, DOI 10.1016/j.tem.2012.06.003; Gao S, 2016, AM J PHYSIOL-CELL PH, V310, pC66, DOI 10.1152/ajpcell.00052.2015; Gomes AV, 2012, FASEB J, V26, P2986, DOI 10.1096/fj.12-204495; Goodman CA, 2013, EXERC SPORT SCI REV, V41, P107, DOI 10.1097/JES.0b013e3182798a95; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hetz C, 2012, NAT REV MOL CELL BIO, V13, P89, DOI 10.1038/nrm3270; Hindi SM, 2014, FASEB J, V28, P1398, DOI 10.1096/fj.13-242123; Hu HL, 2014, CELL PHYSIOL BIOCHEM, V33, P1899, DOI 10.1159/000362967; Hunter RB, 2001, AM J PHYSIOL-CELL PH, V281, pC1285, DOI 10.1152/ajpcell.2001.281.4.C1285; Hwee DT, 2014, AGING CELL, V13, P92, DOI 10.1111/acel.12150; Ikezoe K, 2007, ACTA NEUROPATHOL, V114, P527, DOI 10.1007/s00401-007-0267-9; Iwasa K, 2014, J NEUROIMMUNOL, V273, P72, DOI 10.1016/j.jneuroim.2014.05.006; Johns N, 2013, INT J BIOCHEM CELL B, V45, P2215, DOI 10.1016/j.biocel.2013.05.032; Judge SM, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-997; Koh HJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2851; Kuga A, 2011, HUM MOL GENET, V20, P2975, DOI 10.1093/hmg/ddr201; Ma YJ, 2002, J MOL BIOL, V318, P1351, DOI 10.1016/S0022-2836(02)00234-6; Mittal A, 2010, J CELL BIOL, V188, P833, DOI 10.1083/jcb.200909117; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mounier R, 2015, TRENDS ENDOCRIN MET, V26, P275, DOI 10.1016/j.tem.2015.02.009; Nagaraju K, 2005, ARTHRITIS RHEUM, V52, P1824, DOI 10.1002/art.21103; Nakanishi K, 2005, J CELL BIOL, V169, P555, DOI 10.1083/jcb.200412024; Nakanishi K, 2007, FASEB J, V21, P2994, DOI 10.1096/fj.06-6408com; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Paul PK, 2012, MOL CELL BIOL, V32, P1248, DOI 10.1128/MCB.06351-11; Paul PK, 2010, J CELL BIOL, V191, P1395, DOI 10.1083/jcb.201006098; Penna F, 2013, AM J PATHOL, V182, P1367, DOI 10.1016/j.ajpath.2012.12.023; Rayavarapu S, 2012, CURR RHEUMATOL REP, V14, P238, DOI 10.1007/s11926-012-0247-5; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Roxburgh CSD, 2010, FUTURE ONCOL, V6, P149, DOI 10.2217/FON.09.136; Salvado L, 2013, DIABETOLOGIA, V56, P1372, DOI 10.1007/s00125-013-2867-3; Sandri M., 2015, CELL DEV BIOL, DOI [10.1016/j.semcdb.2015.11.002S1084-9521(15)00248-7, DOI 10.1016/J.SEMCDB.2015.11.002S1084-9521(15)00248-7]; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Sandri M, 2010, FEBS LETT, V584, P1411, DOI 10.1016/j.febslet.2010.01.056; Sartori R, 2013, NAT GENET, V45, P1309, DOI 10.1038/ng.2772; Sato S, 2015, FASEB J, V29, P988, DOI 10.1096/fj.14-260703; Schwartz AL, 1999, ANNU REV MED, V50, P57; Seto DN, 2015, J BIOL CHEM, V290, P19976, DOI 10.1074/jbc.M115.638411; Tian M, 2010, INT J ONCOL, V37, P347, DOI 10.3892/ijo_00000683; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; Vattemi G, 2004, AM J PATHOL, V164, P1, DOI 10.1016/S0002-9440(10)63089-1; Wang M, 2014, NAT REV CANCER, V14, P581, DOI 10.1038/nrc3800; Wang YC, 2013, CURR OPIN CLIN NUTR, V16, P243, DOI 10.1097/MCO.0b013e328360272d; Wu J, 2006, CELL DEATH DIFFER, V13, P374, DOI 10.1038/sj.cdd.4401840; Wu J, 2007, DEV CELL, V13, P351, DOI 10.1016/j.devcel.2007.07.005; Wu J, 2011, CELL METAB, V13, P160, DOI 10.1016/j.cmet.2011.01.003; Yamamoto K, 2007, DEV CELL, V13, P365, DOI 10.1016/j.devcel.2007.07.018; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yu AP, 2014, ACTA PHYSIOL, V211, P201, DOI 10.1111/apha.12263; Zhang GH, 2013, FASEB J, V27, P2893, DOI 10.1096/fj.12-222711; Zhang GH, 2011, EMBO J, V30, P4323, DOI 10.1038/emboj.2011.292; Zhang PC, 2002, MOL CELL BIOL, V22, P3864, DOI 10.1128/MCB.22.11.3864-3874.2002; Zhao J, 2007, CELL METAB, V6, P472, DOI 10.1016/j.cmet.2007.11.004; Zode GS, 2015, J CLIN INVEST, V125, P3303, DOI 10.1172/JCI82799	69	76	77	1	26	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3053	3068		10.1096/fj.201600250RR	http://dx.doi.org/10.1096/fj.201600250RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27206451	Green Published			2022-12-28	WOS:000382816300006
J	Carrasco-Benso, MP; Rivero-Gutierrez, B; Lopez-Minguez, J; Anzola, A; Diez-Noguera, A; Madrid, JA; Lujan, JA; Martinez-Augustin, O; Scheer, FAJL; Garaulet, M				Carrasco-Benso, Maria P.; Rivero-Gutierrez, Belen; Lopez-Minguez, Jesus; Anzola, Andrea; Diez-Noguera, Antoni; Madrid, Juan A.; Lujan, Juan A.; Martinez-Augustin, Olga; Scheer, Frank A. J. L.; Garaulet, Marta			Human adipose tissue expresses intrinsic circadian rhythm in insulin sensitivity	FASEB JOURNAL			English	Article						obesity; glucose tolerance; diabetes	GLUCOSE-TOLERANCE; DIURNAL-VARIATION; SECRETION; CLOCK; ADIPONECTIN	In humans, insulin sensitivity varies according to time of day, with decreased values in the evening and at night. Mechanisms responsible for the diurnal variation in insulin sensitivity are unclear. We investigated whether human adipose tissue (AT) expresses intrinsic circadian rhythms in insulin sensitivity that could contribute to this phenomenon. Subcutaneous and visceral AT biopsies were obtained from extremely obese participants (body mass index, 41.8 +/- 6.3 kg/m(2); 46 +/- 11 y) during gastric-bypass surgery. To assess the rhythm in insulin signaling, AKT phosphorylation was determined every 4 h over 24 h in vitro in response to different insulin concentrations (0, 1, 10, and 100 nM). Data revealed that subcutaneous AT exhibited robust circadian rhythms in insulin signaling (P < 0.00001). Insulin sensitivity reached its maximum (acrophase) around noon, being 54% higher than during midnight (P = 0.009). The amplitude of the rhythm was positively correlated with in vivo sleep duration (r = 0.53; P = 0.023) and negatively correlated with in vivo bedtime (r = -0.54; P = 0.020). No circadian rhythms were detected in visceral AT (P = 0.643). Here, we demonstrate the relevance of the time of the day for how sensitive AT is to the effects of insulin. Subcutaneous AT shows an endogenous circadian rhythm in insulin sensitivity that could provide an underlying mechanism for the daily rhythm in systemic insulin sensitivity.Carrasco-Benso, M. P., Rivero-Gutierrez, B., Lopez-Minguez, J., Anzola, A., Diez-Noguera, A., Madrid, J. A., Lujan, J. A., Martinez-Augustin, O., Scheer, F. A. J. L., Garaulet, M. Human adipose tissue expresses intrinsic circadian rhythm in insulin sensitivity.	[Carrasco-Benso, Maria P.; Lopez-Minguez, Jesus; Madrid, Juan A.; Garaulet, Marta] Univ Murcia, Biomed Res Inst Murcia IMIB Arrixaca, Fac Biol, Dept Physiol,Biol, Murcia, Spain; [Rivero-Gutierrez, Belen; Anzola, Andrea; Martinez-Augustin, Olga] Univ Granada, Inst Invest Biosanitaria Granada, Biomed Res Networking Ctr Hepat & Digest Dis CIBE, Dept Biochem & Mol Biol 2,Sch Pharm, Granada, Spain; [Diez-Noguera, Antoni] Univ Barcelona, Fac Pharm, Dept Physiol, Barcelona, Spain; [Lujan, Juan A.] Univ Hosp Virgen de la Arrixaca, Gen Surg Serv, Murcia, Spain; [Scheer, Frank A. J. L.] Brigham & Womens Hosp, Div Sleep & Circadian Disorders, 75 Francis St, Boston, MA 02115 USA; [Scheer, Frank A. J. L.] Harvard Med Sch, Div Sleep Med, Boston, MA USA	Hospital Clinico Universitario Virgen de la Arrixaca; University of Murcia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Instituto de Investigacion Biosanitaria IBS Granada; University of Granada; University of Barcelona; Hospital Clinico Universitario Virgen de la Arrixaca; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Scheer, FAJL (corresponding author), Brigham & Womens Hosp, Med Chronobiol Program, Div Sleep & Circadian Disorders, 221 Longwood Ave, Boston, MA 02115 USA.; Garaulet, M (corresponding author), Univ Murcia, Dept Physiol, Campus Espinardo, E-30100 Murcia, Spain.	fscheer@bwh.harvard.edu; garaulet@um.es	Augustin, Olga Martínez/K-6720-2014; Garaulet, Marta/K-6625-2014; Rivero-Gutiérrez, Belen/K-8784-2019; Scheer, Frank A.J.L./C-2795-2012	Augustin, Olga Martínez/0000-0001-8291-3468; Garaulet, Marta/0000-0002-4066-3509; Rivero-Gutiérrez, Belen/0000-0002-1263-0873; Scheer, Frank A.J.L./0000-0002-2014-7582; Lujan Mompean, Juan Antonio/0000-0003-4987-7578; Madrid, Juan Antonio/0000-0002-9286-1371; Maria Paz, Carrasco-Benso/0000-0001-5611-4929	Spanish Government of Economy and Competitiveness [SAF2014-52480-R]; European Regional Development Fund (ERDF) [SAF2011-22812]; Seneca Foundation from the Government of Murcia [15123/PI/10]; U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [R01-DK099512]; U.S. National Institutes of Health (National Heart, Lung, and Blood Institute) [R01-HL118601]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL118601] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK099512] Funding Source: NIH RePORTER	Spanish Government of Economy and Competitiveness; European Regional Development Fund (ERDF)(European Commission); Seneca Foundation from the Government of Murcia(Fundacion Seneca); U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Institutes of Health (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Spanish Government of Economy and Competitiveness (Grant SAF2014-52480-R) and from European Regional Development Fund (ERDF) (to M.G.), Grant SAF2011-22812 (to O.M.-A.), the Seneca Foundation from the Government of Murcia (15123/PI/10; to M.G.), and by U.S. National Institutes of Health Grants R01-DK099512 (National Institute of Diabetes and Digestive and Kidney Diseases) and R01-HL118601 (National Heart, Lung, and Blood Institute) (to F.A.J.L.S.). Author contributions: M. P. Carrasco-Benso conducted the experiments, performed the cultures, analyzed data, and wrote the paper; B. Rivero-Gutierrez performed Western blot experiments; J. Lopez-Minguez performed the cultures; A. Anzola performed Western blot experiments; A. Diez-Noguera analyzed circadian data; J. A. Madrid gave advice for circadian aspects; J. A. Lujan recruited the study participants and performed the biopsies; O. Martinez-Augustin directed the Western blot experiments; and F. A. J. L. Scheer and M. Garaulet designed research, wrote the paper, and have primary responsibility for final content.	Anothaisintawee T, 2016, SLEEP MED REV, V30, P11, DOI 10.1016/j.smrv.2015.10.002; Barnea M, 2015, MOL CELL ENDOCRINOL, V399, P284, DOI 10.1016/j.mce.2014.10.018; Batschelet E, 1981, CIRCULAR STAT BIOL, V111; Bray MS, 2007, OBES REV, V8, P169, DOI 10.1111/j.1467-789X.2006.00277.x; Broussard JL, 2012, ANN INTERN MED, V157, P549, DOI 10.7326/0003-4819-157-8-201210160-00005; Brown SA, 2008, P NATL ACAD SCI USA, V105, P1602, DOI 10.1073/pnas.0707772105; CARROLL KF, 1973, DIABETES, V22, P333, DOI 10.2337/diab.22.5.333; Corbalan-Tutau D, 2014, PHYSIOL BEHAV, V123, P231, DOI 10.1016/j.physbeh.2012.06.005; Garaulet M, 2006, J PHYSIOL BIOCHEM, V62, P245, DOI 10.1007/BF03165753; Garaulet M, 2007, PUBLIC HEALTH NUTR, V10, P1145, DOI 10.1017/S1368980007000638; Garaulet M, 2011, J CELL PHYSIOL, V226, P2075, DOI 10.1002/jcp.22531; Gomez-Abellan P, 2010, ENDOCRINOLOGY, V151, P115, DOI 10.1210/en.2009-0647; Gomez-Santos C, 2009, OBESITY, V17, P1481, DOI 10.1038/oby.2009.164; Harfmann BD, 2015, J BIOL RHYTHM, V30, P84, DOI 10.1177/0748730414561638; Jakubowicz D, 2013, OBESITY, V21, P2504, DOI 10.1002/oby.20460; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Morris CJ, 2015, P NATL ACAD SCI USA, V112, pE2225, DOI 10.1073/pnas.1418955112; Nakajima K, 2015, J DIABETES METAB DIS, V14, DOI 10.1186/s40200-015-0147-0; Pagani L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013376; Saad A, 2012, DIABETES, V61, P2691, DOI 10.2337/db11-1478; Sadacca LA, 2011, DIABETOLOGIA, V54, P120, DOI 10.1007/s00125-010-1920-8; Saini C, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00095; Scheer FAJL, 2010, DIABETOLOGIA, V53, P2401, DOI 10.1007/s00125-010-1869-7; Scheer FAJL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000721; Scheer FAJL, 2009, P NATL ACAD SCI USA, V106, P4453, DOI 10.1073/pnas.0808180106; SERVICE FJ, 1983, DIABETOLOGIA, V25, P316, DOI 10.1007/BF00253193; SHAPIRO ET, 1988, J CLIN ENDOCR METAB, V67, P307, DOI 10.1210/jcem-67-2-307; Van Cauter E, 2011, DIABETIC MED, V28, P1455, DOI 10.1111/j.1464-5491.2011.03459.x; van der Spek R, 2012, PROG BRAIN RES, V199, P183, DOI 10.1016/B978-0-444-59427-3.00011-3; VANCAUTER E, 1991, J CLIN INVEST, V88, P934, DOI 10.1172/JCI115396; Yoshino J, 2014, J CLIN ENDOCR METAB, V99, pE1666, DOI 10.1210/jc.2014-1579	31	45	47	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3117	3123		10.1096/fj.201600269RR	http://dx.doi.org/10.1096/fj.201600269RR			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27256623	Green Published			2022-12-28	WOS:000382816300012
J	Croasdell, A; Sime, PJ; Phipps, RP				Croasdell, Amanda; Sime, Patricia J.; Phipps, Richard P.			Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes	FASEB JOURNAL			English	Article						inflammation; LPS; MD-2; microRNA-146a; SPM	TOLL-LIKE RECEPTORS; LIPID MEDIATORS; PROMOTE RESOLUTION; ACUTE-INFLAMMATION; PROTECTS MICE; MEMBER RELB; LIPOXIN A4; D1; LIPOPOLYSACCHARIDE; PATHWAY	TLRs are critical for innate immunity, but excessive activation can lead to tissue damage and disease. Specialized proresolving mediators (SPMs), including resolvin D2 (RvD2), promote the active resolution of inflammation. How SPMs regulate early LPS signaling, including activation of TLR4, is unknown. We treated human THP-1 monocytic cells and primary human blood monocytes with RvD2 and LPS to evaluate modulation of TLRs. miRNA-146a overexpression and inhibition were used to dissect the mechanism of RvD2-mediated actions. We validated our studies using ELISAs for cytokines, PCR, Western blot analysis, and flow cytometry. Cells treated with 0.1% ethanol (control for RvD2) and/or PBS (control for LPS), and control microRNA mimics and inhibitors were used as controls. RvD2 reduced LPS-induced cytokines and TLR4 expression in human monocytes by up to 75%. In THP-1 cells, RvD2 reduced expression of TLR4, lymphocyte antigen 96 (MD-2), and downstream signals (MyD88, TRIF, and TAK1). These effects were partially mediated through RvD2 induction of microRNA-146a, and RvD2's actions were blocked by microRNA-146a inhibition. These new findings reveal the ability of RvD2 to reduce TLR4 expression and attenuate LPS-induced inflammation, providing a new area of SPM activity to investigate in this major area of therapeutic research.Croasdell, A., Sime, P. J., Phipps, R. P. Resolvin D2 decreases TLR4 expression to mediate resolution in human monocytes.	[Croasdell, Amanda; Sime, Patricia J.; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Dept Environm Med, Box 850,Del Monte Bldg,601 Elmwood Ave, Rochester, NY 14642 USA; [Sime, Patricia J.; Phipps, Richard P.] Univ Rochester, Sch Med & Dent, Dept Med, Rochester, NY 14642 USA	University of Rochester; University of Rochester	Phipps, RP (corresponding author), Univ Rochester, Sch Med & Dent, Dept Environm Med, Box 850,Del Monte Bldg,601 Elmwood Ave, Rochester, NY 14642 USA.	richard_phipps@urmc.rochester.edu			U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences [T32ES007026, P30ES01247]; NIH National Heart, Lung, and Blood Institute [R01HL120908, T32HL066988]; NIH Clinical and Translational Science Institute (CTSI) Incubator [UL1RR024160]; NIH CTSI Trainee Pilot [8UL1TR000042]; PhRMA Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000042] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024160] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL120908, T32HL066988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [T32ES007026, P30ES001247] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH Clinical and Translational Science Institute (CTSI) Incubator(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH CTSI Trainee Pilot(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PhRMA Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank the University of Rochester Medical Center Blood Bank and A. Casey for phlebotomy assistance in collecting blood donations, C. Woeller for his guidance on the microRNA experiments, and the University of Rochester Medical Center Flow Cytometry Core for its flow cytometry assistance. This work was supported by the U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grants T32ES007026 and P30ES01247; NIH National Heart, Lung, and Blood Institute Grants R01HL120908 and T32HL066988; NIH Clinical and Translational Science Institute (CTSI) Incubator Grant UL1RR024160, NIH CTSI Trainee Pilot Grant 8UL1TR000042; and the PhRMA Foundation. Author contributions: A. Croasdell designed and performed experiments, analyzed and interpreted data, and wrote the manuscript. P. Sime and R. Phipps designed experiments, interpreted data, and wrote the manuscript. All authors are members of the Lung Biology and Disease Program (University of Rochester School of Medicine and Dentistry).	Abdulnour RE, 2016, MUCOSAL IMMUNOL, V9, P1278, DOI 10.1038/mi.2015.129; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bauernfeind F, 2012, J IMMUNOL, V189, P4175, DOI 10.4049/jimmunol.1201516; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Boldin MP, 2011, J EXP MED, V208, P1189, DOI 10.1084/jem.20101823; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Ceppi M, 2009, P NATL ACAD SCI USA, V106, P2735, DOI 10.1073/pnas.0811073106; Chen F, 2014, EUR J CLIN MICROBIOL, V33, P457, DOI 10.1007/s10096-013-1978-6; Chiang N, 2015, J EXP MED, V212, P1203, DOI 10.1084/jem.20150225; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Claria J, 2012, J IMMUNOL, V189, P2597, DOI 10.4049/jimmunol.1201272; Correia JD, 2002, J BIOL CHEM, V277, P1845, DOI 10.1074/jbc.M109910200; Croasdell A, 2016, J IMMUNOL, V196, P2742, DOI 10.4049/jimmunol.1502331; Croasdell A, 2015, AM J PHYSIOL-LUNG C, V309, pL888, DOI 10.1152/ajplung.00125.2015; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; Dalli J, 2012, BLOOD, V120, pE60, DOI 10.1182/blood-2012-04-423525; El Gazzar M, 2011, J LEUKOCYTE BIOL, V90, P509, DOI 10.1189/jlb.0211074; Gu Z, 2016, INNATE IMMUN-LONDON, V22, P186, DOI 10.1177/1753425916628618; Hashimoto A, 2007, J RHEUMATOL, V34, P2144; He XB, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/945169; Hsiao HM, 2015, AM J PATHOL, V185, P3189, DOI 10.1016/j.ajpath.2015.08.008; Hsiao HM, 2014, J IMMUNOL, V193, P4980, DOI 10.4049/jimmunol.1400313; Hsiao HM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058258; Huang C, 2016, INT IMMUNOPHARMACOL, V32, P46, DOI 10.1016/j.intimp.2016.01.009; Jia HP, 2004, AM J PHYSIOL-LUNG C, V287, pL428, DOI 10.1152/ajplung.00377.2003; Koltsida O, 2013, EMBO MOL MED, V5, P762, DOI 10.1002/emmm.201201891; Kong X, 2015, MOL MED REP, V12, P895, DOI 10.3892/mmr.2015.3443; Kovach MA, 2011, INT IMMUNOPHARMACOL, V11, P1399, DOI 10.1016/j.intimp.2011.05.013; Krishnamoorthy S, 2012, AM J PATHOL, V180, P2018, DOI 10.1016/j.ajpath.2012.01.028; Lafferty EI, 2010, J INFLAMM-LOND, V7, DOI 10.1186/1476-9255-7-57; Lamping N, 1998, J CLIN INVEST, V101, P2065, DOI 10.1172/JCI2338; Lastrucci C, 2015, FASEB J, V29, P1914, DOI 10.1096/fj.14-259341; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Li YH, 2009, AM J PHYSIOL-REG I, V297, pR1670, DOI 10.1152/ajpregu.00445.2009; Liao ZL, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-110; Maris NA, 2006, EUR RESPIR J, V28, P622, DOI 10.1183/09031936.06.00010806; McGettrick AF, 2010, CURR OPIN IMMUNOL, V22, P20, DOI 10.1016/j.coi.2009.12.002; McMillan DH, 2013, AM J PHYSIOL-LUNG C, V304, pL774, DOI 10.1152/ajplung.00352.2012; Miyake K, 2006, J ENDOTOXIN RES, V12, P195, DOI 10.1179/096805106X118807; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Nahid MA, 2011, CELL MOL IMMUNOL, V8, P388, DOI 10.1038/cmi.2011.26; Nahid MA, 2009, J BIOL CHEM, V284, P34590, DOI 10.1074/jbc.M109.056317; O'Connell RM, 2007, P NATL ACAD SCI USA, V104, P1604, DOI 10.1073/pnas.0610731104; Ostuni R, 2010, CELL MOL LIFE SCI, V67, P4109, DOI 10.1007/s00018-010-0464-x; Pace E, 2011, HUM IMMUNOL, V72, P54, DOI 10.1016/j.humimm.2010.09.009; Palmer CD, 2011, J LEUKOCYTE BIOL, V90, P459, DOI 10.1189/jlb.0311145; Park BS, 2009, NATURE, V458, P1191, DOI 10.1038/nature07830; Perera PY, 1997, J IMMUNOL, V158, P4422; Ramon S, 2012, J IMMUNOL, V189, P1036, DOI 10.4049/jimmunol.1103483; Recchiuti A, 2011, FASEB J, V25, P544, DOI 10.1096/fj.10-169599; Rogerio AP, 2012, J IMMUNOL, V189, P1983, DOI 10.4049/jimmunol.1101665; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Spite M, 2009, NATURE, V461, P1287, DOI 10.1038/nature08541; Szatmary Z, 2012, GEN PHYSIOL BIOPHYS, V31, P357, DOI 10.4149/gpb_2012_048; Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103; Takahashi K, 2007, J EXP MED, V204, P2963, DOI 10.1084/jem.20071132; Tesse R, 2011, ALLERGY, V66, P307, DOI 10.1111/j.1398-9995.2010.02489.x; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Tumurkhuu G, 2015, J IMMUNOL, V194, P1686, DOI 10.4049/jimmunol.1402123; Wang B, 2011, PULM PHARMACOL THER, V24, P434, DOI 10.1016/j.pupt.2011.04.001; Wang YH, 2014, INFLAMMATION, V37, P1903, DOI 10.1007/s10753-014-9922-1; Wu DR, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/964012; Xie N, 2014, J IMMUNOL, V193, P327, DOI 10.4049/jimmunol.1400203; Yang Y, 2007, IMMUNITY, V26, P215, DOI 10.1016/j.immuni.2006.12.005; Zago M, 2014, TOXICOL LETT, V226, P107, DOI 10.1016/j.toxlet.2014.01.020	66	19	20	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3181	3193		10.1096/fj.201600375R	http://dx.doi.org/10.1096/fj.201600375R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27256622	Green Published			2022-12-28	WOS:000382816300018
J	McFadden, BR; Lusk, JL				McFadden, Brandon R.; Lusk, Jayson L.			What consumers don't know about genetically modified food, and how that affects beliefs	FASEB JOURNAL			English	Article						GM food; labeling; public acceptance; public knowledge	SCIENCE; BIASES; MATTER; RISK	In the debates surrounding biotechnology and genetically modified (GM) food, data from consumer polls are often presented as evidence for precaution and labeling. But how much do consumers actually know about the issue? New data collected from a nationwide U.S. survey reveal low levels of knowledge and numerous misperceptions about GM food. Nearly equal numbers of consumers prefer mandatory labeling of foods containing DNA as do those preferring mandatory labeling of GM foods. When given the option, the majority of consumers prefer that decisions about GM food be taken out of their hands and be made by experts. After answering a list of questions testing objective knowledge of GM food, subjective, self-reported knowledge declines somewhat, and beliefs about GM food safety increase slightly. Results suggest that consumers think they know more than they actually do about GM food, and queries about GM facts cause respondents to reassess how much they know. The findings question the usefulness of results from opinion polls as a motivation for creating public policy surrounding GM food.McFadden, B. R., Lusk, J. L. What consumers don't know about genetically modified food, and how that affects beliefs.	[McFadden, Brandon R.] Univ Florida, Dept Food & Resource Econ, 1195 McCarty Hall A, Gainesville, FL 32611 USA; [Lusk, Jayson L.] Oklahoma State Univ, Dept Agr Econ, Stillwater, OK 74078 USA	State University System of Florida; University of Florida; Oklahoma State University System; Oklahoma State University - Stillwater	McFadden, BR (corresponding author), Univ Florida, Dept Food & Resource Econ, 1195 McCarty Hall A, Gainesville, FL 32611 USA.	brandon.mcfadden@ufl.edu			Hatch Research, Education, and Extension project [FLA-FRE-005422]	Hatch Research, Education, and Extension project	The authors acknowledge the Willard Sparks Endowed Chair (Oklahoma State University) and the Hatch Research, Education, and Extension project online reporting tool (REEport; FLA-FRE-005422) (U.S. Department of Agriculture; https://nifa.usda.gov/tool/reeport). Author contributions: B. R. McFadden and J. L. Lusk were involved in all parts of the research and writing of this article.	Ansolabehere S, 2014, POLIT ANAL, V22, P285, DOI 10.1093/pan/mpt025; Bensaude-Vincent B, 2001, PUBLIC UNDERST SCI, V10, P99, DOI 10.1088/0963-6625/10/1/307; Funk C., 2015, PUBLIC SCI VIEWS SCI; Gaskell G, 1999, SCIENCE, V285, P384, DOI 10.1126/science.285.5426.384; Gaskell G, 2005, SCIENCE, V310, P1908, DOI 10.1126/science.1119444; Kahan D. M., 2011, TRAGEDY RISK PERCEPT; Kahan DM, 2011, J RISK RES, V14, P147, DOI 10.1080/13669877.2010.511246; Kahneman D., 2011, THINKING FAST SLOW; Lusk JL, 2014, ANNU REV RESOUR ECON, V6, P381, DOI 10.1146/annurev-resource-100913-012735; MARRIS C, 2001, PUBLIC ATTITUDES AGR; McFadden BR, 2015, FOOD POLICY, V54, P35, DOI 10.1016/j.foodpol.2015.04.010; Onyango B., 2006, Journal of Food Distribution Research, V37, P126; PAGE BI, 1983, AM POLIT SCI REV, V77, P175, DOI 10.2307/1956018; Phillips DM, 2013, PSYCHOL MARKET, V30, P739, DOI 10.1002/mar.20642; Rabin M, 1999, Q J ECON, V114, P37, DOI 10.1162/003355399555945; SLOVIC P, 1987, SCIENCE, V236, P280, DOI 10.1126/science.3563507; TVERSKY A, 1974, SCIENCE, V185, P1124, DOI 10.1126/science.185.4157.1124; U.S. Department of Agriculture (USDA), 2021, PROF STAND DAT; U.S. Senate Committee on Agriculture Nutrition and Forestry, NAT VOL BIOENG FOOD; ZIMAN J, 1991, SCI TECHNOL HUM VAL, V16, P99, DOI 10.1177/016224399101600106	20	50	50	1	97	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3091	3096		10.1096/fj.201600598	http://dx.doi.org/10.1096/fj.201600598			6	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27199295				2022-12-28	WOS:000382816300009
J	Ruffin, M; Bilodeau, C; Maille, E; LaFayette, SL; McKay, GA; Trinh, NTN; Beaudoin, T; Desrosiers, MY; Rousseau, S; Nguyen, D; Brochiero, E				Ruffin, Manon; Bilodeau, Claudia; Maille, Emilie; LaFayette, Shantelle L.; McKay, Geoffrey A.; Nguyen Thu Ngan Trinh; Beaudoin, Trevor; Desrosiers, Martin-Yvon; Rousseau, Simon; Dao Nguyen; Brochiero, Emmanuelle			Quorum-sensing inhibition abrogates the deleterious impact of Pseudomonas aeruginosa on airway epithelial repair	FASEB JOURNAL			English	Article						furanone QSI; cystic fibrosis; LasB elastase; infection; LasR	CYSTIC-FIBROSIS PATIENTS; TRANSMEMBRANE CONDUCTANCE REGULATOR; TRANSPOSON MUTANT LIBRARY; RESPONSES IN-VITRO; WOUND REPAIR; LUNG; CELLS; VIRULENCE; ELASTASE; DIVERSIFICATION	Chronic Pseudomonas aeruginosa lung infections are associated with progressive epithelial damage and lung function decline. In addition to its role in tissue injury, the persistent presence of P. aeruginosa-secreted products may also affect epithelial repair ability, raising the need for new antivirulence therapies. The purpose of our study was to better understand the outcomes of P. aeruginosa exoproducts exposure on airway epithelial repair processes to identify a strategy to counteract their deleterious effect. We found that P. aeruginosa exoproducts significantly decreased wound healing, migration, and proliferation rates, and impaired the ability of directional migration of primary non-cystic fibrosis (CF) human airway epithelial cells. Impact of exoproducts was inhibited after mutations in P. aeruginosa genes that encoded for the quorum-sensing (QS) transcriptional regulator, LasR, and the elastase, LasB, whereas impact was restored by LasB induction in lasR mutants. P. aeruginosa purified elastase also induced a significant decrease in non-CF epithelial repair, whereas protease inhibition with phosphoramidon prevented the effect of P. aeruginosa exoproducts. Furthermore, treatment of P. aeruginosa cultures with 4-hydroxy-2,5-dimethyl-3(2H)-furanone, a QS inhibitor, abrogated the negative impact of P. aeruginosa exoproducts on airway epithelial repair. Finally, we confirmed our findings in human airway epithelial cells from patients with CF, a disease featuring P. aeruginosa chronic respiratory infection. These data demonstrate that secreted proteases under the control of the LasR QS system impair airway epithelial repair and that QS inhibitors could be of benefit to counteract the deleterious effect of P. aeruginosa in infected patients.Ruffin, M., Bilodeau, C., Maille, E., LaFayette, S. L., McKay, G. A., Trinh, N. T. N., Beaudoin, T., Desrosiers, M.-Y., Rousseau, S., Nguyen, D., Brochiero, E. Quorum-sensing inhibition abrogates the deleterious impact of Pseudomonas aeruginosa on airway epithelial repair.	[Ruffin, Manon; Bilodeau, Claudia; Maille, Emilie; Nguyen Thu Ngan Trinh; Desrosiers, Martin-Yvon; Brochiero, Emmanuelle] Ctr Rech Ctr Hosp Univ Montreal, R08-424,900 Rue St Denis, Montreal, PQ H2X 0A9, Canada; [Ruffin, Manon; Bilodeau, Claudia; Nguyen Thu Ngan Trinh; Brochiero, Emmanuelle] Univ Montreal, Dept Med, Montreal, PQ, Canada; [LaFayette, Shantelle L.; McKay, Geoffrey A.; Beaudoin, Trevor; Rousseau, Simon; Dao Nguyen] McGill Univ, Meakins Christie Labs, Res Inst, Dept Med,McGill Univ Hlth Ctr, Montreal, PQ, Canada	Universite de Montreal; Universite de Montreal; McGill University	Brochiero, E (corresponding author), Ctr Rech Ctr Hosp Univ Montreal, R08-424,900 Rue St Denis, Montreal, PQ H2X 0A9, Canada.	emmanuelle.brochiero@umontreal.ca		Rousseau, Simon/0000-0002-8773-575X; Ruffin, Manon/0000-0002-4454-7492	(Seattle Children's Hospital, Seattle, WA, USA) (U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases) [P30 DK 089507]; Cystic Fibrosis Canada [2368]	(Seattle Children's Hospital, Seattle, WA, USA) (U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases); Cystic Fibrosis Canada	The authors thank Jane L. Burns (Seattle Children's Hospital, Seattle, WA, USA) (U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant P30 DK 089507) for providing the AMT0023-30 and AMT0023-34 isolates for this project. The PAO1-V and isogenic Delta aprA, Delta lasB, Delta lasA Delta lasB and Delta aprA Delta lasA Delta lasB mutants were kindly provided by Jeffery A. Hobben (Louisiana State University Health Sciences Center, New Orleans, LA, USA) and Suzanne Fleiszig (University of California-Berkeley, Berkeley, CA, USA). The authors acknowledge the Respiratory Health Network of Fonds de Recherche du QuebecSante (FRQS) for the support of our Respiratory Tissue Biobank of Centre de Recherche du Centre Hospitalier de l'Universite de Montreal (CRCHUM)/Institut de Recherches Cliniques de Montreal. Logistical assistance was provided by the Research Support Office, CRCHUM. This work was supported by Cystic Fibrosis Canada (Grant 2368 to E.B., studentship to C.B., and scholarship to D.N.), CRCHUM, and Universite de Montreal (scholarship to E.B.). M.R. acknowledges a postdoctoral fellowship from the training program of Canadian Institutes of Health Research (CIHR) and Respiratory Health Network of the FRQS as well as a postdoctoral award from FRQS. D.N. acknowledges a salary award from CIHR and FRQS. S.L.L. acknowledges a studentship from CIHR and Cystic Fibrosis Canada. The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication. Author contributions: E. Brochiero, M. Ruffin, D. Nguyen, and S. Rousseau designed research; M. Ruffin, E. Brochiero, D. Nguyen, C. Bilodeau, E. Maille, S. L. Lafayette, G. A. McKay, and T. Beaudoin analyzed and interpreted the data; M. Ruffin, C. Bilodeau, E. Maille, S. L. Lafayette, G. A. McKay, N. T. Trinh, and T. Beaudoin performed research; M.-Y. Desrosiers contributed to human tissue collection; M. Ruffin and E. Brochiero wrote the paper; D. Nguyen and S. Rousseau revised the paper for important intellectual content; and all authors approved the final version of the manuscript. The authors declare no conflicts of interest.	BALTIMORE RS, 1989, AM REV RESPIR DIS, V140, P1650, DOI 10.1164/ajrccm/140.6.1650; Beaudoin T, 2013, J INFECT DIS, V207, P1544, DOI 10.1093/infdis/jit059; Beaudoin T, 2012, BIOCHEM BIOPH RES CO, V428, P150, DOI 10.1016/j.bbrc.2012.10.030; Bhardwaj Ashima K, 2013, Recent Pat Antiinfect Drug Discov, V8, P68; Bilodeau C, 2016, J CYST FIBROS, V15, P43, DOI 10.1016/j.jcf.2015.04.002; Bjarnsholt T, 2008, WOUND REPAIR REGEN, V16, P2, DOI 10.1111/j.1524-475X.2007.00283.x; Burns JL, 2001, J INFECT DIS, V183, P444, DOI 10.1086/318075; Choi SC, 2014, J MICROBIOL, V52, P734, DOI 10.1007/s12275-014-4060-x; Coopersmith CM, 2003, CRIT CARE MED, V31, P1630, DOI 10.1097/01.CCM.0000055385.29232.11; Courtney J M, 2004, J Cyst Fibros, V3, P223, DOI 10.1016/j.jcf.2004.06.006; Crosby LM, 2010, AM J PHYSIOL-LUNG C, V298, pL715, DOI 10.1152/ajplung.00361.2009; Nguyen D, 2011, SCIENCE, V334, P982, DOI 10.1126/science.1211037; de Bentzmann S, 2000, LAB INVEST, V80, P209, DOI 10.1038/labinvest.3780024; deBentzmann S, 1996, AM J RESP CRIT CARE, V154, pS155, DOI 10.1164/ajrccm/154.4_Pt_2.S155; DOVEY M, 1989, J SUBMICR CYTOL PATH, V21, P521; Feliziani S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012669; Folkesson A, 2012, NAT REV MICROBIOL, V10, P841, DOI 10.1038/nrmicro2907; Geiser TK, 2001, CELL MICROBIOL, V3, P223, DOI 10.1046/j.1462-5822.2001.00107.x; Girault A, 2014, INT J ONCOL, V44, P838, DOI 10.3892/ijo.2013.2228; Haji R, 2007, J PATHOL, V211, P340, DOI 10.1002/path.2118; Hansen SK, 2012, ISME J, V6, P31, DOI 10.1038/ismej.2011.83; Hao YH, 2012, CELL MICROBIOL, V14, P401, DOI 10.1111/j.1462-5822.2011.01727.x; Held K, 2012, J BACTERIOL, V194, P6387, DOI 10.1128/JB.01479-12; Hobden JA, 2002, DNA CELL BIOL, V21, P391, DOI 10.1089/10445490260099674; Hurley MN, 2012, EUR RESPIR J, V40, P1014, DOI 10.1183/09031936.00042012; Iizuka M, 2011, WORLD J GASTROENTERO, V17, P2161, DOI 10.3748/wjg.v17.i17.2161; Jacobs MA, 2003, P NATL ACAD SCI USA, V100, P14339, DOI 10.1073/pnas.2036282100; Jacobsen JN, 2012, SCAND J INFECT DIS, V44, P615, DOI 10.3109/00365548.2011.653583; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Jorth P, 2015, CELL HOST MICROBE, V18, P307, DOI 10.1016/j.chom.2015.07.006; Kalia VC, 2013, BIOTECHNOL ADV, V31, P224, DOI 10.1016/j.biotechadv.2012.10.004; KESSLER E, 1984, CURR EYE RES, V3, P1075, DOI 10.3109/02713688409011755; Kessler E, 1997, J BIOL CHEM, V272, P9884; Knipping S, 2007, EUR ARCH OTO-RHINO-L, V264, P1413, DOI 10.1007/s00405-007-0393-y; LaFayette SL, 2015, SCI ADV, V1, DOI 10.1126/sciadv.1500199; Lu L, 2001, EXP BIOL MED, V226, P653, DOI 10.1177/153537020222600711; Maille E, 2011, AM J PHYSIOL-LUNG C, V301, pL945, DOI 10.1152/ajplung.00149.2011; Marano RJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep13296; Marquart ME, 2005, INVEST OPHTH VIS SCI, V46, P3761, DOI 10.1167/iovs.04-1483; MORIHARA K, 1978, JPN J EXP MED, V48, P81; Muller M, 2009, BURNS, V35, P500, DOI 10.1016/j.burns.2008.11.010; Trinh NTN, 2015, EUR RESPIR J, V45, P1590, DOI 10.1183/09031936.00076214; Nguyen TNT, 2012, EUR RESPIR J, V40, P1390, DOI 10.1183/09031936.00221711; Nomura K, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-21; Piorunek T, 2008, J PHYSIOL PHARMACOL, V59, P565; Puchelle Edith, 2006, Proc Am Thorac Soc, V3, P726, DOI 10.1513/pats.200605-126SF; Rejman J, 2007, HUM GENE THER, V18, P642, DOI 10.1089/hum.2006.192; Perez LRR, 2013, CURR MICROBIOL, V66, P418, DOI 10.1007/s00284-012-0290-5; Ruffin M, 2013, BBA-MOL BASIS DIS, V1832, P2340, DOI 10.1016/j.bbadis.2013.09.012; Rutherford ST, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a012427; Sacco Oliviero, 2004, Paediatr Respir Rev, V5 Suppl A, pS35, DOI 10.1016/S1526-0542(04)90008-5; Schiller KR, 2010, AM J PHYSIOL-CELL PH, V299, pC912, DOI 10.1152/ajpcell.00215.2010; Scutera S, 2014, EXPERT OPIN DRUG DIS, V9, P353, DOI 10.1517/17460441.2014.894974; Shute Janis, 2003, Paediatr Respir Rev, V4, P120, DOI 10.1016/S1526-0542(03)00028-9; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Trinh NTN, 2008, AM J PHYSIOL-LUNG C, V295, pL866, DOI 10.1152/ajplung.90224.2008; Tsang KW, 2003, EUR RESPIR J, V21, P932, DOI 10.1183/09031936.03.00097302; Workentine ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060225; Worlitzsch D, 2002, J CLIN INVEST, V109, P317, DOI 10.1172/JCI0213870	59	26	26	0	21	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3011	3025		10.1096/fj.201500166R	http://dx.doi.org/10.1096/fj.201500166R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27178322	Green Published			2022-12-28	WOS:000382816300003
J	Chatterjee, A; Komshian, S; Sansbury, BE; Wu, B; Mottola, G; Chen, M; Spite, M; Conte, MS				Chatterjee, Anuran; Komshian, Sevan; Sansbury, Brian E.; Wu, Bian; Mottola, Giorgio; Chen, Mian; Spite, Matthew; Conte, Michael S.			Biosynthesis of proresolving lipid mediators by vascular cells and tissues	FASEB JOURNAL			English	Article						resolution of inflammation; resolvins; omega-3 fatty acids	RESOLVIN D1; DOCOSAHEXAENOIC ACID; 5-LIPOXYGENASE EXPRESSION; ANTIINFLAMMATORY ACTIONS; ACUTE-INFLAMMATION; FATTY-ACIDS; HUMAN BLOOD; FISH-OIL; RESOLUTION; SUPPLEMENTATION	Recent evidence suggests that specialized proresolving lipid mediators (SPMs) generated from docosahexaenoic acid (DHA) can modulate the vascular injury response. However, cellular sources for these autacoids within the vessel wall remain unclear. Here, we investigated whether isolated vascular cells and tissues can produce SPMs and assessed expression and subcellular localization of the key SPM biosynthetic enzyme 5-lipoxygenase (LOX) in vascular cells. Intact human arteries incubated with DHA ex vivo produced 17-hydroxy DHA (17-HDHA) and D-series resolvins, as assessed by liquid chromatography-tandem mass spectrometry. Addition of 17-HDHA to humanarteries similarly increased resolvin production. Primary cultures of human saphenous vein endothelial cells (ECs) and vascular smooth muscle cells (VSMCs) converted 17-HDHA to SPMs, including resolvin D1 (RvD1) and other D-series resolvins and protectins. This was accompanied by a rapid translocation of 5-LOX from nucleus to cytoplasm in both ECs and VSMCs, potentially facilitating SPM biosynthesis. Conditioned medium from cells exposed to 17-HDHA inhibited monocyte adhesion to TNF-alpha-stimulated EC monolayers. These downstream effects were partially reversed by antibodies against the RvD1 receptors ALX/FPR2 and GPR32. These results suggest that autocrine and/or paracrine signaling via locally generated SPMs in the vasculature may represent a novel homeostatic mechanism of relevance to vascular health and disease.	[Chatterjee, Anuran; Wu, Bian; Mottola, Giorgio; Chen, Mian; Conte, Michael S.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA USA; [Chatterjee, Anuran; Wu, Bian; Mottola, Giorgio; Chen, Mian; Conte, Michael S.] Univ Calif San Francisco, Dept Surg, San Francisco, CA USA; [Komshian, Sevan] Boston Univ, Sch Med, Boston, MA 02118 USA; [Sansbury, Brian E.; Spite, Matthew] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Dept Anesthesiol Perioperat & Pain Med, 75 Francis St, Boston, MA 02115 USA; [Sansbury, Brian E.; Spite, Matthew] Harvard Med Sch, Boston, MA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Boston University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School	Conte, MS (corresponding author), 400 Parnassus Ave, San Francisco, CA 94143 USA.	michael.conte2@ucsf.edu	Mottola, Giorgio/AAO-4375-2021	Mottola, Giorgio/0000-0003-0670-8619	American Heart Association [13SDG16940069]; U.S. National Institutes of Health (NIH) Heart, Lung, and Blood Institute [HL119508, HL106173]; NIH National Institute of General Medical Sciences Grant [GM095467]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119508, R01HL106173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM095467] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); U.S. National Institutes of Health (NIH) Heart, Lung, and Blood Institute; NIH National Institute of General Medical Sciences Grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by American Heart Association Grant 13SDG16940069 (to A.C.), and by U.S. National Institutes of Health (NIH) Heart, Lung, and Blood Institute Grants HL119508 (to M.S.C.) and HL106173, and NIH National Institute of General Medical Sciences Grant GM095467 (to M.S.). A.C. and S.K. are cofirst authors. The authors declare no conflicts of interest.	Akagi D, 2015, FASEB J, V29, P2504, DOI 10.1096/fj.14-265363; Bannenberg GL, 2005, J IMMUNOL, V174, P4345, DOI 10.4049/jimmunol.174.7.4345; Bisgaard H, 2016, NEW ENGL J MED, V375, P2530, DOI 10.1056/NEJMoa1503734; Buckley CD, 2013, NAT REV IMMUNOL, V13, P59, DOI 10.1038/nri3362; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Chatterjee A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113480; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Chiu CY, 2012, INFLAMM RES, V61, P967, DOI 10.1007/s00011-012-0489-8; Chu SJ, 2000, J IMMUNOL, V165, P4640, DOI 10.4049/jimmunol.165.8.4640; Cipollone F, 2005, ARTERIOSCL THROM VAS, V25, P1665, DOI 10.1161/01.ATV.0000172632.96987.2d; CLARIA J, 1995, P NATL ACAD SCI USA, V92, P9475, DOI 10.1073/pnas.92.21.9475; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; De Ley M, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005986.pub2; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Fredman G, 2014, P NATL ACAD SCI USA, V111, P14530, DOI 10.1073/pnas.1410851111; Geppert J, 2005, LIPIDS, V40, P807, DOI 10.1007/s11745-005-1442-9; Gilbert B, 2015, BBA-GENE REGUL MECH, V1849, P1003, DOI 10.1016/j.bbagrm.2015.06.004; Hong S, 2003, J BIOL CHEM, V278, P14677, DOI 10.1074/jbc.M300218200; Kasuga K, 2008, J IMMUNOL, V181, P8677, DOI 10.4049/jimmunol.181.12.8677; Kim N, 2016, EUR J IMMUNOL, V46, P81, DOI 10.1002/eji.201545673; Krishnamoorthy S, 2010, P NATL ACAD SCI USA, V107, P1660, DOI 10.1073/pnas.0907342107; Lance KD, 2017, J BIOMED MATER RES A, V105, P31, DOI 10.1002/jbm.a.35861; Levy BD, 2001, NAT IMMUNOL, V2, P612, DOI 10.1038/89759; Mas E, 2012, CLIN CHEM, V58, P1476, DOI 10.1373/clinchem.2012.190199; Massaro M, 2008, PROSTAG LEUKOTR ESS, V79, P109, DOI 10.1016/j.plefa.2008.09.009; Miyahara T, 2013, FASEB J, V27, P2220, DOI 10.1096/fj.12-225615; Neuhofer A, 2013, DIABETES, V62, P1945, DOI 10.2337/db12-0828; Norling LV, 2012, ARTERIOSCL THROM VAS, V32, P1970, DOI 10.1161/ATVBAHA.112.249508; Osher E, 2006, MOL CELL ENDOCRINOL, V252, P201, DOI 10.1016/j.mce.2006.03.038; Pope NH, 2016, FASEB J, V30, P4192, DOI 10.1096/fj.201600144RR; Pruss H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055859; Qiu H, 2008, J EXP MED, V205, P19, DOI 10.1084/jem.20070201; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Raederstorff D, 1996, INT ARCH ALLERGY IMM, V111, P284, DOI 10.1159/000237379; Ramon S, 2012, J IMMUNOL, V189, P1036, DOI 10.4049/jimmunol.1103483; Sansbury BE, 2016, CIRC RES, V119, P113, DOI 10.1161/CIRCRESAHA.116.307308; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2006, J IMMUNOL, V176, P1848, DOI 10.4049/jimmunol.176.3.1848; Serhan CN, 2002, J EXP MED, V196, P1025, DOI 10.1084/jem.20020760; Serhan CN, 2000, J EXP MED, V192, P1197, DOI 10.1084/jem.192.8.1197; Silverman ES, 1998, AM J RESP CELL MOL, V19, P316, DOI 10.1165/ajrcmb.19.2.3154; Spite M, 2014, CELL METAB, V19, P21, DOI 10.1016/j.cmet.2013.10.006; Tanaskovic S, 2011, ANGIOLOGY, V62, P535, DOI 10.1177/0003319710398010; Tiesset H, 2009, J NUTR, V139, P82, DOI 10.3945/jn.108.096115; Turner D, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006443; Turner D, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006320.pub3; Wang XZ, 2015, J LIPID RES, V56, P674, DOI 10.1194/jlr.P055418; Weintraub WS, 2007, AM J CARDIOL, V100, p3K, DOI 10.1016/j.amjcard.2007.06.002; Wright L, 1998, AM J RESP CRIT CARE, V157, P219, DOI 10.1164/ajrccm.157.1.9704003; Wu B, 2017, J VASC SURG, V65, P207, DOI 10.1016/j.jvs.2016.01.030; Yang H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080048; Yurko-Mauro K, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0109-z; Zhang YY, 2002, BIOCHEM J, V361, P267, DOI 10.1042/0264-6021:3610267	54	27	29	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3393	3402		10.1096/fj.201700082R	http://dx.doi.org/10.1096/fj.201700082R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28442547	Green Published			2022-12-28	WOS:000405932400018
J	Chauhan, AS; Kumar, M; Chaudhary, S; Patidar, A; Dhiman, A; Sheokand, N; Malhotra, H; Raje, CI; Raje, M				Chauhan, Anoop Singh; Kumar, Manoj; Chaudhary, Surbhi; Patidar, Anil; Dhiman, Asmita; Sheokand, Navdeep; Malhotra, Himanshu; Raje, Chaaya Iyengar; Raje, Manoj			Moonlighting glycolytic protein glyceraldehyde-3-phosphate dehydrogenase (GAPDH): an evolutionarily conserved plasminogen receptor on mammalian cells	FASEB JOURNAL			English	Article						cell migration; inflammation; multifunctional protein; plasmin; urokinase activator receptor	EXTRACELLULAR-MATRIX; MACROPHAGE-MIGRATION; TRANSFERRIN RECEPTOR; SURFACE; IRON; BINDING; S100A10; LACTOFERRIN; ACTIVATION; MECHANISMS	Prokaryotic pathogens establish infection in mammals by capturing the proteolytic enzyme plasminogen (Plg) onto their surface to digest host extracellular matrix (ECM). One of the bacterial surface Plg receptors is the multifunctional glycolytic enzyme glyceraldehyde-3-phosphate dehydrogenase (GAPDH). In a defensive response, the host mounts an inflammatory response, which involves infiltration of leukocytes to sites of inflammation. This requires macrophage exit from the blood and migration across basement membranes, a phenomenon dependent on proteolytic remodeling of the ECM utilizing Plg. The ability of Plg to facilitate inflammatory cell recruitment critically depends on receptors on the surface of phagocyte cells. Utilizing a combination of biochemical, cellular, knockdown, and in vivo approaches, we demonstrated that upon inflammation, macrophages recruit GAPDH onto their surface to carry out the same task of capturing Plg to digest ECM to aid rapid phagocyte migration and combat the invading pathogens. We propose that GAPDH is an ancient, evolutionarily conserved receptor that plays a key role in the Plg-dependent regulation of macrophage recruitment in the inflammatory response to microbial aggression, thus pitting prokaryotic GAPDH against mammalian GAPDH, with both involved in a conserved role of Plg activation on the surface of their respective cells, to conflicting ends.	[Chauhan, Anoop Singh; Kumar, Manoj; Chaudhary, Surbhi; Patidar, Anil; Dhiman, Asmita; Sheokand, Navdeep; Malhotra, Himanshu; Raje, Manoj] CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India; [Raje, Chaaya Iyengar] Natl Inst Pharmaceut Educ & Res, Sahibzada Ajit Singh Nag, Punjab, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Institute of Microbial Technology (IMTECH); National Institute of Pharmaceutical Education & Research (NIPER); National Institute of Pharmaceutical Education & Research, S.A.S. Nagar (Mohali)	Raje, M (corresponding author), CSIR, Inst Microbial Technol, Sect 39A, Chandigarh 160036, India.	manoj@imtech.res.in	Chauhan, Anoop/GYD-7325-2022; Raje, Chaaya Iyengar/AAU-2651-2021; Malik, Navdeep/AAU-3303-2020; Malik, Navdeep/V-9125-2019	Chauhan, Anoop/0000-0001-8722-2404; Malik, Navdeep/0000-0003-1113-2562; KUMAR, MANOJ/0000-0001-6934-2103; Chaudhary, Surbhi/0000-0002-7457-7166; , Asmita/0000-0002-6415-6819; Iyengar, Chaaya/0000-0003-4434-0536	Department of Biotechnology (DBT; Ministry of Science and Technology of India); Council of Scientific and Industrial Research (CSIR); University Grants Commission (UGC; New Delhi, India); CSIR; Department of Science and Technology of India (DST)	Department of Biotechnology (DBT; Ministry of Science and Technology of India); Council of Scientific and Industrial Research (CSIR)(Council of Scientific & Industrial Research (CSIR) - India); University Grants Commission (UGC; New Delhi, India)(University Grants Commission, India); CSIR(Council of Scientific & Industrial Research (CSIR) - India); Department of Science and Technology of India (DST)(Department of Science & Technology (India))	A. Theophilus and R. Sharma (Institute of Microbial Technology) are acknowledged for technical assistance. A.S.C. and A.P. received fellowships from the Department of Biotechnology (DBT; Ministry of Science and Technology of India). N.S. and M.K. received financial support from the Council of Scientific and Industrial Research (CSIR), and H.M. and S.C. received fellowships from the University Grants Commission (UGC; New Delhi, India). The financial support of CSIR and the Department of Science and Technology of India (DST) is acknowledged. This article is Institute of Microbial Technology (IMTECH) communication 060/2016.	Altenberg B, 2004, GENOMICS, V84, P1014, DOI 10.1016/j.ygeno.2004.08.010; Andronicos NM, 2010, BLOOD, V115, P1319, DOI 10.1182/blood-2008-11-188938; Attali C, 2008, INFECT IMMUN, V76, P5350, DOI 10.1128/IAI.00184-08; Bergmann S, 2005, THROMB HAEMOSTASIS, V94, P304, DOI 10.1160/TH05-05-0369; Bhattacharya S, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/482096; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; Boradia VM, 2014, BIOCHEM SOC T, V42, P1796, DOI 10.1042/BST20140220; Boradia VM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5730; Bugge TH, 1997, BLOOD, V90, P4522; Chauhan AS, 2015, SCI REP-UK, V5, DOI 10.1038/srep18465; Condeelis J, 2006, CELL, V124, P263, DOI 10.1016/j.cell.2006.01.007; Das R, 2007, BLOOD, V110, P3763, DOI 10.1182/blood-2007-03-079392; Didiasova M, 2014, INT J MOL SCI, V15, P21229, DOI 10.3390/ijms151121229; Egea L, 2007, INT J BIOCHEM CELL B, V39, P1190, DOI 10.1016/j.biocel.2007.03.008; Gong YQ, 2008, J CLIN INVEST, V118, P3012, DOI 10.1172/JCI32750; HALL SW, 1991, J BIOL CHEM, V266, P12329; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Jones AL, 2004, J BIOL CHEM, V279, P38267, DOI 10.1074/jbc.M406027200; Kumar S, 2012, INT J BIOCHEM CELL B, V44, P189, DOI 10.1016/j.biocel.2011.10.016; Lighvani S, 2011, BLOOD, V118, P5622, DOI 10.1182/blood-2011-03-344242; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Madureira PA, 2011, BLOOD, V118, P4789, DOI 10.1182/blood-2011-06-334672; Magalhaes V, 2007, MICROBES INFECT, V9, P1276, DOI 10.1016/j.micinf.2007.06.001; Matta SK, 2010, BBA-PROTEINS PROTEOM, V1804, P2111, DOI 10.1016/j.bbapap.2010.08.004; Miles LA, 2005, FRONT BIOSCI-LANDMRK, V10, P1754; MILES LA, 1991, BIOCHEMISTRY-US, V30, P1682, DOI 10.1021/bi00220a034; Miles LA, 2013, SEMIN THROMB HEMOST, V39, P329, DOI 10.1055/s-0033-1334483; Modun B, 2000, TRENDS MICROBIOL, V8, P231, DOI 10.1016/S0966-842X(00)01728-5; O'Connell PA, 2010, BLOOD, V116, P1136, DOI 10.1182/blood-2010-01-264754; Pancholi V, 2003, INT J MED MICROBIOL, V293, P391, DOI 10.1078/1438-4221-00283; Phipps KD, 2011, CANCER RES, V71, P6676, DOI 10.1158/0008-5472.CAN-11-1748; Ploplis VA, 1998, BLOOD, V91, P2005, DOI 10.1182/blood.V91.6.2005.2005_2005_2009; Plow E. F., 2012, J BIOMED BIOTECHNOL, V2012, P1, DOI DOI 10.1155/2012/141806.141806; Qian BZ, 2010, CELL, V141, P39, DOI 10.1016/j.cell.2010.03.014; Raje CI, 2007, J BIOL CHEM, V282, P3252, DOI 10.1074/jbc.M608328200; Ranson M, 1998, BRIT J CANCER, V77, P1586, DOI 10.1038/bjc.1998.261; Rawat P, 2012, BIOCHEM CELL BIOL, V90, P329, DOI [10.1139/O11-058, 10.1139/o11-058]; Rozario T, 2010, DEV BIOL, V341, P126, DOI 10.1016/j.ydbio.2009.10.026; Seidler NW, 2012, GAPDH BIOL PROPERTIE; Sheokand N, 2014, J CELL SCI, V127, P4279, DOI 10.1242/jcs.154005; Sheokand N, 2013, BBA-GEN SUBJECTS, V1830, P3816, DOI 10.1016/j.bbagen.2013.03.019; Shibuya A, 2002, HEPATOL RES, V22, P174, DOI 10.1016/S1386-6346(01)00134-6; Sirover MA, 2012, J CELL BIOCHEM, V113, P2193, DOI 10.1002/jcb.24113; Sirover MA, 2011, BBA-GEN SUBJECTS, V1810, P741, DOI 10.1016/j.bbagen.2011.05.010; Smith HW, 2010, NAT REV MOL CELL BIO, V11, P23, DOI 10.1038/nrm2821; WUN TC, 1988, CRIT REV BIOTECHNOL, V8, P131, DOI 10.3109/07388558809150542; Zhang LB, 2004, J BIOL CHEM, V279, P2053, DOI 10.1074/jbc.M310357200	47	23	23	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2638	2648		10.1096/fj.201600982R	http://dx.doi.org/10.1096/fj.201600982R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28298336				2022-12-28	WOS:000401553400034
J	Parzych, K; Zetterqvist, AV; Wright, WR; Kirkby, NS; Mitchell, JA; Paul-Clark, MJ				Parzych, Katarzyna; Zetterqvist, Anna V.; Wright, William R.; Kirkby, Nicholas S.; Mitchell, Jane A.; Paul-Clark, Mark J.			Differential role of pannexin-1/ATP/P2X(7) axis in IL-1 beta release by human monocytes	FASEB JOURNAL			English	Article						inflammasome; innate immunity; Toll-like receptors; potassium channels	INTERLEUKIN-1-BETA RELEASE; CELL ACTIVATION; P2X(7) RECEPTOR; INFLAMMASOME; MACROPHAGES; CHANNEL; ENDOTOXIN; COMPLEX; MAXIK; ATP	IL-1 beta release is integral to the innate immune system. The release ofmature IL-1 beta depends on 2 regulated events: the de novo induction of pro-IL-1 beta, generally via NF-kappa B-dependent transduction pathways; and the assembly and activation of the NLRP3 inflammasome. This latter step is reliant on active caspase-1, pannexin-1, and P2X7 receptor activation. Pathogen-associated molecular patterns in gram-positive and gram-negative bacteria activate IL-1 beta release from immune cells via TLR2 and TLR4 receptors, respectively. We found that pro-IL-1 beta and mature IL-1 beta release from human monocytes is stimulated by the TLR2 agonists Pam(3)CSK4 or FSL-1, as well as the TLR4 agonist LPS in the absence of additional ATP. TLR2 agonists required pannexin-1 and P2X(7) receptor activation to stimulate IL-1 beta release. In contrast, IL-1 beta release stimulated by the TLR4 agonist LPS is independent of both pannexin-1 and P2X(7) activation. In the absence of exogenous ATP, P2X(7) activation requires endogenous ATP release, which occurs in some cells via pannexin-1. In line with this, we found that LPS-stimulated human monocytes released relatively low levels of ATP, whereas cells stimulated with TLR2 agonists released high levels of ATP. These findings suggest that in humanmonocytes, both TLR2 and TLR4 signaling induce pro-IL-1 beta expression, but the mechanism by which they activate caspase-1diverges at the level of the pannexin-1/ATP/P2X(7) axis.	[Parzych, Katarzyna; Wright, William R.; Kirkby, Nicholas S.; Mitchell, Jane A.; Paul-Clark, Mark J.] Imperial Coll London, Natl Heart & Lung Inst, Dept Cardiovasc Pharmacol, Vasc Biol, Dovehouse St, London SW3 6LY, England; [Zetterqvist, Anna V.] Lund Univ, Dept Clin Sci, Malmo, Sweden	Imperial College London; Lund University	Paul-Clark, MJ (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Dept Cardiovasc Pharmacol, Vasc Biol, Dovehouse St, London SW3 6LY, England.	m.paul-clark@imperial.ac.uk		Kirkby, Nicholas/0000-0003-3509-8549	Wellcome Trust Foundation; National Heart And Lung Institute Foundation	Wellcome Trust Foundation(Wellcome Trust); National Heart And Lung Institute Foundation	This work was supported, in part, by the Wellcome Trust Foundation and the National Heart And Lung Institute Foundation.	Chu J, 2009, J LEUKOCYTE BIOL, V86, P1227, DOI 10.1189/jlb.0309164; Connors BW, 2012, EPILEPSY CURR, V12, P66, DOI 10.5698/1535-7511-12.2.66; Dinarello CA, 2013, SEMIN IMMUNOL, V25, P469, DOI 10.1016/j.smim.2013.10.008; Ferrari D, 1997, J EXP MED, V185, P579, DOI 10.1084/jem.185.3.579; Iglesias R, 2008, AM J PHYSIOL-CELL PH, V295, pC752, DOI 10.1152/ajpcell.00228.2008; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Le Feuvre RA, 2002, J BIOL CHEM, V277, P3210, DOI 10.1074/jbc.M104388200; Locovei S, 2006, FEBS LETT, V580, P239, DOI 10.1016/j.febslet.2005.12.004; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Muller M, 2003, J ENDOTOXIN RES, V9, P181, DOI 10.1179/096805103125001595; Netea MG, 2009, BLOOD, V113, P2324, DOI 10.1182/blood-2008-03-146720; Pelegrin P, 2007, J BIOL CHEM, V282, P2386, DOI 10.1074/jbc.M610351200; Pelegrin P, 2006, EMBO J, V25, P5071, DOI 10.1038/sj.emboj.7601378; Petrilli V, 2007, CURR OPIN IMMUNOL, V19, P615, DOI 10.1016/j.coi.2007.09.002; Scheel O, 2006, INFECT IMMUN, V74, P4354, DOI 10.1128/IAI.01783-05; Seydel U, 2001, J ENDOTOXIN RES, V7, P243, DOI 10.1177/09680519010070030901; Stokes L, 2006, BRIT J PHARMACOL, V149, P880, DOI 10.1038/sj.bjp.0706933; Yazdi AS, 2010, P NATL ACAD SCI USA, V107, P19449, DOI 10.1073/pnas.1008155107	19	35	35	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2439	2445		10.1096/fj.201600256	http://dx.doi.org/10.1096/fj.201600256			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28246166	Green Published			2022-12-28	WOS:000401553400019
J	Montassar, F; Darche, M; Blaizot, A; Augustin, S; Conart, JB; Millet, A; Elayeb, M; Sahel, JA; Goazigo, ARL; Sennlaub, F; Marrakchi, N; Messadi, E; Guillonneau, X				Montassar, Fadoua; Darche, Marie; Blaizot, Amandine; Augustin, Sebastien; Conart, Jean-Baptiste; Millet, Aurelie; Elayeb, Mohamed; Sahel, Jose-Alain; Goazigo, Annabelle Reaux-Le; Sennlaub, Florian; Marrakchi, Naziha; Messadi, Erij; Guillonneau, Xavier			Lebecetin, a C-type lectin, inhibits choroidal and retinal neovascularization	FASEB JOURNAL			English	Article						integrins; snake venom; retinopathy; angiogenesis; macular degeneration	OXYGEN-INDUCED RETINOPATHY; INTEGRIN ALPHA-5-BETA-1; MACULAR DEGENERATION; MOUSE MODEL; IN-VITRO; ANGIOGENESIS; ANTAGONIST; ALPHA(V)BETA(3); RANIBIZUMAB; ACTIVATION	Angiogenesis is a cause of visual impairment and blindness in the wet form of age-related macular degeneration and in ischemic retinopathies. Current therapies include use of anti-VEGF agents to reduce choroidal neovascularization (CNV) and edema. These treatments are effective in most cases, but spontaneous or acquired resistance to anti-VEGF and possible adverse effects of long-term VEGF inhibition in the retina and choroid highlight a need for additional alternative therapies. Integrins alpha v beta 3 and alpha v beta 5, which regulate endothelial cell proliferation and stabilization, have been implicated in ocular angiogenesis. Lebecetin (LCT) is a 30-kDa heterodimeric C-type lectin that is isolated from Macrovipera lebetina venom and interacts with alpha 5 beta 1-and alpha v-containing integrins. We previously showed that LCT inhibits human brain microvascular endothelial cell adhesion, migration, proliferation, and tubulogenesis. To evaluate the inhibitory effect of LCT on ocular angiogenesis, we cultured aortic and choroidal explants in the presence of LCT and analyzed the effect of LCT on CNV in the mouse CNV model and on retinal neovascularization in the oxygen-induced retinopathy model. Our data demonstrate that a single injection of LCT efficiently reduced CNV and retinal neovascularization in these models.	[Montassar, Fadoua; Darche, Marie; Blaizot, Amandine; Augustin, Sebastien; Conart, Jean-Baptiste; Sahel, Jose-Alain; Goazigo, Annabelle Reaux-Le; Sennlaub, Florian; Guillonneau, Xavier] Sorbonne Univ, Univ Pierre & Marie Curie, Ctr Natl Rech Sci, INSERM,Inst Vis, Paris, France; [Montassar, Fadoua; Millet, Aurelie; Elayeb, Mohamed; Marrakchi, Naziha; Messadi, Erij] Inst Pasteur Tunis, Lab Venins & Biomol Therapeut LR11IPT08, Tunis, Tunisia; [Montassar, Fadoua] Univ Carthage, Fac Sci Bizerte, Bizerte, Tunisia	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Le Reseau International des Instituts Pasteur (RIIP); Universite de Tunis-El-Manar; Institut Pasteur Tunis; Universite de Carthage	Guillonneau, X (corresponding author), INSERM, Inst Vis, Unit Mixte Rech S968, 17 Rue Moreau, F-75012 Paris, France.	xavier.guillonneau@inserm.fr	Goazigo, Annabelle Reaux-Le/F-2753-2017; Guillonneau, xavier/E-3995-2017; Sennlaub, Florian/F-2756-2017; guillonneau, xavier/AAF-9495-2021; Sahel, Jose-Alain/F-3172-2017; Conart, Jean-Baptiste/AAD-8547-2019	Goazigo, Annabelle Reaux-Le/0000-0003-3855-9523; Guillonneau, xavier/0000-0001-7379-3935; Sennlaub, Florian/0000-0003-4412-1341; guillonneau, xavier/0000-0001-7379-3935; Sahel, Jose-Alain/0000-0002-4831-1153; Michaelides, Michel/0000-0002-1552-7046	INSERM; Labex Lifesenses; Partenariat Hubert Curien (PHC)-Utique Program (Ministere de l'Enseignement Superieur et de la Recherche Scientifique de Tunisie and the Ministere des Affaires Etrangeres de France); Institute Pasteur International Network; Carnot	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Labex Lifesenses; Partenariat Hubert Curien (PHC)-Utique Program (Ministere de l'Enseignement Superieur et de la Recherche Scientifique de Tunisie and the Ministere des Affaires Etrangeres de France); Institute Pasteur International Network; Carnot	This work was supported by grants from INSERM, Labex Lifesenses, Carnot, Partenariat Hubert Curien (PHC)-Utique Program (Ministere de l'Enseignement Superieur et de la Recherche Scientifique de Tunisie and the Ministere des Affaires Etrangeres de France), and the Institute Pasteur International Network. The authors declare no conflicts of interest.	Alghisi GC, 2006, ENDOTHELIUM-J ENDOTH, V13, P113, DOI 10.1080/10623320600698037; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Berger A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096494; Bishop PN, 2015, EXP EYE RES, V133, P30, DOI 10.1016/j.exer.2014.10.021; BROOKS PC, 1994, CELL, V79, P1157, DOI 10.1016/0092-8674(94)90007-8; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Buffo A, 2010, BIOCHEM PHARMACOL, V79, P77, DOI 10.1016/j.bcp.2009.09.014; Chavakis E, 2002, DIABETOLOGIA, V45, P262, DOI 10.1007/s00125-001-0727-z; Connor KM, 2009, NAT PROTOC, V4, P1565, DOI 10.1038/nprot.2009.187; DAMORE PA, 1994, INVEST OPHTH VIS SCI, V35, P3974; Dominguez E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132644; Eghoj MS, 2012, BRIT J OPHTHALMOL, V96, P21, DOI 10.1136/bjo.2011.203893; Forooghian F, 2009, RETINA-J RET VIT DIS, V29, P723, DOI 10.1097/IAE.0b013e3181a2c1c3; FRIEDLANDER M, 1995, SCIENCE, V270, P1500, DOI 10.1126/science.270.5241.1500; Friedlander M, 1996, P NATL ACAD SCI USA, V93, P9764, DOI 10.1073/pnas.93.18.9764; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fu YL, 2007, INVEST OPHTH VIS SCI, V48, P5184, DOI 10.1167/iovs.07-0469; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Honda S, 2009, GRAEF ARCH CLIN EXP, V247, P515, DOI 10.1007/s00417-008-1010-5; Huang H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021411; Kempen JH, 2004, ARCH OPHTHALMOL-CHIC, V122, P552; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Kim S, 2002, J CLIN INVEST, V110, P933, DOI 10.1172/JCI200214268; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Kovach JL, 2012, J OPHTHALMOL, V2012, DOI 10.1155/2012/786870; Lambert V, 2013, NAT PROTOC, V8, P2197, DOI 10.1038/nprot.2013.135; Langmann T, 2007, J LEUKOCYTE BIOL, V81, P1345, DOI 10.1189/jlb.0207114; Launay PS, 2016, NEUROBIOL DIS, V88, P16, DOI 10.1016/j.nbd.2015.12.017; Lavalette S, 2011, AM J PATHOL, V178, P2416, DOI 10.1016/j.ajpath.2011.01.013; Legler DF, 2001, FASEB J, V15, P1601, DOI 10.1096/fj.00-0841fje; Martinez-Zapata MJ, 2014, COCHRANE DB SYST REV, V11, DOI DOI 10.1002/14651858.CD008721.PUB2; Nakajima T, 2014, MOL VIS, V20, P864; Papadopoulos N, 2012, ANGIOGENESIS, V15, P171, DOI 10.1007/s10456-011-9249-6; Pilorget A, 2007, J CELL PHYSIOL, V211, P307, DOI 10.1002/jcp.20935; REMTULLA S, 1985, VISION RES, V25, P21, DOI 10.1016/0042-6989(85)90076-8; Reynolds AR, 2009, NAT MED, V15, P392, DOI 10.1038/nm.1941; ROBBINS SG, 1994, INVEST OPHTH VIS SCI, V35, P3475; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Salehi-Had H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018864; Santulli RJ, 2008, J PHARMACOL EXP THER, V324, P894, DOI 10.1124/jpet.107.131656; Sarray S, 2003, BBA-PROTEINS PROTEOM, V1651, P30, DOI 10.1016/S1570-9639(03)00232-2; Sarray S, 2007, MATRIX BIOL, V26, P306, DOI 10.1016/j.matbio.2007.01.001; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Shao Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069552; SMITH LEH, 1994, INVEST OPHTH VIS SCI, V35, P101; Stahl A, 2009, ANGIOGENESIS, V12, P297, DOI 10.1007/s10456-009-9155-3; Strauss O, 2005, PHYSIOL REV, V85, P845, DOI 10.1152/physrev.00021.2004; Takagi H, 2002, JPN J OPHTHALMOL, V46, P270, DOI 10.1016/S0021-5155(02)00482-3; Tokunaga CC, 2014, INVEST OPHTH VIS SCI, V55, P1884, DOI 10.1167/iovs.13-13397; Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814; Umeda N, 2006, MOL PHARMACOL, V69, P1820, DOI 10.1124/mol.105.020941; Wang MH, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-173; Wang WQ, 2011, INVEST OPHTH VIS SCI, V52, P7213, DOI 10.1167/iovs.10-7097; Wilkinson-Berka JL, 2006, INVEST OPHTH VIS SCI, V47, P1600, DOI 10.1167/iovs.05-1314; Zahn G, 2009, ARCH OPHTHALMOL-CHIC, V127, P1329, DOI 10.1001/archophthalmol.2009.265	55	13	14	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1107	+		10.1096/fj.201600351R	http://dx.doi.org/10.1096/fj.201600351R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27974593	Green Submitted			2022-12-28	WOS:000395671200024
J	Rajshankar, D; Wang, YQ; McCulloch, CA				Rajshankar, Dhaarmini; Wang, Yongqiang; McCulloch, Christopher A.			Osteogenesis requires FAK-dependent collagen synthesis by fibroblasts and osteoblasts	FASEB JOURNAL			English	Article						focal adhesions; periodontal ligament; picrosirius red stain; polarized light microscopy; quantitative RT-PCR	FOCAL ADHESION KINASE; MESENCHYMAL STEM-CELLS; PERIODONTAL-LIGAMENT; BONE-MARROW; ADHERENT CELLS; DIFFERENTIATION; EXPRESSION; PROTEIN; OSTEOPOROSIS; ACTIVATION	Focal adhesion kinase (FAK) is critical in adhesion-dependent signaling, but its role in osteogenesis in vivo is ill defined. We deleted Fak in fibroblasts and osteoblasts in Floxed-Fak mice bred with those expressing Cre-recombinase driven by 3.6-kb alpha 1(I)-collagen promoter. Compared with wild-type (WT), conditional FAK-knockout (CFKO) mice were shorter (2-fold; P < 0.0001) and had crooked, shorter tails (50%; P < 0.0001). Microcomputed tomography analysis showed reduced bone volume (4-fold in tails; P < 0.0001; 2-fold in mandibles; P < 0.0001), whereas bone surface area/bone volume increased (3-fold in tails; P < 0.0001; 2.5-fold in mandibles; P < 0.001). Collagen density and fiber alignment in periodontal ligament were reduced by 4-fold (P < 0.0001) and 30%(P < 0.05), respectively, in CFKO mice. In cultured CFKO osteoblasts, mineralization at d 7 and mineralizing colony-forming units atd21 were 30%(P< 0.0001) and >3-fold less than WT, respectively. Disruptions of FAK function in osteoblasts by conditional knockout, siRNA-knockdown, or FAK inhibitor reduced mRNA and protein expression of Runx2 (>30%), Osterix (>25%), and collagen-1 (2-fold). Collagen synthesis was abrogated in WT osteoblasts with Runx2 knockdown and in Fak-null fibroblasts transfected with an FAK kinase domain mutant or akinase-impaired mutant (Y397F). These data indicate that FAK regulates osteogenesis through transcription factors that regulate collagen synthesis.	[Rajshankar, Dhaarmini; Wang, Yongqiang; McCulloch, Christopher A.] Univ Toronto, Fac Dent, Matrix Dynam Grp, Toronto, ON, Canada	University of Toronto	Rajshankar, D (corresponding author), Univ Toronto, Room 243,Fitzgerald Bldg,150 Coll St, Toronto, ON M5S 3E2, Canada.	dhaarmini.rajshankar@utoronto.ca			Canadian Institutes of Health Research operating Grant [MOP- 84254]; Canada Research Chair (Tier 1)	Canadian Institutes of Health Research operating Grant(Canadian Institutes of Health Research (CIHR)); Canada Research Chair (Tier 1)(Canada Research Chairs)	The authors thank Dominic Fritz (University of Toronto) for assisting with troubleshooting the mice breeding strategy, and to Doug Holmyard (Mount Sinai Hospital, Toronto, ON, Canada) for assisting with TEM. This research was funded by a Canadian Institutes of Health Research operating Grant MOP-84254 (to C.A.M.). C.A.M. is also supported by a Canada Research Chair (Tier 1). The authors declare no conflicts of interest.	Ajami E, 2014, ACTA BIOMATER, V10, P394, DOI 10.1016/j.actbio.2013.09.020; [Anonymous], 2014, Osteoporos Int, V25 Suppl 6, P659, DOI 10.1007/s00198-014-2893-0; Avraham H, 2000, CELL SIGNAL, V12, P123, DOI 10.1016/S0898-6568(99)00076-5; Bakker AD, 2012, METHODS MOL BIOL, V816, P19, DOI 10.1007/978-1-61779-415-5_2; Beertsen W, 1997, PERIODONTOL 2000, V13, P20, DOI 10.1111/j.1600-0757.1997.tb00094.x; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; BELLOWS CG, 1989, DEV BIOL, V133, P8, DOI 10.1016/0012-1606(89)90291-1; Bentovim L, 2012, DEVELOPMENT, V139, P4473, DOI 10.1242/dev.083881; Berendsen AD, 2015, BONE, V80, P14, DOI 10.1016/j.bone.2015.04.035; Bernabei R, 2014, CLIN CASES MINER BON, V11, P201, DOI 10.11138/ccmbm/2014.11.3.201; Bouxsein ML, 2010, J BONE MINER RES, V25, P1468, DOI 10.1002/jbmr.141; BROWN M, 1986, J VIROL, V60, P290, DOI 10.1128/JVI.60.1.290-293.1986; Buckbinder L, 2007, P NATL ACAD SCI USA, V104, P10619, DOI 10.1073/pnas.0701421104; Castillo AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043291; Chang J, 2007, J BIOL CHEM, V282, P30938, DOI 10.1074/jbc.M702391200; Chen YJ, 2014, J BONE MINER METAB, V32, P671, DOI 10.1007/s00774-013-0549-3; Compston JE, 2014, J BONE MINER RES, V29, P487, DOI 10.1002/jbmr.2051; Dacic S, 2001, J BONE MINER RES, V16, P1228, DOI 10.1359/jbmr.2001.16.7.1228; Everts V, 2012, METHODS MOL BIOL, V816, P351, DOI 10.1007/978-1-61779-415-5_23; Franceschi RT, 2007, ANN NY ACAD SCI, V1116, P196, DOI 10.1196/annals.1402.081; Greenblatt MB, 2013, ANNU REV CELL DEV BI, V29, P63, DOI 10.1146/annurev-cellbio-101512-122347; Gregory CA, 2004, ANAL BIOCHEM, V329, P77, DOI 10.1016/j.ab.2004.02.002; Hall JE, 2011, INT REV CEL MOL BIO, V288, P185, DOI 10.1016/B978-0-12-386041-5.00005-4; Hamidouche Z, 2009, P NATL ACAD SCI USA, V106, P18587, DOI 10.1073/pnas.0812334106; Hu HM, 2013, INT J CLIN EXP PATHO, V6, P841; Hu J, 2016, SCI REP-UK, V6, DOI 10.1038/srep20875; HUNTER GK, 1993, J CELL SCI, V104, P1031; Ilic D, 1997, J CELL SCI, V110, P401; Ilic Dusko, 1995, Nature (London), V377, P539, DOI 10.1038/377539a0; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Kim EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055296; Kim JB, 2007, BONE, V41, P39, DOI 10.1016/j.bone.2007.01.024; Kingsley LA, 2007, P NATL ACAD SCI USA, V104, P10753, DOI 10.1073/pnas.0704357104; Kling JM, 2014, J WOMENS HEALTH, V23, P563, DOI 10.1089/jwh.2013.4611; Lian JB, 2004, CRIT REV EUKAR GENE, V14, P1; Liao XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042709; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Lo YYC, 1998, J BIOL CHEM, V273, P7059, DOI 10.1074/jbc.273.12.7059; MANOLAGAS SC, 1995, NEW ENGL J MED, V332, P305, DOI 10.1056/NEJM199502023320506; Marcus R, 2001, RHEUM DIS CLIN N AM, V27, P131, DOI 10.1016/S0889-857X(05)70190-3; MCCULLOCH CAG, 1991, BLOOD, V77, P1906; Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549; Mizuno M, 2001, J BIOCHEM-TOKYO, V129, P133, DOI 10.1093/oxfordjournals.jbchem.a002824; Mohammadi H, 2014, BIOMATERIALS, V35, P1138, DOI 10.1016/j.biomaterials.2013.10.059; Pala D, 2008, J BIOL CHEM, V283, P9239, DOI 10.1074/jbc.M705175200; Perinpanayagam H, 2001, J ORTHOPAED RES, V19, P993, DOI 10.1016/S0736-0266(01)00045-6; Raisz LG, 2001, J BONE MINER RES, V16, P1948, DOI 10.1359/jbmr.2001.16.11.1948; Reginster JY, 2006, BONE, V38, P4, DOI 10.1016/j.bone.2005.11.024; Rossert JA, 1996, P NATL ACAD SCI USA, V93, P1027, DOI 10.1073/pnas.93.3.1027; Salasznyk RM, 2007, EXP CELL RES, V313, P22, DOI 10.1016/j.yexcr.2006.09.013; Schaller MD, 2010, J CELL SCI, V123, P1007, DOI 10.1242/jcs.045112; Shih YRV, 2011, J BONE MINER RES, V26, P730, DOI 10.1002/jbmr.278; Sieg DJ, 1998, EMBO J, V17, P5933, DOI 10.1093/emboj/17.20.5933; SODEK J, 1977, ARCH ORAL BIOL, V22, P647, DOI 10.1016/0003-9969(77)90094-2; Sun CH, 2016, J BONE MINER RES, V31, P2227, DOI 10.1002/jbmr.2908; Suzawa M, 2002, J BONE MINER RES, V17, P240, DOI 10.1359/jbmr.2002.17.2.240; Takeuchi Y, 1997, J BIOL CHEM, V272, P29309, DOI 10.1074/jbc.272.46.29309; Tamura Y, 2001, J BONE MINER RES, V16, P1772, DOI 10.1359/jbmr.2001.16.10.1772; Vasikaran S, 2011, OSTEOPOROSIS INT, V22, P391, DOI 10.1007/s00198-010-1501-1; Viale-Bouroncle S, 2014, ARCH ORAL BIOL, V59, P1249, DOI 10.1016/j.archoralbio.2014.07.013; Ward Donald F. Jr., 2007, Molecular & Cellular Biomechanics, V4, P177; Yan SG, 2011, BIOMATERIALS, V32, P8676, DOI 10.1016/j.biomaterials.2011.07.072; Zheng CH, 1998, J BIOL CHEM, V273, P2384, DOI 10.1074/jbc.273.4.2384	63	20	20	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					937	953		10.1096/fj.201600645R	http://dx.doi.org/10.1096/fj.201600645R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27881487				2022-12-28	WOS:000395671200011
J	Han, HY; Liang, XM; Ekberg, M; Kritikou, JS; Brunnstrom, A; Pelcman, B; Matl, M; Miao, XY; Andersson, M; Yuan, XT; Schain, F; Parvin, S; Melin, E; Sjoberg, J; Xu, DW; Westerberg, LS; Bjorkholm, M; Claesson, HE				Han, Hongya; Liang, Xiuming; Ekberg, Monica; Kritikou, Joanna S.; Brunnstrom, Asa; Pelcman, Benjamin; Matl, Maria; Miao, Xinyan; Andersson, Margareta; Yuan, Xiaotian; Schain, Frida; Parvin, Selina; Melin, Eva; Sjoberg, Jan; Xu, Dawei; Westerberg, Lisa S.; Bjorkholm, Magnus; Claesson, Hans-Erik			Human 15-lipoxygenase-1 is a regulator of dendritic-cell spreading and podosome formation	FASEB JOURNAL			English	Article						arachidonic acid; cell migration; dermatitis; endocytosis	PRORESOLVING MEDIATORS; SURFACE EXPRESSION; UP-REGULATION; SOLUBLE FORM; CD83; 12/15-LIPOXYGENASE; ACID; INFLAMMATION; EOXINS; PROSTAGLANDIN-E2	Dendritic cells (DCs) involved in proinflammatory immune responses derive mainly from peripheral monocytes, and the cells subsequently mature and migrate into the inflammatory micromilieu. Here we report that suppressing of 15-lipoxygenase-1 led to a substantial reduction in DC spreading and podosome formation in vitro. The surface expression of CD83 was significantly lower in both sh-15-lipoxygenase-1 (15-LOX-1)-transduced cells and DCs cultivated in the presence of a novel specific 15-LOX-1 inhibitor. The T-cell response against tetanus-pulsed DCs was only affected to a minor extent on inhibition of 15-LOX-1. In contrast, endocytosis and migration ability of DCs were significantly suppressed on 15-LOX-1 inhibition. The expression of 15-LOX-1 in DCs was also demonstrated in affected human skin in atopic and contact dermatitis, showing that the enzyme is indeed expressed in inflammatory diseases in vivo. This study demonstrated that inhibiting 15-LOX-1 led to an impaired podosome formation in DCs, and consequently suppressed antigen uptake and migration capacity. These results indicated that 15-LOX-1 is a potential target for inhibiting the trafficking of DCs to lymphoid organs and inflamed tissues and decreasing the inflammatory response attenuating symptoms of certain immunologic and inflammatory disorders such as dermatitis.-Han, H., Liang, X., Ekberg, M., Kritikou, J. S., Brunnstro " m, angstrom., Pelcman, B., Matl, M., Miao, X., Andersson, M., Yuan, X., Schain, F., Parvin, S., Melin, E., Sjoberg, J., Xu, D., Westerberg, L. S., Bjorkholm, M., Claesson, H.- E. Human 15-lipoxygenase- 1 is a regulator of dendritic-cell spreading and podosome formation.	[Han, Hongya] Karolinska Univ, Huddinge Hosp, Ctr Hematol & Regenerat Med, Karolinska Inst,Dept Med, Stockholm, Sweden; [Han, Hongya; Liang, Xiuming; Ekberg, Monica; Brunnstrom, Asa; Andersson, Margareta; Yuan, Xiaotian; Schain, Frida; Parvin, Selina; Sjoberg, Jan; Xu, Dawei; Bjorkholm, Magnus; Claesson, Hans-Erik] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Med,Div Hematol, Stockholm, Sweden; [Matl, Maria] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Med,Clin Immunol & Allergy Unit, Stockholm, Sweden; [Miao, Xinyan] Karolinska Univ, Hosp Solna, Karolinska Inst, Dept Med,Clin Pharmacol Grp, Stockholm, Sweden; [Kritikou, Joanna S.; Westerberg, Lisa S.] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, Stockholm, Sweden; [Pelcman, Benjamin] Uppsala Univ, Dept Med Chem, Organ Pharmaceut Chem, Uppsala, Sweden; [Melin, Eva] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Uppsala University; Danderyds Hospital; Karolinska Institutet	Han, HY (corresponding author), Karolinska Univ, Huddinge Hosp, Ctr Hematol & Regenerat Med, Karolinska Inst,Dept Med, Halsovagen 7, Huddinge, Sweden.	ya.han@ki.se	Melin, Eva/AAF-8222-2020; Westerberg, Lisa/AAB-3808-2019	Claesson, Hans-Erik/0000-0002-1960-6542; Westerberg, Lisa/0000-0003-2943-2192	Cancer Foundation; Swedish Cancer Society; Lars Hiertas Foundation; Karolinska Institutet	Cancer Foundation; Swedish Cancer Society(Swedish Cancer Society); Lars Hiertas Foundation; Karolinska Institutet(Karolinska Institutet)	The authors thank A. Cimarelli (INSERM Unite 1111, Lyon, France), for providing the plasmid SIV3<SUP>+</SUP>. The authors also thank S. Ganesan (Karolinska Institutet, Karolinska University Hospital Huddinge) for helpful discussion. This work was supported, in part, by the Cancer Foundation, Swedish Cancer Society, the Lars Hiertas Foundation, and the Karolinska Institutet.	Andersson CK, 2008, AM J RESP CELL MOL, V39, P648, DOI 10.1165/rcmb.2007-0443OC; Berger G, 2011, NAT PROTOC, V6, P806, DOI 10.1038/nprot.2011.327; Brunnstrom A, 2015, PROSTAG OTH LIPID M, V121, P83, DOI 10.1016/j.prostaglandins.2015.04.010; Claesson HE, 2008, FEBS J, V275, P4222, DOI 10.1111/j.1742-4658.2008.06570.x; Claesson HE, 2009, PROSTAG OTH LIPID M, V89, P120, DOI 10.1016/j.prostaglandins.2008.12.003; CONRAD DJ, 1992, P NATL ACAD SCI USA, V89, P217, DOI 10.1073/pnas.89.1.217; Deschamps JD, 2006, BIOORGAN MED CHEM, V14, P4295, DOI 10.1016/j.bmc.2006.01.057; Feltenmark S, 2008, P NATL ACAD SCI USA, V105, P680, DOI 10.1073/pnas.0710127105; Goujon C, 2006, GENE THER, V13, P991, DOI 10.1038/sj.gt.3302753; Gulliksson M, 2007, BBA-MOL CELL BIOL L, V1771, P1156, DOI 10.1016/j.bbalip.2007.06.001; Hajek AR, 2008, J ALLERGY CLIN IMMUN, V122, P633, DOI 10.1016/j.jaci.2008.06.021; Han H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091499; Han HY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085085; Heydeck D, 1998, BLOOD, V92, P2503, DOI 10.1182/blood.V92.7.2503.2503_2503_2510; Hock BD, 2001, INT IMMUNOL, V13, P959, DOI 10.1093/intimm/13.7.959; Hsieh Chia-Jung, 2007, Clin Mol Allergy, V5, P5, DOI 10.1186/1476-7961-5-5; Hunger RE, 2004, J CLIN INVEST, V113, P701, DOI 10.1172/JCI200419655; Ivanov I, 2015, GENE, V573, P1, DOI 10.1016/j.gene.2015.07.073; James A, 2013, INT ARCH ALLERGY IMM, V162, P37, DOI 10.1159/000351422; Kotzor N, 2004, IMMUNOBIOLOGY, V209, P129, DOI 10.1016/j.imbio.2004.04.003; Kruse M, 2000, J EXP MED, V191, P1581, DOI 10.1084/jem.191.9.1581; Kuhn H, 1999, LIPIDS, V34, pS273, DOI 10.1007/BF02562317; Kumar J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111759; Lechmann M, 2002, TRENDS IMMUNOL, V23, P273, DOI 10.1016/S1471-4906(02)02214-7; Lechmann M, 2001, J EXP MED, V194, P1813, DOI 10.1084/jem.194.12.1813; Liu C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052703; Liu C, 2012, EXP CELL RES, V318, P169, DOI 10.1016/j.yexcr.2011.10.017; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mildner A, 2014, IMMUNITY, V40, P642, DOI 10.1016/j.immuni.2014.04.016; Miller YI, 2001, J BIOL CHEM, V276, P19431, DOI 10.1074/jbc.M011276200; Murphy DA, 2011, NAT REV MOL CELL BIO, V12, P413, DOI 10.1038/nrm3141; Norgauer J, 2003, INT J MOL MED, V12, P83; Prechtel AT, 2007, J IMMUNOL, V178, P5454, DOI 10.4049/jimmunol.178.9.5454; Rice RL, 1998, INT J CANCER, V77, P271, DOI 10.1002/(SICI)1097-0215(19980717)77:2<271::AID-IJC17>3.0.CO;2-E; Rothe T, 2015, J CLIN INVEST, V125, P1944, DOI 10.1172/JCI78490; Sacharzewska E, 2016, ADV MED SCI-POLAND, V61, P141, DOI 10.1016/j.advms.2015.11.001; SALLUSTO F, 1994, J EXP MED, V179, P1109, DOI 10.1084/jem.179.4.1109; Satoh Takeshi, 2013, Methods Mol Biol, V960, P401, DOI 10.1007/978-1-62703-218-6_30; Scandella E, 2002, BLOOD, V100, P1354, DOI 10.1182/blood-2001-11-0017; Schwartz S, 2005, PSYCHOACTIVE HERBS IN VETERINARY BEHAVIOR MEDICINE, P1, DOI 10.1002/9780470344644; SCHWENK U, 1992, J BIOL CHEM, V267, P12482; Senechal B, 2004, BLOOD, V103, P4207, DOI 10.1182/blood-2003-12-4350; Spanbroek R, 2001, P NATL ACAD SCI USA, V98, P5152, DOI 10.1073/pnas.091076998; Sreeramkumar V, 2016, IMMUNOL CELL BIOL, V94, P39, DOI 10.1038/icb.2015.62; Stein K, 2016, J LEUKOCYTE BIOL, V99, P231, DOI 10.1189/jlb.3HI0515-189R; Tang K, 1997, ADV EXP MED BIOL, V422, P71; Wilson NS, 2004, IMMUNOL CELL BIOL, V82, P91, DOI 10.1111/j.1440-1711.2004.01216.x; Yamada T, 2011, FASEB J, V25, P561, DOI 10.1096/fj.10-170027; Zhan YF, 2012, MOL IMMUNOL, V52, P30, DOI 10.1016/j.molimm.2012.04.009; Zhao JM, 2011, P NATL ACAD SCI USA, V108, P14246, DOI 10.1073/pnas.1018075108; Zhou LJ, 1996, P NATL ACAD SCI USA, V93, P2588, DOI 10.1073/pnas.93.6.2588; Zinser E, 2004, J EXP MED, V200, P345, DOI 10.1084/jem.20030973	52	11	14	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					491	504		10.1096/fj.201600679RR	http://dx.doi.org/10.1096/fj.201600679RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27825104				2022-12-28	WOS:000394235400006
J	Shafiee, A; Patel, J; Wong, HY; Donovan, P; Hutmacher, DW; Fisk, NM; Khosrotehrani, K				Shafiee, Abbas; Patel, Jatin; Wong, Ho Yi; Donovan, Prudence; Hutmacher, Dietmar W.; Fisk, Nicholas M.; Khosrotehrani, Kiarash			Priming of endothelial colony-forming cells in a mesenchymal niche improves engraftment and vasculogenic potential by initiating mesenchymal transition orchestrated by NOTCH signaling	FASEB JOURNAL			English	Article						ECFC; vacularization; primed ECFC	STEM-CELLS; PROGENITOR CELLS; IN-VIVO; RISK-FACTORS; BLOOD; ORIGIN; ANGIOGENESIS; FETAL; ACTIVATION; PROLIFERATION	The prospect of using endothelial progenitors is currently hampered by their low engraftment upon transplantation. We report that mesenchymal stem/stromal cells (MSCs), independent of source and age, improve the engraftment of endothelial colony forming cells (ECFCs). MSC coculture altered ECFC appearance to an elongated mesenchymal morphology with reduced proliferation. ECFC primed via MSC contact had reduced self-renewal potential, but improved capacity to form tube structures in vitro and engraftment in vivo. Primed ECFCs displayed major differences in transcriptome compared to ECFCs never exposed to MSCs, affecting genes involved in the cell cycle, up-regulating of genes influencing mesenchymal transition, adhesion, extracellular matrix. Inhibition of NOTCH signaling, a potential upstream regulator of mesenchymal transition, in large part modulated this gene expression pattern and functionally reversed the mesenchymal morphology of ECFCs. The collective results showed that primed ECFCs survive better and undergo a mesenchymal transition that is dependent on NOTCH signaling, resulting in significantly increased vasculogenic potential.	[Shafiee, Abbas; Patel, Jatin; Wong, Ho Yi; Fisk, Nicholas M.; Khosrotehrani, Kiarash] Univ Queensland, Clin Res Ctr, Brisbane, Qld, Australia; [Donovan, Prudence; Khosrotehrani, Kiarash] Univ Queensland, UQ Diamantina Inst, Translat Res Inst, Brisbane, Qld, Australia; [Hutmacher, Dietmar W.] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Brisbane, Qld, Australia; [Fisk, Nicholas M.] Royal Brisbane & Womens Hosp, Ctr Adv Prenatal Care, Brisbane, Qld, Australia	University of Queensland; University of Queensland; Queensland University of Technology (QUT); Royal Brisbane & Women's Hospital	Khosrotehrani, K (corresponding author), Univ Queensland, Royal Brisbane & Womens Hosp, UQ Ctr Clin Res, Bldg 71-918, Brisbane, Qld 4029, Australia.	k.khosrotehrani@uq.edu.au	Khosrotehrani, Kiarash/M-8025-2015; Fisk, Nicholas M/B-2126-2009; shafiee, Abbas/H-9230-2019; Patel, Jatin/P-2668-2016	Khosrotehrani, Kiarash/0000-0002-6406-4076; Fisk, Nicholas M/0000-0003-0031-7975; shafiee, Abbas/0000-0002-8885-9025; Patel, Jatin/0000-0002-6731-0009; Hutmacher, Dietmar Werner/0000-0001-5678-2134; Wong, Ho Yi/0000-0002-1245-4056; Patel, Jatin/0000-0002-3511-0029	National Health and Medical Research Council [1023368]; American Society for Reproductive Medicine; National Health and Medical Research Council Career Development Fellowship Grant [1023371]; National Heart Foundation of Australia Postdoctoral Fellowship	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); American Society for Reproductive Medicine; National Health and Medical Research Council Career Development Fellowship Grant; National Heart Foundation of Australia Postdoctoral Fellowship(National Heart Foundation of Australia)	The authors thank Paula Hall and Grace Chojnowski [Queensland Institute of Medical Research (QIMR), Berghofer Flow Cytometry Unit] for assistance with FACS, Susan Brown and Royal Brisbane and Women's Hospital midwifery staffs for contribution in placenta collection, and the mothers who donated placenta for the research. This study was supported by National Health and Medical Research Council Project Grant 1023368 and American Society for Reproductive Medicine; National Health and Medical Research Council Career Development Fellowship Grant 1023371 (to K. K); and National Heart Foundation of Australia Postdoctoral Fellowship (to J.P.). K.K., N.M.F., and J.P. are coinventors on a patent regarding the placental isolation of ECFC and fPL-MSC.	Armulik A, 2005, CIRC RES, V97, P512, DOI 10.1161/01.RES.0000182903.16652.d7; Armulik A, 2011, DEV CELL, V21, P193, DOI 10.1016/j.devcel.2011.07.001; Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Au P, 2008, BLOOD, V111, P4551, DOI 10.1182/blood-2007-10-118273; Bautch VL, 2011, NAT MED, V17, P1437, DOI 10.1038/nm.2539; Bennis Y, 2012, J THROMB HAEMOST, V10, P1914, DOI 10.1111/j.1538-7836.2012.04835.x; Bianco P, 2008, CELL STEM CELL, V2, P313, DOI 10.1016/j.stem.2008.03.002; Bianco P, 2013, NAT MED, V19, P35, DOI 10.1038/nm.3028; Carvalho JL, 2013, J CELL MOL MED, V17, P617, DOI 10.1111/jcmm.12036; Case J, 2007, EXP HEMATOL, V35, P1109, DOI 10.1016/j.exphem.2007.04.002; Cheng L., 2014, BLOOD, V124, P2765; Chong MSK, 2016, STEM CELL TRANSL MED, V5, P530, DOI 10.5966/sctm.2015-0227; Corselli M, 2010, ARTERIOSCL THROM VAS, V30, P1104, DOI 10.1161/ATVBAHA.109.191643; Covas DT, 2008, EXP HEMATOL, V36, P642, DOI 10.1016/j.exphem.2007.12.015; Crisan M, 2008, CELL STEM CELL, V3, P301, DOI 10.1016/j.stem.2008.07.003; Crist CG, 2012, CELL STEM CELL, V11, P118, DOI 10.1016/j.stem.2012.03.011; Danieli P, 2015, STEM CELL TRANSL MED, V4, P448, DOI 10.5966/sctm.2014-0253; Ezzati M, 2015, NAT REV CARDIOL, V12, P508, DOI 10.1038/nrcardio.2015.82; Fahmy RG, 2003, NAT MED, V9, P1026, DOI 10.1038/nm905; Feng JF, 2011, P NATL ACAD SCI USA, V108, P6503, DOI 10.1073/pnas.1015449108; Foubert P, 2007, J CLIN INVEST, V117, P1527, DOI 10.1172/JCI28338; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hirschi KK, 2008, ARTERIOSCL THROM VAS, V28, P1584, DOI 10.1161/ATVBAHA.107.155960; Hofmann JJ, 2007, CIRC RES, V100, P1556, DOI 10.1161/01.RES.0000266408.42939.e4; Ingram DA, 2004, BLOOD, V104, P2752, DOI 10.1182/blood-2004-04-1396; Jain RK, 2003, NAT MED, V9, P685, DOI 10.1038/nm0603-685; Kim CJ, 2011, INT J ONCOL, V38, P1759, DOI 10.3892/ijo.2011.997; Kim H, 2015, MICROVASC RES, V101, P72, DOI 10.1016/j.mvr.2015.06.006; Kim H, 2015, CYTOTHERAPY, V17, P579, DOI 10.1016/j.jcyt.2014.12.003; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; Lin RZ, 2012, ANGIOGENESIS, V15, P443, DOI 10.1007/s10456-012-9272-2; Liu YC, 2012, STEM CELLS, V30, P1911, DOI 10.1002/stem.1164; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Noseda M, 2004, CIRC RES, V94, P910, DOI 10.1161/01.RES.0000124300.76171.C9; Parant O, 2009, LAB INVEST, V89, P915, DOI 10.1038/labinvest.2009.55; Patel J, 2014, PLACENTA, V35, P969, DOI 10.1016/j.placenta.2014.09.001; Patel J, 2016, STEM CELLS, V34, P902, DOI 10.1002/stem.2262; Patel J, 2013, STEM CELL TRANSL MED, V2, P839, DOI 10.5966/sctm.2013-0092; Pedersen TO, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt412; Poitevin S, 2014, CARDIOVASC RES, V103, P121, DOI 10.1093/cvr/cvu104; Polchert D, 2008, EUR J IMMUNOL, V38, P1745, DOI 10.1002/eji.200738129; Rapp BM, 2011, CELL MED, V2, P85, DOI 10.3727/215517911X617888; Sainson RCA, 2005, FASEB J, V19, P1027, DOI 10.1096/fj.04-3172fje; Samatov TR, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-107; Schmidt D, 2007, EMBO J, V26, P710, DOI 10.1038/sj.emboj.7601539; Segarra M, 2012, BLOOD, V120, P4104, DOI 10.1182/blood-2012-02-410076; Shabbir A, 2015, STEM CELLS DEV, V24, P1635, DOI 10.1089/scd.2014.0316; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Sun Y, 2015, P NATL ACAD SCI USA, V112, P10401, DOI 10.1073/pnas.1504387112; Tasev D, 2016, TISSUE ENG PART B-RE, V22, P371, DOI 10.1089/ten.teb.2016.0050; Traktuev DO, 2009, CIRC RES, V104, P1410, DOI 10.1161/CIRCRESAHA.108.190926; Vodyanik MA, 2010, CELL STEM CELL, V7, P718, DOI 10.1016/j.stem.2010.11.011; Yan W, 2006, J BIOL CHEM, V281, P19700, DOI 10.1074/jbc.M601856200; Yoder MC, 2007, BLOOD, V109, P1801, DOI 10.1182/blood-2006-08-043471; Yusuf S, 2001, CIRCULATION, V104, P2746, DOI 10.1161/hc4601.099487; Zemani F, 2008, ARTERIOSCL THROM VAS, V28, P644, DOI 10.1161/ATVBAHA.107.160044; Zhang ZY, 2009, STEM CELLS, V27, P126, DOI 10.1634/stemcells.2008-0456	59	27	27	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					610	624		10.1096/fj.201600937	http://dx.doi.org/10.1096/fj.201600937			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	28045376				2022-12-28	WOS:000394235400015
J	Suarez-Bregua, P; Torres-Nunez, E; Saxena, A; Guerreiro, P; Braasch, I; Prober, DA; Moran, P; Cerda-Reverter, JM; Du, SJ; Adrio, F; Power, DM; Canario, AVM; Postlethwait, JH; Bronner, ME; Canestro, C; Rotllant, J				Suarez-Bregua, Paula; Torres-Nunez, Eva; Saxena, Ankur; Guerreiro, Pedro; Braasch, Ingo; Prober, David A.; Moran, Paloma; Miguel Cerda-Reverter, Jose; Du, Shao Jun; Adrio, Fatima; Power, Deborah M.; Canario, Adelino V. M.; Postlethwait, John H.; Bronner, Marianne E.; Canestro, Cristian; Rotllant, Josep			Pth4, an ancient parathyroid hormone lost in eutherian mammals, reveals a new brain-to-bone signaling pathway	FASEB JOURNAL			English	Article						runx; phosphate; calcium; hypothalamus; fgf23	BASS DICENTRARCHUS-LABRAX; WHOLE-GENOME DUPLICATION; PHOSPHATE HOMEOSTASIS; SKELETAL MINERALIZATION; CONSERVED SYNTENY; TELEOST FISH; ZEBRAFISH; RECEPTOR; CALCIUM; GENE	Regulation of bone development, growth, and remodeling traditionally has been thought to depend on endocrine and autocrine/paracrine modulators. Recently, however, brain-derived signals have emerged as key regulators of bone metabolism, although their mechanisms of action have been poorly understood. We reveal the existence of an ancient parathyroid hormone (Pth)4 in zebrafish that was secondarily lost in the eutherian mammals' lineage, including humans, and that is specifically expressed in neurons of the hypothalamus and appears to be a central neural regulator of bone development and mineral homeostasis. Transgenic fish lines enabled mapping of axonal projections leading from the hypothalamus to the brainstem and spinal cord. Targeted laser ablation demonstrated an essential role for of pth4-expressing neurons in larval bone mineralization. Moreover, we show that Runx2 is a direct regulator of pth4 expression and that Pth4 can activate cAMP signaling mediated by Pth receptors. Finally, gain-of-function experiments show that Pth4 can alter calcium/phosphorus levels and affect expression of genes involved in phosphate homeostasis. Based on our discovery and characterization of Pth4, we propose a model for evolution of bone homeostasis in the context of the vertebrate transition from an aquatic to a terrestrial lifestyle.	[Suarez-Bregua, Paula; Torres-Nunez, Eva; Rotllant, Josep] Inst Marine Res, Spanish Natl Res Council, IIM CSIC, Vigo, Spain; [Saxena, Ankur; Prober, David A.] CALTECH, Pasadena, CA 91125 USA; [Saxena, Ankur] Univ Illinois, Dept Biol Sci, Chicago, IL 60680 USA; [Guerreiro, Pedro; Power, Deborah M.; Canario, Adelino V. M.] Univ Algarve, Ctr Marine Sci CCMAR, Faro, Portugal; [Postlethwait, John H.] Univ Oregon, Inst Neurosci, Eugene, OR 97403 USA; [Moran, Paloma] Univ Vigo, Dept Biochem Genet & Immunol, Vigo, Spain; [Miguel Cerda-Reverter, Jose] IATS, CSIC, Castellon de La Plana, Spain; [Du, Shao Jun] Univ Maryland, Dept Mol & Cellular Biol, Baltimore, MD 21201 USA; [Adrio, Fatima] Univ Santiago de Compostela, Dept Cell Biol, Santiago De Compostela, Spain; [Canestro, Cristian] Univ Barcelona, Inst Recerca Biodiversitat IRBio, Dept Genet Microbiol & Estadist, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Marinas (IIM); California Institute of Technology; University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital; Universidade do Algarve; University of Oregon; Universidade de Vigo; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Acuicultura de Torre de la Sal (IATS); University System of Maryland; University of Maryland Baltimore; Universidade de Santiago de Compostela; University of Barcelona	Rotllant, J (corresponding author), Inst Marine Res, Spanish Natl Res Council, IIM CSIC, Vigo, Spain.	rotllant@iim.csic.es	Morán, Paloma/J-6877-2014; Braasch, Ingo/A-6948-2010; Cañestro, Cristian/L-9661-2014; Suarez-Bregua, Paula/A-5124-2019; Power, Deborah M/D-3333-2011; Canario, Adelino/C-7942-2009; Guerreiro, P. M./A-2539-2009; Adrio, Fatima/ABD-6556-2021; Cerda-Reverter, Jose Miguel/K-4934-2014; Rotllant, Josep/K-1146-2014	Morán, Paloma/0000-0002-3644-8507; Braasch, Ingo/0000-0003-4766-611X; Cañestro, Cristian/0000-0003-4623-8105; Power, Deborah M/0000-0003-1366-0246; Canario, Adelino/0000-0002-6244-6468; Adrio, Fatima/0000-0002-3196-7682; Cerda-Reverter, Jose Miguel/0000-0003-1405-5750; Rotllant, Josep/0000-0001-5331-807X; Saxena, Ankur/0000-0001-8646-2887; Bronner, Marianne/0000-0003-4274-1862	Spanish Economy and Competitiveness Ministry Project [ALG2011-23581, AGL2014-52473R]; Portuguese Foundation for Science and Technology [PTDC/BIA-ANM/4225/2012-phos-fate]; U. S. National Institutes of Health/Office of the Director Grant [R01OD011116, R01 RR020833]; Generalitat de Catalunya [SGR2014-290]; Spanish Economy and Competitiveness Ministry [BFU2010-14875]; Science and Innovation Ministry [AGL2010-22247-C03-01]; Campus do Mar Ph.D. grant; Xunta de Galicia (Santiago, Spain) [AGL2014-52473R]; Fundação para a Ciência e a Tecnologia [PTDC/BIA-ANM/4225/2012] Funding Source: FCT; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR020833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS094390, R01NS095824, R01NS070911] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD011116] Funding Source: NIH RePORTER	Spanish Economy and Competitiveness Ministry Project; Portuguese Foundation for Science and Technology(Portuguese Foundation for Science and Technology); U. S. National Institutes of Health/Office of the Director Grant; Generalitat de Catalunya(Generalitat de Catalunya); Spanish Economy and Competitiveness Ministry(Spanish Government); Science and Innovation Ministry; Campus do Mar Ph.D. grant; Xunta de Galicia (Santiago, Spain)(Xunta de Galicia); Fundação para a Ciência e a Tecnologia; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	The authors thank Yi-lin Yan (University of Oregon) for providing the tip39 (PTH2) expression vector; Prof. N. Lawson (University of Massachusetts Medical School, Worcester, MA, USA) and Prof. K. Kawakami (National Institute of Genetics, Mishima, Japan) for providing the iTol2 constructs; D.A.P. for the hcrt: tdTomato line and Prof. K. M. Kwan (University Of Utah, Salt Lake City, UT, USA) for the bactin2: H2A-mCherry line; Ines Pazos and Jesus Mendez [Scientific and Technological Research Assistance Centre (CACTI), University of Vigo] for their advice and assistance with the confocal microscope; Ruben Chamorro and Rosa Ceinos (IIM-CSIC) for their help in handling and care of the fish and David Guede and Jose R. Caeiro (University of Santiago de Compostela, Santiago, Spain) for their advice and assistance with the micro-CT SkyScan. This work was funded by the Spanish Economy and Competitiveness Ministry Project ALG2011-23581 and AGL2014-52473R (to J. R.); the Portuguese Foundation for Science and Technology (Project PTDC/BIA-ANM/4225/2012-phos-fate; to P.G.); U. S. National Institutes of Health/Office of the Director Grant R01OD011116 (alias R01 RR020833; to J.H.P.); Generalitat de Catalunya (Grant SGR2014-290) and the Spanish Economy and Competitiveness Ministry (Project BFU2010-14875; to C.C.). Partial funding was obtained from Science and Innovation Ministry (AGL2010-22247-C03-01; to J.M.C.-R.), a Campus do Mar Ph.D. grant, and Xunta de Galicia (Santiago, Spain; Project AGL2014-52473R) (to P.S.B.). C.C. and J.R. are co-senior authors.	Abbink W, 2006, J EXP BIOL, V209, P3550, DOI 10.1242/jeb.02399; Albalat R, 2016, NAT REV GENET, V17, P379, DOI 10.1038/nrg.2016.39; Anjos L, 2013, GEN COMP ENDOCR, V191, P102, DOI 10.1016/j.ygcen.2013.05.014; Bajayo A, 2012, P NATL ACAD SCI USA, V109, P15455, DOI 10.1073/pnas.1206061109; Bhattacharya P, 2011, J ENDOCRINOL, V211, P187, DOI 10.1530/JOE-10-0439; Blair HC, 2008, BIOL REV, V83, P401, DOI 10.1111/j.1469-185X.2008.00048.x; Canario AVM, 2006, FEBS LETT, V580, P291, DOI 10.1016/j.febslet.2005.12.023; Canestro C, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000496; Cariestro C., 2012, POLYPLOIDY GENOME EV, P309, DOI DOI 10.1007/978-3-642-31442-1_16; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Catchen JM, 2011, METHOD CELL BIOL, V104, P259, DOI 10.1016/B978-0-12-374814-0.00015-X; Catchen JM, 2009, GENOME RES, V19, P1497, DOI 10.1101/gr.090480.108; Cerda-Reverter JM, 2000, J COMP NEUROL, V426, P197, DOI 10.1002/1096-9861(20001016)426:2<197::AID-CNE3>3.0.CO;2-3; CHEN WB, 1995, ANAL BIOCHEM, V226, P349, DOI 10.1006/abio.1995.1235; Christov M, 2013, SEMIN NEPHROL, V33, P143, DOI 10.1016/j.semnephrol.2012.12.015; Dehal P, 2005, PLOS BIOL, V3, P1700, DOI 10.1371/journal.pbio.0030314; Driessler F, 2010, J MOL ENDOCRINOL, V45, P175, DOI 10.1677/JME-10-0015; Elefteriou F, 2008, ARCH BIOCHEM BIOPHYS, V473, P231, DOI 10.1016/j.abb.2008.03.016; FELDKAMP LA, 1984, J OPT SOC AM A, V1, P612, DOI 10.1364/JOSAA.1.000612; Flores MV, 2006, DEV DYNAM, V235, P3166, DOI 10.1002/dvdy.20957; Galitzer H, 2008, CURR OPIN NEPHROL HY, V17, P363, DOI 10.1097/MNH.0b013e328303e172; Gardella TJ, 2001, TRENDS ENDOCRIN MET, V12, P210, DOI 10.1016/S1043-2760(01)00409-X; Gensure RC, 2004, ENDOCRINOLOGY, V145, P1634, DOI 10.1210/en.2003-0964; Graham C, 2003, AM J PHYSIOL-RENAL, V284, pF727, DOI 10.1152/ajprenal.00356.2002; Guerreiro PM, 2007, AM J PHYSIOL-REG I, V292, pR679, DOI 10.1152/ajpregu.00480.2006; Guerreiro PM, 2010, AM J PHYSIOL-REG I, V299, pR603, DOI 10.1152/ajpregu.00509.2009; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hoare SRJ, 2000, ENDOCRINOLOGY, V141, P3080, DOI 10.1210/en.141.9.3080; Hori M, 2011, ENDOCRINOLOGY, V152, P4, DOI 10.1210/en.2010-0800; Hoshi K, 1999, BONE, V25, P639, DOI 10.1016/S8756-3282(99)00223-9; Huitema LFA, 2012, P NATL ACAD SCI USA, V109, P21372, DOI 10.1073/pnas.1214231110; Kalev-Zylinska ML, 2003, DEV DYNAM, V228, P323, DOI 10.1002/dvdy.10388; Kawakami K, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-S1-S7; Khanal RC, 2008, CLIN EXP PHARMACOL P, V35, P1277, DOI 10.1111/j.1440-1681.2008.05053.x; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kronenberg HM, 1998, RECENT PROG HORM RES, V53, P283; Kronenberg HM, 1998, RECENT PROG HORM RES, V53, P301; Lewis-McCrea LM, 2010, J APPL ICHTHYOL, V26, P334, DOI 10.1111/j.1439-0426.2010.01431.x; Li N, 2009, DEV DYNAM, V238, P459, DOI 10.1002/dvdy.21838; Lu Yongbo, 2011, Curr Osteoporos Rep, V9, P103, DOI 10.1007/s11914-011-0053-4; Martin A, 2012, PHYSIOL REV, V92, P131, DOI 10.1152/physrev.00002.2011; Nishio Y, 2006, GENE, V372, P62, DOI 10.1016/j.gene.2005.12.022; Okabe M, 2004, P NATL ACAD SCI USA, V101, P17716, DOI 10.1073/pnas.0406116101; On JSW, 2015, MOL BIOL EVOL, V32, P2048, DOI 10.1093/molbev/msv087; Penido MGMG, 2012, PEDIATR NEPHROL, V27, P2039, DOI 10.1007/s00467-012-2175-z; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pinheiro PLC, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-373; Potts JT, 2005, J ENDOCRINOL, V187, P311, DOI 10.1677/joe.1.06057; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Quiros-Gonzalez I, 2014, ARCH BIOCHEM BIOPHYS, V561, P130, DOI 10.1016/j.abb.2014.06.005; Radanovic T, 2005, AM J PHYSIOL-GASTR L, V288, pG496, DOI 10.1152/ajpgi.00167.2004; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Rotllant J, 2006, CELL TISSUE RES, V323, P333, DOI 10.1007/s00441-005-0070-7; Rotllant J, 2005, REGUL PEPTIDES, V132, P33, DOI 10.1016/j.regpep.2005.08.004; Rotllant J, 2008, MATRIX BIOL, V27, P561, DOI 10.1016/j.matbio.2008.03.001; Rubin DA, 1999, J BIOL CHEM, V274, P23035, DOI 10.1074/jbc.274.33.23035; Sanchez E, 2009, J EXP BIOL, V212, P3901, DOI 10.1242/jeb.035121; Sanchez E, 2009, AM J PHYSIOL-REG I, V296, pR1293, DOI 10.1152/ajpregu.90948.2008; Saxena A, 2013, ELIFE, V2, DOI 10.7554/eLife.00336; Suzuki N, 2011, BONE, V48, P1186, DOI 10.1016/j.bone.2011.02.004; Tseng DY, 2009, AM J PHYSIOL-REG I, V296, pR549, DOI 10.1152/ajpregu.90742.2008; van der Velden YU, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073997; Wang J, 2001, BIOTECHNIQUES, V31, P722, DOI 10.2144/01314bm01; Westerfield M., 2007, GUIDE LAB USE ZEBRAF; Witten PE, 2009, BIOL REV, V84, P315, DOI 10.1111/j.1469-185X.2009.00077.x; Wolfe K, 2000, NAT GENET, V25, P3, DOI 10.1038/75560; Yadav MC, 2011, J BONE MINER RES, V26, P286, DOI 10.1002/jbmr.195; Yan YL, 2012, J ENDOCRINOL, V214, P421, DOI 10.1530/JOE-12-0110; Zheng QP, 2003, J CELL BIOL, V162, P833, DOI 10.1083/jcb.200211089	69	11	12	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					569	583		10.1096/fj.201600815R	http://dx.doi.org/10.1096/fj.201600815R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	28148780	Green Published, Green Submitted			2022-12-28	WOS:000394235400012
J	Cui, XW; You, LH; Li, Y; Zhu, LJ; Zhang, F; Xie, KP; Cao, Y; Ji, CB; Guo, XR				Cui, Xianwei; You, Lianghui; Li, Yun; Zhu, Lijun; Zhang, Fan; Xie, Kaipeng; Cao, Yan; Ji, Chenbo; Guo, Xirong			A transcribed ultraconserved noncoding RNA, uc.417, serves as a negative regulator of brown adipose tissue thermogenesis	FASEB JOURNAL			English	Article						lncRNA; uc.417; brown adipocytes; energy expenditure	FAT; ADIPOCYTES; REVEALS; WHITE; BEIGE; CODE	Brown adipose tissue (BAT) oxidizes fatty acids for thermogenesis and could therefore be considered as part of a new strategy in combating obesity and associated metabolic diseases. It is well established that aging is accompanied by a decline of brown adipocyte regenerative capacity. How aging contributes to this loss is poorly understood. Here, we identify a long noncoding RNA, uc.417, which is transcribed from an ultraconserved region in rodents. Expression of uc.417 increases with age. Ectopic expression of uc.417 impairs adipogenesis and the thermogenic program in brown adipocytes. However, uc.417 is not required for brown fat function. In vivo, uc.417 attenuates the cold-induced thermogenic program in mouse BAT. Moreover, we find that uc.417 moderately inhibits phosphorylation of p38MAPK without affecting the total protein level of p38MAPK. The p38MAPK pathway is essential for activating BAT to stimulate uncoupling protein 1 gene expression. The data point to uc.417 as being an important factor in an age-dependent loss of function of brown adipose tissue.	[Cui, Xianwei] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China; [Cui, Xianwei; You, Lianghui; Li, Yun; Zhu, Lijun; Xie, Kaipeng; Cao, Yan; Ji, Chenbo; Guo, Xirong] Nanjing Med Univ, Affiliated Nanjing Childrens Hosp, Nanjing Maternal & Child Hlth Med Inst, Nanjing, Jiangsu, Peoples R China; [Zhang, Fan] Nanjing Med Univ, Affiliated Nanjing Childrens Hosp, Dept Endocrinol, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University; Nanjing Medical University; Nanjing Medical University	Ji, CB; Guo, XR (corresponding author), Nanjing Med Univ, Nanjing Maternal & Child Hlth Med Inst, Affiliated Nanjing Maternal & Child Hlth Hosp, Nanjing 210004, Jiangsu, Peoples R China.	chenboji@njmu.edu.cn; xrguo@njmu.edu.cn			National Key Basic Research Program of China [2013CB530604]; Key project of the National Natural Science Foundation of China [81330067]; National Natural Science Foundation of China [81300683, 81200642]; Natural Science Foundation of Jiangsu Province, China [BK20140086]; Nanjing Medical Science and Technique Development Foundation [JQX13012]	National Key Basic Research Program of China(National Basic Research Program of China); Key project of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province); Nanjing Medical Science and Technique Development Foundation	This work was funded by the National Key Basic Research Program of China (Grant 2013CB530604), the Key project of the National Natural Science Foundation of China (Grant 81330067), the National Natural Science Foundation of China (Grants 81300683 and 81200642), the Natural Science Foundation of Jiangsu Province, China (Grant BK20140086), and the Nanjing Medical Science and Technique Development Foundation (Grant JQX13012). The authors declare no conflicts of interest.	Alvarez-Dominguez JR, 2015, CELL METAB, V21, P764, DOI 10.1016/j.cmet.2015.04.003; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Batista PJ, 2013, CELL, V152, P1298, DOI 10.1016/j.cell.2013.02.012; Cao WH, 2001, J BIOL CHEM, V276, P27077, DOI 10.1074/jbc.M101049200; Collins Sheila, 2011, Front Endocrinol (Lausanne), V2, P102, DOI 10.3389/fendo.2011.00102; Emont MP, 2015, J ENDOCRINOL, V225, pR35, DOI 10.1530/JOE-15-0026; Fatica A, 2014, NAT REV GENET, V15, P7, DOI 10.1038/nrg3606; Gburcik V, 2012, AM J PHYSIOL-ENDOC M, V303, pE1053, DOI 10.1152/ajpendo.00104.2012; Graja A, 2015, GERONTOLOGY, V61, P211, DOI 10.1159/000366557; Halley P, 2014, CELL REP, V6, P222, DOI 10.1016/j.celrep.2013.12.015; Jeanson Y, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00158; Knoll M, 2015, NAT REV ENDOCRINOL, V11, P151, DOI 10.1038/nrendo.2014.229; Kong XX, 2014, CELL, V158, P69, DOI 10.1016/j.cell.2014.04.049; Kooijman S, 2015, TRENDS ENDOCRIN MET, V26, P657, DOI 10.1016/j.tem.2015.09.008; Peng JC, 2013, RNA BIOL, V10, P1771, DOI 10.4161/rna.26995; Pfeifer A, 2015, ANNU REV PHARMACOL, V55, P207, DOI 10.1146/annurev-pharmtox-010814-124346; Poekes L, 2015, CLIN SCI, V129, P933, DOI 10.1042/CS20150339; Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006; Sun L, 2013, P NATL ACAD SCI USA, V110, P3387, DOI 10.1073/pnas.1222643110; Svensson KJ, 2016, CELL METAB, V23, P454, DOI 10.1016/j.cmet.2016.01.008; Tan CY, 2015, CELL REP, V13, P2039, DOI 10.1016/j.celrep.2015.11.004; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Xiao TF, 2015, STEM CELL REP, V5, P856, DOI 10.1016/j.stemcr.2015.09.007; You LH, 2015, MOL GENET GENOMICS, V290, P1659, DOI 10.1007/s00438-015-1026-6; Zhao XY, 2015, TRENDS BIOCHEM SCI, V40, P586, DOI 10.1016/j.tibs.2015.08.002; Zhao XY, 2014, MOL CELL, V55, P372, DOI 10.1016/j.molcel.2014.06.004	26	36	41	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4301	4312		10.1096/fj.201600694R	http://dx.doi.org/10.1096/fj.201600694R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27655899				2022-12-28	WOS:000388201500034
J	Martella, A; Sepe, RM; Silvestri, C; Zang, JJ; Fasano, G; Carnevali, O; De Girolamo, P; Neuhauss, SCF; Sordino, P; Di Marzo, V				Martella, Andrea; Sepe, Rosa M.; Silvestri, Cristoforo; Zang, Jingjing; Fasano, Giulia; Carnevali, Oliana; De Girolamo, Paolo; Neuhauss, Stephan C. F.; Sordino, Paolo; Di Marzo, Vincenzo			Important role of endocannabinoid signaling in the development of functional vision and locomotion in zebrafish	FASEB JOURNAL			English	Article						CB1; DAGL; MAGL; 2-arachidonoylglycerol; axonal pathfinding	LONG-TERM PLASTICITY; CANNABINOID RECEPTOR; LARVAL ZEBRAFISH; AXONAL GROWTH; MESSENGER-RNA; NITRIC-OXIDE; DANIO-RERIO; BRAIN; SYSTEM; ANANDAMIDE	The developmental role of the endocannabinoid system still remains to be fully understood. Here, we report the presence of a complete endocannabinoid system during zebrafish development and show that the genes that code for enzymes that catalyze the anabolism and catabolism (mgll and dagla) of the endocannabinoid, 2-AG (2-arachidonoylglycerol), as well as 2-AG main receptor in the brain, cannabinoid receptor type 1, are coexpressed in defined regions of axonal growth. By using morpholino-induced transient knockdown of the zebrafish Dagl alpha homolog and its pharmacologic rescue, we suggest that synthesis of 2-AG is implicated in the control of axon formation in the midbrain-hindbrain region and that animals that lack Dagl alpha display abnormal physiological behaviors in tests that measure stereotyped movement and motion perception. Our results suggest that the well-established role for 2-AG in axonal outgrowth has implications for the control of vision and movement in zebrafish and, thus, is likely common to all vertebrates.	[Martella, Andrea; Silvestri, Cristoforo; Di Marzo, Vincenzo] CNR, Inst Biomol Chem, Endocannabinoid Res Grp, Pozzuoli, Italy; [Sepe, Rosa M.; Fasano, Giulia; Sordino, Paolo] Staz Zool Anton Dohrn, Biol & Evolut Marine Organisms, I-80121 Naples, Italy; [Zang, Jingjing; Neuhauss, Stephan C. F.] Univ Zurich, Inst Mol Life Sci, Zurich, Switzerland; [Carnevali, Oliana] Polytech Univ Marche, Dept Life & Environm Sci, Ancona, Italy; [De Girolamo, Paolo] Univ Naples Federico II, Dipartimento Med Vet & Prod Anim, Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Stazione Zoologica Anton Dohrn di Napoli; University of Zurich; Marche Polytechnic University; University of Naples Federico II	Sordino, P (corresponding author), Staz Zool Anton Dohrn, Biol & Evolut Marine Organisms, I-80121 Naples, Italy.; Di Marzo, V (corresponding author), CNR, Inst Biomol Chem, Via Campi Flegrei,34 Comprensorio Olivetti, I-80078 Pozzuoli, Italy.	paolo.sordino@szn.it; vdimarzo@icb.cnr.it	Di Marzo, Vincenzo/AAD-7742-2019; Silvestri, Cristoforo/Y-2504-2019	Di Marzo, Vincenzo/0000-0002-1490-3070; Silvestri, Cristoforo/0000-0001-5635-1545; Martella, Andrea/0000-0002-4680-7702; de girolamo, paolo/0000-0003-1557-4763	Progetto Operativo Nazionale Grant [PONa3_00239]; Italian Ministry of Education, University and Research (MIUR) [RBFR12QW4I]; University of Naples "Federico II" Ph.D. fellowship; University of Sannio Ph.D. fellowship	Progetto Operativo Nazionale Grant; Italian Ministry of Education, University and Research (MIUR)(Ministry of Education, Universities and Research (MIUR)); University of Naples "Federico II" Ph.D. fellowship; University of Sannio Ph.D. fellowship	The authors thank Luigi Ippolito (Stazione Zoologica Anton Dohrn) for contributing to the early stages of the project, Fabiana Piscitelli for help with LC-MS analyses, and Enrico D'Aniello (both from the Institute of Biomolecular Chemistry, Consiglio Nazionale delle Ricerche) for critical reading of the manuscript. This work was supported by Progetto Operativo Nazionale Grant PONa3_00239, and a Fondo Italiano Ricerca di Base Grant RBFR12QW4I from the Italian Ministry of Education, University and Research (MIUR) (to P.S.), and a University of Naples "Federico II" Ph.D. fellowship (to R.M.S.) and a University of Sannio Ph.D. fellowship (to G.F.). P.S. and V.D.M. share senior authorship. The authors declare no conflicts of interest.	Alpar A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5421; Berghuis P, 2007, SCIENCE, V316, P1212, DOI 10.1126/science.1137406; Berrendero F, 1999, SYNAPSE, V33, P181, DOI 10.1002/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R; Bisogno T, 1997, BBA-LIPID LIPID MET, V1345, P338, DOI 10.1016/S0005-2760(97)00009-X; Bisogno T, 2003, J CELL BIOL, V163, P463, DOI 10.1083/jcb.200305129; Bisogno T, 2007, PHARMACOL RES, V56, P428, DOI 10.1016/j.phrs.2007.09.002; Brend Tim, 2009, J Vis Exp, DOI 10.3791/1229; Brustein E, 2003, J PHYSIOL-PARIS, V97, P77, DOI 10.1016/j.jphysparis.2003.10.009; Cecyre B, 2013, INVEST OPHTH VIS SCI, V54, P8079, DOI 10.1167/iovs.13-12514; Cottone E, 2005, J COMP NEUROL, V485, P293, DOI 10.1002/cne.20502; Cravatt BF, 1996, NATURE, V384, P83, DOI 10.1038/384083a0; De Petrocellis L, 2004, BRIT J PHARMACOL, V141, P765, DOI 10.1038/sj.bjp.0705666; DEVANE WA, 1992, SCIENCE, V258, P1946, DOI 10.1126/science.1470919; Di Marzo V, 2007, CURR OPIN LIPIDOL, V18, P129, DOI 10.1097/MOL.0b013e32803dbdec; Di Marzo V, 2012, PHILOS T R SOC B, V367, P3216, DOI 10.1098/rstb.2011.0382; DIMARZO V, 1994, NATURE, V372, P686, DOI 10.1038/372686a0; Dinh TP, 2002, P NATL ACAD SCI USA, V99, P10819, DOI 10.1073/pnas.152334899; El Manira A, 2010, PHYSIOLOGY, V25, P230, DOI 10.1152/physiol.00007.2010; Elphick MR, 2012, PHILOS T R SOC B, V367, P3201, DOI 10.1098/rstb.2011.0394; Elphick Maurice R., 2009, P123, DOI 10.1007/978-1-59745-503-9_5; Fride E, 2001, EUR J PHARMACOL, V419, P207, DOI 10.1016/S0014-2999(01)00953-0; Gahtan E, 2005, J NEUROSCI, V25, P9294, DOI 10.1523/JNEUROSCI.2678-05.2005; Godlewski G, 2009, PROSTAG OTH LIPID M, V89, P105, DOI 10.1016/j.prostaglandins.2009.07.001; Hanus L, 2001, P NATL ACAD SCI USA, V98, P3662, DOI 10.1073/pnas.061029898; Haug MF, 2010, FRONT ZOOL, V7, DOI 10.1186/1742-9994-7-8; Heap LA, 2013, FRONT NEURAL CIRCUIT, V7, DOI 10.3389/fncir.2013.00053; Jung KM, 2011, MOL PHARMACOL, V80, P60, DOI 10.1124/mol.110.070458; Kani S, 2010, DEV BIOL, V343, P1, DOI 10.1016/j.ydbio.2010.03.024; Keimpema E, 2013, P NATL ACAD SCI USA, V110, P1935, DOI 10.1073/pnas.1212563110; Keimpema E, 2010, J NEUROSCI, V30, P13992, DOI 10.1523/JNEUROSCI.2126-10.2010; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Kozak KR, 2000, J BIOL CHEM, V275, P33744, DOI 10.1074/jbc.M007088200; Kyriakatos A, 2007, J NEUROSCI, V27, P12664, DOI 10.1523/JNEUROSCI.3174-07.2007; Lam CS, 2006, NEUROSCIENCE, V138, P83, DOI 10.1016/j.neuroscience.2005.10.069; Lindsay SM, 2004, CHEM SENSES, V29, P93, DOI 10.1093/chemse/bjh009; Maccarrone M, 2004, TRENDS PHARMACOL SCI, V25, P353, DOI 10.1016/j.tips.2004.05.002; Matias I, 2007, BRIT J PHARMACOL, V152, P676, DOI 10.1038/sj.bjp.0707424; McPartland JM, 2007, MOL GENET GENOMICS, V277, P555, DOI 10.1007/s00438-007-0207-3; McPartland JM, 2006, GENE, V370, P64, DOI 10.1016/j.gene.2005.11.004; Mechoulam R, 2006, INT J OBESITY, V30, pS24, DOI 10.1038/sj.ijo.0803274; Migharini B, 2009, MOL CELL ENDOCRINOL, V299, P172, DOI 10.1016/j.mce.2008.11.014; Muccioli GG, 2010, DRUG DISCOV TODAY, V15, P474, DOI 10.1016/j.drudis.2010.03.007; Mulder J, 2008, P NATL ACAD SCI USA, V105, P8760, DOI 10.1073/pnas.0803545105; Robles E, 2011, FRONT NEURAL CIRCUIT, V5, DOI 10.3389/fncir.2011.00001; Ryskamp Daniel A, 2014, Cells, V3, P914, DOI 10.3390/cells3030914; Sanudo-Pena MC, 2000, EUR J PHARMACOL, V391, P269, DOI 10.1016/S0014-2999(00)00044-3; Schmidt R, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-3; Soderstrom K, 2001, J PHARMACOL EXP THER, V297, P189; Song JR, 2012, J NEUROSCI, V32, P5097, DOI 10.1523/JNEUROSCI.5850-11.2012; Starowicz K, 2007, PHARMACOL THERAPEUT, V114, P13, DOI 10.1016/j.pharmthera.2007.01.005; STUERMER CAO, 1988, J NEUROSCI, V8, P4513; SUGIURA T, 1995, BIOCHEM BIOPH RES CO, V215, P89, DOI 10.1006/bbrc.1995.2437; Valenti M, 2005, J NEUROCHEM, V95, P662, DOI 10.1111/j.1471-4159.2005.03406.x; Wang X, 2003, NEUROSCIENCE, V118, P681, DOI 10.1016/S0306-4522(03)00020-4; Watson S, 2008, MOL CELL NEUROSCI, V38, P89, DOI 10.1016/j.mcn.2008.02.001; Westerfield M., 1993, ZEBRAFISH BOOK GUIDE; Williams EJ, 2003, J CELL BIOL, V160, P481, DOI 10.1083/jcb.200210164; Yoneda T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053082; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181	59	19	19	0	24	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4275	4288		10.1096/fj.201600602R	http://dx.doi.org/10.1096/fj.201600602R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27623930				2022-12-28	WOS:000388201500032
J	Napoli, E; Song, G; Schneider, A; Hagerman, R; Eldeeb, MA; Azarang, A; Tassone, F; Giulivi, C				Napoli, Eleonora; Song, Gyu; Schneider, Andrea; Hagerman, Randi; Eldeeb, Marwa Abd Al Azaim; Azarang, Atoosa; Tassone, Flora; Giulivi, Cecilia			Warburg effect linked to cognitive-executive deficits in FMR1 premutation	FASEB JOURNAL			English	Article						fragile X; mitochondria; proteomics; triplet nucleotide diseases; neurological disorder	INNATE IMMUNE-RESPONSES; LARGE GENE LISTS; TREMOR/ATAXIA SYNDROME; MITOCHONDRIAL DYSFUNCTION; PARKINSONS-DISEASE; MESSENGER-RNA; UNCOUPLING PROTEINS; ALZHEIMERS-DISEASE; STATISTICAL-MODEL; DELETION SYNDROME	A 55-200 CGG repeat expansion in the 5 '-UTR of the fragile X mental retardation 1 (FMR1) gene is known as a premutation. Some carriers are affected by the neurodegenerative disorder fragile X-associated tremor/ataxia syndrome (FXTAS), primary ovarian insufficiency, and neurobehavioral impairments. Based on the mitochondrial dysfunction observed in fibroblasts and brain samples from carriers, as well as in neurons and brains from a mouse model of the premutation, we evaluated the presence of the Warburg effect in peripheral blood mononuclear cells (PBMCs) from 30 premutation carriers with either a rebalance of the metabolism [increasing glycolysis while decreasing oxidative phosphorylation (oxphos)] or a metabolic amplification (increasing glycolysis while maintaining/increasing oxphos). Deficits in oxphosmore pronounced in FXTAS-affected subjects-were accompanied by a shift toward glycolysis, suggesting increased glycolysis despite aerobic conditions. Differential proteomics extended these findings, unveiling a decreased antioxidant response, translation, and disrupted extracellular matrix and cytoskeleton organization with activation of prosenescence pathways. Lower bioenergetics segregated with increased incidence of low executive function, tremors, below-average IQ, and FXTAS. The combination of functional and proteomic data unveiled new mechanisms related to energy production in the premutation, showing the potential of being applicable to other psychiatric disorders to identify endophenotype-specific responses relevant to neurobiology.-Napoli, E., Song, G., Schneider, A., Hagerman, R., Eldeeb, M. A. A. A., Azarang, A., Tassone, F., Giulivi, C. Warburg effect linked to cognitive-executive deficits in FMR1 premutation.	[Napoli, Eleonora; Song, Gyu; Giulivi, Cecilia] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Tassone, Flora] Univ Calif Davis, Sch Med, Dept Biochem & Mol Med, Davis, CA 95616 USA; [Schneider, Andrea; Hagerman, Randi; Eldeeb, Marwa Abd Al Azaim; Azarang, Atoosa; Tassone, Flora] Univ Calif Davis, Med Invest Neurodev Disorders MIND Inst, Davis, CA 95616 USA; [Schneider, Andrea; Hagerman, Randi; Giulivi, Cecilia] Univ Calif Davis, Med Ctr, Dept Pediat, Sacramento, CA 95817 USA	University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis; University of California System; University of California Davis	Giulivi, C (corresponding author), Univ Calif Davis, Dept Mol Biosci, Vet Med 3B 3009, 1089 Vet Med Dr, Davis, CA 95616 USA.	cgiulivi@ucdavis.edu	Giulivi, Cecilia/ABB-7809-2020; Napoli, Eleonora/AAQ-6079-2021; Schneider, Andrea/Y-5200-2019; Giulivi, Cecilia/AAV-6774-2021	Giulivi, Cecilia/0000-0003-1033-7435; Napoli, Eleonora/0000-0001-8808-4242; Schneider, Andrea/0000-0002-4674-7244; 	U.S. National Institutes for Health (NIH) National Institute of Environmental Health Sciences [ES12691, ES020392]; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD036071]; Simons Foundation [271406]; MIND Institute Intellectual and Developmental Disabilities Research Center [U54 HD079125]; Health and Human Administration of Developmental Disabilities [90DD0596]; Novartis; Roche/Genentech; Alcobra; Neuren; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD079125, R01HD036071] Funding Source: NIH RePORTER; National Center on Birth Defects and Developmental Disabilities [U50DD000596] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020392, R01ES012691] Funding Source: NIH RePORTER	U.S. National Institutes for Health (NIH) National Institute of Environmental Health Sciences; NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Simons Foundation; MIND Institute Intellectual and Developmental Disabilities Research Center; Health and Human Administration of Developmental Disabilities; Novartis(Novartis); Roche/Genentech(Roche HoldingGenentech); Alcobra; Neuren; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center on Birth Defects and Developmental Disabilities(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank all families that provided the samples, making the study possible. The study was funded by U.S. National Institutes for Health (NIH) National Institute of Environmental Health Sciences Grants ES12691 and ES020392; the NIH Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant HD036071; Simons Foundation Grant 271406; MIND Institute Intellectual and Developmental Disabilities Research Center Grant U54 HD079125; and Health and Human Administration of Developmental Disabilities Grant 90DD0596. R.H. has received funding from Novartis, Roche/Genentech, Alcobra, and Neuren for treatment trials in FXS, autism, and Down syndrome, and has also consulted with Novartis and Roche/Genentech regarding treatment for FXS.	Andrews ZB, 2005, NAT REV NEUROSCI, V6, P829, DOI 10.1038/nrn1767; Armstrong DL, 2015, J BIOL CHEM, V290, P12595, DOI 10.1074/jbc.M115.639021; Arnoult D, 2011, EMBO REP, V12, P901, DOI 10.1038/embor.2011.157; Arocena DG, 2005, HUM MOL GENET, V14, P3661, DOI 10.1093/hmg/ddi394; Blandini F, 2013, J NEUROIMMUNE PHARM, V8, P189, DOI 10.1007/s11481-013-9435-y; Boisse L, 2004, J NEUROSCI, V24, P4928, DOI 10.1523/JNEUROSCI.1077-04.2004; Capkova M, 2002, INT J OBESITY, V26, P1110, DOI 10.1038/sj.ijo.0802055; Caron M, 2007, CELL DEATH DIFFER, V14, P1759, DOI 10.1038/sj.cdd.4402197; Carvalho AF, 2014, CNS NEUROL DISORD-DR, V13, P1819; Catherman AD, 2013, MOL CELL PROTEOMICS, V12, P3465, DOI 10.1074/mcp.M113.030114; Chen Y, 2012, J BIOL CHEM, V287, P27227, DOI 10.1074/jbc.M112.340315; CHRETIEN D, 1994, CLIN CHIM ACTA, V228, P53, DOI 10.1016/0009-8981(94)90056-6; Cloonan SM, 2012, CURR OPIN IMMUNOL, V24, P32, DOI 10.1016/j.coi.2011.11.001; Conley KE, 2000, J PHYSIOL-LONDON, V526, P203, DOI 10.1111/j.1469-7793.2000.t01-1-00203.x; Da Pozzo E, 2012, CURR MOL MED, V12, P426; Darshi M, 2011, J BIOL CHEM, V286, P2918, DOI 10.1074/jbc.M110.171975; De Matteis MA, 2005, BBA-MOL CELL RES, V1744, P396, DOI 10.1016/j.bbamcr.2005.04.013; Dhull DK, 2012, J MOL NEUROSCI, V46, P223, DOI 10.1007/s12031-011-9583-6; Dioguardi CC, 2016, MOL HUM REPROD, V22, P384, DOI 10.1093/molehr/gaw023; Ellis S, 2005, FASEB J, V19, P1519, DOI 10.1096/fj.04-3569fje; Fleury C, 1997, NAT GENET, V15, P269, DOI 10.1038/ng0397-269; Floyd RA, 1999, P SOC EXP BIOL MED, V222, P236, DOI 10.1046/j.1525-1373.1999.d01-140.x; Fornuskova D, 2008, BBA-MOL BASIS DIS, V1782, P317, DOI 10.1016/j.bbadis.2008.02.001; Fossati G, 2003, J IMMUNOL, V170, P1964, DOI 10.4049/jimmunol.170.4.1964; Friedman JR, 2015, ELIFE, V4, DOI 10.7554/eLife.07739; Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882; Garcia-Arocena D, 2010, HUM MOL GENET, V19, pR83, DOI 10.1093/hmg/ddq166; Gibson GE, 2010, BBA-MOL BASIS DIS, V1802, P122, DOI 10.1016/j.bbadis.2009.08.010; Giulivi C, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/609602; Giulivi C, 2010, JAMA-J AM MED ASSOC, V304, P2389, DOI 10.1001/jama.2010.1706; Glatt SJ, 2012, J AM ACAD CHILD PSY, V51, P934, DOI 10.1016/j.jaac.2012.07.007; GRIGSBY J, 2000, J CLIN GEROPSYCHOLOG, V6, P259, DOI DOI 10.1023/A:1009582728548; Hagerman PJ, 2015, ANN NY ACAD SCI, V1338, P58, DOI 10.1111/nyas.12693; Hagerman R, 2013, LANCET NEUROL, V12, P786, DOI 10.1016/S1474-4422(13)70125-X; Hammond G, 2004, CURR TOP MICROBIOL, V282, P177; Harikrishnareddy D, 2015, REV NEUROSCIENCE, V26, P161, DOI 10.1515/revneuro-2014-0057; Hmadcha A, 1998, J LAB CLIN MED, V131, P170, DOI 10.1016/S0022-2143(98)90160-3; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Infantino V, 2011, BIOCHEM J, V438, P433, DOI 10.1042/BJ20111275; Jacome ASV, 2015, PROTEOMICS, V15, P2519, DOI 10.1002/pmic.201400617; Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321; Jasinska AJ, 2009, HUM MOL GENET, V18, P4415, DOI 10.1093/hmg/ddp397; Jin P, 2007, NEURON, V55, P556, DOI 10.1016/j.neuron.2007.07.020; Junn E, 2009, J NEUROSCI RES, V87, P123, DOI 10.1002/jnr.21831; Kaplan ES, 2012, J NEUROCHEM, V123, P613, DOI 10.1111/j.1471-4159.2012.07936.x; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khalifeh S, 2016, CELL MOL NEUROBIOL, V36, P553, DOI 10.1007/s10571-015-0236-0; Klegeris A, 2007, CURR OPIN NEUROL, V20, P351, DOI 10.1097/WCO.0b013e3280adc943; Klingenberg M, 2001, BBA-BIOENERGETICS, V1504, P128, DOI 10.1016/S0005-2728(00)00242-5; Kong SW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049475; Koppenol WH, 2011, NAT REV CANCER, V11, P325, DOI 10.1038/nrc3038; Laughton JD, 2000, NEUROSCIENCE, V96, P619, DOI 10.1016/S0306-4522(99)00580-1; Lin CC, 2012, SCI REP-UK, V2, DOI 10.1038/srep00785; Liu BH, 2005, NAT MED, V11, P780, DOI 10.1038/nm1266; Loomis EW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004294; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Luckhart S, 2015, CURR OPIN IMMUNOL, V36, P73, DOI 10.1016/j.coi.2015.07.002; Luckhart S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003180; Mao WG, 1999, FEBS LETT, V443, P326, DOI 10.1016/S0014-5793(98)01713-X; MARKERT CL, 1975, SCIENCE, V189, P102, DOI 10.1126/science.1138367; Meechan DW, 2011, INT J DEV NEUROSCI, V29, P283, DOI 10.1016/j.ijdevneu.2010.08.005; Napoli E, 2016, CEREBELLUM, V15, P552, DOI 10.1007/s12311-016-0779-8; Napoli E, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00159; Napoli E, 2015, J BIOL CHEM, V290, P23240, DOI 10.1074/jbc.M115.672360; Napoli E, 2013, HUM MOL GENET, V22, P989, DOI 10.1093/hmg/dds503; Napoli E, 2011, HUM MOL GENET, V20, P3079, DOI 10.1093/hmg/ddr211; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Nicholls DG, 2000, PHYSIOL REV, V80, P315, DOI 10.1152/physrev.2000.80.1.315; Padmos RC, 2008, ARCH GEN PSYCHIAT, V65, P395, DOI 10.1001/archpsyc.65.4.395; Pastoris O, 2000, EXP GERONTOL, V35, P95, DOI 10.1016/S0531-5565(99)00077-7; Pellegrino MW, 2014, NATURE, V516, P414, DOI 10.1038/nature13818; Porporato PE, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00049; Rakhshandehroo M, 2010, PPAR RES, V2010, DOI 10.1155/2010/612089; Ross-Inta C, 2010, BIOCHEM J, V429, P545, DOI 10.1042/BJ20091960; Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594; Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003; Sanchis D, 1998, J BIOL CHEM, V273, P34611, DOI 10.1074/jbc.273.51.34611; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Sekar S, 2015, NEUROBIOL AGING, V36, P583, DOI 10.1016/j.neurobiolaging.2014.09.027; Sellier C, 2013, CELL REP, V3, P869, DOI 10.1016/j.celrep.2013.02.004; Sellier C, 2010, EMBO J, V29, P1248, DOI 10.1038/emboj.2010.21; Shanks N, 2000, P NATL ACAD SCI USA, V97, P5645, DOI 10.1073/pnas.090571897; Short KR, 2005, P NATL ACAD SCI USA, V102, P5618, DOI 10.1073/pnas.0501559102; Sparaco M, 2006, CEPHALALGIA, V26, P361, DOI 10.1111/j.1468-2982.2005.01059.x; Spencer SJ, 2005, BEHAV BRAIN RES, V164, P231, DOI 10.1016/j.bbr.2005.06.032; Sullivan PF, 2006, AM J MED GENET B, V141B, P261, DOI 10.1002/ajmg.b.30272; Tabb DL, 2008, J PROTEOME RES, V7, P45, DOI 10.1021/pr700728t; Tang BS, 2006, HUM MOL GENET, V15, P1816, DOI 10.1093/hmg/ddl104; Tassone F, 2000, AM J HUM GENET, V66, P6, DOI 10.1086/302720; Todd PK, 2013, NEURON, V79, P402, DOI 10.1016/j.neuron.2013.07.008; Todd PK, 2013, NEURON, V78, P440, DOI 10.1016/j.neuron.2013.03.026; Vats D, 2006, CELL METAB, V4, P13, DOI 10.1016/j.cmet.2006.05.011; WARBURG O, 1956, SCIENCE, V124, P269; Washizuka S, 2009, NEUROSCI RES, V63, P199, DOI 10.1016/j.neures.2008.12.004; West AP, 2011, NAT REV IMMUNOL, V11, P389, DOI 10.1038/nri2975; Xiong H, 2009, J CLIN INVEST, V119, P650, DOI 10.1172/JCI37617	97	23	23	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3334	3351		10.1096/fj.201600315R	http://dx.doi.org/10.1096/fj.201600315R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27335370	Green Published			2022-12-28	WOS:000384329800007
J	Drel, VR; Tan, CY; Barnes, JL; Gorin, Y; Lee, DY; Wagner, B				Drel, Viktor R.; Tan, Chunyan; Barnes, Jeffrey L.; Gorin, Yves; Lee, Doug-Yoon; Wagner, Brent			Centrality of bone marrow in the severity of gadolinium-based contrast-induced systemic fibrosis	FASEB JOURNAL			English	Article						nephrogenic fibrosing dermopathy; skin diseases; NADPH oxidase; chemokine CCL2; CCR2	ACTIVATION; BIODISTRIBUTION; MACROPHAGES; FIBROCYTES; OXIDASE; INJURY; AGENTS; CELLS; MICE	Systemic fibrosis can be induced in humans with gadolinium-based contrast, and cumulative doses correlate with severity. Bone marrow-derived fibrocytes accumulate in the dermis. Whether target organs liberate chemokines to recruit these fibrocytes or whether fibrocytes are stimulated to home to the affected tissue is unknown. Transgenic (tagged) donor rats were treated with gadolinium-based contrast. Bone marrow was obtained from diseased animals and age-matched controls. Rats with subtotal nephrectomies were lethally irradiated and underwent salvage transplantation with either the contrast-naive or contrast-exposed bone marrow. Groups were randomly assigned to control or contrast treatment. Contrast treatment led to dermal fibrosis, and this was exacerbated in recipients of contrast-exposed marrow. Fibronectin, C-C chemokine receptors (CCRs)2 and 7, and oxidative stress were all increased in skin from contrast-treated animalsall parameters more severe in recipients of contrast-treated animals. The respective ligands, monocyte chemoattractant protein and C-C motif ligand 19, were both elevated in skin from contrast-treated animals. Coadministration of gadolinium-based contrast and a CCR2 inhibitor reduced the severity of skin disease as well as dermal cellularity. The functional role of chemokines in the effects of gadolinium-based contrast was further confirmed in in situ coculture studies using neutralizing CCR2 antibodies. These data implicate dermal liberation of specific chemokines in the recruitment of circulating bone marrow-derived cells. The disease is augmented by bone marrow exposure to contrast, which explains why multiple exposures correlate with severity.Drel, V. R., Tan, C., Barnes, J. L., Gorin, Y., Lee, D.-Y., Wagner, B. Centrality of bone marrow in the severity of gadolinium-based contrast-induced systemic fibrosis.	[Drel, Viktor R.; Tan, Chunyan; Barnes, Jeffrey L.; Gorin, Yves; Lee, Doug-Yoon; Wagner, Brent] Univ Texas Hlth Sci Ctr San Antonio, San Antonio, TX 78229 USA; [Barnes, Jeffrey L.; Wagner, Brent] South Texas Vet Hlth Care Syst, San Antonio, TX USA	University of Texas System; University of Texas Health San Antonio; US Department of Veterans Affairs; Veterans Health Administration (VHA); Audie L. Murphy Memorial Veterans Hospital	Wagner, B (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Div Nephrol, Dept Med, 7703 Floyd Curl Dr,MC 7882, San Antonio, TX 78229 USA.	wagnerb@uthscsa.edu	Wagner, Brent/AAA-8291-2020; Drel, Viktor/G-8883-2016	Wagner, Brent/0000-0002-7063-0142; Drel, Viktor/0000-0003-4542-0132	Veterans Administration Merit [I01 BX001958]; U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases [R01-DK102085, R01-DK080106, R01-DK079996, R01-DK78971]; NIH National Center for Advancing Translational Sciences/Linked Specialized Center Cooperative Agreement [UL1-TR001120]; Qatar National Research Fund, National Priorities Research Program [NPRP8-1750-3-360]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK078971, R01DK080106, R01DK079996, R01DK102085] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001958] Funding Source: NIH RePORTER	Veterans Administration Merit(US Department of Veterans Affairs); U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH National Center for Advancing Translational Sciences/Linked Specialized Center Cooperative Agreement; Qatar National Research Fund, National Priorities Research Program; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	This work was funded by Veterans Administration Merit Award I01 BX001958 (to B.W.), U.S. National Institutes of Health (NIH) National Institute of Diabetes and Digestive and Kidney Diseases Grants R01-DK102085 (to B.W.), R01-DK080106 (to J.L.B.), R01-DK079996 (to Y.G.), and R01-DK78971 (to Y.G.), NIH National Center for Advancing Translational Sciences/Linked Specialized Center Cooperative Agreement Grant UL1-TR001120 (to Y.G.), and an award from the Qatar National Research Fund, National Priorities Research Program (NPRP8-1750-3-360) (to Y.G.). Author contributions: B. Wagner and Y. Gorin designed the research, analyzed the data, and wrote the paper; J. L. Barnes provided the hPAP donor animals; and C. Tan, D.-Y. Lee, and V. R. Drel performed the experiments. The authors declare no conflicts of interest.	Barnes JL, 2011, KIDNEY INT, V79, P944, DOI 10.1038/ki.2010.516; Bondi CD, 2010, J AM SOC NEPHROL, V21, P93, DOI 10.1681/ASN.2009020146; Bucala Richard, 2008, J Am Coll Radiol, V5, P36, DOI 10.1016/j.jacr.2007.08.016; Cowper SE, 2003, AM J DERMATOPATH, V25, P358, DOI 10.1097/00000372-200308000-00017; Cowper SE, 2000, LANCET, V356, P1000, DOI 10.1016/S0140-6736(00)02694-5; Del Galdo F, 2010, ANN RHEUM DIS, V69, P2024, DOI 10.1136/ard.2010.134858; Do C, 2014, AM J PHYSIOL-RENAL, V307, pF844, DOI 10.1152/ajprenal.00379.2014; Girardi M, 2011, J AM ACAD DERMATOL, V65, P1095, DOI 10.1016/j.jaad.2010.08.041; Gorin Y, 2015, AM J PHYSIOL-RENAL, V308, pF1276, DOI 10.1152/ajprenal.00396.2014; Gorin Y, 2013, FREE RADICAL BIO MED, V61, P130, DOI 10.1016/j.freeradbiomed.2013.03.014; Gorin Y, 2013, CLIN SCI, V125, P361, DOI 10.1042/CS20130065; Hecker L, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008182; Hecker L, 2009, NAT MED, V15, P1077, DOI 10.1038/nm.2005; Lan T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129743; Martin DR, 2008, PEDIATR RADIOL, V38, pS125, DOI 10.1007/s00247-007-0589-8; McDonald RJ, 2015, RADIOLOGY, V275, P772, DOI 10.1148/radiol.15150025; Pilling D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007475; Ramalho J, 2015, RADIOLOGY, V276, P836, DOI 10.1148/radiol.2015150872; Swaminathan S, 2013, AM J PATHOL, V183, P796, DOI 10.1016/j.ajpath.2013.06.008; TWEEDLE MF, 1995, INVEST RADIOL, V30, P372, DOI 10.1097/00004424-199506000-00008; Wadas TJ, 2010, MAGN RESON MED, V64, P1274, DOI 10.1002/mrm.22553; Wagner B, 2012, AM J PATHOL, V181, P1941, DOI 10.1016/j.ajpath.2012.08.026; Wan M, 2012, STEM CELLS, V30, P2498, DOI 10.1002/stem.1208	23	10	10	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3026	3038		10.1096/fj.201500188R	http://dx.doi.org/10.1096/fj.201500188R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27221979	Green Published			2022-12-28	WOS:000382816300004
J	Sotolongo, A; Monica, FZ; Kots, A; Xiao, HJ; Liu, J; Seto, E; Bian, K; Murad, F				Sotolongo, Alex; Monica, Fabiola Zakia; Kots, Alex; Xiao, Haijie; Liu, Jun; Seto, Edward; Bian, Ka; Murad, Ferid			Epigenetic regulation of soluble guanylate cyclase (sGC) 1 in breast cancer cells	FASEB JOURNAL			English	Article						histone acetyltransferase; histone deacetylase; inhibitors	HISTONE DEACETYLASE INHIBITORS; NITRIC-OXIDE SYNTHASE; MESENCHYMAL TRANSITION; PROTEIN ACETYLATION; TRICHOSTATIN-A; EXPRESSION; GENE; DIFFERENTIATION; STIMULATION; REPRESSION	Soluble guanylate cyclase (sGC) is a heterodimer composed of and subunits. The loss of sGC1 has been implicated in several vascular and nonvascular diseases. Our analysis showed that higher levels of sGC1 in breast cancer tissues are correlated with greater survival probability than lower sGC1 levels. However, there is no information on sGC regulation by epigenetic mechanisms. We examined the role of histone deacetylase (HDAC) inhibitors in regulating sGC1 and -1 expression in human breast cancer MDA-MB-231 and MDA-MB-468 cell lines. The class I HDAC inhibitors increased the expression of sGC1 more than sGC1. Transient overexpression of HDAC3, but not HDAC1 or HDAC2, significantly reduced sGC1 mRNA. Chromatin immunoprecipitation assay confirmed an enhanced binding of HDAC3 to the sGC1 proximal promoter, which could be reversed by panobinostat (LBH-589) treatment. Mutations at the CCAAT binding sequence, a major element regulating sGC1 expression, markedly reduced the efficacy of LBH-589 in augmenting sGC1 promoter activity. LBH-589 markedly enhanced the binding of nuclear transcription factor Y, subunit , to the sGC1 promoter (CCAAT binding sequence). In summary, HDAC3 is an endogenous antagonist of sGC1 expression. Inhibition of HDAC3 with targeted therapy could benefit treatment of the diseases associated with sGC1 down-regulation and/or deficiency such as cancer and several vascular-related diseases.Sotolongo, A., Monica, F. Z., Kots, A., Xiao, H., Liu, J., Seto, E., Bian, K., Murad, F. Epigenetic regulation of soluble guanylate cyclase (sGC) 1 in breast cancer cells.	[Sotolongo, Alex; Monica, Fabiola Zakia; Kots, Alex; Xiao, Haijie; Liu, Jun; Seto, Edward; Bian, Ka; Murad, Ferid] George Washington Univ, Dept Biochem & Mol Med, Washington, DC USA; [Seto, Edward] George Washington Univ, Ctr Canc, Washington, DC USA; [Monica, Fabiola Zakia] Univ Estadual Campinas, Fac Med Sci, Dept Pharmacol, Campinas, SP, Brazil	George Washington University; George Washington University; Universidade Estadual de Campinas	Bian, K (corresponding author), George Washington Univ, Sch Med, Dept Biochem & Mol Med, 2300 Eye St NW, Washington, DC 20037 USA.	bcmkxb@gwu.edu	Kots, Alexander/AAF-5404-2020; Monica, Fabiola Zakia/B-4191-2013	Kots, Alexander/0000-0002-5278-5888; Monica, Fabiola Zakia/0000-0002-8449-6677	SAo Paulo Research Foundation (FAPESP) [2013/02246-7]; Coordination for the Improvement of Higher Education Personnel Foundation (CAPES) [BEX 6718-14]; State University of Campinas (UNICAMP); George Washington University	SAo Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel Foundation (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); State University of Campinas (UNICAMP); George Washington University	F.Z.M. acknowledges the SAo Paulo Research Foundation (FAPESP; 2013/02246-7), the Coordination for the Improvement of Higher Education Personnel Foundation (CAPES; BEX 6718-14), the State University of Campinas (UNICAMP), and George Washington University for research support. The authors thank Kleber Fertrin (University of Campinas) for valuable discussion of the experimental methods and results. Author contributions: A. Sotolongo and H. Xiao performed the experiments and analyzed the data; F. Z. Monica analyzed the data and wrote the manuscript; A. Kots analyzed the data; J. Liu perfomed the experiments; E. Seto supported the experiments and corrected the manuscript; K. Bian designed the experiments, analyzed the data and wrote the manuscript; and F. Murad conceived and supported the experiments, contributed reagents, sourced materials, provided analysis tools, and wrote the paper.	Alexandre EC, 2014, J PHARMACOL EXP THER, V349, P2, DOI 10.1124/jpet.113.211029; Ayer DE, 1999, TRENDS CELL BIOL, V9, P193, DOI 10.1016/S0962-8924(99)01536-6; Bian K, 2014, NITRIC OXIDE-BIOL CH, V43, P3, DOI 10.1016/j.niox.2014.08.006; Bian K, 2012, IUBMB LIFE, V64, P676, DOI 10.1002/iub.1057; Bowers EM, 2010, CHEM BIOL, V17, P471, DOI 10.1016/j.chembiol.2010.03.006; Budworth J, 1999, BIOCHEM BIOPH RES CO, V263, P696, DOI 10.1006/bbrc.1999.1444; Calabrese V, 2007, NAT REV NEUROSCI, V8, P766, DOI 10.1038/nrn2214; Campanero MR, 2008, ONCOGENE, V27, P1263, DOI 10.1038/sj.onc.1210735; Chan Y, 2004, J BIOL CHEM, V279, P35087, DOI 10.1074/jbc.M405063200; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Dokmanovic M, 2005, J CELL BIOCHEM, V96, P293, DOI 10.1002/jcb.20532; Elsheikh SE, 2009, CANCER RES, V69, P3802, DOI 10.1158/0008-5472.CAN-08-3907; Fish JE, 2005, J BIOL CHEM, V280, P24824, DOI 10.1074/jbc.M502115200; Gan YH, 2005, J BIOL CHEM, V280, P16467, DOI 10.1074/jbc.M412960200; Glaser KB, 2004, BIOCHEM BIOPH RES CO, V325, P683, DOI 10.1016/j.bbrc.2004.10.082; Glozak MA, 2007, ONCOGENE, V26, P5420, DOI 10.1038/sj.onc.1210610; Gyorffy B, 2010, BREAST CANCER RES TR, V123, P725, DOI 10.1007/s10549-009-0674-9; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Kang JH, 2008, J CELL BIOCHEM, V104, P1192, DOI 10.1002/jcb.21697; KATSUKI S, 1977, J CYCLIC NUCL PROT, V3, P23; Kourea Helen P, 2014, Curr Mol Pharmacol, V7, P4; Leiria LO, 2014, J UROLOGY, V191, P539, DOI 10.1016/j.juro.2013.09.020; Li Y, 2015, ONCOTARGET, V6, P4345, DOI 10.18632/oncotarget.2999; Lin JE, 2010, GASTROENTEROLOGY, V138, P241, DOI 10.1053/j.gastro.2009.08.064; Marro ML, 2008, J BIOL CHEM, V283, P20027, DOI 10.1074/jbc.M801223200; Minucci S, 2006, NAT REV CANCER, V6, P38, DOI 10.1038/nrc1779; Monica F. Z., 2014, OA BIOCH, V2, P3; Mottamal M, 2015, MOLECULES, V20, P3898, DOI 10.3390/molecules20033898; Muller BM, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-215; Mujoo K, 2010, NITRIC OXIDE-BIOL CH, V22, P43, DOI 10.1016/j.niox.2009.11.007; MURAD F, 1988, COLD SPRING HARB SYM, V53, P1005, DOI 10.1101/SQB.1988.053.01.115; Nakane M, 1994, Adv Pharmacol, V26, P7, DOI 10.1016/S1054-3589(08)60048-4; Nielsen TO, 2015, CLIN CANCER RES, V21, P1779, DOI 10.1158/1078-0432.CCR-14-2552; Oshiro MM, 2005, BREAST CANCER RES, V7, pR669, DOI 10.1186/bcr1273; Peng Lirong, 2011, Handb Exp Pharmacol, V206, P39, DOI 10.1007/978-3-642-21631-2_3; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Rakha EA, 2006, J PATHOL, V208, P495, DOI 10.1002/path.1916; RIBEIRO MO, 1992, HYPERTENSION, V20, P298, DOI 10.1161/01.HYP.20.3.298; Romanov SR, 2001, NATURE, V409, P633, DOI 10.1038/35054579; Sengupta N, 2004, J CELL BIOCHEM, V93, P57, DOI 10.1002/jcb.20179; Shailubhai K, 2000, CANCER RES, V60, P5151; Sharina IG, 2003, P NATL ACAD SCI USA, V100, P11523, DOI 10.1073/pnas.1934338100; Sharma D, 2006, CANCER RES, V66, P6370, DOI 10.1158/0008-5472.CAN-06-0402; Silva FH, 2014, J SEX MED, V11, P2661, DOI 10.1111/jsm.12682; Suzuki J, 2009, CLIN CANCER RES, V15, P3163, DOI 10.1158/1078-0432.CCR-08-2319; Weissmann N, 2014, AM J RESP CRIT CARE, V189, P1359, DOI 10.1164/rccm.201311-2037OC; Wen HC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125518; Wilson C, 2014, CANCER EPIDEM BIOMAR, V23, P2328, DOI 10.1158/1055-9965.EPI-14-0440; Yang WM, 2002, J BIOL CHEM, V277, P9447, DOI 10.1074/jbc.M105993200; Yang XJ, 2008, NAT REV MOL CELL BIO, V9, P206, DOI 10.1038/nrm2346; Yao RS, 2014, CANCER RES, V74, P5656, DOI 10.1158/0008-5472.CAN-14-0800; Zeng LF, 2006, J CELL BIOL, V174, P1059, DOI 10.1083/jcb.200605113; Zhang XH, 2004, MOL CELL BIOL, V24, P5106, DOI 10.1128/MCB.24.12.5106-5118.2004; Zhu HF, 2011, MOL PHARMACOL, V80, P1076, DOI 10.1124/mol.111.073585; Zuzga DS, 2012, INT J CANCER, V130, P2539, DOI 10.1002/ijc.26257	55	7	7	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3171	3180		10.1096/fj.201600339R	http://dx.doi.org/10.1096/fj.201600339R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27279362				2022-12-28	WOS:000382816300017
J	Stanger, SJ; Law, EA; Jamsai, D; O'Bryan, MK; Nixon, B; McLaughlin, EA; Aitken, RJ; Roman, SD				Stanger, Simone J.; Law, Estelle A.; Jamsai, Duangporn; O'Bryan, Moira K.; Nixon, Brett; McLaughlin, Eileen A.; Aitken, R. John; Roman, Shaun D.			A novel germ cell protein, SPIF (sperm PKA interacting factor), is essential for the formation of a PKA/TCP11 complex that undergoes conformational and phosphorylation changes upon capacitation	FASEB JOURNAL			English	Article						protein kinase A; tyrosine kinase; protein complex; sperm capacitation	MOUSE T-COMPLEX; SOLUBLE ADENYLYL-CYCLASE; FERTILIZATION PROMOTING PEPTIDE; TRANSMISSION RATIO DISTORTION; TYROSINE PHOSPHORYLATION; KINASE-A; CATALYTIC SUBUNIT; ACROSOME REACTION; MOLECULAR CHAPERONE; ESCHERICHIA-COLI	Spermatozoa require the process of capacitation to enable them to fertilize an egg. PKA is crucial to capacitation and the development of hyperactivated motility. Sperm PKA is activated by cAMP generated by the germ cell-enriched adenylyl cyclase encoded by Adcy10. Male mice lacking Adcy10 are sterile, because their spermatozoa are immotile. The current study was designed to identify binding partners of the sperm-specific (C alpha 2) catalytic subunit of PKA (PRKACA) by using it as the "bait" in a yeast 2-hybrid system. This approach was used to identify a novel germ cell-enriched protein, sperm PKA interacting factor (SPIF), in 25% of the positive clones. Homozygous Spif-null mice were embryonically lethal. SPIF was coexpressed and coregulated with PRKACA and with t-complex protein (TCP)-11, a protein associated with PKA signaling. We established that these 3 proteins form part of a novel complex in mouse spermatozoa. Upon capacitation, the SPIF protein becomes tyrosine phosphorylated in>95% of sperm. An apparent molecular rearrangement in the complex occurs, bringing PRKACA and TCP11 into proximity. Taken together, these results suggest a role for the novel complex of SPIF, PRKACA, and TCP11 during sperm capacitation, fertilization, and embryogenesis.	[Stanger, Simone J.; Nixon, Brett; McLaughlin, Eileen A.; Roman, Shaun D.] Univ Newcastle, Ctr Chem Biol, Callaghan, NSW, Australia; [Stanger, Simone J.; Nixon, Brett; McLaughlin, Eileen A.; Aitken, R. John; Roman, Shaun D.] Univ Newcastle, Prior Res Ctr Reprod Sci, Callaghan, NSW, Australia; [Stanger, Simone J.; Law, Estelle A.; Nixon, Brett; McLaughlin, Eileen A.; Roman, Shaun D.] Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia; [Stanger, Simone J.; Jamsai, Duangporn; O'Bryan, Moira K.; Nixon, Brett; McLaughlin, Eileen A.; Aitken, R. John; Roman, Shaun D.] Univ Newcastle, Australian Res Council, Ctr Excellence Biotechnol & Dev, Callaghan, NSW, Australia; [Jamsai, Duangporn; O'Bryan, Moira K.] Monash Univ, Dept Anat & Dev Biol, Melbourne, Vic, Australia	University of Newcastle; University of Newcastle; University of Newcastle; University of Newcastle; Monash University	Aitken, RJ; Roman, SD (corresponding author), Univ Newcastle, Sch Environm & Life Sci, Callaghan, NSW 2308, Australia.	john.aitken@newcastle.edu.au; shaun.roman@newcastle.edu.au	O'Bryan, Moira K/F-8256-2012; McLaughlin, Eileen A/G-7620-2013; McLaughlin, Eileen/AAF-5588-2021; Aitken, Robert John/AAY-8238-2020; Roman, Shaun/AFR-5087-2022; ROMAN, SHAUN/G-7047-2013; Nixon, Brett/B-5121-2012	O'Bryan, Moira K/0000-0001-7298-4940; Aitken, Robert John/0000-0002-9152-156X; McLaughlin, Eileen/0000-0002-5837-3876; ROMAN, SHAUN/0000-0002-7758-7757; Nixon, Brett/0000-0003-2745-8188	Australian Research Council Centre of Excellence in Biotechnology and Development	Australian Research Council Centre of Excellence in Biotechnology and Development(Australian Research Council)	The authors thank Amanda Anderson (Priority Research Centre for Reproductive Science and School of Environmental and Life Sciences, University of Newcastle) for providing samples for the PLAs. The study was supported by the Australian Research Council Centre of Excellence in Biotechnology and Development. The authors declare no conflicts of interest.	Aitken RJ, 1998, J CELL SCI, V111, P645; Andrade MA, 2001, J STRUCT BIOL, V134, P117, DOI 10.1006/jsbi.2001.4392; Asquith KL, 2004, J CELL SCI, V117, P3645, DOI 10.1242/jcs.01214; AUSTIN CR, 1952, NATURE, V170, P326, DOI 10.1038/170326a0; Baker MA, 2006, J CELL SCI, V119, P3182, DOI 10.1242/jcs.03055; Baker MA, 2009, DEV BIOL, V333, P57, DOI 10.1016/j.ydbio.2009.06.022; Baleato RM, 2005, DEV BIOL, V286, P78, DOI 10.1016/j.ydbio.2005.07.009; Battistone MA, 2014, MOL HUM REPROD, V20, P1054, DOI 10.1093/molehr/gau073; BIGGERS J. D., 1971, Methods in mammalian embryology, P86; Breitbart H, 2003, CELL MOL BIOL, V49, P321; BROWN J, 1989, DEVELOPMENT, V106, P769; Buck J, 1999, P NATL ACAD SCI USA, V96, P79, DOI 10.1073/pnas.96.1.79; Burton KA, 1999, J BIOL CHEM, V274, P24131, DOI 10.1074/jbc.274.34.24131; Burton KA, 2007, PHYSIOLOGY, V22, P40, DOI 10.1152/physiol.00034.2006; Ecroyd HW, 2003, BIOL REPROD, V69, P347, DOI 10.1095/biolreprod.102.012716; Esposito G, 2004, P NATL ACAD SCI USA, V101, P2993, DOI 10.1073/pnas.0400050101; Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T; Fraser LR, 1997, MOL REPROD DEV, V48, P375, DOI 10.1002/(SICI)1098-2795(199711)48:3&lt;375::AID-MRD11&gt;3.0.CO;2-V; Fraser LR, 1998, ANDROLOGIA, V30, P241; GUAN KL, 1991, ANAL BIOCHEM, V192, P262, DOI 10.1016/0003-2697(91)90534-Z; Herrmann BG, 1999, NATURE, V402, P141, DOI 10.1038/45970; Hess KC, 2005, DEV CELL, V9, P249, DOI 10.1016/j.devcel.2005.06.007; HOSSEINI R, 1994, MECH DEVELOP, V47, P73, DOI 10.1016/0925-4773(94)90097-3; Jamsai D, 2006, GENOMICS, V88, P309, DOI 10.1016/j.ygeno.2006.03.009; Kirschner LS, 2009, ENDOCR-RELAT CANCER, V16, P773, DOI 10.1677/ERC-09-0068; Krapf D, 2010, J BIOL CHEM, V285, P7977, DOI 10.1074/jbc.M109.085845; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Lefievre L, 2002, J ANDROL, V23, P709; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Liu YY, 2011, TOHOKU J EXP MED, V224, P111, DOI 10.1620/tjem.224.111; Luconi M, 2005, BIOL REPROD, V72, P22, DOI 10.1095/biolreprod.104.032490; Luconi M, 2004, J CELL SCI, V117, P1235, DOI 10.1242/jcs.00931; LYON MF, 1986, CELL, V44, P357, DOI 10.1016/0092-8674(86)90770-1; Lyon MF, 2003, ANNU REV GENET, V37, P393, DOI 10.1146/annurev.genet.37.110801.143030; Ma YX, 2002, MOL HUM REPROD, V8, P24, DOI 10.1093/molehr/8.1.24; Mahadevaiah SK, 2001, NAT GENET, V27, P271, DOI 10.1038/85830; MAZARAKIS ND, 1991, DEVELOPMENT, V111, P561; MORTIMER D, 1987, J REPROD FERTIL, V81, P127; Nixon B, 2006, BIOL REPROD, V74, P275, DOI 10.1095/biolreprod.105.044644; Nolan MA, 2004, P NATL ACAD SCI USA, V101, P13483, DOI 10.1073/pnas.0405580101; OYEN O, 1990, BIOL REPROD, V43, P46, DOI 10.1095/biolreprod43.1.46; Redgrove KA, 2013, MOL HUM REPROD, V19, P120, DOI 10.1093/molehr/gas064; Reinton N, 2000, BIOL REPROD, V63, P607, DOI 10.1095/biolreprod63.2.607; San Agustin JT, 1998, J BIOL CHEM, V273, P24874, DOI 10.1074/jbc.273.38.24874; San Agustin JT, 2001, BIOL REPROD, V65, P151, DOI 10.1095/biolreprod65.1.151; San Agustin JT, 2000, MOL BIOL CELL, V11, P3031, DOI 10.1091/mbc.11.9.3031; SANAGUSTIN JT, 1994, CELL MOTIL CYTOSKEL, V27, P206, DOI 10.1002/cm.970270303; Sinclair ML, 2000, MOL REPROD DEV, V56, P6, DOI 10.1002/(SICI)1098-2795(200005)56:1&lt;6::AID-MRD2&gt;3.0.CO;2-M; Skalhegg BS, 2002, MOL ENDOCRINOL, V16, P630, DOI 10.1210/me.16.3.630; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; UHLER MD, 1986, J BIOL CHEM, V261, P5360; VISCONTI PE, 1995, DEVELOPMENT, V121, P1139; Walsh A, 2008, BIOL REPROD, V78, P983, DOI 10.1095/biolreprod.107.066860; Zimmermann B, 1999, J BIOL CHEM, V274, P5370, DOI 10.1074/jbc.274.9.5370	54	7	8	1	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2777	2791		10.1096/fj.201500136R	http://dx.doi.org/10.1096/fj.201500136R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27105888				2022-12-28	WOS:000380994000014
J	Walker, ME; Souza, PR; Colas, RA; Dalli, J				Walker, Mary E.; Souza, Patricia R.; Colas, Romain A.; Dalli, Jesmond			13-Series resolvins mediate the leukocyte-platelet actions of atorvastatin and pravastatin in inflammatory arthritis	FASEB JOURNAL			English	Article						pharmacology; resolution; eicosanoids; omega-3; vascular inflammation	RHEUMATOID-ARTHRITIS; DISEASE-ACTIVITY; LIPID MEDIATORS; NEUTROPHIL APOPTOSIS; RESOLUTION; SIMVASTATIN; LOVASTATIN; REDUCE; ALPHA; RISK	Rheumatoid arthritis is an inflammatory condition characterized by overzealous inflammation that leads to joint damage and is associated with an increased incidence of cardiovascular disease. Statins are frontline therapeutics for patients with cardiovascular disease and exert beneficial actions in rheumatoid arthritis. The mechanism that mediates the beneficial actions of statins in rheumatoid arthritis remains of interest. In the present study, we found that the administration of 2 clinically relevant statins-atorvastatin (0.2 mg/kg) or pravastatin (0.2 mg/kg)-to mice during inflammatory arthritis up-regulated systemic and tissue amounts of a novel family of proresolving mediators, termed 13-series resolvins (RvTs), and significantly reduced joint disease. Of note, administration of simvastatin (0.2 mg/kg) did not significantly up-regulate RvTs or reduce joint inflammation. We also found that atorvastatin and pravastatin each reduced systemic leukocyte activation, including platelet-monocyte aggregates (similar to 25-60%). These statins decreased neutrophil trafficking to the joint as well as joint monocyte and macrophage numbers. Atorvastatin and pravastatin produced significant reductions (similar to 30-50%) in expression of CD11b and major histocompatibility complex class II on both monocytes and monocyte-derived macrophages in joints. Administration of an inhibitor to cyclooxygenase-2, the initiating enzyme in the RvT pathway, reversed the protective actions of these statins on both joint and systemic inflammation. Together, these findings provide evidence for the role of RvTs in mediating the protective actions of atorvastatin and pravastatin in reducing local and vascular inflammation, and suggest that RvTs may be useful in measuring the anti-inflammatory actions of statins.	[Walker, Mary E.; Souza, Patricia R.; Colas, Romain A.; Dalli, Jesmond] Queen Mary Univ London, Barts & London Sch Med, William Harvey Res Inst, Lipid Mediator Unit,Ctr Biochem Pharmacol, London, England	University of London; Queen Mary University London	Dalli, J (corresponding author), John Vane Sci Ctr, William Harvey Res Inst, Charterhouse Sq, London EC1M 6BQ, England.	j.dalli@qmul.ac.uk	Souza, Patricia/GLQ-8979-2022	Souza, Patricia/0000-0003-3826-6261; Dalli, Jesmond/0000-0001-6328-3640	European Research Council under European Union [677542]; Sir Henry Dale Fellowship - Wellcome Trust; Royal Society [107613/Z/15/Z]; Barts Charity Grant [MGU0343]; Medical Research Council Advance Course Masters Grant [MR/J015741/1]	European Research Council under European Union(European Research Council (ERC)); Sir Henry Dale Fellowship - Wellcome Trust(Wellcome Trust); Royal Society(Royal Society of London); Barts Charity Grant; Medical Research Council Advance Course Masters Grant	This work was supported by funding from the European Research Council under the European Union's Horizon 2020 research and innovation program (Grant 677542), a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant 107613/Z/15/Z), and the Barts Charity (Grant MGU0343). This work was also funded, in part, by Medical Research Council Advance Course Masters (Grant MR/J015741/1). The authors declare no conflicts of interest.	Akiyama M, 2015, CLIN RHEUMATOL, V34, P1867, DOI 10.1007/s10067-015-3049-0; Barra LJ, 2017, RHEUMATOLOGY, V56, P768, DOI 10.1093/rheumatology/kew474; Birnbaum Y, 2006, CIRCULATION, V114, P929, DOI 10.1161/CIRCULATIONAHA.106.629907; Cojocaru L, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/326258; Colas RA, 2014, AM J PHYSIOL-CELL PH, V307, pC39, DOI 10.1152/ajpcell.00024.2014; Dalli J, 2015, NAT MED, V21, P1071, DOI 10.1038/nm.3911; Danninger K, 2014, INT J RHEUM DIS, V17, P606, DOI 10.1111/1756-185X.12415; El Kebir D, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00060; El Kebir D, 2012, P NATL ACAD SCI USA, V109, P14983, DOI 10.1073/pnas.1206641109; Filer A, 2006, CURR OPIN PHARMACOL, V6, P393, DOI 10.1016/j.coph.2006.03.007; Fredman G, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12859; Fullerton JN, 2016, NAT REV DRUG DISCOV, V15, P551, DOI 10.1038/nrd.2016.39; Funk JL, 2008, J RHEUMATOL, V35, P1083; Giles JT, 2015, BEST PRACT RES CL RH, V29, P597, DOI 10.1016/j.berh.2015.09.003; Gittens BR, 2015, METHODS MOL BIOL, V1207, P133, DOI 10.1007/978-1-4939-1396-1_9; Haka AS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044823; Haworth O, 2015, SEMIN IMMUNOL, V27, P194, DOI 10.1016/j.smim.2015.04.002; Ji H, 1999, IMMUNOL REV, V169, P139, DOI 10.1111/j.1600-065X.1999.tb01312.x; Kling D, 2013, THROMB RES, V131, P401, DOI 10.1016/j.thromres.2013.02.020; Lea AP, 1997, DRUGS, V53, P828, DOI 10.2165/00003495-199753050-00011; Maki-Petaja KM, 2007, J AM COLL CARDIOL, V50, P852, DOI 10.1016/j.jacc.2007.04.076; Misharin AV, 2014, CELL REP, V9, P591, DOI 10.1016/j.celrep.2014.09.032; Mowla K, 2016, J CLIN DIAGN RES, V10, pOC32, DOI 10.7860/JCDR/2016/16538.7814; Neuvonen PJ, 2008, CLIN PHARMACOKINET, V47, P463, DOI 10.2165/00003088-200847070-00003; Norling LV, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.85922; Perretti M, 2017, NAT REV RHEUMATOL, V13, P87, DOI 10.1038/nrrheum.2016.193; Pfluecke C, 2016, CLIN RES CARDIOL, V105, P314, DOI 10.1007/s00392-015-0922-4; Planaguma A, 2010, MUCOSAL IMMUNOL, V3, P270, DOI 10.1038/mi.2009.141; Primdahl KG, 2016, J NAT PROD, V79, P2693, DOI 10.1021/acs.jnatprod.6b00634; Rathod KS, 2017, J CLIN INVEST, V127, P169, DOI 10.1172/JCI89429; Sarabi Zhaleh Shariati, 2016, Electron Physician, V8, P2700; Serhan CN, 2017, FASEB J, V31, P1273, DOI [10.1096/fj.201601222R, 10.1096/fj.201601222r]; Shinohara M, 2014, AM J PHYSIOL-LUNG C, V307, pL746, DOI 10.1152/ajplung.00166.2014; Shirinsky IV, 2009, SCAND J RHEUMATOL, V38, P23, DOI 10.1080/03009740802363776; Spite M, 2010, CIRC RES, V107, P1170, DOI 10.1161/CIRCRESAHA.110.223883; Taylor FC, 2013, JAMA-J AM MED ASSOC, V310, P2451, DOI 10.1001/jama.2013.281348; Thieblemont N, 2016, SEMIN IMMUNOL, V28, P159, DOI 10.1016/j.smim.2016.03.004; Viola JR, 2016, CIRC RES, V119, P1030, DOI 10.1161/CIRCRESAHA.116.309492; Wang YM, 2005, CIRCULATION, V112, P2993, DOI 10.1161/CIRCULATIONAHA.105.571315; WEYRICH AS, 1995, J CLIN INVEST, V95, P2297, DOI 10.1172/JCI117921	40	21	23	1	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3636	3648		10.1096/fj.201700268	http://dx.doi.org/10.1096/fj.201700268			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28465323	hybrid, Green Published			2022-12-28	WOS:000405932400035
J	Isoe, J; Petchampai, N; Isoe, YE; Co, K; Mazzalupo, S; Scaraffia, PY				Isoe, Jun; Petchampai, Natthida; Isoe, Yurika E.; Co, Katrina; Mazzalupo, Stacy; Scaraffia, Patricia Y.			Xanthine dehydrogenase-1 silencing in Aedes aegypti mosquitoes promotes a blood feeding-induced adulticidal activity	FASEB JOURNAL			English	Article						ammonia; antioxidant genes; gene silencing; metabolic target	DROSOPHILA-MELANOGASTER; PROTEIN CATABOLISM; AMMONIA METABOLISM; MEAL PROTEIN; STRESS; DENGUE; URATE; ACTIVATION; RECEPTORS; TOXICITY	Aedes aegypti has 2 genes encoding xanthine dehydrogenase (XDH). We analyzed XDH1 and XDH2 gene expression by real-time quantitative PCR in tissues from sugar-and blood-fed females. Differential XDH1 and XDH2 gene expression was observed in tissues dissected throughout a time course. We next exposed females to blood meals supplemented with allopurinol, a well-characterized XDH inhibitor. We also tested the effects of injecting double-stranded RNA(dsRNA) against XDH1, XDH2, or both. Disruption of XDH by allopurinol or XDH1 by RNA interference significantly affected mosquito survival, causing a disruption in blood digestion, excretion, oviposition, and reproduction. XDH1-deficient mosquitoes showed a persistence of serine proteases in the midgut at 48 h after blood feeding and a reduction in the uptake of vitellogenin by the ovaries. Surprisingly, analysis of the fat body from dsRNA-XDH1-injected mosquitoes fell into 2 groups: one group was characterized by a reduction of the XDH1 transcript, whereas the other group was characterized by an up-regulation of several transcripts, including XDH1, glutamine synthetase, alanine aminotransferase, catalase, superoxide dismutase, ornithine decarboxylase, glutamate receptor, and ammonia transporter. Our data demonstrate that XDH1 plays an essential role and that XDH1 has the potential to be used as a metabolic target for Ae. aegypti vector control.	[Isoe, Jun; Isoe, Yurika E.] Univ Arizona, Dept Chem & Biochem, Tucson, AZ USA; [Petchampai, Natthida; Co, Katrina; Scaraffia, Patricia Y.] Tulane Univ, Sch Publ Hlth & Trop Med, Vector Borne Infect Dis Res Ctr, Dept Trop Med, New Orleans, LA USA; [Mazzalupo, Stacy] Univ Arizona, Dept Cellular & Mol Med, Tucson, AZ USA; [Co, Katrina] Indiana Univ, Ryan White Ctr Infect Dis & Global Hlth, Indianapolis, IN 46204 USA; [Mazzalupo, Stacy] Roche Tissue Diagnost, Tucson, AZ USA	University of Arizona; Tulane University; University of Arizona; Indiana University System; Indiana University-Purdue University Indianapolis	Scaraffia, PY (corresponding author), Vector Borne Infect Dis Res Ctr, Dept Trop Med, 1430 Tulane Ave,SL-17,J Bennett Johnston Bldg, New Orleans, LA 70112 USA.	pscaraff@tulane.edu			Corine Adams Baines Professorship Award; U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases [R01AI088092]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI088092] Funding Source: NIH RePORTER	Corine Adams Baines Professorship Award; U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The authors thank the Louisiana Clinical and Translational Science Center (Baton Rouge, LA, USA) for statistical advice. This work was financially supported by Corine Adams Baines Professorship Award, and by the U.S. National Institutes of Health, National Institute of Allergy and Infectious Diseases (Grant R01AI088092 to P.Y.S.).	Attar N., 2016, NAT REV MICROBIOL, V14, P62, DOI DOI 10.1038/NRMICR0.2015.28; Barros MP, 2000, PHOTOCHEM PHOTOBIOL, V71, P648, DOI 10.1562/0031-8655(2000)071&lt;0648:LAUMAA&gt;2.0.CO;2; Belloni V, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-373; Benedict MQ, 1996, ANN ENTOMOL SOC AM, V89, P261, DOI 10.1093/aesa/89.2.261; BRIEGEL H, 1985, J INSECT PHYSIOL, V31, P15, DOI 10.1016/0022-1910(85)90036-8; Buttner S, 2014, CELL CYCLE, V13, P3903, DOI 10.4161/15384101.2014.973309; Campbell LP, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0135; Choumet V, 2015, REV SCI TECH OIE, V34, P473; Fauci AS, 2016, NEW ENGL J MED, V374, P601, DOI 10.1056/NEJMp1600297; Fredericks AC, 2014, ANN GLOB HEALTH, V80, P466, DOI 10.1016/j.aogh.2015.02.006; Graca-Souza AV, 2006, INSECT BIOCHEM MOLEC, V36, P322, DOI 10.1016/j.ibmb.2006.01.009; Ha HC, 1998, P NATL ACAD SCI USA, V95, P11140, DOI 10.1073/pnas.95.19.11140; Hermenegildo C, 2000, HEPATOLOGY, V31, P709, DOI 10.1002/hep.510310322; HILLIKER AJ, 1992, P NATL ACAD SCI USA, V89, P4343, DOI 10.1073/pnas.89.10.4343; Hrnjakovic Cvjetkovic Ivana B, 2015, Med Pregl, V68, P122; Ip YK, 2010, FRONT PHYSIOL, V1, DOI 10.3389/fphys.2010.00134; Isoe J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065393; Kogan PH, 2000, J INSECT PHYSIOL, V46, P1079, DOI 10.1016/S0022-1910(99)00084-0; Krebs HA, 1932, H-S Z PHYSIOL CHEM, V210, P33, DOI 10.1515/bchm2.1932.210.1-2.33; Kularatne SAM, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4661; Liyou N, 2000, EXP APPL ACAROL, V24, P235, DOI 10.1023/A:1006452325210; Mazzalupo S, 2016, FASEB J, V30, P111, DOI 10.1096/fj.15-277087; Minois N, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.139; Molina-Cruz A, 2008, J BIOL CHEM, V283, P3217, DOI 10.1074/jbc.M705873200; Monfort P, 2000, NEUROCHEM INT, V37, P249, DOI 10.1016/S0197-0186(00)00027-9; Murthy CRK, 2001, J NEUROSCI RES, V66, P282, DOI 10.1002/jnr.1222; Nogueira NP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116712; Norwood PF, 2015, REV SCI TECH OIE, V34, P479, DOI 10.20506/rst.34.2.2373; Peng DD, 2016, PROTOPLASMA, V253, P1243, DOI 10.1007/s00709-015-0880-8; Petchampai N, 2016, ADV INSECT PHYSIOL, V51, P363, DOI 10.1016/bs.aiip.2016.04.002; Peterson TML, 2007, FREE RADICAL BIO MED, V42, P132, DOI 10.1016/j.freeradbiomed.2006.10.037; Pybus OG, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2014.2878; Sanders HR, 2003, INSECT BIOCHEM MOLEC, V33, P1105, DOI 10.1016/S0965-1748(03)00124-3; Sant'Anna MRV, 2008, INSECT BIOCHEM MOLEC, V38, P652, DOI 10.1016/j.ibmb.2008.03.012; Scaraffia PY, 2008, P NATL ACAD SCI USA, V105, P518, DOI 10.1073/pnas.0708098105; Scaraffia PY, 2006, INSECT BIOCHEM MOLEC, V36, P614, DOI 10.1016/j.ibmb.2006.05.003; Scaraffia PY, 2016, GENETIC CONTROL OF MALARIA AND DENGUE, P253; Scaraffia PY, 2010, J INSECT PHYSIOL, V56, P1040, DOI 10.1016/j.jinsphys.2010.02.016; Scaraffia PY, 2005, INSECT BIOCHEM MOLEC, V35, P491, DOI 10.1016/j.ibmb.2005.01.012; Scaraffia PY, 2003, J INSECT PHYSIOL, V49, P591, DOI 10.1016/S0022-1910(03)00031-3; Souza AVG, 1997, FREE RADICAL BIO MED, V22, P209, DOI 10.1016/S0891-5849(96)00293-6; von Dungern P, 2001, J INSECT PHYSIOL, V47, P73, DOI 10.1016/S0022-1910(00)00095-0; von Dungern P, 2001, J INSECT PHYSIOL, V47, P131, DOI 10.1016/S0022-1910(00)00096-2; Zhou GL, 2004, J INSECT PHYSIOL, V50, P337, DOI 10.1016/j.jinsphys.2004.02.003	44	10	10	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2276	2286		10.1096/fj.201601185R	http://dx.doi.org/10.1096/fj.201601185R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28179423	Green Published			2022-12-28	WOS:000401553400006
J	Aluksanasuwan, S; Sueksakit, K; Fong-Ngern, K; Thongboonkerd, V				Aluksanasuwan, Siripat; Sueksakit, Kanyarat; Fong-ngern, Kedsarin; Thongboonkerd, Visith			Role of HSP60 (HSPD1) in diabetes-induced renal tubular dysfunction: regulation of intracellular protein aggregation, ATP production, and oxidative stress	FASEB JOURNAL			English	Article						chaperone; chaperonin; diabetic nephropathy; diabetic tubulopathy; high glucose	MONOHYDRATE CRYSTAL ADHESION; HIGH GLUCOSE-CONCENTRATIONS; PROTEOMIC-ANALYSIS; MESANGIAL CELLS; MOLECULAR CHAPERONES; MITOCHONDRIAL HSP60; CARDIAC MYOCYTES; ALTERED PROTEINS; MAMMALIAN-CELLS; PROXIMAL TUBULE	Because underlying mechanisms of diabetic nephropathy/tubulopathy remained poorly understood, we aimed to define a key protein involving in hyperglycemia-induced renal tubular dysfunction. All altered renal proteins identified from previous large-scale proteome studies were subjected to global protein network analysis, which revealed heat shock protein 60 (HSP60, also known as HSPD1) as the central node of protein-protein interactions. Functional validation was performed using small interfering RNA (siRNA) to knock down HSP60 (siHSP60). At 48 h after exposure to high-glucose (HG) (25 mM), Madin-Darby canine kidney (MDCK) renal tubular cells transfected with controlled siRNA (siControl) had significantly increased level of HSP60 compared to normal-glucose (NG) (5.5 mM), whereas siHSP60-transfected cells showed a dramatically decreased HSP60 level. siHSP60 modestly increased intracellular protein aggregates in both NG and HG conditions. Luciferin-luciferase assay showed that HG modestly increased intracellular ATP, and siHSP60 further enhanced such an increase. OxyBlot assay showed significantly increased level of oxidized proteins in HG-treated siControl-transfected cells, whereas siHSP60 caused marked increase of oxidized proteins under the NG condition. However, the siHSP60-induced accumulation of oxidized proteins was abolished by HG. In summary, our data demonstrated that HSP60 plays roles in regulation of intracellular protein aggregation, ATP production, and oxidative stress in renal tubular cells. Its involvement in HG-induced tubular cell dysfunction was most likely via regulation of intracellular ATP production.-Aluksanasuwan, S., Sueksakit, K., Fong-ngern, K., Thongboonkerd, V. Role of HSP60 (HSPD1) in diabetes-induced renal tubular dysfunction: regulation of intracellular protein aggregation, ATP production, and oxidative stress	Mahidol Univ, Fac Med, Siriraj Hosp, Med Prote Unit,Off Res & Dev, Bangkok, Thailand; Mahidol Univ, Ctr Res Complex Syst Sci, Bangkok, Thailand	Mahidol University; Mahidol University	Thongboonkerd, V (corresponding author), Mahidol Univ, Med Prote Unit, Off Res & Dev, Siriraj Hosp, 6th Floor,SiMR Bldg,2 Wanglang Rd, Bangkok 10700, Thailand.	thongboonkerd@dr.com	Thongboonkerd, Visith/C-6920-2009; Aluksanasuwan, Siripat/AAS-5223-2021	Thongboonkerd, Visith/0000-0001-7865-0765; Aluksanasuwan, Siripat/0000-0002-3542-5880	Mahidol University; Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; Thailand Research Fund [RTA5680004, IRG5980006]; Siriraj Hospital Faculty of Medicine; Royal Golden Jubilee Ph.D. Program of the Thailand Research Fund [PHD/0084/2553]	Mahidol University; Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative; Thailand Research Fund(Thailand Research Fund (TRF)); Siriraj Hospital Faculty of Medicine; Royal Golden Jubilee Ph.D. Program of the Thailand Research Fund(Thailand Research Fund (TRF))	This study was supported by a Mahidol University research grant, the Office of the Higher Education Commission and Mahidol University under the National Research Universities Initiative, and by the Thailand Research Fund (RTA5680004 and IRG5980006). V.T. was also supported by Chalermphrakiat and Research Staff grants from the Siriraj Hospital Faculty of Medicine. S.A. was supported by the Royal Golden Jubilee Ph.D. Program of the Thailand Research Fund (PHD/0084/2553).	Allen DA, 2003, FASEB J, V17, P908, DOI 10.1096/fj.02-0130fje; Barati MT, 2007, AM J PHYSIOL-RENAL, V293, pF1157, DOI 10.1152/ajprenal.00411.2006; Barutta F, 2008, AM J PHYSIOL-RENAL, V295, pF1817, DOI 10.1152/ajprenal.90234.2008; Calabrese V, 2010, ANTIOXID REDOX SIGN, V13, P1763, DOI 10.1089/ars.2009.3074; Chandra D, 2007, J BIOL CHEM, V282, P31289, DOI 10.1074/jbc.M702777200; Chutipongtanate S, 2012, J PROTEOME RES, V11, P3650, DOI 10.1021/pr3000738; Cornelius C, 2013, IMMUN AGEING, V10, DOI 10.1186/1742-4933-10-15; Cummins TD, 2010, BBA-PROTEINS PROTEOM, V1804, P653, DOI 10.1016/j.bbapap.2009.09.029; Fan QL, 2011, AM J NEPHROL, V34, P18, DOI 10.1159/000328733; Feng HP, 2002, BLOOD, V100, P4108, DOI 10.1182/blood-2002-05-1389; Forbes JM, 2008, DIABETES, V57, P1446, DOI 10.2337/db08-0057; Fugmann T, 2011, KIDNEY INT, V80, P272, DOI 10.1038/ki.2011.116; Ghosh JC, 2010, CANCER RES, V70, P8988, DOI 10.1158/0008-5472.CAN-10-2225; Gilbert RE, 1999, KIDNEY INT, V56, P1627, DOI 10.1046/j.1523-1755.1999.00721.x; Gong DM, 2009, PROTEOMICS, V9, P4309, DOI 10.1002/pmic.200900285; Gonzalez-Ramos M, 2016, INT J BIOCHEM CELL B, V71, P119, DOI 10.1016/j.biocel.2015.12.013; Gonzalez-Ramos M, 2013, INT J BIOCHEM CELL B, V45, P232, DOI 10.1016/j.biocel.2012.10.001; Gupta S, 2007, AM J PHYSIOL-HEART C, V292, pH3052, DOI 10.1152/ajpheart.01355.2006; Han HJ, 2000, KIDNEY INT, V57, P918, DOI 10.1038/sj.ki.4491414; HUCKRIEDE A, 1995, VIRCHOWS ARCH, V427, P159; Kanlaya R, 2013, J PROTEOMICS, V80, P55, DOI 10.1016/j.jprot.2013.01.001; Karaagac N, 2011, ENDOCR RES, V36, P124, DOI 10.3109/07435800.2011.566237; Kenyon WJ, 2002, MICROBIOL-SGM, V148, P113, DOI 10.1099/00221287-148-1-113; Kirchhoff SR, 2002, CIRCULATION, V105, P2899, DOI 10.1161/01.CIR.0000019403.35847.23; Li BY, 2008, J CELL BIOCHEM, V104, P668, DOI 10.1002/jcb.21658; Li H, 2011, CELL SIGNAL, V23, P1625, DOI 10.1016/j.cellsig.2011.05.016; Li JH, 2004, AM J PATHOL, V164, P1389, DOI 10.1016/S0002-9440(10)63225-7; Li ZG, 2010, BIOCHEM CELL BIOL, V88, P635, DOI 10.1139/O09-185; Lin KM, 2001, CIRCULATION, V103, P1787, DOI 10.1161/01.CIR.103.13.1787; Lv ZM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022806; Macario AJL, 2007, FRONT BIOSCI-LANDMRK, V12, P2588, DOI 10.2741/2257; Magnoni R, 2014, FREE RADICAL RES, V48, P168, DOI 10.3109/10715762.2013.858147; Magnoni R, 2013, NEUROBIOL DIS, V54, P12, DOI 10.1016/j.nbd.2013.02.012; Oksala NKJ, 2007, ANTIOXID REDOX SIGN, V9, P497, DOI 10.1089/ars.2006.1450; Peerapen P, 2016, BBA-PROTEINS PROTEOM, V1864, P683, DOI 10.1016/j.bbapap.2016.03.007; Phillips AO, 1997, KIDNEY INT, V52, P973, DOI 10.1038/ki.1997.419; Quintana FJ, 2011, TRENDS IMMUNOL, V32, P89, DOI 10.1016/j.it.2010.11.001; Rane MJ, 2010, AM J PHYSIOL-RENAL, V298, pF49, DOI 10.1152/ajprenal.00032.2009; Saibil H, 2013, NAT REV MOL CELL BIO, V14, P630, DOI 10.1038/nrm3658; Schordan S, 2009, PROTEOMICS, V9, P4519, DOI 10.1002/pmic.200800214; Semangoen T, 2008, PROTEOM CLIN APPL, V2, P1099, DOI 10.1002/prca.200780136; Semangoen T, 2008, J PROTEOME RES, V7, P2889, DOI 10.1021/pr800113k; Shan YX, 2003, J MOL CELL CARDIOL, V35, P1135, DOI 10.1016/S0022-2828(03)00229-3; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Singh LP, 2007, INT J BIOL SCI, V3, P27; So EJ, 2008, PROTEOM CLIN APPL, V2, P1118, DOI 10.1002/prca.200780151; Soltys BJ, 1997, CELL BIOL INT, V21, P315, DOI 10.1006/cbir.1997.0144; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Starkey JM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011095; Thongboonkerd V, 2004, J AM SOC NEPHROL, V15, P650, DOI 10.1097/01.ASN.0000115334.65095.9B; Thongboonkerd V, 2008, J PROTEOME RES, V7, P4689, DOI 10.1021/pr8002408; Tilton RG, 2007, PROTEOMICS, V7, P1729, DOI 10.1002/pmic.200700017; Tojo A, 2001, HISTOCHEM CELL BIOL, V116, P269, DOI 10.1007/s004180100317; Veereshwarayya V, 2006, J BIOL CHEM, V281, P29468, DOI 10.1074/jbc.M602533200; Xiao HB, 2012, AM J PHYSIOL-RENAL, V303, pF757, DOI 10.1152/ajprenal.00470.2011; Zhang DJ, 2011, AM J PHYSIOL-ENDOC M, V300, pE287, DOI 10.1152/ajpendo.00308.2010	56	26	27	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2157	2167		10.1096/fj.201600910RR	http://dx.doi.org/10.1096/fj.201600910RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28196897				2022-12-28	WOS:000399195500034
J	George, AA; Bloy, A; Miwa, JM; Lindstrom, JM; Lukas, RJ; Whiteaker, P				George, Andrew A.; Bloy, Abigail; Miwa, Julie M.; Lindstrom, Jon M.; Lukas, Ronald J.; Whiteaker, Paul			Isoform-specific mechanisms of alpha 3 beta 4*-nicotinic acetylcholine receptor modulation by the prototoxin lynx1	FASEB JOURNAL			English	Article						GPI-linked proteins; neurotoxins; single-channel electrophysiology; TEVC; concatenated; receptor subunits	NEURONAL NICOTINIC RECEPTORS; AGONIST-BINDING-SITE; HABENULO-INTERPEDUNCULAR PATHWAY; SINGLE-CHANNEL PROPERTIES; STEM-CELL ANTIGEN; MEDIAL HABENULA; XENOPUS OOCYTES; IN-VIVO; ALPHA-4-ALPHA-4 INTERFACE; KINETIC-PROPERTIES	This study investigates-for the first time to our knowledge-the existence and mechanisms of functional interactions between the endogenous mammalian prototoxin, lynx1, and alpha 3-and beta 4-subunit-containing human nicotinic acetylcholine receptors (alpha 3 beta 4*-nAChRs). Concatenated gene constructs were used to express precisely defined alpha 3 beta 4*-nAChR isoforms (alpha 3 beta 4)(2)beta 4-, (alpha 3 beta 4)(2)alpha 3-, (alpha 3 beta 4)(2)alpha 5(398D)-, and (alpha 3 beta 4)(2)alpha 5(398N)-nAChR in Xenopus oocytes. In the presence or absence of lynx1, a3b4*-nAChR agonist responses were recorded by using 2-electrode voltage clamp and single-channel electrophysiology, whereas radioimmunolabeling measured cellsurface expression. Lynx1 reduced (alpha 3 beta 4)(2)beta 4-nAChR function principally by lowering cell-surface expression, whereas single-channel effects were primarily responsible for reducing (alpha 3 beta 4) 2a3-nAChR function [decreased unitary conductance (>= 50%), altered burst proportions (3-fold reduction in the proportion of long bursts), and enhanced closed dwell times (3-to 6-fold increase)]. Alterations in both cell-surface expression and single-channel properties accounted for the reduction in (alpha 3 beta 4) (2)alpha 5-nAChR function that wasmediated by lynx1. No effects were observed when alpha 3 beta 4*-nAChRs were coexpressed with mutated lynx1 (control). Lynx1 is expressed in the habenulopeduncular tract, where alpha 3 beta 4*-alpha 5*-nAChR subtypes are critical contributors to the balance between nicotine aversion and reward. This gives our findings a high likelihood of physiologic significance. The exquisite isoform selectivity of lynx1 interactions provides new insights into the mechanisms and allosteric sites [a(2)-interface containing] by which prototoxins can modulate nAChRfunction.-George, A. A., Bloy, A., Miwa, J. M., Lindstrom, J. M., Lukas, R. J., Whiteaker, P. Isoform-specific mechanisms of alpha 3 beta 4*-nicotinic acetylcholine receptor modulation by the prototoxin lynx1. FASEB J. 31, 1398-1420 (2017). www.fasebj.org	[George, Andrew A.; Bloy, Abigail; Lukas, Ronald J.; Whiteaker, Paul] St Josephs Hosp, Barrow Neurol Inst, Div Neurobiol, Phoenix, AZ USA; [Bloy, Abigail] St James Univ Hosp, Leeds Inst Canc & Pathol, Leeds, W Yorkshire, England; [Miwa, Julie M.] Lehigh Univ, Dept Biol Sci, Bethlehem, PA 18015 USA; [Lindstrom, Jon M.] Univ Penn, Dept Neurosci, Med Sch, Philadelphia, PA 19104 USA	Barrow Neurological Institute; St. Joseph's Hospital and Medical Center; Saint James's University Hospital; Lehigh University; University of Pennsylvania	George, AA (corresponding author), St Josephs Hosp, 350 W Thomas Rd, Phoenix, AZ 85013 USA.	andrew.george@dignityhealth.org		Miwa, Julie/0000-0002-4418-3756	National Institute on Drug Abuse [R21DA027070-02S1, R21- DA026627]; Men's and Women's Boards of the Barrow Neurological Foundation; U.S. National Institutes of Health; NATIONAL INSTITUTE ON DRUG ABUSE [R21DA026627, R21DA027070] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); Men's and Women's Boards of the Barrow Neurological Foundation; U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the U.S. National Institutes of Health, National Institute on Drug Abuse [Grants R21DA027070-02S1 and R21- DA026627 (to P.W.)] and by endowment and capitalization funds from the Men's and Women's Boards of the Barrow Neurological Foundation (to P.W. and A.A.G.). All authors certify that they have no affiliations with or involvement in any organization or entity with any financial interest (such as honoraria; educational grants; participation in speakers' bureaus; membership, employment, consultancies, stock ownership, or other equity interest; and expert testimony or patent- licensing arrangements) or nonfinancial interest (such as personal or professional relationships, affiliations, knowledge, or beliefs) in the subject matter or materials discussed in this article.	Ahring PK, 2015, NEUROPHARMACOLOGY, V92, P135, DOI 10.1016/j.neuropharm.2014.12.035; Akk G, 2003, J PHYSIOL-LONDON, V551, P155, DOI 10.1113/jphysiol.2003.043885; Antil-Delbeke S, 2000, J BIOL CHEM, V275, P29594, DOI 10.1074/jbc.M909746199; Antolin-Fontes B, 2015, NEUROPHARMACOLOGY, V96, P213, DOI 10.1016/j.neuropharm.2014.11.019; Auerbach A, 1998, J GEN PHYSIOL, V112, P181, DOI 10.1085/jgp.112.2.181; Baker TB, 2009, NICOTINE TOB RES, V11, P785, DOI 10.1093/ntr/ntp064; Barrantes Francisco J, 2014, Front Synaptic Neurosci, V6, P25, DOI 10.3389/fnsyn.2014.00025; BERTRAND D, 1990, P NATL ACAD SCI USA, V87, P1993, DOI 10.1073/pnas.87.5.1993; Bierut LJ, 2008, AM J PSYCHIAT, V165, P1163, DOI 10.1176/appi.ajp.2008.07111711; Boorman JP, 2003, J BIOL CHEM, V278, P44033, DOI 10.1074/jbc.M211719200; Boorman JPB, 2000, J PHYSIOL-LONDON, V529, P565, DOI 10.1111/j.1469-7793.2000.00565.x; Bourne Y, 2005, EMBO J, V24, P1512, DOI 10.1038/sj.emboj.7600620; Bruneau E, 2005, J NEUROSCI, V25, P9949, DOI 10.1523/JNEUROSCI.3169-05.2005; Buisson B, 1998, MOL PHARMACOL, V53, P555, DOI 10.1124/mol.53.3.555; CHARNET P, 1990, NEURON, V4, P87, DOI 10.1016/0896-6273(90)90445-L; CHARNET P, 1992, J PHYSIOL-LONDON, V450, P375, DOI 10.1113/jphysiol.1992.sp019132; Chen XN, 2009, AM J MED GENET B, V150B, P926, DOI 10.1002/ajmg.b.30919; Colquhoun D, 2009, SINGLE CHANNEL RECOR, P483; Dao DQ, 2014, J NEUROSCI, V34, P4273, DOI 10.1523/JNEUROSCI.2736-13.2014; Dellisanti CD, 2007, CHANNELS, V1, P234, DOI 10.4161/chan.4909; Dessaud E, 2006, MOL CELL NEUROSCI, V31, P232, DOI 10.1016/j.mcn.2005.09.010; Eaton JB, 2014, J PHARMACOL EXP THER, V348, P46, DOI 10.1124/jpet.113.208389; Fowler CD, 2011, NATURE, V471, P597, DOI 10.1038/nature09797; Frahm S, 2011, NEURON, V70, P522, DOI 10.1016/j.neuron.2011.04.013; Galat A, 2008, CELL MOL LIFE SCI, V65, P3481, DOI 10.1007/s00018-008-8473-8; George AA, 2012, J BIOL CHEM, V287, P25151, DOI 10.1074/jbc.M112.379339; Gotti C, 2009, BIOCHEM PHARMACOL, V78, P703, DOI 10.1016/j.bcp.2009.05.024; Grady SR, 2009, J NEUROSCI, V29, P2272, DOI 10.1523/JNEUROSCI.5121-08.2009; Grosman C, 2001, P NATL ACAD SCI USA, V98, P14102, DOI 10.1073/pnas.251402498; Grucza RA, 2008, BIOL PSYCHIAT, V64, P922, DOI 10.1016/j.biopsych.2008.04.018; Hales TG, 2006, J BIOL CHEM, V281, P8062, DOI 10.1074/jbc.M513222200; Hansen SB, 2008, J BIOL CHEM, V283, P36066, DOI 10.1074/jbc.C800194200; Harpsoe K, 2011, J NEUROSCI, V31, P10759, DOI 10.1523/JNEUROSCI.1509-11.2011; Horie M, 1998, GENOMICS, V53, P365, DOI 10.1006/geno.1998.5462; Hruska M, 2009, J NEUROSCI, V29, P14847, DOI 10.1523/JNEUROSCI.2271-09.2009; Hsiao B, 2008, J NEUROPHYSIOL, V99, P999, DOI 10.1152/jn.01040.2007; Hurst R, 2013, PHARMACOL THERAPEUT, V137, P22, DOI 10.1016/j.pharmthera.2012.08.012; Ibanez-Tallon I, 2002, NEURON, V33, P893, DOI 10.1016/S0896-6273(02)00632-3; JACKSON MB, 1983, BIOPHYS J, V42, P109, DOI 10.1016/S0006-3495(83)84375-6; Jensen MM, 2015, NEUROBIOL AGING, V36, P1629, DOI 10.1016/j.neurobiolaging.2015.01.001; Karlin A, 2002, NAT REV NEUROSCI, V3, P102, DOI 10.1038/nrn731; Kobayashi A, 2014, J MOL NEUROSCI, V53, P525, DOI 10.1007/s12031-014-0352-1; Krashia P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013611; Kumari S, 2008, J CELL BIOL, V181, P1179, DOI 10.1083/jcb.200709086; Kuryatov A, 2011, MOL PHARMACOL, V79, P119, DOI 10.1124/mol.110.066357; Li P, 2011, MOL PHARMACOL, V80, P818, DOI 10.1124/mol.111.073841; Li P, 2010, BRIT J PHARMACOL, V160, P1906, DOI 10.1111/j.1476-5381.2010.00761.x; Lucero LM, 2016, J BIOL CHEM, V291, P2444, DOI 10.1074/jbc.M115.684373; Lukas RJ, 1999, PHARMACOL REV, V51, P397; Lyukmanova EN, 2013, J BIOL CHEM, V288, P15888, DOI 10.1074/jbc.M112.436576; Lyukmanova EN, 2011, J BIOL CHEM, V286, P10618, DOI 10.1074/jbc.M110.189100; Marotta CB, 2014, NEUROPHARMACOLOGY, V77, P342, DOI 10.1016/j.neuropharm.2013.09.028; Mazzaferro S, 2014, J BIOL CHEM, V289, P21795, DOI 10.1074/jbc.M114.555136; McCallum SE, 2012, NEUROPHARMACOLOGY, V63, P434, DOI 10.1016/j.neuropharm.2012.04.015; Militante J, 2008, MOL PHARMACOL, V74, P764, DOI 10.1124/mol.108.047134; Miwa JM, 1999, NEURON, V23, P105, DOI 10.1016/S0896-6273(00)80757-6; Miwa JM, 2006, NEURON, V51, P587, DOI 10.1016/j.neuron.2006.07.025; Miwa JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043302; Miwa JM, 2012, PHYSIOLOGY, V27, P187, DOI 10.1152/physiol.00002.2012; Moretti M, 2014, MOL PHARMACOL, V86, P306, DOI 10.1124/mol.114.093377; Morishita H, 2010, SCIENCE, V330, P1238, DOI 10.1126/science.1195320; Moroni M, 2008, J NEUROSCI, V28, P6884, DOI 10.1523/JNEUROSCI.1228-08.2008; Moroni M, 2011, J BIOL CHEM, V286, P13414, DOI 10.1074/jbc.M110.204610; Nelson ME, 1999, J PHYSIOL-LONDON, V516, P657, DOI 10.1111/j.1469-7793.1999.0657u.x; Nichols WA, 2014, J BIOL CHEM, V289, P31423, DOI 10.1074/jbc.M114.573667; Nirthanan S, 2002, J BIOL CHEM, V277, P17811, DOI 10.1074/jbc.M111152200; Ochoa V, 2016, FASEB J, V30, P1109, DOI 10.1096/fj.15-274548; PAPKE RL, 1991, J PHYSIOL-LONDON, V440, P95, DOI 10.1113/jphysiol.1991.sp018698; Parker RL, 2011, BIOCHEM PHARMACOL, V82, P1037, DOI 10.1016/j.bcp.2011.07.037; Premkumar LS, 1997, J GEN PHYSIOL, V109, P181, DOI 10.1085/jgp.109.2.181; Qin F, 1996, BIOPHYS J, V70, P264, DOI 10.1016/S0006-3495(96)79568-1; Saccone NL, 2009, CANCER RES, V69, P6848, DOI 10.1158/0008-5472.CAN-09-0786; Saccone SF, 2007, HUM MOL GENET, V16, P36, DOI 10.1093/hmg/ddl438; SACHS F, 1982, PFLUG ARCH EUR J PHY, V395, P331, DOI 10.1007/BF00580798; SAKMANN B, 1980, NATURE, V286, P71, DOI 10.1038/286071a0; SAKMANN B, 1984, ANNU REV PHYSIOL, V46, P455, DOI 10.1146/annurev.ph.46.030184.002323; Salas R, 2009, J NEUROSCI, V29, P3014, DOI 10.1523/JNEUROSCI.4934-08.2009; Shahsavar A, 2015, MOL PHARMACOL, V88, P697, DOI 10.1124/mol.115.098061; Sheffield EB, 2000, NEUROPHARMACOLOGY, V39, P2591, DOI 10.1016/S0028-3908(00)00138-6; Shih PY, 2014, J NEUROSCI, V34, P9789, DOI 10.1523/JNEUROSCI.0476-14.2014; Shulepko MA, 2013, BIOCHEMISTRY-MOSCOW+, V78, P204, DOI 10.1134/S0006297913020090; SINE SM, 1984, BIOPHYS J, V45, P175, DOI 10.1016/S0006-3495(84)84146-6; Sivilotti LG, 1997, J PHYSIOL-LONDON, V500, P123, DOI 10.1113/jphysiol.1997.sp022004; Slimak MA, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00012; Srinivasan R, 2011, J GEN PHYSIOL, V137, P59, DOI 10.1085/jgp.201010532; St John PA, 2009, ACTA PHARMACOL SIN, V30, P656, DOI 10.1038/aps.2009.76; Stevens VL, 2008, CANCER EPIDEM BIOMAR, V17, P3517, DOI 10.1158/1055-9965.EPI-08-0585; Wang JY, 2015, J BIOL CHEM, V290, P13907, DOI 10.1074/jbc.M115.646786; Whiteaker P, 2000, MOL PHARMACOL, V57, P913; Whiteaker P, 2002, J NEUROSCI, V22, P2522, DOI 10.1523/JNEUROSCI.22-07-02522.2002; WHITING PJ, 1986, BIOCHEMISTRY-US, V25, P2082, DOI 10.1021/bi00356a037; Wu J, 2011, BIOCHEM PHARMACOL, V82, P800, DOI 10.1016/j.bcp.2011.07.067; Wu ML, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148215; Wu ML, 2015, J BIOL CHEM, V290, P24509, DOI 10.1074/jbc.M115.647248; Zhang YF, 2010, MOL BIOL REP, V37, P2055, DOI 10.1007/s11033-009-9663-7; Zhou Y, 2003, J NEUROSCI, V23, P9004	96	24	25	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1398	1420		10.1096/fj.201600733R	http://dx.doi.org/10.1096/fj.201600733R			23	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28100642	Green Published			2022-12-28	WOS:000398504300012
J	Gombedza, F; Kondeti, V; Al-Azzam, N; Koppes, S; Duah, E; Patil, P; Hexter, M; Phillips, D; Thodeti, CK; Paruchuri, S				Gombedza, Farai; Kondeti, Vinay; Al-Azzam, Nosayba; Koppes, Stephanie; Duah, Ernest; Patil, Prachi; Hexter, Madison; Phillips, Daniel; Thodeti, Charles K.; Paruchuri, Sailaja			Mechanosensitive transient receptor potential vanilloid 4 regulates Dermatophagoides farinae-induced airway remodeling via 2 distinct pathways modulating matrix synthesis and degradation	FASEB JOURNAL			English	Article						TGF-beta 1; myofibroblasts; PI3K; PAI-1; fibronectin	INTESTINAL EPITHELIAL-CELLS; GROWTH-FACTOR-BETA; TRPV4 CHANNELS; BRONCHIAL-ASTHMA; PULMONARY-FIBROSIS; ENDOTHELIAL-CELLS; LUNG INJURY; ACTIVATION; MYOFIBROBLAST; DIFFERENTIATION	Contributions of mechanical signals to airway remodeling during asthma are poorly understood. Transient receptor potential vanilloid 4 (TRPV4), a mechanosensitive ion channel, has been implicated in cardiac and pulmonary fibrosis; however, its role in asthma remains elusive. Employing a Dermatophagoides farinae-induced asthma model, we report here that TRPV4-knockout mice were protected from D. farinae-induced airway remodeling. Furthermore, lung fibroblasts that were isolated from TRPV4-knockout mice showed diminished differentiation potential compared with wild-type mice. Fibroblasts from asthmatic lung exhibited increased TRPV4 activity and enhanced differentiation potential compared with normal human lung fibroblasts. Of interest, TGF-beta 1 treatment enhanced TRPV4 activation in a PI3K-dependent manner in normal human lung fibroblasts in vitro Mechanistically, TRPV4 modulated matrix remodeling in the lung via 2 distinct but dependent pathways: one enhances matrix deposition by fibrotic gene activation, whereas the other slows down matrix degradation by increased plasminogen activator inhibitor 1. Of importance, both pathways are regulated by Rho/myocardin-related transcription factor-A and contribute to fibroblast differentiation and matrix remodeling in the lung. Thus, our results support a unique role for TRPV4 in D. farinae-induced airway remodeling and warrant further studies in humans for it to be used as a novel therapeutic target in the treatment of asthma.-Gombedza, F., Kondeti, V., Al-Azzam, N., Koppes, S., Duah, E., Patil, P., Hexter, M., Phillips, D., Thodeti, C. K., Paruchuri, S. Mechanosensitive transient receptor potential vanilloid 4 regulates Dermatophagoides farinae-induced airway remodeling via 2 distinct pathways modulating matrix synthesis and degradation.	[Gombedza, Farai; Kondeti, Vinay; Al-Azzam, Nosayba; Koppes, Stephanie; Duah, Ernest; Patil, Prachi; Hexter, Madison; Phillips, Daniel; Paruchuri, Sailaja] Univ Akron, Dept Chem, Akron, OH 44325 USA; [Thodeti, Charles K.] Northeast Ohio Med Univ, Dept Integrat Med Sci, Rootstown, OH USA	University System of Ohio; University of Akron; Northeast Ohio Medical University (NEOMED)	Paruchuri, S (corresponding author), Dept Chem, KNCL 406,190 E Buchtel Common, Akron, OH 44325 USA.	sp97@uakron.edu	Duah, Ernest/I-5985-2019; Gombedza, Farai/AAO-9776-2020	Duah, Ernest/0000-0002-5125-0830; Gombedza, Farai/0000-0002-1977-6242	James Foght Assistant Professorship (University of Akron); U.S. National Institutes of Health, National Heart, Lung, and Blood Institute grant [R01HL119705]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL119705] Funding Source: NIH RePORTER	James Foght Assistant Professorship (University of Akron); U.S. National Institutes of Health, National Heart, Lung, and Blood Institute grant; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by a James Foght Assistant Professorship (University of Akron; to S.P.), and U.S. National Institutes of Health, National Heart, Lung, and Blood Institute grant (R01HL119705 to C.K.T.).	Adapala RK, 2016, ONCOGENE, V35, P314, DOI 10.1038/onc.2015.83; Adapala RK, 2013, J MOL CELL CARDIOL, V54, P45, DOI 10.1016/j.yjmcc.2012.10.016; Adapala RK, 2011, AM J PHYSIOL-HEART C, V301, pH757, DOI 10.1152/ajpheart.00142.2011; Alvarez DF, 2006, CIRC RES, V99, P988, DOI 10.1161/01.RES.0000247065.11756.19; Bagher P, 2012, P NATL ACAD SCI USA, V109, P18174, DOI 10.1073/pnas.1211946109; Balakrishna S, 2014, AM J PHYSIOL-LUNG C, V307, pL158, DOI 10.1152/ajplung.00065.2014; Benayoun L, 2003, AM J RESP CRIT CARE, V167, P1360, DOI 10.1164/rccm.200209-1030OC; Biernacka A, 2011, GROWTH FACTORS, V29, P196, DOI 10.3109/08977194.2011.595714; Boxall C, 2006, EUR RESPIR J, V27, P208, DOI 10.1183/09031936.06.00130004; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Chapman HA, 2004, J CLIN INVEST, V113, P148, DOI 10.1172/JCI200420729; Chaudhuri R, 2014, EUR RESPIR J, V44, P895, DOI 10.1183/09031936.00047014; Cho S, 2011, ANN ALLERG ASTHMA IM, V106, P371, DOI 10.1016/j.anai.2010.12.021; Conte E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024663; Du KL, 2003, MOL CELL BIOL, V23, P2425, DOI 10.1128/MCB.23.7.2425-2437.2003; Duah E, 2013, SCI REP-UK, V3, DOI 10.1038/srep03274; Elias JA, 1999, J CLIN INVEST, V104, P1001, DOI 10.1172/JCI8124; Ghosh AK, 2012, J CELL PHYSIOL, V227, P493, DOI 10.1002/jcp.22783; Habibovic A, 2016, JCI INSIGHT, V1, DOI 10.1172/jci.insight.88811; Hamanaka K, 2010, AM J PHYSIOL-LUNG C, V299, pL353, DOI 10.1152/ajplung.00315.2009; Hinz B, 2007, J INVEST DERMATOL, V127, P526, DOI 10.1038/sj.jid.5700613; Hinz B, 2007, AM J PATHOL, V170, P1807, DOI 10.2353/ajpath.2007.070112; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Holgate ST, 2008, CLIN EXP ALLERGY, V38, P872, DOI 10.1111/j.1365-2222.2008.02971.x; Hoshino M, 1998, THORAX, V53, P21, DOI 10.1136/thx.53.1.21; Huang J, 1999, AM J RESP CRIT CARE, V160, P725, DOI 10.1164/ajrccm.160.2.9809040; Huang XW, 2012, AM J RESP CELL MOL, V47, P340, DOI 10.1165/rcmb.2012-0050OC; Kim S, 1997, MOL CELL BIOL, V17, P2266, DOI 10.1128/MCB.17.4.2266; Le Cras TD, 2011, AM J PHYSIOL-LUNG C, V300, pL414, DOI 10.1152/ajplung.00346.2010; Lee SH, 2012, AM J RESP CELL MOL, V46, P842, DOI 10.1165/rcmb.2011-0369OC; Liedtke W., 2007, V179, P473; Liedtke W, 2007, EXP PHYSIOL, V92, P507, DOI 10.1113/expphysiol.2006.035642; Minshall EM, 1997, AM J RESP CELL MOL, V17, P326, DOI 10.1165/ajrcmb.17.3.2733; Miyamoto S, 2011, AM J PHYSIOL-LUNG C, V301, pL908, DOI 10.1152/ajplung.00115.2011; Naumov DE, 2016, DOKL BIOCHEM BIOPHYS, V469, P260, DOI 10.1134/S1607672916040074; Nilius B., 2004, NOVART FDN SYMP, V258, P149; Nilius B., 2004, NOVARTIS FDN S, V258, P263; Nilius Bernd, 2004, Novartis Found Symp, V258, P140; Parmacek MS, 2007, CIRC RES, V100, P633, DOI 10.1161/01.RES.0000259563.61091.e8; Paruchuri S, 2005, J BIOL CHEM, V280, P13538, DOI 10.1074/jbc.M409811200; Paruchuri S, 2002, J CELL SCI, V115, P1883; Paruchuri S, 2009, J EXP MED, V206, P2543, DOI 10.1084/jem.20091240; Rahaman SO, 2014, J CLIN INVEST, V124, P5225, DOI 10.1172/JCI75331; Ramirez AM, 2006, AM J TRANSPLANT, V6, P2080, DOI 10.1111/j.1600-6143.2006.01430.x; ROCHE WR, 1989, LANCET, V1, P520; Schmidt-Weber CB, 2004, CURR OPIN IMMUNOL, V16, P709, DOI 10.1016/j.coi.2004.09.008; Stumm CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095959; Sullivan MN, 2012, MOL PHARMACOL, V82, P464, DOI 10.1124/mol.112.078584; Sun QZ, 2016, CELL SIGNAL, V28, P307, DOI 10.1016/j.cellsig.2016.01.004; Swartz MA, 2001, P NATL ACAD SCI USA, V98, P6180, DOI 10.1073/pnas.111133298; Tang MLK, 2006, PHARMACOL THERAPEUT, V112, P474, DOI 10.1016/j.pharmthera.2006.05.001; Thodeti CK, 2009, CIRC RES, V104, P1123, DOI 10.1161/CIRCRESAHA.108.192930; Turato G, 2008, AM J RESP CRIT CARE, V178, P476, DOI 10.1164/rccm.200712-1818OC; Vriens J, 2004, P NATL ACAD SCI USA, V101, P396, DOI 10.1073/pnas.0303329101; Wang JHC, 2006, BIOMECH MODEL MECHAN, V5, P1, DOI 10.1007/s10237-005-0012-z; Wilson JW, 1997, CLIN EXP ALLERGY, V27, P363; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Xiao W, 2005, CHEST, V128, P2316, DOI 10.1378/chest.128.4.2316; Zhou Y, 2013, J CLIN INVEST, V123, P1096, DOI 10.1172/JCI66700	59	23	24	1	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1556	1570		10.1096/fj.201601045R	http://dx.doi.org/10.1096/fj.201601045R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28073835	Green Published			2022-12-28	WOS:000398504300023
J	Kim, HJ; Kwon, S; Nam, SH; Jung, JW; Kang, M; Ryu, J; Kim, JE; Cheong, JG; Cho, CY; Kim, S; Song, DG; Kim, YN; Kim, TY; Jung, MK; Lee, KM; Pack, CG; Lee, JW				Kim, Hye-Jin; Kwon, Sojung; Nam, Seo Hee; Jung, Jae Woo; Kang, Minkyung; Ryu, Jihye; Kim, Ji Eon; Cheong, Jin-Gyu; Cho, Chang Yun; Kim, Somi; Song, Dae-Geun; Kim, Yong-Nyun; Kim, Tai Young; Jung, Min-Kyo; Lee, Kyung-Min; Pack, Chan-Gi; Lee, Jung Weon			Dynamic and coordinated single-molecular interactions at TM4SF5-enriched microdomains guide invasive behaviors in 2-and 3-dimensional environments	FASEB JOURNAL			English	Article						3D cell culture; FCCS; migration; protein interaction affinity; membrane proteins	TUMOR MICROENVIRONMENT; TETRASPANIN PROTEINS; INTEGRIN ALPHA-2; TM4SF5; PALMITOYLATION; MODULATION; EXPRESSION; CANCER; CELLS	Membrane proteins sense extracellular cues and transduce intracellular signaling to coordinate directionality and speed during cellular migration. They are often localized to specific regions, as with lipid rafts or tetraspanin-enriched microdomains; however, the dynamic interactions of tetraspanins with diverse receptors within tetraspanin-enriched microdomains on cellular surfaces remain largely unexplored. Here, we investigated effects of tetraspan(in) TM4SF5 (transmembrane 4 L6 family member 5)-enriched microdomains (T5ERMs) on the directionality of cell migration. Physical association of TM4SF5 with epidermal growth factor receptor (EGFR) and integrin alpha 5 was visualized by live fluorescence cross-correlation spectroscopy and higher-resolution microscopy at the leading edge of migratory cells, presumably forming TM4SF5-enriched microdomains. Whereas TM4SF5 and EGFR colocalized at themigrating leading region more than at the rear, TM4SF5 and integrin a5 colocalized evenly throughout cells. Cholesterol depletion and disruption in TM4SF5 post-translational modifications, including N-glycosylation and palmitoylation, altered TM4SF5 interactions and cellular localization, which led to less cellular migration speed and directionality in 2-or 3-dimensional conditions. TM4SF5 controlled directional cell migration and invasion, and importantly, these TM4SF5 functions were dependent on cholesterol, TM4SF5 post-translational modifications, and EGFR and integrin alpha 5 activity. Altogether, we showed that TM4SF5 dynamically interacted with EGFR and integrin a5 in migratory cells to control directionality and invasion.-Kim, H.-J., Kwon, S., Nam, S. H., Jung, J. W., Kang, M., Ryu, J., Kim, J. E., Cheong, J.-G., Cho, C. Y., Kim, S., Song, D.-G., Kim, Y.-N., Kim, T. Y., Jung, M.-K., Lee, K.-M., Pack, C.-G., Lee, J. W. Dynamic and coordinated single-molecular interactions at TM4SF5-enriched microdomains guide invasive behaviors in 2-and 3-dimensional environments. FASEB J. 31, 1461-1481 (2017). www.fasebj.org	[Kim, Hye-Jin; Kwon, Sojung; Kang, Minkyung; Ryu, Jihye; Kim, Ji Eon; Cheong, Jin-Gyu; Cho, Chang Yun; Kim, Somi; Song, Dae-Geun; Kim, Tai Young; Lee, Kyung-Min; Lee, Jung Weon] Seoul Natl Univ, Coll Pharm, Res Inst Pharmaceut Sci, Dept Pharm, Seoul, South Korea; [Nam, Seo Hee; Jung, Jae Woo; Lee, Jung Weon] Seoul Natl Univ, Interdisciplinary Program Genet Engn, Seoul, South Korea; [Kim, Yong-Nyun] Natl Canc Ctr, Gyeonggi Do, South Korea; [Jung, Min-Kyo; Pack, Chan-Gi] Univ Ulsan, Coll Med, Dept Convergence Med, Seoul, South Korea; [Jung, Min-Kyo; Pack, Chan-Gi] Asan Med Ctr, Asan Inst Life Sci, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); National Cancer Center - Korea (NCC); University of Ulsan; University of Ulsan; Asan Medical Center	Lee, JW (corresponding author), Seoul Natl Univ, Coll Pharm, 1 Gwanak Ro, Seoul 08826, South Korea.	jwl@snu.ac.kr	Lee, Jung Weon/F-9149-2012; Lee, Jung Weon/AAC-1146-2020	Lee, Jung Weon/0000-0003-2722-8200; KIM, TAI YOUNG/0000-0001-8086-2476; Jung, Jae Woo/0000-0001-7178-7400; Cheong, Jin-gyu/0000-0002-6190-0411	National Research Foundation (NRF) of Korea for Basic Science Research Program [NRF-2014R1A1A2058183, NRF-2016R1C1B2013275]; Tumor Microenvironment Global Core Research Center [20110030001]; Medicinal Bioconvergence Research Center [NRF-2013M3A6A4044019]; Bio and Medical Technology Development Program [NRF-2016M3A9A8915731]	National Research Foundation (NRF) of Korea for Basic Science Research Program; Tumor Microenvironment Global Core Research Center; Medicinal Bioconvergence Research Center; Bio and Medical Technology Development Program	FCCS study and Airyscan imaging was performed at the Confocal Microscope Core at Asan Institute for Life Sciences of Asan Medical Center. This work was supported by the National Research Foundation (NRF) of Korea for Basic Science Research Program [NRF-2014R1A1A2058183 (to C.-G.P.) and NRF-2016R1C1B2013275 (to K.-M.L.)], the Tumor Microenvironment Global Core Research Center (20110030001), the Medicinal Bioconvergence Research Center (NRF-2013M3A6A4044019), and the Bio and Medical Technology Development Program (NRF-2016M3A9A8915731; to J.W.L.).	Bacia K, 2006, NAT METHODS, V3, P83, DOI 10.1038/NMETH822; Berditchevski F, 2002, J BIOL CHEM, V277, P36991, DOI 10.1074/jbc.M205265200; Berditchevski F, 2001, J CELL SCI, V114, P4143; Choi YJ, 2014, BIOCHEM J, V462, P89, DOI 10.1042/BJ20140177; Detchokul S, 2014, BRIT J PHARMACOL, V171, P5462, DOI 10.1111/bph.12260; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; Jung O, 2013, BBA-MOL CELL RES, V1833, P629, DOI 10.1016/j.bbamcr.2012.11.026; Jung O, 2012, J CELL SCI, V125, P5960, DOI 10.1242/jcs.100586; Kang M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102817; Lee D, 2015, HEPATOLOGY, V61, P1978, DOI 10.1002/hep.27721; Lee SA, 2011, FRONT BIOSCI-LANDMRK, V16, P1752, DOI 10.2741/3818; Lee SA, 2009, CARCINOGENESIS, V30, P1872, DOI 10.1093/carcin/bgp234; Lee SY, 2006, EXP CELL RES, V312, P2983, DOI 10.1016/j.yexcr.2006.06.001; Levy S, 2005, PHYSIOLOGY, V20, P218, DOI 10.1152/physiol.00015.2005; Muller-Pillasch F, 1998, GENE, V208, P25, DOI 10.1016/S0378-1119(97)00633-1; Nam SH, 2015, ONCOTARGET, V6, P21655, DOI 10.18632/oncotarget.4130; Pack CG, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4396; Park EK, 2009, J PATHOL, V218, P337, DOI 10.1002/path.2531; Parton RG, 2004, TRENDS CELL BIOL, V14, P141, DOI 10.1016/j.tcb.2004.02.001; Rubinstein E, 2011, BIOCHEM SOC T, V39, P501, DOI 10.1042/BST0390501; Wright MD, 2000, PROTEIN SCI, V9, P1594, DOI 10.1110/ps.9.8.1594; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275	23	21	21	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1461	1481		10.1096/fj.201600944RR	http://dx.doi.org/10.1096/fj.201600944RR			21	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28073834				2022-12-28	WOS:000398504300016
J	Sen, CK; Khanna, S; Harris, H; Stewart, R; Balch, M; Heigel, M; Teplitsky, S; Gnyawali, S; Rink, C				Sen, Chandan K.; Khanna, Savita; Harris, Hallie; Stewart, Richard; Balch, Maria; Heigel, Mallory; Teplitsky, Seth; Gnyawali, Surya; Rink, Cameron			Robot-assisted mechanical therapy attenuates strokeinduced limb skeletal muscle injury	FASEB JOURNAL			English	Article						ischemia; rehabilitation; physical therapy; cerebrovascular accident	ACUTE ISCHEMIC-STROKE; MOTOR RECOVERY; BOBATH CONCEPT; BLOOD-FLOW; REHABILITATION; MASSAGE; BDNF; EXPRESSION; OUTCOMES; DIFFERENTIATION	The efficacy and optimization of poststroke physical therapy paradigms is challenged in part by a lack of objective tools available to researchers for systematic preclinical testing. This work represents a maiden effort to develop a robot-assisted mechanical therapy (RAMT) device to objectively address the significance of mechanical physiotherapy on poststroke outcomes. Wistar rats were subjected to right hemisphere middle-cerebral artery occlusion and reperfusion. After 24 h, rats were split into control (RAMT-) or RAMT+ groups (30 min daily RAMT over the stroke-affected gastrocnemius) and were followed up to poststroke d 14. RAMT+ increased perfusion 1.5-fold in stroke-affected gastrocnemius as compared to RAMT- controls. Furthermore, RAMT+ rats demonstrated improved poststroke track width (11% wider), stride length (21% longer), and travel distance (61% greater), as objectively measured using software-automated testing platforms. Stroke injury acutely increased myostatin (3-fold) and lowered brain-derived neurotrophic factor (BDNF) expression (0.6-fold) in the stroke-affected gastrocnemius, as compared to the contralateral one. RAMT attenuated the stroke-induced increase in myostatin and increased BDNF expression in skeletal muscle. Additional RAMT-sensitive myokine targets in skeletal muscle (IL-1ra and IP-10/CXCL10) were identified from a cytokine array. Taken together, outcomes suggest stroke acutely influences signal transduction in hindlimb skeletal muscle. Regimens based on mechanical therapy have the clear potential to protect hindlimb function from such adverse influence.Sen, C. K., Khanna, S., Harris, H., Stewart R., Balch, M., Heigel, M., Teplitsky, S., Gnyawali, S., Rink, C. Robot-assisted mechanical therapy attenuates stroke-induced limb skeletal muscle injury.	[Sen, Chandan K.; Khanna, Savita; Harris, Hallie; Stewart, Richard; Balch, Maria; Heigel, Mallory; Teplitsky, Seth; Gnyawali, Surya; Rink, Cameron] Ohio State Univ, Wexner Med Ctr, Davis Heart & Lung Res Inst, Dept Surg, Columbus, OH 43210 USA	University System of Ohio; Ohio State University	Rink, C (corresponding author), Ohio State Univ, Wexner Med Ctr, Davis Heart & Lung Res Inst 505, 473 West 12th Ave, Columbus, OH 43210 USA.	cameron.rink@osumc.edu	Rink, Cameron/AAA-4484-2021; Gnyawali, Surya/AAC-3082-2020; Gnyawali, Surya/AAC-3082-2020	Gnyawali, Surya/0000-0001-8980-4889; Rink, Cameron/0000-0002-3149-3624; Balch, Maria/0000-0003-2011-6345; Gnyawali, Surya/0000-0002-4214-8068; Khanna, Savita/0000-0001-6661-9293; Teplitsky, Seth/0000-0001-9242-1360	U.S.National Institutes of Health,National Institute of Neurological Disorders and Stroke [NS42617, NS085272]; American Heart Association Scientific Development [12SDG11780023]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042617, R01NS085272] Funding Source: NIH RePORTER	U.S.National Institutes of Health,National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); American Heart Association Scientific Development(American Heart Association); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by U.S.National Institutes of Health, National Institute of Neurological Disorders and Stroke Grants NS42617 (to C.K.S.) and NS085272 (to C.R.,S.K., and A.H.A.), and American Heart Association Scientific Development Grant 12SDG11780023 (to C. R.). The authors declare no conflicts of interest.	Arend WP, 1998, ANNU REV IMMUNOL, V16, P27, DOI 10.1146/annurev.immunol.16.1.27; Ballinger C, 1999, CLIN REHABIL, V13, P301, DOI 10.1191/026921599673198490; Barnes Patricia M, 2008, Natl Health Stat Report, P1; Barrientos RM, 2004, J NEUROIMMUNOL, V155, P119, DOI 10.1016/j.jneuroim.2004.06.009; Barrientos RM, 2003, NEUROSCIENCE, V121, P847, DOI 10.1016/S0306-4522(03)00564-5; Beare JE, 2009, J NEUROTRAUM, V26, P2045, DOI 10.1089/neu.2009.0914; Canu MH, 1996, EUR J APPL PHYSIOL O, V74, P297, DOI 10.1007/s004210050078; Carroll P, 1998, NAT NEUROSCI, V1, P42, DOI 10.1038/242; Choe MA, 2004, NURS RES, V53, P283, DOI 10.1097/00006199-200409000-00001; Clow C, 2010, MOL BIOL CELL, V21, P2182, DOI 10.1091/mbc.E10-02-0154; Coelho HJ, 2016, MEDIAT INFLAMM, V2016, DOI 10.1155/2016/3957958; Crane JD, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3002882; Crescioli C, 2012, EUR J CELL BIOL, V91, P139, DOI 10.1016/j.ejcb.2011.09.011; DeVries AC, 2001, NEUROSCI BIOBEHAV R, V25, P325, DOI 10.1016/S0149-7634(01)00017-3; Gao L, 2012, GROWTH FACTORS, V30, P167, DOI 10.3109/08977194.2012.678842; Go AS, 2013, CIRCULATION, V127, pE6, DOI 10.1161/CIR.0b013e31828124ad; GOATS GC, 1994, BRIT J SPORT MED, V28, P153, DOI 10.1136/bjsm.28.3.153; Hafer-Macko CE, 2008, J REHABIL RES DEV, V45, P261, DOI 10.1682/JRRD.2007.02.0040; Herson PS, 2011, NEUROMETHODS, V50, P307, DOI 10.1007/978-1-60761-883-6_12; Hiraiwa Y, 2013, CRANIO, V31, P291, DOI 10.1179/crn.2013.31.4.007; Husemann B, 2007, STROKE, V38, P349, DOI 10.1161/01.STR.0000254607.48765.cb; Junhua Z, 2009, STROKE, V40, P2797, DOI 10.1161/STROKEAHA.109.555227; Khanna S, 2005, STROKE, V36, pE144, DOI 10.1161/01.STR.0000181082.70763.22; Khanna S, 2013, J CEREBR BLOOD F MET, V33, P1197, DOI 10.1038/jcbfm.2013.68; Kollen BJ, 2009, STROKE, V40, pE89, DOI 10.1161/STROKEAHA.108.533828; Krakauer JW, 2012, NEUROREHAB NEURAL RE, V26, P923, DOI 10.1177/1545968312440745; Kwakkel G, 2002, PHYS THER, V82, P432, DOI 10.1093/ptj/82.5.432; Langhorne P, 2011, LANCET, V377, P1693, DOI 10.1016/S0140-6736(11)60325-5; Lennon S, 2001, DISABIL REHABIL, V23, P254; Li L, 2013, BRAIN INJURY, V27, P408, DOI 10.3109/02699052.2012.750750; Liu YH, 2016, INT J NEUROSCI, V126, P168, DOI 10.3109/00207454.2014.998759; Long RP, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8524560; Loubinoux I, 1997, STROKE, V28, P419, DOI 10.1161/01.STR.28.2.419; Manceau M, 2008, GENE DEV, V22, P668, DOI 10.1101/gad.454408; McIlwrath SL, 2005, NEUROSCIENCE, V131, P499, DOI 10.1016/j.neuroscience.2004.11.030; Miller EL, 2010, STROKE, V41, P2402, DOI 10.1161/STR.0b013e3181e7512b; Mori H, 2004, MED SCI MONITOR, V10, pCR173; Pedersen BK, 2012, NAT REV ENDOCRINOL, V8, P457, DOI 10.1038/nrendo.2012.49; Pomeroy VM, 2000, LANCET, V355, P836, DOI 10.1016/S0140-6736(99)08143-X; Rink C, 2011, J CEREBR BLOOD F MET, V31, P2218, DOI 10.1038/jcbfm.2011.85; Rink C, 2010, J CEREBR BLOOD F MET, V30, P1275, DOI 10.1038/jcbfm.2010.7; Ryan A. S., 2011, J AM HEART ASSOC, V42, P416; Salter K, 2006, J REHABIL MED, V38, P113, DOI 10.1080/16501970500314350; Sefton JM, 2010, J ALTERN COMPLEM MED, V16, P723, DOI 10.1089/acm.2009.0441; Shoemaker JK, 1997, MED SCI SPORT EXER, V29, P610, DOI 10.1097/00005768-199705000-00004; Stinear C, 2013, STROKE, V44, P2039, DOI 10.1161/STROKEAHA.113.000968; Trayhurn Paul, 2011, Archives of Physiology and Biochemistry, V117, P47, DOI 10.3109/13813455.2010.535835; Wu JJ, 2014, COMPLEMENT THER MED, V22, P456, DOI 10.1016/j.ctim.2014.04.001; Yamamoto M, 1996, NEUROCHEM RES, V21, P929, DOI 10.1007/BF02532343; Zhu CL, 2010, J CEREBR BLOOD F MET, V30, P1017, DOI 10.1038/jcbfm.2009.274	50	11	11	1	23	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					927	936		10.1096/fj.201600437R	http://dx.doi.org/10.1096/fj.201600437R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27895105	Green Published			2022-12-28	WOS:000395671200010
J	Prokesch, A; Graef, FA; Madl, T; Kahlhofer, J; Heidenreich, S; Schumann, A; Moyschewitz, E; Pristoynik, P; Blaschitz, A; Knauer, M; Muenzner, M; Bogner-Strauss, JG; Dohr, G; Schulz, TJ; Schupp, M				Prokesch, Andreas; Graef, Franziska A.; Madl, Tobias; Kahlhofer, Jennifer; Heidenreich, Steffi; Schumann, Anne; Moyschewitz, Elisabeth; Pristoynik, Petra; Blaschitz, Astrid; Knauer, Miriam; Muenzner, Matthias; Bogner-Strauss, Juliane G.; Dohr, Gottfried; Schulz, Tim J.; Schupp, Michael			Liver p53 is stabilized upon starvation and required for amino acid catabolism and gluconeogenesis	FASEB JOURNAL			English	Article						AMPK; hepatic steatosis; liver metabolism; nutrient deprivation; fasting	HUMAN HEPATOCELLULAR-CARCINOMA; LIPID-METABOLISM; MICE; NUTRIENT; CELLS; RESPIRATION; GLYCOLYSIS; EXPRESSION; REGULATOR; OXIDATION	The ability to adapt cellular metabolism to nutrient availability is critical for survival. The liver plays a central role in the adaptation to starvation by switching from glucose-consuming processes and lipid synthesis to providing energy substrates like glucose to the organism. Here we report a previously unrecognized role of the tumor suppressor p53 in the physiologic adaptation to food withdrawal. We found that starvation robustly increases p53 protein in mouse liver. This induction was posttranscriptional and mediated by a hepatocyte-autonomous and AMP-activated protein kinase-dependent mechanism. p53 stabilization was required for the adaptive expression of genes involved in amino acid catabolism. Indeed, acute deletion of p53 in livers of adult mice impaired hepatic glycogen storage and induced steatosis. Upon food withdrawal, p53-deleted mice became hypoglycemic and showed defects in the starvation-associated utilization of hepatic amino acids. In summary, we provide novel evidence for a p53-dependent integration of acute changes of cellular energy status and the metabolic adaptation to starvation. Because of its tumor suppressor function, p53 stabilization by starvation could have implications for both metabolic and oncological diseases of the liver.	[Prokesch, Andreas; Kahlhofer, Jennifer; Moyschewitz, Elisabeth; Pristoynik, Petra; Blaschitz, Astrid; Dohr, Gottfried] Med Univ Graz, Inst Cell Biol Histol & Embryol, Harrachgasse 21-7, A-8010 Graz, Austria; [Madl, Tobias] Med Univ Graz, Inst Mol Biol & Biochem, Graz, Austria; [Graef, Franziska A.; Heidenreich, Steffi; Schumann, Anne; Knauer, Miriam; Muenzner, Matthias; Schupp, Michael] Charite, Cardiovasc Res Ctr, Inst Pharmacol, Hess Str 3-4, D-10115 Berlin, Germany; [Bogner-Strauss, Juliane G.] Graz Univ Technol, Inst Biochem, Graz, Austria; [Schulz, Tim J.] German Inst Human Nutr, Dept Adipocyte Dev & Nutr, Potsdam, Germany; [Schulz, Tim J.] German Ctr Diabet Res DZD, Munich, Germany	Medical University of Graz; Medical University of Graz; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Graz University of Technology; Deutsches Institut fur Ernahrungsforschung Potsdam-Rehbrucke (DIfE)	Prokesch, A (corresponding author), Med Univ Graz, Inst Cell Biol Histol & Embryol, Harrachgasse 21-7, A-8010 Graz, Austria.; Schupp, M (corresponding author), Charite, Cardiovasc Res Ctr, Inst Pharmacol, Hess Str 3-4, D-10115 Berlin, Germany.	andreas.prokesch@medunigraz.at; michael.schupp@charite.de	Schulz, Tim/F-4842-2013; Madl, Tobias/B-1682-2012; Dohr, Gottfried/E-8070-2010; PROKESCH, ANDREAS/B-6786-2019	Schulz, Tim/0000-0002-8413-3972; Madl, Tobias/0000-0002-9725-5231; Graef, Franziska/0000-0002-7492-4447; PROKESCH, ANDREAS/0000-0002-8487-7103; Schupp, Michael/0000-0003-3720-1052	Franz-Lanyar grant, a starting grant of the Medical University Graz [389]; Austrian Science Fund (FWF) [P29328-B26]; German Research Foundation (DFG; Emmy Noether Grant) [SCHU 2546/1-1]; Career Integration grant from the European Union (CIG) [291867]; German Research Foundation [SCHU 2445/2-1]; European Research Council [ERC-StG-2012-311082]; German Center for Diabetes Research (DZD)	Franz-Lanyar grant, a starting grant of the Medical University Graz; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); German Research Foundation (DFG; Emmy Noether Grant)(German Research Foundation (DFG)); Career Integration grant from the European Union (CIG); German Research Foundation(German Research Foundation (DFG)); European Research Council(European Research Council (ERC)European Commission); German Center for Diabetes Research (DZD)	A.P. was supported by a Franz-Lanyar grant (389), a starting grant of the Medical University Graz, and a grant from the Austrian Science Fund (FWF; P29328-B26). M.S. was supported by the German Research Foundation (DFG; Emmy Noether Grant SCHU 2546/1-1) and a Career Integration grant from the European Union (CIG; 291867). T.J.S. was supported by the German Research Foundation (SCHU 2445/2-1), the European Research Council (ERC-StG-2012-311082), and the German Center for Diabetes Research (DZD). A. P. is grateful to D. Kummer for help with bioinformatic quantification of histology images, to R. Malli (both from Medical University Graz) for providing AMPK siRNAs, and to QPS Hepatic Biosciences for provision of primary human hepatocytes.	Aguilar V, 2010, EMBO MOL MED, V2, P338, DOI 10.1002/emmm.201000089; AIKAWA T, 1973, J BIOCHEM, V74, P1003; Allen MA, 2014, ELIFE, V3, DOI 10.7554/eLife.02200; Armata HL, 2010, MOL CELL BIOL, V30, P5787, DOI 10.1128/MCB.00347-10; BAQUET A, 1991, BIOCHEM J, V273, P57, DOI 10.1042/bj2730057; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Berkers CR, 2013, CELL METAB, V18, P617, DOI 10.1016/j.cmet.2013.06.019; BRESSAC B, 1990, P NATL ACAD SCI USA, V87, P1973, DOI 10.1073/pnas.87.5.1973; Burgess SC, 2007, CELL METAB, V5, P313, DOI 10.1016/j.cmet.2007.03.004; Cui Q, 2008, NAT BIOTECHNOL, V26, P162, DOI 10.1038/nbt0208-162; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; DONEHOWER LA, 1992, NATURE, V356, P215, DOI 10.1038/356215a0; Fajas L, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00004; Fischer M, 2014, CELL CYCLE, V13, P3037, DOI 10.4161/15384101.2014.949083; Goldstein I, 2013, CANCER METAB, V1, DOI 10.1186/2049-3002-1-9; Goldstein I, 2012, TRENDS ENDOCRIN MET, V23, P567, DOI 10.1016/j.tem.2012.06.007; Goldstein I, 2012, J HEPATOL, V56, P656, DOI 10.1016/j.jhep.2011.08.022; Guan HP, 2009, J BIOL CHEM, V284, P24644, DOI 10.1074/jbc.M109.034397; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Imamura K, 2001, BIOCHEM BIOPH RES CO, V287, P562, DOI 10.1006/bbrc.2001.5627; Jones RG, 2005, MOL CELL, V18, P283, DOI 10.1016/j.molcel.2005.03.027; Junttila MR, 2009, NAT REV CANCER, V9, P821, DOI 10.1038/nrc2728; Katz S. F., 2012, GASTROENTEROLOGY, V142; Kung CP, 2016, CELL REP, V14, P2413, DOI 10.1016/j.celrep.2016.02.037; Lee JM, 2014, NATURE, V516, P112, DOI 10.1038/nature13961; LEVITAN IB, 1980, BRAIN RES, V187, P415, DOI 10.1016/0006-8993(80)90212-7; Liu K, 2013, CELL DEATH DIFFER, V20, P3, DOI 10.1038/cdd.2012.63; Liu Y, 2014, P NATL ACAD SCI USA, V111, pE2414, DOI 10.1073/pnas.1315605111; Longo VD, 2014, CELL METAB, V19, P181, DOI 10.1016/j.cmet.2013.12.008; Ma WZ, 2007, J BIOENERG BIOMEMBR, V39, P243, DOI 10.1007/s10863-007-9083-0; Maiuri MC, 2010, CURR OPIN CELL BIOL, V22, P181, DOI 10.1016/j.ceb.2009.12.001; Marino S, 2000, GENE DEV, V14, P994; Matoba S, 2006, SCIENCE, V312, P1650, DOI 10.1126/science.1126863; Minamino T, 2009, NAT MED, V15, P1082, DOI 10.1038/nm.2014; Muller PAJ, 2014, CANCER CELL, V25, P304, DOI 10.1016/j.ccr.2014.01.021; Perry ME, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000968; Prokesch A, 2016, SCI REP-UK, V6, DOI 10.1038/srep23723; Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107; Schupp M, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-758; Schupp M, 2009, J BIOL CHEM, V284, P9458, DOI 10.1074/jbc.M809498200; Sermeus A, 2013, J CELL PHYSIOL, V228, P2365, DOI 10.1002/jcp.24409; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tschaharganeh DF, 2016, CELL, V165, P1546, DOI 10.1016/j.cell.2016.05.058; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Vousden KH, 2009, NAT REV CANCER, V9, P691, DOI 10.1038/nrc2715; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; Wang WG, 2011, CANCER BIOL THER, V12, P229, DOI 10.4161/cbt.12.3.17033; Wang XW, 2013, J MOL CELL BIOL, V5, P147, DOI 10.1093/jmcb/mjs064; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Wilson CG, 2010, ENDOCRINOLOGY, V151, P5174, DOI 10.1210/en.2010-0379; Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529; Zhang P, 2014, P NATL ACAD SCI USA, V111, P10684, DOI 10.1073/pnas.1411026111	53	46	46	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					732	742		10.1096/fj.201600845R	http://dx.doi.org/10.1096/fj.201600845R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27811061	Green Published, hybrid			2022-12-28	WOS:000394235400025
J	Zhang, C; Zhou, LW; Zhang, F; Lu, DY; Li, N; Zheng, L; Xu, YH; Li, Z; Sun, SJ; Long, M				Zhang, Chen; Zhou, Luwen; Zhang, Fan; Lu, Dongyuan; Li, Ning; Zheng, Lu; Xu, Yanhong; Li, Zhan; Sun, Shujin; Long, Mian			Mechanical remodeling of normally sized mammalian cells under a gravity vector	FASEB JOURNAL			English	Article						gravity-directed; mechanosensing; nucleus translocation; cytoskeletal remodeling; FAC reorganization	FOCAL ADHESION DYNAMICS; ROS 17/2.8 CELLS; NANOSCALE ARCHITECTURE; ACTIN; FORCE; MECHANOTRANSDUCTION; CYTOSKELETON; STRESS; TALIN; MICROTUBULES	Translocation of the dense nucleus along a gravity vector initiates mechanical remodeling of a cell, but the underlying mechanisms of cytoskeletal network and focal adhesion complex (FAC) reorganization in a mammalian cell remain unclear. We quantified the remodeling of an MC3T3-E1 cell placed in upward-, downward-, or edge-on-orientated substrate. Nucleus longitudinal translocation presents a high value in downward orientation at 24 h or in edge-on orientation at 72 h, which is consistent with orientation-dependent distribution of perinuclear actin stress fibers and vimentin cords. Redistribution of total FAC area and fractionized super mature adhesion number coordinates this dependence at short duration. This orientation-dependent remodeling is associated with nucleus flattering and lamin A/C phosphorylation. Actin depolymerization or Rho-associated protein kinase signaling inhibition abolishes the orientation dependence of nucleus translocation, whereas tubulin polymerization inhibition or vimentin disruption reserves the dependence. A biomechanical model is therefore proposed for integrating the mechanosensing of nucleus translocation with cytoskeletal remodeling and FAC reorganization induced by a gravity vector.	[Zhang, Chen; Zhou, Luwen; Zhang, Fan; Lu, Dongyuan; Li, Ning; Zheng, Lu; Xu, Yanhong; Li, Zhan; Sun, Shujin; Long, Mian] Chinese Acad Sci, Ctr Biomech & Bioengn, Key Lab Micrograv, Natl Micrograv Lab, Beijing, Peoples R China; [Zhang, Chen; Zhou, Luwen; Zhang, Fan; Lu, Dongyuan; Li, Ning; Zheng, Lu; Xu, Yanhong; Li, Zhan; Sun, Shujin; Long, Mian] Chinese Acad Sci, Inst Mech, Beijing Key Lab Engn Construct & Mechanobiol, Beijing, Peoples R China; [Long, Mian] Chinese Acad Sci, Inst Mech, 15 North 4th Ring Rd, Beijing 100190, Peoples R China	Chinese Academy of Sciences; Chinese Academy of Sciences; Institute of Mechanics, CAS; Chinese Academy of Sciences; Institute of Mechanics, CAS	Long, M (corresponding author), Chinese Acad Sci, Inst Mech, 15 North 4th Ring Rd, Beijing 100190, Peoples R China.	mlong@imech.ac.cn			National Key Basic Research Foundation of China [2011CB710904]; Strategic Priority Research Program [XDA04020219, XDA01030102]; National Natural Science Foundation of China [31110103918]; National High Technology Research and Development Program of China [2011AA020109]	National Key Basic Research Foundation of China(National Basic Research Program of China); Strategic Priority Research Program(Chinese Academy of Sciences); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China)	The authors thank Dr. Yan Zhang (Institute of Mechanics, Chinese Academy of Sciences), for technical assistance. This work was supported by National Key Basic Research Foundation of China Grant 2011CB710904, Strategic Priority Research Program Grants XDA04020219 and XDA01030102, National Natural Science Foundation of China Grant 31110103918, and National High Technology Research and Development Program of China Grant 2011AA020109.	Bershadsky AD, 2006, EUR J CELL BIOL, V85, P165, DOI 10.1016/j.ejcb.2005.11.001; Biggs MJP, 2007, J ORTHOP RES, V25, P273, DOI 10.1002/jor.20319; Brangwynne CP, 2011, P NATL ACAD SCI USA, V108, P4334, DOI 10.1073/pnas.1017150108; Cassidy JW, 2014, ACTA BIOMATER, V10, P651, DOI 10.1016/j.actbio.2013.11.008; Chambliss AB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01087; Christophorou N, 2015, NAT CELL BIOL, V17, P1388, DOI 10.1038/ncb3249; Dahl KN, 2008, CIRC RES, V102, P1307, DOI 10.1161/CIRCRESAHA.108.173989; del Rio A, 2009, SCIENCE, V323, P638, DOI 10.1126/science.1162912; Ezratty EJ, 2005, NAT CELL BIOL, V7, P581, DOI 10.1038/ncb1262; Feric M, 2013, NAT CELL BIOL, V15, P1253, DOI 10.1038/ncb2830; Franz CM, 2005, J CELL SCI, V118, P5315, DOI 10.1242/jcs.02653; George TF, 2011, COMPUTATIONAL STUDIE; Guignandon A, 1997, EXP CELL RES, V236, P66, DOI 10.1006/excr.1997.3703; Hanggi P, 2002, CHEMPHYSCHEM, V3, P285, DOI 10.1002/1439-7641(20020315)3:3<285::AID-CPHC285>3.0.CO;2-A; Helmstetter CE, 1997, P NATL ACAD SCI USA, V94, P10195, DOI 10.1073/pnas.94.19.10195; Hoffman BD, 2011, NATURE, V475, P316, DOI 10.1038/nature10316; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Ihalainen TO, 2015, NAT MATER, V14, P1252, DOI [10.1038/NMAT4389, 10.1038/nmat4389]; Kacena MA, 2002, CYTOTECHNOLOGY, V39, P147, DOI 10.1023/A:1023936503105; Kanchanawong P, 2010, NATURE, V468, P580, DOI 10.1038/nature09621; Li H, 2010, SCI CHINA LIFE SCI, V53, P1085, DOI 10.1007/s11427-010-4057-6; Li Y, 2015, BIOPHYS J, V109, P670, DOI 10.1016/j.bpj.2015.07.006; Liu JR, 2015, P NATL ACAD SCI USA, V112, pE4864, DOI 10.1073/pnas.1512025112; Maraldi M, 2014, BIOPHYS J, V106, P1890, DOI 10.1016/j.bpj.2014.03.027; Meloni MA, 2011, CYTOSKELETON, V68, P125, DOI 10.1002/cm.20499; MESLAND DAM, 1992, ADV SPACE RES-SERIES, V12, P15, DOI 10.1016/0273-1177(92)90259-Z; Morita MT, 2010, ANNU REV PLANT BIOL, V61, P705, DOI 10.1146/annurev.arplant.043008.092042; Neelam S, 2015, P NATL ACAD SCI USA, V112, P5720, DOI 10.1073/pnas.1502111112; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Qi R, 2015, J CELL SCI, V128, P2830, DOI 10.1242/jcs.164566; ROBERTS WE, 1982, AM J ANAT, V165, P373, DOI 10.1002/aja.1001650403; Schaedel L, 2015, NAT MATER, V14, P1156, DOI [10.1038/NMAT4396, 10.1038/nmat4396]; Schwarz US, 2002, BIOPHYS J, V83, P1380, DOI 10.1016/S0006-3495(02)73909-X; Singh KP, 2010, J CELL BIOCHEM, V111, P123, DOI 10.1002/jcb.22674; Sugawara Y, 2005, BONE, V36, P877, DOI 10.1016/j.bone.2004.10.008; Swift J, 2013, SCIENCE, V341, DOI 10.1126/science.1240104; Tamiello C, 2015, SCI REP-UK, V5, DOI 10.1038/srep08752; Ulbrich C, 2011, CELL PHYSIOL BIOCHEM, V28, P185, DOI 10.1159/000331730; Van Loon JJWA, 2009, J MICROSC-OXFORD, V233, P234, DOI 10.1111/j.1365-2818.2009.03113.x; Vassy J., 2001, FASEB Journal, V15, P1104; Vorselen D, 2014, FASEB J, V28, P536, DOI 10.1096/fj.13-236356; Wegener J, 1998, EUR BIOPHYS J BIOPHY, V28, P26, DOI 10.1007/s002490050180; Wehrle-Haller B, 2003, INT J BIOCHEM CELL B, V35, P39, DOI 10.1016/S1357-2725(02)00071-7; WOROFKA R, 1978, BIOCHIM BIOPHYS ACTA, V518, P61, DOI 10.1016/0005-2787(78)90116-8; WYROBEK AJ, 1976, BIOPHYS J, V16, P811, DOI 10.1016/S0006-3495(76)85730-X	45	14	15	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					802	813		10.1096/fj.201600897RR	http://dx.doi.org/10.1096/fj.201600897RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27871065	Green Submitted			2022-12-28	WOS:000394235400032
J	Schaaf, MBE; Keulers, TG; Vooijs, MA; Rouschop, KMA				Schaaf, Marco B. E.; Keulers, Tom G.; Vooijs, Marc A.; Rouschop, Kasper M. A.			LC3/GABARAP family proteins: autophagy-(un) related functions	FASEB JOURNAL			English	Article						cancer; ATG7; Atg8 orthologues; autophagosome	RECEPTOR-ASSOCIATED PROTEIN; GABA(A) RECEPTOR; AUTOPHAGOSOME BIOGENESIS; SKELETAL-MUSCLE; MEMBRANE-FUSION; ANTIBACTERIAL AUTOPHAGY; REGULATES AUTOPHAGY; GLYCOGEN-METABOLISM; COLORECTAL-CANCER; PLASMA-MEMBRANE	From yeast to mammals, autophagy is an important mechanism for sustaining cellular homeostasis through facilitating the degradation and recycling of aged and cytotoxic components. During autophagy, cargo is captured in double-membraned vesicles, the autophagosomes, and degraded through lysosomal fusion. In yeast, autophagy initiation, cargo recognition, cargo engulfment, and vesicle closure is Atg8 dependent. In higher eukaryotes, Atg8 has evolved into the LC3/GABARAP protein family, consisting of 7 family proteins [LC3A(2 splice variants), LC3B, LC3C, GABARAP, GABARAPL1, and GABARAPL2]. LC3B, the most studied family protein, is associated with autophagosome development and maturation and is used to monitor autophagic activity. Given the high homology, the other LC3/GABARAP family proteins are often presumed to fulfill similar functions. Nevertheless, substantial evidence shows that the LC3/GABARAP family proteins are unique in function and important in autophagy-independent mechanisms. In this review, we discuss the current knowledge and functions of the LC3/GABARAP family proteins. We focus on processing of the individual family proteins and their role in autophagy initiation, cargo recognition, vesicle closure, and trafficking, a complex and tightly regulated process that requires selective presentation and recruitment of these family proteins. In addition, functions unrelated to autophagy of the LC3/GABARAP protein family members are discussed.-Schaaf, M. B. E., Keulers, T. G, Vooijs, M. A., Rouschop, K. M. A. LC3/GABARAP family proteins: autophagy-(un) related functions.	[Schaaf, Marco B. E.; Keulers, Tom G.; Vooijs, Marc A.; Rouschop, Kasper M. A.] Maastricht Univ, Med Ctr, Dept Radiat Oncol, Maastro Lab,GROW Sch Oncol & Dev Biol, Maastricht, Netherlands	Maastricht University	Rouschop, KMA (corresponding author), Maastricht Univ, Med Ctr, Univ Singel 50,Room 3-318, NL-6200 MD Maastricht, Netherlands.	kasper.rouschop@maastrichtuniversity.nl	Vooijs, Marc/K-3522-2019	Rouschop, Kasper/0000-0002-4208-5415	Dutch Cancer Society (KWF) [UM 2012-5506, 2015-7735]; Worldwide Cancer Research Award [16-0265]; European Research Council under the European Union's Seventh Framework Programme (FP)/ERC Grant [617060]	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Worldwide Cancer Research Award; European Research Council under the European Union's Seventh Framework Programme (FP)/ERC Grant(European Research Council (ERC))	The authors apologize to researchers whose work could not be included due to the extensive field of autophagy. This work was supported by the Dutch Cancer Society (KWF) Grants UM 2012-5506 and 2015-7735 (to K.R.), Worldwide Cancer Research Award 16-0265 (to K.R.), and European Research Council under the European Union's Seventh Framework Programme (FP) 2007-2013/ERC Grant Agreement 617060 (to M.V.).	Alam J, 2010, REGUL PEPTIDES, V159, P78, DOI 10.1016/j.regpep.2009.09.002; Alemu EA, 2012, J BIOL CHEM, V287, DOI 10.1074/jbc.M112.378109; Axe EL, 2008, J CELL BIOL, V182, P685, DOI 10.1083/jcb.200803137; B'chir W, 2013, NUCLEIC ACIDS RES, V41, P7683, DOI 10.1093/nar/gkt563; Bai H, 2012, ONCOGENE, V31, P4397, DOI 10.1038/onc.2011.613; Behrends C, 2010, NATURE, V466, P68, DOI 10.1038/nature09204; Betin VMS, 2009, J CELL SCI, V122, P2554, DOI 10.1242/jcs.046250; Boyer-Guittaut M, 2014, AUTOPHAGY, V10, P986, DOI 10.4161/auto.28390; Burman C, 2010, FEBS LETT, V584, P1302, DOI 10.1016/j.febslet.2010.01.011; Cali T, 2008, BIOCHEM BIOPH RES CO, V371, P405, DOI 10.1016/j.bbrc.2008.04.098; Cemma M, 2016, AUTOPHAGY, V12, P1440, DOI 10.1080/15548627.2016.1191724; Chanturiya A, 2000, J MEMBRANE BIOL, V176, P67, DOI 10.1007/s002320001076; Chauhan S, 2013, MOL CELL, V50, P16, DOI 10.1016/j.molcel.2013.01.024; Chen CG, 2011, J BIOL CHEM, V286, P15106, DOI 10.1074/jbc.M111.230896; Chen DD, 2012, MOL CELL, V45, P629, DOI 10.1016/j.molcel.2011.12.036; Chen ZW, 2007, J NEUROSCI, V27, P6655, DOI 10.1523/JNEUROSCI.0919-07.2007; Cherra SJ, 2010, J CELL BIOL, V190, P533, DOI 10.1083/jcb.201002108; Choi S, 2014, BIOCHEM BIOPH RES CO, V443, P56, DOI 10.1016/j.bbrc.2013.11.044; Clausen TH, 2010, AUTOPHAGY, V6, P330, DOI 10.4161/auto.6.3.11226; Comes F, 2007, CELL DEATH DIFFER, V14, P693, DOI 10.1038/sj.cdd.4402076; Cook JL, 2008, CIRC RES, V102, P1539, DOI 10.1161/CIRCRESAHA.108.176594; Cowey CL, 2009, CURR ONCOL REP, V11, P94, DOI 10.1007/s11912-009-0015-5; Coyle JE, 2002, NEURON, V33, P63, DOI 10.1016/S0896-6273(01)00558-X; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Fader CM, 2009, CELL DEATH DIFFER, V16, P70, DOI 10.1038/cdd.2008.168; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Fullgrabe J, 2014, NAT REV MOL CELL BIO, V15, P65, DOI 10.1038/nrm3716; Genau HM, 2015, MOL CELL, V57, P995, DOI 10.1016/j.molcel.2014.12.040; Geng JF, 2008, EMBO REP, V9, P859, DOI 10.1038/embor.2008.163; Giatromanolaki A, 2015, LUNG CANCER, V90, P98, DOI 10.1016/j.lungcan.2015.07.008; Huang J, 2009, P NATL ACAD SCI USA, V106, P6226, DOI 10.1073/pnas.0811045106; Huang R, 2015, MOL CELL, V57, P456, DOI 10.1016/j.molcel.2014.12.013; Ichimura Y, 2000, NATURE, V408, P488, DOI 10.1038/35044114; Ishihara N, 2001, MOL BIOL CELL, V12, P3690, DOI 10.1091/mbc.12.11.3690; Jacob TC, 2005, J NEUROSCI, V25, P10469, DOI 10.1523/JNEUROSCI.2267-05.2005; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jensen D, 2011, J CELL SCI, V124, P1, DOI 10.1242/jcs.069773; Jiang SX, 2011, BIOCHEM BIOPH RES CO, V413, P420, DOI 10.1016/j.bbrc.2011.08.106; Jiang SX, 2010, J BIOL CHEM, V285, P34960, DOI 10.1074/jbc.M110.150839; Kabeya Y, 2004, J CELL SCI, V117, P2805, DOI 10.1242/jcs.01131; Kang YA, 2012, MOL CELL BIOL, V32, P226, DOI 10.1128/MCB.06166-11; Kaufmann A, 2014, CELL, V156, P469, DOI 10.1016/j.cell.2013.12.022; Keulers TG, 2015, RADIOTHER ONCOL, V116, P417, DOI 10.1016/j.radonc.2015.06.023; Kirkin V, 2009, MOL CELL, V33, P505, DOI 10.1016/j.molcel.2009.01.020; Kittler JT, 2001, MOL CELL NEUROSCI, V18, P13, DOI 10.1006/mcne.2001.1005; Klebig C, 2005, CANCER RES, V65, P394; Kneussel M, 2000, P NATL ACAD SCI USA, V97, P8594, DOI 10.1073/pnas.97.15.8594; Kneussel M, 1999, J NEUROSCI, V19, P9289, DOI 10.1523/jneurosci.19-21-09289.1999; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Labonte D, 2014, EUR J CELL BIOL, V93, P338, DOI 10.1016/j.ejcb.2014.07.007; Lainez S, 2010, FASEB J, V24, P1958, DOI 10.1096/fj.09-151472; Lamb CA, 2013, NAT REV MOL CELL BIO, V14, P759, DOI 10.1038/nrm3696; Lazarou M, 2015, NATURE, V524, P309, DOI 10.1038/nature14893; Legesse-Miller A, 1998, J BIOL CHEM, V273, P3105, DOI 10.1074/jbc.273.5.3105; Leil TA, 2004, J NEUROSCI, V24, P11429, DOI 10.1523/JNEUROSCI.3355-04.2004; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Li DD, 2009, ONCOGENE, V28, P886, DOI 10.1038/onc.2008.441; Liu HY, 2009, J BIOL CHEM, V284, P31484, DOI 10.1074/jbc.M109.033936; Liu L, 2012, NAT CELL BIOL, V14, P177, DOI 10.1038/ncb2422; Lu KF, 2014, CELL, V158, P549, DOI 10.1016/j.cell.2014.05.048; Lystad AH, 2014, EMBO REP, V15, P557, DOI 10.1002/embr.201338003; Ma D, 2011, EMBO J, V30, P4642, DOI 10.1038/emboj.2011.322; Malicdan MCV, 2012, BRAIN PATHOL, V22, P82, DOI 10.1111/j.1750-3639.2011.00543.x; Mammucari C, 2007, CELL METAB, V6, P458, DOI 10.1016/j.cmet.2007.11.001; Mandell MA, 2014, AUTOPHAGY, V10, P2387, DOI 10.4161/15548627.2014.984278; Mansuy V, 2004, BIOCHEM BIOPH RES CO, V325, P639, DOI 10.1016/j.bbrc.2004.10.072; Martinez J, 2016, NATURE, V533, P115, DOI 10.1038/nature17950; Martinez J, 2015, NAT CELL BIOL, V17, P893, DOI 10.1038/ncb3192; Martinez J, 2011, P NATL ACAD SCI USA, V108, P17396, DOI 10.1073/pnas.1113421108; Marx J, 2006, SCIENCE, V312, P1160, DOI 10.1126/science.312.5777.1160; McEwan DG, 2015, MOL CELL, V57, P39, DOI 10.1016/j.molcel.2014.11.006; McNew JA, 2000, J CELL BIOL, V150, P105, DOI 10.1083/jcb.150.1.105; Mikhaylova O, 2012, CANCER CELL, V21, P532, DOI 10.1016/j.ccr.2012.02.019; Mizushima N, 2002, CELL STRUCT FUNCT, V27, P421, DOI 10.1247/csf.27.421; Mohrluder J, 2007, FEBS J, V274, P5543, DOI 10.1111/j.1742-4658.2007.06073.x; Monastyrska I, 2009, BIOL REV, V84, P431, DOI 10.1111/j.1469-185X.2009.00082.x; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Nakajima K, 2012, NEURON, V76, P945, DOI 10.1016/j.neuron.2012.10.012; Nath S, 2014, NAT CELL BIOL, V16, P415, DOI 10.1038/ncb2940; Novak I, 2010, EMBO REP, V11, P45, DOI 10.1038/embor.2009.256; O'Sullivan GA, 2005, EUR J NEUROSCI, V22, P2644, DOI 10.1111/j.1460-9568.2005.04448.x; Otomo C, 2013, NAT STRUCT MOL BIOL, V20, P59, DOI 10.1038/nsmb.2431; Pankiv S, 2007, J BIOL CHEM, V282, P24131, DOI 10.1074/jbc.M702824200; Pankiv S, 2010, J CELL BIOL, V188, P253, DOI 10.1083/jcb.200907015; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Rabinowitz JD, 2010, SCIENCE, V330, P1344, DOI 10.1126/science.1193497; Romao S, 2013, J CELL BIOL, V203, P757, DOI 10.1083/jcb.201308173; Rosenbluth JM, 2009, AUTOPHAGY, V5, P114, DOI 10.4161/auto.5.1.7294; Rouschop KMA, 2010, J CLIN INVEST, V120, P127, DOI 10.1172/JCI40027; Rouschop KMA, 2009, RADIOTHER ONCOL, V92, P411, DOI 10.1016/j.radonc.2009.06.029; Sagiv Y, 2000, EMBO J, V19, P1494, DOI 10.1093/emboj/19.7.1494; Salah FS, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.93; Sanchez AMJ, 2012, J CELL BIOCHEM, V113, P695, DOI 10.1002/jcb.23399; Sanchez-Wandelmer J, 2015, J CELL SCI, V128, P185, DOI 10.1242/jcs.158758; Sanjuan MA, 2007, NATURE, V450, P1253, DOI 10.1038/nature06421; Schaaf MBE, 2013, RADIOTHER ONCOL, V108, P529, DOI 10.1016/j.radonc.2013.06.015; Sengupta A, 2009, J BIOL CHEM, V284, P28319, DOI 10.1074/jbc.M109.024406; Seo YK, 2011, CELL METAB, V13, P367, DOI 10.1016/j.cmet.2011.03.005; Settembre C, 2013, NAT CELL BIOL, V15, P647, DOI 10.1038/ncb2718; Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l; Shang LB, 2011, P NATL ACAD SCI USA, V108, P4788, DOI 10.1073/pnas.1100844108; Shpilka T, 2012, J CELL SCI, V125, P2343, DOI 10.1242/jcs.093757; Shvets E, 2011, AUTOPHAGY, V7, P683, DOI 10.4161/auto.7.7.15279; Sou Y, 2006, J BIOL CHEM, V281, P3017, DOI 10.1074/jbc.M505888200; Stadel D, 2015, MOL CELL, V60, P89, DOI 10.1016/j.molcel.2015.09.010; Sugawara K, 2004, GENES CELLS, V9, P611, DOI 10.1111/j.1356-9597.2004.00750.x; Sun T, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-161; Tanida I, 2004, J BIOL CHEM, V279, P36268, DOI 10.1074/jbc.M401461200; Tanida I, 2004, INT J BIOCHEM CELL B, V36, P2503, DOI 10.1016/j.biocel.2004.05.009; Thielmann Y, 2009, PROTEINS, V77, P637, DOI 10.1002/prot.22477; Thurston TLM, 2012, NATURE, V482, P414, DOI 10.1038/nature10744; Tumbarello DA, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005174; Verlhac P, 2015, AUTOPHAGY, V11, P965, DOI 10.1080/15548627.2015.1046672; Verlhac P, 2015, CELL HOST MICROBE, V17, P515, DOI 10.1016/j.chom.2015.02.008; Vernier-Magnin S, 2005, BBA-GENE STRUCT EXPR, V1731, P23, DOI 10.1016/j.bbaexp.2005.05.002; von Muhlinen N, 2012, MOL CELL, V48, P329, DOI 10.1016/j.molcel.2012.08.024; Wang H, 2015, BRIT J NUTR, V114, P519, DOI 10.1017/S0007114515002172; Weidberg H, 2011, DEV CELL, V20, P444, DOI 10.1016/j.devcel.2011.02.006; Weidberg H, 2010, EMBO J, V29, P1792, DOI 10.1038/emboj.2010.74; WELLS A, 1990, SCIENCE, V247, P962, DOI 10.1126/science.2305263; Wild P, 2014, J CELL SCI, V127, P3, DOI 10.1242/jcs.140426; Wild P, 2011, SCIENCE, V333, P228, DOI 10.1126/science.1205405; Wilkinson DS, 2015, MOL CELL, V57, P55, DOI 10.1016/j.molcel.2014.11.019; Wu SH, 2015, INT J CLIN EXP PATHO, V8, P3882; Xie ZP, 2008, MOL BIOL CELL, V19, P3290, DOI 10.1091/mbc.E07-12-1292; Xu P, 2011, GENE DEV, V25, P310, DOI 10.1101/gad.1984311; Zhang YQ, 2011, CELL PHYSIOL BIOCHEM, V27, P503, DOI 10.1159/000329952; Zhu YY, 2013, J BIOL CHEM, V288, P1099, DOI 10.1074/jbc.M112.399345	130	317	355	14	76	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					3961	3978		10.1096/fj.201600698R	http://dx.doi.org/10.1096/fj.201600698R			18	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27601442				2022-12-28	WOS:000388201500005
J	Ganz, AB; Shields, K; Fomin, VG; Lopez, YS; Mohan, S; Lovesky, J; Chuang, JC; Ganti, A; Carrier, B; Yan, J; Taeswuan, S; Cohen, VV; Swersky, CC; Stover, JA; Vitiello, GA; Malysheva, OV; Mudrak, E; Caudill, MA				Ganz, Ariel B.; Shields, Kelsey; Fomin, Vlad G.; Lopez, Yusnier S.; Mohan, Sanjay; Lovesky, Jessica; Chuang, Jasmine C.; Ganti, Anita; Carrier, Bradley; Yan, Jian; Taeswuan, Siraphat; Cohen, Vanessa V.; Swersky, Camille C.; Stover, Julie A.; Vitiello, Gerardo A.; Malysheva, Olga V.; Mudrak, Erika; Caudill, Marie A.			Genetic impairments in folate enzymes increase dependence on dietary choline for phosphatidylcholine production at the expense of betaine synthesis	FASEB JOURNAL			English	Article						nutrigenetics; single nucleotide polymorphisms; 1-carbon metabolism; pregnancy; lactation	HUMAN METHIONINE SYNTHASE; METHYLENETETRAHYDROFOLATE REDUCTASE; PLASMA HOMOCYSTEINE; CDNA CLONING; RISK-FACTOR; METABOLISM; ALTERS; POLYMORPHISMS; VARIANT; IDENTIFICATION	Although single nucleotide polymorphisms (SNPs) in folate-mediated pathways predict susceptibility to choline deficiency during severe choline deprivation, it is unknown if effects persist at recommended intakes. Thus, we used stable isotope liquid chromatography-mass spectrometry (LC-MS) methodology to examine the impact of candidate SNPs on choline metabolism in a long-term, randomized, controlled feeding trial among pregnant, lactating, and nonpregnant (NP) women consuming 480 or 930 mg/d choline (22% as choline-d(9), with d(9) indicating a deuterated trimethyl amine group) and meeting folate-intake recommendations. Variants impairing folate metabolism, methylenetetrahydrofolate reductase (MTHFR) rs1801133, methionine synthase (MTR) rs1805087 [wild-type (WT)], MTR reductase (MTRR) rs1801394, and methylenetetrahydrofolate dehydrogenase-methenyltetrahydrofolate cyclohydrolase-formyltetrahydrofolate synthetase (MTHFD1) rs2236225, influenced choline dynamics, frequently through interactions with reproductive state and choline intake, with fewer genotypic alterations observed among pregnant women. Women with these variants partitioned more dietary choline toward phosphatidylcholine (PC) biosynthesis via the cytidine diphosphate (CDP)-choline pathway at the expense of betaine synthesis even when use of betaine as a methyl donor was increased. Choline intakes of 930 mg/d restored partitioning of dietary choline between betaine and CDP-PC among NP (MTHFR rs1801133 and MTR rs1805087 WT) and lactating (MTHFD1 rs2236225) women with risk genotypes. Overall, our findings indicate that loss-of-function variants in folate-metabolizing enzymes strain cellular PC production, possibly via impaired folate-dependent phosphatidylethanolamine-N-methyltransferase (PEMT)-PC synthesis, and suggest that women with these risk genotypes may benefit from choline intakes exceeding current recommendations.	[Ganz, Ariel B.; Shields, Kelsey; Fomin, Vlad G.; Lopez, Yusnier S.; Mohan, Sanjay; Lovesky, Jessica; Chuang, Jasmine C.; Ganti, Anita; Carrier, Bradley; Yan, Jian; Taeswuan, Siraphat; Cohen, Vanessa V.; Swersky, Camille C.; Stover, Julie A.; Vitiello, Gerardo A.; Malysheva, Olga V.; Caudill, Marie A.] Cornell Univ, Div Nutr Sci, 228 Savage Hall, Ithaca, NY 14850 USA; [Mudrak, Erika] Cornell Univ, Stat Consulting Unit, Ithaca, NY USA	Cornell University; Cornell University	Caudill, MA (corresponding author), Cornell Univ, Div Nutr Sci, 228 Savage Hall, Ithaca, NY 14850 USA.	mac379@cornell.edu		Taesuwan, Siraphat/0000-0002-0140-4942; Mohan, Sanjay/0000-0001-8960-2507; Vitiello, Gerardo/0000-0002-7452-8903	U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases [T32-DK007158]; U.S. Department of Agriculture, National Institute of Food and Agriculture (Hatch Project) [231646]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK007158] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. Department of Agriculture, National Institute of Food and Agriculture (Hatch Project); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A.B.G. thanks Leslie Ruff and LeClairRyan (New York, New York, USA) for generously sharing office space during the writing of the manuscript. This work was supported by the U.S. National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases (T32-DK007158), and by the U.S. Department of Agriculture, National Institute of Food and Agriculture (Hatch Project 231646). The content is the responsibility of the authors.	Akbari MT, 2015, CANCER EPIDEMIOL, V39, P1023, DOI 10.1016/j.canep.2015.11.002; [Anonymous], 2014, R LANG ENV STAT COMP; Boyles AL, 2006, ENVIRON HEALTH PERSP, V114, P1547, DOI 10.1289/ehp.9166; Caudill M. A., 2012, BIOCH PHYSL MOL ASPE, P565; Chen LH, 1997, J BIOL CHEM, V272, P3628, DOI 10.1074/jbc.272.6.3628; Chester DN., 2011, DIETARY INTAKES CHOL; Chew TW, 2011, J NUTR, V141, P1475, DOI 10.3945/jn.111.138859; Christensen KE, 2009, HUM MUTAT, V30, P212, DOI 10.1002/humu.20830; da Costa KA, 2006, FASEB J, V20, P1336, DOI 10.1096/fj.06-5734com; da Costa KA, 2014, FASEB J, V28, P2970, DOI 10.1096/fj.14-249557; Davenport C, 2015, J NUTR BIOCHEM, V26, P903, DOI 10.1016/j.jnutbio.2015.03.004; Fischer LM, 2007, AM J CLIN NUTR, V85, P1275; Fox JT, 2008, VITAM HORM, V79, P1, DOI 10.1016/S0083-6729(08)00401-9; FROSST P, 1995, NAT GENET, V10, P111, DOI 10.1038/ng0595-111; Galbiatti ALS, 2010, BRAZ J MED BIOL RES, V43, P445, DOI 10.1590/S0100-879X2010007500034; Glunde K, 2011, NAT REV CANCER, V11, P835, DOI 10.1038/nrc3162; Guinotte CL, 2003, J NUTR, V133, P1272; Harmon DL, 1999, GENET EPIDEMIOL, V17, P298, DOI 10.1002/(SICI)1098-2272(199911)17:4<298::AID-GEPI5>3.0.CO;2-V; Hol FA, 1998, CLIN GENET, V53, P119; Innis SM, 2008, BRAIN RES, V1237, P35, DOI 10.1016/j.brainres.2008.08.078; Jacobs RL, 2005, J BIOL CHEM, V280, P28299, DOI 10.1074/jbc.M501971200; Jiang XY, 2014, TRENDS ENDOCRIN MET, V25, P263, DOI 10.1016/j.tem.2014.02.001; Jiang XY, 2014, J CELL PHYSIOL, V229, P1016, DOI 10.1002/jcp.24526; Jiang XY, 2012, FASEB J, V26, P3563, DOI 10.1096/fj.12-207894; KANG SS, 1991, AM J HUM GENET, V48, P536; Kim JK, 2005, BIOSCI BIOTECH BIOCH, V69, P1331, DOI 10.1271/bbb.69.1331; Leclerc D, 1996, HUM MOL GENET, V5, P1867, DOI 10.1093/hmg/5.12.1867; Niculescu MD, 2002, J NUTR, V132, p2333S, DOI 10.1093/jn/132.8.2333S; Olteanu H, 2002, BIOCHEMISTRY-US, V41, P13378, DOI 10.1021/bi020536s; Pitkin RM, 2007, AM J CLIN NUTR, V85, p285S, DOI 10.1093/ajcn/85.1.285S; Pynn CJ, 2011, J LIPID RES, V52, P399, DOI 10.1194/jlr.d011916; Reo NV, 2002, BBA-MOL CELL BIOL L, V1580, P171, DOI 10.1016/S1388-1981(01)00202-5; Shaw GM, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-49; Shaw GM, 2004, AM J EPIDEMIOL, V160, P102, DOI 10.1093/aje/kwh187; Silaste ML, 2001, J NUTR, V131, P2643, DOI 10.1093/jn/131.10.2643; Silver MJ, 2015, FASEB J, V29, P3426, DOI 10.1096/fj.15-271056; WALD N, 1991, LANCET, V338, P131; West AA, 2013, AM J CLIN NUTR, V97, P718, DOI 10.3945/ajcn.112.050211; Wilson A, 1999, MOL GENET METAB, V67, P317, DOI 10.1006/mgme.1999.2879; Yan J, 2013, AM J CLIN NUTR, V98, P1459, DOI 10.3945/ajcn.113.066092; Yan J, 2012, AM J CLIN NUTR, V95, P1060, DOI 10.3945/ajcn.111.022772; Yan JA, 2011, AM J CLIN NUTR, V93, P348, DOI 10.3945/ajcn.110.005975	42	29	29	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3321	3333		10.1096/fj.201500138RR	http://dx.doi.org/10.1096/fj.201500138RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27342765	Green Published			2022-12-28	WOS:000384329800006
J	Jorgensen, EM; Alderman, MH; Taylor, HS				Jorgensen, Elisa M.; Alderman, Myles H., III; Taylor, Hugh S.			Preferential epigenetic programming of estrogen response after in utero xenoestrogen (bisphenol-A) exposure	FASEB JOURNAL			English	Article						endocrine disruptor; methylation; ER binding; uterus	MAMMARY-GLAND; ENDOCRINE DISRUPTORS; REPRODUCTIVE HEALTH; GENE-EXPRESSION; AMNIOTIC-FLUID; BREAST-CANCER; RECEPTOR; HYPERMETHYLATION; MECHANISM; ALTERS	Bisphenol-A (BPA) is an environmentally ubiquitous estrogen-like endocrine-disrupting compound. Exposure to BPA in utero has been linked to female reproductive disorders, including endometrial hyperplasia and breast cancer. Estrogens are an etiological factor in many of these conditions. We sought to determine whether in utero exposure to BPA altered the global CpG methylation pattern of the uterine genome, subsequent gene expression, and estrogen response. Pregnant mice were exposed to an environmentally relevant dose of BPA or DMSO control. Uterine DNA and RNA were examined by using methylated DNA immunoprecipitation methylation microarray, expression microarray, and quantitative PCR. In utero BPA exposure altered the global CpG methylation profile of the uterine genome and subsequent gene expression. The effect on gene expression was not apparent until sexual maturation, which suggested that estrogen response was the primary alteration. Indeed, prenatal BPA exposure preferentially altered adult estrogen-responsive gene expression. Changes in estrogen response were accompanied by altered methylation that preferentially affected estrogen receptor- (ER)-binding genes. The majority of genes that demonstrated both altered expression and ER binding had decreased methylation. BPA selectively altered the normal developmental programming of estrogen-responsive genes via modification of the genes that bind ER. Gene-environment interactions driven by early life xenoestrogen exposure likely contributes to increased risk of estrogen-related disease in adults.Jorgensen, E. M., Alderman, M. H., III, Taylor, H. S. Preferential epigenetic programming of estrogen response after in utero xenoestrogen (bisphenol-A) exposure.	[Jorgensen, Elisa M.; Alderman, Myles H., III; Taylor, Hugh S.] Yale Univ, Sch Med, 333 Cedar St,POB 208063, New Haven, CT 06520 USA	Yale University	Taylor, HS (corresponding author), Yale Univ, Sch Med, 333 Cedar St,POB 208063, New Haven, CT 06520 USA.	hugh.taylor@yale.edu		Alderman III, Myles/0000-0001-8515-1462; Jorgensen, Elisa/0000-0002-6405-867X	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01-HD076422]; NIH National Institute of Environmental Health Sciences [R01-ES010610]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD076422] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010610] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development; NIH National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	The authors thank Aiping Lin (Department of Biostatistics, Yale University) and Xiaoqing Yu (Department of Public Health, Yale University) for assistance with data analysis. This work was supported by U.S. National Institutes of Health (NIH) Eunice Kennedy Shriver National Institute of Child Health and Human Development Grant R01-HD076422; and NIH National Institute of Environmental Health Sciences Grant R01-ES010610. Author contributions: E. M. Jorgensen, M. H. Alderman, and H. S. Taylor designed the research, analyzed data, and wrote the paper. E. M. Jorgensen and M. H. Alderman performed the research. The authors declare no conflicts of interest.	Adewale HB, 2009, BIOL REPROD, V81, P690, DOI 10.1095/biolreprod.109.078261; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Bromer JG, 2010, FASEB J, V24, P2273, DOI 10.1096/fj.09-140533; Bromer JG, 2009, ENDOCRINOLOGY, V150, P3376, DOI 10.1210/en.2009-0071; COLBORN T, 1993, ENVIRON HEALTH PERSP, V101, P378, DOI 10.2307/3431890; Crain DA, 2008, FERTIL STERIL, V90, P911, DOI 10.1016/j.fertnstert.2008.08.067; Delmas AL, 2011, CARCINOGENESIS, V32, P1625, DOI 10.1093/carcin/bgr193; Doherty Leo F., 2010, Hormones & Cancer, V1, P146, DOI 10.1007/s12672-010-0015-9; Dolinoy DC, 2007, P NATL ACAD SCI USA, V104, P13056, DOI 10.1073/pnas.0703739104; Engel SM, 2006, REPROD TOXICOL, V21, P110, DOI 10.1016/j.reprotox.2005.07.007; FOLKMAN J, 1971, NEW ENGL J MED, V285, P404, DOI 10.1056/NEJM197108122850711; Gendler SJ, 2001, J MAMMARY GLAND BIOL, V6, P339, DOI 10.1023/A:1011379725811; Haghnegahdar H, 2000, J LEUKOCYTE BIOL, V67, P53, DOI 10.1002/jlb.67.1.53; Hewitt SC, 2012, MOL ENDOCRINOL, V26, P887, DOI 10.1210/me.2011-1311; Hiroi H, 1999, ENDOCR J, V46, P773, DOI 10.1507/endocrj.46.773; Holder AM, 2013, BREAST CANCER RES TR, V137, P319, DOI 10.1007/s10549-012-2354-4; Howdeshell KL, 1999, NATURE, V401, P763, DOI 10.1038/44517; Ikezuki Y, 2002, HUM REPROD, V17, P2839, DOI 10.1093/humrep/17.11.2839; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Lakind JS, 2008, J EXPO SCI ENV EPID, V18, P608, DOI 10.1038/jes.2008.20; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maffini MV, 2006, MOL CELL ENDOCRINOL, V254, P179, DOI 10.1016/j.mce.2006.04.033; Markey CM, 2005, BIOL REPROD, V72, P1344, DOI 10.1095/biolreprod.104.036301; Markey CM, 2001, BIOL REPROD, V65, P1215, DOI 10.1093/biolreprod/65.4.1215; Mileva G, 2014, INT J ENV RES PUB HE, V11, P7537, DOI 10.3390/ijerph110707537; Munoz-de-Toro M, 2005, ENDOCRINOLOGY, V146, P4138, DOI 10.1210/en.2005-0340; Newbold RR, 2009, ENVIRON HEALTH PERSP, V117, P879, DOI 10.1289/ehp.0800045; Peretz J, 2014, ENVIRON HEALTH PERSP, V122, P775, DOI 10.1289/ehp.1307728; Peruzzi D, 2009, CLIN CANCER RES, V15, P4104, DOI 10.1158/1078-0432.CCR-08-3226; Rackow BW, 2008, FERTIL STERIL, V89, P1234, DOI [10.1016/j.fertnstert.2007.04.060, 10.1016/j.fertnstert.2007.12.030]; Santoro M, 2004, CELL MOL LIFE SCI, V61, P2954, DOI 10.1007/s00018-004-4276-8; Schonfelder G, 2002, ENVIRON HEALTH PERSP, V110, pA703, DOI 10.1289/ehp.021100703; Seisenberger S, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2011.0330; Sheehan DM, 2000, P SOC EXP BIOL MED, V224, P57, DOI 10.1046/j.1525-1373.2000.22401.x; Takahashi O, 2000, ENVIRON HEALTH PERSP, V108, P931, DOI 10.2307/3435050; Yamada H, 2002, REPROD TOXICOL, V16, P735, DOI 10.1016/S0890-6238(02)00051-5; Yu NF, 2008, CURR MED CHEM, V15, P1350, DOI 10.2174/092986708784567653	37	37	38	1	25	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3194	3201		10.1096/fj.201500089R	http://dx.doi.org/10.1096/fj.201500089R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27312807	Green Published			2022-12-28	WOS:000382816300019
J	Arora, H; Boulberdaa, M; Qureshi, R; Bitirim, V; Messadeq, N; Dolle, P; Nebigil, CG				Arora, Himanshu; Boulberdaa, Mounia; Qureshi, Rehana; Bitirim, Verda; Messadeq, Nadia; Dolle, Pascal; Nebigil, Canan G.			Prokineticin receptor 1 is required for mesenchymal-epithelial transition in kidney development	FASEB JOURNAL			English	Article						genetically altered mice; receptor pharmacology; renal physiology/pathophysiology	ENDOTHELIAL-CELLS; DISEASE; BRAIN; GENE; MICE; WT1	Identification of factors regulating renal development is important to understand the pathogenesis of congenital kidney diseases. Little is known about the molecular mechanism of renal development and functions triggered by the angiogenic hormone prokineticin-2 and its receptor, PKR1. Utilizing the Gata5 (G5)-Cre and Wilms tumor 1 (Wt1)(GFP)cre transgenic lines, we generated mutant mice with targeted PKR1 gene disruptions in nephron progenitors. These mutant mice exhibited partial embryonic and postnatal lethality. Kidney developmental defects in PKRG5-/- mice are manifested in the adult stage as renal atrophy with glomerular defects, nephropathy, and uremia. PKR1(wt1-/-) embryos exhibit hypoplastic kidneys with premature glomeruli and necrotic nephrons as a result of impaired proliferation and increased apoptosis in Wt1(+) renal mesenchymal cells. PKR1 regulates renal mesenchymal-epithelial transition (MET) that is involved in formation of renal progenitors, regulating glomerulogenesis toward forming nephrons during kidney development. In the isolated embryonic Wt1(+) renal cells, overexpression or activation of PKR1 promotes MET defined by the transition from elongated cell to octagonal cell morphology, and alteration of the expression of MET markers via activating NFATc3 signaling. Together, these results establish PKR1 via NFATc3 as a crucial modifier of MET processing to the development of nephron. Our study should facilitate new therapeutic opportunities in human renal disorders. Arora,	[Arora, Himanshu; Boulberdaa, Mounia; Qureshi, Rehana; Bitirim, Verda; Nebigil, Canan G.] Univ Strasbourg, CNRS, UMR7242, Ecole Super Biotechnol Strasbourg, Illkirch Graffenstaden, France; [Messadeq, Nadia; Dolle, Pascal] Univ Strasbourg, CNRS, UMR 7104, Inst Genet & Biol Mol & Cellulaire, Illkirch Graffenstaden, France; [Messadeq, Nadia; Dolle, Pascal] Univ Strasbourg, INSERM, Unite 964, Illkirch Graffenstaden, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Nebigil, CG (corresponding author), Univ Strasbourg, CNRS, UMR7242, Ecole Super Biotechnol Strasbourg, Illkirch Graffenstaden, France.	nebigil@unistra.fr	Nebigil, Canan/AAK-7162-2021; BITIRIM, VERDA CEYLAN/A-6731-2018; Arora, Himanshu/I-5230-2019	Nebigil, Canan/0000-0002-2035-5795; Arora, Himanshu/0000-0003-3143-6387; bitirim, ceylan verda/0000-0002-7979-0679	Fondation pour la Recherche Medicale (Equipe Labellisee); Centre National de la Recherche Scientifique; Universite de Strasbourg; French government [(ANR)-10-LABX-0034_Medalis]	Fondation pour la Recherche Medicale (Equipe Labellisee)(Fondation pour la Recherche Medicale); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; French government	The authors thank the Mouse Clinical Institute (Illkirch, France) for generating the mouse lines and for assistance with genotyping/phenotyping and ultrastructural analyses. This work was supported in part by grants from Fondation pour la Recherche Medicale (Equipe Labellisee), Centre National de la Recherche Scientifique, and Universite de Strasbourg. This work was published within the "Investissements d'Avenir" des Laboratoires d'Excellence (Labex) Agence Nationale pour la Recherche (ANR)-10-LABX-0034_Medalis and has received financial support from the French government, managed by Agence Nationale de la Recherche under Programme d'Investissement d'Avenir.	Abrahamson DR, 2009, ORGANOGENESIS, V5, P275; Beale KEL, 2013, BRIT J PHARMACOL, V168, P403, DOI 10.1111/j.1476-5381.2012.02191.x; Boulberdaa M, 2011, CARDIOVASC RES, V92, P191, DOI 10.1093/cvr/cvr228; Boulberdaa M, 2011, ARTERIOSCL THROM VAS, V31, P842, DOI 10.1161/ATVBAHA.110.222323; Burn SF, 2011, DEV BIOL, V352, P288, DOI 10.1016/j.ydbio.2011.01.033; Dormishian M, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000411; Gao XB, 2005, DEVELOPMENT, V132, P5437, DOI 10.1242/dev.02095; Guilini C, 2010, AM J PHYSIOL-HEART C, V298, pH844, DOI 10.1152/ajpheart.00898.2009; Haney S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064946; Hartwig S, 2010, DEVELOPMENT, V137, P1189, DOI 10.1242/dev.045732; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Hendry C, 2011, PEDIATR NEPHROL, V26, P1395, DOI 10.1007/s00467-010-1750-4; Hoy WE, 2005, J AM SOC NEPHROL, V16, P2557, DOI 10.1681/ASN.2005020172; Huang RYJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.442; Kiela PR, 2003, J BIOL CHEM, V278, P5659, DOI 10.1074/jbc.M209473200; Kitamoto Y, 2002, NEPHROL DIAL TRANSPL, V17, P25, DOI 10.1093/ndt/17.suppl_9.25; Kreidberg JA, 2010, ORGANOGENESIS, V6, P61, DOI 10.4161/org.6.2.11928; Lechner MS, 1997, MECH DEVELOP, V62, P105, DOI 10.1016/S0925-4773(97)00667-9; Little MH, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008300; Masuda Y, 2002, BIOCHEM BIOPH RES CO, V293, P396, DOI 10.1016/S0006-291X(02)00239-5; Merki E, 2005, P NATL ACAD SCI USA, V102, P18455, DOI 10.1073/pnas.0504343102; Ohse T, 2008, J AM SOC NEPHROL, V19, P1879, DOI 10.1681/ASN.2007101087; Putaala H, 2001, HUM MOL GENET, V10, P1, DOI 10.1093/hmg/10.1.1; Saadi-Kheddouci S, 2001, ONCOGENE, V20, P5972, DOI 10.1038/sj.onc.1204825; Szatkowski C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081175; Toka HR, 2010, SEMIN NEPHROL, V30, P374, DOI 10.1016/j.semnephrol.2010.06.004; Urayama K, 2008, ARTERIOSCL THROM VAS, V28, P841, DOI 10.1161/ATVBAHA.108.162404; Urayama K, 2007, FASEB J, V21, P2980, DOI 10.1096/fj.07-8116com; Zhou B, 2012, METHODS MOL BIOL, V843, P155, DOI 10.1007/978-1-61779-523-7_15	29	6	6	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2733	2740		10.1096/fj.201600181R	http://dx.doi.org/10.1096/fj.201600181R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27084889				2022-12-28	WOS:000380994000010
J	Cerqueira, DM; Bodnar, AJ; Phua, YL; Freer, R; Hemker, SL; Walensky, LD; Hukriede, NA; Ho, J				Cerqueira, Debora M.; Bodnar, Andrew J.; Phua, Yu Leng; Freer, Rachel; Hemker, Shelby L.; Walensky, Loren D.; Hukriede, Neil A.; Ho, Jacqueline			Bim gene dosage is critical in modulating nephron progenitor survival in the absence of microRNAs during kidney development	FASEB JOURNAL			English	Article						nephrogenesis; metanephros; Bcl-2L11; Dicer; apoptosis	APOPTOTIC PROTEIN BIM; BCL-2 RELATIVE BIM; CELL-DEATH; TRANSCRIPTIONAL REGULATION; BH3-ONLY PROTEINS; LYMPHOBLASTIC-LEUKEMIA; METANEPHRIC MESENCHYME; POLYCYSTIC KIDNEY; OXIDATIVE STRESS; MAMMALIAN KIDNEY	Low nephron endowment at birth has been associated with an increased risk for developing hypertension and chronic kidney disease. We demonstrated in an earlier study that conditional deletion of the microRNA (miRNA)-processing enzyme Dicer from nephron progenitors results in premature depletion of the progenitors and increased expression of the proapoptotic protein Bim (also known as Bcl-2L11). In this study, we generated a compound mouse model with conditional deletion of both Dicer and Bim, to determine the biologic significance of increased Bim expression in Dicer-deficient nephron progenitors. The loss of Bim partially restored the number of nephron progenitors and improved nephron formation. The number of progenitors undergoing apoptosis was significantly reduced in kidneys with loss of a single allele, or both alleles, of Bim compared to mutant kidneys. Furthermore, 2 miRNAs expressed in nephron progenitors (miR-17 and miR-106b) regulated Bim levels in vitro and in vivo. Together, these data suggest that miRNA-mediated regulation of Bim controls nephron progenitor survival during nephrogenesis, as one potential means of regulating nephron endowment.	[Cerqueira, Debora M.; Bodnar, Andrew J.; Phua, Yu Leng; Freer, Rachel; Hemker, Shelby L.; Ho, Jacqueline] Univ Pittsburgh, Sch Med, Dept Pediat, Div Nephrol, Pittsburgh, PA 15261 USA; [Hukriede, Neil A.] Univ Pittsburgh, Dept Dev Biol, Pittsburgh, PA USA; [Walensky, Loren D.] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Walensky, Loren D.] Dana Farber Canc Inst, Linde Program Canc Chem Biol, Boston, MA 02115 USA; [Walensky, Loren D.] Harvard Med Sch, Boston Childrens Hosp, Dept Pediat, Boston, MA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Boston Children's Hospital; Harvard Medical School	Ho, J (corresponding author), UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Div Nephrol,Rangos Res Ctr, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	jacqueline.ho2@chp.edu	Cerqueira, Debora Malta/CAF-4323-2022; Ho, Jackie/AAP-1531-2021; Cerqueira, Debora Malta/AAB-6204-2020	Ho, Jackie/0000-0001-7115-1381; Hemker, Shelby/0000-0002-9135-7042; Phua, Yu Leng/0000-0002-3428-8669; Malta Cerqueira Sant'Anna Santos, Debora/0000-0001-9773-4606	U. S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) [P30DK079307]; Children's Hospital of Pittsburgh of UPMC's Histology Core Laboratory; University of Pittsburgh Flow Cytometry Core Laboratory; NIH NIDDK [DK087922, DK103776]; NIH, NIDDK [DK069403, DK079307, T32 DK061296]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [HD053287]; Children's Hospital of Pittsburgh Research Advisory Council Postdoctoral Fellowship; George B. Rathmann Research Fellowship by American Society of Nephrology Ben J. Lipps Research Fellowship Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD053287] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK087922, R01DK069403, P30DK079307, R01DK103776, R00DK087922, T32DK061296] Funding Source: NIH RePORTER	U. S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Children's Hospital of Pittsburgh of UPMC's Histology Core Laboratory; University of Pittsburgh Flow Cytometry Core Laboratory; NIH NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH, NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Children's Hospital of Pittsburgh Research Advisory Council Postdoctoral Fellowship; George B. Rathmann Research Fellowship by American Society of Nephrology Ben J. Lipps Research Fellowship Program; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. Oliver Wessely (Cleveland Clinic Lerner Research Institute, Cleveland, OH, USA) for intellectual input; the Kidney Imaging Core of the Pittsburgh Center for Kidney Research for providing expert pathological and 3-dimensional stereological support [funded by U. S. National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Grant P30DK079307]; the Children's Hospital of Pittsburgh of UPMC's Histology Core Laboratory, University of Pittsburgh Flow Cytometry Core Laboratory; the Kansas State University Veterinary Diagnostic Laboratories for technical assistance; and the University of Pittsburgh Cell Culture and Cytogenetics Facility for cell line authentication. This work was supported by NIH NIDDK Grants DK087922 and DK103776 (to J.H.); NIH, NIDDK Grants DK069403, DK079307, and Eunice Kennedy Shriver National Institute of Child Health and Human Development HD053287 (to N.A.H.); NIH, NIDDK Grant T32 DK061296 (to S.L.H.); a Children's Hospital of Pittsburgh Research Advisory Council Postdoctoral Fellowship (to D.M.C.); and a George B. Rathmann Research Fellowship supported by the American Society of Nephrology Ben J. Lipps Research Fellowship Program (to Y.L.P.). L.D.W is a scientific advisory member and consultant for Aileron Therapeutics. The remaining authors declare no conflicts of interest.	Aerbajinai W, 2003, BLOOD, V102, P712, DOI 10.1182/blood-2002-11-3324; Akiyama T, 2009, MOL CANCER THER, V8, P3173, DOI 10.1158/1535-7163.MCT-09-0685; Barak H, 2012, DEV CELL, V22, P1191, DOI 10.1016/j.devcel.2012.04.018; Barreyro FJ, 2007, J BIOL CHEM, V282, P27141, DOI 10.1074/jbc.M704391200; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Barthson J, 2011, J BIOL CHEM, V286, P39632, DOI 10.1074/jbc.M111.253591; Bernardo-Garcia FJ, 2016, DEVELOPMENT, V143, P1413, DOI 10.1242/dev.128801; Bertram JF, 2014, PEDIATR NEPHROL, V29, P575, DOI 10.1007/s00467-013-2600-y; Biswas SC, 2007, J BIOL CHEM, V282, P29368, DOI 10.1074/jbc.M702634200; Biswas SC, 2007, J NEUROSCI, V27, P893, DOI 10.1523/JNEUROSCI.3524-06.2007; Bonev Boyan, 2012, Methods Mol Biol, V917, P445, DOI 10.1007/978-1-61779-992-1_25; Bouillet P, 2001, DEV CELL, V1, P645, DOI 10.1016/S1534-5807(01)00083-1; Bouillet P, 1999, SCIENCE, V286, P1735, DOI 10.1126/science.286.5445.1735; Bouillet P, 2001, MAMM GENOME, V12, P163, DOI 10.1007/s003350010242; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; Brunjes PC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138541; Brunskill EW, 2011, BMC DEV BIOL, V11, DOI 10.1186/1471-213X-11-15; Campone M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-110; Castoldi M, 2006, RNA, V12, P913, DOI 10.1261/rna.2332406; Castoldi M, 2007, METHODS, V43, P146, DOI 10.1016/j.ymeth.2007.04.009; Cebrian C, 2014, CELL REP, V7, P127, DOI 10.1016/j.celrep.2014.02.033; Chen M, 2007, BLOOD, V109, P4360, DOI 10.1182/blood-2006-11-056424; Chen S, 2015, DEV CELL, V35, P49, DOI 10.1016/j.devcel.2015.09.009; Chi LJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065448; Chu JYS, 2014, AM J PHYSIOL-RENAL, V306, pF764, DOI 10.1152/ajprenal.00426.2013; Cullen-McEwen Luise A, 2012, Methods Mol Biol, V886, P333, DOI 10.1007/978-1-61779-851-1_30; Davila D, 2014, MOL BIOL CELL, V25, P3413, DOI 10.1091/mbc.E13-08-0495; Dijkers PF, 2000, CURR BIOL, V10, P1201, DOI 10.1016/S0960-9822(00)00728-4; Dressler GR, 2009, DEVELOPMENT, V136, P3863, DOI 10.1242/dev.034876; Eichhorn JM, 2014, EXP CELL RES, V322, P415, DOI 10.1016/j.yexcr.2014.02.010; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Fuchs C, 2012, HUM MOL GENET, V21, P1049, DOI 10.1093/hmg/ddr535; Gebeshuber CA, 2013, NAT MED, V19, P481, DOI 10.1038/nm.3142; Georgas K, 2009, DEV BIOL, V332, P273, DOI 10.1016/j.ydbio.2009.05.578; Giam M, 2008, ONCOGENE, V27, pS128, DOI 10.1038/onc.2009.50; Gilley J, 2003, J CELL BIOL, V162, P613, DOI 10.1083/jcb.200303026; Gogada R, 2013, J BIOL CHEM, V288, P368, DOI 10.1074/jbc.M112.386102; Grieshammer U, 2005, DEVELOPMENT, V132, P3847, DOI 10.1242/dev.01944; Guo CE, 2015, J CELL MOL MED, V19, P103, DOI 10.1111/jcmm.12393; Harada M, 2012, LEUKEMIA LYMPHOMA, V53, P2041, DOI 10.3109/10428194.2012.678004; Harfe BD, 2005, P NATL ACAD SCI USA, V102, P10898, DOI 10.1073/pnas.0504834102; Hartman HA, 2007, DEV BIOL, V310, P379, DOI 10.1016/j.ydbio.2007.08.021; Hendrickx A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074305; Hershko T, 2004, J BIOL CHEM, V279, P8627, DOI 10.1074/jbc.M312866200; HINCHLIFFE SA, 1991, LAB INVEST, V64, P777; Ho J, 2011, J AM SOC NEPHROL, V22, P1053, DOI 10.1681/ASN.2010080841; Hubner A, 2008, MOL CELL, V30, P415, DOI 10.1016/j.molcel.2008.03.025; Hutcheson J, 2008, IMMUNITY, V28, P206, DOI 10.1016/j.immuni.2007.12.015; Ingelfinger JR, 2008, ADV CHRONIC KIDNEY D, V15, P107, DOI 10.1053/j.ackd.2008.01.003; KAMADA S, 1995, CANCER RES, V55, P354; Kan T, 2009, GASTROENTEROLOGY, V136, P1689, DOI 10.1053/j.gastro.2009.02.002; Katz SG, 2014, BLOOD, V123, P884, DOI 10.1182/blood-2013-04-499079; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Kohler UA, 2014, HEPATOLOGY, V60, P670, DOI 10.1002/hep.26964; KREIDBERG JA, 1993, CELL, V74, P679, DOI 10.1016/0092-8674(93)90515-R; LaBelle JL, 2012, J CLIN INVEST, V122, P2018, DOI 10.1172/JCI46231; Lechner MS, 1997, MECH DEVELOP, V62, P105, DOI 10.1016/S0925-4773(97)00667-9; Lei K, 2003, P NATL ACAD SCI USA, V100, P2432, DOI 10.1073/pnas.0438011100; Leon R, 2010, EUR J NEUROSCI, V31, P1915, DOI 10.1111/j.1460-9568.2010.07215.x; Ley R, 2005, CELL DEATH DIFFER, V12, P1008, DOI 10.1038/sj.cdd.4401688; Liu R, 2015, ONCOTARGET, V6, P43831, DOI 10.18632/oncotarget.6257; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu JH, 2006, FEBS LETT, V580, P3539, DOI 10.1016/j.febslet.2006.05.031; Luyckx VA, 2010, J AM SOC NEPHROL, V21, P898, DOI 10.1681/ASN.2009121248; Mao ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068206; Marrone AK, 2014, J AM SOC NEPHROL, V25, P1440, DOI 10.1681/ASN.2013040390; Matsui H, 2007, MOL CELL, V25, P99, DOI 10.1016/j.molcel.2006.12.007; Montagne C, 2014, DEVELOPMENT, V141, P2014, DOI 10.1242/dev.104240; Nagalakshmi VK, 2011, KIDNEY INT, V79, P317, DOI 10.1038/ki.2010.385; NAKAYAMA K, 1994, P NATL ACAD SCI USA, V91, P3700, DOI 10.1073/pnas.91.9.3700; Neves J, 2011, DEVELOPMENT, V138, P735, DOI 10.1242/dev.060657; Nieuwkoop PD., 1956, DEVELOPMENT, DOI [DOI 10.1242/DEV.200356, 10.1242/dev.200356]; Nishinakamura R, 2001, DEVELOPMENT, V128, P3105; Perantoni AO, 2005, DEVELOPMENT, V132, P3859, DOI 10.1242/dev.01945; Perier C, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a009332; Poladia DP, 2006, DEV BIOL, V291, P325, DOI 10.1016/j.ydbio.2005.12.034; Puthalakath H, 2007, CELL, V129, P1337, DOI 10.1016/j.cell.2007.04.027; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Quinlan J, 2007, J AM SOC NEPHROL, V18, P1915, DOI 10.1681/ASN.2006101107; Ren DC, 2014, DIABETES, V63, P3378, DOI 10.2337/db13-1814; Ridinger-Saison M, 2013, CELL DEATH DIFFER, V20, P1268, DOI 10.1038/cdd.2013.88; Romaker D, 2014, P NATL ACAD SCI USA, V111, P6335, DOI 10.1073/pnas.1320577111; ROTHENPIELER UW, 1993, DEVELOPMENT, V119, P711; Rumballe BA, 2011, DEV BIOL, V360, P110, DOI 10.1016/j.ydbio.2011.09.011; Sanphui P, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.148; SAXEN L, 1987, PEDIATR NEPHROL, V1, P385, DOI 10.1007/BF00849241; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Sims-Lucas S, 2011, DEV DYNAM, V240, P240, DOI 10.1002/dvdy.22501; Sionov RV, 2015, ONCOTARGET, V6, P23058, DOI 10.18632/oncotarget.5492; Sive HL, 1998, EARLY DEV XENOPUS LA; SORENSON CM, 1995, AM J PHYSIOL-RENAL, V268, pF73, DOI 10.1152/ajprenal.1995.268.1.F73; Strasser A, 2005, NAT REV IMMUNOL, V5, P189, DOI 10.1038/nri1568; Sunters A, 2003, J BIOL CHEM, V278, P49795, DOI 10.1074/jbc.M309523200; Takasato M, 2014, NAT CELL BIOL, V16, P118, DOI 10.1038/ncb2894; Takeuchi O, 2005, P NATL ACAD SCI USA, V102, P11272, DOI 10.1073/pnas.0504783102; Ventura A, 2008, CELL, V132, P875, DOI 10.1016/j.cell.2008.02.019; Vize P.D., 2003, KIDNEY NORMAL DEV CO; Wali JA, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.88; Wang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085389; Weber S, 2008, J AM SOC NEPHROL, V19, P891, DOI 10.1681/ASN.2006111282; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Xiao CC, 2008, NAT IMMUNOL, V9, P405, DOI 10.1038/ni1575; Xiao GY, 2016, SCI REP-UK, V6, DOI 10.1038/srep23120; Yang Y, 2009, NEOPLASIA, V11, P313, DOI 10.1593/neo.81358; Zhang LZ, 2004, J BIOL CHEM, V279, P20858, DOI 10.1074/jbc.M310643200; Zhang Z, 2008, J AM SOC NEPHROL, V19, P2027, DOI 10.1681/ASN.2007101098; Zhong B, 2012, NAT IMMUNOL, V13, P1110, DOI 10.1038/ni.2427	108	12	13	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3540	3554		10.1096/fj.201700010R	http://dx.doi.org/10.1096/fj.201700010R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28446592	Green Published			2022-12-28	WOS:000405932400029
J	Elayyan, J; Lee, EJ; Gabay, O; Smith, CA; Qiq, O; Reich, E; Mobasheri, A; Henrotin, Y; Kimber, SJ; Dvir-Ginzberg, M				Elayyan, Jinan; Lee, Eun-Jin; Gabay, Odile; Smith, Christopher A.; Qiq, Omar; Reich, Eli; Mobasheri, Ali; Henrotin, Yves; Kimber, Susan J.; Dvir-Ginzberg, Mona			LEF1-mediated MMP13 gene expression is repressed by SIRT1 in human chondrocytes	FASEB JOURNAL			English	Article						cartilage; osteoarthritis; inflammation; IL-10; catabolism	MESENCHYMAL STEM-CELLS; NF-KAPPA-B; ARTICULAR CHONDROCYTES; INHIBITS APOPTOSIS; MMP-13 EXPRESSION; ACTIVATING SIRT1; OSTEOARTHRITIS; CARTILAGE; PROTEIN; PATHOGENESIS	Reduced SIRT1 activity and levels during osteoarthritis (OA) promote gradual loss of cartilage. Loss of cartilage matrix is accompanied by an increase in matrix metalloproteinase (MMP) 13, partially because of enhanced LEF1 transcriptional activity. In this study, we assessed the role of SIRT1 in LEF1-mediated MMP13 gene expression in human OA chondrocytes. Results showed that MMP13 protein levels and enzymatic activity decreased significantly during SIRT1 overexpression or activation by resveratrol. Conversely, MMP13 gene expression was reduced in chondrocytes transfected with SIRT1 siRNA or treated with nicotinamide (NAM), a sirtuin inhibitor. Chondrocytes challenged with IL-113, a cytokine involved in OA pathogenesis, enhanced LEF1 protein levels and gene expression, resulting in increased MMP13 gene expression; however, overexpression of SIRT1 during IL-113 challenge impeded LEF1 levels and MMP13 gene expression. Previous reports showed that LEF1 binds to the MMP13 promoter and transactivates its expression, but we observed that SIRT1 repressed LEF1 protein and mRNA expression, ultimately reducing LEF1 transcriptional activity, as judged by luciferase assay. Finally, mouse articular cartilage from Sirt1-/presented increased LEF1 and MMP13 protein levels, similar to human OA cartilage. Thus, demonstrating for the first time that SIRT1 represses MMP13 in human OA chondrocytes, which appears to be mediated, at least in part, through repression of the transcription factor LEF1, a known modulator of MMP13 gene expression. Elayyan, J., Lee, E.-J., Gabay, O., Smith, C. A., Qiq, O., Reich, E., Mobasheri, A., Henrotin, Y., Kimber, S. J., Dvir-Ginzberg, M. LEF1-mediated MMP13 gene expression is repressed by SIRT1 in human chondrocytes.	[Elayyan, Jinan; Qiq, Omar; Reich, Eli; Dvir-Ginzberg, Mona] Hebrew Univ Jerusalem, Fac Med Dent, Inst Dent Sci, Lab Cartilage Biol, Hadassah Ein Kerem Campus, Jerusalem, Israel; [Lee, Eun-Jin] Univ Ulsan, Coll Med, Asan Med Ctr, Dept Biomed Sci, Seoul, South Korea; [Gabay, Odile] US FDA, Ctr Drug Evaluat & Res, Div Biotechnol Review & Res 1, Silver Spring, MD USA; [Smith, Christopher A.; Kimber, Susan J.] Univ Manchester, Fac Biol Med & Hlth, Div Cell Matrix Biol & Regenerat Med, Manchester, Lancs, England; [Mobasheri, Ali] Univ Surrey, Fac Hlth & Med Sci, Sch Vet Med, Dept Vet Preclin Sci, Guildford, Surrey, England; [Mobasheri, Ali] Queens Med Ctr, Arthrit Res UK Ctr Sport Exercise & Osteoarthrit, Nottingham, England; [Henrotin, Yves] Univ Liege, Inst Pathol, Arthropole Liege, Bone & Cartilage Res Unit, Liege, Belgium	Hebrew University of Jerusalem; University of Ulsan; Asan Medical Center; US Food & Drug Administration (FDA); University of Manchester; University of Surrey; University of Nottingham; University of Liege	Dvir-Ginzberg, M (corresponding author), Hebrew Univ Jerusalem, Fac Med Dent, Inst Dent Sci, Lab Cartilage Biol, Hadassah Ein Kerem Campus, Jerusalem, Israel.	monad@ekmd.huji.ac.il	Mobasheri, Ali/D-5770-2011; Smith, Christopher Andrew/A-7229-2015	Mobasheri, Ali/0000-0001-6261-1286; Henrotin, Yves/0000-0003-1073-449X; Smith, Christopher Andrew/0000-0001-6478-2310; Lee, Eun-Jin/0000-0001-5718-542X	Israel Science Foundation [121/12]; Rosetrees Trust [A770]; Arthritis Research UK [AR 20786]; European Commission (EU) [HEALTH.2012.2.4.5-2, 305815]; Rosetrees Trust [M447] Funding Source: researchfish; Versus Arthritis [20786] Funding Source: researchfish	Israel Science Foundation(Israel Science Foundation); Rosetrees Trust(Rosetrees Trust); Arthritis Research UK(Versus Arthritis); European Commission (EU)(European CommissionEuropean Commission Joint Research Centre); Rosetrees Trust(Rosetrees Trust); Versus Arthritis(Versus Arthritis)	The authors thank the National Disease Research Interchange for providing the human cartilage tissue samples. This work was funded by Israel Science Foundation Grant 121/12 (to M.D.-G.), Rosetrees Trust Grant A770 (to M.D.-G.), Arthritis Research UK Grant AR 20786 (to S.J.K. and M.D.-G.), and the European Commission Framework 7 Programme (EU FP7; HEALTH.2012.2.4.5-2, Project 305815, Novel Diagnostics and Biomarkers for Early Identification of Chronic Inflammatory Joint Diseases; to A.M., Y.H., and M.D.-G.). The authors declare no conflicts of interest.	Bar Oz M, 2016, AGING CELL, V15, P499, DOI 10.1111/acel.12456; Blander G, 2004, ANNU REV BIOCHEM, V73, P417, DOI 10.1146/annurev.biochem.73.011303.073651; Bondeson J, 2008, CLIN EXP RHEUMATOL, V26, P139; Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817; Caron JP, 1996, ARTHRITIS RHEUM, V39, P1535, DOI 10.1002/art.1780390914; Cheng AX, 2014, STEM CELL TRANSL MED, V3, P1287, DOI 10.5966/sctm.2014-0101; Corr M, 2008, NAT CLIN PRACT RHEUM, V4, P550, DOI 10.1038/ncprheum0904; Derfoul A, 2007, OSTEOARTHR CARTILAGE, V15, P646, DOI 10.1016/j.joca.2007.01.014; Dvir-Ginzberg M, 2016, CURR RHEUMATOL REP, V18, DOI 10.1007/s11926-016-0591-y; Dvir-Ginzberg M, 2011, ARTHRITIS RHEUM-US, V63, P2363, DOI 10.1002/art.30279; Dvir-Ginzberg M, 2008, J BIOL CHEM, V283, P36300, DOI 10.1074/jbc.M803196200; Fujita N, 2011, J ORTHOP RES, V29, P511, DOI 10.1002/jor.21284; Gabay O, 2012, ANN RHEUM DIS, V71, P613, DOI 10.1136/ard.2011.200504; Gagarina V, 2010, ARTHRITIS RHEUM-US, V62, P1383, DOI 10.1002/art.27369; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Hedbom E, 2002, CELL MOL LIFE SCI, V59, P45, DOI 10.1007/s00018-002-8404-z; Huang K, 2008, J INT MED RES, V36, P1149, DOI 10.1177/147323000803600601; Hwang SG, 2004, J BIOL CHEM, V279, P26597, DOI 10.1074/jbc.M401401200; Jiang W, 2014, SCI REP-UK, V4, DOI 10.1038/srep07456; Kim SJ, 2002, BIOCHEM BIOPH RES CO, V296, P221, DOI 10.1016/S0006-291X(02)00824-0; Lei M, 2012, EUR J PHARMACOL, V674, P73, DOI 10.1016/j.ejphar.2011.10.015; Li WY, 2015, J ORTHOP RES, V33, P1061, DOI 10.1002/jor.22859; Lim HD, 2012, J PINEAL RES, V53, P225, DOI 10.1111/j.1600-079X.2012.00991.x; Ma B, 2012, ARTHRITIS RHEUM-US, V64, P2589, DOI 10.1002/art.34425; Martel-Pelletier J, 2001, BEST PRACT RES CL RH, V15, P805, DOI 10.1053/berh.2001.0195; Matsushita T, 2013, J ORTHOP RES, V31, P531, DOI 10.1002/jor.22268; McBurney MW, 2003, MOL CELL BIOL, V23, P38, DOI 10.1128/MCB.23.1.38-54.2003; Mengshol JA, 2001, NUCLEIC ACIDS RES, V29, P4361, DOI 10.1093/nar/29.21.4361; Miclea RL, 2011, OSTEOARTHR CARTILAGE, V19, P1363, DOI 10.1016/j.joca.2011.07.014; Millward-Sadler SJ, 2000, ARTHRITIS RHEUM, V43, P2091, DOI 10.1002/1529-0131(200009)43:9<2091::AID-ANR21>3.0.CO;2-C; Naito S, 2007, PATHOL INT, V57, P703, DOI 10.1111/j.1440-1827.2007.02167.x; Nakamaru Y, 2009, FASEB J, V23, P2810, DOI 10.1096/fj.08-125468; Nakamura Y, 2005, AM J PATHOL, V167, P97, DOI 10.1016/S0002-9440(10)62957-4; Oldershaw RA, 2010, NAT BIOTECHNOL, V28, P1221, DOI 10.1038/nbt.1683; Oppenheimer H, 2012, ARTHRITIS RHEUM-US, V64, P718, DOI 10.1002/art.33407; Pelletier JP, 2001, ARTHRITIS RHEUM-US, V44, P1237, DOI 10.1002/1529-0131(200106)44:6<1237::AID-ART214>3.0.CO;2-F; Sauve AA, 2006, ANNU REV BIOCHEM, V75, P435, DOI 10.1146/annurev.biochem.74.082803.133500; Simic P, 2013, EMBO MOL MED, V5, P430, DOI 10.1002/emmm.201201606; Takayama K, 2009, ARTHRITIS RHEUM-US, V60, P2731, DOI 10.1002/art.24864; VANDELOO FAJ, 1995, ARTHRITIS RHEUM, V38, P164; Wang DW, 2013, AGE, V35, P1741, DOI 10.1007/s11357-012-9474-y; Wang XB, 2004, OSTEOARTHR CARTILAGE, V12, P963, DOI 10.1016/j.joca.2004.08.008; Winnik S, 2012, CURR VASC PHARMACOL, V10, P693, DOI 10.2174/157016112803520756; Yang SR, 2007, AM J PHYSIOL-LUNG C, V292, pL567, DOI 10.1152/ajplung.00308.2006; Yoshizaki T, 2010, AM J PHYSIOL-ENDOC M, V298, pE419, DOI 10.1152/ajpendo.00417.2009; Yun K, 2007, BIOCHEM BIOPH RES CO, V364, P1009, DOI 10.1016/j.bbrc.2007.10.121; Yun K, 2007, BIOCHEM BIOPH RES CO, V364, P270, DOI 10.1016/j.bbrc.2007.09.129; Yun K, 2007, BIOCHEM BIOPH RES CO, V357, P589, DOI 10.1016/j.bbrc.2007.03.170; Yun K, 2009, J IMMUNOL, V183, P5129, DOI 10.4049/jimmunol.0802744	49	32	33	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3116	3125		10.1096/fj.201601253R	http://dx.doi.org/10.1096/fj.201601253R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28389425	Green Published, hybrid			2022-12-28	WOS:000405931000035
J	Sugio, S; Nagasawa, M; Kojima, I; Ishizaki, Y; Shibasaki, K				Sugio, Shouta; Nagasawa, Masami; Kojima, Itaru; Ishizaki, Yasuki; Shibasaki, Koji			Transient receptor potential vanilloid 2 activation by focal mechanical stimulation requires interaction with the actin cytoskeleton and enhances growth cone motility	FASEB JOURNAL			English	Article						TRP channel; axonal outgrowth; neuron; development; TRPV2	TRPV2 CHANNEL; NERVE GROWTH; ION-CHANNEL; NEURONAL EXCITABILITY; NEURITE OUTGROWTH; CALCIUM; TRANSLOCATION; TEMPERATURE; DYNAMICS; PIEZO1	We have previously reported that transient receptor potential vanilloid 2 (TRPV2) can be activated by mechanical stimulation, which enhances axonal outgrowth in developing neurons; however, the molecular mechanisms that govern the contribution of TRPV2 activation to axonal outgrowth remain unclear. In the present study, we examined thismechanismby using PC12 cells as a neuronalmodel. Overexpression of TRPV2 enhanced axonal outgrowth in a mechanical stimulus-dependent manner. Accumulation of TRPV2 at the cell surface was 4-fold greater in the growth cone compared with the soma. In the growth cone, TRPV2 is not static, but dynamically accumulates (within similar to 100ms) to the site ofmechanical stimulation. The dynamic and acute clustering ofTRPV2 can enhance very weak mechanical stimuli via focal accumulation of TRPV2. Focal application of mechanical stimuli dramatically increasedgrowth conemotility andcausedactin reorganization via activationofTRPV2. Wealso found that TRPV2 physically interacts with actin and that changes in the actin cytoskeleton are required for its activation. Here, we demonstrated for the first time to our knowledge that TRPV2 clustering is induced by mechanical stimulation generated by axonal outgrowth and that TRPV2 activation is triggered by actin rearrangements that result frommechanical stimulation. Moreover, TRPV2activationenhances growthcone motility andactinaccumulationto promote axonal outgrowth. Sugio, S., Nagasawa, M., Kojima, I., Ishizaki, Y., Shibasaki, K. Transient receptor potential vanilloid 2 activation by focal mechanical stimulation requires interaction with the actin cytoskeleton and enhances growth cone motility.	[Sugio, Shouta; Ishizaki, Yasuki; Shibasaki, Koji] Gunma Univ, Dept Mol & Cellular Neurobiol, Grad Sch Med, Maebashi, Gunma 3718511, Japan; [Nagasawa, Masami; Kojima, Itaru] Gunma Univ, Inst Mol & Cellular Regulat, Maebashi, Gunma, Japan	Gunma University; Gunma University	Shibasaki, K (corresponding author), Gunma Univ, Dept Mol & Cellular Neurobiol, Grad Sch Med, Maebashi, Gunma 3718511, Japan.	shibasaki@gunma-u.ac.jp	Shibasaki, Koji/U-8674-2018; Ishizaki, Yasuki/AAB-1209-2020	Shibasaki, Koji/0000-0003-2330-1749; 	Japanese Ministry of Education, Culture, Sports, Science, and Technology; a grant from Uehara Memorial Foundation [15H05934, 21200012, 20399554, 24111507+26111702, 26117502, 15H03000, 23650159]; Takeda Science Foundation (Tokyo, Japan); Sumitomo Foundation; Brain Science Foundation; Narishige Neuroscience Research Foundation; Salt Science Research Foundation; Ichiro Kanehara Foundation	Japanese Ministry of Education, Culture, Sports, Science, and Technology; a grant from Uehara Memorial Foundation; Takeda Science Foundation (Tokyo, Japan)(Takeda Science Foundation (TSF)); Sumitomo Foundation; Brain Science Foundation; Narishige Neuroscience Research Foundation; Salt Science Research Foundation; Ichiro Kanehara Foundation	The authors thank Y. Kogure (Gunma University) for technical assistance, and our lab members for helpful discussions. This research was supported by Grants-in-Aid for Scientific Research [KAKENHI Project No. 15H05934 (Thermal Biology), 21200012, 20399554, 24111507+26111702 (Brain Environment), 26117502 ( Glial Assembly), 15H03000; to K. S. and 23650159 to Y. I.] from the Japanese Ministry of Education, Culture, Sports, Science, and Technology; a grant from Uehara Memorial Foundation; a grant from Takeda Science Foundation (Tokyo, Japan); a grant from the Sumitomo Foundation; a grant from the Brain Science Foundation; a grant from Narishige Neuroscience Research Foundation; Grant 14C2 from Salt Science Research Foundation; and a grant from the Ichiro Kanehara Foundation (all to K.S.).	Adapala RK, 2013, J MOL CELL CARDIOL, V54, P45, DOI 10.1016/j.yjmcc.2012.10.016; Bagriantsev SN, 2014, J BIOL CHEM, V289, P31673, DOI 10.1074/jbc.R114.612697; Bang SS, 2007, NEUROSCI LETT, V425, P120, DOI 10.1016/j.neulet.2007.08.035; Bender FLP, 2005, CELL PHYSIOL BIOCHEM, V15, P183, DOI 10.1159/000083651; Benson DL, 2001, NAT REV NEUROSCI, V2, P899, DOI 10.1038/35104078; Caterina MJ, 1999, NATURE, V398, P436, DOI 10.1038/18906; Chalfie M, 2009, NAT REV MOL CELL BIO, V10, P44, DOI 10.1038/nrm2595; Cohen MR, 2015, MOL CELL BIOL, V35, P4238, DOI 10.1128/MCB.00549-15; Coste B, 2010, SCIENCE, V330, P55, DOI 10.1126/science.1193270; Dent EW, 2003, NEURON, V40, P209, DOI 10.1016/S0896-6273(03)00633-0; Ghosh D, 2014, SCI REP-UK, V4, DOI 10.1038/srep07111; Gomez TM, 2000, J NEUROBIOL, V44, P174, DOI 10.1002/1097-4695(200008)44:2<174::AID-NEU7>3.3.CO;2-I; Gottlieb PA, 2010, NEUROSCI LETT, V481, P115, DOI 10.1016/j.neulet.2010.06.066; GOTTMANN K, 1995, PERSPECT DEV NEUROBI, V2, P371; Hong K, 2000, NATURE, V403, P93, DOI 10.1038/47507; Hu HZ, 2004, J BIOL CHEM, V279, P35741, DOI 10.1074/jbc.M404164200; Huynh KW, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11130; Inada H, 2006, BIOCHEM BIOPH RES CO, V350, P762, DOI 10.1016/j.bbrc.2006.09.111; Kalil K, 2014, NAT REV NEUROSCI, V15, P7, DOI 10.1038/nrn3650; Kanzaki M, 1999, NAT CELL BIOL, V1, P165, DOI 10.1038/11086; Katanosaka Y, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4932; Kawashima Y, 2015, PFLUG ARCH EUR J PHY, V467, P85, DOI 10.1007/s00424-014-1582-3; Kerstein PC, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00244; Kholmanskikh SS, 2006, NAT NEUROSCI, V9, P50, DOI 10.1038/nn1619; Kuipers AJ, 2012, EUR J CELL BIOL, V91, P834, DOI 10.1016/j.ejcb.2012.05.006; Lu DC, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00025; Mihara H, 2010, J NEUROSCI, V30, P16536, DOI 10.1523/JNEUROSCI.4426-10.2010; Miyamoto T, 2014, J BIOL CHEM, V289, P16565, DOI 10.1074/jbc.M113.528638; Nagasawa M, 2007, J CELL PHYSIOL, V210, P692, DOI 10.1002/jcp.20883; Nagasawa M, 2015, PHYSIOL REP, V3, DOI 10.14814/phy2.12296; Nagasawa M, 2012, CELL CALCIUM, V51, P186, DOI 10.1016/j.ceca.2011.12.012; Peralvarez-Marin A, 2013, FEBS J, V280, P5471, DOI 10.1111/febs.12302; Ranade SS, 2014, P NATL ACAD SCI USA, V111, P10347, DOI 10.1073/pnas.1409233111; Raper J, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a001933; Shibasaki K, 2016, J ANESTH, V30, P1014, DOI 10.1007/s00540-016-2225-y; Shibasaki K, 2016, J PHYSIOL SCI, V66, P359, DOI 10.1007/s12576-016-0434-7; Shibasaki K, 2015, PFLUG ARCH EUR J PHY, V467, P2495, DOI 10.1007/s00424-015-1726-0; Shibasaki K, 2015, BIOCHEM BIOPH RES CO, V458, P168, DOI 10.1016/j.bbrc.2015.01.087; Shibasaki K, 2014, J BIOL CHEM, V289, P14470, DOI 10.1074/jbc.M114.557132; Shibasaki K, 2013, BIOCHEM BIOPH RES CO, V441, P327, DOI 10.1016/j.bbrc.2013.10.046; Shibasaki K, 2010, J NEUROSCI, V30, P4601, DOI 10.1523/JNEUROSCI.5830-09.2010; Suter DM, 2011, PROG NEUROBIOL, V94, P91, DOI 10.1016/j.pneurobio.2011.04.002; Takahashi M, 2002, ATHEROSCLEROSIS, V161, P387, DOI 10.1016/S0021-9150(01)00674-8; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; Tojima T, 2011, NAT REV NEUROSCI, V12, P191, DOI 10.1038/nrn2996; Tominaga M, 2004, J NEUROBIOL, V61, P3, DOI 10.1002/neu.20079; Vaudry D, 2002, SCIENCE, V296, P1648, DOI 10.1126/science.1071552; Vitriol EA, 2012, NEURON, V73, P1068, DOI 10.1016/j.neuron.2012.03.005; Wang GX, 2005, NATURE, V434, P898, DOI 10.1038/nature03478; Wittmann T, 2001, J CELL SCI, V114, P3795; Yin J, 2010, CELL BIOCHEM BIOPHYS, V56, P1, DOI 10.1007/s12013-009-9067-2; Zhang JY, 2015, ONCOTARGETS THER, V8, P3123, DOI 10.2147/OTT.S92005; Zhou FQ, 2002, J CELL BIOL, V157, P839, DOI 10.1083/jcb.200112014; Zubcevic L, 2016, NAT STRUCT MOL BIOL, V23, P180, DOI 10.1038/nsmb.3159	54	30	31	0	14	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1368	1381		10.1096/fj.201600686RR	http://dx.doi.org/10.1096/fj.201600686RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28007781				2022-12-28	WOS:000398504300010
J	Bourne, HR; Vermillion, EB				Bourne, Henry R.; Vermillion, Eric B.			Lost Dollars Threaten Research in Public Academic Health Centers	FASEB JOURNAL			English	Article						state support; federal support; indirect costs; soft-money salaries		The decrease of federal and state support threatens long-term sustainability of research in publicly supported academic health centers. In weathering these financial threats, research at the University of California, San Francisco (UCSF), has undergone 3 substantial changes: institutional salary support goes preferentially to senior faculty, whereas the young increasingly depend on grants; private and government support for research grows apace in clinical departments but declines in basic science departments; and research is judged more on its quantity (numbersof investigators and federal and private dollars) than on its goals, achievements, or scientific quality. We propose specific measures to alleviate these problems. Other large public academic health centers probably confront similar issues, but- except for UCSF-such centers have not been subjected to detailed public analysis.-Bourne, H. R., Vermillion, E. B. Lost dollars threaten research in public academic health centers.	[Bourne, Henry R.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94143 USA; [Vermillion, Eric B.] Univ Calif San Francisco, Finance Off, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Bourne, HR (corresponding author), UCSF, 1115 West Calif Ave, Mill Valley, CA 94941 USA.; Vermillion, EB (corresponding author), 20 Laurelwood Dr, Novato, CA 94949 USA.	hrbourne@gmail.com; eric.vermillion@ucsf.edu						Alberts B, 2014, P NATL ACAD SCI USA, V111, P5773, DOI 10.1073/pnas.1404402111; American Academy of Arts & Sciences, 2016, NUMB FAC MEMB HUM OT; Bourne H. R., 2016, FOLLOW MONEY FUNDING; Bourne H. R., 2011, PATHS INNOVATION DIS; Kerr C., 1963, USES U; Lauer M., 2016, OPEN MIKE       0531	6	3	3	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					855	863		10.1096/fj.201601352	http://dx.doi.org/10.1096/fj.201601352			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	28246298	Green Submitted			2022-12-28	WOS:000395671200002
J	Cil, O; Phuan, PW; Gillespie, AM; Lee, S; Tradtrantip, L; Yin, JY; Tse, M; Zachos, NC; Lin, RX; Donowitz, M; Verkman, AS				Cil, Onur; Phuan, Puay-Wah; Gillespie, Anne Marie; Lee, Sujin; Tradtrantip, Lukmanee; Yin, Jianyi; Tse, Ming; Zachos, Nicholas C.; Lin, Ruxian; Donowitz, Mark; Verkman, Alan S.			Benzopyrimido-pyrrolo-oxazine-dione CFTR inhibitor (R)-BPO-27 for antisecretory therapy of diarrheas caused by bacterial enterotoxins	FASEB JOURNAL			English	Article						intestinal secretion; secretory diarrhea; cholera; traveler's diarrhea	TRANSMEMBRANE CONDUCTANCE REGULATOR; POLYCYSTIC KIDNEY-DISEASE; INTESTINAL FLUID SECRETION; DEPENDENT PROTEIN-KINASE; ANTIDIARRHEAL EFFICACY; ION-TRANSPORT; CL-SECRETION; CYST GROWTH; CHOLERA; CHANNEL	Secretory diarrheas caused by bacterial enterotoxins, including cholera and traveler's diarrhea, remain a major global health problem. Inappropriate activation of the cystic fibrosis transmembrane conductance regulator (CFTR) chloride channel occurs in these diarrheas. We previously reported that the benzopyrimido-pyrrolo-oxazinedione (R)-BPO-27 inhibits CFTR chloride conductance with low-nanomolar potency. Here, we demonstrate using experimental mouse models and human enterocyte cultures the potential utility of (R)-BPO-27 for treatment of secretory diarrheas caused by cholera and Escherichia coli enterotoxins. (R)-BPO-27 fully blocked CFTR chloride conductance in epithelial cell cultures and intestine after cAMP agonists, cholera toxin, or heat-stable enterotoxin of E. coli (STa toxin), with IC50 down to similar to 5 nM. (R)-BPO-27 prevented cholera toxin and STa toxin-induced fluid accumulation in small intestinal loops, with IC50 down to 0.1 mg/kg. (R)-BPO-27 did not impair intestinal fluid absorption or inhibit other major intestinal transporters. Pharmacokinetics in mice showed >90% oral bioavailability with sustained therapeutic serum levels for >4 h without the significant toxicity seen with 7-d administration at 5 mg/kg/d. As evidence to support efficacy in human diarrheas, (R)-BPO-27 blocked fluid secretion in primary cultures of enteroids from human small intestine and anion current in enteroid monolayers. These studies support the potential utility of (R)-BPO-27 for therapy of CFTR-mediated secretory diarrheas.	[Cil, Onur; Phuan, Puay-Wah; Gillespie, Anne Marie; Lee, Sujin; Tradtrantip, Lukmanee; Verkman, Alan S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Cil, Onur; Phuan, Puay-Wah; Gillespie, Anne Marie; Lee, Sujin; Tradtrantip, Lukmanee; Verkman, Alan S.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA; [Yin, Jianyi; Tse, Ming; Zachos, Nicholas C.; Lin, Ruxian; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Physiol, Baltimore, MD 21205 USA; [Yin, Jianyi; Tse, Ming; Zachos, Nicholas C.; Lin, Ruxian; Donowitz, Mark] Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Johns Hopkins University; Johns Hopkins University	Verkman, AS (corresponding author), Univ Calif San Francisco, 1246 Hlth Sci East Tower, San Francisco, CA 94143 USA.	alan.verkman@ucsf.edu	Cil, Onur/AAK-5166-2020; Zachos, Nicholas/GWC-7914-2022	Cil, Onur/0000-0001-5178-0199; Lee, Sujin/0000-0001-6701-1730	U.S. National Institute of Health [R24 DK099803, P30 DK72517, R01 DK101373, R01 DK35124, R37 EB00415, R01 EY13574, R01 DK26523, R01 DK61765, P30 DK089502, TR000552, TR000504]; Research Development Program grant from the Cystic Fibrosis Foundation; Catalyst grant [UL1 TR000004]; Gates Foundation Grand Challenges grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000004, U18TR000552, UH2TR000504, UH3TR000504] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY013574] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000415] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK101373, R01DK035124, R01DK061765, R24DK099803, R01DK026523, P30DK072517, P30DK089502] Funding Source: NIH RePORTER	U.S. National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research Development Program grant from the Cystic Fibrosis Foundation; Catalyst grant; Gates Foundation Grand Challenges grant; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institute of Health (Grants R24 DK099803, P30 DK72517, R01 DK101373, R01 DK35124, R37 EB00415, R01 EY13574, R01 DK26523, R01 DK61765, P30 DK089502, TR000552, TR000504, and TR000504); a Research Development Program grant from the Cystic Fibrosis Foundation; a Catalyst grant from funds awarded to the University of California San Francisco Clinical and Translational Science Institute (UL1 TR000004); and a Gates Foundation Grand Challenges grant.	Caci E, 2008, BIOCHEM J, V413, P135, DOI 10.1042/BJ20080029; CHAO AC, 1994, EMBO J, V13, P1065, DOI 10.1002/j.1460-2075.1994.tb06355.x; Cil O, 2016, CELL MOL GASTROENTER, V2, P317, DOI 10.1016/j.jcmgh.2015.12.010; Davidow CJ, 1996, KIDNEY INT, V50, P208, DOI 10.1038/ki.1996.304; de Hostos EL, 2011, FUTURE MED CHEM, V3, P1317, DOI [10.4155/FMC.11.87, 10.4155/fmc.11.87]; Felsenstein KM, 2016, ACS CHEM BIOL, V11, P139, DOI 10.1021/acschembio.5b00577; FIELD M, 1979, AM J CLIN NUTR, V32, P189, DOI 10.1093/ajcn/32.1.189; Fiskerstrand T, 2012, NEW ENGL J MED, V366, P1586, DOI 10.1056/NEJMoa1110132; Flores AM, 2016, FASEB J, V30, P1789, DOI 10.1096/fj.201500180; Foulke-Abel J, 2016, GASTROENTEROLOGY, V150, P638, DOI 10.1053/j.gastro.2015.11.047; Guarino A, 2012, EXPERT OPIN PHARMACO, V13, P17, DOI 10.1517/14656566.2011.634800; Harris JB, 2012, LANCET, V379, P2466, DOI 10.1016/S0140-6736(12)60436-X; Hoque KM, 2010, J GEN PHYSIOL, V135, P43, DOI 10.1085/jgp.200910339; Jin BJ, 2013, J GEN PHYSIOL, V141, P261, DOI 10.1085/jgp.201210885; Kim Y, 2015, MOL PHARMACOL, V88, P689, DOI 10.1124/mol.115.098368; Ko EA, 2014, GUT, V63, P1120, DOI 10.1136/gutjnl-2013-305663; Kopeikin Z, 2010, J GEN PHYSIOL, V136, P659, DOI 10.1085/jgp.201010518; KREJS GJ, 1987, AM J MED, V82, P37, DOI 10.1016/0002-9343(87)90425-6; Lee K, 2010, BIOORG MED CHEM LETT, V20, P1767, DOI 10.1016/j.bmcl.2010.01.036; Li HY, 2009, BIODRUGS, V23, P203, DOI 10.2165/11313570-000000000-00000; Li HY, 2004, KIDNEY INT, V66, P1926, DOI 10.1111/j.1523-1755.2004.00967.x; Lin C. M., 2016, VIRUS RES, V1702, P30225; Lin MI, 2015, EUR J MED CHEM, V102, P477, DOI 10.1016/j.ejmech.2015.08.016; Luan J, 2015, FITOTERAPIA, V100, P88, DOI 10.1016/j.fitote.2014.11.001; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Moon C, 2015, PHARMACOL RES, V102, P107, DOI 10.1016/j.phrs.2015.08.024; Moore SR, 2010, GASTROENTEROLOGY, V139, P1156, DOI 10.1053/j.gastro.2010.05.076; Morris AP, 1999, AM J PHYSIOL-GASTR L, V277, pG431, DOI 10.1152/ajpgi.1999.277.2.G431; Muanprasat C, 2004, J GEN PHYSIOL, V124, P125, DOI 10.1085/jgp.200409059; Munos MK, 2010, INT J EPIDEMIOL, V39, P75, DOI 10.1093/ije/dyq025; Namkung W, 2011, J BIOL CHEM, V286, P2365, DOI 10.1074/jbc.M110.175109; Namkung W, 2010, MOL BIOL CELL, V21, P2639, DOI 10.1091/mbc.E09-12-1004; Norimatsu Y, 2012, MOL PHARMACOL, V82, P1042, DOI 10.1124/mol.112.080267; Patanayindee J, 2012, INDIAN J PHARMACOL, V44, P619, DOI 10.4103/0253-7613.100392; Rufo PA, 2004, AM J PHYSIOL-CELL PH, V286, pC998, DOI 10.1152/ajpcell.00357.2003; Selvaraj NG, 2000, BBA-MOL CELL RES, V1498, P32, DOI 10.1016/S0167-4889(00)00075-6; Snyder DS, 2013, ACS MED CHEM LETT, V4, P456, DOI 10.1021/ml400069k; Snyder DS, 2011, J MED CHEM, V54, P5468, DOI 10.1021/jm200505e; Solomon GM, 2016, ANN AM THORAC SOC, V13, pS169, DOI 10.1513/AnnalsATS.201509-601KV; Solomon GM, 2015, PEDIATR PULM, V50, pS3, DOI 10.1002/ppul.23240; Sonawane ND, 2008, CHEM BIOL, V15, P718, DOI 10.1016/j.chembiol.2008.05.015; Sonawane ND, 2007, GASTROENTEROLOGY, V132, P1234, DOI 10.1053/j.gastro.2007.02.018; STEVEN K, 1981, GASTROENTEROLOGY, V80, P1562; Thiagarajah JR, 2015, NAT REV GASTRO HEPAT, V12, P446, DOI 10.1038/nrgastro.2015.111; Thiagarajah JR, 2004, GASTROENTEROLOGY, V126, P511, DOI 10.1053/j.gastro.2003.11.005; Tradtrantip L, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002674; Tradtrantip L, 2010, MOL PHARMACOL, V77, P69, DOI 10.1124/mol.109.061051; Tradtrantip L, 2009, J MED CHEM, V52, P6447, DOI 10.1021/jm9009873; Venkatasubramanian J, 2010, CURR OPIN GASTROEN, V26, P123, DOI 10.1097/MOG.0b013e3283358a45; Verkman AS, 2013, CURR PHARM DESIGN, V19, P3529, DOI 10.2174/13816128113199990321; Verkman AS, 2009, NAT REV DRUG DISCOV, V8, P153, DOI 10.1038/nrd2780; Yang BX, 2008, J AM SOC NEPHROL, V19, P1300, DOI 10.1681/ASN.2007070828	52	29	32	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					751	760		10.1096/fj.201600891R	http://dx.doi.org/10.1096/fj.201600891R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27871064	Green Published			2022-12-28	WOS:000394235400027
J	Gao, Y; Mruk, D; Chen, HQ; Lui, WY; Lee, WM; Cheng, CY				Gao, Ying; Mruk, Dolores; Chen, Haiqi; Lui, Wing-Yee; Lee, Will M.; Cheng, C. Yan			Regulation of the blood-testis barrier by a local axis in the testis: role of laminin 2 in the basement membrane	FASEB JOURNAL			English	Article						spermatogenesis; ectoplasmic specialization; spermatid adhesion; Sertoli cell adhesion	CONGENITAL MUSCULAR-DYSTROPHY; ADULT-RAT TESTES; SEMINIFEROUS EPITHELIUM; EXTRACELLULAR-MATRIX; ALPHA-2 CHAIN; SERTOLI-CELLS; IN-VITRO; ECTOPLASMIC SPECIALIZATION; TRAFFICKING EVENTS; JUNCTION DYNAMICS	Laminin 2 is one of the constituent components of the basement membrane (BM) in adult rat testes. Earlier studies that used a mouse genetic model have shown that a deletion of laminin 2 impedes male fertility by disrupting ectoplasmic specialization (ES; a testis-specific, actin-rich anchoring junction) function along the length of Sertoli cell in the testis. This includes ES at the Sertoli cell-elongating/elongated spermatid interface, which is known as apical ES and possibly the Sertoli-Sertoli cell interface, known as basal ES, at the blood-testis barrier (BTB). Studies have also illustrated that there is a local regulatory axis that functionally links cellular events of spermiation that occur near the luminal edge of tubule lumen at the apical ES and the basal ES/BTB remodeling near the BM at opposite ends of the seminiferous epithelium during the epithelial cycle, known as the apical ES-BTB-BM axis. However, the precise role of BM in this axis remains unknown. Here, we show that laminin 2 in the BM serves as the crucial regulator in this axis as laminin 2, likely its 80-kDa fragment from the C terminus, was found to be transported across the seminiferous epithelium at stages VIII-IX of the epithelial cycle, from the BM to the luminal edge of the tubule, possibly being used to modulate apical ES restructuring at these stages. Of more importance, a knockdown of laminin 2 in Sertoli cells was shown to induce the Sertoli cell tight junction permeability barrier disruption via changes in localization of adhesion proteins at the tight junction and basal ES at the Sertoli cell BTB. These changes were found to be mediated by a disruption of F-actin organization that was induced by changes in the spatiotemporal expression of actin binding/regulatory proteins. Furthermore, laminin 2 knockdown also perturbed microtubule (MT) organization by considerable down-regulation of MT polymerization via changes in the spatiotemporal expression of EB1 (end-binding protein 1), a +TIP (MT plus-end tracking protein). In short, laminin 2 in the BM seems to play a crucial role in the BTB-BM axis by modulating BTB dynamics during spermatogenesis.	[Gao, Ying; Mruk, Dolores; Chen, Haiqi; Cheng, C. Yan] Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA; [Lui, Wing-Yee; Lee, Will M.] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China	Population Council; University of Hong Kong	Cheng, CY (corresponding author), Populat Council, Ctr Biomed Res, Mary M Wohlford Lab Male Contracept Res, 1230 York Ave, New York, NY 10065 USA.	y-cheng@popcbr.rockefeller.edu	Chen, Haiqi/J-7468-2019; Lui, Wing Yee/A-2743-2010	Chen, Haiqi/0000-0001-7179-3229; Cheng, C Yan/0000-0003-3117-3791; Lui, Wing Yee/0000-0002-3096-1158	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development [R01-HD056034, U54-HD029990]; Hong Kong Research Grants Council (RGC) [GRF774213M, GRF11004516, GRF771513]; RGC/National Natural Science Foundation of China Joint Research Scheme [N_HKU 717/12]; Hong Kong University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD029990, R01HD056034] Funding Source: NIH RePORTER	U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Hong Kong Research Grants Council (RGC)(Hong Kong Research Grants Council); RGC/National Natural Science Foundation of China Joint Research Scheme; Hong Kong University(University of Hong Kong); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This work was supported by the U.S. National Institutes of Health, Eunice Kennedy Shriver National Institute of Child Health and Human Development Grants R01-HD056034 (to C.Y.C.) and U54-HD029990 Project 5 (to C.Y.C.); Hong Kong Research Grants Council (RGC) (GRF774213M and GRF11004516 to W.Y.L., and GRF771513 to W.M.L.); RGC/National Natural Science Foundation of China Joint Research Scheme (N_HKU 717/12 to W.M.L.); and Hong Kong University Seed Funding (to W.Y.L. and W.M.L.).	Allamand V, 1997, HUM MOL GENET, V6, P747, DOI 10.1093/hmg/6.5.747; Brunden KR, 2014, BIOORGAN MED CHEM, V22, P5040, DOI 10.1016/j.bmc.2013.12.046; CAMPBELL KP, 1995, CELL, V80, P675, DOI 10.1016/0092-8674(95)90344-5; Cheng CY, 2012, PHARMACOL REV, V64, P16, DOI 10.1124/pr.110.002790; Cheng CY, 2010, NAT REV ENDOCRINOL, V6, P380, DOI 10.1038/nrendo.2010.71; Cheng CY, 2009, CRIT REV BIOCHEM MOL, V44, P245, DOI 10.1080/10409230903061207; Cohn RD, 1998, NEUROLOGY, V51, P94, DOI 10.1212/WNL.51.1.94; Durbeej M, 1998, J HISTOCHEM CYTOCHEM, V46, P449, DOI 10.1177/002215549804600404; DYM M, 1994, ENDOCR REV, V15, P102, DOI 10.1210/er.15.1.102; EHRIG K, 1990, P NATL ACAD SCI USA, V87, P3264, DOI 10.1073/pnas.87.9.3264; Ekblom P, 1996, CURR OPIN CELL BIOL, V8, P700, DOI 10.1016/S0955-0674(96)80112-8; ERVASTI JM, 1993, J CELL BIOL, V122, P809, DOI 10.1083/jcb.122.4.809; GALDIERI M, 1981, J ANDROL, V2, P249; Gao Y, 2016, THESIS; Granger E, 2014, SEMIN CELL DEV BIOL, V31, P20, DOI 10.1016/j.semcdb.2014.04.011; Grima J, 1997, J BIOL CHEM, V272, P6499, DOI 10.1074/jbc.272.10.6499; Guo LT, 2003, NEUROMUSCULAR DISORD, V13, P207, DOI 10.1016/s0960-8966(02)00266-3; HADLEY MA, 1985, J CELL BIOL, V101, P1511, DOI 10.1083/jcb.101.4.1511; Hager M, 2005, AM J PATHOL, V167, P823, DOI 10.1016/S0002-9440(10)62054-8; HELBLINGLECLERC A, 1995, NAT GENET, V11, P216, DOI 10.1038/ng1095-216; Hess RA, 2008, ADV EXP MED BIOL, V636, P1, DOI 10.1007/978-0-387-09597-4_1; Holmberg J, 2013, CELL ADHES MIGR, V7, P111, DOI 10.4161/cam.22618; Jones KJ, 2001, J MED GENET, V38, P649, DOI 10.1136/jmg.38.10.649; Koch M, 1999, J CELL BIOL, V145, P605, DOI 10.1083/jcb.145.3.605; Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705; Lee NPY, 2004, J ANDROL, V25, P200; Li MWM, 2009, INT J BIOCHEM CELL B, V41, P2302, DOI 10.1016/j.biocel.2009.05.016; Li N, 2016, ENDOCRINOLOGY, V157, P2894, DOI 10.1210/en.2016-1133; Margolis RL, 1998, BIOESSAYS, V20, P830, DOI 10.1002/(SICI)1521-1878(199810)20:10<830::AID-BIES8>3.0.CO;2-N; Menezes MJ, 2014, J NEUROSCI, V34, P15260, DOI 10.1523/JNEUROSCI.3678-13.2014; Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7; Miyagoe-Suzuki Y, 2000, MICROSC RES TECHNIQ, V48, P181, DOI 10.1002/(SICI)1097-0029(20000201/15)48:3/4<181::AID-JEMT6>3.0.CO;2-Q; Mok KW, 2015, ENDOCRINOLOGY, V156, P1900, DOI 10.1210/en.2014-1791; Mruk Dolores D, 2011, Spermatogenesis, V1, P121; Mruk DD, 2011, METHODS MOL BIOL, V763, P237, DOI 10.1007/978-1-61779-191-8_16; Naom I, 2000, BRAIN, V123, P31, DOI 10.1093/brain/123.1.31; Neto FTL, 2016, SEMIN CELL DEV BIOL, V59, P10, DOI 10.1016/j.semcdb.2016.04.009; O'Donnell L, 2014, SEMIN CELL DEV BIOL, V30, P45, DOI 10.1016/j.semcdb.2014.01.003; Oberlies NH, 2004, J NAT PROD, V67, P129, DOI 10.1021/np030498t; Pelletier RM, 2011, PROG HISTOCHEM CYTO, V46, P49, DOI 10.1016/j.proghi.2011.05.001; RUSSELL LD, 1989, TISSUE CELL, V21, P361, DOI 10.1016/0040-8166(89)90051-7; Schlatt S, 2014, SEMIN CELL DEV BIOL, V29, P2, DOI 10.1016/j.semcdb.2014.03.007; Sewry CA, 1997, NEUROMUSCULAR DISORD, V7, P169, DOI 10.1016/S0960-8966(97)00425-2; Siu MKY, 2005, J BIOL CHEM, V280, P25029, DOI 10.1074/jbc.M501049200; Siu MKY, 2004, BIOESSAYS, V26, P978, DOI 10.1002/bies.20099; Siu MKY, 2004, BIOL REPROD, V70, P945, DOI 10.1095/biolreprod.103.023606; Siu MKY, 2003, ENDOCRINOLOGY, V144, P371, DOI 10.1210/en.2002-220786; Smith BE, 2012, SCIENCE, V338, P798, DOI 10.1126/science.1219969; Su LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep16271; Su LL, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2171; Su LL, 2010, EXP CELL RES, V316, P2945, DOI 10.1016/j.yexcr.2010.07.018; SUNADA Y, 1994, J BIOL CHEM, V269, P13729; Talts JF, 1998, FEBS LETT, V426, P71, DOI 10.1016/S0014-5793(98)00312-3; Tang EI, 2016, SEMIN CELL DEV BIOL, V59, P35, DOI 10.1016/j.semcdb.2016.01.004; Tang EI, 2016, ENDOCRINOLOGY, V157, P1644, DOI 10.1210/en.2015-1962; Tang EI, 2015, CELL POLARITY 1: BIOLOGICAL ROLE AND BASIC MECHANISMS, P303, DOI 10.1007/978-3-319-14463-4_13; Tang EI, 2015, ENDOCRINOLOGY, V156, P680, DOI 10.1210/en.2014-1720; Tang EI, 2013, J ENDOCRINOL, V217, pR13, DOI 10.1530/JOE-12-0586; TUNG PS, 1986, DEV BIOL, V113, P119, DOI 10.1016/0012-1606(86)90114-4; TUNG PS, 1993, J CELL PHYSIOL, V156, P1, DOI 10.1002/jcp.1041560102; Tzu J, 2008, INT J BIOCHEM CELL B, V40, P199, DOI 10.1016/j.biocel.2007.07.015; Vogl AW, 2008, ADV EXP MED BIOL, V636, P186, DOI 10.1007/978-0-387-09597-4_11; Wong EWP, 2010, P NATL ACAD SCI USA, V107, P11399, DOI 10.1073/pnas.1001077107; Wong EW, 2013, SPERMATOGENESIS, V3, DOI DOI 10.4161/SPMG.25465; Xiao X, 2014, AM J PHYSIOL-ENDOC M, V307, pE553, DOI 10.1152/ajpendo.00176.2014; Xiao X, 2014, PHYSIOLOGY, V29, P286, DOI 10.1152/physiol.00001.2014; Xiao XA, 2011, INT J BIOCHEM CELL B, V43, P651, DOI 10.1016/j.biocel.2011.01.008; Yan HHN, 2008, P NATL ACAD SCI USA, V105, P8950, DOI 10.1073/pnas.0711264105; Yan HHN, 2008, FASEB J, V22, P1945, DOI 10.1096/fj.06-070342; Yan HHN, 2008, CURR TOP DEV BIOL, V80, P57, DOI 10.1016/S0070-2153(07)80002-0; Yan HHN, 2007, BIOESSAYS, V29, P36, DOI 10.1002/bies.20513; Yan HHN, 2006, J BIOL CHEM, V281, P17286, DOI 10.1074/jbc.M513218200; Yao PL, 2010, BIOL REPROD, V82, P516, DOI 10.1095/biolreprod.109.080374; Yao PL, 2009, BIOL REPROD, V80, P581, DOI 10.1095/biolreprod.108.073122	74	35	40	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					584	597		10.1096/fj.201600870R	http://dx.doi.org/10.1096/fj.201600870R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27815338	Green Published			2022-12-28	WOS:000394235400013
J	Gerbier, R; Alvear-Perez, R; Margathe, JF; Flahault, A; Couvineau, P; Gao, J; De Mota, N; Dabire, H; Li, B; Ceraudo, E; Hus-Citharel, A; Esteoulle, L; Bisoo, C; Hibert, M; Berdeaux, A; Iturrioz, X; Bonnet, D; Llorens-Cortes, C				Gerbier, Romain; Alvear-Perez, Rodrigo; Margathe, Jean-Francois; Flahault, Adrien; Couvineau, Pierre; Gao, Ji; De Mota, Nadia; Dabire, Hubert; Li, Bo; Ceraudo, Emilie; Hus-Citharel, Annette; Esteoulle, Lucie; Bisoo, Cynthia; Hibert, Marcel; Berdeaux, Alain; Iturrioz, Xavier; Bonnet, Dominique; Llorens-Cortes, Catherine			Development of original metabolically stable apelin-17 analogs with diuretic and cardiovascular effects	FASEB JOURNAL			English	Article						vascular reactivity; blood pressure; cardiac contractility; vasopressin and diuresis	HUMAN APJ RECEPTOR; HEART-FAILURE; IN-VIVO; ENDOGENOUS LIGAND; BLOOD-PRESSURE; RAT-BRAIN; PEPTIDE; SYSTEM; BINDING; IDENTIFICATION	Apelin, a (neuro)vasoactive peptide, plays a prominent role in controlling cardiovascular functions and water balance. Because the in vivo apelin half-life is in the minute range, we aimed to identify metabolically stable apelin-17 (K17F) analogs. We generated P92 by classic chemical substitutions and LIT01-196 by original addition of a fluorocarbon chain to the N terminus of K17F. Both analogs were much more stable in plasma (half-life >24 h for LIT01-196) than K17F (4.6 min). Analogs displayed a subnanomolar affinity for the apelin receptor and behaved as full agonists with regard to cAMP production, ERK phosphorylation, and apelin receptor internalization. Ex vivo, these compounds induced vasorelaxation of rat aortas and glomerular arterioles, respectively, precontracted with norepinephrine and angiotensin II, and increased cardiac contractility. In vivo, after intracerebroventricular administration in water-deprived mice, P92 and LIT01-196 were 6 and 160 times, respectively, more efficient at inhibiting systemic vasopressin release than K17F. Administered intravenously (nmol/kg range) in normotensive rats, these analogs potently increased urine output and induced a profound and sustained decrease in arterial blood pressure. In summary, these new compounds, which favor diuresis and improve cardiac contractility while reducing vascular resistances, represent promising candidates for the treatment of heart failure and water retention/hyponatremic disorders.	[Gerbier, Romain; Alvear-Perez, Rodrigo; Flahault, Adrien; Couvineau, Pierre; Gao, Ji; De Mota, Nadia; Li, Bo; Ceraudo, Emilie; Hus-Citharel, Annette; Bisoo, Cynthia; Iturrioz, Xavier; Llorens-Cortes, Catherine] Coll France, INSERM, Ctr Natl Rech Sci,Unite 1050,Unit Mixte Rech, Ctr Interdisciplinary Res Biol,Lab Cent Neuropept, Paris, France; [Margathe, Jean-Francois; Esteoulle, Lucie; Hibert, Marcel; Bonnet, Dominique] Univ Strasbourg, Fac Pharm, Ctr Natl Rech Sci, Lab Therapeut Innovat,Unite Mixte Rech 7200, Illkirch Graffenstaden, France; [Berdeaux, Alain] Univ Paris Est, INSERM, Fac Med, Unite 955, Creteil, France	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; PSL Research University Paris; College de France; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite Paris-Est-Creteil-Val-de-Marne (UPEC)	Llorens-Cortes, C (corresponding author), Coll France, INSERM, CNRS, U1050,UMR 7241,Lab Cent Neuropeptides Regulat Bod, 11 Pl Marcelin Berthelot, F-75005 Paris, France.	c.llorens-cortes@college-de-france.fr	DABIRE, Hubert/G-5488-2018; Bonnet, Dominique/N-7275-2014; GERBIER, Romain/ABF-2481-2020; Iturrioz, Xavier/AAS-3555-2020; Llorens-Cortès, catherine/AAL-3893-2021; Llorens-Cortes, Catherine/E-5839-2016; Flahault, Adrien/Q-4576-2017; ITURRIOZ, Xavier/Q-4406-2017	DABIRE, Hubert/0000-0002-5829-2718; Bonnet, Dominique/0000-0002-8252-9199; Iturrioz, Xavier/0000-0001-7143-8323; Llorens-Cortès, catherine/0000-0002-7667-0401; Llorens-Cortes, Catherine/0000-0002-7667-0401; Flahault, Adrien/0000-0003-4632-6332; ITURRIOZ, Xavier/0000-0001-7143-8323; DE MOTA, Nadia/0000-0003-3754-3722; Couvineau, Pierre/0000-0002-4905-7740; Gerbier, Romain/0000-0003-4617-4850	INSERM; Centre National de la Recherche Scientifique; Universite de Strasbourg; College de France; Agence Nationale pour la Recherche "Physique et Chimie du Vivant"; "Cardiovasculaire-Obesite-Rein-Diabete" (Region Ile-de-France); Fondation Lefoulon-Delalande; French "Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche."	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Universite de Strasbourg; College de France; Agence Nationale pour la Recherche "Physique et Chimie du Vivant"(French National Research Agency (ANR)); "Cardiovasculaire-Obesite-Rein-Diabete" (Region Ile-de-France); Fondation Lefoulon-Delalande; French "Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche."	The authors thank Julie Sapa for the editing the article, Jeremie Teillon (Center for Interdisciplinary Research in Biology for Microscopy Core Facility), Patrick Gizzi (TechMedILL Platform, Illkirch, France), and Nicolas Humbert and Hugues de Rocquigny (Laboratory of Biophotonics and Pharmacology, Illkirch, France) for peptides synthesis. This work was supported by INSERM (through financial support for Proof of Concept, CoPoC, in particular), the Centre National de la Recherche Scientifique, the Universite de Strasbourg, the College de France, and the Agence Nationale pour la Recherche "Physique et Chimie du Vivant 2009." R.G., J.G., E.C., and L.E were supported by fellowships from " Cardiovasculaire-Obesite-Rein-Diabete" (Region Ile-de-France), Fondation Lefoulon-Delalande, and the French "Ministere de l'Education Nationale, de l'Enseignement Superieur et de la Recherche."	Ashley EA, 2005, CARDIOVASC RES, V65, P73, DOI 10.1016/j.cardiores.2004.08.018; Azizi M, 2008, J AM SOC NEPHROL, V19, P1015, DOI 10.1681/ASN.2007070816; Barnes GD, 2013, CIRC-HEART FAIL, V6, P482, DOI 10.1161/CIRCHEARTFAILURE.111.000077; Berry MF, 2004, CIRCULATION, V110, pII187, DOI 10.1161/01.CIR.0000138382.57325.5c; Blanchard A, 2013, J CLIN ENDOCR METAB, V98, P2084, DOI 10.1210/jc.2012-3794; Brame AL, 2015, HYPERTENSION, V65, P834, DOI 10.1161/HYPERTENSIONAHA.114.05099; Ceraudo E, 2014, J BIOL CHEM, V289, P24599, DOI 10.1074/jbc.M113.541698; Dabire H, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-011-0240-6; De Mota N, 2000, NEUROENDOCRINOLOGY, V72, P400, DOI 10.1159/000054609; De Mota N, 2004, P NATL ACAD SCI USA, V101, P10464, DOI 10.1073/pnas.0403518101; Evans NA, 2001, J NEUROCHEM, V77, P476, DOI 10.1046/j.1471-4159.2001.00269.x; Fan XJ, 2003, BIOCHEMISTRY-US, V42, P10163, DOI 10.1021/bi030049s; Folino A, 2015, HEART FAIL REV, V20, P505, DOI 10.1007/s10741-015-9475-x; Fosgerau K, 2015, DRUG DISCOV TODAY, V20, P122, DOI 10.1016/j.drudis.2014.10.003; Gerbier R, 2015, FASEB J, V29, P314, DOI 10.1096/fj.14-256339; Habata Y, 1999, BBA-MOL CELL RES, V1452, P25, DOI 10.1016/S0167-4889(99)00114-7; Hamada J, 2008, INT J MOL MED, V22, P547, DOI 10.3892/ijmm_00000054; Hus-Citharel A, 2008, KIDNEY INT, V74, P486, DOI 10.1038/ki.2008.199; Hus-Citharel A, 2014, ENDOCRINOLOGY, V155, P4483, DOI 10.1210/en.2014-1257; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; Iturrioz X, 2010, FASEB J, V24, P1506, DOI 10.1096/fj.09-140715; Japp AG, 2010, CIRCULATION, V121, P1818, DOI 10.1161/CIRCULATIONAHA.109.911339; Japp AG, 2008, J AM COLL CARDIOL, V52, P908, DOI 10.1016/j.jacc.2008.06.013; Japp AG, 2008, BIOCHEM PHARMACOL, V75, P1882, DOI 10.1016/j.bcp.2007.12.015; Jia ZQ, 2012, PEPTIDES, V38, P181, DOI 10.1016/j.peptides.2012.09.003; Katugampola SD, 2002, CAN J PHYSIOL PHARM, V80, P369, DOI 10.1139/Y02-029; Krieg E, 2014, J AM CHEM SOC, V136, P9443, DOI 10.1021/ja503906p; Kuba K, 2007, CIRC RES, V101, pE32, DOI 10.1161/CIRCRESAHA.107.158659; Lee DK, 2000, J NEUROCHEM, V74, P34, DOI 10.1046/j.1471-4159.2000.0740034.x; Llorens-Cortes C., 2016, Patent, Patent No. [WO2016102648 A1, 2016102648]; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; McKeown SC, 2014, BIOORG MED CHEM LETT, V24, P4871, DOI 10.1016/j.bmcl.2014.08.045; Messari SE, 2004, J NEUROCHEM, V90, P1290, DOI 10.1111/j.1471-4159.2004.02591.x; Mitra A, 2006, PHYSIOL BEHAV, V89, P221, DOI 10.1016/j.physbeh.2006.06.006; Murza A, 2015, J MED CHEM, V58, P2431, DOI 10.1021/jm501916k; Murza A, 2014, BIOPOLYMERS, V102, P297, DOI 10.1002/bip.22498; Murza A, 2012, CHEMMEDCHEM, V7, P318, DOI 10.1002/cmdc.201100492; O'Carroll AM, 2000, BBA-GENE STRUCT EXPR, V1492, P72, DOI 10.1016/S0167-4781(00)00072-5; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Reaux A, 2001, J NEUROCHEM, V77, P1085, DOI 10.1046/j.1471-4159.2001.00320.x; Reaux A, 2002, NEUROSCIENCE, V113, P653, DOI 10.1016/S0306-4522(02)00192-6; Reaux A, 1999, P NATL ACAD SCI USA, V96, P13415, DOI 10.1073/pnas.96.23.13415; Reaux-Le Goazigo A, 2004, ENDOCRINOLOGY, V145, P4392, DOI 10.1210/en.2004-0384; Tatemoto K, 2001, REGUL PEPTIDES, V99, P87, DOI 10.1016/S0167-0115(01)00236-1; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; Vlieghe P, 2010, DRUG DISCOV TODAY, V15, P40, DOI 10.1016/j.drudis.2009.10.009; Wang W, 2016, HYPERTENSION, V68, P365, DOI 10.1161/HYPERTENSIONAHA.115.06892; Wang W, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000249; Zhang YY, 2014, BIOORGAN MED CHEM, V22, P2992, DOI 10.1016/j.bmc.2014.04.001	49	34	37	1	18	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					687	700		10.1096/fj.201600784R	http://dx.doi.org/10.1096/fj.201600784R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27815337				2022-12-28	WOS:000394235400021
J	Cai, SB; Bodle, JC; Mathieu, PS; Amos, A; Hamouda, M; Bernacki, S; McCarty, G; Loboa, EG				Cai, Shaobo; Bodle, Josephine C.; Mathieu, Pattie S.; Amos, Alison; Hamouda, Mehdi; Bernacki, Susan; McCarty, Greg; Loboa, Elizabeth G.			Primary cilia are sensors of electrical field stimulation to induce osteogenesis of human adipose-derived stem cells	FASEB JOURNAL			English	Article						polycystin-1; intraflagellar protein-88; siRNA knockdown; signal transduction; calcium oscillations	MESENCHYMAL STROMAL CELLS; VERTEBRATE DEVELOPMENT; SIGNAL-TRANSDUCTION; OSTEOBLAST GROWTH; BONE-CELLS; CALCIUM; TISSUE; DIFFERENTIATION; POLYCYSTIN-1; REGENERATION	In this study, we report for the first time that the primary ciliumacts as a crucial sensor for electrical field stimulation (EFS)-enhanced osteogenic response in osteoprogenitor cells. In addition, primary cilia seem to functionally modulate effects of EFS-induced cellular calcium oscillations. Primary cilia are organelles that have recently been implicated to play a crucial sensor role for many mechanical and chemical stimuli on stem cells. Here, we investigate the role of primary cilia in EFS-enhanced osteogenic response of human adipose-derived stem cells (hASCs) by knocking down 2 primary cilia structural proteins, polycystin-1 and intraflagellar protein-88. Our results indicate that structurally integrated primary cilia are required for detection of electrical field signals in hASCs. Furthermore, by measuring changes of cytoplasmic calcium concentration in hASCs during EFS, our findings also suggest that primary cilia may potentially function as a crucial calcium-signaling nexus in hASCs during EFS.-Cai, S., Bodle, J. C., Mathieu, P. S., Amos, A., Hamouda, M., Bernacki, S., McCarty, G., Loboa, E. G. Primary cilia are sensors of electrical field stimulation to induce osteogenesis of human adipose-derived stem cells.	[Cai, Shaobo] North Carolina State Univ, Dept Mat Sci & Engn, Raleigh, NC USA; [Bodle, Josephine C.; Mathieu, Pattie S.; Amos, Alison; Hamouda, Mehdi; Bernacki, Susan; McCarty, Greg; Loboa, Elizabeth G.] North Carolina State Univ, Joint Dept Biomed Engn, Raleigh, NC USA; [Bodle, Josephine C.; Mathieu, Pattie S.; Amos, Alison; Hamouda, Mehdi; Bernacki, Susan; McCarty, Greg; Loboa, Elizabeth G.] Univ North Carolina Chapel Hill, Raleigh, NC USA; [Loboa, Elizabeth G.] Univ Missouri, Coll Engn, W1051 Thomas & Nell Laferre Hall, Columbia, MO 65211 USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University; University of North Carolina; University of North Carolina Chapel Hill; University of Missouri System; University of Missouri Columbia	Loboa, EG (corresponding author), Univ Missouri, Coll Engn, W1051 Thomas & Nell Laferre Hall, Columbia, MO 65211 USA.	egloboa@missouri.edu	Cai, Shaobo/AAQ-4306-2020	Cai, Shaobo/0000-0003-0165-9846	U.S. National Science Foundation/Chemical, Bioengineering, Environmental, and Transport Systems Grant [1133427]; National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering Grant [1R03-EB008790]; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R03EB008790] Funding Source: NIH RePORTER; Directorate For Engineering [1133427] Funding Source: National Science Foundation	U.S. National Science Foundation/Chemical, Bioengineering, Environmental, and Transport Systems Grant; National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering Grant; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Directorate For Engineering(National Science Foundation (NSF)NSF - Directorate for Engineering (ENG))	This work was supported by U.S. National Science Foundation/Chemical, Bioengineering, Environmental, and Transport Systems Grant 1133427 and National Institutes of Health, National Institute of Biomedical Imaging and Bioengineering Grant 1R03-EB008790.	Balint R, 2013, TISSUE ENG PART B-RE, V19, P48, DOI [10.1089/ten.teb.2012.0183, 10.1089/ten.TEB.2012.0183]; Banks TA, 2015, INTEGR BIOL-UK, V7, P693, DOI 10.1039/c4ib00297k; Basten Sander G, 2013, Cilia, V2, P2, DOI 10.1186/2046-2530-2-2; Bergh JJ, 2004, ENDOCRINOLOGY, V145, P426, DOI 10.1210/en.2003-0319; Bernacki SH, 2008, METHOD CELL BIOL, V86, P257, DOI 10.1016/S0091-679X(08)00011-3; Bijlsma MF, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002798; Bimonte S, 2011, DEV BIOL, V349, P179, DOI 10.1016/j.ydbio.2010.09.020; Bodle JC, 2014, TISSUE ENG PART C-ME, V20, P972, DOI [10.1089/ten.tec.2013.0683, 10.1089/ten.TEC.2013.0683]; Bodle JC, 2011, TISSUE ENG PART B-RE, V17, P195, DOI 10.1089/ten.teb.2010.0738; Bodle JC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062554; Brighton CT, 2001, J BONE JOINT SURG AM, V83A, P1514, DOI 10.2106/00004623-200110000-00009; Brownell WE, 2010, BIOPHYS J, V99, P845, DOI 10.1016/j.bpj.2010.05.025; Delling M, 2013, NATURE, V504, P311, DOI 10.1038/nature12833; Delmas P, 2002, J BIOL CHEM, V277, P11276, DOI 10.1074/jbc.M110483200; Dimitriou R, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-66; Dvir T, 2011, NAT NANOTECHNOL, V6, P13, DOI 10.1038/NNANO.2010.246; Goetz SC, 2010, NAT REV GENET, V11, P331, DOI 10.1038/nrg2774; Hart FX, 2010, BIOELECTROMAGNETICS, V31, P77, DOI 10.1002/bem.20525; Hierck BP, 2008, DEV DYNAM, V237, P725, DOI 10.1002/dvdy.21472; Hoerner C, 2013, CELL, V155, P271, DOI 10.1016/j.cell.2013.09.027; Hoey DA, 2011, BIOCHEM BIOPH RES CO, V412, P182, DOI 10.1016/j.bbrc.2011.07.072; Hronik-Tupaj M, 2012, TISSUE ENG PART B-RE, V18, P167, DOI [10.1089/ten.teb.2011.0244, 10.1089/ten.TEB.2011.0244]; Hu WW, 2014, MAT SCI ENG C-MATER, V37, P28, DOI 10.1016/j.msec.2013.12.019; Hwang SJ, 2012, TISSUE ENG PT A, V18, P432, DOI [10.1089/ten.tea.2010.0752, 10.1089/ten.TEA.2010.0752]; Jin XJ, 2014, CELL MOL LIFE SCI, V71, P2165, DOI 10.1007/s00018-013-1483-1; Khatib L, 2004, FASEB J, V18, P1903, DOI 10.1096/fj.04-1814fje; Kim IS, 2009, TISSUE ENG PT A, V15, P2411, DOI 10.1089/ten.tea.2008.0554; Kleene SJ, 2014, BIOSCIENCE, V64, P1092, DOI 10.1093/biosci/biu181; Lee Kristen L, 2015, Cilia, V4, P7, DOI 10.1186/s13630-015-0016-y; Li JKJ, 2006, ULTRASOUND MED BIOL, V32, P769, DOI 10.1016/j.ultrasmedbio.2006.01.017; Lim JH, 2013, CELL REPROGRAM, V15, P405, DOI 10.1089/cell.2013.0001; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; McCullen SD, 2010, TISSUE ENG PART C-ME, V16, P1377, DOI [10.1089/ten.tec.2009.0751, 10.1089/ten.TEC.2009.0751]; McGlashan SR, 2010, CELL BIOL INT, V34, P441, DOI 10.1042/CBI20090094; Moore NM, 2011, ACTA BIOMATER, V7, P2091, DOI 10.1016/j.actbio.2011.01.019; Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076; Nguyen AM, 2013, BONE, V54, P196, DOI 10.1016/j.bone.2012.11.016; Ozkucur N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006131; Oh EC, 2012, DEVELOPMENT, V139, P443, DOI 10.1242/dev.050054; Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709; Riehl BD, 2012, TISSUE ENG PART B-RE, V18, P288, DOI [10.1089/ten.teb.2011.0465, 10.1089/ten.TEB.2011.0465]; Saadoun S, 2011, J NEUROL NEUROSUR PS, V82, DOI 10.1136/jnnp.2010.232371; Sharif-Naeini R, 2009, CELL, V139, P587, DOI 10.1016/j.cell.2009.08.045; Sun S, 2007, FASEB J, V21, P1472, DOI 10.1096/fj.06-7153com; Temiyasathit S, 2010, ANN NY ACAD SCI, V1192, P422, DOI 10.1111/j.1749-6632.2009.05243.x; Tummala P, 2010, CELL MOL BIOENG, V3, P207, DOI 10.1007/s12195-010-0127-x; Wann AKT, 2012, CELL MOL LIFE SCI, V69, P2967, DOI 10.1007/s00018-012-0980-y; Xiao ZS, 2010, ANN NY ACAD SCI, V1192, P410, DOI 10.1111/j.1749-6632.2009.05239.x; Xu J, 2009, OSTEOARTHR CARTILAGE, V17, P397, DOI 10.1016/j.joca.2008.07.001; Yan JL, 2015, MOL CELL ENDOCRINOL, V404, P132, DOI 10.1016/j.mce.2015.01.031; Zayzafoon M, 2006, J CELL BIOCHEM, V97, P56, DOI 10.1002/jcb.20675; Zhang JY, 2016, ACTA BIOMATER, V32, P46, DOI 10.1016/j.actbio.2015.12.024; Zhang JY, 2013, BIOTECHNOL BIOENG, V110, P1466, DOI 10.1002/bit.24796; Zhou J, 2009, ANNU REV PHYSIOL, V71, P83, DOI 10.1146/annurev.physiol.70.113006.100621	54	15	15	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					346	355		10.1096/fj.201600560R	http://dx.doi.org/10.1096/fj.201600560R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27825103	Green Published			2022-12-28	WOS:000392177600032
J	Butin-Israeli, V; Houser, MC; Feng, ML; Thorp, EB; Nusrat, A; Parkos, CA; Sumagin, R				Butin-Israeli, Veronika; Houser, Madelyn C.; Feng, Mingli; Thorp, Edward B.; Nusrat, Asma; Parkos, Charles A.; Sumagin, Ronen			Deposition of microparticles by neutrophils onto inflamed epithelium: a new mechanism to disrupt epithelial intercellular adhesions and promote transepithelial migration	FASEB JOURNAL			English	Article						inflammation; injury; transmigration; intestine; barrier	INFLAMMATORY-BOWEL-DISEASE; ENDOTHELIAL-CELLS; E-CADHERIN; PROTEIN; RELEASE; MATRIX-METALLOPROTEINASE-9; TRANSMIGRATION; DESMOGLEIN-2; PATHOGENESIS; ACTIVATION	Neutrophil [polymorphonuclear leukocyte (PMN)] transepithelial migration (TEM) is a hallmark of inflammatory mucosal disorders. PMN TEM is associated with epithelial injury; however, mechanisms involved in this process are not well defined. The current work describes a new mechanism whereby deposition of PMN membrane-derived microparticles (PMN-MPs) onto intestinal epithelial cells (IECs) during TEM leads to loss of epithelial cadherins, thus promoting epithelial injury and increased PMN recruitment. PMN-MPs secreted by activated PMNs during TEM displayed a high level of enzymatically active matrix metalloproteinase 9 (MMP-9), and were capable of mediating potent effects on IEC integrity. Isolated PMN-MPs efficiently bound to IEC monolayers and induced cleavage of desmoglein-2 (DSG-2) but not E-cadherin, leading to disruption of IEC intercellular adhesions. Furthermore, PMN-MP binding to intestinal epithelium in vitro in transwell assays and in vivo in ligated intestinal loop preparations facilitated increases in PMN TEM. These effects were MMP-9 dependent and were reversed in the presence of specific pharmacological inhibitors. Finally, we demonstrated that IEC Dsg-2 serves as a barrier for migrating PMNs, and its removal by PMN-MP-associated MMP-9 facilitates PMN trafficking across epithelial layers. Our findings thus implicate PMN-MPs in PMN-mediated inflammation and epithelial damage, as observed in inflammatory disorders of mucosal surfaces.-Butin-Israeli, V., Houser, M. C., Feng, M., Thorp, E. B., Nusrat, A., Parkos, C. A, Sumagin, R. Deposition of microparticles by neutrophils onto inflamed epithelium: a new mechanism to disrupt epithelial intercellular adhesions and promote transepithelial migration.	[Butin-Israeli, Veronika; Thorp, Edward B.; Sumagin, Ronen] Northwestern Univ, Feinberg Sch Med, Dept Pathol, Chicago, IL 60611 USA; [Houser, Madelyn C.] Emory Univ, Sch Med, Dept Physiol, Atlanta, GA 30322 USA; [Feng, Mingli; Nusrat, Asma; Parkos, Charles A.] Univ Michigan, Sch Med, Dept Pathol, Ann Arbor, MI USA	Northwestern University; Feinberg School of Medicine; Emory University; University of Michigan System; University of Michigan	Sumagin, R (corresponding author), Northwestern Univ, Tarry Res Bldg,Room 3-707,303 E Chicago Ave, Chicago, IL 60611 USA.	ronen.sumagin@northwestern.edu	Butin-Israeli, Veronika/AAQ-2391-2020; Houser, Madelyn/AAK-8387-2021	Houser, Madelyn/0000-0002-4049-9876; Thorp, Edward/0000-0003-1387-7058	U.S. National Institutes of Health (NIH), National Cancer Institute Grant [CCSG P30 CA060553]; NIH, National Institute of Diabetes and Digestive and Kidney Diseases [DK072564, DK061379, DK079392, DK055679, DK059888, DK101675]; American Cancer Society [IRG-9303718]; NATIONAL CANCER INSTITUTE [P30CA060553] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL122309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072564, R01DK059888, R29DK055679, R01DK055679, R01DK061379, R01DK079392, K01DK101675] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Cancer Institute Grant; NIH, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank Dr. J. Koch (Northwestern University) and the Northwestern University Center for Advanced Microscopy Core Facility [supported by U.S. National Institutes of Health (NIH), National Cancer Institute Grant CCSG P30 CA060553 awarded to the Robert H. Lurie, Comprehensive Cancer Center] for help with electron microscopic imaging of the PMN-MPs. The authors also thank Lorrain Mascarenhas (Northwestern University) for technical assistance and proofreading of the manuscript. This work was supported by NIH, National Institute of Diabetes and Digestive and Kidney Diseases Grants DK072564, DK061379, and DK079392 (to C.A.P.); DK055679 and DK059888 (to A.N.); and DK101675, as well as American Cancer Society IRG-9303718 (to R.S.). The authors declare no conflicts of interest.	Almkvist J, 2001, INFECT IMMUN, V69, P832, DOI 10.1128/IAI.69.2.832-837.2001; Ardi VC, 2007, P NATL ACAD SCI USA, V104, P20262, DOI 10.1073/pnas.0706438104; Bornslaeger EA, 1996, J CELL BIOL, V134, P985, DOI 10.1083/jcb.134.4.985; Brazil JC, 2013, INFLAMM BOWEL DIS, V19, P1556, DOI 10.1097/MIB.0b013e318281f54e; Chakrabarti S, 2006, J LEUKOCYTE BIOL, V79, P214, DOI 10.1189/jlb.0605353; Chakrabarti S, 2005, J LEUKOCYTE BIOL, V78, P279, DOI 10.1189/jlb.1004612; Chin AC, 2009, J IMMUNOL, V183, P5957, DOI 10.4049/jimmunol.0900789; Chun J, 2009, CELL HOST MICROBE, V5, P47, DOI 10.1016/j.chom.2008.11.009; Corry DB, 2004, FASEB J, V18, P995, DOI 10.1096/fj.03-1412fje; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dalli J, 2008, BLOOD, V112, P2512, DOI 10.1182/blood-2008-02-140533; Dalli J, 2013, MOL CELL PROTEOMICS, V12, P2205, DOI 10.1074/mcp.M113.028589; Daniel L, 2006, KIDNEY INT, V69, P1416, DOI 10.1038/sj.ki.5000306; Du D, 2010, DEV CELL, V18, P52, DOI 10.1016/j.devcel.2009.12.008; ERLANDSEN SL, 1993, J HISTOCHEM CYTOCHEM, V41, P327, DOI 10.1177/41.3.7679125; FARQUHAR MG, 1963, J CELL BIOL, V17, P375, DOI 10.1083/jcb.17.2.375; Gaborski TR, 2013, EUR BIOPHYS J BIOPHY, V42, P851, DOI 10.1007/s00249-013-0931-z; Garrod D, 2008, BBA-BIOMEMBRANES, V1778, P572, DOI 10.1016/j.bbamem.2007.07.014; Gasser O, 2004, BLOOD, V104, P2543, DOI 10.1182/blood-2004-01-0361; Ginzberg HH, 2001, AM J PHYSIOL-GASTR L, V281, pG705, DOI 10.1152/ajpgi.2001.281.3.G705; Headland SE, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac5608; Jiang K, 2014, J BIOL CHEM, V289, P10510, DOI 10.1074/jbc.M113.538538; Johnson BL, 2014, ENDOCR METAB IMMUNE, V14, P210, DOI 10.2174/1871530314666140722083717; Kamekura R, 2014, ONCOGENE, V33, P4531, DOI 10.1038/onc.2013.442; Kamekura R, 2015, MOL BIOL CELL, V26, P3165, DOI 10.1091/mbc.E15-03-0147; Kolaczkowska E, 2013, NAT REV IMMUNOL, V13, P159, DOI 10.1038/nri3399; Kolegraff K, 2011, MOL BIOL CELL, V22, P1121, DOI 10.1091/mbc.E10-10-0845; Kucharzik T, 2001, AM J PATHOL, V159, P2001, DOI 10.1016/S0002-9440(10)63051-9; Kunder CA, 2009, J EXP MED, V206, P2455, DOI 10.1084/jem.20090805; Langhorst J, 2005, INFLAMM BOWEL DIS, V11, P1085, DOI 10.1097/01.MIB.0000187980.08686.18; Lie PPY, 2010, INT J BIOCHEM CELL B, V42, P975, DOI 10.1016/j.biocel.2010.02.010; Lindsey M, 2001, CIRCULATION, V103, P2181; Liu Y, 2002, J BIOL CHEM, V277, P10028, DOI 10.1074/jbc.M109720200; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Mackarel AJ, 2000, AM J RESP CELL MOL, V23, P154, DOI 10.1165/ajrcmb.23.2.3853; Matsuda M, 2004, J CELL SCI, V117, P1247, DOI 10.1242/jcs.00972; Mayerle J, 2005, GASTROENTEROLOGY, V129, P1251, DOI 10.1053/j.gastro.2005.08.002; Multhoff G, 2012, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00098; Nava P, 2007, MOL BIOL CELL, V18, P4565, DOI 10.1091/mbc.E07-05-0426; Nava P, 2011, EMBO REP, V12, P314, DOI 10.1038/embor.2011.16; PARKOS CA, 1992, J CELL BIOL, V117, P757, DOI 10.1083/jcb.117.4.757; Pecina-Slaus N, 2003, CANCER CELL INT, V3, DOI 10.1186/1475-2867-3-17; Pitanga TN, 2014, BMC CELL BIOL, V15, DOI 10.1186/1471-2121-15-21; Pliyev BK, 2014, CYTOKINE, V65, P126, DOI 10.1016/j.cyto.2013.11.010; Schulte D, 2011, EMBO J, V30, P4157, DOI 10.1038/emboj.2011.304; Semb H, 1998, AM J HUM GENET, V63, P1588, DOI 10.1086/302173; Severson EA, 2008, MOL BIOL CELL, V19, P1862, DOI 10.1091/mbc.E07-09-0869; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Stamenkovic I, 2003, J PATHOL, V200, P448, DOI 10.1002/path.1400; Sumagin R, 2016, MUCOSAL IMMUNOL, V9, P1151, DOI 10.1038/mi.2015.135; Sumagin R, 2014, MUCOSAL IMMUNOL, V7, P905, DOI 10.1038/mi.2013.106; Sumagin R, 2015, TISSUE BARRIERS, V3, DOI 10.4161/21688362.2014.969100; Swamydas M, 2013, JOVE-J VIS EXP, DOI 10.3791/50586; Wang Q, 2001, J IMMUNOL, V166, P6877, DOI 10.4049/jimmunol.166.11.6877; Weber DA, 2014, MUCOSAL IMMUNOL, V7, P1221, DOI 10.1038/mi.2014.12; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Zihni C, 2014, J CELL SCI, V127, P3401, DOI 10.1242/jcs.145029	57	42	44	1	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4007	4020		10.1096/fj.201600734R	http://dx.doi.org/10.1096/fj.201600734R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27553226	Green Submitted, Green Published			2022-12-28	WOS:000388201500009
J	Min, HK; Maruyama, H; Jang, BK; Shimada, M; Mirshahi, F; Ren, SL; Oh, YM; Puri, P; Sanyal, AJ				Min, Hae-Ki; Maruyama, Hitoshi; Jang, Byoung Kuk; Shimada, Masahiko; Mirshahi, Faridoddin; Ren, Shunlin; Oh, Youngman; Puri, Puneet; Sanyal, Arun J.			Suppression of IGF binding protein-3 by palmitate promotes hepatic inflammatory responses	FASEB JOURNAL			English	Article						NAFLD; nonalcoholic steatohepatitis; lipotoxicity; interleukin-8; IGFBP-3	FATTY LIVER-DISEASE; BREAST-CANCER CELLS; INSULIN-RESISTANCE; NONALCOHOLIC STEATOHEPATITIS; HEPATOCELLULAR-CARCINOMA; IGFBP-3; LIPOTOXICITY; RECEPTOR; AXIS; DIFFERENTIATION	IGF-binding protein-3 (IGFBP-3) is a liver-derived, anti-inflammatory molecule that is decreased in obesity, a key risk factor for nonalcoholic fatty liver disease (NAFLD). It was not known whether IGFBP-3 levels were altered in NAFLD, whether such alterations could be the result of lipotoxicity, and whether altered IGFBP-3 could affect pathways that are involved in hepatic and systemic inflammation. Serum IGFBP-3 was decreased in patients with NAFLD, whereas liver and circulating IL-8 levels were increased. Palmitate inhibited IGFBP-3 secretion by THP-1macrophages and enhanced IL-8 expression. Exposure of palmitate-treated THP-1macrophages to IGFBP-3-deficient conditioned medium led to a 20-fold increase in palmitate-induced IL-8 expression by hepato-cytes. Conversely, overexpression of IGFBP-3 suppressed JNK and NF-kappa B activation and blocked palmitate-induced IL-8 expression in hepatocytes. Silencing IGFBP-3 in Huh7 cells enhanced JNK and NF-kappa B activity and increased palmitate-induced IL-8 secretion. These data indicate that IGFBP-3 serves as an anti-inflammatory brake in hepatocytes against JNK and NF-kappa B and limits their activation and downstream production of proinflammatory cytokines. Under lipotoxic conditions, palmitate inhibits hepatic macrophage secretion of IGFBP-3, thereby releasing the brake and enhancing palmitate-induced IL-8 synthesis and secretion.	[Min, Hae-Ki; Maruyama, Hitoshi; Jang, Byoung Kuk; Shimada, Masahiko; Mirshahi, Faridoddin; Ren, Shunlin; Puri, Puneet; Sanyal, Arun J.] Virginia Commonwealth Univ, Sch Med, Dept Internal Med, Div Gastroenterol Hepatol & Nutr, Richmond, VA USA; [Oh, Youngman] Virginia Commonwealth Univ, Sch Med, Dept Pathol, Div Cellular & Mol Pathogenesis, Richmond, VA USA	Virginia Commonwealth University; Virginia Commonwealth University	Min, HK; Sanyal, AJ (corresponding author), Virginia Commonwealth Univ, Med Ctr, 1220 E Broad St, Richmond, VA 23219 USA.	hae-ki.min@vcuhealth.org; arun.sanyal@vcuhealth.org		Jang, Byoung Kuk/0000-0002-8950-0866	U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases) [DK081450, T32 DK07150]; U.S. National Institutes of Health (National Institute on Alcohol Abuse and Alcoholism) [AA020758]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081410, T32DK007150, R03DK081450] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020758] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [16K01406] Funding Source: KAKEN	U.S. National Institutes of Health (National Institute of Diabetes and Digestive and Kidney Diseases)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); U.S. National Institutes of Health (National Institute on Alcohol Abuse and Alcoholism); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by U.S. National Institutes of Health Grants DK081450 and T32 DK07150 (National Institute of Diabetes and Digestive and Kidney Diseases) and AA020758 (National Institute on Alcohol Abuse and Alcoholism) (to A.J.S.). This is original work and is not under consideration for publication elsewhere. It has been previously presented in part at the 2012 annual meeting of the American Association for Study of Liver Diseases (Digestive Diseases Week; San Diego, CA, USA; May 2012).	Alkhouri Naim, 2009, Expert Rev Gastroenterol Hepatol, V3, P445, DOI 10.1586/egh.09.32; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; ARANY E, 1994, J CLIN ENDOCR METAB, V79, P1871, DOI 10.1210/jc.79.6.1871; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Baffy G, 2012, J HEPATOL, V56, P1384, DOI 10.1016/j.jhep.2011.10.027; Baxter RC, 2001, J CLIN PATHOL-MOL PA, V54, P145, DOI 10.1136/mp.54.3.145; Baxter RC, 2014, NAT REV CANCER, V14, P329, DOI 10.1038/nrc3720; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Brunt EM, 2007, MODERN PATHOL, V20, pS40, DOI 10.1038/modpathol.3800680; Brunt EM, 1999, LIVER, V19, P263, DOI 10.1111/j.1478-3231.1999.tb00047.x; Butt AJ, 1999, IMMUNOL CELL BIOL, V77, P256, DOI 10.1046/j.1440-1711.1999.00822.x; Cha SJ, 2015, J EXP MED, V212, P1391, DOI 10.1084/jem.20110575; Chitturi S, 2002, HEPATOLOGY, V35, P373, DOI 10.1053/jhep.2002.30692; Cusi K, 2012, GASTROENTEROLOGY, V142, P711, DOI 10.1053/j.gastro.2012.02.003; Ekstedt M, 2006, HEPATOLOGY, V44, P865, DOI 10.1002/hep.21327; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Frystyk J, 1999, DIABETES-METAB RES, V15, P314, DOI 10.1002/(SICI)1520-7560(199909/10)15:5<314::AID-DMRR56>3.0.CO;2-E; Fuchs M, 2012, J HEPATOL, V56, P291, DOI 10.1016/j.jhep.2011.05.019; Ganz M, 2013, HEPATOL INT, V7, pS771, DOI 10.1007/s12072-013-9468-6; Grkovic S, 2013, ONCOGENE, V32, P2412, DOI 10.1038/onc.2012.264; Haukeland JW, 2006, J HEPATOL, V44, P1167, DOI 10.1016/j.jhep.2006.02.011; Hoque R, 2013, J HEPATOL, V58, P1047, DOI 10.1016/j.jhep.2012.12.017; Ibanez de Caceres I, 2010, ONCOGENE, V29, P1681, DOI 10.1038/onc.2009.454; Ingermann AR, 2010, J BIOL CHEM, V285, P30233, DOI 10.1074/jbc.M110.122226; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Joshi-Barve S, 2007, HEPATOLOGY, V46, P823, DOI 10.1002/hep.21752; Kim HS, 2007, PEDIATR RES, V61, P159, DOI 10.1203/pdr.0b013e31802d8a30; Kim Ho-Seong, 2013, Ann Pediatr Endocrinol Metab, V18, P9, DOI 10.6065/apem.2013.18.1.9; Lam CSP, 2010, ARTERIOSCL THROM VAS, V30, P1479, DOI 10.1161/ATVBAHA.110.203943; Lapointe A, 2009, METABOLISM, V58, P180, DOI 10.1016/j.metabol.2008.09.011; Lee YC, 2011, J BIOL CHEM, V286, P17898, DOI 10.1074/jbc.M111.231035; Leung C, 2015, WORLD J GASTROENTERO, V21, P1189, DOI 10.3748/wjg.v21.i4.1189; Li JW, 2013, BIOCHEM BIOPH RES CO, V436, P632, DOI 10.1016/j.bbrc.2013.04.111; Lomonaco R, 2012, HEPATOLOGY, V55, P1389, DOI 10.1002/hep.25539; Marchesini G, 2001, DIABETES, V50, P1844, DOI 10.2337/diabetes.50.8.1844; Martin JL, 2014, MOL CANCER THER, V13, P316, DOI 10.1158/1535-7163.MCT-13-0367; Martin JL, 1999, J BIOL CHEM, V274, P16407, DOI 10.1074/jbc.274.23.16407; Mehta HH, 2011, CANCER RES, V71, P5154, DOI 10.1158/0008-5472.CAN-10-4513; Min HK, 2015, AM J PHYSIOL-GASTR L, V308, pG794, DOI 10.1152/ajpgi.00390.2014; Min HK, 2012, CELL METAB, V15, P665, DOI 10.1016/j.cmet.2012.04.004; Mohanraj L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055084; Oy GF, 2010, INT J CANCER, V126, P350, DOI 10.1002/ijc.24727; Park EK, 2007, INFLAMM RES, V56, P45, DOI 10.1007/s00011-007-6115-5; Roelfsema V, 2001, J AM SOC NEPHROL, V12, P1297, DOI 10.1681/ASN.V1261297; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Sanyal AJ, 2010, NEW ENGL J MED, V362, P1675, DOI 10.1056/NEJMoa0907929; Schedlich LJ, 2007, ARCH BIOCHEM BIOPHYS, V465, P359, DOI 10.1016/j.abb.2007.06.013; Schulz N, 2013, INT J MOL SCI, V14, P18989, DOI 10.3390/ijms140918989; Williams AC, 2007, CELL DEATH DIFFER, V14, P137, DOI 10.1038/sj.cdd.4401919; Younossi ZM, 2016, HEPATOLOGY, V64, P73, DOI 10.1002/hep.28431	50	14	14	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4071	4082		10.1096/fj.201600427R	http://dx.doi.org/10.1096/fj.201600427R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27553225	Green Published, Green Submitted			2022-12-28	WOS:000388201500014
J	Lam, L; Chin, L; Halder, RC; Sagong, B; Famenini, S; Sayre, J; Montoya, D; Rubbi, L; Pellegrini, M; Fiala, M				Lam, Larry; Chin, Lydia; Halder, Ramesh C.; Sagong, Bien; Famenini, Sam; Sayre, James; Montoya, Dennis; Rubbi, Liudmilla; Pellegrini, Matteo; Fiala, Milan			Epigenetic changes in T-cell and monocyte signatures and production of neurotoxic cytokines in ALS patients	FASEB JOURNAL			English	Article						inflammation; ALS; SOD-1	AMYOTROPHIC-LATERAL-SCLEROSIS; SPINAL-CORD TISSUE; DISEASE PROGRESSION; EXPRESSION ANALYSIS; REPEAT EXPANSION; SEQUENCING DATA; MOTOR-NEURONS; MUTANT SOD1; MAST-CELLS; RECEPTOR	We have investigated transcriptional and epigenetic differences in peripheral blood mononuclear cells (PBMCs) of monozygotic female twins discordant in the diagnosis of amyotrophic lateral sclerosis (ALS). Exploring DNA methylation differences by reduced representation bisulfite sequencing (RRBS), we determined that, over time, the ALS twin developed higher abundances of the CD14 macrophages and lower abundances of T cells compared to the non-ALS twin. Higher macrophage signature in the ALS twin was also shown by RNA sequencing (RNA-seq). Moreover, the twins differed in the methylome at loci near several genes, including EGFR and TNFRSF11A, and in the pathways related to the tretinoin and H3K27me3 markers. We also tested cytokine production by PBMCs. The ALS twin's PBMCs spontaneously produced IL-6 and TNF-alpha, whereas PBMCs of the healthy twin produced these cytokines only when stimulated by superoxide dismutase (SOD)-1. These results and flow cytometric detection of CD45 and CD127 suggest the presence of memory T cells in both twins, but effector T cells only in the ALS twin. The ALS twin's PBMC supernatants, but not the healthy twin's, were toxic to rat cortical neurons, and this toxicity was strongly inhibited by an IL-6 receptor antibody (tocilizumab) and less well by TNF-alpha and TNF-beta antibodies. The putative neurotoxicity of IL-6 and TNF-alpha is in agreement with a high expression of these cytokines on infiltrating macrophages in the ALS spinal cord. We hypothesize that higher macrophage abundance and increased neurotoxic cytokines have a fundamental role in the phenotype and treatment of certain individuals with ALS.	[Lam, Larry; Montoya, Dennis; Rubbi, Liudmilla; Pellegrini, Matteo; Fiala, Milan] Univ Calif Los Angeles, UCLA Sch Med, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Chin, Lydia; Halder, Ramesh C.; Sagong, Bien; Famenini, Sam; Fiala, Milan] Univ Calif Los Angeles, UCLA Sch Med, Dept Surg, Los Angeles, CA USA; [Sayre, James] Univ Calif Los Angeles, UCLA Sch Publ Hlth, Dept Biostat, Los Angeles, CA USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles	Fiala, M (corresponding author), UCLA Sch Med, 100 UCLA Med Plaza,Suite 200, Los Angeles, CA 90095 USA.	fiala@mednet.ucla.edu		Fiala, Milan/0000-0001-8023-6053; Pellegrini, Matteo/0000-0001-9355-9564	U.S. National Institutes of Health (NIH) National Institute of Human Genome Research Grant [T32 HG008553-01]; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant [3P50AR063020-03S1]; Genentech, Inc. (South San Francisco, CA, USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P50AR063020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008553] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Human Genome Research Grant; NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant; Genentech, Inc. (South San Francisco, CA, USA)(Roche HoldingGenentech); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Giovanni Coppola for genetic screening of the twins, Anna Caputo for testing toxicities of PBMC supernatants in rat neurons, Julian Whitelegge for fibrillary wild-type SOD-1, Larry Magpantay for testing cytokines, and Elizabeth Rigali (all from UCLA School of Medicine) for assistance with manuscript preparation. Funding was provided by U.S. National Institutes of Health (NIH) National Institute of Human Genome Research Grant T32 HG008553-01 (to L.M.) and NIH National Institute of Arthritis and Musculoskeletal and Skin Diseases Grant 3P50AR063020-03S1 (to D.M.). M.F. was supported by and received paid travel to meetings from Genentech, Inc. (South San Francisco, CA, USA), and honoraria and paid travel from Smartfish AS (Oslo, Norway).	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Andersen PM, 2011, NAT REV NEUROL, V7, P603, DOI 10.1038/nrneurol.2011.150; Baciu C, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-244; Boillee S, 2006, NEURON, V52, P39, DOI 10.1016/j.neuron.2006.09.018; Bosco DA, 2010, NAT NEUROSCI, V13, P1396, DOI 10.1038/nn.2660; Campbell IL, 2014, J NEUROSCI, V34, P2503, DOI 10.1523/JNEUROSCI.2830-13.2014; Cirulli ET, 2015, SCIENCE, V347, P1436, DOI 10.1126/science.aaa3650; Collins MA, 2015, J PROTEOME RES, V14, P4486, DOI 10.1021/acs.jproteome.5b00804; Cooper-Knock J, 2015, ACTA NEUROPATHOL, V130, P63, DOI 10.1007/s00401-015-1429-9; Endo F, 2015, CELL REP, V11, P592, DOI 10.1016/j.celrep.2015.03.053; Feng X, 2005, GENE, V350, P1, DOI 10.1016/j.gene.2005.01.014; Fiala Milan, 2013, Am J Neurodegener Dis, V2, P129; Fiala M, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-76; Forsberg K, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011552; Graves MC, 2004, AMYOTROPH LATERAL SC, V5, P213, DOI 10.1080/14660820410020286; Guareschi S, 2012, P NATL ACAD SCI USA, V109, P5074, DOI 10.1073/pnas.1115402109; Guo WL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-774; Heath PR, 2002, MUSCLE NERVE, V26, P438, DOI 10.1002/mus.10186; Henkel JS, 2004, ANN NEUROL, V55, P221, DOI 10.1002/ana.10805; Holmoy T, 2008, EUR J NEUROL, V15, P360, DOI 10.1111/j.1468-1331.2008.02065.x; Hooten KG, 2015, NEUROTHERAPEUTICS, V12, P364, DOI 10.1007/s13311-014-0329-3; Huster KM, 2004, P NATL ACAD SCI USA, V101, P5610, DOI 10.1073/pnas.0308054101; Israelson A, 2015, NEURON, V86, P218, DOI 10.1016/j.neuron.2015.02.034; JONES AR, 2006, NEUROBIOL AGING, V2015; Kabashi E, 2007, ANN NEUROL, V62, P553, DOI 10.1002/ana.21319; Kang SH, 2013, NAT NEUROSCI, V16, P571, DOI 10.1038/nn.3357; KAWAMATA T, 1992, AM J PATHOL, V140, P691; Kebir H, 2007, NAT MED, V13, P1173, DOI 10.1038/nm1651; Lam Larry, 2015, Am J Neurodegener Dis, V4, P28; Lang L, 2015, P NATL ACAD SCI USA, V112, P9878, DOI 10.1073/pnas.1503328112; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lo HM, 2014, FOOD FUNCT, V5, P140, DOI 10.1039/c3fo60309a; Locksley RM, 2001, CELL, V104, P487, DOI 10.1016/S0092-8674(01)00237-9; Martens JHA, 2013, HAEMATOLOGICA, V98, P1487, DOI 10.3324/haematol.2013.094243; McCall MN, 2010, BIOSTATISTICS, V11, P242, DOI 10.1093/biostatistics/kxp059; McGeer PL, 2002, MUSCLE NERVE, V26, P459, DOI 10.1002/mus.10191; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Mesci P, 2015, BRAIN, V138, P53, DOI 10.1093/brain/awu312; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Nishimoto N, 2008, BLOOD, V112, P3959, DOI 10.1182/blood-2008-05-155846; Paez-Colasante X, 2015, NAT REV NEUROL, V11, P266, DOI 10.1038/nrneurol.2015.57; Persidsky Y, 2003, J LEUKOCYTE BIOL, V74, P691, DOI 10.1189/jlb.0503205; Peters OM, 2015, J CLIN INVEST, V125, P1767, DOI 10.1172/JCI71601; Pollack BP, 2012, ONCOIMMUNOLOGY, V1, P71, DOI 10.4161/onci.1.1.18073; Povlsen GK, 2008, J NEUROCHEM, V104, P624, DOI 10.1111/j.1471-4159.2007.05033.x; Renton AE, 2011, NEURON, V72, P257, DOI 10.1016/j.neuron.2011.09.010; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Sallusto F, 1999, NATURE, V401, P708, DOI 10.1038/44385; Smith ZD, 2009, METHODS, V48, P226, DOI 10.1016/j.ymeth.2009.05.003; Steinberg KM, 2015, AMYOTROPH LAT SCL FR, V16, P385, DOI 10.3109/21678421.2015.1040029; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tovar-y-Romo LB, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00061; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Turner MR, 2013, NEUROLOGY, V81, P1222, DOI 10.1212/WNL.0b013e3182a6cc13; Vucic S, 2014, TRENDS NEUROSCI, V37, P433, DOI 10.1016/j.tins.2014.05.006; Xi ZR, 2014, NEUROLOGY, V83, P1476, DOI 10.1212/WNL.0000000000000886; Xi ZR, 2013, AM J HUM GENET, V92, P981, DOI 10.1016/j.ajhg.2013.04.017; Yamanaka K, 2008, NAT NEUROSCI, V11, P251, DOI 10.1038/nn2047; Young MD, 2011, NUCLEIC ACIDS RES, V39, P7415, DOI 10.1093/nar/gkr416; Zaghi J, 2009, ACTA NEUROPATHOL, V117, P111, DOI 10.1007/s00401-008-0481-0; Zaiss DMW, 2015, IMMUNITY, V42, P216, DOI 10.1016/j.immuni.2015.01.020	63	37	37	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3461	3473		10.1096/fj.201600259RR	http://dx.doi.org/10.1096/fj.201600259RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27368295	Green Published			2022-12-28	WOS:000384329800017
J	Zhang, CW; Xue, P; Gao, LZ; Chen, X; Lin, KB; Yang, XY; Dai, YF; Xu, EY				Zhang, Chenwang; Xue, Peng; Gao, Liuze; Chen, Xia; Lin, Kaibo; Yang, Xiaoyu; Dai, Yifan; Xu, Eugene Yujun			Highly conserved epigenetic regulation of BOULE and DAZL is associated with human fertility	FASEB JOURNAL			English	Article						DNA methylation; epigenetic mechanism; infertility; oligospermia; germ cells	GERM-CELL DEVELOPMENT; HUMAN MALE-INFERTILITY; AZOOSPERMIA-LIKE DAZL; DNA METHYLATION; RAPID EVOLUTION; MESSENGER-RNA; GENE; EXPRESSION; SPERMATOGENESIS; MEN	Separation of germ cells from somatic cells is a widespread feature of animal sexual reproduction, with a core set of germ cell factors conserved among diverse animals. It is not known what controls their conserved gonad-specific expression. Core components of epigenetic machinery are ancient, but its role in conserved tissue expression regulation remains unexplored. We found that promoters of the reproductive genes BOULE and DAZL exhibit differential DNA methylation, consistent with their gonad-specific expression in humans and mice. Low or little promoter methylation from the testicular tissue is attributed to spermatogenic cells of various stages in the testis. Such differential DNA methylation is present in the orthologous promoters not only of other mammalian species, but also of chickens and fish, supporting a highly conserved epigenetic mechanism. Furthermore, hypermethylation of DAZL and BOULE promoters in human sperm is associated with human infertility. Our data strongly suggest that epigenetic regulation may underlie conserved germ-cell-specific expression, and such a mechanism may play an important role in human fertility.	[Zhang, Chenwang; Xue, Peng; Gao, Liuze; Chen, Xia; Lin, Kaibo; Dai, Yifan; Xu, Eugene Yujun] Nanjing Med Univ, State Key Lab Reprod Med, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Xue, Peng; Yang, Xiaoyu] Nanjing Med Univ, Dept Urol, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China	Nanjing Medical University; Nanjing Medical University	Xu, EY (corresponding author), Nanjing Med Univ, State Key Lab Reprod Med, Nanjing 211166, Jiangsu, Peoples R China.	xuyujun@njmu.edu.cn	杨, 玉/W-7221-2019	Xu, Eugene/0000-0002-4344-6606; Lin, Kaibo/0000-0002-2001-8369	National Science Foundation of China [81270737]; National Basic Research Program of China (Program 973) [2013CB945201]; Natural Science Foundation of Jiangsu Province [BK2012838]; Provincial Innovation and Entrepreneurship Grant; Provincial Shuangchuan Program	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (Program 973)(National Basic Research Program of China); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Provincial Innovation and Entrepreneurship Grant; Provincial Shuangchuan Program	The authors thank Dr. Rongfeng Li [Nanjing Medical University (NJMU), Nanjing, China] for facilitating the collection of the pig tissues; Dr. Xin Wu (NJMU) for the kind gift of mouse SSCs; Dr. Michael Rehli (University Hospital, Regensburg, Germany) for the CpG-free luciferase reporter vector; Zhiyuan Zhang for bioinformatics assistance; and Tong Zhu, Haixin Li, and Min Wang (NJMU) for technical assistance. This work was supported by National Science Foundation of China (Grant 81270737), National Basic Research Program of China (Program 973, Grant 2013CB945201), Natural Science Foundation of Jiangsu Province (Grant BK2012838), and a Provincial Innovation and Entrepreneurship Grant. Funding for the open access charge was provided by the Provincial Shuangchuan Program. The authors declare no conflicts of interest.	ARIEL M, 1994, NAT GENET, V7, P59, DOI 10.1038/ng0594-59; BELLVE AR, 1993, METHOD ENZYMOL, V225, P84; Chai NN, 1997, MOL HUM REPROD, V3, P705, DOI 10.1093/molehr/3.8.705; Cinalli RM, 2008, CELL, V132, P559, DOI 10.1016/j.cell.2008.02.003; Cox DN, 1998, GENE DEV, V12, P3715, DOI 10.1101/gad.12.23.3715; Eberhart CG, 1996, NATURE, V381, P783, DOI 10.1038/381783a0; EIRINLOPEZ JM, 2011, INT J EVOL BIOL, V2011, P72457, DOI DOI 10.4061/2011/972457; Extavour CG, 2003, DEVELOPMENT, V130, P5869, DOI 10.1242/dev.00804; Farre D, 2003, NUCLEIC ACIDS RES, V31, P3651, DOI 10.1093/nar/gkg605; Gao M, 2013, MOL REPROD DEV, V80, P610, DOI 10.1002/mrd.22115; Grabole N, 2013, EMBO REP, V14, P629, DOI 10.1038/embor.2013.67; Hedges SB, 2006, BIOINFORMATICS, V22, P2971, DOI 10.1093/bioinformatics/btl505; HOLLIDAY R, 1975, SCIENCE, V187, P226, DOI 10.1126/science.1111098; Hou Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002716; Juliano CE, 2010, DEVELOPMENT, V137, P4113, DOI 10.1242/dev.047969; Karashima T, 2000, DEVELOPMENT, V127, P1069; Klug M, 2006, EPIGENETICS-US, V1, P127, DOI 10.4161/epi.1.3.3327; Kostova E, 2007, MOL HUM REPROD, V13, P85, DOI 10.1093/molehr/gal101; Krausz C, 2011, BEST PRACT RES CL EN, V25, P271, DOI 10.1016/j.beem.2010.08.006; Kumaki Y, 2008, NUCLEIC ACIDS RES, V36, pW170, DOI 10.1093/nar/gkn294; Li B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071215; Lin YF, 2005, DEV BIOL, V288, P309, DOI 10.1016/j.ydbio.2005.06.032; Liu JH, 2009, MOL CELL ENDOCRINOL, V311, P101, DOI 10.1016/j.mce.2009.06.003; Liu ZS, 2011, ANIM REPROD SCI, V126, P258, DOI 10.1016/j.anireprosci.2011.05.013; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Ludwig MZ, 2000, NATURE, V403, P564, DOI 10.1038/35000615; Luetjens CM, 2004, J CLIN ENDOCR METAB, V89, P1926, DOI 10.1210/jc.2003-031178; Maatouk DM, 2006, DEVELOPMENT, V133, P3411, DOI 10.1242/dev.02500; MacLean JA, 2005, CURR TOP DEV BIOL, V71, P131, DOI 10.1016/S0070-2153(05)71005-X; Messeguer X, 2002, BIOINFORMATICS, V18, P333, DOI 10.1093/bioinformatics/18.2.333; Navarro-Costa P, 2010, HUM REPROD, V25, P2647, DOI 10.1093/humrep/deq200; Nicholas CR, 2009, GENESIS, V47, P74, DOI 10.1002/dvg.20460; *PRACT COMM AM SOC, 2006, FERTIL STERIL, V86, pS111; REIJO R, 1995, NAT GENET, V10, P383, DOI 10.1038/ng0895-383; Richardson ME, 2014, HUM MOL GENET, V23, P12, DOI 10.1093/hmg/ddt392; RIGGS AD, 1975, CYTOGENET CELL GENET, V14, P9, DOI 10.1159/000130315; Seisenberger S, 2013, CURR OPIN CELL BIOL, V25, P281, DOI 10.1016/j.ceb.2013.02.013; Shah C, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001022; Smith AD, 2006, P NATL ACAD SCI USA, V103, P6275, DOI 10.1073/pnas.0508169103; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tanaka SS, 2000, GENE DEV, V14, P841; Trasler JM, 2009, MOL CELL ENDOCRINOL, V306, P33, DOI 10.1016/j.mce.2008.12.018; Tsuda M, 2003, SCIENCE, V301, P1239, DOI 10.1126/science.1085222; Tung JY, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-40; Tung JY, 2006, HUM GENET, V118, P730, DOI 10.1007/s00439-005-0098-5; Vangompel Michael J W, 2011, Spermatogenesis, V1, P36; VanGompel MJW, 2010, HUM MOL GENET, V19, P2360, DOI 10.1093/hmg/ddq109; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Xu EYJ, 2003, HUM MOL GENET, V12, P169, DOI 10.1093/hmg/ddg017; Xu HY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006097; Yang ZS, 2013, REPRODUCTION, V146, P501, DOI 10.1530/REP-13-0311; Yen PH, 2004, INT J ANDROL, V27, P125, DOI 10.1111/j.1365-2605.2004.00469.x; Yen PH, 1996, HUM MOL GENET, V5, P2013, DOI 10.1093/hmg/5.12.2013; Yi S, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-10-174	55	14	17	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3424	3440		10.1096/fj.201500167R	http://dx.doi.org/10.1096/fj.201500167R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27358391				2022-12-28	WOS:000384329800014
J	Chen, X; Bode, AM; Dong, ZG; Cao, Y				Chen, Xue; Bode, Ann M.; Dong, Zigang; Cao, Ya			The epithelial-mesenchymal transition (EMT) is regulated by oncoviruses in cancer	FASEB JOURNAL			English	Review						metastasis; carcinogenesis virus; signaling pathway; cancer progression	EPSTEIN-BARR-VIRUS; HEPATITIS-B-VIRUS; CIRCULATING TUMOR-CELLS; E-CADHERIN EXPRESSION; PHASE-I TRIAL; NASOPHARYNGEAL CARCINOMA; TGF-BETA; HEPATOCELLULAR-CARCINOMA; DNA METHYLATION; X-PROTEIN	The epithelial-mesenchymal transition (EMT), defined as transdifferentiation of epithelial cells into mesenchymal cells, is critical for embryonic development, wound healing, tissue regeneration, organ fibrosis, and cancer progression. Recently, the role of EMT in carcinogenesis has attracted much attention. Oncoviruses, including human papillomaviruses (HPVs), Epstein-Barr virus (EBV), and hepatitis B and C viruses (HBVs, HCVs), are known to be involved in the etiology of cancer and have been found to play important roles in cancer metastasis, especially in the EMT process. The HPV encoded oncoproteins E6 and E7 (E6/E7), EBV latent membrane protein-1 and -2A, EBV nuclear antigen, HBV-encoded X antigen, and nonstructural HCV protein 5A are all involved in the regulation of EMT. This review primarily focuses on the role of oncoviruses and their encoded proteins or signaling pathways in the EMT process. Understanding their roles will help us in the development of effective strategies for prevention and treatment of virus-related cancers.Chen, X., Bode, A. M., Dong, Z., Cao, Y. The epithelial-mesenchymal transition (EMT) is regulated by oncoviruses in cancer.	[Chen, Xue; Cao, Ya] Cent S Univ, Mol Imaging Res Ctr, Xiangya Hosp, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China; [Chen, Xue; Cao, Ya] Cent S Univ, Canc Res Inst, Changsha, Hunan, Peoples R China; [Chen, Xue; Cao, Ya] Cent S Univ, Key Lab, Chinese Minist Educ, Changsha, Hunan, Peoples R China; [Chen, Xue; Cao, Ya] Cent S Univ, State Key Lab Carcinogenesis, Chinese Minist Publ Hlth, Changsha, Hunan, Peoples R China; [Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA	Central South University; Central South University; Central South University; Central South University; University of Minnesota System	Cao, Y (corresponding author), Cent S Univ, Mol Imaging Res Ctr, Xiangya Hosp, 110 Xiangya Rd, Changsha 410078, Hunan, Peoples R China.	ycao98@vip.sina.com			National High Technology Research and Development Program of China [2012AA02A501]; National Basic Research Program of China [2011CB504300]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China(National Basic Research Program of China)	The authors thank Professor Yongguang Tao (Cancer Research Institute, Central South University, Hunan, China) and Lunquan Sun (Xiangya Hospital, Central South University, Hunan, China) for review assistance and suggestions. This work was supported by National High Technology Research and Development Program of China Grant 2012AA02A501, and by National Basic Research Program of China Grant 2011CB504300. Author contributions: Y. Cao and X. Chen designed the review; X. Chen wrote the paper; A.M. Bode and Z.G. Dong reviewed and revised the manuscript; and all authors gave final approval of the version to be published. The authors declare no conflicts of interest.	Akkari L, 2012, J HEPATOL, V57, P1021, DOI 10.1016/j.jhep.2012.06.027; Al Moustafa AE, 2004, ONCOGENE, V23, P350, DOI 10.1038/sj.onc.1207148; Anagnostou VK, 2015, CLIN CANCER RES, V21, P976, DOI 10.1158/1078-0432.CCR-14-1187; Arzumanyan A, 2012, ONCOGENE, V31, P563, DOI 10.1038/onc.2011.255; Arzumanyan A, 2013, NAT REV CANCER, V13, P123, DOI 10.1038/nrc3449; Bensouda Y, 2011, EUR ANN OTORHINOLARY, V128, P79, DOI 10.1016/j.anorl.2010.10.003; Benzoubir N, 2013, J HEPATOL, V59, P1160, DOI 10.1016/j.jhep.2013.07.036; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bose SK, 2012, J VIROL, V86, P13621, DOI 10.1128/JVI.02016-12; Boulenouar S, 2010, CARCINOGENESIS, V31, P473, DOI 10.1093/carcin/bgp281; Bryan JT, 2016, CURR OPIN CHEM BIOL, V32, P34, DOI 10.1016/j.cbpa.2016.03.001; Cai LM, 2015, ONCOGENE, V34, P2156, DOI 10.1038/onc.2014.341; Chamulitrat W, 2009, EXP DERMATOL, V18, P1067, DOI 10.1111/j.1600-0625.2009.00888.x; Chan ATC, 2010, ANN ONCOL, V21, P308, DOI 10.1093/annonc/mdq277; Chen C, 2013, CANCER LETT, V338, P47, DOI 10.1016/j.canlet.2012.06.013; Chen LM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6241; Cheng YM, 2012, ONCOL LETT, V3, P667, DOI 10.3892/ol.2011.512; CHOO QL, 1989, SCIENCE, V244, P359, DOI 10.1126/science.2523562; Darai D, 2000, GYNECOL ONCOL, V76, P56, DOI 10.1006/gyno.1999.5656; Dawson CW, 2012, SEMIN CANCER BIOL, V22, P144, DOI 10.1016/j.semcancer.2012.01.004; De Craene B, 2013, NAT REV CANCER, V13, P97, DOI 10.1038/nrc3447; de Martel C, 2012, LANCET ONCOL, V13, DOI 10.1016/S1470-2045(12)70137-7; Diao JY, 2001, CYTOKINE GROWTH F R, V12, P189, DOI 10.1016/S1359-6101(00)00034-4; Durham DP, 2016, P NATL ACAD SCI USA, V113, P5107, DOI 10.1073/pnas.1515528113; Elfimova N, 2013, BBA-MOL CELL RES, V1833, P1190, DOI 10.1016/j.bbamcr.2013.01.023; de Oliveira DE, 2007, CANCER LETT, V247, P182, DOI 10.1016/j.canlet.2006.05.010; Feitelson MA, 1999, J CELL PHYSIOL, V181, P188; Gaur N, 2015, TUMOR BIOL, V36, P3051, DOI 10.1007/s13277-014-2941-6; Geiger T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001574; Ghittoni R, 2010, VIRUS GENES, V40, P1, DOI 10.1007/s11262-009-0412-8; GILLES C, 1994, INT J CANCER, V59, P661, DOI 10.1002/ijc.2910590514; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hatakeyama H, 2014, ONCOL REP, V32, P2673, DOI 10.3892/or.2014.3509; Hay ED, 1995, ACTA ANAT, V154, P8; Heerboth S, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0048-3; Hibner Urszula, 2015, Contemp Oncol (Pozn), V19, pA62, DOI 10.5114/wo.2014.47132; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Horikawa T, 2011, BRIT J CANCER, V104, P1160, DOI 10.1038/bjc.2011.38; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; Hsu CY, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003974; Hu HM, 2013, FASEB J, V27, P163, DOI 10.1096/fj.12-216622; Huang JF, 2010, HEPATOLOGY, V52, P60, DOI 10.1002/hep.23660; Hui EP, 2013, CANCER RES, V73, P1676, DOI 10.1158/0008-5472.CAN-12-2448; Zheng H, 2007, CELL MOL IMMUNOL, V4, P185; HYAMS KC, 1995, CLIN INFECT DIS, V20, P992, DOI 10.1093/clinids/20.4.992; Iqbal J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087464; Javier RT, 2008, CANCER RES, V68, P7693, DOI 10.1158/0008-5472.CAN-08-3301; Jeon YK, 2004, HEAD NECK-J SCI SPEC, V26, P573, DOI 10.1002/hed.10370; Jung YS, 2013, BIOCHEM BIOPH RES CO, V435, P339, DOI 10.1016/j.bbrc.2013.04.060; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Kong QL, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000940; Konstantinou D, 2015, ANN GASTROENTEROL, V28, P221; Koriyama C, 2007, WORLD J GASTROENTERO, V13, P3925, DOI 10.3748/wjg.v13.i29.3925; Lamouille S, 2014, NAT REV MOL CELL BIO, V15, P178, DOI 10.1038/nrm3758; Lavanchy D, 2012, J CLIN VIROL, V55, P296, DOI 10.1016/j.jcv.2012.08.022; Ledford H, 2011, NATURE, V472, P273, DOI 10.1038/472273a; Lee HH, 2009, CANCER EPIDEM BIOMAR, V18, P1562, DOI 10.1158/1055-9965.EPI-09-0039; Li R, 2014, MOL MED REP, V9, P413, DOI 10.3892/mmr.2013.1836; Li Tian-yu, 2007, Zhonghua Wai Ke Za Zhi, V45, P1491; Li TY, 2010, ANN SURG ONCOL, V17, P1937, DOI 10.1245/s10434-010-0925-3; Liang XH, 2011, ORAL ONCOL, V47, P686, DOI 10.1016/j.oraloncology.2011.04.016; Liao SJ, 2013, ONCOL REP, V29, P95, DOI 10.3892/or.2012.2106; Lieberman PM, 2014, SCIENCE, V343, P1323, DOI 10.1126/science.1252786; Lim SHS, 2014, J CLIN PATHOL, V67, P848, DOI 10.1136/jclinpath-2014-202499; Lin CH, 2012, BMC COMPLEM ALTERN M, V12, DOI 10.1186/1472-6882-12-201; Lin X, 2012, EXPERT OPIN DRUG DEL, V9, P767, DOI 10.1517/17425247.2012.685933; Lin Z, 2014, J VIROL, V88, P11872, DOI 10.1128/JVI.01867-14; Lindenbach BD, 2005, NATURE, V436, P933, DOI 10.1038/nature04077; Liu HO, 2012, CANCER SCI, V103, P2072, DOI 10.1111/cas.12017; Liu J, 2006, ONCOGENE, V25, P1008, DOI 10.1038/sj.onc.1209138; Liu L, 2014, ONCOGENE, V33, P909, DOI 10.1038/onc.2013.236; Lok ASF, 2004, GASTROENTEROLOGY, V127, pS303, DOI 10.1053/j.gastro.2004.09.045; McLaughlin-Drubin ME, 2008, BBA-MOL BASIS DIS, V1782, P127, DOI 10.1016/j.bbadis.2007.12.005; Meireles LC, 2015, WORLD J HEPATOL, V7, P2127, DOI 10.4254/wjh.v7.i18.2127; Mesri EA, 2014, CELL HOST MICROBE, V15, P266, DOI 10.1016/j.chom.2014.02.011; Micalizzi DS, 2010, J MAMMARY GLAND BIOL, V15, P117, DOI 10.1007/s10911-010-9178-9; Miyamoto DT, 2014, NAT REV CLIN ONCOL, V11, P401, DOI 10.1038/nrclinonc.2014.82; NAHER H, 1992, J INVEST DERMATOL, V98, P791, DOI 10.1111/1523-1747.ep12499958; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Ock CY, 2016, ONCOTARGET, V7, P15901, DOI 10.18632/oncotarget.7431; Park J, 2014, BIOCHEM BIOPH RES CO, V446, P561, DOI 10.1016/j.bbrc.2014.03.009; Rolfo C, 2014, BBA-REV CANCER, V1846, P539, DOI 10.1016/j.bbcan.2014.10.001; ROTHENPIELER UW, 1993, DEVELOPMENT, V119, P711; Salem MR, 2015, J THERM SCI ENG APPL, V7, DOI 10.1115/1.4030635; Savagner P, 2010, ANN ONCOL, V21, P89, DOI 10.1093/annonc/mdq292; Scanlon CS, 2013, J DENT RES, V92, P114, DOI 10.1177/0022034512467352; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; Shair KHY, 2009, CANCER RES, V69, P5734, DOI 10.1158/0008-5472.CAN-09-0468; Shi Y, 2016, CHIN J CANCER, V35, DOI 10.1186/s40880-016-0079-1; Shinozaki A, 2010, CANCER RES, V70, P4719, DOI 10.1158/0008-5472.CAN-09-4620; Silver MI, 2011, J CLIN MICROBIOL, V49, P2435, DOI 10.1128/JCM.02206-10; Stenner M, 2011, HISTOPATHOLOGY, V58, P1117, DOI 10.1111/j.1365-2559.2011.03805.x; Su PF, 2007, INT J CANCER, V121, P1257, DOI 10.1002/ijc.22849; Sun Q, 2011, BMC COMPLEM ALTERN M, V11, DOI 10.1186/1472-6882-11-134; Tam WL, 2013, NAT MED, V19, P1438, DOI 10.1038/nm.3336; Tan A, 2008, LIVER INT, V28, P175, DOI 10.1111/j.1478-3231.2007.01652.x; Taylor GS, 2014, CLIN CANCER RES, V20, P5009, DOI 10.1158/1078-0432.CCR-14-1122-T; Teng J, 2013, J CELL BIOCHEM, V114, P1097, DOI 10.1002/jcb.24450; Thiery JP, 2009, CELL, V139, P871, DOI 10.1016/j.cell.2009.11.007; Thiery JP, 2006, NAT REV MOL CELL BIO, V7, P131, DOI 10.1038/nrm1835; Tian XJ, 2013, BIOPHYS J, V105, P1079, DOI 10.1016/j.bpj.2013.07.011; Trivedi P, 2004, BLOOD, V103, P313, DOI 10.1182/blood-2003-05-1710; Tsai CL, 2006, CANCER RES, V66, P11668, DOI 10.1158/0008-5472.CAN-06-2194; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Verga-Gerard A, 2013, FASEB J, V27, P4027, DOI 10.1096/fj.13-229187; Wakisaka N, 2015, HISTOPATHOLOGY, V66, P771, DOI 10.1111/his.12496; Wan LL, 2013, NAT MED, V19, P1450, DOI 10.1038/nm.3391; Wang L, 2014, CANCER-AM CANCER SOC, V120, P363, DOI 10.1002/cncr.28418; Watson RA, 2003, J CELL SCI, V116, P4925, DOI 10.1242/jcs.00809; Weitzman MD, 2014, CELL HOST MICROBE, V15, P283, DOI 10.1016/j.chom.2014.02.010; Wilson GK, 2012, J HEPATOL, V56, P803, DOI 10.1016/j.jhep.2011.11.018; Xie Q, 2014, INT J CANCER, V135, P635, DOI 10.1002/ijc.28697; Xu XJ, 2013, J CLIN INVEST, V123, P630, DOI 10.1172/JCI64265; Yang SZ, 2009, BIOCHEM BIOPH RES CO, V382, P555, DOI 10.1016/j.bbrc.2009.03.079; Zazula M, 2006, DIAGN MOL PATHOL, V15, P24, DOI 10.1097/00019606-200603000-00004; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang FJ, 2014, LANCET INFECT DIS, V14, P1065, DOI 10.1016/S1473-3099(14)70946-6; Zhang JY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005304	120	37	38	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3001	3010		10.1096/fj.201600388R	http://dx.doi.org/10.1096/fj.201600388R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27279361				2022-12-28	WOS:000382816300002
J	Gibon, J; Unsain, N; Gamache, K; Thomas, RA; De Leon, A; Johnstone, A; Nader, K; Seguela, P; Barker, PA				Gibon, Julien; Unsain, Nicolas; Gamache, Karine; Thomas, Rhalena A.; De Leon, Andres; Johnstone, Aaron; Nader, Karim; Seguela, Philippe; Barker, Philip A.			The X-linked inhibitor of apoptosis regulates long-term depression and learning rate	FASEB JOURNAL			English	Article						XIAP; caspase-3; hippocampus; AMPAR; synaptic activity	AMPA RECEPTOR; NMR STRUCTURE; CASPASE-3; PROTEIN; PLASTICITY; CONSOLIDATION; TRAFFICKING; HIPPOCAMPUS; ACQUISITION; MUTAGENESIS	Hippocampal long-term depression (LTD) is an active form of synaptic plasticity that is necessary for consolidation of spatial memory, contextual fear memory, and novelty acquisition. Recent studies have shown that caspases (CASPs) play an important role in NMDA receptor-dependent LTD and are involved in postsynaptic remodeling and synaptic maturation. In the present study, we examined the role of X-linked inhibitor of apoptosis (XIAP), a putative endogenous CASP inhibitor, in synaptic plasticity in the hippocampus. Analysis in acute brain slices and in cultured hippocampal neurons revealed that XIAP deletion increases CASP-3 activity, enhances -amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptor internalization, sharply increases LTD, and significantly reduces synapse density. In vivo behaviors related to memory were also altered in XIAP(-/-) mice, with faster acquisition of spatial object location and increased fear memory observed. Together, these results indicate that XIAP plays an important physiologic role in regulating sublethal CASP-3 activity within central neurons and thereby facilitates synaptic plasticity and memory acquisition.Gibon, J., Unsain, N., Gamache, K., Thomas, R. A., De Leon, A., Johnstone, A., Nader, K., Seguela, P., Barker, P. A. The X-linked inhibitor of apoptosis regulates long-term depression and learning rate.	[Gibon, Julien; De Leon, Andres; Johnstone, Aaron; Barker, Philip A.] Univ British Columbia, Biol Unit, Okanagan Campus, Kelowna, BC, Canada; [Gibon, Julien; Thomas, Rhalena A.; De Leon, Andres; Johnstone, Aaron; Seguela, Philippe; Barker, Philip A.] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada; [Gamache, Karine; Nader, Karim] McGill Univ, Dept Psychol, Montreal, PQ, Canada; [Unsain, Nicolas] Univ Nacl Cordoba, Neurobiol Lab, Cordoba, Argentina	University of British Columbia; McGill University; McGill University; National University of Cordoba	Seguela, P (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal Neurol Inst, 3801 Univ,Off 778, Montreal, PQ H3A 2B4, Canada.; Barker, PA (corresponding author), Univ British Columbia, FIP322,3247 Univ Way, Kelowna, BC V1V 1V7, Canada.	philippe.seguela@mcgill.ca; philip.barker@ubc.ca	Thomas, Rhalena/AAT-2032-2021; Unsain, Nicolas/AGZ-4095-2022	Gibon, Julien/0000-0001-7216-5806; Thomas, Rhalena/0000-0002-5396-7587	Canadian Institutes of Health Research [130239, 37850]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This project was supported by grants from the Canadian Institutes of Health Research (130239 to P.S.; 37850 to P.A.B.). Author contributions: J. Gibon and N. Unsain designed the study, performed experiments, analyzed the data, and wrote the paper; K. Gamache, R. A. Thomas, A. De Leon, and A. Johnstone performed experiments and analyzed the data; K. Nader and P. Seguela analyzed the data and wrote the paper; and P. A. Barker designed the study, analyzed the data, and wrote the paper. The authors declare no conflicts of interest.	Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Campbell DS, 2003, NEURON, V37, P939, DOI 10.1016/S0896-6273(03)00158-2; Collingridge GL, 2010, NAT REV NEUROSCI, V11, P459, DOI 10.1038/nrn2867; Erturk A, 2014, J NEUROSCI, V34, P1672, DOI 10.1523/JNEUROSCI.3121-13.2014; Galban S, 2010, CELL DEATH DIFFER, V17, P54, DOI 10.1038/cdd.2009.81; Ge YA, 2010, P NATL ACAD SCI USA, V107, P16697, DOI 10.1073/pnas.1008200107; Harlin H, 2001, MOL CELL BIOL, V21, P3604, DOI 10.1128/MCB.21.10.3604-3608.2001; Hasegawa S, 2015, SCI REP-UK, V5, DOI 10.1038/srep07707; Huesmann GR, 2006, NEURON, V52, P1061, DOI 10.1016/j.neuron.2006.10.033; HUTTNER WB, 1983, J CELL BIOL, V96, P1374, DOI 10.1083/jcb.96.5.1374; Hyman BT, 2012, NAT REV NEUROSCI, V13, P395, DOI 10.1038/nrn3228; Jiao S, 2011, NEURON, V70, P758, DOI 10.1016/j.neuron.2011.04.004; Kaech S, 2006, NAT PROTOC, V1, P2406, DOI 10.1038/nprot.2006.356; Kenneth NS, 2012, CURR OPIN CELL BIOL, V24, P871, DOI 10.1016/j.ceb.2012.11.004; Li Z, 2010, CELL, V141, P859, DOI 10.1016/j.cell.2010.03.053; Liu X, 2014, J NEUROSCI, V34, P8741, DOI 10.1523/JNEUROSCI.2752-13.2014; Lo SC, 2015, J NEUROSCI, V35, P2118, DOI 10.1523/JNEUROSCI.3280-14.2015; Lopez J, 2010, CURR OPIN CELL BIOL, V22, P872, DOI 10.1016/j.ceb.2010.08.025; Manahan-Vaughan D, 1999, P NATL ACAD SCI USA, V96, P8739, DOI 10.1073/pnas.96.15.8739; Martinez LA, 2011, NEUROPHARMACOLOGY, V61, P305, DOI 10.1016/j.neuropharm.2011.04.017; Nagerl UV, 2004, NEURON, V44, P759, DOI 10.1016/j.neuron.2004.11.016; O'Riordan KJ, 2006, J NEUROSCI, V26, P4870, DOI 10.1523/JNEUROSCI.4527-05.2006; Obexer P, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00197; Peineau S, 2007, NEURON, V53, P703, DOI 10.1016/j.neuron.2007.01.029; Riedl SJ, 2001, CELL, V104, P791, DOI 10.1016/S0092-8674(02)02036-6; Scott FL, 2005, EMBO J, V24, P645, DOI 10.1038/sj.emboj.7600544; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Sun CH, 2000, J BIOL CHEM, V275, P33777, DOI 10.1074/jbc.M006226200; Sun CH, 1999, NATURE, V401, P818, DOI 10.1038/44617; Unsain N, 2015, NEURON, V88, P461, DOI 10.1016/j.neuron.2015.08.029; Unsain N, 2014, JOVE-J VIS EXP, DOI 10.3791/51795; Unsain N, 2013, CELL REP, V4, P751, DOI 10.1016/j.celrep.2013.07.015; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011; Zhu JJ, 2002, CELL, V110, P443, DOI 10.1016/S0092-8674(02)00897-8	35	15	15	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3083	3090		10.1096/fj.201600384R	http://dx.doi.org/10.1096/fj.201600384R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27189977				2022-12-28	WOS:000382816300008
J	Lin, JB; He, SL; Sun, XH; Franck, G; Deng, YH; Yang, DF; Haemmig, S; Wara, AKM; Icli, B; Li, DZ; Feinberg, MW				Lin, Jibin; He, Shaolin; Sun, Xinghui; Franck, Gregory; Deng, Yihuan; Yang, Dafeng; Haemmig, Stefan; Wara, A. K. M.; Icli, Basak; Li, Dazhu; Feinberg, Mark W.			MicroRNA-181b inhibits thrombin-mediated endothelial activation and arterial thrombosis by targeting caspase recruitment domain family member 10	FASEB JOURNAL			English	Article						endothelial cells; NF-B; Card10	NF-KAPPA-B; TISSUE FACTOR EXPRESSION; VASCULAR INFLAMMATION; CELLS; RECEPTORS; COAGULATION; MECHANISMS; ADHESION; ATHEROSCLEROSIS; PROMOTER	Thrombogenic and inflammatory mediators, such as thrombin, induce NF-B-mediated endothelial cell (EC) activation and dysfunction, which contribute to pathogenesis of arterial thrombosis. The role of anti-inflammatory microRNA-181b (miR-181b) on thrombosis remains unknown. Our previous study demonstrated that miR-181b inhibits downstream NF-B signaling in response to TNF-. Here, we demonstrate that miR-181b uniquely inhibits upstream NF-B signaling in response to thrombin. Overexpression of miR-181b inhibited thrombin-induced activation of NF-B signaling, demonstrated by reduction of phospho-IKK-, -IB-, and p65 nuclear translocation in ECs. MiR-181b also reduced expression of NF-B target genes VCAM-1, intercellular adhesion molecule-1, E-selectin, and tissue factor. Mechanistically, miR-181b targets caspase recruitment domain family member 10 (Card10), an adaptor protein that participates in activation of the IKK complex in response to signals transduced from protease-activated receptor-1. miR-181b reduced expression of Card10 mRNA and protein, but not protease-activated receptor-1. 3-Untranslated region reporter assays, argonaute-2 microribonucleoprotein immunoprecipitation studies, and Card10 rescue studies revealed that Card10 is a bona fide direct miR-181b target. Small interfering RNA-mediated knockdown of Card10 expression phenocopied effects of miR-181b on NF-B signaling and targets. Card10 deficiency did not affect TNF--induced activation of NF-B signaling, which suggested stimulus-specific regulation of NF-B signaling and endothelial responses by miR-181b in ECs. Finally, in response to photochemical injury-induced arterial thrombosis, systemic delivery of miR-181b reduced thrombus formation by 73% in carotid arteries and prolonged time to occlusion by 1.6-fold, effects recapitulated by Card10 small interfering RNA. These data demonstrate that miR-181b and Card10 are important regulators of thrombin-induced EC activation and arterial thrombosis. These studies highlight the relevance of microRNA-dependent targets in response to ligand-specific signaling in ECs.Lin, J., He, S., Sun, X., Franck, G., Deng, Y., Yang, D., Haemmig, S., Wara, A. K. M., Icli, B., Li, D., Feinberg, M. W. MicroRNA-181b inhibits thrombin-mediated endothelial activation and arterial thrombosis by targeting caspase recruitment domain family member 10.	[Lin, Jibin; Sun, Xinghui; Franck, Gregory; Deng, Yihuan; Yang, Dafeng; Haemmig, Stefan; Wara, A. K. M.; Icli, Basak; Feinberg, Mark W.] Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc, Dept Med, 77 Ave Louis Pasteur,NRB-742F, Boston, MA 02115 USA; [Lin, Jibin; He, Shaolin; Deng, Yihuan; Li, Dazhu] Huazhong Univ Sci & Technol, Inst Cardiovasc Dis, Union Hosp, Dept Cardiol,Tongji Med Coll, Wuhan, Peoples R China; [Yang, Dafeng] Cent S Univ, Xiangya Hosp, Dept Cardiol, Changsha, Hunan, Peoples R China	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Huazhong University of Science & Technology; Central South University	Feinberg, MW (corresponding author), Harvard Med Sch, Brigham & Womens Hosp, Div Cardiovasc, Dept Med, 77 Ave Louis Pasteur,NRB-742F, Boston, MA 02115 USA.	mfeinberg@partners.org	Haemmig, Stefan/V-6585-2019; Yang, Dafeng/HIK-2106-2022	Haemmig, Stefan/0000-0001-5014-4393; Yang, Dafeng/0000-0002-8320-8215; Feinberg, Mark/0000-0001-9523-3859; FRANCK, Gregory/0000-0002-4288-9034	National Institutes of Health (NIH) (National Heart, Lung, and Blood Institute) [HL115141, HL117994]; National Institutes of Health (NIH) (National Institute of General Medical Sciences) [GM115605]; A Arthur K. Watson Charitable Trust; Dr. Ralph and Marian Falk Medical Research Trust, Bank of America, N.A. Trustee; State Scholarship Fund of the China Scholarship Council; Jonathan Levy Research Fund; American Heart Association (SDG) [15SDG25400012]; Boston Nutrition Obesity Research Center Pilot and Feasibility award under NIH National Institute of Diabetes and Digestive and Kidney Diseases [P30KD046200]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL115141, R01HL117994] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115605] Funding Source: NIH RePORTER	National Institutes of Health (NIH) (National Heart, Lung, and Blood Institute)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health (NIH) (National Institute of General Medical Sciences)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); A Arthur K. Watson Charitable Trust; Dr. Ralph and Marian Falk Medical Research Trust, Bank of America, N.A. Trustee; State Scholarship Fund of the China Scholarship Council(China Scholarship Council); Jonathan Levy Research Fund; American Heart Association (SDG)(American Heart Association); Boston Nutrition Obesity Research Center Pilot and Feasibility award under NIH National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) Grants HL115141 and HL117994 (National Heart, Lung, and Blood Institute), and GM115605 (National Institute of General Medical Sciences) (all to M.W.F.); the Arthur K. Watson Charitable Trust (to M.W.F.); the Dr. Ralph and Marian Falk Medical Research Trust, Bank of America, N.A. Trustee (to M.W.F.); a State Scholarship Fund of the China Scholarship Council (to J.L.); a Jonathan Levy Research Fund (to M.W.F.), the American Heart Association (SDG#15SDG25400012) (to X.S.); and a Boston Nutrition Obesity Research Center Pilot and Feasibility award under NIH National Institute of Diabetes and Digestive and Kidney Diseases Grant P30KD046200 (to X.S.). Author contributions: X. Sun and M. W. Feinberg designed research; J. Lin, S. He, X. Sun, Y. Deng, D. Yang, S. Haemmig, and M. W. Feinberg analyzed data; J. Lin, S. He, X. Sun, G. Franck, Y. Deng, S. D. Yang, and Haemmig performed research; J. Lin, X. Sun, and M. W. Feinberg wrote the paper; and X. Sun, A. K. M. Wara, B. Icli, D. Li, and M. W. Feinberg contributed to experimental design.	BARTHA K, 1993, J BIOL CHEM, V268, P421; Barua RS, 2013, ARTERIOSCL THROM VAS, V33, P1460, DOI 10.1161/ATVBAHA.112.300154; Coughlin SR, 2005, J THROMB HAEMOST, V3, P1800, DOI 10.1111/j.1538-7836.2005.01377.x; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; Croce K, 2007, CURR OPIN HEMATOL, V14, P55, DOI 10.1097/00062752-200701000-00011; Delekta PC, 2010, J BIOL CHEM, V285, P41432, DOI 10.1074/jbc.M110.158949; Eisenreich A, 2014, TRENDS CARDIOVAS MED, V24, P128, DOI 10.1016/j.tcm.2013.09.005; Esmon CT, 2003, J THROMB HAEMOST, V1, P1343, DOI 10.1046/j.1538-7836.2003.00261.x; FURIE B, 1988, CELL, V53, P505, DOI 10.1016/0092-8674(88)90567-3; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Grabiner BC, 2007, GENE DEV, V21, P984, DOI 10.1101/gad.1502507; Hadi HAR, 2005, VASC HEALTH RISK MAN, V1, P183; HENRY PD, 1995, CURR OPIN LIPIDOL, V6, P190, DOI 10.1097/00041433-199508000-00002; Hirano K, 2007, ARTERIOSCL THROM VAS, V27, P27, DOI 10.1161/01.ATV.0000251995.73307.2d; Israel A, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a000158; Jackson SP, 2011, NAT MED, V17, P1423, DOI 10.1038/nm.2515; Jiang CY, 2012, IMMUNOL REV, V246, P141, DOI 10.1111/j.1600-065X.2012.01110.x; Kaplanski G, 1998, BLOOD, V92, P1259, DOI 10.1182/blood.V92.4.1259.416k11_1259_1267; Leger AJ, 2006, CIRCULATION, V114, P1070, DOI 10.1161/CIRCULATIONAHA.105.574830; Li SF, 2014, ATHEROSCLEROSIS, V237, P514, DOI 10.1016/j.atherosclerosis.2014.09.033; Li SF, 2014, J MOL CELL CARDIOL, V75, P49, DOI 10.1016/j.yjmcc.2014.06.017; Li YD, 2009, J BIOL CHEM, V284, P4473, DOI 10.1074/jbc.M806010200; Mackman N, 1997, THROMB HAEMOSTASIS, V78, P747; Medoff BD, 2009, AM J RESP CELL MOL, V40, P286, DOI 10.1165/rcmb.2008-0129OC; Minami T, 2004, ARTERIOSCL THROM VAS, V24, P41, DOI 10.1161/01.ATV.0000099880.09014.7D; MOLL T, 1995, J BIOL CHEM, V270, P3849, DOI 10.1074/jbc.270.8.3849; PARRY GCN, 1995, ARTERIOSCL THROM VAS, V15, P612, DOI 10.1161/01.ATV.15.5.612; Popovic M, 2012, MOL CELL BIOCHEM, V359, P301, DOI 10.1007/s11010-011-1024-x; Rahman A, 1999, J IMMUNOL, V162, P5466; Rezaie AR, 2014, THROMB HAEMOSTASIS, V112, P876, DOI 10.1160/TH14-02-0167; Samad F, 2013, BLOOD, V122, P3415, DOI 10.1182/blood-2013-05-427708; Stewart SA, 2003, RNA, V9, P493, DOI 10.1261/rna.2192803; Sun XH, 2014, CIRC RES, V114, P32, DOI 10.1161/CIRCRESAHA.113.302089; Sun XH, 2012, J CLIN INVEST, V122, P1973, DOI 10.1172/JCI61495; van Hinsbergh VWM, 2012, SEMIN IMMUNOPATHOL, V34, P93, DOI 10.1007/s00281-011-0285-5; Wang YM, 2014, J CLIN INVEST, V124, P2160, DOI 10.1172/JCI70966; Westrick RJ, 2007, ARTERIOSCL THROM VAS, V27, P2079, DOI 10.1161/ATVBAHA.107.142810	37	27	27	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3216	3226		10.1096/fj.201500163R	http://dx.doi.org/10.1096/fj.201500163R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27297585	Green Published			2022-12-28	WOS:000382816300021
J	Green, BB; Houseman, EA; Johnson, KC; Guerin, DJ; Armstrong, DA; Christensen, BC; Marsit, CJ				Green, Benjamin B.; Houseman, E. Andres; Johnson, Kevin C.; Guerin, Dylan J.; Armstrong, David A.; Christensen, Brock C.; Marsit, Carmen J.			Hydroxymethylation is uniquely distributed within term placenta, and is associated with gene expression	FASEB JOURNAL			English	Article						5-hydroxymethylcytosine; RNA-seq; DOHaD	EMBRYONIC STEM-CELLS; GENOME-WIDE ANALYSIS; DNA METHYLATION; BASE-RESOLUTION; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; REVEALS; BRAIN; 5-FORMYLCYTOSINE; BLOOD	The conversion of cytosine to 5-methylcystosine (5mC) is an important regulator of gene expression. 5mC may be enzymatically converted to 5-hydroxymethylcytosine (5hmC), with a potentially distinct regulatory function. We sought to investigate these cytosine modifications and their effect on gene expression by parallel processing of genomic DNA using bisulfite and oxidative bisulfite conversion in conjunction with RNA sequencing. Although values of 5hmC across the placental genome were generally low, we identified similar to 21,000 loci with consistently elevated levels of 5-hydroxymethycytosine. Absence of 5hmC was observed in CpG islands and, to a greater extent, in non-CpG island-associated regions. 5hmC was enriched within poised enhancers, and depleted within active enhancers, as defined by H3K27ac and H3K4me1 measurements. 5hmC and 5mC were significantly elevated in transcriptionally silent genes when compared with actively transcribed genes. 5hmC was positively associated with transcription in actively transcribed genes only. Our data suggest that dynamic cytosine regulation, associated with transcription, provides the most complete epigenomic landscape of the humanplacenta, and will be useful for future studies of the placental epigenome.	[Green, Benjamin B.; Johnson, Kevin C.; Guerin, Dylan J.; Armstrong, David A.; Christensen, Brock C.; Marsit, Carmen J.] Dartmouth Coll, Geisel Sch Med, Dept Epidemiol, Hanover, NH USA; [Green, Benjamin B.; Johnson, Kevin C.; Guerin, Dylan J.; Armstrong, David A.; Christensen, Brock C.; Marsit, Carmen J.] Dartmouth Coll, Geisel Sch Med, Dept Pharmacol & Toxicol, Hanover, NH USA; [Houseman, E. Andres] Oregon State Univ, Coll Publ Hlth & Human Sci, Sch Biol & Populat Hlth Sci, Corvallis, OR USA	Dartmouth College; Dartmouth College; Oregon State University	Green, BB (corresponding author), Geisel Sch Med, 7650 Williamson, Lebanon, NH 03756 USA.	benjamin.b.green@dartmouth.edu		Marsit, Carmen/0000-0003-4566-150X	U.S. National Institutes of Health (NIH), National Institute of Mental Illness [R01MH094609]; NIH National Institute of Environmental Health Sciences [R01ES022223, P01 ES022832]; U.S. Environmental Protection Agency (EPA) [RD83544201]; NATIONAL CANCER INSTITUTE [R25CA134286] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES022832, R01ES022223] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM104416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH094609] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH), National Institute of Mental Illness; NIH National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); U.S. Environmental Protection Agency (EPA)(United States Environmental Protection Agency); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by the U.S. National Institutes of Health (NIH), National Institute of Mental Illness (Grant R01MH094609), the NIH National Institute of Environmental Health Sciences (Grants R01ES022223 and P01 ES022832), and by the U.S. Environmental Protection Agency (EPA; Grant RD83544201). This article's contents are solely the responsibility of the grantee, and do not necessarily represent the official views of the EPA. Furthermore, the EPA does not endorse the purchase of any commercial products or services mentioned in the presentation. B.B.G. contributed to the concept and design of the experiment, performed statistical analyses, interpreted the results, and wrote and revised the manuscript. E.A.H. generated the statistical models, performed statistical analyses, interpreted the results, and revised the manuscript. K.C.J. performed statistical analyses, interpreted the results, and revised the manuscript. D.J.G. collected the data and revised the manuscript. D.A.A. collected data and revised the manuscript. B.C.C. contributed to the concept and design of the experiment, interpreted the results, and revised the manuscript. C.J.M. contributed to the concept and design of the experiment, interpreted the results, and revised the manuscript. All authors have read and approved the final manuscript. The authors declare no conflicts of interest.	Bachman M, 2014, NAT CHEM, V6, P1049, DOI [10.1038/nchem.2064, 10.1038/NCHEM.2064]; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Binder AM, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0116-y; Chapman CG, 2015, SCI REP-UK, V5, DOI 10.1038/srep17568; Chen YA, 2013, EPIGENETICS-US, V8, P203, DOI 10.4161/epi.23470; Christensen BC, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000602; Field SF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118202; Finer S, 2015, HUM MOL GENET, V24, P3021, DOI 10.1093/hmg/ddv013; Gelmann EP, 2003, PROSTATE, V55, P111, DOI 10.1002/pros.10210; Globisch D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015367; Green Benjamin B, 2015, Curr Environ Health Rep, V2, P126, DOI 10.1007/s40572-015-0045-0; Ito S, 2011, SCIENCE, V333, P1300, DOI 10.1126/science.1210597; Kim D, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-4-r36; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lister R, 2013, SCIENCE, V341, P629, DOI 10.1126/science.1237905; Maccani JZJ, 2015, REPROD TOXICOL, V57, P43, DOI 10.1016/j.reprotox.2015.05.002; Maccani JZJ, 2015, ENVIRON HEALTH PERSP, V123, P723, DOI 10.1289/ehp.1408561; Maccani MA, 2009, AM J REPROD IMMUNOL, V62, P78, DOI 10.1111/j.1600-0897.2009.00716.x; Mellen M, 2012, CELL, V151, P1417, DOI 10.1016/j.cell.2012.11.022; Mikheev AM, 2008, REPROD SCI, V15, P866, DOI 10.1177/1933719108322425; Nestor C, 2010, BIOTECHNIQUES, V48, P317, DOI 10.2144/000113403; Nestor CE, 2012, GENOME RES, V22, P467, DOI 10.1101/gr.126417.111; Pastor WA, 2011, NATURE, V473, P394, DOI 10.1038/nature10102; Peffers MJ, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4278; Piyasena C, 2015, EPIGENETICS-US, V10, P692, DOI 10.1080/15592294.2015.1062963; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; Robinson WP, 2015, CSH PERSPECT MED, V5, DOI 10.1101/cshperspect.a023044; Ruchat SM, 2013, EPIGENETICS-US, V8, P935, DOI 10.4161/epi.25578; Shen L, 2013, CELL, V153, P692, DOI 10.1016/j.cell.2013.04.002; Song CX, 2013, CELL, V153, P678, DOI 10.1016/j.cell.2013.04.001; Song CX, 2011, NAT BIOTECHNOL, V29, P68, DOI 10.1038/nbt.1732; Stewart SK, 2015, METHODS, V72, P9, DOI 10.1016/j.ymeth.2014.08.009; Stroud H, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r54; Sui WG, 2015, INT J MOL MED, V35, P1467, DOI 10.3892/ijmm.2015.2149; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Taylor SEB, 2015, ARTHRITIS RHEUMATOL, V67, P2129, DOI 10.1002/art.39179; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Wen L, 2014, GENOMICS, V104, P341, DOI 10.1016/j.ygeno.2014.08.020; Wen L, 2014, GENOME BIOL, V15, DOI 10.1186/gb-2014-15-3-r49; Wu H, 2011, GENE DEV, V25, P679, DOI 10.1101/gad.2036011; Xu YF, 2011, MOL CELL, V42, P451, DOI 10.1016/j.molcel.2011.04.005; Yu M, 2012, CELL, V149, P1368, DOI 10.1016/j.cell.2012.04.027; Ziller MJ, 2013, NATURE, V500, P477, DOI 10.1038/nature12433	44	26	26	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2874	2884		10.1096/fj.201600310R	http://dx.doi.org/10.1096/fj.201600310R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27118675	Green Published			2022-12-28	WOS:000380994000022
J	Gu, Y; Ampofo, E; Menger, MD; Laschke, MW				Gu, Yuan; Ampofo, Emmanuel; Menger, Michael D.; Laschke, Matthias W.			miR-191 suppresses angiogenesis by activation of NF-kappa B signaling	FASEB JOURNAL			English	Article						miRNA; blood vessels; endothelial cells; MMP-1; p21	ENDOTHELIAL GROWTH-FACTOR; CYCLIN-DEPENDENT KINASES; PHYSIOLOGICAL ANGIOGENESIS; GENE-EXPRESSION; CELL-GROWTH; IN-VITRO; CANCER; TRANSCRIPTION; INHIBITION; MECHANISM	MicroRNAs (miRNAs) are powerful regulators of diverse biologic processes. However, the function of most miRNAs in angiogenesis remains elusive. In this study, we identified miR-191-5p (miR-191) as a potent inhibitor of blood vessel development. Transfection of human dermal microvascular endothelial cells with miR-191 mimic (miR-191m) inhibited their proliferation, migration, and tube formation. Moreover, vascular sprouting of miR-191m-transfected mouse aortic rings was significantly reduced when compared with controls. Transfection with miR-191 inhibitor (miR-191i) induced proangiogenic effects. The anti-and proangiogenic activities of miR-191m and -191i were further demonstrated in vivo. Additional molecular biologic analyses revealed that miR-191m activates NF-kappa B signaling by up-regulating the mRNA expression of p65. miR-191 also increased the mRNA levels of the antiangiogenic factors p21 and tissue inhibitor of metalloproteinase-1 and reduced the expression of the proangiogenic factors eNOS and matrix metalloproteinase-1 and -9. Blockade of NF-kB activation with Bay 11-7082 reversed the antiangiogenic effects of miR-191m. These findings indicate that miR-191 effectively suppresses angiogenesis by activation of the NF-kB signaling pathway.	[Gu, Yuan; Ampofo, Emmanuel; Menger, Michael D.; Laschke, Matthias W.] Saarland Univ, Inst Clin & Expt Surg, D-66421 Homburg, Germany	Universitatsklinikum des Saarlandes	Laschke, MW (corresponding author), Saarland Univ, Inst Clin & Expt Surg, D-66421 Homburg, Germany.	matthias.laschke@uks.eu	Ampofo, Emmanuel/T-4197-2018	/0000-0002-1886-5657; Gu, Yuan/0000-0003-1401-6233	Medical Faculty of Saarland University (HOMFORexzellenz)	Medical Faculty of Saarland University (HOMFORexzellenz)	This work was supported by a research grant from the Medical Faculty of Saarland University (HOMFORexzellenz 2015; to Y.G.). The authors thank Janine Becker, Christina Max, and Ruth Nickels (all from the Institute for Clinical and Experimental Surgery) for excellent technical assistance.	Auerbach R, 2003, CLIN CHEM, V49, P32, DOI 10.1373/49.1.32; Aurora AB, 2010, BLOOD, V116, P475, DOI 10.1182/blood-2009-07-232132; Bonauer A, 2009, SCIENCE, V324, P1710, DOI 10.1126/science.1174381; Bouis D, 2006, PHARMACOL RES, V53, P89, DOI 10.1016/j.phrs.2005.10.006; Chen G, 1997, ONCOGENE, V15, P1643, DOI 10.1038/sj.onc.1201347; Chen Y, 2010, MOL CELL BIOL, V30, P3902, DOI 10.1128/MCB.01237-09; Chung AS, 2010, NAT REV CANCER, V10, P505, DOI 10.1038/nrc2868; Dangwal S, 2015, ARTERIOSCL THROM VAS, V35, P1480, DOI 10.1161/ATVBAHA.114.305048; dela Paz NG, 2007, J BIOL CHEM, V282, P8424, DOI 10.1074/jbc.M606923200; Dorr J, 2008, MOL CELL BIOCHEM, V316, P187, DOI 10.1007/s11010-008-9820-7; Ehrmantraut S, 2010, EUR CELLS MATER, V19, P107, DOI 10.22203/eCM.v019a11; Eilken HM, 2010, CURR OPIN CELL BIOL, V22, P617, DOI 10.1016/j.ceb.2010.08.010; Elyakim E, 2010, CANCER RES, V70, P8077, DOI 10.1158/0008-5472.CAN-10-1313; Farina AR, 1999, CELL GROWTH DIFFER, V10, P353; Feng DL, 2012, ANGIOGENESIS, V15, P243, DOI 10.1007/s10456-012-9256-2; Feng JQ, 2003, J BIOL CHEM, V278, P29130, DOI 10.1074/jbc.M212296200; Fish JE, 2008, DEV CELL, V15, P272, DOI 10.1016/j.devcel.2008.07.008; Fukuhara S, 2010, HISTOL HISTOPATHOL, V25, P387, DOI 10.14670/HH-25.387; Gilmore AP, 2005, CELL DEATH DIFFER, V12, P1473, DOI 10.1038/sj.cdd.4401723; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Gu Y, 2016, ONCOTARGET, V7, P5258, DOI 10.18632/oncotarget.6676; Gu Y, 2013, ANTI-CANCER DRUG, V24, P781, DOI 10.1097/CAD.0b013e328362fb84; Heiss M, 2015, FASEB J, V29, P3076, DOI 10.1096/fj.14-267633; Hinata K, 2003, ONCOGENE, V22, P1955, DOI 10.1038/sj.onc.1206198; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Kaufmann K, 2002, J CELL BIOCHEM, V85, P381, DOI 10.1002/jcb.10145; Kisseleva T, 2006, J CLIN INVEST, V116, P2955, DOI 10.1172/JCI27392; Lee KS, 2014, BIOCHEM BIOPH RES CO, V448, P101, DOI 10.1016/j.bbrc.2014.04.079; Lou YL, 2012, MOL CELL BIOCHEM, V370, P45, DOI 10.1007/s11010-012-1396-6; Lu YC, 2014, MOL MED REP, V10, P1475, DOI 10.3892/mmr.2014.2319; Menden H, 2015, J BIOL CHEM, V290, P5449, DOI 10.1074/jbc.M114.600692; Nagpal N, 2015, SCI REP-UK, V5, DOI 10.1038/srep09650; Nagpal N, 2014, FRONT GENET, V5, DOI 10.3389/fgene.2014.00099; Nicosia RF, 2011, INT J DEV BIOL, V55, P447, DOI 10.1387/ijdb.103222rn; Ogryzko VV, 1997, MOL CELL BIOL, V17, P4877, DOI 10.1128/MCB.17.8.4877; Pahl HL, 1999, ONCOGENE, V18, P6853, DOI 10.1038/sj.onc.1203239; Pollet I, 2003, BLOOD, V102, P1740, DOI 10.1182/blood-2003-01-0288; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Sengupta S, 2003, ARTERIOSCL THROM VAS, V23, P69, DOI 10.1161/01.ATV.0000048701.86621.D0; Shi XJ, 2011, ACTA BIOCH BIOPH SIN, V43, P849, DOI 10.1093/abbs/gmr084; Sohur US, 1999, GENE EXPRESSION, V8, P219; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tabruyn SP, 2007, CELL DEATH DIFFER, V14, P1393, DOI 10.1038/sj.cdd.4402156; Tabruyn SP, 2008, ANGIOGENESIS, V11, P101, DOI 10.1007/s10456-008-9094-4; Tabruyn SP, 2009, MOL CANCER THER, V8, P2645, DOI 10.1158/1535-7163.MCT-09-0383; Terzuoli E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084358; van Rooij E, 2014, EMBO MOL MED, V6, P851, DOI 10.15252/emmm.201100899; Vincenti MP, 1998, ARTHRITIS RHEUM, V41, P1987, DOI 10.1002/1529-0131(199811)41:11<1987::AID-ART14>3.3.CO;2-#; Vollmar B, 2001, AM J PATHOL, V159, P1661, DOI 10.1016/S0002-9440(10)63013-1; WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Wilczynska KM, 2006, J BIOL CHEM, V281, P34955, DOI 10.1074/jbc.M604616200; WU HY, 1994, J BIOL CHEM, V269, P20067; Xiao QL, 2005, BIOCHEM J, V388, P913, DOI 10.1042/BJ20041739; Zhang XF, 2015, ONCOTARGET, V6, P4144, DOI 10.18632/oncotarget.2864; Zhou QB, 2011, P NATL ACAD SCI USA, V108, P8287, DOI 10.1073/pnas.1105254108	56	32	37	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3321	3333		10.1096/fj.201601263R	http://dx.doi.org/10.1096/fj.201601263R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28424351				2022-12-28	WOS:000405932400012
J	Roux, A; Loranger, A; Lavoie, JN; Marceau, N				Roux, Alexandra; Loranger, Anne; Lavoie, Josee N.; Marceau, Normand			Keratin 8/18 regulation of insulin receptor signaling and trafficking in hepatocytes through a concerted phosphoinositide-dependent Akt and Rab5 modulation	FASEB JOURNAL			English	Article						intermediate filament; PIP signaling; PI3K; endosomes; microtubules	INTERMEDIATE-FILAMENTS; MEMBRANE-TRANSPORT; GLUCOSE-METABOLISM; EARLY ENDOSOME; PHOSPHORYLATION; ACTIVATION; IMPACT; CELLS; CYTOSKELETAL; ORGANIZATION	Keratins (Ks) are epithelial cell intermediate filament (IF) proteins that are expressed as pairs in a differentiation-regulated manner. Hepatocyte IFs are made only of K8/K18 pairs, which means that a K8 loss in K8-null mice leads to degradation of K18. Functionally, there is accumulating evidence that IFs contribute to signaling platforms. Here, we investigate the role of K8/K18 IFs in the regulation of insulin receptor (IR) signaling and trafficking in hepatocytes. We find that the IR substrate 1 (IRS1)/PI3K/Akt signaling cascade-downstream of IR-displays prolonged activation in K8-null compared with wild-type hepatocytes. Assessment of the Akt/mammalian target of rapamycin complex 1-mediated feedback loop to IRS1/PI3K, in the absence or presence of drug inhibitors, further supports a preferential K8/K18 IF intervention at the surface membrane. In K8-null hepatocytes, IR trafficking vesicles that are labeled by Rab5/EEA1/phosphatidylinositol 3-phosphate accumulate at a juxtanuclear region via a microtubule-dependent process. Moreover, interference with phosphatidylinositol 4,5-biphosphate signaling aggravates IR/Rab5 accumulation. Overall, results uncover K8/K18 IF regulation of IR signaling via a concerted modulation of phosphatidylinositol 4,5-biphosphate-dependent IRS1/PI3K/Akt signaling and Rab5/phosphatidylinositol 3-phosphate/microtubule trafficking in hepatocytes.	Univ Laval, Ctr Rech Canc, Quebec City, PQ, Canada; Univ Laval, Ctr Hosp Univ Quebec, Ctr Rech, Hotel Dieu Quebec, Quebec City, PQ, Canada	Laval University; Laval University	Marceau, N (corresponding author), CHU Quebec, Ctr Rech, 9 McMahon, Quebec City, PQ G1R 2J6, Canada.	normand.marceau@crchudequebec.ulaval.ca		Lavoie, Josee N/0000-0001-6912-1132	Canadian Institutes of Health Research [MOP 15529]; Fondation du Centre Hospitalier Universitaire de Quebec-Universite Laval Grant [2698]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Fondation du Centre Hospitalier Universitaire de Quebec-Universite Laval Grant	This work was supported by the Canadian Institutes of Health Research (Grant MOP 15529; to N.M.), and the Fondation du Centre Hospitalier Universitaire de Quebec-Universite Laval (Grant 2698; to N.M.). The authors thank H. Baribault (Surrozen Biotechnology, San Francisco, CA, USA) for the original WT and K8-null mouse colonies, and J. Huot and S. Gilbert [both from Centre de Recherche du Centre Hospitalier Universitaire (CRCHU) de Quebec-Universite Laval] for critical reading of the manuscript. The authors declare no conflicts of interest.	Alam CM, 2013, J CELL SCI, V126, P5635, DOI 10.1242/jcs.132795; Balbis A, 2004, J BIOL CHEM, V279, P39348, DOI 10.1074/jbc.M404280200; Betz C, 2013, J CELL BIOL, V203, P563, DOI 10.1083/jcb.201306041; Betz C, 2013, P NATL ACAD SCI USA, V110, P12526, DOI 10.1073/pnas.1302455110; Bordeleau F, 2010, MOL BIOL CELL, V21, P1698, DOI 10.1091/mbc.E09-05-0373; Braunger JA, 2014, J BIOL CHEM, V289, P9833, DOI 10.1074/jbc.M113.530659; Bruckner BR, 2015, SCI REP-UK, V5, DOI 10.1038/srep14700; Chen XM, 2001, EMBO REP, V2, P842, DOI 10.1093/embo-reports/kve179; Chen XM, 2001, EMBO REP, V2, P68, DOI 10.1093/embo-reports/kve005; Copps KD, 2012, DIABETOLOGIA, V55, P2565, DOI 10.1007/s00125-012-2644-8; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; de Lartigue J, 2009, TRAFFIC, V10, P883, DOI 10.1111/j.1600-0854.2009.00915.x; Desbuquois Bernard, 2014, Biologie Aujourd hui, V208, P137, DOI 10.1051/jbio/2014016; Di Paolo G, 2006, NATURE, V443, P651, DOI 10.1038/nature05185; Eriksson JE, 2009, J CLIN INVEST, V119, P1763, DOI 10.1172/JCI38339; Foti M, 2004, NOVART FDN SYMP, V262; Foti M, 2004, NOVART FDN SYMP, V262, P265; Foti Michelangelo, 2004, Novartis Found Symp, V262, P125; Gao XX, 2011, P NATL ACAD SCI USA, V108, P14509, DOI 10.1073/pnas.1019386108; Gilbert S, 2008, APOPTOSIS, V13, P1479, DOI 10.1007/s10495-008-0274-x; Gilbert S, 2016, J CELL SCI, V129, P3262, DOI 10.1242/jcs.171124; Gilbert S, 2012, APOPTOSIS, V17, P880, DOI 10.1007/s10495-012-0733-2; He T, 2002, J BIOL CHEM, V277, P10767, DOI 10.1074/jbc.M111436200; Hirosako K, 2004, BIOCHEM BIOPH RES CO, V316, P845, DOI 10.1016/j.bbrc.2004.02.119; Hoepfner S, 2005, CELL, V121, P437, DOI 10.1016/j.cell.2005.02.017; Holthuis JCM, 2003, MOL MEMBR BIOL, V20, P231, DOI 10.1080/0988768031000100768; Humphries JD, 2007, J CELL BIOL, V179, P1043, DOI 10.1083/jcb.200703036; Hunker CM, 2006, ARCH BIOCHEM BIOPHYS, V449, P130, DOI 10.1016/j.abb.2006.01.020; Hunt SD, 2011, BIOCHEM SOC T, V39, P1179, DOI 10.1042/BST0391179; Ikonomov OC, 2006, AM J PHYSIOL-CELL PH, V291, pC393, DOI 10.1152/ajpcell.00019.2006; Jean S, 2012, NAT REV MOL CELL BIO, V13, P463, DOI 10.1038/nrm3379; Jozic Ivan, 2011, Curr Cell Biochem, V1, P20; Kido Y, 2000, DIABETES, V49, P589, DOI 10.2337/diabetes.49.4.589; Klopfenstein DR, 2002, CELL, V109, P347, DOI 10.1016/S0092-8674(02)00708-0; Ku NO, 2006, J CELL BIOL, V174, P115, DOI 10.1083/jcb.200602146; Ku NO, 2010, NAT CELL BIOL, V12, P876, DOI 10.1038/ncb2091; Ku NO, 1997, J BIOL CHEM, V272, P7556, DOI 10.1074/jbc.272.11.7556; Ku NO, 2004, J CELL BIOL, V166, P479, DOI 10.1083/jcb.200402051; Laketa V, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2004532; Lasserre R, 2008, NAT CHEM BIOL, V4, P538, DOI 10.1038/nchembio.103; Lawe DC, 2002, J BIOL CHEM, V277, P8611, DOI 10.1074/jbc.M109239200; Loranger A, 1997, AM J PATHOL, V151, P1673; Loranger A, 2006, EXP CELL RES, V312, P4108, DOI 10.1016/j.yexcr.2006.09.031; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Marceau N, 2004, METHOD CELL BIOL, V78, P95; Marceau N, 2001, BIOCHEM CELL BIOL, V79, P543, DOI 10.1139/bcb-79-5-543; Marceau N., 2014, INTERMEDIATE FILAMEN; Mathew J, 2008, FREE RADICAL BIO MED, V45, P413, DOI 10.1016/j.freeradbiomed.2008.04.031; Mathew J, 2013, EXP CELL RES, V319, P474, DOI 10.1016/j.yexcr.2012.11.011; McNamara CR, 2011, FUTURE MED CHEM, V3, P549, DOI [10.4155/fmc.11.12, 10.4155/FMC.11.12]; Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008; Omary MB, 2009, J CLIN INVEST, V119, P1794, DOI 10.1172/JCI37762; Omary MB, 2009, J CLIN INVEST, V119, P1756, DOI 10.1172/JCI39894; OMARY MB, 1992, J CELL BIOL, V117, P583, DOI 10.1083/jcb.117.3.583; Picas Laura, 2016, F1000Res, V5, DOI 10.12688/f1000research.7537.1; Posor Y, 2015, BBA-MOL CELL BIOL L, V1851, P794, DOI 10.1016/j.bbalip.2014.09.014; Preta G, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0102-1; Ricoult SJH, 2013, EMBO REP, V14, P242, DOI 10.1038/embor.2013.5; Roux A, 2016, FASEB J, V30, P491, DOI 10.1096/fj.15-277905; Saarikangas J, 2010, PHYSIOL REV, V90, P259, DOI 10.1152/physrev.00036.2009; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schweizer J, 2006, J CELL BIOL, V174, P169, DOI 10.1083/jcb.200603161; Siddle K, 2011, J MOL ENDOCRINOL, V47, pR1, DOI 10.1530/JME-11-0022; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Skjeldal FM, 2012, J CELL SCI, V125, P1910, DOI 10.1242/jcs.092569; Su X, 2006, J BIOL CHEM, V281, P27982, DOI 10.1074/jbc.M602873200; Toivola DM, 2015, CURR OPIN CELL BIOL, V32, P73, DOI 10.1016/j.ceb.2014.12.008; Toivola DM, 2001, HEPATOLOGY, V34, P1174, DOI 10.1053/jhep.2001.29374; Vainio S, 2002, EMBO REP, V3, P95, DOI 10.1093/embo-reports/kvf010; Virkamaki A, 1999, J CLIN INVEST, V103, P931, DOI 10.1172/JCI6609; Zajac AL, 2013, CURR BIOL, V23, P1173, DOI 10.1016/j.cub.2013.05.015	71	6	6	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3555	3573		10.1096/fj.201700036R	http://dx.doi.org/10.1096/fj.201700036R			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28442548				2022-12-28	WOS:000405932400030
J	Balczon, R; Morrow, KA; Zhou, C; Edmonds, B; Alexeyev, M; Pittet, JF; Wagener, BM; Moser, SA; Leavesley, S; Zha, XM; Frank, DW; Stevens, T				Balczon, Ron; Morrow, K. Adam; Zhou, Chun; Edmonds, Bradley; Alexeyev, Mikhail; Pittet, Jean-Francois; Wagener, Brant M.; Moser, Stephen A.; Leavesley, Silas; Zha, Xiangming; Frank, Dara W.; Stevens, Troy			Pseudomonas aeruginosa infection liberates transmissible, cytotoxic prion amyloids	FASEB JOURNAL			English	Article							VENTILATOR-ASSOCIATED PNEUMONIA; HOSPITAL-ACQUIRED PNEUMONIA; RISK-FACTORS; MORTALITY; PROTEIN; PROGNOSIS; CYCLASE; EXOY; MICROBIOLOGY; COLONIZATION	Patients who recover from pneumonia subsequently have elevated rates of death after hospital discharge as a result of secondary organ damage, the causes of which are unknown. We used the bacterium Pseudomonas aeruginosa, a common cause of hospital-acquired pneumonia, as a model for investigating this phenomenon. We show that infection of pulmonary endothelial cells by P. aeruginosa induces production and release of a cytotoxic amyloid molecule with prion characteristics, including resistance to various nucleases and proteases. This cytotoxin was self-propagating, was neutralized by anti-amyloid Abs, and induced death of endothelial cells and neurons. Moreover, the cytotoxin induced edema in isolated lungs. Endothelial cells and isolated lungs were protected from cytotoxin-induced death by stimulation of signal transduction pathways that are linked to prion protein. Analysis of bronchoalveolar lavage fluid collected from human patients with P. aeruginosa pneumonia demonstrated cytotoxic activity, and lavage fluid contained amyloid molecules, including oligomeric-r and AI3. Demonstration of long-lived cytotoxic agents after Pseudomonas infection may establish a molecular link to the high rates of death as a result of end-organ damage in the months after recovery from pneumonia, and modulation of signal transduction pathways that have been linked to prion protein may provide a mechanism for intervention.	[Balczon, Ron] Univ S Alabama, Coll Med, Dept Biochem & Mol Biol, Mobile, AL USA; [Morrow, K. Adam; Zhou, Chun; Alexeyev, Mikhail; Zha, Xiangming; Stevens, Troy] Univ S Alabama, Coll Med, Dept Physiol & Cell Biol, Mobile, AL USA; [Leavesley, Silas] Univ S Alabama, Coll Med, Dept Chem & Biomed Engn, Mobile, AL USA; [Balczon, Ron; Morrow, K. Adam; Zhou, Chun; Edmonds, Bradley; Alexeyev, Mikhail; Leavesley, Silas; Zha, Xiangming; Stevens, Troy] Univ S Alabama, Coll Med, Ctr Lung Biol, Mobile, AL USA; [Pittet, Jean-Francois; Wagener, Brant M.] Univ Alabama Birmingham, Med Sch Birmingham, Dept Anesthesia & Perioperat Med, Birmingham, AL USA; [Moser, Stephen A.] Univ Alabama Birmingham, Dept Pathol, Med Sch Birmingham, Birmingham, AL 35294 USA; [Frank, Dara W.] Med Coll Wisconsin, Dept Microbiol & Mol Genet, Milwaukee, WI 53226 USA	University of South Alabama; University of South Alabama; University of South Alabama; University of South Alabama; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; Medical College of Wisconsin	Balczon, R (corresponding author), Univ S Alabama, Ctr Lung Biol, Dept Biochem & Mol Biol, 5851 USA Dr North,MSB 2265C, Mobile, AL 36608 USA.	rbalczon@southalabama.edu	Wagener, Brant/AAI-7480-2020	Zha, Xiangming/0000-0001-9490-2731	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute [HL-60024, HL-66299]; American Heart Association Postdoctoral Fellowship Grant [14POST18080004]; NIH [1R01-RR031286]; NATIONAL CENTER FOR RESEARCH RESOURCES [R01RR031286] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060024, P01HL066299, R37HL060024, R01HL135003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI104922] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [R01OD010944] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Heart Association Postdoctoral Fellowship Grant(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute Grants HL-60024 (to T.S.) and HL-66299 (to T.S., R.B., and M.A.), American Heart Association Postdoctoral Fellowship Grant 14POST18080004 (to K.A.M.), and NIH Research Project Grant 1R01-RR031286 (to M.A.). The authors declare no conflicts of interest.	Agodi A, 2007, INTENS CARE MED, V33, P1155, DOI 10.1007/s00134-007-0671-6; Alvarez DF, 2004, AM J PHYSIOL-LUNG C, V286, pL445, DOI 10.1152/ajplung.00150.2003; Balczon R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074343; Barbieri JT, 2005, REV PHYSIOL BIOCH P, V152, P79, DOI 10.1007/s10254-004-0031-7; Beckert U, 2014, BIOCHEM BIOPH RES CO, V450, P870, DOI 10.1016/j.bbrc.2014.06.088; BRANCATI FL, 1993, LANCET, V342, P30, DOI 10.1016/0140-6736(93)91887-R; Centers for Disease Control and Prevention, FASTSTATS MORT; Centers for Disease Control and Prevention, BOV SPONG ENC; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Corrales-Medina VF, 2015, JAMA-J AM MED ASSOC, V313, P264, DOI 10.1001/jama.2014.18229; Dick AW, 2015, AM J INFECT CONTROL, V43, P4, DOI 10.1016/j.ajic.2014.07.014; Eber MR, 2010, ARCH INTERN MED, V170, P347, DOI 10.1001/archinternmed.2009.509; Engel J, 2009, CURR OPIN MICROBIOL, V12, P61, DOI 10.1016/j.mib.2008.12.007; Frank DW, 1997, MOL MICROBIOL, V26, P621, DOI 10.1046/j.1365-2958.1997.6251991.x; Garau J, 2003, CURR OPIN INFECT DIS, V16, P135, DOI 10.1097/00001432-200304000-00010; Glabe CG, 2004, TRENDS BIOCHEM SCI, V29, P542, DOI 10.1016/j.tibs.2004.08.009; Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932; Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004; HEDLUND JU, 1993, THORAX, V48, P785, DOI 10.1136/thx.48.8.785; Hirota N, 1997, PROTEIN SCI, V6, P416; Horvath P, 2010, SCIENCE, V327, P167, DOI 10.1126/science.1179555; Hunter N, 2007, BBA-MOL BASIS DIS, V1772, P619, DOI 10.1016/j.bbadis.2007.04.007; Kanj S. S., 2016, PSEUD AER PN; Kayed R, 2004, J BIOL CHEM, V279, P46363, DOI 10.1074/jbc.C400260200; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kessels HW, 2010, NATURE, V466, pE3, DOI 10.1038/nature09217; Kim YJ, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-161; King J, 2004, MICROVASC RES, V67, P139, DOI 10.1016/j.mvr.2003.11.006; Koivula I, 1999, ARCH INTERN MED, V159, P1550, DOI 10.1001/archinte.159.14.1550; Kumar DKV, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf1059; LACROIX AZ, 1989, PUBLIC HEALTH REP, V104, P350; Llanes C, 2004, ANTIMICROB AGENTS CH, V48, P1797, DOI 10.1128/AAC.48.5.1797-1802.2004; Lynch JP, 2001, CHEST, V119, p373S, DOI 10.1378/chest.119.2_suppl.373S; Marraffini LA, 2010, NAT REV GENET, V11, P181, DOI 10.1038/nrg2749; Meier CR, 1998, LANCET, V351, P1467, DOI 10.1016/S0140-6736(97)11084-4; Morrow KA, 2015, AM J PHYSIOL-LUNG C, V309, pL1199, DOI 10.1152/ajplung.00165.2015; Morrow KA, 2016, AM J PHYSIOL-LUNG C, V310, P1337, DOI 10.1152/ajplung.00103.2015; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Muder RR, 1996, ARCH INTERN MED, V156, P2365, DOI 10.1001/archinte.156.20.2365; Nathanson N, 1997, AM J EPIDEMIOL, V145, P959, DOI 10.1093/oxfordjournals.aje.a009064; Neuhauser MM, 2003, JAMA-J AM MED ASSOC, V289, P885, DOI 10.1001/jama.289.7.885; Nonaka T, 2013, CELL REP, V4, P124, DOI 10.1016/j.celrep.2013.06.007; Ochoa CD, 2012, J BIOL CHEM, V287, P25407, DOI 10.1074/jbc.M111.301440; Ochoa CD, 2011, AM J PHYSIOL-LUNG C, V300, pL132, DOI 10.1152/ajplung.00185.2010; PRUSINER S B, 1989, Alzheimer Disease and Associated Disorders, V3, P52, DOI 10.1097/00002093-198903010-00007; Sanders DW, 2014, NEURON, V82, P1271, DOI 10.1016/j.neuron.2014.04.047; Sandiumenge A, 2012, CURR OPIN PULM MED, V18, P187, DOI 10.1097/MCP.0b013e328351f974; Sato H, 2003, EMBO J, V22, P2959, DOI 10.1093/emboj/cdg290; Sato H, 2004, MOL MICROBIOL, V53, P1279, DOI 10.1111/j.1365-2958.2004.04194.x; Sayner SL, 2004, CIRC RES, V95, P196, DOI 10.1161/01.RES.0000134922.25721.d9; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Six DA, 2000, BBA-MOL CELL BIOL L, V1488, P1, DOI 10.1016/S1388-1981(00)00105-0; Smeeth L, 2004, NEW ENGL J MED, V351, P2611, DOI 10.1056/NEJMoa041747; Stevens TC, 2014, AM J PHYSIOL-LUNG C, V306, pL915, DOI 10.1152/ajplung.00135.2013; Valles J, 2004, INTENS CARE MED, V30, P1768, DOI 10.1007/s00134-004-2382-6; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Waterer GW, 2004, AM J RESP CRIT CARE, V169, P910, DOI 10.1164/rccm.200310-1448OC; Weber DJ, 2007, INFECT CONT HOSP EP, V28, P825, DOI 10.1086/518460; Wemmie JA, 2004, P NATL ACAD SCI USA, V101, P3621, DOI 10.1073/pnas.0308753101; Yahr TL, 1998, P NATL ACAD SCI USA, V95, P13899, DOI 10.1073/pnas.95.23.13899; Yende S, 2008, AM J RESP CRIT CARE, V177, P1242, DOI 10.1164/rccm.200712-1777OC; Zavascki AP, 2006, CRIT CARE, V10, DOI 10.1186/cc5006	62	22	22	0	26	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2785	2796		10.1096/fj.201601042RR	http://dx.doi.org/10.1096/fj.201601042RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28314768	Green Published			2022-12-28	WOS:000405931000007
J	Iyer, JK; Koh, CY; Kazimirova, M; Roller, L; Jobichen, C; Swaminathan, K; Mizuguchi, J; Iwanaga, S; Nuttall, PA; Chan, MY; Kini, RM				Iyer, Janaki Krishnamoorthy; Koh, Cho Yeow; Kazimirova, Maria; Roller, Ladislav; Jobichen, Chacko; Swaminathan, Kunchithapadam; Mizuguchi, Jun; Iwanaga, Sadaaki; Nuttall, Patricia A.; Chan, Mark Y.; Kini, R. Manjunatha			Avathrin: a novel thrombin inhibitor derived from a multicopy precursor in the salivary glands of the ixodid tick, Amblyomma variegatum	FASEB JOURNAL			English	Article						direct thrombin inhibitor; exosite-I inhibitor; blood-feeding arthropods; blood-sucking animals; thrombin-inhibitor complex	BRADYKININ-POTENTIATING PEPTIDES; TROPICAL BONT TICK; ORAL ANTICOAGULANTS; HEPARIN; IDENTIFICATION; BIVALIRUDIN; COMPLEXES; HIRUDIN; PROTEIN; VENOM	Tick saliva is a rich source of antihemostatic compounds. We amplified a cDNA from the salivary glands of the tropical bont tick (Amblyomma variegatum) using primers based on the variegin sequence, which we previously identified as a novel thrombin inhibitor from the same tick species. The transcript encodes a precursor protein comprising a signal peptide and 5 repeats of variegin-like sequences that could be processed into multiple short peptides. These peptides share 31 to 34% identity with variegin. Here, we structurally and functionally characterized one of these peptides named "avathrin." Avathrin is a fast, tight binding competitive inhibitor with an affinity of 545 pM for thrombin and is 4 orders of magnitude more selective towards thrombin than to the other serine proteases of the coagulation cascade. The crystal structure of thrombin-avathrin complex at 2.09 A revealed that avathrin interacts with the thrombin active site and exosite-I. Although avathrin is cleaved by thrombin, the C-terminal cleavage product continues to exert prolonged inhibition. Avathrin is more potent than hirulog-1 in a murine carotid artery thrombosis model. Such precursor proteins that could be processed into multiple thrombin inhibiting peptides appear to be widespread among Amblyomminae, providing an enormous library of molecules for development as potent antithrombotics. Iyer, J. K., Koh, C. Y., Kazimirova, M., Roller, L., Jobichen, C., Swaminathan, K., Mizuguchi, J., Iwanaga, S., Nuttall, P. A., Chan, M. Y., Kini, R. M. Avathrin: a novel thrombin inhibitor derived from a multicopy precursor in the salivary glands of the ixodid tick, Amblyomma variegatum.	[Iyer, Janaki Krishnamoorthy; Koh, Cho Yeow; Jobichen, Chacko; Swaminathan, Kunchithapadam; Kini, R. Manjunatha] Natl Univ Singapore, Prot Sci Lab, Dept Biol Sci, Singapore, Singapore; [Chan, Mark Y.] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore, Singapore; [Iyer, Janaki Krishnamoorthy] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Kazimirova, Maria; Roller, Ladislav] Slovak Acad Sci, Inst Zool, Bratislava, Slovakia; [Mizuguchi, Jun; Iwanaga, Sadaaki] Chemoserotherapeut Res Inst, Kumamoto, Japan; [Nuttall, Patricia A.] Univ Oxford, Dept Zool, Oxford, England; [Chan, Mark Y.] Natl Univ Heart Ctr, Dept Cardiol, Singapore, Singapore; [Kini, R. Manjunatha] Singapore Eye Res Inst, Singapore, Singapore	National University of Singapore; National University of Singapore; McMaster University; Slovak Academy of Sciences; University of Oxford; National University of Singapore; National University of Singapore; Singapore National Eye Center	Kini, RM (corresponding author), Natl Univ Singapore, Prot Sci Lab, Dept Biol Sci, Fac Sci, 14,Sci Dr 4, Singapore 117543, Singapore.	dbskinim@nus.edu.sg	Roller, Ladislav/ABB-2988-2021; Chan, Yan Yee Mark/ABE-1929-2021; Jobichen, Chacko/AAR-7637-2020; Jobichen, Chacko/D-1978-2014; Kazimirova, Maria/U-8222-2017; Chan, Rebecca/D-9859-2018; Koh, Cho Yeow/J-4635-2019; Nuttall, Pat/I-6142-2012	Chan, Yan Yee Mark/0000-0003-0389-7450; Jobichen, Chacko/0000-0001-5927-1815; Kazimirova, Maria/0000-0001-6904-8342; Chan, Rebecca/0000-0001-6158-3885; Koh, Cho Yeow/0000-0003-0002-4603; Roller, Ladislav/0000-0002-9824-2096; Nuttall, Pat/0000-0002-0385-8294; Kini, Manjunatha/0000-0002-6100-3251	Ministry of Education [R-154-000-687-112]; National Medical Research Council; Research and Development "Bridging Discovery to Development of a Novel Parenteral Direct Thrombin Inhibitor" Project; European Regional Development Fund Operational Programme [ITMS: 26240220044]; Singapore Ministry of Education	Ministry of Education; National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Research and Development "Bridging Discovery to Development of a Novel Parenteral Direct Thrombin Inhibitor" Project; European Regional Development Fund Operational Programme; Singapore Ministry of Education(Ministry of Education, Singapore)	This work was funded by the Ministry of Education "New Factor Xa Inhibitors from Tick Saliva: Structure-Function Relationships" Project; Academic Research Fund: Development of Cardiovascular Agents (R-154-000-687-112); and National Medical Research Council, Research and Development "Bridging Discovery to Development of a Novel Parenteral Direct Thrombin Inhibitor" Project; the European Regional Development Fund Operational Programme (ITMS: 26240220044 to L.R.); and by a graduate research fellowship from the Singapore Ministry of Education (to J.K.I.). The authors declare no conflicts of interest.	[Anonymous], GUIDE IDENTIFICATION; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bauer KA, 2013, HEMATOL-AM SOC HEMAT, P464, DOI 10.1182/asheducation-2013.1.464; Berliner L. J., 1992, J CHEM INF MODEL, P118; BERRY CN, 1994, THROMB HAEMOSTASIS, V72, P381; Bode W, 2006, BLOOD CELL MOL DIS, V36, P122, DOI 10.1016/j.bcmd.2005.12.027; BOURDON P, 1991, FEBS LETT, V294, P163, DOI 10.1016/0014-5793(91)80659-Q; Bridge KI, 2014, THROMB HAEMOSTASIS, V112, P901, DOI 10.1160/TH14-02-0184; Campeiro JD, 2015, BIOCHEM PHARMACOL, V96, P202, DOI 10.1016/j.bcp.2015.05.012; Cavender MA, 2014, LANCET, V384, P599, DOI 10.1016/S0140-6736(14)61216-2; CHANG JY, 1986, BIOCHEM J, V240, P797, DOI 10.1042/bj2400797; Chaudhari K, 2014, NAT REV DRUG DISCOV, V13, P571, DOI 10.1038/nrd4365; Chen W, 2015, J THROMB HAEMOST, V13, P248, DOI 10.1111/jth.12797; Copeland R. A., 2000, ENZYMES PRACTICAL IN, V7; Coppens M, 2012, CIRC RES, V111, P920, DOI 10.1161/CIRCRESAHA.112.264903; Di Cera E, 2008, MOL ASPECTS MED, V29, P203, DOI 10.1016/j.mam.2008.01.001; Eckly A, 2011, J THROMB HAEMOST, V9, P779, DOI 10.1111/j.1538-7836.2011.04218.x; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Francischetti IMB, 1999, BIOCHEMISTRY-US, V38, P16678, DOI 10.1021/bi991231p; Gallaher MP, 2012, PUBLIC INVESTMENTS IN ENERGY TECHNOLOGY, P7; Hirsh J, 2001, CIRCULATION, V103, P2994, DOI 10.1161/01.CIR.103.24.2994; Huntington JA, 2014, THROMB HAEMOSTASIS, V111, P583, DOI 10.1160/TH13-10-0811; Jablonka W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133991; KLINE T, 1991, BIOCHEM BIOPH RES CO, V177, P1049, DOI 10.1016/0006-291X(91)90644-M; Koh CY, 2007, J BIOL CHEM, V282, P29101, DOI 10.1074/jbc.M705600200; Koh CY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026367; Koh CY, 2009, CHEMBIOCHEM, V10, P2155, DOI 10.1002/cbic.200900371; Leslie AGW, 2007, NATO SCI SER II-MATH, V245, P41, DOI 10.1007/978-1-4020-6316-9_4; McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975; Monroe D, 2002, ARTERIOSCL THROM VAS, V22, P1381, DOI 10.1161/01.ATV.0000031340.68494.34; Nene V, 2002, INT J PARASITOL, V32, P1447, DOI 10.1016/S0020-7519(02)00159-5; QIU XY, 1992, BIOCHEMISTRY-US, V31, P11689, DOI 10.1021/bi00162a004; Rawlings ND, 2012, NUCLEIC ACIDS RES, V40, pD343, DOI [10.1093/nar/gkr987, 10.1093/nar/gkt953]; Ribeiro JMC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-136; Roller L, 2016, PEPTIDES, V80, P72, DOI 10.1016/j.peptides.2016.02.003; RYDEL TJ, 1994, J BIOL CHEM, V269, P22000; SKRZYPCZAKJANKUN E, 1991, J MOL BIOL, V221, P1379; Soares MR, 2005, TOXICON, V46, P31, DOI 10.1016/j.toxicon.2005.03.006; Steg PG, 2013, JAMA-J AM MED ASSOC, V310, P1145, DOI 10.1001/jama.2013.277165; STUBBS MT, 1993, THROMB RES, V69, P1, DOI 10.1016/0049-3848(93)90002-6; Versteeg HH, 2013, PHYSIOL REV, V93, P327, DOI 10.1152/physrev.00016.2011; Warkentin TE, 2004, BEST PRACT RES CL HA, V17, P105, DOI 10.1016/j.beha.2004.02.002; Yeh CH, 2015, ARTERIOSCL THROM VAS, V35, P1056, DOI 10.1161/ATVBAHA.115.303397	44	11	11	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2981	2995		10.1096/fj.201601216R	http://dx.doi.org/10.1096/fj.201601216R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28363953				2022-12-28	WOS:000405931000023
J	Zheng, HM; Wang, XX; Guo, PF; Ge, WZ; Yan, QF; Gao, WQ; Xi, YM; Yang, XH				Zheng, Huimei; Wang, Xuexiang; Guo, Pengfei; Ge, Wanzhong; Yan, Qinfeng; Gao, Weiqiang; Xi, Yongmei; Yang, Xiaohang			Premature remodeling of fat body and fat mobilization triggered by platelet-derived growth factor/VEGF receptor in Drosophila	FASEB JOURNAL			English	Article						CD117/c-kit; lipid metabolism; ecdysone; Rac1; fat cell	PROGRAMMED CELL-DEATH; PDGF/VEGF RECEPTOR; LIPID DROPLETS; ADIPOSE-TISSUE; MATRIX METALLOPROTEINASES; ECDYSONE RECEPTOR; RHO-GTPASES; STEM-CELL; C-KIT; MELANOGASTER	In Drosophila, fat-body remodeling accompanied with fat mobilization is an ecdysone-induced dynamic process that only occurs during metamorphosis. Here, we show that the activated Drosophila platelet-derived growth factor/VEGF receptor (PVR) is sufficient to induce shape changes in the fat body, from thin layers of tightly conjugated polygonal cells to clusters of disaggregated round-shaped cells. These morphologic changes are reminiscent of those seen during early pupation upon initiation of fat-body remodeling. Activation of PVR also triggers an early onset of lipolysis and mobilization of internal storage, as revealed by the appearance of small lipid droplets and up-regulated lipolysis-related genes. We found that PVR displays a dynamic expression pattern in the fat body and peaks at the larval-prepupal transition under the control of ecdysone signaling. Removal of PVR, although it does not prevent ecdysone-induced fat-body remodeling, causes ecdysone signaling to be up-regulated. Our data reveal that PVR is active in a dual-secured mechanism that involves an ecdysone-induced fat-body remodeling pathway and a reinforced PVR pathway for effective lipid mobilization. Ectopic expression of activated c-kit-the mouse homolog of PVR in the Drosophila fat body-also results in a similar phenotype. This may suggest a novel function of c-kit as it relates to lipid metabolism in mammals.-Zheng, H., Wang, X., Guo, P., Ge, W., Yan, Q., Gao, W., Xi, Y., Yang, X. Premature remodeling of fat body and fat mobilization triggered by platelet-derived growth factor/VEGF receptor in Drosophila.	[Zheng, Huimei; Guo, Pengfei; Ge, Wanzhong; Xi, Yongmei; Yang, Xiaohang] Zhejiang Univ, Sch Med, Womens Hosp, Div Human Reprod & Dev Genet, Hangzhou, Zhejiang, Peoples R China; [Zheng, Huimei; Guo, Pengfei; Ge, Wanzhong; Xi, Yongmei; Yang, Xiaohang] Zhejiang Univ, Sch Med, Dept Genet, Hangzhou, Zhejiang, Peoples R China; [Zheng, Huimei; Guo, Pengfei; Ge, Wanzhong; Xi, Yongmei; Yang, Xiaohang] Zhejiang Univ, Inst Genet, Hangzhou, Zhejiang, Peoples R China; [Zheng, Huimei; Wang, Xuexiang; Yan, Qinfeng] Zhejiang Univ, Coll Life Sci, Hangzhou, Zhejiang, Peoples R China; [Gao, Weiqiang] Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai, Peoples R China; [Gao, Weiqiang] Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai, Peoples R China; [Yang, Xiaohang] Zhejiang Univ, Univ Toronto, Joint Inst Genet & Genom Med, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; University of Toronto; Zhejiang University	Xi, YM; Yang, XH (corresponding author), Zhejiang Univ, Yuhangtang Rd 866, Hangzhou 310058, Zhejiang, Peoples R China.	xyyongm@zju.edu.cn; xhyang@zju.edu.cn	Gao, Wei/GXH-0380-2022; Guo, Peng/GWC-0572-2022; 席, 咏梅/AAE-1909-2022; guo, peng/AAG-4052-2019	ZHENG, HUIMEI/0000-0001-7129-8412; Ge, Wanzhong/0000-0003-1334-2723	National Key Basic Research Program of China (973 Program) [2012CB966801]; National Natural Science Foundation of China [31371319]	National Key Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The authors thank P. Rorth (National University of Singapore, Singapore), C. Tong (Zhejiang University), the Bloomington Drosophila Stock Center (Indiana University, Bloomington, IN, USA), Vijaya Development Resource Centre and the Tsinghua Fly Center for providing fly stocks. The authors also thank H. Zhu (Jiao Tong University) for providing the c-kit plasmid, and R. Yang (Jiao Tong University School of Medicine) for suggestions. This study was supported by grants from the National Key Basic Research Program of China (973 Program; 2012CB966801) and National Natural Science Foundation of China (31371319).	ABEL T, 1993, DEVELOPMENT, V119, P623; Aguila JR, 2013, J EXP BIOL, V216, P399, DOI 10.1242/jeb.078311; Ariotti N, 2012, MOL BIOL CELL, V23, P1826, DOI 10.1091/mbc.E11-10-0847; Asha H, 2003, GENETICS, V163, P203; Bailey AP, 2015, CELL, V163, P340, DOI 10.1016/j.cell.2015.09.020; BAINBRIDGE SP, 1981, J EMBRYOL EXP MORPH, V66, P57; Beller M, 2006, MOL CELL PROTEOMICS, V5, P1082, DOI 10.1074/mcp.M600011-MCP200; Beller M, 2010, CELL METAB, V12, P521, DOI 10.1016/j.cmet.2010.10.001; Bi JF, 2012, J CELL SCI, V125, P3568, DOI 10.1242/jcs.101329; Bond ND, 2011, DEV BIOL, V360, P286, DOI 10.1016/j.ydbio.2011.09.015; Bond ND, 2010, COMP BIOCHEM PHYS A, V157, P398, DOI [10.1016/J.cbpa.2010.08.025, 10.1016/j.cbpa.2010.08.025]; Britton JS, 1998, DEVELOPMENT, V125, P2149; Bruckner K, 2004, DEV CELL, V7, P73, DOI 10.1016/j.devcel.2004.06.007; Bunt S, 2010, DEV CELL, V19, P296, DOI 10.1016/j.devcel.2010.07.019; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Cho NK, 2002, CELL, V108, P865, DOI 10.1016/S0092-8674(02)00676-1; Corless CL, 2002, AM J PATHOL, V160, P1567, DOI 10.1016/S0002-9440(10)61103-0; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; Dano K, 1999, APMIS, V107, P120, DOI 10.1111/j.1699-0463.1999.tb01534.x; Davidowitz G, 2003, EVOL DEV, V5, P188, DOI 10.1046/j.1525-142X.2003.03026.x; de Souza CJ, 2001, DIABETES, V50, P1863, DOI 10.2337/diabetes.50.8.1863; Divoux A, 2011, OBES REV, V12, pe494, DOI 10.1111/j.1467-789X.2010.00811.x; Duchek P, 2001, CELL, V107, P17, DOI 10.1016/S0092-8674(01)00502-5; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Gavert N, 2013, CANCER RES, V73, P5754, DOI 10.1158/0008-5472.CAN-13-0576; Ge WZ, 2015, GENETICS, V200, P255, DOI 10.1534/genetics.115.174748; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Harris KE, 2007, MECH DEVELOP, V124, P441, DOI 10.1016/j.mod.2007.03.003; Hay BA, 2006, ANNU REV CELL DEV BI, V22, P623, DOI 10.1146/annurev.cellbio.21.012804.093845; Heino TI, 2001, MECH DEVELOP, V109, P69, DOI 10.1016/S0925-4773(01)00510-X; Hinz B, 2012, AM J PATHOL, V180, P1340, DOI 10.1016/j.ajpath.2012.02.004; Hodi FS, 2013, J CLIN ONCOL, V31, P3182, DOI 10.1200/JCO.2012.47.7836; HOSHIZAKI DK, 1994, DEV BIOL, V163, P133, DOI 10.1006/dbio.1994.1129; HOSHIZAKI DK, 2005, COMPLETE MOL INSECT, V2, P315; Ishimaru S, 2004, EMBO J, V23, P3984, DOI 10.1038/sj.emboj.7600417; Jaworski K, 2007, AM J PHYSIOL-GASTR L, V293, pG1, DOI 10.1152/ajpgi.00554.2006; Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004; Johnsen A, 1998, P ROY SOC B-BIOL SCI, V265, P1313, DOI 10.1098/rspb.1998.0435; KITAYAMA H, 1995, BLOOD, V85, P790, DOI 10.1182/blood.V85.3.790.bloodjournal853790; KOELLE MR, 1991, CELL, V67, P59, DOI 10.1016/0092-8674(91)90572-G; Kuhnlein RP, 2011, PROG LIPID RES, V50, P348, DOI 10.1016/j.plipres.2011.04.001; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Learte AR, 2008, GLIA, V56, P164, DOI 10.1002/glia.20601; Leong KG, 2008, NATURE, V456, P804, DOI 10.1038/nature07427; Li M, 2011, P NATL ACAD SCI USA, V108, P638, DOI 10.1073/pnas.1013914108; Liu Y, 2009, DEVELOPMENT, V136, P2015, DOI 10.1242/dev.033712; LOCKETT TJ, 1989, DEV BIOL, V134, P430, DOI 10.1016/0012-1606(89)90115-2; Martin S, 2006, NAT REV MOL CELL BIO, V7, P373, DOI 10.1038/nrm1912; Miettinen M, 2005, APPL IMMUNOHISTO M M, V13, P205, DOI 10.1097/01.pai.0000173054.83414.22; Miyoshi H, 2008, J CELL BIOCHEM, V105, P1430, DOI 10.1002/jcb.21964; Munier AI, 2002, EMBO REP, V3, P1195, DOI 10.1093/embo-reports/kvf242; Nelliot A, 2006, GENESIS, V44, P396, DOI 10.1002/dvg.20229; Paar M, 2012, J BIOL CHEM, V287, P11164, DOI 10.1074/jbc.M111.316794; Page-McCaw A, 2003, DEV CELL, V4, P95, DOI 10.1016/S1534-5807(02)00400-8; Page-McCaw A, 2007, NAT REV MOL CELL BIO, V8, P221, DOI 10.1038/nrm2125; Palanker L, 2009, CELL METAB, V9, P228, DOI 10.1016/j.cmet.2009.01.009; Patnaik MM, 2007, CURR CANCER DRUG TAR, V7, P492; Pignoni F, 1997, DEVELOPMENT, V124, P271; Riddiford L M, 2000, Vitam Horm, V60, P1, DOI 10.1016/S0083-6729(00)60016-X; Rosin D, 2004, DEVELOPMENT, V131, P1939, DOI 10.1242/dev.01101; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; Sears HC, 2003, DEVELOPMENT, V130, P3557, DOI 10.1242/dev.00586; Shin I, 2005, J BIOL CHEM, V280, P14675, DOI 10.1074/jbc.M411625200; Shingleton AW, 2005, CURR BIOL, V15, pR825, DOI 10.1016/j.cub.2005.10.006; Slaidina M, 2009, DEV CELL, V17, P874, DOI 10.1016/j.devcel.2009.10.009; Sousa-Nunes R, 2011, NATURE, V471, P508, DOI 10.1038/nature09867; Srahna M, 2006, PLOS BIOL, V4, P2076, DOI 10.1371/journal.pbio.0040348; Sztalryd C, 2003, J CELL BIOL, V161, P1093, DOI 10.1083/jcb.200210169; Tan WJ, 2015, MODERN PATHOL, V28, P352, DOI 10.1038/modpathol.2014.111; Tian L, 2013, AUTOPHAGY, V9, P1172, DOI 10.4161/auto.24731; Untergasser G, 2005, EXP GERONTOL, V40, P121, DOI 10.1016/j.exger.2004.12.008; Vignola AM, 2000, J ALLERGY CLIN IMMUN, V105, P1041, DOI 10.1067/mai.2000.107195; Xu J, 2005, HYPERTENSION, V45, P747, DOI 10.1161/01.HYP.0000153322.04859.81; Yamada M, 2000, DEVELOPMENT, V127, P5083; YAO TP, 1993, NATURE, V366, P476, DOI 10.1038/366476a0; Yin VP, 2005, SEMIN CELL DEV BIOL, V16, P237, DOI 10.1016/j.semcdb.2004.12.007; Zettervall CJ, 2004, P NATL ACAD SCI USA, V101, P14192, DOI 10.1073/pnas.0403789101; Zhuge Y, 2001, J BIOL CHEM, V276, P16248, DOI 10.1074/jbc.M010190200	79	7	10	0	20	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1964	1975		10.1096/fj.201601127R	http://dx.doi.org/10.1096/fj.201601127R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28126734				2022-12-28	WOS:000399195500018
J	Fujishima, Y; Maeda, N; Matsuda, K; Masuda, S; Mori, T; Fukuda, S; Sekimoto, R; Yamaoka, M; Obata, Y; Kita, S; Nishizawa, H; Funahashi, T; Ranscht, B; Shimomura, I				Fujishima, Yuya; Maeda, Norikazu; Matsuda, Keisuke; Masuda, Shigeki; Mori, Takuya; Fukuda, Shiro; Sekimoto, Ryohei; Yamaoka, Masaya; Obata, Yoshinari; Kita, Shunbun; Nishizawa, Hitoshi; Funahashi, Tohru; Ranscht, Barbara; Shimomura, Iichiro			Adiponectin association with T-cadherin protects against neointima proliferation and atherosclerosis	FASEB JOURNAL			English	Article							ADIPOSE-SPECIFIC PROTEIN; GENOME-WIDE ASSOCIATION; CELL-ADHESION MOLECULE; SMOOTH-MUSCLE-CELLS; INSULIN-RESISTANCE; EXPRESSION; PLASMA; ACTIVATION; GROWTH; CDH13	Adiponectin, an adipocyte-derived protein abundant in the circulation, is thought to be protective against atherosclerosis. However, it is not fully understood how the association of adiponectin with vascular cells and its antiatherogenic effect are connected. In this study, T-cadherin was essential for accumulation of adiponectin in the neointima and atherosclerotic plaque lesions, and the adiponectin-T-cadherin association protected against vascular injury. In the apolipoprotein E-knockout (ApoE-KO) mice, adiponectin and T-cadherin colocalized on endothelial cells and synthetic smooth muscle cells in the aortic intima. Notably, aortic adiponectin protein disappeared in T-cadherin/ApoE double-knockout (Tcad/ApoE-DKO) mice with significant elevation of blood adiponectin concentration. Furthermore, in Tcad/ApoE-DKO mice, carotid artery ligation resulted in a significant increase of neointimal thickness compared with ApoE-KO mice. Finally, on a high-cholesterol diet, Tcad/ApoE-DKO mice increased atherosclerotic plaque formation, despite a 5-fold increase in plasma adiponectin level compared with that in ApoE-KO mice. In vitro, knockdown of T-cadherin from human aortic smooth muscle cells (HASMCs) with synthetic phenotype significantly reduced adiponectin accumulation on HASMCs and negated the inhibitory effect of adiponectin on proinflammatory change. Collective evidence showed that adiponectin accumulates in the vasculature via T-cadherin, and the adiponectin-T-cadherin association plays a protective role against neointimal and atherosclerotic plaque formations.-Fujishima, Y., Maeda, N., Matsuda, K., Masuda, S., Mori, T., Fukuda, S., Sekimoto, R., Yamaoka, M., Obata, Y., Kita, S., Nishizawa, H., Funahashi, T., Ranscht, B., Shimomura, I. Adiponectin association with T-cadherin protects against neointima proliferation and atherosclerosis.	[Fujishima, Yuya; Maeda, Norikazu; Matsuda, Keisuke; Masuda, Shigeki; Mori, Takuya; Fukuda, Shiro; Sekimoto, Ryohei; Yamaoka, Masaya; Obata, Yoshinari; Kita, Shunbun; Nishizawa, Hitoshi; Funahashi, Tohru; Shimomura, Iichiro] Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2-B5 Yamada Oka, Suita, Osaka 5650871, Japan; [Maeda, Norikazu; Kita, Shunbun; Funahashi, Tohru] Osaka Univ, Grad Sch Med, Dept Metab & Atherosclerosis, Osaka, Japan; [Ranscht, Barbara] Sanford Burnham Prebys Med Discovery Inst, La Jolla, CA USA	Osaka University; Osaka University; Sanford Burnham Prebys Medical Discovery Institute	Maeda, N (corresponding author), Osaka Univ, Grad Sch Med, Dept Metab Med, 2-2-B5 Yamada Oka, Suita, Osaka 5650871, Japan.	norikazu_maeda@endmet.med.osaka-u.ac.jp		Fukuda, Shiro/0000-0002-0065-662X	Japan Society for the Promotion of Science (JSPS) KAKENHI [JP16K09801]; JSPS KAKENHI [JP15H04853, JP26293221]; Takeda Science Foundation; Japan Foundation for Applied Enzymology; Novo Nordisk Pharma Ltd; Kowa Life Science Foundation; MSD Life Science Foundation; Suzuken Memorial Foundation	Japan Society for the Promotion of Science (JSPS) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Foundation for Applied Enzymology; Novo Nordisk Pharma Ltd(Novo Nordisk); Kowa Life Science Foundation; MSD Life Science Foundation; Suzuken Memorial Foundation	The authors thank the Center of Medical Research and Education (Osaka University) for exceptional technical support; Futoshi Nakagami (Osaka University) for providing an excellent procedure for carotid artery ligation; and all members of the IIIrd Laboratory (Adiposcience Laboratory; Osaka University) for helpful discussions during the project. This work was supported in part by Japan Society for the Promotion of Science (JSPS) KAKENHI Grant JP16K09801 (to N.M.), JSPS KAKENHI Grant JP15H04853 (to I.S.), JSPS KAKENHI Grant JP26293221 (to T.F.), Takeda Science Foundation (to N.M.), Japan Foundation for Applied Enzymology (to Y.F.), Junior Scientist Development Grant supported by Novo Nordisk Pharma Ltd. (to Y.F.), Kowa Life Science Foundation (to Y.F.), MSD Life Science Foundation (to Y.F.), and Suzuken Memorial Foundation (to Y.F.). The funding agencies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; BJORKERUD S, 1991, ARTERIOSCLER THROMB, V11, P892, DOI 10.1161/01.ATV.11.4.892; Cattaruzza M, 2002, J BIOL CHEM, V277, P6582, DOI 10.1074/jbc.M108283200; Chen PY, 2015, J CLIN INVEST, V125, P4514, DOI 10.1172/JCI82719; Chung CM, 2011, DIABETES, V60, P2417, DOI 10.2337/db10-1321; Deaton RA, 2005, J BIOL CHEM, V280, P31172, DOI 10.1074/jbc.M504774200; Denzel MS, 2010, J CLIN INVEST, V120, P4342, DOI 10.1172/JCI43464; Fruebis J, 2001, P NATL ACAD SCI USA, V98, P2005, DOI 10.1073/pnas.041591798; Fujita K, 2008, ARTERIOSCL THROM VAS, V28, P863, DOI 10.1161/ATVBAHA.107.156687; Gao H, 2013, DIABETES, V62, P4277, DOI 10.2337/db13-0129; Gomez D, 2012, CARDIOVASC RES, V95, P156, DOI 10.1093/cvr/cvs115; Hansson GK, 2015, J INTERN MED, V278, P483, DOI 10.1111/joim.12406; Hebbard LW, 2008, CANCER RES, V68, P1407, DOI 10.1158/0008-5472.CAN-07-2953; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Hu E, 1996, J BIOL CHEM, V271, P10697, DOI 10.1074/jbc.271.18.10697; Hug C, 2004, P NATL ACAD SCI USA, V101, P10308, DOI 10.1073/pnas.0403382101; Ivanov D, 2004, CARDIOVASC RES, V64, P132, DOI 10.1016/j.cardiores.2004.06.010; Ivanov D, 2001, HISTOCHEM CELL BIOL, V115, P231; Joshi MB, 2007, FASEB J, V21, P3083, DOI 10.1096/fj.06-7723com; Kamada Y, 2003, GASTROENTEROLOGY, V125, P1796, DOI 10.1053/j.gastro.2003.08.029; Komura N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071271; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Kumada M, 2003, ARTERIOSCL THROM VAS, V23, P85, DOI 10.1161/01.ATV.0000048856.22331.50; Lindsay RS, 2002, LANCET, V360, P57, DOI 10.1016/S0140-6736(02)09335-2; Maeda K, 1996, BIOCHEM BIOPH RES CO, V221, P286, DOI 10.1006/bbrc.1996.0587; Maeda N, 2002, NAT MED, V8, P731, DOI 10.1038/nm724; Matsuda K, 2015, ENDOCRINOLOGY, V156, P934, DOI 10.1210/en.2014-1618; Matsuda M, 2002, J BIOL CHEM, V277, P37487, DOI 10.1074/jbc.M206083200; Matsuzawa Y, 2006, NAT CLIN PRACT CARD, V3, P35, DOI 10.1038/ncpcardio0380; Matsuzawa Y, 2004, ARTERIOSCL THROM VAS, V24, P29, DOI 10.1161/01.ATV.0000099786.99623.EF; Moonen JRAJ, 2015, CARDIOVASC RES, V108, P377, DOI 10.1093/cvr/cvv175; Mori T, 2014, SCI REP-UK, V4, DOI 10.1038/srep04895; Mori T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076199; Mukai Y, 2006, J CLIN INVEST, V116, P334, DOI 10.1172/JCI26223; Nakagami F, 2010, ATHEROSCLEROSIS, V211, P41, DOI 10.1016/j.atherosclerosis.2010.01.016; Nakano Y, 1996, J BIOCHEM-TOKYO, V120, P803; Noma K, 2008, J CLIN INVEST, V118, P1632, DOI 10.1172/JCI29226; Okamoto Y, 2002, CIRCULATION, V106, P2767, DOI 10.1161/01.CIR.0000042707.50032.19; Owens GK, 2004, PHYSIOL REV, V84, P767, DOI 10.1152/physrev.00041.2003; Parker-Duffen JL, 2013, J BIOL CHEM, V288, P24886, DOI 10.1074/jbc.M113.454835; Philippova M, 2008, MOL CELL BIOL, V28, P4004, DOI 10.1128/MCB.00157-08; Philippova MP, 1998, FEBS LETT, V429, P207, DOI 10.1016/S0014-5793(98)00598-5; Pischon T, 2004, JAMA-J AM MED ASSOC, V291, P1730, DOI 10.1001/jama.291.14.1730; Raines E.W., 2000, ANN NY ACAD SCI, V902, P51; Raines EW, 2000, ANN NY ACAD SCI, V902, P39; RANSCHT B, 1991, NEURON, V7, P391, DOI 10.1016/0896-6273(91)90291-7; Salabei JK, 2013, BIOCHEM J, V451, P375, DOI 10.1042/BJ20121344; SCHERER PE, 1995, J BIOL CHEM, V270, P26746, DOI 10.1074/jbc.270.45.26746; Shankman LS, 2015, NAT MED, V21, P628, DOI 10.1038/nm.3866; Spranger J, 2003, LANCET, V361, P226, DOI 10.1016/S0140-6736(03)12255-6; Tang YF, 2010, J BIOL CHEM, V285, P17556, DOI 10.1074/jbc.M109.076414; VESTAL DJ, 1992, J CELL BIOL, V119, P451, DOI 10.1083/jcb.119.2.451; Wang YJ, 2014, CIRC RES, V114, P792, DOI 10.1161/CIRCRESAHA.114.302439; Wu Y, 2010, HUM MOL GENET, V19, P4955, DOI 10.1093/hmg/ddq423; Yamauchi T, 2003, NATURE, V423, P762, DOI 10.1038/nature01705; Yokota T, 2000, BLOOD, V96, P1723, DOI 10.1182/blood.V96.5.1723	57	60	67	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1571	1583		10.1096/fj.201601064R	http://dx.doi.org/10.1096/fj.201601064R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28062540				2022-12-28	WOS:000398504300024
J	Wang, WQ; Zhu, YL; Huang, K; Shan, YL; Du, J; Dong, XY; Ma, P; Wu, PF; Zhang, J; Huang, WH; Zhang, T; Liao, BJ; Yao, DY; Pan, GJ; Liu, JJ				Wang, Wenqian; Zhu, Yanling; Huang, Ke; Shan, Yongli; Du, Juan; Dong, Xiaoya; Ma, Ping; Wu, Penafei; Zhang, Jian; Huang, Wenhao; Zhang, Tian; Liao, Baojian; Yao, Deyang; Pan, Guangjin; Liu, Jiajun			Suppressing P16(Ink4a) and P14(ARF) pathways overcomes apoptosis in individualized human embryonic stem cells	FASEB JOURNAL			English	Article						BMI1; hESCs; mESCs; senescence	CELLULAR SENESCENCE; INK4A-ARF LOCUS; FREE CULTURE; BMI-1; CONTRIBUTES; SURVIVAL; GROWTH; STATES; NAIVE; LINES	Dissociation-induced apoptosis is a striking phenomenon in human embryonic stem cells (hESCs), but not in naive mouse ESCs. Rho-associated kinase-dependent actin-myosin hyperactivation is an underlying mechanism that triggers apoptosis in dissociated hESCs; however, in this study, we show that the Ink4A-ARFmediated senescence pathway is another mechanism to cause apoptosis in individualized hESCs. We show that P16(INK4A) and P14(ARF) are immediately induced in hESCs upon dissociation, but not in mouse ESCs. Overexpression of BMI1, a suppressor for Ink4A-ARF, greatly promotes survival and cloning efficiency of individualized hESCs mechanistically via direct binding the H3K27me3-marked Ink4A-ARF locus. Forced expression of BMI1 in hESCs does not reduce the actin-myosin activation that is triggered by dissociation, which indicates it is an independent pathway for hESC survival. Furthermore, dual inhibition of both Ink4A-ARF and actin-myosin hyperactivation enables successful passaging of hESCs via gelatin, a nonbioactive matrix. In sum, we provide an additional mechanism that underlies cell death in individualized hESCs that might help to fully understand the differential cell characteristics between naive and primed ESCs.-Wang, W., Zhu, Y., Huang, K., Shan, Y., Du, J., Dong, X., Ma, P. , Wu, P., Zhang, J., Huang, W., Zhang, T., Liao, B., Yao, D., Pan, G., Liu, J. Suppressing P16(Ink4a) and P14(ARF) pathways overcomes apoptosis in individualized human embryonic stem cells.	[Wang, Wenqian; Dong, Xiaoya; Ma, Ping; Liu, Jiajun] Sun Yat Sen Univ, Dept Hematol, 600 Tianhe Ave, Guangzhou 510530, Peoples R China; [Zhu, Yanling; Huang, Ke; Shan, Yongli; Du, Juan; Wu, Penafei; Zhang, Jian; Huang, Wenhao; Zhang, Tian; Yao, Deyang; Pan, Guangjin] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Key Lab Regenerat Biol, Guangzhou, Peoples R China; [Zhu, Yanling; Huang, Ke; Shan, Yongli; Du, Juan; Wu, Penafei; Zhang, Jian; Huang, Wenhao; Zhang, Tian; Liao, Baojian; Yao, Deyang; Pan, Guangjin] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Guangdong Prov Key Lab Stem Cell & Regenerat Med, Guangzhou, Peoples R China	Sun Yat Sen University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Liu, JJ (corresponding author), Sun Yat Sen Univ, Dept Hematol, 600 Tianhe Ave, Guangzhou 510530, Peoples R China.; Pan, GJ (corresponding author), Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, 190 Kaiyuan Ave, Guangzhou 510530, Peoples R China.	jiajun.l@163.com	Liao, Baojian/AAI-6286-2021	Zhu, Yanling/0000-0003-4728-5421	National Basic Research Program of China; 973 Program of China [2012CB966503, 2015CB964902, 2015CB964901]; National Natural Science Foundation of China [31371514, 31421004, 31500948]; Natural Science Foundation of Guangdong Province [2014A030312012]; Science and Information Technology of Guangzhou Key [201508020258]; Youth Innovation Promotion Association of the Chinese Academy of Sciences [2015293, 2014327]; Frontier and Key Technology Innovation; Department of Science and Technology of Guangdong Province [2014B020225005, 2014B020225006, 2016B030229008]; International Science and Technology Cooperation Program of China [2014DFA30180]; Chinese Academy of Science; Science and Technology Planning Project of Guangdong Province [2014B030301058]	National Basic Research Program of China(National Basic Research Program of China); 973 Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Science and Information Technology of Guangzhou Key; Youth Innovation Promotion Association of the Chinese Academy of Sciences; Frontier and Key Technology Innovation; Department of Science and Technology of Guangdong Province; International Science and Technology Cooperation Program of China; Chinese Academy of Science(Chinese Academy of Sciences); Science and Technology Planning Project of Guangdong Province	The authors thank the laboratory members at Guangzhou Institutes of Biomedicine and Health for their kind assistance. This work was supported by the National Basic Research Program of China, 973 Program of China (2012CB966503, 2015CB964902, 2015CB964901); the National Natural Science Foundation of China (31371514, 31421004, 31500948); a cooperation grant of the Natural Science Foundation of Guangdong Province (2014A030312012); the Science and Information Technology of Guangzhou Key Project (201508020258); the Youth Innovation Promotion Association of the Chinese Academy of Sciences (2015293, 2014327); the Frontier and Key Technology Innovation special grant from the Department of Science and Technology of Guangdong Province (2014B020225005, 2014B020225006, 2016B030229008); International Science and Technology Cooperation Program of China (2014DFA30180); "Hundred Talents Program" of the Chinese Academy of Science (to G.P.); and the Science and Technology Planning Project of Guangdong Province (2014B030301058). The authors declare no conflicts of interest.	Agger K, 2009, GENE DEV, V23, P1171, DOI 10.1101/gad.510809; Bracken AP, 2007, GENE DEV, V21, P525, DOI 10.1101/gad.415507; Campisi J, 2007, NAT REV MOL CELL BIO, V8, P729, DOI 10.1038/nrm2233; Chen GK, 2010, CELL STEM CELL, V7, P240, DOI 10.1016/j.stem.2010.06.017; Chicas A, 2012, P NATL ACAD SCI USA, V109, P8971, DOI 10.1073/pnas.1119836109; De Los Angeles A, 2012, CURR OPIN GENET DEV, V22, P272, DOI 10.1016/j.gde.2012.03.001; EVANS MJ, 1981, NATURE, V292, P154, DOI 10.1038/292154a0; Greenlee AR, 2005, TOXICOL IN VITRO, V19, P389, DOI 10.1016/j.tiv.2004.11.002; Hanna J, 2010, P NATL ACAD SCI USA, V107, P9222, DOI 10.1073/pnas.1004584107; Kong YP, 2013, SCI REP-UK, V3, DOI 10.1038/srep03474; Lanigan F, 2011, ONCOGENE, V30, P2901, DOI 10.1038/onc.2011.34; Lei T, 2007, CELL RES, V17, P682, DOI 10.1038/cr.2007.61; Lessard J, 2003, NATURE, V423, P255, DOI 10.1038/nature01572; Li XY, 2009, HUM REPROD, V24, P580, DOI 10.1093/humrep/den404; Mallon BS, 2006, INT J BIOCHEM CELL B, V38, P1063, DOI 10.1016/j.biocel.2005.12.014; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Morey L, 2010, TRENDS BIOCHEM SCI, V35, P323, DOI 10.1016/j.tibs.2010.02.009; Narita M, 2003, CELL, V113, P703, DOI 10.1016/S0092-8674(03)00401-X; Nichols J, 2009, CELL STEM CELL, V4, P487, DOI 10.1016/j.stem.2009.05.015; Ohgushi M, 2011, TRENDS CELL BIOL, V21, P274, DOI 10.1016/j.tcb.2011.02.004; Ohgushi M, 2010, CELL STEM CELL, V7, P225, DOI 10.1016/j.stem.2010.06.018; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Tesar PJ, 2007, NATURE, V448, P196, DOI 10.1038/nature05972; Thomson JA, 1998, SCIENCE, V282, P1145, DOI 10.1126/science.282.5391.1145; Xu CH, 2001, NAT BIOTECHNOL, V19, P971, DOI 10.1038/nbt1001-971	26	6	7	0	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1130	1140		10.1096/fj.201600782R	http://dx.doi.org/10.1096/fj.201600782R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27965321				2022-12-28	WOS:000395671200026
J	Lee, JH; Hsieh, CF; Liu, HW; Chen, CY; Wu, SC; Chen, TW; Hsu, CS; Liao, YH; Yang, CY; Shyu, JF; Fischer, WB; Lin, CH				Lee, Jui-Hao; Hsieh, Chia-Fen; Liu, Hong-Wen; Chen, Chin-Yau; Wu, Shao-Chin; Chen, Tung-Wei; Hsu, Chih-Sin; Liao, Yu-Hsiu; Yang, Chih-Yung; Shyu, Jia-Fwu; Fischer, Wolfgang B.; Lin, Chi-Hung			Lipid raft-associated stomatin enhances cell fusion	FASEB JOURNAL			English	Article						exosome; membrane permeability; osteoclastogenesis	INFLUENZA HEMAGGLUTININ; ELECTRON-MICROSCOPY; MEMBRANE-PROTEIN; DC-STAMP; OSTEOCLASTOGENESIS; DOMAIN; STOMATOCYTOSIS; IDENTIFICATION; MICRODOMAINS; CYTOKINESIS	Membrane fusions that occur during vesicle transport, virus infection, and tissue development, involve receptors that mediate membrane contact and initiate fusion and effectors that execute membrane reorganization and fusion pore formation. Some of these fusogenic receptors/effectors are preferentially recruited to lipid raft membrane microdomains. Therefore, major constituents of lipid rafts, such as stomatin, may be involved in the regulation of cell-cell fusion. Stomatin produced in cells can be released to the extracellular environment, either through protein refolding to pass across lipid bilayer or through exosome trafficking. We report that cells expressing more stomatin or exposed to exogenous stomatin are more prone to undergoing cell fusion. During osteoclastogenesis, depletion of stomatin inhibited cell fusion but had little effect on tartrate-resistant acid phosphatase production. Moreover, in stomatin transgenic mice, increased cell fusion leading to enhanced bone resorption and subsequent osteoporosis were observed. With its unique molecular topology, stomatin forms molecular assembly within lipid rafts or on the appositional plasma membranes, and promotes membrane fusion by modulating fusogenic protein engagement.-Lee, J.-H., Hsieh, C.-F., Liu, H.-W., Chen, C.-Y., Wu, S.-C., Chen, T.-W., Hsu, C.-S., Liao, Y.-H., Yang, C.-Y., Shyu, J.-F., Fischer, W. B., Lin, C.-H. Lipid raft-associated stomatin enhances cell fusion.	[Lee, Jui-Hao; Lin, Chi-Hung] Natl Yang Ming Univ, Taiwan Int Grad Program Mol Med, Taipei, Taiwan; [Lee, Jui-Hao; Lin, Chi-Hung] Acad Sinica, Taipei, Taiwan; [Lee, Jui-Hao; Hsieh, Chia-Fen; Liu, Hong-Wen; Chen, Chin-Yau; Hsu, Chih-Sin; Lin, Chi-Hung] Natl Yang Ming Univ, Inst Microbiol & Immunol, 155 Li Nong St,Sec 2, Taipei 112, Taiwan; [Lee, Jui-Hao] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei, Taiwan; [Liu, Hong-Wen] Natl Yang Ming Univ, Chong Hin Loon Mem Canc & Biotherapy Res Ctr, Taipei, Taiwan; [Wu, Shao-Chin; Chen, Tung-Wei; Liao, Yu-Hsiu; Fischer, Wolfgang B.; Lin, Chi-Hung] Natl Yang Ming Univ, Inst Biophoton, Taipei, Taiwan; [Chen, Chin-Yau] Dept Surg, Ilan, Taiwan; [Yang, Chih-Yung] Taipei City Hosp, Dept Educ & Res, Taipei, Taiwan; [Shyu, Jia-Fwu] Natl Def Med Ctr, Dept Biol & Anat, Taipei, Taiwan	National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; National Yang Ming Chiao Tung University; Taipei City Hospital; National Defense Medical Center	Lin, CH (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, 155 Li Nong St,Sec 2, Taipei 112, Taiwan.	linch@ym.edu.tw			Ministry of Education, Aim for the Top University Plan [MOST 104-2319-B-010-001]	Ministry of Education, Aim for the Top University Plan(Ministry of Education, Taiwan)	The authors thank Dr. Li-Li Li (Institute of Microbiology and Immunology, National Yang-Ming University) for her helpful proofreading of the manuscript; Dr. Chien-Yi Tung (Institute of Microbiology and Immunology, National Yang-Ming University) for the statistical analysis; Chia-Wen Wang (Institute of Biophotonics, National Yang-Ming University) for the operation of planar lipid bilayer system; the Molecular and Genetic Imaging Core from the National Research Program for Genomic Medicine (NRPGM); and the Taiwan Mouse Clinic (TMC) from the National Research Program for Biopharmaceutics (NRPB) Resource Center for technical support. This work was supported by the Ministry of Education, Aim for the Top University Plan: MOST 104-2319-B-010-001. The authors declare no conflicts of interest.	BALCH WE, 1984, CELL, V39, P405, DOI 10.1016/0092-8674(84)90019-9; Biswas S, 2008, J GEN PHYSIOL, V131, P503, DOI 10.1085/jgp.200709932; Brand J, 2012, EMBO J, V31, P3635, DOI 10.1038/emboj.2012.203; BULLOUGH PA, 1994, NATURE, V371, P37, DOI 10.1038/371037a0; Chamberlain LH, 2001, P NATL ACAD SCI USA, V98, P5619, DOI 10.1073/pnas.091502398; Chen A, 2008, J CELL SCI, V121, P3619, DOI 10.1242/jcs.032169; de Gassart A, 2003, BLOOD, V102, P4336, DOI 10.1182/blood-2003-03-0871; Desneves J, 1996, BIOCHEM BIOPH RES CO, V224, P108, DOI 10.1006/bbrc.1996.0992; Feuk-Lagerstedt E, 2002, J LEUKOCYTE BIOL, V72, P970; Fricke B, 2003, BLOOD, V102, P2268, DOI 10.1182/blood-2002-06-1705; Fujiwara T, 2005, NATURE, V437, P1043, DOI 10.1038/nature04217; Hanson PI, 1997, CELL, V90, P523, DOI 10.1016/S0092-8674(00)80512-7; Harder T, 1998, J CELL BIOL, V141, P929, DOI 10.1083/jcb.141.4.929; Hess ST, 2005, J CELL BIOL, V169, P965, DOI 10.1083/jcb.200412058; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Ishii M, 2006, J BONE MINER RES, V21, P965, DOI 10.1359/JBMR.060308; Kadurin I, 2009, BIOCHEM J, V418, P587, DOI 10.1042/BJ20081662; Kanazawa K, 2005, J BONE MINER RES, V20, P2053, DOI 10.1359/JBMR.050706; Kukita T, 2004, J EXP MED, V200, P941, DOI 10.1084/jem.20040518; LANDE WM, 1982, J CLIN INVEST, V70, P1273, DOI 10.1172/JCI110726; Li N, 2003, PROTEOMICS, V3, P536, DOI 10.1002/pmic.200390067; Lim HWG, 2002, P NATL ACAD SCI USA, V99, P16766, DOI 10.1073/pnas.202617299; Mairhofer M, 2002, BLOOD, V100, P897, DOI 10.1182/blood.V100.3.897; Mehnert T, 2008, PROTEINS, V70, P1488, DOI 10.1002/prot.21642; Mi S, 2000, NATURE, V403, P785, DOI 10.1038/35001608; Millay DP, 2013, NATURE, V499, P301, DOI 10.1038/nature12343; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; NOVICK P, 1980, CELL, V21, P205, DOI 10.1016/0092-8674(80)90128-2; Podbilewicz B, 2006, DEV CELL, V11, P471, DOI 10.1016/j.devcel.2006.09.004; Rengstl B, 2013, P NATL ACAD SCI USA, V110, P20729, DOI 10.1073/pnas.1312509110; Salzer U, 2001, BLOOD, V97, P1141, DOI 10.1182/blood.V97.4.1141; Salzer U, 2008, TRANSFUSION, V48, P451, DOI 10.1111/j.1537-2995.2007.01549.x; Snyers L, 1999, FEBS LETT, V449, P101, DOI 10.1016/S0014-5793(99)00417-2; Snyers L, 1998, J BIOL CHEM, V273, P17221, DOI 10.1074/jbc.273.27.17221; Takayanagi H, 2002, DEV CELL, V3, P889, DOI 10.1016/S1534-5807(02)00369-6; Takeda M, 2003, P NATL ACAD SCI USA, V100, P14610, DOI 10.1073/pnas.2235620100; Tavano R, 2006, NAT CELL BIOL, V8, P1270, DOI 10.1038/ncb1492; Umlauf E, 2004, J BIOL CHEM, V279, P23699, DOI 10.1074/jbc.M310546200; Umlauf E, 2006, J BIOL CHEM, V281, P23349, DOI 10.1074/jbc.M513720200; Viola A, 1999, SCIENCE, V283, P680, DOI 10.1126/science.283.5402.680; WOODING FBP, 1992, PLACENTA, V13, P101, DOI 10.1016/0143-4004(92)90025-O; Wu CY, 2012, HUM MOL GENET, V21, P3956, DOI 10.1093/hmg/dds210; Yagi M, 2005, J EXP MED, V202, P345, DOI 10.1084/jem.20050645; Yokoyama H, 2008, J MOL BIOL, V376, P868, DOI 10.1016/j.jmb.2007.12.024; Zhu YW, 1999, BLOOD, V93, P2404, DOI 10.1182/blood.V93.7.2404.407k13_2404_2410	45	14	17	3	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					47	59		10.1096/fj.201600643R	http://dx.doi.org/10.1096/fj.201600643R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27663861				2022-12-28	WOS:000392177600008
J	Dinnes, DLM; White, MY; Kockx, M; Traini, M; Hsieh, V; Kim, MJ; Hou, LM; Jessup, W; Rye, KA; Thaysen-Andersen, M; Cordwell, SJ; Kritharides, L				Dinnes, Donna Lee M.; White, Melanie Y.; Kockx, Maaike; Traini, Mathew; Hsieh, Victar; Kim, Mi-Jurng; Hou, Liming; Jessup, Wendy; Rye, Kerry-Anne; Thaysen-Andersen, Morten; Cordwell, Stuart J.; Kritharides, Leonard			Human macrophage cathepsin B-mediated C-terminal cleavage of apolipoprotein A-I at Ser(228) severely impairs antiatherogenic capacity	FASEB JOURNAL			English	Article						atherosclerosis; coronary artery disease; high-density lipoprotein; proteolysis	LECITHIN-CHOLESTEROL ACYLTRANSFERASE; HIGH-DENSITY-LIPOPROTEINS; MAST-CELL CHYMASE; FOAM CELLS; LIPID-FREE; APOA-I; ATHEROSCLEROTIC PLAQUES; PLASMA-MEMBRANE; EFFLUX CAPACITY; HUMAN-SERUM	Apolipoprotein A-I (apoA-I) is the major component of HDL and central to the ability of HDL to stimulate ATP-binding cassette transporter A1 (ABCA1)-dependent, antiatherogenic export of cholesterol from macrophage foam cells, a key player in the pathology of atherosclerosis. Cell-mediated modifications of apoA-I, such as chlorination, nitration, oxidation, and proteolysis, can impair its antiatherogenic function, although it is unknown whether macrophages themselves contribute to such modifications. To investigate this, human monocyte-derived macrophages (HMDMs) were incubated with human apoA-I under conditions used to induce cholesterol export. Two-dimensional gel electrophoresis and Western blot analysis identified that apoA-I is cleaved (similar to 20-80%) by HMDMs in a time-dependent manner, generating apoA-I of lower MW and isoelectric point. Mass spectrometry analysis identified a novel C-terminal cleavage site of apoA-I between Ser(228)-Phe(229). Recombinant apoA-I truncated at Ser(228) demonstrated profound loss of capacity to solubilize lipid and to promote ABCA1-dependent cholesterol efflux. Protease inhibitors, small interfering RNA knockdown in HMDMs, mass spectrometry analysis, and cathepsin B activity assays identified secreted cathepsin B as responsible for apoA-I cleavage at Ser(228). Importantly, C-terminal cleavage of apoA-I was also detected in human carotid plaque. Cleavage at Ser(228) is a novel, functionally important post-translational modification of apoA-Imediated by HMDMs that limits the antiatherogenic properties of apo A-I.	[Dinnes, Donna Lee M.; Kockx, Maaike; Traini, Mathew; Jessup, Wendy; Kritharides, Leonard] Univ Sydney, Atherosclerosis Lab, ANZAC Res Inst, Sydney, NSW, Australia; [White, Melanie Y.; Cordwell, Stuart J.] Univ Sydney, Sch Mol Biosci, Discipline Pathol, Sch Med Sci, Sydney, NSW, Australia; [White, Melanie Y.; Cordwell, Stuart J.] Univ Sydney, Charles Perkins Ctr, Sydney, NSW, Australia; [Hsieh, Victar] St George Hosp, Dept Cardiol, Sydney, NSW, Australia; [Kim, Mi-Jurng] Univ New South Wales, Sch Med Sci, Sydney, NSW, Australia; [Hou, Liming; Rye, Kerry-Anne] Univ New South Wales, Lipid Res Grp, Sch Med Sci, Sydney, NSW, Australia; [Thaysen-Andersen, Morten] Macquarie Univ, Fac Sci & Engn, Dept Chem & Biomol Sci, Sydney, NSW, Australia; [Kritharides, Leonard] Concord Repatriat Gen Hosp, Dept Cardiol, Sydney, NSW, Australia	University of Sydney; ANZAC Research Institute; University of Sydney; University of Sydney; St George Hospital; University of New South Wales Sydney; University of New South Wales Sydney; Macquarie University; Concord Repatriation General Hospital	Kritharides, L (corresponding author), Concord Repatriat Gen Hosp, Dept Cardiol, Concord, NSW 2137, Australia.	leonard.kritharides@sydney.edu.au	Research Institute, ANZAC/CAE-9030-2022; Kritharides, Leonard/AAQ-2720-2020; Ekanayake, Kanchana/P-8817-2016	White, Melanie/0000-0003-2571-2816; Cordwell, Stuart/0000-0002-0995-0171; Hsieh, Victar/0000-0003-0085-5933; Hou, Liming/0000-0002-4551-5636; Thaysen-Andersen, Morten/0000-0001-8327-6843; Traini, Mathew/0000-0002-9423-5294	National Health and Medical Research Council of Australia [1037903]; Natural Sciences and Engineering Research Council of Canada [PDF-358145-2008]; Australian Research Council [DE120102556]; Cancer Institute NSW	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Australian Research Council(Australian Research Council); Cancer Institute NSW	This work was supported by National Health and Medical Research Council of Australia Program Grant 1037903 (to L.K., W.J., K.-A.R.), Natural Sciences and Engineering Research Council of Canada Postdoctoral Fellowship PDF-358145-2008 (to D.L.D.), and Australian Research Council Discovery Early Career Researcher Award DE120102556 (to M.Y.W.). M.T.-A. was supported by a fellowship from the Cancer Institute NSW. The authors thank D. Nawara (Atherosclerosis Research Group) for assisting with monocyte isolations. K. Shearston (Lipid Research Group) provided apoA-IV. M. Patel (Lipid Research Group) prepared lipid-free apoA-I. MS analyses were facilitated by access to the University of SydneyMass Spectrometry Core Facility. The authors acknowledge B. Brown and C. Hawkins (Heart Research Institute) for guidance with establishing CTSB activity assays. The authors declare no conflicts of interest.	Albrecht C, 2004, STROKE, V35, P2801, DOI 10.1161/01.STR.0000147036.07307.93; Bhatt A, 2016, CURR ATHEROSCLER REP, V18, DOI 10.1007/s11883-015-0554-1; Bielicki JK, 1999, J LIPID RES, V40, P85; CHAPMAN MJ, 1981, J LIPID RES, V22, P339; Cordwell SJ, 2002, METHOD ENZYMOL, V358, P207; DEAN RT, 1979, EXP CELL BIOL, V47, P454; Du XM, 2015, CIRC RES, V116, P1133, DOI 10.1161/CIRCRESAHA.116.305485; Eberini I, 2002, BIOCHEM J, V362, P627, DOI 10.1042/0264-6021:3620627; EBISUI C, 1994, BIOCHEM MOL BIOL INT, V32, P515; Favari E, 2009, BIOCHEMISTRY-US, V48, P11067, DOI 10.1021/bi901564g; FIELDING CJ, 1972, BIOCHEM BIOPH RES CO, V46, P1493, DOI 10.1016/0006-291X(72)90776-0; Gelissen IC, 1999, J LIPID RES, V40, P1636; Gursky O, 1996, P NATL ACAD SCI USA, V93, P2991, DOI 10.1073/pnas.93.7.2991; Headlam HA, 2006, FREE RADICAL BIO MED, V40, P1539, DOI 10.1016/j.freeradbiomed.2005.12.036; Hsieh V, 2014, J BIOL CHEM, V289, P7524, DOI 10.1074/jbc.M113.515890; Huang R, 2011, NAT STRUCT MOL BIOL, V18, P416, DOI 10.1038/nsmb.2028; Huang WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042507; Hwang IK, 2004, BBA-PROTEINS PROTEOM, V1702, P79, DOI 10.1016/j.bbapap.2004.08.001; Jaguin M, 2013, CELL IMMUNOL, V281, P51, DOI 10.1016/j.cellimm.2013.01.010; Jane DT, 2006, BIOL CHEM, V387, P223, DOI 10.1515/BC.2006.030; JONAS A, 1989, J BIOL CHEM, V264, P4818; Jormsjo S, 2002, AM J PATHOL, V161, P939, DOI 10.1016/S0002-9440(10)64254-X; Kim DE, 2010, ARTERIOSCL THROM VAS, V30, P449, DOI 10.1161/ATVBAHA.109.194613; Kockx M, 2004, J BIOL CHEM, V279, P25966, DOI 10.1074/jbc.M401177200; Kockx M, 2007, CIRC RES, V101, P607, DOI 10.1161/CIRCRESAHA.107.157198; Kritharides L, 1998, ARTERIOSCL THROM VAS, V18, P1589, DOI 10.1161/01.ATV.18.10.1589; KRITHARIDES L, 1995, ARTERIOSCL THROM VAS, V15, P276, DOI 10.1161/01.ATV.15.2.276; Lee M, 2000, J LIPID RES, V41, P975; Lee Y, 2010, MOL CELL PROTEOMICS, V9, P1968, DOI 10.1074/mcp.M900430-MCP200; Lee-Rueckert M, 2011, CURR OPIN LIPIDOL, V22, P394, DOI 10.1097/MOL.0b013e32834a3d24; LIANG HQ, 1994, J LIPID RES, V35, P1187; Lindstedt L, 2003, BIOCHEM BIOPH RES CO, V312, P1019, DOI 10.1016/j.bbrc.2003.11.020; Lindstedt L, 1999, J BIOL CHEM, V274, P22627, DOI 10.1074/jbc.274.32.22627; Liu HT, 2008, IMMUNOL LETT, V117, P70, DOI 10.1016/j.imlet.2007.12.012; Martinez FO, 2006, J IMMUNOL, V177, P7303, DOI 10.4049/jimmunol.177.10.7303; MATZ CE, 1982, J BIOL CHEM, V257, P4535; Moore KJ, 2013, NAT REV IMMUNOL, V13, P709, DOI 10.1038/nri3520; Murray P.J., 2014, FRONT IMMUNOL, V41, P14, DOI DOI 10.1016/J.IMMUNI.2014.06.008; Naghavi M, 2002, ATHEROSCLEROSIS, V164, P27, DOI 10.1016/S0021-9150(02)00018-7; Nissen SE, 2003, JAMA-J AM MED ASSOC, V290, P2292, DOI 10.1001/jama.290.17.2292; Palgunachari MN, 1996, ARTERIOSCL THROM VAS, V16, P328, DOI 10.1161/01.ATV.16.2.328; Panagotopulos SE, 2002, J BIOL CHEM, V277, P39477, DOI 10.1074/jbc.M207005200; Roberts LM, 1997, BIOCHEMISTRY-US, V36, P7615, DOI 10.1021/bi962952g; Rogers DP, 1998, BIOCHEMISTRY-US, V37, P11714, DOI 10.1021/bi973112k; Rohatgi A, 2015, PROG CARDIOVASC DIS, V58, P32, DOI 10.1016/j.pcad.2015.05.004; Roshy S, 2003, CANCER METAST REV, V22, P271, DOI 10.1023/A:1023007717757; Rothblat GH, 1999, J LIPID RES, V40, P781; RYE KA, 1990, BIOCHIM BIOPHYS ACTA, V1042, P227, DOI 10.1016/0005-2760(90)90013-N; Rye KA, 2004, ARTERIOSCL THROM VAS, V24, P421, DOI 10.1161/01.ATV.0000104029.74961.f5; SILVER IA, 1988, EXP CELL RES, V175, P266, DOI 10.1016/0014-4827(88)90191-7; SORCITHOMAS M, 1993, J BIOL CHEM, V268, P21403; STEINMETZ A, 1989, J CHROMATOGR-BIOMED, V487, P154, DOI 10.1016/S0378-4347(00)83018-2; Nguyen SD, 2016, ARTERIOSCL THROM VAS, V36, P274, DOI 10.1161/ATVBAHA.115.306827; Tangirala RK, 1999, CIRCULATION, V100, P1816, DOI 10.1161/01.CIR.100.17.1816; Tubb MR, 2007, J BIOL CHEM, V282, P28385, DOI 10.1074/jbc.M704070200; Usami Y, 2011, J IMMUNOL METHODS, V369, P51, DOI 10.1016/j.jim.2011.04.002; Wang N, 2003, J CLIN INVEST, V111, P99, DOI 10.1172/JCI200316808; Weinberg RB, 1996, METHOD ENZYMOL, V263, P282	58	15	15	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4239	4255		10.1096/fj.201600508R	http://dx.doi.org/10.1096/fj.201600508R			17	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27630170				2022-12-28	WOS:000388201500029
J	Hou, S; Hang, Q; Isaji, T; Lu, J; Fukuda, T; Gu, J				Hou, Sicong; Hang, Qinglei; Isaji, Tomoya; Lu, Jishun; Fukuda, Tomohiko; Gu, Jianguo			Importance of membrane-proximal N-glycosylation on integrin beta 1 in its activation and complex formation	FASEB JOURNAL			English	Article						cell migration; cell signaling; sialylation	GROWTH-FACTOR RECEPTOR; I-LIKE DOMAIN; CELL-MIGRATION; ALPHA-5-BETA-1 INTEGRIN; CANCER-CELLS; BIOLOGICAL FUNCTION; PROPELLER DOMAIN; BISECTING GLCNAC; EXPRESSION; ADHESION	N-Glycosylation of integrin alpha 5 beta 1 plays important roles in cell biologic functions; however, the mechanisms that underlie those roles remain poorly understood. Here, we present evidence that the membrane-proximal N-glycosylation on integrin beta 1 could positively regulate cell migration by promoting beta 1 activation. The S4-6 beta 1 mutant contains only 3 N-glycosylation sites, which are essential for alpha 5 and beta 1 heterodimer formation, and despite only a small difference in expression levels of alpha 5 beta 1 between wild-type and S4-6 mutant, cell spreading and migration of the S4-6 mutant was significantly decreased compared with that of control. Consistent with these phenotypes, beta 1-mediated cellular signaling and its activation were clearly suppressed in the S4-6 mutant. Of note, these developments could be rescued by restoration of N-glycosylation sites in the membrane-proximal domain. Further study on the regulatory mechanisms suggested that membrane-proximal N-glycosylation is critical for intermolecular interactions between integrin beta 1 and other cell membrane proteins, such as syndecan-4 and epidermal growth factor receptor. Moreover, alpha 2,6-sialylation is required for beta 1 activation. These data suggest a novel regulatory mechanism where in N-glycosylation near the cell membraneon beta 1 may serve as a platform that facilitates its complex formation on the cell membrane, thereby affecting integrin-mediated functions.	[Hou, Sicong; Hang, Qinglei; Isaji, Tomoya; Lu, Jishun; Fukuda, Tomohiko; Gu, Jianguo] Tohoku Med & Pharmaceut Univ, Inst Mol Biomembrane & Glycobiol, Div Regulatory Glycobiol, Sendai, Miyagi, Japan	Tohoku Medical & Pharmaceutical University	Gu, J (corresponding author), Tohoku Med & Pharmaceut Univ, Aoba Ku, 4-4-1 Komatsushima, Sendai, Miyagi, Japan.	jgu@tohoku-mpu.ac.jp	Gu, Jianguo/ABC-9257-2020; Isaji, Tomoya/ABC-9285-2021; Hang, Qinglei/GOP-0218-2022	Hang, Qinglei/0000-0003-0419-6621	Japan Society for the Promotion of Science [15K14408, 15H04354]; Ministry of Education, Culture, Sports, Science, and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a Grant-in-Aid for Scientific Research (15H04354; to J.G.), a grant for Challenging Exploratory Research (15K14408; to J.G.) from the Japan Society for the Promotion of Science, and by a Strategic Research Foundation Grant-aided Project for Private Universities from the Ministry of Education, Culture, Sports, Science, and Technology of Japan.	Asada M, 1997, CANCER RES, V57, P1073; Assoian RK, 2001, CURR OPIN GENET DEV, V11, P48, DOI 10.1016/S0959-437X(00)00155-6; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Bendas Gerd, 2012, Int J Cell Biol, V2012, P676731, DOI 10.1155/2012/676731; Bull C, 2014, CANCER RES, V74, P3199, DOI 10.1158/0008-5472.CAN-14-0728; Byron A, 2016, CURR OPIN CELL BIOL, V39, P93, DOI 10.1016/j.ceb.2016.02.013; Calderwood DA, 2013, NAT REV MOL CELL BIO, V14, P503, DOI 10.1038/nrm3624; Campbell ID, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004994; Christie DR, 2008, J OVARIAN RES, V1, DOI 10.1186/1757-2215-1-3; Danen EHJ, 2002, J CELL BIOL, V159, P1071, DOI 10.1083/jcb.200205014; Danguy A, 2002, BBA-GEN SUBJECTS, V1572, P285, DOI 10.1016/S0304-4165(02)00315-X; Fiore VF, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5886; Frisch SM, 1996, J CELL BIOL, V134, P793, DOI 10.1083/jcb.134.3.793; Gu JG, 2009, BIOL PHARM BULL, V32, P780, DOI 10.1248/bpb.32.780; Guo HB, 2002, CANCER RES, V62, P6837; Guo WJ, 2004, NAT REV MOL CELL BIO, V5, P816, DOI 10.1038/nrm1490; Hang QL, 2015, J BIOL CHEM, V290, P29345, DOI 10.1074/jbc.M115.682229; Hou S, 2016, SCI REP-UK, V6, DOI 10.1038/srep18430; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Isaji T, 2004, J BIOL CHEM, V279, P19747, DOI 10.1074/jbc.M311627200; Isaji T, 2006, J BIOL CHEM, V281, P33258, DOI 10.1074/jbc.M607771200; Isaji T, 2014, J BIOL CHEM, V289, P20694, DOI 10.1074/jbc.M113.542688; Isaji T, 2009, J BIOL CHEM, V284, P12207, DOI 10.1074/jbc.M807920200; Josefsson EC, 2005, J BIOL CHEM, V280, P18025, DOI 10.1074/jbc.M501178200; Kariya Y, 2010, J BIOL CHEM, V285, P3330, DOI 10.1074/jbc.M109.038836; Kim C, 2011, ANNU REV CELL DEV BI, V27, P321, DOI 10.1146/annurev-cellbio-100109-104104; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Lu JS, 2016, J BIOL CHEM, V291, P5708, DOI 10.1074/jbc.M115.712836; Luo BH, 2003, P NATL ACAD SCI USA, V100, P2403, DOI 10.1073/pnas.0438060100; Margadant C, 2012, CURR BIOL, V22, P1554, DOI 10.1016/j.cub.2012.06.060; Margadant C, 2011, CURR OPIN CELL BIOL, V23, P607, DOI 10.1016/j.ceb.2011.08.005; Mitra SK, 2006, CURR OPIN CELL BIOL, V18, P516, DOI 10.1016/j.ceb.2006.08.011; Morini M, 2000, INT J CANCER, V87, P336, DOI 10.1002/1097-0215(20000801)87:3<336::AID-IJC5>3.0.CO;2-3; Nagae M, 2012, J CELL BIOL, V197, P131, DOI 10.1083/jcb.201111077; Pan D, 2010, BIOPHYS J, V99, P208, DOI 10.1016/j.bpj.2010.03.063; Paszek MJ, 2014, NATURE, V511, P319, DOI 10.1038/nature13535; Petrich BG, 2007, J CLIN INVEST, V117, P2250, DOI 10.1172/JCI31024; Pillozzi S, 2007, BLOOD, V110, P1238, DOI 10.1182/blood-2006-02-003772; Pochec E, 2013, EUR J CELL BIOL, V92, P355, DOI 10.1016/j.ejcb.2013.10.007; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Saito Y, 2007, J BIOL CHEM, V282, P34929, DOI 10.1074/jbc.M705608200; Sato Y, 2009, J BIOL CHEM, V284, P11873, DOI 10.1074/jbc.M807660200; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Seales EC, 2005, CANCER RES, V65, P4645, DOI 10.1158/0008-5472.CAN-04-3117; Shattil SJ, 2010, NAT REV MOL CELL BIO, V11, P288, DOI 10.1038/nrm2871; Streuli CH, 2009, BIOCHEM J, V418, P491, DOI 10.1042/BJ20081948; Takagi J, 2002, IMMUNOL REV, V186, P141, DOI 10.1034/j.1600-065X.2002.18613.x; Vial D, 2012, J BIOL CHEM, V287, P40371, DOI 10.1074/jbc.M112.389577; Wang HY, 2014, J BIOL CHEM, V289, P30318, DOI 10.1074/jbc.M114.586438; Yoon SJ, 2006, P NATL ACAD SCI USA, V103, P18987, DOI 10.1073/pnas.0609281103; Zhuo Y, 2008, J BIOL CHEM, V283, P22177, DOI 10.1074/jbc.M8000015200	51	28	28	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4120	4131		10.1096/fj.201600665R	http://dx.doi.org/10.1096/fj.201600665R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27565712				2022-12-28	WOS:000388201500018
J	Mediero, A; Wilder, T; Ramkhelawon, B; Moore, KJ; Cronstein, BN				Mediero, Aranzazu; Wilder, Tuere; Ramkhelawon, Bhama; Moore, Kathryn J.; Cronstein, Bruce N.			Netrin-1 and its receptor Unc5b are novel targets for the treatment of inflammatory arthritis	FASEB JOURNAL			English	Article						K; BxN; rheumatoid arthritis; inflammation	INHIBITS LEUKOCYTE MIGRATION; ISCHEMIA-REPERFUSION INJURY; RHEUMATOID-ARTHRITIS; MACROPHAGE RETENTION; CYTOKINE PRODUCTION; KIDNEY; DISEASE; ATHEROSCLEROSIS; EXPRESSION; PROTECTS	Rheumatoid arthritis is an autoimmune disease that is characterized by chronic inflammation and destruction of joints. Netrin-1, a chemorepulsant, laminin-like matrix protein, promotes inflammation by preventing macrophage egress from inflamed sites and is required for osteoclast differentiation. We asked whether blockade of Netrin-1 or its receptors [Unc5b and DCC (deleted in colorectal carcinoma)] may be useful therapeutic targets for treatment of inflammatory arthritis. Arthritis was induced in 8-wk-old C57Bl/6 mice by intraperitoneal injection of K/BxN serum. Murine monoclonal antibodies against Netrin-1, Unc5b, or DCC (10 mu g/mouse) were injected weekly for 4 wk (n = 10). Paw swelling and thickness were assessed and following euthanasia 2-4 wk after serum transfer, paws were prepared for micro-computed tomography and histology. Paw inflammation was maximal 2 wk after injection. Anti-Netrin-1 or anti-Unc5b, but not anti-DCC, antibodies significantly reduced paw inflammation (clinical score: 9.8 +/- 0.8, 10.4 +/- 0.9, and 13.5 +/- 0.5, respectively vs. 16 +/- 0 for control; P < 0.001). Micro-computed tomography showed bony erosions in untreated or anti-DCC-treated mice, whereas there were no erosions in anti-Netrin-1/anti-Unc5b-treated-animals. Tartrate-resistant acid phosphatase staining demonstrated a marked decrease in osteoclasts in anti-Netrin-1/anti-Unc5b-treated animals. Immunofluorescence staining revealed a decrease in cathepsin K+ and CD68(+) cells in anti-Netrin-1/anti-Unc5b-treated animals. Blockade of Netrin-1/Unc5b by monoclonal antibodies prevents bone destruction and reduces the severity of K/BxN serum transfer-induced arthritis. Netrin-1 may be a novel therapeutic target for treatment of inflammatory bone destruction.Mediero, A., Wilder, T., Ramkhelawon, B., Moore, K. J., Cronstein, B. N. Netrin-1 and its receptor Unc5b are novel targets for the treatment of inflammatory arthritis.	[Mediero, Aranzazu] Univ Autonoma Madrid, Inst Invest Sanitaria, Bone & Joint Res Unit, Fdn Jimenez Diaz, Madrid, Spain; [Mediero, Aranzazu; Wilder, Tuere; Cronstein, Bruce N.] NYU, Sch Med, Dept Med, Div Translat Med, 550 First Ave,MSB251, New York, NY 10016 USA; [Ramkhelawon, Bhama; Moore, Kathryn J.] NYU, Sch Med, Leon H Charney Div Cardiol, New York, NY USA	Autonomous University of Madrid; Fundacion Jimenez Diaz; New York University; New York University	Cronstein, BN (corresponding author), NYU, Sch Med, Dept Med, Div Translat Med, 550 First Ave,MSB251, New York, NY 10016 USA.	bruce.cronstein@nyumc.org	Moore, Kathryn/ABE-6416-2020; Mediero, Aranzazu/AAA-8362-2020	Moore, Kathryn/0000-0003-2505-2547; Pintor, Jesus/0000-0002-9191-7679; Cronstein, Bruce/0000-0002-4295-7383; Mediero, Aranzazu/0000-0002-5368-574X	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR56672, AR54897, AR046121]; NIH National Heart, Lung, and Blood Institute [RC1HL100815, K99 HL125667]; New York University (NYU) Health and Hospitals Corporation Clinical and Translational Science Institute [UL1TR000038]; NYU Caregiver Intervention Center (Support Grant 9NIH/National Cancer Institute (NCI)) [5 P30CA16087-310]; Celgene and Gilead Pharmaceuticals; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000038, UL1TR001445] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K99HL125667, RC1HL100815] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR054897, R01AR068593, P30AR046121, R01AR056672, R56AR056672] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIH National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); New York University (NYU) Health and Hospitals Corporation Clinical and Translational Science Institute; NYU Caregiver Intervention Center (Support Grant 9NIH/National Cancer Institute (NCI)); Celgene and Gilead Pharmaceuticals(Bristol-Myers SquibbCelgene Corporation); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the U.S. National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases (Grants AR56672, AR54897, and AR046121) and NIH National Heart, Lung, and Blood Institute (Grants RC1HL100815 and K99 HL125667); New York University (NYU) Health and Hospitals Corporation Clinical and Translational Science Institute (Grant UL1TR000038); NYU Caregiver Intervention Center (Support Grant 9NIH/National Cancer Institute (NCI) 5 P30CA16087-310); and grants from Celgene and Gilead Pharmaceuticals. A.M. and B.N.C. have filed a patent on the use of adenosine A<INF>2A</INF>R agonists to prevent prosthesis loosening (pending). A.M., B.N.C., B.R., and K.J.M. have filed a patent on the use of antibodies against Netrin-1 for the treatment of bone diseases. T.W.declares no conflicts of interest.. B.N.C. holds patent numbers 5,932,558; 6,020,321; 6,555,545; 7,795,427; adenosine A<INF>1</INF>R and A<INF>2B</INF>R antagonists to treat fatty liver (pending); and adenosine A<INF>2A</INF>R agonists to prevent prosthesis loosening (pending). B.N.C. is a consultant for Bristol-Myers Squibb, AstraZeneca, Novartis, CanFite Biopharmaceuticals, Cypress Laboratories, Regeneron (Westat, Data and Safety Monitoring Board), Endocyte, Protalex, Allos, Savient, Gismo Therapeutics, Antares Pharmaceutical, Medivector, King Pharmaceutical, Celizome, Tap Pharmaceuticals, Prometheus Laboratories, Sepracor, Amgen, Combinatorx, Kyowa Hakka, Hoffman-LaRoche, and Avidimer Therapeutics. B.N.C. has stock in CanFite Biopharmaceuticals.	Aherne CM, 2013, TISSUE BARRIERS, V1, DOI 10.4161/tisb.24957; Aherne CM, 2012, GUT, V61, P695, DOI 10.1136/gutjnl-2011-300012; Bresnihan B, 1999, J RHEUMATOL, V26, P717; Chen J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046201; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Grenz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014812; Han Y, 2012, INVEST OPHTH VIS SCI, V53, P1285, DOI 10.1167/iovs.11-8722; Hu Y, 2015, ARTHRITIS RHEUMATOL, V67, P1778, DOI 10.1002/art.39116; Korganow AS, 1999, IMMUNITY, V10, P451, DOI 10.1016/S1074-7613(00)80045-X; Kouskoff V, 1996, CELL, V87, P811, DOI 10.1016/S0092-8674(00)81989-3; Ly NP, 2005, P NATL ACAD SCI USA, V102, P14729, DOI 10.1073/pnas.0506233102; Mediero A, 2016, ANN RHEUM DIS, V75, P1706, DOI 10.1136/annrheumdis-2015-207593; Mediero A, 2015, J BONE MINER RES, V30, P837, DOI 10.1002/jbmr.2421; Mediero A, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003393; Mirakaj V, 2014, J EXP MED, V211, P1037, DOI 10.1084/jem.20132103; Mirakaj V, 2011, P NATL ACAD SCI USA, V108, P6555, DOI 10.1073/pnas.1015605108; Mirakaj V, 2011, J IMMUNOL, V186, P549, DOI 10.4049/jimmunol.1002671; Mirakaj V, 2010, AM J RESP CRIT CARE, V181, P815, DOI 10.1164/rccm.200905-0717OC; Monach Paul, 2007, V136, P269; Moore KJ, 2012, FUTUR CARDIOL, V8, P349, DOI [10.2217/FCA.12.30, 10.2217/fca.12.30]; Podjaski C, 2015, BRAIN, V138, P1598, DOI 10.1093/brain/awv092; Ramkhelawon B, 2014, NAT MED, V20, P377, DOI 10.1038/nm.3467; Ramkhelawon B, 2013, ARTERIOSCL THROM VAS, V33, P1180, DOI 10.1161/ATVBAHA.112.301008; Ranganathan P, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/525891; Ranganathan PV, 2013, KIDNEY INT, V83, P1087, DOI 10.1038/ki.2012.423; Ranganathan PV, 2013, AM J PHYSIOL-RENAL, V304, pF948, DOI 10.1152/ajprenal.00580.2012; Rao Y, 2002, GENE DEV, V16, P2973, DOI 10.1101/gad.1005802; Rosenberger P, 2009, NAT IMMUNOL, V10, P195, DOI 10.1038/ni.1683; Schett G, 2012, NAT REV RHEUMATOL, V8, P656, DOI 10.1038/nrrheum.2012.153; Schlegel M, 2016, HEPATOLOGY, V63, P1689, DOI 10.1002/hep.28347; Schubert T, 2009, INT J IMMUNOPATH PH, V22, P715, DOI 10.1177/039463200902200317; Tadagavadi RK, 2010, J IMMUNOL, V185, P3750, DOI 10.4049/jimmunol.1000435; Takagawa S, 2013, BMC MUSCULOSKEL DIS, V14, DOI 10.1186/1471-2474-14-40; van Gils JM, 2013, ARTERIOSCL THROM VAS, V33, P911, DOI 10.1161/ATVBAHA.112.301155; van Gils JM, 2012, NAT IMMUNOL, V13, P136, DOI 10.1038/ni.2205; Wang WW, 2008, AM J PHYSIOL-RENAL, V294, pF739, DOI 10.1152/ajprenal.00508.2007; Yoshida Y, 2015, ARTHRITIS RHEUMATOL, V67, P1481, DOI 10.1002/art.39086	37	22	26	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3835	3844		10.1096/fj.201600615R	http://dx.doi.org/10.1096/fj.201600615R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27502509	Green Published			2022-12-28	WOS:000386474700017
J	Daly, MC; Atkinson, SJ; Varisco, BM; Klingbeil, L; Hake, P; Lahni, P; Piraino, G; Wu, D; Hogan, SP; Zingarelli, B; Wong, HR				Daly, Meghan C.; Atkinson, Sarah J.; Varisco, Brian M.; Klingbeil, Lindsey; Hake, Paul; Lahni, Patrick; Piraino, Giovanna; Wu, David; Hogan, Simon P.; Zingarelli, Basilia; Wong, Hector R.			Role of matrix metalloproteinase-8 as a mediator of injury in intestinal ischemia and reperfusion	FASEB JOURNAL			English	Article						barrier function; tight junction; collagenase; epithelium; protease	ISCHEMIA/REPERFUSION INJURY; DRUG TARGETS; INFLAMMATION; DISEASE; MICE; INHIBITION; SEPSIS	Acute mesenteric ischemia is associated with high morbidity and mortality. In recent studies, we found that the intestine is an important source of matrix metalloproteinase (MMP)8 during intestinal injury. We hypothesized that genetic ablation or pharmacological inhibition of MMP8 would reduce intestinal injury in mice subjected to intestinal ischemia-reperfusion (I/R) injury. Male mice aged 8-12 wk were subjected to intestinal I/R injury by transient occlusion of the superior mesenteric artery for 30 min. MMP8 was inhibited by genetic and pharmacological approaches. In vivo study endpoints included several functional, histological, and biochemical assays. Intestinal sections were assessed for barrier function and expression of tight junction proteins. I/R injury led to increased intestinal and systemic expression of MMP8. This increase was associated with increased intestinal neutrophil infiltration, epithelial injury, and permeability. I/R injury was associated with increased systemic inflammation and weight loss. These parameters were ameliorated by inhibiting MMP8. I/R injury caused a loss of the tight junction protein claudin-3, which was ameliorated by genetic ablation of MMP8. MMP8 plays an important role in intestinal I/R injury through mechanisms involving increased inflammation and loss of claudin-3. Inhibition of MMP8 is a potential therapeutic strategy in this setting.	[Daly, Meghan C.; Atkinson, Sarah J.; Varisco, Brian M.; Klingbeil, Lindsey; Hake, Paul; Lahni, Patrick; Piraino, Giovanna; Zingarelli, Basilia; Wong, Hector R.] Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, MLC 2005,3333 Burnet Ave, Cincinnati, OH 45229 USA; [Wu, David; Hogan, Simon P.] Cincinnati Childrens Hosp Med Ctr, Dept Pediat, Div Allergy & Immunol, Cincinnati, OH 45229 USA; [Daly, Meghan C.] Cincinnati Childrens Res Fdn, Cincinnati, OH USA; [Daly, Meghan C.; Atkinson, Sarah J.; Klingbeil, Lindsey] Univ Cincinnati, Coll Med, Dept Surg, Cincinnati, OH USA; [Varisco, Brian M.; Zingarelli, Basilia; Wong, Hector R.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University of Cincinnati; Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Research Foundation; University of Cincinnati; University of Cincinnati	Wong, HR (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Crit Care Med, MLC 2005,3333 Burnet Ave, Cincinnati, OH 45229 USA.	hector.wong@cchmc.org	, Basilia/AAV-7582-2021	Wong, Hector/0000-0001-7989-1173; Varisco, Brian/0000-0003-0180-2577	U.S. National Institutes of Health National Institute of General Medicine [T32GM008478, R01GM096994]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK078392] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008478, R01GM096994] Funding Source: NIH RePORTER	U.S. National Institutes of Health National Institute of General Medicine; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The study was supported by U.S. National Institutes of Health National Institute of General Medicine Grants T32GM008478 and R01GM096994. The authors declare no conflicts of interest.	Ackland G, 2000, CRIT CARE, V4, P269, DOI 10.1186/cc709; Atkinson SJ, 2014, SHOCK, V41, P67; Atkinson SJ, 2016, CRIT CARE MED, V44, pe200, DOI 10.1097/CCM.0000000000001374; Balbin M, 2003, NAT GENET, V35, P252, DOI 10.1038/ng1249; Barnes PJ, 2004, LANCET, V364, P985, DOI 10.1016/S0140-6736(04)17025-6; Dejonckheere E, 2011, DRUG DISCOV TODAY, V16, P762, DOI 10.1016/j.drudis.2011.06.009; Feinman R, 2010, AM J PHYSIOL-GASTR L, V299, pG833, DOI 10.1152/ajpgi.00065.2010; Fingleton B, 2008, SEMIN CELL DEV BIOL, V19, P61, DOI 10.1016/j.semcdb.2007.06.006; Gobbetti T, 2012, AM J PATHOL, V180, P141, DOI 10.1016/j.ajpath.2011.09.031; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Koelink PJ, 2014, GUT, V63, P578, DOI 10.1136/gutjnl-2012-303252; Manicone AM, 2008, SEMIN CELL DEV BIOL, V19, P34, DOI 10.1016/j.semcdb.2007.07.003; Medina C, 2006, J PHARMACOL EXP THER, V318, P933, DOI 10.1124/jpet.106.103465; Owen CA, 2004, J IMMUNOL, V172, P7791, DOI 10.4049/jimmunol.172.12.7791; PATEL A, 1992, SURG CLIN N AM, V72, P31; Quintero PA, 2010, J IMMUNOL, V184, P1575, DOI 10.4049/jimmunol.0900290; Rosario HS, 2004, AM J PATHOL, V164, P1707, DOI 10.1016/S0002-9440(10)63729-7; Solan PD, 2012, CRIT CARE MED, V40, P379, DOI 10.1097/CCM.0b013e318232e404; Sternlicht MD, 2001, ANNU REV CELL DEV BI, V17, P463, DOI 10.1146/annurev.cellbio.17.1.463; Tester AM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000312; Van Lint P, 2005, J IMMUNOL, V175, P7642, DOI 10.4049/jimmunol.175.11.7642; Van Lint P, 2007, J LEUKOCYTE BIOL, V82, P1375, DOI 10.1189/jlb.0607338; Vandenbroucke RE, 2014, NAT REV DRUG DISCOV, V13, P904, DOI 10.1038/nrd4390; Yabluchanskiy A, 2013, CURR DRUG TARGETS, V14, P276	25	11	13	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3453	3460		10.1096/fj.201600242R	http://dx.doi.org/10.1096/fj.201600242R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27435263	Green Published			2022-12-28	WOS:000384329800016
J	Maddipati, KR; Romero, R; Chaiworapongsa, T; Chaemsaithong, P; Zhou, SL; Xu, ZH; Tarca, AL; Kusanovic, JP; Gomez, R; Chaiyasit, N; Honn, KV				Maddipati, Krishna Rao; Romero, Roberto; Chaiworapongsa, Tinnakorn; Chaemsaithong, Piya; Zhou, Sen-Lin; Xu, Zhonghui; Tarca, Adi L.; Kusanovic, Juan Pedro; Gomez, Ricardo; Chaiyasit, Noppadol; Honn, Kenneth V.			Lipidomic analysis of patients with microbial invasion of the amniotic cavity reveals up-regulation of leukotriene B-4	FASEB JOURNAL			English	Article						infection; inflammation; clinical chorioamnionitis; amniotic fluid; 5-lipoxygenase	TUMOR-NECROSIS-FACTOR; PRETERM LABOR; CLINICAL CHORIOAMNIONITIS; INTRAAMNIOTIC INFLAMMATION; CONCENTRATIONS INCREASE; FLUID CONCENTRATIONS; HUMAN-NEUTROPHILS; TERM; PROSTAGLANDINS; INFECTION	Bioactive lipids derived from the metabolism of polyunsaturated fatty acids are important mediators of the inflammatory response. Labor per se is considered a sterile inflammatory process. Intra-amniotic inflammation (IAI) due to microorganisms (i.e., intra-amniotic infection) or danger signals (i.e., sterile IAI) has been implicated in the pathogenesis of preterm labor and clinical chorioamnionitis at term. Early and accurate diagnosis of microbial invasion of the amniotic cavity (MIAC) requires analysis of amniotic fluid (AF). It is possible that IAI caused by microorganisms is associated with a stereotypic lipidomic profile, and that analysis of AF may help in the identification of patients with this condition. To test this hypothesis, we analyzed the fatty acyl lipidome of AF by liquid chromatography-mass spectrometry from patients in spontaneous labor at term and preterm gestations. We report that the AF concentrations of proinflammatory lipid mediators of the 5-lipoxygenase pathway are significantly higher in MIAC than in cases of sterile IAI. These results suggest that the concentrations of 5-lipoxygenase metabolites of arachidonic acid, 5-hydroxyeicosatetraenoic acid, and leukotriene B-4 in particular could serve as potential biomarkers of MIAC. This finding could have important implications for the rapid identification of patients who may benefit from anti-microbial treatment.-Maddipati, K. R., Romero, R., Chaiworapongsa ,T., Chaemsaithong, P., Zhou, S.-L., Xu, Z., Tarca, A. L., Kusanovic, J. P., Gomez, R., Chaiyasit, N., Honn, K. V. Lipidomic analysis of patients with microbial invasion of the amniotic cavity reveals up-regulation of leukotriene B-4.	[Maddipati, Krishna Rao; Zhou, Sen-Lin; Honn, Kenneth V.] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Maddipati, Krishna Rao; Zhou, Sen-Lin] Wayne State Univ, Sch Med, Lipid Core Facil, Detroit, MI USA; [Chaiworapongsa, Tinnakorn; Chaemsaithong, Piya; Tarca, Adi L.; Chaiyasit, Noppadol] Wayne State Univ, Sch Med, Dept Obstet & Gynecol, Detroit, MI 48201 USA; [Romero, Roberto; Chaiworapongsa, Tinnakorn; Chaemsaithong, Piya; Xu, Zhonghui; Tarca, Adi L.; Kusanovic, Juan Pedro; Chaiyasit, Noppadol] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Perinatol Res Branch, Div Intramural Res, Natl Inst Hlth,Dept Hlth & Human Serv, Bethesda, MD USA; [Romero, Roberto] Univ Michigan, Dept Obstet & Gynecol, Ann Arbor, MI 48109 USA; [Romero, Roberto] Wayne State Univ, Ctr Mol Med & Genet, Detroit, MI USA; [Tarca, Adi L.] Wayne State Univ, Dept Comp Sci, Detroit, MI 48202 USA; [Romero, Roberto] Michigan State Univ, Dept Epidemiol & Biostat, E Lansing, MI 48824 USA; [Kusanovic, Juan Pedro] Hosp Dr Sotero del Rio, Dept Obstet & Gynecol, Ctr Res & Innovat Maternal Fetal Med CIMAF, Santiago, Chile; [Kusanovic, Juan Pedro; Gomez, Ricardo] Pontificia Univ Catolica Chile, Div Obstet & Gynecol, Santiago, Chile; [Gomez, Ricardo] Hosp Clin La Florida, Res & Acad Innovat, Ctr Perinatal Diag CEDIP, Santiago, Chile	Wayne State University; Wayne State University; Wayne State University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); University of Michigan System; University of Michigan; Wayne State University; Wayne State University; Michigan State University; Universidad de Chile; Pontificia Universidad Catolica de Chile	Maddipati, KR (corresponding author), Wayne State Univ, Dept Pathol, 435 Chem Bldg,410 W Warren Ave, Detroit, MI 48202 USA.	maddipati@wayne.edu	Maddipati, Krishna Rao/G-1859-2011; Kusanovic, Juan Pedro/AAM-5782-2020; Xu, Zhonghui/F-3353-2018; Maddipati, Krishna Rao/H-3569-2019; Kusanovic, Juan Pedro/R-8616-2019; Romero, Roberto/A-5268-2019	Maddipati, Krishna Rao/0000-0003-1445-791X; Kusanovic, Juan Pedro/0000-0003-0640-2070; Xu, Zhonghui/0000-0002-6469-9178; Maddipati, Krishna Rao/0000-0003-1445-791X; Gomez, Ricardo/0000-0001-9267-304X; Romero, Roberto/0000-0002-4448-5121; chaemsaithong, piya/0000-0003-1750-9834; Chaemsaithong, piya/0000-0002-5398-6868	Perinatology Research Branch, Division of Intramural Research Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, U.S. National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS); NICHD/NIH/DHHS [HHSN275201300006C]; National Center for Research Resources [S10RR027926]; Wayne State University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD002400] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR027926] Funding Source: NIH RePORTER	Perinatology Research Branch, Division of Intramural Research Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, U.S. National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS); NICHD/NIH/DHHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Wayne State University; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This research was supported, in part, by the Perinatology Research Branch, Division of Intramural Research Branch of the Eunice Kennedy Shriver National Institute of Child Health and Human Development, U.S. National Institutes of Health, U.S. Department of Health and Human Services (NICHD/NIH/DHHS); and, in part, with Federal funds from NICHD/NIH/DHHS Contract No. HHSN275201300006C; and, in part, by the National Center for Research Resources Grant S10RR027926 and the Perinatal Virtual Discovery Grant from Wayne State University (to K.R.M.). The authors declare no conflicts of interest.	ANDERSEN HF, 1990, AM J OBSTET GYNECOL, V163, P859, DOI 10.1016/0002-9378(90)91084-P; ANDREWS WW, 1995, AM J OBSTET GYNECOL, V173, P606, DOI 10.1016/0002-9378(95)90290-2; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERRYMAN GK, 1987, LIFE SCI, V41, P1611, DOI 10.1016/0024-3205(87)90728-4; Bowers RC, 2000, J BIOL CHEM, V275, P29931, DOI 10.1074/jbc.C000502200; Buckley CD, 2014, IMMUNITY, V40, P315, DOI 10.1016/j.immuni.2014.02.009; Chaemsaithong P, 2015, J MATERN-FETAL NEO M, V28, P1510, DOI 10.3109/14767058.2014.961417; Chiang N, 2012, NATURE, V484, P524, DOI 10.1038/nature11042; Cobo T, 2014, AM J OBSTET GYNECOL, V211, P708, DOI 10.1016/j.ajog.2014.06.060; Combs CA, 2014, AM J OBSTET GYNECOL, V210, DOI 10.1016/j.ajog.2013.11.032; Eckert DJ, 2010, EXPERT REV MOL DIAGN, V10, P399, DOI [10.1586/erm.10.24, 10.1586/ERM.10.24]; Eshoo MW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036825; Esplin M S, 2003, J Matern Fetal Neonatal Med, V14, P51, DOI 10.1080/713605933; FORDHUTCHINSON AW, 1990, CRIT REV IMMUNOL, V10, P1; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gervasi MT, 2012, J PERINAT MED, V40, P329, DOI 10.1515/jpm-2012-0034; Gibb W, 1998, ANN MED, V30, P235, DOI 10.3109/07853899809005850; GIBBS RS, 1988, OBSTET GYNECOL, V72, P823, DOI 10.1097/00006250-198812000-00001; GIBBS RS, 1992, AM J OBSTET GYNECOL, V166, P1515, DOI 10.1016/0002-9378(92)91628-N; Gomez-Lopez N, 2009, J REPROD IMMUNOL, V80, P122, DOI 10.1016/j.jri.2009.01.002; Gomez-Lopez N, 2011, AM J OBSTET GYNECOL, V204, DOI 10.1016/j.ajog.2010.11.010; Grant GE, 2009, PROSTAG OTH LIPID M, V89, P98, DOI 10.1016/j.prostaglandins.2009.05.002; GRAVETT MG, 1986, OBSTET GYNECOL, V67, P229, DOI 10.1097/00006250-198602000-00013; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Henningsen A, 2011, CENSREG CENSORED REG; Hevko JM, 2002, J BIOL CHEM, V277, P7037, DOI 10.1074/jbc.M108942200; Hsu CD, 1998, AM J PERINAT, V15, P683, DOI 10.1055/s-2007-999302; Iams JD, 1996, NEW ENGL J MED, V334, P567, DOI 10.1056/NEJM199602293340904; Jones CE, 2003, MOL PHARMACOL, V63, P471, DOI 10.1124/mol.63.3.471; KARIM SMM, 1971, P ROY SOC MED, V64, P10, DOI 10.1177/003591577106400105; Keelan JA, 2003, PLACENTA, V24, pS33, DOI 10.1053/plac.2002.0948; KUMLIN M, 1990, BIOCHEM BIOPH RES CO, V170, P23, DOI 10.1016/0006-291X(90)91235-K; Lee J, 2016, J MATERN-FETAL NEO M, V29, P707, DOI 10.3109/14767058.2015.1020293; Lee SE, 2008, J MATERN-FETAL NEO M, V21, P89, DOI 10.1080/14767050701830514; Lee SE, 2009, J MATERN-FETAL NEO M, V22, P880, DOI 10.1080/14767050902994648; LEE TH, 1989, CLIN SCI, V77, P195, DOI 10.1042/cs0770195; Liggins G. C, 1981, CERVIX PREGNANCY LAB, P1; Maddipati KR, 2014, FASEB J, V28, P4835, DOI 10.1096/fj.14-254383; Maddipati KR, 2011, PROSTAG OTH LIPID M, V94, P59, DOI 10.1016/j.prostaglandins.2011.01.003; Maymon E, 1999, AM J OBSTET GYNECOL, V181, P1142, DOI 10.1016/S0002-9378(99)70097-9; Menon R, 2011, OBSTET GYNECOL, V118, P121, DOI 10.1097/AOG.0b013e3182204eaa; Mercer BM, 1997, JAMA-J AM MED ASSOC, V278, P989, DOI 10.1001/jama.278.12.989; Metzgar D, 2013, J CLIN MICROBIOL, V51, P2670, DOI 10.1128/JCM.00966-13; Mitchell MD, 2005, J CLIN ENDOCR METAB, V90, P4244, DOI 10.1210/jc.2004-2496; MITCHELL MD, 1995, REPROD FERT DEVELOP, V7, P623, DOI 10.1071/RD9950623; MITCHELL MD, 1981, J REPROD FERTIL, V62, P305; Nakamura M, 2011, CHEM REV, V111, P6231, DOI 10.1021/cr100392s; NIEDER J, 1983, PROSTA LEUKOTR MED, V12, P289, DOI 10.1016/0262-1746(83)90007-0; O'Flaherty JT, 1998, J BIOL CHEM, V273, P32535, DOI 10.1074/jbc.273.49.32535; Olson DM, 2003, BEST PRACT RES CL OB, V17, P717, DOI 10.1016/S1521-6934(03)00069-5; Osman I, 2003, MOL HUM REPROD, V9, P41, DOI 10.1093/molehr/gag001; Papayianni A, 1996, J IMMUNOL, V156, P2264; Patel P, 2009, J PHARMACOL EXP THER, V329, P335, DOI 10.1124/jpet.108.143453; Peters-Golden M, 2005, J IMMUNOL, V174, P589, DOI 10.4049/jimmunol.174.2.589; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; ROMERO R, 1987, AM J OBSTET GYNECOL, V157, P1454, DOI 10.1016/S0002-9378(87)80243-0; ROMERO R, 1990, AM J OBSTET GYNECOL, V163, P968, DOI 10.1016/0002-9378(90)91106-M; ROMERO R, 1992, CIBA F SYMP, V167, P205; ROMERO R, 1988, AM J OBSTET GYNECOL, V159, P114, DOI 10.1016/0002-9378(88)90503-0; ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P821, DOI 10.1016/0002-9378(91)90423-O; ROMERO R, 1994, PROSTAG LEUKOTR ESS, V50, P97, DOI 10.1016/0952-3278(94)90154-6; ROMERO R, 1992, AM J OBSTET GYNECOL, V166, P1576, DOI 10.1016/0002-9378(92)91636-O; ROMERO R, 1991, AM J OBSTET GYNECOL, V165, P813, DOI 10.1016/0002-9378(91)90422-N; ROMERO R, 1989, AM J OBSTET GYNECOL, V160, P1117, DOI 10.1016/0002-9378(89)90172-5; Romero R, 1996, PROSTAG LEUKOTR ESS, V54, P187, DOI 10.1016/S0952-3278(96)90015-0; ROMERO R, 1992, AM J REPROD IMMUNOL, V27, P117, DOI 10.1111/j.1600-0897.1992.tb00737.x; ROMERO R, 1994, AM J OBSTET GYNECOL, V171, P1613, DOI 10.1016/0002-9378(94)90412-X; Romero R, 2016, J PERINAT MED, V44, P33, DOI 10.1515/jpm-2015-0119; Romero R, 2016, J PERINAT MED, V44, P53, DOI 10.1515/jpm-2015-0121; Romero R, 2016, J PERINAT MED, V44, P5, DOI 10.1515/jpm-2015-0045; Romero R, 2016, J PERINAT MED, V44, P23, DOI 10.1515/jpm-2015-0044; Romero R, 2015, J MATERN-FETAL NEO M, V28, P1394, DOI 10.3109/14767058.2014.958463; Romero R, 2015, J PERINAT MED, V43, P19, DOI 10.1515/jpm-2014-0249; Romero R, 2014, AM J REPROD IMMUNOL, V72, P458, DOI 10.1111/aji.12296; Romero R, 2014, SCIENCE, V345, P760, DOI 10.1126/science.1251816; Romero R, 2014, AM J REPROD IMMUNOL, V71, P330, DOI 10.1111/aji.12189; SAITO S, 1993, CYTOKINE, V5, P81, DOI 10.1016/1043-4666(93)90027-3; SAMUELSSON B, 1983, SCIENCE, V220, P568, DOI 10.1126/science.6301011; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Serhan CN, 2008, PROSTAG LEUKOTR ESS, V79, P157, DOI 10.1016/j.plefa.2008.09.012; Serhan CN, 2005, PROSTAG LEUKOTR ESS, V73, P141, DOI 10.1016/j.plefa.2005.05.002; SERHAN CN, 1994, BBA-LIPID LIPID MET, V1212, P1, DOI 10.1016/0005-2760(94)90185-6; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shin JH, 2013, J CLIN MICROBIOL, V51, P136, DOI 10.1128/JCM.01907-12; Shynlova O, 2008, J IMMUNOL, V181, P1470, DOI 10.4049/jimmunol.181.2.1470; STRICKLAND DM, 1983, SCIENCE, V220, P521, DOI 10.1126/science.6573023; VANDERELST CW, 1991, OBSTET GYNECOL, V77, P672; Yoon BH, 2001, AM J OBSTET GYNECOL, V185, P1130, DOI 10.1067/mob.2001.117680; Zarini S, 2009, P NATL ACAD SCI USA, V106, P8296, DOI 10.1073/pnas.0903851106	90	33	34	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3296	3307		10.1096/fj.201600583R	http://dx.doi.org/10.1096/fj.201600583R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27312808	Green Published, Green Submitted			2022-12-28	WOS:000384329800004
J	Mezawa, M; Pinto, VI; Kazembe, MP; Lee, WS; McCulloch, CA				Mezawa, Masaru; Pinto, Vanessa I.; Kazembe, Mwayi P.; Lee, Wilson S.; McCulloch, Christopher A.			Filamin A regulates the organization and remodeling of the pericellular collagen matrix	FASEB JOURNAL			English	Article						phagocytosis; matrix metalloproteinases; lysosomes; degradation	FORCE-INDUCED APOPTOSIS; EXTRACELLULAR-MATRIX; PERIODONTAL-LIGAMENT; CELL INVASION; ADHESION; PHAGOCYTOSIS; TURNOVER; TISSUES; PROTEIN; MECHANOTRANSDUCTION	Extracellular matrix remodeling by cell adhesion-related processes is critical for proliferation and tissue homeostasis, but how adhesions and the cytoskeleton interact to organize the pericellular matrix (PCM) is not understood. We examined the role of the actin-binding protein, filamin A (FLNa), in pericellular collagen remodeling. Compared with wild-type (WT), mice with fibroblast-specific deletion of FLNa exhibited higher density but reduced organization of collagen fibers after increased loading of the periodontal ligament for 2 wk. In cultured fibroblasts, FLNa knockdown (KD) did not affect collagen mRNA, but after 24 h of culture, FLNa WT cells exhibited similar to 2-fold higher cell-surface collagen KD cells and 13-fold higher levels of activated beta 1 integrins. In FLNa WT cells, there was 3-fold more colocalization of talin with pericellular cleaved collagen than in FLNa KD cells. MMP-9 mRNA and protein expression were >2-fold higher in FLNa KD cells than in WT cells. Cathepsin B, which is necessary for intracellular collagen digestion, was >3-fold higher in FLNa WT cells than in KD cells. FLNa WT cells exhibited 2-fold more collagen phagocytosis than KD cells, which involved the FLNa actin-binding domain. Evidently, FLNa regulates PCM remodeling through its effects on degradation pathways that affect the abundance and organization of collagen.	[Mezawa, Masaru] Nihon Univ, Dept Periodontol, Sch Dent Matsudo, Matsudo, Chiba, Japan; [Pinto, Vanessa I.; Kazembe, Mwayi P.; Lee, Wilson S.; McCulloch, Christopher A.] Univ Toronto, Matrix Dynam Grp, Fac Dent, Toronto, ON, Canada	Nihon University; University of Toronto	McCulloch, CA (corresponding author), Univ Toronto, Fitzgerald Bldg,Room 244,150 Coll St, Toronto, ON M5S 3E2, Canada.	christopher.mcculloch@utoronto.ca			Canada Research Chair (Tier 1) in Matrix Dynamics; Canadian Institutes of Health operating grant [MOP-11106]	Canada Research Chair (Tier 1) in Matrix Dynamics(Canada Research Chairs); Canadian Institutes of Health operating grant(Canadian Institutes of Health Research (CIHR))	Christopher McCulloch is supported by a Canada Research Chair (Tier 1) in Matrix Dynamics. The research was supported by a Canadian Institutes of Health operating grant, MOP-11106 (to C.M.). The authors declare no conflicts of interest.	Arora PD, 2013, MOL BIOL CELL, V24, P734, DOI 10.1091/mbc.E12-10-0754; Arora PD, 2008, MOL BIOL CELL, V19, P5032, DOI 10.1091/mbc.E08-04-0430; Arora PD, 2000, J BIOL CHEM, V275, P35432, DOI 10.1074/jbc.M003221200; Baldassarre M, 2012, J CELL SCI, V125, P3858, DOI 10.1242/jcs.104018; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Bonnans C, 2014, NAT REV MOL CELL BIO, V15, P786, DOI 10.1038/nrm3904; BURLEIGH MC, 1974, BIOCHEM J, V137, P387, DOI 10.1042/bj1370387; Campbell ID, 2008, BIOCHEM SOC T, V36, P263, DOI 10.1042/BST0360263; Carraher CL, 2013, J BIOL CHEM, V288, P14805, DOI 10.1074/jbc.M112.435271; DEWEY CF, 1981, J BIOMECH ENG-T ASME, V103, P177, DOI 10.1115/1.3138276; Evanko SP, 2015, MATRIX BIOL, V42, P74, DOI 10.1016/j.matbio.2014.12.001; Everts V, 1996, HISTOCHEM J, V28, P229, DOI 10.1007/BF02409011; Feng YY, 2006, P NATL ACAD SCI USA, V103, P19836, DOI 10.1073/pnas.0609628104; Feng YY, 2004, NAT CELL BIOL, V6, P1034, DOI 10.1038/ncb1104-1034; Gasparski AN, 2015, ARCH BIOCHEM BIOPHYS, V586, P20, DOI 10.1016/j.abb.2015.07.017; Graham LV, 2010, J BIOL CHEM, V285, P7067, DOI 10.1074/jbc.M109.006841; Humphrey JD, 2014, NAT REV MOL CELL BIO, V15, P802, DOI 10.1038/nrm3896; Jeon PD, 1999, AM J ORTHOD DENTOFAC, V115, P267, DOI 10.1016/S0889-5406(99)70328-8; Kainulainen T, 2002, J BIOL CHEM, V277, P21998, DOI 10.1074/jbc.M200715200; Kiema T, 2006, MOL CELL, V21, P337, DOI 10.1016/j.molcel.2006.01.011; Kim H, 2011, FEBS LETT, V585, P18, DOI 10.1016/j.febslet.2010.11.033; Kim H, 2010, EXP CELL RES, V316, P1829, DOI 10.1016/j.yexcr.2010.02.007; Kim H, 2010, AM J PHYSIOL-CELL PH, V298, pC221, DOI 10.1152/ajpcell.00323.2009; Klamer S, 2014, CELL ADHES MIGR, V8, P563, DOI 10.4161/19336918.2014.968501; Lecaille F, 2008, BIOCHIMIE, V90, P208, DOI 10.1016/j.biochi.2007.08.011; LEE GM, 1993, J CELL BIOL, V123, P1899, DOI 10.1083/jcb.123.6.1899; Lee H, 2007, BIOCHEM SOC T, V35, P704, DOI 10.1042/BST0350704; Lee HJ, 2006, MOL BIOL CELL, V17, P4812, DOI 10.1091/mbc.E06-06-0486; LENTER M, 1993, P NATL ACAD SCI USA, V90, P9051, DOI 10.1073/pnas.90.19.9051; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; LIU ZQ, 1991, APPL OPTICS, V30, P1369, DOI 10.1364/AO.30.001369; Lukashev ME, 1998, TRENDS CELL BIOL, V8, P437, DOI 10.1016/S0962-8924(98)01362-2; MELCHER AH, 1981, J ULTRA MOL STRUCT R, V77, P1, DOI 10.1016/S0022-5320(81)80064-0; Mohammad I, 2012, FASEB J, V26, P3260, DOI 10.1096/fj.11-202051; Mohammadi H, 2015, J INVEST DERMATOL, V135, P2852, DOI 10.1038/jid.2015.251; Monslow J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00231; Nakamura F, 2011, CELL ADHES MIGR, V5, P160, DOI 10.4161/cam.5.2.14401; Navab R, 2016, ONCOGENE, V35, P1899, DOI 10.1038/onc.2015.254; Nazac A, 2015, MICROSC RES TECHNIQ, V78, P723, DOI 10.1002/jemt.22530; Panwar P, 2013, J BIOL CHEM, V288, P5940, DOI 10.1074/jbc.M112.419689; PERERA KAS, 1981, J ANAT, V133, P359; Pickup MW, 2014, EMBO REP, V15, P1243, DOI 10.15252/embr.201439246; Pinto VI, 2014, FASEB J, V28, P453, DOI 10.1096/fj.13-233759; Popowicz GM, 2006, TRENDS BIOCHEM SCI, V31, P411, DOI 10.1016/j.tibs.2006.05.006; RIPPIN JW, 1976, J PERIODONTAL RES, V11, P101, DOI 10.1111/j.1600-0765.1976.tb00057.x; Sardone F, 2014, J CELL PHYSIOL, V229, P878, DOI 10.1002/jcp.24518; Schiller HB, 2013, EMBO REP, V14, P509, DOI 10.1038/embor.2013.49; Shi ZD, 2011, ANN BIOMED ENG, V39, P1608, DOI 10.1007/s10439-011-0309-2; Shifrin Y, 2012, BIOCHEM J, V445, P57, DOI 10.1042/BJ20112119; Shifrin Y, 2009, MOL BIOL CELL, V20, P1269, DOI 10.1091/mbc.E08-08-0872; SILL HW, 1995, AM J PHYSIOL-HEART C, V268, pH535, DOI 10.1152/ajpheart.1995.268.2.H535; SODEK J, 1977, ARCH ORAL BIOL, V22, P655, DOI 10.1016/0003-9969(77)90095-4; Staudinger LA, 2013, BIOL OPEN, V2, P1148, DOI 10.1242/bio.20135090; Steffen A, 2013, J CELL SCI, V126, P4572, DOI 10.1242/jcs.118232; Stossel TP, 2001, NAT REV MOL CELL BIO, V2, P138, DOI 10.1038/35052082; SUGRUE SP, 1981, J CELL BIOL, V91, P45, DOI 10.1083/jcb.91.1.45; TENCATE AR, 1974, ARCH ORAL BIOL, V19, P339; Theocharis AD, 2016, ADV DRUG DELIVER REV, V97, P4, DOI 10.1016/j.addr.2015.11.001; Vincent TL, 2013, CURR OPIN PHARMACOL, V13, P449, DOI 10.1016/j.coph.2013.01.010; von Nandelstadh P, 2014, MOL BIOL CELL, V25, P2556, DOI 10.1091/mbc.E13-11-0667; Yao Y, 2007, AM J PHYSIOL-HEART C, V293, pH1023, DOI 10.1152/ajpheart.00162.2007; Zhang ZJ, 2015, TISSUE ENG PART B-RE, V21, P267, DOI [10.1089/ten.teb.2014.0286, 10.1089/ten.TEB.2014.0286]; Zhou AX, 2010, TRENDS CELL BIOL, V20, P113, DOI 10.1016/j.tcb.2009.12.001	63	12	14	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3613	3627		10.1096/fj.201600354RR	http://dx.doi.org/10.1096/fj.201600354RR			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27407006				2022-12-28	WOS:000384329800029
J	Wang, Y; Zhang, KY; Shi, XC; Wang, C; Wang, F; Fan, JW; Shen, FG; Xu, JC; Bao, WG; Liu, MY; Yu, L				Wang, Yang; Zhang, Kaiyu; Shi, Xiaochen; Wang, Chao; Wang, Feng; Fan, Junwen; Shen, Fengge; Xu, Jiancheng; Bao, Wanguo; Liu, Mingyuan; Yu, Lu			Critical role of bacterial isochorismatase in the autophagic process induced by Acinetobacter baumannii in mammalian cells	FASEB JOURNAL			English	Article						bacteria clearance; septin; pathway	COLORIMETRIC DETERMINATION; PSEUDOMONAS-AERUGINOSA; SIGNALING PATHWAY; IRON ACQUISITION; RECEPTOR NDP52; PROTEIN; TARGET; SALMONELLA; KINASE; AMPK	A recent study reported that Acinetobacter baumannii could induce autophagy, but the recognition and clearance mechanism of intracytosolic A. baumannii in the autophagic process and the molecular mechanism of autophagy induced by the pathogen remains unknown. In this study, we first demonstrated that invading A. baumannii induced a complete, ubiquitin-mediated autophagic response that is dependent upon septins SEPT2 and SEPT9 in mammalian cells. We also demonstrated that autophagy induced by A. baumannii was Beclin-1 dependent via the AMPK/ERK/mammalian target of rapamycin pathway. Of interest, we found that the isochorismatase mutant strain had significantly decreased siderophore-mediated ferric iron acquisition ability and had a reduced the ability to induce autophagy. We verified that isochorismatase was required for the recognition of intracytosolic A. baumannii mediated by septin cages, ubiquitinated proteins, and ubiquitin-binding adaptor proteins p62 and NDP52 in autophagic response. We also confirmed that isochorismatase was required for the clearance of invading A. baumannii by autophagy in vitro and in the mouse model of infection. Together, these findings provide insight into the distinctive recognition and clearance of intracytosolic A. baumannii by autophagy in host cells, and that isochorismatase plays a critical role in the A. baumannii-induced autophagic process.	[Wang, Yang; Zhang, Kaiyu; Shi, Xiaochen; Wang, Chao; Wang, Feng; Shen, Fengge; Bao, Wanguo; Liu, Mingyuan; Yu, Lu] Jilin Univ, Key Lab Zoonosis Res, Minist Med Sci, Dept Infect Dis,Hosp 1,Inst Zoonosis, Changchun, Peoples R China; [Fan, Junwen] Acad Mil Med Sci, Lab Anim Ctr, Beijing, Peoples R China; [Xu, Jiancheng] Jilin Univ, Coll Vet Med & Anim Sci, Changchun, Peoples R China; [Liu, Mingyuan] Jilin Univ, Dept Clin Lab, Hosp 1, Changchun, Peoples R China; [Shen, Fengge; Yu, Lu] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou, Jiangsu, Peoples R China	Jilin University; Academy of Military Medical Sciences - China; Jilin University; Jilin University	Yu, L (corresponding author), Jilin Univ, Coll Vet Med, Xian Rd 5333, Changchun 130062, Peoples R China.	yu_lu@jlu.edu.cn		shen, fengge/0000-0001-8814-513X; Wang, Yang/0000-0001-8055-9522	National Nature Science Foundation of China [31172364, 31271951]; fund for Science and Technology Development of Jilin Province [20150101108JC]; Important National Science and Technology Specific Projects [2012ZX10003002]; Program for New Century Excellent Talents in University [NCET-09-0434, NCET-13-0245]; China Postdoctoral Science Foundation [2013M530142]; Fundamental Research Program of Shenzhen [JCYJ20130401172016183, ZDSY20120616141302982]; Shenzhen Science and Technology Research and Development funds [JCYJ20130401173155808]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); fund for Science and Technology Development of Jilin Province; Important National Science and Technology Specific Projects; Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); China Postdoctoral Science Foundation(China Postdoctoral Science Foundation); Fundamental Research Program of Shenzhen; Shenzhen Science and Technology Research and Development funds	This work was supported by funds form the National Nature Science Foundation of China (31172364 and 31271951), fund for Science and Technology Development of Jilin Province (20150101108JC), the Important National Science and Technology Specific Projects (2012ZX10003002), the Program for New Century Excellent Talents in University (NCET-09-0434; NCET-13-0245), China Postdoctoral Science Foundation (2013M530142), Fundamental Research Program of Shenzhen (JCYJ20130401172016183 and ZDSY20120616141302982), and Shenzhen Science and Technology Research and Development funds (JCYJ20130401173155808). The authors thank Dr. Luis A. Actis (Miami University, Miami, FL, USA) for providing the pMU125 plasmid; Dr. Yoshimori Tamotsu (Research Institute for Microbial Diseases, Osaka University, Japan) for providing plasmids pmRFP-LC3, ptfLC3, and pEGFP-LC3; Dr. Philip N. Rather (Research Service Veterans Affairs Medical Center, Decatur, GA, USA) for providing strains M2 and abaI::Km M2'; and Dr. Paul M. Dunman (University of Rochester School of Medicine and Dentistry, Rochester, NY, USA) for providing strain 98-37-09, ACJ6.	Anand PK, 2011, J BIOL CHEM, V286, P42981, DOI 10.1074/jbc.M111.310599; Arnow LE, 1937, J BIOL CHEM, V118, P531; Arroyo DS, 2013, FASEB J, V27, P299, DOI 10.1096/fj.12-214312; Mestre MB, 2010, AUTOPHAGY, V6, P110, DOI 10.4161/auto.6.1.10698; Caruthers J, 2005, PROTEIN SCI, V14, P2887, DOI 10.1110/ps.051783005; Cemma M, 2011, AUTOPHAGY, V7, P341, DOI 10.4161/auto.7.3.14046; Checroun C, 2006, P NATL ACAD SCI USA, V103, P14578, DOI 10.1073/pnas.0601838103; Dauphinee SM, 2014, GENES IMMUN, V15, P282, DOI 10.1038/gene.2014.17; Fiester SE, 2015, INFECT IMMUN, V83, P1354, DOI 10.1128/IAI.02925-14; Gaddy JA, 2012, INFECT IMMUN, V80, P1015, DOI 10.1128/IAI.06279-11; Goral Anna M., 2012, Journal of Structural and Functional Genomics, V13, P27, DOI 10.1007/s10969-012-9127-5; Hardie DG, 2011, EMBO J, V30, P634, DOI 10.1038/emboj.2011.12; Harris J, 2011, CYTOKINE, V56, P140, DOI 10.1016/j.cyto.2011.08.022; Huett A, 2012, CELL HOST MICROBE, V12, P778, DOI 10.1016/j.chom.2012.10.019; Jacobs AC, 2010, INFECT IMMUN, V78, P1952, DOI 10.1128/IAI.00889-09; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kierbel A, 2005, MOL BIOL CELL, V16, P2577, DOI 10.1091/mbc.E04-08-0717; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Kirienko NV, 2015, P NATL ACAD SCI USA, V112, P1821, DOI 10.1073/pnas.1424954112; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; LAPENTA D, 1994, P NATL ACAD SCI USA, V91, P12115, DOI 10.1073/pnas.91.25.12115; Li S, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003730; Mihaylova MM, 2011, NAT CELL BIOL, V13, P1016, DOI 10.1038/ncb2329; Mostowy S, 2011, J BIOL CHEM, V286, P26987, DOI 10.1074/jbc.M111.223610; Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009; Nagy TA, 2013, INFECT IMMUN, V81, P4063, DOI 10.1128/IAI.00412-13; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakahira K, 2013, AM J PHYSIOL-LUNG C, V305, pL93, DOI 10.1152/ajplung.00072.2013; NEILANDS JB, 1991, BIOL MET, V4, P1, DOI 10.1007/BF01135550; Ohsumi Y, 2004, SEMIN CELL DEV BIOL, V15, P231, DOI 10.1016/j.semcdb.2003.12.004; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Ozpolat B, 2015, CANCER MANAG RES, V7, P291, DOI 10.2147/CMAR.S34859; Peleg AY, 2008, CLIN MICROBIOL REV, V21, P538, DOI 10.1128/CMR.00058-07; Perrin AJ, 2004, CURR BIOL, V14, P806, DOI 10.1016/j.cub.2004.04.033; Qiu HY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040019; RIOUX C, 1983, ANAL BIOCHEM, V133, P163, DOI 10.1016/0003-2697(83)90238-5; Rumbo C, 2014, INFECT IMMUN, V82, P4666, DOI 10.1128/IAI.02034-14; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Shang LB, 2011, AUTOPHAGY, V7, P924, DOI 10.4161/auto.7.8.15860; Sun YJ, 2014, J VIROL, V88, P525, DOI 10.1128/JVI.01849-13; Tattoli I, 2012, AUTOPHAGY, V8, P1848, DOI 10.4161/auto.21863; Tayabali AF, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037024; Thurston TLM, 2009, NAT IMMUNOL, V10, P1215, DOI 10.1038/ni.1800; Tomaras AP, 2003, MICROBIOL-SGM, V149, P3473, DOI 10.1099/mic.0.26541-0; Wiedemann A, 2012, J BIOL CHEM, V287, P31148, DOI 10.1074/jbc.M112.392134; Yan Q., 2015, BIOPROTOC, V5, DOI [10.21769/bioprotoc.1406, DOI 10.21769/BIOPROTOC.1406]; Yu SW, 2008, MOL CANCER THER, V7, P2609, DOI 10.1158/1535-7163.MCT-07-2400; Yuan KF, 2012, J CELL SCI, V125, P507, DOI 10.1242/jcs.094573; Zhang Xia, 2008, Curr Protoc Immunol, VChapter 14, DOI 10.1002/0471142735.im1401s83; Zheng YT, 2009, J IMMUNOL, V183, P5909, DOI 10.4049/jimmunol.0900441; Zhu BL, 2012, J VIROL, V86, P12003, DOI 10.1128/JVI.01434-12; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	52	16	20	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3563	3577		10.1096/fj.201500019R	http://dx.doi.org/10.1096/fj.201500019R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27432399	Green Published, hybrid			2022-12-28	WOS:000384329800025
J	Guillonneau, M; Paris, F; Dutoit, S; Estephan, H; Beneteau, E; Huot, J; Corre, I				Guillonneau, Maeva; Paris, Francois; Dutoit, Soizic; Estephan, Hala; Beneteau, Elise; Huot, Jacques; Corre, Isabelle			Oxidative stress disassembles the p38/NPM/PP2A complex, which leads to modulation of nucleophosmin-mediated signaling to DNA damage response	FASEB JOURNAL			English	Article						reactive oxygen species; p38MAPK; endothelial dysfunction; phosphatases; double-strand breaks	PROTEIN PHOSPHATASE 2A; DOUBLE-STRAND BREAKS; ENDOTHELIAL DYSFUNCTION; HEAT-SHOCK; HYDROGEN-PEROXIDE; IONIZING-RADIATION; PROTEOMIC APPROACH; SHEAR-STRESS; KINASE; REPAIR	Oxidative stress is a leading cause of endothelial dysfunction. The p38 MAPK pathway plays a determinant role in allowing cells to cope with oxidative stress and is tightly regulated by a balanced interaction between p38 protein and its interacting partners. By using a proteomic approach, we identified nucleophosmin (NPM) as a new partner of p38 in HUVECs. Coimmunoprecipitation and microscopic analyses confirmed the existence of a cytosolic nucleophosmin (NPM)/p38 interaction in basal condition. Oxidative stress, which was generated by exposure to 500 mu M H2O2, induces a rapid dephosphorylation of NPM at T199 that depends on phosphatase PP2A, another partner of the NPM/p38 complex. Blocking PP2A activity leads to accumulation of NPM-pT199 and to an increased association of NPM with p38. Concomitantly to its dephosphorylation, oxidative stress promotes translocation of NPM to the nucleus to affect the DNA damage response. Dephosphorylated NPM impairs the signaling of oxidative stress-induced DNA damage via inhibition of the phosphorylation of ataxia-telangiectasia mutated and DNA-dependent protein kinase catalytic subunit. Overall, these results suggest that the p38/NPM/PP2A complex acts as a dynamic sensor, allowing endothelial cells to react rapidly to acute oxidative stress.	[Guillonneau, Maeva; Paris, Francois; Dutoit, Soizic; Estephan, Hala; Beneteau, Elise; Corre, Isabelle] CNRS, Unite Mixte Rech 6299, Nantes, France; [Guillonneau, Maeva; Paris, Francois; Dutoit, Soizic; Estephan, Hala; Beneteau, Elise; Corre, Isabelle] INSERM, Unite Mixte Rech 892, Nantes, France; [Guillonneau, Maeva; Paris, Francois; Dutoit, Soizic; Estephan, Hala; Beneteau, Elise; Corre, Isabelle] Univ Nantes, Nantes, France; [Guillonneau, Maeva; Huot, Jacques; Corre, Isabelle] Univ Laval, Ctr Hosp Univ Quebec, Ctr Rech, Quebec City, PQ, Canada; [Guillonneau, Maeva; Huot, Jacques; Corre, Isabelle] Univ Laval, Ctr Rech Canc, Quebec City, PQ, Canada	Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; Laval University; Laval University	Corre, I (corresponding author), Ctr Reg Rech Cancerol Nantes Angers CRCNA, IRS UN, CNRS 6299, INSERM U892, 8 Quai Moncousu, F-44007 Nantes, France.	isabelle.corre@inserm.fr	Corre, Isabelle/L-2583-2015; Paris, francois E/L-4915-2015	Paris, francois E/0000-0002-0176-7348; dutoit, soizic/0000-0003-1094-7823; CORRE, Isabelle/0000-0001-6444-1145	International Outgoing Fellowship; Marie Curie People Programme of the European Union's Seventh Framework Program FP7 [326512]; La Ligue contre le Cancer (Comites Loire-Atlantique, Morbihan, Cotes d'Armor); Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council; French Ministry of Research studentship	International Outgoing Fellowship; Marie Curie People Programme of the European Union's Seventh Framework Program FP7; La Ligue contre le Cancer (Comites Loire-Atlantique, Morbihan, Cotes d'Armor); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); French Ministry of Research studentship	The authors thank Drs. Jean-Yves Masson (Universite Laval), Claude Prigent and David Reboutier (Institut de Genetique and Developpement, Universite de Rennes, Rennes, France) for providing NPM mutants and purified Aurora kinase, respectively, and for advice and helpful discussions. The authors also thank Charlotte Degorre (Cancer Research Center Nantes-Angers, Nantes, France) for technical expertise, Dr. Jacques Landry (Universite Laval) for providing the p38 MAPK antibody, and Dr. Beatrice Charreau (INSERM Unite Mixte de Recherche 1064, Nantes, France) for providing human arterial endothelial cells. The authors are grateful to Dr. Simon Rousseau (McGill University, Montreal, QC, Canada), Dr. Julie Gavard (Cancer Research Center Nantes-Angers), and Francois Houle (Universite Laval) for carefully reading the manuscript. The authors are also grateful to Philippe Hulin and Steven Nedellec (MicroPICell-Cellular Imaging Core Facility, Nantes, France; Structure Federative de Recherche Francois Bonamy) for their help and advice. The authors thank Dr. Eric Bonneil (Proteomic Platform of the Institute for Research in Immunology and Cancer, University of Montreal, Montreal, QC, Canada) for performing the mass spectrometry analyses. This work was funded by the International Outgoing Fellowship, Marie Curie People Programme of the European Union's Seventh Framework Program FP7/2007-2013, under REA grant agreement No. 326512, and by a subvention from La Ligue contre le Cancer (Comites Loire-Atlantique, Morbihan, Cotes d'Armor) (to I.C.), Canadian Institutes of Health Research, and Natural Sciences and Engineering Research Council (to J.H.). M.G. was a recipient of the French Ministry of Research studentship.	Arregi I, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130610; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Bharath LP, 2015, DIABETES, V64, P3914, DOI 10.2337/db15-0244; Bolli N, 2007, CANCER RES, V67, P6230, DOI 10.1158/0008-5472.CAN-07-0273; Boueiz A, 2009, MICROVASC RES, V77, P26, DOI 10.1016/j.mvr.2008.10.005; Chambers JW, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M111.223602; Chang TM, 2011, EVID-BASED COMPL ALT, V2011, DOI 10.1155/2011/213050; Chen BPC, 2007, J BIOL CHEM, V282, P6582, DOI 10.1074/jbc.M611605200; Cicchillitti L, 2003, J BIOL CHEM, V278, P19509, DOI 10.1074/jbc.M300511200; Corre I, 2013, INT J MOL SCI, V14, P22678, DOI 10.3390/ijms141122678; Cote MC, 2010, J BIOL CHEM, V285, P8013, DOI 10.1074/jbc.M109.098665; Coulthard LR, 2009, TRENDS MOL MED, V15, P369, DOI 10.1016/j.molmed.2009.06.005; Csiszar A, 2008, J APPL PHYSIOL, V105, P1333, DOI 10.1152/japplphysiol.90470.2008; Cuadrado A, 2007, EMBO J, V26, P2115, DOI 10.1038/sj.emboj.7601657; Cuenda A, 2007, BBA-MOL CELL RES, V1773, P1358, DOI 10.1016/j.bbamcr.2007.03.010; Davis AJ, 2014, DNA REPAIR, V17, P21, DOI 10.1016/j.dnarep.2014.02.020; Driessens N, 2009, ENDOCR-RELAT CANCER, V16, P845, DOI 10.1677/ERC-09-0020; Du YC, 2006, MOL CELL PROTEOMICS, V5, P1033, DOI 10.1074/mcp.M500327-MCP200; Falini B, 2005, NEW ENGL J MED, V352, P254, DOI 10.1056/NEJMoa041974; Falini B, 2009, LEUKEMIA, V23, P1731, DOI 10.1038/leu.2009.124; Fan L, 2005, CELL CYCLE, V4, P1616, DOI 10.4161/cc.4.11.2125; Garrett TA, 2007, EXP CELL RES, V313, P3285, DOI 10.1016/j.yexcr.2007.05.027; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Guay J, 1997, J CELL SCI, V110, P357; Haendeler J, 2005, J BIOL CHEM, V280, P42945, DOI 10.1074/jbc.M506985200; Harrison D, 2003, AM J CARDIOL, V91, p7A; Hermann C, 1997, ARTERIOSCL THROM VAS, V17, P3588, DOI 10.1161/01.ATV.17.12.3588; Hiromura K, 2002, ONCOGENE, V21, P1750, DOI 10.1038/sj.onc.1205238; Hsu S, 2005, BIOCHEM BIOPH RES CO, V337, P401, DOI 10.1016/j.bbrc.2005.08.272; HUOT J, 1995, EUR J BIOCHEM, V227, P416, DOI 10.1111/j.1432-1033.1995.tb20404.x; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; Ishitsuka K, 2008, BRIT J HAEMATOL, V141, P598, DOI 10.1111/j.1365-2141.2008.07044.x; Iyama T, 2013, DNA REPAIR, V12, P620, DOI 10.1016/j.dnarep.2013.04.015; Javeshghani D, 2009, J AM SOC HYPERTENS, V3, P295, DOI 10.1016/j.jash.2009.07.002; Jung KJ, 2013, FREE RADICAL BIO MED, V61, P206, DOI 10.1016/j.freeradbiomed.2013.04.005; Khandelwal N, 2011, CELL DEATH DIFFER, V18, P1889, DOI 10.1038/cdd.2011.79; Kinumi T, 2005, FREE RADICAL RES, V39, P1335, DOI 10.1080/10715760500306695; Koike A, 2010, CANCER RES, V70, P6746, DOI 10.1158/0008-5472.CAN-10-0382; Kumar P, 2004, J BIOL CHEM, V279, P43352, DOI 10.1074/jbc.M405777200; Lee SY, 2005, BIOCHEM J, V388, P7, DOI 10.1042/BJ20042033; Lin CY, 2010, MOL BIOL CELL, V21, P4409, DOI 10.1091/mbc.E10-03-0239; Martin D, 2002, J BIOL CHEM, V277, P42943, DOI 10.1074/jbc.M201070200; Okuda M, 2000, CELL, V103, P127, DOI 10.1016/S0092-8674(00)00093-3; Okuwaki M, 2008, J BIOCHEM, V143, P441, DOI 10.1093/jb/mvm222; Papaharalambus CA, 2007, TRENDS CARDIOVAS MED, V17, P48, DOI 10.1016/j.tcm.2006.11.005; Paron I, 2004, BIOCHEM J, V378, P929, DOI 10.1042/BJ20031190; Peng YL, 2005, CANCER RES, V65, P1670, DOI 10.1158/0008-5472.CAN-04-3451; Poletto M, 2014, MOL BIOL CELL, V25, P1641, DOI 10.1091/mbc.E13-12-0717; Ramos-Echazabal G, 2012, J CELL BIOCHEM, V113, P2364, DOI 10.1002/jcb.24108; RAMSAMOOJ P, 1995, RADIAT RES, V143, P158, DOI 10.2307/3579152; Rao RK, 2002, BIOCHEM BIOPH RES CO, V293, P610, DOI 10.1016/S0006-291X(02)00268-1; Reboutier D, 2012, J CELL BIOL, V197, P19, DOI 10.1083/jcb.201107134; Ren Z, 2015, ONCOGENE, V34, P1650, DOI 10.1038/onc.2014.109; Sakamoto N, 2009, J CELL PHYSIOL, V220, P706, DOI 10.1002/jcp.21818; Sarek G, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000818; Schini-Kerth V, 2014, FREE RADICAL BIO MED, V75, pS11, DOI 10.1016/j.freeradbiomed.2014.10.858; Seal JB, 2005, ANN VASC SURG, V19, P572, DOI 10.1007/s10016-005-4616-7; Sekhar KR, 2014, INT J RADIAT ONCOL, V89, P1106, DOI 10.1016/j.ijrobp.2014.04.012; Sekhar KR, 2011, CLIN CANCER RES, V17, P6490, DOI 10.1158/1078-0432.CCR-11-1054; Sommer D, 2002, ARCH BIOCHEM BIOPHYS, V404, P271, DOI 10.1016/S0003-9861(02)00242-4; Stiff T, 2004, CANCER RES, V64, P2390, DOI 10.1158/0008-5472.CAN-03-3207; Stone JR, 2002, ENDOTHELIUM-J ENDOTH, V9, P231, DOI 10.1080/10623320214733; Tarapore P, 2006, FEBS LETT, V580, P399, DOI 10.1016/j.febslet.2005.12.022; Tokuyama Y, 2001, J BIOL CHEM, V276, P21529, DOI 10.1074/jbc.M100014200; Touyz RM, 2011, HYPERTENS RES, V34, P5, DOI 10.1038/hr.2010.201; Trempolec N, 2013, CELL, V152, P656, DOI [10.1016/j.cell.2013.01.029, 10.1016/j.cell.2013.01.047]; Vanderwaal RP, 2009, CANCER RES, V69, P6454, DOI 10.1158/0008-5472.CAN-08-4896; Velic D, 2015, BIOMOLECULES, V5, P3204, DOI 10.3390/biom5043204; Victor VM, 2009, CURR PHARM DESIGN, V15, P2988, DOI 10.2174/138161209789058093; Wang W, 2005, NAT CELL BIOL, V7, P823, DOI 10.1038/ncb1282; Wu MH, 2002, CARCINOGENESIS, V23, P93, DOI 10.1093/carcin/23.1.93; Yan L, 2012, BIOCHEM J, V444, P239, DOI 10.1042/BJ20111606; Yang C, 2002, NUCLEIC ACIDS RES, V30, P2251, DOI 10.1093/nar/30.10.2251; Zhan H, 2010, J BIOL CHEM, V285, P29662, DOI 10.1074/jbc.M110.125138; Zoughlami Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068477	75	15	15	1	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2899	+		10.1096/fj.201500194R	http://dx.doi.org/10.1096/fj.201500194R			20	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27142525				2022-12-28	WOS:000380994000024
J	Bejar, MT; Ferrer-Lorente, R; Pena, E; Badimon, L				Teresa Bejar, Maria; Ferrer-Lorente, Raquel; Pena, Esther; Badimon, Lina			Inhibition of Notch rescues the angiogenic potential impaired by cardiovascular risk factors in epicardial adipose stem cells	FASEB JOURNAL			English	Article						angiogenesis; ZDF; epicardial adipose tissue; Hes/Hey family; differentiation	CORONARY-ARTERY-DISEASE; IN-VIVO; INSULIN-RESISTANCE; SIGNALING PATHWAY; OBESE-PATIENTS; TISSUE; DIFFERENTIATION; PROFILE; GAMMA; RATS	The epicardial adipose tissue (EAT) is a reservoir of adipose-derived stem cells (ASCs), with as yet unknown effects on myocardial and coronary arteries homeostasis. The purpose of this study was to investigate the angiogenic function of epicardial ASCs and their regulation by the common cardiovascular risk factors (CVRFs) affecting heart disease. Epicardial fat was obtained from a rodent model with clustering of CVRFs [Zucker diabetic fatty (ZDF)-Lepr(fa)] rats and from their lean control (ZDF-Crl) littermates without CVRFs, ASCs were isolated, and their function was assessed by proliferation and differentiation assays, flow cytometry, gene expression, and in vivo Matrigel angiogenesis analysis. Epicardial ASCs from both groups showed adipogenic and osteogenic differentiation capacity; however, epicardial ASCs from CVRF animals had a lesser ability to form tubular structures in vitro after endothelial differentiation, as well as a reduced angiogenic potential in vivo compared to control animals. Epicardial ASCs from CVRF rats showed up-regulation of the downstream Notch signaling genes Hes7, Hey1, and Heyl compared with control animals. The inhibition of Notch signaling by conditioning epicardial ASCs from CVRF animals with a gamma-secretase inhibitor induced a reduction in Hes/Hey gene expression and rescued their angiogenic function in vivo. We report for the first time the impact of CVRF burden on the ASCs of EAT and that the defective function is in part caused by increased Notch signaling. Conditioning ASCs by blocking Notch signaling rescues their angiogenic potential.	[Teresa Bejar, Maria] CSIC, Inst Catala Ciencies Cardiovasc, Inst Invest Biomed St Pau, Cardiovasc Res Ctr, Barcelona, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Institut Catala de Ciencies Cardiovasculars (ICCC)	Badimon, L (corresponding author), Cardiovasc Res Ctr, C St Antoni Maria Claret 167, Barcelona 08025, Spain.	lbadimon@csic-iccc.org	BADIMON, LINA/S-2950-2019; Peña, Esther/AAB-8217-2019; Ferrer-Lorente, Raquel/M-4416-2014; Bejar, Maria Teresa/M-3876-2014; Badimon, Lina/O-4711-2014	Ferrer-Lorente, Raquel/0000-0002-2052-9011; Bejar, Maria Teresa/0000-0002-8850-0178; Pena, Esther/0000-0003-2750-0614; Badimon, Lina/0000-0002-9162-2459	Spanish Ministry of Health-Instituto de Salud Carlos III [RIC RD/13/000, RETIC TERCEL RD/13/0010]; Spanish Ministry of Science and Innovation [PNS SAF2010/16549]; Catalan Government (FI-DGR); Spanish Ministry of Science and Innovation-Instituto de Salud Carlos III	Spanish Ministry of Health-Instituto de Salud Carlos III(Instituto de Salud Carlos IIISpanish Government); Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Catalan Government (FI-DGR); Spanish Ministry of Science and Innovation-Instituto de Salud Carlos III(Instituto de Salud Carlos IIIMinistry of Science and Innovation, Spain (MICINN)Spanish Government)	The authors thank Dr. Javier Crespo and Dr. Sandra Camino from the Cardiovascular Research Center (CSIC-ICCC) for technical help with flow cytometry and support in gene expression analyses, respectively. This work was supported Spanish Ministry of Health-Instituto de Salud Carlos III (Grants RIC RD/13/000 and RETIC TERCEL RD/13/0010), and the Spanish Ministry of Science and Innovation (Grant PNS SAF2010/16549). M.T.B. holds a predoctoral fellowship from the Catalan Government (FI-DGR2013), and R.F.L. is the recipient of a Sara Borrell contract from the Spanish Ministry of Science and Innovation-Instituto de Salud Carlos III. L.B. is the Cardiovascular Research Chair, Universitat Autonoma de Barcelona (Barcelona, Spain). The authors declare no conflicts of interest.	Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Baker AR, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-1; Barolo S, 2002, GENE DEV, V16, P1964, DOI 10.1101/gad.987402; Bernal-Lopez MR, 2013, ACTA DIABETOL, V50, P553, DOI 10.1007/s00592-011-0337-2; Bigas A, 2012, BLOOD, V119, P3226, DOI 10.1182/blood-2011-10-355826; Borggrefe T, 2016, BBA-MOL CELL RES, V1863, P303, DOI 10.1016/j.bbamcr.2015.11.020; Burchfield JS, 2008, FIBROGENESIS TISSUE, V1, DOI 10.1186/1755-1536-1-4; Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478; Chapouton P, 2010, J NEUROSCI, V30, P7961, DOI 10.1523/JNEUROSCI.6170-09.2010; Distel E, 2012, BIOCHIMIE, V94, P1660, DOI 10.1016/j.biochi.2012.04.014; Faber DR, 2010, ATHEROSCLEROSIS, V212, P274, DOI 10.1016/j.atherosclerosis.2010.04.029; Ferrer-Lorente R., 2014, DIABETOLOGIA; Ferrer-Lorente R, 2014, STEM CELLS DEV, V23, P3034, DOI 10.1089/scd.2014.0070; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gomes SA, 2013, P NATL ACAD SCI USA, V110, P2834, DOI 10.1073/pnas.1220185110; Guo YJ, 2014, INT J MOL SCI, V15, P159, DOI 10.3390/ijms15010159; Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571; Hsiao ST, 2013, STEM CELLS DEV, V22, P1614, DOI 10.1089/scd.2012.0602; Huang Y, 2010, CELL PROLIFERAT, V43, P147, DOI 10.1111/j.1365-2184.2009.00661.x; Iacobellis G, 2005, NAT CLIN PRACT CARD, V2, P536, DOI 10.1038/ncpcardio0319; Iacobellis G, 2011, INT J CARDIOL, V146, P452, DOI 10.1016/j.ijcard.2010.10.117; Jing W, 2010, BIOCHEM BIOPH RES CO, V392, P442, DOI 10.1016/j.bbrc.2010.01.043; Karastergiou K, 2010, ARTERIOSCL THROM VAS, V30, P1340, DOI 10.1161/ATVBAHA.110.204719; Kilroy GE, 2007, J CELL PHYSIOL, V212, P702, DOI 10.1002/jcp.21068; Koch U, 2013, DEVELOPMENT, V140, P689, DOI 10.1242/dev.080614; Ladi E, 2005, J CELL BIOL, V170, P983, DOI 10.1083/jcb.200503113; Leppanen VM, 2011, BLOOD, V117, P1507, DOI 10.1182/blood-2010-08-301549; Li HL, 2014, AM J PHYSIOL-ENDOC M, V306, pE197, DOI 10.1152/ajpendo.00202.2013; Li TS, 2006, AM J PHYSIOL-HEART C, V290, pH1362, DOI 10.1152/ajpheart.00766.2005; Liu JN, 2010, CURR TOP DEV BIOL, V92, P367, DOI [10.1016/S0070-2153(10)92012-7, 10.1016/S0070-2153(10)91012-7]; Maier D, 2006, HEREDITAS, V143, P212, DOI 10.1111/j.2007.0018-0661.01971.x; Marconcini L, 1999, P NATL ACAD SCI USA, V96, P9671, DOI 10.1073/pnas.96.17.9671; Matsuda K, 2013, TISSUE ENG PT A, V19, P1327, DOI [10.1089/ten.tea.2012.0391, 10.1089/ten.TEA.2012.0391]; Mazurek T, 2003, CIRCULATION, V108, P2460, DOI 10.1161/01.CIR.0000099542.57313.C5; McAninch EA, 2015, OBESITY, V23, P1267, DOI 10.1002/oby.21059; Ninov N, 2012, DEVELOPMENT, V139, P1557, DOI 10.1242/dev.076000; Onate B, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-625; Onate B, 2012, FASEB J, V26, P4327, DOI 10.1096/fj.12-207217; Osathanon T, 2012, CELL BIOL INT, V36, P1161, DOI 10.1042/CBI20120288; Pajvani UB, 2011, NAT MED, V17, P961, DOI 10.1038/nm.2378; Rubina K, 2009, TISSUE ENG PT A, V15, P2039, DOI 10.1089/ten.tea.2008.0359; Ryden L, 2013, EUR HEART J, V34, P3035, DOI 10.1093/eurheartj/eht108; Stefansson S, 2001, J BIOL CHEM, V276, P8135, DOI 10.1074/jbc.M007609200; Tepper OM, 2002, CIRCULATION, V106, P2781, DOI 10.1161/01.CIR.0000039526.42991.93; Wang CP, 2009, CLIN ENDOCRINOL, V70, P876, DOI 10.1111/j.1365-2265.2008.03411.x; Wang H, 2013, J BIOL CHEM, V288, P16761, DOI 10.1074/jbc.M112.446633; Xin XH, 1999, J BIOL CHEM, V274, P9116, DOI 10.1074/jbc.274.13.9116	48	10	10	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2849	2859		10.1096/fj.201600204R	http://dx.doi.org/10.1096/fj.201600204R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27150622				2022-12-28	WOS:000380994000020
J	Nueda, ML; Naranjo, AI; Baladron, V; Laborda, J				Nueda, Maria-Luisa; Naranjo, Ana-Isabel; Baladron, Victoriano; Laborda, Jorge			Different expression levels of DLK1 inversely modulate the oncogenic potential of human MDA-MB-231 breast cancer cells through inhibition of NOTCH1 signaling	FASEB JOURNAL			English	Article						PREF-1/DLK1; cell growth; cell invasion; MAPK/ERK signaling; rpS6 signaling	DELTA-LIKE PROTEIN; MESENCHYMAL TRANSITION; NEGATIVE REGULATOR; TRANSGENIC MICE; E-CADHERIN; ACTIVATION; GENE; GROWTH; LINES; OVEREXPRESSION	NOTCH receptors participate in cancer cell proliferation and survival. Accumulated evidence indicates that, depending on the cellular context, these receptors can function as oncogenes or as tumor-suppressor genes. The epidermal growth factor-like protein delta-like homolog (DLK) 1 acts as a NOTCH inhibitor and is involved in the regulation of normal and tumoral growth. In this work, we focused on the role of DLK1 in the control of breast cancer cell growth, a tumor type in which NOTCH receptors have been shown to play both opposite roles. We found that human DLK1 inhibits NOTCH signaling in MDA-MB-231 breast cancer cells. The proliferation rate and invasion capabilities of these cells depended on the level of NOTCH activation and signaling, as regulated by DLK1. High levels of DLK1 expression led to a significant decrease in NOTCH signaling, which was associated with a decrease in breast cancer cell proliferation and invasion. On the contrary, lower levels of NOTCH inhibition, caused by lower levels of DLK1 overexpression, led to enhanced in vitro MDA-MB-231 cell invasion, and to both in vitro and in vivo increased cell proliferation. The data presented in this work suggest that a fine regulation of NOTCH signaling plays an important role in the control of breast cancer cell proliferation and invasion.	[Nueda, Maria-Luisa; Naranjo, Ana-Isabel; Baladron, Victoriano; Laborda, Jorge] Univ Castilla La Mancha, Spanish Natl Res Council CSIC, Dept Inorgan & Organ Chem & Biochem, Biochem & Mol Biol Branch, Albacete, Spain; [Nueda, Maria-Luisa; Laborda, Jorge] Univ Castilla La Mancha, Spanish Natl Res Council CSIC, Sch Pharm, Albacete, Spain; [Naranjo, Ana-Isabel; Baladron, Victoriano] Univ Castilla La Mancha, Spanish Natl Res Council CSIC, Sch Med, Albacete, Spain; [Naranjo, Ana-Isabel; Baladron, Victoriano] Univ Castilla La Mancha, Spanish Natl Res Council CSIC, Reg Ctr Biomed Res CRIB, Biomed Unit, Albacete, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad de Castilla-La Mancha	Nueda, ML; Laborda, J (corresponding author), Univ Castilla La Mancha, CRIB, Sch Pharm, Lab Biochem & Mol Biol, C Almansa 14, Albacete 02006, Spain.	marialuisa.nueda@uclm.es; jorge.laborda@uclm.es	Nueda, María-Luisa/L-3044-2014; Laborda, Jorge/L-5726-2014; Baladron, Victoriano/L-1758-2014	Nueda, María-Luisa/0000-0002-5456-5045; Laborda, Jorge/0000-0002-9210-838X; Baladron, Victoriano/0000-0003-4574-8760	Spanish Cancer Association (AECC) [PI-2008/20]; Health Council of the Regional Government of Castilla-La Mancha, Spain [PEI-2014-033]; Fonds Europeen de Developpement Regional (FEDER); Ministry of Economy and Competitiveness [BFU2010-16433]	Spanish Cancer Association (AECC); Health Council of the Regional Government of Castilla-La Mancha, Spain; Fonds Europeen de Developpement Regional (FEDER)(European Commission); Ministry of Economy and Competitiveness	This work was supported by Grant PI-2008/20 (to M.L.N.) from the Spanish Cancer Association (AECC), Grant PEI-2014-033 (to J.L.) from the Health Council of the Regional Government of Castilla-La Mancha, Spain, supported by the Fonds Europeen de Developpement Regional (FEDER), and Grant BFU2010-16433 (to J.L.) from the Ministry of Economy and Competitiveness. The authors declare no conflicts of interest.	Acar A, 2016, STEM CELLS INT, V2016, DOI 10.1155/2016/2498764; Baker AT, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00360; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; Beatus P, 1999, DEVELOPMENT, V126, P3925; Bolos V, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3447; Bray SJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-11; CAILLEAU R, 1974, J NATL CANCER I, V53, P661, DOI 10.1093/jnci/53.3.661; Callahan R, 1998, BIOCHEM SOC SYMP, P211; Chen CF, 2016, CELL CYCLE, V15, P432, DOI 10.1080/15384101.2015.1127474; Chen L, 2011, J BIOL CHEM, V286, P32140, DOI 10.1074/jbc.M111.230110; Dezso K, 2008, VIRCHOWS ARCH, V452, P443, DOI 10.1007/s00428-007-0571-8; Difeo A, 2006, ONCOGENE, V25, P6026, DOI 10.1038/sj.onc.1209611; DUMONT FJ, 1990, J IMMUNOL, V144, P251; Falix FA, 2012, BBA-MOL BASIS DIS, V1822, P988, DOI 10.1016/j.bbadis.2012.02.003; Fender AW, 2015, J CELL BIOCHEM, V116, P2517, DOI 10.1002/jcb.25196; Friedrichsen BN, 2003, J ENDOCRINOL, V176, P257, DOI 10.1677/joe.0.1760257; Fukazawa H, 2002, MOL CANCER THER, V1, P303; Gallahan D, 1996, CANCER RES, V56, P1775; Gil-Garcia B, 2016, BIOL CELL, V108, P29, DOI 10.1111/boc.201500029; Grishina IB, 2015, AM J CLIN EXP UROL, V3, P24; Gubina E, 1999, CYTOGENET CELL GENET, V84, P206, DOI 10.1159/000015259; Hajra KM, 2002, CANCER RES, V62, P1613; Hirata H, 2002, SCIENCE, V298, P840, DOI 10.1126/science.1074560; Hu CY, 2006, AM J PATHOL, V168, P973, DOI 10.2353/ajpath.2006.050416; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Izrailit J, 2013, P NATL ACAD SCI USA, V110, P1714, DOI 10.1073/pnas.1214014110; Jolicoeur P, 1998, BIOCHEM SOC SYMP, P159; Kawakami T, 2006, HUM MOL GENET, V15, P821, DOI 10.1093/hmg/ddl001; Laborda J, 2000, HISTOL HISTOPATHOL, V15, P119, DOI 10.14670/HH-15.119; LABORDA J, 1993, J BIOL CHEM, V268, P3817; LEE YL, 1995, BBA-GENE STRUCT EXPR, V1261, P223; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Li L, 2005, ONCOGENE, V24, P4472, DOI 10.1038/sj.onc.1208637; Lobry C, 2014, BLOOD, V123, P2451, DOI 10.1182/blood-2013-08-355818; Mazzone M, 2010, P NATL ACAD SCI USA, V107, P5012, DOI 10.1073/pnas.1000896107; Mirshekar-Syahkal B, 2013, HAEMATOLOGICA, V98, P163, DOI 10.3324/haematol.2012.070789; Nueda ML, 2008, J MOL BIOL, V379, P428, DOI 10.1016/j.jmb.2008.03.070; Nueda ML, 2007, J MOL BIOL, V367, P1281, DOI 10.1016/j.jmb.2006.10.043; Nueda ML, 2014, BBA-MOL CELL RES, V1843, P2674, DOI 10.1016/j.bbamcr.2014.07.015; Pinnix CC, 2009, CANCER RES, V69, P5312, DOI 10.1158/0008-5472.CAN-08-3767; Qi XF, 2008, INT J MOL MED, V22, P61; ROBBINS J, 1992, J VIROL, V66, P2594, DOI 10.1128/JVI.66.4.2594-2599.1992; Ruiz-Hidalgo MJ, 2002, EXP CELL RES, V274, P178, DOI 10.1006/excr.2001.5464; Samulewicz SJ, 2002, WOUND REPAIR REGEN, V10, P215, DOI 10.1046/j.1524-475X.2002.10404.x; Sanchez-Solana B, 2011, BBA-MOL CELL RES, V1813, P1153, DOI 10.1016/j.bbamcr.2011.03.004; SATYAPRAKASH KL, 1981, CANCER GENET CYTOGEN, V3, P61, DOI 10.1016/0165-4608(81)90057-1; Savagner P, 1997, J CELL BIOL, V137, P1403, DOI 10.1083/jcb.137.6.1403; Shao S, 2015, MOL CANCER, V14, DOI 10.1186/s12943-015-0295-3; Sul HS, 2009, MOL ENDOCRINOL, V23, P1717, DOI 10.1210/me.2009-0160; VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241; Weber D, 2014, CURR TOP DEV BIOL, V110, P285, DOI 10.1016/B978-0-12-405943-6.00008-7; Xu JM, 2016, TUMOR BIOL, V37, P1871, DOI 10.1007/s13277-015-3961-6; Yanai H, 2010, J BIOCHEM, V148, P85, DOI 10.1093/jb/mvq034; Yin D, 2006, ONCOGENE, V25, P1852, DOI 10.1038/sj.onc.1209219; Yu F, 2010, LIVER INT, V30, P703, DOI 10.1111/j.1478-3231.2010.02214.x; Zhang HB, 2003, J BIOL CHEM, V278, P20906, DOI 10.1074/jbc.M300022200; Zhang ZY, 2010, AM J PATHOL, V177, P1459, DOI 10.2353/ajpath.2010.090476	57	13	16	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3484	3496		10.1096/fj.201601341RRR	http://dx.doi.org/10.1096/fj.201601341RRR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28461338				2022-12-28	WOS:000405932400025
J	Shindou, H; Shiraishi, S; Tokuoka, SM; Takahashi, Y; Harayama, T; Abe, T; Bando, K; Miyano, K; Kita, Y; Uezono, Y; Shimizu, T				Shindou, Hideo; Shiraishi, Seiji; Tokuoka, Suzumi M.; Takahashi, Yoshikazu; Harayama, Takeshi; Abe, Takaya; Bando, Kana; Miyano, Kanako; Kita, Yoshihiro; Uezono, Yasuhito; Shimizu, Takao			Relief from neuropathic pain by blocking of the platelet-activating factor-pain loop	FASEB JOURNAL			English	Article						PAF; lysophosphatidylcholine acyltransferase 2; LPCAT2; analgesic drug; feedback loop	LYSOPHOSPHATIDYLCHOLINE ACYLTRANSFERASE 2; PERIPHERAL-NERVE INJURY; TACTILE ALLODYNIA; FACTOR PAF; LYSOPHOSPHOLIPID ACYLTRANSFERASES; SPINAL MICROGLIA; LIPID MEDIATORS; MUTANT MICE; RECEPTOR; MOUSE	Neuropathic pain resulting from peripheral neuronal damage is largely resistant to treatment with currently available analgesic drugs. Recently, ATP, lysophosphatidic acid, and platelet-activating factor (PAF) have been reported to play important inductive roles in neuropathic pain. In the present study, we found that pain-like behaviors resulting from partial sciatic nerve ligation (PSL) were largely attenuated by deficiency of lysophosphatidylcholine acyltransferase (LPCAT)2, which is one of the PAF biosynthetic enzymes. By contrast, deficiency of the other PAF biosynthetic enzyme, LPCAT1, did not ameliorate neuropathic pain. With regard to the mechanism of the observed effects, LPCAT2 was detected in wild-type spinal cord microglia, and the absence of LPCAT2 expression precluded spinal PAF expression in LPCAT2-knockout mice. Furthermore, ATP-stimulated PAF biosynthesis in macrophages was decreased by pretreatment with the PAF receptor antagonist ABT-491, indicating the existence of a positive feedback loop of PAF biosynthesis, which we designated the PAF-pain loop. In conclusion, LPCAT2 is a novel therapeutic target for newly categorized analgesic drugs; in addition, our data call for the reevaluation of the clinical utility of PAF receptor antagonists. Shindou, H., Shiraishi, S., Tokuoka, S. M., Takahashi Y., Harayama, T., Abe, T., Bando, K., Miyano, K., Kita, Y., Uezono, Y., Shimizu, T. Relief from neuropathic pain by blocking of the platelet-activating factor-pain loop.	[Shindou, Hideo; Takahashi, Yoshikazu; Harayama, Takeshi; Shimizu, Takao] Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Tokyo, Japan; [Shindou, Hideo; Shiraishi, Seiji; Miyano, Kanako; Uezono, Yasuhito] Agcy Res & Med Dev AMED, Tokyo, Japan; [Shindou, Hideo] Univ Tokyo, Grad Sch Med, Dept Lipid Sci, Tokyo, Japan; [Tokuoka, Suzumi M.; Kita, Yoshihiro; Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Lipid, Tokyo, Japan; [Kita, Yoshihiro] Univ Tokyo, Grad Sch Med, Life Sci Core Facil, Tokyo, Japan; [Shiraishi, Seiji; Miyano, Kanako; Uezono, Yasuhito] Natl Canc Ctr, Res Inst, Div Canc Pathophysiol, Tokyo, Japan; [Abe, Takaya; Bando, Kana] RIKEN Ctr Life Sci Technol, Genet Engn Team, Kobe, Hyogo, Japan; [Bando, Kana] RIKEN Ctr Life Sci Technol, Anim Resource Dev Unit, Kobe, Hyogo, Japan; [Uezono, Yasuhito] Natl Canc Ctr, Exploratory Oncol Res & Clin Trial Ctr, Div Support Care Res, Tokyo, Japan	National Center for Global Health & Medicine - Japan; University of Tokyo; University of Tokyo; University of Tokyo; National Cancer Center - Japan; RIKEN; RIKEN; National Cancer Center - Japan	Shindou, H (corresponding author), Natl Ctr Global Hlth & Med, Shinjuku Ku, 1-21-1 Toyama, Tokyo 1628655, Japan.	hshindou-tky@umin.net	Harayama, Takeshi/AAD-8852-2022; Shiraishi, Seiji/GPX-5566-2022; Shimizu, Takao/AAV-7052-2021	Harayama, Takeshi/0000-0003-2255-4197; Miyano, Kanako/0000-0003-1673-6074	Japan Society for the Promotion of Science (JSPS) (KAKENHI) [26460380, 24229003]; Takeda Science Foundation; Japan Science and Technology Agency Core Research for Evolutional Science and Technology (JST CREST); Agency for Research and Medical Development (AMED) CREST [16GM0710002H0104]; Project for Cancer Research and Therapeutic Evolution (P-CREATE AMED); Ono Medical Research Foundation; Nakatomi Foundation; Cell Science Research Foundation; Shimadzu Corp.; Ono Pharmaceutical Co., Ltd.; JSPS	Japan Society for the Promotion of Science (JSPS) (KAKENHI)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Takeda Science Foundation(Takeda Science Foundation (TSF)); Japan Science and Technology Agency Core Research for Evolutional Science and Technology (JST CREST)(Japan Science & Technology Agency (JST)Core Research for Evolutional Science and Technology (CREST)); Agency for Research and Medical Development (AMED) CREST(Japan Agency for Medical Research and Development (AMED)); Project for Cancer Research and Therapeutic Evolution (P-CREATE AMED); Ono Medical Research Foundation; Nakatomi Foundation; Cell Science Research Foundation(Cell Science Research Foundation, Japan); Shimadzu Corp.; Ono Pharmaceutical Co., Ltd.(Ono Pharmaceutical Co Ltd); JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank K. Waku (Teikyo University, Tokyo, Japan) for constructive comments; M. Mishina (Ritsumeikan University, Kyoto, Japan) for providing telencephalin-Cre mice; William J. Valentine (National Center for Global Health And Medicine) for proofreading the manuscript; and all members of the T.S. laboratory (National Center for Global Health and Medicine and the University of Tokyo) for advice, discussions, and technical support. This study was supported by the Japan Society for the Promotion of Science (JSPS) Grant-in-Aid for Scientific Research (KAKENHI: 26460380 to H.S., and 24229003 to T.S.); the Takeda Science Foundation (to T.S.); Japan Science and Technology Agency Core Research for Evolutional Science and Technology (JST CREST) and Agency for Research and Medical Development (AMED) CREST (16GM0710002H0104; to H.S.); and the Project for Cancer Research and Therapeutic Evolution (P-CREATE AMED; to H.S., S.S., K.M., and Y.U.). H.S. was supported by the Ono Medical Research Foundation, the Nakatomi Foundation, and the Cell Science Research Foundation. The Department of Lipidomics (Graduate School of Medicine, The University of Tokyo) is financially supported by Shimadzu Corp. and Ono Pharmaceutical Co., Ltd. T.H. was supported by a JSPS Postdoctoral Fellowship for Research Abroad. The authors declare no conflicts of interest.	Albert DH, 1997, EUR J PHARMACOL, V325, P69, DOI 10.1016/S0014-2999(97)00109-X; Friedman JS, 2010, P NATL ACAD SCI USA, V107, P15523, DOI 10.1073/pnas.1002897107; Fuse T, 2004, BIOCHEM BIOPH RES CO, V318, P665, DOI 10.1016/j.bbrc.2004.04.076; Gao L, 2015, J CLIN INVEST, V125, P2808, DOI 10.1172/JCI78544; Harayama T, 2008, J BIOL CHEM, V283, P11097, DOI 10.1074/jbc.M708909200; Harayama T, 2014, CELL METAB, V20, P295, DOI 10.1016/j.cmet.2014.05.019; Hasegawa S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010467; Inoue M, 2004, NAT MED, V10, P712, DOI 10.1038/nm1060; Ishii S, 2000, PROG LIPID RES, V39, P41, DOI 10.1016/S0163-7827(99)00016-8; Kasperska-Zajac A, 2008, RECENT PATENTS INFLA, V2, P72, DOI 10.2174/187221308783399306; Kita Y, 2005, ANAL BIOCHEM, V342, P134, DOI 10.1016/j.ab.2005.03.048; Kiyonari H, 2010, GENESIS, V48, P317, DOI 10.1002/dvg.20614; Malmberg AB, 1998, PAIN, V76, P215, DOI 10.1016/S0304-3959(98)00045-1; Masuda T, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12529; MINAMI T, 1995, PAIN, V61, P285, DOI 10.1016/0304-3959(94)00183-F; Morimoto R, 2014, J BIOL CHEM, V289, P15566, DOI 10.1074/jbc.M114.558874; Morimoto R, 2010, J BIOL CHEM, V285, P29857, DOI 10.1074/jbc.M110.147025; Morita I, 2002, PROSTAG OTH LIPID M, V68-9, P165, DOI 10.1016/S0090-6980(02)00029-1; Morita K, 2004, PAIN, V111, P351, DOI 10.1016/j.pain.2004.07.016; Morita K, 2008, PAIN, V138, P525, DOI 10.1016/j.pain.2008.01.030; Motoyama N, 2013, EUR J PAIN, V17, P1156, DOI 10.1002/j.1532-2149.2013.00289.x; Nakamura K, 2001, EUR J NEUROSCI, V13, P179, DOI 10.1046/j.0953-816X.2000.01366.x; Narumiya S, 2011, FASEB J, V25, P813, DOI 10.1096/fj.11-0302ufm; Okubo M, 2012, MOL PAIN, V8, DOI 10.1186/1744-8069-8-8; PRESCOTT SM, 1990, J BIOL CHEM, V265, P17381; SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shindou H, 2005, J IMMUNOL, V175, P1177, DOI 10.4049/jimmunol.175.2.1177; Shindou H, 2007, J BIOL CHEM, V282, P6532, DOI 10.1074/jbc.M609641200; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; Tarui M, 2014, J LIPID RES, V55, P1386, DOI 10.1194/jlr.M049205; Tozaki-Saitoh H, 2008, J NEUROSCI, V28, P4949, DOI 10.1523/JNEUROSCI.0323-08.2008; Tsuda M, 2003, NATURE, V424, P778, DOI 10.1038/nature01786; Tsuda M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00191; Tsuda M, 2011, BIOL PHARM BULL, V34, P1159, DOI 10.1248/bpb.34.1159; Ueda H, 2013, BBA-MOL CELL BIOL L, V1831, P61, DOI 10.1016/j.bbalip.2012.08.014; Yamada M, 2015, J CHROMATOGR B, V995, P74, DOI 10.1016/j.jchromb.2015.05.015	38	23	23	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2973	2980		10.1096/fj.201601183R	http://dx.doi.org/10.1096/fj.201601183R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28341636	hybrid, Green Published			2022-12-28	WOS:000405931000022
J	Cui, J; Pang, J; Lin, YJ; Gong, H; Wang, ZH; Li, YX; Li, J; Wang, Z; Jiang, P; Dai, DP; Li, J; Cai, JP; Huang, JD; Zhang, TM				Cui, Ju; Pang, Jing; Lin, Ya-Jun; Gong, Huan; Wang, Zhen-He; Li, Yun-Xuan; Li, Jin; Wang, Zai; Jiang, Ping; Dai, Da-Peng; Li, Jian; Cai, Jian-Ping; Huang, Jian-Dong; Zhang, Tie-Mei			Adipose-specific deletion of Kif5b exacerbates obesity and insulin resistance in a mouse model of diet-induced obesity	FASEB JOURNAL			English	Article						adipogenesis and lipolysis; adipokine; motor protein; thermogenesis	KINESIN HEAVY-CHAIN; ADIPONECTIN KNOCKOUT MICE; PANCREATIC BETA-CELLS; HIGH-FAT DIET; CONVENTIONAL KINESIN; GLUT4 TRANSLOCATION; ENERGY-BALANCE; BROWN FAT; PROTEIN; EXPRESSION	Recent studies haveshownthatKIF5B (conventionalkinesin heavy chain) mediates glucose transporter type 4 translocation and adiponectin secretion in 3T3-L1 adipocytes, suggesting an involvement of KIF5B in the homeostasis of metabolism. However, the in vivo physiologic function ofKIF5B in adipose tissue remains to be determined. In this study, adipose-specific Kif5b knockout (F-K5bKO) mice were generated using the Cre-LoxP strategy. F-K5bKO mice had similar body weights to controls fed on a standard chow diet. However, F-K5bKO mice had hyperlipidemia and significant glucose intolerance and insulin resistance. Deletion of Kif5b aggravated the deleterious impact of a high-fat diet (HFD) on body weight gain, hepatosteatosis, glucose tolerance, and systematic insulin sensitivity. These changes were accompanied by impaired insulin signaling, decreased secretion of adiponectin, and increased serum levels of leptin and proinflammatory adipokines. F-K5bKO mice fed on an HFD exhibited lower energy expenditure and thermogenic dysfunction as a result of whitening of brown adipose due to decreased mitochondria biogenesis and down regulation of key thermogenicgene expression. In conclusion, selective deletion of Kif5b in adipose tissue exacerbates HFD-induced obesity and its associated metabolic disorders, partly through a decrease in energy expenditure, dysregulation of adipokine secretion, and insulin signaling.-Cui, J., Pang, J., Lin, Y.-J., Gong, H., Wang, Z.-H., Li, Y.-X., Li, J., Wang, Z., Jiang, P., Dai, D.-P., Li, J., Cai, J.-P., Huang, J.-D., Zhang, T.-M. Adipose-specific deletionof Kif5b exacerbates obesity and insulin resistance in a mousemodel of diet-induced obesity.	[Cui, Ju; Pang, Jing; Lin, Ya-Jun; Gong, Huan; Li, Jin; Jiang, Ping; Dai, Da-Peng; Li, Jian; Cai, Jian-Ping; Zhang, Tie-Mei] Minist Hlth, Key Lab Geriatr, Natl Ctr Gerontol, Beijing Hosp, Beijing 100730, Peoples R China; [Wang, Zhen-He; Li, Yun-Xuan] Wenzhou Med Univ, Sch Pharm, Wenzhou, Peoples R China; [Wang, Zai] China Japan Friendship Hosp, Inst Clin Med Sci, Beijing, Peoples R China; [Huang, Jian-Dong] Univ Hong Kong, Sch Biomed Sci, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China; [Huang, Jian-Dong] Univ Hong Kong, Shenzhen Inst Res & Innovat, Hong Kong, Hong Kong, Peoples R China; [Huang, Jian-Dong] Shenzhen Inst Adv Technol, Ctr Synthet Biol Engn Res, Shenzhen, Peoples R China	Beijing Hospital; Wenzhou Medical University; China-Japan Friendship Hospital; University of Hong Kong; University of Hong Kong; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Zhang, TM (corresponding author), Minist Hlth, Key Lab Geriatr, Natl Ctr Gerontol, Beijing Hosp, Beijing 100730, Peoples R China.; Huang, JD (corresponding author), Univ Hong Kong, Sch Biomed Sci, 21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	jdhuang@hku.hk; tmzhang126@126.com	/C-4277-2009	/0000-0001-7531-2816	National Natural Science Foundation of China [31400995]; Beijing Natural Science Foundation [7154234]; Beijing Hospital Nova Project [BJ-2016-034]; 12th Five-Year National Science and Technology Project [2012BA110B01]; Hong Kong Research Grants Council [HKU 767012, HKU 768113M, HKU 17127015, HKUST10/CRF/12R]; Shenzhen Peacock Project [KQTD2015033117210153]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Hospital Nova Project; 12th Five-Year National Science and Technology Project; Hong Kong Research Grants Council(Hong Kong Research Grants Council); Shenzhen Peacock Project	This work was supported, in part, by the National Natural Science Foundation of China (Grant 31400995), the Beijing Natural Science Foundation (Grant 7154234), the Beijing Hospital Nova Project (BJ-2016-034 to J.C).; the 12th Five-Year National Science and Technology Project (2012BA110B01 to T.M.Z), and the Hong Kong Research Grants Council (Grants HKU 767012; HKU 768113M; HKU 17127015; HKUST10/CRF/12R; to J.D.H.). This work was also supported by the Shenzhen Peacock Project (KQTD2015033117210153).	Abel ED, 2001, NATURE, V409, P729, DOI 10.1038/35055575; Argyropoulos G, 2009, PHYSIOL GENOMICS, V36, P79, DOI 10.1152/physiolgenomics.00003.2008; Arita Y, 1999, BIOCHEM BIOPH RES CO, V257, P79, DOI 10.1006/bbrc.1999.0255; Asano T, 2009, J GASTROEN HEPATOL, V24, P1669, DOI 10.1111/j.1440-1746.2009.06039.x; Batut J, 2007, DEV CELL, V12, P261, DOI 10.1016/j.devcel.2007.01.010; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Cho KI, 2007, TRAFFIC, V8, P1722, DOI 10.1111/j.1600-0854.2007.00647.x; Choi DK, 2011, CELL PHYSIOL BIOCHEM, V28, P933, DOI 10.1159/000335807; Cui J, 2016, BIOCHEM BIOPH RES CO, V476, P620, DOI 10.1016/j.bbrc.2016.06.008; Cui J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126002; Cui J, 2011, DIABETES, V60, P320, DOI 10.2337/db09-1078; D'Agati VD, 2016, NAT REV NEPHROL, V12, P453, DOI 10.1038/nrneph.2016.75; Garcia-Arcos I, 2013, J BIOL CHEM, V288, P14046, DOI 10.1074/jbc.M113.469270; Goldstein LSB, 2000, ANNU REV NEUROSCI, V23, P39, DOI 10.1146/annurev.neuro.23.1.39; Guo HL, 2012, CELL RES, V22, P1246, DOI 10.1038/cr.2012.52; Gustafsson AB, 2005, METH MOLEC MED, V112, P81; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Hirokawa N, 2009, NAT REV MOL CELL BIO, V10, P682, DOI 10.1038/nrm2774; Hoeke G, 2016, CIRC RES, V118, P173, DOI 10.1161/CIRCRESAHA.115.306647; Hotta K, 2000, ARTERIOSCL THROM VAS, V20, P1595, DOI 10.1161/01.ATV.20.6.1595; Huang J, 2001, P NATL ACAD SCI USA, V98, P13084, DOI 10.1073/pnas.241368698; Imamura T, 2003, MOL CELL BIOL, V23, P4892, DOI 10.1128/MCB.23.14.4892-4900.2003; Junco A, 2001, BIOL REPROD, V64, P1320, DOI 10.1095/biolreprod64.5.1320; Klaus S, 1997, BIOESSAYS, V19, P215, DOI 10.1002/bies.950190307; Kubota N, 2002, J BIOL CHEM, V277, P25863, DOI 10.1074/jbc.C200251200; Lalioti VS, 2009, J CELL PHYSIOL, V218, P416, DOI 10.1002/jcp.21614; Lee KY, 2013, DIABETES, V62, P864, DOI 10.2337/db12-1089; Levitsky DA, 2012, PUBLIC HEALTH NUTR, V15, P126, DOI 10.1017/S1368980011002187; Liu ML, 2014, CELL METAB, V19, P967, DOI 10.1016/j.cmet.2014.03.018; Maebuchi M, 2003, ARCH BIOCHEM BIOPHYS, V416, P164, DOI 10.1016/S0003-9861(03)00279-0; Meng YX, 1997, ENDOCRINOLOGY, V138, P1979, DOI 10.1210/en.138.5.1979; Mitchell SJ, 2016, CELL METAB, V23, P1093, DOI 10.1016/j.cmet.2016.05.027; Nie T, 2012, FEBS LETT, V586, P3618, DOI 10.1016/j.febslet.2012.08.006; Pang J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146675; Rahman A, 1998, J BIOL CHEM, V273, P15395, DOI 10.1074/jbc.273.25.15395; Rosen ED, 2006, NATURE, V444, P847, DOI 10.1038/nature05483; Semiz S, 2003, EMBO J, V22, P2387, DOI 10.1093/emboj/cdg237; Shimizu I, 2014, J CLIN INVEST, V124, P2099, DOI 10.1172/JCI71643; Sivitz WI, 1997, ENDOCRINOLOGY, V138, P3395, DOI 10.1210/en.138.8.3395; Sohle J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031193; Spalding KL, 2008, NATURE, V453, P783, DOI 10.1038/nature06902; Steppan CM, 2001, NATURE, V409, P307, DOI 10.1038/35053000; Sun SY, 2012, ANNU REV NUTR, V32, P261, DOI 10.1146/annurev-nutr-071811-150623; Tchkonia T, 2013, CELL METAB, V17, P644, DOI 10.1016/j.cmet.2013.03.008; Valle A, 2005, AM J PHYSIOL-ENDOC M, V289, pE15, DOI 10.1152/ajpendo.00553.2004; Varadi A, 2002, J CELL SCI, V115, P4177, DOI 10.1242/jcs.00083; Wang N, 2016, BLOOD, V127, P1949, DOI 10.1182/blood-2016-01-631259; Wang ZV, 2010, ENDOCRINOLOGY, V151, P2933, DOI 10.1210/en.2010-0136; Wang ZJ, 2013, ACS APPL MATER INTER, V5, P2013, DOI 10.1021/am3028553; Xia CH, 1998, GENOMICS, V52, P209, DOI 10.1006/geno.1998.5427; YANG JT, 1989, CELL, V56, P879, DOI 10.1016/0092-8674(89)90692-2; Yoshizaki T, 2007, MOL CELL BIOL, V27, P5172, DOI 10.1128/MCB.02298-06; Zhang XM, 2010, J BIOL CHEM, V285, P32869, DOI 10.1074/jbc.M110.135509; Zhao JH, 2012, BMC MED GENET, V13, DOI 10.1186/1471-2350-13-89; Zhou MY, 2008, HEPATOLOGY, V48, P1087, DOI 10.1002/hep.22444	55	14	14	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2533	2547		10.1096/fj.201601103R	http://dx.doi.org/10.1096/fj.201601103R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28242773				2022-12-28	WOS:000401553400026
J	Jablonski, RP; Kim, SJ; Cheresh, P; Williams, DB; Morales-Nebreda, L; Cheng, Y; Yeldandi, A; Bhorade, S; Pardo, A; Selman, M; Ridge, K; Gius, D; Budinger, GRS; Kamp, DW				Jablonski, Renea P.; Kim, Seok-Jo; Cheresh, Paul; Williams, David B.; Morales-Nebreda, Luisa; Cheng, Yuan; Yeldandi, Anjana; Bhorade, Sangeeta; Pardo, Annie; Selman, Moises; Ridge, Karen; Gius, David; Budinger, G. R. Scott; Kamp, David W.			SIRT3 deficiency promotes lung fibrosis by augmenting alveolar epithelial cell mitochondrial DNA damage and apoptosis	FASEB JOURNAL			English	Article						sirtuin 3; oxidative stress; pulmonary fibrosis	MANGANESE SUPEROXIDE-DISMUTASE; IDIOPATHIC PULMONARY-FIBROSIS; TUMOR-SUPPRESSOR; OXIDATIVE DAMAGE; INJURY; MICE; DEACETYLATION; BLOCKS; DEATH; SUSCEPTIBILITY	Alveolar epithelial cell (AEC) mitochondrial dysfunction and apoptosis are important in idiopathic pulmonary fibrosis and asbestosis. Sirtuin 3 (SIRT3) detoxifies mitochondrial reactive oxygen species, in part, by deacetylatingmanganese superoxide dismutase (MnSOD) andmitochondrial 8-oxoguanine DNA glycosylase. We reasoned that SIRT3 deficiency occurs in fibrotic lungs and thereby augments AEC mtDNA damage and apoptosis. Human lungswere assessed by using immunohistochemistry for SIRT3 activity via acetylated MnSODK68. Murine AEC SIRT3 and cleaved caspase-9 (CC-9) expression were assayed by immunoblotting with or without SIRT3 enforced expression or silencing. mtDNA damage was measured by using quantitative PCR and apoptosis via ELISA. Pulmonary fibrosis after asbestos or bleomycin exposure was evaluated in 129SJ/wild-type and SIRT3-knockout mice (Sirt3(-/-)) by using fibrosis scoring and lung collagen levels. Idiopathic pulmonary fibrosis lung alveolar type II cells have increased MnSODK68 acetylation compared with controls. Asbestos andH(2)O(2) diminished AEC SIRT3 protein expression and increased mitochondrial protein acetylation, including MnSODK68. SIRT3 enforced expression reduced oxidant-induced AEC OGG1(K338/341) acetylation, mtDNA damage, and apoptosis, whereas SIRT3 silencing promoted these effects. Asbestos-or bleomycin-induced lung fibrosis, AEC mtDNA damage, and apoptosis in wild-type mice were amplified in Sirt3(-/-) animals. These data suggest a novel role for SIRT3 deficiency in mediating AEC mtDNA damage, apoptosis, and lung fibrosis.-Jablonski, R. P., Kim, S.-J., Cheresh, P., Williams, D. B., Morales-Nebreda, L., Cheng, Y., Yeldandi, A., Bhorade, S., Pardo, A., Selman, M., Ridge, K., Gius, D., Budinger, G. R. S., Kamp, D. W. SIRT3deficiencypromotes lungfibrosisbyaugmentingalveolar epithelial cell mitochondrial DNA damage and apoptosis.	[Jablonski, Renea P.; Kim, Seok-Jo; Cheresh, Paul; Williams, David B.; Morales-Nebreda, Luisa; Cheng, Yuan; Ridge, Karen; Budinger, G. R. Scott; Kamp, David W.] Jesse Brown Vet Affairs Med Ctr, Div Pulm & Crit Care Med, Dept Med, Chicago, IL USA; [Jablonski, Renea P.; Kim, Seok-Jo; Cheresh, Paul; Williams, David B.; Morales-Nebreda, Luisa; Cheng, Yuan; Bhorade, Sangeeta; Ridge, Karen; Budinger, G. R. Scott; Kamp, David W.] Northwestern Univ, Dept Med, Feinberg Sch Med, Chicago, IL 60611 USA; [Yeldandi, Anjana] Northwestern Univ, Dept Pathol, Feinberg Sch Med, Chicago, IL 60611 USA; [Gius, David] Northwestern Univ, Dept Radiat Biol, Feinberg Sch Med, Chicago, IL 60611 USA; [Pardo, Annie] Univ Nacl Autonoma Mexico, Fac Ciencias, Mexico City, DF, Mexico; [Selman, Moises] Inst Nacl Enfermedades Resp Ismael Cosio Villegas, Mexico City, DF, Mexico	US Department of Veterans Affairs; Veterans Health Administration (VHA); Jesse Brown VA Medical Center; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Northwestern University; Feinberg School of Medicine; Universidad Nacional Autonoma de Mexico	Kamp, DW (corresponding author), Northwestern Univ, Pulm & Crit Care Med, Feinberg Sch Med, McGaw M-330,240 E Huron St, Chicago, IL 60611 USA.	d-kamp@northwestern.edu		Morales-Nebreda, Luisa/0000-0002-7126-0518	U.S. Veteran's Administration Merit Grant [2I01BX000786-05A2]; U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences [R01-ES020357]; NIH National Heart, Lung, and Blood Institute Training Grant [2T32HL076139-11A1]; NIH [2R01CA152601-A1, 1R01CA152799-01A1, 1R01CA168292-01A1, 1R01CA214025-01]; Avon Foundation for Breast Cancer Research; Lynn Sage Cancer Research Foundation; Zell Family Foundation; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL CANCER INSTITUTE [R01CA152799, R01CA152601, R01CA168292, R01CA214025] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001422] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL134222, T32HL076139, P01HL071643] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES020357] Funding Source: NIH RePORTER; Veterans Affairs [I01BX000201, I01BX000786] Funding Source: NIH RePORTER	U.S. Veteran's Administration Merit Grant; U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences; NIH National Heart, Lung, and Blood Institute Training Grant; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Avon Foundation for Breast Cancer Research; Lynn Sage Cancer Research Foundation; Zell Family Foundation; Chicago Biomedical Consortium; Searle Funds at The Chicago Community Trust; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by U.S. Veteran's Administration Merit Grant 2I01BX000786-05A2 (to D.W.K.), U.S. National Institutes of Health (NIH) National Institute of Environmental Health Sciences Grant R01-ES020357 (to D.W.K.), and NIH National Heart, Lung, and Blood Institute Training Grant 2T32HL076139-11A1 (to R.P.J.). D.G. was supported by NIH grants 2R01CA152601-A1, 1R01CA152799-01A1, 1R01CA168292-01A1, and 1R01CA214025-01; the Avon Foundation for Breast Cancer Research; the Lynn Sage Cancer Research Foundation; the Zell Family Foundation; and the Chicago Biomedical Consortium; as well as support from the Searle Funds at The Chicago Community Trust.	Akamata K, 2016, ONCOTARGET, V7, P69321, DOI 10.18632/oncotarget.12504; Beck JM, 2009, INFECT IMMUN, V77, P1053, DOI 10.1128/IAI.00967-08; Bindu S, 2017, AM J PHYSIOL-LUNG C, V312, pL68, DOI 10.1152/ajplung.00188.2016; Bohr VA, 2002, GENE, V286, P127, DOI 10.1016/S0378-1119(01)00813-7; Brar SS, 2012, AM J PHYSIOL-LUNG C, V303, pL413, DOI 10.1152/ajplung.00343.2011; BRODY AR, 1989, AM J PATHOL, V134, P133; Bueno M, 2015, J CLIN INVEST, V125, P521, DOI 10.1172/JCI74942; CHANG LY, 1988, AM J PATHOL, V131, P156; Chen Y, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.14; Chen YH, 2011, EMBO REP, V12, P534, DOI 10.1038/embor.2011.65; Chen YW, 2013, ECON POLIT STUD-EPS, V1, P3, DOI 10.1080/20954816.2013.11673857; Cheresh P, 2015, AM J RESP CELL MOL, V52, P25, DOI 10.1165/rcmb.2014-0038OC; Coleman MC, 2014, ANTIOXID REDOX SIGN, V20, P1423, DOI 10.1089/ars.2012.5091; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; de Souza-Pinto NC, 2002, INT REV NEUROBIOL, V53, P519; Fattman CL, 2006, FREE RADICAL BIO MED, V40, P601, DOI 10.1016/j.freeradbiomed.2005.09.030; Fingerlin TE, 2013, NAT GENET, V45, P613, DOI 10.1038/ng.2609; Haigis MC, 2012, CANCER RES, V72, P2468, DOI 10.1158/0008-5472.CAN-11-3633; Hebert SL, 2015, J GERONTOL A-BIOL, V70, P1409, DOI 10.1093/gerona/glv086; Hirschey MD, 2011, MOL CELL, V44, P177, DOI 10.1016/j.molcel.2011.07.019; Huang SXL, 2011, J TOXICOL ENV HEAL B, V14, P179, DOI 10.1080/10937404.2011.556051; Joseph AM, 2012, AGING CELL, V11, P801, DOI 10.1111/j.1474-9726.2012.00844.x; Kawamura Y, 2010, J CLIN INVEST, V120, P2817, DOI 10.1172/JCI42020; Kim HS, 2010, CANCER CELL, V17, P41, DOI 10.1016/j.ccr.2009.11.023; Kim SJ, 2016, FREE RADICAL BIO MED, V101, P482, DOI 10.1016/j.freeradbiomed.2016.11.007; Kim SJ, 2014, J BIOL CHEM, V289, P6165, DOI 10.1074/jbc.M113.515130; Kincaid B, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00048; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Korfei M, 2008, AM J RESP CRIT CARE, V178, P838, DOI 10.1164/rccm.200802-313OC; Kuwano K, 1996, AM J RESP CRIT CARE, V154, P477, DOI 10.1164/ajrccm.154.2.8756825; Lam AP, 2014, AM J RESP CRIT CARE, V190, P185, DOI 10.1164/rccm.201401-0079OC; Li SD, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010486; Liu G, 2013, ANNU REV PATHOL-MECH, V8, P161, DOI 10.1146/annurev-pathol-020712-163942; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; Lopez-Otin C, 2013, CELL, V153, P1194, DOI 10.1016/j.cell.2013.05.039; Lu JQ, 2015, FREE RADICAL BIO MED, V85, P114, DOI 10.1016/j.freeradbiomed.2015.04.011; Mahjabeen I, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146948; McGlynn LM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131344; Mercer PF, 2009, AM J RESP CRIT CARE, V179, P414, DOI 10.1164/rccm.200712-1827OC; Minagawa S, 2011, AM J PHYSIOL-LUNG C, V300, pL391, DOI 10.1152/ajplung.00097.2010; Morigi M, 2015, J CLIN INVEST, V125, P715, DOI 10.1172/JCI77632; Mossman BT, 2011, J TOXICOL ENV HEAL B, V14, P76, DOI 10.1080/10937404.2011.556047; Murthy S, 2009, AM J PHYSIOL-LUNG C, V297, pL846, DOI 10.1152/ajplung.90590.2008; Olson AL, 2007, AM J RESP CRIT CARE, V176, P277, DOI 10.1164/rccm.200701-044OC; Ozden O, 2014, FREE RADICAL BIO MED, V76, P163, DOI 10.1016/j.freeradbiomed.2014.08.001; Panduri V, 2003, AM J RESP CELL MOL, V28, P241, DOI 10.1165/rcmb.4903; Panduri V, 2009, FREE RADICAL BIO MED, V47, P750, DOI 10.1016/j.freeradbiomed.2009.06.010; Patel AS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121246; Pillai VB, 2016, AM J PHYSIOL-HEART C, V310, pH962, DOI 10.1152/ajpheart.00832.2015; Pillai VB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7656; Porter GA, 2014, AM J PHYSIOL-HEART C, V306, pH1602, DOI 10.1152/ajpheart.00027.2014; Raghu G, 2015, AM J RESP CRIT CARE, V192, pE3, DOI 10.1164/rccm.201506-1063ST; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Rato L, 2014, BBA-BIOENERGETICS, V1837, P335, DOI 10.1016/j.bbabio.2013.12.008; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Santos Janine H, 2002, Methods Mol Biol, V197, P159, DOI 10.1385/1-59259-284-8:159; Santos JH, 2003, J BIOL CHEM, V278, P1728, DOI 10.1074/jbc.M208752200; Selman M, 2014, AM J RESP CRIT CARE, V189, P1161, DOI 10.1164/rccm.201312-2221PP; Shulga N, 2010, J CELL SCI, V123, P4117, DOI 10.1242/jcs.073502; Someya S, 2010, CELL, V143, P802, DOI 10.1016/j.cell.2010.10.002; Sosulski M. L., 2016, J GERONTOL A; Sundaresan NR, 2008, MOL CELL BIOL, V28, P6384, DOI 10.1128/MCB.00426-08; Sundaresan NR, 2016, MOL CELL BIOL, V36, P678, DOI 10.1128/MCB.00586-15; Sundaresan NR, 2009, J CLIN INVEST, V119, P2758, DOI 10.1172/JCI39162; Tao RD, 2014, ANTIOXID REDOX SIGN, V20, P1646, DOI 10.1089/ars.2013.5482; Tao RD, 2010, MOL CELL, V40, P893, DOI 10.1016/j.molcel.2010.12.013; Thannickal VJ, 2015, AM J RESP CRIT CARE, V191, P261, DOI 10.1164/rccm.201410-1876PP; Uhal BD, 2013, AM J PHYSIOL-LUNG C, V305, pL906, DOI 10.1152/ajplung.00246.2013; Urich D, 2009, FASEB J, V23, P2055, DOI 10.1096/fj.08-114546; Yan SM, 2014, MED ONCOL, V31, DOI 10.1007/s12032-014-0103-8; Yang B, 2014, BIOCHEM BIOPH RES CO, V443, P156, DOI 10.1016/j.bbrc.2013.11.068; Zhang CZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051703	72	77	79	1	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2520	2532		10.1096/fj.201601077R	http://dx.doi.org/10.1096/fj.201601077R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28258190	Green Published			2022-12-28	WOS:000401553400025
J	Houthuijzen, JM; Oosterom, I; Hudson, BD; Hirasawa, A; Daenen, LGM; McLean, CM; Hansen, SVF; van Jaarsveld, MTM; Peeper, DS; Sadatmand, SJ; Roodhart, JML; van de Lest, CHA; Ulven, T; Ishihara, K; Milligan, G; Voest, EE				Houthuijzen, Julia M.; Oosterom, Ilse; Hudson, Brian D.; Hirasawa, Akira; Daenen, Laura G. M.; McLean, Chelsea M.; Hansen, Steffen V. F.; van Jaarsveld, Marijn T. M.; Peeper, Daniel S.; Sadatmand, Sahar Jafari; Roodhart, Jeanine M. L.; van de Lest, Chris H. A.; Ulven, Trond; Ishihara, Kenji; Milligan, Graeme; Voest, Emile E.			Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistance	FASEB JOURNAL			English	Article						FFAR4; GPR40; FFAR1; PIFA	RECEPTOR GPR40; GPR120; IDENTIFICATION; AGONISTS; CELLS; CANCER; POTENT; OMEGA-3-FATTY-ACIDS; PHARMACOLOGY; SECRETION	Although chemotherapy is designed to eradicate tumor cells, it also has significant effects on normal tissues. The platinum-induced fatty acid 16:4(n-3) (hexadeca-4,7,10,13-tetraenoic acid) induces systemic resistance to a broad range of DNA-damaging chemotherapeutics. We show that 16:4(n-3) exerts its effect by activating splenic F4/80(+)/CD11b(low) macrophages, which results in production of chemoprotective lysophosphatidylcholines (LPCs). Pharmacologic studies, together with analysis of expression patterns, identified GPR120 on F4/80(+)/CD11b(low) macrophages as the relevant receptor for 16:4(n-3). Studies that used splenocytes from GPR120-deficient mice have confirmed this conclusion. Activation of the 16:4(n-3)-GPR120 axis led to enhanced cPLA(2) activity in these splenic macrophages and secretion of the resistance-inducing lipid mediator, lysophosphatidylcholine(24:1). These studies identify a novel and unexpected function for GPR120 and suggest that antagonists of this receptor might be effective agents to limit development of chemotherapy resistance.-Houthuijzen, J. M., Oosterom, I., Hudson, B. D., Hirasawa, A., Daenen, L. G. M., McLean, C. M., Hansen, S. V. F., van Jaarsveld, M. T. M., Peeper, D. S., Jafari Sadatmand, S., Roodhart, J. M. L., van de Lest, C. H. A., Ulven, T., Ishihara, K., Milligan, G., Voest, E. E. Fatty acid 16:4(n-3) stimulates a GPR120-induced signaling cascade in splenic macrophages to promote chemotherapy resistance.	[Houthuijzen, Julia M.; McLean, Chelsea M.; van Jaarsveld, Marijn T. M.; Peeper, Daniel S.; Sadatmand, Sahar Jafari; Voest, Emile E.] Netherlands Canc Inst, Dept Mol Oncol, Amsterdam, Netherlands; [Houthuijzen, Julia M.] Netherlands Canc Inst, Dept Mol Pathol, Amsterdam, Netherlands; [Oosterom, Ilse; Daenen, Laura G. M.; Roodhart, Jeanine M. L.] Univ Med Ctr Utrecht, Dept Med Oncol, Utrecht, Netherlands; [Hudson, Brian D.; Milligan, Graeme] Univ Glasgow, Ctr Translat Pharmacol, Inst Mol Cell & Syst Biol, Glasgow, Lanark, Scotland; [Hirasawa, Akira] Kyoto Univ, Dept Genom Drug Discovery Sci, Kyoto, Japan; [Hansen, Steffen V. F.; Ulven, Trond] Univ Southern Denmark, Dept Phys Chem & Pharm, Odense, Denmark; [van de Lest, Chris H. A.] Univ Utrecht, Dept Biochem & Cell Biol, Fac Vet Med, Utrecht, Netherlands; [Ishihara, Kenji] Natl Res Inst Fisheries Sci, Kanazawa Ku, Yokohama, Kanagawa, Japan	Netherlands Cancer Institute; Netherlands Cancer Institute; Utrecht University; Utrecht University Medical Center; University of Glasgow; Kyoto University; University of Southern Denmark; Utrecht University; Japan Fisheries Research & Education Agency (FRA)	Voest, EE (corresponding author), Netherlands Canc Inst Raad van Bestuur, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	e.voest@nki.nl	Peeper, Daniel/AAA-2430-2020; Ulven, Trond/H-5500-2015; Hudson, Brian/H-4845-2013	Ulven, Trond/0000-0002-8135-1755; Houthuijzen, Julia/0000-0003-0404-1961; Hudson, Brian/0000-0001-7059-0091; McLean, Chelsea/0000-0002-3548-3482	Dutch Cancer Society (KWF) [UU 2009-4534]; Biotechnology and Biologic Sciences Research Council [BB/K019864/1]; University of Glasgow Leadership Fellowship; Danish Council for Strategic Research [11-1161-96]; BBSRC [BB/K019864/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K019864/1] Funding Source: researchfish	Dutch Cancer Society (KWF)(KWF Kankerbestrijding); Biotechnology and Biologic Sciences Research Council; University of Glasgow Leadership Fellowship; Danish Council for Strategic Research(Danske Strategiske Forskningsrad (DSF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This research was supported by the Dutch Cancer Society (KWF; Grant UU 2009-4534), Biotechnology and Biologic Sciences Research Council (Grant BB/K019864/1), a University of Glasgow Leadership Fellowship (to B.D.H.), and the Danish Council for Strategic Research (Grant 11-1161-96). The authors declare no conflicts of interest.	Azevedo CMG, 2016, J MED CHEM, V59, P8868, DOI 10.1021/acs.jmedchem.6b00685; Bolognini D, 2016, MOL PHARMACOL, V89, P388, DOI 10.1124/mol.115.102301; Briscoe CP, 2006, BRIT J PHARMACOL, V148, P619, DOI 10.1038/sj.bjp.0706770; Briscoe CP, 2003, J BIOL CHEM, V278, P11303, DOI 10.1074/jbc.M211495200; Colussi G., 2016, NUTR METAB CARDIOVAS; Davies LC, 2013, NAT IMMUNOL, V14, P986, DOI 10.1038/ni.2705; Fukushima K, 2015, BIOCHEM BIOPH RES CO, V465, P512, DOI 10.1016/j.bbrc.2015.08.050; Gao B, 2015, SCI REP-UK, V5, DOI 10.1038/srep14080; Gras D, 2009, AM J PHYSIOL-LUNG C, V296, pL970, DOI 10.1152/ajplung.90219.2008; Hara T, 2009, N-S ARCH PHARMACOL, V380, P247, DOI 10.1007/s00210-009-0425-9; Hirasawa A, 2005, NAT MED, V11, P90, DOI 10.1038/nm1168; Hopkins MM, 2017, HANDB EXP PHARMACOL, V236, P233, DOI 10.1007/164_2016_48; Houthuijzen JM, 2016, MOL PHARMACOL, V90, P738, DOI 10.1124/mol.116.105932; Houthuijzen JM, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6275; Hudson BD, 2013, MOL PHARMACOL, V84, P710, DOI 10.1124/mol.113.087783; Ichimura A, 2012, NATURE, V483, P350, DOI 10.1038/nature10798; Ishihara K, 2000, BIOSCI BIOTECH BIOCH, V64, P2454, DOI 10.1271/bbb.64.2454; Li Z, 2016, EXPERT OPIN INV DRUG, V25, P871, DOI 10.1080/13543784.2016.1189530; Liu YQ, 2014, IMMUNOLOGY, V143, P81, DOI 10.1111/imm.12296; Liu Z, 2015, J PHARMACOL EXP THER, V352, P380, DOI 10.1124/jpet.114.218974; Miyauchi S, 2009, N-S ARCH PHARMACOL, V379, P427, DOI 10.1007/s00210-008-0390-8; Mizuta K, 2015, AM J PHYSIOL-LUNG C, V309, pL970, DOI 10.1152/ajplung.00041.2015; Oh DY, 2014, NAT MED, V20, P942, DOI 10.1038/nm.3614; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Raynor A, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0070-x; Retra K, 2008, RAPID COMMUN MASS SP, V22, P1853, DOI 10.1002/rcm.3562; Roodhart JML, 2011, CANCER CELL, V20, P370, DOI 10.1016/j.ccr.2011.08.010; Schneider G, 2014, MOL CANCER RES, V12, P1560, DOI 10.1158/1541-7786.MCR-14-0188; Shimpukade B, 2012, J MED CHEM, V55, P4511, DOI 10.1021/jm300215x; Sparks SM, 2014, BIOORG MED CHEM LETT, V24, P3100, DOI [10.1016/j.bmcl.2014.05.012, 10.1016/j.bmcl.2014.07.008]; Sun Q, 2010, MOL PHARMACOL, V78, P804, DOI 10.1124/mol.110.066324; Ulven T, 2015, ANNU REV NUTR, V35, P239, DOI 10.1146/annurev-nutr-071714-034410; Wauquier F, 2013, J BIOL CHEM, V288, P6542, DOI 10.1074/jbc.M112.429084; Wu JHY, 2012, BRIT J NUTR, V107, pS214, DOI 10.1017/S0007114512001602; Wu Q, 2013, ONCOGENE, V32, P5541, DOI 10.1038/onc.2013.264; Yore MM, 2014, CELL, V159, P318, DOI 10.1016/j.cell.2014.09.035	37	20	22	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2195	2209		10.1096/fj.201601248R	http://dx.doi.org/10.1096/fj.201601248R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28183801	Green Accepted, hybrid, Green Published			2022-12-28	WOS:000399195500037
J	Schulze, U; Brast, S; Grabner, A; Albiker, C; Snieder, B; Holle, S; Schlatter, E; Schroter, R; Pavenstadt, H; Herrmann, E; Lambert, C; Spoden, GA; Florin, L; Saftig, P; Ciarimboli, G				Schulze, Ulf; Brast, Sabine; Grabner, Alexander; Albiker, Christian; Snieder, Beatrice; Holle, Svenja; Schlatter, Eberhard; Schroeter, Rita; Pavenstaedt, Hermann; Herrmann, Edwin; Lambert, Carsten; Spoden, Gilles A.; Florin, Luise; Saftig, Paul; Ciarimboli, Giuliano			Tetraspanin CD63 controls basolateral sorting of organic cation transporter 2 in renal proximal tubules	FASEB JOURNAL			English	Article						regulation; trafficking; transport	MONOAMINE NEUROTRANSMITTERS; PROTEIN TRAFFICKING; ENDOTHELIAL-CELLS; PLASMA-MEMBRANE; IN-VIVO; METFORMIN; OCT2; CISPLATIN; POLYMORPHISMS; CD151	CD63 is a ubiquitously expressed member of the tetraspanin superfamily. Using a mating-based splitubiquitin-yeast 2-hybrid system, pull-down experiments, total internal reflection fluorescence microscopy, F oorster resonance energy transfer, and biotinylation assays, we found that CD63 interacts with human organic cation transporter 2 (hOCT2), which transports endogenous and exogenous substrates, such as neurotransmitters and drugs in several epithelial cells. CD63 overexpression affects cellular localization of hOCT2 expressed inhuman embryonic kidney (HEK) 293 cells. Studies with CD63-knockout mice indicate that in renal proximal tubules, CD63 determines the insertion of the mouse ortholog of the transporter into the proper membrane domain and mediates transporter regulation by trafficking processes. In polarized Madin-Darby kidney canine kidney (MDCK) epithelial cells, CD63 and hOCT2 colocalize with the small GTPase Rab4, which controls the rapid recycling from sorting end osomes back to the cell surface. Suitable negative and positive control experiments were performed for each experimental approach. Empty vector transfected cells and wild-type mice were used as control. CD63 seems to play a role in the recycling of hOCT2 from endosomes to the basolateral membrane in polarized epithelia. These data indicate that CD63 has a previously uncharacterized function in regulating trafficking of specific membrane proteins in polarized cells.-Schulze, U., Brast, S., Grabner, A., Albiker, C., Snieder, B., Holle, S., Schlatter, E., Schroter, R., Pavenstadt, H., Herrmann, E., Lambert, C., Spoden, G. A., Florin, L., Saftig, P., Ciarimboli, G. Tetraspanin CD63 controls basolateral sorting of organic cation transporter 2 in renal proximal tubules. FASEB J. 31, 1421-1433 (2017). www.fasebj.org	[Schulze, Ulf; Brast, Sabine; Grabner, Alexander; Albiker, Christian; Snieder, Beatrice; Holle, Svenja; Schlatter, Eberhard; Schroeter, Rita; Pavenstaedt, Hermann; Ciarimboli, Giuliano] Westfal Wilhelms Univ, Expt Nephrol, Med Klin D, Munster, Germany; [Herrmann, Edwin] Westfal Wilhelms Univ, Klin & Poliklin Urol, Munster, Germany; [Lambert, Carsten; Spoden, Gilles A.; Florin, Luise] Johannes Gutenberg Univ Mainz, Inst Med Mikrobiol & Hyg, Mainz, Germany; [Saftig, Paul] Univ Kiel, Med Fak, Biochem Inst, Kiel, Germany	University of Munster; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Munster; Johannes Gutenberg University of Mainz; University of Kiel	Ciarimboli, G (corresponding author), Med Klin D, Expt Nephrol, Albert Schweitzer Campus 1-A14, D-48149 Munster, Germany.	gciari@uni-muenster.de	Saftig, Paul/A-7966-2010		Deutsche Forschungsgemeinschaft [CI 107/4-1-3, DFG SCHL 277/12-3, DFG SA687/7-1, DFG FL 696/2-1]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	The authors are grateful to A. Dirks, B. Gelschefarth, D. Guckel, J. Humberg, U. Neugebauer, and A. Stober for technical assistance. This work was supported in part by the Deutsche Forschungsgemeinschaft (CI 107/4- 1-3 to G.C. and E.S.; DFG SCHL 277/12-3 to E. S.; DFG SA687/7-1 to P. S.; and DFG FL 696/2-1 to L.F.).	ALEKSUNES LM, 2016, ORGANIC CATION TRANS, P171; Aperia AC, 2000, ANNU REV PHYSIOL, V62, P621, DOI 10.1146/annurev.physiol.62.1.621; Arribas M, 2000, TRAFFIC, V1, P783, DOI 10.1034/j.1600-0854.2000.011005.x; Banning C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009344; Becker ML, 2010, PHARMACOGENET GENOM, V20, P38, DOI 10.1097/FPC.0b013e328333bb11; Biber J, 2007, NAT PROTOC, V2, P1356, DOI 10.1038/nprot.2007.156; Biermann J, 2006, AM J PHYSIOL-CELL PH, V290, pC1521, DOI 10.1152/ajpcell.00622.2005; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Brast S, 2012, FASEB J, V26, P976, DOI 10.1096/fj.11-180679; Busch AE, 1998, MOL PHARMACOL, V54, P342, DOI 10.1124/mol.54.2.342; Ciarimboli G, 2005, AM J PATHOL, V167, P1477, DOI 10.1016/S0002-9440(10)61234-5; Ciarimboli G, 2005, PFLUG ARCH EUR J PHY, V449, P423, DOI 10.1007/s00424-004-1355-5; Ciarimboli G, 2011, EXPERT OPIN DRUG MET, V7, P159, DOI 10.1517/17425255.2011.547474; Ciarimboli G, 2011, MOL PHARMACEUT, V8, P270, DOI 10.1021/mp100329u; Ciarimboli G, 2010, AM J PATHOL, V176, P1169, DOI 10.2353/ajpath.2010.090610; Duan HC, 2010, J PHARMACOL EXP THER, V335, P743, DOI 10.1124/jpet.110.170142; Duffield A, 2003, P NATL ACAD SCI USA, V100, P15560, DOI 10.1073/pnas.2536699100; Duning K, 2008, J AM SOC NEPHROL, V19, P1891, DOI 10.1681/ASN.2007080916; Ernst S, 2004, CELL MOL LIFE SCI, V61, P1684, DOI 10.1007/s00018-004-4116-x; Grabner A, 2011, CELL MOL LIFE SCI, V68, P4079, DOI 10.1007/s00018-011-0694-6; Grefen C, 2008, MOL PLANT, V1, P308, DOI 10.1093/mp/ssm015; Grefen Christopher, 2007, Curr Protoc Neurosci, VChapter 5, DOI 10.1002/0471142301.ns0527s41; Guckel D, 2012, CELL PHYSIOL BIOCHEM, V30, P269, DOI 10.1159/000339063; Hochdorfer D, 2016, J VIROL, V90, P6430, DOI 10.1128/JVI.00145-16; Holle SK, 2011, PFLUG ARCH EUR J PHY, V462, P359, DOI 10.1007/s00424-011-0969-7; Hutagalung AH, 2011, PHYSIOL REV, V91, P119, DOI 10.1152/physrev.00059.2009; Kimura N, 2009, BIOCHEM PHARMACOL, V77, P1429, DOI 10.1016/j.bcp.2009.01.010; Kobayashi T, 2000, MOL BIOL CELL, V11, P1829, DOI 10.1091/mbc.11.5.1829; Lanvers-Kaminsky C, 2015, PHARMACOGENOMICS, V16, P323, DOI [10.2217/pgs.14.182, 10.2217/PGS.14.182]; Lazar A, 2006, CLIN EXP HYPERTENS, V28, P645, DOI 10.1080/10641960600946411; Lee M, 2005, J BIOL CHEM, V280, P125, DOI 10.1074/jbc.M408858200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maecker HT, 1997, FASEB J, V11, P428, DOI 10.1096/fasebj.11.6.9194523; Marc DT, 2011, NEUROSCI BIOBEHAV R, V35, P635, DOI 10.1016/j.neubiorev.2010.07.007; Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315; Montpellier C, 2011, J BIOL CHEM, V286, P13954, DOI 10.1074/jbc.M111.220103; Motohashi H, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V134866; Muth TR, 2003, ANNU REV CELL DEV BI, V19, P333, DOI 10.1146/annurev.cellbio.19.110701.161425; Ogasawara M, 2006, J PHARMACOL SCI, V101, P24, DOI 10.1254/jphs.FMJ06001X6; Pols MS, 2009, EXP CELL RES, V315, P1584, DOI 10.1016/j.yexcr.2008.09.020; Sallinen R, 2010, ANN MED, V42, P296, DOI 10.3109/07853891003777109; Scheffer KD, 2014, VIRUSES-BASEL, V6, P893, DOI 10.3390/v6020893; Scheffer KD, 2013, J VIROL, V87, P3435, DOI 10.1128/JVI.02906-12; SCHLATTER E, 2016, ORGANIC CATION TRANS, P139, DOI DOI 10.1016/J.TIBS.2015.12.001; Schneider E, 2005, J EXP MED, V202, P387, DOI 10.1084/jem.20050195; Schroder J, 2009, MOL CELL BIOL, V29, P1083, DOI 10.1128/MCB.01163-08; Shikata E, 2007, J HUM GENET, V52, P117, DOI 10.1007/s10038-006-0087-0; Spiro DJ, 1996, MOL BIOL CELL, V7, P355, DOI 10.1091/mbc.7.3.355; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Tajika Y, 2004, ENDOCRINOLOGY, V145, P4375, DOI 10.1210/en.2004-0073; Taubert D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000385; Tzvetkov MV, 2009, CLIN PHARMACOL THER, V86, P299, DOI 10.1038/clpt.2009.92; Umehara KI, 2007, XENOBIOTICA, V37, P618, DOI 10.1080/00498250701397705; Wang DS, 2003, MOL PHARMACOL, V63, P844, DOI 10.1124/mol.63.4.844; Wang DS, 2002, J PHARMACOL EXP THER, V302, P510, DOI 10.1124/jpet.102.034140; Wessler I, 2001, BRIT J PHARMACOL, V134, P951, DOI 10.1038/sj.bjp.0704335; Wilde S, 2009, CELL MOL LIFE SCI, V66, P1729, DOI 10.1007/s00018-009-9145-z; Yonezawa A, 2006, J PHARMACOL EXP THER, V319, P879, DOI 10.1124/jpet.106.110346; Zhang SZ, 2006, CANCER RES, V66, P8847, DOI 10.1158/0008-5472.CAN-06-0769; Zhang XA, 2001, J BIOL CHEM, V276, P25005, DOI 10.1074/jbc.M102156200	60	15	15	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1421	1433		10.1096/fj.201600901R	http://dx.doi.org/10.1096/fj.201600901R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28031320				2022-12-28	WOS:000398504300013
J	Chen, SY; Wen, XA; Zhang, WX; Wang, C; Liu, J; Liu, C				Chen, Siyu; Wen, Xiaoan; Zhang, Wenxiang; Wang, Chen; Liu, Jun; Liu, Chang			Hypolipidemic effect of oleanolic acid is mediated by the miR-98-5p/PGC-1 beta axis in high-fat diet-induced hyperlipidemic mice	FASEB JOURNAL			English	Article						triterpenoid compound; lipid-lowering function; liver; molecular target; miRNA	INDUCED DIABETIC-RATS; INSULIN-RESISTANCE; URSOLIC ACID; SERUM-LIPIDS; PGC-1-BETA; LIPOPROTEINS; ANTIOXIDANT; METABOLISM; SECRETION; CELLS	Oleanolic acid (OA) is an active component of the traditional Chinese herb Olea europaea L. and has been found to exhibit a significant lipid-lowering effect; however, its direct molecular target is still unknown, which limits its clinical application and the possible structure modification to improve its beneficial functions. In this regard, we carried out the present study to identify potential hepatic targets of OA to mediate its lipid-lowering effect. We found that both acute and chronic OA treatments reduced serum levels of triglycerides, total cholesterol, and LDL cholesterol, and decreased hepatic expression levels of peroxisome proliferator-activated receptor- gamma coactivator-1 beta (PGC-1 beta), which is an important regulator in maintaining hepatic lipid homeostasis, and its down stream target genes. Of note, liver-specific knockdown of PGC-1 beta recapitulated the hypolipidemic effects of OA. At the molecular level, OA accelerated mRNA degradation of PGC-1 beta. Microarray analysis revealed a host of microRNAs that potentially mediate OA-induced PGC-1 beta mRNA degradation, among which, miR-98-5p significantly inhibited activity of Pgc-1 beta 3 ' UTR as well as PGC-1 beta expression and promoted its mRNA degradation. Conversely, miR-98-5p inhibitors blunted the inhibitory effects of OA on PGC-1 beta expression. Collectively, our data demonstrated that OA ameliorated hyperlipidemia, likely via regulation of the miR-98-5p/ PGC-1 beta axis.	[Chen, Siyu; Wen, Xiaoan; Liu, Jun; Liu, Chang] China Pharmaceut Univ, State Key Lab Nat Med, Jiangsu Key Lab Drug Discovery Metab Dis, Nanjing, Peoples R China; [Zhang, Wenxiang; Liu, Chang] China Pharmaceut Univ, Sch Life Sci, Nanjing, Peoples R China; [Chen, Siyu] Nanjing Med Univ, Jiangsu Key Lab Human Funct Gen, Nanjing, Jiangsu, Peoples R China; [Liu, Chang] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Peoples R China	China Pharmaceutical University; China Pharmaceutical University; Nanjing Medical University; Nanjing Normal University	Liu, C (corresponding author), China Pharmaceut Univ, 24 Tongjiaxiang St, Nanjing 210009, Jiangsu, Peoples R China.; Liu, C (corresponding author), China Pharmaceut Univ, 639 Longmian Ave, Nanjing 211198, Jiangsu, Peoples R China.	changliu@njnu.edu.cn		Zhang, Wenxiang/0000-0002-1077-8014; Chen, Siyu/0000-0002-3809-1062	National Basic Research Program of China (973 Program) [2013CB911600]; National Natural Science Foundation of China [31422028, 31271261, 31401009, 81373303, 81473080, 81573299]; Ten Thousand Talents Program; Natural Science Foundation of Jiangsu Province of China [BK20140041]; Six Talents Summit Project; 333 Talents Project [BRA2015323]; Jiangsu Postdoctoral Research Funding Plan [1601020A]; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); Priority Academic Program Development of Jiangsu Higher Education Institutions	National Basic Research Program of China (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ten Thousand Talents Program; Natural Science Foundation of Jiangsu Province of China(Natural Science Foundation of Jiangsu Province); Six Talents Summit Project; 333 Talents Project; Jiangsu Postdoctoral Research Funding Plan; Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work is supported by grants from the National Basic Research Program of China (973 Program; 2013CB911600), the National Natural Science Foundation of China (31422028, 31271261, 31401009, 81373303, 81473080, and 81573299), Ten Thousand Talents Program, Natural Science Foundation of Jiangsu Province of China (BK20140041), Six Talents Summit Project, 333 Talents Project (BRA2015323), Jiangsu Postdoctoral Research Funding Plan (1601020A), the Collaborative Innovation Center for Cardiovascular Disease Translational Medicine (Nanjing Medical University), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. The authors declare no conflicts of interest.	Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; BISGAIER CL, 1983, ANNU REV PHYSIOL, V45, P625, DOI 10.1146/annurev.ph.45.030183.003205; Bogdanova Katerina, 2007, Biomedical Papers (Olomouc), V151, P237; Carrer M, 2012, P NATL ACAD SCI USA, V109, P15330, DOI 10.1073/pnas.1207605109; de Melo CL, 2010, CHEM-BIOL INTERACT, V185, P59, DOI 10.1016/j.cbi.2010.02.028; DUNN FL, 1990, DIABETES METAB REV, V6, P47, DOI 10.1002/dmr.5610060103; Farnier M, 1998, AM J CARDIOL, V82, p3J, DOI 10.1016/S0002-9149(98)00423-8; Farnier M, 2007, AM HEART J, V153, DOI 10.1016/j.ahj.2006.10.031; Fazio Sergio, 2004, Curr Atheroscler Rep, V6, P148, DOI 10.1007/s11883-004-0104-8; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Fujita H, 2015, EMBO J, V34, P1042, DOI 10.15252/embj.201489897; Gao DW, 2009, PHYTOTHER RES, V23, P1257, DOI 10.1002/ptr.2603; Ge X, 2015, INT J MOL SCI, V16, P28180, DOI 10.3390/ijms161226093; Goldberg A, 2000, AM J CARDIOL, V85, P1100, DOI 10.1016/S0002-9149(00)00703-7; Golomb BA, 2008, AM J CARDIOVASC DRUG, V8, P373, DOI 10.2165/0129784-200808060-00004; Haffner SM, 1999, AM J CARDIOL, V83, p17F; Hemandez C, 2010, CELL METAB, V12, P411, DOI 10.1016/j.cmet.2010.09.001; Jeong HG, 1999, TOXICOL LETT, V105, P215, DOI 10.1016/S0378-4274(99)00004-1; Kang JS, 2014, BIOORG MED CHEM LETT, V24, P4763, DOI 10.1016/j.bmcl.2014.07.005; Kawano Y, 2013, J GASTROENTEROL, V48, P434, DOI 10.1007/s00535-013-0758-5; Kelly TJ, 2009, J BIOL CHEM, V284, P19945, DOI 10.1074/jbc.M109.015164; Kim DH, 2005, ARCH PHARM RES, V28, P550, DOI 10.1007/BF02977757; Kim HS, 2014, EXP BIOL MED, V239, P284, DOI 10.1177/1535370213514511; Kim YD, 2008, DIABETES, V57, P306, DOI 10.2337/db07-0381; Lin JD, 2005, CELL, V120, P261, DOI 10.1016/j.cell.2004.11.043; Liu C, 2011, ACTA BIOCH BIOPH SIN, V43, P248, DOI 10.1093/abbs/gmr007; LIU J, 1993, J PHARMACOL EXP THER, V266, P1607; Liu J, 1995, J ETHNOPHARMACOL, V49, P57, DOI 10.1016/0378-8741(95)90032-2; LIU J, 1995, ACTA PHARM SINIC, V16, P97; Liu J, 2007, DRUG DEVELOP RES, V68, P261, DOI 10.1002/ddr.20187; Liu W, 2015, WIRES RNA, V6, P581, DOI 10.1002/wrna.1295; Liu YT, 2009, J PHARM SCI-US, V98, P4391, DOI 10.1002/jps.21721; LIU YP, 1993, J PHARMACOL EXP THER, V266, P400; McKenney J, 2005, CURR MED RES OPIN, V21, P1403, DOI 10.1185/030079905X59157; MENDELSON JH, 1973, SCIENCE, V180, P1372, DOI 10.1126/science.180.4093.1372; Musabayane CT, 2010, RENAL FAILURE, V32, P832, DOI 10.3109/0886022X.2010.494802; Nagai Y, 2009, CELL METAB, V9, P252, DOI 10.1016/j.cmet.2009.01.011; NESTEL PJ, 1962, J CLIN INVEST, V41, P1915, DOI 10.1172/JCI104648; Ngubane PS, 2011, RENAL FAILURE, V33, P434, DOI 10.3109/0886022X.2011.568147; Ni WQ, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0073-7; Panda H, 2012, J CLIN ENDOCR METAB, V97, pE1316, DOI 10.1210/jc.2012-1018; Plutzky J, 2000, CURR OPIN CARDIOL, V15, P416, DOI 10.1097/00001573-200011000-00008; SACHS BA, 1974, P SOC EXP BIOL MED, V147, P694; SINGH GB, 1992, J PHARM PHARMACOL, V44, P456, DOI 10.1111/j.2042-7158.1992.tb03646.x; Siragam V, 2012, ONCOTARGET, V3, P1370, DOI 10.18632/oncotarget.717; Somova LO, 2003, PHYTOMEDICINE, V10, P115, DOI 10.1078/094471103321659807; SPRECHER DL, 1994, ANN INTERN MED, V120, P537, DOI 10.7326/0003-4819-120-7-199404010-00002; STONE NJ, 1994, MED CLIN N AM, V78, P117, DOI 10.1016/S0025-7125(16)30179-1; Teodoro T, 2008, FEBS LETT, V582, P1375, DOI 10.1016/j.febslet.2008.03.026; Tsai SJ, 2012, EUR J PHARMACOL, V689, P81, DOI 10.1016/j.ejphar.2012.05.018; Wang HN, 2016, ADV MATER SCI ENG, V2016, DOI 10.1155/2016/6264317; Wang X.J., 2010, GANSU AGR SCI TECHNO, V2, P2; Wang X, 2013, MOL CELL ENDOCRINOL, V376, P70, DOI 10.1016/j.mce.2013.06.014; Wang ZH, 2010, EUR J PHARMACOL, V628, P255, DOI 10.1016/j.ejphar.2009.11.019; Wen XY, 2012, J ETHNOPHARMACOL, V142, P144, DOI 10.1016/j.jep.2012.04.028; Wolfrum C, 2006, CELL METAB, V3, P99, DOI 10.1016/j.cmet.2006.01.001; Yang H. X., 2013, CHIN J ARTERIOSCLER, V6; Yang WY, 2012, CIRCULATION, V125, P2212, DOI 10.1161/CIRCULATIONAHA.111.065904; Yunoki K, 2008, J AGR FOOD CHEM, V56, P12052, DOI 10.1021/jf8026217; Zeng XY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042115	60	33	37	2	42	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1085	1096		10.1096/fj.201601022R	http://dx.doi.org/10.1096/fj.201601022R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27903618				2022-12-28	WOS:000395671200022
J	Saupe, F; Reichel, M; Huijbers, EJM; Femel, J; Markgren, PO; Andersson, CE; Deindl, S; Danielson, UH; Hellman, LT; Olsson, AK				Saupe, Falk; Reichel, Matthias; Huijbers, Elisabeth J. M.; Femel, Julia; Markgren, Per-Olof; Andersson, C. Evalena; Deindl, Sebastian; Danielson, U. Helena; Hellman, Lars T.; Olsson, Anna-Karin			Development of a novel therapeutic vaccine carrier that sustains high antibody titers against several targets simultaneously	FASEB JOURNAL			English	Article						cancer; VLRB; tolerance; ED-A; ED-B	EPITOPE-SPECIFIC REGULATION; ADAPTIVE IMMUNITY; FIBRONECTIN; RESPONSES; CANCER; DOMAIN; IGE; ANGIOGENESIS; SUPPRESSION; VERTEBRATES	With the aim to improve the efficacy of therapeutic vaccines that target self-antigens, we have developed a novel fusion protein vaccine on the basis of the C-terminal multimerizing end of the variable lymphocyte receptor B (VLRB), the Ig equivalent in jawless fishes. Recombinant vaccines were produced in Escherichia coli by fusing the VLRB sequence to 4 different cancer-associated target molecules. The anti-self-immune response generated in mice that were vaccinated with VLRB vaccines was compared with the response in mice that received vaccines that contained bacterial thioredoxin (TRX), previously identified as an efficient carrier. The anti-self-Abswere analyzed with respect to titers, binding properties, and duration of response. VLRB-vaccinatedmice displayed a 2-to 10-fold increase in anti-self-Ab titers and a substantial decrease in Abs against the foreign part of the fusion protein compared with the response in TRX-vaccinated mice (P < 0.01). VLRB-generated Ab response had duration similar to the corresponding TRX-generatedAbs, but displayed a higher diversity in binding characteristics. Of importance, VLRB vaccines could sustain an immune response against several targets simultaneously. VLRB vaccines fulfill several key criteria for an efficient therapeutic vaccine that targets self-antigens as a result of its small size, its multimerizing capacity, and nonexposed foreign sequences in the fusion protein.- Saupe, F., Reichel, M., Huijbers, E. J. M., Femel, J., Markgren, P.- O., Andersson, C. E., Deindl, S., Danielson, U. H., Hellman, L. T., Olsson, A.- K. Development of a novel therapeutic vaccine carrier that sustains high antibody titers against several targets simultaneously.	[Saupe, Falk; Reichel, Matthias; Huijbers, Elisabeth J. M.; Femel, Julia; Olsson, Anna-Karin] Uppsala Univ, Dept Med Biochem & Microbiol, Husargatan 3,Box 582, SE-75123 Uppsala, Sweden; [Markgren, Per-Olof; Danielson, U. Helena] Uppsala Univ, Chem BMC, Biomed Ctr, Uppsala, Sweden; [Andersson, C. Evalena; Deindl, Sebastian; Hellman, Lars T.] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden; [Huijbers, Elisabeth J. M.] Vrije Univ Amsterdam Med Ctr, Dept Med Oncol, Amsterdam, Netherlands; [Femel, Julia] Oregon Hlth & Sci Univ, Dept Cell Dev & Canc Biol, Portland, OR 97201 USA	Uppsala University; Uppsala University; Uppsala University; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; Oregon Health & Science University	Olsson, AK (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Husargatan 3,Box 582, SE-75123 Uppsala, Sweden.	anna-karin.olsson@imbim.uu.se	Danielson, Helena/A-4217-2012; Huijbers, Elisabeth J.M./K-7764-2013	Danielson, Helena/0000-0003-2728-0340; Huijbers, Elisabeth J.M./0000-0002-7742-9839; Deindl, Sebastian/0000-0001-6807-8654	Swedish Cancer Society [110653]; Vinnova; Swedish Research Council [D0571301]; Alice Wallenberg Foundation/Wallenberg Academy; Ragna and Emil Borjeson's Foundation (Uppsala University)	Swedish Cancer Society(Swedish Cancer Society); Vinnova(Vinnova); Swedish Research Council(Swedish Research CouncilEuropean Commission); Alice Wallenberg Foundation/Wallenberg Academy; Ragna and Emil Borjeson's Foundation (Uppsala University)	This work was supported by the Swedish Cancer Society (110653; to A.-K.O.) and Vinnova (to L.T.H.). U.H.D. was funded by the Swedish Research Council (VR; D0571301) and S.D. by Alice Wallenberg Foundation/Wallenberg Academy Fellows and VR. F.S. was supported by Ragna and Emil Borjeson's Foundation (Uppsala University).	Astorgues-Xerri L, 2014, CANCER TREAT REV, V40, P307, DOI 10.1016/j.ctrv.2013.07.007; Astrof S, 2009, ANGIOGENESIS, V12, P165, DOI 10.1007/s10456-009-9136-6; Bachmann MF, 2010, NAT REV IMMUNOL, V10, P787, DOI 10.1038/nri2868; Berndt A, 2010, HISTOCHEM CELL BIOL, V133, P467, DOI 10.1007/s00418-010-0685-y; CASTELLANI P, 1994, INT J CANCER, V59, P612, DOI 10.1002/ijc.2910590507; Cavelti-Weder C, 2016, MOL THER, V24, P1003, DOI 10.1038/mt.2015.227; Cho M, 1996, BIOCHEMISTRY-US, V35, P13081, DOI 10.1021/bi961181d; Fattorusso R, 1999, STRUCTURE, V7, P381, DOI 10.1016/S0969-2126(99)80051-3; Femel J, 2014, ONCOTARGET, V5, P12418, DOI 10.18632/oncotarget.2628; Guan Q, 2012, CLIN EXP ALLERGY, V42, P1397, DOI 10.1111/j.1365-2222.2012.04022.x; Hellman L, 2008, EXPERT REV VACCINES, V7, P193, DOI 10.1586/14760584.7.2.193; Herrin BR, 2008, P NATL ACAD SCI USA, V105, P2040, DOI 10.1073/pnas.0711619105; HERZENBERG LA, 1982, J EXP MED, V155, P1741, DOI 10.1084/jem.155.6.1741; HERZENBERG LA, 1982, J EXP MED, V155, P1730, DOI 10.1084/jem.155.6.1730; Hirano M, 2011, ADV IMMUNOL, V109, P125, DOI 10.1016/B978-0-12-387664-5.00004-2; Huijbers EJM, 2012, VACCINE, V30, P225, DOI 10.1016/j.vaccine.2011.11.010; Huijbers EJM, 2010, FASEB J, V24, P4535, DOI 10.1096/fj.10-163022; Jegerlehner A, 2010, VACCINE, V28, P5503, DOI 10.1016/j.vaccine.2010.02.103; Johansson J, 2004, VACCINE, V22, P2873, DOI 10.1016/j.vaccine.2003.12.029; Johansson J, 2007, VACCINE, V25, P1676, DOI 10.1016/j.vaccine.2006.10.055; Kasahara M, 2014, ADV IMMUNOL, V122, P59, DOI 10.1016/B978-0-12-800267-4.00002-X; La Greca F, 2011, HUM VACCINES, V7, P1225, DOI 10.4161/hv.7.11.18203; Lei Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133774; Long CA, 2016, CURR OPIN MICROBIOL, V32, P96, DOI 10.1016/j.mib.2016.04.006; McCluskie MJ, 2016, IMMUNOPHARM IMMUNOT, V38, P184, DOI 10.3109/08923973.2016.1165246; Molehin AJ, 2016, EXPERT REV VACCINES, V15, P619, DOI 10.1586/14760584.2016.1131127; Nandakumar KS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013511; Pancer Z, 2004, NATURE, V430, P174, DOI 10.1038/nature02740; Ringvall M, 2009, VACCINE, V28, P48, DOI 10.1016/j.vaccine.2009.09.122; Saupe F, 2015, FASEB J, V29, P3253, DOI 10.1096/fj.15-271502; Tissot AC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009809; Vernersson M, 2002, FASEB J, V16, P875, DOI 10.1096/fj.01-0879fje	32	10	11	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					1204	1214		10.1096/fj.201600820R	http://dx.doi.org/10.1096/fj.201600820R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27993994				2022-12-28	WOS:000395671200032
J	Ren, XM; Li, XZ; Jia, LN; Chen, DH; Hou, H; Rui, LY; Zhao, YJ; Chen, Z				Ren, Xiaomeng; Li, Xinzhi; Jia, Linna; Chen, Deheng; Hou, Hai; Rui, Liangyou; Zhao, Yujun; Chen, Zheng			A small-molecule inhibitor of NF-kappa B-inducing kinase (NIK) protects liver from toxin-induced inflammation, oxidative stress, and injury	FASEB JOURNAL			English	Article						NIK; liver injury; inflammation; CCl4	REGULATES GLUCOSE-METABOLISM; CARBON-TETRACHLORIDE; HEPATIC-FIBROSIS; INSULIN-RESISTANCE; SIGNALING PATHWAY; IKK-ALPHA; RAT-LIVER; ACTIVATION; MICE; EXPRESSION	Potent and selective chemical probes are valuable tools for discovery of novel treatments for human diseases. NF-B-inducing kinase (NIK) is a key trigger in the development of liver injury and fibrosis. Whether inhibition of NIK activity by chemical probes ameliorates liver inflammation and injury is largely unknown. In this study, a small-molecule inhibitor of NIK, B022, was found to be a potent and selective chemical probe for liver inflammation and injury. B022 inhibited the NIK signaling pathway, including NIK-induced p100-to-p52 processing and inflammatory gene expression, both in vitro and in vivo. Furthermore, in vivo administration of B022 protected against not only NIK but also CCl4-induced liver inflammation and injury. Our data suggest that inhibition of NIK is a novel strategy for treatment of liver inflammation, oxidative stress, and injury.-Ren, X., Li, X., Jia, L., Chen, D., Hou, H., Rui, L., Zhao, Y., Chen, Z. A small-molecule inhibitor of NF-kappa B-inducing kinase (NIK) protects liver from toxin-induced inflammation, oxidative stress, and injury.	[Ren, Xiaomeng; Li, Xinzhi; Jia, Linna; Chen, Zheng] Northeast Normal Univ, Sch Life Sci, Key Lab Mol Epigenet, Minist Educ, Changchun, Peoples R China; [Chen, Deheng; Zhao, Yujun] Chinese Acad Sci, Shanghai Inst Met Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China; [Hou, Hai] Northwestern Polytech Univ, Sch Life Sci, Key Lab Space Bioscience & Biotechnol, Xian, Peoples R China; [Rui, Liangyou] Univ Michigan, Sch Med, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA	Northeast Normal University - China; Chinese Academy of Sciences; Northwestern Polytechnical University; University of Michigan System; University of Michigan	Zhao, YJ (corresponding author), Chinese Acad Sci, Shanghai Inst Met Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China.; Chen, Z (corresponding author), Northeast Normal Univ, Sch Life Sci, Changchun 130024, Jilin, Peoples R China.	yjzhao@simm.ac.cn	ZHAO, YUJUN/F-6552-2013; ZHAO, YUJUN/M-6027-2019	ZHAO, YUJUN/0000-0003-1035-2272; ZHAO, YUJUN/0000-0003-1035-2272	Changbai Mountain Scholars Program of The People's Government of Jilin Province Grant [2013046]; Jilin Science and Technology Development Program Grant [20160101204JC]; Jilin Talent Development Foundation Grant [111860000]; Fok Ying Tong Education Foundation Grant [151022]; National Natural Science Foundation of China Grants [31500957, 31671225]; startup funds from Northeast Normal University [120401204]; Shanghai Institute of Materia Medica startup grant; Young Overseas High-Level Talents Introduction Plan from the Chinese government	Changbai Mountain Scholars Program of The People's Government of Jilin Province Grant; Jilin Science and Technology Development Program Grant; Jilin Talent Development Foundation Grant; Fok Ying Tong Education Foundation Grant(Fok Ying Tung Education Foundation); National Natural Science Foundation of China Grants(National Natural Science Foundation of China (NSFC)); startup funds from Northeast Normal University; Shanghai Institute of Materia Medica startup grant; Young Overseas High-Level Talents Introduction Plan from the Chinese government	The authors thank laboratory members Wangshu Qin, Sha Li, Xue Dong, Xiaoyue Chen, and Jiana Liu (Northeast Normal University), for helpful discussions and Shu-Sin Chng (National University of Singapore) for proofreading the manuscript. This study was supported by Changbai Mountain Scholars Program of The People's Government of Jilin Province Grant 2013046, Jilin Science and Technology Development Program Grant 20160101204JC, Jilin Talent Development Foundation Grant 111860000, Fok Ying Tong Education Foundation Grant 151022, National Natural Science Foundation of China Grants 31500957 and 31671225, and startup funds from Northeast Normal University 120401204 (all to Z.C.), and a Shanghai Institute of Materia Medica startup grant and Young Overseas High-Level Talents Introduction Plan from the Chinese government (to Y.Z.). The authors declare no conflicts of interest.	Armendariz-Borunda J, 2006, GUT, V55, P1663, DOI 10.1136/gut.2006.107136; BERGER ML, 1986, HEPATOLOGY, V6, P36, DOI 10.1002/hep.1840060108; Chen G., 2009, PCT Patent Publication, Patent No. [WO 2009159011, 2009159011]; Chen Z, 2015, MOL METAB, V4, P951, DOI 10.1016/j.molmet.2015.09.013; Chen Z, 2015, AM J PHYSIOL-ENDOC M, V308, pE460, DOI 10.1152/ajpendo.00470.2014; Chen Z, 2014, MOL ENDOCRINOL, V28, P696, DOI 10.1210/me.2013-1333; Chen Z, 2014, DIABETES, V63, P585, DOI 10.2337/db13-0666; Chen Z, 2012, DIABETES, V61, P566, DOI 10.2337/db11-0474; Cubero FJ, 2015, J HEPATOL, V62, P140, DOI 10.1016/j.jhep.2014.08.029; CZAJA MJ, 1995, GASTROENTEROLOGY, V108, P1849, DOI 10.1016/0016-5085(95)90149-3; de Leon-Boenig G, 2012, STRUCTURE, V20, P1704, DOI 10.1016/j.str.2012.07.013; Demchenko YN, 2014, ONCOTARGET, V5, P4554, DOI 10.18632/oncotarget.2128; Fagone P, 2016, DRUG DISCOV TODAY, V21, P369, DOI 10.1016/j.drudis.2015.10.015; Jiang BJ, 2015, J BIOL CHEM, V290, P11704, DOI 10.1074/jbc.M114.635086; Kluwe J, 2010, GASTROENTEROLOGY, V138, P347, DOI 10.1053/j.gastro.2009.09.015; Kovalovich K, 2000, HEPATOLOGY, V31, P149, DOI 10.1002/hep.510310123; Lee IC, 2014, FOOD CHEM TOXICOL, V63, P174, DOI 10.1016/j.fct.2013.11.006; Qin WS, 2016, NUCLEIC ACIDS RES, V44, P6423, DOI 10.1093/nar/gkw341; ROCKEY DC, 1994, J INVEST MED, V42, P660; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Shen H, 2014, HEPATOLOGY, V60, P2065, DOI 10.1002/hep.27348; Shi JL, 1998, AM J PATHOL, V153, P515, DOI 10.1016/S0002-9440(10)65594-0; SLATER TF, 1966, NATURE, V209, P36, DOI 10.1038/209036a0; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Xiao GT, 2004, J BIOL CHEM, V279, P30099, DOI 10.1074/jbc.M401428200; Xiao GT, 2001, MOL CELL, V7, P401, DOI 10.1016/S1097-2765(01)00187-3	26	38	40	2	27	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					711	718		10.1096/fj.201600840R	http://dx.doi.org/10.1096/fj.201600840R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27871061	Green Submitted			2022-12-28	WOS:000394235400023
J	Famenini, S; Rigali, EA; Olivera-Perez, HM; Dang, J; Chang, MT; Halder, R; Rao, RV; Pellegrini, M; Porter, V; Bredesen, D; Fiala, M				Famenini, Sam; Rigali, Elizabeth A.; Olivera-Perez, Henry M.; Dang, Johnny; Chang, Michael To; Halder, Ramesh; Rao, Rammohan V.; Pellegrini, Matteo; Porter, Verna; Bredesen, Dale; Fiala, Milan			Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on omega-3 supplementation	FASEB JOURNAL			English	Article						omega-3 fatty acids; resolvin D1; amyloid-beta phagocytosis; inflammation; ApoE genotype	AMYLOID-BETA PHAGOCYTOSIS; ALZHEIMERS-DISEASE PATIENTS; RESOLVING LIPID MEDIATORS; APOLIPOPROTEIN-E; APOE EPSILON-4; DOUBLE-BLIND; INFLAMMATION; ACTIVATION; RESOLUTION; BRAIN	Monocyte/macrophages of patients with mild cognitive impairment (MCI) and Alzheimer disease (AD) are defective in phagocytosis and degradation amyloid beta(1-42) (A beta(1-42)), but are improved by omega-3 fatty acids (omega-3s). The hypothesis of this study was that active A beta(1-42) phagocytosis by macrophages prevents brain amyloidosis and thus maintains cognition. We studied the effects of self-supplementation with a drink withv-3s, antioxidants, and resveratrol on Mini-Mental State Examination (MMSE) scores, macrophage M1M2 phenotype [the ratio of inflammatory cluster of differentiation (CD) 54+CD80 and proresolution markers CD163+CD206], and A beta(1-42) phagocytosis in patients initially diagnosed as having MCI or subjective cognitive impairment (SCI). At baseline, the median MMSE score in patients in both the apolipoprotein E (ApoE) epsilon 3/epsilon 3 and ApoE epsilon 3/epsilon 4 groups was 26.0 and macrophage Ab1-42 phagocytosis was defective. The MMSE rate of change increased in the ApoE epsilon 3/epsilon 3 group a median 2.2 points per year (P=0.015 compared to 0) but did not change in the ApoE epsilon 3/epsilon 4 group(P = 0.014 between groups). In the ApoE epsilon 3/epsilon 3 group, all patients remained cognitively stable or improved; in the ApoE epsilon 3/epsilon 4 group, 1 recovered from dementia, but 3 lapsed into dementia. The macrophage phenotype polarized in patients bearing ApoE epsilon 3/epsilon 3 to an intermediate (green zone) M1-M2 type at the rate of 0.226 U/yr, whereas in patients bearing ApoE epsilon 3/epsilon 4, polarization was negative (P=0.08 between groups). The baseline M1M2 type in the extreme M1(red zone) or M2 (white zone) was unfavorable for cognitive outcome. A beta(1-42) phagocytosis increased in both ApoE groups (P= 0.03 in each groups). In vitro, the lipidic mediator resolv in D1(RvD1) down regulated the M1 type in patients with ApoE epsilon 3/epsilon 3 but in some patients with epsilon 3/epsilon 4, paradoxically up-regulated the M1 type. Antioxidant/omega-3/resveratrol supplementation was associated with favorable immune and cognitive responses in ApoE epsilon 3/epsilon 3 and individual patients bearing ApoE epsilon 3/epsilon 4, and brings into personalized clinical practice the immune benefits expected from omega-3 mediators called resolvins. The validity of this study is limited by its small size and uncontrolled design.-Famenini, S., Rigali, E. A., Olivera-Perez, H. M., Dang, J., Chang, M T., Halder, R., Rao, R. V., Pellegrini, M., Porter, V., Bredesen, D., Fiala, M. Increased intermediate M1-M2 macrophage polarization and improved cognition in mild cognitive impairment patients on v-3 supplementation.	[Famenini, Sam; Rigali, Elizabeth A.; Olivera-Perez, Henry M.; Dang, Johnny; Chang, Michael To; Halder, Ramesh; Pellegrini, Matteo; Fiala, Milan] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA USA; [Rao, Rammohan V.; Bredesen, Dale] Buck Inst Res Aging, Novato, CA USA; [Porter, Verna; Bredesen, Dale] Univ Calif Los Angeles, Sch Med, Dept Neurol, Los Angeles, CA 90024 USA; [Porter, Verna; Bredesen, Dale] Univ Calif Los Angeles, Sch Med, Easton Labs Neurodegenerat Dis, Los Angeles, CA USA	University of California System; University of California Los Angeles; Buck Institute for Research on Aging; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA	Fiala, M (corresponding author), 100 UCLA Med Plaza,Suite 220, Los Angeles, CA 90095 USA.	mfiala@ucla.edu		Pellegrini, Matteo/0000-0001-9355-9564; Fiala, Milan/0000-0001-8023-6053	U.S. National Institutes of Health Institute of General Medical Sciences [5P01GM099134-03]; Alzheimer's Association; Smartfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P01GM099134] Funding Source: NIH RePORTER	U.S. National Institutes of Health Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Alzheimer's Association(Alzheimer's Association); Smartfish; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Jeffrey Gornbein for statistical analysis of the data and Sarah Weitzman and Leonard Haller (all from the University of California, Los Angeles) for data collection and assistance with statistical analysis. The studies were supported by U.S. National Institutes of Health Institute of General Medical Sciences Grant 5P01GM099134-03 (to M.P.), a grant from the Alzheimer's Association, and a donation from Smartfish AS (to M.F.). Smartfish AS supplied the drink to the patients who requested it. Smartfish was not involved in the design of the study, analysis or interpretation of the data, or the decision to submit the manuscript for publication. M.F. received paid travel to meetings and honoraria from Smartfish. The remaining authors declare no conflicts of interest.	Annweiler C, 2013, J ALZHEIMERS DIS, V33, P659, DOI 10.3233/JAD-2012-121432; Bredesen DE, 2016, AGING-US, V8, P1250, DOI 10.18632/aging.100981; Bredesen DE, 2014, AGING-US, V6, P707, DOI 10.18632/aging.100690; Calder PC, 2015, BBA-MOL CELL BIOL L, V1851, P469, DOI 10.1016/j.bbalip.2014.08.010; Castellano JM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002156; Cederholm T, 2013, ADV NUTR, V4, P672, DOI 10.3945/an.113.004556; Croasdell A, 2015, AM J PHYSIOL-LUNG C, V309, pL888, DOI 10.1152/ajplung.00125.2015; Duara R, 2011, AM J GERIAT PSYCHIAT, V19, P951, DOI 10.1097/JGP.0b013e3182107c69; Elali A, 2016, BRAIN BEHAV IMMUN, V55, P138, DOI 10.1016/j.bbi.2015.07.021; Fiala M, 2002, EUR J CLIN INVEST, V32, P360, DOI 10.1046/j.1365-2362.2002.00994.x; Fiala M, 2007, P NATL ACAD SCI USA, V104, P12849, DOI 10.1073/pnas.0701267104; Fiala M, 2015, J ALZHEIMERS DIS, V48, P293, DOI 10.3233/JAD-150367; Fiala M, 2015, FASEB J, V29, P2681, DOI 10.1096/fj.14-264218; Freund-Levi Y, 2006, ARCH NEUROL-CHICAGO, V63, P1402, DOI 10.1001/archneur.63.10.1402; Girodet PO, 2016, AM J RESP CELL MOL B; Hardy J, 2002, SCIENCE, V297, P353, DOI 10.1126/science.1072994; Huang TL, 2005, NEUROLOGY, V65, P1409, DOI 10.1212/01.wnl.0000183148.34197.2e; Jicha GA, 2010, CLIN INTERV AGING, V5, P45; Jofro-Monseny L, 2007, BIOCHEM BIOPH RES CO, V357, P319, DOI 10.1016/j.bbrc.2007.03.150; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Li LY, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-72; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; McGeer PL, 2015, EXPERT OPIN THER TAR, V19, P497, DOI 10.1517/14728222.2014.988707; MCGEER PL, 1989, NEUROSCI LETT, V107, P341, DOI 10.1016/0304-3940(89)90843-4; Mizwicki MT, 2013, J ALZHEIMERS DIS, V34, P155, DOI 10.3233/JAD-121735; Mizwicki MT, 2012, J ALZHEIMERS DIS, V29, P51, DOI 10.3233/JAD-2012-110560; Morris MC, 2016, JAMA-J AM MED ASSOC, V315, P489, DOI 10.1001/jama.2015.19451; Mrak RE, 2001, NEUROBIOL AGING, V22, P903, DOI 10.1016/S0197-4580(01)00287-1; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Raine A, 2015, J CHILD PSYCHOL PSYC, V56, P509, DOI 10.1111/jcpp.12314; ROGERS J, 1992, RES IMMUNOL, V143, P624, DOI 10.1016/0923-2494(92)80046-N; Salem N, 2015, PROSTAG LEUKOTR ESS, V92, P15, DOI 10.1016/j.plefa.2014.10.003; Schif-Zuck S, 2011, EUR J IMMUNOL, V41, P366, DOI 10.1002/eji.201040801; Serhan CN, 2015, SEMIN IMMUNOL, V27, P200, DOI 10.1016/j.smim.2015.03.004; Serhan CN, 2014, NATURE, V510, P92, DOI 10.1038/nature13479; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Serhan CN, 2011, CURR TOP MED CHEM, V11, P629; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Theendakara V, 2016, J NEUROSCI, V36, P685, DOI 10.1523/JNEUROSCI.3562-15.2016; Theendakara V, 2013, P NATL ACAD SCI USA, V110, P18303, DOI 10.1073/pnas.1314145110; Xue J, 2014, IMMUNITY, V40, P274, DOI 10.1016/j.immuni.2014.01.006; Zaghi J, 2009, ACTA NEUROPATHOL, V117, P111, DOI 10.1007/s00401-008-0481-0	42	54	54	1	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					148	160		10.1096/fj.201600677RR	http://dx.doi.org/10.1096/fj.201600677RR			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27677546	hybrid, Green Published			2022-12-28	WOS:000392177600016
J	Pederson, T				Pederson, Thoru			Alzheimer's Disease and the Quest for Causation	FASEB JOURNAL			English	Editorial Material																			0	0	0	0	1	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					1	1		10.1096/fj.170101ufm	http://dx.doi.org/10.1096/fj.170101ufm			1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	28049153				2022-12-28	WOS:000392177600001
J	Kirkby, NS; Tesfai, A; Ahmetaj-Shala, B; Gashaw, HH; Sampaio, W; Etelvino, G; Leao, NM; Santos, RA; Mitchell, JA				Kirkby, Nicholas S.; Tesfai, Abel; Ahmetaj-Shala, Blerina; Gashaw, Hime H.; Sampaio, Walkyria; Etelvino, Gisele; Leao, Nadia Miriceia; Santos, Robson A.; Mitchell, Jane A.			Ibuprofen arginate retains eNOS substrate activity and reverses endothelial dysfunction: implications for the COX-2/ADMA axis	FASEB JOURNAL			English	Article						aspirin; methylarginines; nitric oxide; prostacyclin; Vioxx	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INCREASED ASYMMETRIC DIMETHYLARGININE; NITRIC-OXIDE SYNTHASE; L-ARGININE; RELAXING FACTOR; LINKS LOSS; IN-VITRO; KAPPA-B; CYCLOOXYGENASE-2; CELLS	Nonsteroidal antiinflammatory drugs, including ibuprofen, are among the most commonly used medications and produce their antiinflammatory effects by blocking cyclooxygenase (COX)-2. Their use is associated with increased risk of heart attacks caused by blocking COX-2 in the vasculature and/or kidney, with our recent work implicating the endogenous NOS inhibitor asymmetric dimethylarginine (ADMA), a cardiotoxic hormone whose effects can be prevented by L-arginine. The ibuprofen salt ibuprofen arginate (Spididol) was created to increase solubility but we suggest that it could also augment the NO pathway through codelivery of arginine. Here we investigated the idea that ibuprofen arginate can act to simultaneously inhibit COX-2 and preserve the NO pathway. Ibuprofen arginate functioned similarly to ibuprofen sodium for inhibition of mouse/human COX-2, but only ibuprofen arginate served as a substrate for NOS. Ibuprofen arginate but not ibuprofen sodium also reversed the inhibitory effects of ADMA and N-G-nitro-L-arginine methyl ester on inducible NOS(macrophages) and endothelial NOS in vitro (aorta) and in vivo (blood pressure). These observations show that ibuprofen arginate provides, in one preparation, a COX-2 inhibitor and NOS substrate that could act to negate the harmful cardiovascular consequences mediated by blocking renal COX-2 and increased ADMA. While remarkably simple, our findings are potentially game-changing in the nonsteroidal antiinflammatory drug arena.	[Kirkby, Nicholas S.; Tesfai, Abel; Ahmetaj-Shala, Blerina; Gashaw, Hime H.; Mitchell, Jane A.] Imperial Coll London, Natl Heart & Lung Inst, Vasc Biol Sect, London SW3 6LY, England; [Sampaio, Walkyria; Etelvino, Gisele; Leao, Nadia Miriceia; Santos, Robson A.] Univ Fed Minas Gerais, Dept Physiol & Biophys, Natl Inst Sci & Technol Nanobiopharmaceut, Belo Horizonte, MG, Brazil	Imperial College London; Universidade Federal de Minas Gerais	Kirkby, NS; Mitchell, JA (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Vasc Biol Sect, London SW3 6LY, England.	n.kirkby@imperial.ac.uk; j.a.mitchell@ic.ac.uk	Santos, Robson A S/C-9336-2011; Tesfai, Abel/Z-2699-2019	Santos, Robson A S/0000-0001-8738-5852; Kirkby, Nicholas/0000-0003-3509-8549; Tesfai, Abel/0000-0003-2209-5808	Wellcome Trust [0852551Z108/Z]; Imperial College (Wellcome Trust) [PS2124]; Medical Research Council [1416296] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Imperial College (Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Wellcome Trust program grant (0852551Z108/Z, to J.A.M.) and an Imperial College (Wellcome Trust) Junior Research Fellowship (PS2124, to N.S.K.).	Ahmetaj-Shala B, 2015, CIRCULATION, V132, pE213, DOI 10.1161/CIRCULATIONAHA.115.017260; Ahmetaj-Shala B, 2015, CIRCULATION, V131, P633, DOI 10.1161/CIRCULATIONAHA.114.011591; Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Boger RH, 2009, CIRCULATION, V119, P1592, DOI 10.1161/CIRCULATIONAHA.108.838268; Bouras G, 2013, CURR TOP MED CHEM, V13, P180, DOI 10.2174/1568026611313020007; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; De Palma C, 2009, PHARMACOL RES, V60, P221, DOI 10.1016/j.phrs.2009.06.002; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Garcia Rodriguez Luis A, 2013, Recent Results Cancer Res, V191, P67, DOI 10.1007/978-3-642-30331-9_4; GEISSLINGER G, 1989, INT J CLIN PHARM TH, V27, P324; Harrington LS, 2007, AM J PHYSIOL-HEART C, V293, pH1682, DOI 10.1152/ajpheart.00389.2007; Harris RC, 2006, CLIN J AM SOC NEPHRO, V1, P236, DOI 10.2215/CJN.00890805; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; Kirkby NS, 2016, P NATL ACAD SCI USA, V113, P434, DOI 10.1073/pnas.1517642113; Kirkby NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098165; Kirkby NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069524; Kittel A, 2014, CURR PHARM DESIGN, V20, P3530, DOI 10.2174/13816128113196660750; Leiper J, 2011, NAT REV DRUG DISCOV, V10, P277, DOI 10.1038/nrd3358; Luneburg N, 2011, J NUTR, V141, P2186, DOI 10.3945/jn.111.148197; MCCALL TB, 1991, BRIT J PHARMACOL, V102, P234, DOI 10.1111/j.1476-5381.1991.tb12159.x; Mehlisch DR, 2002, J CLIN PHARMACOL, V42, P904, DOI 10.1177/009127002401102821; Mitchell JA, 1997, MOL PHARMACOL, V51, P907, DOI 10.1124/mol.51.6.907; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; MITCHELL JA, 1994, BRIT J PHARMACOL, V113, P1008, DOI 10.1111/j.1476-5381.1994.tb17093.x; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; MITCHELL JA, 1990, EUR J PHARMACOL, V182, P573, DOI 10.1016/0014-2999(90)90058-E; Mitchell JA, 2006, FASEB J, V20, P2468, DOI 10.1096/fj.06-6615com; Pahlavani N., 2014, F100 RES, V306, P2, DOI DOI 10.12688/f1000research.5877.1; PALMER RMJ, 1988, BIOCHEM BIOPH RES CO, V153, P1251, DOI 10.1016/S0006-291X(88)81362-7; Patrono C, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0702-4; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; REES DD, 1989, BRIT J PHARMACOL, V96, P418, DOI 10.1111/j.1476-5381.1989.tb11833.x; Scarpignato C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0285-8; SESSA WC, 1990, P NATL ACAD SCI USA, V87, P8607, DOI 10.1073/pnas.87.21.8607; Surdacki A, 2007, ARTHRITIS RHEUM-US, V56, P809, DOI 10.1002/art.22424; SWIERKOSZ TA, 1990, BIOCHEM BIOPH RES CO, V172, P143, DOI 10.1016/S0006-291X(05)80184-6; Wallace JL, 1998, GASTROENTEROLOGY, V115, P101, DOI 10.1016/S0016-5085(98)70370-1; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Warner TD, 2008, LANCET, V371, P270, DOI 10.1016/S0140-6736(08)60137-3; Yu Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003787	42	9	9	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4172	4179		10.1096/fj.201600647R	http://dx.doi.org/10.1096/fj.201600647R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27601438	Green Submitted, Green Published, hybrid			2022-12-28	WOS:000388201500023
J	Wiedemann, A; Mijouin, L; Ayoub, MA; Barilleau, E; Canepa, S; Teixeira-Gomes, AP; Le Vern, Y; Rosselin, M; Reiter, E; Velge, P				Wiedemann, Agnes; Mijouin, Lily; Ayoub, Mohammed Akli; Barilleau, Emilie; Canepa, Sylvie; Teixeira-Gomes, Ana Paula; Le Vern, Yves; Rosselin, Manon; Reiter, Eric; Velge, Philippe			Identification of the epidermal growth factor receptor as the receptor for Salmonella Rck-dependent invasion	FASEB JOURNAL			English	Article						bacterial internalization; membrane receptor; cell signaling	TIME-RESOLVED FRET; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; PROTEIN; ACTIVATION; ENTERITIDIS; BINDING; FAMILY; EGFR; TRANSACTIVATION	The Salmonella Rck outer membrane protein binds to the cell surface, which leads to bacterial internalization via a Zipper mechanism. This invasion process requires induction of cellular signals, including phosphorylation of tyrosine proteins, and activation of c-Src and PI3K, which arises as a result of an interaction with a host cell surface receptor. In this study, epidermal growth factor receptor (EGFR) was identified as the cell signaling receptor required for Rck-mediated adhesion and internalization. First, Rck-mediated adhesion and internalization were shown to be altered when EGFR expression and activity were modulated. Then, immunoprecipitations were performed to demonstrate the Rck-EGFR interaction. Furthermore, surface plasmon resonance biosensor and homogeneous time-resolved fluorescence technologies were used to demonstrate the direct interaction of Rck with the extracellular domain of human EGFR. Finally, our study strongly suggests a noncompetitive binding of Rck and EGF to EGFR. Overall, these results demonstrate that Rck is able to bind to EGFR and thereby establish a tight adherence to provide a signaling cascade, which leads to internalization of Rck-expressing bacteria.	[Wiedemann, Agnes; Mijouin, Lily; Barilleau, Emilie; Teixeira-Gomes, Ana Paula; Le Vern, Yves; Rosselin, Manon; Velge, Philippe] INRA, Unite Mixtes Rech 1282, Infectiol & Sante Publ, F-37380 Nouzilly, France; [Wiedemann, Agnes; Mijouin, Lily; Barilleau, Emilie; Teixeira-Gomes, Ana Paula; Le Vern, Yves; Rosselin, Manon; Velge, Philippe] Univ Francois Rabelais Tours, Unite Mixtes Rech 1282, Infectiol & Sante Publ, Tours, France; [Ayoub, Mohammed Akli; Reiter, Eric] INRA, Unite Mixtes Rech 85, Unite Physiol Reprod & Comportements, Nouzilly, France; [Ayoub, Mohammed Akli; Canepa, Sylvie; Reiter, Eric] CNRS, Unite Mixtes Rech 7247, Nouzilly, France; [Ayoub, Mohammed Akli; Canepa, Sylvie; Reiter, Eric] Inst Francais Cheval & Equitat, Nouzilly, France; [Ayoub, Mohammed Akli] Le Studium Loire Valley Inst Adv Studies, Orleans, France; [Canepa, Sylvie; Teixeira-Gomes, Ana Paula; Le Vern, Yves] INRA, Unite Mixtes Rech 85, Plate Forme Anal Integrat Biomol, Nouzilly, France; [Mijouin, Lily] Ctr Biophys Mol, UPR 4301, Orleans, France; [Rosselin, Manon] Univ Geneva, Dept Physiol Cellulaire & Metab, Geneva, Switzerland	INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); University of Geneva	Wiedemann, A (corresponding author), INRA, Unite Mixtes Rech 1282, Infectiol & Sante Publ, F-37380 Nouzilly, France.	agnes.wiedemann@tours.inra.fr	velge, philippe/AAK-4165-2021	Wiedemann, Agnes/0000-0001-8237-3545; AYOUB, Mohammed Akli/0000-0003-0022-578X				Abed N, 2014, MOL MICROBIOL, V94, P254, DOI 10.1111/mmi.12738; Alonso A, 2004, INT MICROBIOL, V7, P181; Ayoub MA, 2010, FASEB J, V24, P3522, DOI 10.1096/fj.10-154997; BLISKA JB, 1993, CELL, V73, P903, DOI 10.1016/0092-8674(93)90270-Z; Chan G, 2009, P NATL ACAD SCI USA, V106, P22369, DOI 10.1073/pnas.0908787106; COURTNEIDGE SA, 1993, DEVELOPMENT, P57; Dyszel JL, 2010, J BACTERIOL, V192, P29, DOI 10.1128/JB.01139-09; Eierhoff T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001099; FRANCIS CL, 1993, NATURE, V364, P639, DOI 10.1038/364639a0; GALAN JE, 1992, NATURE, V357, P588, DOI 10.1038/357588a0; GUSTERSON B, 1984, CELL BIOL INT REP, V8, P649, DOI 10.1016/0309-1651(84)90045-6; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hayes N, 2004, CANCER LETT, V206, P129, DOI 10.1016/j.canlet.2003.08.030; HEFFERNAN EJ, 1994, INFECT IMMUN, V62, P5183, DOI 10.1128/IAI.62.11.5183-5186.1994; HONEGGER AM, 1990, J CELL BIOL, V110, P1541, DOI 10.1083/jcb.110.5.1541; JONES BD, 1993, P NATL ACAD SCI USA, V90, P10390, DOI 10.1073/pnas.90.21.10390; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Keller B, 2015, CELL MICROBIOL, V17, P1179, DOI 10.1111/cmi.12429; Lahti JL, 2011, FEBS LETT, V585, P1135, DOI 10.1016/j.febslet.2011.03.044; Leyris JP, 2011, ANAL BIOCHEM, V408, P253, DOI 10.1016/j.ab.2010.09.030; LOPEZ JG, 1992, INVEST OPHTH VIS SCI, V33, P2053; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Mijouin L, 2012, FASEB J, V26, P1569, DOI 10.1096/fj.11-189647; Molleken K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003325; MOUNIER J, 1992, INFECT IMMUN, V60, P237, DOI 10.1128/IAI.60.1.237-248.1992; Muller KM, 1998, ANAL BIOCHEM, V261, P149, DOI 10.1006/abio.1998.2725; Oueslati N, 2015, METHODS MOL BIOL, V1272, P23, DOI 10.1007/978-1-4939-2336-6_2; PACE J, 1993, CELL, V72, P505, DOI 10.1016/0092-8674(93)90070-7; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Rosselin M, 2010, CELL RES, V20, P647, DOI 10.1038/cr.2010.45; Singh B, 2014, ANNU REV PHYSIOL, V76, P275, DOI 10.1146/annurev-physiol-021113-170406; Slanina H, 2014, INFECT IMMUN, V82, P1243, DOI 10.1128/IAI.01346-13; Smith JN, 2003, J BACTERIOL, V185, P1357, DOI 10.1128/JB.185.4.1357-1366.2003; Sorkin A, 2001, BIOCHEM SOC T, V29, P480, DOI 10.1042/BST0290480; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Swanson KV, 2011, CELL MICROBIOL, V13, P1078, DOI 10.1111/j.1462-5822.2011.01603.x; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Velge P, 2012, MICROBIOLOGYOPEN, V1, P243, DOI 10.1002/mbo3.28; Wiedemann A, 2012, J BIOL CHEM, V287, P31148, DOI 10.1074/jbc.M112.392134; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Yan F, 2009, GASTROENTEROLOGY, V136, P1297, DOI 10.1053/j.gastro.2008.12.059; Zhang J, 2004, INVEST OPHTH VIS SCI, V45, P2569, DOI 10.1167/iovs.03-1323; Zhang YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058606; Zwier JM, 2010, J BIOMOL SCREEN, V15, P1248, DOI 10.1177/1087057110384611	47	26	30	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4180	4191		10.1096/fj.201600701R	http://dx.doi.org/10.1096/fj.201600701R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27609774				2022-12-28	WOS:000388201500024
J	Amrutkar, M; Chursa, U; Kern, M; Nunez-Duran, E; Stahlman, M; Sutt, S; Boren, J; Johansson, BR; Marschall, HU; Bluher, M; Mahlapuu, M				Amrutkar, Manoj; Chursa, Urszula; Kern, Matthias; Nunez-Duran, Esther; Stahlman, Marcus; Suett, Silva; Boren, Jan; Johansson, Bengt R.; Marschall, Hanns-Ulrich; Blueher, Matthias; Mahlapuu, Margit			STK25 is a critical determinant in nonalcoholic steatohepatitis	FASEB JOURNAL			English	Article						NAFLD; NASH; oxidative stress; inflammation; liver fibrosis	FATTY LIVER-DISEASE; HEPATIC STEATOSIS; ANIMAL-MODELS; LIPID-PEROXIDATION; IN-VITRO; PROGRESSION; NAFLD; MICE; INFLAMMATION; RECEPTOR	Nonalcoholic fatty liver disease (NAFLD) is the most common chronic liver disease, and 10-20% of patients with NAFLD progress to nonalcoholic steatohepatitis (NASH) with a high risk of cirrhosis, liver failure, and hepatocellular carcinoma. Despite its high medical importance, the molecular mechanisms controlling progression from simple liver steatosis to NASH remain elusive. We recently identified serine/threonine protein kinase (STK)25 as a critical regulator of ectopic lipid deposition, systemic glucose, and insulin homeostasis. To elucidate the role of STK25 in the development of NASH, we challenged Stk25-knockout and transgenic mice with a methionine and choline-deficient (MCD) diet. We show that Stk25(-/-) mice are protected against MCD-diet-induced NASH, as evidenced by repressed liver steatosis, oxidative damage, inflammation, and fibrosis, whereas Stk25 transgenic mice developed a more severe NASH phenotype, compared with corresponding wild-type littermates. Consistently, NASH features were suppressed in STK25-deficient human hepatocytes cultured in MCD medium, and reciprocally enhanced in STK25-overexpressing cells. We also found a significant positive correlation in human liver biopsies between STK25 expression and NASH development. The study provides evidence for multiple roles of STK25 in NASH pathogenesis and future investigations to address the potential therapeutic relevance of pharmacological STK25 inhibitors in prevention and treatment of NASH are warranted.	[Amrutkar, Manoj; Chursa, Urszula; Nunez-Duran, Esther; Suett, Silva; Mahlapuu, Margit] Univ Gothenburg, Sahlgrenska Univ Hosp, Lundberg Lab Diabet Res, Dept Mol & Clin Med, Gothenburg, Sweden; [Stahlman, Marcus; Boren, Jan; Marschall, Hanns-Ulrich] Univ Gothenburg, Sahlgrenska Univ Hosp, Wallenberg Lab, Dept Mol & Clin Med, Gothenburg, Sweden; [Johansson, Bengt R.] Univ Gothenburg, Sahlgrenska Univ Hosp, Inst Biomed, Electron Microscopy Unit, Gothenburg, Sweden; [Kern, Matthias; Blueher, Matthias] Univ Leipzig, Dept Med, Leipzig, Germany	Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Leipzig University	Mahlapuu, M (corresponding author), Univ Gothenburg, Lundberg Lab Diabet Res, Dept Mol & Clin Med, Sahlgrenska Acad, Bla Straket 5, SE-41345 Gothenburg, Sweden.	margit.mahlapuu@gu.se	StÃhlman, Marcus/M-4597-2019; Amrutkar, Manoj/J-2848-2019; Marschall, Hanns-Ulrich/K-8842-2017	Amrutkar, Manoj/0000-0002-1868-0249; Marschall, Hanns-Ulrich/0000-0001-7347-3085; Henricsson, Marcus/0000-0002-4202-0339; Mahlapuu, Margit/0000-0001-8740-8874	Swedish Research Council; European Foundation for the Study of Diabetes/Lilly Research; Novo Nordisk Foundation; Swedish Heart and Lung Foundation; Diabetes Wellness Network Sweden; Swedish Diabetes Foundation; P. and A. Hedlunds Foundation; A. Wiberg Foundation; Adlerbert Research Foundation; I. Hultman Foundation; S. and E. Goljes Foundation; West Sweden Medical Training and Research Agreement (Avtal om Lakarutbildning och Forskning; ALF) Program; F. Neubergh Foundation; Estonian Science Foundation; European Foundation for the Study of Diabetes/Novo Nordisk research grant; Novo Nordisk Fonden [NNF15OC0015842, NNF16OC0020802] Funding Source: researchfish; European Foundation for the Study of Diabetes [NN 2016_2] Funding Source: researchfish	Swedish Research Council(Swedish Research CouncilEuropean Commission); European Foundation for the Study of Diabetes/Lilly Research; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Heart and Lung Foundation(Swedish Heart-Lung Foundation); Diabetes Wellness Network Sweden; Swedish Diabetes Foundation; P. and A. Hedlunds Foundation; A. Wiberg Foundation; Adlerbert Research Foundation; I. Hultman Foundation; S. and E. Goljes Foundation; West Sweden Medical Training and Research Agreement (Avtal om Lakarutbildning och Forskning; ALF) Program; F. Neubergh Foundation; Estonian Science Foundation; European Foundation for the Study of Diabetes/Novo Nordisk research grant; Novo Nordisk Fonden(Novo Nordisk Foundation); European Foundation for the Study of Diabetes	This work was supported by grants from the Swedish Research Council, the European Foundation for the Study of Diabetes/Lilly Research, the Novo Nordisk Foundation, the Swedish Heart and Lung Foundation, the Diabetes Wellness Network Sweden, the Swedish Diabetes Foundation, the P. and A. Hedlunds Foundation, the A. Wiberg Foundation, the Adlerbert Research Foundation, the I. Hultman Foundation, the S. and E. Goljes Foundation, the West Sweden Medical Training and Research Agreement (Avtal om Lakarutbildning och Forskning; ALF) Program, the F. Neubergh Foundation, the Estonian Science Foundation, and a European Foundation for the Study of Diabetes/Novo Nordisk research grant. The authors declare no conflicts of interest.	Amrutkar M, 2016, DIABETOLOGIA, V59, P341, DOI 10.1007/s00125-015-3801-7; Amrutkar M, 2015, DIABETES, V64, P2791, DOI 10.2337/db15-0060; Amrutkar M, 2015, FASEB J, V29, P1564, DOI 10.1096/fj.14-264937; Anderberg C, 2013, J EXP MED, V210, P563, DOI 10.1084/jem.20120662; Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Anstee QM, 2013, NAT REV GASTRO HEPAT, V10, P330, DOI 10.1038/nrgastro.2013.41; Anstee QM, 2010, J HEPATOL, V53, P542, DOI 10.1016/j.jhep.2010.03.016; Begriche K, 2013, HEPATOLOGY, V58, P1497, DOI 10.1002/hep.26226; Behari J, 2010, AM J PATHOL, V176, P744, DOI 10.2353/ajpath.2010.090667; Bellafante E, 2013, HEPATOLOGY, V57, P1343, DOI 10.1002/hep.26222; Browning JD, 2004, J CLIN INVEST, V114, P147, DOI 10.1172/JCI200422422; Brunt EM, 1999, AM J GASTROENTEROL, V94, P2467, DOI 10.1111/j.1572-0241.1999.01377.x; Caldwell SH, 2009, HEPATOLOGY, V49, P1888, DOI 10.1002/hep.22851; Cansby E, 2013, FASEB J, V27, P3660, DOI 10.1096/fj.13-228494; Chen LG, 2014, P NATL ACAD SCI USA, V111, P9983, DOI 10.1073/pnas.1314939111; Cortez-Pinto H, 1999, JAMA-J AM MED ASSOC, V282, P1659, DOI 10.1001/jama.282.17.1659; Coulon S, 2013, HEPATOLOGY, V57, P1793, DOI 10.1002/hep.26219; Day CP, 1998, GASTROENTEROLOGY, V114, P842, DOI 10.1016/S0016-5085(98)70599-2; Dongiovanni P, 2013, WORLD J GASTROENTERO, V19, P6969, DOI 10.3748/wjg.v19.i41.6969; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; Hatting M, 2013, HEPATOLOGY, V57, P2189, DOI 10.1002/hep.26271; Henao-Mejia J, 2012, NATURE, V482, P179, DOI 10.1038/nature10809; Heymann F, 2012, HEPATOLOGY, V55, P898, DOI 10.1002/hep.24764; Karlmark KR, 2009, HEPATOLOGY, V50, P261, DOI 10.1002/hep.22950; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kohli R, 2011, J HEPATOL, V55, P941, DOI 10.1016/j.jhep.2011.04.010; Loomba R, 2013, NAT REV GASTRO HEPAT, V10, P686, DOI 10.1038/nrgastro.2013.171; Macdonald GA, 2001, J GASTROEN HEPATOL, V16, P599, DOI 10.1046/j.1440-1746.2001.02445.x; Matsuki T, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-21; McManaman JL, 2013, J LIPID RES, V54, P1346, DOI 10.1194/jlr.M035063; Michelotti GA, 2013, NAT REV GASTRO HEPAT, V10, P656, DOI 10.1038/nrgastro.2013.183; Miller YI, 2011, CIRC RES, V108, P235, DOI 10.1161/CIRCRESAHA.110.223875; Perez-Carreras M, 2003, HEPATOLOGY, V38, P999, DOI 10.1053/jhep.2003.50398; Ratziu V, 2012, HEPATOLOGY, V55, P419, DOI 10.1002/hep.24747; Sanyal AJ, 2001, GASTROENTEROLOGY, V120, P1183, DOI 10.1053/gast.2001.23256; Seki S, 2002, J HEPATOL, V37, P56, DOI 10.1016/S0168-8278(02)00073-9; Shen B, 2008, HEPATOLOGY, V47, P473, DOI 10.1002/hep.22039; Sugden PH, 2013, BIOCHEM J, V454, P13, DOI 10.1042/BJ20130219; Sutti S, 2014, HEPATOLOGY, V59, P886, DOI 10.1002/hep.26749; Tacke F, 2014, J HEPATOL, V60, P1090, DOI 10.1016/j.jhep.2013.12.025; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Tariq Z, 2014, LIVER INT, V34, pE180, DOI 10.1111/liv.12523; Tilg H, 2010, HEPATOLOGY, V52, P1836, DOI 10.1002/hep.24001; Weismann D, 2012, BBA-BIOMEMBRANES, V1818, P2465, DOI 10.1016/j.bbamem.2012.01.018; Xie L, 2012, J HEPATOL, V57, P1076, DOI 10.1016/j.jhep.2012.07.002; Yamaguchi K, 2007, HEPATOLOGY, V45, P1366, DOI 10.1002/hep.21655	46	34	35	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3628	3643		10.1096/fj.201600562R	http://dx.doi.org/10.1096/fj.201600562R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27421788				2022-12-28	WOS:000384329800030
J	Abulizi, A; Perry, RJ; Camporez, JPG; Jurczak, MJ; Petersen, KF; Aspichueta, P; Shulman, GI				Abulizi, Abudukadier; Perry, Rachel J.; Camporez, Joao Paulo G.; Jurczak, Michael J.; Petersen, Kitt Falk; Aspichueta, Patricia; Shulman, Gerald I.			A controlled-release mitochondrial protonophore reverses hypertriglyceridemia, nonalcoholic steatohepatitis, and diabetes in lipodystrophic mice	FASEB JOURNAL			English	Article						NAFLD; NASH; type 2 diabetes; insulin resistance; mitochondrial uncoupling	HEPATIC INSULIN-RESISTANCE; LEPTIN-REPLACEMENT THERAPY; UNFOLDED PROTEIN RESPONSE; ACTIVATION; MECHANISM; EFFICACY; STRESS; THETA	Lipodystrophy is a rare disorder characterized by complete or partial loss of adipose tissue. Patients with lipodystrophy exhibit hypertriglyceridemia, severe insulin resistance, type 2 diabetes, and nonalcoholic steatohepatitis (NASH). Efforts to ameliorate NASH in lipodystrophies with pharmacologic agents have met with limited success. We examined whether a controlled -release mitochondrial protonophore (CRMP) that produces mild liver targeted mitochondrial uncoupling could decrease hypertriglyceridemia and reverse NASH and diabetes in a mouse model (fatless AZIP/F-1 mice) of severe lipodystrophy and diabetes. After 4 wk of oral CRMP (2 mg/kg body weight per day) or vehicle treatment, mice underwent hyperinsulinemic-euglycemic clamps combined with radiolabeled glucose to assess liver and muscle insulin responsiveness and tissue lipid measurements. CRMP treatment reversed hypertriglyceridemia and insulin resistance in liver and skeletal muscle. Reversal of insulin resistance could be attributed to reductions in diacylglycerol content and reduced PKC-E and PKC-0 activity in liver and muscle respectively. CRMP treatment also reversed NASH as reflected by reductions in plasma aspartate aminotransferase and alanine aminotransferase concentrations; hepatic steatosis; and hepatic expression of IL -la, -13, -2, 4, -6, -10, -12, CD69, and caspase 3 and attenuated activation of the IRE -la branch of the unfolded protein response. Taken together, these results provide proof of concept for the development of liver -targeted mitochondrial uncoupling agents as a potential novel therapy for lipodystrophy-associated hypertriglyceridemia, NASH and diabetes. Abulizi, A., Perry, R. J., Camporez, J. P. G., Jurczak, M. J., Petersen, K. F., Aspichueta, P., Shulman, G. I. A controlled release mitochondrial protonophore reverses hypertriglyceridemia, nonalcoholic steatohepatitis, and diabetes in lipodystrophic mice.	[Abulizi, Abudukadier; Perry, Rachel J.; Camporez, Joao Paulo G.; Jurczak, Michael J.; Petersen, Kitt Falk; Aspichueta, Patricia; Shulman, Gerald I.] Yale Univ, Sch Med, Dept Internal Med, New Haven, CT 06510 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06510 USA; [Shulman, Gerald I.] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06510 USA; [Aspichueta, Patricia] Univ Basque Country UPV EHU, Fac Med & Nursing, Dept Physiol, Leioa, Spain; [Aspichueta, Patricia] Biocruces Res Inst, Baracaldo, Spain	Yale University; Yale University; Howard Hughes Medical Institute; Yale University; University of Basque Country	Shulman, GI (corresponding author), Yale Univ, Sch Med, TAC S269,POB 9812, New Haven, CT 06536 USA.	gerald.shulman@yale.edu	Blanco, Leire/O-5114-2017; Aspichueta, Patricia/M-3490-2018; Shulman, Gerald I./P-7176-2019	Aspichueta, Patricia/0000-0002-3553-1755; Shulman, Gerald I./0000-0003-1529-5668; Perry, Rachel/0000-0003-0748-8064; Camporez, Joao Paulo/0000-0003-3486-4301	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [R01 DK40936]; Harrington Discovery Institute [DK099402]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK099402, P30DK034989, R01DK040936] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Harrington Discovery Institute; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (Grant R01 DK40936), and the Harrington Discovery Institute (Grant DK099402; to M.J.J.). The authors thank Dr. Jeffrey Friedman (Rockerfeller University, New York, NY, USA) for kindly providing the AZIP/F-1 lipodystrophic mice, and Ali Nasiri and Gina Butrico (both from the Yale University School of Medicine) for their skilled technical assistance. The authors declare no conflicts of interest.	Al-Rabia MW, 2004, J LEUKOCYTE BIOL, V75, P1045, DOI 10.1189/jlb.0803404; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Chavez JA, 2012, CELL METAB, V15, P585, DOI 10.1016/j.cmet.2012.04.002; Fiorenza CG, 2011, NAT REV ENDOCRINOL, V7, P137, DOI 10.1038/nrendo.2010.199; Garg A, 2000, AM J MED, V108, P143, DOI 10.1016/S0002-9343(99)00414-3; Gavrilova O, 1999, P NATL ACAD SCI USA, V96, P14623, DOI 10.1073/pnas.96.25.14623; Griffin ME, 1999, DIABETES, V48, P1270, DOI 10.2337/diabetes.48.6.1270; Haque WA, 2002, J CLIN ENDOCR METAB, V87, P2395, DOI 10.1210/jc.87.5.2395; Holland WL, 2011, NAT MED, V17, P55, DOI 10.1038/nm.2277; Javor ED, 2005, HEPATOLOGY, V41, P753, DOI 10.1002/hep.20672; Jurczak MJ, 2012, J BIOL CHEM, V287, P2558, DOI 10.1074/jbc.M111.316760; Kim JK, 2000, J BIOL CHEM, V275, P8456, DOI 10.1074/jbc.275.12.8456; Kleiner DE, 2005, HEPATOLOGY, V41, P1313, DOI 10.1002/hep.20701; Kumashiro N, 2011, P NATL ACAD SCI USA, V108, P16381, DOI 10.1073/pnas.1113359108; Moitra J, 1998, GENE DEV, V12, P3168, DOI 10.1101/gad.12.20.3168; Oral EA, 2002, NEW ENGL J MED, V346, P570, DOI 10.1056/NEJMoa012437; Park JY, 2007, METABOLISM, V56, P508, DOI 10.1016/j.metabol.2006.11.010; Perry RJ, 2015, SCIENCE, V347, P1253, DOI 10.1126/science.aaa0672; Petersen KF, 2002, J CLIN INVEST, V109, P1345, DOI [10.1172/JCI0215001, 10.1172/JCI200215001]; Petersen MC, 2016, J CLIN INVEST, V126, P4361, DOI 10.1172/JCI86013; Puri P, 2008, GASTROENTEROLOGY, V134, P568, DOI 10.1053/j.gastro.2007.10.039; Samuel VT, 2007, J CLIN INVEST, V117, P739, DOI 10.1172/JCI30400; Samuel VT, 2010, LANCET, V375, P2267, DOI 10.1016/S0140-6736(10)60408-4; Samuel VT, 2004, J BIOL CHEM, V279, P32345, DOI 10.1074/jbc.M313478200; Savage DB, 2009, DIS MODEL MECH, V2, P554, DOI 10.1242/dmm.002907; Scheuner D, 2001, MOL CELL, V7, P1165, DOI 10.1016/S1097-2765(01)00265-9; Simha V, 2012, J CLIN ENDOCR METAB, V97, P785, DOI 10.1210/jc.2011-2229; Szendroedi J, 2014, P NATL ACAD SCI USA, V111, P9597, DOI 10.1073/pnas.1409229111; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; Yu CL, 2002, J BIOL CHEM, V277, P50230, DOI 10.1074/jbc.M200958200; Zadeh ES, 2013, J HEPATOL, V59, P131, DOI 10.1016/j.jhep.2013.02.007; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	32	29	31	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					2916	2924		10.1096/fj.201700001R	http://dx.doi.org/10.1096/fj.201700001R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28330852	Green Published			2022-12-28	WOS:000405931000017
J	Le Gonidec, S; Chaves-Almagro, C; Bai, YS; Kang, HJ; Smith, A; Wanecq, E; Huang, XP; Prats, H; Knibiehler, B; Roth, BL; Barak, LS; Caron, MG; Valet, P; Audigier, Y; Masri, B				Le Gonidec, Sophie; Chaves-Almagro, Carline; Bai, Yushi; Kang, Hye Jin; Smith, Allyson; Wanecq, Estelle; Huang, Xi-Ping; Prats, Herve; Knibiehler, Bernard; Roth, Bryan L.; Barak, Larry S.; Caron, Marc G.; Valet, Philippe; Audigier, Yves; Masri, Bernard			Protamine is an antagonist of apelin receptor, and its activity is reversed by heparin	FASEB JOURNAL			English	Article						GPCR; APJ; angiogenesis; metabolism; blood pressure	ENDOTHELIAL GROWTH-FACTOR; G-PROTEIN; ENDOGENOUS LIGAND; IN-VIVO; APJ; ANGIOGENESIS; PATHWAY; ELABELA; CANCER; MOUSE	Apelin signaling plays an important role during embryo development and regulates angiogenesis, cardiovascular activity, and energy metabolism in adulthood. Overexpression and hyperactivity of this signaling pathway is observed in various pathologic states, such as cardiovascular diseases and cancer, which highlights the importance of inhibiting apelin receptor (APJ); therefore, we developed a cell-based screening assay that uses fluorescence microscopy to identify APJ antagonists. This approach led us to identify the U.S. Food and Drug Administration-approved compound protamine-already used clinically after cardiac surgery-as an agent to bind to heparin and thereby reverse its anticlotting activity. Protamine displays a 390-nM affinity for APJ and behaves as a full antagonist with regard to G protein and beta-arrestin-dependent intracellular signaling. Ex vivo and in vivo, protamine abolishes well-known apelin effects, such as angiogenesis, glucose tolerance, and vasodilatation. Remarkably, protamine antagonist activity is fully reversed by heparin treatment both in vitro and in vivo. Thus, our results demonstrate a new pharmacologic property of protamine-blockade of APJ-that could explain some adverse effects observed in protamine-treated patients. Moreover, our data reveal that the established anti-angiogenic activity of protamine would rely on APJ antagonism.-Le Gonidec, S., Chaves-Almagro, C., Bai, Y., Kang, H. J., Smith, A., Wanecq, E., Huang, X.-P., Prats, H., Knibiehler, B., Roth, B. L., Barak, L. S., Caron, M. G., Valet, P., Audigier, Y., Masri, B. Protamine is an antagonist of apelin receptor, and its activity is reversed by heparin.	[Le Gonidec, Sophie; Chaves-Almagro, Carline; Wanecq, Estelle; Valet, Philippe; Audigier, Yves; Masri, Bernard] Univ Paul Sabatier, Univ Toulouse, INSERM Unite 1048, Inst Malad Metab & Cardiovasc, Toulouse, France; [Le Gonidec, Sophie] Univ Paul Sabatier, Univ Toulouse, Serv Phenotypage, Ctr Reg Explorat Fonct & Ressources Expt,INSERM U, Toulouse, France; [Prats, Herve; Knibiehler, Bernard] Univ Paul Sabatier, Univ Toulouse, Ctr Rech Cancerol Toulouse, Unit Mixte Rech INSERM 1037, Toulouse, France; [Bai, Yushi; Smith, Allyson; Barak, Larry S.; Caron, Marc G.] Duke Univ, Med Ctr, Dept Cell Biol, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA; [Caron, Marc G.] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA; [Kang, Hye Jin; Huang, Xi-Ping; Roth, Bryan L.] Univ North Carolina Chapel Hill, Med Sch, Dept Pharmacol, Chapel Hill, NC USA	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Duke University; Duke University; Duke University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine	Masri, B (corresponding author), Univ Toulouse, Inst Malad Metab & Cardiovasc, INSERM U1048, UPS,Toulouse 3,CHU Rangueil, Bat L4,1 Ave Jean Poulhes,BP 84225, F-31432 Toulouse, France.	bernard.masri@inserm.fr	Masri, Bernard/N-9856-2018; Aragão, Marinalva de Souza/J-7420-2017; Valet, Philippe/N-7472-2017; Roth, Bryan/ABE-7032-2020; Roth, Bryan L/F-3928-2010	Masri, Bernard/0000-0002-4027-2604; Aragão, Marinalva de Souza/0000-0002-8485-2053; Valet, Philippe/0000-0001-6520-7393; Roth, Bryan/0000-0002-0561-6520; Prats, Herve/0000-0002-4861-2167; Huang, Xi-Ping/0000-0002-2585-653X; Kang, Hye Jin/0000-0001-9067-9050; Le Gonidec, Sophie/0000-0002-8141-690X	Ligue Regionale Midi Pyrenees Contre le Cancer [R12018BB/RAB12003BBA]; Canceropole GSO Emergence [R11109BB/RPS11008BBA]; ATCS-AO1 Grant from Toulouse University; Marie Curie Outgoing International Fellowship of the European Commission [FP6-2005-Mobility-6]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK116195] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [P30DA029925] Funding Source: NIH RePORTER	Ligue Regionale Midi Pyrenees Contre le Cancer; Canceropole GSO Emergence; ATCS-AO1 Grant from Toulouse University; Marie Curie Outgoing International Fellowship of the European Commission; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	The authors thank Aurore Desquesnes from the phenotyping platform (Anexplo-US006/CREFRE) for technical assistance, the Cellular Imaging Facility of Rangueil (Toulouse, France), and Dr. Sean M. Peterson (Duke University Medical Center) for helpful discussions. This work was supported by Ligue Regionale Midi Pyrenees Contre le Cancer (R12018BB/RAB12003BBA), Canceropole GSO Emergence (R11109BB/RPS11008BBA), and an ATCS-AO1 Grant from Toulouse University (to B.M.). During the initial stages of this work, B.M. was recipient of a Marie Curie Outgoing International Fellowship of the European Commission (FP6-2005-Mobility-6). The authors declare no conflicts of interest.	Alastalo TP, 2011, J CLIN INVEST, V121, P3735, DOI 10.1172/JCI43382; Arrieta O, 1998, EUR J CANCER, V34, P2101, DOI 10.1016/S0959-8049(98)00244-5; Audigier Y, 2013, PROG MOL BIOL TRANSL, V115, P143, DOI 10.1016/B978-0-12-394587-7.00004-X; Berta J, 2014, ONCOTARGET, V5, P4426, DOI 10.18632/oncotarget.2032; Berta J, 2010, J THORAC ONCOL, V5, P1120, DOI 10.1097/JTO.0b013e3181e2c1ff; Bertrand C, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00115; Casanovas O, 2005, CANCER CELL, V8, P299, DOI 10.1016/j.ccr.2005.09.005; Castan-Iaurell I, 2012, TRENDS ENDOCRIN MET, V23, P234, DOI 10.1016/j.tem.2012.02.005; Ceraudo E, 2014, J BIOL CHEM, V289, P24599, DOI 10.1074/jbc.M113.541698; Chandra SM, 2011, ARTERIOSCL THROM VAS, V31, P814, DOI 10.1161/ATVBAHA.110.219980; Chaves-Almagro C, 2015, EUR J PHARMACOL, V763, P149, DOI 10.1016/j.ejphar.2015.05.017; Chng SC, 2013, DEV CELL, V27, P672, DOI 10.1016/j.devcel.2013.11.002; Chun HJ, 2008, J CLIN INVEST, V118, P3343, DOI 10.1172/JCI34871; Cox CM, 2006, DEV BIOL, V296, P177, DOI 10.1016/j.ydbio.2006.04.452; De Mota N, 2004, P NATL ACAD SCI USA, V101, P10464, DOI 10.1073/pnas.0403518101; Dray C, 2008, CELL METAB, V8, P437, DOI 10.1016/j.cmet.2008.10.003; Duparc T, 2011, ANTIOXID REDOX SIGN, V15, P1477, DOI 10.1089/ars.2010.3454; Evron T, 2014, J BIOL CHEM, V289, P33442, DOI 10.1074/jbc.M114.581397; Habata Y, 1999, BBA-MOL CELL RES, V1452, P25, DOI 10.1016/S0167-4889(99)00114-7; Hashimoto T, 2007, AM J PATHOL, V171, P1705, DOI 10.2353/ajpath.2007.070471; Heo K, 2012, ORAL ONCOL, V48, P500, DOI 10.1016/j.oraloncology.2011.12.015; Ho L, 2015, CELL STEM CELL, V17, P435, DOI 10.1016/j.stem.2015.08.010; Hosoya M, 2000, J BIOL CHEM, V275, P21061, DOI 10.1074/jbc.M908417199; HUANG JS, 1984, J CELL BIOCHEM, V26, P205, DOI 10.1002/jcb.240260402; Huang XP, 2010, ASSAY DRUG DEV TECHN, V8, P727, DOI 10.1089/adt.2010.0331; HUGHES LE, 1964, LANCET, V1, P408; Ishida J, 2004, J BIOL CHEM, V279, P26274, DOI 10.1074/jbc.M404149200; Japp AG, 2008, J AM COLL CARDIOL, V52, P908, DOI 10.1016/j.jacc.2008.06.013; Kalin RE, 2007, DEV BIOL, V305, P599, DOI 10.1016/j.ydbio.2007.03.004; Lacquaniti A, 2015, CLIN EXP MED, V15, P97, DOI 10.1007/s10238-014-0272-y; Lee DK, 2005, ENDOCRINOLOGY, V146, P231, DOI 10.1210/en.2004-0359; Lu Q, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069703; Macaluso NJM, 2011, CHEMMEDCHEM, V6, P1017, DOI 10.1002/cmdc.201100069; Masri B, 2005, CELL SIGNAL, V17, P415, DOI 10.1016/j.cellsig.2004.09.018; Masri B, 2004, FASEB J, V18, P1909, DOI 10.1096/fj.04-1930fje; Masri B, 2002, BIOCHEM BIOPH RES CO, V290, P539, DOI 10.1006/bbrc.2001.6230; Masri B, 2008, P NATL ACAD SCI USA, V105, P13656, DOI 10.1073/pnas.0803522105; Masri B, 2006, J BIOL CHEM, V281, P18317, DOI 10.1074/jbc.M600606200; NEUFELD G, 1987, J CELL PHYSIOL, V132, P287, DOI 10.1002/jcp.1041320213; O'Carroll AM, 2013, J ENDOCRINOL, V219, pR13, DOI 10.1530/JOE-13-0227; ODOWD BF, 1993, GENE, V136, P355, DOI 10.1016/0378-1119(93)90495-O; Pauli A, 2014, SCIENCE, V343, P746, DOI 10.1126/science.1248636; Picault FX, 2014, EUR J CANCER, V50, P663, DOI 10.1016/j.ejca.2013.11.017; Sorli SC, 2007, ONCOGENE, V26, P7692, DOI 10.1038/sj.onc.1210573; Sorli SC, 2006, DRUG DISCOV TODAY, V11, P1100, DOI 10.1016/j.drudis.2006.10.011; Szokodi I, 2002, CIRC RES, V91, P434, DOI 10.1161/01.RES.0000033522.37861.69; Tao Y, 2010, INVEST OPHTH VIS SCI, V51, P4237, DOI 10.1167/iovs.09-4466; Tatemoto K, 1998, BIOCHEM BIOPH RES CO, V251, P471, DOI 10.1006/bbrc.1998.9489; TAYLOR S, 1982, NATURE, V297, P307, DOI 10.1038/297307a0; Tiam C, 2009, J HEPATOL, V50, P296, DOI 10.1016/j.jhep.2008.09.019; Wang Z, 2015, SCI REP-UK, V5, DOI 10.1038/srep08170; Xin Q, 2015, PEPTIDES, V63, P55, DOI 10.1016/j.peptides.2014.09.016; Yang JC, 2003, NEW ENGL J MED, V349, P427, DOI 10.1056/NEJMoa021491; Yue P, 2010, AM J PHYSIOL-ENDOC M, V298, pE59, DOI 10.1152/ajpendo.00385.2009; Zeng XJ, 2010, EXP CELL RES, V316, P1773, DOI 10.1016/j.yexcr.2010.02.005; Zhao T, 2011, MOL VIS, V17, P1044; Zhou NM, 2003, VIROLOGY, V312, P196, DOI 10.1016/S0042-6822(03)00185-5	57	16	16	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2507	2519		10.1096/fj.201601074R	http://dx.doi.org/10.1096/fj.201601074R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28242772	Green Published, Green Submitted			2022-12-28	WOS:000401553400024
J	Vorrink, SU; Ullah, S; Schmidt, SF; Nandania, JT; Velagapudi, V; Beck, O; Ingelman-Sundberg, M; Lauschke, VM				Vorrink, Sabine U.; Ullah, Shahid; Schmidt, Staffan; Nandania, Jatin; Velagapudi, Vidya; Beck, Olof; Ingelman-Sundberg, Magnus; Lauschke, Volker M.			Endogenous and xenobiotic metabolic stability of primary human hepatocytes in long-term 3D spheroid cultures revealed by a combination of targeted and untargeted metabolomics	FASEB JOURNAL			English	Article						3D cell culture; hepatic metabolism; drug metabolism; cytochrome P450 enzymes; mass spectrometry	CONSTITUTIVE ANDROSTANE RECEPTOR; INDUCED LIVER-INJURY; SPECTROMETRY-BASED METABOLOMICS; ORBITRAP MASS-SPECTROMETRY; PREGNANE-X-RECEPTOR; DRUG-METABOLISM; HEPARG CELLS; IN-VITRO; DEXTROMETHORPHAN METABOLISM; GLUCOCORTICOID-RECEPTOR	Adverse reactions or lack of response to medications are important concerns for drug development programs. However, faithful predictions of drug metabolism and toxicity are difficult because animal models show only limited translatability to humans. Furthermore, current in vitro systems, such as hepatic cell lines or primary human hepatocyte (PHH) 2-dimensional (2D) monolayer cultures, can be used only for acute toxicity tests because of their immature phenotypes and inherent instability. Therefore, the migration to novel phenotypically stable models is of prime importance for the pharmaceutical industry. Novel 3-dimensional (3D) culture systems have been shown to accurately mimic in vivo hepatic phenotypes on transcriptomic and proteomic level, but information about their metabolic stability is lacking. Using a combination of targeted and untargeted high-resolution mass spectrometry, we found that PHHs in 3D spheroid cultures remained metabolically stable for multiple weeks, whereas metabolic patterns of PHHs from the same donors cultured as conventional 2D monolayers rapidly deteriorated. Furthermore, pharmacokinetic differences between donors were maintained in 3D spheroid cultures, enabling studies of interindividual variability in drug metabolism and toxicity. We conclude that the 3D spheroid system is metabolically stable and constitutes a suitable model for in vitro studies of long-term drug metabolism and pharmacokinetics.	[Vorrink, Sabine U.; Ingelman-Sundberg, Magnus; Lauschke, Volker M.] Karolinska Inst, Dept Physiol & Pharmacol, Sect Pharmacogenet, SE-17177 Stockholm, Sweden; [Ullah, Shahid; Schmidt, Staffan; Beck, Olof] Karolinska Inst, Dept Lab Med, Div Clin Pharmacol, Stockholm, Sweden; [Nandania, Jatin; Velagapudi, Vidya] Univ Helsinki, Inst Mol Med Finland FIMM, Metabol Unit, Helsinki, Finland	Karolinska Institutet; Karolinska Institutet; University of Helsinki	Lauschke, VM (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Sect Pharmacogenet, SE-17177 Stockholm, Sweden.	volker.lauschke@ki.se	Lauschke, Volker/O-3014-2017; Velagapudi, Vidya/L-7278-2015; Ullah, Shahid/AAC-3054-2020; Ingelman-Sundberg, Magnus/ABD-9302-2021	Lauschke, Volker/0000-0002-1140-6204; Velagapudi, Vidya/0000-0002-8261-7164; 	Karolinska Institutet Early Verification Program; Innovative Medicine Initiative [115336]; Swedish Research Council [2016-01153, 2016-01154]	Karolinska Institutet Early Verification Program; Innovative Medicine Initiative; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study was supported by the Karolinska Institutet Early Verification Program (to V.M.L.), Innovative Medicine Initiative Project MIP-DILI Grant 115336 (to M.I.-S.), and by Swedish Research Council Grants 2016-01153 and 2016-01154 (both to V.M.L.). V.M.L. and M.I.-S. are cofounders and owners of HepaPredict AB.	Antherieu S, 2010, DRUG METAB DISPOS, V38, P516, DOI 10.1124/dmd.109.030197; Azimifar SB, 2014, CELL METAB, V20, P1076, DOI 10.1016/j.cmet.2014.11.002; Baxter M, 2015, J HEPATOL, V62, P581, DOI 10.1016/j.jhep.2014.10.016; Bell C., 2017, DRUG METAB DISPOS; Bell CC, 2016, SCI REP-UK, V6, DOI 10.1038/srep25187; Bjornsson E, 2005, HEPATOLOGY, V42, P481, DOI 10.1002/hep.20800; Bjornsson ES, 2013, GASTROENTEROLOGY, V144, P1419, DOI 10.1053/j.gastro.2013.02.006; BOWSHER RR, 1994, ANTIMICROB AGENTS CH, V38, P2134, DOI 10.1128/AAC.38.9.2134; Brown MV, 2013, OBESITY, V21, pE561, DOI 10.1002/oby.20440; Cajka T, 2016, ANAL CHEM, V88, P524, DOI 10.1021/acs.analchem.5b04491; Garcia-Canaveras JC, 2016, SCI REP-UK, V6, DOI 10.1038/srep27239; Chapman KL, 2013, REGUL TOXICOL PHARM, V66, P88, DOI 10.1016/j.yrtph.2013.03.001; Cook D, 2014, NAT REV DRUG DISCOV, V13, P419, DOI 10.1038/nrd4309; Eliuk S, 2015, ANNU REV ANAL CHEM, V8, P61, DOI 10.1146/annurev-anchem-071114-040325; Ferguson SS, 2005, MOL PHARMACOL, V68, P747, DOI 10.1124/mol.105.013169; Goodwin B, 1999, MOL PHARMACOL, V56, P1329, DOI 10.1124/mol.56.6.1329; Gpmez-Lechon M. J., 2014, EXPERT OPIN DRUG MET, V10, P1553; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Haberle J, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-32; Hay M, 2014, NAT BIOTECHNOL, V32, P40, DOI 10.1038/nbt.2786; HAYES KC, 1981, ANNU REV NUTR, V1, P401, DOI 10.1146/annurev.nu.01.070181.002153; Henry H, 2012, RAPID COMMUN MASS SP, V26, P499, DOI 10.1002/rcm.6121; Houtkooper RH, 2010, ENDOCR REV, V31, P194, DOI 10.1210/er.2009-0026; Ihunnah CA, 2011, BBA-MOL BASIS DIS, V1812, P956, DOI 10.1016/j.bbadis.2011.01.014; Inoue Y, 2006, J LIPID RES, V47, P215, DOI 10.1194/jlr.M500430-JLR200; Jeon SM, 2016, EXP MOL MED, V48, DOI 10.1038/emm.2016.81; Jones DR, 1996, CLIN PHARMACOL THER, V60, P374, DOI 10.1016/S0009-9236(96)90194-0; Kanebratt KP, 2008, DRUG METAB DISPOS, V36, P1444, DOI 10.1124/dmd.107.020016; Kim SR, 2014, J TOXICOL SCI, V39, P717, DOI 10.2131/jts.39.717; Kir S, 2012, J BIOL CHEM, V287, P41334, DOI 10.1074/jbc.M112.421834; Krauss RM, 2013, CLIN PHARMACOL THER, V94, P562, DOI 10.1038/clpt.2013.164; Lasser KE, 2002, JAMA-J AM MED ASSOC, V287, P2215, DOI 10.1001/jama.287.17.2215; Lauschke VM, 2016, CHEM RES TOXICOL, V29, P1936, DOI 10.1021/acs.chemrestox.6b00150; Lauschke VM, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17101714; Lauschke VM, 2016, HEPATOLOGY, V64, P1743, DOI 10.1002/hep.28780; Maglich JM, 2003, J BIOL CHEM, V278, P17277, DOI 10.1074/jbc.M300138200; Manning FJ, 1995, REV FIALURIDINE FIAU; Martignoni M, 2006, EXPERT OPIN DRUG MET, V2, P875, DOI 10.1517/17425255.2.6.875; Marudanayagam R, 2009, HPB, V11, P429, DOI 10.1111/j.1477-2574.2009.00086.x; Maurel P, 1996, ADV DRUG DELIVER REV, V22, P105, DOI 10.1016/S0169-409X(96)00417-6; MCKENZIE R, 1995, NEW ENGL J MED, V333, P1099, DOI 10.1056/NEJM199510263331702; Meissen JK, 2015, METABOLOMICS, V11, P707, DOI 10.1007/s11306-014-0729-8; Najdekr L, 2016, ANAL CHEM, V88, P11429, DOI 10.1021/acs.analchem.6b02319; Olson H, 2000, REGUL TOXICOL PHARM, V32, P56, DOI 10.1006/rtph.2000.1399; Oshiro C, 2010, PHARMACOGENET GENOM, V20, P211, DOI 10.1097/FPC.0b013e328333b99c; Ranninger C, 2016, ANAL CHIM ACTA, V930, P13, DOI 10.1016/j.aca.2016.05.017; Renwick AB, 2000, DRUG METAB DISPOS, V28, P1202; Reuben A, 2010, HEPATOLOGY, V52, P2065, DOI 10.1002/hep.23937; Roe B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023641; Roman-Garcia P, 2014, J CLIN INVEST, V124, P2988, DOI 10.1172/JCI72606; Rowe C, 2013, HEPATOLOGY, V58, P799, DOI 10.1002/hep.26414; Sahi J, 2009, J BIOCHEM MOL TOXIC, V23, P43, DOI 10.1002/jbt.20264; SCHMID B, 1985, CLIN PHARMACOL THER, V38, P618, DOI 10.1038/clpt.1985.235; Sgro C, 2002, HEPATOLOGY, V36, P451, DOI 10.1053/jhep.2002.34857; Shan J, 2013, NAT CHEM BIOL, V9, P514, DOI 10.1038/nchembio.1270; Sison-Young RL, 2017, ARCH TOXICOL, V91, P1385, DOI 10.1007/s00204-016-1745-4; Spaggiari D, 2014, J PHARMACEUT BIOMED, V101, P221, DOI 10.1016/j.jpba.2014.03.018; Sugatani J, 2005, MOL PHARMACOL, V67, P845, DOI 10.1124/mol.104.007161; Tiziani S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004251; Tostoes RM, 2012, HEPATOLOGY, V55, P1227, DOI 10.1002/hep.24760; Tufts Center for the Study of Drug Development, 2014, TUFTS CTR STUD DRUG; Van den Eede N, 2015, TOXICOL IN VITRO, V29, P2045, DOI 10.1016/j.tiv.2015.08.012; Venkatakrishnan K, 2005, DRUG METAB DISPOS, V33, P845, DOI 10.1124/dmd.105.004077; Vrzal R, 2009, CHEM-BIOL INTERACT, V179, P288, DOI 10.1016/j.cbi.2008.10.035; Wang Y, 2013, DIAGN PATHOL, V8, DOI 10.1186/1746-1596-8-8; Ware BR, 2017, TRENDS BIOTECHNOL, V35, P172, DOI 10.1016/j.tibtech.2016.08.001; Watson M, 2009, MOL CELL BIOL, V29, P5872, DOI 10.1128/MCB.00112-09; Yoshinari K, 2010, BIOCHEM PHARMACOL, V79, P261, DOI 10.1016/j.bcp.2009.08.008; Yu AM, 2001, DRUG METAB DISPOS, V29, P1514; Zhou JT, 2016, ANALYST, V141, P6362, DOI 10.1039/c6an01753c	70	85	86	1	32	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2696	2708		10.1096/fj.201601375R	http://dx.doi.org/10.1096/fj.201601375R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28264975	Green Published, hybrid			2022-12-28	WOS:000401553400039
J	Gimenez-Bastida, JA; Shibata, T; Uchida, K; Schneider, C				Gimenez-Bastida, Juan A.; Shibata, Takahiro; Uchida, Koji; Schneider, Claus			Roles of 5-lipoxygenase and cyclooxygenase-2 in the biosynthesis of hemiketals E-2 and D-2 by activated human leukocytes	FASEB JOURNAL			English	Article						arachidonic acid; prostaglandin; leukotriene	NF-KAPPA-B; ARACHIDONIC-ACID METABOLISM; POLYMORPHONUCLEAR LEUKOCYTES; COX-2 INHIBITION; PROSTAGLANDIN; CURCUMIN; MACROPHAGES; OXYGENATION; LEUKOTRIENE; EXPRESSION	The 2 hemiketal (HK) eicosanoids HKD2 and HKE2 are the major products of the biosynthetic crossover of the 5-lipoxygenase (5-LOX) and cyclooxygenase-2 (COX-2) pathways. HKs result from the rearrangement of a di-endoperoxide intermediate formed in the COX-2-dependent oxygenation of 5S-hydroxyeicosatetraenoic acid (5S-HETE). We analyzed HK biosynthesis in human leukocytes stimulated ex vivo and defined the biosynthetic roles of 5-LOX and COX-2, using inhibitors and incubations with exogenous substrates. Activation of leukocytes with LPS followed by treatment with the calcium ionophore A23187 resulted in the formation of PGE(2), 5-HETE, and LTB4 as the principal metabolites of COX-2 and 5-LOX, respectively. The formation of HKD2 and HKE2 was highest after 15min LPS treatment, and at that time, levels were similar to PGE(2), but less than 5-HETE and LTB4. The time course of HK formation paralleled that of 5-HETE and LTB4, implying the availability of the 5S-HETE substrate as a limiting factor in biosynthesis rather than expression levels of COX-2. Specific inhibitors of COX-2 and 5-LOX decreased formation of HKD2 and HKE2. Platelets didnot form HKs from exogenous 5S-HETE, implying that COX-1 is not involved. HKs are early products during an inflammatory event and require cells that express 5-LOX and COX-2 for their biosynthesis.-Gimenez-Bastida, J. A., Shibata, T., Uchida, K., Schneider, C. Roles of 5-lipoxygenase and cyclooxygenase-2 in the biosynthesis of hemiketals E-2 and D-2 by activated human leukocytes.	[Gimenez-Bastida, Juan A.; Schneider, Claus] Vanderbilt Univ, Dept Pharmacol, Med Sch, RRB 514,23rd Av S & Pierce, Nashville, TN 37232 USA; [Gimenez-Bastida, Juan A.; Schneider, Claus] Vanderbilt Univ, Vanderbilt Inst Chem Biol, Med Sch, Nashville, TN USA; [Shibata, Takahiro; Uchida, Koji] Nagoya Univ, Grad Sch Bioagr Sci, Div Biofunct Chem, Nagoya, Aichi, Japan; [Uchida, Koji] Univ Tokyo, Grad Sch Agr & Life Sci, Tokyo, Japan	Vanderbilt University; Vanderbilt University; Nagoya University; University of Tokyo	Schneider, C (corresponding author), Vanderbilt Univ, Dept Pharmacol, Med Sch, RRB 514,23rd Av S & Pierce, Nashville, TN 37232 USA.	claus.schneider@vanderbilt.edu	Gimenez Bastida, Juan Antonio/T-2721-2017; Shibata, Takahiro/I-6872-2014	Gimenez Bastida, Juan Antonio/0000-0002-1244-8764; Uchida, Koji/0000-0003-3894-5299; Shibata, Takahiro/0000-0003-3194-607X	U. S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) [R01GM076592]; National Center for Complementary and Integrative Health [R01AT006896]; American Heart Association [16POST30690001]; Ministry of Education, Sciences, Sports, Technology (MEXT), Japan [26111011]; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO) program;  [26252018]; National Center for Complementary & Integrative Health [R01AT006896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076592] Funding Source: NIH RePORTER	U. S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS); National Center for Complementary and Integrative Health; American Heart Association(American Heart Association); Ministry of Education, Sciences, Sports, Technology (MEXT), Japan; Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO) program; ; National Center for Complementary & Integrative Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors thank Dr. Ginger Milne for providing the AMPP reagent used in the initial phase of the study, and Dr. Noemi Tejera Hernandez (both from Vanderbilt University) for exploratory work on this project. This work was supported by U. S. National Institutes of Health (NIH) National Institute of General Medical Sciences (NIGMS) Grant R01GM076592 and National Center for Complementary and Integrative Health Grant R01AT006896 (to C.S); postdoctoral award 16POST30690001 from the American Heart Association (to J.A.G.-B.); Grant-in-Aid for Scientific Research 26252018 (to K.U.); and Grant-in-Aid for Scientific Research on Innovative Areas "Oxygen Biology: a new criterion for integrated understanding of life" 26111011 of the Ministry of Education, Sciences, Sports, Technology (MEXT), Japan; and a grant from the Japan Science and Technology Agency Precursory Research for Embryonic Science and Technology (PRESTO) program (to T.S.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIGMS or the NIH. The authors declare no conflicts of interest.	Aluwi MFFM, 2016, BIOORG MED CHEM LETT, V26, P2531, DOI 10.1016/j.bmcl.2016.03.092; Blobaum AL, 2007, J BIOL CHEM, V282, P16379, DOI 10.1074/jbc.M609883200; BOKOCH GM, 1981, J BIOL CHEM, V256, P4156; Bollinger JG, 2010, ANAL CHEM, V82, P6790, DOI 10.1021/ac100720p; Brenneis C, 2006, FASEB J, V20, P1352, DOI 10.1096/fj.05-5346com; Brock TG, 1997, J BIOL CHEM, V272, P8276, DOI 10.1074/jbc.272.13.8276; CHEN XS, 1994, NATURE, V372, P179, DOI 10.1038/372179a0; COREY EJ, 1981, TETRAHEDRON LETT, V22, P299, DOI 10.1016/0040-4039(81)80080-9; FitzGerald GA, 2004, NEW ENGL J MED, V351, P1709, DOI 10.1056/NEJMp048288; Funk CD, 2001, SCIENCE, V294, P1871, DOI 10.1126/science.294.5548.1871; Gimenez-Bastida J. A., 2016, PROSTAG OTH LIPID M, DOI [10.1016/j.prostaglandins.2016.09.001, DOI 10.1016/J.PROSTAGLANDINS.2016.09]; GOLDYNE ME, 1984, J BIOL CHEM, V259, P8815; Gordon ON, 2013, J LABELLED COMPD RAD, V56, P696, DOI 10.1002/jlcr.3102; Griesser M, 2011, P NATL ACAD SCI USA, V108, P6945, DOI 10.1073/pnas.1019473108; Griesser M, 2009, J LIPID RES, V50, P2455, DOI 10.1194/jlr.M900181-JLR200; Grosser T, 2006, J CLIN INVEST, V116, P4, DOI 10.1172/JCI27291; Hermanson DJ, 2014, TRENDS PHARMACOL SCI, V35, P358, DOI 10.1016/j.tips.2014.04.006; Hong JI, 2004, CARCINOGENESIS, V25, P1671, DOI 10.1093/carcin/bgh165; Jin J, 2013, J LIPID RES, V54, P754, DOI 10.1194/jlr.M033746; Jobin C, 1999, J IMMUNOL, V163, P3474; Kozak KR, 2002, J BIOL CHEM, V277, P44877, DOI 10.1074/jbc.M206788200; Kuwata H, 2015, BIOCHEM BIOPH RES CO, V465, P528, DOI 10.1016/j.bbrc.2015.08.054; Lynch KR, 1999, NATURE, V399, P789; Mulugeta S, 2010, J LIPID RES, V51, P575, DOI 10.1194/jlr.M001719; MURPHY RC, 1979, P NATL ACAD SCI USA, V76, P4275, DOI 10.1073/pnas.76.9.4275; Murphy RC, 2007, BIOCHEM J, V405, P379, DOI 10.1042/BJ20070289; OFLaherty JT, 1996, J IMMUNOL, V157, P336; PATRIGNANI P, 1994, J PHARMACOL EXP THER, V271, P1705; Plummer SM, 1999, ONCOGENE, V18, P6013, DOI 10.1038/sj.onc.1202980; Powell WS, 2005, PROG LIPID RES, V44, P154, DOI 10.1016/j.plipres.2005.04.002; POWELL WS, 1992, J BIOL CHEM, V267, P19233; Raetz CRH, 2006, J LIPID RES, V47, P1097, DOI 10.1194/jlr.M600027-JLR200; Rhee SH, 2000, J BIOL CHEM, V275, P34035, DOI 10.1074/jbc.M007386200; Ricciotti E, 2011, ARTERIOSCL THROM VAS, V31, P986, DOI 10.1161/ATVBAHA.110.207449; ROUZER CA, 1986, P NATL ACAD SCI USA, V83, P857, DOI 10.1073/pnas.83.4.857; Rouzer CA, 2003, CHEM REV, V103, P2239, DOI 10.1021/cr000068x; Rouzer CA, 2006, BIOCHEM J, V399, P91, DOI 10.1042/BJ20060615; Schneider C, 2006, J AM CHEM SOC, V128, P720, DOI 10.1021/ja056517y; Schneider C, 2004, J BIOL CHEM, V279, P4404, DOI 10.1074/jbc.M307431200; Schneider C, 2002, J BIOL CHEM, V277, P478, DOI 10.1074/jbc.M107471200; Smith CJ, 1998, P NATL ACAD SCI USA, V95, P13313, DOI 10.1073/pnas.95.22.13313; Smith JP, 2010, THROMB RES, V126, pE23, DOI 10.1016/j.thromres.2010.04.003; Smith WL, 2011, CHEM REV, V111, P5821, DOI 10.1021/cr2002992; Smyth EM, 2009, J LIPID RES, V50, pS423, DOI 10.1194/jlr.R800094-JLR200; Tejera N, 2012, J LIPID RES, V53, P87, DOI 10.1194/jlr.M017822; Yu M, 1997, J BIOL CHEM, V272, P21181, DOI 10.1074/jbc.272.34.21181	46	12	12	0	5	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1867	1878		10.1096/fj.201601136R	http://dx.doi.org/10.1096/fj.201601136R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28096231	Green Published			2022-12-28	WOS:000399195500010
J	Zhou, J; Wang, S; Qi, Q; Yang, XY; Zhu, ED; Yuan, HR; Li, XM; Liu, Y; Li, XX; Wang, BL				Zhou, Jie; Wang, Shan; Qi, Qi; Yang, Xiaoyue; Zhu, Endong; Yuan, Hairui; Li, Xuemei; Liu, Ying; Li, Xiaoxia; Wang, Baoli			Nuclear factor I-C reciprocally regulates adipocyte and osteoblast differentiation via control of canonical Wnt signaling	FASEB JOURNAL			English	Article						adipogenesis; osteogenesis; Wnt/b; catenin; Lrp5	TOOTH ROOT DEVELOPMENT; MESENCHYMAL STEM-CELLS; OSTEOGENIC DIFFERENTIATION; BETA-CATENIN; ODONTOBLAST DIFFERENTIATION; BRAIN-DEVELOPMENT; GENE-EXPRESSION; ADIPOSE-TISSUE; BONE-FORMATION; C/EBP-ALPHA	Nuclear factor I-C (NFIC) has recently been identified as an important player in osteogenesis and bone homeostasis in vivo. However, the molecular mechanisms involved have yet to be defined. In the current study, Nfic expression was altered in primary marrow stromal cells and established progenitor lines after adipogenic and osteogenic treatment. Overexpression of Nfic in stromal cells ST2, mesenchymal cells C3H10T1/2, and primary marrow stromal cells inhibited adipogenic differentiation, whereas it promoted osteogenic differentiation. Conversely, silencing of endogenous Nfic in the cell lines enhanced adipogenic differentiation, whereas it blocked osteogenic differentiation. Mechanism investigations revealed that Nfic overexpression promoted nuclear translocation of beta-catenin and increased nuclear protein levels of b-catenin and transcription factor 7-like 2 (TCF7L2). Promoter studies and the chromatin immunoprecipitation (ChIP) assay revealed that NFIC directly binds to the promoter of low-density lipoprotein receptor-related protein 5 (Lrp5) and thereafter transactivates the promoter. Finally, inactivation of canonical Wnt signaling in ST2 attenuated the inhibition of adipogenic differentiation and stimulation of osteogenic differentiation by NFIC. Our study suggests that NFIC balances adipogenic and osteogenic differentiation from progenitor cells through controlling canonical Wnt signaling and highlights the potential of NFIC as a target for new therapies to control metabolic disorders like osteoporosis and obesity.-Zhou, J., Wang, S., Qi, Q., Yang, X., Zhu, E., Yuan, H., Li, X., Liu, Y., Li, X., Wang, B. Nuclear factor I-C reciprocally regulates adipocyte and osteoblast differentiation via control of canonical Wnt signaling.	[Zhou, Jie; Qi, Qi; Zhu, Endong; Yuan, Hairui; Li, Xuemei; Wang, Baoli] Tianjin Med Univ, Tianjin Key Lab Metab Dis, Minist Hlth, Key Lab Hormones & Dev, Tianjin, Peoples R China; [Zhou, Jie; Wang, Baoli] Tianjin Med Univ, Collaborat Innovat Ctr Metab Dis 2011, Metab Dis Hosp, Tianjin, Peoples R China; [Zhou, Jie; Wang, Baoli] Tianjin Med Univ, Inst Endocrinol, Tianjin, Peoples R China; [Wang, Shan; Li, Xiaoxia] Tianjin Med Univ, Coll Basic Med Sci, Tianjin, Peoples R China; [Yang, Xiaoyue; Liu, Ying] Tianjin Med Univ, Stomatol Hosp, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Wang, BL (corresponding author), Tianjin Med Univ, 22 Qi Xiang Tai Rd,Box 126, Tianjin 300070, Tianjin, Peoples R China.	blwang@tmu.edu.cn			Natural Science Foundation of China [81672116, 81472040, 81271977, 81101596, 81501846]; Key Laboratory of Hormones and Development, Ministry of Health	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Laboratory of Hormones and Development, Ministry of Health	This work was supported by Natural Science Foundation of China Grants 81672116, 81472040, and 81271977 (to B.W.), Grant 81101596 (to X.L.), and Grant 81501846 (to E.Z.); and by an Open Grant from the Key Laboratory of Hormones and Development, Ministry of Health. The authors declare no conflicts of interest.	Abdallah BM, 2015, BONE, V70, P28, DOI 10.1016/j.bone.2014.07.028; Akune T, 2004, J CLIN INVEST, V113, P846, DOI 10.1172/JCI200419900; Bennett CN, 2007, J BONE MINER RES, V22, P1924, DOI 10.1359/JBMR.070810; Cai T, 2016, EXP CELL RES, V345, P206, DOI 10.1016/j.yexcr.2016.06.007; Campbell CE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-52; Cheng HC, 2011, ACTA BIOCH BIOPH SIN, V43, P204, DOI 10.1093/abbs/gmq130; Day TF, 2005, DEV CELL, V8, P739, DOI 10.1016/j.devcel.2005.03.016; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; Felber K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144982; FREYTAG SO, 1994, GENE DEV, V8, P1654, DOI 10.1101/gad.8.14.1654; Glass DA, 2005, DEV CELL, V8, P751, DOI 10.1016/j.devcel.2005.02.017; Guan XH, 2015, STEM CELLS, V33, P1589, DOI 10.1002/stem.1947; Harris L, 2015, DEV DYNAM, V244, P227, DOI 10.1002/dvdy.24182; He W, 2014, J DENT RES, V93, P496, DOI 10.1177/0022034514525200; Heng YHE, 2014, CEREB CORTEX, V24, P261, DOI 10.1093/cercor/bhs307; Hill TP, 2005, DEV CELL, V8, P727, DOI 10.1016/j.devcel.2005.02.013; Holmen SL, 2004, J BONE MINER RES, V19, P2033, DOI 10.1359/JBMR.040907; Holmen SL, 2005, J BIOL CHEM, V280, P21162, DOI 10.1074/jbc.M501900200; Karasik D, 2016, NAT REV RHEUMATOL, V12, P323, DOI 10.1038/nrrheum.2016.48; Kennell JA, 2005, J BIOL CHEM, V280, P24004, DOI 10.1074/jbc.M501080200; Komori T, 2010, CELL TISSUE RES, V339, P189, DOI 10.1007/s00441-009-0832-8; Kook SH, 2015, MOL CELL BIOCHEM, V402, P213, DOI 10.1007/s11010-015-2329-y; Kramer I, 2010, MOL CELL BIOL, V30, P3071, DOI 10.1128/MCB.01428-09; Lee DS, 2014, STEM CELLS, V32, P2467, DOI 10.1002/stem.1733; Lee DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029160; Lee DS, 2009, J BIOL CHEM, V284, P17293, DOI 10.1074/jbc.M109.009084; Linhart HG, 2001, P NATL ACAD SCI USA, V98, P12532, DOI 10.1073/pnas.211416898; Liu Y, 2015, DEVELOPMENT, V142, P3374, DOI 10.1242/dev.127068; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacDonald BT, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007880; Mason S, 2009, MOL NEUROBIOL, V39, P10, DOI 10.1007/s12035-008-8048-6; Miclea RL, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-26; Nemoto E, 2016, J PERIODONTAL RES, V51, P164, DOI 10.1111/jre.12294; Oh HJ, 2012, J CELL BIOCHEM, V113, P877, DOI 10.1002/jcb.23421; Pignolo RJ, 2015, APPL CLIN GENET, V8, P37, DOI 10.2147/TACG.S51064; Pjanic M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-181; Plachez C, 2012, J COMP NEUROL, V520, P3135, DOI 10.1002/cne.23081; Rudnicki MA, 2015, BONE, V80, P60, DOI 10.1016/j.bone.2015.02.009; Ryoo HM, 2006, GENE, V366, P51, DOI 10.1016/j.gene.2005.10.011; Smink JJ, 2012, GENE, V497, P10, DOI 10.1016/j.gene.2012.01.043; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; Tanaka T, 1997, EMBO J, V16, P7432, DOI 10.1093/emboj/16.24.7432; Wang J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.356; WANG ND, 1995, SCIENCE, V269, P1108, DOI 10.1126/science.7652557; Wang YP, 2014, FRONT BIOSCI-LANDMRK, V19, P379, DOI 10.2741/4214; Wong YW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r72; Xiong JH, 2011, NAT MED, V17, P1235, DOI 10.1038/nm.2448; Zhang JF, 2004, P NATL ACAD SCI USA, V101, P10703, DOI 10.1073/pnas.0403652101; Zhao M, 2004, J BIOL CHEM, V279, P12854, DOI 10.1074/jbc.M313294200	50	27	27	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1939	1952		10.1096/fj.201600975RR	http://dx.doi.org/10.1096/fj.201600975RR			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28122918				2022-12-28	WOS:000399195500016
J	Lopez-Yoldi, M; Stanhope, KL; Garaulet, M; Chen, XGX; Marcos-Gomez, B; Carrasco-Benso, MP; Santa Maria, EM; Escote, X; Lee, V; Nunez, MV; Medici, V; Martinez-Anso, E; Sainz, N; Huerta, AE; Laiglesia, LM; Prieto, J; Martinez, JA; Bustos, M; Havel, PJ; Moreno-Aliaga, MJ				Lopez-Yoldi, Miguel; Stanhope, Kimber L.; Garaulet, Marta; Chen, X. Guoxia; Marcos-Gomez, Beatriz; Paz Carrasco-Benso, Maria; Santa Maria, Eva M.; Escote, Xavier; Lee, Vivien; Nunez, Marinelle V.; Medici, Valentina; Martinez-Anso, Eduardo; Sainz, Neira; Huerta, Ana E.; Laiglesia, Laura M.; Prieto, Jesus; Alfredo Martinez, J.; Bustos, Matilde; Havel, Peter J.; Moreno-Aliaga, Maria J.			Role of cardiotrophin-1 in the regulation of metabolic circadian rhythms and adipose core clock genes in mice and characterization of 24-h circulating CT-1 profiles in normal-weight and overweight/obese subjects	FASEB JOURNAL			English	Article						adipose tissue; obesity; Bmal1; Per2; Cry1	HIGH-FAT DIET; CHRONOBIOLOGICAL ASPECTS; DOWN-SYNDROME; GROWTH-FACTOR; OBESITY; TISSUE; LEPTIN; IMPACT; SLEEP; CYCLE	Cardiotrophin (CT)-1 is a regulator of glucose and lipid homeostasis. In the present study, we analyzed whether CT-1 also acts to peripherally regulate metabolic rhythms and adipose tissue core clock genes in mice. Moreover, the circadian pattern of plasma CT-1 levels was evaluated in normal-weight and overweight subjects. The circadian rhythmicity of oxygen consumption rate (Vo(2)) was disrupted in aged obese CT-1-deficient (CT-1(-/-)) mice (12 mo). Although circadian rhythms of Vo(2) were conserved in young lean CT-1(-/-) mice (2 mo), CT-1 deficiency caused a phase shift of the acrophase. Most of the clock genes studied (Clock, Bmal1, and Per2) displayed a circadian rhythm in adipose tissue of both wild-type (WT) and CT-1(-/-) mice. However, the pattern was altered in CT-1(-/-) mice toward a lower percentage of the rhythm or lower amplitude, especially for Bmal1 and Clock. Moreover, CT-1 mRNA levels in adipose tissue showed significant circadian fluctuations in young WT mice. In humans, CT-1 plasma profile exhibited a 24-h circadian rhythm in normal-weight but not in overweight subjects. The 24-h pattern of CT-1 was characterized by a pronounced increase during the night (from 02:00 to 08:00). These observations suggest a potential role for CT-1 in the regulation of metabolic circadian rhythms.-Lopez-Yoldi, M., Stanhope, K. L., Garaulet, M., Chen, X. G., Marcos-Gomez, B., Carrasco-Benso, M. P., Santa Maria, E. M., Escote, X., Lee, V., Nunez, M. V., Medici, V., Martinez-Anso, E., Sainz, N., Huerta, A. E., Laiglesia, L. M., Prieto, J., Martinez, J. A., Bustos, M., Havel, P. J., Moreno-Aliaga, M. J. Role of cardiotrophin-1 in the regulation of metabolic circadian rhythms and adipose core clock genes in mice and characterization of 24-h circulating CT-1 profiles in normal-weight and overweight/obese subjects.	[Lopez-Yoldi, Miguel; Marcos-Gomez, Beatriz; Escote, Xavier; Sainz, Neira; Huerta, Ana E.; Laiglesia, Laura M.; Alfredo Martinez, J.; Moreno-Aliaga, Maria J.] Univ Navarra, Ctr Appl Med Res CIMA, Dept Nutr Food Sci & Physiol, Pamplona, Spain; [Lopez-Yoldi, Miguel; Escote, Xavier; Sainz, Neira; Huerta, Ana E.; Laiglesia, Laura M.; Alfredo Martinez, J.; Moreno-Aliaga, Maria J.] Univ Navarra, Ctr Appl Med Res CIMA, Ctr Nutr Res, Pamplona, Spain; [Martinez-Anso, Eduardo; Prieto, Jesus; Bustos, Matilde] Univ Navarra, Ctr Appl Med Res CIMA, Dept Hepatol & Gene Therapy, Pamplona, Spain; [Stanhope, Kimber L.; Chen, X. Guoxia; Lee, Vivien; Nunez, Marinelle V.; Medici, Valentina; Havel, Peter J.] Univ Calif Davis, Sch Vet Med, Dept Mol Biosci, Davis, CA 95616 USA; [Garaulet, Marta; Paz Carrasco-Benso, Maria] Univ Murcia, Fac Biol, Dept Physiol, Murcia, Spain; [Santa Maria, Eva M.; Prieto, Jesus] Inst Hlth Carlos III, Biomed Res Ctr Hepat & Digest Dis CIBERehd, Madrid, Spain; [Alfredo Martinez, J.; Moreno-Aliaga, Maria J.] Inst Hlth Carlos III, Biomed Res Ctr Physiopathol Obes & Nutr CIBERobn, Madrid, Spain; [Alfredo Martinez, J.; Moreno-Aliaga, Maria J.] Navarra Inst Hlth Res IdiSNA, Pamplona, Spain	University of Navarra; University of Navarra; University of Navarra; University of California System; University of California Davis; University of Murcia; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Moreno-Aliaga, MJ (corresponding author), Univ Navarra, Dept Nutr Food Sci & Physiol, C Irunlarrea S-N, Pamplona 31008, Navarra, Spain.	mjmoreno@unav.es	Escoté, Xavier/AAH-2973-2020; Sáinz, Neira/AAA-4624-2019; Escote, Xavier/AAC-6335-2019; Moreno-Aliaga, Maria J/M-7015-2018; Santa María Monasteri, Eva/Z-4537-2019; Garaulet, Marta/K-6625-2014	Escote, Xavier/0000-0003-1172-3995; Moreno-Aliaga, Maria J/0000-0002-2018-6434; Santa María Monasteri, Eva/0000-0003-0629-6175; Garaulet, Marta/0000-0002-4066-3509; Medici, Valentina/0000-0001-5438-284X; Huerta Hernandez, Ana Elsa/0000-0003-1911-5310; Maria Paz, Carrasco-Benso/0000-0001-5611-4929; Havel, Peter/0000-0003-3652-8301; Lopez-Yoldi, Miguel/0000-0002-6004-4051; Laiglesia, Laura/0000-0002-4636-1421; Bustos, Matilde/0000-0003-2306-9548	Navarra Department of Health [2007/10]; Mutua Madrilena Foundation; Fondo de Investigacion Sanitaria (FIS) [PI10/01516, PI13/01851]; CIBERobn; Linea Especial ''Nutricion, Obesidad y Salud"; Universidad de Navarra Centre for Nutrition Research; International Agricultural Machinery Fair (FIMSA) [SAF2014-52480-R]; "Temporary Business Association (UTE) project CIMA" Spanish Government of Science and Innovation [SAF2014-52480-R]; European Regional Development Fund ERDF; Asociacion de Amigos University of Navarra; U.S. National Institutes of Health (NIH)/National Heart, Lung and Blood Institute [1R01 HL09133, 1R01 HL107256]; National Center for Research Resources, a component of the NIH; NIH Roadmap for Medical Research, National Institute of General Medical Sciences [UL1 RR024146]; Building Interdisciplinary Research Careers in Women's Health Award - NIH National Institute of Child Health and Human Development, Office of Research on Women's Health, Office of Dietary Supplements [K12 HD051958]; NIH National Institute of Aging; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K12HD051958] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024146] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107256, F32HL009133] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U24DK092993, U2CDK092993] Funding Source: NIH RePORTER	Navarra Department of Health; Mutua Madrilena Foundation; Fondo de Investigacion Sanitaria (FIS)(Instituto de Salud Carlos III); CIBERobn; Linea Especial ''Nutricion, Obesidad y Salud"; Universidad de Navarra Centre for Nutrition Research; International Agricultural Machinery Fair (FIMSA); "Temporary Business Association (UTE) project CIMA" Spanish Government of Science and Innovation; European Regional Development Fund ERDF(European Commission); Asociacion de Amigos University of Navarra; U.S. National Institutes of Health (NIH)/National Heart, Lung and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Center for Research Resources, a component of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH Roadmap for Medical Research, National Institute of General Medical Sciences; Building Interdisciplinary Research Careers in Women's Health Award - NIH National Institute of Child Health and Human Development, Office of Research on Women's Health, Office of Dietary Supplements; NIH National Institute of Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by Grant 2007/10 from the Navarra Department of Health; the Mutua Madrilena Foundation; Fondo de Investigacion Sanitaria (FIS) Grants PI10/01516 and PI13/01851; CIBERobn; Linea Especial ''Nutricion, Obesidad y Salud" and Universidad de Navarra Centre for Nutrition Research; by agreement between International Agricultural Machinery Fair (FIMSA) and the "Temporary Business Association (UTE) project CIMA" Spanish Government of Science and Innovation Grant SAF2014-52480-R; and European Regional Development Fund ERDF grant (to M.G.). M.L.-Y.was supported by a fellowship from Asociacion de Amigos University of Navarra. The human study was supported by U.S. National Institutes of Health (NIH)/National Heart, Lung and Blood Institute Grants 1R01 HL09133 and 1R01 HL107256 (to P.J.H.); National Center for Research Resources, a component of the NIH, and NIH Roadmap for Medical Research, National Institute of General Medical Sciences Grant UL1 RR024146. K.L.S. was supported by Building Interdisciplinary Research Careers in Women's Health Award K12 HD051958, funded by the NIH National Institute of Child Health and Human Development, Office of Research on Women's Health, Office of Dietary Supplements, and the NIH National Institute of Aging. The authors declare no conflicts of interest.	Agorastos A, 2014, PSYCHONEUROENDOCRINO, V44, P71, DOI 10.1016/j.psyneuen.2014.02.020; Ando H, 2005, ENDOCRINOLOGY, V146, P5631, DOI 10.1210/en.2005-0771; Ando H, 2011, ENDOCRINOLOGY, V152, P1347, DOI 10.1210/en.2010-1068; Antunes LC, 2010, NUTR RES REV, V23, P155, DOI 10.1017/S0954422410000016; Barclay JL, 2013, AM J PHYSIOL-ENDOC M, V304, pE1053, DOI 10.1152/ajpendo.00512.2012; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Batschelet E., 1981, CIRCULAR STAT BIOL; BAUER J, 1994, CLIN INVESTIGATOR, V72, P315; Beraza N, 2005, HEPATOLOGY, V41, P460, DOI 10.1002/hep.20590; Bodosi B, 2004, AM J PHYSIOL-REG I, V287, pR1071, DOI 10.1152/ajpregu.00294.2004; Bray MS, 2007, OBES REV, V8, P169, DOI 10.1111/j.1467-789X.2006.00277.x; Buxton OM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003200; Colas D, 2004, NEUROBIOL DIS, V16, P291, DOI 10.1016/j.nbd.2004.03.009; Eckel-Mahan K, 2013, PHYSIOL REV, V93, P107, DOI 10.1152/physrev.00016.2012; Erren TC, 2009, J PINEAL RES, V46, P245, DOI 10.1111/j.1600-079X.2009.00665.x; Froy Oren, 2012, ISRN Obes, V2012, P437198, DOI 10.5402/2012/437198; Garaulet M, 2010, INT J OBESITY, V34, P1667, DOI 10.1038/ijo.2010.118; Garaulet M, 2014, PHYSIOL BEHAV, V134, P44, DOI 10.1016/j.physbeh.2014.01.001; Garaulet M, 2011, J CELL PHYSIOL, V226, P2075, DOI 10.1002/jcp.22531; Garaulet M, 2010, ADV DRUG DELIVER REV, V62, P967, DOI 10.1016/j.addr.2010.05.005; Garaulet M, 2009, CURR OPIN LIPIDOL, V20, P127, DOI 10.1097/MOL.0b013e3283292399; Gimble JM, 2011, NAT REV ENDOCRINOL, V7, P98, DOI 10.1038/nrendo.2010.214; Griebel G, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00049; Hashinaga T, 2013, ENDOCR J, V60, P483; Hemmeryckx B, 2011, OBESITY, V19, P659, DOI 10.1038/oby.2010.266; Hughes ME, 2010, J BIOL RHYTHM, V25, P372, DOI 10.1177/0748730410379711; Jha PK, 2015, MOL CELL ENDOCRINOL, V418, P74, DOI 10.1016/j.mce.2015.01.024; Johnston JD, 2012, MOL CELL ENDOCRINOL, V349, P45, DOI 10.1016/j.mce.2011.05.008; Jung C, 2008, HYPERTENSION, V52, pE6, DOI 10.1161/HYPERTENSIONAHA.108.114421; Kennaway DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065255; Kraves S, 2006, NAT NEUROSCI, V9, P212, DOI 10.1038/nn1633; Malavazos AE, 2008, HYPERTENSION, V51, pE8, DOI 10.1161/HYPERTENSIONAHA.107.105346; MIFFLIN MD, 1990, AM J CLIN NUTR, V51, P241, DOI 10.1093/ajcn/51.2.241; Mingrone G, 2005, FASEB J, V19, P1380, DOI 10.1096/fj.04-3453fje; Mohawk JA, 2012, ANNU REV NEUROSCI, V35, P445, DOI 10.1146/annurev-neuro-060909-153128; Moreno-Aliaga MJ, 2011, CELL METAB, V14, P242, DOI 10.1016/j.cmet.2011.05.013; Morris CJ, 2012, PROG BRAIN RES, V199, P337, DOI 10.1016/B978-0-444-59427-3.00019-8; Natal C, 2008, AM J PHYSIOL-ENDOC M, V294, pE52, DOI 10.1152/ajpendo.00506.2007; Oppenheim RW, 2001, J NEUROSCI, V21, P1283; Paschos GK, 2012, NAT MED, V18, P1768, DOI 10.1038/nm.2979; Peplonska B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133761; Reichman TW, 2015, WORLD J HEPATOL, V7, P1484, DOI 10.4254/wjh.v7.i11.1484; Rendo-Urteaga T, 2013, METABOLISM, V62, P1429, DOI 10.1016/j.metabol.2013.05.011; Reppert SM, 2002, NATURE, V418, P935, DOI 10.1038/nature00965; RUBAL A, 1992, CHRONOBIOL INT, V9, P341, DOI 10.3109/07420529209064545; Rubio-Sastre P, 2014, CHRONOBIOL INT, V31, P276, DOI 10.3109/07420528.2013.833215; Sahar S, 2012, TRENDS ENDOCRIN MET, V23, P1, DOI 10.1016/j.tem.2011.10.005; SALORANTA C, 1993, DIABETES, V42, P1559, DOI 10.2337/diabetes.42.11.1559; Scheer FAJL, 2013, OBESITY, V21, P421, DOI 10.1002/oby.20351; Stanhope KL, 2011, J CLIN ENDOCR METAB, V96, pE1596, DOI 10.1210/jc.2011-1251; Stewart LS, 2007, BEHAV GENET, V37, P388, DOI 10.1007/s10519-006-9119-y; Sukumaran S, 2010, PHYSIOL GENOMICS, V42A, P141, DOI 10.1152/physiolgenomics.00106.2010; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Vgontzas AN, 2005, NEUROIMMUNOMODULAT, V12, P131, DOI 10.1159/000084844; Yildiz BO, 2004, P NATL ACAD SCI USA, V101, P10434, DOI 10.1073/pnas.0403465101; Yu HY, 2011, CLIN CHEM, V57, P691, DOI 10.1373/clinchem.2010.155184	56	3	3	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1639	1649		10.1096/fj.201600396RR	http://dx.doi.org/10.1096/fj.201600396RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28096235	Green Submitted, Green Published			2022-12-28	WOS:000398504300029
J	Straubinger, J; Boldt, K; Kuret, A; Deng, L; Krattenmacher, D; Bork, N; Desch, M; Feil, R; Feil, S; Nemer, M; Ueffing, M; Ruth, P; Just, S; Lukowski, R				Straubinger, Julia; Boldt, Karsten; Kuret, Anna; Deng, Lisa; Krattenmacher, Diana; Bork, Nadja; Desch, Matthias; Feil, Robert; Feil, Susanne; Nemer, Mona; Ueffing, Marius; Ruth, Peter; Just, Steffen; Lukowski, Robert			Amplified pathogenic actions of angiotensin II in cysteine-rich LIM-only protein 4-negative mouse hearts	FASEB JOURNAL			English	Article						BNP; cGMP; CRP4; Crip1; cardiac hypertrophy	FAMILIAL HYPERTROPHIC CARDIOMYOPATHY; CARDIAC TROPONIN-T; KINASE-I; DILATED CARDIOMYOPATHY; NATRIURETIC PEPTIDES; NEOINTIMA FORMATION; ALPHA-TROPOMYOSIN; GENE; MUTATIONS; EXPRESSION	LIM domain proteins have been identified as essential modulators of cardiac biology and pathology; however, it is unclear which role the cysteine-rich LIM-only protein (CRP)4 plays in these processes. In studying CRP4 mutant mice, we found that their hearts developed normally, but lack of CRP4 exaggerated multiple parameters of the cardiac stress response to the neurohormone angiotensin II (Ang II). Aiming to dissect the molecular details, we found a link between CRP4 and the cardioprotective cGMP pathway, as well as a multiprotein complex comprising well-known hypertrophy-associated factors. Significant enrichment of the cysteine-rich intestinal protein (CRIP)1 in murine hearts lacking CRP4, as well as severe cardiac defects and premature death of CRIP1 and CRP4 morphant zebrafish embryos, further support the notion that depleting CRP4 is incompatible with a proper cardiac development and function. Together, amplified Ang II signaling identified CRP4 as a novel antiremodeling factor regulated, at least to some extent, by cardiac cGMP.-Straubinger, J., Boldt, K., Kuret, A., Deng, L., Krattenmacher, D., Bork, N., Desch, M., Feil, R., Feil, S., Nemer, M., Ueffing, M., Ruth, P., Just, S., Lukowski, R. Amplified pathogenic actions of angiotensin II in cysteine-rich LIM-only protein 4 negative mouse hearts.	[Straubinger, Julia; Kuret, Anna; Deng, Lisa; Bork, Nadja; Desch, Matthias; Ruth, Peter; Lukowski, Robert] Univ Tubingen, Dept Pharmacol Toxicol & Clin Pharm, Inst Pharm, Tubingen, Germany; [Boldt, Karsten; Ueffing, Marius] Univ Tubingen, Inst Ophthalm Res, Mol Biol Retinal Degenerat, Tubingen, Germany; [Boldt, Karsten; Ueffing, Marius] Univ Tubingen, Med Proteome Ctr, Tubingen, Germany; [Feil, Robert; Feil, Susanne] Univ Tubingen, Interfac Inst Biochem, Tubingen, Germany; [Krattenmacher, Diana; Just, Steffen] Univ Ulm, Dept Internal Med 2, Mol Cardiol, Ulm, Germany; [Nemer, Mona] Univ Ottawa, Dept Biochem Immunol & Microbiol, Lab Cardiac Dev & Differentiat, Ottawa, ON, Canada; [Bork, Nadja] Univ Med Ctr Hamburg Eppendorf, Inst Expt Cardiovasc Res, Hamburg, Germany; [Desch, Matthias] Madonnen Apotheke, Vienna, Austria	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Ulm University; University of Ottawa; University of Hamburg; University Medical Center Hamburg-Eppendorf	Lukowski, R (corresponding author), Univ Tubingen, Dept Pharmacol Toxicol & Clin Pharm, Inst Pharm, Tubingen, Germany.	robert.lukowski@uni-tuebingen.de	Feil, Robert/B-8918-2014; Feil, Susanne/AAF-7032-2019	Feil, Robert/0000-0002-7335-4841; 	Deutsche Forschungsgemeinschaft (DFG); DFG; cGMP Signaling in Cell Growth and Survival; Eliteprogramm fur Postdoktorandinnen und Postdoktoranden der Baden-Wuerttemberg Stiftung	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG)); cGMP Signaling in Cell Growth and Survival; Eliteprogramm fur Postdoktorandinnen und Postdoktoranden der Baden-Wuerttemberg Stiftung	The authors thank Clement Kabagema-Bilan, Michael Glaser, and Katrin Junger (all from the Institute of Pharmacy, University of Tubingen) for excellent technical help. The authors also thank Franz Hofmann (Institute of Pharmacology and Toxicology, Technical University Munich, Munich, Germany) for helpful discussions. Work the authors' laboratories is supported by grants from the Deutsche Forschungsgemeinschaft (DFG) (to R.L. and P.R.); the DFG Research Unit 2060, "cGMP Signaling in Cell Growth and Survival"; and by the Eliteprogramm fur Postdoktorandinnen und Postdoktoranden der Baden-Wuerttemberg Stiftung (to R.L.). The authors declare no conflicts of interest.	Arber S, 1997, CELL, V88, P393, DOI 10.1016/S0092-8674(00)81878-4; Boateng SY, 2007, AM J PHYSIOL-HEART C, V292, pH259, DOI 10.1152/ajpheart.00766.2006; Boateng SY, 2009, J MOL CELL CARDIOL, V47, P426, DOI 10.1016/j.yjmcc.2009.04.006; Boldt K, 2009, METHOD CELL BIOL, V91, P143, DOI 10.1016/S0091-679X(08)91009-8; Bos JM, 2006, MOL GENET METAB, V88, P78, DOI 10.1016/j.ymgme.2005.10.008; Buyandelger B, 2011, PFLUG ARCH EUR J PHY, V462, P135, DOI 10.1007/s00424-011-0961-2; Cahill TJ, 2013, CIRC RES, V113, P660, DOI 10.1161/CIRCRESAHA.113.300282; Cheung AKL, 2011, P NATL ACAD SCI USA, V108, P8390, DOI 10.1073/pnas.1101747108; Chiu C, 2010, J AM COLL CARDIOL, V55, P1127, DOI 10.1016/j.jacc.2009.11.016; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Elliott K, 2000, J BIOL CHEM, V275, P22069, DOI 10.1074/jbc.M002502200; Frantz S, 2013, EUR HEART J, V34, P1233, DOI 10.1093/eurheartj/ehr445; Geier C, 2003, CIRCULATION, V107, P1390, DOI 10.1161/01.CIR.0000056522.82563.5F; Girolami F, 2014, CIRC-CARDIOVASC GENE, V7, P741, DOI 10.1161/CIRCGENETICS.113.000486; Harris SP, 2002, CIRC RES, V90, P594, DOI 10.1161/01.RES.0000012222.70819.64; Henderson JR, 1999, DEV DYNAM, V214, P229, DOI 10.1002/(SICI)1097-0177(199903)214:3<229::AID-AJA6>3.3.CO;2-J; Hu XQ, 2011, J CELL MOL MED, V15, P1865, DOI 10.1111/j.1582-4934.2010.01182.x; Huang XP, 1999, CIRC RES, V84, P1; Huber A, 2000, J BIOL CHEM, V275, P5504, DOI 10.1074/jbc.275.8.5504; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; KAPLAN ML, 1994, AM J PHYSIOL, V267, pH1167, DOI 10.1152/ajpheart.1994.267.3.H1167; Karim MA, 1996, GENOMICS, V31, P167, DOI 10.1006/geno.1996.0028; Kehat I, 2010, CIRCULATION, V122, P2727, DOI 10.1161/CIRCULATIONAHA.110.942268; Kessler M, 2015, EXPERT OPIN DRUG DIS, V10, P1231, DOI 10.1517/17460441.2015.1078788; Kim JD, 2014, MOL CELLS, V37, P406, DOI 10.14348/molcells.2014.0072; Kinoshita H, 2010, CIRC RES, V106, P1849, DOI 10.1161/CIRCRESAHA.109.208314; Kishimoto I, 2009, CURR CARDIOL REV, V5, P45, DOI 10.2174/157340309787048068; Klaiber M, 2010, BASIC RES CARDIOL, V105, P583, DOI 10.1007/s00395-010-0098-z; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/S0092-8674(02)01226-6; Koitabashi N, 2010, J MOL CELL CARDIOL, V48, P713, DOI 10.1016/j.yjmcc.2009.11.015; Kruger M, 2009, CIRC RES, V104, P87, DOI 10.1161/CIRCRESAHA.108.184408; Kuhn C, 2012, BASIC RES CARDIOL, V107, DOI 10.1007/s00395-012-0262-8; Kuhn Michaela, 2009, V191, P47, DOI 10.1007/978-3-540-68964-5_4; Lee DI, 2010, BASIC RES CARDIOL, V105, P337, DOI 10.1007/s00395-010-0084-5; Lilly B, 2010, ARTERIOSCL THROM VAS, V30, P694, DOI 10.1161/ATVBAHA.109.200741; Liu Y, 1998, CIRC RES, V82, P1145, DOI 10.1161/01.RES.82.11.1145; Lukowski R, 2008, ARTERIOSCL THROM VAS, V28, P1244, DOI 10.1161/ATVBAHA.108.166405; Ma YL, 2016, CELL SIGNAL, V28, P585, DOI 10.1016/j.cellsig.2016.02.019; Majalahti T, 2007, MOL CELL ENDOCRINOL, V273, P59, DOI 10.1016/j.mce.2007.05.003; Meder B, 2011, BIOCHEM BIOPH RES CO, V408, P218, DOI 10.1016/j.bbrc.2011.03.121; Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2; Nishida M, 2010, J BIOL CHEM, V285, P13244, DOI 10.1074/jbc.M109.074104; OKANO I, 1993, FEBS LETT, V333, P51, DOI 10.1016/0014-5793(93)80373-3; Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200; Paradis P, 2000, P NATL ACAD SCI USA, V97, P931, DOI 10.1073/pnas.97.2.931; Patrucco E, 2014, P NATL ACAD SCI USA, V111, P12925, DOI 10.1073/pnas.1414364111; Sagave JF, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-80; Schluter KD, 2008, PHARMACOL THERAPEUT, V119, P311, DOI 10.1016/j.pharmthera.2008.05.010; Schmidtko A, 2008, J NEUROSCI, V28, P1320, DOI 10.1523/JNEUROSCI.5037-07.2008; Song DW, 2015, BIOCHEM BIOPH RES CO, V463, P975, DOI 10.1016/j.bbrc.2015.06.045; Staudt D, 2012, ANNU REV GENET, V46, P397, DOI 10.1146/annurev-genet-110711-155646; Straubinger J, 2015, J PHARMACOL EXP THER, V354, P406, DOI 10.1124/jpet.115.226092; Sun XJ, 2008, CIRC RES, V102, P831, DOI 10.1161/CIRCRESAHA.107.166488; Takahashi S, 2008, J PHYSIOL-LONDON, V586, P4209, DOI 10.1113/jphysiol.2008.156083; Takimoto E, 2009, J CLIN INVEST, V119, P408, DOI 10.1172/JCI35620; Tang M, 2003, NAT MED, V9, P1506, DOI 10.1038/nm958; Texier Y, 2014, MOL CELL PROTEOMICS, V13, P1382, DOI 10.1074/mcp.O113.033233; THIERFELDER L, 1994, CELL, V77, P701, DOI 10.1016/0092-8674(94)90054-X; Thoonen R, 2015, CIRC-HEART FAIL, V8, P1115, DOI 10.1161/CIRCHEARTFAILURE.115.002308; Tokudome T, 2008, CIRCULATION, V117, P2329, DOI 10.1161/CIRCULATIONAHA.107.732990; Tyanova S, 2016, NAT METHODS, V13, P731, DOI [10.1038/nmeth.3901, 10.1038/NMETH.3901]; Vasile VC, 2006, BIOCHEM BIOPH RES CO, V349, P709, DOI 10.1016/j.bbrc.2006.08.106; Vasile VC, 2006, BIOCHEM BIOPH RES CO, V345, P998, DOI 10.1016/j.bbrc.2006.04.151; Vogel B, 2009, BIOCHEM BIOPH RES CO, V390, P516, DOI 10.1016/j.bbrc.2009.09.129; Wang G, 2015, J PHYSIOL-LONDON, V593, P3013, DOI 10.1113/JP270033; WATKINS H, 1995, NEW ENGL J MED, V332, P1058, DOI 10.1056/NEJM199504203321603; WATKINS H, 1995, NAT GENET, V11, P434, DOI 10.1038/ng1295-434; Wei J, 2005, CIRC RES, V97, P1323, DOI 10.1161/01.RES.0000194331.76925.5c; Wei TC, 2011, GENE EXPR PATTERNS, V11, P384, DOI 10.1016/j.gep.2011.05.001; Wells QS, 2011, CARDIOGENETICS, V1, P45, DOI 10.4081/cardiogenetics.2011.e10; Yamamoto R, 2007, CIRC J, V71, P1958, DOI 10.1253/circj.71.1958; Yu TS, 2002, MECH DEVELOP, V116, P187, DOI 10.1016/S0925-4773(02)00139-9; Yuasa K, 1999, J BIOL CHEM, V274, P37429, DOI 10.1074/jbc.274.52.37429; Zemljic-Harpf AE, 2007, MOL CELL BIOL, V27, P7522, DOI 10.1128/MCB.00728-07; Zhang T, 2007, J BIOL CHEM, V282, P33367, DOI 10.1074/jbc.M707186200	75	9	9	2	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1620	1638		10.1096/fj.201601186	http://dx.doi.org/10.1096/fj.201601186			19	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28138039				2022-12-28	WOS:000398504300028
J	Ponnusamy, S; Tran, QT; Harvey, I; Smallwood, HS; Thiyagarajan, T; Banerjee, S; Johnson, DL; Dalton, JT; Sullivan, RD; Miller, DD; Bridges, D; Narayanan, R				Ponnusamy, Suriyan; Tran, Quynh T.; Harvey, Innocence; Smallwood, Heather S.; Thiyagarajan, Thirumagal; Banerjee, Souvik; Johnson, Daniel L.; Dalton, James T.; Sullivan, Ryan D.; Miller, Duane D.; Bridges, Dave; Narayanan, Ramesh			Pharmacologic activation of estrogen receptor beta increases mitochondrial function, energy expenditure, and brown adipose tissue	FASEB JOURNAL			English	Article						exercise mimetic; mitochondria; oxygen consumption; obesity; metabolic diseases	HIGH-FAT DIET; BEIGE ADIPOCYTES; INDUCED OBESITY; SEX-DIFFERENCES; MESSENGER-RNA; ER-ALPHA; WHITE; EXPRESSION; ESTRADIOL; AGONIST	Most satiety-inducing obesity therapeutics, despite modest efficacy, have safety concerns that underscore the need for effective peripherally acting drugs. An attractive therapeutic approach for obesity is to optimize/maximize energy expenditure by increasing energy-utilizing thermogenic brown adipose tissue. We used in vivo and in vitro models to determine the role of estrogen receptor beta (ER-beta) and its ligands on adipose biology. RNA sequencing and metabolomics were used to determine the mechanism of action of ER-beta and its ligands. Estrogen receptor beta (ER-beta) and its selective ligand reprogrammed preadipocytes and precursor stemcells into brown adipose tissue and increased mitochondrial respiration. An ER-beta-selective ligand increased markers of tricarboxylic acid dependent and-independent energy biogenesis and oxygen consumption in mice without a concomitant increase in physical activity or food consumption, all culminating in significantly reduced weight gain and adiposity. The antiobesity effects of ER-beta ligand were not observed in ER-beta-knockout mice. Serum metabolite profiles of adult lean and juvenile mice were comparable, while that of adult obese mice was distinct, indicating a possible impact of obesity on age-dependent metabolism. This phenotype was partially reversed by ER-beta-selective ligand. These data highlight a new role for ER-beta in adipose biology and its potential to be a safer alternative peripheral therapeutic target for obesity.-Ponnusamy, S., Tran, Q. T., Harvey, I., Smallwood, H. S., Thiyagarajan, T., Banerjee, S., Johnson, D. L., Dalton, J. T., Sullivan, R. D., Miller, D. D., Bridges, D., Narayanan, R. Pharmacologic activation of estrogen receptor beta increases mitochondrial function, energy expenditure, and brown adipose tissue.	[Ponnusamy, Suriyan; Thiyagarajan, Thirumagal; Narayanan, Ramesh] Univ Tennessee, Hlth Sci Ctr, Dept Med, 19 South Manassas,Room 120, Memphis, TN 38103 USA; [Tran, Quynh T.] Univ Tennessee, Ctr Hlth Sci, Dept Prevent Med, Memphis, TN 38163 USA; [Harvey, Innocence; Bridges, Dave] Univ Tennessee, Ctr Hlth Sci, Dept Physiol, Memphis, TN 38163 USA; [Smallwood, Heather S.; Bridges, Dave] Univ Tennessee, Ctr Hlth Sci, Dept Pediat, Memphis, TN 38163 USA; [Banerjee, Souvik; Miller, Duane D.] Univ Tennessee, Ctr Hlth Sci, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Johnson, Daniel L.] Univ Tennessee, Ctr Hlth Sci, Mol Informat Core, Memphis, TN 38163 USA; [Sullivan, Ryan D.] Univ Tennessee, Ctr Hlth Sci, Dept Comparat Med, Memphis, TN 38163 USA; [Dalton, James T.] GTx Inc, Preclin Res & Dev, Memphis, TN USA; [Narayanan, Ramesh] West Canc Ctr, Memphis, TN USA; [Dalton, James T.] Univ Michigan, Coll Pharm, 428 Church St, Ann Arbor, MI 48109 USA; [Bridges, Dave] Univ Michigan, Sch Publ Hlth, Dept Nutr Sci, Ann Arbor, MI 48109 USA	University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Narayanan, R (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Med, 19 South Manassas,Room 120, Memphis, TN 38103 USA.	rnaraya4@uthsc.edu	Sullivan, Ryan D./AAX-6919-2020; Bridges, Dave/A-8825-2010	Sullivan, Ryan D./0000-0001-7633-2210; Bridges, Dave/0000-0002-5334-972X; Dalton, James T/0000-0002-3915-7326; Smallwood, Heather/0000-0001-5711-5771	U.S. National Institutes of Health; National Institute of Diabetes and Digestive and Kidney Diseases Grant [DK107575]; Memphis Research Consortium; Quigley Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK107535] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Diabetes and Digestive and Kidney Diseases Grant; Memphis Research Consortium; Quigley Award; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The authors thank M. Lee Barret, M. Star, and N. Koehler all from the University of Tennessee Health Science Center) for their help with the animal studies. The authors also thank R. H. Getzenberg (GTx, Inc.) for reviewing an early version of the article. Part of the work was supported by U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases Grant DK107575, a Memphis Research Consortium grant (to D.B.), and the Quigley Award (to I.H.).	An S, 2010, J MED FOOD, V13, P406, DOI 10.1089/jmf.2009.1295; Bag S, 2015, J THEOR BIOL, V364, P344, DOI 10.1016/j.jtbi.2014.09.034; Bhardwaj P, 2015, CANCER PREV RES, V8, P751, DOI 10.1158/1940-6207.CAPR-15-0082; BRAY GA, 1988, WESTERN J MED, V149, P429; Burke LK, 2014, ENDOCRINOLOGY, V155, P3732, DOI 10.1210/en.2014-1223; Catalan V, 2009, J MOL MED, V87, P803, DOI 10.1007/s00109-009-0486-8; Chan DC, 2006, CELL, V125, P1241, DOI 10.1016/j.cell.2006.06.010; Chiang SH, 2006, METHOD ENZYMOL, V406, P701, DOI 10.1016/S0076-6879(06)06055-1; Choi SW, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/520618; Chrysovergis K, 2014, INT J OBESITY, V38, P1555, DOI 10.1038/ijo.2014.27; Cooke PS, 2001, MOL CELL ENDOCRINOL, V178, P147, DOI 10.1016/S0303-7207(01)00414-2; Costanzo-Garvey DL, 2009, CELL METAB, V10, P366, DOI 10.1016/j.cmet.2009.09.010; Cunningham JW, 2014, CLIN CARDIOL, V37, P693, DOI 10.1002/clc.22304; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Davis KE, 2014, HORM BEHAV, V66, P196, DOI 10.1016/j.yhbeh.2014.02.004; DIERKSVENTLING C, 1977, NUCLEIC ACIDS RES, V4, P381, DOI 10.1093/nar/4.2.381; Fan WW, 2013, J MOL ENDOCRINOL, V51, pT87, DOI 10.1530/JME-13-0258; Fang S, 2015, NAT MED, V21, P159, DOI 10.1038/nm.3760; Fink T, 2011, METHODS MOL BIOL, V698, P243, DOI 10.1007/978-1-60761-999-4_19; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Foryst-Ludwig A, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000108; Fried SK, 2012, ENDOCRINOLOGY, V153, P1582, DOI 10.1210/en.2012-1012; Gnad T, 2014, NATURE, V516, P395, DOI 10.1038/nature13816; Guirguis E, 2013, ENDOCRINOLOGY, V154, P3152, DOI 10.1210/en.2012-2185; Gustafson B, 2015, DIABETES, V64, P1670, DOI 10.2337/db14-1127; Hao Q, 2015, AM J PHYSIOL-ENDOC M, V308, pE380, DOI 10.1152/ajpendo.00277.2014; Harms M, 2013, NAT MED, V19, P1252, DOI 10.1038/nm.3361; Heine PA, 2000, P NATL ACAD SCI USA, V97, P12729, DOI 10.1073/pnas.97.23.12729; Heinonen S, 2015, DIABETES, V64, P3135, DOI 10.2337/db14-1937; INGALLS AM, 1950, J HERED, V41, P317, DOI 10.1093/oxfordjournals.jhered.a106073; Ivanova T, 2000, CELL TISSUE RES, V300, P231, DOI 10.1007/s004410000199; Jensen MD, 2014, J AM COLL CARDIOL, V63, P2985, DOI 10.1016/j.jacc.2013.11.004; Ji LJ, 2016, ENDOCRINOLOGY, V157, P91, DOI 10.1210/en.2015-1674; Jones BJ, 2015, DRUGS, V75, P935, DOI 10.1007/s40265-015-0410-1; Jungbauer A, 2014, J STEROID BIOCHEM, V139, P277, DOI 10.1016/j.jsbmb.2012.12.009; Karolczak M, 1998, NEUROENDOCRINOLOGY, V68, P229, DOI 10.1159/000054370; Kuiper GGJM, 1996, P NATL ACAD SCI USA, V93, P5925, DOI 10.1073/pnas.93.12.5925; Kurek K, 2015, J DIABETES RES, V2015, DOI 10.1155/2015/154762; LEAN MEJ, 1983, FEBS LETT, V163, P235, DOI 10.1016/0014-5793(83)80826-6; Lee YK, 2013, NAT CELL BIOL, V15, P568, DOI 10.1038/ncb2776; Li A, 2012, J CELL PHYSIOL, V227, P172, DOI 10.1002/jcp.22715; Liang JY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8926; Lidell ME, 2011, DIABETES, V60, P427, DOI 10.2337/db10-0409; Luglio HF, 2014, ACTA MED INDONES, V46, P333; Madden N., 2015, WASHINGTON TIMES; Matula K, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1718-7; Mercken EM, 2012, AGEING RES REV, V11, P390, DOI 10.1016/j.arr.2011.11.005; Meyer MR, 2014, SCI REP-UK, V4, DOI 10.1038/srep07564; Miao YF, 2015, P NATL ACAD SCI USA, V112, P14006, DOI 10.1073/pnas.1519358112; Moisan A, 2015, NAT CELL BIOL, V17, P57, DOI 10.1038/ncb3075; Musatov S, 2007, P NATL ACAD SCI USA, V104, P2501, DOI 10.1073/pnas.0610787104; Narkar VA, 2008, CELL, V134, P405, DOI 10.1016/j.cell.2008.06.051; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Patel D, 2015, METABOLISM, V64, P1376, DOI 10.1016/j.metabol.2015.08.001; Pedram A, 2013, MOL BIOL CELL, V24, P3805, DOI 10.1091/mbc.E13-08-0444; Pedram A, 2013, ENDOCRINOLOGY, V154, P4352, DOI 10.1210/en.2013-1358; Pedram A, 2010, MOL ENDOCRINOL, V24, P2152, DOI 10.1210/me.2010-0154; Peng XR, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00174; Perez SE, 2003, DEV BRAIN RES, V145, P117, DOI 10.1016/S0165-3806(03)00223-2; Qian SW, 2013, P NATL ACAD SCI USA, V110, pE798, DOI 10.1073/pnas.1215236110; Reboucas ECC, 2016, NEUROL RES, V38, P740, DOI 10.1080/01616412.2016.1203124; Revankar CM, 2005, SCIENCE, V307, P1625, DOI 10.1126/science.1106943; Rivera HM, 2012, PHYSIOL BEHAV, V105, P188, DOI 10.1016/j.physbeh.2011.08.018; Roberts LD, 2014, CELL METAB, V19, P96, DOI 10.1016/j.cmet.2013.12.003; Rosen ED, 2002, GENE DEV, V16, P22, DOI 10.1101/gad.948702; Ruperez AI, 2014, J NUTRIGENET NUTRIGE, V7, P130, DOI 10.1159/000368833; SALAMANCA S, 1992, PHARMACOL BIOCHEM BE, V43, P953, DOI 10.1016/0091-3057(92)90431-E; Santollo J, 2013, J NEUROENDOCRINOL, V25, P570, DOI 10.1111/jne.12032; Schmid GM, 2004, PROTEOMICS, V4, P2270, DOI 10.1002/pmic.200300810; Shrager B, 2012, INT J SURG ONCOL, V2012, DOI 10.1155/2012/915128; Smith BM, 2008, J MED CHEM, V51, P305, DOI 10.1021/jm0709034; Smith SR, 2010, NEW ENGL J MED, V363, P245, DOI 10.1056/NEJMoa0909809; Tharp KM, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00164; Thomsen WJ, 2008, J PHARMACOL EXP THER, V325, P577, DOI 10.1124/jpet.107.133348; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Wang QD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123795; Wang WS, 2014, P NATL ACAD SCI USA, V111, P14466, DOI 10.1073/pnas.1412685111; Wang Y, 2015, AM J PHYSIOL-ENDOC M, V308, pE1066, DOI 10.1152/ajpendo.00030.2015; Weigt C, 2013, MOL CELL ENDOCRINOL, V377, P147, DOI 10.1016/j.mce.2013.07.007; Wu J, 2012, CELL, V150, P366, DOI 10.1016/j.cell.2012.05.016; Wu Q, 2015, MOL MED REP, V12, P5891, DOI 10.3892/mmr.2015.4117; Yepuru M, 2010, J BIOL CHEM, V285, P31292, DOI 10.1074/jbc.M110.147850; Yoshii Taishi, 2015, J Clin Med Res, V7, P762, DOI 10.14740/jocmr2278w	83	34	37	0	11	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					266	281		10.1096/fj.201600787RR	http://dx.doi.org/10.1096/fj.201600787RR			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27733447	Green Published, Green Submitted			2022-12-28	WOS:000392177600026
J	Makinodan, M; Ikawa, D; Miyamoto, Y; Yamauchi, J; Yamamuro, K; Yamashita, Y; Toritsuka, M; Kimoto, S; Okumura, K; Yamauchi, T; Fukami, S; Yoshino, H; Wanaka, A; Kishimoto, T				Makinodan, Manabu; Ikawa, Daisuke; Miyamoto, Yuki; Yamauchi, Junji; Yamamuro, Kazuhiko; Yamashita, Yasunori; Toritsuka, Michihiro; Kimoto, Sohei; Okumura, Kazuki; Yamauchi, Takahira; Fukami, Shin-ichi; Yoshino, Hiroki; Wanaka, Akio; Kishimoto, Toshifumi			Social isolation impairs remyelination in mice through modulation of IL-6	FASEB JOURNAL			English	Article						oligodendrocyte; prefrontal cortex; social experience; cytokines; multiple sclerosis	CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; LATE OLIGODENDROCYTE PROGENITORS; BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; STRUCTURAL CONNECTIVITY; PREFRONTAL CORTEX; INTERLEUKIN-6; MYELINATION; STRESS	Recent studies have revealed that social experience affects myelination. These findings have important implications for disorders that feature abnormal myelination, such as multiple sclerosis ( MS), as previous studies have shown that psychosocial stress exacerbates the pathobiology of MS. However, most studies have focused on psychosocial stress during the demyelination phase of MS and have not investigated the effects of social experience on remyelination. Thus, the current study sought to determine whether social experience can alter remyelination after myelin depletion. Myelin in the mouse medial prefrontal cortex was depleted with cuprizone, and the effects of subsequent social isolation on remyelination were evaluated. Remyelination was severely impaired in socially isolated mice. Social isolation also increased IL-6 levels in the medial prefrontal cortex, and administration of an IL-6 inhibitor (ND50 = 0.01-0.03 mu g for 0.25 ng/ml IL-6) ameliorated remyelination impairments. Consistent with this result, IL-6 administration (ED50 = 0.02-0.06 ng/ml) disturbed remyelination. In addition, neuron-oligodendrocyte coculture experiments showed that IL-6 treatment (ED50 <= 0.02 ng/ml) markedly impeded myelination, which was recovered with IL-6 inhibitor administration (ND50 = 0.01-0.03 mg for 0.25 ng/ml IL-6). This study provides the first direct evidence, to our knowledge, that social experience influences remyelination via modulation of IL-6 expression. These findings indicate that psychosocial stress may disturb remyelination through regulation of IL-6 expression in patients with such demyelinating diseases that involve remyelination as MS.	[Makinodan, Manabu; Ikawa, Daisuke; Yamamuro, Kazuhiko; Yamashita, Yasunori; Toritsuka, Michihiro; Kimoto, Sohei; Okumura, Kazuki; Yamauchi, Takahira; Fukami, Shin-ichi; Yoshino, Hiroki; Kishimoto, Toshifumi] Nara Med Univ, Sch Med, Dept Psychiat, 840 Shijo Cho, Kashihara, Nara 6348522, Japan; [Wanaka, Akio] Nara Med Univ, Sch Med, Dept Anat & Neurosci, Nara, Japan; [Miyamoto, Yuki; Yamauchi, Junji] Natl Res Inst Child Hlth & Dev, Dept Pharmacol, Tokyo, Japan	Nara Medical University; Nara Medical University; National Center for Child Health & Development - Japan	Makinodan, M (corresponding author), Nara Med Univ, Sch Med, Dept Psychiat, 840 Shijo Cho, Kashihara, Nara 6348522, Japan.	mmm@naramed-u.ac.jp	Wanaka, Akio/ABE-4671-2020; Wanaka, Akio/GPW-8926-2022; Okumura, Kazuki/AAH-8945-2020; Wanaka, Akio/AAC-9754-2019	Okumura, Kazuki/0000-0002-3019-7049; Wanaka, Akio/0000-0001-9951-9862; Kimoto, Sohei/0000-0002-3148-690X	Uehara Memorial Foundation; Naito Foundation; Takeda Science Foundation;  [15K15432]	Uehara Memorial Foundation(Uehara Memorial Foundation); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); 	The authors thank Kouji Okuda for tissue sectioning for the electron microscopy study. This work was supported by The Uehara Memorial Foundation, the Naito Foundation, the Takeda Science Foundation, and Grant-in-Aid for Scientific Research 15K15432.	Agis-Balboa RC, 2007, P NATL ACAD SCI USA, V104, P18736, DOI 10.1073/pnas.0709419104; Back SA, 2001, J NEUROSCI, V21, P1302; Back SA, 2002, J NEUROSCI, V22, P455, DOI 10.1523/JNEUROSCI.22-02-00455.2002; BANKS WA, 1989, BRAIN RES BULL, V23, P433, DOI 10.1016/0361-9230(89)90185-8; Barr TA, 2012, J EXP MED, V209, P1001, DOI 10.1084/jem.20111675; Ben Menachem-Zidon O, 2008, NEUROPSYCHOPHARMACOL, V33, P2251, DOI 10.1038/sj.npp.1301606; Bengtsson SL, 2005, NAT NEUROSCI, V8, P1148, DOI 10.1038/nn1516; Bogosian A, 2015, MULT SCLER J, V21, P1184, DOI 10.1177/1352458515576261; Butts BD, 2008, CELL DEATH DIFFER, V15, P1178, DOI 10.1038/cdd.2008.70; Chan JR, 2004, NEURON, V43, P183, DOI 10.1016/j.neuron.2004.06.024; ERMISCH A, 1985, J CEREBR BLOOD F MET, V5, P350, DOI 10.1038/jcbfm.1985.49; Erta M, 2012, INT J BIOL SCI, V8, P1254, DOI 10.7150/ijbs.4679; Fang XX, 2013, CELL MOL NEUROBIOL, V33, P241, DOI 10.1007/s10571-012-9891-6; Filipovic R, 2008, GLIA, V56, P1, DOI 10.1002/glia.20582; FREI K, 1991, J NEUROIMMUNOL, V31, P147; Gananca L, 2016, PSYCHONEUROENDOCRINO, V63, P296, DOI 10.1016/j.psyneuen.2015.10.008; GIJBELS K, 1995, MOL MED, V1, P795, DOI 10.1007/BF03401894; GUTIERREZ EG, 1993, J NEUROIMMUNOL, V47, P169, DOI 10.1016/0165-5728(93)90027-V; Ireland SJ, 2015, CYTOKINE, V73, P236, DOI 10.1016/j.cyto.2015.01.009; Jankord R, 2010, AM J PHYSIOL-REG I, V299, pR343, DOI 10.1152/ajpregu.00131.2010; Krugel U, 2014, ARCH TOXICOL, V88, P853, DOI 10.1007/s00204-014-1203-0; Li YY, 2012, HUM BRAIN MAPP, V33, P349, DOI 10.1002/hbm.21215; Liu J, 2012, NAT NEUROSCI, V15, P1621, DOI 10.1038/nn.3263; Lovera J, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0398-4; Lundgaard I, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001743; Mackey AP, 2012, FRONT NEUROANAT, V6, DOI 10.3389/fnana.2012.00032; Makinodan M, 2012, SCIENCE, V337, P1357, DOI 10.1126/science.1220845; Makinodan M, 2009, PROG NEURO-PSYCHOPH, V33, P978, DOI 10.1016/j.pnpbp.2009.05.006; Malmestrom C, 2006, J NEUROIMMUNOL, V175, P176, DOI 10.1016/j.jneuroim.2006.03.004; Mandolesi G, 2015, CEREBELLUM, V14, P19, DOI 10.1007/s12311-014-0613-0; MCLENNAN H, 1983, PROG NEUROBIOL, V20, P251, DOI 10.1016/0301-0082(83)90004-7; Miao W, 2013, AM J NEURORADIOL, V34, P1264, DOI 10.3174/ajnr.A3370; Miyamoto Y, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003661; Mohr DC, 2000, NEUROLOGY, V55, P55, DOI 10.1212/WNL.55.1.55; Mohr DC, 2004, BMJ-BRIT MED J, V328, P731, DOI 10.1136/bmj.38041.724421.55; Mohr DC, 2002, PSYCHOSOM MED, V64, P803, DOI 10.1097/01.PSY.0000024238.11538.EC; Morita S, 2014, NEUROCHEM RES, V39, P59, DOI 10.1007/s11064-013-1190-1; Nave KA, 2014, JAMA PSYCHIAT, V71, P582, DOI 10.1001/jamapsychiatry.2014.189; Okuda Y, 1998, INT IMMUNOL, V10, P703, DOI 10.1093/intimm/10.5.703; Passos IC, 2015, LANCET PSYCHIAT, V2, P1002, DOI 10.1016/S2215-0366(15)00309-0; Qiu ZH, 1998, J NEUROSCI, V18, P10445; Rohleder N, 2012, ANN NY ACAD SCI, V1261, P88, DOI 10.1111/j.1749-6632.2012.06634.x; Rothwell N J, 1994, Adv Pharmacol, V25, P1, DOI 10.1016/S1054-3589(08)60428-7; Schiavone S, 2017, MOL NEUROBIOL, V54, P2031, DOI 10.1007/s12035-016-9791-8; Scholz J, 2009, NAT NEUROSCI, V12, P1370, DOI 10.1038/nn.2412; Simpson R, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-15; Takeuchi H, 2010, J NEUROSCI, V30, P3297, DOI 10.1523/JNEUROSCI.4611-09.2010; Volpe JJ, 2011, INT J DEV NEUROSCI, V29, P423, DOI 10.1016/j.ijdevneu.2011.02.012; Wake H, 2011, SCIENCE, V333, P1647, DOI 10.1126/science.1206998; Wilson EH, 2010, J CLIN INVEST, V120, P1368, DOI 10.1172/JCI41911; Yamauchi J, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002802; Young KM, 2013, NEURON, V77, P873, DOI 10.1016/j.neuron.2013.01.006; Zhang PL, 2006, MOL CELL NEUROSCI, V31, P387, DOI 10.1016/j.mcn.2005.10.014	53	17	17	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4267	4274		10.1096/fj.201600537R	http://dx.doi.org/10.1096/fj.201600537R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27613805				2022-12-28	WOS:000388201500031
J	Goetzl, EJ; Mustapic, M; Kapogiannis, D; Eitan, E; Lobach, IV; Goetzl, L; Schwartz, JB; Miller, BL				Goetzl, Edward J.; Mustapic, Maja; Kapogiannis, Dimitrios; Eitan, Erez; Lobach, Irina V.; Goetzl, Laura; Schwartz, Janice B.; Miller, Bruce L.			Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease	FASEB JOURNAL			English	Article						dementia; amyloid; tau; biomarkers	BETA-SECRETASE; TRANSCRIPTIONAL REGULATION; EXTRACELLULAR VESICLES; OXIDATIVE STRESS; CLINICAL-TRIALS; NERVOUS-SYSTEM; BLOOD EXOSOMES; ADAS-COG; A-BETA; NEURONS	Efficient intercellular transfer of RNAs, proteins, and lipids as protected exosomal cargo has been demonstrated in the CNS, but distinct physiologic and pathologic roles have not been well defined for this pathway. The capacity to isolate immunochemically human plasma neuron-derived exosomes (NDEs), containing neuron-specific cargo, has permitted characterization of CNS-derived exosomes in living humans. Constituents of the amyloid -peptide (A)42-generating system now are examined in 2 distinct sets of human neural cells by quantification in astrocyte-derived exosomes (ADEs) and NDEs, enriched separately from plasmas of patients with Alzheimer's disease (AD) or frontotemporal dementia (FTD) and matched cognitively normal controls. ADE levels of -site amyloid precursor protein-cleaving enzyme 1 (BACE-1), -secretase, soluble A42, soluble amyloid precursor protein (sAPP), sAPP, glial-derived neurotrophic factor (GDNF), P-T181-tau, and P-S396-tau were significantly (3- to 20-fold) higher than levels in NDEs for patients and controls. BACE-1 levels also were a mean of 7-fold higher in ADEs than in NDEs from cultured rat type-specific neural cells. Levels of BACE-1 and sAPP were significantly higher and of GDNF significantly lower in ADEs of patients with AD than in those of controls, but not significantly different in patients with FTD than in controls. Abundant proteins of the A42 peptide-generating system in ADEs may sustain levels in neurons. ADE cargo proteins may be useful for studies of mechanisms of cellular interactions and effects of BACE-1 inhibitors in AD.Goetzl, E. J., Mustapic, M., Kapogiannis, D., Eitan, E., Lobach, I. V., Goetzl, L., Schwartz, J. B., Miller, B. L. Cargo proteins of plasma astrocyte-derived exosomes in Alzheimer's disease.	[Goetzl, Edward J.; Schwartz, Janice B.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lobach, Irina V.] Univ Calif San Francisco, Clin Translat Sci Inst, San Francisco, CA 94143 USA; [Schwartz, Janice B.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Miller, Bruce L.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Goetzl, Edward J.; Schwartz, Janice B.] Jewish Home San Francisco, Geriatr Res Ctr, San Francisco, CA USA; [Mustapic, Maja; Kapogiannis, Dimitrios; Eitan, Erez] NIA, Lab Neurosci, NIH, Baltimore, MD 21224 USA; [Goetzl, Laura] Temple Univ, Dept Obstet Gynecol & Reprod Sci, Philadelphia, PA 19122 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University	Goetzl, EJ (corresponding author), Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Kapogiannis, Dimitrios/AAW-4934-2020; Schwartz, Janice/K-6354-2019; Mustapic, Maja/AAV-3212-2020	Kapogiannis, Dimitrios/0000-0003-2181-3118; Mustapic, Maja/0000-0003-0511-2047; Goetzl, Laura/0000-0003-4130-2809	Biomarkers Across Neurodegenerative Diseases 2 program of the Michael J. Fox Foundation for Parkinson's Research; Alzheimer's Association; Alzheimer's Research UK; Weston Brain Institute; U.S. National Institues of Health (NIH) National Institute on Aging (NIA) Intramural Program; NIH/NIA [P30 AG028383]; NATIONAL INSTITUTE ON AGING [ZIAAG000975, P30AG028383] Funding Source: NIH RePORTER	Biomarkers Across Neurodegenerative Diseases 2 program of the Michael J. Fox Foundation for Parkinson's Research; Alzheimer's Association(Alzheimer's Association); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Weston Brain Institute; U.S. National Institues of Health (NIH) National Institute on Aging (NIA) Intramural Program; NIH/NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by a grant from the Biomarkers Across Neurodegenerative Diseases 2 program of the Michael J. Fox Foundation for Parkinson's Research, the Alzheimer's Association, Alzheimer's Research UK and the Weston Brain Institute, the U.S. National Institues of Health (NIH) National Institute on Aging (NIA) Intramural Program (to M.M., D.K. and E.E.), and NIH/NIA grant P30 AG028383 (to E.L.A.). The authors thank Judith H. Goetzl (Jewish Home of San Francisco) for expert preparation of the illustrations. E.J.G. has filed a provisional patent application with the U.S. Patent Office for the methodology of immunochemical isolation and analytical applications of astrocyte-derived exosomes. The remaining authors declare no competing financial interests.	Abramov AY, 2004, J NEUROSCI, V24, P565, DOI 10.1523/JNEUROSCI.4042-03.2004; Alzheimer's Disease Neuroimaging Initiative, 2009, ANN NEUROL, V65, P403; Bi B, 2011, J NEUROSCI, V31, P9205, DOI 10.1523/JNEUROSCI.0518-11.2011; Budnik V, 2016, NAT REV NEUROSCI, V17, P160, DOI 10.1038/nrn.2015.29; Cano SJ, 2010, J NEUROL NEUROSUR PS, V81, P1363, DOI 10.1136/jnnp.2009.204008; Chojnacki A, 2008, NAT PROTOC, V3, P935, DOI 10.1038/nprot.2008.55; Christensen MA, 2004, MOL CELL BIOL, V24, P865, DOI 10.1128/MCB.24.2.865-874.2004; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Farmer WT, 2016, SCIENCE, V351, P849, DOI 10.1126/science.aab3103; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Goetzl EJ, 2015, NEUROLOGY, V85, P40, DOI 10.1212/WNL.0000000000001702; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Hartlage-Rubsamen M, 2003, GLIA, V41, P169, DOI 10.1002/glia.10178; Hochstim C, 2008, CELL, V133, P510, DOI 10.1016/j.cell.2008.02.046; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; Hong HS, 2003, BIOCHEM BIOPH RES CO, V307, P922, DOI 10.1016/S0006-291X(03)01270-1; Irizarry MC, 2008, J ALZHEIMERS DIS, V14, P301; Ishibashi T, 2006, NEURON, V49, P823, DOI 10.1016/j.neuron.2006.02.006; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Koistinaho M, 2004, NAT MED, V10, P719, DOI 10.1038/nm1058; Kurkinen KMA, 2016, J CELL SCI, V129, P2224, DOI 10.1242/jcs.185215; Liao MC, 2016, J NEUROSCI, V36, P1730, DOI 10.1523/JNEUROSCI.2735-15.2016; Matos M, 2008, NEUROSCIENCE, V156, P898, DOI 10.1016/j.neuroscience.2008.08.022; MATTSON MP, 1995, METHOD CELL BIOL, V46, P187; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Mei ZR, 2015, NEUROCHEM RES, V40, P829, DOI 10.1007/s11064-015-1533-1; Multhaup G, 2015, J BIOL CHEM, V290, P23515, DOI 10.1074/jbc.R115.677211; Natunen T, 2016, NEUROBIOL DIS, V85, P187, DOI 10.1016/j.nbd.2015.11.005; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Rajendran L, 2014, J NEUROSCI, V34, P15482, DOI 10.1523/JNEUROSCI.3258-14.2014; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Ruth L, 2000, ACTA CRYSTALLOGR D, V56, P524, DOI 10.1107/S090744490000007X; Santello M, 2009, NEUROSCIENCE, V158, P253, DOI 10.1016/j.neuroscience.2008.03.039; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; TIEU PT, 1995, HUM MUTAT, V6, P55, DOI 10.1002/humu.1380060111; Walz W, 2000, NEUROCHEM INT, V36, P291, DOI 10.1016/S0197-0186(99)00137-0; Wyss-Coray T, 2003, NAT MED, V9, P453, DOI 10.1038/nm838; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150	39	190	191	1	39	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3853	3859		10.1096/fj.201600756R	http://dx.doi.org/10.1096/fj.201600756R			7	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27511944	Green Published			2022-12-28	WOS:000386474700019
J	Bechir, N; Pecchi, E; Vilmen, C; Le Fur, Y; Amthor, H; Bernard, M; Bendahan, D; Giannesini, B				Bechir, Nelly; Pecchi, Emilie; Vilmen, Christophe; Le Fur, Yann; Amthor, Helge; Bernard, Monique; Bendahan, David; Giannesini, Benoit			ActRIIB blockade increases force-generating capacity and preserves energy supply in exercising mdx mouse muscle in vivo	FASEB JOURNAL			English	Article						skeletal muscle hypertrophy; myostatin inhibition; Duchenne muscular dystrophy; muscle fatigue	DUCHENNE MUSCULAR-DYSTROPHY; HUMAN SKELETAL-MUSCLE; MAGNETIC-RESONANCE-SPECTROSCOPY; MYOSTATIN-DEFICIENT MICE; IIB RECEPTOR; MECHANICAL PERFORMANCE; GASTROCNEMIUS-MUSCLE; INSULIN SENSITIVITY; GENE-EXPRESSION; ADIPOSE-TISSUE	Postnatal blockade of the activin type IIB receptor (ActRIIB) represents a promising therapeutic strategy for counteracting dystrophic muscle wasting. However, its impact on muscle function and bioenergetics remains poorly documented in physiologic conditions. We have investigated totally noninvasively the effect of 8-wk administration of either soluble ActRIIB signaling inhibitor (sActRIIB-Fc) or vehicle PBS (control) on gastrocnemius muscle force-generating capacity, energy metabolism, and anatomy in dystrophic mdx mice using magnetic resonance (MR) imaging and dynamic [P-31]-MR spectroscopy ([P-31]-MRS) in vivo. ActRIIB inhibition increased muscle volume (+33%) without changing fiber-type distribution, and increased basal animal oxygen consumption (+22%) and energy expenditure (+23%). During an in vivo standardized fatiguing exercise, maximum and total absolute contractile forces were larger (+40 and 24%, respectively) in sActRIIB-Fc treated animals, whereas specific force-generating capacity and fatigue resistance remained unaffected. Furthermore, sActRIIB-Fc administration did not alter metabolic fluxes, ATP homeostasis, or contractile efficiency during the fatiguing bout of exercise, although it dramatically reduced the intrinsic mitochondrial capacity for producing ATP. Overall, sActRIIB-Fc treatment increased muscle mass and strength without altering the fundamental weakness characteristic of dystrophic mdx muscle. These data support the clinical interest of ActRIIB blockade for reversing dystrophic muscle wasting.	[Bechir, Nelly; Pecchi, Emilie; Vilmen, Christophe; Le Fur, Yann; Bernard, Monique; Bendahan, David; Giannesini, Benoit] Aix Marseille Univ, CNRS, Ctr Resonance Magnet Biol & Med, UMR 7339, Marseille, France; [Amthor, Helge] Univ Versailles St Quentin En Yvelines, Unite Format Sci Sante, INSERM U1179,Cellules Soches Mesenchymateuses, St Quentin Yvelines Therapeut,Lab Int Associe,Bio, Montigny Le Bretonneux, France; [Amthor, Helge] Univ Versailles St Quentin En Yvelines, Unite Rech Sci Sante, INSERM U1179,Cellules Soches Mesenchymateuses, St Quentin Yvelines Therapeut,Lab Int Associe,Bio, Montigny Le Bretonneux, France; [Amthor, Helge] Univ Paris 05, Ctr Hosp Univ Necker Enfants Malad, Serv Genet Med, Paris, France; [Amthor, Helge] Ctr Hosp Univ CHU Raymond Poincare, Serv Pediat, Garches, France	Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite	Giannesini, B (corresponding author), Aix Marseille Univ, CRMBM, UMR CNRS 7339, Fac Med Marseille, 27 Blvd Jean Moulin, F-13385 Marseille, France.	benoit.giannesini@univ-amu.fr	Bendahan, David/AAU-1420-2020; Bernard, Monique/Q-7254-2017	Bernard, Monique/0000-0002-3179-8698	French Muscular Dystrophy Association (AFM-Telethon)	French Muscular Dystrophy Association (AFM-Telethon)	The authors thank Acceleron Pharma, Inc. for the gift of sActRIIB-Fc, Ms. Laurence Louis (Aix-Marseille Universite) for helpful assistance with infrared imaging, and Drs. Delphine Bastelica and Marie-Christine Alessi (Aix-Marseille Universite) for sharing the indirect calorimetry system. This work was financially supported by the French Muscular Dystrophy Association (AFM-Telethon). The authors declare no conflicts of interest. Acceleron Pharma, Inc. did not influence data collection, analysis, interpretation and decision to publish the present study.	ADAMS GR, 1990, J APPL PHYSIOL, V69, P968, DOI 10.1152/jappl.1990.69.3.968; Akpan I, 2009, INT J OBESITY, V33, P1265, DOI 10.1038/ijo.2009.162; Amara CE, 2007, P NATL ACAD SCI USA, V104, P1057, DOI 10.1073/pnas.0610131104; Amthor H, 2007, P NATL ACAD SCI USA, V104, P1835, DOI 10.1073/pnas.0604893104; Amthor H, 2012, CURR GENE THER, V12, P245, DOI 10.2174/156652312800840577; ARNOLD DL, 1984, MAGNET RESON MED, V1, P307, DOI 10.1002/mrm.1910010303; ARNOLD DL, 1984, LANCET, V1, P1367; Attie KM, 2013, MUSCLE NERVE, V47, P416, DOI 10.1002/mus.23539; Baligand C, 2010, GENE THER, V17, P328, DOI 10.1038/gt.2009.141; Birot OJG, 2003, J PHYSIOL-LONDON, V552, P213, DOI 10.1113/jphysiol.2003.043026; Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154; Bogdanovich S, 2005, FASEB J, V19, P543, DOI 10.1096/fj.04-2796com; Cadena SM, 2010, J APPL PHYSIOL, V109, P635, DOI 10.1152/japplphysiol.00866.2009; Carlson CG, 2011, MUSCLE NERVE, V43, P694, DOI 10.1002/mus.21944; Chiu CS, 2013, J GERONTOL A-BIOL, V68, P1181, DOI 10.1093/gerona/glt030; Cole MA, 2002, NEUROMUSCULAR DISORD, V12, P247, DOI 10.1016/S0960-8966(01)00278-4; Conley KE, 1997, AM J PHYSIOL-CELL PH, V273, pC306, DOI 10.1152/ajpcell.1997.273.1.C306; Conley KE, 1998, J PHYSIOL-LONDON, V511, P935, DOI 10.1111/j.1469-7793.1998.935bg.x; de Caestecker M, 2004, CYTOKINE GROWTH F R, V15, P1, DOI 10.1016/j.cytogfr.2003.10.004; Dumonceaux Julie, 2009, Neuromuscul Disord, V19, P797, DOI 10.1016/j.nmd.2009.08.001; Erkintalo M, 1998, METABOLISM, V47, P769, DOI 10.1016/S0026-0495(98)90110-X; Farvid MS, 2005, DIABETES OBES METAB, V7, P406, DOI 10.1111/j.1463-1326.2004.00410.x; Giannesini B, 2001, J PHYSIOL-LONDON, V536, P905, DOI 10.1111/j.1469-7793.2001.00905.x; Giannesini B, 2013, AM J PHYSIOL-ENDOC M, V305, pE33, DOI 10.1152/ajpendo.00651.2012; Giannesini B, 2010, MAGN RESON MED, V64, P262, DOI 10.1002/mrm.22386; Godin Richard, 2012, J Physiol, V590, P5487, DOI 10.1113/jphysiol.2012.240390; Guo TQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004937; GYULAI L, 1985, J BIOL CHEM, V260, P3947; HOCHACHKA PW, 1983, SCIENCE, V219, P1391, DOI 10.1126/science.6298937; HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4; Kemp GJ, 2015, ACTA PHYSIOL, V213, P107, DOI 10.1111/apha.12307; KEMP GJ, 1994, MAGN RESON QUART, V10, P43; Kemp GJ, 1996, NMR BIOMED, V9, P261, DOI 10.1002/(SICI)1099-1492(199609)9:6<261::AID-NBM430>3.0.CO;2-B; Lach-Trifilieff E, 2014, MOL CELL BIOL, V34, P606, DOI 10.1128/MCB.01307-13; Lanza IR, 2011, J MAGN RESON IMAGING, V34, P1143, DOI 10.1002/jmri.22733; Lawlor MW, 2011, AM J PATHOL, V178, P784, DOI 10.1016/j.ajpath.2010.10.035; Le Fur Y, 2010, MAGN RESON MATER PHY, V23, P23, DOI 10.1007/s10334-009-0186-y; LeBrasseur NK, 2009, J GERONTOL A-BIOL, V64, P940, DOI 10.1093/gerona/glp068; Lee SJ, 2005, P NATL ACAD SCI USA, V102, P18117, DOI 10.1073/pnas.0505996102; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; Macia M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129579; Mattei JP, 2006, MAGN RESON MATER PHY, V19, P275, DOI 10.1007/s10334-006-0051-1; McPherron AC, 2002, J CLIN INVEST, V109, P595, DOI 10.1172/JCI200213562; Mendias CL, 2006, J APPL PHYSIOL, V101, P898, DOI 10.1152/japplphysiol.00126.2006; Morine KJ, 2010, MUSCLE NERVE, V42, P722, DOI 10.1002/mus.21743; Morrison BM, 2009, EXP NEUROL, V217, P258, DOI 10.1016/j.expneurol.2009.02.017; Mouisel E, 2014, AM J PHYSIOL-REG I, V307, pR444, DOI 10.1152/ajpregu.00377.2013; Petrof BJ, 1998, MOL CELL BIOCHEM, V179, P111, DOI 10.1023/A:1006812004945; Pistilli EE, 2011, AM J PATHOL, V178, P1287, DOI 10.1016/j.ajpath.2010.11.071; Rahimov F, 2011, PHYSIOL GENOMICS, V43, P398, DOI 10.1152/physiolgenomics.00223.2010; Relizani K, 2014, MOL THER, V22, P1423, DOI 10.1038/mt.2014.90; ROTH K, 1991, MAGNET RESON MED, V22, P505, DOI 10.1002/mrm.1910220258; Russ DW, 2009, MED SCI SPORT EXER, V41, P1504, DOI 10.1249/MSS.0b013e31819b3607; Rybalka E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115763; Vanhamme L, 1997, J MAGN RESON, V129, P35, DOI 10.1006/jmre.1997.1244; Wang Q, 2012, J PHYSIOL-LONDON, V590, P2151, DOI 10.1113/jphysiol.2011.226001; Welle S, 2009, PHYSIOL GENOMICS, V38, P342, DOI 10.1152/physiolgenomics.00054.2009; Wisloff U, 2005, SCIENCE, V307, P418, DOI 10.1126/science.1108177; WOLFE CL, 1988, BIOCHIM BIOPHYS ACTA, V971, P9, DOI 10.1016/S0005-2728(88)80003-3; Zhao BP, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-305; Zhao BQ, 2005, BIOCHEM BIOPH RES CO, V337, P248, DOI 10.1016/j.bbrc.2005.09.044	61	12	12	0	2	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3551	3562		10.1096/fj.201600271RR	http://dx.doi.org/10.1096/fj.201600271RR			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27416839	Green Submitted			2022-12-28	WOS:000384329800024
J	Lopez-Cardona, AP; Perez-Cerezales, S; Fernandez-Gonzalez, R; Laguna-Barraza, R; Pericuesta, E; Agirregoitia, N; Gutierrez-Adan, A; Agirregoitia, E				Lopez-Cardona, Angela Patricia; Perez-Cerezales, Serafin; Fernandez-Gonzalez, Raul; Laguna-Barraza, Ricardo; Pericuesta, Eva; Agirregoitia, Naiara; Gutierrez-Adan, Alfonso; Agirregoitia, Ekaitz			CB1 cannabinoid receptor drives oocyte maturation and embryo development via PI3K/Akt and MAPK pathways	FASEB JOURNAL			English	Article						fertility; assisted reproductive technology; embryology	PROTEIN-KINASE-B; MEIOTIC MATURATION; MOUSE OOCYTES; ENDOCANNABINOID SYSTEM; MAMMALIAN OOCYTES; ANANDAMIDE LEVELS; ACTIVATION; EXPRESSION; OVARY; AKT	Endocannabinoids have been recognized as mediators of practically all reproductive events in mammals. However, little is known about the role of this system in oocyte maturation. In a mouse model, we observed that activation of cannabinoid receptor 1 (CB1) during in vitro oocyte maturation modulated the phosphorylation status of Akt and ERK1/2 and enhanced the subsequent embryo production. In the absence of CB1, in vivo oocyte maturation was impaired and embryo development delayed. Cannabinoid receptor 2 (CB2) was unable to rescue these effects. Finally, we confirmed abnormal oocyte maturation rather than impaired embryonic transport through the oviduct in CB1 knockouts. Our data suggest that cannabinoid agonists may be useful in vitro maturation supplements. For in vitro fertilization patients intolerant to gonadotropins, this could be a promising and only option.	[Lopez-Cardona, Angela Patricia; Perez-Cerezales, Serafin; Fernandez-Gonzalez, Raul; Laguna-Barraza, Ricardo; Pericuesta, Eva; Gutierrez-Adan, Alfonso] Inst Nacl Invest & Tecnol Agr & Alimentaria INIA, Dept Anim Reprod, Madrid, Spain; [Lopez-Cardona, Angela Patricia] Univ Antioquia, Grp Invest GI Biogenesis, Medellin, Colombia; [Agirregoitia, Naiara; Agirregoitia, Ekaitz] Univ Basque Country UPV EHU, Dept Physiol, Fac Med & Nursing, Leioa, Spain	Instituto Nacional Investigacion Tecnologia Agraria Alimentaria (INIA); Universidad de Antioquia; University of Basque Country	Agirregoitia, E (corresponding author), Univ Basque Country, Dept Physiol, Fac Med & Nursing, Leioa, Bizkaia, Spain.	e.agirregoitia@ehu.eus	Gutierrez-Adan, Alfonso/A-1485-2014; Lopez-Cardona, Angela Patricia A/I-1111-2015; Perez-Cerezales, Serafin/F-8494-2014; Blanco, Leire/O-5114-2017	Gutierrez-Adan, Alfonso/0000-0001-9893-9179; Perez-Cerezales, Serafin/0000-0003-2119-6228; Fernandez Gonzalez, Raul/0000-0003-1989-2945; Lopez Cardona, Angela Patricia/0000-0003-4803-2557	Spanish Ministry of Science and Innovation [AGL2012-39652-C02-01, AGL2015-66145-R]; University of the Basque Country [GIU14/26]; Basque government [KK-2016/00026]; Universidad de Antioquia (COLCIENCIAS) through Francisco Jose de Caldas fellowship [512/2010]	Spanish Ministry of Science and Innovation(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); University of the Basque Country; Basque government(Basque Government); Universidad de Antioquia (COLCIENCIAS) through Francisco Jose de Caldas fellowship	This work received financial support from the Spanish Ministry of Science and Innovation (Grants AGL2012-39652-C02-01 and AGL2015-66145-R), University of the Basque Country (Grant GIU14/26), and the Basque government (KK-2016/00026). A.P.L.-C. acknowledges the financial support of the Universidad de Antioquia (COLCIENCIAS) through the Francisco Jose de Caldas fellowship (512/2010). The authors thank I. Galve-Roperh and G. Velasco (Universidad Complutense de Madrid, Madrid, Spain) for donating Cnr12/2 and Cnr22/2 mice which were used to set up a permanent colony and establish the Cnr12/2/Cnr22/2 double-KO mouse model in our laboratory. The authors also thank S. Giker (University of the Basque Country) for personal and technical support, and R. Andrade (University of the Basque Country) for his assistance with confocal microscopy analysis.	Agirregoitia E, 2016, CELL TISSUE RES, V365, P393, DOI 10.1007/s00441-016-2381-2; Agirregoitia E, 2015, FERTIL STERIL, V104, P753, DOI 10.1016/j.fertnstert.2015.06.013; Bagavandoss P, 2010, ANAT REC, V293, P1425, DOI 10.1002/ar.21181; Buckley  NE, 2000, EUR J PHARMACOL, V396, P141, DOI 10.1016/S0014-2999(00)00211-9; Cahill CM, 2007, TRENDS PHARMACOL SCI, V28, P23, DOI 10.1016/j.tips.2006.11.003; Cecconi S, 2014, EUR J OBSTET GYN R B, V178, P6, DOI 10.1016/j.ejogrb.2014.04.011; Cecconi S, 2012, INT J DEV BIOL, V56, P809, DOI 10.1387/ijdb.120146sc; Chang Eun Mi, 2014, Clin Exp Reprod Med, V41, P41, DOI 10.5653/cerm.2014.41.2.41; Chen J, 2013, NAT CELL BIOL, V15, P1415, DOI 10.1038/ncb2873; Chian RC, 2004, REPROD BIOMED ONLINE, V8, P148, DOI 10.1016/S1472-6483(10)60511-1; Coticchio G, 2015, HUM REPROD UPDATE, V21, P427, DOI 10.1093/humupd/dmv011; Coy P, 2008, REPRODUCTION, V135, P19, DOI 10.1530/REP-07-0280; Dalton GD, 2012, BRIT J PHARMACOL, V165, P2497, DOI 10.1111/j.1476-5381.2011.01455.x; El-Talatini MR, 2009, HUM REPROD, V24, P1989, DOI 10.1093/humrep/dep065; El-Talatini MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004579; Ernst J, 2016, MOL CELL ENDOCRINOL, V423, P67, DOI 10.1016/j.mce.2016.01.006; Freudzon L, 2005, J CELL BIOL, V171, P255, DOI 10.1083/jcb.200506194; Gebeh AK, 2012, J CLIN ENDOCR METAB, V97, P2827, DOI 10.1210/jc.2012-1780; Gutierrez-Adan A, 2000, TRANSGENIC RES, V9, P81, DOI 10.1023/A:1008926022370; Han SJ, 2005, CURR BIOL, V15, P1670, DOI 10.1016/j.cub.2005.07.056; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Kalinowski RR, 2003, DEV BIOL, V253, P139, DOI 10.1006/dbio.2002.0860; Kalous J, 2009, REPRODUCTION, V138, P645, DOI 10.1530/REP-08-0461; Kupka MS, 2014, HUM REPROD, V29, P2099, DOI 10.1093/humrep/deu175; Lopez-Cardona AP, 2016, REPRODUCTION, V152, P603, DOI 10.1530/REP-16-0199; Marsicano G, 2002, NATURE, V418, P530, DOI 10.1038/nature00839; Mehlmann LM, 2005, REPRODUCTION, V130, P791, DOI 10.1530/rep.1.00793; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Miller MR, 2016, SCIENCE, V352, P555, DOI 10.1126/science.aad6887; Moos J, 1996, J CELL SCI, V109, P739; Nader S, 2010, MINERVA ENDOCRINOL, V35, P211; Nikseresht M., 2015, J CLIN DIAGN RES, V9; Okumura E, 2002, NAT CELL BIOL, V4, P111, DOI 10.1038/ncb741; Paria BC, 2001, J BIOL CHEM, V276, P20523, DOI 10.1074/jbc.M100679200; Peralta L, 2011, REPROD BIOMED ONLINE, V23, P372, DOI 10.1016/j.rbmo.2011.05.011; Phillips KP, 2002, DEV BIOL, V247, P210, DOI 10.1006/dbio.2002.0680; Picton H, 1998, MOL CELL ENDOCRINOL, V145, P27, DOI 10.1016/S0303-7207(98)00166-X; QUINN P, 1982, J REPROD FERTIL, V66, P161; Rapino C, 2014, HUM REPROD UPDATE, V20, P501, DOI 10.1093/humupd/dmu004; REICH R, 1982, BIOL REPROD, V27, P223, DOI 10.1095/biolreprod27.1.223; Sanchez F, 2012, BBA-MOL BASIS DIS, V1822, P1896, DOI 10.1016/j.bbadis.2012.05.013; Schindler K, 2011, RESULTS PROBL CELL D, V53, P309, DOI 10.1007/978-3-642-19065-0_14; Schmitt A, 2002, J CELL SCI, V115, P2457; Schuel H, 2002, CHEM PHYS LIPIDS, V121, P211, DOI 10.1016/S0009-3084(02)00158-5; Schuel H, 2006, J CLIN INVEST, V116, P2087, DOI 10.1172/JCI29424; SHILLING F, 1989, DEV BIOL, V133, P605, DOI 10.1016/0012-1606(89)90063-8; Simonds WF, 1999, TRENDS PHARMACOL SCI, V20, P66, DOI 10.1016/S0165-6147(99)01307-3; Sun XF, 2012, ACS CHEM NEUROSCI, V3, P349, DOI 10.1021/cn300014e; Tomek W, 2005, REPRODUCTION, V130, P423, DOI 10.1530/rep.1.00754; Wang HB, 2006, ENDOCR REV, V27, P427, DOI 10.1210/er.2006-0006; Wang HB, 2004, NAT MED, V10, P1074, DOI 10.1038/nm1104; Wang HB, 2003, P NATL ACAD SCI USA, V100, P14914, DOI 10.1073/pnas.2436379100	52	32	33	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3372	3382		10.1096/fj.201601382RR	http://dx.doi.org/10.1096/fj.201601382RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28428264				2022-12-28	WOS:000405932400016
J	Chatel, B; Bendahan, D; Hourde, C; Pellerin, L; Lengacher, S; Magistretti, P; Le Fur, Y; Vilmen, C; Bernard, M; Messonnier, LA				Chatel, Benjamin; Bendahan, David; Hourde, Christophe; Pellerin, Luc; Lengacher, Sylvain; Magistretti, Pierre; Le Fur, Yann; Vilmen, Christophe; Bernard, Monique; Messonnier, Laurent A.			Role of MCT1 and CAII in skeletal muscle pH homeostasis, energetics, and function: in vivo insights from MCT1 haploinsufficient mice	FASEB JOURNAL			English	Article						magnetic resonance spectroscopy; monocarboxylate transporters; carbonic anhydrases	PHOSPHOCREATINE RECOVERY KINETICS; LACTATE-PROTON COTRANSPORT; LOW CELL PH; MONOCARBOXYLATE TRANSPORTERS; INTRACELLULAR PH; LACTIC-ACID; MECHANICAL PERFORMANCE; SUPRAMAXIMAL EXERCISE; INORGANIC-PHOSPHATE; EXPRESSION	The purpose of this study was to investigate the effects of a partial suppression of monocarboxylate transporter (MCT)-1 on skeletalmuscle pH, energetics, and function (MCT1(+/-) mice). Twenty-fourMCT1(+/-) and 13 wild-type (WT) mice were subjected to a rest-exercise-recovery protocol, allowing assessment of muscle energetics (bymagnetic resonance spectroscopy) and function. The study included analysis of enzyme activities and content of protein involved in pH regulation. Skeletalmuscle ofMCT1(+/-) mice had lower MCT1 (-61%; P < 0.05) and carbonic anhydrase (CA)-II (254%; P < 0.05) contents. Although intramuscular pH was higher in MCT1(+/-) mice at rest (P < 0.001), the mice showed higher acidosis during the first minute of exercise (P < 0.01). Then, the pH time course was similar among groups until exercise completion. MCT1(+/-) mice had higher specific peak (P < 0.05) and maximumtetanic (P < 0.01) forces and lower fatigability (P < 0.001) when compared to WT mice. We conclude that both MCT1 and CAII are involved in the homeostatic control of pH in skeletal muscle, both at rest and at the onset of exercise. The improved muscle function and resistance to fatigue in MCT1(+/-) mice remain unexplained.-Chatel, B., Bendahan, D., Hourd e, C., Pellerin, L., Lengacher, S., Magistretti, P., Fur, Y. L., Vilmen, C., Bernard, M., Messonnier, L. A. Role of MCT1 and CAII in skeletal muscle pH homeostasis, energetics, and function: in vivo insights from MCT1 haploinsufficient mice.	[Chatel, Benjamin; Bendahan, David; Le Fur, Yann; Vilmen, Christophe; Bernard, Monique; Messonnier, Laurent A.] Aix Marseille Univ, Ctr Resonance Magnet Biol & Med, CNRS, Marseille, France; [Hourde, Christophe; Messonnier, Laurent A.] Univ Savoie Mt Blanc, Lab Interuniv Biol Motricit, Chambery, France; [Pellerin, Luc; Lengacher, Sylvain] Univ Lausanne, Dept Physiol, Lausanne, Switzerland; [Lengacher, Sylvain; Magistretti, Pierre] Ecole Polytech Fed Lausanne, Lab Neuroenerget & Cellular Dynam, Brain & Mind Inst, Lausanne, Switzerland; [Magistretti, Pierre] King Abdullah Univ Sci & Technol, Div Biol & Environm Sci & Engn, Thuwal, Saudi Arabia	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; University of Lausanne; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; King Abdullah University of Science & Technology	Chatel, B (corresponding author), Aix Marseille Univ, Fac Med, Ctr Resonance Magnet Biol & Med, 27 Blvd Jean Moulin, F-13385 Marseille 05, France.	benjamin.chatel@live.fr	Bernard, Monique/Q-7254-2017; Hourdé, Christophe/H-3844-2011; Lengacher, Sylvain/C-2591-2009; CHATEL, Benjamin/AAE-2000-2019; Bendahan, David/AAU-1420-2020; Pellerin, Luc/A-8912-2017	Bernard, Monique/0000-0002-3179-8698; Hourdé, Christophe/0000-0001-5209-2590; Lengacher, Sylvain/0000-0003-2190-9654; CHATEL, Benjamin/0000-0002-8197-1903; Pellerin, Luc/0000-0002-1016-1970; Magistretti, Pierre Julius/0000-0002-6678-320X	Centre National de la Recherche Scientifique Unite Mixte de Recherche [7339]; Societe Francaise de Myologie; Genzyme;  [ANR-11-INBS-0006]	Centre National de la Recherche Scientifique Unite Mixte de Recherche(Centre National de la Recherche Scientifique (CNRS)); Societe Francaise de Myologie; Genzyme(Sanofi-AventisGenzyme Corporation); 	The authors thank Cendrine Repond (University of Lausanne) for technical assistance. This study was supported by the Centre National de la Recherche Scientifique Unite Mixte de Recherche 7339, and a grant from the Societe Francaise de Myologie and Genzyme. This work was performed by a laboratory member of France Life Imaging Network, funded by Grant ANR-11-INBS-0006. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript. The authors declare no conflicts of interest.	Abe H, 2000, BIOCHEMISTRY-MOSCOW+, V65, P757; AICKIN CC, 1977, J PHYSIOL-LONDON, V273, P295, DOI 10.1113/jphysiol.1977.sp012095; Andrews MAW, 1996, J APPL PHYSIOL, V80, P2060, DOI 10.1152/jappl.1996.80.6.2060; ARNOLD DL, 1984, MAGNET RESON MED, V1, P307, DOI 10.1002/mrm.1910010303; Baker SK, 1998, J APPL PHYSIOL, V84, P987, DOI 10.1152/jappl.1998.84.3.987; Bandschapp O, 2012, AM J PHYSIOL-CELL PH, V302, pC1019, DOI 10.1152/ajpcell.00279.2011; Bechir N, 2016, FASEB J, V30, P3551, DOI 10.1096/fj.201600271RR; Becker HM, 2005, J BIOL CHEM, V280, P39882, DOI 10.1074/jbc.M503081200; Becker HM, 2008, J BIOL CHEM, V283, P21655, DOI 10.1074/jbc.M802134200; Becker HM, 2011, P NATL ACAD SCI USA, V108, P3071, DOI 10.1073/pnas.1014293108; Benton CR, 2008, PHYSIOL GENOMICS, V35, P45, DOI 10.1152/physiolgenomics.90217.2008; Bonen A, 2001, EUR J APPL PHYSIOL, V86, P6, DOI 10.1007/s004210100516; Bonen A, 2006, APPL PHYSIOL NUTR ME, V31, P31, DOI 10.1139/H05-002; Brooks GA, 2002, J PHYSIOL-LONDON, V541, P333, DOI 10.1113/jphysiol.2002.023705; Brooks GA, 2000, MED SCI SPORT EXER, V32, P790, DOI 10.1097/00005768-200004000-00011; Brooks GA, 2009, J PHYSIOL-LONDON, V587, P5591, DOI 10.1113/jphysiol.2009.178350; CHASIOTIS D, 1983, J PHYSIOL-LONDON, V335, P197, DOI 10.1113/jphysiol.1983.sp014528; Debold EP, 2012, MED SCI SPORT EXER, V44, P1440, DOI 10.1249/MSS.0b013e31824cfd26; Debold EP, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00151; Dimmer KS, 2000, BIOCHEM J, V350, P219, DOI 10.1042/0264-6021:3500219; Dubouchaud H, 2000, AM J PHYSIOL-ENDOC M, V278, pE571, DOI 10.1152/ajpendo.2000.278.4.E571; Emhoff CAW, 2013, J APPL PHYSIOL, V115, P829, DOI 10.1152/japplphysiol.00538.2013; Favero TG, 1997, J APPL PHYSIOL, V82, P447, DOI 10.1152/jappl.1997.82.2.447; FITTS RH, 1994, PHYSIOL REV, V74, P49, DOI 10.1152/physrev.1994.74.1.49; Fitts RH, 2008, J APPL PHYSIOL, V104, P551, DOI 10.1152/japplphysiol.01200.2007; Fox JEM, 2000, J PHYSIOL-LONDON, V529, P285, DOI 10.1111/j.1469-7793.2000.00285.x; GARCIA CK, 1995, J BIOL CHEM, V270, P1843, DOI 10.1074/jbc.270.4.1843; Giannesini B, 2013, AM J PHYSIOL-ENDOC M, V305, pE33, DOI 10.1152/ajpendo.00651.2012; Giannesini B, 2010, MAGN RESON MED, V64, P262, DOI 10.1002/mrm.22386; Gineste C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072294; Gineste C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061517; Gore CJ, 2001, ACTA PHYSIOL SCAND, V173, P275, DOI 10.1046/j.1365-201X.2001.00906.x; Guthrie B M, 1996, Can J Appl Physiol, V21, P251; Halestrap AP, 2013, COMPR PHYSIOL, V3, P1611, DOI 10.1002/cphy.c130008; Halestrap AP, 2012, IUBMB LIFE, V64, P109, DOI 10.1002/iub.572; Halestrap AP, 2012, IUBMB LIFE, V64, P1, DOI 10.1002/iub.573; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Halestrap AP, 2004, PFLUG ARCH EUR J PHY, V447, P619, DOI 10.1007/s00424-003-1067-2; Hashimoto T, 2005, J PHYSIOL-LONDON, V567, P121, DOI 10.1113/jphysiol.2005.087411; Hashimoto T, 2006, AM J PHYSIOL-ENDOC M, V290, pE1237, DOI 10.1152/ajpendo.00594.2005; HOGAN MC, 1995, MED SCI SPORT EXER, V27, P371; Hollidge-Horvat MG, 1999, AM J PHYSIOL-ENDOC M, V277, pE647, DOI 10.1152/ajpendo.1999.277.4.E647; Jackson VN, 1997, BIOCHEM J, V324, P447, DOI 10.1042/bj3240447; Jubrias SA, 2003, J PHYSIOL-LONDON, V553, P589, DOI 10.1113/jphysiol.2003.045872; Juel C, 2008, ACTA PHYSIOL, V193, P17, DOI 10.1111/j.1748-1716.2008.01840.x; Juel C, 1996, ACTA PHYSIOL SCAND, V156, P369, DOI 10.1046/j.1365-201X.1996.206000.x; Juel C, 2001, EUR J APPL PHYSIOL, V86, P12, DOI 10.1007/s004210100517; Juel C, 1998, PFLUG ARCH EUR J PHY, V436, P560, DOI 10.1007/s004240050672; Juel C, 1999, J PHYSIOL-LONDON, V517, P633, DOI 10.1111/j.1469-7793.1999.0633s.x; Juel C, 1997, PHYSIOL REV, V77, P321, DOI 10.1152/physrev.1997.77.2.321; Knuth ST, 2006, J PHYSIOL-LONDON, V575, P887, DOI 10.1113/jphysiol.2006.106732; Kobayashi Masaki, 2004, Drug Metab Pharmacokinet, V19, P363, DOI 10.2133/dmpk.19.363; Layec G, 2013, NMR BIOMED, V26, P1403, DOI 10.1002/nbm.2966; Le Fur Y, 2010, MAGN RESON MATER PHY, V23, P23, DOI 10.1007/s10334-009-0186-y; Leite TC, 2007, BIOCHEM J, V408, P123, DOI 10.1042/BJ20070687; Lengacher S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082505; Lindinger MI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084451; MAINWOOD GW, 1985, CAN J PHYSIOL PHARM, V63, P403, DOI 10.1139/y85-072; MANNION AF, 1993, J APPL PHYSIOL, V75, P1412, DOI 10.1152/jappl.1993.75.3.1412; Marcinek DJ, 2010, J APPL PHYSIOL, V108, P1479, DOI 10.1152/japplphysiol.01189.2009; Marqueste T., 2008, J APPL PHYSIOL, V105, P299; McCullagh KJA, 1997, AM J PHYSIOL-ENDOC M, V273, pE239, DOI 10.1152/ajpendo.1997.273.2.E239; McCullagh KJA, 1996, AM J PHYSIOL-ENDOC M, V271, pE143, DOI 10.1152/ajpendo.1996.271.1.E143; Messonnier L, 2007, J APPL PHYSIOL, V102, P1936, DOI 10.1152/japplphysiol.00691.2006; Messonnier LA, 2013, J APPL PHYSIOL, V114, P1593, DOI 10.1152/japplphysiol.00043.2013; METZGER JM, 1987, J APPL PHYSIOL, V62, P1392, DOI 10.1152/jappl.1987.62.4.1392; MOON RB, 1973, J BIOL CHEM, V248, P7276; Nelson CR, 2014, AM J PHYSIOL-CELL PH, V306, pC670, DOI 10.1152/ajpcell.00347.2013; Passonneau J.V., 1972, FLEXIBLE SYSTEM ENZY; Pedersen TH, 2004, SCIENCE, V305, P1144, DOI 10.1126/science.1101141; Pellerin L, 2005, J NEUROSCI RES, V79, P55, DOI 10.1002/jnr.20307; Pilegaard H, 1999, AM J PHYSIOL-ENDOC M, V276, pE843, DOI 10.1152/ajpendo.1999.276.5.E843; PILEGAARD H, 1994, J APPL PHYSIOL, V77, P1858, DOI 10.1152/jappl.1994.77.4.1858; Polanski R, 2014, CLIN CANCER RES, V20, P926, DOI 10.1158/1078-0432.CCR-13-2270; Renaud JM, 2006, J APPL PHYSIOL, V101, P367, DOI 10.1152/japplphysiol.00181.2006; Rivero-Gutierrez B, 2014, ANAL BIOCHEM, V467, P1, DOI 10.1016/j.ab.2014.08.027; Roussel M, 2000, BBA-BIOENERGETICS, V1457, P18, DOI 10.1016/S0005-2728(99)00111-5; Roussel M, 2003, J APPL PHYSIOL, V94, P1145, DOI 10.1152/japplphysiol.01024.2000; Sahlin K., 2006, J APPL PHYSIOL, V101, P369; Saxena S, 2016, HIGH ALT MED BIOL, V17, P32, DOI 10.1089/ham.2015.0048; Semenza GL, 2008, J CLIN INVEST, V118, P3835, DOI 10.1172/JCI37373; Stridh MH, 2012, J PHYSIOL-LONDON, V590, P2333, DOI 10.1113/jphysiol.2011.220152; SUTTON JR, 1981, CLIN SCI, V61, P331, DOI 10.1042/cs0610331; Thomas C, 2005, J APPL PHYSIOL, V98, P804, DOI 10.1152/japplphysiol.01057.2004; TRIVEDI B, 1966, J BIOL CHEM, V241, P4110; Westerblad H, 2002, NEWS PHYSIOL SCI, V17, P17; Wilson MC, 1998, J BIOL CHEM, V273, P15920, DOI 10.1074/jbc.273.26.15920; Yoshida Y, 2004, J APPL PHYSIOL, V97, P527, DOI 10.1152/japplphysiol.01347.2003; Zaccagnini G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142111	89	15	15	0	16	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2562	2575		10.1096/fj.201601259R	http://dx.doi.org/10.1096/fj.201601259R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28254758				2022-12-28	WOS:000401553400028
J	Reynolds, JD; Case, LK; Krementsov, DN; Raza, A; Bartiss, R; Teuscher, C				Reynolds, Jacob D.; Case, Laure K.; Krementsov, Dimitry N.; Raza, Abbas; Bartiss, Rose; Teuscher, Cory			Modeling month-season of birth as a risk factor in mouse models of chronic disease: from multiple sclerosis to autoimmune encephalomyelitis	FASEB JOURNAL			English	Article						autoimmunity; cytokines; EAE; month of birth; seasonal variation	EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; REPRODUCTIVE-PERFORMANCE; ENVIRONMENTAL-FACTORS; SEX-RATIO; VITAMIN-D; ULTRAVIOLET-RADIATION; CIRCANNUAL RHYTHM; ATOPIC-DERMATITIS; GUT MICROBIOME; LITTER SIZE	Month-season of birth (M-SOB) is a risk factor in multiple chronic diseases, including multiple sclerosis (MS), where the lowest and greatest risk of developing MS coincide with the lowest and highest birth rates, respectively. To determine whether M-SOB effects in such chronic diseases as MS can be experimentally modeled, we examined the effect of M-SOB on susceptibility of C57BL/6J mice to experimental autoimmune encephalomyelitis (EAE). As in MS, mice that were born during the M-SOB with the lowest birth rate were less susceptible to EAE than mice born during the M-SOB with the highest birth rate. We also show that the M-SOB effect on EAE susceptibility is associated with differential production of multiple cytokines/chemokines by neuroantigen-specific T cells that are known to play a role in EAE pathogenesis. Taken together, these results support the existence of an M-SOB effect that may reflect seasonally dependent developmental differences in adaptive immune responses to self-antigens independent of external stimuli, including exposure to sunlight and vitamin D. Moreover, our documentation of an M-SOB effect on EAE susceptibility in mice allows for modeling and detailed analysis of mechanisms that underlie the M-SOB effect in not only MS but in numerous other diseases in which M-SOB impacts susceptibility.	[Reynolds, Jacob D.; Case, Laure K.; Krementsov, Dimitry N.; Raza, Abbas; Teuscher, Cory] Univ Vermont, Dept Med, Burlington, VT USA; [Teuscher, Cory] Univ Vermont, Dept Pathol, Burlington, VT 05405 USA; [Bartiss, Rose] Trudeau Inst, Saranac Lake, NY USA	University of Vermont; University of Vermont; Trudeau Institute	Teuscher, C (corresponding author), Univ Vermont, C331 Given Bldg,89 Beaumont Ave, Burlington, VT 05405 USA.	c.teuscher@uvm.edu	Raza, Abbas/AAF-2541-2021; Krementsov, Dimitry/Y-8288-2019	Krementsov, Dimitry/0000-0003-2709-7466; Raza, Abbas/0000-0003-0359-5647	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke [NS061014, NS060901, AI041747, NS036526, NS069628]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI041747] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM118228, P20GM103496] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060901, R01NS069628, R01NS036526, R01NS061014] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the U.S. National Institutes of Health, National Institute of Neurological Disorders and Stroke Grants NS061014, AI041747, NS060901, NS036526, and NS069628 (all to C.T.).	Aggarwal R, 2013, J RHEUMATOL, V40, P430, DOI 10.3899/jrheum.120643; Alizadeh A, 2016, TOXINS, V8, DOI 10.3390/toxins8110334; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Ascherio A, 2010, LANCET NEUROL, V9, P599, DOI 10.1016/S1474-4422(10)70086-7; Barnard DE, 2009, J AM ASSOC LAB ANIM, V48, P709; Bartiss R., 2015, AT JACKSON LAB, V1, P1; Baschat A A, 2003, J Matern Fetal Neonatal Med, V13, P381, DOI 10.1080/jmf.13.6.381.384; Bennetts H. W., 1946, AUSTRALIAN VET JOUR, V22, P2, DOI 10.1111/j.1751-0813.1946.tb15473.x; Berthiller F, 2013, MOL NUTR FOOD RES, V57, P165, DOI 10.1002/mnfr.201100764; BIGGERS JD, 1954, BIOCHEM J, V58, P278, DOI 10.1042/bj0580278; Blankenhorn EP, 2000, J IMMUNOL, V164, P3420, DOI 10.4049/jimmunol.164.6.3420; Blay M, 2010, J PHARMACEUT BIOMED, V51, P382, DOI 10.1016/j.jpba.2009.03.028; Boland Mary Regina, 2016, AMIA Jt Summits Transl Sci Proc, V2016, P189; Boland MR, 2015, J AM MED INFORM ASSN, V22, P1042, DOI 10.1093/jamia/ocv046; Bondy GS, 2000, J TOXICOL ENV HEAL B, V3, P109, DOI 10.1080/109374000281113; BRADEN AWH, 1967, AUST J AGR RES, V18, P335, DOI 10.1071/AR9670355; Brewerton TD, 2012, INT J EAT DISORDER, V45, P131, DOI 10.1002/eat.20898; BROCK MA, 1983, J IMMUNOL, V130, P2586; Burrell AM, 2011, DISCOV MED, V11, P187; Butterfield RJ, 1998, J IMMUNOL, V161, P1860; Cano PM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053647; Case LK, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0591-7; Castro SBR, 2012, INT IMMUNOPHARMACOL, V12, P465, DOI 10.1016/j.intimp.2011.12.025; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28484; CORRIER DE, 1991, VET IMMUNOL IMMUNOP, V30, P73, DOI 10.1016/0165-2427(91)90010-A; Cruz PMR, 2016, JAMA NEUROL, V73, P954, DOI 10.1001/jamaneurol.2016.1463; De Paula ML, 2008, INT IMMUNOPHARMACOL, V8, P1291, DOI 10.1016/j.intimp.2008.05.002; Delgado LF, 2012, SCI TOTAL ENVIRON, V435, P509, DOI 10.1016/j.scitotenv.2012.07.046; Disanto G, 2013, JAMA NEUROL, V70, P527, DOI 10.1001/jamaneurol.2013.2116; Disanto G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-69; Disanto G, 2012, CNS NEUROL DISORD-DR, V11, P545, DOI 10.2174/187152712801661266; Disanto G, 2011, BRIT J PSYCHIAT, V198, P404, DOI 10.1192/bjp.bp.110.085944; Doblhammer G, 2001, P NATL ACAD SCI USA, V98, P2934, DOI 10.1073/pnas.041431898; Donald DB, 2007, ENVIRON HEALTH PERSP, V115, P1183, DOI 10.1289/ehp.9435; Dopico XC, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8000; DRICKAMER L C, 1977, Laboratory Animals (London), V11, P159, DOI 10.1258/002367777780936639; DRICKAMER LC, 1990, LAB ANIM SCI, V40, P284; Fiddes B, 2014, J NEUROL, V261, P1851, DOI 10.1007/s00415-014-7241-y; Fiddes B, 2013, ANN NEUROL, V73, P714, DOI 10.1002/ana.23925; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Gardener H, 2010, MOVEMENT DISORD, V25, P1560, DOI 10.1002/mds.23339; Goldinger A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126995; Grytten N, 2013, MULT SCLER J, V19, P1028, DOI 10.1177/1352458512471094; Gwinner E., 1986, CIRCANNUAL RHYTHMS, Vfirst; Halldner L, 2014, J CHILD PSYCHOL PSYC, V55, P897, DOI 10.1111/jcpp.12229; Handel AE, 2010, NAT REV NEUROL, V6, P156, DOI 10.1038/nrneurol.2010.1; Hanson FB, 1924, GENETICS, V9, P363; Hart PH, 2011, NAT REV IMMUNOL, V11, P584, DOI 10.1038/nri3045; HAUS E, 1983, AM J ANAT, V168, P467, DOI 10.1002/aja.1001680406; Haus E, 1999, CHRONOBIOL INT, V16, P581, DOI 10.3109/07420529908998730; Helm B, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0016; Hintzen R, 2013, NAT REV NEUROL, V9, P489, DOI 10.1038/nrneurol.2013.156; Huber S, 2008, HUM REPROD, V23, P1187, DOI 10.1093/humrep/den079; Huber S, 2004, HUM REPROD, V19, P1081, DOI 10.1093/humrep/deh247; Huber S, 2009, AM J HUM BIOL, V21, P25, DOI 10.1002/ajhb.20799; Huber S, 2011, AM J HUM BIOL, V23, P546, DOI 10.1002/ajhb.21184; Hueza IM, 2014, TOXINS, V6, P1080, DOI 10.3390/toxins6031080; Jahromi SR, 2014, IRAN J ALLERGY ASTHM, V13, P256; Javaras KN, 2011, INT J EAT DISORDER, V44, P630, DOI 10.1002/eat.20864; Jorg S, 2016, CELL MOL LIFE SCI, V73, P4611, DOI 10.1007/s00018-016-2311-1; Kahn HS, 2009, DIABETES CARE, V32, P2010, DOI 10.2337/dc09-0891; Kemkes A, 2010, J BIOSOC SCI, V42, P177, DOI 10.1017/S002193200999054X; KORSGAARD J, 1983, CLIN ALLERGY, V13, P529, DOI 10.1111/j.1365-2222.1983.tb02634.x; Krementsov DN, 2013, MULT SCLER J, V19, P1684, DOI 10.1177/1352458513506954; Kuo CL, 2016, ALLERGY, V71, P1626, DOI 10.1111/all.12954; Kusunoki T, 1999, J ALLERGY CLIN IMMUN, V103, P1148, DOI 10.1016/S0091-6749(99)70191-0; Langgartner D, 2017, STRESS, V20, P10, DOI 10.1080/10253890.2016.1254186; Levitan RD, 2010, NEUROPSYCHOPHARMACOL, V35, P1729, DOI 10.1038/npp.2010.38; LIGHTFOOT RJ, 1967, AUST J AGR RES, V18, P755, DOI 10.1071/AR9670755; Lu CM, 2010, P NATL ACAD SCI USA, V107, P18967, DOI 10.1073/pnas.1008816107; Martinez-Bakker M, 2015, TRENDS ECOL EVOL, V30, P314, DOI 10.1016/j.tree.2015.03.012; McDowell TY, 2010, NEUROEPIDEMIOLOGY, V34, P238, DOI 10.1159/000297749; McGrath JJ, 2010, ARCH GEN PSYCHIAT, V67, P889, DOI 10.1001/archgenpsychiatry.2010.110; Messias E, 2006, J NERV MENT DIS, V194, P870, DOI 10.1097/01.nmd.0000243762.63694.e6; Mika KM, 2016, AM J HUM GENET, V99, P1059, DOI 10.1016/j.ajhg.2016.09.002; Mills SY, 2007, COMPLEMENT THER MED, V15, P1, DOI [10.1002/0471142735.im1501s77, 10.1002/0471142735.im1501s88]; MOCK EJ, 1980, BIOL REPROD, V22, P119, DOI 10.1095/biolreprod22.2.119; MOCK EJ, 1978, BIOL REPROD, V18, P772, DOI 10.1095/biolreprod18.5.772; MOCK EJ, 1975, NATURE, V256, P61, DOI 10.1038/256061a0; MOCK EJ, 1978, BIOL REPROD, V19, P927, DOI 10.1095/biolreprod19.4.927; Mohammad-Shahi M, 2011, BIOIMPACTS, V1, P161, DOI 10.5681/bi.2011.022; Moorthy LN, 2008, LUPUS, V17, P128, DOI 10.1177/0961203307085111; Nagamine Satomi, 2011, Open Orthop J, V5, P134, DOI 10.2174/1874325001105010134; Nakaya N, 2003, IN VITRO CELL DEV-AN, V39, P383, DOI 10.1290/1543-706X(2003)039<0383:ECSIPI>2.0.CO;2; Nelson RJ, 1996, Q REV BIOL, V71, P511, DOI 10.1086/419555; Norval M, 2008, PHOTOCHEM PHOTOBIOL, V84, P19, DOI 10.1111/j.1751-1097.2007.00239.x; Noubade R, 2007, J CLIN INVEST, V117, P3507, DOI 10.1172/JCI32792; Ober C, 1998, HUM REPROD, V13, P33, DOI 10.1093/humrep/13.1.33; Ober C, 2003, AM J HUM GENET, V72, P1425, DOI 10.1086/375501; OBER C, 1992, AM J HUM GENET, V50, P6; OBER CL, 1983, AM J HUM GENET, V35, P994; Ohzu E., 1963, ZOOL MAG TOKYO, V72, P139; Oswald IP, 2005, FOOD ADDIT CONTAM A, V22, P354, DOI 10.1080/02652030500058320; Parkes AS, 1926, BR J EXP BIOL, V4, P93; PATI AK, 1987, CELL IMMUNOL, V108, P227, DOI 10.1016/0008-8749(87)90207-3; Paul MJ, 2008, PHILOS T R SOC B, V363, P341, DOI 10.1098/rstb.2007.2143; PAYNE CM, 1986, DIAGN MICR INFEC DIS, V5, P39, DOI 10.1016/0732-8893(86)90090-8; Paynter S, 2015, J INFECTION, V70, P1, DOI 10.1016/j.jinf.2014.09.006; Pelikan J., 1981, Symposia of the Zoological Society of London, P205; PENNYCUIK PR, 1972, AUST J BIOL SCI, V25, P627; PLANELLES D, 1994, CELL PROLIFERAT, V27, P333, DOI 10.1111/j.1365-2184.1994.tb01430.x; Plytycz Barbara, 1997, Archivum Immunologiae et Therapiae Experimentalis, V45, P157; Poltavskiy Eduard, 2016, Online J Public Health Inform, V8, pe186; POPE GS, 1954, DAIRY SCI ABSTR, V16, P334; Prasad M, 2010, PUBLIC HEALTH NUTR, V13, P939, DOI 10.1017/S1368980010001138; Rafii F, 2015, METABOLITES, V5, P56, DOI 10.3390/metabo5010056; Reddersen K, 2002, CHEMOSPHERE, V49, P539, DOI 10.1016/S0045-6535(02)00387-9; Robinson AP, 2014, HAND CLINIC, V122, P173, DOI 10.1016/B978-0-444-52001-2.00008-X; ROENNEBERG T, 1990, J BIOL RHYTHM, V5, P195, DOI 10.1177/074873049000500303; Roenneberg T, 2004, J BIOL RHYTHM, V19, P193, DOI 10.1177/0748730404264863; Salib E, 2006, BRIT J PSYCHIAT, V188, P416, DOI 10.1192/bjp.bp.105.009118; Saligrama N, 2014, FASEB J, V28, P1898, DOI 10.1096/fj.13-239939; SCHLAGER G, 1968, J HERED, V59, P363, DOI 10.1093/oxfordjournals.jhered.a107747; Setchell KDR, 2010, J NUTR, V140, p1355S, DOI 10.3945/jn.109.119776; Simmons SB, 2013, TRENDS IMMUNOL, V34, P410, DOI 10.1016/j.it.2013.04.006; Sofi MH, 2014, DIABETES, V63, P632, DOI 10.2337/db13-0981; Spach KM, 2009, J IMMUNOL, V182, P7776, DOI 10.4049/jimmunol.0900142; Stackelberg PE, 2004, SCI TOTAL ENVIRON, V329, P99, DOI 10.1016/j.scitotenv.2004.03.015; Staples J, 2010, BMJ-BRIT MED J, V340, DOI 10.1136/bmj.c1640; Stensballe LG, 2009, J ALLERGY CLIN IMMUN, V123, P398, DOI 10.1016/j.jaci.2008.10.043; Stevenson TJ, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.1453; Teuschert C, 2006, P NATL ACAD SCI USA, V103, P8024, DOI 10.1073/pnas.0600536103; Thigpen JE, 2007, ENVIRON HEALTH PERSP, V115, P1717, DOI 10.1289/ehp.10165; Thigpen JE, 2013, J AM ASSOC LAB ANIM, V52, P130; Thysen AH, 2016, J ALLERGY CLIN IMMUN, V137, P1238, DOI 10.1016/j.jaci.2015.08.041; Torkildsen O, 2012, ACTA NEUROL SCAND, V126, P58, DOI 10.1111/ane.12040; Torkildsen O, 2014, ANN CLIN TRANSL NEUR, V1, P141, DOI 10.1002/acn3.37; Tyagi AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021216; van der Mei IAF, 2016, MULT SCLER J, V22, P461, DOI 10.1177/1352458515594040; Vassallo MF, 2010, ANN ALLERG ASTHMA IM, V104, P307, DOI 10.1016/j.anai.2010.01.019; Visser ME, 2010, PHILOS T R SOC B, V365, P3113, DOI 10.1098/rstb.2010.0111; Watson PE, 2007, EUR J CLIN NUTR, V61, P1271, DOI 10.1038/sj.ejcn.1602644; Wedekind C, 1996, HEREDITY, V77, P400, DOI 10.1038/hdy.1996.160; Willer CJ, 2005, BMJ-BRIT MED J, V330, P120, DOI 10.1136/bmj.38301.686030.63; Wolf KJ, 2014, J HISTOCHEM CYTOCHEM, V62, P237, DOI 10.1369/0022155413519650; WONG CC, 1983, J ENDOCRINOL, V97, P179, DOI 10.1677/joe.0.0970179	136	7	7	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2709	2719		10.1096/fj.201700062	http://dx.doi.org/10.1096/fj.201700062			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28292961	Green Published			2022-12-28	WOS:000401553400040
J	Leveque, M; Simonin-Le Jeune, K; Jouneau, S; Moulis, S; Desrues, B; Belleguic, C; Brinchault, G; Le Trionnaire, S; Gangneux, JP; Dimanche-Boitrel, MT; Martin-Chouly, C				Leveque, Manuella; Simonin-Le Jeune, Karin; Jouneau, Stephane; Moulis, Solenn; Desrues, Benoit; Belleguic, Chantal; Brinchault, Graziella; Le Trionnaire, Sophie; Gangneux, Jean-Pierre; Dimanche-Boitrel, Marie-Therese; Martin-Chouly, Corinne			Soluble CD14 acts as a DAMP in human macrophages: origin and involvement in inflammatory cytokine/chemokine production	FASEB JOURNAL			English	Article						inflammation; cystic fibrosis; NF-kappa B; inflammasome	LPS-BINDING-PROTEIN; NECROSIS-FACTOR-ALPHA; HUMAN MONOCYTES; LIPOPOLYSACCHARIDE RECEPTOR; IMMUNE-RESPONSES; CYSTIC-FIBROSIS; DIFFERENTIATION ANTIGEN; CEREBROSPINAL-FLUID; MEMBRANE CD14; CELL-SURFACE	The innate immune system is able to detect bacterial LPS through the pattern recognition receptor CD14, which delivers LPS to various TLR signaling complexes that subsequently induce intracellular proinflammatory signaling cascades. In a previous study, we showed the overproduction of the soluble form of CD14 (sCD14) by macrophages from patients with cystic fibrosis (CF). CF is an autosomal recessive disorder that is caused by mutations in the gene that encodes the CFTR protein and is characterized by persistent inflammation. Macrophages play a significant role in the initial stages of this disease due to their inability to act as suppressor cells, leading to chronic inflammation in CF. In this work, we investigated the origin of sCD14 by human macrophages and studied the effect of sCD14 on the production of inflammatory cytokine/chemokine. Our data indicate that sCD14 stimulate proinflammatory cytokine/chemokine production in a manner that is independent of LPS but dependent on the TLR-4/CD14 membrane complex, NF-kappa B, and the inflammasome. Therefore, sCD14, overproduced by CF macrophages, originates primarily from the endocytosis/exocytosis process and should be considered to be a danger associated molecular pattern. This elucidation of the origin and inflammation-induced mechanisms associated with sCD14 contributes to our understanding of maintained tissue inflammation.-Lev eque, M., Simonin-Le Jeune, K., Jouneau, S., Moulis, S., Desrues, B., Belleguic, C., Brinchault, G., Le Trionnaire, S., Gangneux, J.-P., DimancheBoitrel, M.-T., Martin-Chouly, C. Soluble CD14 acts as aDAMPin human macrophages: origin and involvement in inflammatory cytokine/chemokine production.	[Leveque, Manuella; Simonin-Le Jeune, Karin; Moulis, Solenn; Le Trionnaire, Sophie; Dimanche-Boitrel, Marie-Therese; Martin-Chouly, Corinne] INSERM, Unite 1085, Res Inst Environm & Occupat Hlth IRSET, Stress Membrane & Signaling Team, Rennes, France; [Jouneau, Stephane] INSERM, Unite 1085, Res Inst Environm & Occupat Hlth IRSET, Chem Contaminant Immun & Inflammat Team, Rennes, France; [Leveque, Manuella; Simonin-Le Jeune, Karin; Jouneau, Stephane; Moulis, Solenn; Desrues, Benoit; Le Trionnaire, Sophie; Gangneux, Jean-Pierre; Dimanche-Boitrel, Marie-Therese; Martin-Chouly, Corinne] Univ Rennes 1, Unit Mixte Serv Biosit 3480, Rennes, France; [Jouneau, Stephane; Desrues, Benoit; Belleguic, Chantal; Brinchault, Graziella; Gangneux, Jean-Pierre] Ctr Hosp Univ Rennes, Ctr Ressource & Competences Mucoviscidose, Rennes, France; [Desrues, Benoit] INSERM, Unite 1242, Ctr Eugene Marquis, Chem Oncogenesis Stress & Signaling, Rennes, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Rennes; CHU Rennes; Universite de Rennes; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Eugene Marquis	Martin-Chouly, C (corresponding author), 2 Ave Pr Leon Bernard, F-35043 Rennes, France.	corinne.chouly@univ-rennes1.fr	Dimanche-Boitrel, Marie-Therese M/I-4642-2015; Jouneau, Stephane/K-9956-2015; MARTIN-CHOULY, Corinne AE/K-4288-2015; Gangneux, Jean-Pierre/J-2960-2015	Gangneux, Jean-Pierre/0000-0002-4974-5607; MARTIN-CHOULY, corinne/0000-0001-7493-0612; Dimanche-Boitrel, Marie-Therese/0000-0002-8038-7780; Leveque, Manuella/0000-0001-6642-0372	Cystic Fibrosis French Foundation "Vaincre La Mucoviscidose" [RF20130500807]	Cystic Fibrosis French Foundation "Vaincre La Mucoviscidose"	This work was supported by Grant RF20130500807 from the Cystic Fibrosis French Foundation "Vaincre La Mucoviscidose." The authors thank secretary Laurence Hiard and the nurses Marie-Therese Jousseaume and Isabelle Berhault at the Centre de Ressources et de Competences pour la Mucoviscidose (Rennes University Hospital).	Arai Y, 2015, J INFECT CHEMOTHER, V21, P564, DOI 10.1016/j.jiac.2015.04.011; BAZIL V, 1989, MOL IMMUNOL, V26, P657, DOI 10.1016/0161-5890(89)90048-5; BAZIL V, 1986, EUR J IMMUNOL, V16, P1583, DOI 10.1002/eji.1830161218; BAZIL V, 1991, J IMMUNOL, V147, P1567; BUFLER P, 1995, EUR J IMMUNOL, V25, P604, DOI 10.1002/eji.1830250244; Cifani N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071717; Coyne CP, 2002, J ENDOTOXIN RES, V8, P273, DOI 10.1179/096805102125000489; Del Porto P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019970; DENTENER MA, 1993, J IMMUNOL, V150, P2885; Dessing MC, 2007, AM J RESP CRIT CARE, V175, P604, DOI 10.1164/rccm.200606-824OC; Douglas TA, 2009, EUR RESPIR J, V33, P305, DOI 10.1183/09031936.00043108; DURIEUX JJ, 1994, EUR J IMMUNOL, V24, P2006, DOI 10.1002/eji.1830240911; Egerer K, 2000, LUPUS, V9, P614, DOI 10.1191/096120300678828749; Eickmeier O, 2010, CYTOKINE, V50, P152, DOI 10.1016/j.cyto.2010.02.004; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Frey T, 2007, MOL MED, V13, P592, DOI 10.2119/2007-00054.Frey; GEGNER JA, 1995, J BIOL CHEM, V270, P5320, DOI 10.1074/jbc.270.10.5320; HAZIOT A, 1988, J IMMUNOL, V141, P547; HAZIOT A, 1994, J IMMUNOL, V152, P5868; Ikonen E, 2001, CURR OPIN CELL BIOL, V13, P470, DOI 10.1016/S0955-0674(00)00238-6; Jersmann HPA, 2005, IMMUNOL CELL BIOL, V83, P462, DOI 10.1111/j.1440-1711.2005.01370.x; Kirkland TN, 1998, PROG CLIN BIOL RES, V397, P79; LABETA MO, 1993, EUR J IMMUNOL, V23, P2144, DOI 10.1002/eji.1830230915; Le-Barillec K, 1999, J CLIN INVEST, V103, P1039, DOI 10.1172/JCI5779; Lin B, 2000, J INFECT DIS, V181, P1185, DOI 10.1086/315357; Marcos V, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-32; MARTIN TR, 1994, CHEST, V105, pS55, DOI 10.1378/chest.105.3.55S; Martin-Chouly CAE, 2004, LIFE SCI, V75, P823, DOI 10.1016/j.lfs.2004.01.021; MILLER SG, 1992, J CELL BIOL, V118, P267, DOI 10.1083/jcb.118.2.267; Miwako I, 2001, J CELL SCI, V114, P1765; Nichols BJ, 2001, J CELL BIOL, V153, P529, DOI 10.1083/jcb.153.3.529; Nockher WA, 1999, J NEUROIMMUNOL, V101, P161, DOI 10.1016/S0165-5728(99)00141-1; Opal SM, 1999, J INFECT DIS, V180, P1584, DOI 10.1086/315093; Pierce JW, 1997, J BIOL CHEM, V272, P21096, DOI 10.1074/jbc.272.34.21096; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Ratner D, 2012, AM J RESP CELL MOL, V46, P715, DOI 10.1165/rcmb.2011-0399RT; Salomao R, 2012, SHOCK, V38, P227, DOI 10.1097/SHK.0b013e318262c4b0; Schiff DE, 1997, J LEUKOCYTE BIOL, V62, P786, DOI 10.1002/jlb.62.6.786; Schmitz G, 2002, CURR OPIN LIPIDOL, V13, P513, DOI 10.1097/00041433-200210000-00007; SCHUETT C, 1991, Allergie und Immunologie (Leipzig), V37, P159; Schutt C, 1999, INT J BIOCHEM CELL B, V31, P545, DOI 10.1016/S1357-2725(98)00153-8; SIMMONS DL, 1989, BLOOD, V73, P284; Simonin-Le Jeune K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075667; Stelter F, 1996, EUR J BIOCHEM, V236, P457, DOI 10.1111/j.1432-1033.1996.00457.x; Tang A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037689; Tapping RI, 2000, CHEM IMMUNOL, V74, P108; Thieblemont N, 1999, J EXP MED, V190, P523, DOI 10.1084/jem.190.4.523; Vaincre la Mucoviscidose, 2019, BILAN DONNEES; van Grevenynghe J, 2003, J IMMUNOL, V170, P2374, DOI 10.4049/jimmunol.170.5.2374; WRIGHT SD, 1995, J IMMUNOL, V155, P6; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Yu B, 1997, J CLIN INVEST, V99, P315, DOI 10.1172/JCI119160; Yu HB, 2008, CELL HOST MICROBE, V4, P198, DOI 10.1016/j.chom.2008.08.007	53	29	31	1	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1891	1902		10.1096/fj.201600772R	http://dx.doi.org/10.1096/fj.201600772R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28122919	Green Submitted			2022-12-28	WOS:000399195500012
J	Wang, YF; Li, JP; Huang, YT; Dai, XQ; Liu, YB; Liu, ZJ; Wang, Y; Wang, NP; Zhang, P				Wang, Yinfang; Li, Jinping; Huang, Yitong; Dai, Xiuqin; Liu, Youbin; Liu, Zongjun; Wang, Ying; Wang, Nanping; Zhang, Peng			Tripartite motif-containing 28 bridges endothelial inflammation and angiogenic activity by retaining expression of TNFR-1 and-2 and VEGFR2 in endothelial cells	FASEB JOURNAL			English	Article						NF-kappa B; KMT5B; TRIM28	NF-KAPPA-B; E3 UBIQUITIN LIGASE; NEGATIVE REGULATOR; ANTIVIRAL RESPONSE; RIG-I; TRIM28; ALPHA; PROTEIN; TRANSCRIPTION; SUMOYLATION	Angiogenesis and inflammation are regarded as important factors in the pathogenesis of chronic inflammation, cancer, and wound healing. Recent studies have supported prior evidence that common signaling pathways are involved in angiogenesis and inflammatory responses; however, key factors controlling both processes remain unclear. Although tripartite motif-containing (TRIM)-28 is known to have an immunosuppressive role in immune cells, its expression level and role in endothelial cells (ECs) are still unclear. In this study, we investigated the role of TRIM28 in inflammatory responses and angiogenic activity of ECs for the first time. Weshowed that TRIM28 is the most abundant TRIM family member and is localized in nuclei of ECs. Small interfering RNA-mediated knockdown of TRIM28 strikingly suppressed expression of TNF receptor (TNFR)-1 and -2, decreased TNF-alpha-induced phosphorylation of IKK alpha/beta and IkBa and degradation of IkB alpha and nuclear translocation of p65, and suppressed basal level and TNF-alpha-induced expression of chemokines and adhesion molecules, including VCAM-1, IL-6, ICAM-1, E-selectin, and monocyte chemoattractant protein (MCP)-1. Unexpectedly, IL-8 was potentiated by TRIM28 knockdown in ECs in an NF-kappa B-inducing kinase-dependent manner. Meanwhile, knockdown of TRIM28 inhibited expression of VEGF receptor 2 and suppressed VEGF-induced proliferation and tube formation by ECs. Finally, knockdown of TRIM28 suppressed recruitment of ECs in vivo in a murine synthetic basement membrane model. In summary, we found that TRIM28 acts as a central factor in controlling endothelial inflammatory responses and angiogenic activities by retaining expression of TNFR-1 and -2 and VEGF receptor 2 in ECs.-Wang, Y., Li, J., Huang Y., Dai, X., Liu, Y., Liu, Z., Wang, Y., Wang, N., Zhang, P. Tripartite motif-containing 28 bridges endothelial inflammation and angiogenic activity by retaining expression of TNFR1 and -2 and VEGFR2 in endothelial cells.	[Wang, Yinfang; Li, Jinping; Huang, Yitong; Dai, Xiuqin; Zhang, Peng] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Cent Lab, 164 Lanxi Rd, Shanghai 200062, Peoples R China; [Liu, Youbin; Liu, Zongjun; Zhang, Peng] Shanghai Univ Tradit Chinese Med, Putuo Hosp, Dept Cardiovasc Med, Shanghai, Peoples R China; [Wang, Ying] Mayo Clin, Dept Biochem & Mol Biol, Jacksonville, FL 32224 USA; [Wang, Nanping] Dalian Med Univ, Adv Inst Med Sci, Dalian, Peoples R China	Shanghai University of Traditional Chinese Medicine; Shanghai University of Traditional Chinese Medicine; Mayo Clinic; Dalian Medical University	Zhang, P (corresponding author), Shanghai Univ Tradit Chinese Med, Putuo Hosp, Cent Lab, 164 Lanxi Rd, Shanghai 200062, Peoples R China.	zhangnep@hotmail.com		Wang, Ying/0000-0002-7852-386X; Wang, Nanping/0000-0002-8528-8132	National Natural Science Foundation of China [81570398, 81502142, 31430045]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Natural Science Foundation of China (Grants 81570398, 81502142, and 31430045). The authors declare no conflicts of interest.	Addison JB, 2015, CANCER RES, V75, P344, DOI 10.1158/0008-5472.CAN-14-1561; Alexander KA, 2015, CELL REP, V13, P1194, DOI 10.1016/j.celrep.2015.09.078; Bentz GL, 2015, J VIROL, V89, P7465, DOI 10.1128/JVI.00711-15; Bhattacharyya S, 2010, J BIOL CHEM, V285, P39511, DOI 10.1074/jbc.M110.159681; Bieler G, 2007, ONCOGENE, V26, P5722, DOI 10.1038/sj.onc.1210354; Bunch H, 2014, NAT STRUCT MOL BIOL, V21, P876, DOI 10.1038/nsmb.2878; Chen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101040; Chikuma S, 2012, NAT IMMUNOL, V13, P596, DOI 10.1038/ni.2293; Choi UY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099267; Coltrini D, 2013, ANGIOGENESIS, V16, P469, DOI 10.1007/s10456-012-9324-7; Costa Carla, 2007, Angiogenesis, V10, P149, DOI 10.1007/s10456-007-9074-0; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Sio FRS, 2012, FASEB J, V26, P4561, DOI 10.1096/fj.12-206177; de Sio FRS, 2012, BLOOD, V119, P4675, DOI 10.1182/blood-2011-12-401117; Eames HL, 2012, IMMUNOBIOLOGY, V217, P1315, DOI 10.1016/j.imbio.2012.07.026; Fiedler U, 2006, NAT MED, V12, P235, DOI 10.1038/nm1351; Gao BC, 2002, AM J PHYSIOL-CELL PH, V283, pC1196, DOI 10.1152/ajpcell.00064.2002; Gjyshi O, 2015, J VIROL, V89, P7874, DOI 10.1128/JVI.00895-15; Herzog M, 2011, DEV BIOL, V350, P548, DOI 10.1016/j.ydbio.2010.12.014; Hu MM, 2015, J IMMUNOL, V195, P4415, DOI 10.4049/jimmunol.1500859; Imhof BA, 2006, NAT MED, V12, P171, DOI 10.1038/nm0206-171; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Kamitani S, 2011, J IMMUNOL, V187, P2476, DOI 10.4049/jimmunol.1003243; Kimura T, 2015, J CELL BIOL, V210, P973, DOI 10.1083/jcb.201503023; Kondo T, 2012, BIOCHEM BIOPH RES CO, V422, P501, DOI 10.1016/j.bbrc.2012.05.028; Li Q, 2011, P NATL ACAD SCI USA, V108, P19341, DOI 10.1073/pnas.1110946108; Liang QM, 2011, J IMMUNOL, V187, P4754, DOI 10.4049/jimmunol.1101704; Luo QQ, 2015, INT J CLIN ONCOL, V20, P508, DOI 10.1007/s10147-014-0752-9; Luo Y, 2010, ARTERIOSCL THROM VAS, V30, P1307, DOI 10.1161/ATVBAHA.110.204222; Mapp PI, 2012, NAT REV RHEUMATOL, V8, P390, DOI 10.1038/nrrheum.2012.80; Mcnab FW, 2011, CURR OPIN IMMUNOL, V23, P46, DOI 10.1016/j.coi.2010.10.021; McNamara RP, 2016, MOL CELL, V61, P39, DOI 10.1016/j.molcel.2015.11.004; Messerschmidt DM, 2012, SCIENCE, V335, P1499, DOI 10.1126/science.1216154; Miles DC, 2017, STEM CELLS, V35, P147, DOI 10.1002/stem.2453; Narayan K, 2014, J VIROL, V88, P10748, DOI 10.1128/JVI.02593-13; Neo SH, 2015, MOL CELL BIOL, V35, P2851, DOI 10.1128/MCB.01064-14; Noguchi K, 2011, CARCINOGENESIS, V32, P995, DOI 10.1093/carcin/bgr068; Noort AR, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0527-3; Noort AR, 2014, J PATHOL, V234, P375, DOI 10.1002/path.4403; Qiu Hui, 2013, Virologica Sinica, V28, P209, DOI 10.1007/s12250-013-3343-4; Razani B, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000778; Sainson RCA, 2008, BLOOD, V111, P4997, DOI 10.1182/blood-2007-08-108597; Santos J, 2014, IMMUNOL LETT, V162, P281, DOI 10.1016/j.imlet.2014.08.011; Shi MD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5820; Shibata M, 2012, BIOCHEM BIOPH RES CO, V423, P104, DOI 10.1016/j.bbrc.2012.05.090; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Tanji K, 2010, NEUROBIOL DIS, V38, P210, DOI 10.1016/j.nbd.2010.01.007; Tsuruma R, 2008, ONCOGENE, V27, P3054, DOI 10.1038/sj.onc.1210952; Turelli P, 2014, GENOME RES, V24, P1260, DOI 10.1101/gr.172833.114; Wei CL, 2016, SCI REP-UK, V6, DOI 10.1038/srep29822; Yan J, 2014, J MOL CELL BIOL, V6, P154, DOI 10.1093/jmcb/mju005; Yoshimi R, 2009, J IMMUNOL, V182, P7527, DOI 10.4049/jimmunol.0804121; Yu SS, 2011, BIOCHEM BIOPH RES CO, V410, P247, DOI 10.1016/j.bbrc.2011.05.124; Zhang HF, 2008, J CLIN INVEST, V118, P3904, DOI 10.1172/JCI36168; Zhang LM, 2014, J VIROL, V88, P6873, DOI 10.1128/JVI.00283-14; Zhang R, 2003, J BIOL CHEM, V278, P51267, DOI 10.1074/jbc.M310678200; Zhao W, 2012, J IMMUNOL, V188, P5311, DOI 10.4049/jimmunol.1103506; Zhao W, 2012, J IMMUNOL, V188, P2567, DOI 10.4049/jimmunol.1103255; Zhou XF, 2012, P NATL ACAD SCI USA, V109, P20083, DOI 10.1073/pnas.1214704109	59	23	23	0	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					2026	2036		10.1096/fj.201600988RR	http://dx.doi.org/10.1096/fj.201600988RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28159803				2022-12-28	WOS:000399195500023
J	Okuno, T; Koutsogiannaki, S; Ohba, M; Chamberlain, M; Bu, WM; Lin, FY; Eckenhoff, RG; Yokomizo, T; Yuki, K				Okuno, Toshiaki; Koutsogiannaki, Sophia; Ohba, Mai; Chamberlain, Matthew; Bu, Weiming; Lin, Fu-Yan; Eckenhoff, Roderic G.; Yokomizo, Takehiko; Yuki, Koichi			Intravenous anesthetic propofol binds to 5-lipoxygenase and attenuates leukotriene B-4 production	FASEB JOURNAL			English	Article						anesthesia; lipid mediator; inhibitor	NEUTROPHIL RESPIRATORY BURST; SUPPRESSES PROSTAGLANDIN E-2; MURINE DENDRITIC CELLS; ARACHIDONIC-ACID; INHIBITORS; CHEMOTAXIS; ISOFLURANE; QUANTITATION; INFUSION; RECEPTOR	Propofol is an intravenous anesthetic that produces its anesthetic effect, largely via the GABA(A) receptor in the CNS, and also reduces the N-formyl-methionyl-leucyl-phenylalanine (fMLP)-induced neutrophil respiratory burst. Because fMLP-stimulated neutrophils produce leukotriene (LT)B-4, we examined the effect of propofol on LTB4 production in vivo and in vitro Cecal ligation and puncture surgery was performed in mice, with or without exposure to propofol. Propofol attenuated the production of 5-lipoxygenase (5-LOX)-related arachidonic acid (AA) derivatives in the peritoneal fluid. Also, in the in vitro experiments on fMLP-stimulated neutrophils and 5-LOX-transfected human embryonic kidney cells, propofol attenuated the production of 5-LOX-related AA derivatives. Based on these results, we hypothesized that propofol would directly affect 5-LOX function. Using meta-azi-propofol (AziPm), we photolabeled stable 5-LOX protein, which had been used to solve the X-ray crystallographic structure of 5-LOX, and examined the binding site(s) of propofol on 5-LOX. Two propofol binding pockets were identified near the active site of 5-LOX. Alanine scanning mutagenesis was performed for the residues of 5-LOX in the vicinity of propofol, and we evaluated the functional role of these pockets in LTB4 production. We demonstrated that these pockets were functionally important for 5-LOX activity. These two pockets can be used to explore a novel 5-LOX inhibitor in the future.-Okuno, T., Koutsogiannaki, S., Ohba, M., Chamberlain, M., Bu, W., Lin, F.-Y., Eckenhoff, R. G., Yokomizo T., Yuki, K. Intravenous anesthetic propofol binds to 5-lipoxygenase and attenuates leukotriene B-4 production.	[Okuno, Toshiaki; Ohba, Mai; Yokomizo, Takehiko] Juntendo Univ, Dept Biochem, Sch Med, Tokyo, Japan; [Koutsogiannaki, Sophia; Chamberlain, Matthew; Yuki, Koichi] Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, Div Cardiac Anesthesia, Boston, MA USA; [Lin, Fu-Yan] Boston Childrens Hosp, Immune Dis Inst, Boston, MA USA; [Koutsogiannaki, Sophia; Yuki, Koichi] Harvard Med Sch, Dept Anesthesia, Boston, MA USA; [Bu, Weiming; Eckenhoff, Roderic G.] Univ Penn, Dept Anesthesiol & Crit Care, Perelman Sch Med, Philadelphia, PA 19104 USA	Juntendo University; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Harvard Medical School; University of Pennsylvania; Pennsylvania Medicine	Yuki, K (corresponding author), Boston Childrens Hosp, Dept Anesthesiol Perioperat & Pain Med, 300 Longwood Ave, Boston, MA 02115 USA.	koichi.yuki@childrens.harvard.edu	Yokomizo, Takehiko/P-5673-2016	Yokomizo, Takehiko/0000-0002-5219-1553; Eckenhoff, Roderic/0000-0002-5581-746X; Koutsogiannaki, Sophia/0000-0003-3555-1681	U.S. National Institutes of Health, Institute of General Medical Sciences [GM101345, GM118277, P01GM055876]; Children's Hospital Medical Center (CHMC) Anesthesia Foundation; Foundation of Strategic Research Projects in Private Universities - Ministry of Education, Culture, Sports, Science and Technology (MEXT) [S1311011]; MEXT/Japan Society for the Promotion of Science (JSPS) [15H05901, 15H05904, 15H04708, 16K08596, 15KK0320]; Takeda Science Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118277, P01GM055876, K08GM101345] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [15H05897] Funding Source: KAKEN	U.S. National Institutes of Health, Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Children's Hospital Medical Center (CHMC) Anesthesia Foundation; Foundation of Strategic Research Projects in Private Universities - Ministry of Education, Culture, Sports, Science and Technology (MEXT); MEXT/Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Takeda Science Foundation(Takeda Science Foundation (TSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported, in part, by U.S. National Institutes of Health, Institute of General Medical Sciences Grants GM101345 and GM118277 (to K.Y.) and P01GM055876 (to R.G.E); Children's Hospital Medical Center (CHMC) Anesthesia Foundation (to K.Y.); Grant-in-Aid S1311011 from the Foundation of Strategic Research Projects in Private Universities from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (to T.Y.); MEXT/Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) 15H05901, 15H05904, and 15H04708 (to T.Y.) and 16K08596 and 15KK0320) (to T.O.); and the Takeda Science Foundation (to T.Y. and T.O.). The authors declare no conflicts of interest.	Afonso PV, 2012, DEV CELL, V22, P1079, DOI 10.1016/j.devcel.2012.02.003; ALBANESE J, 1990, ANESTHESIOLOGY, V73, P214, DOI 10.1097/00000542-199008000-00004; Carbo C, 2013, J ANESTH, V27, P261, DOI 10.1007/s00540-012-1508-1; CARTER GW, 1991, J PHARMACOL EXP THER, V256, P929; Choi J, 2008, PROTEINS, V70, P1023, DOI 10.1002/prot.21590; Feng Y, 2011, ANESTHESIOLOGY, V115, P555, DOI 10.1097/ALN.0b013e31822a22f7; Frohlich D, 1996, EUR J ANAESTH, V13, P582, DOI 10.1046/j.1365-2346.1996.d01-405.x; GEPTS E, 1987, ANESTH ANALG, V66, P1256; Gerstmeier J, 2016, FASEB J, V30, P1892, DOI 10.1096/fj.201500210R; Gilbert NC, 2011, SCIENCE, V331, P217, DOI 10.1126/science.1197203; Hall MA, 2010, J MED CHEM, V53, P5667, DOI 10.1021/jm1004072; Heine J, 2000, BRIT J ANAESTH, V85, P424, DOI 10.1093/bja/85.3.424; Inada T, 2015, J IMMUNOTOXICOL, V12, P261, DOI 10.3109/1547691X.2014.938874; Inada T, 2013, J IMMUNOTOXICOL, V10, P262, DOI 10.3109/1547691X.2012.712066; Inada T, 2011, J IMMUNOTOXICOL, V8, P359, DOI 10.3109/1547691X.2011.620036; Jurd R, 2002, FASEB J, V16, P250, DOI 10.1096/fj.02-0611fje; Kita Y, 2005, ANAL BIOCHEM, V342, P134, DOI 10.1016/j.ab.2005.03.048; Landa P, 2013, NAT PROD COMMUN, V8, P105; Matsunobu T, 2013, J LIPID RES, V54, P2979, DOI 10.1194/jlr.M037754; MCMILLAN RM, 1992, TRENDS PHARMACOL SCI, V13, P323, DOI 10.1016/0165-6147(92)90100-K; Mitra S, 2015, BIOCHEMISTRY-US, V54, P6333, DOI 10.1021/acs.biochem.5b00930; Murphy PG, 1996, EUR J ANAESTH, V13, P471, DOI 10.1046/j.1365-2346.1996.00003.x; Oh SF, 2011, J CLIN INVEST, V121, P569, DOI 10.1172/JCI42545; OHISHI N, 1990, J BIOL CHEM, V265, P7520; Okuno T, 2005, J BIOL CHEM, V280, P32049, DOI 10.1074/jbc.R500007200; PERKINS RS, 1995, BIOCHEM J, V310, P795, DOI 10.1042/bj3100795; Radmark O, 2015, BBA-MOL CELL BIOL L, V1851, P331, DOI 10.1016/j.bbalip.2014.08.012; Rittirsch D, 2009, NAT PROTOC, V4, P31, DOI 10.1038/nprot.2008.214; SERHAN CN, 1995, AM J RESP CELL MOL, V12, P251, DOI 10.1165/ajrcmb.12.3.7873189; SHORT TG, 1994, BRIT J ANAESTH, V72, P302, DOI 10.1093/bja/72.3.302; Steinhilber D, 2014, BASIC CLIN PHARMACOL, V114, P70, DOI 10.1111/bcpt.12114; Werz O, 2005, BIOCHEM PHARMACOL, V70, P327, DOI 10.1016/j.bcp.2005.04.018; Wu YR, 2012, J MED CHEM, V55, P2597, DOI 10.1021/jm201497k; Yokomizo T, 2001, ARCH BIOCHEM BIOPHYS, V385, P231, DOI 10.1006/abbi.2000.2168; Yokomizo T, 1997, NATURE, V387, P620, DOI 10.1038/42506; Yuki K, 2016, ANESTH ANALG, V123, P326, DOI 10.1213/ANE.0000000000001403; Yuki K, 2013, ANESTH ANALG, V117, P803, DOI 10.1213/ANE.0b013e3182a00ae0	38	10	10	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	APR	2017	31	4					1584	1594		10.1096/fj.201601095R	http://dx.doi.org/10.1096/fj.201601095R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ER0UR	28069825	Green Published			2022-12-28	WOS:000398504300025
J	Ahmad, A; Mitrofanova, A; Bielawski, J; Yang, YD; Marples, B; Fornoni, A; Zeidan, YH				Ahmad, Anis; Mitrofanova, Alla; Bielawski, Jacek; Yang, Yidong; Marples, Brian; Fornoni, Alessia; Zeidan, Youssef H.			Sphingomyelinase-like phosphodiesterase 3b mediates radiation-induced damage of renal podocytes	FASEB JOURNAL			English	Article						lipids; cancer; ceramide; radioprotection	ACID CERAMIDASE; RESISTANCE; SPHINGOLIPIDS; NEPHROPATHY; RITUXIMAB; PREVENTS; NEPHRIN; PATHWAY	The molecular mechanisms responsible for the development of proteinuria and glomerulosclerosis in radiation nephropathy remain largely unknown. Podocytes are increasingly recognized as key players in the pathogenesis of proteinuria in primary and secondary glomerular disorders. The lipid-modulating enzyme sphingomyelin phosphodiesterase acid-like 3B (SMPDL3b) is a key determinant of podocyte injury and a known off target of the anti-CD20 antibody rituximab (RTX). The current study investigates the role of sphingolipids in radiation-induced podocytopathy. After a single dose of radiation (8 Gy), several ceramide species were significantly elevated. In particular, C16:00, C24:00, and C24:1 ceramides were the most abundant ceramide species detected. These changes were paralleled by a time-dependent drop in SMPDL3b protein, sphingosine, and sphingosine-1-phosphate levels. Interestingly, SMPDL3b-overexpressing podocytes had higher basal levels of sphingosine-1-phosphate and maintained basal ceramide levels after irradiation. Morphologically, irradiated podocytes demonstrated loss of filopodia and remodeling of cortical actin. Furthermore, the actin binding protein ezrin relocated from the plasma membrane to the cytosol as early as 2 h after radiation. In contrast, SMPDL3b overexpressing podocytes were protected from radiation-induced cytoskeletal remodeling. Treatment with RTX before radiation exposure partially protected podocytes from SMPDL3b loss, cytoskeletal remodeling, and caspase 3 cleavage. Our results demonstrate that radiation injury induces early cytoskeletal remodeling, down-regulation of SMPDL3b, and elevation of cellular ceramide levels. Overexpression of SMPDL3b and pretreatment with RTX confer a radioprotective effect in cultured podocytes. These findings indicate a potential role for SMPDL3b and RTX in radiation-induced podocytopathy.	[Ahmad, Anis; Yang, Yidong; Marples, Brian; Zeidan, Youssef H.] Univ Miami, Miller Sch Med, Sylvester Canc Ctr, Dept Radiat Oncol, Miami, FL 33136 USA; [Mitrofanova, Alla; Fornoni, Alessia] Univ Miami, Peggy & Harold Katz Family Drug Discovery Ctr, Miami, FL 33136 USA; [Mitrofanova, Alla] Univ Miami, Dept Surg, Miami, FL 33136 USA; [Fornoni, Alessia] Univ Miami, Div Nephrol, Miami, FL 33136 USA; [Mitrofanova, Alla; Fornoni, Alessia] Univ Miami, Dept Med, Miami, FL 33136 USA; [Bielawski, Jacek] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Zeidan, Youssef H.] Amer Univ Beirut, Dept Radiat Oncol, Beirut, Lebanon	University of Miami; University of Miami; University of Miami; University of Miami; University of Miami; Medical University of South Carolina; American University of Beirut	Zeidan, YH (corresponding author), Amer Univ Beirut, Med Ctr, Dept Radiat Oncol, POB 11-0236, Beirut 11072020, Lebanon.	yz09@aub.edu.lb	Mitrofanova, Alla/L-1590-2019; Zeidan, Youssef H./H-7578-2019; Ahmad, Anis/AAA-7263-2019	Mitrofanova, Alla/0000-0001-5065-9522; Zeidan, Youssef H./0000-0002-1951-8585; Ahmad, Anis/0000-0001-9820-2126; fornoni, Alessia/0000-0002-1313-7773	U.S. National Institutes of Health [DK104753, DK090316]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000460] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK090316, R01DK104753] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	A.F. is an inventor of pending patents aimed to diagnose or treat proteinuric renal diseases, and stands to gain royalties from their future commercialization. A.F. is also a consultant for Hoffman-La Roche, Genentech, Jannsen, Mesoblast, Abbvie, Boehringer Ingelheim, Alexion, and Bristol- Myers Squibb. A.F. is funded by U.S. National Institutes of Health Grants DK104753 and DK090316.	Aureli M, 2014, GLYCOCONJUGATE J, V31, P449, DOI 10.1007/s10719-014-9541-y; Basic-Jukic N, 2013, CURR PHARM DESIGN, V19, P6046; Bielawski J, 2006, METHODS, V39, P82, DOI 10.1016/j.ymeth.2006.05.004; CASSADY JR, 1995, INT J RADIAT ONCOL, V31, P1249, DOI 10.1016/0360-3016(94)00428-N; Cheng JC, 2008, INT J RADIAT ONCOL, V71, P1436, DOI 10.1016/j.ijrobp.2007.12.009; Cheng JC, 2013, J CLIN INVEST, V123, P4344, DOI 10.1172/JCI64791; Cohen EP, 2003, SEMIN NEPHROL, V23, P486, DOI 10.1016/S0270-9295(03)00093-7; Dawson LA, 2010, INT J RADIAT ONCOL, V76, pS108, DOI 10.1016/j.ijrobp.2009.02.089; Fornoni A, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002231; Gandy KAO, 2013, BIOCHEM J, V449, P661, DOI 10.1042/BJ20120213; Geoffroy K, 2004, J BIOL CHEM, V279, P34343, DOI 10.1074/jbc.M403273200; Heinz LX, 2015, CELL REP, V11, P1919, DOI 10.1016/j.celrep.2015.05.006; Lacour S, 2004, CANCER RES, V64, P3593, DOI 10.1158/0008-5472.CAN-03-2787; Lennon R, 2009, NEPHROL DIAL TRANSPL, V24, P3288, DOI 10.1093/ndt/gfp302; LUXTON RW, 1961, LANCET, V2, P1221; Mahdy AEM, 2009, MOL THER, V17, P430, DOI 10.1038/mt.2008.281; Merscher S, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00127; Oikawa T, 1997, KIDNEY INT, V51, P164, DOI 10.1038/ki.1997.20; Perosa F, 2006, BLOOD, V107, P1070, DOI 10.1182/blood-2005-04-1769; Ruotsalainen V, 1999, P NATL ACAD SCI USA, V96, P7962, DOI 10.1073/pnas.96.14.7962; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sera N, 2013, RADIAT RES, V179, P46, DOI 10.1667/RR2863.1; Sha H, 2016, ONCOTARGET, V7, P18825, DOI 10.18632/oncotarget.7939; STEPHENS LC, 1995, INT J RADIAT ONCOL, V31, P865, DOI 10.1016/0360-3016(94)00437-4; Tasaki M, 2014, J AM SOC NEPHROL, V25, P737, DOI 10.1681/ASN.2013040363; Truman JP, 2010, PLOS ONE, V5, DOI [10.1371/annotation/6e222ad5-b175-4a00-9d04-4d120568a897, 10.1371/journal.pone.0012310]; Uehara N, 2008, MOL CANCER RES, V6, P186, DOI 10.1158/1541-7786.MCR-07-0254; Wu BX, 2007, J LIPID RES, V48, P600, DOI 10.1194/jlr.M600423-JLR200; Yang GY, 2010, INT J RADIAT ONCOL, V78, P539, DOI 10.1016/j.ijrobp.2009.07.1744; Yoo TH, 2015, J AM SOC NEPHROL, V26, P133, DOI 10.1681/ASN.2013111213; Zeidan YH, 2010, CURR MOL MED, V10, P454, DOI 10.2174/156652410791608225; Zeidan YH, 2008, CURR DRUG TARGETS, V9, P653, DOI 10.2174/138945008785132358; Zeidan YH, 2008, J CELL BIOL, V181, P335, DOI 10.1083/jcb.200705060; Zeidan YH, 2007, TRENDS MOL MED, V13, P327, DOI 10.1016/j.molmed.2007.06.002; Zeng J, 2014, LANCET ONCOL, V15, pE426, DOI 10.1016/S1470-2045(14)70026-9	35	29	30	3	10	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					771	780		10.1096/fj.201600618R	http://dx.doi.org/10.1096/fj.201600618R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27836988	Green Published			2022-12-28	WOS:000394235400029
J	Karwad, MA; Macpherson, T; Wang, B; Theophilidou, E; Sarmad, S; Barrett, DA; Larvin, M; Wright, KL; Lund, JN; O'Sullivan, SE				Karwad, Mustafa A.; Macpherson, Tara; Wang, Bo; Theophilidou, Elena; Sarmad, Sarir; Barrett, David A.; Larvin, Michael; Wright, Karen L.; Lund, Jonathan N.; O'Sullivan, Saoirse E.			Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitro via TRPV1 and PPAR alpha	FASEB JOURNAL			English	Article						gut; cannabinoid; nuclear receptor	TIGHT JUNCTION PERMEABILITY; INFLAMMATORY-BOWEL-DISEASE; BARRIER FUNCTION; FOOD-INTAKE; ENDOCANNABINOID SYSTEM; CROHNS-DISEASE; CB1 RECEPTORS; BODY-WEIGHT; C-SRC; MECHANISMS	Cannabinoids modulate intestinal permeability through cannabinoid receptor 1 (CB1). The endocannabinoid-like compounds oleoylethanolamine (OEA) and palmitoylethanolamine (PEA) play an important role in digestive regulation, and we hypothesized they would also modulate intestinal permeability. Transepithelial electrical resistance (TEER) was measured in human Caco-2 cells to assess permeability after application of OEA and PEA and relevant antagonists. Cells treated with OEA and PEA were stained for cytoskeletal F-actin changes and lysed for immunoassay. OEA and PEA were measured by liquid chromatography-tandem mass spectrometry. OEA (applied apically, logEC(50) -5.4) and PEA (basolaterally, logEC(50) -4.9; apically logEC(50) -5.3) increased Caco-2 resistance by 20-30% via transient receptor potential vanilloid (TRPV)-1 and peroxisome proliferator-activated receptor (PPAR)-. Preventing their degradation (by inhibiting fatty acid amide hydrolase) enhanced the effects of OEA and PEA. OEA and PEA induced cytoskeletal changes and activated focal adhesion kinase and ERKs 1/2, and decreased Src kinases and aquaporins 3 and 4. In Caco-2 cells treated with IFN and TNF, OEA (via TRPV1) and PEA (via PPAR) prevented or reversed the cytokine-induced increased permeability compared to vehicle (0.1% ethanol). PEA (basolateral) also reversed increased permeability when added 48 or 72 h after cytokines (P < 0.001, via PPAR). Cellular and secreted levels of OEA and PEA (P < 0.001-0.001) were increased in response to inflammatory mediators. OEA and PEA have endogenous roles and potential therapeutic applications in conditions of intestinal hyperpermeability and inflammation.Karwad, M. A., Macpherson, T., Wang, B., Theophilidou, E., Sarmad, S., Barrett, D. A., Larvin, M., Wright, K. L., Lund, J. N., O'Sullivan, S. E. Oleoylethanolamine and palmitoylethanolamine modulate intestinal permeability in vitrovia TRPV1 and PPAR alpha.	[Karwad, Mustafa A.; Theophilidou, Elena; Lund, Jonathan N.; O'Sullivan, Saoirse E.] Univ Nottingham, Royal Derby Hosp, Sch Med, Nottingham NG7 2RD, England; [Sarmad, Sarir; Barrett, David A.] Univ Nottingham, Ctr Analyt Biosci, Sch Pharm, Nottingham NG7 2RD, England; [Macpherson, Tara; Wang, Bo; Wright, Karen L.] Univ Lancaster, Fac Hlth & Med, Div Biomed & Life Sci, Lancaster LA1 4YW, England; [Larvin, Michael] Univ Limerick, Grad Entry Med Sch, Limerick, Ireland; [Larvin, Michael; O'Sullivan, Saoirse E.] Univ Limerick, Hlth Res Inst, Limerick, Ireland	University of Nottingham; University of Nottingham; Lancaster University; University of Limerick; University of Limerick	O'Sullivan, SE (corresponding author), Univ Nottingham, Royal Derby Hosp, Sch Med, Derby DE22 3DT, England.	saoirse.osullivan@nottingham.ac.uk	Wright, Karen Leslie/C-7959-2011; Larvin, Michael/AAE-4674-2019; Lund, Jonathan/K-6631-2019; Barrett, David/C-9922-2011	Wright, Karen Leslie/0000-0003-0040-9247; Lund, Jonathan/0000-0001-5195-2181; Barrett, David/0000-0001-6900-9474; O'Sullivan, Saoirse Elizabeth/0000-0002-1672-6610				Adami M, 2002, BRIT J PHARMACOL, V135, P1598, DOI 10.1038/sj.bjp.0704625; Ahern GP, 2003, J BIOL CHEM, V278, P30429, DOI 10.1074/jbc.M305051200; Alhamoruni A, 2012, BRIT J PHARMACOL, V165, P2598, DOI 10.1111/j.1476-5381.2011.01589.x; Alhamoruni A, 2010, J PHARMACOL EXP THER, V335, P92, DOI 10.1124/jpet.110.168237; Alhouayek M, 2011, FASEB J, V25, P2711, DOI 10.1096/fj.10-176602; AlSuleimani YM, 2013, EUR J PHARMACOL, V702, P1, DOI 10.1016/j.ejphar.2013.01.006; Astarita G, 2006, AM J PHYSIOL-REG I, V290, pR1407, DOI 10.1152/ajpregu.00664.2005; Basuroy S, 2003, J BIOL CHEM, V278, P11916, DOI 10.1074/jbc.M211710200; Bischoff SC, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-24; Borrelli F, 2015, BRIT J PHARMACOL, V172, P142, DOI 10.1111/bph.12907; Borrelli F, 2009, BEST PRACT RES CL EN, V23, P33, DOI 10.1016/j.beem.2008.10.003; Brandtzaeg P, 2011, EUR J PHARMACOL, V668, pS16, DOI 10.1016/j.ejphar.2011.07.006; Camilleri M, 2012, NEUROGASTROENT MOTIL, V24, P503, DOI 10.1111/j.1365-2982.2012.01921.x; Camilleri M, 2012, AM J PHYSIOL-GASTR L, V303, pG775, DOI 10.1152/ajpgi.00155.2012; Capasso R, 2014, BRIT J PHARMACOL, V171, P4026, DOI 10.1111/bph.12759; de Fonseca FR, 2001, NATURE, V414, P209, DOI 10.1038/35102582; Di Carlo G., 2005, EXPERT OPIN INV DRUG, V12, P39; Di Marzo V, 2006, GUT, V55, P1373, DOI 10.1136/gut.2005.090472; Di Paola R, 2012, J LEUKOCYTE BIOL, V91, P911, DOI 10.1189/jlb.0911485; Dunlop SP, 2006, AM J GASTROENTEROL, V101, P1288, DOI 10.1111/j.1572-0241.2006.00672.x; Esposito G, 2014, GUT, V63, P1300, DOI 10.1136/gutjnl-2013-305005; Fredriksson R, 2003, FEBS LETT, V554, P381, DOI 10.1016/S0014-5793(03)01196-7; Fu J, 2005, NEUROPHARMACOLOGY, V48, P1147, DOI 10.1016/j.neuropharm.2005.02.013; Fu J, 2003, NATURE, V425, P90, DOI 10.1038/nature01921; Fu J, 2007, J BIOL CHEM, V282, P1518, DOI 10.1074/jbc.M607809200; Groschwitz KR, 2009, J ALLERGY CLIN IMMUN, V124, P3, DOI 10.1016/j.jaci.2009.05.038; Guzman M, 2004, J BIOL CHEM, V279, P27849, DOI 10.1074/jbc.M404087200; Hansen JJ, 2009, INFLAMM BOWEL DIS, V15, P890, DOI 10.1002/ibd.20850; Heitzmann D, 2008, PHYSIOL REV, V88, P1119, DOI 10.1152/physrev.00020.2007; Helander HF, 2014, SCAND J GASTROENTERO, V49, P681, DOI 10.3109/00365521.2014.898326; Hering NA, 2012, J PHYSIOL-LONDON, V590, P1035, DOI 10.1113/jphysiol.2011.224568; Heyman M, 2012, GUT, V61, P1355, DOI 10.1136/gutjnl-2011-300327; HOLLANDER D, 1986, ANN INTERN MED, V105, P883, DOI 10.7326/0003-4819-105-6-883; Izzo AA, 2001, BRIT J PHARMACOL, V134, P563, DOI 10.1038/sj.bjp.0704293; Izzo AA, 2010, OBESITY, V18, P55, DOI 10.1038/oby.2009.186; Kitchen P, 2015, BIOCH BIOPHYSICA, V12, P2410; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Lo Verme J, 2005, CELL MOL LIFE SCI, V62, P708, DOI 10.1007/s00018-004-4494-0; Ma TH, 1997, J CLIN INVEST, V100, P957, DOI 10.1172/JCI231; Ma TY, 2004, AM J PHYSIOL-GASTR L, V286, pG367, DOI 10.1152/ajpgi.00173.2003; Ma YJ, 2013, BBA-MOL BASIS DIS, V1832, P151, DOI 10.1016/j.bbadis.2012.10.006; Maccarrone M, 2003, CELL DEATH DIFFER, V10, P946, DOI 10.1038/sj.cdd.4401284; Mankertz J, 2007, CURR OPIN GASTROEN, V23, P379, DOI 10.1097/MOG.0b013e32816aa392; Massa F, 2006, J MOL MED, V84, P142, DOI 10.1007/s00109-005-0016-2; MAY GR, 1993, GASTROENTEROLOGY, V104, P1627, DOI 10.1016/0016-5085(93)90638-S; MECHOULAM R, 1995, BIOCHEM PHARMACOL, V50, P83, DOI 10.1016/0006-2952(95)00109-D; Mechoulam R., 1986, CANNABINOIDS THERAPE; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; O'Sullivan SE, 2007, BRIT J PHARMACOL, V152, P576, DOI 10.1038/sj.bjp.0707423; Odenwald MA, 2013, CLIN GASTROENTEROL H, V11, P1075, DOI 10.1016/j.cgh.2013.07.001; Pasantes-Morales H, 2016, MOL PHARMACOL, V90, P358, DOI 10.1124/mol.116.104158; Pertwee RG, 1997, PHARMACOL THERAPEUT, V74, P129, DOI 10.1016/S0163-7258(97)82001-3; Piomelli D, 1998, NEUROBIOL DIS, V5, P462, DOI 10.1006/nbdi.1998.0221; Piomelli D, 2013, TRENDS ENDOCRIN MET, V24, P332, DOI 10.1016/j.tem.2013.03.001; Rao JN, 2002, AM J PHYSIOL-CELL PH, V282, pC885, DOI 10.1152/ajpcell.00361.2001; Ricanek P, 2015, CLIN EXP GASTROENTER, V8, P49, DOI 10.2147/CEG.S70119; Richardson D, 2007, ANAL BIOCHEM, V360, P216, DOI 10.1016/j.ab.2006.10.039; Ryberg E, 2007, BRIT J PHARMACOL, V152, P1092, DOI 10.1038/sj.bjp.0707460; Samak G, 2014, AM J PHYSIOL-GASTR L, V306, pG947, DOI 10.1152/ajpgi.00396.2013; Sartor RB, 2006, NAT CLIN PRACT GASTR, V3, P390, DOI 10.1038/ncpgasthep0528; Schifilliti C, 2014, PAIN RES TREAT, V2014, DOI 10.1155/2014/849623; Turner JR, 2006, AM J PATHOL, V169, P1901, DOI 10.2353/ajpath.2006.060681; Turner JR, 2009, NAT REV IMMUNOL, V9, P799, DOI 10.1038/nri2653; Ulluwishewa D, 2011, J NUTR, V141, P769, DOI 10.3945/jn.110.135657; Van Sickle MD, 2001, GASTROENTEROLOGY, V121, P767, DOI 10.1053/gast.2001.28466; Wang JR, 2014, DIGEST DIS SCI, V59, P2693, DOI 10.1007/s10620-014-3212-5; Wang KS, 2000, AM J PHYSIOL-GASTR L, V279, pG463, DOI 10.1152/ajpgi.2000.279.2.G463; Welcker K, 2004, EUR J MED RES, V9, P456; Wheal AJ, 2010, BRIT J PHARMACOL, V160, P701, DOI 10.1111/j.1476-5381.2010.00770.x; Wyatt J, 1997, AM J GASTROENTEROL, V92, P1891; Zhang WJ, 2011, FEBS LETT, V585, P3113, DOI 10.1016/j.febslet.2011.08.045; Zhou Y, 2012, NEUROPHARMACOLOGY, V63, P242, DOI 10.1016/j.neuropharm.2012.03.008	72	55	55	0	35	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					469	481		10.1096/fj.201500132	http://dx.doi.org/10.1096/fj.201500132			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27623929	Green Accepted			2022-12-28	WOS:000394235400004
J	Alvarado, R; To, J; Lund, ME; Pinar, A; Mansell, A; Robinson, MW; O'Brien, BA; Dalton, JP; Donnelly, S				Alvarado, Raquel; To, Joyce; Lund, Maria E.; Pinar, Anita; Mansell, Ashley; Robinson, Mark W.; O'Brien, Bronwyn A.; Dalton, John P.; Donnelly, Sheila			The immune modulatory peptide FhHDM-1 secreted by the helminth Fasciola hepatica prevents NLRP3 inflammasome activation by inhibiting endolysosomal acidification in macrophages	FASEB JOURNAL			English	Article						trematode; liver fluke; IL-1 beta; lysosome	NALP3 INFLAMMASOME; LYSOSOMAL DAMAGE; RAT HEPATOCYTES; MECHANISM; DISEASE; CELLS; CYTOKINES; RESPONSES; CRYSTALS; VACCINE	The NLRP3 inflammasome is a multimeric protein complex that controls the production of IL-1 beta, a cytokine that influences the development of both innate and adaptive immune responses. Helminth parasites secrete molecules that interact with innate immune cells, modulating their activity to ultimately determine the phenotype of differentiated T cells, thus creating an immune environment that is conducive to sustaining chronic infection. We show that one of these molecules, FhHDM-1, a cathelicidin-like peptide secreted by the helminth parasite, Fasciola hepatica, inhibits the activation of the NLRP3 inflammasome resulting in reduced secretion of IL-1 beta by macrophages. FhHDM-1 had no effect on the synthesis of pro-IL-1 beta. Rather, the inhibitory effect was associatedwith the capacity of the peptide to prevent acidification of the endolysosome. The activation of cathepsin B protease by lysosomal destabilization was prevented in FhHDM-1-treated macrophages. By contrast, peptide derivatives of FhHDM-1 that did not alter the lysosomal pH did not inhibit secretion of IL-1 beta. Wepropose a novel immunemodulatory strategy usedby F. hepatica, whereby secretion of the FhHDM-1 peptide impairs the activation of NLRP3 by lysosomal cathepsin B protease, which prevents the downstream production of IL-1 beta and the development of protective T helper 1 type immune responses that are detrimental to parasite survival.-Alvarado, R., To, J., Lund, M. E., Pinar, A., Mansell, A., Robinson, M. W., O'Brien, B. A., Dalton, J. P., Donnelly, S. The immune modulatory peptide FhHDM-1 secreted by the helminth Fasciola hepatica prevents NLRP3 inflammasome activation by inhibiting endolysosomal acidification in macrophages.	[Alvarado, Raquel; To, Joyce; Lund, Maria E.; O'Brien, Bronwyn A.; Donnelly, Sheila] Univ Technol Sydney, Sch Life Sci, Sydney, NSW, Australia; [Pinar, Anita; Mansell, Ashley] Monash Univ, Monash Inst Med Res, Clayton, Vic, Australia; [Robinson, Mark W.; Dalton, John P.] Queens Univ, Sch Biol Sci, Belfast, Antrim, North Ireland	University of Technology Sydney; Monash University; Queens University Belfast	Donnelly, S (corresponding author), Univ Technol Sydney, Fac Sci, Sch Life Sci, POB 123, Broadway, NSW 2007, Australia.	sheila.donnelly@uts.edu.au	Mansell, Ashley/B-9553-2008; Alvarado, Raquel/J-5073-2019	Mansell, Ashley/0000-0002-6540-1281; Alvarado, Raquel/0000-0001-7250-2200; Lund, Maria/0000-0001-7360-5041; Robinson, Mark/0000-0001-7191-0034; Pinar, Anita/0000-0001-7779-4986; Donnelly, Sheila/0000-0003-2005-3698; To, Joyce/0000-0003-3482-4369	Diabetes Australia Research Trust (DART) project grant; National Health and Medical Research Council (NHMRC) [1087341]; European Research Council Advanced Grant HELIVAC [322725]; Biotechnology and Biological Sciences Research Council (BBSRC) [BB/L019612/1]; Horizon; Biotechnology and Biological Sciences Research Council [BB/L019612/1] Funding Source: researchfish; BBSRC [BB/L019612/1] Funding Source: UKRI	Diabetes Australia Research Trust (DART) project grant; National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); European Research Council Advanced Grant HELIVAC; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Horizon; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	The authors thank Dr. Suat Dervish (Centenary Institute, Sydney, NSW, Australia) for technical support with flow cytometry analysis and the technical staff at the UTS i3 Microbial Imaging Facility for advice and provision of instrumentation. This work was funded in part by a Diabetes Australia Research Trust (DART) project grant; in part by National Health and Medical Research Council (NHMRC) Project Grant 1087341; European Research Council Advanced Grant HELIVAC, 322725 (to J.P.D.); and Biotechnology and Biological Sciences Research Council (BBSRC) Grant BB/L019612/1. J.P.D. is a member of the Horizon 2020-funded Consortium Paragone. The authors declare no conflicts of interest.	Alvarado R, 2015, IMMUNOBIOLOGY, V220, P262, DOI 10.1016/j.imbio.2014.11.008; Andrews SJ, 1999, FASCIOLOSIS, P1; Baska P, 2013, ACTA PARASITOL, V58, P215, DOI 10.2478/s11686-013-0126-x; Bauernfeind F, 2011, CELL MOL LIFE SCI, V68, P765, DOI 10.1007/s00018-010-0567-4; Berbudi A, 2016, DIABETES-METAB RES, V32, P238, DOI 10.1002/dmrr.2673; Chen Z, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11596; Ciraci C, 2012, MICROBES INFECT, V14, P1263, DOI 10.1016/j.micinf.2012.07.007; Cliffe LJ, 2005, SCIENCE, V308, P1463, DOI 10.1126/science.1108661; Correale J, 2011, J NEUROIMMUNOL, V233, P6, DOI 10.1016/j.jneuroim.2011.01.002; De Nardo D, 2011, TRENDS IMMUNOL, V32, P373, DOI 10.1016/j.it.2011.05.004; Dolman N. J., 2013, CURR PROTOC CYTOM; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gaide O, 2008, EXPERT REV CLIN IMMU, V4, P61, DOI 10.1586/1744666X.4.1.61; Gavet O, 2010, DEV CELL, V18, P533, DOI 10.1016/j.devcel.2010.02.013; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; Heid ME, 2013, J IMMUNOL, V191, P5230, DOI 10.4049/jimmunol.1301490; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2010, EUR J IMMUNOL, V40, P620, DOI 10.1002/eji.200940185; Leemans JC, 2011, IMMUNOL REV, V243, P152, DOI 10.1111/j.1600-065X.2011.01043.x; Man SM, 2015, IMMUNOL REV, V265, P6, DOI 10.1111/imr.12296; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Mathis D, 2001, NATURE, V414, P792, DOI 10.1038/414792a; Molina-Hernandez V, 2015, VET PARASITOL, V208, P101, DOI 10.1016/j.vetpar.2015.01.004; Montaser M, 2002, BIOL CHEM, V383, P1305, DOI 10.1515/BC.2002.147; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Murakami T, 2012, P NATL ACAD SCI USA, V109, P11282, DOI 10.1073/pnas.1117765109; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Robinson MW, 2012, FASEB J, V26, P4614, DOI 10.1096/fj.12-213876; Robinson MW, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002042; Rojas-Caraballo J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134910; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Schmitz ML, 2011, BBA-MOL CELL RES, V1813, P2165, DOI 10.1016/j.bbamcr.2011.06.019; Schorn C, 2011, J BIOL CHEM, V286, P35, DOI 10.1074/jbc.M110.139048; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Shaw PJ, 2011, TRENDS MOL MED, V17, P57, DOI 10.1016/j.molmed.2010.11.001; Siemieniuk E, 2008, TOXICOL MECH METHOD, V18, P519, DOI 10.1080/15376510701624001; Thibodeau MS, 2004, TOXICOL SCI, V80, P34, DOI 10.1093/toxsci/kfh121; THILO L, 1995, J CELL SCI, V108, P1791; VanNoorden CJF, 1997, ANAL BIOCHEM, V252, P71, DOI 10.1006/abio.1997.2312; Wen HT, 2012, NAT IMMUNOL, V13, P352, DOI 10.1038/ni.2228; Wesolowska A, 2012, PARASITOL RES, V110, P395, DOI 10.1007/s00436-011-2504-3; Wiria AE, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004140; Wolfs IMJ, 2014, FASEB J, V28, P288, DOI 10.1096/fj.13-235911; Wree A, 2014, HEPATOLOGY, V59, P898, DOI 10.1002/hep.26592; Zaiss MM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003531; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	53	41	41	1	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					85	+		10.1096/fj.201500093R	http://dx.doi.org/10.1096/fj.201500093R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27682204				2022-12-28	WOS:000392177600011
J	Shi, N; Zhang, J; Chen, SY				Shi, Ning; Zhang, Jing; Chen, Shi-You			Runx2, a novel regulator for goblet cell differentiation and asthma development	FASEB JOURNAL			English	Article						mucus overproduction; airway epithelial remodeling; transcriptional activation; SPDEF	MUCIN GENE-EXPRESSION; TRANSCRIPTION FACTORS; AIRWAY EPITHELIUM; CANCER CELLS; HYPERPLASIA; METAPLASIA; INFLAMMATION; MUCUS; ABNORMALITIES	Airway goblet cell differentiation and related mucus overproduction are critical processes in the development of respiratory diseases, including asthma. The underlying mechanisms, however, are not fully understood. We identified Runt-related transcription factor 2 (Runx2) as a novel regulator for goblet cell differentiation. Runx2 was up-regulated by 6.4-fold during IL-13-induced goblet cell differentiation of human bronchial epithelial cells. Knockdown of Runx2 attenuated the IL-13-induced differentiation/mucus production by 67%. Mechanistically, Runx2 bound to the promoter of SAM-pointed domain-containing Ets-like factor (SPDEF), a known factor for goblet cell differentiation, resulting in an activation of SPDEF transcription. In vivo, Runx2 was induced by 6.2-fold in pulmonary epithelium of house dust mite-challenged mice. Blockade of Runx2 inhibited the house dust mite-induced goblet cell differentiation with a 75% reduction in mucus overproduction while improving airway responsiveness to methacholine by 41%. More importantly, a 12.3-fold increase in Runx2 expression was observed in human asthma lung epithelium, underlying the potential clinical importance of these findings.-Shi, N., Zhang, J., Chen, S.-Y. Runx2, a novel regulator for goblet cell differentiation and asthma development.	[Shi, Ning; Zhang, Jing; Chen, Shi-You] Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA; [Zhang, Jing] Hubei Univ Med, Taihe Hosp, Dept Resp Med, Shiyan, Hubei, Peoples R China	University System of Georgia; University of Georgia; Hubei University of Medicine	Chen, SY (corresponding author), Univ Georgia, Dept Physiol & Pharmacol, 501 DW Brooks Dr, Athens, GA 30602 USA.	sc229@uga.edu			U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL123302, HL119053]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL123302, R01HL119053] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in part, by grants from the U.S. National Institutes of Health, National Heart, Lung, and Blood Institute (HL123302 and HL119053).	Atherton HC, 2003, AM J PHYSIOL-LUNG C, V285, pL730, DOI 10.1152/ajplung.00089.2003; Chen G, 2009, J CLIN INVEST, V119, P2914, DOI 10.1172/JCI39731; Coffman JA, 2003, CELL BIOL INT, V27, P315, DOI 10.1016/S1065-6995(03)00018-0; Curran DR, 2010, AM J RESP CELL MOL, V42, P268, DOI 10.1165/rcmb.2009-0151TR; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Fahy JV, 2002, CHEST, V122, p320S, DOI 10.1378/chest.122.6_suppl.320S; Haley KJ, 2011, AM J PHYSIOL-LUNG C, V301, pL693, DOI 10.1152/ajplung.00348.2010; Ito Y, 2015, NAT REV CANCER, V15, P81, DOI 10.1038/nrc3877; Kanoh S, 2011, CLIN EXP ALLERGY, V41, P1747, DOI 10.1111/j.1365-2222.2011.03852.x; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Laoukili J, 2001, J CLIN INVEST, V108, P1817, DOI 10.1172/JCI13557; Lim M, 2010, LAB INVEST, V90, P222, DOI 10.1038/labinvest.2009.128; Long AJ, 2006, AM J RESP CELL MOL, V35, P357, DOI 10.1165/rcmb.2005-0451OC; Ordonez CL, 2001, AM J RESP CRIT CARE, V163, P517, DOI 10.1164/ajrccm.163.2.2004039; Pain M, 2014, EUR RESPIR REV, V23, P118, DOI 10.1183/09059180.00004413; Park KS, 2007, J CLIN INVEST, V117, P978, DOI 10.1172/JCI29176; Rajavelu P, 2015, J CLIN INVEST, V125, P2021, DOI 10.1172/JCI79422; Ren XM, 2013, MOL CELL BIOL, V33, P371, DOI 10.1128/MCB.00934-12; Rogers DF, 2002, CLIN EXP ALLERGY, V32, P1124, DOI 10.1046/j.1365-2745.2002.01474.x; Rogers DF, 2001, RESP PHYSIOL, V125, P129, DOI 10.1016/S0034-5687(00)00209-7; Rose MC, 2000, J AEROSOL MED, V13, P245, DOI 10.1089/jam.2000.13.245; Tandon M, 2012, MOL CANCER, V11, DOI 10.1186/1476-4598-11-27; Tesfaigzi Y, 2008, CURR MOL MED, V8, P408, DOI 10.2174/156652408785160961; Thavagnanam S, 2011, PEDIATR RES, V69, P95, DOI 10.1203/PDR.0b013e318204edb5; Tsao PN, 2011, DEVELOPMENT, V138, P3533, DOI 10.1242/dev.063727; Wang Y, 2004, AM J PHYSIOL-LUNG C, V286, pL1188, DOI 10.1152/ajplung.00288.2003	27	15	16	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					412	420		10.1096/fj.201600954R	http://dx.doi.org/10.1096/fj.201600954R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27825108	Green Published			2022-12-28	WOS:000392177600038
J	Garcia-Barros, M; Coant, N; Kawamori, T; Wada, M; Snider, AJ; Truman, JP; Wu, BX; Furuya, H; Clarke, CJ; Bialkowska, AB; Ghaleb, A; Yang, VW; Obeid, LM; Hannun, YA				Garcia-Barros, Monica; Coant, Nicolas; Kawamori, Toshihiko; Wada, Masayuki; Snider, Ashley J.; Truman, Jean-Philip; Wu, Bill X.; Furuya, Hideki; Clarke, Christopher J.; Bialkowska, Agnieszka B.; Ghaleb, Amr; Yang, Vincent W.; Obeid, Lina M.; Hannun, Yusuf A.			Role of neutral ceramidase in colon cancer	FASEB JOURNAL			English	Article						sphingolipids ceramide; aberrant crypt foci; azoxymethane; apoptosis	RENAL MESANGIAL CELLS; NECROSIS-FACTOR-ALPHA; SPHINGOSINE KINASE 1; BETA-CATENIN; COLORECTAL-CANCER; IN-VIVO; INTESTINAL TUMORIGENESIS; TUMOR-GROWTH; CRYPT FOCI; CF1 MICE	Alterations in sphingolipid metabolism, especially ceramide and sphingosine 1-phosphate, have been linked to colon cancer, suggesting that enzymes of sphingolipid metabolism may emerge as novel regulators and targets in colon cancer. Neutral ceramidase (nCDase), a key enzyme in sphingolipid metabolism that hydrolyzes ceramide into sphingosine, is highly expressed in the intestine; however, its role in colon cancer has not been defined. Here we show that molecular and pharmacological inhibition of nCDase in colon cancer cells increases ceramide, and this is accompanied by decreased cell survival and increased apoptosis and autophagy, with minimal effects on noncancerous cells. Inhibition of nCDase resulted in loss of beta-catenin and inhibition of ERK, components of pathways relevant for colon cancer development. Furthermore, inhibition of nCDase in a xenograft model delayed tumor growth and increased ceramide while decreasing proliferation. It is noteworthy that mice lacking nCDase treated with azoxymethane were protected from tumor formation. Taken together, these studies show that nCDase is pivotal for regulating initiation and development of colon cancer, and these data suggest that this enzyme is a suitable and novel target for colon cancer therapy.	[Garcia-Barros, Monica; Coant, Nicolas; Wada, Masayuki; Snider, Ashley J.; Truman, Jean-Philip; Clarke, Christopher J.; Bialkowska, Agnieszka B.; Ghaleb, Amr; Yang, Vincent W.; Obeid, Lina M.; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Biochem, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Garcia-Barros, Monica; Coant, Nicolas; Wada, Masayuki; Snider, Ashley J.; Truman, Jean-Philip; Clarke, Christopher J.; Obeid, Lina M.; Hannun, Yusuf A.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Kawamori, Toshihiko; Furuya, Hideki] Univ Hawaii, Ctr Canc, Canc Biol Program, Honolulu, HI 96822 USA; [Kawamori, Toshihiko] Tokyo Leon Clin, Res Inst Canc Prevent & Pathol Diag, Nagoya, Aichi, Japan; [Snider, Ashley J.; Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northport, NY USA; [Wu, Bill X.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Cancer Research Center of Hawaii; University of Hawaii System; Medical University of South Carolina	Hannun, YA (corresponding author), Dept Biochem, 101 Nicolls Rd,T15,023, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), Dept Pharmacol, 101 Nicolls Rd,T15,023, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), Dept Pathol, 101 Nicolls Rd,T15,023, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), Dept Med, 101 Nicolls Rd,T15,023, Stony Brook, NY 11794 USA.	yusuf.hannun@stonybrookmedicine.edu	Furuya, Hideki/AAH-5719-2021	Furuya, Hideki/0000-0002-9536-8662; COANT, Nicolas/0000-0001-9237-2132	U.S. National Institutes of Health, National Cancer Institute [R01-CA172517, P01-CA97132, R01-CA172113]; ONO Co.; NATIONAL CANCER INSTITUTE [P01CA097132, R01CA172113, R01CA172517] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ONO Co.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U.S. National Institutes of Health, National Cancer Institute Grants R01-CA172517 (to Y.A.H.), P01-CA97132 (to L.M.O.), and R01-CA172113 (to V.W.Y.). The authors thank the Lipidomics Core facility at the State University of New York at Stony Brook for lipid analysis, the Lipidomic Facility at the Medical University of South Carolina for providing the nCDase inhibitor, the Flow Cytometry Core facility for assistance with cell cycle analysis, the Research Core Histology Laboratory at Stony Brook University for technical assistance, and Dr. Takuji Tanaka (certified pathologist and toxicologist; Gifu Municipal Hospital, Gifu, Japan) for assistance with AOM-induced tumors diagnosis. The laboratory of Dr. Y.A.H. has research support from ONO Co., for a distinct project.	Arnold CN, 2005, CANCER-AM CANCER SOC, V104, P2035, DOI 10.1002/cncr.21462; Begagne E, 2014, J CLIN INVEST, V124, P5368, DOI 10.1172/JCI74188; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; BLAY J, 1985, BIOCHEM J, V225, P85, DOI 10.1042/bj2250085; Brabletz T, 2000, AM J PATHOL, V156, P865, DOI 10.1016/S0002-9440(10)64955-3; Castro ME, 2008, CARCINOGENESIS, V29, P491, DOI 10.1093/carcin/bgm246; Chen Y, 2015, MOL CANCER THER, V14, P259, DOI 10.1158/1535-7163.MCT-14-0468-T; Dahm F, 2008, BRIT J CANCER, V98, P98, DOI 10.1038/sj.bjc.6604099; DILLEHAY DL, 1994, J NUTR, V124, P615, DOI 10.1093/jn/124.5.615; El Alwani M, 2006, PHARMACOL THERAPEUT, V112, P171, DOI 10.1016/j.pharmthera.2006.04.004; El Bawab S, 1999, J BIOL CHEM, V274, P27948, DOI 10.1074/jbc.274.39.27948; Franzen R, 2002, J BIOL CHEM, V277, P46184, DOI 10.1074/jbc.M204034200; Franzen R, 2001, J BIOL CHEM, V276, P35382, DOI 10.1074/jbc.M102153200; Gandy KAO, 2013, BIOCHEM J, V449, P661, DOI 10.1042/BJ20120213; Garcia-Barros M, 2014, BBA-MOL CELL BIOL L, V1841, P773, DOI 10.1016/j.bbalip.2013.09.007; Garzotto M, 1998, CANCER RES, V58, P2260; Green DW, 2001, J SURG RES, V101, P16, DOI 10.1006/jsre.2001.6241; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hernandez-Corbacho MJ, 2015, J BIOL CHEM, V290, P25356, DOI 10.1074/jbc.M115.658658; Hertervig E, 1997, CANCER, V79, P448, DOI 10.1002/(SICI)1097-0142(19970201)79:3<448::AID-CNCR4>3.0.CO;2-E; Huwiler A, 1999, J BIOL CHEM, V274, P7190, DOI 10.1074/jbc.274.11.7190; Ito M, 2014, BBA-MOL CELL BIOL L, V1841, P682, DOI 10.1016/j.bbalip.2013.09.008; Johnson RL, 2013, CANCER METAST REV, V32, P39, DOI 10.1007/s10555-012-9404-6; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; KIM JH, 1986, CANCER RES, V46, P1120; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; Kraveka JM, 2003, ARCH BIOCHEM BIOPHYS, V419, P110, DOI 10.1016/j.abb.2003.08.034; Krutovskikh V A, 1994, IARC Sci Publ, P195; Kung CP, 2011, CRIT REV EUKAR GENE, V21, P71, DOI 10.1615/CritRevEukarGeneExpr.v21.i1.50; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Marchesini N, 2007, BBA-MOL CELL BIOL L, V1771, P1418, DOI 10.1016/j.bbalip.2007.10.003; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86; Novgorodov SA, 2011, J BIOL CHEM, V286, P25352, DOI 10.1074/jbc.M110.214866; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Oskouian B, 2007, CELL CYCLE, V6, P522, DOI 10.4161/cc.6.5.3903; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Pretlow TP, 2005, BBA-REV CANCER, V1756, P83, DOI 10.1016/j.bbcan.2005.06.002; Roh H, 2001, CANCER RES, V61, P6563; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; Schmelz EM, 1996, CANCER RES, V56, P4936; Schmelz EM, 2001, CANCER RES, V61, P6723; Selzner M, 2001, CANCER RES, V61, P1233; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Symolon H, 2011, MOL CANCER THER, V10, P648, DOI 10.1158/1535-7163.MCT-10-0754; Tai CJ, 2012, POL J PATHOL, V63, P93; Tan SSL, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2013.21; Tanaka K, 2012, J BIOCHEM, V151, P611, DOI 10.1093/jb/mvs033; Uchida Y, 2010, J INVEST DERMATOL, V130, P2472, DOI 10.1038/jid.2010.153; Usta J, 2001, BIOCHEMISTRY-US, V40, P9657, DOI 10.1021/bi010535k; Venable ME, 2009, CELL BIOCHEM FUNCT, V27, P547, DOI 10.1002/cbf.1605; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Verma UN, 2003, CLIN CANCER RES, V9, P1291; Voelkel-Johnson C, 2005, MOL CANCER THER, V4, P1320, DOI 10.1158/1535-7163.MCT-05-0086; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wargovich Michael J, 2010, Cancers (Basel), V2, P1705, DOI 10.3390/cancers2031705; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Wu BX, 2009, BBA-MOL CELL BIOL L, V1791, P730, DOI 10.1016/j.bbalip.2009.03.012	64	36	38	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4159	4171		10.1096/fj.201600611R	http://dx.doi.org/10.1096/fj.201600611R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27609772	Green Published			2022-12-28	WOS:000388201500022
J	Chen, X; Bode, AM; Dong, ZG; Cao, Y				Chen, Xue; Bode, Ann M.; Dong, Zigang; Cao, Ya			The epithelial-mesenchymal transition (EMT) is regulated by oncoviruses in cancer (vol 30, pg 3001, 2016)	FASEB JOURNAL			English	Correction									[Chen, Xue; Cao, Ya] Cent S Univ, Xiangya Hosp, Key Lab Carcinogenesis & Invas, Chinese Minist Educ, Changsha 410078, Hunan, Peoples R China; [Chen, Xue; Cao, Ya] Cent S Univ, Canc Res Inst, Xiangya Sch Med, Changsha, Hunan, Peoples R China; [Chen, Xue; Cao, Ya] Chinese Minist Hlth, Key Lab Carcinogenesis, Changsha, Hunan, Peoples R China; [Chen, Xue] Hunan Canc Hosp, Changsha, Hunan, Peoples R China; [Bode, Ann M.; Dong, Zigang] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA	Central South University; Central South University; University of Minnesota System	Cao, Y (corresponding author), Cent S Univ, Xiangya Hosp, Key Lab Carcinogenesis & Invas, Chinese Minist Educ, Changsha 410078, Hunan, Peoples R China.	ycao98@vip.sina.com						Chen X, 2016, FASEB J, V30, P3001, DOI 10.1096/fj.201600388R	1	5	5	0	8	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3901	3901		10.1096/fj.201600388RERR	http://dx.doi.org/10.1096/fj.201600388RERR			1	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27803213				2022-12-28	WOS:000386474700024
J	Hand, LE; Hopwood, TW; Dickson, SH; Walker, AL; Loudon, ASI; Ray, DW; Bechtold, DA; Gibbs, JE				Hand, Laura E.; Hopwood, Thomas W.; Dickson, Suzanna H.; Walker, Amy L.; Loudon, Andrew S. I.; Ray, David W.; Bechtold, David A.; Gibbs, Julie E.			The circadian clock regulates inflammatory arthritis	FASEB JOURNAL			English	Article						rheumatoid arthritis; fibroblast-like synoviocyte; diurnal; cryptochrome	COLLAGEN-INDUCED ARTHRITIS; TUMOR-NECROSIS-FACTOR; REV-ERB-ALPHA; RHEUMATOID-ARTHRITIS; GENE-EXPRESSION; CONSTANT LIGHT; PROINFLAMMATORY CYTOKINES; INSULIN-RESISTANCE; INNATE IMMUNITY; CRYPTOCHROME	There is strong diurnal variation in the symptoms and severity of chronic inflammatory diseases, such as rheumatoid arthritis. In addition, disruption of the circadian clock is an aggravating factor associated with a range of human inflammatory diseases. To investigate mechanistic links between the biological clock and pathways underlying inflammatory arthritis, mice were administered collagen (or saline as a control) to induce arthritis. The treatment provoked an inflammatory response within the limbs, which showed robust daily variation in paw swelling and inflammatory cytokine expression. Inflammatory markers were significantly repressed during the dark phase. Further work demonstrated an active molecular clock within the inflamed limbs and highlighted the resident inflammatory cells, fibroblast-like synoviocytes (FLSs), as a potential source of the rhythmic inflammatory signal. Exposure of mice to constant light disrupted the clock in peripheral tissues, causing loss of the nighttime repression of local inflammation. Finally, the results show that the core clock proteins cryptochrome (CRY) 1 and 2 repressed inflammation within the FLSs, and provide novel evidence that a CRY activator has anti-inflammatory properties in human cells. We conclude that under chronic inflammatory conditions, the clock actively represses inflammatory pathways during the dark phase. This interaction has exciting potential as a therapeutic avenue for treatment of inflammatory disease.Hand, L. E., Hopwood, T. W., Dickson, S. H., Walker, A. L., Loudon, A. S. I., Ray, D. W., Bechtold, D. A., Gibbs, J. E. The circadian clock regulates inflammatory arthritis.	Univ Manchester, Fac Biol Med & Hlth, Manchester, Lancs, England; Manchester Acad Hlth Sci Ctr, Manchester, Lancs, England	University of Manchester; University of Manchester	Gibbs, JE (corresponding author), Univ Manchester, AV Hill Bldg,Oxford Rd, Manchester M13 9PT, Lancs, England.	julie.gibbs@manchester.ac.uk		Gibbs, Julie/0000-0002-4248-2947; Ray, David/0000-0002-4739-6773; Bechtold, David/0000-0001-8676-8704; Hopwood, Thomas/0000-0002-7856-5023; Loudon, Andrew/0000-0003-3648-445X; Dickson, Suzanna/0000-0003-4975-2572	joint University of Manchester Promoting Interface Networking (PIN) award; Arthritis Research UK Fellowship; Medical Research Council New Investigator Research Grant; University of Manchester Stepping Stones Fellowship; Society for Endocrinology Early Career Grant; BBSRC [BB/L000954/1, BB/I018654/1, BB/J017744/1] Funding Source: UKRI; MRC [MR/M008908/1, MR/L018640/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/J017744/1, BB/L000954/1, BB/I018654/1, 1497765] Funding Source: researchfish; Medical Research Council [MR/L018640/1, 1369788] Funding Source: researchfish; Versus Arthritis [20629] Funding Source: researchfish	joint University of Manchester Promoting Interface Networking (PIN) award; Arthritis Research UK Fellowship(Versus Arthritis); Medical Research Council New Investigator Research Grant(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University of Manchester Stepping Stones Fellowship; Society for Endocrinology Early Career Grant; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Versus Arthritis(Versus Arthritis)	The authors thank Prof. Margaret Harnett and Dr. Miguel Pineda (University of Glasgow, Glasgow, United Kingdom) for guidance with the CIA model; Prof. Hugh Piggins (University of Manchester) for the provision of cry DKO mouse tissue; and Louise Ince and Nicola Begley (University of Manchester) for technical assistance. This study was supported by a joint University of Manchester Promoting Interface Networking (PIN) award (to D.B. and J.G.), an Arthritis Research UK Fellowship, Medical Research Council New Investigator Research Grant, University of Manchester Stepping Stones Fellowship, and Society for Endocrinology Early Career Grant (to J.G.).	Alves-Simoes M, 2016, LAB ANIM-UK, V50, P21, DOI 10.1177/0023677215588052; Ando N, 2015, J INVEST DERMATOL, V135, P3001, DOI 10.1038/jid.2015.316; Arjona A, 2005, J IMMUNOL, V174, P7618, DOI 10.4049/jimmunol.174.12.7618; Armaka M. G. V., 2009, NAT PROTOCOL EXCH; ARVIDSON NG, 1994, ANN RHEUM DIS, V53, P521, DOI 10.1136/ard.53.8.521; Bae K, 2003, J BIOL RHYTHM, V18, P123, DOI 10.1177/0748730403252248; Bartok B, 2010, IMMUNOL REV, V233, P233, DOI 10.1111/j.0105-2896.2009.00859.x; Baumann A, 2013, IMMUNOLOGY, V140, P465, DOI 10.1111/imm.12157; Bellet MM, 2013, P NATL ACAD SCI USA, V110, P9897, DOI 10.1073/pnas.1120636110; Bollinger T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029801; Bonney S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071493; Bottini N, 2013, NAT REV RHEUMATOL, V9, P24, DOI 10.1038/nrrheum.2012.190; Castanon-Cervantes O, 2010, J IMMUNOL, V185, P5796, DOI 10.4049/jimmunol.1001026; Coomans CP, 2013, FASEB J, V27, P1721, DOI 10.1096/fj.12-210898; Crofford LJ, 1997, J CLIN ENDOCR METAB, V82, P1279, DOI 10.1210/jc.82.4.1279; Curtis AM, 2015, P NATL ACAD SCI USA, V112, P7231, DOI 10.1073/pnas.1501327112; DEPRESBRUMMER P, 1995, AM J PHYSIOL-REG I, V268, pR1111, DOI 10.1152/ajpregu.1995.268.5.R1111; Gibbs J, 2014, NAT MED, V20, P919, DOI 10.1038/nm.3599; Gibbs JE, 2013, ARTHRITIS RES THER, V15, DOI 10.1186/ar4146; Gibbs JE, 2012, P NATL ACAD SCI USA, V109, P582, DOI 10.1073/pnas.1106750109; Grant D, 2010, ACS CHEM BIOL, V5, P925, DOI 10.1021/cb100141y; Guo B, 2015, OSTEOARTHR CARTILAGE, V23, P1981, DOI 10.1016/j.joca.2015.02.020; Haas S, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3852; Haimovich B, 2010, CRIT CARE MED, V38, P751, DOI 10.1097/CCM.0b013e3181cd131c; Hamaguchi Y, 2015, J BIOL RHYTHM, V30, P533, DOI 10.1177/0748730415609727; Hashiramoto A, 2010, J IMMUNOL, V184, P1560, DOI 10.4049/jimmunol.0903284; Hastings MH, 2008, J NEUROENDOCRINOL, V20, P812, DOI 10.1111/j.1365-2826.2008.01715.x; Hirota T, 2012, SCIENCE, V337, P1094, DOI 10.1126/science.1223710; Ingpen M L, 1968, Ann Phys Med, V9, P322; Keller M, 2009, P NATL ACAD SCI USA, V106, P21407, DOI 10.1073/pnas.0906361106; Kouri VP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054049; Kumar N, 2010, ENDOCRINOLOGY, V151, P3015, DOI 10.1210/en.2009-0800; Labrecque N, 2015, J BIOL RHYTHM, V30, P277, DOI 10.1177/0748730415577723; Narasimamurthy R, 2012, P NATL ACAD SCI USA, V109, P12662, DOI 10.1073/pnas.1209965109; Nguyen KD, 2013, SCIENCE, V341, P1483, DOI 10.1126/science.1240636; Ohta H, 2005, NAT NEUROSCI, V8, P267, DOI 10.1038/nn1395; Perry MG, 2009, ANN RHEUM DIS, V68, P63, DOI 10.1136/ard.2007.086561; Qin B, 2015, IMMUNOL LETT, V163, P76, DOI 10.1016/j.imlet.2014.11.014; Raatz Y, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3922; Sakhi K, 2014, J PHYSIOL-LONDON, V592, P5025, DOI 10.1113/jphysiol.2014.280065; Shi SQ, 2013, CURR BIOL, V23, P372, DOI 10.1016/j.cub.2013.01.048; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; Solt LA, 2011, NATURE, V472, P491, DOI 10.1038/nature10075; Sugimoto T, 2014, MOL CELL NEUROSCI, V59, P37, DOI 10.1016/j.mcn.2014.01.003; Taberner M, 2005, INFLAMM RES, V54, P10, DOI 10.1007/s00011-004-1315-8; van der Horst GTJ, 1999, NATURE, V398, P627, DOI 10.1038/19323; van Holten J, 2004, ARTHRITIS RES THER, V6, pR239, DOI 10.1186/ar1165; Vermeire K, 1997, J IMMUNOL, V158, P5507; Wang XJ, 2011, BRAIN BEHAV IMMUN, V25, P127, DOI 10.1016/j.bbi.2010.09.007; Williams AS, 2007, ARTHRITIS RHEUM-US, V56, P2244, DOI 10.1002/art.22732; Xu H, 2014, J BIOL CHEM, V289, P16374, DOI 10.1074/jbc.M113.539601; Yang L, 2015, INT IMMUNOPHARMACOL, V28, P525, DOI 10.1016/j.intimp.2015.07.001; Yoo SH, 2004, P NATL ACAD SCI USA, V101, P5339, DOI 10.1073/pnas.0308709101	53	56	59	1	43	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3759	3770		10.1096/fj.201600353R	http://dx.doi.org/10.1096/fj.201600353R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27488122	Green Published, hybrid			2022-12-28	WOS:000386474700011
J	Schweizer, U; Fradejas-Villar, N				Schweizer, Ulrich; Fradejas-Villar, Noelia			Why 21? The significance of selenoproteins for human health revealed by inborn errors of metabolism	FASEB JOURNAL			English	Review						brain development; epilepsy; interneuron; deiodinase; Sedaghatian	MITOCHONDRIAL THIOREDOXIN REDUCTASE; GLUTATHIONE-PEROXIDASE DEFICIENCY; SELENIUM DEFICIENCY; NEUROLOGICAL DYSFUNCTION; CEREBELLAR HYPOPLASIA; TARGETED DISRUPTION; GENE-EXPRESSION; BRAIN SELENIUM; NEURONAL LOSS; SELENOCYSTEINE	Selenocysteine is the 21st proteinogenic amino acid in mammals. The human genome contains 25 genes encoding selenoproteins, and their significance for human health is increasingly recognized through the identification of patients with inborn errors in selenoprotein biosynthetic factors or in individual selenoproteins. Mutations in selenoprotein N (SEPN1) lead to a spectrum of disorders collectively called SEPN1-related myopathy, and mutations in glutathione peroxidase 4 (GPX4) cause respiratory failure and bone defects, and mutations in thioredoxin reductase 2 (TXNRD2) are associated with familial glucocorticoid deficiency. Pathogenic mutations in selenocysteine synthase (SEPSECS) cause neurodevelopmental disorders, but also other factors epistatic to selenoprotein biosynthesis, such as SECIS-binding protein 2 (SECISBP2) and tRNA([Ser]Sec), are known to cause complex disorders. Mutations in the latter 2 genes involve impaired metabolism and action of thyroid hormones, which lead to delayed bone growth and maturation. Mutations in SECISBP2 sometimes affect nervous system development, muscle, inner ear, skin, and immune system function, underlining the significance of selenoproteins for the organism. Mouse models helped to delineate the functions of selenoproteins and explain pathomechanisms. For brevity, this review is focused on human genetic disorders associated with selenoprotein deficiency and only briefly touches on health effects of nutritional selenium deficiency.Schweizer, U., Fradejas-Villar, N. Why 21? The significance of selenoproteins for human health revealed by inborn errors of metabolism.	[Schweizer, Ulrich; Fradejas-Villar, Noelia] Univ Bonn, Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany	University of Bonn	Schweizer, U (corresponding author), Univ Bonn, Inst Biochem & Mol Biol, Nussallee 11, D-53115 Bonn, Germany.	ulrich.schweizer@uni-bonn.de		Schweizer, Ulrich/0000-0003-1380-4780; Fradejas-Villar, Noelia/0000-0003-3418-0743	Deutsche Forschungsgemeinschaft (DFG) [SCHW914/2-2, SCHW914/5-1]; Rheinische Friedrich-Wilhelms-Universitat Bonn	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Rheinische Friedrich-Wilhelms-Universitat Bonn	This work was supported by Deutsche Forschungsgemeinschaft (DFG; SCHW914/2-2 and SCHW914/5-1) and Rheinische Friedrich-Wilhelms-Universitat Bonn. The authors declare no conflicts of interest.	Agamy O, 2010, AM J HUM GENET, V87, P538, DOI 10.1016/j.ajhg.2010.09.007; Alazami AM, 2015, CELL REP, V10, P148, DOI 10.1016/j.celrep.2014.12.015; Allamand V, 2006, EMBO REP, V7, P450, DOI 10.1038/sj.embor.7400648; Angeli JPF, 2014, NAT CELL BIOL, V16, P1180, DOI 10.1038/ncb3064; Anttonen AK, 2015, NEUROLOGY, V85, P306, DOI 10.1212/WNL.0000000000001787; Aygun C, 2012, AM J MED GENET A, V158A, P1400, DOI 10.1002/ajmg.a.35306; Azevedo MF, 2010, J CLIN ENDOCR METAB, V95, P4066, DOI 10.1210/jc.2009-2611; Bassett JHD, 2010, P NATL ACAD SCI USA, V107, P7604, DOI 10.1073/pnas.0911346107; BEHNE D, 1988, BIOCHIM BIOPHYS ACTA, V966, P12, DOI 10.1016/0304-4165(88)90123-7; Ben-Zeev B, 2003, J MED GENET, V40, DOI 10.1136/jmg.40.8.e96; BERMANO G, 1995, BIOCHEM J, V311, P425, DOI 10.1042/bj3110425; BERRY MJ, 1991, NATURE, V353, P273, DOI 10.1038/353273a0; BEUTLER E, 1991, LANCET, V338, P700, DOI 10.1016/0140-6736(91)91280-8; BOCK A, 1991, TRENDS BIOCHEM SCI, V16, P463, DOI 10.1016/0968-0004(91)90180-4; BROWN MR, 1986, AM J CLIN NUTR, V43, P549, DOI 10.1093/ajcn/43.4.549; Budde BS, 2008, NAT GENET, V40, P1113, DOI 10.1038/ng.204; Burk RF, 2007, J NEUROSCI, V27, P6207, DOI 10.1523/JNEUROSCI.1153-07.2007; Burk RF, 2015, ANNU REV NUTR, V35, P109, DOI 10.1146/annurev-nutr-071714-034250; Carlson BA, 2009, MOLECULES, V14, P3509, DOI 10.3390/molecules14093509; Carlson BA, 2009, BIOCHEM J, V418, P61, DOI 10.1042/BJ20081304; Castets P, 2012, J MOL MED, V90, P1095, DOI 10.1007/s00109-012-0896-x; Castex MT, 2016, MOL NEUROBIOL, V53, P5818, DOI 10.1007/s12035-015-9505-7; CHAMBERS I, 1986, EMBO J, V5, P1221, DOI 10.1002/j.1460-2075.1986.tb04350.x; Chen LJ, 2015, J BIOL CHEM, V290, P28097, DOI 10.1074/jbc.M115.680090; Chiu-Ugalde J, 2010, BIOCHEM J, V431, P103, DOI 10.1042/BJ20100779; COLLIPP PJ, 1981, NEW ENGL J MED, V304, P1304, DOI 10.1056/NEJM198105213042120; Conrad M, 2004, MOL CELL BIOL, V24, P9414, DOI 10.1128/MCB.24.21.9414-9423.2004; Copeland PR, 2000, EMBO J, V19, P306, DOI 10.1093/emboj/19.2.306; Di Cosmo C, 2009, J CLIN ENDOCR METAB, V94, P4003, DOI 10.1210/jc.2009-0686; Downey CM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000616; Dumitrescu AM, 2013, BBA-GEN SUBJECTS, V1830, P3987, DOI 10.1016/j.bbagen.2012.08.005; Dumitrescu AM, 2005, NAT GENET, V37, P1247, DOI 10.1038/ng1654; Fagegaltier D, 2000, EMBO J, V19, P4796, DOI 10.1093/emboj/19.17.4796; FLEMING CR, 1982, GASTROENTEROLOGY, V83, P689; Fradejas N, 2013, BIOCHEM J, V450, P427, DOI 10.1042/BJ20121713; Hamajima T, 2012, EUR J ENDOCRINOL, V166, P757, DOI 10.1530/EJE-11-0812; Hao B, 2002, SCIENCE, V296, P1462, DOI 10.1126/science.1069556; Hatfield DL, 2014, TRENDS BIOCHEM SCI, V39, P112, DOI 10.1016/j.tibs.2013.12.007; Hill KE, 2003, J BIOL CHEM, V278, P13640, DOI 10.1074/jbc.M300755200; Hill KE, 2004, J NUTR, V134, P157, DOI 10.1093/jn/134.1.157; Holzerova E, 2016, BRAIN, V139, P346, DOI 10.1093/brain/awv350; Howard MT, 2005, EMBO J, V24, P1596, DOI 10.1038/sj.emboj.7600642; Iwama K, 2016, J HUM GENET, V61, P527, DOI 10.1038/jhg.2016.9; Jurynec MJ, 2008, P NATL ACAD SCI USA, V105, P12485, DOI 10.1073/pnas.0806015105; Kantarci S, 2007, NAT GENET, V39, P957, DOI 10.1038/ng2063; Kasaikina MV, 2013, CARCINOGENESIS, V34, P1089, DOI 10.1093/carcin/bgt011; KIEN CL, 1983, AM J CLIN NUTR, V37, P319, DOI 10.1093/ajcn/37.2.319; Kryukov GV, 2003, SCIENCE, V300, P1439, DOI 10.1126/science.1083516; Kurokawa S, 2014, FREE RADICAL BIO MED, V69, P67, DOI 10.1016/j.freeradbiomed.2014.01.010; Labunskyy VM, 2014, PHYSIOL REV, V94, P739, DOI 10.1152/physrev.00039.2013; Liu J, 2015, ANTIOXID REDOX SIGN, V23, P795, DOI 10.1089/ars.2015.6388; Loscalzo J, 2014, NEW ENGL J MED, V370, P1756, DOI 10.1056/NEJMcibr1402199; Maiti B, 2009, HUM MUTAT, V30, P411, DOI 10.1002/humu.20879; Makrythanasis P, 2014, HUM MUTAT, V35, P1203, DOI 10.1002/humu.22617; Mehta A, 2004, J BIOL CHEM, V279, P37852, DOI 10.1074/jbc.M404639200; Moghadaszadeh B, 2001, NAT GENET, V29, P17, DOI 10.1038/ng713; Mondal S, 2016, ANGEW CHEM INT EDIT, V55, P7606, DOI 10.1002/anie.201601116; Moreno-Reyes R, 1998, NEW ENGL J MED, V339, P1112, DOI 10.1056/NEJM199810153391604; MUTH OH, 1958, SCIENCE, V128, P1090, DOI 10.1126/science.128.3331.1090; Ng L, 2004, P NATL ACAD SCI USA, V101, P3474, DOI 10.1073/pnas.0307402101; Ng L, 2010, J NEUROSCI, V30, P3347, DOI 10.1523/JNEUROSCI.5267-09.2010; Ng L, 2009, ENDOCRINOLOGY, V150, P1952, DOI 10.1210/en.2008-1419; Olson GE, 2008, J BIOL CHEM, V283, P6854, DOI 10.1074/jbc.M709945200; Olson GE, 2007, J BIOL CHEM, V282, P12290, DOI 10.1074/jbc.M611403200; Palioura S, 2009, SCIENCE, V325, P321, DOI 10.1126/science.1173755; Pavlidou E, 2016, EUR J PAEDIATR NEURO, V20, P483, DOI 10.1016/j.ejpn.2015.12.016; Peters MM, 2006, MOL NEURODEGENER, V1, DOI 10.1186/1750-1326-1-12; Pitts MW, 2012, NEUROSCIENCE, V208, P58, DOI 10.1016/j.neuroscience.2012.02.017; Prasad R, 2014, J CLIN ENDOCR METAB, V99, pE1556, DOI 10.1210/jc.2013-3844; RAMAEKERS VT, 1994, NEUROPEDIATRICS, V25, P217, DOI 10.1055/s-2008-1073025; Rederstorff M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023094; Renko K, 2008, BIOCHEM J, V409, P741, DOI 10.1042/BJ20071172; Roth S, 2010, J TRACE ELEM MED BIO, V24, P130, DOI 10.1016/j.jtemb.2010.01.007; Schneider MJ, 2001, MOL ENDOCRINOL, V15, P2137, DOI 10.1210/me.15.12.2137; Schneider MJ, 2006, ENDOCRINOLOGY, V147, P580, DOI 10.1210/en.2005-0739; Schoenmakers E, 2016, J CLIN INVEST, V126, P992, DOI 10.1172/JCI84747; Schoenmakers E, 2010, J CLIN INVEST, V120, P4220, DOI 10.1172/JCI43653; Schomburg L, 2003, BIOCHEM J, V370, P397, DOI 10.1042/BJ20021853; Schweizer U, 2004, BIOCHEM J, V378, P21, DOI 10.1042/BJ20031795; Schweizer U, 2004, BRAIN RES REV, V45, P164, DOI 10.1016/j.brainresrev.2004.03.004; Schweizer U, 2005, BIOCHEM J, V386, P221, DOI 10.1042/BJ20041973; SEDAGHATIAN MR, 1980, AM J MED GENET, V6, P269, DOI 10.1002/ajmg.1320060403; Seeher S, 2014, BIOCHEM J, V462, P67, DOI 10.1042/BJ20140423; Seiler A, 2008, CELL METAB, V8, P237, DOI 10.1016/j.cmet.2008.07.005; Sibbing D, 2011, EUR HEART J, V32, P1121, DOI 10.1093/eurheartj/ehq507; Smith AC, 2014, J MED GENET, V51, P470, DOI 10.1136/jmedgenet-2013-102218; Soerensen J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001813; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Ursini F, 1999, SCIENCE, V285, P1393, DOI 10.1126/science.285.5432.1393; Valentine WM, 2008, J NEUROPATH EXP NEUR, V67, P68, DOI 10.1097/NEN.0b013e318160f347; Valentine WM, 2005, TOXICOL PATHOL, V33, P570, DOI 10.1080/01926230500243045; Wang L, 2006, AM J HUM GENET, V78, P770, DOI 10.1086/503712; WEBER GF, 1991, LANCET, V337, P1443, DOI 10.1016/0140-6736(91)93130-2; Wirth EK, 2014, BIOL TRACE ELEM RES, V158, P203, DOI 10.1007/s12011-014-9920-z; Wirth EK, 2010, FASEB J, V24, P844, DOI 10.1096/fj.09-143974; Xu XM, 2007, PLOS BIOL, V5, P96, DOI 10.1371/journal.pbio.0050004; Yarham JW, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004424; Yoo SE, 2012, FREE RADICAL BIO MED, V52, P1820, DOI 10.1016/j.freeradbiomed.2012.02.043; Yuan J, 2006, P NATL ACAD SCI USA, V103, P18923, DOI 10.1073/pnas.0609703104; Zachara B A, 2001, Med Sci Monit, V7, P1002; Zhang Y, 2008, J BIOL CHEM, V283, P2427, DOI 10.1074/jbc.M707951200; Zhu XL, 2015, GENET MED, V17, P774, DOI 10.1038/gim.2014.191; ZINONI F, 1987, P NATL ACAD SCI USA, V84, P3156, DOI 10.1073/pnas.84.10.3156	103	50	54	2	41	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3669	3681		10.1096/fj.201600424	http://dx.doi.org/10.1096/fj.201600424			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27473727				2022-12-28	WOS:000386474700003
J	Zhang, Y; Li, FY; Song, YL; Sheng, XL; Ren, FZ; Xiong, K; Chen, L; Zhang, HQ; Liu, DQ; Lengner, CJ; Xue, LX; Yu, ZQ				Zhang, Yue; Li, Fengyin; Song, Yongli; Sheng, Xiaole; Ren, Fazheng; Xiong, Kai; Chen, Lei; Zhang, Hongquan; Liu, Dequan; Lengner, Christopher J.; Xue, Lixiang; Yu, Zhengquan			Numb and Numbl act to determine mammary myoepithelial cell fate, maintain epithelial identity, and support lactogenesis	FASEB JOURNAL			English	Article						mammary gland development; EMT; Notch signaling pathway; p53	GLAND DEVELOPMENT; BRANCHING MORPHOGENESIS; MESENCHYMAL TRANSITION; MYELOID-LEUKEMIA; STEM-CELL; NOTCH; P63; DIFFERENTIATION; COMMITMENT; ACTIVATION	Mammary epithelium is comprised of an inner layer of luminal epithelial cells and an outer layer of contractile myoepithelial cells with mesenchymal properties. These two compartments interact throughout mammary morphogenesis to form branching ducts during puberty and terminate in secretory alveoli during lactation. It is not known how the myoepithelial cell lineage is specified, nor how signals in myoepithelial cells contribute to lactogenesis. Here, we show that Numb and Numbl are enriched in mammary myoepithelial cells, with their expression peaking during pregnancy. We use conditional Numb- and Numbl-knockout mouse models to demonstrate that loss of Numb/Numbl compromised the myoepithelial layer and expanded the luminal layer, led epithelial cells to undergo epithelial-to-mesenchymal transition, and resulted in lactation failure as a result of abnormal alveolar formation during pregnancy. Numb and Numbl function via repression of the Notch signaling pathway and of the p53-p21 axis during mammary gland development. These findings highlight the importance of Numb and Numbl in the control of myoepithelial cell fate determination, epithelial identity, and lactogenesis.	[Zhang, Yue; Song, Yongli; Sheng, Xiaole; Ren, Fazheng; Yu, Zhengquan] China Agr Univ, Coll Biol Sci, Beijing Adv Innovat Ctr Food Nutr & Human Hlth, Beijing, Peoples R China; [Zhang, Yue; Li, Fengyin; Song, Yongli; Sheng, Xiaole; Yu, Zhengquan] China Agr Univ, Coll Biol Sci, State Key Labs Agrobiotechnol, Beijing, Peoples R China; [Xiong, Kai; Xue, Lixiang] Peking Univ, Hosp 3, Med Res Ctr, Dept Radiat Oncol, Beijing, Peoples R China; [Chen, Lei] Southwest Univ, Dept Anim Sci, Chongqing, Peoples R China; [Zhang, Hongquan] Peking Univ, Hlth Sci Ctr, Lab Mol Cell Biol & Tumor Biol, Beijing, Peoples R China; [Zhang, Hongquan] Peking Univ, Hlth Sci Ctr, Dept Anat Histol & Embryol, Beijing, Peoples R China; [Liu, Dequan] Kunming Med Univ, Affiliated Hosp 3, Dept Breast Surg, Kunming, Yunnan, Peoples R China; [Lengner, Christopher J.] Univ Penn, Med Res Ctr, Dept Biomed Sci, Philadelphia, PA 19104 USA; [Lengner, Christopher J.] Univ Penn, Med Res Ctr, Dept Cell & Dev Biol, Philadelphia, PA 19104 USA; [Lengner, Christopher J.] Univ Penn, Med Res Ctr, Inst Regenerat Med, Philadelphia, PA 19104 USA	China Agricultural University; China Agricultural University; Peking University; Southwest University - China; Peking University; Peking University; Kunming Medical University; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania	Xue, LX (corresponding author), Peking Univ, Hosp 3, 49 Huayuan North Rd, Beijing 100191, Peoples R China.; Yu, ZQ (corresponding author), China Agr Univ, Yuanmingyuan West Rd 2, Beijing 100193, Peoples R China.	lixiangxue@bjmu.eu.cn; zyu@cau.edu.cn	tian, yuhua/AAK-1312-2020; Li, Fengyin/AAG-9476-2019	Lengner, Christopher/0000-0002-0574-5189	National Natural Science Foundation [81572614, 31271584, 81541142]; Modern Agro-industry Technology Research Program Grant [CARAS-37]; Beijing Nature Foundation [5162018]; Basic Research Program [2015QC104, 2015TC041, 2016SY001]; State Key Laboratory Open Project [2015SKLB6-16]	National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Modern Agro-industry Technology Research Program Grant; Beijing Nature Foundation; Basic Research Program; State Key Laboratory Open Project	The authors thank Cong Lv, Xiang Li, and Feifei Li (Peking University) for kindly sharing the reagents and methods. The authors also thank the Core Facilities at School of Life Sciences (Peking University), for assistance with the MoFlo XDP cell sorter and are grateful to Liying Du (Peking University) for the sorting of mammary epithelia. This work was supported by National Natural Science Foundation Grants 81572614, 31271584 (to Z.Y.), and 81541142 (to L.X.); Modern Agro-industry Technology Research Program Grant CARAS-37 (to Z.Y.); Beijing Nature Foundation Grant 5162018 (to Z.Y.); Basic Research Program Grants 2015QC104, 2015TC041, and 2016SY001; and State Key Laboratory Open Project Grant 2015SKLB6-16. The authors declare no conflicts of interest.	Asselin-Labat ML, 2007, NAT CELL BIOL, V9, P201, DOI 10.1038/ncb1530; Baxter FO, 2007, J MAMMARY GLAND BIOL, V12, P3, DOI 10.1007/s10911-007-9033-9; Benetka W, 2008, CELL CYCLE, V7, P3709, DOI 10.4161/cc.7.23.7176; Bouras T, 2008, CELL STEM CELL, V3, P429, DOI 10.1016/j.stem.2008.08.001; Brisken C, 1999, DEV BIOL, V210, P96, DOI 10.1006/dbio.1999.9271; Casimiro MC, 2013, MOL ENDOCRINOL, V27, P1415, DOI 10.1210/me.2013-1065; Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265; Chakrabarti R, 2012, NAT CELL BIOL, V14, P1212, DOI 10.1038/ncb2607; Colaluca IN, 2008, NATURE, V451, P76, DOI 10.1038/nature06412; Conboy IM, 2002, DEV CELL, V3, P397, DOI 10.1016/S1534-5807(02)00254-X; Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003; Ewald AJ, 2012, J CELL SCI, V125, P2638, DOI 10.1242/jcs.096875; Forster N, 2014, DEV CELL, V28, P147, DOI 10.1016/j.devcel.2013.11.019; Foubert E, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2585; Gallego MI, 2001, DEV BIOL, V229, P163, DOI 10.1006/dbio.2000.9961; Godde NJ, 2010, J MAMMARY GLAND BIOL, V15, P149, DOI 10.1007/s10911-010-9180-2; Ibarra I, 2007, GENE DEV, V21, P3238, DOI 10.1101/gad.1616307; Ito T, 2010, NATURE, V466, P765, DOI 10.1038/nature09171; Katz Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03915; Kharas MG, 2010, NAT MED, V16, P903, DOI 10.1038/nm.2187; Kouros-Mehr H, 2006, DEV DYNAM, V235, P3404, DOI 10.1002/dvdy.20978; Leong KG, 2007, J EXP MED, V204, P2935, DOI 10.1084/jem.20071082; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Muraoka-Cook RS, 2008, J MAMMARY GLAND BIOL, V13, P235, DOI 10.1007/s10911-008-9080-x; Oakes SR, 2008, GENE DEV, V22, P581, DOI 10.1101/gad.1614608; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; RHYU MS, 1994, CELL, V76, P477, DOI 10.1016/0092-8674(94)90112-0; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Santolini E, 2000, J CELL BIOL, V151, P1345, DOI 10.1083/jcb.151.6.1345; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shehata M, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3334; TAVERNA D, 1991, CELL GROWTH DIFFER, V2, P145; Tosoni D, 2015, J CELL BIOL, V211, P845, DOI 10.1083/jcb.201505037; Watanabe K, 2014, DEV CELL, V29, P59, DOI 10.1016/j.devcel.2014.03.006; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Watson CJ, 2011, INT J DEV BIOL, V55, P757, DOI 10.1387/ijdb.113414cw; Wu MF, 2007, CELL STEM CELL, V1, P541, DOI 10.1016/j.stem.2007.08.009; Yalcin-Ozuysal O, 2010, CELL DEATH DIFFER, V17, P1600, DOI 10.1038/cdd.2010.37; Yallowitz AR, 2014, CELL DEATH DIFFER, V21, P645, DOI 10.1038/cdd.2013.199; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Zhong WM, 1996, NEURON, V17, P43, DOI 10.1016/S0896-6273(00)80279-2	42	20	22	1	22	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3474	3488		10.1096/fj.201600387R	http://dx.doi.org/10.1096/fj.201600387R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27383182				2022-12-28	WOS:000384329800018
J	Nwadozi, E; Roudier, E; Rullman, E; Tharmalingam, S; Liu, HY; Gustafsson, T; Haas, TL				Nwadozi, Emmanuel; Roudier, Emilie; Rullman, Eric; Tharmalingam, Sujeenthar; Liu, Hsin-yi; Gustafsson, Thomas; Haas, Tara L.			Endothelial FoxO proteins impair insulin sensitivity and restrain muscle angiogenesis in response to a high-fat diet	FASEB JOURNAL			English	Article						capillary; obesity; diabetes; microcirculation; gene expression	TRANSCRIPTION FACTOR FOXO1; NECROSIS-FACTOR-ALPHA; SKELETAL-MUSCLE; ADIPOSE-TISSUE; CAPILLARY DENSITY; INFLAMMATORY PATHWAYS; VASCULAR ENDOTHELIUM; ISCHEMIC MUSCLE; HUMAN OBESITY; RESISTANCE	Skeletal muscle microvascular dysfunction contributes to disease severity in type 2 diabetes. Recent studies indicate a role for Forkhead box O (FoxO) transcription factors in modulating endothelial cell phenotype. We hypothesized that a high-fat (HF) diet generates a dysfunctional vascular niche through an increased expression of endothelial FoxO. FoxO1 protein increased (+130%) in the skeletal muscle capillaries from HF compared to normal chow-fed mice. FoxO1 protein was significantly elevated in cultured endothelial cells exposed to the saturated fatty acid palmitate or the proinflammatory cytokine TNF-. In HF-fed mice, endothelium-directed depletion of FoxO1/3/4 (FoxO) improved insulin sensitivity (+110%) compared to that of the controls (FoxO(L/L)). The number of skeletal muscle capillaries increased significantly in the HF-FoxO mice. Transcript profiling of skeletal muscle identified significant increases in genes associated with angiogenesis and lipid metabolism in HF-FoxOvs. HF-FoxO(L/L) mice. HF-FoxO muscle also was characterized by a decrease in inflammation-related genes and an enriched M2 macrophage signature. We conclude that endothelial FoxO proteins promote insulin resistance in HF diet, which may in part result from FoxO proteins establishing an antiangiogenic and proinflammatory microenvironment within skeletal muscle. These findings provide mechanistic insight into the development of microvascular dysfunction in the progression of type 2 diabetes.Nwadozi, E., Roudier, E., Rullman, E., Tharmalingam, S., Liu, H.-Y., Gustafsson, T., Haas, T. L. Endothelial FoxO proteins impair insulin sensitivity and restrain muscle angiogenesis in response to a high-fat diet.	[Nwadozi, Emmanuel; Roudier, Emilie; Tharmalingam, Sujeenthar; Liu, Hsin-yi; Haas, Tara L.] York Univ, Fac Hlth, Sch Kinesiol & Hlth Sci, Toronto, ON, Canada; [Rullman, Eric; Gustafsson, Thomas] Karolinska Inst, Dept Lab Med, Clin Physiol, Stockholm, Sweden; [Rullman, Eric] Karolinska Univ Hosp, Dept Cardiol, Stockholm, Sweden; [Gustafsson, Thomas] Karolinska Univ Hosp, Dept Clin Physiol, Stockholm, Sweden	York University - Canada; Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Haas, TL (corresponding author), York Univ, Angiogenesis Res Grp, Fac Hlth, Rm 339-341 Farquharson Bldg,4700 Keele St, Toronto, ON M3J 1P3, Canada.	thaas@yorku.ca	Gustafsson, Thomas/AAH-1056-2019	Gustafsson, Thomas/0000-0002-1559-4206; Nwadozi, Emmanuel/0000-0003-3572-9021	Canadian Institutes of Health Research [MOP-107537, MOP-130491]; Natural Science and Engineering Research Council of Canada; Ontario Graduate Scholarship; Swedish County Council (ALF); Swedish Society for Medical Research (SSMF)	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Ontario Graduate Scholarship(Ontario Graduate Scholarship); Swedish County Council (ALF); Swedish Society for Medical Research (SSMF)	The authors thank Ghoncheh Abdifarkosh and Purnadeo Persaud (both from York University) for assistance with sample preparation. This work was funded by Canadian Institutes of Health Research Grants MOP-107537 (to T.L.H.) and MOP-130491 (to T.L.H. and E.Ro.). E.N. was supported by a Canadian Graduate Scholarship-Masters from the Natural Science and Engineering Research Council of Canada and an Ontario Graduate Scholarship. E.Ru. received funding from the Swedish County Council (ALF) and Swedish Society for Medical Research (SSMF). Author contributions: E. Nwadozi, E. Roudier, T. Gustafsson, and T. Haas designed the research; E. Nwadozi, E. Roudier, S. Tharmalingam, and H.-Y. Liu performed research and analyzed data; E. Rullman conducted bioinformatics; E. Nwadozi, E. Roudier, T. Gustafsson, and T. L. Haas wrote the paper. The authors declare no conflicts of interest.	Arner E, 2010, NEW ENGL J MED, V362, P1151, DOI 10.1056/NEJMc0910718; Aroor AR, 2013, METABOLISM, V62, P1543, DOI 10.1016/j.metabol.2013.07.001; Bilan Phillip J., 2009, Archives of Physiology and Biochemistry, V115, P176, DOI 10.1080/13813450903079314; Cornier MA, 2011, CIRCULATION, V124, P840, DOI 10.1161/CIRCULATIONAHA.110.968461; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Furuyama T, 2004, J BIOL CHEM, V279, P34741, DOI 10.1074/jbc.M314214200; Gavin TP, 2005, J APPL PHYSIOL, V98, P315, DOI 10.1152/japplphysiol.00353.2004; Gustafson B, 2007, ARTERIOSCL THROM VAS, V27, P2276, DOI 10.1161/ATVBAHA.107.147835; Hedman A, 2000, ACTA PHYSIOL SCAND, V169, P125; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Huang HJ, 2007, J CELL SCI, V120, P2479, DOI 10.1242/jcs.001222; Iso T, 2013, ARTERIOSCL THROM VAS, V33, P2549, DOI 10.1161/ATVBAHA.113.301588; Jablonski KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145342; Karki S, 2015, ARTERIOSCL THROM VAS, V35, P1498, DOI 10.1161/ATVBAHA.114.305139; Kramer A, 2014, BIOINFORMATICS, V30, P523, DOI 10.1093/bioinformatics/btt703; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; LAAKSO M, 1990, J CLIN INVEST, V85, P1844, DOI 10.1172/JCI114644; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Lee JS, 2006, J APPL PHYSIOL, V100, P1467, DOI 10.1152/japplphysiol.01438.2005; LILLIOJA S, 1987, J CLIN INVEST, V80, P415, DOI 10.1172/JCI113088; MARIN P, 1994, DIABETES CARE, V17, P382, DOI 10.2337/diacare.17.5.382; Matsumoto M, 2007, CELL METAB, V6, P208, DOI 10.1016/j.cmet.2007.08.006; Mauer J, 2014, NAT IMMUNOL, V15, P423, DOI 10.1038/ni.2865; Michaud J, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-363; Milkiewicz M, 2011, AM J PATHOL, V178, P935, DOI 10.1016/j.ajpath.2010.10.042; Paik JH, 2007, CELL, V128, P309, DOI 10.1016/j.cell.2006.12.029; Pan DA, 1997, DIABETES, V46, P983, DOI 10.2337/diabetes.46.6.983; Pillon NJ, 2015, AM J PHYSIOL-ENDOC M, V309, pE35, DOI 10.1152/ajpendo.00611.2014; Prior SJ, 2015, DIABETES, V64, P3386, DOI 10.2337/db14-1771; Roudier E, 2013, ANGIOGENESIS, V16, P759, DOI 10.1007/s10456-013-9353-x; Seoane J, 2004, CELL, V117, P211, DOI 10.1016/S0092-8674(04)00298-3; Silvennoinen M, 2013, ANGIOGENESIS, V16, P297, DOI 10.1007/s10456-012-9315-8; Sjostrand M, 2002, DIABETES, V51, P2742, DOI 10.2337/diabetes.51.9.2742; Slopack D, 2014, J PHYSIOL-LONDON, V592, P4069, DOI 10.1113/jphysiol.2014.275867; Steinberg HO, 2000, DIABETES, V49, P1231, DOI 10.2337/diabetes.49.7.1231; Sun XH, 2016, CIRC RES, V118, P810, DOI 10.1161/CIRCRESAHA.115.308166; Takemoto M, 2002, AM J PATHOL, V161, P799, DOI 10.1016/S0002-9440(10)64239-3; Tanaka J, 2009, DIABETES, V58, P2344, DOI 10.2337/db09-0167; Tsuchiya K, 2012, CELL METAB, V15, P372, DOI 10.1016/j.cmet.2012.01.018; Vincent MA, 2004, DIABETES, V53, P1418, DOI 10.2337/diabetes.53.6.1418; Wilhelm K, 2016, NATURE, V529, P216, DOI 10.1038/nature16498	41	23	24	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3039	3052		10.1096/fj.201600245R	http://dx.doi.org/10.1096/fj.201600245R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27235148				2022-12-28	WOS:000382816300005
J	Deckx, S; Heymans, S; Papageorgiou, AP				Deckx, Sophie; Heymans, Stephane; Papageorgiou, Anna-Pia			The diverse functions of osteoglycin: a deceitful dwarf, or a master regulator of disease?	FASEB JOURNAL			English	Review						glycosylation; matrix; SLRPs	LEUCINE-RICH PROTEOGLYCANS; KERATAN SULFATE PROTEOGLYCAN; GROWTH-FACTOR-BETA; HUMAN MIMECAN PROMOTER; CHRONIC HEART-FAILURE; GENE-EXPRESSION; EXTRACELLULAR-MATRIX; MOLECULAR-CLONING; ARTICULAR-CARTILAGE; PROTEOMIC ANALYSIS	Small leucine-rich proteoglycans are emerging as important regulatory proteins within the extracellular matrix, where they exert both structural and nonstructural functions and hence are modulators of numerous biological processes, such as inflammation, fibrosis, and cell proliferation. One proteoglycan in particular, osteoglycin (OGN), also known as mimecan, shows great structural and functional diversity in normal physiology and in disease states, therefore making it a very interesting candidate for the development of novel therapeutic strategies. Unfortunately, the literature on OGN is confusing, as it has different names, and different transcript and protein variants have been identified. This review will give a clear overview of the different structures and functions of OGN that have been identified to date, portray its central role in pathophysiology, and highlight the importance of posttranslational processing, such as glycosylation, for the diversity of its functions.-Deckx, S., Heymans, S., Papageorgiou, A.-P. The diverse functions of osteoglycin: a deceitful dwarf, or a master regulator of disease?	[Deckx, Sophie; Heymans, Stephane; Papageorgiou, Anna-Pia] Maastricht Univ, Dept Cardiol, NL-6200 MD Maastricht, Netherlands; [Deckx, Sophie; Heymans, Stephane; Papageorgiou, Anna-Pia] Katholieke Univ KU Leuven, Ctr Mol & Vasc Biol, Leuven, Belgium	Maastricht University; KU Leuven	Deckx, S (corresponding author), Maastricht Univ, Dept Cardiol, NL-6200 MD Maastricht, Netherlands.	s.deckx@maastrichtuniversity.nl		Heymans, Stephane/0000-0001-9477-7803	European Commission [602904, 261409]	European Commission(European CommissionEuropean Commission Joint Research Centre)	This work was supported by European Commission Fibro-Targets Grant 602904 and Media Grant 261409. The authors declare no conflicts of interest.	Balakrishnan L, 2014, CLIN PROTEOM, V11, DOI 10.1186/1559-0275-11-6; Balint E, 2003, J CELL BIOCHEM, V89, P401, DOI 10.1002/jcb.10515; Balint G, 2011, PHYS THER, V91, P665, DOI 10.2522/ptj.20100065; Barascuk N, 2011, BIOMARK INSIGHTS, V6, P97, DOI 10.4137/BMI.S7777; Beecher N, 2005, INVEST OPHTH VIS SCI, V46, P4046, DOI 10.1167/iovs.05-0325; BENTZ H, 1991, MATRIX, V11, P269, DOI 10.1016/S0934-8832(11)80234-9; Berryhill BL, 2001, INVEST OPHTH VIS SCI, V42, P1201; Cao HM, 2015, EBIOMEDICINE, V2, P1718, DOI 10.1016/j.ebiom.2015.09.044; Chelyshev YA, 2014, NEUROSCIENCE, V280, P328, DOI 10.1016/j.neuroscience.2014.09.004; Chen SJ, 2013, FEBS J, V280, P2120, DOI 10.1111/febs.12136; Cheng JM, 2014, ARTERIOSCL THROM VAS, V34, P1078, DOI 10.1161/ATVBAHA.114.303486; Corpuz LM, 2000, MATRIX BIOL, V19, P693, DOI 10.1016/S0945-053X(00)00116-5; Cui XN, 2008, ACTA BIOCH BIOPH SIN, V40, P349, DOI 10.1111/j.1745-7270.2008.00392.x; De Ceuninck Frederic, 2005, J Biomol Tech, V16, P256; Dellett M, 2012, DEV GROWTH DIFFER, V54, P327, DOI 10.1111/j.1440-169X.2012.01339.x; Dimasi DP, 2010, MOL VIS, V16, P562; Diskin S, 2006, INVEST OPHTH VIS SCI, V47, P1491, DOI 10.1167/iovs.05-0736; Dunlevy JR, 2000, EXP EYE RES, V70, P349, DOI 10.1006/exer.1999.0789; Feng H, 2015, BIOMED REP, V3, P681, DOI 10.3892/br.2015.488; Fernandez B, 2003, MOL CELL BIOCHEM, V246, P3, DOI 10.1023/A:1023487424751; Funderburgh JL, 1997, J BIOL CHEM, V272, P28089, DOI 10.1074/jbc.272.44.28089; Funderburgh JL, 2001, J BIOL CHEM, V276, P44173, DOI 10.1074/jbc.M107596200; Ge GX, 2004, J BIOL CHEM, V279, P41626, DOI 10.1074/jbc.M406630200; Gu XS, 2011, MOL CELL BIOCHEM, V352, P309, DOI 10.1007/s11010-011-0767-8; Guntur AR, 2012, ENDOCR PRACT, V18, P758, DOI 10.4158/EP12141.RA; Haglund L, 2008, MATRIX BIOL, V27, P107, DOI 10.1016/j.matbio.2007.09.009; Hamajima S, 2003, LASER MED SCI, V18, P78, DOI 10.1007/s10103-003-0255-9; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hou C, 2012, J MOL HISTOL, V43, P9, DOI 10.1007/s10735-011-9368-9; Hu SM, 2005, J CLIN ENDOCR METAB, V90, P6657, DOI 10.1210/jc.2005-0322; Huang H, 2013, J BIOL CHEM, V288, P17589, DOI 10.1074/jbc.M113.467498; Igwe JC, 2011, CONNECT TISSUE RES, V52, P401, DOI 10.3109/03008207.2010.546536; Insenser M, 2012, MOL CELL ENDOCRINOL, V363, P10, DOI 10.1016/j.mce.2012.07.001; Iozzo RV, 2010, FEBS J, V277, P3864, DOI 10.1111/j.1742-4658.2010.07797.x; Iozzo RV, 1997, CRIT REV BIOCHEM MOL, V32, P141, DOI 10.3109/10409239709108551; Jazbutyte V, 2013, AGE, V35, P747, DOI 10.1007/s11357-012-9407-9; Jeong EY, 2013, NEUROSCI LETT, V548, P249, DOI 10.1016/j.neulet.2013.05.038; Juchtmans N, 2015, ARTHRITIS RHEUMATOL, V67, P435, DOI 10.1002/art.38930; Jung S, 2012, BMC NEUROSCI, V13, DOI 10.1186/1471-2202-13-58; Jungbauer CG, 2014, BIOMARK MED, V8, P777, DOI [10.2217/BMM.14.31, 10.2217/bmm.14.31]; Kampmann A, 2009, MOL CELL BIOCHEM, V322, P15, DOI 10.1007/s11010-008-9935-x; Kawahara R, 2014, J PROTEOME RES, V13, P2080, DOI 10.1021/pr401224u; Kawao N, 2015, J CELL BIOCHEM, V116, P687, DOI 10.1002/jcb.25040; Keenan TDL, 2012, INVEST OPHTH VIS SCI, V53, P7528, DOI 10.1167/iovs.12-10797; Lee JY, 2003, GENOMICS, V82, P78, DOI 10.1016/S0888-7543(03)00098-3; Li L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090181; Li X, 2002, J BIOL CHEM, V277, P45129, DOI 10.1074/jbc.M205165200; Liu CY, 1998, J BIOL CHEM, V273, P22584, DOI 10.1074/jbc.273.35.22584; Lomnytska MI, 2010, PROTEOM CLIN APPL, V4, P17, DOI 10.1002/prca.200900086; Long CJ, 2000, J BIOL CHEM, V275, P13918, DOI 10.1074/jbc.275.18.13918; Ma QY, 2010, MOL CELL ENDOCRINOL, V321, P239, DOI 10.1016/j.mce.2010.02.021; MADISEN L, 1990, DNA CELL BIOL, V9, P303, DOI 10.1089/dna.1990.9.303; Malaud E, 2014, ATHEROSCLEROSIS, V233, P551, DOI 10.1016/j.atherosclerosis.2013.12.019; Matsumoto K, 2012, INT J MOL MED, V30, P417, DOI 10.3892/ijmm.2012.985; Matsushima N, 2000, PROTEINS, V38, P210, DOI 10.1002/(SICI)1097-0134(20000201)38:2<210::AID-PROT9>3.0.CO;2-1; Moncayo-Arlandi J, 2014, ATHEROSCLEROSIS, V237, P418, DOI 10.1016/j.atherosclerosis.2014.09.016; Moreth K, 2012, CELL CYCLE, V11, P2084, DOI 10.4161/cc.20316; Motiwala SR, 2014, J CARDIOVASC TRANSL, V7, P250, DOI 10.1007/s12265-013-9522-8; Nastase MV, 2014, BBA-GEN SUBJECTS, V1840, P2460, DOI 10.1016/j.bbagen.2014.01.035; Osawa A, 2006, GENOMICS, V88, P52, DOI 10.1016/j.ygeno.2006.02.013; Pan Q, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-34; Park JG, 2009, DENT MATER, V25, P1569, DOI 10.1016/j.dental.2009.07.010; Petretto E, 2008, NAT GENET, V40, P546, DOI 10.1038/ng.134; Pravenec M, 2010, METHODS MOL BIOL, V597, P415, DOI 10.1007/978-1-60327-389-3_28; Rienks M, 2014, CIRC RES, V114, P872, DOI 10.1161/CIRCRESAHA.114.302533; Rower C, 2011, INT J CLIN EXP PATHO, V4, P454; Romero R, 2010, J MATERN-FETAL NEO M, V23, P1344, DOI 10.3109/14767058.2010.482618; Schaefer L, 2008, J BIOL CHEM, V283, P21305, DOI 10.1074/jbc.R800020200; Seher A, 2011, MOL VIS, V17, P53; Shanahan CM, 1997, ARTERIOSCL THROM VAS, V17, P2437, DOI 10.1161/01.ATV.17.11.2437; Shankar R, 2010, REPROD SCI, V17, P297, DOI 10.1177/1933719109353454; Sponziello M, 2013, ENDOCRINOLOGY, V154, P3043, DOI 10.1210/en.2013-1028; Stratil A, 2006, ANIM GENET, V37, P415, DOI 10.1111/j.1365-2052.2006.01480.x; Tanaka K, 2014, BIOCHEM BIOPH RES CO, V450, P482, DOI 10.1016/j.bbrc.2014.05.145; Tanaka K, 2012, J BIOL CHEM, V287, P11616, DOI 10.1074/jbc.M111.292193; Tasheva E, 2003, MOL VIS, V9, P1; Tasheva ES, 1999, DNA SEQUENCE, V10, P67, DOI 10.3109/10425179909033939; Tasheva ES, 1999, J BIOL CHEM, V274, P18693, DOI 10.1074/jbc.274.26.18693; Tasheva ES, 2000, BBA-GENE STRUCT EXPR, V1492, P452, DOI 10.1016/S0167-4781(00)00129-9; Tasheva ES, 2004, MOL VIS, V10, P403; Tasheva ES, 2003, MOL VIS, V9, P277; Tasheva ES, 2002, MOL VIS, V8, P407; Tasheva ES, 2001, BBA-GENE STRUCT EXPR, V1517, P333, DOI 10.1016/S0167-4781(00)00288-8; Tasheva ES, 1997, J BIOL CHEM, V272, P32551, DOI 10.1074/jbc.272.51.32551; Ueland T, 2015, J CARD FAIL, V21, P153, DOI 10.1016/j.cardfail.2014.10.016; UJITA M, 1995, GENE, V158, P237, DOI 10.1016/0378-1119(95)00070-M; Van Aelst LNL, 2015, CIRC RES, V116, P425, DOI 10.1161/CIRCRESAHA.116.304599; Vuillermoz B, 2005, MOL CELL BIOCHEM, V277, P63, DOI 10.1007/s11010-005-5073-x; Wang XL, 2012, PROTEOM CLIN APPL, V6, P615, DOI 10.1002/prca.201200049; Wang YH, 2007, EXP BIOL MED, V232, P1152, DOI 10.3181/0701-RM-8; Weyers A, 2013, FEBS J, V280, P2285, DOI 10.1111/febs.12165; Wheater MK, 1999, BIOTECH HISTOCHEM, V74, P146, DOI 10.3109/10520299909047967; Williamson RE, 2008, HEARING RES, V237, P57, DOI 10.1016/j.heares.2007.12.006; Xing WR, 2005, J CELL BIOCHEM, V96, P1049, DOI 10.1002/jcb.20606; Yang CH, 2012, VET J, V193, P374, DOI 10.1016/j.tvjl.2012.01.018; Yuan XY, 2010, CORNEA, V29, P674, DOI 10.1097/ICO.0b013e3181c29744; Zhang YT, 2011, J BIOL CHEM, V286, P13011, DOI 10.1074/jbc.M110.169813; Zhao XJ, 2004, INVEST OPHTH VIS SCI, V45, P4023, DOI 10.1167/iovs.04-0535; Zhen EY, 2008, ARTHRITIS RHEUM-US, V58, P2420, DOI 10.1002/art.23654; Zheng CX, 2009, ONCOL REP, V22, P1057, DOI 10.3892/or_00000536	101	34	34	2	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2651	2661		10.1096/fj.201500096R	http://dx.doi.org/10.1096/fj.201500096R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27080639				2022-12-28	WOS:000380994000003
J	Huang, WC; Liang, J; Nagahashi, M; Avni, D; Yamada, A; Maceyka, M; Wolen, AR; Kordula, T; Milstien, S; Takabe, K; Oravecz, T; Spiegel, S				Huang, Wei-Ching; Liang, Jie; Nagahashi, Masayuki; Avni, Dorit; Yamada, Akimitsu; Maceyka, Michael; Wolen, Aaron R.; Kordula, Tomasz; Milstien, Sheldon; Takabe, Kazuaki; Oravecz, Tamas; Spiegel, Sarah			Sphingosine-1-phosphate phosphatase 2 promotes disruption of mucosal integrity, and contributes to ulcerative colitis in mice and humans	FASEB JOURNAL			English	Article						SGPP1; SGPP2; S1P; inflammatory bowel disease	INFLAMMATORY-BOWEL-DISEASE; INTESTINAL EPITHELIAL-CELLS; SODIUM-INDUCED COLITIS; SPHINGOSINE KINASE; STAT3 ACTIVATION; IN-VITRO; PHOSPHOHYDROLASE; APOPTOSIS; SURVIVAL; BARRIER	The bioactive sphingolipid sphingosine-1-phosphate (S1P) and the kinase that produces it have been implicated in inflammatory bowel diseases in mice and humans; however, little is known about the role of the 2 S1P-specific phosphohydrolase isoforms, SGPP1 and SGPP2, which catalyze dephosphorylation of S1P to sphingosine. To elucidate their functions, we generated specific knockout mice. Deletion of Sgpp2, which is mainly expressed in the gastrointestinal tract, significantly reduced dextran sodium sulfate (DSS)-induced colitis severity, whereas deletion of ubiquitously expressed Sgpp1 slightly worsened colitis. Moreover, Sgpp1 deletion enhanced expression of multifunctional proin-flammatory cytokines, IL-6, TNF-alpha, and IL-1 beta, activation of the transcription factor signal transducer and activator of transcription 3, and immune cell infiltration into the colon. Conversely, Sgpp2-nullmice failed to mount a DSS-induced systemic inflammatory response. Of interest, Sgpp2 deficiency suppressed DSS-induced intestinal epithelial cell apoptosis and improved mucosal barrier integrity. Furthermore, down-regulation of Sgpp2 attenuated LPS-induced para-cellular permeability in cultured cells and enhanced expression of the adherens junction protein E-cadherin. Finally, in patients with ulcerative colitis, SGPP2 expression was elevated in colitis tissues relative to that in uninvolved tissues. These results indicate that induction of SGPP2 expression contributes to the pathogenesis of colitis by promoting disruption of the mucosal barrier function. SGPP2 may represent a novel therapeutic target in inflammatory bowel disease.	[Huang, Wei-Ching; Liang, Jie; Nagahashi, Masayuki; Avni, Dorit; Yamada, Akimitsu; Maceyka, Michael; Kordula, Tomasz; Milstien, Sheldon; Takabe, Kazuaki; Spiegel, Sarah] Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA; [Nagahashi, Masayuki; Yamada, Akimitsu; Takabe, Kazuaki] Virginia Commonwealth Univ, Dept Surg, Div Surg Oncol, Sch Med, Richmond, VA USA; [Wolen, Aaron R.] Virginia Commonwealth Univ, Sch Med, Ctr Clin & Translat Res, Richmond, VA USA; Massey Canc Ctr, Richmond, VA USA; [Oravecz, Tamas] Lexicon Pharmaceut, The Woodlands, TX USA; [Huang, Wei-Ching] Chang Gung Mem Hosp, Inst Stem Cell & Translat Canc Res, Taoyuan, Taiwan; [Liang, Jie] State Key Lab Canc Biol, Xian, Peoples R China; [Nagahashi, Masayuki] Niigata Univ, Grad Sch Med & Dent Sci, Div Digest & Gen Surg, Niigata, Japan; [Yamada, Akimitsu] Yokohama City Univ, Med Ctr, Yokohama, Kanagawa, Japan; [Oravecz, Tamas] Celgene, Cambridge, MA USA	Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Virginia Commonwealth University; Lexicon Pharmaceuticals; Chang Gung Memorial Hospital; Air Force Military Medical University; Niigata University; Yokohama City University; Bristol-Myers Squibb; Celgene Corporation	Spiegel, S (corresponding author), Virginia Commonwealth Univ, Sch Med, Dept Biochem & Mol Biol, Richmond, VA 23298 USA.	sarah.spiegel@vcuhelath.org	Nagahashi, Masayuki/AAB-4202-2020; Maceyka, Michael/B-9277-2008; Wolen, Aaron/H-9545-2014	Takabe, Kazuaki/0000-0002-6435-4241; Avni, Dorit/0000-0002-0444-881X; Huang, Wei-Ching/0000-0003-1255-2067; Wolen, Aaron/0000-0003-2542-2202	National Institutes of Health (NIH) National Cancer Institute (NCI) [R01CA61774]; NIH National Institute of General Medical Sciences [R01GM043880]; NIH NCI [R01CA160688]; NIH Center for Clinical and Translational Research Grant [UL1TR000058]; NIH NCI Cancer Center Support Grant [P30CA016059]; NATIONAL CANCER INSTITUTE [R01CA061774, P30CA016059, R01CA160688] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000058] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM043880] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIH NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH Center for Clinical and Translational Research Grant; NIH NCI Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the National Institutes of Health (NIH) National Cancer Institute (NCI) Grant R01CA61774 and NIH National Institute of General Medical Sciences Grant R01GM043880 (to S.S.). This study was also supported, in part, by NIH NCI Grant R01CA160688 (to K.T.) and NIH Center for Clinical and Translational Research Grant UL1TR000058 (to A.R.W.). The authors acknowledge the Virginia Commonwealth University Lipidomics and Microscopy Cores, which are supported, in part, by funding from the NIH NCI Cancer Center Support Grant P30CA016059.	Akbari P, 2014, FASEB J, V28, P2414, DOI 10.1096/fj.13-238717; Allende ML, 2013, J BIOL CHEM, V288, P18381, DOI 10.1074/jbc.M113.478420; Begagne E, 2014, J CLIN INVEST, V124, P5368, DOI 10.1172/JCI74188; Bollrath J, 2009, CANCER CELL, V15, P91, DOI 10.1016/j.ccr.2009.01.002; Breart B, 2011, J EXP MED, V208, P1267, DOI 10.1084/jem.20102551; Cohen RD, 2010, NAT REV GASTRO HEPAT, V7, P103, DOI 10.1038/nrgastro.2009.232; Daniel C, 2007, MOL IMMUNOL, V44, P3305, DOI 10.1016/j.molimm.2007.02.026; Daniel C, 2007, J IMMUNOL, V178, P2458, DOI 10.4049/jimmunol.178.4.2458; Deguchi Y, 2006, ONCOL REP, V16, P699; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Giussani P, 2006, MOL CELL BIOL, V26, P5055, DOI 10.1128/MCB.02107-05; Greenspon J, 2011, DIGEST DIS SCI, V56, P1342, DOI 10.1007/s10620-010-1421-0; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Guo SH, 2013, AM J PATHOL, V182, P375, DOI 10.1016/j.ajpath.2012.10.014; Halpert G, 2014, J BIOL CHEM, V289, P17215, DOI 10.1074/jbc.M113.536664; Huber W, 2015, NAT METHODS, V12, P115, DOI [10.1038/nmeth.3252, 10.1038/NMETH.3252]; Johnson KR, 2003, J BIOL CHEM, V278, P34541, DOI 10.1074/jbc.M301741200; Kabashima K, 2002, J CLIN INVEST, V109, P883, DOI 10.1172/JCI14459; Karin M, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000141; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Laukoetter MG, 2008, WORLD J GASTROENTERO, V14, P401, DOI 10.3748/wjg.14.401; Le Stunff H, 2004, J BIOL CHEM, V279, P34290, DOI 10.1074/jbc.M404907200; Le Stunff H, 2002, J CELL BIOL, V158, P1039, DOI 10.1083/jcb.200203123; Le Stunff H, 2002, BBA-MOL CELL BIOL L, V1582, P8, DOI 10.1016/S1388-1981(02)00132-4; Lepage P, 2011, GASTROENTEROLOGY, V141, P227, DOI 10.1053/j.gastro.2011.04.011; Lepine S, 2011, CELL DEATH DIFFER, V18, P350, DOI 10.1038/cdd.2010.104; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Maceyka M, 2007, METHOD ENZYMOL, V434, P243, DOI 10.1016/S0076-6879(07)34013-5; Maceyka M, 2014, NATURE, V510, P58, DOI 10.1038/nature13475; Maines LW, 2008, DIGEST DIS SCI, V53, P997, DOI 10.1007/s10620-007-0133-6; Mechtcheriakova D, 2007, CELL SIGNAL, V19, P748, DOI 10.1016/j.cellsig.2006.09.004; Molodecky NA, 2012, GASTROENTEROLOGY, V142, P46, DOI 10.1053/j.gastro.2011.10.001; Neurath MF, 2014, NAT REV IMMUNOL, V14, P329, DOI 10.1038/nri3661; Noble CL, 2008, GUT, V57, P1398, DOI 10.1136/gut.2008.148395; Ogawa C, 2003, J BIOL CHEM, V278, P1268, DOI 10.1074/jbc.M209514200; Peter BF, 2008, CIRC RES, V103, P315, DOI 10.1161/CIRCRESAHA.108.173575; Sanada Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023933; Schneider MR, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014325; Siegmund B, 2001, P NATL ACAD SCI USA, V98, P13249, DOI 10.1073/pnas.231473998; Snider AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113998; Snider AJ, 2009, FASEB J, V23, P143, DOI 10.1096/fj.08-118109; Song J, 2008, J PHARMACOL EXP THER, V324, P276, DOI 10.1124/jpet.106.119172; Vetuschi A, 2002, DIGEST DIS SCI, V47, P1447, DOI 10.1023/A:1015931128583; von Roon AC, 2007, DIS COLON RECTUM, V50, P839, DOI 10.1007/s10350-006-0848-z; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Williams KL, 2001, GASTROENTEROLOGY, V120, P925, DOI 10.1053/gast.2001.22470; Xavier RJ, 2007, NATURE, V448, P427, DOI 10.1038/nature06005; Yang T, 2016, SHOCK, V45, P228, DOI 10.1097/SHK.0000000000000503; Yu LCH, 2005, FASEB J, V19, P1822, DOI 10.1096/fj.05-4226com	49	38	39	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2945	2958		10.1096/fj.201600394R	http://dx.doi.org/10.1096/fj.201600394R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27130484	Green Published			2022-12-28	WOS:000380994000027
J	Solleti, SK; Srisuma, S; Bhattacharya, S; Rangel-Moreno, J; Bijli, KM; Randall, TD; Rahman, A; Mariani, TJ				Solleti, Siva Kumar; Srisuma, Sorachai; Bhattacharya, Soumyaroop; Rangel-Moreno, Javier; Bijli, Kaiser M.; Randall, Troy D.; Rahman, Arshad; Mariani, Thomas J.			Serpine2 deficiency results in lung lymphocyte accumulation and bronchus-associated lymphoid tissue formation	FASEB JOURNAL			English	Article						serine protease inhibitor; protease nexin-1; thrombin; chemokines; tertiary lymphoid structures	OBSTRUCTIVE PULMONARY-DISEASE; NF-KAPPA-B; PROTEASE NEXIN 1; ENDOTHELIAL-CELLS; THROMBIN ACTIVITY; EPITHELIAL-CELLS; MICE LACKING; ACTIVATION; EXPRESSION; GENE	Serine proteinase inhibitor, clade E, member 2 (SERPINE2), is a cell- and extracellular matrix-associated inhibitor of thrombin. Although SERPINE2 is a candidate susceptibility gene for chronic obstructive pulmonary disease, the physiologic role of this protease inhibitor in lung development and homeostasis is unknown. We observed spontaneous monocytic-cell infiltration in the lungs of Serpine2-deficient (SE2(-/-)) mice, beginning at or before the time of lung maturity, which resulted in lesions that resembled bronchus-associated lymphoid tissue (BALT). The initiation of lymphocyte accumulation in the lungs of SE2(-/-) mice involved the excessive expression of chemokines, cytokines, and adhesion molecules that are essential for BALT induction, organization, and maintenance. BALT-like lesion formation in the lungs of SE2(-/-) mice was also associated with a significant increase in the activation of thrombin, a recognized target of SE2, and excess stimulation of NF-kappa B, a major regulator of chemokine expression and inflammation. Finally, systemic delivery of thrombin rapidly stimulated lung chemokine expression in vivo. These data uncover a novelmechanism where by loss of serine protease inhibition leads to lung lymphocyte accumulation.-Solleti, S. K., Srisuma, S., Bhattacharya, S., Rangel-Moreno, J., Bijli, K. M., Randall, T. D., Rahman, A., Mariani, T. J. Serpine2 deficiency results in lung lymphocyte accumulation and bronchus-associated lymphoid tissue formation.	[Solleti, Siva Kumar; Bhattacharya, Soumyaroop; Bijli, Kaiser M.; Rahman, Arshad; Mariani, Thomas J.] Univ Rochester, Med Ctr, Dept Pediat, Div Neonatol, Rochester, NY 14642 USA; [Rangel-Moreno, Javier] Univ Rochester, Med Ctr, Div Allergy Immunol & Rheumatol, Rochester, NY 14642 USA; [Srisuma, Sorachai] Mahidol Univ, Siriraj Hosp, Fac Med, Dept Physiol, Bangkok 10700, Thailand; [Bijli, Kaiser M.] Emory Univ, Atlanta Vet Affairs Med Ctr, Div Pulm Allergy & Crit Care Med, Atlanta, GA 30322 USA; [Randall, Troy D.] Univ Alabama Birmingham, Dept Med, Div Clin Immunol & Rheumatol, Birmingham, AL 35294 USA	University of Rochester; University of Rochester; Mahidol University; Emory University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Atlanta VA Health Care System; University of Alabama System; University of Alabama Birmingham	Mariani, TJ (corresponding author), Univ Rochester, Med Ctr, Div Neonatol & Pediat Mol, 601 Elmwood Ave,Box 850, Rochester, NY 14642 USA.; Mariani, TJ (corresponding author), Univ Rochester, Med Ctr, Personalized Med Program, 601 Elmwood Ave,Box 850, Rochester, NY 14642 USA.	tom_mariani@urmc.rochester.edu		Solleti, Siva Kumar/0000-0002-7885-3164; Rangel-Moreno, Javier/0000-0002-9738-1182	Flight Attendant Medical Research Institute; U.S. National Institutes of Health (NIH); National Institute of Environmental Health Sciences [ES014372]; NIH National Heart, Lung, and Blood Institutes [HL094431, HL116632]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094431, R01HL116632] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES014372] Funding Source: NIH RePORTER	Flight Attendant Medical Research Institute; U.S. National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIH National Heart, Lung, and Blood Institutes; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by Flight Attendant Medical Research Institute, U.S. National Institutes of Health (NIH), National Institute of Environmental Health Sciences (Grant ES014372), and NIH National Heart, Lung, and Blood Institutes (Grants HL094431 and HL116632). The authors thank Dr. Mohammad Minhajuddin, Dr. Fabeha Fazal, Dr. Maria da la Luz Garcia-Hernandez, Valerie Lunger, Ashley Lopez, Swati Shimpi, Jared Mereness, and Muranda Maurer (University of Rochester Medical Center, Rochester, NY, USA) and Temana Andalcio, Jungha Hong, and Roberto Landazury (Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA) for assistance.	An L, 2012, MOL BIOL REP, V39, P1427, DOI 10.1007/s11033-011-0877-0; Ashitani J, 2002, INTERNAL MED, V41, P181, DOI 10.2169/internalmedicine.41.181; BAKER JB, 1980, CELL, V21, P37, DOI 10.1016/0092-8674(80)90112-9; Baraldo S, 2015, AM J RESP CRIT CARE, V191, P402, DOI 10.1164/rccm.201403-0529OC; Barnes PJ, 2008, NAT REV IMMUNOL, V8, P183, DOI 10.1038/nri2254; Bedard J, 2003, MOL REPROD DEV, V64, P152, DOI 10.1002/mrd.10239; Bijli KM, 2008, J BIOL CHEM, V283, P14674, DOI 10.1074/jbc.M802094200; Boulaftali Y, 2013, ARTERIOSCL THROM VAS, V33, P1647, DOI 10.1161/ATVBAHA.113.301494; Bouton MC, 2012, BLOOD, V119, P2452, DOI 10.1182/blood-2011-10-387464; Bouton MC, 2003, ARTERIOSCL THROM VAS, V23, P142, DOI 10.1161/01.ATV.0000047867.98019.2D; Bracke KR, 2013, AM J RESP CRIT CARE, V188, P343, DOI 10.1164/rccm.201211-2055OC; Brusselle GG, 2009, EUR RESPIR J, V34, P219, DOI 10.1183/09031936.00150208; Castaldi PJ, 2009, CHEST, V135, P737, DOI 10.1378/chest.08-1993; Cha SI, 2009, J KOREAN MED SCI, V24, P1119, DOI 10.3346/jkms.2009.24.6.1119; Chen D, 2009, J THROMB HAEMOST, V7, P122, DOI 10.1111/j.1538-7836.2009.03413.x; Davalos-Misslitz ACM, 2007, EUR J IMMUNOL, V37, P613, DOI 10.1002/eji.200636656; DeMeo DL, 2006, AM J HUM GENET, V78, P253, DOI 10.1086/499828; Demoor T, 2009, EUR RESPIR J, V34, P405, DOI 10.1183/09031936.00101408; Drapkin Paola T, 2002, BMC Developmental Biology, V2, P1; Fazal F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059965; Feutz AC, 2008, J CELL SCI, V121, P1435, DOI 10.1242/jcs.018689; Foo SY, 2010, MUCOSAL IMMUNOL, V3, P537, DOI 10.1038/mi.2010.52; Francois D, 2014, LAB INVEST, V94, P1237, DOI 10.1038/labinvest.2014.111; Gabazza EC, 1999, LUNG, V177, P253, DOI 10.1007/PL00007645; Gomez D, 2013, ARTERIOSCL THROM VAS, V33, P2222, DOI 10.1161/ATVBAHA.113.301327; GUTTRIDGE DC, 1993, J BIOL CHEM, V268, P18966; HERNANDEZRODRIGUEZ NA, 1995, LANCET, V346, P1071, DOI 10.1016/S0140-6736(95)91744-6; Hogg JC, 2004, NEW ENGL J MED, V350, P2645, DOI 10.1056/NEJMoa032158; Hunninghake GM, 2009, NEW ENGL J MED, V361, P2599, DOI 10.1056/NEJMoa0904006; Jankowski M, 2011, THROMB RES, V127, P242, DOI 10.1016/j.thromres.2010.11.005; Kelly FM, 2009, AM J PHYSIOL-RENAL, V296, pF512, DOI 10.1152/ajprenal.90629.2008; Kleeberger SR, 2005, ANNU REV MED, V56, P383, DOI 10.1146/annurev.med.56.062904.144908; Kukkonen MK, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-157; Levi M, 2004, CIRCULATION, V109, P2698, DOI 10.1161/01.CIR.0000131660.51520.9A; Lin CH, 2014, J IMMUNOL, V192, P338, DOI 10.4049/jimmunol.1203323; Lin CH, 2013, CELL SIGNAL, V25, P1166, DOI 10.1016/j.cellsig.2013.01.018; Lin CH, 2011, J BIOL CHEM, V286, P10483, DOI 10.1074/jbc.M110.112433; Lino MM, 2007, J NEUROSCI, V27, P3677, DOI 10.1523/JNEUROSCI.0277-07.2007; Livraghi A, 2009, J IMMUNOL, V182, P4357, DOI 10.4049/jimmunol.0802557; Lomas DA, 2001, RESP RES, V2, P20, DOI 10.1186/rr34; Luthi A, 1997, J NEUROSCI, V17, P4688; MANSUY IM, 1993, DEVELOPMENT, V119, P1119; Marin V, 2001, BLOOD, V98, P667, DOI 10.1182/blood.V98.3.667; Mckee CM, 2015, ONCOTARGET, V6, P3784, DOI 10.18632/oncotarget.2921; McKee CM, 2013, ONCOTARGET, V4, P1; Minhajuddin M, 2009, J BIOL CHEM, V284, P4052, DOI 10.1074/jbc.M805032200; Murer V, 2001, P NATL ACAD SCI USA, V98, P3029, DOI 10.1073/pnas.051630698; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Polverino F, 2015, AM J RESP CRIT CARE, V192, P695, DOI 10.1164/rccm.201501-0107OC; Rahman A, 2002, CIRC RES, V91, P398, DOI 10.1161/01.RES.0000033520.95242.A2; Rahman Arshad, 2011, Proc Am Thorac Soc, V8, P497, DOI 10.1513/pats.201101-009MW; Solleti SK, 2015, AM J PHYSIOL-LUNG C, V309, pL293, DOI 10.1152/ajplung.00287.2014; Sorheim IC, 2010, COPD, V7, P262, DOI 10.3109/15412555.2010.496821; Srisuma S, 2010, AM J RESP CRIT CARE, V181, P838, DOI 10.1164/rccm.200904-0544OC; Sun H, 2001, NAT IMMUNOL, V2, P1040, DOI 10.1038/ni721; Terada M, 2004, AM J RESP CRIT CARE, V169, P373, DOI 10.1164/rccm.200308-1156OC; VAUGHAN PJ, 1993, J BIOL CHEM, V268, P3720; Wakida N, 2006, KIDNEY INT, V70, P1432, DOI 10.1038/sj.ki.5001787; Zhu G, 2007, AM J RESP CRIT CARE, V176, P167, DOI 10.1164/rccm.200611-1723OC	59	17	18	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2615	2626		10.1096/fj.201500159R	http://dx.doi.org/10.1096/fj.201500159R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	27059719	Green Published			2022-12-28	WOS:000379249500016
J	He, Y; Pan, SY; Xu, MJ; He, RN; Huang, W; Song, PP; Huang, JN; Zhang, HT; Hu, Y				He, Yong; Pan, Suyue; Xu, Miaojing; He, Rongni; Huang, Wei; Song, Pingping; Huang, Jianou; Zhang, Han-Ting; Hu, Yafang			Adeno-associated virus 9-mediated Cdk5 inhibitory peptide reverses pathologic changes and behavioral deficits in the Alzheimer's disease mouse model	FASEB JOURNAL			English	Article						AAV9; CIP; tau pathology; beta-amyloid	CYCLIN-DEPENDENT KINASE-5; PAIRED HELICAL FILAMENTS; PROTEIN-TAU TAU; A-BETA; NEURODEGENERATION; PHOSPHORYLATION; ACTIVATOR; MICE; P25; P35	Cyclin-dependent kinase 5 (Cdk5), which binds to and is activated by p35, phosphorylates multiple substrates and plays an essential role in the development and function of the CNS; however, proteolytic production of p25 from p35 under stress conditions leads to the inappropriate activation of Cdk5 and contributes to hyper-phosphorylation of tau and other substrates that are related to the pathogenesis of Alzheimer's disease. Selective inhibition of aberrant Cdk5 activity via genetic overexpression of Cdk5 inhibitory peptide (CIP) reduces pathologic changes and prevents brain atrophy and memory loss in p25-transgenic mice. In the present study, we delivered adeno-associated virus 9 carrying green fluorescent protein-CIP (AAV9-GFP-CIP) to brain cells via intra-cerebroventricular infusion in amyloid precursor protein/presenilin 1 (APP/PS1) double-transgenic 3-mo-old mice after the occurrence of beta-amyloid (A beta) aggregation and the hyperphosphorylation of tau. Three months of treatment of AAV9-GFP-CIP reduced pathologic changes, including tau hyperphosphorylation, (A beta) deposit, astrocytosis, and microgliosis, which were correlated with the reversal of memory loss and anxiety-like behavior observed in APP/PS1 mice. The neuroprotection effect of AAV9-GFP-CIP lasted an additional 7 mo-the end point of the study. These findings provide a novel strategy to selectively target Cdk5 for the treatment of Alzheimer's disease.	[He, Yong; Pan, Suyue; Xu, Miaojing; Song, Pingping; Hu, Yafang] Southern Med Univ, Nanfang Hosp, Dept Neurol, 1838 Guangzhou Ave North, Guangzhou 510515, Guangdong, Peoples R China; [He, Yong] First Peoples Hosp Chenzhou, Dept Neurol, Chenzhou, Peoples R China; [He, Rongni; Huang, Wei] Southern Med Univ, Zhujiang Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Huang, Jianou] 421 Hosp, Dept Neurol, Guangzhou, Guangdong, Peoples R China; [Zhang, Han-Ting] West Virginia Univ, Hlth Sci Ctr, Dept Behav Med & Psychiat, Morgantown, WV USA; [Zhang, Han-Ting] West Virginia Univ, Hlth Sci Ctr, Dept Physiol & Pharmacol, Morgantown, WV USA	Southern Medical University - China; Southern Medical University - China; West Virginia University; West Virginia University	Hu, Y (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Neurol, 1838 Guangzhou Ave North, Guangzhou 510515, Guangdong, Peoples R China.	yafanghu@smu.edu.cn		Pan, Suyue/0000-0003-2744-1984	National Nature Science Fund of China [81271430]; Guangdong Provincial Universities fund for Experts Recruitment Program [2012-328]	National Nature Science Fund of China(National Natural Science Foundation of China (NSFC)); Guangdong Provincial Universities fund for Experts Recruitment Program	This work was supported by the National Nature Science Fund of China (Grant 81271430) and Guangdong Provincial Universities fund (2012-328) for Experts Recruitment Program (to Y.H.). A patent application (HX2016-187) has been filed regarding AAV9-GFP-CIP as a potential therapeutic method for AD.	Ahlijanian MK, 2000, P NATL ACAD SCI USA, V97, P2910, DOI 10.1073/pnas.040577797; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Bian F, 2002, J COMP NEUROL, V446, P257, DOI 10.1002/cne.10186; Binukumar BK, 2015, MOL BIOL CELL, V26, P4478, DOI 10.1091/mbc.E15-06-0415; Castro-Alvarez JF, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00243; Cruz JC, 2003, NEURON, V40, P471, DOI 10.1016/S0896-6273(03)00627-5; Dashkoff J, 2016, MOL THER-METH CLIN D, V3, DOI 10.1038/mtm.2016.81; Gerard C, 2014, MOL THER-METH CLIN D, V1, DOI 10.1038/mtm.2014.44; Glicksman MA, 2007, CURR ALZHEIMER RES, V4, P547, DOI 10.2174/156720507783018181; Goncalves MAFV, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-43; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Helal CJ, 2009, BIOORG MED CHEM LETT, V19, P5703, DOI 10.1016/j.bmcl.2009.08.019; Huang KB, 2015, CRIT CARE MED, V43, pE341, DOI 10.1097/CCM.0000000000001093; Kerokoski P, 2001, BIOCHEM BIOPH RES CO, V280, P998, DOI 10.1006/bbrc.2001.4240; KOSIK KS, 1986, P NATL ACAD SCI USA, V83, P4044, DOI 10.1073/pnas.83.11.4044; Kurt MA, 2003, NEUROBIOL DIS, V14, P89, DOI 10.1016/S0969-9961(03)00084-6; LEE VMY, 1991, SCIENCE, V251, P675, DOI 10.1126/science.1899488; Lok K, 2013, J NEUROL SCI, V335, P145, DOI 10.1016/j.jns.2013.09.018; Mah L, 2015, AM J GERIAT PSYCHIAT, V23, P466, DOI 10.1016/j.jagp.2014.10.005; Markel SF, 2017, J NEUROCHEM, V140, P216, DOI 10.1111/jnc.13861; Markiewicz I, 2006, ACTA NEUROBIOL EXP, V66, P343; Menn B, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012117; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Muyllaert D, 2008, AM J PATHOL, V172, P470, DOI 10.2353/ajpath.2008.070693; Nguyen MD, 2001, NEURON, V30, P135, DOI 10.1016/S0896-6273(01)00268-9; Nikolic M, 1996, GENE DEV, V10, P816, DOI 10.1101/gad.10.7.816; Oddo S, 2003, NEURON, V39, P409, DOI 10.1016/S0896-6273(03)00434-3; Ohshima T, 1996, P NATL ACAD SCI USA, V93, P11173, DOI 10.1073/pnas.93.20.11173; Patrick GN, 1999, NATURE, V402, P615, DOI 10.1038/45159; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Qu D, 2007, NEURON, V55, P37, DOI 10.1016/j.neuron.2007.05.033; Remondes M, 2004, NATURE, V431, P699, DOI 10.1038/nature02965; Rupp NJ, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.08.014; Sadleir KR, 2015, MOL NEURODEGENER, V10, DOI 10.1186/1750-1326-10-1; Shukla V, 2011, ADV PHARMACOL SCI, V2011, DOI 10.1155/2011/572634; Shukla V, 2013, FASEB J, V27, P174, DOI 10.1096/fj.12-217497; Smith PD, 2003, P NATL ACAD SCI USA, V100, P13650, DOI 10.1073/pnas.2232515100; Su SC, 2011, ANNU REV CELL DEV BI, V27, P465, DOI 10.1146/annurev-cellbio-092910-154023; Sundaram JR, 2012, J NEUROSCI, V32, P1020, DOI 10.1523/JNEUROSCI.5177-11.2012; Sundaram JR, 2013, J NEUROSCI, V33, P334, DOI 10.1523/JNEUROSCI.3593-12.2013; Takashima A, 2001, NEUROSCI LETT, V306, P37, DOI 10.1016/S0304-3940(01)01864-X; Weinberg MS, 2013, NEUROPHARMACOLOGY, V69, P82, DOI 10.1016/j.neuropharm.2012.03.004; Zhang HT, 2008, NEUROPSYCHOPHARMACOL, V33, P1611, DOI 10.1038/sj.npp.1301537; Zhang QS, 2016, NEUROSCI LETT, V632, P1, DOI 10.1016/j.neulet.2016.08.023; Zhao CX, 2015, MOL THER, V23, P866, DOI 10.1038/mt.2015.29; Zheng YL, 2005, EMBO J, V24, P209, DOI 10.1038/sj.emboj.7600441; Zheng YL, 2002, EUR J BIOCHEM, V269, P4427, DOI 10.1046/j.1432-1033.2002.03133.x; Zhou X, 2016, J ALZHEIMERS DIS, V53, P843, DOI 10.3233/JAD-160191; Zou DH, 2016, ONCOTARGET, V7, P39148, DOI 10.18632/oncotarget.9834	49	13	13	1	12	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2017	31	8					3383	3392		10.1096/fj.201700064R	http://dx.doi.org/10.1096/fj.201700064R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VS	28420695				2022-12-28	WOS:000405932400017
J	Li, ZR; Zhang, J; Mulholland, M; Zhang, WZ				Li, Ziru; Zhang, Jing; Mulholland, Michael; Zhang, Weizhen			mTOR activation protects liver from ischemia/reperfusion-induced injury through NF-kappa B pathway	FASEB JOURNAL			English	Article						hepatic steatosis; IKKI3; nuclear translocation; TSC1	NONALCOHOLIC FATTY LIVER; REPERFUSION INJURY; MAMMALIAN TARGET; MOUSE-LIVER; RAPAMYCIN; ISCHEMIA; COMPLEX; METABOLISM; AUTOPHAGY; DISEASE	Hepatic steatosis renders liver more vulnerable to ischemia/reperfusion injury (IRI), which commonly occurs in transplantation, trauma, and liver resection. The underlying mechanism is not fully characterized. We aimed to clarify the role of mechanistic target of rapamycin (mTOR) signaling in hepatic ischemidreperfusion injury (HIRI) in normal and steatotic liver using Alb-TSC1(-/-) (AT) and Alb-mTOR(-/-) (Am) transgenic mice. Steatotic liver induced by high-fat diet was more vulnerable to IRI. Activation of hepatic mTOR in AT mice decreased lipid accumulation attenuated HIRI as measured by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining, circulating levels of alanine aminotransferase and lactate dehydrogenase, and inflammatory mediators such as monocyte chemoattractant protein 1 (MCP-1), TNF-alpha, and IL-6 and hepatic cleaved caspase 3 in mice fed either a normal chow diet or a high-fat diet. The effects of mTOR activation on hepatic cleaved caspase 3 were reversed by rapamycin, an inhibitor of mTOR signaling. Inhibition of hepatic mTOR in Am mice increased hepatic lipid deposition and HIRI. The increment in hepatic susceptibility to IRI was significantly attenuated by pretreatment with IKKI3 inhibitor. Further, suppression of mTOR facilitated nuclear translocation of NF-KB p65. In conclusion, our study suggests that mTOR activity in hepatocytes decreases hepatic vulnerability to injury through a mechanism dependent on NF-KB proinflammatory cytokine signaling pathway in both normal and steatotic liver. Li, Z., Zhang, J., Mulholland, M., Zhang, W. mTOR activation protects liver from ischemia/ reperfusion-induced injury through NF-KB pathway.	[Li, Ziru; Zhang, Jing; Mulholland, Michael; Zhang, Weizhen] Univ Michigan, Med Ctr, Dept Surg, Ann Arbor, MI 48109 USA; [Zhang, Weizhen] Peking Univ, Hlth Sci Ctr, Dept Physiol & Pathophysiol, Beijing, Peoples R China	University of Michigan System; University of Michigan; Peking University	Mulholland, M (corresponding author), Univ Michigan, Med Ctr, Dept Surg, MSII, 4618B,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.; Zhang, WZ (corresponding author), Univ Michigan, Med Ctr, Dept Physiol & Pathophysiol, MSII, 4618B,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	micham@umich.edu; weizhenz@umich.edu	zhang, weizhen/K-1484-2018	zhang, weizhen/0000-0001-8791-2798; Li, Ziru/0000-0002-2755-9299	National Natural Science Foundation of China [81330010, 81390354]; American Diabetes Association [1-13-BS-225]; U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases [1R01DK110273-01A1]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK110273] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); American Diabetes Association(American Diabetes Association); U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in part, by grants from the National Natural Science Foundation of China (81330010 and 81390354; to J.Z. and W.Z.), the American Diabetes Association (1-13-BS-225; to Z.L.), and the U.S. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (1R01DK110273-01A1; to M.M. and W.Z.). The authors declare no conflicts of interest.	Ai D, 2012, J CLIN INVEST, V122, P1677, DOI 10.1172/JCI61248; Bae EJ, 2012, J BIOL CHEM, V287, P18769, DOI 10.1074/jbc.M112.365544; Busaidy NL, 2012, J CLIN ONCOL, V30, P2919, DOI 10.1200/JCO.2011.39.7356; Chaveroux C, 2013, CELL METAB, V17, P586, DOI 10.1016/j.cmet.2013.03.003; Fouraschen Suomi Mg, 2013, World J Transplant, V3, P36, DOI 10.5500/wjt.v3.i3.36; Gulati P, 2007, BIOCHEM SOC T, V35, P236, DOI 10.1042/BST0350236; Houde VP, 2010, DIABETES, V59, P1338, DOI 10.2337/db09-1324; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacobs MD, 1998, CELL, V95, P749, DOI 10.1016/S0092-8674(00)81698-0; Kang JW, 2014, CELL PHYSIOL BIOCHEM, V33, P23, DOI 10.1159/000356647; Kenerson HL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117000; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Luedde T, 2005, J CLIN INVEST, V115, P849, DOI 10.1172/JCI200523493; Palmes D, 2008, VIRCHOWS ARCH, V452, P545, DOI 10.1007/s00428-008-0604-y; PALOMBELLA VJ, 1994, CELL, V78, P773, DOI 10.1016/S0092-8674(94)90482-0; Ringelhan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046469; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Selzner M, 2001, SEMIN LIVER DIS, V21, P105, DOI 10.1055/s-2001-12933; Sheng M, 2015, TRANSPL P, V47, P275, DOI 10.1016/j.transproceed.2015.01.010; Shimada S, 2015, SURG TODAY, V45, P892, DOI 10.1007/s00595-014-1064-4; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; Wan FY, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a000067; Wang YG, 2010, MOL MED REP, V3, P909, DOI 10.3892/mmr.2010.365; Wang YH, 2015, NAT REV MOL CELL BIO, V16, P678, DOI 10.1038/nrm4074; Wertz IE, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003350; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xu G, 2012, DIABETOLOGIA, V55, P1813, DOI 10.1007/s00125-012-2509-1; Zhu J, 2015, TRANSPL P, V47, P1646, DOI 10.1016/j.transproceed.2015.05.013; Zhu JJ, 2015, TRANSPLANTATION, V99, P48, DOI 10.1097/TP.0000000000000476	29	27	29	0	12	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3018	3026		10.1096/fj.201601278R	http://dx.doi.org/10.1096/fj.201601278R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28356345	Green Published			2022-12-28	WOS:000405931000026
J	Ricci, E; Ronchetti, S; Pericolini, E; Gabrielli, E; Cari, L; Gentili, M; Roselletti, E; Migliorati, G; Vecchiarelli, A; Riccardi, C				Ricci, Erika; Ronchetti, Simona; Pericolini, Eva; Gabrielli, Elena; Cari, Luigi; Gentili, Marco; Roselletti, Elena; Migliorati, Graziella; Vecchiarelli, Anna; Riccardi, Carlo			Role of the glucocorticoid-induced leucine zipper gene in dexamethasone-induced inhibition of mouse neutrophil migration via control of annexin A1 expression	FASEB JOURNAL			English	Article						inflammation; peritonitis; transcription	NF-KAPPA-B; IN-VIVO; GILZ EXPRESSION; T-LYMPHOCYTES; CELL-SURFACE; INFLAMMATION; PU.1; RECEPTOR; BINDING; PROTEIN	The glucocorticoid-induced leucine zipper (GILZ) gene is a pivotal mediator of the anti-inflammatory effects of glucocorticoids (GCs) that are known to regulate the function of both adaptive and innate immunity cells. Our aim was to investigate the role of GILZ in GC-induced inhibition of neutrophil migration, as this role has not been investigated before. We found that GILZ expression was induced by dexamethasone (DEX), a synthetic GC, in neutrophils, and that it regulated migration of these cells into inflamed tissues under DEX treatment. Of note, inhibition of neutrophil migration was not observed in GILZ-knockout mice with peritonitis that were treated by DEX. This was because DEX was unable to up-regulate annexin Al (Anxal) expression in the absence of GILZ. Furthermore, we showed that GILZ mediates Anxal induction by GCs by transactivating Anxal expression at the promoter level via binding with the transcription factor, PU.1. The present findings shed light on the role of GILZ in the mechanism of induction of Anxal by GCs. As Anxal is an important protein for the resolution of inflammatory response, GILZ may represent a new pharmacologic target for treatment of inflammatory diseases. Ricci, E., Ronchetti, S., Pericolini, E., Gabrielli, E., Cari, L., Gentili, M., Roselletti, E., Migliorati, G., Vecchiarelli, A., Riccardi, C. Role of the glucocorticoid-induced leucine zipper gene in dexamethasone-induced inhibition of mouse neutrophil migration via control of annexin Al expression.	[Ricci, Erika; Ronchetti, Simona; Cari, Luigi; Gentili, Marco; Migliorati, Graziella; Riccardi, Carlo] Univ Perugia, Dept Med, Pharmacol Sect, Ple Lucio Severi 1, I-06132 Perugia, Italy; [Pericolini, Eva; Gabrielli, Elena; Roselletti, Elena; Vecchiarelli, Anna] Univ Perugia, Dept Expt Med, Microbiol Sect, Perugia, Italy; [Pericolini, Eva] Univ Modena & Reggio Emilia, Dept Diagnost Clin & Publ Hlth Med, Modena, Italy	University of Perugia; University of Perugia; Universita di Modena e Reggio Emilia	Riccardi, C (corresponding author), Univ Perugia, Dept Med, Pharmacol Sect, Ple Lucio Severi 1, I-06132 Perugia, Italy.	carlo.riccardi@unipg.it	Riccardi, Carlo/N-4610-2014; Gentili, Marco/ABA-7786-2021; Pericolini, Eva/AAZ-5848-2021; Cari, Luigi/P-4428-2019; Cari, Luigi/I-8598-2018; Ronchetti, Simona/L-2325-2013	Riccardi, Carlo/0000-0001-9257-3997; Gentili, Marco/0000-0002-2305-4488; Cari, Luigi/0000-0003-0698-3872; Cari, Luigi/0000-0003-0698-3872; Ronchetti, Simona/0000-0002-5639-4243; Pericolini, Eva/0000-0002-5299-8197; MIGLIORATI, Graziella/0000-0002-9475-6399; Roselletti, Elena/0000-0003-3929-7502; Vecchiarelli, Anna/0000-0002-3185-6720	Associazione Italiana per la Ricerca sul Cancro (Milan, Italy) [IG14291]	Associazione Italiana per la Ricerca sul Cancro (Milan, Italy)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by the Associazione Italiana per la Ricerca sul Cancro (Milan, Italy; Grant IG14291 to C.R.)	Alves JC, 2009, P NATL ACAD SCI USA, V106, P4018, DOI 10.1073/pnas.0900196106; Antonicelli F, 2001, EUR J BIOCHEM, V268, P62, DOI 10.1046/j.1432-1327.2001.01840.x; Ayroldi E, 2015, CELL DEATH DIFFER, V22, P118, DOI 10.1038/cdd.2014.129; Ayroldi E, 2002, MOL CELL BIOL, V22, P7929, DOI 10.1128/MCB.22.22.7929-7941.2002; Ayroldi E, 2007, J CLIN INVEST, V117, P1605, DOI 10.1172/JCI30724; Ayroldi E, 2014, FASEB J, V28, P5055, DOI 10.1096/fj.14-254755; Ayroldi E, 2009, FASEB J, V23, P3649, DOI 10.1096/fj.09-134684; Bereshchenko O, 2014, CELL REP, V7, P464, DOI 10.1016/j.celrep.2014.03.004; Bruscoli S, 2015, BLOOD, V126, P1790, DOI 10.1182/blood-2015-03-631580; Bruscoli S, 2012, J BIOL CHEM, V287, P1242, DOI 10.1074/jbc.M111.316372; Cannarile L, 2006, BLOOD, V107, P1039, DOI 10.1182/blood-2005-05-2183; Cari Luigi, 2015, Results Immunol, V5, P37, DOI 10.1016/j.rinim.2015.10.003; Chatterjee BE, 2005, J LEUKOCYTE BIOL, V78, P639, DOI 10.1189/jlb.0405206; CHEN HM, 1995, BLOOD, V85, P2918, DOI 10.1182/blood.V85.10.2918.bloodjournal85102918; Cheng Q, 2014, FRONT PHARMACOL, V5, DOI 10.3389/fphar.2014.00169; Cheng Q, 2013, J IMMUNOL, V191, P424, DOI 10.4049/jimmunol.1202662; Cohen N, 2006, BLOOD, V107, P2037, DOI 10.1182/blood-2005-07-2760; CRONSTEIN BN, 1992, P NATL ACAD SCI USA, V89, P9991, DOI 10.1073/pnas.89.21.9991; D'Acunto CW, 2014, CELL SIGNAL, V26, P173, DOI 10.1016/j.cellsig.2013.09.020; D'Adamio F, 1997, IMMUNITY, V7, P803, DOI 10.1016/S1074-7613(00)80398-2; da Cunha EE, 2012, PULM PHARMACOL THER, V25, P303, DOI 10.1016/j.pupt.2012.04.002; Dalli J, 2008, BLOOD, V112, P2512, DOI 10.1182/blood-2008-02-140533; Damazo AS, 2006, J IMMUNOL, V176, P4410, DOI 10.4049/jimmunol.176.7.4410; de Coupade C, 2003, BRIT J PHARMACOL, V140, P133, DOI 10.1038/sj.bjp.0705413; Delfino DV, 2006, INT IMMUNOPHARMACOL, V6, P1126, DOI 10.1016/j.intimp.2006.02.001; Di Marco B, 2007, NUCLEIC ACIDS RES, V35, P517, DOI 10.1093/nar/gkl1080; Espinasse MA, 2016, J INNATE IMMUN, V8, P81, DOI 10.1159/000439052; Futosi K, 2013, INT IMMUNOPHARMACOL, V17, P638, DOI 10.1016/j.intimp.2013.06.034; Gabrielli E, 2016, VIRULENCE, V7, P819, DOI 10.1080/21505594.2016.1184385; Gastardelo TS, 2009, AM J PATHOL, V174, P177, DOI 10.2353/ajpath.2009.080342; Geering B, 2013, TRENDS IMMUNOL, V34, P398, DOI 10.1016/j.it.2013.04.002; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Gimenes AD, 2015, EXP EYE RES, V134, P24, DOI 10.1016/j.exer.2015.03.013; Girol AP, 2013, J IMMUNOL, V190, P5689, DOI 10.4049/jimmunol.1202030; Glowacka E, 2010, ADV MED SCI-POLAND, V55, P254, DOI 10.2478/v10039-010-0037-0; Gunzer M, 2014, BRIT J HAEMATOL, V164, P189, DOI 10.1111/bjh.12608; Hannon R, 2002, FASEB J, V16, P253, DOI 10.1096/fj.02-0239fje; HARRIS JG, 1995, EUR J PHARMACOL, V279, P149, DOI 10.1016/0014-2999(95)00145-B; Hayhoe RPG, 2006, BLOOD, V107, P2123, DOI 10.1182/blood-2005-08-3099; Hoppstadter J, 2015, J IMMUNOL, V194, P6057, DOI 10.4049/jimmunol.1403207; Iseki Y, 2009, LEUKEMIA RES, V33, P1658, DOI 10.1016/j.leukres.2009.04.010; Lecona E, 2008, MOL CELL BIOL, V28, P4665, DOI 10.1128/MCB.00650-07; Leech M, 1998, CLIN EXP IMMUNOL, V112, P383; Maitra S, 2000, MOL CELL BIOL, V20, P1911, DOI 10.1128/MCB.20.6.1911-1922.2000; MANCUSO F, 1995, J IMMUNOL, V155, P377; Mittelstadt PR, 2001, J BIOL CHEM, V276, P29603, DOI 10.1074/jbc.M101522200; Perretti M, 2000, CELL BIOL INT, V24, P163, DOI 10.1006/cbir.1999.0468; Perretti M, 2009, BRIT J PHARMACOL, V158, P936, DOI 10.1111/j.1476-5381.2009.00483.x; Perretti M, 2009, NAT REV IMMUNOL, V9, P62, DOI 10.1038/nri2470; RAYNAL P, 1994, BBA-REV BIOMEMBRANES, V1197, P63, DOI 10.1016/0304-4157(94)90019-1; Riccardi C, 2001, ADV EXP MED BIOL, V495, P31; Rocksen D, 2000, CLIN EXP IMMUNOL, V122, P249, DOI 10.1046/j.1365-2249.2000.01373.x; Rogers JH, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/3983686; Ronchetti S, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00170; Schramm R, 2004, INFLAMM RES, V53, P644, DOI 10.1007/s00011-004-1307-8; Solomon LA, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1303-0; Srinivasan M, 2011, J BIOL CHEM, V286, P44799, DOI 10.1074/jbc.M111.279257; Stopka T, 2005, EMBO J, V24, P3712, DOI 10.1038/sj.emboj.7600834; Sugimoto MA, 2016, J IMMUNOL RES, V2016, DOI 10.1155/2016/8239258; Throm SL, 2003, J LEUKOCYTE BIOL, V74, P111, DOI 10.1189/jlb.0203061; Vago JP, 2015, J IMMUNOL, V194, P4940, DOI 10.4049/jimmunol.1401722; Vago JP, 2012, J LEUKOCYTE BIOL, V92, P249, DOI 10.1189/jlb.0112008; Vicari L, 2006, LEUKEMIA, V20, P2208, DOI 10.1038/sj.leu.2404447; Wang J, 2014, ANN NY ACAD SCI, V1319, P66, DOI 10.1111/nyas.12445; Yang YH, 2009, J IMMUNOL, V183, P1435, DOI 10.4049/jimmunol.0804000; Zhang P, 2000, BLOOD, V96, P2641	66	27	28	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2017	31	7					3054	3065		10.1096/fj.201601315R	http://dx.doi.org/10.1096/fj.201601315R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	FB1VF	28373208				2022-12-28	WOS:000405931000029
J	Osinga, TE; Links, TP; Dullaart, RPF; Pacak, K; van der Horst-Schrivers, ANA; Kerstens, MN; Kema, IP				Osinga, Thamara E.; Links, Thera P.; Dullaart, Robin P. F.; Pacak, Karel; van der Horst-Schrivers, Anouk N. A.; Kerstens, Michiel N.; Kema, Ido P.			Emerging role of dopamine in neovascularization of pheochromocytoma and paraganglioma	FASEB JOURNAL			English	Review						angiogenesis; hypoxia-inducible factor; VEGF	HYDROXYLASE GENE-EXPRESSION; CELL LUNG-CANCER; TYROSINE-HYDROXYLASE; RECEPTOR EXPRESSION; URINARY-EXCRETION; TUMOR-GROWTH; CATECHOLAMINE METABOLISM; MONOAMINE TRANSPORTERS; PERIVASCULAR NERVES; GERMLINE MUTATIONS	Dopamine is a catecholamine that acts both as a neurotransmitter and as a hormone, exerting its functions via dopamine (DA) receptors that are present in a broad variety of organs and cells throughout the body. In the circulation, DA is primarily stored in and transported by blood platelets. Recently, the important contribution of DA in the regulation of angiogenesis has been recognized. In vitro and in vivo studies have shown that DA inhibits angiogenesis through activation of the DA receptor type 2. Overproduction of catecholamines is the biochemical hallmark of pheochromocytoma (PCC) and paraganglioma (PGL). The increased production of DA has been shown to be an independent predictor of malignancy in these tumors. The precise relationship underlying the association between DA production and PCC and PGL behavior needs further clarification. Herein, we review the biochemical and physiologic aspects of DA with a focus on its relations with VEGF and hypoxia inducible factor related angiogenesis pathways, with special emphasis on DA producing PCC and PGL.	[Osinga, Thamara E.; Links, Thera P.; Dullaart, Robin P. F.; van der Horst-Schrivers, Anouk N. A.; Kerstens, Michiel N.] Univ Groningen, Univ Med Ctr Groningen, Dept Endocrinol, Groningen, Netherlands; [Kema, Ido P.] Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [Pacak, Karel] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, NIH, Bethesda, MD USA	University of Groningen; University of Groningen; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Kema, IP (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Lab Med, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	i.p.kema@umcg.nl						Adam J, 2014, ONCOGENE, V33, P2547, DOI 10.1038/onc.2013.222; Amar L, 2005, J CLIN ENDOCR METAB, V90, P2110, DOI 10.1210/jc.2004-1398; ANGGARD E, 1974, LIFE SCI, V15, P111, DOI 10.1016/0024-3205(74)90199-4; Ashraf S, 1996, BRIT J CANCER, V73, P349, DOI 10.1038/bjc.1996.60; Ashraf S, 1997, CLIN EXP METASTAS, V15, P484, DOI 10.1023/A:1018466608614; Astuti D, 2011, ENDOCR-RELAT CANCER, V18, P73, DOI 10.1677/ERC-10-0113; Bambace NM, 2011, J THROMB HAEMOST, V9, P237, DOI 10.1111/j.1538-7836.2010.04131.x; BASU S, 1995, J NEUROIMMUNOL, V60, P1, DOI 10.1016/0165-5728(95)00044-3; Basu S, 2004, CANCER RES, V64, P5551, DOI 10.1158/0008-5472.CAN-04-1600; Basu S, 2000, J NEUROIMMUNOL, V102, P113, DOI 10.1016/S0165-5728(99)00176-9; Basu S, 2001, NAT MED, V7, P569, DOI 10.1038/87895; Basu S, 1997, DIGEST DIS SCI, V42, P1260, DOI 10.1023/A:1018862309440; Basu S, 1999, DIGEST DIS SCI, V44, P916, DOI 10.1023/A:1026644110737; Basu S, 2000, ENDOCRINE, V12, P237, DOI 10.1385/ENDO:12:3:237; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; BENOT AR, 1990, EUR J NEUROSCI, V2, P809, DOI 10.1111/j.1460-9568.1990.tb00473.x; Blank A, 2010, ENDOCR-RELAT CANCER, V17, P919, DOI 10.1677/ERC-09-0316; Borcherding DC, 2016, ONCOGENE, V35, P3103, DOI 10.1038/onc.2015.369; Bravo EL, 2003, ENDOCR REV, V24, P539, DOI 10.1210/er.2002-0013; Bromek E, 2011, J NEUROCHEM, V118, P806, DOI 10.1111/j.1471-4159.2011.07339.x; CARLSSON A, 1959, PHARMACOL REV, V11, P490; CARON MG, 2010, DOPAMINE HDB, P88; Caronti B, 2001, J NEURAL TRANSM, V108, P803, DOI 10.1007/s007020170030; Castro-Vega LJ, 2014, HUM MOL GENET, V23, P2440, DOI 10.1093/hmg/ddt639; Chakroborty D, 2004, CLIN CANCER RES, V10, P4349, DOI 10.1158/1078-0432.CCR-04-0059; Chakroborty D, 2008, J CLIN INVEST, V118, P1380, DOI 10.1172/JCI33125; Chakroborty D, 2011, P NATL ACAD SCI USA, V108, P20730, DOI 10.1073/pnas.1108696108; Chamary VL, 2000, EUR J SURG ONCOL, V26, P588, DOI 10.1053/ejso.2000.0952; Chen R, 2010, FUTUR NEUROL, V5, P123, DOI 10.2217/FNL.09.76; Cherubini E, 2016, J CELL PHYSIOL, V231, P345, DOI 10.1002/jcp.25079; Comino-Mendez I, 2011, NAT GENET, V43, P663, DOI 10.1038/ng.861; Cosentino M, 2007, BLOOD, V109, P632, DOI 10.1182/blood-2006-01-028423; Coughtrie MWH, 1998, CHEM-BIOL INTERACT, V109, P3, DOI 10.1016/S0009-2797(97)00117-8; Crona J, 2013, J CLIN ENDOCR METAB, V98, pE1266, DOI 10.1210/jc.2012-4257; CZYZYKKRZESKA MF, 1994, J BIOL CHEM, V269, P760; CZYZYKKRZESKA MF, 1992, J NEUROCHEM, V58, P1538, DOI 10.1111/j.1471-4159.1992.tb11376.x; Dahia PLM, 2005, PLOS GENET, V1, P72, DOI 10.1371/journal.pgen.0010008; DAPRADA M, 1979, BRIT J PHARMACOL, V65, P653; EISENHOFER G, 1992, CIRCULATION, V85, P1775, DOI 10.1161/01.CIR.85.5.1775; Eisenhofer G, 1997, J CLIN ENDOCR METAB, V82, P3864, DOI 10.1210/jc.82.11.3864; EISENHOFER G, 1995, AM J PHYSIOL-GASTR L, V268, pG641, DOI 10.1152/ajpgi.1995.268.4.G641; Eisenhofer G, 2004, ENDOCR-RELAT CANCER, V11, P897, DOI 10.1677/erc.1.00838; Eisenhofer G, 2004, PHARMACOL REV, V56, P331, DOI 10.1124/pr.56.3.1; Eisenhofer G, 2012, EUR J CANCER, V48, P1739, DOI 10.1016/j.ejca.2011.07.016; Eisenhofer G, 2012, ENDOCR PATHOL, V23, P4, DOI 10.1007/s12022-011-9188-1; Eisenhofer G, 2011, CLIN CHEM, V57, P411, DOI 10.1373/clinchem.2010.153320; Favier J, 1999, FEBS LETT, V462, P19, DOI 10.1016/S0014-5793(99)01476-3; Favier J, 2015, NAT REV ENDOCRINOL, V11, P101, DOI 10.1038/nrendo.2014.188; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Frankhauser P, 2006, NEUROSCI LETT, V399, P197, DOI 10.1016/j.neulet.2006.01.062; Gaal J, 2010, J CLIN ENDOCR METAB, V95, P1274, DOI 10.1210/jc.2009-2170; George SR, 2014, PROG BRAIN RES, V211, P183, DOI 10.1016/B978-0-444-63425-2.00008-8; Gimenez-Roqueplo AP, 2012, HORM METAB RES, V44, P328, DOI 10.1055/s-0031-1301302; Goldstein DS, 2008, CLIN CHEM, V54, P1864, DOI 10.1373/clinchem.2008.107193; Goldstein DS, 1999, J CLIN ENDOCR METAB, V84, P2523, DOI 10.1210/jc.84.7.2523; GRIMSBY J, 1991, P NATL ACAD SCI USA, V88, P3637, DOI 10.1073/pnas.88.9.3637; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Harris RC, 2012, CURR HYPERTENS REP, V14, P138, DOI 10.1007/s11906-012-0253-z; Hiroi T, 1998, BIOCHEM BIOPH RES CO, V249, P838, DOI 10.1006/bbrc.1998.9232; Hoffmann BR, 2013, PHYSIOL GENOMICS, V45, P1021, DOI 10.1152/physiolgenomics.00070.2013; Hohmann S, 2011, CELL TISSUE RES, V346, P151, DOI 10.1007/s00441-011-1256-9; Hrascan R, 2008, J NEUROENDOCRINOL, V20, P1015, DOI 10.1111/j.1365-2826.2008.01755.x; ISHIBASHI M, 1994, CANCER RES, V54, P3442; Italiano JE, 2008, BLOOD, V111, P1227, DOI 10.1182/blood-2007-09-113837; Jochmanova I, 2015, HORM CANCER-US, V6, P191, DOI 10.1007/s12672-015-0231-4; Jochmanova I, 2013, JNCI-J NATL CANCER I, V105, P1270, DOI 10.1093/jnci/djt201; Johansen JL, 2010, J NEUROCHEM, V115, P209, DOI 10.1111/j.1471-4159.2010.06917.x; Joseph V., 2003, OXYGEN SENSING RESPO, P482; Kaelin WG, 2005, ANNU REV BIOCHEM, V74, P115, DOI 10.1146/annurev.biochem.74.082803.133142; Kaelin WG, 2008, MOL CELL, V30, P393, DOI 10.1016/j.molcel.2008.04.009; Keith B, 2012, NAT REV CANCER, V12, P9, DOI 10.1038/nrc3183; KEMA IP, 1992, CLIN CHEM, V38, P1730; Kimura NCR, 2004, WHO CLASSIFICATION T, P159; Kirillova GP, 2008, J NEUROSCI METH, V174, P272, DOI 10.1016/j.jneumeth.2008.07.018; KLIEWER KE, 1989, HUM PATHOL, V20, P29, DOI 10.1016/0046-8177(89)90199-8; KOPIN IJ, 1964, PHARMACOL REV, V16, P179; KOPIN IJ, 1985, PHARMACOL REV, V37, P333; KUHAR M, 2006, BASIC NEUROCHEMISTRY; Ladroue C, 2008, NEW ENGL J MED, V359, P2685, DOI 10.1056/NEJMoa0806277; Laukova M, 2013, IMMUNOBIOLOGY, V218, P780, DOI 10.1016/j.imbio.2012.08.279; Leclere N, 2004, Prague Med Rep, V105, P291; Leknes S, 2008, NAT REV NEUROSCI, V9, P314, DOI 10.1038/nrn2333; Lenders JWM, 2005, LANCET, V366, P665, DOI 10.1016/S0140-6736(05)67139-5; Letouze E, 2013, CANCER CELL, V23, P739, DOI 10.1016/j.ccr.2013.04.018; Lorenzo FR, 2013, J MOL MED, V91, P507, DOI 10.1007/s00109-012-0967-z; Majmundar AJ, 2010, MOL CELL, V40, P294, DOI 10.1016/j.molcel.2010.09.022; McKenna F, 2002, J NEUROIMMUNOL, V132, P34, DOI 10.1016/S0165-5728(02)00280-1; MCMILLAN M, 1956, LANCET, V271, P284; Menko FH, 2014, FAM CANCER, V13, P637, DOI 10.1007/s10689-014-9735-2; Mezey E, 1996, P NATL ACAD SCI USA, V93, P10377, DOI 10.1073/pnas.93.19.10377; Millhorn DE, 1997, KIDNEY INT, V51, P527, DOI 10.1038/ki.1997.73; Milosevic J, 2007, J NEUROSCI, V27, P412, DOI 10.1523/JNEUROSCI.2482-06.2007; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; MOLINOFF PB, 1971, ANNU REV BIOCHEM, V40, P465, DOI 10.1146/annurev.bi.40.070171.002341; Moreno-Smith M, 2013, NEOPLASIA, V15, P502, DOI 10.1593/neo.121412; Moreno-Smith M, 2011, CLIN CANCER RES, V17, P3649, DOI 10.1158/1078-0432.CCR-10-2441; NAGATSU T, 1973, BIOCH CATECHOLAMINES; Neumann HPH, 2002, NEW ENGL J MED, V346, P1459, DOI 10.1056/NEJMoa020152; Nguyen MVC, 2007, J NEUROSCI RES, V85, P1119, DOI 10.1002/jnr.21202; Osinga TE, 2016, CLIN CHEM LAB MED, V54, P1395, DOI 10.1515/cclm-2015-0631; Osinga TE, 2015, NEUROENDOCRINOLOGY, V101, P289, DOI 10.1159/000377703; Pacak K, 2007, PHEOCHROMOCYTOMA DIA; Pacak K, 2013, J CLIN ONCOL, V31, P1690, DOI 10.1200/JCO.2012.47.1912; Pardridge WM, 2007, DRUG DISCOV TODAY, V12, P54, DOI 10.1016/j.drudis.2006.10.013; Parsons SM, 2000, FASEB J, V14, P2423, DOI 10.1096/fj.00-0203rev; PEARSE AGE, 1969, J HISTOCHEM CYTOCHEM, V17, P303, DOI 10.1177/17.5.303; Perreault ML, 2014, NEUROPSYCHOPHARMACOL, V39, P156, DOI 10.1038/npp.2013.148; Pivonello R, 2004, J CLIN ENDOCR METAB, V89, P4493, DOI 10.1210/jc.2003-031746; PODOLIN DA, 1991, J APPL PHYSIOL, V71, P1427, DOI 10.1152/jappl.1991.71.4.1427; Pradeep C R, 2005, Integr Cancer Ther, V4, P315, DOI 10.1177/1534735405282557; Prandoni P, 2005, LANCET ONCOL, V6, P401, DOI 10.1016/S1470-2045(05)70207-2; Qin YJ, 2010, NAT GENET, V42, P229, DOI 10.1038/ng.533; Rios M, 1999, J NEUROSCI, V19, P3519; Robinson R., 1980, TUMOURS SECRETE CATE; Roy S., 2016, J BIOL CHEM; Rubi B, 2005, J BIOL CHEM, V280, P36824, DOI 10.1074/jbc.M505560200; Rubi B, 2010, ENDOCRINOLOGY, V151, P5570, DOI 10.1210/en.2010-0745; Salamone JD, 2012, NEURON, V76, P470, DOI 10.1016/j.neuron.2012.10.021; SALDANA MJ, 1973, HUM PATHOL, V4, P251, DOI 10.1016/S0046-8177(73)80012-7; Salman S, 2014, J EXP BIOL, V217, P673, DOI 10.1242/jeb.086165; SANCHEZFERRER A, 1995, BBA-PROTEIN STRUCT M, V1247, P1; Sarkar C, 2008, CLIN CANCER RES, V14, P2502, DOI 10.1158/1078-0432.CCR-07-1778; Sarkar C, 2013, J NEUROIMMUNE PHARM, V8, P7, DOI 10.1007/s11481-012-9395-7; Saveanu A, 2013, J CLIN ENDOCR METAB, V98, pE1951, DOI 10.1210/jc.2013-2269; Saveanu A, 2011, ENDOCR-RELAT CANCER, V18, P287, DOI 10.1530/ERC-10-0175; Schlisio S, 2008, GENE DEV, V22, P884, DOI 10.1101/gad.1648608; Schnell PO, 2003, J NEUROCHEM, V85, P483, DOI 10.1046/j.1471-4159.2003.01696.x; Schovanek J, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-523; SCHULDINER S, 1995, PHYSIOL REV, V75, P369, DOI 10.1152/physrev.1995.75.2.369; Schultz W, 2007, ANNU REV NEUROSCI, V30, P259, DOI 10.1146/annurev.neuro.28.061604.135722; Senogles SE, 2007, ANTI-CANCER DRUG, V18, P801, DOI 10.1097/CAD.0b013e3280b10d36; Shah U, 2012, MINERVA ENDOCRINOL, V37, P141; Shimazu S, 2012, EUR J ENDOCRINOL, V166, P383, DOI 10.1530/EJE-11-0656; Shome S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025215; Shtukmaster S, 2013, NEURAL DEV, V8, DOI 10.1186/1749-8104-8-12; Sorriento D, 2012, HYPERTENSION, V60, P129, DOI 10.1161/HYPERTENSIONAHA.111.189605; Tang F, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4284; TELENIUSBERG M, 1987, ACTA MED SCAND, V222, P351; Thompson RJ, 1997, J PHYSIOL-LONDON, V498, P503, DOI 10.1113/jphysiol.1997.sp021876; Torres GE, 2003, NAT REV NEUROSCI, V4, P13, DOI 10.1038/nrn1008; van der Horst-Schrivers ANA, 2010, ANTICANCER RES, V30, P5153; van Duinen N, 2013, EUR J ENDOCRINOL, V169, P377, DOI 10.1530/EJE-13-0529; van Duinen N, 2010, J CLIN ENDOCR METAB, V95, P209, DOI 10.1210/jc.2009-1632; van Hulsteijn LT, 2012, J MED GENET, V49, P768, DOI 10.1136/jmedgenet-2012-101192; Wang Q, 2012, BIOCHEM BIOPH RES CO, V417, P197, DOI 10.1016/j.bbrc.2011.11.084; Waterfall JJ, 2014, BIOCHEM BIOPH RES CO, V455, P16, DOI 10.1016/j.bbrc.2014.08.003; Welander J, 2011, ENDOCR-RELAT CANCER, V18, pR253, DOI 10.1530/ERC-11-0170; WICK MM, 1978, J INVEST DERMATOL, V71, P163, DOI 10.1111/1523-1747.ep12546959.1; WILLEMS JL, 1985, PHARMACOL REV, V37, P165; Willemsen MA, 2010, BRAIN, V133, P1810, DOI 10.1093/brain/awq087; Wimalasena K, 2011, MED RES REV, V31, P483, DOI 10.1002/med.20187; Yang CZ, 2015, J MOL MED, V93, P93, DOI 10.1007/s00109-014-1205-7; Zarei S, 2006, J THROMB HAEMOST, V4, P1588, DOI 10.1111/j.1538-7836.2006.01998.x; Zeng CY, 2011, HYPERTENSION, V57, P11, DOI 10.1161/HYPERTENSIONAHA.110.157727; Zhao W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065860; Zhuang ZP, 2012, NEW ENGL J MED, V367, P922, DOI 10.1056/NEJMoa1205119; Zimna A, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/549412; Zornberg GL, 2000, LANCET, V356, P1219, DOI 10.1016/S0140-6736(00)02784-7	160	8	9	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUN	2017	31	6					2226	2240		10.1096/fj.201601131R	http://dx.doi.org/10.1096/fj.201601131R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EV2AB	28264974	Green Published			2022-12-28	WOS:000401553400002
J	Antonelli, M; Kushner, I				Antonelli, Maria; Kushner, Irving			It's time to redefine inflammation	FASEB JOURNAL			English	Review						C-reactive protein; unfolded protein response; homeostasis; Claude Bernard; innate immunity	C-REACTIVE PROTEIN; ENDOPLASMIC-RETICULUM STRESS; CORONARY-HEART-DISEASE; SOCIAL-ISOLATION; HOMEOSTASIS; MECHANISMS; MORTALITY; EVOLUTION; RESPONSES; ADULTS	Inflammation has been defined formany years as the response to tissue injury and infection. We are now forced to reconsider this definition by the avalanche of reports that molecules and cells associated with inflammation are activated or expressed in high concentration in a large variety of states in the absence of tissue injury or infection. Modest increases in concentration of C-reactive protein, a circulating marker of inflammation, have been reported to be associated with an astounding number of conditions and lifestyles felt to be associated with poor health; these conditions represent or reflect minor metabolic stresses. In recent years we have learned that inflammation is triggered by sentinel cells that monitor for tissue stress and malfunction-deviations from optimal homeostasis-and that molecules that participate in the inflammatory process play a role in restoring normal homeostasis. Accordingly, we suggest that inflammation be redefined as the innate immune response to potentially harmful stimuli such as pathogens, injury, and metabolic stress.-Antonelli, M., Kushner, I. It's time to redefine inflammation.	[Antonelli, Maria; Kushner, Irving] Case Western Reserve Univ, Div Rheumatol, MetroHlth Med Ctr, 2500 MetroHlth Dr, Cleveland, OH 44109 USA	Case Western Reserve University; MetroHealth System	Kushner, I (corresponding author), Case Western Reserve Univ, Div Rheumatol, MetroHlth Med Ctr, 2500 MetroHlth Dr, Cleveland, OH 44109 USA.	ixk2@case.edu						Artis D, 2015, NATURE, V517, P293, DOI 10.1038/nature14189; Cevenini E, 2013, CURR OPIN CLIN NUTR, V16, P14, DOI 10.1097/MCO.0b013e32835ada13; Chambers JC, 2001, CIRCULATION, V104, P145, DOI 10.1161/01.CIR.104.2.145; Chaudhari N, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00213; Chovatiya R, 2014, MOL CELL, V54, P281, DOI 10.1016/j.molcel.2014.03.030; Donath MY, 2011, NAT REV IMMUNOL, V11, P98, DOI 10.1038/nri2925; Eaker ED, 2007, PSYCHOSOM MED, V69, P509, DOI 10.1097/PSY.0b013e3180f62357; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Gabay C, 1999, NEW ENGL J MED, V340, P448, DOI 10.1056/NEJM199902113400607; Gold EB, 2016, J WOMENS HEALTH, V25, P865, DOI 10.1089/jwh.2015.5529; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Heffner KL, 2011, SOC SCI MED, V72, P1482, DOI 10.1016/j.socscimed.2011.03.016; Heidland A, 2006, J NEPHROL, V19, pS102; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Karin M, 2016, NATURE, V529, P307, DOI 10.1038/nature17039; Kotas ME, 2015, CELL, V160, P816, DOI 10.1016/j.cell.2015.02.010; Kushner I, 1998, CYTOKINE GROWTH F R, V9, P191, DOI 10.1016/S1359-6101(98)00016-1; Kushner I, 2015, ANN INTERN MED, V163, P326, DOI 10.7326/L15-5126; Kushner Irving, 2015, Pharos Alpha Omega Alpha Honor Med Soc, V78, P22; Kushner I, 2010, ARTHRIT CARE RES, V62, P442, DOI 10.1002/acr.20052; Medzhitov R, 2008, NATURE, V454, P428, DOI 10.1038/nature07201; Misra J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086342; Murdoch JR, 2010, MUTAT RES-FUND MOL M, V690, P24, DOI 10.1016/j.mrfmmm.2009.09.005; Nandeesha H, 2015, CLIN CHIM ACTA, V451, P338, DOI 10.1016/j.cca.2015.10.022; Okin D, 2012, CURR BIOL, V22, pR733, DOI 10.1016/j.cub.2012.07.029; Orozco LD, 2012, CELL, V151, P658, DOI 10.1016/j.cell.2012.08.043; Park KH, 2014, METABOLISM, V63, P233, DOI 10.1016/j.metabol.2013.10.011; Rasheed H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147939; Rodier F, 2011, J CELL BIOL, V192, P547, DOI 10.1083/jcb.201009094; Samols D., 2006, AM J MED, V119, p166., DOI [DOI 10.1016/J.AMJMED.2005.06.057, 10.1016/j.amjmed.2005.06.057]; Shankar A, 2011, HEALTH PSYCHOL, V30, P377, DOI 10.1037/a0022826; Shin DY, 2012, BLOOD, V119, P2523, DOI 10.1182/blood-2011-07-366690; TURK JL, 1994, INT J EXP PATHOL, V75, P385; Vinay Kumar AA., 2020, ROBBINS COTRAN PATHO, P1328; Wang M, 2016, NATURE, V529, P326, DOI 10.1038/nature17041; Weissmann G, 2010, FASEB J, V24, P4129, DOI 10.1096/fj.10-1101ufm; Wu WT, 2015, SLEEP BREATH, V19, P1449, DOI 10.1007/s11325-015-1166-2; Zhang CB, 2012, HEPATOLOGY, V55, P1070, DOI 10.1002/hep.24783; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040	41	63	68	2	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1787	1791		10.1096/fj.201601326R	http://dx.doi.org/10.1096/fj.201601326R			5	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28179421				2022-12-28	WOS:000399195500003
J	Goetzl, EJ; Miller, BL				Goetzl, Edward J.; Miller, Bruce L.			Multicellular hypothesis for the pathogenesis of Alzheimer's disease	FASEB JOURNAL			English	Article						neurodegeneration; proteinopathic dementia; neurons; astrocytes; microglia	HUMAN ASTROCYTES; BLOOD EXOSOMES; PROTEINS; NEUROINFLAMMATION; PROLIFERATION; MECHANISMS; MICROGLIA; PATHOLOGY; DYNAMICS; GAMMA	Extensive abnormal interactions among microglia, astrocytes, and neurons of the CNS have been observed in proteinopathic neurodegenerative dementias of the elderly. Thesemulticellular interactions are initiated by insoluble tangles of phosphorylated tau protein and plaques of amyloid peptides. Most research has focused on these neurotoxic proteins, but much less is known about the pathogenic roles of the responding resident and recruited neural cells. Principal interactions among the major 3 sets of CNS cells are herein considered at several levels in relation to cellular phenotypic alterations, mechanisms of cellular communication, and extent of involvement in the pathogenesis of Alzheimer's disease and related proteinopathic dementias. It remains to be determined which of these abnormal neurocellular phenomena are primary events and sufficiently contributory to neurodegeneration to be useful targets for therapy of senile dementias.-Goetzl, E. J., Miller, B. L. Multicellular hypothesis for the pathogenesis of Alzheimer's disease.	[Goetzl, Edward J.] Univ Calif San Francisco, Dept Med, Memory & Aging Ctr, San Francisco, CA 94110 USA; [Miller, Bruce L.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Goetzl, Edward J.] Jewish Home San Francisco, San Francisco, CA USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Goetzl, EJ (corresponding author), Univ Calif San Francisco, Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu			Biomarkers Across Neurodegenerative Diseases 2 (BAND2) Program of the Michael J. Fox Foundation; Alzheimer's Association; Alzheimer's Research UK; Weston Brain Institute (Toronto, ON, Canada)	Biomarkers Across Neurodegenerative Diseases 2 (BAND2) Program of the Michael J. Fox Foundation; Alzheimer's Association(Alzheimer's Association); Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); Weston Brain Institute (Toronto, ON, Canada)	This work was supported by a grant from the Biomarkers Across Neurodegenerative Diseases 2 (BAND2) Program of the Michael J. Fox Foundation for Parkinson's Research, the Alzheimer's Association, the Alzheimer's Research UK, and the Weston Brain Institute (Toronto, ON, Canada; to E.J.G.). E.J.G. is a founder of Nanosomix, Inc., but now functions only as an occasional consultant and receives no salary, consulting fees, or support for laboratory supplies. B.L.M. declares no conflicts of interest.	Aron L, 2016, NATURE, V540, P207, DOI 10.1038/540207a; Blasko I, 2000, NEUROBIOL DIS, V7, P682, DOI 10.1006/nbdi.2000.0321; Choi SS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092325; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Goetzl EJ, 2016, FASEB J, V30, P3853, DOI 10.1096/fj.201600756R; Goetzl EJ, 2015, ANN CLIN TRANSL NEUR, V2, P769, DOI 10.1002/acn3.211; Goldmann T, 2016, NAT IMMUNOL, V17, P797, DOI 10.1038/ni.3423; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Heneka MT, 2015, LANCET NEUROL, V14, P388, DOI 10.1016/S1474-4422(15)70016-5; Hickman SE, 2010, CNS NEUROL DISORD-DR, V9, P168, DOI 10.2174/187152710791011982; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Howitt J, 2016, J BIOL CHEM, V291, P26589, DOI 10.1074/jbc.R116.757955; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Ku MC, 2013, ACTA NEUROPATHOL, V125, P609, DOI 10.1007/s00401-013-1079-8; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu C, 2014, INT J CLIN EXP PATHO, V7, P8342; Morales I, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00112; Mullins RJ, 2017, HUM BRAIN MAPP, V38, P1933, DOI 10.1002/hbm.23494; Olmos-Alonso A, 2016, BRAIN, V139, P891, DOI 10.1093/brain/awv379; Palop JJ, 2016, NAT REV NEUROSCI, V17, P777, DOI 10.1038/nrn.2016.141; Rossi D, 2015, PROG NEUROBIOL, V130, P86, DOI 10.1016/j.pneurobio.2015.04.003; Serrano-Pozo A, 2013, J NEUROPATH EXP NEUR, V72, P462, DOI 10.1097/NEN.0b013e3182933788; Song JH, 2015, MOL NEUROBIOL, V52, P1477, DOI 10.1007/s12035-014-8958-4; Theriault P, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0125-2; Turola E, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00149; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Vinters HV, 2015, ANNU REV PATHOL-MECH, V10, P291, DOI 10.1146/annurev-pathol-020712-163927; Winston Charisse N, 2016, Alzheimers Dement (Amst), V3, P63, DOI 10.1016/j.dadm.2016.04.001; YONG VW, 1991, P NATL ACAD SCI USA, V88, P7016, DOI 10.1073/pnas.88.16.7016; Zhao J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-150	31	11	12	0	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1792	1795		10.1096/fj.201601221R	http://dx.doi.org/10.1096/fj.201601221R			4	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28100644				2022-12-28	WOS:000399195500004
J	Henriques, FS; Sertie, RAL; Franco, FO; Knobl, P; Neves, RX; Andreotti, S; Lima, FB; Guilherme, A; Seelaender, M; Batista, ML				Henriques, Felipe Santos; Laurato Sertie, Rogerio Antonio; Franco, Felipe Oliveira; Knobl, Pamela; Neves, Rodrigo Xavier; Andreotti, Sandra; Lima, Fabio Bessa; Guilherme, Adilson; Seelaender, Marilia; Batista, Miguel Luiz, Jr.			Early suppression of adipocyte lipid turnover induces immunometabolic modulation in cancer cachexia syndrome	FASEB JOURNAL			English	Article						de novo lipogenesis; lipolysis; inflammation; adipose tissue	ADIPOSE-TISSUE LIPOLYSIS; INSULIN-RESISTANCE; FAT; BIOMARKERS; METABOLISM; LIPASES; OBESITY; MICE	Cancer cachexia is a multifactorial syndrome characterized by body weight loss, atrophy of adipose tissue (AT) and systemic inflammation. However, there is limited information regarding the mechanisms of immunometabolic response in AT from cancer cachexia. Male Wistar rats were inoculated with 2 3 107 of Walker 256 tumor cells [tumor bearing (TB) rats]. The mesenteric AT (MeAT) was collected on d 0, 4, 7 (early stage), and 14 (cachexia stage) after tumor cell injection. Surgical biopsies for MeAT were obtained from patients who had gastrointestinal cancer with cachexia. Lipolysis showed an early decrease in glycerol release in TB d 4 (TB4) rats in relation to the control, followed by a 6-fold increase in TB14 rats, whereas de novo lipogenesis was markedly lower in the incorporation of glucose into fatty acids in TB14 rats during the development of cachexia. CD11b and CD68 were positive in TB7 and TB14 rats, respectively. In addition, we found cachexia stage results similar to those of animals in MeAT from patients: an increased presence of CD68(+), iNOS2(+), TNF alpha(+), and HSL+ cells. In summary, translational analysis of MeAT from patients and an animal model of cancer cachexia enabled us to identify early disruption in Adl turnover and subsequent inflammatory response during the development of cancer cachexia.-Henriques, F. S., Serti ' e, R. A. L., Franco, F. O., Knobl, P., Neves, R. X., Andreotti, S., Lima, F. B., Guilherme, A., Seelaender, M., Batista, M. L., Jr. Early suppression of adipocyte lipid turnover induces immunometabolic modulation in cancer cachexia syndrome.	[Henriques, Felipe Santos; Franco, Felipe Oliveira; Knobl, Pamela; Batista, Miguel Luiz, Jr.] Univ Mogi das Cruzes, Integrated Grp Biotechnol, Lab Adipose Tissue Biol, Sao Paulo, Brazil; [Henriques, Felipe Santos] Univ Massachusetts, Med Sch, Program Mol Med, Worcester, MA USA; [Laurato Sertie, Rogerio Antonio; Andreotti, Sandra; Lima, Fabio Bessa; Guilherme, Adilson] Univ Sao Paulo, Inst Biomed Sci, Physiol Lab, Sao Paulo, Brazil; [Neves, Rodrigo Xavier; Seelaender, Marilia] Univ Sao Paulo, Inst Biomed Sci, Canc Metab Res Grp, Sao Paulo, Brazil	Universidade de Mogi das Cruzes; University of Massachusetts System; University of Massachusetts Worcester; Universidade de Sao Paulo; Universidade de Sao Paulo	Batista, ML (corresponding author), Ave Doutor Candido Xavier de Almeida Souza 200, BR-08780911 Mogi Das Cruzes, SP, Brazil.	migueljr4@me.com	Batista Jr., Miguel Luiz/E-7748-2015; Seelaender, Marilia Cerqueira Leite/B-9101-2011; Lima, Fabio/L-5634-2019; de Oliveira Franco, Felipe/AAP-3905-2020; Henriques, Felipe/I-6312-2015	Batista Jr., Miguel Luiz/0000-0001-7022-5131; Seelaender, Marilia Cerqueira Leite/0000-0002-9999-8020; Lima, Fabio/0000-0003-0573-9544; Henriques, Felipe/0000-0002-9245-7141; Franco, Felipe/0000-0002-4185-223X	Sao Paulo Research Foundation (FAPESP) [2010/51078-1, 2012/500790-0, 2015/19259-0]; CNPq [311966/2015-2]	Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was sponsored by Sao Paulo Research Foundation (FAPESP) Grants: 2010/51078-1 (to M. L. B.), 2012/500790-0 (to M. S.), and 2015/19259-0 (to M. L. B.) and CNPq 311966/2015-2 (to M. L. B.). The authors thank Dr. Jose Pinhata Otoch and Dr. Paulo S. M. de Alcantara and team for their excellent support and assistance in clinical data management and acquisition. The contents of this article are solely the responsibility of the authors and do not necessarily represent the official views of FAPESP. The authors declare no conflicts of interest.	Agustsson T, 2007, CANCER RES, V67, P5531, DOI 10.1158/0008-5472.CAN-06-4585; [Anonymous], 2011, CURR PROB CANCER, V35, P58, DOI 10.1016/j.currproblcancer.2011.01.001; Argiles JM, 2014, NAT REV CANCER, V14, P754, DOI 10.1038/nrc3829; Arner P, 2014, TRENDS ENDOCRIN MET, V25, P255, DOI 10.1016/j.tem.2014.03.002; Arner P, 2011, NATURE, V478, P110, DOI 10.1038/nature10426; Arner P, 2011, SCIENCE, V333, P163, DOI 10.1126/science.1209418; Batista ML, 2013, CYTOKINE, V61, P532, DOI 10.1016/j.cyto.2012.10.023; Batista ML, 2012, J ENDOCRINOL, V215, P363, DOI 10.1530/JOE-12-0307; Batista ML, 2016, J CACHEXIA SARCOPENI, V7, P37, DOI 10.1002/jcsm.12037; Bing C, 2006, BRIT J CANCER, V95, P1028, DOI 10.1038/sj.bjc.6603360; Borges-Silva CN, 2005, J PINEAL RES, V39, P178, DOI 10.1111/j.1600-079X.2005.00241.x; Das SK, 2011, SCIENCE, V333, P233, DOI 10.1126/science.1198973; de Matos-Neto EM, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00629; Ebadi M, 2014, NUTRIENTS, V6, P5280, DOI 10.3390/nu6115280; Evans WJ, 2008, CLIN NUTR, V27, P793, DOI 10.1016/j.clnu.2008.06.013; Fearon K, 2011, LANCET ONCOL, V12, P489, DOI 10.1016/S1470-2045(10)70218-7; Fouladiun M, 2005, CANCER-AM CANCER SOC, V103, P2189, DOI 10.1002/cncr.21013; Franco FD, 2017, J ENDOCRINOL, V232, P493, DOI 10.1530/JOE-16-0305; Greenberg AS, 2001, J BIOL CHEM, V276, P45456, DOI 10.1074/jbc.M104436200; Guilherme A, 2008, NAT REV MOL CELL BIO, V9, P367, DOI 10.1038/nrm2391; Kir S, 2014, NATURE, V513, P100, DOI 10.1038/nature13528; Kliewer KL, 2015, CANCER BIOL THER, V16, P886, DOI 10.4161/15384047.2014.987075; Kwon SJ, 2011, J GASTRIC CANCER, V11, P78, DOI 10.5230/jgc.2011.11.2.78; Langin D, 2006, TRENDS ENDOCRIN MET, V17, P314, DOI 10.1016/j.tem.2006.08.003; Murphy RA, 2010, CLIN NUTR, V29, P482, DOI 10.1016/j.clnu.2009.11.006; Neves RX, 2016, J CACHEXIA SARCOPENI, V7, P193, DOI 10.1002/jcsm.12041; Penafuerte CA, 2016, BRIT J CANCER, V114, P680, DOI 10.1038/bjc.2016.3; Petruzzelli M, 2014, CELL METAB, V20, P433, DOI 10.1016/j.cmet.2014.06.011; Seelaender M, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/536954; Tsoli M, 2016, SEMIN CELL DEV BIOL, V54, P68, DOI 10.1016/j.semcdb.2015.10.039; Tsoli M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092966; WEX T, 1995, FEBS LETT, V374, P341, DOI 10.1016/0014-5793(95)01139-6	32	12	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1976	1986		10.1096/fj.201601151R	http://dx.doi.org/10.1096/fj.201601151R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28138038				2022-12-28	WOS:000399195500019
J	Uchida, H; Matsumura, S; Okada, S; Suzuki, T; Minami, T; Ito, S				Uchida, Hitoshi; Matsumura, Shinji; Okada, Shunpei; Suzuki, Tsutomu; Minami, Toshiaki; Ito, Seiji			RNA editing enzyme ADAR2 is a mediator of neuropathic pain after peripheral nerve injury	FASEB JOURNAL			English	Article						tactile allodynia; posttranscriptional regulation; dorsal root ganglion; adenosine deaminase	MESSENGER-RNA; ENDONUCLEASE V; SEROTONIN 2C; RECEPTOR; NEURONS; SYSTEM; BRAIN; ACTIVATION; MECHANISMS; EXPRESSION	Transcriptional and post-translational regulations are important in peripheral nerve injury-induced neuropathic pain, but little is known about the role of post-transcriptional modification. Our objective was to determine the possible effect of adenosine deaminase acting on RNA (ADAR) enzymes, which catalyze post-transcriptional RNA editing, in tactile allodynia, a hallmark of neuropathic pain. Seven days after L5 spinal nerve transection (SNT) in adultmice, we found an increase in ADAR2 expression and a decrease in ADAR3 expression in the injured, but not in the uninjured, dorsal root ganglions (DRGs). These changes were accompanied by elevated levels of editing at the D site of the serotonin (5-hydroxytryptamine) 2C receptor (5-HT2CR), at the I/V site of coatomer protein complex subunit alpha(COPA), and at the R/G site of AMPA receptor subunit GluA2 in the injured DRG. Compared to Adar2(+/+)/Gria2(R/R) littermate controls, Adar2(+/+)/Gria2(R/R) mice completely lacked the increased editing of 5-HT2CR, COPA, and GluA2 transcripts in the injured DRG and showed attenuated tactile allodynia after SNT. Furthermore, the antidepressant fluoxetine inhibited neuropathic allodynia after injury and reduced the COPAI/V site editing in the injured DRG. These findings suggest that ADAR2 is a mediator of injury-induced tactile allodynia and thus a potential therapeutic target for the treatment of neuropathic pain.-Uchida, H., Matsumura, S., Okada, S., Suzuki, T., Minami, T., Ito, S. RNA editing enzyme ADAR2 is a mediator of neuropathic pain after peripheral nerve injury.	[Uchida, Hitoshi; Matsumura, Shinji; Ito, Seiji] Kansai Med Univ, Dept Med Chem, 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan; [Okada, Shunpei; Suzuki, Tsutomu] Univ Tokyo, Grad Sch Engn, Dept Chem & Biotechnol, Tokyo, Japan; [Minami, Toshiaki] Osaka Med Coll, Dept Anesthesiol, Osaka, Japan; [Uchida, Hitoshi] Niigata Univ, Dept Cellular Neurobiol, Brain Res Inst, Niigata, Japan	Kansai Medical University; University of Tokyo; Osaka Medical College; Niigata University	Ito, S (corresponding author), Kansai Med Univ, Dept Med Chem, 2-5-1 Shin Machi, Hirakata, Osaka 5731010, Japan.	ito@hirakata.kmu.ac.jp	Suzuki, Tsutomu/J-1776-2015	Suzuki, Tsutomu/0000-0002-9731-1731; ito, Seiji/0000-0002-0942-1624	Japan Society for the Promotion of Science [22390063, 11J09224, 24590735]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	The authors thank Prof. Peter H. Seeburg and Dr. Miyoko Higuchi (Max Planck Institute for Medical Research, Heidelberg, Germany) for providing Adar2<SUP>+/+/</SUP>Gria2<SUP>R/R</SUP> and Adar2<SUP>-/-</SUP>/Gria2<SUP>R/R</SUP> mice. This work was supported by Grants-in-Aid for Scientific Research 22390063 (to S.I.), 11J09224 (to H.U.), and 24590735 (to S.M.) from the Japan Society for the Promotion of Science. H.U. is a research fellow of the Japan Society for the Promotion of Science. The authors declare no conflicts of interest.	Balik A, 2013, NUCLEIC ACIDS RES, V41, P1124, DOI 10.1093/nar/gks1045; Barbon A, 2010, J NEUROCHEM, V114, P397, DOI 10.1111/j.1471-4159.2010.06767.x; Beck R, 2009, FEBS LETT, V583, P2701, DOI 10.1016/j.febslet.2009.07.032; Campbell JN, 2006, NEURON, V52, P77, DOI 10.1016/j.neuron.2006.09.021; Chen CX, 2000, RNA, V6, P755, DOI 10.1017/S1355838200000170; Deffit SN, 2016, WIRES RNA, V7, P113, DOI 10.1002/wrna.1319; Denk F, 2012, NEURON, V73, P435, DOI 10.1016/j.neuron.2012.01.012; Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905; Favereaux A, 2011, EMBO J, V30, P3830, DOI 10.1038/emboj.2011.249; Feng Y, 2006, MOL CELL BIOL, V26, P480, DOI 10.1128/MCB.26.2.480-488.2006; Gan ZJ, 2006, J BIOL CHEM, V281, P33386, DOI 10.1074/jbc.M604484200; Hang PNT, 2008, NEUROSCI RES, V61, P398, DOI 10.1016/j.neures.2008.04.007; Hideyama T, 2012, NEUROBIOL DIS, V45, P1121, DOI 10.1016/j.nbd.2011.12.033; Hideyama T, 2010, J NEUROSCI, V30, P11917, DOI 10.1523/JNEUROSCI.2021-10.2010; Higuchi M, 2000, NATURE, V406, P78, DOI 10.1038/35017558; Hoopengardner B, 2003, SCIENCE, V301, P832, DOI 10.1126/science.1086763; Horsch M, 2011, J BIOL CHEM, V286, P18614, DOI 10.1074/jbc.M110.200881; Hulse RP, 2014, NEUROBIOL DIS, V71, P245, DOI 10.1016/j.nbd.2014.08.012; Hwang T, 2016, NAT NEUROSCI, V19, P1093, DOI 10.1038/nn.4337; Inceoglu B, 2015, P NATL ACAD SCI USA, V112, P9082, DOI 10.1073/pnas.1510137112; Iwamoto K, 2005, NEUROSCI RES, V53, P69, DOI 10.1016/j.neures.2005.06.001; Ji Ru-Rong, 2004, Sci STKE, V2004, preE14; Joseph DJ, 2011, DEV NEUROBIOL, V71, P818, DOI 10.1002/dneu.20906; LaBuda CJ, 2005, J NEUROSCI METH, V144, P175, DOI 10.1016/j.jneumeth.2004.11.008; Maas S, 2011, BIOCHEM BIOPH RES CO, V412, P407, DOI 10.1016/j.bbrc.2011.07.075; Maas S, 2001, P NATL ACAD SCI USA, V98, P14687, DOI 10.1073/pnas.251531398; Mabuchi T, 2004, J NEUROSCI, V24, P7283, DOI 10.1523/JNEUROSCI.0983-04.2004; Marcucci R, 2011, EMBO J, V30, P4211, DOI 10.1038/emboj.2011.303; Morita Y, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3273; Murray KC, 2010, NAT MED, V16, P694, DOI 10.1038/nm.2160; Nakae A, 2008, NEUROSCI RES, V60, P228, DOI 10.1016/j.neures.2007.10.004; Navarrett S, 2012, NEUROSCI LETT, V506, P74, DOI 10.1016/j.neulet.2011.10.052; Nishikura K, 2016, NAT REV MOL CELL BIO, V17, P83, DOI 10.1038/nrm.2015.4; Nishikura K, 2010, ANNU REV BIOCHEM, V79, P321, DOI 10.1146/annurev-biochem-060208-105251; Obata K, 2004, J NEUROSCI, V24, P10211, DOI 10.1523/JNEUROSCI.3388-04.2004; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; Persson AK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-7; Rosenthal JJC, 2012, NEURON, V74, P432, DOI 10.1016/j.neuron.2012.04.010; Rueter SM, 1999, NATURE, V399, P75, DOI 10.1038/19992; Sakurai M, 2014, GENOME RES, V24, P522, DOI 10.1101/gr.162537.113; Sakurai M, 2011, METHODS MOL BIOL, V718, P89, DOI 10.1007/978-1-61779-018-8_5; Sakurai M, 2010, NAT CHEM BIOL, V6, P733, DOI 10.1038/nchembio.434; Schmidt HD, 2015, MOL PSYCHIATR, V20, P1460, DOI 10.1038/mp.2014.134; Singh M, 2007, J BIOL CHEM, V282, P22448, DOI 10.1074/jbc.M700265200; Tariq A, 2013, NUCLEIC ACIDS RES, V41, P2581, DOI 10.1093/nar/gks1353; Vik ES, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3271; Watkin LB, 2015, NAT GENET, V47, P654, DOI 10.1038/ng.3279; Wei J, 2014, ACTA NEUROCHIR, V156, P1135, DOI 10.1007/s00701-014-2004-1; Wu SG, 2016, MOL PAIN, V12, DOI 10.1177/1744806916629048	49	8	8	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAY	2017	31	5					1847	1855		10.1096/fj.201600950R	http://dx.doi.org/10.1096/fj.201600950R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	ES0DE	28126736				2022-12-28	WOS:000399195500008
J	Masuda, K; Kitakami, J; Kozasa, T; Kodama, T; Ihara, S; Hamakubo, T				Masuda, Kazuyuki; Kitakami, Jun-ichi; Kozasa, Tohru; Kodama, Tatsuhiko; Ihara, Sigeo; Hamakubo, Takao			Visualization of ligand-induced Gi-protein activation in chemotaxing cells	FASEB JOURNAL			English	Article						FRET; GPCR; heterotrimeric G protein; HL-60; RGS	COUPLED RECEPTOR ACTIVATION; RESONANCE ENERGY-TRANSFER; LEUKOTRIENE B-4 RECEPTOR; LIVING CELLS; LIVE CELLS; CHEMOATTRACTANT RECEPTOR; LIPID MEDIATORS; REGULATORS; MEMBRANE; ALPHA	Cell migration to chemoattractants is critically important in both normal physiology and the pathogenesis of many diseases. In GPCR-mediated chemotaxis, GPCRs transduce the gradient of an extracellular chemotactic ligand into intracellular responses via the activation of heterotrimeric G proteins. However, ligand-induced G protein activation has not been directly imaged as yet in mammalian chemotaxing cells. We developed a Forster resonance energy transfer (FRET) probe (R10-Gi) by linking the Gi protein ? subunit to the regulator of G protein signaling domain. The R10-Gi probe was coupled with a chemoattractant leukotriene B4 (LTB4) receptor 1 (BLT1) that induced the receptor to display a high-affinity ligand binding activity (Kd = 0.91 nM) in HEK293 cells. The R10-Gi probe exhibited an increased FRET signal in accord with the LTB4-dependent activation of Gi. Furthermore, neutrophil-like differentiated human leukemia cell line 60 that expressed the intrinsic BLT1 displayed temporal Gi protein activation in an area localized to the leading edge during chemotaxis in a shallow gradient of LTB4. These findings afford an opportunity to clarify the mechanisms underlying the subcellular regulation of Gi protein activity, as well as GPCR-mediated ligand sensing, during chemotaxis in mammalian cells.Masuda, K., Kitakami, J., Kozasa, T., Kodama, T., Ihara, S., Hamakubo, T. Visualization of ligand-induced Gi protein activation in chemotaxing cells.	[Masuda, Kazuyuki; Kozasa, Tohru; Hamakubo, Takao] Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Tokyo, Japan; [Kitakami, Jun-ichi; Kodama, Tatsuhiko; Ihara, Sigeo] Univ Tokyo, Res Ctr Adv Sci & Technol, Lab Syst Biol & Med, Tokyo, Japan	University of Tokyo; University of Tokyo	Hamakubo, T (corresponding author), Univ Tokyo, Res Ctr Adv Sci & Technol, Dept Quantitat Biol & Med, Meguro Ku, 4-6-1 Komaba, Tokyo 1538904, Japan.	hamakubo@qbm.rcast.u-tokyo.ac.jp		Masuda, Kazuyuki/0000-0003-3813-8550	New Antibody Technologies of New Energy and Industrial Technology Development Organization (NEDO) of Japan; Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program), initiated by the Council for Science and Technology Policy (CSTP);  [21790239];  [20221010]	New Antibody Technologies of New Energy and Industrial Technology Development Organization (NEDO) of Japan; Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program), initiated by the Council for Science and Technology Policy (CSTP); ; 	The authors thank M. Matsuda (Kyoto University, Kyoto, Japan) for advice and technical training, and H. Tamaru (University of Tokyo), N. Mochizuki (National Cerebral and Cardiovascular Center, Osaka, Japan), and the members of our laboratories for helpful comments. The authors are grateful to K. Boru ( Pacific Edit, San Francisco, CA, USA) for review of the article. This work was supported, in part, by research grants from the New Antibody Technologies of New Energy and Industrial Technology Development Organization (NEDO) of Japan; the Japan Society for the Promotion of Science (JSPS) through the Funding Program for World-Leading Innovative Research and Development on Science and Technology (FIRST Program), initiated by the Council for Science and Technology Policy (CSTP); JSPS Grant-in-Aid for Scientific Research 21790239; and the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grant-in-Aid for Scientific Research 20221010.	Arrieumerlou C, 2005, DEV CELL, V8, P215, DOI 10.1016/j.devcel.2004.12.007; Back M, 2014, BRIT J PHARMACOL, V171, P3551, DOI 10.1111/bph.12665; Back M, 2011, PHARMACOL REV, V63, P539, DOI 10.1124/pr.110.004184; Bunemann M, 2003, P NATL ACAD SCI USA, V100, P16077, DOI 10.1073/pnas.2536719100; Byrne MB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085726; Cho H, 2012, MOL CELL BIOL, V32, P4561, DOI 10.1128/MCB.00651-12; Clister T, 2015, J BIOL CHEM, V290, P6681, DOI 10.1074/jbc.R114.616391; Cotton M, 2009, CELL SIGNAL, V21, P1045, DOI 10.1016/j.cellsig.2009.02.008; Di Gennaro A, 2012, ADV IMMUNOL, V116, P51, DOI 10.1016/B978-0-12-394300-2.00002-8; Foxman EF, 1997, J CELL BIOL, V139, P1349, DOI 10.1083/jcb.139.5.1349; Foxman EF, 1999, J CELL BIOL, V147, P577, DOI 10.1083/jcb.147.3.577; Gibson SK, 2006, P NATL ACAD SCI USA, V103, P212, DOI 10.1073/pnas.0509763102; Hoffmann C, 2005, NAT METHODS, V2, P171, DOI 10.1038/NMETH742; Hughes TE, 2001, J BIOL CHEM, V276, P4227, DOI 10.1074/jbc.M007608200; Hwang IY, 2015, J IMMUNOL, V194, P2128, DOI 10.4049/jimmunol.1401952; Janetopoulos C, 2001, SCIENCE, V291, P2408, DOI 10.1126/science.1055835; Kimple AJ, 2007, BBA-PROTEINS PROTEOM, V1774, P1213, DOI 10.1016/j.bbapap.2007.06.002; Kimple AJ, 2011, PHARMACOL REV, V63, P728, DOI 10.1124/pr.110.003038; Lambert NA, 2012, P NATL ACAD SCI USA, V109, P2175, DOI 10.1073/pnas.1200427109; Lambert NA, 2010, P NATL ACAD SCI USA, V107, P7066, DOI 10.1073/pnas.0912934107; Lohse MJ, 2012, PHARMACOL REV, V64, P299, DOI 10.1124/pr.110.004309; Masuda K, 2003, J BIOL CHEM, V278, P24552, DOI 10.1074/jbc.M302801200; McCoy KL, 2009, PROG MOL BIOL TRANSL, V86, P49, DOI 10.1016/S1877-1173(09)86003-1; Miyawaki A, 2011, ANNU REV BIOCHEM, V80, P357, DOI 10.1146/annurev-biochem-072909-094736; Nakamura M, 2011, CHEM REV, V111, P6231, DOI 10.1021/cr100392s; O'Hayre M, 2014, CURR OPIN CELL BIOL, V27, P126, DOI 10.1016/j.ceb.2014.01.005; Okuno T, 2003, J BIOL CHEM, V278, P41500, DOI 10.1074/jbc.M307335200; Oldham WM, 2008, NAT REV MOL CELL BIO, V9, P60, DOI 10.1038/nrm2299; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Servant G, 2000, SCIENCE, V287, P1037, DOI 10.1126/science.287.5455.1037; Sjogren B, 2010, MOL PHARMACOL, V78, P550, DOI 10.1124/mol.110.065219; Smith B, 2009, CELL SIGNAL, V21, P1151, DOI 10.1016/j.cellsig.2009.03.004; Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048; Terai K, 2006, EMBO J, V25, P3556, DOI 10.1038/sj.emboj.7601241; Tyson RA, 2010, MATH MODEL NAT PHENO, V5, P34, DOI 10.1051/mmnp/20105102; Tyson RA, 2014, P NATL ACAD SCI USA, V111, P11703, DOI 10.1073/pnas.1322291111; Vellano CP, 2013, J BIOL CHEM, V288, P3620, DOI 10.1074/jbc.M112.440057; Vilardaga JP, 2009, MOL ENDOCRINOL, V23, P590, DOI 10.1210/me.2008-0204; Wang F, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a002980; Yokomizo T, 2001, J BIOL CHEM, V276, P12454, DOI 10.1074/jbc.M011361200; Yokomizo T, 2015, J BIOCHEM, V157, P65, DOI 10.1093/jb/mvu078; Zabel BA, 2015, ANNU REV PATHOL-MECH, V10, P51, DOI 10.1146/annurev-pathol-012513-104640; Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539; Zhao Q, 2003, MOL PHARMACOL, V64, P1085, DOI 10.1124/mol.64.5.1085; ZIGMOND SH, 1989, AM J RESP CELL MOL, V1, P451, DOI 10.1165/ajrcmb/1.6.451	45	2	2	1	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2017	31	3					910	+		10.1096/fj.201601102R	http://dx.doi.org/10.1096/fj.201601102R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EM9ZX	27881485				2022-12-28	WOS:000395671200008
J	Baillet, A; Hograindleur, MA; El Benna, J; Grichine, A; Berthier, S; Morel, F; Paclet, MH				Baillet, Athan; Hograindleur, Marc-Andre; El Benna, Jamel; Grichine, Alexei; Berthier, Sylvie; Morel, Francoise; Paclet, Marie-Helene			Unexpected function of the phagocyte NADPH oxidase in supporting hyperglycolysis in stimulated neutrophils: key role of 6-phosphofructo-2-kinase	FASEB JOURNAL			English	Article						Nox2; PMN; PFK-2; reactive oxygen species; energetic metabolism	PROTEIN-KINASE-C; NUCLEOSIDE DIPHOSPHATE KINASE; RESPIRATORY BURST OXIDASE; CYTOCHROME B(558); LIPID RAFTS; ACTIVATION; PHOSPHORYLATION; COMPONENT; NOX; P67(PHOX)	The phagocyte NADPH oxidase 2 (Nox2) is an enzymatic complex that is involved in innate immunity, notably via its capacity to produce toxic reactive oxygen species. Recently, a proteomic analysis of the constitutively active Nox2 complex, isolated from neutrophil fractions, highlighted the presence of 6-phosphofructo-2-kinase (PFK-2). The purpose of this work was to study the relationship between PFK-2 and NADPH oxidase in neutrophils. Data have underlined a specific association of the active phosphorylated form of PFK-2 with Nox2 complex in stimulated neutrophils. In its active form, PFK-2 catalyzes the production of fructose-2,6-bisphosphate, which is the main allosteric activator of phosphofructo-1-kinase, the limiting enzyme in glycolysis. Pharmacologic inhibition of PFK-2 phosphorylation and cell depletion in PFK-2 by a small interfering RNA strategy led to a decrease in the glycolysis rate and a reduction in NADPH oxidase activity in stimulated cells. Surprisingly, alteration of Nox2 activity impacted the glycolysis rate, which indicated that Nox2 in neutrophils was not only required for reactive oxygen species production but was also involved in supporting the energetic metabolism increase that was induced by inflammatory conditions. PFK-2 seems to be a strategic element that links NADPH oxidase activation and glycolysis modulation, and, as such, is proposed as a potential therapeutic target in inflammatory diseases.	[Baillet, Athan; Hograindleur, Marc-Andre; Berthier, Sylvie; Morel, Francoise; Paclet, Marie-Helene] Univ Grenoble Alpes, GREPI, EA 7408, St Martin Dheres, France; [Baillet, Athan] Univ Grenoble Alpes, Dept Rheumatol, La Tronche, France; [Morel, Francoise; Paclet, Marie-Helene] Univ Grenoble Alpes, Ctr Hosp, La Tronche, France; [El Benna, Jamel] INSERM, Ctr Natl Rech Sci, Ctr Rech Inflammat, ERL8252,Unite 1149, Paris, France; [El Benna, Jamel] Univ Paris Diderot, Dept Hosp Univ Fibrosis,Site Xavier Bichat, Sorbonne Paris Cite,DHU FIRE,Fac Med, Inflammat Remodeling,Cardiovasc Resp & Renal Dis, Paris, France; [Grichine, Alexei] Univ Joseph Fourier, INSERM, Inst Albert Bonniot, Platform Opt Microscopy Cell Imaging,Unit 823, La Tronche, France	Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); CHU Grenoble Alpes; Communaute Universite Grenoble Alpes; UDICE-French Research Universities; Universite Grenoble Alpes (UGA); Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Bichat-Claude Bernard - APHP; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Communaute Universite Grenoble Alpes; Universite Grenoble Alpes (UGA)	Paclet, MH (corresponding author), Univ Grenoble Alpes, GREPI, EA 7408, St Martin Dheres, France.; Paclet, MH (corresponding author), Univ Grenoble Alpes, Grp Rech & Etude Proc Inflammatoire, EFS Site Grenoble, 29 Ave Maquis Gr Esivaudan,BP35, F-38701 La Tronche, France.	mhpaclet@chu-grenoble.fr	Grichine, Alexei/M-3923-2013; Paclet, Marie-Hélène/AAS-5029-2020; Grichine, Alexei/P-8377-2019	Grichine, Alexei/0000-0002-7335-9706; Grichine, Alexei/0000-0002-7335-9706	Ministere de l'Enseignement Superieur de la Recherche et Technologie (Paris, France); Societe Francaise de Rhumatologie; Etablissement Francais du Sang (Rhone-Alpes); Direction de la Recherche Clinique et de l'Innovation (Centre Hospitalier Universitaire de Grenoble)	Ministere de l'Enseignement Superieur de la Recherche et Technologie (Paris, France); Societe Francaise de Rhumatologie; Etablissement Francais du Sang (Rhone-Alpes)(Region Auvergne-Rhone-Alpes); Direction de la Recherche Clinique et de l'Innovation (Centre Hospitalier Universitaire de Grenoble)	The authors thank Edgar Pick (Tel Aviv University, Tel Aviv, Israel) for helpful discussions on NDPK. This study was supported by grants from the Ministere de l'Enseignement Superieur de la Recherche et Technologie (Paris, France), the Societe Francaise de Rhumatologie, the Etablissement Francais du Sang (Rhone-Alpes), and the Direction de la Recherche Clinique et de l'Innovation (Centre Hospitalier Universitaire de Grenoble). The authors declare no conflicts of interest.	Baillet A, 2011, FASEB J, V25, P2333, DOI 10.1096/fj.10-173807; BENGTSSON T, 1991, J LEUKOCYTE BIOL, V49, P236, DOI 10.1002/jlb.49.3.236; Bertrand L, 1999, J BIOL CHEM, V274, P30927, DOI 10.1074/jbc.274.43.30927; BORREGAARD N, 1982, J CLIN INVEST, V70, P550, DOI 10.1172/JCI110647; Bouin AP, 1998, J BIOL CHEM, V273, P30097, DOI 10.1074/jbc.273.46.30097; Boussetta T, 2010, BLOOD, V116, P5795, DOI 10.1182/blood-2010-03-273094; Campion Y, 2007, BIOCHIMIE, V89, P1145, DOI 10.1016/j.biochi.2007.01.010; Campion Y, 2009, J INNATE IMMUN, V1, P556, DOI 10.1159/000231977; Cross AR, 2004, BBA-BIOENERGETICS, V1657, P1, DOI 10.1016/j.bbabio.2004.03.008; Dang PMC, 2011, BIOCHEM PHARMACOL, V82, P1145, DOI 10.1016/j.bcp.2011.07.070; Dang PMC, 2001, J IMMUNOL, V166, P1206, DOI 10.4049/jimmunol.166.2.1206; David A, 2005, EXP CELL RES, V308, P156, DOI 10.1016/j.yexcr.2005.03.034; El-Benna J, 2009, EXP MOL MED, V41, P217, DOI 10.3858/emm.2009.41.4.058; ELBENNA J, 1994, J BIOL CHEM, V269, P6729; ElBenna J, 1997, J BIOL CHEM, V272, P17204, DOI 10.1074/jbc.272.27.17204; Guichard C, 2005, J BIOL CHEM, V280, P37021, DOI 10.1074/jbc.M506594200; Guignard F, 1996, BIOCHEM J, V316, P233, DOI 10.1042/bj3160233; KLINGER E, 1992, BIOCHEM J, V285, P635, DOI 10.1042/bj2850635; Li JR, 1997, BIOCHEMISTRY-US, V36, P5529, DOI 10.1021/bi963013r; Li XJ, 2007, J LEUKOCYTE BIOL, V81, P238, DOI 10.1189/jlb.0905541; Lu W, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001357; Maianski NA, 2004, CELL DEATH DIFFER, V11, P143, DOI 10.1038/sj.cdd.4401320; Mizrahi A, 2005, J BIOL CHEM, V280, P3802, DOI 10.1074/jbc.M410257200; Nauseef WM, 2008, SEMIN IMMUNOPATHOL, V30, P195, DOI 10.1007/s00281-008-0117-4; Nguyen MVC, 2015, M S-MED SCI, V31, P43, DOI 10.1051/medsci/20153101012; Paclet MH, 2007, FASEB J, V21, P1244, DOI 10.1096/fj.06-6852com; Paclet MH, 2000, BIOCHEMISTRY-US, V39, P9302, DOI 10.1021/bi000483j; PEVERI P, 1992, P NATL ACAD SCI USA, V89, P2494, DOI 10.1073/pnas.89.6.2494; Raad H, 2009, FASEB J, V23, P1011, DOI 10.1096/fj.08-114553; Regier DS, 1999, J BIOL CHEM, V274, P36601, DOI 10.1074/jbc.274.51.36601; Rider MH, 2004, BIOCHEM J, V381, P561, DOI 10.1042/BJ20040752; RIDER MH, 1986, BIOCHEM J, V240, P57, DOI 10.1042/bj2400057; Rodriguez-Espinosa O, 2015, IMMUNOLOGY, V145, P213, DOI 10.1111/imm.12437; Shao DM, 2003, FEBS LETT, V550, P101, DOI 10.1016/S0014-5793(03)00845-7; SMOLEN JE, 1980, J CLIN INVEST, V65, P1077, DOI 10.1172/JCI109760; Stasia MJ, 2008, SEMIN IMMUNOPATHOL, V30, P209, DOI 10.1007/s00281-008-0121-8; Tilton B, 1997, J BIOL CHEM, V272, P28096, DOI 10.1074/jbc.272.44.28096; Vergnaud S, 2000, EUR J BIOCHEM, V267, P1059, DOI 10.1046/j.1432-1327.2000.01097.x; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; WILSON PD, 1981, HISTOCHEM J, V13, P31, DOI 10.1007/BF01005837; Yu LX, 1997, J BIOL CHEM, V272, P27288, DOI 10.1074/jbc.272.43.27288; ZUCKER-FRANKLIN DOROTHEA, 1968, SEMINAR HEMATOL, V5, P109	42	21	21	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					663	673		10.1096/fj.201600720R	http://dx.doi.org/10.1096/fj.201600720R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27799347				2022-12-28	WOS:000394235400019
J	Barnes, EA; Chen, CH; Sedan, O; Cornfield, DN				Barnes, Elizabeth A.; Chen, Chih-Hsin; Sedan, Oshra; Cornfield, David N.			Loss of smooth muscle cell hypoxia inducible factor-1 alpha underlies increased vascular contractility in pulmonary hypertension	FASEB JOURNAL			English	Article						MLCK; pMLC; prolyl hydroxylase domain; PAH; vasoconstriction	ARTERIAL-HYPERTENSION; IN-VIVO; TRANSCRIPTION; EXPRESSION; PROTEIN; MICE; TONE	Pulmonary arterial hypertension (PAH) is an often fatal disease with limited treatment options. Whereas current data support the notion that, in pulmonary artery endothelial cells (PAECs), expression of transcription factor hypoxia inducible factor-1 alpha (HIF-1 alpha) is increased, the role of HIF-1 alpha in pulmonary artery smooth muscle cells (PASMCs) remains controversial. This study investigates the hypothesis that, in PASMCs from patients with PAH, decreases in HIF-1 alpha expression and activity underlie augmented pulmonary vascular contractility. PASMCs and tissues were isolated from nonhypertensive control patients and patients with PAH. Compared with controls, HIF-1 alpha and Kv1.5 protein expression were decreased in PAH smooth muscle cells (primary culture). Myosin light chain (MLC) phosphorylation and MLC kinase (MLCK) activitymajor determinants of vascular tonewere increased in patients with PAH. Cofactors involved in prolyl hydroxylase domain activity were increased in PAH smooth muscle cells. Functionally, PASMC contractility was inversely correlated with HIF-1 alpha activity. In PASMCs derived from patients with PAH, HIF-1 alpha expression is decreased, and MLCK activity, MLC phosphorylation, and cell contraction are increased. We conclude that compromised PASMC HIF-1 alpha expression may contribute to the increased tone that characterizes pulmonary hypertension.	[Barnes, Elizabeth A.; Chen, Chih-Hsin; Sedan, Oshra; Cornfield, David N.] Stanford Univ, Sch Med, Ctr Excellence Pulm Biol, Dept Pediat, Stanford, CA 94305 USA	Stanford University	Cornfield, DN (corresponding author), Stanford Univ, Sch Med, Ctr Excellence Pulm Biol, 770 Welch Rd, Stanford, CA 94305 USA.	dcornfield@stanford.edu			U.S. National Institutes of Health, National Heart, Lung, and Blood Institute [HL060784, HL0706280]; Cardiovascular Medical Research and Education Fund (University of Pennsylvania, PA, USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL060784] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Cardiovascular Medical Research and Education Fund (University of Pennsylvania, PA, USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The authors thank Dr. A. J. Giaccia (Stanford University) for providing the HIF-1 alpha<SUP>CA</SUP> construct. This research was supported by U.S. National Institutes of Health, National Heart, Lung, and Blood Institute Grants HL060784 and HL0706280 (to D.N.C.). Tissue sections were provided by the Pulmonary Hypertensive Breakthrough Initiative (PHBI). Funding for the PHBI is provided by the Cardiovascular Medical Research and Education Fund (University of Pennsylvania, PA, USA). The authors declare no conflicts of interest.	Ahmad A, 2013, AM J RESP CELL MOL, V49, P78, DOI 10.1165/rcmb.2012-0107OC; Ball MK, 2014, AM J RESP CRIT CARE, V189, P314, DOI 10.1164/rccm.201302-0302OC; Benza RL, 2010, CIRCULATION, V122, P164, DOI 10.1161/CIRCULATIONAHA.109.898122; Bonnet S, 2007, P NATL ACAD SCI USA, V104, P11418, DOI 10.1073/pnas.0610467104; Bonnet S, 2006, CIRCULATION, V113, P2630, DOI 10.1161/CIRCULATIONAHA.105.609008; Dai ZY, 2016, CIRCULATION, V133, P2447, DOI 10.1161/CIRCULATIONAHA.116.021494; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Fijalkowska I, 2010, AM J PATHOL, V176, P1130, DOI 10.2353/ajpath.2010.090832; Fong GH, 2008, CELL DEATH DIFFER, V15, P635, DOI 10.1038/cdd.2008.10; Formenti F, 2011, FASEB J, V25, P2001, DOI 10.1096/fj.10-177378; Humbert M, 2004, J AM COLL CARDIOL, V43, p13S, DOI 10.1016/j.jacc.2004.02.029; Kapitsinou PP, 2016, MOL CELL BIOL, V36, P1584, DOI 10.1128/MCB.01055-15; Kim YM, 2013, CIRC RES, V112, P1230, DOI 10.1161/CIRCRESAHA.112.300646; Makino Y, 2001, NATURE, V414, P550, DOI 10.1038/35107085; Marsboom G, 2012, CIRC RES, V110, P1484, DOI 10.1161/CIRCRESAHA.111.263848; Pan Y, 2007, MOL CELL BIOL, V27, P912, DOI 10.1128/MCB.01223-06; Pozeg ZI, 2003, CIRCULATION, V107, P2037, DOI 10.1161/01.CIR.0000062688.76508.B3; Remillard CV, 2007, AM J PHYSIOL-CELL PH, V292, pC1837, DOI 10.1152/ajpcell.00405.2006; Samizo K, 1999, BIOCHEM BIOPH RES CO, V261, P95, DOI 10.1006/bbrc.1999.0956; Stenmark KR, 2006, CIRC RES, V99, P675, DOI 10.1161/01.RES.0000243584.45145.3f; Stroka DM, 2001, FASEB J, V15, P2445, DOI 10.1096/fj.01-0125com; Tuder RM, 2001, J PATHOL, V195, P367, DOI 10.1002/path.953; WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230; Ying LH, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aad0376; Yu AY, 1998, AM J PHYSIOL-LUNG C, V275, pL818, DOI 10.1152/ajplung.1998.275.4.L818; Yu AY, 1999, J CLIN INVEST, V103, P691, DOI 10.1172/JCI5912; Yuan XJ, 1998, LANCET, V351, P726, DOI 10.1016/S0140-6736(05)78495-6	27	26	26	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					650	662		10.1096/fj.201600557R	http://dx.doi.org/10.1096/fj.201600557R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27811062	Green Published			2022-12-28	WOS:000394235400018
J	Lou, YY; Hu, MH; Mao, LN; Zheng, YM; Jin, F				Lou, Yiyun; Hu, Minhao; Mao, Luna; Zheng, Yingming; Jin, Fan			Involvement of serum glucocorticoid-regulated kinase 1 in reproductive success	FASEB JOURNAL			English	Review						SGK1; embryo implantation; infertility; spontaneous abortion; endometriosis	EPITHELIAL NA+ CHANNEL; INDUCIBLE KINASE; EMBRYO IMPLANTATION; ENDOMETRIAL RECEPTIVITY; SODIUM-CHANNEL; CELL-SURVIVAL; IN-VITRO; DIFFERENTIAL EXPRESSION; RECURRENT MISCARRIAGE; SURFACE EXPRESSION	Reproductive processes, in particular events that concern pregnancy, are fine-tuned to produce offspring. Reproductive success is of prime importance for the survival of every species. The highly conserved and ubiquitously expressed serum glucocorticoid-regulated kinase 1 ( SGK1) was first implicated in infertility as a regulator of a Na+ channel. In this review, we emphasize the prominent role of SGK1 during early pregnancy: 1) balancing uterine luminal fluid secretion and reabsorption to aid blastocyst adhesion and to import nutrients and energy; 2) transducing signals from the blastocyst to the receptive endometrium; 3) inducing multiple genes that are involved in uterine receptivity and trophoblast invasion; 4) regulating cell differentiation and antioxidant defenses at the fetomaternal interface; and 5) contributing to the proliferation and survival of decidual stromal cells. Accordingly, SGK1 coordinates many cellular processes that are crucial to reproductive activities. Aberrant expression or function of SGK1 results in implantation failure and early pregnancy loss. Further investigation of the molecular mechanisms of the function of SGK1 might provide novel diagnostic tools and interventions for reproductive complications.-Lou, Y., Hu, M., Mao, L., Zheng, Y., Jin, F. Involvement of serum glucocorticoid-regulated kinase 1 in reproductive success.	[Lou, Yiyun; Hu, Minhao; Mao, Luna; Zheng, Yingming; Jin, Fan] Zhejiang Univ, Womens Hosp, Dept Reprod Endocrinol, Hangzhou, Zhejiang, Peoples R China; [Jin, Fan] Zhejiang Univ, Sch Med, Dept Biochem & Genet, Hangzhou, Zhejiang, Peoples R China; [Lou, Yiyun] Hangzhou Hosp Tradit Chinese Med, Dept Gynaecol, Hangzhou, Zhejiang, Peoples R China; [Jin, Fan] Zhejiang Univ, Key Lab Reprod Genet, Hangzhou, Zhejiang, Peoples R China; [Jin, Fan] Zhejiang Univ, Womens Reprod Hlth Lab Zhejiang Prov, Natl Minist Educ, Hangzhou, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University; Zhejiang University; Zhejiang University	Jin, F (corresponding author), Zhejiang Univ, Womens Hosp, Sch Med, 1 Xueshi Rd, Hangzhou 310006, Zhejiang, Peoples R China.	jinfan@zju.edu.cn			National Basic Research Program of China [2014CB943300, 2012CB944901]; National Natural Science Program of China [81070532, 81070541]; Natural Science Program of Zhejiang Province, China [Y2100822]; Zhejiang Provincial Natural Science Foundation of China [LZ13H040001]; Medical Scientific Research Program of Zhejiang Province [2014KYA269]; Health Science and Technology Program of Hangzhou [2014A54]; Traditional Chinese Medicine Program of Zhejiang Province [2015ZA159]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Program of China(National Natural Science Foundation of China (NSFC)); Natural Science Program of Zhejiang Province, China; Zhejiang Provincial Natural Science Foundation of China(Natural Science Foundation of Zhejiang Province); Medical Scientific Research Program of Zhejiang Province; Health Science and Technology Program of Hangzhou; Traditional Chinese Medicine Program of Zhejiang Province	This work was supported by the National Basic Research Program of China (Grants 2014CB943300 and 2012CB944901); the National Natural Science Program of China (Grants 81070532 and 81070541); the Natural Science Program of Zhejiang Province, China (Grant Y2100822); the Zhejiang Provincial Natural Science Foundation of China (Grant LZ13H040001); the Medical Scientific Research Program of Zhejiang Province (Grant 2014KYA269); the Health Science and Technology Program of Hangzhou (Grant 2014A54); and the Traditional Chinese Medicine Program of Zhejiang Province (Grant 2015ZA159).	Agostinis C, 2012, HUM REPROD, V27, P2941, DOI 10.1093/humrep/des289; Altmae S, 2015, REPROD BIOMED ONLINE, V31, P581, DOI 10.1016/j.rbmo.2015.09.008; Baskin R, 2012, CELL SIGNAL, V24, P435, DOI 10.1016/j.cellsig.2011.09.016; Bauersachs S, 2015, ANNU REV ANIM BIOSCI, V3, P489, DOI 10.1146/annurev-animal-022114-110639; BelAiba RS, 2006, CIRC RES, V98, P828, DOI 10.1161/01.RES.0000210539.54861.27; Bomberger JM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089599; Brickley DR, 2013, J BIOL CHEM, V288, P32708, DOI 10.1074/jbc.M113.507210; Brosens JJ, 2014, SCI REP-UK, V4, DOI 10.1038/srep03894; Bruhn MA, 2010, GROWTH FACTORS, V28, P394, DOI 10.3109/08977194.2010.518616; Burris HA, 2013, CANCER CHEMOTH PHARM, V71, P829, DOI 10.1007/s00280-012-2043-3; Catela C, 2010, DEV DYNAM, V239, P2149, DOI 10.1002/dvdy.22345; Cha JY, 2012, NAT MED, V18, P1754, DOI 10.1038/nm.3012; Chan HC, 2009, J PHYSIOL-LONDON, V587, P2187, DOI 10.1113/jphysiol.2008.164970; Collins-Hooper H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120524; Dai ZL, 2015, MOL HUM REPROD, V21, P389, DOI 10.1093/molehr/gav003; Debonneville C, 2001, EMBO J, V20, P7052, DOI 10.1093/emboj/20.24.7052; Deng WB, 2013, THERIOGENOLOGY, V79, P1196, DOI 10.1016/j.theriogenology.2013.02.018; Di Pietro N, 2010, MOL ENDOCRINOL, V24, P370, DOI 10.1210/me.2009-0265; Ding GL, 2015, ASIAN J ANDROL, V17, P948, DOI 10.4103/1008-682X.150844; Doherty LF, 2012, FERTIL STERIL, V98, pS61, DOI 10.1016/j.fertnstert.2012.07.216; Eylenstein A, 2012, J BIOL CHEM, V287, P2719, DOI 10.1074/jbc.M111.275925; Eylenstein A, 2011, FASEB J, V25, P2012, DOI 10.1096/fj.10-178210; Ezra DG, 2012, J CLIN PATHOL, V65, P608, DOI 10.1136/jclinpath-2012-200719; Fang Z, 2012, J BIOL CHEM, V287, P2090, DOI 10.1074/jbc.M111.323303; Feroze-Zaidi F, 2007, ENDOCRINOLOGY, V148, P5020, DOI 10.1210/en.2007-0659; Ferrelli F, 2015, ACTA DIABETOL, V52, P55, DOI 10.1007/s00592-014-0600-4; Fisher SJ, 2011, NAT MED, V17, P1348, DOI 10.1038/nm.2549; Fyffe Chanse, 2013, Cancer Manag Res, V5, P271, DOI 10.2147/CMAR.S35026; Geraghty AC, 2015, ADV EXP MED BIOL, V872, P253, DOI 10.1007/978-1-4939-2895-8_11; Grahammer F, 2016, J CLIN INVEST, V126, P1773, DOI 10.1172/JCI80304; Hagiwara A, 2012, CELL METAB, V15, P725, DOI 10.1016/j.cmet.2012.03.015; Hall BA, 2012, BREAST CANCER RES TR, V135, P469, DOI 10.1007/s10549-012-2161-y; He J, 2015, EXP CELL RES, V331, P164, DOI 10.1016/j.yexcr.2014.09.024; He Q, 2010, FERTIL STERIL, V93, P2608, DOI 10.1016/j.fertnstert.2010.01.040; Kaczynski P, 2016, REPRODUCTION, V151, P539, DOI 10.1530/REP-15-0496; Kajihara T, 2006, MOL ENDOCRINOL, V20, P2444, DOI 10.1210/me.2006-0118; Kajihara T, 2013, MED MOL MORPHOL, V46, P61, DOI 10.1007/s00795-013-0018-z; Kim M, 2013, EMBO MOL MED, V5, P1415, DOI 10.1002/emmm.201302618; Kong CC, 2016, J CLIN ENDOCR METAB, V101, P1478, DOI 10.1210/jc.2015-1588; Lang F, 2006, PHYSIOL REV, V86, P1151, DOI 10.1152/physrev.00050.2005; Lang F, 2013, HORM-INT J ENDOCRINO, V12, P160, DOI 10.14310/horm.2002.1401; Lang F, 2013, FASEB J, V27, P3, DOI 10.1096/fj.12-218230; Lang F, 2010, INT J BIOCHEM CELL B, V42, P1571, DOI 10.1016/j.biocel.2010.05.016; Lang F, 2009, EXPERT OPIN THER TAR, V13, P1303, DOI 10.1517/14728220903260807; Lin XH, 2015, FERTIL STERIL, V103, P228, DOI 10.1016/j.fertnstert.2014.10.002; Liu XM, 2014, PHYSIOLOGY, V29, P186, DOI 10.1152/physiol.00039.2013; Luo JL, 2016, J AM SOC NEPHROL, V27, P2797, DOI 10.1681/ASN.2015080867; Lv Y, 2016, EUR J OBSTET GYN R B, V197, P27, DOI 10.1016/j.ejogrb.2015.11.003; Mason JA, 2016, CELL DEATH DIFFER, V23, P1271, DOI 10.1038/cdd.2016.15; Monsivais D, 2016, FERTIL STERIL, V105, P1266, DOI 10.1016/j.fertnstert.2016.01.012; Morrish DW, 1996, PLACENTA, V17, P431, DOI 10.1016/S0143-4004(96)90025-9; Naqvi H, 2016, REPROD SCI, V23, P186, DOI 10.1177/1933719115613449; Notch EG, 2012, COMP BIOCHEM PHYS A, V162, P443, DOI 10.1016/j.cbpa.2012.04.025; Pan XY, 2015, INT J CLIN EXP MED, V8, P20035; Pearce LR, 2011, BIOCHEM J, V436, P169, DOI 10.1042/BJ20102103; Rexhepaj R, 2008, AM J PHYSIOL-REG I, V294, pR2008, DOI 10.1152/ajpregu.00737.2007; Rhee JS, 2016, HUM REPROD, V31, P1315, DOI 10.1093/humrep/dew048; Rosario GX, 2016, AM J REPROD IMMUNOL, V75, P246, DOI 10.1111/aji.12474; Ruan YC, 2014, HUM REPROD UPDATE, V20, P517, DOI 10.1093/humupd/dmu006; Ruan YC, 2012, NAT MED, V18, P1112, DOI 10.1038/nm.2771; Rull K, 2013, PLACENTA, V34, P141, DOI 10.1016/j.placenta.2012.11.032; Sahin P, 2013, NEUROPATH APPL NEURO, V39, P623, DOI 10.1111/nan.12023; Saini KS, 2013, CANCER TREAT REV, V39, P935, DOI 10.1016/j.ctrv.2013.03.009; Salker MS, 2016, CELL PHYSIOL BIOCHEM, V39, P1295, DOI 10.1159/000447834; Salker MS, 2011, NAT MED, V17, P1509, DOI 10.1038/nm.2498; Schmid E, 2013, AM J PHYSIOL-CELL PH, V304, pC49, DOI 10.1152/ajpcell.00179.2012; Schmidt S, 2014, MOL HUM REPROD, V20, P139, DOI 10.1093/molehr/gat066; Setiawan I, 2002, PFLUG ARCH EUR J PHY, V444, P426, DOI 10.1007/s00424-002-0823-z; Singh Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17723; Sun X, 2014, REPRODUCTION, V148, P559, DOI 10.1530/REP-14-0386; Tang M, 2005, HUM REPROD, V20, P872, DOI 10.1093/humrep/deh717; Tang MY, 2005, HUM REPROD, V20, P1772, DOI 10.1093/humrep/deh849; Tepekoy F, 2015, J ASSIST REPROD GEN, V32, P337, DOI 10.1007/s10815-014-0409-7; Tian Y, 2013, MOL MED REP, V8, P294, DOI 10.3892/mmr.2013.1473; Towhid ST, 2013, CELL PHYSIOL BIOCHEM, V32, P838, DOI 10.1159/000354486; Tsai V, 2014, CEREB CORTEX, V24, P315, DOI 10.1093/cercor/bhs310; Tzivion G, 2011, BBA-MOL CELL RES, V1813, P1938, DOI 10.1016/j.bbamcr.2011.06.002; Verrey F, 2003, ANN NY ACAD SCI, V986, P554, DOI 10.1111/j.1749-6632.2003.tb07253.x; Vuagniaux G, 2002, J GEN PHYSIOL, V120, P191, DOI 10.1085/jgp.20028598; Waldegger S, 1998, GENOMICS, V51, P299, DOI 10.1006/geno.1998.5258; Wang Y, 2015, FERTIL STERIL, V103, P980, DOI 10.1016/j.fertnstert.2015.01.003; Winship A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129110; Xu H, 2015, FERTIL STERIL, V104, pE171, DOI 10.1016/j.fertnstert.2015.07.530; Xu WF, 2016, METABOLISM, V65, P73, DOI 10.1016/j.metabol.2015.10.026; Yamahara H, 2009, KIDNEY BLOOD PRESS R, V32, P185, DOI 10.1159/000225379; Yan Lijun, 2008, Biochem J, V416, pe19, DOI 10.1042/BJ20082202; Yang H, 2016, J ENDOCRINOL INVEST, V39, P785, DOI 10.1007/s40618-016-0435-7; Yang JZ, 2011, FERTIL STERIL, V95, P2100, DOI 10.1016/j.fertnstert.2011.02.036; Yang JZ, 2004, CELL BIOL INT, V28, P433, DOI 10.1016/j.cellbi.2004.03.011; Young SL, 2013, REPROD BIOMED ONLINE, V27, P497, DOI 10.1016/j.rbmo.2013.06.010; Yue P, 2013, BBA-MOL CELL RES, V1833, P2101, DOI 10.1016/j.bbamcr.2013.05.004; Zarrinpashneh E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080268; Zhang RJ, 2012, J CLIN ENDOCR METAB, V97, P543, DOI 10.1210/jc.2011-2108; Zhang S, 2013, MOL ASPECTS MED, V34, P939, DOI 10.1016/j.mam.2012.12.011; Zhou M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099521; Zhou RF, 2010, J BIOL CHEM, V285, P30523, DOI 10.1074/jbc.M110.150755; Zygmunt M, 2003, EUR J OBSTET GYN R B, V110, pS10, DOI 10.1016/S0301-2115(03)00168-4	97	20	21	0	19	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2017	31	2					447	456		10.1096/fj.201600760R	http://dx.doi.org/10.1096/fj.201600760R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EK9HR	27871060				2022-12-28	WOS:000394235400002
J	Kumar, B; Arora, S; Ahmed, S; Banerjea, AC				Kumar, Binod; Arora, Sakshi; Ahmed, Shaista; Banerjea, Akhil C.			Hyperactivation of mammalian target of rapamycin complex 1 by HIV-1 is necessary for virion production and latent viral reactivation	FASEB JOURNAL			English	Article						protein synthesis; 4E-BP1; nucleotide biogenesis; CAD; Tat	PENTOSE-PHOSPHATE PATHWAY; T-CELL-ACTIVATION; TAT PROTEIN; MTOR; EXPRESSION; GROWTH; METABOLISM; INDUCTION; PHOSPHORYLATION; REPLICATION	Generation of new HIV-1 virions requires the constant supply of proteins, nucleotides, and energy; however, it is not known which cellular pathways are perturbed and what molecular mechanisms are employed. We hypothesized that HIV-1 may regulate pathways that control synthesis of biomolecules in the cell. In this study, we provide evidence that HIV-1 hyperactivates mammalian target of rapamycin complex 1 (mTORC1), the central regulator of biosynthesis. Mechanistically, we identify the viral regulatory gene tat (transactivator) as being responsible for increasing mTORC1 activity in a PI3K-dependent manner. Furthermore, we show that hyperactivation of mTORC1 leads to activation of the enzyme, carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, dihydroorotase, and repression of initiation factor 4E-binding protein 1 activity. These are regulators of nucleotide biogenesis and protein translation, respectively. Moreover, we are able to replicate these results in HIV-1 latent cell line models. Finally, we show that inhibition of mTORC1 or PI3K inhibits viral replication and viral reactivation as a result of a decrease in biosynthesis. Overall, our study identifies a new avenue in HIV-1 biology that can lead to development of novel therapeutic targets.-Kumar, B., Arora, S., Ahmed, S., Banerjea, A. C. Hyperactivation of mammalian target of rapamycin complex 1 byHIV-1 is necessary for virion production and latent viral reactivation.	[Kumar, Binod; Arora, Sakshi; Ahmed, Shaista; Banerjea, Akhil C.] Natl Inst Immunol, Virol Lab, New Delhi, India; [Arora, Sakshi] Univ Heidelberg Hosp, Heidelberg, Germany	Department of Biotechnology (DBT) India; National Institute of Immunology (NII); Ruprecht Karls University Heidelberg	Kumar, B; Banerjea, AC (corresponding author), Natl Inst Immunol, Aruna Asaf Ali Marg, New Delhi 110067, India.	binod@nii.ac.in; akhil@nii.res.in	arora, sakshi/AAU-5305-2021	arora, sakshi/0000-0002-4347-480X; Ahmed, Shaista/0000-0003-4695-4718	Department of Biotechnology [BT/PR8322/Med/14/1245/2006]; Department of Science and Technology; Indian Council of Medical Research [HIV/50/142/9/2011-ECD-II]; National Institute of Immunology (New Delhi, India)	Department of Biotechnology; Department of Science and Technology(Department of Science & Technology (India)); Indian Council of Medical Research(Indian Council of Medical Research (ICMR)); National Institute of Immunology (New Delhi, India)	This work was supported by grants from the Department of Biotechnology (Grant BT/PR8322/Med/14/1245/2006), Department of Science and Technology, the Indian Council of Medical Research (Grant HIV/50/142/9/2011-ECD-II), and National Institute of Immunology (New Delhi, India). The authors thank all members of the A.C.B. laboratory for helpful insights, in particular, Richa Kapoor for critical reading of the manuscript and Sanket Singh Ponia for ideas and advice. The authors also thank Utpreksha Vaish and Alaknanda Mishra for helping with PBL cultures and given a special thanks to Amanda Chase for critically editing the revised manuscript.	Abbas Wasim, 2013, Open Virol J, V7, P57, DOI 10.2174/1874357920130621001; Arora S, 2014, J VIROL, V88, P9141, DOI 10.1128/JVI.00619-14; Bar-Peled L, 2014, TRENDS CELL BIOL, V24, P400, DOI 10.1016/j.tcb.2014.03.003; Barillari G, 1999, BLOOD, V94, P663; Ben-Sahra I, 2013, SCIENCE, V339, P1323, DOI 10.1126/science.1228792; Biancotto A, 2008, BLOOD, V111, P699, DOI 10.1182/blood-2007-05-088435; Bond P, 2016, J INT SOC SPORT NUTR, V13, DOI 10.1186/s12970-016-0118-y; Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99; Buchkovich NJ, 2008, NAT REV MICROBIOL, V6, P265, DOI 10.1038/nrmicro1855; Buel GR, 2013, CELL METAB, V17, P633, DOI 10.1016/j.cmet.2013.04.018; Chan EY, 2009, J VIROL, V83, P9283, DOI 10.1128/JVI.00814-09; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Ciobanasu C, 2010, BIOPHYS J, V99, P153, DOI 10.1016/j.bpj.2010.03.065; Cornall A, 2010, J VIROL METHODS, V165, P90, DOI 10.1016/j.jviromet.2010.01.010; Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322; Deregibus MC, 2002, J BIOL CHEM, V277, P25195, DOI 10.1074/jbc.M200921200; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Duvel K, 2010, MOL CELL, V39, P171, DOI 10.1016/j.molcel.2010.06.022; ENSOLI B, 1990, NATURE, V345, P84, DOI 10.1038/345084a0; Evans DR, 2004, J BIOL CHEM, V279, P33035, DOI 10.1074/jbc.R400007200; Fenton TR, 2011, INT J BIOCHEM CELL B, V43, P47, DOI 10.1016/j.biocel.2010.09.018; Frankel AD, 1998, ANNU REV BIOCHEM, V67, P1, DOI 10.1146/annurev.biochem.67.1.1; Gangwani MR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-136; Groenewoud MJ, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130185; Haas A, 2010, EMBO MOL MED, V2, P231, DOI 10.1002/emmm.201000075; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Herbein G, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-34; Heredia A, 2015, P NATL ACAD SCI USA, V112, P9412, DOI 10.1073/pnas.1511144112; Hudson CC, 2002, MOL CELL BIOL, V22, P7004, DOI 10.1128/MCB.22.20.7004-7014.2002; Janoo A, 2005, J CELL BIOCHEM, V94, P816, DOI 10.1002/jcb.20347; Jiang P, 2014, PROTEIN CELL, V5, P592, DOI 10.1007/s13238-014-0082-8; Johnson TP, 2013, P NATL ACAD SCI USA, V110, P13588, DOI 10.1073/pnas.1308673110; Karn J, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006916; Laplante M, 2013, J CELL SCI, V126, P1713, DOI 10.1242/jcs.125773; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; LI Y, 1993, J VIROL, V67, P584, DOI 10.1128/JVI.67.1.584-588.1993; MacPherson JI, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000863; MICHAEL NL, 1991, J VIROL, V65, P1291, DOI 10.1128/JVI.65.3.1291-1303.1991; Mitchell NC, 2015, CELL SIGNAL, V27, P2045, DOI 10.1016/j.cellsig.2015.07.018; Morita M, 2013, CELL METAB, V18, P698, DOI 10.1016/j.cmet.2013.10.001; Patra KC, 2014, TRENDS BIOCHEM SCI, V39, P347, DOI 10.1016/j.tibs.2014.06.005; Perelson AS, 1996, SCIENCE, V271, P1582, DOI 10.1126/science.271.5255.1582; POMERANTZ RJ, 1990, CELL, V61, P1271, DOI 10.1016/0092-8674(90)90691-7; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Pritchard LK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8479; Ringrose J, 2008, J VIROL, V82, P4320, DOI 10.1128/JVI.01819-07; Robitaille AM, 2013, SCIENCE, V339, P1320, DOI 10.1126/science.1228771; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Shimobayashi M, 2014, NAT REV MOL CELL BIO, V15, P155, DOI 10.1038/nrm3757; STEVENSON M, 1990, EMBO J, V9, P1551, DOI 10.1002/j.1460-2075.1990.tb08274.x; Swingler S, 2003, NATURE, V424, P213, DOI 10.1038/nature01749; Tsouko E, 2014, ONCOGENESIS, V3, DOI 10.1038/oncsis.2014.18; Vatakis DN, 2010, IMMUNOL RES, V48, P110, DOI 10.1007/s12026-010-8171-0; Waickman AT, 2012, IMMUNOL REV, V249, P43, DOI 10.1111/j.1600-065X.2012.01152.x; West MJ, 1998, ONCOGENE, V17, P769, DOI 10.1038/sj.onc.1201990; WESTENDORP MO, 1994, J VIROL, V68, P4177, DOI 10.1128/JVI.68.7.4177-4185.1994; Yecies JL, 2011, CANCER RES, V71, P2815, DOI 10.1158/0008-5472.CAN-10-4158; ZACK JA, 1990, CELL, V61, P213, DOI 10.1016/0092-8674(90)90802-L	59	12	12	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JAN	2017	31	1					180	191		10.1096/fj.201600813R	http://dx.doi.org/10.1096/fj.201600813R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EI0PW	27702769				2022-12-28	WOS:000392177600019
J	Nguyen, TT; Quan, XL; Xu, SH; Das, R; Cha, SK; Kong, ID; Shong, M; Wollheim, CB; Park, KS				Tuyet Thi Nguyen; Quan, Xianglan; Xu, Shanhua; Das, Ranjan; Cha, Seung-Kuy; Kong, In Deok; Shong, Minho; Wollheim, Claes B.; Park, Kyu-Sang			Intracellular alkalinization by phosphate uptake via type III sodium-phosphate cotransporter participates in high-phosphate-induced mitochondrial oxidative stress and defective insulin secretion	FASEB JOURNAL			English	Article						inorganic phosphate; pancreatic beta cells; mitochondrial permeability transition; endoplasmic reticulum stress; superoxide	PERMEABILITY TRANSITION PORE; INORGANIC-PHOSPHATE; BETA-CELLS; KLOTHO; CALCIFICATION; STIMULATION; METABOLISM; FLUORESCENCE; HOMEOSTASIS; GENERATION	Elevated plasma levels of inorganic phosphate (Pi) are harmful, causing, among other complications, vascular calcification and defective insulin secretion. The underlying molecular mechanisms of these complications remain poorly understood. We demonstrated the role of Pi transport across the plasmalemma on Pi toxicity in INS-1E rat clonal beta cells and rat pancreatic islet cells. Type III sodium-phosphate cotransporters (NaP(i)s) are the predominant P-i transporters expressed in insulin-secreting cells. Transcript and protein levels of sodium-dependent phosphate transporter 1 and 2 (PiT-1and -2), isotypes of type III NaPi, were up-regulated by high-Pi incubation. In patch-clamp experiments, extracellular P-i elicited a Na+-dependent, inwardly rectifying current, which was markedly reduced under acidic extracellular conditions. Cellular uptake of P-i elicited cytosolic alkalinization; intriguingly, this pH change facilitated P-i transport into the mitochondrial matrix. Increased mitochondrial P-i uptake accelerated superoxide generation, mitochondrial permeability transition (mPT), and endoplasmic reticulum stress-mediated translational attenuation, leading to reduced insulin content and impaired glucose-stimulated insulin secretion. Silencing of PiT-1/2 prevented Pi-induced superoxide generation and mPT, and restored insulin secretion. We propose that P-i transport across the plasma membrane and consequent cytosolic alkalinization could be a therapeutic target for protection from P-i toxicity in insulin-secreting cells, as well as in other cell types.-Nguyen, T. T., Quan, X., Xu, S., Das, R., Cha, S.-K., Kong, I. D., Shong, M., Wollheim, C. B., Park, K.-S. Intracellular alkalinization by phosphate uptake via type III sodium-phosphate cotransporter participates in high-phosphate-induced mitochondrial oxidative stress and defective insulin secretion.	[Tuyet Thi Nguyen; Quan, Xianglan; Xu, Shanhua; Das, Ranjan; Cha, Seung-Kuy; Kong, In Deok; Park, Kyu-Sang] Yonsei Univ, Wonju Coll Med, Dept Physiol, Wonju, South Korea; [Tuyet Thi Nguyen] Yonsei Univ, Wonju Coll Med, Mitohormesis Translat Res Ctr, Wonju, South Korea; [Tuyet Thi Nguyen] Tan Tao Univ, Dept Physiol, Coll Med, Long An, Vietnam; [Shong, Minho] Chungnam Natl Univ, Sch Med, Res Ctr Endocrine & Metab Dis, Daejeon, South Korea; [Wollheim, Claes B.] Univ Geneva, Dept Cell Physiol & Metab, Geneva, Switzerland	Yonsei University; Yonsei University; Chungnam National University; University of Geneva	Park, KS (corresponding author), Yonsei Univ, Dept Physiol, Mitohormesis Translat Res Ctr, Wonju Coll Med, Ilsan Ro 20, Wonju 26426, Gangwon Do, South Korea.	qsang@yonsei.ac.kr	/H-7803-2012; Das, Ranjan/AFQ-6329-2022; DAS, RANJAN/ABE-4002-2021	Das, Ranjan/0000-0002-7951-4121; Park, Kyu-Sang/0000-0003-0322-9807; shong, minho/0000-0002-0247-7115; Wollheim, Claes/0000-0002-4570-9879	Korean National Research Foundation (NRF) - Ministry of Science, Information and Communications Technology, and Future Planning [NRF-2014M3A9D8034464]	Korean National Research Foundation (NRF) - Ministry of Science, Information and Communications Technology, and Future Planning	This work was supported in part by a grant from the Korean National Research Foundation (NRF) funded by the Ministry of Science, Information and Communications Technology, and Future Planning (NRF-2014M3A9D8034464) (to M.S.).	Alavian KN, 2014, P NATL ACAD SCI USA, V111, P10580, DOI 10.1073/pnas.1401591111; Back SH, 2012, ANNU REV BIOCHEM, V81, P767, DOI 10.1146/annurev-biochem-072909-095555; Back SH, 2012, EXP DIABETES RES, DOI 10.1155/2012/618396; Bose S, 2003, J BIOL CHEM, V278, P39155, DOI 10.1074/jbc.M306409200; BUKOWIECKI L, 1979, BIOCHIM BIOPHYS ACTA, V583, P370, DOI 10.1016/0304-4165(79)90461-6; Crouthamel MH, 2013, ARTERIOSCL THROM VAS, V33, P2625, DOI 10.1161/ATVBAHA.113.302249; Di Marco GS, 2013, KIDNEY INT, V83, P213, DOI 10.1038/ki.2012.300; FADDA GZ, 1991, J CLIN INVEST, V87, P255, DOI 10.1172/JCI114979; Forster IC, 2013, MOL ASPECTS MED, V34, P386, DOI 10.1016/j.mam.2012.07.007; Forster IC, 2012, CURR TOP MEMBR, V70, P313, DOI 10.1016/B978-0-12-394316-3.00010-7; Gautier CA, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-22; Gonzalez-Parra E, 2012, CARDIOVASC PATHOL, V21, P372, DOI 10.1016/j.carpath.2012.02.008; Halestrap AP, 2015, FASEB J, V78, P129; HAROOTUNIAN AT, 1989, J BIOL CHEM, V264, P19458; Hu MC, 2013, SEMIN NEPHROL, V33, P118, DOI 10.1016/j.semnephrol.2012.12.013; Jain N, 2013, J NEPHROL, V26, P856, DOI 10.5301/jn.5000242; JANJIC D, 1992, DIABETOLOGIA, V35, P482, DOI 10.1007/BF02342448; Koshkin V, 2004, J BIOL CHEM, V279, P41368, DOI 10.1074/jbc.M406914200; Kuro-o M, 2013, KIDNEY INT SUPPL, V3, P420, DOI 10.1038/kisup.2013.88; Kuro-o M, 2013, NAT REV NEPHROL, V9, P650, DOI 10.1038/nrneph.2013.111; Leibrock CB, 2015, J AM SOC NEPHROL, V26, P2423, DOI 10.1681/ASN.2014030230; Li XW, 2006, CIRC RES, V98, P905, DOI 10.1161/01.RES.0000216409.20863.e7; Lorenzo C, 2014, DIABETOLOGIA, V57, P1366, DOI 10.1007/s00125-014-3241-9; Massry SG, 2001, AM J KIDNEY DIS, V38, pS58, DOI 10.1053/ajkd.2001.27404; Miyamoto KI, 2011, J PHARM SCI-US, V100, P3719, DOI 10.1002/jps.22614; Parnaud G, 2008, DIABETOLOGIA, V51, P91, DOI 10.1007/s00125-007-0855-1; Penido MGMG, 2012, PEDIATR NEPHROL, V27, P2039, DOI 10.1007/s00467-012-2175-z; Petronilli V, 1999, BIOPHYS J, V76, P725, DOI 10.1016/S0006-3495(99)77239-5; PIERCE M, 1978, ENDOCRINOLOGY, V103, P971, DOI 10.1210/endo-103-3-971; Quan XL, 2015, J BIOL CHEM, V290, P4086, DOI 10.1074/jbc.M114.632547; Quan X, 2013, MOL CELL ENDOCRINOL, V381, P198, DOI 10.1016/j.mce.2013.08.003; Razzaque MS, 2011, CLIN SCI, V120, P91, DOI 10.1042/CS20100377; Scheuner D, 2008, ENDOCR REV, V29, P317, DOI 10.1210/er.2007-0039; Sekiguchi S, 2011, AM J PHYSIOL-RENAL, V300, pF848, DOI 10.1152/ajprenal.00334.2010; Selivanov VA, 2008, J BIOL CHEM, V283, P29292, DOI 10.1074/jbc.M801019200; Takeda E, 2004, BIOFACTORS, V21, P345, DOI 10.1002/biof.552210167; Takeda E, 2004, J CELL MOL MED, V8, P191, DOI 10.1111/j.1582-4934.2004.tb00274.x; Nguyen TT, 2015, AM J PHYSIOL-ENDOC M, V308, pE933, DOI 10.1152/ajpendo.00009.2015; Utsugi T, 2000, METABOLISM, V49, P1118, DOI 10.1053/meta.2000.8606; Werner A, 1998, J EXP BIOL, V201, P3135; Wiederkehr A, 2009, EMBO J, V28, P417, DOI 10.1038/emboj.2008.302; Zorov DB, 2009, CARDIOVASC RES, V83, P213, DOI 10.1093/cvr/cvp151	42	12	13	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					3979	3988		10.1096/fj.201600455RR	http://dx.doi.org/10.1096/fj.201600455RR			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27565711	Green Published			2022-12-28	WOS:000388201500006
J	Deniz, M; Kaufmann, J; Stahl, A; Gundelach, T; Janni, W; Hoffmann, I; Keimling, M; Hampp, S; Ihle, M; Wiesmuller, L				Deniz, Miriam; Kaufmann, Julia; Stahl, Andreea; Gundelach, Theresa; Janni, Wolfgang; Hoffmann, Isabell; Keimling, Marlen; Hampp, Stephanie; Ihle, Michaela; Wiesmueller, Lisa			In vitro model for DNA double-strand break repair analysis in breast cancer reveals cell type-specific associations with age and prognosis	FASEB JOURNAL			English	Article						aging; chemotherapy; epithelial-mesenchymal transition; PARP inhibition	EPITHELIAL-MESENCHYMAL TRANSITION; HOMOLOGOUS RECOMBINATION; HEREDITARY BREAST; POLY(ADP-RIBOSE) POLYMERASE; OVARIAN-CANCER; HIGH-GRADE; BRCA1; SUSCEPTIBILITY; MUTATIONS; PREDICTION	Dysfunction of homologous recombination is a common denominator of changes associated with breast cancer-predisposing mutations. In our previous work, we identified a functional signature in peripheral blood lymphocytes from women who were predisposed that indicated a shift from homologous recombination to alternative, error-prone DNA double-strand break (DSB) repair pathways. To capture both hereditary and nonhereditary factors, we newly established a protocol for isolation and ex vivo analysis of epithelial cells, epithelial-mesenchymal transition cells (EMTs), and fibroblasts from breast cancer specimens (147 patients). By applying a fluorescence-based test system, we analyzed the error-prone DSB repair pathway microhomology-mediated end joining in these tumor-derived cell types and peripheral blood lymphocytes. In parallel, we investigated DNA lesion processing by quantitative immunofluorescence microscopy of histone H2AX phosphorylated on Ser139 focus after radiomimetic treatment. Our study reveals elevated histone H2AX phosphorylated on Ser139 damage removal in epithelial cells, not EMTs, and poly(ADP-ribose)polymerase inhibitor sensitivities, which suggested a DSB repair pathway shift with increasing patient age. Of interest, we found elevated microhomology-mediated end joining in EMTs, not epithelial cells, from patients who received a treatment recommendation of adjuvant chemotherapy, that is, those with high-risk tumors. Our discoveries of altered DSB repair activities in cells may serve as a method to further classify breast cancer to predict responsiveness to adjuvant chemotherapy and/or therapeutics that target DSB repair-dysfunctional tumors.Deniz, M., Kaufmann, J., Stahl, A., Gundelach, T., Janni, W., Hoffmann, I., Keimling, M., Hampp, S., Ihle, M., Wiesmuller, L. In vitro model for DNA double-strand break repair analysis in breast cancer reveals cell type-specific associations with age and prognosis.	[Deniz, Miriam; Kaufmann, Julia; Stahl, Andreea; Gundelach, Theresa; Janni, Wolfgang; Keimling, Marlen; Hampp, Stephanie; Ihle, Michaela; Wiesmueller, Lisa] Univ Ulm, Dept Obstet & Gynecol, Prittwitzstr 43, D-89075 Ulm, Germany; [Hoffmann, Isabell] Johannes Gutenberg Univ Mainz, Inst Med Biostat Epidemiol & Informat, Univ Med Ctr, Mainz, Germany	Ulm University; Johannes Gutenberg University of Mainz	Wiesmuller, L (corresponding author), Univ Ulm, Dept Obstet & Gynecol, Prittwitzstr 43, D-89075 Ulm, Germany.	lisa.wiesmueller@uni-ulm.de			Federal Ministry of Education and Research (BMBF; Bonn, Germany) (BRENDA) [012P0505]; Deutsche Forchungsgemeinschaft (DFG) Graduate School of Molecular Medicine at Ulm University (Ulm, Germany) [110388]	Federal Ministry of Education and Research (BMBF; Bonn, Germany) (BRENDA)(Federal Ministry of Education & Research (BMBF)); Deutsche Forchungsgemeinschaft (DFG) Graduate School of Molecular Medicine at Ulm University (Ulm, Germany)(German Research Foundation (DFG))	This work was supported by grants from Federal Ministry of Education and Research (BMBF; Bonn, Germany) (BRENDA #012P0505), the Deutsche Forchungsgemeinschaft (DFG) Graduate School of Molecular Medicine at Ulm University (Ulm, Germany; Ph.D. fellowship to S.H.), and the Deutsche Krebshilfe (#110388). The authors thank Rolf Kreienberg, Karin Koretz, and Peter Moller (Institute of Pathology, Ulm University) for the continuous support of our molecular oncological studies; Harald Binder and Maria Blettner (Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Centre, Johannes-Gutenberg-University of Mainz) for sharing their expertise regarding statistical evaluation of the data; and Ralf Hass (Department of Gynecology, Medical School Hannover, Hannover, Germany) for sharing reagents and technical advice during the initial phase of primary epithelial cell culture establishment.	Akyuz N, 2002, MOL CELL BIOL, V22, P6306, DOI 10.1128/MCB.22.17.6306-6317.2002; Antoniou AC, 2014, NEW ENGL J MED, V371, P497, DOI [10.1056/NEJMoa1400382, 10.1056/NEJMc1410673]; Asakawa H, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2486; Audeh MW, 2010, LANCET, V376, P245, DOI 10.1016/S0140-6736(10)60893-8; Bae YK, 2015, J BREAST CANCER, V18, P256, DOI 10.4048/jbc.2015.18.3.256; Bai F, 2014, CANCER RES, V74, P6161, DOI 10.1158/0008-5472.CAN-14-1119; Baldeyron C, 2002, ONCOGENE, V21, P1401, DOI 10.1038/sj.onc.1205200; Bauer KR, 2007, CANCER, V109, P1721, DOI 10.1002/cncr.22618; Blows FM, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000279; Bohringer M, 2013, ONCOGENE, V32, P5458, DOI 10.1038/onc.2013.38; Bryant HE, 2005, NATURE, V434, P913, DOI 10.1038/nature03443; Couch FJ, 2015, J CLIN ONCOL, V33, P304, DOI 10.1200/JCO.2014.57.1414; Couch FJ, 2014, SCIENCE, V343, P1466, DOI 10.1126/science.1251827; Curtin NJ, 2012, NAT REV CANCER, V12, P801, DOI 10.1038/nrc3399; Easton Douglas F, 2015, N Engl J Med, V372, P2243, DOI 10.1056/NEJMsr1501341; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Foroni C, 2012, CANCER TREAT REV, V38, P689, DOI 10.1016/j.ctrv.2011.11.001; Garm C, 2013, AGING CELL, V12, P58, DOI 10.1111/acel.12019; Gatz SA, 2006, CELL DEATH DIFFER, V13, P1003, DOI 10.1038/sj.cdd.4401903; Gelmon KA, 2011, LANCET ONCOL, V12, P852, DOI 10.1016/S1470-2045(11)70214-5; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Graeser M, 2010, CLIN CANCER RES, V16, P6159, DOI 10.1158/1078-0432.CCR-10-1027; Honrado E, 2005, MODERN PATHOL, V18, P1305, DOI 10.1038/modpathol.3800453; Ireno IC, 2014, CARCINOGENESIS, V35, P2273, DOI 10.1093/carcin/bgu160; Jeggo PA, 2011, RADIOTHER ONCOL, V101, P7, DOI 10.1016/j.radonc.2011.06.019; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Keimling M, 2008, INT J CANCER, V123, P730, DOI 10.1002/ijc.23551; Keimling M, 2012, FASEB J, V26, P2094, DOI 10.1096/fj.11-200790; Keimling M, 2011, FASEB J, V25, P3849, DOI 10.1096/fj.11-185546; Keimling M, 2009, CARCINOGENESIS, V30, P1260, DOI 10.1093/carcin/bgp117; Larsen MJ, 2014, BREAST CANCER-BASIC, V8, P145, DOI 10.4137/BCBCR.S18715; Le Du F, 2015, ONCOTARGET, V6, P12890, DOI 10.18632/oncotarget.3849; Lobrich M, 2010, CELL CYCLE, V9, P662, DOI 10.4161/cc.9.4.10764; Mandel K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056591; Mavaddat N, 2012, CANCER EPIDEM BIOMAR, V21, P134, DOI 10.1158/1055-9965.EPI-11-0775; Meindl A, 2011, DTSCH ARZTEBL INT, V108, P323, DOI 10.3238/arztebl.2011.0323; Meindl A, 2010, NAT GENET, V42, P410, DOI 10.1038/ng.569; Melchor L, 2013, HUM GENET, V132, P845, DOI 10.1007/s00439-013-1299-y; Minafra L, 2014, ANTICANCER RES, V34, P2173; Mukhopadhyay A, 2010, CLIN CANCER RES, V16, P2344, DOI 10.1158/1078-0432.CCR-09-2758; Naipal KAT, 2014, CLIN CANCER RES, V20, P4816, DOI 10.1158/1078-0432.CCR-14-0571; National Comprehensive Cancer Network, NCCN CLIN PRACT GUID; Obermeier K, 2016, ONCOGENE, V35, P3796, DOI 10.1038/onc.2015.448; Ossovskaya Valeria, 2011, Genes Cancer, V2, P870, DOI 10.1177/1947601911432496; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pharoah PDP, 2002, NAT GENET, V31, P33, DOI 10.1038/ng853; Popova T, 2012, CANCER RES, V72, P5454, DOI 10.1158/0008-5472.CAN-12-1470; Redon CE, 2010, CLIN CANCER RES, V16, P4532, DOI 10.1158/1078-0432.CCR-10-0523; Reis JS, 2006, J CLIN PATHOL, V59, P225, DOI 10.1136/jcp.2005.028324; Ribeiro E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066243; Rothfuss A, 2000, CANCER RES, V60, P390; Sharma PM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121083; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stark JM, 2004, MOL CELL BIOL, V24, P9305, DOI 10.1128/MCB.24.21.9305-9316.2004; Steinestel K, 2014, CLIN TRANSL MED, V3, DOI 10.1186/2001-1326-3-17; Stratton MR, 2008, NAT GENET, V40, P17, DOI 10.1038/ng.2007.53; Thompson LH, 2009, MUTAT RES-FUND MOL M, V668, P54, DOI 10.1016/j.mrfmmm.2009.02.003; Tomaskovic-Crook E, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2416; Turnbull C, 2008, ANNU REV GENOM HUM G, V9, P321, DOI 10.1146/annurev.genom.9.081307.164339; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Turner NC, 2006, ONCOGENE, V25, P5846, DOI 10.1038/sj.onc.1209876; Tutt A, 2010, LANCET, V376, P235, DOI 10.1016/S0140-6736(10)60892-6; Vaidya A, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004511; Walsh CS, 2015, GYNECOL ONCOL, V137, P343, DOI 10.1016/j.ygyno.2015.02.017; Walsh T, 2007, CANCER CELL, V11, P103, DOI 10.1016/j.ccr.2007.01.010; Weigelt B, 2010, J PATHOL, V220, P263, DOI 10.1002/path.2648; Willers H, 2009, MOL CANCER RES, V7, P1304, DOI 10.1158/1541-7786.MCR-09-0149; Wilson CA, 1999, NAT GENET, V21, P236, DOI 10.1038/6029; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Zubeldia-Plazaola A, 2015, FRONT CELL DEV BIOL, V3, DOI 10.3389/fcell.2015.00032	71	9	9	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0892-6638	1530-6860		FASEB J	Faseb J.	NOV	2016	30	11					3786	3799		10.1096/fj.201600453R	http://dx.doi.org/10.1096/fj.201600453R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EA3BY	27494941				2022-12-28	WOS:000386474700013
J	Bastakoty, D; Young, PP				Bastakoty, Dikshya; Young, Pampee P.			Wnt/beta-catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration	FASEB JOURNAL			English	Review						inhibitor; wound healing; scar; fibrosis; repair	EPIDERMAL STEM-CELLS; HAIR FOLLICLE MORPHOGENESIS; SMALL-MOLECULE INHIBITORS; CARDIAC PROGENITOR CELLS; BETA-CATENIN; SELF-RENEWAL; BINDING-PROTEIN; CANCER CELLS; TGF-BETA; MYOCARDIAL-INFARCTION	The Wnt/beta-catenin pathway is an evolutionarily conserved set of signals with critical roles in embryonic and neonatal development across species. In mammals the pathway is quiescent in many organs. It is reactivated in response to injury and is reported to play complex and contrasting roles in promoting regeneration and fibrosis. We review the current understanding of the role of the Wnt/beta-catenin pathway in injury of various mammalian organs and discuss the current advances and potential of Wnt inhibitory therapeutics toward promoting tissue regeneration and reducing fibrosis.-Bastakoty, D., Young, P. P. Wnt/beta-catenin pathway in tissue injury: roles in pathology and therapeutic opportunities for regeneration.	[Bastakoty, Dikshya; Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Young, Pampee P.] Vanderbilt Univ, Med Ctr, Dept Internal Med, Nashville, TN USA	Vanderbilt University; Vanderbilt University	Young, PP (corresponding author), Vanderbilt Univ, Med Ctr, Dept Pathol, 1161 21st Ave S,C2217A MCN, Nashville, TN 37232 USA.	pampee.young@vanderbilt.edu			U.S. National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering Biology Grant [R21EB019505-01A1]; NIH National Institute of General Medical Sciences Grant [R01GM118300]; NIH National Center for Research Resources and philanthropic funds for scientific work on regenerative medicine [UL1 RR024975-01]; American Heart Association Predoctoral Fellowship [3PRE16080004]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R21EB019509] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM118300] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering Biology Grant; NIH National Institute of General Medical Sciences Grant; NIH National Center for Research Resources and philanthropic funds for scientific work on regenerative medicine; American Heart Association Predoctoral Fellowship(American Heart Association); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by U.S. National Institutes of Health (NIH) National Institute of Biomedical Imaging and Bioengineering Biology Grant R21EB019505-01A1 and NIH National Institute of General Medical Sciences Grant R01GM118300; Veterans Affairs Merit Award (to P.P.Y.), Vanderbilt University Clinical and Translational Science Grant UL1 RR024975-01 from the NIH National Center for Research Resources and philanthropic funds for scientific work on regenerative medicine (to P.P.Y.); and American Heart Association Predoctoral Fellowship 3PRE16080004 (to D.B.). P.P.Y. is listed as inventor on a patent application related to wound healing owned by Vanderbilt University. The authors declare no conflicts of interest.	Aisagbonhi O, 2011, DIS MODEL MECH, V4, P469, DOI 10.1242/dmm.006510; Akhmetshina A, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1734; Alfaro MP, 2010, J BIOL CHEM, V285, P35645, DOI 10.1074/jbc.M110.135335; Alfaro MP, 2008, P NATL ACAD SCI USA, V105, P18366, DOI 10.1073/pnas.0803437105; Alonso L, 2003, GENE DEV, V17, P1189, DOI 10.1101/gad.1086903; Amini-Nik S, 2014, J CLIN INVEST, V124, P2599, DOI 10.1172/JCI62059; Amit S, 2002, GENE DEV, V16, P1066, DOI 10.1101/gad.230302; [Anonymous], 2014, FDA LIFTS PART HOLD; Asselin-Labat ML, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120094; Banziger C, 2006, CELL, V125, P509, DOI 10.1016/j.cell.2006.02.049; Barandon L, 2003, CIRCULATION, V108, P2282, DOI 10.1161/01.CIR.0000093186.22847.4C; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Barker N, 2010, CELL STEM CELL, V6, P25, DOI 10.1016/j.stem.2009.11.013; Bartscherer K, 2006, CELL, V125, P523, DOI 10.1016/j.cell.2006.04.009; Bastakoty D, 2016, CELL STEM CELLS REGE, V2; Bastakoty D, 2015, FASEB J, V29, P4881, DOI 10.1096/fj.15-275941; Baurand A, 2007, CIRC RES, V100, P1353, DOI 10.1161/01.RES.0000266605.63681.5a; Beers MF, 2011, J CLIN INVEST, V121, P2065, DOI 10.1172/JCI45961; Beltrami AP, 2001, NEW ENGL J MED, V344, P1750, DOI 10.1056/NEJM200106073442303; Beltrami AP, 2003, CELL, V114, P763, DOI 10.1016/S0092-8674(03)00687-1; Berger K, 2014, SEMIN NEPHROL, V34, P394, DOI 10.1016/j.semnephrol.2014.06.006; Berger K, 2014, P NATL ACAD SCI USA, V111, P1533, DOI 10.1073/pnas.1316177111; Bergmann MW, 2010, CIRC RES, V107, P1198, DOI 10.1161/CIRCRESAHA.110.223768; Bergmann O, 2009, SCIENCE, V324, P98, DOI 10.1126/science.1164680; Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Blagodatski Artem, 2014, Mol Cell Ther, V2, P28, DOI 10.1186/2052-8426-2-28; Blanpain C, 2006, ANNU REV CELL DEV BI, V22, P339, DOI 10.1146/annurev.cellbio.22.010305.104357; BLENKINSOPP WK, 1967, EXP CELL RES, V46, P144, DOI 10.1016/0014-4827(67)90416-8; Bonventre JV, 2011, J CLIN INVEST, V121, P4210, DOI 10.1172/JCI45161; Boulter L, 2015, J CLIN INVEST, V125, P1269, DOI 10.1172/JCI76452; Brack AS, 2008, CELL STEM CELL, V2, P50, DOI 10.1016/j.stem.2007.10.006; Brack AS, 2007, SCIENCE, V317, P807, DOI 10.1126/science.1144090; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; Cadigan KM, 1997, GENE DEV, V11, P3286, DOI 10.1101/gad.11.24.3286; Caubit X, 1997, DEV DYNAM, V210, P1, DOI 10.1002/(SICI)1097-0177(199709)210:1<1::AID-AJA1>3.0.CO;2-L; Chen BZ, 2009, NAT CHEM BIOL, V5, P100, DOI 10.1038/nchembio.137; Chen MY, 2009, BIOCHEMISTRY-US, V48, P10267, DOI 10.1021/bi9009677; Cheon S, 2005, LAB INVEST, V85, P416, DOI 10.1038/labinvest.3700237; Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com; Cheon SS, 2002, P NATL ACAD SCI USA, V99, P6973, DOI 10.1073/pnas.102657399; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Clevers H, 2014, SCIENCE, V346, P54, DOI 10.1126/science.1248012; da Silva-Diz V, 2013, ONCOGENE, V32, P3732, DOI 10.1038/onc.2012.375; Dai CS, 2009, J AM SOC NEPHROL, V20, P1997, DOI 10.1681/ASN.2009010019; DasGupta R, 1999, DEVELOPMENT, V126, P4557; de Jong R, 2014, CIRC-CARDIOVASC INTE, V7, P424, DOI 10.1161/HCV.0000000000000008; de Jong R, 2014, CIRC-CARDIOVASC INTE, V7, P156, DOI 10.1161/CIRCINTERVENTIONS.113.001009; DeAlmeida VI, 2007, CANCER RES, V67, P5371, DOI 10.1158/0008-5472.CAN-07-0266; Dihlmann S, 2001, ONCOGENE, V20, P645, DOI 10.1038/sj.onc.1204123; DiRocco DP, 2013, J AM SOC NEPHROL, V24, P1399, DOI 10.1681/ASN.2012050512; Duan JZ, 2012, EMBO J, V31, P429, DOI 10.1038/emboj.2011.418; Emami K. H., 2004, P NATL ACAD SCI USA, V101, P16707; Emami KH, 2004, P NATL ACAD SCI USA, V101, P12682, DOI 10.1073/pnas.0404875101; Essers MAG, 2005, SCIENCE, V308, P1181, DOI 10.1126/science.1109083; Fevr T, 2007, MOL CELL BIOL, V27, P7551, DOI 10.1128/MCB.01034-07; Fuchs E, 2008, J CELL BIOL, V180, P273, DOI 10.1083/jcb.200708185; Gat U, 1998, CELL, V95, P605, DOI 10.1016/S0092-8674(00)81631-1; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Giangreco A, 2002, AM J PATHOL, V161, P173, DOI 10.1016/S0002-9440(10)64169-7; GIARDIELLO FM, 1993, NEW ENGL J MED, V328, P1313, DOI 10.1056/NEJM199305063281805; Gonsalves FC, 2011, P NATL ACAD SCI USA, V108, P5954, DOI 10.1073/pnas.1017496108; Gougelet A, 2012, INT J HEPATOL, V2012, DOI 10.1155/2012/816125; Green J, 2014, CSH PERSPECT BIOL, V6, DOI 10.1101/cshperspect.a009175; Grover N., 2014, ONCOMED HALTS ENROLL; Gurley KA, 2008, SCIENCE, V319, P323, DOI 10.1126/science.1150029; Gurley KA, 2010, DEV BIOL, V347, P24, DOI 10.1016/j.ydbio.2010.08.007; Haegebarth A, 2009, AM J PATHOL, V174, P715, DOI 10.2353/ajpath.2009.080758; Hahn JY, 2006, J BIOL CHEM, V281, P30979, DOI 10.1074/jbc.M603916200; Hanaki H, 2012, MOL CANCER THER, V11, P298, DOI 10.1158/1535-7163.MCT-11-0682; Hanson AJ, 2012, MOL CELL, V45, P619, DOI 10.1016/j.molcel.2011.12.032; Hao S, 2011, J AM SOC NEPHROL, V22, P1642, DOI 10.1681/ASN.2010101079; He BA, 2005, ONCOGENE, V24, P3054, DOI 10.1038/sj.onc.1208511; He W, 2010, P NATL ACAD SCI USA, V107, P21110, DOI 10.1073/pnas.1004708107; He WC, 2009, J AM SOC NEPHROL, V20, P765, DOI 10.1681/ASN.2008060566; Henderson WR, 2010, P NATL ACAD SCI USA, V107, P14309, DOI 10.1073/pnas.1001520107; Holstein TW, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a007922; Hong KU, 2004, AM J PATHOL, V164, P577, DOI 10.1016/S0002-9440(10)63147-1; Huang SMA, 2009, NATURE, V461, P614, DOI 10.1038/nature08356; Huelsken J, 2001, CELL, V105, P533, DOI 10.1016/S0092-8674(01)00336-1; Humphreys BD, 2008, CELL STEM CELL, V2, P284, DOI 10.1016/j.stem.2008.01.014; Hurlstone AFL, 2003, NATURE, V425, P633, DOI 10.1038/nature02028; Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Kabiri Z, 2015, BLOOD, V126, P1086, DOI 10.1182/blood-2014-09-598540; Kadowaki T, 1996, GENE DEV, V10, P3116, DOI 10.1101/gad.10.24.3116; Kahn M, 2014, NAT REV DRUG DISCOV, V13, P513, DOI 10.1038/nrd4233; Kato H, 2011, J BIOL CHEM, V286, P26003, DOI 10.1074/jbc.M111.223164; Kawakami Y, 2006, GENE DEV, V20, P3232, DOI 10.1101/gad.1475106; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Kim W, 2013, BIOCHEM J, V450, P9, DOI 10.1042/BJ20121284; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Kishimoto J, 2000, GENE DEV, V14, P1181; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Komekado H, 2007, GENES CELLS, V12, P521, DOI 10.1111/j.1365-2443.2007.01068.x; Korinek V, 1998, NAT GENET, V19, P379, DOI 10.1038/1270; Kotton DN, 2014, NAT MED, V20, P822, DOI 10.1038/nm.3642; Kramann R, 2014, SEMIN NEPHROL, V34, P374, DOI 10.1016/j.semnephrol.2014.06.004; Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7; Krausova M, 2014, CELL SIGNAL, V26, P570, DOI 10.1016/j.cellsig.2013.11.032; Kusaba T, 2014, P NATL ACAD SCI USA, V111, P5754, DOI 10.1073/pnas.1403446111; Kusaba T, 2014, P NATL ACAD SCI USA, V111, P1527, DOI 10.1073/pnas.1310653110; Laeremans H, 2011, CIRCULATION, V124, P1626, DOI 10.1161/CIRCULATIONAHA.110.976969; Laugwitz KL, 2005, NATURE, V433, P647, DOI 10.1038/nature03215; Lavine KJ, 2008, J CLIN INVEST, V118, P2404, DOI 10.1172/JCI34561; Lechler T, 2005, NATURE, V437, P275, DOI 10.1038/nature03922; Lee E, 2003, PLOS BIOL, V1, P116, DOI 10.1371/journal.pbio.0000010; Lemaire R, 2010, J INVEST DERMATOL, V130, P1514, DOI 10.1038/jid.2010.15; Lepourcelet M, 2004, CANCER CELL, V5, P91, DOI 10.1016/S1535-6108(03)00334-9; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Ley Brett, 2013, Clin Epidemiol, V5, P483, DOI 10.2147/CLEP.S54815; Lim XH, 2013, SCIENCE, V342, P1226, DOI 10.1126/science.1239730; Lim XH, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008029; Lin SL, 2010, P NATL ACAD SCI USA, V107, P4194, DOI 10.1073/pnas.0912228107; Liu J, 2013, P NATL ACAD SCI USA, V110, P20224, DOI 10.1073/pnas.1314239110; Liu WG, 2000, NAT GENET, V26, P146, DOI 10.1038/79859; Marikawa Y, 1998, MECH DEVELOP, V77, P75, DOI 10.1016/S0925-4773(98)00134-8; MCMAHON AP, 1989, CELL, V58, P1075, DOI 10.1016/0092-8674(89)90506-0; Messina E, 2004, CIRC RES, V95, P911, DOI 10.1161/01.RES.0000147315.71699.51; Miao CG, 2013, BIOCHIMIE, V95, P2326, DOI 10.1016/j.biochi.2013.09.003; Mikels AJ, 2006, ONCOGENE, V25, P7461, DOI 10.1038/sj.onc.1210053; Mirotsou M, 2007, P NATL ACAD SCI USA, V104, P1643, DOI 10.1073/pnas.0610024104; Miyabayashi T, 2007, P NATL ACAD SCI USA, V104, P5668, DOI 10.1073/pnas.0701331104; Morin PJ, 1997, SCIENCE, V275, P1787, DOI 10.1126/science.275.5307.1787; Myung SJ, 2007, FEBS LETT, V581, P2954, DOI 10.1016/j.febslet.2007.05.050; Narayanan BA, 2012, ANTICANCER RES, V32, P4697; Noack C, 2012, EMBO MOL MED, V4, P992, DOI 10.1002/emmm.201101043; NUSSE R, 1982, CELL, V31, P99, DOI 10.1016/0092-8674(82)90409-3; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; NUSSLEINVOLHARD C, 1980, NATURE, V287, P795, DOI 10.1038/287795a0; Oerlemans MIFJ, 2010, BASIC RES CARDIOL, V105, P631, DOI 10.1007/s00395-010-0100-9; Oh H, 2003, P NATL ACAD SCI USA, V100, P12313, DOI 10.1073/pnas.2132126100; Oikonomopoulos A, 2011, CIRC RES, V109, P1363, DOI 10.1161/CIRCRESAHA.111.250282; Oka T, 2007, SEMIN CELL DEV BIOL, V18, P117, DOI 10.1016/j.semcdb.2006.11.012; Ordonez-Moran P, 2012, EMBO J, V31, P2064, DOI 10.1038/emboj.2012.73; Oskarsson T, 2011, NAT MED, V17, P867, DOI 10.1038/nm.2379; Paik DT, 2015, CIRC RES, V117, P804, DOI 10.1161/CIRCRESAHA.115.306886; PEIFER M, 1993, DEVELOPMENT, P163; PEIFER M, 1991, DEVELOPMENT, V111, P1029; Petersen CP, 2009, CELL, V139, P1056, DOI 10.1016/j.cell.2009.11.035; Pfister O, 2005, CIRC RES, V97, P52, DOI 10.1161/01.RES.0000173297.53793.fa; Plaks V, 2013, CELL REP, V3, P70, DOI 10.1016/j.celrep.2012.12.017; Poon R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037940; Poss KD, 2000, DEV DYNAM, V219, P282, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1045>3.3.CO;2-3; Price MA, 2006, GENE DEV, V20, P399, DOI 10.1101/gad.1394306; Proffitt KD, 2013, CANCER RES, V73, P502, DOI 10.1158/0008-5472.CAN-12-2258; Reya T, 2003, NATURE, V423, P409, DOI 10.1038/nature01593; Ro S, 2004, EMBO REP, V5, P914, DOI 10.1038/sj.embor.7400218; Saraswati S, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015521; Sasaki T., 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0075010; Schmeckpeper J, 2015, J MOL CELL CARDIOL, V85, P215, DOI 10.1016/j.yjmcc.2015.06.003; SHARMA RP, 1976, DEV BIOL, V48, P461, DOI 10.1016/0012-1606(76)90108-1; Steventon B, 2012, DEV BIOL, V365, P196, DOI 10.1016/j.ydbio.2012.02.029; Stoick-Cooper CL, 2007, DEVELOPMENT, V134, P479, DOI 10.1242/dev.001123; Sugimura R, 2010, BIRTH DEFECTS RES C, V90, P243, DOI 10.1002/bdrc.20195; Teo JL, 2005, P NATL ACAD SCI USA, V102, P12171, DOI 10.1073/pnas.0504600102; Thorne CA, 2010, NAT CHEM BIOL, V6, P829, DOI 10.1038/NCHEMBIO.453; Tian XH, 2013, J EXP CLIN CANC RES, V32, DOI 10.1186/1756-9966-32-100; Tuynman JB, 2008, CANCER RES, V68, P1213, DOI 10.1158/0008-5472.CAN-07-5172; Uitterdijk A, 2016, LAB INVEST, V96, P168, DOI 10.1038/labinvest.2015.139; Vo N, 2001, J BIOL CHEM, V276, P13505, DOI 10.1074/jbc.R000025200; Waaler J, 2012, CANCER RES, V72, P2822, DOI 10.1158/0008-5472.CAN-11-3336; Wang B, 2015, NATURE, V524, P180, DOI 10.1038/nature14863; Wang C, 2014, AM J PHYSIOL-CELL PH, V307, pC234, DOI 10.1152/ajpcell.00366.2013; Watt FM, 2009, EMBO MOL MED, V1, P260, DOI 10.1002/emmm.200900033; Wehner D, 2014, CELL REP, V6, P777, DOI 10.1016/j.celrep.2014.02.009; Wehner D, 2014, CELL REP, V6, P467, DOI 10.1016/j.celrep.2013.12.036; Wei J, 2011, ARTHRITIS RHEUM-US, V63, P1707, DOI 10.1002/art.30312; Xiao L., J AM SOC NEPHROL, V27, P1727; Yacoub Magdi H, 2013, Glob Cardiol Sci Pract, V2013, P5, DOI 10.5339/gcsp.2013.3; Yang CC, 2010, J DERMATOL SCI, V57, P2, DOI 10.1016/j.jdermsci.2009.11.005; Yang W, 2008, CANCER RES, V68, P4287, DOI 10.1158/0008-5472.CAN-07-6691; YangSnyder J, 1996, CURR BIOL, V6, P1302, DOI 10.1016/S0960-9822(02)70716-1; Yokoyama H, 2007, DEV BIOL, V306, P170, DOI 10.1016/j.ydbio.2007.03.014; Yoon J, 2007, EXP MOL MED, V39, P653, DOI 10.1038/emm.2007.71; Zelarayan LC, 2008, P NATL ACAD SCI USA, V105, P19762, DOI 10.1073/pnas.0808393105; Zemke AC, 2009, AM J RESP CELL MOL, V41, P535, DOI 10.1165/rcmb.2008-0407OC; Zhang Y, 2008, NAT GENET, V40, P862, DOI 10.1038/ng.157; Zhang ZY, 2009, J MOL CELL CARDIOL, V46, P370, DOI 10.1016/j.yjmcc.2008.11.016; Zhou D, 2012, KIDNEY INT, V82, P537, DOI 10.1038/ki.2012.173	181	74	81	1	34	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3271	3284		10.1096/fj.201600502R	http://dx.doi.org/10.1096/fj.201600502R			14	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27335371	Green Published			2022-12-28	WOS:000384329800002
J	Xu, L; Zhou, XY; Wang, WS; Wang, YJ; Yin, YB; van der Laan, LJW; Sprengers, D; Metselaar, HJ; Peppelenbosch, MP; Pan, QW				Xu, Lei; Zhou, Xinying; Wang, Wenshi; Wang, Yijin; Yin, Yuebang; van der Laan, Luc J. W.; Sprengers, Dave; Metselaar, Herold J.; Peppelenbosch, Maikel P.; Pan, Qiuwei			IFN regulatory factor 1 restricts hepatitis E virus replication by activating STAT1 to induce antiviral IFN-stimulated genes	FASEB JOURNAL			English	Article						innate immunity; ribavirin; transcription	C-VIRUS; IN-VITRO; INTERFERON; INFECTION; RIBAVIRIN; PROTEINS; ALPHA; IDENTIFICATION; EXPRESSION; MECHANISM	IFN regulatory factor 1 (IRF1) is one of the most important IFN-stimulated genes (ISGs) in cellular antiviral immunity. Although hepatitis E virus (HEV) is a leading cause of acute hepatitis worldwide, how ISGs counteract HEV infection is largely unknown. This study was conducted to investigate the effect of IRF1 on HEV replication. Multiple cell lines were used in 2 models that harbor HEV. In different HEV cell culture systems, IRF1 effectively inhibited HEV replication. IRF1 did not trigger IFN production, and chromatin immunoprecipitation sequencing data analysis revealed that IRF1 bound to the promoter region of signal transducers and activators of transcription 1 (STAT1). Functional assay confirmed that IRF1 could drive the transcription of STAT1, resulting in elevation of total and phosphorylated STAT1 proteins and further activating the transcription of a panel of downstream antiviral ISGs. By pharmacological inhibitors and RNAi-mediated gene-silencing approaches, we revealed that antiviral function of IRF1 is dependent on the JAK-STAT cascade. Furthermore, induction of ISGs and the anti-HEV effect of IRF1 overlapped that of IFN, but was potentiated by ribavirin. We demonstrated that IRF1 effectively inhibits HEV replication through the activation of the JAK-STAT pathway, and the subsequent transcription of antiviral ISGs, but independent of IFN production.-Xu, L., Zhou, X., Wang, W., Wang, Y., Yin, Y., van der Laan, L. J. W., Sprengers, D., Metselaar, H. J., Peppelenbosch, M. P., Pan, Q. IFN regulatory factor 1 restricts hepatitis E virus replication by activating STAT1 to induce antiviral IFN-stimulated genes.	[Xu, Lei; Zhou, Xinying; Wang, Wenshi; Wang, Yijin; Yin, Yuebang; Sprengers, Dave; Metselaar, Herold J.; Peppelenbosch, Maikel P.; Pan, Qiuwei] Erasmus MC Univ Med Ctr, Postgrad Sch Mol Med, Dept Gastroenterol & Hepatol, Rotterdam, Netherlands; [van der Laan, Luc J. W.] Erasmus MC Univ Med Ctr, Postgrad Sch Mol Med, Dept Surg, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Pan, QW (corresponding author), Erasmus MC, Dept Gastroenterol & Hepatol, Room Na-617,S Gravendijkwal 230, NL-3015 CE Rotterdam, Netherlands.	q.pan@erasmusmc.nl	Peppelenbosch, Maikel P./U-5304-2019; Wang, Yijin/HCH-6264-2022; wang, yijin/GRS-5538-2022; Wang, Yijin/AAA-8753-2022; Zhou, Xinying/AAH-7382-2019	Wang, Yijin/0000-0002-3700-1766; Pan, Qiuwei/0000-0001-9982-6184; Peppelenbosch, Maikel/0000-0001-9112-6028; van der Laan, Luc/0000-0002-0651-5334	European Association for the Study of the Liver (EASL), Sheila Sherlock Fellowship; Netherlands Organization for Scientific Research (NWO/ZonMw) Veni Grant [916-13-032]; Dutch Digestive Foundation (MLDS) Career Development Grant (CDG) [1304]; Daniel den Hoed Foundation Centennial Award Fellowship, an Erasmus MC Medical Research Advisory Committee (MRace) grant; China Scholarship Council [201306300027, 201206150075, 201303250056, 201207720007, 201307720045]	European Association for the Study of the Liver (EASL), Sheila Sherlock Fellowship; Netherlands Organization for Scientific Research (NWO/ZonMw) Veni Grant; Dutch Digestive Foundation (MLDS) Career Development Grant (CDG); Daniel den Hoed Foundation Centennial Award Fellowship, an Erasmus MC Medical Research Advisory Committee (MRace) grant; China Scholarship Council(China Scholarship Council)	The authors thank Dr. Charles M. Rice (Rockefeller University, New York, NY, USA) for generously providing the overexpressing lentiviral vector; Dr. Suzanne U. Emerson (National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, MD, USA) for generously providing the plasmids to generate subgenomic and full-length HEV genomic RNA; Prof. Ralf Bartenschlager and Dr. Volker Lohmann (University of Heidelberg, Heidelberg, Germany) for providing the HCV replicon cells, and Dr. Steve Ralph (Griffith University, Southpost, QLD, Australia) for generously providing the full- length STAT1 promoter luciferase plasmids. This research was supported by the European Association for the Study of the Liver (EASL), Sheila Sherlock Fellowship (to Q.P.); The Netherlands Organization for Scientific Research (NWO/ZonMw) Veni Grant 916-13-032) (to Q.P.); the Dutch Digestive Foundation (MLDS) Career Development Grant (CDG) 1304 (to Q.P.); an Daniel den Hoed Foundation Centennial Award Fellowship (to Q.P.), an Erasmus MC Medical Research Advisory Committee (MRace) grant (to Q.P.) and the China Scholarship Council Ph.D. Fellowships Grants 201306300027 (to L.X.), 201206150075 (to X.Z.), 201303250056 (to W.W.), 201207720007 (to Y.W.), and 201307720045 (to Y.Y.). The authors declare no conflicts of interest.	Behrendt P, 2014, J HEPATOL, V61, P1418, DOI 10.1016/j.jhep.2014.08.047; Brass AL, 2009, CELL, V139, P1243, DOI 10.1016/j.cell.2009.12.017; Dalton HR, 2012, NAT REV GASTRO HEPAT, V9, P430, DOI 10.1038/nrgastro.2012.121; Debing Y, 2014, GASTROENTEROLOGY, V147, P1008, DOI 10.1053/j.gastro.2014.08.040; Debing Y, 2014, ANTIMICROB AGENTS CH, V58, P267, DOI 10.1128/AAC.01795-13; Dong C, 2012, HEPATOLOGY, V55, P1324, DOI 10.1002/hep.25530; Engelen E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8155; Feld JJ, 2005, NATURE, V436, P967, DOI 10.1038/nature04082; Frese M, 2003, J GEN VIROL, V84, P1253, DOI 10.1099/vir.0.18997-0; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Frontini M, 2009, NUCLEIC ACIDS RES, V37, P1073, DOI 10.1093/nar/gkn1051; FUJITA T, 1989, P NATL ACAD SCI USA, V86, P9936, DOI 10.1073/pnas.86.24.9936; Gripon P, 2002, P NATL ACAD SCI USA, V99, P15655, DOI 10.1073/pnas.232137699; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; Janssen HLA, 2005, LANCET, V365, P123, DOI 10.1016/S0140-6736(05)17701-0; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Kamar N, 2012, LANCET, V379, P2477, DOI 10.1016/S0140-6736(11)61849-7; Keskinen P, 1999, VIROLOGY, V263, P364, DOI 10.1006/viro.1999.9983; Liu SY, 2012, P NATL ACAD SCI USA, V109, P4239, DOI 10.1073/pnas.1114981109; Melchjorsen J, 2013, VIRUSES-BASEL, V5, P470, DOI 10.3390/v5020470; MIYAMOTO M, 1988, CELL, V54, P903, DOI 10.1016/S0092-8674(88)91307-4; O'Neill LAJ, 2010, CURR BIOL, V20, pR328, DOI 10.1016/j.cub.2010.01.044; Pan QW, 2012, HEPATOLOGY, V55, P1673, DOI 10.1002/hep.25562; Pan QW, 2009, J MOL MED, V87, P713, DOI 10.1007/s00109-009-0470-3; Robinson JT, 2011, NAT BIOTECHNOL, V29, P24, DOI 10.1038/nbt.1754; Schneider WM, 2014, ANNU REV IMMUNOL, V32, P513, DOI 10.1146/annurev-immunol-032713-120231; Schoggins JW, 2014, NATURE, V505, P691, DOI 10.1038/nature12862; Schoggins JW, 2011, CURR OPIN VIROL, V1, P519, DOI 10.1016/j.coviro.2011.10.008; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sen GC, 2001, ANNU REV MICROBIOL, V55, P255, DOI 10.1146/annurev.micro.55.1.255; Shukla P, 2012, J VIROL, V86, P5697, DOI 10.1128/JVI.00146-12; Shukla P, 2011, P NATL ACAD SCI USA, V108, P2438, DOI 10.1073/pnas.1018878108; Thomas E, 2011, HEPATOLOGY, V53, P32, DOI 10.1002/hep.23985; Todt D, 2016, ANTIMICROB AGENTS CH, V60, P2132, DOI 10.1128/AAC.02427-15; van Ton AMP, 2015, J VIRAL HEPATITIS, V22, P965, DOI 10.1111/jvh.12403; Xie MR, 2015, J VIROL, V89, P3049, DOI 10.1128/JVI.03416-14; Zhang Y, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-9-r137; Zhou X, 2016, J VIRAL HEPATITIS, V23, P294, DOI 10.1111/jvh.12491; Zhou XY, 2014, J HEPATOL, V61, P746, DOI 10.1016/j.jhep.2014.05.026; Zhou XY, 2013, REV MED VIROL, V23, P295, DOI 10.1002/rmv.1751	40	41	41	1	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	OCT	2016	30	10					3352	3367		10.1096/fj.201600356R	http://dx.doi.org/10.1096/fj.201600356R			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DX4DD	27328944				2022-12-28	WOS:000384329800008
J	Ghadakzadeh, S; Kannu, P; Whetstone, H; Howard, A; Alman, BA				Ghadakzadeh, Saber; Kannu, Peter; Whetstone, Heather; Howard, Andrew; Alman, Benjamin A.			beta-Catenin modulation in neurofibromatosis type 1 bone repair: therapeutic implications	FASEB JOURNAL			English	Article						neurofibromin; Wnt signaling; tibial congenital pseudarthrosis; osteoblast differentiation; fracture nonunion	EMBRYONIC STEM-CELLS; CONGENITAL PSEUDOARTHROSIS; TGF-BETA; OSTEOBLAST DIFFERENTIATION; MURINE MODEL; FRACTURE REPAIR; MINERAL DENSITY; MOUSE MODEL; NF1; WNT	Tibial pseudarthrosis causes substantial morbidity in patients with neurofibromatosis type 1 (NF1). We studied tibial pseudarthrosis tissue from patients with NF1 and found elevated levels of -catenin compared to unaffected bone. To elucidate the role of -catenin in fracture healing, we used a surgically induced tibial fracture model in conditional knockout (KO) Nfl (Nf1(flox/flox)) mice. When treated with a Cre-expressing adenovirus (Ad-Cre), there was a localized knockdown of Nf1 in the healing fracture and a subsequent development of a fibrous pseudarthrosis. Consistent with human data, elevated -catenin levels were found in the murine fracture sites. The increased fibrous tissue at the fracture site was rescued by local treatment with a Wingless-type MMTV integration site (Wnt) antagonist, Dickkopf-1 (Dkk1). The murine pseudarthrosis phenotype was also rescued by conditional -catenin gene inactivation. The number of colony-forming unit osteoblasts (CFU-Os), a surrogate marker of undifferentiated mesenchymal cells able to differentiate to osteoblasts, correlated with the capacity to form bone at the fracture site. Our findings indicate that the protein level of -catenin must be precisely regulated for normal osteoblast differentiation. An up-regulation of -catenin in NF1 causes a shift away from osteoblastic differentiation resulting in a pseudarthrosis in vivo. These results support the notion that pharmacological modulation of -catenin can be used to treat pseudarthrosis in patients with NF1.Ghadakzadeh, S., Kannu, P., Whetstone, H., Howard A., Alman, B. A. -catenin modulation in neurofibromatosis type 1 bone repair: therapeutic implications.	[Ghadakzadeh, Saber; Kannu, Peter; Whetstone, Heather; Alman, Benjamin A.] Univ Toronto, Div Dev & Stem Cell Biol, Toronto, ON, Canada; [Ghadakzadeh, Saber; Kannu, Peter; Alman, Benjamin A.] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Kannu, Peter; Howard, Andrew] Hosp Sick Children, Bone Hlth Ctr, Toronto, ON, Canada; [Howard, Andrew] Hosp Sick Children, Div Orthopaed Surg, Toronto, ON, Canada; [Alman, Benjamin A.] Duke Univ, Dept Orthopaed Surg, Durham, NC 27710 USA	University of Toronto; University of Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Duke University	Alman, BA (corresponding author), Duke Univ, Dept Orthopaed Surg, Durham, NC 27710 USA.	ben.alman@duke.edu		Howard, Andrew/0000-0001-7226-6471	U.S. Army Medical Research Acquisition Activity [W81XWH-13-1-0113]	U.S. Army Medical Research Acquisition Activity	The authors thank the families involved in this study and the NF Society of Ontario (NFSO) for their kind contribution and participation. This study was funded by Grant W81XWH-13-1-0113 from the U.S. Army Medical Research Acquisition Activity. Author contributions: S. Ghadakzadeh and B. A. Alman designed the study; S. Ghadakzadeh and H. Whetstone performed the research; and S. Ghadakzadeh, P. Kannu, A. Howard, and B. A. Alman analyzed the data and wrote the paper. The authors declare no conflicts of interest.	Anton R, 2007, FEBS LETT, V581, P5247, DOI 10.1016/j.febslet.2007.10.012; Birke O, 2010, J CHILD ORTHOP, V4, P507, DOI 10.1007/s11832-010-0293-3; Brault V, 2001, DEVELOPMENT, V128, P1253; Chen GQ, 2012, INT J BIOL SCI, V8, P272, DOI 10.7150/ijbs.2929; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Chen Y, 2009, J CELL BIOCHEM, V106, P353, DOI 10.1002/jcb.22020; Cheon SS, 2006, FASEB J, V20, P692, DOI 10.1096/fj.05-4759com; Cho TJ, 2008, J BONE JOINT SURG AM, V90A, P2735, DOI 10.2106/JBJS.H.00014; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Dulai S, 2007, J PEDIATR ORTHOPED, V27, P472, DOI 10.1097/01.bpb.0000271310.87997.ae; El Khassawna T, 2012, BONE, V51, P651, DOI 10.1016/j.bone.2012.07.011; El-Hoss J, 2014, J BONE JOINT SURG AM, V96A, DOI 10.2106/JBJS.M.00862; El-Hoss J, 2012, J BONE MINER RES, V27, P68, DOI 10.1002/jbmr.528; Elefteriou F, 2009, AM J MED GENET A, V149A, P2327, DOI 10.1002/ajmg.a.33045; Etheridge SL, 2004, STEM CELLS, V22, P849, DOI 10.1634/stemcells.22-5-849; Fang DX, 2007, J BIOL CHEM, V282, P11221, DOI 10.1074/jbc.M611871200; Hadjiargyrou M, 2002, J BIOL CHEM, V277, P30177, DOI 10.1074/jbc.M203171200; Harada N, 1999, EMBO J, V18, P5931, DOI 10.1093/emboj/18.21.5931; Heerva E, 2012, BONE, V50, P798, DOI 10.1016/j.bone.2011.12.011; Heerva E, 2010, BONE, V47, P583, DOI 10.1016/j.bone.2010.06.001; Ippolito E, 2000, J PEDIATR ORTHOP B, V9, P3, DOI 10.1097/01202412-200001000-00002; Jang HD, 2011, J BIOL CHEM, V286, P39043, DOI 10.1074/jbc.M111.256768; Johnston CE, 2002, J BONE JOINT SURG AM, V84A, P1799, DOI 10.2106/00004623-200210000-00010; Kuhnert F, 2004, P NATL ACAD SCI USA, V101, P266, DOI 10.1073/pnas.2536800100; Kuorilehto T, 2004, J BONE MINER RES, V19, P983, DOI 10.1359/JBMR.040130; Kuorilehto T, 2005, OSTEOPOROSIS INT, V16, P928, DOI 10.1007/s00198-004-1801-4; Lammert M, 2005, ARCH DERMATOL, V141, P71, DOI 10.1001/archderm.141.1.71; Le LQ, 2007, ONCOGENE, V26, P4609, DOI 10.1038/sj.onc.1210261; Lee DY, 2011, CLIN ORTHOP SURG, V3, P230, DOI 10.4055/cios.2011.3.3.230; Lee SM, 2012, J ORTHOP RES, V30, P1535, DOI 10.1002/jor.22121; Lemieux E, 2015, ONCOGENE, V34, P4914, DOI 10.1038/onc.2014.416; Leskela HV, 2009, BONE, V44, P243, DOI 10.1016/j.bone.2008.10.050; Li HM, 2009, PEDIATR RES, V65, P613, DOI 10.1203/PDR.0b013e3181a1c607; Liu RJ, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-288; McCarthy TL, 2010, MOL ENDOCRINOL, V24, P587, DOI 10.1210/me.2009-0379; PARFITT AM, 1988, BONE MINER, V4, P1; Paria N, 2014, J BONE MINER RES, V29, P2636, DOI 10.1002/jbmr.2298; Rhodes SD, 2013, J BONE MINER RES, V28, P2476, DOI 10.1002/jbmr.1992; Rosa Adalberto Luiz, 2005, Braz. Dent. J., V16, P225, DOI 10.1590/S0103-64402005000300010; Sato N, 2004, NAT MED, V10, P55, DOI 10.1038/nm979; Schindeler A, 2011, J BONE JOINT SURG BR, V93B, P1134, DOI 10.1302/0301-620X.93B8.25940; Schindeler A, 2008, BONE, V42, P616, DOI 10.1016/j.bone.2007.11.006; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sharma M, 2002, J BIOL CHEM, V277, P30935, DOI 10.1074/jbc.M201919200; Sharma R, 2013, HUM MOL GENET, V22, P4818, DOI 10.1093/hmg/ddt333; Sokol SY, 2011, DEVELOPMENT, V138, P4341, DOI 10.1242/dev.066209; Srivastava AK, 1998, MOL CELL BIOCHEM, V182, P135, DOI 10.1023/A:1006857527588; Stevenson DA, 2011, CLIN GENET, V80, P566, DOI 10.1111/j.1399-0004.2010.01619.x; Theos A, 2006, ANN INTERN MED, V144, P842, DOI 10.7326/0003-4819-144-11-200606060-00010; van den Bosch MH, 2014, CELL SIGNAL, V26, P951, DOI 10.1016/j.cellsig.2014.01.021; Wang WX, 2010, J BONE MINER RES, V25, P1658, DOI 10.1002/jbmr.42; Wei W, 2011, MOL CELL BIOL, V31, P4706, DOI 10.1128/MCB.05980-11; Weivoda MM, 2016, J BONE MINER RES, V31, P65, DOI 10.1002/jbmr.2599; Wu MR, 2016, BONE RES, V4, DOI 10.1038/boneres.2016.9; Wu XH, 2006, HUM MOL GENET, V15, P2837, DOI 10.1093/hmg/ddl208; Wu XM, 2008, CELL, V133, P340, DOI 10.1016/j.cell.2008.01.052; Yan JC, 2008, HUM MOL GENET, V17, P936, DOI 10.1093/hmg/ddm366; Yang FC, 2006, J CLIN INVEST, V116, P2880, DOI 10.1172/JCI29092; Zhu Y, 2001, GENE DEV, V15, P859, DOI 10.1101/gad.862101	59	11	12	0	3	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	SEP	2016	30	9					3227	3237		10.1096/fj.201500190RR	http://dx.doi.org/10.1096/fj.201500190RR			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DV3JD	27306335				2022-12-28	WOS:000382816300022
J	Lee, EJ; Jan, AT; Baig, MH; Ashraf, JM; Nahm, SS; Kim, YW; Park, SY; Choi, I				Lee, Eun Ju; Jan, Arif Tasleem; Baig, Mohammad Hassan; Ashraf, Jalaluddin Mohammad; Nahm, Sang-Soep; Kim, Yong-Woon; Park, So-Young; Choi, Inho			Fibromodulin: a master regulator of myostatin controlling progression of satellite cells through a myogenic program	FASEB JOURNAL			English	Article						extracellular matrix; myostatin; myogenesis; ACRVIIB	GENE-EXPRESSION PROFILES; SKELETAL-MUSCLE ATROPHY; SELF-RENEWAL; STEM-CELL; TRANSCRIPTION FACTORS; DIFFERENTIATION; PROTEIN; TRANSDIFFERENTIATION; IDENTIFICATION; REGENERATION	Differentiation of muscle satellite cells (MSCs) involves interaction of the proteins present in the extracellular matrix (ECM) with MSCs to regulate their activity, and therefore phenotype. Herein, we report fibromodulin(FMOD), a member of the proteoglycan family participating in the assembly of ECM, as a novel regulator of myostatin (MSTN) during myoblast differentiation. In addition to having a pronounced effect on the expression of myogenic marker genes [myogenin (MYOG) and myosin light chain 2 (MYL2)], FMOD was found to maintain the transcriptional activity of MSTN. Moreover, coimmunoprecipitation and in silico studies performed to investigate the interaction of FMOD helped confirm that it antagonizes MSTN function by distorting its folding and preventing its binding to activin receptor type IIB. Furthermore, in vivo studies revealed that FMOD plays an active role in healing by increasing satellite cell recruitment to sites of injury. Together, these findings disclose a hitherto unrecognized regulatory role for FMOD in MSCs and highlight new mechanisms whereby FMOD circumvents the inhibitory effects of MSTN and triggers myoblast differentiation. These findings offer a basis for the design of novel MSTN inhibitors that promote muscle regeneration after injury or for the development of pharmaceutical agents for the treatment of different muscle atrophies.	[Lee, Eun Ju; Jan, Arif Tasleem; Baig, Mohammad Hassan; Ashraf, Jalaluddin Mohammad; Choi, Inho] Yeungnam Univ, Sch Biotechnol, Gyongsan 712749, South Korea; [Kim, Yong-Woon; Park, So-Young] Yeungnam Univ, Dept Physiol, Coll Med, Gyongsan, South Korea; [Nahm, Sang-Soep] Konkuk Univ, Coll Vet Med, Seoul, South Korea	Yeungnam University; Yeungnam University; Konkuk University	Choi, I (corresponding author), Yeungnam Univ, Sch Biotechnol, Gyongsan 712749, South Korea.	inhochoi@ynu.ac.kr	Ashraf, Jalauddin M/P-5391-2014; Jan, Arif Tasleem/AAX-6531-2020; Park, So-Young/AAC-5528-2022	Ashraf, Jalauddin M/0000-0001-7885-2551; Jan, Arif Tasleem/0000-0002-3607-543X; Park, So-Young/0000-0002-6018-0440; Baig, Mohd Hassan/0000-0001-8227-4838	National Research Foundation (NRF) of Korea - Ministry of Education [NRF-2013R1A1A2059308]; NRF - Republic of Korea (MSIP) [2014R1A2A2A01006324]	National Research Foundation (NRF) of Korea - Ministry of Education; NRF - Republic of Korea (MSIP)	This work was supported by the Basic Science Research Program, National Research Foundation (NRF) of Korea, which is funded by Ministry of Education Grant NRF-2013R1A1A2059308, along with the NRF funded by the Republic of Korea (MSIP; 2014R1A2A2A01006324). The authors declare no conflicts of interest.	Allen DL, 2008, COMP BIOCHEM PHYS B, V150, P432, DOI 10.1016/j.cbpb.2008.05.002; Allen DL, 2007, AM J PHYSIOL-CELL PH, V292, pC188, DOI 10.1152/ajpcell.00542.2005; Valdes JA, 2008, AM J PHYSIOL-CELL PH, V294, pC715, DOI 10.1152/ajpcell.00195.2007; Artaza JN, 2002, J CELL PHYSIOL, V190, P170, DOI 10.1002/JCP.10044; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Chang NC, 2014, CURR TOP DEV BIOL, V107, P161, DOI 10.1016/B978-0-12-416022-4.00006-8; Cohen S, 2015, NAT REV DRUG DISCOV, V14, P58, DOI 10.1038/nrd4467; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; Dominique JE, 2006, EXP CELL RES, V312, P2401, DOI 10.1016/j.yexcr.2006.04.012; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Grobet L, 2003, GENESIS, V35, P227, DOI 10.1002/gene.10188; Hawke TJ, 2001, J APPL PHYSIOL, V91, P534, DOI 10.1152/jappl.2001.91.2.534; HILDEBRAND A, 1994, BIOCHEM J, V302, P527, DOI 10.1042/bj3020527; Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; Kim DS, 2015, BIOCHEM BIOPH RES CO, V459, P534, DOI 10.1016/j.bbrc.2015.02.144; Kook SH, 2006, MOL CELLS, V22, P239; Lee EJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092447; Lee EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079780; Lee EJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063627; Lee EJ, 2012, GENOMICS, V100, P195, DOI 10.1016/j.ygeno.2012.06.005; Lee EJ, 2012, GENES GENOM, V34, P133, DOI 10.1007/s13258-011-0096-z; Lee SJ, 2001, P NATL ACAD SCI USA, V98, P9306, DOI 10.1073/pnas.151270098; McCroskery S, 2003, J CELL BIOL, V162, P1135, DOI 10.1083/jcb.200207056; McFarlane C, 2008, EXP CELL RES, V314, P317, DOI 10.1016/j.yexcr.2007.09.012; Mikaelsson E, 2005, BLOOD, V105, P4828, DOI 10.1182/blood-2004-10-3941; Moustakas A, 2005, J CELL SCI, V118, P3573, DOI 10.1242/jcs.02554; OLDBERG A, 1989, EMBO J, V8, P2601, DOI 10.1002/j.1460-2075.1989.tb08399.x; Onnerfjord P, 2004, J BIOL CHEM, V279, P26, DOI 10.1074/jbc.M308689200; Picard B, 1998, BASIC APPL MYOL, V8, P197; Relaix F, 2012, DEVELOPMENT, V139, P2845, DOI 10.1242/dev.069088; Rodriguez J, 2014, CELL MOL LIFE SCI, V71, P4361, DOI 10.1007/s00018-014-1689-x; Sandri M, 2008, PHYSIOLOGY, V23, P160, DOI 10.1152/physiol.00041.2007; Schneidman-Duhovny D, 2005, NUCLEIC ACIDS RES, V33, pW363, DOI 10.1093/nar/gki481; Spiller MP, 2002, MOL CELL BIOL, V22, P7066, DOI 10.1128/MCB.22.20.7066-7082.2002; Svensson L, 1999, J BIOL CHEM, V274, P9636, DOI 10.1074/jbc.274.14.9636; Taylor WE, 2001, AM J PHYSIOL-ENDOC M, V280, pE221, DOI 10.1152/ajpendo.2001.280.2.E221; Valdes JA, 2013, J CELL PHYSIOL, V228, P1452, DOI 10.1002/jcp.24298; Velica P, 2011, MUSCLE NERVE, V44, P366, DOI 10.1002/mus.22056; Wagner KR, 2005, P NATL ACAD SCI USA, V102, P2519, DOI 10.1073/pnas.0408729102; Wang Q, 2012, J PHYSIOL-LONDON, V590, P2151, DOI 10.1113/jphysiol.2011.226001; Yin H, 2013, PHYSIOL REV, V93, P23, DOI 10.1152/physrev.00043.2011; Zammit PS, 2001, DIFFERENTIATION, V68, P193, DOI 10.1046/j.1432-0436.2001.680407.x; Zhu XY, 2004, CYTOKINE, V26, P262, DOI 10.1016/j.cyto.2004.03.007	44	48	50	5	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	AUG	2016	30	8					2708	2719		10.1096/fj.201500133R	http://dx.doi.org/10.1096/fj.201500133R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DS7WP	27069062				2022-12-28	WOS:000380994000008
